id|nct_id|result_group_id|ctgov_group_code|period|reason|count|drop_withdraw_comment|reason_comment|count_units
13221283|NCT01816243|26282551|FG000|Overall Study|Adverse Event|6|||
13392208|NCT00673231|26779338|FG000|Overall Study|Withdrawal by Subject|14|||
13392209|NCT00673231|26779339|FG001|Overall Study|Withdrawal by Subject|10|||
13392210|NCT00673231|26779340|FG002|Overall Study|Withdrawal by Subject|8|||
13392211|NCT00673231|26779341|FG003|Overall Study|Withdrawal by Subject|6|||
13392212|NCT00673231|26779338|FG000|Overall Study|Adverse Event|6|||
13392213|NCT00673231|26779339|FG001|Overall Study|Adverse Event|5|||
13392214|NCT00673231|26779340|FG002|Overall Study|Adverse Event|9|||
13392215|NCT00673231|26779341|FG003|Overall Study|Adverse Event|6|||
13392216|NCT00673231|26779338|FG000|Overall Study|Lost to Follow-up|1|||
13392217|NCT00673231|26779339|FG001|Overall Study|Lost to Follow-up|2|||
13392218|NCT00673231|26779340|FG002|Overall Study|Lost to Follow-up|1|||
13392219|NCT00673231|26779341|FG003|Overall Study|Lost to Follow-up|2|||
13392220|NCT00673231|26779338|FG000|Overall Study|Death|0|||
13392221|NCT00673231|26779339|FG001|Overall Study|Death|0|||
13392222|NCT00673231|26779340|FG002|Overall Study|Death|1|||
13392223|NCT00673231|26779341|FG003|Overall Study|Death|0|||
13392224|NCT00673231|26779338|FG000|Overall Study|Study criteria,compliance,safety, other|8|||
13392225|NCT00673231|26779339|FG001|Overall Study|Study criteria,compliance,safety, other|5|||
13392226|NCT00673231|26779340|FG002|Overall Study|Study criteria,compliance,safety, other|7|||
13392227|NCT00673231|26779341|FG003|Overall Study|Study criteria,compliance,safety, other|4|||
13392228|NCT00673179|26779354|FG000|Overall Study|Toxicity/Complications|3|||
13392229|NCT00673179|26779355|FG001|Overall Study|Toxicity/Complications|0|||
13392230|NCT00673049|26779385|FG000|Before Progression on Erlotinib|Randomized but not treated|3|||
13392231|NCT00673049|26779386|FG001|Before Progression on Erlotinib|Randomized but not treated|1|||
13392232|NCT00673049|26779387|FG002|Before Progression on Erlotinib|Randomized but not treated|0|||
13392233|NCT00673049|26779388|FG003|Before Progression on Erlotinib|Randomized but not treated|0|||
13392234|NCT00673049|26779385|FG000|Before Progression on Erlotinib|Death|235|||
13392235|NCT00673049|26779386|FG001|Before Progression on Erlotinib|Death|167|||
13392236|NCT00673049|26779387|FG002|Before Progression on Erlotinib|Death|1|||
13392237|NCT00673049|26779388|FG003|Before Progression on Erlotinib|Death|0|||
13392238|NCT00673049|26779385|FG000|Before Progression on Erlotinib|Lost to Follow-up|9|||
13392239|NCT00673049|26779386|FG001|Before Progression on Erlotinib|Lost to Follow-up|5|||
13392240|NCT00673049|26779387|FG002|Before Progression on Erlotinib|Lost to Follow-up|0|||
13477483|NCT01595009|27006994|FG000|Core|Patients completed per protocol|85|||
13477484|NCT01595009|27006995|FG001|Core|Patients completed per protocol|44|||
13477485|NCT01595009|27006996|FG002|Core|Patients completed per protocol|0|||
13477486|NCT01595009|27006997|FG003|Core|Patients completed per protocol|0|||
13392241|NCT00673049|26779388|FG003|Before Progression on Erlotinib|Lost to Follow-up|0|||
13392242|NCT00673049|26779385|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26|||
13392243|NCT00673049|26779386|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18|||
13392244|NCT00673049|26779387|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0|||
13392245|NCT00673049|26779388|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0|||
13392246|NCT00673049|26779385|FG000|Before Progression on Erlotinib|Other|1|||
13392247|NCT00673049|26779386|FG001|Before Progression on Erlotinib|Other|2|||
13392248|NCT00673049|26779387|FG002|Before Progression on Erlotinib|Other|0|||
13392249|NCT00673049|26779388|FG003|Before Progression on Erlotinib|Other|0|||
13477487|NCT01595009|27006994|FG000|Core|Adverse Event|19|||
13477488|NCT01595009|27006995|FG001|Core|Adverse Event|23|||
13477489|NCT01595009|27006996|FG002|Core|Adverse Event|0|||
13477490|NCT01595009|27006997|FG003|Core|Adverse Event|0|||
13477491|NCT01595009|27006994|FG000|Core|Disease progression|14|||
13477492|NCT01595009|27006995|FG001|Core|Disease progression|26|||
13135665|NCT02737930|25995939|FG000|Overall Study|Withdrawal by Subject|0|||
13135666|NCT02737930|25995940|FG001|Overall Study|Withdrawal by Subject|1|||
13135667|NCT02737852|25995947|FG000|Overall Study|Withdrawal by Subject|2|||
13135668|NCT02737722|25996006|FG000|Overall Study|Physician Decision|0|||
13135669|NCT02737722|25996007|FG001|Overall Study|Physician Decision|0|||
13135670|NCT02737722|25996008|FG002|Overall Study|Physician Decision|1|||
13135671|NCT02737722|25996009|FG003|Overall Study|Physician Decision|0|||
13135672|NCT02737618|25996016|FG000|Overall Study|Withdrawal by Subject|9|||
13135673|NCT02737592|25996023|FG000|Overall Study|Withdrawal by Subject|1|||
13135674|NCT02737501|25996065|FG000|Randomized Phase|Died|41|||
13135675|NCT02737501|25996066|FG001|Randomized Phase|Died|29|||
13221284|NCT01816243|26282551|FG000|Overall Study|Lost to Follow-up|1|||
13221285|NCT01816243|26282551|FG000|Overall Study|Lack of Efficacy|1|||
13221286|NCT01816243|26282551|FG000|Overall Study|Not eligible for the study|1|||
13221287|NCT01816243|26282551|FG000|Overall Study|Amputation|3|||
13135676|NCT02737501|25996067|FG002|Randomized Phase|Died|0|||
13221288|NCT01816074|26282592|FG000|Phase 1|Time commitment issues|0|||
13221289|NCT01816074|26282593|FG001|Phase 1|Time commitment issues|0|||
13221290|NCT01816074|26282594|FG002|Phase 1|Time commitment issues|1|||
13221291|NCT01816074|26282595|FG003|Phase 1|Time commitment issues|0|||
13221292|NCT01816074|26282592|FG000|Phase 2|Time commitment Issues|0|||
13392250|NCT00673049|26779385|FG000|Before Progression on Erlotinib|study terminated by sponsor|18|||
13477493|NCT01595009|27006996|FG002|Core|Disease progression|0|||
13221293|NCT01816074|26282593|FG001|Phase 2|Time commitment Issues|2|||
13221294|NCT01816074|26282594|FG002|Phase 2|Time commitment Issues|0|||
13221295|NCT01816074|26282595|FG003|Phase 2|Time commitment Issues|0|||
13221296|NCT01816074|26282592|FG000|Phase 2|Unsatisfied with Randomization assignmen|1|||
13221297|NCT01816074|26282593|FG001|Phase 2|Unsatisfied with Randomization assignmen|0|||
13221298|NCT01816074|26282594|FG002|Phase 2|Unsatisfied with Randomization assignmen|0|||
13221299|NCT01816074|26282595|FG003|Phase 2|Unsatisfied with Randomization assignmen|0|||
13221300|NCT01816074|26282592|FG000|Phase 2|Physician Decision|0|||
13221301|NCT01816074|26282593|FG001|Phase 2|Physician Decision|0|||
13221302|NCT01816074|26282594|FG002|Phase 2|Physician Decision|0|||
13221303|NCT01816074|26282595|FG003|Phase 2|Physician Decision|1|||
13221304|NCT01816074|26282592|FG000|Phase 2|Withdrawal by Subject|1|||
13221305|NCT01816074|26282593|FG001|Phase 2|Withdrawal by Subject|0|||
13221306|NCT01816074|26282594|FG002|Phase 2|Withdrawal by Subject|0|||
13221307|NCT01816074|26282595|FG003|Phase 2|Withdrawal by Subject|0|||
13221308|NCT01816061|26282610|FG000|Overall Study|Lost to Follow-up|13|||
13221309|NCT01816061|26282611|FG001|Overall Study|Lost to Follow-up|24|||
13221310|NCT01816048|26282626|FG000|Overall Study|Adverse Event|1|||
13221311|NCT01816048|26282626|FG000|Overall Study|Death|1|||
13221312|NCT01816048|26282626|FG000|Overall Study|Withdrawal by Subject|1|||
13221313|NCT01816048|26282626|FG000|Overall Study|Disease Progression|3|||
13221314|NCT01815918|26282647|FG000|Overall Study|Patient samples not analyzable|3|||
13221315|NCT01815918|26282648|FG001|Overall Study|Patient samples not analyzable|4|||
13221316|NCT01815918|26282647|FG000|Overall Study|Lack of Efficacy|15|||
13221317|NCT01815918|26282648|FG001|Overall Study|Lack of Efficacy|15|||
13221318|NCT01815840|26282683|FG000|Overall Study|Missing|1|||
13221319|NCT01815840|26282684|FG001|Overall Study|Missing|0|||
13221320|NCT01815840|26282683|FG000|Overall Study|Withdrew Consent|31|||
13221321|NCT01815840|26282684|FG001|Overall Study|Withdrew Consent|30|||
13221322|NCT01815840|26282683|FG000|Overall Study|Administrative/Other|1|||
13221323|NCT01815840|26282684|FG001|Overall Study|Administrative/Other|3|||
13221324|NCT01815840|26282683|FG000|Overall Study|Adverse Event|10|||
13221325|NCT01815840|26282684|FG001|Overall Study|Adverse Event|16|||
13221326|NCT01815840|26282683|FG000|Overall Study|Death|2|||
13221327|NCT01815840|26282684|FG001|Overall Study|Death|2|||
13221328|NCT01815840|26282683|FG000|Overall Study|Disease progression|3|||
13221329|NCT01815840|26282684|FG001|Overall Study|Disease progression|2|||
13221330|NCT01815840|26282683|FG000|Overall Study|Investigators Decision|2|||
13221331|NCT01815840|26282684|FG001|Overall Study|Investigators Decision|3|||
13221332|NCT01815840|26282683|FG000|Overall Study|Lost to Follow-up|3|||
13221333|NCT01815840|26282684|FG001|Overall Study|Lost to Follow-up|6|||
13221334|NCT01815840|26282683|FG000|Overall Study|Refused Treatment|5|||
13221335|NCT01815840|26282684|FG001|Overall Study|Refused Treatment|1|||
13221336|NCT01815840|26282683|FG000|Overall Study|Sponsor Termination Treatment|1|||
13221337|NCT01815840|26282684|FG001|Overall Study|Sponsor Termination Treatment|0|||
13221338|NCT01815736|26282717|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11|||
13221339|NCT01815736|26282718|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17|||
13221340|NCT01815736|26282717|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10|||
13221341|NCT01815736|26282718|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9|||
13221342|NCT01815736|26282717|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11|||
13221343|NCT01815736|26282718|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2|||
13221344|NCT01815736|26282717|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7|||
13221345|NCT01815736|26282718|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4|||
13221346|NCT01815736|26282717|FG000|Randomized Treatment Phase-Up to Week 96|Death|4|||
13221347|NCT01815736|26282718|FG001|Randomized Treatment Phase-Up to Week 96|Death|0|||
13221348|NCT01815736|26282717|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1|||
13221349|NCT01815736|26282718|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0|||
13221350|NCT01815736|26282717|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1|||
13221351|NCT01815736|26282718|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0|||
13221352|NCT01815736|26282717|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4|||
13221353|NCT01815736|26282718|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3|||
13221354|NCT01815736|26282717|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31|||
13221355|NCT01815736|26282718|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15|||
13221356|NCT01815736|26282717|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13|||
13221357|NCT01815736|26282718|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9|||
13221358|NCT01815736|26282717|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5|||
13221359|NCT01815736|26282718|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1|||
13221360|NCT01815736|26282717|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1|||
13221361|NCT01815736|26282718|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1|||
13221362|NCT01815736|26282717|FG000|Extension Treatment Phase- After Week 96|Death|1|||
13221363|NCT01815736|26282718|FG001|Extension Treatment Phase- After Week 96|Death|0|||
13221364|NCT01815580|26282748|FG000|Overall Study|Lost to Follow-up|4|||
13221365|NCT01815580|26282749|FG001|Overall Study|Lost to Follow-up|7|||
13221366|NCT01815580|26282748|FG000|Overall Study|Withdrawal by Subject|3|||
13221367|NCT01815580|26282749|FG001|Overall Study|Withdrawal by Subject|4|||
13221368|NCT01815580|26282748|FG000|Overall Study|Excluded from analysis|5|||
13221369|NCT01815580|26282749|FG001|Overall Study|Excluded from analysis|4|||
13221370|NCT01815424|26282957|FG000|Week 0 to 16|Adverse Event|1|||
13221371|NCT01815424|26282958|FG001|Week 0 to 16|Adverse Event|3|||
13221372|NCT01815424|26282959|FG002|Week 0 to 16|Adverse Event|3|||
13221373|NCT01815424|26282960|FG003|Week 0 to 16|Adverse Event|0|||
13221374|NCT01815424|26282961|FG004|Week 0 to 16|Adverse Event|0|||
13221375|NCT01815424|26282957|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2|||
13221376|NCT01815424|26282958|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
13221377|NCT01815424|26282959|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
13221378|NCT01815424|26282960|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
13221379|NCT01815424|26282961|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
13221380|NCT01815424|26282957|FG000|Week 0 to 16|Lost to Follow-up|0|||
13221381|NCT01815424|26282958|FG001|Week 0 to 16|Lost to Follow-up|1|||
13221382|NCT01815424|26282959|FG002|Week 0 to 16|Lost to Follow-up|0|||
13221383|NCT01815424|26282960|FG003|Week 0 to 16|Lost to Follow-up|0|||
13221384|NCT01815424|26282961|FG004|Week 0 to 16|Lost to Follow-up|0|||
13221385|NCT01815424|26282957|FG000|Week 0 to 16|Withdrawal by Subject|0|||
13221386|NCT01815424|26282958|FG001|Week 0 to 16|Withdrawal by Subject|0|||
13221387|NCT01815424|26282959|FG002|Week 0 to 16|Withdrawal by Subject|1|||
13221388|NCT01815424|26282960|FG003|Week 0 to 16|Withdrawal by Subject|0|||
13221389|NCT01815424|26282961|FG004|Week 0 to 16|Withdrawal by Subject|0|||
13221390|NCT01815424|26282957|FG000|Week 0 to 16|Other|1|||
13221391|NCT01815424|26282958|FG001|Week 0 to 16|Other|0|||
13221392|NCT01815424|26282959|FG002|Week 0 to 16|Other|3|||
13221393|NCT01815424|26282960|FG003|Week 0 to 16|Other|0|||
13221394|NCT01815424|26282961|FG004|Week 0 to 16|Other|0|||
13221395|NCT01815424|26282957|FG000|Week 0 to 16|Protocol Violation|1|||
13221396|NCT01815424|26282958|FG001|Week 0 to 16|Protocol Violation|0|||
13221397|NCT01815424|26282959|FG002|Week 0 to 16|Protocol Violation|0|||
13221398|NCT01815424|26282960|FG003|Week 0 to 16|Protocol Violation|0|||
13221399|NCT01815424|26282961|FG004|Week 0 to 16|Protocol Violation|0|||
13221400|NCT01815424|26282957|FG000|Week 0 to 16|Insufficient Clinical Response|2|||
13221401|NCT01815424|26282958|FG001|Week 0 to 16|Insufficient Clinical Response|0|||
13221402|NCT01815424|26282959|FG002|Week 0 to 16|Insufficient Clinical Response|4|||
13221403|NCT01815424|26282960|FG003|Week 0 to 16|Insufficient Clinical Response|0|||
13221404|NCT01815424|26282961|FG004|Week 0 to 16|Insufficient Clinical Response|0|||
13221405|NCT01815424|26282957|FG000|Week 16 to 52|Other|0|||
13221406|NCT01815424|26282958|FG001|Week 16 to 52|Other|1|||
13221407|NCT01815424|26282959|FG002|Week 16 to 52|Other|0|||
13221408|NCT01815424|26282960|FG003|Week 16 to 52|Other|0|||
13221409|NCT01815424|26282961|FG004|Week 16 to 52|Other|0|||
13221410|NCT01815424|26282957|FG000|Week 16 to 52|Adverse Event|0|||
13221411|NCT01815424|26282958|FG001|Week 16 to 52|Adverse Event|0|||
13221412|NCT01815424|26282959|FG002|Week 16 to 52|Adverse Event|0|||
13221413|NCT01815424|26282960|FG003|Week 16 to 52|Adverse Event|0|||
13221414|NCT01815424|26282961|FG004|Week 16 to 52|Adverse Event|1|||
13221415|NCT01815424|26282957|FG000|Week 16 to 52|Insufficient Clinical Response|1|||
13221416|NCT01815424|26282958|FG001|Week 16 to 52|Insufficient Clinical Response|0|||
13221417|NCT01815424|26282959|FG002|Week 16 to 52|Insufficient Clinical Response|0|||
13221418|NCT01815424|26282960|FG003|Week 16 to 52|Insufficient Clinical Response|1|||
13221419|NCT01815424|26282961|FG004|Week 16 to 52|Insufficient Clinical Response|1|||
13221420|NCT01815424|26282957|FG000|Week 16 to 52|Lost to Follow-up|0|||
13221421|NCT01815424|26282958|FG001|Week 16 to 52|Lost to Follow-up|2|||
13221422|NCT01815424|26282959|FG002|Week 16 to 52|Lost to Follow-up|0|||
13221423|NCT01815424|26282960|FG003|Week 16 to 52|Lost to Follow-up|2|||
13221424|NCT01815424|26282961|FG004|Week 16 to 52|Lost to Follow-up|1|||
13221425|NCT01815424|26282957|FG000|Week 16 to 52|Withdrawal by Subject|1|||
13221426|NCT01815424|26282958|FG001|Week 16 to 52|Withdrawal by Subject|2|||
13221427|NCT01815424|26282959|FG002|Week 16 to 52|Withdrawal by Subject|0|||
13221428|NCT01815424|26282960|FG003|Week 16 to 52|Withdrawal by Subject|0|||
13221429|NCT01815424|26282961|FG004|Week 16 to 52|Withdrawal by Subject|0|||
13221430|NCT01815138|26282980|FG000|Overall Study|Withdrawal by Subject|0|||
13221431|NCT01815138|26282981|FG001|Overall Study|Withdrawal by Subject|1|||
13221432|NCT01815138|26282980|FG000|Overall Study|Physician Decision|8|||
13221433|NCT01815138|26282981|FG001|Overall Study|Physician Decision|5|||
13221434|NCT01815099|26282988|FG000|Overall Study|Lack of Efficacy|1|||
13221435|NCT01815099|26282988|FG000|Overall Study|unable to attend study visits|1|||
13221436|NCT01814878|26283015|FG000|Overall Study|Adverse Event|16|||
13221437|NCT01814878|26283016|FG001|Overall Study|Adverse Event|5|||
13221438|NCT01814878|26283015|FG000|Overall Study|Withdrawal by Subject|20|||
13221439|NCT01814878|26283016|FG001|Overall Study|Withdrawal by Subject|16|||
13221440|NCT01814878|26283015|FG000|Overall Study|Protocol Violation|5|||
13221441|NCT01814878|26283016|FG001|Overall Study|Protocol Violation|5|||
13221442|NCT01814878|26283015|FG000|Overall Study|Physician Decision|3|||
13221443|NCT01814878|26283016|FG001|Overall Study|Physician Decision|1|||
13221444|NCT01814878|26283015|FG000|Overall Study|Screening failure (drop-out)|0|||
13221445|NCT01814878|26283016|FG001|Overall Study|Screening failure (drop-out)|3|||
13221446|NCT01814878|26283015|FG000|Overall Study|Other|2|||
13221447|NCT01814878|26283016|FG001|Overall Study|Other|0|||
13221448|NCT01814800|26283055|FG000|Overall Study|Adverse Event|2|||
13221449|NCT01814800|26283055|FG000|Overall Study|Pregnancy|1|||
13221450|NCT01814800|26283055|FG000|Overall Study|Sponsor decision|1|||
13221451|NCT01814800|26283055|FG000|Overall Study|Subject relocation|1|||
13221452|NCT01814761|26283074|FG000|Overall Study|Other Reasons|1|||
13221453|NCT01814761|26283075|FG001|Overall Study|Other Reasons|10|||
13221454|NCT01814761|26283074|FG000|Overall Study|Ocular Adverse Event|6|||
13221455|NCT01814761|26283075|FG001|Overall Study|Ocular Adverse Event|15|||
13221456|NCT01814761|26283074|FG000|Overall Study|Lost to Follow-up|1|||
13221457|NCT01814761|26283075|FG001|Overall Study|Lost to Follow-up|5|||
13221458|NCT01814748|26283102|FG000|Overall Study|Lost to Follow-up|1|||
13221459|NCT01814748|26283103|FG001|Overall Study|Lost to Follow-up|2|||
13221460|NCT01814748|26283102|FG000|Overall Study|Study site terminated by sponsor|1|||
13221461|NCT01814748|26283103|FG001|Overall Study|Study site terminated by sponsor|1|||
13221462|NCT01814748|26283102|FG000|Overall Study|Withdrawal by Subject|6|||
13221463|NCT01814748|26283103|FG001|Overall Study|Withdrawal by Subject|4|||
13221464|NCT01814696|26283128|FG000|Overall Study|Withdrawal by Subject|1|||
13221465|NCT01814696|26283129|FG001|Overall Study|Withdrawal by Subject|0|||
13221466|NCT01814696|26283128|FG000|Overall Study|Randomized to wrong group|1|||
13221467|NCT01814696|26283129|FG001|Overall Study|Randomized to wrong group|0|||
13221468|NCT01814670|26283139|FG000|Overall Study|Protocol Violation|12|||
13221469|NCT01814553|26283160|FG000|Overall Study|PD per clinical progression|6|||
13221470|NCT01814553|26283161|FG001|Overall Study|PD per clinical progression|8|||
13221471|NCT01814553|26283160|FG000|Overall Study|Other Adverse Event|4|||
13221472|NCT01814553|26283161|FG001|Overall Study|Other Adverse Event|5|||
13221473|NCT01814553|26283160|FG000|Overall Study|Withdrawal by Subject|1|||
13221474|NCT01814553|26283161|FG001|Overall Study|Withdrawal by Subject|1|||
13221475|NCT01814553|26283160|FG000|Overall Study|Other than stated|7|||
13221476|NCT01814553|26283161|FG001|Overall Study|Other than stated|8|||
13221477|NCT01814397|26283170|FG000|Overall Study|Adverse Event|7|||
13221478|NCT01814397|26283170|FG000|Overall Study|Withdrawal by Subject|7|||
13221479|NCT01814371|26283210|FG000|Overall Study|Lost to Follow-up|30|||
13221480|NCT01814371|26283211|FG001|Overall Study|Lost to Follow-up|27|||
13221481|NCT01814332|26283230|FG000|Overall Study|Adverse Event|8|||
13221482|NCT01814332|26283231|FG001|Overall Study|Adverse Event|3|||
13221483|NCT01814332|26283230|FG000|Overall Study|Withdrawal by Subject|3|||
13221484|NCT01814332|26283231|FG001|Overall Study|Withdrawal by Subject|8|||
13221485|NCT01814332|26283230|FG000|Overall Study|Protocol Violation|0|||
13221486|NCT01814332|26283231|FG001|Overall Study|Protocol Violation|4|||
13392251|NCT00673049|26779386|FG001|Before Progression on Erlotinib|study terminated by sponsor|14|||
13392252|NCT00673049|26779387|FG002|Before Progression on Erlotinib|study terminated by sponsor|0|||
13392253|NCT00673049|26779388|FG003|Before Progression on Erlotinib|study terminated by sponsor|0|||
13392254|NCT00673049|26779385|FG000|Before Progression on Erlotinib|Switched to figitumumab|0|||
13392255|NCT00673049|26779386|FG001|Before Progression on Erlotinib|Switched to figitumumab|83|||
13392256|NCT00673049|26779387|FG002|Before Progression on Erlotinib|Switched to figitumumab|0|||
13392257|NCT00673049|26779388|FG003|Before Progression on Erlotinib|Switched to figitumumab|0|||
13392258|NCT00673049|26779385|FG000|After Progression on Erlotinib|Death|0|||
13392259|NCT00673049|26779386|FG001|After Progression on Erlotinib|Death|0|||
13392260|NCT00673049|26779387|FG002|After Progression on Erlotinib|Death|0|||
13392261|NCT00673049|26779388|FG003|After Progression on Erlotinib|Death|71|||
13392262|NCT00673049|26779385|FG000|After Progression on Erlotinib|Lost to Follow-up|0|||
13392263|NCT00673049|26779386|FG001|After Progression on Erlotinib|Lost to Follow-up|0|||
13221487|NCT01814332|26283230|FG000|Overall Study|Lost to Follow-up|5|||
13221488|NCT01814332|26283231|FG001|Overall Study|Lost to Follow-up|1|||
13221489|NCT01814137|26283252|FG000|Overall Study|Adverse Event|0|||
13221490|NCT01814137|26283253|FG001|Overall Study|Adverse Event|1|||
13221491|NCT01814137|26283252|FG000|Overall Study|Withdrawal by Subject|2|||
13221492|NCT01814137|26283253|FG001|Overall Study|Withdrawal by Subject|2|||
13221493|NCT01814137|26283252|FG000|Overall Study|Physician Decision|1|||
13221494|NCT01814137|26283253|FG001|Overall Study|Physician Decision|1|||
13221495|NCT01814137|26283252|FG000|Overall Study|Unclassified|2|||
13221496|NCT01814137|26283253|FG001|Overall Study|Unclassified|1|||
13221497|NCT01814072|26283390|FG000|Overall Study|Lost to Follow-up|2|||
13221498|NCT01814072|26283391|FG001|Overall Study|Lost to Follow-up|2|||
13221499|NCT01814072|26283392|FG002|Overall Study|Lost to Follow-up|2|||
13221500|NCT01814072|26283393|FG003|Overall Study|Lost to Follow-up|0|||
13221501|NCT01814072|26283394|FG004|Overall Study|Lost to Follow-up|2|||
13221502|NCT01814072|26283395|FG005|Overall Study|Lost to Follow-up|3|||
13221503|NCT01814072|26283396|FG006|Overall Study|Lost to Follow-up|3|||
13221504|NCT01814072|26283397|FG007|Overall Study|Lost to Follow-up|1|||
13221505|NCT01814072|26283398|FG008|Overall Study|Lost to Follow-up|2|||
13221506|NCT01814072|26283399|FG009|Overall Study|Lost to Follow-up|3|||
13221507|NCT01814072|26283400|FG010|Overall Study|Lost to Follow-up|1|||
13221508|NCT01814072|26283401|FG011|Overall Study|Lost to Follow-up|2|||
13221509|NCT01814072|26283402|FG012|Overall Study|Lost to Follow-up|2|||
13221510|NCT01814072|26283403|FG013|Overall Study|Lost to Follow-up|1|||
13221511|NCT01814072|26283404|FG014|Overall Study|Lost to Follow-up|2|||
13221512|NCT01814072|26283405|FG015|Overall Study|Lost to Follow-up|1|||
13221513|NCT01814072|26283406|FG016|Overall Study|Lost to Follow-up|3|||
13221514|NCT01814072|26283407|FG017|Overall Study|Lost to Follow-up|1|||
13221515|NCT01814072|26283408|FG018|Overall Study|Lost to Follow-up|3|||
13221516|NCT01814072|26283409|FG019|Overall Study|Lost to Follow-up|3|||
13221517|NCT01814072|26283410|FG020|Overall Study|Lost to Follow-up|2|||
13221518|NCT01814072|26283411|FG021|Overall Study|Lost to Follow-up|1|||
13221519|NCT01814072|26283412|FG022|Overall Study|Lost to Follow-up|3|||
13221520|NCT01814072|26283413|FG023|Overall Study|Lost to Follow-up|1|||
13221521|NCT01814072|26283414|FG024|Overall Study|Lost to Follow-up|4|||
13221522|NCT01814072|26283415|FG025|Overall Study|Lost to Follow-up|1|||
13221523|NCT01814072|26283416|FG026|Overall Study|Lost to Follow-up|1|||
13221524|NCT01814072|26283417|FG027|Overall Study|Lost to Follow-up|2|||
13221525|NCT01814072|26283418|FG028|Overall Study|Lost to Follow-up|3|||
13221526|NCT01814072|26283419|FG029|Overall Study|Lost to Follow-up|3|||
13221527|NCT01814072|26283420|FG030|Overall Study|Lost to Follow-up|2|||
13221528|NCT01814072|26283421|FG031|Overall Study|Lost to Follow-up|0|||
13221529|NCT01814072|26283390|FG000|Overall Study|Withdrawal by Subject|2|||
13221530|NCT01814072|26283391|FG001|Overall Study|Withdrawal by Subject|0|||
13221531|NCT01814072|26283392|FG002|Overall Study|Withdrawal by Subject|1|||
13221532|NCT01814072|26283393|FG003|Overall Study|Withdrawal by Subject|0|||
13221533|NCT01814072|26283394|FG004|Overall Study|Withdrawal by Subject|2|||
13221534|NCT01814072|26283395|FG005|Overall Study|Withdrawal by Subject|3|||
13221535|NCT01814072|26283396|FG006|Overall Study|Withdrawal by Subject|1|||
13221536|NCT01814072|26283397|FG007|Overall Study|Withdrawal by Subject|0|||
13221537|NCT01814072|26283398|FG008|Overall Study|Withdrawal by Subject|1|||
13221538|NCT01814072|26283399|FG009|Overall Study|Withdrawal by Subject|2|||
13221539|NCT01814072|26283400|FG010|Overall Study|Withdrawal by Subject|0|||
13221540|NCT01814072|26283401|FG011|Overall Study|Withdrawal by Subject|0|||
13221541|NCT01814072|26283402|FG012|Overall Study|Withdrawal by Subject|1|||
13221542|NCT01814072|26283403|FG013|Overall Study|Withdrawal by Subject|1|||
13221543|NCT01814072|26283404|FG014|Overall Study|Withdrawal by Subject|1|||
13221544|NCT01814072|26283405|FG015|Overall Study|Withdrawal by Subject|1|||
13221545|NCT01814072|26283406|FG016|Overall Study|Withdrawal by Subject|0|||
13221546|NCT01814072|26283407|FG017|Overall Study|Withdrawal by Subject|0|||
13221547|NCT01814072|26283408|FG018|Overall Study|Withdrawal by Subject|0|||
13221548|NCT01814072|26283409|FG019|Overall Study|Withdrawal by Subject|2|||
13221549|NCT01814072|26283410|FG020|Overall Study|Withdrawal by Subject|0|||
13221550|NCT01814072|26283411|FG021|Overall Study|Withdrawal by Subject|0|||
13221551|NCT01814072|26283412|FG022|Overall Study|Withdrawal by Subject|1|||
13221552|NCT01814072|26283413|FG023|Overall Study|Withdrawal by Subject|0|||
13221553|NCT01814072|26283414|FG024|Overall Study|Withdrawal by Subject|2|||
13221554|NCT01814072|26283415|FG025|Overall Study|Withdrawal by Subject|1|||
13221555|NCT01814072|26283416|FG026|Overall Study|Withdrawal by Subject|1|||
13221556|NCT01814072|26283417|FG027|Overall Study|Withdrawal by Subject|2|||
13221557|NCT01814072|26283418|FG028|Overall Study|Withdrawal by Subject|1|||
13221558|NCT01814072|26283419|FG029|Overall Study|Withdrawal by Subject|0|||
13221559|NCT01814072|26283420|FG030|Overall Study|Withdrawal by Subject|0|||
13221560|NCT01814072|26283421|FG031|Overall Study|Withdrawal by Subject|0|||
13221561|NCT01814046|26283440|FG000|Drug Administration|Death due to complications of RSV|1|||
13221562|NCT01814046|26283441|FG001|Drug Administration|Death due to complications of RSV|0|||
13221563|NCT01814046|26283442|FG002|Drug Administration|Death due to complications of RSV|0|||
13221564|NCT01814007|26283454|FG000|Overall Study|Withdrawal by Subject|1|||
13221565|NCT01813890|26283493|FG000|Overall Study|Adverse Event|0|||
13221566|NCT01813890|26283494|FG001|Overall Study|Adverse Event|3|||
13221567|NCT01813890|26283495|FG002|Overall Study|Adverse Event|4|||
13221568|NCT01813890|26283493|FG000|Overall Study|Lack of Efficacy|9|||
13221569|NCT01813890|26283494|FG001|Overall Study|Lack of Efficacy|1|||
13221570|NCT01813890|26283495|FG002|Overall Study|Lack of Efficacy|2|||
13221571|NCT01813721|26283549|FG000|Overall Study|Ineligibility determined|63|||
13221572|NCT01813721|26283549|FG000|Overall Study|Withdrawal by Subject|1|||
13221573|NCT01813474|26283581|FG000|Overall Study|Withdrawal by Subject|0|||
13221574|NCT01813474|26283582|FG001|Overall Study|Withdrawal by Subject|0|||
13221575|NCT01813474|26283583|FG002|Overall Study|Withdrawal by Subject|1|||
13221576|NCT01813474|26283581|FG000|Overall Study|Adverse Event|1|||
13221577|NCT01813474|26283582|FG001|Overall Study|Adverse Event|1|||
13221578|NCT01813474|26283583|FG002|Overall Study|Adverse Event|0|||
13221579|NCT01813474|26283581|FG000|Overall Study|Lack of Efficacy|2|||
13221580|NCT01813474|26283582|FG001|Overall Study|Lack of Efficacy|6|||
13221581|NCT01813474|26283583|FG002|Overall Study|Lack of Efficacy|9|||
13221582|NCT01813474|26283581|FG000|Overall Study|Death|0|||
13221583|NCT01813474|26283582|FG001|Overall Study|Death|0|||
13221584|NCT01813474|26283583|FG002|Overall Study|Death|1|||
13221585|NCT01813435|26283612|FG000|Overall Study|did not finish experimental regimen|1902|||
13221586|NCT01813435|26283613|FG001|Overall Study|did not finish experimental regimen|770|||
13221587|NCT01813435|26283612|FG000|Overall Study|Lost to Follow-up|268|||
13221588|NCT01813435|26283613|FG001|Overall Study|Lost to Follow-up|237|||
13289354|NCT01648023|26478270|FG000|Overall Study|Screen Fail Post Randomization|1|||
13289355|NCT01648023|26478271|FG001|Overall Study|Screen Fail Post Randomization|2|||
13289356|NCT02756208|26478314|FG000|Overall Study|Withdrawal by Subject|1|||
13289357|NCT02756208|26478315|FG001|Overall Study|Withdrawal by Subject|0|||
13289358|NCT02756208|26478316|FG002|Overall Study|Withdrawal by Subject|1|||
13289359|NCT02756208|26478317|FG003|Overall Study|Withdrawal by Subject|3|||
13289360|NCT02756208|26478314|FG000|Overall Study|Lost to Follow-up|3|||
13289361|NCT02756208|26478315|FG001|Overall Study|Lost to Follow-up|1|||
13289362|NCT02756208|26478316|FG002|Overall Study|Lost to Follow-up|1|||
13289363|NCT02756208|26478317|FG003|Overall Study|Lost to Follow-up|1|||
13289364|NCT02756208|26478314|FG000|Overall Study|Physician Decision|1|||
13289365|NCT02756208|26478315|FG001|Overall Study|Physician Decision|0|||
13289366|NCT02756208|26478316|FG002|Overall Study|Physician Decision|0|||
13289367|NCT02756208|26478317|FG003|Overall Study|Physician Decision|0|||
13289368|NCT02756208|26478314|FG000|Overall Study|Protocol Violation|0|||
13289369|NCT02756208|26478315|FG001|Overall Study|Protocol Violation|1|||
13289370|NCT02756208|26478316|FG002|Overall Study|Protocol Violation|0|||
13289371|NCT02756208|26478317|FG003|Overall Study|Protocol Violation|0|||
13289372|NCT02756013|26478324|FG000|Overall Study|Adverse Event|1|||
13289373|NCT02756013|26478324|FG000|Overall Study|Hypersensitivity|1|||
13289389|NCT02279745|26478805|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2|||
13289390|NCT02279745|26478805|FG000|Overall Study|Withdrawal by Subject|2|||
13289391|NCT02279745|26478805|FG000|Overall Study|Pregnancy|1|||
13289392|NCT02279745|26478805|FG000|Overall Study|Study Non-compliance|1|||
13289393|NCT02279745|26478805|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1|||
13289394|NCT02270957|26478822|FG000|Overall Study|Lack of Efficacy|2|||
13289395|NCT02270957|26478823|FG001|Overall Study|Lack of Efficacy|4|||
13289396|NCT02270957|26478822|FG000|Overall Study|Adverse Event|2|||
13289397|NCT02270957|26478823|FG001|Overall Study|Adverse Event|0|||
13289398|NCT02482233|26478864|FG000|Overall Study|Lost to Follow-up|1|||
13289399|NCT02482233|26478865|FG001|Overall Study|Lost to Follow-up|1|||
13289400|NCT02489942|26478993|FG000|Overall Study|Request by patient|602|||
13289401|NCT02489942|26478993|FG000|Overall Study|Improvement/remission|157|||
13289402|NCT02489942|26478993|FG000|Overall Study|No change/Progressive disease|263|||
13289403|NCT02489942|26478993|FG000|Overall Study|Adverse Event|522|||
13289404|NCT02489942|26478993|FG000|Overall Study|Other personal reasons|1218|||
13289405|NCT02489942|26478993|FG000|Overall Study|Lost to Follow-up|456|||
13289406|NCT02489942|26478993|FG000|Overall Study|Not continuously investigated|7|||
13289407|NCT02489942|26478993|FG000|Overall Study|Patient started jardiance treatment out of registration period|1|||
13289408|NCT02489942|26478993|FG000|Overall Study|Multiple registration|1|||
13289409|NCT02489942|26478993|FG000|Overall Study|No patient visit after entry|100|||
13289410|NCT02489942|26478993|FG000|Overall Study|No treatment with Jardiance|2|||
13289411|NCT02489942|26478993|FG000|Overall Study|Patient received Jardiance before registration|1|||
13289412|NCT02489942|26478993|FG000|Overall Study|No CRF collected|86|||
13289413|NCT02484456|26479053|FG000|Washout Period|Withdrawal by Subject|0|||
13289414|NCT02484456|26479054|FG001|Washout Period|Withdrawal by Subject|1|||
13289415|NCT02484456|26479053|FG000|Second Treatment Period: Week 1|Adverse Event|1|||
13289416|NCT02484456|26479054|FG001|Second Treatment Period: Week 1|Adverse Event|0|||
13306663|NCT01289574|26526463|FG000|Overall Study|Lack of Efficacy|4|||
13306664|NCT01289574|26526464|FG001|Overall Study|Lack of Efficacy|0|||
13306665|NCT01289574|26526465|FG002|Overall Study|Lack of Efficacy|1|||
13306666|NCT01289574|26526463|FG000|Overall Study|Lost to Follow-up|2|||
13306667|NCT01289574|26526464|FG001|Overall Study|Lost to Follow-up|0|||
13306668|NCT01289574|26526465|FG002|Overall Study|Lost to Follow-up|1|||
13306669|NCT01289574|26526463|FG000|Overall Study|Withdrawal by Subject|1|||
13306670|NCT01289574|26526464|FG001|Overall Study|Withdrawal by Subject|1|||
13306671|NCT01289574|26526465|FG002|Overall Study|Withdrawal by Subject|1|||
13306672|NCT01289574|26526463|FG000|Overall Study|Adverse Event|0|||
13306673|NCT01289574|26526464|FG001|Overall Study|Adverse Event|1|||
13306674|NCT01289574|26526465|FG002|Overall Study|Adverse Event|0|||
13306675|NCT01289574|26526463|FG000|Overall Study|Subject wanted alternate treatment|0|||
13306676|NCT01289574|26526464|FG001|Overall Study|Subject wanted alternate treatment|1|||
13306677|NCT01289574|26526465|FG002|Overall Study|Subject wanted alternate treatment|0|||
13306678|NCT01289418|26526479|FG000|Day 8 Survey|email address invalid|283|||
13306679|NCT01289418|26526479|FG000|Day 8 Survey|participants did not complete the survey|1935|||
13306680|NCT01289418|26526479|FG000|Day 29 Survey|email address invalid|283|||
13306681|NCT01289418|26526479|FG000|Day 29 Survey|participants did not complete the survey|2185|||
13306682|NCT01289353|26526487|FG000|Overall Study|Lost to Follow-up|2|||
13306683|NCT01289210|26526493|FG000|Overall Study|Adverse Event|1|||
13306684|NCT01289119|26526592|FG000|Overall Study|Adverse Event|2|||
13306685|NCT01289119|26526593|FG001|Overall Study|Adverse Event|1|||
13289417|NCT02484456|26479053|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0|||
13221589|NCT01813422|26283632|FG000|Overall Study|Withdrawal by Subject|14|||
13221590|NCT01813422|26283633|FG001|Overall Study|Withdrawal by Subject|8|||
13221591|NCT01813422|26283632|FG000|Overall Study|Death|2|||
13221592|NCT01813422|26283633|FG001|Overall Study|Death|3|||
13221593|NCT01813422|26283632|FG000|Overall Study|Sponsor Decision|2|||
13221594|NCT01813422|26283633|FG001|Overall Study|Sponsor Decision|1|||
13221595|NCT01813422|26283632|FG000|Overall Study|Lost to Follow-up|2|||
13221596|NCT01813422|26283633|FG001|Overall Study|Lost to Follow-up|4|||
13221597|NCT01813357|26283648|FG000|Overall Study|Lost to Follow-up|5|||
13221598|NCT01813357|26283649|FG001|Overall Study|Lost to Follow-up|6|||
13221599|NCT01813305|26283690|FG000|Overall Study|Withdrawal by Subject|12|||
13221600|NCT01813305|26283691|FG001|Overall Study|Withdrawal by Subject|5|||
13221601|NCT01813305|26283690|FG000|Overall Study|Safety Concern|4|||
13221602|NCT01813305|26283691|FG001|Overall Study|Safety Concern|0|||
13221603|NCT01813305|26283690|FG000|Overall Study|Ulcer became worse|4|||
13221604|NCT01813305|26283691|FG001|Overall Study|Ulcer became worse|0|||
13221605|NCT01813305|26283690|FG000|Overall Study|Physician Decision|4|||
13221606|NCT01813305|26283691|FG001|Overall Study|Physician Decision|0|||
13221607|NCT01813305|26283690|FG000|Overall Study|Lost to Follow-up|3|||
13221608|NCT01813305|26283691|FG001|Overall Study|Lost to Follow-up|1|||
13221609|NCT01813305|26283690|FG000|Overall Study|Protocol Violation|1|||
13221610|NCT01813305|26283691|FG001|Overall Study|Protocol Violation|0|||
13221611|NCT01813305|26283690|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7|||
13221612|NCT01813305|26283691|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2|||
13221613|NCT01813071|26284184|FG000|Overall Study|Protocol Violation|0|||
13221614|NCT01813071|26284185|FG001|Overall Study|Protocol Violation|0|||
13221615|NCT01813071|26284186|FG002|Overall Study|Protocol Violation|0|||
13221616|NCT01813071|26284187|FG003|Overall Study|Protocol Violation|0|||
13221617|NCT01813071|26284188|FG004|Overall Study|Protocol Violation|1|||
13221618|NCT01813071|26284189|FG005|Overall Study|Protocol Violation|4|||
13221619|NCT01813071|26284190|FG006|Overall Study|Protocol Violation|2|||
13221620|NCT01813071|26284191|FG007|Overall Study|Protocol Violation|4|||
13221621|NCT01813071|26284192|FG008|Overall Study|Protocol Violation|2|||
13221622|NCT01813071|26284184|FG000|Overall Study|Withdrawal by Subject|0|||
13221623|NCT01813071|26284185|FG001|Overall Study|Withdrawal by Subject|0|||
13221624|NCT01813071|26284186|FG002|Overall Study|Withdrawal by Subject|0|||
13221625|NCT01813071|26284187|FG003|Overall Study|Withdrawal by Subject|0|||
13221626|NCT01813071|26284188|FG004|Overall Study|Withdrawal by Subject|0|||
13221627|NCT01813071|26284189|FG005|Overall Study|Withdrawal by Subject|1|||
13221628|NCT01813071|26284190|FG006|Overall Study|Withdrawal by Subject|0|||
13221629|NCT01813071|26284191|FG007|Overall Study|Withdrawal by Subject|0|||
13221630|NCT01813071|26284192|FG008|Overall Study|Withdrawal by Subject|0|||
13221631|NCT01813071|26284184|FG000|Overall Study|Adverse Event|0|||
13221632|NCT01813071|26284185|FG001|Overall Study|Adverse Event|0|||
13221633|NCT01813071|26284186|FG002|Overall Study|Adverse Event|0|||
13221634|NCT01813071|26284187|FG003|Overall Study|Adverse Event|0|||
13221635|NCT01813071|26284188|FG004|Overall Study|Adverse Event|0|||
13221636|NCT01813071|26284189|FG005|Overall Study|Adverse Event|1|||
13221637|NCT01813071|26284190|FG006|Overall Study|Adverse Event|0|||
13221638|NCT01813071|26284191|FG007|Overall Study|Adverse Event|0|||
13221639|NCT01813071|26284192|FG008|Overall Study|Adverse Event|0|||
13221640|NCT01813071|26284184|FG000|Overall Study|Physician Decision|0|||
13221641|NCT01813071|26284185|FG001|Overall Study|Physician Decision|0|||
13221642|NCT01813071|26284186|FG002|Overall Study|Physician Decision|0|||
13221643|NCT01813071|26284187|FG003|Overall Study|Physician Decision|0|||
13221644|NCT01813071|26284188|FG004|Overall Study|Physician Decision|0|||
13221645|NCT01813071|26284189|FG005|Overall Study|Physician Decision|0|||
13221646|NCT01813071|26284190|FG006|Overall Study|Physician Decision|1|||
13221647|NCT01813071|26284191|FG007|Overall Study|Physician Decision|0|||
13221648|NCT01813071|26284192|FG008|Overall Study|Physician Decision|0|||
13221649|NCT01813071|26284184|FG000|Overall Study|Met inc/exc criteria|0|||
13221650|NCT01813071|26284185|FG001|Overall Study|Met inc/exc criteria|0|||
13221651|NCT01813071|26284186|FG002|Overall Study|Met inc/exc criteria|0|||
13221652|NCT01813071|26284187|FG003|Overall Study|Met inc/exc criteria|0|||
13221653|NCT01813071|26284188|FG004|Overall Study|Met inc/exc criteria|0|||
13221654|NCT01813071|26284189|FG005|Overall Study|Met inc/exc criteria|1|||
13221655|NCT01813071|26284190|FG006|Overall Study|Met inc/exc criteria|0|||
13221656|NCT01813071|26284191|FG007|Overall Study|Met inc/exc criteria|1|||
13221657|NCT01813071|26284192|FG008|Overall Study|Met inc/exc criteria|1|||
13221658|NCT01813058|26284205|FG000|Overall Study|Withdrawal by Subject|5|||
13221659|NCT01813058|26284206|FG001|Overall Study|Withdrawal by Subject|4|||
13221660|NCT01813019|26284221|FG000|Overall Study|Adverse Event|0|||
13221661|NCT01813019|26284222|FG001|Overall Study|Adverse Event|3|||
13221662|NCT01813019|26284221|FG000|Overall Study|Withdrawal by Subject|3|||
13221663|NCT01813019|26284222|FG001|Overall Study|Withdrawal by Subject|2|||
13221664|NCT01813019|26284221|FG000|Overall Study|administrative problems|2|||
13221665|NCT01813019|26284222|FG001|Overall Study|administrative problems|0|||
13221666|NCT01813019|26284221|FG000|Overall Study|Protocol Deviation|2|||
13221667|NCT01813019|26284222|FG001|Overall Study|Protocol Deviation|1|||
13221668|NCT01812837|26284240|FG000|Overall Study|Lost to Follow-up|1|||
13221669|NCT01812837|26284241|FG001|Overall Study|Lost to Follow-up|1|||
13221670|NCT01812837|26284242|FG002|Overall Study|Lost to Follow-up|0|||
13221671|NCT01812837|26284240|FG000|Overall Study|Protocol Violation|1|||
13221672|NCT01812837|26284241|FG001|Overall Study|Protocol Violation|0|||
13221673|NCT01812837|26284242|FG002|Overall Study|Protocol Violation|0|||
13221674|NCT01812759|26284260|FG000|Overall Study|Physician Decision|0|||
13221675|NCT01812759|26284261|FG001|Overall Study|Physician Decision|0|||
13221676|NCT01812759|26284262|FG002|Overall Study|Physician Decision|1|||
13221677|NCT01812707|26284309|FG000|Overall Study|Adverse Event|0|||
13221678|NCT01812707|26284310|FG001|Overall Study|Adverse Event|0|||
13221679|NCT01812707|26284311|FG002|Overall Study|Adverse Event|0|||
13221680|NCT01812707|26284312|FG003|Overall Study|Adverse Event|2|||
13221681|NCT01812707|26284309|FG000|Overall Study|Poor compliance to protocol|1|||
13221682|NCT01812707|26284310|FG001|Overall Study|Poor compliance to protocol|0|||
13221683|NCT01812707|26284311|FG002|Overall Study|Poor compliance to protocol|0|||
13221684|NCT01812707|26284312|FG003|Overall Study|Poor compliance to protocol|0|||
13221685|NCT01812707|26284309|FG000|Overall Study|Consent withdrawn by participant|1|||
13221686|NCT01812707|26284310|FG001|Overall Study|Consent withdrawn by participant|0|||
13221687|NCT01812707|26284311|FG002|Overall Study|Consent withdrawn by participant|0|||
13221688|NCT01812707|26284312|FG003|Overall Study|Consent withdrawn by participant|0|||
13221689|NCT01812655|26284336|FG000|Overall Study|Protocol Violation|1|||
13221690|NCT01812655|26284337|FG001|Overall Study|Protocol Violation|1|||
13221691|NCT01812655|26284338|FG002|Overall Study|Protocol Violation|0|||
13221692|NCT01812109|26284344|FG000|Overall Study|research personnel delay|16|||
13221693|NCT01812109|26284344|FG000|Overall Study|NIRS Unattainable|17|||
13221694|NCT01812057|26284389|FG000|Overall Study|Protocol Violation|1|||
13221695|NCT01812057|26284390|FG001|Overall Study|Protocol Violation|0|||
13221696|NCT01812057|26284389|FG000|Overall Study|Physician Decision|1|||
13221697|NCT01812057|26284390|FG001|Overall Study|Physician Decision|0|||
13221698|NCT01811953|26284453|FG000|Overall Study|Adverse Event|0|||
13221699|NCT01811953|26284454|FG001|Overall Study|Adverse Event|0|||
13221700|NCT01811953|26284455|FG002|Overall Study|Adverse Event|0|||
13221701|NCT01811953|26284456|FG003|Overall Study|Adverse Event|1|||
13221702|NCT01811953|26284457|FG004|Overall Study|Adverse Event|0|||
13221703|NCT01811953|26284458|FG005|Overall Study|Adverse Event|1|||
13221704|NCT01811953|26284453|FG000|Overall Study|Protocol Violation|0|||
13221705|NCT01811953|26284454|FG001|Overall Study|Protocol Violation|0|||
13221706|NCT01811953|26284455|FG002|Overall Study|Protocol Violation|0|||
13221707|NCT01811953|26284456|FG003|Overall Study|Protocol Violation|0|||
13221708|NCT01811953|26284457|FG004|Overall Study|Protocol Violation|1|||
13221709|NCT01811953|26284458|FG005|Overall Study|Protocol Violation|0|||
13221710|NCT01811732|26284475|FG000|Overall Study|Lost to Follow-up|24|||
13221711|NCT01811732|26284476|FG001|Overall Study|Lost to Follow-up|30|||
13221712|NCT01811732|26284475|FG000|Overall Study|Withdrawal by Subject|16|||
13221713|NCT01811732|26284476|FG001|Overall Study|Withdrawal by Subject|10|||
13221714|NCT01811732|26284475|FG000|Overall Study|Adverse Event|3|||
13221715|NCT01811732|26284476|FG001|Overall Study|Adverse Event|9|||
13221716|NCT01811732|26284475|FG000|Overall Study|Lack of Efficacy|3|||
13221717|NCT01811732|26284476|FG001|Overall Study|Lack of Efficacy|1|||
13221718|NCT01811732|26284475|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
13221719|NCT01811732|26284476|FG001|Overall Study|Non-compliance with study drug/procedure|3|||
13221720|NCT01811732|26284475|FG000|Overall Study|Physician Decision|2|||
13221721|NCT01811732|26284476|FG001|Overall Study|Physician Decision|0|||
13221722|NCT01811732|26284475|FG000|Overall Study|Death|1|||
13221723|NCT01811732|26284476|FG001|Overall Study|Death|1|||
13221724|NCT01811732|26284475|FG000|Overall Study|Insufficient venous access|0|||
13221725|NCT01811732|26284476|FG001|Overall Study|Insufficient venous access|1|||
13221726|NCT01811732|26284475|FG000|Overall Study|Protocol Violation|0|||
13221727|NCT01811732|26284476|FG001|Overall Study|Protocol Violation|1|||
13221728|NCT01811732|26284475|FG000|Overall Study|Subject incarcerated|1|||
13221729|NCT01811732|26284476|FG001|Overall Study|Subject incarcerated|2|||
13221730|NCT01811732|26284475|FG000|Overall Study|Admitted to another facility|1|||
13221731|NCT01811732|26284476|FG001|Overall Study|Admitted to another facility|0|||
13221732|NCT01811732|26284475|FG000|Overall Study|Correct study drug not available on site|1|||
13221733|NCT01811732|26284476|FG001|Overall Study|Correct study drug not available on site|0|||
13221734|NCT01811706|26284489|FG000|First Intervention ( 4 Weeks)|Adverse Event|1|||
13221735|NCT01811706|26284490|FG001|First Intervention ( 4 Weeks)|Adverse Event|0|||
13221736|NCT01811563|26284523|FG000|Overall Study|Lost to Follow-up|5|||
13221737|NCT01811563|26284524|FG001|Overall Study|Lost to Follow-up|2|||
13221738|NCT01811563|26284523|FG000|Overall Study|Incorrect Randomization procedure|0|||
13221739|NCT01811563|26284524|FG001|Overall Study|Incorrect Randomization procedure|1|||
13221740|NCT01811485|26284551|FG000|Overall Study|Adverse Event|1|||
13221741|NCT01811485|26284552|FG001|Overall Study|Adverse Event|3|||
13221742|NCT01811485|26284553|FG002|Overall Study|Adverse Event|2|||
13221743|NCT01811485|26284551|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
13221744|NCT01811485|26284552|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
13221745|NCT01811485|26284553|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
13221746|NCT01811485|26284551|FG000|Overall Study|Administrative problems|1|||
13221747|NCT01811485|26284552|FG001|Overall Study|Administrative problems|0|||
13221748|NCT01811485|26284553|FG002|Overall Study|Administrative problems|0|||
13221749|NCT01811485|26284551|FG000|Overall Study|Protocol Deviation|0|||
13221750|NCT01811485|26284552|FG001|Overall Study|Protocol Deviation|1|||
13221751|NCT01811485|26284553|FG002|Overall Study|Protocol Deviation|0|||
13221752|NCT01811472|26284608|FG000|Overall Study|Adverse Event|1|||
13221753|NCT01811472|26284609|FG001|Overall Study|Adverse Event|0|||
13221754|NCT01811472|26284610|FG002|Overall Study|Adverse Event|4|||
13221755|NCT01811472|26284608|FG000|Overall Study|Lost to Follow-up|0|||
13221756|NCT01811472|26284609|FG001|Overall Study|Lost to Follow-up|0|||
13221757|NCT01811472|26284610|FG002|Overall Study|Lost to Follow-up|1|||
13221758|NCT01811472|26284608|FG000|Overall Study|Subject/guardian decision|1|||
13221759|NCT01811472|26284609|FG001|Overall Study|Subject/guardian decision|0|||
13221760|NCT01811472|26284610|FG002|Overall Study|Subject/guardian decision|0|||
13221761|NCT01811238|26284621|FG000|Overall Study|Withdrawal by Subject|42|||
13221762|NCT01811238|26284621|FG000|Overall Study|Adverse Event|25|||
13221763|NCT01811238|26284621|FG000|Overall Study|Protocol Violation|4|||
13221764|NCT01811238|26284621|FG000|Overall Study|Lack of Efficacy|4|||
13221765|NCT01811238|26284621|FG000|Overall Study|subject refused study medication|6|||
13221766|NCT01811225|26284634|FG000|Treatment Period 1|Adverse Event|2|||
13221767|NCT01811225|26284635|FG001|Treatment Period 1|Adverse Event|3|||
13221768|NCT01811225|26284634|FG000|Treatment Period 1|Lost to Follow-up|12|||
13221769|NCT01811225|26284635|FG001|Treatment Period 1|Lost to Follow-up|8|||
13221770|NCT01811225|26284634|FG000|Treatment Period 1|transporation|1|||
13221771|NCT01811225|26284635|FG001|Treatment Period 1|transporation|0|||
13221772|NCT01811225|26284634|FG000|Treatment Period 1|unable to remain smoke free overnight|10|||
13306686|NCT01289119|26526594|FG002|Overall Study|Adverse Event|0|||
13306687|NCT01289119|26526595|FG003|Overall Study|Adverse Event|2|||
13306688|NCT01289119|26526596|FG004|Overall Study|Adverse Event|1|||
13306689|NCT01289119|26526597|FG005|Overall Study|Adverse Event|0|||
13306690|NCT01289119|26526592|FG000|Overall Study|Major Protocol Deviation|2|||
13306691|NCT01289119|26526593|FG001|Overall Study|Major Protocol Deviation|1|||
13306692|NCT01289119|26526594|FG002|Overall Study|Major Protocol Deviation|3|||
13306693|NCT01289119|26526595|FG003|Overall Study|Major Protocol Deviation|0|||
13306694|NCT01289119|26526596|FG004|Overall Study|Major Protocol Deviation|2|||
13306695|NCT01289119|26526597|FG005|Overall Study|Major Protocol Deviation|1|||
13306696|NCT01289119|26526592|FG000|Overall Study|Lost to Follow-up|0|||
13306697|NCT01289119|26526593|FG001|Overall Study|Lost to Follow-up|3|||
13306698|NCT01289119|26526594|FG002|Overall Study|Lost to Follow-up|0|||
13306699|NCT01289119|26526595|FG003|Overall Study|Lost to Follow-up|0|||
13306700|NCT01289119|26526596|FG004|Overall Study|Lost to Follow-up|0|||
13306701|NCT01289119|26526597|FG005|Overall Study|Lost to Follow-up|1|||
13306702|NCT01289119|26526592|FG000|Overall Study|Withdrawal by Subject|4|||
13306703|NCT01289119|26526593|FG001|Overall Study|Withdrawal by Subject|2|||
13306704|NCT01289119|26526594|FG002|Overall Study|Withdrawal by Subject|4|||
13306705|NCT01289119|26526595|FG003|Overall Study|Withdrawal by Subject|3|||
13306706|NCT01289119|26526596|FG004|Overall Study|Withdrawal by Subject|1|||
13306707|NCT01289119|26526597|FG005|Overall Study|Withdrawal by Subject|1|||
13306708|NCT01289119|26526592|FG000|Overall Study|Pregnancy|0|||
13306709|NCT01289119|26526593|FG001|Overall Study|Pregnancy|1|||
13306710|NCT01289119|26526594|FG002|Overall Study|Pregnancy|0|||
13306711|NCT01289119|26526595|FG003|Overall Study|Pregnancy|0|||
13306712|NCT01289119|26526596|FG004|Overall Study|Pregnancy|0|||
13306713|NCT01289119|26526597|FG005|Overall Study|Pregnancy|0|||
13306714|NCT01289119|26526592|FG000|Overall Study|Lack of Efficacy|0|||
13306715|NCT01289119|26526593|FG001|Overall Study|Lack of Efficacy|1|||
13306716|NCT01289119|26526594|FG002|Overall Study|Lack of Efficacy|1|||
13306717|NCT01289119|26526595|FG003|Overall Study|Lack of Efficacy|1|||
13306718|NCT01289119|26526596|FG004|Overall Study|Lack of Efficacy|1|||
13306719|NCT01289119|26526597|FG005|Overall Study|Lack of Efficacy|1|||
13306720|NCT01289119|26526592|FG000|Overall Study|Other|1|||
13306721|NCT01289119|26526593|FG001|Overall Study|Other|0|||
13306722|NCT01289119|26526594|FG002|Overall Study|Other|1|||
13306723|NCT01289119|26526595|FG003|Overall Study|Other|0|||
13306724|NCT01289119|26526596|FG004|Overall Study|Other|0|||
13306725|NCT01289119|26526597|FG005|Overall Study|Other|0|||
13306726|NCT01289041|26526611|FG000|Overall Study|Adverse Event|24|||
13306727|NCT01289041|26526611|FG000|Overall Study|Physician Decision|1|||
13306728|NCT01289041|26526611|FG000|Overall Study|Progressive Disease|41|||
13306729|NCT01289041|26526611|FG000|Overall Study|Withdrawal by Subject|3|||
13306730|NCT01289041|26526611|FG000|Overall Study|Death|1|||
13306731|NCT01289028|26526625|FG000|Overall Study|Progressive Disease|49|||
13306732|NCT01289028|26526625|FG000|Overall Study|Adverse Event|14|||
13306733|NCT01289028|26526625|FG000|Overall Study|Withdrawal by Subject|6|||
13306734|NCT01289028|26526625|FG000|Overall Study|Death|4|||
13306735|NCT01289028|26526625|FG000|Overall Study|Lack of Efficacy|2|||
13306736|NCT01289028|26526625|FG000|Overall Study|No longer required|2|||
13306737|NCT01289028|26526625|FG000|Overall Study|Lost to Follow-up|2|||
13306738|NCT01289028|26526625|FG000|Overall Study|New Cancer Therapy|2|||
13306739|NCT01289028|26526625|FG000|Overall Study|Abnormal Lab Value|1|||
13306740|NCT01289028|26526625|FG000|Overall Study|Missing reason for discon|1|||
13306741|NCT01289015|26526640|FG000|Overall Study|Protocol Violation|12|||
13306742|NCT01289015|26526641|FG001|Overall Study|Protocol Violation|9|||
13306743|NCT01289015|26526640|FG000|Overall Study|Adverse Event|3|||
13306744|NCT01289015|26526641|FG001|Overall Study|Adverse Event|0|||
13306745|NCT01289015|26526640|FG000|Overall Study|Lost to Follow-up|33|||
13306746|NCT01289015|26526641|FG001|Overall Study|Lost to Follow-up|17|||
13306747|NCT01289015|26526640|FG000|Overall Study|Withdrawal by Subject|17|||
13306748|NCT01289015|26526641|FG001|Overall Study|Withdrawal by Subject|8|||
13306749|NCT01289015|26526640|FG000|Overall Study|Disease progression|1|||
13306750|NCT01289015|26526641|FG001|Overall Study|Disease progression|0|||
13306751|NCT01289015|26526640|FG000|Overall Study|Negative baseline culture and others|33|||
13306752|NCT01289015|26526641|FG001|Overall Study|Negative baseline culture and others|20|||
13306753|NCT01288989|26526715|FG000|Overall Study|Death|0|||
13306754|NCT01288989|26526716|FG001|Overall Study|Death|0|||
13306755|NCT01288989|26526717|FG002|Overall Study|Death|0|||
13306756|NCT01288989|26526718|FG003|Overall Study|Death|1|||
13306757|NCT01288989|26526719|FG004|Overall Study|Death|0|||
13306758|NCT01288989|26526715|FG000|Overall Study|Dose limiting toxicity|1|||
13306759|NCT01288989|26526716|FG001|Overall Study|Dose limiting toxicity|0|||
13306760|NCT01288989|26526717|FG002|Overall Study|Dose limiting toxicity|0|||
13306761|NCT01288989|26526718|FG003|Overall Study|Dose limiting toxicity|0|||
13306762|NCT01288989|26526719|FG004|Overall Study|Dose limiting toxicity|0|||
13306763|NCT01288989|26526715|FG000|Overall Study|Adverse Event|0|||
13306764|NCT01288989|26526716|FG001|Overall Study|Adverse Event|0|||
13306765|NCT01288989|26526717|FG002|Overall Study|Adverse Event|0|||
13306766|NCT01288989|26526718|FG003|Overall Study|Adverse Event|0|||
13306767|NCT01288989|26526719|FG004|Overall Study|Adverse Event|2|||
13306768|NCT01288989|26526715|FG000|Overall Study|Physician Decision|0|||
13306769|NCT01288989|26526716|FG001|Overall Study|Physician Decision|0|||
13306770|NCT01288989|26526717|FG002|Overall Study|Physician Decision|0|||
13306771|NCT01288989|26526718|FG003|Overall Study|Physician Decision|0|||
13306772|NCT01288989|26526719|FG004|Overall Study|Physician Decision|1|||
13306773|NCT01288989|26526715|FG000|Overall Study|Withdrawal by Subject|0|||
13306774|NCT01288989|26526716|FG001|Overall Study|Withdrawal by Subject|0|||
13306775|NCT01288989|26526717|FG002|Overall Study|Withdrawal by Subject|0|||
13306776|NCT01288989|26526718|FG003|Overall Study|Withdrawal by Subject|0|||
13306777|NCT01288989|26526719|FG004|Overall Study|Withdrawal by Subject|3|||
13306778|NCT01288976|26526756|FG000|Overall Study|Withdrawal by Subject|58|||
13306779|NCT01288976|26526757|FG001|Overall Study|Withdrawal by Subject|12|||
13306780|NCT01288976|26526758|FG002|Overall Study|Withdrawal by Subject|9|||
13306781|NCT01288976|26526756|FG000|Overall Study|Death|98|||
13306782|NCT01288976|26526757|FG001|Overall Study|Death|6|||
13306783|NCT01288976|26526758|FG002|Overall Study|Death|4|||
13306784|NCT01288976|26526756|FG000|Overall Study|Data unavailable|22|||
13306785|NCT01288976|26526757|FG001|Overall Study|Data unavailable|9|||
13306786|NCT01288976|26526758|FG002|Overall Study|Data unavailable|7|||
13306787|NCT01288937|26526771|FG000|Overall Study|Adverse Event|1|||
13306788|NCT01288937|26526772|FG001|Overall Study|Adverse Event|0|||
13306789|NCT01288911|26526810|FG000|Double-blind Period|Death|11|||
13306790|NCT01288911|26526811|FG001|Double-blind Period|Death|7|||
13306791|NCT01288911|26526810|FG000|Double-blind Period|Lost to Follow-up|0|||
13306792|NCT01288911|26526811|FG001|Double-blind Period|Lost to Follow-up|2|||
13306793|NCT01288911|26526810|FG000|Double-blind Period|Progressive Disease|75|||
13306794|NCT01288911|26526811|FG001|Double-blind Period|Progressive Disease|103|||
13306795|NCT01288911|26526810|FG000|Double-blind Period|Protocol Violation|1|||
13306796|NCT01288911|26526811|FG001|Double-blind Period|Protocol Violation|0|||
13306797|NCT01288911|26526810|FG000|Double-blind Period|Withdrawal by Subject|25|||
13306798|NCT01288911|26526811|FG001|Double-blind Period|Withdrawal by Subject|26|||
13306799|NCT01288911|26526810|FG000|Double-blind Period|Miscellaneous Reason|29|||
13306800|NCT01288911|26526811|FG001|Double-blind Period|Miscellaneous Reason|42|||
13306801|NCT01288911|26526810|FG000|Double-blind Period|Randomized but never received study drug|1|||
13306802|NCT01288911|26526811|FG001|Double-blind Period|Randomized but never received study drug|2|||
13306803|NCT01288911|26526810|FG000|Open-label Period (All Enzalutamide)|Death|0|||
13306804|NCT01288911|26526811|FG001|Open-label Period (All Enzalutamide)|Death|1|||
13306805|NCT01288911|26526810|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1|||
13306806|NCT01288911|26526811|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0|||
13306807|NCT01288911|26526810|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18|||
13306808|NCT01288911|26526811|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3|||
13306809|NCT01288911|26526810|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1|||
13306810|NCT01288911|26526811|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0|||
13306811|NCT01288911|26526810|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5|||
13306812|NCT01288911|26526811|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0|||
13306813|NCT01288911|26526810|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17|||
13306814|NCT01288911|26526811|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5|||
13306815|NCT01288729|26526824|FG000|Overall Study|Withdrawal by Subject|1|||
13306816|NCT01288729|26526825|FG001|Overall Study|Withdrawal by Subject|0|||
13306817|NCT01288612|26526864|FG000|Overall Study|Unable to contact|11|||
13306818|NCT01288612|26526865|FG001|Overall Study|Unable to contact|16|||
13306819|NCT01288612|26526866|FG002|Overall Study|Unable to contact|20|||
13306820|NCT01288612|26526864|FG000|Overall Study|Declined|78|||
13306821|NCT01288612|26526865|FG001|Overall Study|Declined|63|||
13306822|NCT01288612|26526866|FG002|Overall Study|Declined|62|||
13306823|NCT01288612|26526864|FG000|Overall Study|Unable to intubate|0|||
13306824|NCT01288612|26526865|FG001|Overall Study|Unable to intubate|3|||
13306825|NCT01288612|26526866|FG002|Overall Study|Unable to intubate|0|||
13306826|NCT01288469|26526902|FG000|Overall Study|Adverse Event|4|||
13306827|NCT01288469|26526903|FG001|Overall Study|Adverse Event|1|||
13306828|NCT01288469|26526904|FG002|Overall Study|Adverse Event|1|||
13306829|NCT01288469|26526902|FG000|Overall Study|Poor compliance to protocol|0|||
13306830|NCT01288469|26526903|FG001|Overall Study|Poor compliance to protocol|1|||
13306831|NCT01288469|26526904|FG002|Overall Study|Poor compliance to protocol|0|||
13306832|NCT01288469|26526902|FG000|Overall Study|Participant Moved|1|||
13306833|NCT01288469|26526903|FG001|Overall Study|Participant Moved|0|||
13306834|NCT01288469|26526904|FG002|Overall Study|Participant Moved|0|||
13306835|NCT01288469|26526902|FG000|Overall Study|Consent withdrawn by subject|1|||
13306836|NCT01288469|26526903|FG001|Overall Study|Consent withdrawn by subject|1|||
13306837|NCT01288469|26526904|FG002|Overall Study|Consent withdrawn by subject|1|||
13306838|NCT01288469|26526902|FG000|Overall Study|Exclusion criteria finally met|1|||
13306839|NCT01288469|26526903|FG001|Overall Study|Exclusion criteria finally met|0|||
13306840|NCT01288469|26526904|FG002|Overall Study|Exclusion criteria finally met|0|||
13306841|NCT01288443|26526973|FG000|Overall Study|Adverse Event|0|||
13306842|NCT01288443|26526974|FG001|Overall Study|Adverse Event|0|||
13306843|NCT01288443|26526975|FG002|Overall Study|Adverse Event|1|||
13306844|NCT01288443|26526976|FG003|Overall Study|Adverse Event|1|||
13306845|NCT01288443|26526977|FG004|Overall Study|Adverse Event|3|||
13306846|NCT01288443|26526978|FG005|Overall Study|Adverse Event|1|||
13306847|NCT01288443|26526973|FG000|Overall Study|Poor compliance to protocol|0|||
13306848|NCT01288443|26526974|FG001|Overall Study|Poor compliance to protocol|0|||
13306849|NCT01288443|26526975|FG002|Overall Study|Poor compliance to protocol|0|||
13306850|NCT01288443|26526976|FG003|Overall Study|Poor compliance to protocol|0|||
13306851|NCT01288443|26526977|FG004|Overall Study|Poor compliance to protocol|0|||
13306852|NCT01288443|26526978|FG005|Overall Study|Poor compliance to protocol|1|||
13306853|NCT01288443|26526973|FG000|Overall Study|Participant Moved|0|||
13306854|NCT01288443|26526974|FG001|Overall Study|Participant Moved|0|||
13306855|NCT01288443|26526975|FG002|Overall Study|Participant Moved|0|||
13306856|NCT01288443|26526976|FG003|Overall Study|Participant Moved|1|||
13306857|NCT01288443|26526977|FG004|Overall Study|Participant Moved|2|||
13306858|NCT01288443|26526978|FG005|Overall Study|Participant Moved|1|||
13306859|NCT01288443|26526973|FG000|Overall Study|Consent withdrawn by Participant|0|||
13306860|NCT01288443|26526974|FG001|Overall Study|Consent withdrawn by Participant|0|||
13306861|NCT01288443|26526975|FG002|Overall Study|Consent withdrawn by Participant|0|||
13306862|NCT01288443|26526976|FG003|Overall Study|Consent withdrawn by Participant|0|||
13306863|NCT01288443|26526977|FG004|Overall Study|Consent withdrawn by Participant|0|||
13306864|NCT01288443|26526978|FG005|Overall Study|Consent withdrawn by Participant|1|||
13306865|NCT01288443|26526973|FG000|Overall Study|Lost to Follow-up|0|||
13306866|NCT01288443|26526974|FG001|Overall Study|Lost to Follow-up|1|||
13306867|NCT01288443|26526975|FG002|Overall Study|Lost to Follow-up|0|||
13306868|NCT01288443|26526976|FG003|Overall Study|Lost to Follow-up|0|||
13306869|NCT01288443|26526977|FG004|Overall Study|Lost to Follow-up|0|||
13306870|NCT01288443|26526978|FG005|Overall Study|Lost to Follow-up|0|||
13306871|NCT01288443|26526973|FG000|Overall Study|Study drug auto-injector administration|0|||
13306872|NCT01288443|26526974|FG001|Overall Study|Study drug auto-injector administration|0|||
13306873|NCT01288443|26526975|FG002|Overall Study|Study drug auto-injector administration|0|||
13306874|NCT01288443|26526976|FG003|Overall Study|Study drug auto-injector administration|0|||
13306875|NCT01288443|26526977|FG004|Overall Study|Study drug auto-injector administration|1|||
13306876|NCT01288443|26526978|FG005|Overall Study|Study drug auto-injector administration|1|||
13306877|NCT01288443|26526973|FG000|Overall Study|Other than above|0|||
13306878|NCT01288443|26526974|FG001|Overall Study|Other than above|0|||
13306879|NCT01288443|26526975|FG002|Overall Study|Other than above|0|||
13306880|NCT01288443|26526976|FG003|Overall Study|Other than above|2|||
13306881|NCT01288443|26526977|FG004|Overall Study|Other than above|1|||
13306882|NCT01288443|26526978|FG005|Overall Study|Other than above|0|||
13306883|NCT01288430|26527133|FG000|Part 1|Progressive disease|2|||
13306884|NCT01288430|26527134|FG001|Part 1|Progressive disease|1|||
13135677|NCT02737501|25996065|FG000|Randomized Phase|Withdrawal by Subject|16|||
13306885|NCT01288430|26527135|FG002|Part 1|Progressive disease|1|||
13306886|NCT01288430|26527136|FG003|Part 1|Progressive disease|6|||
13306887|NCT01288430|26527137|FG004|Part 1|Progressive disease|2|||
13306888|NCT01288430|26527138|FG005|Part 1|Progressive disease|4|||
13306889|NCT01288430|26527139|FG006|Part 1|Progressive disease|2|||
13306890|NCT01288430|26527140|FG007|Part 1|Progressive disease|0|||
13306891|NCT01288430|26527141|FG008|Part 1|Progressive disease|0|||
13306892|NCT01288430|26527142|FG009|Part 1|Progressive disease|0|||
13306893|NCT01288430|26527133|FG000|Part 1|Clinical disease progression|0|||
13306894|NCT01288430|26527134|FG001|Part 1|Clinical disease progression|0|||
13306895|NCT01288430|26527135|FG002|Part 1|Clinical disease progression|1|||
13306896|NCT01288430|26527136|FG003|Part 1|Clinical disease progression|0|||
13306897|NCT01288430|26527137|FG004|Part 1|Clinical disease progression|0|||
13306898|NCT01288430|26527138|FG005|Part 1|Clinical disease progression|2|||
13306899|NCT01288430|26527139|FG006|Part 1|Clinical disease progression|2|||
13306900|NCT01288430|26527140|FG007|Part 1|Clinical disease progression|0|||
13392264|NCT00673049|26779387|FG002|After Progression on Erlotinib|Lost to Follow-up|0|||
13392265|NCT00673049|26779388|FG003|After Progression on Erlotinib|Lost to Follow-up|3|||
13477494|NCT01595009|27006997|FG003|Core|Disease progression|0|||
13477495|NCT01595009|27006994|FG000|Core|Withdrawal by Subject|4|||
13477496|NCT01595009|27006995|FG001|Core|Withdrawal by Subject|17|||
13477497|NCT01595009|27006996|FG002|Core|Withdrawal by Subject|0|||
13477498|NCT01595009|27006997|FG003|Core|Withdrawal by Subject|0|||
13477499|NCT01595009|27006994|FG000|Core|Death|3|||
13477500|NCT01595009|27006995|FG001|Core|Death|6|||
13477501|NCT01595009|27006996|FG002|Core|Death|0|||
13392266|NCT00673049|26779385|FG000|After Progression on Erlotinib|Withdrawal by Subject|0|||
13392267|NCT00673049|26779386|FG001|After Progression on Erlotinib|Withdrawal by Subject|0|||
13392268|NCT00673049|26779387|FG002|After Progression on Erlotinib|Withdrawal by Subject|0|||
13392269|NCT00673049|26779388|FG003|After Progression on Erlotinib|Withdrawal by Subject|5|||
13392270|NCT00673049|26779385|FG000|After Progression on Erlotinib|study terminated by sponsor|0|||
13392271|NCT00673049|26779386|FG001|After Progression on Erlotinib|study terminated by sponsor|0|||
13392272|NCT00673049|26779387|FG002|After Progression on Erlotinib|study terminated by sponsor|0|||
13392273|NCT00673049|26779388|FG003|After Progression on Erlotinib|study terminated by sponsor|4|||
13392274|NCT00672984|26779447|FG000|First Intervention|Adverse Event|5|||
13392275|NCT00672984|26779448|FG001|First Intervention|Adverse Event|0|||
13392276|NCT00672984|26779449|FG002|First Intervention|Adverse Event|0|||
13392277|NCT00672984|26779447|FG000|First Intervention|Withdrawal by Subject|1|||
13392278|NCT00672984|26779448|FG001|First Intervention|Withdrawal by Subject|2|||
13392279|NCT00672984|26779449|FG002|First Intervention|Withdrawal by Subject|2|||
13392280|NCT00672984|26779447|FG000|First Intervention|Sponsor decision|3|||
13392281|NCT00672984|26779448|FG001|First Intervention|Sponsor decision|0|||
13392282|NCT00672984|26779449|FG002|First Intervention|Sponsor decision|0|||
13392283|NCT00672984|26779447|FG000|Second Intervention|Non-compliance with facility policies|0|||
13392284|NCT00672984|26779448|FG001|Second Intervention|Non-compliance with facility policies|2|||
13392285|NCT00672984|26779449|FG002|Second Intervention|Non-compliance with facility policies|0|||
13392286|NCT00672984|26779447|FG000|Second Intervention|Withdrawal by Subject|0|||
13392287|NCT00672984|26779448|FG001|Second Intervention|Withdrawal by Subject|3|||
13392288|NCT00672984|26779449|FG002|Second Intervention|Withdrawal by Subject|0|||
13392289|NCT00672984|26779447|FG000|Second Intervention|Protocol Violation|0|||
13392290|NCT00672984|26779448|FG001|Second Intervention|Protocol Violation|1|||
13392291|NCT00672984|26779449|FG002|Second Intervention|Protocol Violation|1|||
13392292|NCT00672984|26779447|FG000|Third Intervention|Adverse Event|1|||
13392293|NCT00672984|26779448|FG001|Third Intervention|Adverse Event|0|||
13392294|NCT00672984|26779449|FG002|Third Intervention|Adverse Event|1|||
13392295|NCT00672958|26779486|FG000|Overall Study|Adverse Event|11|||
13392296|NCT00672958|26779487|FG001|Overall Study|Adverse Event|9|||
13392297|NCT00672958|26779486|FG000|Overall Study|Lack of Efficacy|6|||
13392298|NCT00672958|26779487|FG001|Overall Study|Lack of Efficacy|11|||
13392299|NCT00672958|26779486|FG000|Overall Study|Non-compliance with study drug|2|||
13392300|NCT00672958|26779487|FG001|Overall Study|Non-compliance with study drug|3|||
13392301|NCT00672958|26779486|FG000|Overall Study|Protocol deviations|11|||
13392302|NCT00672958|26779487|FG001|Overall Study|Protocol deviations|5|||
13392303|NCT00672958|26779486|FG000|Overall Study|Voluntary withdrawal|12|||
13392304|NCT00672958|26779487|FG001|Overall Study|Voluntary withdrawal|8|||
13392305|NCT00672958|26779486|FG000|Overall Study|Lost to Follow-up|22|||
13392306|NCT00672958|26779487|FG001|Overall Study|Lost to Follow-up|17|||
13392307|NCT00672958|26779486|FG000|Overall Study|Reason not specified|0|||
13392308|NCT00672958|26779487|FG001|Overall Study|Reason not specified|3|||
13392309|NCT00672841|26779506|FG000|Overall Study|Comfort care|1|||
13392310|NCT00672841|26779507|FG001|Overall Study|Comfort care|4|||
13392311|NCT00672841|26779506|FG000|Overall Study|icteric specimens|0|||
13477502|NCT01595009|27006997|FG003|Core|Death|0|||
13477503|NCT01595009|27006994|FG000|Core|Lost to Follow-up|1|||
13306901|NCT01288430|26527141|FG008|Part 1|Clinical disease progression|0|||
13306902|NCT01288430|26527142|FG009|Part 1|Clinical disease progression|0|||
13306903|NCT01288430|26527133|FG000|Part 1|Death due to disease progression|0|||
13306904|NCT01288430|26527134|FG001|Part 1|Death due to disease progression|0|||
13306905|NCT01288430|26527135|FG002|Part 1|Death due to disease progression|0|||
13477504|NCT01595009|27006995|FG001|Core|Lost to Follow-up|2|||
13306906|NCT01288430|26527136|FG003|Part 1|Death due to disease progression|0|||
13306907|NCT01288430|26527137|FG004|Part 1|Death due to disease progression|1|||
13306908|NCT01288430|26527138|FG005|Part 1|Death due to disease progression|0|||
13306909|NCT01288430|26527139|FG006|Part 1|Death due to disease progression|0|||
13306910|NCT01288430|26527140|FG007|Part 1|Death due to disease progression|0|||
13306911|NCT01288430|26527141|FG008|Part 1|Death due to disease progression|0|||
13306912|NCT01288430|26527142|FG009|Part 1|Death due to disease progression|0|||
13306913|NCT01288430|26527133|FG000|Part 1|Adverse Event|0|||
13306914|NCT01288430|26527134|FG001|Part 1|Adverse Event|0|||
13306915|NCT01288430|26527135|FG002|Part 1|Adverse Event|3|||
13306916|NCT01288430|26527136|FG003|Part 1|Adverse Event|1|||
13306917|NCT01288430|26527137|FG004|Part 1|Adverse Event|0|||
13306918|NCT01288430|26527138|FG005|Part 1|Adverse Event|0|||
13306919|NCT01288430|26527139|FG006|Part 1|Adverse Event|2|||
13306920|NCT01288430|26527140|FG007|Part 1|Adverse Event|0|||
13306921|NCT01288430|26527141|FG008|Part 1|Adverse Event|0|||
13306922|NCT01288430|26527142|FG009|Part 1|Adverse Event|0|||
13306923|NCT01288430|26527133|FG000|Part 1|Other|0|||
13306924|NCT01288430|26527134|FG001|Part 1|Other|2|||
13306925|NCT01288430|26527135|FG002|Part 1|Other|0|||
13306926|NCT01288430|26527136|FG003|Part 1|Other|0|||
13306927|NCT01288430|26527137|FG004|Part 1|Other|0|||
13306928|NCT01288430|26527138|FG005|Part 1|Other|0|||
13306929|NCT01288430|26527139|FG006|Part 1|Other|1|||
13306930|NCT01288430|26527140|FG007|Part 1|Other|0|||
13306931|NCT01288430|26527141|FG008|Part 1|Other|0|||
13306932|NCT01288430|26527142|FG009|Part 1|Other|0|||
13306933|NCT01288430|26527133|FG000|Part 2|Progressive disease|0|||
13306934|NCT01288430|26527134|FG001|Part 2|Progressive disease|0|||
13306935|NCT01288430|26527135|FG002|Part 2|Progressive disease|0|||
13306936|NCT01288430|26527136|FG003|Part 2|Progressive disease|0|||
13306937|NCT01288430|26527137|FG004|Part 2|Progressive disease|0|||
13306938|NCT01288430|26527138|FG005|Part 2|Progressive disease|0|||
13306939|NCT01288430|26527139|FG006|Part 2|Progressive disease|0|||
13306940|NCT01288430|26527140|FG007|Part 2|Progressive disease|8|||
13306941|NCT01288430|26527141|FG008|Part 2|Progressive disease|7|||
13306942|NCT01288430|26527142|FG009|Part 2|Progressive disease|2|||
13306943|NCT01288430|26527133|FG000|Part 2|Clinical disease progression|0|||
13306944|NCT01288430|26527134|FG001|Part 2|Clinical disease progression|0|||
13306945|NCT01288430|26527135|FG002|Part 2|Clinical disease progression|0|||
13306946|NCT01288430|26527136|FG003|Part 2|Clinical disease progression|0|||
13306947|NCT01288430|26527137|FG004|Part 2|Clinical disease progression|0|||
13306948|NCT01288430|26527138|FG005|Part 2|Clinical disease progression|0|||
13306949|NCT01288430|26527139|FG006|Part 2|Clinical disease progression|0|||
13306950|NCT01288430|26527140|FG007|Part 2|Clinical disease progression|2|||
13306951|NCT01288430|26527141|FG008|Part 2|Clinical disease progression|0|||
13306952|NCT01288430|26527142|FG009|Part 2|Clinical disease progression|0|||
13306953|NCT01288430|26527133|FG000|Part 2|Withdrawal by Subject|0|||
13306954|NCT01288430|26527134|FG001|Part 2|Withdrawal by Subject|0|||
13306955|NCT01288430|26527135|FG002|Part 2|Withdrawal by Subject|0|||
13306956|NCT01288430|26527136|FG003|Part 2|Withdrawal by Subject|0|||
13306957|NCT01288430|26527137|FG004|Part 2|Withdrawal by Subject|0|||
13306958|NCT01288430|26527138|FG005|Part 2|Withdrawal by Subject|0|||
13306959|NCT01288430|26527139|FG006|Part 2|Withdrawal by Subject|0|||
13306960|NCT01288430|26527140|FG007|Part 2|Withdrawal by Subject|1|||
13306961|NCT01288430|26527141|FG008|Part 2|Withdrawal by Subject|4|||
13306962|NCT01288430|26527142|FG009|Part 2|Withdrawal by Subject|0|||
13306963|NCT01288430|26527133|FG000|Part 2|Adverse Event|0|||
13306964|NCT01288430|26527134|FG001|Part 2|Adverse Event|0|||
13306965|NCT01288430|26527135|FG002|Part 2|Adverse Event|0|||
13306966|NCT01288430|26527136|FG003|Part 2|Adverse Event|0|||
13306967|NCT01288430|26527137|FG004|Part 2|Adverse Event|0|||
13306968|NCT01288430|26527138|FG005|Part 2|Adverse Event|0|||
13306969|NCT01288430|26527139|FG006|Part 2|Adverse Event|0|||
13306970|NCT01288430|26527140|FG007|Part 2|Adverse Event|1|||
13306971|NCT01288430|26527141|FG008|Part 2|Adverse Event|1|||
13306972|NCT01288430|26527142|FG009|Part 2|Adverse Event|0|||
13306973|NCT01288430|26527133|FG000|Part 2|Other|0|||
13306974|NCT01288430|26527134|FG001|Part 2|Other|0|||
13306975|NCT01288430|26527135|FG002|Part 2|Other|0|||
13306976|NCT01288430|26527136|FG003|Part 2|Other|0|||
13306977|NCT01288430|26527137|FG004|Part 2|Other|0|||
13306978|NCT01288430|26527138|FG005|Part 2|Other|0|||
13306979|NCT01288430|26527139|FG006|Part 2|Other|0|||
13306980|NCT01288430|26527140|FG007|Part 2|Other|0|||
13306981|NCT01288430|26527141|FG008|Part 2|Other|0|||
13306982|NCT01288430|26527142|FG009|Part 2|Other|1|||
13306983|NCT01288287|26527157|FG000|Overall Study|Lost to Follow-up|8|||
13306984|NCT01288287|26527157|FG000|Overall Study|Withdrawal by Subject|4|||
13306985|NCT01288287|26527157|FG000|Overall Study|Lack of Efficacy|13|||
13306986|NCT01288287|26527157|FG000|Overall Study|Other Reason|13|||
13306987|NCT01288287|26527157|FG000|Overall Study|Unknown Reason|1|||
13306988|NCT01288287|26527157|FG000|Overall Study|Unknown Status|7|||
13306989|NCT01288209|26527190|FG000|Overall Study|Withdrawal by Subject|1|||
13306990|NCT01288209|26527191|FG001|Overall Study|Withdrawal by Subject|3|||
13306991|NCT01288209|26527190|FG000|Overall Study|Other|1|||
13306992|NCT01288209|26527191|FG001|Overall Study|Other|0|||
13306993|NCT01288079|26527214|FG000|Overall Study|Withdrawal by Subject|2|||
13306994|NCT01288079|26527215|FG001|Overall Study|Withdrawal by Subject|4|||
13306995|NCT01288079|26527216|FG002|Overall Study|Withdrawal by Subject|1|||
13306996|NCT01288079|26527217|FG003|Overall Study|Withdrawal by Subject|0|||
13306997|NCT01288079|26527214|FG000|Overall Study|Adverse Event|2|||
13306998|NCT01288079|26527215|FG001|Overall Study|Adverse Event|1|||
13306999|NCT01288079|26527216|FG002|Overall Study|Adverse Event|2|||
13307000|NCT01288079|26527217|FG003|Overall Study|Adverse Event|3|||
13307001|NCT01288079|26527214|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
13307002|NCT01288079|26527215|FG001|Overall Study|Severe Non-Compliance to Protocol|3|||
13307003|NCT01288079|26527216|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
13307004|NCT01288079|26527217|FG003|Overall Study|Severe Non-Compliance to Protocol|3|||
13307005|NCT01288079|26527214|FG000|Overall Study|Condition under Investigation Worsened|0|||
13307006|NCT01288079|26527215|FG001|Overall Study|Condition under Investigation Worsened|0|||
13307007|NCT01288079|26527216|FG002|Overall Study|Condition under Investigation Worsened|0|||
13307008|NCT01288079|26527217|FG003|Overall Study|Condition under Investigation Worsened|1|||
13307009|NCT01288079|26527214|FG000|Overall Study|Lack of Efficacy|2|||
13307010|NCT01288079|26527215|FG001|Overall Study|Lack of Efficacy|2|||
13307011|NCT01288079|26527216|FG002|Overall Study|Lack of Efficacy|0|||
13307012|NCT01288079|26527217|FG003|Overall Study|Lack of Efficacy|2|||
13307013|NCT01288079|26527214|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
13307014|NCT01288079|26527215|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
13307015|NCT01288079|26527216|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
13307016|NCT01288079|26527217|FG003|Overall Study|Study-Specific Withdrawal Criteria|0|||
13307017|NCT01288079|26527214|FG000|Overall Study|Lost to Follow-up|1|||
13307018|NCT01288079|26527215|FG001|Overall Study|Lost to Follow-up|1|||
13307019|NCT01288079|26527216|FG002|Overall Study|Lost to Follow-up|1|||
13307020|NCT01288079|26527217|FG003|Overall Study|Lost to Follow-up|0|||
13307021|NCT01288079|26527214|FG000|Overall Study|Other or Study Termination|11|||
13307022|NCT01288079|26527215|FG001|Overall Study|Other or Study Termination|15|||
13307023|NCT01288079|26527216|FG002|Overall Study|Other or Study Termination|14|||
13307024|NCT01288079|26527217|FG003|Overall Study|Other or Study Termination|8|||
13307025|NCT01288053|26527223|FG000|Overall Study|Death|1|||
13307026|NCT01287897|26527285|FG000|Overall Study|Adverse Event|5|||
13307027|NCT01287897|26527286|FG001|Overall Study|Adverse Event|3|||
13307028|NCT01287897|26527287|FG002|Overall Study|Adverse Event|6|||
13307029|NCT01287897|26527288|FG003|Overall Study|Adverse Event|4|||
13307030|NCT01287897|26527285|FG000|Overall Study|Lack of Efficacy|2|||
13307031|NCT01287897|26527286|FG001|Overall Study|Lack of Efficacy|0|||
13307032|NCT01287897|26527287|FG002|Overall Study|Lack of Efficacy|0|||
13307033|NCT01287897|26527288|FG003|Overall Study|Lack of Efficacy|0|||
13307034|NCT01287897|26527285|FG000|Overall Study|Protocol Violation|1|||
13307035|NCT01287897|26527286|FG001|Overall Study|Protocol Violation|1|||
13307036|NCT01287897|26527287|FG002|Overall Study|Protocol Violation|0|||
13307037|NCT01287897|26527288|FG003|Overall Study|Protocol Violation|1|||
13307038|NCT01287897|26527285|FG000|Overall Study|Lost to Follow-up|0|||
13307039|NCT01287897|26527286|FG001|Overall Study|Lost to Follow-up|0|||
13307040|NCT01287897|26527287|FG002|Overall Study|Lost to Follow-up|2|||
13307041|NCT01287897|26527288|FG003|Overall Study|Lost to Follow-up|0|||
13307042|NCT01287897|26527285|FG000|Overall Study|Withdrawal by Subject|1|||
13307043|NCT01287897|26527286|FG001|Overall Study|Withdrawal by Subject|5|||
13307044|NCT01287897|26527287|FG002|Overall Study|Withdrawal by Subject|3|||
13307045|NCT01287897|26527288|FG003|Overall Study|Withdrawal by Subject|2|||
13307046|NCT01287897|26527285|FG000|Overall Study|Not consented properly|0|||
13307047|NCT01287897|26527286|FG001|Overall Study|Not consented properly|1|||
13307048|NCT01287897|26527287|FG002|Overall Study|Not consented properly|0|||
13307049|NCT01287897|26527288|FG003|Overall Study|Not consented properly|0|||
13307050|NCT01287897|26527285|FG000|Overall Study|Not meeting entrance criteria|1|||
13307051|NCT01287897|26527286|FG001|Overall Study|Not meeting entrance criteria|1|||
13307052|NCT01287897|26527287|FG002|Overall Study|Not meeting entrance criteria|0|||
13307053|NCT01287897|26527288|FG003|Overall Study|Not meeting entrance criteria|0|||
13307054|NCT01287897|26527285|FG000|Overall Study|Other|1|||
13307055|NCT01287897|26527286|FG001|Overall Study|Other|0|||
13307056|NCT01287897|26527287|FG002|Overall Study|Other|1|||
13307057|NCT01287897|26527288|FG003|Overall Study|Other|0|||
13307058|NCT01287832|26527301|FG000|Overall Study|Adverse Event|1|||
13307059|NCT01287832|26527302|FG001|Overall Study|Adverse Event|0|||
13307060|NCT01287832|26527301|FG000|Overall Study|Death|0|||
13307061|NCT01287832|26527302|FG001|Overall Study|Death|1|||
13307062|NCT01287754|26527319|FG000|Overall Study|Death|2|||
13307063|NCT01287754|26527320|FG001|Overall Study|Death|12|||
13307064|NCT01287754|26527319|FG000|Overall Study|Lost to Follow-up|1|||
13307065|NCT01287754|26527320|FG001|Overall Study|Lost to Follow-up|6|||
13307066|NCT01287754|26527319|FG000|Overall Study|Protocol Violation|0|||
13307067|NCT01287754|26527320|FG001|Overall Study|Protocol Violation|3|||
13307068|NCT01287520|26527410|FG000|Overall Study|Adverse Event|2|||
13307069|NCT01287520|26527411|FG001|Overall Study|Adverse Event|2|||
13307070|NCT01287520|26527412|FG002|Overall Study|Adverse Event|2|||
13307071|NCT01287520|26527413|FG003|Overall Study|Adverse Event|1|||
13307072|NCT01287520|26527414|FG004|Overall Study|Adverse Event|1|||
13307073|NCT01287520|26527415|FG005|Overall Study|Adverse Event|2|||
13307074|NCT01287520|26527416|FG006|Overall Study|Adverse Event|0|||
13307075|NCT01287520|26527417|FG007|Overall Study|Adverse Event|2|||
13307076|NCT01287520|26527418|FG008|Overall Study|Adverse Event|0|||
13307077|NCT01287520|26527410|FG000|Overall Study|Physician Decision|1|||
13307078|NCT01287520|26527411|FG001|Overall Study|Physician Decision|1|||
13307079|NCT01287520|26527412|FG002|Overall Study|Physician Decision|2|||
13307080|NCT01287520|26527413|FG003|Overall Study|Physician Decision|0|||
13307081|NCT01287520|26527414|FG004|Overall Study|Physician Decision|1|||
13307082|NCT01287520|26527415|FG005|Overall Study|Physician Decision|1|||
13307083|NCT01287520|26527416|FG006|Overall Study|Physician Decision|0|||
13307084|NCT01287520|26527417|FG007|Overall Study|Physician Decision|1|||
13307085|NCT01287520|26527418|FG008|Overall Study|Physician Decision|0|||
13307086|NCT01287520|26527410|FG000|Overall Study|Progressive disease|0|||
13307087|NCT01287520|26527411|FG001|Overall Study|Progressive disease|4|||
13307088|NCT01287520|26527412|FG002|Overall Study|Progressive disease|1|||
13307089|NCT01287520|26527413|FG003|Overall Study|Progressive disease|6|||
13307090|NCT01287520|26527414|FG004|Overall Study|Progressive disease|1|||
13307091|NCT01287520|26527415|FG005|Overall Study|Progressive disease|0|||
13307092|NCT01287520|26527416|FG006|Overall Study|Progressive disease|2|||
13307093|NCT01287520|26527417|FG007|Overall Study|Progressive disease|2|||
13307094|NCT01287520|26527418|FG008|Overall Study|Progressive disease|4|||
13307095|NCT01287520|26527410|FG000|Overall Study|Withdrawal by Subject|0|||
13307096|NCT01287520|26527411|FG001|Overall Study|Withdrawal by Subject|0|||
13307097|NCT01287520|26527412|FG002|Overall Study|Withdrawal by Subject|0|||
13307098|NCT01287520|26527413|FG003|Overall Study|Withdrawal by Subject|0|||
13307099|NCT01287520|26527414|FG004|Overall Study|Withdrawal by Subject|0|||
13307100|NCT01287520|26527415|FG005|Overall Study|Withdrawal by Subject|1|||
13307101|NCT01287520|26527416|FG006|Overall Study|Withdrawal by Subject|0|||
13307102|NCT01287520|26527417|FG007|Overall Study|Withdrawal by Subject|0|||
13307103|NCT01287520|26527418|FG008|Overall Study|Withdrawal by Subject|1|||
13307104|NCT01287416|26527461|FG000|Pre-post Training|Withdrawal by Subject|17|||
13307105|NCT01287416|26527462|FG001|Pre-post Training|Withdrawal by Subject|24|||
13307106|NCT01287416|26527461|FG000|Pre-post Training|Lost to Follow-up|5|||
13307107|NCT01287416|26527462|FG001|Pre-post Training|Lost to Follow-up|1|||
13307108|NCT01287416|26527461|FG000|6 Month Follow-up|Lost to Follow-up|3|||
13307109|NCT01287416|26527462|FG001|6 Month Follow-up|Lost to Follow-up|2|||
13307110|NCT01287403|26527478|FG000|1st Intervention (1 Day)|Adverse Event|1|||
13307111|NCT01287364|26527505|FG000|Overall Study|Adverse Event|0|||
13307112|NCT01287364|26527506|FG001|Overall Study|Adverse Event|3|||
13307113|NCT01287364|26527505|FG000|Overall Study|Protocol Violation|5|||
13307114|NCT01287364|26527506|FG001|Overall Study|Protocol Violation|5|||
13307115|NCT01287364|26527505|FG000|Overall Study|Other Reason|4|||
13307116|NCT01287364|26527506|FG001|Overall Study|Other Reason|2|||
13307117|NCT01287221|26527531|FG000|Overall Study|Lack of Perceived Benefit|1|||
13307118|NCT01287221|26527532|FG001|Overall Study|Lack of Perceived Benefit|1|||
13307119|NCT01287221|26527531|FG000|Overall Study|Adverse Event|3|||
13307120|NCT01287221|26527532|FG001|Overall Study|Adverse Event|3|||
13307121|NCT01287221|26527531|FG000|Overall Study|Withdrawal by Subject|0|||
13307122|NCT01287221|26527532|FG001|Overall Study|Withdrawal by Subject|1|||
13307123|NCT01287195|26527545|FG000|Overall Study|Withdrawal by Subject|2|||
13307124|NCT01287117|26527604|FG000|Overall Study|Adverse Event|2|||
13307125|NCT01287117|26527605|FG001|Overall Study|Adverse Event|1|||
13307126|NCT01287117|26527606|FG002|Overall Study|Adverse Event|1|||
13307127|NCT01287117|26527607|FG003|Overall Study|Adverse Event|1|||
13307128|NCT01287117|26527604|FG000|Overall Study|Lost to Follow-up|1|||
13307129|NCT01287117|26527605|FG001|Overall Study|Lost to Follow-up|1|||
13307130|NCT01287117|26527606|FG002|Overall Study|Lost to Follow-up|0|||
13307131|NCT01287117|26527607|FG003|Overall Study|Lost to Follow-up|0|||
13307132|NCT01287117|26527604|FG000|Overall Study|Physician Decision|0|||
13307133|NCT01287117|26527605|FG001|Overall Study|Physician Decision|1|||
13307134|NCT01287117|26527606|FG002|Overall Study|Physician Decision|1|||
13307135|NCT01287117|26527607|FG003|Overall Study|Physician Decision|1|||
13307136|NCT01287117|26527604|FG000|Overall Study|Patient/Legal Guardian's Decision|2|||
13307137|NCT01287117|26527605|FG001|Overall Study|Patient/Legal Guardian's Decision|6|||
13307138|NCT01287117|26527606|FG002|Overall Study|Patient/Legal Guardian's Decision|8|||
13307139|NCT01287117|26527607|FG003|Overall Study|Patient/Legal Guardian's Decision|5|||
13307140|NCT01287117|26527604|FG000|Overall Study|Disease Progression|10|||
13307141|NCT01287117|26527605|FG001|Overall Study|Disease Progression|5|||
13307142|NCT01287117|26527606|FG002|Overall Study|Disease Progression|6|||
13307143|NCT01287117|26527607|FG003|Overall Study|Disease Progression|5|||
13307144|NCT01287104|26527653|FG000|Overall Study|Patient developed progressive disease|1|||
13307145|NCT01287104|26527654|FG001|Overall Study|Patient developed progressive disease|1|||
13307146|NCT01287104|26527655|FG002|Overall Study|Patient developed progressive disease|3|||
13307147|NCT01287104|26527656|FG003|Overall Study|Patient developed progressive disease|2|||
13307148|NCT01287104|26527653|FG000|Overall Study|Donor anaphylaxis|0|||
13307149|NCT01287104|26527654|FG001|Overall Study|Donor anaphylaxis|1|||
13307150|NCT01287104|26527655|FG002|Overall Study|Donor anaphylaxis|0|||
13307151|NCT01287104|26527656|FG003|Overall Study|Donor anaphylaxis|1|||
13307152|NCT01287104|26527653|FG000|Overall Study|Developed GVHD or complications of BMT|0|||
13307153|NCT01287104|26527654|FG001|Overall Study|Developed GVHD or complications of BMT|1|||
13307154|NCT01287104|26527655|FG002|Overall Study|Developed GVHD or complications of BMT|4|||
13307155|NCT01287104|26527656|FG003|Overall Study|Developed GVHD or complications of BMT|0|||
13307156|NCT01287104|26527653|FG000|Overall Study|Low donor chimerism|0|||
13307157|NCT01287104|26527654|FG001|Overall Study|Low donor chimerism|1|||
13307158|NCT01287104|26527655|FG002|Overall Study|Low donor chimerism|0|||
13307159|NCT01287104|26527656|FG003|Overall Study|Low donor chimerism|0|||
13307160|NCT01287104|26527653|FG000|Overall Study|NK cells did not meet release criteria|0|||
13307161|NCT01287104|26527654|FG001|Overall Study|NK cells did not meet release criteria|1|||
13307162|NCT01287104|26527655|FG002|Overall Study|NK cells did not meet release criteria|0|||
13307163|NCT01287104|26527656|FG003|Overall Study|NK cells did not meet release criteria|0|||
13307164|NCT01287065|26527680|FG000|Treatment Period 1|Adverse Event|0|||
13307165|NCT01287065|26527681|FG001|Treatment Period 1|Adverse Event|0|||
13307166|NCT01287065|26527682|FG002|Treatment Period 1|Adverse Event|0|||
13307167|NCT01287065|26527683|FG003|Treatment Period 1|Adverse Event|0|||
13307168|NCT01287065|26527684|FG004|Treatment Period 1|Adverse Event|1|||
13307169|NCT01287065|26527685|FG005|Treatment Period 1|Adverse Event|0|||
13307170|NCT01287065|26527680|FG000|Treatment Period 1|Withdrawal by Subject|0|||
13307171|NCT01287065|26527681|FG001|Treatment Period 1|Withdrawal by Subject|0|||
13307172|NCT01287065|26527682|FG002|Treatment Period 1|Withdrawal by Subject|0|||
13307173|NCT01287065|26527683|FG003|Treatment Period 1|Withdrawal by Subject|0|||
13307174|NCT01287065|26527684|FG004|Treatment Period 1|Withdrawal by Subject|0|||
13307175|NCT01287065|26527685|FG005|Treatment Period 1|Withdrawal by Subject|1|||
13372812|NCT00806442|26722049|FG000|Overall Study|Withdrawal by Subject|1|||
13372813|NCT00806442|26722050|FG001|Overall Study|Withdrawal by Subject|5|||
13372814|NCT00806416|26722070|FG000|Period 1 - Part I|Adverse Event|0|||
13372815|NCT00806416|26722071|FG001|Period 1 - Part I|Adverse Event|1|||
13372816|NCT00806416|26722072|FG002|Period 1 - Part I|Adverse Event|0|||
13372817|NCT00806416|26722073|FG003|Period 1 - Part I|Adverse Event|0|||
13372818|NCT00806416|26722070|FG000|Period 1 - Part I|Lost to Follow-up|0|||
13372819|NCT00806416|26722071|FG001|Period 1 - Part I|Lost to Follow-up|2|||
13372820|NCT00806416|26722072|FG002|Period 1 - Part I|Lost to Follow-up|0|||
13372821|NCT00806416|26722073|FG003|Period 1 - Part I|Lost to Follow-up|0|||
13372822|NCT00806416|26722070|FG000|Period 1 - Part I|Withdrawal by Subject|3|||
13372823|NCT00806416|26722071|FG001|Period 1 - Part I|Withdrawal by Subject|1|||
13372824|NCT00806416|26722072|FG002|Period 1 - Part I|Withdrawal by Subject|0|||
13372825|NCT00806416|26722073|FG003|Period 1 - Part I|Withdrawal by Subject|0|||
13372826|NCT00806416|26722070|FG000|Period 1 - Part II|Withdrawal by Subject|0|||
13372827|NCT00806416|26722071|FG001|Period 1 - Part II|Withdrawal by Subject|0|||
13372828|NCT00806416|26722072|FG002|Period 1 - Part II|Withdrawal by Subject|0|||
13372829|NCT00806416|26722073|FG003|Period 1 - Part II|Withdrawal by Subject|2|||
13372830|NCT00806351|26722111|FG000|Overall Study|Death|5|||
13372831|NCT00806351|26722112|FG001|Overall Study|Death|4|||
13372832|NCT00806286|26722138|FG000|Overall Study|Adverse Event|5|||
13372833|NCT00806286|26722139|FG001|Overall Study|Adverse Event|2|||
13372834|NCT00806286|26722140|FG002|Overall Study|Adverse Event|0|||
13372835|NCT00806286|26722138|FG000|Overall Study|Disease progression|31|||
13372836|NCT00806286|26722139|FG001|Overall Study|Disease progression|38|||
13372837|NCT00806286|26722140|FG002|Overall Study|Disease progression|1|||
13372838|NCT00806286|26722138|FG000|Overall Study|Death|1|||
13372839|NCT00806286|26722139|FG001|Overall Study|Death|6|||
13372840|NCT00806286|26722140|FG002|Overall Study|Death|0|||
13372841|NCT00806286|26722138|FG000|Overall Study|Lost to Follow-up|0|||
13372842|NCT00806286|26722139|FG001|Overall Study|Lost to Follow-up|1|||
13372843|NCT00806286|26722140|FG002|Overall Study|Lost to Follow-up|0|||
13372844|NCT00806286|26722138|FG000|Overall Study|Withdrawal by Subject|8|||
13372845|NCT00806286|26722139|FG001|Overall Study|Withdrawal by Subject|3|||
13372846|NCT00806286|26722140|FG002|Overall Study|Withdrawal by Subject|1|||
13372847|NCT00806286|26722138|FG000|Overall Study|Physician Decision|2|||
13372848|NCT00806286|26722139|FG001|Overall Study|Physician Decision|2|||
13372849|NCT00806286|26722140|FG002|Overall Study|Physician Decision|0|||
13372850|NCT00806286|26722138|FG000|Overall Study|Due to a variety of reasons|7|||
13372851|NCT00806286|26722139|FG001|Overall Study|Due to a variety of reasons|2|||
13372852|NCT00806286|26722140|FG002|Overall Study|Due to a variety of reasons|1|||
13372853|NCT00806260|26722171|FG000|Period 1 (1 Day)|Adverse Event|0|||
13372854|NCT00806260|26722172|FG001|Period 1 (1 Day)|Adverse Event|0|||
13372855|NCT00806260|26722173|FG002|Period 1 (1 Day)|Adverse Event|0|||
13392312|NCT00672841|26779507|FG001|Overall Study|icteric specimens|3|||
13372856|NCT00806260|26722174|FG003|Period 1 (1 Day)|Adverse Event|0|||
13372857|NCT00806260|26722175|FG004|Period 1 (1 Day)|Adverse Event|3|||
13372858|NCT00806260|26722176|FG005|Period 1 (1 Day)|Adverse Event|0|||
13372859|NCT00806260|26722171|FG000|Period 2|Adverse Event|0|||
13372860|NCT00806260|26722172|FG001|Period 2|Adverse Event|0|||
13307176|NCT01287039|26527722|FG000|Overall Study|Noncompliance with study procedures|0|||
13307177|NCT01287039|26527723|FG001|Overall Study|Noncompliance with study procedures|1|||
13307178|NCT01287039|26527722|FG000|Overall Study|Change of location/residence|0|||
13307179|NCT01287039|26527723|FG001|Overall Study|Change of location/residence|3|||
13307180|NCT01287039|26527722|FG000|Overall Study|Elective surgery|0|||
13307181|NCT01287039|26527723|FG001|Overall Study|Elective surgery|1|||
13307182|NCT01287039|26527722|FG000|Overall Study|Protocol Violation|2|||
13307183|NCT01287039|26527723|FG001|Overall Study|Protocol Violation|3|||
13307184|NCT01287039|26527722|FG000|Overall Study|Excluded medication taken|1|||
13307185|NCT01287039|26527723|FG001|Overall Study|Excluded medication taken|0|||
13307186|NCT01287039|26527722|FG000|Overall Study|Noncompliance with study medication|0|||
13307187|NCT01287039|26527723|FG001|Overall Study|Noncompliance with study medication|1|||
13307188|NCT01287039|26527722|FG000|Overall Study|Problem with travel|0|||
13307189|NCT01287039|26527723|FG001|Overall Study|Problem with travel|1|||
13307190|NCT01287039|26527722|FG000|Overall Study|Death|1|||
13307191|NCT01287039|26527723|FG001|Overall Study|Death|0|||
13307192|NCT01287039|26527722|FG000|Overall Study|Change of residence|1|||
13307193|NCT01287039|26527723|FG001|Overall Study|Change of residence|0|||
13307194|NCT01287039|26527722|FG000|Overall Study|Adverse Event|7|||
13307195|NCT01287039|26527723|FG001|Overall Study|Adverse Event|4|||
13307196|NCT01287039|26527722|FG000|Overall Study|Withdrawal by Subject|14|||
13307197|NCT01287039|26527723|FG001|Overall Study|Withdrawal by Subject|11|||
13307198|NCT01287039|26527722|FG000|Overall Study|Lost to Follow-up|3|||
13307199|NCT01287039|26527723|FG001|Overall Study|Lost to Follow-up|2|||
13307200|NCT01287013|26527748|FG000|Overall Study|Non-evaluable|3|||
13307201|NCT01287013|26527749|FG001|Overall Study|Non-evaluable|5|||
13307202|NCT01287013|26527750|FG002|Overall Study|Non-evaluable|21|||
13307203|NCT01286987|26527937|FG000|Part 1: Dose Escalation|Clinical Progression|1|||
13307204|NCT01286987|26527938|FG001|Part 1: Dose Escalation|Clinical Progression|1|||
13307205|NCT01286987|26527939|FG002|Part 1: Dose Escalation|Clinical Progression|0|||
13307206|NCT01286987|26527940|FG003|Part 1: Dose Escalation|Clinical Progression|1|||
13307207|NCT01286987|26527941|FG004|Part 1: Dose Escalation|Clinical Progression|1|||
13307208|NCT01286987|26527942|FG005|Part 1: Dose Escalation|Clinical Progression|1|||
13307209|NCT01286987|26527943|FG006|Part 1: Dose Escalation|Clinical Progression|0|||
13307210|NCT01286987|26527944|FG007|Part 1: Dose Escalation|Clinical Progression|2|||
13307211|NCT01286987|26527945|FG008|Part 1: Dose Escalation|Clinical Progression|1|||
13307212|NCT01286987|26527946|FG009|Part 1: Dose Escalation|Clinical Progression|0|||
13307213|NCT01286987|26527947|FG010|Part 1: Dose Escalation|Clinical Progression|0|||
13307214|NCT01286987|26527948|FG011|Part 1: Dose Escalation|Clinical Progression|0|||
13307215|NCT01286987|26527949|FG012|Part 1: Dose Escalation|Clinical Progression|0|||
13307216|NCT01286987|26527950|FG013|Part 1: Dose Escalation|Clinical Progression|0|||
13307217|NCT01286987|26527951|FG014|Part 1: Dose Escalation|Clinical Progression|0|||
13307218|NCT01286987|26527937|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
13307219|NCT01286987|26527938|FG001|Part 1: Dose Escalation|Progressive Disease|2|||
13307220|NCT01286987|26527939|FG002|Part 1: Dose Escalation|Progressive Disease|3|||
13307221|NCT01286987|26527940|FG003|Part 1: Dose Escalation|Progressive Disease|2|||
13307222|NCT01286987|26527941|FG004|Part 1: Dose Escalation|Progressive Disease|1|||
13307223|NCT01286987|26527942|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
13307224|NCT01286987|26527943|FG006|Part 1: Dose Escalation|Progressive Disease|5|||
13307225|NCT01286987|26527944|FG007|Part 1: Dose Escalation|Progressive Disease|3|||
13307226|NCT01286987|26527945|FG008|Part 1: Dose Escalation|Progressive Disease|5|||
13307227|NCT01286987|26527946|FG009|Part 1: Dose Escalation|Progressive Disease|0|||
13307228|NCT01286987|26527947|FG010|Part 1: Dose Escalation|Progressive Disease|0|||
13307229|NCT01286987|26527948|FG011|Part 1: Dose Escalation|Progressive Disease|0|||
13307230|NCT01286987|26527949|FG012|Part 1: Dose Escalation|Progressive Disease|0|||
13307231|NCT01286987|26527950|FG013|Part 1: Dose Escalation|Progressive Disease|0|||
13307232|NCT01286987|26527951|FG014|Part 1: Dose Escalation|Progressive Disease|0|||
13307233|NCT01286987|26527937|FG000|Part 1: Dose Escalation|Physician Decision|0|||
13307234|NCT01286987|26527938|FG001|Part 1: Dose Escalation|Physician Decision|0|||
13307235|NCT01286987|26527939|FG002|Part 1: Dose Escalation|Physician Decision|0|||
13307236|NCT01286987|26527940|FG003|Part 1: Dose Escalation|Physician Decision|0|||
13307237|NCT01286987|26527941|FG004|Part 1: Dose Escalation|Physician Decision|1|||
13307238|NCT01286987|26527942|FG005|Part 1: Dose Escalation|Physician Decision|0|||
13307239|NCT01286987|26527943|FG006|Part 1: Dose Escalation|Physician Decision|0|||
13307240|NCT01286987|26527944|FG007|Part 1: Dose Escalation|Physician Decision|0|||
13307241|NCT01286987|26527945|FG008|Part 1: Dose Escalation|Physician Decision|0|||
13307242|NCT01286987|26527946|FG009|Part 1: Dose Escalation|Physician Decision|0|||
13307243|NCT01286987|26527947|FG010|Part 1: Dose Escalation|Physician Decision|0|||
13307244|NCT01286987|26527948|FG011|Part 1: Dose Escalation|Physician Decision|0|||
13307245|NCT01286987|26527949|FG012|Part 1: Dose Escalation|Physician Decision|0|||
13307246|NCT01286987|26527950|FG013|Part 1: Dose Escalation|Physician Decision|0|||
13307247|NCT01286987|26527951|FG014|Part 1: Dose Escalation|Physician Decision|0|||
13307248|NCT01286987|26527937|FG000|Part 2: Dose Expansion|Death|0|||
13307249|NCT01286987|26527938|FG001|Part 2: Dose Expansion|Death|0|||
13307250|NCT01286987|26527939|FG002|Part 2: Dose Expansion|Death|0|||
13307251|NCT01286987|26527940|FG003|Part 2: Dose Expansion|Death|0|||
13307252|NCT01286987|26527941|FG004|Part 2: Dose Expansion|Death|0|||
13307253|NCT01286987|26527942|FG005|Part 2: Dose Expansion|Death|0|||
13307254|NCT01286987|26527943|FG006|Part 2: Dose Expansion|Death|0|||
13307255|NCT01286987|26527944|FG007|Part 2: Dose Expansion|Death|0|||
13307256|NCT01286987|26527945|FG008|Part 2: Dose Expansion|Death|0|||
13307257|NCT01286987|26527946|FG009|Part 2: Dose Expansion|Death|0|||
13307258|NCT01286987|26527947|FG010|Part 2: Dose Expansion|Death|0|||
13307259|NCT01286987|26527948|FG011|Part 2: Dose Expansion|Death|0|||
13307260|NCT01286987|26527949|FG012|Part 2: Dose Expansion|Death|1|||
13307261|NCT01286987|26527950|FG013|Part 2: Dose Expansion|Death|1|||
13307262|NCT01286987|26527951|FG014|Part 2: Dose Expansion|Death|0|||
13307263|NCT01286987|26527937|FG000|Part 2: Dose Expansion|Physician Decision|0|||
13307264|NCT01286987|26527938|FG001|Part 2: Dose Expansion|Physician Decision|0|||
13307265|NCT01286987|26527939|FG002|Part 2: Dose Expansion|Physician Decision|0|||
13307266|NCT01286987|26527940|FG003|Part 2: Dose Expansion|Physician Decision|0|||
13307267|NCT01286987|26527941|FG004|Part 2: Dose Expansion|Physician Decision|0|||
13307268|NCT01286987|26527942|FG005|Part 2: Dose Expansion|Physician Decision|0|||
13307269|NCT01286987|26527943|FG006|Part 2: Dose Expansion|Physician Decision|0|||
13307270|NCT01286987|26527944|FG007|Part 2: Dose Expansion|Physician Decision|0|||
13307271|NCT01286987|26527945|FG008|Part 2: Dose Expansion|Physician Decision|0|||
13307272|NCT01286987|26527946|FG009|Part 2: Dose Expansion|Physician Decision|0|||
13307273|NCT01286987|26527947|FG010|Part 2: Dose Expansion|Physician Decision|1|||
13307274|NCT01286987|26527948|FG011|Part 2: Dose Expansion|Physician Decision|1|||
13307275|NCT01286987|26527949|FG012|Part 2: Dose Expansion|Physician Decision|0|||
13307276|NCT01286987|26527950|FG013|Part 2: Dose Expansion|Physician Decision|1|||
13307277|NCT01286987|26527951|FG014|Part 2: Dose Expansion|Physician Decision|0|||
13307278|NCT01286987|26527937|FG000|Part 2: Dose Expansion|Other|0|||
13307279|NCT01286987|26527938|FG001|Part 2: Dose Expansion|Other|0|||
13307280|NCT01286987|26527939|FG002|Part 2: Dose Expansion|Other|0|||
13307281|NCT01286987|26527940|FG003|Part 2: Dose Expansion|Other|0|||
13307282|NCT01286987|26527941|FG004|Part 2: Dose Expansion|Other|0|||
13307283|NCT01286987|26527942|FG005|Part 2: Dose Expansion|Other|0|||
13307284|NCT01286987|26527943|FG006|Part 2: Dose Expansion|Other|0|||
13307285|NCT01286987|26527944|FG007|Part 2: Dose Expansion|Other|0|||
13307286|NCT01286987|26527945|FG008|Part 2: Dose Expansion|Other|0|||
13307287|NCT01286987|26527946|FG009|Part 2: Dose Expansion|Other|0|||
13307288|NCT01286987|26527947|FG010|Part 2: Dose Expansion|Other|0|||
13307289|NCT01286987|26527948|FG011|Part 2: Dose Expansion|Other|0|||
13307290|NCT01286987|26527949|FG012|Part 2: Dose Expansion|Other|0|||
13307291|NCT01286987|26527950|FG013|Part 2: Dose Expansion|Other|1|||
13307292|NCT01286987|26527951|FG014|Part 2: Dose Expansion|Other|0|||
13307293|NCT01286987|26527937|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
13307294|NCT01286987|26527938|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
13307295|NCT01286987|26527939|FG002|Part 2: Dose Expansion|Progressive Disease|0|||
13307296|NCT01286987|26527940|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
13307297|NCT01286987|26527941|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
13307298|NCT01286987|26527942|FG005|Part 2: Dose Expansion|Progressive Disease|0|||
13307299|NCT01286987|26527943|FG006|Part 2: Dose Expansion|Progressive Disease|0|||
13307300|NCT01286987|26527944|FG007|Part 2: Dose Expansion|Progressive Disease|0|||
13307301|NCT01286987|26527945|FG008|Part 2: Dose Expansion|Progressive Disease|0|||
13307302|NCT01286987|26527946|FG009|Part 2: Dose Expansion|Progressive Disease|11|||
13307303|NCT01286987|26527947|FG010|Part 2: Dose Expansion|Progressive Disease|6|||
13307304|NCT01286987|26527948|FG011|Part 2: Dose Expansion|Progressive Disease|7|||
13307305|NCT01286987|26527949|FG012|Part 2: Dose Expansion|Progressive Disease|11|||
13307306|NCT01286987|26527950|FG013|Part 2: Dose Expansion|Progressive Disease|19|||
13307307|NCT01286987|26527951|FG014|Part 2: Dose Expansion|Progressive Disease|2|||
13307308|NCT01286987|26527937|FG000|Part 2: Dose Expansion|Clinical Progression|0|||
13307309|NCT01286987|26527938|FG001|Part 2: Dose Expansion|Clinical Progression|0|||
13307310|NCT01286987|26527939|FG002|Part 2: Dose Expansion|Clinical Progression|0|||
13307311|NCT01286987|26527940|FG003|Part 2: Dose Expansion|Clinical Progression|0|||
13307312|NCT01286987|26527941|FG004|Part 2: Dose Expansion|Clinical Progression|0|||
13307313|NCT01286987|26527942|FG005|Part 2: Dose Expansion|Clinical Progression|0|||
13307314|NCT01286987|26527943|FG006|Part 2: Dose Expansion|Clinical Progression|0|||
13392313|NCT00672841|26779506|FG000|Overall Study|Antifungal therapy, negative glucan|0|||
13392314|NCT00672841|26779507|FG001|Overall Study|Antifungal therapy, negative glucan|4|||
13392315|NCT00672841|26779506|FG000|Overall Study|Adverse Event|0|||
13392316|NCT00672841|26779507|FG001|Overall Study|Adverse Event|3|||
13392317|NCT00672841|26779506|FG000|Overall Study|Pregnancy|0|||
13392318|NCT00672841|26779507|FG001|Overall Study|Pregnancy|1|||
13392319|NCT00672646|26779540|FG000|Overall Study|Lost to Follow-up|0|||
13392320|NCT00672646|26779541|FG001|Overall Study|Lost to Follow-up|1|||
13392321|NCT00672646|26779542|FG002|Overall Study|Lost to Follow-up|2|||
13392322|NCT00672646|26779540|FG000|Overall Study|Withdrawal by Subject|0|||
13307315|NCT01286987|26527944|FG007|Part 2: Dose Expansion|Clinical Progression|0|||
13307316|NCT01286987|26527945|FG008|Part 2: Dose Expansion|Clinical Progression|0|||
13307317|NCT01286987|26527946|FG009|Part 2: Dose Expansion|Clinical Progression|0|||
13307318|NCT01286987|26527947|FG010|Part 2: Dose Expansion|Clinical Progression|2|||
13307319|NCT01286987|26527948|FG011|Part 2: Dose Expansion|Clinical Progression|2|||
13307320|NCT01286987|26527949|FG012|Part 2: Dose Expansion|Clinical Progression|0|||
13307321|NCT01286987|26527950|FG013|Part 2: Dose Expansion|Clinical Progression|2|||
13307322|NCT01286987|26527951|FG014|Part 2: Dose Expansion|Clinical Progression|0|||
13307323|NCT01286987|26527937|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
13307324|NCT01286987|26527938|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
13307325|NCT01286987|26527939|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
13307326|NCT01286987|26527940|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
13307327|NCT01286987|26527941|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
13307328|NCT01286987|26527942|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0|||
13307329|NCT01286987|26527943|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0|||
13307330|NCT01286987|26527944|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0|||
13307331|NCT01286987|26527945|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
13307332|NCT01286987|26527946|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
13307333|NCT01286987|26527947|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1|||
13307334|NCT01286987|26527948|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
13307335|NCT01286987|26527949|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0|||
13307336|NCT01286987|26527950|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0|||
13307337|NCT01286987|26527951|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0|||
13307338|NCT01286779|26528003|FG000|Overall Study|Withdrawal by Subject|9|||
13307339|NCT01286779|26528003|FG000|Overall Study|Protocol Violation|5|||
13307340|NCT01286779|26528003|FG000|Overall Study|Physician Decision|2|||
13307341|NCT01286779|26528003|FG000|Overall Study|Participant had scheduled surgery|1|||
13307342|NCT01286779|26528003|FG000|Overall Study|Participant moved to another country|1|||
13307343|NCT01286779|26528003|FG000|Overall Study|Discontinued by sponsor|1|||
13307344|NCT01286753|26528028|FG000|Overall Study|Adverse Event|7|||
13307345|NCT01286753|26528029|FG001|Overall Study|Adverse Event|6|||
13307346|NCT01286753|26528028|FG000|Overall Study|Progression|11|||
13307347|NCT01286753|26528029|FG001|Overall Study|Progression|13|||
13307348|NCT01286753|26528028|FG000|Overall Study|Refused Treatment|1|||
13307349|NCT01286753|26528029|FG001|Overall Study|Refused Treatment|0|||
13307350|NCT01286753|26528028|FG000|Overall Study|Withdrawal of Consent|0|||
13307351|NCT01286753|26528029|FG001|Overall Study|Withdrawal of Consent|2|||
13307352|NCT01286753|26528028|FG000|Overall Study|Discontinued to Join Extension Study|6|||
13307353|NCT01286753|26528029|FG001|Overall Study|Discontinued to Join Extension Study|4|||
13307354|NCT01286753|26528028|FG000|Overall Study|Participant to Receive Radiotherapy|1|||
13307355|NCT01286753|26528029|FG001|Overall Study|Participant to Receive Radiotherapy|0|||
13307356|NCT01286740|26528047|FG000|Overall Study|Enrolled but not treated|1|||
13307357|NCT01286740|26528047|FG000|Overall Study|Protocol Violation|1|||
13307358|NCT01286558|26528084|FG000|Overall Study|Adverse Event|1|||
13307359|NCT01286558|26528085|FG001|Overall Study|Adverse Event|1|||
13307360|NCT01286558|26528084|FG000|Overall Study|Withdrawal by Subject|0|||
13307361|NCT01286558|26528085|FG001|Overall Study|Withdrawal by Subject|1|||
13307362|NCT01286480|26528100|FG000|Overall Study|Withdrawal by Subject|5|||
13307363|NCT01286480|26528101|FG001|Overall Study|Withdrawal by Subject|3|||
13307364|NCT01286311|26528122|FG000|Overall Study|Physician did not want outreach sent|14|||
13307365|NCT01286311|26528123|FG001|Overall Study|Physician did not want outreach sent|0|||
13307366|NCT01286168|26528137|FG000|Overall Study|Withdrawal by Subject|1|||
13307367|NCT01286168|26528137|FG000|Overall Study|Surgical Drains Fell Out at Home|2|||
13307368|NCT01286129|26528152|FG000|Overall Study|Withdrawal by Subject|4|||
13307369|NCT01286129|26528153|FG001|Overall Study|Withdrawal by Subject|1|||
13307370|NCT01286129|26528152|FG000|Overall Study|Could not comply with study requirements|4|||
13307371|NCT01286129|26528153|FG001|Overall Study|Could not comply with study requirements|4|||
13307372|NCT01286077|26528194|FG000|Overall Study|Adverse Event|2|||
13307373|NCT01286077|26528195|FG001|Overall Study|Adverse Event|0|||
13307374|NCT01286077|26528194|FG000|Overall Study|Death|1|||
13307375|NCT01286077|26528195|FG001|Overall Study|Death|0|||
13307376|NCT01286077|26528194|FG000|Overall Study|Protocol Violation|1|||
13307377|NCT01286077|26528195|FG001|Overall Study|Protocol Violation|1|||
13307378|NCT01286077|26528194|FG000|Overall Study|Withdrawal by Subject|0|||
13307379|NCT01286077|26528195|FG001|Overall Study|Withdrawal by Subject|2|||
13307380|NCT01286077|26528194|FG000|Overall Study|Intercurrent illness|1|||
13307381|NCT01286077|26528195|FG001|Overall Study|Intercurrent illness|0|||
13307382|NCT01286077|26528194|FG000|Overall Study|Non-compliance|1|||
13307383|NCT01286077|26528195|FG001|Overall Study|Non-compliance|0|||
13307384|NCT01286077|26528194|FG000|Overall Study|The subject starts with alternative MMY|0|||
13307385|NCT01286077|26528195|FG001|Overall Study|The subject starts with alternative MMY|3|||
13307386|NCT01286077|26528194|FG000|Overall Study|Patient's decision to stop treatment|3|||
13307387|NCT01286077|26528195|FG001|Overall Study|Patient's decision to stop treatment|0|||
13307388|NCT01286077|26528194|FG000|Overall Study|Progression of disease|0|||
13307389|NCT01286077|26528195|FG001|Overall Study|Progression of disease|1|||
13307390|NCT01286077|26528194|FG000|Overall Study|refill medication not received in time|1|||
13307391|NCT01286077|26528195|FG001|Overall Study|refill medication not received in time|0|||
13307392|NCT01286012|26528216|FG000|Overall Study|Adverse Event|3|||
13307393|NCT01286012|26528217|FG001|Overall Study|Adverse Event|3|||
13307394|NCT01286012|26528216|FG000|Overall Study|Death|2|||
13307395|NCT01286012|26528217|FG001|Overall Study|Death|3|||
13307396|NCT01286012|26528216|FG000|Overall Study|Protocol Violation|1|||
13307397|NCT01286012|26528217|FG001|Overall Study|Protocol Violation|1|||
13307398|NCT01286012|26528216|FG000|Overall Study|Withdrawal by Subject|4|||
13307399|NCT01286012|26528217|FG001|Overall Study|Withdrawal by Subject|4|||
13307400|NCT01286012|26528216|FG000|Overall Study|Physician Decision|2|||
13307401|NCT01286012|26528217|FG001|Overall Study|Physician Decision|0|||
13307402|NCT01286012|26528216|FG000|Overall Study|peritoneal dialysis, randomized in error|1|||
13307403|NCT01286012|26528217|FG001|Overall Study|peritoneal dialysis, randomized in error|3|||
13307404|NCT01285960|26528223|FG000|Overall Study|Withdrawal by Subject|2|||
13307405|NCT01285960|26528223|FG000|Overall Study|Lost to Follow-up|2|||
13307406|NCT01285960|26528223|FG000|Overall Study|2 subjects received less 10 sonications|2|||
13307407|NCT01285908|26528259|FG000|Baseline Measurement|unable to insert catheter|1|||
13307408|NCT01285908|26528260|FG001|Baseline Measurement|unable to insert catheter|0|||
13307409|NCT01285908|26528261|FG002|Baseline Measurement|unable to insert catheter|0|||
13307410|NCT01285908|26528259|FG000|Baseline Measurement|History of stroke, exclusion criteria|1|||
13307411|NCT01285908|26528260|FG001|Baseline Measurement|History of stroke, exclusion criteria|0|||
13307412|NCT01285908|26528261|FG002|Baseline Measurement|History of stroke, exclusion criteria|0|||
13307413|NCT01285908|26528259|FG000|Baseline Measurement|unable to tolerate procedure|1|||
13307414|NCT01285908|26528260|FG001|Baseline Measurement|unable to tolerate procedure|0|||
13307415|NCT01285908|26528261|FG002|Baseline Measurement|unable to tolerate procedure|0|||
13307416|NCT01285609|26528278|FG000|Randomized|Progressive Disease|41|||
13307417|NCT01285609|26528279|FG001|Randomized|Progressive Disease|61|||
13307418|NCT01285609|26528278|FG000|Randomized|Adverse Event Unrelated to Study Drug|18|||
13307419|NCT01285609|26528279|FG001|Randomized|Adverse Event Unrelated to Study Drug|18|||
13307420|NCT01285609|26528278|FG000|Randomized|Study Drug Toxicity|13|||
13307421|NCT01285609|26528279|FG001|Randomized|Study Drug Toxicity|14|||
13307422|NCT01285609|26528278|FG000|Randomized|Death|5|||
13307423|NCT01285609|26528279|FG001|Randomized|Death|7|||
13307424|NCT01285609|26528278|FG000|Randomized|Withdrawal by Subject|8|||
13307425|NCT01285609|26528279|FG001|Randomized|Withdrawal by Subject|11|||
13307426|NCT01285609|26528278|FG000|Randomized|Subject No Longer Met Study Criteria|1|||
13307427|NCT01285609|26528279|FG001|Randomized|Subject No Longer Met Study Criteria|1|||
13307428|NCT01285609|26528278|FG000|Randomized|Undisclosed Reasons|1|||
13307429|NCT01285609|26528279|FG001|Randomized|Undisclosed Reasons|0|||
13307430|NCT01285609|26528278|FG000|Randomized|Randomized but not Treated|4|||
13307431|NCT01285609|26528279|FG001|Randomized|Randomized but not Treated|4|||
13307432|NCT01285609|26528278|FG000|Treated With Blinded Therapy|Progressive Disease|223|||
13307433|NCT01285609|26528279|FG001|Treated With Blinded Therapy|Progressive Disease|305|||
13307434|NCT01285609|26528278|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87|||
13307435|NCT01285609|26528279|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14|||
13307436|NCT01285609|26528278|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36|||
13307437|NCT01285609|26528279|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14|||
13307438|NCT01285609|26528278|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20|||
13307439|NCT01285609|26528279|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7|||
13307440|NCT01285609|26528278|FG000|Treated With Blinded Therapy|Death|11|||
13307441|NCT01285609|26528279|FG001|Treated With Blinded Therapy|Death|3|||
13307442|NCT01285609|26528278|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2|||
13307443|NCT01285609|26528279|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4|||
13307444|NCT01285609|26528278|FG000|Treated With Blinded Therapy|Not Reported|0|||
13307445|NCT01285609|26528279|FG001|Treated With Blinded Therapy|Not Reported|2|||
13307446|NCT01285609|26528278|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1|||
13307447|NCT01285609|26528279|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2|||
13307448|NCT01285609|26528278|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1|||
13307449|NCT01285609|26528279|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0|||
13307450|NCT01285609|26528278|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1|||
13307451|NCT01285609|26528279|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3|||
13307452|NCT01285609|26528278|FG000|Treated With Blinded Therapy|Physician and Patient decision|1|||
13307453|NCT01285609|26528279|FG001|Treated With Blinded Therapy|Physician and Patient decision|3|||
13307454|NCT01285609|26528278|FG000|Treated With Blinded Therapy|Participant refused participation|1|||
13307455|NCT01285609|26528279|FG001|Treated With Blinded Therapy|Participant refused participation|0|||
13307456|NCT01285609|26528278|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1|||
13307457|NCT01285609|26528279|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0|||
13307458|NCT01285609|26528278|FG000|Treated With Blinded Therapy|Participant hospitalized|1|||
13307459|NCT01285609|26528279|FG001|Treated With Blinded Therapy|Participant hospitalized|0|||
13307460|NCT01285609|26528278|FG000|Treated With Blinded Therapy|Investigator's assessment|1|||
13307461|NCT01285609|26528279|FG001|Treated With Blinded Therapy|Investigator's assessment|0|||
13307462|NCT01285609|26528278|FG000|Treated With Blinded Therapy|PI decision to discontinue|0|||
13307463|NCT01285609|26528279|FG001|Treated With Blinded Therapy|PI decision to discontinue|1|||
13307464|NCT01285609|26528278|FG000|Treated With Blinded Therapy|Worsening of general condition|0|||
13307465|NCT01285609|26528279|FG001|Treated With Blinded Therapy|Worsening of general condition|1|||
13307466|NCT01285518|26528562|FG000|Overall Study|Lost to Follow-up|0|||
13392323|NCT00672646|26779541|FG001|Overall Study|Withdrawal by Subject|0|||
13392324|NCT00672646|26779542|FG002|Overall Study|Withdrawal by Subject|1|||
13392325|NCT00672633|26779559|FG000|Overall Study|Withdrawal by Subject|0|||
13392326|NCT00672633|26779560|FG001|Overall Study|Withdrawal by Subject|1|||
13392327|NCT00672620|26779627|FG000|Overall Study|Adverse Event|7|||
13392328|NCT00672620|26779628|FG001|Overall Study|Adverse Event|7|||
13392329|NCT00672620|26779629|FG002|Overall Study|Adverse Event|12|||
13392330|NCT00672620|26779630|FG003|Overall Study|Adverse Event|17|||
13392331|NCT00672620|26779627|FG000|Overall Study|Lack of Efficacy|1|||
13392332|NCT00672620|26779628|FG001|Overall Study|Lack of Efficacy|2|||
13392333|NCT00672620|26779629|FG002|Overall Study|Lack of Efficacy|2|||
13392334|NCT00672620|26779630|FG003|Overall Study|Lack of Efficacy|0|||
13392335|NCT00672620|26779627|FG000|Overall Study|Noncompliance with Study Drug|3|||
13392336|NCT00672620|26779628|FG001|Overall Study|Noncompliance with Study Drug|4|||
13392337|NCT00672620|26779629|FG002|Overall Study|Noncompliance with Study Drug|0|||
13392338|NCT00672620|26779630|FG003|Overall Study|Noncompliance with Study Drug|2|||
13392339|NCT00672620|26779627|FG000|Overall Study|Protocol Deviations|5|||
13392340|NCT00672620|26779628|FG001|Overall Study|Protocol Deviations|7|||
13392341|NCT00672620|26779629|FG002|Overall Study|Protocol Deviations|2|||
13392342|NCT00672620|26779630|FG003|Overall Study|Protocol Deviations|5|||
13392343|NCT00672620|26779627|FG000|Overall Study|Withdrawal of Consent|6|||
13392344|NCT00672620|26779628|FG001|Overall Study|Withdrawal of Consent|12|||
13392345|NCT00672620|26779629|FG002|Overall Study|Withdrawal of Consent|5|||
13392346|NCT00672620|26779630|FG003|Overall Study|Withdrawal of Consent|6|||
13392347|NCT00672620|26779627|FG000|Overall Study|Lost to Follow-up|8|||
13392348|NCT00672620|26779628|FG001|Overall Study|Lost to Follow-up|19|||
13392349|NCT00672620|26779629|FG002|Overall Study|Lost to Follow-up|8|||
13392350|NCT00672620|26779630|FG003|Overall Study|Lost to Follow-up|11|||
13392351|NCT00672620|26779627|FG000|Overall Study|Reason not Specified|3|||
13392352|NCT00672620|26779628|FG001|Overall Study|Reason not Specified|3|||
13392353|NCT00672620|26779629|FG002|Overall Study|Reason not Specified|2|||
13392354|NCT00672620|26779630|FG003|Overall Study|Reason not Specified|1|||
13392355|NCT00672555|26779641|FG000|Overall Study|Lost to Follow-up|4|||
13392356|NCT00672555|26779641|FG000|Overall Study|Did not want to answer questionnaire|2|||
13392357|NCT00672490|26779670|FG000|Overall Study|Withdrawal by Subject|8|||
13392358|NCT00672490|26779671|FG001|Overall Study|Withdrawal by Subject|8|||
13392359|NCT00672490|26779670|FG000|Overall Study|Lack of Compliance|2|||
13392360|NCT00672490|26779671|FG001|Overall Study|Lack of Compliance|7|||
13392361|NCT00672490|26779670|FG000|Overall Study|Mismatch Include/Exclude Criteria|1|||
13392362|NCT00672490|26779671|FG001|Overall Study|Mismatch Include/Exclude Criteria|0|||
13392363|NCT00672490|26779670|FG000|Overall Study|Adverse Event|5|||
13392364|NCT00672490|26779671|FG001|Overall Study|Adverse Event|8|||
13392365|NCT00672490|26779670|FG000|Overall Study|Violation of Concomitant Medicine|1|||
13392366|NCT00672490|26779671|FG001|Overall Study|Violation of Concomitant Medicine|0|||
13392367|NCT00672490|26779670|FG000|Overall Study|Intolerance|0|||
13392368|NCT00672490|26779671|FG001|Overall Study|Intolerance|2|||
13392369|NCT00672490|26779670|FG000|Overall Study|Lost to Follow-up|1|||
13392370|NCT00672490|26779671|FG001|Overall Study|Lost to Follow-up|5|||
13392371|NCT00672490|26779670|FG000|Overall Study|No reason was provided|6|||
13392372|NCT00672490|26779671|FG001|Overall Study|No reason was provided|2|||
13392373|NCT00672477|26779686|FG000|Overall Study|Adverse Event|10|||
13392374|NCT00672477|26779687|FG001|Overall Study|Adverse Event|7|||
13392375|NCT00672477|26779686|FG000|Overall Study|Death|7|||
13392376|NCT00672477|26779687|FG001|Overall Study|Death|11|||
13392377|NCT00672477|26779686|FG000|Overall Study|Physician Decision|2|||
13392378|NCT00672477|26779687|FG001|Overall Study|Physician Decision|0|||
13392379|NCT00672477|26779686|FG000|Overall Study|Protocol Violation|1|||
13392380|NCT00672477|26779687|FG001|Overall Study|Protocol Violation|1|||
13392381|NCT00672477|26779686|FG000|Overall Study|Withdrawal by Subject|5|||
13392382|NCT00672477|26779687|FG001|Overall Study|Withdrawal by Subject|3|||
13392383|NCT00672477|26779686|FG000|Overall Study|Lack of Efficacy|1|||
13392384|NCT00672477|26779687|FG001|Overall Study|Lack of Efficacy|1|||
13392385|NCT00672477|26779686|FG000|Overall Study|no study drug for low GFR, health cond.|1|||
13392386|NCT00672477|26779687|FG001|Overall Study|no study drug for low GFR, health cond.|3|||
13392387|NCT00672256|26779696|FG000|Overall Study|PI dropped, bad data|44|||
13392388|NCT00672139|26779709|FG000|Overall Study|Death|14|||
13392389|NCT00672139|26779710|FG001|Overall Study|Death|23|||
13392390|NCT00672139|26779709|FG000|Overall Study|Withdrawal by Subject|2|||
13307467|NCT01285518|26528563|FG001|Overall Study|Lost to Follow-up|0|||
13307468|NCT01285518|26528564|FG002|Overall Study|Lost to Follow-up|0|||
13307469|NCT01285518|26528565|FG003|Overall Study|Lost to Follow-up|0|||
13307470|NCT01285518|26528566|FG004|Overall Study|Lost to Follow-up|0|||
13307471|NCT01285518|26528567|FG005|Overall Study|Lost to Follow-up|1|||
13307472|NCT01285518|26528568|FG006|Overall Study|Lost to Follow-up|0|||
13307473|NCT01285518|26528569|FG007|Overall Study|Lost to Follow-up|0|||
13307474|NCT01285492|26528594|FG000|Overall Study|Adverse Event|11|||
13307475|NCT01285492|26528595|FG001|Overall Study|Adverse Event|0|||
13307476|NCT01285492|26528594|FG000|Overall Study|Protocol Violation|3|||
13307477|NCT01285492|26528595|FG001|Overall Study|Protocol Violation|0|||
13307478|NCT01285492|26528594|FG000|Overall Study|Withdrawal by Subject|2|||
13307479|NCT01285492|26528595|FG001|Overall Study|Withdrawal by Subject|1|||
13307480|NCT01285492|26528594|FG000|Overall Study|Death|1|||
13307481|NCT01285492|26528595|FG001|Overall Study|Death|0|||
13307482|NCT01285401|26528640|FG000|Overall Study|Prematurely withdrawn from the study|17|||
13307483|NCT01285401|26528641|FG001|Overall Study|Prematurely withdrawn from the study|29|||
13307484|NCT01285349|26528662|FG000|Overall Study|Lost to Follow-up|27|||
13307485|NCT01285349|26528663|FG001|Overall Study|Lost to Follow-up|20|||
13307486|NCT01285349|26528664|FG002|Overall Study|Lost to Follow-up|27|||
13307487|NCT01285323|26528703|FG000|Overall Study|Adverse Event|9|||
13307488|NCT01285323|26528704|FG001|Overall Study|Adverse Event|8|||
13307489|NCT01285323|26528703|FG000|Overall Study|Lack of Efficacy|4|||
13307490|NCT01285323|26528704|FG001|Overall Study|Lack of Efficacy|2|||
13307491|NCT01285323|26528703|FG000|Overall Study|Withdrawal by Subject|15|||
13307492|NCT01285323|26528704|FG001|Overall Study|Withdrawal by Subject|11|||
13307493|NCT01285323|26528703|FG000|Overall Study|Protocol Violation|1|||
13307494|NCT01285323|26528704|FG001|Overall Study|Protocol Violation|2|||
13307495|NCT01285323|26528703|FG000|Overall Study|Non-compliance with study procedures|2|||
13307496|NCT01285323|26528704|FG001|Overall Study|Non-compliance with study procedures|3|||
13307497|NCT01285323|26528703|FG000|Overall Study|Lost to Follow-up|1|||
13307498|NCT01285323|26528704|FG001|Overall Study|Lost to Follow-up|1|||
13307499|NCT01285323|26528703|FG000|Overall Study|Other|1|||
13307500|NCT01285323|26528704|FG001|Overall Study|Other|3|||
13307501|NCT01285310|26528949|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3|||
13307502|NCT01285310|26528950|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4|||
13307503|NCT01285310|26528951|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6|||
13307504|NCT01285310|26528952|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
13307505|NCT01285310|26528953|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
13307506|NCT01285310|26528949|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1|||
13307507|NCT01285310|26528950|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7|||
13307508|NCT01285310|26528951|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3|||
13307509|NCT01285310|26528952|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
13307510|NCT01285310|26528953|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
13307511|NCT01285310|26528949|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1|||
13307512|NCT01285310|26528950|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
13307513|NCT01285310|26528951|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2|||
13307514|NCT01285310|26528952|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
13307515|NCT01285310|26528953|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
13307516|NCT01285310|26528949|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
13307517|NCT01285310|26528950|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
13307518|NCT01285310|26528951|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2|||
13307519|NCT01285310|26528952|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
13307520|NCT01285310|26528953|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
13307521|NCT01285310|26528949|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
13307522|NCT01285310|26528950|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
13307523|NCT01285310|26528951|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
13307524|NCT01285310|26528952|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
13307525|NCT01285310|26528953|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
13307526|NCT01285310|26528949|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1|||
13307527|NCT01285310|26528950|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0|||
13307528|NCT01285310|26528951|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1|||
13307529|NCT01285310|26528952|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0|||
13307530|NCT01285310|26528953|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0|||
13307531|NCT01285310|26528949|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
13307532|NCT01285310|26528950|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
13307533|NCT01285310|26528951|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3|||
13307534|NCT01285310|26528952|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
13307535|NCT01285310|26528953|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
13307536|NCT01285310|26528949|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
13372861|NCT00806260|26722173|FG002|Period 2|Adverse Event|0|||
13392391|NCT00672139|26779710|FG001|Overall Study|Withdrawal by Subject|11|||
13307537|NCT01285310|26528950|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4|||
13307538|NCT01285310|26528951|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3|||
13307539|NCT01285310|26528952|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1|||
13307540|NCT01285310|26528953|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
13307541|NCT01285310|26528949|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
13307542|NCT01285310|26528950|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3|||
13307543|NCT01285310|26528951|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
13307544|NCT01285310|26528952|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
13307545|NCT01285310|26528953|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
13307546|NCT01285310|26528949|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0|||
13307547|NCT01285310|26528950|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21|||
13307548|NCT01285310|26528951|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19|||
13307549|NCT01285310|26528952|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6|||
13307550|NCT01285310|26528953|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15|||
13307551|NCT01285310|26528949|FG000|Active Treatment Phase: Weeks 25-52|Other|0|||
13307552|NCT01285310|26528950|FG001|Active Treatment Phase: Weeks 25-52|Other|1|||
13307553|NCT01285310|26528951|FG002|Active Treatment Phase: Weeks 25-52|Other|0|||
13307554|NCT01285310|26528952|FG003|Active Treatment Phase: Weeks 25-52|Other|0|||
13307555|NCT01285310|26528953|FG004|Active Treatment Phase: Weeks 25-52|Other|0|||
13307556|NCT01285310|26528949|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
13307557|NCT01285310|26528950|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
13372862|NCT00806260|26722174|FG003|Period 2|Adverse Event|1|||
13392392|NCT00672139|26779709|FG000|Overall Study|Adverse Event|4|||
13392393|NCT00672139|26779710|FG001|Overall Study|Adverse Event|7|||
13392394|NCT00672139|26779709|FG000|Overall Study|Physician Decision|2|||
13392395|NCT00672139|26779710|FG001|Overall Study|Physician Decision|0|||
13392396|NCT00672139|26779709|FG000|Overall Study|Lack of Efficacy|4|||
13392397|NCT00672139|26779710|FG001|Overall Study|Lack of Efficacy|1|||
13392398|NCT00672139|26779709|FG000|Overall Study|Protocol Violation|1|||
13392399|NCT00672139|26779710|FG001|Overall Study|Protocol Violation|1|||
13392400|NCT00672139|26779709|FG000|Overall Study|hospice discharge, caregiver requests|3|||
13392401|NCT00672139|26779710|FG001|Overall Study|hospice discharge, caregiver requests|2|||
13392402|NCT00671931|26779738|FG000|Overall Study|Physician Decision|1|||
13392403|NCT00671931|26779739|FG001|Overall Study|Physician Decision|0|||
13392404|NCT00671931|26779740|FG002|Overall Study|Physician Decision|0|||
13392405|NCT00671931|26779741|FG003|Overall Study|Physician Decision|2|||
13392406|NCT00671931|26779742|FG004|Overall Study|Physician Decision|1|||
13392407|NCT00671879|26779763|FG000|Overall Study|Withdrawal by Subject|0|||
13392408|NCT00671879|26779764|FG001|Overall Study|Withdrawal by Subject|4|||
13392409|NCT00671879|26779765|FG002|Overall Study|Withdrawal by Subject|6|||
13392410|NCT00671853|26779788|FG000|Overall Study|Lack of Efficacy|3|||
13392411|NCT00671853|26779789|FG001|Overall Study|Lack of Efficacy|7|||
13392412|NCT00671853|26779788|FG000|Overall Study|Adverse Event|7|||
13392413|NCT00671853|26779789|FG001|Overall Study|Adverse Event|1|||
13392414|NCT00671853|26779788|FG000|Overall Study|Withdrawal by Subject|1|||
13392415|NCT00671853|26779789|FG001|Overall Study|Withdrawal by Subject|5|||
13392416|NCT00671853|26779788|FG000|Overall Study|Lost to Follow-up|8|||
13392417|NCT00671853|26779789|FG001|Overall Study|Lost to Follow-up|8|||
13392418|NCT00671853|26779788|FG000|Overall Study|Physician Decision|0|||
13392419|NCT00671853|26779789|FG001|Overall Study|Physician Decision|2|||
13392420|NCT00671853|26779788|FG000|Overall Study|Non-adherence with study procedures|1|||
13392421|NCT00671853|26779789|FG001|Overall Study|Non-adherence with study procedures|4|||
13392422|NCT00671788|26779798|FG000|Overall Study|Adverse Event|8|||
13392423|NCT00671788|26779798|FG000|Overall Study|Refused further treatment|3|||
13392424|NCT00671788|26779798|FG000|Overall Study|Ineligible|1|||
13392425|NCT00671788|26779798|FG000|Overall Study|MD Decision|1|||
13392426|NCT00671788|26779798|FG000|Overall Study|Other|1|||
13392427|NCT00671749|26779810|FG000|Overall Study|Adverse Event|2|||
13392428|NCT00671749|26779810|FG000|Overall Study|Withdrawal by Subject|4|||
13392429|NCT00671749|26779810|FG000|Overall Study|Protocol Violation|1|||
13392430|NCT00671749|26779810|FG000|Overall Study|Lost to Follow-up|1|||
13392431|NCT00671658|26779816|FG000|Overall Study|Physician Decision|5|||
13392432|NCT00671554|26779823|FG000|Overall Study|Disease progression|3|||
13392433|NCT00671437|26779844|FG000|Overall Study|Progressive disease before C1 week 8|8|||
13392434|NCT00671437|26779844|FG000|Overall Study|Cutaneous SCC of head and neck|3|||
13392435|NCT00671437|26779844|FG000|Overall Study|Adverse Event|3|||
13392436|NCT00671437|26779844|FG000|Overall Study|Ineligible post-hoc|1|||
13392437|NCT00671060|26779857|FG000|Overall Study|Protocol Violation|1|||
13392438|NCT00671060|26779858|FG001|Overall Study|Protocol Violation|0|||
13392439|NCT00671060|26779857|FG000|Overall Study|Physician Decision|0|||
13392440|NCT00671060|26779858|FG001|Overall Study|Physician Decision|1|||
13392441|NCT00671034|26779903|FG000|Overall Study|Adverse Event|5|||
13392442|NCT00671034|26779904|FG001|Overall Study|Adverse Event|7|||
13392443|NCT00671034|26779905|FG002|Overall Study|Adverse Event|1|||
13392444|NCT00671034|26779903|FG000|Overall Study|Death|3|||
13392445|NCT00671034|26779904|FG001|Overall Study|Death|2|||
13392446|NCT00671034|26779905|FG002|Overall Study|Death|1|||
13392447|NCT00671034|26779903|FG000|Overall Study|Physician Decision|12|||
13392448|NCT00671034|26779904|FG001|Overall Study|Physician Decision|4|||
13392449|NCT00671034|26779905|FG002|Overall Study|Physician Decision|5|||
13392450|NCT00671034|26779903|FG000|Overall Study|VHR ALL feature|8|||
13392451|NCT00671034|26779904|FG001|Overall Study|VHR ALL feature|3|||
13392452|NCT00671034|26779905|FG002|Overall Study|VHR ALL feature|5|||
13392453|NCT00671034|26779903|FG000|Overall Study|Refusal|5|||
13392454|NCT00671034|26779904|FG001|Overall Study|Refusal|3|||
13392455|NCT00671034|26779905|FG002|Overall Study|Refusal|5|||
13392456|NCT00671034|26779903|FG000|Overall Study|includes Alternative therapy, etc.|6|||
13392457|NCT00671034|26779904|FG001|Overall Study|includes Alternative therapy, etc.|1|||
13392458|NCT00671034|26779905|FG002|Overall Study|includes Alternative therapy, etc.|7|||
13392459|NCT00670930|26779926|FG000|Overall Study|Adminstrative Problem|0|||
13392460|NCT00670930|26779927|FG001|Overall Study|Adminstrative Problem|1|||
13392461|NCT00670930|26779926|FG000|Overall Study|Lost to Follow-up|1|||
13392462|NCT00670930|26779927|FG001|Overall Study|Lost to Follow-up|0|||
13392463|NCT00670800|26779950|FG000|Overall Study|2 controls were insulin resistant|0|||
13392464|NCT00670800|26779951|FG001|Overall Study|2 controls were insulin resistant|2|||
13392465|NCT00670748|26779982|FG000|Overall Study|Death during treatment|1|||
13392466|NCT00670748|26779983|FG001|Overall Study|Death during treatment|1|||
13392467|NCT00670748|26779984|FG002|Overall Study|Death during treatment|1|||
13392468|NCT00670748|26779985|FG003|Overall Study|Death during treatment|0|||
13392469|NCT00670748|26779982|FG000|Overall Study|Not off study|2|||
13392470|NCT00670748|26779983|FG001|Overall Study|Not off study|1|||
13392471|NCT00670748|26779984|FG002|Overall Study|Not off study|1|||
13392472|NCT00670748|26779985|FG003|Overall Study|Not off study|1|||
13392473|NCT00670540|26779997|FG000|Overall Study|ineligible|17|||
13392474|NCT00670540|26779997|FG000|Overall Study|not living in France|348|||
13392475|NCT00670540|26779997|FG000|Overall Study|refused to participate|189|||
13392476|NCT00670540|26779997|FG000|Overall Study|controls randomised for no follow up|2770|||
13392477|NCT00670540|26779997|FG000|Overall Study|missing information inclusion criteria|1|||
13392478|NCT00670488|26780180|FG000|Overall Study|Adverse Event|0|||
13392479|NCT00670488|26780181|FG001|Overall Study|Adverse Event|7|||
13392480|NCT00670488|26780182|FG002|Overall Study|Adverse Event|0|||
13392481|NCT00670488|26780183|FG003|Overall Study|Adverse Event|3|||
13392482|NCT00670488|26780184|FG004|Overall Study|Adverse Event|1|||
13392483|NCT00670488|26780185|FG005|Overall Study|Adverse Event|1|||
13392484|NCT00670488|26780186|FG006|Overall Study|Adverse Event|5|||
13392485|NCT00670488|26780187|FG007|Overall Study|Adverse Event|1|||
13392486|NCT00670488|26780188|FG008|Overall Study|Adverse Event|0|||
13392487|NCT00670488|26780189|FG009|Overall Study|Adverse Event|1|||
13392488|NCT00670488|26780180|FG000|Overall Study|Physician Decision|1|||
13392489|NCT00670488|26780181|FG001|Overall Study|Physician Decision|9|||
13392490|NCT00670488|26780182|FG002|Overall Study|Physician Decision|0|||
13392491|NCT00670488|26780183|FG003|Overall Study|Physician Decision|1|||
13392492|NCT00670488|26780184|FG004|Overall Study|Physician Decision|0|||
13392493|NCT00670488|26780185|FG005|Overall Study|Physician Decision|0|||
13392494|NCT00670488|26780186|FG006|Overall Study|Physician Decision|0|||
13392495|NCT00670488|26780187|FG007|Overall Study|Physician Decision|0|||
13392496|NCT00670488|26780188|FG008|Overall Study|Physician Decision|0|||
13392497|NCT00670488|26780189|FG009|Overall Study|Physician Decision|0|||
13392498|NCT00670488|26780180|FG000|Overall Study|Progressive Disease|2|||
13392499|NCT00670488|26780181|FG001|Overall Study|Progressive Disease|41|||
13392500|NCT00670488|26780182|FG002|Overall Study|Progressive Disease|3|||
13392501|NCT00670488|26780183|FG003|Overall Study|Progressive Disease|2|||
13392502|NCT00670488|26780184|FG004|Overall Study|Progressive Disease|2|||
13392503|NCT00670488|26780185|FG005|Overall Study|Progressive Disease|4|||
13392504|NCT00670488|26780186|FG006|Overall Study|Progressive Disease|11|||
13392505|NCT00670488|26780187|FG007|Overall Study|Progressive Disease|2|||
13392506|NCT00670488|26780188|FG008|Overall Study|Progressive Disease|2|||
13392507|NCT00670488|26780189|FG009|Overall Study|Progressive Disease|1|||
13392508|NCT00670488|26780180|FG000|Overall Study|Withdrawal by Subject|0|||
13392509|NCT00670488|26780181|FG001|Overall Study|Withdrawal by Subject|1|||
13392510|NCT00670488|26780182|FG002|Overall Study|Withdrawal by Subject|0|||
13392511|NCT00670488|26780183|FG003|Overall Study|Withdrawal by Subject|1|||
13392512|NCT00670488|26780184|FG004|Overall Study|Withdrawal by Subject|0|||
13392513|NCT00670488|26780185|FG005|Overall Study|Withdrawal by Subject|0|||
13392514|NCT00670488|26780186|FG006|Overall Study|Withdrawal by Subject|1|||
13392515|NCT00670488|26780187|FG007|Overall Study|Withdrawal by Subject|0|||
13392516|NCT00670488|26780188|FG008|Overall Study|Withdrawal by Subject|1|||
13392517|NCT00670488|26780189|FG009|Overall Study|Withdrawal by Subject|0|||
13392518|NCT00670449|26780226|FG000|Overall Study|Adverse Event|6|||
13392519|NCT00670449|26780227|FG001|Overall Study|Adverse Event|2|||
13392520|NCT00670449|26780228|FG002|Overall Study|Adverse Event|8|||
13392521|NCT00670449|26780229|FG003|Overall Study|Adverse Event|5|||
13392522|NCT00670449|26780226|FG000|Overall Study|Protocol Deviation|1|||
13392523|NCT00670449|26780227|FG001|Overall Study|Protocol Deviation|2|||
13392524|NCT00670449|26780228|FG002|Overall Study|Protocol Deviation|0|||
13392525|NCT00670449|26780229|FG003|Overall Study|Protocol Deviation|1|||
13392526|NCT00670449|26780226|FG000|Overall Study|Administrative Problems|0|||
13392527|NCT00670449|26780227|FG001|Overall Study|Administrative Problems|2|||
13392528|NCT00670449|26780228|FG002|Overall Study|Administrative Problems|0|||
13392529|NCT00670449|26780229|FG003|Overall Study|Administrative Problems|1|||
13392530|NCT00670449|26780226|FG000|Overall Study|Subject Withdrew Consent|0|||
13392531|NCT00670449|26780227|FG001|Overall Study|Subject Withdrew Consent|2|||
13392532|NCT00670449|26780228|FG002|Overall Study|Subject Withdrew Consent|0|||
13392533|NCT00670449|26780229|FG003|Overall Study|Subject Withdrew Consent|1|||
13392534|NCT00670449|26780226|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2|||
13392535|NCT00670449|26780227|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
13392536|NCT00670449|26780228|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
13392537|NCT00670449|26780229|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
13392538|NCT00670449|26780226|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
13392539|NCT00670449|26780227|FG001|Overall Study|Abnormal Laboratory Value(s)|2|||
13392540|NCT00670449|26780228|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
13392541|NCT00670449|26780229|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
13392542|NCT00670306|26780235|FG000|Overall Study|Adverse Event|8|||
13392543|NCT00670306|26780235|FG000|Overall Study|Lack of Efficacy|10|||
13392544|NCT00670306|26780235|FG000|Overall Study|Withdrawal by Subject|9|||
13392545|NCT00670306|26780235|FG000|Overall Study|Physician Decision|1|||
13392546|NCT00670306|26780235|FG000|Overall Study|Lost to Follow-up|8|||
13392547|NCT00670306|26780235|FG000|Overall Study|incl/excl criterias did not meet|19|||
13392548|NCT00670228|26780254|FG000|Overall Study|Adverse Event|1|||
13392549|NCT00670228|26780255|FG001|Overall Study|Adverse Event|0|||
13392550|NCT00670228|26780254|FG000|Overall Study|Death or MACE|0|||
13392551|NCT00670228|26780255|FG001|Overall Study|Death or MACE|1|||
13392552|NCT00670228|26780254|FG000|Overall Study|Not treated|2|||
13392553|NCT00670228|26780255|FG001|Overall Study|Not treated|2|||
13392554|NCT00670228|26780254|FG000|Overall Study|Not meeting the selection criteria|2|||
13392555|NCT00670228|26780255|FG001|Overall Study|Not meeting the selection criteria|0|||
13392556|NCT00670111|26780273|FG000|Enrollment to One Month|Testing Failure|0|||
13392557|NCT00670111|26780274|FG001|Enrollment to One Month|Testing Failure|0|||
13392558|NCT00670111|26780275|FG002|Enrollment to One Month|Testing Failure|13|||
13392559|NCT00670111|26780273|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
13392560|NCT00670111|26780274|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
13392561|NCT00670111|26780275|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6|||
13392562|NCT00670111|26780273|FG000|Enrollment to One Month|Physician Decision|1|||
13392563|NCT00670111|26780274|FG001|Enrollment to One Month|Physician Decision|0|||
13392564|NCT00670111|26780275|FG002|Enrollment to One Month|Physician Decision|0|||
13392565|NCT00670046|26780296|FG000|Overall Study|Lost to Follow-up|1|||
13392566|NCT00670046|26780297|FG001|Overall Study|Lost to Follow-up|1|||
13392567|NCT00670046|26780296|FG000|Overall Study|Withdrawal by Subject|0|||
13392568|NCT00670046|26780297|FG001|Overall Study|Withdrawal by Subject|1|||
13393632|NCT00662909|26784486|FG001|Overall Study|Eligibility criterion not met|1|||
13393633|NCT00662909|26784487|FG002|Overall Study|Eligibility criterion not met|1|||
13393634|NCT00662857|26784503|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0|||
13393635|NCT00662857|26784504|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1|||
13393636|NCT00662857|26784503|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0|||
13393637|NCT00662857|26784504|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1|||
13393638|NCT00662857|26784503|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1|||
13393639|NCT00662857|26784504|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0|||
13393640|NCT00662831|26784549|FG000|Overall Study|Death|4|||
13393641|NCT00662831|26784550|FG001|Overall Study|Death|1|||
13393642|NCT00662831|26784549|FG000|Overall Study|Lack of Efficacy|6|||
13393643|NCT00662831|26784550|FG001|Overall Study|Lack of Efficacy|6|||
13393644|NCT00662831|26784549|FG000|Overall Study|Lost to Follow-up|1|||
13393645|NCT00662831|26784550|FG001|Overall Study|Lost to Follow-up|0|||
13393646|NCT00662831|26784549|FG000|Overall Study|Withdrawal by Subject|2|||
13393647|NCT00662831|26784550|FG001|Overall Study|Withdrawal by Subject|1|||
13393648|NCT00662831|26784549|FG000|Overall Study|Other|62|||
13393649|NCT00662831|26784550|FG001|Overall Study|Other|31|||
13393650|NCT00662831|26784549|FG000|Overall Study|Protocol Violation|8|||
13393651|NCT00662831|26784550|FG001|Overall Study|Protocol Violation|4|||
13393652|NCT00662831|26784549|FG000|Overall Study|Adverse Event|23|||
13393653|NCT00662831|26784550|FG001|Overall Study|Adverse Event|16|||
13393654|NCT00662792|26784674|FG000|Period 1|Personal Reasons|0|||
13393655|NCT00662792|26784675|FG001|Period 1|Personal Reasons|0|||
13393656|NCT00662792|26784676|FG002|Period 1|Personal Reasons|1|||
13393657|NCT00662792|26784677|FG003|Period 1|Personal Reasons|0|||
13393658|NCT00662792|26784674|FG000|Period 1|Refused continuing medication|0|||
13393659|NCT00662792|26784675|FG001|Period 1|Refused continuing medication|1|||
13393660|NCT00662792|26784676|FG002|Period 1|Refused continuing medication|1|||
13393661|NCT00662792|26784677|FG003|Period 1|Refused continuing medication|0|||
13393662|NCT00662792|26784674|FG000|Period 1|Lost to Follow-up|1|||
13392569|NCT00670007|26780324|FG000|Overall Study|Drug abuse|1|||
13392570|NCT00670007|26780324|FG000|Overall Study|Lung transplant|1|||
13392571|NCT00670007|26780324|FG000|Overall Study|Travel/Vacation|1|||
13392572|NCT00670007|26780324|FG000|Overall Study|Adverse event, serious fatal|1|||
13392573|NCT00670007|26780324|FG000|Overall Study|Adverse Event|1|||
13392574|NCT00670007|26780324|FG000|Overall Study|Withdrawal by Subject|4|||
13392575|NCT00669955|26780349|FG000|Overall Study|Adverse Event|3|||
13392576|NCT00669955|26780350|FG001|Overall Study|Adverse Event|5|||
13392577|NCT00669955|26780349|FG000|Overall Study|Death|0|||
13392578|NCT00669955|26780350|FG001|Overall Study|Death|1|||
13392579|NCT00669955|26780349|FG000|Overall Study|Withdrawal by Subject|2|||
13392580|NCT00669955|26780350|FG001|Overall Study|Withdrawal by Subject|3|||
13392581|NCT00669955|26780349|FG000|Overall Study|Lost to Follow-up|5|||
13392582|NCT00669955|26780350|FG001|Overall Study|Lost to Follow-up|7|||
13392583|NCT00669955|26780349|FG000|Overall Study|Protocol Violation|2|||
13392584|NCT00669955|26780350|FG001|Overall Study|Protocol Violation|7|||
13392585|NCT00669955|26780349|FG000|Overall Study|Investigator Sponsor Judgement|0|||
13392586|NCT00669955|26780350|FG001|Overall Study|Investigator Sponsor Judgement|1|||
13392587|NCT00669955|26780349|FG000|Overall Study|not compliant with study drug/visit|2|||
13392588|NCT00669955|26780350|FG001|Overall Study|not compliant with study drug/visit|3|||
13392589|NCT00669942|26780449|FG000|Parts 2 and 3|Adverse Event|0|||
13392590|NCT00669942|26780450|FG001|Parts 2 and 3|Adverse Event|0|||
13392591|NCT00669942|26780451|FG002|Parts 2 and 3|Adverse Event|0|||
13392592|NCT00669942|26780452|FG003|Parts 2 and 3|Adverse Event|0|||
13392593|NCT00669942|26780453|FG004|Parts 2 and 3|Adverse Event|0|||
13392594|NCT00669942|26780454|FG005|Parts 2 and 3|Adverse Event|0|||
13392595|NCT00669942|26780455|FG006|Parts 2 and 3|Adverse Event|0|||
13392596|NCT00669942|26780456|FG007|Parts 2 and 3|Adverse Event|2|||
13392597|NCT00669942|26780457|FG008|Parts 2 and 3|Adverse Event|1|||
13392598|NCT00669942|26780458|FG009|Parts 2 and 3|Adverse Event|0|||
13392599|NCT00669942|26780459|FG010|Parts 2 and 3|Adverse Event|0|||
13392600|NCT00669942|26780460|FG011|Parts 2 and 3|Adverse Event|0|||
13392601|NCT00669942|26780449|FG000|Parts 2 and 3|Withdrawal by Subject|0|||
13392602|NCT00669942|26780450|FG001|Parts 2 and 3|Withdrawal by Subject|0|||
13392603|NCT00669942|26780451|FG002|Parts 2 and 3|Withdrawal by Subject|0|||
13392604|NCT00669942|26780452|FG003|Parts 2 and 3|Withdrawal by Subject|0|||
13392605|NCT00669942|26780453|FG004|Parts 2 and 3|Withdrawal by Subject|0|||
13392606|NCT00669942|26780454|FG005|Parts 2 and 3|Withdrawal by Subject|1|||
13392607|NCT00669942|26780455|FG006|Parts 2 and 3|Withdrawal by Subject|0|||
13392608|NCT00669942|26780456|FG007|Parts 2 and 3|Withdrawal by Subject|0|||
13392609|NCT00669942|26780457|FG008|Parts 2 and 3|Withdrawal by Subject|2|||
13392610|NCT00669942|26780458|FG009|Parts 2 and 3|Withdrawal by Subject|0|||
13392611|NCT00669942|26780459|FG010|Parts 2 and 3|Withdrawal by Subject|0|||
13392612|NCT00669942|26780460|FG011|Parts 2 and 3|Withdrawal by Subject|0|||
13392613|NCT00669942|26780449|FG000|Parts 2 and 3|Protocol Violation|0|||
13392614|NCT00669942|26780450|FG001|Parts 2 and 3|Protocol Violation|0|||
13392615|NCT00669942|26780451|FG002|Parts 2 and 3|Protocol Violation|0|||
13392616|NCT00669942|26780452|FG003|Parts 2 and 3|Protocol Violation|0|||
13392617|NCT00669942|26780453|FG004|Parts 2 and 3|Protocol Violation|0|||
13392618|NCT00669942|26780454|FG005|Parts 2 and 3|Protocol Violation|1|||
13392619|NCT00669942|26780455|FG006|Parts 2 and 3|Protocol Violation|0|||
13392620|NCT00669942|26780456|FG007|Parts 2 and 3|Protocol Violation|0|||
13392621|NCT00669942|26780457|FG008|Parts 2 and 3|Protocol Violation|0|||
13392622|NCT00669942|26780458|FG009|Parts 2 and 3|Protocol Violation|0|||
13392623|NCT00669942|26780459|FG010|Parts 2 and 3|Protocol Violation|0|||
13392624|NCT00669942|26780460|FG011|Parts 2 and 3|Protocol Violation|0|||
13392625|NCT00669903|26780503|FG000|Overall Study|Adverse Event|0|||
13392626|NCT00669903|26780504|FG001|Overall Study|Adverse Event|1|||
13392627|NCT00669903|26780505|FG002|Overall Study|Adverse Event|3|||
13392628|NCT00669903|26780506|FG003|Overall Study|Adverse Event|1|||
13392629|NCT00669903|26780503|FG000|Overall Study|Withdrawal by Subject|0|||
13392630|NCT00669903|26780504|FG001|Overall Study|Withdrawal by Subject|2|||
13392631|NCT00669903|26780505|FG002|Overall Study|Withdrawal by Subject|2|||
13392632|NCT00669903|26780506|FG003|Overall Study|Withdrawal by Subject|2|||
13392633|NCT00669903|26780503|FG000|Overall Study|Lost to Follow-up|1|||
13392634|NCT00669903|26780504|FG001|Overall Study|Lost to Follow-up|1|||
13392635|NCT00669903|26780505|FG002|Overall Study|Lost to Follow-up|0|||
13392636|NCT00669903|26780506|FG003|Overall Study|Lost to Follow-up|1|||
13392637|NCT00669903|26780503|FG000|Overall Study|Protocol Violation|0|||
13392638|NCT00669903|26780504|FG001|Overall Study|Protocol Violation|1|||
13392639|NCT00669903|26780505|FG002|Overall Study|Protocol Violation|0|||
13392640|NCT00669903|26780506|FG003|Overall Study|Protocol Violation|0|||
13392641|NCT00669877|26780513|FG000|Overall Study|Disease Progression/Death|4|||
13392642|NCT00669864|26780524|FG000|Overall Study|Lost to Follow-up|2|||
13392643|NCT00669864|26780524|FG000|Overall Study|Protocol Violation|2|||
13392644|NCT00669864|26780524|FG000|Overall Study|Withdrawal by Subject|3|||
13392645|NCT00669864|26780524|FG000|Overall Study|Other|2|||
13392646|NCT00669669|26780539|FG000|Overall Study|To late to start treatment|1|||
13392647|NCT00669617|26780557|FG000|Period 1|Withdrawal by Subject|0|||
13392648|NCT00669617|26780558|FG001|Period 1|Withdrawal by Subject|0|||
13392649|NCT00669617|26780559|FG002|Period 1|Withdrawal by Subject|1|||
13392650|NCT00669617|26780560|FG003|Period 1|Withdrawal by Subject|0|||
13392651|NCT00669617|26780561|FG004|Period 1|Withdrawal by Subject|0|||
13392652|NCT00669617|26780557|FG000|Period 1|Protocol Deviation|0|||
13392653|NCT00669617|26780558|FG001|Period 1|Protocol Deviation|0|||
13392654|NCT00669617|26780559|FG002|Period 1|Protocol Deviation|0|||
13392655|NCT00669617|26780560|FG003|Period 1|Protocol Deviation|0|||
13392656|NCT00669617|26780561|FG004|Period 1|Protocol Deviation|1|||
13392657|NCT00669617|26780557|FG000|Period 3|Lost to Follow-up|1|||
13392658|NCT00669617|26780558|FG001|Period 3|Lost to Follow-up|0|||
13392659|NCT00669617|26780559|FG002|Period 3|Lost to Follow-up|0|||
13392660|NCT00669617|26780560|FG003|Period 3|Lost to Follow-up|0|||
13392661|NCT00669617|26780561|FG004|Period 3|Lost to Follow-up|0|||
13392662|NCT00669409|26780967|FG000|Part 2|Withdrawal by Subject|0|||
13392663|NCT00669409|26780968|FG001|Part 2|Withdrawal by Subject|0|||
13392664|NCT00669409|26780969|FG002|Part 2|Withdrawal by Subject|0|||
13392665|NCT00669409|26780970|FG003|Part 2|Withdrawal by Subject|0|||
13392666|NCT00669409|26780971|FG004|Part 2|Withdrawal by Subject|0|||
13392667|NCT00669409|26780972|FG005|Part 2|Withdrawal by Subject|0|||
13392668|NCT00669409|26780973|FG006|Part 2|Withdrawal by Subject|0|||
13392669|NCT00669409|26780974|FG007|Part 2|Withdrawal by Subject|0|||
13392670|NCT00669409|26780975|FG008|Part 2|Withdrawal by Subject|0|||
13392671|NCT00669409|26780976|FG009|Part 2|Withdrawal by Subject|1|||
13392672|NCT00669409|26780977|FG010|Part 2|Withdrawal by Subject|0|||
13392673|NCT00669396|26780996|FG000|Overall Study|Lost to Follow-up|10|||
13392674|NCT00669396|26780997|FG001|Overall Study|Lost to Follow-up|12|||
13392675|NCT00669331|26781046|FG000|Randomisation to First Dose|Adverse Event|1|||
13392676|NCT00669331|26781047|FG001|Randomisation to First Dose|Adverse Event|0|||
13392677|NCT00669331|26781046|FG000|Randomisation to First Dose|Protocol Violation|1|||
13392678|NCT00669331|26781047|FG001|Randomisation to First Dose|Protocol Violation|0|||
13392679|NCT00669331|26781046|FG000|Randomisation to First Dose|Withdrawal by Subject|3|||
13392680|NCT00669331|26781047|FG001|Randomisation to First Dose|Withdrawal by Subject|2|||
13392681|NCT00669331|26781046|FG000|Randomisation to First Dose|Lost to Follow-up|2|||
13392682|NCT00669331|26781047|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
13392683|NCT00669331|26781046|FG000|Randomisation to First Dose|Death|1|||
13392684|NCT00669331|26781047|FG001|Randomisation to First Dose|Death|0|||
13392685|NCT00669331|26781046|FG000|Randomisation to First Dose|Sponsor decision|0|||
13392686|NCT00669331|26781047|FG001|Randomisation to First Dose|Sponsor decision|1|||
13392687|NCT00669331|26781046|FG000|Randomisation to First Dose|Randomised in error|3|||
13392688|NCT00669331|26781047|FG001|Randomisation to First Dose|Randomised in error|10|||
13392689|NCT00669331|26781046|FG000|Blinded Treatment Period|Adverse Event|16|||
13392690|NCT00669331|26781047|FG001|Blinded Treatment Period|Adverse Event|10|||
13392691|NCT00669331|26781046|FG000|Blinded Treatment Period|Protocol Violation|1|||
13392692|NCT00669331|26781047|FG001|Blinded Treatment Period|Protocol Violation|1|||
13392693|NCT00669331|26781046|FG000|Blinded Treatment Period|Withdrawal by Subject|17|||
13392694|NCT00669331|26781047|FG001|Blinded Treatment Period|Withdrawal by Subject|19|||
13392695|NCT00669331|26781046|FG000|Blinded Treatment Period|Lost to Follow-up|3|||
13392696|NCT00669331|26781047|FG001|Blinded Treatment Period|Lost to Follow-up|2|||
13392697|NCT00669331|26781046|FG000|Blinded Treatment Period|Death|0|||
13392698|NCT00669331|26781047|FG001|Blinded Treatment Period|Death|2|||
13392699|NCT00669331|26781046|FG000|Blinded Treatment Period|Physician Decision|3|||
13392700|NCT00669331|26781047|FG001|Blinded Treatment Period|Physician Decision|3|||
13392701|NCT00669331|26781046|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
13392702|NCT00669331|26781047|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
13392703|NCT00669318|26781057|FG000|Overall Study|Withdrawal by Subject|2|||
13392704|NCT00669240|26781073|FG000|Overall Study|Lack of Efficacy|33|||
13392705|NCT00669240|26781073|FG000|Overall Study|Withdrawal by Subject|42|||
13392706|NCT00669240|26781073|FG000|Overall Study|Lost to Follow-up|34|||
13392707|NCT00669240|26781073|FG000|Overall Study|Adverse Event|21|||
13392708|NCT00669240|26781073|FG000|Overall Study|Other|19|||
13392709|NCT00669240|26781073|FG000|Overall Study|Enrolled but not treated|15|||
13392710|NCT00669240|26781073|FG000|Overall Study|Enrolled but no dosing record|1|||
13392711|NCT00669162|26781079|FG000|Overall Study|Withdrawal by Subject|1|||
13392712|NCT00669110|26781122|FG000|Overall Study|Adverse Event|4|||
13392713|NCT00669110|26781123|FG001|Overall Study|Adverse Event|3|||
13392714|NCT00669110|26781122|FG000|Overall Study|Caregiver request|3|||
13392715|NCT00669110|26781123|FG001|Overall Study|Caregiver request|2|||
13392716|NCT00669110|26781122|FG000|Overall Study|Physician Decision|0|||
13392717|NCT00669110|26781123|FG001|Overall Study|Physician Decision|1|||
13392718|NCT00669110|26781122|FG000|Overall Study|Lost to Follow-up|1|||
13392719|NCT00669110|26781123|FG001|Overall Study|Lost to Follow-up|0|||
13392720|NCT00669110|26781122|FG000|Overall Study|Protocol Violation|0|||
13392721|NCT00669110|26781123|FG001|Overall Study|Protocol Violation|5|||
13392722|NCT00669110|26781122|FG000|Overall Study|Withdrawal by Subject|0|||
13392723|NCT00669110|26781123|FG001|Overall Study|Withdrawal by Subject|2|||
13392724|NCT00669071|26781144|FG000|Overall Study|Lost to Follow-up|3|||
13392725|NCT00669071|26781144|FG000|Overall Study|Final visit 40 days out of window|1|||
13392726|NCT00669032|26781179|FG000|Overall Study|Lost to Follow-up|6|||
13392727|NCT00669032|26781180|FG001|Overall Study|Lost to Follow-up|5|||
13392728|NCT00669032|26781179|FG000|Overall Study|Lack of Efficacy|8|||
13392729|NCT00669032|26781180|FG001|Overall Study|Lack of Efficacy|19|||
13392730|NCT00669032|26781179|FG000|Overall Study|Withdrawal by Subject|12|||
13392731|NCT00669032|26781180|FG001|Overall Study|Withdrawal by Subject|13|||
13392732|NCT00669032|26781179|FG000|Overall Study|Adverse Event|12|||
13392733|NCT00669032|26781180|FG001|Overall Study|Adverse Event|16|||
13392734|NCT00669032|26781179|FG000|Overall Study|Physician Decision|1|||
13392735|NCT00669032|26781180|FG001|Overall Study|Physician Decision|1|||
13392736|NCT00669032|26781179|FG000|Overall Study|No fulfilment of the selection criteria|5|||
13392737|NCT00669032|26781180|FG001|Overall Study|No fulfilment of the selection criteria|5|||
13392738|NCT00668863|26781201|FG000|Overall Study|Objective Progression or Relapse|42|||
13392739|NCT00668863|26781201|FG000|Overall Study|Adverse Event|13|||
13392740|NCT00668863|26781201|FG000|Overall Study|Study Terminated by Sponsor|8|||
13392741|NCT00668863|26781201|FG000|Overall Study|Global Deterioration of Health Status|4|||
13392742|NCT00668863|26781201|FG000|Overall Study|Withdrawal by Subject|1|||
13392743|NCT00668863|26781201|FG000|Overall Study|Surgery|1|||
13392744|NCT00668863|26781201|FG000|Overall Study|Subject's work scheduling problem|1|||
13392745|NCT00668863|26781201|FG000|Overall Study|Physician Decision|1|||
13392746|NCT00668746|26781226|FG000|Overall Study|Lost to Follow-up|2|||
13392747|NCT00668746|26781227|FG001|Overall Study|Lost to Follow-up|1|||
13392748|NCT00668733|26781240|FG000|Overall Study|Lost to Follow-up|2|||
13392749|NCT00668733|26781241|FG001|Overall Study|Lost to Follow-up|3|||
13392750|NCT00668733|26781240|FG000|Overall Study|Withdrawal by Subject|0|||
13392751|NCT00668733|26781241|FG001|Overall Study|Withdrawal by Subject|4|||
13392752|NCT00668707|26781276|FG000|Overall Study|Cancer Recurrence|58|||
13392753|NCT00668707|26781277|FG001|Overall Study|Cancer Recurrence|58|||
13392754|NCT00668707|26781276|FG000|Overall Study|Withdrawal by Subject|117|||
13392755|NCT00668707|26781277|FG001|Overall Study|Withdrawal by Subject|100|||
13392756|NCT00668707|26781276|FG000|Overall Study|Lost to Follow-up|3|||
13392757|NCT00668707|26781277|FG001|Overall Study|Lost to Follow-up|6|||
13392758|NCT00668707|26781276|FG000|Overall Study|Protocol Violation|10|||
13392759|NCT00668707|26781277|FG001|Overall Study|Protocol Violation|12|||
13392760|NCT00668707|26781276|FG000|Overall Study|Death|11|||
13392761|NCT00668707|26781277|FG001|Overall Study|Death|4|||
13392762|NCT00668395|26781295|FG000|Overall Study|Withdrawal by Subject|4|||
13392763|NCT00668395|26781296|FG001|Overall Study|Withdrawal by Subject|4|||
13392764|NCT00668395|26781297|FG002|Overall Study|Withdrawal by Subject|1|||
13392765|NCT00668395|26781295|FG000|Overall Study|Adverse Event|1|||
13392766|NCT00668395|26781296|FG001|Overall Study|Adverse Event|1|||
13392767|NCT00668395|26781297|FG002|Overall Study|Adverse Event|0|||
13392768|NCT00668395|26781295|FG000|Overall Study|Physician Decision|1|||
13392769|NCT00668395|26781296|FG001|Overall Study|Physician Decision|1|||
13392770|NCT00668395|26781297|FG002|Overall Study|Physician Decision|0|||
13392771|NCT00668317|26781303|FG000|Overall Study|Adverse Event|2|||
13392772|NCT00668200|26781311|FG000|Overall Study|Withdrawal by Subject|2|||
13392773|NCT00668200|26781311|FG000|Overall Study|Lost to Follow-up|1|||
13392774|NCT00668148|26781350|FG000|Overall Study|Adverse Event|5|||
13392775|NCT00668148|26781350|FG000|Overall Study|Subject Non-compliance|1|||
13392776|NCT00668148|26781350|FG000|Overall Study|Progressive Disease Before Treatment|2|||
13392777|NCT00668148|26781350|FG000|Overall Study|Withdrawal of Consent|2|||
13477505|NCT01595009|27006996|FG002|Core|Lost to Follow-up|0|||
13477506|NCT01595009|27006997|FG003|Core|Lost to Follow-up|0|||
13477507|NCT01595009|27006994|FG000|Core|Protocol deviation|0|||
13477508|NCT01595009|27006995|FG001|Core|Protocol deviation|1|||
13477509|NCT01595009|27006996|FG002|Core|Protocol deviation|0|||
13477510|NCT01595009|27006997|FG003|Core|Protocol deviation|0|||
13477511|NCT01595009|27006994|FG000|Core|Administrative problems|0|||
13477512|NCT01595009|27006995|FG001|Core|Administrative problems|1|||
13477513|NCT01595009|27006996|FG002|Core|Administrative problems|0|||
13477514|NCT01595009|27006997|FG003|Core|Administrative problems|0|||
13477515|NCT01595009|27006994|FG000|Extension|Administrative problems|0|||
13477516|NCT01595009|27006995|FG001|Extension|Administrative problems|0|||
13477517|NCT01595009|27006996|FG002|Extension|Administrative problems|0|||
13477518|NCT01595009|27006997|FG003|Extension|Administrative problems|1|||
13477519|NCT01595009|27006994|FG000|Extension|Patients completed per protocol|0|||
13477520|NCT01595009|27006995|FG001|Extension|Patients completed per protocol|0|||
13477521|NCT01595009|27006996|FG002|Extension|Patients completed per protocol|0|||
13477522|NCT01595009|27006997|FG003|Extension|Patients completed per protocol|2|||
13477523|NCT01595009|27006994|FG000|Extension|Disease progression|0|||
13477524|NCT01595009|27006995|FG001|Extension|Disease progression|0|||
13477525|NCT01595009|27006996|FG002|Extension|Disease progression|4|||
13477526|NCT01595009|27006997|FG003|Extension|Disease progression|7|||
13477527|NCT01595009|27006994|FG000|Extension|Adverse Event|0|||
13477528|NCT01595009|27006995|FG001|Extension|Adverse Event|0|||
13477529|NCT01595009|27006996|FG002|Extension|Adverse Event|0|||
13477530|NCT01595009|27006997|FG003|Extension|Adverse Event|1|||
13392778|NCT00667992|26781411|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
13392779|NCT00667992|26781412|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
13392780|NCT00667992|26781411|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2|||
13392781|NCT00667992|26781412|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
13392782|NCT00667992|26781411|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
13392783|NCT00667992|26781412|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
13392784|NCT00667992|26781411|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1|||
13392785|NCT00667992|26781412|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0|||
13392786|NCT00667992|26781411|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
13392787|NCT00667992|26781412|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
13392788|NCT00667992|26781411|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1|||
13392789|NCT00667992|26781412|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0|||
13392790|NCT00667992|26781411|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
13392791|NCT00667992|26781412|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
13392792|NCT00667992|26781411|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0|||
13392793|NCT00667992|26781412|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1|||
13392794|NCT00667992|26781411|FG000|Wash-out|Not within one doubling dilution|4|||
13392795|NCT00667992|26781412|FG001|Wash-out|Not within one doubling dilution|3|||
13392796|NCT00667992|26781411|FG000|Wash-out|Failure to wash-out|2|||
13392797|NCT00667992|26781412|FG001|Wash-out|Failure to wash-out|2|||
13392798|NCT00667992|26781411|FG000|Wash-out|Withdrawal by Subject|1|||
13392799|NCT00667992|26781412|FG001|Wash-out|Withdrawal by Subject|0|||
13392800|NCT00667992|26781411|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1|||
13392801|NCT00667992|26781412|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
13392802|NCT00667992|26781411|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0|||
13392803|NCT00667992|26781412|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1|||
13392804|NCT00667888|26781425|FG000|Overall Study|Death|1|||
13392805|NCT00667888|26781426|FG001|Overall Study|Death|1|||
13392806|NCT00667888|26781425|FG000|Overall Study|Withdrawal by Subject|6|||
13392807|NCT00667888|26781426|FG001|Overall Study|Withdrawal by Subject|3|||
13392808|NCT00667888|26781425|FG000|Overall Study|Proceed with other treatment|3|||
13392809|NCT00667888|26781426|FG001|Overall Study|Proceed with other treatment|3|||
13392810|NCT00667888|26781425|FG000|Overall Study|Ineligible after SIM|0|||
13392811|NCT00667888|26781426|FG001|Overall Study|Ineligible after SIM|2|||
13392812|NCT00667875|26781453|FG000|Overall Study|Adverse Event|0|||
13392813|NCT00667875|26781454|FG001|Overall Study|Adverse Event|2|||
13392814|NCT00667875|26781455|FG002|Overall Study|Adverse Event|6|||
13392815|NCT00667875|26781453|FG000|Overall Study|Withdrawal by Subject|10|||
13392816|NCT00667875|26781454|FG001|Overall Study|Withdrawal by Subject|9|||
13392817|NCT00667875|26781455|FG002|Overall Study|Withdrawal by Subject|7|||
13392818|NCT00667862|26781468|FG000|Overall Study|Adverse Event|9|||
13392819|NCT00667862|26781468|FG000|Overall Study|Death|1|||
13392820|NCT00667862|26781468|FG000|Overall Study|Disease Progression|22|||
13392821|NCT00667862|26781468|FG000|Overall Study|Withdrawal by Subject|3|||
13392822|NCT00667823|26781479|FG000|Overall Study|Lost to Follow-up|5|||
13392823|NCT00667823|26781479|FG000|Overall Study|Adverse Event|7|||
13392824|NCT00667823|26781479|FG000|Overall Study|Death|182|||
13392825|NCT00667823|26781479|FG000|Overall Study|Withdrawal by Subject|12|||
13392826|NCT00667823|26781479|FG000|Overall Study|Other|8|||
13392827|NCT00667823|26781479|FG000|Overall Study|Missing (completion page missing)|2|||
13392828|NCT00667810|26781549|FG000|Overall Study|Adverse Event|13|||
13392829|NCT00667810|26781550|FG001|Overall Study|Adverse Event|14|||
13392830|NCT00667810|26781551|FG002|Overall Study|Adverse Event|19|||
13392831|NCT00667810|26781552|FG003|Overall Study|Adverse Event|1|||
13392832|NCT00667810|26781549|FG000|Overall Study|Death|1|||
13392833|NCT00667810|26781550|FG001|Overall Study|Death|1|||
13392834|NCT00667810|26781551|FG002|Overall Study|Death|3|||
13392835|NCT00667810|26781552|FG003|Overall Study|Death|0|||
13392836|NCT00667810|26781549|FG000|Overall Study|Lack of Efficacy|1|||
13392837|NCT00667810|26781550|FG001|Overall Study|Lack of Efficacy|0|||
13392838|NCT00667810|26781551|FG002|Overall Study|Lack of Efficacy|2|||
13392839|NCT00667810|26781552|FG003|Overall Study|Lack of Efficacy|0|||
13392840|NCT00667810|26781549|FG000|Overall Study|Lost to Follow-up|1|||
13392841|NCT00667810|26781550|FG001|Overall Study|Lost to Follow-up|4|||
13392842|NCT00667810|26781551|FG002|Overall Study|Lost to Follow-up|2|||
13392843|NCT00667810|26781552|FG003|Overall Study|Lost to Follow-up|0|||
13392844|NCT00667810|26781549|FG000|Overall Study|Physician Decision|1|||
13392845|NCT00667810|26781550|FG001|Overall Study|Physician Decision|1|||
13392846|NCT00667810|26781551|FG002|Overall Study|Physician Decision|2|||
13392847|NCT00667810|26781552|FG003|Overall Study|Physician Decision|0|||
13392848|NCT00667810|26781549|FG000|Overall Study|Protocol Violation|0|||
13392849|NCT00667810|26781550|FG001|Overall Study|Protocol Violation|2|||
13392850|NCT00667810|26781551|FG002|Overall Study|Protocol Violation|0|||
13392851|NCT00667810|26781552|FG003|Overall Study|Protocol Violation|0|||
13392852|NCT00667810|26781549|FG000|Overall Study|Withdrawal by Subject|14|||
13392853|NCT00667810|26781550|FG001|Overall Study|Withdrawal by Subject|20|||
13392854|NCT00667810|26781551|FG002|Overall Study|Withdrawal by Subject|29|||
13392855|NCT00667810|26781552|FG003|Overall Study|Withdrawal by Subject|1|||
13392856|NCT00667810|26781549|FG000|Overall Study|Discontinuation of Study by Sponsor|130|||
13392857|NCT00667810|26781550|FG001|Overall Study|Discontinuation of Study by Sponsor|118|||
13392858|NCT00667810|26781551|FG002|Overall Study|Discontinuation of Study by Sponsor|155|||
13392859|NCT00667810|26781552|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
13392860|NCT00667810|26781549|FG000|Overall Study|Failed to Return|0|||
13392861|NCT00667810|26781550|FG001|Overall Study|Failed to Return|0|||
13392862|NCT00667810|26781551|FG002|Overall Study|Failed to Return|2|||
13392863|NCT00667810|26781552|FG003|Overall Study|Failed to Return|0|||
13392864|NCT00667810|26781549|FG000|Overall Study|Loss of Caregiver|0|||
13392865|NCT00667810|26781550|FG001|Overall Study|Loss of Caregiver|1|||
13392866|NCT00667810|26781551|FG002|Overall Study|Loss of Caregiver|3|||
13392867|NCT00667810|26781552|FG003|Overall Study|Loss of Caregiver|0|||
13392868|NCT00667810|26781549|FG000|Overall Study|Vasogenic Edema Recurrence|0|||
13392869|NCT00667810|26781550|FG001|Overall Study|Vasogenic Edema Recurrence|3|||
13392870|NCT00667810|26781551|FG002|Overall Study|Vasogenic Edema Recurrence|0|||
13392871|NCT00667810|26781552|FG003|Overall Study|Vasogenic Edema Recurrence|0|||
13392872|NCT00667810|26781549|FG000|Overall Study|Other|6|||
13392873|NCT00667810|26781550|FG001|Overall Study|Other|6|||
13392874|NCT00667810|26781551|FG002|Overall Study|Other|5|||
13392875|NCT00667810|26781552|FG003|Overall Study|Other|0|||
13392876|NCT00667732|26781571|FG000|Run -In (8 Weeks)|Adverse Event|4|||
13392877|NCT00667732|26781572|FG001|Run -In (8 Weeks)|Adverse Event|0|||
13392878|NCT00667732|26781573|FG002|Run -In (8 Weeks)|Adverse Event|0|||
13392879|NCT00667732|26781571|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3|||
13392880|NCT00667732|26781572|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0|||
13392881|NCT00667732|26781573|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0|||
13392882|NCT00667732|26781571|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0|||
13392883|NCT00667732|26781572|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1|||
13392884|NCT00667732|26781573|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0|||
13392885|NCT00667719|26781588|FG000|Overall Study|Adverse Event|39|||
13392886|NCT00667719|26781588|FG000|Overall Study|Abnormal Test Procedure|1|||
13392887|NCT00667719|26781588|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
13392888|NCT00667719|26781588|FG000|Overall Study|Protocol Violation|3|||
13392889|NCT00667719|26781588|FG000|Overall Study|Withdrawal by Subject|17|||
13392890|NCT00667719|26781588|FG000|Overall Study|Lost to Follow-up|8|||
13392891|NCT00667628|26781611|FG000|Overall Study|Lost to Follow-up|1|||
13392892|NCT00667628|26781612|FG001|Overall Study|Lost to Follow-up|0|||
13392893|NCT00667628|26781611|FG000|Overall Study|Death|6|||
13392894|NCT00667628|26781612|FG001|Overall Study|Death|6|||
13392895|NCT00667628|26781611|FG000|Overall Study|Investigator Considers in Best Interest|1|||
13392896|NCT00667628|26781612|FG001|Overall Study|Investigator Considers in Best Interest|0|||
13392897|NCT00667628|26781611|FG000|Overall Study|Sponsor Terminated Study|17|||
13392898|NCT00667628|26781612|FG001|Overall Study|Sponsor Terminated Study|21|||
13392899|NCT00667602|26781668|FG000|Overall Study|Withdrawal by Subject|4|||
13392900|NCT00667602|26781669|FG001|Overall Study|Withdrawal by Subject|9|||
13392901|NCT00667602|26781670|FG002|Overall Study|Withdrawal by Subject|10|||
13392902|NCT00667602|26781668|FG000|Overall Study|Lost to Follow-up|4|||
13392903|NCT00667602|26781669|FG001|Overall Study|Lost to Follow-up|5|||
13392904|NCT00667602|26781670|FG002|Overall Study|Lost to Follow-up|6|||
13392905|NCT00667602|26781668|FG000|Overall Study|Administrative reason|0|||
13392906|NCT00667602|26781669|FG001|Overall Study|Administrative reason|0|||
13392907|NCT00667602|26781670|FG002|Overall Study|Administrative reason|2|||
13392908|NCT00667602|26781668|FG000|Overall Study|Protocol Violation|0|||
13392909|NCT00667602|26781669|FG001|Overall Study|Protocol Violation|1|||
13392910|NCT00667602|26781670|FG002|Overall Study|Protocol Violation|0|||
13392911|NCT00667576|26781733|FG000|Overall Study|Withdrawal by Subject|1|||
13392912|NCT00667576|26781734|FG001|Overall Study|Withdrawal by Subject|0|||
13392913|NCT00667576|26781735|FG002|Overall Study|Withdrawal by Subject|1|||
13392914|NCT00667576|26781736|FG003|Overall Study|Withdrawal by Subject|1|||
13392915|NCT00667576|26781737|FG004|Overall Study|Withdrawal by Subject|1|||
13392916|NCT00667576|26781733|FG000|Overall Study|Adverse Event|1|||
13392917|NCT00667576|26781734|FG001|Overall Study|Adverse Event|1|||
13392918|NCT00667576|26781735|FG002|Overall Study|Adverse Event|0|||
13392919|NCT00667576|26781736|FG003|Overall Study|Adverse Event|0|||
13392920|NCT00667576|26781737|FG004|Overall Study|Adverse Event|0|||
13392921|NCT00667576|26781733|FG000|Overall Study|Lost to Follow-up|0|||
13392922|NCT00667576|26781734|FG001|Overall Study|Lost to Follow-up|0|||
13392923|NCT00667576|26781735|FG002|Overall Study|Lost to Follow-up|1|||
13392924|NCT00667576|26781736|FG003|Overall Study|Lost to Follow-up|0|||
13392925|NCT00667576|26781737|FG004|Overall Study|Lost to Follow-up|0|||
13392926|NCT00667576|26781733|FG000|Overall Study|Protocol Violation|0|||
13392927|NCT00667576|26781734|FG001|Overall Study|Protocol Violation|0|||
13392928|NCT00667576|26781735|FG002|Overall Study|Protocol Violation|0|||
13392929|NCT00667576|26781736|FG003|Overall Study|Protocol Violation|1|||
13392930|NCT00667576|26781737|FG004|Overall Study|Protocol Violation|0|||
13392931|NCT00667576|26781733|FG000|Overall Study|Physician Decision|0|||
13392932|NCT00667576|26781734|FG001|Overall Study|Physician Decision|0|||
13392933|NCT00667576|26781735|FG002|Overall Study|Physician Decision|0|||
13392934|NCT00667576|26781736|FG003|Overall Study|Physician Decision|1|||
13392935|NCT00667576|26781737|FG004|Overall Study|Physician Decision|0|||
13392936|NCT00667576|26781733|FG000|Overall Study|Missed Visit|0|||
13392937|NCT00667576|26781734|FG001|Overall Study|Missed Visit|0|||
13392938|NCT00667576|26781735|FG002|Overall Study|Missed Visit|0|||
13392939|NCT00667576|26781736|FG003|Overall Study|Missed Visit|1|||
13392940|NCT00667576|26781737|FG004|Overall Study|Missed Visit|0|||
13392941|NCT00667563|26781749|FG000|Overall Study|Protocol Violation|24|||
13392942|NCT00667459|26781796|FG000|Overall Study|Death|0|||
13392943|NCT00667459|26781797|FG001|Overall Study|Death|2|||
13392944|NCT00667459|26781796|FG000|Overall Study|Lost to Follow-up|8|||
13392945|NCT00667459|26781797|FG001|Overall Study|Lost to Follow-up|43|||
13392946|NCT00667446|26781826|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13|||
13392947|NCT00667446|26781827|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15|||
13392948|NCT00667446|26781826|FG000|Treatment Period (36 Months)|Other|2|||
13392949|NCT00667446|26781827|FG001|Treatment Period (36 Months)|Other|2|||
13392950|NCT00667446|26781826|FG000|Treatment Period (36 Months)|Personal reasons|2|||
13392951|NCT00667446|26781827|FG001|Treatment Period (36 Months)|Personal reasons|2|||
13392952|NCT00667446|26781826|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0|||
13392953|NCT00667446|26781827|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4|||
13392954|NCT00667446|26781826|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3|||
13392955|NCT00667446|26781827|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0|||
13392956|NCT00667446|26781826|FG000|Treatment Period (36 Months)|Lost to Follow-up|1|||
13392957|NCT00667446|26781827|FG001|Treatment Period (36 Months)|Lost to Follow-up|0|||
13392958|NCT00667446|26781826|FG000|Treatment Period (36 Months)|Protocol Violation|1|||
13392959|NCT00667446|26781827|FG001|Treatment Period (36 Months)|Protocol Violation|1|||
13392960|NCT00667446|26781826|FG000|Treatment Period (36 Months)|Therapeutic Failure|1|||
13392961|NCT00667446|26781827|FG001|Treatment Period (36 Months)|Therapeutic Failure|1|||
13392962|NCT00667446|26781826|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0|||
13392963|NCT00667446|26781827|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1|||
13392964|NCT00667420|26781837|FG000|Overall Study|Adverse Event|2|||
13392965|NCT00667420|26781837|FG000|Overall Study|Lack of Efficacy|5|||
13392966|NCT00667420|26781837|FG000|Overall Study|Physician Decision|1|||
13392967|NCT00667420|26781837|FG000|Overall Study|Withdrawal by Subject|2|||
13392968|NCT00667394|26781852|FG000|Overall Study|Adverse Event|3|||
13392969|NCT00667394|26781853|FG001|Overall Study|Adverse Event|0|||
13392970|NCT00667394|26781852|FG000|Overall Study|Progressive disease|1|||
13392971|NCT00667394|26781853|FG001|Overall Study|Progressive disease|0|||
13392972|NCT00667368|26781868|FG000|Overall Study|Lost to Follow-up|176|||
13392973|NCT00667368|26781869|FG001|Overall Study|Lost to Follow-up|155|||
13392974|NCT00667368|26781868|FG000|Overall Study|Discontinued early|24|||
13392975|NCT00667368|26781869|FG001|Overall Study|Discontinued early|17|||
13392976|NCT00667355|26781893|FG000|Overall Study|Adverse Event|5|||
13392977|NCT00667355|26781893|FG000|Overall Study|Lost to Follow-up|1|||
13392978|NCT00667355|26781893|FG000|Overall Study|Other reason was not specified|5|||
13392979|NCT00667342|26781941|FG000|Overall Study|Protocol Violation|1|||
13392980|NCT00667342|26781942|FG001|Overall Study|Protocol Violation|0|||
13392981|NCT00667342|26781943|FG002|Overall Study|Protocol Violation|0|||
13392982|NCT00667342|26781941|FG000|Overall Study|Withdrawal by Subject|1|||
13392983|NCT00667342|26781942|FG001|Overall Study|Withdrawal by Subject|0|||
13392984|NCT00667342|26781943|FG002|Overall Study|Withdrawal by Subject|0|||
13392985|NCT00667342|26781941|FG000|Overall Study|Physician Decision|3|||
13392986|NCT00667342|26781942|FG001|Overall Study|Physician Decision|0|||
13392987|NCT00667342|26781943|FG002|Overall Study|Physician Decision|0|||
13392988|NCT00667342|26781941|FG000|Overall Study|Relapse or tumor progression|9|||
13392989|NCT00667342|26781942|FG001|Overall Study|Relapse or tumor progression|0|||
13392990|NCT00667342|26781943|FG002|Overall Study|Relapse or tumor progression|7|||
13392991|NCT00667342|26781941|FG000|Overall Study|Adverse Event|0|||
13477531|NCT05553808|27007049|FG000|Overall Study|Death|25|||
13477532|NCT05553808|27007050|FG001|Overall Study|Death|62|||
13477533|NCT05553808|27007049|FG000|Overall Study|Site Closed|6|||
13477534|NCT05553808|27007050|FG001|Overall Study|Site Closed|6|||
13477535|NCT05553808|27007049|FG000|Overall Study|Lost to Follow-up|1|||
13477536|NCT05553808|27007050|FG001|Overall Study|Lost to Follow-up|0|||
13477537|NCT05553808|27007049|FG000|Overall Study|Withdrawal by Subject|3|||
13477538|NCT05553808|27007050|FG001|Overall Study|Withdrawal by Subject|2|||
13477539|NCT04997161|27007060|FG000|Overall Study|Study terminated by sponsor|3|||
13477540|NCT04753216|27007093|FG000|Screening - 1st Response Assessment|Adverse Event|1|||
13477541|NCT04753216|27007093|FG000|Cycle 3 - 2nd Response Assessment|Disease Progression|1|||
13477542|NCT04753216|27007093|FG000|Cycle 5 - 3rd Response Assessment|Withdrawal by Subject|1|||
13477543|NCT04530747|27007166|FG000|Overall Study|Withdrawal by Subject|1|||
13477544|NCT04530747|27007167|FG001|Overall Study|Withdrawal by Subject|0|||
13392992|NCT00667342|26781942|FG001|Overall Study|Adverse Event|0|||
13392993|NCT00667342|26781943|FG002|Overall Study|Adverse Event|1|||
13392994|NCT00667342|26781941|FG000|Overall Study|Ineligible|0|||
13392995|NCT00667342|26781942|FG001|Overall Study|Ineligible|0|||
13392996|NCT00667342|26781943|FG002|Overall Study|Ineligible|1|||
13392997|NCT00667277|26781950|FG000|Overall Study|Withdrawal by Subject|2|||
13392998|NCT00667251|26781981|FG000|Overall Study|Adverse Event|13|||
13392999|NCT00667251|26781982|FG001|Overall Study|Adverse Event|4|||
13393000|NCT00667251|26781981|FG000|Overall Study|Withdrawal by Subject|6|||
13393001|NCT00667251|26781982|FG001|Overall Study|Withdrawal by Subject|2|||
13393002|NCT00667251|26781981|FG000|Overall Study|Other/missing|46|||
13393003|NCT00667251|26781982|FG001|Overall Study|Other/missing|84|||
13393004|NCT00667251|26781981|FG000|Overall Study|Intercurrent Illness|4|||
13393005|NCT00667251|26781982|FG001|Overall Study|Intercurrent Illness|3|||
13393006|NCT00667251|26781981|FG000|Overall Study|Symptomatic progression|1|||
13393007|NCT00667251|26781982|FG001|Overall Study|Symptomatic progression|2|||
13393008|NCT00667225|26781997|FG000|Overall Study|Subject had no more lesions to treat.|1|||
13393009|NCT00667225|26781998|FG001|Overall Study|Subject had no more lesions to treat.|0|||
13393010|NCT00667225|26781997|FG000|Overall Study|Lost to Follow-up|0|||
13393011|NCT00667225|26781998|FG001|Overall Study|Lost to Follow-up|1|||
13393012|NCT00667095|26782021|FG000|Overall Study|Withdrawal by Subject|0|||
13393013|NCT00667095|26782022|FG001|Overall Study|Withdrawal by Subject|1|||
13393014|NCT00667017|26782028|FG000|Overall Study|Withdrawal by Subject|1|||
13393015|NCT00666965|26782071|FG000|Overall Study|Adverse Event|0|||
13393016|NCT00666965|26782072|FG001|Overall Study|Adverse Event|2|||
13393017|NCT00666965|26782073|FG002|Overall Study|Adverse Event|1|||
13393018|NCT00666965|26782074|FG003|Overall Study|Adverse Event|9|||
13393019|NCT00666965|26782071|FG000|Overall Study|Lack of Efficacy|1|||
13393020|NCT00666965|26782072|FG001|Overall Study|Lack of Efficacy|1|||
13393021|NCT00666965|26782073|FG002|Overall Study|Lack of Efficacy|0|||
13393022|NCT00666965|26782074|FG003|Overall Study|Lack of Efficacy|0|||
13393023|NCT00666965|26782071|FG000|Overall Study|Protocol Violation|0|||
13393024|NCT00666965|26782072|FG001|Overall Study|Protocol Violation|0|||
13393025|NCT00666965|26782073|FG002|Overall Study|Protocol Violation|0|||
13393026|NCT00666965|26782074|FG003|Overall Study|Protocol Violation|2|||
13393027|NCT00666965|26782071|FG000|Overall Study|Discontinuation criteria|2|||
13393028|NCT00666965|26782072|FG001|Overall Study|Discontinuation criteria|1|||
13393029|NCT00666965|26782073|FG002|Overall Study|Discontinuation criteria|1|||
13393030|NCT00666965|26782074|FG003|Overall Study|Discontinuation criteria|2|||
13393031|NCT00666965|26782071|FG000|Overall Study|Withdrawal by Subject|0|||
13393032|NCT00666965|26782072|FG001|Overall Study|Withdrawal by Subject|0|||
13393033|NCT00666965|26782073|FG002|Overall Study|Withdrawal by Subject|0|||
13393034|NCT00666965|26782074|FG003|Overall Study|Withdrawal by Subject|2|||
13393035|NCT00666926|26782382|FG000|Overall Study|Adverse Event|0|||
13393036|NCT00666926|26782383|FG001|Overall Study|Adverse Event|0|||
13393037|NCT00666926|26782384|FG002|Overall Study|Adverse Event|0|||
13393038|NCT00666926|26782385|FG003|Overall Study|Adverse Event|0|||
13393039|NCT00666926|26782386|FG004|Overall Study|Adverse Event|0|||
13393040|NCT00666926|26782387|FG005|Overall Study|Adverse Event|0|||
13393041|NCT00666926|26782388|FG006|Overall Study|Adverse Event|0|||
13393042|NCT00666926|26782389|FG007|Overall Study|Adverse Event|0|||
13393043|NCT00666926|26782390|FG008|Overall Study|Adverse Event|0|||
13393044|NCT00666926|26782391|FG009|Overall Study|Adverse Event|2|||
13393045|NCT00666926|26782392|FG010|Overall Study|Adverse Event|2|||
13393046|NCT00666926|26782393|FG011|Overall Study|Adverse Event|2|||
13393047|NCT00666926|26782394|FG012|Overall Study|Adverse Event|0|||
13393048|NCT00666926|26782395|FG013|Overall Study|Adverse Event|1|||
13393049|NCT00666926|26782396|FG014|Overall Study|Adverse Event|0|||
13393050|NCT00666926|26782397|FG015|Overall Study|Adverse Event|0|||
13393051|NCT00666926|26782382|FG000|Overall Study|Laboratory abnormality|0|||
13393052|NCT00666926|26782383|FG001|Overall Study|Laboratory abnormality|0|||
13393053|NCT00666926|26782384|FG002|Overall Study|Laboratory abnormality|0|||
13393054|NCT00666926|26782385|FG003|Overall Study|Laboratory abnormality|0|||
13393055|NCT00666926|26782386|FG004|Overall Study|Laboratory abnormality|0|||
13393056|NCT00666926|26782387|FG005|Overall Study|Laboratory abnormality|0|||
13393057|NCT00666926|26782388|FG006|Overall Study|Laboratory abnormality|0|||
13393058|NCT00666926|26782389|FG007|Overall Study|Laboratory abnormality|0|||
13393059|NCT00666926|26782390|FG008|Overall Study|Laboratory abnormality|0|||
13393060|NCT00666926|26782391|FG009|Overall Study|Laboratory abnormality|0|||
13393061|NCT00666926|26782392|FG010|Overall Study|Laboratory abnormality|1|||
13393062|NCT00666926|26782393|FG011|Overall Study|Laboratory abnormality|0|||
13393063|NCT00666926|26782394|FG012|Overall Study|Laboratory abnormality|0|||
13393064|NCT00666926|26782395|FG013|Overall Study|Laboratory abnormality|0|||
13393065|NCT00666926|26782396|FG014|Overall Study|Laboratory abnormality|0|||
13393066|NCT00666926|26782397|FG015|Overall Study|Laboratory abnormality|1|||
13393067|NCT00666926|26782382|FG000|Overall Study|Lack of Efficacy|0|||
13393068|NCT00666926|26782383|FG001|Overall Study|Lack of Efficacy|0|||
13477545|NCT04325828|27007182|FG000|Overall Study|Ongoing|26|||
13393069|NCT00666926|26782384|FG002|Overall Study|Lack of Efficacy|0|||
13393070|NCT00666926|26782385|FG003|Overall Study|Lack of Efficacy|0|||
13393071|NCT00666926|26782386|FG004|Overall Study|Lack of Efficacy|0|||
13393072|NCT00666926|26782387|FG005|Overall Study|Lack of Efficacy|1|||
13393073|NCT00666926|26782388|FG006|Overall Study|Lack of Efficacy|0|||
13393074|NCT00666926|26782389|FG007|Overall Study|Lack of Efficacy|0|||
13393075|NCT00666926|26782390|FG008|Overall Study|Lack of Efficacy|0|||
13393076|NCT00666926|26782391|FG009|Overall Study|Lack of Efficacy|0|||
13393077|NCT00666926|26782392|FG010|Overall Study|Lack of Efficacy|0|||
13393078|NCT00666926|26782393|FG011|Overall Study|Lack of Efficacy|1|||
13393079|NCT00666926|26782394|FG012|Overall Study|Lack of Efficacy|0|||
13393080|NCT00666926|26782395|FG013|Overall Study|Lack of Efficacy|0|||
13393081|NCT00666926|26782396|FG014|Overall Study|Lack of Efficacy|0|||
13393082|NCT00666926|26782397|FG015|Overall Study|Lack of Efficacy|0|||
13393083|NCT00666926|26782382|FG000|Overall Study|Lost to Follow-up|0|||
13393084|NCT00666926|26782383|FG001|Overall Study|Lost to Follow-up|0|||
13393085|NCT00666926|26782384|FG002|Overall Study|Lost to Follow-up|0|||
13393086|NCT00666926|26782385|FG003|Overall Study|Lost to Follow-up|1|||
13393087|NCT00666926|26782386|FG004|Overall Study|Lost to Follow-up|0|||
13393088|NCT00666926|26782387|FG005|Overall Study|Lost to Follow-up|0|||
13393089|NCT00666926|26782388|FG006|Overall Study|Lost to Follow-up|0|||
13393090|NCT00666926|26782389|FG007|Overall Study|Lost to Follow-up|0|||
13393091|NCT00666926|26782390|FG008|Overall Study|Lost to Follow-up|0|||
13393092|NCT00666926|26782391|FG009|Overall Study|Lost to Follow-up|0|||
13393093|NCT00666926|26782392|FG010|Overall Study|Lost to Follow-up|0|||
13393094|NCT00666926|26782393|FG011|Overall Study|Lost to Follow-up|0|||
13393095|NCT00666926|26782394|FG012|Overall Study|Lost to Follow-up|0|||
13393096|NCT00666926|26782395|FG013|Overall Study|Lost to Follow-up|0|||
13393097|NCT00666926|26782396|FG014|Overall Study|Lost to Follow-up|0|||
13393098|NCT00666926|26782397|FG015|Overall Study|Lost to Follow-up|0|||
13393099|NCT00666926|26782382|FG000|Overall Study|Other|2|||
13393100|NCT00666926|26782383|FG001|Overall Study|Other|4|||
13393101|NCT00666926|26782384|FG002|Overall Study|Other|3|||
13393102|NCT00666926|26782385|FG003|Overall Study|Other|3|||
13393103|NCT00666926|26782386|FG004|Overall Study|Other|3|||
13393104|NCT00666926|26782387|FG005|Overall Study|Other|3|||
13393105|NCT00666926|26782388|FG006|Overall Study|Other|4|||
13393106|NCT00666926|26782389|FG007|Overall Study|Other|0|||
13393107|NCT00666926|26782390|FG008|Overall Study|Other|3|||
13393108|NCT00666926|26782391|FG009|Overall Study|Other|5|||
13393109|NCT00666926|26782392|FG010|Overall Study|Other|3|||
13393110|NCT00666926|26782393|FG011|Overall Study|Other|26|||
13393111|NCT00666926|26782394|FG012|Overall Study|Other|3|||
13393112|NCT00666926|26782395|FG013|Overall Study|Other|2|||
13477546|NCT04040751|27007249|FG000|Overall Study|Withdrawal by Subject|2|||
13477547|NCT04040751|27007250|FG001|Overall Study|Withdrawal by Subject|0|||
13393113|NCT00666926|26782396|FG014|Overall Study|Other|4|||
13393114|NCT00666926|26782397|FG015|Overall Study|Other|4|||
13393115|NCT00666926|26782382|FG000|Overall Study|Withdrawal by Subject|0|||
13393116|NCT00666926|26782383|FG001|Overall Study|Withdrawal by Subject|0|||
13393117|NCT00666926|26782384|FG002|Overall Study|Withdrawal by Subject|0|||
13393118|NCT00666926|26782385|FG003|Overall Study|Withdrawal by Subject|0|||
13393119|NCT00666926|26782386|FG004|Overall Study|Withdrawal by Subject|0|||
13393120|NCT00666926|26782387|FG005|Overall Study|Withdrawal by Subject|0|||
13393121|NCT00666926|26782388|FG006|Overall Study|Withdrawal by Subject|0|||
13393122|NCT00666926|26782389|FG007|Overall Study|Withdrawal by Subject|1|||
13477548|NCT04040751|27007251|FG002|Overall Study|Withdrawal by Subject|2|||
13393123|NCT00666926|26782390|FG008|Overall Study|Withdrawal by Subject|0|||
13393124|NCT00666926|26782391|FG009|Overall Study|Withdrawal by Subject|3|||
13393125|NCT00666926|26782392|FG010|Overall Study|Withdrawal by Subject|0|||
13393126|NCT00666926|26782393|FG011|Overall Study|Withdrawal by Subject|3|||
13393127|NCT00666926|26782394|FG012|Overall Study|Withdrawal by Subject|0|||
13393128|NCT00666926|26782395|FG013|Overall Study|Withdrawal by Subject|1|||
13393129|NCT00666926|26782396|FG014|Overall Study|Withdrawal by Subject|3|||
13393130|NCT00666926|26782397|FG015|Overall Study|Withdrawal by Subject|3|||
13393131|NCT00666926|26782382|FG000|Overall Study|Death|0|||
13393132|NCT00666926|26782383|FG001|Overall Study|Death|0|||
13393133|NCT00666926|26782384|FG002|Overall Study|Death|0|||
13393134|NCT00666926|26782385|FG003|Overall Study|Death|0|||
13393135|NCT00666926|26782386|FG004|Overall Study|Death|0|||
13393136|NCT00666926|26782387|FG005|Overall Study|Death|0|||
13393137|NCT00666926|26782388|FG006|Overall Study|Death|0|||
13393138|NCT00666926|26782389|FG007|Overall Study|Death|0|||
13393139|NCT00666926|26782390|FG008|Overall Study|Death|0|||
13393140|NCT00666926|26782391|FG009|Overall Study|Death|0|||
13393141|NCT00666926|26782392|FG010|Overall Study|Death|0|||
13393142|NCT00666926|26782393|FG011|Overall Study|Death|1|||
13393143|NCT00666926|26782394|FG012|Overall Study|Death|0|||
13393144|NCT00666926|26782395|FG013|Overall Study|Death|0|||
13393145|NCT00666926|26782396|FG014|Overall Study|Death|0|||
13393146|NCT00666926|26782397|FG015|Overall Study|Death|0|||
13393147|NCT00666835|26782412|FG000|Overall Study|Withdrawal by Subject|5|||
13393148|NCT00666835|26782413|FG001|Overall Study|Withdrawal by Subject|2|||
13393149|NCT00666835|26782412|FG000|Overall Study|Lack of Efficacy|0|||
13393150|NCT00666835|26782413|FG001|Overall Study|Lack of Efficacy|1|||
13393151|NCT00666835|26782412|FG000|Overall Study|Incl./excl. not fulfilled|7|||
13393152|NCT00666835|26782413|FG001|Overall Study|Incl./excl. not fulfilled|2|||
13393153|NCT00666835|26782412|FG000|Overall Study|Adverse Event|7|||
13393154|NCT00666835|26782413|FG001|Overall Study|Adverse Event|6|||
13393155|NCT00666835|26782412|FG000|Overall Study|Protocol Violation|2|||
13393156|NCT00666835|26782413|FG001|Overall Study|Protocol Violation|0|||
13393157|NCT00666835|26782412|FG000|Overall Study|Death|15|||
13393158|NCT00666835|26782413|FG001|Overall Study|Death|4|||
13393159|NCT00666835|26782412|FG000|Overall Study|Kidney Transplantation (NTX)|10|||
13393160|NCT00666835|26782413|FG001|Overall Study|Kidney Transplantation (NTX)|2|||
13393161|NCT00666835|26782412|FG000|Overall Study|Hemoglobulin concentration|4|||
13393162|NCT00666835|26782413|FG001|Overall Study|Hemoglobulin concentration|3|||
13393163|NCT00666835|26782412|FG000|Overall Study|Planned operation|2|||
13393164|NCT00666835|26782413|FG001|Overall Study|Planned operation|0|||
13393165|NCT00666835|26782412|FG000|Overall Study|Physician Decision|1|||
13393166|NCT00666835|26782413|FG001|Overall Study|Physician Decision|2|||
13393167|NCT00666757|26782477|FG000|Overall Study|Lost to Follow-up|39|||
13393168|NCT00666757|26782478|FG001|Overall Study|Lost to Follow-up|35|||
13393169|NCT00666757|26782477|FG000|Overall Study|Protocol Violation|23|||
13393170|NCT00666757|26782478|FG001|Overall Study|Protocol Violation|24|||
13393171|NCT00666757|26782477|FG000|Overall Study|Adverse Event|22|||
13393172|NCT00666757|26782478|FG001|Overall Study|Adverse Event|12|||
13393173|NCT00666757|26782477|FG000|Overall Study|Withdrawal by Subject|13|||
13393174|NCT00666757|26782478|FG001|Overall Study|Withdrawal by Subject|17|||
13393175|NCT00666757|26782477|FG000|Overall Study|Lack of Efficacy|3|||
13393176|NCT00666757|26782478|FG001|Overall Study|Lack of Efficacy|6|||
13393177|NCT00666757|26782477|FG000|Overall Study|Physician Decision|0|||
13393178|NCT00666757|26782478|FG001|Overall Study|Physician Decision|2|||
13393179|NCT00666757|26782477|FG000|Overall Study|Sponsor decision|0|||
13393180|NCT00666757|26782478|FG001|Overall Study|Sponsor decision|1|||
13393181|NCT00666718|26782511|FG000|Overall Study|Adverse Event|0|||
13393182|NCT00666718|26782512|FG001|Overall Study|Adverse Event|1|||
13393183|NCT00666718|26782511|FG000|Overall Study|Death|1|||
13393184|NCT00666718|26782512|FG001|Overall Study|Death|0|||
13393185|NCT00666718|26782511|FG000|Overall Study|Lost to Follow-up|1|||
13393186|NCT00666718|26782512|FG001|Overall Study|Lost to Follow-up|0|||
13393187|NCT00666718|26782511|FG000|Overall Study|Entry Criteria Not Met|2|||
13393188|NCT00666718|26782512|FG001|Overall Study|Entry Criteria Not Met|0|||
13393189|NCT00666718|26782511|FG000|Overall Study|Protocol Violation|1|||
13393190|NCT00666718|26782512|FG001|Overall Study|Protocol Violation|3|||
13393191|NCT00666718|26782511|FG000|Overall Study|Withdrawal by Subject|7|||
13393192|NCT00666718|26782512|FG001|Overall Study|Withdrawal by Subject|12|||
13393193|NCT00666718|26782511|FG000|Overall Study|Physician Decision|0|||
13393194|NCT00666718|26782512|FG001|Overall Study|Physician Decision|2|||
13393195|NCT00666705|26782531|FG000|Overall Study|Withdrawal by Subject|1|||
13393196|NCT00666679|26782558|FG000|First Intervention|Lost to Follow-up|1|||
13393197|NCT00666679|26782559|FG001|First Intervention|Lost to Follow-up|0|||
13393198|NCT00666679|26782558|FG000|First Intervention|Protocol Violation|1|||
13393199|NCT00666679|26782559|FG001|First Intervention|Protocol Violation|0|||
13393200|NCT00666679|26782558|FG000|First Intervention|Withdrawal by Subject|1|||
13393201|NCT00666679|26782559|FG001|First Intervention|Withdrawal by Subject|0|||
13393202|NCT00666679|26782558|FG000|First Intervention|Randomized did not start treatment|1|||
13393203|NCT00666679|26782559|FG001|First Intervention|Randomized did not start treatment|1|||
13393204|NCT00666679|26782558|FG000|Washout Period of 1 Week|Lost to Follow-up|0|||
13393205|NCT00666679|26782559|FG001|Washout Period of 1 Week|Lost to Follow-up|1|||
13393206|NCT00666679|26782558|FG000|Washout Period of 1 Week|Protocol Violation|0|||
13393207|NCT00666679|26782559|FG001|Washout Period of 1 Week|Protocol Violation|1|||
13393208|NCT00666679|26782558|FG000|Second Intervention|Adverse Event|1|||
13393209|NCT00666679|26782559|FG001|Second Intervention|Adverse Event|0|||
13393210|NCT00666679|26782558|FG000|Second Intervention|Death|0|||
13393211|NCT00666679|26782559|FG001|Second Intervention|Death|1|||
13393212|NCT00666588|26782602|FG000|Overall Study|ineligible|2|||
13393213|NCT00666588|26782603|FG001|Overall Study|ineligible|0|||
13393214|NCT00666588|26782604|FG002|Overall Study|ineligible|0|||
13393215|NCT00666588|26782605|FG003|Overall Study|ineligible|2|||
13393216|NCT00666588|26782602|FG000|Overall Study|inevaluable|2|||
13393217|NCT00666588|26782603|FG001|Overall Study|inevaluable|0|||
13393218|NCT00666588|26782604|FG002|Overall Study|inevaluable|0|||
13393219|NCT00666588|26782605|FG003|Overall Study|inevaluable|0|||
13393220|NCT00666562|26782660|FG000|Overall Study|Withdrawal by Subject|0|||
13393221|NCT00666562|26782661|FG001|Overall Study|Withdrawal by Subject|1|||
13393222|NCT00666562|26782662|FG002|Overall Study|Withdrawal by Subject|0|||
13393223|NCT00666562|26782660|FG000|Overall Study|Concomitant Medication|0|||
13393224|NCT00666562|26782661|FG001|Overall Study|Concomitant Medication|1|||
13393225|NCT00666562|26782662|FG002|Overall Study|Concomitant Medication|0|||
13393226|NCT00666536|26782685|FG000|Overall Study|Adverse Event|9|||
13393227|NCT00666536|26782686|FG001|Overall Study|Adverse Event|19|||
13393228|NCT00666536|26782685|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
13393229|NCT00666536|26782686|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
13393230|NCT00666536|26782685|FG000|Overall Study|Protocol deviation(s)|8|||
13393231|NCT00666536|26782686|FG001|Overall Study|Protocol deviation(s)|6|||
13393232|NCT00666536|26782685|FG000|Overall Study|Withdrawal by Subject|10|||
13393233|NCT00666536|26782686|FG001|Overall Study|Withdrawal by Subject|9|||
13393234|NCT00666536|26782685|FG000|Overall Study|Lost to Follow-up|4|||
13393235|NCT00666536|26782686|FG001|Overall Study|Lost to Follow-up|3|||
13393236|NCT00666458|26782705|FG000|Overall Study|Adverse Event|8|||
13393237|NCT00666458|26782706|FG001|Overall Study|Adverse Event|7|||
13393238|NCT00666458|26782705|FG000|Overall Study|Withdrawal by Subject|5|||
13393239|NCT00666458|26782706|FG001|Overall Study|Withdrawal by Subject|4|||
13393240|NCT00666458|26782705|FG000|Overall Study|Lost to Follow-up|0|||
13393241|NCT00666458|26782706|FG001|Overall Study|Lost to Follow-up|3|||
13393242|NCT00666458|26782705|FG000|Overall Study|Administrative reason by sponsor|1|||
13393243|NCT00666458|26782706|FG001|Overall Study|Administrative reason by sponsor|1|||
13393244|NCT00666458|26782705|FG000|Overall Study|Incorrect enrollment|7|||
13393245|NCT00666458|26782706|FG001|Overall Study|Incorrect enrollment|1|||
13393246|NCT00666458|26782705|FG000|Overall Study|Study specific discontinuation criteria|14|||
13393247|NCT00666458|26782706|FG001|Overall Study|Study specific discontinuation criteria|7|||
13393248|NCT00666458|26782705|FG000|Overall Study|Severe non-compliance to the protocol|1|||
13393249|NCT00666458|26782706|FG001|Overall Study|Severe non-compliance to the protocol|1|||
13393250|NCT00666458|26782705|FG000|Overall Study|Safety reasons|1|||
13393251|NCT00666458|26782706|FG001|Overall Study|Safety reasons|0|||
13393252|NCT00666458|26782705|FG000|Overall Study|Medical history of anemia|1|||
13393253|NCT00666458|26782706|FG001|Overall Study|Medical history of anemia|0|||
13393254|NCT00666328|26782721|FG000|Overall Study|Death|2|||
13393255|NCT00666328|26782721|FG000|Overall Study|Lost to Follow-up|2|||
13393256|NCT00666328|26782721|FG000|Overall Study|No longer met eligibility criteria|1|||
13393257|NCT00666276|26782747|FG000|Overall Study|Protocol Violation|34|||
13393258|NCT00666263|26782892|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0|||
13393259|NCT00666263|26782893|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1|||
13393260|NCT00666263|26782892|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1|||
13393261|NCT00666263|26782893|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0|||
13393262|NCT00666263|26782892|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0|||
13393263|NCT00666263|26782893|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1|||
13393264|NCT00666237|26782920|FG000|Overall Study|Death|5|||
13393265|NCT00666237|26782921|FG001|Overall Study|Death|5|||
13393266|NCT00666237|26782920|FG000|Overall Study|Lost to Follow-up|29|||
13393267|NCT00666237|26782921|FG001|Overall Study|Lost to Follow-up|25|||
13393663|NCT00662792|26784675|FG001|Period 1|Lost to Follow-up|0|||
13393664|NCT00662792|26784676|FG002|Period 1|Lost to Follow-up|0|||
13393665|NCT00662792|26784677|FG003|Period 1|Lost to Follow-up|0|||
13393666|NCT00662792|26784674|FG000|Period 1|Other adverse event (AE)|0|||
13393667|NCT00662792|26784675|FG001|Period 1|Other adverse event (AE)|2|||
13393668|NCT00662792|26784676|FG002|Period 1|Other adverse event (AE)|0|||
13393669|NCT00662792|26784677|FG003|Period 1|Other adverse event (AE)|0|||
13393670|NCT00662792|26784674|FG000|Period 1|Worsening of disease under study (AE)|1|||
13393671|NCT00662792|26784675|FG001|Period 1|Worsening of disease under study (AE)|3|||
13393672|NCT00662792|26784676|FG002|Period 1|Worsening of disease under study (AE)|2|||
13393673|NCT00662792|26784677|FG003|Period 1|Worsening of disease under study (AE)|0|||
13393674|NCT00662792|26784674|FG000|Period 1|Not treated|0|||
13393675|NCT00662792|26784675|FG001|Period 1|Not treated|1|||
13393676|NCT00662792|26784676|FG002|Period 1|Not treated|0|||
13393677|NCT00662792|26784677|FG003|Period 1|Not treated|0|||
13393678|NCT00662792|26784674|FG000|Period 2|Worsening of disease under study|1|||
13393679|NCT00662792|26784675|FG001|Period 2|Worsening of disease under study|0|||
13393680|NCT00662792|26784676|FG002|Period 2|Worsening of disease under study|0|||
13393681|NCT00662792|26784677|FG003|Period 2|Worsening of disease under study|3|||
13393682|NCT00662792|26784674|FG000|Period 3|Refused continuing medication|1|||
13393683|NCT00662792|26784675|FG001|Period 3|Refused continuing medication|0|||
13393684|NCT00662792|26784676|FG002|Period 3|Refused continuing medication|1|||
13393685|NCT00662792|26784677|FG003|Period 3|Refused continuing medication|0|||
13393686|NCT00662792|26784674|FG000|Period 3|Other adverse event (AE)|0|||
13393687|NCT00662792|26784675|FG001|Period 3|Other adverse event (AE)|0|||
13393688|NCT00662792|26784676|FG002|Period 3|Other adverse event (AE)|1|||
13393689|NCT00662792|26784677|FG003|Period 3|Other adverse event (AE)|1|||
13393690|NCT00662792|26784674|FG000|Period 4|Refused continuing medication|0|||
13393691|NCT00662792|26784675|FG001|Period 4|Refused continuing medication|1|||
13393692|NCT00662792|26784676|FG002|Period 4|Refused continuing medication|0|||
13477549|NCT04040751|27007252|FG003|Overall Study|Withdrawal by Subject|0|||
13393693|NCT00662792|26784677|FG003|Period 4|Refused continuing medication|0|||
13393694|NCT00662792|26784674|FG000|Period 4|Other adverse event (AE)|1|||
13393695|NCT00662792|26784675|FG001|Period 4|Other adverse event (AE)|0|||
13393696|NCT00662792|26784676|FG002|Period 4|Other adverse event (AE)|0|||
13393268|NCT00666224|26782945|FG000|Double-Blind|Adverse Event|15|||
13393269|NCT00666224|26782946|FG001|Double-Blind|Adverse Event|5|||
13393270|NCT00666224|26782945|FG000|Double-Blind|Lost to Follow-up|2|||
13393271|NCT00666224|26782946|FG001|Double-Blind|Lost to Follow-up|2|||
13393272|NCT00666224|26782945|FG000|Double-Blind|Withdrawal by Subject|18|||
13393273|NCT00666224|26782946|FG001|Double-Blind|Withdrawal by Subject|14|||
13393274|NCT00666224|26782945|FG000|Double-Blind|Physician Decision|0|||
13393275|NCT00666224|26782946|FG001|Double-Blind|Physician Decision|3|||
13393276|NCT00666224|26782945|FG000|Double-Blind|Sponsor decision|1|||
13393277|NCT00666224|26782946|FG001|Double-Blind|Sponsor decision|0|||
13393278|NCT00666224|26782945|FG000|Double-Blind|Pregnancy|3|||
13393279|NCT00666224|26782946|FG001|Double-Blind|Pregnancy|2|||
13393280|NCT00666224|26782945|FG000|Double-Blind|Noncompliance|1|||
13393281|NCT00666224|26782946|FG001|Double-Blind|Noncompliance|0|||
13393282|NCT00666224|26782945|FG000|Double-Blind|Death|1|||
13393283|NCT00666224|26782946|FG001|Double-Blind|Death|0|||
13393284|NCT00666224|26782945|FG000|Double-Blind|Undefined/Unknown|4|||
13393285|NCT00666224|26782946|FG001|Double-Blind|Undefined/Unknown|1|||
13393286|NCT00666224|26782945|FG000|Open-Label|Adverse Event|8|||
13393287|NCT00666224|26782946|FG001|Open-Label|Adverse Event|43|||
13393288|NCT00666224|26782945|FG000|Open-Label|Lost to Follow-up|4|||
13393289|NCT00666224|26782946|FG001|Open-Label|Lost to Follow-up|5|||
13393290|NCT00666224|26782945|FG000|Open-Label|Withdrawal by Subject|12|||
13393291|NCT00666224|26782946|FG001|Open-Label|Withdrawal by Subject|25|||
13393292|NCT00666224|26782945|FG000|Open-Label|Physician Decision|7|||
13393293|NCT00666224|26782946|FG001|Open-Label|Physician Decision|5|||
13393294|NCT00666224|26782945|FG000|Open-Label|Pregnancy|1|||
13393295|NCT00666224|26782946|FG001|Open-Label|Pregnancy|5|||
13393296|NCT00666224|26782945|FG000|Open-Label|Noncompliance|2|||
13393297|NCT00666224|26782946|FG001|Open-Label|Noncompliance|1|||
13393298|NCT00666224|26782945|FG000|Open-Label|Undefined/Unknown|1|||
13393299|NCT00666224|26782946|FG001|Open-Label|Undefined/Unknown|1|||
13393300|NCT00666211|26782971|FG000|Overall Study|Withdrawal by Subject|10|||
13393301|NCT00666211|26782972|FG001|Overall Study|Withdrawal by Subject|13|||
13393302|NCT00666211|26782971|FG000|Overall Study|went off medication, no more pain|1|||
13393303|NCT00666211|26782972|FG001|Overall Study|went off medication, no more pain|0|||
13393304|NCT00666211|26782971|FG000|Overall Study|patient non-compliant|6|||
13393305|NCT00666211|26782972|FG001|Overall Study|patient non-compliant|6|||
13393306|NCT00666211|26782971|FG000|Overall Study|disease progression|1|||
13393307|NCT00666211|26782972|FG001|Overall Study|disease progression|8|||
13393308|NCT00666211|26782971|FG000|Overall Study|Lost to Follow-up|2|||
13393309|NCT00666211|26782972|FG001|Overall Study|Lost to Follow-up|0|||
13393310|NCT00666211|26782971|FG000|Overall Study|toxicity|0|||
13393311|NCT00666211|26782972|FG001|Overall Study|toxicity|2|||
13393312|NCT00666211|26782971|FG000|Overall Study|hospital admission|0|||
13393313|NCT00666211|26782972|FG001|Overall Study|hospital admission|5|||
13393314|NCT00666211|26782971|FG000|Overall Study|Death|0|||
13393315|NCT00666211|26782972|FG001|Overall Study|Death|2|||
13393316|NCT00666211|26782971|FG000|Overall Study|off tx for other complicating disease|0|||
13393317|NCT00666211|26782972|FG001|Overall Study|off tx for other complicating disease|1|||
13393318|NCT00666211|26782971|FG000|Overall Study|Physician Decision|0|||
13393319|NCT00666211|26782972|FG001|Overall Study|Physician Decision|1|||
13393320|NCT00666198|26782987|FG000|Overall Study|Protocol Violation|10|||
13393321|NCT00666198|26782987|FG000|Overall Study|No Visit After First Day of Treatment|13|||
13393322|NCT00666198|26782987|FG000|Overall Study|Safety Not Assessable|6|||
13393323|NCT00666198|26782987|FG000|Overall Study|No Drug Administration|4|||
13393324|NCT00665925|26783411|FG000|Overall Study|Lack of Efficacy|10|||
13393325|NCT00665925|26783412|FG001|Overall Study|Lack of Efficacy|8|||
13393326|NCT00665925|26783413|FG002|Overall Study|Lack of Efficacy|9|||
13393327|NCT00665925|26783414|FG003|Overall Study|Lack of Efficacy|8|||
13477550|NCT03997916|27007260|FG000|Overall Study|Protocol Violation|35|||
13477551|NCT03596177|27007368|FG000|Single Blind Period|Withdrawal by Subject|1|||
13477552|NCT03596177|27007369|FG001|Single Blind Period|Withdrawal by Subject|1|||
13477553|NCT03596177|27007368|FG000|Single Blind Period|Other|1|||
13477554|NCT03596177|27007369|FG001|Single Blind Period|Other|0|||
13477555|NCT03596177|27007368|FG000|Double Blind Period|Withdrawal by Subject|0|||
13477556|NCT03596177|27007369|FG001|Double Blind Period|Withdrawal by Subject|1|||
13477557|NCT03596177|27007368|FG000|Double Blind Period|Other|0|||
13477558|NCT03596177|27007369|FG001|Double Blind Period|Other|4|||
13477559|NCT03596177|27007368|FG000|Double Blind Period|Death during safety follow-up|0|||
13477560|NCT03596177|27007369|FG001|Double Blind Period|Death during safety follow-up|1|||
13477561|NCT03579459|27007417|FG000|Overall Study|Adverse Event|7|||
13477562|NCT03579459|27007418|FG001|Overall Study|Adverse Event|6|||
13477563|NCT03579459|27007419|FG002|Overall Study|Adverse Event|2|||
13477564|NCT03579459|27007420|FG003|Overall Study|Adverse Event|6|||
13477565|NCT03579459|27007417|FG000|Overall Study|Death|1|||
13393328|NCT00665925|26783411|FG000|Overall Study|Lost to Follow-up|1|||
13393329|NCT00665925|26783412|FG001|Overall Study|Lost to Follow-up|2|||
13393330|NCT00665925|26783413|FG002|Overall Study|Lost to Follow-up|2|||
13393331|NCT00665925|26783414|FG003|Overall Study|Lost to Follow-up|2|||
13477566|NCT03579459|27007418|FG001|Overall Study|Death|0|||
13477567|NCT03579459|27007419|FG002|Overall Study|Death|1|||
13477568|NCT03579459|27007420|FG003|Overall Study|Death|2|||
13477569|NCT03579459|27007417|FG000|Overall Study|Lost to Follow-up|6|||
13477570|NCT03579459|27007418|FG001|Overall Study|Lost to Follow-up|2|||
13477571|NCT03579459|27007419|FG002|Overall Study|Lost to Follow-up|4|||
13477572|NCT03579459|27007420|FG003|Overall Study|Lost to Follow-up|1|||
13477573|NCT03579459|27007417|FG000|Overall Study|Physician Decision|0|||
13477574|NCT03579459|27007418|FG001|Overall Study|Physician Decision|1|||
13477575|NCT03579459|27007419|FG002|Overall Study|Physician Decision|0|||
13477576|NCT03579459|27007420|FG003|Overall Study|Physician Decision|1|||
13477577|NCT03579459|27007417|FG000|Overall Study|Protocol Violation|1|||
13477578|NCT03579459|27007418|FG001|Overall Study|Protocol Violation|2|||
13477579|NCT03579459|27007419|FG002|Overall Study|Protocol Violation|3|||
13477580|NCT03579459|27007420|FG003|Overall Study|Protocol Violation|5|||
13477581|NCT03579459|27007417|FG000|Overall Study|Withdrawal by Subject|12|||
13477582|NCT03579459|27007418|FG001|Overall Study|Withdrawal by Subject|8|||
13477583|NCT03579459|27007419|FG002|Overall Study|Withdrawal by Subject|11|||
13477584|NCT03579459|27007420|FG003|Overall Study|Withdrawal by Subject|8|||
13477585|NCT03579459|27007417|FG000|Overall Study|Medication error without associated adverse event|2|||
13477586|NCT03579459|27007418|FG001|Overall Study|Medication error without associated adverse event|1|||
13477587|NCT03579459|27007419|FG002|Overall Study|Medication error without associated adverse event|1|||
13477588|NCT03579459|27007420|FG003|Overall Study|Medication error without associated adverse event|0|||
13477589|NCT03579459|27007417|FG000|Overall Study|Other|0|||
13477590|NCT03579459|27007418|FG001|Overall Study|Other|1|||
13477591|NCT03579459|27007419|FG002|Overall Study|Other|1|||
13477592|NCT03579459|27007420|FG003|Overall Study|Other|0|||
13477593|NCT03579459|27007417|FG000|Overall Study|Randomized not vaccinated|0|||
13477594|NCT03579459|27007418|FG001|Overall Study|Randomized not vaccinated|2|||
13477595|NCT03579459|27007419|FG002|Overall Study|Randomized not vaccinated|0|||
13477596|NCT03579459|27007420|FG003|Overall Study|Randomized not vaccinated|1|||
13477597|NCT03340766|27007514|FG000|Overall Study|Death|6|||
13477598|NCT03340766|27007515|FG001|Overall Study|Death|6|||
13477599|NCT03340766|27007516|FG002|Overall Study|Death|2|||
13477600|NCT03340766|27007514|FG000|Overall Study|Withdrawal by Subject|2|||
13477601|NCT03340766|27007515|FG001|Overall Study|Withdrawal by Subject|1|||
13477602|NCT03340766|27007516|FG002|Overall Study|Withdrawal by Subject|2|||
13477603|NCT03340766|27007514|FG000|Overall Study|Continuing Study|3|||
13477604|NCT03340766|27007515|FG001|Overall Study|Continuing Study|3|||
13477605|NCT03340766|27007516|FG002|Overall Study|Continuing Study|5|||
13486695|NCT01471444|27036853|FG000|Overall Study|Withdrawal by Subject|0|||
13486696|NCT01471444|27036854|FG001|Overall Study|Withdrawal by Subject|1|||
13488144|NCT04409262|27042892|FG000|Overall Study|Withdrawal by Subject|5|||
13488145|NCT04409262|27042893|FG001|Overall Study|Withdrawal by Subject|10|||
13488146|NCT04305912|27042916|FG000|First Intervention|COVID-19 Suspension|2|||
13488147|NCT04305912|27042917|FG001|First Intervention|COVID-19 Suspension|0|||
13488148|NCT04305912|27042916|FG000|First Intervention|Withdrawal by Subject|0|||
13488149|NCT04305912|27042917|FG001|First Intervention|Withdrawal by Subject|1|||
13488150|NCT04305912|27042916|FG000|Second Intervention|Adverse Event|0|||
13488151|NCT04305912|27042917|FG001|Second Intervention|Adverse Event|1|||
13488386|NCT02959918|27043322|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
13488387|NCT02959918|27043323|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
13488388|NCT02959918|27043324|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
13488389|NCT02959918|27043325|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
13488390|NCT02959918|27043326|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
13488391|NCT02959918|27043327|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
13488392|NCT02959918|27043328|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
13488393|NCT02959918|27043329|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1|||
13488394|NCT02959918|27043330|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
13488395|NCT02959918|27043331|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
13488396|NCT02959918|27043332|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
13488397|NCT02959918|27043333|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
13488398|NCT02472964|27043346|FG000|Part 1 (up to Week 24)|Adverse Event|2|||
13488399|NCT02472964|27043347|FG001|Part 1 (up to Week 24)|Adverse Event|4|||
13488400|NCT02472964|27043346|FG000|Part 1 (up to Week 24)|disease progression|58|||
13488401|NCT02472964|27043347|FG001|Part 1 (up to Week 24)|disease progression|47|||
13488402|NCT02472964|27043346|FG000|Part 1 (up to Week 24)|Death|3|||
13488403|NCT02472964|27043347|FG001|Part 1 (up to Week 24)|Death|6|||
13488404|NCT02472964|27043346|FG000|Part 1 (up to Week 24)|Physician Decision|3|||
13488405|NCT02472964|27043347|FG001|Part 1 (up to Week 24)|Physician Decision|1|||
13488406|NCT02472964|27043346|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0|||
13488407|NCT02472964|27043347|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1|||
13488408|NCT02472964|27043346|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7|||
13477606|NCT04449276|27007739|FG000|Overall Study|Adverse Event|1|||
13477607|NCT04449276|27007740|FG001|Overall Study|Adverse Event|2|||
13477608|NCT04449276|27007741|FG002|Overall Study|Adverse Event|0|||
13477609|NCT04449276|27007742|FG003|Overall Study|Adverse Event|0|||
13477610|NCT04449276|27007743|FG004|Overall Study|Adverse Event|2|||
13477611|NCT04449276|27007744|FG005|Overall Study|Adverse Event|0|||
13477612|NCT04449276|27007745|FG006|Overall Study|Adverse Event|0|||
13477613|NCT04449276|27007746|FG007|Overall Study|Adverse Event|1|||
13477614|NCT04449276|27007739|FG000|Overall Study|Withdrawal by Subject|2|||
13477615|NCT04449276|27007740|FG001|Overall Study|Withdrawal by Subject|0|||
13477616|NCT04449276|27007741|FG002|Overall Study|Withdrawal by Subject|0|||
13477617|NCT04449276|27007742|FG003|Overall Study|Withdrawal by Subject|1|||
13477618|NCT04449276|27007743|FG004|Overall Study|Withdrawal by Subject|0|||
13477619|NCT04449276|27007744|FG005|Overall Study|Withdrawal by Subject|0|||
13477620|NCT04449276|27007745|FG006|Overall Study|Withdrawal by Subject|0|||
13477621|NCT04449276|27007746|FG007|Overall Study|Withdrawal by Subject|0|||
13477622|NCT04449276|27007739|FG000|Overall Study|Other|0|||
13477623|NCT04449276|27007740|FG001|Overall Study|Other|2|||
13477624|NCT04449276|27007741|FG002|Overall Study|Other|3|||
13477625|NCT04449276|27007742|FG003|Overall Study|Other|2|||
13477626|NCT04449276|27007743|FG004|Overall Study|Other|0|||
13477627|NCT04449276|27007744|FG005|Overall Study|Other|0|||
13477628|NCT04449276|27007745|FG006|Overall Study|Other|0|||
13477629|NCT04449276|27007746|FG007|Overall Study|Other|1|||
13477630|NCT04391894|27007794|FG000|Overall Study|Adverse Event|1|||
13477631|NCT04391894|27007795|FG001|Overall Study|Adverse Event|1|||
13477632|NCT04391894|27007796|FG002|Overall Study|Adverse Event|1|||
13477633|NCT04391894|27007797|FG003|Overall Study|Adverse Event|1|||
13477634|NCT04391894|27007798|FG004|Overall Study|Adverse Event|1|||
13477635|NCT04391894|27007794|FG000|Overall Study|Lost to Follow-up|1|||
13477636|NCT04391894|27007795|FG001|Overall Study|Lost to Follow-up|0|||
13477637|NCT04391894|27007796|FG002|Overall Study|Lost to Follow-up|0|||
13477638|NCT04391894|27007797|FG003|Overall Study|Lost to Follow-up|0|||
13477639|NCT04391894|27007798|FG004|Overall Study|Lost to Follow-up|0|||
13477640|NCT04391894|27007794|FG000|Overall Study|Protocol Violation|0|||
13477641|NCT04391894|27007795|FG001|Overall Study|Protocol Violation|0|||
13477642|NCT04391894|27007796|FG002|Overall Study|Protocol Violation|0|||
13477643|NCT04391894|27007797|FG003|Overall Study|Protocol Violation|1|||
13477644|NCT04391894|27007798|FG004|Overall Study|Protocol Violation|0|||
13477645|NCT04391894|27007794|FG000|Overall Study|Withdrawal by Subject|2|||
13477646|NCT04391894|27007795|FG001|Overall Study|Withdrawal by Subject|0|||
13477647|NCT04391894|27007796|FG002|Overall Study|Withdrawal by Subject|3|||
13477648|NCT04391894|27007797|FG003|Overall Study|Withdrawal by Subject|0|||
13477649|NCT04391894|27007798|FG004|Overall Study|Withdrawal by Subject|1|||
13477650|NCT04391894|27007794|FG000|Overall Study|Unsatisfactory Therapeutic effect|0|||
13477651|NCT04391894|27007795|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
13477652|NCT04391894|27007796|FG002|Overall Study|Unsatisfactory Therapeutic effect|0|||
13477653|NCT04391894|27007797|FG003|Overall Study|Unsatisfactory Therapeutic effect|0|||
13477654|NCT04391894|27007798|FG004|Overall Study|Unsatisfactory Therapeutic effect|1|||
13477655|NCT04166435|27007813|FG000|Overall Study|2 patients ineligible for response|2|||
13477656|NCT03851705|27007932|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|2|||
13477657|NCT03851705|27007933|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
13477658|NCT03851705|27007934|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
13477659|NCT03851705|27007935|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
13477660|NCT03851705|27007932|FG000|Part 1: Double-Blind Period|Other reason|1|||
13477661|NCT03851705|27007933|FG001|Part 1: Double-Blind Period|Other reason|0|||
13477662|NCT03851705|27007934|FG002|Part 1: Double-Blind Period|Other reason|0|||
13477663|NCT03851705|27007935|FG003|Part 1: Double-Blind Period|Other reason|0|||
13477664|NCT03851705|27007932|FG000|Part 2: Open-Label Period|Other reason|0|||
13477665|NCT03851705|27007933|FG001|Part 2: Open-Label Period|Other reason|0|||
13477666|NCT03851705|27007934|FG002|Part 2: Open-Label Period|Other reason|0|||
13477667|NCT03851705|27007935|FG003|Part 2: Open-Label Period|Other reason|1|||
13477668|NCT03851705|27007932|FG000|Part 2: Open-Label Period|Death|0|||
13477669|NCT03851705|27007933|FG001|Part 2: Open-Label Period|Death|0|||
13477670|NCT03851705|27007934|FG002|Part 2: Open-Label Period|Death|3|||
13477671|NCT03851705|27007935|FG003|Part 2: Open-Label Period|Death|0|||
13477672|NCT03851705|27007932|FG000|Part 2: Open-Label Period|Withdrawal by Subject|0|||
13477673|NCT03851705|27007933|FG001|Part 2: Open-Label Period|Withdrawal by Subject|0|||
13477674|NCT03851705|27007934|FG002|Part 2: Open-Label Period|Withdrawal by Subject|2|||
13477675|NCT03851705|27007935|FG003|Part 2: Open-Label Period|Withdrawal by Subject|0|||
13477676|NCT03824366|27007941|FG000|Overall Study|Death|1|||
13477677|NCT03824366|27007941|FG000|Overall Study|Previously unidentified metal artifact|1|||
13477678|NCT03824366|27007941|FG000|Overall Study|Unable to tolerate lying flat on MR table|1|||
13477679|NCT03824366|27007941|FG000|Overall Study|Withdrawal by Subject|1|||
13477680|NCT03810313|27007984|FG000|Overall Study|Study terminated by sponsor|164|||
13477681|NCT03810313|27007985|FG001|Overall Study|Study terminated by sponsor|159|||
13477682|NCT03810313|27007984|FG000|Overall Study|Subject decision|10|||
13477683|NCT03810313|27007985|FG001|Overall Study|Subject decision|11|||
13477684|NCT03810313|27007984|FG000|Overall Study|Lost to Follow-up|3|||
13477685|NCT03810313|27007985|FG001|Overall Study|Lost to Follow-up|3|||
13477686|NCT03810313|27007984|FG000|Overall Study|Adverse Event|2|||
13477687|NCT03810313|27007985|FG001|Overall Study|Adverse Event|1|||
13477688|NCT03810313|27007984|FG000|Overall Study|Death|2|||
13477689|NCT03810313|27007985|FG001|Overall Study|Death|1|||
13477690|NCT03810313|27007984|FG000|Overall Study|Physician Decision|0|||
13477691|NCT03810313|27007985|FG001|Overall Study|Physician Decision|1|||
13477692|NCT03802630|27008028|FG000|Overall Study|Study terminated by sponsor|130|||
13477693|NCT03802630|27008029|FG001|Overall Study|Study terminated by sponsor|134|||
13477694|NCT03802630|27008028|FG000|Overall Study|Subject decision|16|||
13477695|NCT03802630|27008029|FG001|Overall Study|Subject decision|9|||
13477696|NCT03802630|27008028|FG000|Overall Study|Adverse Event|3|||
13477697|NCT03802630|27008029|FG001|Overall Study|Adverse Event|1|||
13477698|NCT03802630|27008028|FG000|Overall Study|Lost to Follow-up|2|||
13477699|NCT03802630|27008029|FG001|Overall Study|Lost to Follow-up|2|||
13477700|NCT03802630|27008028|FG000|Overall Study|Physician Decision|2|||
13477701|NCT03802630|27008029|FG001|Overall Study|Physician Decision|0|||
13477702|NCT03802630|27008028|FG000|Overall Study|Death|0|||
13477703|NCT03802630|27008029|FG001|Overall Study|Death|2|||
13477704|NCT03775213|27008050|FG000|Overall Study|Withdrawal by Subject|51|||
13477705|NCT03775213|27008051|FG001|Overall Study|Withdrawal by Subject|53|||
13477706|NCT03775213|27008050|FG000|Overall Study|Incomplete Survey|7|||
13477707|NCT03775213|27008051|FG001|Overall Study|Incomplete Survey|7|||
13477708|NCT03710564|27008095|FG000|Overall Study|Study Terminated by Sponsor|104|||
13477709|NCT03710564|27008096|FG001|Overall Study|Study Terminated by Sponsor|55|||
13477710|NCT03710564|27008095|FG000|Overall Study|Withdrawal by Subject|57|||
13477711|NCT03710564|27008096|FG001|Overall Study|Withdrawal by Subject|25|||
13477712|NCT03710564|27008095|FG000|Overall Study|Death|10|||
13477713|NCT03710564|27008096|FG001|Overall Study|Death|4|||
13477714|NCT03710564|27008095|FG000|Overall Study|Lost to Follow-up|5|||
13477715|NCT03710564|27008096|FG001|Overall Study|Lost to Follow-up|4|||
13477716|NCT03710564|27008095|FG000|Overall Study|Protocol Violation|3|||
13477717|NCT03710564|27008096|FG001|Overall Study|Protocol Violation|2|||
13477718|NCT03710564|27008095|FG000|Overall Study|Adverse Event|3|||
13477719|NCT03710564|27008096|FG001|Overall Study|Adverse Event|0|||
13477720|NCT03710564|27008095|FG000|Overall Study|Physician Decision|2|||
13477721|NCT03710564|27008096|FG001|Overall Study|Physician Decision|3|||
13477722|NCT03692052|27008114|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1|||
13477723|NCT03692052|27008114|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1|||
13477724|NCT03692052|27008114|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1|||
13477725|NCT03692052|27008114|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17|||
13477726|NCT03624127|27008172|FG000|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
13477727|NCT03624127|27008173|FG001|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|1|||
13477728|NCT03624127|27008174|FG002|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
13477729|NCT03624127|27008172|FG000|Treatment Week 0 - Week 16|Adverse Event|5|||
13477730|NCT03624127|27008173|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
13477731|NCT03624127|27008174|FG002|Treatment Week 0 - Week 16|Adverse Event|10|||
13477732|NCT03624127|27008172|FG000|Treatment Week 0 - Week 16|Death|0|||
13477733|NCT03624127|27008173|FG001|Treatment Week 0 - Week 16|Death|1|||
13477734|NCT03624127|27008174|FG002|Treatment Week 0 - Week 16|Death|0|||
13477735|NCT03624127|27008172|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|0|||
13477736|NCT03624127|27008173|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
13477737|NCT03624127|27008174|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
13477738|NCT03624127|27008172|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|7|||
13477739|NCT03624127|27008173|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
13477740|NCT03624127|27008174|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|4|||
13477741|NCT03624127|27008172|FG000|Treatment Week 0 - Week 16|Protocol Violation|1|||
13477742|NCT03624127|27008173|FG001|Treatment Week 0 - Week 16|Protocol Violation|1|||
13477743|NCT03624127|27008174|FG002|Treatment Week 0 - Week 16|Protocol Violation|2|||
13477744|NCT03624127|27008172|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|4|||
13477745|NCT03624127|27008173|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
13477746|NCT03624127|27008174|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
13477747|NCT03624127|27008172|FG000|Treatment Week 0 - Week 16|Other reasons|8|||
13477748|NCT03624127|27008173|FG001|Treatment Week 0 - Week 16|Other reasons|5|||
13477749|NCT03624127|27008174|FG002|Treatment Week 0 - Week 16|Other reasons|3|||
13477750|NCT03624127|27008172|FG000|Treatment Week 16 - Week 24|Adverse Event|1|||
13477751|NCT03624127|27008173|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
13477752|NCT03624127|27008174|FG002|Treatment Week 16 - Week 24|Adverse Event|1|||
13477753|NCT03624127|27008172|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|3|||
13477754|NCT03624127|27008173|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
13477755|NCT03624127|27008174|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
13477756|NCT03624127|27008172|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
13477757|NCT03624127|27008173|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
13477758|NCT03624127|27008174|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
13477759|NCT03624127|27008172|FG000|Treatment Week 16 - Week 24|Protocol Violation|1|||
13477760|NCT03624127|27008173|FG001|Treatment Week 16 - Week 24|Protocol Violation|0|||
13477761|NCT03624127|27008174|FG002|Treatment Week 16 - Week 24|Protocol Violation|0|||
13477762|NCT03624127|27008172|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
13477763|NCT03624127|27008173|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
13477764|NCT03624127|27008174|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
13477765|NCT03624127|27008172|FG000|Treatment Week 16 - Week 24|Other reasons|3|||
13477766|NCT03624127|27008173|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
13477767|NCT03624127|27008174|FG002|Treatment Week 16 - Week 24|Other reasons|0|||
13477768|NCT03624127|27008172|FG000|Treatment Week 24 - Week 52|Adverse Event|8|||
13477769|NCT03624127|27008173|FG001|Treatment Week 24 - Week 52|Adverse Event|0|||
13477770|NCT03624127|27008174|FG002|Treatment Week 24 - Week 52|Adverse Event|1|||
13477771|NCT03624127|27008172|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|6|||
13477772|NCT03624127|27008173|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
13477773|NCT03624127|27008174|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
13477774|NCT03624127|27008172|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|5|||
13477775|NCT03624127|27008173|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
13477776|NCT03624127|27008174|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|1|||
13477777|NCT03624127|27008172|FG000|Treatment Week 24 - Week 52|Protocol Violation|2|||
13477778|NCT03624127|27008173|FG001|Treatment Week 24 - Week 52|Protocol Violation|0|||
13477779|NCT03624127|27008174|FG002|Treatment Week 24 - Week 52|Protocol Violation|0|||
13477780|NCT03624127|27008172|FG000|Treatment Week 24 - Week 52|Site terminated by sponsor|2|||
13477781|NCT03624127|27008173|FG001|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
13477782|NCT03624127|27008174|FG002|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
13477783|NCT03624127|27008172|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|10|||
13477784|NCT03624127|27008173|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
13477785|NCT03624127|27008174|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
13477786|NCT03624127|27008172|FG000|Treatment Week 24 - Week 52|Other reasons|19|||
13477787|NCT03624127|27008173|FG001|Treatment Week 24 - Week 52|Other reasons|0|||
13477788|NCT03624127|27008174|FG002|Treatment Week 24 - Week 52|Other reasons|2|||
13477789|NCT03616912|27008233|FG000|Overall Study|Adverse Event|17|||
13477790|NCT03616912|27008234|FG001|Overall Study|Adverse Event|21|||
13477791|NCT03616912|27008235|FG002|Overall Study|Adverse Event|9|||
13477792|NCT03616912|27008236|FG003|Overall Study|Adverse Event|0|||
13477793|NCT03616912|27008237|FG004|Overall Study|Adverse Event|0|||
13477794|NCT03616912|27008238|FG005|Overall Study|Adverse Event|0|||
13477795|NCT03616912|27008233|FG000|Overall Study|Death|1|||
13477796|NCT03616912|27008234|FG001|Overall Study|Death|1|||
13477797|NCT03616912|27008235|FG002|Overall Study|Death|0|||
13477798|NCT03616912|27008236|FG003|Overall Study|Death|0|||
13477799|NCT03616912|27008237|FG004|Overall Study|Death|0|||
13477800|NCT03616912|27008238|FG005|Overall Study|Death|0|||
13477801|NCT03616912|27008233|FG000|Overall Study|Lack of Efficacy|13|||
13477802|NCT03616912|27008234|FG001|Overall Study|Lack of Efficacy|6|||
13477803|NCT03616912|27008235|FG002|Overall Study|Lack of Efficacy|8|||
13477804|NCT03616912|27008236|FG003|Overall Study|Lack of Efficacy|4|||
13477805|NCT03616912|27008237|FG004|Overall Study|Lack of Efficacy|5|||
13477806|NCT03616912|27008238|FG005|Overall Study|Lack of Efficacy|1|||
13477807|NCT03616912|27008233|FG000|Overall Study|Lost to Follow-up|1|||
13477808|NCT03616912|27008234|FG001|Overall Study|Lost to Follow-up|2|||
13477809|NCT03616912|27008235|FG002|Overall Study|Lost to Follow-up|3|||
13477810|NCT03616912|27008236|FG003|Overall Study|Lost to Follow-up|0|||
13477811|NCT03616912|27008237|FG004|Overall Study|Lost to Follow-up|0|||
13477812|NCT03616912|27008238|FG005|Overall Study|Lost to Follow-up|0|||
13477813|NCT03616912|27008233|FG000|Overall Study|Due to Epidemic/Pandemic|4|||
13477814|NCT03616912|27008234|FG001|Overall Study|Due to Epidemic/Pandemic|2|||
13477815|NCT03616912|27008235|FG002|Overall Study|Due to Epidemic/Pandemic|5|||
13477816|NCT03616912|27008236|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
13477817|NCT03616912|27008237|FG004|Overall Study|Due to Epidemic/Pandemic|0|||
13477818|NCT03616912|27008238|FG005|Overall Study|Due to Epidemic/Pandemic|0|||
13477819|NCT03616912|27008233|FG000|Overall Study|Withdrawal by Subject|12|||
13477820|NCT03616912|27008234|FG001|Overall Study|Withdrawal by Subject|12|||
13477821|NCT03616912|27008235|FG002|Overall Study|Withdrawal by Subject|15|||
13477822|NCT03616912|27008236|FG003|Overall Study|Withdrawal by Subject|2|||
13477823|NCT03616912|27008237|FG004|Overall Study|Withdrawal by Subject|0|||
13477824|NCT03616912|27008238|FG005|Overall Study|Withdrawal by Subject|2|||
13477825|NCT03616912|27008233|FG000|Overall Study|Study Terminated by Sponsor|0|||
13477826|NCT03616912|27008234|FG001|Overall Study|Study Terminated by Sponsor|0|||
13477827|NCT03616912|27008235|FG002|Overall Study|Study Terminated by Sponsor|0|||
13477828|NCT03616912|27008236|FG003|Overall Study|Study Terminated by Sponsor|10|||
13477829|NCT03616912|27008237|FG004|Overall Study|Study Terminated by Sponsor|9|||
13477830|NCT03616912|27008238|FG005|Overall Study|Study Terminated by Sponsor|11|||
13477831|NCT03616912|27008233|FG000|Overall Study|Protocol Deviation|1|||
13477832|NCT03616912|27008234|FG001|Overall Study|Protocol Deviation|1|||
13477833|NCT03616912|27008235|FG002|Overall Study|Protocol Deviation|0|||
13477834|NCT03616912|27008236|FG003|Overall Study|Protocol Deviation|0|||
13477835|NCT03616912|27008237|FG004|Overall Study|Protocol Deviation|0|||
13477836|NCT03616912|27008238|FG005|Overall Study|Protocol Deviation|0|||
13477837|NCT03616912|27008233|FG000|Overall Study|Pregnancy|1|||
13477838|NCT03616912|27008234|FG001|Overall Study|Pregnancy|0|||
13477839|NCT03616912|27008235|FG002|Overall Study|Pregnancy|4|||
13477840|NCT03616912|27008236|FG003|Overall Study|Pregnancy|0|||
13477841|NCT03616912|27008237|FG004|Overall Study|Pregnancy|0|||
13477842|NCT03616912|27008238|FG005|Overall Study|Pregnancy|0|||
13477843|NCT03616912|27008233|FG000|Overall Study|Protocol Violation|1|||
13477844|NCT03616912|27008234|FG001|Overall Study|Protocol Violation|0|||
13477845|NCT03616912|27008235|FG002|Overall Study|Protocol Violation|2|||
13477846|NCT03616912|27008236|FG003|Overall Study|Protocol Violation|0|||
13477847|NCT03616912|27008237|FG004|Overall Study|Protocol Violation|0|||
13477848|NCT03616912|27008238|FG005|Overall Study|Protocol Violation|0|||
13477849|NCT03616912|27008233|FG000|Overall Study|Physician Decision|2|||
13477850|NCT03616912|27008234|FG001|Overall Study|Physician Decision|0|||
13477851|NCT03616912|27008235|FG002|Overall Study|Physician Decision|0|||
13477852|NCT03616912|27008236|FG003|Overall Study|Physician Decision|0|||
13477853|NCT03616912|27008237|FG004|Overall Study|Physician Decision|1|||
13477854|NCT03616912|27008238|FG005|Overall Study|Physician Decision|0|||
13477855|NCT03616912|27008233|FG000|Overall Study|Randomized But Never Treated|0|||
13477856|NCT03616912|27008234|FG001|Overall Study|Randomized But Never Treated|2|||
13477857|NCT03616912|27008235|FG002|Overall Study|Randomized But Never Treated|0|||
13477858|NCT03616912|27008236|FG003|Overall Study|Randomized But Never Treated|0|||
13477859|NCT03616912|27008237|FG004|Overall Study|Randomized But Never Treated|0|||
13477860|NCT03616912|27008238|FG005|Overall Study|Randomized But Never Treated|0|||
13477861|NCT03499899|27008323|FG000|Overall Study|Adverse Event|2|||
13477862|NCT03499899|27008324|FG001|Overall Study|Adverse Event|3|||
13477863|NCT03499899|27008325|FG002|Overall Study|Adverse Event|3|||
13477864|NCT03499899|27008323|FG000|Overall Study|Death|0|||
13477865|NCT03499899|27008324|FG001|Overall Study|Death|0|||
13477866|NCT03499899|27008325|FG002|Overall Study|Death|1|||
13477867|NCT03499899|27008323|FG000|Overall Study|Physician Decision|3|||
13477868|NCT03499899|27008324|FG001|Overall Study|Physician Decision|6|||
13477869|NCT03499899|27008325|FG002|Overall Study|Physician Decision|6|||
13477870|NCT03499899|27008323|FG000|Overall Study|Progressive disease|15|||
13477871|NCT03499899|27008324|FG001|Overall Study|Progressive disease|23|||
13477872|NCT03499899|27008325|FG002|Overall Study|Progressive disease|23|||
13477873|NCT03499899|27008323|FG000|Overall Study|Patient decision|0|||
13477874|NCT03499899|27008324|FG001|Overall Study|Patient decision|1|||
13477875|NCT03499899|27008325|FG002|Overall Study|Patient decision|1|||
13477876|NCT03499899|27008323|FG000|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
13477877|NCT03499899|27008324|FG001|Overall Study|Terminated by sponsor (end of study definition was met)|1|||
13477878|NCT03499899|27008325|FG002|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
13477879|NCT03481634|27008441|FG000|Overall Study|Withdrawal by Subject|16|||
13477880|NCT03481634|27008442|FG001|Overall Study|Withdrawal by Subject|19|||
13477881|NCT03481634|27008443|FG002|Overall Study|Withdrawal by Subject|14|||
13477882|NCT03481634|27008441|FG000|Overall Study|Protocol Violation|1|||
13477883|NCT03481634|27008442|FG001|Overall Study|Protocol Violation|0|||
13477884|NCT03481634|27008443|FG002|Overall Study|Protocol Violation|1|||
13477885|NCT03481634|27008441|FG000|Overall Study|Progressive disease|0|||
13477886|NCT03481634|27008442|FG001|Overall Study|Progressive disease|1|||
13477887|NCT03481634|27008443|FG002|Overall Study|Progressive disease|0|||
13477888|NCT03481634|27008441|FG000|Overall Study|Physician Decision|3|||
13477889|NCT03481634|27008442|FG001|Overall Study|Physician Decision|0|||
13477890|NCT03481634|27008443|FG002|Overall Study|Physician Decision|1|||
13477891|NCT03481634|27008441|FG000|Overall Study|Lost to Follow-up|3|||
13477892|NCT03481634|27008442|FG001|Overall Study|Lost to Follow-up|4|||
13477893|NCT03481634|27008443|FG002|Overall Study|Lost to Follow-up|4|||
13477894|NCT03481634|27008441|FG000|Overall Study|Death|4|||
13477895|NCT03481634|27008442|FG001|Overall Study|Death|8|||
13477896|NCT03481634|27008443|FG002|Overall Study|Death|7|||
13477897|NCT03481634|27008441|FG000|Overall Study|Adverse Event|6|||
13477898|NCT03481634|27008442|FG001|Overall Study|Adverse Event|3|||
13477899|NCT03481634|27008443|FG002|Overall Study|Adverse Event|7|||
13477900|NCT03460756|27008490|FG000|Overall Study|Adverse Event|0|||
13477901|NCT03460756|27008491|FG001|Overall Study|Adverse Event|0|||
13477902|NCT03460756|27008492|FG002|Overall Study|Adverse Event|0|||
13477903|NCT03460756|27008493|FG003|Overall Study|Adverse Event|1|||
13477904|NCT03460756|27008490|FG000|Overall Study|Lack of Efficacy|0|||
13477905|NCT03460756|27008491|FG001|Overall Study|Lack of Efficacy|0|||
13477906|NCT03460756|27008492|FG002|Overall Study|Lack of Efficacy|0|||
13477907|NCT03460756|27008493|FG003|Overall Study|Lack of Efficacy|2|||
13477908|NCT03460756|27008490|FG000|Overall Study|Lost to Follow-up|0|||
13477909|NCT03460756|27008491|FG001|Overall Study|Lost to Follow-up|1|||
13477910|NCT03460756|27008492|FG002|Overall Study|Lost to Follow-up|2|||
13477911|NCT03460756|27008493|FG003|Overall Study|Lost to Follow-up|1|||
13477912|NCT03460756|27008490|FG000|Overall Study|Pregnancy|0|||
13477913|NCT03460756|27008491|FG001|Overall Study|Pregnancy|0|||
13477914|NCT03460756|27008492|FG002|Overall Study|Pregnancy|0|||
13477915|NCT03460756|27008493|FG003|Overall Study|Pregnancy|1|||
13477916|NCT03460756|27008490|FG000|Overall Study|Protocol Violation|0|||
13477917|NCT03460756|27008491|FG001|Overall Study|Protocol Violation|0|||
13477918|NCT03460756|27008492|FG002|Overall Study|Protocol Violation|0|||
13477919|NCT03460756|27008493|FG003|Overall Study|Protocol Violation|1|||
13477920|NCT03460756|27008490|FG000|Overall Study|Withdrawal by Subject|0|||
13477921|NCT03460756|27008491|FG001|Overall Study|Withdrawal by Subject|4|||
13477922|NCT03460756|27008492|FG002|Overall Study|Withdrawal by Subject|7|||
13477923|NCT03460756|27008493|FG003|Overall Study|Withdrawal by Subject|3|||
13477924|NCT03373461|27008640|FG000|Part 2|Adverse Event|0|||
13477925|NCT03373461|27008641|FG001|Part 2|Adverse Event|1|||
13477926|NCT03373461|27008642|FG002|Part 2|Adverse Event|0|||
13477927|NCT03373461|27008643|FG003|Part 2|Adverse Event|0|||
13477928|NCT03373461|27008644|FG004|Part 2|Adverse Event|1|||
13477929|NCT03364751|27008732|FG000|Overall Study|Withdrawal by Subject|1|||
13477930|NCT03364751|27008733|FG001|Overall Study|Withdrawal by Subject|0|||
13477931|NCT03364751|27008734|FG002|Overall Study|Withdrawal by Subject|0|||
13477932|NCT03364751|27008735|FG003|Overall Study|Withdrawal by Subject|0|||
13477933|NCT03364751|27008732|FG000|Overall Study|Lost to Follow-up|0|||
13477934|NCT03364751|27008733|FG001|Overall Study|Lost to Follow-up|1|||
13477935|NCT03364751|27008734|FG002|Overall Study|Lost to Follow-up|0|||
13477936|NCT03364751|27008735|FG003|Overall Study|Lost to Follow-up|0|||
13477937|NCT03149003|27008786|FG000|Overall Study|Randomized but not treated|0|||
13477938|NCT03149003|27008787|FG001|Overall Study|Randomized but not treated|1|||
13477939|NCT03149003|27008788|FG002|Overall Study|Randomized but not treated|18|||
13477940|NCT02990806|27008895|FG000|Stage 1 (22 Weeks)|Adverse Event|1|||
13477941|NCT02990806|27008896|FG001|Stage 1 (22 Weeks)|Adverse Event|15|||
13477942|NCT02990806|27008897|FG002|Stage 1 (22 Weeks)|Adverse Event|0|||
13477943|NCT02990806|27008898|FG003|Stage 1 (22 Weeks)|Adverse Event|0|||
13477944|NCT02990806|27008895|FG000|Stage 1 (22 Weeks)|Physician Decision|1|||
13477945|NCT02990806|27008896|FG001|Stage 1 (22 Weeks)|Physician Decision|1|||
13477946|NCT02990806|27008897|FG002|Stage 1 (22 Weeks)|Physician Decision|0|||
13477947|NCT02990806|27008898|FG003|Stage 1 (22 Weeks)|Physician Decision|0|||
13477948|NCT02990806|27008895|FG000|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
13477949|NCT02990806|27008896|FG001|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
13477950|NCT02990806|27008897|FG002|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
13477951|NCT02990806|27008898|FG003|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
13477952|NCT02990806|27008895|FG000|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
13477953|NCT02990806|27008896|FG001|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
13477954|NCT02990806|27008897|FG002|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
13477955|NCT02990806|27008898|FG003|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
13477956|NCT02990806|27008895|FG000|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
13477957|NCT02990806|27008896|FG001|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
13477958|NCT02990806|27008897|FG002|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
13477959|NCT02990806|27008898|FG003|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
13477960|NCT02990806|27008895|FG000|Stage 1 (22 Weeks)|Withdrawal by Subject|4|||
13477961|NCT02990806|27008896|FG001|Stage 1 (22 Weeks)|Withdrawal by Subject|26|||
13477962|NCT02990806|27008897|FG002|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
13477963|NCT02990806|27008898|FG003|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
13477964|NCT02990806|27008895|FG000|Stage 1 (22 Weeks)|Lack of Efficacy|1|||
13477965|NCT02990806|27008896|FG001|Stage 1 (22 Weeks)|Lack of Efficacy|2|||
13477966|NCT02990806|27008897|FG002|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
13477967|NCT02990806|27008898|FG003|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
13477968|NCT02990806|27008895|FG000|Stage 1 (22 Weeks)|Death|0|||
13477969|NCT02990806|27008896|FG001|Stage 1 (22 Weeks)|Death|1|||
13477970|NCT02990806|27008897|FG002|Stage 1 (22 Weeks)|Death|0|||
13477971|NCT02990806|27008898|FG003|Stage 1 (22 Weeks)|Death|0|||
13477972|NCT02990806|27008895|FG000|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
13477973|NCT02990806|27008896|FG001|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|1|||
13477974|NCT02990806|27008897|FG002|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
13477975|NCT02990806|27008898|FG003|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
13477976|NCT02990806|27008895|FG000|Stage 1 (22 Weeks)|Protocol deviation|0|||
13477977|NCT02990806|27008896|FG001|Stage 1 (22 Weeks)|Protocol deviation|1|||
13477978|NCT02990806|27008897|FG002|Stage 1 (22 Weeks)|Protocol deviation|0|||
13477979|NCT02990806|27008898|FG003|Stage 1 (22 Weeks)|Protocol deviation|0|||
13477980|NCT02990806|27008895|FG000|Stage 1 (22 Weeks)|Other|1|||
13477981|NCT02990806|27008896|FG001|Stage 1 (22 Weeks)|Other|3|||
13477982|NCT02990806|27008897|FG002|Stage 1 (22 Weeks)|Other|0|||
13477983|NCT02990806|27008898|FG003|Stage 1 (22 Weeks)|Other|0|||
13477984|NCT02990806|27008895|FG000|Stage 2 (32 Weeks)|Adverse Event|9|||
13477985|NCT02990806|27008896|FG001|Stage 2 (32 Weeks)|Adverse Event|0|||
13477986|NCT02990806|27008897|FG002|Stage 2 (32 Weeks)|Adverse Event|7|||
13477987|NCT02990806|27008898|FG003|Stage 2 (32 Weeks)|Adverse Event|7|||
13477988|NCT02990806|27008895|FG000|Stage 2 (32 Weeks)|Death|1|||
13477989|NCT02990806|27008896|FG001|Stage 2 (32 Weeks)|Death|0|||
13477990|NCT02990806|27008897|FG002|Stage 2 (32 Weeks)|Death|0|||
13477991|NCT02990806|27008898|FG003|Stage 2 (32 Weeks)|Death|0|||
13477992|NCT02990806|27008895|FG000|Stage 2 (32 Weeks)|Physician Decision|3|||
13477993|NCT02990806|27008896|FG001|Stage 2 (32 Weeks)|Physician Decision|0|||
13477994|NCT02990806|27008897|FG002|Stage 2 (32 Weeks)|Physician Decision|1|||
13477995|NCT02990806|27008898|FG003|Stage 2 (32 Weeks)|Physician Decision|0|||
13477996|NCT02990806|27008895|FG000|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
13477997|NCT02990806|27008896|FG001|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
13477998|NCT02990806|27008897|FG002|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
13477999|NCT02990806|27008898|FG003|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
13478000|NCT02990806|27008895|FG000|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
13478001|NCT02990806|27008896|FG001|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|0|||
13478002|NCT02990806|27008897|FG002|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
13478003|NCT02990806|27008898|FG003|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
13478004|NCT02990806|27008895|FG000|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|1|||
13478005|NCT02990806|27008896|FG001|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
13478006|NCT02990806|27008897|FG002|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
13478007|NCT02990806|27008898|FG003|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|2|||
13478008|NCT02990806|27008895|FG000|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
13478009|NCT02990806|27008896|FG001|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
13478010|NCT02990806|27008897|FG002|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|6|||
13478011|NCT02990806|27008898|FG003|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|5|||
13478012|NCT02990806|27008895|FG000|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
13478013|NCT02990806|27008896|FG001|Stage 2 (32 Weeks)|Lost to Follow-up|0|||
13478014|NCT02990806|27008897|FG002|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
13478015|NCT02990806|27008898|FG003|Stage 2 (32 Weeks)|Lost to Follow-up|2|||
13478016|NCT02990806|27008895|FG000|Stage 2 (32 Weeks)|Protocol deviation|2|||
13478017|NCT02990806|27008896|FG001|Stage 2 (32 Weeks)|Protocol deviation|0|||
13478018|NCT02990806|27008897|FG002|Stage 2 (32 Weeks)|Protocol deviation|2|||
13478019|NCT02990806|27008898|FG003|Stage 2 (32 Weeks)|Protocol deviation|3|||
13478020|NCT02990806|27008895|FG000|Stage 2 (32 Weeks)|Withdrawal by Subject|14|||
13478021|NCT02990806|27008896|FG001|Stage 2 (32 Weeks)|Withdrawal by Subject|0|||
13478022|NCT02990806|27008897|FG002|Stage 2 (32 Weeks)|Withdrawal by Subject|4|||
13478023|NCT02990806|27008898|FG003|Stage 2 (32 Weeks)|Withdrawal by Subject|8|||
13478024|NCT02990806|27008895|FG000|Stage 2 (32 Weeks)|Lack of Efficacy|4|||
13478025|NCT02990806|27008896|FG001|Stage 2 (32 Weeks)|Lack of Efficacy|0|||
13478026|NCT02990806|27008897|FG002|Stage 2 (32 Weeks)|Lack of Efficacy|2|||
13478027|NCT02990806|27008898|FG003|Stage 2 (32 Weeks)|Lack of Efficacy|3|||
13478028|NCT02990806|27008895|FG000|Stage 2 (32 Weeks)|Other|3|||
13478029|NCT02990806|27008896|FG001|Stage 2 (32 Weeks)|Other|0|||
13478030|NCT02990806|27008897|FG002|Stage 2 (32 Weeks)|Other|4|||
13478031|NCT02990806|27008898|FG003|Stage 2 (32 Weeks)|Other|1|||
13478032|NCT02990806|27008895|FG000|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
13478033|NCT02990806|27008896|FG001|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
13478034|NCT02990806|27008897|FG002|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
13478035|NCT02990806|27008898|FG003|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|1|||
13478036|NCT02990806|27008895|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|5|||
13478037|NCT02990806|27008896|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|0|||
13478038|NCT02990806|27008897|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|4|||
13478039|NCT02990806|27008898|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|3|||
13478040|NCT02990806|27008895|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
13478041|NCT02990806|27008896|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|0|||
13478042|NCT02990806|27008897|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
13478043|NCT02990806|27008898|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
13478044|NCT02990806|27008895|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
13478045|NCT02990806|27008896|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
13478046|NCT02990806|27008897|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
13478047|NCT02990806|27008898|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
13478048|NCT02990806|27008895|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
13478049|NCT02990806|27008896|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
13478050|NCT02990806|27008897|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
13478051|NCT02990806|27008898|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
13478052|NCT02990806|27008895|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
13478053|NCT02990806|27008896|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
13478054|NCT02990806|27008897|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|2|||
13478055|NCT02990806|27008898|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|1|||
13478056|NCT02990806|27008895|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
13478057|NCT02990806|27008896|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
13478058|NCT02990806|27008897|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|1|||
13478059|NCT02990806|27008898|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
13478060|NCT02990806|27008895|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
13478061|NCT02990806|27008896|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
13478062|NCT02990806|27008897|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
13478063|NCT02990806|27008898|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Other|2|||
13478064|NCT02990806|27008895|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
13478065|NCT02990806|27008896|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
13478066|NCT02990806|27008897|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|1|||
13478067|NCT02990806|27008898|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
13478068|NCT02987543|27008925|FG000|Overall Study|Ongoing study at data cut off|49|||
13478069|NCT02987543|27008926|FG001|Overall Study|Ongoing study at data cut off|21|||
13478070|NCT02987543|27008927|FG002|Overall Study|Ongoing study at data cut off|19|||
13478071|NCT02987543|27008928|FG003|Overall Study|Ongoing study at data cut off|12|||
13478072|NCT02987543|27008925|FG000|Overall Study|Death|88|||
13478073|NCT02987543|27008926|FG001|Overall Study|Death|54|||
13478074|NCT02987543|27008927|FG002|Overall Study|Death|67|||
13478075|NCT02987543|27008928|FG003|Overall Study|Death|28|||
13478076|NCT02987543|27008925|FG000|Overall Study|Lost to Follow-up|3|||
13478077|NCT02987543|27008926|FG001|Overall Study|Lost to Follow-up|0|||
13478078|NCT02987543|27008927|FG002|Overall Study|Lost to Follow-up|1|||
13478079|NCT02987543|27008928|FG003|Overall Study|Lost to Follow-up|0|||
13478080|NCT02987543|27008925|FG000|Overall Study|Screen failure|0|||
13478081|NCT02987543|27008926|FG001|Overall Study|Screen failure|0|||
13478082|NCT02987543|27008927|FG002|Overall Study|Screen failure|0|||
13478083|NCT02987543|27008928|FG003|Overall Study|Screen failure|1|||
13478084|NCT02987543|27008925|FG000|Overall Study|Withdrawal by Subject|21|||
13478085|NCT02987543|27008926|FG001|Overall Study|Withdrawal by Subject|7|||
13478086|NCT02987543|27008927|FG002|Overall Study|Withdrawal by Subject|7|||
13478087|NCT02987543|27008928|FG003|Overall Study|Withdrawal by Subject|6|||
13478088|NCT02987543|27008925|FG000|Overall Study|Study terminated by sponsor|1|||
13478089|NCT02987543|27008926|FG001|Overall Study|Study terminated by sponsor|0|||
13478090|NCT02987543|27008927|FG002|Overall Study|Study terminated by sponsor|0|||
13478091|NCT02987543|27008928|FG003|Overall Study|Study terminated by sponsor|0|||
13478092|NCT02987543|27008925|FG000|Overall Study|Investigator decision|0|||
13478093|NCT02987543|27008926|FG001|Overall Study|Investigator decision|1|||
13478094|NCT02987543|27008927|FG002|Overall Study|Investigator decision|0|||
13478095|NCT02987543|27008928|FG003|Overall Study|Investigator decision|0|||
13478096|NCT02987543|27008925|FG000|Overall Study|Disease progression|0|||
13478097|NCT02987543|27008926|FG001|Overall Study|Disease progression|0|||
13478098|NCT02987543|27008927|FG002|Overall Study|Disease progression|0|||
13478099|NCT02987543|27008928|FG003|Overall Study|Disease progression|1|||
13478100|NCT02828358|27009032|FG000|Overall Study|Physician Decision|7|||
13478101|NCT02828358|27009033|FG001|Overall Study|Physician Decision|1|||
13478102|NCT02828358|27009032|FG000|Overall Study|Treatment Failure|6|||
13478103|NCT02828358|27009033|FG001|Overall Study|Treatment Failure|0|||
13478104|NCT02828358|27009032|FG000|Overall Study|Patients without KMT2A rearrangement|0|||
13478105|NCT02828358|27009033|FG001|Overall Study|Patients without KMT2A rearrangement|21|||
13478106|NCT02828358|27009032|FG000|Overall Study|Refusal of further protocol therapy|2|||
13478107|NCT02828358|27009033|FG001|Overall Study|Refusal of further protocol therapy|0|||
13478108|NCT02828358|27009032|FG000|Overall Study|Relapse|25|||
13478109|NCT02828358|27009033|FG001|Overall Study|Relapse|0|||
13478110|NCT02828358|27009032|FG000|Overall Study|Still on therapy|5|||
13478111|NCT02828358|27009033|FG001|Overall Study|Still on therapy|0|||
13478112|NCT02601313|27009109|FG000|Overall Study|Death|2|||
13478113|NCT02601313|27009110|FG001|Overall Study|Death|16|||
13478114|NCT02601313|27009111|FG002|Overall Study|Death|4|||
13478115|NCT02601313|27009109|FG000|Overall Study|Enrolled, did not initiate CTE/KTE-X19|0|||
13478116|NCT02601313|27009110|FG001|Overall Study|Enrolled, did not initiate CTE/KTE-X19|5|||
13478117|NCT02601313|27009111|FG002|Overall Study|Enrolled, did not initiate CTE/KTE-X19|2|||
13478118|NCT02601313|27009109|FG000|Overall Study|Enrolled, did not initiate KTE-X19|0|||
13478119|NCT02601313|27009110|FG001|Overall Study|Enrolled, did not initiate KTE-X19|1|||
13478120|NCT02601313|27009111|FG002|Overall Study|Enrolled, did not initiate KTE-X19|1|||
13478121|NCT02601313|27009109|FG000|Overall Study|Still on study|0|||
13478122|NCT02601313|27009110|FG001|Overall Study|Still on study|52|||
13478123|NCT02601313|27009111|FG002|Overall Study|Still on study|10|||
13478124|NCT02601313|27009109|FG000|Overall Study|Enrolled, did not initiate AC|4|||
13478125|NCT02601313|27009110|FG001|Overall Study|Enrolled, did not initiate AC|0|||
13478126|NCT02601313|27009111|FG002|Overall Study|Enrolled, did not initiate AC|0|||
13478127|NCT02420821|27009237|FG000|Overall Study|Lost to Follow-up|6|||
13478128|NCT02420821|27009238|FG001|Overall Study|Lost to Follow-up|6|||
13478129|NCT02420821|27009237|FG000|Overall Study|Non-compliance|0|||
13478130|NCT02420821|27009238|FG001|Overall Study|Non-compliance|2|||
13478131|NCT02420821|27009237|FG000|Overall Study|Physician Decision|6|||
13478132|NCT02420821|27009238|FG001|Overall Study|Physician Decision|2|||
13478133|NCT02420821|27009237|FG000|Overall Study|Withdrawal by Subject|32|||
13478134|NCT02420821|27009238|FG001|Overall Study|Withdrawal by Subject|25|||
13478135|NCT02420821|27009237|FG000|Overall Study|Death|270|||
13478136|NCT02420821|27009238|FG001|Overall Study|Death|263|||
13478137|NCT02420821|27009237|FG000|Overall Study|Study Terminated By Sponsor|145|||
13478138|NCT02420821|27009238|FG001|Overall Study|Study Terminated By Sponsor|149|||
13478139|NCT02420821|27009237|FG000|Overall Study|Patient refused end of treatment visit due to Covid-19|0|||
13478140|NCT02420821|27009238|FG001|Overall Study|Patient refused end of treatment visit due to Covid-19|1|||
13478141|NCT02420821|27009237|FG000|Overall Study|Adverse Event|0|||
13478142|NCT02420821|27009238|FG001|Overall Study|Adverse Event|1|||
13478143|NCT02420821|27009237|FG000|Overall Study|Protinuria|0|||
13478144|NCT02420821|27009238|FG001|Overall Study|Protinuria|1|||
13478145|NCT02420821|27009237|FG000|Overall Study|Progressive Disease|1|||
13478146|NCT02420821|27009238|FG001|Overall Study|Progressive Disease|1|||
13478147|NCT02420821|27009237|FG000|Overall Study|Disease Progression|0|||
13478148|NCT02420821|27009238|FG001|Overall Study|Disease Progression|1|||
13478149|NCT02420821|27009237|FG000|Overall Study|Patient missing record of discontinuation from Atezo.|0|||
13478150|NCT02420821|27009238|FG001|Overall Study|Patient missing record of discontinuation from Atezo.|1|||
13478151|NCT02101853|27009277|FG000|Block 1 Induction|Adverse Event|11|||
13478152|NCT02101853|27009278|FG001|Block 1 Induction|Adverse Event|0|||
13478153|NCT02101853|27009279|FG002|Block 1 Induction|Adverse Event|0|||
13478154|NCT02101853|27009280|FG003|Block 1 Induction|Adverse Event|0|||
13478155|NCT02101853|27009281|FG004|Block 1 Induction|Adverse Event|0|||
13478156|NCT02101853|27009282|FG005|Block 1 Induction|Adverse Event|0|||
13478157|NCT02101853|27009277|FG000|Block 1 Induction|Death|20|||
13478158|NCT02101853|27009278|FG001|Block 1 Induction|Death|0|||
13478159|NCT02101853|27009279|FG002|Block 1 Induction|Death|0|||
13478160|NCT02101853|27009280|FG003|Block 1 Induction|Death|0|||
13478161|NCT02101853|27009281|FG004|Block 1 Induction|Death|0|||
13478162|NCT02101853|27009282|FG005|Block 1 Induction|Death|0|||
13478163|NCT02101853|27009277|FG000|Block 1 Induction|Lack of Efficacy|6|||
13478164|NCT02101853|27009278|FG001|Block 1 Induction|Lack of Efficacy|0|||
13478165|NCT02101853|27009279|FG002|Block 1 Induction|Lack of Efficacy|0|||
13478166|NCT02101853|27009280|FG003|Block 1 Induction|Lack of Efficacy|0|||
13478167|NCT02101853|27009281|FG004|Block 1 Induction|Lack of Efficacy|0|||
13478168|NCT02101853|27009282|FG005|Block 1 Induction|Lack of Efficacy|0|||
13478169|NCT02101853|27009277|FG000|Block 1 Induction|Physician Decision|61|||
13478170|NCT02101853|27009278|FG001|Block 1 Induction|Physician Decision|0|||
13478171|NCT02101853|27009279|FG002|Block 1 Induction|Physician Decision|0|||
13478172|NCT02101853|27009280|FG003|Block 1 Induction|Physician Decision|0|||
13478173|NCT02101853|27009281|FG004|Block 1 Induction|Physician Decision|0|||
13478174|NCT02101853|27009282|FG005|Block 1 Induction|Physician Decision|0|||
13478175|NCT02101853|27009277|FG000|Block 1 Induction|Protocol Violation|2|||
13478176|NCT02101853|27009278|FG001|Block 1 Induction|Protocol Violation|0|||
13478177|NCT02101853|27009279|FG002|Block 1 Induction|Protocol Violation|0|||
13478178|NCT02101853|27009280|FG003|Block 1 Induction|Protocol Violation|0|||
13478179|NCT02101853|27009281|FG004|Block 1 Induction|Protocol Violation|0|||
13478180|NCT02101853|27009282|FG005|Block 1 Induction|Protocol Violation|0|||
13478181|NCT02101853|27009277|FG000|Block 1 Induction|Withdrawal by Subject|65|||
13478182|NCT02101853|27009278|FG001|Block 1 Induction|Withdrawal by Subject|0|||
13478183|NCT02101853|27009279|FG002|Block 1 Induction|Withdrawal by Subject|0|||
13478184|NCT02101853|27009280|FG003|Block 1 Induction|Withdrawal by Subject|0|||
13478185|NCT02101853|27009281|FG004|Block 1 Induction|Withdrawal by Subject|0|||
13478186|NCT02101853|27009282|FG005|Block 1 Induction|Withdrawal by Subject|0|||
13478187|NCT02101853|27009277|FG000|Block 1 Induction|Ineligible|8|||
13478188|NCT02101853|27009278|FG001|Block 1 Induction|Ineligible|0|||
13478189|NCT02101853|27009279|FG002|Block 1 Induction|Ineligible|0|||
13478190|NCT02101853|27009280|FG003|Block 1 Induction|Ineligible|0|||
13478191|NCT02101853|27009281|FG004|Block 1 Induction|Ineligible|0|||
13478192|NCT02101853|27009282|FG005|Block 1 Induction|Ineligible|0|||
13478193|NCT02101853|27009277|FG000|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|1|||
13478194|NCT02101853|27009278|FG001|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
13478195|NCT02101853|27009279|FG002|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
13478196|NCT02101853|27009280|FG003|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
13478197|NCT02101853|27009281|FG004|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
13478198|NCT02101853|27009282|FG005|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
13478199|NCT02101853|27009277|FG000|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|1|||
13478200|NCT02101853|27009278|FG001|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
13478201|NCT02101853|27009279|FG002|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
13478202|NCT02101853|27009280|FG003|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
13478203|NCT02101853|27009281|FG004|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
13478204|NCT02101853|27009282|FG005|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
13478205|NCT02101853|27009277|FG000|Post Induction Randomization|Adverse Event|0|||
13478206|NCT02101853|27009278|FG001|Post Induction Randomization|Adverse Event|3|||
13478207|NCT02101853|27009279|FG002|Post Induction Randomization|Adverse Event|8|||
13478208|NCT02101853|27009280|FG003|Post Induction Randomization|Adverse Event|4|||
13478209|NCT02101853|27009281|FG004|Post Induction Randomization|Adverse Event|4|||
13478210|NCT02101853|27009282|FG005|Post Induction Randomization|Adverse Event|0|||
13478211|NCT02101853|27009277|FG000|Post Induction Randomization|Death|0|||
13478212|NCT02101853|27009278|FG001|Post Induction Randomization|Death|9|||
13478213|NCT02101853|27009279|FG002|Post Induction Randomization|Death|2|||
13478214|NCT02101853|27009280|FG003|Post Induction Randomization|Death|2|||
13478215|NCT02101853|27009281|FG004|Post Induction Randomization|Death|0|||
13478216|NCT02101853|27009282|FG005|Post Induction Randomization|Death|0|||
13478217|NCT02101853|27009277|FG000|Post Induction Randomization|Lack of Efficacy|0|||
13478218|NCT02101853|27009278|FG001|Post Induction Randomization|Lack of Efficacy|14|||
13478219|NCT02101853|27009279|FG002|Post Induction Randomization|Lack of Efficacy|23|||
13478220|NCT02101853|27009280|FG003|Post Induction Randomization|Lack of Efficacy|18|||
13478221|NCT02101853|27009281|FG004|Post Induction Randomization|Lack of Efficacy|21|||
13478222|NCT02101853|27009282|FG005|Post Induction Randomization|Lack of Efficacy|0|||
13478223|NCT02101853|27009277|FG000|Post Induction Randomization|Physician Decision|0|||
13478224|NCT02101853|27009278|FG001|Post Induction Randomization|Physician Decision|43|||
13478225|NCT02101853|27009279|FG002|Post Induction Randomization|Physician Decision|23|||
13478226|NCT02101853|27009280|FG003|Post Induction Randomization|Physician Decision|14|||
13478227|NCT02101853|27009281|FG004|Post Induction Randomization|Physician Decision|14|||
13478228|NCT02101853|27009282|FG005|Post Induction Randomization|Physician Decision|0|||
13478229|NCT02101853|27009277|FG000|Post Induction Randomization|Protocol Violation|0|||
13478230|NCT02101853|27009278|FG001|Post Induction Randomization|Protocol Violation|3|||
13478231|NCT02101853|27009279|FG002|Post Induction Randomization|Protocol Violation|0|||
13478232|NCT02101853|27009280|FG003|Post Induction Randomization|Protocol Violation|0|||
13478233|NCT02101853|27009281|FG004|Post Induction Randomization|Protocol Violation|0|||
13478234|NCT02101853|27009282|FG005|Post Induction Randomization|Protocol Violation|0|||
13478235|NCT02101853|27009277|FG000|Post Induction Randomization|Withdrawal by Subject|0|||
13478236|NCT02101853|27009278|FG001|Post Induction Randomization|Withdrawal by Subject|13|||
13478237|NCT02101853|27009279|FG002|Post Induction Randomization|Withdrawal by Subject|12|||
13478238|NCT02101853|27009280|FG003|Post Induction Randomization|Withdrawal by Subject|7|||
13478239|NCT02101853|27009281|FG004|Post Induction Randomization|Withdrawal by Subject|8|||
13478240|NCT02101853|27009282|FG005|Post Induction Randomization|Withdrawal by Subject|0|||
13478241|NCT02101853|27009277|FG000|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
13478242|NCT02101853|27009278|FG001|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
13478243|NCT02101853|27009279|FG002|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
13478244|NCT02101853|27009280|FG003|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|1|||
13478245|NCT02101853|27009281|FG004|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
13478246|NCT02101853|27009282|FG005|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
13478247|NCT02101853|27009277|FG000|Post Induction Randomization|Found to be ineligible for HSCT|0|||
13478248|NCT02101853|27009278|FG001|Post Induction Randomization|Found to be ineligible for HSCT|5|||
13478249|NCT02101853|27009279|FG002|Post Induction Randomization|Found to be ineligible for HSCT|8|||
13478250|NCT02101853|27009280|FG003|Post Induction Randomization|Found to be ineligible for HSCT|0|||
13478251|NCT02101853|27009281|FG004|Post Induction Randomization|Found to be ineligible for HSCT|0|||
13478252|NCT02101853|27009282|FG005|Post Induction Randomization|Found to be ineligible for HSCT|0|||
13478253|NCT02101853|27009277|FG000|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
13478254|NCT02101853|27009278|FG001|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|5|||
13478255|NCT02101853|27009279|FG002|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
13478256|NCT02101853|27009280|FG003|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
13478257|NCT02101853|27009281|FG004|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
13478258|NCT02101853|27009282|FG005|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
13478259|NCT02101853|27009277|FG000|Post Induction Randomization|Patient still receiving protocol therapy|0|||
13478260|NCT02101853|27009278|FG001|Post Induction Randomization|Patient still receiving protocol therapy|0|||
13478261|NCT02101853|27009279|FG002|Post Induction Randomization|Patient still receiving protocol therapy|0|||
13478262|NCT02101853|27009280|FG003|Post Induction Randomization|Patient still receiving protocol therapy|5|||
13478263|NCT02101853|27009281|FG004|Post Induction Randomization|Patient still receiving protocol therapy|1|||
13478264|NCT02101853|27009282|FG005|Post Induction Randomization|Patient still receiving protocol therapy|0|||
13478265|NCT02101853|27009277|FG000|Blinatumomab Salvage Therapy|Death|0|||
13478266|NCT02101853|27009278|FG001|Blinatumomab Salvage Therapy|Death|0|||
13478267|NCT02101853|27009279|FG002|Blinatumomab Salvage Therapy|Death|0|||
13478268|NCT02101853|27009280|FG003|Blinatumomab Salvage Therapy|Death|0|||
13478269|NCT02101853|27009281|FG004|Blinatumomab Salvage Therapy|Death|0|||
13478270|NCT02101853|27009282|FG005|Blinatumomab Salvage Therapy|Death|2|||
13478271|NCT02101853|27009277|FG000|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
13478272|NCT02101853|27009278|FG001|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
13478273|NCT02101853|27009279|FG002|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
13478274|NCT02101853|27009280|FG003|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
13478275|NCT02101853|27009281|FG004|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
13478276|NCT02101853|27009282|FG005|Blinatumomab Salvage Therapy|Lack of Efficacy|7|||
13478277|NCT02101853|27009277|FG000|Blinatumomab Salvage Therapy|Physician Decision|0|||
13478278|NCT02101853|27009278|FG001|Blinatumomab Salvage Therapy|Physician Decision|0|||
13478279|NCT02101853|27009279|FG002|Blinatumomab Salvage Therapy|Physician Decision|0|||
13478280|NCT02101853|27009280|FG003|Blinatumomab Salvage Therapy|Physician Decision|0|||
13478281|NCT02101853|27009281|FG004|Blinatumomab Salvage Therapy|Physician Decision|0|||
13478282|NCT02101853|27009282|FG005|Blinatumomab Salvage Therapy|Physician Decision|14|||
13478283|NCT02101853|27009277|FG000|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
13478284|NCT02101853|27009278|FG001|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
13478285|NCT02101853|27009279|FG002|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
13478286|NCT02101853|27009280|FG003|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
13478287|NCT02101853|27009281|FG004|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
13478288|NCT02101853|27009282|FG005|Blinatumomab Salvage Therapy|Withdrawal by Subject|2|||
13478289|NCT02066181|27009309|FG000|Overall Study|Withdrawal by Subject|1|||
13478290|NCT02066181|27009310|FG001|Overall Study|Withdrawal by Subject|1|||
13478291|NCT02059265|27009320|FG000|Overall Study|Ineligible|4|||
13478292|NCT02039063|27009371|FG000|Treatment Phase|Inadequate therapeutic effect|3|||
13478293|NCT02039063|27009372|FG001|Treatment Phase|Inadequate therapeutic effect|2|||
13478294|NCT02039063|27009373|FG002|Treatment Phase|Inadequate therapeutic effect|1|||
13478295|NCT02039063|27009374|FG003|Treatment Phase|Inadequate therapeutic effect|1|||
13478296|NCT02039063|27009371|FG000|Treatment Phase|Progression of disease|0|||
13478297|NCT02039063|27009372|FG001|Treatment Phase|Progression of disease|0|||
13478298|NCT02039063|27009373|FG002|Treatment Phase|Progression of disease|1|||
13478299|NCT02039063|27009374|FG003|Treatment Phase|Progression of disease|1|||
13478300|NCT02039063|27009371|FG000|Extension Phase|Inadequate therapeutic effect|0|||
13478301|NCT02039063|27009372|FG001|Extension Phase|Inadequate therapeutic effect|1|||
13478302|NCT02039063|27009373|FG002|Extension Phase|Inadequate therapeutic effect|2|||
13478303|NCT02039063|27009374|FG003|Extension Phase|Inadequate therapeutic effect|0|||
13478304|NCT02039063|27009371|FG000|Extension Phase|Progression of disease|0|||
13478305|NCT02039063|27009372|FG001|Extension Phase|Progression of disease|0|||
13478306|NCT02039063|27009373|FG002|Extension Phase|Progression of disease|0|||
13478307|NCT02039063|27009374|FG003|Extension Phase|Progression of disease|1|||
13478308|NCT02039063|27009371|FG000|Extension Phase|Adverse Event|0|||
13478309|NCT02039063|27009372|FG001|Extension Phase|Adverse Event|0|||
13478310|NCT02039063|27009373|FG002|Extension Phase|Adverse Event|1|||
13478311|NCT02039063|27009374|FG003|Extension Phase|Adverse Event|0|||
13478312|NCT01746173|27009425|FG000|Overall Study|Disease Progression|2|||
13486697|NCT03745651|27037123|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
13486698|NCT03745651|27037124|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
13486699|NCT03745651|27037125|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
13486700|NCT03745651|27037126|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
13486701|NCT03745651|27037127|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
13486702|NCT03745651|27037128|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
13486703|NCT03745651|27037129|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
13486704|NCT03745651|27037123|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3|||
13486705|NCT03745651|27037124|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13|||
13486706|NCT03745651|27037125|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4|||
13486707|NCT03745651|27037126|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
13486708|NCT03745651|27037127|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
13486709|NCT03745651|27037128|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
13486710|NCT03745651|27037129|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
13486711|NCT03745651|27037123|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3|||
13486712|NCT03745651|27037124|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
13486713|NCT03745651|27037125|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
13486714|NCT03745651|27037126|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
13486715|NCT03745651|27037127|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
13486716|NCT03745651|27037128|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
13478313|NCT03164616|27009552|FG000|Overall Study|Death|250|||
13478314|NCT03164616|27009553|FG001|Overall Study|Death|264|||
13478315|NCT03164616|27009554|FG002|Overall Study|Death|279|||
13478316|NCT03164616|27009552|FG000|Overall Study|Lost to Follow-up|2|||
13478317|NCT03164616|27009553|FG001|Overall Study|Lost to Follow-up|2|||
13478318|NCT03164616|27009554|FG002|Overall Study|Lost to Follow-up|2|||
13478319|NCT03164616|27009552|FG000|Overall Study|Withdrawal by Subject|6|||
13478320|NCT03164616|27009553|FG001|Overall Study|Withdrawal by Subject|7|||
13478321|NCT03164616|27009554|FG002|Overall Study|Withdrawal by Subject|16|||
13478322|NCT02995733|27009573|FG000|Overall Study|Study site closed|9|||
13478323|NCT02995733|27009574|FG001|Overall Study|Study site closed|10|||
13478324|NCT02995733|27009573|FG000|Overall Study|Death|3|||
13478325|NCT02995733|27009574|FG001|Overall Study|Death|4|||
13478326|NCT02995733|27009573|FG000|Overall Study|Withdrawal by Subject|6|||
13478327|NCT02995733|27009574|FG001|Overall Study|Withdrawal by Subject|2|||
13478328|NCT02995733|27009573|FG000|Overall Study|Removed by study team due to inappropriate behavior|1|||
13478329|NCT02995733|27009574|FG001|Overall Study|Removed by study team due to inappropriate behavior|0|||
13478330|NCT02995733|27009573|FG000|Overall Study|Lost to Follow-up|48|||
13478331|NCT02995733|27009574|FG001|Overall Study|Lost to Follow-up|37|||
13478332|NCT02995733|27009573|FG000|Overall Study|Other|0|||
13478333|NCT02995733|27009574|FG001|Overall Study|Other|1|||
13478334|NCT02815566|27009612|FG000|Overall Study|Adverse Event|1|||
13478335|NCT02815566|27009613|FG001|Overall Study|Adverse Event|1|||
13478336|NCT02815566|27009612|FG000|Overall Study|Withdrawal by Subject|1|||
13478337|NCT02815566|27009613|FG001|Overall Study|Withdrawal by Subject|0|||
13478338|NCT02815566|27009612|FG000|Overall Study|Lost to Follow-up|0|||
13478339|NCT02815566|27009613|FG001|Overall Study|Lost to Follow-up|1|||
13478340|NCT02578680|27009636|FG000|Overall Study|Death|124|||
13478341|NCT02578680|27009637|FG001|Overall Study|Death|104|||
13478342|NCT02578680|27009636|FG000|Overall Study|Protocol Violation|1|||
13478343|NCT02578680|27009637|FG001|Overall Study|Protocol Violation|1|||
13478344|NCT02578680|27009636|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
13478345|NCT02578680|27009637|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
13478346|NCT02578680|27009636|FG000|Overall Study|Withdrawal by Subject|8|||
13478347|NCT02578680|27009637|FG001|Overall Study|Withdrawal by Subject|5|||
13478348|NCT02578680|27009636|FG000|Overall Study|Ongoing in Study|276|||
13478349|NCT02578680|27009637|FG001|Overall Study|Ongoing in Study|96|||
13478350|NCT02562235|27009708|FG000|Overall Study|Adverse Event|3|||
13478351|NCT02525783|27009725|FG000|Overall Study|Lost to Follow-up|10|||
13478352|NCT02466243|27009780|FG000|Part B Open-label Treatment Period|Adverse Event|1|||
13478353|NCT02466243|27009781|FG001|Part B Open-label Treatment Period|Adverse Event|0|||
13478354|NCT02466243|27009780|FG000|Part B Open-label Treatment Period|Withdrawal by Subject|0|||
13478355|NCT02466243|27009781|FG001|Part B Open-label Treatment Period|Withdrawal by Subject|2|||
13478356|NCT02466243|27009780|FG000|Part B Open-label Treatment Period|Sponsor Decision|8|||
13478357|NCT02466243|27009781|FG001|Part B Open-label Treatment Period|Sponsor Decision|6|||
13478358|NCT02466243|27009780|FG000|Part B Open-label Treatment Period|Missing|2|||
13478359|NCT02466243|27009781|FG001|Part B Open-label Treatment Period|Missing|2|||
13478360|NCT02321098|27009800|FG000|12 Weeks Treament|Lost to Follow-up|1|||
13478361|NCT02321098|27009801|FG001|12 Weeks Treament|Lost to Follow-up|1|||
13478362|NCT02321098|27009802|FG002|12 Weeks Treament|Lost to Follow-up|0|||
13478363|NCT02321098|27009800|FG000|Additional 15 Months Treatment|Lack of Efficacy|0|||
13478364|NCT02321098|27009801|FG001|Additional 15 Months Treatment|Lack of Efficacy|0|||
13478365|NCT02321098|27009802|FG002|Additional 15 Months Treatment|Lack of Efficacy|6|||
13478366|NCT02321098|27009800|FG000|Additional 15 Months Treatment|Lost to Follow-up|0|||
13478367|NCT02321098|27009801|FG001|Additional 15 Months Treatment|Lost to Follow-up|0|||
13478368|NCT02321098|27009802|FG002|Additional 15 Months Treatment|Lost to Follow-up|1|||
13478369|NCT02321098|27009800|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0|||
13478370|NCT02321098|27009801|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0|||
13478371|NCT02321098|27009802|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1|||
13478372|NCT02213926|27009808|FG000|Overall Study|Death|59|||
13478373|NCT02213926|27009808|FG000|Overall Study|Withdrawal by Subject|10|||
13478374|NCT02213926|27009808|FG000|Overall Study|study terminated by sponsor|51|||
13478375|NCT02213926|27009808|FG000|Overall Study|Lost to Follow-up|3|||
13478376|NCT02213926|27009808|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1|||
13478377|NCT02043678|27009847|FG000|Overall Study|Never treated|11|||
13478378|NCT02043678|27009848|FG001|Overall Study|Never treated|9|||
13478379|NCT02043678|27009847|FG000|Overall Study|AE with clinical progressive disease(PD)|18|||
13478380|NCT02043678|27009848|FG001|Overall Study|AE with clinical progressive disease(PD)|18|||
13478381|NCT02043678|27009847|FG000|Overall Study|AE without clinical PD|51|||
13478382|NCT02043678|27009848|FG001|Overall Study|AE without clinical PD|34|||
13478383|NCT02043678|27009847|FG000|Overall Study|Lost to Follow-up|1|||
13478384|NCT02043678|27009848|FG001|Overall Study|Lost to Follow-up|1|||
13478385|NCT02043678|27009847|FG000|Overall Study|Other|19|||
13478386|NCT02043678|27009848|FG001|Overall Study|Other|16|||
13478387|NCT02043678|27009847|FG000|Overall Study|Clinical PD|108|||
13478388|NCT02043678|27009848|FG001|Overall Study|Clinical PD|138|||
13478389|NCT02043678|27009847|FG000|Overall Study|Radiological PD|91|||
13478390|NCT02043678|27009848|FG001|Overall Study|Radiological PD|80|||
13478391|NCT02043678|27009847|FG000|Overall Study|Protocol-driven decision point|56|||
13478392|NCT02043678|27009848|FG001|Overall Study|Protocol-driven decision point|56|||
13478393|NCT02043678|27009847|FG000|Overall Study|Withdrawal by Subject|12|||
13478394|NCT02043678|27009848|FG001|Overall Study|Withdrawal by Subject|15|||
13478395|NCT02043678|27009847|FG000|Overall Study|Ongoing with treatment|34|||
13478396|NCT02043678|27009848|FG001|Overall Study|Ongoing with treatment|38|||
13478397|NCT01966731|27009854|FG000|Overall Study|Death|2|||
13478398|NCT01966731|27009854|FG000|Overall Study|Lost to Follow-up|1|||
13478399|NCT01966731|27009854|FG000|Overall Study|Physician Decision|2|||
13478400|NCT01966731|27009854|FG000|Overall Study|Follow up is not complete|600|||
13478401|NCT01966731|27009854|FG000|Overall Study|Screening Failure|29|||
13478402|NCT01966731|27009854|FG000|Overall Study|Found to be ineligible|1|||
13478403|NCT01843374|27009885|FG000|Overall Study|Death|155|||
13478404|NCT01843374|27009886|FG001|Overall Study|Death|313|||
13478405|NCT01843374|27009885|FG000|Overall Study|Withdrawal by Subject|14|||
13478406|NCT01843374|27009886|FG001|Overall Study|Withdrawal by Subject|20|||
13478407|NCT01843374|27009885|FG000|Overall Study|Withdrawing due to Other reason|20|||
13478408|NCT01843374|27009886|FG001|Overall Study|Withdrawing due to Other reason|46|||
13486717|NCT03745651|27037129|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
13486718|NCT03745651|27037123|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
13486719|NCT03745651|27037124|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2|||
13486720|NCT03745651|27037125|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
13486721|NCT03745651|27037126|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
13486722|NCT03745651|27037127|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
13486723|NCT03745651|27037128|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
13486724|NCT03745651|27037129|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
13486725|NCT03745651|27037123|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
13486726|NCT03745651|27037124|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21|||
13486727|NCT03745651|27037125|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15|||
13486728|NCT03745651|27037126|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
13486729|NCT03745651|27037127|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
13486730|NCT03745651|27037128|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
13486731|NCT03745651|27037129|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
13486732|NCT03745651|27037123|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1|||
13486733|NCT03745651|27037124|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
13486734|NCT03745651|27037125|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
13486735|NCT03745651|27037126|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
13486736|NCT03745651|27037127|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
13486737|NCT03745651|27037128|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
13486738|NCT03745651|27037129|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
13486739|NCT03745651|27037123|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
13486740|NCT03745651|27037124|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
13486741|NCT03745651|27037125|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
13486742|NCT03745651|27037126|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
13486743|NCT03745651|27037127|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
13486744|NCT03745651|27037128|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4|||
13486745|NCT03745651|27037129|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
13486746|NCT03745651|27037123|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
13486747|NCT03745651|27037124|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
13486748|NCT03745651|27037125|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
13486749|NCT03745651|27037126|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
13486750|NCT03745651|27037127|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
13486751|NCT03745651|27037128|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
13486752|NCT03745651|27037129|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
13486753|NCT03745651|27037123|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
13486754|NCT03745651|27037124|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
13486755|NCT03745651|27037125|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
13486756|NCT03745651|27037126|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4|||
13486757|NCT03745651|27037127|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2|||
13486758|NCT03745651|27037128|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
13486759|NCT03745651|27037129|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10|||
13486760|NCT03745651|27037123|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
13486761|NCT03745651|27037124|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
13486762|NCT03745651|27037125|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
13486763|NCT03745651|27037126|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
13478409|NCT00565851|27009945|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
13478410|NCT00565851|27009946|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
13478411|NCT00565851|27009947|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3|||
13478412|NCT00565851|27009948|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18|||
13478413|NCT00565851|27009949|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
13478414|NCT00565851|27009950|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
13478415|NCT00565851|27009951|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
13478416|NCT00565851|27009952|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
13478417|NCT00565851|27009945|FG000|Chemotherapy Assignment|Still On Chemotherapy|0|||
13478418|NCT00565851|27009946|FG001|Chemotherapy Assignment|Still On Chemotherapy|14|||
13478419|NCT00565851|27009947|FG002|Chemotherapy Assignment|Still On Chemotherapy|0|||
13478420|NCT00565851|27009948|FG003|Chemotherapy Assignment|Still On Chemotherapy|18|||
13478421|NCT00565851|27009949|FG004|Chemotherapy Assignment|Still On Chemotherapy|0|||
13478422|NCT00565851|27009950|FG005|Chemotherapy Assignment|Still On Chemotherapy|1|||
13478423|NCT00565851|27009951|FG006|Chemotherapy Assignment|Still On Chemotherapy|0|||
13478424|NCT00565851|27009952|FG007|Chemotherapy Assignment|Still On Chemotherapy|1|||
13478425|NCT01620944|27009991|FG000|Overall Study|Early termination of Study|2|||
13478426|NCT01620944|27009992|FG001|Overall Study|Early termination of Study|1|||
13478427|NCT01627561|27010063|FG000|Overall Study|Lost to Follow-up|1|||
13478428|NCT01627561|27010064|FG001|Overall Study|Lost to Follow-up|0|||
13478429|NCT01627561|27010063|FG000|Overall Study|Withdrawal by Subject|0|||
13478430|NCT01627561|27010064|FG001|Overall Study|Withdrawal by Subject|1|||
13478431|NCT01627561|27010063|FG000|Overall Study|Migrated/moved from study area|0|||
13478432|NCT01627561|27010064|FG001|Overall Study|Migrated/moved from study area|2|||
13478433|NCT01652534|27010143|FG000|Overall Study|Lack of Efficacy|1|||
13478434|NCT01652534|27010144|FG001|Overall Study|Lack of Efficacy|0|||
13478435|NCT04709575|27010184|FG000|Overall Study|Withdrawal by Subject|6|||
13478436|NCT04709575|27010185|FG001|Overall Study|Withdrawal by Subject|2|||
13478437|NCT04709575|27010184|FG000|Overall Study|Lost to Follow-up|2|||
13478438|NCT04709575|27010185|FG001|Overall Study|Lost to Follow-up|2|||
13478439|NCT04709575|27010184|FG000|Overall Study|Adverse Event|1|||
13478440|NCT04709575|27010185|FG001|Overall Study|Adverse Event|0|||
13478441|NCT04709575|27010184|FG000|Overall Study|Protocol Violation|1|||
13478442|NCT04709575|27010185|FG001|Overall Study|Protocol Violation|1|||
13478443|NCT04450407|27010209|FG000|Overall Study|Withdrawal by Subject|10|||
13478444|NCT04450407|27010210|FG001|Overall Study|Withdrawal by Subject|1|||
13478445|NCT04450407|27010211|FG002|Overall Study|Withdrawal by Subject|4|||
13478446|NCT04450407|27010209|FG000|Overall Study|Adverse Event|0|||
13478447|NCT04450407|27010210|FG001|Overall Study|Adverse Event|0|||
13478448|NCT04450407|27010211|FG002|Overall Study|Adverse Event|1|||
13478449|NCT04450407|27010209|FG000|Overall Study|Lost to Follow-up|1|||
13478450|NCT04450407|27010210|FG001|Overall Study|Lost to Follow-up|0|||
13478451|NCT04450407|27010211|FG002|Overall Study|Lost to Follow-up|0|||
13478452|NCT04450407|27010209|FG000|Overall Study|Physician Decision|0|||
13478453|NCT04450407|27010210|FG001|Overall Study|Physician Decision|0|||
13478454|NCT04450407|27010211|FG002|Overall Study|Physician Decision|1|||
13478455|NCT04450407|27010209|FG000|Overall Study|Pregnancy|1|||
13478456|NCT04450407|27010210|FG001|Overall Study|Pregnancy|0|||
13478457|NCT04450407|27010211|FG002|Overall Study|Pregnancy|0|||
13478458|NCT04450407|27010209|FG000|Overall Study|Protocol Violation|2|||
13478459|NCT04450407|27010210|FG001|Overall Study|Protocol Violation|0|||
13478460|NCT04450407|27010211|FG002|Overall Study|Protocol Violation|0|||
13478461|NCT04450407|27010209|FG000|Overall Study|Investigational site terminated by sponsor|3|||
13478462|NCT04450407|27010210|FG001|Overall Study|Investigational site terminated by sponsor|0|||
13478463|NCT04450407|27010211|FG002|Overall Study|Investigational site terminated by sponsor|2|||
13478464|NCT04418765|27010337|FG000|Overall Study|Adverse Event|1|||
13478465|NCT04418765|27010338|FG001|Overall Study|Adverse Event|1|||
13478466|NCT04418765|27010339|FG002|Overall Study|Adverse Event|6|||
13478467|NCT04418765|27010337|FG000|Overall Study|Lack of Efficacy|1|||
13478468|NCT04418765|27010338|FG001|Overall Study|Lack of Efficacy|3|||
13478469|NCT04418765|27010339|FG002|Overall Study|Lack of Efficacy|0|||
13478470|NCT04418765|27010337|FG000|Overall Study|Protocol Violation|0|||
13478471|NCT04418765|27010338|FG001|Overall Study|Protocol Violation|1|||
13478472|NCT04418765|27010339|FG002|Overall Study|Protocol Violation|1|||
13478473|NCT04418765|27010337|FG000|Overall Study|Withdrawal by Subject|1|||
13478474|NCT04418765|27010338|FG001|Overall Study|Withdrawal by Subject|5|||
13478475|NCT04418765|27010339|FG002|Overall Study|Withdrawal by Subject|2|||
13478476|NCT04418765|27010337|FG000|Overall Study|Lost to Follow-up|0|||
13478477|NCT04418765|27010338|FG001|Overall Study|Lost to Follow-up|1|||
13478478|NCT04418765|27010339|FG002|Overall Study|Lost to Follow-up|0|||
13478479|NCT04418765|27010337|FG000|Overall Study|Other than specified|2|||
13478480|NCT04418765|27010338|FG001|Overall Study|Other than specified|0|||
13478481|NCT04418765|27010339|FG002|Overall Study|Other than specified|1|||
13478482|NCT04418765|27010337|FG000|Overall Study|Randomized but not treated|1|||
13478483|NCT04418765|27010338|FG001|Overall Study|Randomized but not treated|0|||
13478484|NCT04418765|27010339|FG002|Overall Study|Randomized but not treated|0|||
13478485|NCT04388826|27010360|FG000|Overall Study|Lost to Follow-up|3|||
13478486|NCT04388826|27010361|FG001|Overall Study|Lost to Follow-up|2|||
13478487|NCT04388826|27010360|FG000|Overall Study|Adverse Event|1|||
13478488|NCT04388826|27010361|FG001|Overall Study|Adverse Event|0|||
13486764|NCT03745651|27037127|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
13486765|NCT03745651|27037128|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4|||
13486766|NCT03745651|27037129|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2|||
13486767|NCT03745651|27037123|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
13486768|NCT03745651|27037124|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
13486769|NCT03745651|27037125|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
13486770|NCT03745651|27037126|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
13486771|NCT03745651|27037127|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
13486772|NCT03745651|27037128|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
13486773|NCT03745651|27037129|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
13486774|NCT03745651|27037123|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
13486775|NCT03745651|27037124|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
13486776|NCT03745651|27037125|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
13486777|NCT03745651|27037126|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
13486778|NCT03745651|27037127|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
13486779|NCT03745651|27037128|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
13486780|NCT03745651|27037129|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
13486781|NCT03745651|27037123|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
13486782|NCT03745651|27037124|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
13486783|NCT03745651|27037125|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
13486784|NCT03745651|27037126|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12|||
13486785|NCT03745651|27037127|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8|||
13486786|NCT03745651|27037128|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26|||
13486787|NCT03745651|27037129|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34|||
13486788|NCT03745651|27037123|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
13486789|NCT03745651|27037124|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
13486790|NCT03745651|27037125|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
13486791|NCT03745651|27037126|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
13486792|NCT03745651|27037127|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
13486793|NCT03745651|27037128|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
13486794|NCT03745651|27037129|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
13486795|NCT03745638|27037280|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4|||
13486796|NCT03745638|27037281|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2|||
13486797|NCT03745638|27037282|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
13486798|NCT03745638|27037283|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
13486799|NCT03745638|27037284|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
13486800|NCT03745638|27037285|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
13486801|NCT03745638|27037286|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
13486802|NCT03745638|27037280|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1|||
13486803|NCT03745638|27037281|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
13486804|NCT03745638|27037282|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
13486805|NCT03745638|27037283|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
13486806|NCT03745638|27037284|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
13486807|NCT03745638|27037285|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
13486808|NCT03745638|27037286|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
13486809|NCT03745638|27037280|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5|||
13486810|NCT03745638|27037281|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12|||
13486811|NCT03745638|27037282|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8|||
13486812|NCT03745638|27037283|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
13486813|NCT03745638|27037284|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
13486814|NCT03745638|27037285|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
13486815|NCT03745638|27037286|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
13486816|NCT03745638|27037280|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
13486817|NCT03745638|27037281|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
13486818|NCT03745638|27037282|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
13486819|NCT03745638|27037283|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
13486820|NCT03745638|27037284|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
13486821|NCT03745638|27037285|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
13486822|NCT03745638|27037286|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
13486823|NCT03745638|27037280|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1|||
13478489|NCT04218266|27010415|FG000|Overall Study|Death|1|||
13478490|NCT04218266|27010416|FG001|Overall Study|Death|2|||
13478491|NCT04218266|27010417|FG002|Overall Study|Death|3|||
13478492|NCT04218266|27010415|FG000|Overall Study|Adverse Event|13|||
13478493|NCT04218266|27010416|FG001|Overall Study|Adverse Event|14|||
13478494|NCT04218266|27010417|FG002|Overall Study|Adverse Event|11|||
13478495|NCT04218266|27010415|FG000|Overall Study|Other|7|||
13478496|NCT04218266|27010416|FG001|Overall Study|Other|5|||
13478497|NCT04218266|27010417|FG002|Overall Study|Other|14|||
13478498|NCT04218266|27010415|FG000|Overall Study|Physician Decision|1|||
13478499|NCT04218266|27010416|FG001|Overall Study|Physician Decision|3|||
13478500|NCT04218266|27010417|FG002|Overall Study|Physician Decision|2|||
13478501|NCT04218266|27010415|FG000|Overall Study|Non-compliance with study drug|0|||
13478502|NCT04218266|27010416|FG001|Overall Study|Non-compliance with study drug|0|||
13478503|NCT04218266|27010417|FG002|Overall Study|Non-compliance with study drug|1|||
13478504|NCT04218266|27010415|FG000|Overall Study|Withdrawal by Subject|1|||
13478505|NCT04218266|27010416|FG001|Overall Study|Withdrawal by Subject|3|||
13478506|NCT04218266|27010417|FG002|Overall Study|Withdrawal by Subject|1|||
13478507|NCT04218266|27010415|FG000|Overall Study|Study drug never administered|2|||
13478508|NCT04218266|27010416|FG001|Overall Study|Study drug never administered|0|||
13478509|NCT04218266|27010417|FG002|Overall Study|Study drug never administered|0|||
13478510|NCT03894904|27010451|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|2|||
13478511|NCT03894904|27010452|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|3|||
13478512|NCT03894904|27010451|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|2|||
13478513|NCT03894904|27010452|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|1|||
13478514|NCT03518086|27010530|FG000|Overall Study|Adverse Event|23|||
13478515|NCT03518086|27010531|FG001|Overall Study|Adverse Event|15|||
13478516|NCT03518086|27010532|FG002|Overall Study|Adverse Event|0|||
13478517|NCT03518086|27010533|FG003|Overall Study|Adverse Event|0|||
13478518|NCT03518086|27010530|FG000|Overall Study|Withdrawal by Subject|8|||
13478519|NCT03518086|27010531|FG001|Overall Study|Withdrawal by Subject|5|||
13478520|NCT03518086|27010532|FG002|Overall Study|Withdrawal by Subject|0|||
13478521|NCT03518086|27010533|FG003|Overall Study|Withdrawal by Subject|0|||
13478522|NCT03518086|27010530|FG000|Overall Study|Lack of Efficacy|5|||
13478523|NCT03518086|27010531|FG001|Overall Study|Lack of Efficacy|5|||
13478524|NCT03518086|27010532|FG002|Overall Study|Lack of Efficacy|0|||
13478525|NCT03518086|27010533|FG003|Overall Study|Lack of Efficacy|0|||
13478526|NCT03518086|27010530|FG000|Overall Study|Protocol Violation|1|||
13478527|NCT03518086|27010531|FG001|Overall Study|Protocol Violation|5|||
13478528|NCT03518086|27010532|FG002|Overall Study|Protocol Violation|0|||
13478529|NCT03518086|27010533|FG003|Overall Study|Protocol Violation|0|||
13478530|NCT03518086|27010530|FG000|Overall Study|Lost to Follow-up|0|||
13478531|NCT03518086|27010531|FG001|Overall Study|Lost to Follow-up|3|||
13478532|NCT03518086|27010532|FG002|Overall Study|Lost to Follow-up|0|||
13478533|NCT03518086|27010533|FG003|Overall Study|Lost to Follow-up|0|||
13478534|NCT03518086|27010530|FG000|Overall Study|Insufficient Diary Data|0|||
13478535|NCT03518086|27010531|FG001|Overall Study|Insufficient Diary Data|2|||
13478536|NCT03518086|27010532|FG002|Overall Study|Insufficient Diary Data|0|||
13478537|NCT03518086|27010533|FG003|Overall Study|Insufficient Diary Data|0|||
13478538|NCT03518086|27010530|FG000|Overall Study|Non- compliance to Protocol|0|||
13478539|NCT03518086|27010531|FG001|Overall Study|Non- compliance to Protocol|1|||
13478540|NCT03518086|27010532|FG002|Overall Study|Non- compliance to Protocol|0|||
13478541|NCT03518086|27010533|FG003|Overall Study|Non- compliance to Protocol|0|||
13478542|NCT03518086|27010530|FG000|Overall Study|COVID-19 Related Study Disruption|0|||
13478543|NCT03518086|27010531|FG001|Overall Study|COVID-19 Related Study Disruption|2|||
13478544|NCT03518086|27010532|FG002|Overall Study|COVID-19 Related Study Disruption|0|||
13478545|NCT03518086|27010533|FG003|Overall Study|COVID-19 Related Study Disruption|0|||
13478546|NCT03518086|27010530|FG000|Overall Study|Site Terminated by Sponsor|0|||
13478547|NCT03518086|27010531|FG001|Overall Study|Site Terminated by Sponsor|1|||
13478548|NCT03518086|27010532|FG002|Overall Study|Site Terminated by Sponsor|0|||
13478549|NCT03518086|27010533|FG003|Overall Study|Site Terminated by Sponsor|0|||
13478550|NCT03225287|27010611|FG000|Overall Study|Adverse Event|0|||
13478551|NCT03225287|27010612|FG001|Overall Study|Adverse Event|0|||
13478552|NCT03225287|27010613|FG002|Overall Study|Adverse Event|1|||
13478553|NCT03225287|27010611|FG000|Overall Study|Protocol non-compliance|0|||
13478554|NCT03225287|27010612|FG001|Overall Study|Protocol non-compliance|0|||
13478555|NCT03225287|27010613|FG002|Overall Study|Protocol non-compliance|1|||
13478556|NCT03225287|27010611|FG000|Overall Study|Subject withdraws consent|3|||
13478557|NCT03225287|27010612|FG001|Overall Study|Subject withdraws consent|0|||
13478558|NCT03225287|27010613|FG002|Overall Study|Subject withdraws consent|0|||
13478559|NCT03225287|27010611|FG000|Overall Study|Sponsor, regulatory, or EC/IRB request|7|||
13478560|NCT03225287|27010612|FG001|Overall Study|Sponsor, regulatory, or EC/IRB request|3|||
13478561|NCT03225287|27010613|FG002|Overall Study|Sponsor, regulatory, or EC/IRB request|1|||
13478562|NCT03225287|27010611|FG000|Overall Study|Trial drug not effective|0|||
13478563|NCT03225287|27010612|FG001|Overall Study|Trial drug not effective|1|||
13478564|NCT03225287|27010613|FG002|Overall Study|Trial drug not effective|0|||
13478565|NCT03225287|27010611|FG000|Overall Study|Need of transfusions and signs of hemolysis|0|||
13478566|NCT03225287|27010612|FG001|Overall Study|Need of transfusions and signs of hemolysis|1|||
13478567|NCT03225287|27010613|FG002|Overall Study|Need of transfusions and signs of hemolysis|0|||
13478568|NCT03225287|27010611|FG000|Overall Study|Stem cell transplantation|0|||
13478569|NCT03225287|27010612|FG001|Overall Study|Stem cell transplantation|1|||
13478570|NCT03225287|27010613|FG002|Overall Study|Stem cell transplantation|0|||
13478571|NCT03125902|27010665|FG000|Overall Study|Death|52|||
13478572|NCT03125902|27010666|FG001|Overall Study|Death|123|||
13478573|NCT03125902|27010665|FG000|Overall Study|Lost to Follow-up|1|||
13478574|NCT03125902|27010666|FG001|Overall Study|Lost to Follow-up|0|||
13478575|NCT03125902|27010665|FG000|Overall Study|Mastectomy|0|||
13478576|NCT03125902|27010666|FG001|Overall Study|Mastectomy|1|||
13478577|NCT03125902|27010665|FG000|Overall Study|Physician Decision|1|||
13478578|NCT03125902|27010666|FG001|Overall Study|Physician Decision|0|||
13478579|NCT03125902|27010665|FG000|Overall Study|Withdrawal by Subject|13|||
13478580|NCT03125902|27010666|FG001|Overall Study|Withdrawal by Subject|25|||
13478581|NCT03125902|27010665|FG000|Overall Study|Study is ongoing|153|||
13478582|NCT03125902|27010666|FG001|Overall Study|Study is ongoing|282|||
13478583|NCT03099265|27010678|FG000|Overall Study|Adverse Event|1|||
13478584|NCT03016312|27010705|FG000|Overall Study|Death|194|||
13478585|NCT03016312|27010706|FG001|Overall Study|Death|164|||
13478586|NCT03016312|27010705|FG000|Overall Study|Lost to Follow-up|11|||
13478587|NCT03016312|27010706|FG001|Overall Study|Lost to Follow-up|12|||
13478588|NCT03016312|27010705|FG000|Overall Study|Started new therapy, loss of contact|2|||
13478589|NCT03016312|27010706|FG001|Overall Study|Started new therapy, loss of contact|1|||
13478590|NCT03016312|27010705|FG000|Overall Study|Physician Decision|0|||
13478591|NCT03016312|27010706|FG001|Overall Study|Physician Decision|2|||
13478592|NCT03016312|27010705|FG000|Overall Study|Withdrawal by Subject|34|||
13478593|NCT03016312|27010706|FG001|Overall Study|Withdrawal by Subject|39|||
13478594|NCT02658656|27010794|FG000|Screening|Failed eligibility criteria|0|||
13478595|NCT02658656|27010795|FG001|Screening|Failed eligibility criteria|0|||
13478596|NCT02658656|27010796|FG002|Screening|Failed eligibility criteria|263|||
13478597|NCT02658656|27010794|FG000|Randomization|Withdrawal by Subject|8|||
13478598|NCT02658656|27010795|FG001|Randomization|Withdrawal by Subject|7|||
13478599|NCT02658656|27010796|FG002|Randomization|Withdrawal by Subject|0|||
13478600|NCT02658656|27010794|FG000|Randomization|Lost to Follow-up|1|||
13478601|NCT02658656|27010795|FG001|Randomization|Lost to Follow-up|3|||
13478602|NCT02658656|27010796|FG002|Randomization|Lost to Follow-up|0|||
13478603|NCT02658656|27010794|FG000|Randomization|Adverse Event|4|||
13478604|NCT02658656|27010795|FG001|Randomization|Adverse Event|0|||
13478605|NCT02658656|27010796|FG002|Randomization|Adverse Event|0|||
13478606|NCT02658656|27010794|FG000|Randomization|Administrative Termination|3|||
13478607|NCT02658656|27010795|FG001|Randomization|Administrative Termination|1|||
13478608|NCT02658656|27010796|FG002|Randomization|Administrative Termination|0|||
13478609|NCT02658656|27010794|FG000|Randomization|Administrative Termination due to COVID-19 Restrictions|13|||
13478610|NCT02658656|27010795|FG001|Randomization|Administrative Termination due to COVID-19 Restrictions|15|||
13478611|NCT02658656|27010796|FG002|Randomization|Administrative Termination due to COVID-19 Restrictions|0|||
13478612|NCT02658656|27010794|FG000|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|2|||
13478613|NCT02658656|27010795|FG001|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
13478614|NCT02658656|27010796|FG002|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
13478615|NCT02658656|27010794|FG000|Randomization|Not eligible for Randomization|1|||
13478616|NCT02658656|27010795|FG001|Randomization|Not eligible for Randomization|0|||
13478617|NCT02658656|27010796|FG002|Randomization|Not eligible for Randomization|0|||
13478618|NCT02658656|27010794|FG000|Randomization|Protocol Violation|1|||
13478619|NCT02658656|27010795|FG001|Randomization|Protocol Violation|0|||
13478620|NCT02658656|27010796|FG002|Randomization|Protocol Violation|0|||
13478621|NCT02151981|27010956|FG000|Overall Study|Death|184|||
13478622|NCT02151981|27010957|FG001|Overall Study|Death|88|||
13478623|NCT02151981|27010956|FG000|Overall Study|Lost to Follow-up|7|||
13478624|NCT02151981|27010957|FG001|Overall Study|Lost to Follow-up|1|||
13478625|NCT02151981|27010956|FG000|Overall Study|Withdrawal by Subject|27|||
13478626|NCT02151981|27010957|FG001|Overall Study|Withdrawal by Subject|21|||
13478627|NCT02151981|27010956|FG000|Overall Study|Ongoing Study at Data Cut-off|60|||
13478628|NCT02151981|27010957|FG001|Overall Study|Ongoing Study at Data Cut-off|27|||
13478629|NCT02151981|27010956|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
13478630|NCT02151981|27010957|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
13478631|NCT02151981|27010956|FG000|Overall Study|Patient had no clinical benefit|1|||
13478632|NCT02151981|27010957|FG001|Overall Study|Patient had no clinical benefit|0|||
13478633|NCT02151981|27010956|FG000|Overall Study|Unwilling to continue to follow up visit|0|||
13478634|NCT02151981|27010957|FG001|Overall Study|Unwilling to continue to follow up visit|1|||
13478635|NCT02151981|27010956|FG000|Overall Study|Study terminated|0|||
13478636|NCT02151981|27010957|FG001|Overall Study|Study terminated|1|||
13478637|NCT02066636|27010994|FG000|Overall Study|Disease progression|51|||
13478638|NCT02066636|27010995|FG001|Overall Study|Disease progression|60|||
13478639|NCT02066636|27010996|FG002|Overall Study|Disease progression|700|||
13478640|NCT02066636|27010994|FG000|Overall Study|Study drug toxicity|13|||
13478641|NCT02066636|27010995|FG001|Overall Study|Study drug toxicity|2|||
13478642|NCT02066636|27010996|FG002|Overall Study|Study drug toxicity|58|||
13478643|NCT02066636|27010994|FG000|Overall Study|Death|4|||
13478644|NCT02066636|27010995|FG001|Overall Study|Death|2|||
13478645|NCT02066636|27010996|FG002|Overall Study|Death|158|||
13478646|NCT02066636|27010994|FG000|Overall Study|Adverse event unrelated to study drug|6|||
13478647|NCT02066636|27010995|FG001|Overall Study|Adverse event unrelated to study drug|4|||
13478648|NCT02066636|27010996|FG002|Overall Study|Adverse event unrelated to study drug|45|||
13478649|NCT02066636|27010994|FG000|Overall Study|Participant request to discontinue treatment|12|||
13478650|NCT02066636|27010995|FG001|Overall Study|Participant request to discontinue treatment|12|||
13478651|NCT02066636|27010996|FG002|Overall Study|Participant request to discontinue treatment|70|||
13478652|NCT02066636|27010994|FG000|Overall Study|Participant withdrew consent|10|||
13478653|NCT02066636|27010995|FG001|Overall Study|Participant withdrew consent|18|||
13478654|NCT02066636|27010996|FG002|Overall Study|Participant withdrew consent|61|||
13478655|NCT02066636|27010994|FG000|Overall Study|Lost to Follow-up|0|||
13478656|NCT02066636|27010995|FG001|Overall Study|Lost to Follow-up|2|||
13478657|NCT02066636|27010996|FG002|Overall Study|Lost to Follow-up|2|||
13478658|NCT02066636|27010994|FG000|Overall Study|Maximum clinical benefit|2|||
13478659|NCT02066636|27010995|FG001|Overall Study|Maximum clinical benefit|2|||
13478660|NCT02066636|27010996|FG002|Overall Study|Maximum clinical benefit|3|||
13478661|NCT02066636|27010994|FG000|Overall Study|Poor/non-compliance|2|||
13478662|NCT02066636|27010995|FG001|Overall Study|Poor/non-compliance|1|||
13478663|NCT02066636|27010996|FG002|Overall Study|Poor/non-compliance|1|||
13478664|NCT02066636|27010994|FG000|Overall Study|Participant no loner meets study criteria|3|||
13478665|NCT02066636|27010995|FG001|Overall Study|Participant no loner meets study criteria|2|||
13478666|NCT02066636|27010996|FG002|Overall Study|Participant no loner meets study criteria|28|||
13478667|NCT02066636|27010994|FG000|Overall Study|Administrative reasons by sponsor|8|||
13478668|NCT02066636|27010995|FG001|Overall Study|Administrative reasons by sponsor|5|||
13478669|NCT02066636|27010996|FG002|Overall Study|Administrative reasons by sponsor|0|||
13478670|NCT02066636|27010994|FG000|Overall Study|Other reasons|16|||
13478671|NCT02066636|27010995|FG001|Overall Study|Other reasons|15|||
13478672|NCT02066636|27010996|FG002|Overall Study|Other reasons|50|||
13478673|NCT01486264|27011033|FG000|Overall Study|Death|1|||
13478674|NCT01486264|27011034|FG001|Overall Study|Death|1|||
13478675|NCT01486264|27011033|FG000|Overall Study|Adverse Event|3|||
13478676|NCT01486264|27011034|FG001|Overall Study|Adverse Event|3|||
13478677|NCT01486264|27011033|FG000|Overall Study|Lack of Efficacy|6|||
13478678|NCT01486264|27011034|FG001|Overall Study|Lack of Efficacy|10|||
13478679|NCT01486264|27011033|FG000|Overall Study|Withdrawal by Subject|7|||
13478680|NCT01486264|27011034|FG001|Overall Study|Withdrawal by Subject|18|||
13478681|NCT01486264|27011033|FG000|Overall Study|Physician Decision|1|||
13478682|NCT01486264|27011034|FG001|Overall Study|Physician Decision|1|||
13478683|NCT01486264|27011033|FG000|Overall Study|Protocol Violation|3|||
13478684|NCT01486264|27011034|FG001|Overall Study|Protocol Violation|0|||
13478685|NCT01486264|27011033|FG000|Overall Study|Lost to Follow-up|3|||
13478686|NCT01486264|27011034|FG001|Overall Study|Lost to Follow-up|2|||
13478687|NCT01486264|27011033|FG000|Overall Study|Other|5|||
13478688|NCT01486264|27011034|FG001|Overall Study|Other|11|||
13478689|NCT01486264|27011033|FG000|Overall Study|Not treated|0|||
13478690|NCT01486264|27011034|FG001|Overall Study|Not treated|1|||
13478691|NCT01323270|27011061|FG000|Overall Study|Withdrawal by Subject|19|||
13478692|NCT01323270|27011062|FG001|Overall Study|Withdrawal by Subject|10|||
13478693|NCT01323270|27011061|FG000|Overall Study|Protocol Violation|9|||
13478694|NCT01323270|27011062|FG001|Overall Study|Protocol Violation|7|||
13478695|NCT01323270|27011061|FG000|Overall Study|Lost to Follow-up|4|||
13478696|NCT01323270|27011062|FG001|Overall Study|Lost to Follow-up|6|||
13478697|NCT01323270|27011061|FG000|Overall Study|Adverse Event|8|||
13478698|NCT01323270|27011062|FG001|Overall Study|Adverse Event|0|||
13478699|NCT01323270|27011061|FG000|Overall Study|Other|0|||
13478700|NCT01323270|27011062|FG001|Overall Study|Other|3|||
13478701|NCT01323270|27011061|FG000|Overall Study|Physician Decision|0|||
13478702|NCT01323270|27011062|FG001|Overall Study|Physician Decision|2|||
13478703|NCT01323270|27011061|FG000|Overall Study|Not eligible|1|||
13478704|NCT01323270|27011062|FG001|Overall Study|Not eligible|1|||
13478705|NCT01323270|27011061|FG000|Overall Study|Death|1|||
13478706|NCT01323270|27011062|FG001|Overall Study|Death|0|||
13478707|NCT01323270|27011061|FG000|Overall Study|Randomized, but not vaccinated|1|||
13478708|NCT01323270|27011062|FG001|Overall Study|Randomized, but not vaccinated|0|||
13478709|NCT01300728|27011083|FG000|Overall Study|Withdrawal by Subject|1|||
13478710|NCT01300728|27011084|FG001|Overall Study|Withdrawal by Subject|1|||
13478711|NCT01300728|27011083|FG000|Overall Study|Physician Decision|1|||
13478712|NCT01300728|27011084|FG001|Overall Study|Physician Decision|0|||
13478713|NCT01299480|27011135|FG000|Overall Study|No longer willing to participate|19|||
13478714|NCT01299480|27011136|FG001|Overall Study|No longer willing to participate|17|||
13478715|NCT01299480|27011137|FG002|Overall Study|No longer willing to participate|14|||
13478716|NCT01299480|27011138|FG003|Overall Study|No longer willing to participate|13|||
13478717|NCT01299480|27011139|FG004|Overall Study|No longer willing to participate|10|||
13478718|NCT01299480|27011135|FG000|Overall Study|Protocol Violation|7|||
13478719|NCT01299480|27011136|FG001|Overall Study|Protocol Violation|5|||
13478720|NCT01299480|27011137|FG002|Overall Study|Protocol Violation|8|||
13478721|NCT01299480|27011138|FG003|Overall Study|Protocol Violation|1|||
13478722|NCT01299480|27011139|FG004|Overall Study|Protocol Violation|1|||
13478723|NCT01299480|27011135|FG000|Overall Study|Withdrawal by Subject|3|||
13478724|NCT01299480|27011136|FG001|Overall Study|Withdrawal by Subject|4|||
13478725|NCT01299480|27011137|FG002|Overall Study|Withdrawal by Subject|7|||
13478726|NCT01299480|27011138|FG003|Overall Study|Withdrawal by Subject|3|||
13478727|NCT01299480|27011139|FG004|Overall Study|Withdrawal by Subject|4|||
13478728|NCT01299480|27011135|FG000|Overall Study|Adverse Event|6|||
13478729|NCT01299480|27011136|FG001|Overall Study|Adverse Event|4|||
13478730|NCT01299480|27011137|FG002|Overall Study|Adverse Event|5|||
13478731|NCT01299480|27011138|FG003|Overall Study|Adverse Event|4|||
13478732|NCT01299480|27011139|FG004|Overall Study|Adverse Event|0|||
13478733|NCT01299480|27011135|FG000|Overall Study|Withdrawal due to pregnancy|0|||
13478734|NCT01299480|27011136|FG001|Overall Study|Withdrawal due to pregnancy|1|||
13478735|NCT01299480|27011137|FG002|Overall Study|Withdrawal due to pregnancy|1|||
13478736|NCT01299480|27011138|FG003|Overall Study|Withdrawal due to pregnancy|0|||
13478737|NCT01299480|27011139|FG004|Overall Study|Withdrawal due to pregnancy|0|||
13478738|NCT01299480|27011135|FG000|Overall Study|Physician Decision|1|||
13478739|NCT01299480|27011136|FG001|Overall Study|Physician Decision|1|||
13478740|NCT01299480|27011137|FG002|Overall Study|Physician Decision|0|||
13478741|NCT01299480|27011138|FG003|Overall Study|Physician Decision|2|||
13478742|NCT01299480|27011139|FG004|Overall Study|Physician Decision|0|||
13478743|NCT01299480|27011135|FG000|Overall Study|Lost to Follow-up|3|||
13478744|NCT01299480|27011136|FG001|Overall Study|Lost to Follow-up|1|||
13478745|NCT01299480|27011137|FG002|Overall Study|Lost to Follow-up|2|||
13478746|NCT01299480|27011138|FG003|Overall Study|Lost to Follow-up|1|||
13478747|NCT01299480|27011139|FG004|Overall Study|Lost to Follow-up|2|||
13478748|NCT01299480|27011135|FG000|Overall Study|Other|3|||
13478749|NCT01299480|27011136|FG001|Overall Study|Other|2|||
13478750|NCT01299480|27011137|FG002|Overall Study|Other|3|||
13478751|NCT01299480|27011138|FG003|Overall Study|Other|0|||
13478752|NCT01299480|27011139|FG004|Overall Study|Other|3|||
13478753|NCT01299480|27011135|FG000|Overall Study|Started, but not vaccinated|0|||
13478754|NCT01299480|27011136|FG001|Overall Study|Started, but not vaccinated|0|||
13478755|NCT01299480|27011137|FG002|Overall Study|Started, but not vaccinated|1|||
13478756|NCT01299480|27011138|FG003|Overall Study|Started, but not vaccinated|1|||
13478757|NCT01299480|27011139|FG004|Overall Study|Started, but not vaccinated|0|||
13486824|NCT03745638|27037281|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
13486825|NCT03745638|27037282|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
13486826|NCT03745638|27037283|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
13486827|NCT03745638|27037284|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
13486828|NCT03745638|27037285|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
13486829|NCT03745638|27037286|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
13486830|NCT03745638|27037280|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
13486831|NCT03745638|27037281|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3|||
13486832|NCT03745638|27037282|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
13486833|NCT03745638|27037283|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
13486834|NCT03745638|27037284|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
13486835|NCT03745638|27037285|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
13486836|NCT03745638|27037286|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
13486837|NCT03745638|27037280|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17|||
13486838|NCT03745638|27037281|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
13486839|NCT03745638|27037282|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19|||
13486840|NCT03745638|27037283|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
13486841|NCT03745638|27037284|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
13486842|NCT03745638|27037285|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
13486843|NCT03745638|27037286|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
13486844|NCT03745638|27037280|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2|||
13486845|NCT03745638|27037281|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1|||
13486846|NCT03745638|27037282|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
13486847|NCT03745638|27037283|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
13486848|NCT03745638|27037284|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
13486849|NCT03745638|27037285|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
13486850|NCT03745638|27037286|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
13486851|NCT03745638|27037280|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
13486852|NCT03745638|27037281|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
13478758|NCT04799405|27011173|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2|||
13478759|NCT04529499|27011197|FG000|Overall Study|Withdrawal by Subject|9|||
13478760|NCT04529499|27011198|FG001|Overall Study|Withdrawal by Subject|11|||
13478761|NCT04529499|27011197|FG000|Overall Study|Physician Decision|1|||
13478762|NCT04529499|27011198|FG001|Overall Study|Physician Decision|2|||
13478763|NCT04529499|27011197|FG000|Overall Study|Adverse Event|4|||
13478764|NCT04529499|27011198|FG001|Overall Study|Adverse Event|4|||
13478765|NCT04529499|27011197|FG000|Overall Study|Death|14|||
13478766|NCT04529499|27011198|FG001|Overall Study|Death|11|||
13478767|NCT04529499|27011197|FG000|Overall Study|Lost to Follow-up|1|||
13478768|NCT04529499|27011198|FG001|Overall Study|Lost to Follow-up|1|||
13478769|NCT04529499|27011197|FG000|Overall Study|Others|7|||
13478770|NCT04529499|27011198|FG001|Overall Study|Others|11|||
13478771|NCT04501094|27011219|FG000|Overall Study|Death (unrelated to research)|1|||
13478772|NCT04501094|27011220|FG001|Overall Study|Death (unrelated to research)|0|||
13478773|NCT04414618|27011257|FG000|Overall Study|Death|3|||
13478774|NCT04414618|27011258|FG001|Overall Study|Death|3|||
13478775|NCT04414618|27011257|FG000|Overall Study|Withdrawal by Subject|2|||
13478776|NCT04414618|27011258|FG001|Overall Study|Withdrawal by Subject|1|||
13478777|NCT04414618|27011257|FG000|Overall Study|Lost to Follow-up|2|||
13478778|NCT04414618|27011258|FG001|Overall Study|Lost to Follow-up|3|||
13478779|NCT04414618|27011257|FG000|Overall Study|Physician Decision|1|||
13478780|NCT04414618|27011258|FG001|Overall Study|Physician Decision|0|||
13478781|NCT04412057|27011273|FG000|Overall Study|Death|3|||
13478782|NCT04412057|27011274|FG001|Overall Study|Death|7|||
13478783|NCT04412057|27011273|FG000|Overall Study|Discharged prior to receiving study treatment|1|||
13478784|NCT04412057|27011274|FG001|Overall Study|Discharged prior to receiving study treatment|0|||
13478785|NCT04402060|27011338|FG000|Overall Study|Death|1|||
13478786|NCT04402060|27011339|FG001|Overall Study|Death|12|||
13478787|NCT04402060|27011340|FG002|Overall Study|Death|7|||
13478788|NCT04402060|27011338|FG000|Overall Study|Adverse Event|0|||
13478789|NCT04402060|27011339|FG001|Overall Study|Adverse Event|0|||
13478790|NCT04402060|27011340|FG002|Overall Study|Adverse Event|1|||
13478791|NCT04402060|27011338|FG000|Overall Study|Withdrawal by Subject|0|||
13478792|NCT04402060|27011339|FG001|Overall Study|Withdrawal by Subject|1|||
13478793|NCT04402060|27011340|FG002|Overall Study|Withdrawal by Subject|2|||
13478794|NCT04402060|27011338|FG000|Overall Study|Sponsor Request|0|||
13478795|NCT04402060|27011339|FG001|Overall Study|Sponsor Request|2|||
13478796|NCT04402060|27011340|FG002|Overall Study|Sponsor Request|0|||
13478797|NCT04402060|27011338|FG000|Overall Study|Physician Decision|0|||
13478798|NCT04402060|27011339|FG001|Overall Study|Physician Decision|0|||
13478799|NCT04402060|27011340|FG002|Overall Study|Physician Decision|1|||
13478800|NCT04402060|27011338|FG000|Overall Study|Other|0|||
13478801|NCT04402060|27011339|FG001|Overall Study|Other|1|||
13478802|NCT04402060|27011340|FG002|Overall Study|Other|0|||
13478803|NCT04396626|27011362|FG000|Overall Study|Premature termination of study|975|||
13478804|NCT04376684|27011511|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7|||
13478805|NCT04376684|27011512|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8|||
13478806|NCT04376684|27011513|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
13478807|NCT04376684|27011514|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
13478808|NCT04376684|27011511|FG000|Part 1 (Up to Day 60)|Protocol Violation|2|||
13478809|NCT04376684|27011512|FG001|Part 1 (Up to Day 60)|Protocol Violation|3|||
13478810|NCT04376684|27011513|FG002|Part 1 (Up to Day 60)|Protocol Violation|0|||
13478811|NCT04376684|27011514|FG003|Part 1 (Up to Day 60)|Protocol Violation|0|||
13478812|NCT04376684|27011511|FG000|Part 1 (Up to Day 60)|Physician Decision|2|||
13478813|NCT04376684|27011512|FG001|Part 1 (Up to Day 60)|Physician Decision|5|||
13478814|NCT04376684|27011513|FG002|Part 1 (Up to Day 60)|Physician Decision|0|||
13478815|NCT04376684|27011514|FG003|Part 1 (Up to Day 60)|Physician Decision|0|||
13478816|NCT04376684|27011511|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4|||
13478817|NCT04376684|27011512|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8|||
13478818|NCT04376684|27011513|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
13478819|NCT04376684|27011514|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
13478820|NCT04376684|27011511|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
13478821|NCT04376684|27011512|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
13478822|NCT04376684|27011513|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
13478823|NCT04376684|27011514|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
13478824|NCT04376684|27011511|FG000|Part 2 (Up to Day 60)|Physician Decision|0|||
13478825|NCT04376684|27011512|FG001|Part 2 (Up to Day 60)|Physician Decision|0|||
13478826|NCT04376684|27011513|FG002|Part 2 (Up to Day 60)|Physician Decision|1|||
13478827|NCT04376684|27011514|FG003|Part 2 (Up to Day 60)|Physician Decision|1|||
13478828|NCT04376684|27011511|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
13478829|NCT04376684|27011512|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
13478830|NCT04376684|27011513|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3|||
13478831|NCT04376684|27011514|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2|||
13478832|NCT04353284|27011549|FG000|Overall Study|Adverse Event|1|||
13478833|NCT04353284|27011550|FG001|Overall Study|Adverse Event|1|||
13478834|NCT04353284|27011549|FG000|Overall Study|Lost to Follow-up|1|||
13478835|NCT04353284|27011550|FG001|Overall Study|Lost to Follow-up|0|||
13478836|NCT04294147|27011579|FG000|Overall Study|Protocol Violation|2|||
13478837|NCT04294147|27011580|FG001|Overall Study|Protocol Violation|0|||
13478838|NCT04231825|27011607|FG000|Overall Study|Protocol Violation|3|||
13478839|NCT04231825|27011608|FG001|Overall Study|Protocol Violation|3|||
13478840|NCT04231825|27011607|FG000|Overall Study|Lost to Follow-up|0|||
13478841|NCT04231825|27011608|FG001|Overall Study|Lost to Follow-up|1|||
13486853|NCT03745638|27037282|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
13486854|NCT03745638|27037283|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
13486855|NCT03745638|27037284|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
13486856|NCT03745638|27037285|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6|||
13486857|NCT03745638|27037286|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1|||
13486858|NCT03745638|27037280|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
13486859|NCT03745638|27037281|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
13486860|NCT03745638|27037282|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
13486861|NCT03745638|27037283|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
13486862|NCT03745638|27037284|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
13486863|NCT03745638|27037285|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
13486864|NCT03745638|27037286|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
13486865|NCT03745638|27037280|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
13486866|NCT03745638|27037281|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
13486867|NCT03745638|27037282|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
13486868|NCT03745638|27037283|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3|||
13486869|NCT03745638|27037284|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5|||
13486870|NCT03745638|27037285|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
13486871|NCT03745638|27037286|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24|||
13486872|NCT03745638|27037280|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
13486873|NCT03745638|27037281|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
13486874|NCT03745638|27037282|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
13486875|NCT03745638|27037283|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
13486876|NCT03745638|27037284|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
13486877|NCT03745638|27037285|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3|||
13486878|NCT03745638|27037286|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
13486879|NCT03745638|27037280|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
13486880|NCT03745638|27037281|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
13486881|NCT03745638|27037282|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
13486882|NCT03745638|27037283|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
13486883|NCT03745638|27037284|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
13486884|NCT03745638|27037285|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
13486885|NCT03745638|27037286|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
13486886|NCT03745638|27037280|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
13486887|NCT03745638|27037281|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
13486888|NCT03745638|27037282|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
13486889|NCT03745638|27037283|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7|||
13486890|NCT03745638|27037284|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
13486891|NCT03745638|27037285|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17|||
13486892|NCT03745638|27037286|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21|||
13486893|NCT03745638|27037280|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
13486894|NCT03745638|27037281|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
13486895|NCT03745638|27037282|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
13486896|NCT03745638|27037283|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
13486897|NCT03745638|27037284|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
13486898|NCT03745638|27037285|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4|||
13486899|NCT03745638|27037286|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3|||
13486900|NCT03715764|27037305|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2|||
13486901|NCT03715764|27037306|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3|||
13486902|NCT03715764|27037305|FG000|3 Month Follow-up|Lost to Follow-up|2|||
13486903|NCT03715764|27037306|FG001|3 Month Follow-up|Lost to Follow-up|2|||
13486904|NCT03715764|27037305|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
13486905|NCT03715764|27037306|FG001|3 Month Follow-up|Withdrawal by Subject|1|||
13486906|NCT03715764|27037305|FG000|6 Month Follow-up|Lost to Follow-up|3|||
13486907|NCT03715764|27037306|FG001|6 Month Follow-up|Lost to Follow-up|0|||
13486908|NCT03715764|27037305|FG000|12 Month Follow-up|Lost to Follow-up|2|||
13486909|NCT03715764|27037306|FG001|12 Month Follow-up|Lost to Follow-up|3|||
13486910|NCT03715764|27037305|FG000|12 Month Follow-up|Pregnancy|0|||
13486911|NCT03715764|27037306|FG001|12 Month Follow-up|Pregnancy|1|||
13486912|NCT03715764|27037305|FG000|12 Month Follow-up|Surgery|2|||
13478842|NCT04178772|27011630|FG000|Overall Study|Unsatisfacotry VIsual Response|1|||
13478843|NCT04178772|27011630|FG000|Overall Study|study terminated early due to COVID-19|7|||
13478844|NCT04148651|27011640|FG000|Overall Study|Lost to Follow-up|2|||
13478845|NCT03924427|27011669|FG000|Overall Study|Adverse Event|4|||
13478846|NCT03924427|27011669|FG000|Overall Study|Lack of Efficacy|1|||
13478847|NCT03924427|27011669|FG000|Overall Study|Withdrawal by Subject|1|||
13478848|NCT03893448|27011721|FG000|Overall Study|Withdrawal by Parent/Guardian|59|||
13478849|NCT03893448|27011722|FG001|Overall Study|Withdrawal by Parent/Guardian|85|||
13478850|NCT03893448|27011721|FG000|Overall Study|Physician Decision|8|||
13478851|NCT03893448|27011722|FG001|Overall Study|Physician Decision|14|||
13478852|NCT03893448|27011721|FG000|Overall Study|Lost to Follow-up|34|||
13478853|NCT03893448|27011722|FG001|Overall Study|Lost to Follow-up|27|||
13478854|NCT03893448|27011721|FG000|Overall Study|Death|1|||
13478855|NCT03893448|27011722|FG001|Overall Study|Death|0|||
13478856|NCT03811574|27011936|FG000|Overall Study|Withdrawal by Subject|2|||
13478857|NCT03811574|27011937|FG001|Overall Study|Withdrawal by Subject|4|||
13478858|NCT03811574|27011938|FG002|Overall Study|Withdrawal by Subject|0|||
13478859|NCT03727750|27012040|FG000|Overall Study|Death|45|||
13478860|NCT03727750|27012040|FG000|Overall Study|Withdrawal by Subject|2|||
13478861|NCT03727750|27012040|FG000|Overall Study|Lost to Follow-up|1|||
13478862|NCT03727750|27012040|FG000|Overall Study|Other|1|||
13478863|NCT03715829|27012271|FG000|Dose Ranging Period|Adverse Event|2|||
13478864|NCT03715829|27012272|FG001|Dose Ranging Period|Adverse Event|4|||
13478865|NCT03715829|27012273|FG002|Dose Ranging Period|Adverse Event|5|||
13478866|NCT03715829|27012274|FG003|Dose Ranging Period|Adverse Event|2|||
13478867|NCT03715829|27012275|FG004|Dose Ranging Period|Adverse Event|3|||
13478868|NCT03715829|27012276|FG005|Dose Ranging Period|Adverse Event|3|||
13478869|NCT03715829|27012277|FG006|Dose Ranging Period|Adverse Event|0|||
13478870|NCT03715829|27012278|FG007|Dose Ranging Period|Adverse Event|0|||
13478871|NCT03715829|27012279|FG008|Dose Ranging Period|Adverse Event|0|||
13478872|NCT03715829|27012280|FG009|Dose Ranging Period|Adverse Event|0|||
13478873|NCT03715829|27012281|FG010|Dose Ranging Period|Adverse Event|0|||
13478874|NCT03715829|27012271|FG000|Dose Ranging Period|Lack of Efficacy|0|||
13478875|NCT03715829|27012272|FG001|Dose Ranging Period|Lack of Efficacy|1|||
13478876|NCT03715829|27012273|FG002|Dose Ranging Period|Lack of Efficacy|0|||
13478877|NCT03715829|27012274|FG003|Dose Ranging Period|Lack of Efficacy|1|||
13478878|NCT03715829|27012275|FG004|Dose Ranging Period|Lack of Efficacy|0|||
13478879|NCT03715829|27012276|FG005|Dose Ranging Period|Lack of Efficacy|0|||
13478880|NCT03715829|27012277|FG006|Dose Ranging Period|Lack of Efficacy|0|||
13478881|NCT03715829|27012278|FG007|Dose Ranging Period|Lack of Efficacy|0|||
13478882|NCT03715829|27012279|FG008|Dose Ranging Period|Lack of Efficacy|0|||
13478883|NCT03715829|27012280|FG009|Dose Ranging Period|Lack of Efficacy|0|||
13478884|NCT03715829|27012281|FG010|Dose Ranging Period|Lack of Efficacy|0|||
13478885|NCT03715829|27012271|FG000|Dose Ranging Period|Lost to Follow-up|2|||
13478886|NCT03715829|27012272|FG001|Dose Ranging Period|Lost to Follow-up|0|||
13478887|NCT03715829|27012273|FG002|Dose Ranging Period|Lost to Follow-up|1|||
13478888|NCT03715829|27012274|FG003|Dose Ranging Period|Lost to Follow-up|1|||
13478889|NCT03715829|27012275|FG004|Dose Ranging Period|Lost to Follow-up|1|||
13478890|NCT03715829|27012276|FG005|Dose Ranging Period|Lost to Follow-up|2|||
13478891|NCT03715829|27012277|FG006|Dose Ranging Period|Lost to Follow-up|0|||
13478892|NCT03715829|27012278|FG007|Dose Ranging Period|Lost to Follow-up|0|||
13478893|NCT03715829|27012279|FG008|Dose Ranging Period|Lost to Follow-up|0|||
13478894|NCT03715829|27012280|FG009|Dose Ranging Period|Lost to Follow-up|0|||
13478895|NCT03715829|27012281|FG010|Dose Ranging Period|Lost to Follow-up|0|||
13478896|NCT03715829|27012271|FG000|Dose Ranging Period|Protocol Violation|0|||
13478897|NCT03715829|27012272|FG001|Dose Ranging Period|Protocol Violation|0|||
13478898|NCT03715829|27012273|FG002|Dose Ranging Period|Protocol Violation|0|||
13478899|NCT03715829|27012274|FG003|Dose Ranging Period|Protocol Violation|1|||
13478900|NCT03715829|27012275|FG004|Dose Ranging Period|Protocol Violation|0|||
13478901|NCT03715829|27012276|FG005|Dose Ranging Period|Protocol Violation|0|||
13478902|NCT03715829|27012277|FG006|Dose Ranging Period|Protocol Violation|0|||
13478903|NCT03715829|27012278|FG007|Dose Ranging Period|Protocol Violation|0|||
13478904|NCT03715829|27012279|FG008|Dose Ranging Period|Protocol Violation|0|||
13478905|NCT03715829|27012280|FG009|Dose Ranging Period|Protocol Violation|0|||
13478906|NCT03715829|27012281|FG010|Dose Ranging Period|Protocol Violation|0|||
13478907|NCT03715829|27012271|FG000|Dose Ranging Period|Withdrawal by Subject|8|||
13478908|NCT03715829|27012272|FG001|Dose Ranging Period|Withdrawal by Subject|4|||
13478909|NCT03715829|27012273|FG002|Dose Ranging Period|Withdrawal by Subject|3|||
13478910|NCT03715829|27012274|FG003|Dose Ranging Period|Withdrawal by Subject|9|||
13478911|NCT03715829|27012275|FG004|Dose Ranging Period|Withdrawal by Subject|2|||
13478912|NCT03715829|27012276|FG005|Dose Ranging Period|Withdrawal by Subject|3|||
13478913|NCT03715829|27012277|FG006|Dose Ranging Period|Withdrawal by Subject|0|||
13478914|NCT03715829|27012278|FG007|Dose Ranging Period|Withdrawal by Subject|0|||
13478915|NCT03715829|27012279|FG008|Dose Ranging Period|Withdrawal by Subject|0|||
13478916|NCT03715829|27012280|FG009|Dose Ranging Period|Withdrawal by Subject|0|||
13478917|NCT03715829|27012281|FG010|Dose Ranging Period|Withdrawal by Subject|0|||
13486913|NCT03715764|27037306|FG001|12 Month Follow-up|Surgery|0|||
13478918|NCT03715829|27012271|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
13478919|NCT03715829|27012272|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
13478920|NCT03715829|27012273|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1|||
13478921|NCT03715829|27012274|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
13478922|NCT03715829|27012275|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
13478923|NCT03715829|27012276|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
13478924|NCT03715829|27012277|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
13478925|NCT03715829|27012278|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
13478926|NCT03715829|27012279|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
13478927|NCT03715829|27012280|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
13478928|NCT03715829|27012281|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
13478929|NCT03715829|27012271|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
13478930|NCT03715829|27012272|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
13478931|NCT03715829|27012273|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
13478932|NCT03715829|27012274|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
13478933|NCT03715829|27012275|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
13478934|NCT03715829|27012276|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
13478935|NCT03715829|27012277|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
13478936|NCT03715829|27012278|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
13478937|NCT03715829|27012279|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
13478938|NCT03715829|27012280|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
13478939|NCT03715829|27012281|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
13478940|NCT03715829|27012271|FG000|Dose Ranging Period|Other|0|||
13478941|NCT03715829|27012272|FG001|Dose Ranging Period|Other|0|||
13478942|NCT03715829|27012273|FG002|Dose Ranging Period|Other|2|||
13478943|NCT03715829|27012274|FG003|Dose Ranging Period|Other|0|||
13478944|NCT03715829|27012275|FG004|Dose Ranging Period|Other|0|||
13478945|NCT03715829|27012276|FG005|Dose Ranging Period|Other|3|||
13478946|NCT03715829|27012277|FG006|Dose Ranging Period|Other|0|||
13478947|NCT03715829|27012278|FG007|Dose Ranging Period|Other|0|||
13478948|NCT03715829|27012279|FG008|Dose Ranging Period|Other|0|||
13478949|NCT03715829|27012280|FG009|Dose Ranging Period|Other|0|||
13478950|NCT03715829|27012281|FG010|Dose Ranging Period|Other|0|||
13478951|NCT03715829|27012271|FG000|Extension Period|Adverse Event|0|||
13478952|NCT03715829|27012272|FG001|Extension Period|Adverse Event|0|||
13478953|NCT03715829|27012273|FG002|Extension Period|Adverse Event|0|||
13478954|NCT03715829|27012274|FG003|Extension Period|Adverse Event|0|||
13478955|NCT03715829|27012275|FG004|Extension Period|Adverse Event|0|||
13478956|NCT03715829|27012276|FG005|Extension Period|Adverse Event|0|||
13478957|NCT03715829|27012277|FG006|Extension Period|Adverse Event|3|||
13478958|NCT03715829|27012278|FG007|Extension Period|Adverse Event|1|||
13478959|NCT03715829|27012279|FG008|Extension Period|Adverse Event|6|||
13478960|NCT03715829|27012280|FG009|Extension Period|Adverse Event|0|||
13478961|NCT03715829|27012281|FG010|Extension Period|Adverse Event|0|||
13478962|NCT03715829|27012271|FG000|Extension Period|Lack of Efficacy|0|||
13478963|NCT03715829|27012272|FG001|Extension Period|Lack of Efficacy|0|||
13478964|NCT03715829|27012273|FG002|Extension Period|Lack of Efficacy|0|||
13478965|NCT03715829|27012274|FG003|Extension Period|Lack of Efficacy|0|||
13478966|NCT03715829|27012275|FG004|Extension Period|Lack of Efficacy|0|||
13478967|NCT03715829|27012276|FG005|Extension Period|Lack of Efficacy|0|||
13478968|NCT03715829|27012277|FG006|Extension Period|Lack of Efficacy|1|||
13478969|NCT03715829|27012278|FG007|Extension Period|Lack of Efficacy|9|||
13478970|NCT03715829|27012279|FG008|Extension Period|Lack of Efficacy|2|||
13478971|NCT03715829|27012280|FG009|Extension Period|Lack of Efficacy|0|||
13478972|NCT03715829|27012281|FG010|Extension Period|Lack of Efficacy|0|||
13478973|NCT03715829|27012271|FG000|Extension Period|Lost to Follow-up|0|||
13478974|NCT03715829|27012272|FG001|Extension Period|Lost to Follow-up|0|||
13478975|NCT03715829|27012273|FG002|Extension Period|Lost to Follow-up|0|||
13478976|NCT03715829|27012274|FG003|Extension Period|Lost to Follow-up|0|||
13478977|NCT03715829|27012275|FG004|Extension Period|Lost to Follow-up|0|||
13478978|NCT03715829|27012276|FG005|Extension Period|Lost to Follow-up|0|||
13478979|NCT03715829|27012277|FG006|Extension Period|Lost to Follow-up|0|||
13478980|NCT03715829|27012278|FG007|Extension Period|Lost to Follow-up|0|||
13478981|NCT03715829|27012279|FG008|Extension Period|Lost to Follow-up|2|||
13478982|NCT03715829|27012280|FG009|Extension Period|Lost to Follow-up|0|||
13478983|NCT03715829|27012281|FG010|Extension Period|Lost to Follow-up|0|||
13478984|NCT03715829|27012271|FG000|Extension Period|Protocol Violation|0|||
13478985|NCT03715829|27012272|FG001|Extension Period|Protocol Violation|0|||
13478986|NCT03715829|27012273|FG002|Extension Period|Protocol Violation|0|||
13478987|NCT03715829|27012274|FG003|Extension Period|Protocol Violation|0|||
13478988|NCT03715829|27012275|FG004|Extension Period|Protocol Violation|0|||
13478989|NCT03715829|27012276|FG005|Extension Period|Protocol Violation|0|||
13478990|NCT03715829|27012277|FG006|Extension Period|Protocol Violation|0|||
13478991|NCT03715829|27012278|FG007|Extension Period|Protocol Violation|0|||
13478992|NCT03715829|27012279|FG008|Extension Period|Protocol Violation|1|||
13478993|NCT03715829|27012280|FG009|Extension Period|Protocol Violation|0|||
13478994|NCT03715829|27012281|FG010|Extension Period|Protocol Violation|0|||
13478995|NCT03715829|27012271|FG000|Extension Period|Withdrawal by Subject|0|||
13478996|NCT03715829|27012272|FG001|Extension Period|Withdrawal by Subject|0|||
13478997|NCT03715829|27012273|FG002|Extension Period|Withdrawal by Subject|0|||
13478998|NCT03715829|27012274|FG003|Extension Period|Withdrawal by Subject|0|||
13478999|NCT03715829|27012275|FG004|Extension Period|Withdrawal by Subject|0|||
13479000|NCT03715829|27012276|FG005|Extension Period|Withdrawal by Subject|0|||
13479001|NCT03715829|27012277|FG006|Extension Period|Withdrawal by Subject|3|||
13479002|NCT03715829|27012278|FG007|Extension Period|Withdrawal by Subject|3|||
13479003|NCT03715829|27012279|FG008|Extension Period|Withdrawal by Subject|12|||
13479004|NCT03715829|27012280|FG009|Extension Period|Withdrawal by Subject|3|||
13479005|NCT03715829|27012281|FG010|Extension Period|Withdrawal by Subject|0|||
13479006|NCT03715829|27012271|FG000|Extension Period|Medication Error Without Associated Adverse Event|0|||
13479007|NCT03715829|27012272|FG001|Extension Period|Medication Error Without Associated Adverse Event|0|||
13479008|NCT03715829|27012273|FG002|Extension Period|Medication Error Without Associated Adverse Event|0|||
13479009|NCT03715829|27012274|FG003|Extension Period|Medication Error Without Associated Adverse Event|0|||
13479010|NCT03715829|27012275|FG004|Extension Period|Medication Error Without Associated Adverse Event|0|||
13479011|NCT03715829|27012276|FG005|Extension Period|Medication Error Without Associated Adverse Event|0|||
13479012|NCT03715829|27012277|FG006|Extension Period|Medication Error Without Associated Adverse Event|0|||
13479013|NCT03715829|27012278|FG007|Extension Period|Medication Error Without Associated Adverse Event|1|||
13479014|NCT03715829|27012279|FG008|Extension Period|Medication Error Without Associated Adverse Event|1|||
13479015|NCT03715829|27012280|FG009|Extension Period|Medication Error Without Associated Adverse Event|0|||
13479016|NCT03715829|27012281|FG010|Extension Period|Medication Error Without Associated Adverse Event|0|||
13479017|NCT03715829|27012271|FG000|Extension Period|No Longer Meets Eligibility Criteria|0|||
13479018|NCT03715829|27012272|FG001|Extension Period|No Longer Meets Eligibility Criteria|0|||
13479019|NCT03715829|27012273|FG002|Extension Period|No Longer Meets Eligibility Criteria|0|||
13479020|NCT03715829|27012274|FG003|Extension Period|No Longer Meets Eligibility Criteria|0|||
13479021|NCT03715829|27012275|FG004|Extension Period|No Longer Meets Eligibility Criteria|0|||
13479022|NCT03715829|27012276|FG005|Extension Period|No Longer Meets Eligibility Criteria|0|||
13479023|NCT03715829|27012277|FG006|Extension Period|No Longer Meets Eligibility Criteria|0|||
13479024|NCT03715829|27012278|FG007|Extension Period|No Longer Meets Eligibility Criteria|0|||
13479025|NCT03715829|27012279|FG008|Extension Period|No Longer Meets Eligibility Criteria|1|||
13479026|NCT03715829|27012280|FG009|Extension Period|No Longer Meets Eligibility Criteria|0|||
13479027|NCT03715829|27012281|FG010|Extension Period|No Longer Meets Eligibility Criteria|0|||
13479028|NCT03715829|27012271|FG000|Extension Period|Other|0|||
13479029|NCT03715829|27012272|FG001|Extension Period|Other|0|||
13479030|NCT03715829|27012273|FG002|Extension Period|Other|0|||
13479031|NCT03715829|27012274|FG003|Extension Period|Other|0|||
13479032|NCT03715829|27012275|FG004|Extension Period|Other|0|||
13479033|NCT03715829|27012276|FG005|Extension Period|Other|0|||
13479034|NCT03715829|27012277|FG006|Extension Period|Other|1|||
13479035|NCT03715829|27012278|FG007|Extension Period|Other|2|||
13479036|NCT03715829|27012279|FG008|Extension Period|Other|4|||
13479037|NCT03715829|27012280|FG009|Extension Period|Other|0|||
13479038|NCT03715829|27012281|FG010|Extension Period|Other|0|||
13479039|NCT03693430|27012366|FG000|Overall Study|Lost to Follow-up|3|||
13479040|NCT03693430|27012367|FG001|Overall Study|Lost to Follow-up|14|||
13479041|NCT03693430|27012366|FG000|Overall Study|Death|1|||
13479042|NCT03693430|27012367|FG001|Overall Study|Death|0|||
13479043|NCT03693430|27012366|FG000|Overall Study|Withdrawal by Subject|0|||
13479044|NCT03693430|27012367|FG001|Overall Study|Withdrawal by Subject|4|||
13479045|NCT03575104|27012581|FG000|Overall Study|Adverse Event|4|||
13479046|NCT03575104|27012582|FG001|Overall Study|Adverse Event|3|||
13479047|NCT03575104|27012583|FG002|Overall Study|Adverse Event|4|||
13479048|NCT03575104|27012581|FG000|Overall Study|Withdrawal by Subject|13|||
13479049|NCT03575104|27012582|FG001|Overall Study|Withdrawal by Subject|16|||
13479050|NCT03575104|27012583|FG002|Overall Study|Withdrawal by Subject|11|||
13479051|NCT03575104|27012581|FG000|Overall Study|Other reasons|6|||
13479052|NCT03575104|27012582|FG001|Overall Study|Other reasons|8|||
13479053|NCT03575104|27012583|FG002|Overall Study|Other reasons|6|||
13479054|NCT03575104|27012581|FG000|Overall Study|Lost to Follow-up|1|||
13479055|NCT03575104|27012582|FG001|Overall Study|Lost to Follow-up|2|||
13479056|NCT03575104|27012583|FG002|Overall Study|Lost to Follow-up|1|||
13479057|NCT03569475|27012607|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
13479058|NCT03569475|27012608|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2|||
13479059|NCT03569475|27012609|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5|||
13479060|NCT03569475|27012607|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
13479061|NCT03569475|27012608|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
13479062|NCT03569475|27012609|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
13479063|NCT03569475|27012607|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7|||
13479064|NCT03569475|27012608|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10|||
13479065|NCT03569475|27012609|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9|||
13479066|NCT03569475|27012607|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
13479067|NCT03569475|27012608|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
13479068|NCT03569475|27012609|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6|||
13479069|NCT03569475|27012607|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
13479070|NCT03569475|27012608|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
13479071|NCT03569475|27012609|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
13479072|NCT03569475|27012607|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
13479073|NCT03569475|27012608|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
13479074|NCT03569475|27012609|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
13479075|NCT03569475|27012607|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
13479076|NCT03569475|27012608|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
13479077|NCT03569475|27012609|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2|||
13479078|NCT03569475|27012607|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0|||
13479079|NCT03569475|27012608|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
13479080|NCT03569475|27012609|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
13479081|NCT03569475|27012607|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0|||
13479082|NCT03569475|27012608|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
13479083|NCT03569475|27012609|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
13479084|NCT03545191|27012719|FG000|Overall Study|Death|1|||
13479085|NCT03545191|27012720|FG001|Overall Study|Death|0|||
13479086|NCT03545191|27012721|FG002|Overall Study|Death|0|||
13479087|NCT03545191|27012719|FG000|Overall Study|Adverse Event|4|||
13479088|NCT03545191|27012720|FG001|Overall Study|Adverse Event|2|||
13479089|NCT03545191|27012721|FG002|Overall Study|Adverse Event|7|||
13479090|NCT03545191|27012719|FG000|Overall Study|Other reasons|3|||
13479091|NCT03545191|27012720|FG001|Overall Study|Other reasons|11|||
13479092|NCT03545191|27012721|FG002|Overall Study|Other reasons|8|||
13479093|NCT03545191|27012719|FG000|Overall Study|Withdrawal by Subject|13|||
13479094|NCT03545191|27012720|FG001|Overall Study|Withdrawal by Subject|10|||
13479095|NCT03545191|27012721|FG002|Overall Study|Withdrawal by Subject|12|||
13479096|NCT03545191|27012719|FG000|Overall Study|Lost to Follow-up|1|||
13479097|NCT03545191|27012720|FG001|Overall Study|Lost to Follow-up|2|||
13479098|NCT03545191|27012721|FG002|Overall Study|Lost to Follow-up|3|||
13479099|NCT03500549|27012787|FG000|RCP (Day 1 - Week 16)|Adverse Event|3|||
13479100|NCT03500549|27012788|FG001|RCP (Day 1 - Week 16)|Adverse Event|0|||
13479101|NCT03500549|27012787|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3|||
13479102|NCT03500549|27012788|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7|||
13486914|NCT03715764|27037305|FG000|12 Month Follow-up|Wrong address|1|||
13486915|NCT03715764|27037306|FG001|12 Month Follow-up|Wrong address|0|||
13486916|NCT03715764|27037305|FG000|12 Month Follow-up|No symptoms|1|||
13486917|NCT03715764|27037306|FG001|12 Month Follow-up|No symptoms|0|||
13486918|NCT03715764|27037305|FG000|12 Month Follow-up|Changed primary care centre|0|||
13486919|NCT03715764|27037306|FG001|12 Month Follow-up|Changed primary care centre|1|||
13486920|NCT03654729|27037357|FG000|Overall Study|Death|9|||
13486921|NCT03654729|27037358|FG001|Overall Study|Death|9|||
13486922|NCT03654729|27037359|FG002|Overall Study|Death|16|||
13486923|NCT03654729|27037357|FG000|Overall Study|Withdrawal by Subject|8|||
13486924|NCT03654729|27037358|FG001|Overall Study|Withdrawal by Subject|6|||
13486925|NCT03654729|27037359|FG002|Overall Study|Withdrawal by Subject|4|||
13486926|NCT03654729|27037357|FG000|Overall Study|Study terminated by Sponsor|3|||
13486927|NCT03654729|27037358|FG001|Overall Study|Study terminated by Sponsor|5|||
13486928|NCT03654729|27037359|FG002|Overall Study|Study terminated by Sponsor|4|||
13486929|NCT03654729|27037357|FG000|Overall Study|Not reported|2|||
13486930|NCT03654729|27037358|FG001|Overall Study|Not reported|4|||
13486931|NCT03654729|27037359|FG002|Overall Study|Not reported|5|||
13486932|NCT03654729|27037357|FG000|Overall Study|Progressive disease|3|||
13486933|NCT03654729|27037358|FG001|Overall Study|Progressive disease|0|||
13486934|NCT03654729|27037359|FG002|Overall Study|Progressive disease|0|||
13486935|NCT03654729|27037357|FG000|Overall Study|Lost to Follow-up|2|||
13486936|NCT03654729|27037358|FG001|Overall Study|Lost to Follow-up|0|||
13486937|NCT03654729|27037359|FG002|Overall Study|Lost to Follow-up|0|||
13486938|NCT03654729|27037357|FG000|Overall Study|Physician Decision|2|||
13486939|NCT03654729|27037358|FG001|Overall Study|Physician Decision|0|||
13486940|NCT03654729|27037359|FG002|Overall Study|Physician Decision|0|||
13486941|NCT03654729|27037357|FG000|Overall Study|Protocol Violation|1|||
13486942|NCT03654729|27037358|FG001|Overall Study|Protocol Violation|1|||
13486943|NCT03654729|27037359|FG002|Overall Study|Protocol Violation|0|||
13486944|NCT03654729|27037357|FG000|Overall Study|Non-compliance with study drug|0|||
13486945|NCT03654729|27037358|FG001|Overall Study|Non-compliance with study drug|1|||
13486946|NCT03654729|27037359|FG002|Overall Study|Non-compliance with study drug|0|||
13486947|NCT03654729|27037357|FG000|Overall Study|Site terminated by Sponsor|1|||
13479103|NCT03427411|27012832|FG000|Overall Study|Screen failure - platelets too low|0|||
13479104|NCT03427411|27012833|FG001|Overall Study|Screen failure - platelets too low|1|||
13479105|NCT03387150|27012934|FG000|Overall Study|Withdrawal by Subject|3|||
13479106|NCT03387150|27012935|FG001|Overall Study|Withdrawal by Subject|0|||
13479107|NCT03387150|27012936|FG002|Overall Study|Withdrawal by Subject|3|||
13479108|NCT03387150|27012937|FG003|Overall Study|Withdrawal by Subject|4|||
13479109|NCT03387150|27012938|FG004|Overall Study|Withdrawal by Subject|1|||
13479110|NCT03387150|27012939|FG005|Overall Study|Withdrawal by Subject|2|||
13479111|NCT03387150|27012940|FG006|Overall Study|Withdrawal by Subject|0|||
13479112|NCT03387150|27012934|FG000|Overall Study|Lost to Follow-up|3|||
13479113|NCT03387150|27012935|FG001|Overall Study|Lost to Follow-up|2|||
13479114|NCT03387150|27012936|FG002|Overall Study|Lost to Follow-up|2|||
13479115|NCT03387150|27012937|FG003|Overall Study|Lost to Follow-up|3|||
13479116|NCT03387150|27012938|FG004|Overall Study|Lost to Follow-up|3|||
13479117|NCT03387150|27012939|FG005|Overall Study|Lost to Follow-up|3|||
13479118|NCT03387150|27012940|FG006|Overall Study|Lost to Follow-up|0|||
13479119|NCT03387150|27012934|FG000|Overall Study|Participant unable to adhere to visit|0|||
13479120|NCT03387150|27012935|FG001|Overall Study|Participant unable to adhere to visit|1|||
13479121|NCT03387150|27012936|FG002|Overall Study|Participant unable to adhere to visit|0|||
13479122|NCT03387150|27012937|FG003|Overall Study|Participant unable to adhere to visit|0|||
13479123|NCT03387150|27012938|FG004|Overall Study|Participant unable to adhere to visit|2|||
13479124|NCT03387150|27012939|FG005|Overall Study|Participant unable to adhere to visit|2|||
13479125|NCT03387150|27012940|FG006|Overall Study|Participant unable to adhere to visit|0|||
13479126|NCT03366792|27012947|FG000|Overall Study|Withdrawal by Subject|7|||
13479127|NCT03366792|27012947|FG000|Overall Study|Lost to Follow-up|2|||
13479128|NCT03366792|27012947|FG000|Overall Study|Ineligible (could not reach perinium)|2|||
13479129|NCT03366792|27012947|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4|||
13479130|NCT03366337|27012970|FG000|Overall Study|Lost to Follow-up|1|||
13479131|NCT03366337|27012971|FG001|Overall Study|Lost to Follow-up|0|||
13479132|NCT03366337|27012972|FG002|Overall Study|Lost to Follow-up|1|||
13479133|NCT03366337|27012973|FG003|Overall Study|Lost to Follow-up|0|||
13479134|NCT03366337|27012970|FG000|Overall Study|Withdrawal by Subject|2|||
13479135|NCT03366337|27012971|FG001|Overall Study|Withdrawal by Subject|0|||
13479136|NCT03366337|27012972|FG002|Overall Study|Withdrawal by Subject|1|||
13479137|NCT03366337|27012973|FG003|Overall Study|Withdrawal by Subject|1|||
13479138|NCT03342053|27013000|FG000|Overall Study|Adverse Event|2|||
13479139|NCT03342053|27013001|FG001|Overall Study|Adverse Event|0|||
13479140|NCT03342053|27013000|FG000|Overall Study|Withdrawal by Subject|0|||
13479141|NCT03342053|27013001|FG001|Overall Study|Withdrawal by Subject|1|||
13479142|NCT03283241|27013034|FG000|Overall Study|Adverse Event|4|||
13479143|NCT03283241|27013035|FG001|Overall Study|Adverse Event|1|||
13479144|NCT03283241|27013034|FG000|Overall Study|Withdrawal by Subject|0|||
13479145|NCT03283241|27013035|FG001|Overall Study|Withdrawal by Subject|1|||
13479146|NCT03283241|27013034|FG000|Overall Study|Subject relocated to Finland|0|||
13479147|NCT03283241|27013035|FG001|Overall Study|Subject relocated to Finland|1|||
13479148|NCT03242772|27013054|FG000|Overall Study|Lost to Follow-up|2|||
13479149|NCT03242772|27013055|FG001|Overall Study|Lost to Follow-up|0|||
13479150|NCT03242772|27013054|FG000|Overall Study|Physician Decision|0|||
13479151|NCT03242772|27013055|FG001|Overall Study|Physician Decision|1|||
13479152|NCT03242772|27013054|FG000|Overall Study|Withdrawal by Subject|1|||
13479153|NCT03242772|27013055|FG001|Overall Study|Withdrawal by Subject|0|||
13479154|NCT03236311|27013072|FG000|Overall Study|Study terminated by sponsor|0|||
13479155|NCT03236311|27013073|FG001|Overall Study|Study terminated by sponsor|2|||
13479156|NCT03236311|27013072|FG000|Overall Study|Adverse Event|0|||
13479157|NCT03236311|27013073|FG001|Overall Study|Adverse Event|1|||
13479158|NCT03192046|27013090|FG000|Overall Study|Withdrawal by Subject|1|||
13479159|NCT03192046|27013091|FG001|Overall Study|Withdrawal by Subject|1|||
13479160|NCT03190369|27013116|FG000|Overall Study|Poor compliance to protocol|0|||
13479161|NCT03190369|27013117|FG001|Overall Study|Poor compliance to protocol|1|||
13479162|NCT03190369|27013116|FG000|Overall Study|Withdraw before treatment|1|||
13479163|NCT03190369|27013117|FG001|Overall Study|Withdraw before treatment|5|||
13479164|NCT03190369|27013116|FG000|Overall Study|Randomized but not treated|0|||
13479165|NCT03190369|27013117|FG001|Overall Study|Randomized but not treated|2|||
13479166|NCT04657198|27013157|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|1|||
13479167|NCT04657198|27013158|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
13479168|NCT04657198|27013159|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
13479169|NCT04590586|27013255|FG000|Overall Study|Death|7|||
13479170|NCT04590586|27013256|FG001|Overall Study|Death|1|||
13479171|NCT04590586|27013257|FG002|Overall Study|Death|37|||
13479172|NCT04590586|27013258|FG003|Overall Study|Death|34|||
13479173|NCT04590586|27013259|FG004|Overall Study|Death|19|||
13479174|NCT04590586|27013260|FG005|Overall Study|Death|3|||
13479175|NCT04590586|27013255|FG000|Overall Study|Lost to Follow-up|3|||
13479176|NCT04590586|27013256|FG001|Overall Study|Lost to Follow-up|0|||
13479177|NCT04590586|27013257|FG002|Overall Study|Lost to Follow-up|11|||
13479178|NCT04590586|27013258|FG003|Overall Study|Lost to Follow-up|11|||
13479179|NCT04590586|27013259|FG004|Overall Study|Lost to Follow-up|6|||
13479180|NCT04590586|27013260|FG005|Overall Study|Lost to Follow-up|0|||
13479181|NCT04590586|27013255|FG000|Overall Study|Withdrawal by Subject|0|||
13479182|NCT04590586|27013256|FG001|Overall Study|Withdrawal by Subject|0|||
13479183|NCT04590586|27013257|FG002|Overall Study|Withdrawal by Subject|6|||
13479184|NCT04590586|27013258|FG003|Overall Study|Withdrawal by Subject|0|||
13479185|NCT04590586|27013259|FG004|Overall Study|Withdrawal by Subject|3|||
13479186|NCT04590586|27013260|FG005|Overall Study|Withdrawal by Subject|0|||
13479187|NCT04590586|27013255|FG000|Overall Study|Other|3|||
13479188|NCT04590586|27013256|FG001|Overall Study|Other|0|||
13479189|NCT04590586|27013257|FG002|Overall Study|Other|1|||
13479190|NCT04590586|27013258|FG003|Overall Study|Other|1|||
13479191|NCT04590586|27013259|FG004|Overall Study|Other|2|||
13479192|NCT04590586|27013260|FG005|Overall Study|Other|1|||
13486948|NCT03654729|27037358|FG001|Overall Study|Site terminated by Sponsor|0|||
13486949|NCT03654729|27037359|FG002|Overall Study|Site terminated by Sponsor|0|||
13486950|NCT02976038|27037516|FG000|Overall Study|Physician Decision|22|||
13486951|NCT02976038|27037516|FG000|Overall Study|Withdrawal by Subject|3|||
13486952|NCT02976038|27037516|FG000|Overall Study|Lost to Follow-up|2|||
13486953|NCT02976038|27037516|FG000|Overall Study|Adverse Event|1|||
13486954|NCT02631070|27037583|FG000|Overall Study|Withdrawal by Subject|35|||
13486955|NCT02631070|27037584|FG001|Overall Study|Withdrawal by Subject|13|||
13486956|NCT02631070|27037583|FG000|Overall Study|Death|45|||
13486957|NCT02631070|27037584|FG001|Overall Study|Death|24|||
13486958|NCT02631070|27037583|FG000|Overall Study|Lost to Follow-up|5|||
13486959|NCT02631070|27037584|FG001|Overall Study|Lost to Follow-up|1|||
13486960|NCT02631070|27037583|FG000|Overall Study|Transition to rollover protocol|52|||
13486961|NCT02631070|27037584|FG001|Overall Study|Transition to rollover protocol|21|||
13486962|NCT02631070|27037583|FG000|Overall Study|Other reasons|12|||
13486963|NCT02631070|27037584|FG001|Overall Study|Other reasons|5|||
13486964|NCT02202434|27037721|FG000|Overall Study|Death|70|||
13486965|NCT02202434|27037722|FG001|Overall Study|Death|39|||
13486966|NCT02202434|27037723|FG002|Overall Study|Death|13|||
13486967|NCT02202434|27037724|FG003|Overall Study|Death|27|||
13486968|NCT02202434|27037721|FG000|Overall Study|Lost to Follow-up|1|||
13486969|NCT02202434|27037722|FG001|Overall Study|Lost to Follow-up|1|||
13486970|NCT02202434|27037723|FG002|Overall Study|Lost to Follow-up|1|||
13486971|NCT02202434|27037724|FG003|Overall Study|Lost to Follow-up|0|||
13486972|NCT02202434|27037721|FG000|Overall Study|Physician Decision|2|||
13486973|NCT02202434|27037722|FG001|Overall Study|Physician Decision|3|||
13486974|NCT02202434|27037723|FG002|Overall Study|Physician Decision|0|||
13486975|NCT02202434|27037724|FG003|Overall Study|Physician Decision|0|||
13486976|NCT02202434|27037721|FG000|Overall Study|Withdrawal by Subject|13|||
13486977|NCT02202434|27037722|FG001|Overall Study|Withdrawal by Subject|14|||
13486978|NCT02202434|27037723|FG002|Overall Study|Withdrawal by Subject|1|||
13486979|NCT02202434|27037724|FG003|Overall Study|Withdrawal by Subject|4|||
13486980|NCT02202434|27037721|FG000|Overall Study|Completed Study|1|||
13486981|NCT02202434|27037722|FG001|Overall Study|Completed Study|0|||
13486982|NCT02202434|27037723|FG002|Overall Study|Completed Study|0|||
13486983|NCT02202434|27037724|FG003|Overall Study|Completed Study|0|||
13486984|NCT02202434|27037721|FG000|Overall Study|Visit Missed|21|||
13486985|NCT02202434|27037722|FG001|Overall Study|Visit Missed|12|||
13486986|NCT02202434|27037723|FG002|Overall Study|Visit Missed|0|||
13486987|NCT02202434|27037724|FG003|Overall Study|Visit Missed|5|||
13486988|NCT02202434|27037721|FG000|Overall Study|Other|1|||
13486989|NCT02202434|27037722|FG001|Overall Study|Other|0|||
13486990|NCT02202434|27037723|FG002|Overall Study|Other|0|||
13486991|NCT02202434|27037724|FG003|Overall Study|Other|1|||
13488152|NCT03987919|27042982|FG000|Overall Study|Adverse Event|1|||
13488153|NCT03987919|27042983|FG001|Overall Study|Adverse Event|4|||
13488154|NCT03987919|27042984|FG002|Overall Study|Adverse Event|1|||
13488155|NCT03987919|27042985|FG003|Overall Study|Adverse Event|3|||
13488156|NCT03987919|27042982|FG000|Overall Study|Death|4|||
13488157|NCT03987919|27042983|FG001|Overall Study|Death|4|||
13488158|NCT03987919|27042984|FG002|Overall Study|Death|4|||
13488159|NCT03987919|27042985|FG003|Overall Study|Death|1|||
13488160|NCT03987919|27042982|FG000|Overall Study|Lost to Follow-up|5|||
13488161|NCT03987919|27042983|FG001|Overall Study|Lost to Follow-up|6|||
13488162|NCT03987919|27042984|FG002|Overall Study|Lost to Follow-up|8|||
13488163|NCT03987919|27042985|FG003|Overall Study|Lost to Follow-up|12|||
13488164|NCT03987919|27042982|FG000|Overall Study|Physician Decision|0|||
13488165|NCT03987919|27042983|FG001|Overall Study|Physician Decision|2|||
13488166|NCT03987919|27042984|FG002|Overall Study|Physician Decision|0|||
13488167|NCT03987919|27042985|FG003|Overall Study|Physician Decision|4|||
13488168|NCT03987919|27042982|FG000|Overall Study|Pregnancy|1|||
13488169|NCT03987919|27042983|FG001|Overall Study|Pregnancy|0|||
13488170|NCT03987919|27042984|FG002|Overall Study|Pregnancy|1|||
13488171|NCT03987919|27042985|FG003|Overall Study|Pregnancy|1|||
13488172|NCT03987919|27042982|FG000|Overall Study|Protocol Violation|0|||
13488173|NCT03987919|27042983|FG001|Overall Study|Protocol Violation|1|||
13488174|NCT03987919|27042984|FG002|Overall Study|Protocol Violation|0|||
13488175|NCT03987919|27042985|FG003|Overall Study|Protocol Violation|0|||
13479193|NCT04312009|27013299|FG000|Overall Study|Withdrawal by Subject|2|||
13479194|NCT04312009|27013300|FG001|Overall Study|Withdrawal by Subject|1|||
13479195|NCT03937466|27013351|FG000|Overall Study|not eligbile after the 2-week diary|9|||
13479196|NCT03937466|27013351|FG000|Overall Study|never returned their diary|6|||
13479197|NCT03937466|27013351|FG000|Overall Study|dropped out of study before getting Chilipad|5|||
13479198|NCT03937466|27013351|FG000|Overall Study|3 did not complete follow-up questionnaire.|3|||
13479199|NCT03850483|27013589|FG000|Treatment for Stage 1|Adverse Event|1|||
13479200|NCT03850483|27013590|FG001|Treatment for Stage 1|Adverse Event|1|||
13479201|NCT03850483|27013591|FG002|Treatment for Stage 1|Adverse Event|3|||
13479202|NCT03850483|27013592|FG003|Treatment for Stage 1|Adverse Event|0|||
13479203|NCT03850483|27013593|FG004|Treatment for Stage 1|Adverse Event|2|||
13479204|NCT03850483|27013594|FG005|Treatment for Stage 1|Adverse Event|0|||
13479205|NCT03850483|27013595|FG006|Treatment for Stage 1|Adverse Event|2|||
13479206|NCT03850483|27013596|FG007|Treatment for Stage 1|Adverse Event|2|||
13479207|NCT03850483|27013597|FG008|Treatment for Stage 1|Adverse Event|0|||
13479208|NCT03850483|27013598|FG009|Treatment for Stage 1|Adverse Event|0|||
13479209|NCT03850483|27013589|FG000|Treatment for Stage 1|Withdrawal by Subject|4|||
13479210|NCT03850483|27013590|FG001|Treatment for Stage 1|Withdrawal by Subject|4|||
13479211|NCT03850483|27013591|FG002|Treatment for Stage 1|Withdrawal by Subject|2|||
13479212|NCT03850483|27013592|FG003|Treatment for Stage 1|Withdrawal by Subject|2|||
13479213|NCT03850483|27013593|FG004|Treatment for Stage 1|Withdrawal by Subject|2|||
13479214|NCT03850483|27013594|FG005|Treatment for Stage 1|Withdrawal by Subject|1|||
13479215|NCT03850483|27013595|FG006|Treatment for Stage 1|Withdrawal by Subject|2|||
13479216|NCT03850483|27013596|FG007|Treatment for Stage 1|Withdrawal by Subject|3|||
13479217|NCT03850483|27013597|FG008|Treatment for Stage 1|Withdrawal by Subject|0|||
13479218|NCT03850483|27013598|FG009|Treatment for Stage 1|Withdrawal by Subject|0|||
13479219|NCT03850483|27013589|FG000|Treatment for Stage 1|Protocol Violation|1|||
13479220|NCT03850483|27013590|FG001|Treatment for Stage 1|Protocol Violation|0|||
13479221|NCT03850483|27013591|FG002|Treatment for Stage 1|Protocol Violation|0|||
13479222|NCT03850483|27013592|FG003|Treatment for Stage 1|Protocol Violation|0|||
13479223|NCT03850483|27013593|FG004|Treatment for Stage 1|Protocol Violation|0|||
13479224|NCT03850483|27013594|FG005|Treatment for Stage 1|Protocol Violation|0|||
13479225|NCT03850483|27013595|FG006|Treatment for Stage 1|Protocol Violation|1|||
13479226|NCT03850483|27013596|FG007|Treatment for Stage 1|Protocol Violation|0|||
13479227|NCT03850483|27013597|FG008|Treatment for Stage 1|Protocol Violation|0|||
13479228|NCT03850483|27013598|FG009|Treatment for Stage 1|Protocol Violation|0|||
13479229|NCT03850483|27013589|FG000|Treatment for Stage 1|Physician Decision|0|||
13479230|NCT03850483|27013590|FG001|Treatment for Stage 1|Physician Decision|0|||
13479231|NCT03850483|27013591|FG002|Treatment for Stage 1|Physician Decision|0|||
13479232|NCT03850483|27013592|FG003|Treatment for Stage 1|Physician Decision|0|||
13479233|NCT03850483|27013593|FG004|Treatment for Stage 1|Physician Decision|0|||
13479234|NCT03850483|27013594|FG005|Treatment for Stage 1|Physician Decision|1|||
13479235|NCT03850483|27013595|FG006|Treatment for Stage 1|Physician Decision|0|||
13479236|NCT03850483|27013596|FG007|Treatment for Stage 1|Physician Decision|0|||
13479237|NCT03850483|27013597|FG008|Treatment for Stage 1|Physician Decision|0|||
13479238|NCT03850483|27013598|FG009|Treatment for Stage 1|Physician Decision|0|||
13479239|NCT03850483|27013589|FG000|Treatment for Stage 1|Other|0|||
13479240|NCT03850483|27013590|FG001|Treatment for Stage 1|Other|0|||
13479241|NCT03850483|27013591|FG002|Treatment for Stage 1|Other|0|||
13479242|NCT03850483|27013592|FG003|Treatment for Stage 1|Other|0|||
13479243|NCT03850483|27013593|FG004|Treatment for Stage 1|Other|2|||
13479244|NCT03850483|27013594|FG005|Treatment for Stage 1|Other|1|||
13479245|NCT03850483|27013595|FG006|Treatment for Stage 1|Other|0|||
13479246|NCT03850483|27013596|FG007|Treatment for Stage 1|Other|0|||
13479247|NCT03850483|27013597|FG008|Treatment for Stage 1|Other|0|||
13479248|NCT03850483|27013598|FG009|Treatment for Stage 1|Other|0|||
13479249|NCT03850483|27013589|FG000|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
13479250|NCT03850483|27013590|FG001|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
13479251|NCT03850483|27013591|FG002|Treatment for Stage 1|Non-Compliance With Study Drug|1|||
13479252|NCT03850483|27013592|FG003|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
13479253|NCT03850483|27013593|FG004|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
13479254|NCT03850483|27013594|FG005|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
13479255|NCT03850483|27013595|FG006|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
13479256|NCT03850483|27013596|FG007|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
13479257|NCT03850483|27013597|FG008|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
13479258|NCT03850483|27013598|FG009|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
13479259|NCT03850483|27013589|FG000|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
13479260|NCT03850483|27013590|FG001|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
13479261|NCT03850483|27013591|FG002|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
13479262|NCT03850483|27013592|FG003|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
13479263|NCT03850483|27013593|FG004|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
13479264|NCT03850483|27013594|FG005|Treatment for Stage 1|No Longer Met Eligibility Criteria|1|||
13479265|NCT03850483|27013595|FG006|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
13479266|NCT03850483|27013596|FG007|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
13479267|NCT03850483|27013597|FG008|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
13479268|NCT03850483|27013598|FG009|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
13479269|NCT03850483|27013589|FG000|Treatment for Stage 1|Lost to Follow-up|0|||
13479270|NCT03850483|27013590|FG001|Treatment for Stage 1|Lost to Follow-up|1|||
13479271|NCT03850483|27013591|FG002|Treatment for Stage 1|Lost to Follow-up|1|||
13479272|NCT03850483|27013592|FG003|Treatment for Stage 1|Lost to Follow-up|1|||
13479273|NCT03850483|27013593|FG004|Treatment for Stage 1|Lost to Follow-up|0|||
13479274|NCT03850483|27013594|FG005|Treatment for Stage 1|Lost to Follow-up|1|||
13479275|NCT03850483|27013595|FG006|Treatment for Stage 1|Lost to Follow-up|2|||
13479276|NCT03850483|27013596|FG007|Treatment for Stage 1|Lost to Follow-up|0|||
13479277|NCT03850483|27013597|FG008|Treatment for Stage 1|Lost to Follow-up|0|||
13479278|NCT03850483|27013598|FG009|Treatment for Stage 1|Lost to Follow-up|0|||
13479279|NCT03850483|27013589|FG000|Treatment for Stage 1|Lack of Efficacy|1|||
13479280|NCT03850483|27013590|FG001|Treatment for Stage 1|Lack of Efficacy|2|||
13479281|NCT03850483|27013591|FG002|Treatment for Stage 1|Lack of Efficacy|2|||
13479282|NCT03850483|27013592|FG003|Treatment for Stage 1|Lack of Efficacy|3|||
13479283|NCT03850483|27013593|FG004|Treatment for Stage 1|Lack of Efficacy|2|||
13479284|NCT03850483|27013594|FG005|Treatment for Stage 1|Lack of Efficacy|4|||
13479285|NCT03850483|27013595|FG006|Treatment for Stage 1|Lack of Efficacy|3|||
13479286|NCT03850483|27013596|FG007|Treatment for Stage 1|Lack of Efficacy|1|||
13479287|NCT03850483|27013597|FG008|Treatment for Stage 1|Lack of Efficacy|0|||
13479288|NCT03850483|27013598|FG009|Treatment for Stage 1|Lack of Efficacy|0|||
13479289|NCT03850483|27013589|FG000|Treatment for Stage 1|Death|0|||
13479290|NCT03850483|27013590|FG001|Treatment for Stage 1|Death|0|||
13479291|NCT03850483|27013591|FG002|Treatment for Stage 1|Death|0|||
13479292|NCT03850483|27013592|FG003|Treatment for Stage 1|Death|0|||
13479293|NCT03850483|27013593|FG004|Treatment for Stage 1|Death|0|||
13479294|NCT03850483|27013594|FG005|Treatment for Stage 1|Death|1|||
13479295|NCT03850483|27013595|FG006|Treatment for Stage 1|Death|0|||
13479296|NCT03850483|27013596|FG007|Treatment for Stage 1|Death|0|||
13479297|NCT03850483|27013597|FG008|Treatment for Stage 1|Death|0|||
13479298|NCT03850483|27013598|FG009|Treatment for Stage 1|Death|0|||
13479299|NCT03850483|27013589|FG000|Treatment for Stage 1|Refused Further Treatment|1|||
13479300|NCT03850483|27013590|FG001|Treatment for Stage 1|Refused Further Treatment|0|||
13479301|NCT03850483|27013591|FG002|Treatment for Stage 1|Refused Further Treatment|2|||
13479302|NCT03850483|27013592|FG003|Treatment for Stage 1|Refused Further Treatment|0|||
13479303|NCT03850483|27013593|FG004|Treatment for Stage 1|Refused Further Treatment|1|||
13479304|NCT03850483|27013594|FG005|Treatment for Stage 1|Refused Further Treatment|0|||
13479305|NCT03850483|27013595|FG006|Treatment for Stage 1|Refused Further Treatment|1|||
13479306|NCT03850483|27013596|FG007|Treatment for Stage 1|Refused Further Treatment|0|||
13479307|NCT03850483|27013597|FG008|Treatment for Stage 1|Refused Further Treatment|0|||
13479308|NCT03850483|27013598|FG009|Treatment for Stage 1|Refused Further Treatment|0|||
13479309|NCT03850483|27013589|FG000|Treatment for Stage 1|Randomized but not Treated|0|||
13479310|NCT03850483|27013590|FG001|Treatment for Stage 1|Randomized but not Treated|0|||
13479311|NCT03850483|27013591|FG002|Treatment for Stage 1|Randomized but not Treated|0|||
13479312|NCT03850483|27013592|FG003|Treatment for Stage 1|Randomized but not Treated|0|||
13479313|NCT03850483|27013593|FG004|Treatment for Stage 1|Randomized but not Treated|0|||
13479314|NCT03850483|27013594|FG005|Treatment for Stage 1|Randomized but not Treated|1|||
13479315|NCT03850483|27013595|FG006|Treatment for Stage 1|Randomized but not Treated|0|||
13479316|NCT03850483|27013596|FG007|Treatment for Stage 1|Randomized but not Treated|0|||
13479317|NCT03850483|27013597|FG008|Treatment for Stage 1|Randomized but not Treated|0|||
13479318|NCT03850483|27013598|FG009|Treatment for Stage 1|Randomized but not Treated|0|||
13479319|NCT03850483|27013589|FG000|Follow-up for Stage 1|Withdrawal by Subject|0|||
13479320|NCT03850483|27013590|FG001|Follow-up for Stage 1|Withdrawal by Subject|0|||
13479321|NCT03850483|27013591|FG002|Follow-up for Stage 1|Withdrawal by Subject|0|||
13479322|NCT03850483|27013592|FG003|Follow-up for Stage 1|Withdrawal by Subject|0|||
13479323|NCT03850483|27013593|FG004|Follow-up for Stage 1|Withdrawal by Subject|0|||
13479324|NCT03850483|27013594|FG005|Follow-up for Stage 1|Withdrawal by Subject|0|||
13479325|NCT03850483|27013595|FG006|Follow-up for Stage 1|Withdrawal by Subject|1|||
13479326|NCT03850483|27013596|FG007|Follow-up for Stage 1|Withdrawal by Subject|2|||
13479327|NCT03850483|27013597|FG008|Follow-up for Stage 1|Withdrawal by Subject|0|||
13479328|NCT03850483|27013598|FG009|Follow-up for Stage 1|Withdrawal by Subject|0|||
13479329|NCT03850483|27013589|FG000|Follow-up for Stage 1|Physician Decision|0|||
13479330|NCT03850483|27013590|FG001|Follow-up for Stage 1|Physician Decision|0|||
13479331|NCT03850483|27013591|FG002|Follow-up for Stage 1|Physician Decision|0|||
13479332|NCT03850483|27013592|FG003|Follow-up for Stage 1|Physician Decision|0|||
13479333|NCT03850483|27013593|FG004|Follow-up for Stage 1|Physician Decision|1|||
13479334|NCT03850483|27013594|FG005|Follow-up for Stage 1|Physician Decision|0|||
13479335|NCT03850483|27013595|FG006|Follow-up for Stage 1|Physician Decision|1|||
13479336|NCT03850483|27013596|FG007|Follow-up for Stage 1|Physician Decision|0|||
13479337|NCT03850483|27013597|FG008|Follow-up for Stage 1|Physician Decision|0|||
13479338|NCT03850483|27013598|FG009|Follow-up for Stage 1|Physician Decision|0|||
13479339|NCT03850483|27013589|FG000|Follow-up for Stage 1|Lack of Efficacy|0|||
13479340|NCT03850483|27013590|FG001|Follow-up for Stage 1|Lack of Efficacy|0|||
13479341|NCT03850483|27013591|FG002|Follow-up for Stage 1|Lack of Efficacy|1|||
13479342|NCT03850483|27013592|FG003|Follow-up for Stage 1|Lack of Efficacy|0|||
13479343|NCT03850483|27013593|FG004|Follow-up for Stage 1|Lack of Efficacy|0|||
13479344|NCT03850483|27013594|FG005|Follow-up for Stage 1|Lack of Efficacy|0|||
13479345|NCT03850483|27013595|FG006|Follow-up for Stage 1|Lack of Efficacy|0|||
13479346|NCT03850483|27013596|FG007|Follow-up for Stage 1|Lack of Efficacy|1|||
13479347|NCT03850483|27013597|FG008|Follow-up for Stage 1|Lack of Efficacy|0|||
13479348|NCT03850483|27013598|FG009|Follow-up for Stage 1|Lack of Efficacy|0|||
13479349|NCT03850483|27013589|FG000|Follow-up for Stage 1|Adverse Event|0|||
13479350|NCT03850483|27013590|FG001|Follow-up for Stage 1|Adverse Event|0|||
13479351|NCT03850483|27013591|FG002|Follow-up for Stage 1|Adverse Event|1|||
13479352|NCT03850483|27013592|FG003|Follow-up for Stage 1|Adverse Event|0|||
13479353|NCT03850483|27013593|FG004|Follow-up for Stage 1|Adverse Event|0|||
13479354|NCT03850483|27013594|FG005|Follow-up for Stage 1|Adverse Event|1|||
13479355|NCT03850483|27013595|FG006|Follow-up for Stage 1|Adverse Event|0|||
13479356|NCT03850483|27013596|FG007|Follow-up for Stage 1|Adverse Event|0|||
13479357|NCT03850483|27013597|FG008|Follow-up for Stage 1|Adverse Event|0|||
13479358|NCT03850483|27013598|FG009|Follow-up for Stage 1|Adverse Event|0|||
13479359|NCT03850483|27013589|FG000|Follow-up for Stage 1|Refused Further Study Procedures|0|||
13479360|NCT03850483|27013590|FG001|Follow-up for Stage 1|Refused Further Study Procedures|1|||
13479361|NCT03850483|27013591|FG002|Follow-up for Stage 1|Refused Further Study Procedures|0|||
13479362|NCT03850483|27013592|FG003|Follow-up for Stage 1|Refused Further Study Procedures|0|||
13479363|NCT03850483|27013593|FG004|Follow-up for Stage 1|Refused Further Study Procedures|2|||
13479364|NCT03850483|27013594|FG005|Follow-up for Stage 1|Refused Further Study Procedures|2|||
13479365|NCT03850483|27013595|FG006|Follow-up for Stage 1|Refused Further Study Procedures|0|||
13479366|NCT03850483|27013596|FG007|Follow-up for Stage 1|Refused Further Study Procedures|0|||
13479367|NCT03850483|27013597|FG008|Follow-up for Stage 1|Refused Further Study Procedures|0|||
13479368|NCT03850483|27013598|FG009|Follow-up for Stage 1|Refused Further Study Procedures|0|||
13479369|NCT03850483|27013589|FG000|Follow-up for Stage 1|Other|0|||
13479370|NCT03850483|27013590|FG001|Follow-up for Stage 1|Other|2|||
13479371|NCT03850483|27013591|FG002|Follow-up for Stage 1|Other|0|||
13479372|NCT03850483|27013592|FG003|Follow-up for Stage 1|Other|2|||
13479373|NCT03850483|27013593|FG004|Follow-up for Stage 1|Other|0|||
13479374|NCT03850483|27013594|FG005|Follow-up for Stage 1|Other|1|||
13479375|NCT03850483|27013595|FG006|Follow-up for Stage 1|Other|0|||
13479376|NCT03850483|27013596|FG007|Follow-up for Stage 1|Other|0|||
13479377|NCT03850483|27013597|FG008|Follow-up for Stage 1|Other|0|||
13479378|NCT03850483|27013598|FG009|Follow-up for Stage 1|Other|0|||
13479379|NCT03850483|27013589|FG000|Treatment for Stage 2|Adverse Event|0|||
13479380|NCT03850483|27013590|FG001|Treatment for Stage 2|Adverse Event|0|||
13479381|NCT03850483|27013591|FG002|Treatment for Stage 2|Adverse Event|0|||
13479382|NCT03850483|27013592|FG003|Treatment for Stage 2|Adverse Event|0|||
13479383|NCT03850483|27013593|FG004|Treatment for Stage 2|Adverse Event|0|||
13479384|NCT03850483|27013594|FG005|Treatment for Stage 2|Adverse Event|0|||
13479385|NCT03850483|27013595|FG006|Treatment for Stage 2|Adverse Event|0|||
13479386|NCT03850483|27013596|FG007|Treatment for Stage 2|Adverse Event|0|||
13479387|NCT03850483|27013597|FG008|Treatment for Stage 2|Adverse Event|0|||
13479388|NCT03850483|27013598|FG009|Treatment for Stage 2|Adverse Event|1|||
13479389|NCT03850483|27013589|FG000|Treatment for Stage 2|Lack of Efficacy|0|||
13479390|NCT03850483|27013590|FG001|Treatment for Stage 2|Lack of Efficacy|0|||
13479391|NCT03850483|27013591|FG002|Treatment for Stage 2|Lack of Efficacy|0|||
13479392|NCT03850483|27013592|FG003|Treatment for Stage 2|Lack of Efficacy|0|||
13479393|NCT03850483|27013593|FG004|Treatment for Stage 2|Lack of Efficacy|0|||
13479394|NCT03850483|27013594|FG005|Treatment for Stage 2|Lack of Efficacy|0|||
13479395|NCT03850483|27013595|FG006|Treatment for Stage 2|Lack of Efficacy|0|||
13479396|NCT03850483|27013596|FG007|Treatment for Stage 2|Lack of Efficacy|0|||
13479397|NCT03850483|27013597|FG008|Treatment for Stage 2|Lack of Efficacy|1|||
13479398|NCT03850483|27013598|FG009|Treatment for Stage 2|Lack of Efficacy|0|||
13479399|NCT03850483|27013589|FG000|Treatment for Stage 2|Lost to Follow-up|0|||
13479400|NCT03850483|27013590|FG001|Treatment for Stage 2|Lost to Follow-up|0|||
13479401|NCT03850483|27013591|FG002|Treatment for Stage 2|Lost to Follow-up|0|||
13479402|NCT03850483|27013592|FG003|Treatment for Stage 2|Lost to Follow-up|0|||
13479403|NCT03850483|27013593|FG004|Treatment for Stage 2|Lost to Follow-up|0|||
13479404|NCT03850483|27013594|FG005|Treatment for Stage 2|Lost to Follow-up|0|||
13479405|NCT03850483|27013595|FG006|Treatment for Stage 2|Lost to Follow-up|0|||
13479406|NCT03850483|27013596|FG007|Treatment for Stage 2|Lost to Follow-up|0|||
13479407|NCT03850483|27013597|FG008|Treatment for Stage 2|Lost to Follow-up|0|||
13479408|NCT03850483|27013598|FG009|Treatment for Stage 2|Lost to Follow-up|3|||
13479409|NCT03850483|27013589|FG000|Treatment for Stage 2|Physician Decision|0|||
13479410|NCT03850483|27013590|FG001|Treatment for Stage 2|Physician Decision|0|||
13479411|NCT03850483|27013591|FG002|Treatment for Stage 2|Physician Decision|0|||
13479412|NCT03850483|27013592|FG003|Treatment for Stage 2|Physician Decision|0|||
13479413|NCT03850483|27013593|FG004|Treatment for Stage 2|Physician Decision|0|||
13479414|NCT03850483|27013594|FG005|Treatment for Stage 2|Physician Decision|0|||
13479415|NCT03850483|27013595|FG006|Treatment for Stage 2|Physician Decision|0|||
13479416|NCT03850483|27013596|FG007|Treatment for Stage 2|Physician Decision|0|||
13479417|NCT03850483|27013597|FG008|Treatment for Stage 2|Physician Decision|0|||
13479418|NCT03850483|27013598|FG009|Treatment for Stage 2|Physician Decision|1|||
13479419|NCT03850483|27013589|FG000|Treatment for Stage 2|Protocol Violation|0|||
13479420|NCT03850483|27013590|FG001|Treatment for Stage 2|Protocol Violation|0|||
13479421|NCT03850483|27013591|FG002|Treatment for Stage 2|Protocol Violation|0|||
13479422|NCT03850483|27013592|FG003|Treatment for Stage 2|Protocol Violation|0|||
13479423|NCT03850483|27013593|FG004|Treatment for Stage 2|Protocol Violation|0|||
13479424|NCT03850483|27013594|FG005|Treatment for Stage 2|Protocol Violation|0|||
13479425|NCT03850483|27013595|FG006|Treatment for Stage 2|Protocol Violation|0|||
13479426|NCT03850483|27013596|FG007|Treatment for Stage 2|Protocol Violation|0|||
13479427|NCT03850483|27013597|FG008|Treatment for Stage 2|Protocol Violation|1|||
13479428|NCT03850483|27013598|FG009|Treatment for Stage 2|Protocol Violation|0|||
13479429|NCT03850483|27013589|FG000|Treatment for Stage 2|Withdrawal by Subject|0|||
13479430|NCT03850483|27013590|FG001|Treatment for Stage 2|Withdrawal by Subject|0|||
13479431|NCT03850483|27013591|FG002|Treatment for Stage 2|Withdrawal by Subject|0|||
13479432|NCT03850483|27013592|FG003|Treatment for Stage 2|Withdrawal by Subject|0|||
13479433|NCT03850483|27013593|FG004|Treatment for Stage 2|Withdrawal by Subject|0|||
13479434|NCT03850483|27013594|FG005|Treatment for Stage 2|Withdrawal by Subject|0|||
13479435|NCT03850483|27013595|FG006|Treatment for Stage 2|Withdrawal by Subject|0|||
13479436|NCT03850483|27013596|FG007|Treatment for Stage 2|Withdrawal by Subject|0|||
13479437|NCT03850483|27013597|FG008|Treatment for Stage 2|Withdrawal by Subject|2|||
13479438|NCT03850483|27013598|FG009|Treatment for Stage 2|Withdrawal by Subject|5|||
13479439|NCT03850483|27013589|FG000|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
13479440|NCT03850483|27013590|FG001|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
13479441|NCT03850483|27013591|FG002|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
13479442|NCT03850483|27013592|FG003|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
13479443|NCT03850483|27013593|FG004|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
13479444|NCT03850483|27013594|FG005|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
13479445|NCT03850483|27013595|FG006|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
13479446|NCT03850483|27013596|FG007|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
13479447|NCT03850483|27013597|FG008|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
13479448|NCT03850483|27013598|FG009|Treatment for Stage 2|No Longer Meets Eligibility Criteria|1|||
13479449|NCT03850483|27013589|FG000|Treatment for Stage 2|Refused Further Treatment|0|||
13479450|NCT03850483|27013590|FG001|Treatment for Stage 2|Refused Further Treatment|0|||
13479451|NCT03850483|27013591|FG002|Treatment for Stage 2|Refused Further Treatment|0|||
13479452|NCT03850483|27013592|FG003|Treatment for Stage 2|Refused Further Treatment|0|||
13479453|NCT03850483|27013593|FG004|Treatment for Stage 2|Refused Further Treatment|0|||
13479454|NCT03850483|27013594|FG005|Treatment for Stage 2|Refused Further Treatment|0|||
13479455|NCT03850483|27013595|FG006|Treatment for Stage 2|Refused Further Treatment|0|||
13479456|NCT03850483|27013596|FG007|Treatment for Stage 2|Refused Further Treatment|0|||
13479457|NCT03850483|27013597|FG008|Treatment for Stage 2|Refused Further Treatment|1|||
13479458|NCT03850483|27013598|FG009|Treatment for Stage 2|Refused Further Treatment|0|||
13479459|NCT03850483|27013589|FG000|Follow-up For Stage 2|Lost to Follow-up|0|||
13479460|NCT03850483|27013590|FG001|Follow-up For Stage 2|Lost to Follow-up|0|||
13479461|NCT03850483|27013591|FG002|Follow-up For Stage 2|Lost to Follow-up|0|||
13479462|NCT03850483|27013592|FG003|Follow-up For Stage 2|Lost to Follow-up|0|||
13479463|NCT03850483|27013593|FG004|Follow-up For Stage 2|Lost to Follow-up|0|||
13479464|NCT03850483|27013594|FG005|Follow-up For Stage 2|Lost to Follow-up|0|||
13479465|NCT03850483|27013595|FG006|Follow-up For Stage 2|Lost to Follow-up|0|||
13479466|NCT03850483|27013596|FG007|Follow-up For Stage 2|Lost to Follow-up|0|||
13479467|NCT03850483|27013597|FG008|Follow-up For Stage 2|Lost to Follow-up|0|||
13479468|NCT03850483|27013598|FG009|Follow-up For Stage 2|Lost to Follow-up|1|||
13479469|NCT03850483|27013589|FG000|Follow-up For Stage 2|Other|0|||
13479470|NCT03850483|27013590|FG001|Follow-up For Stage 2|Other|0|||
13479471|NCT03850483|27013591|FG002|Follow-up For Stage 2|Other|0|||
13479472|NCT03850483|27013592|FG003|Follow-up For Stage 2|Other|0|||
13479473|NCT03850483|27013593|FG004|Follow-up For Stage 2|Other|0|||
13479474|NCT03850483|27013594|FG005|Follow-up For Stage 2|Other|0|||
13479475|NCT03850483|27013595|FG006|Follow-up For Stage 2|Other|0|||
13479476|NCT03850483|27013596|FG007|Follow-up For Stage 2|Other|0|||
13479477|NCT03850483|27013597|FG008|Follow-up For Stage 2|Other|0|||
13479478|NCT03850483|27013598|FG009|Follow-up For Stage 2|Other|1|||
13479479|NCT03473925|27013676|FG000|Overall Study|Death|48|||
13479480|NCT03473925|27013677|FG001|Overall Study|Death|44|||
13479481|NCT03473925|27013676|FG000|Overall Study|Sponsor Decision|2|||
13479482|NCT03473925|27013677|FG001|Overall Study|Sponsor Decision|7|||
13479483|NCT03473925|27013676|FG000|Overall Study|Withdrawal by Subject|1|||
13479484|NCT03473925|27013677|FG001|Overall Study|Withdrawal by Subject|3|||
13479485|NCT03473925|27013676|FG000|Overall Study|Not Treated|1|||
13479486|NCT03473925|27013677|FG001|Overall Study|Not Treated|1|||
13479487|NCT03230097|27013698|FG000|Overall Study|Adverse Event|2|||
13479488|NCT03230097|27013699|FG001|Overall Study|Adverse Event|1|||
13479489|NCT03230097|27013698|FG000|Overall Study|non-compliance|0|||
13479490|NCT03230097|27013699|FG001|Overall Study|non-compliance|1|||
13479491|NCT03230097|27013698|FG000|Overall Study|Lost to Follow-up|2|||
13479492|NCT03230097|27013699|FG001|Overall Study|Lost to Follow-up|4|||
13479493|NCT03230097|27013698|FG000|Overall Study|Withdrawal by Subject|7|||
13479494|NCT03230097|27013699|FG001|Overall Study|Withdrawal by Subject|3|||
13479495|NCT03230097|27013698|FG000|Overall Study|Trial termination|4|||
13479496|NCT03230097|27013699|FG001|Overall Study|Trial termination|5|||
13479497|NCT03230097|27013698|FG000|Overall Study|Covid-19 pandemic outbreak|0|||
13479498|NCT03230097|27013699|FG001|Overall Study|Covid-19 pandemic outbreak|1|||
13479499|NCT03230097|27013698|FG000|Overall Study|outcome event|0|||
13479500|NCT03230097|27013699|FG001|Overall Study|outcome event|1|||
13479501|NCT02803593|27013808|FG000|Overall Study|Lost to Follow-up|17|||
13479502|NCT02803593|27013809|FG001|Overall Study|Lost to Follow-up|35|||
13479503|NCT02663908|27013858|FG000|Overall Study|Withdrawal by Subject|8|||
13479504|NCT02663908|27013859|FG001|Overall Study|Withdrawal by Subject|5|||
13479505|NCT02663908|27013858|FG000|Overall Study|Lost to Follow-up|1|||
13479506|NCT02663908|27013859|FG001|Overall Study|Lost to Follow-up|5|||
13479507|NCT02663908|27013858|FG000|Overall Study|Adverse Event|13|||
13479508|NCT02663908|27013859|FG001|Overall Study|Adverse Event|11|||
13479509|NCT02663908|27013858|FG000|Overall Study|Protocol Violation|1|||
13479510|NCT02663908|27013859|FG001|Overall Study|Protocol Violation|2|||
13479511|NCT02663908|27013858|FG000|Overall Study|Lack of therapeutic response|2|||
13479512|NCT02663908|27013859|FG001|Overall Study|Lack of therapeutic response|0|||
13479513|NCT02663908|27013858|FG000|Overall Study|COVID-19|1|||
13479514|NCT02663908|27013859|FG001|Overall Study|COVID-19|0|||
13479515|NCT02663908|27013858|FG000|Overall Study|Site closed|1|||
13479516|NCT02663908|27013859|FG001|Overall Study|Site closed|0|||
13479517|NCT02663908|27013858|FG000|Overall Study|Subject to begin treatment with an exclusionary medication|1|||
13479518|NCT02663908|27013859|FG001|Overall Study|Subject to begin treatment with an exclusionary medication|0|||
13479519|NCT02663908|27013858|FG000|Overall Study|Subject ended trial due to being prescribed prohibited medication|1|||
13479520|NCT02663908|27013859|FG001|Overall Study|Subject ended trial due to being prescribed prohibited medication|0|||
13479521|NCT02663908|27013858|FG000|Overall Study|Intolerance to FIRMAGON therapy|1|||
13479522|NCT02663908|27013859|FG001|Overall Study|Intolerance to FIRMAGON therapy|0|||
13479523|NCT02663908|27013858|FG000|Overall Study|Death|1|||
13479524|NCT02663908|27013859|FG001|Overall Study|Death|0|||
13479525|NCT02663908|27013858|FG000|Overall Study|Subject randomized in error and did not receive the IMP|1|||
13479526|NCT02663908|27013859|FG001|Overall Study|Subject randomized in error and did not receive the IMP|0|||
13479527|NCT02663908|27013858|FG000|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|0|||
13479528|NCT02663908|27013859|FG001|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|1|||
13479529|NCT02650284|27013884|FG000|Overall Study|Lost to Follow-up|3|||
13479530|NCT02650284|27013885|FG001|Overall Study|Lost to Follow-up|3|||
13479531|NCT02650284|27013884|FG000|Overall Study|Consent incorrectly taken|0|||
13479532|NCT02650284|27013885|FG001|Overall Study|Consent incorrectly taken|1|||
13479533|NCT02175030|27013900|FG000|Overall Study|Failed screen after consent|7|||
13479534|NCT02175030|27013901|FG001|Overall Study|Failed screen after consent|6|||
13479535|NCT02175030|27013900|FG000|Overall Study|Failed IUD Insertion|20|||
13479536|NCT02175030|27013901|FG001|Overall Study|Failed IUD Insertion|21|||
13479537|NCT02175030|27013900|FG000|Overall Study|Physician Decision|1|||
13479538|NCT02175030|27013901|FG001|Overall Study|Physician Decision|1|||
13479539|NCT02175030|27013900|FG000|Overall Study|Lost to Follow-up|6|||
13479540|NCT02175030|27013901|FG001|Overall Study|Lost to Follow-up|6|||
13479541|NCT02175030|27013900|FG000|Overall Study|Withdrawal by Subject|1|||
13479542|NCT02175030|27013901|FG001|Overall Study|Withdrawal by Subject|4|||
13479543|NCT02017717|27013987|FG000|Before Treatment Period|Adverse Event unrelated to study drug|0|||
13479544|NCT02017717|27013988|FG001|Before Treatment Period|Adverse Event unrelated to study drug|0|||
13479545|NCT02017717|27013989|FG002|Before Treatment Period|Adverse Event unrelated to study drug|0|||
13479546|NCT02017717|27013990|FG003|Before Treatment Period|Adverse Event unrelated to study drug|1|||
13479547|NCT02017717|27013991|FG004|Before Treatment Period|Adverse Event unrelated to study drug|0|||
13479548|NCT02017717|27013992|FG005|Before Treatment Period|Adverse Event unrelated to study drug|0|||
13479549|NCT02017717|27013993|FG006|Before Treatment Period|Adverse Event unrelated to study drug|0|||
13479550|NCT02017717|27013994|FG007|Before Treatment Period|Adverse Event unrelated to study drug|0|||
13479551|NCT02017717|27013995|FG008|Before Treatment Period|Adverse Event unrelated to study drug|0|||
13479552|NCT02017717|27013987|FG000|Before Treatment Period|Participant request to stop therapy|0|||
13479553|NCT02017717|27013988|FG001|Before Treatment Period|Participant request to stop therapy|0|||
13479554|NCT02017717|27013989|FG002|Before Treatment Period|Participant request to stop therapy|0|||
13479555|NCT02017717|27013990|FG003|Before Treatment Period|Participant request to stop therapy|0|||
13486992|NCT01230242|27037736|FG000|Overall Study|Physician Decision|2|||
13479556|NCT02017717|27013991|FG004|Before Treatment Period|Participant request to stop therapy|5|||
13479557|NCT02017717|27013992|FG005|Before Treatment Period|Participant request to stop therapy|0|||
13479558|NCT02017717|27013993|FG006|Before Treatment Period|Participant request to stop therapy|0|||
13479559|NCT02017717|27013994|FG007|Before Treatment Period|Participant request to stop therapy|0|||
13479560|NCT02017717|27013995|FG008|Before Treatment Period|Participant request to stop therapy|0|||
13479561|NCT02017717|27013987|FG000|Before Treatment Period|Participant withdrew consent|0|||
13479562|NCT02017717|27013988|FG001|Before Treatment Period|Participant withdrew consent|0|||
13479563|NCT02017717|27013989|FG002|Before Treatment Period|Participant withdrew consent|0|||
13479564|NCT02017717|27013990|FG003|Before Treatment Period|Participant withdrew consent|0|||
13479565|NCT02017717|27013991|FG004|Before Treatment Period|Participant withdrew consent|11|||
13479566|NCT02017717|27013992|FG005|Before Treatment Period|Participant withdrew consent|0|||
13479567|NCT02017717|27013993|FG006|Before Treatment Period|Participant withdrew consent|0|||
13479568|NCT02017717|27013994|FG007|Before Treatment Period|Participant withdrew consent|0|||
13479569|NCT02017717|27013995|FG008|Before Treatment Period|Participant withdrew consent|2|||
13479570|NCT02017717|27013987|FG000|Before Treatment Period|Lost to Follow-up|0|||
13479571|NCT02017717|27013988|FG001|Before Treatment Period|Lost to Follow-up|0|||
13479572|NCT02017717|27013989|FG002|Before Treatment Period|Lost to Follow-up|0|||
13479573|NCT02017717|27013990|FG003|Before Treatment Period|Lost to Follow-up|0|||
13479574|NCT02017717|27013991|FG004|Before Treatment Period|Lost to Follow-up|1|||
13479575|NCT02017717|27013992|FG005|Before Treatment Period|Lost to Follow-up|0|||
13479576|NCT02017717|27013993|FG006|Before Treatment Period|Lost to Follow-up|0|||
13479577|NCT02017717|27013994|FG007|Before Treatment Period|Lost to Follow-up|0|||
13479578|NCT02017717|27013995|FG008|Before Treatment Period|Lost to Follow-up|0|||
13479579|NCT02017717|27013987|FG000|Before Treatment Period|Participant no longer met criteria|0|||
13479580|NCT02017717|27013988|FG001|Before Treatment Period|Participant no longer met criteria|0|||
13479581|NCT02017717|27013989|FG002|Before Treatment Period|Participant no longer met criteria|0|||
13479582|NCT02017717|27013990|FG003|Before Treatment Period|Participant no longer met criteria|1|||
13479583|NCT02017717|27013991|FG004|Before Treatment Period|Participant no longer met criteria|2|||
13479584|NCT02017717|27013992|FG005|Before Treatment Period|Participant no longer met criteria|0|||
13479585|NCT02017717|27013993|FG006|Before Treatment Period|Participant no longer met criteria|0|||
13479586|NCT02017717|27013994|FG007|Before Treatment Period|Participant no longer met criteria|1|||
13479587|NCT02017717|27013995|FG008|Before Treatment Period|Participant no longer met criteria|0|||
13479588|NCT02017717|27013987|FG000|Before Treatment Period|other reason|0|||
13479589|NCT02017717|27013988|FG001|Before Treatment Period|other reason|0|||
13479590|NCT02017717|27013989|FG002|Before Treatment Period|other reason|0|||
13479591|NCT02017717|27013990|FG003|Before Treatment Period|other reason|0|||
13479592|NCT02017717|27013991|FG004|Before Treatment Period|other reason|1|||
13479593|NCT02017717|27013992|FG005|Before Treatment Period|other reason|0|||
13479594|NCT02017717|27013993|FG006|Before Treatment Period|other reason|0|||
13479595|NCT02017717|27013994|FG007|Before Treatment Period|other reason|0|||
13479596|NCT02017717|27013995|FG008|Before Treatment Period|other reason|0|||
13479597|NCT02017717|27013987|FG000|Treatment Period|Disease progression|7|||
13479598|NCT02017717|27013988|FG001|Treatment Period|Disease progression|9|||
13479599|NCT02017717|27013989|FG002|Treatment Period|Disease progression|12|||
13479600|NCT02017717|27013990|FG003|Treatment Period|Disease progression|165|||
13479601|NCT02017717|27013991|FG004|Treatment Period|Disease progression|134|||
13479602|NCT02017717|27013992|FG005|Treatment Period|Disease progression|20|||
13479603|NCT02017717|27013993|FG006|Treatment Period|Disease progression|26|||
13479604|NCT02017717|27013994|FG007|Treatment Period|Disease progression|17|||
13479605|NCT02017717|27013995|FG008|Treatment Period|Disease progression|22|||
13479606|NCT02017717|27013987|FG000|Treatment Period|Study drug toxicity|3|||
13479607|NCT02017717|27013988|FG001|Treatment Period|Study drug toxicity|0|||
13479608|NCT02017717|27013989|FG002|Treatment Period|Study drug toxicity|1|||
13479609|NCT02017717|27013990|FG003|Treatment Period|Study drug toxicity|7|||
13479610|NCT02017717|27013991|FG004|Treatment Period|Study drug toxicity|11|||
13479611|NCT02017717|27013992|FG005|Treatment Period|Study drug toxicity|4|||
13479612|NCT02017717|27013993|FG006|Treatment Period|Study drug toxicity|4|||
13479613|NCT02017717|27013994|FG007|Treatment Period|Study drug toxicity|5|||
13479614|NCT02017717|27013995|FG008|Treatment Period|Study drug toxicity|3|||
13479615|NCT02017717|27013987|FG000|Treatment Period|Death|0|||
13479616|NCT02017717|27013988|FG001|Treatment Period|Death|0|||
13479617|NCT02017717|27013989|FG002|Treatment Period|Death|1|||
13479618|NCT02017717|27013990|FG003|Treatment Period|Death|0|||
13479619|NCT02017717|27013991|FG004|Treatment Period|Death|0|||
13479620|NCT02017717|27013992|FG005|Treatment Period|Death|0|||
13479621|NCT02017717|27013993|FG006|Treatment Period|Death|0|||
13479622|NCT02017717|27013994|FG007|Treatment Period|Death|1|||
13479623|NCT02017717|27013995|FG008|Treatment Period|Death|0|||
13479624|NCT02017717|27013987|FG000|Treatment Period|Adverse event unrelated to study drug|0|||
13479625|NCT02017717|27013988|FG001|Treatment Period|Adverse event unrelated to study drug|0|||
13479626|NCT02017717|27013989|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
13479627|NCT02017717|27013990|FG003|Treatment Period|Adverse event unrelated to study drug|4|||
13479628|NCT02017717|27013991|FG004|Treatment Period|Adverse event unrelated to study drug|5|||
13479629|NCT02017717|27013992|FG005|Treatment Period|Adverse event unrelated to study drug|0|||
13479630|NCT02017717|27013993|FG006|Treatment Period|Adverse event unrelated to study drug|0|||
13479631|NCT02017717|27013994|FG007|Treatment Period|Adverse event unrelated to study drug|0|||
13479632|NCT02017717|27013995|FG008|Treatment Period|Adverse event unrelated to study drug|1|||
13479633|NCT02017717|27013987|FG000|Treatment Period|Participant request to stop therapy|0|||
13479634|NCT02017717|27013988|FG001|Treatment Period|Participant request to stop therapy|0|||
13479635|NCT02017717|27013989|FG002|Treatment Period|Participant request to stop therapy|3|||
13479636|NCT02017717|27013990|FG003|Treatment Period|Participant request to stop therapy|4|||
13479637|NCT02017717|27013991|FG004|Treatment Period|Participant request to stop therapy|7|||
13479638|NCT02017717|27013992|FG005|Treatment Period|Participant request to stop therapy|5|||
13479639|NCT02017717|27013993|FG006|Treatment Period|Participant request to stop therapy|0|||
13479640|NCT02017717|27013994|FG007|Treatment Period|Participant request to stop therapy|2|||
13479641|NCT02017717|27013995|FG008|Treatment Period|Participant request to stop therapy|1|||
13479642|NCT02017717|27013987|FG000|Treatment Period|Participant withdrew consent|0|||
13479643|NCT02017717|27013988|FG001|Treatment Period|Participant withdrew consent|0|||
13479644|NCT02017717|27013989|FG002|Treatment Period|Participant withdrew consent|1|||
13479645|NCT02017717|27013990|FG003|Treatment Period|Participant withdrew consent|1|||
13479646|NCT02017717|27013991|FG004|Treatment Period|Participant withdrew consent|4|||
13479647|NCT02017717|27013992|FG005|Treatment Period|Participant withdrew consent|0|||
13479648|NCT02017717|27013993|FG006|Treatment Period|Participant withdrew consent|0|||
13479649|NCT02017717|27013994|FG007|Treatment Period|Participant withdrew consent|2|||
13479650|NCT02017717|27013995|FG008|Treatment Period|Participant withdrew consent|0|||
13479651|NCT02017717|27013987|FG000|Treatment Period|Participant no longer met criteria|0|||
13479652|NCT02017717|27013988|FG001|Treatment Period|Participant no longer met criteria|0|||
13479653|NCT02017717|27013989|FG002|Treatment Period|Participant no longer met criteria|0|||
13479654|NCT02017717|27013990|FG003|Treatment Period|Participant no longer met criteria|0|||
13479655|NCT02017717|27013991|FG004|Treatment Period|Participant no longer met criteria|1|||
13479656|NCT02017717|27013992|FG005|Treatment Period|Participant no longer met criteria|0|||
13479657|NCT02017717|27013993|FG006|Treatment Period|Participant no longer met criteria|0|||
13479658|NCT02017717|27013994|FG007|Treatment Period|Participant no longer met criteria|0|||
13479659|NCT02017717|27013995|FG008|Treatment Period|Participant no longer met criteria|0|||
13479660|NCT02017717|27013987|FG000|Treatment Period|other reasons|0|||
13479661|NCT02017717|27013988|FG001|Treatment Period|other reasons|0|||
13479662|NCT02017717|27013989|FG002|Treatment Period|other reasons|0|||
13479663|NCT02017717|27013990|FG003|Treatment Period|other reasons|0|||
13479664|NCT02017717|27013991|FG004|Treatment Period|other reasons|1|||
13479665|NCT02017717|27013992|FG005|Treatment Period|other reasons|0|||
13479666|NCT02017717|27013993|FG006|Treatment Period|other reasons|0|||
13479667|NCT02017717|27013994|FG007|Treatment Period|other reasons|1|||
13479668|NCT02017717|27013995|FG008|Treatment Period|other reasons|1|||
13479669|NCT02017717|27013987|FG000|Treatment Period|Maximum clinical benefit|0|||
13479670|NCT02017717|27013988|FG001|Treatment Period|Maximum clinical benefit|0|||
13479671|NCT02017717|27013989|FG002|Treatment Period|Maximum clinical benefit|0|||
13479672|NCT02017717|27013990|FG003|Treatment Period|Maximum clinical benefit|0|||
13479673|NCT02017717|27013991|FG004|Treatment Period|Maximum clinical benefit|1|||
13479674|NCT02017717|27013992|FG005|Treatment Period|Maximum clinical benefit|0|||
13479675|NCT02017717|27013993|FG006|Treatment Period|Maximum clinical benefit|0|||
13479676|NCT02017717|27013994|FG007|Treatment Period|Maximum clinical benefit|0|||
13479677|NCT02017717|27013995|FG008|Treatment Period|Maximum clinical benefit|0|||
13479678|NCT00316888|27014056|FG000|Overall Study|Adverse Event|4|||
13479679|NCT00316888|27014057|FG001|Overall Study|Adverse Event|5|||
13479680|NCT00316888|27014056|FG000|Overall Study|Withdrawal by Subject|2|||
13479681|NCT00316888|27014057|FG001|Overall Study|Withdrawal by Subject|2|||
13479682|NCT00316888|27014056|FG000|Overall Study|Not start protocol therapy|0|||
13479683|NCT00316888|27014057|FG001|Overall Study|Not start protocol therapy|1|||
13479684|NCT03178487|27014098|FG000|Overall Study|Adverse Event|1|||
13479685|NCT03178487|27014099|FG001|Overall Study|Adverse Event|1|||
13479686|NCT03178487|27014098|FG000|Overall Study|Withdrawal by Subject|2|||
13479687|NCT03178487|27014099|FG001|Overall Study|Withdrawal by Subject|1|||
13479688|NCT03178487|27014098|FG000|Overall Study|Lost to Follow-up|1|||
13479689|NCT03178487|27014099|FG001|Overall Study|Lost to Follow-up|0|||
13479690|NCT03178487|27014098|FG000|Overall Study|Other|0|||
13479691|NCT03178487|27014099|FG001|Overall Study|Other|2|||
13479692|NCT03096834|27014127|FG000|Double-Blind Treatment Epoch|Protocol deviation|2|||
13479693|NCT03096834|27014128|FG001|Double-Blind Treatment Epoch|Protocol deviation|1|||
13479694|NCT03096834|27014129|FG002|Double-Blind Treatment Epoch|Protocol deviation|0|||
13479695|NCT03096834|27014130|FG003|Double-Blind Treatment Epoch|Protocol deviation|0|||
13479696|NCT03096834|27014127|FG000|Double-Blind Treatment Epoch|Pregnancy|0|||
13479697|NCT03096834|27014128|FG001|Double-Blind Treatment Epoch|Pregnancy|1|||
13479698|NCT03096834|27014129|FG002|Double-Blind Treatment Epoch|Pregnancy|0|||
13479699|NCT03096834|27014130|FG003|Double-Blind Treatment Epoch|Pregnancy|0|||
13479700|NCT03096834|27014127|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
13479701|NCT03096834|27014128|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
13479702|NCT03096834|27014129|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
13479703|NCT03096834|27014130|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
13479704|NCT03096834|27014127|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0|||
13479705|NCT03096834|27014128|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0|||
13479706|NCT03096834|27014129|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15|||
13479707|NCT03096834|27014130|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15|||
13479708|NCT03096834|27014127|FG000|Open-Label Treatment Epoch|Adverse Event|0|||
13479709|NCT03096834|27014128|FG001|Open-Label Treatment Epoch|Adverse Event|0|||
13479710|NCT03096834|27014129|FG002|Open-Label Treatment Epoch|Adverse Event|5|||
13479711|NCT03096834|27014130|FG003|Open-Label Treatment Epoch|Adverse Event|6|||
13479712|NCT03096834|27014127|FG000|Open-Label Treatment Epoch|New therapy for study indication|0|||
13479713|NCT03096834|27014128|FG001|Open-Label Treatment Epoch|New therapy for study indication|0|||
13479714|NCT03096834|27014129|FG002|Open-Label Treatment Epoch|New therapy for study indication|1|||
13479715|NCT03096834|27014130|FG003|Open-Label Treatment Epoch|New therapy for study indication|1|||
13479716|NCT03096834|27014127|FG000|Open-Label Treatment Epoch|Physician Decision|0|||
13479717|NCT03096834|27014128|FG001|Open-Label Treatment Epoch|Physician Decision|0|||
13479718|NCT03096834|27014129|FG002|Open-Label Treatment Epoch|Physician Decision|1|||
13479719|NCT03096834|27014130|FG003|Open-Label Treatment Epoch|Physician Decision|0|||
13479720|NCT03096834|27014127|FG000|Open-Label Treatment Epoch|Pregnancy|0|||
13479721|NCT03096834|27014128|FG001|Open-Label Treatment Epoch|Pregnancy|0|||
13479722|NCT03096834|27014129|FG002|Open-Label Treatment Epoch|Pregnancy|1|||
13479723|NCT03096834|27014130|FG003|Open-Label Treatment Epoch|Pregnancy|0|||
13479724|NCT03096834|27014127|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0|||
13479725|NCT03096834|27014128|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0|||
13479726|NCT03096834|27014129|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9|||
13479727|NCT03096834|27014130|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17|||
13479728|NCT03096834|27014127|FG000|Safety Follow-Up Epoch|New therapy for study indication|0|||
13479729|NCT03096834|27014128|FG001|Safety Follow-Up Epoch|New therapy for study indication|0|||
13479730|NCT03096834|27014129|FG002|Safety Follow-Up Epoch|New therapy for study indication|0|||
13479731|NCT03096834|27014130|FG003|Safety Follow-Up Epoch|New therapy for study indication|1|||
13479732|NCT03096834|27014127|FG000|Safety Follow-Up Epoch|Protocol deviation|0|||
13479733|NCT03096834|27014128|FG001|Safety Follow-Up Epoch|Protocol deviation|0|||
13479734|NCT03096834|27014129|FG002|Safety Follow-Up Epoch|Protocol deviation|0|||
13479735|NCT03096834|27014130|FG003|Safety Follow-Up Epoch|Protocol deviation|1|||
13479736|NCT03096834|27014127|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0|||
13479737|NCT03096834|27014128|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0|||
13479738|NCT03096834|27014129|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1|||
13479739|NCT03096834|27014130|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0|||
13479740|NCT03070392|27014156|FG000|Overall Study|Not Treated|7|||
13479741|NCT03070392|27014157|FG001|Overall Study|Not Treated|0|||
13479742|NCT03070392|27014158|FG002|Overall Study|Not Treated|3|||
13479743|NCT03070392|27014159|FG003|Overall Study|Not Treated|12|||
13479744|NCT03070392|27014156|FG000|Overall Study|Death|3|||
13479745|NCT03070392|27014157|FG001|Overall Study|Death|0|||
13479746|NCT03070392|27014158|FG002|Overall Study|Death|0|||
13479747|NCT03070392|27014159|FG003|Overall Study|Death|1|||
13479748|NCT03070392|27014156|FG000|Overall Study|Withdrawal by Subject|7|||
13479749|NCT03070392|27014157|FG001|Overall Study|Withdrawal by Subject|0|||
13479750|NCT03070392|27014158|FG002|Overall Study|Withdrawal by Subject|0|||
13479751|NCT03070392|27014159|FG003|Overall Study|Withdrawal by Subject|3|||
13479752|NCT03070392|27014156|FG000|Overall Study|Physician Decision|1|||
13479753|NCT03070392|27014157|FG001|Overall Study|Physician Decision|0|||
13479754|NCT03070392|27014158|FG002|Overall Study|Physician Decision|0|||
13479755|NCT03070392|27014159|FG003|Overall Study|Physician Decision|2|||
13479756|NCT03070392|27014156|FG000|Overall Study|Progressive Disease|154|||
13479757|NCT03070392|27014157|FG001|Overall Study|Progressive Disease|6|||
13479758|NCT03070392|27014158|FG002|Overall Study|Progressive Disease|2|||
13479759|NCT03070392|27014159|FG003|Overall Study|Progressive Disease|70|||
13479760|NCT03070392|27014156|FG000|Overall Study|Adverse Event|6|||
13479761|NCT03070392|27014157|FG001|Overall Study|Adverse Event|1|||
13479762|NCT03070392|27014158|FG002|Overall Study|Adverse Event|1|||
13479763|NCT03070392|27014159|FG003|Overall Study|Adverse Event|3|||
13479764|NCT03070392|27014156|FG000|Overall Study|Alternate anticancer treatment|1|||
13479765|NCT03070392|27014157|FG001|Overall Study|Alternate anticancer treatment|0|||
13479766|NCT03070392|27014158|FG002|Overall Study|Alternate anticancer treatment|0|||
13479767|NCT03070392|27014159|FG003|Overall Study|Alternate anticancer treatment|1|||
13479768|NCT03070392|27014156|FG000|Overall Study|Ongoing|73|||
13479769|NCT03070392|27014157|FG001|Overall Study|Ongoing|0|||
13479770|NCT03070392|27014158|FG002|Overall Study|Ongoing|0|||
13479771|NCT03070392|27014159|FG003|Overall Study|Ongoing|11|||
13486993|NCT01230242|27037736|FG000|Overall Study|Withdrawal by Subject|1|||
13479772|NCT03015194|27014166|FG000|Overall Study|Death|10|||
13479773|NCT03015194|27014166|FG000|Overall Study|Withdrawal by Subject|2|||
13479774|NCT03012815|27014193|FG000|Overall Study|Lost to Follow-up|1|||
13479775|NCT03012815|27014194|FG001|Overall Study|Lost to Follow-up|0|||
13479776|NCT03012815|27014193|FG000|Overall Study|Physician Decision|3|||
13479777|NCT03012815|27014194|FG001|Overall Study|Physician Decision|2|||
13479778|NCT03012815|27014193|FG000|Overall Study|Adverse Event|1|||
13479779|NCT03012815|27014194|FG001|Overall Study|Adverse Event|0|||
13479780|NCT03001011|27014233|FG000|Overall Study|Adverse Event|9|||
13479781|NCT03001011|27014234|FG001|Overall Study|Adverse Event|3|||
13479782|NCT03001011|27014233|FG000|Overall Study|Chronic kidney disease lead to dialysis|15|||
13479783|NCT03001011|27014234|FG001|Overall Study|Chronic kidney disease lead to dialysis|10|||
13479784|NCT03001011|27014233|FG000|Overall Study|Other than specified above|3|||
13479785|NCT03001011|27014234|FG001|Overall Study|Other than specified above|8|||
13479786|NCT02993757|27014273|FG000|Overall Study|Non compliance with the protocol|155|||
13479787|NCT02993757|27014274|FG001|Overall Study|Non compliance with the protocol|170|||
13479788|NCT02993757|27014273|FG000|Overall Study|Lost to Follow-up|1|||
13479789|NCT02993757|27014274|FG001|Overall Study|Lost to Follow-up|0|||
13479790|NCT02993757|27014273|FG000|Overall Study|Voluntary withdraw not due adverse event|8|||
13479791|NCT02993757|27014274|FG001|Overall Study|Voluntary withdraw not due adverse event|8|||
13479792|NCT02979535|27014315|FG000|Overall Study|Non compliance with the protocol|78|||
13479793|NCT02979535|27014316|FG001|Overall Study|Non compliance with the protocol|82|||
13479794|NCT02979535|27014315|FG000|Overall Study|Consent withdrawn by participant|11|||
13479795|NCT02979535|27014316|FG001|Overall Study|Consent withdrawn by participant|18|||
13479796|NCT02979535|27014315|FG000|Overall Study|Lost to Follow-up|6|||
13479797|NCT02979535|27014316|FG001|Overall Study|Lost to Follow-up|1|||
13479798|NCT02978716|27014436|FG000|Overall Study|Death|25|||
13479799|NCT02978716|27014437|FG001|Overall Study|Death|13|||
13479800|NCT02978716|27014438|FG002|Overall Study|Death|20|||
13479801|NCT02978716|27014436|FG000|Overall Study|Lost to Follow-up|0|||
13479802|NCT02978716|27014437|FG001|Overall Study|Lost to Follow-up|0|||
13479803|NCT02978716|27014438|FG002|Overall Study|Lost to Follow-up|1|||
13479804|NCT02978716|27014436|FG000|Overall Study|Withdrawal by Subject|6|||
13479805|NCT02978716|27014437|FG001|Overall Study|Withdrawal by Subject|4|||
13479806|NCT02978716|27014438|FG002|Overall Study|Withdrawal by Subject|5|||
13479807|NCT02978716|27014436|FG000|Overall Study|Sponsor terminated|2|||
13479808|NCT02978716|27014437|FG001|Overall Study|Sponsor terminated|13|||
13479809|NCT02978716|27014438|FG002|Overall Study|Sponsor terminated|9|||
13479810|NCT02978716|27014436|FG000|Overall Study|Other|1|||
13479811|NCT02978716|27014437|FG001|Overall Study|Other|3|||
13479812|NCT02978716|27014438|FG002|Overall Study|Other|0|||
13479813|NCT02973321|27014512|FG000|Overall Study|Other than specified|0|||
13479814|NCT02973321|27014513|FG001|Overall Study|Other than specified|5|||
13479815|NCT02973321|27014514|FG002|Overall Study|Other than specified|3|||
13479816|NCT02973321|27014515|FG003|Overall Study|Other than specified|3|||
13479817|NCT02973321|27014516|FG004|Overall Study|Other than specified|1|||
13479818|NCT02973321|27014512|FG000|Overall Study|Lack of Efficacy|0|||
13479819|NCT02973321|27014513|FG001|Overall Study|Lack of Efficacy|0|||
13479820|NCT02973321|27014514|FG002|Overall Study|Lack of Efficacy|0|||
13479821|NCT02973321|27014515|FG003|Overall Study|Lack of Efficacy|0|||
13479822|NCT02973321|27014516|FG004|Overall Study|Lack of Efficacy|1|||
13479823|NCT02973321|27014512|FG000|Overall Study|Adverse Event|1|||
13479824|NCT02973321|27014513|FG001|Overall Study|Adverse Event|10|||
13479825|NCT02973321|27014514|FG002|Overall Study|Adverse Event|11|||
13479826|NCT02973321|27014515|FG003|Overall Study|Adverse Event|13|||
13479827|NCT02973321|27014516|FG004|Overall Study|Adverse Event|3|||
13479828|NCT02943785|27014551|FG000|Overall Study|Adverse Event|112|||
13479829|NCT02943785|27014552|FG001|Overall Study|Adverse Event|97|||
13479830|NCT02943785|27014551|FG000|Overall Study|Withdrawal by Subject|63|||
13479831|NCT02943785|27014552|FG001|Overall Study|Withdrawal by Subject|126|||
13479832|NCT02943785|27014551|FG000|Overall Study|Physician Decision|23|||
13479833|NCT02943785|27014552|FG001|Overall Study|Physician Decision|47|||
13479834|NCT02943785|27014551|FG000|Overall Study|Death|46|||
13479835|NCT02943785|27014552|FG001|Overall Study|Death|46|||
13479836|NCT02943785|27014551|FG000|Overall Study|Lost to Follow-up|1|||
13479837|NCT02943785|27014552|FG001|Overall Study|Lost to Follow-up|0|||
13479838|NCT02943785|27014551|FG000|Overall Study|Other|16|||
13479839|NCT02943785|27014552|FG001|Overall Study|Other|19|||
13479840|NCT02943785|27014551|FG000|Overall Study|Did not receive any study medication|21|||
13479841|NCT02943785|27014552|FG001|Overall Study|Did not receive any study medication|28|||
13479842|NCT02923674|27014576|FG000|Overall Study|Clinic Closed Due to COVID-19|14|||
13479843|NCT02923674|27014577|FG001|Overall Study|Clinic Closed Due to COVID-19|11|||
13479844|NCT02923674|27014578|FG002|Overall Study|Clinic Closed Due to COVID-19|14|||
13479845|NCT02923674|27014576|FG000|Overall Study|Lost to Follow-up|7|||
13479846|NCT02923674|27014577|FG001|Overall Study|Lost to Follow-up|12|||
13479847|NCT02923674|27014578|FG002|Overall Study|Lost to Follow-up|7|||
13479848|NCT02923674|27014576|FG000|Overall Study|Problem with intervention|2|||
13479849|NCT02923674|27014577|FG001|Overall Study|Problem with intervention|2|||
13479850|NCT02923674|27014578|FG002|Overall Study|Problem with intervention|1|||
13479851|NCT02923674|27014576|FG000|Overall Study|Adverse Event|3|||
13479852|NCT02923674|27014577|FG001|Overall Study|Adverse Event|1|||
13479853|NCT02923674|27014578|FG002|Overall Study|Adverse Event|1|||
13479854|NCT02923674|27014576|FG000|Overall Study|Withdrawal by Subject|2|||
13479855|NCT02923674|27014577|FG001|Overall Study|Withdrawal by Subject|2|||
13479856|NCT02923674|27014578|FG002|Overall Study|Withdrawal by Subject|2|||
13479857|NCT02921971|27014597|FG000|Overall Study|Adverse Event|1|||
13479858|NCT02921971|27014598|FG001|Overall Study|Adverse Event|2|||
13479859|NCT02921971|27014597|FG000|Overall Study|Lack of Efficacy|3|||
13479860|NCT02921971|27014598|FG001|Overall Study|Lack of Efficacy|1|||
13479861|NCT02921971|27014597|FG000|Overall Study|Other than specified above|2|||
13479862|NCT02921971|27014598|FG001|Overall Study|Other than specified above|1|||
13479863|NCT02886286|27014621|FG000|Overall Study|pump motor stall|0|||
13479864|NCT02886286|27014622|FG001|Overall Study|pump motor stall|1|||
13479865|NCT02865187|27014637|FG000|Overall Study|Lost to Follow-up|12|||
13479866|NCT02865187|27014638|FG001|Overall Study|Lost to Follow-up|7|||
13479867|NCT02865187|27014637|FG000|Overall Study|Adverse Event|1|||
13479868|NCT02865187|27014638|FG001|Overall Study|Adverse Event|0|||
13479869|NCT02824198|27014675|FG000|Overall Study|Non-compliance with the protocol|5|||
13479870|NCT02824198|27014676|FG001|Overall Study|Non-compliance with the protocol|1|||
13479871|NCT02824198|27014675|FG000|Overall Study|Lost to Follow-up|5|||
13479872|NCT02824198|27014676|FG001|Overall Study|Lost to Follow-up|2|||
13479873|NCT02824198|27014675|FG000|Overall Study|Withdrawal by Subject|5|||
13479874|NCT02824198|27014676|FG001|Overall Study|Withdrawal by Subject|0|||
13479875|NCT02821754|27014696|FG000|Overall Study|Procedure not required prior to amendment change|13|||
13479876|NCT02821754|27014697|FG001|Overall Study|Procedure not required prior to amendment change|11|||
13479877|NCT02821754|27014698|FG002|Overall Study|Procedure not required prior to amendment change|0|||
13479878|NCT02821754|27014696|FG000|Overall Study|Participant's Clinical status|2|||
13479879|NCT02821754|27014697|FG001|Overall Study|Participant's Clinical status|0|||
13479880|NCT02821754|27014698|FG002|Overall Study|Participant's Clinical status|0|||
13479881|NCT02821754|27014696|FG000|Overall Study|Participant removed for noncompliance|1|||
13479882|NCT02821754|27014697|FG001|Overall Study|Participant removed for noncompliance|0|||
13479883|NCT02821754|27014698|FG002|Overall Study|Participant removed for noncompliance|0|||
13479884|NCT02821754|27014696|FG000|Overall Study|Drug not available.|0|||
13479885|NCT02821754|27014697|FG001|Overall Study|Drug not available.|0|||
13479886|NCT02821754|27014698|FG002|Overall Study|Drug not available.|1|||
13479887|NCT02821754|27014696|FG000|Overall Study|Participant declined to participate (before treatment started.)|0|||
13479888|NCT02821754|27014697|FG001|Overall Study|Participant declined to participate (before treatment started.)|1|||
13479889|NCT02821754|27014698|FG002|Overall Study|Participant declined to participate (before treatment started.)|1|||
13479890|NCT02787551|27014737|FG000|Core Period: 26 Weeks|Adverse Event|10|||
13479891|NCT02787551|27014738|FG001|Core Period: 26 Weeks|Adverse Event|0|||
13479892|NCT02787551|27014737|FG000|Core Period: 26 Weeks|Lack of Efficacy|1|||
13479893|NCT02787551|27014738|FG001|Core Period: 26 Weeks|Lack of Efficacy|0|||
13479894|NCT02787551|27014737|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2|||
13479895|NCT02787551|27014738|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0|||
13479896|NCT02787551|27014737|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9|||
13479897|NCT02787551|27014738|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9|||
13479898|NCT02787551|27014737|FG000|Core Period: 26 Weeks|Randomized but not treated|2|||
13479899|NCT02787551|27014738|FG001|Core Period: 26 Weeks|Randomized but not treated|1|||
13479900|NCT02787551|27014737|FG000|Core Period: 26 Weeks|Other than specified|3|||
13479901|NCT02787551|27014738|FG001|Core Period: 26 Weeks|Other than specified|1|||
13479902|NCT02787551|27014737|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1|||
13479903|NCT02787551|27014738|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0|||
13479904|NCT02787551|27014737|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3|||
13479905|NCT02787551|27014738|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0|||
13479906|NCT02787551|27014737|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5|||
13479907|NCT02787551|27014738|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0|||
13479908|NCT02735044|27014787|FG000|Overall Study|Adverse Event|3|||
13479909|NCT02735044|27014788|FG001|Overall Study|Adverse Event|3|||
13479910|NCT02735044|27014787|FG000|Overall Study|Lack of Efficacy|1|||
13479911|NCT02735044|27014788|FG001|Overall Study|Lack of Efficacy|0|||
13479912|NCT02735044|27014787|FG000|Overall Study|Poor compliance to protocol|7|||
13479913|NCT02735044|27014788|FG001|Overall Study|Poor compliance to protocol|7|||
13479914|NCT02735044|27014787|FG000|Overall Study|Randomized and not treated|0|||
13479915|NCT02735044|27014788|FG001|Overall Study|Randomized and not treated|2|||
13479916|NCT02735044|27014787|FG000|Overall Study|Other, not specified above|5|||
13479917|NCT02735044|27014788|FG001|Overall Study|Other, not specified above|11|||
13479918|NCT02720744|27014805|FG000|Overall Study|Protocol Violation|0|||
13479919|NCT02720744|27014806|FG001|Overall Study|Protocol Violation|2|||
13479920|NCT02720744|27014805|FG000|Overall Study|Pregnancy|2|||
13479921|NCT02720744|27014806|FG001|Overall Study|Pregnancy|0|||
13479922|NCT02720744|27014805|FG000|Overall Study|Lack of Efficacy|2|||
13479923|NCT02720744|27014806|FG001|Overall Study|Lack of Efficacy|8|||
13479924|NCT02720744|27014805|FG000|Overall Study|Adverse Event|21|||
13479925|NCT02720744|27014806|FG001|Overall Study|Adverse Event|3|||
13479926|NCT02720744|27014805|FG000|Overall Study|Withdrawal by Subject|11|||
13479927|NCT02720744|27014806|FG001|Overall Study|Withdrawal by Subject|11|||
13479928|NCT02720744|27014805|FG000|Overall Study|Lost to follow up|2|||
13479929|NCT02720744|27014806|FG001|Overall Study|Lost to follow up|0|||
13479930|NCT02720744|27014805|FG000|Overall Study|Non Compliance with Investigational Product|0|||
13479931|NCT02720744|27014806|FG001|Overall Study|Non Compliance with Investigational Product|1|||
13479932|NCT02720744|27014805|FG000|Overall Study|Excluded Concomitant Medication|0|||
13479933|NCT02720744|27014806|FG001|Overall Study|Excluded Concomitant Medication|1|||
13479934|NCT02713867|27014849|FG000|Randomization|Other Reason|2|||
13479935|NCT02713867|27014850|FG001|Randomization|Other Reason|1|||
13479936|NCT02713867|27014849|FG000|Randomization|Participant Withdrew consent|0|||
13479937|NCT02713867|27014850|FG001|Randomization|Participant Withdrew consent|2|||
13479938|NCT02713867|27014849|FG000|Treatment Period|Not Reported|1|||
13479939|NCT02713867|27014850|FG001|Treatment Period|Not Reported|0|||
13479940|NCT02713867|27014849|FG000|Treatment Period|Other Reasons|12|||
13479941|NCT02713867|27014850|FG001|Treatment Period|Other Reasons|18|||
13479942|NCT02713867|27014849|FG000|Treatment Period|Administrative reason by sponsor|9|||
13479943|NCT02713867|27014850|FG001|Treatment Period|Administrative reason by sponsor|4|||
13479944|NCT02713867|27014849|FG000|Treatment Period|No longer meets study criteria|2|||
13479945|NCT02713867|27014850|FG001|Treatment Period|No longer meets study criteria|1|||
13479946|NCT02713867|27014849|FG000|Treatment Period|Poor/Non Compliance|1|||
13479947|NCT02713867|27014850|FG001|Treatment Period|Poor/Non Compliance|0|||
13479948|NCT02713867|27014849|FG000|Treatment Period|Maximum Clinical Benefit|3|||
13479949|NCT02713867|27014850|FG001|Treatment Period|Maximum Clinical Benefit|4|||
13479950|NCT02713867|27014849|FG000|Treatment Period|Withdrew consent|1|||
13479951|NCT02713867|27014850|FG001|Treatment Period|Withdrew consent|6|||
13479952|NCT02713867|27014849|FG000|Treatment Period|Requested to Discontinue|8|||
13479953|NCT02713867|27014850|FG001|Treatment Period|Requested to Discontinue|7|||
13479954|NCT02713867|27014849|FG000|Treatment Period|AE unrelated to Study Drug|8|||
13479955|NCT02713867|27014850|FG001|Treatment Period|AE unrelated to Study Drug|9|||
13479956|NCT02713867|27014849|FG000|Treatment Period|Death|7|||
13479957|NCT02713867|27014850|FG001|Treatment Period|Death|3|||
13479958|NCT02713867|27014849|FG000|Treatment Period|Study Drug Toxicity|16|||
13479959|NCT02713867|27014850|FG001|Treatment Period|Study Drug Toxicity|20|||
13479960|NCT02713867|27014849|FG000|Treatment Period|Disease Progression|79|||
13479961|NCT02713867|27014850|FG001|Treatment Period|Disease Progression|78|||
13479962|NCT02694185|27014867|FG000|Overall Study|Withdrawal by Subject|45|||
13479963|NCT02694185|27014868|FG001|Overall Study|Withdrawal by Subject|0|||
13479964|NCT02692651|27014885|FG000|Study Treatment|Death|7|||
13479965|NCT02692651|27014886|FG001|Study Treatment|Death|3|||
13479966|NCT02692651|27014885|FG000|Study Treatment|comfort care|1|||
13479967|NCT02692651|27014886|FG001|Study Treatment|comfort care|1|||
13479968|NCT02692651|27014885|FG000|Study Treatment|Protocol violation per treating team preference|8|||
13479969|NCT02692651|27014886|FG001|Study Treatment|Protocol violation per treating team preference|6|||
13479970|NCT02692651|27014885|FG000|Post Study Treatment Follow-up|Death|4|||
13479971|NCT02692651|27014886|FG001|Post Study Treatment Follow-up|Death|4|||
13479972|NCT02674061|27015085|FG000|Overall Study|Death|229|||
13479973|NCT02674061|27015086|FG001|Overall Study|Death|77|||
13479974|NCT02674061|27015085|FG000|Overall Study|Lost to Follow-up|3|||
13479975|NCT02674061|27015086|FG001|Overall Study|Lost to Follow-up|3|||
13479976|NCT02674061|27015085|FG000|Overall Study|Withdrawal by Subject|9|||
13479977|NCT02674061|27015086|FG001|Overall Study|Withdrawal by Subject|1|||
13479978|NCT02674061|27015085|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44|||
13479979|NCT02674061|27015086|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10|||
13479980|NCT02656706|27015093|FG000|Overall Study|Insurance Denial|1|||
13479981|NCT02628444|27015226|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1|||
13479982|NCT02628444|27015227|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
13479983|NCT02628444|27015228|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
13479984|NCT02628444|27015229|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
13479985|NCT02628444|27015230|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
13479986|NCT02628444|27015231|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
13479987|NCT02628444|27015232|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
13479988|NCT02628444|27015233|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
13479989|NCT02628444|27015234|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
13479990|NCT02628444|27015226|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
13479991|NCT02628444|27015227|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4|||
13479992|NCT02628444|27015228|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3|||
13479993|NCT02628444|27015229|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
13479994|NCT02628444|27015230|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
13479995|NCT02628444|27015231|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
13479996|NCT02628444|27015232|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
13479997|NCT02628444|27015233|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
13479998|NCT02628444|27015234|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
13479999|NCT02628444|27015226|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21|||
13480000|NCT02628444|27015227|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16|||
13480001|NCT02628444|27015228|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25|||
13480002|NCT02628444|27015229|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
13480003|NCT02628444|27015230|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
13480004|NCT02628444|27015231|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
13480005|NCT02628444|27015232|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
13480006|NCT02628444|27015233|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
13480007|NCT02628444|27015234|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
13480008|NCT02628444|27015226|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
13480009|NCT02628444|27015227|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16|||
13480010|NCT02628444|27015228|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
13480011|NCT02628444|27015229|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
13480012|NCT02628444|27015230|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
13480013|NCT02628444|27015231|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
13480014|NCT02628444|27015232|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
13480015|NCT02628444|27015233|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
13480016|NCT02628444|27015234|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
13480017|NCT02628444|27015226|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
13480018|NCT02628444|27015227|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3|||
13480019|NCT02628444|27015228|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
13480020|NCT02628444|27015229|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
13480021|NCT02628444|27015230|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
13480022|NCT02628444|27015231|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
13480023|NCT02628444|27015232|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
13480024|NCT02628444|27015233|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
13480025|NCT02628444|27015234|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
13480026|NCT02628444|27015226|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
13480027|NCT02628444|27015227|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
13480028|NCT02628444|27015228|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
13480029|NCT02628444|27015229|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1|||
13480030|NCT02628444|27015230|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
13480031|NCT02628444|27015231|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
13480032|NCT02628444|27015232|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
13480033|NCT02628444|27015233|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
13480034|NCT02628444|27015234|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
13480035|NCT02628444|27015226|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
13480036|NCT02628444|27015227|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
13480037|NCT02628444|27015228|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
13480038|NCT02628444|27015229|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
13480039|NCT02628444|27015230|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
13480040|NCT02628444|27015231|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
13480041|NCT02628444|27015232|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81|||
13480042|NCT02628444|27015233|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84|||
13480043|NCT02628444|27015234|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85|||
13480044|NCT02628444|27015226|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
13480045|NCT02628444|27015227|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
13480046|NCT02628444|27015228|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
13480047|NCT02628444|27015229|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5|||
13480048|NCT02628444|27015230|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6|||
13480049|NCT02628444|27015231|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10|||
13480050|NCT02628444|27015232|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12|||
13480051|NCT02628444|27015233|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11|||
13480052|NCT02628444|27015234|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9|||
13480053|NCT02628444|27015226|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
13480054|NCT02628444|27015227|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
13480055|NCT02628444|27015228|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
13480056|NCT02628444|27015229|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
13480057|NCT02628444|27015230|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
13480058|NCT02628444|27015231|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
13480059|NCT02628444|27015232|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
13480060|NCT02628444|27015233|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2|||
13480061|NCT02628444|27015234|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
13480062|NCT02628444|27015226|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
13480063|NCT02628444|27015227|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
13480064|NCT02628444|27015228|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
13480065|NCT02628444|27015229|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
13480066|NCT02628444|27015230|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
13480067|NCT02628444|27015231|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
13480068|NCT02628444|27015232|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3|||
13480069|NCT02628444|27015233|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
13480070|NCT02628444|27015234|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
13480071|NCT02623725|27015297|FG000|Overall Study|Non compliance with protocol|9|||
13480072|NCT02623725|27015298|FG001|Overall Study|Non compliance with protocol|3|||
13480073|NCT02623725|27015297|FG000|Overall Study|Serious adverse event|0|||
13480074|NCT02623725|27015298|FG001|Overall Study|Serious adverse event|2|||
13480075|NCT02623725|27015297|FG000|Overall Study|Withdrawal by Subject|7|||
13480076|NCT02623725|27015298|FG001|Overall Study|Withdrawal by Subject|1|||
13480077|NCT02608684|27015310|FG000|Overall Study|Physician Decision|2|||
13480078|NCT02608684|27015310|FG000|Overall Study|Withdrawal by Subject|1|||
13480079|NCT02603887|27015319|FG000|Stage 1|Adverse Event|4|||
13480080|NCT02603887|27015319|FG000|Stage 1|Disease progression|1|||
13480081|NCT02603887|27015319|FG000|Stage 2|FDA guidance|1|||
13480082|NCT02587520|27015412|FG000|Overall Study|Protocol Violation|2|||
13480083|NCT02587520|27015413|FG001|Overall Study|Protocol Violation|0|||
13480084|NCT02587520|27015414|FG002|Overall Study|Protocol Violation|0|||
13480085|NCT02587520|27015415|FG003|Overall Study|Protocol Violation|2|||
13480086|NCT02587520|27015416|FG004|Overall Study|Protocol Violation|0|||
13480087|NCT02587520|27015417|FG005|Overall Study|Protocol Violation|1|||
13480088|NCT02587520|27015418|FG006|Overall Study|Protocol Violation|1|||
13480089|NCT02587520|27015419|FG007|Overall Study|Protocol Violation|1|||
13480090|NCT02587520|27015420|FG008|Overall Study|Protocol Violation|3|||
13480091|NCT02587520|27015421|FG009|Overall Study|Protocol Violation|3|||
13480092|NCT02587520|27015422|FG010|Overall Study|Protocol Violation|1|||
13480093|NCT02587520|27015423|FG011|Overall Study|Protocol Violation|2|||
13480094|NCT02587520|27015424|FG012|Overall Study|Protocol Violation|0|||
13480095|NCT02587520|27015425|FG013|Overall Study|Protocol Violation|0|||
13480096|NCT02587520|27015426|FG014|Overall Study|Protocol Violation|0|||
13480097|NCT02587520|27015427|FG015|Overall Study|Protocol Violation|0|||
13480098|NCT02587520|27015428|FG016|Overall Study|Protocol Violation|0|||
13480099|NCT02587520|27015429|FG017|Overall Study|Protocol Violation|0|||
13480100|NCT02587520|27015412|FG000|Overall Study|Adverse Event|0|||
13480101|NCT02587520|27015413|FG001|Overall Study|Adverse Event|0|||
13480102|NCT02587520|27015414|FG002|Overall Study|Adverse Event|0|||
13480103|NCT02587520|27015415|FG003|Overall Study|Adverse Event|0|||
13480104|NCT02587520|27015416|FG004|Overall Study|Adverse Event|0|||
13480105|NCT02587520|27015417|FG005|Overall Study|Adverse Event|0|||
13480106|NCT02587520|27015418|FG006|Overall Study|Adverse Event|0|||
13480107|NCT02587520|27015419|FG007|Overall Study|Adverse Event|0|||
13480108|NCT02587520|27015420|FG008|Overall Study|Adverse Event|0|||
13480109|NCT02587520|27015421|FG009|Overall Study|Adverse Event|0|||
13480110|NCT02587520|27015422|FG010|Overall Study|Adverse Event|0|||
13480111|NCT02587520|27015423|FG011|Overall Study|Adverse Event|1|||
13480112|NCT02587520|27015424|FG012|Overall Study|Adverse Event|0|||
13480113|NCT02587520|27015425|FG013|Overall Study|Adverse Event|0|||
13480114|NCT02587520|27015426|FG014|Overall Study|Adverse Event|0|||
13480115|NCT02587520|27015427|FG015|Overall Study|Adverse Event|0|||
13480116|NCT02587520|27015428|FG016|Overall Study|Adverse Event|0|||
13480117|NCT02587520|27015429|FG017|Overall Study|Adverse Event|0|||
13480118|NCT02587520|27015412|FG000|Overall Study|Withdrawal by Subject|0|||
13480119|NCT02587520|27015413|FG001|Overall Study|Withdrawal by Subject|0|||
13480120|NCT02587520|27015414|FG002|Overall Study|Withdrawal by Subject|1|||
13480121|NCT02587520|27015415|FG003|Overall Study|Withdrawal by Subject|1|||
13480122|NCT02587520|27015416|FG004|Overall Study|Withdrawal by Subject|0|||
13480123|NCT02587520|27015417|FG005|Overall Study|Withdrawal by Subject|1|||
13480124|NCT02587520|27015418|FG006|Overall Study|Withdrawal by Subject|1|||
13480125|NCT02587520|27015419|FG007|Overall Study|Withdrawal by Subject|0|||
13480126|NCT02587520|27015420|FG008|Overall Study|Withdrawal by Subject|0|||
13480127|NCT02587520|27015421|FG009|Overall Study|Withdrawal by Subject|0|||
13480128|NCT02587520|27015422|FG010|Overall Study|Withdrawal by Subject|0|||
13480129|NCT02587520|27015423|FG011|Overall Study|Withdrawal by Subject|0|||
13480130|NCT02587520|27015424|FG012|Overall Study|Withdrawal by Subject|0|||
13480131|NCT02587520|27015425|FG013|Overall Study|Withdrawal by Subject|1|||
13480132|NCT02587520|27015426|FG014|Overall Study|Withdrawal by Subject|0|||
13480133|NCT02587520|27015427|FG015|Overall Study|Withdrawal by Subject|0|||
13480134|NCT02587520|27015428|FG016|Overall Study|Withdrawal by Subject|0|||
13480135|NCT02587520|27015429|FG017|Overall Study|Withdrawal by Subject|0|||
13480136|NCT02587520|27015412|FG000|Overall Study|Lost to Follow-up|0|||
13480137|NCT02587520|27015413|FG001|Overall Study|Lost to Follow-up|2|||
13480138|NCT02587520|27015414|FG002|Overall Study|Lost to Follow-up|0|||
13480139|NCT02587520|27015415|FG003|Overall Study|Lost to Follow-up|2|||
13480140|NCT02587520|27015416|FG004|Overall Study|Lost to Follow-up|0|||
13480141|NCT02587520|27015417|FG005|Overall Study|Lost to Follow-up|1|||
13480142|NCT02587520|27015418|FG006|Overall Study|Lost to Follow-up|1|||
13480143|NCT02587520|27015419|FG007|Overall Study|Lost to Follow-up|1|||
13480144|NCT02587520|27015420|FG008|Overall Study|Lost to Follow-up|0|||
13480145|NCT02587520|27015421|FG009|Overall Study|Lost to Follow-up|2|||
13480146|NCT02587520|27015422|FG010|Overall Study|Lost to Follow-up|2|||
13480147|NCT02587520|27015423|FG011|Overall Study|Lost to Follow-up|1|||
13480148|NCT02587520|27015424|FG012|Overall Study|Lost to Follow-up|0|||
13480149|NCT02587520|27015425|FG013|Overall Study|Lost to Follow-up|0|||
13480150|NCT02587520|27015426|FG014|Overall Study|Lost to Follow-up|0|||
13480151|NCT02587520|27015427|FG015|Overall Study|Lost to Follow-up|0|||
13480152|NCT02587520|27015428|FG016|Overall Study|Lost to Follow-up|0|||
13480153|NCT02587520|27015429|FG017|Overall Study|Lost to Follow-up|0|||
13480154|NCT02584829|27015450|FG000|Overall Study|Physician Decision|1|||
13480155|NCT02584829|27015451|FG001|Overall Study|Physician Decision|0|||
13480156|NCT02584829|27015450|FG000|Overall Study|Withdrawal by Subject|0|||
13480157|NCT02584829|27015451|FG001|Overall Study|Withdrawal by Subject|1|||
13480158|NCT02584829|27015450|FG000|Overall Study|Progressive Disease|0|||
13480159|NCT02584829|27015451|FG001|Overall Study|Progressive Disease|3|||
13480160|NCT02570308|27015518|FG000|Overall Study|Death|1|||
13480161|NCT02570308|27015519|FG001|Overall Study|Death|5|||
13480162|NCT02570308|27015520|FG002|Overall Study|Death|4|||
13480163|NCT02570308|27015521|FG003|Overall Study|Death|4|||
13480164|NCT02570308|27015522|FG004|Overall Study|Death|69|||
13480165|NCT02570308|27015518|FG000|Overall Study|Lost to Follow-up|0|||
13480166|NCT02570308|27015519|FG001|Overall Study|Lost to Follow-up|0|||
13480167|NCT02570308|27015520|FG002|Overall Study|Lost to Follow-up|0|||
13480168|NCT02570308|27015521|FG003|Overall Study|Lost to Follow-up|0|||
13480169|NCT02570308|27015522|FG004|Overall Study|Lost to Follow-up|2|||
13480170|NCT02570308|27015518|FG000|Overall Study|Withdrawal by Subject|0|||
13480171|NCT02570308|27015519|FG001|Overall Study|Withdrawal by Subject|0|||
13480172|NCT02570308|27015520|FG002|Overall Study|Withdrawal by Subject|0|||
13480173|NCT02570308|27015521|FG003|Overall Study|Withdrawal by Subject|0|||
13480174|NCT02570308|27015522|FG004|Overall Study|Withdrawal by Subject|1|||
13480175|NCT02570308|27015518|FG000|Overall Study|Other|0|||
13480176|NCT02570308|27015519|FG001|Overall Study|Other|0|||
13480177|NCT02570308|27015520|FG002|Overall Study|Other|0|||
13480178|NCT02570308|27015521|FG003|Overall Study|Other|0|||
13480179|NCT02570308|27015522|FG004|Overall Study|Other|2|||
13486994|NCT00965757|27037777|FG000|Double-blind Phase|Progression of concomitant disease|1|||
13486995|NCT00965757|27037778|FG001|Double-blind Phase|Progression of concomitant disease|2|||
13486996|NCT00965757|27037779|FG002|Double-blind Phase|Progression of concomitant disease|0|||
13486997|NCT00965757|27037780|FG003|Double-blind Phase|Progression of concomitant disease|0|||
13486998|NCT00965757|27037777|FG000|Double-blind Phase|Adverse drug reaction|2|||
13486999|NCT00965757|27037778|FG001|Double-blind Phase|Adverse drug reaction|1|||
13487000|NCT00965757|27037779|FG002|Double-blind Phase|Adverse drug reaction|0|||
13487001|NCT00965757|27037780|FG003|Double-blind Phase|Adverse drug reaction|0|||
13487002|NCT00965757|27037777|FG000|Double-blind Phase|Abnormal Laboratory Value|2|||
13487003|NCT00965757|27037778|FG001|Double-blind Phase|Abnormal Laboratory Value|0|||
13487004|NCT00965757|27037779|FG002|Double-blind Phase|Abnormal Laboratory Value|0|||
13487005|NCT00965757|27037780|FG003|Double-blind Phase|Abnormal Laboratory Value|0|||
13487006|NCT00965757|27037777|FG000|Double-blind Phase|Lack of Efficacy|7|||
13487007|NCT00965757|27037778|FG001|Double-blind Phase|Lack of Efficacy|11|||
13487008|NCT00965757|27037779|FG002|Double-blind Phase|Lack of Efficacy|0|||
13487009|NCT00965757|27037780|FG003|Double-blind Phase|Lack of Efficacy|0|||
13487010|NCT00965757|27037777|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2|||
13487011|NCT00965757|27037778|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
13487012|NCT00965757|27037779|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
13487013|NCT00965757|27037780|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
13487014|NCT00965757|27037777|FG000|Double-blind Phase|Lost to Follow-up|0|||
13487015|NCT00965757|27037778|FG001|Double-blind Phase|Lost to Follow-up|1|||
13487016|NCT00965757|27037779|FG002|Double-blind Phase|Lost to Follow-up|0|||
13487017|NCT00965757|27037780|FG003|Double-blind Phase|Lost to Follow-up|0|||
13487018|NCT00965757|27037777|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2|||
13480180|NCT02514083|27015529|FG000|Overall Study|Adverse Event|1|||
13480181|NCT02497612|27015668|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57|||
13480182|NCT02497612|27015669|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51|||
13480183|NCT02497612|27015670|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39|||
13480184|NCT02497612|27015671|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41|||
13480185|NCT02497612|27015668|FG000|Overall Study|Participant's request|2|||
13480186|NCT02497612|27015669|FG001|Overall Study|Participant's request|3|||
13480187|NCT02497612|27015670|FG002|Overall Study|Participant's request|4|||
13480188|NCT02497612|27015671|FG003|Overall Study|Participant's request|1|||
13480189|NCT02497612|27015668|FG000|Overall Study|Investigator's judgement|1|||
13480190|NCT02497612|27015669|FG001|Overall Study|Investigator's judgement|0|||
13480191|NCT02497612|27015670|FG002|Overall Study|Investigator's judgement|0|||
13480192|NCT02497612|27015671|FG003|Overall Study|Investigator's judgement|2|||
13480193|NCT02497612|27015668|FG000|Overall Study|Adverse Event|3|||
13480194|NCT02497612|27015669|FG001|Overall Study|Adverse Event|1|||
13480195|NCT02497612|27015670|FG002|Overall Study|Adverse Event|4|||
13480196|NCT02497612|27015671|FG003|Overall Study|Adverse Event|1|||
13480197|NCT02497612|27015668|FG000|Overall Study|Lost to Follow-up|1|||
13480198|NCT02497612|27015669|FG001|Overall Study|Lost to Follow-up|1|||
13480199|NCT02497612|27015670|FG002|Overall Study|Lost to Follow-up|0|||
13480200|NCT02497612|27015671|FG003|Overall Study|Lost to Follow-up|1|||
13480201|NCT02497612|27015668|FG000|Overall Study|Other unspecified|1|||
13480202|NCT02497612|27015669|FG001|Overall Study|Other unspecified|1|||
13480203|NCT02497612|27015670|FG002|Overall Study|Other unspecified|2|||
13480204|NCT02497612|27015671|FG003|Overall Study|Other unspecified|0|||
13480205|NCT02497612|27015668|FG000|Overall Study|Not eligible|1|||
13480206|NCT02497612|27015669|FG001|Overall Study|Not eligible|0|||
13480207|NCT02497612|27015670|FG002|Overall Study|Not eligible|0|||
13480208|NCT02497612|27015671|FG003|Overall Study|Not eligible|1|||
13480209|NCT02460458|27015687|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analyses|47|||
13480210|NCT02460458|27015687|FG000|Confirmatory Phase|Patients excluded due to lack of samples for central analyses|27|||
13480211|NCT02460458|27015687|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|14|||
13480212|NCT02460458|27015687|FG000|First Prospective Phase|Lost to Follow-up|16|||
13480213|NCT02460458|27015687|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|9|||
13480214|NCT02457559|27015803|FG000|Overall Study|Progressive Disease|1|||
13480215|NCT02457559|27015804|FG001|Overall Study|Progressive Disease|2|||
13480216|NCT02457559|27015805|FG002|Overall Study|Progressive Disease|3|||
13480217|NCT02457559|27015806|FG003|Overall Study|Progressive Disease|0|||
13480218|NCT02457559|27015807|FG004|Overall Study|Progressive Disease|0|||
13480219|NCT02457559|27015808|FG005|Overall Study|Progressive Disease|2|||
13480220|NCT02457559|27015809|FG006|Overall Study|Progressive Disease|1|||
13480221|NCT02457559|27015810|FG007|Overall Study|Progressive Disease|0|||
13480222|NCT02457559|27015811|FG008|Overall Study|Progressive Disease|1|||
13480223|NCT02457559|27015812|FG009|Overall Study|Progressive Disease|1|||
13480224|NCT02457559|27015813|FG010|Overall Study|Progressive Disease|1|||
13480225|NCT02457559|27015803|FG000|Overall Study|Investigator's Discretion|0|||
13480226|NCT02457559|27015804|FG001|Overall Study|Investigator's Discretion|0|||
13480227|NCT02457559|27015805|FG002|Overall Study|Investigator's Discretion|2|||
13480228|NCT02457559|27015806|FG003|Overall Study|Investigator's Discretion|0|||
13480229|NCT02457559|27015807|FG004|Overall Study|Investigator's Discretion|1|||
13480230|NCT02457559|27015808|FG005|Overall Study|Investigator's Discretion|0|||
13480231|NCT02457559|27015809|FG006|Overall Study|Investigator's Discretion|1|||
13480232|NCT02457559|27015810|FG007|Overall Study|Investigator's Discretion|0|||
13480233|NCT02457559|27015811|FG008|Overall Study|Investigator's Discretion|1|||
13480234|NCT02457559|27015812|FG009|Overall Study|Investigator's Discretion|0|||
13480235|NCT02457559|27015813|FG010|Overall Study|Investigator's Discretion|1|||
13480236|NCT02457559|27015803|FG000|Overall Study|Adverse Event|0|||
13480237|NCT02457559|27015804|FG001|Overall Study|Adverse Event|1|||
13480238|NCT02457559|27015805|FG002|Overall Study|Adverse Event|2|||
13480239|NCT02457559|27015806|FG003|Overall Study|Adverse Event|0|||
13480240|NCT02457559|27015807|FG004|Overall Study|Adverse Event|0|||
13480241|NCT02457559|27015808|FG005|Overall Study|Adverse Event|0|||
13480242|NCT02457559|27015809|FG006|Overall Study|Adverse Event|0|||
13480243|NCT02457559|27015810|FG007|Overall Study|Adverse Event|0|||
13480244|NCT02457559|27015811|FG008|Overall Study|Adverse Event|0|||
13480245|NCT02457559|27015812|FG009|Overall Study|Adverse Event|0|||
13480246|NCT02457559|27015813|FG010|Overall Study|Adverse Event|0|||
13480247|NCT02457559|27015803|FG000|Overall Study|Reason not Specified|1|||
13480248|NCT02457559|27015804|FG001|Overall Study|Reason not Specified|0|||
13480249|NCT02457559|27015805|FG002|Overall Study|Reason not Specified|0|||
13480250|NCT02457559|27015806|FG003|Overall Study|Reason not Specified|0|||
13480251|NCT02457559|27015807|FG004|Overall Study|Reason not Specified|0|||
13480252|NCT02457559|27015808|FG005|Overall Study|Reason not Specified|0|||
13480253|NCT02457559|27015809|FG006|Overall Study|Reason not Specified|0|||
13480254|NCT02457559|27015810|FG007|Overall Study|Reason not Specified|0|||
13480255|NCT02457559|27015811|FG008|Overall Study|Reason not Specified|0|||
13480256|NCT02457559|27015812|FG009|Overall Study|Reason not Specified|2|||
13480257|NCT02457559|27015813|FG010|Overall Study|Reason not Specified|0|||
13480258|NCT02457559|27015803|FG000|Overall Study|Death|0|||
13480259|NCT02457559|27015804|FG001|Overall Study|Death|0|||
13480260|NCT02457559|27015805|FG002|Overall Study|Death|0|||
13480261|NCT02457559|27015806|FG003|Overall Study|Death|0|||
13480262|NCT02457559|27015807|FG004|Overall Study|Death|0|||
13480263|NCT02457559|27015808|FG005|Overall Study|Death|0|||
13480264|NCT02457559|27015809|FG006|Overall Study|Death|0|||
13480265|NCT02457559|27015810|FG007|Overall Study|Death|0|||
13480266|NCT02457559|27015811|FG008|Overall Study|Death|1|||
13480267|NCT02457559|27015812|FG009|Overall Study|Death|1|||
13480268|NCT02457559|27015813|FG010|Overall Study|Death|0|||
13480269|NCT02381652|27015849|FG000|Overall Study|Withdrawal by Subject|0|||
13480270|NCT02381652|27015850|FG001|Overall Study|Withdrawal by Subject|0|||
13480271|NCT02381652|27015851|FG002|Overall Study|Withdrawal by Subject|1|||
13480272|NCT02367794|27015927|FG000|Overall Study|Death|252|||
13480273|NCT02367794|27015928|FG001|Overall Study|Death|245|||
13480274|NCT02367794|27015929|FG002|Overall Study|Death|243|||
13480275|NCT02367794|27015927|FG000|Overall Study|Lost to Follow-up|1|||
13480276|NCT02367794|27015928|FG001|Overall Study|Lost to Follow-up|2|||
13480277|NCT02367794|27015929|FG002|Overall Study|Lost to Follow-up|2|||
13480278|NCT02367794|27015927|FG000|Overall Study|Physician Decision|0|||
13480279|NCT02367794|27015928|FG001|Overall Study|Physician Decision|5|||
13480280|NCT02367794|27015929|FG002|Overall Study|Physician Decision|3|||
13480281|NCT02367794|27015927|FG000|Overall Study|Protocol Violation|1|||
13480282|NCT02367794|27015928|FG001|Overall Study|Protocol Violation|0|||
13480283|NCT02367794|27015929|FG002|Overall Study|Protocol Violation|1|||
13480284|NCT02367794|27015927|FG000|Overall Study|Withdrawal by Subject|25|||
13480285|NCT02367794|27015928|FG001|Overall Study|Withdrawal by Subject|12|||
13480286|NCT02367794|27015929|FG002|Overall Study|Withdrawal by Subject|20|||
13480287|NCT02367794|27015927|FG000|Overall Study|Brain metastasis|1|||
13480288|NCT02367794|27015928|FG001|Overall Study|Brain metastasis|0|||
13480289|NCT02367794|27015929|FG002|Overall Study|Brain metastasis|0|||
13480290|NCT02367794|27015927|FG000|Overall Study|Randomized in error|0|||
13480291|NCT02367794|27015928|FG001|Overall Study|Randomized in error|0|||
13480292|NCT02367794|27015929|FG002|Overall Study|Randomized in error|1|||
13480293|NCT02367794|27015927|FG000|Overall Study|Patient unable to receive carboplatin|0|||
13480294|NCT02367794|27015928|FG001|Overall Study|Patient unable to receive carboplatin|0|||
13480295|NCT02367794|27015929|FG002|Overall Study|Patient unable to receive carboplatin|1|||
13480296|NCT02367794|27015927|FG000|Overall Study|Hypercalcemia prior to C1D1|0|||
13480297|NCT02367794|27015928|FG001|Overall Study|Hypercalcemia prior to C1D1|0|||
13480298|NCT02367794|27015929|FG002|Overall Study|Hypercalcemia prior to C1D1|1|||
13480299|NCT02367794|27015927|FG000|Overall Study|Adverse Event|0|||
13480300|NCT02367794|27015928|FG001|Overall Study|Adverse Event|0|||
13480301|NCT02367794|27015929|FG002|Overall Study|Adverse Event|2|||
13480302|NCT02367794|27015927|FG000|Overall Study|Study Terminated By Sponsor|0|||
13480303|NCT02367794|27015928|FG001|Overall Study|Study Terminated By Sponsor|1|||
13480304|NCT02367794|27015929|FG002|Overall Study|Study Terminated By Sponsor|1|||
13480305|NCT02367794|27015927|FG000|Overall Study|Moved to Roll-Over Study|0|||
13480306|NCT02367794|27015928|FG001|Overall Study|Moved to Roll-Over Study|15|||
13480307|NCT02367794|27015929|FG002|Overall Study|Moved to Roll-Over Study|13|||
13480308|NCT02367794|27015927|FG000|Overall Study|Sponsor Request|60|||
13480309|NCT02367794|27015928|FG001|Overall Study|Sponsor Request|57|||
13480310|NCT02367794|27015929|FG002|Overall Study|Sponsor Request|45|||
13480311|NCT02367794|27015927|FG000|Overall Study|Moved into PTAP Study|0|||
13480312|NCT02367794|27015928|FG001|Overall Study|Moved into PTAP Study|2|||
13480313|NCT02367794|27015929|FG002|Overall Study|Moved into PTAP Study|3|||
13480314|NCT02367794|27015927|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0|||
13480315|NCT02367794|27015928|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2|||
13480316|NCT02367794|27015929|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1|||
13480317|NCT02367794|27015927|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0|||
13480318|NCT02367794|27015928|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1|||
13480319|NCT02367794|27015929|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0|||
13480320|NCT02367794|27015927|FG000|Overall Study|Participant Enrolled in Extended Protocol|0|||
13480321|NCT02367794|27015928|FG001|Overall Study|Participant Enrolled in Extended Protocol|1|||
13480322|NCT02367794|27015929|FG002|Overall Study|Participant Enrolled in Extended Protocol|0|||
13480323|NCT02367794|27015927|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
13480324|NCT02367794|27015928|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
13480325|NCT02367794|27015929|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1|||
13480326|NCT02353832|27016044|FG000|Overall Study|Ineligible after enrollment|1|||
13480327|NCT02353832|27016044|FG000|Overall Study|Lost to Follow-up|1|||
13480328|NCT02353728|27016050|FG000|Overall Study|Subject non-compliance|1|||
13480329|NCT02345070|27016074|FG000|Overall Study|Adverse Event|12|||
13480330|NCT02345070|27016075|FG001|Overall Study|Adverse Event|8|||
13480331|NCT02345070|27016076|FG002|Overall Study|Adverse Event|16|||
13480332|NCT02345070|27016074|FG000|Overall Study|Poor compliance to protocol|2|||
13480333|NCT02345070|27016075|FG001|Overall Study|Poor compliance to protocol|0|||
13480334|NCT02345070|27016076|FG002|Overall Study|Poor compliance to protocol|0|||
13480335|NCT02345070|27016074|FG000|Overall Study|Other than specified above|6|||
13480336|NCT02345070|27016075|FG001|Overall Study|Other than specified above|3|||
13480337|NCT02345070|27016076|FG002|Overall Study|Other than specified above|7|||
13480338|NCT02325466|27016097|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
13480339|NCT02325466|27016098|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
13480340|NCT02325466|27016099|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1|||
13480341|NCT02325466|27016097|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
13480342|NCT02325466|27016098|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2|||
13480343|NCT02325466|27016099|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
13480344|NCT02325466|27016097|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1|||
13480345|NCT02325466|27016098|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0|||
13480346|NCT02325466|27016099|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2|||
13480347|NCT02325466|27016097|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1|||
13480348|NCT02325466|27016098|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
13480349|NCT02325466|27016099|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
13480350|NCT02325466|27016097|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
13480351|NCT02325466|27016098|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
13480352|NCT02325466|27016099|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0|||
13480353|NCT02325466|27016097|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1|||
13480354|NCT02325466|27016098|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
13480355|NCT02325466|27016099|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
13480356|NCT02325466|27016097|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1|||
13480357|NCT02325466|27016098|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
13480358|NCT02325466|27016099|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
13480359|NCT02325466|27016097|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
13480360|NCT02325466|27016098|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1|||
13480361|NCT02325466|27016099|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
13480362|NCT02325466|27016097|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
13480363|NCT02325466|27016098|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1|||
13480364|NCT02325466|27016099|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
13480365|NCT02322710|27016112|FG000|Overall Study|No efficacy assessment post-baseline|0|||
13480366|NCT02322710|27016113|FG001|Overall Study|No efficacy assessment post-baseline|1|||
13480367|NCT02322710|27016112|FG000|Overall Study|Protocol Violation|20|||
13480368|NCT02322710|27016113|FG001|Overall Study|Protocol Violation|25|||
13480369|NCT02234310|27016298|FG000|Overall Study|Physician Decision|1|||
13480370|NCT02234310|27016298|FG000|Overall Study|Adverse Event|1|||
13480371|NCT02234310|27016298|FG000|Overall Study|Eligibility Criteria not fulfilled|2|||
13480372|NCT02234310|27016298|FG000|Overall Study|Withdrawal by Subject|2|||
13480373|NCT02106195|27016392|FG000|Overall Study|Adverse Event|2|||
13480374|NCT02106195|27016392|FG000|Overall Study|Protocol Violation|1|||
13480375|NCT02104180|27016405|FG000|Overall Study|Protocol Violation|1|||
13480376|NCT02104180|27016406|FG001|Overall Study|Protocol Violation|0|||
13480377|NCT02040857|27016430|FG000|Overall Study|Adverse Event|14|||
13480378|NCT02040857|27016430|FG000|Overall Study|Physician Decision|5|||
13480379|NCT02040857|27016430|FG000|Overall Study|Withdrawal by Subject|31|||
13480380|NCT02040857|27016430|FG000|Overall Study|patient non-compliance|3|||
13480381|NCT02040857|27016430|FG000|Overall Study|Lost to Follow-up|2|||
13480382|NCT02040857|27016430|FG000|Overall Study|recurrence|4|||
13480383|NCT02040857|27016430|FG000|Overall Study|ineligible|1|||
13480384|NCT01943825|27016495|FG000|Overall Study|Lost to Follow-up|9|||
13480385|NCT01943825|27016496|FG001|Overall Study|Lost to Follow-up|3|||
13480386|NCT01943825|27016497|FG002|Overall Study|Lost to Follow-up|12|||
13480387|NCT01943825|27016498|FG003|Overall Study|Lost to Follow-up|8|||
13480388|NCT01943825|27016495|FG000|Overall Study|Withdrawal by Subject|1|||
13480389|NCT01943825|27016496|FG001|Overall Study|Withdrawal by Subject|0|||
13480390|NCT01943825|27016497|FG002|Overall Study|Withdrawal by Subject|3|||
13480391|NCT01943825|27016498|FG003|Overall Study|Withdrawal by Subject|2|||
13480392|NCT01943825|27016495|FG000|Overall Study|Other than specified above|0|||
13480393|NCT01943825|27016496|FG001|Overall Study|Other than specified above|1|||
13480394|NCT01943825|27016497|FG002|Overall Study|Other than specified above|0|||
13480395|NCT01943825|27016498|FG003|Overall Study|Other than specified above|1|||
13480396|NCT01817751|27016535|FG000|Overall Study|Physician Decision|1|||
13480397|NCT01722331|27016588|FG000|Part 1|Adverse Event|5|||
13480398|NCT01722331|27016589|FG001|Part 1|Adverse Event|0|||
13480399|NCT01722331|27016590|FG002|Part 1|Adverse Event|0|||
13480400|NCT01722331|27016591|FG003|Part 1|Adverse Event|0|||
13480401|NCT01722331|27016592|FG004|Part 1|Adverse Event|0|||
13480402|NCT01722331|27016593|FG005|Part 1|Adverse Event|0|||
13480403|NCT01722331|27016594|FG006|Part 1|Adverse Event|0|||
13480404|NCT01722331|27016588|FG000|Part 1|Lack of Efficacy|0|||
13480405|NCT01722331|27016589|FG001|Part 1|Lack of Efficacy|0|||
13480406|NCT01722331|27016590|FG002|Part 1|Lack of Efficacy|1|||
13480407|NCT01722331|27016591|FG003|Part 1|Lack of Efficacy|0|||
13480408|NCT01722331|27016592|FG004|Part 1|Lack of Efficacy|2|||
13480409|NCT01722331|27016593|FG005|Part 1|Lack of Efficacy|0|||
13480410|NCT01722331|27016594|FG006|Part 1|Lack of Efficacy|0|||
13480411|NCT01722331|27016588|FG000|Part 1|Lost to Follow-up|1|||
13480412|NCT01722331|27016589|FG001|Part 1|Lost to Follow-up|0|||
13480413|NCT01722331|27016590|FG002|Part 1|Lost to Follow-up|2|||
13480414|NCT01722331|27016591|FG003|Part 1|Lost to Follow-up|0|||
13480415|NCT01722331|27016592|FG004|Part 1|Lost to Follow-up|1|||
13480416|NCT01722331|27016593|FG005|Part 1|Lost to Follow-up|0|||
13480417|NCT01722331|27016594|FG006|Part 1|Lost to Follow-up|0|||
13480418|NCT01722331|27016588|FG000|Part 1|Physician Decision|0|||
13480419|NCT01722331|27016589|FG001|Part 1|Physician Decision|0|||
13480420|NCT01722331|27016590|FG002|Part 1|Physician Decision|3|||
13480421|NCT01722331|27016591|FG003|Part 1|Physician Decision|0|||
13480422|NCT01722331|27016592|FG004|Part 1|Physician Decision|1|||
13480423|NCT01722331|27016593|FG005|Part 1|Physician Decision|0|||
13480424|NCT01722331|27016594|FG006|Part 1|Physician Decision|0|||
13480425|NCT01722331|27016588|FG000|Part 1|Pregnancy|1|||
13480426|NCT01722331|27016589|FG001|Part 1|Pregnancy|0|||
13480427|NCT01722331|27016590|FG002|Part 1|Pregnancy|0|||
13480428|NCT01722331|27016591|FG003|Part 1|Pregnancy|0|||
13480429|NCT01722331|27016592|FG004|Part 1|Pregnancy|0|||
13480430|NCT01722331|27016593|FG005|Part 1|Pregnancy|0|||
13480431|NCT01722331|27016594|FG006|Part 1|Pregnancy|0|||
13480432|NCT01722331|27016588|FG000|Part 1|Progressive Disease|0|||
13480433|NCT01722331|27016589|FG001|Part 1|Progressive Disease|0|||
13480434|NCT01722331|27016590|FG002|Part 1|Progressive Disease|0|||
13480435|NCT01722331|27016591|FG003|Part 1|Progressive Disease|0|||
13480436|NCT01722331|27016592|FG004|Part 1|Progressive Disease|1|||
13480437|NCT01722331|27016593|FG005|Part 1|Progressive Disease|0|||
13480438|NCT01722331|27016594|FG006|Part 1|Progressive Disease|0|||
13480439|NCT01722331|27016588|FG000|Part 1|Protocol Violation|1|||
13480440|NCT01722331|27016589|FG001|Part 1|Protocol Violation|0|||
13480441|NCT01722331|27016590|FG002|Part 1|Protocol Violation|0|||
13480442|NCT01722331|27016591|FG003|Part 1|Protocol Violation|0|||
13480443|NCT01722331|27016592|FG004|Part 1|Protocol Violation|1|||
13480444|NCT01722331|27016593|FG005|Part 1|Protocol Violation|0|||
13480445|NCT01722331|27016594|FG006|Part 1|Protocol Violation|0|||
13480446|NCT01722331|27016588|FG000|Part 1|Withdrawal by Subject|2|||
13480447|NCT01722331|27016589|FG001|Part 1|Withdrawal by Subject|0|||
13480448|NCT01722331|27016590|FG002|Part 1|Withdrawal by Subject|3|||
13480449|NCT01722331|27016591|FG003|Part 1|Withdrawal by Subject|0|||
13480450|NCT01722331|27016592|FG004|Part 1|Withdrawal by Subject|3|||
13480451|NCT01722331|27016593|FG005|Part 1|Withdrawal by Subject|0|||
13480452|NCT01722331|27016594|FG006|Part 1|Withdrawal by Subject|0|||
13480453|NCT01722331|27016588|FG000|Part 2|Adverse Event|3|||
13480454|NCT01722331|27016589|FG001|Part 2|Adverse Event|0|||
13480455|NCT01722331|27016590|FG002|Part 2|Adverse Event|0|||
13480456|NCT01722331|27016591|FG003|Part 2|Adverse Event|0|||
13480457|NCT01722331|27016592|FG004|Part 2|Adverse Event|0|||
13480458|NCT01722331|27016593|FG005|Part 2|Adverse Event|1|||
13480459|NCT01722331|27016594|FG006|Part 2|Adverse Event|0|||
13480460|NCT01722331|27016588|FG000|Part 2|Lack of Efficacy|3|||
13480461|NCT01722331|27016589|FG001|Part 2|Lack of Efficacy|0|||
13480462|NCT01722331|27016590|FG002|Part 2|Lack of Efficacy|11|||
13480463|NCT01722331|27016591|FG003|Part 2|Lack of Efficacy|0|||
13480464|NCT01722331|27016592|FG004|Part 2|Lack of Efficacy|0|||
13480465|NCT01722331|27016593|FG005|Part 2|Lack of Efficacy|3|||
13480466|NCT01722331|27016594|FG006|Part 2|Lack of Efficacy|3|||
13480467|NCT01722331|27016588|FG000|Part 2|Lost to Follow-up|0|||
13480468|NCT01722331|27016589|FG001|Part 2|Lost to Follow-up|0|||
13480469|NCT01722331|27016590|FG002|Part 2|Lost to Follow-up|3|||
13480470|NCT01722331|27016591|FG003|Part 2|Lost to Follow-up|0|||
13480471|NCT01722331|27016592|FG004|Part 2|Lost to Follow-up|0|||
13480472|NCT01722331|27016593|FG005|Part 2|Lost to Follow-up|1|||
13480473|NCT01722331|27016594|FG006|Part 2|Lost to Follow-up|1|||
13480474|NCT01722331|27016588|FG000|Part 2|Non-Compliance with Study Drug|1|||
13480475|NCT01722331|27016589|FG001|Part 2|Non-Compliance with Study Drug|0|||
13480476|NCT01722331|27016590|FG002|Part 2|Non-Compliance with Study Drug|1|||
13480477|NCT01722331|27016591|FG003|Part 2|Non-Compliance with Study Drug|0|||
13480478|NCT01722331|27016592|FG004|Part 2|Non-Compliance with Study Drug|0|||
13480479|NCT01722331|27016593|FG005|Part 2|Non-Compliance with Study Drug|0|||
13480480|NCT01722331|27016594|FG006|Part 2|Non-Compliance with Study Drug|0|||
13480481|NCT01722331|27016588|FG000|Part 2|Physician Decision|0|||
13480482|NCT01722331|27016589|FG001|Part 2|Physician Decision|0|||
13480483|NCT01722331|27016590|FG002|Part 2|Physician Decision|2|||
13480484|NCT01722331|27016591|FG003|Part 2|Physician Decision|0|||
13480485|NCT01722331|27016592|FG004|Part 2|Physician Decision|0|||
13480486|NCT01722331|27016593|FG005|Part 2|Physician Decision|0|||
13480487|NCT01722331|27016594|FG006|Part 2|Physician Decision|0|||
13480488|NCT01722331|27016588|FG000|Part 2|Pregnancy|0|||
13480489|NCT01722331|27016589|FG001|Part 2|Pregnancy|0|||
13480490|NCT01722331|27016590|FG002|Part 2|Pregnancy|0|||
13480491|NCT01722331|27016591|FG003|Part 2|Pregnancy|0|||
13480492|NCT01722331|27016592|FG004|Part 2|Pregnancy|0|||
13480493|NCT01722331|27016593|FG005|Part 2|Pregnancy|1|||
13480494|NCT01722331|27016594|FG006|Part 2|Pregnancy|0|||
13480495|NCT01722331|27016588|FG000|Part 2|Progressive Disease|0|||
13480496|NCT01722331|27016589|FG001|Part 2|Progressive Disease|0|||
13480497|NCT01722331|27016590|FG002|Part 2|Progressive Disease|1|||
13480498|NCT01722331|27016591|FG003|Part 2|Progressive Disease|0|||
13480499|NCT01722331|27016592|FG004|Part 2|Progressive Disease|0|||
13480500|NCT01722331|27016593|FG005|Part 2|Progressive Disease|0|||
13480501|NCT01722331|27016594|FG006|Part 2|Progressive Disease|0|||
13480502|NCT01722331|27016588|FG000|Part 2|Protocol Violation|1|||
13480503|NCT01722331|27016589|FG001|Part 2|Protocol Violation|0|||
13480504|NCT01722331|27016590|FG002|Part 2|Protocol Violation|0|||
13480505|NCT01722331|27016591|FG003|Part 2|Protocol Violation|0|||
13480506|NCT01722331|27016592|FG004|Part 2|Protocol Violation|0|||
13480507|NCT01722331|27016593|FG005|Part 2|Protocol Violation|0|||
13480508|NCT01722331|27016594|FG006|Part 2|Protocol Violation|0|||
13480509|NCT01722331|27016588|FG000|Part 2|Withdrawal by Subject|5|||
13480510|NCT01722331|27016589|FG001|Part 2|Withdrawal by Subject|0|||
13480511|NCT01722331|27016590|FG002|Part 2|Withdrawal by Subject|3|||
13480512|NCT01722331|27016591|FG003|Part 2|Withdrawal by Subject|0|||
13480513|NCT01722331|27016592|FG004|Part 2|Withdrawal by Subject|0|||
13480514|NCT01722331|27016593|FG005|Part 2|Withdrawal by Subject|2|||
13480515|NCT01722331|27016594|FG006|Part 2|Withdrawal by Subject|2|||
13480516|NCT01722331|27016588|FG000|Part 2|Other Protocol Specified Criteria|6|||
13480517|NCT01722331|27016589|FG001|Part 2|Other Protocol Specified Criteria|0|||
13480518|NCT01722331|27016590|FG002|Part 2|Other Protocol Specified Criteria|10|||
13480519|NCT01722331|27016591|FG003|Part 2|Other Protocol Specified Criteria|0|||
13480520|NCT01722331|27016592|FG004|Part 2|Other Protocol Specified Criteria|0|||
13480521|NCT01722331|27016593|FG005|Part 2|Other Protocol Specified Criteria|2|||
13480522|NCT01722331|27016594|FG006|Part 2|Other Protocol Specified Criteria|1|||
13480523|NCT01722331|27016588|FG000|Part 3|Adverse Event|2|||
13480524|NCT01722331|27016589|FG001|Part 3|Adverse Event|2|||
13480525|NCT01722331|27016590|FG002|Part 3|Adverse Event|0|||
13480526|NCT01722331|27016591|FG003|Part 3|Adverse Event|1|||
13480527|NCT01722331|27016592|FG004|Part 3|Adverse Event|0|||
13480528|NCT01722331|27016593|FG005|Part 3|Adverse Event|0|||
13480529|NCT01722331|27016594|FG006|Part 3|Adverse Event|0|||
13480530|NCT01722331|27016588|FG000|Part 3|Death|1|||
13480531|NCT01722331|27016589|FG001|Part 3|Death|0|||
13480532|NCT01722331|27016590|FG002|Part 3|Death|0|||
13480533|NCT01722331|27016591|FG003|Part 3|Death|0|||
13480534|NCT01722331|27016592|FG004|Part 3|Death|0|||
13480535|NCT01722331|27016593|FG005|Part 3|Death|0|||
13480536|NCT01722331|27016594|FG006|Part 3|Death|0|||
13480537|NCT01722331|27016588|FG000|Part 3|Lack of Efficacy|1|||
13480538|NCT01722331|27016589|FG001|Part 3|Lack of Efficacy|0|||
13480539|NCT01722331|27016590|FG002|Part 3|Lack of Efficacy|0|||
13480540|NCT01722331|27016591|FG003|Part 3|Lack of Efficacy|0|||
13480541|NCT01722331|27016592|FG004|Part 3|Lack of Efficacy|0|||
13480542|NCT01722331|27016593|FG005|Part 3|Lack of Efficacy|0|||
13480543|NCT01722331|27016594|FG006|Part 3|Lack of Efficacy|0|||
13480544|NCT01722331|27016588|FG000|Part 3|Lost to Follow-up|3|||
13480545|NCT01722331|27016589|FG001|Part 3|Lost to Follow-up|4|||
13480546|NCT01722331|27016590|FG002|Part 3|Lost to Follow-up|0|||
13480547|NCT01722331|27016591|FG003|Part 3|Lost to Follow-up|0|||
13480548|NCT01722331|27016592|FG004|Part 3|Lost to Follow-up|0|||
13480549|NCT01722331|27016593|FG005|Part 3|Lost to Follow-up|1|||
13480550|NCT01722331|27016594|FG006|Part 3|Lost to Follow-up|0|||
13480551|NCT01722331|27016588|FG000|Part 3|Non-Compliance with Study Drug|0|||
13480552|NCT01722331|27016589|FG001|Part 3|Non-Compliance with Study Drug|1|||
13480553|NCT01722331|27016590|FG002|Part 3|Non-Compliance with Study Drug|0|||
13480554|NCT01722331|27016591|FG003|Part 3|Non-Compliance with Study Drug|0|||
13480555|NCT01722331|27016592|FG004|Part 3|Non-Compliance with Study Drug|0|||
13480556|NCT01722331|27016593|FG005|Part 3|Non-Compliance with Study Drug|0|||
13480557|NCT01722331|27016594|FG006|Part 3|Non-Compliance with Study Drug|0|||
13480558|NCT01722331|27016588|FG000|Part 3|Physician Decision|1|||
13480559|NCT01722331|27016589|FG001|Part 3|Physician Decision|1|||
13480560|NCT01722331|27016590|FG002|Part 3|Physician Decision|0|||
13480561|NCT01722331|27016591|FG003|Part 3|Physician Decision|0|||
13480562|NCT01722331|27016592|FG004|Part 3|Physician Decision|0|||
13480563|NCT01722331|27016593|FG005|Part 3|Physician Decision|0|||
13480564|NCT01722331|27016594|FG006|Part 3|Physician Decision|1|||
13480565|NCT01722331|27016588|FG000|Part 3|Protocol Violation|2|||
13480566|NCT01722331|27016589|FG001|Part 3|Protocol Violation|1|||
13480567|NCT01722331|27016590|FG002|Part 3|Protocol Violation|0|||
13480568|NCT01722331|27016591|FG003|Part 3|Protocol Violation|0|||
13480569|NCT01722331|27016592|FG004|Part 3|Protocol Violation|0|||
13480570|NCT01722331|27016593|FG005|Part 3|Protocol Violation|0|||
13480571|NCT01722331|27016594|FG006|Part 3|Protocol Violation|0|||
13480572|NCT01722331|27016588|FG000|Part 3|Withdrawal by Subject|4|||
13480573|NCT01722331|27016589|FG001|Part 3|Withdrawal by Subject|7|||
13480574|NCT01722331|27016590|FG002|Part 3|Withdrawal by Subject|0|||
13480575|NCT01722331|27016591|FG003|Part 3|Withdrawal by Subject|0|||
13480576|NCT01722331|27016592|FG004|Part 3|Withdrawal by Subject|0|||
13480577|NCT01722331|27016593|FG005|Part 3|Withdrawal by Subject|2|||
13480578|NCT01722331|27016594|FG006|Part 3|Withdrawal by Subject|1|||
13480579|NCT01722331|27016588|FG000|Part 3|Other Protocol Specified Criteria|1|||
13480580|NCT01722331|27016589|FG001|Part 3|Other Protocol Specified Criteria|1|||
13480581|NCT01722331|27016590|FG002|Part 3|Other Protocol Specified Criteria|0|||
13480582|NCT01722331|27016591|FG003|Part 3|Other Protocol Specified Criteria|0|||
13480583|NCT01722331|27016592|FG004|Part 3|Other Protocol Specified Criteria|0|||
13480584|NCT01722331|27016593|FG005|Part 3|Other Protocol Specified Criteria|0|||
13480585|NCT01722331|27016594|FG006|Part 3|Other Protocol Specified Criteria|0|||
13480586|NCT01698905|27016607|FG000|Overall Study|Adverse Event|4|||
13480587|NCT01698905|27016607|FG000|Overall Study|Physician Decision|2|||
13480588|NCT01698905|27016607|FG000|Overall Study|Pregnancy|1|||
13480589|NCT01698905|27016607|FG000|Overall Study|Protocol Violation|1|||
13480590|NCT01698905|27016607|FG000|Overall Study|Subject/guardian decision|2|||
13480591|NCT01698905|27016607|FG000|Overall Study|Death|1|||
13480592|NCT01630590|27016614|FG000|Overall Study|Adverse Event|9|||
13480593|NCT01630590|27016614|FG000|Overall Study|Lack of Efficacy|37|||
13480594|NCT01630590|27016614|FG000|Overall Study|Withdrawal by Subject|4|||
13480595|NCT01630590|27016614|FG000|Overall Study|2nd primary tumor|2|||
13480596|NCT01630590|27016614|FG000|Overall Study|Automobile accident|1|||
13480597|NCT01630590|27016614|FG000|Overall Study|Maximum benefit|4|||
13480598|NCT01619085|27016627|FG000|Overall Study|Adverse Event|231|||
13480599|NCT01619085|27016627|FG000|Overall Study|Protocol Violation|4|||
13480600|NCT01619085|27016627|FG000|Overall Study|Lost to Follow-up|3|||
13480601|NCT01619085|27016627|FG000|Overall Study|Withdrawal by Subject|45|||
13480602|NCT01619085|27016627|FG000|Overall Study|Other than specified|96|||
13480603|NCT01619085|27016627|FG000|Overall Study|Not treated|1|||
13480604|NCT01619085|27016627|FG000|Overall Study|Death|145|||
13487019|NCT00965757|27037778|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3|||
13487020|NCT00965757|27037779|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0|||
13487021|NCT00965757|27037780|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0|||
13487022|NCT00965757|27037777|FG000|Double-blind Phase|Other|1|||
13487023|NCT00965757|27037778|FG001|Double-blind Phase|Other|0|||
13487024|NCT00965757|27037779|FG002|Double-blind Phase|Other|0|||
13487025|NCT00965757|27037780|FG003|Double-blind Phase|Other|0|||
13487026|NCT00965757|27037777|FG000|Extension Phase|Progression of concomitant disease|0|||
13487027|NCT00965757|27037778|FG001|Extension Phase|Progression of concomitant disease|0|||
13487028|NCT00965757|27037779|FG002|Extension Phase|Progression of concomitant disease|4|||
13487029|NCT00965757|27037780|FG003|Extension Phase|Progression of concomitant disease|2|||
13487030|NCT00965757|27037777|FG000|Extension Phase|Adverse drug reaction|0|||
13487031|NCT00965757|27037778|FG001|Extension Phase|Adverse drug reaction|0|||
13487032|NCT00965757|27037779|FG002|Extension Phase|Adverse drug reaction|6|||
13487033|NCT00965757|27037780|FG003|Extension Phase|Adverse drug reaction|3|||
13487034|NCT00965757|27037777|FG000|Extension Phase|Abnormal Laboratory Value|0|||
13487035|NCT00965757|27037778|FG001|Extension Phase|Abnormal Laboratory Value|0|||
13487036|NCT00965757|27037779|FG002|Extension Phase|Abnormal Laboratory Value|6|||
13487037|NCT00965757|27037780|FG003|Extension Phase|Abnormal Laboratory Value|1|||
13487038|NCT00965757|27037777|FG000|Extension Phase|Lack of Efficacy|0|||
13487039|NCT00965757|27037778|FG001|Extension Phase|Lack of Efficacy|0|||
13487040|NCT00965757|27037779|FG002|Extension Phase|Lack of Efficacy|8|||
13487041|NCT00965757|27037780|FG003|Extension Phase|Lack of Efficacy|12|||
13487042|NCT00965757|27037777|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0|||
13487043|NCT00965757|27037778|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0|||
13487044|NCT00965757|27037779|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4|||
13487045|NCT00965757|27037780|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0|||
13487046|NCT00965757|27037777|FG000|Extension Phase|Lost to Follow-up|0|||
13487047|NCT00965757|27037778|FG001|Extension Phase|Lost to Follow-up|0|||
13487048|NCT00965757|27037779|FG002|Extension Phase|Lost to Follow-up|0|||
13487049|NCT00965757|27037780|FG003|Extension Phase|Lost to Follow-up|1|||
13487050|NCT00965757|27037777|FG000|Extension Phase|Ineligible after Taking Study Drug|0|||
13487051|NCT00965757|27037778|FG001|Extension Phase|Ineligible after Taking Study Drug|0|||
13487052|NCT00965757|27037779|FG002|Extension Phase|Ineligible after Taking Study Drug|3|||
13487053|NCT00965757|27037780|FG003|Extension Phase|Ineligible after Taking Study Drug|3|||
13487054|NCT00965757|27037777|FG000|Extension Phase|Protocol Violation|0|||
13487055|NCT00965757|27037778|FG001|Extension Phase|Protocol Violation|0|||
13487056|NCT00965757|27037779|FG002|Extension Phase|Protocol Violation|0|||
13487057|NCT00965757|27037780|FG003|Extension Phase|Protocol Violation|1|||
13487058|NCT00965757|27037777|FG000|Extension Phase|Other|0|||
13487059|NCT00965757|27037778|FG001|Extension Phase|Other|0|||
13487060|NCT00965757|27037779|FG002|Extension Phase|Other|2|||
13487061|NCT00965757|27037780|FG003|Extension Phase|Other|1|||
13487062|NCT00928447|27037790|FG000|Overall Study|Withdrawal by Subject|1|||
13487063|NCT00928447|27037790|FG000|Overall Study|Investigator's decision|1|||
13487064|NCT00893789|27037885|FG000|Overall Study|Withdrawal by Subject|3|||
13487065|NCT00893789|27037886|FG001|Overall Study|Withdrawal by Subject|1|||
13487066|NCT00893789|27037887|FG002|Overall Study|Withdrawal by Subject|3|||
13487067|NCT00893789|27037888|FG003|Overall Study|Withdrawal by Subject|1|||
13480605|NCT01499095|27016662|FG000|Overall Study|Randomized But Not Treated|1|||
13480606|NCT01499095|27016663|FG001|Overall Study|Randomized But Not Treated|1|||
13480607|NCT01499095|27016662|FG000|Overall Study|Adverse Event|12|||
13480608|NCT01499095|27016663|FG001|Overall Study|Adverse Event|7|||
13480609|NCT01499095|27016662|FG000|Overall Study|Lack of Efficacy|2|||
13480610|NCT01499095|27016663|FG001|Overall Study|Lack of Efficacy|1|||
13480611|NCT01499095|27016662|FG000|Overall Study|Protocol Violation|6|||
13480612|NCT01499095|27016663|FG001|Overall Study|Protocol Violation|7|||
13480613|NCT01499095|27016662|FG000|Overall Study|Received Rescue Therapy|32|||
13480614|NCT01499095|27016663|FG001|Overall Study|Received Rescue Therapy|40|||
13480615|NCT01499095|27016662|FG000|Overall Study|Diverse Reasons|22|||
13480616|NCT01499095|27016663|FG001|Overall Study|Diverse Reasons|25|||
13480617|NCT01499095|27016662|FG000|Overall Study|Lost to Follow-up|6|||
13480618|NCT01499095|27016663|FG001|Overall Study|Lost to Follow-up|4|||
13480619|NCT01499095|27016662|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0|||
13480620|NCT01499095|27016663|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5|||
13480621|NCT01499095|27016662|FG000|Overall Study|Hypoglycemia|3|||
13480622|NCT01499095|27016663|FG001|Overall Study|Hypoglycemia|1|||
13480623|NCT01499095|27016662|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2|||
13480624|NCT01499095|27016663|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1|||
13480625|NCT01499095|27016662|FG000|Overall Study|Change in Injection Schedule|2|||
13480626|NCT01499095|27016663|FG001|Overall Study|Change in Injection Schedule|0|||
13480627|NCT01499095|27016662|FG000|Overall Study|Perceived Lack of Efficacy|1|||
13480628|NCT01499095|27016663|FG001|Overall Study|Perceived Lack of Efficacy|1|||
13480629|NCT01499082|27016698|FG000|Overall Study|Randomized but not Treated|0|||
13480630|NCT01499082|27016699|FG001|Overall Study|Randomized but not Treated|1|||
13480631|NCT01499082|27016698|FG000|Overall Study|Adverse Event|12|||
13480632|NCT01499082|27016699|FG001|Overall Study|Adverse Event|16|||
13480633|NCT01499082|27016698|FG000|Overall Study|Lack of Efficacy|1|||
13480634|NCT01499082|27016699|FG001|Overall Study|Lack of Efficacy|1|||
13480635|NCT01499082|27016698|FG000|Overall Study|Protocol Violation|6|||
13480636|NCT01499082|27016699|FG001|Overall Study|Protocol Violation|8|||
13480637|NCT01499082|27016698|FG000|Overall Study|Diverse Reasons|18|||
13480638|NCT01499082|27016699|FG001|Overall Study|Diverse Reasons|14|||
13480639|NCT01499082|27016698|FG000|Overall Study|Site Closure for Noncompliance|5|||
13480640|NCT01499082|27016699|FG001|Overall Study|Site Closure for Noncompliance|2|||
13480641|NCT01499082|27016698|FG000|Overall Study|Hypoglycemia|2|||
13480642|NCT01499082|27016699|FG001|Overall Study|Hypoglycemia|3|||
13480643|NCT01499082|27016698|FG000|Overall Study|Lost to Follow-up|1|||
13480644|NCT01499082|27016699|FG001|Overall Study|Lost to Follow-up|3|||
13480645|NCT01488890|27016750|FG000|Overall Study|Serious adverse event|2|||
13480646|NCT01488890|27016751|FG001|Overall Study|Serious adverse event|0|||
13480647|NCT01488890|27016752|FG002|Overall Study|Serious adverse event|0|||
13480648|NCT01488890|27016753|FG003|Overall Study|Serious adverse event|0|||
13480649|NCT01488890|27016750|FG000|Overall Study|Protocol Violation|3|||
13480650|NCT01488890|27016751|FG001|Overall Study|Protocol Violation|0|||
13480651|NCT01488890|27016752|FG002|Overall Study|Protocol Violation|4|||
13480652|NCT01488890|27016753|FG003|Overall Study|Protocol Violation|0|||
13480653|NCT01488890|27016750|FG000|Overall Study|Lost to Follow-up|13|||
13480654|NCT01488890|27016751|FG001|Overall Study|Lost to Follow-up|10|||
13480655|NCT01488890|27016752|FG002|Overall Study|Lost to Follow-up|20|||
13480656|NCT01488890|27016753|FG003|Overall Study|Lost to Follow-up|3|||
13480657|NCT01488890|27016750|FG000|Overall Study|Withdrawal by Subject|14|||
13480658|NCT01488890|27016751|FG001|Overall Study|Withdrawal by Subject|10|||
13480659|NCT01488890|27016752|FG002|Overall Study|Withdrawal by Subject|11|||
13480660|NCT01488890|27016753|FG003|Overall Study|Withdrawal by Subject|2|||
13480661|NCT01436396|27016792|FG000|Overall Study|Protocol Violation|7|||
13480662|NCT01436396|27016793|FG001|Overall Study|Protocol Violation|5|||
13480663|NCT01436396|27016792|FG000|Overall Study|Adverse Event|1|||
13480664|NCT01436396|27016793|FG001|Overall Study|Adverse Event|2|||
13480665|NCT01436396|27016792|FG000|Overall Study|Withdrawal by Subject|19|||
13480666|NCT01436396|27016793|FG001|Overall Study|Withdrawal by Subject|29|||
13480667|NCT01436396|27016792|FG000|Overall Study|Serious adverse event|2|||
13480668|NCT01436396|27016793|FG001|Overall Study|Serious adverse event|3|||
13480669|NCT01436396|27016792|FG000|Overall Study|Lost to Follow-up|3|||
13480670|NCT01436396|27016793|FG001|Overall Study|Lost to Follow-up|3|||
13480671|NCT01411241|27016822|FG000|Overall Study|Protocol Violation|0|||
13480672|NCT01411241|27016823|FG001|Overall Study|Protocol Violation|5|||
13480673|NCT01411241|27016822|FG000|Overall Study|Withdrawal by Subject|9|||
13480674|NCT01411241|27016823|FG001|Overall Study|Withdrawal by Subject|10|||
13480675|NCT01411241|27016822|FG000|Overall Study|Serious Adverse Event|0|||
13480676|NCT01411241|27016823|FG001|Overall Study|Serious Adverse Event|3|||
13480677|NCT01411241|27016822|FG000|Overall Study|Lost to Follow-up|2|||
13480678|NCT01411241|27016823|FG001|Overall Study|Lost to Follow-up|4|||
13480679|NCT01374516|27016862|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43|||
13480680|NCT01374516|27016863|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14|||
13480681|NCT01374516|27016862|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3|||
13480682|NCT01374516|27016863|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0|||
13480683|NCT01374516|27016862|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480|||
13480684|NCT01374516|27016863|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240|||
13480685|NCT01374516|27016862|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106|||
13480686|NCT01374516|27016863|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46|||
13480687|NCT01374516|27016862|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7|||
13480688|NCT01374516|27016863|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9|||
13480689|NCT01374516|27016862|FG000|Surveillance Expansion Period|Protocol Violation|386|||
13480690|NCT01374516|27016863|FG001|Surveillance Expansion Period|Protocol Violation|217|||
13480691|NCT01374516|27016862|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870|||
13480692|NCT01374516|27016863|FG001|Surveillance Expansion Period|Withdrawal by Subject|986|||
13480693|NCT01374516|27016862|FG000|Surveillance Expansion Period|Lost to Follow-up|73|||
13480694|NCT01374516|27016863|FG001|Surveillance Expansion Period|Lost to Follow-up|45|||
13480695|NCT01374516|27016862|FG000|Surveillance Expansion Period|Serious adverse event|20|||
13480696|NCT01374516|27016863|FG001|Surveillance Expansion Period|Serious adverse event|5|||
13480697|NCT01373281|27016902|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40|||
13480698|NCT01373281|27016903|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23|||
13480699|NCT01373281|27016902|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5|||
13480700|NCT01373281|27016903|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2|||
13480701|NCT01373281|27016902|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5|||
13480702|NCT01373281|27016903|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1|||
13480703|NCT01373281|27016902|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4|||
13480704|NCT01373281|27016903|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1|||
13480705|NCT01373281|27016902|FG000|Surveillance Expansion Period|Withdrawal by Subject|180|||
13480706|NCT01373281|27016903|FG001|Surveillance Expansion Period|Withdrawal by Subject|105|||
13480707|NCT01373281|27016902|FG000|Surveillance Expansion Period|Protocol Violation|9|||
13480708|NCT01373281|27016903|FG001|Surveillance Expansion Period|Protocol Violation|1|||
13480709|NCT01373281|27016902|FG000|Surveillance Expansion Period|Lost to Follow-up|10|||
13480710|NCT01373281|27016903|FG001|Surveillance Expansion Period|Lost to Follow-up|8|||
13480711|NCT01373281|27016902|FG000|Surveillance Expansion Period|Serious adverse event|3|||
13480712|NCT01373281|27016903|FG001|Surveillance Expansion Period|Serious adverse event|4|||
13480713|NCT01302847|27017058|FG000|Overall Study|Ongoing|0|||
13480714|NCT01302847|27017059|FG001|Overall Study|Ongoing|0|||
13480715|NCT01302847|27017060|FG002|Overall Study|Ongoing|0|||
13480716|NCT01302847|27017061|FG003|Overall Study|Ongoing|0|||
13480717|NCT01302847|27017062|FG004|Overall Study|Ongoing|0|||
13480718|NCT01302847|27017063|FG005|Overall Study|Ongoing|27|||
13480719|NCT01302847|27017064|FG006|Overall Study|Ongoing|22|||
13480720|NCT01302847|27017065|FG007|Overall Study|Ongoing|17|||
13480721|NCT01302847|27017058|FG000|Overall Study|Death|0|||
13480722|NCT01302847|27017059|FG001|Overall Study|Death|1|||
13480723|NCT01302847|27017060|FG002|Overall Study|Death|0|||
13480724|NCT01302847|27017061|FG003|Overall Study|Death|0|||
13480725|NCT01302847|27017062|FG004|Overall Study|Death|0|||
13480726|NCT01302847|27017063|FG005|Overall Study|Death|1|||
13480727|NCT01302847|27017064|FG006|Overall Study|Death|1|||
13480728|NCT01302847|27017065|FG007|Overall Study|Death|0|||
13480729|NCT01302847|27017058|FG000|Overall Study|Pregnancy|2|||
13480730|NCT01302847|27017059|FG001|Overall Study|Pregnancy|0|||
13480731|NCT01302847|27017060|FG002|Overall Study|Pregnancy|0|||
13480732|NCT01302847|27017061|FG003|Overall Study|Pregnancy|0|||
13480733|NCT01302847|27017062|FG004|Overall Study|Pregnancy|0|||
13480734|NCT01302847|27017063|FG005|Overall Study|Pregnancy|0|||
13480735|NCT01302847|27017064|FG006|Overall Study|Pregnancy|0|||
13480736|NCT01302847|27017065|FG007|Overall Study|Pregnancy|0|||
13480737|NCT01302847|27017058|FG000|Overall Study|Virologic failure|0|||
13480738|NCT01302847|27017059|FG001|Overall Study|Virologic failure|2|||
13480739|NCT01302847|27017060|FG002|Overall Study|Virologic failure|2|||
13480740|NCT01302847|27017061|FG003|Overall Study|Virologic failure|0|||
13480741|NCT01302847|27017062|FG004|Overall Study|Virologic failure|1|||
13480742|NCT01302847|27017063|FG005|Overall Study|Virologic failure|1|||
13480743|NCT01302847|27017064|FG006|Overall Study|Virologic failure|0|||
13480744|NCT01302847|27017065|FG007|Overall Study|Virologic failure|2|||
13480745|NCT01302847|27017058|FG000|Overall Study|Severe debilitation, unable to continue|0|||
13480746|NCT01302847|27017059|FG001|Overall Study|Severe debilitation, unable to continue|0|||
13480747|NCT01302847|27017060|FG002|Overall Study|Severe debilitation, unable to continue|0|||
13480748|NCT01302847|27017061|FG003|Overall Study|Severe debilitation, unable to continue|0|||
13480749|NCT01302847|27017062|FG004|Overall Study|Severe debilitation, unable to continue|0|||
13480750|NCT01302847|27017063|FG005|Overall Study|Severe debilitation, unable to continue|1|||
13480751|NCT01302847|27017064|FG006|Overall Study|Severe debilitation, unable to continue|1|||
13480752|NCT01302847|27017065|FG007|Overall Study|Severe debilitation, unable to continue|0|||
13480753|NCT01302847|27017058|FG000|Overall Study|Not able to get to clinic|1|||
13480754|NCT01302847|27017059|FG001|Overall Study|Not able to get to clinic|1|||
13480755|NCT01302847|27017060|FG002|Overall Study|Not able to get to clinic|0|||
13480756|NCT01302847|27017061|FG003|Overall Study|Not able to get to clinic|0|||
13480757|NCT01302847|27017062|FG004|Overall Study|Not able to get to clinic|0|||
13480758|NCT01302847|27017063|FG005|Overall Study|Not able to get to clinic|0|||
13480759|NCT01302847|27017064|FG006|Overall Study|Not able to get to clinic|0|||
13480760|NCT01302847|27017065|FG007|Overall Study|Not able to get to clinic|0|||
13480761|NCT01302847|27017058|FG000|Overall Study|Site closing|2|||
13480762|NCT01302847|27017059|FG001|Overall Study|Site closing|2|||
13480763|NCT01302847|27017060|FG002|Overall Study|Site closing|0|||
13480764|NCT01302847|27017061|FG003|Overall Study|Site closing|0|||
13480765|NCT01302847|27017062|FG004|Overall Study|Site closing|0|||
13480766|NCT01302847|27017063|FG005|Overall Study|Site closing|0|||
13480767|NCT01302847|27017064|FG006|Overall Study|Site closing|0|||
13480768|NCT01302847|27017065|FG007|Overall Study|Site closing|0|||
13480769|NCT01302847|27017058|FG000|Overall Study|Withdrawal by Subject|1|||
13480770|NCT01302847|27017059|FG001|Overall Study|Withdrawal by Subject|0|||
13480771|NCT01302847|27017060|FG002|Overall Study|Withdrawal by Subject|0|||
13480772|NCT01302847|27017061|FG003|Overall Study|Withdrawal by Subject|0|||
13480773|NCT01302847|27017062|FG004|Overall Study|Withdrawal by Subject|1|||
13480774|NCT01302847|27017063|FG005|Overall Study|Withdrawal by Subject|0|||
13480775|NCT01302847|27017064|FG006|Overall Study|Withdrawal by Subject|0|||
13480776|NCT01302847|27017065|FG007|Overall Study|Withdrawal by Subject|1|||
13480777|NCT01302847|27017058|FG000|Overall Study|Not willing to adhere to requirements|5|||
13480778|NCT01302847|27017059|FG001|Overall Study|Not willing to adhere to requirements|0|||
13480779|NCT01302847|27017060|FG002|Overall Study|Not willing to adhere to requirements|0|||
13480780|NCT01302847|27017061|FG003|Overall Study|Not willing to adhere to requirements|1|||
13480781|NCT01302847|27017062|FG004|Overall Study|Not willing to adhere to requirements|0|||
13480782|NCT01302847|27017063|FG005|Overall Study|Not willing to adhere to requirements|0|||
13480783|NCT01302847|27017064|FG006|Overall Study|Not willing to adhere to requirements|0|||
13480784|NCT01302847|27017065|FG007|Overall Study|Not willing to adhere to requirements|2|||
13480785|NCT01302847|27017058|FG000|Overall Study|Site unable to contact participant|2|||
13480786|NCT01302847|27017059|FG001|Overall Study|Site unable to contact participant|1|||
13480787|NCT01302847|27017060|FG002|Overall Study|Site unable to contact participant|0|||
13480788|NCT01302847|27017061|FG003|Overall Study|Site unable to contact participant|0|||
13480789|NCT01302847|27017062|FG004|Overall Study|Site unable to contact participant|0|||
13480790|NCT01302847|27017063|FG005|Overall Study|Site unable to contact participant|0|||
13480791|NCT01302847|27017064|FG006|Overall Study|Site unable to contact participant|2|||
13480792|NCT01302847|27017065|FG007|Overall Study|Site unable to contact participant|0|||
13480793|NCT01287611|27017080|FG000|Overall Study|Lost to Follow-up|29|||
13480794|NCT01287611|27017081|FG001|Overall Study|Lost to Follow-up|16|||
13480795|NCT01287611|27017080|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
13480796|NCT01287611|27017081|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
13480797|NCT01254422|27017112|FG000|Overall Study|Protocol Violation|1|||
13480798|NCT01254422|27017113|FG001|Overall Study|Protocol Violation|0|||
13480799|NCT01254422|27017112|FG000|Overall Study|Adverse Event|1|||
13480800|NCT01254422|27017113|FG001|Overall Study|Adverse Event|0|||
13480801|NCT01254422|27017112|FG000|Overall Study|Serious adverse event|0|||
13480802|NCT01254422|27017113|FG001|Overall Study|Serious adverse event|1|||
13480803|NCT01254422|27017112|FG000|Overall Study|Lost to Follow-up|1|||
13480804|NCT01254422|27017113|FG001|Overall Study|Lost to Follow-up|0|||
13480805|NCT01187433|27017146|FG000|Overall Study|Protocol Violation|6|||
13480806|NCT01187433|27017147|FG001|Overall Study|Protocol Violation|2|||
13480807|NCT01187433|27017146|FG000|Overall Study|Withdrawal by Subject|5|||
13480808|NCT01187433|27017147|FG001|Overall Study|Withdrawal by Subject|2|||
13480809|NCT01150045|27017170|FG000|Overall Study|Protocol Violation|0|||
13480810|NCT01150045|27017171|FG001|Overall Study|Protocol Violation|1|||
13480811|NCT01150045|27017172|FG002|Overall Study|Protocol Violation|0|||
13480812|NCT01150045|27017173|FG003|Overall Study|Protocol Violation|1|||
13480813|NCT01098032|27017186|FG000|Overall Study|Withdrawal by Subject|1|||
13480814|NCT01098032|27017187|FG001|Overall Study|Withdrawal by Subject|1|||
13480815|NCT01034306|27017204|FG000|Overall Study|Adverse Event|1|||
13480816|NCT01034306|27017205|FG001|Overall Study|Adverse Event|0|||
13480817|NCT01034306|27017204|FG000|Overall Study|Lost to Follow-up|0|||
13480818|NCT01034306|27017205|FG001|Overall Study|Lost to Follow-up|1|||
13480819|NCT01034306|27017204|FG000|Overall Study|Withdrawal by Subject|2|||
13480820|NCT01034306|27017205|FG001|Overall Study|Withdrawal by Subject|2|||
13480821|NCT01034306|27017204|FG000|Overall Study|hospitalized and decided to stop|1|||
13480822|NCT01034306|27017205|FG001|Overall Study|hospitalized and decided to stop|0|||
13480823|NCT01034306|27017204|FG000|Overall Study|Noncomplience|1|||
13480824|NCT01034306|27017205|FG001|Overall Study|Noncomplience|0|||
13480825|NCT00993447|27017242|FG000|Overall Study|Withdrawal by Subject|23|||
13480826|NCT00993447|27017243|FG001|Overall Study|Withdrawal by Subject|8|||
13480827|NCT00993447|27017242|FG000|Overall Study|Protocol Violation|12|||
13480828|NCT00993447|27017243|FG001|Overall Study|Protocol Violation|8|||
13480829|NCT00993447|27017242|FG000|Overall Study|Lost to Follow-up|1|||
13480830|NCT00993447|27017243|FG001|Overall Study|Lost to Follow-up|3|||
13480831|NCT00993447|27017242|FG000|Overall Study|Adverse Event|1|||
13480832|NCT00993447|27017243|FG001|Overall Study|Adverse Event|0|||
13480833|NCT00945009|27017263|FG000|Overall Study|Lack of Efficacy|10|||
13480834|NCT00945009|27017264|FG001|Overall Study|Lack of Efficacy|0|||
13480835|NCT00945009|27017265|FG002|Overall Study|Lack of Efficacy|0|||
13480836|NCT00945009|27017263|FG000|Overall Study|Physician Decision|21|||
13480837|NCT00945009|27017264|FG001|Overall Study|Physician Decision|4|||
13480838|NCT00945009|27017265|FG002|Overall Study|Physician Decision|3|||
13480839|NCT00945009|27017263|FG000|Overall Study|Protocol Violation|6|||
13480840|NCT00945009|27017264|FG001|Overall Study|Protocol Violation|1|||
13480841|NCT00945009|27017265|FG002|Overall Study|Protocol Violation|0|||
13480842|NCT00945009|27017263|FG000|Overall Study|Withdrawal by Subject|1|||
13480843|NCT00945009|27017264|FG001|Overall Study|Withdrawal by Subject|0|||
13480844|NCT00945009|27017265|FG002|Overall Study|Withdrawal by Subject|0|||
13480845|NCT00945009|27017263|FG000|Overall Study|Ineligible|6|||
13480846|NCT00945009|27017264|FG001|Overall Study|Ineligible|1|||
13480847|NCT00945009|27017265|FG002|Overall Study|Ineligible|0|||
13480848|NCT00945009|27017263|FG000|Overall Study|Inevaluable|0|||
13480849|NCT00945009|27017264|FG001|Overall Study|Inevaluable|1|||
13480850|NCT00945009|27017265|FG002|Overall Study|Inevaluable|0|||
13480851|NCT00945009|27017263|FG000|Overall Study|Refusal of further protocol|1|||
13480852|NCT00945009|27017264|FG001|Overall Study|Refusal of further protocol|0|||
13480853|NCT00945009|27017265|FG002|Overall Study|Refusal of further protocol|0|||
13480854|NCT00942877|27017282|FG000|Overall Study|Refused further treatment|1|||
13480855|NCT00942877|27017283|FG001|Overall Study|Refused further treatment|1|||
13480856|NCT00942877|27017282|FG000|Overall Study|Patient was not treated|1|||
13480857|NCT00942877|27017283|FG001|Overall Study|Patient was not treated|0|||
13480858|NCT00942877|27017282|FG000|Overall Study|Adverse Event|1|||
13480859|NCT00942877|27017283|FG001|Overall Study|Adverse Event|0|||
13480860|NCT00942877|27017282|FG000|Overall Study|Progressive disease|42|||
13480861|NCT00942877|27017283|FG001|Overall Study|Progressive disease|3|||
13480862|NCT00880893|27017354|FG000|Overall Study|Protocol Violation|13|||
13480863|NCT00880893|27017355|FG001|Overall Study|Protocol Violation|1|||
13480864|NCT00880893|27017354|FG000|Overall Study|Withdrawal by Subject|15|||
13480865|NCT00880893|27017355|FG001|Overall Study|Withdrawal by Subject|11|||
13480866|NCT00880893|27017354|FG000|Overall Study|Lost to Follow-up|76|||
13480867|NCT00880893|27017355|FG001|Overall Study|Lost to Follow-up|33|||
13480868|NCT00880893|27017354|FG000|Overall Study|Serious adverse event|3|||
13480869|NCT00880893|27017355|FG001|Overall Study|Serious adverse event|0|||
13480870|NCT00587301|27017370|FG000|Overall Study|Screen Failure|9|||
13480871|NCT00587301|27017370|FG000|Overall Study|Lost to Follow-up|22|||
13480872|NCT00587301|27017370|FG000|Overall Study|Withdrawal by Subject|7|||
13480873|NCT00587301|27017370|FG000|Overall Study|Protocol Violation|7|||
13480874|NCT00579527|27017384|FG000|Overall Study|Death|4|||
13480875|NCT00576836|27017399|FG000|Overall Study|Death|0|||
13480876|NCT00576836|27017400|FG001|Overall Study|Death|1|||
13480877|NCT00576836|27017399|FG000|Overall Study|Physician Decision|0|||
13480878|NCT00576836|27017400|FG001|Overall Study|Physician Decision|1|||
13480879|NCT00576407|27017414|FG000|Overall Study|Death|7|||
13480880|NCT00576407|27017414|FG000|Overall Study|Physician Decision|1|||
13480881|NCT00531232|27017465|FG000|Overall Study|Investigator decision|0|||
13480882|NCT00531232|27017466|FG001|Overall Study|Investigator decision|0|||
13480883|NCT00531232|27017467|FG002|Overall Study|Investigator decision|4|||
13480884|NCT00531232|27017465|FG000|Overall Study|Participants refused further treatment|0|||
13480885|NCT00531232|27017466|FG001|Overall Study|Participants refused further treatment|1|||
13480886|NCT00531232|27017467|FG002|Overall Study|Participants refused further treatment|2|||
13480887|NCT00531232|27017465|FG000|Overall Study|Adverse events (AEs)|1|||
13480888|NCT00531232|27017466|FG001|Overall Study|Adverse events (AEs)|2|||
13480889|NCT00531232|27017467|FG002|Overall Study|Adverse events (AEs)|2|||
13480890|NCT00531232|27017465|FG000|Overall Study|Treatment failure|1|||
13480891|NCT00531232|27017466|FG001|Overall Study|Treatment failure|3|||
13480892|NCT00531232|27017467|FG002|Overall Study|Treatment failure|7|||
13480893|NCT00531232|27017465|FG000|Overall Study|Disease recurrence|0|||
13480894|NCT00531232|27017466|FG001|Overall Study|Disease recurrence|0|||
13480895|NCT00531232|27017467|FG002|Overall Study|Disease recurrence|1|||
13480896|NCT00531232|27017465|FG000|Overall Study|Deceased|2|||
13480897|NCT00531232|27017466|FG001|Overall Study|Deceased|2|||
13480898|NCT00531232|27017467|FG002|Overall Study|Deceased|2|||
13480899|NCT00531232|27017465|FG000|Overall Study|Withdrawal by Subject|0|||
13480900|NCT00531232|27017466|FG001|Overall Study|Withdrawal by Subject|1|||
13480901|NCT00531232|27017467|FG002|Overall Study|Withdrawal by Subject|2|||
13480902|NCT00531232|27017465|FG000|Overall Study|Other|0|||
13480903|NCT00531232|27017466|FG001|Overall Study|Other|0|||
13480904|NCT00531232|27017467|FG002|Overall Study|Other|5|||
13480905|NCT00379340|27017496|FG000|Overall Study|Death|0|||
13480906|NCT00379340|27017497|FG001|Overall Study|Death|0|||
13480907|NCT00379340|27017498|FG002|Overall Study|Death|0|||
13480908|NCT00379340|27017499|FG003|Overall Study|Death|2|||
13480909|NCT00379340|27017500|FG004|Overall Study|Death|0|||
13480910|NCT00379340|27017496|FG000|Overall Study|Lack of Efficacy|6|||
13480911|NCT00379340|27017497|FG001|Overall Study|Lack of Efficacy|1|||
13480912|NCT00379340|27017498|FG002|Overall Study|Lack of Efficacy|0|||
13480913|NCT00379340|27017499|FG003|Overall Study|Lack of Efficacy|4|||
13480914|NCT00379340|27017500|FG004|Overall Study|Lack of Efficacy|3|||
13480915|NCT00379340|27017496|FG000|Overall Study|Physician Decision|6|||
13480916|NCT00379340|27017497|FG001|Overall Study|Physician Decision|2|||
13480917|NCT00379340|27017498|FG002|Overall Study|Physician Decision|1|||
13480918|NCT00379340|27017499|FG003|Overall Study|Physician Decision|2|||
13480919|NCT00379340|27017500|FG004|Overall Study|Physician Decision|3|||
13480920|NCT00379340|27017496|FG000|Overall Study|Withdrawal by Subject|0|||
13480921|NCT00379340|27017497|FG001|Overall Study|Withdrawal by Subject|0|||
13480922|NCT00379340|27017498|FG002|Overall Study|Withdrawal by Subject|0|||
13480923|NCT00379340|27017499|FG003|Overall Study|Withdrawal by Subject|1|||
13480924|NCT00379340|27017500|FG004|Overall Study|Withdrawal by Subject|0|||
13480925|NCT00379340|27017496|FG000|Overall Study|Refusal of further protocol therapy|1|||
13480926|NCT00379340|27017497|FG001|Overall Study|Refusal of further protocol therapy|0|||
13480927|NCT00379340|27017498|FG002|Overall Study|Refusal of further protocol therapy|1|||
13480928|NCT00379340|27017499|FG003|Overall Study|Refusal of further protocol therapy|1|||
13480929|NCT00379340|27017500|FG004|Overall Study|Refusal of further protocol therapy|7|||
13480930|NCT00379340|27017496|FG000|Overall Study|On more than 1 tumor therapeutic study|0|||
13480931|NCT00379340|27017497|FG001|Overall Study|On more than 1 tumor therapeutic study|0|||
13480932|NCT00379340|27017498|FG002|Overall Study|On more than 1 tumor therapeutic study|0|||
13480933|NCT00379340|27017499|FG003|Overall Study|On more than 1 tumor therapeutic study|2|||
13480934|NCT00379340|27017500|FG004|Overall Study|On more than 1 tumor therapeutic study|0|||
13480935|NCT00379340|27017496|FG000|Overall Study|Delayed nephrectomy and anaplasia|0|||
13480936|NCT00379340|27017497|FG001|Overall Study|Delayed nephrectomy and anaplasia|0|||
13480937|NCT00379340|27017498|FG002|Overall Study|Delayed nephrectomy and anaplasia|0|||
13480938|NCT00379340|27017499|FG003|Overall Study|Delayed nephrectomy and anaplasia|1|||
13480939|NCT00379340|27017500|FG004|Overall Study|Delayed nephrectomy and anaplasia|1|||
13480940|NCT00304070|27017522|FG000|Overall Study|Death|0|||
13480941|NCT00304070|27017523|FG001|Overall Study|Death|0|||
13480942|NCT00304070|27017524|FG002|Overall Study|Death|3|||
13480943|NCT00304070|27017522|FG000|Overall Study|Lost to Follow-up|0|||
13480944|NCT00304070|27017523|FG001|Overall Study|Lost to Follow-up|0|||
13480945|NCT00304070|27017524|FG002|Overall Study|Lost to Follow-up|1|||
13480946|NCT00304070|27017522|FG000|Overall Study|Physician Decision|0|||
13480947|NCT00304070|27017523|FG001|Overall Study|Physician Decision|0|||
13480948|NCT00304070|27017524|FG002|Overall Study|Physician Decision|3|||
13480949|NCT00304070|27017522|FG000|Overall Study|Withdrawal by Subject|0|||
13480950|NCT00304070|27017523|FG001|Overall Study|Withdrawal by Subject|0|||
13480951|NCT00304070|27017524|FG002|Overall Study|Withdrawal by Subject|1|||
13480952|NCT00304070|27017522|FG000|Overall Study|Progressive Disease|3|||
13480953|NCT00304070|27017523|FG001|Overall Study|Progressive Disease|7|||
13480954|NCT00304070|27017524|FG002|Overall Study|Progressive Disease|4|||
13487068|NCT00893789|27037885|FG000|Overall Study|Noncompliance With Study Drug|1|||
13487069|NCT00893789|27037886|FG001|Overall Study|Noncompliance With Study Drug|0|||
13487070|NCT00893789|27037887|FG002|Overall Study|Noncompliance With Study Drug|1|||
13487071|NCT00893789|27037888|FG003|Overall Study|Noncompliance With Study Drug|2|||
13487072|NCT00893789|27037885|FG000|Overall Study|Noncompliance With Study Procedures|1|||
13487073|NCT00893789|27037886|FG001|Overall Study|Noncompliance With Study Procedures|0|||
13487074|NCT00893789|27037887|FG002|Overall Study|Noncompliance With Study Procedures|0|||
13487075|NCT00893789|27037888|FG003|Overall Study|Noncompliance With Study Procedures|0|||
13487076|NCT00893789|27037885|FG000|Overall Study|Taking Excluded Concomitant Medication|1|||
13487077|NCT00893789|27037886|FG001|Overall Study|Taking Excluded Concomitant Medication|0|||
13487078|NCT00893789|27037887|FG002|Overall Study|Taking Excluded Concomitant Medication|1|||
13487079|NCT00893789|27037888|FG003|Overall Study|Taking Excluded Concomitant Medication|0|||
13487080|NCT00893789|27037885|FG000|Overall Study|Adverse Event|0|||
13487081|NCT00893789|27037886|FG001|Overall Study|Adverse Event|2|||
13487082|NCT00893789|27037887|FG002|Overall Study|Adverse Event|1|||
13487083|NCT00893789|27037888|FG003|Overall Study|Adverse Event|5|||
13487084|NCT00893789|27037885|FG000|Overall Study|Protocol Violation|0|||
13487085|NCT00893789|27037886|FG001|Overall Study|Protocol Violation|1|||
13487086|NCT00893789|27037887|FG002|Overall Study|Protocol Violation|1|||
13487087|NCT00893789|27037888|FG003|Overall Study|Protocol Violation|4|||
13487088|NCT00893789|27037885|FG000|Overall Study|Lost to Follow-up|0|||
13487089|NCT00893789|27037886|FG001|Overall Study|Lost to Follow-up|0|||
13487090|NCT00893789|27037887|FG002|Overall Study|Lost to Follow-up|0|||
13487091|NCT00893789|27037888|FG003|Overall Study|Lost to Follow-up|1|||
13488176|NCT03987919|27042982|FG000|Overall Study|Site terminated by Sponsor|0|||
13488177|NCT03987919|27042983|FG001|Overall Study|Site terminated by Sponsor|0|||
13488178|NCT03987919|27042984|FG002|Overall Study|Site terminated by Sponsor|0|||
13488179|NCT03987919|27042985|FG003|Overall Study|Site terminated by Sponsor|1|||
13488180|NCT03987919|27042982|FG000|Overall Study|Withdrawal by Subject|7|||
13488181|NCT03987919|27042983|FG001|Overall Study|Withdrawal by Subject|7|||
13488182|NCT03987919|27042984|FG002|Overall Study|Withdrawal by Subject|8|||
13480955|NCT01701583|27017540|FG000|Overall Study|Withdrawal by Subject|2|||
13480956|NCT01701583|27017541|FG001|Overall Study|Withdrawal by Subject|0|||
13480957|NCT01714817|27017642|FG000|Year 1 Period|Lack of Efficacy|11|||
13480958|NCT01714817|27017643|FG001|Year 1 Period|Lack of Efficacy|9|||
13480959|NCT01714817|27017642|FG000|Year 1 Period|Adverse Event|20|||
13480960|NCT01714817|27017643|FG001|Year 1 Period|Adverse Event|17|||
13480961|NCT01714817|27017642|FG000|Year 1 Period|Withdrawal by Subject|6|||
13480962|NCT01714817|27017643|FG001|Year 1 Period|Withdrawal by Subject|7|||
13480963|NCT01714817|27017642|FG000|Year 1 Period|Death|1|||
13480964|NCT01714817|27017643|FG001|Year 1 Period|Death|1|||
13480965|NCT01714817|27017642|FG000|Year 1 Period|Lost to Follow-up|0|||
13480966|NCT01714817|27017643|FG001|Year 1 Period|Lost to Follow-up|2|||
13480967|NCT01714817|27017642|FG000|Year 1 Period|Poor / non-compliance|0|||
13480968|NCT01714817|27017643|FG001|Year 1 Period|Poor / non-compliance|1|||
13480969|NCT01714817|27017642|FG000|Year 1 Period|Pregnancy|2|||
13480970|NCT01714817|27017643|FG001|Year 1 Period|Pregnancy|0|||
13480971|NCT01714817|27017642|FG000|Year 1 Period|Participant no longer meets criteria|6|||
13480972|NCT01714817|27017643|FG001|Year 1 Period|Participant no longer meets criteria|2|||
13480973|NCT01714817|27017642|FG000|Year 1 Period|Not treated- received ACE inhibition|1|||
13480974|NCT01714817|27017643|FG001|Year 1 Period|Not treated- received ACE inhibition|0|||
13480975|NCT01714817|27017642|FG000|Year 1 Period|Change in Concomitant Medication|0|||
13480976|NCT01714817|27017643|FG001|Year 1 Period|Change in Concomitant Medication|1|||
13480977|NCT01714817|27017642|FG000|Year 1 Period|Need of use of Prohibited Medications|1|||
13480978|NCT01714817|27017643|FG001|Year 1 Period|Need of use of Prohibited Medications|0|||
13480979|NCT01714817|27017642|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0|||
13480980|NCT01714817|27017643|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1|||
13480981|NCT01714817|27017642|FG000|Year 1 Period|Hypersensitivity to the medication|0|||
13480982|NCT01714817|27017643|FG001|Year 1 Period|Hypersensitivity to the medication|1|||
13480983|NCT01714817|27017642|FG000|Year 2 Period|Lack of Efficacy|4|||
13480984|NCT01714817|27017643|FG001|Year 2 Period|Lack of Efficacy|12|||
13480985|NCT01714817|27017642|FG000|Year 2 Period|Adverse Event|7|||
13480986|NCT01714817|27017643|FG001|Year 2 Period|Adverse Event|6|||
13480987|NCT01714817|27017642|FG000|Year 2 Period|Participant request to stop treatment|4|||
13480988|NCT01714817|27017643|FG001|Year 2 Period|Participant request to stop treatment|4|||
13480989|NCT01714817|27017642|FG000|Year 2 Period|Administrative reason by Sponsor|4|||
13480990|NCT01714817|27017643|FG001|Year 2 Period|Administrative reason by Sponsor|3|||
13480991|NCT01714817|27017642|FG000|Year 2 Period|Participant withdrew consent|1|||
13480992|NCT01714817|27017643|FG001|Year 2 Period|Participant withdrew consent|5|||
13480993|NCT01714817|27017642|FG000|Year 2 Period|Participant no longer meets criteria|1|||
13480994|NCT01714817|27017643|FG001|Year 2 Period|Participant no longer meets criteria|4|||
13480995|NCT01714817|27017642|FG000|Year 2 Period|Lost to Follow-up|2|||
13480996|NCT01714817|27017643|FG001|Year 2 Period|Lost to Follow-up|0|||
13480997|NCT01714817|27017642|FG000|Year 2 Period|Participant went to US stopped treatment|0|||
13480998|NCT01714817|27017643|FG001|Year 2 Period|Participant went to US stopped treatment|1|||
13480999|NCT01714817|27017642|FG000|Year 2 Period|Pregnancy|1|||
13481000|NCT01714817|27017643|FG001|Year 2 Period|Pregnancy|1|||
13481001|NCT01714817|27017642|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2|||
13481002|NCT01714817|27017643|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1|||
13481003|NCT01714817|27017642|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0|||
13481004|NCT01714817|27017643|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1|||
13481005|NCT01714817|27017642|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27|||
13481006|NCT01714817|27017643|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21|||
13481007|NCT01714817|27017642|FG000|Long-Term Extension (LTE) Period|Disease progression|1|||
13481008|NCT01714817|27017643|FG001|Long-Term Extension (LTE) Period|Disease progression|4|||
13481009|NCT01714817|27017642|FG000|Long-Term Extension (LTE) Period|Not effective|0|||
13481010|NCT01714817|27017643|FG001|Long-Term Extension (LTE) Period|Not effective|1|||
13481011|NCT01714817|27017642|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
13481012|NCT01714817|27017643|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
13481013|NCT01714817|27017642|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
13481014|NCT01714817|27017643|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
13481015|NCT01714817|27017642|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1|||
13481016|NCT01714817|27017643|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0|||
13481017|NCT01714817|27017642|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
13481018|NCT01714817|27017643|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
13481019|NCT01714817|27017642|FG000|Long-Term Extension (LTE) Period|Pregnancy|1|||
13481020|NCT01714817|27017643|FG001|Long-Term Extension (LTE) Period|Pregnancy|0|||
13481021|NCT01714817|27017642|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1|||
13481022|NCT01714817|27017643|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0|||
13481023|NCT01714817|27017642|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1|||
13481024|NCT01714817|27017643|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0|||
13481025|NCT01714817|27017642|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33|||
13481026|NCT01714817|27017643|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38|||
13481027|NCT01714817|27017642|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0|||
13481028|NCT01714817|27017643|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1|||
13481029|NCT01714817|27017642|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0|||
13481030|NCT01714817|27017643|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1|||
13481031|NCT01714817|27017642|FG000|Long-Term Extension (LTE) Period|Study was terminated|0|||
13481032|NCT01714817|27017643|FG001|Long-Term Extension (LTE) Period|Study was terminated|1|||
13487092|NCT03901144|27037931|FG000|Overall Study|Lost to Follow-up|1|||
13487093|NCT03901144|27037932|FG001|Overall Study|Lost to Follow-up|1|||
13487094|NCT03901144|27037933|FG002|Overall Study|Lost to Follow-up|1|||
13487095|NCT03901144|27037934|FG003|Overall Study|Lost to Follow-up|1|||
13487096|NCT03461211|27037988|FG000|Overall Study|Adverse Event|1|||
13487097|NCT03461211|27037989|FG001|Overall Study|Adverse Event|1|||
13487098|NCT03461211|27037988|FG000|Overall Study|Lack of Efficacy|0|||
13487099|NCT03461211|27037989|FG001|Overall Study|Lack of Efficacy|1|||
13487100|NCT03050814|27038045|FG000|Overall Study|Screen failures|0|||
13487101|NCT03050814|27038046|FG001|Overall Study|Screen failures|0|||
13487102|NCT03050814|27038047|FG002|Overall Study|Screen failures|4|||
13487103|NCT02797262|27038067|FG000|Overall Study|Withdrawal by Subject|5|||
13487104|NCT02797262|27038068|FG001|Overall Study|Withdrawal by Subject|1|||
13487105|NCT02797262|27038067|FG000|Overall Study|Lost to Follow-up|10|||
13487106|NCT02797262|27038068|FG001|Overall Study|Lost to Follow-up|7|||
13487107|NCT02797262|27038067|FG000|Overall Study|Death|1|||
13487108|NCT02797262|27038068|FG001|Overall Study|Death|2|||
13487109|NCT02797262|27038067|FG000|Overall Study|Adverse Event|1|||
13487110|NCT02797262|27038068|FG001|Overall Study|Adverse Event|0|||
13487111|NCT02797262|27038067|FG000|Overall Study|COVID-19|2|||
13487112|NCT02797262|27038068|FG001|Overall Study|COVID-19|1|||
13487113|NCT02797262|27038067|FG000|Overall Study|Out-of-country|1|||
13487114|NCT02797262|27038068|FG001|Overall Study|Out-of-country|0|||
13487115|NCT01285102|27038563|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4|||
13488183|NCT03987919|27042985|FG003|Overall Study|Withdrawal by Subject|4|||
13488184|NCT03987919|27042982|FG000|Overall Study|Other - as reported by the investigator|1|||
13488185|NCT03987919|27042983|FG001|Overall Study|Other - as reported by the investigator|3|||
13488186|NCT03987919|27042984|FG002|Overall Study|Other - as reported by the investigator|2|||
13488187|NCT03987919|27042985|FG003|Overall Study|Other - as reported by the investigator|0|||
13488188|NCT03861039|27043069|FG000|Overall Study|Adverse Event|2|||
13488189|NCT03861039|27043070|FG001|Overall Study|Adverse Event|5|||
13488190|NCT03861039|27043071|FG002|Overall Study|Adverse Event|11|||
13488191|NCT03861039|27043069|FG000|Overall Study|Withdrawal by Subject|1|||
13488192|NCT03861039|27043070|FG001|Overall Study|Withdrawal by Subject|3|||
13488193|NCT03861039|27043071|FG002|Overall Study|Withdrawal by Subject|4|||
13488194|NCT03730662|27043118|FG000|Treatment Period (52 Weeks)|Adverse Event|3|||
13488195|NCT03730662|27043119|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
13488196|NCT03730662|27043120|FG002|Treatment Period (52 Weeks)|Adverse Event|0|||
13488197|NCT03730662|27043121|FG003|Treatment Period (52 Weeks)|Adverse Event|3|||
13488198|NCT03730662|27043118|FG000|Treatment Period (52 Weeks)|Screen Failure|0|||
13488199|NCT03730662|27043119|FG001|Treatment Period (52 Weeks)|Screen Failure|1|||
13488200|NCT03730662|27043120|FG002|Treatment Period (52 Weeks)|Screen Failure|0|||
13488201|NCT03730662|27043121|FG003|Treatment Period (52 Weeks)|Screen Failure|0|||
13488202|NCT03730662|27043118|FG000|Treatment Period (52 Weeks)|Death|6|||
13488203|NCT03730662|27043119|FG001|Treatment Period (52 Weeks)|Death|2|||
13488204|NCT03730662|27043120|FG002|Treatment Period (52 Weeks)|Death|2|||
13488205|NCT03730662|27043121|FG003|Treatment Period (52 Weeks)|Death|9|||
13488206|NCT03730662|27043118|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4|||
13488207|NCT03730662|27043119|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
13488208|NCT03730662|27043120|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
13488209|NCT03730662|27043121|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11|||
13488210|NCT03730662|27043118|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
13488211|NCT03730662|27043119|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
13488212|NCT03730662|27043120|FG002|Treatment Period (52 Weeks)|Physician Decision|0|||
13488213|NCT03730662|27043121|FG003|Treatment Period (52 Weeks)|Physician Decision|3|||
13488214|NCT03730662|27043118|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
13488215|NCT03730662|27043119|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
13488216|NCT03730662|27043120|FG002|Treatment Period (52 Weeks)|Protocol Violation|0|||
13488217|NCT03730662|27043121|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
13488218|NCT03730662|27043118|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
13488219|NCT03730662|27043119|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
13488220|NCT03730662|27043120|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
13488221|NCT03730662|27043121|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23|||
13488222|NCT03730662|27043118|FG000|Treatment Period (52 Weeks)|Personal Reason|2|||
13488223|NCT03730662|27043119|FG001|Treatment Period (52 Weeks)|Personal Reason|2|||
13481033|NCT01755689|27017754|FG000|Overall Study|Withdrawal by Subject|1|||
13481034|NCT01755689|27017755|FG001|Overall Study|Withdrawal by Subject|3|||
13481035|NCT01755689|27017756|FG002|Overall Study|Withdrawal by Subject|2|||
13481036|NCT01755689|27017757|FG003|Overall Study|Withdrawal by Subject|1|||
13481037|NCT01755689|27017758|FG004|Overall Study|Withdrawal by Subject|1|||
13481038|NCT01755689|27017754|FG000|Overall Study|Migrated/moved from study area|0|||
13481039|NCT01755689|27017755|FG001|Overall Study|Migrated/moved from study area|1|||
13481040|NCT01755689|27017756|FG002|Overall Study|Migrated/moved from study area|1|||
13481041|NCT01755689|27017757|FG003|Overall Study|Migrated/moved from study area|1|||
13481042|NCT01755689|27017758|FG004|Overall Study|Migrated/moved from study area|1|||
13481043|NCT01755689|27017754|FG000|Overall Study|Lost to Follow-up|1|||
13481044|NCT01755689|27017755|FG001|Overall Study|Lost to Follow-up|0|||
13481045|NCT01755689|27017756|FG002|Overall Study|Lost to Follow-up|1|||
13481046|NCT01755689|27017757|FG003|Overall Study|Lost to Follow-up|0|||
13481047|NCT01755689|27017758|FG004|Overall Study|Lost to Follow-up|2|||
13481048|NCT01755689|27017754|FG000|Overall Study|Pregnancy|1|||
13481049|NCT01755689|27017755|FG001|Overall Study|Pregnancy|1|||
13481050|NCT01755689|27017756|FG002|Overall Study|Pregnancy|2|||
13481051|NCT01755689|27017757|FG003|Overall Study|Pregnancy|4|||
13481052|NCT01755689|27017758|FG004|Overall Study|Pregnancy|2|||
13481053|NCT01762761|27017819|FG000|Overall Study|Adverse Event|15|||
13481054|NCT01762761|27017820|FG001|Overall Study|Adverse Event|17|||
13481055|NCT01762761|27017819|FG000|Overall Study|Lack of Efficacy|9|||
13481056|NCT01762761|27017820|FG001|Overall Study|Lack of Efficacy|25|||
13481057|NCT01762761|27017819|FG000|Overall Study|Protocol Violation|1|||
13481058|NCT01762761|27017820|FG001|Overall Study|Protocol Violation|1|||
13481059|NCT01762761|27017819|FG000|Overall Study|Study closed/terminated|0|||
13481060|NCT01762761|27017820|FG001|Overall Study|Study closed/terminated|2|||
13481061|NCT01762761|27017819|FG000|Overall Study|Lost to Follow-up|3|||
13481062|NCT01762761|27017820|FG001|Overall Study|Lost to Follow-up|6|||
13481063|NCT01762761|27017819|FG000|Overall Study|Physician Decision|4|||
13481064|NCT01762761|27017820|FG001|Overall Study|Physician Decision|6|||
13481065|NCT01762761|27017819|FG000|Overall Study|Withdrawal by Subject|7|||
13481066|NCT01762761|27017820|FG001|Overall Study|Withdrawal by Subject|8|||
13481071|NCT01774370|27017878|FG000|Overall Study|Never taken the PRADAXA during the study|4|||
13481072|NCT01774370|27017878|FG000|Overall Study|Administered prior to the contract date|4|||
13481073|NCT01774370|27017878|FG000|Overall Study|Subjects of contraindications|34|||
13481074|NCT01774370|27017878|FG000|Overall Study|Violated inclusion/exclusion criteria|53|||
13481075|NCT01774370|27017878|FG000|Overall Study|Follow-up failure|34|||
13481076|NCT01777295|27018087|FG000|Overall Study|Withdrawal by Subject|2|||
13481077|NCT01777295|27018088|FG001|Overall Study|Withdrawal by Subject|2|||
13481078|NCT01777295|27018087|FG000|Overall Study|Pregnancy|0|||
13481079|NCT01777295|27018088|FG001|Overall Study|Pregnancy|1|||
13481080|NCT01777295|27018087|FG000|Overall Study|Personal problem|1|||
13481081|NCT01777295|27018088|FG001|Overall Study|Personal problem|0|||
13481082|NCT01777295|27018087|FG000|Overall Study|Investigator call for AEs check|1|||
13481083|NCT01777295|27018088|FG001|Overall Study|Investigator call for AEs check|0|||
13481084|NCT01787552|27018169|FG000|Overall Study|Withdrawal by Subject|2|||
13481085|NCT01787552|27018170|FG001|Overall Study|Withdrawal by Subject|0|||
13481086|NCT01787552|27018171|FG002|Overall Study|Withdrawal by Subject|0|||
13481087|NCT01787552|27018172|FG003|Overall Study|Withdrawal by Subject|4|||
13481088|NCT01787552|27018169|FG000|Overall Study|Physician Decision|2|||
13481089|NCT01787552|27018170|FG001|Overall Study|Physician Decision|2|||
13481090|NCT01787552|27018171|FG002|Overall Study|Physician Decision|1|||
13481091|NCT01787552|27018172|FG003|Overall Study|Physician Decision|2|||
13481092|NCT01787552|27018169|FG000|Overall Study|Death|0|||
13481093|NCT01787552|27018170|FG001|Overall Study|Death|0|||
13481094|NCT01787552|27018171|FG002|Overall Study|Death|0|||
13481095|NCT01787552|27018172|FG003|Overall Study|Death|1|||
13481096|NCT01787552|27018169|FG000|Overall Study|Adverse Event|2|||
13481097|NCT01787552|27018170|FG001|Overall Study|Adverse Event|5|||
13481098|NCT01787552|27018171|FG002|Overall Study|Adverse Event|2|||
13481099|NCT01787552|27018172|FG003|Overall Study|Adverse Event|16|||
13481100|NCT01787552|27018169|FG000|Overall Study|Study terminated by Sponsor|0|||
13481101|NCT01787552|27018170|FG001|Overall Study|Study terminated by Sponsor|0|||
13481102|NCT01787552|27018171|FG002|Overall Study|Study terminated by Sponsor|1|||
13481103|NCT01787552|27018172|FG003|Overall Study|Study terminated by Sponsor|3|||
13481104|NCT01787552|27018169|FG000|Overall Study|Progressive Disease|2|||
13481105|NCT01787552|27018170|FG001|Overall Study|Progressive Disease|2|||
13481106|NCT01787552|27018171|FG002|Overall Study|Progressive Disease|1|||
13481107|NCT01787552|27018172|FG003|Overall Study|Progressive Disease|1|||
13481108|NCT01808261|27018233|FG000|Overall Study|Physician Decision|0|||
13481109|NCT01808261|27018234|FG001|Overall Study|Physician Decision|2|||
13481110|NCT01808261|27018233|FG000|Overall Study|Study Closed/Terminated|25|||
13481111|NCT01808261|27018234|FG001|Overall Study|Study Closed/Terminated|23|||
13481112|NCT01808261|27018233|FG000|Overall Study|Adverse event, non-fatal|2|||
13481113|NCT01808261|27018234|FG001|Overall Study|Adverse event, non-fatal|0|||
13481114|NCT01808261|27018233|FG000|Overall Study|Consent withdrawn by subject|6|||
13481067|NCT01763788|27017867|FG000|Overall Study|Lost to Follow-up|0|||
13481068|NCT01763788|27017868|FG001|Overall Study|Lost to Follow-up|0|||
13481069|NCT01763788|27017869|FG002|Overall Study|Lost to Follow-up|1|||
13481070|NCT01763788|27017870|FG003|Overall Study|Lost to Follow-up|0|||
13481115|NCT01808261|27018234|FG001|Overall Study|Consent withdrawn by subject|7|||
13481116|NCT01808261|27018233|FG000|Overall Study|Lost to Follow-up|3|||
13481117|NCT01808261|27018234|FG001|Overall Study|Lost to Follow-up|1|||
13487116|NCT03761056|27038703|FG000|Overall Study|Still on Study|34|||
13487117|NCT03761056|27038703|FG000|Overall Study|Death|6|||
13487118|NCT03761056|27038703|FG000|Overall Study|Investigator Decision|1|||
13487119|NCT03761056|27038703|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|1|||
13487120|NCT03639311|27038792|FG000|Overall Study|Ongoing at the time of analysis|88|||
13487121|NCT03639311|27038793|FG001|Overall Study|Ongoing at the time of analysis|0|||
13487122|NCT03639311|27038792|FG000|Overall Study|Lost to Follow-up|1|||
13487123|NCT03639311|27038793|FG001|Overall Study|Lost to Follow-up|0|||
13487124|NCT03639311|27038792|FG000|Overall Study|Adverse Event|1|||
13487125|NCT03639311|27038793|FG001|Overall Study|Adverse Event|0|||
13487126|NCT02717611|27038810|FG000|Overall Study|Death|13|||
13487127|NCT02717611|27038810|FG000|Overall Study|Withdrawal by Subject|6|||
13487128|NCT02717611|27038810|FG000|Overall Study|Active, not recruiting|40|||
13487129|NCT02717611|27038810|FG000|Overall Study|Complicating disease|1|||
13487130|NCT02362035|27038836|FG000|Overall Study|Death|67|||
13487131|NCT02362035|27038836|FG000|Overall Study|Lost to Follow-up|3|||
13487132|NCT02362035|27038836|FG000|Overall Study|Adverse Event|1|||
13487133|NCT02362035|27038836|FG000|Overall Study|Physician Decision|1|||
13487134|NCT02362035|27038836|FG000|Overall Study|Subject started another cancer therapy|10|||
13487135|NCT02362035|27038836|FG000|Overall Study|Study terminated by sponsor|45|||
13487136|NCT02362035|27038836|FG000|Overall Study|Decision by subject not related to AE/SAE|2|||
13487137|NCT02362035|27038836|FG000|Overall Study|Decision by PI not related to AE/SAE|1|||
13487138|NCT02362035|27038836|FG000|Overall Study|Disease progression|11|||
13487139|NCT02362035|27038836|FG000|Overall Study|Withdrawal by Subject|20|||
13487140|NCT02328014|27038859|FG000|Overall Study|Adverse Event|1|||
13487141|NCT02328014|27038860|FG001|Overall Study|Adverse Event|0|||
13487142|NCT02328014|27038861|FG002|Overall Study|Adverse Event|0|||
13487143|NCT02328014|27038862|FG003|Overall Study|Adverse Event|1|||
13487144|NCT02328014|27038859|FG000|Overall Study|Death|0|||
13487145|NCT02328014|27038860|FG001|Overall Study|Death|0|||
13487146|NCT02328014|27038861|FG002|Overall Study|Death|0|||
13487147|NCT02328014|27038862|FG003|Overall Study|Death|4|||
13487148|NCT02328014|27038859|FG000|Overall Study|Physician Decision|0|||
13487149|NCT02328014|27038860|FG001|Overall Study|Physician Decision|0|||
13487150|NCT02328014|27038861|FG002|Overall Study|Physician Decision|0|||
13487151|NCT02328014|27038862|FG003|Overall Study|Physician Decision|1|||
13487152|NCT02328014|27038859|FG000|Overall Study|Disease Progression|1|||
13487153|NCT02328014|27038860|FG001|Overall Study|Disease Progression|0|||
13487154|NCT02328014|27038861|FG002|Overall Study|Disease Progression|1|||
13487155|NCT02328014|27038862|FG003|Overall Study|Disease Progression|3|||
13487156|NCT02328014|27038859|FG000|Overall Study|Study Terminated by Sponsor|4|||
13487157|NCT02328014|27038860|FG001|Overall Study|Study Terminated by Sponsor|1|||
13487158|NCT02328014|27038861|FG002|Overall Study|Study Terminated by Sponsor|1|||
13487159|NCT02328014|27038862|FG003|Overall Study|Study Terminated by Sponsor|0|||
13487160|NCT02328014|27038859|FG000|Overall Study|Subject Started Another Cancer Therapy|0|||
13487161|NCT02328014|27038860|FG001|Overall Study|Subject Started Another Cancer Therapy|5|||
13487162|NCT02328014|27038861|FG002|Overall Study|Subject Started Another Cancer Therapy|4|||
13487163|NCT02328014|27038862|FG003|Overall Study|Subject Started Another Cancer Therapy|12|||
13487164|NCT02328014|27038859|FG000|Overall Study|Withdrawal by Subject|0|||
13487165|NCT02328014|27038860|FG001|Overall Study|Withdrawal by Subject|0|||
13487166|NCT02328014|27038861|FG002|Overall Study|Withdrawal by Subject|0|||
13487167|NCT02328014|27038862|FG003|Overall Study|Withdrawal by Subject|1|||
13487168|NCT02087423|27038897|FG000|Overall Study|Withdrawal by Subject|20|||
13487169|NCT02087423|27038898|FG001|Overall Study|Withdrawal by Subject|20|||
13487170|NCT02087423|27038899|FG002|Overall Study|Withdrawal by Subject|3|||
13487171|NCT02087423|27038897|FG000|Overall Study|Death|68|||
13487172|NCT02087423|27038898|FG001|Overall Study|Death|207|||
13487173|NCT02087423|27038899|FG002|Overall Study|Death|40|||
13487174|NCT02087423|27038897|FG000|Overall Study|Lost to Follow-up|0|||
13487175|NCT02087423|27038898|FG001|Overall Study|Lost to Follow-up|2|||
13487176|NCT02087423|27038899|FG002|Overall Study|Lost to Follow-up|0|||
13487177|NCT02087423|27038897|FG000|Overall Study|Terminated from study at final DCO|23|||
13487178|NCT02087423|27038898|FG001|Overall Study|Terminated from study at final DCO|36|||
13487179|NCT02087423|27038899|FG002|Overall Study|Terminated from study at final DCO|25|||
13487180|NCT03877926|27038987|FG000|Overall Study|Adverse Event|1|||
13487181|NCT03877926|27038988|FG001|Overall Study|Adverse Event|0|||
13487182|NCT03877926|27038989|FG002|Overall Study|Adverse Event|0|||
13487183|NCT03877926|27038990|FG003|Overall Study|Adverse Event|0|||
13487184|NCT03877926|27038987|FG000|Overall Study|Death|2|||
13487185|NCT03877926|27038988|FG001|Overall Study|Death|2|||
13487186|NCT03877926|27038989|FG002|Overall Study|Death|2|||
13481118|NCT01814826|27018317|FG000|Overall Study|Other|3|||
13481119|NCT01814826|27018318|FG001|Overall Study|Other|5|||
13481120|NCT01814826|27018319|FG002|Overall Study|Other|0|||
13481121|NCT01814826|27018317|FG000|Overall Study|Death|29|||
13481122|NCT01814826|27018318|FG001|Overall Study|Death|24|||
13481123|NCT01814826|27018319|FG002|Overall Study|Death|3|||
13481124|NCT01829711|27018352|FG000|Overall Study|Lost to Follow-up|2|||
13481125|NCT01829711|27018352|FG000|Overall Study|Withdrawal by Subject|3|||
13481126|NCT01829711|27018352|FG000|Overall Study|Death|4|||
13481127|NCT01829711|27018352|FG000|Overall Study|Started new therapies|17|||
13481128|NCT01829711|27018352|FG000|Overall Study|Adverse Event|3|||
13481129|NCT01829711|27018352|FG000|Overall Study|Due to progression of disease|13|||
13481130|NCT01829711|27018352|FG000|Overall Study|Due to lack of response|1|||
13481131|NCT01846273|27018416|FG000|Overall Study|Adverse Event|9|||
13481132|NCT01846273|27018417|FG001|Overall Study|Adverse Event|7|||
13481133|NCT01846273|27018418|FG002|Overall Study|Adverse Event|0|||
13481134|NCT01846273|27018416|FG000|Overall Study|Subject withdrew consent|5|||
13481135|NCT01846273|27018417|FG001|Overall Study|Subject withdrew consent|8|||
13481136|NCT01846273|27018418|FG002|Overall Study|Subject withdrew consent|0|||
13481137|NCT01846273|27018416|FG000|Overall Study|Lost to Follow-up|2|||
13481138|NCT01846273|27018417|FG001|Overall Study|Lost to Follow-up|1|||
13481139|NCT01846273|27018418|FG002|Overall Study|Lost to Follow-up|0|||
13481140|NCT01846273|27018416|FG000|Overall Study|Administrative problems|1|||
13481141|NCT01846273|27018417|FG001|Overall Study|Administrative problems|0|||
13481142|NCT01846273|27018418|FG002|Overall Study|Administrative problems|0|||
13481143|NCT01846273|27018416|FG000|Overall Study|Death|2|||
13481144|NCT01846273|27018417|FG001|Overall Study|Death|1|||
13481145|NCT01846273|27018418|FG002|Overall Study|Death|0|||
13481146|NCT01846273|27018416|FG000|Overall Study|Disease Progression|0|||
13481147|NCT01846273|27018417|FG001|Overall Study|Disease Progression|4|||
13481148|NCT01846273|27018418|FG002|Overall Study|Disease Progression|0|||
13481149|NCT01846273|27018416|FG000|Overall Study|Protocol Deviation|2|||
13481150|NCT01846273|27018417|FG001|Overall Study|Protocol Deviation|3|||
13481151|NCT01846273|27018418|FG002|Overall Study|Protocol Deviation|0|||
13481152|NCT01846273|27018416|FG000|Overall Study|Physician Decision|1|||
13481153|NCT01846273|27018417|FG001|Overall Study|Physician Decision|2|||
13481154|NCT01846273|27018418|FG002|Overall Study|Physician Decision|0|||
13481155|NCT01875185|27018437|FG000|Overall Study|study was terminated|52|||
13481156|NCT01875185|27018438|FG001|Overall Study|study was terminated|48|||
13481157|NCT01901432|27018530|FG000|Overall Study|Adverse Event|0|||
13481158|NCT01901432|27018531|FG001|Overall Study|Adverse Event|1|||
13481159|NCT01901432|27018532|FG002|Overall Study|Adverse Event|1|||
13481160|NCT01901432|27018533|FG003|Overall Study|Adverse Event|0|||
13481161|NCT01901432|27018534|FG004|Overall Study|Adverse Event|1|||
13481162|NCT01901432|27018530|FG000|Overall Study|Withdrawal by Subject|0|||
13481163|NCT01901432|27018531|FG001|Overall Study|Withdrawal by Subject|0|||
13481164|NCT01901432|27018532|FG002|Overall Study|Withdrawal by Subject|1|||
13481165|NCT01901432|27018533|FG003|Overall Study|Withdrawal by Subject|0|||
13481166|NCT01901432|27018534|FG004|Overall Study|Withdrawal by Subject|5|||
13481167|NCT01901432|27018530|FG000|Overall Study|Physician Decision|0|||
13481168|NCT01901432|27018531|FG001|Overall Study|Physician Decision|0|||
13481169|NCT01901432|27018532|FG002|Overall Study|Physician Decision|0|||
13481170|NCT01901432|27018533|FG003|Overall Study|Physician Decision|0|||
13481171|NCT01901432|27018534|FG004|Overall Study|Physician Decision|2|||
13481172|NCT01901432|27018530|FG000|Overall Study|Patient decision to stop study drug|0|||
13481173|NCT01901432|27018531|FG001|Overall Study|Patient decision to stop study drug|0|||
13481174|NCT01901432|27018532|FG002|Overall Study|Patient decision to stop study drug|0|||
13481175|NCT01901432|27018533|FG003|Overall Study|Patient decision to stop study drug|0|||
13481176|NCT01901432|27018534|FG004|Overall Study|Patient decision to stop study drug|1|||
13481177|NCT01904279|27018561|FG000|Overall Study|Lack of Efficacy|2|||
13481178|NCT01904279|27018562|FG001|Overall Study|Lack of Efficacy|3|||
13481179|NCT01904279|27018561|FG000|Overall Study|Withdrawal by Subject|1|||
13481180|NCT01904279|27018562|FG001|Overall Study|Withdrawal by Subject|0|||
13481181|NCT01917318|27018589|FG000|First Treatment|Withdrawal by Subject|0|||
13481182|NCT01917318|27018590|FG001|First Treatment|Withdrawal by Subject|1|||
13481183|NCT01923168|27018657|FG000|Overall Study|Protocol Violation|1|||
13481184|NCT01923168|27018658|FG001|Overall Study|Protocol Violation|1|||
13481185|NCT01923168|27018659|FG002|Overall Study|Protocol Violation|0|||
13481186|NCT01923168|27018657|FG000|Overall Study|Subject/guardian decision|14|||
13481187|NCT01923168|27018658|FG001|Overall Study|Subject/guardian decision|14|||
13481188|NCT01923168|27018659|FG002|Overall Study|Subject/guardian decision|4|||
13481189|NCT01923168|27018657|FG000|Overall Study|Adverse Event|12|||
13481190|NCT01923168|27018658|FG001|Overall Study|Adverse Event|12|||
13481191|NCT01923168|27018659|FG002|Overall Study|Adverse Event|0|||
13481192|NCT01923168|27018657|FG000|Overall Study|Physician Decision|6|||
13481193|NCT01923168|27018658|FG001|Overall Study|Physician Decision|9|||
13481194|NCT01923168|27018659|FG002|Overall Study|Physician Decision|5|||
13481195|NCT01923168|27018657|FG000|Overall Study|Progressive disease|4|||
13481196|NCT01923168|27018658|FG001|Overall Study|Progressive disease|3|||
13481197|NCT01923168|27018659|FG002|Overall Study|Progressive disease|7|||
13481198|NCT01923168|27018657|FG000|Overall Study|Death|0|||
13481199|NCT01923168|27018658|FG001|Overall Study|Death|0|||
13481200|NCT01923168|27018659|FG002|Overall Study|Death|1|||
13487187|NCT03877926|27038990|FG003|Overall Study|Death|0|||
13487188|NCT03877926|27038987|FG000|Overall Study|Lost to Follow-up|41|||
13487189|NCT03877926|27038988|FG001|Overall Study|Lost to Follow-up|52|||
13487190|NCT03877926|27038989|FG002|Overall Study|Lost to Follow-up|45|||
13487191|NCT03877926|27038990|FG003|Overall Study|Lost to Follow-up|17|||
13487192|NCT03877926|27038987|FG000|Overall Study|Physician Decision|2|||
13487193|NCT03877926|27038988|FG001|Overall Study|Physician Decision|0|||
13487194|NCT03877926|27038989|FG002|Overall Study|Physician Decision|2|||
13487195|NCT03877926|27038990|FG003|Overall Study|Physician Decision|0|||
13487196|NCT03877926|27038987|FG000|Overall Study|Withdrawal by Subject|18|||
13487197|NCT03877926|27038988|FG001|Overall Study|Withdrawal by Subject|21|||
13487198|NCT03877926|27038989|FG002|Overall Study|Withdrawal by Subject|12|||
13487199|NCT03877926|27038990|FG003|Overall Study|Withdrawal by Subject|4|||
13487200|NCT03877926|27038987|FG000|Overall Study|Other - Various|4|||
13487201|NCT03877926|27038988|FG001|Overall Study|Other - Various|1|||
13487202|NCT03877926|27038989|FG002|Overall Study|Other - Various|1|||
13487203|NCT03877926|27038990|FG003|Overall Study|Other - Various|0|||
13487204|NCT03877926|27038987|FG000|Overall Study|Not Treated|3|||
13487205|NCT03877926|27038988|FG001|Overall Study|Not Treated|1|||
13487206|NCT03877926|27038989|FG002|Overall Study|Not Treated|1|||
13487207|NCT03877926|27038990|FG003|Overall Study|Not Treated|0|||
13487208|NCT03862807|27039002|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1|||
13487209|NCT03857867|27039010|FG000|Overall Study|Physician Decision|1|||
13487210|NCT03436199|27039037|FG000|Overall Study|Adverse Event|15|||
13487211|NCT03436199|27039038|FG001|Overall Study|Adverse Event|40|||
13487212|NCT03436199|27039039|FG002|Overall Study|Adverse Event|7|||
13487213|NCT03436199|27039037|FG000|Overall Study|Withdrawal by Subject|4|||
13487214|NCT03436199|27039038|FG001|Overall Study|Withdrawal by Subject|10|||
13487215|NCT03436199|27039039|FG002|Overall Study|Withdrawal by Subject|3|||
13487216|NCT03436199|27039037|FG000|Overall Study|Lost to Follow-up|1|||
13487217|NCT03436199|27039038|FG001|Overall Study|Lost to Follow-up|0|||
13487218|NCT03436199|27039039|FG002|Overall Study|Lost to Follow-up|2|||
13487219|NCT03436199|27039037|FG000|Overall Study|Protocol Violation|1|||
13487220|NCT03436199|27039038|FG001|Overall Study|Protocol Violation|1|||
13487221|NCT03436199|27039039|FG002|Overall Study|Protocol Violation|0|||
13487222|NCT03436199|27039037|FG000|Overall Study|Physician Decision|0|||
13487223|NCT03436199|27039038|FG001|Overall Study|Physician Decision|1|||
13487224|NCT03436199|27039039|FG002|Overall Study|Physician Decision|0|||
13487225|NCT03436199|27039037|FG000|Overall Study|Could not return to clinic|1|||
13487226|NCT03436199|27039038|FG001|Overall Study|Could not return to clinic|0|||
13487227|NCT03436199|27039039|FG002|Overall Study|Could not return to clinic|0|||
13487228|NCT03436199|27039037|FG000|Overall Study|Withdrawn per physician|0|||
13487229|NCT03436199|27039038|FG001|Overall Study|Withdrawn per physician|1|||
13487230|NCT03436199|27039039|FG002|Overall Study|Withdrawn per physician|0|||
13488224|NCT03730662|27043120|FG002|Treatment Period (52 Weeks)|Personal Reason|0|||
13488225|NCT03730662|27043121|FG003|Treatment Period (52 Weeks)|Personal Reason|2|||
13488226|NCT03730662|27043118|FG000|Variable Treatment Period|Adverse Event|1|||
13488227|NCT03730662|27043119|FG001|Variable Treatment Period|Adverse Event|2|||
13488228|NCT03730662|27043120|FG002|Variable Treatment Period|Adverse Event|0|||
13488229|NCT03730662|27043121|FG003|Variable Treatment Period|Adverse Event|7|||
13488230|NCT03730662|27043118|FG000|Variable Treatment Period|Death|9|||
13488231|NCT03730662|27043119|FG001|Variable Treatment Period|Death|0|||
13488232|NCT03730662|27043120|FG002|Variable Treatment Period|Death|6|||
13488233|NCT03730662|27043121|FG003|Variable Treatment Period|Death|26|||
13488234|NCT03730662|27043118|FG000|Variable Treatment Period|Lost to Follow-up|2|||
13488235|NCT03730662|27043119|FG001|Variable Treatment Period|Lost to Follow-up|1|||
13488236|NCT03730662|27043120|FG002|Variable Treatment Period|Lost to Follow-up|4|||
13488237|NCT03730662|27043121|FG003|Variable Treatment Period|Lost to Follow-up|11|||
13488238|NCT03730662|27043118|FG000|Variable Treatment Period|Personal Reason|0|||
13488239|NCT03730662|27043119|FG001|Variable Treatment Period|Personal Reason|2|||
13488240|NCT03730662|27043120|FG002|Variable Treatment Period|Personal Reason|1|||
13488241|NCT03730662|27043121|FG003|Variable Treatment Period|Personal Reason|6|||
13488242|NCT03730662|27043118|FG000|Variable Treatment Period|Physician Decision|0|||
13488243|NCT03730662|27043119|FG001|Variable Treatment Period|Physician Decision|0|||
13488244|NCT03730662|27043120|FG002|Variable Treatment Period|Physician Decision|0|||
13488245|NCT03730662|27043121|FG003|Variable Treatment Period|Physician Decision|3|||
13488246|NCT03730662|27043118|FG000|Variable Treatment Period|Protocol Violation|0|||
13488247|NCT03730662|27043119|FG001|Variable Treatment Period|Protocol Violation|1|||
13488248|NCT03730662|27043120|FG002|Variable Treatment Period|Protocol Violation|1|||
13488249|NCT03730662|27043121|FG003|Variable Treatment Period|Protocol Violation|1|||
13488250|NCT03730662|27043118|FG000|Variable Treatment Period|Withdrawal by Subject|2|||
13488251|NCT03730662|27043119|FG001|Variable Treatment Period|Withdrawal by Subject|1|||
13488252|NCT03730662|27043120|FG002|Variable Treatment Period|Withdrawal by Subject|4|||
13481201|NCT01931098|27018680|FG000|Overall Study|Withdrawal by Subject|0|||
13481202|NCT01931098|27018681|FG001|Overall Study|Withdrawal by Subject|1|||
13481203|NCT01931098|27018680|FG000|Overall Study|Enrolled in different protocol|0|||
13481204|NCT01931098|27018681|FG001|Overall Study|Enrolled in different protocol|1|||
13481205|NCT01931098|27018680|FG000|Overall Study|Unable to begin trmt:active infection|0|||
13481206|NCT01931098|27018681|FG001|Overall Study|Unable to begin trmt:active infection|1|||
13481207|NCT01931098|27018680|FG000|Overall Study|Refused further treatment|0|||
13481208|NCT01931098|27018681|FG001|Overall Study|Refused further treatment|1|||
13481209|NCT01945021|27018697|FG000|Overall Study|Adverse Event|1|||
13481210|NCT01945021|27018697|FG000|Overall Study|Withdrawal of consent|12|||
13481211|NCT01945021|27018697|FG000|Overall Study|Lost to Follow-up|5|||
13481212|NCT01945021|27018697|FG000|Overall Study|Death|65|||
13481213|NCT03951077|27018898|FG000|Overall Study|Adverse Event|1|||
13481214|NCT03951077|27018899|FG001|Overall Study|Adverse Event|0|||
13481215|NCT03951077|27018900|FG002|Overall Study|Adverse Event|0|||
13481216|NCT03951077|27018901|FG003|Overall Study|Adverse Event|0|||
13481217|NCT03951077|27018902|FG004|Overall Study|Adverse Event|0|||
13481218|NCT03951077|27018903|FG005|Overall Study|Adverse Event|0|||
13481219|NCT03951077|27018898|FG000|Overall Study|Withdrawal by Subject|3|||
13481220|NCT03951077|27018899|FG001|Overall Study|Withdrawal by Subject|3|||
13481221|NCT03951077|27018900|FG002|Overall Study|Withdrawal by Subject|0|||
13481222|NCT03951077|27018901|FG003|Overall Study|Withdrawal by Subject|3|||
13481223|NCT03951077|27018902|FG004|Overall Study|Withdrawal by Subject|3|||
13481224|NCT03951077|27018903|FG005|Overall Study|Withdrawal by Subject|2|||
13481225|NCT03951077|27018898|FG000|Overall Study|Lost to Follow-up|1|||
13481226|NCT03951077|27018899|FG001|Overall Study|Lost to Follow-up|1|||
13481227|NCT03951077|27018900|FG002|Overall Study|Lost to Follow-up|2|||
13481228|NCT03951077|27018901|FG003|Overall Study|Lost to Follow-up|3|||
13481229|NCT03951077|27018902|FG004|Overall Study|Lost to Follow-up|2|||
13481230|NCT03951077|27018903|FG005|Overall Study|Lost to Follow-up|3|||
13481231|NCT03951077|27018898|FG000|Overall Study|Non-Compliance With Study Procedures|0|||
13481232|NCT03951077|27018899|FG001|Overall Study|Non-Compliance With Study Procedures|0|||
13481233|NCT03951077|27018900|FG002|Overall Study|Non-Compliance With Study Procedures|0|||
13481234|NCT03951077|27018901|FG003|Overall Study|Non-Compliance With Study Procedures|0|||
13481235|NCT03951077|27018902|FG004|Overall Study|Non-Compliance With Study Procedures|1|||
13481236|NCT03951077|27018903|FG005|Overall Study|Non-Compliance With Study Procedures|0|||
13481237|NCT03951077|27018898|FG000|Overall Study|Other, Not Specified|12|||
13481238|NCT03951077|27018899|FG001|Overall Study|Other, Not Specified|10|||
13481239|NCT03951077|27018900|FG002|Overall Study|Other, Not Specified|10|||
13481240|NCT03951077|27018901|FG003|Overall Study|Other, Not Specified|5|||
13481241|NCT03951077|27018902|FG004|Overall Study|Other, Not Specified|9|||
13481242|NCT03951077|27018903|FG005|Overall Study|Other, Not Specified|6|||
13481243|NCT03951077|27018898|FG000|Overall Study|Did Not Receive Any Study Drug|1|||
13481244|NCT03951077|27018899|FG001|Overall Study|Did Not Receive Any Study Drug|0|||
13481245|NCT03951077|27018900|FG002|Overall Study|Did Not Receive Any Study Drug|1|||
13481246|NCT03951077|27018901|FG003|Overall Study|Did Not Receive Any Study Drug|1|||
13481247|NCT03951077|27018902|FG004|Overall Study|Did Not Receive Any Study Drug|1|||
13481248|NCT03951077|27018903|FG005|Overall Study|Did Not Receive Any Study Drug|0|||
13481329|NCT02330562|27019192|FG005|Overall Study|Withdrawal by Subject|0|||
13481330|NCT02330562|27019193|FG006|Overall Study|Withdrawal by Subject|0|||
13481331|NCT02330562|27019194|FG007|Overall Study|Withdrawal by Subject|0|||
13481332|NCT02330562|27019195|FG008|Overall Study|Withdrawal by Subject|0|||
13481333|NCT02330562|27019196|FG009|Overall Study|Withdrawal by Subject|1|||
13481334|NCT02330562|27019197|FG010|Overall Study|Withdrawal by Subject|0|||
13487231|NCT03181542|27039076|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1|||
13487232|NCT03181542|27039077|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0|||
13487233|NCT03985293|27039342|FG000|DOUBLE-BLIND TREATMENT|Adverse Event|5|||
13487234|NCT03985293|27039343|FG001|DOUBLE-BLIND TREATMENT|Adverse Event|2|||
13487235|NCT03985293|27039344|FG002|DOUBLE-BLIND TREATMENT|Adverse Event|3|||
13487236|NCT03985293|27039345|FG003|DOUBLE-BLIND TREATMENT|Adverse Event|8|||
13487237|NCT03985293|27039346|FG004|DOUBLE-BLIND TREATMENT|Adverse Event|15|||
13487238|NCT03985293|27039347|FG005|DOUBLE-BLIND TREATMENT|Adverse Event|24|||
13487239|NCT03985293|27039342|FG000|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
13487240|NCT03985293|27039343|FG001|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
13487241|NCT03985293|27039344|FG002|DOUBLE-BLIND TREATMENT|Lost to Follow-up|0|||
13487242|NCT03985293|27039345|FG003|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
13487243|NCT03985293|27039346|FG004|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
13487244|NCT03985293|27039347|FG005|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
13487245|NCT03985293|27039342|FG000|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
13487246|NCT03985293|27039343|FG001|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
13487247|NCT03985293|27039344|FG002|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
13487248|NCT03985293|27039345|FG003|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
13481249|NCT03873246|27018939|FG000|Overall Study|Adverse Event|1|||
13481250|NCT03873246|27018940|FG001|Overall Study|Adverse Event|3|||
13481251|NCT03873246|27018941|FG002|Overall Study|Adverse Event|3|||
13481252|NCT03873246|27018939|FG000|Overall Study|Lost to Follow-up|4|||
13481253|NCT03873246|27018940|FG001|Overall Study|Lost to Follow-up|4|||
13481254|NCT03873246|27018941|FG002|Overall Study|Lost to Follow-up|5|||
13481255|NCT03873246|27018939|FG000|Overall Study|Protocol Violation|0|||
13481256|NCT03873246|27018940|FG001|Overall Study|Protocol Violation|1|||
13481257|NCT03873246|27018941|FG002|Overall Study|Protocol Violation|0|||
13481258|NCT03873246|27018939|FG000|Overall Study|Withdrawal by Subject|0|||
13481259|NCT03873246|27018940|FG001|Overall Study|Withdrawal by Subject|4|||
13481260|NCT03873246|27018941|FG002|Overall Study|Withdrawal by Subject|1|||
13481261|NCT03769649|27018964|FG000|Overall Study|Lost to Follow-up|4|||
13481262|NCT02862548|27019045|FG000|Randomized Phase (Up to Week 48)|Death|0|||
13481263|NCT02862548|27019046|FG001|Randomized Phase (Up to Week 48)|Death|1|||
13481264|NCT02862548|27019045|FG000|OLE Phase (Week 49 to Week 192)|Death|2|||
13481265|NCT02862548|27019046|FG001|OLE Phase (Week 49 to Week 192)|Death|0|||
13481266|NCT02862548|27019045|FG000|OLE Phase (Week 49 to Week 192)|Adverse Event|1|||
13481267|NCT02862548|27019046|FG001|OLE Phase (Week 49 to Week 192)|Adverse Event|0|||
13481268|NCT02862548|27019045|FG000|OLE Phase (Week 49 to Week 192)|Withdrew Consent|0|||
13481269|NCT02862548|27019046|FG001|OLE Phase (Week 49 to Week 192)|Withdrew Consent|1|||
13481270|NCT02335099|27019077|FG000|Treatment|Withdrawal by Subject|1|||
13481271|NCT02335099|27019078|FG001|Treatment|Withdrawal by Subject|3|||
13481272|NCT02335099|27019077|FG000|Treatment|Lost to Follow-up|2|||
13481273|NCT02335099|27019078|FG001|Treatment|Lost to Follow-up|0|||
13481274|NCT02335099|27019077|FG000|Treatment|Death|1|||
13481275|NCT02335099|27019078|FG001|Treatment|Death|0|||
13481276|NCT02335099|27019077|FG000|Treatment|Adverse Event|1|||
13481277|NCT02335099|27019078|FG001|Treatment|Adverse Event|2|||
13481278|NCT02335099|27019077|FG000|Follow-up|Death|0|||
13481279|NCT02335099|27019078|FG001|Follow-up|Death|1|||
13481280|NCT02330562|27019187|FG000|Overall Study|Adverse Event|0|||
13481281|NCT02330562|27019188|FG001|Overall Study|Adverse Event|0|||
13481282|NCT02330562|27019189|FG002|Overall Study|Adverse Event|3|||
13481283|NCT02330562|27019190|FG003|Overall Study|Adverse Event|0|||
13481284|NCT02330562|27019191|FG004|Overall Study|Adverse Event|3|||
13481285|NCT02330562|27019192|FG005|Overall Study|Adverse Event|1|||
13481286|NCT02330562|27019193|FG006|Overall Study|Adverse Event|0|||
13481287|NCT02330562|27019194|FG007|Overall Study|Adverse Event|0|||
13481288|NCT02330562|27019195|FG008|Overall Study|Adverse Event|0|||
13481289|NCT02330562|27019196|FG009|Overall Study|Adverse Event|1|||
13481290|NCT02330562|27019197|FG010|Overall Study|Adverse Event|1|||
13481291|NCT02330562|27019187|FG000|Overall Study|Participant decision|1|||
13481292|NCT02330562|27019188|FG001|Overall Study|Participant decision|0|||
13481293|NCT02330562|27019189|FG002|Overall Study|Participant decision|4|||
13481294|NCT02330562|27019190|FG003|Overall Study|Participant decision|1|||
13481295|NCT02330562|27019191|FG004|Overall Study|Participant decision|5|||
13481296|NCT02330562|27019192|FG005|Overall Study|Participant decision|2|||
13481297|NCT02330562|27019193|FG006|Overall Study|Participant decision|0|||
13481298|NCT02330562|27019194|FG007|Overall Study|Participant decision|0|||
13481299|NCT02330562|27019195|FG008|Overall Study|Participant decision|0|||
13481300|NCT02330562|27019196|FG009|Overall Study|Participant decision|3|||
13481301|NCT02330562|27019197|FG010|Overall Study|Participant decision|0|||
13481302|NCT02330562|27019187|FG000|Overall Study|Disease progression|5|||
13481303|NCT02330562|27019188|FG001|Overall Study|Disease progression|3|||
13481304|NCT02330562|27019189|FG002|Overall Study|Disease progression|20|||
13481305|NCT02330562|27019190|FG003|Overall Study|Disease progression|28|||
13481306|NCT02330562|27019191|FG004|Overall Study|Disease progression|23|||
13481307|NCT02330562|27019192|FG005|Overall Study|Disease progression|7|||
13481308|NCT02330562|27019193|FG006|Overall Study|Disease progression|1|||
13481309|NCT02330562|27019194|FG007|Overall Study|Disease progression|1|||
13481310|NCT02330562|27019195|FG008|Overall Study|Disease progression|1|||
13481311|NCT02330562|27019196|FG009|Overall Study|Disease progression|0|||
13481312|NCT02330562|27019197|FG010|Overall Study|Disease progression|5|||
13481313|NCT02330562|27019187|FG000|Overall Study|Other reasons|0|||
13481314|NCT02330562|27019188|FG001|Overall Study|Other reasons|0|||
13481315|NCT02330562|27019189|FG002|Overall Study|Other reasons|0|||
13481316|NCT02330562|27019190|FG003|Overall Study|Other reasons|1|||
13481317|NCT02330562|27019191|FG004|Overall Study|Other reasons|0|||
13481318|NCT02330562|27019192|FG005|Overall Study|Other reasons|0|||
13481319|NCT02330562|27019193|FG006|Overall Study|Other reasons|0|||
13481320|NCT02330562|27019194|FG007|Overall Study|Other reasons|0|||
13481321|NCT02330562|27019195|FG008|Overall Study|Other reasons|0|||
13481322|NCT02330562|27019196|FG009|Overall Study|Other reasons|0|||
13481323|NCT02330562|27019197|FG010|Overall Study|Other reasons|0|||
13481324|NCT02330562|27019187|FG000|Overall Study|Withdrawal by Subject|0|||
13481325|NCT02330562|27019188|FG001|Overall Study|Withdrawal by Subject|0|||
13481326|NCT02330562|27019189|FG002|Overall Study|Withdrawal by Subject|0|||
13481327|NCT02330562|27019190|FG003|Overall Study|Withdrawal by Subject|0|||
13481328|NCT02330562|27019191|FG004|Overall Study|Withdrawal by Subject|0|||
13481335|NCT03703102|27019503|FG000|Overall Study|Adverse Event|4|||
13481336|NCT03703102|27019504|FG001|Overall Study|Adverse Event|3|||
13481337|NCT03703102|27019505|FG002|Overall Study|Adverse Event|7|||
13481338|NCT03703102|27019506|FG003|Overall Study|Adverse Event|3|||
13481339|NCT03703102|27019507|FG004|Overall Study|Adverse Event|13|||
13481340|NCT03703102|27019503|FG000|Overall Study|Lack of Efficacy|4|||
13481341|NCT03703102|27019504|FG001|Overall Study|Lack of Efficacy|0|||
13481342|NCT03703102|27019505|FG002|Overall Study|Lack of Efficacy|1|||
13481343|NCT03703102|27019506|FG003|Overall Study|Lack of Efficacy|4|||
13481344|NCT03703102|27019507|FG004|Overall Study|Lack of Efficacy|1|||
13481345|NCT03703102|27019503|FG000|Overall Study|Lost to Follow-up|0|||
13481346|NCT03703102|27019504|FG001|Overall Study|Lost to Follow-up|0|||
13481347|NCT03703102|27019505|FG002|Overall Study|Lost to Follow-up|1|||
13481348|NCT03703102|27019506|FG003|Overall Study|Lost to Follow-up|2|||
13481349|NCT03703102|27019507|FG004|Overall Study|Lost to Follow-up|2|||
13481350|NCT03703102|27019503|FG000|Overall Study|Physician Decision|2|||
13481351|NCT03703102|27019504|FG001|Overall Study|Physician Decision|2|||
13481352|NCT03703102|27019505|FG002|Overall Study|Physician Decision|2|||
13481353|NCT03703102|27019506|FG003|Overall Study|Physician Decision|2|||
13481354|NCT03703102|27019507|FG004|Overall Study|Physician Decision|4|||
13481355|NCT03703102|27019503|FG000|Overall Study|Withdrawal by Subject|7|||
13481356|NCT03703102|27019504|FG001|Overall Study|Withdrawal by Subject|5|||
13481357|NCT03703102|27019505|FG002|Overall Study|Withdrawal by Subject|5|||
13481358|NCT03703102|27019506|FG003|Overall Study|Withdrawal by Subject|5|||
13481359|NCT03703102|27019507|FG004|Overall Study|Withdrawal by Subject|9|||
13481360|NCT03703102|27019503|FG000|Overall Study|Ineligibility|0|||
13481361|NCT03703102|27019504|FG001|Overall Study|Ineligibility|0|||
13481362|NCT03703102|27019505|FG002|Overall Study|Ineligibility|1|||
13481363|NCT03703102|27019506|FG003|Overall Study|Ineligibility|0|||
13481364|NCT03703102|27019507|FG004|Overall Study|Ineligibility|0|||
13481365|NCT03703102|27019503|FG000|Overall Study|Protocol Deviation|4|||
13481366|NCT03703102|27019504|FG001|Overall Study|Protocol Deviation|4|||
13481367|NCT03703102|27019505|FG002|Overall Study|Protocol Deviation|3|||
13481368|NCT03703102|27019506|FG003|Overall Study|Protocol Deviation|0|||
13481369|NCT03703102|27019507|FG004|Overall Study|Protocol Deviation|0|||
13481370|NCT03703102|27019503|FG000|Overall Study|Non-Compliance with Study Drug|1|||
13481371|NCT03703102|27019504|FG001|Overall Study|Non-Compliance with Study Drug|1|||
13481372|NCT03703102|27019505|FG002|Overall Study|Non-Compliance with Study Drug|2|||
13481373|NCT03703102|27019506|FG003|Overall Study|Non-Compliance with Study Drug|1|||
13481374|NCT03703102|27019507|FG004|Overall Study|Non-Compliance with Study Drug|4|||
13481375|NCT03395704|27019526|FG000|Overall Study|Adverse Event|2|||
13481376|NCT03395704|27019527|FG001|Overall Study|Adverse Event|1|||
13481377|NCT03395704|27019526|FG000|Overall Study|Withdrawal by Subject|2|||
13481378|NCT03395704|27019527|FG001|Overall Study|Withdrawal by Subject|1|||
13481379|NCT03395704|27019526|FG000|Overall Study|Physician Decision|0|||
13481380|NCT03395704|27019527|FG001|Overall Study|Physician Decision|1|||
13481381|NCT03335813|27019544|FG000|Overall Study|Withdrawal by Subject|1|||
13481382|NCT03246503|27019552|FG000|Overall Study|Lost to Follow-up|23|||
13481383|NCT03246503|27019552|FG000|Overall Study|Withdrawal by Subject|20|||
13481384|NCT03246503|27019552|FG000|Overall Study|Physician Decision|5|||
13481385|NCT03246503|27019552|FG000|Overall Study|Received phtototherapy prior to study visit=4, blood specimen not obtained =1|5|||
13481386|NCT02514447|27019894|FG000|Overall Study|Withdrawal by Subject|3|||
13481387|NCT02514447|27019895|FG001|Overall Study|Withdrawal by Subject|1|||
13481388|NCT02514447|27019896|FG002|Overall Study|Withdrawal by Subject|1|||
13481389|NCT02514447|27019897|FG003|Overall Study|Withdrawal by Subject|0|||
13481390|NCT02514447|27019898|FG004|Overall Study|Withdrawal by Subject|0|||
13481391|NCT02514447|27019899|FG005|Overall Study|Withdrawal by Subject|0|||
13481392|NCT02514447|27019900|FG006|Overall Study|Withdrawal by Subject|0|||
13481393|NCT02514447|27019901|FG007|Overall Study|Withdrawal by Subject|1|||
13481394|NCT02514447|27019902|FG008|Overall Study|Withdrawal by Subject|1|||
13481395|NCT02514447|27019894|FG000|Overall Study|Death|24|||
13481396|NCT02514447|27019895|FG001|Overall Study|Death|28|||
13481397|NCT02514447|27019896|FG002|Overall Study|Death|29|||
13481398|NCT02514447|27019897|FG003|Overall Study|Death|0|||
13481399|NCT02514447|27019898|FG004|Overall Study|Death|3|||
13481400|NCT02514447|27019899|FG005|Overall Study|Death|4|||
13481401|NCT02514447|27019900|FG006|Overall Study|Death|8|||
13481402|NCT02514447|27019901|FG007|Overall Study|Death|6|||
13481403|NCT02514447|27019902|FG008|Overall Study|Death|5|||
13481404|NCT02514447|27019894|FG000|Overall Study|Lost to Follow-up|1|||
13481405|NCT02514447|27019895|FG001|Overall Study|Lost to Follow-up|0|||
13481406|NCT02514447|27019896|FG002|Overall Study|Lost to Follow-up|0|||
13481407|NCT02514447|27019897|FG003|Overall Study|Lost to Follow-up|0|||
13481408|NCT02514447|27019898|FG004|Overall Study|Lost to Follow-up|0|||
13481409|NCT02514447|27019899|FG005|Overall Study|Lost to Follow-up|0|||
13481410|NCT02514447|27019900|FG006|Overall Study|Lost to Follow-up|0|||
13481411|NCT02514447|27019901|FG007|Overall Study|Lost to Follow-up|0|||
13481412|NCT02514447|27019902|FG008|Overall Study|Lost to Follow-up|1|||
13481413|NCT02514447|27019894|FG000|Overall Study|Sponsor Termination of Study|0|||
13481414|NCT02514447|27019895|FG001|Overall Study|Sponsor Termination of Study|1|||
13481415|NCT02514447|27019896|FG002|Overall Study|Sponsor Termination of Study|1|||
13481416|NCT02514447|27019897|FG003|Overall Study|Sponsor Termination of Study|0|||
13481417|NCT02514447|27019898|FG004|Overall Study|Sponsor Termination of Study|0|||
13481418|NCT02514447|27019899|FG005|Overall Study|Sponsor Termination of Study|0|||
13481419|NCT02514447|27019900|FG006|Overall Study|Sponsor Termination of Study|0|||
13481420|NCT02514447|27019901|FG007|Overall Study|Sponsor Termination of Study|0|||
13481421|NCT02514447|27019902|FG008|Overall Study|Sponsor Termination of Study|0|||
13481422|NCT02514447|27019894|FG000|Overall Study|Study completion per Investigator|1|||
13481423|NCT02514447|27019895|FG001|Overall Study|Study completion per Investigator|0|||
13481424|NCT02514447|27019896|FG002|Overall Study|Study completion per Investigator|1|||
13481425|NCT02514447|27019897|FG003|Overall Study|Study completion per Investigator|2|||
13481426|NCT02514447|27019898|FG004|Overall Study|Study completion per Investigator|0|||
13481427|NCT02514447|27019899|FG005|Overall Study|Study completion per Investigator|0|||
13481428|NCT02514447|27019900|FG006|Overall Study|Study completion per Investigator|0|||
13481429|NCT02514447|27019901|FG007|Overall Study|Study completion per Investigator|0|||
13481430|NCT02514447|27019902|FG008|Overall Study|Study completion per Investigator|1|||
13481431|NCT01785563|27019915|FG000|Overall Study|Physician Decision|10|||
13481432|NCT01785563|27019915|FG000|Overall Study|Withdrawal by Subject|1|||
13481433|NCT01785563|27019915|FG000|Overall Study|Protocol Violation|2|||
13481434|NCT01434290|27019964|FG000|Overall Study|Protocol Violation|6|||
13481435|NCT01434290|27019965|FG001|Overall Study|Protocol Violation|3|||
13481436|NCT01434290|27019964|FG000|Overall Study|No protocol treatment|2|||
13481437|NCT01434290|27019965|FG001|Overall Study|No protocol treatment|4|||
13481438|NCT00750269|27020026|FG000|Overall Study|Protocol Violation|0|||
13481439|NCT00750269|27020027|FG001|Overall Study|Protocol Violation|1|||
13481440|NCT00750269|27020028|FG002|Overall Study|Protocol Violation|1|||
13481441|NCT00750269|27020029|FG003|Overall Study|Protocol Violation|2|||
13481442|NCT00750269|27020030|FG004|Overall Study|Protocol Violation|4|||
13481443|NCT00750269|27020026|FG000|Overall Study|Withdrawal by Subject|0|||
13481444|NCT00750269|27020027|FG001|Overall Study|Withdrawal by Subject|0|||
13481445|NCT00750269|27020028|FG002|Overall Study|Withdrawal by Subject|2|||
13481446|NCT00750269|27020029|FG003|Overall Study|Withdrawal by Subject|2|||
13481447|NCT00750269|27020030|FG004|Overall Study|Withdrawal by Subject|2|||
13481448|NCT00750269|27020026|FG000|Overall Study|Physician Decision|0|||
13481449|NCT00750269|27020027|FG001|Overall Study|Physician Decision|0|||
13481450|NCT00750269|27020028|FG002|Overall Study|Physician Decision|0|||
13481451|NCT00750269|27020029|FG003|Overall Study|Physician Decision|0|||
13481452|NCT00750269|27020030|FG004|Overall Study|Physician Decision|2|||
13481453|NCT00750269|27020026|FG000|Overall Study|Patient too large for positioning|0|||
13481454|NCT00750269|27020027|FG001|Overall Study|Patient too large for positioning|0|||
13481455|NCT00750269|27020028|FG002|Overall Study|Patient too large for positioning|1|||
13481456|NCT00750269|27020029|FG003|Overall Study|Patient too large for positioning|0|||
13481457|NCT00750269|27020030|FG004|Overall Study|Patient too large for positioning|0|||
13481458|NCT00750269|27020026|FG000|Overall Study|Site error|0|||
13481459|NCT00750269|27020027|FG001|Overall Study|Site error|0|||
13481460|NCT00750269|27020028|FG002|Overall Study|Site error|0|||
13481461|NCT00750269|27020029|FG003|Overall Study|Site error|1|||
13481462|NCT00750269|27020030|FG004|Overall Study|Site error|0|||
13481463|NCT00750269|27020026|FG000|Overall Study|SBRT plan could not be drawn|0|||
13481464|NCT00750269|27020027|FG001|Overall Study|SBRT plan could not be drawn|0|||
13481465|NCT00750269|27020028|FG002|Overall Study|SBRT plan could not be drawn|0|||
13481466|NCT00750269|27020029|FG003|Overall Study|SBRT plan could not be drawn|0|||
13481467|NCT00750269|27020030|FG004|Overall Study|SBRT plan could not be drawn|1|||
13481468|NCT00750269|27020026|FG000|Overall Study|Fiducials could not be placed|0|||
13481469|NCT00750269|27020027|FG001|Overall Study|Fiducials could not be placed|0|||
13481470|NCT00750269|27020028|FG002|Overall Study|Fiducials could not be placed|0|||
13481471|NCT00750269|27020029|FG003|Overall Study|Fiducials could not be placed|0|||
13481472|NCT00750269|27020030|FG004|Overall Study|Fiducials could not be placed|1|||
13481473|NCT00712322|27020069|FG000|Overall Study|Protocol deviation|0|||
13481474|NCT00712322|27020070|FG001|Overall Study|Protocol deviation|1|||
13481475|NCT00712322|27020071|FG002|Overall Study|Protocol deviation|0|||
13481476|NCT00323856|27020086|FG000|Overall Study|Withdrawal by Subject|1|||
13481477|NCT00323856|27020086|FG000|Overall Study|Was uncooperative and noncompliant|1|||
13481478|NCT00323856|27020086|FG000|Overall Study|Reason not specified|1|||
13481479|NCT00323856|27020086|FG000|Overall Study|Missing|2|||
13487249|NCT03985293|27039346|FG004|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
13487250|NCT03985293|27039347|FG005|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
13487251|NCT03985293|27039342|FG000|DOUBLE-BLIND TREATMENT|Other|1|||
13487252|NCT03985293|27039343|FG001|DOUBLE-BLIND TREATMENT|Other|2|||
13487253|NCT03985293|27039344|FG002|DOUBLE-BLIND TREATMENT|Other|0|||
13487254|NCT03985293|27039345|FG003|DOUBLE-BLIND TREATMENT|Other|2|||
13487255|NCT03985293|27039346|FG004|DOUBLE-BLIND TREATMENT|Other|1|||
13487256|NCT03985293|27039347|FG005|DOUBLE-BLIND TREATMENT|Other|0|||
13487257|NCT03985293|27039342|FG000|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
13481480|NCT04524663|27020122|FG000|Overall Study|Withdrawal by Subject|0|||
13481481|NCT04524663|27020123|FG001|Overall Study|Withdrawal by Subject|2|||
13481482|NCT03738423|27020334|FG000|Overall Study|Withdrawal by Subject|9|||
13481483|NCT03738423|27020335|FG001|Overall Study|Withdrawal by Subject|12|||
13481484|NCT03738423|27020336|FG002|Overall Study|Withdrawal by Subject|9|||
13481485|NCT03738423|27020337|FG003|Overall Study|Withdrawal by Subject|12|||
13481486|NCT03738423|27020338|FG004|Overall Study|Withdrawal by Subject|10|||
13481487|NCT03738423|27020334|FG000|Overall Study|Lack of Efficacy|3|||
13481488|NCT03738423|27020335|FG001|Overall Study|Lack of Efficacy|1|||
13481489|NCT03738423|27020336|FG002|Overall Study|Lack of Efficacy|1|||
13481490|NCT03738423|27020337|FG003|Overall Study|Lack of Efficacy|1|||
13481491|NCT03738423|27020338|FG004|Overall Study|Lack of Efficacy|2|||
13481492|NCT03738423|27020334|FG000|Overall Study|Lost to Follow-up|1|||
13481493|NCT03738423|27020335|FG001|Overall Study|Lost to Follow-up|0|||
13481494|NCT03738423|27020336|FG002|Overall Study|Lost to Follow-up|1|||
13481495|NCT03738423|27020337|FG003|Overall Study|Lost to Follow-up|1|||
13481496|NCT03738423|27020338|FG004|Overall Study|Lost to Follow-up|0|||
13481497|NCT03738423|27020334|FG000|Overall Study|Protocol Violation|1|||
13481498|NCT03738423|27020335|FG001|Overall Study|Protocol Violation|0|||
13481499|NCT03738423|27020336|FG002|Overall Study|Protocol Violation|0|||
13481500|NCT03738423|27020337|FG003|Overall Study|Protocol Violation|0|||
13481501|NCT03738423|27020338|FG004|Overall Study|Protocol Violation|1|||
13481502|NCT03738423|27020334|FG000|Overall Study|Physician Decision|0|||
13481503|NCT03738423|27020335|FG001|Overall Study|Physician Decision|0|||
13481504|NCT03738423|27020336|FG002|Overall Study|Physician Decision|1|||
13481505|NCT03738423|27020337|FG003|Overall Study|Physician Decision|0|||
13481506|NCT03738423|27020338|FG004|Overall Study|Physician Decision|1|||
13481507|NCT03738423|27020334|FG000|Overall Study|Death|0|||
13481508|NCT03738423|27020335|FG001|Overall Study|Death|0|||
13481509|NCT03738423|27020336|FG002|Overall Study|Death|0|||
13481510|NCT03738423|27020337|FG003|Overall Study|Death|0|||
13481511|NCT03738423|27020338|FG004|Overall Study|Death|1|||
13481512|NCT03738423|27020334|FG000|Overall Study|Randomized but never treated|0|||
13481513|NCT03738423|27020335|FG001|Overall Study|Randomized but never treated|0|||
13481514|NCT03738423|27020336|FG002|Overall Study|Randomized but never treated|1|||
13481515|NCT03738423|27020337|FG003|Overall Study|Randomized but never treated|1|||
13481516|NCT03738423|27020338|FG004|Overall Study|Randomized but never treated|0|||
13481517|NCT03712228|27020454|FG000|Treatment Period 1|Lack of Efficacy|0|||
13481518|NCT03712228|27020455|FG001|Treatment Period 1|Lack of Efficacy|0|||
13481519|NCT03712228|27020456|FG002|Treatment Period 1|Lack of Efficacy|0|||
13481520|NCT03712228|27020457|FG003|Treatment Period 1|Lack of Efficacy|0|||
13481521|NCT03712228|27020458|FG004|Treatment Period 1|Lack of Efficacy|0|||
13481522|NCT03712228|27020459|FG005|Treatment Period 1|Lack of Efficacy|1|||
13481523|NCT03712228|27020454|FG000|Treatment Period 2|Pregnancy|0|||
13481524|NCT03712228|27020455|FG001|Treatment Period 2|Pregnancy|0|||
13481525|NCT03712228|27020456|FG002|Treatment Period 2|Pregnancy|0|||
13481526|NCT03712228|27020457|FG003|Treatment Period 2|Pregnancy|1|||
13481527|NCT03712228|27020458|FG004|Treatment Period 2|Pregnancy|0|||
13481528|NCT03712228|27020459|FG005|Treatment Period 2|Pregnancy|0|||
13481529|NCT03712228|27020454|FG000|Treatment Period 2|Withdrawal by Subject|0|||
13481530|NCT03712228|27020455|FG001|Treatment Period 2|Withdrawal by Subject|0|||
13481531|NCT03712228|27020456|FG002|Treatment Period 2|Withdrawal by Subject|0|||
13481532|NCT03712228|27020457|FG003|Treatment Period 2|Withdrawal by Subject|1|||
13481533|NCT03712228|27020458|FG004|Treatment Period 2|Withdrawal by Subject|0|||
13481534|NCT03712228|27020459|FG005|Treatment Period 2|Withdrawal by Subject|0|||
13481535|NCT03600818|27020502|FG000|Overall Study|Adverse Event|4|||
13481536|NCT03600818|27020503|FG001|Overall Study|Adverse Event|7|||
13481537|NCT03600818|27020502|FG000|Overall Study|Lack of Efficacy|9|||
13481538|NCT03600818|27020503|FG001|Overall Study|Lack of Efficacy|4|||
13481539|NCT03600818|27020502|FG000|Overall Study|Withdrawal by Subject|4|||
13481540|NCT03600818|27020503|FG001|Overall Study|Withdrawal by Subject|3|||
13481541|NCT03600818|27020502|FG000|Overall Study|Other-unspecified|5|||
13481542|NCT03600818|27020503|FG001|Overall Study|Other-unspecified|3|||
13481543|NCT03600818|27020502|FG000|Overall Study|Randomized and not treated|0|||
13481544|NCT03600818|27020503|FG001|Overall Study|Randomized and not treated|1|||
13481545|NCT03578276|27020520|FG000|Overall Study|Subjects did not comply with study protocol instructions.|2|||
13481546|NCT03578276|27020521|FG001|Overall Study|Subjects did not comply with study protocol instructions.|2|||
13481547|NCT02971761|27020545|FG000|Overall Study|GTx-024 drug supply was withdrawn|2|||
13481548|NCT01968213|27020599|FG000|Overall Study|Ongoing|90|||
13481549|NCT01968213|27020600|FG001|Overall Study|Ongoing|9|||
13481550|NCT01627574|27020625|FG000|Overall Study|Withdrawal by Subject|8|||
13481551|NCT01627574|27020626|FG001|Overall Study|Withdrawal by Subject|5|||
13481552|NCT01627574|27020625|FG000|Overall Study|Lost to Follow-up|13|||
13481553|NCT01627574|27020626|FG001|Overall Study|Lost to Follow-up|13|||
13481554|NCT01498458|27020637|FG000|Overall Study|Adverse Event|4|||
13481555|NCT01498458|27020637|FG000|Overall Study|Physician Decision|3|||
13481556|NCT01427712|27020657|FG000|Overall Study|Transfer to a different hospital|2|||
13481557|NCT01427712|27020657|FG000|Overall Study|Lost to Follow-up|1|||
13481558|NCT01427712|27020657|FG000|Overall Study|Aggravation of cystic fibrosis|3|||
13481559|NCT01427712|27020657|FG000|Overall Study|Failure to visit|1|||
13481560|NCT01369147|27020693|FG000|Overall Study|All collected data were unintentionally destroyed|0|||
13481561|NCT01369147|27020694|FG001|Overall Study|All collected data were unintentionally destroyed|1|||
13481562|NCT01369147|27020695|FG002|Overall Study|All collected data were unintentionally destroyed|0|||
13481563|NCT01079780|27020722|FG000|Overall Study|Disease progression|43|||
13481564|NCT01079780|27020723|FG001|Overall Study|Disease progression|7|||
13481565|NCT01079780|27020724|FG002|Overall Study|Disease progression|31|||
13481566|NCT01079780|27020722|FG000|Overall Study|Adverse Event|13|||
13481567|NCT01079780|27020723|FG001|Overall Study|Adverse Event|5|||
13481568|NCT01079780|27020724|FG002|Overall Study|Adverse Event|7|||
13481569|NCT01079780|27020722|FG000|Overall Study|Death|2|||
13481570|NCT01079780|27020723|FG001|Overall Study|Death|0|||
13481571|NCT01079780|27020724|FG002|Overall Study|Death|2|||
13481572|NCT01079780|27020722|FG000|Overall Study|Withdrawal by Subject|6|||
13481573|NCT01079780|27020723|FG001|Overall Study|Withdrawal by Subject|4|||
13481574|NCT01079780|27020724|FG002|Overall Study|Withdrawal by Subject|4|||
13481575|NCT01079780|27020722|FG000|Overall Study|Alternative therapy|2|||
13481576|NCT01079780|27020723|FG001|Overall Study|Alternative therapy|0|||
13481577|NCT01079780|27020724|FG002|Overall Study|Alternative therapy|2|||
13481578|NCT01079780|27020722|FG000|Overall Study|Physician Decision|1|||
13481579|NCT01079780|27020723|FG001|Overall Study|Physician Decision|0|||
13481580|NCT01079780|27020724|FG002|Overall Study|Physician Decision|1|||
13481581|NCT01079780|27020722|FG000|Overall Study|Error made in lesion measurement|1|||
13481582|NCT01079780|27020723|FG001|Overall Study|Error made in lesion measurement|0|||
13481583|NCT01079780|27020724|FG002|Overall Study|Error made in lesion measurement|0|||
13481584|NCT01079780|27020722|FG000|Overall Study|Patient had surgery|1|||
13481585|NCT01079780|27020723|FG001|Overall Study|Patient had surgery|0|||
13481586|NCT01079780|27020724|FG002|Overall Study|Patient had surgery|0|||
13481587|NCT01079780|27020722|FG000|Overall Study|Treatment cycle delay|0|||
13481588|NCT01079780|27020723|FG001|Overall Study|Treatment cycle delay|0|||
13481589|NCT01079780|27020724|FG002|Overall Study|Treatment cycle delay|1|||
13481590|NCT01079780|27020722|FG000|Overall Study|Never started treatment|1|||
13481591|NCT01079780|27020723|FG001|Overall Study|Never started treatment|0|||
13481592|NCT01079780|27020724|FG002|Overall Study|Never started treatment|2|||
13481593|NCT00075946|27020753|FG000|Overall Study|Path ineligible: undetermined histology|0|||
13481594|NCT00075946|27020754|FG001|Overall Study|Path ineligible: undetermined histology|0|||
13481595|NCT00075946|27020755|FG002|Overall Study|Path ineligible: undetermined histology|0|||
13481596|NCT00075946|27020756|FG003|Overall Study|Path ineligible: undetermined histology|0|||
13481597|NCT00075946|27020757|FG004|Overall Study|Path ineligible: undetermined histology|6|||
13481598|NCT00075946|27020753|FG000|Overall Study|Did not achieve response after induction|0|||
13481599|NCT00075946|27020754|FG001|Overall Study|Did not achieve response after induction|0|||
13481600|NCT00075946|27020755|FG002|Overall Study|Did not achieve response after induction|0|||
13481601|NCT00075946|27020756|FG003|Overall Study|Did not achieve response after induction|0|||
13481602|NCT00075946|27020757|FG004|Overall Study|Did not achieve response after induction|182|||
13481603|NCT00075946|27020753|FG000|Overall Study|Incorrectly randomized (no response)|5|||
13481604|NCT00075946|27020754|FG001|Overall Study|Incorrectly randomized (no response)|5|||
13481605|NCT00075946|27020755|FG002|Overall Study|Incorrectly randomized (no response)|5|||
13481606|NCT00075946|27020756|FG003|Overall Study|Incorrectly randomized (no response)|1|||
13481607|NCT00075946|27020757|FG004|Overall Study|Incorrectly randomized (no response)|0|||
13481608|NCT00075946|27020753|FG000|Overall Study|Still on treatment at time of analysis|52|||
13481609|NCT00075946|27020754|FG001|Overall Study|Still on treatment at time of analysis|19|||
13481610|NCT00075946|27020755|FG002|Overall Study|Still on treatment at time of analysis|3|||
13481611|NCT00075946|27020756|FG003|Overall Study|Still on treatment at time of analysis|9|||
13481612|NCT00075946|27020757|FG004|Overall Study|Still on treatment at time of analysis|0|||
13481613|NCT00075946|27020753|FG000|Overall Study|Adverse Event|2|||
13481614|NCT00075946|27020754|FG001|Overall Study|Adverse Event|10|||
13481615|NCT00075946|27020755|FG002|Overall Study|Adverse Event|0|||
13481616|NCT00075946|27020756|FG003|Overall Study|Adverse Event|2|||
13481617|NCT00075946|27020757|FG004|Overall Study|Adverse Event|0|||
13481618|NCT00075946|27020753|FG000|Overall Study|Death|0|||
13481619|NCT00075946|27020754|FG001|Overall Study|Death|1|||
13481620|NCT00075946|27020755|FG002|Overall Study|Death|0|||
13481621|NCT00075946|27020756|FG003|Overall Study|Death|0|||
13481622|NCT00075946|27020757|FG004|Overall Study|Death|0|||
13481623|NCT00075946|27020753|FG000|Overall Study|Withdrawal by Subject|23|||
13481624|NCT00075946|27020754|FG001|Overall Study|Withdrawal by Subject|58|||
13481625|NCT00075946|27020755|FG002|Overall Study|Withdrawal by Subject|4|||
13481626|NCT00075946|27020756|FG003|Overall Study|Withdrawal by Subject|9|||
13481627|NCT00075946|27020757|FG004|Overall Study|Withdrawal by Subject|0|||
13481628|NCT00075946|27020753|FG000|Overall Study|Alternative therapy|16|||
13481629|NCT00075946|27020754|FG001|Overall Study|Alternative therapy|2|||
13481630|NCT00075946|27020755|FG002|Overall Study|Alternative therapy|5|||
13481631|NCT00075946|27020756|FG003|Overall Study|Alternative therapy|0|||
13481632|NCT00075946|27020757|FG004|Overall Study|Alternative therapy|0|||
13481633|NCT00075946|27020753|FG000|Overall Study|Other complicating disease|7|||
13481634|NCT00075946|27020754|FG001|Overall Study|Other complicating disease|13|||
13481635|NCT00075946|27020755|FG002|Overall Study|Other complicating disease|1|||
13481636|NCT00075946|27020756|FG003|Overall Study|Other complicating disease|4|||
13481637|NCT00075946|27020757|FG004|Overall Study|Other complicating disease|0|||
13481638|NCT00075946|27020753|FG000|Overall Study|No response to retreatment|23|||
13481639|NCT00075946|27020754|FG001|Overall Study|No response to retreatment|0|||
13481640|NCT00075946|27020755|FG002|Overall Study|No response to retreatment|2|||
13481641|NCT00075946|27020756|FG003|Overall Study|No response to retreatment|0|||
13481642|NCT00075946|27020757|FG004|Overall Study|No response to retreatment|0|||
13481643|NCT00075946|27020753|FG000|Overall Study|Time to progression less than 6 months|15|||
13481644|NCT00075946|27020754|FG001|Overall Study|Time to progression less than 6 months|30|||
13481645|NCT00075946|27020755|FG002|Overall Study|Time to progression less than 6 months|8|||
13481646|NCT00075946|27020756|FG003|Overall Study|Time to progression less than 6 months|3|||
13481647|NCT00075946|27020757|FG004|Overall Study|Time to progression less than 6 months|0|||
13481648|NCT00075946|27020753|FG000|Overall Study|Other|5|||
13481649|NCT00075946|27020754|FG001|Overall Study|Other|13|||
13481650|NCT00075946|27020755|FG002|Overall Study|Other|0|||
13481651|NCT00075946|27020756|FG003|Overall Study|Other|2|||
13481652|NCT00075946|27020757|FG004|Overall Study|Other|0|||
13481653|NCT00003641|27020772|FG000|Overall Study|Withdrawal by Subject|0|||
13481654|NCT00003641|27020773|FG001|Overall Study|Withdrawal by Subject|100|||
13481655|NCT00003641|27020772|FG000|Overall Study|Adverse Event|0|||
13481656|NCT00003641|27020773|FG001|Overall Study|Adverse Event|38|||
13481657|NCT00003641|27020772|FG000|Overall Study|Disease progression|0|||
13481658|NCT00003641|27020773|FG001|Overall Study|Disease progression|2|||
13481659|NCT00003641|27020772|FG000|Overall Study|Unknown/missing|0|||
13481660|NCT00003641|27020773|FG001|Overall Study|Unknown/missing|22|||
13481661|NCT00003641|27020772|FG000|Overall Study|Should not receive interferon therapy|2|||
13481662|NCT00003641|27020773|FG001|Overall Study|Should not receive interferon therapy|0|||
13481663|NCT00003641|27020772|FG000|Overall Study|Never started interferon|567|||
13481664|NCT00003641|27020773|FG001|Overall Study|Never started interferon|12|||
13487258|NCT03985293|27039343|FG001|DOUBLE-BLIND TREATMENT|Protocol Violation|2|||
13487259|NCT03985293|27039344|FG002|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
13487260|NCT03985293|27039345|FG003|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
13487261|NCT03985293|27039346|FG004|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
13487262|NCT03985293|27039347|FG005|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
13487263|NCT03985293|27039342|FG000|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
13487264|NCT03985293|27039343|FG001|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|4|||
13487265|NCT03985293|27039344|FG002|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|2|||
13487266|NCT03985293|27039345|FG003|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
13487267|NCT03985293|27039346|FG004|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|1|||
13487268|NCT03985293|27039347|FG005|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|7|||
13487269|NCT03985293|27039342|FG000|FOLLOW-UP|Lost to Follow-up|0|||
13487270|NCT03985293|27039343|FG001|FOLLOW-UP|Lost to Follow-up|0|||
13487271|NCT03985293|27039344|FG002|FOLLOW-UP|Lost to Follow-up|1|||
13487272|NCT03985293|27039345|FG003|FOLLOW-UP|Lost to Follow-up|0|||
13487273|NCT03985293|27039346|FG004|FOLLOW-UP|Lost to Follow-up|0|||
13487274|NCT03985293|27039347|FG005|FOLLOW-UP|Lost to Follow-up|0|||
13487275|NCT03846427|27039353|FG000|Overall Study|Death|7|||
13487276|NCT03846427|27039353|FG000|Overall Study|Withdrawal by Subject|2|||
13487277|NCT03846427|27039353|FG000|Overall Study|Remaining in study|59|||
13487278|NCT03776357|27039362|FG000|Overall Study|Lost to Follow-up|3|||
13487279|NCT03656068|27039450|FG000|Overall Study|Withdrawal by Subject|4|||
13487280|NCT03656068|27039450|FG000|Overall Study|Adverse Event|1|||
13488253|NCT03730662|27043121|FG003|Variable Treatment Period|Withdrawal by Subject|17|||
13488254|NCT03538444|27043134|FG000|Overall Study|opioid withdrawal|1|||
13488255|NCT03538444|27043135|FG001|Overall Study|opioid withdrawal|0|||
13488256|NCT03252925|27043150|FG000|Overall Study|Withdrawal by Subject|1|||
13488257|NCT03252925|27043151|FG001|Overall Study|Withdrawal by Subject|0|||
13488258|NCT03252925|27043150|FG000|Overall Study|Protocol Violation|6|||
13488259|NCT03252925|27043151|FG001|Overall Study|Protocol Violation|0|||
13488260|NCT03252925|27043150|FG000|Overall Study|Adverse Event|1|||
13488261|NCT03252925|27043151|FG001|Overall Study|Adverse Event|0|||
13488262|NCT03252925|27043150|FG000|Overall Study|Lost to Follow-up|6|||
13488263|NCT03252925|27043151|FG001|Overall Study|Lost to Follow-up|6|||
13488264|NCT03185832|27043179|FG000|Overall Study|Death|9|||
13488265|NCT03185832|27043180|FG001|Overall Study|Death|14|||
13488266|NCT03185832|27043181|FG002|Overall Study|Death|9|||
13488267|NCT03185832|27043182|FG003|Overall Study|Death|7|||
13488268|NCT03185832|27043179|FG000|Overall Study|Withdrawn - vital status available|0|||
13488269|NCT03185832|27043180|FG001|Overall Study|Withdrawn - vital status available|1|||
13488270|NCT03185832|27043181|FG002|Overall Study|Withdrawn - vital status available|1|||
13488271|NCT03185832|27043182|FG003|Overall Study|Withdrawn - vital status available|4|||
13488272|NCT02959918|27043320|FG000|Overall Study|Adverse Event|1|||
13488273|NCT02959918|27043321|FG001|Overall Study|Adverse Event|1|||
13481665|NCT01956669|27020890|FG000|Overall Study|Disease Progression|12|||
13481666|NCT01956669|27020891|FG001|Overall Study|Disease Progression|7|||
13481667|NCT01956669|27020892|FG002|Overall Study|Disease Progression|7|||
13481668|NCT01956669|27020893|FG003|Overall Study|Disease Progression|8|||
13481669|NCT01956669|27020894|FG004|Overall Study|Disease Progression|4|||
13481670|NCT01956669|27020895|FG005|Overall Study|Disease Progression|3|||
13481671|NCT01956669|27020896|FG006|Overall Study|Disease Progression|5|||
13481672|NCT01956669|27020890|FG000|Overall Study|Adverse Event|0|||
13481673|NCT01956669|27020891|FG001|Overall Study|Adverse Event|2|||
13481674|NCT01956669|27020892|FG002|Overall Study|Adverse Event|2|||
13481675|NCT01956669|27020893|FG003|Overall Study|Adverse Event|1|||
13481676|NCT01956669|27020894|FG004|Overall Study|Adverse Event|0|||
13481677|NCT01956669|27020895|FG005|Overall Study|Adverse Event|0|||
13481678|NCT01956669|27020896|FG006|Overall Study|Adverse Event|0|||
13481679|NCT01956669|27020890|FG000|Overall Study|Physician Decision|0|||
13481680|NCT01956669|27020891|FG001|Overall Study|Physician Decision|2|||
13481681|NCT01956669|27020892|FG002|Overall Study|Physician Decision|0|||
13481682|NCT01956669|27020893|FG003|Overall Study|Physician Decision|0|||
13481683|NCT01956669|27020894|FG004|Overall Study|Physician Decision|0|||
13481684|NCT01956669|27020895|FG005|Overall Study|Physician Decision|1|||
13481685|NCT01956669|27020896|FG006|Overall Study|Physician Decision|0|||
13481686|NCT01956669|27020890|FG000|Overall Study|Withdrawal by Subject|0|||
13481687|NCT01956669|27020891|FG001|Overall Study|Withdrawal by Subject|0|||
13481688|NCT01956669|27020892|FG002|Overall Study|Withdrawal by Subject|1|||
13481689|NCT01956669|27020893|FG003|Overall Study|Withdrawal by Subject|1|||
13481690|NCT01956669|27020894|FG004|Overall Study|Withdrawal by Subject|0|||
13481691|NCT01956669|27020895|FG005|Overall Study|Withdrawal by Subject|0|||
13481692|NCT01956669|27020896|FG006|Overall Study|Withdrawal by Subject|1|||
13481693|NCT01967823|27020907|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1|||
13481694|NCT01989676|27020934|FG000|Overall Study|Death|52|||
13481695|NCT01989676|27020935|FG001|Overall Study|Death|60|||
13481696|NCT01989676|27020934|FG000|Overall Study|Protocol Violation|2|||
13481697|NCT01989676|27020935|FG001|Overall Study|Protocol Violation|1|||
13481698|NCT01989676|27020934|FG000|Overall Study|Lost to Follow-up|8|||
13481699|NCT01989676|27020935|FG001|Overall Study|Lost to Follow-up|18|||
13481700|NCT01989676|27020934|FG000|Overall Study|No longer willing to participate in study|26|||
13481701|NCT01989676|27020935|FG001|Overall Study|No longer willing to participate in study|26|||
13481702|NCT01989676|27020934|FG000|Overall Study|Participants terminated from study by Sponsor|26|||
13481703|NCT01989676|27020935|FG001|Overall Study|Participants terminated from study by Sponsor|30|||
13481704|NCT01989676|27020934|FG000|Overall Study|Other|4|||
13481705|NCT01989676|27020935|FG001|Overall Study|Other|3|||
13481706|NCT01992653|27021186|FG000|Overall Study|Death|0|||
13481707|NCT01992653|27021187|FG001|Overall Study|Death|0|||
13481708|NCT01992653|27021188|FG002|Overall Study|Death|1|||
13481709|NCT01992653|27021189|FG003|Overall Study|Death|0|||
13481710|NCT01992653|27021190|FG004|Overall Study|Death|1|||
13481711|NCT01992653|27021191|FG005|Overall Study|Death|0|||
13481712|NCT01992653|27021192|FG006|Overall Study|Death|4|||
13481713|NCT01992653|27021193|FG007|Overall Study|Death|2|||
13481714|NCT01992653|27021186|FG000|Overall Study|Lost to Follow-up|0|||
13481715|NCT01992653|27021187|FG001|Overall Study|Lost to Follow-up|0|||
13481716|NCT01992653|27021188|FG002|Overall Study|Lost to Follow-up|0|||
13481717|NCT01992653|27021189|FG003|Overall Study|Lost to Follow-up|0|||
13481718|NCT01992653|27021190|FG004|Overall Study|Lost to Follow-up|0|||
13481719|NCT01992653|27021191|FG005|Overall Study|Lost to Follow-up|0|||
13481720|NCT01992653|27021192|FG006|Overall Study|Lost to Follow-up|0|||
13481721|NCT01992653|27021193|FG007|Overall Study|Lost to Follow-up|1|||
13481722|NCT01992653|27021186|FG000|Overall Study|Study Completed|0|||
13481723|NCT01992653|27021187|FG001|Overall Study|Study Completed|0|||
13481724|NCT01992653|27021188|FG002|Overall Study|Study Completed|0|||
13481725|NCT01992653|27021189|FG003|Overall Study|Study Completed|0|||
13481726|NCT01992653|27021190|FG004|Overall Study|Study Completed|0|||
13481727|NCT01992653|27021191|FG005|Overall Study|Study Completed|0|||
13481728|NCT01992653|27021192|FG006|Overall Study|Study Completed|0|||
13481729|NCT01992653|27021193|FG007|Overall Study|Study Completed|1|||
13481730|NCT01992653|27021186|FG000|Overall Study|Disease Progression|0|||
13481731|NCT01992653|27021187|FG001|Overall Study|Disease Progression|0|||
13481732|NCT01992653|27021188|FG002|Overall Study|Disease Progression|0|||
13481733|NCT01992653|27021189|FG003|Overall Study|Disease Progression|0|||
13481734|NCT01992653|27021190|FG004|Overall Study|Disease Progression|0|||
13481735|NCT01992653|27021191|FG005|Overall Study|Disease Progression|0|||
13481736|NCT01992653|27021192|FG006|Overall Study|Disease Progression|4|||
13481737|NCT01992653|27021193|FG007|Overall Study|Disease Progression|0|||
13481738|NCT02001974|27021304|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2|||
13481739|NCT02001974|27021305|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3|||
13481740|NCT02001974|27021306|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14|||
13481741|NCT02001974|27021304|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1|||
13481742|NCT02001974|27021305|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0|||
13487281|NCT03126539|27039491|FG000|Overall Study|Lost to Follow-up|1|||
13481743|NCT02001974|27021306|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4|||
13481744|NCT02001974|27021304|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1|||
13481745|NCT02001974|27021305|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0|||
13481746|NCT02001974|27021306|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6|||
13481747|NCT02001974|27021304|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
13481748|NCT02001974|27021305|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
13481749|NCT02001974|27021306|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2|||
13487282|NCT03126539|27039492|FG001|Overall Study|Lost to Follow-up|1|||
13487283|NCT03126539|27039493|FG002|Overall Study|Lost to Follow-up|1|||
13487284|NCT03126539|27039494|FG003|Overall Study|Lost to Follow-up|0|||
13487285|NCT03126539|27039495|FG004|Overall Study|Lost to Follow-up|0|||
13487286|NCT02819635|27039661|FG000|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
13487287|NCT02819635|27039662|FG001|Substudy 1 and Substudy 2, Part 1|Adverse Event|1|||
13487288|NCT02819635|27039663|FG002|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
13487289|NCT02819635|27039664|FG003|Substudy 1 and Substudy 2, Part 1|Adverse Event|5|||
13487290|NCT02819635|27039665|FG004|Substudy 1 and Substudy 2, Part 1|Adverse Event|4|||
13487291|NCT02819635|27039666|FG005|Substudy 1 and Substudy 2, Part 1|Adverse Event|9|||
13487292|NCT02819635|27039667|FG006|Substudy 1 and Substudy 2, Part 1|Adverse Event|6|||
13487293|NCT02819635|27039668|FG007|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
13487294|NCT02819635|27039669|FG008|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
13487295|NCT02819635|27039670|FG009|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
13487296|NCT02819635|27039671|FG010|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
13487297|NCT02819635|27039672|FG011|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
13487298|NCT02819635|27039661|FG000|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
13487299|NCT02819635|27039662|FG001|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
13487300|NCT02819635|27039663|FG002|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
13487301|NCT02819635|27039664|FG003|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
13487302|NCT02819635|27039665|FG004|Substudy 1 and Substudy 2, Part 1|Withdrew consent|1|||
13487303|NCT02819635|27039666|FG005|Substudy 1 and Substudy 2, Part 1|Withdrew consent|3|||
13487304|NCT02819635|27039667|FG006|Substudy 1 and Substudy 2, Part 1|Withdrew consent|2|||
13487305|NCT02819635|27039668|FG007|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
13487306|NCT02819635|27039669|FG008|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
13487307|NCT02819635|27039670|FG009|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
13487308|NCT02819635|27039671|FG010|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
13487309|NCT02819635|27039672|FG011|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
13487310|NCT02819635|27039661|FG000|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
13487311|NCT02819635|27039662|FG001|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
13487312|NCT02819635|27039663|FG002|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
13487313|NCT02819635|27039664|FG003|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
13487314|NCT02819635|27039665|FG004|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
13487315|NCT02819635|27039666|FG005|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
13487316|NCT02819635|27039667|FG006|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
13487317|NCT02819635|27039668|FG007|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
13487318|NCT02819635|27039669|FG008|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
13487319|NCT02819635|27039670|FG009|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
13487320|NCT02819635|27039671|FG010|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
13487321|NCT02819635|27039672|FG011|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
13487322|NCT02819635|27039661|FG000|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
13487323|NCT02819635|27039662|FG001|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
13487324|NCT02819635|27039663|FG002|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
13487325|NCT02819635|27039664|FG003|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
13487326|NCT02819635|27039665|FG004|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
13487327|NCT02819635|27039666|FG005|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
13487328|NCT02819635|27039667|FG006|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|1|||
13487329|NCT02819635|27039668|FG007|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
13487330|NCT02819635|27039669|FG008|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
13487331|NCT02819635|27039670|FG009|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
13487332|NCT02819635|27039671|FG010|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
13487333|NCT02819635|27039672|FG011|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
13487334|NCT02819635|27039661|FG000|Substudy 1 and Substudy 2, Part 1|Other, not specified|2|||
13487335|NCT02819635|27039662|FG001|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
13487336|NCT02819635|27039663|FG002|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
13487337|NCT02819635|27039664|FG003|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
13487338|NCT02819635|27039665|FG004|Substudy 1 and Substudy 2, Part 1|Other, not specified|5|||
13487339|NCT02819635|27039666|FG005|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
13481750|NCT02014558|27021654|FG000|Overall Study|Never Received Study Drug|0|||
13481751|NCT02014558|27021655|FG001|Overall Study|Never Received Study Drug|0|||
13481752|NCT02014558|27021656|FG002|Overall Study|Never Received Study Drug|0|||
13481753|NCT02014558|27021657|FG003|Overall Study|Never Received Study Drug|0|||
13481754|NCT02014558|27021658|FG004|Overall Study|Never Received Study Drug|1|||
13481755|NCT02014558|27021659|FG005|Overall Study|Never Received Study Drug|0|||
13481756|NCT02014558|27021660|FG006|Overall Study|Never Received Study Drug|1|||
13481757|NCT02014558|27021661|FG007|Overall Study|Never Received Study Drug|0|||
13481758|NCT02014558|27021662|FG008|Overall Study|Never Received Study Drug|2|||
13481759|NCT02014558|27021663|FG009|Overall Study|Never Received Study Drug|0|||
13481760|NCT02014558|27021664|FG010|Overall Study|Never Received Study Drug|2|||
13481761|NCT02014558|27021665|FG011|Overall Study|Never Received Study Drug|2|||
13481762|NCT02014558|27021666|FG012|Overall Study|Never Received Study Drug|0|||
13481763|NCT02014558|27021654|FG000|Overall Study|Adverse Event|0|||
13481764|NCT02014558|27021655|FG001|Overall Study|Adverse Event|0|||
13481765|NCT02014558|27021656|FG002|Overall Study|Adverse Event|0|||
13481766|NCT02014558|27021657|FG003|Overall Study|Adverse Event|0|||
13481767|NCT02014558|27021658|FG004|Overall Study|Adverse Event|1|||
13481768|NCT02014558|27021659|FG005|Overall Study|Adverse Event|0|||
13481769|NCT02014558|27021660|FG006|Overall Study|Adverse Event|0|||
13481770|NCT02014558|27021661|FG007|Overall Study|Adverse Event|0|||
13481771|NCT02014558|27021662|FG008|Overall Study|Adverse Event|2|||
13481772|NCT02014558|27021663|FG009|Overall Study|Adverse Event|2|||
13481773|NCT02014558|27021664|FG010|Overall Study|Adverse Event|5|||
13481774|NCT02014558|27021665|FG011|Overall Study|Adverse Event|21|||
13481775|NCT02014558|27021666|FG012|Overall Study|Adverse Event|3|||
13481776|NCT02014558|27021654|FG000|Overall Study|Death|1|||
13481777|NCT02014558|27021655|FG001|Overall Study|Death|0|||
13481778|NCT02014558|27021656|FG002|Overall Study|Death|0|||
13481779|NCT02014558|27021657|FG003|Overall Study|Death|0|||
13481780|NCT02014558|27021658|FG004|Overall Study|Death|0|||
13481781|NCT02014558|27021659|FG005|Overall Study|Death|0|||
13481782|NCT02014558|27021660|FG006|Overall Study|Death|1|||
13481783|NCT02014558|27021661|FG007|Overall Study|Death|1|||
13481784|NCT02014558|27021662|FG008|Overall Study|Death|2|||
13481785|NCT02014558|27021663|FG009|Overall Study|Death|5|||
13481786|NCT02014558|27021664|FG010|Overall Study|Death|5|||
13481787|NCT02014558|27021665|FG011|Overall Study|Death|19|||
13481788|NCT02014558|27021666|FG012|Overall Study|Death|2|||
13481789|NCT02014558|27021654|FG000|Overall Study|Lack of Efficacy|1|||
13481790|NCT02014558|27021655|FG001|Overall Study|Lack of Efficacy|2|||
13481791|NCT02014558|27021656|FG002|Overall Study|Lack of Efficacy|1|||
13481792|NCT02014558|27021657|FG003|Overall Study|Lack of Efficacy|1|||
13481793|NCT02014558|27021658|FG004|Overall Study|Lack of Efficacy|0|||
13481794|NCT02014558|27021659|FG005|Overall Study|Lack of Efficacy|0|||
13481795|NCT02014558|27021660|FG006|Overall Study|Lack of Efficacy|1|||
13481796|NCT02014558|27021661|FG007|Overall Study|Lack of Efficacy|3|||
13481797|NCT02014558|27021662|FG008|Overall Study|Lack of Efficacy|3|||
13481798|NCT02014558|27021663|FG009|Overall Study|Lack of Efficacy|3|||
13481799|NCT02014558|27021664|FG010|Overall Study|Lack of Efficacy|16|||
13481800|NCT02014558|27021665|FG011|Overall Study|Lack of Efficacy|8|||
13481801|NCT02014558|27021666|FG012|Overall Study|Lack of Efficacy|5|||
13481802|NCT02014558|27021654|FG000|Overall Study|Lost to Follow-up|0|||
13481803|NCT02014558|27021655|FG001|Overall Study|Lost to Follow-up|0|||
13481804|NCT02014558|27021656|FG002|Overall Study|Lost to Follow-up|0|||
13481805|NCT02014558|27021657|FG003|Overall Study|Lost to Follow-up|0|||
13481806|NCT02014558|27021658|FG004|Overall Study|Lost to Follow-up|0|||
13481807|NCT02014558|27021659|FG005|Overall Study|Lost to Follow-up|0|||
13481808|NCT02014558|27021660|FG006|Overall Study|Lost to Follow-up|0|||
13481809|NCT02014558|27021661|FG007|Overall Study|Lost to Follow-up|0|||
13481810|NCT02014558|27021662|FG008|Overall Study|Lost to Follow-up|0|||
13481811|NCT02014558|27021663|FG009|Overall Study|Lost to Follow-up|0|||
13481812|NCT02014558|27021664|FG010|Overall Study|Lost to Follow-up|1|||
13481813|NCT02014558|27021665|FG011|Overall Study|Lost to Follow-up|0|||
13481814|NCT02014558|27021666|FG012|Overall Study|Lost to Follow-up|0|||
13481815|NCT02014558|27021654|FG000|Overall Study|Progressive Disease|1|||
13481816|NCT02014558|27021655|FG001|Overall Study|Progressive Disease|0|||
13481817|NCT02014558|27021656|FG002|Overall Study|Progressive Disease|1|||
13481818|NCT02014558|27021657|FG003|Overall Study|Progressive Disease|1|||
13481819|NCT02014558|27021658|FG004|Overall Study|Progressive Disease|1|||
13481820|NCT02014558|27021659|FG005|Overall Study|Progressive Disease|2|||
13481821|NCT02014558|27021660|FG006|Overall Study|Progressive Disease|1|||
13481822|NCT02014558|27021661|FG007|Overall Study|Progressive Disease|6|||
13481823|NCT02014558|27021662|FG008|Overall Study|Progressive Disease|5|||
13481824|NCT02014558|27021663|FG009|Overall Study|Progressive Disease|6|||
13481825|NCT02014558|27021664|FG010|Overall Study|Progressive Disease|22|||
13481826|NCT02014558|27021665|FG011|Overall Study|Progressive Disease|31|||
13481827|NCT02014558|27021666|FG012|Overall Study|Progressive Disease|6|||
13481828|NCT02014558|27021654|FG000|Overall Study|Withdrawal by Subject|0|||
13481829|NCT02014558|27021655|FG001|Overall Study|Withdrawal by Subject|0|||
13481830|NCT02014558|27021656|FG002|Overall Study|Withdrawal by Subject|0|||
13481831|NCT02014558|27021657|FG003|Overall Study|Withdrawal by Subject|0|||
13481832|NCT02014558|27021658|FG004|Overall Study|Withdrawal by Subject|1|||
13481833|NCT02014558|27021659|FG005|Overall Study|Withdrawal by Subject|0|||
13481834|NCT02014558|27021660|FG006|Overall Study|Withdrawal by Subject|0|||
13481835|NCT02014558|27021661|FG007|Overall Study|Withdrawal by Subject|0|||
13481836|NCT02014558|27021662|FG008|Overall Study|Withdrawal by Subject|0|||
13481837|NCT02014558|27021663|FG009|Overall Study|Withdrawal by Subject|2|||
13481838|NCT02014558|27021664|FG010|Overall Study|Withdrawal by Subject|6|||
13481839|NCT02014558|27021665|FG011|Overall Study|Withdrawal by Subject|10|||
13481840|NCT02014558|27021666|FG012|Overall Study|Withdrawal by Subject|0|||
13481841|NCT02014558|27021654|FG000|Overall Study|Miscellaneous|2|||
13481842|NCT02014558|27021655|FG001|Overall Study|Miscellaneous|1|||
13481843|NCT02014558|27021656|FG002|Overall Study|Miscellaneous|1|||
13481844|NCT02014558|27021657|FG003|Overall Study|Miscellaneous|1|||
13481845|NCT02014558|27021658|FG004|Overall Study|Miscellaneous|0|||
13481846|NCT02014558|27021659|FG005|Overall Study|Miscellaneous|1|||
13481847|NCT02014558|27021660|FG006|Overall Study|Miscellaneous|0|||
13481848|NCT02014558|27021661|FG007|Overall Study|Miscellaneous|1|||
13481849|NCT02014558|27021662|FG008|Overall Study|Miscellaneous|1|||
13481850|NCT02014558|27021663|FG009|Overall Study|Miscellaneous|3|||
13481851|NCT02014558|27021664|FG010|Overall Study|Miscellaneous|12|||
13481852|NCT02014558|27021665|FG011|Overall Study|Miscellaneous|11|||
13481853|NCT02014558|27021666|FG012|Overall Study|Miscellaneous|1|||
13487340|NCT02819635|27039667|FG006|Substudy 1 and Substudy 2, Part 1|Other, not specified|3|||
13487341|NCT02819635|27039668|FG007|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
13487342|NCT02819635|27039669|FG008|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
13487343|NCT02819635|27039670|FG009|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
13487344|NCT02819635|27039671|FG010|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
13487345|NCT02819635|27039672|FG011|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
13487346|NCT02819635|27039661|FG000|Substudy 2, Part 2|Adverse Event|0|||
13487347|NCT02819635|27039662|FG001|Substudy 2, Part 2|Adverse Event|0|||
13487348|NCT02819635|27039663|FG002|Substudy 2, Part 2|Adverse Event|0|||
13487349|NCT02819635|27039664|FG003|Substudy 2, Part 2|Adverse Event|0|||
13487350|NCT02819635|27039665|FG004|Substudy 2, Part 2|Adverse Event|0|||
13487351|NCT02819635|27039666|FG005|Substudy 2, Part 2|Adverse Event|4|||
13487352|NCT02819635|27039667|FG006|Substudy 2, Part 2|Adverse Event|0|||
13487353|NCT02819635|27039668|FG007|Substudy 2, Part 2|Adverse Event|0|||
13487354|NCT02819635|27039669|FG008|Substudy 2, Part 2|Adverse Event|0|||
13487355|NCT02819635|27039670|FG009|Substudy 2, Part 2|Adverse Event|0|||
13487356|NCT02819635|27039671|FG010|Substudy 2, Part 2|Adverse Event|0|||
13487357|NCT02819635|27039672|FG011|Substudy 2, Part 2|Adverse Event|0|||
13487358|NCT02819635|27039661|FG000|Substudy 2, Part 2|Withdrew consent|0|||
13487359|NCT02819635|27039662|FG001|Substudy 2, Part 2|Withdrew consent|0|||
13487360|NCT02819635|27039663|FG002|Substudy 2, Part 2|Withdrew consent|0|||
13487361|NCT02819635|27039664|FG003|Substudy 2, Part 2|Withdrew consent|0|||
13487362|NCT02819635|27039665|FG004|Substudy 2, Part 2|Withdrew consent|0|||
13487363|NCT02819635|27039666|FG005|Substudy 2, Part 2|Withdrew consent|3|||
13487364|NCT02819635|27039667|FG006|Substudy 2, Part 2|Withdrew consent|1|||
13487365|NCT02819635|27039668|FG007|Substudy 2, Part 2|Withdrew consent|0|||
13487366|NCT02819635|27039669|FG008|Substudy 2, Part 2|Withdrew consent|0|||
13487367|NCT02819635|27039670|FG009|Substudy 2, Part 2|Withdrew consent|0|||
13487368|NCT02819635|27039671|FG010|Substudy 2, Part 2|Withdrew consent|0|||
13487369|NCT02819635|27039672|FG011|Substudy 2, Part 2|Withdrew consent|0|||
13487370|NCT02819635|27039661|FG000|Substudy 2, Part 2|Lost to Follow-up|0|||
13487371|NCT02819635|27039662|FG001|Substudy 2, Part 2|Lost to Follow-up|0|||
13487372|NCT02819635|27039663|FG002|Substudy 2, Part 2|Lost to Follow-up|0|||
13487373|NCT02819635|27039664|FG003|Substudy 2, Part 2|Lost to Follow-up|0|||
13487374|NCT02819635|27039665|FG004|Substudy 2, Part 2|Lost to Follow-up|0|||
13487375|NCT02819635|27039666|FG005|Substudy 2, Part 2|Lost to Follow-up|0|||
13487376|NCT02819635|27039667|FG006|Substudy 2, Part 2|Lost to Follow-up|1|||
13487377|NCT02819635|27039668|FG007|Substudy 2, Part 2|Lost to Follow-up|0|||
13487378|NCT02819635|27039669|FG008|Substudy 2, Part 2|Lost to Follow-up|0|||
13487379|NCT02819635|27039670|FG009|Substudy 2, Part 2|Lost to Follow-up|0|||
13487380|NCT02819635|27039671|FG010|Substudy 2, Part 2|Lost to Follow-up|0|||
13487381|NCT02819635|27039672|FG011|Substudy 2, Part 2|Lost to Follow-up|0|||
13487382|NCT02819635|27039661|FG000|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
13487383|NCT02819635|27039662|FG001|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
13487384|NCT02819635|27039663|FG002|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
13487385|NCT02819635|27039664|FG003|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
13487386|NCT02819635|27039665|FG004|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
13487387|NCT02819635|27039666|FG005|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
13487388|NCT02819635|27039667|FG006|Substudy 2, Part 2|COVID-19 Logistical Restrictions|2|||
13487389|NCT02819635|27039668|FG007|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
13487390|NCT02819635|27039669|FG008|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
13487391|NCT02819635|27039670|FG009|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
13481854|NCT02024555|27021727|FG000|Overall Study|Lost to Follow-up|1|||
13481855|NCT02024555|27021728|FG001|Overall Study|Lost to Follow-up|1|||
13481856|NCT02024555|27021727|FG000|Overall Study|Withdrawal by Subject|5|||
13481857|NCT02024555|27021728|FG001|Overall Study|Withdrawal by Subject|1|||
13481858|NCT02025010|27021749|FG000|Overall Study|Symptomatic or radiographic progression|36|||
13481859|NCT02025010|27021749|FG000|Overall Study|Adverse Event|6|||
13481860|NCT02025010|27021749|FG000|Overall Study|Physician Decision|7|||
13481861|NCT02025010|27021749|FG000|Overall Study|Withdrawal by Subject|3|||
13481862|NCT02025010|27021749|FG000|Overall Study|Intercurrent illness|3|||
13481863|NCT02025010|27021749|FG000|Overall Study|Patients still on treatment|3|||
13481864|NCT02025010|27021749|FG000|Overall Study|Never initiate the treatment|2|||
13481865|NCT02040584|27021789|FG000|Overall Study|Adverse Event|13|||
13481866|NCT02040584|27021790|FG001|Overall Study|Adverse Event|6|||
13481867|NCT02040584|27021789|FG000|Overall Study|Protocol Violation|9|||
13481868|NCT02040584|27021790|FG001|Overall Study|Protocol Violation|11|||
13481869|NCT02040584|27021789|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
13481870|NCT02040584|27021790|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
13481871|NCT02040584|27021789|FG000|Overall Study|Death|6|||
13481872|NCT02040584|27021790|FG001|Overall Study|Death|3|||
13481873|NCT02040584|27021789|FG000|Overall Study|Transplant rejection/retransplant|0|||
13481874|NCT02040584|27021790|FG001|Overall Study|Transplant rejection/retransplant|1|||
13481875|NCT02040584|27021789|FG000|Overall Study|Immunosuppressant/prohibited med use|7|||
13481876|NCT02040584|27021790|FG001|Overall Study|Immunosuppressant/prohibited med use|10|||
13481877|NCT02045797|27021943|FG000|Overall Study|Adverse Event|3|||
13481878|NCT02045797|27021944|FG001|Overall Study|Adverse Event|1|||
13481879|NCT02045797|27021945|FG002|Overall Study|Adverse Event|0|||
13481880|NCT02045797|27021943|FG000|Overall Study|Lack of Efficacy|1|||
13481881|NCT02045797|27021944|FG001|Overall Study|Lack of Efficacy|0|||
13481882|NCT02045797|27021945|FG002|Overall Study|Lack of Efficacy|0|||
13481883|NCT02045797|27021943|FG000|Overall Study|Lost to Follow-up|2|||
13481884|NCT02045797|27021944|FG001|Overall Study|Lost to Follow-up|3|||
13481885|NCT02045797|27021945|FG002|Overall Study|Lost to Follow-up|1|||
13481886|NCT02045797|27021943|FG000|Overall Study|Physician Decision|0|||
13481887|NCT02045797|27021944|FG001|Overall Study|Physician Decision|1|||
13481888|NCT02045797|27021945|FG002|Overall Study|Physician Decision|0|||
13481889|NCT02045797|27021943|FG000|Overall Study|Withdrawal by Subject|1|||
13481890|NCT02045797|27021944|FG001|Overall Study|Withdrawal by Subject|2|||
13481891|NCT02045797|27021945|FG002|Overall Study|Withdrawal by Subject|0|||
13481892|NCT02049710|27021958|FG000|Overall Study|Lost to Follow-up|319|||
13481893|NCT02049710|27021959|FG001|Overall Study|Lost to Follow-up|324|||
13481894|NCT02055547|27022126|FG000|Overall Study|Protocol Violation|0|||
13481895|NCT02055547|27022127|FG001|Overall Study|Protocol Violation|0|||
13481896|NCT02055547|27022128|FG002|Overall Study|Protocol Violation|1|||
13481897|NCT02055547|27022129|FG003|Overall Study|Protocol Violation|0|||
13481898|NCT02055547|27022130|FG004|Overall Study|Protocol Violation|0|||
13481899|NCT02055547|27022131|FG005|Overall Study|Protocol Violation|0|||
13481900|NCT02055547|27022132|FG006|Overall Study|Protocol Violation|1|||
13481901|NCT02055547|27022133|FG007|Overall Study|Protocol Violation|0|||
13481902|NCT02055547|27022134|FG008|Overall Study|Protocol Violation|0|||
13481903|NCT02055547|27022135|FG009|Overall Study|Protocol Violation|0|||
13481904|NCT02055547|27022136|FG010|Overall Study|Protocol Violation|0|||
13481905|NCT02055547|27022137|FG011|Overall Study|Protocol Violation|0|||
13481906|NCT02055547|27022138|FG012|Overall Study|Protocol Violation|0|||
13481907|NCT02055547|27022139|FG013|Overall Study|Protocol Violation|0|||
13481908|NCT02055547|27022140|FG014|Overall Study|Protocol Violation|0|||
13481909|NCT02055547|27022141|FG015|Overall Study|Protocol Violation|0|||
13481910|NCT02055547|27022142|FG016|Overall Study|Protocol Violation|0|||
13481911|NCT02055547|27022143|FG017|Overall Study|Protocol Violation|0|||
13481912|NCT02055547|27022144|FG018|Overall Study|Protocol Violation|0|||
13481913|NCT02055547|27022126|FG000|Overall Study|Physician Decision|0|||
13481914|NCT02055547|27022127|FG001|Overall Study|Physician Decision|1|||
13481915|NCT02055547|27022128|FG002|Overall Study|Physician Decision|1|||
13481916|NCT02055547|27022129|FG003|Overall Study|Physician Decision|0|||
13481917|NCT02055547|27022130|FG004|Overall Study|Physician Decision|1|||
13481918|NCT02055547|27022131|FG005|Overall Study|Physician Decision|0|||
13481919|NCT02055547|27022132|FG006|Overall Study|Physician Decision|0|||
13481920|NCT02055547|27022133|FG007|Overall Study|Physician Decision|0|||
13481921|NCT02055547|27022134|FG008|Overall Study|Physician Decision|0|||
13481922|NCT02055547|27022135|FG009|Overall Study|Physician Decision|1|||
13481923|NCT02055547|27022136|FG010|Overall Study|Physician Decision|1|||
13481924|NCT02055547|27022137|FG011|Overall Study|Physician Decision|0|||
13481925|NCT02055547|27022138|FG012|Overall Study|Physician Decision|0|||
13481926|NCT02055547|27022139|FG013|Overall Study|Physician Decision|0|||
13481927|NCT02055547|27022140|FG014|Overall Study|Physician Decision|0|||
13481928|NCT02055547|27022141|FG015|Overall Study|Physician Decision|0|||
13481929|NCT02055547|27022142|FG016|Overall Study|Physician Decision|0|||
13481930|NCT02055547|27022143|FG017|Overall Study|Physician Decision|0|||
13481931|NCT02055547|27022144|FG018|Overall Study|Physician Decision|0|||
13481932|NCT02055547|27022126|FG000|Overall Study|Adverse Event|0|||
13481933|NCT02055547|27022127|FG001|Overall Study|Adverse Event|0|||
13481934|NCT02055547|27022128|FG002|Overall Study|Adverse Event|0|||
13481935|NCT02055547|27022129|FG003|Overall Study|Adverse Event|0|||
13481936|NCT02055547|27022130|FG004|Overall Study|Adverse Event|0|||
13481937|NCT02055547|27022131|FG005|Overall Study|Adverse Event|0|||
13481938|NCT02055547|27022132|FG006|Overall Study|Adverse Event|1|||
13481939|NCT02055547|27022133|FG007|Overall Study|Adverse Event|0|||
13481940|NCT02055547|27022134|FG008|Overall Study|Adverse Event|1|||
13481941|NCT02055547|27022135|FG009|Overall Study|Adverse Event|0|||
13481942|NCT02055547|27022136|FG010|Overall Study|Adverse Event|0|||
13481943|NCT02055547|27022137|FG011|Overall Study|Adverse Event|0|||
13481944|NCT02055547|27022138|FG012|Overall Study|Adverse Event|0|||
13481945|NCT02055547|27022139|FG013|Overall Study|Adverse Event|0|||
13481946|NCT02055547|27022140|FG014|Overall Study|Adverse Event|0|||
13481947|NCT02055547|27022141|FG015|Overall Study|Adverse Event|0|||
13481948|NCT02055547|27022142|FG016|Overall Study|Adverse Event|0|||
13481949|NCT02055547|27022143|FG017|Overall Study|Adverse Event|0|||
13481950|NCT02055547|27022144|FG018|Overall Study|Adverse Event|0|||
13481951|NCT02055547|27022126|FG000|Overall Study|Withdrawal by Subject|0|||
13481952|NCT02055547|27022127|FG001|Overall Study|Withdrawal by Subject|0|||
13481953|NCT02055547|27022128|FG002|Overall Study|Withdrawal by Subject|0|||
13481954|NCT02055547|27022129|FG003|Overall Study|Withdrawal by Subject|0|||
13481955|NCT02055547|27022130|FG004|Overall Study|Withdrawal by Subject|0|||
13481956|NCT02055547|27022131|FG005|Overall Study|Withdrawal by Subject|1|||
13481957|NCT02055547|27022132|FG006|Overall Study|Withdrawal by Subject|0|||
13481958|NCT02055547|27022133|FG007|Overall Study|Withdrawal by Subject|0|||
13481959|NCT02055547|27022134|FG008|Overall Study|Withdrawal by Subject|1|||
13481960|NCT02055547|27022135|FG009|Overall Study|Withdrawal by Subject|0|||
13481961|NCT02055547|27022136|FG010|Overall Study|Withdrawal by Subject|0|||
13481962|NCT02055547|27022137|FG011|Overall Study|Withdrawal by Subject|0|||
13481963|NCT02055547|27022138|FG012|Overall Study|Withdrawal by Subject|0|||
13481964|NCT02055547|27022139|FG013|Overall Study|Withdrawal by Subject|1|||
13481965|NCT02055547|27022140|FG014|Overall Study|Withdrawal by Subject|0|||
13481966|NCT02055547|27022141|FG015|Overall Study|Withdrawal by Subject|1|||
13481967|NCT02055547|27022142|FG016|Overall Study|Withdrawal by Subject|0|||
13481968|NCT02055547|27022143|FG017|Overall Study|Withdrawal by Subject|0|||
13481969|NCT02055547|27022144|FG018|Overall Study|Withdrawal by Subject|0|||
13481970|NCT02055547|27022126|FG000|Overall Study|Lost to Follow-up|0|||
13481971|NCT02055547|27022127|FG001|Overall Study|Lost to Follow-up|0|||
13481972|NCT02055547|27022128|FG002|Overall Study|Lost to Follow-up|1|||
13481973|NCT02055547|27022129|FG003|Overall Study|Lost to Follow-up|0|||
13481974|NCT02055547|27022130|FG004|Overall Study|Lost to Follow-up|0|||
13481975|NCT02055547|27022131|FG005|Overall Study|Lost to Follow-up|0|||
13481976|NCT02055547|27022132|FG006|Overall Study|Lost to Follow-up|0|||
13481977|NCT02055547|27022133|FG007|Overall Study|Lost to Follow-up|0|||
13481978|NCT02055547|27022134|FG008|Overall Study|Lost to Follow-up|0|||
13481979|NCT02055547|27022135|FG009|Overall Study|Lost to Follow-up|0|||
13481980|NCT02055547|27022136|FG010|Overall Study|Lost to Follow-up|0|||
13481981|NCT02055547|27022137|FG011|Overall Study|Lost to Follow-up|0|||
13481982|NCT02055547|27022138|FG012|Overall Study|Lost to Follow-up|0|||
13481983|NCT02055547|27022139|FG013|Overall Study|Lost to Follow-up|0|||
13481984|NCT02055547|27022140|FG014|Overall Study|Lost to Follow-up|0|||
13481985|NCT02055547|27022141|FG015|Overall Study|Lost to Follow-up|0|||
13481986|NCT02055547|27022142|FG016|Overall Study|Lost to Follow-up|0|||
13481987|NCT02055547|27022143|FG017|Overall Study|Lost to Follow-up|0|||
13481988|NCT02055547|27022144|FG018|Overall Study|Lost to Follow-up|0|||
13487392|NCT02819635|27039671|FG010|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
13487393|NCT02819635|27039672|FG011|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
13487394|NCT02819635|27039661|FG000|Substudy 2, Part 2|Other, not specified|0|||
13487395|NCT02819635|27039662|FG001|Substudy 2, Part 2|Other, not specified|0|||
13487396|NCT02819635|27039663|FG002|Substudy 2, Part 2|Other, not specified|0|||
13487397|NCT02819635|27039664|FG003|Substudy 2, Part 2|Other, not specified|0|||
13487398|NCT02819635|27039665|FG004|Substudy 2, Part 2|Other, not specified|0|||
13487399|NCT02819635|27039666|FG005|Substudy 2, Part 2|Other, not specified|4|||
13487400|NCT02819635|27039667|FG006|Substudy 2, Part 2|Other, not specified|8|||
13487401|NCT02819635|27039668|FG007|Substudy 2, Part 2|Other, not specified|0|||
13487402|NCT02819635|27039669|FG008|Substudy 2, Part 2|Other, not specified|0|||
13487403|NCT02819635|27039670|FG009|Substudy 2, Part 2|Other, not specified|0|||
13487404|NCT02819635|27039671|FG010|Substudy 2, Part 2|Other, not specified|0|||
13487405|NCT02819635|27039672|FG011|Substudy 2, Part 2|Other, not specified|0|||
13487406|NCT02819635|27039661|FG000|Substudy 3|Adverse Event|0|||
13487407|NCT02819635|27039662|FG001|Substudy 3|Adverse Event|0|||
13487408|NCT02819635|27039663|FG002|Substudy 3|Adverse Event|0|||
13487409|NCT02819635|27039664|FG003|Substudy 3|Adverse Event|0|||
13487410|NCT02819635|27039665|FG004|Substudy 3|Adverse Event|0|||
13487411|NCT02819635|27039666|FG005|Substudy 3|Adverse Event|0|||
13487412|NCT02819635|27039667|FG006|Substudy 3|Adverse Event|0|||
13487413|NCT02819635|27039668|FG007|Substudy 3|Adverse Event|0|||
13487414|NCT02819635|27039669|FG008|Substudy 3|Adverse Event|32|||
13481989|NCT02064387|27022492|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0|||
13481990|NCT02064387|27022493|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0|||
13481991|NCT02064387|27022494|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0|||
13481992|NCT02064387|27022495|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0|||
13481993|NCT02064387|27022496|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0|||
13481994|NCT02064387|27022497|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0|||
13481995|NCT02064387|27022498|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0|||
13481996|NCT02064387|27022499|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1|||
13481997|NCT02064387|27022500|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0|||
13481998|NCT02064387|27022501|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1|||
13481999|NCT02064387|27022502|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0|||
13482000|NCT02064387|27022503|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0|||
13482001|NCT02064387|27022492|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
13482002|NCT02064387|27022493|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
13482003|NCT02064387|27022494|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
13482004|NCT02064387|27022495|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
13482005|NCT02064387|27022496|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
13482006|NCT02064387|27022497|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
13482007|NCT02064387|27022498|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
13482008|NCT02064387|27022499|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1|||
13482009|NCT02064387|27022500|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
13482010|NCT02064387|27022501|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
13482011|NCT02064387|27022502|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
13482012|NCT02064387|27022503|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
13482013|NCT02064387|27022492|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
13482014|NCT02064387|27022493|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
13482015|NCT02064387|27022494|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
13482016|NCT02064387|27022495|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
13482017|NCT02064387|27022496|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
13482018|NCT02064387|27022497|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
13482019|NCT02064387|27022498|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
13482020|NCT02064387|27022499|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
13482021|NCT02064387|27022500|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1|||
13482022|NCT02064387|27022501|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
13482023|NCT02064387|27022502|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
13482024|NCT02064387|27022503|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
13482025|NCT02064387|27022492|FG000|Part 2 Max 35 Months Followup Duration|Death|0|||
13482026|NCT02064387|27022493|FG001|Part 2 Max 35 Months Followup Duration|Death|0|||
13482027|NCT02064387|27022494|FG002|Part 2 Max 35 Months Followup Duration|Death|0|||
13482028|NCT02064387|27022495|FG003|Part 2 Max 35 Months Followup Duration|Death|0|||
13482029|NCT02064387|27022496|FG004|Part 2 Max 35 Months Followup Duration|Death|0|||
13482030|NCT02064387|27022497|FG005|Part 2 Max 35 Months Followup Duration|Death|0|||
13482031|NCT02064387|27022498|FG006|Part 2 Max 35 Months Followup Duration|Death|0|||
13482032|NCT02064387|27022499|FG007|Part 2 Max 35 Months Followup Duration|Death|0|||
13482033|NCT02064387|27022500|FG008|Part 2 Max 35 Months Followup Duration|Death|0|||
13482034|NCT02064387|27022501|FG009|Part 2 Max 35 Months Followup Duration|Death|0|||
13482035|NCT02064387|27022502|FG010|Part 2 Max 35 Months Followup Duration|Death|5|||
13482036|NCT02064387|27022503|FG011|Part 2 Max 35 Months Followup Duration|Death|3|||
13482037|NCT02064387|27022492|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
13482038|NCT02064387|27022493|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
13482039|NCT02064387|27022494|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
13482040|NCT02064387|27022495|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
13482041|NCT02064387|27022496|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
13482042|NCT02064387|27022497|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
13482043|NCT02064387|27022498|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
13482044|NCT02064387|27022499|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
13482045|NCT02064387|27022500|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
13482046|NCT02064387|27022501|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
13482047|NCT02064387|27022502|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1|||
13482048|NCT02064387|27022503|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
13482049|NCT02076178|27022593|FG000|Oral Phase|Adverse Event|0|||
13482050|NCT02076178|27022594|FG001|Oral Phase|Adverse Event|7|||
13482051|NCT02076178|27022593|FG000|Oral Phase|Withdrawal by Subject|0|||
13482052|NCT02076178|27022594|FG001|Oral Phase|Withdrawal by Subject|4|||
13482053|NCT02076178|27022593|FG000|Oral Phase|Physician Decision|0|||
13482054|NCT02076178|27022594|FG001|Oral Phase|Physician Decision|1|||
13482055|NCT02076178|27022593|FG000|Injection Phase|Protocol defined stopping criteria|1|||
13482056|NCT02076178|27022594|FG001|Injection Phase|Protocol defined stopping criteria|0|||
13482057|NCT02076178|27022593|FG000|Injection Phase|Withdrawal by Subject|0|||
13482058|NCT02076178|27022594|FG001|Injection Phase|Withdrawal by Subject|3|||
13482059|NCT02076178|27022593|FG000|Injection Phase|Physician Decision|0|||
13482060|NCT02076178|27022594|FG001|Injection Phase|Physician Decision|3|||
13482061|NCT02076178|27022593|FG000|Injection Phase|Lost to Follow-up|0|||
13482062|NCT02076178|27022594|FG001|Injection Phase|Lost to Follow-up|1|||
13487415|NCT02819635|27039670|FG009|Substudy 3|Adverse Event|3|||
13487416|NCT02819635|27039671|FG010|Substudy 3|Adverse Event|12|||
13487417|NCT02819635|27039672|FG011|Substudy 3|Adverse Event|18|||
13487418|NCT02819635|27039661|FG000|Substudy 3|Withdrew consent|0|||
13487419|NCT02819635|27039662|FG001|Substudy 3|Withdrew consent|0|||
13487420|NCT02819635|27039663|FG002|Substudy 3|Withdrew consent|0|||
13487421|NCT02819635|27039664|FG003|Substudy 3|Withdrew consent|0|||
13487422|NCT02819635|27039665|FG004|Substudy 3|Withdrew consent|0|||
13487423|NCT02819635|27039666|FG005|Substudy 3|Withdrew consent|0|||
13487424|NCT02819635|27039667|FG006|Substudy 3|Withdrew consent|0|||
13487425|NCT02819635|27039668|FG007|Substudy 3|Withdrew consent|0|||
13487426|NCT02819635|27039669|FG008|Substudy 3|Withdrew consent|11|||
13487427|NCT02819635|27039670|FG009|Substudy 3|Withdrew consent|1|||
13487428|NCT02819635|27039671|FG010|Substudy 3|Withdrew consent|4|||
13487429|NCT02819635|27039672|FG011|Substudy 3|Withdrew consent|9|||
13487430|NCT02819635|27039661|FG000|Substudy 3|Lost to Follow-up|0|||
13487431|NCT02819635|27039662|FG001|Substudy 3|Lost to Follow-up|0|||
13487432|NCT02819635|27039663|FG002|Substudy 3|Lost to Follow-up|0|||
13487433|NCT02819635|27039664|FG003|Substudy 3|Lost to Follow-up|0|||
13487434|NCT02819635|27039665|FG004|Substudy 3|Lost to Follow-up|0|||
13487435|NCT02819635|27039666|FG005|Substudy 3|Lost to Follow-up|0|||
13487436|NCT02819635|27039667|FG006|Substudy 3|Lost to Follow-up|0|||
13487437|NCT02819635|27039668|FG007|Substudy 3|Lost to Follow-up|0|||
13487438|NCT02819635|27039669|FG008|Substudy 3|Lost to Follow-up|1|||
13487439|NCT02819635|27039670|FG009|Substudy 3|Lost to Follow-up|0|||
13487440|NCT02819635|27039671|FG010|Substudy 3|Lost to Follow-up|1|||
13487441|NCT02819635|27039672|FG011|Substudy 3|Lost to Follow-up|1|||
13487442|NCT02819635|27039661|FG000|Substudy 3|COVID-19 Logistical Restrictions|0|||
13487443|NCT02819635|27039662|FG001|Substudy 3|COVID-19 Logistical Restrictions|0|||
13487444|NCT02819635|27039663|FG002|Substudy 3|COVID-19 Logistical Restrictions|0|||
13487445|NCT02819635|27039664|FG003|Substudy 3|COVID-19 Logistical Restrictions|0|||
13487446|NCT02819635|27039665|FG004|Substudy 3|COVID-19 Logistical Restrictions|0|||
13487447|NCT02819635|27039666|FG005|Substudy 3|COVID-19 Logistical Restrictions|0|||
13487448|NCT02819635|27039667|FG006|Substudy 3|COVID-19 Logistical Restrictions|0|||
13487449|NCT02819635|27039668|FG007|Substudy 3|COVID-19 Logistical Restrictions|0|||
13487450|NCT02819635|27039669|FG008|Substudy 3|COVID-19 Logistical Restrictions|0|||
13487451|NCT02819635|27039670|FG009|Substudy 3|COVID-19 Logistical Restrictions|0|||
13487452|NCT02819635|27039671|FG010|Substudy 3|COVID-19 Logistical Restrictions|0|||
13487453|NCT02819635|27039672|FG011|Substudy 3|COVID-19 Logistical Restrictions|1|||
13487454|NCT02819635|27039661|FG000|Substudy 3|Other, not specified|0|||
13487455|NCT02819635|27039662|FG001|Substudy 3|Other, not specified|0|||
13487456|NCT02819635|27039663|FG002|Substudy 3|Other, not specified|0|||
13487457|NCT02819635|27039664|FG003|Substudy 3|Other, not specified|0|||
13487458|NCT02819635|27039665|FG004|Substudy 3|Other, not specified|0|||
13487459|NCT02819635|27039666|FG005|Substudy 3|Other, not specified|0|||
13487460|NCT02819635|27039667|FG006|Substudy 3|Other, not specified|0|||
13487461|NCT02819635|27039668|FG007|Substudy 3|Other, not specified|0|||
13487462|NCT02819635|27039669|FG008|Substudy 3|Other, not specified|202|||
13487463|NCT02819635|27039670|FG009|Substudy 3|Other, not specified|5|||
13487464|NCT02819635|27039671|FG010|Substudy 3|Other, not specified|89|||
13487465|NCT02819635|27039672|FG011|Substudy 3|Other, not specified|39|||
13487466|NCT02419807|27039742|FG000|Overall Study|Withdrawal by Subject|4|||
13487467|NCT02419807|27039742|FG000|Overall Study|Physician Decision|1|||
13487468|NCT02419807|27039742|FG000|Overall Study|Protocol Violation|5|||
13488274|NCT02959918|27043322|FG002|Overall Study|Adverse Event|2|||
13488275|NCT02959918|27043323|FG003|Overall Study|Adverse Event|0|||
13488276|NCT02959918|27043324|FG004|Overall Study|Adverse Event|0|||
13488277|NCT02959918|27043325|FG005|Overall Study|Adverse Event|2|||
13488278|NCT02959918|27043326|FG006|Overall Study|Adverse Event|2|||
13488279|NCT02959918|27043327|FG007|Overall Study|Adverse Event|1|||
13488280|NCT02959918|27043328|FG008|Overall Study|Adverse Event|2|||
13488281|NCT02959918|27043329|FG009|Overall Study|Adverse Event|1|||
13488282|NCT02959918|27043330|FG010|Overall Study|Adverse Event|1|||
13488283|NCT02959918|27043331|FG011|Overall Study|Adverse Event|3|||
13488284|NCT02959918|27043332|FG012|Overall Study|Adverse Event|2|||
13488285|NCT02959918|27043333|FG013|Overall Study|Adverse Event|4|||
13488286|NCT02959918|27043320|FG000|Overall Study|Lost to Follow-up|0|||
13488287|NCT02959918|27043321|FG001|Overall Study|Lost to Follow-up|0|||
13488288|NCT02959918|27043322|FG002|Overall Study|Lost to Follow-up|0|||
13488289|NCT02959918|27043323|FG003|Overall Study|Lost to Follow-up|0|||
13488290|NCT02959918|27043324|FG004|Overall Study|Lost to Follow-up|0|||
13482063|NCT02079766|27022608|FG000|Overall Study|Physician Decision|1|||
13482064|NCT02079766|27022609|FG001|Overall Study|Physician Decision|0|||
13482065|NCT02079766|27022608|FG000|Overall Study|Withdrawal by Subject|1|||
13482066|NCT02079766|27022609|FG001|Overall Study|Withdrawal by Subject|0|||
13482115|NCT02087189|27022685|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2|||
13482116|NCT02112916|27022757|FG000|Overall Study|Adverse Event|6|||
13482117|NCT02112916|27022758|FG001|Overall Study|Adverse Event|9|||
13482118|NCT02112916|27022759|FG002|Overall Study|Adverse Event|3|||
13482119|NCT02112916|27022760|FG003|Overall Study|Adverse Event|2|||
13482120|NCT02112916|27022757|FG000|Overall Study|Death|9|||
13482121|NCT02112916|27022758|FG001|Overall Study|Death|9|||
13482122|NCT02112916|27022759|FG002|Overall Study|Death|3|||
13482123|NCT02112916|27022760|FG003|Overall Study|Death|4|||
13482124|NCT02112916|27022757|FG000|Overall Study|Lost to Follow-up|1|||
13482125|NCT02112916|27022758|FG001|Overall Study|Lost to Follow-up|0|||
13482126|NCT02112916|27022759|FG002|Overall Study|Lost to Follow-up|0|||
13482127|NCT02112916|27022760|FG003|Overall Study|Lost to Follow-up|0|||
13482128|NCT02112916|27022757|FG000|Overall Study|Physician Decision|94|||
13482129|NCT02112916|27022758|FG001|Overall Study|Physician Decision|72|||
13482130|NCT02112916|27022759|FG002|Overall Study|Physician Decision|24|||
13482131|NCT02112916|27022760|FG003|Overall Study|Physician Decision|15|||
13482132|NCT02112916|27022757|FG000|Overall Study|Withdrawal by Subject|5|||
13482133|NCT02112916|27022758|FG001|Overall Study|Withdrawal by Subject|3|||
13482134|NCT02112916|27022759|FG002|Overall Study|Withdrawal by Subject|1|||
13482135|NCT02112916|27022760|FG003|Overall Study|Withdrawal by Subject|1|||
13482136|NCT02112916|27022757|FG000|Overall Study|Ineligible|4|||
13482137|NCT02112916|27022758|FG001|Overall Study|Ineligible|8|||
13482138|NCT02112916|27022759|FG002|Overall Study|Ineligible|3|||
13482139|NCT02112916|27022760|FG003|Overall Study|Ineligible|8|||
13482140|NCT02112916|27022757|FG000|Overall Study|Inevaluable|6|||
13482141|NCT02112916|27022758|FG001|Overall Study|Inevaluable|4|||
13482142|NCT02112916|27022759|FG002|Overall Study|Inevaluable|5|||
13482143|NCT02112916|27022760|FG003|Overall Study|Inevaluable|5|||
13482144|NCT02112916|27022757|FG000|Overall Study|Refusal of further protocol therapy|19|||
13482145|NCT02112916|27022758|FG001|Overall Study|Refusal of further protocol therapy|16|||
13482146|NCT02112916|27022759|FG002|Overall Study|Refusal of further protocol therapy|1|||
13482147|NCT02112916|27022760|FG003|Overall Study|Refusal of further protocol therapy|7|||
13482148|NCT02112916|27022757|FG000|Overall Study|Development of SMN|1|||
13482149|NCT02112916|27022758|FG001|Overall Study|Development of SMN|0|||
13482150|NCT02112916|27022759|FG002|Overall Study|Development of SMN|0|||
13482151|NCT02112916|27022760|FG003|Overall Study|Development of SMN|1|||
13482152|NCT02112916|27022757|FG000|Overall Study|Relapse/Progression|10|||
13482153|NCT02112916|27022758|FG001|Overall Study|Relapse/Progression|18|||
13482154|NCT02112916|27022759|FG002|Overall Study|Relapse/Progression|15|||
13482155|NCT02112916|27022760|FG003|Overall Study|Relapse/Progression|2|||
13482156|NCT02112916|27022757|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
13482157|NCT02112916|27022758|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
13482158|NCT02112916|27022759|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
13482159|NCT02112916|27022760|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
13482160|NCT02112916|27022757|FG000|Overall Study|Still on Therapy|44|||
13482161|NCT02112916|27022758|FG001|Overall Study|Still on Therapy|47|||
13482162|NCT02112916|27022759|FG002|Overall Study|Still on Therapy|3|||
13482163|NCT02112916|27022760|FG003|Overall Study|Still on Therapy|2|||
13482164|NCT02112916|27022757|FG000|Overall Study|Identified to have Ph+ T-ALL|0|||
13482165|NCT02112916|27022758|FG001|Overall Study|Identified to have Ph+ T-ALL|1|||
13482166|NCT02112916|27022759|FG002|Overall Study|Identified to have Ph+ T-ALL|0|||
13482167|NCT02112916|27022760|FG003|Overall Study|Identified to have Ph+ T-ALL|0|||
13482168|NCT02112916|27022757|FG000|Overall Study|Identified to have Ph+ T-Lly|0|||
13482169|NCT02112916|27022758|FG001|Overall Study|Identified to have Ph+ T-Lly|0|||
13482170|NCT02112916|27022759|FG002|Overall Study|Identified to have Ph+ T-Lly|1|||
13482171|NCT02112916|27022760|FG003|Overall Study|Identified to have Ph+ T-Lly|0|||
13482172|NCT02114697|27022773|FG000|Overall Study|Study terminated|5|||
13482173|NCT02114697|27022774|FG001|Overall Study|Study terminated|4|||
13482174|NCT02135029|27022872|FG000|Overall Study|Adverse Event|2|||
13482175|NCT02135029|27022873|FG001|Overall Study|Adverse Event|2|||
13482176|NCT02135029|27022874|FG002|Overall Study|Adverse Event|2|||
13482177|NCT02135029|27022872|FG000|Overall Study|Lost to Follow-up|0|||
13482178|NCT02135029|27022873|FG001|Overall Study|Lost to Follow-up|1|||
13482179|NCT02135029|27022874|FG002|Overall Study|Lost to Follow-up|0|||
13482180|NCT02135029|27022872|FG000|Overall Study|Withdrawal by Subject|2|||
13482181|NCT02135029|27022873|FG001|Overall Study|Withdrawal by Subject|0|||
13482182|NCT02135029|27022874|FG002|Overall Study|Withdrawal by Subject|1|||
13482183|NCT02135029|27022872|FG000|Overall Study|Other|0|||
13482184|NCT02135029|27022873|FG001|Overall Study|Other|1|||
13482185|NCT02135029|27022874|FG002|Overall Study|Other|0|||
13482186|NCT02135029|27022872|FG000|Overall Study|Death|0|||
13482067|NCT02081391|27022674|FG000|12-hour Treatment|Withdrawal by Subject|3|||
13482068|NCT02081391|27022675|FG001|12-hour Treatment|Withdrawal by Subject|2|||
13482069|NCT02081391|27022676|FG002|12-hour Treatment|Withdrawal by Subject|0|||
13482070|NCT02081391|27022677|FG003|12-hour Treatment|Withdrawal by Subject|0|||
13482071|NCT02081391|27022674|FG000|12-hour Treatment|Physician Decision|4|||
13482072|NCT02081391|27022675|FG001|12-hour Treatment|Physician Decision|1|||
13482073|NCT02081391|27022676|FG002|12-hour Treatment|Physician Decision|0|||
13482074|NCT02081391|27022677|FG003|12-hour Treatment|Physician Decision|0|||
13482075|NCT02081391|27022674|FG000|12-hour Treatment|Lack of Efficacy|3|||
13482076|NCT02081391|27022675|FG001|12-hour Treatment|Lack of Efficacy|0|||
13482077|NCT02081391|27022676|FG002|12-hour Treatment|Lack of Efficacy|0|||
13482078|NCT02081391|27022677|FG003|12-hour Treatment|Lack of Efficacy|0|||
13482079|NCT02081391|27022674|FG000|12-hour Treatment|Adverse Event|4|||
13482080|NCT02081391|27022675|FG001|12-hour Treatment|Adverse Event|2|||
13482081|NCT02081391|27022676|FG002|12-hour Treatment|Adverse Event|0|||
13482082|NCT02081391|27022677|FG003|12-hour Treatment|Adverse Event|0|||
13482083|NCT02081391|27022674|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2|||
13482084|NCT02081391|27022675|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0|||
13482085|NCT02081391|27022676|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1|||
13482086|NCT02081391|27022677|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0|||
13482087|NCT02081391|27022674|FG000|12-hour Treatment|Further reasons|2|||
13482088|NCT02081391|27022675|FG001|12-hour Treatment|Further reasons|1|||
13482089|NCT02081391|27022676|FG002|12-hour Treatment|Further reasons|0|||
13482090|NCT02081391|27022677|FG003|12-hour Treatment|Further reasons|0|||
13482091|NCT02081391|27022674|FG000|24-hour Treatment and Trial Completion|Physician Decision|10|||
13482092|NCT02081391|27022675|FG001|24-hour Treatment and Trial Completion|Physician Decision|5|||
13482093|NCT02081391|27022676|FG002|24-hour Treatment and Trial Completion|Physician Decision|0|||
13482094|NCT02081391|27022677|FG003|24-hour Treatment and Trial Completion|Physician Decision|0|||
13482095|NCT02081391|27022674|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1|||
13482096|NCT02081391|27022675|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3|||
13482097|NCT02081391|27022676|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
13482098|NCT02081391|27022677|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
13482099|NCT02081391|27022674|FG000|24-hour Treatment and Trial Completion|Adverse Event|1|||
13482100|NCT02081391|27022675|FG001|24-hour Treatment and Trial Completion|Adverse Event|0|||
13482101|NCT02081391|27022676|FG002|24-hour Treatment and Trial Completion|Adverse Event|0|||
13482102|NCT02081391|27022677|FG003|24-hour Treatment and Trial Completion|Adverse Event|0|||
13482103|NCT02081391|27022674|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11|||
13482104|NCT02081391|27022675|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5|||
13482105|NCT02081391|27022676|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1|||
13482106|NCT02081391|27022677|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0|||
13482107|NCT02081391|27022674|FG000|24-hour Treatment and Trial Completion|Technical Problems|1|||
13482108|NCT02081391|27022675|FG001|24-hour Treatment and Trial Completion|Technical Problems|1|||
13482109|NCT02081391|27022676|FG002|24-hour Treatment and Trial Completion|Technical Problems|0|||
13482110|NCT02081391|27022677|FG003|24-hour Treatment and Trial Completion|Technical Problems|0|||
13482111|NCT02081391|27022674|FG000|24-hour Treatment and Trial Completion|Further reasons|3|||
13482112|NCT02081391|27022675|FG001|24-hour Treatment and Trial Completion|Further reasons|4|||
13482113|NCT02081391|27022676|FG002|24-hour Treatment and Trial Completion|Further reasons|0|||
13482114|NCT02081391|27022677|FG003|24-hour Treatment and Trial Completion|Further reasons|0|||
13482187|NCT02135029|27022873|FG001|Overall Study|Death|1|||
13482188|NCT02135029|27022874|FG002|Overall Study|Death|0|||
13487469|NCT02181413|27039755|FG000|Overall Study|Adverse Event|7|||
13487470|NCT02181413|27039756|FG001|Overall Study|Adverse Event|24|||
13487471|NCT02181413|27039755|FG000|Overall Study|Progressive Disease|121|||
13487472|NCT02181413|27039756|FG001|Overall Study|Progressive Disease|143|||
13487473|NCT02181413|27039755|FG000|Overall Study|Withdrawal by Subject|5|||
13487474|NCT02181413|27039756|FG001|Overall Study|Withdrawal by Subject|8|||
13487475|NCT02181413|27039755|FG000|Overall Study|Reason Not Specified|19|||
13487476|NCT02181413|27039756|FG001|Overall Study|Reason Not Specified|20|||
13487477|NCT02181413|27039755|FG000|Overall Study|Ongoing Study Treatment|0|||
13487478|NCT02181413|27039756|FG001|Overall Study|Ongoing Study Treatment|1|||
13487479|NCT02181413|27039755|FG000|Overall Study|Lost to Follow-up|0|||
13487480|NCT02181413|27039756|FG001|Overall Study|Lost to Follow-up|1|||
13487481|NCT02095678|27039780|FG000|Overall Study|Withdrawal by Subject|0|||
13487482|NCT02095678|27039781|FG001|Overall Study|Withdrawal by Subject|1|||
13487483|NCT02095678|27039780|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11|||
13487484|NCT02095678|27039781|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12|||
13487485|NCT02095678|27039780|FG000|Overall Study|lesion impacted by previous treatment|1|||
13487486|NCT02095678|27039781|FG001|Overall Study|lesion impacted by previous treatment|1|||
13487487|NCT02095678|27039780|FG000|Overall Study|No Confirmed Diagnosis|0|||
13487488|NCT02095678|27039781|FG001|Overall Study|No Confirmed Diagnosis|3|||
13487489|NCT02095678|27039780|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
13482189|NCT02137239|27022941|FG000|Overall Study|Discontinued Study Treatment|0|||
13482190|NCT02137239|27022942|FG001|Overall Study|Discontinued Study Treatment|3|||
13482191|NCT02137239|27022941|FG000|Overall Study|Withdrew Consent|1|||
13482192|NCT02137239|27022942|FG001|Overall Study|Withdrew Consent|1|||
13482193|NCT02137239|27022941|FG000|Overall Study|Adverse Event|2|||
13482194|NCT02137239|27022942|FG001|Overall Study|Adverse Event|2|||
13482195|NCT05090852|27022948|FG000|Overall Study|Physician Decision|5|||
13482196|NCT04522141|27022981|FG000|Overall Study|Withdrawal by Subject|1|||
13482197|NCT04522141|27022982|FG001|Overall Study|Withdrawal by Subject|0|||
13482198|NCT04465916|27022997|FG000|Overall Study|Withdrawal by Subject|0|||
13482199|NCT04465916|27022998|FG001|Overall Study|Withdrawal by Subject|1|||
13482200|NCT04354155|27023006|FG000|Overall Study|Withdrawal by Subject|1|||
13482201|NCT04354155|27023006|FG000|Overall Study|Did not meet criteria for study intervention|1|||
13482202|NCT04043455|27023083|FG000|Main Study Double-Blind Treatment Period|Adverse Event|2|||
13482203|NCT04043455|27023084|FG001|Main Study Double-Blind Treatment Period|Adverse Event|3|||
13482204|NCT04043455|27023085|FG002|Main Study Double-Blind Treatment Period|Adverse Event|2|||
13482205|NCT04043455|27023086|FG003|Main Study Double-Blind Treatment Period|Adverse Event|3|||
13482206|NCT04043455|27023087|FG004|Main Study Double-Blind Treatment Period|Adverse Event|0|||
13482207|NCT04043455|27023088|FG005|Main Study Double-Blind Treatment Period|Adverse Event|0|||
13482208|NCT04043455|27023083|FG000|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
13482209|NCT04043455|27023084|FG001|Main Study Double-Blind Treatment Period|Withdrawal by Subject|5|||
13482210|NCT04043455|27023085|FG002|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
13482211|NCT04043455|27023086|FG003|Main Study Double-Blind Treatment Period|Withdrawal by Subject|9|||
13482212|NCT04043455|27023087|FG004|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
13482213|NCT04043455|27023088|FG005|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
13482214|NCT04043455|27023083|FG000|Main Study Double-Blind Treatment Period|Physician Decision|0|||
13482215|NCT04043455|27023084|FG001|Main Study Double-Blind Treatment Period|Physician Decision|2|||
13482216|NCT04043455|27023085|FG002|Main Study Double-Blind Treatment Period|Physician Decision|1|||
13482217|NCT04043455|27023086|FG003|Main Study Double-Blind Treatment Period|Physician Decision|0|||
13482218|NCT04043455|27023087|FG004|Main Study Double-Blind Treatment Period|Physician Decision|0|||
13482219|NCT04043455|27023088|FG005|Main Study Double-Blind Treatment Period|Physician Decision|0|||
13482220|NCT04043455|27023083|FG000|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
13482221|NCT04043455|27023084|FG001|Main Study Double-Blind Treatment Period|Lost to Follow-up|2|||
13482222|NCT04043455|27023085|FG002|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
13482223|NCT04043455|27023086|FG003|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
13482224|NCT04043455|27023087|FG004|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
13482225|NCT04043455|27023088|FG005|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
13482226|NCT04043455|27023083|FG000|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
13482227|NCT04043455|27023084|FG001|Main Study Double-Blind Treatment Period|Protocol Violation|1|||
13482228|NCT04043455|27023085|FG002|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
13482229|NCT04043455|27023086|FG003|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
13482230|NCT04043455|27023087|FG004|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
13482231|NCT04043455|27023088|FG005|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
13482232|NCT04043455|27023083|FG000|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|1|||
13482233|NCT04043455|27023084|FG001|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
13482234|NCT04043455|27023085|FG002|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
13482235|NCT04043455|27023086|FG003|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
13482236|NCT04043455|27023087|FG004|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
13482237|NCT04043455|27023088|FG005|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
13482238|NCT04043455|27023083|FG000|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
13482239|NCT04043455|27023084|FG001|Main Study Double-Blind Treatment Period|Did not receive treatment|1|||
13482240|NCT04043455|27023085|FG002|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
13482241|NCT04043455|27023086|FG003|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
13482242|NCT04043455|27023087|FG004|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
13482243|NCT04043455|27023088|FG005|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
13482244|NCT04043455|27023083|FG000|Double-Blind LTE Treatment Period|Adverse Event|0|||
13482245|NCT04043455|27023084|FG001|Double-Blind LTE Treatment Period|Adverse Event|0|||
13482246|NCT04043455|27023085|FG002|Double-Blind LTE Treatment Period|Adverse Event|0|||
13482247|NCT04043455|27023086|FG003|Double-Blind LTE Treatment Period|Adverse Event|0|||
13482248|NCT04043455|27023087|FG004|Double-Blind LTE Treatment Period|Adverse Event|0|||
13482249|NCT04043455|27023088|FG005|Double-Blind LTE Treatment Period|Adverse Event|2|||
13482250|NCT04043455|27023083|FG000|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
13482251|NCT04043455|27023084|FG001|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
13482252|NCT04043455|27023085|FG002|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
13482253|NCT04043455|27023086|FG003|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
13482254|NCT04043455|27023087|FG004|Double-Blind LTE Treatment Period|Withdrawal by Subject|5|||
13482255|NCT04043455|27023088|FG005|Double-Blind LTE Treatment Period|Withdrawal by Subject|6|||
13482256|NCT04043455|27023083|FG000|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
13135678|NCT02737501|25996066|FG001|Randomized Phase|Withdrawal by Subject|6|||
13135679|NCT02737501|25996067|FG002|Randomized Phase|Withdrawal by Subject|0|||
13135680|NCT02737501|25996065|FG000|Randomized Phase|Lost to Follow-up|0|||
13135681|NCT02737501|25996066|FG001|Randomized Phase|Lost to Follow-up|1|||
13135682|NCT02737501|25996067|FG002|Randomized Phase|Lost to Follow-up|0|||
13135683|NCT02737501|25996065|FG000|Randomized Phase|Site Terminated by Sponsor|58|||
13135684|NCT02737501|25996066|FG001|Randomized Phase|Site Terminated by Sponsor|16|||
13135685|NCT02737501|25996067|FG002|Randomized Phase|Site Terminated by Sponsor|0|||
13482257|NCT04043455|27023084|FG001|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
13482258|NCT04043455|27023085|FG002|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
13482259|NCT04043455|27023086|FG003|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
13482260|NCT04043455|27023087|FG004|Double-Blind LTE Treatment Period|Lost to Follow-up|1|||
13482261|NCT04043455|27023088|FG005|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
13482262|NCT04043455|27023083|FG000|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
13482263|NCT04043455|27023084|FG001|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
13482264|NCT04043455|27023085|FG002|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
13482265|NCT04043455|27023086|FG003|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
13482266|NCT04043455|27023087|FG004|Double-Blind LTE Treatment Period|Study termination by Sponsor|47|||
13482267|NCT04043455|27023088|FG005|Double-Blind LTE Treatment Period|Study termination by Sponsor|44|||
13487490|NCT02095678|27039781|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
13487491|NCT02095678|27039780|FG000|Overall Study|No Visible Lesion or Pathological Finding|4|||
13487492|NCT02095678|27039781|FG001|Overall Study|No Visible Lesion or Pathological Finding|0|||
13487493|NCT01955109|27039848|FG000|Overall Study|Adverse Event|2|||
13487494|NCT01955109|27039849|FG001|Overall Study|Adverse Event|0|||
13487495|NCT01955109|27039848|FG000|Overall Study|Participant unwilling to continue|35|||
13487496|NCT01955109|27039849|FG001|Overall Study|Participant unwilling to continue|7|||
13487497|NCT01955109|27039848|FG000|Overall Study|Physician Decision|2|||
13487498|NCT01955109|27039849|FG001|Overall Study|Physician Decision|0|||
13487499|NCT01955109|27039848|FG000|Overall Study|Lost to Follow-up|3|||
13487500|NCT01955109|27039849|FG001|Overall Study|Lost to Follow-up|1|||
13487501|NCT01955109|27039848|FG000|Overall Study|Non-compliance|3|||
13487502|NCT01955109|27039849|FG001|Overall Study|Non-compliance|1|||
13487503|NCT01854775|27039930|FG000|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
13487504|NCT01854775|27039931|FG001|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
13487505|NCT01854775|27039932|FG002|Treatment Phase (48 Weeks)|Withdrawal by Subject|0|||
13487506|NCT01854775|27039930|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1|||
13487507|NCT01854775|27039931|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
13487508|NCT01854775|27039932|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
13487509|NCT01854775|27039930|FG000|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
13487510|NCT01854775|27039931|FG001|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
13487511|NCT01854775|27039932|FG002|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|9|||
13487512|NCT01854775|27039930|FG000|Extension Phase|Pregnancy|3|||
13487513|NCT01854775|27039931|FG001|Extension Phase|Pregnancy|0|||
13487514|NCT01854775|27039932|FG002|Extension Phase|Pregnancy|0|||
13487515|NCT01854775|27039930|FG000|Extension Phase|Investigator's Discretion|1|||
13487516|NCT01854775|27039931|FG001|Extension Phase|Investigator's Discretion|0|||
13487517|NCT01854775|27039932|FG002|Extension Phase|Investigator's Discretion|0|||
13487518|NCT01854775|27039930|FG000|Extension Phase|Non-Compliance with Study Drug|1|||
13487519|NCT01854775|27039931|FG001|Extension Phase|Non-Compliance with Study Drug|0|||
13487520|NCT01854775|27039932|FG002|Extension Phase|Non-Compliance with Study Drug|0|||
13487521|NCT01854775|27039930|FG000|Extension Phase|Lost to Follow-up|2|||
13487522|NCT01854775|27039931|FG001|Extension Phase|Lost to Follow-up|0|||
13487523|NCT01854775|27039932|FG002|Extension Phase|Lost to Follow-up|0|||
13487524|NCT01854775|27039930|FG000|Extension Phase|Still on Study|32|||
13487525|NCT01854775|27039931|FG001|Extension Phase|Still on Study|47|||
13487526|NCT01854775|27039932|FG002|Extension Phase|Still on Study|18|||
13487527|NCT01235234|27039985|FG000|Overall Study|Adverse Event|2|||
13487528|NCT01235234|27039986|FG001|Overall Study|Adverse Event|2|||
13487529|NCT01235234|27039987|FG002|Overall Study|Adverse Event|1|||
13487530|NCT01160211|27040027|FG000|Overall Study|ongoing|90|||
13487531|NCT01160211|27040028|FG001|Overall Study|ongoing|75|||
13487532|NCT01160211|27040029|FG002|Overall Study|ongoing|79|||
13487533|NCT01160211|27040027|FG000|Overall Study|Withdrawal by Subject|3|||
13487534|NCT01160211|27040028|FG001|Overall Study|Withdrawal by Subject|5|||
13487535|NCT01160211|27040029|FG002|Overall Study|Withdrawal by Subject|3|||
13487536|NCT01160211|27040027|FG000|Overall Study|Physician Decision|2|||
13487537|NCT01160211|27040028|FG001|Overall Study|Physician Decision|0|||
13487538|NCT01160211|27040029|FG002|Overall Study|Physician Decision|0|||
13487539|NCT01160211|27040027|FG000|Overall Study|Lost to Follow-up|4|||
13482268|NCT03810495|27023181|FG000|Overall Study|Lost to Follow-up|2|||
13482269|NCT03810495|27023181|FG000|Overall Study|Withdrawal by Subject|1|||
13482270|NCT03704584|27023206|FG000|Overall Study|Withdrawal by Subject|1|||
13482271|NCT03704584|27023207|FG001|Overall Study|Withdrawal by Subject|0|||
13482272|NCT03538158|27023222|FG000|Overall Study|Lost to Follow-up|13|||
13482273|NCT03538158|27023223|FG001|Overall Study|Lost to Follow-up|7|||
13482274|NCT03538158|27023222|FG000|Overall Study|Withdrawal by Subject|2|||
13482275|NCT03538158|27023223|FG001|Overall Study|Withdrawal by Subject|1|||
13482276|NCT03486912|27023270|FG000|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
13482277|NCT03486912|27023271|FG001|Randomized (Pre-Treatment)|Withdrawal by Subject|1|||
13482278|NCT03486912|27023272|FG002|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
13482279|NCT03486912|27023273|FG003|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
13482280|NCT03486912|27023270|FG000|Treatment Period|Withdrawal by Subject|3|||
13482281|NCT03486912|27023271|FG001|Treatment Period|Withdrawal by Subject|3|||
13482282|NCT03486912|27023272|FG002|Treatment Period|Withdrawal by Subject|3|||
13482283|NCT03486912|27023273|FG003|Treatment Period|Withdrawal by Subject|2|||
13482284|NCT03486912|27023270|FG000|Treatment Period|Other Reasons|0|||
13482285|NCT03486912|27023271|FG001|Treatment Period|Other Reasons|2|||
13482286|NCT03486912|27023272|FG002|Treatment Period|Other Reasons|1|||
13482287|NCT03486912|27023273|FG003|Treatment Period|Other Reasons|1|||
13482288|NCT03486912|27023270|FG000|Treatment Period|Adverse Event|0|||
13482289|NCT03486912|27023271|FG001|Treatment Period|Adverse Event|1|||
13482290|NCT03486912|27023272|FG002|Treatment Period|Adverse Event|1|||
13482291|NCT03486912|27023273|FG003|Treatment Period|Adverse Event|0|||
13482292|NCT03486912|27023270|FG000|Treatment Period|Lost to Follow-up|1|||
13482293|NCT03486912|27023271|FG001|Treatment Period|Lost to Follow-up|0|||
13482294|NCT03486912|27023272|FG002|Treatment Period|Lost to Follow-up|0|||
13482295|NCT03486912|27023273|FG003|Treatment Period|Lost to Follow-up|2|||
13482296|NCT03367403|27023314|FG000|Overall Study|Adverse Event|20|||
13482297|NCT03367403|27023315|FG001|Overall Study|Adverse Event|6|||
13482298|NCT03367403|27023316|FG002|Overall Study|Adverse Event|2|||
13482299|NCT03367403|27023314|FG000|Overall Study|Withdrawal by Subject|12|||
13482300|NCT03367403|27023315|FG001|Overall Study|Withdrawal by Subject|13|||
13482301|NCT03367403|27023316|FG002|Overall Study|Withdrawal by Subject|1|||
13482302|NCT03367403|27023314|FG000|Overall Study|Death|1|||
13482303|NCT03367403|27023315|FG001|Overall Study|Death|2|||
13482304|NCT03367403|27023316|FG002|Overall Study|Death|0|||
13482305|NCT03367403|27023314|FG000|Overall Study|Physician Decision|0|||
13482306|NCT03367403|27023315|FG001|Overall Study|Physician Decision|1|||
13482307|NCT03367403|27023316|FG002|Overall Study|Physician Decision|0|||
13482308|NCT03367403|27023314|FG000|Overall Study|Protocol Violation|1|||
13482309|NCT03367403|27023315|FG001|Overall Study|Protocol Violation|1|||
13482310|NCT03367403|27023316|FG002|Overall Study|Protocol Violation|0|||
13482311|NCT03367403|27023314|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
13482312|NCT03367403|27023315|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2|||
13482313|NCT03367403|27023316|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
13482314|NCT03367403|27023314|FG000|Overall Study|COVID-19|3|||
13482315|NCT03367403|27023315|FG001|Overall Study|COVID-19|6|||
13221773|NCT01811225|26284635|FG001|Treatment Period 1|unable to remain smoke free overnight|6|||
13221774|NCT01811225|26284634|FG000|Treatment Period 2|Lost to Follow-up|1|||
13221775|NCT01811225|26284635|FG001|Treatment Period 2|Lost to Follow-up|2|||
13221776|NCT01811225|26284634|FG000|Treatment Period 2|unable to remain smoke free overnight|3|||
13221777|NCT01811225|26284635|FG001|Treatment Period 2|unable to remain smoke free overnight|4|||
13482316|NCT03367403|27023316|FG002|Overall Study|COVID-19|0|||
13482317|NCT03367403|27023314|FG000|Overall Study|Abuse of Alcohol Intake|0|||
13482318|NCT03367403|27023315|FG001|Overall Study|Abuse of Alcohol Intake|1|||
13482319|NCT03367403|27023316|FG002|Overall Study|Abuse of Alcohol Intake|0|||
13482320|NCT03367403|27023314|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
13482321|NCT03367403|27023315|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1|||
13482322|NCT03367403|27023316|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
13482323|NCT03345342|27023381|FG000|Open-Label Phase|Adverse Event|30|||
13482324|NCT03345342|27023382|FG001|Open-Label Phase|Adverse Event|0|||
13482325|NCT03345342|27023383|FG002|Open-Label Phase|Adverse Event|0|||
13482326|NCT03345342|27023384|FG003|Open-Label Phase|Adverse Event|0|||
13482327|NCT03345342|27023385|FG004|Open-Label Phase|Adverse Event|0|||
13482328|NCT03345342|27023381|FG000|Open-Label Phase|Death|1|||
13482329|NCT03345342|27023382|FG001|Open-Label Phase|Death|0|||
13221778|NCT01811186|26284658|FG000|Overall Study|Adverse Event|54|||
13482330|NCT03345342|27023383|FG002|Open-Label Phase|Death|0|||
13482331|NCT03345342|27023384|FG003|Open-Label Phase|Death|0|||
13482332|NCT03345342|27023385|FG004|Open-Label Phase|Death|0|||
13482333|NCT03345342|27023381|FG000|Open-Label Phase|Initiated Prohibited Medication|2|||
13482334|NCT03345342|27023382|FG001|Open-Label Phase|Initiated Prohibited Medication|0|||
13482335|NCT03345342|27023383|FG002|Open-Label Phase|Initiated Prohibited Medication|0|||
13482336|NCT03345342|27023384|FG003|Open-Label Phase|Initiated Prohibited Medication|0|||
13482337|NCT03345342|27023385|FG004|Open-Label Phase|Initiated Prohibited Medication|0|||
13482338|NCT03345342|27023381|FG000|Open-Label Phase|Lack of Efficacy|6|||
13482339|NCT03345342|27023382|FG001|Open-Label Phase|Lack of Efficacy|0|||
13482340|NCT03345342|27023383|FG002|Open-Label Phase|Lack of Efficacy|0|||
13482341|NCT03345342|27023384|FG003|Open-Label Phase|Lack of Efficacy|0|||
13482342|NCT03345342|27023385|FG004|Open-Label Phase|Lack of Efficacy|0|||
13482343|NCT03345342|27023381|FG000|Open-Label Phase|Lost to Follow-up|9|||
13482344|NCT03345342|27023382|FG001|Open-Label Phase|Lost to Follow-up|0|||
13482345|NCT03345342|27023383|FG002|Open-Label Phase|Lost to Follow-up|0|||
13482346|NCT03345342|27023384|FG003|Open-Label Phase|Lost to Follow-up|0|||
13482347|NCT03345342|27023385|FG004|Open-Label Phase|Lost to Follow-up|0|||
13482348|NCT03345342|27023381|FG000|Open-Label Phase|Non-Compliance with Study Drug|4|||
13482349|NCT03345342|27023382|FG001|Open-Label Phase|Non-Compliance with Study Drug|0|||
13482350|NCT03345342|27023383|FG002|Open-Label Phase|Non-Compliance with Study Drug|0|||
13482351|NCT03345342|27023384|FG003|Open-Label Phase|Non-Compliance with Study Drug|0|||
13482352|NCT03345342|27023385|FG004|Open-Label Phase|Non-Compliance with Study Drug|0|||
13482353|NCT03345342|27023381|FG000|Open-Label Phase|Physician Decision|4|||
13482354|NCT03345342|27023382|FG001|Open-Label Phase|Physician Decision|0|||
13482355|NCT03345342|27023383|FG002|Open-Label Phase|Physician Decision|0|||
13482356|NCT03345342|27023384|FG003|Open-Label Phase|Physician Decision|0|||
13482357|NCT03345342|27023385|FG004|Open-Label Phase|Physician Decision|0|||
13482358|NCT03345342|27023381|FG000|Open-Label Phase|Protocol Violation|8|||
13482359|NCT03345342|27023382|FG001|Open-Label Phase|Protocol Violation|0|||
13482360|NCT03345342|27023383|FG002|Open-Label Phase|Protocol Violation|0|||
13482361|NCT03345342|27023384|FG003|Open-Label Phase|Protocol Violation|0|||
13482362|NCT03345342|27023385|FG004|Open-Label Phase|Protocol Violation|0|||
13482363|NCT03345342|27023381|FG000|Open-Label Phase|Withdrawal by Subject|57|||
13482364|NCT03345342|27023382|FG001|Open-Label Phase|Withdrawal by Subject|0|||
13482365|NCT03345342|27023383|FG002|Open-Label Phase|Withdrawal by Subject|0|||
13482366|NCT03345342|27023384|FG003|Open-Label Phase|Withdrawal by Subject|0|||
13482367|NCT03345342|27023385|FG004|Open-Label Phase|Withdrawal by Subject|0|||
13482368|NCT03345342|27023381|FG000|Open-Label Phase|Other|15|||
13482369|NCT03345342|27023382|FG001|Open-Label Phase|Other|0|||
13482370|NCT03345342|27023383|FG002|Open-Label Phase|Other|0|||
13482371|NCT03345342|27023384|FG003|Open-Label Phase|Other|0|||
13482372|NCT03345342|27023385|FG004|Open-Label Phase|Other|0|||
13482373|NCT03345342|27023381|FG000|Double-Blind Phase|Adverse Event|0|||
13482374|NCT03345342|27023382|FG001|Double-Blind Phase|Adverse Event|1|||
13482375|NCT03345342|27023383|FG002|Double-Blind Phase|Adverse Event|6|||
13482376|NCT03345342|27023384|FG003|Double-Blind Phase|Adverse Event|0|||
13482377|NCT03345342|27023385|FG004|Double-Blind Phase|Adverse Event|0|||
13482378|NCT03345342|27023381|FG000|Double-Blind Phase|Death|0|||
13482379|NCT03345342|27023382|FG001|Double-Blind Phase|Death|2|||
13482380|NCT03345342|27023383|FG002|Double-Blind Phase|Death|1|||
13482381|NCT03345342|27023384|FG003|Double-Blind Phase|Death|0|||
13482382|NCT03345342|27023385|FG004|Double-Blind Phase|Death|0|||
13482383|NCT03345342|27023381|FG000|Double-Blind Phase|Initiated Prohibited Medication|0|||
13482384|NCT03345342|27023382|FG001|Double-Blind Phase|Initiated Prohibited Medication|0|||
13482385|NCT03345342|27023383|FG002|Double-Blind Phase|Initiated Prohibited Medication|2|||
13482386|NCT03345342|27023384|FG003|Double-Blind Phase|Initiated Prohibited Medication|0|||
13482387|NCT03345342|27023385|FG004|Double-Blind Phase|Initiated Prohibited Medication|0|||
13482388|NCT03345342|27023381|FG000|Double-Blind Phase|Lost to Follow-up|0|||
13482389|NCT03345342|27023382|FG001|Double-Blind Phase|Lost to Follow-up|1|||
13482390|NCT03345342|27023383|FG002|Double-Blind Phase|Lost to Follow-up|7|||
13482391|NCT03345342|27023384|FG003|Double-Blind Phase|Lost to Follow-up|0|||
13482392|NCT03345342|27023385|FG004|Double-Blind Phase|Lost to Follow-up|0|||
13482393|NCT03345342|27023381|FG000|Double-Blind Phase|Physician Decision|0|||
13482394|NCT03345342|27023382|FG001|Double-Blind Phase|Physician Decision|1|||
13482395|NCT03345342|27023383|FG002|Double-Blind Phase|Physician Decision|4|||
13482396|NCT03345342|27023384|FG003|Double-Blind Phase|Physician Decision|0|||
13482397|NCT03345342|27023385|FG004|Double-Blind Phase|Physician Decision|0|||
13482398|NCT03345342|27023381|FG000|Double-Blind Phase|Protocol Violation|0|||
13482399|NCT03345342|27023382|FG001|Double-Blind Phase|Protocol Violation|0|||
13482400|NCT03345342|27023383|FG002|Double-Blind Phase|Protocol Violation|1|||
13482401|NCT03345342|27023384|FG003|Double-Blind Phase|Protocol Violation|0|||
13482402|NCT03345342|27023385|FG004|Double-Blind Phase|Protocol Violation|0|||
13482403|NCT03345342|27023381|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
13482404|NCT03345342|27023382|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
13482405|NCT03345342|27023383|FG002|Double-Blind Phase|Withdrawal by Subject|38|||
13482406|NCT03345342|27023384|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
13482407|NCT03345342|27023385|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
13482408|NCT03345342|27023381|FG000|Double-Blind Phase|Other|0|||
13482409|NCT03345342|27023382|FG001|Double-Blind Phase|Other|1|||
13482410|NCT03345342|27023383|FG002|Double-Blind Phase|Other|3|||
13482411|NCT03345342|27023384|FG003|Double-Blind Phase|Other|0|||
13482412|NCT03345342|27023385|FG004|Double-Blind Phase|Other|0|||
13482413|NCT03345342|27023381|FG000|Follow-Up Phase|Adverse Event|0|||
13482414|NCT03345342|27023382|FG001|Follow-Up Phase|Adverse Event|0|||
13482415|NCT03345342|27023383|FG002|Follow-Up Phase|Adverse Event|0|||
13482416|NCT03345342|27023384|FG003|Follow-Up Phase|Adverse Event|0|||
13482417|NCT03345342|27023385|FG004|Follow-Up Phase|Adverse Event|4|||
13482418|NCT03345342|27023381|FG000|Follow-Up Phase|Lost to Follow-up|0|||
13482419|NCT03345342|27023382|FG001|Follow-Up Phase|Lost to Follow-up|0|||
13482420|NCT03345342|27023383|FG002|Follow-Up Phase|Lost to Follow-up|0|||
13482421|NCT03345342|27023384|FG003|Follow-Up Phase|Lost to Follow-up|0|||
13482422|NCT03345342|27023385|FG004|Follow-Up Phase|Lost to Follow-up|6|||
13482423|NCT03345342|27023381|FG000|Follow-Up Phase|Physician Decision|0|||
13482424|NCT03345342|27023382|FG001|Follow-Up Phase|Physician Decision|0|||
13482425|NCT03345342|27023383|FG002|Follow-Up Phase|Physician Decision|0|||
13482426|NCT03345342|27023384|FG003|Follow-Up Phase|Physician Decision|0|||
13482427|NCT03345342|27023385|FG004|Follow-Up Phase|Physician Decision|5|||
13482428|NCT03345342|27023381|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
13482429|NCT03345342|27023382|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
13482430|NCT03345342|27023383|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
13482431|NCT03345342|27023384|FG003|Follow-Up Phase|Withdrawal by Subject|5|||
13482432|NCT03345342|27023385|FG004|Follow-Up Phase|Withdrawal by Subject|15|||
13482433|NCT03345342|27023381|FG000|Follow-Up Phase|Other|0|||
13482434|NCT03345342|27023382|FG001|Follow-Up Phase|Other|0|||
13482435|NCT03345342|27023383|FG002|Follow-Up Phase|Other|0|||
13482436|NCT03345342|27023384|FG003|Follow-Up Phase|Other|3|||
13482437|NCT03345342|27023385|FG004|Follow-Up Phase|Other|1|||
13482438|NCT03292146|27023402|FG000|Baseline to 12 Months|Relocation|1|||
13482439|NCT03292146|27023403|FG001|Baseline to 12 Months|Relocation|0|||
13482440|NCT03292146|27023402|FG000|Baseline to 12 Months|Seeking higher level of care for eating disorder|1|||
13482441|NCT03292146|27023403|FG001|Baseline to 12 Months|Seeking higher level of care for eating disorder|0|||
13482442|NCT03292146|27023402|FG000|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|0|||
13482443|NCT03292146|27023403|FG001|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|1|||
13482444|NCT03292146|27023402|FG000|12 Months to 24 Months|Planning pregnancy|2|||
13482445|NCT03292146|27023403|FG001|12 Months to 24 Months|Planning pregnancy|2|||
13482446|NCT03292146|27023402|FG000|12 Months to 24 Months|Personal reasons|1|||
13482447|NCT03292146|27023403|FG001|12 Months to 24 Months|Personal reasons|0|||
13482448|NCT03292146|27023402|FG000|12 Months to 24 Months|Lost to Follow-up|0|||
13482449|NCT03292146|27023403|FG001|12 Months to 24 Months|Lost to Follow-up|1|||
13482450|NCT03248128|27023454|FG000|Overall Study|Lost to Follow-up|1|||
13482451|NCT03248128|27023455|FG001|Overall Study|Lost to Follow-up|0|||
13482452|NCT03248128|27023454|FG000|Overall Study|Withdrawal by Subject|16|||
13482453|NCT03248128|27023455|FG001|Overall Study|Withdrawal by Subject|14|||
13482454|NCT03248128|27023454|FG000|Overall Study|Site Closed|4|||
13482455|NCT03248128|27023455|FG001|Overall Study|Site Closed|3|||
13482456|NCT03248128|27023454|FG000|Overall Study|Randomized, but did not receive treatment|1|||
13482457|NCT03248128|27023455|FG001|Overall Study|Randomized, but did not receive treatment|3|||
13487540|NCT01160211|27040028|FG001|Overall Study|Lost to Follow-up|7|||
13487541|NCT01160211|27040029|FG002|Overall Study|Lost to Follow-up|5|||
13487542|NCT01093573|27040053|FG000|Overall Study|Physician Decision|0|||
13487543|NCT01093573|27040054|FG001|Overall Study|Physician Decision|0|||
13487544|NCT01093573|27040055|FG002|Overall Study|Physician Decision|1|||
13487545|NCT01093573|27040053|FG000|Overall Study|Insurance Denied|0|||
13487546|NCT01093573|27040054|FG001|Overall Study|Insurance Denied|0|||
13487547|NCT01093573|27040055|FG002|Overall Study|Insurance Denied|1|||
13487548|NCT00828854|27040064|FG000|Overall Study|Disease Progression|17|||
13487549|NCT00828854|27040064|FG000|Overall Study|Adverse Event|9|||
13487550|NCT00828854|27040064|FG000|Overall Study|Reason not Specified|1|||
13488291|NCT02959918|27043325|FG005|Overall Study|Lost to Follow-up|0|||
13488292|NCT02959918|27043326|FG006|Overall Study|Lost to Follow-up|0|||
13488293|NCT02959918|27043327|FG007|Overall Study|Lost to Follow-up|0|||
13488294|NCT02959918|27043328|FG008|Overall Study|Lost to Follow-up|0|||
13488295|NCT02959918|27043329|FG009|Overall Study|Lost to Follow-up|1|||
13488296|NCT02959918|27043330|FG010|Overall Study|Lost to Follow-up|0|||
13488297|NCT02959918|27043331|FG011|Overall Study|Lost to Follow-up|0|||
13488298|NCT02959918|27043332|FG012|Overall Study|Lost to Follow-up|1|||
13488299|NCT02959918|27043333|FG013|Overall Study|Lost to Follow-up|0|||
13488300|NCT02959918|27043320|FG000|Overall Study|Withdrawal by Subject|0|||
13488301|NCT02959918|27043321|FG001|Overall Study|Withdrawal by Subject|0|||
13488302|NCT02959918|27043322|FG002|Overall Study|Withdrawal by Subject|1|||
13488303|NCT02959918|27043323|FG003|Overall Study|Withdrawal by Subject|2|||
13488304|NCT02959918|27043324|FG004|Overall Study|Withdrawal by Subject|0|||
13488305|NCT02959918|27043325|FG005|Overall Study|Withdrawal by Subject|0|||
13488306|NCT02959918|27043326|FG006|Overall Study|Withdrawal by Subject|1|||
13488307|NCT02959918|27043327|FG007|Overall Study|Withdrawal by Subject|0|||
13488308|NCT02959918|27043328|FG008|Overall Study|Withdrawal by Subject|1|||
13488309|NCT02959918|27043329|FG009|Overall Study|Withdrawal by Subject|1|||
13488310|NCT02959918|27043330|FG010|Overall Study|Withdrawal by Subject|2|||
13488311|NCT02959918|27043331|FG011|Overall Study|Withdrawal by Subject|3|||
13488312|NCT02959918|27043332|FG012|Overall Study|Withdrawal by Subject|1|||
13482458|NCT03173560|27023510|FG000|Overall Study|Ongoing on Treatment|38|||
13482459|NCT03173560|27023511|FG001|Overall Study|Ongoing on Treatment|50|||
13482460|NCT03173560|27023510|FG000|Overall Study|Ongoing Survival Follow-up|56|||
13482461|NCT03173560|27023511|FG001|Overall Study|Ongoing Survival Follow-up|57|||
13482462|NCT03173560|27023510|FG000|Overall Study|Lost to Follow-up|1|||
13482463|NCT03173560|27023511|FG001|Overall Study|Lost to Follow-up|4|||
13482464|NCT03173560|27023510|FG000|Overall Study|Withdrawal by Subject|10|||
13482465|NCT03173560|27023511|FG001|Overall Study|Withdrawal by Subject|5|||
13482466|NCT03173560|27023510|FG000|Overall Study|Other|0|||
13482467|NCT03173560|27023511|FG001|Overall Study|Other|1|||
13482468|NCT02994927|27023602|FG000|Overall Study|Withdrawal by parent/guardian|0|||
13482469|NCT02994927|27023603|FG001|Overall Study|Withdrawal by parent/guardian|1|||
13482470|NCT02994927|27023602|FG000|Overall Study|Did not meet eligibility criteria|0|||
13482471|NCT02994927|27023603|FG001|Overall Study|Did not meet eligibility criteria|1|||
13482472|NCT02994927|27023602|FG000|Overall Study|Physician Decision|4|||
13482473|NCT02994927|27023603|FG001|Overall Study|Physician Decision|3|||
13482474|NCT02994927|27023602|FG000|Overall Study|Death|4|||
13482475|NCT02994927|27023603|FG001|Overall Study|Death|2|||
13482476|NCT02994927|27023602|FG000|Overall Study|Adverse Event|2|||
13482477|NCT02994927|27023603|FG001|Overall Study|Adverse Event|1|||
13482478|NCT02994927|27023602|FG000|Overall Study|Withdrawal by Subject|3|||
13482479|NCT02994927|27023603|FG001|Overall Study|Withdrawal by Subject|6|||
13482480|NCT02994927|27023602|FG000|Overall Study|Lost to Follow-up|2|||
13482481|NCT02994927|27023603|FG001|Overall Study|Lost to Follow-up|1|||
13482482|NCT02941549|27023654|FG000|Overall Study|Adverse Event|1|||
13482483|NCT02941549|27023655|FG001|Overall Study|Adverse Event|0|||
13482484|NCT02941549|27023656|FG002|Overall Study|Adverse Event|0|||
13482485|NCT02941549|27023654|FG000|Overall Study|Withdrawal by Subject|2|||
13482486|NCT02941549|27023655|FG001|Overall Study|Withdrawal by Subject|1|||
13482487|NCT02941549|27023656|FG002|Overall Study|Withdrawal by Subject|2|||
13482488|NCT02900352|27023681|FG000|Overall Study|Lost to Follow-up|28|||
13482489|NCT02900352|27023682|FG001|Overall Study|Lost to Follow-up|17|||
13482490|NCT02886494|27023717|FG000|Overall Study|Adverse Event|1|||
13482491|NCT02886494|27023718|FG001|Overall Study|Adverse Event|0|||
13482492|NCT02886494|27023717|FG000|Overall Study|Withdrawal by Subject|12|||
13482493|NCT02886494|27023718|FG001|Overall Study|Withdrawal by Subject|3|||
13482494|NCT02886494|27023717|FG000|Overall Study|Protocol Violation|4|||
13482495|NCT02886494|27023718|FG001|Overall Study|Protocol Violation|1|||
13482496|NCT02716805|27023766|FG000|Overall Study|Progressive disease|2|||
13482497|NCT02716805|27023767|FG001|Overall Study|Progressive disease|0|||
13482498|NCT02716805|27023768|FG002|Overall Study|Progressive disease|0|||
13482499|NCT02716805|27023769|FG003|Overall Study|Progressive disease|0|||
13482500|NCT02715856|27023784|FG000|Overall Study|Software Issues|12|||
13482501|NCT02715856|27023785|FG001|Overall Study|Software Issues|7|||
13482502|NCT02715856|27023784|FG000|Overall Study|Death|6|||
13482503|NCT02715856|27023785|FG001|Overall Study|Death|5|||
13482504|NCT02715856|27023784|FG000|Overall Study|Non- Compliant|0|||
13482505|NCT02715856|27023785|FG001|Overall Study|Non- Compliant|40|||
13482506|NCT02630459|27023865|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
13482507|NCT02630459|27023866|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1|||
13482508|NCT02630459|27023867|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
13482509|NCT02630459|27023868|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2|||
13482510|NCT02630459|27023869|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
13482511|NCT02630459|27023870|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
13482512|NCT02630459|27023871|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
13482513|NCT02630459|27023872|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
13482514|NCT02630459|27023865|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
13482515|NCT02630459|27023866|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
13482516|NCT02630459|27023867|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1|||
13482517|NCT02630459|27023868|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
13482518|NCT02630459|27023869|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
13482519|NCT02630459|27023870|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
13482520|NCT02630459|27023871|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
13482521|NCT02630459|27023872|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
13482522|NCT02630459|27023865|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2|||
13482523|NCT02630459|27023866|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
13482524|NCT02630459|27023867|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4|||
13482525|NCT02630459|27023868|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
13482526|NCT02630459|27023869|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
13482527|NCT02630459|27023870|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
13482528|NCT02630459|27023871|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
13482529|NCT02630459|27023872|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
13482530|NCT02630459|27023865|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1|||
13482531|NCT02630459|27023866|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
13482532|NCT02630459|27023867|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
13482533|NCT02630459|27023868|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
13482534|NCT02630459|27023869|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
13482535|NCT02630459|27023870|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
13482536|NCT02630459|27023871|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
13482537|NCT02630459|27023872|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
13482538|NCT02630459|27023865|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
13482539|NCT02630459|27023866|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
13482540|NCT02630459|27023867|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
13482541|NCT02630459|27023868|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
13482542|NCT02630459|27023869|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4|||
13482543|NCT02630459|27023870|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1|||
13482544|NCT02630459|27023871|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
13482545|NCT02630459|27023872|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
13482546|NCT02630459|27023865|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
13482547|NCT02630459|27023866|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
13482548|NCT02630459|27023867|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
13482549|NCT02630459|27023868|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
13482550|NCT02630459|27023869|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24|||
13482551|NCT02630459|27023870|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3|||
13482552|NCT02630459|27023871|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
13482553|NCT02630459|27023872|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
13482554|NCT02630459|27023865|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
13482555|NCT02630459|27023866|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
13482556|NCT02630459|27023867|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
13482557|NCT02630459|27023868|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
13482558|NCT02630459|27023869|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1|||
13482559|NCT02630459|27023870|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
13482560|NCT02630459|27023871|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
13482561|NCT02630459|27023872|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
13482562|NCT02576509|27023893|FG000|Pre-Treatment Period|Participant request to stop therapy|0|||
13482563|NCT02576509|27023894|FG001|Pre-Treatment Period|Participant request to stop therapy|2|||
13482564|NCT02576509|27023893|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
13482565|NCT02576509|27023894|FG001|Pre-Treatment Period|Participant withdrew consent|5|||
13482566|NCT02576509|27023893|FG000|Pre-Treatment Period|Participant no longer meets criteria|3|||
13482567|NCT02576509|27023894|FG001|Pre-Treatment Period|Participant no longer meets criteria|2|||
13482568|NCT02576509|27023893|FG000|Treatment Period|Disease progression|245|||
13482569|NCT02576509|27023894|FG001|Treatment Period|Disease progression|240|||
13482570|NCT02576509|27023893|FG000|Treatment Period|Study drug toxicity|32|||
13482571|NCT02576509|27023894|FG001|Treatment Period|Study drug toxicity|41|||
13482572|NCT02576509|27023893|FG000|Treatment Period|Death|1|||
13482573|NCT02576509|27023894|FG001|Treatment Period|Death|1|||
13482574|NCT02576509|27023893|FG000|Treatment Period|Adverse event unrelated to study drug|37|||
13482575|NCT02576509|27023894|FG001|Treatment Period|Adverse event unrelated to study drug|40|||
13482576|NCT02576509|27023893|FG000|Treatment Period|Participant request to stop treatment|8|||
13482577|NCT02576509|27023894|FG001|Treatment Period|Participant request to stop treatment|17|||
13482578|NCT02576509|27023893|FG000|Treatment Period|Participant withdrew consent|2|||
13482579|NCT02576509|27023894|FG001|Treatment Period|Participant withdrew consent|7|||
13482580|NCT02576509|27023893|FG000|Treatment Period|Lost to Follow-up|0|||
13482581|NCT02576509|27023894|FG001|Treatment Period|Lost to Follow-up|1|||
13482582|NCT02576509|27023893|FG000|Treatment Period|Maximum clinical benefit|1|||
13482583|NCT02576509|27023894|FG001|Treatment Period|Maximum clinical benefit|0|||
13482584|NCT02576509|27023893|FG000|Treatment Period|Poor/non-compliance|0|||
13482585|NCT02576509|27023894|FG001|Treatment Period|Poor/non-compliance|1|||
13482586|NCT02576509|27023893|FG000|Treatment Period|Participant no longer meets criteria|1|||
13482587|NCT02576509|27023894|FG001|Treatment Period|Participant no longer meets criteria|0|||
13482588|NCT02576509|27023893|FG000|Treatment Period|Other reason|2|||
13482589|NCT02576509|27023894|FG001|Treatment Period|Other reason|7|||
13482590|NCT02576509|27023893|FG000|Follow-up Period|Death|41|||
13482591|NCT02576509|27023894|FG001|Follow-up Period|Death|35|||
13482592|NCT02576509|27023893|FG000|Follow-up Period|Participant withdrew consent|7|||
13482593|NCT02576509|27023894|FG001|Follow-up Period|Participant withdrew consent|14|||
13482594|NCT02576509|27023893|FG000|Follow-up Period|Lost to Follow-up|0|||
13482595|NCT02576509|27023894|FG001|Follow-up Period|Lost to Follow-up|1|||
13482596|NCT02576509|27023893|FG000|Follow-up Period|Other reason|1|||
13482597|NCT02576509|27023894|FG001|Follow-up Period|Other reason|2|||
13482598|NCT02564900|27024105|FG000|Dose Escalation|Progressive disease per RECIST|2|||
13482599|NCT02564900|27024106|FG001|Dose Escalation|Progressive disease per RECIST|3|||
13482600|NCT02564900|27024107|FG002|Dose Escalation|Progressive disease per RECIST|3|||
13482601|NCT02564900|27024108|FG003|Dose Escalation|Progressive disease per RECIST|3|||
13482602|NCT02564900|27024109|FG004|Dose Escalation|Progressive disease per RECIST|3|||
13482603|NCT02564900|27024110|FG005|Dose Escalation|Progressive disease per RECIST|1|||
13482604|NCT02564900|27024111|FG006|Dose Escalation|Progressive disease per RECIST|0|||
13482605|NCT02564900|27024112|FG007|Dose Escalation|Progressive disease per RECIST|0|||
13482606|NCT02564900|27024113|FG008|Dose Escalation|Progressive disease per RECIST|0|||
13482607|NCT02564900|27024114|FG009|Dose Escalation|Progressive disease per RECIST|0|||
13482608|NCT02564900|27024115|FG010|Dose Escalation|Progressive disease per RECIST|0|||
13482609|NCT02564900|27024116|FG011|Dose Escalation|Progressive disease per RECIST|0|||
13482610|NCT02564900|27024117|FG012|Dose Escalation|Progressive disease per RECIST|0|||
13482611|NCT02564900|27024118|FG013|Dose Escalation|Progressive disease per RECIST|0|||
13482612|NCT02564900|27024119|FG014|Dose Escalation|Progressive disease per RECIST|0|||
13482613|NCT02564900|27024105|FG000|Dose Escalation|Ongoing|1|||
13482614|NCT02564900|27024106|FG001|Dose Escalation|Ongoing|0|||
13482615|NCT02564900|27024107|FG002|Dose Escalation|Ongoing|0|||
13482616|NCT02564900|27024108|FG003|Dose Escalation|Ongoing|2|||
13482617|NCT02564900|27024109|FG004|Dose Escalation|Ongoing|2|||
13482618|NCT02564900|27024110|FG005|Dose Escalation|Ongoing|2|||
13482619|NCT02564900|27024111|FG006|Dose Escalation|Ongoing|0|||
13482620|NCT02564900|27024112|FG007|Dose Escalation|Ongoing|0|||
13482621|NCT02564900|27024113|FG008|Dose Escalation|Ongoing|0|||
13482622|NCT02564900|27024114|FG009|Dose Escalation|Ongoing|0|||
13482623|NCT02564900|27024115|FG010|Dose Escalation|Ongoing|0|||
13482624|NCT02564900|27024116|FG011|Dose Escalation|Ongoing|0|||
13482625|NCT02564900|27024117|FG012|Dose Escalation|Ongoing|0|||
13482626|NCT02564900|27024118|FG013|Dose Escalation|Ongoing|0|||
13482627|NCT02564900|27024119|FG014|Dose Escalation|Ongoing|0|||
13482628|NCT02564900|27024105|FG000|Dose Escalation|Adverse Event|0|||
13482629|NCT02564900|27024106|FG001|Dose Escalation|Adverse Event|0|||
13482630|NCT02564900|27024107|FG002|Dose Escalation|Adverse Event|0|||
13482631|NCT02564900|27024108|FG003|Dose Escalation|Adverse Event|1|||
13482632|NCT02564900|27024109|FG004|Dose Escalation|Adverse Event|1|||
13482633|NCT02564900|27024110|FG005|Dose Escalation|Adverse Event|3|||
13482634|NCT02564900|27024111|FG006|Dose Escalation|Adverse Event|0|||
13482635|NCT02564900|27024112|FG007|Dose Escalation|Adverse Event|0|||
13482636|NCT02564900|27024113|FG008|Dose Escalation|Adverse Event|0|||
13482637|NCT02564900|27024114|FG009|Dose Escalation|Adverse Event|0|||
13482638|NCT02564900|27024115|FG010|Dose Escalation|Adverse Event|0|||
13482639|NCT02564900|27024116|FG011|Dose Escalation|Adverse Event|0|||
13482640|NCT02564900|27024117|FG012|Dose Escalation|Adverse Event|0|||
13482641|NCT02564900|27024118|FG013|Dose Escalation|Adverse Event|0|||
13482642|NCT02564900|27024119|FG014|Dose Escalation|Adverse Event|0|||
13482643|NCT02564900|27024105|FG000|Dose Expansion|Progressive disease per RECIST|0|||
13482644|NCT02564900|27024106|FG001|Dose Expansion|Progressive disease per RECIST|0|||
13482645|NCT02564900|27024107|FG002|Dose Expansion|Progressive disease per RECIST|0|||
13482646|NCT02564900|27024108|FG003|Dose Expansion|Progressive disease per RECIST|0|||
13482647|NCT02564900|27024109|FG004|Dose Expansion|Progressive disease per RECIST|0|||
13482648|NCT02564900|27024110|FG005|Dose Expansion|Progressive disease per RECIST|0|||
13482649|NCT02564900|27024111|FG006|Dose Expansion|Progressive disease per RECIST|19|||
13482650|NCT02564900|27024112|FG007|Dose Expansion|Progressive disease per RECIST|17|||
13482651|NCT02564900|27024113|FG008|Dose Expansion|Progressive disease per RECIST|8|||
13482652|NCT02564900|27024114|FG009|Dose Expansion|Progressive disease per RECIST|16|||
13482653|NCT02564900|27024115|FG010|Dose Expansion|Progressive disease per RECIST|13|||
13482654|NCT02564900|27024116|FG011|Dose Expansion|Progressive disease per RECIST|19|||
13482655|NCT02564900|27024117|FG012|Dose Expansion|Progressive disease per RECIST|10|||
13482656|NCT02564900|27024118|FG013|Dose Expansion|Progressive disease per RECIST|13|||
13482657|NCT02564900|27024119|FG014|Dose Expansion|Progressive disease per RECIST|11|||
13482658|NCT02564900|27024105|FG000|Dose Expansion|Clinical progression|0|||
13482659|NCT02564900|27024106|FG001|Dose Expansion|Clinical progression|0|||
13482660|NCT02564900|27024107|FG002|Dose Expansion|Clinical progression|0|||
13482661|NCT02564900|27024108|FG003|Dose Expansion|Clinical progression|0|||
13482662|NCT02564900|27024109|FG004|Dose Expansion|Clinical progression|0|||
13482663|NCT02564900|27024110|FG005|Dose Expansion|Clinical progression|0|||
13482664|NCT02564900|27024111|FG006|Dose Expansion|Clinical progression|5|||
13482665|NCT02564900|27024112|FG007|Dose Expansion|Clinical progression|12|||
13482666|NCT02564900|27024113|FG008|Dose Expansion|Clinical progression|0|||
13482667|NCT02564900|27024114|FG009|Dose Expansion|Clinical progression|3|||
13482668|NCT02564900|27024115|FG010|Dose Expansion|Clinical progression|2|||
13482669|NCT02564900|27024116|FG011|Dose Expansion|Clinical progression|0|||
13482670|NCT02564900|27024117|FG012|Dose Expansion|Clinical progression|1|||
13482671|NCT02564900|27024118|FG013|Dose Expansion|Clinical progression|3|||
13482672|NCT02564900|27024119|FG014|Dose Expansion|Clinical progression|1|||
13482673|NCT02564900|27024105|FG000|Dose Expansion|Adverse Event|0|||
13482674|NCT02564900|27024106|FG001|Dose Expansion|Adverse Event|0|||
13482675|NCT02564900|27024107|FG002|Dose Expansion|Adverse Event|0|||
13482676|NCT02564900|27024108|FG003|Dose Expansion|Adverse Event|0|||
13482677|NCT02564900|27024109|FG004|Dose Expansion|Adverse Event|0|||
13482678|NCT02564900|27024110|FG005|Dose Expansion|Adverse Event|0|||
13482679|NCT02564900|27024111|FG006|Dose Expansion|Adverse Event|9|||
13482680|NCT02564900|27024112|FG007|Dose Expansion|Adverse Event|22|||
13482681|NCT02564900|27024113|FG008|Dose Expansion|Adverse Event|0|||
13482682|NCT02564900|27024114|FG009|Dose Expansion|Adverse Event|11|||
13482683|NCT02564900|27024115|FG010|Dose Expansion|Adverse Event|0|||
13482684|NCT02564900|27024116|FG011|Dose Expansion|Adverse Event|5|||
13482685|NCT02564900|27024117|FG012|Dose Expansion|Adverse Event|2|||
13482686|NCT02564900|27024118|FG013|Dose Expansion|Adverse Event|2|||
13482687|NCT02564900|27024119|FG014|Dose Expansion|Adverse Event|1|||
13482688|NCT02564900|27024105|FG000|Dose Expansion|Ongoing|0|||
13482689|NCT02564900|27024106|FG001|Dose Expansion|Ongoing|0|||
13482690|NCT02564900|27024107|FG002|Dose Expansion|Ongoing|0|||
13482691|NCT02564900|27024108|FG003|Dose Expansion|Ongoing|0|||
13482692|NCT02564900|27024109|FG004|Dose Expansion|Ongoing|0|||
13482693|NCT02564900|27024110|FG005|Dose Expansion|Ongoing|0|||
13482694|NCT02564900|27024111|FG006|Dose Expansion|Ongoing|9|||
13482695|NCT02564900|27024112|FG007|Dose Expansion|Ongoing|10|||
13482696|NCT02564900|27024113|FG008|Dose Expansion|Ongoing|11|||
13482697|NCT02564900|27024114|FG009|Dose Expansion|Ongoing|3|||
13482698|NCT02564900|27024115|FG010|Dose Expansion|Ongoing|0|||
13482699|NCT02564900|27024116|FG011|Dose Expansion|Ongoing|0|||
13482700|NCT02564900|27024117|FG012|Dose Expansion|Ongoing|4|||
13482701|NCT02564900|27024118|FG013|Dose Expansion|Ongoing|0|||
13482702|NCT02564900|27024119|FG014|Dose Expansion|Ongoing|6|||
13482703|NCT02564900|27024105|FG000|Dose Expansion|Death|0|||
13482704|NCT02564900|27024106|FG001|Dose Expansion|Death|0|||
13482705|NCT02564900|27024107|FG002|Dose Expansion|Death|0|||
13482706|NCT02564900|27024108|FG003|Dose Expansion|Death|0|||
13482707|NCT02564900|27024109|FG004|Dose Expansion|Death|0|||
13482708|NCT02564900|27024110|FG005|Dose Expansion|Death|0|||
13482709|NCT02564900|27024111|FG006|Dose Expansion|Death|1|||
13482710|NCT02564900|27024112|FG007|Dose Expansion|Death|0|||
13482711|NCT02564900|27024113|FG008|Dose Expansion|Death|0|||
13482712|NCT02564900|27024114|FG009|Dose Expansion|Death|0|||
13482713|NCT02564900|27024115|FG010|Dose Expansion|Death|1|||
13482714|NCT02564900|27024116|FG011|Dose Expansion|Death|0|||
13482715|NCT02564900|27024117|FG012|Dose Expansion|Death|1|||
13482716|NCT02564900|27024118|FG013|Dose Expansion|Death|1|||
13482717|NCT02564900|27024119|FG014|Dose Expansion|Death|0|||
13482718|NCT02564900|27024105|FG000|Dose Expansion|Withdrawal by Subject|0|||
13482719|NCT02564900|27024106|FG001|Dose Expansion|Withdrawal by Subject|0|||
13482720|NCT02564900|27024107|FG002|Dose Expansion|Withdrawal by Subject|0|||
13482721|NCT02564900|27024108|FG003|Dose Expansion|Withdrawal by Subject|0|||
13482722|NCT02564900|27024109|FG004|Dose Expansion|Withdrawal by Subject|0|||
13482723|NCT02564900|27024110|FG005|Dose Expansion|Withdrawal by Subject|0|||
13482724|NCT02564900|27024111|FG006|Dose Expansion|Withdrawal by Subject|4|||
13482725|NCT02564900|27024112|FG007|Dose Expansion|Withdrawal by Subject|0|||
13482726|NCT02564900|27024113|FG008|Dose Expansion|Withdrawal by Subject|0|||
13482727|NCT02564900|27024114|FG009|Dose Expansion|Withdrawal by Subject|0|||
13482728|NCT02564900|27024115|FG010|Dose Expansion|Withdrawal by Subject|1|||
13482729|NCT02564900|27024116|FG011|Dose Expansion|Withdrawal by Subject|0|||
13482730|NCT02564900|27024117|FG012|Dose Expansion|Withdrawal by Subject|0|||
13482731|NCT02564900|27024118|FG013|Dose Expansion|Withdrawal by Subject|1|||
13482732|NCT02564900|27024119|FG014|Dose Expansion|Withdrawal by Subject|1|||
13482733|NCT02564900|27024105|FG000|Dose Expansion|Other|0|||
13482734|NCT02564900|27024106|FG001|Dose Expansion|Other|0|||
13482735|NCT02564900|27024107|FG002|Dose Expansion|Other|0|||
13482736|NCT02564900|27024108|FG003|Dose Expansion|Other|0|||
13482737|NCT02564900|27024109|FG004|Dose Expansion|Other|0|||
13482738|NCT02564900|27024110|FG005|Dose Expansion|Other|0|||
13482739|NCT02564900|27024111|FG006|Dose Expansion|Other|1|||
13482740|NCT02564900|27024112|FG007|Dose Expansion|Other|0|||
13482741|NCT02564900|27024113|FG008|Dose Expansion|Other|1|||
13482742|NCT02564900|27024114|FG009|Dose Expansion|Other|0|||
13482743|NCT02564900|27024115|FG010|Dose Expansion|Other|0|||
13482744|NCT02564900|27024116|FG011|Dose Expansion|Other|0|||
13482745|NCT02564900|27024117|FG012|Dose Expansion|Other|0|||
13482746|NCT02564900|27024118|FG013|Dose Expansion|Other|0|||
13482747|NCT02564900|27024119|FG014|Dose Expansion|Other|1|||
13482748|NCT02564900|27024105|FG000|Dose Expansion|Did not receive treatment|0|||
13482749|NCT02564900|27024106|FG001|Dose Expansion|Did not receive treatment|0|||
13482750|NCT02564900|27024107|FG002|Dose Expansion|Did not receive treatment|0|||
13482751|NCT02564900|27024108|FG003|Dose Expansion|Did not receive treatment|0|||
13482752|NCT02564900|27024109|FG004|Dose Expansion|Did not receive treatment|0|||
13482753|NCT02564900|27024110|FG005|Dose Expansion|Did not receive treatment|0|||
13482754|NCT02564900|27024111|FG006|Dose Expansion|Did not receive treatment|1|||
13482755|NCT02564900|27024112|FG007|Dose Expansion|Did not receive treatment|1|||
13482756|NCT02564900|27024113|FG008|Dose Expansion|Did not receive treatment|0|||
13482757|NCT02564900|27024114|FG009|Dose Expansion|Did not receive treatment|0|||
13482758|NCT02564900|27024115|FG010|Dose Expansion|Did not receive treatment|0|||
13482759|NCT02564900|27024116|FG011|Dose Expansion|Did not receive treatment|0|||
13482760|NCT02564900|27024117|FG012|Dose Expansion|Did not receive treatment|0|||
13482761|NCT02564900|27024118|FG013|Dose Expansion|Did not receive treatment|0|||
13482762|NCT02564900|27024119|FG014|Dose Expansion|Did not receive treatment|1|||
13482763|NCT02525939|27024158|FG000|Overall Study|Lost to Follow-up|27|||
13482764|NCT02525939|27024159|FG001|Overall Study|Lost to Follow-up|24|||
13482765|NCT02525939|27024158|FG000|Overall Study|Physician Decision|0|||
13482766|NCT02525939|27024159|FG001|Overall Study|Physician Decision|1|||
13482767|NCT02525939|27024158|FG000|Overall Study|Withdrawal by Subject|24|||
13482768|NCT02525939|27024159|FG001|Overall Study|Withdrawal by Subject|39|||
13482769|NCT02525939|27024158|FG000|Overall Study|Death|180|||
13482770|NCT02525939|27024159|FG001|Overall Study|Death|179|||
13482771|NCT02419742|27024178|FG000|Overall Study|Adverse Event|2|||
13482772|NCT02419742|27024179|FG001|Overall Study|Adverse Event|0|||
13482773|NCT02419742|27024178|FG000|Overall Study|Disease Progression|0|||
13482774|NCT02419742|27024179|FG001|Overall Study|Disease Progression|1|||
13482775|NCT02419742|27024178|FG000|Overall Study|Withdrew Consent|2|||
13482776|NCT02419742|27024179|FG001|Overall Study|Withdrew Consent|1|||
13482777|NCT02419742|27024178|FG000|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|1|||
13482778|NCT02419742|27024179|FG001|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|0|||
13482779|NCT02410629|27024198|FG000|Overall Study|Family cannot commit to the study|2|||
13482780|NCT02410629|27024199|FG001|Overall Study|Family cannot commit to the study|1|||
13482781|NCT02410629|27024198|FG000|Overall Study|Subject returned to work|1|||
13482782|NCT02410629|27024199|FG001|Overall Study|Subject returned to work|0|||
13482783|NCT02410629|27024198|FG000|Overall Study|Subject moved back to home country|0|||
13482784|NCT02410629|27024199|FG001|Overall Study|Subject moved back to home country|1|||
13482785|NCT02410629|27024198|FG000|Overall Study|Subject underwent heart surgery|0|||
13482786|NCT02410629|27024199|FG001|Overall Study|Subject underwent heart surgery|1|||
13482787|NCT02252211|27024264|FG000|Overall Study|Adverse Event|0|||
13482788|NCT02252211|27024265|FG001|Overall Study|Adverse Event|1|||
13482789|NCT02252211|27024266|FG002|Overall Study|Adverse Event|0|||
13482790|NCT02252211|27024264|FG000|Overall Study|Progressive disease|3|||
13482791|NCT02252211|27024265|FG001|Overall Study|Progressive disease|2|||
13482792|NCT02252211|27024266|FG002|Overall Study|Progressive disease|0|||
13482793|NCT02252211|27024264|FG000|Overall Study|Withdrawal by Subject|1|||
13482794|NCT02252211|27024265|FG001|Overall Study|Withdrawal by Subject|0|||
13482795|NCT02252211|27024266|FG002|Overall Study|Withdrawal by Subject|0|||
13482796|NCT02252211|27024264|FG000|Overall Study|Serious Adverse Event During Screening|1|||
13482797|NCT02252211|27024265|FG001|Overall Study|Serious Adverse Event During Screening|0|||
13482798|NCT02252211|27024266|FG002|Overall Study|Serious Adverse Event During Screening|1|||
13482799|NCT02174861|27024280|FG000|Overall Study|Decision by sponsor|8|||
13482800|NCT02174861|27024280|FG000|Overall Study|Withdrawal by Subject|124|||
13482801|NCT02174861|27024280|FG000|Overall Study|Lost to Follow-up|26|||
13482802|NCT02066415|27024353|FG000|Overall Study|Decision by Sponsor|5|||
13482803|NCT02066415|27024354|FG001|Overall Study|Decision by Sponsor|4|||
13482804|NCT02066415|27024355|FG002|Overall Study|Decision by Sponsor|2|||
13482805|NCT02066415|27024353|FG000|Overall Study|Withdrawal by Subject|9|||
13482806|NCT02066415|27024354|FG001|Overall Study|Withdrawal by Subject|1|||
13482807|NCT02066415|27024355|FG002|Overall Study|Withdrawal by Subject|4|||
13482808|NCT02066415|27024353|FG000|Overall Study|Lost to Follow-up|7|||
13482809|NCT02066415|27024354|FG001|Overall Study|Lost to Follow-up|2|||
13482810|NCT02066415|27024355|FG002|Overall Study|Lost to Follow-up|2|||
13482811|NCT01981551|27024364|FG000|Overall Study|Refused further treatment|8|||
13482812|NCT01981551|27024364|FG000|Overall Study|Adverse Event|1|||
13487551|NCT04600076|27040131|FG000|Overall Study|Lost to Follow-up|3|||
13487552|NCT04375397|27040166|FG000|Overall Study|Death|1|||
13487553|NCT04375397|27040167|FG001|Overall Study|Death|1|||
13487554|NCT04375397|27040166|FG000|Overall Study|Withdrew consent|2|||
13487555|NCT04375397|27040167|FG001|Overall Study|Withdrew consent|0|||
13487556|NCT04375397|27040166|FG000|Overall Study|Lost to Follow-up|6|||
13487557|NCT04375397|27040167|FG001|Overall Study|Lost to Follow-up|4|||
13487558|NCT04375397|27040166|FG000|Overall Study|Other, not specified|0|||
13487559|NCT04375397|27040167|FG001|Overall Study|Other, not specified|1|||
13487560|NCT04075734|27040258|FG000|Overall Study|Lost to Follow-up|1|||
13487561|NCT04075734|27040259|FG001|Overall Study|Lost to Follow-up|1|||
13487562|NCT04075734|27040260|FG002|Overall Study|Lost to Follow-up|0|||
13487563|NCT04075734|27040258|FG000|Overall Study|Withdrawal by Subject|3|||
13487564|NCT04075734|27040259|FG001|Overall Study|Withdrawal by Subject|0|||
13487565|NCT04075734|27040260|FG002|Overall Study|Withdrawal by Subject|0|||
13487566|NCT03915470|27040293|FG000|Overall Study|Death|3|||
13487567|NCT03915470|27040294|FG001|Overall Study|Death|1|||
13487568|NCT03915470|27040293|FG000|Overall Study|Adverse Event|1|||
13487569|NCT03915470|27040294|FG001|Overall Study|Adverse Event|0|||
13487570|NCT03915470|27040293|FG000|Overall Study|Physician Decision|1|||
13487571|NCT03915470|27040294|FG001|Overall Study|Physician Decision|0|||
13487572|NCT03915470|27040293|FG000|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
13482813|NCT01975831|27024457|FG000|Overall Study|Adverse Event|1|||
13482814|NCT01975831|27024458|FG001|Overall Study|Adverse Event|2|||
13482815|NCT01975831|27024459|FG002|Overall Study|Adverse Event|2|||
13482816|NCT01975831|27024460|FG003|Overall Study|Adverse Event|0|||
13482817|NCT01975831|27024461|FG004|Overall Study|Adverse Event|1|||
13482818|NCT01975831|27024462|FG005|Overall Study|Adverse Event|1|||
13482819|NCT01975831|27024463|FG006|Overall Study|Adverse Event|3|||
13482820|NCT01975831|27024464|FG007|Overall Study|Adverse Event|4|||
13482821|NCT01975831|27024465|FG008|Overall Study|Adverse Event|1|||
13482822|NCT01975831|27024457|FG000|Overall Study|Death|1|||
13482823|NCT01975831|27024458|FG001|Overall Study|Death|1|||
13482824|NCT01975831|27024459|FG002|Overall Study|Death|0|||
13482825|NCT01975831|27024460|FG003|Overall Study|Death|0|||
13482826|NCT01975831|27024461|FG004|Overall Study|Death|1|||
13482827|NCT01975831|27024462|FG005|Overall Study|Death|0|||
13482828|NCT01975831|27024463|FG006|Overall Study|Death|1|||
13482829|NCT01975831|27024464|FG007|Overall Study|Death|0|||
13482830|NCT01975831|27024465|FG008|Overall Study|Death|0|||
13482831|NCT01975831|27024457|FG000|Overall Study|Progressive Disease|1|||
13482832|NCT01975831|27024458|FG001|Overall Study|Progressive Disease|3|||
13482833|NCT01975831|27024459|FG002|Overall Study|Progressive Disease|2|||
13482834|NCT01975831|27024460|FG003|Overall Study|Progressive Disease|4|||
13482835|NCT01975831|27024461|FG004|Overall Study|Progressive Disease|13|||
13482836|NCT01975831|27024462|FG005|Overall Study|Progressive Disease|9|||
13482837|NCT01975831|27024463|FG006|Overall Study|Progressive Disease|10|||
13482838|NCT01975831|27024464|FG007|Overall Study|Progressive Disease|8|||
13482839|NCT01975831|27024465|FG008|Overall Study|Progressive Disease|10|||
13482840|NCT01975831|27024457|FG000|Overall Study|Withdrawal by Subject|0|||
13482841|NCT01975831|27024458|FG001|Overall Study|Withdrawal by Subject|3|||
13482842|NCT01975831|27024459|FG002|Overall Study|Withdrawal by Subject|0|||
13482843|NCT01975831|27024460|FG003|Overall Study|Withdrawal by Subject|0|||
13482844|NCT01975831|27024461|FG004|Overall Study|Withdrawal by Subject|3|||
13482845|NCT01975831|27024462|FG005|Overall Study|Withdrawal by Subject|1|||
13482846|NCT01975831|27024463|FG006|Overall Study|Withdrawal by Subject|1|||
13482847|NCT01975831|27024464|FG007|Overall Study|Withdrawal by Subject|0|||
13482848|NCT01975831|27024465|FG008|Overall Study|Withdrawal by Subject|0|||
13482849|NCT01975831|27024457|FG000|Overall Study|Physician Decision|0|||
13482850|NCT01975831|27024458|FG001|Overall Study|Physician Decision|0|||
13482851|NCT01975831|27024459|FG002|Overall Study|Physician Decision|0|||
13482852|NCT01975831|27024460|FG003|Overall Study|Physician Decision|0|||
13482853|NCT01975831|27024461|FG004|Overall Study|Physician Decision|0|||
13482854|NCT01975831|27024462|FG005|Overall Study|Physician Decision|1|||
13482855|NCT01975831|27024463|FG006|Overall Study|Physician Decision|0|||
13482856|NCT01975831|27024464|FG007|Overall Study|Physician Decision|1|||
13482857|NCT01975831|27024465|FG008|Overall Study|Physician Decision|0|||
13482858|NCT01975831|27024457|FG000|Overall Study|Initiation of Subsequent Therapy|0|||
13482859|NCT01975831|27024458|FG001|Overall Study|Initiation of Subsequent Therapy|0|||
13482860|NCT01975831|27024459|FG002|Overall Study|Initiation of Subsequent Therapy|0|||
13482861|NCT01975831|27024460|FG003|Overall Study|Initiation of Subsequent Therapy|0|||
13482862|NCT01975831|27024461|FG004|Overall Study|Initiation of Subsequent Therapy|0|||
13482863|NCT01975831|27024462|FG005|Overall Study|Initiation of Subsequent Therapy|1|||
13482864|NCT01975831|27024463|FG006|Overall Study|Initiation of Subsequent Therapy|0|||
13482865|NCT01975831|27024464|FG007|Overall Study|Initiation of Subsequent Therapy|2|||
13482866|NCT01975831|27024465|FG008|Overall Study|Initiation of Subsequent Therapy|0|||
13482867|NCT01975831|27024457|FG000|Overall Study|Entered Hospice|0|||
13482868|NCT01975831|27024458|FG001|Overall Study|Entered Hospice|0|||
13482869|NCT01975831|27024459|FG002|Overall Study|Entered Hospice|0|||
13482870|NCT01975831|27024460|FG003|Overall Study|Entered Hospice|0|||
13482871|NCT01975831|27024461|FG004|Overall Study|Entered Hospice|0|||
13482872|NCT01975831|27024462|FG005|Overall Study|Entered Hospice|1|||
13482873|NCT01975831|27024463|FG006|Overall Study|Entered Hospice|0|||
13482874|NCT01975831|27024464|FG007|Overall Study|Entered Hospice|0|||
13482875|NCT01975831|27024465|FG008|Overall Study|Entered Hospice|0|||
13482876|NCT01975831|27024457|FG000|Overall Study|Unable to Treat Within Protocol Windows|0|||
13482877|NCT01975831|27024458|FG001|Overall Study|Unable to Treat Within Protocol Windows|0|||
13482878|NCT01975831|27024459|FG002|Overall Study|Unable to Treat Within Protocol Windows|0|||
13482879|NCT01975831|27024460|FG003|Overall Study|Unable to Treat Within Protocol Windows|0|||
13482880|NCT01975831|27024461|FG004|Overall Study|Unable to Treat Within Protocol Windows|0|||
13482881|NCT01975831|27024462|FG005|Overall Study|Unable to Treat Within Protocol Windows|0|||
13482882|NCT01975831|27024463|FG006|Overall Study|Unable to Treat Within Protocol Windows|1|||
13482883|NCT01975831|27024464|FG007|Overall Study|Unable to Treat Within Protocol Windows|0|||
13482884|NCT01975831|27024465|FG008|Overall Study|Unable to Treat Within Protocol Windows|1|||
13482885|NCT01952574|27024524|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9|||
13482886|NCT01952574|27024525|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3|||
13482887|NCT01952574|27024526|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3|||
13482888|NCT01952574|27024527|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4|||
13482889|NCT01952574|27024528|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
13482890|NCT01952574|27024529|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0|||
13482891|NCT01952574|27024530|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0|||
13482892|NCT01952574|27024524|FG000|Double-blind Treatment Phase|Sponsor Decision|6|||
13482893|NCT01952574|27024525|FG001|Double-blind Treatment Phase|Sponsor Decision|0|||
13482894|NCT01952574|27024526|FG002|Double-blind Treatment Phase|Sponsor Decision|5|||
13482895|NCT01952574|27024527|FG003|Double-blind Treatment Phase|Sponsor Decision|2|||
13482896|NCT01952574|27024528|FG004|Double-blind Treatment Phase|Sponsor Decision|0|||
13482897|NCT01952574|27024529|FG005|Double-blind Treatment Phase|Sponsor Decision|0|||
13482898|NCT01952574|27024530|FG006|Double-blind Treatment Phase|Sponsor Decision|0|||
13482899|NCT01952574|27024524|FG000|Double-blind Treatment Phase|Lost to Follow-up|2|||
13482900|NCT01952574|27024525|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
13482901|NCT01952574|27024526|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
13482902|NCT01952574|27024527|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
13482903|NCT01952574|27024528|FG004|Double-blind Treatment Phase|Lost to Follow-up|0|||
13482904|NCT01952574|27024529|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
13482905|NCT01952574|27024530|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
13482906|NCT01952574|27024524|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
13482907|NCT01952574|27024525|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
13482908|NCT01952574|27024526|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
13482909|NCT01952574|27024527|FG003|Open-label Treatment Phase|Withdrawal by Subject|0|||
13482910|NCT01952574|27024528|FG004|Open-label Treatment Phase|Withdrawal by Subject|121|||
13482911|NCT01952574|27024529|FG005|Open-label Treatment Phase|Withdrawal by Subject|0|||
13482912|NCT01952574|27024530|FG006|Open-label Treatment Phase|Withdrawal by Subject|0|||
13482913|NCT01952574|27024524|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
13482914|NCT01952574|27024525|FG001|Open-label Treatment Phase|Decision by Sponsor|0|||
13482915|NCT01952574|27024526|FG002|Open-label Treatment Phase|Decision by Sponsor|0|||
13482916|NCT01952574|27024527|FG003|Open-label Treatment Phase|Decision by Sponsor|0|||
13482917|NCT01952574|27024528|FG004|Open-label Treatment Phase|Decision by Sponsor|17|||
13482918|NCT01952574|27024529|FG005|Open-label Treatment Phase|Decision by Sponsor|0|||
13482919|NCT01952574|27024530|FG006|Open-label Treatment Phase|Decision by Sponsor|0|||
13482920|NCT01952574|27024524|FG000|Open-label Treatment Phase|Missing|0|||
13482921|NCT01952574|27024525|FG001|Open-label Treatment Phase|Missing|0|||
13482922|NCT01952574|27024526|FG002|Open-label Treatment Phase|Missing|0|||
13482923|NCT01952574|27024527|FG003|Open-label Treatment Phase|Missing|0|||
13482924|NCT01952574|27024528|FG004|Open-label Treatment Phase|Missing|4|||
13482925|NCT01952574|27024529|FG005|Open-label Treatment Phase|Missing|0|||
13482926|NCT01952574|27024530|FG006|Open-label Treatment Phase|Missing|0|||
13482927|NCT01952574|27024524|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
13482928|NCT01952574|27024525|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
13482929|NCT01952574|27024526|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
13482930|NCT01952574|27024527|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
13482931|NCT01952574|27024528|FG004|Open-label Treatment Phase|Lost to Follow-up|19|||
13482932|NCT01952574|27024529|FG005|Open-label Treatment Phase|Lost to Follow-up|0|||
13482933|NCT01952574|27024530|FG006|Open-label Treatment Phase|Lost to Follow-up|0|||
13482934|NCT01952574|27024524|FG000|Open-label Treatment Phase|Death|0|||
13482935|NCT01952574|27024525|FG001|Open-label Treatment Phase|Death|0|||
13482936|NCT01952574|27024526|FG002|Open-label Treatment Phase|Death|0|||
13482937|NCT01952574|27024527|FG003|Open-label Treatment Phase|Death|0|||
13482938|NCT01952574|27024528|FG004|Open-label Treatment Phase|Death|1|||
13482939|NCT01952574|27024529|FG005|Open-label Treatment Phase|Death|0|||
13482940|NCT01952574|27024530|FG006|Open-label Treatment Phase|Death|0|||
13482941|NCT01952574|27024524|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0|||
13482942|NCT01952574|27024525|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0|||
13482943|NCT01952574|27024526|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0|||
13482944|NCT01952574|27024527|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0|||
13482945|NCT01952574|27024528|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0|||
13482946|NCT01952574|27024529|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1|||
13482947|NCT01952574|27024530|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0|||
13482948|NCT01952574|27024524|FG000|Clinical Home Use Substudy|Decision by Sponsor|0|||
13482949|NCT01952574|27024525|FG001|Clinical Home Use Substudy|Decision by Sponsor|0|||
13482950|NCT01952574|27024526|FG002|Clinical Home Use Substudy|Decision by Sponsor|0|||
13482951|NCT01952574|27024527|FG003|Clinical Home Use Substudy|Decision by Sponsor|0|||
13482952|NCT01952574|27024528|FG004|Clinical Home Use Substudy|Decision by Sponsor|0|||
13482953|NCT01952574|27024529|FG005|Clinical Home Use Substudy|Decision by Sponsor|2|||
13482954|NCT01952574|27024530|FG006|Clinical Home Use Substudy|Decision by Sponsor|1|||
13482955|NCT01810016|27024551|FG000|Overall Study|Progressive disease|1|||
13482956|NCT01810016|27024552|FG001|Overall Study|Progressive disease|1|||
13482957|NCT01810016|27024553|FG002|Overall Study|Progressive disease|0|||
13482958|NCT01810016|27024551|FG000|Overall Study|Death|0|||
13482959|NCT01810016|27024552|FG001|Overall Study|Death|0|||
13482960|NCT01810016|27024553|FG002|Overall Study|Death|1|||
13482961|NCT01722266|27024606|FG000|Overall Study|Withdrawal by Subject|1|||
13482962|NCT01722266|27024607|FG001|Overall Study|Withdrawal by Subject|2|||
13482963|NCT01722266|27024608|FG002|Overall Study|Withdrawal by Subject|0|||
13482964|NCT01722266|27024609|FG003|Overall Study|Withdrawal by Subject|0|||
13482965|NCT01722266|27024606|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
13482966|NCT01722266|27024607|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1|||
13482967|NCT01722266|27024608|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3|||
13482968|NCT01722266|27024609|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
13482969|NCT01722266|27024606|FG000|Overall Study|Dropped out due to Nausea|0|||
13482970|NCT01722266|27024607|FG001|Overall Study|Dropped out due to Nausea|0|||
13482971|NCT01722266|27024608|FG002|Overall Study|Dropped out due to Nausea|2|||
13482972|NCT01722266|27024609|FG003|Overall Study|Dropped out due to Nausea|0|||
13482973|NCT01468454|27024616|FG000|Overall Study|Did not have surgery after PET|9|||
13482974|NCT01464593|27024625|FG000|Overall Study|Study terminated early due to lack of enrollment|1|||
13482975|NCT01365182|27024696|FG000|Overall Study|Withdrawal by Subject|10|||
13482976|NCT01365182|27024697|FG001|Overall Study|Withdrawal by Subject|13|||
13482977|NCT01365182|27024698|FG002|Overall Study|Withdrawal by Subject|12|||
13482978|NCT01361711|27024704|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1|||
13482979|NCT01361711|27024704|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1|||
13482980|NCT01361711|27024704|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7|||
13482981|NCT01361711|27024704|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2|||
13482982|NCT01361711|27024704|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1|||
13482983|NCT01361711|27024704|FG000|Completed Week 18 of Treatment|Complete Remission|2|||
13482984|NCT01361711|27024704|FG000|Completed Week 18 of Treatment|Other|9|||
13482985|NCT01361711|27024704|FG000|10 Year Follow-up|Still in follow-up|22|||
13482986|NCT01361711|27024704|FG000|10 Year Follow-up|Death|7|||
13482987|NCT01361711|27024704|FG000|10 Year Follow-up|Developed new cancer|1|||
13482988|NCT01361711|27024704|FG000|10 Year Follow-up|Lost to Follow-up|2|||
13482989|NCT01361711|27024704|FG000|10 Year Follow-up|New treatment started|6|||
13482990|NCT01361711|27024704|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11|||
13482991|NCT01361711|27024704|FG000|10 Year Follow-up|Progressive Disease|1|||
13482992|NCT01081951|27024815|FG000|Overall Study|Death|54|||
13482993|NCT01081951|27024816|FG001|Overall Study|Death|47|||
13482994|NCT01081951|27024815|FG000|Overall Study|Withdrawal by Subject|2|||
13482995|NCT01081951|27024816|FG001|Overall Study|Withdrawal by Subject|6|||
13482996|NCT01081951|27024815|FG000|Overall Study|Allocated treatment but did not take it|0|||
13482997|NCT01081951|27024816|FG001|Overall Study|Allocated treatment but did not take it|1|||
13482998|NCT01081951|27024815|FG000|Overall Study|Lost to Follow-up|0|||
13482999|NCT01081951|27024816|FG001|Overall Study|Lost to Follow-up|1|||
13483000|NCT00972309|27024838|FG000|Overall Study|Switched to alternative treatment|0|||
13483001|NCT00972309|27024839|FG001|Overall Study|Switched to alternative treatment|2|||
13483002|NCT00972309|27024838|FG000|Overall Study|Refused further treatment|0|||
13483003|NCT00972309|27024839|FG001|Overall Study|Refused further treatment|1|||
13483004|NCT00972309|27024838|FG000|Overall Study|Late determination of ineligibility|0|||
13483005|NCT00972309|27024839|FG001|Overall Study|Late determination of ineligibility|1|||
13483006|NCT00972309|27024838|FG000|Overall Study|Second malignancy|1|||
13483007|NCT00972309|27024839|FG001|Overall Study|Second malignancy|1|||
13483008|NCT00972309|27024838|FG000|Overall Study|Visa issues|0|||
13483009|NCT00972309|27024839|FG001|Overall Study|Visa issues|1|||
13483010|NCT00972309|27024838|FG000|Overall Study|Secondary cancer (SCC)|0|||
13483011|NCT00972309|27024839|FG001|Overall Study|Secondary cancer (SCC)|1|||
13483012|NCT00972309|27024838|FG000|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|0|||
13483013|NCT00972309|27024839|FG001|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|1|||
13483014|NCT00972309|27024838|FG000|Overall Study|Lost to Follow-up|1|||
13483015|NCT00972309|27024839|FG001|Overall Study|Lost to Follow-up|1|||
13483016|NCT00972309|27024838|FG000|Overall Study|Disease progression on study|10|||
13483017|NCT00972309|27024839|FG001|Overall Study|Disease progression on study|4|||
13483018|NCT00842348|27024856|FG000|Patients Randomised in Study 726|Did not enter Study 729|59|||
13483019|NCT00842348|27024857|FG001|Patients Randomised in Study 726|Did not enter Study 729|56|||
13483020|NCT00842348|27024856|FG000|Study 729|Disease progression/death|19|||
13483021|NCT00842348|27024857|FG001|Study 729|Disease progression/death|30|||
13483022|NCT00842348|27024856|FG000|Study 729|Adverse Event|1|||
13483023|NCT00842348|27024857|FG001|Study 729|Adverse Event|1|||
13483024|NCT00842348|27024856|FG000|Study 729|Protocol Violation|1|||
13483025|NCT00842348|27024857|FG001|Study 729|Protocol Violation|1|||
13483026|NCT00842348|27024856|FG000|Study 729|Withdrawal by Subject|2|||
13483027|NCT00842348|27024857|FG001|Study 729|Withdrawal by Subject|4|||
13483028|NCT00842348|27024856|FG000|Study 729|Due to Sponsor stopping the study|1|||
13483029|NCT00842348|27024857|FG001|Study 729|Due to Sponsor stopping the study|1|||
13483030|NCT00842348|27024856|FG000|Study 729|Due to non-availability of IP|0|||
13483031|NCT00842348|27024857|FG001|Study 729|Due to non-availability of IP|1|||
13483032|NCT00842348|27024856|FG000|Study 729|Sponsor's decision|1|||
13483033|NCT00842348|27024857|FG001|Study 729|Sponsor's decision|0|||
13483034|NCT00842348|27024856|FG000|Study 729|Surgical resection|1|||
13483035|NCT00842348|27024857|FG001|Study 729|Surgical resection|0|||
13483036|NCT00803569|27024867|FG000|Overall Study|Progressive Disease|3|||
13483037|NCT00803569|27024867|FG000|Overall Study|Noncompliance|1|||
13483038|NCT00663351|27024884|FG000|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|10|||
13483039|NCT00663351|27024885|FG001|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|19|||
13221779|NCT01811186|26284659|FG001|Overall Study|Adverse Event|38|||
13221780|NCT01811186|26284658|FG000|Overall Study|Protocol Violation|5|||
13221781|NCT01811186|26284659|FG001|Overall Study|Protocol Violation|6|||
13483040|NCT00663351|27024884|FG000|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|29|||
13483041|NCT00663351|27024885|FG001|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|10|||
13483042|NCT00663351|27024884|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|8|||
13483043|NCT00663351|27024885|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|15|||
13483044|NCT00663351|27024884|FG000|Post-Approval Study (Year 6 to Year 10)|Death|18|||
13483045|NCT00663351|27024885|FG001|Post-Approval Study (Year 6 to Year 10)|Death|7|||
13483046|NCT00663351|27024884|FG000|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|13|||
13483047|NCT00663351|27024885|FG001|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|7|||
13483048|NCT00663351|27024884|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|44|||
13483049|NCT00663351|27024885|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|32|||
13483050|NCT00616941|27024918|FG000|Overall Study|Progressive Disease|1|||
13483051|NCT00616941|27024919|FG001|Overall Study|Progressive Disease|2|||
13483052|NCT00616941|27024920|FG002|Overall Study|Progressive Disease|1|||
13483053|NCT00616941|27024918|FG000|Overall Study|Adverse Event|0|||
13483054|NCT00616941|27024919|FG001|Overall Study|Adverse Event|1|||
13483055|NCT00616941|27024920|FG002|Overall Study|Adverse Event|1|||
13483056|NCT00616941|27024918|FG000|Overall Study|Subject Non-compliance|0|||
13483057|NCT00616941|27024919|FG001|Overall Study|Subject Non-compliance|0|||
13483058|NCT00616941|27024920|FG002|Overall Study|Subject Non-compliance|1|||
13483059|NCT00616941|27024918|FG000|Overall Study|Unrelated Medical Illness/Complication|0|||
13483060|NCT00616941|27024919|FG001|Overall Study|Unrelated Medical Illness/Complication|2|||
13483061|NCT00616941|27024920|FG002|Overall Study|Unrelated Medical Illness/Complication|0|||
13483062|NCT00616941|27024918|FG000|Overall Study|Vaccination Suspended|0|||
13483063|NCT00616941|27024919|FG001|Overall Study|Vaccination Suspended|0|||
13483064|NCT00616941|27024920|FG002|Overall Study|Vaccination Suspended|3|||
13483065|NCT00564850|27024940|FG000|Overall Study|Protocol Violation|2|||
13483066|NCT00561340|27024955|FG000|Overall Study|refused to drink pediasure|6|||
13483067|NCT00561340|27024956|FG001|Overall Study|refused to drink pediasure|0|||
13483068|NCT00520533|27024974|FG000|Overall Study|Death|1|||
13483069|NCT00520533|27024974|FG000|Overall Study|Suspension of the study for safety reasons|1|||
13483070|NCT00520533|27024974|FG000|Overall Study|Withdrawal by Subject|1|||
13483071|NCT00520533|27024974|FG000|Overall Study|Physician Decision|1|||
13483072|NCT00353496|27024996|FG000|Overall Study|Adverse Event|1|||
13483073|NCT00353496|27024997|FG001|Overall Study|Adverse Event|0|||
13483074|NCT00353496|27024996|FG000|Overall Study|Protocol Violation|2|||
13483075|NCT00353496|27024997|FG001|Overall Study|Protocol Violation|2|||
13483076|NCT00353496|27024996|FG000|Overall Study|Withdrawal by Subject|3|||
13483077|NCT00353496|27024997|FG001|Overall Study|Withdrawal by Subject|4|||
13483078|NCT00353496|27024996|FG000|Overall Study|Physician Decision|6|||
13483079|NCT00353496|27024997|FG001|Overall Study|Physician Decision|9|||
13483080|NCT00353496|27024996|FG000|Overall Study|Not otherwise specified|4|||
13483081|NCT00353496|27024997|FG001|Overall Study|Not otherwise specified|2|||
13483082|NCT00140855|27025005|FG000|Overall Study|Progressive disease|2|||
13483083|NCT00112957|27025019|FG000|Overall Study|Progressive disease|18|||
13483084|NCT00112957|27025019|FG000|Overall Study|Physician Decision|1|||
13487573|NCT03915470|27040294|FG001|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
13487574|NCT03881553|27040313|FG000|Overall Study|Discharged prior to participation|1|||
13487575|NCT03881553|27040314|FG001|Overall Study|Discharged prior to participation|1|||
13487576|NCT03881553|27040315|FG002|Overall Study|Discharged prior to participation|0|||
13487577|NCT03881553|27040313|FG000|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
13487578|NCT03881553|27040314|FG001|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
13487579|NCT03881553|27040315|FG002|Overall Study|Developed infection prior to participation--excluded per protocol criteria|1|||
13488313|NCT02959918|27043333|FG013|Overall Study|Withdrawal by Subject|1|||
13488314|NCT02959918|27043320|FG000|Overall Study|Protocol Violation|0|||
13488315|NCT02959918|27043321|FG001|Overall Study|Protocol Violation|0|||
13488316|NCT02959918|27043322|FG002|Overall Study|Protocol Violation|1|||
13488317|NCT02959918|27043323|FG003|Overall Study|Protocol Violation|0|||
13488318|NCT02959918|27043324|FG004|Overall Study|Protocol Violation|0|||
13488319|NCT02959918|27043325|FG005|Overall Study|Protocol Violation|1|||
13488320|NCT02959918|27043326|FG006|Overall Study|Protocol Violation|0|||
13488321|NCT02959918|27043327|FG007|Overall Study|Protocol Violation|0|||
13488322|NCT02959918|27043328|FG008|Overall Study|Protocol Violation|2|||
13488323|NCT02959918|27043329|FG009|Overall Study|Protocol Violation|1|||
13221782|NCT01811186|26284658|FG000|Overall Study|Withdrawal by Subject|5|||
13483085|NCT02148133|27025040|FG000|Overall Study|Investigator discretion|1|||
13483086|NCT02148133|27025040|FG000|Overall Study|Lack of Efficacy|1|||
13483087|NCT02148133|27025040|FG000|Overall Study|Protocol deviation|1|||
13483088|NCT02148133|27025040|FG000|Overall Study|Protocol-defined stopping criteria|2|||
13483089|NCT02165215|27025182|FG000|Induction Phase|Adverse Event|1|||
13483090|NCT02165215|27025183|FG001|Induction Phase|Adverse Event|0|||
13483091|NCT02165215|27025184|FG002|Induction Phase|Adverse Event|0|||
13483092|NCT02165215|27025182|FG000|Induction Phase|Withdrawal by Subject|10|||
13483093|NCT02165215|27025183|FG001|Induction Phase|Withdrawal by Subject|0|||
13483094|NCT02165215|27025184|FG002|Induction Phase|Withdrawal by Subject|0|||
13483095|NCT02165215|27025182|FG000|Induction Phase|Protocol Violation|1|||
13483096|NCT02165215|27025183|FG001|Induction Phase|Protocol Violation|0|||
13483097|NCT02165215|27025184|FG002|Induction Phase|Protocol Violation|0|||
13483098|NCT02165215|27025182|FG000|Induction Phase|Physician Decision|1|||
13483099|NCT02165215|27025183|FG001|Induction Phase|Physician Decision|0|||
13483100|NCT02165215|27025184|FG002|Induction Phase|Physician Decision|0|||
13483101|NCT02165215|27025182|FG000|Induction Phase|Lack of Efficacy|2|||
13483102|NCT02165215|27025183|FG001|Induction Phase|Lack of Efficacy|0|||
13483103|NCT02165215|27025184|FG002|Induction Phase|Lack of Efficacy|0|||
13483104|NCT02165215|27025182|FG000|Induction Phase|Non-Compliance|2|||
13483105|NCT02165215|27025183|FG001|Induction Phase|Non-Compliance|0|||
13483106|NCT02165215|27025184|FG002|Induction Phase|Non-Compliance|0|||
13483107|NCT02165215|27025182|FG000|Induction Phase|Lost to Follow-up|6|||
13483108|NCT02165215|27025183|FG001|Induction Phase|Lost to Follow-up|0|||
13483109|NCT02165215|27025184|FG002|Induction Phase|Lost to Follow-up|0|||
13483110|NCT02165215|27025182|FG000|Maintenance Phase|Withdrawal by Subject|0|||
13483111|NCT02165215|27025183|FG001|Maintenance Phase|Withdrawal by Subject|7|||
13483112|NCT02165215|27025184|FG002|Maintenance Phase|Withdrawal by Subject|3|||
13483113|NCT02165215|27025182|FG000|Maintenance Phase|Multiple reasons|0|||
13483114|NCT02165215|27025183|FG001|Maintenance Phase|Multiple reasons|2|||
13483115|NCT02165215|27025184|FG002|Maintenance Phase|Multiple reasons|1|||
13483116|NCT02165215|27025182|FG000|Maintenance Phase|Lost to Follow-up|0|||
13483117|NCT02165215|27025183|FG001|Maintenance Phase|Lost to Follow-up|2|||
13483118|NCT02165215|27025184|FG002|Maintenance Phase|Lost to Follow-up|0|||
13483119|NCT02165215|27025182|FG000|Maintenance Phase|Adverse Event|0|||
13483120|NCT02165215|27025183|FG001|Maintenance Phase|Adverse Event|1|||
13483121|NCT02165215|27025184|FG002|Maintenance Phase|Adverse Event|1|||
13483122|NCT02180217|27025264|FG000|Overall Study|Adverse Event|3|||
13483123|NCT02180217|27025265|FG001|Overall Study|Adverse Event|2|||
13483124|NCT02180217|27025266|FG002|Overall Study|Adverse Event|22|||
13483125|NCT02180217|27025264|FG000|Overall Study|Death|1|||
13483126|NCT02180217|27025265|FG001|Overall Study|Death|1|||
13483127|NCT02180217|27025266|FG002|Overall Study|Death|0|||
13483128|NCT02180217|27025264|FG000|Overall Study|Withdrawal by Subject|1|||
13483129|NCT02180217|27025265|FG001|Overall Study|Withdrawal by Subject|1|||
13483130|NCT02180217|27025266|FG002|Overall Study|Withdrawal by Subject|4|||
13483131|NCT02180217|27025264|FG000|Overall Study|Subject/Guardian decision|5|||
13483132|NCT02180217|27025265|FG001|Overall Study|Subject/Guardian decision|3|||
13483133|NCT02180217|27025266|FG002|Overall Study|Subject/Guardian decision|6|||
13483134|NCT02180217|27025264|FG000|Overall Study|Physician Decision|1|||
13483135|NCT02180217|27025265|FG001|Overall Study|Physician Decision|1|||
13483136|NCT02180217|27025266|FG002|Overall Study|Physician Decision|6|||
13483137|NCT02180217|27025264|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
13483138|NCT02180217|27025265|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
13483139|NCT02180217|27025266|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
13483140|NCT02193867|27025298|FG000|Overall Study|Death|2|||
13483141|NCT02193867|27025298|FG000|Overall Study|Sponsor Study Termination|2|||
13483142|NCT02221037|27025401|FG000|Overall Study|Physician Decision|0|||
13483143|NCT02221037|27025402|FG001|Overall Study|Physician Decision|0|||
13483144|NCT02221037|27025403|FG002|Overall Study|Physician Decision|1|||
13483145|NCT02221037|27025404|FG003|Overall Study|Physician Decision|0|||
13483146|NCT02224456|27025433|FG000|Overall Study|Lack of Efficacy|1|||
13483147|NCT02224456|27025433|FG000|Overall Study|Lost to Follow-up|15|||
13483148|NCT02224456|27025433|FG000|Overall Study|Withdrawal by Subject|9|||
13483149|NCT02224456|27025433|FG000|Overall Study|Physician Decision|3|||
13483150|NCT02224456|27025433|FG000|Overall Study|Death|2|||
13483151|NCT02224456|27025433|FG000|Overall Study|Pregnancy|4|||
13483152|NCT02224456|27025433|FG000|Overall Study|Protocol Violation|1|||
13483153|NCT02224456|27025433|FG000|Overall Study|Treatment Interruptions of ≥28 days|1|||
13483154|NCT02231762|27025469|FG000|Combination Phase|Adverse Event|10|||
13483155|NCT02231762|27025470|FG001|Combination Phase|Adverse Event|0|||
13483156|NCT02231762|27025471|FG002|Combination Phase|Adverse Event|0|||
13483157|NCT02231762|27025472|FG003|Combination Phase|Adverse Event|0|||
13483158|NCT02231762|27025469|FG000|Combination Phase|Withdrawal by Subject|2|||
13483159|NCT02231762|27025470|FG001|Combination Phase|Withdrawal by Subject|0|||
13483160|NCT02231762|27025471|FG002|Combination Phase|Withdrawal by Subject|0|||
13483161|NCT02231762|27025472|FG003|Combination Phase|Withdrawal by Subject|0|||
13483162|NCT02231762|27025469|FG000|Combination Phase|Disease Progression|6|||
13483163|NCT02231762|27025470|FG001|Combination Phase|Disease Progression|0|||
13483164|NCT02231762|27025471|FG002|Combination Phase|Disease Progression|0|||
13483165|NCT02231762|27025472|FG003|Combination Phase|Disease Progression|0|||
13483166|NCT02231762|27025469|FG000|Combination Phase|Did not meet inclusion criteria|1|||
13483167|NCT02231762|27025470|FG001|Combination Phase|Did not meet inclusion criteria|0|||
13483168|NCT02231762|27025471|FG002|Combination Phase|Did not meet inclusion criteria|0|||
13483169|NCT02231762|27025472|FG003|Combination Phase|Did not meet inclusion criteria|0|||
13483170|NCT02231762|27025469|FG000|Combination Phase|Protocol Violation|1|||
13483171|NCT02231762|27025470|FG001|Combination Phase|Protocol Violation|0|||
13483172|NCT02231762|27025471|FG002|Combination Phase|Protocol Violation|0|||
13483173|NCT02231762|27025472|FG003|Combination Phase|Protocol Violation|0|||
13483174|NCT02231762|27025469|FG000|Maintenance Phase|Disease progression|0|||
13483175|NCT02231762|27025470|FG001|Maintenance Phase|Disease progression|3|||
13483176|NCT02231762|27025471|FG002|Maintenance Phase|Disease progression|4|||
13483177|NCT02231762|27025472|FG003|Maintenance Phase|Disease progression|3|||
13483178|NCT02231762|27025469|FG000|Maintenance Phase|Adverse Event|0|||
13483179|NCT02231762|27025470|FG001|Maintenance Phase|Adverse Event|0|||
13483180|NCT02231762|27025471|FG002|Maintenance Phase|Adverse Event|1|||
13483181|NCT02231762|27025472|FG003|Maintenance Phase|Adverse Event|2|||
13487580|NCT03718000|27040538|FG000|Overall Study|Relocation|2|||
13487581|NCT03718000|27040539|FG001|Overall Study|Relocation|4|||
13487582|NCT03718000|27040538|FG000|Overall Study|Pregnancy|0|||
13487583|NCT03718000|27040539|FG001|Overall Study|Pregnancy|1|||
13487584|NCT03654651|27040592|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
13487585|NCT03654651|27040593|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
13487586|NCT03633396|27040612|FG000|Overall Study|Withdrawal by Subject|4|||
13487587|NCT03633396|27040613|FG001|Overall Study|Withdrawal by Subject|4|||
13487588|NCT03633396|27040612|FG000|Overall Study|Adverse Event|1|||
13487589|NCT03633396|27040613|FG001|Overall Study|Adverse Event|1|||
13487590|NCT03633396|27040612|FG000|Overall Study|Lack of Efficacy|1|||
13487591|NCT03633396|27040613|FG001|Overall Study|Lack of Efficacy|0|||
13487592|NCT03633396|27040612|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|0|||
13487593|NCT03633396|27040613|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|1|||
13487594|NCT03612856|27040775|FG000|Pre-dose Period|Physician Decision|0|||
13487595|NCT03612856|27040776|FG001|Pre-dose Period|Physician Decision|1|||
13487596|NCT03612856|27040777|FG002|Pre-dose Period|Physician Decision|1|||
13487597|NCT03612856|27040775|FG000|Pre-dose Period|Withdrawal by Subject|0|||
13487598|NCT03612856|27040776|FG001|Pre-dose Period|Withdrawal by Subject|1|||
13487599|NCT03612856|27040777|FG002|Pre-dose Period|Withdrawal by Subject|0|||
13487600|NCT03505671|27040810|FG000|Overall Study|Withdrawal by Subject|2|||
13487601|NCT03505671|27040811|FG001|Overall Study|Withdrawal by Subject|1|||
13487602|NCT03505671|27040810|FG000|Overall Study|Lost to Follow-up|1|||
13487603|NCT03505671|27040811|FG001|Overall Study|Lost to Follow-up|0|||
13487604|NCT03469999|27040821|FG000|Overall Study|Lost to Follow-up|2|||
13487605|NCT03463993|27040858|FG000|Overall Study|Lost to Follow-up|7|||
13487606|NCT03463993|27040859|FG001|Overall Study|Lost to Follow-up|8|||
13487607|NCT03463993|27040858|FG000|Overall Study|Withdrawal by Subject|2|||
13487608|NCT03463993|27040859|FG001|Overall Study|Withdrawal by Subject|0|||
13487609|NCT03463993|27040858|FG000|Overall Study|Protocol Violation|4|||
13487610|NCT03463993|27040859|FG001|Overall Study|Protocol Violation|1|||
13487611|NCT03463993|27040858|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9|||
13487612|NCT03463993|27040859|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11|||
13487613|NCT03463993|27040858|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7|||
13487614|NCT03463993|27040859|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6|||
13487615|NCT03390101|27040877|FG000|Weeks 0-12|Withdrawal by Subject|0|||
13487616|NCT03390101|27040878|FG001|Weeks 0-12|Withdrawal by Subject|1|||
13487617|NCT03390101|27040879|FG002|Weeks 0-12|Withdrawal by Subject|1|||
13487618|NCT03390101|27040877|FG000|Weeks 0-12|Lost to Follow-up|0|||
13487619|NCT03390101|27040878|FG001|Weeks 0-12|Lost to Follow-up|1|||
13487620|NCT03390101|27040879|FG002|Weeks 0-12|Lost to Follow-up|0|||
13487621|NCT03390101|27040877|FG000|Weeks 12-54|Withdrawal by Subject|0|||
13487622|NCT03390101|27040878|FG001|Weeks 12-54|Withdrawal by Subject|3|||
13487623|NCT03390101|27040879|FG002|Weeks 12-54|Withdrawal by Subject|1|||
13487624|NCT03390101|27040877|FG000|Weeks 12-54|Pregnancy|1|||
13487625|NCT03390101|27040878|FG001|Weeks 12-54|Pregnancy|0|||
13487626|NCT03390101|27040879|FG002|Weeks 12-54|Pregnancy|0|||
13487627|NCT03390101|27040877|FG000|Weeks 12-54|Adverse Event|2|||
13487628|NCT03390101|27040878|FG001|Weeks 12-54|Adverse Event|1|||
13487629|NCT03390101|27040879|FG002|Weeks 12-54|Adverse Event|1|||
13487630|NCT03179605|27040887|FG000|Overall Study|Withdrawal by Subject|1|||
13487631|NCT03074695|27040918|FG000|Overall Study|Delivered with caesarean before request for analgesia|1|||
13487632|NCT03074695|27040919|FG001|Overall Study|Delivered with caesarean before request for analgesia|1|||
13487633|NCT03074695|27040918|FG000|Overall Study|Research staff not available|1|||
13487634|NCT03074695|27040919|FG001|Overall Study|Research staff not available|2|||
13487635|NCT03074695|27040918|FG000|Overall Study|Did not receive neuraxial block|2|||
13483182|NCT02234843|27025610|FG000|Overall Study|Death|1|||
13483183|NCT02234843|27025611|FG001|Overall Study|Death|0|||
13483184|NCT02234843|27025612|FG002|Overall Study|Death|0|||
13483185|NCT02234843|27025613|FG003|Overall Study|Death|0|||
13483186|NCT02234843|27025614|FG004|Overall Study|Death|0|||
13483187|NCT02234843|27025615|FG005|Overall Study|Death|0|||
13483188|NCT02234843|27025616|FG006|Overall Study|Death|0|||
13483189|NCT02234843|27025617|FG007|Overall Study|Death|0|||
13483190|NCT02234843|27025618|FG008|Overall Study|Death|0|||
13483191|NCT02234843|27025619|FG009|Overall Study|Death|0|||
13483192|NCT02234843|27025610|FG000|Overall Study|Protocol Violation|1|||
13483193|NCT02234843|27025611|FG001|Overall Study|Protocol Violation|0|||
13483194|NCT02234843|27025612|FG002|Overall Study|Protocol Violation|1|||
13483195|NCT02234843|27025613|FG003|Overall Study|Protocol Violation|0|||
13483196|NCT02234843|27025614|FG004|Overall Study|Protocol Violation|0|||
13483197|NCT02234843|27025615|FG005|Overall Study|Protocol Violation|0|||
13483198|NCT02234843|27025616|FG006|Overall Study|Protocol Violation|0|||
13483199|NCT02234843|27025617|FG007|Overall Study|Protocol Violation|0|||
13483200|NCT02234843|27025618|FG008|Overall Study|Protocol Violation|0|||
13483201|NCT02234843|27025619|FG009|Overall Study|Protocol Violation|0|||
13483202|NCT02234843|27025610|FG000|Overall Study|Efficacy outcome reached|2|||
13483203|NCT02234843|27025611|FG001|Overall Study|Efficacy outcome reached|0|||
13483204|NCT02234843|27025612|FG002|Overall Study|Efficacy outcome reached|0|||
13483205|NCT02234843|27025613|FG003|Overall Study|Efficacy outcome reached|0|||
13483206|NCT02234843|27025614|FG004|Overall Study|Efficacy outcome reached|0|||
13483207|NCT02234843|27025615|FG005|Overall Study|Efficacy outcome reached|2|||
13483208|NCT02234843|27025616|FG006|Overall Study|Efficacy outcome reached|0|||
13483209|NCT02234843|27025617|FG007|Overall Study|Efficacy outcome reached|0|||
13483210|NCT02234843|27025618|FG008|Overall Study|Efficacy outcome reached|0|||
13483211|NCT02234843|27025619|FG009|Overall Study|Efficacy outcome reached|0|||
13483212|NCT02234843|27025610|FG000|Overall Study|Patient convenience|2|||
13483213|NCT02234843|27025611|FG001|Overall Study|Patient convenience|0|||
13483214|NCT02234843|27025612|FG002|Overall Study|Patient convenience|0|||
13483215|NCT02234843|27025613|FG003|Overall Study|Patient convenience|0|||
13483216|NCT02234843|27025614|FG004|Overall Study|Patient convenience|0|||
13483217|NCT02234843|27025615|FG005|Overall Study|Patient convenience|1|||
13483218|NCT02234843|27025616|FG006|Overall Study|Patient convenience|0|||
13483219|NCT02234843|27025617|FG007|Overall Study|Patient convenience|0|||
13483220|NCT02234843|27025618|FG008|Overall Study|Patient convenience|0|||
13483221|NCT02234843|27025619|FG009|Overall Study|Patient convenience|0|||
13483222|NCT02234843|27025610|FG000|Overall Study|Withdrawal by Subject|5|||
13483223|NCT02234843|27025611|FG001|Overall Study|Withdrawal by Subject|1|||
13483224|NCT02234843|27025612|FG002|Overall Study|Withdrawal by Subject|1|||
13483225|NCT02234843|27025613|FG003|Overall Study|Withdrawal by Subject|0|||
13483226|NCT02234843|27025614|FG004|Overall Study|Withdrawal by Subject|0|||
13483227|NCT02234843|27025615|FG005|Overall Study|Withdrawal by Subject|7|||
13483228|NCT02234843|27025616|FG006|Overall Study|Withdrawal by Subject|0|||
13483229|NCT02234843|27025617|FG007|Overall Study|Withdrawal by Subject|0|||
13483230|NCT02234843|27025618|FG008|Overall Study|Withdrawal by Subject|0|||
13483231|NCT02234843|27025619|FG009|Overall Study|Withdrawal by Subject|0|||
13483232|NCT02234843|27025610|FG000|Overall Study|Recovery|1|||
13483233|NCT02234843|27025611|FG001|Overall Study|Recovery|0|||
13483234|NCT02234843|27025612|FG002|Overall Study|Recovery|0|||
13483235|NCT02234843|27025613|FG003|Overall Study|Recovery|0|||
13483236|NCT02234843|27025614|FG004|Overall Study|Recovery|0|||
13483237|NCT02234843|27025615|FG005|Overall Study|Recovery|0|||
13483238|NCT02234843|27025616|FG006|Overall Study|Recovery|0|||
13483239|NCT02234843|27025617|FG007|Overall Study|Recovery|0|||
13483240|NCT02234843|27025618|FG008|Overall Study|Recovery|0|||
13483241|NCT02234843|27025619|FG009|Overall Study|Recovery|0|||
13483242|NCT02234843|27025610|FG000|Overall Study|Other|0|||
13483243|NCT02234843|27025611|FG001|Overall Study|Other|2|||
13483244|NCT02234843|27025612|FG002|Overall Study|Other|0|||
13483245|NCT02234843|27025613|FG003|Overall Study|Other|1|||
13372863|NCT00806260|26722175|FG004|Period 2|Adverse Event|0|||
13483246|NCT02234843|27025614|FG004|Overall Study|Other|0|||
13483247|NCT02234843|27025615|FG005|Overall Study|Other|1|||
13483248|NCT02234843|27025616|FG006|Overall Study|Other|0|||
13483249|NCT02234843|27025617|FG007|Overall Study|Other|1|||
13483250|NCT02234843|27025618|FG008|Overall Study|Other|0|||
13483251|NCT02234843|27025619|FG009|Overall Study|Other|0|||
13483252|NCT02234843|27025610|FG000|Overall Study|Physician Decision|4|||
13483253|NCT02234843|27025611|FG001|Overall Study|Physician Decision|1|||
13483254|NCT02234843|27025612|FG002|Overall Study|Physician Decision|0|||
13483255|NCT02234843|27025613|FG003|Overall Study|Physician Decision|1|||
13483256|NCT02234843|27025614|FG004|Overall Study|Physician Decision|0|||
13483257|NCT02234843|27025615|FG005|Overall Study|Physician Decision|0|||
13483258|NCT02234843|27025616|FG006|Overall Study|Physician Decision|0|||
13483259|NCT02234843|27025617|FG007|Overall Study|Physician Decision|1|||
13483260|NCT02234843|27025618|FG008|Overall Study|Physician Decision|0|||
13483261|NCT02234843|27025619|FG009|Overall Study|Physician Decision|0|||
13483262|NCT02234843|27025610|FG000|Overall Study|Adverse Event|5|||
13483263|NCT02234843|27025611|FG001|Overall Study|Adverse Event|1|||
13483264|NCT02234843|27025612|FG002|Overall Study|Adverse Event|1|||
13483265|NCT02234843|27025613|FG003|Overall Study|Adverse Event|3|||
13483266|NCT02234843|27025614|FG004|Overall Study|Adverse Event|2|||
13483267|NCT02234843|27025615|FG005|Overall Study|Adverse Event|1|||
13483268|NCT02234843|27025616|FG006|Overall Study|Adverse Event|0|||
13483269|NCT02234843|27025617|FG007|Overall Study|Adverse Event|0|||
13483270|NCT02234843|27025618|FG008|Overall Study|Adverse Event|1|||
13483271|NCT02234843|27025619|FG009|Overall Study|Adverse Event|0|||
13483272|NCT02234843|27025610|FG000|Overall Study|Non-compliance with study drug|1|||
13483273|NCT02234843|27025611|FG001|Overall Study|Non-compliance with study drug|0|||
13483274|NCT02234843|27025612|FG002|Overall Study|Non-compliance with study drug|0|||
13483275|NCT02234843|27025613|FG003|Overall Study|Non-compliance with study drug|0|||
13483276|NCT02234843|27025614|FG004|Overall Study|Non-compliance with study drug|0|||
13483277|NCT02234843|27025615|FG005|Overall Study|Non-compliance with study drug|1|||
13483278|NCT02234843|27025616|FG006|Overall Study|Non-compliance with study drug|1|||
13483279|NCT02234843|27025617|FG007|Overall Study|Non-compliance with study drug|0|||
13483280|NCT02234843|27025618|FG008|Overall Study|Non-compliance with study drug|0|||
13483281|NCT02234843|27025619|FG009|Overall Study|Non-compliance with study drug|0|||
13483282|NCT02234843|27025610|FG000|Overall Study|Lost to Follow-up|0|||
13483283|NCT02234843|27025611|FG001|Overall Study|Lost to Follow-up|1|||
13483284|NCT02234843|27025612|FG002|Overall Study|Lost to Follow-up|0|||
13483285|NCT02234843|27025613|FG003|Overall Study|Lost to Follow-up|0|||
13483286|NCT02234843|27025614|FG004|Overall Study|Lost to Follow-up|0|||
13483287|NCT02234843|27025615|FG005|Overall Study|Lost to Follow-up|0|||
13483288|NCT02234843|27025616|FG006|Overall Study|Lost to Follow-up|1|||
13483289|NCT02234843|27025617|FG007|Overall Study|Lost to Follow-up|0|||
13483290|NCT02234843|27025618|FG008|Overall Study|Lost to Follow-up|0|||
13483291|NCT02234843|27025619|FG009|Overall Study|Lost to Follow-up|0|||
13487636|NCT03074695|27040919|FG001|Overall Study|Did not receive neuraxial block|2|||
13487637|NCT03052608|27040984|FG000|Treatment Phase|Adverse Event|10|||
13487638|NCT03052608|27040985|FG001|Treatment Phase|Adverse Event|12|||
13487639|NCT03052608|27040984|FG000|Treatment Phase|Death|6|||
13487640|NCT03052608|27040985|FG001|Treatment Phase|Death|4|||
13487641|NCT03052608|27040984|FG000|Treatment Phase|Withdrawal by Subject|4|||
13487642|NCT03052608|27040985|FG001|Treatment Phase|Withdrawal by Subject|12|||
13487643|NCT03052608|27040984|FG000|Treatment Phase|Global Deterioration of Health Status|0|||
13487644|NCT03052608|27040985|FG001|Treatment Phase|Global Deterioration of Health Status|3|||
13487645|NCT03052608|27040984|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0|||
13487646|NCT03052608|27040985|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1|||
13487647|NCT03052608|27040984|FG000|Treatment Phase|Subject didn't receive study treatment.|0|||
13487648|NCT03052608|27040985|FG001|Treatment Phase|Subject didn't receive study treatment.|1|||
13487649|NCT03052608|27040984|FG000|Treatment Phase|Ongoing|103|||
13487650|NCT03052608|27040985|FG001|Treatment Phase|Ongoing|31|||
13487651|NCT03052608|27040984|FG000|Long-Term Follow-up Phase|Death|23|||
13487652|NCT03052608|27040985|FG001|Long-Term Follow-up Phase|Death|28|||
13487653|NCT03052608|27040984|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0|||
13487654|NCT03052608|27040985|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2|||
13487655|NCT03052608|27040984|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4|||
13487656|NCT03052608|27040985|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18|||
13487657|NCT03052608|27040984|FG000|Long-Term Follow-up Phase|Ongoing|122|||
13487658|NCT03052608|27040985|FG001|Long-Term Follow-up Phase|Ongoing|99|||
13487659|NCT02922725|27041002|FG000|Overall Study|Withdrawal by Subject|1|||
13487660|NCT02922725|27041003|FG001|Overall Study|Withdrawal by Subject|0|||
13487661|NCT02922725|27041004|FG002|Overall Study|Withdrawal by Subject|0|||
13488324|NCT02959918|27043330|FG010|Overall Study|Protocol Violation|0|||
13488325|NCT02959918|27043331|FG011|Overall Study|Protocol Violation|1|||
13488326|NCT02959918|27043332|FG012|Overall Study|Protocol Violation|1|||
13488327|NCT02959918|27043333|FG013|Overall Study|Protocol Violation|0|||
13488328|NCT02959918|27043320|FG000|Overall Study|Stopping Rule Met|1|||
13488329|NCT02959918|27043321|FG001|Overall Study|Stopping Rule Met|0|||
13488330|NCT02959918|27043322|FG002|Overall Study|Stopping Rule Met|3|||
13488331|NCT02959918|27043323|FG003|Overall Study|Stopping Rule Met|4|||
13488332|NCT02959918|27043324|FG004|Overall Study|Stopping Rule Met|5|||
13488333|NCT02959918|27043325|FG005|Overall Study|Stopping Rule Met|3|||
13488334|NCT02959918|27043326|FG006|Overall Study|Stopping Rule Met|2|||
13488335|NCT02959918|27043327|FG007|Overall Study|Stopping Rule Met|4|||
13488336|NCT02959918|27043328|FG008|Overall Study|Stopping Rule Met|1|||
13488337|NCT02959918|27043329|FG009|Overall Study|Stopping Rule Met|1|||
13488338|NCT02959918|27043330|FG010|Overall Study|Stopping Rule Met|3|||
13488339|NCT02959918|27043331|FG011|Overall Study|Stopping Rule Met|5|||
13488340|NCT02959918|27043332|FG012|Overall Study|Stopping Rule Met|2|||
13488341|NCT02959918|27043333|FG013|Overall Study|Stopping Rule Met|1|||
13488342|NCT02959918|27043320|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
13488343|NCT02959918|27043321|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2|||
13488344|NCT02959918|27043322|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
13483292|NCT03926611|27025728|FG000|Overall Study|Adverse Event|0|||
13483293|NCT03926611|27025729|FG001|Overall Study|Adverse Event|0|||
13483294|NCT03926611|27025730|FG002|Overall Study|Adverse Event|0|||
13483295|NCT03926611|27025731|FG003|Overall Study|Adverse Event|3|||
13483296|NCT03926611|27025732|FG004|Overall Study|Adverse Event|1|||
13483297|NCT03926611|27025733|FG005|Overall Study|Adverse Event|3|||
13483298|NCT03926611|27025734|FG006|Overall Study|Adverse Event|0|||
13483299|NCT03926611|27025728|FG000|Overall Study|Lack of Efficacy|1|||
13483300|NCT03926611|27025729|FG001|Overall Study|Lack of Efficacy|2|||
13483301|NCT03926611|27025730|FG002|Overall Study|Lack of Efficacy|0|||
13483302|NCT03926611|27025731|FG003|Overall Study|Lack of Efficacy|0|||
13483303|NCT03926611|27025732|FG004|Overall Study|Lack of Efficacy|1|||
13483304|NCT03926611|27025733|FG005|Overall Study|Lack of Efficacy|0|||
13483305|NCT03926611|27025734|FG006|Overall Study|Lack of Efficacy|1|||
13483306|NCT03926611|27025728|FG000|Overall Study|Physician Decision|0|||
13483307|NCT03926611|27025729|FG001|Overall Study|Physician Decision|0|||
13483308|NCT03926611|27025730|FG002|Overall Study|Physician Decision|0|||
13483309|NCT03926611|27025731|FG003|Overall Study|Physician Decision|0|||
13483310|NCT03926611|27025732|FG004|Overall Study|Physician Decision|0|||
13483311|NCT03926611|27025733|FG005|Overall Study|Physician Decision|1|||
13483312|NCT03926611|27025734|FG006|Overall Study|Physician Decision|0|||
13483313|NCT03926611|27025728|FG000|Overall Study|Protocol Violation|1|||
13483314|NCT03926611|27025729|FG001|Overall Study|Protocol Violation|0|||
13483315|NCT03926611|27025730|FG002|Overall Study|Protocol Violation|0|||
13483316|NCT03926611|27025731|FG003|Overall Study|Protocol Violation|1|||
13483317|NCT03926611|27025732|FG004|Overall Study|Protocol Violation|1|||
13483318|NCT03926611|27025733|FG005|Overall Study|Protocol Violation|1|||
13483319|NCT03926611|27025734|FG006|Overall Study|Protocol Violation|1|||
13483320|NCT03926611|27025728|FG000|Overall Study|Technical problems|0|||
13483321|NCT03926611|27025729|FG001|Overall Study|Technical problems|0|||
13483322|NCT03926611|27025730|FG002|Overall Study|Technical problems|0|||
13483323|NCT03926611|27025731|FG003|Overall Study|Technical problems|0|||
13483324|NCT03926611|27025732|FG004|Overall Study|Technical problems|0|||
13483325|NCT03926611|27025733|FG005|Overall Study|Technical problems|1|||
13483326|NCT03926611|27025734|FG006|Overall Study|Technical problems|0|||
13483327|NCT03926611|27025728|FG000|Overall Study|Withdrawal by Subject|1|||
13483328|NCT03926611|27025729|FG001|Overall Study|Withdrawal by Subject|1|||
13483329|NCT03926611|27025730|FG002|Overall Study|Withdrawal by Subject|1|||
13483330|NCT03926611|27025731|FG003|Overall Study|Withdrawal by Subject|0|||
13483331|NCT03926611|27025732|FG004|Overall Study|Withdrawal by Subject|0|||
13483332|NCT03926611|27025733|FG005|Overall Study|Withdrawal by Subject|1|||
13483333|NCT03926611|27025734|FG006|Overall Study|Withdrawal by Subject|3|||
13483334|NCT03926611|27025728|FG000|Overall Study|Covid-19 pandemic|0|||
13483335|NCT03926611|27025729|FG001|Overall Study|Covid-19 pandemic|0|||
13483336|NCT03926611|27025730|FG002|Overall Study|Covid-19 pandemic|1|||
13483337|NCT03926611|27025731|FG003|Overall Study|Covid-19 pandemic|0|||
13483338|NCT03926611|27025732|FG004|Overall Study|Covid-19 pandemic|1|||
13483339|NCT03926611|27025733|FG005|Overall Study|Covid-19 pandemic|2|||
13483340|NCT03926611|27025734|FG006|Overall Study|Covid-19 pandemic|0|||
13483341|NCT03814720|27025805|FG000|Overall Study|Lost to Follow-up|0|||
13483342|NCT03814720|27025806|FG001|Overall Study|Lost to Follow-up|1|||
13483343|NCT03814720|27025807|FG002|Overall Study|Lost to Follow-up|0|||
13483344|NCT03814720|27025808|FG003|Overall Study|Lost to Follow-up|0|||
13483345|NCT03814720|27025809|FG004|Overall Study|Lost to Follow-up|0|||
13483346|NCT03529110|27025830|FG000|Overall Study|Progressive Disease|66|||
13483347|NCT03529110|27025831|FG001|Overall Study|Progressive Disease|158|||
13483348|NCT03529110|27025830|FG000|Overall Study|Clinical Progression|4|||
13483349|NCT03529110|27025831|FG001|Overall Study|Clinical Progression|12|||
13483350|NCT03529110|27025830|FG000|Overall Study|Adverse Event|35|||
13483351|NCT03529110|27025831|FG001|Overall Study|Adverse Event|17|||
13483352|NCT03529110|27025830|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13|||
13483353|NCT03529110|27025831|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11|||
13483354|NCT03529110|27025830|FG000|Overall Study|Lack of Efficacy|3|||
13483355|NCT03529110|27025831|FG001|Overall Study|Lack of Efficacy|3|||
13483356|NCT03529110|27025830|FG000|Overall Study|Physician Decision|2|||
13483357|NCT03529110|27025831|FG001|Overall Study|Physician Decision|8|||
13483358|NCT03529110|27025830|FG000|Overall Study|Miscellaneous|2|||
13483359|NCT03529110|27025831|FG001|Overall Study|Miscellaneous|5|||
13483360|NCT03517540|27025862|FG000|Overall Study|Protocol Violation|2|||
13483361|NCT03517540|27025863|FG001|Overall Study|Protocol Violation|0|||
13483362|NCT03517540|27025864|FG002|Overall Study|Protocol Violation|0|||
13483363|NCT03517540|27025865|FG003|Overall Study|Protocol Violation|1|||
13483364|NCT03517540|27025862|FG000|Overall Study|Adverse Event|9|||
13483365|NCT03517540|27025863|FG001|Overall Study|Adverse Event|3|||
13483366|NCT03517540|27025864|FG002|Overall Study|Adverse Event|8|||
13483367|NCT03517540|27025865|FG003|Overall Study|Adverse Event|1|||
13483368|NCT03517540|27025862|FG000|Overall Study|Withdrawal by Subject|3|||
13483369|NCT03517540|27025863|FG001|Overall Study|Withdrawal by Subject|4|||
13483370|NCT03517540|27025864|FG002|Overall Study|Withdrawal by Subject|1|||
13483371|NCT03517540|27025865|FG003|Overall Study|Withdrawal by Subject|3|||
13483372|NCT03437278|27025927|FG000|Overall Study|Adverse Event|0|||
13483373|NCT03437278|27025928|FG001|Overall Study|Adverse Event|0|||
13483374|NCT03437278|27025929|FG002|Overall Study|Adverse Event|1|||
13483375|NCT03437278|27025927|FG000|Overall Study|Progressive disease|1|||
13483376|NCT03437278|27025928|FG001|Overall Study|Progressive disease|0|||
13483377|NCT03437278|27025929|FG002|Overall Study|Progressive disease|0|||
13483378|NCT03437278|27025927|FG000|Overall Study|Physician Decision|1|||
13483379|NCT03437278|27025928|FG001|Overall Study|Physician Decision|0|||
13483380|NCT03437278|27025929|FG002|Overall Study|Physician Decision|1|||
13483381|NCT03350815|27025958|FG000|Period 1|Adverse Event|10|||
13483382|NCT03350815|27025959|FG001|Period 1|Adverse Event|0|||
13483383|NCT03350815|27025960|FG002|Period 1|Adverse Event|0|||
13483384|NCT03350815|27025961|FG003|Period 1|Adverse Event|0|||
13483385|NCT03350815|27025958|FG000|Period 1|Technical problems|1|||
13483386|NCT03350815|27025959|FG001|Period 1|Technical problems|0|||
13483387|NCT03350815|27025960|FG002|Period 1|Technical problems|0|||
13483388|NCT03350815|27025961|FG003|Period 1|Technical problems|0|||
13483389|NCT03350815|27025958|FG000|Period 1|Lost to Follow-up|3|||
13483390|NCT03350815|27025959|FG001|Period 1|Lost to Follow-up|0|||
13483391|NCT03350815|27025960|FG002|Period 1|Lost to Follow-up|0|||
13483392|NCT03350815|27025961|FG003|Period 1|Lost to Follow-up|0|||
13483393|NCT03350815|27025958|FG000|Period 1|Physician Decision|1|||
13483394|NCT03350815|27025959|FG001|Period 1|Physician Decision|0|||
13483395|NCT03350815|27025960|FG002|Period 1|Physician Decision|0|||
13483396|NCT03350815|27025961|FG003|Period 1|Physician Decision|0|||
13483397|NCT03350815|27025958|FG000|Period 1|Withdrawal by Subject|8|||
13483398|NCT03350815|27025959|FG001|Period 1|Withdrawal by Subject|0|||
13483399|NCT03350815|27025960|FG002|Period 1|Withdrawal by Subject|0|||
13483400|NCT03350815|27025961|FG003|Period 1|Withdrawal by Subject|0|||
13483401|NCT03350815|27025958|FG000|Period 1|Lack of Efficacy|15|||
13483402|NCT03350815|27025959|FG001|Period 1|Lack of Efficacy|0|||
13483403|NCT03350815|27025960|FG002|Period 1|Lack of Efficacy|0|||
13483404|NCT03350815|27025961|FG003|Period 1|Lack of Efficacy|0|||
13483405|NCT03350815|27025958|FG000|Period 1|Non-compliance with study treatment|2|||
13483406|NCT03350815|27025959|FG001|Period 1|Non-compliance with study treatment|0|||
13483407|NCT03350815|27025960|FG002|Period 1|Non-compliance with study treatment|0|||
13483408|NCT03350815|27025961|FG003|Period 1|Non-compliance with study treatment|0|||
13483409|NCT03350815|27025958|FG000|Period 1|Protocol Violation|3|||
13483410|NCT03350815|27025959|FG001|Period 1|Protocol Violation|0|||
13483411|NCT03350815|27025960|FG002|Period 1|Protocol Violation|0|||
13483412|NCT03350815|27025961|FG003|Period 1|Protocol Violation|0|||
13483413|NCT03350815|27025958|FG000|Period 2|Adverse Event|0|||
13483414|NCT03350815|27025959|FG001|Period 2|Adverse Event|3|||
13483415|NCT03350815|27025960|FG002|Period 2|Adverse Event|5|||
13483416|NCT03350815|27025961|FG003|Period 2|Adverse Event|0|||
13483417|NCT03350815|27025958|FG000|Period 2|Technical problem|0|||
13483418|NCT03350815|27025959|FG001|Period 2|Technical problem|1|||
13483419|NCT03350815|27025960|FG002|Period 2|Technical problem|0|||
13483420|NCT03350815|27025961|FG003|Period 2|Technical problem|0|||
13483421|NCT03350815|27025958|FG000|Period 2|Lost to Follow-up|0|||
13483422|NCT03350815|27025959|FG001|Period 2|Lost to Follow-up|3|||
13483423|NCT03350815|27025960|FG002|Period 2|Lost to Follow-up|3|||
13483424|NCT03350815|27025961|FG003|Period 2|Lost to Follow-up|0|||
13483425|NCT03350815|27025958|FG000|Period 2|Physician Decision|0|||
13483426|NCT03350815|27025959|FG001|Period 2|Physician Decision|0|||
13483427|NCT03350815|27025960|FG002|Period 2|Physician Decision|1|||
13483428|NCT03350815|27025961|FG003|Period 2|Physician Decision|0|||
13483429|NCT03350815|27025958|FG000|Period 2|Withdrawal by Subject|0|||
13483430|NCT03350815|27025959|FG001|Period 2|Withdrawal by Subject|3|||
13483431|NCT03350815|27025960|FG002|Period 2|Withdrawal by Subject|4|||
13483432|NCT03350815|27025961|FG003|Period 2|Withdrawal by Subject|0|||
13483433|NCT03350815|27025958|FG000|Period 2|Lack of Efficacy|0|||
13483434|NCT03350815|27025959|FG001|Period 2|Lack of Efficacy|6|||
13483435|NCT03350815|27025960|FG002|Period 2|Lack of Efficacy|2|||
13483436|NCT03350815|27025961|FG003|Period 2|Lack of Efficacy|0|||
13483437|NCT03350815|27025958|FG000|Period 2|Protocol Violation|0|||
13483438|NCT03350815|27025959|FG001|Period 2|Protocol Violation|0|||
13483439|NCT03350815|27025960|FG002|Period 2|Protocol Violation|1|||
13483440|NCT03350815|27025961|FG003|Period 2|Protocol Violation|0|||
13483441|NCT03350815|27025958|FG000|Period 2|New therapy for study indication|0|||
13483442|NCT03350815|27025959|FG001|Period 2|New therapy for study indication|0|||
13483443|NCT03350815|27025960|FG002|Period 2|New therapy for study indication|1|||
13483444|NCT03350815|27025961|FG003|Period 2|New therapy for study indication|0|||
13483445|NCT03249714|27026003|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
13483446|NCT03249714|27026004|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
13483447|NCT03249714|27026003|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
13483448|NCT03249714|27026004|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
13483449|NCT03249714|27026003|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1|||
13483450|NCT03249714|27026004|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0|||
13483451|NCT03249714|27026003|FG000|Open-label Treatment (Extension Part)|Adverse Event|2|||
13483452|NCT03249714|27026004|FG001|Open-label Treatment (Extension Part)|Adverse Event|0|||
13483453|NCT03074318|27026061|FG000|Overall Study|Adverse Event|0|||
13483454|NCT03074318|27026062|FG001|Overall Study|Adverse Event|1|||
13483455|NCT03074318|27026063|FG002|Overall Study|Adverse Event|1|||
13483456|NCT03074318|27026064|FG003|Overall Study|Adverse Event|1|||
13483457|NCT03074318|27026061|FG000|Overall Study|Death|1|||
13483458|NCT03074318|27026062|FG001|Overall Study|Death|0|||
13483459|NCT03074318|27026063|FG002|Overall Study|Death|0|||
13483460|NCT03074318|27026064|FG003|Overall Study|Death|0|||
13483461|NCT03074318|27026061|FG000|Overall Study|Withdrawal by Subject|1|||
13483462|NCT03074318|27026062|FG001|Overall Study|Withdrawal by Subject|2|||
13483463|NCT03074318|27026063|FG002|Overall Study|Withdrawal by Subject|2|||
13483464|NCT03074318|27026064|FG003|Overall Study|Withdrawal by Subject|4|||
13483465|NCT03074318|27026061|FG000|Overall Study|Trial Closure|2|||
13483466|NCT03074318|27026062|FG001|Overall Study|Trial Closure|2|||
13483467|NCT03074318|27026063|FG002|Overall Study|Trial Closure|3|||
13483468|NCT03074318|27026064|FG003|Overall Study|Trial Closure|11|||
13483469|NCT03010319|27026085|FG000|Overall Study|Adverse Event|15|||
13483470|NCT03010319|27026086|FG001|Overall Study|Adverse Event|9|||
13483471|NCT03010319|27026085|FG000|Overall Study|Withdrawal by Subject|1|||
13483472|NCT03010319|27026086|FG001|Overall Study|Withdrawal by Subject|6|||
13483473|NCT03010319|27026085|FG000|Overall Study|Physician Decision|2|||
13483474|NCT03010319|27026086|FG001|Overall Study|Physician Decision|4|||
13483475|NCT03010319|27026085|FG000|Overall Study|Sponsor requested withdrawal|2|||
13483476|NCT03010319|27026086|FG001|Overall Study|Sponsor requested withdrawal|2|||
13483477|NCT03010319|27026085|FG000|Overall Study|Death|1|||
13483478|NCT03010319|27026086|FG001|Overall Study|Death|0|||
13483479|NCT03010319|27026085|FG000|Overall Study|Lost to Follow-up|0|||
13483480|NCT03010319|27026086|FG001|Overall Study|Lost to Follow-up|1|||
13483481|NCT03010319|27026085|FG000|Overall Study|Other Reason|5|||
13483482|NCT03010319|27026086|FG001|Overall Study|Other Reason|7|||
13483483|NCT02915016|27026321|FG000|Overall Study|Lost to Follow-up|4|||
13483484|NCT02915016|27026322|FG001|Overall Study|Lost to Follow-up|2|||
13483485|NCT02915016|27026323|FG002|Overall Study|Lost to Follow-up|5|||
13483486|NCT02915016|27026324|FG003|Overall Study|Lost to Follow-up|3|||
13483487|NCT02915016|27026325|FG004|Overall Study|Lost to Follow-up|5|||
13483488|NCT02915016|27026326|FG005|Overall Study|Lost to Follow-up|2|||
13483489|NCT02915016|27026327|FG006|Overall Study|Lost to Follow-up|8|||
13483490|NCT02915016|27026328|FG007|Overall Study|Lost to Follow-up|2|||
13483491|NCT02915016|27026321|FG000|Overall Study|Physician Decision|0|||
13483492|NCT02915016|27026322|FG001|Overall Study|Physician Decision|0|||
13483493|NCT02915016|27026323|FG002|Overall Study|Physician Decision|1|||
13483494|NCT02915016|27026324|FG003|Overall Study|Physician Decision|0|||
13483495|NCT02915016|27026325|FG004|Overall Study|Physician Decision|0|||
13483496|NCT02915016|27026326|FG005|Overall Study|Physician Decision|1|||
13483497|NCT02915016|27026327|FG006|Overall Study|Physician Decision|2|||
13483498|NCT02915016|27026328|FG007|Overall Study|Physician Decision|0|||
13483499|NCT02915016|27026321|FG000|Overall Study|Withdrawal by Subject|2|||
13483500|NCT02915016|27026322|FG001|Overall Study|Withdrawal by Subject|0|||
13483501|NCT02915016|27026323|FG002|Overall Study|Withdrawal by Subject|1|||
13483502|NCT02915016|27026324|FG003|Overall Study|Withdrawal by Subject|0|||
13483503|NCT02915016|27026325|FG004|Overall Study|Withdrawal by Subject|1|||
13483504|NCT02915016|27026326|FG005|Overall Study|Withdrawal by Subject|3|||
13483505|NCT02915016|27026327|FG006|Overall Study|Withdrawal by Subject|1|||
13483506|NCT02915016|27026328|FG007|Overall Study|Withdrawal by Subject|1|||
13483507|NCT02915016|27026321|FG000|Overall Study|Elected not to continue|0|||
13483508|NCT02915016|27026322|FG001|Overall Study|Elected not to continue|0|||
13483509|NCT02915016|27026323|FG002|Overall Study|Elected not to continue|0|||
13483510|NCT02915016|27026324|FG003|Overall Study|Elected not to continue|1|||
13483511|NCT02915016|27026325|FG004|Overall Study|Elected not to continue|0|||
13483512|NCT02915016|27026326|FG005|Overall Study|Elected not to continue|0|||
13483513|NCT02915016|27026327|FG006|Overall Study|Elected not to continue|1|||
13483514|NCT02915016|27026328|FG007|Overall Study|Elected not to continue|0|||
13483515|NCT02915016|27026321|FG000|Overall Study|HIV infection|1|||
13483516|NCT02915016|27026322|FG001|Overall Study|HIV infection|1|||
13483517|NCT02915016|27026323|FG002|Overall Study|HIV infection|1|||
13483518|NCT02915016|27026324|FG003|Overall Study|HIV infection|0|||
13483519|NCT02915016|27026325|FG004|Overall Study|HIV infection|1|||
13483520|NCT02915016|27026326|FG005|Overall Study|HIV infection|0|||
13483521|NCT02915016|27026327|FG006|Overall Study|HIV infection|0|||
13483522|NCT02915016|27026328|FG007|Overall Study|HIV infection|0|||
13483523|NCT02915016|27026321|FG000|Overall Study|Participant unable to adhere|0|||
13483524|NCT02915016|27026322|FG001|Overall Study|Participant unable to adhere|0|||
13483525|NCT02915016|27026323|FG002|Overall Study|Participant unable to adhere|0|||
13483526|NCT02915016|27026324|FG003|Overall Study|Participant unable to adhere|0|||
13483527|NCT02915016|27026325|FG004|Overall Study|Participant unable to adhere|0|||
13483528|NCT02915016|27026326|FG005|Overall Study|Participant unable to adhere|0|||
13483529|NCT02915016|27026327|FG006|Overall Study|Participant unable to adhere|0|||
13483530|NCT02915016|27026328|FG007|Overall Study|Participant unable to adhere|1|||
13483531|NCT02871401|27026349|FG000|Overall Study|Adverse Event|1|||
13483532|NCT02871401|27026350|FG001|Overall Study|Adverse Event|0|||
13483533|NCT02696031|27026430|FG000|Up to Week 24|Adverse Event|2|||
13483534|NCT02696031|27026431|FG001|Up to Week 24|Adverse Event|4|||
13483535|NCT02696031|27026432|FG002|Up to Week 24|Adverse Event|2|||
13483536|NCT02696031|27026433|FG003|Up to Week 24|Adverse Event|0|||
13483537|NCT02696031|27026434|FG004|Up to Week 24|Adverse Event|0|||
13483538|NCT02696031|27026435|FG005|Up to Week 24|Adverse Event|0|||
13483539|NCT02696031|27026430|FG000|Up to Week 24|Lack of Efficacy|2|||
13483540|NCT02696031|27026431|FG001|Up to Week 24|Lack of Efficacy|1|||
13483541|NCT02696031|27026432|FG002|Up to Week 24|Lack of Efficacy|2|||
13483542|NCT02696031|27026433|FG003|Up to Week 24|Lack of Efficacy|0|||
13483543|NCT02696031|27026434|FG004|Up to Week 24|Lack of Efficacy|0|||
13483544|NCT02696031|27026435|FG005|Up to Week 24|Lack of Efficacy|0|||
13483545|NCT02696031|27026430|FG000|Up to Week 24|Lost to Follow-up|0|||
13483546|NCT02696031|27026431|FG001|Up to Week 24|Lost to Follow-up|1|||
13483547|NCT02696031|27026432|FG002|Up to Week 24|Lost to Follow-up|1|||
13483548|NCT02696031|27026433|FG003|Up to Week 24|Lost to Follow-up|0|||
13483549|NCT02696031|27026434|FG004|Up to Week 24|Lost to Follow-up|0|||
13483550|NCT02696031|27026435|FG005|Up to Week 24|Lost to Follow-up|0|||
13483551|NCT02696031|27026430|FG000|Up to Week 24|Physician Decision|1|||
13483552|NCT02696031|27026431|FG001|Up to Week 24|Physician Decision|0|||
13483553|NCT02696031|27026432|FG002|Up to Week 24|Physician Decision|1|||
13483554|NCT02696031|27026433|FG003|Up to Week 24|Physician Decision|0|||
13483555|NCT02696031|27026434|FG004|Up to Week 24|Physician Decision|0|||
13483556|NCT02696031|27026435|FG005|Up to Week 24|Physician Decision|0|||
13483557|NCT02696031|27026430|FG000|Up to Week 24|Protocol Violation|1|||
13483558|NCT02696031|27026431|FG001|Up to Week 24|Protocol Violation|0|||
13483559|NCT02696031|27026432|FG002|Up to Week 24|Protocol Violation|0|||
13483560|NCT02696031|27026433|FG003|Up to Week 24|Protocol Violation|0|||
13483561|NCT02696031|27026434|FG004|Up to Week 24|Protocol Violation|0|||
13483562|NCT02696031|27026435|FG005|Up to Week 24|Protocol Violation|0|||
13483563|NCT02696031|27026430|FG000|Up to Week 24|Withdrawal by Subject|4|||
13483564|NCT02696031|27026431|FG001|Up to Week 24|Withdrawal by Subject|1|||
13483565|NCT02696031|27026432|FG002|Up to Week 24|Withdrawal by Subject|5|||
13483566|NCT02696031|27026433|FG003|Up to Week 24|Withdrawal by Subject|0|||
13483567|NCT02696031|27026434|FG004|Up to Week 24|Withdrawal by Subject|0|||
13483568|NCT02696031|27026435|FG005|Up to Week 24|Withdrawal by Subject|0|||
13483569|NCT02696031|27026430|FG000|Up to Week 52|Adverse Event|4|||
13483570|NCT02696031|27026431|FG001|Up to Week 52|Adverse Event|5|||
13483571|NCT02696031|27026432|FG002|Up to Week 52|Adverse Event|3|||
13483572|NCT02696031|27026433|FG003|Up to Week 52|Adverse Event|0|||
13483573|NCT02696031|27026434|FG004|Up to Week 52|Adverse Event|0|||
13483574|NCT02696031|27026435|FG005|Up to Week 52|Adverse Event|0|||
13483575|NCT02696031|27026430|FG000|Up to Week 52|Lack of Efficacy|10|||
13483576|NCT02696031|27026431|FG001|Up to Week 52|Lack of Efficacy|7|||
13483577|NCT02696031|27026432|FG002|Up to Week 52|Lack of Efficacy|11|||
13483578|NCT02696031|27026433|FG003|Up to Week 52|Lack of Efficacy|0|||
13483579|NCT02696031|27026434|FG004|Up to Week 52|Lack of Efficacy|0|||
13483580|NCT02696031|27026435|FG005|Up to Week 52|Lack of Efficacy|0|||
13483581|NCT02696031|27026430|FG000|Up to Week 52|Lost to Follow-up|1|||
13483582|NCT02696031|27026431|FG001|Up to Week 52|Lost to Follow-up|1|||
13483583|NCT02696031|27026432|FG002|Up to Week 52|Lost to Follow-up|1|||
13483584|NCT02696031|27026433|FG003|Up to Week 52|Lost to Follow-up|0|||
13483585|NCT02696031|27026434|FG004|Up to Week 52|Lost to Follow-up|0|||
13483586|NCT02696031|27026435|FG005|Up to Week 52|Lost to Follow-up|0|||
13483587|NCT02696031|27026430|FG000|Up to Week 52|Physician Decision|1|||
13483588|NCT02696031|27026431|FG001|Up to Week 52|Physician Decision|1|||
13483589|NCT02696031|27026432|FG002|Up to Week 52|Physician Decision|2|||
13483590|NCT02696031|27026433|FG003|Up to Week 52|Physician Decision|0|||
13483591|NCT02696031|27026434|FG004|Up to Week 52|Physician Decision|0|||
13483592|NCT02696031|27026435|FG005|Up to Week 52|Physician Decision|0|||
13483593|NCT02696031|27026430|FG000|Up to Week 52|Pregnancy|0|||
13483594|NCT02696031|27026431|FG001|Up to Week 52|Pregnancy|2|||
13483595|NCT02696031|27026432|FG002|Up to Week 52|Pregnancy|0|||
13483596|NCT02696031|27026433|FG003|Up to Week 52|Pregnancy|0|||
13483597|NCT02696031|27026434|FG004|Up to Week 52|Pregnancy|0|||
13483598|NCT02696031|27026435|FG005|Up to Week 52|Pregnancy|0|||
13483599|NCT02696031|27026430|FG000|Up to Week 52|Protocol Violation|1|||
13483600|NCT02696031|27026431|FG001|Up to Week 52|Protocol Violation|0|||
13483601|NCT02696031|27026432|FG002|Up to Week 52|Protocol Violation|0|||
13483602|NCT02696031|27026433|FG003|Up to Week 52|Protocol Violation|0|||
13483603|NCT02696031|27026434|FG004|Up to Week 52|Protocol Violation|0|||
13483604|NCT02696031|27026435|FG005|Up to Week 52|Protocol Violation|0|||
13483605|NCT02696031|27026430|FG000|Up to Week 52|Withdrawal by Subject|12|||
13483606|NCT02696031|27026431|FG001|Up to Week 52|Withdrawal by Subject|3|||
13483607|NCT02696031|27026432|FG002|Up to Week 52|Withdrawal by Subject|9|||
13483608|NCT02696031|27026433|FG003|Up to Week 52|Withdrawal by Subject|0|||
13483609|NCT02696031|27026434|FG004|Up to Week 52|Withdrawal by Subject|0|||
13483610|NCT02696031|27026435|FG005|Up to Week 52|Withdrawal by Subject|0|||
13483611|NCT02696031|27026430|FG000|Up to Week 104|Pregnancy|0|||
13483612|NCT02696031|27026431|FG001|Up to Week 104|Pregnancy|2|||
13483613|NCT02696031|27026432|FG002|Up to Week 104|Pregnancy|1|||
13483614|NCT02696031|27026433|FG003|Up to Week 104|Pregnancy|0|||
13483615|NCT02696031|27026434|FG004|Up to Week 104|Pregnancy|0|||
13483616|NCT02696031|27026435|FG005|Up to Week 104|Pregnancy|0|||
13483617|NCT02696031|27026430|FG000|Up to Week 104|Withdrawal by Subject|15|||
13483618|NCT02696031|27026431|FG001|Up to Week 104|Withdrawal by Subject|10|||
13483619|NCT02696031|27026432|FG002|Up to Week 104|Withdrawal by Subject|16|||
13483620|NCT02696031|27026433|FG003|Up to Week 104|Withdrawal by Subject|0|||
13483621|NCT02696031|27026434|FG004|Up to Week 104|Withdrawal by Subject|0|||
13483622|NCT02696031|27026435|FG005|Up to Week 104|Withdrawal by Subject|0|||
13483623|NCT02696031|27026430|FG000|Up to Week 104|Protocol Violation|1|||
13483624|NCT02696031|27026431|FG001|Up to Week 104|Protocol Violation|0|||
13483625|NCT02696031|27026432|FG002|Up to Week 104|Protocol Violation|0|||
13483626|NCT02696031|27026433|FG003|Up to Week 104|Protocol Violation|0|||
13483627|NCT02696031|27026434|FG004|Up to Week 104|Protocol Violation|0|||
13483628|NCT02696031|27026435|FG005|Up to Week 104|Protocol Violation|0|||
13483629|NCT02696031|27026430|FG000|Up to Week 104|Physician Decision|1|||
13483630|NCT02696031|27026431|FG001|Up to Week 104|Physician Decision|2|||
13483631|NCT02696031|27026432|FG002|Up to Week 104|Physician Decision|3|||
13483632|NCT02696031|27026433|FG003|Up to Week 104|Physician Decision|0|||
13483633|NCT02696031|27026434|FG004|Up to Week 104|Physician Decision|0|||
13483634|NCT02696031|27026435|FG005|Up to Week 104|Physician Decision|0|||
13483635|NCT02696031|27026430|FG000|Up to Week 104|Lost to Follow-up|2|||
13483636|NCT02696031|27026431|FG001|Up to Week 104|Lost to Follow-up|3|||
13483637|NCT02696031|27026432|FG002|Up to Week 104|Lost to Follow-up|1|||
13483638|NCT02696031|27026433|FG003|Up to Week 104|Lost to Follow-up|0|||
13483639|NCT02696031|27026434|FG004|Up to Week 104|Lost to Follow-up|0|||
13483640|NCT02696031|27026435|FG005|Up to Week 104|Lost to Follow-up|0|||
13483641|NCT02696031|27026430|FG000|Up to Week 104|Lack of Efficacy|13|||
13483642|NCT02696031|27026431|FG001|Up to Week 104|Lack of Efficacy|12|||
13483643|NCT02696031|27026432|FG002|Up to Week 104|Lack of Efficacy|11|||
13483644|NCT02696031|27026433|FG003|Up to Week 104|Lack of Efficacy|0|||
13483645|NCT02696031|27026434|FG004|Up to Week 104|Lack of Efficacy|0|||
13483646|NCT02696031|27026435|FG005|Up to Week 104|Lack of Efficacy|0|||
13483647|NCT02696031|27026430|FG000|Up to Week 104|Adverse Event|7|||
13483648|NCT02696031|27026431|FG001|Up to Week 104|Adverse Event|11|||
13483649|NCT02696031|27026432|FG002|Up to Week 104|Adverse Event|5|||
13483650|NCT02696031|27026433|FG003|Up to Week 104|Adverse Event|0|||
13483651|NCT02696031|27026434|FG004|Up to Week 104|Adverse Event|0|||
13483652|NCT02696031|27026435|FG005|Up to Week 104|Adverse Event|0|||
13483653|NCT02696031|27026430|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
13483654|NCT02696031|27026431|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1|||
13483655|NCT02696031|27026432|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
13483656|NCT02696031|27026433|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
13483657|NCT02696031|27026434|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
13483658|NCT02696031|27026435|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
13483659|NCT02696031|27026430|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
13483660|NCT02696031|27026431|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
13483661|NCT02696031|27026432|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
13483662|NCT02696031|27026433|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6|||
13483663|NCT02696031|27026434|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8|||
13483664|NCT02696031|27026435|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2|||
13483665|NCT02696031|27026430|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
13483666|NCT02696031|27026431|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
13483667|NCT02696031|27026432|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
13483668|NCT02696031|27026433|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
13483669|NCT02696031|27026434|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
13483670|NCT02696031|27026435|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
13483671|NCT02696031|27026430|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
13483672|NCT02696031|27026431|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
13483673|NCT02696031|27026432|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
13483674|NCT02696031|27026433|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1|||
13483675|NCT02696031|27026434|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
13483676|NCT02696031|27026435|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
13483677|NCT02696031|27026430|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
13483678|NCT02696031|27026431|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
13483679|NCT02696031|27026432|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
13483680|NCT02696031|27026433|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
13483681|NCT02696031|27026434|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1|||
13135686|NCT02737501|25996065|FG000|Randomized Phase|Reason not Specified|1|||
13483682|NCT02696031|27026435|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
13483683|NCT02696031|27026430|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
13483684|NCT02696031|27026431|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
13483685|NCT02696031|27026432|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
13483686|NCT02696031|27026433|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
13483687|NCT02696031|27026434|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
13483688|NCT02696031|27026435|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3|||
13483689|NCT02696031|27026430|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
13483690|NCT02696031|27026431|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
13483691|NCT02696031|27026432|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
13483692|NCT02696031|27026433|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
13483693|NCT02696031|27026434|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4|||
13483694|NCT02696031|27026435|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
13483695|NCT02689453|27026472|FG000|Overall Study|Progressive disease|0|||
13483696|NCT02689453|27026473|FG001|Overall Study|Progressive disease|1|||
13483697|NCT02689453|27026474|FG002|Overall Study|Progressive disease|1|||
13487662|NCT02886572|27041014|FG000|Overall Study|Death|8|||
13487663|NCT02805257|27041041|FG000|Overall Study|Lost to Follow-up|7|||
13487664|NCT02805257|27041042|FG001|Overall Study|Lost to Follow-up|6|||
13487665|NCT02805257|27041041|FG000|Overall Study|Death|0|||
13487666|NCT02805257|27041042|FG001|Overall Study|Death|1|||
13487667|NCT02696564|27041113|FG000|Overall Study|Death|1|||
13487668|NCT02696564|27041114|FG001|Overall Study|Death|2|||
13487669|NCT02696564|27041113|FG000|Overall Study|Withdrawal by Subject|3|||
13487670|NCT02696564|27041114|FG001|Overall Study|Withdrawal by Subject|2|||
13487671|NCT02696564|27041113|FG000|Overall Study|Lost to Follow-up|3|||
13487672|NCT02696564|27041114|FG001|Overall Study|Lost to Follow-up|3|||
13487673|NCT02696564|27041113|FG000|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|3|||
13487674|NCT02696564|27041114|FG001|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|1|||
13487675|NCT02696564|27041113|FG000|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
13487676|NCT02696564|27041114|FG001|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
13487677|NCT02696564|27041113|FG000|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
13487678|NCT02696564|27041114|FG001|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
13487679|NCT02696564|27041113|FG000|Overall Study|Participant diagnosed with lung cancer|1|||
13487680|NCT02696564|27041114|FG001|Overall Study|Participant diagnosed with lung cancer|0|||
13487681|NCT02696564|27041113|FG000|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|0|||
13487682|NCT02696564|27041114|FG001|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|2|||
13487683|NCT02640950|27041125|FG000|Overall Study|Adverse Event|1|||
13487684|NCT02640950|27041125|FG000|Overall Study|Withdrawal by Subject|1|||
13487685|NCT02639065|27041133|FG000|Study Treatment|Disease Progression|11|||
13487686|NCT02639065|27041133|FG000|Study Treatment|Adverse Event|8|||
13487687|NCT02639065|27041133|FG000|Study Treatment|Withdrawal by Subject|1|||
13487688|NCT02639065|27041133|FG000|Follow up|Withdrawal by Subject|1|||
13487689|NCT02639065|27041133|FG000|Follow up|Symptomatic Deterioration|2|||
13487690|NCT02639065|27041133|FG000|Follow up|Death|2|||
13487691|NCT02639065|27041133|FG000|Follow up|Study Terminated|1|||
13487692|NCT02639065|27041133|FG000|Follow up|Disease Progression|3|||
13487693|NCT02564263|27041162|FG000|Overall Study|Adverse Event|31|||
13487694|NCT02564263|27041163|FG001|Overall Study|Adverse Event|29|||
13487695|NCT02564263|27041162|FG000|Overall Study|Death|236|||
13487696|NCT02564263|27041163|FG001|Overall Study|Death|242|||
13487697|NCT02564263|27041162|FG000|Overall Study|Withdrawal by Subject|5|||
13487698|NCT02564263|27041163|FG001|Overall Study|Withdrawal by Subject|18|||
13487699|NCT02564263|27041162|FG000|Overall Study|Ongoing in Study|42|||
13487700|NCT02564263|27041163|FG001|Overall Study|Ongoing in Study|25|||
13487701|NCT02372136|27041188|FG000|Overall Study|Death|3|||
13487702|NCT02372136|27041189|FG001|Overall Study|Death|1|||
13487703|NCT02367456|27041236|FG000|Overall Study|Death|8|||
13487704|NCT02367456|27041237|FG001|Overall Study|Death|21|||
13487705|NCT02367456|27041238|FG002|Overall Study|Death|14|||
13487706|NCT02367456|27041236|FG000|Overall Study|Lost to Follow-up|1|||
13487707|NCT02367456|27041237|FG001|Overall Study|Lost to Follow-up|3|||
13487708|NCT02367456|27041238|FG002|Overall Study|Lost to Follow-up|1|||
13487709|NCT02367456|27041236|FG000|Overall Study|Ongoing|0|||
13487710|NCT02367456|27041237|FG001|Overall Study|Ongoing|6|||
13487711|NCT02367456|27041238|FG002|Overall Study|Ongoing|15|||
13487712|NCT02367456|27041236|FG000|Overall Study|Other reason|3|||
13487713|NCT02367456|27041237|FG001|Overall Study|Other reason|0|||
13487714|NCT02367456|27041238|FG002|Overall Study|Other reason|0|||
13487715|NCT02022033|27041245|FG000|Overall Study|Physician Decision|1|||
13487716|NCT01559363|27041328|FG000|Phase 1b: Up to 36 Months|Withdrawal by Subject|2|||
13487717|NCT01559363|27041329|FG001|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
13487718|NCT01559363|27041330|FG002|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
13483698|NCT02476851|27026487|FG000|Overall Study|Protocol Violation|1|||
13483699|NCT02476851|27026488|FG001|Overall Study|Protocol Violation|1|||
13483700|NCT02208024|27026568|FG000|Overall Study|Withdrawal by Subject|1|||
13483701|NCT01866111|27026595|FG000|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|14|||
13483702|NCT01866111|27026596|FG001|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|13|||
13483703|NCT01866111|27026597|FG002|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|20|||
13483704|NCT01866111|27026598|FG003|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|30|||
13483705|NCT01866111|27026595|FG000|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|65|||
13483706|NCT01866111|27026596|FG001|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|67|||
13483707|NCT01866111|27026597|FG002|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|63|||
13483708|NCT01866111|27026598|FG003|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|52|||
13483709|NCT01767129|27026627|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
13483710|NCT01767129|27026628|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
13483711|NCT01586910|27026688|FG000|Overall Study|Death|4|||
13483712|NCT01586910|27026689|FG001|Overall Study|Death|4|||
13483713|NCT01586910|27026688|FG000|Overall Study|Withdrawal by Subject|6|||
13483714|NCT01586910|27026689|FG001|Overall Study|Withdrawal by Subject|43|||
13483715|NCT01586910|27026688|FG000|Overall Study|Physician withdrew Subject|5|||
13483716|NCT01586910|27026689|FG001|Overall Study|Physician withdrew Subject|24|||
13487719|NCT01559363|27041331|FG003|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
13487720|NCT01559363|27041332|FG004|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
13487721|NCT01559363|27041333|FG005|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
13487722|NCT01559363|27041328|FG000|Phase 1b: Up to 36 Months|Investigator decision|1|||
13487723|NCT01559363|27041329|FG001|Phase 1b: Up to 36 Months|Investigator decision|0|||
13487724|NCT01559363|27041330|FG002|Phase 1b: Up to 36 Months|Investigator decision|0|||
13487725|NCT01559363|27041331|FG003|Phase 1b: Up to 36 Months|Investigator decision|0|||
13487726|NCT01559363|27041332|FG004|Phase 1b: Up to 36 Months|Investigator decision|0|||
13487727|NCT01559363|27041333|FG005|Phase 1b: Up to 36 Months|Investigator decision|0|||
13487728|NCT01559363|27041328|FG000|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
13487729|NCT01559363|27041329|FG001|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
13487730|NCT01559363|27041330|FG002|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
13487731|NCT01559363|27041331|FG003|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
13487732|NCT01559363|27041332|FG004|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
13487733|NCT01559363|27041333|FG005|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
13487734|NCT01559363|27041328|FG000|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|2|||
13487735|NCT01559363|27041329|FG001|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
13487736|NCT01559363|27041330|FG002|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|1|||
13487737|NCT01559363|27041331|FG003|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
13487738|NCT01559363|27041332|FG004|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
13487739|NCT01559363|27041333|FG005|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
13487740|NCT01559363|27041328|FG000|Phase 1b: Up to 36 Months|Unspecified reason|0|||
13487741|NCT01559363|27041329|FG001|Phase 1b: Up to 36 Months|Unspecified reason|1|||
13487742|NCT01559363|27041330|FG002|Phase 1b: Up to 36 Months|Unspecified reason|0|||
13487743|NCT01559363|27041331|FG003|Phase 1b: Up to 36 Months|Unspecified reason|0|||
13487744|NCT01559363|27041332|FG004|Phase 1b: Up to 36 Months|Unspecified reason|0|||
13487745|NCT01559363|27041333|FG005|Phase 1b: Up to 36 Months|Unspecified reason|0|||
13487746|NCT01559363|27041328|FG000|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
13487747|NCT01559363|27041329|FG001|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
13487748|NCT01559363|27041330|FG002|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
13487749|NCT01559363|27041331|FG003|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
13487750|NCT01559363|27041332|FG004|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
13487751|NCT01559363|27041333|FG005|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
13487752|NCT01559363|27041328|FG000|Phase 2a: Up to 28 Months|Unspecified reason|0|||
13487753|NCT01559363|27041329|FG001|Phase 2a: Up to 28 Months|Unspecified reason|0|||
13487754|NCT01559363|27041330|FG002|Phase 2a: Up to 28 Months|Unspecified reason|0|||
13487755|NCT01559363|27041331|FG003|Phase 2a: Up to 28 Months|Unspecified reason|1|||
13487756|NCT01559363|27041332|FG004|Phase 2a: Up to 28 Months|Unspecified reason|0|||
13487757|NCT01559363|27041333|FG005|Phase 2a: Up to 28 Months|Unspecified reason|0|||
13487758|NCT01434602|27041387|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
13487759|NCT01434602|27041388|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1|||
13487760|NCT01434602|27041389|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
13487761|NCT01434602|27041390|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
13487762|NCT01434602|27041391|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
13483717|NCT02257918|27026769|FG000|Overall Study|Lost to Follow-up|4|||
13483718|NCT02257918|27026770|FG001|Overall Study|Lost to Follow-up|1|||
13483719|NCT02257918|27026771|FG002|Overall Study|Lost to Follow-up|0|||
13483720|NCT02257918|27026769|FG000|Overall Study|Withdrawal by Subject|0|||
13483721|NCT02257918|27026770|FG001|Overall Study|Withdrawal by Subject|0|||
13483722|NCT02257918|27026771|FG002|Overall Study|Withdrawal by Subject|1|||
13483723|NCT02257918|27026769|FG000|Overall Study|Pregnancy|0|||
13483724|NCT02257918|27026770|FG001|Overall Study|Pregnancy|0|||
13483725|NCT02257918|27026771|FG002|Overall Study|Pregnancy|1|||
13483758|NCT03817190|27027085|FG000|Overall Study|Early Termination|13|||
13483759|NCT03817190|27027086|FG001|Overall Study|Early Termination|20|||
13483760|NCT03817190|27027085|FG000|Overall Study|Adverse Event|10|||
13483761|NCT03817190|27027086|FG001|Overall Study|Adverse Event|17|||
13483762|NCT03817190|27027085|FG000|Overall Study|Withdrawal by Subject|12|||
13483763|NCT03817190|27027086|FG001|Overall Study|Withdrawal by Subject|8|||
13483764|NCT03817190|27027085|FG000|Overall Study|Lost to Follow-up|11|||
13483765|NCT03817190|27027086|FG001|Overall Study|Lost to Follow-up|7|||
13483766|NCT03817190|27027085|FG000|Overall Study|Lack of Efficacy|7|||
13483767|NCT03817190|27027086|FG001|Overall Study|Lack of Efficacy|5|||
13483768|NCT03817190|27027085|FG000|Overall Study|Investigator Decision|5|||
13483769|NCT03817190|27027086|FG001|Overall Study|Investigator Decision|1|||
13483770|NCT03817190|27027085|FG000|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|0|||
13483771|NCT03817190|27027086|FG001|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|1|||
13483772|NCT03817190|27027085|FG000|Overall Study|Lack of Contact|1|||
13483773|NCT03817190|27027086|FG001|Overall Study|Lack of Contact|0|||
13483774|NCT03817190|27027085|FG000|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|1|||
13483775|NCT03817190|27027086|FG001|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|0|||
13483776|NCT03797222|27027106|FG000|Overall Study|Withdrawal by Subject|1|||
13483777|NCT03715465|27027145|FG000|Overall Study|Withdrawal by Subject|1|||
13483778|NCT03715465|27027146|FG001|Overall Study|Withdrawal by Subject|2|||
13483779|NCT03667924|27027170|FG000|Baseline Completed|Lost to Follow-up|0|||
13483780|NCT03667924|27027171|FG001|Baseline Completed|Lost to Follow-up|2|||
13483781|NCT03667924|27027172|FG002|Baseline Completed|Lost to Follow-up|0|||
13483782|NCT03667924|27027170|FG000|1-month Completed/Training (Volunteers)|One client was hospitalized;|1|||
13483783|NCT03667924|27027171|FG001|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
13483784|NCT03667924|27027172|FG002|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
13483785|NCT03667924|27027170|FG000|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
13483786|NCT03667924|27027171|FG001|1-month Completed/Training (Volunteers)|Did not complete full training|16|||
13483787|NCT03667924|27027172|FG002|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
13483788|NCT03667924|27027170|FG000|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
13483789|NCT03667924|27027171|FG001|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
13483790|NCT03667924|27027172|FG002|1-month Completed/Training (Volunteers)|Lost to Follow-up|1|||
13483791|NCT03667924|27027170|FG000|3-month/Volunteers Who Enrolled Clients|Death|1|||
13483792|NCT03667924|27027171|FG001|3-month/Volunteers Who Enrolled Clients|Death|0|||
13483793|NCT03667924|27027172|FG002|3-month/Volunteers Who Enrolled Clients|Death|0|||
13483794|NCT03667924|27027170|FG000|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
13483795|NCT03667924|27027171|FG001|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|10|||
13483796|NCT03667924|27027172|FG002|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
13483797|NCT03667924|27027170|FG000|Post-study Interview Completed|Lost to Follow-up|0|||
13483798|NCT03667924|27027171|FG001|Post-study Interview Completed|Lost to Follow-up|1|||
13483799|NCT03667924|27027172|FG002|Post-study Interview Completed|Lost to Follow-up|0|||
13483800|NCT03524092|27027216|FG000|Blinded Maintenance Period (Wk 0-40)|Adverse Event|16|||
13483801|NCT03524092|27027217|FG001|Blinded Maintenance Period (Wk 0-40)|Adverse Event|6|||
13483802|NCT03524092|27027218|FG002|Blinded Maintenance Period (Wk 0-40)|Adverse Event|1|||
13483803|NCT03524092|27027219|FG003|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
13483804|NCT03524092|27027220|FG004|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
13483805|NCT03524092|27027221|FG005|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
13483806|NCT03524092|27027216|FG000|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|8|||
13483807|NCT03524092|27027217|FG001|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|6|||
13483808|NCT03524092|27027218|FG002|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|7|||
13483809|NCT03524092|27027219|FG003|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
13483810|NCT03524092|27027220|FG004|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
13483811|NCT03524092|27027221|FG005|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
13483812|NCT03524092|27027216|FG000|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
13483813|NCT03524092|27027217|FG001|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|1|||
13483814|NCT03524092|27027218|FG002|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
13372864|NCT00806260|26722176|FG005|Period 2|Adverse Event|0|||
13483726|NCT02258542|27027008|FG000|Overall Study|eg. not made to the visit|7|||
13483727|NCT02258542|27027009|FG001|Overall Study|eg. not made to the visit|4|||
13483728|NCT02258542|27027010|FG002|Overall Study|eg. not made to the visit|0|||
13483729|NCT02258542|27027011|FG003|Overall Study|eg. not made to the visit|1|||
13483730|NCT02258542|27027008|FG000|Overall Study|study specific discount. criteria|1|||
13483731|NCT02258542|27027009|FG001|Overall Study|study specific discount. criteria|1|||
13483732|NCT02258542|27027010|FG002|Overall Study|study specific discount. criteria|0|||
13483733|NCT02258542|27027011|FG003|Overall Study|study specific discount. criteria|0|||
13483734|NCT02258542|27027008|FG000|Overall Study|Withdrawal by Subject|20|||
13483735|NCT02258542|27027009|FG001|Overall Study|Withdrawal by Subject|20|||
13483736|NCT02258542|27027010|FG002|Overall Study|Withdrawal by Subject|7|||
13483737|NCT02258542|27027011|FG003|Overall Study|Withdrawal by Subject|1|||
13483738|NCT02258542|27027008|FG000|Overall Study|Lost to Follow-up|5|||
13483739|NCT02258542|27027009|FG001|Overall Study|Lost to Follow-up|12|||
13483740|NCT02258542|27027010|FG002|Overall Study|Lost to Follow-up|1|||
13483741|NCT02258542|27027011|FG003|Overall Study|Lost to Follow-up|2|||
13483742|NCT02258542|27027008|FG000|Overall Study|Death|5|||
13483743|NCT02258542|27027009|FG001|Overall Study|Death|4|||
13483744|NCT02258542|27027010|FG002|Overall Study|Death|0|||
13483745|NCT02258542|27027011|FG003|Overall Study|Death|1|||
13483746|NCT02258542|27027008|FG000|Overall Study|Adverse Event|3|||
13483747|NCT02258542|27027009|FG001|Overall Study|Adverse Event|4|||
13483748|NCT02258542|27027010|FG002|Overall Study|Adverse Event|0|||
13483749|NCT02258542|27027011|FG003|Overall Study|Adverse Event|0|||
13483750|NCT02258542|27027008|FG000|Overall Study|Protocol Violation|1|||
13483751|NCT02258542|27027009|FG001|Overall Study|Protocol Violation|2|||
13483752|NCT02258542|27027010|FG002|Overall Study|Protocol Violation|0|||
13483753|NCT02258542|27027011|FG003|Overall Study|Protocol Violation|0|||
13483754|NCT02258542|27027008|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
13483755|NCT02258542|27027009|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
13483756|NCT02258542|27027010|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
13483757|NCT02258542|27027011|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
13483815|NCT03524092|27027219|FG003|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
13483816|NCT03524092|27027220|FG004|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
13483817|NCT03524092|27027221|FG005|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
13483818|NCT03524092|27027216|FG000|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
13483819|NCT03524092|27027217|FG001|Blinded Maintenance Period (Wk 0-40)|Physician Decision|1|||
13483820|NCT03524092|27027218|FG002|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
13483821|NCT03524092|27027219|FG003|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
13483822|NCT03524092|27027220|FG004|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
13483823|NCT03524092|27027221|FG005|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
13483824|NCT03524092|27027216|FG000|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
13483825|NCT03524092|27027217|FG001|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
13483826|NCT03524092|27027218|FG002|Blinded Maintenance Period (Wk 0-40)|Pregnancy|1|||
13483827|NCT03524092|27027219|FG003|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
13483828|NCT03524092|27027220|FG004|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
13483829|NCT03524092|27027221|FG005|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
13483830|NCT03524092|27027216|FG000|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
13483831|NCT03524092|27027217|FG001|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
13483832|NCT03524092|27027218|FG002|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
13483833|NCT03524092|27027219|FG003|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
13483834|NCT03524092|27027220|FG004|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
13483835|NCT03524092|27027221|FG005|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
13483836|NCT03524092|27027216|FG000|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|7|||
13483837|NCT03524092|27027217|FG001|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|8|||
13483838|NCT03524092|27027218|FG002|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|6|||
13483839|NCT03524092|27027219|FG003|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
13483840|NCT03524092|27027220|FG004|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
13483841|NCT03524092|27027221|FG005|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
13483842|NCT03524092|27027216|FG000|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|42|||
13483843|NCT03524092|27027217|FG001|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|19|||
13483844|NCT03524092|27027218|FG002|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|29|||
13483845|NCT03524092|27027219|FG003|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
13483846|NCT03524092|27027220|FG004|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
13483847|NCT03524092|27027221|FG005|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
13483848|NCT03524092|27027216|FG000|Loss of Response Rescue Period|Adverse Event|0|||
13483849|NCT03524092|27027217|FG001|Loss of Response Rescue Period|Adverse Event|0|||
13483850|NCT03524092|27027218|FG002|Loss of Response Rescue Period|Adverse Event|0|||
13483851|NCT03524092|27027219|FG003|Loss of Response Rescue Period|Adverse Event|2|||
13483852|NCT03524092|27027220|FG004|Loss of Response Rescue Period|Adverse Event|0|||
13483853|NCT03524092|27027221|FG005|Loss of Response Rescue Period|Adverse Event|0|||
13483854|NCT03524092|27027216|FG000|Loss of Response Rescue Period|Lack of Efficacy|0|||
13483855|NCT03524092|27027217|FG001|Loss of Response Rescue Period|Lack of Efficacy|0|||
13483856|NCT03524092|27027218|FG002|Loss of Response Rescue Period|Lack of Efficacy|0|||
13483857|NCT03524092|27027219|FG003|Loss of Response Rescue Period|Lack of Efficacy|5|||
13483858|NCT03524092|27027220|FG004|Loss of Response Rescue Period|Lack of Efficacy|0|||
13483859|NCT03524092|27027221|FG005|Loss of Response Rescue Period|Lack of Efficacy|0|||
13483860|NCT03524092|27027216|FG000|Loss of Response Rescue Period|Pregnancy|0|||
13483861|NCT03524092|27027217|FG001|Loss of Response Rescue Period|Pregnancy|0|||
13483862|NCT03524092|27027218|FG002|Loss of Response Rescue Period|Pregnancy|0|||
13483863|NCT03524092|27027219|FG003|Loss of Response Rescue Period|Pregnancy|1|||
13483864|NCT03524092|27027220|FG004|Loss of Response Rescue Period|Pregnancy|0|||
13483865|NCT03524092|27027221|FG005|Loss of Response Rescue Period|Pregnancy|0|||
13483866|NCT03524092|27027216|FG000|Loss of Response Rescue Period|Withdrawal by Subject|0|||
13483867|NCT03524092|27027217|FG001|Loss of Response Rescue Period|Withdrawal by Subject|0|||
13483868|NCT03524092|27027218|FG002|Loss of Response Rescue Period|Withdrawal by Subject|0|||
13483869|NCT03524092|27027219|FG003|Loss of Response Rescue Period|Withdrawal by Subject|1|||
13483870|NCT03524092|27027220|FG004|Loss of Response Rescue Period|Withdrawal by Subject|0|||
13483871|NCT03524092|27027221|FG005|Loss of Response Rescue Period|Withdrawal by Subject|0|||
13483872|NCT03524092|27027216|FG000|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
13483873|NCT03524092|27027217|FG001|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
13483874|NCT03524092|27027218|FG002|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
13483875|NCT03524092|27027219|FG003|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
13483876|NCT03524092|27027220|FG004|Open Label Extended Induction (Wk 0-12)|Adverse Event|11|||
13483877|NCT03524092|27027221|FG005|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
13483878|NCT03524092|27027216|FG000|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
13483879|NCT03524092|27027217|FG001|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
13483880|NCT03524092|27027218|FG002|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
13483881|NCT03524092|27027219|FG003|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
13483882|NCT03524092|27027220|FG004|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|4|||
13483883|NCT03524092|27027221|FG005|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
13483884|NCT03524092|27027216|FG000|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
13483885|NCT03524092|27027217|FG001|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
13483886|NCT03524092|27027218|FG002|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
13483887|NCT03524092|27027219|FG003|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
13483888|NCT03524092|27027220|FG004|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|162|||
13483889|NCT03524092|27027221|FG005|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
13483890|NCT03524092|27027216|FG000|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
13483891|NCT03524092|27027217|FG001|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
13483892|NCT03524092|27027218|FG002|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
13483893|NCT03524092|27027219|FG003|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
13483894|NCT03524092|27027220|FG004|Open Label Extended Induction (Wk 0-12)|Physician Decision|1|||
13483895|NCT03524092|27027221|FG005|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
13483896|NCT03524092|27027216|FG000|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
13483897|NCT03524092|27027217|FG001|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
13483898|NCT03524092|27027218|FG002|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
13483899|NCT03524092|27027219|FG003|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
13483900|NCT03524092|27027220|FG004|Open Label Extended Induction (Wk 0-12)|Protocol Violation|5|||
13483901|NCT03524092|27027221|FG005|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
13483902|NCT03524092|27027216|FG000|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
13483903|NCT03524092|27027217|FG001|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
13483904|NCT03524092|27027218|FG002|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
13483905|NCT03524092|27027219|FG003|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
13483906|NCT03524092|27027220|FG004|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|6|||
13483907|NCT03524092|27027221|FG005|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
13483908|NCT03524092|27027216|FG000|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
13483909|NCT03524092|27027217|FG001|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
13483910|NCT03524092|27027218|FG002|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
13483911|NCT03524092|27027219|FG003|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
13483912|NCT03524092|27027220|FG004|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|1|||
13483913|NCT03524092|27027221|FG005|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
13483914|NCT03524092|27027216|FG000|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
13221783|NCT01811186|26284659|FG001|Overall Study|Withdrawal by Subject|10|||
13483915|NCT03524092|27027217|FG001|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
13483916|NCT03524092|27027218|FG002|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
13483917|NCT03524092|27027219|FG003|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
13483918|NCT03524092|27027220|FG004|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
13483919|NCT03524092|27027221|FG005|Open Label Maintenance Period (Wk 12-40)|Adverse Event|4|||
13483920|NCT03524092|27027216|FG000|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
13483921|NCT03524092|27027217|FG001|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
13483922|NCT03524092|27027218|FG002|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
13483923|NCT03524092|27027219|FG003|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
13483924|NCT03524092|27027220|FG004|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
13124992|NCT02935192|25954760|FG000|Overall Study|Withdrawal by Subject|8|||
13124993|NCT02935192|25954761|FG001|Overall Study|Withdrawal by Subject|4|||
13124994|NCT02934503|25954771|FG000|Overall Study|progression of disease|3|||
13124995|NCT02934503|25954771|FG000|Overall Study|Withdrawal by Subject|1|||
13124996|NCT02934178|25954870|FG000|Received Vaccination 2|Death|0|||
13124997|NCT02934178|25954871|FG001|Received Vaccination 2|Death|1|||
13124998|NCT02934178|25954870|FG000|Received Vaccination 3|Withdrawal by Subject|1|||
13124999|NCT02934178|25954871|FG001|Received Vaccination 3|Withdrawal by Subject|0|||
13125000|NCT02933528|25954877|FG000|Overall Study|Lost to Follow-up|2|||
13125007|NCT02933060|25954927|FG000|Overall Study|Withdrawal by Subject|0|||
13125008|NCT02933060|25954928|FG001|Overall Study|Withdrawal by Subject|1|||
13125009|NCT02932943|25954947|FG000|Overall Study|Lost to Follow-up|0|||
13125010|NCT02932943|25954948|FG001|Overall Study|Lost to Follow-up|2|||
13125011|NCT02932943|25954947|FG000|Overall Study|Adverse Event|2|||
13125012|NCT02932943|25954948|FG001|Overall Study|Adverse Event|2|||
13125013|NCT02932943|25954947|FG000|Overall Study|Withdrawal by Subject|3|||
13125014|NCT02932943|25954948|FG001|Overall Study|Withdrawal by Subject|3|||
13125015|NCT02932904|25954996|FG000|Overall Study|Reason not Specified|1|||
13125016|NCT02932904|25954997|FG001|Overall Study|Reason not Specified|0|||
13125017|NCT02932904|25954998|FG002|Overall Study|Reason not Specified|2|||
13125018|NCT02932904|25954999|FG003|Overall Study|Reason not Specified|2|||
13125019|NCT02932904|25954996|FG000|Overall Study|Noncompliance with Study Drug|2|||
13125020|NCT02932904|25954997|FG001|Overall Study|Noncompliance with Study Drug|3|||
13125021|NCT02932904|25954998|FG002|Overall Study|Noncompliance with Study Drug|3|||
13125022|NCT02932904|25954999|FG003|Overall Study|Noncompliance with Study Drug|4|||
13125023|NCT02932904|25954996|FG000|Overall Study|Pregnancy|0|||
13125024|NCT02932904|25954997|FG001|Overall Study|Pregnancy|1|||
13125025|NCT02932904|25954998|FG002|Overall Study|Pregnancy|1|||
13125026|NCT02932904|25954999|FG003|Overall Study|Pregnancy|0|||
13125027|NCT02932904|25954996|FG000|Overall Study|Study Termination|0|||
13125028|NCT02932904|25954997|FG001|Overall Study|Study Termination|1|||
13125029|NCT02932904|25954998|FG002|Overall Study|Study Termination|0|||
13125030|NCT02932904|25954999|FG003|Overall Study|Study Termination|0|||
13125031|NCT02932904|25954996|FG000|Overall Study|Voluntary Withdrawal|2|||
13125032|NCT02932904|25954997|FG001|Overall Study|Voluntary Withdrawal|1|||
13125033|NCT02932904|25954998|FG002|Overall Study|Voluntary Withdrawal|4|||
13125034|NCT02932904|25954999|FG003|Overall Study|Voluntary Withdrawal|2|||
13125035|NCT02932904|25954996|FG000|Overall Study|Lost to Follow-up|5|||
13125036|NCT02932904|25954997|FG001|Overall Study|Lost to Follow-up|3|||
13125037|NCT02932904|25954998|FG002|Overall Study|Lost to Follow-up|6|||
13125038|NCT02932904|25954999|FG003|Overall Study|Lost to Follow-up|0|||
13125039|NCT02932904|25954996|FG000|Overall Study|Significant Protocol Deviation|2|||
13125040|NCT02932904|25954997|FG001|Overall Study|Significant Protocol Deviation|3|||
13125041|NCT02932904|25954998|FG002|Overall Study|Significant Protocol Deviation|6|||
13125042|NCT02932904|25954999|FG003|Overall Study|Significant Protocol Deviation|1|||
13125043|NCT02932904|25954996|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
13135687|NCT02737501|25996066|FG001|Randomized Phase|Reason not Specified|1|||
13125044|NCT02932904|25954997|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
13125045|NCT02932904|25954998|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
13125046|NCT02932904|25954999|FG003|Overall Study|Pretreatment Event/Adverse Event|3|||
13125047|NCT02932904|25954996|FG000|Overall Study|Randomized But Not Treated|1|||
13125048|NCT02932904|25954997|FG001|Overall Study|Randomized But Not Treated|1|||
13125049|NCT02932904|25954998|FG002|Overall Study|Randomized But Not Treated|0|||
13125050|NCT02932904|25954999|FG003|Overall Study|Randomized But Not Treated|2|||
13125051|NCT02932891|25955005|FG000|Overall Study|Lost to Follow-up|2|||
13125052|NCT02932891|25955005|FG000|Overall Study|HPA Suppress|2|||
13125053|NCT02932878|25955018|FG000|Overall Study|Due to Lab Results|2|||
13483925|NCT03524092|27027221|FG005|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|1|||
13483926|NCT03524092|27027216|FG000|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
13483927|NCT03524092|27027217|FG001|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
13483928|NCT03524092|27027218|FG002|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
13483929|NCT03524092|27027219|FG003|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
13483930|NCT03524092|27027220|FG004|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
13483931|NCT03524092|27027221|FG005|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|9|||
13483932|NCT03524092|27027216|FG000|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
13483933|NCT03524092|27027217|FG001|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
13483934|NCT03524092|27027218|FG002|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
13483935|NCT03524092|27027219|FG003|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
13483936|NCT03524092|27027220|FG004|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
13483937|NCT03524092|27027221|FG005|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|1|||
13483938|NCT03517449|27027244|FG000|Overall Study|Death|184|||
13483939|NCT03517449|27027245|FG001|Overall Study|Death|236|||
13483940|NCT03517449|27027244|FG000|Overall Study|Lost to Follow-up|0|||
13483941|NCT03517449|27027245|FG001|Overall Study|Lost to Follow-up|2|||
13483942|NCT03517449|27027244|FG000|Overall Study|Withdrawal by Subject|7|||
13483943|NCT03517449|27027245|FG001|Overall Study|Withdrawal by Subject|26|||
13483944|NCT03517449|27027244|FG000|Overall Study|Participants Ongoing|220|||
13483945|NCT03517449|27027245|FG001|Overall Study|Participants Ongoing|152|||
13483946|NCT03434379|27027336|FG000|Global Period|Lost to Follow-up|3|||
13483947|NCT03434379|27027337|FG001|Global Period|Lost to Follow-up|1|||
13483948|NCT03434379|27027338|FG002|Global Period|Lost to Follow-up|0|||
13483949|NCT03434379|27027339|FG003|Global Period|Lost to Follow-up|0|||
13483950|NCT03434379|27027336|FG000|Global Period|Death|99|||
13483951|NCT03434379|27027337|FG001|Global Period|Death|179|||
13483952|NCT03434379|27027338|FG002|Global Period|Death|0|||
13483953|NCT03434379|27027339|FG003|Global Period|Death|0|||
13483954|NCT03434379|27027336|FG000|Global Period|Withdrawal by Subject|20|||
13483955|NCT03434379|27027337|FG001|Global Period|Withdrawal by Subject|20|||
13483956|NCT03434379|27027338|FG002|Global Period|Withdrawal by Subject|0|||
13483957|NCT03434379|27027339|FG003|Global Period|Withdrawal by Subject|0|||
13483958|NCT03434379|27027336|FG000|Global Period|On Study|43|||
13483959|NCT03434379|27027337|FG001|Global Period|On Study|136|||
13483960|NCT03434379|27027338|FG002|Global Period|On Study|0|||
13483961|NCT03434379|27027339|FG003|Global Period|On Study|0|||
13483962|NCT03434379|27027336|FG000|China Extension Period|Lost to Follow-up|0|||
13483963|NCT03434379|27027337|FG001|China Extension Period|Lost to Follow-up|0|||
13483964|NCT03434379|27027338|FG002|China Extension Period|Lost to Follow-up|1|||
13483965|NCT03434379|27027339|FG003|China Extension Period|Lost to Follow-up|0|||
13483966|NCT03434379|27027336|FG000|China Extension Period|Death|0|||
13483967|NCT03434379|27027337|FG001|China Extension Period|Death|0|||
13483968|NCT03434379|27027338|FG002|China Extension Period|Death|38|||
13483969|NCT03434379|27027339|FG003|China Extension Period|Death|61|||
13483970|NCT03434379|27027336|FG000|China Extension Period|Withdrawal by Subject|0|||
13483971|NCT03434379|27027337|FG001|China Extension Period|Withdrawal by Subject|0|||
13483972|NCT03434379|27027338|FG002|China Extension Period|Withdrawal by Subject|7|||
13483973|NCT03434379|27027339|FG003|China Extension Period|Withdrawal by Subject|6|||
13483974|NCT03434379|27027336|FG000|China Extension Period|On Study|0|||
13483975|NCT03434379|27027337|FG001|China Extension Period|On Study|0|||
13483976|NCT03434379|27027338|FG002|China Extension Period|On Study|15|||
13483977|NCT03434379|27027339|FG003|China Extension Period|On Study|66|||
13483978|NCT03382821|27027409|FG000|Overall Study|Did not receive allocated intervention.|0|||
13483979|NCT03382821|27027410|FG001|Overall Study|Did not receive allocated intervention.|3|||
13483980|NCT03256344|27027550|FG000|Overall Study|Death|6|||
13483981|NCT03256344|27027551|FG001|Overall Study|Death|22|||
13483982|NCT03256344|27027550|FG000|Overall Study|Withdrawal by Subject|3|||
13483983|NCT03256344|27027551|FG001|Overall Study|Withdrawal by Subject|3|||
13483984|NCT03256344|27027550|FG000|Overall Study|Sponsor Decision|1|||
13483985|NCT03256344|27027551|FG001|Overall Study|Sponsor Decision|0|||
13487763|NCT01434602|27041387|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
13487764|NCT01434602|27041388|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
13487765|NCT01434602|27041389|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
13487766|NCT01434602|27041390|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1|||
13487767|NCT01434602|27041391|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
13487768|NCT01434602|27041387|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
13487769|NCT01434602|27041388|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
13487770|NCT01434602|27041389|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
13487771|NCT01434602|27041390|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1|||
13483986|NCT02908685|27027669|FG000|Part 1 Exploratory|Withdrawal by Subject|0|||
13483987|NCT02908685|27027670|FG001|Part 1 Exploratory|Withdrawal by Subject|1|||
13483988|NCT02908685|27027671|FG002|Part 1 Exploratory|Withdrawal by Subject|0|||
13483989|NCT02908685|27027672|FG003|Part 1 Exploratory|Withdrawal by Subject|0|||
13483990|NCT02908685|27027673|FG004|Part 1 Exploratory|Withdrawal by Subject|0|||
13483991|NCT02908685|27027674|FG005|Part 1 Exploratory|Withdrawal by Subject|0|||
13483992|NCT02908685|27027675|FG006|Part 1 Exploratory|Withdrawal by Subject|0|||
13483993|NCT02908685|27027676|FG007|Part 1 Exploratory|Withdrawal by Subject|0|||
13483994|NCT02908685|27027677|FG008|Part 1 Exploratory|Withdrawal by Subject|0|||
13483995|NCT02908685|27027678|FG009|Part 1 Exploratory|Withdrawal by Subject|0|||
13483996|NCT02908685|27027679|FG010|Part 1 Exploratory|Withdrawal by Subject|0|||
13483997|NCT02908685|27027680|FG011|Part 1 Exploratory|Withdrawal by Subject|0|||
13483998|NCT02908685|27027669|FG000|Part 2 Confirmatory|Changed to Spinraza|0|||
13483999|NCT02908685|27027670|FG001|Part 2 Confirmatory|Changed to Spinraza|0|||
13484000|NCT02908685|27027671|FG002|Part 2 Confirmatory|Changed to Spinraza|0|||
13484001|NCT02908685|27027672|FG003|Part 2 Confirmatory|Changed to Spinraza|0|||
13484002|NCT02908685|27027673|FG004|Part 2 Confirmatory|Changed to Spinraza|0|||
13484003|NCT02908685|27027674|FG005|Part 2 Confirmatory|Changed to Spinraza|0|||
13484004|NCT02908685|27027675|FG006|Part 2 Confirmatory|Changed to Spinraza|0|||
13484005|NCT02908685|27027676|FG007|Part 2 Confirmatory|Changed to Spinraza|0|||
13484006|NCT02908685|27027677|FG008|Part 2 Confirmatory|Changed to Spinraza|0|||
13484007|NCT02908685|27027678|FG009|Part 2 Confirmatory|Changed to Spinraza|0|||
13484008|NCT02908685|27027679|FG010|Part 2 Confirmatory|Changed to Spinraza|2|||
13484009|NCT02908685|27027680|FG011|Part 2 Confirmatory|Changed to Spinraza|1|||
13484010|NCT02908685|27027669|FG000|Part 2 Confirmatory|Changed to other treatment|0|||
13484011|NCT02908685|27027670|FG001|Part 2 Confirmatory|Changed to other treatment|0|||
13484012|NCT02908685|27027671|FG002|Part 2 Confirmatory|Changed to other treatment|0|||
13484013|NCT02908685|27027672|FG003|Part 2 Confirmatory|Changed to other treatment|0|||
13484014|NCT02908685|27027673|FG004|Part 2 Confirmatory|Changed to other treatment|0|||
13484015|NCT02908685|27027674|FG005|Part 2 Confirmatory|Changed to other treatment|0|||
13484016|NCT02908685|27027675|FG006|Part 2 Confirmatory|Changed to other treatment|0|||
13484017|NCT02908685|27027676|FG007|Part 2 Confirmatory|Changed to other treatment|0|||
13484018|NCT02908685|27027677|FG008|Part 2 Confirmatory|Changed to other treatment|0|||
13484019|NCT02908685|27027678|FG009|Part 2 Confirmatory|Changed to other treatment|0|||
13484020|NCT02908685|27027679|FG010|Part 2 Confirmatory|Changed to other treatment|1|||
13484021|NCT02908685|27027680|FG011|Part 2 Confirmatory|Changed to other treatment|0|||
13484022|NCT02867592|27027742|FG000|Overall Study|Adverse Event|3|||
13484023|NCT02867592|27027743|FG001|Overall Study|Adverse Event|0|||
13484024|NCT02867592|27027744|FG002|Overall Study|Adverse Event|2|||
13484025|NCT02867592|27027745|FG003|Overall Study|Adverse Event|1|||
13484026|NCT02867592|27027746|FG004|Overall Study|Adverse Event|1|||
13484027|NCT02867592|27027747|FG005|Overall Study|Adverse Event|5|||
13484028|NCT02867592|27027742|FG000|Overall Study|Death|0|||
13484029|NCT02867592|27027743|FG001|Overall Study|Death|0|||
13484030|NCT02867592|27027744|FG002|Overall Study|Death|0|||
13484031|NCT02867592|27027745|FG003|Overall Study|Death|1|||
13484032|NCT02867592|27027746|FG004|Overall Study|Death|0|||
13484033|NCT02867592|27027747|FG005|Overall Study|Death|1|||
13484034|NCT02867592|27027742|FG000|Overall Study|Lack of Efficacy|8|||
13484035|NCT02867592|27027743|FG001|Overall Study|Lack of Efficacy|10|||
13484036|NCT02867592|27027744|FG002|Overall Study|Lack of Efficacy|8|||
13484037|NCT02867592|27027745|FG003|Overall Study|Lack of Efficacy|8|||
13484038|NCT02867592|27027746|FG004|Overall Study|Lack of Efficacy|12|||
13484039|NCT02867592|27027747|FG005|Overall Study|Lack of Efficacy|17|||
13484040|NCT02867592|27027742|FG000|Overall Study|Physician Decision|1|||
13484041|NCT02867592|27027743|FG001|Overall Study|Physician Decision|2|||
13484042|NCT02867592|27027744|FG002|Overall Study|Physician Decision|2|||
13484043|NCT02867592|27027745|FG003|Overall Study|Physician Decision|0|||
13484044|NCT02867592|27027746|FG004|Overall Study|Physician Decision|5|||
13484045|NCT02867592|27027747|FG005|Overall Study|Physician Decision|1|||
13484046|NCT02867592|27027742|FG000|Overall Study|Protocol Violation|0|||
13484047|NCT02867592|27027743|FG001|Overall Study|Protocol Violation|0|||
13484048|NCT02867592|27027744|FG002|Overall Study|Protocol Violation|0|||
13484049|NCT02867592|27027745|FG003|Overall Study|Protocol Violation|0|||
13484050|NCT02867592|27027746|FG004|Overall Study|Protocol Violation|1|||
13484051|NCT02867592|27027747|FG005|Overall Study|Protocol Violation|1|||
13484052|NCT02867592|27027742|FG000|Overall Study|Withdrawal by Subject|0|||
13484053|NCT02867592|27027743|FG001|Overall Study|Withdrawal by Subject|1|||
13484054|NCT02867592|27027744|FG002|Overall Study|Withdrawal by Subject|0|||
13484055|NCT02867592|27027745|FG003|Overall Study|Withdrawal by Subject|1|||
13484056|NCT02867592|27027746|FG004|Overall Study|Withdrawal by Subject|3|||
13484057|NCT02867592|27027747|FG005|Overall Study|Withdrawal by Subject|3|||
13484058|NCT02867592|27027742|FG000|Overall Study|Ineligible|1|||
13484059|NCT02867592|27027743|FG001|Overall Study|Ineligible|1|||
13484060|NCT02867592|27027744|FG002|Overall Study|Ineligible|0|||
13484061|NCT02867592|27027745|FG003|Overall Study|Ineligible|0|||
13484062|NCT02867592|27027746|FG004|Overall Study|Ineligible|2|||
13484063|NCT02867592|27027747|FG005|Overall Study|Ineligible|0|||
13484064|NCT02867592|27027742|FG000|Overall Study|No Treatment|1|||
13484065|NCT02867592|27027743|FG001|Overall Study|No Treatment|0|||
13484066|NCT02867592|27027744|FG002|Overall Study|No Treatment|0|||
13484067|NCT02867592|27027745|FG003|Overall Study|No Treatment|0|||
13484068|NCT02867592|27027746|FG004|Overall Study|No Treatment|0|||
13484069|NCT02867592|27027747|FG005|Overall Study|No Treatment|0|||
13484070|NCT02867592|27027742|FG000|Overall Study|Still on Therapy|0|||
13484071|NCT02867592|27027743|FG001|Overall Study|Still on Therapy|0|||
13484072|NCT02867592|27027744|FG002|Overall Study|Still on Therapy|0|||
13484073|NCT02867592|27027745|FG003|Overall Study|Still on Therapy|0|||
13484074|NCT02867592|27027746|FG004|Overall Study|Still on Therapy|1|||
13484075|NCT02867592|27027747|FG005|Overall Study|Still on Therapy|0|||
13484076|NCT02867592|27027742|FG000|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
13484077|NCT02867592|27027743|FG001|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
13484078|NCT02867592|27027744|FG002|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
13484079|NCT02867592|27027745|FG003|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
13484080|NCT02867592|27027746|FG004|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
13484081|NCT02867592|27027747|FG005|Overall Study|Patient received concurrent anticancer or investigational therapy|1|||
13484082|NCT02867592|27027742|FG000|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
13484083|NCT02867592|27027743|FG001|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
13484084|NCT02867592|27027744|FG002|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
13484085|NCT02867592|27027745|FG003|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|2|||
13484086|NCT02867592|27027746|FG004|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
13484087|NCT02867592|27027747|FG005|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
13484088|NCT02253810|27027762|FG000|Overall Study|Withdrawal by Subject|2|||
13484089|NCT02253810|27027763|FG001|Overall Study|Withdrawal by Subject|1|||
13484090|NCT02253810|27027762|FG000|Overall Study|Unknown concomitant procedure|3|||
13484091|NCT02253810|27027763|FG001|Overall Study|Unknown concomitant procedure|2|||
13484092|NCT02094261|27027772|FG000|Overall Study|Death|24|||
13484093|NCT02094261|27027772|FG000|Overall Study|Lost to Follow-up|1|||
13484094|NCT02094261|27027772|FG000|Overall Study|Withdrawal by Subject|4|||
13484095|NCT02094261|27027772|FG000|Overall Study|Ongoing Study at Data Cut-off|181|||
13484096|NCT02032823|27027799|FG000|Overall Study|Death|59|||
13484097|NCT02032823|27027800|FG001|Overall Study|Death|86|||
13484098|NCT02032823|27027799|FG000|Overall Study|Lost to Follow-up|12|||
13484099|NCT02032823|27027800|FG001|Overall Study|Lost to Follow-up|15|||
13484100|NCT02032823|27027799|FG000|Overall Study|Withdrawal by Subject|65|||
13484101|NCT02032823|27027800|FG001|Overall Study|Withdrawal by Subject|49|||
13484102|NCT02032823|27027799|FG000|Overall Study|Ongoing study at data cut-off|782|||
13484103|NCT02032823|27027800|FG001|Overall Study|Ongoing study at data cut-off|760|||
13484104|NCT02032823|27027799|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3|||
13484105|NCT02032823|27027800|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5|||
13484106|NCT02029443|27027993|FG000|Overall Study|Completed 30-Day safety follow-up visit|53|||
13484107|NCT02029443|27027994|FG001|Overall Study|Completed 30-Day safety follow-up visit|16|||
13484108|NCT02029443|27027995|FG002|Overall Study|Completed 30-Day safety follow-up visit|12|||
13484109|NCT02029443|27027996|FG003|Overall Study|Completed 30-Day safety follow-up visit|2|||
13484110|NCT02029443|27027997|FG004|Overall Study|Completed 30-Day safety follow-up visit|1|||
13484111|NCT02029443|27027993|FG000|Overall Study|Death|13|||
13484112|NCT02029443|27027994|FG001|Overall Study|Death|2|||
13484113|NCT02029443|27027995|FG002|Overall Study|Death|2|||
13484114|NCT02029443|27027996|FG003|Overall Study|Death|11|||
13484115|NCT02029443|27027997|FG004|Overall Study|Death|2|||
13484116|NCT02029443|27027993|FG000|Overall Study|Lost to Follow-up|1|||
13484117|NCT02029443|27027994|FG001|Overall Study|Lost to Follow-up|0|||
13484118|NCT02029443|27027995|FG002|Overall Study|Lost to Follow-up|1|||
13484119|NCT02029443|27027996|FG003|Overall Study|Lost to Follow-up|1|||
13484120|NCT02029443|27027997|FG004|Overall Study|Lost to Follow-up|0|||
13484121|NCT02029443|27027993|FG000|Overall Study|Started other anti-cancer therapy|17|||
13484122|NCT02029443|27027994|FG001|Overall Study|Started other anti-cancer therapy|4|||
13484123|NCT02029443|27027995|FG002|Overall Study|Started other anti-cancer therapy|7|||
13484124|NCT02029443|27027996|FG003|Overall Study|Started other anti-cancer therapy|9|||
13484125|NCT02029443|27027997|FG004|Overall Study|Started other anti-cancer therapy|3|||
13484126|NCT02029443|27027993|FG000|Overall Study|Withdrawal by Subject|3|||
13484127|NCT02029443|27027994|FG001|Overall Study|Withdrawal by Subject|1|||
13484128|NCT02029443|27027995|FG002|Overall Study|Withdrawal by Subject|1|||
13484129|NCT02029443|27027996|FG003|Overall Study|Withdrawal by Subject|1|||
13484130|NCT02029443|27027997|FG004|Overall Study|Withdrawal by Subject|0|||
13484131|NCT02029443|27027993|FG000|Overall Study|Other|6|||
13484132|NCT02029443|27027994|FG001|Overall Study|Other|6|||
13484133|NCT02029443|27027995|FG002|Overall Study|Other|4|||
13484134|NCT02029443|27027996|FG003|Overall Study|Other|2|||
13484135|NCT02029443|27027997|FG004|Overall Study|Other|0|||
13484136|NCT01776424|27028049|FG000|Antithrombotic Part (Double Blind)|Lost to Follow-up|10|||
13484137|NCT01776424|27028050|FG001|Antithrombotic Part (Double Blind)|Lost to Follow-up|8|||
13484138|NCT01776424|27028051|FG002|Antithrombotic Part (Double Blind)|Lost to Follow-up|9|||
13484139|NCT01776424|27028049|FG000|Antithrombotic Part (Double Blind)|Withdrawal by Subject|10|||
13484140|NCT01776424|27028050|FG001|Antithrombotic Part (Double Blind)|Withdrawal by Subject|11|||
13484141|NCT01776424|27028051|FG002|Antithrombotic Part (Double Blind)|Withdrawal by Subject|15|||
13484142|NCT01776424|27028049|FG000|LTOLE Part (Open Label)|Lost to Follow-up|6|||
13484143|NCT01776424|27028050|FG001|LTOLE Part (Open Label)|Lost to Follow-up|2|||
13484144|NCT01776424|27028051|FG002|LTOLE Part (Open Label)|Lost to Follow-up|5|||
13484145|NCT01776424|27028049|FG000|LTOLE Part (Open Label)|Refused|5|||
13484146|NCT01776424|27028050|FG001|LTOLE Part (Open Label)|Refused|2|||
13484147|NCT01776424|27028051|FG002|LTOLE Part (Open Label)|Refused|11|||
13484148|NCT01776424|27028049|FG000|LTOLE Part (Open Label)|Missing final visit|68|||
13484149|NCT01776424|27028050|FG001|LTOLE Part (Open Label)|Missing final visit|58|||
13484150|NCT01776424|27028051|FG002|LTOLE Part (Open Label)|Missing final visit|62|||
13484151|NCT01750281|27028072|FG000|Overall Study|Discontinued Selumetinib/Placebo|37|||
13484152|NCT01750281|27028073|FG001|Overall Study|Discontinued Selumetinib/Placebo|77|||
13484153|NCT01750281|27028074|FG002|Overall Study|Discontinued Selumetinib/Placebo|75|||
13484154|NCT01750281|27028072|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6|||
13484155|NCT01750281|27028073|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7|||
13484156|NCT01750281|27028074|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9|||
13484157|NCT01750281|27028072|FG000|Overall Study|Did not receive treatment|0|||
13484158|NCT01750281|27028073|FG001|Overall Study|Did not receive treatment|1|||
13484159|NCT01750281|27028074|FG002|Overall Study|Did not receive treatment|0|||
13484160|NCT01347645|27028108|FG000|Overall Study|Death|1|||
13484161|NCT01347645|27028109|FG001|Overall Study|Death|5|||
13484162|NCT01347645|27028110|FG002|Overall Study|Death|2|||
13484163|NCT01347645|27028111|FG003|Overall Study|Death|7|||
13484164|NCT01347645|27028112|FG004|Overall Study|Death|7|||
13484165|NCT01347645|27028108|FG000|Overall Study|Lost to Follow-up|1|||
13484166|NCT01347645|27028109|FG001|Overall Study|Lost to Follow-up|1|||
13484167|NCT01347645|27028110|FG002|Overall Study|Lost to Follow-up|0|||
13484168|NCT01347645|27028111|FG003|Overall Study|Lost to Follow-up|1|||
13484169|NCT01347645|27028112|FG004|Overall Study|Lost to Follow-up|1|||
13484170|NCT01347645|27028108|FG000|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|0|||
13484171|NCT01347645|27028109|FG001|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|2|||
13484172|NCT01347645|27028110|FG002|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|1|||
13484173|NCT01347645|27028111|FG003|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|22|||
13484174|NCT01347645|27028112|FG004|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|20|||
13484175|NCT01347645|27028108|FG000|Overall Study|Other|1|||
13484176|NCT01347645|27028109|FG001|Overall Study|Other|0|||
13484177|NCT01347645|27028110|FG002|Overall Study|Other|0|||
13484178|NCT01347645|27028111|FG003|Overall Study|Other|0|||
13484179|NCT01347645|27028112|FG004|Overall Study|Other|1|||
13484180|NCT01347645|27028108|FG000|Overall Study|Withdrawal by Subject|0|||
13484181|NCT01347645|27028109|FG001|Overall Study|Withdrawal by Subject|0|||
13484182|NCT01347645|27028110|FG002|Overall Study|Withdrawal by Subject|0|||
13484183|NCT01347645|27028111|FG003|Overall Study|Withdrawal by Subject|3|||
13484184|NCT01347645|27028112|FG004|Overall Study|Withdrawal by Subject|3|||
13484185|NCT01347645|27028108|FG000|Overall Study|Physician Decision|0|||
13484186|NCT01347645|27028109|FG001|Overall Study|Physician Decision|0|||
13484187|NCT01347645|27028110|FG002|Overall Study|Physician Decision|0|||
13484188|NCT01347645|27028111|FG003|Overall Study|Physician Decision|0|||
13484189|NCT01347645|27028112|FG004|Overall Study|Physician Decision|1|||
13484190|NCT01347645|27028108|FG000|Overall Study|Adverse Event|0|||
13484191|NCT01347645|27028109|FG001|Overall Study|Adverse Event|0|||
13484192|NCT01347645|27028110|FG002|Overall Study|Adverse Event|0|||
13484193|NCT01347645|27028111|FG003|Overall Study|Adverse Event|1|||
13484194|NCT01347645|27028112|FG004|Overall Study|Adverse Event|1|||
13484195|NCT01320085|27028217|FG000|Overall Study|Treatment Ongoing|0|||
13484196|NCT01320085|27028218|FG001|Overall Study|Treatment Ongoing|13|||
13484197|NCT01320085|27028219|FG002|Overall Study|Treatment Ongoing|2|||
13484198|NCT01320085|27028217|FG000|Overall Study|Disease Progression|26|||
13484199|NCT01320085|27028218|FG001|Overall Study|Disease Progression|86|||
13484200|NCT01320085|27028219|FG002|Overall Study|Disease Progression|16|||
13484201|NCT01320085|27028217|FG000|Overall Study|Adverse Event|12|||
13484202|NCT01320085|27028218|FG001|Overall Study|Adverse Event|14|||
13484203|NCT01320085|27028219|FG002|Overall Study|Adverse Event|5|||
13484204|NCT01320085|27028217|FG000|Overall Study|Withdrawal by Subject|2|||
13484205|NCT01320085|27028218|FG001|Overall Study|Withdrawal by Subject|4|||
13484206|NCT01320085|27028219|FG002|Overall Study|Withdrawal by Subject|1|||
13484207|NCT01320085|27028217|FG000|Overall Study|Protocol Deviation|1|||
13484208|NCT01320085|27028218|FG001|Overall Study|Protocol Deviation|0|||
13484209|NCT01320085|27028219|FG002|Overall Study|Protocol Deviation|1|||
13484210|NCT00805129|27028228|FG000|Overall Study|Not treated|1|||
13487772|NCT01434602|27041391|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
13487773|NCT01434602|27041387|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
13487774|NCT01434602|27041388|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
13487775|NCT01434602|27041389|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
13487776|NCT01434602|27041390|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1|||
13487777|NCT01434602|27041391|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
13487778|NCT01434602|27041387|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
13487779|NCT01434602|27041388|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
13487780|NCT01434602|27041389|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
13487781|NCT01434602|27041390|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1|||
13487782|NCT01434602|27041391|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
13487783|NCT01434602|27041387|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
13487784|NCT01434602|27041388|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
13487785|NCT01434602|27041389|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
13487786|NCT01434602|27041390|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1|||
13487787|NCT01434602|27041391|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
13487788|NCT01434602|27041387|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
13487789|NCT01434602|27041388|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
13487790|NCT01434602|27041389|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
13487791|NCT01434602|27041390|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
13487792|NCT01434602|27041391|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1|||
13487793|NCT01434602|27041387|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
13487794|NCT01434602|27041388|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
13487795|NCT01434602|27041389|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
13487796|NCT01434602|27041390|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
13487797|NCT01434602|27041391|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
13487798|NCT01434602|27041387|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
13487799|NCT01434602|27041388|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
13487800|NCT01434602|27041389|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
13487801|NCT01434602|27041390|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1|||
13487802|NCT01434602|27041391|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
13487803|NCT01434602|27041387|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
13487804|NCT01434602|27041388|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
13487805|NCT01434602|27041389|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
13487806|NCT01434602|27041390|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2|||
13487807|NCT01434602|27041391|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
13487808|NCT01239797|27041414|FG000|Randomized Participants|Participant no longer meets study criteria|1|||
13487809|NCT01239797|27041415|FG001|Randomized Participants|Participant no longer meets study criteria|1|||
13487810|NCT01239797|27041414|FG000|Randomized Participants|Participant withdrew consent|1|||
13487811|NCT01239797|27041415|FG001|Randomized Participants|Participant withdrew consent|7|||
13487812|NCT01239797|27041414|FG000|Randomized Participants|Adverse event unrelated to study drug|0|||
13487813|NCT01239797|27041415|FG001|Randomized Participants|Adverse event unrelated to study drug|1|||
13487814|NCT01239797|27041414|FG000|Treated Participants|Disease progression|185|||
13487815|NCT01239797|27041415|FG001|Treated Participants|Disease progression|185|||
13487816|NCT01239797|27041414|FG000|Treated Participants|Study drug toxicity|39|||
13487817|NCT01239797|27041415|FG001|Treated Participants|Study drug toxicity|45|||
13487818|NCT01239797|27041414|FG000|Treated Participants|Adverse event unrelated to study drug|31|||
13487819|NCT01239797|27041415|FG001|Treated Participants|Adverse event unrelated to study drug|37|||
13487820|NCT01239797|27041414|FG000|Treated Participants|Participants request to discontinue study treatment|28|||
13487821|NCT01239797|27041415|FG001|Treated Participants|Participants request to discontinue study treatment|18|||
13487822|NCT01239797|27041414|FG000|Treated Participants|Administrative reason by sponsor|13|||
13487823|NCT01239797|27041415|FG001|Treated Participants|Administrative reason by sponsor|4|||
13487824|NCT01239797|27041414|FG000|Treated Participants|Other reasons|14|||
13487825|NCT01239797|27041415|FG001|Treated Participants|Other reasons|14|||
13487826|NCT01239797|27041414|FG000|Treated Participants|Participant withdrew consent|6|||
13487827|NCT01239797|27041415|FG001|Treated Participants|Participant withdrew consent|11|||
13487828|NCT01239797|27041414|FG000|Treated Participants|Death|1|||
13487829|NCT01239797|27041415|FG001|Treated Participants|Death|1|||
13487830|NCT01239797|27041414|FG000|Treated Participants|Participant no longer meets study criteria|1|||
13125054|NCT02932878|25955019|FG001|Overall Study|Due to Lab Results|1|||
13204517|NCT01972776|26229181|FG005|Part 2|Administrative problems|7|||
13484211|NCT02285595|27028235|FG000|Overall Study|Lost to Follow-up|14|||
13484212|NCT02285595|27028235|FG000|Overall Study|Withdrawal by Subject|1|||
13484213|NCT02290431|27028256|FG000|Overall Study|Adverse Event|20|||
13484214|NCT02290431|27028256|FG000|Overall Study|Progressive disease|4|||
13484215|NCT02290431|27028256|FG000|Overall Study|Study terminated by Sponsor|1|||
13484216|NCT02290431|27028256|FG000|Overall Study|Physician Decision|2|||
13484217|NCT02302963|27028269|FG000|Overall Study|Withdrawal by Subject|2|||
13484218|NCT02302963|27028270|FG001|Overall Study|Withdrawal by Subject|1|||
13484219|NCT02302963|27028269|FG000|Overall Study|Steroid injection|0|||
13484220|NCT02302963|27028270|FG001|Overall Study|Steroid injection|1|||
13484221|NCT02302963|27028269|FG000|Overall Study|Physician Decision|1|||
13484222|NCT02302963|27028270|FG001|Overall Study|Physician Decision|0|||
13484223|NCT02314923|27028394|FG000|Overall Study|Death|0|||
13484224|NCT02314923|27028395|FG001|Overall Study|Death|0|||
13484225|NCT02314923|27028396|FG002|Overall Study|Death|0|||
13484226|NCT02314923|27028397|FG003|Overall Study|Death|1|||
13484227|NCT02314923|27028398|FG004|Overall Study|Death|0|||
13484228|NCT02314923|27028399|FG005|Overall Study|Death|0|||
13484229|NCT02314923|27028400|FG006|Overall Study|Death|0|||
13484230|NCT02314923|27028401|FG007|Overall Study|Death|0|||
13484231|NCT02314923|27028402|FG008|Overall Study|Death|0|||
13484232|NCT02314923|27028403|FG009|Overall Study|Death|0|||
13484233|NCT02314923|27028394|FG000|Overall Study|Lost to Follow-up|2|||
13484234|NCT02314923|27028395|FG001|Overall Study|Lost to Follow-up|3|||
13484235|NCT02314923|27028396|FG002|Overall Study|Lost to Follow-up|1|||
13484236|NCT02314923|27028397|FG003|Overall Study|Lost to Follow-up|0|||
13484237|NCT02314923|27028398|FG004|Overall Study|Lost to Follow-up|0|||
13484238|NCT02314923|27028399|FG005|Overall Study|Lost to Follow-up|0|||
13484239|NCT02314923|27028400|FG006|Overall Study|Lost to Follow-up|3|||
13484240|NCT02314923|27028401|FG007|Overall Study|Lost to Follow-up|4|||
13484241|NCT02314923|27028402|FG008|Overall Study|Lost to Follow-up|2|||
13484242|NCT02314923|27028403|FG009|Overall Study|Lost to Follow-up|0|||
13484243|NCT02314923|27028394|FG000|Overall Study|Withdrawal by Subject|0|||
13484244|NCT02314923|27028395|FG001|Overall Study|Withdrawal by Subject|0|||
13484245|NCT02314923|27028396|FG002|Overall Study|Withdrawal by Subject|1|||
13484246|NCT02314923|27028397|FG003|Overall Study|Withdrawal by Subject|0|||
13484247|NCT02314923|27028398|FG004|Overall Study|Withdrawal by Subject|1|||
13484248|NCT02314923|27028399|FG005|Overall Study|Withdrawal by Subject|0|||
13484249|NCT02314923|27028400|FG006|Overall Study|Withdrawal by Subject|1|||
13484250|NCT02314923|27028401|FG007|Overall Study|Withdrawal by Subject|0|||
13484251|NCT02314923|27028402|FG008|Overall Study|Withdrawal by Subject|0|||
13484252|NCT02314923|27028403|FG009|Overall Study|Withdrawal by Subject|0|||
13484253|NCT02314923|27028394|FG000|Overall Study|Physician Decision|0|||
13484254|NCT02314923|27028395|FG001|Overall Study|Physician Decision|1|||
13484255|NCT02314923|27028396|FG002|Overall Study|Physician Decision|0|||
13484256|NCT02314923|27028397|FG003|Overall Study|Physician Decision|0|||
13484257|NCT02314923|27028398|FG004|Overall Study|Physician Decision|0|||
13484258|NCT02314923|27028399|FG005|Overall Study|Physician Decision|0|||
13484259|NCT02314923|27028400|FG006|Overall Study|Physician Decision|0|||
13484260|NCT02314923|27028401|FG007|Overall Study|Physician Decision|0|||
13484261|NCT02314923|27028402|FG008|Overall Study|Physician Decision|0|||
13484262|NCT02314923|27028403|FG009|Overall Study|Physician Decision|0|||
13484263|NCT02314923|27028394|FG000|Overall Study|Participant unavailable|0|||
13484264|NCT02314923|27028395|FG001|Overall Study|Participant unavailable|0|||
13484265|NCT02314923|27028396|FG002|Overall Study|Participant unavailable|0|||
13484266|NCT02314923|27028397|FG003|Overall Study|Participant unavailable|0|||
13484267|NCT02314923|27028398|FG004|Overall Study|Participant unavailable|0|||
13484268|NCT02314923|27028399|FG005|Overall Study|Participant unavailable|1|||
13484269|NCT02314923|27028400|FG006|Overall Study|Participant unavailable|0|||
13484270|NCT02314923|27028401|FG007|Overall Study|Participant unavailable|0|||
13484271|NCT02314923|27028402|FG008|Overall Study|Participant unavailable|0|||
13484272|NCT02314923|27028403|FG009|Overall Study|Participant unavailable|0|||
13484273|NCT02314923|27028394|FG000|Overall Study|Screen failure|0|||
13484274|NCT02314923|27028395|FG001|Overall Study|Screen failure|0|||
13484275|NCT02314923|27028396|FG002|Overall Study|Screen failure|0|||
13484276|NCT02314923|27028397|FG003|Overall Study|Screen failure|0|||
13484277|NCT02314923|27028398|FG004|Overall Study|Screen failure|0|||
13484278|NCT02314923|27028399|FG005|Overall Study|Screen failure|0|||
13484279|NCT02314923|27028400|FG006|Overall Study|Screen failure|1|||
13484280|NCT02314923|27028401|FG007|Overall Study|Screen failure|0|||
13221784|NCT01811186|26284658|FG000|Overall Study|Lack of Efficacy|3|||
13221785|NCT01811186|26284659|FG001|Overall Study|Lack of Efficacy|6|||
13484281|NCT02314923|27028402|FG008|Overall Study|Screen failure|0|||
13484282|NCT02314923|27028403|FG009|Overall Study|Screen failure|0|||
13484283|NCT02314923|27028394|FG000|Overall Study|Participant relocation|1|||
13484284|NCT02314923|27028395|FG001|Overall Study|Participant relocation|0|||
13484285|NCT02314923|27028396|FG002|Overall Study|Participant relocation|0|||
13484286|NCT02314923|27028397|FG003|Overall Study|Participant relocation|0|||
13484287|NCT02314923|27028398|FG004|Overall Study|Participant relocation|0|||
13484288|NCT02314923|27028399|FG005|Overall Study|Participant relocation|0|||
13484289|NCT02314923|27028400|FG006|Overall Study|Participant relocation|0|||
13484290|NCT02314923|27028401|FG007|Overall Study|Participant relocation|1|||
13484291|NCT02314923|27028402|FG008|Overall Study|Participant relocation|0|||
13484292|NCT02314923|27028403|FG009|Overall Study|Participant relocation|0|||
13487831|NCT01239797|27041415|FG001|Treated Participants|Participant no longer meets study criteria|1|||
13487832|NCT01239797|27041414|FG000|Treated Participants|Poor/non-compliance|0|||
13487833|NCT01239797|27041415|FG001|Treated Participants|Poor/non-compliance|1|||
13487834|NCT01236521|27041450|FG000|Overall Study|Withdrawal by Subject|12|||
13487835|NCT01236521|27041451|FG001|Overall Study|Withdrawal by Subject|17|||
13487836|NCT01236521|27041450|FG000|Overall Study|Death|2|||
13487837|NCT01236521|27041451|FG001|Overall Study|Death|1|||
13487838|NCT01236521|27041450|FG000|Overall Study|Lost to Follow-up|9|||
13487839|NCT01236521|27041451|FG001|Overall Study|Lost to Follow-up|7|||
13487840|NCT01103349|27041472|FG000|Overall Study|Adverse Event|8|||
13487841|NCT01103349|27041473|FG001|Overall Study|Adverse Event|5|||
13487842|NCT01103349|27041474|FG002|Overall Study|Adverse Event|3|||
13487843|NCT01103349|27041472|FG000|Overall Study|Consent withdrawn|1|||
13487844|NCT01103349|27041473|FG001|Overall Study|Consent withdrawn|0|||
13487845|NCT01103349|27041474|FG002|Overall Study|Consent withdrawn|0|||
13487846|NCT01103349|27041472|FG000|Overall Study|Incorrectly included in the trial|1|||
13487847|NCT01103349|27041473|FG001|Overall Study|Incorrectly included in the trial|0|||
13487848|NCT01103349|27041474|FG002|Overall Study|Incorrectly included in the trial|0|||
13487849|NCT01103349|27041472|FG000|Overall Study|Withdrawal by Subject|1|||
13487850|NCT01103349|27041473|FG001|Overall Study|Withdrawal by Subject|1|||
13487851|NCT01103349|27041474|FG002|Overall Study|Withdrawal by Subject|0|||
13487852|NCT01103349|27041472|FG000|Overall Study|did not want to take trial medication|0|||
13487853|NCT01103349|27041473|FG001|Overall Study|did not want to take trial medication|1|||
13487854|NCT01103349|27041474|FG002|Overall Study|did not want to take trial medication|0|||
13487855|NCT01103349|27041472|FG000|Overall Study|forgot to take medication|0|||
13487856|NCT01103349|27041473|FG001|Overall Study|forgot to take medication|0|||
13487857|NCT01103349|27041474|FG002|Overall Study|forgot to take medication|1|||
13487858|NCT01092143|27041507|FG000|Overall Study|Adverse Event|10|||
13487859|NCT01092143|27041508|FG001|Overall Study|Adverse Event|5|||
13487860|NCT01092143|27041509|FG002|Overall Study|Adverse Event|1|||
13487861|NCT01092143|27041510|FG003|Overall Study|Adverse Event|4|||
13487862|NCT01092143|27041511|FG004|Overall Study|Adverse Event|3|||
13487863|NCT01092143|27041507|FG000|Overall Study|Lost to Follow-up|1|||
13487864|NCT01092143|27041508|FG001|Overall Study|Lost to Follow-up|0|||
13487865|NCT01092143|27041509|FG002|Overall Study|Lost to Follow-up|1|||
13487866|NCT01092143|27041510|FG003|Overall Study|Lost to Follow-up|0|||
13487867|NCT01092143|27041511|FG004|Overall Study|Lost to Follow-up|0|||
13487868|NCT01092143|27041507|FG000|Overall Study|Consent withdrawn|2|||
13487869|NCT01092143|27041508|FG001|Overall Study|Consent withdrawn|1|||
13487870|NCT01092143|27041509|FG002|Overall Study|Consent withdrawn|0|||
13487871|NCT01092143|27041510|FG003|Overall Study|Consent withdrawn|1|||
13487872|NCT01092143|27041511|FG004|Overall Study|Consent withdrawn|3|||
13487873|NCT01092143|27041507|FG000|Overall Study|Not treated|0|||
13487874|NCT01092143|27041508|FG001|Overall Study|Not treated|0|||
13487875|NCT01092143|27041509|FG002|Overall Study|Not treated|1|||
13487876|NCT01092143|27041510|FG003|Overall Study|Not treated|0|||
13487877|NCT01092143|27041511|FG004|Overall Study|Not treated|0|||
13487878|NCT01092143|27041507|FG000|Overall Study|did not reversibility criteria|0|||
13487879|NCT01092143|27041508|FG001|Overall Study|did not reversibility criteria|0|||
13487880|NCT01092143|27041509|FG002|Overall Study|did not reversibility criteria|1|||
13487881|NCT01092143|27041510|FG003|Overall Study|did not reversibility criteria|0|||
13487882|NCT01092143|27041511|FG004|Overall Study|did not reversibility criteria|0|||
13487883|NCT01092143|27041507|FG000|Overall Study|Increased Albuterol use for >2 days|0|||
13487884|NCT01092143|27041508|FG001|Overall Study|Increased Albuterol use for >2 days|1|||
13487885|NCT01092143|27041509|FG002|Overall Study|Increased Albuterol use for >2 days|0|||
13487886|NCT01092143|27041510|FG003|Overall Study|Increased Albuterol use for >2 days|0|||
13487887|NCT01092143|27041511|FG004|Overall Study|Increased Albuterol use for >2 days|0|||
13487888|NCT01092143|27041507|FG000|Overall Study|Ineligible patient|1|||
13487889|NCT01092143|27041508|FG001|Overall Study|Ineligible patient|0|||
13487890|NCT01092143|27041509|FG002|Overall Study|Ineligible patient|0|||
13487891|NCT01092143|27041510|FG003|Overall Study|Ineligible patient|0|||
13487892|NCT01092143|27041511|FG004|Overall Study|Ineligible patient|0|||
13487893|NCT01092143|27041507|FG000|Overall Study|Drop in FEV1 at visit 9|1|||
13487894|NCT01092143|27041508|FG001|Overall Study|Drop in FEV1 at visit 9|0|||
13487895|NCT01092143|27041509|FG002|Overall Study|Drop in FEV1 at visit 9|0|||
13487896|NCT01092143|27041510|FG003|Overall Study|Drop in FEV1 at visit 9|0|||
13487897|NCT01092143|27041511|FG004|Overall Study|Drop in FEV1 at visit 9|0|||
13487898|NCT01092143|27041507|FG000|Overall Study|Patient travel|0|||
13221786|NCT01811186|26284658|FG000|Overall Study|Lost to Follow-up|4|||
13487899|NCT01092143|27041508|FG001|Overall Study|Patient travel|0|||
13487900|NCT01092143|27041509|FG002|Overall Study|Patient travel|0|||
13487901|NCT01092143|27041510|FG003|Overall Study|Patient travel|0|||
13487902|NCT01092143|27041511|FG004|Overall Study|Patient travel|1|||
13484293|NCT04524507|27028447|FG000|Overall Study|Lost to Follow-up|2|||
13484294|NCT04524507|27028448|FG001|Overall Study|Lost to Follow-up|4|||
13484295|NCT04524507|27028447|FG000|Overall Study|Withdrawal by Subject|2|||
13484296|NCT04524507|27028448|FG001|Overall Study|Withdrawal by Subject|9|||
13484297|NCT04524507|27028447|FG000|Overall Study|Death|2|||
13484298|NCT04524507|27028448|FG001|Overall Study|Death|10|||
13484299|NCT04382924|27028490|FG000|Overall Study|Death|2|||
13484300|NCT04382924|27028491|FG001|Overall Study|Death|5|||
13484301|NCT04382924|27028492|FG002|Overall Study|Death|4|||
13484302|NCT04382924|27028490|FG000|Overall Study|Protocol Violation|0|||
13484303|NCT04382924|27028491|FG001|Overall Study|Protocol Violation|1|||
13484304|NCT04382924|27028492|FG002|Overall Study|Protocol Violation|1|||
13484305|NCT04382924|27028490|FG000|Overall Study|Transferred to other hospital/declined in person visits|0|||
13484306|NCT04382924|27028491|FG001|Overall Study|Transferred to other hospital/declined in person visits|1|||
13484307|NCT04382924|27028492|FG002|Overall Study|Transferred to other hospital/declined in person visits|1|||
13484308|NCT04382924|27028490|FG000|Overall Study|Withdrawal by Subject|6|||
13484309|NCT04382924|27028491|FG001|Overall Study|Withdrawal by Subject|3|||
13484310|NCT04382924|27028492|FG002|Overall Study|Withdrawal by Subject|6|||
13484311|NCT03446768|27028590|FG000|Overall Study|Withdrawal by Subject|0|||
13484312|NCT03446768|27028591|FG001|Overall Study|Withdrawal by Subject|1|||
13484313|NCT03253393|27028736|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6|||
13484314|NCT03253393|27028737|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7|||
13484315|NCT03253393|27028738|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0|||
13484316|NCT03128671|27028751|FG000|Allocation|ICU discharge prior to intervention initiation|4|||
13484317|NCT03128671|27028752|FG001|Allocation|ICU discharge prior to intervention initiation|0|||
13484318|NCT03128671|27028751|FG000|Allocation|Death|1|||
13484319|NCT03128671|27028752|FG001|Allocation|Death|0|||
13484320|NCT03128671|27028751|FG000|Allocation|Withdrawal by Subject|4|||
13484321|NCT03128671|27028752|FG001|Allocation|Withdrawal by Subject|0|||
13484322|NCT03128671|27028751|FG000|Intervention|Withdrawal by Subject|11|||
13484323|NCT03128671|27028752|FG001|Intervention|Withdrawal by Subject|10|||
13484324|NCT03128671|27028751|FG000|Intervention|Palliative/hospice care initiated|9|||
13484325|NCT03128671|27028752|FG001|Intervention|Palliative/hospice care initiated|10|||
13484326|NCT03128671|27028751|FG000|Intervention|Death|13|||
13484327|NCT03128671|27028752|FG001|Intervention|Death|11|||
13484328|NCT03128671|27028751|FG000|Intervention|Interrupted by hurricane|1|||
13484329|NCT03128671|27028752|FG001|Intervention|Interrupted by hurricane|0|||
13484330|NCT03128671|27028751|FG000|Intervention|Physician Decision|2|||
13484331|NCT03128671|27028752|FG001|Intervention|Physician Decision|3|||
13484332|NCT03111732|27028776|FG000|Overall Study|Enrolled in different study|1|||
13484333|NCT03111732|27028776|FG000|Overall Study|Progressive disease|3|||
13484334|NCT03111732|27028776|FG000|Overall Study|Withdrawal by Subject|1|||
13484335|NCT03065244|27028803|FG000|Overall Study|Lost to Follow-up|1|||
13484336|NCT03065244|27028804|FG001|Overall Study|Lost to Follow-up|1|||
13484337|NCT03065244|27028803|FG000|Overall Study|Diagnosed with a different disease|1|||
13484338|NCT03065244|27028804|FG001|Overall Study|Diagnosed with a different disease|1|||
13484339|NCT03065244|27028803|FG000|Overall Study|Protocol Violation|0|||
13484340|NCT03065244|27028804|FG001|Overall Study|Protocol Violation|1|||
13484341|NCT03065244|27028803|FG000|Overall Study|Withdrawal by Subject|1|||
13484342|NCT03065244|27028804|FG001|Overall Study|Withdrawal by Subject|1|||
13484343|NCT02879305|27028887|FG000|Overall Study|Investigator Site Closed|55|||
13484344|NCT02879305|27028888|FG001|Overall Study|Investigator Site Closed|57|||
13484345|NCT02879305|27028887|FG000|Overall Study|Withdrawal by Subject|44|||
13484346|NCT02879305|27028888|FG001|Overall Study|Withdrawal by Subject|42|||
13484347|NCT02879305|27028887|FG000|Overall Study|Lost to Follow-up|17|||
13484348|NCT02879305|27028888|FG001|Overall Study|Lost to Follow-up|12|||
13484349|NCT02879305|27028887|FG000|Overall Study|Other|1|||
13484350|NCT02879305|27028888|FG001|Overall Study|Other|0|||
13484351|NCT02787850|27028934|FG000|Overall Study|Withdrawal by Subject|0|||
13484352|NCT02787850|27028935|FG001|Overall Study|Withdrawal by Subject|1|||
13484353|NCT02676284|27028942|FG000|Overall Study|Withdrawal by Subject|1|||
13484354|NCT02431702|27029023|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7|||
13125055|NCT02932579|25955034|FG000|Overall Study|Withdrawal by Subject|4|||
13125056|NCT02932579|25955035|FG001|Overall Study|Withdrawal by Subject|1|||
13125057|NCT02932462|25955052|FG000|Overall Study|Adverse Event|1|||
13125058|NCT02932462|25955053|FG001|Overall Study|Adverse Event|2|||
13125059|NCT02932462|25955052|FG000|Overall Study|Lost to Follow-up|4|||
13125060|NCT02932462|25955053|FG001|Overall Study|Lost to Follow-up|1|||
13125061|NCT02932462|25955052|FG000|Overall Study|Protocol Violation|0|||
13125062|NCT02932462|25955053|FG001|Overall Study|Protocol Violation|5|||
13125063|NCT02932462|25955052|FG000|Overall Study|Withdrawal by Subject|1|||
13125064|NCT02932462|25955053|FG001|Overall Study|Withdrawal by Subject|4|||
13484355|NCT02431702|27029024|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
13484356|NCT02431702|27029025|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
13484357|NCT02431702|27029026|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
13484358|NCT02431702|27029027|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
13484359|NCT02431702|27029028|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
13484360|NCT02431702|27029029|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
13484361|NCT02431702|27029023|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11|||
13484362|NCT02431702|27029024|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
13484363|NCT02431702|27029025|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
13484364|NCT02431702|27029026|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
13484365|NCT02431702|27029027|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
13484366|NCT02431702|27029028|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
13484367|NCT02431702|27029029|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23|||
13484368|NCT02431702|27029023|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9|||
13484369|NCT02431702|27029024|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
13484370|NCT02431702|27029025|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
13484371|NCT02431702|27029026|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
13484372|NCT02431702|27029027|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
13484373|NCT02431702|27029028|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
13484374|NCT02431702|27029029|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6|||
13484375|NCT02431702|27029023|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5|||
13484376|NCT02431702|27029024|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0|||
13484377|NCT02431702|27029025|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0|||
13484378|NCT02431702|27029026|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0|||
13484379|NCT02431702|27029027|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0|||
13484380|NCT02431702|27029028|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0|||
13484381|NCT02431702|27029029|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3|||
13484382|NCT02431702|27029023|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2|||
13484383|NCT02431702|27029024|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
13484384|NCT02431702|27029025|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
13484385|NCT02431702|27029026|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
13484386|NCT02431702|27029027|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
13484387|NCT02431702|27029028|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
13484388|NCT02431702|27029029|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
13484389|NCT02431702|27029023|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
13484390|NCT02431702|27029024|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5|||
13484391|NCT02431702|27029025|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1|||
13484392|NCT02431702|27029026|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
13484393|NCT02431702|27029027|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
13484394|NCT02431702|27029028|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
13484395|NCT02431702|27029029|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
13484396|NCT02431702|27029023|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
13484397|NCT02431702|27029024|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6|||
13484398|NCT02431702|27029025|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13|||
13484399|NCT02431702|27029026|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
13484400|NCT02431702|27029027|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
13484401|NCT02431702|27029028|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
13484402|NCT02431702|27029029|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
13484403|NCT02431702|27029023|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
13484404|NCT02431702|27029024|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11|||
13484405|NCT02431702|27029025|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8|||
13484406|NCT02431702|27029026|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
13484407|NCT02431702|27029027|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
13484408|NCT02431702|27029028|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
13484409|NCT02431702|27029029|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
13484410|NCT02431702|27029023|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
13484411|NCT02431702|27029024|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2|||
13484412|NCT02431702|27029025|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
13484413|NCT02431702|27029026|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
13484414|NCT02431702|27029027|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
13484415|NCT02431702|27029028|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
13484416|NCT02431702|27029029|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
13484417|NCT02431702|27029023|FG000|Part 2: 9Month Disease Progression Phase|Other|0|||
13484418|NCT02431702|27029024|FG001|Part 2: 9Month Disease Progression Phase|Other|2|||
13484419|NCT02431702|27029025|FG002|Part 2: 9Month Disease Progression Phase|Other|2|||
13484420|NCT02431702|27029026|FG003|Part 2: 9Month Disease Progression Phase|Other|0|||
13484421|NCT02431702|27029027|FG004|Part 2: 9Month Disease Progression Phase|Other|0|||
13484422|NCT02431702|27029028|FG005|Part 2: 9Month Disease Progression Phase|Other|0|||
13484423|NCT02431702|27029029|FG006|Part 2: 9Month Disease Progression Phase|Other|0|||
13484424|NCT02431702|27029023|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
13484425|NCT02431702|27029024|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
13484426|NCT02431702|27029025|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5|||
13484427|NCT02431702|27029026|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
13484428|NCT02431702|27029027|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
13484429|NCT02431702|27029028|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
13484430|NCT02431702|27029029|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
13125065|NCT02932462|25955052|FG000|Overall Study|Non-Compliance With Study Drug|0|||
13125066|NCT02932462|25955053|FG001|Overall Study|Non-Compliance With Study Drug|1|||
13125067|NCT02932462|25955052|FG000|Overall Study|Progressive Disease|1|||
13125068|NCT02932462|25955053|FG001|Overall Study|Progressive Disease|0|||
13125069|NCT02932332|25955084|FG000|Overall Study|Withdrawal by Subject|1|||
13125070|NCT02932332|25955085|FG001|Overall Study|Withdrawal by Subject|1|||
13125071|NCT02932332|25955086|FG002|Overall Study|Withdrawal by Subject|0|||
13125072|NCT02932332|25955087|FG003|Overall Study|Withdrawal by Subject|1|||
13125073|NCT02932332|25955084|FG000|Overall Study|Chest pain|0|||
13125074|NCT02932332|25955085|FG001|Overall Study|Chest pain|0|||
13125075|NCT02932332|25955086|FG002|Overall Study|Chest pain|0|||
13125076|NCT02932332|25955087|FG003|Overall Study|Chest pain|1|||
13125077|NCT02932332|25955084|FG000|Overall Study|Not Dyspneic cough|1|||
13125078|NCT02932332|25955085|FG001|Overall Study|Not Dyspneic cough|2|||
13125079|NCT02932332|25955086|FG002|Overall Study|Not Dyspneic cough|1|||
13125080|NCT02932332|25955087|FG003|Overall Study|Not Dyspneic cough|0|||
13125081|NCT02932306|25955108|FG000|Overall Study|Withdrawal by Subject|16|||
13125082|NCT02932306|25955109|FG001|Overall Study|Withdrawal by Subject|25|||
13125083|NCT02932306|25955108|FG000|Overall Study|Adverse Event|3|||
13125084|NCT02932306|25955109|FG001|Overall Study|Adverse Event|0|||
13125085|NCT02932306|25955108|FG000|Overall Study|Pregnancy|2|||
13125086|NCT02932306|25955109|FG001|Overall Study|Pregnancy|0|||
13125087|NCT02932306|25955108|FG000|Overall Study|Protocol Violation|1|||
13125088|NCT02932306|25955109|FG001|Overall Study|Protocol Violation|1|||
13125089|NCT02932306|25955108|FG000|Overall Study|Noncompliance with Study Drug|1|||
13125090|NCT02932306|25955109|FG001|Overall Study|Noncompliance with Study Drug|1|||
13125091|NCT02932306|25955108|FG000|Overall Study|Lost to Follow-up|36|||
13125092|NCT02932306|25955109|FG001|Overall Study|Lost to Follow-up|40|||
13125093|NCT02932306|25955108|FG000|Overall Study|Withdrawal by Parent or Guardian|6|||
13125094|NCT02932306|25955109|FG001|Overall Study|Withdrawal by Parent or Guardian|8|||
13125095|NCT02932306|25955108|FG000|Overall Study|Lack of Efficacy|0|||
13125096|NCT02932306|25955109|FG001|Overall Study|Lack of Efficacy|2|||
13125097|NCT02932306|25955108|FG000|Overall Study|Worsening condition|2|||
13125098|NCT02932306|25955109|FG001|Overall Study|Worsening condition|0|||
13125099|NCT02932306|25955108|FG000|Overall Study|Withdrew due to burning,itching,stinging|1|||
13125100|NCT02932306|25955109|FG001|Overall Study|Withdrew due to burning,itching,stinging|0|||
13125101|NCT02932267|25955115|FG000|Overall Study|Withdrawal by Subject|3|||
13125102|NCT02932267|25955115|FG000|Overall Study|Lost to Follow-up|4|||
13125103|NCT02932267|25955115|FG000|Overall Study|Pregnancy|1|||
13125104|NCT02932228|25955141|FG000|Overall Study|Death|8|||
13125105|NCT02932228|25955142|FG001|Overall Study|Death|23|||
13125106|NCT02932228|25955141|FG000|Overall Study|not eligible upon chart review|2|||
13125107|NCT02932228|25955142|FG001|Overall Study|not eligible upon chart review|5|||
13125108|NCT02931838|25955210|FG000|Overall Study|Reason not provided by investigator|1|||
13125109|NCT02931838|25955211|FG001|Overall Study|Reason not provided by investigator|0|||
13125110|NCT02931838|25955212|FG002|Overall Study|Reason not provided by investigator|1|||
13125111|NCT02931838|25955213|FG003|Overall Study|Reason not provided by investigator|0|||
13125112|NCT02931838|25955214|FG004|Overall Study|Reason not provided by investigator|0|||
13125113|NCT02931838|25955215|FG005|Overall Study|Reason not provided by investigator|0|||
13125114|NCT02931838|25955210|FG000|Overall Study|Poor/non-compliance|0|||
13125115|NCT02931838|25955211|FG001|Overall Study|Poor/non-compliance|0|||
13125116|NCT02931838|25955212|FG002|Overall Study|Poor/non-compliance|1|||
13125117|NCT02931838|25955213|FG003|Overall Study|Poor/non-compliance|0|||
13125118|NCT02931838|25955214|FG004|Overall Study|Poor/non-compliance|0|||
13125119|NCT02931838|25955215|FG005|Overall Study|Poor/non-compliance|0|||
13125120|NCT02931838|25955210|FG000|Overall Study|Lack of Efficacy|5|||
13125121|NCT02931838|25955211|FG001|Overall Study|Lack of Efficacy|4|||
13125122|NCT02931838|25955212|FG002|Overall Study|Lack of Efficacy|0|||
13125123|NCT02931838|25955213|FG003|Overall Study|Lack of Efficacy|0|||
13125124|NCT02931838|25955214|FG004|Overall Study|Lack of Efficacy|0|||
13125125|NCT02931838|25955215|FG005|Overall Study|Lack of Efficacy|1|||
13125126|NCT02931838|25955210|FG000|Overall Study|Lost to Follow-up|1|||
13125127|NCT02931838|25955211|FG001|Overall Study|Lost to Follow-up|0|||
13125128|NCT02931838|25955212|FG002|Overall Study|Lost to Follow-up|1|||
13125129|NCT02931838|25955213|FG003|Overall Study|Lost to Follow-up|1|||
13125130|NCT02931838|25955214|FG004|Overall Study|Lost to Follow-up|2|||
13484431|NCT02431702|27029023|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
13484432|NCT02431702|27029024|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
13484433|NCT02431702|27029025|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
13484434|NCT02431702|27029026|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2|||
13484435|NCT02431702|27029027|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3|||
13484436|NCT02431702|27029028|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
13484437|NCT02431702|27029029|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
13484438|NCT02431702|27029023|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
13484439|NCT02431702|27029024|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
13484440|NCT02431702|27029025|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
13484441|NCT02431702|27029026|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1|||
13484442|NCT02431702|27029027|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
13484443|NCT02431702|27029028|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5|||
13484444|NCT02431702|27029029|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
13484445|NCT02431702|27029023|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
13484446|NCT02431702|27029024|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
13484447|NCT02431702|27029025|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
13484448|NCT02431702|27029026|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5|||
13484449|NCT02431702|27029027|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
13484450|NCT02431702|27029028|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
13484451|NCT02431702|27029029|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
13484452|NCT02431702|27029023|FG000|Part 3: 9 Month of Additional Treatment|Other|0|||
13484453|NCT02431702|27029024|FG001|Part 3: 9 Month of Additional Treatment|Other|0|||
13484454|NCT02431702|27029025|FG002|Part 3: 9 Month of Additional Treatment|Other|0|||
13484455|NCT02431702|27029026|FG003|Part 3: 9 Month of Additional Treatment|Other|1|||
13484456|NCT02431702|27029027|FG004|Part 3: 9 Month of Additional Treatment|Other|1|||
13484457|NCT02431702|27029028|FG005|Part 3: 9 Month of Additional Treatment|Other|6|||
13484458|NCT02431702|27029029|FG006|Part 3: 9 Month of Additional Treatment|Other|0|||
13484459|NCT02200770|27029100|FG000|Randomized-controlled Period (RCP)|Adverse Event|0|||
13484460|NCT02200770|27029101|FG001|Randomized-controlled Period (RCP)|Adverse Event|2|||
13484461|NCT02200770|27029100|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
13484462|NCT02200770|27029101|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
13484463|NCT02200770|27029100|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0|||
13484464|NCT02200770|27029101|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1|||
13484465|NCT02200770|27029100|FG000|Randomized-controlled Period (RCP)|Other|1|||
13484466|NCT02200770|27029101|FG001|Randomized-controlled Period (RCP)|Other|2|||
13484467|NCT02200770|27029100|FG000|Open-label Period (OLP)|Adverse Event|1|||
13484468|NCT02200770|27029101|FG001|Open-label Period (OLP)|Adverse Event|2|||
13484469|NCT02200770|27029100|FG000|Open-label Period (OLP)|Death|1|||
13484470|NCT02200770|27029101|FG001|Open-label Period (OLP)|Death|2|||
13484471|NCT02200770|27029100|FG000|Open-label Period (OLP)|Lost to Follow-up|0|||
13484472|NCT02200770|27029101|FG001|Open-label Period (OLP)|Lost to Follow-up|1|||
13484473|NCT02200770|27029100|FG000|Open-label Period (OLP)|Withdrawal by Subject|0|||
13484474|NCT02200770|27029101|FG001|Open-label Period (OLP)|Withdrawal by Subject|14|||
13484475|NCT02200770|27029100|FG000|Open-label Period (OLP)|Other|6|||
13484476|NCT02200770|27029101|FG001|Open-label Period (OLP)|Other|15|||
13484477|NCT02136069|27029154|FG000|Overall Study|UC flare-up|1|||
13484478|NCT02136069|27029155|FG001|Overall Study|UC flare-up|0|||
13484479|NCT02136069|27029154|FG000|Overall Study|Adverse Event|6|||
13484480|NCT02136069|27029155|FG001|Overall Study|Adverse Event|8|||
13484481|NCT02136069|27029154|FG000|Overall Study|Death|0|||
13484482|NCT02136069|27029155|FG001|Overall Study|Death|1|||
13484483|NCT02136069|27029154|FG000|Overall Study|Lack of Efficacy|10|||
13484484|NCT02136069|27029155|FG001|Overall Study|Lack of Efficacy|4|||
13484485|NCT02136069|27029154|FG000|Overall Study|Lost to Follow-up|1|||
13484486|NCT02136069|27029155|FG001|Overall Study|Lost to Follow-up|0|||
13484487|NCT02136069|27029154|FG000|Overall Study|Non-Compliance|1|||
13484488|NCT02136069|27029155|FG001|Overall Study|Non-Compliance|0|||
13484489|NCT02136069|27029154|FG000|Overall Study|Physician Decision|5|||
13484490|NCT02136069|27029155|FG001|Overall Study|Physician Decision|4|||
13484491|NCT02136069|27029154|FG000|Overall Study|Withdrawal by Subject|10|||
13484492|NCT02136069|27029155|FG001|Overall Study|Withdrawal by Subject|11|||
13484493|NCT02086552|27029164|FG000|Overall Study|Withdrawal by Subject|1|||
13484494|NCT01209767|27029183|FG000|Overall Study|Withdrawal by Subject|1|||
13484495|NCT01209767|27029183|FG000|Overall Study|Lost to Follow-up|3|||
13484496|NCT01186848|27029191|FG000|Overall Study|Lost to Follow-up|4|||
13484497|NCT01186848|27029191|FG000|Overall Study|Withdrawal by Subject|2|||
13484498|NCT01186848|27029191|FG000|Overall Study|Adverse Event|2|||
13484499|NCT01024608|27029224|FG000|Overall Study|Adverse Event|1|||
13484500|NCT01024608|27029225|FG001|Overall Study|Adverse Event|0|||
13484501|NCT01024608|27029224|FG000|Overall Study|Withdrawal by Subject|1|||
13484502|NCT01024608|27029225|FG001|Overall Study|Withdrawal by Subject|0|||
13484503|NCT01024608|27029224|FG000|Overall Study|Lost to Follow-up|0|||
13484504|NCT01024608|27029225|FG001|Overall Study|Lost to Follow-up|1|||
13484505|NCT01024608|27029224|FG000|Overall Study|Protocol Violation|0|||
13484506|NCT01024608|27029225|FG001|Overall Study|Protocol Violation|3|||
13484507|NCT01024608|27029224|FG000|Overall Study|Never received study treatment|2|||
13484508|NCT01024608|27029225|FG001|Overall Study|Never received study treatment|0|||
13484509|NCT00730639|27029339|FG000|Overall Study|Adverse Event|3|||
13484510|NCT00730639|27029340|FG001|Overall Study|Adverse Event|0|||
13484511|NCT00730639|27029341|FG002|Overall Study|Adverse Event|9|||
13484512|NCT00730639|27029342|FG003|Overall Study|Adverse Event|8|||
13484513|NCT00730639|27029343|FG004|Overall Study|Adverse Event|23|||
13484514|NCT00730639|27029339|FG000|Overall Study|Complete Response|0|||
13484515|NCT00730639|27029340|FG001|Overall Study|Complete Response|0|||
13484516|NCT00730639|27029341|FG002|Overall Study|Complete Response|2|||
13484517|NCT00730639|27029342|FG003|Overall Study|Complete Response|2|||
13484518|NCT00730639|27029343|FG004|Overall Study|Complete Response|1|||
13484519|NCT00730639|27029339|FG000|Overall Study|Completed Maximum Cycles|0|||
13484520|NCT00730639|27029340|FG001|Overall Study|Completed Maximum Cycles|0|||
13484521|NCT00730639|27029341|FG002|Overall Study|Completed Maximum Cycles|11|||
13484522|NCT00730639|27029342|FG003|Overall Study|Completed Maximum Cycles|3|||
13484523|NCT00730639|27029343|FG004|Overall Study|Completed Maximum Cycles|6|||
13484524|NCT00730639|27029339|FG000|Overall Study|Death|0|||
13484525|NCT00730639|27029340|FG001|Overall Study|Death|0|||
13484526|NCT00730639|27029341|FG002|Overall Study|Death|0|||
13484527|NCT00730639|27029342|FG003|Overall Study|Death|0|||
13484528|NCT00730639|27029343|FG004|Overall Study|Death|2|||
13484529|NCT00730639|27029339|FG000|Overall Study|Disease Progression|12|||
13484530|NCT00730639|27029340|FG001|Overall Study|Disease Progression|13|||
13484531|NCT00730639|27029341|FG002|Overall Study|Disease Progression|48|||
13484532|NCT00730639|27029342|FG003|Overall Study|Disease Progression|32|||
13484533|NCT00730639|27029343|FG004|Overall Study|Disease Progression|88|||
13484534|NCT00730639|27029339|FG000|Overall Study|non-specified|0|||
13484535|NCT00730639|27029340|FG001|Overall Study|non-specified|0|||
13484536|NCT00730639|27029341|FG002|Overall Study|non-specified|4|||
13484537|NCT00730639|27029342|FG003|Overall Study|non-specified|2|||
13484538|NCT00730639|27029343|FG004|Overall Study|non-specified|3|||
13484539|NCT00730639|27029339|FG000|Overall Study|Protocol Violation|0|||
13484540|NCT00730639|27029340|FG001|Overall Study|Protocol Violation|0|||
13484541|NCT00730639|27029341|FG002|Overall Study|Protocol Violation|1|||
13484542|NCT00730639|27029342|FG003|Overall Study|Protocol Violation|0|||
13484543|NCT00730639|27029343|FG004|Overall Study|Protocol Violation|0|||
13484544|NCT00730639|27029339|FG000|Overall Study|Withdrawal by Subject|0|||
13484545|NCT00730639|27029340|FG001|Overall Study|Withdrawal by Subject|0|||
13484546|NCT00730639|27029341|FG002|Overall Study|Withdrawal by Subject|6|||
13484547|NCT00730639|27029342|FG003|Overall Study|Withdrawal by Subject|3|||
13484548|NCT00730639|27029343|FG004|Overall Study|Withdrawal by Subject|4|||
13484549|NCT00730639|27029339|FG000|Overall Study|Treatment on-going|2|||
13484550|NCT00730639|27029340|FG001|Overall Study|Treatment on-going|5|||
13484551|NCT00730639|27029341|FG002|Overall Study|Treatment on-going|5|||
13484552|NCT00730639|27029342|FG003|Overall Study|Treatment on-going|4|||
13484553|NCT00730639|27029343|FG004|Overall Study|Treatment on-going|4|||
13484554|NCT04834362|27029368|FG000|Overall Study|Death|1|||
13484555|NCT04834362|27029369|FG001|Overall Study|Death|2|||
13484556|NCT04611789|27029427|FG000|Overall Study|Lost to Follow-up|1|||
13484557|NCT04611789|27029428|FG001|Overall Study|Lost to Follow-up|0|||
13484558|NCT04611789|27029429|FG002|Overall Study|Lost to Follow-up|0|||
13484559|NCT04254809|27029633|FG000|Overall Study|Lost to Follow-up|5|||
13484560|NCT04254809|27029634|FG001|Overall Study|Lost to Follow-up|10|||
13484561|NCT04230122|27029649|FG000|Overall Study|Lost to Follow-up|1|||
13484562|NCT04230122|27029650|FG001|Overall Study|Lost to Follow-up|0|||
13484563|NCT04033068|27029778|FG000|Overall Study|Withdrawal by Subject|0|||
13484564|NCT04033068|27029779|FG001|Overall Study|Withdrawal by Subject|0|||
13484565|NCT04033068|27029780|FG002|Overall Study|Withdrawal by Subject|1|||
13484566|NCT04033068|27029781|FG003|Overall Study|Withdrawal by Subject|0|||
13484567|NCT04033068|27029778|FG000|Overall Study|Lost to Follow-up|0|||
13484568|NCT04033068|27029779|FG001|Overall Study|Lost to Follow-up|1|||
13484569|NCT04033068|27029780|FG002|Overall Study|Lost to Follow-up|0|||
13484570|NCT04033068|27029781|FG003|Overall Study|Lost to Follow-up|0|||
13484571|NCT04033068|27029778|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
13484572|NCT04033068|27029779|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
13484573|NCT04033068|27029780|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
13484574|NCT04033068|27029781|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1|||
13487903|NCT01092143|27041507|FG000|Overall Study|Non compliance with study medication|0|||
13487904|NCT01092143|27041508|FG001|Overall Study|Non compliance with study medication|0|||
13487905|NCT01092143|27041509|FG002|Overall Study|Non compliance with study medication|0|||
13487906|NCT01092143|27041510|FG003|Overall Study|Non compliance with study medication|0|||
13487907|NCT01092143|27041511|FG004|Overall Study|Non compliance with study medication|1|||
13487908|NCT01092143|27041507|FG000|Overall Study|Randomized by mistake|0|||
13484575|NCT03561597|27029840|FG000|Overall Study|Lost to Follow-up|20|||
13484576|NCT03350984|27029857|FG000|Overall Study|Death|1|||
13484577|NCT03350984|27029858|FG001|Overall Study|Death|0|||
13484578|NCT03350984|27029857|FG000|Overall Study|Lost to Follow-up|5|||
13484579|NCT03350984|27029858|FG001|Overall Study|Lost to Follow-up|6|||
13484580|NCT03350984|27029857|FG000|Overall Study|Protocol Violation|1|||
13484581|NCT03350984|27029858|FG001|Overall Study|Protocol Violation|2|||
13484582|NCT03350984|27029857|FG000|Overall Study|Physician Decision|1|||
13484583|NCT03350984|27029858|FG001|Overall Study|Physician Decision|0|||
13484584|NCT03179462|27029876|FG000|Overall Study|screening failure|1|||
13484585|NCT03179462|27029877|FG001|Overall Study|screening failure|2|||
13484586|NCT03179462|27029878|FG002|Overall Study|screening failure|0|||
13484587|NCT03099707|27029941|FG000|Overall Study|Withdrawal by Subject|0|||
13484588|NCT03099707|27029942|FG001|Overall Study|Withdrawal by Subject|3|||
13484589|NCT03099707|27029941|FG000|Overall Study|Lost to Follow-up|0|||
13484590|NCT03099707|27029942|FG001|Overall Study|Lost to Follow-up|1|||
13484591|NCT02906033|27030007|FG000|Baseline|Protocol Violation|37|||
13484592|NCT02906033|27030008|FG001|Baseline|Protocol Violation|33|||
13484593|NCT02906033|27030007|FG000|Follow-up|Lost to Follow-up|46|||
13484594|NCT02906033|27030008|FG001|Follow-up|Lost to Follow-up|62|||
13484595|NCT02837783|27030039|FG000|Overall Study|Adverse Event|1|||
13484596|NCT02837783|27030040|FG001|Overall Study|Adverse Event|0|||
13484597|NCT02837783|27030039|FG000|Overall Study|Other, Not Specified|1|||
13484598|NCT02837783|27030040|FG001|Overall Study|Other, Not Specified|2|||
13484599|NCT02786537|27030188|FG000|As Randomized|Adverse Event|0|||
13484600|NCT02786537|27030189|FG001|As Randomized|Adverse Event|11|||
13484601|NCT02786537|27030190|FG002|As Randomized|Adverse Event|0|||
13484602|NCT02786537|27030191|FG003|As Randomized|Adverse Event|4|||
13484603|NCT02786537|27030192|FG004|As Randomized|Adverse Event|6|||
13484604|NCT02786537|27030193|FG005|As Randomized|Adverse Event|2|||
13484605|NCT02786537|27030188|FG000|As Randomized|Lack of Efficacy|0|||
13484606|NCT02786537|27030189|FG001|As Randomized|Lack of Efficacy|0|||
13484607|NCT02786537|27030190|FG002|As Randomized|Lack of Efficacy|0|||
13484608|NCT02786537|27030191|FG003|As Randomized|Lack of Efficacy|1|||
13484609|NCT02786537|27030192|FG004|As Randomized|Lack of Efficacy|0|||
13484610|NCT02786537|27030193|FG005|As Randomized|Lack of Efficacy|0|||
13484611|NCT02786537|27030188|FG000|As Randomized|Withdrawal by Subject|1|||
13484612|NCT02786537|27030189|FG001|As Randomized|Withdrawal by Subject|2|||
13484613|NCT02786537|27030190|FG002|As Randomized|Withdrawal by Subject|0|||
13484614|NCT02786537|27030191|FG003|As Randomized|Withdrawal by Subject|1|||
13484615|NCT02786537|27030192|FG004|As Randomized|Withdrawal by Subject|1|||
13484616|NCT02786537|27030193|FG005|As Randomized|Withdrawal by Subject|0|||
13484617|NCT02786537|27030188|FG000|As Randomized|Death|0|||
13484618|NCT02786537|27030189|FG001|As Randomized|Death|2|||
13484619|NCT02786537|27030190|FG002|As Randomized|Death|0|||
13484620|NCT02786537|27030191|FG003|As Randomized|Death|3|||
13484621|NCT02786537|27030192|FG004|As Randomized|Death|1|||
13484622|NCT02786537|27030193|FG005|As Randomized|Death|0|||
13484623|NCT02786537|27030188|FG000|As Randomized|Non-compliance with study drug|1|||
13484624|NCT02786537|27030189|FG001|As Randomized|Non-compliance with study drug|11|||
13484625|NCT02786537|27030190|FG002|As Randomized|Non-compliance with study drug|0|||
13484626|NCT02786537|27030191|FG003|As Randomized|Non-compliance with study drug|1|||
13484627|NCT02786537|27030192|FG004|As Randomized|Non-compliance with study drug|0|||
13484628|NCT02786537|27030193|FG005|As Randomized|Non-compliance with study drug|1|||
13484629|NCT02786537|27030188|FG000|As Randomized|Lost to treatment follow-up|4|||
13125131|NCT02931838|25955215|FG005|Overall Study|Lost to Follow-up|0|||
13125132|NCT02931838|25955210|FG000|Overall Study|Subject request to discontinue treatment|4|||
13125133|NCT02931838|25955211|FG001|Overall Study|Subject request to discontinue treatment|3|||
13125134|NCT02931838|25955212|FG002|Overall Study|Subject request to discontinue treatment|3|||
13125135|NCT02931838|25955213|FG003|Overall Study|Subject request to discontinue treatment|0|||
13125136|NCT02931838|25955214|FG004|Overall Study|Subject request to discontinue treatment|1|||
13125137|NCT02931838|25955215|FG005|Overall Study|Subject request to discontinue treatment|0|||
13125138|NCT02931838|25955210|FG000|Overall Study|Withdrawal by Subject|1|||
13125139|NCT02931838|25955211|FG001|Overall Study|Withdrawal by Subject|2|||
13125140|NCT02931838|25955212|FG002|Overall Study|Withdrawal by Subject|0|||
13125141|NCT02931838|25955213|FG003|Overall Study|Withdrawal by Subject|1|||
13125142|NCT02931838|25955214|FG004|Overall Study|Withdrawal by Subject|0|||
13125143|NCT02931838|25955215|FG005|Overall Study|Withdrawal by Subject|0|||
13125144|NCT02931838|25955210|FG000|Overall Study|Adverse Event|2|||
13125145|NCT02931838|25955211|FG001|Overall Study|Adverse Event|1|||
13125146|NCT02931838|25955212|FG002|Overall Study|Adverse Event|2|||
13125147|NCT02931838|25955213|FG003|Overall Study|Adverse Event|1|||
13125148|NCT02931838|25955214|FG004|Overall Study|Adverse Event|3|||
13125149|NCT02931838|25955215|FG005|Overall Study|Adverse Event|1|||
13125150|NCT02931539|25955284|FG000|Period 1: Treatment Phase|Investigator discretion|1|||
13125151|NCT02931539|25955285|FG001|Period 1: Treatment Phase|Investigator discretion|1|||
13125152|NCT02931539|25955286|FG002|Period 1: Treatment Phase|Investigator discretion|0|||
13484630|NCT02786537|27030189|FG001|As Randomized|Lost to treatment follow-up|32|||
13484631|NCT02786537|27030190|FG002|As Randomized|Lost to treatment follow-up|0|||
13484632|NCT02786537|27030191|FG003|As Randomized|Lost to treatment follow-up|24|||
13484633|NCT02786537|27030192|FG004|As Randomized|Lost to treatment follow-up|4|||
13484634|NCT02786537|27030193|FG005|As Randomized|Lost to treatment follow-up|4|||
13484635|NCT02786537|27030188|FG000|As Randomized|Incarceration|0|||
13484636|NCT02786537|27030189|FG001|As Randomized|Incarceration|1|||
13484637|NCT02786537|27030190|FG002|As Randomized|Incarceration|0|||
13484638|NCT02786537|27030191|FG003|As Randomized|Incarceration|0|||
13484639|NCT02786537|27030192|FG004|As Randomized|Incarceration|0|||
13484640|NCT02786537|27030193|FG005|As Randomized|Incarceration|0|||
13484641|NCT02786537|27030188|FG000|As Randomized|Opiate Dependency Relapse|0|||
13484642|NCT02786537|27030189|FG001|As Randomized|Opiate Dependency Relapse|1|||
13484643|NCT02786537|27030190|FG002|As Randomized|Opiate Dependency Relapse|0|||
13484644|NCT02786537|27030191|FG003|As Randomized|Opiate Dependency Relapse|0|||
13484645|NCT02786537|27030192|FG004|As Randomized|Opiate Dependency Relapse|0|||
13484646|NCT02786537|27030193|FG005|As Randomized|Opiate Dependency Relapse|0|||
13484647|NCT02786537|27030188|FG000|As Randomized|HCV drugs stolen from pt|0|||
13484648|NCT02786537|27030189|FG001|As Randomized|HCV drugs stolen from pt|1|||
13484649|NCT02786537|27030190|FG002|As Randomized|HCV drugs stolen from pt|0|||
13484650|NCT02786537|27030191|FG003|As Randomized|HCV drugs stolen from pt|0|||
13484651|NCT02786537|27030192|FG004|As Randomized|HCV drugs stolen from pt|0|||
13484652|NCT02786537|27030193|FG005|As Randomized|HCV drugs stolen from pt|0|||
13484653|NCT02786537|27030188|FG000|As Randomized|Advised to stop after lapse in dosing|0|||
13484654|NCT02786537|27030189|FG001|As Randomized|Advised to stop after lapse in dosing|1|||
13484655|NCT02786537|27030190|FG002|As Randomized|Advised to stop after lapse in dosing|0|||
13484656|NCT02786537|27030191|FG003|As Randomized|Advised to stop after lapse in dosing|0|||
13484657|NCT02786537|27030192|FG004|As Randomized|Advised to stop after lapse in dosing|0|||
13484658|NCT02786537|27030193|FG005|As Randomized|Advised to stop after lapse in dosing|0|||
13484659|NCT02786537|27030188|FG000|As Randomized|Subject lost insurance|0|||
13484660|NCT02786537|27030189|FG001|As Randomized|Subject lost insurance|0|||
13484661|NCT02786537|27030190|FG002|As Randomized|Subject lost insurance|0|||
13484662|NCT02786537|27030191|FG003|As Randomized|Subject lost insurance|1|||
13484663|NCT02786537|27030192|FG004|As Randomized|Subject lost insurance|0|||
13484664|NCT02786537|27030193|FG005|As Randomized|Subject lost insurance|0|||
13484665|NCT02786537|27030188|FG000|As Treated|Adverse Event|0|||
13484666|NCT02786537|27030189|FG001|As Treated|Adverse Event|11|||
13484667|NCT02786537|27030190|FG002|As Treated|Adverse Event|0|||
13484668|NCT02786537|27030191|FG003|As Treated|Adverse Event|4|||
13484669|NCT02786537|27030192|FG004|As Treated|Adverse Event|6|||
13484670|NCT02786537|27030193|FG005|As Treated|Adverse Event|2|||
13484671|NCT02786537|27030188|FG000|As Treated|Death|0|||
13484672|NCT02786537|27030189|FG001|As Treated|Death|2|||
13484673|NCT02786537|27030190|FG002|As Treated|Death|0|||
13484674|NCT02786537|27030191|FG003|As Treated|Death|3|||
13484675|NCT02786537|27030192|FG004|As Treated|Death|1|||
13484676|NCT02786537|27030193|FG005|As Treated|Death|0|||
13484677|NCT02786537|27030188|FG000|As Treated|Lack of Efficacy|0|||
13484678|NCT02786537|27030189|FG001|As Treated|Lack of Efficacy|0|||
13484679|NCT02786537|27030190|FG002|As Treated|Lack of Efficacy|0|||
13484680|NCT02786537|27030191|FG003|As Treated|Lack of Efficacy|1|||
13484681|NCT02786537|27030192|FG004|As Treated|Lack of Efficacy|0|||
13484682|NCT02786537|27030193|FG005|As Treated|Lack of Efficacy|0|||
13484683|NCT02786537|27030188|FG000|As Treated|Lost to Follow-up|4|||
13484684|NCT02786537|27030189|FG001|As Treated|Lost to Follow-up|32|||
13484685|NCT02786537|27030190|FG002|As Treated|Lost to Follow-up|0|||
13484686|NCT02786537|27030191|FG003|As Treated|Lost to Follow-up|25|||
13484687|NCT02786537|27030192|FG004|As Treated|Lost to Follow-up|4|||
13484688|NCT02786537|27030193|FG005|As Treated|Lost to Follow-up|4|||
13484689|NCT02786537|27030188|FG000|As Treated|Non-compliance with study drug|1|||
13484690|NCT02786537|27030189|FG001|As Treated|Non-compliance with study drug|11|||
13484691|NCT02786537|27030190|FG002|As Treated|Non-compliance with study drug|0|||
13484692|NCT02786537|27030191|FG003|As Treated|Non-compliance with study drug|1|||
13484693|NCT02786537|27030192|FG004|As Treated|Non-compliance with study drug|0|||
13484694|NCT02786537|27030193|FG005|As Treated|Non-compliance with study drug|1|||
13484695|NCT02786537|27030188|FG000|As Treated|Lost insurance|0|||
13484696|NCT02786537|27030189|FG001|As Treated|Lost insurance|0|||
13484697|NCT02786537|27030190|FG002|As Treated|Lost insurance|0|||
13484698|NCT02786537|27030191|FG003|As Treated|Lost insurance|1|||
13221787|NCT01811186|26284659|FG001|Overall Study|Lost to Follow-up|2|||
13484699|NCT02786537|27030192|FG004|As Treated|Lost insurance|0|||
13484700|NCT02786537|27030193|FG005|As Treated|Lost insurance|0|||
13484701|NCT02786537|27030188|FG000|As Treated|Withdrawal by Subject|1|||
13484702|NCT02786537|27030189|FG001|As Treated|Withdrawal by Subject|2|||
13484703|NCT02786537|27030190|FG002|As Treated|Withdrawal by Subject|0|||
13484704|NCT02786537|27030191|FG003|As Treated|Withdrawal by Subject|0|||
13484705|NCT02786537|27030192|FG004|As Treated|Withdrawal by Subject|1|||
13484706|NCT02786537|27030193|FG005|As Treated|Withdrawal by Subject|0|||
13484707|NCT02786537|27030188|FG000|As Treated|Incarceration|0|||
13484708|NCT02786537|27030189|FG001|As Treated|Incarceration|1|||
13484709|NCT02786537|27030190|FG002|As Treated|Incarceration|0|||
13484710|NCT02786537|27030191|FG003|As Treated|Incarceration|0|||
13484711|NCT02786537|27030192|FG004|As Treated|Incarceration|0|||
13484712|NCT02786537|27030193|FG005|As Treated|Incarceration|0|||
13484713|NCT02786537|27030188|FG000|As Treated|Opiate dependency relapse|0|||
13484714|NCT02786537|27030189|FG001|As Treated|Opiate dependency relapse|1|||
13484715|NCT02786537|27030190|FG002|As Treated|Opiate dependency relapse|0|||
13484716|NCT02786537|27030191|FG003|As Treated|Opiate dependency relapse|0|||
13484717|NCT02786537|27030192|FG004|As Treated|Opiate dependency relapse|0|||
13484718|NCT02786537|27030193|FG005|As Treated|Opiate dependency relapse|0|||
13484719|NCT02786537|27030188|FG000|As Treated|Drugs stolen from patient|0|||
13484720|NCT02786537|27030189|FG001|As Treated|Drugs stolen from patient|1|||
13484721|NCT02786537|27030190|FG002|As Treated|Drugs stolen from patient|0|||
13484722|NCT02786537|27030191|FG003|As Treated|Drugs stolen from patient|0|||
13484723|NCT02786537|27030192|FG004|As Treated|Drugs stolen from patient|0|||
13484724|NCT02786537|27030193|FG005|As Treated|Drugs stolen from patient|0|||
13484725|NCT02786537|27030188|FG000|As Treated|Advised to stop tx after loss of meds|0|||
13484726|NCT02786537|27030189|FG001|As Treated|Advised to stop tx after loss of meds|1|||
13484727|NCT02786537|27030190|FG002|As Treated|Advised to stop tx after loss of meds|0|||
13484728|NCT02786537|27030191|FG003|As Treated|Advised to stop tx after loss of meds|0|||
13484729|NCT02786537|27030192|FG004|As Treated|Advised to stop tx after loss of meds|0|||
13484730|NCT02786537|27030193|FG005|As Treated|Advised to stop tx after loss of meds|0|||
13484731|NCT02740231|27030230|FG000|Overall Study|Withdrawal by Subject|1|||
13125153|NCT02931539|25955284|FG000|Period 1: Treatment Phase|Adverse Event|5|||
13125154|NCT02931539|25955285|FG001|Period 1: Treatment Phase|Adverse Event|1|||
13125155|NCT02931539|25955286|FG002|Period 1: Treatment Phase|Adverse Event|0|||
13125156|NCT02931539|25955284|FG000|Period 1: Treatment Phase|Lost to Follow-up|1|||
13125157|NCT02931539|25955285|FG001|Period 1: Treatment Phase|Lost to Follow-up|2|||
13125158|NCT02931539|25955286|FG002|Period 1: Treatment Phase|Lost to Follow-up|0|||
13125159|NCT02931539|25955284|FG000|Period 1: Treatment Phase|Death|8|||
13125160|NCT02931539|25955285|FG001|Period 1: Treatment Phase|Death|24|||
13125161|NCT02931539|25955286|FG002|Period 1: Treatment Phase|Death|0|||
13125162|NCT02931539|25955284|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16|||
13125163|NCT02931539|25955285|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8|||
13125164|NCT02931539|25955286|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0|||
13125165|NCT02931539|25955284|FG000|Period 1: Treatment Phase|Protocol Violation|6|||
13125166|NCT02931539|25955285|FG001|Period 1: Treatment Phase|Protocol Violation|0|||
13125167|NCT02931539|25955286|FG002|Period 1: Treatment Phase|Protocol Violation|0|||
13125168|NCT02931539|25955284|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22|||
13125169|NCT02931539|25955285|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
13125170|NCT02931539|25955286|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
13221788|NCT01810939|26284676|FG000|Part A Treatment Period|Non-compliance with Study Drug|1|||
13221789|NCT01810939|26284677|FG001|Part A Treatment Period|Non-compliance with Study Drug|0|||
13221790|NCT01810939|26284678|FG002|Part A Treatment Period|Non-compliance with Study Drug|0|||
13221791|NCT01810939|26284676|FG000|Part A Treatment Period|Protocol Violation|2|||
13221792|NCT01810939|26284677|FG001|Part A Treatment Period|Protocol Violation|0|||
13125171|NCT02931539|25955284|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
13125172|NCT02931539|25955285|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
13125173|NCT02931539|25955286|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2|||
13125174|NCT02931396|25955303|FG000|Overall Study|Lost to Follow-up|3|||
13125175|NCT02931396|25955304|FG001|Overall Study|Lost to Follow-up|0|||
13125176|NCT02931396|25955303|FG000|Overall Study|Withdrawal by Subject|2|||
13125177|NCT02931396|25955304|FG001|Overall Study|Withdrawal by Subject|0|||
13125178|NCT02930941|25955327|FG000|Overall Study|Lost to Follow-up|1|||
13125179|NCT02930941|25955328|FG001|Overall Study|Lost to Follow-up|2|||
13125180|NCT02930889|25955338|FG000|Overall Study|Lost to Follow-up|2|||
13125181|NCT02930889|25955338|FG000|Overall Study|Withdrawal by Subject|6|||
13125182|NCT02930889|25955338|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8|||
13125183|NCT02930837|25955350|FG000|Overall Study|Adverse Event|6|||
13125184|NCT02930837|25955350|FG000|Overall Study|Lost to Follow-up|5|||
13125185|NCT02930837|25955350|FG000|Overall Study|Withdrawal by Subject|1|||
13125186|NCT02930343|25955369|FG000|Overall Study|Lost to Follow-up|9|||
13125187|NCT02930343|25955370|FG001|Overall Study|Lost to Follow-up|7|||
13125188|NCT02930226|25955423|FG000|Overall Study|Technical Problems: Leak in plasma bag|0|||
13125189|NCT02930226|25955424|FG001|Overall Study|Technical Problems: Leak in plasma bag|0|||
13125190|NCT02930226|25955425|FG002|Overall Study|Technical Problems: Leak in plasma bag|0|||
13125191|NCT02930226|25955426|FG003|Overall Study|Technical Problems: Leak in plasma bag|0|||
13125192|NCT02930226|25955427|FG004|Overall Study|Technical Problems: Leak in plasma bag|1|||
13125193|NCT02930226|25955428|FG005|Overall Study|Technical Problems: Leak in plasma bag|0|||
13125194|NCT02930122|25955447|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
13484732|NCT02740231|27030231|FG001|Overall Study|Withdrawal by Subject|1|||
13484733|NCT02740231|27030232|FG002|Overall Study|Withdrawal by Subject|1|||
13135688|NCT02737501|25996067|FG002|Randomized Phase|Reason not Specified|0|||
13135689|NCT02737501|25996065|FG000|Randomized Phase|Never Treated|1|||
13135690|NCT02737501|25996066|FG001|Randomized Phase|Never Treated|1|||
13135691|NCT02737501|25996067|FG002|Randomized Phase|Never Treated|0|||
13135692|NCT02737501|25996065|FG000|Crossover Phase|Died|0|||
13135693|NCT02737501|25996066|FG001|Crossover Phase|Died|0|||
13135694|NCT02737501|25996067|FG002|Crossover Phase|Died|22|||
13135695|NCT02737501|25996065|FG000|Crossover Phase|Withdrew Consent|0|||
13135696|NCT02737501|25996066|FG001|Crossover Phase|Withdrew Consent|0|||
13484734|NCT02740231|27030233|FG003|Overall Study|Withdrawal by Subject|0|||
13484735|NCT02740231|27030230|FG000|Overall Study|Lack of Efficacy|0|||
13484736|NCT02740231|27030231|FG001|Overall Study|Lack of Efficacy|1|||
13484737|NCT02740231|27030232|FG002|Overall Study|Lack of Efficacy|0|||
13484738|NCT02740231|27030233|FG003|Overall Study|Lack of Efficacy|4|||
13484739|NCT02740231|27030230|FG000|Overall Study|Lost to Follow-up|1|||
13484740|NCT02740231|27030231|FG001|Overall Study|Lost to Follow-up|3|||
13484741|NCT02740231|27030232|FG002|Overall Study|Lost to Follow-up|0|||
13484742|NCT02740231|27030233|FG003|Overall Study|Lost to Follow-up|3|||
13484743|NCT02740231|27030230|FG000|Overall Study|Adverse Event|0|||
13484744|NCT02740231|27030231|FG001|Overall Study|Adverse Event|1|||
13484745|NCT02740231|27030232|FG002|Overall Study|Adverse Event|0|||
13484746|NCT02740231|27030233|FG003|Overall Study|Adverse Event|1|||
13484747|NCT02710084|27030270|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3|||
13484748|NCT02710084|27030271|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1|||
13484749|NCT02660034|27030470|FG000|Overall Study|Progressive Disease (Radiographic)|3|||
13484750|NCT02660034|27030471|FG001|Overall Study|Progressive Disease (Radiographic)|1|||
13484751|NCT02660034|27030472|FG002|Overall Study|Progressive Disease (Radiographic)|0|||
13484752|NCT02660034|27030473|FG003|Overall Study|Progressive Disease (Radiographic)|1|||
13484753|NCT02660034|27030474|FG004|Overall Study|Progressive Disease (Radiographic)|0|||
13484754|NCT02660034|27030475|FG005|Overall Study|Progressive Disease (Radiographic)|0|||
13484755|NCT02660034|27030476|FG006|Overall Study|Progressive Disease (Radiographic)|0|||
13484756|NCT02660034|27030477|FG007|Overall Study|Progressive Disease (Radiographic)|0|||
13484757|NCT02660034|27030478|FG008|Overall Study|Progressive Disease (Radiographic)|0|||
13484758|NCT02660034|27030479|FG009|Overall Study|Progressive Disease (Radiographic)|0|||
13484759|NCT02660034|27030480|FG010|Overall Study|Progressive Disease (Radiographic)|0|||
13484760|NCT02660034|27030481|FG011|Overall Study|Progressive Disease (Radiographic)|0|||
13484761|NCT02660034|27030482|FG012|Overall Study|Progressive Disease (Radiographic)|0|||
13484762|NCT02660034|27030483|FG013|Overall Study|Progressive Disease (Radiographic)|0|||
13484763|NCT02660034|27030470|FG000|Overall Study|Progressive Disease (Clinical)|7|||
13484764|NCT02660034|27030471|FG001|Overall Study|Progressive Disease (Clinical)|8|||
13484765|NCT02660034|27030472|FG002|Overall Study|Progressive Disease (Clinical)|3|||
13484766|NCT02660034|27030473|FG003|Overall Study|Progressive Disease (Clinical)|9|||
13484767|NCT02660034|27030474|FG004|Overall Study|Progressive Disease (Clinical)|3|||
13484768|NCT02660034|27030475|FG005|Overall Study|Progressive Disease (Clinical)|0|||
13484769|NCT02660034|27030476|FG006|Overall Study|Progressive Disease (Clinical)|0|||
13484770|NCT02660034|27030477|FG007|Overall Study|Progressive Disease (Clinical)|0|||
13484771|NCT02660034|27030478|FG008|Overall Study|Progressive Disease (Clinical)|0|||
13484772|NCT02660034|27030479|FG009|Overall Study|Progressive Disease (Clinical)|0|||
13484773|NCT02660034|27030480|FG010|Overall Study|Progressive Disease (Clinical)|0|||
13484774|NCT02660034|27030481|FG011|Overall Study|Progressive Disease (Clinical)|0|||
13484775|NCT02660034|27030482|FG012|Overall Study|Progressive Disease (Clinical)|0|||
13484776|NCT02660034|27030483|FG013|Overall Study|Progressive Disease (Clinical)|0|||
13484777|NCT02660034|27030470|FG000|Overall Study|Lost to Follow-up|0|||
13484778|NCT02660034|27030471|FG001|Overall Study|Lost to Follow-up|0|||
13484779|NCT02660034|27030472|FG002|Overall Study|Lost to Follow-up|1|||
13484780|NCT02660034|27030473|FG003|Overall Study|Lost to Follow-up|1|||
13484781|NCT02660034|27030474|FG004|Overall Study|Lost to Follow-up|0|||
13484782|NCT02660034|27030475|FG005|Overall Study|Lost to Follow-up|0|||
13484783|NCT02660034|27030476|FG006|Overall Study|Lost to Follow-up|0|||
13484784|NCT02660034|27030477|FG007|Overall Study|Lost to Follow-up|0|||
13484785|NCT02660034|27030478|FG008|Overall Study|Lost to Follow-up|0|||
13484786|NCT02660034|27030479|FG009|Overall Study|Lost to Follow-up|1|||
13484787|NCT02660034|27030480|FG010|Overall Study|Lost to Follow-up|1|||
13484788|NCT02660034|27030481|FG011|Overall Study|Lost to Follow-up|1|||
13484789|NCT02660034|27030482|FG012|Overall Study|Lost to Follow-up|0|||
13484790|NCT02660034|27030483|FG013|Overall Study|Lost to Follow-up|0|||
13484791|NCT02660034|27030470|FG000|Overall Study|Participant moved into special access scheme|1|||
13484792|NCT02660034|27030471|FG001|Overall Study|Participant moved into special access scheme|2|||
13484793|NCT02660034|27030472|FG002|Overall Study|Participant moved into special access scheme|0|||
13484794|NCT02660034|27030473|FG003|Overall Study|Participant moved into special access scheme|0|||
13135697|NCT02737501|25996067|FG002|Crossover Phase|Withdrew Consent|9|||
13135698|NCT02737501|25996065|FG000|Crossover Phase|Physician Decision|0|||
13135699|NCT02737501|25996066|FG001|Crossover Phase|Physician Decision|0|||
13135700|NCT02737501|25996067|FG002|Crossover Phase|Physician Decision|1|||
13484795|NCT02660034|27030474|FG004|Overall Study|Participant moved into special access scheme|0|||
13484796|NCT02660034|27030475|FG005|Overall Study|Participant moved into special access scheme|0|||
13484797|NCT02660034|27030476|FG006|Overall Study|Participant moved into special access scheme|0|||
13484798|NCT02660034|27030477|FG007|Overall Study|Participant moved into special access scheme|0|||
13484799|NCT02660034|27030478|FG008|Overall Study|Participant moved into special access scheme|0|||
13484800|NCT02660034|27030479|FG009|Overall Study|Participant moved into special access scheme|0|||
13484801|NCT02660034|27030480|FG010|Overall Study|Participant moved into special access scheme|0|||
13484802|NCT02660034|27030481|FG011|Overall Study|Participant moved into special access scheme|0|||
13484803|NCT02660034|27030482|FG012|Overall Study|Participant moved into special access scheme|0|||
13484804|NCT02660034|27030483|FG013|Overall Study|Participant moved into special access scheme|0|||
13484805|NCT02660034|27030470|FG000|Overall Study|Adverse Event|1|||
13484806|NCT02660034|27030471|FG001|Overall Study|Adverse Event|0|||
13484807|NCT02660034|27030472|FG002|Overall Study|Adverse Event|0|||
13484808|NCT02660034|27030473|FG003|Overall Study|Adverse Event|0|||
13484809|NCT02660034|27030474|FG004|Overall Study|Adverse Event|0|||
13484810|NCT02660034|27030475|FG005|Overall Study|Adverse Event|0|||
13484811|NCT02660034|27030476|FG006|Overall Study|Adverse Event|0|||
13484812|NCT02660034|27030477|FG007|Overall Study|Adverse Event|0|||
13484813|NCT02660034|27030478|FG008|Overall Study|Adverse Event|0|||
13484814|NCT02660034|27030479|FG009|Overall Study|Adverse Event|0|||
13484815|NCT02660034|27030480|FG010|Overall Study|Adverse Event|0|||
13484816|NCT02660034|27030481|FG011|Overall Study|Adverse Event|0|||
13484817|NCT02660034|27030482|FG012|Overall Study|Adverse Event|0|||
13484818|NCT02660034|27030483|FG013|Overall Study|Adverse Event|0|||
13484819|NCT02660034|27030470|FG000|Overall Study|Sponsor Decision|0|||
13484820|NCT02660034|27030471|FG001|Overall Study|Sponsor Decision|1|||
13484821|NCT02660034|27030472|FG002|Overall Study|Sponsor Decision|2|||
13484822|NCT02660034|27030473|FG003|Overall Study|Sponsor Decision|2|||
13484823|NCT02660034|27030474|FG004|Overall Study|Sponsor Decision|3|||
13484824|NCT02660034|27030475|FG005|Overall Study|Sponsor Decision|0|||
13484825|NCT02660034|27030476|FG006|Overall Study|Sponsor Decision|0|||
13484826|NCT02660034|27030477|FG007|Overall Study|Sponsor Decision|0|||
13484827|NCT02660034|27030478|FG008|Overall Study|Sponsor Decision|0|||
13484828|NCT02660034|27030479|FG009|Overall Study|Sponsor Decision|0|||
13484829|NCT02660034|27030480|FG010|Overall Study|Sponsor Decision|0|||
13484830|NCT02660034|27030481|FG011|Overall Study|Sponsor Decision|0|||
13484831|NCT02660034|27030482|FG012|Overall Study|Sponsor Decision|0|||
13484832|NCT02660034|27030483|FG013|Overall Study|Sponsor Decision|1|||
13484833|NCT02660034|27030470|FG000|Overall Study|Withdrawal by Subject|0|||
13484834|NCT02660034|27030471|FG001|Overall Study|Withdrawal by Subject|0|||
13484835|NCT02660034|27030472|FG002|Overall Study|Withdrawal by Subject|0|||
13484836|NCT02660034|27030473|FG003|Overall Study|Withdrawal by Subject|0|||
13484837|NCT02660034|27030474|FG004|Overall Study|Withdrawal by Subject|0|||
13484838|NCT02660034|27030475|FG005|Overall Study|Withdrawal by Subject|0|||
13484839|NCT02660034|27030476|FG006|Overall Study|Withdrawal by Subject|1|||
13484840|NCT02660034|27030477|FG007|Overall Study|Withdrawal by Subject|1|||
13484841|NCT02660034|27030478|FG008|Overall Study|Withdrawal by Subject|1|||
13484842|NCT02660034|27030479|FG009|Overall Study|Withdrawal by Subject|0|||
13484843|NCT02660034|27030480|FG010|Overall Study|Withdrawal by Subject|0|||
13484844|NCT02660034|27030481|FG011|Overall Study|Withdrawal by Subject|1|||
13484845|NCT02660034|27030482|FG012|Overall Study|Withdrawal by Subject|2|||
13484846|NCT02660034|27030483|FG013|Overall Study|Withdrawal by Subject|0|||
13484847|NCT02660034|27030470|FG000|Overall Study|Death|0|||
13484848|NCT02660034|27030471|FG001|Overall Study|Death|0|||
13484849|NCT02660034|27030472|FG002|Overall Study|Death|0|||
13484850|NCT02660034|27030473|FG003|Overall Study|Death|0|||
13484851|NCT02660034|27030474|FG004|Overall Study|Death|0|||
13484852|NCT02660034|27030475|FG005|Overall Study|Death|13|||
13484853|NCT02660034|27030476|FG006|Overall Study|Death|14|||
13484854|NCT02660034|27030477|FG007|Overall Study|Death|10|||
13484855|NCT02660034|27030478|FG008|Overall Study|Death|9|||
13484856|NCT02660034|27030479|FG009|Overall Study|Death|21|||
13484857|NCT02660034|27030480|FG010|Overall Study|Death|17|||
13484858|NCT02660034|27030481|FG011|Overall Study|Death|15|||
13484859|NCT02660034|27030482|FG012|Overall Study|Death|18|||
13484860|NCT02660034|27030483|FG013|Overall Study|Death|7|||
13484861|NCT02660034|27030470|FG000|Overall Study|Physician Decision|0|||
13484862|NCT02660034|27030471|FG001|Overall Study|Physician Decision|0|||
13484863|NCT02660034|27030472|FG002|Overall Study|Physician Decision|0|||
13484864|NCT02660034|27030473|FG003|Overall Study|Physician Decision|0|||
13484865|NCT02660034|27030474|FG004|Overall Study|Physician Decision|0|||
13484866|NCT02660034|27030475|FG005|Overall Study|Physician Decision|0|||
13484867|NCT02660034|27030476|FG006|Overall Study|Physician Decision|0|||
13484868|NCT02660034|27030477|FG007|Overall Study|Physician Decision|0|||
13484869|NCT02660034|27030478|FG008|Overall Study|Physician Decision|0|||
13484870|NCT02660034|27030479|FG009|Overall Study|Physician Decision|0|||
13484871|NCT02660034|27030480|FG010|Overall Study|Physician Decision|0|||
13484872|NCT02660034|27030481|FG011|Overall Study|Physician Decision|0|||
13484873|NCT02660034|27030482|FG012|Overall Study|Physician Decision|0|||
13484874|NCT02660034|27030483|FG013|Overall Study|Physician Decision|1|||
13484875|NCT02660034|27030470|FG000|Overall Study|Participants transferred to LTE|0|||
13484876|NCT02660034|27030471|FG001|Overall Study|Participants transferred to LTE|0|||
13484877|NCT02660034|27030472|FG002|Overall Study|Participants transferred to LTE|0|||
13484878|NCT02660034|27030473|FG003|Overall Study|Participants transferred to LTE|0|||
13484879|NCT02660034|27030474|FG004|Overall Study|Participants transferred to LTE|0|||
13484880|NCT02660034|27030475|FG005|Overall Study|Participants transferred to LTE|10|||
13484881|NCT02660034|27030476|FG006|Overall Study|Participants transferred to LTE|8|||
13484882|NCT02660034|27030477|FG007|Overall Study|Participants transferred to LTE|8|||
13484883|NCT02660034|27030478|FG008|Overall Study|Participants transferred to LTE|10|||
13484884|NCT02660034|27030479|FG009|Overall Study|Participants transferred to LTE|1|||
13484885|NCT02660034|27030480|FG010|Overall Study|Participants transferred to LTE|2|||
13484886|NCT02660034|27030481|FG011|Overall Study|Participants transferred to LTE|4|||
13484887|NCT02660034|27030482|FG012|Overall Study|Participants transferred to LTE|1|||
13484888|NCT02660034|27030483|FG013|Overall Study|Participants transferred to LTE|1|||
13484889|NCT02640625|27030491|FG000|Overall Study|Adverse Event|1|||
13484890|NCT02500589|27030518|FG000|Overall Study|Withdrawal by Subject|11|||
13484891|NCT02500589|27030519|FG001|Overall Study|Withdrawal by Subject|14|||
13484892|NCT02500589|27030518|FG000|Overall Study|Lost to Follow-up|10|||
13484893|NCT02500589|27030519|FG001|Overall Study|Lost to Follow-up|12|||
13484894|NCT02500589|27030518|FG000|Overall Study|Excluded post rand: cognitive impairment|0|||
13484895|NCT02500589|27030519|FG001|Overall Study|Excluded post rand: cognitive impairment|1|||
13484896|NCT02500589|27030518|FG000|Overall Study|Death|7|||
13484897|NCT02500589|27030519|FG001|Overall Study|Death|5|||
13484898|NCT02474329|27030535|FG000|Overall Study|Withdraw or did not contribute data.|13|||
13484899|NCT01388491|27030602|FG000|Overall Study|Adverse Event|10|||
13484900|NCT01388491|27030603|FG001|Overall Study|Adverse Event|9|||
13484901|NCT01388491|27030602|FG000|Overall Study|Sponsor Request|9|||
13484902|NCT01388491|27030603|FG001|Overall Study|Sponsor Request|7|||
13484903|NCT01388491|27030602|FG000|Overall Study|Withdrawal by Subject|6|||
13484904|NCT01388491|27030603|FG001|Overall Study|Withdrawal by Subject|10|||
13484905|NCT01388491|27030602|FG000|Overall Study|Lost to Follow-up|4|||
13484906|NCT01388491|27030603|FG001|Overall Study|Lost to Follow-up|3|||
13484907|NCT01388491|27030602|FG000|Overall Study|Protocol Violation|2|||
13484908|NCT01388491|27030603|FG001|Overall Study|Protocol Violation|0|||
13484909|NCT01388491|27030602|FG000|Overall Study|Noncompliance|2|||
13484910|NCT01388491|27030603|FG001|Overall Study|Noncompliance|0|||
13484911|NCT01388491|27030602|FG000|Overall Study|Pregnancy|1|||
13484912|NCT01388491|27030603|FG001|Overall Study|Pregnancy|0|||
13484913|NCT01373151|27030753|FG000|Period 1|Lack of Efficacy|3|||
13484914|NCT01373151|27030754|FG001|Period 1|Lack of Efficacy|0|||
13484915|NCT01373151|27030755|FG002|Period 1|Lack of Efficacy|0|||
13125195|NCT02930122|25955448|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
13125196|NCT02930018|25955477|FG000|Overall Study|Lost to Follow-up|1|||
13125197|NCT02930018|25955478|FG001|Overall Study|Lost to Follow-up|1|||
13125198|NCT02930018|25955477|FG000|Overall Study|Withdrawal by Subject|5|||
13125199|NCT02930018|25955478|FG001|Overall Study|Withdrawal by Subject|2|||
13125200|NCT02930005|25955493|FG000|Overall Study|Lost to Follow-up|1|||
13125201|NCT02930005|25955494|FG001|Overall Study|Lost to Follow-up|5|||
13125202|NCT02929498|25955598|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3|||
13125203|NCT02929498|25955599|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
13125204|NCT02929498|25955600|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
13125205|NCT02929498|25955598|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2|||
13125206|NCT02929498|25955599|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
13125207|NCT02929498|25955600|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
13125208|NCT02929407|25955617|FG000|Overall Study|Adverse Event|1|||
13125209|NCT02929329|25955640|FG000|Overall Study|Withdrawal by Subject|24|||
13125210|NCT02929329|25955641|FG001|Overall Study|Withdrawal by Subject|21|||
13125211|NCT02929329|25955640|FG000|Overall Study|Lost to Follow-up|26|||
13125212|NCT02929329|25955641|FG001|Overall Study|Lost to Follow-up|20|||
13125213|NCT02929329|25955640|FG000|Overall Study|Death|1054|||
13125214|NCT02929329|25955641|FG001|Overall Study|Death|1051|||
13125215|NCT02928952|25955688|FG000|Overall Study|Lost to Follow-up|5|||
13125216|NCT02928952|25955689|FG001|Overall Study|Lost to Follow-up|5|||
13125217|NCT02928952|25955688|FG000|Overall Study|Withdrawal by Subject|5|||
13125218|NCT02928952|25955689|FG001|Overall Study|Withdrawal by Subject|1|||
13125219|NCT02928952|25955688|FG000|Overall Study|Physician Decision|0|||
13125220|NCT02928952|25955689|FG001|Overall Study|Physician Decision|1|||
13125221|NCT02928848|25955704|FG000|Arm 2|Withdrawal by Subject|1|||
13125222|NCT02928848|25955705|FG001|Arm 2|Withdrawal by Subject|0|||
13125223|NCT02928770|25955711|FG000|Overall Study|Withdrawal by Subject|2|||
13484916|NCT01373151|27030756|FG003|Period 1|Lack of Efficacy|0|||
13484917|NCT01373151|27030757|FG004|Period 1|Lack of Efficacy|1|||
13484918|NCT01373151|27030758|FG005|Period 1|Lack of Efficacy|0|||
13204518|NCT01972724|26229202|FG000|Double-Blind|Rescue Criteria Met|1|||
13125268|NCT02928029|25955846|FG000|Overall Study|Withdrawal by Subject|0|||
13125269|NCT02928029|25955847|FG001|Overall Study|Withdrawal by Subject|1|||
13125270|NCT02928029|25955846|FG000|Overall Study|Radiological progression|1|||
13125271|NCT02928029|25955847|FG001|Overall Study|Radiological progression|0|||
13125272|NCT02928029|25955846|FG000|Overall Study|Clinical progression|1|||
13125273|NCT02928029|25955847|FG001|Overall Study|Clinical progression|2|||
13125274|NCT02928029|25955846|FG000|Overall Study|AE not related to clinical progression|1|||
13125275|NCT02928029|25955847|FG001|Overall Study|AE not related to clinical progression|1|||
13125276|NCT02927938|25955868|FG000|Overall Study|Death|0|||
13125277|NCT02927938|25955869|FG001|Overall Study|Death|1|||
13125278|NCT02927938|25955870|FG002|Overall Study|Death|0|||
13125279|NCT02927938|25955871|FG003|Overall Study|Death|4|||
13125280|NCT02927938|25955868|FG000|Overall Study|Early Study Termination|1|||
13125281|NCT02927938|25955869|FG001|Overall Study|Early Study Termination|5|||
13125282|NCT02927938|25955870|FG002|Overall Study|Early Study Termination|4|||
13125283|NCT02927938|25955871|FG003|Overall Study|Early Study Termination|3|||
13125284|NCT02927925|25955887|FG000|Overall Study|Death|16|||
13125285|NCT02927925|25955887|FG000|Overall Study|Physician Decision|1|||
13125286|NCT02927925|25955887|FG000|Overall Study|Withdrawal by Subject|11|||
13125287|NCT02927925|25955887|FG000|Overall Study|Other|3|||
13125288|NCT02927925|25955887|FG000|Overall Study|Disease progression at clinical cutoff|1|||
13125289|NCT02927873|25956052|FG000|Overall Study|Lost to Follow-up|0|||
13125290|NCT02927873|25956053|FG001|Overall Study|Lost to Follow-up|1|||
13125291|NCT02927873|25956054|FG002|Overall Study|Lost to Follow-up|0|||
13125292|NCT02927873|25956055|FG003|Overall Study|Lost to Follow-up|0|||
13125293|NCT02927873|25956056|FG004|Overall Study|Lost to Follow-up|0|||
13125294|NCT02927873|25956057|FG005|Overall Study|Lost to Follow-up|0|||
13125295|NCT02927873|25956052|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
13125296|NCT02927873|25956053|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
13125297|NCT02927873|25956054|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
13221793|NCT01810939|26284678|FG002|Part A Treatment Period|Protocol Violation|0|||
13221794|NCT01810939|26284676|FG000|Part A Treatment Period|Adverse Event|10|||
13221795|NCT01810939|26284677|FG001|Part A Treatment Period|Adverse Event|0|||
13125298|NCT02927873|25956055|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
13125299|NCT02927873|25956056|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
13125300|NCT02927873|25956057|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
13125301|NCT02927873|25956052|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
13125302|NCT02927873|25956053|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
13125303|NCT02927873|25956054|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
13125304|NCT02927873|25956055|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
13125305|NCT02927873|25956056|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
13125306|NCT02927873|25956057|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
13125307|NCT02927873|25956052|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
13125308|NCT02927873|25956053|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1|||
13125309|NCT02927873|25956054|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
13125310|NCT02927873|25956055|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
13125311|NCT02927873|25956056|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
13125312|NCT02927873|25956057|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
13125313|NCT02927873|25956052|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1|||
13125314|NCT02927873|25956053|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
13125315|NCT02927873|25956054|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
13125316|NCT02927873|25956055|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
13125317|NCT02927873|25956056|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
13125318|NCT02927873|25956057|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
13125319|NCT02927873|25956052|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1|||
13125320|NCT02927873|25956053|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
13125321|NCT02927873|25956054|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
13125322|NCT02927873|25956055|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
13125323|NCT02927873|25956056|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
13125324|NCT02927873|25956057|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
13125325|NCT02927847|25956074|FG000|Overall Study|Lost to Follow-up|1|||
13125326|NCT02927847|25956075|FG001|Overall Study|Lost to Follow-up|0|||
13125327|NCT02927847|25956074|FG000|Overall Study|Withdrawal by Subject|4|||
13125328|NCT02927847|25956075|FG001|Overall Study|Withdrawal by Subject|2|||
13125329|NCT02927847|25956074|FG000|Overall Study|PI withdrawn due to missed visits|1|||
13125330|NCT02927847|25956075|FG001|Overall Study|PI withdrawn due to missed visits|1|||
13125331|NCT02927834|25956099|FG000|Overall Study|Lost to Follow-up|1|||
13125332|NCT02927834|25956100|FG001|Overall Study|Lost to Follow-up|2|||
13125333|NCT02927834|25956101|FG002|Overall Study|Lost to Follow-up|2|||
13125334|NCT02927795|25956112|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19|||
13125335|NCT02927795|25956112|FG000|Overall Study|Not Treated|4|||
13125336|NCT02927431|25956198|FG000|Overall Study|Withdrawal by Subject|0|||
13125337|NCT02927431|25956199|FG001|Overall Study|Withdrawal by Subject|0|||
13125338|NCT02927431|25956200|FG002|Overall Study|Withdrawal by Subject|1|||
13125339|NCT02927366|25956239|FG000|Overall Study|Adverse Event|1|||
13125340|NCT02927366|25956240|FG001|Overall Study|Adverse Event|0|||
13125341|NCT02927366|25956239|FG000|Overall Study|Patient schedule|1|||
13125342|NCT02927366|25956240|FG001|Overall Study|Patient schedule|0|||
13125343|NCT02927171|25956257|FG000|Overall Study|Lost to Follow-up|0|||
13125344|NCT02927171|25956258|FG001|Overall Study|Lost to Follow-up|1|||
13125345|NCT02927145|25956335|FG000|Initial Recruitment|Withdrawal by Subject|0|||
13125346|NCT02927145|25956336|FG001|Initial Recruitment|Withdrawal by Subject|1|||
13125347|NCT02927145|25956337|FG002|Initial Recruitment|Withdrawal by Subject|1|||
13125348|NCT02927145|25956338|FG003|Initial Recruitment|Withdrawal by Subject|4|||
13125349|NCT02927145|25956339|FG004|Initial Recruitment|Withdrawal by Subject|1|||
13125350|NCT02927145|25956340|FG005|Initial Recruitment|Withdrawal by Subject|1|||
13125351|NCT02927145|25956341|FG006|Initial Recruitment|Withdrawal by Subject|0|||
13125352|NCT02927145|25956342|FG007|Initial Recruitment|Withdrawal by Subject|0|||
13125353|NCT02927145|25956343|FG008|Initial Recruitment|Withdrawal by Subject|2|||
13125354|NCT02927145|25956335|FG000|Initial Recruitment|Adverse Event|0|||
13125355|NCT02927145|25956336|FG001|Initial Recruitment|Adverse Event|0|||
13125356|NCT02927145|25956337|FG002|Initial Recruitment|Adverse Event|0|||
13125357|NCT02927145|25956338|FG003|Initial Recruitment|Adverse Event|0|||
13125358|NCT02927145|25956339|FG004|Initial Recruitment|Adverse Event|2|||
13125359|NCT02927145|25956340|FG005|Initial Recruitment|Adverse Event|0|||
13125360|NCT02927145|25956341|FG006|Initial Recruitment|Adverse Event|0|||
13125361|NCT02927145|25956342|FG007|Initial Recruitment|Adverse Event|0|||
13125362|NCT02927145|25956343|FG008|Initial Recruitment|Adverse Event|0|||
13125363|NCT02927145|25956335|FG000|Invitation for Additional Challenge|Pregnancy|0|||
13125364|NCT02927145|25956336|FG001|Invitation for Additional Challenge|Pregnancy|0|||
13125365|NCT02927145|25956337|FG002|Invitation for Additional Challenge|Pregnancy|0|||
13125366|NCT02927145|25956338|FG003|Invitation for Additional Challenge|Pregnancy|0|||
13125367|NCT02927145|25956339|FG004|Invitation for Additional Challenge|Pregnancy|0|||
13125368|NCT02927145|25956340|FG005|Invitation for Additional Challenge|Pregnancy|0|||
13125369|NCT02927145|25956341|FG006|Invitation for Additional Challenge|Pregnancy|1|||
13125370|NCT02927145|25956342|FG007|Invitation for Additional Challenge|Pregnancy|0|||
13125371|NCT02927145|25956343|FG008|Invitation for Additional Challenge|Pregnancy|0|||
13125372|NCT02927080|25956454|FG000|Overall Study|Withdrawal by Subject|0|||
13125373|NCT02927080|25956455|FG001|Overall Study|Withdrawal by Subject|0|||
13125374|NCT02927080|25956456|FG002|Overall Study|Withdrawal by Subject|0|||
13125375|NCT02927080|25956457|FG003|Overall Study|Withdrawal by Subject|0|||
13125376|NCT02927080|25956458|FG004|Overall Study|Withdrawal by Subject|1|||
13125377|NCT02927080|25956459|FG005|Overall Study|Withdrawal by Subject|0|||
13125378|NCT02927080|25956460|FG006|Overall Study|Withdrawal by Subject|1|||
13125379|NCT02927080|25956461|FG007|Overall Study|Withdrawal by Subject|1|||
13125380|NCT02927080|25956462|FG008|Overall Study|Withdrawal by Subject|0|||
13125381|NCT02927080|25956463|FG009|Overall Study|Withdrawal by Subject|2|||
13125382|NCT02927080|25956454|FG000|Overall Study|Willingness to comply with protocol|0|||
13125383|NCT02927080|25956455|FG001|Overall Study|Willingness to comply with protocol|0|||
13125384|NCT02927080|25956456|FG002|Overall Study|Willingness to comply with protocol|0|||
13125385|NCT02927080|25956457|FG003|Overall Study|Willingness to comply with protocol|0|||
13125386|NCT02927080|25956458|FG004|Overall Study|Willingness to comply with protocol|0|||
13125387|NCT02927080|25956459|FG005|Overall Study|Willingness to comply with protocol|0|||
13125388|NCT02927080|25956460|FG006|Overall Study|Willingness to comply with protocol|0|||
13125389|NCT02927080|25956461|FG007|Overall Study|Willingness to comply with protocol|0|||
13125390|NCT02927080|25956462|FG008|Overall Study|Willingness to comply with protocol|0|||
13125391|NCT02927080|25956463|FG009|Overall Study|Willingness to comply with protocol|1|||
13125392|NCT02927080|25956454|FG000|Overall Study|Study terminated by Sponsor|0|||
13125393|NCT02927080|25956455|FG001|Overall Study|Study terminated by Sponsor|0|||
13125394|NCT02927080|25956456|FG002|Overall Study|Study terminated by Sponsor|0|||
13125395|NCT02927080|25956457|FG003|Overall Study|Study terminated by Sponsor|0|||
13125396|NCT02927080|25956458|FG004|Overall Study|Study terminated by Sponsor|0|||
13125397|NCT02927080|25956459|FG005|Overall Study|Study terminated by Sponsor|0|||
13393697|NCT00662792|26784677|FG003|Period 4|Other adverse event (AE)|0|||
13125398|NCT02927080|25956460|FG006|Overall Study|Study terminated by Sponsor|6|||
13125399|NCT02927080|25956461|FG007|Overall Study|Study terminated by Sponsor|7|||
13125400|NCT02927080|25956462|FG008|Overall Study|Study terminated by Sponsor|2|||
13125401|NCT02927080|25956463|FG009|Overall Study|Study terminated by Sponsor|3|||
13125402|NCT02927080|25956454|FG000|Overall Study|Adverse Event|0|||
13125403|NCT02927080|25956455|FG001|Overall Study|Adverse Event|1|||
13125404|NCT02927080|25956456|FG002|Overall Study|Adverse Event|0|||
13125405|NCT02927080|25956457|FG003|Overall Study|Adverse Event|0|||
13125406|NCT02927080|25956458|FG004|Overall Study|Adverse Event|0|||
13125407|NCT02927080|25956459|FG005|Overall Study|Adverse Event|0|||
13125408|NCT02927080|25956460|FG006|Overall Study|Adverse Event|0|||
13125409|NCT02927080|25956461|FG007|Overall Study|Adverse Event|1|||
13125410|NCT02927080|25956462|FG008|Overall Study|Adverse Event|0|||
13125411|NCT02927080|25956463|FG009|Overall Study|Adverse Event|1|||
13125412|NCT02927080|25956454|FG000|Overall Study|Other|0|||
13125413|NCT02927080|25956455|FG001|Overall Study|Other|0|||
13125414|NCT02927080|25956456|FG002|Overall Study|Other|0|||
13125415|NCT02927080|25956457|FG003|Overall Study|Other|0|||
13125416|NCT02927080|25956458|FG004|Overall Study|Other|0|||
13125417|NCT02927080|25956459|FG005|Overall Study|Other|0|||
13125418|NCT02927080|25956460|FG006|Overall Study|Other|1|||
13125419|NCT02927080|25956461|FG007|Overall Study|Other|0|||
13125420|NCT02927080|25956462|FG008|Overall Study|Other|1|||
13125421|NCT02927080|25956463|FG009|Overall Study|Other|0|||
13125422|NCT02926950|25956492|FG000|Overall Study|Adverse Event|4|||
13125423|NCT02926950|25956493|FG001|Overall Study|Adverse Event|6|||
13125424|NCT02926950|25956492|FG000|Overall Study|At the participant's own request|21|||
13125425|NCT02926950|25956493|FG001|Overall Study|At the participant's own request|25|||
13125426|NCT02926950|25956492|FG000|Overall Study|Reason not Specified|17|||
13125427|NCT02926950|25956493|FG001|Overall Study|Reason not Specified|9|||
13125428|NCT02926950|25956492|FG000|Overall Study|Lost to Follow-up|7|||
13125429|NCT02926950|25956493|FG001|Overall Study|Lost to Follow-up|8|||
13125430|NCT02926937|25956536|FG000|Overall Study|Adverse Event|0|||
13125431|NCT02926937|25956537|FG001|Overall Study|Adverse Event|1|||
13125432|NCT02926937|25956538|FG002|Overall Study|Adverse Event|1|||
13125433|NCT02926937|25956536|FG000|Overall Study|Poor Compliance to Protocol|1|||
13125434|NCT02926937|25956537|FG001|Overall Study|Poor Compliance to Protocol|0|||
13125435|NCT02926937|25956538|FG002|Overall Study|Poor Compliance to Protocol|0|||
13125436|NCT02926937|25956536|FG000|Overall Study|Lost to Follow-up|4|||
13125437|NCT02926937|25956537|FG001|Overall Study|Lost to Follow-up|5|||
13125438|NCT02926937|25956538|FG002|Overall Study|Lost to Follow-up|0|||
13125439|NCT02926937|25956536|FG000|Overall Study|At the Participant's own Request|11|||
13125440|NCT02926937|25956537|FG001|Overall Study|At the Participant's own Request|5|||
13125441|NCT02926937|25956538|FG002|Overall Study|At the Participant's own Request|8|||
13125442|NCT02926937|25956536|FG000|Overall Study|Reason not Specified|3|||
13125443|NCT02926937|25956537|FG001|Overall Study|Reason not Specified|4|||
13125444|NCT02926937|25956538|FG002|Overall Study|Reason not Specified|2|||
13125445|NCT02926833|25956605|FG000|Overall Study|Full Consent Withdrawal|0|||
13125446|NCT02926833|25956606|FG001|Overall Study|Full Consent Withdrawal|0|||
13125447|NCT02926833|25956607|FG002|Overall Study|Full Consent Withdrawal|0|||
13125448|NCT02926833|25956608|FG003|Overall Study|Full Consent Withdrawal|2|||
13125449|NCT02926833|25956605|FG000|Overall Study|Death|1|||
13125450|NCT02926833|25956606|FG001|Overall Study|Death|1|||
13125451|NCT02926833|25956607|FG002|Overall Study|Death|1|||
13125452|NCT02926833|25956608|FG003|Overall Study|Death|7|||
13125453|NCT02926833|25956605|FG000|Overall Study|Still on study|2|||
13125454|NCT02926833|25956606|FG001|Overall Study|Still on study|3|||
13125455|NCT02926833|25956607|FG002|Overall Study|Still on study|5|||
13125456|NCT02926833|25956608|FG003|Overall Study|Still on study|14|||
13125457|NCT02926833|25956605|FG000|Overall Study|Adverse Event|0|||
13125458|NCT02926833|25956606|FG001|Overall Study|Adverse Event|0|||
13125459|NCT02926833|25956607|FG002|Overall Study|Adverse Event|1|||
13125460|NCT02926833|25956608|FG003|Overall Study|Adverse Event|0|||
13125461|NCT02926638|25956627|FG000|Overall Study|Progression|2|||
13125462|NCT02926638|25956628|FG001|Overall Study|Progression|5|||
13125463|NCT02926638|25956627|FG000|Overall Study|Ineligible|1|||
13125464|NCT02926638|25956628|FG001|Overall Study|Ineligible|0|||
13125465|NCT02926638|25956627|FG000|Overall Study|Not protocol specified|1|||
13125466|NCT02926638|25956628|FG001|Overall Study|Not protocol specified|0|||
13125467|NCT02926573|25956653|FG000|Overall Study|Nausea|1|||
13125468|NCT02926573|25956654|FG001|Overall Study|Nausea|0|||
13125469|NCT02926573|25956653|FG000|Overall Study|Remain intubated|2|||
13125470|NCT02926573|25956654|FG001|Overall Study|Remain intubated|2|||
13125471|NCT02926573|25956653|FG000|Overall Study|Change in surgery plan|3|||
13125472|NCT02926573|25956654|FG001|Overall Study|Change in surgery plan|1|||
13125473|NCT02926573|25956653|FG000|Overall Study|Change to outpatient status|5|||
13125474|NCT02926573|25956654|FG001|Overall Study|Change to outpatient status|1|||
13125475|NCT02926573|25956653|FG000|Overall Study|Withdrawal by Subject|0|||
13125476|NCT02926573|25956654|FG001|Overall Study|Withdrawal by Subject|2|||
13125477|NCT02926573|25956653|FG000|Overall Study|Return to operating room|0|||
13125478|NCT02926573|25956654|FG001|Overall Study|Return to operating room|2|||
13125479|NCT02926573|25956653|FG000|Overall Study|Delirium|0|||
13125480|NCT02926573|25956654|FG001|Overall Study|Delirium|1|||
13125481|NCT02926209|25956668|FG000|Study Cohort|Poor Bowel Preparation|1|||
13125482|NCT02926209|25956669|FG001|Study Cohort|Poor Bowel Preparation|0|||
13125483|NCT02925923|25956704|FG000|Overall Study|blood samples hemolyzed|0|||
13125484|NCT02925923|25956705|FG001|Overall Study|blood samples hemolyzed|2|||
13125485|NCT02925793|25956744|FG000|Overall Study|Adverse Event|3|||
13125486|NCT02925793|25956745|FG001|Overall Study|Adverse Event|3|||
13125487|NCT02925793|25956746|FG002|Overall Study|Adverse Event|6|||
13125488|NCT02925793|25956744|FG000|Overall Study|Withdrawal by Subject|16|||
13125489|NCT02925793|25956745|FG001|Overall Study|Withdrawal by Subject|15|||
13125490|NCT02925793|25956746|FG002|Overall Study|Withdrawal by Subject|13|||
13125491|NCT02925793|25956744|FG000|Overall Study|Investigator Discretion|0|||
13125492|NCT02925793|25956745|FG001|Overall Study|Investigator Discretion|1|||
13125493|NCT02925793|25956746|FG002|Overall Study|Investigator Discretion|1|||
13125494|NCT02925793|25956744|FG000|Overall Study|Lost to Follow-up|2|||
13125495|NCT02925793|25956745|FG001|Overall Study|Lost to Follow-up|3|||
13484919|NCT01373151|27030759|FG006|Period 1|Lack of Efficacy|0|||
13125496|NCT02925793|25956746|FG002|Overall Study|Lost to Follow-up|1|||
13125497|NCT02925793|25956744|FG000|Overall Study|Lack of Efficacy|2|||
13125498|NCT02925793|25956745|FG001|Overall Study|Lack of Efficacy|6|||
13125499|NCT02925793|25956746|FG002|Overall Study|Lack of Efficacy|4|||
13125500|NCT02925793|25956744|FG000|Overall Study|Other:|2|||
13125501|NCT02925793|25956745|FG001|Overall Study|Other:|1|||
13125502|NCT02925793|25956746|FG002|Overall Study|Other:|3|||
13125503|NCT02925741|25956763|FG000|Overall Study|Withdrawal by Subject|11|||
13125504|NCT02925741|25956764|FG001|Overall Study|Withdrawal by Subject|0|||
13125505|NCT02925494|25956803|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
13125506|NCT02925494|25956804|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
13125507|NCT02925494|25956805|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
13204519|NCT01972724|26229203|FG001|Double-Blind|Rescue Criteria Met|0|||
13125508|NCT02925494|25956806|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23|||
13125509|NCT02925494|25956803|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
13125510|NCT02925494|25956804|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
13125511|NCT02925494|25956805|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9|||
13125512|NCT02925494|25956806|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10|||
13125513|NCT02925494|25956803|FG000|Post-Treatment Follow-Up Period|Other|1|||
13125514|NCT02925494|25956804|FG001|Post-Treatment Follow-Up Period|Other|4|||
13125515|NCT02925494|25956805|FG002|Post-Treatment Follow-Up Period|Other|3|||
13125516|NCT02925494|25956806|FG003|Post-Treatment Follow-Up Period|Other|6|||
13125517|NCT02925494|25956803|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1|||
13125518|NCT02925494|25956804|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
13125519|NCT02925494|25956805|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
13125520|NCT02925494|25956806|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6|||
13125521|NCT02925494|25956803|FG000|Post-Treatment Follow-Up Period|Pregnancy|1|||
13125522|NCT02925494|25956804|FG001|Post-Treatment Follow-Up Period|Pregnancy|0|||
13125523|NCT02925494|25956805|FG002|Post-Treatment Follow-Up Period|Pregnancy|1|||
13125524|NCT02925494|25956806|FG003|Post-Treatment Follow-Up Period|Pregnancy|2|||
13125525|NCT02925494|25956803|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
13125526|NCT02925494|25956804|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
13125527|NCT02925494|25956805|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
13125528|NCT02925494|25956806|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2|||
13125529|NCT02925494|25956803|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
13125530|NCT02925494|25956804|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
13125531|NCT02925494|25956805|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
13125532|NCT02925494|25956806|FG003|Post-Treatment Follow-Up Period|Adverse Event|1|||
13125533|NCT02925455|25956827|FG000|Overall Study|Withdrawal by Subject|2|||
13125534|NCT02925455|25956828|FG001|Overall Study|Withdrawal by Subject|0|||
13125535|NCT02925403|25956847|FG000|Overall Study|Lost to Follow-up|0|||
13125536|NCT02925403|25956848|FG001|Overall Study|Lost to Follow-up|1|||
13125537|NCT02925312|25956867|FG000|Overall Study|Lost to Follow-up|25|||
13125538|NCT02925312|25956868|FG001|Overall Study|Lost to Follow-up|0|||
13125539|NCT02925312|25956867|FG000|Overall Study|Adverse Event|2|||
13125540|NCT02925312|25956868|FG001|Overall Study|Adverse Event|0|||
13125541|NCT02925117|25956987|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
13125542|NCT02925117|25956988|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3|||
13125543|NCT02925117|25956989|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
13125544|NCT02925117|25956990|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2|||
13125545|NCT02925117|25956991|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
13125546|NCT02925117|25956992|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
13125547|NCT02925117|25956993|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
13125548|NCT02925117|25956994|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
13125549|NCT02925117|25956995|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
13125550|NCT02925117|25956996|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
13125551|NCT02925117|25956997|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
13125552|NCT02925117|25956998|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
13125553|NCT02925117|25956987|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10|||
13125554|NCT02925117|25956988|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
13221796|NCT01810939|26284678|FG002|Part A Treatment Period|Adverse Event|0|||
13221797|NCT01810939|26284676|FG000|Part A Treatment Period|Withdrawal by Subject|5|||
13221798|NCT01810939|26284677|FG001|Part A Treatment Period|Withdrawal by Subject|0|||
13221799|NCT01810939|26284678|FG002|Part A Treatment Period|Withdrawal by Subject|0|||
13221800|NCT01810939|26284676|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2|||
13221801|NCT01810939|26284677|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0|||
13221802|NCT01810939|26284678|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0|||
13221803|NCT01810939|26284676|FG000|Part A Treatment Period|Protocol-specified (High K+)|3|||
13221804|NCT01810939|26284677|FG001|Part A Treatment Period|Protocol-specified (High K+)|0|||
13221805|NCT01810939|26284678|FG002|Part A Treatment Period|Protocol-specified (High K+)|0|||
13221806|NCT01810939|26284676|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1|||
13221807|NCT01810939|26284677|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0|||
13221808|NCT01810939|26284678|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0|||
13221809|NCT01810939|26284676|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0|||
13221810|NCT01810939|26284677|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
13221811|NCT01810939|26284678|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
13221812|NCT01810939|26284676|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
13221813|NCT01810939|26284677|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1|||
13221814|NCT01810939|26284678|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
13221815|NCT01810939|26284676|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0|||
13221816|NCT01810939|26284677|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
13221817|NCT01810939|26284678|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
13221818|NCT01810939|26284676|FG000|Part B Placebo-Controlled Withdrawal|Death|0|||
13221819|NCT01810939|26284677|FG001|Part B Placebo-Controlled Withdrawal|Death|0|||
13221820|NCT01810939|26284678|FG002|Part B Placebo-Controlled Withdrawal|Death|1|||
13221821|NCT01810939|26284676|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
13221822|NCT01810939|26284677|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
13221823|NCT01810939|26284678|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1|||
13221824|NCT01810939|26284676|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0|||
13221825|NCT01810939|26284677|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
13221826|NCT01810939|26284678|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
13221827|NCT01810939|26284676|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0|||
13221828|NCT01810939|26284677|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1|||
13221829|NCT01810939|26284678|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2|||
13221830|NCT01810939|26284676|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0|||
13221831|NCT01810939|26284677|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2|||
13221832|NCT01810939|26284678|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14|||
13221833|NCT01810939|26284676|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0|||
13221834|NCT01810939|26284677|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2|||
13221835|NCT01810939|26284678|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1|||
13221836|NCT01810939|26284676|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
13221837|NCT01810939|26284677|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1|||
13221838|NCT01810939|26284678|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
13221839|NCT01810783|26284684|FG000|Overall Study|Adverse Event|32|||
13221840|NCT01810783|26284684|FG000|Overall Study|Withdrawal by Subject|22|||
13221841|NCT01810783|26284684|FG000|Overall Study|Lack of Efficacy|12|||
13221842|NCT01810783|26284684|FG000|Overall Study|Lost to Follow-up|10|||
13221843|NCT01810783|26284684|FG000|Overall Study|Protocol Violation|5|||
13221844|NCT01810783|26284684|FG000|Overall Study|Non-compliance with IMP|4|||
13221845|NCT01810783|26284684|FG000|Overall Study|Adminstrative or other reason(s)|23|||
13221846|NCT01810783|26284684|FG000|Overall Study|Enrolled, not treated|1|||
13221847|NCT01810432|26284697|FG000|Washout|Protocol Violation|0|||
13221848|NCT01810432|26284698|FG001|Washout|Protocol Violation|1|||
13221849|NCT01810432|26284697|FG000|Washout|Adverse Event|1|||
13221850|NCT01810432|26284698|FG001|Washout|Adverse Event|0|||
13221851|NCT01810432|26284697|FG000|Period 2|Withdrawal by Subject|2|||
13221852|NCT01810432|26284698|FG001|Period 2|Withdrawal by Subject|1|||
13221853|NCT01810432|26284697|FG000|Period 2|Physician Decision|1|||
13221854|NCT01810432|26284698|FG001|Period 2|Physician Decision|0|||
13221855|NCT01810432|26284697|FG000|Period 2|Lost to Follow-up|1|||
13221856|NCT01810432|26284698|FG001|Period 2|Lost to Follow-up|1|||
13125555|NCT02925117|25956989|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
13125556|NCT02925117|25956990|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
13125557|NCT02925117|25956991|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
13125558|NCT02925117|25956992|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
13125559|NCT02925117|25956993|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
13125560|NCT02925117|25956994|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
13125561|NCT02925117|25956995|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
13125562|NCT02925117|25956996|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
13125563|NCT02925117|25956997|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
13125564|NCT02925117|25956998|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
13125565|NCT02925117|25956987|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2|||
13125566|NCT02925117|25956988|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1|||
13125567|NCT02925117|25956989|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
13125568|NCT02925117|25956990|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
13125569|NCT02925117|25956991|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
13125570|NCT02925117|25956992|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
13125571|NCT02925117|25956993|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
13125572|NCT02925117|25956994|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
13125573|NCT02925117|25956995|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
13125574|NCT02925117|25956996|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
13125575|NCT02925117|25956997|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
13125576|NCT02925117|25956998|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
13125577|NCT02925117|25956987|FG000|Period 1 (Weeks 0 - 16)|Other|5|||
13125578|NCT02925117|25956988|FG001|Period 1 (Weeks 0 - 16)|Other|4|||
13125579|NCT02925117|25956989|FG002|Period 1 (Weeks 0 - 16)|Other|1|||
13125580|NCT02925117|25956990|FG003|Period 1 (Weeks 0 - 16)|Other|1|||
13125581|NCT02925117|25956991|FG004|Period 1 (Weeks 0 - 16)|Other|0|||
13125582|NCT02925117|25956992|FG005|Period 1 (Weeks 0 - 16)|Other|0|||
13125583|NCT02925117|25956993|FG006|Period 1 (Weeks 0 - 16)|Other|0|||
13125584|NCT02925117|25956994|FG007|Period 1 (Weeks 0 - 16)|Other|0|||
13125585|NCT02925117|25956995|FG008|Period 1 (Weeks 0 - 16)|Other|0|||
13125586|NCT02925117|25956996|FG009|Period 1 (Weeks 0 - 16)|Other|0|||
13125587|NCT02925117|25956997|FG010|Period 1 (Weeks 0 - 16)|Other|0|||
13125588|NCT02925117|25956998|FG011|Period 1 (Weeks 0 - 16)|Other|0|||
13125589|NCT02925117|25956987|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
13125590|NCT02925117|25956988|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
13125591|NCT02925117|25956989|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
13125592|NCT02925117|25956990|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
13125593|NCT02925117|25956991|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
13125594|NCT02925117|25956992|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1|||
13135701|NCT02737501|25996065|FG000|Crossover Phase|Site Terminated by Sponsor|0|||
13372865|NCT00806260|26722171|FG000|Period 2|Protocol Violation|1|||
13125595|NCT02925117|25956993|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
13125596|NCT02925117|25956994|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
13221857|NCT01810380|26284767|FG000|Overall Study|Randomised not treated|2|||
13125597|NCT02925117|25956995|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
13221858|NCT01810380|26284768|FG001|Overall Study|Randomised not treated|1|||
13125598|NCT02925117|25956996|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
13125599|NCT02925117|25956997|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3|||
13125600|NCT02925117|25956998|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2|||
13372866|NCT00806260|26722172|FG001|Period 2|Protocol Violation|0|||
13221859|NCT01810380|26284769|FG002|Overall Study|Randomised not treated|1|||
13221860|NCT01810380|26284767|FG000|Overall Study|Adverse Event|11|||
13221861|NCT01810380|26284768|FG001|Overall Study|Adverse Event|14|||
13221862|NCT01810380|26284769|FG002|Overall Study|Adverse Event|4|||
13221863|NCT01810380|26284767|FG000|Overall Study|Lack of Efficacy|24|||
13221864|NCT01810380|26284768|FG001|Overall Study|Lack of Efficacy|10|||
13221865|NCT01810380|26284769|FG002|Overall Study|Lack of Efficacy|11|||
13221866|NCT01810380|26284767|FG000|Overall Study|Protocol Violation|1|||
13221867|NCT01810380|26284768|FG001|Overall Study|Protocol Violation|0|||
13221868|NCT01810380|26284769|FG002|Overall Study|Protocol Violation|1|||
13221869|NCT01810380|26284767|FG000|Overall Study|Withdrawal by Subject|6|||
13221870|NCT01810380|26284768|FG001|Overall Study|Withdrawal by Subject|0|||
13221871|NCT01810380|26284769|FG002|Overall Study|Withdrawal by Subject|6|||
13221872|NCT01810380|26284767|FG000|Overall Study|Administrative or other reasons|11|||
13221873|NCT01810380|26284768|FG001|Overall Study|Administrative or other reasons|13|||
13221874|NCT01810380|26284769|FG002|Overall Study|Administrative or other reasons|9|||
13221875|NCT01810302|26284784|FG000|Overall Study|Death|1|||
13221876|NCT01810302|26284785|FG001|Overall Study|Death|0|||
13221877|NCT01810302|26284784|FG000|Overall Study|Physician Decision|0|||
13221878|NCT01810302|26284785|FG001|Overall Study|Physician Decision|1|||
13221879|NCT01810263|26284798|FG000|Overall Study|Lost to Follow-up|8|||
13221880|NCT01810263|26284799|FG001|Overall Study|Lost to Follow-up|7|||
13135702|NCT02737501|25996066|FG001|Crossover Phase|Site Terminated by Sponsor|0|||
13484920|NCT01373151|27030753|FG000|Period 1|Adverse Event|0|||
13484921|NCT01373151|27030754|FG001|Period 1|Adverse Event|0|||
13484922|NCT01373151|27030755|FG002|Period 1|Adverse Event|1|||
13484923|NCT01373151|27030756|FG003|Period 1|Adverse Event|0|||
13484924|NCT01373151|27030757|FG004|Period 1|Adverse Event|4|||
13484925|NCT01373151|27030758|FG005|Period 1|Adverse Event|3|||
13484926|NCT01373151|27030759|FG006|Period 1|Adverse Event|0|||
13125601|NCT02925117|25956987|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
13125602|NCT02925117|25956988|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
13125603|NCT02925117|25956989|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
13125604|NCT02925117|25956990|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
13125605|NCT02925117|25956991|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
13125606|NCT02925117|25956992|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1|||
13125607|NCT02925117|25956993|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4|||
13125608|NCT02925117|25956994|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3|||
13125609|NCT02925117|25956995|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
13125610|NCT02925117|25956996|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
13125611|NCT02925117|25956997|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
13125612|NCT02925117|25956998|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
13125613|NCT02925117|25956987|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
13125614|NCT02925117|25956988|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
13125615|NCT02925117|25956989|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
13125616|NCT02925117|25956990|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
13125617|NCT02925117|25956991|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
13125618|NCT02925117|25956992|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2|||
13125619|NCT02925117|25956993|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
13125620|NCT02925117|25956994|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
13125621|NCT02925117|25956995|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
13125622|NCT02925117|25956996|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
13125623|NCT02925117|25956997|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
13125624|NCT02925117|25956998|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
13125625|NCT02925117|25956987|FG000|Period 2 (Weeks 16 - 88)|Other|0|||
13125626|NCT02925117|25956988|FG001|Period 2 (Weeks 16 - 88)|Other|0|||
13125627|NCT02925117|25956989|FG002|Period 2 (Weeks 16 - 88)|Other|0|||
13125628|NCT02925117|25956990|FG003|Period 2 (Weeks 16 - 88)|Other|0|||
13125629|NCT02925117|25956991|FG004|Period 2 (Weeks 16 - 88)|Other|1|||
13125630|NCT02925117|25956992|FG005|Period 2 (Weeks 16 - 88)|Other|1|||
13125631|NCT02925117|25956993|FG006|Period 2 (Weeks 16 - 88)|Other|1|||
13125632|NCT02925117|25956994|FG007|Period 2 (Weeks 16 - 88)|Other|1|||
13125633|NCT02925117|25956995|FG008|Period 2 (Weeks 16 - 88)|Other|3|||
13125634|NCT02925117|25956996|FG009|Period 2 (Weeks 16 - 88)|Other|4|||
13125635|NCT02925117|25956997|FG010|Period 2 (Weeks 16 - 88)|Other|3|||
13125636|NCT02925117|25956998|FG011|Period 2 (Weeks 16 - 88)|Other|0|||
13125637|NCT02924883|25957029|FG000|Overall Study|Death|39|||
13125638|NCT02924883|25957030|FG001|Overall Study|Death|20|||
13125639|NCT02924883|25957029|FG000|Overall Study|Lost to Follow-up|1|||
13125640|NCT02924883|25957030|FG001|Overall Study|Lost to Follow-up|0|||
13125641|NCT02924883|25957029|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0|||
13484927|NCT01373151|27030753|FG000|Period 1|Withdrawal by Subject|2|||
13484928|NCT01373151|27030754|FG001|Period 1|Withdrawal by Subject|0|||
13484929|NCT01373151|27030755|FG002|Period 1|Withdrawal by Subject|3|||
13125642|NCT02924883|25957030|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1|||
13125643|NCT02924883|25957029|FG000|Overall Study|Protocol Violation|1|||
13125644|NCT02924883|25957030|FG001|Overall Study|Protocol Violation|0|||
13125645|NCT02924883|25957029|FG000|Overall Study|Withdrawal by Subject|22|||
13484930|NCT01373151|27030756|FG003|Period 1|Withdrawal by Subject|1|||
13484931|NCT01373151|27030757|FG004|Period 1|Withdrawal by Subject|0|||
13484932|NCT01373151|27030758|FG005|Period 1|Withdrawal by Subject|1|||
13484933|NCT01373151|27030759|FG006|Period 1|Withdrawal by Subject|0|||
13484934|NCT01373151|27030753|FG000|Period 2|Lack of Efficacy|9|||
13484935|NCT01373151|27030754|FG001|Period 2|Lack of Efficacy|0|||
13484936|NCT01373151|27030755|FG002|Period 2|Lack of Efficacy|0|||
13484937|NCT01373151|27030756|FG003|Period 2|Lack of Efficacy|1|||
13484938|NCT01373151|27030757|FG004|Period 2|Lack of Efficacy|2|||
13484939|NCT01373151|27030758|FG005|Period 2|Lack of Efficacy|0|||
13484940|NCT01373151|27030759|FG006|Period 2|Lack of Efficacy|3|||
13484941|NCT01373151|27030753|FG000|Period 2|Adverse Event|0|||
13484942|NCT01373151|27030754|FG001|Period 2|Adverse Event|0|||
13484943|NCT01373151|27030755|FG002|Period 2|Adverse Event|3|||
13484944|NCT01373151|27030756|FG003|Period 2|Adverse Event|3|||
13484945|NCT01373151|27030757|FG004|Period 2|Adverse Event|0|||
13484946|NCT01373151|27030758|FG005|Period 2|Adverse Event|0|||
13484947|NCT01373151|27030759|FG006|Period 2|Adverse Event|1|||
13484948|NCT01373151|27030753|FG000|Period 2|subject request to discontinue|0|||
13484949|NCT01373151|27030754|FG001|Period 2|subject request to discontinue|1|||
13484950|NCT01373151|27030755|FG002|Period 2|subject request to discontinue|0|||
13484951|NCT01373151|27030756|FG003|Period 2|subject request to discontinue|0|||
13484952|NCT01373151|27030757|FG004|Period 2|subject request to discontinue|0|||
13484953|NCT01373151|27030758|FG005|Period 2|subject request to discontinue|0|||
13484954|NCT01373151|27030759|FG006|Period 2|subject request to discontinue|0|||
13484955|NCT01373151|27030753|FG000|Period 2|Withdrawal by Subject|0|||
13484956|NCT01373151|27030754|FG001|Period 2|Withdrawal by Subject|0|||
13484957|NCT01373151|27030755|FG002|Period 2|Withdrawal by Subject|0|||
13484958|NCT01373151|27030756|FG003|Period 2|Withdrawal by Subject|1|||
13484959|NCT01373151|27030757|FG004|Period 2|Withdrawal by Subject|0|||
13484960|NCT01373151|27030758|FG005|Period 2|Withdrawal by Subject|0|||
13484961|NCT01373151|27030759|FG006|Period 2|Withdrawal by Subject|0|||
13484962|NCT01373151|27030753|FG000|Period 2|Other|0|||
13484963|NCT01373151|27030754|FG001|Period 2|Other|0|||
13484964|NCT01373151|27030755|FG002|Period 2|Other|1|||
13484965|NCT01373151|27030756|FG003|Period 2|Other|0|||
13484966|NCT01373151|27030757|FG004|Period 2|Other|0|||
13484967|NCT01373151|27030758|FG005|Period 2|Other|0|||
13204520|NCT01972724|26229204|FG002|Double-Blind|Rescue Criteria Met|0|||
13484968|NCT01373151|27030759|FG006|Period 2|Other|1|||
13484969|NCT01281644|27030789|FG000|Overall Study|Lost to Follow-up|3|||
13484970|NCT01281644|27030789|FG000|Overall Study|Withdrawal by Subject|2|||
13484971|NCT00960297|27030800|FG000|Overall Study|Physician Decision|1|||
13125646|NCT02924883|25957030|FG001|Overall Study|Withdrawal by Subject|16|||
13125647|NCT02924883|25957029|FG000|Overall Study|Progressive Disease|1|||
13125648|NCT02924883|25957030|FG001|Overall Study|Progressive Disease|0|||
13125649|NCT02924883|25957029|FG000|Overall Study|Study Terminated by Sponsor|69|||
13125650|NCT02924883|25957030|FG001|Overall Study|Study Terminated by Sponsor|32|||
13125651|NCT02924688|25957117|FG000|Overall Study|Adverse Event|9|||
13125652|NCT02924688|25957118|FG001|Overall Study|Adverse Event|3|||
13125653|NCT02924688|25957119|FG002|Overall Study|Adverse Event|2|||
13125654|NCT02924688|25957120|FG003|Overall Study|Adverse Event|2|||
13125655|NCT02924688|25957121|FG004|Overall Study|Adverse Event|3|||
13125656|NCT02924688|25957122|FG005|Overall Study|Adverse Event|2|||
13125657|NCT02924688|25957117|FG000|Overall Study|Lack of Efficacy|2|||
13125658|NCT02924688|25957118|FG001|Overall Study|Lack of Efficacy|3|||
13125659|NCT02924688|25957119|FG002|Overall Study|Lack of Efficacy|4|||
13125660|NCT02924688|25957120|FG003|Overall Study|Lack of Efficacy|2|||
13125661|NCT02924688|25957121|FG004|Overall Study|Lack of Efficacy|1|||
13125662|NCT02924688|25957122|FG005|Overall Study|Lack of Efficacy|1|||
13125663|NCT02924688|25957117|FG000|Overall Study|Protocol Violation|3|||
13125664|NCT02924688|25957118|FG001|Overall Study|Protocol Violation|7|||
13125665|NCT02924688|25957119|FG002|Overall Study|Protocol Violation|5|||
13125666|NCT02924688|25957120|FG003|Overall Study|Protocol Violation|6|||
13125667|NCT02924688|25957121|FG004|Overall Study|Protocol Violation|2|||
13125668|NCT02924688|25957122|FG005|Overall Study|Protocol Violation|2|||
13125669|NCT02924688|25957117|FG000|Overall Study|Protocol defined withdrawal criteria met|1|||
13125670|NCT02924688|25957118|FG001|Overall Study|Protocol defined withdrawal criteria met|0|||
13125671|NCT02924688|25957119|FG002|Overall Study|Protocol defined withdrawal criteria met|1|||
13125672|NCT02924688|25957120|FG003|Overall Study|Protocol defined withdrawal criteria met|1|||
13125673|NCT02924688|25957121|FG004|Overall Study|Protocol defined withdrawal criteria met|1|||
13125674|NCT02924688|25957122|FG005|Overall Study|Protocol defined withdrawal criteria met|0|||
13125675|NCT02924688|25957117|FG000|Overall Study|Lost to Follow-up|2|||
13125676|NCT02924688|25957118|FG001|Overall Study|Lost to Follow-up|4|||
13125677|NCT02924688|25957119|FG002|Overall Study|Lost to Follow-up|2|||
13125678|NCT02924688|25957120|FG003|Overall Study|Lost to Follow-up|4|||
13125679|NCT02924688|25957121|FG004|Overall Study|Lost to Follow-up|2|||
13125680|NCT02924688|25957122|FG005|Overall Study|Lost to Follow-up|4|||
13125681|NCT02924688|25957117|FG000|Overall Study|Physician Decision|2|||
13125682|NCT02924688|25957118|FG001|Overall Study|Physician Decision|1|||
13125683|NCT02924688|25957119|FG002|Overall Study|Physician Decision|0|||
13125684|NCT02924688|25957120|FG003|Overall Study|Physician Decision|1|||
13125685|NCT02924688|25957121|FG004|Overall Study|Physician Decision|1|||
13125686|NCT02924688|25957122|FG005|Overall Study|Physician Decision|1|||
13125687|NCT02924688|25957117|FG000|Overall Study|Withdrawal by Subject|14|||
13125688|NCT02924688|25957118|FG001|Overall Study|Withdrawal by Subject|13|||
13125689|NCT02924688|25957119|FG002|Overall Study|Withdrawal by Subject|9|||
13125690|NCT02924688|25957120|FG003|Overall Study|Withdrawal by Subject|12|||
13125691|NCT02924688|25957121|FG004|Overall Study|Withdrawal by Subject|13|||
13125692|NCT02924688|25957122|FG005|Overall Study|Withdrawal by Subject|14|||
13125693|NCT02924428|25957149|FG000|Overall Study|Adverse Event|1|||
13125694|NCT02924428|25957150|FG001|Overall Study|Adverse Event|0|||
13125695|NCT02924428|25957149|FG000|Overall Study|Physician Decision|1|||
13125696|NCT02924428|25957150|FG001|Overall Study|Physician Decision|0|||
13125697|NCT02924428|25957149|FG000|Overall Study|Lost to Follow-up|2|||
13125698|NCT02924428|25957150|FG001|Overall Study|Lost to Follow-up|4|||
13484972|NCT00960297|27030800|FG000|Overall Study|Venous port infection|1|||
13484973|NCT00960297|27030800|FG000|Overall Study|Disease progression|1|||
13484974|NCT00910650|27030807|FG000|Overall Study|Death|2|||
13487909|NCT01092143|27041508|FG001|Overall Study|Randomized by mistake|0|||
13487910|NCT01092143|27041509|FG002|Overall Study|Randomized by mistake|0|||
13487911|NCT01092143|27041510|FG003|Overall Study|Randomized by mistake|1|||
13487912|NCT01092143|27041511|FG004|Overall Study|Randomized by mistake|0|||
13487913|NCT01092143|27041507|FG000|Overall Study|Pregnancy|0|||
13487914|NCT01092143|27041508|FG001|Overall Study|Pregnancy|0|||
13487915|NCT01092143|27041509|FG002|Overall Study|Pregnancy|0|||
13487916|NCT01092143|27041510|FG003|Overall Study|Pregnancy|1|||
13487917|NCT01092143|27041511|FG004|Overall Study|Pregnancy|0|||
13487918|NCT00593567|27041562|FG000|Overall Study|Adverse Event|2|||
13487919|NCT00593567|27041563|FG001|Overall Study|Adverse Event|0|||
13487920|NCT00593567|27041562|FG000|Overall Study|Physician Decision|2|||
13487921|NCT00593567|27041563|FG001|Overall Study|Physician Decision|0|||
13487922|NCT00593567|27041562|FG000|Overall Study|Protocol Violation|13|||
13487923|NCT00593567|27041563|FG001|Overall Study|Protocol Violation|7|||
13487924|NCT00593567|27041562|FG000|Overall Study|Lack of Efficacy|2|||
13487925|NCT00593567|27041563|FG001|Overall Study|Lack of Efficacy|1|||
13487926|NCT00593567|27041562|FG000|Overall Study|Withdrawal by Subject|1|||
13487927|NCT00593567|27041563|FG001|Overall Study|Withdrawal by Subject|2|||
13488345|NCT02959918|27043323|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3|||
13488346|NCT02959918|27043324|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
13488347|NCT02959918|27043325|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
13488348|NCT02959918|27043326|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
13488349|NCT02959918|27043327|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
13488350|NCT02959918|27043328|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
13488351|NCT02959918|27043329|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
13488352|NCT02959918|27043330|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
13488353|NCT02959918|27043331|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
13488354|NCT02959918|27043332|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
13488355|NCT02959918|27043333|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
13488356|NCT02959918|27043320|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
13488357|NCT02959918|27043321|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
13488358|NCT02959918|27043322|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
13488359|NCT02959918|27043323|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
13488360|NCT02959918|27043324|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
13488361|NCT02959918|27043325|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
13488362|NCT02959918|27043326|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
13488363|NCT02959918|27043327|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1|||
13488364|NCT02959918|27043328|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
13488365|NCT02959918|27043329|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
13484975|NCT03996876|27030836|FG000|Overall Study|Incomplete Data|2|||
13484976|NCT03996876|27030837|FG001|Overall Study|Incomplete Data|4|||
13484977|NCT03135262|27030972|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1|||
13484978|NCT03135262|27030973|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
13484979|NCT03135262|27030974|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
13484980|NCT03135262|27030975|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
13484981|NCT03135262|27030976|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
13484982|NCT03135262|27030972|FG000|Overall Study|Progression of disease|0|||
13484983|NCT03135262|27030973|FG001|Overall Study|Progression of disease|0|||
13484984|NCT03135262|27030974|FG002|Overall Study|Progression of disease|0|||
13484985|NCT03135262|27030975|FG003|Overall Study|Progression of disease|1|||
13484986|NCT03135262|27030976|FG004|Overall Study|Progression of disease|0|||
13484987|NCT03135262|27030972|FG000|Overall Study|Death|6|||
13484988|NCT03135262|27030973|FG001|Overall Study|Death|2|||
13484989|NCT03135262|27030974|FG002|Overall Study|Death|2|||
13484990|NCT03135262|27030975|FG003|Overall Study|Death|2|||
13484991|NCT03135262|27030976|FG004|Overall Study|Death|0|||
13125699|NCT02924428|25957149|FG000|Overall Study|Pregnancy|0|||
13125700|NCT02924428|25957150|FG001|Overall Study|Pregnancy|1|||
13125701|NCT02924129|25957163|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2|||
13125702|NCT02924129|25957164|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1|||
13125703|NCT02924129|25957163|FG000|Overall Study|Withdrawal by Subject|2|||
13125704|NCT02924129|25957164|FG001|Overall Study|Withdrawal by Subject|2|||
13125705|NCT02924129|25957163|FG000|Overall Study|Physician Decision|1|||
13125706|NCT02924129|25957164|FG001|Overall Study|Physician Decision|0|||
13125707|NCT02924129|25957163|FG000|Overall Study|Missed Visit|0|||
13125708|NCT02924129|25957164|FG001|Overall Study|Missed Visit|1|||
13125709|NCT02924051|25957181|FG000|Overall Study|Withdrawal by Subject|1|||
13125710|NCT02924051|25957182|FG001|Overall Study|Withdrawal by Subject|9|||
13125711|NCT02923921|25957205|FG000|Overall Study|Sponsor Decision|39|||
13125712|NCT02923921|25957206|FG001|Overall Study|Sponsor Decision|38|||
13125713|NCT02923921|25957205|FG000|Overall Study|Lost to Follow-up|1|||
13125714|NCT02923921|25957206|FG001|Overall Study|Lost to Follow-up|0|||
13125715|NCT02923921|25957205|FG000|Overall Study|Withdrawal by Subject|6|||
13125716|NCT02923921|25957206|FG001|Overall Study|Withdrawal by Subject|13|||
13125717|NCT02923921|25957205|FG000|Overall Study|Unknown, Not Collected|7|||
13125718|NCT02923921|25957206|FG001|Overall Study|Unknown, Not Collected|6|||
13125719|NCT02923830|25957231|FG000|Overall Study|Physician Decision|13|||
13125720|NCT02923830|25957232|FG001|Overall Study|Physician Decision|15|||
13125721|NCT02923427|25957259|FG000|Overall Study|convert to laparatomy|2|||
13125722|NCT02923427|25957260|FG001|Overall Study|convert to laparatomy|2|||
13125723|NCT02923427|25957259|FG000|Overall Study|destaturation|1|||
13125724|NCT02923427|25957260|FG001|Overall Study|destaturation|0|||
13125725|NCT02923427|25957259|FG000|Overall Study|can not replace LMA|1|||
13125726|NCT02923427|25957260|FG001|Overall Study|can not replace LMA|0|||
13125727|NCT02923349|25957354|FG000|Overall Study|Other|1|||
13125728|NCT02923349|25957355|FG001|Overall Study|Other|2|||
13125729|NCT02923349|25957356|FG002|Overall Study|Other|4|||
13125730|NCT02923349|25957357|FG003|Overall Study|Other|1|||
13125731|NCT02923349|25957358|FG004|Overall Study|Other|3|||
13125732|NCT02923349|25957359|FG005|Overall Study|Other|0|||
13125733|NCT02923349|25957360|FG006|Overall Study|Other|1|||
13125734|NCT02923349|25957354|FG000|Overall Study|Withdrawal by Subject|2|||
13125735|NCT02923349|25957355|FG001|Overall Study|Withdrawal by Subject|2|||
13125736|NCT02923349|25957356|FG002|Overall Study|Withdrawal by Subject|8|||
13125737|NCT02923349|25957357|FG003|Overall Study|Withdrawal by Subject|10|||
13125738|NCT02923349|25957358|FG004|Overall Study|Withdrawal by Subject|12|||
13125739|NCT02923349|25957359|FG005|Overall Study|Withdrawal by Subject|3|||
13125740|NCT02923349|25957360|FG006|Overall Study|Withdrawal by Subject|0|||
13125741|NCT02923349|25957354|FG000|Overall Study|Physician Decision|0|||
13125742|NCT02923349|25957355|FG001|Overall Study|Physician Decision|0|||
13125743|NCT02923349|25957356|FG002|Overall Study|Physician Decision|0|||
13125744|NCT02923349|25957357|FG003|Overall Study|Physician Decision|1|||
13125745|NCT02923349|25957358|FG004|Overall Study|Physician Decision|1|||
13125746|NCT02923349|25957359|FG005|Overall Study|Physician Decision|0|||
13125747|NCT02923349|25957360|FG006|Overall Study|Physician Decision|2|||
13125748|NCT02923349|25957354|FG000|Overall Study|Lost to Follow-up|0|||
13125749|NCT02923349|25957355|FG001|Overall Study|Lost to Follow-up|0|||
13125750|NCT02923349|25957356|FG002|Overall Study|Lost to Follow-up|3|||
13125751|NCT02923349|25957357|FG003|Overall Study|Lost to Follow-up|0|||
13125752|NCT02923349|25957358|FG004|Overall Study|Lost to Follow-up|1|||
13125753|NCT02923349|25957359|FG005|Overall Study|Lost to Follow-up|1|||
13125754|NCT02923349|25957360|FG006|Overall Study|Lost to Follow-up|0|||
13125755|NCT02923349|25957354|FG000|Overall Study|Death|1|||
13125756|NCT02923349|25957355|FG001|Overall Study|Death|0|||
13125757|NCT02923349|25957356|FG002|Overall Study|Death|2|||
13125758|NCT02923349|25957357|FG003|Overall Study|Death|4|||
13125759|NCT02923349|25957358|FG004|Overall Study|Death|2|||
13125760|NCT02923349|25957359|FG005|Overall Study|Death|3|||
13125761|NCT02923349|25957360|FG006|Overall Study|Death|0|||
13125762|NCT02923245|25957384|FG000|Overall Study|ultrasound order was cancelled|2|||
13125763|NCT02923245|25957385|FG001|Overall Study|ultrasound order was cancelled|1|||
13125764|NCT02923115|25957445|FG000|Overall Study|Lost to Follow-up|0|||
13125765|NCT02923115|25957446|FG001|Overall Study|Lost to Follow-up|0|||
13125766|NCT02923115|25957447|FG002|Overall Study|Lost to Follow-up|0|||
13125767|NCT02923115|25957448|FG003|Overall Study|Lost to Follow-up|1|||
13125768|NCT02923115|25957449|FG004|Overall Study|Lost to Follow-up|0|||
13125769|NCT02923115|25957450|FG005|Overall Study|Lost to Follow-up|0|||
13125770|NCT02923115|25957445|FG000|Overall Study|Withdrawal by Subject|0|||
13125771|NCT02923115|25957446|FG001|Overall Study|Withdrawal by Subject|1|||
13125772|NCT02923115|25957447|FG002|Overall Study|Withdrawal by Subject|0|||
13125773|NCT02923115|25957448|FG003|Overall Study|Withdrawal by Subject|0|||
13125774|NCT02923115|25957449|FG004|Overall Study|Withdrawal by Subject|0|||
13125775|NCT02923115|25957450|FG005|Overall Study|Withdrawal by Subject|0|||
13125776|NCT02923115|25957445|FG000|Overall Study|Randomized, but not dosed|0|||
13125777|NCT02923115|25957446|FG001|Overall Study|Randomized, but not dosed|0|||
13125778|NCT02923115|25957447|FG002|Overall Study|Randomized, but not dosed|3|||
13125779|NCT02923115|25957448|FG003|Overall Study|Randomized, but not dosed|1|||
13125780|NCT02923115|25957449|FG004|Overall Study|Randomized, but not dosed|5|||
13125781|NCT02923115|25957450|FG005|Overall Study|Randomized, but not dosed|0|||
13125782|NCT02922634|25957485|FG000|Overall Study|Withdrawal by Subject|5|||
13125783|NCT02922634|25957485|FG000|Overall Study|Did not have their surgery|5|||
13125784|NCT02922153|25957514|FG000|Overall Study|Death|8|||
13125785|NCT02922153|25957515|FG001|Overall Study|Death|1|||
13125786|NCT02922153|25957514|FG000|Overall Study|Lost to Follow-up|1|||
13125787|NCT02922153|25957515|FG001|Overall Study|Lost to Follow-up|0|||
13125788|NCT02922153|25957514|FG000|Overall Study|Physician Decision|1|||
13125789|NCT02922153|25957515|FG001|Overall Study|Physician Decision|1|||
13125790|NCT02921919|25957540|FG000|Overall Study|Other|5|||
13125791|NCT02921919|25957541|FG001|Overall Study|Other|6|||
13125792|NCT02921919|25957540|FG000|Overall Study|Lost to Follow-up|0|||
13125793|NCT02921919|25957541|FG001|Overall Study|Lost to Follow-up|1|||
13125794|NCT02921919|25957540|FG000|Overall Study|Withdrawal by Subject|5|||
13125795|NCT02921919|25957541|FG001|Overall Study|Withdrawal by Subject|1|||
13125796|NCT02921919|25957540|FG000|Overall Study|Disease Progression|47|||
13125797|NCT02921919|25957541|FG001|Overall Study|Disease Progression|38|||
13125798|NCT02921919|25957540|FG000|Overall Study|Physician Decision|3|||
13125799|NCT02921919|25957541|FG001|Overall Study|Physician Decision|2|||
13125800|NCT02921919|25957540|FG000|Overall Study|Adverse Event|6|||
13125801|NCT02921919|25957541|FG001|Overall Study|Adverse Event|4|||
13125802|NCT02921776|25957682|FG000|Overall Study|patient deterioration, fatigue|2|||
13125803|NCT02921776|25957683|FG001|Overall Study|patient deterioration, fatigue|6|||
13125804|NCT02921776|25957684|FG002|Overall Study|patient deterioration, fatigue|0|||
13125805|NCT02921776|25957685|FG003|Overall Study|patient deterioration, fatigue|0|||
13125806|NCT02921776|25957686|FG004|Overall Study|patient deterioration, fatigue|0|||
13125807|NCT02921776|25957687|FG005|Overall Study|patient deterioration, fatigue|0|||
13125808|NCT02921776|25957688|FG006|Overall Study|patient deterioration, fatigue|0|||
13125809|NCT02921776|25957689|FG007|Overall Study|patient deterioration, fatigue|0|||
13125810|NCT02921776|25957682|FG000|Overall Study|Withdrawal by Subject|0|||
13125811|NCT02921776|25957683|FG001|Overall Study|Withdrawal by Subject|2|||
13125812|NCT02921776|25957684|FG002|Overall Study|Withdrawal by Subject|0|||
13125813|NCT02921776|25957685|FG003|Overall Study|Withdrawal by Subject|1|||
13125814|NCT02921776|25957686|FG004|Overall Study|Withdrawal by Subject|1|||
13125815|NCT02921776|25957687|FG005|Overall Study|Withdrawal by Subject|0|||
13125816|NCT02921776|25957688|FG006|Overall Study|Withdrawal by Subject|8|||
13125817|NCT02921776|25957689|FG007|Overall Study|Withdrawal by Subject|1|||
13125818|NCT02921776|25957682|FG000|Overall Study|Death|0|||
13125819|NCT02921776|25957683|FG001|Overall Study|Death|0|||
13125820|NCT02921776|25957684|FG002|Overall Study|Death|0|||
13125821|NCT02921776|25957685|FG003|Overall Study|Death|2|||
13125822|NCT02921776|25957686|FG004|Overall Study|Death|0|||
13125823|NCT02921776|25957687|FG005|Overall Study|Death|0|||
13125824|NCT02921776|25957688|FG006|Overall Study|Death|0|||
13125825|NCT02921776|25957689|FG007|Overall Study|Death|0|||
13125826|NCT02921776|25957682|FG000|Overall Study|extubation or early discharge|0|||
13125827|NCT02921776|25957683|FG001|Overall Study|extubation or early discharge|0|||
13125828|NCT02921776|25957684|FG002|Overall Study|extubation or early discharge|0|||
13125829|NCT02921776|25957685|FG003|Overall Study|extubation or early discharge|5|||
13125830|NCT02921776|25957686|FG004|Overall Study|extubation or early discharge|5|||
13125831|NCT02921776|25957687|FG005|Overall Study|extubation or early discharge|0|||
13125832|NCT02921776|25957688|FG006|Overall Study|extubation or early discharge|0|||
13125833|NCT02921776|25957689|FG007|Overall Study|extubation or early discharge|0|||
13125834|NCT02921776|25957682|FG000|Overall Study|Lost to Follow-up|0|||
13125835|NCT02921776|25957683|FG001|Overall Study|Lost to Follow-up|0|||
13125836|NCT02921776|25957684|FG002|Overall Study|Lost to Follow-up|0|||
13125837|NCT02921776|25957685|FG003|Overall Study|Lost to Follow-up|0|||
13125838|NCT02921776|25957686|FG004|Overall Study|Lost to Follow-up|0|||
13125839|NCT02921776|25957687|FG005|Overall Study|Lost to Follow-up|2|||
13125840|NCT02921776|25957688|FG006|Overall Study|Lost to Follow-up|3|||
13125841|NCT02921776|25957689|FG007|Overall Study|Lost to Follow-up|6|||
13125842|NCT02921763|25957731|FG000|Overall Study|Adverse Event|4|||
13125843|NCT02921763|25957731|FG000|Overall Study|Lost to Follow-up|4|||
13125844|NCT02921763|25957731|FG000|Overall Study|Lack of Efficacy|3|||
13125845|NCT02921763|25957731|FG000|Overall Study|Protocol Violation|2|||
13135703|NCT02737501|25996067|FG002|Crossover Phase|Site Terminated by Sponsor|23|||
13125846|NCT02921763|25957731|FG000|Overall Study|Withdrawal by Subject|2|||
13125847|NCT02921763|25957731|FG000|Overall Study|Physician Decision|1|||
13125848|NCT02921763|25957731|FG000|Overall Study|No data obtained|2|||
13125849|NCT02921750|25957758|FG000|Overall Study|Adverse Event|1|||
13125850|NCT02921750|25957759|FG001|Overall Study|Adverse Event|2|||
13125851|NCT02921750|25957758|FG000|Overall Study|Withdrawal by Subject|1|||
13125852|NCT02921750|25957759|FG001|Overall Study|Withdrawal by Subject|1|||
13125853|NCT02921750|25957758|FG000|Overall Study|Lost to Follow-up|3|||
13125854|NCT02921750|25957759|FG001|Overall Study|Lost to Follow-up|3|||
13125855|NCT02921750|25957758|FG000|Overall Study|Wound healed|3|||
13125856|NCT02921750|25957759|FG001|Overall Study|Wound healed|3|||
13125857|NCT02921750|25957758|FG000|Overall Study|Serious Adverse Event|1|||
13125858|NCT02921750|25957759|FG001|Overall Study|Serious Adverse Event|2|||
13125859|NCT02921425|25957775|FG000|Overall Study|Protocol Violation|9|||
13125860|NCT02921087|25957802|FG000|Overall Study|Withdrawal by Subject|0|||
13125861|NCT02921087|25957803|FG001|Overall Study|Withdrawal by Subject|1|||
13125862|NCT02920983|25957839|FG000|Dispense 1|Unacceptable Lens Fit|0|||
13125863|NCT02920983|25957840|FG001|Dispense 1|Unacceptable Lens Fit|0|||
13125864|NCT02920983|25957841|FG002|Dispense 1|Unacceptable Lens Fit|0|||
13125865|NCT02920983|25957842|FG003|Dispense 1|Unacceptable Lens Fit|0|||
13125866|NCT02920983|25957843|FG004|Dispense 1|Unacceptable Lens Fit|1|||
13125867|NCT02920983|25957844|FG005|Dispense 1|Unacceptable Lens Fit|0|||
13125868|NCT02920983|25957839|FG000|Dispense 2|Unscceptable lens fit|1|||
13125869|NCT02920983|25957840|FG001|Dispense 2|Unscceptable lens fit|0|||
13125870|NCT02920983|25957841|FG002|Dispense 2|Unscceptable lens fit|0|||
13125871|NCT02920983|25957842|FG003|Dispense 2|Unscceptable lens fit|0|||
13125872|NCT02920983|25957843|FG004|Dispense 2|Unscceptable lens fit|1|||
13125873|NCT02920983|25957844|FG005|Dispense 2|Unscceptable lens fit|0|||
13125874|NCT02920983|25957839|FG000|Dispense 3|Unacceptable Lens Fit|1|||
13125875|NCT02920983|25957840|FG001|Dispense 3|Unacceptable Lens Fit|1|||
13125876|NCT02920983|25957841|FG002|Dispense 3|Unacceptable Lens Fit|0|||
13125877|NCT02920983|25957842|FG003|Dispense 3|Unacceptable Lens Fit|0|||
13125878|NCT02920983|25957843|FG004|Dispense 3|Unacceptable Lens Fit|1|||
13125879|NCT02920983|25957844|FG005|Dispense 3|Unacceptable Lens Fit|0|||
13125880|NCT02920970|25957873|FG000|First Intervention|Protocol Violation|0|||
13125881|NCT02920970|25957874|FG001|First Intervention|Protocol Violation|1|||
13125882|NCT02920970|25957873|FG000|First Intervention|Adverse Event|0|||
13125883|NCT02920970|25957874|FG001|First Intervention|Adverse Event|1|||
13125884|NCT02920970|25957873|FG000|Second Intervention|Poor Lens Fit|1|||
13125885|NCT02920970|25957874|FG001|Second Intervention|Poor Lens Fit|0|||
13125886|NCT02920957|25957929|FG000|First Intervention : 1 Month|Withdrawal by Subject|2|||
13125887|NCT02920957|25957930|FG001|First Intervention : 1 Month|Withdrawal by Subject|0|||
13125888|NCT02920957|25957929|FG000|First Intervention : 1 Month|Lost to Follow-up|1|||
13125889|NCT02920957|25957930|FG001|First Intervention : 1 Month|Lost to Follow-up|0|||
13125890|NCT02920957|25957929|FG000|First Intervention : 1 Month|Adverse Event|1|||
13125891|NCT02920957|25957930|FG001|First Intervention : 1 Month|Adverse Event|0|||
13125892|NCT02920957|25957929|FG000|Second Intervention: 1 Month|Lost to Follow-up|0|||
13125893|NCT02920957|25957930|FG001|Second Intervention: 1 Month|Lost to Follow-up|1|||
13125894|NCT02920528|25957954|FG000|Overall Study|Incomplete Data|1|||
13125895|NCT02920528|25957955|FG001|Overall Study|Incomplete Data|1|||
13125896|NCT02920528|25957956|FG002|Overall Study|Incomplete Data|1|||
13125897|NCT02920528|25957954|FG000|Overall Study|Adverse Event|0|||
13125898|NCT02920528|25957955|FG001|Overall Study|Adverse Event|0|||
13125899|NCT02920528|25957956|FG002|Overall Study|Adverse Event|3|||
13125900|NCT02920528|25957954|FG000|Overall Study|Did not meet inclusion criteria|2|||
13125901|NCT02920528|25957955|FG001|Overall Study|Did not meet inclusion criteria|0|||
13125902|NCT02920528|25957956|FG002|Overall Study|Did not meet inclusion criteria|1|||
13125903|NCT02920450|25957969|FG000|Overall Study|Death|1|||
13125904|NCT02920450|25957970|FG001|Overall Study|Death|0|||
13125905|NCT02920450|25957971|FG002|Overall Study|Death|0|||
13125906|NCT02920450|25957972|FG003|Overall Study|Death|0|||
13125907|NCT02920450|25957969|FG000|Overall Study|Withdrawal by Subject|1|||
13125908|NCT02920450|25957970|FG001|Overall Study|Withdrawal by Subject|0|||
13125909|NCT02920450|25957971|FG002|Overall Study|Withdrawal by Subject|0|||
13125910|NCT02920450|25957972|FG003|Overall Study|Withdrawal by Subject|0|||
13125911|NCT02920242|25958008|FG000|Overall Study|Withdrawal by Subject|1|||
13125912|NCT02920242|25958009|FG001|Overall Study|Withdrawal by Subject|0|||
13125913|NCT02920242|25958010|FG002|Overall Study|Withdrawal by Subject|1|||
13125914|NCT02920242|25958008|FG000|Overall Study|Did not meet inc./exc. criteria|1|||
13125915|NCT02920242|25958009|FG001|Overall Study|Did not meet inc./exc. criteria|0|||
13125916|NCT02920242|25958010|FG002|Overall Study|Did not meet inc./exc. criteria|0|||
13125917|NCT02920177|25958031|FG000|Overall Study|Withdrawal by Subject|1|||
13125918|NCT02920177|25958032|FG001|Overall Study|Withdrawal by Subject|1|||
13125919|NCT02920177|25958031|FG000|Overall Study|Physician Decision|1|||
13125920|NCT02920177|25958032|FG001|Overall Study|Physician Decision|0|||
13125921|NCT02920177|25958031|FG000|Overall Study|Lost to Follow-up|0|||
13125922|NCT02920177|25958032|FG001|Overall Study|Lost to Follow-up|1|||
13125923|NCT02919995|25958076|FG000|Overall Study|Adverse Event|0|||
13125924|NCT02919995|25958077|FG001|Overall Study|Adverse Event|0|||
13125925|NCT02919995|25958078|FG002|Overall Study|Adverse Event|0|||
13125926|NCT02919995|25958079|FG003|Overall Study|Adverse Event|0|||
13125927|NCT02919995|25958080|FG004|Overall Study|Adverse Event|0|||
13125928|NCT02919995|25958081|FG005|Overall Study|Adverse Event|1|||
13125929|NCT02919761|25958111|FG000|Part 1: Open Label|Withdrawal by Subject|12|||
13125930|NCT02919761|25958112|FG001|Part 1: Open Label|Withdrawal by Subject|0|||
13125931|NCT02919761|25958113|FG002|Part 1: Open Label|Withdrawal by Subject|0|||
13125932|NCT02919761|25958111|FG000|Part 1: Open Label|Adverse Event|1|||
13125933|NCT02919761|25958112|FG001|Part 1: Open Label|Adverse Event|0|||
13125934|NCT02919761|25958113|FG002|Part 1: Open Label|Adverse Event|0|||
13125935|NCT02919761|25958111|FG000|Part 1: Open Label|Lost to Follow-up|1|||
13125936|NCT02919761|25958112|FG001|Part 1: Open Label|Lost to Follow-up|0|||
13125937|NCT02919761|25958113|FG002|Part 1: Open Label|Lost to Follow-up|0|||
13125938|NCT02919761|25958111|FG000|Part 1: Open Label|Met withdrawal criteria|5|||
13125939|NCT02919761|25958112|FG001|Part 1: Open Label|Met withdrawal criteria|0|||
13125940|NCT02919761|25958113|FG002|Part 1: Open Label|Met withdrawal criteria|0|||
13125941|NCT02919761|25958111|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2|||
13125942|NCT02919761|25958112|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
13125943|NCT02919761|25958113|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
13125944|NCT02919761|25958111|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1|||
13125945|NCT02919761|25958112|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
13125946|NCT02919761|25958113|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
13125947|NCT02919761|25958111|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1|||
13125948|NCT02919761|25958112|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0|||
13125949|NCT02919761|25958113|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0|||
13125950|NCT02919761|25958111|FG000|Part 1: Open Label|Termination by Sponsor|1|||
13125951|NCT02919761|25958112|FG001|Part 1: Open Label|Termination by Sponsor|0|||
13125952|NCT02919761|25958113|FG002|Part 1: Open Label|Termination by Sponsor|0|||
13125953|NCT02919761|25958111|FG000|Part 2: Double-blind|Withdrawal by Subject|0|||
13125954|NCT02919761|25958112|FG001|Part 2: Double-blind|Withdrawal by Subject|0|||
13125955|NCT02919761|25958113|FG002|Part 2: Double-blind|Withdrawal by Subject|2|||
13125956|NCT02919761|25958111|FG000|Part 2: Double-blind|Adverse Event|0|||
13125957|NCT02919761|25958112|FG001|Part 2: Double-blind|Adverse Event|1|||
13125958|NCT02919761|25958113|FG002|Part 2: Double-blind|Adverse Event|0|||
13125959|NCT02919761|25958111|FG000|Part 2: Double-blind|Lost to Follow-up|0|||
13125960|NCT02919761|25958112|FG001|Part 2: Double-blind|Lost to Follow-up|0|||
13125961|NCT02919761|25958113|FG002|Part 2: Double-blind|Lost to Follow-up|3|||
13125962|NCT02919761|25958111|FG000|Part 2: Double-blind|Met withdrawal criteria|0|||
13125963|NCT02919761|25958112|FG001|Part 2: Double-blind|Met withdrawal criteria|1|||
13125964|NCT02919761|25958113|FG002|Part 2: Double-blind|Met withdrawal criteria|2|||
13125965|NCT02919761|25958111|FG000|Part 2: Double-blind|Worsening of disease activity|0|||
13125966|NCT02919761|25958112|FG001|Part 2: Double-blind|Worsening of disease activity|4|||
13125967|NCT02919761|25958113|FG002|Part 2: Double-blind|Worsening of disease activity|10|||
13125968|NCT02919761|25958111|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
13125969|NCT02919761|25958112|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
13125970|NCT02919761|25958113|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1|||
13125971|NCT02919761|25958111|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
13125972|NCT02919761|25958112|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
13125973|NCT02919761|25958113|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1|||
13125974|NCT02919761|25958111|FG000|Part 2: Double-blind|Discontinued exclusion 16|0|||
13125975|NCT02919761|25958112|FG001|Part 2: Double-blind|Discontinued exclusion 16|0|||
13125976|NCT02919761|25958113|FG002|Part 2: Double-blind|Discontinued exclusion 16|2|||
13125977|NCT02919696|25958140|FG000|Overall Study|Adverse Event|1|||
13125978|NCT02919696|25958141|FG001|Overall Study|Adverse Event|2|||
13125979|NCT02919696|25958140|FG000|Overall Study|Withdrawal by Subject|2|||
13125980|NCT02919696|25958141|FG001|Overall Study|Withdrawal by Subject|1|||
13125981|NCT02919696|25958140|FG000|Overall Study|Sponsor Decision|1|||
13125982|NCT02919696|25958141|FG001|Overall Study|Sponsor Decision|1|||
13125983|NCT02919696|25958140|FG000|Overall Study|Never Treated|0|||
13125984|NCT02919696|25958141|FG001|Overall Study|Never Treated|1|||
13125985|NCT02919618|25958160|FG000|Overall Study|Death|1|||
13125986|NCT02919475|25958232|FG000|Overall Study|Adverse Event|3|||
13125987|NCT02919475|25958233|FG001|Overall Study|Adverse Event|3|||
13125988|NCT02919475|25958234|FG002|Overall Study|Adverse Event|3|||
13125989|NCT02919475|25958235|FG003|Overall Study|Adverse Event|9|||
13125990|NCT02919475|25958236|FG004|Overall Study|Adverse Event|2|||
13125991|NCT02919475|25958232|FG000|Overall Study|Death|0|||
13125992|NCT02919475|25958233|FG001|Overall Study|Death|1|||
13125993|NCT02919475|25958234|FG002|Overall Study|Death|0|||
13125994|NCT02919475|25958235|FG003|Overall Study|Death|0|||
13125995|NCT02919475|25958236|FG004|Overall Study|Death|0|||
13125996|NCT02919475|25958232|FG000|Overall Study|Lost to Follow-up|0|||
13125997|NCT02919475|25958233|FG001|Overall Study|Lost to Follow-up|0|||
13125998|NCT02919475|25958234|FG002|Overall Study|Lost to Follow-up|0|||
13125999|NCT02919475|25958235|FG003|Overall Study|Lost to Follow-up|1|||
13126000|NCT02919475|25958236|FG004|Overall Study|Lost to Follow-up|0|||
13126001|NCT02919475|25958232|FG000|Overall Study|Withdrawal by Subject|2|||
13126002|NCT02919475|25958233|FG001|Overall Study|Withdrawal by Subject|3|||
13126003|NCT02919475|25958234|FG002|Overall Study|Withdrawal by Subject|1|||
13126004|NCT02919475|25958235|FG003|Overall Study|Withdrawal by Subject|2|||
13126005|NCT02919475|25958236|FG004|Overall Study|Withdrawal by Subject|2|||
13126006|NCT02919475|25958232|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
13126007|NCT02919475|25958233|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
13126008|NCT02919475|25958234|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
13126009|NCT02919475|25958235|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
13126010|NCT02919475|25958236|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
13126011|NCT02919436|25958253|FG000|Overall Study|Did not undergo surgery|16|||
13126012|NCT02919436|25958254|FG001|Overall Study|Did not undergo surgery|20|||
13126013|NCT02919436|25958253|FG000|Overall Study|Enrolled before trial registration|44|||
13126014|NCT02919436|25958254|FG001|Overall Study|Enrolled before trial registration|33|||
13126015|NCT02919267|25958277|FG000|Overall Study|Protocol Violation|0|||
13126016|NCT02919267|25958278|FG001|Overall Study|Protocol Violation|3|||
13126017|NCT02919267|25958279|FG002|Overall Study|Protocol Violation|3|||
13126018|NCT02919267|25958280|FG003|Overall Study|Protocol Violation|4|||
13126019|NCT02918968|25958309|FG000|1st Line AAT|Progressive disease|9|||
13126020|NCT02918968|25958310|FG001|1st Line AAT|Progressive disease|4|||
13126021|NCT02918968|25958309|FG000|1st Line AAT|Adverse Event|12|||
13126022|NCT02918968|25958310|FG001|1st Line AAT|Adverse Event|3|||
13126023|NCT02918968|25958309|FG000|1st Line AAT|Physician Decision|4|||
13126024|NCT02918968|25958310|FG001|1st Line AAT|Physician Decision|2|||
13126025|NCT02918968|25958309|FG000|1st Line AAT|Withdrawal by Subject|2|||
13126026|NCT02918968|25958310|FG001|1st Line AAT|Withdrawal by Subject|1|||
13126027|NCT02918968|25958309|FG000|1st Line AAT|Lost to Follow-up|0|||
13126028|NCT02918968|25958310|FG001|1st Line AAT|Lost to Follow-up|1|||
13126029|NCT02918968|25958309|FG000|1st Line AAT|Death|1|||
13126030|NCT02918968|25958310|FG001|1st Line AAT|Death|0|||
13126031|NCT02918968|25958309|FG000|1st Line AAT|Miscellaneous|1|||
13126032|NCT02918968|25958310|FG001|1st Line AAT|Miscellaneous|0|||
13126033|NCT02918968|25958309|FG000|2nd Line AAT|Progressive disease|21|||
13126034|NCT02918968|25958310|FG001|2nd Line AAT|Progressive disease|3|||
13126035|NCT02918968|25958309|FG000|2nd Line AAT|Adverse Event|2|||
13126036|NCT02918968|25958310|FG001|2nd Line AAT|Adverse Event|5|||
13126037|NCT02918968|25958309|FG000|2nd Line AAT|Physician Decision|0|||
13126038|NCT02918968|25958310|FG001|2nd Line AAT|Physician Decision|1|||
13126039|NCT02918968|25958309|FG000|2nd Line AAT|Withdrawal by Subject|2|||
13126040|NCT02918968|25958310|FG001|2nd Line AAT|Withdrawal by Subject|2|||
13126041|NCT02918968|25958309|FG000|2nd Line AAT|Death|0|||
13126042|NCT02918968|25958310|FG001|2nd Line AAT|Death|1|||
13126043|NCT02918877|25958335|FG000|Overall Study|Withdrawal by Subject|2|||
13126044|NCT02918877|25958336|FG001|Overall Study|Withdrawal by Subject|2|||
13126045|NCT02918877|25958335|FG000|Overall Study|Surgery cancelled|1|||
13126046|NCT02918877|25958336|FG001|Overall Study|Surgery cancelled|0|||
13126047|NCT02918877|25958335|FG000|Overall Study|Physician Decision|1|||
13126048|NCT02918877|25958336|FG001|Overall Study|Physician Decision|0|||
13126049|NCT02918877|25958335|FG000|Overall Study|Received intraoperative steroids|1|||
13126050|NCT02918877|25958336|FG001|Overall Study|Received intraoperative steroids|0|||
13126051|NCT02918877|25958335|FG000|Overall Study|Unable to obtain lab samples|1|||
13126052|NCT02918877|25958336|FG001|Overall Study|Unable to obtain lab samples|0|||
13126053|NCT02918877|25958335|FG000|Overall Study|Unsafe to perform BAL|0|||
13126054|NCT02918877|25958336|FG001|Overall Study|Unsafe to perform BAL|1|||
13126055|NCT02918552|25958377|FG000|Overall Study|Failed Pharmacokinetics|1|||
13126056|NCT02918552|25958378|FG001|Overall Study|Failed Pharmacokinetics|0|||
13126057|NCT02918552|25958377|FG000|Overall Study|Withdrawal by Subject|0|||
13126058|NCT02918552|25958378|FG001|Overall Study|Withdrawal by Subject|1|||
13126059|NCT02918552|25958377|FG000|Overall Study|Lost to Follow-up|0|||
13126060|NCT02918552|25958378|FG001|Overall Study|Lost to Follow-up|1|||
13126061|NCT02918318|25958451|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1|||
13126062|NCT02918318|25958452|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4|||
13204521|NCT01972724|26229202|FG000|Double-Blind|Adverse Event|1|||
13126063|NCT02918318|25958453|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2|||
13126064|NCT02918318|25958454|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3|||
13126065|NCT02918318|25958455|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0|||
13126066|NCT02918318|25958451|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
13126067|NCT02918318|25958452|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
13126068|NCT02918318|25958453|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
13126069|NCT02918318|25958454|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2|||
13126070|NCT02918318|25958455|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
13126071|NCT02918318|25958451|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
13126072|NCT02918318|25958452|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
13126073|NCT02918318|25958453|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
13126074|NCT02918318|25958454|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1|||
13126075|NCT02918318|25958455|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
13126076|NCT02918318|25958451|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
13126077|NCT02918318|25958452|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
13126078|NCT02918318|25958453|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
13126079|NCT02918318|25958454|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
13126080|NCT02918318|25958455|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
13126081|NCT02918318|25958451|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
13126082|NCT02918318|25958452|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
13126083|NCT02918318|25958453|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
13126084|NCT02918318|25958454|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1|||
13126085|NCT02918318|25958455|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
13126086|NCT02918318|25958451|FG000|Double-blind Induction Phase: 4 Weeks|Other|0|||
13126087|NCT02918318|25958452|FG001|Double-blind Induction Phase: 4 Weeks|Other|2|||
13126088|NCT02918318|25958453|FG002|Double-blind Induction Phase: 4 Weeks|Other|0|||
13126089|NCT02918318|25958454|FG003|Double-blind Induction Phase: 4 Weeks|Other|1|||
13126090|NCT02918318|25958455|FG004|Double-blind Induction Phase: 4 Weeks|Other|0|||
13126091|NCT02918318|25958451|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
13126092|NCT02918318|25958452|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
13126093|NCT02918318|25958453|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
13126094|NCT02918318|25958454|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2|||
13126095|NCT02918318|25958455|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
13126096|NCT02918318|25958451|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
13126097|NCT02918318|25958452|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
13126098|NCT02918318|25958453|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
13126099|NCT02918318|25958454|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
13126100|NCT02918318|25958455|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
13126101|NCT02918318|25958451|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
13126102|NCT02918318|25958452|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
13126103|NCT02918318|25958453|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
13126104|NCT02918318|25958454|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
13126105|NCT02918318|25958455|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
13126106|NCT02918318|25958451|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0|||
13126107|NCT02918318|25958452|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3|||
13126108|NCT02918318|25958453|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1|||
13221881|NCT01810042|26284808|FG000|Overall Study|Lost to Follow-up|10|||
13126109|NCT02918318|25958454|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1|||
13126110|NCT02918318|25958455|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0|||
13126111|NCT02918318|25958451|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
13126112|NCT02918318|25958452|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
13126113|NCT02918318|25958453|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
13126114|NCT02918318|25958454|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
13126115|NCT02918318|25958455|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1|||
13126116|NCT02918318|25958451|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
13126117|NCT02918318|25958452|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
13126118|NCT02918318|25958453|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
13126119|NCT02918318|25958454|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
13126120|NCT02918318|25958455|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1|||
13126121|NCT02918279|25958587|FG000|Overall Study|Lost to Follow-up|3|||
13126122|NCT02918279|25958588|FG001|Overall Study|Lost to Follow-up|6|||
13126123|NCT02918279|25958587|FG000|Overall Study|Withdrawal by Subject|5|||
13126124|NCT02918279|25958588|FG001|Overall Study|Withdrawal by Subject|15|||
13126125|NCT02918279|25958587|FG000|Overall Study|Withdrawal by parent/guardian|2|||
13126126|NCT02918279|25958588|FG001|Overall Study|Withdrawal by parent/guardian|1|||
13126127|NCT02918279|25958587|FG000|Overall Study|Other|3|||
13126128|NCT02918279|25958588|FG001|Overall Study|Other|1|||
13204522|NCT01972724|26229203|FG001|Double-Blind|Adverse Event|0|||
13204523|NCT01972724|26229204|FG002|Double-Blind|Adverse Event|0|||
13221882|NCT01809327|26284866|FG000|Overall Study|Lost to Follow-up|5|||
13221883|NCT01809327|26284867|FG001|Overall Study|Lost to Follow-up|2|||
13221884|NCT01809327|26284868|FG002|Overall Study|Lost to Follow-up|4|||
13221885|NCT01809327|26284869|FG003|Overall Study|Lost to Follow-up|2|||
13221886|NCT01809327|26284870|FG004|Overall Study|Lost to Follow-up|3|||
13221887|NCT01809327|26284866|FG000|Overall Study|Withdrawal by Subject|6|||
13221888|NCT01809327|26284867|FG001|Overall Study|Withdrawal by Subject|4|||
13221889|NCT01809327|26284868|FG002|Overall Study|Withdrawal by Subject|4|||
13221890|NCT01809327|26284869|FG003|Overall Study|Withdrawal by Subject|2|||
13221891|NCT01809327|26284870|FG004|Overall Study|Withdrawal by Subject|5|||
13221892|NCT01809327|26284866|FG000|Overall Study|Adverse Event|4|||
13221893|NCT01809327|26284867|FG001|Overall Study|Adverse Event|3|||
13221894|NCT01809327|26284868|FG002|Overall Study|Adverse Event|7|||
13221895|NCT01809327|26284869|FG003|Overall Study|Adverse Event|4|||
13221896|NCT01809327|26284870|FG004|Overall Study|Adverse Event|8|||
13221897|NCT01809327|26284866|FG000|Overall Study|Death|1|||
13221898|NCT01809327|26284867|FG001|Overall Study|Death|0|||
13221899|NCT01809327|26284868|FG002|Overall Study|Death|0|||
13221900|NCT01809327|26284869|FG003|Overall Study|Death|0|||
13221901|NCT01809327|26284870|FG004|Overall Study|Death|0|||
13221902|NCT01809327|26284866|FG000|Overall Study|Protocol Violation|0|||
13221903|NCT01809327|26284867|FG001|Overall Study|Protocol Violation|1|||
13221904|NCT01809327|26284868|FG002|Overall Study|Protocol Violation|0|||
13221905|NCT01809327|26284869|FG003|Overall Study|Protocol Violation|0|||
13221906|NCT01809327|26284870|FG004|Overall Study|Protocol Violation|0|||
13221907|NCT01809327|26284866|FG000|Overall Study|Physician Decision|1|||
13221908|NCT01809327|26284867|FG001|Overall Study|Physician Decision|1|||
13221909|NCT01809327|26284868|FG002|Overall Study|Physician Decision|0|||
13221910|NCT01809327|26284869|FG003|Overall Study|Physician Decision|0|||
13221911|NCT01809327|26284870|FG004|Overall Study|Physician Decision|0|||
13221912|NCT01809327|26284866|FG000|Overall Study|Pregnancy|1|||
13221913|NCT01809327|26284867|FG001|Overall Study|Pregnancy|0|||
13221914|NCT01809327|26284868|FG002|Overall Study|Pregnancy|0|||
13221915|NCT01809327|26284869|FG003|Overall Study|Pregnancy|0|||
13221916|NCT01809327|26284870|FG004|Overall Study|Pregnancy|0|||
13221917|NCT01809327|26284866|FG000|Overall Study|Other|14|||
13221918|NCT01809327|26284867|FG001|Overall Study|Other|15|||
13221919|NCT01809327|26284868|FG002|Overall Study|Other|7|||
13204524|NCT01972724|26229202|FG000|Double-Blind|Withdrawal of Consent|2|||
13204525|NCT01972724|26229203|FG001|Double-Blind|Withdrawal of Consent|1|||
13204526|NCT01972724|26229204|FG002|Double-Blind|Withdrawal of Consent|0|||
13204527|NCT01972724|26229202|FG000|Double-Blind|Significant Protocol Deviation|5|||
13204528|NCT01972724|26229203|FG001|Double-Blind|Significant Protocol Deviation|8|||
13204529|NCT01972724|26229204|FG002|Double-Blind|Significant Protocol Deviation|0|||
13204530|NCT01972724|26229202|FG000|Open-Label|Withdrew Consent|0|||
13204531|NCT01972724|26229203|FG001|Open-Label|Withdrew Consent|0|||
13204532|NCT01972724|26229204|FG002|Open-Label|Withdrew Consent|3|||
13204533|NCT01972724|26229202|FG000|Open-Label|Significant Protocol Deviation|0|||
13204534|NCT01972724|26229203|FG001|Open-Label|Significant Protocol Deviation|0|||
13221920|NCT01809327|26284869|FG003|Overall Study|Other|4|||
13221921|NCT01809327|26284870|FG004|Overall Study|Other|9|||
13221922|NCT01809314|26284878|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
13221923|NCT01809314|26284878|FG000|Overall Study|Adverse Event|6|||
13221924|NCT01809314|26284878|FG000|Overall Study|Insufficient Therapeutic Response|14|||
13221925|NCT01809314|26284878|FG000|Overall Study|Lost to Follow-up|724|||
13221926|NCT01809262|26284956|FG000|Period 1 (First Dose + Washout)|Adverse Event|0|||
13221927|NCT01809262|26284957|FG001|Period 1 (First Dose + Washout)|Adverse Event|0|||
13221928|NCT01809262|26284958|FG002|Period 1 (First Dose + Washout)|Adverse Event|0|||
13221929|NCT01809262|26284959|FG003|Period 1 (First Dose + Washout)|Adverse Event|0|||
13221930|NCT01809262|26284960|FG004|Period 1 (First Dose + Washout)|Adverse Event|1|||
13221931|NCT01809262|26284961|FG005|Period 1 (First Dose + Washout)|Adverse Event|0|||
13221932|NCT01809262|26284962|FG006|Period 1 (First Dose + Washout)|Adverse Event|0|||
13221933|NCT01809262|26284963|FG007|Period 1 (First Dose + Washout)|Adverse Event|0|||
13221934|NCT01809262|26284964|FG008|Period 1 (First Dose + Washout)|Adverse Event|0|||
13221935|NCT01809262|26284965|FG009|Period 1 (First Dose + Washout)|Adverse Event|0|||
13221936|NCT01809262|26284956|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0|||
13221937|NCT01809262|26284957|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1|||
13221938|NCT01809262|26284958|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0|||
13221939|NCT01809262|26284959|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0|||
13221940|NCT01809262|26284960|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0|||
13221941|NCT01809262|26284961|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0|||
13221942|NCT01809262|26284962|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0|||
13221943|NCT01809262|26284963|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0|||
13221944|NCT01809262|26284964|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0|||
13221945|NCT01809262|26284965|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0|||
13221946|NCT01809210|26285059|FG000|Overall Study|Withdrawal by Subject|0|||
13221947|NCT01809210|26285060|FG001|Overall Study|Withdrawal by Subject|0|||
13484992|NCT03135262|27030972|FG000|Overall Study|Withdrawal by Subject|0|||
13484993|NCT03135262|27030973|FG001|Overall Study|Withdrawal by Subject|0|||
13484994|NCT03135262|27030974|FG002|Overall Study|Withdrawal by Subject|1|||
13484995|NCT03135262|27030975|FG003|Overall Study|Withdrawal by Subject|0|||
13484996|NCT03135262|27030976|FG004|Overall Study|Withdrawal by Subject|1|||
13484997|NCT03135262|27030972|FG000|Overall Study|Study terminated by sponsor|2|||
13484998|NCT03135262|27030973|FG001|Overall Study|Study terminated by sponsor|4|||
13484999|NCT03135262|27030974|FG002|Overall Study|Study terminated by sponsor|4|||
13485000|NCT03135262|27030975|FG003|Overall Study|Study terminated by sponsor|3|||
13485001|NCT03135262|27030976|FG004|Overall Study|Study terminated by sponsor|0|||
13485002|NCT03104075|27030995|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1|||
13485003|NCT03104075|27030996|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0|||
13485004|NCT03038087|27031004|FG000|Overall Study|lost data|1|||
13485005|NCT02662985|27031104|FG000|Treatment Period 1|Adverse Event|0|||
13485006|NCT02662985|27031105|FG001|Treatment Period 1|Adverse Event|2|||
13485007|NCT02662985|27031104|FG000|Treatment Period 1|Protocol Violation|0|||
13485008|NCT02662985|27031105|FG001|Treatment Period 1|Protocol Violation|1|||
13485009|NCT02662985|27031104|FG000|Treatment Period 1|Physician Decision|1|||
13485010|NCT02662985|27031105|FG001|Treatment Period 1|Physician Decision|0|||
13485011|NCT02662985|27031104|FG000|Treatment Period 1|Withdrawal by Subject|0|||
13485012|NCT02662985|27031105|FG001|Treatment Period 1|Withdrawal by Subject|1|||
13485013|NCT02662985|27031104|FG000|Treatment Period 2|Lack of Efficacy|0|||
13485014|NCT02662985|27031105|FG001|Treatment Period 2|Lack of Efficacy|1|||
13485015|NCT02662985|27031104|FG000|Treatment Period 2|Lost to Follow-up|1|||
13485016|NCT02662985|27031105|FG001|Treatment Period 2|Lost to Follow-up|0|||
13485017|NCT02662985|27031104|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
13485018|NCT02662985|27031105|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
13485019|NCT02662985|27031104|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1|||
13485020|NCT02662985|27031105|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1|||
13485021|NCT02662985|27031104|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0|||
13485022|NCT02662985|27031105|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1|||
13221948|NCT01809210|26285061|FG002|Overall Study|Withdrawal by Subject|1|||
13221949|NCT01809210|26285062|FG003|Overall Study|Withdrawal by Subject|1|||
13372867|NCT00806260|26722173|FG002|Period 2|Protocol Violation|1|||
13126129|NCT02918266|25958721|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0|||
13126130|NCT02918266|25958722|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
13126131|NCT02918266|25958723|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
13126132|NCT02918266|25958724|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
13126133|NCT02918266|25958725|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
13126134|NCT02918266|25958726|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
13126135|NCT02918266|25958727|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
13126136|NCT02918266|25958728|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
13126137|NCT02918266|25958729|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
13126138|NCT02918266|25958730|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
13126139|NCT02918266|25958731|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
13133528|NCT02769065|25988350|FG009|Overall Study|Pre-treatment Event/Adverse Event|0|||
13133529|NCT02769065|25988351|FG010|Overall Study|Pre-treatment Event/Adverse Event|1|||
13133530|NCT02769065|25988352|FG011|Overall Study|Pre-treatment Event/Adverse Event|0|||
13133531|NCT02769065|25988353|FG012|Overall Study|Pre-treatment Event/Adverse Event|0|||
13133532|NCT02769065|25988354|FG013|Overall Study|Pre-treatment Event/Adverse Event|0|||
13133533|NCT02769065|25988355|FG014|Overall Study|Pre-treatment Event/Adverse Event|0|||
13133534|NCT02769065|25988356|FG015|Overall Study|Pre-treatment Event/Adverse Event|0|||
13133535|NCT02769065|25988357|FG016|Overall Study|Pre-treatment Event/Adverse Event|0|||
13133536|NCT02769065|25988358|FG017|Overall Study|Pre-treatment Event/Adverse Event|0|||
13133537|NCT02769065|25988359|FG018|Overall Study|Pre-treatment Event/Adverse Event|0|||
13133538|NCT02769065|25988360|FG019|Overall Study|Pre-treatment Event/Adverse Event|0|||
13133539|NCT02769065|25988361|FG020|Overall Study|Pre-treatment Event/Adverse Event|0|||
13133540|NCT02769065|25988362|FG021|Overall Study|Pre-treatment Event/Adverse Event|0|||
13133541|NCT02769065|25988363|FG022|Overall Study|Pre-treatment Event/Adverse Event|0|||
13133542|NCT02769065|25988364|FG023|Overall Study|Pre-treatment Event/Adverse Event|0|||
13133543|NCT02769065|25988365|FG024|Overall Study|Pre-treatment Event/Adverse Event|0|||
13133544|NCT02769065|25988366|FG025|Overall Study|Pre-treatment Event/Adverse Event|0|||
13133545|NCT02769065|25988367|FG026|Overall Study|Pre-treatment Event/Adverse Event|0|||
13133546|NCT02769065|25988368|FG027|Overall Study|Pre-treatment Event/Adverse Event|0|||
13133547|NCT02769065|25988369|FG028|Overall Study|Pre-treatment Event/Adverse Event|0|||
13133548|NCT02769065|25988370|FG029|Overall Study|Pre-treatment Event/Adverse Event|0|||
13133549|NCT02768792|25988381|FG000|Overall Study|Adverse Event|1|||
13133550|NCT02768298|25988402|FG000|Overall Study|Adverse Event|1|||
13133551|NCT02768298|25988403|FG001|Overall Study|Adverse Event|4|||
13133552|NCT02768298|25988402|FG000|Overall Study|Death|2|||
13133553|NCT02768298|25988403|FG001|Overall Study|Death|1|||
13133554|NCT02768298|25988402|FG000|Overall Study|Non-compliance with study treatment|0|||
13133555|NCT02768298|25988403|FG001|Overall Study|Non-compliance with study treatment|1|||
13133556|NCT02768298|25988402|FG000|Overall Study|Subject/guardian decision|1|||
13221950|NCT01809210|26285063|FG004|Overall Study|Withdrawal by Subject|1|||
13372868|NCT00806260|26722174|FG003|Period 2|Protocol Violation|0|||
13126140|NCT02918071|25958743|FG000|Overall Study|Withdrawal by Subject|2|||
13126141|NCT02918071|25958743|FG000|Overall Study|Lost to Follow-up|1|||
13126142|NCT02917941|25958757|FG000|Treatment Period|Adverse Event|11|||
13126143|NCT02917941|25958757|FG000|Treatment Period|Progressive Disease|11|||
13126144|NCT02917941|25958757|FG000|Treatment Period|Reason not Specified|2|||
13126145|NCT02917941|25958757|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
13126146|NCT02917941|25958757|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
13126147|NCT02917265|25958778|FG000|Overall Study|Physician Decision|1|||
13126148|NCT02917265|25958779|FG001|Overall Study|Physician Decision|0|||
13126149|NCT02917265|25958778|FG000|Overall Study|Withdrawal by Subject|1|||
13126150|NCT02917265|25958779|FG001|Overall Study|Withdrawal by Subject|0|||
13126151|NCT02917031|25958807|FG000|Overall Study|Reason not specified|7|||
13126152|NCT02917031|25958808|FG001|Overall Study|Reason not specified|5|||
13126153|NCT02917031|25958809|FG002|Overall Study|Reason not specified|6|||
13126154|NCT02917031|25958807|FG000|Overall Study|Development of study-specific withdrawal criteria|1|||
13126155|NCT02917031|25958808|FG001|Overall Study|Development of study-specific withdrawal criteria|1|||
13126156|NCT02917031|25958809|FG002|Overall Study|Development of study-specific withdrawal criteria|0|||
13126157|NCT02917031|25958807|FG000|Overall Study|Withdrawal by Subject|3|||
13126158|NCT02917031|25958808|FG001|Overall Study|Withdrawal by Subject|3|||
13126159|NCT02917031|25958809|FG002|Overall Study|Withdrawal by Subject|0|||
13126160|NCT02917031|25958807|FG000|Overall Study|Physician Decision|1|||
13221951|NCT01809210|26285064|FG005|Overall Study|Withdrawal by Subject|0|||
13126161|NCT02917031|25958808|FG001|Overall Study|Physician Decision|0|||
13126162|NCT02917031|25958809|FG002|Overall Study|Physician Decision|0|||
13126163|NCT02917031|25958807|FG000|Overall Study|Adverse Event|4|||
13126164|NCT02917031|25958808|FG001|Overall Study|Adverse Event|1|||
13126165|NCT02917031|25958809|FG002|Overall Study|Adverse Event|5|||
13126166|NCT02917031|25958807|FG000|Overall Study|Death|2|||
13126167|NCT02917031|25958808|FG001|Overall Study|Death|3|||
13126168|NCT02917031|25958809|FG002|Overall Study|Death|4|||
13126169|NCT02916927|25958830|FG000|Overall Study|Discharged prior to study drug receipt|0|||
13126170|NCT02916927|25958831|FG001|Overall Study|Discharged prior to study drug receipt|2|||
13126171|NCT02916927|25958830|FG000|Overall Study|At radiology for 45 & 60 min time points|0|||
13126172|NCT02916927|25958831|FG001|Overall Study|At radiology for 45 & 60 min time points|1|||
13126173|NCT02916927|25958830|FG000|Overall Study|Withdrawal before first time point|1|||
13126174|NCT02916927|25958831|FG001|Overall Study|Withdrawal before first time point|0|||
13126175|NCT02916693|25958846|FG000|Overall Study|Lost to Follow-up|7|||
13126176|NCT02916433|25958862|FG000|Overall Study|Withdrawal by Subject|1|||
13126177|NCT02916433|25958863|FG001|Overall Study|Withdrawal by Subject|0|||
13126178|NCT02916433|25958862|FG000|Overall Study|Physician Decision|1|||
13126179|NCT02916433|25958863|FG001|Overall Study|Physician Decision|0|||
13126180|NCT02916056|25958869|FG000|Overall Study|Adverse Event|6|||
13126181|NCT02916056|25958869|FG000|Overall Study|Lost to Follow-up|1|||
13126182|NCT02916056|25958869|FG000|Overall Study|Other|12|||
13126183|NCT02916056|25958869|FG000|Overall Study|Protocol Violation|1|||
13126184|NCT02916056|25958869|FG000|Overall Study|Withdrawal by Subject|8|||
13126185|NCT02916056|25958869|FG000|Overall Study|Study Terminated by Sponsor|269|||
13126186|NCT02915978|25958929|FG000|Overall Study|Adverse Event|2|||
13126187|NCT02915978|25958930|FG001|Overall Study|Adverse Event|1|||
13126188|NCT02915978|25958931|FG002|Overall Study|Adverse Event|0|||
13126189|NCT02915874|25958956|FG000|Overall Study|Lost to Follow-up|5|||
13126190|NCT02915874|25958957|FG001|Overall Study|Lost to Follow-up|4|||
13126191|NCT02915874|25958956|FG000|Overall Study|Withdrawal by Subject|1|||
13126192|NCT02915874|25958957|FG001|Overall Study|Withdrawal by Subject|1|||
13126193|NCT02915874|25958956|FG000|Overall Study|Started New Anxiety Medication|0|||
13221952|NCT01809210|26285065|FG006|Overall Study|Withdrawal by Subject|4|||
13221953|NCT01809210|26285059|FG000|Overall Study|Death|1|||
13221954|NCT01809210|26285060|FG001|Overall Study|Death|1|||
13221955|NCT01809210|26285061|FG002|Overall Study|Death|2|||
13221956|NCT01809210|26285062|FG003|Overall Study|Death|0|||
13221957|NCT01809210|26285063|FG004|Overall Study|Death|1|||
13221958|NCT01809210|26285064|FG005|Overall Study|Death|3|||
13221959|NCT01809210|26285065|FG006|Overall Study|Death|1|||
13221960|NCT01809197|26285078|FG000|Overall Study|Lost to Follow-up|4|||
13221961|NCT01809197|26285079|FG001|Overall Study|Lost to Follow-up|2|||
13221962|NCT01809197|26285078|FG000|Overall Study|Adverse Event|2|||
13221963|NCT01809197|26285079|FG001|Overall Study|Adverse Event|3|||
13126194|NCT02915874|25958957|FG001|Overall Study|Started New Anxiety Medication|1|||
13126195|NCT02915835|25959088|FG000|Overall Study|Physician Decision|1|||
13126196|NCT02915835|25959089|FG001|Overall Study|Physician Decision|0|||
13126197|NCT02915835|25959088|FG000|Overall Study|Withdrawal by Subject|0|||
13126198|NCT02915835|25959089|FG001|Overall Study|Withdrawal by Subject|1|||
13126199|NCT02915302|25959106|FG000|Overall Study|Adverse Event|3|||
13126200|NCT02915302|25959107|FG001|Overall Study|Adverse Event|0|||
13126201|NCT02915302|25959106|FG000|Overall Study|Protocol Violation|20|||
13126202|NCT02915302|25959107|FG001|Overall Study|Protocol Violation|27|||
13126203|NCT02915302|25959106|FG000|Overall Study|Lost to Follow-up|19|||
13126204|NCT02915302|25959107|FG001|Overall Study|Lost to Follow-up|22|||
13126205|NCT02915302|25959106|FG000|Overall Study|Withdrawal by Subject|22|||
13126206|NCT02915302|25959107|FG001|Overall Study|Withdrawal by Subject|29|||
13126207|NCT02915302|25959106|FG000|Overall Study|Other|1|||
13126208|NCT02915302|25959107|FG001|Overall Study|Other|0|||
13126209|NCT02915159|25959198|FG000|Overall Study|Participant no longer meets criteria|2|||
13126210|NCT02915159|25959199|FG001|Overall Study|Participant no longer meets criteria|0|||
13126211|NCT02915159|25959198|FG000|Overall Study|poor/non-compliance|1|||
13126212|NCT02915159|25959199|FG001|Overall Study|poor/non-compliance|0|||
13126213|NCT02915159|25959198|FG000|Overall Study|Participant withdrew consent|5|||
13126214|NCT02915159|25959199|FG001|Overall Study|Participant withdrew consent|1|||
13126215|NCT02915159|25959198|FG000|Overall Study|Request to discontinue treatment|1|||
13126216|NCT02915159|25959199|FG001|Overall Study|Request to discontinue treatment|2|||
13126217|NCT02915159|25959198|FG000|Overall Study|Adverse Event|2|||
13126218|NCT02915159|25959199|FG001|Overall Study|Adverse Event|2|||
13126219|NCT02915159|25959198|FG000|Overall Study|Lack of Efficacy|0|||
13126220|NCT02915159|25959199|FG001|Overall Study|Lack of Efficacy|3|||
13126221|NCT02914834|25959222|FG000|Overall Study|Study halted due to COVID|1|||
13126222|NCT02914834|25959223|FG001|Overall Study|Study halted due to COVID|1|||
13126223|NCT02914834|25959222|FG000|Overall Study|1 subject withdrew|0|||
13126224|NCT02914834|25959223|FG001|Overall Study|1 subject withdrew|1|||
13126225|NCT02914548|25959264|FG000|Overall Study|Adverse Event|15|||
13126226|NCT02914548|25959265|FG001|Overall Study|Adverse Event|7|||
13126227|NCT02914548|25959266|FG002|Overall Study|Adverse Event|15|||
13126228|NCT02914548|25959264|FG000|Overall Study|Physician Decision|2|||
13126229|NCT02914548|25959265|FG001|Overall Study|Physician Decision|2|||
13126230|NCT02914548|25959266|FG002|Overall Study|Physician Decision|0|||
13126231|NCT02914548|25959264|FG000|Overall Study|Protocol Violation|1|||
13126232|NCT02914548|25959265|FG001|Overall Study|Protocol Violation|0|||
13126233|NCT02914548|25959266|FG002|Overall Study|Protocol Violation|0|||
13126234|NCT02914548|25959264|FG000|Overall Study|Withdrawal by Subject|3|||
13126235|NCT02914548|25959265|FG001|Overall Study|Withdrawal by Subject|4|||
13126236|NCT02914548|25959266|FG002|Overall Study|Withdrawal by Subject|4|||
13126237|NCT02914548|25959264|FG000|Overall Study|>40% of body surface area|0|||
13126238|NCT02914548|25959265|FG001|Overall Study|>40% of body surface area|1|||
13126239|NCT02914548|25959266|FG002|Overall Study|>40% of body surface area|1|||
13126240|NCT02914522|25959383|FG000|Induction Study: Up to Week 11|Adverse Event|5|||
13126241|NCT02914522|25959384|FG001|Induction Study: Up to Week 11|Adverse Event|6|||
13126242|NCT02914522|25959385|FG002|Induction Study: Up to Week 11|Adverse Event|4|||
13126243|NCT02914522|25959386|FG003|Induction Study: Up to Week 11|Adverse Event|18|||
13126244|NCT02914522|25959387|FG004|Induction Study: Up to Week 11|Adverse Event|14|||
13126245|NCT02914522|25959388|FG005|Induction Study: Up to Week 11|Adverse Event|10|||
13126246|NCT02914522|25959389|FG006|Induction Study: Up to Week 11|Adverse Event|0|||
13126247|NCT02914522|25959390|FG007|Induction Study: Up to Week 11|Adverse Event|0|||
13126248|NCT02914522|25959391|FG008|Induction Study: Up to Week 11|Adverse Event|0|||
13126249|NCT02914522|25959392|FG009|Induction Study: Up to Week 11|Adverse Event|0|||
13126250|NCT02914522|25959393|FG010|Induction Study: Up to Week 11|Adverse Event|0|||
13126251|NCT02914522|25959383|FG000|Induction Study: Up to Week 11|Withdrew Consent|4|||
13126252|NCT02914522|25959384|FG001|Induction Study: Up to Week 11|Withdrew Consent|11|||
13372869|NCT00806260|26722175|FG004|Period 2|Protocol Violation|0|||
13221964|NCT01809197|26285078|FG000|Overall Study|Failed slit lamp exam|1|||
13221965|NCT01809197|26285079|FG001|Overall Study|Failed slit lamp exam|0|||
13221966|NCT01809197|26285078|FG000|Overall Study|Non-Compliance|1|||
13221967|NCT01809197|26285079|FG001|Overall Study|Non-Compliance|1|||
13221968|NCT01809197|26285078|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
13485023|NCT02662985|27031104|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1|||
13485024|NCT02662985|27031105|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2|||
13485025|NCT02662985|27031104|FG000|Treatment Period 3 (Extension Period)|Death|0|||
13485026|NCT02662985|27031105|FG001|Treatment Period 3 (Extension Period)|Death|1|||
13485027|NCT02536339|27031137|FG000|Overall Study|Death|20|||
13485028|NCT02536339|27031137|FG000|Overall Study|Withdrawal by Subject|3|||
13485029|NCT02536339|27031137|FG000|Overall Study|Lost to Follow-up|2|||
13485030|NCT02536339|27031137|FG000|Overall Study|Treatment discontinued|2|||
13485031|NCT02536339|27031137|FG000|Overall Study|Physician Decision|1|||
13485032|NCT02323295|27031176|FG000|Overall Study|Adverse Event|0|||
13485033|NCT02323295|27031177|FG001|Overall Study|Adverse Event|1|||
13485034|NCT02323295|27031176|FG000|Overall Study|Withdrawal by Subject|0|||
13485035|NCT02323295|27031177|FG001|Overall Study|Withdrawal by Subject|1|||
13485036|NCT02323295|27031176|FG000|Overall Study|Patient did not have surgery as planned.|0|||
13485037|NCT02323295|27031177|FG001|Overall Study|Patient did not have surgery as planned.|1|||
13485038|NCT01941719|27031214|FG000|Overall Study|Lost to Follow-up|20|||
13485039|NCT01941719|27031215|FG001|Overall Study|Lost to Follow-up|19|||
13485040|NCT00943618|27031268|FG000|Overall Study|Lost to Follow-up|38|||
13485041|NCT00943618|27031269|FG001|Overall Study|Lost to Follow-up|48|||
13485042|NCT00943618|27031270|FG002|Overall Study|Lost to Follow-up|20|||
13485043|NCT00943618|27031268|FG000|Overall Study|Discontinued Medication|17|||
13126253|NCT02914522|25959385|FG002|Induction Study: Up to Week 11|Withdrew Consent|4|||
13126254|NCT02914522|25959386|FG003|Induction Study: Up to Week 11|Withdrew Consent|6|||
13126255|NCT02914522|25959387|FG004|Induction Study: Up to Week 11|Withdrew Consent|3|||
13126256|NCT02914522|25959388|FG005|Induction Study: Up to Week 11|Withdrew Consent|3|||
13126257|NCT02914522|25959389|FG006|Induction Study: Up to Week 11|Withdrew Consent|0|||
13126258|NCT02914522|25959390|FG007|Induction Study: Up to Week 11|Withdrew Consent|0|||
13126259|NCT02914522|25959391|FG008|Induction Study: Up to Week 11|Withdrew Consent|0|||
13126260|NCT02914522|25959392|FG009|Induction Study: Up to Week 11|Withdrew Consent|0|||
13126261|NCT02914522|25959393|FG010|Induction Study: Up to Week 11|Withdrew Consent|0|||
13126262|NCT02914522|25959383|FG000|Induction Study: Up to Week 11|Protocol Violation|0|||
13126263|NCT02914522|25959384|FG001|Induction Study: Up to Week 11|Protocol Violation|2|||
13126264|NCT02914522|25959385|FG002|Induction Study: Up to Week 11|Protocol Violation|1|||
13126265|NCT02914522|25959386|FG003|Induction Study: Up to Week 11|Protocol Violation|3|||
13126266|NCT02914522|25959387|FG004|Induction Study: Up to Week 11|Protocol Violation|4|||
13126267|NCT02914522|25959388|FG005|Induction Study: Up to Week 11|Protocol Violation|2|||
13126268|NCT02914522|25959389|FG006|Induction Study: Up to Week 11|Protocol Violation|0|||
13126269|NCT02914522|25959390|FG007|Induction Study: Up to Week 11|Protocol Violation|0|||
13126270|NCT02914522|25959391|FG008|Induction Study: Up to Week 11|Protocol Violation|0|||
13126271|NCT02914522|25959392|FG009|Induction Study: Up to Week 11|Protocol Violation|0|||
13126272|NCT02914522|25959393|FG010|Induction Study: Up to Week 11|Protocol Violation|0|||
13126273|NCT02914522|25959383|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0|||
13126274|NCT02914522|25959384|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2|||
13126275|NCT02914522|25959385|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1|||
13126276|NCT02914522|25959386|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1|||
13126277|NCT02914522|25959387|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0|||
13126278|NCT02914522|25959388|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0|||
13126279|NCT02914522|25959389|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0|||
13126280|NCT02914522|25959390|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0|||
13126281|NCT02914522|25959391|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0|||
13126282|NCT02914522|25959392|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0|||
13126283|NCT02914522|25959393|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0|||
13126284|NCT02914522|25959383|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0|||
13126285|NCT02914522|25959384|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0|||
13126286|NCT02914522|25959385|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0|||
13126287|NCT02914522|25959386|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0|||
13126288|NCT02914522|25959387|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1|||
13126289|NCT02914522|25959388|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0|||
13126290|NCT02914522|25959389|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0|||
13126291|NCT02914522|25959390|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0|||
13126292|NCT02914522|25959391|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0|||
13126293|NCT02914522|25959392|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0|||
13126294|NCT02914522|25959393|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0|||
13126295|NCT02914522|25959383|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1|||
13126296|NCT02914522|25959384|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
13126297|NCT02914522|25959385|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
13126298|NCT02914522|25959386|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
13126299|NCT02914522|25959387|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
13126300|NCT02914522|25959388|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
13126301|NCT02914522|25959389|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
13126302|NCT02914522|25959390|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
13126303|NCT02914522|25959391|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
13126304|NCT02914522|25959392|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
13126305|NCT02914522|25959393|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
13126306|NCT02914522|25959383|FG000|Induction Study: Up to Week 11|Pregnancy|0|||
13126307|NCT02914522|25959384|FG001|Induction Study: Up to Week 11|Pregnancy|0|||
13126308|NCT02914522|25959385|FG002|Induction Study: Up to Week 11|Pregnancy|0|||
13126309|NCT02914522|25959386|FG003|Induction Study: Up to Week 11|Pregnancy|0|||
13126310|NCT02914522|25959387|FG004|Induction Study: Up to Week 11|Pregnancy|1|||
13126311|NCT02914522|25959388|FG005|Induction Study: Up to Week 11|Pregnancy|0|||
13126312|NCT02914522|25959389|FG006|Induction Study: Up to Week 11|Pregnancy|0|||
13126313|NCT02914522|25959390|FG007|Induction Study: Up to Week 11|Pregnancy|0|||
13126314|NCT02914522|25959391|FG008|Induction Study: Up to Week 11|Pregnancy|0|||
13126315|NCT02914522|25959392|FG009|Induction Study: Up to Week 11|Pregnancy|0|||
13126316|NCT02914522|25959393|FG010|Induction Study: Up to Week 11|Pregnancy|0|||
13126317|NCT02914522|25959383|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
13126318|NCT02914522|25959384|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
13126319|NCT02914522|25959385|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
13126320|NCT02914522|25959386|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
13126321|NCT02914522|25959387|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
13126322|NCT02914522|25959388|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
13126323|NCT02914522|25959389|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
13126324|NCT02914522|25959390|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
13126325|NCT02914522|25959391|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
13126326|NCT02914522|25959392|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
13126327|NCT02914522|25959393|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
13126328|NCT02914522|25959383|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
13126329|NCT02914522|25959384|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
13126330|NCT02914522|25959385|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
13126331|NCT02914522|25959386|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
13126332|NCT02914522|25959387|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
13126333|NCT02914522|25959388|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
13126334|NCT02914522|25959389|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34|||
13126335|NCT02914522|25959390|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49|||
13126336|NCT02914522|25959391|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53|||
13126337|NCT02914522|25959392|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39|||
13126338|NCT02914522|25959393|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21|||
13126339|NCT02914522|25959383|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
13126340|NCT02914522|25959384|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
13126341|NCT02914522|25959385|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
13126342|NCT02914522|25959386|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
13126343|NCT02914522|25959387|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
13126344|NCT02914522|25959388|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
13126345|NCT02914522|25959389|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7|||
13126346|NCT02914522|25959390|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2|||
13126347|NCT02914522|25959391|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10|||
13126348|NCT02914522|25959392|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4|||
13126349|NCT02914522|25959393|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3|||
13126350|NCT02914522|25959383|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
13126351|NCT02914522|25959384|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
13126352|NCT02914522|25959385|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
13126353|NCT02914522|25959386|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
13126354|NCT02914522|25959387|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
13126355|NCT02914522|25959388|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
13126356|NCT02914522|25959389|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
13126357|NCT02914522|25959390|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
13126358|NCT02914522|25959391|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3|||
13126359|NCT02914522|25959392|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
13126360|NCT02914522|25959393|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1|||
13126361|NCT02914522|25959383|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
13126362|NCT02914522|25959384|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
13126363|NCT02914522|25959385|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
13126364|NCT02914522|25959386|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
13126365|NCT02914522|25959387|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
13126366|NCT02914522|25959388|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
13126367|NCT02914522|25959389|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
13126368|NCT02914522|25959390|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1|||
13126369|NCT02914522|25959391|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6|||
13126370|NCT02914522|25959392|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3|||
13126371|NCT02914522|25959393|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
13126372|NCT02914522|25959383|FG000|Maintenance Study: Week 11 to Week 58|Death|0|||
13126373|NCT02914522|25959384|FG001|Maintenance Study: Week 11 to Week 58|Death|0|||
13126374|NCT02914522|25959385|FG002|Maintenance Study: Week 11 to Week 58|Death|0|||
13126375|NCT02914522|25959386|FG003|Maintenance Study: Week 11 to Week 58|Death|0|||
13126376|NCT02914522|25959387|FG004|Maintenance Study: Week 11 to Week 58|Death|0|||
13126377|NCT02914522|25959388|FG005|Maintenance Study: Week 11 to Week 58|Death|0|||
13126378|NCT02914522|25959389|FG006|Maintenance Study: Week 11 to Week 58|Death|2|||
13126379|NCT02914522|25959390|FG007|Maintenance Study: Week 11 to Week 58|Death|0|||
13126380|NCT02914522|25959391|FG008|Maintenance Study: Week 11 to Week 58|Death|0|||
13126381|NCT02914522|25959392|FG009|Maintenance Study: Week 11 to Week 58|Death|0|||
13126382|NCT02914522|25959393|FG010|Maintenance Study: Week 11 to Week 58|Death|0|||
13135704|NCT02737358|25996084|FG000|Overall Study|Withdrawal by Subject|7|||
13126383|NCT02914522|25959383|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
13126384|NCT02914522|25959384|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
13126385|NCT02914522|25959385|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
13126386|NCT02914522|25959386|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
13126387|NCT02914522|25959387|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
13126388|NCT02914522|25959388|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
13126389|NCT02914522|25959389|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
13126390|NCT02914522|25959390|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1|||
13126391|NCT02914522|25959391|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2|||
13126392|NCT02914522|25959392|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
13126393|NCT02914522|25959393|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
13126394|NCT02914522|25959383|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
13126395|NCT02914522|25959384|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
13126396|NCT02914522|25959385|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
13126397|NCT02914522|25959386|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
13126398|NCT02914522|25959387|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
13126399|NCT02914522|25959388|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
13126400|NCT02914522|25959389|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
13126401|NCT02914522|25959390|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
13126402|NCT02914522|25959391|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1|||
13126403|NCT02914522|25959392|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2|||
13126404|NCT02914522|25959393|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
13126405|NCT02914522|25959383|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
13126406|NCT02914522|25959384|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
13126407|NCT02914522|25959385|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
13126408|NCT02914522|25959386|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
13126409|NCT02914522|25959387|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
13126410|NCT02914522|25959388|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
13126411|NCT02914522|25959389|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
13126412|NCT02914522|25959390|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
13126413|NCT02914522|25959391|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
13126414|NCT02914522|25959392|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1|||
13126415|NCT02914522|25959393|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
13126416|NCT02914457|25959403|FG000|Overall Study|Withdrawal by Subject|1|||
13126417|NCT02914457|25959403|FG000|Overall Study|Physician Decision|1|||
13126418|NCT02914457|25959403|FG000|Overall Study|No veins available for lead placement|1|||
13126419|NCT02914457|25959403|FG000|Overall Study|Electrical instability of patient|1|||
13126420|NCT02914457|25959403|FG000|Overall Study|ECG acquisition error due to sweating|1|||
13126421|NCT02914457|25959403|FG000|Overall Study|Protocol Violation|1|||
13126422|NCT02914275|25959442|FG000|Overall Study|Lost to Follow-up|84|||
13126423|NCT02914275|25959443|FG001|Overall Study|Lost to Follow-up|29|||
13126424|NCT02914275|25959442|FG000|Overall Study|Withdrawal by Subject|26|||
13126425|NCT02914275|25959443|FG001|Overall Study|Withdrawal by Subject|10|||
13126426|NCT02914275|25959442|FG000|Overall Study|Protocol Violation|1|||
13126427|NCT02914275|25959443|FG001|Overall Study|Protocol Violation|1|||
13221969|NCT01809197|26285079|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
13126428|NCT02914275|25959442|FG000|Overall Study|Physician Decision|3|||
13126429|NCT02914275|25959443|FG001|Overall Study|Physician Decision|1|||
13126430|NCT02914275|25959442|FG000|Overall Study|Other|4|||
13126431|NCT02914275|25959443|FG001|Overall Study|Other|1|||
13126432|NCT02914275|25959442|FG000|Overall Study|Excluded due to invalid informed consent|3|||
13126433|NCT02914275|25959443|FG001|Overall Study|Excluded due to invalid informed consent|0|||
13126434|NCT02914236|25959453|FG000|Overall Study|Lost to Follow-up|1|||
13126435|NCT02914184|25959505|FG000|Overall Study|Lost to Follow-up|7|||
13126436|NCT02914184|25959506|FG001|Overall Study|Lost to Follow-up|10|||
13126437|NCT02914184|25959507|FG002|Overall Study|Lost to Follow-up|8|||
13126438|NCT02914184|25959508|FG003|Overall Study|Lost to Follow-up|7|||
13126439|NCT02914184|25959505|FG000|Overall Study|Withdrawal by Subject|4|||
13126440|NCT02914184|25959506|FG001|Overall Study|Withdrawal by Subject|2|||
13126441|NCT02914184|25959507|FG002|Overall Study|Withdrawal by Subject|7|||
13126442|NCT02914184|25959508|FG003|Overall Study|Withdrawal by Subject|3|||
13126443|NCT02914184|25959505|FG000|Overall Study|Other|1|||
13126444|NCT02914184|25959506|FG001|Overall Study|Other|0|||
13126445|NCT02914184|25959507|FG002|Overall Study|Other|0|||
13126446|NCT02914184|25959508|FG003|Overall Study|Other|0|||
13126447|NCT02914184|25959505|FG000|Overall Study|Migrated/moved from the study area|2|||
13126448|NCT02914184|25959506|FG001|Overall Study|Migrated/moved from the study area|1|||
13126449|NCT02914184|25959507|FG002|Overall Study|Migrated/moved from the study area|2|||
13126450|NCT02914184|25959508|FG003|Overall Study|Migrated/moved from the study area|1|||
13126451|NCT02913326|25959535|FG000|Overall Study|Reason not listed|0|||
13126452|NCT02913326|25959536|FG001|Overall Study|Reason not listed|1|||
13126453|NCT02913326|25959535|FG000|Overall Study|Lost to Follow-up|0|||
13126454|NCT02913326|25959536|FG001|Overall Study|Lost to Follow-up|1|||
13126455|NCT02913326|25959535|FG000|Overall Study|Adverse Event|1|||
13126456|NCT02913326|25959536|FG001|Overall Study|Adverse Event|0|||
13126457|NCT02913105|25959595|FG000|Overall Study|Adverse Event|11|||
13126458|NCT02913105|25959596|FG001|Overall Study|Adverse Event|0|||
13126459|NCT02913105|25959597|FG002|Overall Study|Adverse Event|4|||
13126460|NCT02913105|25959595|FG000|Overall Study|Non-Compliance With Study Drug|0|||
13126461|NCT02913105|25959596|FG001|Overall Study|Non-Compliance With Study Drug|0|||
13126462|NCT02913105|25959597|FG002|Overall Study|Non-Compliance With Study Drug|1|||
13126463|NCT02913105|25959595|FG000|Overall Study|Reason Not Specified|3|||
13126464|NCT02913105|25959596|FG001|Overall Study|Reason Not Specified|1|||
13126465|NCT02913105|25959597|FG002|Overall Study|Reason Not Specified|1|||
13126466|NCT02913105|25959595|FG000|Overall Study|Physician Decision|1|||
13126467|NCT02913105|25959596|FG001|Overall Study|Physician Decision|1|||
13126468|NCT02913105|25959597|FG002|Overall Study|Physician Decision|0|||
13126469|NCT02913105|25959595|FG000|Overall Study|Withdrawal by Subject|0|||
13126470|NCT02913105|25959596|FG001|Overall Study|Withdrawal by Subject|3|||
13126471|NCT02913105|25959597|FG002|Overall Study|Withdrawal by Subject|1|||
13126472|NCT02912650|25959692|FG000|Overall Study|Withdrawal by Subject|1|||
13126473|NCT02912650|25959693|FG001|Overall Study|Withdrawal by Subject|0|||
13126474|NCT02912650|25959694|FG002|Overall Study|Withdrawal by Subject|1|||
13126475|NCT02912650|25959695|FG003|Overall Study|Withdrawal by Subject|5|||
13126476|NCT02912650|25959692|FG000|Overall Study|Adverse Event|0|||
13126477|NCT02912650|25959693|FG001|Overall Study|Adverse Event|0|||
13126478|NCT02912650|25959694|FG002|Overall Study|Adverse Event|1|||
13126479|NCT02912650|25959695|FG003|Overall Study|Adverse Event|0|||
13221970|NCT01809197|26285078|FG000|Overall Study|Withdrawal by Subject|1|||
13126480|NCT02912468|25959779|FG000|Overall Study|Adverse Event|3|||
13126481|NCT02912468|25959780|FG001|Overall Study|Adverse Event|2|||
13126482|NCT02912468|25959779|FG000|Overall Study|Withdrawal by Subject|6|||
13126483|NCT02912468|25959780|FG001|Overall Study|Withdrawal by Subject|2|||
13126484|NCT02912468|25959779|FG000|Overall Study|Randomized and not treated|0|||
13126485|NCT02912468|25959780|FG001|Overall Study|Randomized and not treated|1|||
13126486|NCT02912455|25959825|FG000|Overall Study|Withdrawal by Subject|0|||
13221971|NCT01809197|26285079|FG001|Overall Study|Withdrawal by Subject|1|||
13126487|NCT02912455|25959826|FG001|Overall Study|Withdrawal by Subject|1|||
13126488|NCT02912455|25959825|FG000|Overall Study|Lack of Efficacy|0|||
13126489|NCT02912455|25959826|FG001|Overall Study|Lack of Efficacy|1|||
13126490|NCT02912455|25959825|FG000|Overall Study|Lost to Follow-up|2|||
13126491|NCT02912455|25959826|FG001|Overall Study|Lost to Follow-up|1|||
13126492|NCT02911948|25959893|FG000|Overall Study|Protocol Violation|0|||
13126493|NCT02911948|25959894|FG001|Overall Study|Protocol Violation|1|||
13126494|NCT02911948|25959893|FG000|Overall Study|Withdrawal by Subject|0|||
13126495|NCT02911948|25959894|FG001|Overall Study|Withdrawal by Subject|2|||
13126496|NCT02911948|25959893|FG000|Overall Study|Lack of Efficacy|0|||
13126497|NCT02911948|25959894|FG001|Overall Study|Lack of Efficacy|1|||
13126498|NCT02911948|25959893|FG000|Overall Study|Unclassified|0|||
13126499|NCT02911948|25959894|FG001|Overall Study|Unclassified|3|||
13126500|NCT02911935|25959919|FG000|Overall Study|Lost to Follow-up|5|||
13126501|NCT02911935|25959920|FG001|Overall Study|Lost to Follow-up|7|||
13126502|NCT02911688|25959949|FG000|Washout|Lost to Follow-up|1|||
13126503|NCT02911688|25959950|FG001|Washout|Lost to Follow-up|1|||
13126504|NCT02911688|25959949|FG000|Washout|Withdrawal by Subject|0|||
13126505|NCT02911688|25959950|FG001|Washout|Withdrawal by Subject|1|||
13126506|NCT02911519|25959977|FG000|Overall Study|Lost to Follow-up|2|||
13126507|NCT02911519|25959978|FG001|Overall Study|Lost to Follow-up|2|||
13126508|NCT02911519|25959977|FG000|Overall Study|Death|0|||
13126509|NCT02911519|25959978|FG001|Overall Study|Death|2|||
13126510|NCT02911285|25959997|FG000|Overall Study|Lost to Follow-up|8|||
13126511|NCT02911285|25959998|FG001|Overall Study|Lost to Follow-up|5|||
13126512|NCT02911285|25959997|FG000|Overall Study|Participant got a job and no longer had time to participate.|1|||
13126513|NCT02911285|25959998|FG001|Overall Study|Participant got a job and no longer had time to participate.|0|||
13221972|NCT01809197|26285078|FG000|Overall Study|Product not available|0|||
13485044|NCT00943618|27031269|FG001|Overall Study|Discontinued Medication|29|||
13485045|NCT00943618|27031270|FG002|Overall Study|Discontinued Medication|11|||
13487928|NCT02983617|27041584|FG000|Overall Study|Adverse Event|0|||
13487929|NCT02983617|27041585|FG001|Overall Study|Adverse Event|7|||
13487930|NCT02983617|27041584|FG000|Overall Study|Death|0|||
13372870|NCT00806260|26722176|FG005|Period 2|Protocol Violation|0|||
13487931|NCT02983617|27041585|FG001|Overall Study|Death|1|||
13487932|NCT02983617|27041584|FG000|Overall Study|Investigator's Discretion|0|||
13487933|NCT02983617|27041585|FG001|Overall Study|Investigator's Discretion|1|||
13487934|NCT02649946|27041708|FG000|Overall Study|Withdrawal by Subject|1|||
13487935|NCT02649946|27041709|FG001|Overall Study|Withdrawal by Subject|1|||
13307558|NCT01285310|26528951|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
13487936|NCT02649946|27041708|FG000|Overall Study|Death|7|||
13126514|NCT02911116|25960053|FG000|Overall Study|Insufficient Therapeutic Response|1|||
13126515|NCT02911116|25960054|FG001|Overall Study|Insufficient Therapeutic Response|0|||
13126516|NCT02911116|25960053|FG000|Overall Study|Lost to Follow-up|0|||
13126517|NCT02911116|25960054|FG001|Overall Study|Lost to Follow-up|1|||
13126518|NCT02911025|25960061|FG000|Overall Study|Lost to Follow-up|3|||
13126519|NCT02910739|25960096|FG000|Overall Study|Adverse Event|1|||
13126520|NCT02910739|25960097|FG001|Overall Study|Adverse Event|0|||
13126521|NCT02910739|25960098|FG002|Overall Study|Adverse Event|0|||
13126522|NCT02910739|25960099|FG003|Overall Study|Adverse Event|0|||
13126523|NCT02910713|25960108|FG000|Overall Study|Protocol Violation|2|||
13126524|NCT02910713|25960108|FG000|Overall Study|Subject Choice|4|||
13126525|NCT02910713|25960108|FG000|Overall Study|Received One Application|10|||
13126526|NCT02910713|25960108|FG000|Overall Study|Received Neither Application|18|||
13126527|NCT02910713|25960108|FG000|Overall Study|Enrollment cap|7|||
13126528|NCT02910713|25960108|FG000|Overall Study|Investigator Discretion|1|||
13126529|NCT02910583|25960188|FG000|Overall Study|Withdrawal by Subject|6|||
13126530|NCT02910583|25960189|FG001|Overall Study|Withdrawal by Subject|7|||
13126531|NCT02910583|25960188|FG000|Overall Study|Other, Not Specified|1|||
13126532|NCT02910583|25960189|FG001|Overall Study|Other, Not Specified|0|||
13126533|NCT02910466|25960220|FG000|Overall Study|Adverse Event|1|||
13126534|NCT02910466|25960220|FG000|Overall Study|Withdrawal by Subject|3|||
13126535|NCT02910466|25960220|FG000|Overall Study|Lost to Follow-up|5|||
13126536|NCT02910466|25960220|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29|||
13126537|NCT02910466|25960220|FG000|Overall Study|Participant didn't meet inclusion criteria|1|||
13126538|NCT02910219|25960251|FG000|Overall Study|Withdrawal by Subject|1|||
13126539|NCT02910219|25960252|FG001|Overall Study|Withdrawal by Subject|1|||
13126540|NCT02910167|25960262|FG000|Overall Study|Adverse Event|1|||
13126541|NCT02910167|25960262|FG000|Overall Study|Lost to Follow-up|18|||
13126542|NCT02910089|25960281|FG000|Overall Study|Lost insurance eligibility|22|||
13126543|NCT02910089|25960282|FG001|Overall Study|Lost insurance eligibility|16|||
13126544|NCT02910063|25960327|FG000|Phase 2|Withdrawal by Subject|3|||
13126545|NCT02910063|25960328|FG001|Phase 2|Withdrawal by Subject|0|||
13126546|NCT02910063|25960329|FG002|Phase 2|Withdrawal by Subject|0|||
13126547|NCT02910063|25960327|FG000|Phase 2|Lost to Follow-up|1|||
13126548|NCT02910063|25960328|FG001|Phase 2|Lost to Follow-up|0|||
13126549|NCT02910063|25960329|FG002|Phase 2|Lost to Follow-up|0|||
13126550|NCT02910063|25960327|FG000|Phase 2|Death|24|||
13126551|NCT02910063|25960328|FG001|Phase 2|Death|0|||
13126552|NCT02910063|25960329|FG002|Phase 2|Death|0|||
13126553|NCT02910037|25960352|FG000|Overall Study|Withdrawal by Subject|4|||
13126554|NCT02910037|25960352|FG000|Overall Study|Lost to Follow-up|6|||
13126555|NCT02910011|25960360|FG000|Overall Study|Physician Decision|2|||
13126556|NCT02909907|25960389|FG000|Overall Study|Withdrawal by Subject|0|||
13126557|NCT02909907|25960390|FG001|Overall Study|Withdrawal by Subject|1|||
13126558|NCT02909504|25960397|FG000|Overall Study|Adverse Event|2|||
13126559|NCT02909504|25960397|FG000|Overall Study|Lack of Efficacy|3|||
13126560|NCT02909504|25960397|FG000|Overall Study|Withdrawal by Subject|4|||
13126561|NCT02909504|25960397|FG000|Overall Study|Pregnancy|1|||
13126562|NCT02909504|25960397|FG000|Overall Study|Subject moved|1|||
13126563|NCT02909504|25960397|FG000|Overall Study|Lost to Follow-up|1|||
13126564|NCT02909153|25960455|FG000|Overall Study|Withdrawal by Subject|0|||
13126565|NCT02909153|25960456|FG001|Overall Study|Withdrawal by Subject|1|||
13126566|NCT02909153|25960457|FG002|Overall Study|Withdrawal by Subject|0|||
13126567|NCT02909153|25960458|FG003|Overall Study|Withdrawal by Subject|0|||
13126568|NCT02909153|25960459|FG004|Overall Study|Withdrawal by Subject|0|||
13126569|NCT02909101|25960484|FG000|Overall Study|Lost to Follow-up|1|||
13126570|NCT02909101|25960485|FG001|Overall Study|Lost to Follow-up|1|||
13126571|NCT02908880|25960495|FG000|Overall Study|Lost to Follow-up|4|||
13126572|NCT02908880|25960495|FG000|Overall Study|Explantation of the device|1|||
13126573|NCT02908880|25960495|FG000|Overall Study|Withdrawal by Subject|17|||
13126574|NCT02908880|25960495|FG000|Overall Study|Death|5|||
13126575|NCT02908841|25960518|FG000|Overall Study|Physician Decision|4|||
13126576|NCT02908841|25960519|FG001|Overall Study|Physician Decision|0|||
13126577|NCT02908529|25960530|FG000|Overall Study|Lost to Follow-up|0|||
13126578|NCT02908529|25960531|FG001|Overall Study|Lost to Follow-up|2|||
13126579|NCT02908516|25960552|FG000|Overall Study|Study Terminated|3|||
13126580|NCT02908516|25960553|FG001|Overall Study|Study Terminated|3|||
13126581|NCT02908464|25960579|FG000|Overall Study|Withdrawal by Subject|2|||
13126582|NCT02908464|25960580|FG001|Overall Study|Withdrawal by Subject|1|||
13126583|NCT02908464|25960579|FG000|Overall Study|Found ineligible after randomization|0|||
13126584|NCT02908464|25960580|FG001|Overall Study|Found ineligible after randomization|2|||
13126585|NCT02908347|25960635|FG000|Overall Study|Adverse Event|0|||
13126586|NCT02908347|25960636|FG001|Overall Study|Adverse Event|1|||
13126587|NCT02908347|25960635|FG000|Overall Study|Lost to Follow-up|1|||
13126588|NCT02908347|25960636|FG001|Overall Study|Lost to Follow-up|0|||
13126589|NCT02908100|25960680|FG000|Overall Study|Adverse Event|7|||
13126590|NCT02908100|25960681|FG001|Overall Study|Adverse Event|6|||
13126591|NCT02908100|25960682|FG002|Overall Study|Adverse Event|9|||
13126592|NCT02908100|25960680|FG000|Overall Study|Death|2|||
13126593|NCT02908100|25960681|FG001|Overall Study|Death|0|||
13126594|NCT02908100|25960682|FG002|Overall Study|Death|0|||
13126595|NCT02908100|25960680|FG000|Overall Study|Lack of Efficacy|2|||
13126596|NCT02908100|25960681|FG001|Overall Study|Lack of Efficacy|3|||
13126597|NCT02908100|25960682|FG002|Overall Study|Lack of Efficacy|3|||
13126598|NCT02908100|25960680|FG000|Overall Study|Lost to Follow-up|0|||
13126599|NCT02908100|25960681|FG001|Overall Study|Lost to Follow-up|1|||
13126600|NCT02908100|25960682|FG002|Overall Study|Lost to Follow-up|2|||
13126601|NCT02908100|25960680|FG000|Overall Study|Non-Compliance With Study Drug|1|||
13126602|NCT02908100|25960681|FG001|Overall Study|Non-Compliance With Study Drug|1|||
13126603|NCT02908100|25960682|FG002|Overall Study|Non-Compliance With Study Drug|2|||
13126604|NCT02908100|25960680|FG000|Overall Study|Non-Compliance With Contraceptive Method|1|||
13126605|NCT02908100|25960681|FG001|Overall Study|Non-Compliance With Contraceptive Method|0|||
13126606|NCT02908100|25960682|FG002|Overall Study|Non-Compliance With Contraceptive Method|0|||
13126607|NCT02908100|25960680|FG000|Overall Study|Physician Decision|0|||
13126608|NCT02908100|25960681|FG001|Overall Study|Physician Decision|1|||
13126609|NCT02908100|25960682|FG002|Overall Study|Physician Decision|0|||
13126610|NCT02908100|25960680|FG000|Overall Study|Pregnancy|1|||
13126611|NCT02908100|25960681|FG001|Overall Study|Pregnancy|2|||
13126612|NCT02908100|25960682|FG002|Overall Study|Pregnancy|0|||
13126613|NCT02908100|25960680|FG000|Overall Study|Withdrawal by Subject|8|||
13126614|NCT02908100|25960681|FG001|Overall Study|Withdrawal by Subject|7|||
13126615|NCT02908100|25960682|FG002|Overall Study|Withdrawal by Subject|5|||
13126616|NCT02908100|25960680|FG000|Overall Study|Randomised in Error|1|||
13126617|NCT02908100|25960681|FG001|Overall Study|Randomised in Error|0|||
13126618|NCT02908100|25960682|FG002|Overall Study|Randomised in Error|0|||
13126619|NCT02907892|25960695|FG000|Overall Study|Lost to Follow-up|27|||
13126620|NCT02907892|25960696|FG001|Overall Study|Lost to Follow-up|40|||
13126621|NCT02907619|25960911|FG000|Overall Study|Study terminated by sponsor|18|||
13126622|NCT02907619|25960912|FG001|Overall Study|Study terminated by sponsor|18|||
13126623|NCT02907619|25960913|FG002|Overall Study|Study terminated by sponsor|19|||
13126624|NCT02907619|25960911|FG000|Overall Study|Death|0|||
13126625|NCT02907619|25960912|FG001|Overall Study|Death|0|||
13126626|NCT02907619|25960913|FG002|Overall Study|Death|1|||
13126627|NCT02907619|25960911|FG000|Overall Study|Withdrawal by Subject|1|||
13126628|NCT02907619|25960912|FG001|Overall Study|Withdrawal by Subject|1|||
13126629|NCT02907619|25960913|FG002|Overall Study|Withdrawal by Subject|0|||
13126630|NCT02907619|25960911|FG000|Overall Study|Other|0|||
13126631|NCT02907619|25960912|FG001|Overall Study|Other|1|||
13126632|NCT02907619|25960913|FG002|Overall Study|Other|0|||
13126633|NCT02907463|25960985|FG000|Overall Study|Lost to Follow-up|17|||
13126634|NCT02907463|25960985|FG000|Overall Study|Death|10|||
13126635|NCT02907463|25960985|FG000|Overall Study|Withdrawal by Subject|4|||
13126636|NCT02907463|25960985|FG000|Overall Study|MIS Approach was not used|2|||
13126637|NCT02907463|25960985|FG000|Overall Study|Not Implanted with Study Device|2|||
13126638|NCT02907463|25960985|FG000|Overall Study|Device Explanted|1|||
13126639|NCT02907463|25960985|FG000|Overall Study|Missing Exit Form|1|||
13126640|NCT02907216|25961024|FG000|Overall Study|No benefit to be obtained by continuing|0|||
13126641|NCT02907216|25961025|FG001|Overall Study|No benefit to be obtained by continuing|1|||
13126642|NCT02907216|25961024|FG000|Overall Study|Withdrawal by Subject|1|||
13126643|NCT02907216|25961025|FG001|Overall Study|Withdrawal by Subject|0|||
13126644|NCT02907177|25961044|FG000|Overall Study|Death|0|||
13126645|NCT02907177|25961045|FG001|Overall Study|Death|1|||
13126646|NCT02907177|25961044|FG000|Overall Study|Physician Decision|3|||
13126647|NCT02907177|25961045|FG001|Overall Study|Physician Decision|3|||
13126648|NCT02907177|25961044|FG000|Overall Study|Withdrawal by Subject|15|||
13126649|NCT02907177|25961045|FG001|Overall Study|Withdrawal by Subject|7|||
13126650|NCT02907177|25961044|FG000|Overall Study|Sponsor's Decision|50|||
13126651|NCT02907177|25961045|FG001|Overall Study|Sponsor's Decision|57|||
13126652|NCT02906930|25961249|FG000|Overall Study|Withdrawal by Subject|0|||
13126653|NCT02906930|25961250|FG001|Overall Study|Withdrawal by Subject|5|||
13126654|NCT02906930|25961251|FG002|Overall Study|Withdrawal by Subject|5|||
13126655|NCT02906930|25961252|FG003|Overall Study|Withdrawal by Subject|4|||
13126656|NCT02906930|25961249|FG000|Overall Study|Lost to Follow-up|5|||
13126657|NCT02906930|25961250|FG001|Overall Study|Lost to Follow-up|7|||
13126658|NCT02906930|25961251|FG002|Overall Study|Lost to Follow-up|5|||
13485046|NCT03938272|27031285|FG000|Overall Study|Withdrawal by Subject|1|||
13485047|NCT03938272|27031286|FG001|Overall Study|Withdrawal by Subject|0|||
13126659|NCT02906930|25961252|FG003|Overall Study|Lost to Follow-up|2|||
13221973|NCT01809197|26285079|FG001|Overall Study|Product not available|1|||
13221974|NCT01809132|26285106|FG000|Overall Study|Withdrawal by Subject|0|||
13485048|NCT03938272|27031285|FG000|Overall Study|Physician Decision|0|||
13485049|NCT03938272|27031286|FG001|Overall Study|Physician Decision|2|||
13485050|NCT03938272|27031285|FG000|Overall Study|Study termination by sponsor|10|||
13485051|NCT03938272|27031286|FG001|Overall Study|Study termination by sponsor|8|||
13485052|NCT03641339|27031325|FG000|Overall Study|Physician Decision|1|||
13485053|NCT03641339|27031326|FG001|Overall Study|Physician Decision|0|||
13485054|NCT03641339|27031327|FG002|Overall Study|Physician Decision|0|||
13485055|NCT03641339|27031328|FG003|Overall Study|Physician Decision|0|||
13485056|NCT03641339|27031329|FG004|Overall Study|Physician Decision|0|||
13221975|NCT01809132|26285107|FG001|Overall Study|Withdrawal by Subject|0|||
13485057|NCT03641339|27031330|FG005|Overall Study|Physician Decision|0|||
13485058|NCT03641339|27031325|FG000|Overall Study|Withdrawal by Subject|0|||
13485059|NCT03641339|27031326|FG001|Overall Study|Withdrawal by Subject|2|||
13485060|NCT03641339|27031327|FG002|Overall Study|Withdrawal by Subject|0|||
13485061|NCT03641339|27031328|FG003|Overall Study|Withdrawal by Subject|2|||
13485062|NCT03641339|27031329|FG004|Overall Study|Withdrawal by Subject|0|||
13485063|NCT03641339|27031330|FG005|Overall Study|Withdrawal by Subject|1|||
13485064|NCT03625466|27031353|FG000|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
13485065|NCT03625466|27031354|FG001|Placebo-controlled Period (48 Weeks)|Adverse Event|1|||
13485066|NCT03625466|27031355|FG002|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
13485067|NCT03625466|27031353|FG000|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
13485068|NCT03625466|27031354|FG001|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
13485069|NCT03625466|27031355|FG002|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
13485070|NCT03625466|27031353|FG000|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
13485071|NCT03625466|27031354|FG001|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
13485072|NCT03625466|27031355|FG002|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
13487937|NCT02649946|27041709|FG001|Overall Study|Death|9|||
13487938|NCT02649946|27041708|FG000|Overall Study|Physician Decision|1|||
13487939|NCT02649946|27041709|FG001|Overall Study|Physician Decision|0|||
13487940|NCT02649946|27041708|FG000|Overall Study|Lost to Follow-up|2|||
13487941|NCT02649946|27041709|FG001|Overall Study|Lost to Follow-up|1|||
13487942|NCT02649946|27041708|FG000|Overall Study|Erroneously enrolled|1|||
13487943|NCT02649946|27041709|FG001|Overall Study|Erroneously enrolled|0|||
13487944|NCT02649946|27041708|FG000|Overall Study|Missed 6-month follow-up visit|0|||
13487945|NCT02649946|27041709|FG001|Overall Study|Missed 6-month follow-up visit|4|||
13487946|NCT02345850|27041787|FG000|Overall Study|Not transplanted|10|||
13487947|NCT02345850|27041788|FG001|Overall Study|Not transplanted|5|||
13487948|NCT02345850|27041789|FG002|Overall Study|Not transplanted|4|||
13487949|NCT02345850|27041787|FG000|Overall Study|Lost to Follow-up|2|||
13487950|NCT02345850|27041788|FG001|Overall Study|Lost to Follow-up|3|||
13487951|NCT02345850|27041789|FG002|Overall Study|Lost to Follow-up|2|||
13487952|NCT02345850|27041787|FG000|Overall Study|Withdrawal by Subject|1|||
13487953|NCT02345850|27041788|FG001|Overall Study|Withdrawal by Subject|0|||
13487954|NCT02345850|27041789|FG002|Overall Study|Withdrawal by Subject|0|||
13487955|NCT02343302|27041804|FG000|Overall Study|Physician Decision|1|||
13487956|NCT02343302|27041805|FG001|Overall Study|Physician Decision|1|||
13487957|NCT01464164|27041903|FG000|Overall Study|Screen failure|0|||
13487958|NCT01464164|27041904|FG001|Overall Study|Screen failure|1|||
13487959|NCT01464164|27041905|FG002|Overall Study|Screen failure|2|||
13487960|NCT01464164|27041906|FG003|Overall Study|Screen failure|0|||
13487961|NCT01464164|27041907|FG004|Overall Study|Screen failure|0|||
13487962|NCT01464164|27041908|FG005|Overall Study|Screen failure|0|||
13487963|NCT01464164|27041909|FG006|Overall Study|Screen failure|0|||
13487964|NCT01464164|27041903|FG000|Overall Study|Physician Decision|0|||
13487965|NCT01464164|27041904|FG001|Overall Study|Physician Decision|0|||
13126660|NCT02906930|25961249|FG000|Overall Study|Death|0|||
13126661|NCT02906930|25961250|FG001|Overall Study|Death|0|||
13126662|NCT02906930|25961251|FG002|Overall Study|Death|1|||
13126663|NCT02906930|25961252|FG003|Overall Study|Death|0|||
13126664|NCT02906930|25961249|FG000|Overall Study|Other|1|||
13126665|NCT02906930|25961250|FG001|Overall Study|Other|2|||
13126666|NCT02906930|25961251|FG002|Overall Study|Other|1|||
13126667|NCT02906930|25961252|FG003|Overall Study|Other|2|||
13126668|NCT02906917|25961287|FG000|Initiation Period (Week 0-26)|Unclassified|1|||
13126669|NCT02906917|25961288|FG001|Initiation Period (Week 0-26)|Unclassified|3|||
13126670|NCT02906917|25961287|FG000|Initiation Period (Week 0-26)|Adverse Event|1|||
13126671|NCT02906917|25961288|FG001|Initiation Period (Week 0-26)|Adverse Event|0|||
13126672|NCT02906917|25961287|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1|||
13126673|NCT02906917|25961288|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4|||
13126674|NCT02906917|25961287|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3|||
13126675|NCT02906917|25961288|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4|||
13126676|NCT02906917|25961287|FG000|Intensification Period (Week 26-38)|Unclassified|3|||
13126677|NCT02906917|25961288|FG001|Intensification Period (Week 26-38)|Unclassified|2|||
13126678|NCT02906917|25961287|FG000|Intensification Period (Week 26-38)|Adverse Event|0|||
13126679|NCT02906917|25961288|FG001|Intensification Period (Week 26-38)|Adverse Event|2|||
13126680|NCT02906917|25961287|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3|||
13126681|NCT02906917|25961288|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1|||
13126682|NCT02906917|25961287|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3|||
13126683|NCT02906917|25961288|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2|||
13126684|NCT02906709|25961327|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1|||
13126685|NCT02906709|25961328|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2|||
13126686|NCT02906709|25961327|FG000|Phase A (Week 0 to Week 16)|Death|0|||
13126687|NCT02906709|25961328|FG001|Phase A (Week 0 to Week 16)|Death|1|||
13126688|NCT02906709|25961327|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3|||
13126689|NCT02906709|25961328|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0|||
13126690|NCT02906709|25961327|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2|||
13126691|NCT02906709|25961328|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0|||
13126692|NCT02906670|25961474|FG000|Cohort 1, QW|Radiological Progression|1|||
13126693|NCT02906670|25961475|FG001|Cohort 1, QW|Radiological Progression|0|||
13126694|NCT02906670|25961476|FG002|Cohort 1, QW|Radiological Progression|0|||
13126695|NCT02906670|25961477|FG003|Cohort 1, QW|Radiological Progression|0|||
13126696|NCT02906670|25961478|FG004|Cohort 1, QW|Radiological Progression|0|||
13126697|NCT02906670|25961479|FG005|Cohort 1, QW|Radiological Progression|0|||
13126698|NCT02906670|25961480|FG006|Cohort 1, QW|Radiological Progression|0|||
13126699|NCT02906670|25961481|FG007|Cohort 1, QW|Radiological Progression|0|||
13126700|NCT02906670|25961482|FG008|Cohort 1, QW|Radiological Progression|0|||
13126701|NCT02906670|25961483|FG009|Cohort 1, QW|Radiological Progression|0|||
13126702|NCT02906670|25961474|FG000|Cohort 2, QW|Radiological Progression|0|||
13126703|NCT02906670|25961475|FG001|Cohort 2, QW|Radiological Progression|1|||
13126704|NCT02906670|25961476|FG002|Cohort 2, QW|Radiological Progression|0|||
13126705|NCT02906670|25961477|FG003|Cohort 2, QW|Radiological Progression|0|||
13126706|NCT02906670|25961478|FG004|Cohort 2, QW|Radiological Progression|0|||
13126707|NCT02906670|25961479|FG005|Cohort 2, QW|Radiological Progression|0|||
13126708|NCT02906670|25961480|FG006|Cohort 2, QW|Radiological Progression|0|||
13126709|NCT02906670|25961481|FG007|Cohort 2, QW|Radiological Progression|0|||
13126710|NCT02906670|25961482|FG008|Cohort 2, QW|Radiological Progression|0|||
13126711|NCT02906670|25961483|FG009|Cohort 2, QW|Radiological Progression|0|||
13126712|NCT02906670|25961474|FG000|Cohort 3, QW|Radiological Progression|0|||
13126713|NCT02906670|25961475|FG001|Cohort 3, QW|Radiological Progression|0|||
13485073|NCT03317795|27031380|FG000|Overall Study|IUD Expulsion|1|||
13485074|NCT03317795|27031381|FG001|Overall Study|IUD Expulsion|0|||
13485075|NCT03317795|27031380|FG000|Overall Study|Lost to Follow-up|1|||
13485076|NCT03317795|27031381|FG001|Overall Study|Lost to Follow-up|3|||
13485077|NCT03317795|27031380|FG000|Overall Study|Treatment change|0|||
13485078|NCT03317795|27031381|FG001|Overall Study|Treatment change|3|||
13485079|NCT03317795|27031380|FG000|Overall Study|Intolerance of medication|0|||
13485080|NCT03317795|27031381|FG001|Overall Study|Intolerance of medication|1|||
13485081|NCT03287245|27031512|FG000|Overall Study|Study terminated by sponsor|3|||
13485082|NCT03287245|27031513|FG001|Overall Study|Study terminated by sponsor|0|||
13485083|NCT03287245|27031514|FG002|Overall Study|Study terminated by sponsor|3|||
13485084|NCT03287245|27031515|FG003|Overall Study|Study terminated by sponsor|1|||
13485085|NCT03287245|27031512|FG000|Overall Study|Adverse Event|1|||
13485086|NCT03287245|27031513|FG001|Overall Study|Adverse Event|0|||
13485087|NCT03287245|27031514|FG002|Overall Study|Adverse Event|0|||
13485088|NCT03287245|27031515|FG003|Overall Study|Adverse Event|0|||
13485089|NCT03287245|27031512|FG000|Overall Study|Withdrawal by Subject|8|||
13485090|NCT03287245|27031513|FG001|Overall Study|Withdrawal by Subject|3|||
13485091|NCT03287245|27031514|FG002|Overall Study|Withdrawal by Subject|3|||
13485092|NCT03287245|27031515|FG003|Overall Study|Withdrawal by Subject|0|||
13485093|NCT03287245|27031512|FG000|Overall Study|Physician Decision|3|||
13485094|NCT03287245|27031513|FG001|Overall Study|Physician Decision|2|||
13485095|NCT03287245|27031514|FG002|Overall Study|Physician Decision|0|||
13485096|NCT03287245|27031515|FG003|Overall Study|Physician Decision|0|||
13485097|NCT03092219|27031579|FG000|Overall Study|Protocol Violation|7|||
13485098|NCT03092219|27031580|FG001|Overall Study|Protocol Violation|4|||
13485099|NCT03033069|27031603|FG000|Overall Study|Adverse Event|6|||
13485100|NCT03033069|27031604|FG001|Overall Study|Adverse Event|7|||
13485101|NCT03033069|27031605|FG002|Overall Study|Adverse Event|4|||
13485102|NCT03033069|27031606|FG003|Overall Study|Adverse Event|6|||
13485103|NCT03033069|27031603|FG000|Overall Study|Lack of Efficacy|0|||
13485104|NCT03033069|27031604|FG001|Overall Study|Lack of Efficacy|0|||
13485105|NCT03033069|27031605|FG002|Overall Study|Lack of Efficacy|1|||
13485106|NCT03033069|27031606|FG003|Overall Study|Lack of Efficacy|0|||
13485107|NCT03033069|27031603|FG000|Overall Study|Lost to Follow-up|6|||
13485108|NCT03033069|27031604|FG001|Overall Study|Lost to Follow-up|5|||
13485109|NCT03033069|27031605|FG002|Overall Study|Lost to Follow-up|5|||
13485110|NCT03033069|27031606|FG003|Overall Study|Lost to Follow-up|6|||
13485111|NCT03033069|27031603|FG000|Overall Study|Non-Compliance With Study Drug|1|||
13485112|NCT03033069|27031604|FG001|Overall Study|Non-Compliance With Study Drug|1|||
13221976|NCT01809132|26285108|FG002|Overall Study|Withdrawal by Subject|1|||
13221977|NCT01808690|26285133|FG000|Overall Study|Withdrawal by Subject|1|||
13221978|NCT01808690|26285134|FG001|Overall Study|Withdrawal by Subject|2|||
13126714|NCT02906670|25961476|FG002|Cohort 3, QW|Radiological Progression|2|||
13126715|NCT02906670|25961477|FG003|Cohort 3, QW|Radiological Progression|0|||
13126716|NCT02906670|25961478|FG004|Cohort 3, QW|Radiological Progression|0|||
13126717|NCT02906670|25961479|FG005|Cohort 3, QW|Radiological Progression|0|||
13126718|NCT02906670|25961480|FG006|Cohort 3, QW|Radiological Progression|0|||
13126719|NCT02906670|25961481|FG007|Cohort 3, QW|Radiological Progression|0|||
13126720|NCT02906670|25961482|FG008|Cohort 3, QW|Radiological Progression|0|||
13126721|NCT02906670|25961483|FG009|Cohort 3, QW|Radiological Progression|0|||
13126722|NCT02906670|25961474|FG000|Cohort 3, QW|Lack of Clinical Benefit|0|||
13126723|NCT02906670|25961475|FG001|Cohort 3, QW|Lack of Clinical Benefit|0|||
13126724|NCT02906670|25961476|FG002|Cohort 3, QW|Lack of Clinical Benefit|2|||
13126725|NCT02906670|25961477|FG003|Cohort 3, QW|Lack of Clinical Benefit|0|||
13126726|NCT02906670|25961478|FG004|Cohort 3, QW|Lack of Clinical Benefit|0|||
13126727|NCT02906670|25961479|FG005|Cohort 3, QW|Lack of Clinical Benefit|0|||
13126728|NCT02906670|25961480|FG006|Cohort 3, QW|Lack of Clinical Benefit|0|||
13126729|NCT02906670|25961481|FG007|Cohort 3, QW|Lack of Clinical Benefit|0|||
13126730|NCT02906670|25961482|FG008|Cohort 3, QW|Lack of Clinical Benefit|0|||
13126731|NCT02906670|25961483|FG009|Cohort 3, QW|Lack of Clinical Benefit|0|||
13126732|NCT02906670|25961474|FG000|Cohort 4, Q2W|Radiological Progression|0|||
13126733|NCT02906670|25961475|FG001|Cohort 4, Q2W|Radiological Progression|0|||
13126734|NCT02906670|25961476|FG002|Cohort 4, Q2W|Radiological Progression|0|||
13126735|NCT02906670|25961477|FG003|Cohort 4, Q2W|Radiological Progression|0|||
13126736|NCT02906670|25961478|FG004|Cohort 4, Q2W|Radiological Progression|0|||
13126737|NCT02906670|25961479|FG005|Cohort 4, Q2W|Radiological Progression|1|||
13126738|NCT02906670|25961480|FG006|Cohort 4, Q2W|Radiological Progression|0|||
13126739|NCT02906670|25961481|FG007|Cohort 4, Q2W|Radiological Progression|0|||
13126740|NCT02906670|25961482|FG008|Cohort 4, Q2W|Radiological Progression|0|||
13126741|NCT02906670|25961483|FG009|Cohort 4, Q2W|Radiological Progression|0|||
13126742|NCT02906670|25961474|FG000|Cohort 4, Q2W|Clinical Progression|0|||
13126743|NCT02906670|25961475|FG001|Cohort 4, Q2W|Clinical Progression|0|||
13126744|NCT02906670|25961476|FG002|Cohort 4, Q2W|Clinical Progression|0|||
13126745|NCT02906670|25961477|FG003|Cohort 4, Q2W|Clinical Progression|0|||
13126746|NCT02906670|25961478|FG004|Cohort 4, Q2W|Clinical Progression|0|||
13126747|NCT02906670|25961479|FG005|Cohort 4, Q2W|Clinical Progression|2|||
13126748|NCT02906670|25961480|FG006|Cohort 4, Q2W|Clinical Progression|0|||
13126749|NCT02906670|25961481|FG007|Cohort 4, Q2W|Clinical Progression|0|||
13126750|NCT02906670|25961482|FG008|Cohort 4, Q2W|Clinical Progression|0|||
13126751|NCT02906670|25961483|FG009|Cohort 4, Q2W|Clinical Progression|0|||
13126752|NCT02906670|25961474|FG000|Cohort 5, Q2W|Radiological Progression|0|||
13126753|NCT02906670|25961475|FG001|Cohort 5, Q2W|Radiological Progression|0|||
13126754|NCT02906670|25961476|FG002|Cohort 5, Q2W|Radiological Progression|0|||
13126755|NCT02906670|25961477|FG003|Cohort 5, Q2W|Radiological Progression|0|||
13126756|NCT02906670|25961478|FG004|Cohort 5, Q2W|Radiological Progression|0|||
13126757|NCT02906670|25961479|FG005|Cohort 5, Q2W|Radiological Progression|0|||
13126758|NCT02906670|25961480|FG006|Cohort 5, Q2W|Radiological Progression|4|||
13126759|NCT02906670|25961481|FG007|Cohort 5, Q2W|Radiological Progression|0|||
13126760|NCT02906670|25961482|FG008|Cohort 5, Q2W|Radiological Progression|0|||
13126761|NCT02906670|25961483|FG009|Cohort 5, Q2W|Radiological Progression|0|||
13126762|NCT02906670|25961474|FG000|Cohort 5, Q2W|Clinical Progression|0|||
13126763|NCT02906670|25961475|FG001|Cohort 5, Q2W|Clinical Progression|0|||
13126764|NCT02906670|25961476|FG002|Cohort 5, Q2W|Clinical Progression|0|||
13126765|NCT02906670|25961477|FG003|Cohort 5, Q2W|Clinical Progression|0|||
13393332|NCT00665925|26783411|FG000|Overall Study|Withdrawal by Subject|2|||
13126766|NCT02906670|25961478|FG004|Cohort 5, Q2W|Clinical Progression|0|||
13126767|NCT02906670|25961479|FG005|Cohort 5, Q2W|Clinical Progression|0|||
13126768|NCT02906670|25961480|FG006|Cohort 5, Q2W|Clinical Progression|1|||
13126769|NCT02906670|25961481|FG007|Cohort 5, Q2W|Clinical Progression|0|||
13126770|NCT02906670|25961482|FG008|Cohort 5, Q2W|Clinical Progression|0|||
13126771|NCT02906670|25961483|FG009|Cohort 5, Q2W|Clinical Progression|0|||
13126772|NCT02906670|25961474|FG000|Cohort 5, Q2W|Adverse Event|0|||
13126773|NCT02906670|25961475|FG001|Cohort 5, Q2W|Adverse Event|0|||
13126774|NCT02906670|25961476|FG002|Cohort 5, Q2W|Adverse Event|0|||
13126775|NCT02906670|25961477|FG003|Cohort 5, Q2W|Adverse Event|0|||
13126776|NCT02906670|25961478|FG004|Cohort 5, Q2W|Adverse Event|0|||
13126777|NCT02906670|25961479|FG005|Cohort 5, Q2W|Adverse Event|0|||
13126778|NCT02906670|25961480|FG006|Cohort 5, Q2W|Adverse Event|1|||
13126779|NCT02906670|25961481|FG007|Cohort 5, Q2W|Adverse Event|0|||
13126780|NCT02906670|25961482|FG008|Cohort 5, Q2W|Adverse Event|0|||
13126781|NCT02906670|25961483|FG009|Cohort 5, Q2W|Adverse Event|0|||
13126782|NCT02906670|25961474|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
13126783|NCT02906670|25961475|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
13126784|NCT02906670|25961476|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
13126785|NCT02906670|25961477|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
13126786|NCT02906670|25961478|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
13126787|NCT02906670|25961479|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
13126788|NCT02906670|25961480|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1|||
13126789|NCT02906670|25961481|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
13126790|NCT02906670|25961482|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
13126791|NCT02906670|25961483|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
13126792|NCT02906670|25961474|FG000|Cohort 5P, Q2W|Radiological Progression|0|||
13126793|NCT02906670|25961475|FG001|Cohort 5P, Q2W|Radiological Progression|0|||
13126794|NCT02906670|25961476|FG002|Cohort 5P, Q2W|Radiological Progression|0|||
13126795|NCT02906670|25961477|FG003|Cohort 5P, Q2W|Radiological Progression|0|||
13126796|NCT02906670|25961478|FG004|Cohort 5P, Q2W|Radiological Progression|0|||
13126797|NCT02906670|25961479|FG005|Cohort 5P, Q2W|Radiological Progression|0|||
13126798|NCT02906670|25961480|FG006|Cohort 5P, Q2W|Radiological Progression|0|||
13126799|NCT02906670|25961481|FG007|Cohort 5P, Q2W|Radiological Progression|2|||
13126800|NCT02906670|25961482|FG008|Cohort 5P, Q2W|Radiological Progression|0|||
13126801|NCT02906670|25961483|FG009|Cohort 5P, Q2W|Radiological Progression|0|||
13126802|NCT02906670|25961474|FG000|Cohort 5P, Q2W|Adverse Event|0|||
13126803|NCT02906670|25961475|FG001|Cohort 5P, Q2W|Adverse Event|0|||
13126804|NCT02906670|25961476|FG002|Cohort 5P, Q2W|Adverse Event|0|||
13126805|NCT02906670|25961477|FG003|Cohort 5P, Q2W|Adverse Event|0|||
13126806|NCT02906670|25961478|FG004|Cohort 5P, Q2W|Adverse Event|0|||
13126807|NCT02906670|25961479|FG005|Cohort 5P, Q2W|Adverse Event|0|||
13126808|NCT02906670|25961480|FG006|Cohort 5P, Q2W|Adverse Event|0|||
13126809|NCT02906670|25961481|FG007|Cohort 5P, Q2W|Adverse Event|1|||
13126810|NCT02906670|25961482|FG008|Cohort 5P, Q2W|Adverse Event|0|||
13126811|NCT02906670|25961483|FG009|Cohort 5P, Q2W|Adverse Event|0|||
13126812|NCT02906670|25961474|FG000|Cohort 6P, Q2W|Radiological Progression|0|||
13126813|NCT02906670|25961475|FG001|Cohort 6P, Q2W|Radiological Progression|0|||
13126814|NCT02906670|25961476|FG002|Cohort 6P, Q2W|Radiological Progression|0|||
13126815|NCT02906670|25961477|FG003|Cohort 6P, Q2W|Radiological Progression|0|||
13126816|NCT02906670|25961478|FG004|Cohort 6P, Q2W|Radiological Progression|0|||
13126817|NCT02906670|25961479|FG005|Cohort 6P, Q2W|Radiological Progression|0|||
13126818|NCT02906670|25961480|FG006|Cohort 6P, Q2W|Radiological Progression|0|||
13126819|NCT02906670|25961481|FG007|Cohort 6P, Q2W|Radiological Progression|0|||
13126820|NCT02906670|25961482|FG008|Cohort 6P, Q2W|Radiological Progression|1|||
13126821|NCT02906670|25961483|FG009|Cohort 6P, Q2W|Radiological Progression|0|||
13126822|NCT02906670|25961474|FG000|Cohort 6P, Q2W|Clinical Progression|0|||
13126823|NCT02906670|25961475|FG001|Cohort 6P, Q2W|Clinical Progression|0|||
13126824|NCT02906670|25961476|FG002|Cohort 6P, Q2W|Clinical Progression|0|||
13126825|NCT02906670|25961477|FG003|Cohort 6P, Q2W|Clinical Progression|0|||
13126826|NCT02906670|25961478|FG004|Cohort 6P, Q2W|Clinical Progression|0|||
13126827|NCT02906670|25961479|FG005|Cohort 6P, Q2W|Clinical Progression|0|||
13126828|NCT02906670|25961480|FG006|Cohort 6P, Q2W|Clinical Progression|0|||
13126829|NCT02906670|25961481|FG007|Cohort 6P, Q2W|Clinical Progression|0|||
13126830|NCT02906670|25961482|FG008|Cohort 6P, Q2W|Clinical Progression|3|||
13126831|NCT02906670|25961483|FG009|Cohort 6P, Q2W|Clinical Progression|0|||
13126832|NCT02906670|25961474|FG000|Cohort 4P, QW|Radiological Progression|0|||
13126833|NCT02906670|25961475|FG001|Cohort 4P, QW|Radiological Progression|0|||
13126834|NCT02906670|25961476|FG002|Cohort 4P, QW|Radiological Progression|0|||
13126835|NCT02906670|25961477|FG003|Cohort 4P, QW|Radiological Progression|3|||
13126836|NCT02906670|25961478|FG004|Cohort 4P, QW|Radiological Progression|0|||
13126837|NCT02906670|25961479|FG005|Cohort 4P, QW|Radiological Progression|0|||
13126838|NCT02906670|25961480|FG006|Cohort 4P, QW|Radiological Progression|0|||
13126839|NCT02906670|25961481|FG007|Cohort 4P, QW|Radiological Progression|0|||
13126840|NCT02906670|25961482|FG008|Cohort 4P, QW|Radiological Progression|0|||
13126841|NCT02906670|25961483|FG009|Cohort 4P, QW|Radiological Progression|0|||
13126842|NCT02906670|25961474|FG000|Cohort 7P, Q2W|Adverse Event|0|||
13126843|NCT02906670|25961475|FG001|Cohort 7P, Q2W|Adverse Event|0|||
13126844|NCT02906670|25961476|FG002|Cohort 7P, Q2W|Adverse Event|0|||
13126845|NCT02906670|25961477|FG003|Cohort 7P, Q2W|Adverse Event|0|||
13126846|NCT02906670|25961478|FG004|Cohort 7P, Q2W|Adverse Event|0|||
13126847|NCT02906670|25961479|FG005|Cohort 7P, Q2W|Adverse Event|0|||
13126848|NCT02906670|25961480|FG006|Cohort 7P, Q2W|Adverse Event|0|||
13126849|NCT02906670|25961481|FG007|Cohort 7P, Q2W|Adverse Event|0|||
13126850|NCT02906670|25961482|FG008|Cohort 7P, Q2W|Adverse Event|0|||
13126851|NCT02906670|25961483|FG009|Cohort 7P, Q2W|Adverse Event|1|||
13126852|NCT02906670|25961474|FG000|Cohort 7P, Q2W|Physician Decision|0|||
13126853|NCT02906670|25961475|FG001|Cohort 7P, Q2W|Physician Decision|0|||
13126854|NCT02906670|25961476|FG002|Cohort 7P, Q2W|Physician Decision|0|||
13126855|NCT02906670|25961477|FG003|Cohort 7P, Q2W|Physician Decision|0|||
13126856|NCT02906670|25961478|FG004|Cohort 7P, Q2W|Physician Decision|0|||
13126857|NCT02906670|25961479|FG005|Cohort 7P, Q2W|Physician Decision|0|||
13126858|NCT02906670|25961480|FG006|Cohort 7P, Q2W|Physician Decision|0|||
13126859|NCT02906670|25961481|FG007|Cohort 7P, Q2W|Physician Decision|0|||
13126860|NCT02906670|25961482|FG008|Cohort 7P, Q2W|Physician Decision|0|||
13126861|NCT02906670|25961483|FG009|Cohort 7P, Q2W|Physician Decision|1|||
13126862|NCT02906670|25961474|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
13126863|NCT02906670|25961475|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
13221979|NCT01808651|26285176|FG000|Study Period 1|Lost to Follow-up|1|||
13126864|NCT02906670|25961476|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
13126865|NCT02906670|25961477|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
13126866|NCT02906670|25961478|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
13126867|NCT02906670|25961479|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
13126868|NCT02906670|25961480|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
13126869|NCT02906670|25961481|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
13126870|NCT02906670|25961482|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
13126871|NCT02906670|25961483|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1|||
13126872|NCT02906670|25961474|FG000|Cohort 5P, QW|Radiological Progression|0|||
13126873|NCT02906670|25961475|FG001|Cohort 5P, QW|Radiological Progression|0|||
13126874|NCT02906670|25961476|FG002|Cohort 5P, QW|Radiological Progression|0|||
13126875|NCT02906670|25961477|FG003|Cohort 5P, QW|Radiological Progression|0|||
13126876|NCT02906670|25961478|FG004|Cohort 5P, QW|Radiological Progression|3|||
13126877|NCT02906670|25961479|FG005|Cohort 5P, QW|Radiological Progression|0|||
13126878|NCT02906670|25961480|FG006|Cohort 5P, QW|Radiological Progression|0|||
13126879|NCT02906670|25961481|FG007|Cohort 5P, QW|Radiological Progression|0|||
13126880|NCT02906670|25961482|FG008|Cohort 5P, QW|Radiological Progression|0|||
13126881|NCT02906670|25961483|FG009|Cohort 5P, QW|Radiological Progression|0|||
13126882|NCT02906644|25961506|FG000|First 2 Weeks|Withdrawal by Subject|0|||
13126883|NCT02906644|25961507|FG001|First 2 Weeks|Withdrawal by Subject|2|||
13126884|NCT02906644|25961506|FG000|First 2 Weeks|Physician Decision|1|||
13126885|NCT02906644|25961507|FG001|First 2 Weeks|Physician Decision|1|||
13126886|NCT02906644|25961506|FG000|Weeks 3 to 14|Withdrawal by Subject|13|||
13126887|NCT02906644|25961507|FG001|Weeks 3 to 14|Withdrawal by Subject|7|||
13126888|NCT02906644|25961506|FG000|Weeks 3 to 14|Lost to Follow-up|3|||
13126889|NCT02906644|25961507|FG001|Weeks 3 to 14|Lost to Follow-up|4|||
13126890|NCT02906579|25961694|FG000|Overall Study|Adverse Event|1|||
13126891|NCT02906579|25961694|FG000|Overall Study|Physician Decision|1|||
13126892|NCT02906358|25961729|FG000|Overall Study|Withdrawal by Subject|10|||
13126893|NCT02906358|25961730|FG001|Overall Study|Withdrawal by Subject|7|||
13126894|NCT02906358|25961729|FG000|Overall Study|Lost to Follow-up|12|||
13126895|NCT02906358|25961730|FG001|Overall Study|Lost to Follow-up|15|||
13126896|NCT02905435|25961751|FG000|Overall Study|Death|2|||
13126897|NCT02905435|25961751|FG000|Overall Study|Physician Decision|1|||
13126898|NCT02905435|25961751|FG000|Overall Study|Lost to Follow-up|4|||
13126899|NCT02905331|25961785|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1|||
13126900|NCT02905331|25961786|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
13126901|NCT02905331|25961787|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
13126902|NCT02905331|25961785|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2|||
13126903|NCT02905331|25961786|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
13126904|NCT02905331|25961787|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
13126905|NCT02905331|25961785|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
13126906|NCT02905331|25961786|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1|||
13126907|NCT02905331|25961787|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
13126908|NCT02905331|25961785|FG000|Active Treatment and Follow up (wk16-40)|Other|0|||
13126909|NCT02905331|25961786|FG001|Active Treatment and Follow up (wk16-40)|Other|6|||
13126910|NCT02905331|25961787|FG002|Active Treatment and Follow up (wk16-40)|Other|0|||
13126911|NCT02905331|25961785|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
13126912|NCT02905331|25961786|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2|||
13126913|NCT02905331|25961787|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
13126914|NCT02905266|25961820|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1|||
13126915|NCT02905266|25961821|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0|||
13126916|NCT02905266|25961820|FG000|Treatment Phase Part 1|Disease Progression|6|||
13126917|NCT02905266|25961821|FG001|Treatment Phase Part 1|Disease Progression|7|||
13126918|NCT02905266|25961820|FG000|Treatment Phase Part 1|Study Drug Toxicity|22|||
13126919|NCT02905266|25961821|FG001|Treatment Phase Part 1|Study Drug Toxicity|16|||
13126920|NCT02905266|25961820|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1|||
13126921|NCT02905266|25961821|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0|||
13126922|NCT02905266|25961820|FG000|Transition From Part 1 to Part 2|Disease progression|2|||
13126923|NCT02905266|25961821|FG001|Transition From Part 1 to Part 2|Disease progression|1|||
13126924|NCT02905266|25961820|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0|||
13126925|NCT02905266|25961821|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4|||
13126926|NCT02905266|25961820|FG000|Transition From Part 1 to Part 2|Death|0|||
13221980|NCT01808651|26285177|FG001|Study Period 1|Lost to Follow-up|3|||
13126927|NCT02905266|25961821|FG001|Transition From Part 1 to Part 2|Death|1|||
13126928|NCT02905266|25961820|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0|||
13126929|NCT02905266|25961821|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1|||
13126930|NCT02905266|25961820|FG000|Transition From Part 1 to Part 2|Adverse Event|1|||
13126931|NCT02905266|25961821|FG001|Transition From Part 1 to Part 2|Adverse Event|1|||
13126932|NCT02905266|25961820|FG000|Maintenance Phase Part 2|Disease Progression|9|||
13126933|NCT02905266|25961821|FG001|Maintenance Phase Part 2|Disease Progression|2|||
13126934|NCT02905266|25961820|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3|||
13126935|NCT02905266|25961821|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4|||
13126936|NCT02905266|25961820|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0|||
13126937|NCT02905266|25961821|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2|||
13126938|NCT02905149|25961840|FG000|Overall Study|Lost to Follow-up|2|||
13126939|NCT02905149|25961841|FG001|Overall Study|Lost to Follow-up|0|||
13126940|NCT02905006|25962074|FG000|Overall Study|Adverse Event|1|||
13126941|NCT02905006|25962075|FG001|Overall Study|Adverse Event|1|||
13126942|NCT02905006|25962076|FG002|Overall Study|Adverse Event|1|||
13126943|NCT02905006|25962077|FG003|Overall Study|Adverse Event|1|||
13126944|NCT02905006|25962078|FG004|Overall Study|Adverse Event|0|||
13126945|NCT02905006|25962079|FG005|Overall Study|Adverse Event|1|||
13126946|NCT02905006|25962074|FG000|Overall Study|Lack of Efficacy|1|||
13126947|NCT02905006|25962075|FG001|Overall Study|Lack of Efficacy|0|||
13126948|NCT02905006|25962076|FG002|Overall Study|Lack of Efficacy|0|||
13126949|NCT02905006|25962077|FG003|Overall Study|Lack of Efficacy|0|||
13126950|NCT02905006|25962078|FG004|Overall Study|Lack of Efficacy|0|||
13126951|NCT02905006|25962079|FG005|Overall Study|Lack of Efficacy|0|||
13126952|NCT02905006|25962074|FG000|Overall Study|Protocol Violation|2|||
13126953|NCT02905006|25962075|FG001|Overall Study|Protocol Violation|0|||
13126954|NCT02905006|25962076|FG002|Overall Study|Protocol Violation|0|||
13126955|NCT02905006|25962077|FG003|Overall Study|Protocol Violation|0|||
13126956|NCT02905006|25962078|FG004|Overall Study|Protocol Violation|0|||
13126957|NCT02905006|25962079|FG005|Overall Study|Protocol Violation|0|||
13126958|NCT02905006|25962074|FG000|Overall Study|Lost to Follow-up|0|||
13126959|NCT02905006|25962075|FG001|Overall Study|Lost to Follow-up|0|||
13126960|NCT02905006|25962076|FG002|Overall Study|Lost to Follow-up|0|||
13126961|NCT02905006|25962077|FG003|Overall Study|Lost to Follow-up|1|||
13126962|NCT02905006|25962078|FG004|Overall Study|Lost to Follow-up|1|||
13126963|NCT02905006|25962079|FG005|Overall Study|Lost to Follow-up|0|||
13126964|NCT02905006|25962074|FG000|Overall Study|Withdrawal by Subject|0|||
13126965|NCT02905006|25962075|FG001|Overall Study|Withdrawal by Subject|0|||
13126966|NCT02905006|25962076|FG002|Overall Study|Withdrawal by Subject|1|||
13126967|NCT02905006|25962077|FG003|Overall Study|Withdrawal by Subject|1|||
13126968|NCT02905006|25962078|FG004|Overall Study|Withdrawal by Subject|0|||
13126969|NCT02905006|25962079|FG005|Overall Study|Withdrawal by Subject|1|||
13126970|NCT02905006|25962074|FG000|Overall Study|Screening exclusion criteria met|1|||
13126971|NCT02905006|25962075|FG001|Overall Study|Screening exclusion criteria met|0|||
13126972|NCT02905006|25962076|FG002|Overall Study|Screening exclusion criteria met|0|||
13126973|NCT02905006|25962077|FG003|Overall Study|Screening exclusion criteria met|0|||
13126974|NCT02905006|25962078|FG004|Overall Study|Screening exclusion criteria met|0|||
13126975|NCT02905006|25962079|FG005|Overall Study|Screening exclusion criteria met|0|||
13126976|NCT02905006|25962074|FG000|Overall Study|Lab withdrawal criterion met|0|||
13126977|NCT02905006|25962075|FG001|Overall Study|Lab withdrawal criterion met|1|||
13126978|NCT02905006|25962076|FG002|Overall Study|Lab withdrawal criterion met|2|||
13126979|NCT02905006|25962077|FG003|Overall Study|Lab withdrawal criterion met|2|||
13126980|NCT02905006|25962078|FG004|Overall Study|Lab withdrawal criterion met|2|||
13126981|NCT02905006|25962079|FG005|Overall Study|Lab withdrawal criterion met|1|||
13126982|NCT02905006|25962074|FG000|Overall Study|Positive for Tuberculosis|0|||
13126983|NCT02905006|25962075|FG001|Overall Study|Positive for Tuberculosis|1|||
13126984|NCT02905006|25962076|FG002|Overall Study|Positive for Tuberculosis|0|||
13126985|NCT02905006|25962077|FG003|Overall Study|Positive for Tuberculosis|0|||
13126986|NCT02905006|25962078|FG004|Overall Study|Positive for Tuberculosis|0|||
13126987|NCT02905006|25962079|FG005|Overall Study|Positive for Tuberculosis|0|||
13126988|NCT02905006|25962074|FG000|Overall Study|Subject positive for Hep B|0|||
13126989|NCT02905006|25962075|FG001|Overall Study|Subject positive for Hep B|0|||
13126990|NCT02905006|25962076|FG002|Overall Study|Subject positive for Hep B|1|||
13126991|NCT02905006|25962077|FG003|Overall Study|Subject positive for Hep B|0|||
13126992|NCT02905006|25962078|FG004|Overall Study|Subject positive for Hep B|0|||
13126993|NCT02905006|25962079|FG005|Overall Study|Subject positive for Hep B|0|||
13126994|NCT02905006|25962074|FG000|Overall Study|Patient moved abroad|0|||
13126995|NCT02905006|25962075|FG001|Overall Study|Patient moved abroad|0|||
13126996|NCT02905006|25962076|FG002|Overall Study|Patient moved abroad|0|||
13126997|NCT02905006|25962077|FG003|Overall Study|Patient moved abroad|1|||
13126998|NCT02905006|25962078|FG004|Overall Study|Patient moved abroad|0|||
13126999|NCT02905006|25962079|FG005|Overall Study|Patient moved abroad|0|||
13127000|NCT02905006|25962074|FG000|Overall Study|Patient randomized by mistake|0|||
13127001|NCT02905006|25962075|FG001|Overall Study|Patient randomized by mistake|0|||
13127002|NCT02905006|25962076|FG002|Overall Study|Patient randomized by mistake|0|||
13127003|NCT02905006|25962077|FG003|Overall Study|Patient randomized by mistake|0|||
13127004|NCT02905006|25962078|FG004|Overall Study|Patient randomized by mistake|0|||
13127005|NCT02905006|25962079|FG005|Overall Study|Patient randomized by mistake|1|||
13127006|NCT02904902|25962088|FG000|Overall Study|Withdrawal by Subject|1|||
13127007|NCT02904512|25962105|FG000|Overall Study|Withdrawal by Subject|1|||
13127008|NCT02904512|25962106|FG001|Overall Study|Withdrawal by Subject|0|||
13127009|NCT02904512|25962105|FG000|Overall Study|Transferred to ICU|1|||
13127010|NCT02904512|25962106|FG001|Overall Study|Transferred to ICU|0|||
13127011|NCT02904512|25962105|FG000|Overall Study|Minor Bleeding at site of device insertion|1|||
13127012|NCT02904512|25962106|FG001|Overall Study|Minor Bleeding at site of device insertion|0|||
13127013|NCT02904265|25962119|FG000|Overall Study|Physician Decision|1|||
13127014|NCT02904265|25962120|FG001|Overall Study|Physician Decision|2|||
13127015|NCT02904200|25962128|FG000|Overall Study|Withdrawal by Subject|1|||
13127016|NCT02904200|25962129|FG001|Overall Study|Withdrawal by Subject|0|||
13127017|NCT02904096|25962160|FG000|Overall Study|Adverse Event|1|||
13127018|NCT02904096|25962161|FG001|Overall Study|Adverse Event|0|||
13127019|NCT02904096|25962160|FG000|Overall Study|Withdrawal by Subject|4|||
13127020|NCT02904096|25962161|FG001|Overall Study|Withdrawal by Subject|3|||
13127021|NCT02904096|25962160|FG000|Overall Study|Lost to Follow-up|10|||
13127022|NCT02904096|25962161|FG001|Overall Study|Lost to Follow-up|17|||
13127023|NCT02904096|25962160|FG000|Overall Study|Non-compliant|3|||
13127024|NCT02904096|25962161|FG001|Overall Study|Non-compliant|1|||
13127025|NCT02904096|25962160|FG000|Overall Study|Sponsor instructed|1|||
13127026|NCT02904096|25962161|FG001|Overall Study|Sponsor instructed|0|||
13127027|NCT02903966|25962234|FG000|Part A (Day 1 to 43)|Adverse Event|1|||
13127028|NCT02903966|25962235|FG001|Part A (Day 1 to 43)|Adverse Event|0|||
13127029|NCT02903966|25962234|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0|||
13127030|NCT02903966|25962235|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1|||
13127031|NCT02903966|25962234|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0|||
13127032|NCT02903966|25962235|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1|||
13127033|NCT02903914|25962280|FG000|Overall Study|Adverse Event|0|||
13127034|NCT02903914|25962281|FG001|Overall Study|Adverse Event|0|||
13127035|NCT02903914|25962282|FG002|Overall Study|Adverse Event|1|||
13127036|NCT02903914|25962283|FG003|Overall Study|Adverse Event|0|||
13127037|NCT02903914|25962284|FG004|Overall Study|Adverse Event|0|||
13127038|NCT02903914|25962285|FG005|Overall Study|Adverse Event|1|||
13127039|NCT02903914|25962286|FG006|Overall Study|Adverse Event|2|||
13127040|NCT02903914|25962287|FG007|Overall Study|Adverse Event|1|||
13127041|NCT02903914|25962280|FG000|Overall Study|Withdrawal by Subject|3|||
13127042|NCT02903914|25962281|FG001|Overall Study|Withdrawal by Subject|1|||
13127043|NCT02903914|25962282|FG002|Overall Study|Withdrawal by Subject|28|||
13127044|NCT02903914|25962283|FG003|Overall Study|Withdrawal by Subject|0|||
13127045|NCT02903914|25962284|FG004|Overall Study|Withdrawal by Subject|1|||
13127046|NCT02903914|25962285|FG005|Overall Study|Withdrawal by Subject|1|||
13127047|NCT02903914|25962286|FG006|Overall Study|Withdrawal by Subject|12|||
13127048|NCT02903914|25962287|FG007|Overall Study|Withdrawal by Subject|0|||
13127049|NCT02903914|25962280|FG000|Overall Study|Progressive Disease|1|||
13127050|NCT02903914|25962281|FG001|Overall Study|Progressive Disease|0|||
13221981|NCT01808651|26285178|FG002|Study Period 1|Lost to Follow-up|0|||
13221982|NCT01808651|26285176|FG000|Study Period 1|Protocol Violation|1|||
13127051|NCT02903914|25962282|FG002|Overall Study|Progressive Disease|4|||
13127052|NCT02903914|25962283|FG003|Overall Study|Progressive Disease|0|||
13127053|NCT02903914|25962284|FG004|Overall Study|Progressive Disease|0|||
13127054|NCT02903914|25962285|FG005|Overall Study|Progressive Disease|0|||
13127055|NCT02903914|25962286|FG006|Overall Study|Progressive Disease|2|||
13127056|NCT02903914|25962287|FG007|Overall Study|Progressive Disease|4|||
13127057|NCT02903914|25962280|FG000|Overall Study|Death|0|||
13127058|NCT02903914|25962281|FG001|Overall Study|Death|0|||
13127059|NCT02903914|25962282|FG002|Overall Study|Death|9|||
13127060|NCT02903914|25962283|FG003|Overall Study|Death|0|||
13127061|NCT02903914|25962284|FG004|Overall Study|Death|1|||
13127062|NCT02903914|25962285|FG005|Overall Study|Death|3|||
13127063|NCT02903914|25962286|FG006|Overall Study|Death|24|||
13127064|NCT02903914|25962287|FG007|Overall Study|Death|0|||
13127065|NCT02903914|25962280|FG000|Overall Study|Lost to Follow-up|0|||
13127066|NCT02903914|25962281|FG001|Overall Study|Lost to Follow-up|1|||
13127067|NCT02903914|25962282|FG002|Overall Study|Lost to Follow-up|0|||
13127068|NCT02903914|25962283|FG003|Overall Study|Lost to Follow-up|0|||
13127069|NCT02903914|25962284|FG004|Overall Study|Lost to Follow-up|2|||
13127070|NCT02903914|25962285|FG005|Overall Study|Lost to Follow-up|0|||
13127071|NCT02903914|25962286|FG006|Overall Study|Lost to Follow-up|1|||
13127072|NCT02903914|25962287|FG007|Overall Study|Lost to Follow-up|0|||
13127073|NCT02903914|25962280|FG000|Overall Study|Physician Decision|0|||
13127074|NCT02903914|25962281|FG001|Overall Study|Physician Decision|0|||
13127075|NCT02903914|25962282|FG002|Overall Study|Physician Decision|1|||
13127076|NCT02903914|25962283|FG003|Overall Study|Physician Decision|0|||
13127077|NCT02903914|25962284|FG004|Overall Study|Physician Decision|0|||
13127078|NCT02903914|25962285|FG005|Overall Study|Physician Decision|0|||
13127079|NCT02903914|25962286|FG006|Overall Study|Physician Decision|1|||
13127080|NCT02903914|25962287|FG007|Overall Study|Physician Decision|0|||
13127081|NCT02903914|25962280|FG000|Overall Study|Symptomatic Deterioration|0|||
13221983|NCT01808651|26285177|FG001|Study Period 1|Protocol Violation|0|||
13221984|NCT01808651|26285178|FG002|Study Period 1|Protocol Violation|1|||
13221985|NCT01808651|26285176|FG000|Study Period 1|Physician Decision|3|||
13221986|NCT01808651|26285177|FG001|Study Period 1|Physician Decision|2|||
13221987|NCT01808651|26285178|FG002|Study Period 1|Physician Decision|0|||
13221988|NCT01808651|26285176|FG000|Study Period 1|Lack of Efficacy|2|||
13221989|NCT01808651|26285177|FG001|Study Period 1|Lack of Efficacy|1|||
13221990|NCT01808651|26285178|FG002|Study Period 1|Lack of Efficacy|0|||
13221991|NCT01808651|26285176|FG000|Study Period 1|Adverse Event|10|||
13221992|NCT01808651|26285177|FG001|Study Period 1|Adverse Event|4|||
13221993|NCT01808651|26285178|FG002|Study Period 1|Adverse Event|1|||
13221994|NCT01808651|26285176|FG000|Study Period 1|Participant Decision|9|||
13221995|NCT01808651|26285177|FG001|Study Period 1|Participant Decision|7|||
13221996|NCT01808651|26285178|FG002|Study Period 1|Participant Decision|3|||
13221997|NCT01808612|26285217|FG000|Treatment Period|Adverse Event|8|||
13221998|NCT01808612|26285218|FG001|Treatment Period|Adverse Event|4|||
13221999|NCT01808612|26285219|FG002|Treatment Period|Adverse Event|3|||
13222000|NCT01808612|26285217|FG000|Treatment Period|Lost to Follow-up|2|||
13222001|NCT01808612|26285218|FG001|Treatment Period|Lost to Follow-up|2|||
13222002|NCT01808612|26285219|FG002|Treatment Period|Lost to Follow-up|1|||
13222003|NCT01808612|26285217|FG000|Treatment Period|Protocol Violation|1|||
13222004|NCT01808612|26285218|FG001|Treatment Period|Protocol Violation|0|||
13222005|NCT01808612|26285219|FG002|Treatment Period|Protocol Violation|0|||
13222006|NCT01808612|26285217|FG000|Treatment Period|Withdrawal by Subject|1|||
13222007|NCT01808612|26285218|FG001|Treatment Period|Withdrawal by Subject|0|||
13222008|NCT01808612|26285219|FG002|Treatment Period|Withdrawal by Subject|4|||
13222009|NCT01808612|26285217|FG000|Treatment Period|Physician Decision|1|||
13222010|NCT01808612|26285218|FG001|Treatment Period|Physician Decision|0|||
13222011|NCT01808612|26285219|FG002|Treatment Period|Physician Decision|4|||
13222012|NCT01808612|26285217|FG000|Treatment Period|Sponsor Decision|1|||
13222013|NCT01808612|26285218|FG001|Treatment Period|Sponsor Decision|0|||
13222014|NCT01808612|26285219|FG002|Treatment Period|Sponsor Decision|0|||
13222015|NCT01808612|26285217|FG000|Treatment Period|Lack of Efficacy|1|||
13222016|NCT01808612|26285218|FG001|Treatment Period|Lack of Efficacy|1|||
13222017|NCT01808612|26285219|FG002|Treatment Period|Lack of Efficacy|2|||
13222018|NCT01808612|26285217|FG000|Discontinuation Period|Adverse Event|1|||
13222019|NCT01808612|26285218|FG001|Discontinuation Period|Adverse Event|0|||
13222020|NCT01808612|26285219|FG002|Discontinuation Period|Adverse Event|0|||
13127082|NCT02903914|25962281|FG001|Overall Study|Symptomatic Deterioration|0|||
13127083|NCT02903914|25962282|FG002|Overall Study|Symptomatic Deterioration|1|||
13127084|NCT02903914|25962283|FG003|Overall Study|Symptomatic Deterioration|0|||
13127085|NCT02903914|25962284|FG004|Overall Study|Symptomatic Deterioration|0|||
13222021|NCT01808612|26285217|FG000|Discontinuation Period|Physician Decision|1|||
13222022|NCT01808612|26285218|FG001|Discontinuation Period|Physician Decision|0|||
13127086|NCT02903914|25962285|FG005|Overall Study|Symptomatic Deterioration|0|||
13127087|NCT02903914|25962286|FG006|Overall Study|Symptomatic Deterioration|0|||
13127088|NCT02903914|25962287|FG007|Overall Study|Symptomatic Deterioration|0|||
13127089|NCT02903914|25962280|FG000|Overall Study|New Cancer Therapy|2|||
13127090|NCT02903914|25962281|FG001|Overall Study|New Cancer Therapy|2|||
13127091|NCT02903914|25962282|FG002|Overall Study|New Cancer Therapy|21|||
13127092|NCT02903914|25962283|FG003|Overall Study|New Cancer Therapy|4|||
13127093|NCT02903914|25962284|FG004|Overall Study|New Cancer Therapy|3|||
13127094|NCT02903914|25962285|FG005|Overall Study|New Cancer Therapy|6|||
13127095|NCT02903914|25962286|FG006|Overall Study|New Cancer Therapy|55|||
13127096|NCT02903914|25962287|FG007|Overall Study|New Cancer Therapy|0|||
13127097|NCT02903914|25962280|FG000|Overall Study|Reasoning not specified|2|||
13127098|NCT02903914|25962281|FG001|Overall Study|Reasoning not specified|3|||
13127099|NCT02903914|25962282|FG002|Overall Study|Reasoning not specified|20|||
13127100|NCT02903914|25962283|FG003|Overall Study|Reasoning not specified|3|||
13127101|NCT02903914|25962284|FG004|Overall Study|Reasoning not specified|3|||
13127102|NCT02903914|25962285|FG005|Overall Study|Reasoning not specified|3|||
13127103|NCT02903914|25962286|FG006|Overall Study|Reasoning not specified|20|||
13127104|NCT02903914|25962287|FG007|Overall Study|Reasoning not specified|0|||
13127105|NCT02903511|25962306|FG000|Overall Study|Withdrawal by Subject|1|||
13127106|NCT02903511|25962307|FG001|Overall Study|Withdrawal by Subject|0|||
13127107|NCT02903511|25962306|FG000|Overall Study|Lost to Follow-up|3|||
13127108|NCT02903511|25962307|FG001|Overall Study|Lost to Follow-up|2|||
13127109|NCT02903238|25962318|FG000|Overall Study|Lost to Follow-up|4|||
13127110|NCT02903030|25962343|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
13127111|NCT02903030|25962344|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
13127112|NCT02902965|25962356|FG000|Overall Study|Withdrawal by Subject|10|||
13127113|NCT02902809|25962366|FG000|Overall Study|Discontinuation of asthma program|28|||
13127114|NCT02902120|25962378|FG000|Overall Study|Lack of Efficacy|1|||
13127115|NCT02901548|25962385|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4|||
13127116|NCT02901431|25962460|FG000|PK Part|Adverse Event|0|||
13127117|NCT02901431|25962461|FG001|PK Part|Adverse Event|1|||
13127118|NCT02901431|25962462|FG002|PK Part|Adverse Event|0|||
13127119|NCT02901431|25962463|FG003|PK Part|Adverse Event|0|||
13127120|NCT02901431|25962464|FG004|PK Part|Adverse Event|0|||
13127121|NCT02901431|25962465|FG005|PK Part|Adverse Event|0|||
13127122|NCT02901431|25962466|FG006|PK Part|Adverse Event|0|||
13127123|NCT02901431|25962467|FG007|PK Part|Adverse Event|0|||
13127124|NCT02901431|25962468|FG008|PK Part|Adverse Event|0|||
13127125|NCT02901431|25962469|FG009|PK Part|Adverse Event|0|||
13127126|NCT02901431|25962470|FG010|PK Part|Adverse Event|0|||
13127127|NCT02901431|25962471|FG011|PK Part|Adverse Event|0|||
13127128|NCT02901431|25962472|FG012|PK Part|Adverse Event|0|||
13127129|NCT02901431|25962460|FG000|PK Part|Lost to Follow-up|0|||
13127130|NCT02901431|25962461|FG001|PK Part|Lost to Follow-up|0|||
13127131|NCT02901431|25962462|FG002|PK Part|Lost to Follow-up|1|||
13127132|NCT02901431|25962463|FG003|PK Part|Lost to Follow-up|0|||
13127133|NCT02901431|25962464|FG004|PK Part|Lost to Follow-up|0|||
13127134|NCT02901431|25962465|FG005|PK Part|Lost to Follow-up|0|||
13127135|NCT02901431|25962466|FG006|PK Part|Lost to Follow-up|0|||
13127136|NCT02901431|25962467|FG007|PK Part|Lost to Follow-up|0|||
13127137|NCT02901431|25962468|FG008|PK Part|Lost to Follow-up|0|||
13127138|NCT02901431|25962469|FG009|PK Part|Lost to Follow-up|0|||
13127139|NCT02901431|25962470|FG010|PK Part|Lost to Follow-up|0|||
13127140|NCT02901431|25962471|FG011|PK Part|Lost to Follow-up|0|||
13127141|NCT02901431|25962472|FG012|PK Part|Lost to Follow-up|0|||
13127142|NCT02901431|25962460|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2|||
13127143|NCT02901431|25962461|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0|||
13127144|NCT02901431|25962462|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0|||
13127145|NCT02901431|25962463|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0|||
13127146|NCT02901431|25962464|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0|||
13127147|NCT02901431|25962465|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0|||
13127148|NCT02901431|25962466|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0|||
13127149|NCT02901431|25962467|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0|||
13127150|NCT02901431|25962468|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0|||
13127151|NCT02901431|25962469|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0|||
13127152|NCT02901431|25962470|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0|||
13127153|NCT02901431|25962471|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0|||
13127154|NCT02901431|25962472|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0|||
13127155|NCT02901431|25962460|FG000|PK Part|Pending dose confirmation|0|||
13127156|NCT02901431|25962461|FG001|PK Part|Pending dose confirmation|1|||
13127157|NCT02901431|25962462|FG002|PK Part|Pending dose confirmation|0|||
13127158|NCT02901431|25962463|FG003|PK Part|Pending dose confirmation|0|||
13127159|NCT02901431|25962464|FG004|PK Part|Pending dose confirmation|0|||
13127160|NCT02901431|25962465|FG005|PK Part|Pending dose confirmation|0|||
13127161|NCT02901431|25962466|FG006|PK Part|Pending dose confirmation|0|||
13127162|NCT02901431|25962467|FG007|PK Part|Pending dose confirmation|0|||
13127163|NCT02901431|25962468|FG008|PK Part|Pending dose confirmation|0|||
13127164|NCT02901431|25962469|FG009|PK Part|Pending dose confirmation|0|||
13127165|NCT02901431|25962470|FG010|PK Part|Pending dose confirmation|0|||
13127166|NCT02901431|25962471|FG011|PK Part|Pending dose confirmation|0|||
13127167|NCT02901431|25962472|FG012|PK Part|Pending dose confirmation|0|||
13127168|NCT02901431|25962460|FG000|PK Part|8 weeks of treatment ran out|2|||
13127169|NCT02901431|25962461|FG001|PK Part|8 weeks of treatment ran out|0|||
13127170|NCT02901431|25962462|FG002|PK Part|8 weeks of treatment ran out|0|||
13127171|NCT02901431|25962463|FG003|PK Part|8 weeks of treatment ran out|0|||
13127172|NCT02901431|25962464|FG004|PK Part|8 weeks of treatment ran out|0|||
13127173|NCT02901431|25962465|FG005|PK Part|8 weeks of treatment ran out|0|||
13127174|NCT02901431|25962466|FG006|PK Part|8 weeks of treatment ran out|0|||
13127175|NCT02901431|25962467|FG007|PK Part|8 weeks of treatment ran out|0|||
13127176|NCT02901431|25962468|FG008|PK Part|8 weeks of treatment ran out|0|||
13127177|NCT02901431|25962469|FG009|PK Part|8 weeks of treatment ran out|0|||
13127178|NCT02901431|25962470|FG010|PK Part|8 weeks of treatment ran out|0|||
13127179|NCT02901431|25962471|FG011|PK Part|8 weeks of treatment ran out|0|||
13127180|NCT02901431|25962472|FG012|PK Part|8 weeks of treatment ran out|0|||
13127181|NCT02901431|25962460|FG000|PK Part|Stopped treatment after 8 weeks|1|||
13127182|NCT02901431|25962461|FG001|PK Part|Stopped treatment after 8 weeks|0|||
13127183|NCT02901431|25962462|FG002|PK Part|Stopped treatment after 8 weeks|1|||
13127184|NCT02901431|25962463|FG003|PK Part|Stopped treatment after 8 weeks|0|||
13127185|NCT02901431|25962464|FG004|PK Part|Stopped treatment after 8 weeks|0|||
13127186|NCT02901431|25962465|FG005|PK Part|Stopped treatment after 8 weeks|0|||
13127187|NCT02901431|25962466|FG006|PK Part|Stopped treatment after 8 weeks|0|||
13127188|NCT02901431|25962467|FG007|PK Part|Stopped treatment after 8 weeks|0|||
13127189|NCT02901431|25962468|FG008|PK Part|Stopped treatment after 8 weeks|0|||
13127190|NCT02901431|25962469|FG009|PK Part|Stopped treatment after 8 weeks|0|||
13127191|NCT02901431|25962470|FG010|PK Part|Stopped treatment after 8 weeks|0|||
13127192|NCT02901431|25962471|FG011|PK Part|Stopped treatment after 8 weeks|0|||
13127193|NCT02901431|25962472|FG012|PK Part|Stopped treatment after 8 weeks|0|||
13127194|NCT02901431|25962460|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1|||
13127195|NCT02901431|25962461|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
13127196|NCT02901431|25962462|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4|||
13127197|NCT02901431|25962463|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
13127198|NCT02901431|25962464|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
13127199|NCT02901431|25962465|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
13127200|NCT02901431|25962466|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
13127201|NCT02901431|25962467|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
13127202|NCT02901431|25962468|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
13127203|NCT02901431|25962469|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
13127204|NCT02901431|25962470|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
13127205|NCT02901431|25962471|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
13127206|NCT02901431|25962472|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
13127207|NCT02901431|25962460|FG000|PK Part|Discontinued per Sponsor|0|||
13127208|NCT02901431|25962461|FG001|PK Part|Discontinued per Sponsor|3|||
13127209|NCT02901431|25962462|FG002|PK Part|Discontinued per Sponsor|0|||
13127210|NCT02901431|25962463|FG003|PK Part|Discontinued per Sponsor|0|||
13127211|NCT02901431|25962464|FG004|PK Part|Discontinued per Sponsor|0|||
13127212|NCT02901431|25962465|FG005|PK Part|Discontinued per Sponsor|0|||
13127213|NCT02901431|25962466|FG006|PK Part|Discontinued per Sponsor|0|||
13127214|NCT02901431|25962467|FG007|PK Part|Discontinued per Sponsor|0|||
13127215|NCT02901431|25962468|FG008|PK Part|Discontinued per Sponsor|0|||
13127216|NCT02901431|25962469|FG009|PK Part|Discontinued per Sponsor|0|||
13127217|NCT02901431|25962470|FG010|PK Part|Discontinued per Sponsor|0|||
13127218|NCT02901431|25962471|FG011|PK Part|Discontinued per Sponsor|0|||
13127219|NCT02901431|25962472|FG012|PK Part|Discontinued per Sponsor|0|||
13127220|NCT02901431|25962460|FG000|PK Part|Withdrawal by Subject|1|||
13127221|NCT02901431|25962461|FG001|PK Part|Withdrawal by Subject|1|||
13127222|NCT02901431|25962462|FG002|PK Part|Withdrawal by Subject|3|||
13127223|NCT02901431|25962463|FG003|PK Part|Withdrawal by Subject|0|||
13127224|NCT02901431|25962464|FG004|PK Part|Withdrawal by Subject|0|||
13127225|NCT02901431|25962465|FG005|PK Part|Withdrawal by Subject|0|||
13127226|NCT02901431|25962466|FG006|PK Part|Withdrawal by Subject|0|||
13127227|NCT02901431|25962467|FG007|PK Part|Withdrawal by Subject|0|||
13127228|NCT02901431|25962468|FG008|PK Part|Withdrawal by Subject|0|||
13127229|NCT02901431|25962469|FG009|PK Part|Withdrawal by Subject|0|||
13127230|NCT02901431|25962470|FG010|PK Part|Withdrawal by Subject|0|||
13127231|NCT02901431|25962471|FG011|PK Part|Withdrawal by Subject|0|||
13127232|NCT02901431|25962472|FG012|PK Part|Withdrawal by Subject|0|||
13127233|NCT02901431|25962460|FG000|Main Treatment Part|Adverse Event|0|||
13127234|NCT02901431|25962461|FG001|Main Treatment Part|Adverse Event|0|||
13127235|NCT02901431|25962462|FG002|Main Treatment Part|Adverse Event|0|||
13127236|NCT02901431|25962463|FG003|Main Treatment Part|Adverse Event|3|||
13127237|NCT02901431|25962464|FG004|Main Treatment Part|Adverse Event|3|||
13127238|NCT02901431|25962465|FG005|Main Treatment Part|Adverse Event|4|||
13127239|NCT02901431|25962466|FG006|Main Treatment Part|Adverse Event|1|||
13127240|NCT02901431|25962467|FG007|Main Treatment Part|Adverse Event|0|||
13127241|NCT02901431|25962468|FG008|Main Treatment Part|Adverse Event|0|||
13127242|NCT02901431|25962469|FG009|Main Treatment Part|Adverse Event|0|||
13127243|NCT02901431|25962470|FG010|Main Treatment Part|Adverse Event|0|||
13127244|NCT02901431|25962471|FG011|Main Treatment Part|Adverse Event|0|||
13127245|NCT02901431|25962472|FG012|Main Treatment Part|Adverse Event|0|||
13127246|NCT02901431|25962460|FG000|Main Treatment Part|Lack of Efficacy|0|||
13127247|NCT02901431|25962461|FG001|Main Treatment Part|Lack of Efficacy|0|||
13127248|NCT02901431|25962462|FG002|Main Treatment Part|Lack of Efficacy|0|||
13127249|NCT02901431|25962463|FG003|Main Treatment Part|Lack of Efficacy|1|||
13127250|NCT02901431|25962464|FG004|Main Treatment Part|Lack of Efficacy|0|||
13127251|NCT02901431|25962465|FG005|Main Treatment Part|Lack of Efficacy|0|||
13127252|NCT02901431|25962466|FG006|Main Treatment Part|Lack of Efficacy|0|||
13127253|NCT02901431|25962467|FG007|Main Treatment Part|Lack of Efficacy|0|||
13127254|NCT02901431|25962468|FG008|Main Treatment Part|Lack of Efficacy|0|||
13127255|NCT02901431|25962469|FG009|Main Treatment Part|Lack of Efficacy|0|||
13127256|NCT02901431|25962470|FG010|Main Treatment Part|Lack of Efficacy|0|||
13127257|NCT02901431|25962471|FG011|Main Treatment Part|Lack of Efficacy|0|||
13487966|NCT01464164|27041905|FG002|Overall Study|Physician Decision|0|||
13127258|NCT02901431|25962472|FG012|Main Treatment Part|Lack of Efficacy|0|||
13127259|NCT02901431|25962460|FG000|Main Treatment Part|Lost to Follow-up|0|||
13127260|NCT02901431|25962461|FG001|Main Treatment Part|Lost to Follow-up|0|||
13127261|NCT02901431|25962462|FG002|Main Treatment Part|Lost to Follow-up|0|||
13127262|NCT02901431|25962463|FG003|Main Treatment Part|Lost to Follow-up|3|||
13127263|NCT02901431|25962464|FG004|Main Treatment Part|Lost to Follow-up|1|||
13127264|NCT02901431|25962465|FG005|Main Treatment Part|Lost to Follow-up|2|||
13487967|NCT01464164|27041906|FG003|Overall Study|Physician Decision|0|||
13487968|NCT01464164|27041907|FG004|Overall Study|Physician Decision|0|||
13487969|NCT01464164|27041908|FG005|Overall Study|Physician Decision|0|||
13487970|NCT01464164|27041909|FG006|Overall Study|Physician Decision|2|||
13487971|NCT01111565|27041931|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3|||
13487972|NCT01111565|27041932|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
13487973|NCT01111565|27041933|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
13487974|NCT01111565|27041934|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
13487975|NCT01111565|27041935|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
13487976|NCT01111565|27041931|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1|||
13487977|NCT01111565|27041932|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0|||
13127265|NCT02901431|25962466|FG006|Main Treatment Part|Lost to Follow-up|3|||
13127266|NCT02901431|25962467|FG007|Main Treatment Part|Lost to Follow-up|0|||
13127267|NCT02901431|25962468|FG008|Main Treatment Part|Lost to Follow-up|0|||
13127268|NCT02901431|25962469|FG009|Main Treatment Part|Lost to Follow-up|0|||
13127269|NCT02901431|25962470|FG010|Main Treatment Part|Lost to Follow-up|0|||
13127270|NCT02901431|25962471|FG011|Main Treatment Part|Lost to Follow-up|0|||
13127271|NCT02901431|25962472|FG012|Main Treatment Part|Lost to Follow-up|0|||
13127272|NCT02901431|25962460|FG000|Main Treatment Part|Withdrawal by Caregiver|0|||
13127273|NCT02901431|25962461|FG001|Main Treatment Part|Withdrawal by Caregiver|0|||
13127274|NCT02901431|25962462|FG002|Main Treatment Part|Withdrawal by Caregiver|0|||
13127275|NCT02901431|25962463|FG003|Main Treatment Part|Withdrawal by Caregiver|0|||
13127276|NCT02901431|25962464|FG004|Main Treatment Part|Withdrawal by Caregiver|0|||
13127277|NCT02901431|25962465|FG005|Main Treatment Part|Withdrawal by Caregiver|1|||
13127278|NCT02901431|25962466|FG006|Main Treatment Part|Withdrawal by Caregiver|0|||
13127279|NCT02901431|25962467|FG007|Main Treatment Part|Withdrawal by Caregiver|0|||
13127280|NCT02901431|25962468|FG008|Main Treatment Part|Withdrawal by Caregiver|0|||
13127281|NCT02901431|25962469|FG009|Main Treatment Part|Withdrawal by Caregiver|0|||
13127282|NCT02901431|25962470|FG010|Main Treatment Part|Withdrawal by Caregiver|0|||
13127283|NCT02901431|25962471|FG011|Main Treatment Part|Withdrawal by Caregiver|0|||
13127284|NCT02901431|25962472|FG012|Main Treatment Part|Withdrawal by Caregiver|0|||
13127285|NCT02901431|25962460|FG000|Main Treatment Part|Physician Decision|0|||
13127286|NCT02901431|25962461|FG001|Main Treatment Part|Physician Decision|0|||
13127287|NCT02901431|25962462|FG002|Main Treatment Part|Physician Decision|0|||
13127288|NCT02901431|25962463|FG003|Main Treatment Part|Physician Decision|1|||
13127289|NCT02901431|25962464|FG004|Main Treatment Part|Physician Decision|0|||
13127290|NCT02901431|25962465|FG005|Main Treatment Part|Physician Decision|0|||
13127291|NCT02901431|25962466|FG006|Main Treatment Part|Physician Decision|1|||
13127292|NCT02901431|25962467|FG007|Main Treatment Part|Physician Decision|0|||
13127293|NCT02901431|25962468|FG008|Main Treatment Part|Physician Decision|0|||
13127294|NCT02901431|25962469|FG009|Main Treatment Part|Physician Decision|0|||
13127295|NCT02901431|25962470|FG010|Main Treatment Part|Physician Decision|0|||
13127296|NCT02901431|25962471|FG011|Main Treatment Part|Physician Decision|0|||
13127297|NCT02901431|25962472|FG012|Main Treatment Part|Physician Decision|0|||
13127298|NCT02901431|25962460|FG000|Main Treatment Part|Withdrawal by Subject|0|||
13127299|NCT02901431|25962461|FG001|Main Treatment Part|Withdrawal by Subject|0|||
13127300|NCT02901431|25962462|FG002|Main Treatment Part|Withdrawal by Subject|0|||
13127301|NCT02901431|25962463|FG003|Main Treatment Part|Withdrawal by Subject|18|||
13127302|NCT02901431|25962464|FG004|Main Treatment Part|Withdrawal by Subject|3|||
13127303|NCT02901431|25962465|FG005|Main Treatment Part|Withdrawal by Subject|5|||
13127304|NCT02901431|25962466|FG006|Main Treatment Part|Withdrawal by Subject|6|||
13127305|NCT02901431|25962467|FG007|Main Treatment Part|Withdrawal by Subject|0|||
13127306|NCT02901431|25962468|FG008|Main Treatment Part|Withdrawal by Subject|0|||
13127307|NCT02901431|25962469|FG009|Main Treatment Part|Withdrawal by Subject|0|||
13127308|NCT02901431|25962470|FG010|Main Treatment Part|Withdrawal by Subject|0|||
13127309|NCT02901431|25962471|FG011|Main Treatment Part|Withdrawal by Subject|0|||
13127310|NCT02901431|25962472|FG012|Main Treatment Part|Withdrawal by Subject|0|||
13127311|NCT02901431|25962460|FG000|Open Label Part|Adverse Event|0|||
13127312|NCT02901431|25962461|FG001|Open Label Part|Adverse Event|0|||
13127313|NCT02901431|25962462|FG002|Open Label Part|Adverse Event|0|||
13127314|NCT02901431|25962463|FG003|Open Label Part|Adverse Event|0|||
13127315|NCT02901431|25962464|FG004|Open Label Part|Adverse Event|0|||
13127316|NCT02901431|25962465|FG005|Open Label Part|Adverse Event|0|||
13127317|NCT02901431|25962466|FG006|Open Label Part|Adverse Event|0|||
13127318|NCT02901431|25962467|FG007|Open Label Part|Adverse Event|0|||
13127319|NCT02901431|25962468|FG008|Open Label Part|Adverse Event|4|||
13127320|NCT02901431|25962469|FG009|Open Label Part|Adverse Event|4|||
13127321|NCT02901431|25962470|FG010|Open Label Part|Adverse Event|0|||
13127322|NCT02901431|25962471|FG011|Open Label Part|Adverse Event|4|||
13127323|NCT02901431|25962472|FG012|Open Label Part|Adverse Event|1|||
13127324|NCT02901431|25962460|FG000|Open Label Part|Lost to Follow-up|0|||
13127325|NCT02901431|25962461|FG001|Open Label Part|Lost to Follow-up|0|||
13127326|NCT02901431|25962462|FG002|Open Label Part|Lost to Follow-up|0|||
13127327|NCT02901431|25962463|FG003|Open Label Part|Lost to Follow-up|0|||
13127328|NCT02901431|25962464|FG004|Open Label Part|Lost to Follow-up|0|||
13127329|NCT02901431|25962465|FG005|Open Label Part|Lost to Follow-up|0|||
13127330|NCT02901431|25962466|FG006|Open Label Part|Lost to Follow-up|0|||
13127331|NCT02901431|25962467|FG007|Open Label Part|Lost to Follow-up|0|||
13127332|NCT02901431|25962468|FG008|Open Label Part|Lost to Follow-up|2|||
13127333|NCT02901431|25962469|FG009|Open Label Part|Lost to Follow-up|2|||
13127334|NCT02901431|25962470|FG010|Open Label Part|Lost to Follow-up|1|||
13127335|NCT02901431|25962471|FG011|Open Label Part|Lost to Follow-up|1|||
13127336|NCT02901431|25962472|FG012|Open Label Part|Lost to Follow-up|1|||
13127337|NCT02901431|25962460|FG000|Open Label Part|Physician Decision|0|||
13127338|NCT02901431|25962461|FG001|Open Label Part|Physician Decision|0|||
13127339|NCT02901431|25962462|FG002|Open Label Part|Physician Decision|0|||
13127340|NCT02901431|25962463|FG003|Open Label Part|Physician Decision|0|||
13127341|NCT02901431|25962464|FG004|Open Label Part|Physician Decision|0|||
13127342|NCT02901431|25962465|FG005|Open Label Part|Physician Decision|0|||
13127343|NCT02901431|25962466|FG006|Open Label Part|Physician Decision|0|||
13127344|NCT02901431|25962467|FG007|Open Label Part|Physician Decision|0|||
13127345|NCT02901431|25962468|FG008|Open Label Part|Physician Decision|1|||
13127346|NCT02901431|25962469|FG009|Open Label Part|Physician Decision|1|||
13127347|NCT02901431|25962470|FG010|Open Label Part|Physician Decision|0|||
13127348|NCT02901431|25962471|FG011|Open Label Part|Physician Decision|0|||
13127349|NCT02901431|25962472|FG012|Open Label Part|Physician Decision|0|||
13127350|NCT02901431|25962460|FG000|Open Label Part|Study Terminated By Sponsor|0|||
13127351|NCT02901431|25962461|FG001|Open Label Part|Study Terminated By Sponsor|0|||
13127352|NCT02901431|25962462|FG002|Open Label Part|Study Terminated By Sponsor|0|||
13127353|NCT02901431|25962463|FG003|Open Label Part|Study Terminated By Sponsor|0|||
13127354|NCT02901431|25962464|FG004|Open Label Part|Study Terminated By Sponsor|0|||
13127355|NCT02901431|25962465|FG005|Open Label Part|Study Terminated By Sponsor|0|||
13127356|NCT02901431|25962466|FG006|Open Label Part|Study Terminated By Sponsor|0|||
13135705|NCT02737358|25996085|FG001|Overall Study|Withdrawal by Subject|12|||
13135706|NCT02737358|25996084|FG000|Overall Study|Lost to Follow-up|2|||
13135707|NCT02737358|25996085|FG001|Overall Study|Lost to Follow-up|3|||
13135708|NCT02736890|25996112|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1|||
13135709|NCT02736890|25996113|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2|||
13135710|NCT02736890|25996112|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1|||
13135711|NCT02736890|25996113|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0|||
13135712|NCT02736825|25996160|FG000|Overall Study|Lost to Follow-up|10|||
13135713|NCT02736825|25996161|FG001|Overall Study|Lost to Follow-up|11|||
13135714|NCT02736825|25996160|FG000|Overall Study|Early Termination|0|||
13135715|NCT02736825|25996161|FG001|Overall Study|Early Termination|1|||
13135716|NCT02736721|25996172|FG000|Overall Study|Adverse Event|8|||
13135717|NCT02736721|25996172|FG000|Overall Study|Lost to Follow-up|3|||
13135718|NCT02736721|25996172|FG000|Overall Study|Other|5|||
13135719|NCT02736578|25996197|FG000|Overall Study|Adverse Event|1|||
13135720|NCT02736578|25996198|FG001|Overall Study|Adverse Event|0|||
13135721|NCT02736474|25996239|FG000|Overall Study|Lost to Follow-up|0|||
13135722|NCT02736474|25996240|FG001|Overall Study|Lost to Follow-up|1|||
13135723|NCT02736409|25996393|FG000|Overall Study|Withdrawal by Subject|4|||
13135724|NCT02736409|25996394|FG001|Overall Study|Withdrawal by Subject|2|||
13135725|NCT02736409|25996395|FG002|Overall Study|Withdrawal by Subject|17|||
13135726|NCT02736409|25996396|FG003|Overall Study|Withdrawal by Subject|3|||
13135727|NCT02736409|25996393|FG000|Overall Study|Non-Compliance with Study Drug|0|||
13135728|NCT02736409|25996394|FG001|Overall Study|Non-Compliance with Study Drug|0|||
13135729|NCT02736409|25996395|FG002|Overall Study|Non-Compliance with Study Drug|0|||
13135730|NCT02736409|25996396|FG003|Overall Study|Non-Compliance with Study Drug|1|||
13135731|NCT02736409|25996393|FG000|Overall Study|Adverse Event|0|||
13135732|NCT02736409|25996394|FG001|Overall Study|Adverse Event|1|||
13135733|NCT02736409|25996395|FG002|Overall Study|Adverse Event|5|||
13135734|NCT02736409|25996396|FG003|Overall Study|Adverse Event|4|||
13135735|NCT02736409|25996393|FG000|Overall Study|Other|0|||
13135736|NCT02736409|25996394|FG001|Overall Study|Other|0|||
13135737|NCT02736409|25996395|FG002|Overall Study|Other|1|||
13135738|NCT02736409|25996396|FG003|Overall Study|Other|1|||
13135739|NCT02736409|25996393|FG000|Overall Study|Pregnancy|0|||
13135740|NCT02736409|25996394|FG001|Overall Study|Pregnancy|0|||
13135741|NCT02736409|25996395|FG002|Overall Study|Pregnancy|1|||
13135742|NCT02736409|25996396|FG003|Overall Study|Pregnancy|0|||
13135743|NCT02736409|25996393|FG000|Overall Study|Lost to Follow-up|0|||
13135744|NCT02736409|25996394|FG001|Overall Study|Lost to Follow-up|0|||
13135745|NCT02736409|25996395|FG002|Overall Study|Lost to Follow-up|2|||
13135746|NCT02736409|25996396|FG003|Overall Study|Lost to Follow-up|1|||
13135747|NCT02736409|25996393|FG000|Overall Study|Physician Decision|0|||
13135748|NCT02736409|25996394|FG001|Overall Study|Physician Decision|0|||
13135749|NCT02736409|25996395|FG002|Overall Study|Physician Decision|0|||
13135750|NCT02736409|25996396|FG003|Overall Study|Physician Decision|2|||
13135751|NCT02736188|25996422|FG000|Overall Study|Discontinuation of Study by Sponsor|134|||
13135752|NCT02736188|25996422|FG000|Overall Study|Adverse Event|1|||
13135753|NCT02736188|25996422|FG000|Overall Study|Withdrawal by Subject|1|||
13135754|NCT02736188|25996422|FG000|Overall Study|Other|6|||
13135755|NCT02735980|25996461|FG000|Overall Study|Adverse Event|0|||
13135756|NCT02735980|25996462|FG001|Overall Study|Adverse Event|4|||
13135757|NCT02735980|25996463|FG002|Overall Study|Adverse Event|1|||
13135758|NCT02735980|25996461|FG000|Overall Study|Death|5|||
13135759|NCT02735980|25996462|FG001|Overall Study|Death|4|||
13135760|NCT02735980|25996463|FG002|Overall Study|Death|0|||
13135761|NCT02735980|25996461|FG000|Overall Study|Physician Decision|3|||
13135762|NCT02735980|25996462|FG001|Overall Study|Physician Decision|1|||
13135763|NCT02735980|25996463|FG002|Overall Study|Physician Decision|0|||
13135764|NCT02735980|25996461|FG000|Overall Study|Screen failure|1|||
13135765|NCT02735980|25996462|FG001|Overall Study|Screen failure|0|||
13135766|NCT02735980|25996463|FG002|Overall Study|Screen failure|0|||
13135767|NCT02735980|25996461|FG000|Overall Study|Withdrawal by Subject|1|||
13135768|NCT02735980|25996462|FG001|Overall Study|Withdrawal by Subject|2|||
13135769|NCT02735980|25996463|FG002|Overall Study|Withdrawal by Subject|0|||
13135770|NCT02735915|25996484|FG000|Overall Study|Not vaccinated but subject ID assigned|8|||
13135771|NCT02735915|25996484|FG000|Overall Study|Withdrawal following SAE|2|||
13135772|NCT02735915|25996484|FG000|Overall Study|Withdrawal by Subject|1|||
13135773|NCT02735577|25996490|FG000|Disulfiram Treatment|Lost to Follow-up|1|||
13135774|NCT02735577|25996490|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2|||
13135775|NCT02735421|25996529|FG000|Part A (Randomized): up to 24 Weeks|Adverse Event|2|||
13135776|NCT02735421|25996529|FG000|Part A (Randomized): up to 24 Weeks|Withdrawal by Subject|6|||
13135777|NCT02735421|25996529|FG000|Part A (Randomized): up to 24 Weeks|Lost to Follow-up|3|||
13135778|NCT02735421|25996529|FG000|Part A (Randomized): up to 24 Weeks|Inadequate compliance to treatment|1|||
13135779|NCT02735421|25996529|FG000|Part A (Randomized): up to 24 Weeks|Pregnancy|1|||
13135780|NCT02735421|25996529|FG000|Part 2 (Open Label): up to 48 Weeks|Withdrawal by Subject|1|||
13135781|NCT02735421|25996529|FG000|Part 2 (Open Label): up to 48 Weeks|Lost to Follow-up|3|||
13135782|NCT02735200|25996542|FG000|Overall Study|Lost to Follow-up|0|||
13135783|NCT02735200|25996543|FG001|Overall Study|Lost to Follow-up|5|||
13135784|NCT02735200|25996542|FG000|Overall Study|Withdrawal by Subject|8|||
13135785|NCT02735200|25996543|FG001|Overall Study|Withdrawal by Subject|0|||
13135786|NCT02735096|25996552|FG000|Overall Study|No symptoms in clinic/personal leave|1|||
13135787|NCT02734862|25996588|FG000|Part A|Death|3|||
13135788|NCT02734862|25996589|FG001|Part A|Death|4|||
13135789|NCT02734862|25996590|FG002|Part A|Death|6|||
13135790|NCT02734862|25996588|FG000|Part A|Lost to Follow-up|2|||
13135791|NCT02734862|25996589|FG001|Part A|Lost to Follow-up|1|||
13135792|NCT02734862|25996590|FG002|Part A|Lost to Follow-up|1|||
13135793|NCT02734862|25996588|FG000|Part A|Withdrawal by Subject|1|||
13135794|NCT02734862|25996589|FG001|Part A|Withdrawal by Subject|1|||
13135795|NCT02734862|25996590|FG002|Part A|Withdrawal by Subject|2|||
13135796|NCT02734862|25996588|FG000|Part A|Physician Decision|2|||
13135797|NCT02734862|25996589|FG001|Part A|Physician Decision|0|||
13135798|NCT02734862|25996590|FG002|Part A|Physician Decision|1|||
13135799|NCT02734862|25996588|FG000|Part A|Adverse Event|2|||
13135800|NCT02734862|25996589|FG001|Part A|Adverse Event|0|||
13135801|NCT02734862|25996590|FG002|Part A|Adverse Event|1|||
13135802|NCT02734862|25996588|FG000|Part A|Noncompliance|1|||
13135803|NCT02734862|25996589|FG001|Part A|Noncompliance|1|||
13135804|NCT02734862|25996590|FG002|Part A|Noncompliance|0|||
13135805|NCT02734862|25996588|FG000|Part A|Other|1|||
13135806|NCT02734862|25996589|FG001|Part A|Other|1|||
13135807|NCT02734862|25996590|FG002|Part A|Other|3|||
13135808|NCT02734862|25996588|FG000|Part B|Death|8|||
13135809|NCT02734862|25996589|FG001|Part B|Death|3|||
13135810|NCT02734862|25996590|FG002|Part B|Death|5|||
13135811|NCT02734862|25996588|FG000|Part B|Lost to Follow-up|2|||
13135812|NCT02734862|25996589|FG001|Part B|Lost to Follow-up|2|||
13135813|NCT02734862|25996590|FG002|Part B|Lost to Follow-up|0|||
13135814|NCT02734862|25996588|FG000|Part B|Withdrawal by Subject|3|||
13135815|NCT02734862|25996589|FG001|Part B|Withdrawal by Subject|1|||
13135816|NCT02734862|25996590|FG002|Part B|Withdrawal by Subject|0|||
13135817|NCT02734862|25996588|FG000|Part B|Other|0|||
13135818|NCT02734862|25996589|FG001|Part B|Other|1|||
13135819|NCT02734862|25996590|FG002|Part B|Other|0|||
13135820|NCT02734810|25996603|FG000|Overall Study|Adverse Event|1|||
13135821|NCT02734810|25996604|FG001|Overall Study|Adverse Event|0|||
13135822|NCT02734810|25996603|FG000|Overall Study|Lack of Efficacy|1|||
13135823|NCT02734810|25996604|FG001|Overall Study|Lack of Efficacy|0|||
13135824|NCT02734693|25996631|FG000|Overall Study|Adverse Event|1|||
13135825|NCT02734693|25996632|FG001|Overall Study|Adverse Event|3|||
13135826|NCT02734693|25996633|FG002|Overall Study|Adverse Event|3|||
13135827|NCT02734693|25996631|FG000|Overall Study|Lack of Efficacy|1|||
13135828|NCT02734693|25996632|FG001|Overall Study|Lack of Efficacy|0|||
13135829|NCT02734693|25996633|FG002|Overall Study|Lack of Efficacy|0|||
13135830|NCT02734693|25996631|FG000|Overall Study|Lost to Follow-up|2|||
13135831|NCT02734693|25996632|FG001|Overall Study|Lost to Follow-up|0|||
13135832|NCT02734693|25996633|FG002|Overall Study|Lost to Follow-up|0|||
13135833|NCT02734693|25996631|FG000|Overall Study|Protocol Violation|1|||
13135834|NCT02734693|25996632|FG001|Overall Study|Protocol Violation|0|||
13135835|NCT02734693|25996633|FG002|Overall Study|Protocol Violation|0|||
13135836|NCT02734693|25996631|FG000|Overall Study|Withdrawal by Subject|1|||
13135837|NCT02734693|25996632|FG001|Overall Study|Withdrawal by Subject|0|||
13135838|NCT02734693|25996633|FG002|Overall Study|Withdrawal by Subject|0|||
13135839|NCT02734433|25996672|FG000|Overall Study|Disease progression|1|||
13135840|NCT02734433|25996673|FG001|Overall Study|Disease progression|5|||
13135841|NCT02734433|25996672|FG000|Overall Study|Clinical progression|0|||
13135842|NCT02734433|25996673|FG001|Overall Study|Clinical progression|1|||
13135843|NCT02734433|25996672|FG000|Overall Study|Withdrawal by Subject|1|||
13135844|NCT02734433|25996673|FG001|Overall Study|Withdrawal by Subject|2|||
13135845|NCT02734212|25996690|FG000|Overall Study|Lost to Follow-up|5|||
13135846|NCT02734212|25996691|FG001|Overall Study|Lost to Follow-up|10|||
13135847|NCT02733991|25996708|FG000|Overall Study|Adverse Event|1|||
13135848|NCT02733991|25996709|FG001|Overall Study|Adverse Event|0|||
13135849|NCT02733991|25996708|FG000|Overall Study|Withdrawal by Subject|0|||
13135850|NCT02733991|25996709|FG001|Overall Study|Withdrawal by Subject|5|||
13135851|NCT02733627|25996744|FG000|Overall Study|Adverse Event|0|||
13135852|NCT02733627|25996745|FG001|Overall Study|Adverse Event|1|||
13135853|NCT02733627|25996746|FG002|Overall Study|Adverse Event|1|||
13135854|NCT02733627|25996747|FG003|Overall Study|Adverse Event|0|||
13135855|NCT02733627|25996744|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
13135856|NCT02733627|25996745|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
13135857|NCT02733627|25996746|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1|||
13135858|NCT02733627|25996747|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
13135859|NCT02733367|25996756|FG000|Overall Study|Withdrawal by Subject|6|||
13135860|NCT02732951|25996771|FG000|Overall Study|Other than listed|1|||
13135861|NCT02732951|25996772|FG001|Overall Study|Other than listed|0|||
13135862|NCT02732951|25996771|FG000|Overall Study|Lost to Follow-up|0|||
13135863|NCT02732951|25996772|FG001|Overall Study|Lost to Follow-up|1|||
13135864|NCT02732951|25996771|FG000|Overall Study|Adverse Event|4|||
13135865|NCT02732951|25996772|FG001|Overall Study|Adverse Event|4|||
13135866|NCT02732951|25996771|FG000|Overall Study|Protocol Violation|0|||
13135867|NCT02732951|25996772|FG001|Overall Study|Protocol Violation|1|||
13135868|NCT02732938|25996824|FG000|Overall Study|Death|0|||
13135869|NCT02732938|25996825|FG001|Overall Study|Death|11|||
13135870|NCT02732938|25996826|FG002|Overall Study|Death|0|||
13135871|NCT02732938|25996824|FG000|Overall Study|Randomized but did not receive treatment|0|||
13135872|NCT02732938|25996825|FG001|Overall Study|Randomized but did not receive treatment|1|||
13135873|NCT02732938|25996826|FG002|Overall Study|Randomized but did not receive treatment|0|||
13135874|NCT02732938|25996824|FG000|Overall Study|Refused further follow-up|1|||
13135875|NCT02732938|25996825|FG001|Overall Study|Refused further follow-up|0|||
13135876|NCT02732938|25996826|FG002|Overall Study|Refused further follow-up|0|||
13135877|NCT02732938|25996824|FG000|Overall Study|Study terminated by sponsor|3|||
13135878|NCT02732938|25996825|FG001|Overall Study|Study terminated by sponsor|6|||
13135879|NCT02732938|25996826|FG002|Overall Study|Study terminated by sponsor|0|||
13135880|NCT02732912|25996847|FG000|Overall Study|Discharged before night|2|||
13135881|NCT02732912|25996848|FG001|Overall Study|Discharged before night|6|||
13135882|NCT02732912|25996847|FG000|Overall Study|Incomplete completion of questionnaire|2|||
13135883|NCT02732912|25996848|FG001|Overall Study|Incomplete completion of questionnaire|3|||
13135884|NCT02732912|25996847|FG000|Overall Study|No outcome; discharged or refused|6|||
13135885|NCT02732912|25996848|FG001|Overall Study|No outcome; discharged or refused|9|||
13135886|NCT02732847|25996861|FG000|Overall Study|some filled early|42|||
13135887|NCT02732847|25996862|FG001|Overall Study|some filled early|42|||
13135888|NCT02732639|25996891|FG000|Overall Study|Lost to Follow-up|1|||
13135889|NCT02732561|25996906|FG000|Overall Study|Lost to Follow-up|1|||
13135890|NCT02732561|25996907|FG001|Overall Study|Lost to Follow-up|1|||
13135891|NCT02732561|25996906|FG000|Overall Study|Withdrawal by Subject|1|||
13135892|NCT02732561|25996907|FG001|Overall Study|Withdrawal by Subject|0|||
13135893|NCT02732327|25996920|FG000|Overall Study|Protocol Violation|0|||
13135894|NCT02732327|25996921|FG001|Overall Study|Protocol Violation|1|||
13135895|NCT02732119|25996970|FG000|Phase I|Adverse Event|1|||
13135896|NCT02732119|25996971|FG001|Phase I|Adverse Event|3|||
13135897|NCT02732119|25996972|FG002|Phase I|Adverse Event|1|||
13135898|NCT02732119|25996973|FG003|Phase I|Adverse Event|0|||
13135899|NCT02732119|25996974|FG004|Phase I|Adverse Event|0|||
13135900|NCT02732119|25996970|FG000|Phase I|Progressive disease|7|||
13135901|NCT02732119|25996971|FG001|Phase I|Progressive disease|3|||
13135902|NCT02732119|25996972|FG002|Phase I|Progressive disease|2|||
13135903|NCT02732119|25996973|FG003|Phase I|Progressive disease|0|||
13135904|NCT02732119|25996974|FG004|Phase I|Progressive disease|0|||
13135905|NCT02732119|25996970|FG000|Phase I|Protocol deviation|0|||
13135906|NCT02732119|25996971|FG001|Phase I|Protocol deviation|1|||
13135907|NCT02732119|25996972|FG002|Phase I|Protocol deviation|0|||
13135908|NCT02732119|25996973|FG003|Phase I|Protocol deviation|0|||
13135909|NCT02732119|25996974|FG004|Phase I|Protocol deviation|0|||
13135910|NCT02732119|25996970|FG000|Phase I|Physician Decision|0|||
13135911|NCT02732119|25996971|FG001|Phase I|Physician Decision|3|||
13135912|NCT02732119|25996972|FG002|Phase I|Physician Decision|4|||
13135913|NCT02732119|25996973|FG003|Phase I|Physician Decision|0|||
13135914|NCT02732119|25996974|FG004|Phase I|Physician Decision|0|||
13135915|NCT02732119|25996970|FG000|Phase II|Adverse Event|0|||
13135916|NCT02732119|25996971|FG001|Phase II|Adverse Event|0|||
13135917|NCT02732119|25996972|FG002|Phase II|Adverse Event|0|||
13135918|NCT02732119|25996973|FG003|Phase II|Adverse Event|3|||
13135919|NCT02732119|25996974|FG004|Phase II|Adverse Event|3|||
13135920|NCT02732119|25996970|FG000|Phase II|Death|0|||
13135921|NCT02732119|25996971|FG001|Phase II|Death|0|||
13135922|NCT02732119|25996972|FG002|Phase II|Death|0|||
13135923|NCT02732119|25996973|FG003|Phase II|Death|1|||
13135924|NCT02732119|25996974|FG004|Phase II|Death|0|||
13135925|NCT02732119|25996970|FG000|Phase II|Progressive dissease|0|||
13135926|NCT02732119|25996971|FG001|Phase II|Progressive dissease|0|||
13135927|NCT02732119|25996972|FG002|Phase II|Progressive dissease|0|||
13135928|NCT02732119|25996973|FG003|Phase II|Progressive dissease|30|||
13135929|NCT02732119|25996974|FG004|Phase II|Progressive dissease|23|||
13135930|NCT02732119|25996970|FG000|Phase II|Study terminated by sponsor|0|||
13135931|NCT02732119|25996971|FG001|Phase II|Study terminated by sponsor|0|||
13135932|NCT02732119|25996972|FG002|Phase II|Study terminated by sponsor|0|||
13135933|NCT02732119|25996973|FG003|Phase II|Study terminated by sponsor|2|||
13135934|NCT02732119|25996974|FG004|Phase II|Study terminated by sponsor|2|||
13135935|NCT02732119|25996970|FG000|Phase II|Other|0|||
13135936|NCT02732119|25996971|FG001|Phase II|Other|0|||
13135937|NCT02732119|25996972|FG002|Phase II|Other|0|||
13135938|NCT02732119|25996973|FG003|Phase II|Other|2|||
13135939|NCT02732119|25996974|FG004|Phase II|Other|0|||
13135940|NCT02732119|25996970|FG000|Phase II|Physician Decision|0|||
13135941|NCT02732119|25996971|FG001|Phase II|Physician Decision|0|||
13135942|NCT02732119|25996972|FG002|Phase II|Physician Decision|0|||
13135943|NCT02732119|25996973|FG003|Phase II|Physician Decision|8|||
13135944|NCT02732119|25996974|FG004|Phase II|Physician Decision|5|||
13135945|NCT02732015|25996987|FG000|Overall Study|Lost to Follow-up|0|||
13135946|NCT02732015|25996988|FG001|Overall Study|Lost to Follow-up|1|||
13135947|NCT02731755|25997011|FG000|First Intervention|Withdrawal by Subject|0|||
13135948|NCT02731755|25997012|FG001|First Intervention|Withdrawal by Subject|2|||
13135949|NCT02731742|25997043|FG000|Overall Study|Death|1|||
13135950|NCT02731742|25997044|FG001|Overall Study|Death|2|||
13135951|NCT02731742|25997045|FG002|Overall Study|Death|5|||
13135952|NCT02731742|25997046|FG003|Overall Study|Death|0|||
13135953|NCT02731742|25997043|FG000|Overall Study|Physician Decision|0|||
13135954|NCT02731742|25997044|FG001|Overall Study|Physician Decision|0|||
13135955|NCT02731742|25997045|FG002|Overall Study|Physician Decision|0|||
13135956|NCT02731742|25997046|FG003|Overall Study|Physician Decision|1|||
13135957|NCT02731742|25997043|FG000|Overall Study|Study Terminated by Sponsor|2|||
13135958|NCT02731742|25997044|FG001|Overall Study|Study Terminated by Sponsor|1|||
13135959|NCT02731742|25997045|FG002|Overall Study|Study Terminated by Sponsor|1|||
13135960|NCT02731742|25997046|FG003|Overall Study|Study Terminated by Sponsor|1|||
13135961|NCT02731690|25997066|FG000|Overall Study|Adverse Event|1|||
13135962|NCT02731690|25997066|FG000|Overall Study|Withdrawal by Subject|3|||
13135963|NCT02731690|25997066|FG000|Overall Study|Discontinuation of Study by Sponsor|26|||
13204535|NCT01972724|26229204|FG002|Open-Label|Significant Protocol Deviation|2|||
13204536|NCT01972659|26229217|FG000|Overall Study|Protocol Violation|2|||
13204537|NCT01972659|26229218|FG001|Overall Study|Protocol Violation|2|||
13204538|NCT01972659|26229217|FG000|Overall Study|problems realted to acceleromyograph|2|||
13204539|NCT01972659|26229218|FG001|Overall Study|problems realted to acceleromyograph|1|||
13204540|NCT01972568|26229263|FG000|Overall Study|Other events|3|||
13204541|NCT01972568|26229264|FG001|Overall Study|Other events|0|||
13204542|NCT01972568|26229265|FG002|Overall Study|Other events|0|||
13204543|NCT01972568|26229263|FG000|Overall Study|Lack of Efficacy|0|||
13204544|NCT01972568|26229264|FG001|Overall Study|Lack of Efficacy|1|||
13204545|NCT01972568|26229265|FG002|Overall Study|Lack of Efficacy|2|||
13204546|NCT01972568|26229263|FG000|Overall Study|Protocol Violation|1|||
13204547|NCT01972568|26229264|FG001|Overall Study|Protocol Violation|2|||
13204548|NCT01972568|26229265|FG002|Overall Study|Protocol Violation|2|||
13204549|NCT01972568|26229263|FG000|Overall Study|Withdrawal by Subject|6|||
13204550|NCT01972568|26229264|FG001|Overall Study|Withdrawal by Subject|3|||
13204551|NCT01972568|26229265|FG002|Overall Study|Withdrawal by Subject|7|||
13204552|NCT01972568|26229263|FG000|Overall Study|Lost to Follow-up|1|||
13204553|NCT01972568|26229264|FG001|Overall Study|Lost to Follow-up|0|||
13204554|NCT01972568|26229265|FG002|Overall Study|Lost to Follow-up|0|||
13204555|NCT01972568|26229263|FG000|Overall Study|Adverse Event|5|||
13204556|NCT01972568|26229264|FG001|Overall Study|Adverse Event|6|||
13204557|NCT01972568|26229265|FG002|Overall Study|Adverse Event|5|||
13204558|NCT01972529|26229304|FG000|Overall Study|Adverse Event|0|||
13204559|NCT01972529|26229305|FG001|Overall Study|Adverse Event|1|||
13135964|NCT02731638|25997087|FG000|Overall Study|Lost to Follow-up|6|||
13135965|NCT02731638|25997088|FG001|Overall Study|Lost to Follow-up|9|||
13135966|NCT02731157|25997106|FG000|First Rejuvenated RCE|Withdrawal by Subject|1|||
13135967|NCT02731131|25997129|FG000|Overall Study|Psychiatric Disorder|0|||
13135968|NCT02731131|25997130|FG001|Overall Study|Psychiatric Disorder|1|||
13135969|NCT02731131|25997129|FG000|Overall Study|Refused Therapy|0|||
13135970|NCT02731131|25997130|FG001|Overall Study|Refused Therapy|1|||
13135971|NCT02730871|25997151|FG000|Overall Study|Adverse Event|6|||
13135972|NCT02730871|25997152|FG001|Overall Study|Adverse Event|0|||
13135973|NCT02730819|25997160|FG000|Overall Study|Lost to Follow-up|9|||
13135974|NCT02730793|25997189|FG000|Overall Study|Physician Decision|0|||
13135975|NCT02730793|25997190|FG001|Overall Study|Physician Decision|1|||
13135976|NCT02730793|25997189|FG000|Overall Study|Withdrawal by Subject|0|||
13135977|NCT02730793|25997190|FG001|Overall Study|Withdrawal by Subject|1|||
13135978|NCT02730728|25997217|FG000|Overall Study|Withdrawal by Subject|0|||
13135979|NCT02730728|25997218|FG001|Overall Study|Withdrawal by Subject|1|||
13135980|NCT02730728|25997219|FG002|Overall Study|Withdrawal by Subject|0|||
13135981|NCT02730728|25997217|FG000|Overall Study|Lack of Efficacy|0|||
13135982|NCT02730728|25997218|FG001|Overall Study|Lack of Efficacy|1|||
13135983|NCT02730728|25997219|FG002|Overall Study|Lack of Efficacy|1|||
13135984|NCT02730598|25997246|FG000|Overall Study|Withdrawal by Subject|3|||
13135985|NCT02730598|25997247|FG001|Overall Study|Withdrawal by Subject|3|||
13135986|NCT02730598|25997246|FG000|Overall Study|Protocol Violation|0|||
13135987|NCT02730598|25997247|FG001|Overall Study|Protocol Violation|1|||
13135988|NCT02730598|25997246|FG000|Overall Study|Unrelated Injury affecting outcomes.|1|||
13135989|NCT02730598|25997247|FG001|Overall Study|Unrelated Injury affecting outcomes.|0|||
13135990|NCT02730455|25997289|FG000|Overall Study|Death|5|||
13135991|NCT02730455|25997290|FG001|Overall Study|Death|6|||
13135992|NCT02730455|25997291|FG002|Overall Study|Death|4|||
13135993|NCT02730455|25997289|FG000|Overall Study|Consent withdrawn|2|||
13135994|NCT02730455|25997290|FG001|Overall Study|Consent withdrawn|4|||
13135995|NCT02730455|25997291|FG002|Overall Study|Consent withdrawn|1|||
13135996|NCT02730455|25997289|FG000|Overall Study|Lost to Follow-up|3|||
13135997|NCT02730455|25997290|FG001|Overall Study|Lost to Follow-up|1|||
13135998|NCT02730455|25997291|FG002|Overall Study|Lost to Follow-up|4|||
13135999|NCT02730455|25997289|FG000|Overall Study|Other|1|||
13136000|NCT02730455|25997290|FG001|Overall Study|Other|1|||
13136001|NCT02730455|25997291|FG002|Overall Study|Other|2|||
13136002|NCT02730455|25997289|FG000|Overall Study|Other|2|||
13136003|NCT02730455|25997290|FG001|Overall Study|Other|2|||
13136004|NCT02730455|25997291|FG002|Overall Study|Other|0|||
13136005|NCT02730377|25997348|FG000|Overall Study|Other|5|||
13136006|NCT02730377|25997349|FG001|Overall Study|Other|4|||
13136007|NCT02730377|25997348|FG000|Overall Study|Death|1|||
13136008|NCT02730377|25997349|FG001|Overall Study|Death|8|||
13136009|NCT02730377|25997348|FG000|Overall Study|Inadequate glycaemic control|368|||
13136010|NCT02730377|25997349|FG001|Overall Study|Inadequate glycaemic control|473|||
13136011|NCT02730377|25997348|FG000|Overall Study|Adverse Event|79|||
13136012|NCT02730377|25997349|FG001|Overall Study|Adverse Event|41|||
13136013|NCT02730377|25997348|FG000|Overall Study|Protocol Violation|23|||
13136014|NCT02730377|25997349|FG001|Overall Study|Protocol Violation|30|||
13136015|NCT02730377|25997348|FG000|Overall Study|Lack of Efficacy|4|||
13136016|NCT02730377|25997349|FG001|Overall Study|Lack of Efficacy|13|||
13136017|NCT02730377|25997348|FG000|Overall Study|Pregnancy|0|||
13136018|NCT02730377|25997349|FG001|Overall Study|Pregnancy|1|||
13136019|NCT02730377|25997348|FG000|Overall Study|Withdrawal by Subject|45|||
13136020|NCT02730377|25997349|FG001|Overall Study|Withdrawal by Subject|42|||
13136021|NCT02730377|25997348|FG000|Overall Study|Lost to Follow-up|25|||
13136022|NCT02730377|25997349|FG001|Overall Study|Lost to Follow-up|21|||
13136023|NCT02730351|25997364|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1|||
13136024|NCT02730351|25997365|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0|||
13136025|NCT02730351|25997364|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0|||
13136026|NCT02730351|25997365|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1|||
13136027|NCT02730351|25997364|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1|||
13136028|NCT02730351|25997365|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0|||
13136029|NCT02730351|25997364|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1|||
13136030|NCT02730351|25997365|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0|||
13136031|NCT02730351|25997364|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1|||
13136032|NCT02730351|25997365|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0|||
13136033|NCT02730208|25997380|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
13136034|NCT02730208|25997381|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
13136035|NCT02730195|25997389|FG000|Overall Study|Withdrawal by Subject|1|||
13136036|NCT02730169|25997462|FG000|Overall Study|Protocol Violation|1|||
13136037|NCT02730169|25997463|FG001|Overall Study|Protocol Violation|0|||
13136038|NCT02730169|25997464|FG002|Overall Study|Protocol Violation|0|||
13136039|NCT02730169|25997465|FG003|Overall Study|Protocol Violation|1|||
13136040|NCT02730169|25997462|FG000|Overall Study|Adverse Event|2|||
13136041|NCT02730169|25997463|FG001|Overall Study|Adverse Event|3|||
13136042|NCT02730169|25997464|FG002|Overall Study|Adverse Event|3|||
13136043|NCT02730169|25997465|FG003|Overall Study|Adverse Event|0|||
13136044|NCT02730169|25997462|FG000|Overall Study|Adverse Event of Special Interest|0|||
13136045|NCT02730169|25997463|FG001|Overall Study|Adverse Event of Special Interest|1|||
13136046|NCT02730169|25997464|FG002|Overall Study|Adverse Event of Special Interest|2|||
13136047|NCT02730169|25997465|FG003|Overall Study|Adverse Event of Special Interest|0|||
13136048|NCT02730169|25997462|FG000|Overall Study|Withdrawal by Subject|6|||
13136049|NCT02730169|25997463|FG001|Overall Study|Withdrawal by Subject|11|||
13136050|NCT02730169|25997464|FG002|Overall Study|Withdrawal by Subject|6|||
13136051|NCT02730169|25997465|FG003|Overall Study|Withdrawal by Subject|8|||
13136052|NCT02730169|25997462|FG000|Overall Study|Lost to Follow-up|5|||
13136053|NCT02730169|25997463|FG001|Overall Study|Lost to Follow-up|6|||
13136054|NCT02730169|25997464|FG002|Overall Study|Lost to Follow-up|5|||
13136055|NCT02730169|25997465|FG003|Overall Study|Lost to Follow-up|6|||
13136056|NCT02730169|25997462|FG000|Overall Study|Other|0|||
13136057|NCT02730169|25997463|FG001|Overall Study|Other|0|||
13136058|NCT02730169|25997464|FG002|Overall Study|Other|1|||
13136059|NCT02730169|25997465|FG003|Overall Study|Other|1|||
13136060|NCT02729909|25997488|FG000|Overall Study|Lost to Follow-up|0|||
13136061|NCT02729909|25997489|FG001|Overall Study|Lost to Follow-up|1|||
13136062|NCT02729909|25997488|FG000|Overall Study|Lack of Efficacy|0|||
13136063|NCT02729909|25997489|FG001|Overall Study|Lack of Efficacy|2|||
13136064|NCT02729909|25997488|FG000|Overall Study|Significant Protocol Deviation|0|||
13136065|NCT02729909|25997489|FG001|Overall Study|Significant Protocol Deviation|2|||
13136066|NCT02729909|25997488|FG000|Overall Study|Voluntary Withdrawal|1|||
13136067|NCT02729909|25997489|FG001|Overall Study|Voluntary Withdrawal|0|||
13136068|NCT02729896|25997540|FG000|Overall Study|Death|0|||
13136069|NCT02729896|25997541|FG001|Overall Study|Death|2|||
13136070|NCT02729896|25997542|FG002|Overall Study|Death|13|||
13136071|NCT02729896|25997540|FG000|Overall Study|Lost to Follow-up|0|||
13136072|NCT02729896|25997541|FG001|Overall Study|Lost to Follow-up|2|||
13136073|NCT02729896|25997542|FG002|Overall Study|Lost to Follow-up|3|||
13136074|NCT02729896|25997540|FG000|Overall Study|Other|0|||
13136075|NCT02729896|25997541|FG001|Overall Study|Other|2|||
13136076|NCT02729896|25997542|FG002|Overall Study|Other|0|||
13136077|NCT02729896|25997540|FG000|Overall Study|Physician Decision|1|||
13136078|NCT02729896|25997541|FG001|Overall Study|Physician Decision|2|||
13136079|NCT02729896|25997542|FG002|Overall Study|Physician Decision|3|||
13136080|NCT02729896|25997540|FG000|Overall Study|Progressive Disease|0|||
13136081|NCT02729896|25997541|FG001|Overall Study|Progressive Disease|1|||
13136082|NCT02729896|25997542|FG002|Overall Study|Progressive Disease|0|||
13136083|NCT02729896|25997540|FG000|Overall Study|Withdrawal by Subject|1|||
13136084|NCT02729896|25997541|FG001|Overall Study|Withdrawal by Subject|0|||
13136085|NCT02729896|25997542|FG002|Overall Study|Withdrawal by Subject|3|||
13136086|NCT02729831|25997581|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38|||
13136087|NCT02729831|25997582|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23|||
13136088|NCT02729831|25997583|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18|||
13136089|NCT02729831|25997584|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17|||
13136090|NCT02729831|25997581|FG000|1 Week Post-visit|Lost to Follow-up|43|||
13136091|NCT02729831|25997582|FG001|1 Week Post-visit|Lost to Follow-up|40|||
13136092|NCT02729831|25997583|FG002|1 Week Post-visit|Lost to Follow-up|38|||
13136093|NCT02729831|25997584|FG003|1 Week Post-visit|Lost to Follow-up|36|||
13136094|NCT02729831|25997581|FG000|6 Month Follow-up|Lost to Follow-up|54|||
13136095|NCT02729831|25997582|FG001|6 Month Follow-up|Lost to Follow-up|51|||
13136096|NCT02729831|25997583|FG002|6 Month Follow-up|Lost to Follow-up|48|||
13136097|NCT02729831|25997584|FG003|6 Month Follow-up|Lost to Follow-up|42|||
13136098|NCT02729831|25997581|FG000|6 Month Follow-up|Death|1|||
13136099|NCT02729831|25997582|FG001|6 Month Follow-up|Death|3|||
13136100|NCT02729831|25997583|FG002|6 Month Follow-up|Death|0|||
13136101|NCT02729831|25997584|FG003|6 Month Follow-up|Death|1|||
13136102|NCT02729753|25997603|FG000|Overall Study|Device Malfunction. No units in stock.|0|||
13136103|NCT02729753|25997604|FG001|Overall Study|Device Malfunction. No units in stock.|1|||
13136104|NCT02729740|25997613|FG000|Overall Study|Early Termination|130|||
13136105|NCT02729740|25997613|FG000|Overall Study|Other|1|||
13136106|NCT02729545|25997642|FG000|Overall Study|Pregnancy|1|||
13136107|NCT02729545|25997643|FG001|Overall Study|Pregnancy|1|||
13136108|NCT02729545|25997642|FG000|Overall Study|Lost to Follow-up|0|||
13136109|NCT02729545|25997643|FG001|Overall Study|Lost to Follow-up|1|||
13136110|NCT02729545|25997642|FG000|Overall Study|Withdrawal by Subject|2|||
13136111|NCT02729545|25997643|FG001|Overall Study|Withdrawal by Subject|3|||
13136112|NCT02729194|25997655|FG000|Overall Study|Withdrawal by Subject|3|||
13136113|NCT02729051|25997678|FG000|Overall Study|Adverse Event|21|||
13136114|NCT02729051|25997679|FG001|Overall Study|Adverse Event|11|||
13136115|NCT02729051|25997678|FG000|Overall Study|Lack of Efficacy|1|||
13136116|NCT02729051|25997679|FG001|Overall Study|Lack of Efficacy|1|||
13136117|NCT02729051|25997678|FG000|Overall Study|Lost to Follow-up|1|||
13136118|NCT02729051|25997679|FG001|Overall Study|Lost to Follow-up|2|||
13136119|NCT02729051|25997678|FG000|Overall Study|Physician Decision|1|||
13136120|NCT02729051|25997679|FG001|Overall Study|Physician Decision|1|||
13136121|NCT02729051|25997678|FG000|Overall Study|Withdrawal by Subject|6|||
13136122|NCT02729051|25997679|FG001|Overall Study|Withdrawal by Subject|17|||
13136123|NCT02729025|25997698|FG000|Overall Study|Sponsor Decision|0|||
13136124|NCT02729025|25997699|FG001|Overall Study|Sponsor Decision|1|||
13136125|NCT02728895|25997726|FG000|Overall Study|Other|1|||
13136126|NCT02728895|25997727|FG001|Overall Study|Other|2|||
13136127|NCT02728895|25997726|FG000|Overall Study|Withdrawal by Subject|0|||
13136128|NCT02728895|25997727|FG001|Overall Study|Withdrawal by Subject|3|||
13136129|NCT02728830|25997736|FG000|Overall Study|Exclusionary Surgery|9|||
13136130|NCT02728830|25997736|FG000|Overall Study|Exclusionary Pathology|6|||
13136131|NCT02728830|25997736|FG000|Overall Study|Physician Decision|3|||
13136132|NCT02728830|25997736|FG000|Overall Study|Withdrawal by Subject|2|||
13136133|NCT02728830|25997736|FG000|Overall Study|Lost to Follow-up|1|||
13136134|NCT02728830|25997736|FG000|Overall Study|Exclusionary Lab Values|1|||
13136135|NCT02728830|25997736|FG000|Overall Study|Contraindicated Illness|1|||
13136136|NCT02728830|25997736|FG000|Overall Study|Language Barrier|1|||
13136137|NCT02728596|25997771|FG000|Overall Study|Refusal unrelated to adverse event|3|||
13136138|NCT02728596|25997772|FG001|Overall Study|Refusal unrelated to adverse event|6|||
13136139|NCT02728596|25997773|FG002|Overall Study|Refusal unrelated to adverse event|7|||
13136140|NCT02728596|25997774|FG003|Overall Study|Refusal unrelated to adverse event|7|||
13136141|NCT02728596|25997771|FG000|Overall Study|Death|44|||
13136142|NCT02728596|25997772|FG001|Overall Study|Death|42|||
13136143|NCT02728596|25997773|FG002|Overall Study|Death|123|||
13136144|NCT02728596|25997774|FG003|Overall Study|Death|68|||
13136145|NCT02728206|25997784|FG000|Overall Study|Death|1|||
13136146|NCT02728089|25997801|FG000|Overall Study|Physician Decision|2|||
13136147|NCT02728089|25997801|FG000|Overall Study|Withdrawal by Subject|1|||
13136148|NCT02727777|25997825|FG000|Overall Study|Screen Failure|2|||
13136149|NCT02727777|25997826|FG001|Overall Study|Screen Failure|0|||
13136150|NCT02727777|25997827|FG002|Overall Study|Screen Failure|0|||
13136151|NCT02727777|25997825|FG000|Overall Study|Progressive disease|2|||
13136152|NCT02727777|25997826|FG001|Overall Study|Progressive disease|0|||
13136153|NCT02727777|25997827|FG002|Overall Study|Progressive disease|0|||
13136154|NCT02727699|25997852|FG000|Overall Study|Adverse Event|2|||
13136155|NCT02727699|25997853|FG001|Overall Study|Adverse Event|0|||
13136156|NCT02727699|25997852|FG000|Overall Study|Withdrawal by Subject|5|||
13136157|NCT02727699|25997853|FG001|Overall Study|Withdrawal by Subject|3|||
13136158|NCT02727699|25997852|FG000|Overall Study|Protocol Violation|0|||
13136159|NCT02727699|25997853|FG001|Overall Study|Protocol Violation|1|||
13136160|NCT02727699|25997852|FG000|Overall Study|Physician Decision|0|||
13136161|NCT02727699|25997853|FG001|Overall Study|Physician Decision|1|||
13136162|NCT02727699|25997852|FG000|Overall Study|Lost to Follow-up|1|||
13136163|NCT02727699|25997853|FG001|Overall Study|Lost to Follow-up|0|||
13136164|NCT02727699|25997852|FG000|Overall Study|Sponsor Decision|1|||
13136165|NCT02727699|25997853|FG001|Overall Study|Sponsor Decision|0|||
13136166|NCT02727660|25997880|FG000|Overall Study|Lack of Efficacy|40|||
13136167|NCT02727660|25997881|FG001|Overall Study|Lack of Efficacy|40|||
13136168|NCT02727660|25997882|FG002|Overall Study|Lack of Efficacy|70|||
13136169|NCT02727660|25997880|FG000|Overall Study|Adverse Event|28|||
13136170|NCT02727660|25997881|FG001|Overall Study|Adverse Event|21|||
13136171|NCT02727660|25997882|FG002|Overall Study|Adverse Event|32|||
13136172|NCT02727660|25997880|FG000|Overall Study|Withdrawal by Subject|26|||
13136173|NCT02727660|25997881|FG001|Overall Study|Withdrawal by Subject|25|||
13136174|NCT02727660|25997882|FG002|Overall Study|Withdrawal by Subject|30|||
13136175|NCT02727660|25997880|FG000|Overall Study|Physician Decision|3|||
13136176|NCT02727660|25997881|FG001|Overall Study|Physician Decision|8|||
13136177|NCT02727660|25997882|FG002|Overall Study|Physician Decision|14|||
13136178|NCT02727660|25997880|FG000|Overall Study|Lost to Follow-up|5|||
13136179|NCT02727660|25997881|FG001|Overall Study|Lost to Follow-up|9|||
13136180|NCT02727660|25997882|FG002|Overall Study|Lost to Follow-up|8|||
13136181|NCT02727660|25997880|FG000|Overall Study|Protocol Violation|7|||
13136182|NCT02727660|25997881|FG001|Overall Study|Protocol Violation|5|||
13136183|NCT02727660|25997882|FG002|Overall Study|Protocol Violation|5|||
13136184|NCT02727660|25997880|FG000|Overall Study|Protocol Specified Disc. Criteria|5|||
13136185|NCT02727660|25997881|FG001|Overall Study|Protocol Specified Disc. Criteria|5|||
13136186|NCT02727660|25997882|FG002|Overall Study|Protocol Specified Disc. Criteria|2|||
13136187|NCT02727660|25997880|FG000|Overall Study|Administrative Reasons|2|||
13136188|NCT02727660|25997881|FG001|Overall Study|Administrative Reasons|3|||
13136189|NCT02727660|25997882|FG002|Overall Study|Administrative Reasons|4|||
13136190|NCT02727322|25997899|FG000|Overall Study|Withdrawal by Subject|1|||
13136191|NCT02727322|25997900|FG001|Overall Study|Withdrawal by Subject|1|||
13136192|NCT02727322|25997899|FG000|Overall Study|Protocol Violation|1|||
13136193|NCT02727322|25997900|FG001|Overall Study|Protocol Violation|0|||
13136194|NCT02727192|25997935|FG000|Overall Study|Lost to Follow-up|1|||
13136195|NCT02727192|25997936|FG001|Overall Study|Lost to Follow-up|0|||
13136196|NCT02727192|25997937|FG002|Overall Study|Lost to Follow-up|0|||
13136197|NCT02726945|25997958|FG000|Overall Study|Withdrawal by Subject|0|||
13136198|NCT02726945|25997959|FG001|Overall Study|Withdrawal by Subject|0|||
13136199|NCT02726945|25997960|FG002|Overall Study|Withdrawal by Subject|1|||
13136200|NCT02726945|25997958|FG000|Overall Study|Elected to have total knee replacement|0|||
13136201|NCT02726945|25997959|FG001|Overall Study|Elected to have total knee replacement|1|||
13136202|NCT02726945|25997960|FG002|Overall Study|Elected to have total knee replacement|0|||
13136203|NCT02726399|25997966|FG000|Overall Study|Participant Non-Compliance|1|||
13136204|NCT02726399|25997966|FG000|Overall Study|Adverse Event|2|||
13136205|NCT02726399|25997966|FG000|Overall Study|Progression of disease|4|||
13136206|NCT02726113|25997980|FG000|Total Enrollment|Physician Decision|0|||
13136207|NCT02726113|25997981|FG001|Total Enrollment|Physician Decision|1|||
13136208|NCT02726113|25997980|FG000|Total Enrollment|Protocol Violation|1|||
13136209|NCT02726113|25997981|FG001|Total Enrollment|Protocol Violation|0|||
13136210|NCT02726113|25997980|FG000|Total Enrollment|Withdrawal by Subject|2|||
13136211|NCT02726113|25997981|FG001|Total Enrollment|Withdrawal by Subject|1|||
13136212|NCT02726113|25997980|FG000|Total Enrollment|Insurance non-coverage for surgery|1|||
13136213|NCT02726113|25997981|FG001|Total Enrollment|Insurance non-coverage for surgery|1|||
13136214|NCT02726113|25997980|FG000|Genomic Analysis|Protocol Violation|1|||
13136215|NCT02726113|25997981|FG001|Genomic Analysis|Protocol Violation|0|||
13136216|NCT02726113|25997980|FG000|Genomic Analysis|Withdrawal by Subject|2|||
13136217|NCT02726113|25997981|FG001|Genomic Analysis|Withdrawal by Subject|1|||
13136218|NCT02726113|25997980|FG000|Genomic Analysis|Insurance non-coverage for surgery|1|||
13136219|NCT02726113|25997981|FG001|Genomic Analysis|Insurance non-coverage for surgery|1|||
13136220|NCT02726074|25997995|FG000|Overall Study|Withdrawal by Subject|4|||
13136221|NCT02726074|25997995|FG000|Overall Study|Adverse Event|14|||
13136222|NCT02726074|25997995|FG000|Overall Study|Protocol Violation|3|||
13136223|NCT02726074|25997995|FG000|Overall Study|Lost to Follow-up|2|||
13136224|NCT02726074|25997995|FG000|Overall Study|Others|3|||
13136225|NCT02726022|25998006|FG000|Overall Study|Adverse Event|14|||
13136226|NCT02726022|25998006|FG000|Overall Study|Treatment Failure|8|||
13136227|NCT02726022|25998006|FG000|Overall Study|Poor Compliance|13|||
13136228|NCT02726022|25998006|FG000|Overall Study|Treatment Failure and Poor Compliance|1|||
13136229|NCT02725866|25998019|FG000|Overall Study|Failure to return|6|||
13136230|NCT02725866|25998019|FG000|Overall Study|Withdrew consent|3|||
13136231|NCT02725866|25998019|FG000|Overall Study|Insufficient virological response|1|||
13136232|NCT02725866|25998019|FG000|Overall Study|Other, not specified|4|||
13136233|NCT02725788|25998032|FG000|Overall Study|Lost to Follow-up|1|||
13136234|NCT02725788|25998033|FG001|Overall Study|Lost to Follow-up|1|||
13136235|NCT02725788|25998032|FG000|Overall Study|Protocol Violation|0|||
13136236|NCT02725788|25998033|FG001|Overall Study|Protocol Violation|1|||
13136237|NCT02725710|25998068|FG000|Overall Study|Lost to Follow-up|1|||
13136238|NCT02725710|25998069|FG001|Overall Study|Lost to Follow-up|0|||
13136239|NCT02725671|25998080|FG000|Overall Study|Lost to Follow-up|1|||
13136240|NCT02725515|25998097|FG000|Overall Study|Refused infusion (no study treatment)|1|||
13136241|NCT02725515|25998098|FG001|Overall Study|Refused infusion (no study treatment)|0|||
13136242|NCT02725515|25998097|FG000|Overall Study|Loss of Improvement per Protocol|14|||
13136243|NCT02725515|25998098|FG001|Overall Study|Loss of Improvement per Protocol|25|||
13136244|NCT02725515|25998097|FG000|Overall Study|Withdrawal by Subject|2|||
13136245|NCT02725515|25998098|FG001|Overall Study|Withdrawal by Subject|1|||
13136246|NCT02725515|25998097|FG000|Overall Study|Non-Compliance With Study Drug|0|||
13136247|NCT02725515|25998098|FG001|Overall Study|Non-Compliance With Study Drug|3|||
13136248|NCT02725515|25998097|FG000|Overall Study|Lost to Follow-up|1|||
13136249|NCT02725515|25998098|FG001|Overall Study|Lost to Follow-up|1|||
13136250|NCT02725515|25998097|FG000|Overall Study|Adverse Event|7|||
13136251|NCT02725515|25998098|FG001|Overall Study|Adverse Event|2|||
13136252|NCT02725515|25998097|FG000|Overall Study|No Documented Disease Improvement|0|||
13136253|NCT02725515|25998098|FG001|Overall Study|No Documented Disease Improvement|1|||
13136254|NCT02725515|25998097|FG000|Overall Study|Completed Study Under Original Protocol|0|||
13136255|NCT02725515|25998098|FG001|Overall Study|Completed Study Under Original Protocol|1|||
13136256|NCT02725515|25998097|FG000|Overall Study|Lack of Response|0|||
13136257|NCT02725515|25998098|FG001|Overall Study|Lack of Response|1|||
13136258|NCT02725476|25998113|FG000|Overall Study|Physician Decision|2|||
13136259|NCT02725476|25998114|FG001|Overall Study|Physician Decision|0|||
13136260|NCT02725476|25998113|FG000|Overall Study|Adverse Event|1|||
13136261|NCT02725476|25998114|FG001|Overall Study|Adverse Event|1|||
13136262|NCT02725411|25998336|FG000|Treatment Period (56 Weeks)|Adverse Event|3|||
13136263|NCT02725411|25998337|FG001|Treatment Period (56 Weeks)|Adverse Event|5|||
13136264|NCT02725411|25998338|FG002|Treatment Period (56 Weeks)|Adverse Event|4|||
13136265|NCT02725411|25998336|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
13136266|NCT02725411|25998337|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4|||
13136267|NCT02725411|25998338|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
13136268|NCT02725411|25998336|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
13136269|NCT02725411|25998337|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1|||
13136270|NCT02725411|25998338|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
13136271|NCT02725411|25998336|FG000|Treatment Period (56 Weeks)|Other|1|||
13136272|NCT02725411|25998337|FG001|Treatment Period (56 Weeks)|Other|4|||
13136273|NCT02725411|25998338|FG002|Treatment Period (56 Weeks)|Other|5|||
13136274|NCT02725411|25998336|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0|||
13136275|NCT02725411|25998337|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1|||
13136276|NCT02725411|25998338|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4|||
13136277|NCT02725411|25998336|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25|||
13136278|NCT02725411|25998337|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
13136279|NCT02725411|25998338|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
13136280|NCT02725411|25998336|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
13222023|NCT01808612|26285219|FG002|Discontinuation Period|Physician Decision|0|||
13136281|NCT02725411|25998337|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
13136282|NCT02725411|25998338|FG002|Follow-up Period (24 Weeks)|Adverse Event|0|||
13136283|NCT02725411|25998336|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
13136284|NCT02725411|25998337|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2|||
13136285|NCT02725411|25998338|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
13136286|NCT02725411|25998336|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
13136287|NCT02725411|25998337|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
13136288|NCT02725411|25998338|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0|||
13136289|NCT02725411|25998336|FG000|Follow-up Period (24 Weeks)|Other|1|||
13136290|NCT02725411|25998337|FG001|Follow-up Period (24 Weeks)|Other|4|||
13136291|NCT02725411|25998338|FG002|Follow-up Period (24 Weeks)|Other|2|||
13136292|NCT02725411|25998336|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
13136293|NCT02725411|25998337|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
13136294|NCT02725411|25998338|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
13136295|NCT02725268|25998385|FG000|Overall Study|Death|58|||
13127357|NCT02901431|25962467|FG007|Open Label Part|Study Terminated By Sponsor|0|||
13127358|NCT02901431|25962468|FG008|Open Label Part|Study Terminated By Sponsor|35|||
13127359|NCT02901431|25962469|FG009|Open Label Part|Study Terminated By Sponsor|12|||
13127360|NCT02901431|25962470|FG010|Open Label Part|Study Terminated By Sponsor|21|||
13127361|NCT02901431|25962471|FG011|Open Label Part|Study Terminated By Sponsor|31|||
13127362|NCT02901431|25962472|FG012|Open Label Part|Study Terminated By Sponsor|0|||
13127363|NCT02901431|25962460|FG000|Open Label Part|Withdrawal by Subject|0|||
13127364|NCT02901431|25962461|FG001|Open Label Part|Withdrawal by Subject|0|||
13127365|NCT02901431|25962462|FG002|Open Label Part|Withdrawal by Subject|0|||
13127366|NCT02901431|25962463|FG003|Open Label Part|Withdrawal by Subject|0|||
13127367|NCT02901431|25962464|FG004|Open Label Part|Withdrawal by Subject|0|||
13127368|NCT02901431|25962465|FG005|Open Label Part|Withdrawal by Subject|0|||
13127369|NCT02901431|25962466|FG006|Open Label Part|Withdrawal by Subject|0|||
13127370|NCT02901431|25962467|FG007|Open Label Part|Withdrawal by Subject|0|||
13127371|NCT02901431|25962468|FG008|Open Label Part|Withdrawal by Subject|6|||
13127372|NCT02901431|25962469|FG009|Open Label Part|Withdrawal by Subject|5|||
13127373|NCT02901431|25962470|FG010|Open Label Part|Withdrawal by Subject|7|||
13127374|NCT02901431|25962471|FG011|Open Label Part|Withdrawal by Subject|3|||
13127375|NCT02901431|25962472|FG012|Open Label Part|Withdrawal by Subject|1|||
13127376|NCT02901054|25962478|FG000|Overall Study|Physician Decision|1|||
13127377|NCT02901054|25962478|FG000|Overall Study|Withdrawal by Subject|3|||
13127378|NCT02900378|25962529|FG000|Randomization (Visit 2)|Adverse Event|14|||
13127379|NCT02900378|25962530|FG001|Randomization (Visit 2)|Adverse Event|11|||
13127380|NCT02900378|25962529|FG000|Randomization (Visit 2)|Death|1|||
13127381|NCT02900378|25962530|FG001|Randomization (Visit 2)|Death|4|||
13127382|NCT02900378|25962529|FG000|Randomization (Visit 2)|Lost to Follow-up|1|||
13127383|NCT02900378|25962530|FG001|Randomization (Visit 2)|Lost to Follow-up|0|||
13127384|NCT02900378|25962529|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
13127385|NCT02900378|25962530|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
13127386|NCT02900378|25962529|FG000|Randomization (Visit 2)|Protocol Deviation|1|||
13127387|NCT02900378|25962530|FG001|Randomization (Visit 2)|Protocol Deviation|7|||
13127388|NCT02900378|25962529|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5|||
13127389|NCT02900378|25962530|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3|||
13127390|NCT02900378|25962529|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0|||
13127391|NCT02900378|25962530|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2|||
13127392|NCT02900170|25962536|FG000|Overall Study|Lost to Follow-up|8|||
13127393|NCT02900092|25962542|FG000|Overall Study|Adverse Event|1|||
13127394|NCT02899988|25962621|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
13127395|NCT02899988|25962622|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
13127396|NCT02899988|25962623|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
13127397|NCT02899988|25962624|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
13127398|NCT02899988|25962625|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
13127399|NCT02899988|25962626|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
13127400|NCT02899988|25962627|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
13127401|NCT02899988|25962628|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
13127402|NCT02899988|25962629|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
13127403|NCT02899988|25962630|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
13127404|NCT02899988|25962631|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
13127405|NCT02899988|25962621|FG000|Induction Period (16 Weeks)|Adverse Event|0|||
13127406|NCT02899988|25962622|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
13127407|NCT02899988|25962623|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
13127408|NCT02899988|25962624|FG003|Induction Period (16 Weeks)|Adverse Event|2|||
13127409|NCT02899988|25962625|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
13127410|NCT02899988|25962626|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
13127411|NCT02899988|25962627|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
13127412|NCT02899988|25962628|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
13127413|NCT02899988|25962629|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
13127414|NCT02899988|25962630|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
13127415|NCT02899988|25962631|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
13127416|NCT02899988|25962621|FG000|Induction Period (16 Weeks)|Physician Decision|0|||
13127417|NCT02899988|25962622|FG001|Induction Period (16 Weeks)|Physician Decision|1|||
13127418|NCT02899988|25962623|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
13127419|NCT02899988|25962624|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
13127420|NCT02899988|25962625|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
13127421|NCT02899988|25962626|FG005|Induction Period (16 Weeks)|Physician Decision|0|||
13127422|NCT02899988|25962627|FG006|Induction Period (16 Weeks)|Physician Decision|0|||
13127423|NCT02899988|25962628|FG007|Induction Period (16 Weeks)|Physician Decision|0|||
13127424|NCT02899988|25962629|FG008|Induction Period (16 Weeks)|Physician Decision|0|||
13127425|NCT02899988|25962630|FG009|Induction Period (16 Weeks)|Physician Decision|0|||
13127426|NCT02899988|25962631|FG010|Induction Period (16 Weeks)|Physician Decision|0|||
13136296|NCT02725268|25998386|FG001|Overall Study|Death|59|||
13127427|NCT02899988|25962621|FG000|Maintenance Period (88 Weeks)|Adverse Event|0|||
13127428|NCT02899988|25962622|FG001|Maintenance Period (88 Weeks)|Adverse Event|0|||
13127429|NCT02899988|25962623|FG002|Maintenance Period (88 Weeks)|Adverse Event|0|||
13127430|NCT02899988|25962624|FG003|Maintenance Period (88 Weeks)|Adverse Event|0|||
13127431|NCT02899988|25962625|FG004|Maintenance Period (88 Weeks)|Adverse Event|1|||
13127432|NCT02899988|25962626|FG005|Maintenance Period (88 Weeks)|Adverse Event|2|||
13127433|NCT02899988|25962627|FG006|Maintenance Period (88 Weeks)|Adverse Event|1|||
13127434|NCT02899988|25962628|FG007|Maintenance Period (88 Weeks)|Adverse Event|2|||
13127435|NCT02899988|25962629|FG008|Maintenance Period (88 Weeks)|Adverse Event|2|||
13127436|NCT02899988|25962630|FG009|Maintenance Period (88 Weeks)|Adverse Event|2|||
13127437|NCT02899988|25962631|FG010|Maintenance Period (88 Weeks)|Adverse Event|1|||
13127438|NCT02899988|25962621|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
13127439|NCT02899988|25962622|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
13127440|NCT02899988|25962623|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
13127441|NCT02899988|25962624|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
13127442|NCT02899988|25962625|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
13127443|NCT02899988|25962626|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
13127444|NCT02899988|25962627|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
13127445|NCT02899988|25962628|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
13127446|NCT02899988|25962629|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
13127447|NCT02899988|25962630|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
13127448|NCT02899988|25962631|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
13127449|NCT02899988|25962621|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
13127450|NCT02899988|25962622|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
13127451|NCT02899988|25962623|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
13127452|NCT02899988|25962624|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
13127453|NCT02899988|25962625|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
13127454|NCT02899988|25962626|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
13127455|NCT02899988|25962627|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3|||
13127456|NCT02899988|25962628|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
13127457|NCT02899988|25962629|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
13127458|NCT02899988|25962630|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
13127459|NCT02899988|25962631|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
13127460|NCT02899962|25962646|FG000|Open-label Phase|Adverse Event|2|||
13127461|NCT02899962|25962647|FG001|Open-label Phase|Adverse Event|0|||
13127462|NCT02899962|25962648|FG002|Open-label Phase|Adverse Event|0|||
13127463|NCT02899962|25962646|FG000|Open-label Phase|Lost to Follow-up|9|||
13127464|NCT02899962|25962647|FG001|Open-label Phase|Lost to Follow-up|0|||
13127465|NCT02899962|25962648|FG002|Open-label Phase|Lost to Follow-up|0|||
13127466|NCT02899962|25962646|FG000|Open-label Phase|Other reasons|9|||
13127467|NCT02899962|25962647|FG001|Open-label Phase|Other reasons|0|||
13127468|NCT02899962|25962648|FG002|Open-label Phase|Other reasons|0|||
13127469|NCT02899962|25962646|FG000|Open-label Phase|Withdrawal by Subject|7|||
13127470|NCT02899962|25962647|FG001|Open-label Phase|Withdrawal by Subject|0|||
13127471|NCT02899962|25962648|FG002|Open-label Phase|Withdrawal by Subject|0|||
13127472|NCT02899962|25962646|FG000|Maintenance Phase|Adverse Event|0|||
13127473|NCT02899962|25962647|FG001|Maintenance Phase|Adverse Event|2|||
13127474|NCT02899962|25962648|FG002|Maintenance Phase|Adverse Event|1|||
13127475|NCT02899962|25962646|FG000|Maintenance Phase|Death|0|||
13127476|NCT02899962|25962647|FG001|Maintenance Phase|Death|0|||
13127477|NCT02899962|25962648|FG002|Maintenance Phase|Death|1|||
13127478|NCT02899962|25962646|FG000|Maintenance Phase|Lack of Efficacy|0|||
13127479|NCT02899962|25962647|FG001|Maintenance Phase|Lack of Efficacy|20|||
13127480|NCT02899962|25962648|FG002|Maintenance Phase|Lack of Efficacy|16|||
13127481|NCT02899962|25962646|FG000|Maintenance Phase|Lost to Follow-up|0|||
13127482|NCT02899962|25962647|FG001|Maintenance Phase|Lost to Follow-up|12|||
13127483|NCT02899962|25962648|FG002|Maintenance Phase|Lost to Follow-up|14|||
13127484|NCT02899962|25962646|FG000|Maintenance Phase|Other reasons|0|||
13127485|NCT02899962|25962647|FG001|Maintenance Phase|Other reasons|9|||
13127486|NCT02899962|25962648|FG002|Maintenance Phase|Other reasons|13|||
13127487|NCT02899962|25962646|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0|||
13127488|NCT02899962|25962647|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3|||
13127489|NCT02899962|25962648|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2|||
13127490|NCT02899962|25962646|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0|||
13127491|NCT02899962|25962647|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65|||
13127492|NCT02899962|25962648|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70|||
13127493|NCT02899962|25962646|FG000|Maintenance Phase|Withdrawal by Subject|0|||
13127494|NCT02899962|25962647|FG001|Maintenance Phase|Withdrawal by Subject|30|||
13127495|NCT02899962|25962648|FG002|Maintenance Phase|Withdrawal by Subject|36|||
13127496|NCT02899728|25962667|FG000|Overall Study|Withdrawal by Subject|1|||
13127497|NCT02899728|25962668|FG001|Overall Study|Withdrawal by Subject|1|||
13127498|NCT02899377|25962706|FG000|Overall Study|Adverse Event|1|||
13127499|NCT02899377|25962707|FG001|Overall Study|Adverse Event|0|||
13127500|NCT02899338|25962726|FG000|Overall Study|Adverse Event|1|||
13127501|NCT02899338|25962727|FG001|Overall Study|Adverse Event|2|||
13127502|NCT02899338|25962726|FG000|Overall Study|Withdrawal by Subject|2|||
13127503|NCT02899338|25962727|FG001|Overall Study|Withdrawal by Subject|0|||
13127504|NCT02899195|25962737|FG000|Concurrent Durvalumab|Adverse Event|4|||
13127505|NCT02899195|25962737|FG000|Concurrent Durvalumab|Physician Decision|1|||
13127506|NCT02899195|25962737|FG000|Concurrent Durvalumab|Withdrawal by Subject|1|||
13127507|NCT02899195|25962737|FG000|Concurrent Durvalumab|Progressive Disease|5|||
13127508|NCT02899195|25962737|FG000|Maintenance Durvalumab|Adverse Event|1|||
13127509|NCT02899195|25962737|FG000|Maintenance Durvalumab|Physician Decision|1|||
13127510|NCT02899195|25962737|FG000|Maintenance Durvalumab|Withdrawal by Subject|1|||
13127511|NCT02899195|25962737|FG000|Maintenance Durvalumab|Progressive Disease|31|||
13127512|NCT02899156|25962762|FG000|Overall Study|Death|1|||
13127513|NCT02899156|25962763|FG001|Overall Study|Death|0|||
13127514|NCT02899156|25962762|FG000|Overall Study|Physician Decision|0|||
13127515|NCT02899156|25962763|FG001|Overall Study|Physician Decision|1|||
13127516|NCT02898662|25962792|FG000|Overall Study|Adverse Event|1|||
13127517|NCT02898662|25962793|FG001|Overall Study|Adverse Event|0|||
13127518|NCT02898662|25962792|FG000|Overall Study|Loss of asthma control|23|||
13127519|NCT02898662|25962793|FG001|Overall Study|Loss of asthma control|24|||
13127520|NCT02898662|25962792|FG000|Overall Study|Withdrawal by Subject|4|||
13127521|NCT02898662|25962793|FG001|Overall Study|Withdrawal by Subject|1|||
13127522|NCT02898662|25962792|FG000|Overall Study|Technical issue|0|||
13127523|NCT02898662|25962793|FG001|Overall Study|Technical issue|1|||
13127524|NCT02898662|25962792|FG000|Overall Study|Randomized in error|0|||
13127525|NCT02898662|25962793|FG001|Overall Study|Randomized in error|1|||
13127526|NCT02898662|25962792|FG000|Overall Study|Subject decision|1|||
13127527|NCT02898662|25962793|FG001|Overall Study|Subject decision|0|||
13127528|NCT02898662|25962792|FG000|Overall Study|Other|0|||
13127529|NCT02898662|25962793|FG001|Overall Study|Other|1|||
13127530|NCT02898597|25962806|FG000|Overall Study|Protocol Violation|4|||
13127531|NCT02898597|25962807|FG001|Overall Study|Protocol Violation|2|||
13127532|NCT02898597|25962806|FG000|Overall Study|Lost to Follow-up|0|||
13127533|NCT02898597|25962807|FG001|Overall Study|Lost to Follow-up|9|||
13127534|NCT02898597|25962806|FG000|Overall Study|Death|0|||
13127535|NCT02898597|25962807|FG001|Overall Study|Death|1|||
13127536|NCT02898454|25962930|FG000|Overall Study|Adverse Event|4|||
13127537|NCT02898454|25962931|FG001|Overall Study|Adverse Event|1|||
13127538|NCT02898454|25962932|FG002|Overall Study|Adverse Event|2|||
13127539|NCT02898454|25962930|FG000|Overall Study|Protocol Violation|1|||
13127540|NCT02898454|25962931|FG001|Overall Study|Protocol Violation|0|||
13127541|NCT02898454|25962932|FG002|Overall Study|Protocol Violation|1|||
13127542|NCT02898454|25962930|FG000|Overall Study|Lack of Efficacy|4|||
13127543|NCT02898454|25962931|FG001|Overall Study|Lack of Efficacy|1|||
13127544|NCT02898454|25962932|FG002|Overall Study|Lack of Efficacy|0|||
13127545|NCT02898454|25962930|FG000|Overall Study|Withdrawal by Subject|6|||
13127546|NCT02898454|25962931|FG001|Overall Study|Withdrawal by Subject|3|||
13127547|NCT02898454|25962932|FG002|Overall Study|Withdrawal by Subject|3|||
13127548|NCT02898454|25962930|FG000|Overall Study|Lost to Follow-up|1|||
13127549|NCT02898454|25962931|FG001|Overall Study|Lost to Follow-up|0|||
13127550|NCT02898454|25962932|FG002|Overall Study|Lost to Follow-up|0|||
13127551|NCT02898454|25962930|FG000|Overall Study|Did Not Met Eligibility Criteria|1|||
13127552|NCT02898454|25962931|FG001|Overall Study|Did Not Met Eligibility Criteria|0|||
13127553|NCT02898454|25962932|FG002|Overall Study|Did Not Met Eligibility Criteria|0|||
13133557|NCT02768298|25988403|FG001|Overall Study|Subject/guardian decision|0|||
13133558|NCT02768298|25988402|FG000|Overall Study|Withdrawal of informed consent|0|||
13133559|NCT02768298|25988403|FG001|Overall Study|Withdrawal of informed consent|1|||
13133560|NCT02768194|25988421|FG000|Period 1|Adverse Event|0|||
13133561|NCT02768194|25988422|FG001|Period 1|Adverse Event|0|||
13133562|NCT02768194|25988423|FG002|Period 1|Adverse Event|0|||
13133563|NCT02768194|25988424|FG003|Period 1|Adverse Event|1|||
13133564|NCT02768194|25988425|FG004|Period 1|Adverse Event|0|||
13133565|NCT02768194|25988426|FG005|Period 1|Adverse Event|0|||
13133566|NCT02768194|25988421|FG000|Period 2|Other (Reason not specified)|1|||
13133567|NCT02768194|25988422|FG001|Period 2|Other (Reason not specified)|0|||
13133568|NCT02768194|25988423|FG002|Period 2|Other (Reason not specified)|0|||
13133569|NCT02768194|25988424|FG003|Period 2|Other (Reason not specified)|0|||
13133570|NCT02768194|25988425|FG004|Period 2|Other (Reason not specified)|0|||
13133571|NCT02768194|25988426|FG005|Period 2|Other (Reason not specified)|0|||
13133572|NCT02768194|25988421|FG000|Period 3|Other (Reason not specified)|0|||
13133573|NCT02768194|25988422|FG001|Period 3|Other (Reason not specified)|1|||
13133574|NCT02768194|25988423|FG002|Period 3|Other (Reason not specified)|0|||
13133575|NCT02768194|25988424|FG003|Period 3|Other (Reason not specified)|0|||
13133576|NCT02768194|25988425|FG004|Period 3|Other (Reason not specified)|0|||
13133577|NCT02768194|25988426|FG005|Period 3|Other (Reason not specified)|0|||
13133578|NCT02768103|25988434|FG000|Overall Study|1 participant did not fit in the fMRI|1|||
13133579|NCT02767856|25988453|FG000|Overall Study|Lost to Follow-up|9|||
13133580|NCT02767856|25988454|FG001|Overall Study|Lost to Follow-up|1|||
13127554|NCT02898259|25962986|FG000|Overall Study|Adverse Event|0|||
13127555|NCT02898259|25962987|FG001|Overall Study|Adverse Event|0|||
13127556|NCT02898259|25962988|FG002|Overall Study|Adverse Event|1|||
13127557|NCT02898259|25962989|FG003|Overall Study|Adverse Event|0|||
13127558|NCT02898259|25962990|FG004|Overall Study|Adverse Event|0|||
13127559|NCT02898259|25962986|FG000|Overall Study|Lack of Efficacy|1|||
13127560|NCT02898259|25962987|FG001|Overall Study|Lack of Efficacy|1|||
13127561|NCT02898259|25962988|FG002|Overall Study|Lack of Efficacy|3|||
13127562|NCT02898259|25962989|FG003|Overall Study|Lack of Efficacy|0|||
13127563|NCT02898259|25962990|FG004|Overall Study|Lack of Efficacy|0|||
13127564|NCT02898259|25962986|FG000|Overall Study|Lost to Follow-up|0|||
13127565|NCT02898259|25962987|FG001|Overall Study|Lost to Follow-up|0|||
13127566|NCT02898259|25962988|FG002|Overall Study|Lost to Follow-up|1|||
13127567|NCT02898259|25962989|FG003|Overall Study|Lost to Follow-up|0|||
13127568|NCT02898259|25962990|FG004|Overall Study|Lost to Follow-up|0|||
13127569|NCT02898259|25962986|FG000|Overall Study|Transformation before study began|0|||
13127570|NCT02898259|25962987|FG001|Overall Study|Transformation before study began|0|||
13127571|NCT02898259|25962988|FG002|Overall Study|Transformation before study began|0|||
13127572|NCT02898259|25962989|FG003|Overall Study|Transformation before study began|1|||
13127573|NCT02898259|25962990|FG004|Overall Study|Transformation before study began|0|||
13127574|NCT02898116|25962998|FG000|Overall Study|Adverse Event|1|||
13127575|NCT02898116|25962998|FG000|Overall Study|Progressive disease|1|||
13127576|NCT02897349|25963025|FG000|Overall Study|Lost to Follow-up|2|||
13127577|NCT02897349|25963026|FG001|Overall Study|Lost to Follow-up|2|||
13127578|NCT02897349|25963025|FG000|Overall Study|Adverse Event|3|||
13127579|NCT02897349|25963026|FG001|Overall Study|Adverse Event|3|||
13127580|NCT02897349|25963025|FG000|Overall Study|Other than listed above|0|||
13127581|NCT02897349|25963026|FG001|Overall Study|Other than listed above|1|||
13127582|NCT02897115|25963103|FG000|Overall Study|Early termination of study by sponsor|11|||
13127583|NCT02897115|25963104|FG001|Overall Study|Early termination of study by sponsor|8|||
13127584|NCT02896569|25963129|FG000|Overall Study|Lost to Follow-up|2|||
13127585|NCT02896569|25963130|FG001|Overall Study|Lost to Follow-up|1|||
13127586|NCT02896569|25963129|FG000|Overall Study|Physician Decision|1|||
13127587|NCT02896569|25963130|FG001|Overall Study|Physician Decision|3|||
13127588|NCT02896569|25963129|FG000|Overall Study|Adverse Event|0|||
13127589|NCT02896569|25963130|FG001|Overall Study|Adverse Event|1|||
13127590|NCT02896569|25963129|FG000|Overall Study|Withdrawal by Subject|1|||
13127591|NCT02896569|25963130|FG001|Overall Study|Withdrawal by Subject|0|||
13127592|NCT02896400|25963205|FG000|1 Month Follow-up|Lost to Follow-up|7|||
13127593|NCT02896400|25963206|FG001|1 Month Follow-up|Lost to Follow-up|7|||
13127594|NCT02896400|25963207|FG002|1 Month Follow-up|Lost to Follow-up|5|||
13127595|NCT02896400|25963208|FG003|1 Month Follow-up|Lost to Follow-up|8|||
13127596|NCT02896400|25963209|FG004|1 Month Follow-up|Lost to Follow-up|9|||
13127597|NCT02896400|25963210|FG005|1 Month Follow-up|Lost to Follow-up|6|||
13127598|NCT02896400|25963211|FG006|1 Month Follow-up|Lost to Follow-up|5|||
13127599|NCT02896400|25963212|FG007|1 Month Follow-up|Lost to Follow-up|6|||
13127600|NCT02896400|25963213|FG008|1 Month Follow-up|Lost to Follow-up|4|||
13127601|NCT02896400|25963214|FG009|1 Month Follow-up|Lost to Follow-up|7|||
13127602|NCT02896400|25963215|FG010|1 Month Follow-up|Lost to Follow-up|5|||
13127603|NCT02896400|25963216|FG011|1 Month Follow-up|Lost to Follow-up|5|||
13127604|NCT02896400|25963217|FG012|1 Month Follow-up|Lost to Follow-up|3|||
13127605|NCT02896400|25963218|FG013|1 Month Follow-up|Lost to Follow-up|4|||
13136297|NCT02725268|25998387|FG002|Overall Study|Death|30|||
13127606|NCT02896400|25963219|FG014|1 Month Follow-up|Lost to Follow-up|1|||
13127607|NCT02896400|25963220|FG015|1 Month Follow-up|Lost to Follow-up|2|||
13127608|NCT02896400|25963205|FG000|1 Month Follow-up|Death|0|||
13127609|NCT02896400|25963206|FG001|1 Month Follow-up|Death|0|||
13127610|NCT02896400|25963207|FG002|1 Month Follow-up|Death|0|||
13127611|NCT02896400|25963208|FG003|1 Month Follow-up|Death|0|||
13127612|NCT02896400|25963209|FG004|1 Month Follow-up|Death|0|||
13127613|NCT02896400|25963210|FG005|1 Month Follow-up|Death|0|||
13127614|NCT02896400|25963211|FG006|1 Month Follow-up|Death|0|||
13127615|NCT02896400|25963212|FG007|1 Month Follow-up|Death|0|||
13127616|NCT02896400|25963213|FG008|1 Month Follow-up|Death|0|||
13127617|NCT02896400|25963214|FG009|1 Month Follow-up|Death|0|||
13127618|NCT02896400|25963215|FG010|1 Month Follow-up|Death|0|||
13127619|NCT02896400|25963216|FG011|1 Month Follow-up|Death|0|||
13127620|NCT02896400|25963217|FG012|1 Month Follow-up|Death|0|||
13127621|NCT02896400|25963218|FG013|1 Month Follow-up|Death|0|||
13127622|NCT02896400|25963219|FG014|1 Month Follow-up|Death|0|||
13127623|NCT02896400|25963220|FG015|1 Month Follow-up|Death|1|||
13127624|NCT02896400|25963205|FG000|3 Month Follow-up|Lost to Follow-up|6|||
13127625|NCT02896400|25963206|FG001|3 Month Follow-up|Lost to Follow-up|3|||
13127626|NCT02896400|25963207|FG002|3 Month Follow-up|Lost to Follow-up|6|||
13127627|NCT02896400|25963208|FG003|3 Month Follow-up|Lost to Follow-up|11|||
13127628|NCT02896400|25963209|FG004|3 Month Follow-up|Lost to Follow-up|12|||
13127629|NCT02896400|25963210|FG005|3 Month Follow-up|Lost to Follow-up|6|||
13127630|NCT02896400|25963211|FG006|3 Month Follow-up|Lost to Follow-up|4|||
13127631|NCT02896400|25963212|FG007|3 Month Follow-up|Lost to Follow-up|3|||
13127632|NCT02896400|25963213|FG008|3 Month Follow-up|Lost to Follow-up|6|||
13127633|NCT02896400|25963214|FG009|3 Month Follow-up|Lost to Follow-up|5|||
13127634|NCT02896400|25963215|FG010|3 Month Follow-up|Lost to Follow-up|6|||
13127635|NCT02896400|25963216|FG011|3 Month Follow-up|Lost to Follow-up|6|||
13127636|NCT02896400|25963217|FG012|3 Month Follow-up|Lost to Follow-up|3|||
13127637|NCT02896400|25963218|FG013|3 Month Follow-up|Lost to Follow-up|5|||
13127638|NCT02896400|25963219|FG014|3 Month Follow-up|Lost to Follow-up|3|||
13127639|NCT02896400|25963220|FG015|3 Month Follow-up|Lost to Follow-up|2|||
13127640|NCT02896400|25963205|FG000|3 Month Follow-up|Death|0|||
13127641|NCT02896400|25963206|FG001|3 Month Follow-up|Death|0|||
13127642|NCT02896400|25963207|FG002|3 Month Follow-up|Death|0|||
13127643|NCT02896400|25963208|FG003|3 Month Follow-up|Death|0|||
13127644|NCT02896400|25963209|FG004|3 Month Follow-up|Death|0|||
13127645|NCT02896400|25963210|FG005|3 Month Follow-up|Death|0|||
13127646|NCT02896400|25963211|FG006|3 Month Follow-up|Death|0|||
13127647|NCT02896400|25963212|FG007|3 Month Follow-up|Death|0|||
13127648|NCT02896400|25963213|FG008|3 Month Follow-up|Death|0|||
13127649|NCT02896400|25963214|FG009|3 Month Follow-up|Death|0|||
13127650|NCT02896400|25963215|FG010|3 Month Follow-up|Death|0|||
13127651|NCT02896400|25963216|FG011|3 Month Follow-up|Death|0|||
13127652|NCT02896400|25963217|FG012|3 Month Follow-up|Death|0|||
13127653|NCT02896400|25963218|FG013|3 Month Follow-up|Death|1|||
13127654|NCT02896400|25963219|FG014|3 Month Follow-up|Death|1|||
13127655|NCT02896400|25963220|FG015|3 Month Follow-up|Death|0|||
13127656|NCT02896400|25963205|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
13127657|NCT02896400|25963206|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
13127658|NCT02896400|25963207|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
13127659|NCT02896400|25963208|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
13127660|NCT02896400|25963209|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
13127661|NCT02896400|25963210|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
13127662|NCT02896400|25963211|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
13127663|NCT02896400|25963212|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2|||
13127664|NCT02896400|25963213|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
13127665|NCT02896400|25963214|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
13127666|NCT02896400|25963215|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
13127667|NCT02896400|25963216|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
13127668|NCT02896400|25963217|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
13127669|NCT02896400|25963218|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
13127670|NCT02896400|25963219|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
13127671|NCT02896400|25963220|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
13127672|NCT02896400|25963205|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
13127673|NCT02896400|25963206|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
13127674|NCT02896400|25963207|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46|||
13127675|NCT02896400|25963208|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40|||
13127676|NCT02896400|25963209|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
13127677|NCT02896400|25963210|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
13127678|NCT02896400|25963211|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
13127679|NCT02896400|25963212|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47|||
13127680|NCT02896400|25963213|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44|||
13127681|NCT02896400|25963214|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
13127682|NCT02896400|25963215|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55|||
13127683|NCT02896400|25963216|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41|||
13127684|NCT02896400|25963217|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
13127685|NCT02896400|25963218|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
13127686|NCT02896400|25963219|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
13127687|NCT02896400|25963220|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56|||
13127688|NCT02896361|25963242|FG000|Third Intervention (2 Weeks)|Protocol Violation|1|||
13127689|NCT02896361|25963243|FG001|Third Intervention (2 Weeks)|Protocol Violation|0|||
13127690|NCT02896361|25963244|FG002|Third Intervention (2 Weeks)|Protocol Violation|0|||
13127691|NCT02896361|25963242|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
13127692|NCT02896361|25963243|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1|||
13127693|NCT02896361|25963244|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
13127694|NCT02896296|25963252|FG000|Overall Study|Adverse Event|1|||
13127695|NCT02896296|25963252|FG000|Overall Study|Lost to Follow-up|19|||
13127696|NCT02896296|25963252|FG000|Overall Study|Pregnancy|1|||
13127697|NCT02896296|25963252|FG000|Overall Study|Physician Decision|2|||
13127698|NCT02896296|25963252|FG000|Overall Study|Withdrawal by Subject|10|||
13127699|NCT02896296|25963252|FG000|Overall Study|Site closing|7|||
13127700|NCT02896296|25963252|FG000|Overall Study|Incarceration|1|||
13127701|NCT02896296|25963252|FG000|Overall Study|Relocation|1|||
13127702|NCT02896127|25963279|FG000|COMPLETED WEEK 52|Adverse Event|9|||
13127703|NCT02896127|25963280|FG001|COMPLETED WEEK 52|Adverse Event|2|||
13127704|NCT02896127|25963279|FG000|COMPLETED WEEK 52|Lack of Efficacy|2|||
13127705|NCT02896127|25963280|FG001|COMPLETED WEEK 52|Lack of Efficacy|3|||
13127706|NCT02896127|25963279|FG000|COMPLETED WEEK 52|Lost to Follow-up|0|||
13127707|NCT02896127|25963280|FG001|COMPLETED WEEK 52|Lost to Follow-up|1|||
13127708|NCT02896127|25963279|FG000|COMPLETED WEEK 52|Physician Decision|1|||
13127709|NCT02896127|25963280|FG001|COMPLETED WEEK 52|Physician Decision|1|||
13127710|NCT02896127|25963279|FG000|COMPLETED WEEK 52|Pregnancy|2|||
13127711|NCT02896127|25963280|FG001|COMPLETED WEEK 52|Pregnancy|0|||
13127712|NCT02896127|25963279|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12|||
13127713|NCT02896127|25963280|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4|||
13127714|NCT02896127|25963279|FG000|COMPLETED WEEK 52|Technical problems|1|||
13127715|NCT02896127|25963280|FG001|COMPLETED WEEK 52|Technical problems|0|||
13127716|NCT02896127|25963279|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2|||
13127717|NCT02896127|25963280|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3|||
13127718|NCT02896127|25963279|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0|||
13127719|NCT02896127|25963280|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1|||
13127720|NCT02896127|25963279|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1|||
13127721|NCT02896127|25963280|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0|||
13127722|NCT02896127|25963279|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1|||
13127723|NCT02896127|25963280|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0|||
13127724|NCT02896127|25963279|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0|||
13127725|NCT02896127|25963280|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1|||
13127726|NCT02895945|25963326|FG000|Overall Study|Physician Decision|2|||
13127727|NCT02895945|25963327|FG001|Overall Study|Physician Decision|1|||
13127728|NCT02895347|25963343|FG000|Overall Study|Withdrawal by Subject|3|||
13127729|NCT02895347|25963344|FG001|Overall Study|Withdrawal by Subject|1|||
13127730|NCT02895295|25963371|FG000|Overall Study|Survey Non-response|71|||
13127731|NCT02895295|25963372|FG001|Overall Study|Survey Non-response|94|||
13127732|NCT02895295|25963373|FG002|Overall Study|Survey Non-response|92|||
13127733|NCT02894840|25963408|FG000|Overall Study|Lost to Follow-up|1|||
13127734|NCT02894840|25963409|FG001|Overall Study|Lost to Follow-up|0|||
13127735|NCT02894840|25963410|FG002|Overall Study|Lost to Follow-up|3|||
13127736|NCT02894840|25963411|FG003|Overall Study|Lost to Follow-up|0|||
13127737|NCT02894502|25963435|FG000|Baseline|Withdrawal by Subject|24|||
13127738|NCT02894502|25963436|FG001|Baseline|Withdrawal by Subject|31|||
13127739|NCT02894502|25963437|FG002|Baseline|Withdrawal by Subject|36|||
13127740|NCT02894502|25963435|FG000|Baseline|Death|3|||
13127741|NCT02894502|25963436|FG001|Baseline|Death|1|||
13127742|NCT02894502|25963437|FG002|Baseline|Death|9|||
13127743|NCT02894502|25963435|FG000|First Follow up|Withdrawal by Subject|32|||
13127744|NCT02894502|25963436|FG001|First Follow up|Withdrawal by Subject|29|||
13127745|NCT02894502|25963437|FG002|First Follow up|Withdrawal by Subject|37|||
13127746|NCT02894502|25963435|FG000|First Follow up|Death|2|||
13127747|NCT02894502|25963436|FG001|First Follow up|Death|2|||
13127748|NCT02894502|25963437|FG002|First Follow up|Death|3|||
13127749|NCT02894502|25963435|FG000|Second Follow up|Withdrawal by Subject|13|||
13127750|NCT02894502|25963436|FG001|Second Follow up|Withdrawal by Subject|15|||
13127751|NCT02894502|25963437|FG002|Second Follow up|Withdrawal by Subject|13|||
13127752|NCT02894502|25963435|FG000|Second Follow up|Death|2|||
13127753|NCT02894502|25963436|FG001|Second Follow up|Death|3|||
13127754|NCT02894502|25963437|FG002|Second Follow up|Death|1|||
13127755|NCT02894502|25963435|FG000|Third Follow up|Withdrawal by Subject|5|||
13127756|NCT02894502|25963436|FG001|Third Follow up|Withdrawal by Subject|6|||
13127757|NCT02894502|25963437|FG002|Third Follow up|Withdrawal by Subject|3|||
13127758|NCT02894502|25963435|FG000|Third Follow up|Death|1|||
13127759|NCT02894502|25963436|FG001|Third Follow up|Death|1|||
13127760|NCT02894502|25963437|FG002|Third Follow up|Death|0|||
13127761|NCT02892760|25963479|FG000|Overall Study|Withdrawal by Subject|3|||
13127762|NCT02892734|25963489|FG000|Treatment on Study|Progressive Disease|2|||
13127763|NCT02892734|25963489|FG000|Follow up for 2 Years|Death|2|||
13127764|NCT02892734|25963489|FG000|Follow up for 2 Years|Study closed early|1|||
13127765|NCT02892513|25963502|FG000|Overall Study|Withdrawal by Subject|0|||
13127766|NCT02892513|25963503|FG001|Overall Study|Withdrawal by Subject|1|||
13127767|NCT02892448|25963533|FG000|Overall Study|Screening failure|2|||
13127768|NCT02892448|25963534|FG001|Overall Study|Screening failure|2|||
13127769|NCT02892448|25963535|FG002|Overall Study|Screening failure|1|||
13127770|NCT02892422|25963541|FG000|Overall Study|Enrolled not treated|4|||
13127771|NCT02892422|25963541|FG000|Overall Study|Adverse Event|38|||
13127772|NCT02892422|25963541|FG000|Overall Study|Lack of Efficacy|32|||
13127773|NCT02892422|25963541|FG000|Overall Study|Non-compliance with study drug|11|||
13127774|NCT02892422|25963541|FG000|Overall Study|Protocol Violation|4|||
13127775|NCT02892422|25963541|FG000|Overall Study|Withdrawal by Subject|56|||
13127776|NCT02892422|25963541|FG000|Overall Study|Lost to Follow-up|5|||
13127777|NCT02892422|25963541|FG000|Overall Study|sponsor information 16159A results|21|||
13127778|NCT02892422|25963541|FG000|Overall Study|withdrawal of consent|13|||
13127779|NCT02892422|25963541|FG000|Overall Study|exclusion criteria met|3|||
13127780|NCT02892422|25963541|FG000|Overall Study|moving elsewhere|4|||
13127781|NCT02892422|25963541|FG000|Overall Study|non-compliance|10|||
13127782|NCT02892422|25963541|FG000|Overall Study|patient legally incapable|1|||
13127783|NCT02892422|25963541|FG000|Overall Study|patient decision|7|||
13127784|NCT02892422|25963541|FG000|Overall Study|Investigator decision|1|||
13127785|NCT02892409|25963568|FG000|Overall Study|Adverse Event|1|||
13127786|NCT02892409|25963569|FG001|Overall Study|Adverse Event|0|||
13127787|NCT02892409|25963568|FG000|Overall Study|Withdrawal by Subject|2|||
13127788|NCT02892409|25963569|FG001|Overall Study|Withdrawal by Subject|1|||
13127789|NCT02892344|25963610|FG000|Overall Study|Protocol deviation|3|||
13127790|NCT02892344|25963611|FG001|Overall Study|Protocol deviation|4|||
13127791|NCT02892344|25963610|FG000|Overall Study|Adverse Event|1|||
13127792|NCT02892344|25963611|FG001|Overall Study|Adverse Event|8|||
13127793|NCT02892344|25963610|FG000|Overall Study|Lost to Follow-up|0|||
13127794|NCT02892344|25963611|FG001|Overall Study|Lost to Follow-up|1|||
13127795|NCT02892344|25963610|FG000|Overall Study|Non-compliance with study treatment|0|||
13127796|NCT02892344|25963611|FG001|Overall Study|Non-compliance with study treatment|1|||
13127797|NCT02892344|25963610|FG000|Overall Study|Physician Decision|0|||
13127798|NCT02892344|25963611|FG001|Overall Study|Physician Decision|2|||
13127799|NCT02892344|25963610|FG000|Overall Study|Subject/guardian decision|0|||
13127800|NCT02892344|25963611|FG001|Overall Study|Subject/guardian decision|4|||
13127801|NCT02892344|25963610|FG000|Overall Study|Technical problems|0|||
13127802|NCT02892344|25963611|FG001|Overall Study|Technical problems|1|||
13127803|NCT02892149|25963636|FG000|Overall Study|Death|262|||
13127804|NCT02892149|25963637|FG001|Overall Study|Death|278|||
13127805|NCT02892149|25963636|FG000|Overall Study|Withdrawal by Subject|53|||
13127806|NCT02892149|25963637|FG001|Overall Study|Withdrawal by Subject|47|||
13127807|NCT02892149|25963636|FG000|Overall Study|Lost to Follow-up|37|||
13127808|NCT02892149|25963637|FG001|Overall Study|Lost to Follow-up|31|||
13127809|NCT02892019|25963666|FG000|Overall Study|randomized but not treated|0|||
13127810|NCT02892019|25963667|FG001|Overall Study|randomized but not treated|1|||
13127811|NCT02892019|25963666|FG000|Overall Study|Withdrawal by Subject|0|||
13127812|NCT02892019|25963667|FG001|Overall Study|Withdrawal by Subject|1|||
13127813|NCT02892019|25963666|FG000|Overall Study|Adverse Event|1|||
13127814|NCT02892019|25963667|FG001|Overall Study|Adverse Event|1|||
13127815|NCT02891915|25963702|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
13127816|NCT02891915|25963703|FG001|Overall Study|Enrolled but Treatment Not Administered|4|||
13127817|NCT02891915|25963702|FG000|Overall Study|Withdrawal by Subject|3|||
13127818|NCT02891915|25963703|FG001|Overall Study|Withdrawal by Subject|3|||
13127819|NCT02891915|25963702|FG000|Overall Study|Became Ineligible After Enrollment|2|||
13127820|NCT02891915|25963703|FG001|Overall Study|Became Ineligible After Enrollment|1|||
13127821|NCT02891915|25963702|FG000|Overall Study|Lost to Follow-up|1|||
13127822|NCT02891915|25963703|FG001|Overall Study|Lost to Follow-up|4|||
13127823|NCT02891915|25963702|FG000|Overall Study|Physician Decision|1|||
13127824|NCT02891915|25963703|FG001|Overall Study|Physician Decision|0|||
13127825|NCT02891850|25963724|FG000|Overall Study|Adverse Event|3|||
13127826|NCT02891850|25963725|FG001|Overall Study|Adverse Event|0|||
13127827|NCT02891850|25963724|FG000|Overall Study|Death|0|||
13127828|NCT02891850|25963725|FG001|Overall Study|Death|4|||
13127829|NCT02891850|25963724|FG000|Overall Study|Physician Decision|1|||
13127830|NCT02891850|25963725|FG001|Overall Study|Physician Decision|0|||
13127831|NCT02891850|25963724|FG000|Overall Study|Pregnancy|1|||
13127832|NCT02891850|25963725|FG001|Overall Study|Pregnancy|0|||
13127833|NCT02891850|25963724|FG000|Overall Study|Withdrawal by Subject|2|||
13127834|NCT02891850|25963725|FG001|Overall Study|Withdrawal by Subject|3|||
13127835|NCT02891681|25963743|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
13127836|NCT02891681|25963744|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
13127837|NCT02891681|25963745|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1|||
13127838|NCT02891681|25963743|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2|||
13127839|NCT02891681|25963744|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
13127840|NCT02891681|25963745|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
13127841|NCT02891681|25963743|FG000|Overall Study|Taken off study after first imaging appointment|1|||
13127842|NCT02891681|25963744|FG001|Overall Study|Taken off study after first imaging appointment|0|||
13127843|NCT02891681|25963745|FG002|Overall Study|Taken off study after first imaging appointment|0|||
13127844|NCT02891408|25963878|FG000|Overall Study|Lost to Follow-up|0|||
13127845|NCT02891408|25963879|FG001|Overall Study|Lost to Follow-up|0|||
13127846|NCT02891408|25963880|FG002|Overall Study|Lost to Follow-up|1|||
13127847|NCT02891408|25963881|FG003|Overall Study|Lost to Follow-up|0|||
13127848|NCT02891408|25963882|FG004|Overall Study|Lost to Follow-up|0|||
13127849|NCT02891408|25963883|FG005|Overall Study|Lost to Follow-up|0|||
13127850|NCT02891408|25963884|FG006|Overall Study|Lost to Follow-up|0|||
13127851|NCT02891226|25963961|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4|||
13127852|NCT02891226|25963962|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1|||
13127853|NCT02891226|25963963|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3|||
13127854|NCT02891226|25963964|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
13127855|NCT02891226|25963965|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
13127856|NCT02891226|25963966|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
13127857|NCT02891226|25963967|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
13127858|NCT02891226|25963968|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
13127859|NCT02891226|25963969|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
13127860|NCT02891226|25963970|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
13127861|NCT02891226|25963971|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
13127862|NCT02891226|25963972|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
13127863|NCT02891226|25963973|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
13127864|NCT02891226|25963974|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
13127865|NCT02891226|25963975|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
13127866|NCT02891226|25963976|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
13127867|NCT02891226|25963961|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
13127868|NCT02891226|25963962|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
13127869|NCT02891226|25963963|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
13127870|NCT02891226|25963964|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
13127871|NCT02891226|25963965|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
13127872|NCT02891226|25963966|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
13127873|NCT02891226|25963967|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
13127874|NCT02891226|25963968|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
13127875|NCT02891226|25963969|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
13127876|NCT02891226|25963970|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
13127877|NCT02891226|25963971|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
13127878|NCT02891226|25963972|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
13127879|NCT02891226|25963973|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
13127880|NCT02891226|25963974|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
13127881|NCT02891226|25963975|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
13127882|NCT02891226|25963976|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
13127883|NCT02891226|25963961|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
13127884|NCT02891226|25963962|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
13127885|NCT02891226|25963963|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
13127886|NCT02891226|25963964|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2|||
13127887|NCT02891226|25963965|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
13127888|NCT02891226|25963966|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
13127889|NCT02891226|25963967|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
13127890|NCT02891226|25963968|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
13127891|NCT02891226|25963969|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
13127892|NCT02891226|25963970|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
13127893|NCT02891226|25963971|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
13127894|NCT02891226|25963972|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
13127895|NCT02891226|25963973|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
13127896|NCT02891226|25963974|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
13127897|NCT02891226|25963975|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
13127898|NCT02891226|25963976|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
13127899|NCT02891226|25963961|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
13127900|NCT02891226|25963962|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
13127901|NCT02891226|25963963|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1|||
13127902|NCT02891226|25963964|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
13136298|NCT02725268|25998388|FG003|Overall Study|Death|16|||
13136299|NCT02725268|25998385|FG000|Overall Study|Lost to Follow-up|4|||
13136300|NCT02725268|25998386|FG001|Overall Study|Lost to Follow-up|3|||
13136301|NCT02725268|25998387|FG002|Overall Study|Lost to Follow-up|0|||
13136302|NCT02725268|25998388|FG003|Overall Study|Lost to Follow-up|1|||
13136303|NCT02725268|25998385|FG000|Overall Study|Site Terminated by Sponsor|0|||
13136304|NCT02725268|25998386|FG001|Overall Study|Site Terminated by Sponsor|1|||
13136305|NCT02725268|25998387|FG002|Overall Study|Site Terminated by Sponsor|0|||
13136306|NCT02725268|25998388|FG003|Overall Study|Site Terminated by Sponsor|0|||
13136307|NCT02725268|25998385|FG000|Overall Study|Withdrawal by Subject|8|||
13136308|NCT02725268|25998386|FG001|Overall Study|Withdrawal by Subject|6|||
13136309|NCT02725268|25998387|FG002|Overall Study|Withdrawal by Subject|8|||
13136310|NCT02725268|25998388|FG003|Overall Study|Withdrawal by Subject|1|||
13136311|NCT02725268|25998385|FG000|Overall Study|Reason not Specified|2|||
13136312|NCT02725268|25998386|FG001|Overall Study|Reason not Specified|1|||
13136313|NCT02725268|25998387|FG002|Overall Study|Reason not Specified|0|||
13136314|NCT02725268|25998388|FG003|Overall Study|Reason not Specified|0|||
13136315|NCT02725008|25998403|FG000|Overall Study|Lost to Follow-up|7|||
13136316|NCT02725008|25998404|FG001|Overall Study|Lost to Follow-up|9|||
13136317|NCT02725008|25998403|FG000|Overall Study|Withdrawal by Subject|2|||
13136318|NCT02725008|25998404|FG001|Overall Study|Withdrawal by Subject|2|||
13136319|NCT02725008|25998403|FG000|Overall Study|Admitted to hospital|0|||
13136320|NCT02725008|25998404|FG001|Overall Study|Admitted to hospital|1|||
13136321|NCT02724956|25998427|FG000|Overall Study|Physician Decision|1|||
13136322|NCT02724956|25998428|FG001|Overall Study|Physician Decision|0|||
13136323|NCT02724956|25998427|FG000|Overall Study|Lack of Efficacy|0|||
13136324|NCT02724956|25998428|FG001|Overall Study|Lack of Efficacy|1|||
13136325|NCT02724956|25998427|FG000|Overall Study|Withdrawal by Subject|0|||
13136326|NCT02724956|25998428|FG001|Overall Study|Withdrawal by Subject|1|||
13136327|NCT02724878|25998453|FG000|Overall Study|Still on Active Therapy|15|||
13136328|NCT02724878|25998453|FG000|Overall Study|Disease Progression|31|||
13127903|NCT02891226|25963965|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
13127904|NCT02891226|25963966|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
13127905|NCT02891226|25963967|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
13127906|NCT02891226|25963968|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
13127907|NCT02891226|25963969|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
13127908|NCT02891226|25963970|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
13127909|NCT02891226|25963971|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
13127910|NCT02891226|25963972|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
13127911|NCT02891226|25963973|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
13127912|NCT02891226|25963974|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
13127913|NCT02891226|25963975|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
13127914|NCT02891226|25963976|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
13127915|NCT02891226|25963961|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
13127916|NCT02891226|25963962|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
13127917|NCT02891226|25963963|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
13127918|NCT02891226|25963964|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1|||
13127919|NCT02891226|25963965|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
13127920|NCT02891226|25963966|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
13127921|NCT02891226|25963967|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
13127922|NCT02891226|25963968|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
13127923|NCT02891226|25963969|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
13127924|NCT02891226|25963970|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
13127925|NCT02891226|25963971|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
13127926|NCT02891226|25963972|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
13127927|NCT02891226|25963973|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
13127928|NCT02891226|25963974|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
13127929|NCT02891226|25963975|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
13127930|NCT02891226|25963976|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
13127931|NCT02891226|25963961|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
13127932|NCT02891226|25963962|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
13127933|NCT02891226|25963963|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
13127934|NCT02891226|25963964|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1|||
13127935|NCT02891226|25963965|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
13127936|NCT02891226|25963966|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
13127937|NCT02891226|25963967|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
13127938|NCT02891226|25963968|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
13127939|NCT02891226|25963969|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
13127940|NCT02891226|25963970|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
13127941|NCT02891226|25963971|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
13127942|NCT02891226|25963972|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
13127943|NCT02891226|25963973|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
13127944|NCT02891226|25963974|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
13127945|NCT02891226|25963975|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
13127946|NCT02891226|25963976|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
13127947|NCT02891226|25963961|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
13127948|NCT02891226|25963962|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
13127949|NCT02891226|25963963|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
13127950|NCT02891226|25963964|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
13127951|NCT02891226|25963965|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
13127952|NCT02891226|25963966|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
13127953|NCT02891226|25963967|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
13127954|NCT02891226|25963968|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
13127955|NCT02891226|25963969|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3|||
13127956|NCT02891226|25963970|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7|||
13127957|NCT02891226|25963971|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
13127958|NCT02891226|25963972|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
13127959|NCT02891226|25963973|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
13127960|NCT02891226|25963974|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
13127961|NCT02891226|25963975|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
13127962|NCT02891226|25963976|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
13127963|NCT02891226|25963961|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
13127964|NCT02891226|25963962|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
13127965|NCT02891226|25963963|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
13127966|NCT02891226|25963964|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
13127967|NCT02891226|25963965|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
13127968|NCT02891226|25963966|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
13127969|NCT02891226|25963967|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
13127970|NCT02891226|25963968|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
13127971|NCT02891226|25963969|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
13127972|NCT02891226|25963970|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
13127973|NCT02891226|25963971|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
13127974|NCT02891226|25963972|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
13127975|NCT02891226|25963973|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
13127976|NCT02891226|25963974|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
13127977|NCT02891226|25963975|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
13127978|NCT02891226|25963976|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
13127979|NCT02891226|25963961|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
13127980|NCT02891226|25963962|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
13127981|NCT02891226|25963963|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
13127982|NCT02891226|25963964|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
13127983|NCT02891226|25963965|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
13127984|NCT02891226|25963966|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
13127985|NCT02891226|25963967|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
13127986|NCT02891226|25963968|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2|||
13127987|NCT02891226|25963969|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
13127988|NCT02891226|25963970|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6|||
13127989|NCT02891226|25963971|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
13127990|NCT02891226|25963972|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
13127991|NCT02891226|25963973|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
13127992|NCT02891226|25963974|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
13127993|NCT02891226|25963975|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
13127994|NCT02891226|25963976|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
13127995|NCT02891226|25963961|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
13127996|NCT02891226|25963962|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
13127997|NCT02891226|25963963|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
13127998|NCT02891226|25963964|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
13127999|NCT02891226|25963965|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1|||
13128000|NCT02891226|25963966|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
13128001|NCT02891226|25963967|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
13128002|NCT02891226|25963968|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
13128003|NCT02891226|25963969|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
13128004|NCT02891226|25963970|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
13128005|NCT02891226|25963971|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
13128006|NCT02891226|25963972|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
13128007|NCT02891226|25963973|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
13128008|NCT02891226|25963974|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
13136329|NCT02724878|25998453|FG000|Overall Study|Toxicity|5|||
13128009|NCT02891226|25963975|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
13128010|NCT02891226|25963976|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
13128011|NCT02891226|25963961|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
13128012|NCT02891226|25963962|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
13128013|NCT02891226|25963963|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
13128014|NCT02891226|25963964|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
13128015|NCT02891226|25963965|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
13128016|NCT02891226|25963966|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
13128017|NCT02891226|25963967|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1|||
13128018|NCT02891226|25963968|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
13128019|NCT02891226|25963969|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
13128020|NCT02891226|25963970|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
13128021|NCT02891226|25963971|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
13128022|NCT02891226|25963972|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
13128023|NCT02891226|25963973|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
13128024|NCT02891226|25963974|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
13128025|NCT02891226|25963975|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
13128026|NCT02891226|25963976|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
13128027|NCT02891226|25963961|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
13128028|NCT02891226|25963962|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
13128029|NCT02891226|25963963|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
13128030|NCT02891226|25963964|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
13128031|NCT02891226|25963965|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
13128032|NCT02891226|25963966|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
13128033|NCT02891226|25963967|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
13128034|NCT02891226|25963968|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
13128035|NCT02891226|25963969|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
13128036|NCT02891226|25963970|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
13128037|NCT02891226|25963971|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
13128038|NCT02891226|25963972|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
13128039|NCT02891226|25963973|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
13128040|NCT02891226|25963974|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
13128041|NCT02891226|25963975|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
13128042|NCT02891226|25963976|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
13128043|NCT02891226|25963961|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
13128044|NCT02891226|25963962|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
13128045|NCT02891226|25963963|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
13128046|NCT02891226|25963964|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
13128047|NCT02891226|25963965|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
13128048|NCT02891226|25963966|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
13128049|NCT02891226|25963967|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
13128050|NCT02891226|25963968|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1|||
13128051|NCT02891226|25963969|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
13128052|NCT02891226|25963970|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
13128053|NCT02891226|25963971|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
13128054|NCT02891226|25963972|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
13222024|NCT01808612|26285217|FG000|Discontinuation Period|Lost to Follow-up|0|||
13222025|NCT01808612|26285218|FG001|Discontinuation Period|Lost to Follow-up|1|||
13222026|NCT01808612|26285219|FG002|Discontinuation Period|Lost to Follow-up|0|||
13222027|NCT01808573|26285244|FG000|Overall Study|Death|212|||
13222028|NCT01808573|26285245|FG001|Overall Study|Death|240|||
13222029|NCT01808573|26285244|FG000|Overall Study|Withdrawal by Subject|12|||
13222030|NCT01808573|26285245|FG001|Overall Study|Withdrawal by Subject|10|||
13222031|NCT01808573|26285244|FG000|Overall Study|Lost to Follow-up|3|||
13222032|NCT01808573|26285245|FG001|Overall Study|Lost to Follow-up|0|||
13222033|NCT01808573|26285244|FG000|Overall Study|Discontinuation of study by sponsor|79|||
13222034|NCT01808573|26285245|FG001|Overall Study|Discontinuation of study by sponsor|64|||
13222035|NCT01808573|26285244|FG000|Overall Study|Randomized in Error|1|||
13222036|NCT01808573|26285245|FG001|Overall Study|Randomized in Error|0|||
13222037|NCT01808534|26285255|FG000|Overall Study|Disease progression|3|||
13222038|NCT01808534|26285255|FG000|Overall Study|Physician Decision|1|||
13222039|NCT01808508|26285282|FG000|Overall Study|Lost to Follow-up|1|||
13222040|NCT01808508|26285283|FG001|Overall Study|Lost to Follow-up|0|||
13222041|NCT01808508|26285284|FG002|Overall Study|Lost to Follow-up|0|||
13222042|NCT01808339|26285308|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
13222043|NCT01808339|26285309|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
13222044|NCT01808339|26285310|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
13222045|NCT01808339|26285311|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
13222046|NCT01808339|26285312|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2|||
13222047|NCT01808339|26285313|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
13222048|NCT01808339|26285308|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
13222049|NCT01808339|26285309|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
13222050|NCT01808339|26285310|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
13222051|NCT01808339|26285311|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
13222052|NCT01808339|26285312|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
13222053|NCT01808339|26285313|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
13222054|NCT01808339|26285308|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
13289418|NCT02484456|26479054|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1|||
13128055|NCT02891226|25963973|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
13128056|NCT02891226|25963974|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
13128057|NCT02891226|25963975|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
13128058|NCT02891226|25963976|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
13136330|NCT02724878|25998453|FG000|Overall Study|Death|1|||
13222055|NCT01808339|26285309|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
13222056|NCT01808339|26285310|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
13222057|NCT01808339|26285311|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
13222058|NCT01808339|26285312|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
13222059|NCT01808339|26285313|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
13222060|NCT01808313|26285343|FG000|Overall Study|Adverse Event|5|||
13222061|NCT01808313|26285343|FG000|Overall Study|Protocol Violation|2|||
13222062|NCT01808313|26285343|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
13222063|NCT01808313|26285343|FG000|Overall Study|Lost to Follow-up|1|||
13222064|NCT01808313|26285343|FG000|Overall Study|Physician Decision|1|||
13222065|NCT01808248|26285361|FG000|Overall Study|Lack of Efficacy|3|||
13222066|NCT01808248|26285361|FG000|Overall Study|Withdrawal by Subject|1|||
13222067|NCT01808248|26285361|FG000|Overall Study|Lost to Follow-up|1|||
13222068|NCT01808222|26285368|FG000|Overall Study|mpMR scan was not performed|1|||
13222069|NCT01808209|26285417|FG000|Overall Study|Lost to Follow-up|0|||
13222070|NCT01808209|26285418|FG001|Overall Study|Lost to Follow-up|1|||
13222071|NCT01808196|26285426|FG000|Overall Study|Lost to Follow-up|1|||
13289419|NCT02484456|26479053|FG000|Second Treatment Period: Week 2|Adverse Event|0|||
13289420|NCT02484456|26479054|FG001|Second Treatment Period: Week 2|Adverse Event|1|||
13292316|NCT00706654|26485251|FG003|Conversion Phase|Withdrawn by Investigator|0|||
13292317|NCT00706654|26485248|FG000|Conversion Phase|Withdrew Consent|38|||
13292318|NCT00706654|26485249|FG001|Conversion Phase|Withdrew Consent|0|||
13292319|NCT00706654|26485250|FG002|Conversion Phase|Withdrew Consent|0|||
13292320|NCT00706654|26485251|FG003|Conversion Phase|Withdrew Consent|0|||
13204560|NCT01972529|26229306|FG002|Overall Study|Adverse Event|0|||
13292321|NCT00706654|26485248|FG000|Conversion Phase|Adverse Event|18|||
13292322|NCT00706654|26485249|FG001|Conversion Phase|Adverse Event|0|||
13128059|NCT02891226|25963961|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
13128060|NCT02891226|25963962|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
13128061|NCT02891226|25963963|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
13128062|NCT02891226|25963964|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
13128063|NCT02891226|25963965|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
13128064|NCT02891226|25963966|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
13128065|NCT02891226|25963967|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
13128066|NCT02891226|25963968|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
13128067|NCT02891226|25963969|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1|||
13128068|NCT02891226|25963970|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
13128069|NCT02891226|25963971|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
13128070|NCT02891226|25963972|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
13128071|NCT02891226|25963973|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
13128072|NCT02891226|25963974|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
13128073|NCT02891226|25963975|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
13128074|NCT02891226|25963976|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
13128075|NCT02891226|25963961|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
13128076|NCT02891226|25963962|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
13128077|NCT02891226|25963963|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
13128078|NCT02891226|25963964|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
13128079|NCT02891226|25963965|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
13128080|NCT02891226|25963966|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
13204561|NCT01972529|26229307|FG003|Overall Study|Adverse Event|0|||
13128081|NCT02891226|25963967|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
13128082|NCT02891226|25963968|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
13128083|NCT02891226|25963969|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
13128084|NCT02891226|25963970|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1|||
13128085|NCT02891226|25963971|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
13128086|NCT02891226|25963972|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
13128087|NCT02891226|25963973|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
13128088|NCT02891226|25963974|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
13128089|NCT02891226|25963975|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
13128090|NCT02891226|25963976|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
13128091|NCT02891226|25963961|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
13128092|NCT02891226|25963962|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
13128093|NCT02891226|25963963|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
13128094|NCT02891226|25963964|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
13128095|NCT02891226|25963965|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
13128096|NCT02891226|25963966|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
13128097|NCT02891226|25963967|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
13128098|NCT02891226|25963968|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
13128099|NCT02891226|25963969|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
13128100|NCT02891226|25963970|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1|||
13128101|NCT02891226|25963971|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
13128102|NCT02891226|25963972|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
13128103|NCT02891226|25963973|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
13128104|NCT02891226|25963974|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
13128105|NCT02891226|25963975|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
13128106|NCT02891226|25963976|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
13128107|NCT02891226|25963961|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
13128108|NCT02891226|25963962|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
13128109|NCT02891226|25963963|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
13128110|NCT02891226|25963964|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
13393333|NCT00665925|26783412|FG001|Overall Study|Withdrawal by Subject|2|||
13204562|NCT01972529|26229304|FG000|Overall Study|Lost to Follow-up|1|||
13128111|NCT02891226|25963965|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
13128112|NCT02891226|25963966|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
13128113|NCT02891226|25963967|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
13128114|NCT02891226|25963968|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
13128115|NCT02891226|25963969|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
13128116|NCT02891226|25963970|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
13128117|NCT02891226|25963971|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5|||
13128118|NCT02891226|25963972|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
13128119|NCT02891226|25963973|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
13128120|NCT02891226|25963974|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
13128121|NCT02891226|25963975|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
13128122|NCT02891226|25963976|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
13128123|NCT02891226|25963961|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
13128124|NCT02891226|25963962|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
13128125|NCT02891226|25963963|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
13128126|NCT02891226|25963964|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
13128127|NCT02891226|25963965|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
13128128|NCT02891226|25963966|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
13128129|NCT02891226|25963967|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
13128130|NCT02891226|25963968|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
13128131|NCT02891226|25963969|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
13128132|NCT02891226|25963970|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
13128133|NCT02891226|25963971|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1|||
13128134|NCT02891226|25963972|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
13128135|NCT02891226|25963973|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
13128136|NCT02891226|25963974|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
13128137|NCT02891226|25963975|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
13128138|NCT02891226|25963976|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
13128139|NCT02891226|25963961|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
13128140|NCT02891226|25963962|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
13128141|NCT02891226|25963963|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
13128142|NCT02891226|25963964|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
13128143|NCT02891226|25963965|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
13128144|NCT02891226|25963966|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
13128145|NCT02891226|25963967|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
13128146|NCT02891226|25963968|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
13128147|NCT02891226|25963969|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
13128148|NCT02891226|25963970|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
13128149|NCT02891226|25963971|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14|||
13128150|NCT02891226|25963972|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
13128151|NCT02891226|25963973|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
13128152|NCT02891226|25963974|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
13128153|NCT02891226|25963975|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
13128154|NCT02891226|25963976|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
13128155|NCT02891226|25963961|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
13128156|NCT02891226|25963962|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
13128157|NCT02891226|25963963|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
13128158|NCT02891226|25963964|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
13128159|NCT02891226|25963965|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
13128160|NCT02891226|25963966|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
13128161|NCT02891226|25963967|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
13128162|NCT02891226|25963968|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
13128163|NCT02891226|25963969|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
13128164|NCT02891226|25963970|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
13128165|NCT02891226|25963971|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108|||
13128166|NCT02891226|25963972|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
13128167|NCT02891226|25963973|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
13128168|NCT02891226|25963974|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
13128169|NCT02891226|25963975|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
13128170|NCT02891226|25963976|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
13128171|NCT02891226|25963961|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
13128172|NCT02891226|25963962|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
13128173|NCT02891226|25963963|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
13128174|NCT02891226|25963964|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
13128175|NCT02891226|25963965|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
13204563|NCT01972529|26229305|FG001|Overall Study|Lost to Follow-up|0|||
13204564|NCT01972529|26229306|FG002|Overall Study|Lost to Follow-up|0|||
13128176|NCT02891226|25963966|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
13128177|NCT02891226|25963967|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
13128178|NCT02891226|25963968|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
13128179|NCT02891226|25963969|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
13128180|NCT02891226|25963970|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
13128181|NCT02891226|25963971|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2|||
13128182|NCT02891226|25963972|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
13128183|NCT02891226|25963973|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
13128184|NCT02891226|25963974|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
13128185|NCT02891226|25963975|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
13128186|NCT02891226|25963976|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
13128187|NCT02891226|25963961|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
13128188|NCT02891226|25963962|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
13128189|NCT02891226|25963963|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
13128190|NCT02891226|25963964|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
13128191|NCT02891226|25963965|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
13128192|NCT02891226|25963966|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
13128193|NCT02891226|25963967|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
13128194|NCT02891226|25963968|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
13128195|NCT02891226|25963969|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
13128196|NCT02891226|25963970|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
13128197|NCT02891226|25963971|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3|||
13128198|NCT02891226|25963972|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
13128199|NCT02891226|25963973|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
13128200|NCT02891226|25963974|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
13128201|NCT02891226|25963975|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
13128202|NCT02891226|25963976|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
13128203|NCT02891226|25963961|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
13128204|NCT02891226|25963962|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
13128205|NCT02891226|25963963|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
13204565|NCT01972529|26229307|FG003|Overall Study|Lost to Follow-up|0|||
13204566|NCT01972529|26229304|FG000|Overall Study|Participant Choice|0|||
13128206|NCT02891226|25963964|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
13128207|NCT02891226|25963965|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
13128208|NCT02891226|25963966|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
13128209|NCT02891226|25963967|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
13128210|NCT02891226|25963968|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
13128211|NCT02891226|25963969|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
13128212|NCT02891226|25963970|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
13128213|NCT02891226|25963971|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2|||
13128214|NCT02891226|25963972|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
13128215|NCT02891226|25963973|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
13128216|NCT02891226|25963974|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
13128217|NCT02891226|25963975|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
13128218|NCT02891226|25963976|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
13128219|NCT02891226|25963961|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
13128220|NCT02891226|25963962|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
13128221|NCT02891226|25963963|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
13128222|NCT02891226|25963964|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
13128223|NCT02891226|25963965|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
13128224|NCT02891226|25963966|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
13128225|NCT02891226|25963967|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
13128226|NCT02891226|25963968|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
13128227|NCT02891226|25963969|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
13128228|NCT02891226|25963970|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
13128229|NCT02891226|25963971|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2|||
13128230|NCT02891226|25963972|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
13128231|NCT02891226|25963973|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
13128232|NCT02891226|25963974|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
13128233|NCT02891226|25963975|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
13128234|NCT02891226|25963976|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
13128235|NCT02891226|25963961|FG000|Follow-up Period|Withdrawal by Subject|0|||
13128236|NCT02891226|25963962|FG001|Follow-up Period|Withdrawal by Subject|0|||
13128237|NCT02891226|25963963|FG002|Follow-up Period|Withdrawal by Subject|0|||
13128238|NCT02891226|25963964|FG003|Follow-up Period|Withdrawal by Subject|0|||
13128239|NCT02891226|25963965|FG004|Follow-up Period|Withdrawal by Subject|0|||
13128240|NCT02891226|25963966|FG005|Follow-up Period|Withdrawal by Subject|0|||
13128241|NCT02891226|25963967|FG006|Follow-up Period|Withdrawal by Subject|0|||
13128242|NCT02891226|25963968|FG007|Follow-up Period|Withdrawal by Subject|0|||
13128243|NCT02891226|25963969|FG008|Follow-up Period|Withdrawal by Subject|0|||
13128244|NCT02891226|25963970|FG009|Follow-up Period|Withdrawal by Subject|0|||
13485113|NCT03033069|27031605|FG002|Overall Study|Non-Compliance With Study Drug|1|||
13485114|NCT03033069|27031606|FG003|Overall Study|Non-Compliance With Study Drug|0|||
13485115|NCT03033069|27031603|FG000|Overall Study|Protocol Deviation|0|||
13485116|NCT03033069|27031604|FG001|Overall Study|Protocol Deviation|1|||
13485117|NCT03033069|27031605|FG002|Overall Study|Protocol Deviation|0|||
13485118|NCT03033069|27031606|FG003|Overall Study|Protocol Deviation|0|||
13485119|NCT03033069|27031603|FG000|Overall Study|Withdrawal by Subject|10|||
13485120|NCT03033069|27031604|FG001|Overall Study|Withdrawal by Subject|10|||
13485121|NCT03033069|27031605|FG002|Overall Study|Withdrawal by Subject|11|||
13485122|NCT03033069|27031606|FG003|Overall Study|Withdrawal by Subject|6|||
13485123|NCT03033069|27031603|FG000|Overall Study|Withdrawal By Caregiver|1|||
13485124|NCT03033069|27031604|FG001|Overall Study|Withdrawal By Caregiver|0|||
13485125|NCT03033069|27031605|FG002|Overall Study|Withdrawal By Caregiver|0|||
13485126|NCT03033069|27031606|FG003|Overall Study|Withdrawal By Caregiver|0|||
13485127|NCT03033069|27031603|FG000|Overall Study|Reason not Specified|0|||
13128245|NCT02891226|25963971|FG010|Follow-up Period|Withdrawal by Subject|0|||
13128246|NCT02891226|25963972|FG011|Follow-up Period|Withdrawal by Subject|1|||
13128247|NCT02891226|25963973|FG012|Follow-up Period|Withdrawal by Subject|0|||
13128248|NCT02891226|25963974|FG013|Follow-up Period|Withdrawal by Subject|0|||
13128249|NCT02891226|25963975|FG014|Follow-up Period|Withdrawal by Subject|1|||
13128250|NCT02891226|25963976|FG015|Follow-up Period|Withdrawal by Subject|1|||
13128251|NCT02891200|25964009|FG000|Overall Study|Lost to Follow-up|31|||
13128252|NCT02891200|25964010|FG001|Overall Study|Lost to Follow-up|36|||
13128253|NCT02891200|25964009|FG000|Overall Study|Death|10|||
13128254|NCT02891200|25964010|FG001|Overall Study|Death|9|||
13128255|NCT02891200|25964009|FG000|Overall Study|Withdrawal by Subject|1|||
13128256|NCT02891200|25964010|FG001|Overall Study|Withdrawal by Subject|4|||
13128257|NCT02891174|25964029|FG000|First Intervention (24 Hours)|Declined any study medication|1|||
13128258|NCT02891174|25964030|FG001|First Intervention (24 Hours)|Declined any study medication|5|||
13128259|NCT02891174|25964029|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0|||
13128260|NCT02891174|25964030|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2|||
13128261|NCT02891174|25964029|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2|||
13128262|NCT02891174|25964030|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6|||
13128263|NCT02891174|25964029|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1|||
13128264|NCT02891174|25964030|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0|||
13128265|NCT02891174|25964029|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3|||
13128266|NCT02891174|25964030|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5|||
13128267|NCT02891174|25964029|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2|||
13128268|NCT02891174|25964030|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1|||
13128269|NCT02891174|25964029|FG000|Second Intervention (24 Hours)|Protocol Violation|0|||
13128270|NCT02891174|25964030|FG001|Second Intervention (24 Hours)|Protocol Violation|1|||
13128271|NCT02891070|25964055|FG000|Overall Study|Adverse Event|1|||
13128272|NCT02891070|25964056|FG001|Overall Study|Adverse Event|0|||
13128273|NCT02891070|25964055|FG000|Overall Study|Physician Decision|0|||
13128274|NCT02891070|25964056|FG001|Overall Study|Physician Decision|1|||
13128275|NCT02891070|25964055|FG000|Overall Study|Lost to Follow-up|4|||
13128276|NCT02891070|25964056|FG001|Overall Study|Lost to Follow-up|4|||
13128277|NCT02891070|25964055|FG000|Overall Study|Other|1|||
13128278|NCT02891070|25964056|FG001|Overall Study|Other|0|||
13128279|NCT02891070|25964055|FG000|Overall Study|Protocol Violation|0|||
13128280|NCT02891070|25964056|FG001|Overall Study|Protocol Violation|1|||
13128281|NCT02891070|25964055|FG000|Overall Study|Withdrawal by Subject|1|||
13128282|NCT02891070|25964056|FG001|Overall Study|Withdrawal by Subject|2|||
13128283|NCT02891070|25964055|FG000|Overall Study|Death|3|||
13128284|NCT02891070|25964056|FG001|Overall Study|Death|0|||
13128285|NCT02890992|25964247|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0|||
13128286|NCT02890992|25964248|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1|||
13128287|NCT02890992|25964249|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0|||
13128288|NCT02890992|25964250|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0|||
13128289|NCT02890992|25964251|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0|||
13128290|NCT02890992|25964252|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0|||
13128291|NCT02890992|25964253|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0|||
13128292|NCT02890992|25964254|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0|||
13128293|NCT02890992|25964247|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0|||
13128294|NCT02890992|25964248|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0|||
13128295|NCT02890992|25964249|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0|||
13128296|NCT02890992|25964250|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0|||
13128297|NCT02890992|25964251|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0|||
13128298|NCT02890992|25964252|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0|||
13128299|NCT02890992|25964253|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1|||
13128300|NCT02890992|25964254|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1|||
13128301|NCT02890992|25964247|FG000|130 Weeks Open-Label Extension Period|Other than specified|0|||
13128302|NCT02890992|25964248|FG001|130 Weeks Open-Label Extension Period|Other than specified|2|||
13128303|NCT02890992|25964249|FG002|130 Weeks Open-Label Extension Period|Other than specified|0|||
13128304|NCT02890992|25964250|FG003|130 Weeks Open-Label Extension Period|Other than specified|0|||
13128305|NCT02890992|25964251|FG004|130 Weeks Open-Label Extension Period|Other than specified|0|||
13128306|NCT02890992|25964252|FG005|130 Weeks Open-Label Extension Period|Other than specified|0|||
13128307|NCT02890992|25964253|FG006|130 Weeks Open-Label Extension Period|Other than specified|0|||
13128308|NCT02890992|25964254|FG007|130 Weeks Open-Label Extension Period|Other than specified|0|||
13128309|NCT02889861|25964277|FG000|Overall Study|Ongoing in Survival Follow-up|2|||
13128310|NCT02889796|25964657|FG000|Overall Study|Withdrew Consent|18|||
13128311|NCT02889796|25964658|FG001|Overall Study|Withdrew Consent|29|||
13128312|NCT02889796|25964659|FG002|Overall Study|Withdrew Consent|20|||
13128313|NCT02889796|25964660|FG003|Overall Study|Withdrew Consent|1|||
13128314|NCT02889796|25964661|FG004|Overall Study|Withdrew Consent|2|||
13128315|NCT02889796|25964662|FG005|Overall Study|Withdrew Consent|35|||
13128316|NCT02889796|25964657|FG000|Overall Study|Investigator's Discretion|10|||
13128317|NCT02889796|25964658|FG001|Overall Study|Investigator's Discretion|9|||
13128318|NCT02889796|25964659|FG002|Overall Study|Investigator's Discretion|10|||
13128319|NCT02889796|25964660|FG003|Overall Study|Investigator's Discretion|3|||
13128320|NCT02889796|25964661|FG004|Overall Study|Investigator's Discretion|0|||
13128321|NCT02889796|25964662|FG005|Overall Study|Investigator's Discretion|15|||
13128322|NCT02889796|25964657|FG000|Overall Study|Adverse Event|17|||
13128323|NCT02889796|25964658|FG001|Overall Study|Adverse Event|8|||
13128324|NCT02889796|25964659|FG002|Overall Study|Adverse Event|8|||
13128325|NCT02889796|25964660|FG003|Overall Study|Adverse Event|4|||
13128326|NCT02889796|25964661|FG004|Overall Study|Adverse Event|1|||
13128327|NCT02889796|25964662|FG005|Overall Study|Adverse Event|7|||
13128328|NCT02889796|25964657|FG000|Overall Study|Lost to Follow-up|5|||
13128329|NCT02889796|25964658|FG001|Overall Study|Lost to Follow-up|7|||
13128330|NCT02889796|25964659|FG002|Overall Study|Lost to Follow-up|2|||
13128331|NCT02889796|25964660|FG003|Overall Study|Lost to Follow-up|0|||
13128332|NCT02889796|25964661|FG004|Overall Study|Lost to Follow-up|2|||
13128333|NCT02889796|25964662|FG005|Overall Study|Lost to Follow-up|6|||
13128334|NCT02889796|25964657|FG000|Overall Study|Protocol Violation|0|||
13128335|NCT02889796|25964658|FG001|Overall Study|Protocol Violation|1|||
13128336|NCT02889796|25964659|FG002|Overall Study|Protocol Violation|3|||
13128337|NCT02889796|25964660|FG003|Overall Study|Protocol Violation|0|||
13128338|NCT02889796|25964661|FG004|Overall Study|Protocol Violation|0|||
13128339|NCT02889796|25964662|FG005|Overall Study|Protocol Violation|4|||
13128340|NCT02889796|25964657|FG000|Overall Study|Non-compliance With Study Drug|0|||
13128341|NCT02889796|25964658|FG001|Overall Study|Non-compliance With Study Drug|2|||
13128342|NCT02889796|25964659|FG002|Overall Study|Non-compliance With Study Drug|0|||
13128343|NCT02889796|25964660|FG003|Overall Study|Non-compliance With Study Drug|0|||
13128344|NCT02889796|25964661|FG004|Overall Study|Non-compliance With Study Drug|1|||
13128345|NCT02889796|25964662|FG005|Overall Study|Non-compliance With Study Drug|2|||
13128346|NCT02889796|25964657|FG000|Overall Study|Death|1|||
13128347|NCT02889796|25964658|FG001|Overall Study|Death|1|||
13128348|NCT02889796|25964659|FG002|Overall Study|Death|0|||
13128349|NCT02889796|25964660|FG003|Overall Study|Death|1|||
13128350|NCT02889796|25964661|FG004|Overall Study|Death|0|||
13128351|NCT02889796|25964662|FG005|Overall Study|Death|1|||
13128352|NCT02889796|25964657|FG000|Overall Study|Pregnancy|0|||
13128353|NCT02889796|25964658|FG001|Overall Study|Pregnancy|1|||
13128354|NCT02889796|25964659|FG002|Overall Study|Pregnancy|1|||
13128355|NCT02889796|25964660|FG003|Overall Study|Pregnancy|0|||
13128356|NCT02889796|25964661|FG004|Overall Study|Pregnancy|0|||
13128357|NCT02889796|25964662|FG005|Overall Study|Pregnancy|0|||
13128358|NCT02889796|25964657|FG000|Overall Study|Randomized but not Dosed|2|||
13128359|NCT02889796|25964658|FG001|Overall Study|Randomized but not Dosed|0|||
13128360|NCT02889796|25964659|FG002|Overall Study|Randomized but not Dosed|0|||
13128361|NCT02889796|25964660|FG003|Overall Study|Randomized but not Dosed|0|||
13128362|NCT02889796|25964661|FG004|Overall Study|Randomized but not Dosed|0|||
13128363|NCT02889796|25964662|FG005|Overall Study|Randomized but not Dosed|2|||
13128364|NCT02889562|25964683|FG000|Overall Study|Physician Decision|0|||
13128365|NCT02889562|25964684|FG001|Overall Study|Physician Decision|1|||
13128366|NCT02889562|25964683|FG000|Overall Study|Withdrawal by Subject|0|||
13128367|NCT02889562|25964684|FG001|Overall Study|Withdrawal by Subject|1|||
13128368|NCT02888756|25964735|FG000|Analytical Treatment Interruption|Physician Decision|10|||
13128369|NCT02888756|25964736|FG001|Analytical Treatment Interruption|Physician Decision|6|||
13128370|NCT02888756|25964737|FG002|Analytical Treatment Interruption|Physician Decision|5|||
13128371|NCT02888171|25964758|FG000|Overall Study|Lost to Follow-up|2|||
13128372|NCT02888171|25964759|FG001|Overall Study|Lost to Follow-up|1|||
13128373|NCT02888171|25964758|FG000|Overall Study|Withdrawal by Subject|3|||
13128374|NCT02888171|25964759|FG001|Overall Study|Withdrawal by Subject|2|||
13128375|NCT02888171|25964758|FG000|Overall Study|Adverse Event|0|||
13128376|NCT02888171|25964759|FG001|Overall Study|Adverse Event|1|||
13128377|NCT02888106|25964864|FG000|Overall Study|Withdrawal by Subject|1|||
13128378|NCT02888106|25964865|FG001|Overall Study|Withdrawal by Subject|2|||
13128379|NCT02888106|25964866|FG002|Overall Study|Withdrawal by Subject|0|||
13128380|NCT02888106|25964867|FG003|Overall Study|Withdrawal by Subject|1|||
13128381|NCT02888106|25964868|FG004|Overall Study|Withdrawal by Subject|0|||
13128382|NCT02888106|25964869|FG005|Overall Study|Withdrawal by Subject|0|||
13128383|NCT02888106|25964864|FG000|Overall Study|Lost to Follow-up|1|||
13128384|NCT02888106|25964865|FG001|Overall Study|Lost to Follow-up|0|||
13128385|NCT02888106|25964866|FG002|Overall Study|Lost to Follow-up|0|||
13128386|NCT02888106|25964867|FG003|Overall Study|Lost to Follow-up|1|||
13128387|NCT02888106|25964868|FG004|Overall Study|Lost to Follow-up|0|||
13128388|NCT02888106|25964869|FG005|Overall Study|Lost to Follow-up|1|||
13128389|NCT02888106|25964864|FG000|Overall Study|Adverse Event|2|||
13128390|NCT02888106|25964865|FG001|Overall Study|Adverse Event|0|||
13128391|NCT02888106|25964866|FG002|Overall Study|Adverse Event|0|||
13128392|NCT02888106|25964867|FG003|Overall Study|Adverse Event|0|||
13128393|NCT02888106|25964868|FG004|Overall Study|Adverse Event|0|||
13128394|NCT02888106|25964869|FG005|Overall Study|Adverse Event|0|||
13128395|NCT02888106|25964864|FG000|Overall Study|Withdrawal of consent|0|||
13128396|NCT02888106|25964865|FG001|Overall Study|Withdrawal of consent|0|||
13128397|NCT02888106|25964866|FG002|Overall Study|Withdrawal of consent|0|||
13128398|NCT02888106|25964867|FG003|Overall Study|Withdrawal of consent|0|||
13128399|NCT02888106|25964868|FG004|Overall Study|Withdrawal of consent|1|||
13128400|NCT02888106|25964869|FG005|Overall Study|Withdrawal of consent|0|||
13128401|NCT02888106|25964864|FG000|Overall Study|Pregnancy|1|||
13128402|NCT02888106|25964865|FG001|Overall Study|Pregnancy|0|||
13128403|NCT02888106|25964866|FG002|Overall Study|Pregnancy|0|||
13128404|NCT02888106|25964867|FG003|Overall Study|Pregnancy|0|||
13128405|NCT02888106|25964868|FG004|Overall Study|Pregnancy|0|||
13128406|NCT02888106|25964869|FG005|Overall Study|Pregnancy|0|||
13128407|NCT02888080|25964900|FG000|Overall Study|Subject / Guardian decision|1|||
13128408|NCT02888080|25964901|FG001|Overall Study|Subject / Guardian decision|3|||
13128409|NCT02888080|25964900|FG000|Overall Study|New Therapy for study indication|1|||
13128410|NCT02888080|25964901|FG001|Overall Study|New Therapy for study indication|0|||
13128411|NCT02888080|25964900|FG000|Overall Study|Lack of Efficacy|0|||
13128412|NCT02888080|25964901|FG001|Overall Study|Lack of Efficacy|1|||
13128413|NCT02888080|25964900|FG000|Overall Study|Adverse Event|0|||
13128414|NCT02888080|25964901|FG001|Overall Study|Adverse Event|1|||
13128415|NCT02887989|25964918|FG000|Overall Study|Withdrawal by Subject|8|||
13128416|NCT02887989|25964919|FG001|Overall Study|Withdrawal by Subject|11|||
13128417|NCT02887989|25964918|FG000|Overall Study|Death|1|||
13128418|NCT02887989|25964919|FG001|Overall Study|Death|0|||
13128419|NCT02887521|25964938|FG000|Overall Study|Withdrawal by Subject|0|||
13128420|NCT02887521|25964939|FG001|Overall Study|Withdrawal by Subject|3|||
13128421|NCT02887183|25964954|FG000|Overall Study|Adverse Event|44|||
13128422|NCT02887183|25964954|FG000|Overall Study|Death|30|||
13128423|NCT02887183|25964954|FG000|Overall Study|Pregnancy|1|||
13128424|NCT02887183|25964954|FG000|Overall Study|Protocol Violation|6|||
13128425|NCT02887183|25964954|FG000|Overall Study|Technical Problems|2|||
13128426|NCT02887183|25964954|FG000|Overall Study|Lost to Follow-up|13|||
13128427|NCT02887183|25964954|FG000|Overall Study|Physician Decision|10|||
13128428|NCT02887183|25964954|FG000|Overall Study|Withdrawal by Subject|35|||
13128429|NCT02886884|25965001|FG000|Follow-up|Withdrawal by Subject|0|||
13128430|NCT02886884|25965002|FG001|Follow-up|Withdrawal by Subject|0|||
13128431|NCT02886884|25965003|FG002|Follow-up|Withdrawal by Subject|0|||
13128432|NCT02886884|25965004|FG003|Follow-up|Withdrawal by Subject|1|||
13128433|NCT02886728|25965195|FG000|Overall Study|Withdrew Consent|31|||
13128434|NCT02886728|25965196|FG001|Overall Study|Withdrew Consent|13|||
13128435|NCT02886728|25965197|FG002|Overall Study|Withdrew Consent|11|||
13128436|NCT02886728|25965198|FG003|Overall Study|Withdrew Consent|47|||
13128437|NCT02886728|25965195|FG000|Overall Study|Lost to Follow-up|12|||
13128438|NCT02886728|25965196|FG001|Overall Study|Lost to Follow-up|6|||
13128439|NCT02886728|25965197|FG002|Overall Study|Lost to Follow-up|13|||
13128440|NCT02886728|25965198|FG003|Overall Study|Lost to Follow-up|12|||
13128441|NCT02886728|25965195|FG000|Overall Study|Adverse Event|13|||
13128442|NCT02886728|25965196|FG001|Overall Study|Adverse Event|5|||
13128443|NCT02886728|25965197|FG002|Overall Study|Adverse Event|5|||
13128444|NCT02886728|25965198|FG003|Overall Study|Adverse Event|11|||
13128445|NCT02886728|25965195|FG000|Overall Study|Investigator's Discretion|11|||
13128446|NCT02886728|25965196|FG001|Overall Study|Investigator's Discretion|7|||
13128447|NCT02886728|25965197|FG002|Overall Study|Investigator's Discretion|5|||
13128448|NCT02886728|25965198|FG003|Overall Study|Investigator's Discretion|11|||
13128449|NCT02886728|25965195|FG000|Overall Study|Death|3|||
13128450|NCT02886728|25965196|FG001|Overall Study|Death|1|||
13128451|NCT02886728|25965197|FG002|Overall Study|Death|0|||
13128452|NCT02886728|25965198|FG003|Overall Study|Death|0|||
13128453|NCT02886728|25965195|FG000|Overall Study|Protocol Violation|0|||
13128454|NCT02886728|25965196|FG001|Overall Study|Protocol Violation|0|||
13128455|NCT02886728|25965197|FG002|Overall Study|Protocol Violation|0|||
13128456|NCT02886728|25965198|FG003|Overall Study|Protocol Violation|4|||
13128457|NCT02886728|25965195|FG000|Overall Study|Non-Compliance with Study Drug|1|||
13128458|NCT02886728|25965196|FG001|Overall Study|Non-Compliance with Study Drug|0|||
13128459|NCT02886728|25965197|FG002|Overall Study|Non-Compliance with Study Drug|1|||
13128460|NCT02886728|25965198|FG003|Overall Study|Non-Compliance with Study Drug|0|||
13128461|NCT02886728|25965195|FG000|Overall Study|Pregnancy|0|||
13128462|NCT02886728|25965196|FG001|Overall Study|Pregnancy|0|||
13128463|NCT02886728|25965197|FG002|Overall Study|Pregnancy|1|||
13128464|NCT02886728|25965198|FG003|Overall Study|Pregnancy|0|||
13128465|NCT02886728|25965195|FG000|Overall Study|Randomized but Not Dosed|1|||
13128466|NCT02886728|25965196|FG001|Overall Study|Randomized but Not Dosed|0|||
13128467|NCT02886728|25965197|FG002|Overall Study|Randomized but Not Dosed|0|||
13128468|NCT02886728|25965198|FG003|Overall Study|Randomized but Not Dosed|2|||
13128469|NCT02886715|25965222|FG000|Overall Study|Non-Compliance With Study Drug|0|||
13128470|NCT02886715|25965223|FG001|Overall Study|Non-Compliance With Study Drug|2|||
13128471|NCT02886715|25965224|FG002|Overall Study|Non-Compliance With Study Drug|0|||
13128472|NCT02886715|25965222|FG000|Overall Study|Adverse Event|4|||
13128473|NCT02886715|25965223|FG001|Overall Study|Adverse Event|2|||
13128474|NCT02886715|25965224|FG002|Overall Study|Adverse Event|0|||
13128475|NCT02886715|25965222|FG000|Overall Study|Lack of Efficacy|0|||
13128476|NCT02886715|25965223|FG001|Overall Study|Lack of Efficacy|2|||
13128477|NCT02886715|25965224|FG002|Overall Study|Lack of Efficacy|1|||
13128478|NCT02886715|25965222|FG000|Overall Study|Lost to Follow-up|29|||
13128479|NCT02886715|25965223|FG001|Overall Study|Lost to Follow-up|26|||
13128480|NCT02886715|25965224|FG002|Overall Study|Lost to Follow-up|10|||
13128481|NCT02886715|25965222|FG000|Overall Study|Pregnancy|1|||
13128482|NCT02886715|25965223|FG001|Overall Study|Pregnancy|1|||
13128483|NCT02886715|25965224|FG002|Overall Study|Pregnancy|1|||
13128484|NCT02886715|25965222|FG000|Overall Study|Protocol Violation|3|||
13128485|NCT02886715|25965223|FG001|Overall Study|Protocol Violation|2|||
13128486|NCT02886715|25965224|FG002|Overall Study|Protocol Violation|1|||
13128487|NCT02886715|25965222|FG000|Overall Study|Withdrawal by Subject|20|||
13128488|NCT02886715|25965223|FG001|Overall Study|Withdrawal by Subject|18|||
13128489|NCT02886715|25965224|FG002|Overall Study|Withdrawal by Subject|5|||
13128490|NCT02886715|25965222|FG000|Overall Study|missing|7|||
13128491|NCT02886715|25965223|FG001|Overall Study|missing|2|||
13128492|NCT02886715|25965224|FG002|Overall Study|missing|2|||
13128493|NCT02886702|25965248|FG000|Overall Study|Other|4|||
13128494|NCT02886702|25965249|FG001|Overall Study|Other|3|||
13128495|NCT02886702|25965250|FG002|Overall Study|Other|9|||
13128496|NCT02886702|25965248|FG000|Overall Study|Withdrawal by Subject|24|||
13128497|NCT02886702|25965249|FG001|Overall Study|Withdrawal by Subject|18|||
13128498|NCT02886702|25965250|FG002|Overall Study|Withdrawal by Subject|22|||
13128499|NCT02886702|25965248|FG000|Overall Study|Significant Worsening of Condition|0|||
13128500|NCT02886702|25965249|FG001|Overall Study|Significant Worsening of Condition|1|||
13128501|NCT02886702|25965250|FG002|Overall Study|Significant Worsening of Condition|0|||
13128502|NCT02886702|25965248|FG000|Overall Study|Protocol Violation|2|||
13128503|NCT02886702|25965249|FG001|Overall Study|Protocol Violation|2|||
13128504|NCT02886702|25965250|FG002|Overall Study|Protocol Violation|1|||
13128505|NCT02886702|25965248|FG000|Overall Study|Non-Compliance With Study Drug|0|||
13128506|NCT02886702|25965249|FG001|Overall Study|Non-Compliance With Study Drug|1|||
13128507|NCT02886702|25965250|FG002|Overall Study|Non-Compliance With Study Drug|4|||
13128508|NCT02886702|25965248|FG000|Overall Study|Lost to Follow-up|11|||
13128509|NCT02886702|25965249|FG001|Overall Study|Lost to Follow-up|13|||
13128510|NCT02886702|25965250|FG002|Overall Study|Lost to Follow-up|8|||
13128511|NCT02886702|25965248|FG000|Overall Study|Lack of Efficacy|3|||
13128512|NCT02886702|25965249|FG001|Overall Study|Lack of Efficacy|4|||
13128513|NCT02886702|25965250|FG002|Overall Study|Lack of Efficacy|5|||
13128514|NCT02886702|25965248|FG000|Overall Study|Adverse Event|4|||
13128515|NCT02886702|25965249|FG001|Overall Study|Adverse Event|9|||
13128516|NCT02886702|25965250|FG002|Overall Study|Adverse Event|3|||
13128517|NCT02886702|25965248|FG000|Overall Study|Administrative Reasons|0|||
13128518|NCT02886702|25965249|FG001|Overall Study|Administrative Reasons|0|||
13128519|NCT02886702|25965250|FG002|Overall Study|Administrative Reasons|1|||
13128520|NCT02886624|25965261|FG000|12-week Post Treatment Follow-up|Death|1|||
13128521|NCT02886624|25965261|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1|||
13128522|NCT02886338|25965267|FG000|Overall Study|Withdrawal by Subject|1|||
13128523|NCT02885181|25965306|FG000|Overall Study|Investigator's Discretion|0|||
13128524|NCT02885181|25965307|FG001|Overall Study|Investigator's Discretion|1|||
13128525|NCT02885181|25965308|FG002|Overall Study|Investigator's Discretion|0|||
13128526|NCT02885181|25965309|FG003|Overall Study|Investigator's Discretion|1|||
13128527|NCT02885181|25965306|FG000|Overall Study|Adverse Event|0|||
13128528|NCT02885181|25965307|FG001|Overall Study|Adverse Event|0|||
13128529|NCT02885181|25965308|FG002|Overall Study|Adverse Event|0|||
13128530|NCT02885181|25965309|FG003|Overall Study|Adverse Event|1|||
13128531|NCT02885181|25965306|FG000|Overall Study|Withdrawal by Subject|0|||
13128532|NCT02885181|25965307|FG001|Overall Study|Withdrawal by Subject|0|||
13128533|NCT02885181|25965308|FG002|Overall Study|Withdrawal by Subject|0|||
13128534|NCT02885181|25965309|FG003|Overall Study|Withdrawal by Subject|1|||
13128535|NCT02884089|25965328|FG000|Period 1|Dosing error|2|||
13128536|NCT02884089|25965329|FG001|Period 1|Dosing error|2|||
13128537|NCT02884089|25965330|FG002|Period 1|Dosing error|0|||
13128538|NCT02884089|25965331|FG003|Period 1|Dosing error|0|||
13128539|NCT02884089|25965328|FG000|Washout Period 1|Lost to Follow-up|0|||
13128540|NCT02884089|25965329|FG001|Washout Period 1|Lost to Follow-up|1|||
13128541|NCT02884089|25965330|FG002|Washout Period 1|Lost to Follow-up|0|||
13128542|NCT02884089|25965331|FG003|Washout Period 1|Lost to Follow-up|1|||
13128543|NCT02884089|25965328|FG000|Washout Period 1|Withdrawal by Subject|0|||
13128544|NCT02884089|25965329|FG001|Washout Period 1|Withdrawal by Subject|1|||
13128545|NCT02884089|25965330|FG002|Washout Period 1|Withdrawal by Subject|0|||
13128546|NCT02884089|25965331|FG003|Washout Period 1|Withdrawal by Subject|0|||
13128547|NCT02884089|25965328|FG000|Period 2|Adverse Event|1|||
13128548|NCT02884089|25965329|FG001|Period 2|Adverse Event|0|||
13128549|NCT02884089|25965330|FG002|Period 2|Adverse Event|0|||
13128550|NCT02884089|25965331|FG003|Period 2|Adverse Event|0|||
13128551|NCT02884089|25965328|FG000|Period 3|Withdrawal by Subject|0|||
13128552|NCT02884089|25965329|FG001|Period 3|Withdrawal by Subject|0|||
13128553|NCT02884089|25965330|FG002|Period 3|Withdrawal by Subject|1|||
13128554|NCT02884089|25965331|FG003|Period 3|Withdrawal by Subject|0|||
13128555|NCT02884089|25965328|FG000|Washout Period 3|Withdrawal by Subject|0|||
13128556|NCT02884089|25965329|FG001|Washout Period 3|Withdrawal by Subject|0|||
13128557|NCT02884089|25965330|FG002|Washout Period 3|Withdrawal by Subject|1|||
13128558|NCT02884089|25965331|FG003|Washout Period 3|Withdrawal by Subject|0|||
13128559|NCT02884089|25965328|FG000|Washout Period 3|Lost to Follow-up|0|||
13128560|NCT02884089|25965329|FG001|Washout Period 3|Lost to Follow-up|0|||
13128561|NCT02884089|25965330|FG002|Washout Period 3|Lost to Follow-up|0|||
13128562|NCT02884089|25965331|FG003|Washout Period 3|Lost to Follow-up|1|||
13128563|NCT02884089|25965328|FG000|Period 4|Withdrawal by Subject|0|||
13128564|NCT02884089|25965329|FG001|Period 4|Withdrawal by Subject|1|||
13128565|NCT02884089|25965330|FG002|Period 4|Withdrawal by Subject|0|||
13128566|NCT02884089|25965331|FG003|Period 4|Withdrawal by Subject|0|||
13128567|NCT02884089|25965328|FG000|Period 4|Lost to Follow-up|1|||
13128568|NCT02884089|25965329|FG001|Period 4|Lost to Follow-up|0|||
13128569|NCT02884089|25965330|FG002|Period 4|Lost to Follow-up|0|||
13128570|NCT02884089|25965331|FG003|Period 4|Lost to Follow-up|0|||
13128571|NCT02884089|25965328|FG000|Follow-up Visit|Withdrawal by Subject|1|||
13128572|NCT02884089|25965329|FG001|Follow-up Visit|Withdrawal by Subject|0|||
13128573|NCT02884089|25965330|FG002|Follow-up Visit|Withdrawal by Subject|0|||
13128574|NCT02884089|25965331|FG003|Follow-up Visit|Withdrawal by Subject|1|||
13128575|NCT02883452|25965376|FG000|Overall Study|Withdrawal by Subject|1|||
13128576|NCT02883452|25965377|FG001|Overall Study|Withdrawal by Subject|1|||
13128577|NCT02883452|25965378|FG002|Overall Study|Withdrawal by Subject|3|||
13128578|NCT02883452|25965379|FG003|Overall Study|Withdrawal by Subject|0|||
13128579|NCT02883452|25965380|FG004|Overall Study|Withdrawal by Subject|2|||
13128580|NCT02883452|25965381|FG005|Overall Study|Withdrawal by Subject|5|||
13128581|NCT02883452|25965376|FG000|Overall Study|Disease progression|1|||
13128582|NCT02883452|25965377|FG001|Overall Study|Disease progression|0|||
13128583|NCT02883452|25965378|FG002|Overall Study|Disease progression|0|||
13128584|NCT02883452|25965379|FG003|Overall Study|Disease progression|1|||
13128585|NCT02883452|25965380|FG004|Overall Study|Disease progression|4|||
13128586|NCT02883452|25965381|FG005|Overall Study|Disease progression|5|||
13128587|NCT02883452|25965376|FG000|Overall Study|Adverse Event|2|||
13128588|NCT02883452|25965377|FG001|Overall Study|Adverse Event|1|||
13128589|NCT02883452|25965378|FG002|Overall Study|Adverse Event|1|||
13128590|NCT02883452|25965379|FG003|Overall Study|Adverse Event|1|||
13128591|NCT02883452|25965380|FG004|Overall Study|Adverse Event|1|||
13128592|NCT02883452|25965381|FG005|Overall Study|Adverse Event|3|||
13128593|NCT02883452|25965376|FG000|Overall Study|Physician Decision|0|||
13128594|NCT02883452|25965377|FG001|Overall Study|Physician Decision|0|||
13128595|NCT02883452|25965378|FG002|Overall Study|Physician Decision|0|||
13128596|NCT02883452|25965379|FG003|Overall Study|Physician Decision|0|||
13128597|NCT02883452|25965380|FG004|Overall Study|Physician Decision|4|||
13128598|NCT02883452|25965381|FG005|Overall Study|Physician Decision|1|||
13128599|NCT02883452|25965376|FG000|Overall Study|Death|1|||
13128600|NCT02883452|25965377|FG001|Overall Study|Death|0|||
13128601|NCT02883452|25965378|FG002|Overall Study|Death|1|||
13128602|NCT02883452|25965379|FG003|Overall Study|Death|0|||
13128603|NCT02883452|25965380|FG004|Overall Study|Death|0|||
13128604|NCT02883452|25965381|FG005|Overall Study|Death|0|||
13128605|NCT02883452|25965376|FG000|Overall Study|Other|0|||
13128606|NCT02883452|25965377|FG001|Overall Study|Other|0|||
13128607|NCT02883452|25965378|FG002|Overall Study|Other|0|||
13128608|NCT02883452|25965379|FG003|Overall Study|Other|0|||
13128609|NCT02883452|25965380|FG004|Overall Study|Other|0|||
13128610|NCT02883452|25965381|FG005|Overall Study|Other|1|||
13128611|NCT02883244|25965404|FG000|Overall Study|Lost to Follow-up|0|||
13128612|NCT02883244|25965405|FG001|Overall Study|Lost to Follow-up|1|||
13128613|NCT02882854|25965434|FG000|Overall Study|Lost to Follow-up|1|||
13128614|NCT02882854|25965435|FG001|Overall Study|Lost to Follow-up|2|||
13128615|NCT02882854|25965434|FG000|Overall Study|Physician Decision|0|||
13128616|NCT02882854|25965435|FG001|Overall Study|Physician Decision|1|||
13128617|NCT02882152|25965450|FG000|Overall Study|Lost to Follow-up|1|||
13128618|NCT02882152|25965451|FG001|Overall Study|Lost to Follow-up|0|||
13128619|NCT02881567|25965465|FG000|Overall Study|Adverse Event|1|||
13128620|NCT02881567|25965465|FG000|Overall Study|Lost to Follow-up|3|||
13128621|NCT02881567|25965465|FG000|Overall Study|Consent withdrawn|1|||
13128622|NCT02881567|25965465|FG000|Overall Study|Investigator decision|1|||
13128623|NCT02881567|25965465|FG000|Overall Study|Study terminated by sponsor|9|||
13128624|NCT02881567|25965465|FG000|Overall Study|Reason not Specified|3|||
13128625|NCT02881047|25965473|FG000|Overall Study|Adverse Event|1|||
13128626|NCT02881047|25965473|FG000|Overall Study|Withdrawal by Subject|1|||
13128627|NCT02880956|25965673|FG000|Overall Study|Adverse Event|3|||
13128628|NCT02880956|25965674|FG001|Overall Study|Adverse Event|6|||
13128629|NCT02880956|25965675|FG002|Overall Study|Adverse Event|5|||
13128630|NCT02880956|25965676|FG003|Overall Study|Adverse Event|4|||
13128631|NCT02880956|25965673|FG000|Overall Study|Withdrawal by Subject|9|||
13128632|NCT02880956|25965674|FG001|Overall Study|Withdrawal by Subject|4|||
13128633|NCT02880956|25965675|FG002|Overall Study|Withdrawal by Subject|6|||
13128634|NCT02880956|25965676|FG003|Overall Study|Withdrawal by Subject|11|||
13128635|NCT02880956|25965673|FG000|Overall Study|Lost to Follow-up|0|||
13128636|NCT02880956|25965674|FG001|Overall Study|Lost to Follow-up|1|||
13128637|NCT02880956|25965675|FG002|Overall Study|Lost to Follow-up|0|||
13128638|NCT02880956|25965676|FG003|Overall Study|Lost to Follow-up|0|||
13128639|NCT02880956|25965673|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
13128640|NCT02880956|25965674|FG001|Overall Study|COVID-19 Logistical Restrictions|2|||
13128641|NCT02880956|25965675|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
13128642|NCT02880956|25965676|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
13128643|NCT02880956|25965673|FG000|Overall Study|Other, Not Specified|4|||
13128644|NCT02880956|25965674|FG001|Overall Study|Other, Not Specified|2|||
13128645|NCT02880956|25965675|FG002|Overall Study|Other, Not Specified|0|||
13128646|NCT02880956|25965676|FG003|Overall Study|Other, Not Specified|3|||
13128647|NCT02880865|25965738|FG000|Overall Study|Adverse Event|1|||
13128648|NCT02880865|25965739|FG001|Overall Study|Adverse Event|0|||
13128649|NCT02880865|25965738|FG000|Overall Study|Withdrawal by Subject|0|||
13128650|NCT02880865|25965739|FG001|Overall Study|Withdrawal by Subject|2|||
13128651|NCT02880865|25965738|FG000|Overall Study|Physician Decision|0|||
13128652|NCT02880865|25965739|FG001|Overall Study|Physician Decision|1|||
13128653|NCT02880761|25965756|FG000|Overall Study|Death|6|||
13128654|NCT02880761|25965757|FG001|Overall Study|Death|8|||
13128655|NCT02880761|25965756|FG000|Overall Study|Withdrawal by Subject|3|||
13128656|NCT02880761|25965757|FG001|Overall Study|Withdrawal by Subject|6|||
13128657|NCT02880761|25965756|FG000|Overall Study|Protocol Violation|4|||
13128658|NCT02880761|25965757|FG001|Overall Study|Protocol Violation|3|||
13128659|NCT02880761|25965756|FG000|Overall Study|Lost to Follow-up|3|||
13128660|NCT02880761|25965757|FG001|Overall Study|Lost to Follow-up|4|||
13128661|NCT02879994|25965765|FG000|Overall Study|off treatment early|7|||
13128662|NCT02879994|25965765|FG000|Overall Study|Adverse Event|2|||
13128663|NCT02879994|25965765|FG000|Overall Study|Death|2|||
13128664|NCT02879578|25965783|FG000|Overall Study|Adverse Event|1|||
13128665|NCT02879578|25965784|FG001|Overall Study|Adverse Event|2|||
13393334|NCT00665925|26783413|FG002|Overall Study|Withdrawal by Subject|3|||
13128666|NCT02879578|25965785|FG002|Overall Study|Adverse Event|14|||
13128667|NCT02879578|25965783|FG000|Overall Study|Protocol Violation|0|||
13128668|NCT02879578|25965784|FG001|Overall Study|Protocol Violation|1|||
13128669|NCT02879578|25965785|FG002|Overall Study|Protocol Violation|1|||
13128670|NCT02879578|25965783|FG000|Overall Study|Withdrawal by Subject|8|||
13128671|NCT02879578|25965784|FG001|Overall Study|Withdrawal by Subject|6|||
13128672|NCT02879578|25965785|FG002|Overall Study|Withdrawal by Subject|9|||
13128673|NCT02879578|25965783|FG000|Overall Study|Lost to Follow-up|1|||
13128674|NCT02879578|25965784|FG001|Overall Study|Lost to Follow-up|0|||
13128675|NCT02879578|25965785|FG002|Overall Study|Lost to Follow-up|4|||
13128676|NCT02879578|25965783|FG000|Overall Study|Physician Decision|0|||
13128677|NCT02879578|25965784|FG001|Overall Study|Physician Decision|0|||
13128678|NCT02879578|25965785|FG002|Overall Study|Physician Decision|4|||
13128679|NCT02879383|25965814|FG000|First 24 Weeks|Physician Decision|0|||
13128680|NCT02879383|25965815|FG001|First 24 Weeks|Physician Decision|1|||
13128681|NCT02879383|25965816|FG002|First 24 Weeks|Physician Decision|0|||
13128682|NCT02879383|25965817|FG003|First 24 Weeks|Physician Decision|0|||
13128683|NCT02878603|25965874|FG000|Overall Study|Lost to Follow-up|4|||
13128684|NCT02878603|25965875|FG001|Overall Study|Lost to Follow-up|1|||
13128685|NCT02878603|25965874|FG000|Overall Study|Withdrawal by Subject|1|||
13128686|NCT02878603|25965875|FG001|Overall Study|Withdrawal by Subject|1|||
13128687|NCT02878603|25965874|FG000|Overall Study|Death|1|||
13128688|NCT02878603|25965875|FG001|Overall Study|Death|0|||
13128689|NCT02878603|25965874|FG000|Overall Study|Physician Decision|0|||
13128690|NCT02878603|25965875|FG001|Overall Study|Physician Decision|3|||
13128691|NCT02878590|25965881|FG000|Overall Study|Withdrawal by Subject|2|||
13128692|NCT02878330|25965904|FG000|Overall Study|Death|3|||
13128693|NCT02878330|25965905|FG001|Overall Study|Death|2|||
13128694|NCT02878330|25965904|FG000|Overall Study|Lost to Follow-up|11|||
13128695|NCT02878330|25965905|FG001|Overall Study|Lost to Follow-up|26|||
13128696|NCT02878330|25965904|FG000|Overall Study|Withdrawal by Subject|11|||
13128697|NCT02878330|25965905|FG001|Overall Study|Withdrawal by Subject|21|||
13128698|NCT02878330|25965904|FG000|Overall Study|Other|4|||
13128699|NCT02878330|25965905|FG001|Overall Study|Other|7|||
13128700|NCT02878213|25965912|FG000|Overall Study|Withdrawal by Subject|2|||
13128701|NCT02878213|25965912|FG000|Overall Study|Adverse Event|1|||
13128702|NCT02877927|25965929|FG000|Overall Study|Adverse Event|1|||
13128703|NCT02877927|25965930|FG001|Overall Study|Adverse Event|0|||
13128704|NCT02877927|25965929|FG000|Overall Study|Lost to Follow-up|37|||
13128705|NCT02877927|25965930|FG001|Overall Study|Lost to Follow-up|38|||
13128706|NCT02877927|25965929|FG000|Overall Study|Withdrawal by Subject|11|||
13128707|NCT02877927|25965930|FG001|Overall Study|Withdrawal by Subject|12|||
13128708|NCT02877927|25965929|FG000|Overall Study|Physician Decision|0|||
13128709|NCT02877927|25965930|FG001|Overall Study|Physician Decision|1|||
13128710|NCT02877927|25965929|FG000|Overall Study|Missed EOT/PTE Visit|5|||
13128711|NCT02877927|25965930|FG001|Overall Study|Missed EOT/PTE Visit|6|||
13128712|NCT02877680|25965976|FG000|Overall Study|Lost to Follow-up|1|||
13128713|NCT02877680|25965977|FG001|Overall Study|Lost to Follow-up|1|||
13128714|NCT02877134|25966047|FG000|Overall Study|Death|0|||
13128715|NCT02877134|25966048|FG001|Overall Study|Death|1|||
13128716|NCT02877134|25966049|FG002|Overall Study|Death|0|||
13128717|NCT02877134|25966050|FG003|Overall Study|Death|0|||
13128718|NCT02877134|25966051|FG004|Overall Study|Death|0|||
13128719|NCT02877134|25966052|FG005|Overall Study|Death|1|||
13128720|NCT02877134|25966053|FG006|Overall Study|Death|0|||
13128721|NCT02877134|25966047|FG000|Overall Study|Lost to Follow-up|0|||
13128722|NCT02877134|25966048|FG001|Overall Study|Lost to Follow-up|4|||
13128723|NCT02877134|25966049|FG002|Overall Study|Lost to Follow-up|0|||
13128724|NCT02877134|25966050|FG003|Overall Study|Lost to Follow-up|1|||
13128725|NCT02877134|25966051|FG004|Overall Study|Lost to Follow-up|0|||
13128726|NCT02877134|25966052|FG005|Overall Study|Lost to Follow-up|0|||
13128727|NCT02877134|25966053|FG006|Overall Study|Lost to Follow-up|0|||
13128728|NCT02877134|25966047|FG000|Overall Study|Withdrawal by Subject|13|||
13128729|NCT02877134|25966048|FG001|Overall Study|Withdrawal by Subject|19|||
13128730|NCT02877134|25966049|FG002|Overall Study|Withdrawal by Subject|4|||
13128731|NCT02877134|25966050|FG003|Overall Study|Withdrawal by Subject|6|||
13128732|NCT02877134|25966051|FG004|Overall Study|Withdrawal by Subject|3|||
13128733|NCT02877134|25966052|FG005|Overall Study|Withdrawal by Subject|5|||
13128734|NCT02877134|25966053|FG006|Overall Study|Withdrawal by Subject|0|||
13128735|NCT02877134|25966047|FG000|Overall Study|Other|1|||
13128736|NCT02877134|25966048|FG001|Overall Study|Other|1|||
13128737|NCT02877134|25966049|FG002|Overall Study|Other|2|||
13128738|NCT02877134|25966050|FG003|Overall Study|Other|6|||
13128739|NCT02877134|25966051|FG004|Overall Study|Other|3|||
13128740|NCT02877134|25966052|FG005|Overall Study|Other|1|||
13128741|NCT02877134|25966053|FG006|Overall Study|Other|1|||
13128742|NCT02877082|25966063|FG000|Overall Study|Trial was closed early|5|||
13128743|NCT02877004|25966084|FG000|Overall Study|Pregnancy|0|||
13128744|NCT02877004|25966085|FG001|Overall Study|Pregnancy|0|||
13128745|NCT02877004|25966086|FG002|Overall Study|Pregnancy|1|||
13393335|NCT00665925|26783414|FG003|Overall Study|Withdrawal by Subject|2|||
13128746|NCT02876835|25966180|FG000|Treatment Period (51.1 Month)|Other|1|||
13128747|NCT02876835|25966181|FG001|Treatment Period (51.1 Month)|Other|0|||
13128748|NCT02876835|25966180|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6|||
13128749|NCT02876835|25966181|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13|||
13128750|NCT02876835|25966180|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32|||
13128751|NCT02876835|25966181|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23|||
13128752|NCT02876835|25966180|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25|||
13128753|NCT02876835|25966181|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29|||
13128754|NCT02876601|25966244|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
13128755|NCT02876601|25966245|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
13128756|NCT02876601|25966246|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1|||
13128757|NCT02876601|25966247|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
13128758|NCT02876328|25966346|FG000|Overall Study|Death|2|||
13128759|NCT02876328|25966347|FG001|Overall Study|Death|1|||
13128760|NCT02876328|25966348|FG002|Overall Study|Death|3|||
13128761|NCT02876328|25966349|FG003|Overall Study|Death|0|||
13128762|NCT02876328|25966350|FG004|Overall Study|Death|0|||
13128763|NCT02876328|25966351|FG005|Overall Study|Death|0|||
13128764|NCT02876328|25966352|FG006|Overall Study|Death|1|||
13128765|NCT02876328|25966353|FG007|Overall Study|Death|3|||
13128766|NCT02876328|25966354|FG008|Overall Study|Death|0|||
13128767|NCT02876328|25966355|FG009|Overall Study|Death|1|||
13128768|NCT02876328|25966356|FG010|Overall Study|Death|1|||
13128769|NCT02876328|25966357|FG011|Overall Study|Death|0|||
13128770|NCT02876328|25966358|FG012|Overall Study|Death|0|||
13128771|NCT02876328|25966359|FG013|Overall Study|Death|0|||
13128772|NCT02876328|25966360|FG014|Overall Study|Death|0|||
13128773|NCT02876328|25966361|FG015|Overall Study|Death|0|||
13128774|NCT02876328|25966362|FG016|Overall Study|Death|1|||
13128775|NCT02876328|25966363|FG017|Overall Study|Death|1|||
13128776|NCT02876328|25966364|FG018|Overall Study|Death|0|||
13128777|NCT02876328|25966365|FG019|Overall Study|Death|0|||
13128778|NCT02876328|25966366|FG020|Overall Study|Death|0|||
13128779|NCT02876328|25966367|FG021|Overall Study|Death|1|||
13128780|NCT02876328|25966368|FG022|Overall Study|Death|0|||
13128781|NCT02876328|25966369|FG023|Overall Study|Death|0|||
13128782|NCT02876328|25966346|FG000|Overall Study|Withdrawal by Subject|0|||
13128783|NCT02876328|25966347|FG001|Overall Study|Withdrawal by Subject|2|||
13128784|NCT02876328|25966348|FG002|Overall Study|Withdrawal by Subject|3|||
13128785|NCT02876328|25966349|FG003|Overall Study|Withdrawal by Subject|3|||
13128786|NCT02876328|25966350|FG004|Overall Study|Withdrawal by Subject|0|||
13128787|NCT02876328|25966351|FG005|Overall Study|Withdrawal by Subject|1|||
13128788|NCT02876328|25966352|FG006|Overall Study|Withdrawal by Subject|0|||
13128789|NCT02876328|25966353|FG007|Overall Study|Withdrawal by Subject|1|||
13128790|NCT02876328|25966354|FG008|Overall Study|Withdrawal by Subject|1|||
13128791|NCT02876328|25966355|FG009|Overall Study|Withdrawal by Subject|2|||
13128792|NCT02876328|25966356|FG010|Overall Study|Withdrawal by Subject|0|||
13128793|NCT02876328|25966357|FG011|Overall Study|Withdrawal by Subject|0|||
13128794|NCT02876328|25966358|FG012|Overall Study|Withdrawal by Subject|0|||
13128795|NCT02876328|25966359|FG013|Overall Study|Withdrawal by Subject|0|||
13128796|NCT02876328|25966360|FG014|Overall Study|Withdrawal by Subject|0|||
13128797|NCT02876328|25966361|FG015|Overall Study|Withdrawal by Subject|0|||
13128798|NCT02876328|25966362|FG016|Overall Study|Withdrawal by Subject|1|||
13128799|NCT02876328|25966363|FG017|Overall Study|Withdrawal by Subject|3|||
13128800|NCT02876328|25966364|FG018|Overall Study|Withdrawal by Subject|0|||
13128801|NCT02876328|25966365|FG019|Overall Study|Withdrawal by Subject|0|||
13128802|NCT02876328|25966366|FG020|Overall Study|Withdrawal by Subject|1|||
13128803|NCT02876328|25966367|FG021|Overall Study|Withdrawal by Subject|0|||
13128804|NCT02876328|25966368|FG022|Overall Study|Withdrawal by Subject|0|||
13128805|NCT02876328|25966369|FG023|Overall Study|Withdrawal by Subject|0|||
13128806|NCT02876328|25966346|FG000|Overall Study|Missed 12 Month Visit|15|||
13222072|NCT01808144|26285441|FG000|Overall Study|Death|1|||
13222073|NCT01808144|26285442|FG001|Overall Study|Death|0|||
13128807|NCT02876328|25966347|FG001|Overall Study|Missed 12 Month Visit|10|||
13128808|NCT02876328|25966348|FG002|Overall Study|Missed 12 Month Visit|11|||
13128809|NCT02876328|25966349|FG003|Overall Study|Missed 12 Month Visit|6|||
13128810|NCT02876328|25966350|FG004|Overall Study|Missed 12 Month Visit|10|||
13128811|NCT02876328|25966351|FG005|Overall Study|Missed 12 Month Visit|14|||
13128812|NCT02876328|25966352|FG006|Overall Study|Missed 12 Month Visit|3|||
13128813|NCT02876328|25966353|FG007|Overall Study|Missed 12 Month Visit|8|||
13128814|NCT02876328|25966354|FG008|Overall Study|Missed 12 Month Visit|9|||
13128815|NCT02876328|25966355|FG009|Overall Study|Missed 12 Month Visit|5|||
13128816|NCT02876328|25966356|FG010|Overall Study|Missed 12 Month Visit|4|||
13128817|NCT02876328|25966357|FG011|Overall Study|Missed 12 Month Visit|1|||
13128818|NCT02876328|25966358|FG012|Overall Study|Missed 12 Month Visit|5|||
13128819|NCT02876328|25966359|FG013|Overall Study|Missed 12 Month Visit|4|||
13128820|NCT02876328|25966360|FG014|Overall Study|Missed 12 Month Visit|4|||
13128821|NCT02876328|25966361|FG015|Overall Study|Missed 12 Month Visit|4|||
13128822|NCT02876328|25966362|FG016|Overall Study|Missed 12 Month Visit|3|||
13128823|NCT02876328|25966363|FG017|Overall Study|Missed 12 Month Visit|6|||
13128824|NCT02876328|25966364|FG018|Overall Study|Missed 12 Month Visit|2|||
13128825|NCT02876328|25966365|FG019|Overall Study|Missed 12 Month Visit|2|||
13128826|NCT02876328|25966366|FG020|Overall Study|Missed 12 Month Visit|11|||
13204567|NCT01972529|26229305|FG001|Overall Study|Participant Choice|1|||
13128827|NCT02876328|25966367|FG021|Overall Study|Missed 12 Month Visit|7|||
13128828|NCT02876328|25966368|FG022|Overall Study|Missed 12 Month Visit|1|||
13128829|NCT02876328|25966369|FG023|Overall Study|Missed 12 Month Visit|0|||
13128830|NCT02875977|25966390|FG000|Overall Study|Lost to Follow-up|42|||
13128831|NCT02875977|25966391|FG001|Overall Study|Lost to Follow-up|29|||
13128832|NCT02875860|25966436|FG000|Overall Study|Withdrawal by Subject|0|||
13128833|NCT02875860|25966437|FG001|Overall Study|Withdrawal by Subject|1|||
13128834|NCT02875834|25966508|FG000|Open-label Phase|Withdrawal by Subject|3|||
13128835|NCT02875834|25966509|FG001|Open-label Phase|Withdrawal by Subject|0|||
13128836|NCT02875834|25966510|FG002|Open-label Phase|Withdrawal by Subject|0|||
13128837|NCT02875834|25966511|FG003|Open-label Phase|Withdrawal by Subject|0|||
13128838|NCT02875834|25966508|FG000|Open-label Phase|(Not collected)|4|||
13128839|NCT02875834|25966509|FG001|Open-label Phase|(Not collected)|0|||
13128840|NCT02875834|25966510|FG002|Open-label Phase|(Not collected)|0|||
13128841|NCT02875834|25966511|FG003|Open-label Phase|(Not collected)|0|||
13128842|NCT02875834|25966508|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
13128843|NCT02875834|25966509|FG001|Randomized Treatment Phase|Withdrawal by Subject|3|||
13128844|NCT02875834|25966510|FG002|Randomized Treatment Phase|Withdrawal by Subject|1|||
13128845|NCT02875834|25966511|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
13128846|NCT02875834|25966508|FG000|Randomized Treatment Phase|Protocol Violation|0|||
13128847|NCT02875834|25966509|FG001|Randomized Treatment Phase|Protocol Violation|2|||
13128848|NCT02875834|25966510|FG002|Randomized Treatment Phase|Protocol Violation|0|||
13128849|NCT02875834|25966511|FG003|Randomized Treatment Phase|Protocol Violation|0|||
13128850|NCT02875834|25966508|FG000|Randomized Treatment Phase|(Not collected)|0|||
13128851|NCT02875834|25966509|FG001|Randomized Treatment Phase|(Not collected)|9|||
13128852|NCT02875834|25966510|FG002|Randomized Treatment Phase|(Not collected)|10|||
13128853|NCT02875834|25966511|FG003|Randomized Treatment Phase|(Not collected)|9|||
13128854|NCT02875613|25966517|FG000|Overall Study|Withdrawal by Subject|1|||
13128855|NCT02875392|25966534|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7|||
13128856|NCT02875392|25966535|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8|||
13128857|NCT02875366|25966594|FG000|Overall Study|Adverse Event|0|||
13128858|NCT02875366|25966595|FG001|Overall Study|Adverse Event|2|||
13128859|NCT02875366|25966594|FG000|Overall Study|Noncompliance|0|||
13128860|NCT02875366|25966595|FG001|Overall Study|Noncompliance|1|||
13128861|NCT02875340|25966619|FG000|Overall Study|Death|2|||
13128862|NCT02875340|25966619|FG000|Overall Study|Withdrawal by Subject|2|||
13128863|NCT02875340|25966619|FG000|Overall Study|Physician Decision|3|||
13128864|NCT02875340|25966619|FG000|Overall Study|Adverse Event|1|||
13128865|NCT02875080|25966640|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2|||
13128866|NCT02875080|25966641|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
13128867|NCT02875080|25966642|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
13128868|NCT02875067|25966657|FG000|Overall Study|Withdrawal by Subject|1|||
13128869|NCT02875067|25966657|FG000|Overall Study|Withdrawal by Termination of Study|5|||
13128870|NCT02875028|25966692|FG000|Washout Period|Withdrawal by Subject|0|||
13128871|NCT02875028|25966693|FG001|Washout Period|Withdrawal by Subject|1|||
13128872|NCT02874924|25966723|FG000|Overall Study|Adverse Event|2|||
13128873|NCT02874924|25966724|FG001|Overall Study|Adverse Event|0|||
13128874|NCT02874924|25966725|FG002|Overall Study|Adverse Event|0|||
13128875|NCT02874924|25966723|FG000|Overall Study|Withdrawal by Subject|1|||
13128876|NCT02874924|25966724|FG001|Overall Study|Withdrawal by Subject|0|||
13128877|NCT02874924|25966725|FG002|Overall Study|Withdrawal by Subject|0|||
13128878|NCT02874794|25966761|FG000|Overall Study|Physician Decision|3|||
13128879|NCT02874794|25966762|FG001|Overall Study|Physician Decision|2|||
13128880|NCT02874794|25966761|FG000|Overall Study|Withdrawal by Subject|2|||
13128881|NCT02874794|25966762|FG001|Overall Study|Withdrawal by Subject|8|||
13128882|NCT02874794|25966761|FG000|Overall Study|Death|2|||
13128883|NCT02874794|25966762|FG001|Overall Study|Death|1|||
13128884|NCT02874742|25966824|FG000|Overall Study|Death|3|||
13128885|NCT02874742|25966825|FG001|Overall Study|Death|1|||
13128886|NCT02874742|25966826|FG002|Overall Study|Death|1|||
13128887|NCT02874742|25966824|FG000|Overall Study|Lost to Follow-up|2|||
13128888|NCT02874742|25966825|FG001|Overall Study|Lost to Follow-up|0|||
13128889|NCT02874742|25966826|FG002|Overall Study|Lost to Follow-up|0|||
13128890|NCT02874742|25966824|FG000|Overall Study|Withdrawal by Subject|8|||
13128891|NCT02874742|25966825|FG001|Overall Study|Withdrawal by Subject|4|||
13128892|NCT02874742|25966826|FG002|Overall Study|Withdrawal by Subject|0|||
13128893|NCT02874742|25966824|FG000|Overall Study|Other|3|||
13128894|NCT02874742|25966825|FG001|Overall Study|Other|1|||
13128895|NCT02874742|25966826|FG002|Overall Study|Other|0|||
13128896|NCT02874742|25966824|FG000|Overall Study|Ongoing|87|||
13128897|NCT02874742|25966825|FG001|Overall Study|Ongoing|98|||
13128898|NCT02874742|25966826|FG002|Overall Study|Ongoing|15|||
13128899|NCT02874534|25966841|FG000|Overall Study|Withdrawal by Subject|5|||
13128900|NCT02874534|25966842|FG001|Overall Study|Withdrawal by Subject|8|||
13128901|NCT02874534|25966841|FG000|Overall Study|Lost to Follow-up|2|||
13128902|NCT02874534|25966842|FG001|Overall Study|Lost to Follow-up|2|||
13128903|NCT02874534|25966841|FG000|Overall Study|Ongoing in study|1|||
13128904|NCT02874534|25966842|FG001|Overall Study|Ongoing in study|1|||
13128905|NCT02873936|25966980|FG000|Overall Study|Withdrew Consent|4|||
13128906|NCT02873936|25966981|FG001|Overall Study|Withdrew Consent|11|||
13128907|NCT02873936|25966982|FG002|Overall Study|Withdrew Consent|20|||
13128908|NCT02873936|25966980|FG000|Overall Study|Investigator's Discretion|3|||
13128909|NCT02873936|25966981|FG001|Overall Study|Investigator's Discretion|5|||
13128910|NCT02873936|25966982|FG002|Overall Study|Investigator's Discretion|4|||
13128911|NCT02873936|25966980|FG000|Overall Study|Adverse Event|3|||
13128912|NCT02873936|25966981|FG001|Overall Study|Adverse Event|5|||
13128913|NCT02873936|25966982|FG002|Overall Study|Adverse Event|3|||
13128914|NCT02873936|25966980|FG000|Overall Study|Protocol Violation|0|||
13128915|NCT02873936|25966981|FG001|Overall Study|Protocol Violation|1|||
13128916|NCT02873936|25966982|FG002|Overall Study|Protocol Violation|3|||
13128917|NCT02873936|25966980|FG000|Overall Study|Lost to Follow-up|1|||
13128918|NCT02873936|25966981|FG001|Overall Study|Lost to Follow-up|1|||
13128919|NCT02873936|25966982|FG002|Overall Study|Lost to Follow-up|1|||
13128920|NCT02873936|25966980|FG000|Overall Study|Non-compliance With Study Drug|1|||
13128921|NCT02873936|25966981|FG001|Overall Study|Non-compliance With Study Drug|0|||
13128922|NCT02873936|25966982|FG002|Overall Study|Non-compliance With Study Drug|1|||
13128923|NCT02873936|25966980|FG000|Overall Study|Randomized but not Dosed|1|||
13128924|NCT02873936|25966981|FG001|Overall Study|Randomized but not Dosed|0|||
13128925|NCT02873936|25966982|FG002|Overall Study|Randomized but not Dosed|0|||
13128926|NCT02873754|25966999|FG000|Overall Study|Lost to Follow-up|5|||
13128927|NCT02873754|25966999|FG000|Overall Study|Couldn't complete study procedures|1|||
13128928|NCT02873702|25967018|FG000|Healing Period (up to Week 8)|Adverse Event|1|||
13128929|NCT02873702|25967019|FG001|Healing Period (up to Week 8)|Adverse Event|0|||
13128930|NCT02873702|25967020|FG002|Healing Period (up to Week 8)|Adverse Event|0|||
13128931|NCT02873702|25967021|FG003|Healing Period (up to Week 8)|Adverse Event|0|||
13128932|NCT02873702|25967018|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
13128933|NCT02873702|25967019|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1|||
13128934|NCT02873702|25967020|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
13128935|NCT02873702|25967021|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
13128936|NCT02873702|25967018|FG000|Maintenance Period (up to Month 6)|Adverse Event|0|||
13128937|NCT02873702|25967019|FG001|Maintenance Period (up to Month 6)|Adverse Event|0|||
13128938|NCT02873702|25967020|FG002|Maintenance Period (up to Month 6)|Adverse Event|1|||
13128939|NCT02873702|25967021|FG003|Maintenance Period (up to Month 6)|Adverse Event|0|||
13128940|NCT02873702|25967018|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0|||
13128941|NCT02873702|25967019|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0|||
13128942|NCT02873702|25967020|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4|||
13128943|NCT02873702|25967021|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1|||
13128944|NCT02873702|25967018|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
13128945|NCT02873702|25967019|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
13128946|NCT02873702|25967020|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2|||
13128947|NCT02873702|25967021|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1|||
13128948|NCT02873689|25967036|FG000|Overall Study|Lack of Efficacy|1|||
13128949|NCT02873689|25967037|FG001|Overall Study|Lack of Efficacy|0|||
13128950|NCT02873689|25967036|FG000|Overall Study|Withdrawal by Subject|2|||
13128951|NCT02873689|25967037|FG001|Overall Study|Withdrawal by Subject|2|||
13128952|NCT02873689|25967036|FG000|Overall Study|Protocol Violation|1|||
13128953|NCT02873689|25967037|FG001|Overall Study|Protocol Violation|0|||
13128954|NCT02873689|25967036|FG000|Overall Study|Adverse Event|2|||
13128955|NCT02873689|25967037|FG001|Overall Study|Adverse Event|2|||
13128956|NCT02873689|25967036|FG000|Overall Study|Randomized but not Treated|1|||
13128957|NCT02873689|25967037|FG001|Overall Study|Randomized but not Treated|1|||
13128958|NCT02873429|25967054|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10|||
13128959|NCT02873429|25967055|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1|||
13128960|NCT02873429|25967054|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2|||
13128961|NCT02873429|25967055|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2|||
13128962|NCT02873429|25967054|FG000|16 Weeks|Lost to Follow-up|3|||
13128963|NCT02873429|25967055|FG001|16 Weeks|Lost to Follow-up|0|||
13222074|NCT01808144|26285441|FG000|Overall Study|Withdrawal by Subject|16|||
13222075|NCT01808144|26285442|FG001|Overall Study|Withdrawal by Subject|23|||
13222076|NCT01808144|26285441|FG000|Overall Study|Lost to Follow-up|6|||
13222077|NCT01808144|26285442|FG001|Overall Study|Lost to Follow-up|3|||
13222078|NCT01808144|26285441|FG000|Overall Study|Protocol Violation|6|||
13222079|NCT01808144|26285442|FG001|Overall Study|Protocol Violation|6|||
13222080|NCT01808144|26285441|FG000|Overall Study|Gout flare|0|||
13222081|NCT01808144|26285442|FG001|Overall Study|Gout flare|1|||
13222082|NCT01808144|26285441|FG000|Overall Study|Adverse Event|11|||
13222083|NCT01808144|26285442|FG001|Overall Study|Adverse Event|15|||
13222084|NCT01808118|26285507|FG000|Period 1|Adverse Event|15|||
13222085|NCT01808118|26285508|FG001|Period 1|Adverse Event|0|||
13222086|NCT01808118|26285509|FG002|Period 1|Adverse Event|0|||
13222087|NCT01808118|26285507|FG000|Period 1|Withdrew consent|24|||
13222088|NCT01808118|26285508|FG001|Period 1|Withdrew consent|0|||
13222089|NCT01808118|26285509|FG002|Period 1|Withdrew consent|0|||
13222090|NCT01808118|26285507|FG000|Period 1|Lost to Follow-up|9|||
13222091|NCT01808118|26285508|FG001|Period 1|Lost to Follow-up|0|||
13222092|NCT01808118|26285509|FG002|Period 1|Lost to Follow-up|0|||
13222093|NCT01808118|26285507|FG000|Period 1|Did not meet criteria for remission|303|||
13222094|NCT01808118|26285508|FG001|Period 1|Did not meet criteria for remission|0|||
13222095|NCT01808118|26285509|FG002|Period 1|Did not meet criteria for remission|0|||
13222096|NCT01808118|26285507|FG000|Period 1|Enrolled in error|7|||
13222097|NCT01808118|26285508|FG001|Period 1|Enrolled in error|0|||
13222098|NCT01808118|26285509|FG002|Period 1|Enrolled in error|0|||
13222099|NCT01808118|26285507|FG000|Period 1|Did not meet inclusion criteria|3|||
13222100|NCT01808118|26285508|FG001|Period 1|Did not meet inclusion criteria|0|||
13222101|NCT01808118|26285509|FG002|Period 1|Did not meet inclusion criteria|0|||
13222102|NCT01808118|26285507|FG000|Period 1|Non-conformance with inclusion criteria|3|||
13222103|NCT01808118|26285508|FG001|Period 1|Non-conformance with inclusion criteria|0|||
13222104|NCT01808118|26285509|FG002|Period 1|Non-conformance with inclusion criteria|0|||
13222105|NCT01808118|26285507|FG000|Period 1|Investigator decision: site closure|2|||
13222106|NCT01808118|26285508|FG001|Period 1|Investigator decision: site closure|0|||
13292323|NCT00706654|26485250|FG002|Conversion Phase|Adverse Event|0|||
13128964|NCT02873377|25967081|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
13128965|NCT02873377|25967082|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
13128966|NCT02873377|25967081|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15|||
13128967|NCT02873377|25967082|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23|||
13128968|NCT02873338|25967130|FG000|Overall Study|Adverse Event|0|||
13128969|NCT02873338|25967131|FG001|Overall Study|Adverse Event|2|||
13128970|NCT02873338|25967132|FG002|Overall Study|Adverse Event|1|||
13128971|NCT02873338|25967130|FG000|Overall Study|Death|2|||
13128972|NCT02873338|25967131|FG001|Overall Study|Death|1|||
13128973|NCT02873338|25967132|FG002|Overall Study|Death|1|||
13128974|NCT02873338|25967130|FG000|Overall Study|Withdrawal by Subject|2|||
13128975|NCT02873338|25967131|FG001|Overall Study|Withdrawal by Subject|1|||
13128976|NCT02873338|25967132|FG002|Overall Study|Withdrawal by Subject|3|||
13128977|NCT02873338|25967130|FG000|Overall Study|Lack of Efficacy|0|||
13128978|NCT02873338|25967131|FG001|Overall Study|Lack of Efficacy|2|||
13128979|NCT02873338|25967132|FG002|Overall Study|Lack of Efficacy|0|||
13128980|NCT02873338|25967130|FG000|Overall Study|Other or Missing|14|||
13128981|NCT02873338|25967131|FG001|Overall Study|Other or Missing|15|||
13128982|NCT02873338|25967132|FG002|Overall Study|Other or Missing|13|||
13128983|NCT02873221|25967162|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
13128984|NCT02873221|25967163|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
13128985|NCT02873221|25967164|FG002|Treatment Period|Other Miscellaneous Reasons|1|||
13128986|NCT02873221|25967162|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
13128987|NCT02873221|25967163|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
13128988|NCT02873221|25967164|FG002|Treatment Period|Non-Compliance with Study Drug|2|||
13128989|NCT02873221|25967162|FG000|Treatment Period|Protocol Violation|2|||
13128990|NCT02873221|25967163|FG001|Treatment Period|Protocol Violation|5|||
13128991|NCT02873221|25967164|FG002|Treatment Period|Protocol Violation|8|||
13128992|NCT02873221|25967162|FG000|Treatment Period|Pregnancy|4|||
13128993|NCT02873221|25967163|FG001|Treatment Period|Pregnancy|6|||
13128994|NCT02873221|25967164|FG002|Treatment Period|Pregnancy|3|||
13128995|NCT02873221|25967162|FG000|Treatment Period|Lack of Qualifying Event|0|||
13128996|NCT02873221|25967163|FG001|Treatment Period|Lack of Qualifying Event|3|||
13128997|NCT02873221|25967164|FG002|Treatment Period|Lack of Qualifying Event|1|||
13128998|NCT02873221|25967162|FG000|Treatment Period|Withdrawal of Consent|52|||
13128999|NCT02873221|25967163|FG001|Treatment Period|Withdrawal of Consent|51|||
13129000|NCT02873221|25967164|FG002|Treatment Period|Withdrawal of Consent|41|||
13129001|NCT02873221|25967162|FG000|Treatment Period|Lack of Efficacy|0|||
13129002|NCT02873221|25967163|FG001|Treatment Period|Lack of Efficacy|17|||
13129003|NCT02873221|25967164|FG002|Treatment Period|Lack of Efficacy|12|||
13129004|NCT02873221|25967162|FG000|Treatment Period|Adverse Event|4|||
13129005|NCT02873221|25967163|FG001|Treatment Period|Adverse Event|9|||
13129006|NCT02873221|25967164|FG002|Treatment Period|Adverse Event|11|||
13129007|NCT02873221|25967162|FG000|Treatment Period|Lost to Follow-up|26|||
13129008|NCT02873221|25967163|FG001|Treatment Period|Lost to Follow-up|30|||
13129009|NCT02873221|25967164|FG002|Treatment Period|Lost to Follow-up|26|||
13129010|NCT02873221|25967162|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
13129011|NCT02873221|25967163|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2|||
13129012|NCT02873221|25967164|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
13129013|NCT02873221|25967162|FG000|Safety Follow-up Period|Protocol Violation|0|||
13129014|NCT02873221|25967163|FG001|Safety Follow-up Period|Protocol Violation|0|||
13129015|NCT02873221|25967164|FG002|Safety Follow-up Period|Protocol Violation|1|||
13129016|NCT02873221|25967162|FG000|Safety Follow-up Period|Lost to Follow-up|3|||
13129017|NCT02873221|25967163|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
13129018|NCT02873221|25967164|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
13129019|NCT02873221|25967162|FG000|Safety Follow-up Period|Withdrawal of Consent|4|||
13129020|NCT02873221|25967163|FG001|Safety Follow-up Period|Withdrawal of Consent|10|||
13129021|NCT02873221|25967164|FG002|Safety Follow-up Period|Withdrawal of Consent|8|||
13129022|NCT02873208|25967170|FG000|Overall Study|Withdrawal by Subject|36|||
13129023|NCT02873208|25967170|FG000|Overall Study|Lost to Follow-up|22|||
13129024|NCT02873208|25967170|FG000|Overall Study|Adverse Event|15|||
13129025|NCT02873208|25967170|FG000|Overall Study|Non-compliance with study drug|12|||
13129026|NCT02873208|25967170|FG000|Overall Study|Protocol Violation|8|||
13129027|NCT02873208|25967170|FG000|Overall Study|Pregnancy|2|||
13129028|NCT02873208|25967170|FG000|Overall Study|Incarceration|1|||
13129029|NCT02873208|25967170|FG000|Overall Study|Lack of Efficacy|1|||
13129030|NCT02873208|25967170|FG000|Overall Study|Physician Decision|1|||
13129031|NCT02872935|25967185|FG000|Overall Study|Other|0|||
13129032|NCT02872935|25967186|FG001|Overall Study|Other|1|||
13129033|NCT02872311|25967261|FG000|Overall Study|Death|2|||
13129034|NCT02872311|25967262|FG001|Overall Study|Death|0|||
13129035|NCT02872311|25967263|FG002|Overall Study|Death|0|||
13129036|NCT02872311|25967264|FG003|Overall Study|Death|0|||
13129037|NCT02872311|25967265|FG004|Overall Study|Death|0|||
13129038|NCT02872311|25967261|FG000|Overall Study|Lost to Follow-up|2|||
13129039|NCT02872311|25967262|FG001|Overall Study|Lost to Follow-up|0|||
13129040|NCT02872311|25967263|FG002|Overall Study|Lost to Follow-up|0|||
13129041|NCT02872311|25967264|FG003|Overall Study|Lost to Follow-up|0|||
13129042|NCT02872311|25967265|FG004|Overall Study|Lost to Follow-up|0|||
13129043|NCT02872311|25967261|FG000|Overall Study|Protocol Violation|0|||
13129044|NCT02872311|25967262|FG001|Overall Study|Protocol Violation|2|||
13129045|NCT02872311|25967263|FG002|Overall Study|Protocol Violation|1|||
13129046|NCT02872311|25967264|FG003|Overall Study|Protocol Violation|0|||
13129047|NCT02872311|25967265|FG004|Overall Study|Protocol Violation|0|||
13133581|NCT02767856|25988453|FG000|Overall Study|Withdrawal by Subject|2|||
13133582|NCT02767856|25988454|FG001|Overall Study|Withdrawal by Subject|1|||
13133695|NCT02765165|25988892|FG001|Treatment Period|Physician Decision|1|||
13133696|NCT02765165|25988893|FG002|Treatment Period|Physician Decision|0|||
13133697|NCT02765165|25988894|FG003|Treatment Period|Physician Decision|0|||
13133698|NCT02765165|25988895|FG004|Treatment Period|Physician Decision|0|||
13133699|NCT02765165|25988896|FG005|Treatment Period|Physician Decision|0|||
13133700|NCT02765165|25988897|FG006|Treatment Period|Physician Decision|0|||
13133701|NCT02765165|25988891|FG000|Treatment Period|Adverse Event|0|||
13133702|NCT02765165|25988892|FG001|Treatment Period|Adverse Event|1|||
13133703|NCT02765165|25988893|FG002|Treatment Period|Adverse Event|0|||
13133704|NCT02765165|25988894|FG003|Treatment Period|Adverse Event|0|||
13133705|NCT02765165|25988895|FG004|Treatment Period|Adverse Event|0|||
13133706|NCT02765165|25988896|FG005|Treatment Period|Adverse Event|0|||
13222107|NCT01808118|26285509|FG002|Period 1|Investigator decision: site closure|0|||
13222108|NCT01808118|26285507|FG000|Period 1|Non-compliance per sponsor|1|||
13222109|NCT01808118|26285508|FG001|Period 1|Non-compliance per sponsor|0|||
13222110|NCT01808118|26285509|FG002|Period 1|Non-compliance per sponsor|0|||
13222111|NCT01808118|26285507|FG000|Period 1|Lack of Efficacy|1|||
13222112|NCT01808118|26285508|FG001|Period 1|Lack of Efficacy|0|||
13222113|NCT01808118|26285509|FG002|Period 1|Lack of Efficacy|0|||
13222114|NCT01808118|26285507|FG000|Period 2|Adverse Event|0|||
13222115|NCT01808118|26285508|FG001|Period 2|Adverse Event|4|||
13222116|NCT01808118|26285509|FG002|Period 2|Adverse Event|0|||
13222117|NCT01808118|26285507|FG000|Period 2|Withdrew consent|0|||
13222118|NCT01808118|26285508|FG001|Period 2|Withdrew consent|7|||
13222119|NCT01808118|26285509|FG002|Period 2|Withdrew consent|6|||
13222120|NCT01808118|26285507|FG000|Period 2|Lost to Follow-up|0|||
13222121|NCT01808118|26285508|FG001|Period 2|Lost to Follow-up|0|||
13133707|NCT02765165|25988897|FG006|Treatment Period|Adverse Event|0|||
13133708|NCT02765165|25988891|FG000|Treatment Period|Withdrawal by Subject|0|||
13133709|NCT02765165|25988892|FG001|Treatment Period|Withdrawal by Subject|0|||
13133710|NCT02765165|25988893|FG002|Treatment Period|Withdrawal by Subject|0|||
13133711|NCT02765165|25988894|FG003|Treatment Period|Withdrawal by Subject|0|||
13133712|NCT02765165|25988895|FG004|Treatment Period|Withdrawal by Subject|2|||
13133713|NCT02765165|25988896|FG005|Treatment Period|Withdrawal by Subject|0|||
13133714|NCT02765165|25988897|FG006|Treatment Period|Withdrawal by Subject|0|||
13133715|NCT02765165|25988891|FG000|Treatment Period|Study terminated|0|||
13133716|NCT02765165|25988892|FG001|Treatment Period|Study terminated|0|||
13222122|NCT01808118|26285509|FG002|Period 2|Lost to Follow-up|2|||
13222123|NCT01808118|26285507|FG000|Period 2|Investigator no longer conducting trials|0|||
13222124|NCT01808118|26285508|FG001|Period 2|Investigator no longer conducting trials|1|||
13129048|NCT02872285|25967286|FG000|Overall Study|Withdrawal by Subject|2|||
13129049|NCT02872285|25967287|FG001|Overall Study|Withdrawal by Subject|0|||
13129050|NCT02872285|25967286|FG000|Overall Study|Lost to Follow-up|2|||
13129051|NCT02872285|25967287|FG001|Overall Study|Lost to Follow-up|2|||
13129052|NCT02872285|25967286|FG000|Overall Study|Discontinued due to back surgery|1|||
13129053|NCT02872285|25967287|FG001|Overall Study|Discontinued due to back surgery|0|||
13129054|NCT02872142|25967309|FG000|Overall Study|Adverse Event|2|||
13129055|NCT02872142|25967309|FG000|Overall Study|Death|1|||
13129056|NCT02872142|25967309|FG000|Overall Study|Participant Decision|3|||
13129057|NCT02872116|25967340|FG000|Pre-Treatment|Disease Progression|0|||
13129058|NCT02872116|25967341|FG001|Pre-Treatment|Disease Progression|1|||
13129059|NCT02872116|25967342|FG002|Pre-Treatment|Disease Progression|0|||
13129060|NCT02872116|25967340|FG000|Pre-Treatment|Adverse event unrelated to study drug|0|||
13129061|NCT02872116|25967341|FG001|Pre-Treatment|Adverse event unrelated to study drug|2|||
13129062|NCT02872116|25967342|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
13129063|NCT02872116|25967340|FG000|Pre-Treatment|Participants request to discontinue study treatment|0|||
13129064|NCT02872116|25967341|FG001|Pre-Treatment|Participants request to discontinue study treatment|2|||
13129065|NCT02872116|25967342|FG002|Pre-Treatment|Participants request to discontinue study treatment|0|||
13129066|NCT02872116|25967340|FG000|Pre-Treatment|Participant withdrew consent|2|||
13129067|NCT02872116|25967341|FG001|Pre-Treatment|Participant withdrew consent|20|||
13129068|NCT02872116|25967342|FG002|Pre-Treatment|Participant withdrew consent|3|||
13129069|NCT02872116|25967340|FG000|Pre-Treatment|Participant no longer meets study criteria|4|||
13129070|NCT02872116|25967341|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
13129071|NCT02872116|25967342|FG002|Pre-Treatment|Participant no longer meets study criteria|0|||
13129072|NCT02872116|25967340|FG000|Pre-Treatment|Other reasons|1|||
13129073|NCT02872116|25967341|FG001|Pre-Treatment|Other reasons|2|||
13129074|NCT02872116|25967342|FG002|Pre-Treatment|Other reasons|2|||
13129075|NCT02872116|25967340|FG000|Treatment|Death|122|||
13129076|NCT02872116|25967341|FG001|Treatment|Death|94|||
13129077|NCT02872116|25967342|FG002|Treatment|Death|68|||
13129078|NCT02872116|25967340|FG000|Treatment|Lost to Follow-up|5|||
13129079|NCT02872116|25967341|FG001|Treatment|Lost to Follow-up|7|||
13129080|NCT02872116|25967342|FG002|Treatment|Lost to Follow-up|3|||
13129081|NCT02872116|25967340|FG000|Treatment|Participant withdrew consent|20|||
13129082|NCT02872116|25967341|FG001|Treatment|Participant withdrew consent|40|||
13129083|NCT02872116|25967342|FG002|Treatment|Participant withdrew consent|8|||
13129084|NCT02872116|25967340|FG000|Treatment|Other reasons|12|||
13129085|NCT02872116|25967341|FG001|Treatment|Other reasons|12|||
13129086|NCT02872116|25967342|FG002|Treatment|Other reasons|5|||
13129087|NCT02872012|25967372|FG000|Overall Study|Withdrawal by Subject|1|||
13129088|NCT02872012|25967373|FG001|Overall Study|Withdrawal by Subject|0|||
13129089|NCT02872012|25967374|FG002|Overall Study|Withdrawal by Subject|0|||
13129090|NCT02872012|25967375|FG003|Overall Study|Withdrawal by Subject|0|||
13129091|NCT02872012|25967376|FG004|Overall Study|Withdrawal by Subject|0|||
13129092|NCT02871791|25967395|FG000|Phase 1b|Death|0|||
13129093|NCT02871791|25967396|FG001|Phase 1b|Death|1|||
13129094|NCT02871791|25967395|FG000|Phase 1b|progressive disease|6|||
13129095|NCT02871791|25967396|FG001|Phase 1b|progressive disease|2|||
13129096|NCT02871791|25967395|FG000|Phase 2|Death|1|||
13129097|NCT02871791|25967396|FG001|Phase 2|Death|0|||
13129098|NCT02871791|25967395|FG000|Phase 2|Lost to Follow-up|2|||
13129099|NCT02871791|25967396|FG001|Phase 2|Lost to Follow-up|0|||
13129100|NCT02871739|25967419|FG000|Overall Study|Lost to Follow-up|3|||
13129101|NCT02871739|25967420|FG001|Overall Study|Lost to Follow-up|2|||
13129102|NCT02871739|25967421|FG002|Overall Study|Lost to Follow-up|0|||
13129103|NCT02871739|25967422|FG003|Overall Study|Lost to Follow-up|2|||
13129104|NCT02871635|25967453|FG000|Overall Study|Primary lack of efficacy|4|||
13129105|NCT02871635|25967454|FG001|Overall Study|Primary lack of efficacy|4|||
13129106|NCT02871635|25967453|FG000|Overall Study|Protocol Violation|3|||
13129107|NCT02871635|25967454|FG001|Overall Study|Protocol Violation|1|||
13129108|NCT02871635|25967453|FG000|Overall Study|Lost to Follow-up|1|||
13129109|NCT02871635|25967454|FG001|Overall Study|Lost to Follow-up|2|||
13129110|NCT02871635|25967453|FG000|Overall Study|Pregnancy|0|||
13129111|NCT02871635|25967454|FG001|Overall Study|Pregnancy|2|||
13129112|NCT02871635|25967453|FG000|Overall Study|Physician Decision|1|||
13129113|NCT02871635|25967454|FG001|Overall Study|Physician Decision|1|||
13129114|NCT02871635|25967453|FG000|Overall Study|Withdrawal by Subject|3|||
13129115|NCT02871635|25967454|FG001|Overall Study|Withdrawal by Subject|4|||
13129116|NCT02871635|25967453|FG000|Overall Study|Adverse Event|4|||
13129117|NCT02871635|25967454|FG001|Overall Study|Adverse Event|4|||
13129118|NCT02871635|25967453|FG000|Overall Study|Secondary lack of efficacy|2|||
13129119|NCT02871635|25967454|FG001|Overall Study|Secondary lack of efficacy|1|||
13129120|NCT02871492|25967472|FG000|Overall Study|Lost to Follow-up|6|||
13129121|NCT02871492|25967473|FG001|Overall Study|Lost to Follow-up|3|||
13129122|NCT02871492|25967474|FG002|Overall Study|Lost to Follow-up|5|||
13129123|NCT02871492|25967472|FG000|Overall Study|Withdrawal by Subject|0|||
13129124|NCT02871492|25967473|FG001|Overall Study|Withdrawal by Subject|0|||
13222125|NCT01808118|26285509|FG002|Period 2|Investigator no longer conducting trials|0|||
13129125|NCT02871492|25967474|FG002|Overall Study|Withdrawal by Subject|1|||
13129126|NCT02871375|25967486|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0|||
13129127|NCT02871375|25967487|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1|||
13129128|NCT02870972|25967555|FG000|Overall Study|Adverse Event|1|||
13129129|NCT02870972|25967556|FG001|Overall Study|Adverse Event|0|||
13129130|NCT02870972|25967557|FG002|Overall Study|Adverse Event|0|||
13129131|NCT02870972|25967558|FG003|Overall Study|Adverse Event|0|||
13129132|NCT02870972|25967559|FG004|Overall Study|Adverse Event|0|||
13129133|NCT02870933|25967588|FG000|Overall Study|Death|2|||
13129134|NCT02870933|25967589|FG001|Overall Study|Death|1|||
13129135|NCT02870933|25967588|FG000|Overall Study|Withdrawal by Subject|0|||
13129136|NCT02870933|25967589|FG001|Overall Study|Withdrawal by Subject|1|||
13129137|NCT02870348|25967603|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4|||
13129138|NCT02869893|25967611|FG000|Overall Study|participant aversion to IV|5|||
13129139|NCT02869893|25967611|FG000|Overall Study|participant fear of MRI scanner|2|||
13129140|NCT02869438|25967666|FG000|Overall Study|Lost to Follow-up|1|||
13129141|NCT02869438|25967667|FG001|Overall Study|Lost to Follow-up|0|||
13129142|NCT02869438|25967666|FG000|Overall Study|Adverse Event|1|||
13129143|NCT02869438|25967667|FG001|Overall Study|Adverse Event|0|||
13129144|NCT02869438|25967666|FG000|Overall Study|Withdrawal by Subject|1|||
13129145|NCT02869438|25967667|FG001|Overall Study|Withdrawal by Subject|2|||
13129146|NCT02868892|25967675|FG000|Overall Study|Investigator left site and no follow-up|6|||
13129147|NCT02868554|25967708|FG000|Overall Study|Lost to Follow-up|3|||
13129148|NCT02868554|25967709|FG001|Overall Study|Lost to Follow-up|0|||
13129149|NCT02868554|25967710|FG002|Overall Study|Lost to Follow-up|1|||
13129150|NCT02868281|25967739|FG000|Overall Study|Adverse Event|2|||
13129151|NCT02868281|25967740|FG001|Overall Study|Adverse Event|2|||
13129152|NCT02868281|25967739|FG000|Overall Study|Protocol Violation|13|||
13129153|NCT02868281|25967740|FG001|Overall Study|Protocol Violation|10|||
13129154|NCT02868281|25967739|FG000|Overall Study|Lost to Follow-up|3|||
13129155|NCT02868281|25967740|FG001|Overall Study|Lost to Follow-up|6|||
13129156|NCT02868281|25967739|FG000|Overall Study|Withdrawal by Subject|11|||
13129157|NCT02868281|25967740|FG001|Overall Study|Withdrawal by Subject|15|||
13129158|NCT02868281|25967739|FG000|Overall Study|Physician Decision|2|||
13129159|NCT02868281|25967740|FG001|Overall Study|Physician Decision|0|||
13129160|NCT02868281|25967739|FG000|Overall Study|Had protocol-defined asthma exacerbation|8|||
13129161|NCT02868281|25967740|FG001|Overall Study|Had protocol-defined asthma exacerbation|8|||
13129162|NCT02868281|25967739|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
13129163|NCT02868281|25967740|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
13129164|NCT02868281|25967739|FG000|Overall Study|Long journey/moving away|1|||
13129165|NCT02868281|25967740|FG001|Overall Study|Long journey/moving away|1|||
13129166|NCT02868229|25968288|FG000|Overall Study|Adverse Event|1|||
13129167|NCT02868229|25968289|FG001|Overall Study|Adverse Event|0|||
13129168|NCT02868229|25968290|FG002|Overall Study|Adverse Event|0|||
13129169|NCT02868229|25968291|FG003|Overall Study|Adverse Event|1|||
13129170|NCT02868229|25968288|FG000|Overall Study|Death|0|||
13129171|NCT02868229|25968289|FG001|Overall Study|Death|0|||
13129172|NCT02868229|25968290|FG002|Overall Study|Death|1|||
13129173|NCT02868229|25968291|FG003|Overall Study|Death|1|||
13129174|NCT02868229|25968288|FG000|Overall Study|Missed dose|0|||
13129175|NCT02868229|25968289|FG001|Overall Study|Missed dose|0|||
13129176|NCT02868229|25968290|FG002|Overall Study|Missed dose|0|||
13129177|NCT02868229|25968291|FG003|Overall Study|Missed dose|3|||
13129178|NCT02868216|25968304|FG000|Overall Study|Death|0|||
13129179|NCT02868216|25968305|FG001|Overall Study|Death|1|||
13129180|NCT02868216|25968304|FG000|Overall Study|coronary artery bypass|1|||
13129181|NCT02868216|25968305|FG001|Overall Study|coronary artery bypass|0|||
13129182|NCT02868216|25968304|FG000|Overall Study|Withdrawal by Subject|7|||
13129183|NCT02868216|25968305|FG001|Overall Study|Withdrawal by Subject|5|||
13129184|NCT02867995|25968328|FG000|Overall Study|Withdrawal by Subject|0|||
13129185|NCT02867995|25968329|FG001|Overall Study|Withdrawal by Subject|1|||
13129186|NCT02867995|25968328|FG000|Overall Study|Lost to Follow-up|0|||
13485128|NCT03033069|27031604|FG001|Overall Study|Reason not Specified|1|||
13485129|NCT03033069|27031605|FG002|Overall Study|Reason not Specified|0|||
13129187|NCT02867995|25968329|FG001|Overall Study|Lost to Follow-up|2|||
13129188|NCT02867761|25968368|FG000|Overall Study|Participant withdrawn by investigator|0|||
13129189|NCT02867761|25968369|FG001|Overall Study|Participant withdrawn by investigator|1|||
13129190|NCT02867761|25968368|FG000|Overall Study|Lost to Follow-up|25|||
13129191|NCT02867761|25968369|FG001|Overall Study|Lost to Follow-up|18|||
13129192|NCT02867761|25968368|FG000|Overall Study|Unable to complete protocol|3|||
13129193|NCT02867761|25968369|FG001|Overall Study|Unable to complete protocol|7|||
13129194|NCT02867709|25968408|FG000|Treatment Period|Adverse Event|1|||
13129195|NCT02867709|25968409|FG001|Treatment Period|Adverse Event|1|||
13129196|NCT02867709|25968410|FG002|Treatment Period|Adverse Event|2|||
13129197|NCT02867709|25968408|FG000|Treatment Period|Withdrawal of Consent|7|||
13129198|NCT02867709|25968409|FG001|Treatment Period|Withdrawal of Consent|9|||
13129199|NCT02867709|25968410|FG002|Treatment Period|Withdrawal of Consent|8|||
13129200|NCT02867709|25968408|FG000|Treatment Period|Lost to Follow-up|17|||
13129201|NCT02867709|25968409|FG001|Treatment Period|Lost to Follow-up|20|||
13129202|NCT02867709|25968410|FG002|Treatment Period|Lost to Follow-up|20|||
13129203|NCT02867709|25968408|FG000|Treatment Period|Lack of Qualifying Event|42|||
13129204|NCT02867709|25968409|FG001|Treatment Period|Lack of Qualifying Event|55|||
13129205|NCT02867709|25968410|FG002|Treatment Period|Lack of Qualifying Event|42|||
13129206|NCT02867709|25968408|FG000|Treatment Period|Protocol Violation|3|||
13129207|NCT02867709|25968409|FG001|Treatment Period|Protocol Violation|2|||
13129208|NCT02867709|25968410|FG002|Treatment Period|Protocol Violation|3|||
13129209|NCT02867709|25968408|FG000|Safety Follow-up Period|Withdrawal of Consent|1|||
13129210|NCT02867709|25968409|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
13129211|NCT02867709|25968410|FG002|Safety Follow-up Period|Withdrawal of Consent|6|||
13129212|NCT02867709|25968408|FG000|Safety Follow-up Period|Lost to Follow-up|10|||
13129213|NCT02867709|25968409|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
13129214|NCT02867709|25968410|FG002|Safety Follow-up Period|Lost to Follow-up|7|||
13129215|NCT02867709|25968408|FG000|Safety Follow-up Period|Pregnancy|0|||
13129216|NCT02867709|25968409|FG001|Safety Follow-up Period|Pregnancy|1|||
13129217|NCT02867709|25968410|FG002|Safety Follow-up Period|Pregnancy|0|||
13129218|NCT02867709|25968408|FG000|Safety Follow-up Period|Protocol Violation|0|||
13129219|NCT02867709|25968409|FG001|Safety Follow-up Period|Protocol Violation|1|||
13129220|NCT02867709|25968410|FG002|Safety Follow-up Period|Protocol Violation|1|||
13129221|NCT02866942|25968417|FG000|Overall Study|Invalid consent|1|||
13129222|NCT02866175|25968442|FG000|Overall Study|Adverse Event|56|||
13129223|NCT02866175|25968443|FG001|Overall Study|Adverse Event|54|||
13129224|NCT02866175|25968442|FG000|Overall Study|Withdrawal by Subject|31|||
13129225|NCT02866175|25968443|FG001|Overall Study|Withdrawal by Subject|52|||
13129226|NCT02866175|25968442|FG000|Overall Study|Death|30|||
13129227|NCT02866175|25968443|FG001|Overall Study|Death|23|||
13129228|NCT02866175|25968442|FG000|Overall Study|Other|7|||
13129229|NCT02866175|25968443|FG001|Overall Study|Other|14|||
13129230|NCT02866175|25968442|FG000|Overall Study|Progressive disease|1|||
13129231|NCT02866175|25968443|FG001|Overall Study|Progressive disease|1|||
13129232|NCT02866175|25968442|FG000|Overall Study|Lost to Follow-up|2|||
13129233|NCT02866175|25968443|FG001|Overall Study|Lost to Follow-up|0|||
13129234|NCT02866175|25968442|FG000|Overall Study|Lack of Efficacy|0|||
13129235|NCT02866175|25968443|FG001|Overall Study|Lack of Efficacy|1|||
13129236|NCT02866175|25968442|FG000|Overall Study|Physician Decision|3|||
13129237|NCT02866175|25968443|FG001|Overall Study|Physician Decision|15|||
13129238|NCT02866175|25968442|FG000|Overall Study|Did not receive treatment|5|||
13129239|NCT02866175|25968443|FG001|Overall Study|Did not receive treatment|15|||
13129240|NCT02865915|25968458|FG000|Overall Study|Pregnancy|1|||
13129241|NCT02865915|25968459|FG001|Overall Study|Pregnancy|0|||
13129242|NCT02865915|25968458|FG000|Overall Study|Withdrawal by Subject|1|||
13129243|NCT02865915|25968459|FG001|Overall Study|Withdrawal by Subject|1|||
13129244|NCT02865915|25968458|FG000|Overall Study|Adverse Event|0|||
13129245|NCT02865915|25968459|FG001|Overall Study|Adverse Event|4|||
13222126|NCT01808118|26285507|FG000|Period 2|Switched to other therapy|0|||
13222127|NCT01808118|26285508|FG001|Period 2|Switched to other therapy|1|||
13222128|NCT01808118|26285509|FG002|Period 2|Switched to other therapy|0|||
13222129|NCT01808092|26285618|FG000|Overall Study|Death|39|||
13222130|NCT01808092|26285619|FG001|Overall Study|Death|29|||
13222131|NCT01808092|26285618|FG000|Overall Study|Lost to Follow-up|3|||
13222132|NCT01808092|26285619|FG001|Overall Study|Lost to Follow-up|7|||
13222133|NCT01808092|26285618|FG000|Overall Study|Withdrawal by Subject|9|||
13222134|NCT01808092|26285619|FG001|Overall Study|Withdrawal by Subject|4|||
13222135|NCT01808092|26285618|FG000|Overall Study|Other Eligibility criteria|3|||
13222136|NCT01808092|26285619|FG001|Overall Study|Other Eligibility criteria|5|||
13129246|NCT02865915|25968458|FG000|Overall Study|Lost to Follow-up|0|||
13222137|NCT01808066|26285629|FG000|Overall Study|Withdrawal by Subject|15|||
13129247|NCT02865915|25968459|FG001|Overall Study|Lost to Follow-up|1|||
13129248|NCT02865915|25968458|FG000|Overall Study|Protocol Violation|0|||
13129249|NCT02865915|25968459|FG001|Overall Study|Protocol Violation|1|||
13129250|NCT02865915|25968458|FG000|Overall Study|Study terminated by sponsor|23|||
13129251|NCT02865915|25968459|FG001|Overall Study|Study terminated by sponsor|18|||
13129252|NCT02865915|25968458|FG000|Overall Study|Dosing group discontinued|0|||
13129253|NCT02865915|25968459|FG001|Overall Study|Dosing group discontinued|5|||
13129254|NCT02865538|25968757|FG000|Overall Study|Withdrawal by Subject|0|||
13129255|NCT02865538|25968758|FG001|Overall Study|Withdrawal by Subject|0|||
13129256|NCT02865538|25968759|FG002|Overall Study|Withdrawal by Subject|1|||
13129257|NCT02865538|25968760|FG003|Overall Study|Withdrawal by Subject|0|||
13129258|NCT02865538|25968761|FG004|Overall Study|Withdrawal by Subject|0|||
13129259|NCT02865538|25968757|FG000|Overall Study|Lost to Follow-up|1|||
13129260|NCT02865538|25968758|FG001|Overall Study|Lost to Follow-up|0|||
13129261|NCT02865538|25968759|FG002|Overall Study|Lost to Follow-up|0|||
13129262|NCT02865538|25968760|FG003|Overall Study|Lost to Follow-up|0|||
13129263|NCT02865538|25968761|FG004|Overall Study|Lost to Follow-up|0|||
13129264|NCT02865499|25968767|FG000|Baseline|Adverse Event|1|||
13129265|NCT02865499|25968767|FG000|Baseline|Withdrawal by Subject|1|||
13129266|NCT02865395|25968788|FG000|Overall Study|Physician Decision|6|||
13129267|NCT02865395|25968789|FG001|Overall Study|Physician Decision|10|||
13129268|NCT02865395|25968790|FG002|Overall Study|Physician Decision|7|||
13129269|NCT02865122|25968808|FG000|Overall Study|Adverse Event|1|||
13129270|NCT02865122|25968809|FG001|Overall Study|Adverse Event|0|||
13129271|NCT02865122|25968810|FG002|Overall Study|Adverse Event|0|||
13129272|NCT02865083|25968835|FG000|Overall Study|Early Termination|3|||
13129273|NCT02865083|25968836|FG001|Overall Study|Early Termination|1|||
13129274|NCT02864498|25968866|FG000|Overall Study|Unacceptable Adverse Events (AEs)|0|||
13129275|NCT02864498|25968867|FG001|Overall Study|Unacceptable Adverse Events (AEs)|3|||
13129276|NCT02864498|25968868|FG002|Overall Study|Unacceptable Adverse Events (AEs)|1|||
13129277|NCT02864498|25968866|FG000|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|6|||
13129278|NCT02864498|25968867|FG001|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|10|||
13129279|NCT02864498|25968868|FG002|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|4|||
13129280|NCT02864498|25968866|FG000|Overall Study|Investigator Discretion|0|||
13129281|NCT02864498|25968867|FG001|Overall Study|Investigator Discretion|2|||
13129282|NCT02864498|25968868|FG002|Overall Study|Investigator Discretion|1|||
13129283|NCT02864498|25968866|FG000|Overall Study|Lost to Follow-up|8|||
13129284|NCT02864498|25968867|FG001|Overall Study|Lost to Follow-up|6|||
13129285|NCT02864498|25968868|FG002|Overall Study|Lost to Follow-up|3|||
13129286|NCT02864498|25968866|FG000|Overall Study|Lack of Efficacy|5|||
13129287|NCT02864498|25968867|FG001|Overall Study|Lack of Efficacy|3|||
13129288|NCT02864498|25968868|FG002|Overall Study|Lack of Efficacy|3|||
13129289|NCT02864498|25968866|FG000|Overall Study|Other - Subject discontinued following database lock.|1|||
13129290|NCT02864498|25968867|FG001|Overall Study|Other - Subject discontinued following database lock.|0|||
13129291|NCT02864498|25968868|FG002|Overall Study|Other - Subject discontinued following database lock.|0|||
13129292|NCT02864498|25968866|FG000|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
13129293|NCT02864498|25968867|FG001|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|1|||
13129294|NCT02864498|25968868|FG002|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
13129295|NCT02864498|25968866|FG000|Overall Study|Subject moved out of the country.|0|||
13129296|NCT02864498|25968867|FG001|Overall Study|Subject moved out of the country.|0|||
13129297|NCT02864498|25968868|FG002|Overall Study|Subject moved out of the country.|1|||
13129298|NCT02864407|25968892|FG000|Overall Study|Protocol Violation|3|||
13129299|NCT02864407|25968892|FG000|Overall Study|Lost to Follow-up|115|||
13222138|NCT01807949|26285688|FG000|Overall Study|Adverse Event|1|||
13129300|NCT02864407|25968892|FG000|Overall Study|Not treated with Vahelva® Respimat®|1|||
13129301|NCT02864407|25968892|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3|||
13129302|NCT02864407|25968892|FG000|Overall Study|Consent prior to the contract date|1|||
13129303|NCT02864381|25968915|FG000|Overall Study|Death|58|||
13129304|NCT02864381|25968916|FG001|Overall Study|Death|61|||
13129305|NCT02864381|25968915|FG000|Overall Study|Withdrew Consent|5|||
13129306|NCT02864381|25968916|FG001|Overall Study|Withdrew Consent|6|||
13129307|NCT02864381|25968915|FG000|Overall Study|Reason Unknown|7|||
13129308|NCT02864381|25968916|FG001|Overall Study|Reason Unknown|3|||
13129309|NCT02864381|25968915|FG000|Overall Study|Lost to Follow-up|1|||
13129310|NCT02864381|25968916|FG001|Overall Study|Lost to Follow-up|1|||
13129311|NCT02864381|25968915|FG000|Overall Study|Investigator's Discretion|1|||
13129312|NCT02864381|25968916|FG001|Overall Study|Investigator's Discretion|0|||
13129313|NCT02864381|25968915|FG000|Overall Study|Protocol Violation|0|||
13129314|NCT02864381|25968916|FG001|Overall Study|Protocol Violation|1|||
13129315|NCT02864342|25968938|FG000|Overall Study|Eligibility Criteria Deviation|2|||
13129316|NCT02864342|25968939|FG001|Overall Study|Eligibility Criteria Deviation|3|||
13129317|NCT02864342|25968938|FG000|Overall Study|Withdrawal by Subject|4|||
13129318|NCT02864342|25968939|FG001|Overall Study|Withdrawal by Subject|2|||
13129319|NCT02864342|25968938|FG000|Overall Study|Device Technology Issue|6|||
13129320|NCT02864342|25968939|FG001|Overall Study|Device Technology Issue|7|||
13129321|NCT02864342|25968938|FG000|Overall Study|Death|0|||
13129322|NCT02864342|25968939|FG001|Overall Study|Death|1|||
13129323|NCT02864342|25968938|FG000|Overall Study|Did Not Start Treatment with Symbicort|0|||
13129324|NCT02864342|25968939|FG001|Overall Study|Did Not Start Treatment with Symbicort|1|||
13129325|NCT02864342|25968938|FG000|Overall Study|Lost to Follow-up|1|||
13129326|NCT02864342|25968939|FG001|Overall Study|Lost to Follow-up|5|||
13129327|NCT02864342|25968938|FG000|Overall Study|Lost Device|1|||
13129328|NCT02864342|25968939|FG001|Overall Study|Lost Device|0|||
13129329|NCT02864342|25968938|FG000|Overall Study|Adverse Event|1|||
13129330|NCT02864342|25968939|FG001|Overall Study|Adverse Event|0|||
13129331|NCT02864316|25968962|FG000|Overall Study|Progressive Disease|2|||
13129332|NCT02864316|25968963|FG001|Overall Study|Progressive Disease|1|||
13129333|NCT02864316|25968962|FG000|Overall Study|Adverse Event|0|||
13129334|NCT02864316|25968963|FG001|Overall Study|Adverse Event|1|||
13129335|NCT02864082|25968994|FG000|Overall Study|Adverse Event|1|||
13129336|NCT02864082|25968995|FG001|Overall Study|Adverse Event|1|||
13129337|NCT02864082|25968994|FG000|Overall Study|Lost to Follow-up|0|||
13129338|NCT02864082|25968995|FG001|Overall Study|Lost to Follow-up|1|||
13129339|NCT02864082|25968994|FG000|Overall Study|Withdrawal by Subject|2|||
13129340|NCT02864082|25968995|FG001|Overall Study|Withdrawal by Subject|2|||
13129341|NCT02863575|25969054|FG000|Overall Study|Participants Unable To Swallow Capsule|1|||
13129342|NCT02863575|25969055|FG001|Overall Study|Participants Unable To Swallow Capsule|0|||
13129343|NCT02863575|25969056|FG002|Overall Study|Participants Unable To Swallow Capsule|0|||
13129344|NCT02863575|25969054|FG000|Overall Study|Withdrawal by Subject|0|||
13129345|NCT02863575|25969055|FG001|Overall Study|Withdrawal by Subject|1|||
13129346|NCT02863575|25969056|FG002|Overall Study|Withdrawal by Subject|1|||
13129347|NCT02863575|25969054|FG000|Overall Study|Adverse Event|0|||
13129348|NCT02863575|25969055|FG001|Overall Study|Adverse Event|1|||
13129349|NCT02863575|25969056|FG002|Overall Study|Adverse Event|0|||
13129350|NCT02863419|25969181|FG000|Overall Study|Lost to Follow-up|0|||
13129351|NCT02863419|25969182|FG001|Overall Study|Lost to Follow-up|1|||
13129352|NCT02863419|25969183|FG002|Overall Study|Lost to Follow-up|4|||
13129353|NCT02863419|25969181|FG000|Overall Study|Withdrawal by Subject|5|||
13129354|NCT02863419|25969182|FG001|Overall Study|Withdrawal by Subject|5|||
13129355|NCT02863419|25969183|FG002|Overall Study|Withdrawal by Subject|3|||
13129356|NCT02863419|25969181|FG000|Overall Study|Died|3|||
13129357|NCT02863419|25969182|FG001|Overall Study|Died|4|||
13129358|NCT02863419|25969183|FG002|Overall Study|Died|1|||
13129359|NCT02863354|25969218|FG000|Year 1|Lost to Follow-up|1|||
13129360|NCT02863354|25969219|FG001|Year 1|Lost to Follow-up|1|||
13129361|NCT02863354|25969218|FG000|Year 1|Withdrawal by Subject|3|||
13129362|NCT02863354|25969219|FG001|Year 1|Withdrawal by Subject|0|||
13222139|NCT01807949|26285689|FG001|Overall Study|Adverse Event|2|||
13222140|NCT01807949|26285690|FG002|Overall Study|Adverse Event|2|||
13222141|NCT01807949|26285688|FG000|Overall Study|Withdrawal by Subject|1|||
13129363|NCT02863354|25969218|FG000|Year 1|Death|0|||
13129364|NCT02863354|25969219|FG001|Year 1|Death|1|||
13129365|NCT02863354|25969218|FG000|Year 2|Lost to Follow-up|2|||
13129366|NCT02863354|25969219|FG001|Year 2|Lost to Follow-up|2|||
13129367|NCT02863328|25969323|FG000|Overall Study|Lost to Follow-up|4|||
13129368|NCT02863328|25969324|FG001|Overall Study|Lost to Follow-up|10|||
13129369|NCT02863328|25969323|FG000|Overall Study|Withdrawal by Subject|7|||
13129370|NCT02863328|25969324|FG001|Overall Study|Withdrawal by Subject|12|||
13129371|NCT02863328|25969323|FG000|Overall Study|Died|0|||
13129372|NCT02863328|25969324|FG001|Overall Study|Died|1|||
13129373|NCT02862730|25969387|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
13129374|NCT02862730|25969388|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
13129375|NCT02862730|25969389|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1|||
13129376|NCT02862730|25969390|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
13129377|NCT02862730|25969391|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
13129378|NCT02862730|25969392|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
13129379|NCT02862730|25969393|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
13129380|NCT02862730|25969387|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1|||
13129381|NCT02862730|25969388|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
13129382|NCT02862730|25969389|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
13129383|NCT02862730|25969390|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
13129384|NCT02862730|25969391|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
13129385|NCT02862730|25969392|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
13129386|NCT02862730|25969393|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
13129387|NCT02862730|25969387|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
13129388|NCT02862730|25969388|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
13129389|NCT02862730|25969389|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
13129390|NCT02862730|25969390|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
13129391|NCT02862730|25969391|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
13129392|NCT02862730|25969392|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
13129393|NCT02862730|25969393|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
13129394|NCT02862730|25969387|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
13129395|NCT02862730|25969388|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
13129396|NCT02862730|25969389|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
13129397|NCT02862730|25969390|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1|||
13129398|NCT02862730|25969391|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
13129399|NCT02862730|25969392|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
13129400|NCT02862730|25969393|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
13129401|NCT02862600|25969402|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9|||
13129402|NCT02862600|25969402|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3|||
13129403|NCT02862600|25969402|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1|||
13129404|NCT02862600|25969402|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7|||
13129405|NCT02862574|25969430|FG000|Double-Blind Treatment Period|Adverse Event|0|||
13129406|NCT02862574|25969431|FG001|Double-Blind Treatment Period|Adverse Event|1|||
13129407|NCT02862574|25969432|FG002|Double-Blind Treatment Period|Adverse Event|0|||
13129408|NCT02862574|25969430|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3|||
13129409|NCT02862574|25969431|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1|||
13129410|NCT02862574|25969432|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4|||
13129411|NCT02862574|25969430|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
13129412|NCT02862574|25969431|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3|||
13129413|NCT02862574|25969432|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
13129414|NCT02862535|25969467|FG000|Overall Study|Death|7|||
13129415|NCT02862535|25969468|FG001|Overall Study|Death|3|||
13129416|NCT02862535|25969469|FG002|Overall Study|Death|2|||
13129417|NCT02862535|25969470|FG003|Overall Study|Death|5|||
13129418|NCT02862535|25969467|FG000|Overall Study|Study Terminated by Sponsor|1|||
13129419|NCT02862535|25969468|FG001|Overall Study|Study Terminated by Sponsor|3|||
13129420|NCT02862535|25969469|FG002|Overall Study|Study Terminated by Sponsor|8|||
13129421|NCT02862535|25969470|FG003|Overall Study|Study Terminated by Sponsor|5|||
13129422|NCT02862535|25969467|FG000|Overall Study|Enrolled, not Treated|1|||
13129423|NCT02862535|25969468|FG001|Overall Study|Enrolled, not Treated|0|||
13129424|NCT02862535|25969469|FG002|Overall Study|Enrolled, not Treated|0|||
13129425|NCT02862535|25969470|FG003|Overall Study|Enrolled, not Treated|1|||
13129426|NCT02862457|25969556|FG000|Overall Study|Death|1|||
13129427|NCT02862457|25969557|FG001|Overall Study|Death|3|||
13129428|NCT02862457|25969558|FG002|Overall Study|Death|2|||
13129429|NCT02862457|25969559|FG003|Overall Study|Death|3|||
13129430|NCT02862457|25969560|FG004|Overall Study|Death|0|||
13129431|NCT02862457|25969561|FG005|Overall Study|Death|2|||
13129432|NCT02862457|25969562|FG006|Overall Study|Death|1|||
13129433|NCT02862457|25969556|FG000|Overall Study|Lost to Follow-up|1|||
13129434|NCT02862457|25969557|FG001|Overall Study|Lost to Follow-up|0|||
13129435|NCT02862457|25969558|FG002|Overall Study|Lost to Follow-up|0|||
13129436|NCT02862457|25969559|FG003|Overall Study|Lost to Follow-up|1|||
13129437|NCT02862457|25969560|FG004|Overall Study|Lost to Follow-up|0|||
13129438|NCT02862457|25969561|FG005|Overall Study|Lost to Follow-up|0|||
13129439|NCT02862457|25969562|FG006|Overall Study|Lost to Follow-up|0|||
13129440|NCT02862457|25969556|FG000|Overall Study|Withdrawal by Subject|0|||
13129441|NCT02862457|25969557|FG001|Overall Study|Withdrawal by Subject|0|||
13129442|NCT02862457|25969558|FG002|Overall Study|Withdrawal by Subject|1|||
13129443|NCT02862457|25969559|FG003|Overall Study|Withdrawal by Subject|0|||
13129444|NCT02862457|25969560|FG004|Overall Study|Withdrawal by Subject|0|||
13129445|NCT02862457|25969561|FG005|Overall Study|Withdrawal by Subject|1|||
13129446|NCT02862457|25969562|FG006|Overall Study|Withdrawal by Subject|0|||
13129447|NCT02862171|25969571|FG000|Overall Study|Death|1|||
13129448|NCT02862171|25969571|FG000|Overall Study|Lost to Follow-up|13|||
13129449|NCT02862171|25969571|FG000|Overall Study|Withdrawal by Subject|57|||
13129450|NCT02862171|25969571|FG000|Overall Study|Non-compliance|4|||
13129451|NCT02862171|25969571|FG000|Overall Study|HIV-1 seroconversion|18|||
13129452|NCT02862106|25969644|FG000|Overall Study|Adverse Event|4|||
13129453|NCT02862106|25969645|FG001|Overall Study|Adverse Event|0|||
13129454|NCT02862106|25969644|FG000|Overall Study|Protocol Violation|16|||
13129455|NCT02862106|25969645|FG001|Overall Study|Protocol Violation|1|||
13129456|NCT02862106|25969644|FG000|Overall Study|Lost to Follow-up|15|||
13129457|NCT02862106|25969645|FG001|Overall Study|Lost to Follow-up|5|||
13129458|NCT02862106|25969644|FG000|Overall Study|Withdrawal by Subject|2|||
13129459|NCT02862106|25969645|FG001|Overall Study|Withdrawal by Subject|0|||
13129460|NCT02862106|25969644|FG000|Overall Study|Subjects moved to other city|1|||
13129461|NCT02862106|25969645|FG001|Overall Study|Subjects moved to other city|0|||
13129462|NCT02861807|25969666|FG000|Overall Study|Lost to Follow-up|7|||
13129463|NCT02861807|25969667|FG001|Overall Study|Lost to Follow-up|6|||
13129464|NCT02861807|25969666|FG000|Overall Study|Withdrawal by Subject|5|||
13129465|NCT02861807|25969667|FG001|Overall Study|Withdrawal by Subject|8|||
13129466|NCT02861664|25969684|FG000|Overall Study|Withdrawal of Consent|0|||
13129467|NCT02861664|25969685|FG001|Overall Study|Withdrawal of Consent|1|||
13129468|NCT02861586|25969796|FG000|Overall Study|Withdrawal by Subject|1|||
13129469|NCT02861586|25969797|FG001|Overall Study|Withdrawal by Subject|2|||
13129470|NCT02861586|25969798|FG002|Overall Study|Withdrawal by Subject|0|||
13129471|NCT02861586|25969799|FG003|Overall Study|Withdrawal by Subject|0|||
13129472|NCT02861586|25969800|FG004|Overall Study|Withdrawal by Subject|0|||
13129473|NCT02861586|25969801|FG005|Overall Study|Withdrawal by Subject|1|||
13129474|NCT02861586|25969802|FG006|Overall Study|Withdrawal by Subject|1|||
13129475|NCT02861586|25969803|FG007|Overall Study|Withdrawal by Subject|0|||
13129476|NCT02861586|25969796|FG000|Overall Study|Lost to Follow-up|3|||
13129477|NCT02861586|25969797|FG001|Overall Study|Lost to Follow-up|1|||
13129478|NCT02861586|25969798|FG002|Overall Study|Lost to Follow-up|1|||
13129479|NCT02861586|25969799|FG003|Overall Study|Lost to Follow-up|0|||
13129480|NCT02861586|25969800|FG004|Overall Study|Lost to Follow-up|0|||
13129481|NCT02861586|25969801|FG005|Overall Study|Lost to Follow-up|3|||
13129482|NCT02861586|25969802|FG006|Overall Study|Lost to Follow-up|0|||
13129483|NCT02861586|25969803|FG007|Overall Study|Lost to Follow-up|0|||
13129484|NCT02861586|25969796|FG000|Overall Study|Adverse Event|0|||
13129485|NCT02861586|25969797|FG001|Overall Study|Adverse Event|0|||
13129486|NCT02861586|25969798|FG002|Overall Study|Adverse Event|0|||
13129487|NCT02861586|25969799|FG003|Overall Study|Adverse Event|0|||
13129488|NCT02861586|25969800|FG004|Overall Study|Adverse Event|0|||
13129489|NCT02861586|25969801|FG005|Overall Study|Adverse Event|1|||
13393336|NCT00665925|26783411|FG000|Overall Study|Physician Decision|0|||
13129490|NCT02861586|25969802|FG006|Overall Study|Adverse Event|0|||
13129491|NCT02861586|25969803|FG007|Overall Study|Adverse Event|0|||
13129492|NCT02861534|25969834|FG000|Overall Study|Death|541|||
13129493|NCT02861534|25969835|FG001|Overall Study|Death|552|||
13129494|NCT02861534|25969834|FG000|Overall Study|Lost to Follow-up|14|||
13129495|NCT02861534|25969835|FG001|Overall Study|Lost to Follow-up|14|||
13129496|NCT02861534|25969834|FG000|Overall Study|Site Terminated by Sponsor|4|||
13129497|NCT02861534|25969835|FG001|Overall Study|Site Terminated by Sponsor|3|||
13129498|NCT02861534|25969834|FG000|Overall Study|Withdrawal by Subject|15|||
13129499|NCT02861534|25969835|FG001|Overall Study|Withdrawal by Subject|18|||
13129500|NCT02860546|25969851|FG000|Overall Study|Clinical Progression|6|||
13129501|NCT02860546|25969851|FG000|Overall Study|Radiological Progression|12|||
13129502|NCT02860169|25969873|FG000|Part A|Withdrawal by Subject|1|||
13129503|NCT02860169|25969873|FG000|Part A|Other (Screening failure)|6|||
13129504|NCT02860169|25969873|FG000|Part A|Other (Survey not completed)|3|||
13129505|NCT02860169|25969873|FG000|Part A|Other (did not completed consent)|1|||
13129506|NCT02860169|25969873|FG000|Part B|Other (Screening failure)|10|||
13129507|NCT02860169|25969873|FG000|Part B|Withdrawal by Subject|1|||
13129508|NCT02860169|25969873|FG000|Part C|Other (Screening failure)|1|||
13129509|NCT02860130|25969932|FG000|Overall Study|Adverse Event|2|||
13129510|NCT02860130|25969933|FG001|Overall Study|Adverse Event|3|||
13129511|NCT02860130|25969932|FG000|Overall Study|Protocol Violation|1|||
13129512|NCT02860130|25969933|FG001|Overall Study|Protocol Violation|1|||
13129513|NCT02860130|25969932|FG000|Overall Study|Withdrawal by Subject|0|||
13129514|NCT02860130|25969933|FG001|Overall Study|Withdrawal by Subject|2|||
13129515|NCT02860130|25969932|FG000|Overall Study|Physician Decision|2|||
13129516|NCT02860130|25969933|FG001|Overall Study|Physician Decision|2|||
13129517|NCT02860130|25969932|FG000|Overall Study|Other|2|||
13129518|NCT02860130|25969933|FG001|Overall Study|Other|1|||
13129519|NCT02859558|25969968|FG000|Step 1|Not Eligible|0|||
13129520|NCT02859558|25969969|FG001|Step 1|Not Eligible|0|||
13129521|NCT02859558|25969970|FG002|Step 1|Not Eligible|0|||
13129522|NCT02859558|25969971|FG003|Step 1|Not Eligible|0|||
13129523|NCT02859558|25969972|FG004|Step 1|Not Eligible|3|||
13129524|NCT02859558|25969968|FG000|Step 1|Lost to Follow-up|1|||
13129525|NCT02859558|25969969|FG001|Step 1|Lost to Follow-up|3|||
13129526|NCT02859558|25969970|FG002|Step 1|Lost to Follow-up|3|||
13129527|NCT02859558|25969971|FG003|Step 1|Lost to Follow-up|0|||
13129528|NCT02859558|25969972|FG004|Step 1|Lost to Follow-up|0|||
13129529|NCT02859558|25969968|FG000|Step 1|Did Not Return to Clinic|2|||
13129530|NCT02859558|25969969|FG001|Step 1|Did Not Return to Clinic|3|||
13129531|NCT02859558|25969970|FG002|Step 1|Did Not Return to Clinic|4|||
13129532|NCT02859558|25969971|FG003|Step 1|Did Not Return to Clinic|0|||
13129533|NCT02859558|25969972|FG004|Step 1|Did Not Return to Clinic|0|||
13129534|NCT02859558|25969968|FG000|Step 1|Moved|0|||
13129535|NCT02859558|25969969|FG001|Step 1|Moved|1|||
13129536|NCT02859558|25969970|FG002|Step 1|Moved|1|||
13222142|NCT01807949|26285689|FG001|Overall Study|Withdrawal by Subject|2|||
13222143|NCT01807949|26285690|FG002|Overall Study|Withdrawal by Subject|2|||
13222144|NCT01807949|26285688|FG000|Overall Study|Non-Compliance|0|||
13222145|NCT01807949|26285689|FG001|Overall Study|Non-Compliance|0|||
13222146|NCT01807949|26285690|FG002|Overall Study|Non-Compliance|1|||
13222147|NCT01807949|26285688|FG000|Overall Study|Undefined|0|||
13222148|NCT01807949|26285689|FG001|Overall Study|Undefined|1|||
13222149|NCT01807949|26285690|FG002|Overall Study|Undefined|2|||
13222150|NCT01807949|26285688|FG000|Overall Study|Randomized But Not Treated|0|||
13222151|NCT01807949|26285689|FG001|Overall Study|Randomized But Not Treated|2|||
13222152|NCT01807949|26285690|FG002|Overall Study|Randomized But Not Treated|2|||
13222153|NCT01807923|26285749|FG000|Overall Study|Adverse Event|2|||
13222154|NCT01807923|26285750|FG001|Overall Study|Adverse Event|1|||
13222155|NCT01807923|26285751|FG002|Overall Study|Adverse Event|2|||
13222156|NCT01807923|26285749|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
13222157|NCT01807923|26285750|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3|||
13222158|NCT01807923|26285751|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2|||
13222159|NCT01807923|26285749|FG000|Overall Study|Physician Decision|0|||
13222160|NCT01807923|26285750|FG001|Overall Study|Physician Decision|0|||
13222161|NCT01807923|26285751|FG002|Overall Study|Physician Decision|1|||
13222162|NCT01807923|26285749|FG000|Overall Study|Not Eligible (Genotype)|0|||
13222163|NCT01807923|26285750|FG001|Overall Study|Not Eligible (Genotype)|0|||
13222164|NCT01807923|26285751|FG002|Overall Study|Not Eligible (Genotype)|1|||
13129537|NCT02859558|25969971|FG003|Step 1|Moved|0|||
13129538|NCT02859558|25969972|FG004|Step 1|Moved|0|||
13129539|NCT02859558|25969968|FG000|Step 1|Withdrawal By Participant|1|||
13129540|NCT02859558|25969969|FG001|Step 1|Withdrawal By Participant|2|||
13129541|NCT02859558|25969970|FG002|Step 1|Withdrawal By Participant|1|||
13129542|NCT02859558|25969971|FG003|Step 1|Withdrawal By Participant|0|||
13129543|NCT02859558|25969972|FG004|Step 1|Withdrawal By Participant|0|||
13129544|NCT02859558|25969968|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1|||
13222165|NCT01807923|26285749|FG000|Overall Study|Randomized But Not Treated|3|||
13222166|NCT01807923|26285750|FG001|Overall Study|Randomized But Not Treated|2|||
13222167|NCT01807923|26285751|FG002|Overall Study|Randomized But Not Treated|5|||
13129545|NCT02859558|25969969|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
13129546|NCT02859558|25969970|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
13129547|NCT02859558|25969971|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
13129548|NCT02859558|25969972|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
13129549|NCT02859558|25969968|FG000|Step 1|Incarceration|0|||
13129550|NCT02859558|25969969|FG001|Step 1|Incarceration|1|||
13129551|NCT02859558|25969970|FG002|Step 1|Incarceration|0|||
13129552|NCT02859558|25969971|FG003|Step 1|Incarceration|0|||
13129553|NCT02859558|25969972|FG004|Step 1|Incarceration|0|||
13129554|NCT02859558|25969968|FG000|Step 1|Non-Adherence to Study Drug|2|||
13129555|NCT02859558|25969969|FG001|Step 1|Non-Adherence to Study Drug|0|||
13307559|NCT01285310|26528952|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
13129556|NCT02859558|25969970|FG002|Step 1|Non-Adherence to Study Drug|1|||
13129557|NCT02859558|25969971|FG003|Step 1|Non-Adherence to Study Drug|0|||
13129558|NCT02859558|25969972|FG004|Step 1|Non-Adherence to Study Drug|0|||
13129559|NCT02859558|25969968|FG000|Step 1|Non-Adherence to Study Requirements|3|||
13129560|NCT02859558|25969969|FG001|Step 1|Non-Adherence to Study Requirements|1|||
13129561|NCT02859558|25969970|FG002|Step 1|Non-Adherence to Study Requirements|0|||
13129562|NCT02859558|25969971|FG003|Step 1|Non-Adherence to Study Requirements|0|||
13129563|NCT02859558|25969972|FG004|Step 1|Non-Adherence to Study Requirements|0|||
13129564|NCT02859558|25969968|FG000|Step 1|Virologic Failure|2|||
13129565|NCT02859558|25969969|FG001|Step 1|Virologic Failure|1|||
13129566|NCT02859558|25969970|FG002|Step 1|Virologic Failure|1|||
13129567|NCT02859558|25969971|FG003|Step 1|Virologic Failure|0|||
13129568|NCT02859558|25969972|FG004|Step 1|Virologic Failure|0|||
13129569|NCT02859558|25969968|FG000|Step 2|Active On Study|23|||
13129570|NCT02859558|25969969|FG001|Step 2|Active On Study|38|||
13129571|NCT02859558|25969970|FG002|Step 2|Active On Study|20|||
13129572|NCT02859558|25969971|FG003|Step 2|Active On Study|0|||
13129573|NCT02859558|25969972|FG004|Step 2|Active On Study|0|||
13129574|NCT02859558|25969968|FG000|Step 2|Did Not Return to Clinic|2|||
13129575|NCT02859558|25969969|FG001|Step 2|Did Not Return to Clinic|0|||
13129576|NCT02859558|25969970|FG002|Step 2|Did Not Return to Clinic|0|||
13129577|NCT02859558|25969971|FG003|Step 2|Did Not Return to Clinic|0|||
13129578|NCT02859558|25969972|FG004|Step 2|Did Not Return to Clinic|0|||
13129579|NCT02859558|25969968|FG000|Step 2|Unexpected Closure of Site|0|||
13129580|NCT02859558|25969969|FG001|Step 2|Unexpected Closure of Site|1|||
13129581|NCT02859558|25969970|FG002|Step 2|Unexpected Closure of Site|1|||
13129582|NCT02859558|25969971|FG003|Step 2|Unexpected Closure of Site|0|||
13129583|NCT02859558|25969972|FG004|Step 2|Unexpected Closure of Site|0|||
13129584|NCT02859454|25969986|FG000|Overall Study|PI discretion/off study prior to trtmt|1|||
13129585|NCT02859415|25970014|FG000|Overall Study|Physician Decision|1|||
13129586|NCT02859415|25970015|FG001|Overall Study|Physician Decision|0|||
13129587|NCT02859415|25970014|FG000|Overall Study|Off treatment due to cardiac event|0|||
13129588|NCT02859415|25970015|FG001|Overall Study|Off treatment due to cardiac event|1|||
13129589|NCT02859324|25970069|FG000|Overall Study|Death|4|||
13129590|NCT02859324|25970070|FG001|Overall Study|Death|6|||
13129591|NCT02859324|25970071|FG002|Overall Study|Death|5|||
13129592|NCT02859324|25970069|FG000|Overall Study|Other reasons|3|||
13129593|NCT02859324|25970070|FG001|Overall Study|Other reasons|3|||
13129594|NCT02859324|25970071|FG002|Overall Study|Other reasons|0|||
13129595|NCT02859246|25970078|FG000|Overall Study|Screen fails|3|||
13129596|NCT02859246|25970078|FG000|Overall Study|Adverse Event|1|||
13129597|NCT02859246|25970078|FG000|Overall Study|Withdrawal by Subject|1|||
13129598|NCT02859142|25970101|FG000|Overall Study|Adverse Event|1|||
13129599|NCT02859142|25970102|FG001|Overall Study|Adverse Event|2|||
13129600|NCT02859142|25970101|FG000|Overall Study|Lost to Follow-up|1|||
13129601|NCT02859142|25970102|FG001|Overall Study|Lost to Follow-up|4|||
13129602|NCT02859142|25970101|FG000|Overall Study|Withdrawal by Subject|2|||
13129603|NCT02859142|25970102|FG001|Overall Study|Withdrawal by Subject|0|||
13129604|NCT02859142|25970101|FG000|Overall Study|Scheduling difficulties|0|||
13222168|NCT01807650|26285804|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13|||
13129605|NCT02859142|25970102|FG001|Overall Study|Scheduling difficulties|3|||
13129606|NCT02858895|25970119|FG000|Overall Study|Disease progression|31|||
13129607|NCT02858895|25970119|FG000|Overall Study|Death|2|||
13129608|NCT02858895|25970119|FG000|Overall Study|Adverse Event|1|||
13129609|NCT02858895|25970119|FG000|Overall Study|Withdrawal by Subject|3|||
13129610|NCT02858895|25970119|FG000|Overall Study|hospice,|1|||
13129611|NCT02858895|25970119|FG000|Overall Study|did not receive drug due to catheters misplaced|1|||
13129612|NCT02858726|25970146|FG000|Overall Study|Adverse Event|4|||
13129613|NCT02858726|25970147|FG001|Overall Study|Adverse Event|4|||
13129614|NCT02858726|25970148|FG002|Overall Study|Adverse Event|9|||
13129615|NCT02858726|25970149|FG003|Overall Study|Adverse Event|1|||
13129616|NCT02858726|25970146|FG000|Overall Study|Physician Decision|0|||
13129617|NCT02858726|25970147|FG001|Overall Study|Physician Decision|0|||
13222169|NCT01807650|26285804|FG000|Overall Study|Adverse Event|5|||
13129618|NCT02858726|25970148|FG002|Overall Study|Physician Decision|1|||
13222170|NCT01807650|26285804|FG000|Overall Study|Other|2|||
13393337|NCT00665925|26783412|FG001|Overall Study|Physician Decision|0|||
13222171|NCT01807598|26285817|FG000|Overall Study|Withdrawal by Subject|4|||
13129619|NCT02858726|25970149|FG003|Overall Study|Physician Decision|0|||
13129620|NCT02858726|25970146|FG000|Overall Study|Protocol Violation|0|||
13129621|NCT02858726|25970147|FG001|Overall Study|Protocol Violation|0|||
13129622|NCT02858726|25970148|FG002|Overall Study|Protocol Violation|0|||
13129623|NCT02858726|25970149|FG003|Overall Study|Protocol Violation|1|||
13129624|NCT02858726|25970146|FG000|Overall Study|Study Terminated by Sponsor|0|||
13129625|NCT02858726|25970147|FG001|Overall Study|Study Terminated by Sponsor|0|||
13129626|NCT02858726|25970148|FG002|Overall Study|Study Terminated by Sponsor|0|||
13129627|NCT02858726|25970149|FG003|Overall Study|Study Terminated by Sponsor|1|||
13307560|NCT01285310|26528953|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
13222172|NCT01807598|26285817|FG000|Overall Study|Adverse Event|1|||
13222173|NCT01807598|26285817|FG000|Overall Study|Other Physician Decision|1|||
13222174|NCT01807520|26285850|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
13222175|NCT01807520|26285851|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1|||
13222176|NCT01807520|26285852|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3|||
13222177|NCT01807520|26285853|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
13222178|NCT01807520|26285854|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
13222179|NCT01807520|26285855|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
13222180|NCT01807520|26285856|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
13222181|NCT01807520|26285850|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
13222182|NCT01807520|26285851|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
13222183|NCT01807520|26285852|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
13222184|NCT01807520|26285853|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
13222185|NCT01807520|26285854|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
13222186|NCT01807520|26285855|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
13222187|NCT01807520|26285856|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
13292324|NCT00706654|26485251|FG003|Conversion Phase|Adverse Event|0|||
13222188|NCT01807520|26285850|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
13222189|NCT01807520|26285851|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
13222190|NCT01807520|26285852|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1|||
13222191|NCT01807520|26285853|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
13222192|NCT01807520|26285854|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
13222193|NCT01807520|26285855|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
13222194|NCT01807520|26285856|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
13129628|NCT02858726|25970146|FG000|Overall Study|Withdrawal by Subject|1|||
13129629|NCT02858726|25970147|FG001|Overall Study|Withdrawal by Subject|2|||
13129630|NCT02858726|25970148|FG002|Overall Study|Withdrawal by Subject|1|||
13129631|NCT02858726|25970149|FG003|Overall Study|Withdrawal by Subject|0|||
13129632|NCT02858726|25970146|FG000|Overall Study|Noncompliance|0|||
13129633|NCT02858726|25970147|FG001|Overall Study|Noncompliance|1|||
13129634|NCT02858726|25970148|FG002|Overall Study|Noncompliance|0|||
13129635|NCT02858726|25970149|FG003|Overall Study|Noncompliance|0|||
13129636|NCT02858492|25970338|FG000|Overall Study|Withdrawal by Subject|0|||
13129637|NCT02858492|25970339|FG001|Overall Study|Withdrawal by Subject|1|||
13129638|NCT02858492|25970340|FG002|Overall Study|Withdrawal by Subject|0|||
13129639|NCT02858492|25970341|FG003|Overall Study|Withdrawal by Subject|1|||
13129640|NCT02858492|25970338|FG000|Overall Study|Adverse Event|0|||
13129641|NCT02858492|25970339|FG001|Overall Study|Adverse Event|0|||
13129642|NCT02858492|25970340|FG002|Overall Study|Adverse Event|0|||
13129643|NCT02858492|25970341|FG003|Overall Study|Adverse Event|3|||
13129644|NCT02858492|25970338|FG000|Overall Study|Lack of Efficacy|0|||
13129645|NCT02858492|25970339|FG001|Overall Study|Lack of Efficacy|0|||
13129646|NCT02858492|25970340|FG002|Overall Study|Lack of Efficacy|0|||
13129647|NCT02858492|25970341|FG003|Overall Study|Lack of Efficacy|1|||
13129648|NCT02858492|25970338|FG000|Overall Study|Protocol defined stopping criteria|0|||
13129649|NCT02858492|25970339|FG001|Overall Study|Protocol defined stopping criteria|0|||
13129650|NCT02858492|25970340|FG002|Overall Study|Protocol defined stopping criteria|0|||
13129651|NCT02858492|25970341|FG003|Overall Study|Protocol defined stopping criteria|1|||
13129652|NCT02858440|25970369|FG000|Overall Study|Lost to Follow-up|3|||
13129653|NCT02858440|25970369|FG000|Overall Study|Protocol Violation|2|||
13129654|NCT02858440|25970369|FG000|Overall Study|Consent withdrawal|3|||
13129655|NCT02858440|25970369|FG000|Overall Study|Migrated/moved from study area|4|||
13129656|NCT02858401|25970799|FG000|Overall Study|Withdrew Consent|0|||
13129657|NCT02858401|25970800|FG001|Overall Study|Withdrew Consent|0|||
13129658|NCT02858401|25970801|FG002|Overall Study|Withdrew Consent|0|||
13129659|NCT02858401|25970802|FG003|Overall Study|Withdrew Consent|0|||
13129660|NCT02858401|25970803|FG004|Overall Study|Withdrew Consent|0|||
13129661|NCT02858401|25970804|FG005|Overall Study|Withdrew Consent|1|||
13129662|NCT02858401|25970805|FG006|Overall Study|Withdrew Consent|0|||
13129663|NCT02858401|25970799|FG000|Overall Study|Lost to Follow-up|0|||
13129664|NCT02858401|25970800|FG001|Overall Study|Lost to Follow-up|1|||
13129665|NCT02858401|25970801|FG002|Overall Study|Lost to Follow-up|0|||
13129666|NCT02858401|25970802|FG003|Overall Study|Lost to Follow-up|0|||
13129667|NCT02858401|25970803|FG004|Overall Study|Lost to Follow-up|0|||
13129668|NCT02858401|25970804|FG005|Overall Study|Lost to Follow-up|0|||
13129669|NCT02858401|25970805|FG006|Overall Study|Lost to Follow-up|0|||
13129670|NCT02858362|25970850|FG000|Overall Study|Protocol Violation|0|||
13129671|NCT02858362|25970851|FG001|Overall Study|Protocol Violation|1|||
13129672|NCT02858362|25970852|FG002|Overall Study|Protocol Violation|0|||
13129673|NCT02858362|25970850|FG000|Overall Study|Withdrawal by Subject|1|||
13129674|NCT02858362|25970851|FG001|Overall Study|Withdrawal by Subject|0|||
13129675|NCT02858362|25970852|FG002|Overall Study|Withdrawal by Subject|0|||
13129676|NCT02858362|25970850|FG000|Overall Study|Early Study Termination|0|||
13129677|NCT02858362|25970851|FG001|Overall Study|Early Study Termination|0|||
13129678|NCT02858362|25970852|FG002|Overall Study|Early Study Termination|3|||
13129679|NCT02858362|25970850|FG000|Overall Study|Lost to Follow-up|1|||
13129680|NCT02858362|25970851|FG001|Overall Study|Lost to Follow-up|0|||
13129681|NCT02858362|25970852|FG002|Overall Study|Lost to Follow-up|0|||
13129682|NCT02858180|25970871|FG000|Overall Study|Lost to Follow-up|0|||
13129683|NCT02858180|25970872|FG001|Overall Study|Lost to Follow-up|2|||
13129684|NCT02858076|25970915|FG000|Overall Study|Death|6|||
13129685|NCT02858076|25970916|FG001|Overall Study|Death|3|||
13129686|NCT02858076|25970915|FG000|Overall Study|Withdrawal by Subject|1|||
13129687|NCT02858076|25970916|FG001|Overall Study|Withdrawal by Subject|5|||
13129688|NCT02858076|25970915|FG000|Overall Study|Lost to Follow-up|2|||
13129689|NCT02858076|25970916|FG001|Overall Study|Lost to Follow-up|7|||
13129690|NCT02858076|25970915|FG000|Overall Study|Completed Out of Window|1|||
13129691|NCT02858076|25970916|FG001|Overall Study|Completed Out of Window|3|||
13129692|NCT02858037|25970925|FG000|Overall Study|Death|1|||
13129693|NCT02858037|25970925|FG000|Overall Study|Withdrawal by Subject|18|||
13129694|NCT02858037|25970925|FG000|Overall Study|Participant Relocated, no follow-up planned|26|||
13129695|NCT02858037|25970925|FG000|Overall Study|Lost to Follow-up|3|||
13129696|NCT02858037|25970925|FG000|Overall Study|Other|4|||
13129697|NCT02857816|25970933|FG000|Overall Study|Screen Failure|33|||
13129698|NCT02857816|25970933|FG000|Overall Study|Withdrawal by Subject|4|||
13129699|NCT02857816|25970933|FG000|Overall Study|Lost to Follow-up|1|||
13129700|NCT02857283|25970974|FG000|First Exposure|Withdrawal by Subject|1|||
13129701|NCT02857283|25970975|FG001|First Exposure|Withdrawal by Subject|0|||
13129702|NCT02856880|25971001|FG000|Overall Study|Withdrawal of consent|1|||
13129703|NCT02856802|25971020|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
13129704|NCT02856802|25971021|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2|||
13129705|NCT02856802|25971020|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1|||
13129706|NCT02856802|25971021|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0|||
13129707|NCT02856802|25971020|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
13129708|NCT02856802|25971021|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
13129709|NCT02856802|25971020|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1|||
13129710|NCT02856802|25971021|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0|||
13129711|NCT02856802|25971020|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0|||
13129712|NCT02856802|25971021|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2|||
13129713|NCT02856802|25971020|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1|||
13129714|NCT02856802|25971021|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0|||
13129715|NCT02856555|25971039|FG000|Overall Study|Adverse Event|1|||
13129716|NCT02856555|25971040|FG001|Overall Study|Adverse Event|0|||
13129717|NCT02856555|25971041|FG002|Overall Study|Adverse Event|0|||
13129718|NCT02856555|25971039|FG000|Overall Study|Lost to Follow-up|1|||
13222195|NCT01807520|26285850|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1|||
13222196|NCT01807520|26285851|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
13222197|NCT01807520|26285852|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
13222198|NCT01807520|26285853|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
13129719|NCT02856555|25971040|FG001|Overall Study|Lost to Follow-up|3|||
13129720|NCT02856555|25971041|FG002|Overall Study|Lost to Follow-up|0|||
13129721|NCT02856555|25971039|FG000|Overall Study|Withdrawal by Subject|3|||
13129722|NCT02856555|25971040|FG001|Overall Study|Withdrawal by Subject|0|||
13129723|NCT02856555|25971041|FG002|Overall Study|Withdrawal by Subject|0|||
13129724|NCT02856555|25971039|FG000|Overall Study|Randomized but Never Treated|0|||
13129725|NCT02856555|25971040|FG001|Overall Study|Randomized but Never Treated|1|||
13129726|NCT02856555|25971041|FG002|Overall Study|Randomized but Never Treated|0|||
13129727|NCT02856282|25971053|FG000|Overall Study|Withdrawal by Subject|1|||
13129728|NCT02856113|25971088|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
13129729|NCT02856113|25971089|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
13129730|NCT02856113|25971088|FG000|Overall Study|Significant Protocol Deviation|1|||
13129731|NCT02856113|25971089|FG001|Overall Study|Significant Protocol Deviation|0|||
13129732|NCT02856113|25971088|FG000|Overall Study|Lost to Follow-up|3|||
13129733|NCT02856113|25971089|FG001|Overall Study|Lost to Follow-up|5|||
13129734|NCT02856113|25971088|FG000|Overall Study|Voluntary Withdrawal|3|||
13129735|NCT02856113|25971089|FG001|Overall Study|Voluntary Withdrawal|5|||
13129736|NCT02856113|25971088|FG000|Overall Study|Pregnancy|0|||
13129737|NCT02856113|25971089|FG001|Overall Study|Pregnancy|1|||
13129738|NCT02856113|25971088|FG000|Overall Study|Principal Investigator Discretion|2|||
13129739|NCT02856113|25971089|FG001|Overall Study|Principal Investigator Discretion|1|||
13129740|NCT02856113|25971088|FG000|Overall Study|Randomized but not Treated|1|||
13129741|NCT02856113|25971089|FG001|Overall Study|Randomized but not Treated|0|||
13129742|NCT02856113|25971088|FG000|Overall Study|Did not Complete Study but Contacted at Week 52|0|||
13129743|NCT02856113|25971089|FG001|Overall Study|Did not Complete Study but Contacted at Week 52|3|||
13129744|NCT02855944|25971121|FG000|Period 1: Treatment|Ongoing|44|||
13129745|NCT02855944|25971122|FG001|Period 1: Treatment|Ongoing|5|||
13129746|NCT02855944|25971121|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1|||
13222199|NCT01807520|26285854|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
13129747|NCT02855944|25971122|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3|||
13129748|NCT02855944|25971121|FG000|Period 2: Crossover to Rucaparib|Ongoing|0|||
13129749|NCT02855944|25971122|FG001|Period 2: Crossover to Rucaparib|Ongoing|27|||
13129750|NCT02855541|25971135|FG000|Overall Study|Change in health status|2|||
13129751|NCT02855541|25971135|FG000|Overall Study|Withdrawal by Subject|2|||
13129752|NCT02855450|25971150|FG000|Overall Study|Adverse Event|1|||
13222200|NCT01807520|26285855|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
13222201|NCT01807520|26285856|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
13222202|NCT01807520|26285850|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
13222203|NCT01807520|26285851|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
13222204|NCT01807520|26285852|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2|||
13222205|NCT01807520|26285853|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
13222206|NCT01807520|26285854|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
13222207|NCT01807520|26285855|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
13222208|NCT01807520|26285856|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
13222209|NCT01807520|26285850|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2|||
13222210|NCT01807520|26285851|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
13222211|NCT01807520|26285852|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
13222212|NCT01807520|26285853|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
13222213|NCT01807520|26285854|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
13222214|NCT01807520|26285855|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
13222215|NCT01807520|26285856|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
13222216|NCT01807520|26285850|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7|||
13222217|NCT01807520|26285851|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4|||
13222218|NCT01807520|26285852|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
13222219|NCT01807520|26285853|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
13222220|NCT01807520|26285854|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2|||
13222221|NCT01807520|26285855|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
13222222|NCT01807520|26285856|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
13222223|NCT01807520|26285850|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
13222224|NCT01807520|26285851|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
13222225|NCT01807520|26285852|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
13222226|NCT01807520|26285853|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1|||
13222227|NCT01807520|26285854|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
13222228|NCT01807520|26285855|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
13222229|NCT01807520|26285856|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
13222230|NCT01807520|26285850|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1|||
13222231|NCT01807520|26285851|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
13222232|NCT01807520|26285852|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
13222233|NCT01807520|26285853|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
13222234|NCT01807520|26285854|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
13222235|NCT01807520|26285855|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
13222236|NCT01807520|26285856|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
13222237|NCT01807520|26285850|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
13222238|NCT01807520|26285851|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2|||
13222239|NCT01807520|26285852|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
13222240|NCT01807520|26285853|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
13222241|NCT01807520|26285854|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
13222242|NCT01807520|26285855|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
13222243|NCT01807520|26285856|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
13222244|NCT01807520|26285850|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4|||
13222245|NCT01807520|26285851|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
13222246|NCT01807520|26285852|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
13222247|NCT01807520|26285853|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1|||
13222248|NCT01807520|26285854|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
13222249|NCT01807520|26285855|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
13129753|NCT02855450|25971151|FG001|Overall Study|Adverse Event|0|||
13129754|NCT02855450|25971150|FG000|Overall Study|Lost to Follow-up|4|||
13129755|NCT02855450|25971151|FG001|Overall Study|Lost to Follow-up|0|||
13129756|NCT02855411|25971173|FG000|Overall Study|Study terminated by sponsor|21|||
13129757|NCT02855411|25971173|FG000|Overall Study|Does not meet entrance criteria|14|||
13129758|NCT02855359|25971214|FG000|Overall Study|Death|2|||
13129759|NCT02855359|25971215|FG001|Overall Study|Death|2|||
13129760|NCT02855359|25971216|FG002|Overall Study|Death|0|||
13129761|NCT02855359|25971217|FG003|Overall Study|Death|0|||
13129762|NCT02855359|25971214|FG000|Overall Study|Study Termination by Sponsor|9|||
13129763|NCT02855359|25971215|FG001|Overall Study|Study Termination by Sponsor|11|||
13129764|NCT02855359|25971216|FG002|Overall Study|Study Termination by Sponsor|0|||
13129765|NCT02855359|25971217|FG003|Overall Study|Study Termination by Sponsor|0|||
13129766|NCT02855164|25971397|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
13129767|NCT02855164|25971398|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
13129768|NCT02855164|25971399|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
13129769|NCT02855164|25971400|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2|||
13129770|NCT02855164|25971401|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
13129771|NCT02855164|25971402|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
13129772|NCT02855164|25971403|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
13129773|NCT02855164|25971404|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
13129774|NCT02855164|25971397|FG000|Parts A + B (Randomized Set)|Physician Decision|0|||
13129775|NCT02855164|25971398|FG001|Parts A + B (Randomized Set)|Physician Decision|0|||
13129776|NCT02855164|25971399|FG002|Parts A + B (Randomized Set)|Physician Decision|0|||
13129777|NCT02855164|25971400|FG003|Parts A + B (Randomized Set)|Physician Decision|2|||
13129778|NCT02855164|25971401|FG004|Parts A + B (Randomized Set)|Physician Decision|0|||
13129779|NCT02855164|25971402|FG005|Parts A + B (Randomized Set)|Physician Decision|0|||
13129780|NCT02855164|25971403|FG006|Parts A + B (Randomized Set)|Physician Decision|0|||
13129781|NCT02855164|25971404|FG007|Parts A + B (Randomized Set)|Physician Decision|0|||
13129782|NCT02855164|25971397|FG000|Parts A + B (Randomized Set)|Adverse Event|0|||
13129783|NCT02855164|25971398|FG001|Parts A + B (Randomized Set)|Adverse Event|0|||
13129784|NCT02855164|25971399|FG002|Parts A + B (Randomized Set)|Adverse Event|0|||
13129785|NCT02855164|25971400|FG003|Parts A + B (Randomized Set)|Adverse Event|4|||
13129786|NCT02855164|25971401|FG004|Parts A + B (Randomized Set)|Adverse Event|0|||
13129787|NCT02855164|25971402|FG005|Parts A + B (Randomized Set)|Adverse Event|0|||
13129788|NCT02855164|25971403|FG006|Parts A + B (Randomized Set)|Adverse Event|0|||
13129789|NCT02855164|25971404|FG007|Parts A + B (Randomized Set)|Adverse Event|0|||
13129790|NCT02855164|25971397|FG000|Part C (Randomized Set)|Adverse Event|0|||
13129791|NCT02855164|25971398|FG001|Part C (Randomized Set)|Adverse Event|0|||
13129792|NCT02855164|25971399|FG002|Part C (Randomized Set)|Adverse Event|0|||
13129793|NCT02855164|25971400|FG003|Part C (Randomized Set)|Adverse Event|0|||
13129794|NCT02855164|25971401|FG004|Part C (Randomized Set)|Adverse Event|0|||
13129795|NCT02855164|25971402|FG005|Part C (Randomized Set)|Adverse Event|5|||
13129796|NCT02855164|25971403|FG006|Part C (Randomized Set)|Adverse Event|9|||
13129797|NCT02855164|25971404|FG007|Part C (Randomized Set)|Adverse Event|2|||
13129798|NCT02855164|25971397|FG000|Part C (Randomized Set)|Lost to Follow-up|0|||
13129799|NCT02855164|25971398|FG001|Part C (Randomized Set)|Lost to Follow-up|0|||
13129800|NCT02855164|25971399|FG002|Part C (Randomized Set)|Lost to Follow-up|0|||
13129801|NCT02855164|25971400|FG003|Part C (Randomized Set)|Lost to Follow-up|0|||
13129802|NCT02855164|25971401|FG004|Part C (Randomized Set)|Lost to Follow-up|0|||
13129803|NCT02855164|25971402|FG005|Part C (Randomized Set)|Lost to Follow-up|1|||
13129804|NCT02855164|25971403|FG006|Part C (Randomized Set)|Lost to Follow-up|1|||
13129805|NCT02855164|25971404|FG007|Part C (Randomized Set)|Lost to Follow-up|1|||
13129806|NCT02855164|25971397|FG000|Part C (Randomized Set)|Physician Decision|0|||
13129807|NCT02855164|25971398|FG001|Part C (Randomized Set)|Physician Decision|0|||
13129808|NCT02855164|25971399|FG002|Part C (Randomized Set)|Physician Decision|0|||
13129809|NCT02855164|25971400|FG003|Part C (Randomized Set)|Physician Decision|0|||
13129810|NCT02855164|25971401|FG004|Part C (Randomized Set)|Physician Decision|0|||
13129811|NCT02855164|25971402|FG005|Part C (Randomized Set)|Physician Decision|1|||
13129812|NCT02855164|25971403|FG006|Part C (Randomized Set)|Physician Decision|0|||
13222250|NCT01807520|26285856|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
13222251|NCT01807520|26285850|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5|||
13222252|NCT01807520|26285851|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3|||
13222253|NCT01807520|26285852|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
13222254|NCT01807520|26285853|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
13222255|NCT01807520|26285854|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1|||
13222256|NCT01807520|26285855|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
13222257|NCT01807520|26285856|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
13222258|NCT01807520|26285850|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
13222259|NCT01807520|26285851|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
13222260|NCT01807520|26285852|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
13222261|NCT01807520|26285853|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
13222262|NCT01807520|26285854|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
13222263|NCT01807520|26285855|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
13222264|NCT01807520|26285856|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
13393338|NCT00665925|26783413|FG002|Overall Study|Physician Decision|1|||
13129813|NCT02855164|25971404|FG007|Part C (Randomized Set)|Physician Decision|1|||
13129814|NCT02855164|25971397|FG000|Part C (Randomized Set)|Withdrawal by Subject|0|||
13129815|NCT02855164|25971398|FG001|Part C (Randomized Set)|Withdrawal by Subject|0|||
13129816|NCT02855164|25971399|FG002|Part C (Randomized Set)|Withdrawal by Subject|0|||
13129817|NCT02855164|25971400|FG003|Part C (Randomized Set)|Withdrawal by Subject|0|||
13129818|NCT02855164|25971401|FG004|Part C (Randomized Set)|Withdrawal by Subject|0|||
13129819|NCT02855164|25971402|FG005|Part C (Randomized Set)|Withdrawal by Subject|5|||
13129820|NCT02855164|25971403|FG006|Part C (Randomized Set)|Withdrawal by Subject|4|||
13129821|NCT02855164|25971404|FG007|Part C (Randomized Set)|Withdrawal by Subject|3|||
13129822|NCT02854800|25971452|FG000|Overall Study|Protocol Violation|16|||
13129823|NCT02854800|25971453|FG001|Overall Study|Protocol Violation|11|||
13129824|NCT02854800|25971454|FG002|Overall Study|Protocol Violation|3|||
13129825|NCT02854800|25971452|FG000|Overall Study|Withdrawal by Subject|4|||
13129826|NCT02854800|25971453|FG001|Overall Study|Withdrawal by Subject|2|||
13129827|NCT02854800|25971454|FG002|Overall Study|Withdrawal by Subject|3|||
13129828|NCT02854631|25971519|FG000|Overall Study|Adverse Event|1|||
13129829|NCT02854631|25971520|FG001|Overall Study|Adverse Event|2|||
13129830|NCT02854631|25971519|FG000|Overall Study|Withdrew Consent|3|||
13129831|NCT02854631|25971520|FG001|Overall Study|Withdrew Consent|2|||
13129832|NCT02854631|25971519|FG000|Overall Study|Investigator's Discretion|2|||
13129833|NCT02854631|25971520|FG001|Overall Study|Investigator's Discretion|0|||
13129834|NCT02854631|25971519|FG000|Overall Study|Death|12|||
13129835|NCT02854631|25971520|FG001|Overall Study|Death|8|||
13129836|NCT02854631|25971519|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2|||
13129837|NCT02854631|25971520|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0|||
13129838|NCT02854631|25971519|FG000|Overall Study|Protocol Violation|0|||
13129839|NCT02854631|25971520|FG001|Overall Study|Protocol Violation|1|||
13129840|NCT02854631|25971519|FG000|Overall Study|Subjects Randomized but Never Treated|2|||
13129841|NCT02854631|25971520|FG001|Overall Study|Subjects Randomized but Never Treated|0|||
13129842|NCT02854631|25971519|FG000|Overall Study|Lost to Follow-up|4|||
13129843|NCT02854631|25971520|FG001|Overall Study|Lost to Follow-up|2|||
13129844|NCT02854605|25971541|FG000|Overall Study|Adverse Event|1|||
13129845|NCT02854605|25971542|FG001|Overall Study|Adverse Event|5|||
13129846|NCT02854605|25971543|FG002|Overall Study|Adverse Event|2|||
13129847|NCT02854605|25971541|FG000|Overall Study|Lost to Follow-up|0|||
13129848|NCT02854605|25971542|FG001|Overall Study|Lost to Follow-up|2|||
13129849|NCT02854605|25971543|FG002|Overall Study|Lost to Follow-up|0|||
13129850|NCT02854605|25971541|FG000|Overall Study|Withdrew Consent|1|||
13129851|NCT02854605|25971542|FG001|Overall Study|Withdrew Consent|0|||
13129852|NCT02854605|25971543|FG002|Overall Study|Withdrew Consent|1|||
13129853|NCT02854605|25971541|FG000|Overall Study|Investigator's Discretion|1|||
13129854|NCT02854605|25971542|FG001|Overall Study|Investigator's Discretion|0|||
13129855|NCT02854605|25971543|FG002|Overall Study|Investigator's Discretion|0|||
13129856|NCT02854605|25971541|FG000|Overall Study|Protocol Violation|0|||
13129857|NCT02854605|25971542|FG001|Overall Study|Protocol Violation|0|||
13129858|NCT02854605|25971543|FG002|Overall Study|Protocol Violation|1|||
13129859|NCT02854527|25971605|FG000|Overall Study|Adverse Event|0|||
13129860|NCT02854527|25971606|FG001|Overall Study|Adverse Event|0|||
13129861|NCT02854527|25971607|FG002|Overall Study|Adverse Event|0|||
13129862|NCT02854527|25971608|FG003|Overall Study|Adverse Event|0|||
13129863|NCT02854527|25971609|FG004|Overall Study|Adverse Event|1|||
13129864|NCT02854527|25971610|FG005|Overall Study|Adverse Event|0|||
13129865|NCT02854527|25971611|FG006|Overall Study|Adverse Event|0|||
13129866|NCT02854527|25971612|FG007|Overall Study|Adverse Event|0|||
13129867|NCT02854527|25971613|FG008|Overall Study|Adverse Event|0|||
13129868|NCT02854527|25971614|FG009|Overall Study|Adverse Event|0|||
13129869|NCT02854527|25971605|FG000|Overall Study|Lost to Follow-up|0|||
13129870|NCT02854527|25971606|FG001|Overall Study|Lost to Follow-up|0|||
13129871|NCT02854527|25971607|FG002|Overall Study|Lost to Follow-up|0|||
13129872|NCT02854527|25971608|FG003|Overall Study|Lost to Follow-up|1|||
13129873|NCT02854527|25971609|FG004|Overall Study|Lost to Follow-up|0|||
13129874|NCT02854527|25971610|FG005|Overall Study|Lost to Follow-up|0|||
13129875|NCT02854527|25971611|FG006|Overall Study|Lost to Follow-up|0|||
13129876|NCT02854527|25971612|FG007|Overall Study|Lost to Follow-up|0|||
13129877|NCT02854527|25971613|FG008|Overall Study|Lost to Follow-up|0|||
13129878|NCT02854527|25971614|FG009|Overall Study|Lost to Follow-up|0|||
13129879|NCT02853929|25971659|FG000|Overall Study|Lost to Follow-up|3|||
13129880|NCT02853929|25971660|FG001|Overall Study|Lost to Follow-up|0|||
13129881|NCT02853929|25971659|FG000|Overall Study|Withdrawal by Subject|1|||
13129882|NCT02853929|25971660|FG001|Overall Study|Withdrawal by Subject|0|||
13129883|NCT02853929|25971659|FG000|Overall Study|Subjects enrolled but not vaccinated|7|||
13129884|NCT02853929|25971660|FG001|Overall Study|Subjects enrolled but not vaccinated|4|||
13129885|NCT02853760|25971690|FG000|Washout (1 Week)|acute illness (not connected with the study)|0|||
13129886|NCT02853760|25971691|FG001|Washout (1 Week)|acute illness (not connected with the study)|0|||
13129887|NCT02853760|25971692|FG002|Washout (1 Week)|acute illness (not connected with the study)|1|||
13129888|NCT02853760|25971693|FG003|Washout (1 Week)|acute illness (not connected with the study)|2|||
13129889|NCT02853760|25971694|FG004|Washout (1 Week)|acute illness (not connected with the study)|0|||
13129890|NCT02853760|25971695|FG005|Washout (1 Week)|acute illness (not connected with the study)|2|||
13129891|NCT02853435|25972016|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
13129892|NCT02853435|25972017|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
13129893|NCT02853435|25972018|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
13129894|NCT02853435|25972019|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
13129895|NCT02853435|25972020|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1|||
13129896|NCT02853435|25972021|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
13129897|NCT02853344|25972048|FG000|Overall Study|Death|23|||
13129898|NCT02853344|25972049|FG001|Overall Study|Death|84|||
13129899|NCT02853344|25972048|FG000|Overall Study|Withdrawal by Subject|1|||
13129900|NCT02853344|25972049|FG001|Overall Study|Withdrawal by Subject|3|||
13129901|NCT02853344|25972048|FG000|Overall Study|Ongoing|86|||
13129902|NCT02853344|25972049|FG001|Overall Study|Ongoing|78|||
13129903|NCT02853331|25972088|FG000|Overall Study|Death|59|||
13129904|NCT02853331|25972089|FG001|Overall Study|Death|95|||
13129905|NCT02853331|25972088|FG000|Overall Study|Withdrawal by Subject|5|||
13129906|NCT02853331|25972089|FG001|Overall Study|Withdrawal by Subject|9|||
13129907|NCT02853331|25972088|FG000|Overall Study|Ongoing in study|368|||
13129908|NCT02853331|25972089|FG001|Overall Study|Ongoing in study|325|||
13129909|NCT02853318|25972099|FG000|Overall Study|Withdrawal by Subject|1|||
13129910|NCT02853305|25972174|FG000|Overall Study|Death|244|||
13129911|NCT02853305|25972175|FG001|Overall Study|Death|207|||
13129912|NCT02853305|25972176|FG002|Overall Study|Death|263|||
13129913|NCT02853305|25972174|FG000|Overall Study|Withdrawal by Subject|2|||
13129914|NCT02853305|25972175|FG001|Overall Study|Withdrawal by Subject|4|||
13129915|NCT02853305|25972176|FG002|Overall Study|Withdrawal by Subject|2|||
13129916|NCT02853305|25972174|FG000|Overall Study|Ongoing in Trial|105|||
13129917|NCT02853305|25972175|FG001|Overall Study|Ongoing in Trial|96|||
13129918|NCT02853305|25972176|FG002|Overall Study|Ongoing in Trial|87|||
13129919|NCT02853123|25972200|FG000|Treatment Period 1|Adverse Event|0|||
13129920|NCT02853123|25972201|FG001|Treatment Period 1|Adverse Event|3|||
13129921|NCT02853123|25972200|FG000|Washout Period|Worsening of COPD|0|||
13129922|NCT02853123|25972201|FG001|Washout Period|Worsening of COPD|3|||
13129923|NCT02853123|25972200|FG000|Washout Period|Adverse Event|1|||
13129924|NCT02853123|25972201|FG001|Washout Period|Adverse Event|0|||
13072317|NCT04207749|25273039|FG000|Overall Study|Lost to Follow-up|0|||
13072318|NCT04207749|25273040|FG001|Overall Study|Lost to Follow-up|2|||
13072319|NCT04207749|25273039|FG000|Overall Study|Protocol Violation|0|||
13072320|NCT04207749|25273040|FG001|Overall Study|Protocol Violation|1|||
13072321|NCT04207749|25273039|FG000|Overall Study|Withdrawal by Subject|3|||
13072322|NCT04207749|25273040|FG001|Overall Study|Withdrawal by Subject|0|||
13072323|NCT04207749|25273039|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1|||
13072324|NCT04207749|25273040|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4|||
13072325|NCT04167345|25273082|FG000|Overall Study|Other|1|||
13072326|NCT04167345|25273083|FG001|Overall Study|Other|1|||
13072327|NCT04167345|25273084|FG002|Overall Study|Other|0|||
13072328|NCT04167345|25273085|FG003|Overall Study|Other|0|||
13072329|NCT04167345|25273086|FG004|Overall Study|Other|0|||
13072330|NCT04042077|25273111|FG000|Overall Study|Adverse Event|0|||
13072331|NCT04042077|25273112|FG001|Overall Study|Adverse Event|1|||
13072332|NCT04042077|25273111|FG000|Overall Study|Death|2|||
13072333|NCT04042077|25273112|FG001|Overall Study|Death|1|||
13072334|NCT04042077|25273111|FG000|Overall Study|Physician Decision|2|||
13072335|NCT04042077|25273112|FG001|Overall Study|Physician Decision|0|||
13072336|NCT04042077|25273111|FG000|Overall Study|Withdrawal by Subject|3|||
13072337|NCT04042077|25273112|FG001|Overall Study|Withdrawal by Subject|2|||
13072338|NCT04042077|25273111|FG000|Overall Study|Lack of Efficacy|0|||
13072339|NCT04042077|25273112|FG001|Overall Study|Lack of Efficacy|1|||
13072340|NCT04001803|25273184|FG000|Overall Study|Ongoing at the time of analysis|103|||
13072341|NCT04001803|25273184|FG000|Overall Study|Adverse Event|2|||
13072342|NCT04001803|25273184|FG000|Overall Study|Protocol Violation|2|||
13072343|NCT04001803|25273184|FG000|Overall Study|Lost to Follow-up|2|||
13072344|NCT04001803|25273184|FG000|Overall Study|Physician Decision|1|||
13072345|NCT04001803|25273184|FG000|Overall Study|Withdrawal by Subject|4|||
13072346|NCT03925324|25273233|FG000|Overall Study|Death|1|||
13072347|NCT03925324|25273234|FG001|Overall Study|Death|1|||
13072348|NCT03740009|25273248|FG000|Overall Study|Physician Decision|9|||
13072349|NCT03740009|25273248|FG000|Overall Study|Lost to Follow-up|1|||
13072350|NCT03738397|25273275|FG000|Overall Study|Adverse Event|3|||
13072351|NCT03738397|25273276|FG001|Overall Study|Adverse Event|7|||
13072352|NCT03738397|25273275|FG000|Overall Study|Withdrawal by Subject|8|||
13072353|NCT03738397|25273276|FG001|Overall Study|Withdrawal by Subject|11|||
13072354|NCT03738397|25273275|FG000|Overall Study|Lost to Follow-up|8|||
13072355|NCT03738397|25273276|FG001|Overall Study|Lost to Follow-up|5|||
13072356|NCT03738397|25273275|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
13072357|NCT03738397|25273276|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
13072358|NCT03738397|25273275|FG000|Overall Study|Other|4|||
13072359|NCT03738397|25273276|FG001|Overall Study|Other|6|||
13072360|NCT03666624|25273293|FG000|Overall Study|participant grieving over recent death of parent|1|||
13072361|NCT03666624|25273294|FG001|Overall Study|participant grieving over recent death of parent|0|||
13072362|NCT03649217|25273304|FG000|Overall Study|subject had severe ataxia not initially found|1|||
13072363|NCT03649217|25273304|FG000|Overall Study|subject had cognitive issues not initially found|1|||
13072364|NCT03569293|25273469|FG000|Overall Study|Adverse Event|4|||
13072365|NCT03569293|25273470|FG001|Overall Study|Adverse Event|1|||
13072366|NCT03569293|25273471|FG002|Overall Study|Adverse Event|5|||
13072367|NCT03569293|25273472|FG003|Overall Study|Adverse Event|1|||
13072368|NCT03569293|25273473|FG004|Overall Study|Adverse Event|0|||
13072369|NCT03569293|25273474|FG005|Overall Study|Adverse Event|0|||
13072370|NCT03569293|25273469|FG000|Overall Study|Withdrawal by Subject|16|||
13072371|NCT03569293|25273470|FG001|Overall Study|Withdrawal by Subject|2|||
13072372|NCT03569293|25273471|FG002|Overall Study|Withdrawal by Subject|4|||
13072373|NCT03569293|25273472|FG003|Overall Study|Withdrawal by Subject|1|||
13072374|NCT03569293|25273473|FG004|Overall Study|Withdrawal by Subject|0|||
13072375|NCT03569293|25273474|FG005|Overall Study|Withdrawal by Subject|0|||
13072376|NCT03569293|25273469|FG000|Overall Study|Lost to Follow-up|1|||
13072377|NCT03569293|25273470|FG001|Overall Study|Lost to Follow-up|3|||
13072378|NCT03569293|25273471|FG002|Overall Study|Lost to Follow-up|1|||
13072379|NCT03569293|25273472|FG003|Overall Study|Lost to Follow-up|1|||
13072380|NCT03569293|25273473|FG004|Overall Study|Lost to Follow-up|0|||
13072381|NCT03569293|25273474|FG005|Overall Study|Lost to Follow-up|0|||
13072382|NCT03569293|25273469|FG000|Overall Study|Other|8|||
13072383|NCT03569293|25273470|FG001|Overall Study|Other|2|||
13072384|NCT03569293|25273471|FG002|Overall Study|Other|1|||
13072385|NCT03569293|25273472|FG003|Overall Study|Other|1|||
13072386|NCT03569293|25273473|FG004|Overall Study|Other|0|||
13072387|NCT03569293|25273474|FG005|Overall Study|Other|0|||
13072388|NCT03569293|25273469|FG000|Overall Study|Ongoing at Time of Analysis|8|||
13072389|NCT03569293|25273470|FG001|Overall Study|Ongoing at Time of Analysis|1|||
13072390|NCT03569293|25273471|FG002|Overall Study|Ongoing at Time of Analysis|3|||
13072391|NCT03569293|25273472|FG003|Overall Study|Ongoing at Time of Analysis|0|||
13072392|NCT03569293|25273473|FG004|Overall Study|Ongoing at Time of Analysis|0|||
13072393|NCT03569293|25273474|FG005|Overall Study|Ongoing at Time of Analysis|0|||
13072394|NCT03132753|25273895|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27|||
13072395|NCT03132753|25273896|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32|||
13072396|NCT03132753|25273895|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6|||
13072397|NCT03132753|25273896|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2|||
13072398|NCT03067077|25273923|FG000|Overall Study|Did not receive surgery|4|||
13072399|NCT03067077|25273924|FG001|Overall Study|Did not receive surgery|5|||
13072400|NCT03067077|25273923|FG000|Overall Study|Lost to Follow-up|3|||
13072401|NCT03067077|25273924|FG001|Overall Study|Lost to Follow-up|2|||
13072402|NCT03059446|25273930|FG000|Overall Study|Adverse Event|11|||
13072403|NCT03059446|25273930|FG000|Overall Study|Withdrawal of Consent|16|||
13072404|NCT03059446|25273930|FG000|Overall Study|Lost to Follow-up|3|||
13072405|NCT03059446|25273930|FG000|Overall Study|Protocol Violation|1|||
13072406|NCT03059446|25273930|FG000|Overall Study|Study Terminated by Sponsor|131|||
13072407|NCT03059446|25273930|FG000|Overall Study|Reason not Specified|5|||
13072408|NCT02601014|25274151|FG000|Overall Study|Adverse Event|3|||
13072409|NCT02601014|25274152|FG001|Overall Study|Adverse Event|3|||
13072410|NCT02601014|25274151|FG000|Overall Study|Death|3|||
13072411|NCT02601014|25274152|FG001|Overall Study|Death|1|||
13072412|NCT02601014|25274151|FG000|Overall Study|Disease progression|4|||
13072413|NCT02601014|25274152|FG001|Overall Study|Disease progression|8|||
13129925|NCT02853032|25972282|FG000|Overall Study|Adverse Event|4|||
13129926|NCT02853032|25972283|FG001|Overall Study|Adverse Event|0|||
13129927|NCT02853032|25972282|FG000|Overall Study|Withdrawal by Subject|3|||
13129928|NCT02853032|25972283|FG001|Overall Study|Withdrawal by Subject|1|||
13129929|NCT02853032|25972282|FG000|Overall Study|Requested to withdraw from all treatment|2|||
13129930|NCT02853032|25972283|FG001|Overall Study|Requested to withdraw from all treatment|2|||
13129931|NCT02852967|25972354|FG000|Overall Study|Adverse Event|3|||
13129932|NCT02852967|25972355|FG001|Overall Study|Adverse Event|1|||
13129933|NCT02852967|25972356|FG002|Overall Study|Adverse Event|0|||
13129934|NCT02852967|25972357|FG003|Overall Study|Adverse Event|1|||
13129935|NCT02852967|25972358|FG004|Overall Study|Adverse Event|0|||
13129936|NCT02852967|25972354|FG000|Overall Study|Death|1|||
13129937|NCT02852967|25972355|FG001|Overall Study|Death|0|||
13129938|NCT02852967|25972356|FG002|Overall Study|Death|0|||
13129939|NCT02852967|25972357|FG003|Overall Study|Death|0|||
13129940|NCT02852967|25972358|FG004|Overall Study|Death|0|||
13129941|NCT02852967|25972354|FG000|Overall Study|Lost to Follow-up|1|||
13129942|NCT02852967|25972355|FG001|Overall Study|Lost to Follow-up|2|||
13129943|NCT02852967|25972356|FG002|Overall Study|Lost to Follow-up|3|||
13129944|NCT02852967|25972357|FG003|Overall Study|Lost to Follow-up|4|||
13129945|NCT02852967|25972358|FG004|Overall Study|Lost to Follow-up|4|||
13129946|NCT02852967|25972354|FG000|Overall Study|Withdrawal by Subject|6|||
13129947|NCT02852967|25972355|FG001|Overall Study|Withdrawal by Subject|12|||
13129948|NCT02852967|25972356|FG002|Overall Study|Withdrawal by Subject|7|||
13129949|NCT02852967|25972357|FG003|Overall Study|Withdrawal by Subject|10|||
13129950|NCT02852967|25972358|FG004|Overall Study|Withdrawal by Subject|10|||
13129951|NCT02852967|25972354|FG000|Overall Study|SAE|0|||
13129952|NCT02852967|25972355|FG001|Overall Study|SAE|0|||
13129953|NCT02852967|25972356|FG002|Overall Study|SAE|0|||
13129954|NCT02852967|25972357|FG003|Overall Study|SAE|3|||
13129955|NCT02852967|25972358|FG004|Overall Study|SAE|0|||
13129956|NCT02852967|25972354|FG000|Overall Study|Elevated Liver Enzymes|2|||
13129957|NCT02852967|25972355|FG001|Overall Study|Elevated Liver Enzymes|0|||
13129958|NCT02852967|25972356|FG002|Overall Study|Elevated Liver Enzymes|0|||
13129959|NCT02852967|25972357|FG003|Overall Study|Elevated Liver Enzymes|2|||
13129960|NCT02852967|25972358|FG004|Overall Study|Elevated Liver Enzymes|2|||
13129961|NCT02852967|25972354|FG000|Overall Study|Physician Decision|0|||
13129962|NCT02852967|25972355|FG001|Overall Study|Physician Decision|0|||
13129963|NCT02852967|25972356|FG002|Overall Study|Physician Decision|0|||
13129964|NCT02852967|25972357|FG003|Overall Study|Physician Decision|1|||
13129965|NCT02852967|25972358|FG004|Overall Study|Physician Decision|0|||
13129966|NCT02852967|25972354|FG000|Overall Study|Lack of Efficacy|0|||
13129967|NCT02852967|25972355|FG001|Overall Study|Lack of Efficacy|1|||
13129968|NCT02852967|25972356|FG002|Overall Study|Lack of Efficacy|0|||
13129969|NCT02852967|25972357|FG003|Overall Study|Lack of Efficacy|0|||
13129970|NCT02852967|25972358|FG004|Overall Study|Lack of Efficacy|0|||
13129971|NCT02852967|25972354|FG000|Overall Study|Non-compliance|0|||
13129972|NCT02852967|25972355|FG001|Overall Study|Non-compliance|0|||
13129973|NCT02852967|25972356|FG002|Overall Study|Non-compliance|1|||
13129974|NCT02852967|25972357|FG003|Overall Study|Non-compliance|1|||
13129975|NCT02852967|25972358|FG004|Overall Study|Non-compliance|0|||
13129976|NCT02852967|25972354|FG000|Overall Study|Dispensing Drug Violation|0|||
13129977|NCT02852967|25972355|FG001|Overall Study|Dispensing Drug Violation|0|||
13129978|NCT02852967|25972356|FG002|Overall Study|Dispensing Drug Violation|1|||
13129979|NCT02852967|25972357|FG003|Overall Study|Dispensing Drug Violation|0|||
13129980|NCT02852967|25972358|FG004|Overall Study|Dispensing Drug Violation|0|||
13129981|NCT02852967|25972354|FG000|Overall Study|Inclusion/Exclusion Violation|1|||
13129982|NCT02852967|25972355|FG001|Overall Study|Inclusion/Exclusion Violation|0|||
13129983|NCT02852967|25972356|FG002|Overall Study|Inclusion/Exclusion Violation|0|||
13129984|NCT02852967|25972357|FG003|Overall Study|Inclusion/Exclusion Violation|0|||
13072414|NCT02224573|25274322|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0|||
13072415|NCT02224573|25274323|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1|||
13072416|NCT02224573|25274322|FG000|Treatment Phase|Started on Other IMP|1|||
13072417|NCT02224573|25274323|FG001|Treatment Phase|Started on Other IMP|0|||
13072418|NCT02224573|25274322|FG000|Treatment Phase|Participant Discontinued IMP|0|||
13072419|NCT02224573|25274323|FG001|Treatment Phase|Participant Discontinued IMP|1|||
13072420|NCT02224573|25274322|FG000|Treatment Phase|Lack of Efficacy|15|||
13072421|NCT02224573|25274323|FG001|Treatment Phase|Lack of Efficacy|8|||
13072422|NCT02224573|25274322|FG000|Treatment Phase|Began Commercial Product|1|||
13072423|NCT02224573|25274323|FG001|Treatment Phase|Began Commercial Product|0|||
13072424|NCT02224573|25274322|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
13072425|NCT02224573|25274323|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
13072426|NCT02224573|25274322|FG000|Treatment Phase|Met Withdrawal Criteria|5|||
13072427|NCT02224573|25274323|FG001|Treatment Phase|Met Withdrawal Criteria|7|||
13072428|NCT02224573|25274322|FG000|Treatment Phase|Participant Did Not Return for Visits|0|||
13072429|NCT02224573|25274323|FG001|Treatment Phase|Participant Did Not Return for Visits|1|||
13072430|NCT02224573|25274322|FG000|Treatment Phase|Continued Compassionate Use|1|||
13072431|NCT02224573|25274323|FG001|Treatment Phase|Continued Compassionate Use|0|||
13072432|NCT02224573|25274322|FG000|Treatment Phase|Lack of Efficiency|2|||
13072433|NCT02224573|25274323|FG001|Treatment Phase|Lack of Efficiency|1|||
13072434|NCT02224573|25274322|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0|||
13072435|NCT02224573|25274323|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1|||
13072436|NCT02224573|25274322|FG000|Treatment Phase|Participant Moved|2|||
13072437|NCT02224573|25274323|FG001|Treatment Phase|Participant Moved|0|||
13072438|NCT02224573|25274322|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62|||
13072439|NCT02224573|25274323|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48|||
13072440|NCT02224573|25274322|FG000|Treatment Phase|Refused Medication|1|||
13072441|NCT02224573|25274323|FG001|Treatment Phase|Refused Medication|1|||
13072442|NCT02224573|25274322|FG000|Treatment Phase|Adverse Event|26|||
13072443|NCT02224573|25274323|FG001|Treatment Phase|Adverse Event|38|||
13072444|NCT02224573|25274322|FG000|Treatment Phase|Placed in Group Home|0|||
13072445|NCT02224573|25274323|FG001|Treatment Phase|Placed in Group Home|1|||
13072446|NCT02224573|25274322|FG000|Treatment Phase|Pursued Other Trials|1|||
13072447|NCT02224573|25274323|FG001|Treatment Phase|Pursued Other Trials|0|||
13072448|NCT02224573|25274322|FG000|Treatment Phase|Withdrawn by the Investigator|23|||
13072449|NCT02224573|25274323|FG001|Treatment Phase|Withdrawn by the Investigator|11|||
13072450|NCT02224573|25274322|FG000|Treatment Phase|Lost to Follow-up|2|||
13072451|NCT02224573|25274323|FG001|Treatment Phase|Lost to Follow-up|1|||
13072452|NCT02224573|25274322|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1|||
13072453|NCT02224573|25274323|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0|||
13072454|NCT02224573|25274322|FG000|Taper Phase|Hospitalization/Dose Reduction|1|||
13072455|NCT02224573|25274323|FG001|Taper Phase|Hospitalization/Dose Reduction|0|||
13072456|NCT02224573|25274322|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0|||
13072457|NCT02224573|25274323|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3|||
13072458|NCT02224573|25274322|FG000|Taper Phase|Adverse Event|1|||
13072459|NCT02224573|25274323|FG001|Taper Phase|Adverse Event|1|||
13072460|NCT01991067|25274352|FG000|Overall Study|Lost to Follow-up|6|||
13072461|NCT01991067|25274353|FG001|Overall Study|Lost to Follow-up|5|||
13072462|NCT01774721|25274430|FG000|Overall Study|Death|76|||
13072463|NCT01774721|25274431|FG001|Overall Study|Death|91|||
13072464|NCT01774721|25274430|FG000|Overall Study|Withdrawal by Subject|14|||
13072465|NCT01774721|25274431|FG001|Overall Study|Withdrawal by Subject|10|||
13072466|NCT01774721|25274430|FG000|Overall Study|Lost to Follow-up|1|||
13072467|NCT01774721|25274431|FG001|Overall Study|Lost to Follow-up|1|||
13072468|NCT01774721|25274430|FG000|Overall Study|Did not meet eligibility criteria|0|||
13072469|NCT01774721|25274431|FG001|Overall Study|Did not meet eligibility criteria|3|||
13072470|NCT01774721|25274430|FG000|Overall Study|Ongoing in study|136|||
13072471|NCT01774721|25274431|FG001|Overall Study|Ongoing in study|120|||
13072472|NCT01709331|25274439|FG000|Overall Study|Adverse Event|1|||
13072473|NCT05176717|25274457|FG000|Overall Study|Sponsor Decision|1|||
13072474|NCT05176717|25274458|FG001|Overall Study|Sponsor Decision|2|||
13072475|NCT05176717|25274459|FG002|Overall Study|Sponsor Decision|2|||
13072476|NCT05083559|25274490|FG000|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|4|||
13072477|NCT05083559|25274491|FG001|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|1|||
13072478|NCT05083559|25274490|FG000|Second at Home Period (3-30 Days)|Withdrawal by Subject|2|||
13072479|NCT05083559|25274491|FG001|Second at Home Period (3-30 Days)|Withdrawal by Subject|0|||
13072480|NCT05083559|25274490|FG000|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|1|||
13072481|NCT05083559|25274491|FG001|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|0|||
13072482|NCT04552587|25274530|FG000|Overall Study|Lost to Follow-up|4|||
13072483|NCT04349098|25274567|FG000|Overall Study|Death|16|||
13072484|NCT04349098|25274568|FG001|Overall Study|Death|8|||
13072485|NCT04349098|25274567|FG000|Overall Study|Lost to Follow-up|11|||
13072486|NCT04349098|25274568|FG001|Overall Study|Lost to Follow-up|8|||
13072487|NCT04349098|25274567|FG000|Overall Study|Withdrawal by Subject|8|||
13072488|NCT04349098|25274568|FG001|Overall Study|Withdrawal by Subject|5|||
13072489|NCT04349098|25274567|FG000|Overall Study|Other|3|||
13072490|NCT04349098|25274568|FG001|Overall Study|Other|5|||
13072491|NCT04333498|25274585|FG000|Overall Study|Lost to Follow-up|1|||
13072492|NCT04333498|25274586|FG001|Overall Study|Lost to Follow-up|0|||
13072493|NCT04333498|25274585|FG000|Overall Study|Lost to Follow-up|0|||
13072494|NCT04333498|25274586|FG001|Overall Study|Lost to Follow-up|1|||
13129985|NCT02852967|25972358|FG004|Overall Study|Inclusion/Exclusion Violation|0|||
13129986|NCT02852434|25972379|FG000|Overall Study|Withdrawal by Subject|0|||
13129987|NCT02852434|25972380|FG001|Overall Study|Withdrawal by Subject|1|||
13129988|NCT02852434|25972379|FG000|Overall Study|Unsuccessful Dilator Procedure|2|||
13129989|NCT02852434|25972380|FG001|Overall Study|Unsuccessful Dilator Procedure|0|||
13129990|NCT02852265|25972403|FG000|3-month Follow-up|Lost to Follow-up|1|||
13129991|NCT02852265|25972404|FG001|3-month Follow-up|Lost to Follow-up|1|||
13129992|NCT02852005|25972565|FG000|Overall Study|Lost to Follow-up|0|||
13129993|NCT02852005|25972566|FG001|Overall Study|Lost to Follow-up|0|||
13129994|NCT02852005|25972567|FG002|Overall Study|Lost to Follow-up|0|||
13129995|NCT02852005|25972568|FG003|Overall Study|Lost to Follow-up|0|||
13129996|NCT02852005|25972569|FG004|Overall Study|Lost to Follow-up|1|||
13129997|NCT02852005|25972565|FG000|Overall Study|Withdrawal by Subject|1|||
13129998|NCT02852005|25972566|FG001|Overall Study|Withdrawal by Subject|0|||
13129999|NCT02852005|25972567|FG002|Overall Study|Withdrawal by Subject|0|||
13130000|NCT02852005|25972568|FG003|Overall Study|Withdrawal by Subject|0|||
13130001|NCT02852005|25972569|FG004|Overall Study|Withdrawal by Subject|0|||
13133583|NCT02767765|25988465|FG000|Overall Study|Adverse Event|4|||
13133584|NCT02767765|25988465|FG000|Overall Study|Death|1|||
13133585|NCT02767765|25988465|FG000|Overall Study|Insufficient response|1|||
13222265|NCT01807520|26285850|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5|||
13222266|NCT01807520|26285851|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6|||
13222267|NCT01807520|26285852|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
13222268|NCT01807520|26285853|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
13222269|NCT01807520|26285854|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
13136331|NCT02724878|25998453|FG000|Overall Study|Withdrawal by Subject|4|||
13136332|NCT02724878|25998453|FG000|Overall Study|Lost to Follow-up|2|||
13136333|NCT02724878|25998453|FG000|Overall Study|Protocol Violation|1|||
13136334|NCT02724878|25998453|FG000|Overall Study|Ineligible for Study Drug|5|||
13222270|NCT01807520|26285855|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
13222271|NCT01807520|26285856|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
13222272|NCT01807520|26285850|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
13222273|NCT01807520|26285851|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
13222274|NCT01807520|26285852|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
13222275|NCT01807520|26285853|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
13222276|NCT01807520|26285854|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
13222277|NCT01807520|26285855|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1|||
13222278|NCT01807520|26285856|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
13222279|NCT01807520|26285850|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0|||
13222280|NCT01807520|26285851|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0|||
13222281|NCT01807520|26285852|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0|||
13222282|NCT01807520|26285853|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0|||
13222283|NCT01807520|26285854|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0|||
13222284|NCT01807520|26285855|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1|||
13222285|NCT01807520|26285856|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0|||
13222286|NCT01807520|26285850|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
13222287|NCT01807520|26285851|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
13222288|NCT01807520|26285852|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
13222289|NCT01807520|26285853|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
13222290|NCT01807520|26285854|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
13222291|NCT01807520|26285855|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2|||
13222292|NCT01807520|26285856|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1|||
13222293|NCT01807299|26285879|FG000|Overall Study|Protocol Violation|3|||
13222294|NCT01807299|26285880|FG001|Overall Study|Protocol Violation|1|||
13222295|NCT01807299|26285881|FG002|Overall Study|Protocol Violation|0|||
13222296|NCT01807299|26285882|FG003|Overall Study|Protocol Violation|2|||
13222297|NCT01807234|26285936|FG000|Overall Study|Lost to Follow-up|2|||
13133586|NCT02767765|25988465|FG000|Overall Study|Lost to Follow-up|2|||
13133587|NCT02767765|25988465|FG000|Overall Study|Investigator decision|1|||
13133588|NCT02767765|25988465|FG000|Overall Study|Non-Compliance|1|||
13133589|NCT02767765|25988465|FG000|Overall Study|Withdrawal by Subject|1|||
13133590|NCT02767570|25988488|FG000|Overall Study|Lost to Follow-up|3|||
13133591|NCT02767570|25988489|FG001|Overall Study|Lost to Follow-up|0|||
13133592|NCT02767570|25988488|FG000|Overall Study|COVID shutdown|2|||
13133593|NCT02767570|25988489|FG001|Overall Study|COVID shutdown|5|||
13222298|NCT01807234|26285937|FG001|Overall Study|Lost to Follow-up|5|||
13222299|NCT01807234|26285938|FG002|Overall Study|Lost to Follow-up|1|||
13222300|NCT01807234|26285939|FG003|Overall Study|Lost to Follow-up|1|||
13222301|NCT01807234|26285940|FG004|Overall Study|Lost to Follow-up|1|||
13222302|NCT01807234|26285941|FG005|Overall Study|Lost to Follow-up|2|||
13222303|NCT01807234|26285936|FG000|Overall Study|Withdrawal by Subject|3|||
13222304|NCT01807234|26285937|FG001|Overall Study|Withdrawal by Subject|1|||
13222305|NCT01807234|26285938|FG002|Overall Study|Withdrawal by Subject|1|||
13222306|NCT01807234|26285939|FG003|Overall Study|Withdrawal by Subject|1|||
13222307|NCT01807234|26285940|FG004|Overall Study|Withdrawal by Subject|2|||
13222308|NCT01807234|26285941|FG005|Overall Study|Withdrawal by Subject|1|||
13222309|NCT01807234|26285936|FG000|Overall Study|Lack of Efficacy|0|||
13222310|NCT01807234|26285937|FG001|Overall Study|Lack of Efficacy|0|||
13222311|NCT01807234|26285938|FG002|Overall Study|Lack of Efficacy|0|||
13222312|NCT01807234|26285939|FG003|Overall Study|Lack of Efficacy|0|||
13222313|NCT01807234|26285940|FG004|Overall Study|Lack of Efficacy|1|||
13072495|NCT03829657|25274615|FG000|OL Treatment Period (Week 1 to Week 16)|Adverse Event|12|||
13072496|NCT03829657|25274616|FG001|OL Treatment Period (Week 1 to Week 16)|Adverse Event|4|||
13072497|NCT03829657|25274617|FG002|OL Treatment Period (Week 1 to Week 16)|Adverse Event|2|||
13072498|NCT03829657|25274618|FG003|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
13072499|NCT03829657|25274619|FG004|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
13072500|NCT03829657|25274615|FG000|OL Treatment Period (Week 1 to Week 16)|Physician Decision|1|||
13072501|NCT03829657|25274616|FG001|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
13072502|NCT03829657|25274617|FG002|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
13072503|NCT03829657|25274618|FG003|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
13072504|NCT03829657|25274619|FG004|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
13072505|NCT03829657|25274615|FG000|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|1|||
13072506|NCT03829657|25274616|FG001|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|3|||
13072507|NCT03829657|25274617|FG002|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|9|||
13072508|NCT03829657|25274618|FG003|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
13072509|NCT03829657|25274619|FG004|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
13072510|NCT03829657|25274615|FG000|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|6|||
13072511|NCT03829657|25274616|FG001|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|7|||
13072512|NCT03829657|25274617|FG002|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|5|||
13072513|NCT03829657|25274618|FG003|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
13072514|NCT03829657|25274619|FG004|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
13072515|NCT03829657|25274615|FG000|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|10|||
13072516|NCT03829657|25274616|FG001|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|6|||
13072517|NCT03829657|25274617|FG002|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|4|||
13072518|NCT03829657|25274618|FG003|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
13072519|NCT03829657|25274619|FG004|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
13072520|NCT03829657|25274615|FG000|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|3|||
13072521|NCT03829657|25274616|FG001|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
13072522|NCT03829657|25274617|FG002|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
13072523|NCT03829657|25274618|FG003|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
13072524|NCT03829657|25274619|FG004|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
13072525|NCT03829657|25274615|FG000|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
13072526|NCT03829657|25274616|FG001|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
13072527|NCT03829657|25274617|FG002|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
13072528|NCT03829657|25274618|FG003|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
13072529|NCT03829657|25274619|FG004|RW Treatment Period (Week 16 to Week 24)|Adverse Event|1|||
13072530|NCT03829657|25274615|FG000|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
13072531|NCT03829657|25274616|FG001|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
13072532|NCT03829657|25274617|FG002|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
13072533|NCT03829657|25274618|FG003|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|2|||
13072534|NCT03829657|25274619|FG004|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|3|||
13072535|NCT03829657|25274615|FG000|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
13072536|NCT03829657|25274616|FG001|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
13072537|NCT03829657|25274617|FG002|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
13072538|NCT03829657|25274618|FG003|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
13072539|NCT03829657|25274619|FG004|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
13130002|NCT02851615|25972585|FG000|Overall Study|Cognitive Issue|1|||
13222314|NCT01807234|26285941|FG005|Overall Study|Lack of Efficacy|1|||
13222315|NCT01807221|26286040|FG000|Overall Study|Progressive disease|1|||
13222316|NCT01807221|26286041|FG001|Overall Study|Progressive disease|0|||
13222317|NCT01807221|26286042|FG002|Overall Study|Progressive disease|1|||
13072540|NCT03829657|25274615|FG000|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
13072541|NCT03829657|25274616|FG001|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
13072542|NCT03829657|25274617|FG002|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
13072543|NCT03829657|25274618|FG003|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
13072544|NCT03829657|25274619|FG004|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|1|||
13130003|NCT02851615|25972586|FG001|Overall Study|Cognitive Issue|0|||
13130004|NCT02851615|25972585|FG000|Overall Study|Lost to Follow-up|0|||
13130005|NCT02851615|25972586|FG001|Overall Study|Lost to Follow-up|4|||
13130006|NCT02851407|25972671|FG000|Overall Study|Withdrawal by parent/guardian|2|||
13130007|NCT02851407|25972672|FG001|Overall Study|Withdrawal by parent/guardian|7|||
13130008|NCT02851407|25972671|FG000|Overall Study|Protocol deviation|0|||
13130009|NCT02851407|25972672|FG001|Overall Study|Protocol deviation|1|||
13130010|NCT02851407|25972671|FG000|Overall Study|Transferred to another hospital to continue|1|||
13130011|NCT02851407|25972672|FG001|Overall Study|Transferred to another hospital to continue|0|||
13130012|NCT02851407|25972671|FG000|Overall Study|Other Death|30|||
13130013|NCT02851407|25972672|FG001|Overall Study|Other Death|20|||
13130014|NCT02851407|25972671|FG000|Overall Study|Adverse event, serious fatal|6|||
13130015|NCT02851407|25972672|FG001|Overall Study|Adverse event, serious fatal|8|||
13130016|NCT02851407|25972671|FG000|Overall Study|Consent withdrawn by participant|5|||
13130017|NCT02851407|25972672|FG001|Overall Study|Consent withdrawn by participant|3|||
13130018|NCT02851407|25972671|FG000|Overall Study|Screen failure|2|||
13130019|NCT02851407|25972672|FG001|Overall Study|Screen failure|1|||
13130020|NCT02851407|25972671|FG000|Overall Study|Disease relapse|9|||
13130021|NCT02851407|25972672|FG001|Overall Study|Disease relapse|6|||
13130022|NCT02851407|25972671|FG000|Overall Study|Physician Decision|7|||
13130023|NCT02851407|25972672|FG001|Overall Study|Physician Decision|6|||
13130024|NCT02851407|25972671|FG000|Overall Study|Transferred to hospital closer to home|0|||
13130025|NCT02851407|25972672|FG001|Overall Study|Transferred to hospital closer to home|1|||
13130026|NCT02851407|25972671|FG000|Overall Study|Enrolled in an investigational study|0|||
13130027|NCT02851407|25972672|FG001|Overall Study|Enrolled in an investigational study|1|||
13130028|NCT02851407|25972671|FG000|Overall Study|Early recovery|1|||
13130029|NCT02851407|25972672|FG001|Overall Study|Early recovery|0|||
13130030|NCT02851407|25972671|FG000|Overall Study|Adverse event, non-fatal|7|||
13130031|NCT02851407|25972672|FG001|Overall Study|Adverse event, non-fatal|5|||
13130032|NCT02851407|25972671|FG000|Overall Study|Lost to Follow-up|0|||
13130033|NCT02851407|25972672|FG001|Overall Study|Lost to Follow-up|2|||
13130034|NCT02851069|25972696|FG000|Overall Study|Failure to Return|3|||
13130035|NCT02851069|25972696|FG000|Overall Study|Other|3|||
13130036|NCT02850978|25972703|FG000|Overall Study|Uncollectable CRF|27|||
13130037|NCT02850978|25972703|FG000|Overall Study|No visit since the first visit|35|||
13130038|NCT02850978|25972703|FG000|Overall Study|Adverse Event|81|||
13130039|NCT02850978|25972703|FG000|Overall Study|Lack of Efficacy|40|||
13130040|NCT02850978|25972703|FG000|Overall Study|Improvement in condition|34|||
13130041|NCT02850978|25972703|FG000|Overall Study|Lost to Follow-up|121|||
13130042|NCT02850978|25972703|FG000|Overall Study|Reason not listed|88|||
13130043|NCT02850965|25972726|FG000|Overall Study|Other than listed|3|||
13130044|NCT02850965|25972727|FG001|Overall Study|Other than listed|4|||
13130045|NCT02850965|25972726|FG000|Overall Study|Protocol Violation|0|||
13130046|NCT02850965|25972727|FG001|Overall Study|Protocol Violation|2|||
13130047|NCT02850965|25972726|FG000|Overall Study|Lost to Follow-up|5|||
13130048|NCT02850965|25972727|FG001|Overall Study|Lost to Follow-up|3|||
13130049|NCT02850965|25972726|FG000|Overall Study|Lack of Efficacy|4|||
13130050|NCT02850965|25972727|FG001|Overall Study|Lack of Efficacy|8|||
13130051|NCT02850965|25972726|FG000|Overall Study|Adverse Event|3|||
13130052|NCT02850965|25972727|FG001|Overall Study|Adverse Event|2|||
13130053|NCT02850965|25972726|FG000|Overall Study|Withdrawal by Subject|3|||
13130054|NCT02850965|25972727|FG001|Overall Study|Withdrawal by Subject|4|||
13130055|NCT02850965|25972726|FG000|Overall Study|Physician Decision|0|||
13130056|NCT02850965|25972727|FG001|Overall Study|Physician Decision|1|||
13130057|NCT02850965|25972726|FG000|Overall Study|Randomized but not treated|0|||
13130058|NCT02850965|25972727|FG001|Overall Study|Randomized but not treated|1|||
13130059|NCT02850276|25972740|FG000|Overall Study|screen failure|43|||
13130060|NCT02850276|25972740|FG000|Overall Study|Withdrawal by Subject|14|||
13130061|NCT02850276|25972740|FG000|Overall Study|Physician Decision|2|||
13130062|NCT02850276|25972740|FG000|Overall Study|Lost to Follow-up|2|||
13130063|NCT02850016|25972761|FG000|Overall Study|Withdrawal by Subject|1|||
13130064|NCT02850016|25972762|FG001|Overall Study|Withdrawal by Subject|2|||
13130065|NCT02849743|25972804|FG000|First Intervention (8 Weeks)|Stopping Criteria Met|0|||
13130066|NCT02849743|25972805|FG001|First Intervention (8 Weeks)|Stopping Criteria Met|1|||
13130067|NCT02849743|25972804|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
13130068|NCT02849743|25972805|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
13130069|NCT02849704|25972825|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1|||
13130070|NCT02849704|25972826|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0|||
13130071|NCT02849704|25972825|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1|||
13130072|NCT02849704|25972826|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0|||
13072545|NCT03589768|25274674|FG000|Overall Study|Death|1|||
13072546|NCT03589768|25274675|FG001|Overall Study|Death|0|||
13072547|NCT03589768|25274676|FG002|Overall Study|Death|8|||
13072548|NCT03589768|25274677|FG003|Overall Study|Death|3|||
13072549|NCT03589768|25274674|FG000|Overall Study|Withdrawal by Subject|2|||
13072550|NCT03589768|25274675|FG001|Overall Study|Withdrawal by Subject|0|||
13072551|NCT03589768|25274676|FG002|Overall Study|Withdrawal by Subject|0|||
13072552|NCT03589768|25274677|FG003|Overall Study|Withdrawal by Subject|0|||
13072553|NCT03589768|25274674|FG000|Overall Study|Protocol Violation|1|||
13072554|NCT03589768|25274675|FG001|Overall Study|Protocol Violation|0|||
13072555|NCT03589768|25274676|FG002|Overall Study|Protocol Violation|0|||
13072556|NCT03589768|25274677|FG003|Overall Study|Protocol Violation|0|||
13072557|NCT03520036|25274719|FG000|Overall Study|Adverse Event|1|||
13072558|NCT03520036|25274720|FG001|Overall Study|Adverse Event|2|||
13072559|NCT03520036|25274721|FG002|Overall Study|Adverse Event|0|||
13072560|NCT03520036|25274719|FG000|Overall Study|Protocol Violation|1|||
13072561|NCT03520036|25274720|FG001|Overall Study|Protocol Violation|0|||
13072562|NCT03520036|25274721|FG002|Overall Study|Protocol Violation|0|||
13072563|NCT03520036|25274719|FG000|Overall Study|Withdrawal by Subject|0|||
13072564|NCT03520036|25274720|FG001|Overall Study|Withdrawal by Subject|1|||
13072565|NCT03520036|25274721|FG002|Overall Study|Withdrawal by Subject|4|||
13072566|NCT03520036|25274719|FG000|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
13072567|NCT03520036|25274720|FG001|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|1|||
13072568|NCT03520036|25274721|FG002|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
13072569|NCT03442088|25274731|FG000|Overall Study|Adverse Event|1|||
13072570|NCT03442088|25274731|FG000|Overall Study|Lack of Efficacy|2|||
13072571|NCT03442088|25274731|FG000|Overall Study|Lost to Follow-up|2|||
13072572|NCT03396471|25274744|FG000|Study Treatment - Up to 22 Months|Disease Progression|6|||
13072573|NCT03396471|25274744|FG000|Study Treatment - Up to 22 Months|Alternative Cancer Therapy|2|||
13072574|NCT03396471|25274744|FG000|Study Treatment - Up to 22 Months|AE / Side Effects / Complications|3|||
13072575|NCT03396471|25274744|FG000|Study Treatment - Up to 22 Months|Death|2|||
13072576|NCT03396471|25274744|FG000|Study Treatment - Up to 22 Months|Symptomatic Deterioration|1|||
13072577|NCT03396471|25274744|FG000|Follow up - Up to 2 Years|Death|9|||
13072578|NCT03396471|25274744|FG000|Follow up - Up to 2 Years|Patient lost to follow up|1|||
13072579|NCT03396471|25274744|FG000|Follow up - Up to 2 Years|Patient Refused to follow up|1|||
13072580|NCT03396471|25274744|FG000|Follow up - Up to 2 Years|study terminated|1|||
13072581|NCT03396471|25274744|FG000|Follow up - Up to 2 Years|Patient would like to seek treatments locally.|1|||
13072582|NCT03396471|25274744|FG000|Follow up - Up to 2 Years|Patient stopped protocol treatment due to lack of response to treatment regimen.|1|||
13072583|NCT03377699|25274805|FG000|Overall Study|Withdrawal by Subject|2|||
13072584|NCT03377699|25274806|FG001|Overall Study|Withdrawal by Subject|9|||
13072585|NCT03377699|25274805|FG000|Overall Study|Lost to Follow-up|1|||
13072586|NCT03377699|25274806|FG001|Overall Study|Lost to Follow-up|1|||
13072587|NCT03377699|25274805|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1|||
13072588|NCT03377699|25274806|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0|||
13072589|NCT03377699|25274805|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
13072590|NCT03377699|25274806|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
13072591|NCT03377699|25274805|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11|||
13072592|NCT03377699|25274806|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8|||
13072593|NCT03377699|25274805|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
13072594|NCT03377699|25274806|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
13072595|NCT03361189|25274825|FG000|Overall Study|Received heart transplant|1|||
13072596|NCT03361189|25274826|FG001|Overall Study|Received heart transplant|0|||
13072597|NCT03361189|25274825|FG000|Overall Study|Pacemake replacement|0|||
13072598|NCT03361189|25274826|FG001|Overall Study|Pacemake replacement|1|||
13072599|NCT03358030|25274873|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|2|||
13072600|NCT03358030|25274874|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
13072601|NCT03358030|25274875|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
13072602|NCT03358030|25274876|FG003|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
13072603|NCT03358030|25274873|FG000|Overall Study|Ineligibility|0|||
13072604|NCT03358030|25274874|FG001|Overall Study|Ineligibility|0|||
13072605|NCT03358030|25274875|FG002|Overall Study|Ineligibility|0|||
13072606|NCT03358030|25274876|FG003|Overall Study|Ineligibility|2|||
13072607|NCT03358030|25274873|FG000|Overall Study|Voluntary Withdrawal|1|||
13072608|NCT03358030|25274874|FG001|Overall Study|Voluntary Withdrawal|1|||
13072609|NCT03358030|25274875|FG002|Overall Study|Voluntary Withdrawal|3|||
13072610|NCT03358030|25274876|FG003|Overall Study|Voluntary Withdrawal|1|||
13072611|NCT03358030|25274873|FG000|Overall Study|Other|0|||
13072612|NCT03358030|25274874|FG001|Overall Study|Other|0|||
13072613|NCT03358030|25274875|FG002|Overall Study|Other|1|||
13072614|NCT03358030|25274876|FG003|Overall Study|Other|0|||
13072615|NCT02968004|25274970|FG000|Overall Study|Adverse Event|1|||
13072616|NCT02968004|25274971|FG001|Overall Study|Adverse Event|0|||
13072617|NCT02968004|25274970|FG000|Overall Study|Withdrawal by Subject|0|||
13072618|NCT02968004|25274971|FG001|Overall Study|Withdrawal by Subject|1|||
13072619|NCT02869633|25274983|FG000|Overall Study|Death|2|||
13072620|NCT02869633|25274984|FG001|Overall Study|Death|1|||
13072621|NCT02869633|25274983|FG000|Overall Study|Patient refused follow-up|1|||
13072622|NCT02869633|25274984|FG001|Overall Study|Patient refused follow-up|0|||
13072623|NCT02869633|25274983|FG000|Overall Study|Provider discretion|1|||
13072624|NCT02869633|25274984|FG001|Overall Study|Provider discretion|0|||
13072625|NCT02869633|25274983|FG000|Overall Study|Investigator decision|1|||
13072626|NCT02869633|25274984|FG001|Overall Study|Investigator decision|0|||
13072627|NCT02869633|25274983|FG000|Overall Study|Lost to Follow-up|0|||
13072628|NCT02869633|25274984|FG001|Overall Study|Lost to Follow-up|1|||
13072629|NCT02869633|25274983|FG000|Overall Study|Not eligible|6|||
13072630|NCT02869633|25274984|FG001|Overall Study|Not eligible|1|||
13072631|NCT02869633|25274983|FG000|Overall Study|Protocol-defined follow-up period completed|2|||
13072632|NCT02869633|25274984|FG001|Overall Study|Protocol-defined follow-up period completed|1|||
13072633|NCT02869633|25274983|FG000|Overall Study|Withdrawal by Subject|0|||
13072634|NCT02869633|25274984|FG001|Overall Study|Withdrawal by Subject|1|||
13072635|NCT02807883|25274992|FG000|Overall Study|Withdrawal by Subject|2|||
13072636|NCT02768662|25274998|FG000|Overall Study|Adverse Event|1|||
13072637|NCT02768662|25274998|FG000|Overall Study|Lost to Follow-up|4|||
13072638|NCT02768662|25274998|FG000|Overall Study|Withdrawal by Subject|3|||
13072639|NCT02768662|25274998|FG000|Overall Study|Study terminated by Sponsor|78|||
13130073|NCT02849704|25972825|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1|||
13130074|NCT02849704|25972826|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0|||
13130075|NCT02849678|25972851|FG000|Overall Study|Protocol Violation|3|||
13130076|NCT02849678|25972852|FG001|Overall Study|Protocol Violation|6|||
13130077|NCT02849509|25972889|FG000|Overall Study|Worsening of disease under study|1|||
13130078|NCT02849509|25972890|FG001|Overall Study|Worsening of disease under study|1|||
13130079|NCT02849509|25972891|FG002|Overall Study|Worsening of disease under study|1|||
13130080|NCT02849509|25972889|FG000|Overall Study|Worsening of other pre-existing disease|0|||
13130081|NCT02849509|25972890|FG001|Overall Study|Worsening of other pre-existing disease|1|||
13130082|NCT02849509|25972891|FG002|Overall Study|Worsening of other pre-existing disease|2|||
13130083|NCT02849509|25972889|FG000|Overall Study|Other adverse event|36|||
13130084|NCT02849509|25972890|FG001|Overall Study|Other adverse event|41|||
13130085|NCT02849509|25972891|FG002|Overall Study|Other adverse event|8|||
13130086|NCT02849509|25972889|FG000|Overall Study|Withdrawal by Subject|6|||
13130087|NCT02849509|25972890|FG001|Overall Study|Withdrawal by Subject|17|||
13130088|NCT02849509|25972891|FG002|Overall Study|Withdrawal by Subject|12|||
13130089|NCT02849509|25972889|FG000|Overall Study|Lost to Follow-up|27|||
13130090|NCT02849509|25972890|FG001|Overall Study|Lost to Follow-up|67|||
13130091|NCT02849509|25972891|FG002|Overall Study|Lost to Follow-up|36|||
13130092|NCT02849509|25972889|FG000|Overall Study|Other, reason not specified|14|||
13130093|NCT02849509|25972890|FG001|Overall Study|Other, reason not specified|29|||
13130094|NCT02849509|25972891|FG002|Overall Study|Other, reason not specified|25|||
13130095|NCT02849509|25972889|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6|||
13130096|NCT02849509|25972890|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10|||
13130097|NCT02849509|25972891|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1|||
13130098|NCT02849080|25973025|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7|||
13130099|NCT02849080|25973026|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4|||
13130100|NCT02849080|25973027|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
13130101|NCT02849080|25973028|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
13130102|NCT02849080|25973025|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5|||
13130103|NCT02849080|25973026|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1|||
13130104|NCT02849080|25973027|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
13130105|NCT02849080|25973028|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
13130106|NCT02849080|25973025|FG000|Main Phase: 0 - 52 Weeks|Death|0|||
13130107|NCT02849080|25973026|FG001|Main Phase: 0 - 52 Weeks|Death|2|||
13130108|NCT02849080|25973027|FG002|Main Phase: 0 - 52 Weeks|Death|0|||
13130109|NCT02849080|25973028|FG003|Main Phase: 0 - 52 Weeks|Death|0|||
13130110|NCT02849080|25973025|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2|||
13130111|NCT02849080|25973026|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
13130112|NCT02849080|25973027|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
13130113|NCT02849080|25973028|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
13130114|NCT02849080|25973025|FG000|Extension Phase: 53 - 104 Weeks|Other|0|||
13130115|NCT02849080|25973026|FG001|Extension Phase: 53 - 104 Weeks|Other|0|||
13130116|NCT02849080|25973027|FG002|Extension Phase: 53 - 104 Weeks|Other|1|||
13130117|NCT02849080|25973028|FG003|Extension Phase: 53 - 104 Weeks|Other|0|||
13130118|NCT02849080|25973025|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1|||
13130119|NCT02849080|25973026|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
13130120|NCT02849080|25973027|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
13133594|NCT02767570|25988488|FG000|Overall Study|Increased pain|2|||
13072640|NCT02743494|25275011|FG000|Pre-treatment Period|Participant request to discontinue treatment|0|||
13072641|NCT02743494|25275012|FG001|Pre-treatment Period|Participant request to discontinue treatment|1|||
13072642|NCT02743494|25275011|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0|||
13072643|NCT02743494|25275012|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1|||
13072644|NCT02743494|25275011|FG000|Treatment Period|Completed treatment|229|||
13072645|NCT02743494|25275012|FG001|Treatment Period|Completed treatment|99|||
13072646|NCT02743494|25275011|FG000|Treatment Period|Disease recurrence|149|||
13072647|NCT02743494|25275012|FG001|Treatment Period|Disease recurrence|113|||
13072648|NCT02743494|25275011|FG000|Treatment Period|Study drug toxicity|57|||
13072649|NCT02743494|25275012|FG001|Treatment Period|Study drug toxicity|8|||
13072650|NCT02743494|25275011|FG000|Treatment Period|Death|1|||
13072651|NCT02743494|25275012|FG001|Treatment Period|Death|0|||
13072652|NCT02743494|25275011|FG000|Treatment Period|Adverse event unrelated to study drug|15|||
13072653|NCT02743494|25275012|FG001|Treatment Period|Adverse event unrelated to study drug|9|||
13072654|NCT02743494|25275011|FG000|Treatment Period|Participant request to discontinue treatment|30|||
13072655|NCT02743494|25275012|FG001|Treatment Period|Participant request to discontinue treatment|5|||
13072656|NCT02743494|25275011|FG000|Treatment Period|Participant withdrew consent|12|||
13072657|NCT02743494|25275012|FG001|Treatment Period|Participant withdrew consent|4|||
13072658|NCT02743494|25275011|FG000|Treatment Period|Lost to Follow-up|0|||
13072659|NCT02743494|25275012|FG001|Treatment Period|Lost to Follow-up|1|||
13072660|NCT02743494|25275011|FG000|Treatment Period|Poor/Non-compliance|1|||
13072661|NCT02743494|25275012|FG001|Treatment Period|Poor/Non-compliance|0|||
13072662|NCT02743494|25275011|FG000|Treatment Period|Other reasons|7|||
13072663|NCT02743494|25275012|FG001|Treatment Period|Other reasons|2|||
13072664|NCT02609828|25275131|FG000|Overall Study|Adverse Event|8|||
13072665|NCT02609828|25275132|FG001|Overall Study|Adverse Event|1|||
13072666|NCT02609828|25275133|FG002|Overall Study|Adverse Event|0|||
13072667|NCT02609828|25275134|FG003|Overall Study|Adverse Event|6|||
13072668|NCT02609828|25275131|FG000|Overall Study|Death|15|||
13072669|NCT02609828|25275132|FG001|Overall Study|Death|1|||
13072670|NCT02609828|25275133|FG002|Overall Study|Death|1|||
13072671|NCT02609828|25275134|FG003|Overall Study|Death|19|||
13072672|NCT02609828|25275131|FG000|Overall Study|Insufficient clinical response|2|||
13072673|NCT02609828|25275132|FG001|Overall Study|Insufficient clinical response|1|||
13072674|NCT02609828|25275133|FG002|Overall Study|Insufficient clinical response|0|||
13072675|NCT02609828|25275134|FG003|Overall Study|Insufficient clinical response|0|||
13072676|NCT02609828|25275131|FG000|Overall Study|Lost to Follow-up|0|||
13072677|NCT02609828|25275132|FG001|Overall Study|Lost to Follow-up|0|||
13072678|NCT02609828|25275133|FG002|Overall Study|Lost to Follow-up|0|||
13072679|NCT02609828|25275134|FG003|Overall Study|Lost to Follow-up|1|||
13072680|NCT02609828|25275131|FG000|Overall Study|Protocol Violation|2|||
13072681|NCT02609828|25275132|FG001|Overall Study|Protocol Violation|0|||
13072682|NCT02609828|25275133|FG002|Overall Study|Protocol Violation|0|||
13072683|NCT02609828|25275134|FG003|Overall Study|Protocol Violation|1|||
13072684|NCT02609828|25275131|FG000|Overall Study|Withdrawal by Subject|12|||
13072685|NCT02609828|25275132|FG001|Overall Study|Withdrawal by Subject|1|||
13072686|NCT02609828|25275133|FG002|Overall Study|Withdrawal by Subject|0|||
13072687|NCT02609828|25275134|FG003|Overall Study|Withdrawal by Subject|10|||
13072688|NCT02609828|25275131|FG000|Overall Study|Other|3|||
13072689|NCT02609828|25275132|FG001|Overall Study|Other|0|||
13072690|NCT02609828|25275133|FG002|Overall Study|Other|0|||
13072691|NCT02609828|25275134|FG003|Overall Study|Other|6|||
13072692|NCT02609828|25275131|FG000|Overall Study|Randomized but not treated|1|||
13072693|NCT02609828|25275132|FG001|Overall Study|Randomized but not treated|0|||
13072694|NCT02609828|25275133|FG002|Overall Study|Randomized but not treated|0|||
13072695|NCT02609828|25275134|FG003|Overall Study|Randomized but not treated|0|||
13072696|NCT02431364|25275237|FG000|Overall Study|Adverse Event|0|||
13072697|NCT02431364|25275238|FG001|Overall Study|Adverse Event|1|||
13072698|NCT02431364|25275239|FG002|Overall Study|Adverse Event|0|||
13072699|NCT02431364|25275240|FG003|Overall Study|Adverse Event|0|||
13072700|NCT02431364|25275241|FG004|Overall Study|Adverse Event|0|||
13072701|NCT02431364|25275237|FG000|Overall Study|Randomized but never treated|0|||
13072702|NCT02431364|25275238|FG001|Overall Study|Randomized but never treated|0|||
13072703|NCT02431364|25275239|FG002|Overall Study|Randomized but never treated|0|||
13072704|NCT02431364|25275240|FG003|Overall Study|Randomized but never treated|1|||
13072705|NCT02431364|25275241|FG004|Overall Study|Randomized but never treated|0|||
13072706|NCT02304458|25275371|FG000|Overall Study|Adverse Event|0|||
13072707|NCT02304458|25275372|FG001|Overall Study|Adverse Event|0|||
13072708|NCT02304458|25275373|FG002|Overall Study|Adverse Event|7|||
13072709|NCT02304458|25275374|FG003|Overall Study|Adverse Event|0|||
13072710|NCT02304458|25275375|FG004|Overall Study|Adverse Event|0|||
13072711|NCT02304458|25275376|FG005|Overall Study|Adverse Event|0|||
13072712|NCT02304458|25275377|FG006|Overall Study|Adverse Event|3|||
13072713|NCT02304458|25275378|FG007|Overall Study|Adverse Event|4|||
13072714|NCT02304458|25275371|FG000|Overall Study|Death|0|||
13072715|NCT02304458|25275372|FG001|Overall Study|Death|0|||
13072716|NCT02304458|25275373|FG002|Overall Study|Death|2|||
13072717|NCT02304458|25275374|FG003|Overall Study|Death|0|||
13072718|NCT02304458|25275375|FG004|Overall Study|Death|0|||
13072719|NCT02304458|25275376|FG005|Overall Study|Death|0|||
13072720|NCT02304458|25275377|FG006|Overall Study|Death|1|||
13072721|NCT02304458|25275378|FG007|Overall Study|Death|0|||
13072722|NCT02304458|25275371|FG000|Overall Study|Lack of Efficacy|4|||
13072723|NCT02304458|25275372|FG001|Overall Study|Lack of Efficacy|6|||
13072724|NCT02304458|25275373|FG002|Overall Study|Lack of Efficacy|38|||
13072725|NCT02304458|25275374|FG003|Overall Study|Lack of Efficacy|5|||
13072726|NCT02304458|25275375|FG004|Overall Study|Lack of Efficacy|6|||
13072727|NCT02304458|25275376|FG005|Overall Study|Lack of Efficacy|6|||
13072728|NCT02304458|25275377|FG006|Overall Study|Lack of Efficacy|21|||
13072729|NCT02304458|25275378|FG007|Overall Study|Lack of Efficacy|4|||
13072730|NCT02304458|25275371|FG000|Overall Study|Physician Decision|2|||
13072731|NCT02304458|25275372|FG001|Overall Study|Physician Decision|0|||
13072732|NCT02304458|25275373|FG002|Overall Study|Physician Decision|16|||
13072733|NCT02304458|25275374|FG003|Overall Study|Physician Decision|1|||
13072734|NCT02304458|25275375|FG004|Overall Study|Physician Decision|0|||
13072735|NCT02304458|25275376|FG005|Overall Study|Physician Decision|0|||
13072736|NCT02304458|25275377|FG006|Overall Study|Physician Decision|3|||
13072737|NCT02304458|25275378|FG007|Overall Study|Physician Decision|0|||
13072738|NCT02304458|25275371|FG000|Overall Study|Protocol Violation|0|||
13072739|NCT02304458|25275372|FG001|Overall Study|Protocol Violation|0|||
13072740|NCT02304458|25275373|FG002|Overall Study|Protocol Violation|1|||
13072741|NCT02304458|25275374|FG003|Overall Study|Protocol Violation|0|||
13072742|NCT02304458|25275375|FG004|Overall Study|Protocol Violation|0|||
13072743|NCT02304458|25275376|FG005|Overall Study|Protocol Violation|0|||
13072744|NCT02304458|25275377|FG006|Overall Study|Protocol Violation|0|||
13072745|NCT02304458|25275378|FG007|Overall Study|Protocol Violation|0|||
13072746|NCT02304458|25275371|FG000|Overall Study|Withdrawal by Subject|1|||
13072747|NCT02304458|25275372|FG001|Overall Study|Withdrawal by Subject|0|||
13072748|NCT02304458|25275373|FG002|Overall Study|Withdrawal by Subject|7|||
13072749|NCT02304458|25275374|FG003|Overall Study|Withdrawal by Subject|0|||
13072750|NCT02304458|25275375|FG004|Overall Study|Withdrawal by Subject|0|||
13072751|NCT02304458|25275376|FG005|Overall Study|Withdrawal by Subject|0|||
13072752|NCT02304458|25275377|FG006|Overall Study|Withdrawal by Subject|1|||
13072753|NCT02304458|25275378|FG007|Overall Study|Withdrawal by Subject|0|||
13072754|NCT01995513|25275444|FG000|Open Label Treatment Period|Other|9|||
13072755|NCT01995513|25275445|FG001|Open Label Treatment Period|Other|0|||
13072756|NCT01995513|25275446|FG002|Open Label Treatment Period|Other|0|||
13072757|NCT01995513|25275444|FG000|Open Label Treatment Period|Withdrawal by Subject|14|||
13072758|NCT01995513|25275445|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
13072759|NCT01995513|25275446|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
13072760|NCT01995513|25275444|FG000|Open Label Treatment Period|Protocol Violation|1|||
13072761|NCT01995513|25275445|FG001|Open Label Treatment Period|Protocol Violation|0|||
13072762|NCT01995513|25275446|FG002|Open Label Treatment Period|Protocol Violation|0|||
13072763|NCT01995513|25275444|FG000|Open Label Treatment Period|Disease Progression|64|||
13072764|NCT01995513|25275445|FG001|Open Label Treatment Period|Disease Progression|0|||
13072765|NCT01995513|25275446|FG002|Open Label Treatment Period|Disease Progression|0|||
13072766|NCT01995513|25275444|FG000|Open Label Treatment Period|No PSA response at week 13|43|||
13072767|NCT01995513|25275445|FG001|Open Label Treatment Period|No PSA response at week 13|0|||
13072768|NCT01995513|25275446|FG002|Open Label Treatment Period|No PSA response at week 13|0|||
13072769|NCT01995513|25275444|FG000|Open Label Treatment Period|Adverse Event|35|||
13072770|NCT01995513|25275445|FG001|Open Label Treatment Period|Adverse Event|0|||
13072771|NCT01995513|25275446|FG002|Open Label Treatment Period|Adverse Event|0|||
13072772|NCT01995513|25275444|FG000|Open Label Treatment Period|Death|8|||
13072773|NCT01995513|25275445|FG001|Open Label Treatment Period|Death|0|||
13072774|NCT01995513|25275446|FG002|Open Label Treatment Period|Death|0|||
13072775|NCT01995513|25275444|FG000|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|84|||
13072776|NCT01995513|25275445|FG001|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0|||
13072777|NCT01995513|25275446|FG002|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0|||
13072778|NCT01995513|25275444|FG000|Double Blind Treatment Period|Adverse Event|0|||
13072779|NCT01995513|25275445|FG001|Double Blind Treatment Period|Adverse Event|12|||
13072780|NCT01995513|25275446|FG002|Double Blind Treatment Period|Adverse Event|5|||
13072781|NCT01995513|25275444|FG000|Double Blind Treatment Period|Other|0|||
13072782|NCT01995513|25275445|FG001|Double Blind Treatment Period|Other|1|||
13072783|NCT01995513|25275446|FG002|Double Blind Treatment Period|Other|2|||
13072784|NCT01995513|25275444|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
13072785|NCT01995513|25275445|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
13072786|NCT01995513|25275446|FG002|Double Blind Treatment Period|Withdrawal by Subject|6|||
13072787|NCT01995513|25275444|FG000|Double Blind Treatment Period|Death|0|||
13072788|NCT01995513|25275445|FG001|Double Blind Treatment Period|Death|0|||
13072789|NCT01995513|25275446|FG002|Double Blind Treatment Period|Death|1|||
13072790|NCT01995513|25275444|FG000|Double Blind Treatment Period|Disease Progression|0|||
13072791|NCT01995513|25275445|FG001|Double Blind Treatment Period|Disease Progression|82|||
13072792|NCT01995513|25275446|FG002|Double Blind Treatment Period|Disease Progression|93|||
13072793|NCT01995513|25275444|FG000|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0|||
13072794|NCT01995513|25275445|FG001|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|27|||
13072795|NCT01995513|25275446|FG002|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|18|||
13072796|NCT01529034|25275461|FG000|Overall Study|Discontinued prior to study treatment|14|||
13072797|NCT01529034|25275461|FG000|Overall Study|Site closure|62|||
13072798|NCT01529034|25275461|FG000|Overall Study|Study termination|29|||
13072799|NCT01529034|25275461|FG000|Overall Study|Withdrawal by Subject|25|||
13072800|NCT01529034|25275461|FG000|Overall Study|No treated SCs within protocol window|13|||
13072801|NCT01529034|25275461|FG000|Overall Study|Noncompliance|8|||
13072802|NCT01529034|25275461|FG000|Overall Study|Caregiver no longer available|7|||
13072803|NCT01529034|25275461|FG000|Overall Study|Adverse Event|4|||
13072804|NCT01529034|25275461|FG000|Overall Study|Protocol Violation|4|||
13072805|NCT01529034|25275461|FG000|Overall Study|Lack of Efficacy|4|||
13072806|NCT01529034|25275461|FG000|Overall Study|Investigator no longer available|2|||
13072807|NCT01529034|25275461|FG000|Overall Study|Study drug not available|2|||
13072808|NCT01656434|25275484|FG000|Overall Study|Adverse Event|199|||
13072809|NCT01656434|25275485|FG001|Overall Study|Adverse Event|63|||
13072810|NCT01656434|25275484|FG000|Overall Study|Enrollment terminated at trial site|2|||
13072811|NCT01656434|25275485|FG001|Overall Study|Enrollment terminated at trial site|0|||
13072812|NCT01656434|25275484|FG000|Overall Study|Lost to Follow-up|309|||
13072813|NCT01656434|25275485|FG001|Overall Study|Lost to Follow-up|76|||
13072814|NCT01656434|25275484|FG000|Overall Study|Site discontinued study participation|24|||
13072815|NCT01656434|25275485|FG001|Overall Study|Site discontinued study participation|9|||
13072816|NCT01656434|25275484|FG000|Overall Study|Screen failure|2|||
13072817|NCT01656434|25275485|FG001|Overall Study|Screen failure|0|||
13072818|NCT01656434|25275484|FG000|Overall Study|Protocol Violation|7|||
13072819|NCT01656434|25275485|FG001|Overall Study|Protocol Violation|0|||
13072820|NCT01656434|25275484|FG000|Overall Study|Pregnancy wish|18|||
13072821|NCT01656434|25275485|FG001|Overall Study|Pregnancy wish|6|||
13072822|NCT01656434|25275484|FG000|Overall Study|Pregnancy|45|||
13072823|NCT01656434|25275485|FG001|Overall Study|Pregnancy|10|||
13072824|NCT01656434|25275484|FG000|Overall Study|Physician Decision|7|||
13072825|NCT01656434|25275485|FG001|Overall Study|Physician Decision|2|||
13072826|NCT01656434|25275484|FG000|Overall Study|Non-compliance with study drug|48|||
13072827|NCT01656434|25275485|FG001|Overall Study|Non-compliance with study drug|9|||
13072828|NCT01656434|25275484|FG000|Overall Study|Study terminated by sponsor|1501|||
13072829|NCT01656434|25275485|FG001|Overall Study|Study terminated by sponsor|348|||
13072830|NCT01656434|25275484|FG000|Overall Study|Participant discontinued; drug related|13|||
13072831|NCT01656434|25275485|FG001|Overall Study|Participant discontinued; drug related|4|||
13072832|NCT01656434|25275484|FG000|Overall Study|Part. discontinued; unrelated to drug|55|||
13072833|NCT01656434|25275485|FG001|Overall Study|Part. discontinued; unrelated to drug|10|||
13072834|NCT01656434|25275484|FG000|Overall Study|Non-compliance with protocol|39|||
13072835|NCT01656434|25275485|FG001|Overall Study|Non-compliance with protocol|15|||
13072836|NCT01656434|25275484|FG000|Overall Study|Participant moved|40|||
13072837|NCT01656434|25275485|FG001|Overall Study|Participant moved|12|||
13072838|NCT01656434|25275484|FG000|Overall Study|Participant withdrew consent|28|||
13072839|NCT01656434|25275485|FG001|Overall Study|Participant withdrew consent|9|||
13072840|NCT01656434|25275484|FG000|Overall Study|Withdrawal by Subject|64|||
13072841|NCT01656434|25275485|FG001|Overall Study|Withdrawal by Subject|7|||
13072842|NCT01496118|25275565|FG000|Overall Study|Disease progression|3|||
13072843|NCT01496118|25275566|FG001|Overall Study|Disease progression|2|||
13072844|NCT01496118|25275567|FG002|Overall Study|Disease progression|3|||
13072845|NCT01496118|25275568|FG003|Overall Study|Disease progression|1|||
13072846|NCT01496118|25275569|FG004|Overall Study|Disease progression|2|||
13072847|NCT01496118|25275570|FG005|Overall Study|Disease progression|2|||
13072848|NCT01496118|25275571|FG006|Overall Study|Disease progression|14|||
13072849|NCT01496118|25275572|FG007|Overall Study|Disease progression|10|||
13072850|NCT01496118|25275565|FG000|Overall Study|Physician Decision|0|||
13072851|NCT01496118|25275566|FG001|Overall Study|Physician Decision|0|||
13072852|NCT01496118|25275567|FG002|Overall Study|Physician Decision|0|||
13072853|NCT01496118|25275568|FG003|Overall Study|Physician Decision|0|||
13072854|NCT01496118|25275569|FG004|Overall Study|Physician Decision|1|||
13072855|NCT01496118|25275570|FG005|Overall Study|Physician Decision|0|||
13072856|NCT01496118|25275571|FG006|Overall Study|Physician Decision|3|||
13072857|NCT01496118|25275572|FG007|Overall Study|Physician Decision|6|||
13072858|NCT01496118|25275565|FG000|Overall Study|Adverse Event|1|||
13072859|NCT01496118|25275566|FG001|Overall Study|Adverse Event|1|||
13072860|NCT01496118|25275567|FG002|Overall Study|Adverse Event|0|||
13072861|NCT01496118|25275568|FG003|Overall Study|Adverse Event|0|||
13072862|NCT01496118|25275569|FG004|Overall Study|Adverse Event|0|||
13072863|NCT01496118|25275570|FG005|Overall Study|Adverse Event|0|||
13072864|NCT01496118|25275571|FG006|Overall Study|Adverse Event|6|||
13072865|NCT01496118|25275572|FG007|Overall Study|Adverse Event|10|||
13072866|NCT01496118|25275565|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
13133595|NCT02767570|25988489|FG001|Overall Study|Increased pain|0|||
13072867|NCT01496118|25275566|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
13072868|NCT01496118|25275567|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
13072869|NCT01496118|25275568|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
13072870|NCT01496118|25275569|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
13072871|NCT01496118|25275570|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
13072872|NCT01496118|25275571|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1|||
13072873|NCT01496118|25275572|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
13072874|NCT01496118|25275565|FG000|Overall Study|Death|0|||
13072875|NCT01496118|25275566|FG001|Overall Study|Death|0|||
13072876|NCT01496118|25275567|FG002|Overall Study|Death|0|||
13072877|NCT01496118|25275568|FG003|Overall Study|Death|0|||
13072878|NCT01496118|25275569|FG004|Overall Study|Death|0|||
13072879|NCT01496118|25275570|FG005|Overall Study|Death|0|||
13072880|NCT01496118|25275571|FG006|Overall Study|Death|1|||
13072881|NCT01496118|25275572|FG007|Overall Study|Death|1|||
13072882|NCT01496118|25275565|FG000|Overall Study|Withdrawal by Subject|0|||
13072883|NCT01496118|25275566|FG001|Overall Study|Withdrawal by Subject|0|||
13072884|NCT01496118|25275567|FG002|Overall Study|Withdrawal by Subject|0|||
13072885|NCT01496118|25275568|FG003|Overall Study|Withdrawal by Subject|2|||
13072886|NCT01496118|25275569|FG004|Overall Study|Withdrawal by Subject|0|||
13072887|NCT01496118|25275570|FG005|Overall Study|Withdrawal by Subject|1|||
13072888|NCT01496118|25275571|FG006|Overall Study|Withdrawal by Subject|6|||
13072889|NCT01496118|25275572|FG007|Overall Study|Withdrawal by Subject|3|||
13072890|NCT01350934|25275597|FG000|Base Study|Adverse Event|6|||
13072891|NCT01350934|25275598|FG001|Base Study|Adverse Event|0|||
13072892|NCT01350934|25275597|FG000|Base Study|Lost to Follow-up|1|||
13072893|NCT01350934|25275598|FG001|Base Study|Lost to Follow-up|0|||
13072894|NCT01350934|25275597|FG000|Base Study|Protocol Violation|1|||
13072895|NCT01350934|25275598|FG001|Base Study|Protocol Violation|1|||
13072896|NCT01350934|25275597|FG000|Base Study|Withdrawal by Subject|1|||
13072897|NCT01350934|25275598|FG001|Base Study|Withdrawal by Subject|2|||
13072898|NCT01350934|25275597|FG000|Base Study|Non-Compliance With Study Drug|2|||
13072899|NCT01350934|25275598|FG001|Base Study|Non-Compliance With Study Drug|0|||
13072900|NCT01350934|25275597|FG000|Extension Study|Adverse Event|2|||
13072901|NCT01350934|25275598|FG001|Extension Study|Adverse Event|1|||
13072902|NCT01350934|25275597|FG000|Extension Study|Lost to Follow-up|2|||
13072903|NCT01350934|25275598|FG001|Extension Study|Lost to Follow-up|0|||
13072904|NCT01350934|25275597|FG000|Extension Study|Protocol Violation|1|||
13072905|NCT01350934|25275598|FG001|Extension Study|Protocol Violation|1|||
13072906|NCT01350934|25275597|FG000|Extension Study|Lack of Efficacy|0|||
13072907|NCT01350934|25275598|FG001|Extension Study|Lack of Efficacy|1|||
13072908|NCT01350934|25275597|FG000|Extension Study|Withdrawal by Subject|0|||
13072909|NCT01350934|25275598|FG001|Extension Study|Withdrawal by Subject|1|||
13072910|NCT01286207|25275628|FG000|Overall Study|Adverse Event|27|||
13072911|NCT01286207|25275629|FG001|Overall Study|Adverse Event|41|||
13072912|NCT01286207|25275630|FG002|Overall Study|Adverse Event|8|||
13072913|NCT01286207|25275628|FG000|Overall Study|Lost to Follow-up|49|||
13072914|NCT01286207|25275629|FG001|Overall Study|Lost to Follow-up|43|||
13072915|NCT01286207|25275630|FG002|Overall Study|Lost to Follow-up|20|||
13072916|NCT01286207|25275628|FG000|Overall Study|Withdrawal by Subject|93|||
13072917|NCT01286207|25275629|FG001|Overall Study|Withdrawal by Subject|79|||
13072918|NCT01286207|25275630|FG002|Overall Study|Withdrawal by Subject|41|||
13072919|NCT01286207|25275628|FG000|Overall Study|Lack of Response|92|||
13072920|NCT01286207|25275629|FG001|Overall Study|Lack of Response|38|||
13072921|NCT01286207|25275630|FG002|Overall Study|Lack of Response|8|||
13072922|NCT01286207|25275628|FG000|Overall Study|Other|37|||
13072923|NCT01286207|25275629|FG001|Overall Study|Other|47|||
13072924|NCT01286207|25275630|FG002|Overall Study|Other|13|||
13072925|NCT01227187|25275669|FG000|Overall Study|Physician Decision|0|||
13072926|NCT01227187|25275670|FG001|Overall Study|Physician Decision|0|||
13072927|NCT01227187|25275671|FG002|Overall Study|Physician Decision|0|||
13072928|NCT01227187|25275672|FG003|Overall Study|Physician Decision|1|||
13072929|NCT01144416|25275719|FG000|Intervention Period|Adverse Event|5|||
13072930|NCT01144416|25275720|FG001|Intervention Period|Adverse Event|6|||
13072931|NCT01144416|25275719|FG000|Intervention Period|Insufficient ovarian response|11|||
13072932|NCT01144416|25275720|FG001|Intervention Period|Insufficient ovarian response|17|||
13072933|NCT01144416|25275719|FG000|Intervention Period|Risk of OHSS|0|||
13072934|NCT01144416|25275720|FG001|Intervention Period|Risk of OHSS|1|||
13072935|NCT01144416|25275719|FG000|Intervention Period|Too high ovarian response|4|||
13072936|NCT01144416|25275720|FG001|Intervention Period|Too high ovarian response|2|||
13072937|NCT01144416|25275719|FG000|Intervention Period|No/too few/bad oocytes|7|||
13072938|NCT01144416|25275720|FG001|Intervention Period|No/too few/bad oocytes|5|||
13072939|NCT01144416|25275719|FG000|Intervention Period|No or abnormal fertilization|25|||
13072940|NCT01144416|25275720|FG001|Intervention Period|No or abnormal fertilization|10|||
13072941|NCT01144416|25275719|FG000|Intervention Period|No/too few/bad quality embryos|3|||
13072942|NCT01144416|25275720|FG001|Intervention Period|No/too few/bad quality embryos|3|||
13072943|NCT01144416|25275719|FG000|Intervention Period|Other|7|||
13072944|NCT01144416|25275720|FG001|Intervention Period|Other|5|||
13072945|NCT01140048|25275728|FG000|Overall Study|Physician Decision|1|||
13072946|NCT01140048|25275728|FG000|Overall Study|Withdrawal by Subject|13|||
13072947|NCT01140048|25275728|FG000|Overall Study|Lost to Follow-up|31|||
13072948|NCT00974571|25275771|FG000|Overall Study|Adverse Event|31|||
13072949|NCT00974571|25275772|FG001|Overall Study|Adverse Event|4|||
13072950|NCT00974571|25275773|FG002|Overall Study|Adverse Event|27|||
13072951|NCT00974571|25275771|FG000|Overall Study|Lack of Efficacy|3|||
13072952|NCT00974571|25275772|FG001|Overall Study|Lack of Efficacy|2|||
13072953|NCT00974571|25275773|FG002|Overall Study|Lack of Efficacy|9|||
13072954|NCT00974571|25275771|FG000|Overall Study|Lost to Follow-up|2|||
13072955|NCT00974571|25275772|FG001|Overall Study|Lost to Follow-up|1|||
13072956|NCT00974571|25275773|FG002|Overall Study|Lost to Follow-up|2|||
13072957|NCT00974571|25275771|FG000|Overall Study|Protocol Violation|13|||
13072958|NCT00974571|25275772|FG001|Overall Study|Protocol Violation|4|||
13072959|NCT00974571|25275773|FG002|Overall Study|Protocol Violation|18|||
13072960|NCT00974571|25275771|FG000|Overall Study|Withdrawal by Subject|14|||
13072961|NCT00974571|25275772|FG001|Overall Study|Withdrawal by Subject|5|||
13072962|NCT00974571|25275773|FG002|Overall Study|Withdrawal by Subject|16|||
13072963|NCT00974571|25275771|FG000|Overall Study|Patient Moved|1|||
13072964|NCT00974571|25275772|FG001|Overall Study|Patient Moved|0|||
13072965|NCT00974571|25275773|FG002|Overall Study|Patient Moved|1|||
13072966|NCT00974571|25275771|FG000|Overall Study|Other|4|||
13072967|NCT00974571|25275772|FG001|Overall Study|Other|0|||
13072968|NCT00974571|25275773|FG002|Overall Study|Other|10|||
13072969|NCT00972738|25275806|FG000|Overall Study|Adverse Event|7|||
13072970|NCT00972738|25275807|FG001|Overall Study|Adverse Event|1|||
13072971|NCT00972738|25275808|FG002|Overall Study|Adverse Event|8|||
13072972|NCT00972738|25275806|FG000|Overall Study|Protocol Violation|2|||
13072973|NCT00972738|25275807|FG001|Overall Study|Protocol Violation|1|||
13072974|NCT00972738|25275808|FG002|Overall Study|Protocol Violation|3|||
13072975|NCT00972738|25275806|FG000|Overall Study|Lost to Follow-up|1|||
13072976|NCT00972738|25275807|FG001|Overall Study|Lost to Follow-up|0|||
13072977|NCT00972738|25275808|FG002|Overall Study|Lost to Follow-up|1|||
13072978|NCT00972738|25275806|FG000|Overall Study|Lack of Efficacy|5|||
13072979|NCT00972738|25275807|FG001|Overall Study|Lack of Efficacy|1|||
13072980|NCT00972738|25275808|FG002|Overall Study|Lack of Efficacy|11|||
13072981|NCT00972738|25275806|FG000|Overall Study|Withdrawal by Subject|5|||
13072982|NCT00972738|25275807|FG001|Overall Study|Withdrawal by Subject|1|||
13072983|NCT00972738|25275808|FG002|Overall Study|Withdrawal by Subject|4|||
13072984|NCT00972738|25275806|FG000|Overall Study|Moved|0|||
13072985|NCT00972738|25275807|FG001|Overall Study|Moved|0|||
13072986|NCT00972738|25275808|FG002|Overall Study|Moved|1|||
13072987|NCT00972738|25275806|FG000|Overall Study|Other|1|||
13072988|NCT00972738|25275807|FG001|Overall Study|Other|2|||
13072989|NCT00972738|25275808|FG002|Overall Study|Other|1|||
13072990|NCT00968201|25275875|FG000|Base Study - (Period II)|Adverse Event|8|||
13072991|NCT00968201|25275876|FG001|Base Study - (Period II)|Adverse Event|0|||
13072992|NCT00968201|25275877|FG002|Base Study - (Period II)|Adverse Event|16|||
13072993|NCT00968201|25275875|FG000|Base Study - (Period II)|Lack of Efficacy|0|||
13072994|NCT00968201|25275876|FG001|Base Study - (Period II)|Lack of Efficacy|0|||
13072995|NCT00968201|25275877|FG002|Base Study - (Period II)|Lack of Efficacy|1|||
13072996|NCT00968201|25275875|FG000|Base Study - (Period II)|Lost to Follow-up|2|||
13072997|NCT00968201|25275876|FG001|Base Study - (Period II)|Lost to Follow-up|0|||
13072998|NCT00968201|25275877|FG002|Base Study - (Period II)|Lost to Follow-up|7|||
13072999|NCT00968201|25275875|FG000|Base Study - (Period II)|Protocol Violation|12|||
13073000|NCT00968201|25275876|FG001|Base Study - (Period II)|Protocol Violation|0|||
13073001|NCT00968201|25275877|FG002|Base Study - (Period II)|Protocol Violation|12|||
13073002|NCT00968201|25275875|FG000|Base Study - (Period II)|Withdrawal by Subject|4|||
13073003|NCT00968201|25275876|FG001|Base Study - (Period II)|Withdrawal by Subject|0|||
13073004|NCT00968201|25275877|FG002|Base Study - (Period II)|Withdrawal by Subject|8|||
13073005|NCT00968201|25275875|FG000|Base Study - (Period II)|Site Error|0|||
13073006|NCT00968201|25275876|FG001|Base Study - (Period II)|Site Error|0|||
13073007|NCT00968201|25275877|FG002|Base Study - (Period II)|Site Error|1|||
13073008|NCT00968201|25275875|FG000|Extension Study - (Period III)|Adverse Event|0|||
13073009|NCT00968201|25275876|FG001|Extension Study - (Period III)|Adverse Event|5|||
13073010|NCT00968201|25275877|FG002|Extension Study - (Period III)|Adverse Event|22|||
13073011|NCT00968201|25275875|FG000|Extension Study - (Period III)|Lost to Follow-up|0|||
13073012|NCT00968201|25275876|FG001|Extension Study - (Period III)|Lost to Follow-up|7|||
13073013|NCT00968201|25275877|FG002|Extension Study - (Period III)|Lost to Follow-up|13|||
13073014|NCT00968201|25275875|FG000|Extension Study - (Period III)|Protocol Violation|0|||
13073015|NCT00968201|25275876|FG001|Extension Study - (Period III)|Protocol Violation|17|||
13073016|NCT00968201|25275877|FG002|Extension Study - (Period III)|Protocol Violation|14|||
13073017|NCT00968201|25275875|FG000|Extension Study - (Period III)|Withdrawal by Subject|0|||
13073018|NCT00968201|25275876|FG001|Extension Study - (Period III)|Withdrawal by Subject|20|||
13073019|NCT00968201|25275877|FG002|Extension Study - (Period III)|Withdrawal by Subject|40|||
13073020|NCT00968201|25275875|FG000|Extension Study - (Period III)|Patient Relocated|0|||
13073021|NCT00968201|25275876|FG001|Extension Study - (Period III)|Patient Relocated|1|||
13073022|NCT00968201|25275877|FG002|Extension Study - (Period III)|Patient Relocated|1|||
13073023|NCT00968201|25275875|FG000|Extension Study - (Period III)|Noncompliance|0|||
13073024|NCT00968201|25275876|FG001|Extension Study - (Period III)|Noncompliance|0|||
13073025|NCT00968201|25275877|FG002|Extension Study - (Period III)|Noncompliance|3|||
13073026|NCT00968201|25275875|FG000|Extension Study - (Period III)|Other|0|||
13073027|NCT00968201|25275876|FG001|Extension Study - (Period III)|Other|0|||
13073028|NCT00968201|25275877|FG002|Extension Study - (Period III)|Other|2|||
13073029|NCT00968201|25275875|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0|||
13073030|NCT00968201|25275876|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74|||
13073031|NCT00968201|25275877|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185|||
13073032|NCT00968149|25275904|FG000|Overall Study|Adverse Event|5|||
13073033|NCT00968149|25275905|FG001|Overall Study|Adverse Event|1|||
13073034|NCT00968149|25275904|FG000|Overall Study|Lack of Efficacy|0|||
13073035|NCT00968149|25275905|FG001|Overall Study|Lack of Efficacy|4|||
13073036|NCT00968149|25275904|FG000|Overall Study|Lost to Follow-up|0|||
13073037|NCT00968149|25275905|FG001|Overall Study|Lost to Follow-up|1|||
13073038|NCT00968149|25275904|FG000|Overall Study|Protocol Violation|4|||
13073039|NCT00968149|25275905|FG001|Overall Study|Protocol Violation|0|||
13073040|NCT00968149|25275904|FG000|Overall Study|Withdrawal by Subject|2|||
13073041|NCT00968149|25275905|FG001|Overall Study|Withdrawal by Subject|0|||
13073042|NCT00963469|25275941|FG000|Overall Study|Adverse Event|15|||
13073043|NCT00963469|25275942|FG001|Overall Study|Adverse Event|11|||
13073044|NCT00963469|25275943|FG002|Overall Study|Adverse Event|1|||
13073045|NCT00963469|25275941|FG000|Overall Study|Lack of Efficacy|10|||
13073046|NCT00963469|25275942|FG001|Overall Study|Lack of Efficacy|7|||
13073047|NCT00963469|25275943|FG002|Overall Study|Lack of Efficacy|2|||
13073048|NCT00963469|25275941|FG000|Overall Study|Lost to Follow-up|1|||
13073049|NCT00963469|25275942|FG001|Overall Study|Lost to Follow-up|1|||
13073050|NCT00963469|25275943|FG002|Overall Study|Lost to Follow-up|0|||
13073051|NCT00963469|25275941|FG000|Overall Study|Protocol Violation|5|||
13073052|NCT00963469|25275942|FG001|Overall Study|Protocol Violation|5|||
13073053|NCT00963469|25275943|FG002|Overall Study|Protocol Violation|3|||
13073054|NCT00963469|25275941|FG000|Overall Study|Withdrawal by Subject|4|||
13073055|NCT00963469|25275942|FG001|Overall Study|Withdrawal by Subject|1|||
13073056|NCT00963469|25275943|FG002|Overall Study|Withdrawal by Subject|1|||
13073057|NCT00963469|25275941|FG000|Overall Study|Pre-randomization Adverse Event|1|||
13073058|NCT00963469|25275942|FG001|Overall Study|Pre-randomization Adverse Event|2|||
13073059|NCT00963469|25275943|FG002|Overall Study|Pre-randomization Adverse Event|0|||
13073060|NCT00963469|25275941|FG000|Overall Study|Moved|1|||
13073061|NCT00963469|25275942|FG001|Overall Study|Moved|0|||
13073062|NCT00963469|25275943|FG002|Overall Study|Moved|0|||
13073063|NCT00963469|25275941|FG000|Overall Study|Site closed (local pollen Season ended)|4|||
13073064|NCT00963469|25275942|FG001|Overall Study|Site closed (local pollen Season ended)|1|||
13073065|NCT00963469|25275943|FG002|Overall Study|Site closed (local pollen Season ended)|3|||
13073066|NCT00960141|25275976|FG000|Overall Study|Adverse Event|4|||
13073067|NCT00960141|25275977|FG001|Overall Study|Adverse Event|8|||
13073068|NCT00960141|25275978|FG002|Overall Study|Adverse Event|2|||
13073069|NCT00960141|25275976|FG000|Overall Study|Lack of Efficacy|3|||
13073070|NCT00960141|25275977|FG001|Overall Study|Lack of Efficacy|4|||
13073071|NCT00960141|25275978|FG002|Overall Study|Lack of Efficacy|2|||
13073072|NCT00960141|25275976|FG000|Overall Study|Lost to Follow-up|1|||
13073073|NCT00960141|25275977|FG001|Overall Study|Lost to Follow-up|0|||
13073074|NCT00960141|25275978|FG002|Overall Study|Lost to Follow-up|0|||
13073075|NCT00960141|25275976|FG000|Overall Study|Protocol Violation|1|||
13073076|NCT00960141|25275977|FG001|Overall Study|Protocol Violation|3|||
13073077|NCT00960141|25275978|FG002|Overall Study|Protocol Violation|2|||
13073078|NCT00960141|25275976|FG000|Overall Study|Withdrawal by Subject|1|||
13073079|NCT00960141|25275977|FG001|Overall Study|Withdrawal by Subject|2|||
13073080|NCT00960141|25275978|FG002|Overall Study|Withdrawal by Subject|1|||
13073081|NCT00943683|25275991|FG000|Overall Study|Adverse Event|3|||
13073082|NCT00943683|25275992|FG001|Overall Study|Adverse Event|3|||
13073083|NCT00943683|25275991|FG000|Overall Study|Lost to Follow-up|1|||
13073084|NCT00943683|25275992|FG001|Overall Study|Lost to Follow-up|1|||
13073085|NCT00943683|25275991|FG000|Overall Study|Protocol Violation|1|||
13073086|NCT00943683|25275992|FG001|Overall Study|Protocol Violation|2|||
13073087|NCT00943683|25275991|FG000|Overall Study|Withdrawal by Subject|1|||
13073088|NCT00943683|25275992|FG001|Overall Study|Withdrawal by Subject|0|||
13073089|NCT00943683|25275991|FG000|Overall Study|Patient Moved|1|||
13073090|NCT00943683|25275992|FG001|Overall Study|Patient Moved|0|||
13073091|NCT00943397|25276005|FG000|Overall Study|Adverse Event|0|||
13073092|NCT00943397|25276006|FG001|Overall Study|Adverse Event|6|||
13073093|NCT00943397|25276005|FG000|Overall Study|Lost to Follow-up|0|||
13073094|NCT00943397|25276006|FG001|Overall Study|Lost to Follow-up|4|||
13073095|NCT00943397|25276005|FG000|Overall Study|Protocol Violation|2|||
13073096|NCT00943397|25276006|FG001|Overall Study|Protocol Violation|5|||
13073097|NCT00943397|25276005|FG000|Overall Study|Withdrawal by Subject|1|||
13073098|NCT00943397|25276006|FG001|Overall Study|Withdrawal by Subject|1|||
13073099|NCT00943397|25276005|FG000|Overall Study|Site terminated and other|12|||
13073100|NCT00943397|25276006|FG001|Overall Study|Site terminated and other|56|||
13073101|NCT00911547|25276045|FG000|Overall Study|Adverse Event|8|||
13073102|NCT00911547|25276046|FG001|Overall Study|Adverse Event|27|||
13073103|NCT00911547|25276047|FG002|Overall Study|Adverse Event|11|||
13073104|NCT00911547|25276048|FG003|Overall Study|Adverse Event|6|||
13073105|NCT00911547|25276045|FG000|Overall Study|Lost to Follow-up|0|||
13073106|NCT00911547|25276046|FG001|Overall Study|Lost to Follow-up|0|||
13073107|NCT00911547|25276047|FG002|Overall Study|Lost to Follow-up|2|||
13073108|NCT00911547|25276048|FG003|Overall Study|Lost to Follow-up|1|||
13073109|NCT00911547|25276045|FG000|Overall Study|Protocol Violation|0|||
13073110|NCT00911547|25276046|FG001|Overall Study|Protocol Violation|5|||
13073111|NCT00911547|25276047|FG002|Overall Study|Protocol Violation|5|||
13073112|NCT00911547|25276048|FG003|Overall Study|Protocol Violation|1|||
13073113|NCT00911547|25276045|FG000|Overall Study|Withdrawal by Subject|3|||
13073114|NCT00911547|25276046|FG001|Overall Study|Withdrawal by Subject|10|||
13073115|NCT00911547|25276047|FG002|Overall Study|Withdrawal by Subject|4|||
13073116|NCT00911547|25276048|FG003|Overall Study|Withdrawal by Subject|8|||
13073117|NCT00899379|25276076|FG000|Overall Study|Adverse Event|2|||
13073118|NCT00899379|25276077|FG001|Overall Study|Adverse Event|2|||
13073119|NCT00899379|25276078|FG002|Overall Study|Adverse Event|1|||
13073120|NCT00899379|25276079|FG003|Overall Study|Adverse Event|1|||
13073121|NCT00899379|25276080|FG004|Overall Study|Adverse Event|2|||
13073122|NCT00899379|25276076|FG000|Overall Study|Lack of Efficacy|0|||
13073123|NCT00899379|25276077|FG001|Overall Study|Lack of Efficacy|4|||
13073124|NCT00899379|25276078|FG002|Overall Study|Lack of Efficacy|3|||
13073125|NCT00899379|25276079|FG003|Overall Study|Lack of Efficacy|0|||
13073126|NCT00899379|25276080|FG004|Overall Study|Lack of Efficacy|1|||
13073127|NCT00899379|25276076|FG000|Overall Study|Lost to Follow-up|9|||
13073128|NCT00899379|25276077|FG001|Overall Study|Lost to Follow-up|3|||
13073129|NCT00899379|25276078|FG002|Overall Study|Lost to Follow-up|0|||
13073130|NCT00899379|25276079|FG003|Overall Study|Lost to Follow-up|6|||
13073131|NCT00899379|25276080|FG004|Overall Study|Lost to Follow-up|2|||
13073132|NCT00899379|25276076|FG000|Overall Study|Protocol Violation|0|||
13073133|NCT00899379|25276077|FG001|Overall Study|Protocol Violation|0|||
13073134|NCT00899379|25276078|FG002|Overall Study|Protocol Violation|1|||
13073135|NCT00899379|25276079|FG003|Overall Study|Protocol Violation|1|||
13073136|NCT00899379|25276080|FG004|Overall Study|Protocol Violation|0|||
13073137|NCT00899379|25276076|FG000|Overall Study|Withdrawal by Subject|2|||
13073138|NCT00899379|25276077|FG001|Overall Study|Withdrawal by Subject|4|||
13073139|NCT00899379|25276078|FG002|Overall Study|Withdrawal by Subject|2|||
13073140|NCT00899379|25276079|FG003|Overall Study|Withdrawal by Subject|3|||
13073141|NCT00899379|25276080|FG004|Overall Study|Withdrawal by Subject|6|||
13073142|NCT00899379|25276076|FG000|Overall Study|Pregnancy|0|||
13073143|NCT00899379|25276077|FG001|Overall Study|Pregnancy|0|||
13073144|NCT00899379|25276078|FG002|Overall Study|Pregnancy|1|||
13073145|NCT00899379|25276079|FG003|Overall Study|Pregnancy|0|||
13073146|NCT00899379|25276080|FG004|Overall Study|Pregnancy|1|||
13073147|NCT00899379|25276076|FG000|Overall Study|Patient Uncooperative|0|||
13073148|NCT00899379|25276077|FG001|Overall Study|Patient Uncooperative|1|||
13073149|NCT00899379|25276078|FG002|Overall Study|Patient Uncooperative|0|||
13073150|NCT00899379|25276079|FG003|Overall Study|Patient Uncooperative|1|||
13073151|NCT00899379|25276080|FG004|Overall Study|Patient Uncooperative|2|||
13073152|NCT00899379|25276076|FG000|Overall Study|Abnormal Baseline ECG|0|||
13073153|NCT00899379|25276077|FG001|Overall Study|Abnormal Baseline ECG|0|||
13073154|NCT00899379|25276078|FG002|Overall Study|Abnormal Baseline ECG|0|||
13073155|NCT00899379|25276079|FG003|Overall Study|Abnormal Baseline ECG|1|||
13073156|NCT00899379|25276080|FG004|Overall Study|Abnormal Baseline ECG|0|||
13073157|NCT00899379|25276076|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
13073158|NCT00899379|25276077|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1|||
13073159|NCT00899379|25276078|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1|||
13073160|NCT00899379|25276079|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
13073161|NCT00899379|25276080|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
13073162|NCT00899379|25276076|FG000|Overall Study|Not Completed/Entered Extn|5|||
13073163|NCT00899379|25276077|FG001|Overall Study|Not Completed/Entered Extn|1|||
13073164|NCT00899379|25276078|FG002|Overall Study|Not Completed/Entered Extn|6|||
13073165|NCT00899379|25276079|FG003|Overall Study|Not Completed/Entered Extn|4|||
13073166|NCT00899379|25276080|FG004|Overall Study|Not Completed/Entered Extn|3|||
13073167|NCT00899379|25276076|FG000|Overall Study|Study Terminated|3|||
13073168|NCT00899379|25276077|FG001|Overall Study|Study Terminated|0|||
13073169|NCT00899379|25276078|FG002|Overall Study|Study Terminated|3|||
13073170|NCT00899379|25276079|FG003|Overall Study|Study Terminated|3|||
13073171|NCT00899379|25276080|FG004|Overall Study|Study Terminated|1|||
13073172|NCT00899379|25276076|FG000|Overall Study|Lost to Follow-up|3|||
13073173|NCT00899379|25276077|FG001|Overall Study|Lost to Follow-up|1|||
13073174|NCT00899379|25276078|FG002|Overall Study|Lost to Follow-up|0|||
13073175|NCT00899379|25276079|FG003|Overall Study|Lost to Follow-up|2|||
13073176|NCT00899379|25276080|FG004|Overall Study|Lost to Follow-up|5|||
13073177|NCT00899379|25276076|FG000|Overall Study|Withdrawal by Subject|4|||
13073178|NCT00899379|25276077|FG001|Overall Study|Withdrawal by Subject|7|||
13073179|NCT00899379|25276078|FG002|Overall Study|Withdrawal by Subject|4|||
13073180|NCT00899379|25276079|FG003|Overall Study|Withdrawal by Subject|7|||
13073181|NCT00899379|25276080|FG004|Overall Study|Withdrawal by Subject|2|||
13073182|NCT00899379|25276076|FG000|Overall Study|Pregnancy|1|||
13073183|NCT00899379|25276077|FG001|Overall Study|Pregnancy|0|||
13073184|NCT00899379|25276078|FG002|Overall Study|Pregnancy|0|||
13073185|NCT00899379|25276079|FG003|Overall Study|Pregnancy|0|||
13073186|NCT00899379|25276080|FG004|Overall Study|Pregnancy|0|||
13073187|NCT00899379|25276076|FG000|Overall Study|Patient Uncooperative|0|||
13073188|NCT00899379|25276077|FG001|Overall Study|Patient Uncooperative|0|||
13073189|NCT00899379|25276078|FG002|Overall Study|Patient Uncooperative|0|||
13073190|NCT00899379|25276079|FG003|Overall Study|Patient Uncooperative|1|||
13073191|NCT00899379|25276080|FG004|Overall Study|Patient Uncooperative|0|||
13073192|NCT00899379|25276076|FG000|Overall Study|Abnormal Prestudy Labs|0|||
13073193|NCT00899379|25276077|FG001|Overall Study|Abnormal Prestudy Labs|0|||
13073194|NCT00899379|25276078|FG002|Overall Study|Abnormal Prestudy Labs|0|||
13073195|NCT00899379|25276079|FG003|Overall Study|Abnormal Prestudy Labs|0|||
13073196|NCT00899379|25276080|FG004|Overall Study|Abnormal Prestudy Labs|2|||
13073197|NCT00899379|25276076|FG000|Overall Study|Abnormal Baseline ECG|0|||
13073198|NCT00899379|25276077|FG001|Overall Study|Abnormal Baseline ECG|0|||
13073199|NCT00899379|25276078|FG002|Overall Study|Abnormal Baseline ECG|1|||
13073200|NCT00899379|25276079|FG003|Overall Study|Abnormal Baseline ECG|1|||
13073201|NCT00899379|25276080|FG004|Overall Study|Abnormal Baseline ECG|0|||
13073202|NCT00899379|25276076|FG000|Overall Study|No Attack Pretreatment|3|||
13073203|NCT00899379|25276077|FG001|Overall Study|No Attack Pretreatment|5|||
13073204|NCT00899379|25276078|FG002|Overall Study|No Attack Pretreatment|5|||
13073205|NCT00899379|25276079|FG003|Overall Study|No Attack Pretreatment|6|||
13073206|NCT00899379|25276080|FG004|Overall Study|No Attack Pretreatment|4|||
13073207|NCT00899379|25276076|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
13073208|NCT00899379|25276077|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
13073209|NCT00899379|25276078|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
13073210|NCT00899379|25276079|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
13073211|NCT00899379|25276080|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
13073212|NCT00899379|25276076|FG000|Overall Study|Inc/Exc Criteria Not Met|0|||
13073213|NCT00899379|25276077|FG001|Overall Study|Inc/Exc Criteria Not Met|0|||
13073214|NCT00899379|25276078|FG002|Overall Study|Inc/Exc Criteria Not Met|1|||
13073215|NCT00899379|25276079|FG003|Overall Study|Inc/Exc Criteria Not Met|0|||
13073216|NCT00899379|25276080|FG004|Overall Study|Inc/Exc Criteria Not Met|0|||
13073217|NCT00898677|25276119|FG000|Overall Study|Adverse Event|0|||
13073218|NCT00898677|25276120|FG001|Overall Study|Adverse Event|0|||
13073219|NCT00898677|25276121|FG002|Overall Study|Adverse Event|1|||
13073220|NCT00898677|25276122|FG003|Overall Study|Adverse Event|0|||
13073221|NCT00898677|25276119|FG000|Overall Study|Lost to Follow-up|0|||
13073222|NCT00898677|25276120|FG001|Overall Study|Lost to Follow-up|0|||
13073223|NCT00898677|25276121|FG002|Overall Study|Lost to Follow-up|2|||
13073224|NCT00898677|25276122|FG003|Overall Study|Lost to Follow-up|0|||
13073225|NCT00898677|25276119|FG000|Overall Study|Protocol Violation|1|||
13073226|NCT00898677|25276120|FG001|Overall Study|Protocol Violation|1|||
13073227|NCT00898677|25276121|FG002|Overall Study|Protocol Violation|2|||
13073228|NCT00898677|25276122|FG003|Overall Study|Protocol Violation|0|||
13073229|NCT00898677|25276119|FG000|Overall Study|Withdrawal by Subject|0|||
13073230|NCT00898677|25276120|FG001|Overall Study|Withdrawal by Subject|0|||
13073231|NCT00898677|25276121|FG002|Overall Study|Withdrawal by Subject|0|||
13073232|NCT00898677|25276122|FG003|Overall Study|Withdrawal by Subject|1|||
13073233|NCT00898677|25276119|FG000|Overall Study|Not Treated: Adverse Event|0|||
13073234|NCT00898677|25276120|FG001|Overall Study|Not Treated: Adverse Event|2|||
13073235|NCT00898677|25276121|FG002|Overall Study|Not Treated: Adverse Event|1|||
13073236|NCT00898677|25276122|FG003|Overall Study|Not Treated: Adverse Event|0|||
13073237|NCT00898677|25276119|FG000|Overall Study|Not Treated: Lost to Follow-Up|0|||
13073238|NCT00898677|25276120|FG001|Overall Study|Not Treated: Lost to Follow-Up|5|||
13073239|NCT00898677|25276121|FG002|Overall Study|Not Treated: Lost to Follow-Up|5|||
13073240|NCT00898677|25276122|FG003|Overall Study|Not Treated: Lost to Follow-Up|2|||
13073241|NCT00898677|25276119|FG000|Overall Study|Not Treated: Pregnancy|0|||
13073242|NCT00898677|25276120|FG001|Overall Study|Not Treated: Pregnancy|0|||
13073243|NCT00898677|25276121|FG002|Overall Study|Not Treated: Pregnancy|1|||
13073244|NCT00898677|25276122|FG003|Overall Study|Not Treated: Pregnancy|0|||
13073245|NCT00898677|25276119|FG000|Overall Study|Not Treated: Protocol Violation|2|||
13073246|NCT00898677|25276120|FG001|Overall Study|Not Treated: Protocol Violation|0|||
13073247|NCT00898677|25276121|FG002|Overall Study|Not Treated: Protocol Violation|2|||
13073248|NCT00898677|25276122|FG003|Overall Study|Not Treated: Protocol Violation|0|||
13073249|NCT00898677|25276119|FG000|Overall Study|Not Treated: Withdraw by Subject|2|||
13073250|NCT00898677|25276120|FG001|Overall Study|Not Treated: Withdraw by Subject|16|||
13073251|NCT00898677|25276121|FG002|Overall Study|Not Treated: Withdraw by Subject|11|||
13073252|NCT00898677|25276122|FG003|Overall Study|Not Treated: Withdraw by Subject|3|||
13073253|NCT00898677|25276119|FG000|Overall Study|Not Treated: Patient uncooperative|2|||
13073254|NCT00898677|25276120|FG001|Overall Study|Not Treated: Patient uncooperative|3|||
13073255|NCT00898677|25276121|FG002|Overall Study|Not Treated: Patient uncooperative|1|||
13073256|NCT00898677|25276122|FG003|Overall Study|Not Treated: Patient uncooperative|0|||
13073257|NCT00898677|25276119|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
13073258|NCT00898677|25276120|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
13073259|NCT00898677|25276121|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
13073260|NCT00898677|25276122|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1|||
13073261|NCT00898677|25276119|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1|||
13073262|NCT00898677|25276120|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
13073263|NCT00898677|25276121|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
13073264|NCT00898677|25276122|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
13073265|NCT00898677|25276119|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
13073266|NCT00898677|25276120|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3|||
13073267|NCT00898677|25276121|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1|||
13073268|NCT00898677|25276122|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
13073269|NCT00898677|25276119|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9|||
13073270|NCT00898677|25276120|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39|||
13073271|NCT00898677|25276121|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43|||
13073272|NCT00898677|25276122|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12|||
13073273|NCT00898677|25276119|FG000|Overall Study|Not Treated: Other (Not Specified)|0|||
13073274|NCT00898677|25276120|FG001|Overall Study|Not Treated: Other (Not Specified)|0|||
13073275|NCT00898677|25276121|FG002|Overall Study|Not Treated: Other (Not Specified)|2|||
13073276|NCT00898677|25276122|FG003|Overall Study|Not Treated: Other (Not Specified)|0|||
13130121|NCT02849080|25973028|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
13130122|NCT02848833|25973046|FG000|Overall Study|subject who are duplicated|1|||
13130123|NCT02848833|25973046|FG000|Overall Study|have not taken the study drug|11|||
13130124|NCT02848833|25973046|FG000|Overall Study|follow-up failure|6|||
13130125|NCT02848833|25973046|FG000|Overall Study|Protocol Violation|119|||
13130126|NCT02848729|25973070|FG000|Overall Study|Withdrawal by Subject|1|||
13130127|NCT02848729|25973071|FG001|Overall Study|Withdrawal by Subject|0|||
13130128|NCT02848729|25973070|FG000|Overall Study|Emesis|15|||
13130129|NCT02848729|25973071|FG001|Overall Study|Emesis|11|||
13130130|NCT02848664|25973081|FG000|Overall Study|Withdrawal by Subject|2|||
13130131|NCT02848664|25973081|FG000|Overall Study|Adverse Event|1|||
13130132|NCT02848664|25973081|FG000|Overall Study|no assistance for device training|1|||
13130133|NCT02848651|25973110|FG000|Overall Study|Death|85|||
13130134|NCT02848651|25973110|FG000|Overall Study|Lost to Follow-up|1|||
13130135|NCT02848651|25973110|FG000|Overall Study|Non-Compliance|1|||
13130136|NCT02848651|25973110|FG000|Overall Study|Symptomatic Deterioration|1|||
13130137|NCT02848651|25973110|FG000|Overall Study|Physician Decision|4|||
13130138|NCT02848651|25973110|FG000|Overall Study|Withdrawal by Subject|14|||
13130139|NCT02848599|25973133|FG000|Overall Study|Protocol Violation|7|||
13130140|NCT02848599|25973134|FG001|Overall Study|Protocol Violation|9|||
13130141|NCT02848326|25973185|FG000|Treatment Period|Adverse Event|5|||
13130142|NCT02848326|25973186|FG001|Treatment Period|Adverse Event|4|||
13130143|NCT02848326|25973187|FG002|Treatment Period|Adverse Event|11|||
13130144|NCT02848326|25973188|FG003|Treatment Period|Adverse Event|6|||
13130145|NCT02848326|25973189|FG004|Treatment Period|Adverse Event|5|||
13130146|NCT02848326|25973190|FG005|Treatment Period|Adverse Event|7|||
13130147|NCT02848326|25973185|FG000|Treatment Period|Withdrawal of Consent|20|||
13130148|NCT02848326|25973186|FG001|Treatment Period|Withdrawal of Consent|6|||
13130149|NCT02848326|25973187|FG002|Treatment Period|Withdrawal of Consent|9|||
13130150|NCT02848326|25973188|FG003|Treatment Period|Withdrawal of Consent|6|||
13130151|NCT02848326|25973189|FG004|Treatment Period|Withdrawal of Consent|9|||
13130152|NCT02848326|25973190|FG005|Treatment Period|Withdrawal of Consent|6|||
13130153|NCT02848326|25973185|FG000|Treatment Period|Lost to Follow-up|5|||
13130154|NCT02848326|25973186|FG001|Treatment Period|Lost to Follow-up|1|||
13130155|NCT02848326|25973187|FG002|Treatment Period|Lost to Follow-up|11|||
13130156|NCT02848326|25973188|FG003|Treatment Period|Lost to Follow-up|7|||
13130157|NCT02848326|25973189|FG004|Treatment Period|Lost to Follow-up|2|||
13130158|NCT02848326|25973190|FG005|Treatment Period|Lost to Follow-up|3|||
13130159|NCT02848326|25973185|FG000|Treatment Period|Pregnancy|0|||
13130160|NCT02848326|25973186|FG001|Treatment Period|Pregnancy|0|||
13130161|NCT02848326|25973187|FG002|Treatment Period|Pregnancy|1|||
13130162|NCT02848326|25973188|FG003|Treatment Period|Pregnancy|1|||
13130163|NCT02848326|25973189|FG004|Treatment Period|Pregnancy|0|||
13130164|NCT02848326|25973190|FG005|Treatment Period|Pregnancy|1|||
13130165|NCT02848326|25973185|FG000|Treatment Period|Protocol Violation|4|||
13130166|NCT02848326|25973186|FG001|Treatment Period|Protocol Violation|3|||
13130167|NCT02848326|25973187|FG002|Treatment Period|Protocol Violation|4|||
13130168|NCT02848326|25973188|FG003|Treatment Period|Protocol Violation|2|||
13130169|NCT02848326|25973189|FG004|Treatment Period|Protocol Violation|3|||
13073277|NCT00897949|25276155|FG000|Overall Study|Adverse Event|1|||
13073278|NCT00897949|25276156|FG001|Overall Study|Adverse Event|1|||
13073279|NCT00897949|25276157|FG002|Overall Study|Adverse Event|0|||
13073280|NCT00897949|25276155|FG000|Overall Study|Lost to Follow-up|0|||
13073281|NCT00897949|25276156|FG001|Overall Study|Lost to Follow-up|2|||
13073282|NCT00897949|25276157|FG002|Overall Study|Lost to Follow-up|1|||
13073283|NCT00897949|25276155|FG000|Overall Study|Protocol Violation|6|||
13073284|NCT00897949|25276156|FG001|Overall Study|Protocol Violation|3|||
13073285|NCT00897949|25276157|FG002|Overall Study|Protocol Violation|1|||
13073286|NCT00897949|25276155|FG000|Overall Study|Withdrawal by Subject|1|||
13073287|NCT00897949|25276156|FG001|Overall Study|Withdrawal by Subject|2|||
13073288|NCT00897949|25276157|FG002|Overall Study|Withdrawal by Subject|0|||
13073289|NCT00897949|25276155|FG000|Overall Study|Patient Uncoorperative|0|||
13073290|NCT00897949|25276156|FG001|Overall Study|Patient Uncoorperative|2|||
13073291|NCT00897949|25276157|FG002|Overall Study|Patient Uncoorperative|1|||
13073292|NCT00897949|25276155|FG000|Overall Study|Lost to Follow-up|30|||
13073293|NCT00897949|25276156|FG001|Overall Study|Lost to Follow-up|23|||
13073294|NCT00897949|25276157|FG002|Overall Study|Lost to Follow-up|17|||
13073295|NCT00897949|25276155|FG000|Overall Study|Withdrawal by Subject|24|||
13073296|NCT00897949|25276156|FG001|Overall Study|Withdrawal by Subject|31|||
13073297|NCT00897949|25276157|FG002|Overall Study|Withdrawal by Subject|17|||
13073298|NCT00897949|25276155|FG000|Overall Study|Abnormal Prestudy Labs|2|||
13073299|NCT00897949|25276156|FG001|Overall Study|Abnormal Prestudy Labs|3|||
13073300|NCT00897949|25276157|FG002|Overall Study|Abnormal Prestudy Labs|4|||
13073301|NCT00897949|25276155|FG000|Overall Study|Abnormal Baseline ECG|2|||
13073302|NCT00897949|25276156|FG001|Overall Study|Abnormal Baseline ECG|2|||
13073303|NCT00897949|25276157|FG002|Overall Study|Abnormal Baseline ECG|4|||
13073304|NCT00897949|25276155|FG000|Overall Study|Need for Concom. Med.|0|||
13073305|NCT00897949|25276156|FG001|Overall Study|Need for Concom. Med.|1|||
13073306|NCT00897949|25276157|FG002|Overall Study|Need for Concom. Med.|1|||
13073307|NCT00897949|25276155|FG000|Overall Study|Lack of Migraine Attack|29|||
13073308|NCT00897949|25276156|FG001|Overall Study|Lack of Migraine Attack|30|||
13073309|NCT00897949|25276157|FG002|Overall Study|Lack of Migraine Attack|19|||
13073310|NCT00897949|25276155|FG000|Overall Study|Did not take study drug|9|||
13073311|NCT00897949|25276156|FG001|Overall Study|Did not take study drug|3|||
13073312|NCT00897949|25276157|FG002|Overall Study|Did not take study drug|4|||
13073313|NCT00897104|25276193|FG000|Overall Study|Lost to Follow-up|12|||
13073314|NCT00897104|25276194|FG001|Overall Study|Lost to Follow-up|17|||
13073315|NCT00897104|25276195|FG002|Overall Study|Lost to Follow-up|2|||
13073316|NCT00897104|25276193|FG000|Overall Study|Pregnancy|0|||
13073317|NCT00897104|25276194|FG001|Overall Study|Pregnancy|1|||
13073318|NCT00897104|25276195|FG002|Overall Study|Pregnancy|0|||
13073319|NCT00897104|25276193|FG000|Overall Study|Protocol Violation|0|||
13073320|NCT00897104|25276194|FG001|Overall Study|Protocol Violation|1|||
13073321|NCT00897104|25276195|FG002|Overall Study|Protocol Violation|0|||
13073322|NCT00897104|25276193|FG000|Overall Study|Withdrawal by Subject|23|||
13073323|NCT00897104|25276194|FG001|Overall Study|Withdrawal by Subject|27|||
13073324|NCT00897104|25276195|FG002|Overall Study|Withdrawal by Subject|3|||
13073325|NCT00897104|25276193|FG000|Overall Study|Abnormal Prestudy Labs|2|||
13073326|NCT00897104|25276194|FG001|Overall Study|Abnormal Prestudy Labs|0|||
13073327|NCT00897104|25276195|FG002|Overall Study|Abnormal Prestudy Labs|0|||
13073328|NCT00897104|25276193|FG000|Overall Study|Abnormal Baseline ECG|2|||
13073329|NCT00897104|25276194|FG001|Overall Study|Abnormal Baseline ECG|2|||
13073330|NCT00897104|25276195|FG002|Overall Study|Abnormal Baseline ECG|0|||
13073331|NCT00897104|25276193|FG000|Overall Study|Need for Concom. Med.|0|||
13073332|NCT00897104|25276194|FG001|Overall Study|Need for Concom. Med.|1|||
13073333|NCT00897104|25276195|FG002|Overall Study|Need for Concom. Med.|1|||
13073334|NCT00897104|25276193|FG000|Overall Study|Lack of Migraine Attack|20|||
13073335|NCT00897104|25276194|FG001|Overall Study|Lack of Migraine Attack|22|||
13073336|NCT00897104|25276195|FG002|Overall Study|Lack of Migraine Attack|1|||
13073337|NCT00897104|25276193|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
13073338|NCT00897104|25276194|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
13073339|NCT00897104|25276195|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
13073340|NCT00897104|25276193|FG000|Overall Study|Other|3|||
13073341|NCT00897104|25276194|FG001|Overall Study|Other|0|||
13073342|NCT00897104|25276195|FG002|Overall Study|Other|0|||
13073343|NCT00897104|25276193|FG000|Overall Study|Protocol Violation|1|||
13073344|NCT00897104|25276194|FG001|Overall Study|Protocol Violation|0|||
13073345|NCT00897104|25276195|FG002|Overall Study|Protocol Violation|0|||
13073346|NCT00897104|25276193|FG000|Overall Study|Withdrawal by Subject|0|||
13073347|NCT00897104|25276194|FG001|Overall Study|Withdrawal by Subject|0|||
13073348|NCT00897104|25276195|FG002|Overall Study|Withdrawal by Subject|1|||
13073349|NCT00803790|25276215|FG000|Period 1|Adverse Event|0|||
13073350|NCT00803790|25276216|FG001|Period 1|Adverse Event|1|||
13073351|NCT00803790|25276217|FG002|Period 1|Adverse Event|0|||
13073352|NCT00803790|25276218|FG003|Period 1|Adverse Event|0|||
13073353|NCT00803790|25276215|FG000|Period 1|Lost to Follow-up|1|||
13073354|NCT00803790|25276216|FG001|Period 1|Lost to Follow-up|2|||
13073355|NCT00803790|25276217|FG002|Period 1|Lost to Follow-up|0|||
13073356|NCT00803790|25276218|FG003|Period 1|Lost to Follow-up|0|||
13073357|NCT00803790|25276215|FG000|Period 1|Withdrawal by Subject|8|||
13073358|NCT00803790|25276216|FG001|Period 1|Withdrawal by Subject|6|||
13073359|NCT00803790|25276217|FG002|Period 1|Withdrawal by Subject|0|||
13073360|NCT00803790|25276218|FG003|Period 1|Withdrawal by Subject|0|||
13073361|NCT00803790|25276215|FG000|Period 1|positive drug screen or personal reasons|0|||
13073362|NCT00803790|25276216|FG001|Period 1|positive drug screen or personal reasons|3|||
13073363|NCT00803790|25276217|FG002|Period 1|positive drug screen or personal reasons|0|||
13073364|NCT00803790|25276218|FG003|Period 1|positive drug screen or personal reasons|4|||
13073365|NCT00803790|25276215|FG000|Period 1|Protocol Violation|0|||
13073366|NCT00803790|25276216|FG001|Period 1|Protocol Violation|0|||
13073367|NCT00803790|25276217|FG002|Period 1|Protocol Violation|1|||
13073368|NCT00803790|25276218|FG003|Period 1|Protocol Violation|0|||
13073369|NCT00803790|25276215|FG000|Period 2|Adverse Event|0|||
13073370|NCT00803790|25276216|FG001|Period 2|Adverse Event|0|||
13073371|NCT00803790|25276217|FG002|Period 2|Adverse Event|1|||
13073372|NCT00803790|25276218|FG003|Period 2|Adverse Event|1|||
13073373|NCT00803790|25276215|FG000|Period 2|Withdrawal by Subject|1|||
13073374|NCT00803790|25276216|FG001|Period 2|Withdrawal by Subject|0|||
13073375|NCT00803790|25276217|FG002|Period 2|Withdrawal by Subject|0|||
13073376|NCT00803790|25276218|FG003|Period 2|Withdrawal by Subject|0|||
13073377|NCT00803790|25276215|FG000|Period 2|Positive Drug Screen or Personal Reasons|1|||
13073378|NCT00803790|25276216|FG001|Period 2|Positive Drug Screen or Personal Reasons|0|||
13073379|NCT00803790|25276217|FG002|Period 2|Positive Drug Screen or Personal Reasons|0|||
13073380|NCT00803790|25276218|FG003|Period 2|Positive Drug Screen or Personal Reasons|0|||
13073381|NCT00725491|25276231|FG000|Overall Study|Adverse Event|3|||
13073382|NCT00725491|25276232|FG001|Overall Study|Adverse Event|2|||
13073383|NCT00725491|25276231|FG000|Overall Study|Pregnancy|0|||
13073384|NCT00725491|25276232|FG001|Overall Study|Pregnancy|3|||
13073385|NCT00725491|25276231|FG000|Overall Study|Risk for hyperstimulation|2|||
13073386|NCT00725491|25276232|FG001|Overall Study|Risk for hyperstimulation|9|||
13073387|NCT00725491|25276231|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1|||
13073388|NCT00725491|25276232|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1|||
13073389|NCT00725491|25276231|FG000|Overall Study|Fertilization failure|0|||
13073390|NCT00725491|25276232|FG001|Overall Study|Fertilization failure|1|||
13073391|NCT00725491|25276231|FG000|Overall Study|No/too few embryos/ bad quality embryos|3|||
13073392|NCT00725491|25276232|FG001|Overall Study|No/too few embryos/ bad quality embryos|2|||
13073393|NCT00702845|25276277|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2|||
13073394|NCT00702845|25276278|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2|||
13073395|NCT00702845|25276277|FG000|Overall Study|Too high ovarian response|5|||
13073396|NCT00702845|25276278|FG001|Overall Study|Too high ovarian response|1|||
13073397|NCT00702845|25276277|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1|||
13073398|NCT00702845|25276278|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0|||
13073399|NCT00702845|25276277|FG000|Overall Study|Insufficient ovarian response|1|||
13073400|NCT00702845|25276278|FG001|Overall Study|Insufficient ovarian response|0|||
13073401|NCT00702845|25276277|FG000|Overall Study|No/too few/bad quality embryos retrieved|7|||
13073402|NCT00702845|25276278|FG001|Overall Study|No/too few/bad quality embryos retrieved|1|||
13073403|NCT00702845|25276277|FG000|Overall Study|No or abnormal fertilization|4|||
13073404|NCT00702845|25276278|FG001|Overall Study|No or abnormal fertilization|2|||
13073405|NCT00702845|25276277|FG000|Overall Study|Patient's decision|2|||
13073406|NCT00702845|25276278|FG001|Overall Study|Patient's decision|1|||
13073407|NCT00702845|25276277|FG000|Overall Study|Not randomized|0|||
13073408|NCT00702845|25276278|FG001|Overall Study|Not randomized|1|||
13073409|NCT00697255|25276301|FG000|Stage 1a|Insufficient ovarian response|1|||
13073410|NCT00697255|25276302|FG001|Stage 1a|Insufficient ovarian response|0|||
13073411|NCT00697255|25276301|FG000|Stage 1a|Multifollicular growth|1|||
13073412|NCT00697255|25276302|FG001|Stage 1a|Multifollicular growth|0|||
13073413|NCT00697255|25276301|FG000|Stage 1a|Not growing of dominant follicle|1|||
13073414|NCT00697255|25276302|FG001|Stage 1a|Not growing of dominant follicle|0|||
13073415|NCT00697255|25276301|FG000|Stage 1b|Not growing of dominant follicle|0|||
13073416|NCT00697255|25276302|FG001|Stage 1b|Not growing of dominant follicle|1|||
13073417|NCT00697255|25276301|FG000|Stage 1b|Insufficient ovarian response|0|||
13073418|NCT00697255|25276302|FG001|Stage 1b|Insufficient ovarian response|1|||
13073419|NCT00696878|25276376|FG000|Overall Study|Adverse Event|8|||
13073420|NCT00696878|25276376|FG000|Overall Study|Withdrawal by Subject|87|||
13073421|NCT00696878|25276376|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18|||
13073422|NCT00696878|25276376|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304|||
13073423|NCT00696878|25276376|FG000|Overall Study|Trial stopped|32|||
13073424|NCT00696878|25276376|FG000|Overall Study|Other reason (not specified)|55|||
13073425|NCT00696800|25276433|FG000|Overall Study|Adverse Event|16|||
13073426|NCT00696800|25276434|FG001|Overall Study|Adverse Event|3|||
13073427|NCT00696800|25276433|FG000|Overall Study|Insufficient compliance with medication|2|||
13073428|NCT00696800|25276434|FG001|Overall Study|Insufficient compliance with medication|1|||
13073429|NCT00696800|25276433|FG000|Overall Study|Insufficient ovarian response on Day 8|4|||
13073430|NCT00696800|25276434|FG001|Overall Study|Insufficient ovarian response on Day 8|1|||
13073431|NCT00696800|25276433|FG000|Overall Study|Insufficient ovarian response|4|||
13073432|NCT00696800|25276434|FG001|Overall Study|Insufficient ovarian response|1|||
13073433|NCT00696800|25276433|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8|||
13073434|NCT00696800|25276434|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2|||
13073435|NCT00696800|25276433|FG000|Overall Study|Too high ovarian response|6|||
13073436|NCT00696800|25276434|FG001|Overall Study|Too high ovarian response|1|||
13073437|NCT00696800|25276433|FG000|Overall Study|No/too few/bad quality oocytes|4|||
13073438|NCT00696800|25276434|FG001|Overall Study|No/too few/bad quality oocytes|3|||
13073439|NCT00696800|25276433|FG000|Overall Study|No/abnormal fertilization|11|||
13073440|NCT00696800|25276434|FG001|Overall Study|No/abnormal fertilization|13|||
13073441|NCT00696800|25276433|FG000|Overall Study|No/too few/bad quality embryos|24|||
13073442|NCT00696800|25276434|FG001|Overall Study|No/too few/bad quality embryos|18|||
13073443|NCT00696800|25276433|FG000|Overall Study|Other Reasons|5|||
13073444|NCT00696800|25276434|FG001|Overall Study|Other Reasons|3|||
13073445|NCT00696800|25276433|FG000|Overall Study|Not treated|1|||
13073446|NCT00696800|25276434|FG001|Overall Study|Not treated|2|||
13073447|NCT00616967|25276464|FG000|Overall Study|Withdrawal by Subject|0|||
13073448|NCT00616967|25276465|FG001|Overall Study|Withdrawal by Subject|0|||
13073449|NCT00616967|25276466|FG002|Overall Study|Withdrawal by Subject|1|||
13073450|NCT00461032|25276485|FG000|Overall Study|Adverse Event|5|||
13073451|NCT00461032|25276486|FG001|Overall Study|Adverse Event|6|||
13073452|NCT00461032|25276485|FG000|Overall Study|Lack of Efficacy|5|||
13073453|NCT00461032|25276486|FG001|Overall Study|Lack of Efficacy|1|||
13073454|NCT00461032|25276485|FG000|Overall Study|Lost to Follow-up|7|||
13073455|NCT00461032|25276486|FG001|Overall Study|Lost to Follow-up|12|||
13073456|NCT00461032|25276485|FG000|Overall Study|Protocol Violation|4|||
13073457|NCT00461032|25276486|FG001|Overall Study|Protocol Violation|4|||
13073458|NCT00461032|25276485|FG000|Overall Study|Withdrawal by Subject|7|||
13073459|NCT00461032|25276486|FG001|Overall Study|Withdrawal by Subject|15|||
13073460|NCT00461032|25276485|FG000|Overall Study|Patient Moved or Relocated|2|||
13073461|NCT00461032|25276486|FG001|Overall Study|Patient Moved or Relocated|1|||
13073462|NCT00461032|25276485|FG000|Overall Study|Other|7|||
13073463|NCT00461032|25276486|FG001|Overall Study|Other|5|||
13073464|NCT00289874|25276521|FG000|Overall Study|Adverse Event|1|||
13073465|NCT00289874|25276522|FG001|Overall Study|Adverse Event|5|||
13073466|NCT00289874|25276521|FG000|Overall Study|Lost to Follow-up|1|||
13073467|NCT00289874|25276522|FG001|Overall Study|Lost to Follow-up|1|||
13073468|NCT00289874|25276521|FG000|Overall Study|Protocol Violation|3|||
13073469|NCT00289874|25276522|FG001|Overall Study|Protocol Violation|2|||
13073470|NCT00289874|25276521|FG000|Overall Study|Did not meet eligibility|1|||
13073471|NCT00289874|25276522|FG001|Overall Study|Did not meet eligibility|0|||
13073472|NCT00250458|25276537|FG000|Overall Study|Lost to Follow-up|4|||
13073473|NCT00250458|25276538|FG001|Overall Study|Lost to Follow-up|2|||
13073474|NCT00250458|25276537|FG000|Overall Study|Protocol Violation|0|||
13073475|NCT00250458|25276538|FG001|Overall Study|Protocol Violation|1|||
13073476|NCT00250458|25276537|FG000|Overall Study|Withdrawal by Subject|4|||
13073477|NCT00250458|25276538|FG001|Overall Study|Withdrawal by Subject|2|||
13073478|NCT00250458|25276537|FG000|Overall Study|Lack of Migraine Attack|20|||
13073479|NCT00250458|25276538|FG001|Overall Study|Lack of Migraine Attack|9|||
13073480|NCT00250458|25276537|FG000|Overall Study|Qualifying migraine but did not treat|3|||
13073481|NCT00250458|25276538|FG001|Overall Study|Qualifying migraine but did not treat|3|||
13073482|NCT00250458|25276537|FG000|Overall Study|Other|1|||
13073483|NCT00250458|25276538|FG001|Overall Study|Other|0|||
13073484|NCT00245570|25276589|FG000|Washout Between Periods III and IV|Adverse Event|0|||
13073485|NCT00245570|25276590|FG001|Washout Between Periods III and IV|Adverse Event|1|||
13073486|NCT00245570|25276591|FG002|Washout Between Periods III and IV|Adverse Event|0|||
13073487|NCT00245570|25276592|FG003|Washout Between Periods III and IV|Adverse Event|0|||
13073488|NCT00245570|25276593|FG004|Washout Between Periods III and IV|Adverse Event|0|||
13073489|NCT00245570|25276594|FG005|Washout Between Periods III and IV|Adverse Event|0|||
13073490|NCT00092131|25276645|FG000|Treatment Period I|Adverse Event|1|||
13073491|NCT00092131|25276646|FG001|Treatment Period I|Adverse Event|0|||
13073492|NCT00092131|25276645|FG000|Treatment Period II|Adverse Event|0|||
13073493|NCT00092131|25276646|FG001|Treatment Period II|Adverse Event|1|||
13073494|NCT00092118|25276663|FG000|Overall Study|Adverse Event|35|||
13073495|NCT00092118|25276664|FG001|Overall Study|Adverse Event|32|||
13073496|NCT00092118|25276663|FG000|Overall Study|Lack of Efficacy|12|||
13073497|NCT00092118|25276664|FG001|Overall Study|Lack of Efficacy|14|||
13073498|NCT00092118|25276663|FG000|Overall Study|Lost to Follow-up|4|||
13073499|NCT00092118|25276664|FG001|Overall Study|Lost to Follow-up|3|||
13073500|NCT00092118|25276663|FG000|Overall Study|Protocol Violation|23|||
13393339|NCT00665925|26783414|FG003|Overall Study|Physician Decision|2|||
13073501|NCT00092118|25276664|FG001|Overall Study|Protocol Violation|25|||
13073502|NCT00092118|25276663|FG000|Overall Study|Withdrawal by Subject|4|||
13073503|NCT00092118|25276664|FG001|Overall Study|Withdrawal by Subject|10|||
13073504|NCT00092118|25276663|FG000|Overall Study|Other|6|||
13073505|NCT00092118|25276664|FG001|Overall Study|Other|5|||
13073506|NCT00090142|25276695|FG000|Treatment Period I|Lost to Follow-up|1|||
13073507|NCT00090142|25276696|FG001|Treatment Period I|Lost to Follow-up|2|||
13073508|NCT00090142|25276695|FG000|Treatment Period I|Protocol Violation|2|||
13073509|NCT00090142|25276696|FG001|Treatment Period I|Protocol Violation|0|||
13073510|NCT00090142|25276695|FG000|Treatment Period I|Withdrawal by Subject|2|||
13073511|NCT00090142|25276696|FG001|Treatment Period I|Withdrawal by Subject|0|||
13073512|NCT00090142|25276695|FG000|Treatment Period I|Other|0|||
13073513|NCT00090142|25276696|FG001|Treatment Period I|Other|1|||
13073514|NCT00090142|25276695|FG000|Treatment Period II|Other|1|||
13073515|NCT00090142|25276696|FG001|Treatment Period II|Other|0|||
13130170|NCT02848326|25973190|FG005|Treatment Period|Protocol Violation|3|||
13130171|NCT02848326|25973185|FG000|Treatment Period|Non-compliance with Study Drug|4|||
13130172|NCT02848326|25973186|FG001|Treatment Period|Non-compliance with Study Drug|0|||
13130173|NCT02848326|25973187|FG002|Treatment Period|Non-compliance with Study Drug|0|||
13130174|NCT02848326|25973188|FG003|Treatment Period|Non-compliance with Study Drug|1|||
13130175|NCT02848326|25973189|FG004|Treatment Period|Non-compliance with Study Drug|0|||
13130176|NCT02848326|25973190|FG005|Treatment Period|Non-compliance with Study Drug|0|||
13130177|NCT02848326|25973185|FG000|Safety Follow-up Period|Withdrawal of Consent|0|||
13130178|NCT02848326|25973186|FG001|Safety Follow-up Period|Withdrawal of Consent|1|||
13130179|NCT02848326|25973187|FG002|Safety Follow-up Period|Withdrawal of Consent|1|||
13130180|NCT02848326|25973188|FG003|Safety Follow-up Period|Withdrawal of Consent|0|||
13130181|NCT02848326|25973189|FG004|Safety Follow-up Period|Withdrawal of Consent|0|||
13130182|NCT02848326|25973190|FG005|Safety Follow-up Period|Withdrawal of Consent|2|||
13130183|NCT02848326|25973185|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
13130184|NCT02848326|25973186|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
13130185|NCT02848326|25973187|FG002|Safety Follow-up Period|Lost to Follow-up|2|||
13130186|NCT02848326|25973188|FG003|Safety Follow-up Period|Lost to Follow-up|0|||
13130187|NCT02848326|25973189|FG004|Safety Follow-up Period|Lost to Follow-up|1|||
13130188|NCT02848326|25973190|FG005|Safety Follow-up Period|Lost to Follow-up|3|||
13130189|NCT02848313|25973229|FG000|Overall Study|Adverse Event|1|||
13130190|NCT02848313|25973230|FG001|Overall Study|Adverse Event|2|||
13130191|NCT02848313|25973229|FG000|Overall Study|Lack of Efficacy|0|||
13130192|NCT02848313|25973230|FG001|Overall Study|Lack of Efficacy|1|||
13130193|NCT02848313|25973229|FG000|Overall Study|Withdrawal by Subject|1|||
13130194|NCT02848313|25973230|FG001|Overall Study|Withdrawal by Subject|1|||
13130195|NCT02848313|25973229|FG000|Overall Study|Lost to follow up|1|||
13130196|NCT02848313|25973230|FG001|Overall Study|Lost to follow up|0|||
13130197|NCT02847858|25973261|FG000|Overall Study|Lost to Follow-up|401|||
13130198|NCT02847858|25973262|FG001|Overall Study|Lost to Follow-up|269|||
13130199|NCT02847650|25973289|FG000|Overall Study|Adverse Event|2|||
13130200|NCT02847650|25973290|FG001|Overall Study|Adverse Event|4|||
13130201|NCT02847650|25973289|FG000|Overall Study|Lost to Follow-up|1|||
13130202|NCT02847650|25973290|FG001|Overall Study|Lost to Follow-up|0|||
13130203|NCT02847650|25973289|FG000|Overall Study|Protocol Violation|0|||
13130204|NCT02847650|25973290|FG001|Overall Study|Protocol Violation|1|||
13130205|NCT02847650|25973289|FG000|Overall Study|Withdrawal by Subject|1|||
13130206|NCT02847650|25973290|FG001|Overall Study|Withdrawal by Subject|1|||
13130207|NCT02847494|25973307|FG000|Overall Study|Lost to Follow-up|8|||
13130208|NCT02847494|25973308|FG001|Overall Study|Lost to Follow-up|5|||
13130209|NCT02847260|25973322|FG000|Overall Study|Adverse Event|3|||
13130210|NCT02847260|25973322|FG000|Overall Study|Withdrawal by Subject|2|||
13130211|NCT02847260|25973322|FG000|Overall Study|Clinical Deterioration|1|||
13130212|NCT02847260|25973322|FG000|Overall Study|Physician Decision|1|||
13130213|NCT02847182|25973405|FG000|Overall Study|Withdrawal by Subject|0|||
13130214|NCT02847182|25973406|FG001|Overall Study|Withdrawal by Subject|1|||
13130215|NCT02846779|25973439|FG000|Overall Study|Lost Enrollment|83|||
13130216|NCT02846779|25973440|FG001|Overall Study|Lost Enrollment|82|||
13130217|NCT02846779|25973441|FG002|Overall Study|Lost Enrollment|86|||
13130218|NCT02846779|25973439|FG000|Overall Study|Less than 31 days of follow-up|56|||
13130219|NCT02846779|25973440|FG001|Overall Study|Less than 31 days of follow-up|45|||
13130220|NCT02846779|25973441|FG002|Overall Study|Less than 31 days of follow-up|52|||
13130221|NCT02846558|25973490|FG000|Overall Study|Adverse Event|1|||
13130222|NCT02846558|25973491|FG001|Overall Study|Adverse Event|0|||
13130223|NCT02846558|25973492|FG002|Overall Study|Adverse Event|0|||
13130224|NCT02846558|25973493|FG003|Overall Study|Adverse Event|0|||
13130225|NCT02846558|25973490|FG000|Overall Study|Withdrawal by Subject|5|||
13130226|NCT02846558|25973491|FG001|Overall Study|Withdrawal by Subject|4|||
13130227|NCT02846558|25973492|FG002|Overall Study|Withdrawal by Subject|2|||
13130228|NCT02846558|25973493|FG003|Overall Study|Withdrawal by Subject|2|||
13130229|NCT02846558|25973490|FG000|Overall Study|Lost to Follow-up|2|||
13130230|NCT02846558|25973491|FG001|Overall Study|Lost to Follow-up|0|||
13130231|NCT02846558|25973492|FG002|Overall Study|Lost to Follow-up|0|||
13130232|NCT02846558|25973493|FG003|Overall Study|Lost to Follow-up|0|||
13130233|NCT02846532|25973583|FG000|Overall Study|Lost to Follow-up|0|||
13130234|NCT02846532|25973584|FG001|Overall Study|Lost to Follow-up|1|||
13130235|NCT02846532|25973585|FG002|Overall Study|Lost to Follow-up|1|||
13130236|NCT02846532|25973583|FG000|Overall Study|Withdrawal by Subject|1|||
13073516|NCT04771013|25276724|FG000|Overall Study|Withdrawal by Subject|2|||
13073517|NCT04771013|25276725|FG001|Overall Study|Withdrawal by Subject|0|||
13073518|NCT04771013|25276724|FG000|Overall Study|Death|0|||
13073519|NCT04771013|25276725|FG001|Overall Study|Death|5|||
13073520|NCT04771013|25276724|FG000|Overall Study|Referred to another hospital before day 20|0|||
13073521|NCT04771013|25276725|FG001|Overall Study|Referred to another hospital before day 20|1|||
13073522|NCT04497987|25276749|FG000|Overall Study|Adverse Event|1|||
13073523|NCT04497987|25276750|FG001|Overall Study|Adverse Event|0|||
13073524|NCT04497987|25276749|FG000|Overall Study|Death|21|||
13073525|NCT04497987|25276750|FG001|Overall Study|Death|13|||
13073526|NCT04497987|25276749|FG000|Overall Study|Lost to Follow-up|19|||
13073527|NCT04497987|25276750|FG001|Overall Study|Lost to Follow-up|17|||
13073528|NCT04497987|25276749|FG000|Overall Study|Other - as reported by the investigator|22|||
13073529|NCT04497987|25276750|FG001|Overall Study|Other - as reported by the investigator|16|||
13073530|NCT04497987|25276749|FG000|Overall Study|Physician Decision|1|||
13073531|NCT04497987|25276750|FG001|Overall Study|Physician Decision|0|||
13073532|NCT04497987|25276749|FG000|Overall Study|Withdrawal by Subject|35|||
13073533|NCT04497987|25276750|FG001|Overall Study|Withdrawal by Subject|21|||
13073534|NCT03512210|25276803|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3|||
13073535|NCT03512210|25276803|FG000|Step 1: MINMON Intervention|Protocol Violation|1|||
13073536|NCT03512210|25276803|FG000|Step 2:Post-MINMON|Death|2|||
13073537|NCT03512210|25276803|FG000|Step 2:Post-MINMON|Lost to Follow-up|30|||
13073538|NCT03512210|25276803|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2|||
13073539|NCT03180307|25276902|FG000|Overall Study|Lost to Follow-up|2|||
13073540|NCT03180307|25276903|FG001|Overall Study|Lost to Follow-up|0|||
13073541|NCT03180307|25276902|FG000|Overall Study|Death|1|||
13073542|NCT03180307|25276903|FG001|Overall Study|Death|0|||
13073543|NCT03180307|25276902|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3|||
13073544|NCT03180307|25276903|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0|||
13073545|NCT02668822|25276930|FG000|Overall Study|Protocol Violation|2|||
13073546|NCT02668822|25276931|FG001|Overall Study|Protocol Violation|0|||
13073547|NCT02668822|25276930|FG000|Overall Study|Study Terminated by Sponsor|7|||
13073548|NCT02668822|25276931|FG001|Overall Study|Study Terminated by Sponsor|9|||
13073549|NCT02668783|25276958|FG000|Overall Study|Pregnancy|0|||
13073550|NCT02668783|25276959|FG001|Overall Study|Pregnancy|1|||
13073551|NCT02668783|25276958|FG000|Overall Study|Protocol Violation|2|||
13073552|NCT02668783|25276959|FG001|Overall Study|Protocol Violation|1|||
13073553|NCT02668783|25276958|FG000|Overall Study|Study terminated by sponsor|9|||
13073554|NCT02668783|25276959|FG001|Overall Study|Study terminated by sponsor|10|||
13073555|NCT02668783|25276958|FG000|Overall Study|Subject moved|1|||
13073556|NCT02668783|25276959|FG001|Overall Study|Subject moved|0|||
13073557|NCT02668783|25276958|FG000|Overall Study|Withdrawal by Subject|1|||
13073558|NCT02668783|25276959|FG001|Overall Study|Withdrawal by Subject|0|||
13073559|NCT02616146|25276980|FG000|Overall Study|Adverse Event|64|||
13073560|NCT02616146|25276981|FG001|Overall Study|Adverse Event|24|||
13073561|NCT02616146|25276980|FG000|Overall Study|Lost to Follow-up|23|||
13073562|NCT02616146|25276981|FG001|Overall Study|Lost to Follow-up|13|||
13073563|NCT02616146|25276980|FG000|Overall Study|Non-compliance with study protocol|2|||
13073564|NCT02616146|25276981|FG001|Overall Study|Non-compliance with study protocol|0|||
13073565|NCT02616146|25276980|FG000|Overall Study|Non-compliance with study drug|4|||
13073566|NCT02616146|25276981|FG001|Overall Study|Non-compliance with study drug|2|||
13073567|NCT02616146|25276980|FG000|Overall Study|Pregnancy|2|||
13073568|NCT02616146|25276981|FG001|Overall Study|Pregnancy|2|||
13073569|NCT02616146|25276980|FG000|Overall Study|Pregnancy wish|3|||
13073570|NCT02616146|25276981|FG001|Overall Study|Pregnancy wish|0|||
13073571|NCT02616146|25276980|FG000|Overall Study|Protocol Violation|6|||
13073572|NCT02616146|25276981|FG001|Overall Study|Protocol Violation|3|||
13073573|NCT02616146|25276980|FG000|Overall Study|Study terminated by sponsor|1372|||
13073574|NCT02616146|25276981|FG001|Overall Study|Study terminated by sponsor|432|||
13073575|NCT02616146|25276980|FG000|Overall Study|Participant moved|4|||
13073576|NCT02616146|25276981|FG001|Overall Study|Participant moved|3|||
13073577|NCT02616146|25276980|FG000|Overall Study|Withdrawal by Subject|30|||
13073578|NCT02616146|25276981|FG001|Overall Study|Withdrawal by Subject|24|||
13073579|NCT02616146|25276980|FG000|Overall Study|Physician Decision|2|||
13073580|NCT02616146|25276981|FG001|Overall Study|Physician Decision|1|||
13073581|NCT02524288|25276991|FG000|Overall Study|Adverse Event|115|||
13073582|NCT02524288|25276991|FG000|Overall Study|Lost to Follow-up|216|||
13073583|NCT02524288|25276991|FG000|Overall Study|Non-Compliance With Protocol|32|||
13073584|NCT02524288|25276991|FG000|Overall Study|Non-Compliance With Study Drug|14|||
13073585|NCT02524288|25276991|FG000|Overall Study|Pregnancy Wish|6|||
13073586|NCT02524288|25276991|FG000|Overall Study|Protocol Violation|6|||
13073587|NCT02524288|25276991|FG000|Overall Study|Screen Failure|2|||
13073588|NCT02524288|25276991|FG000|Overall Study|Site Discontinued Study Participation|1|||
13073589|NCT02524288|25276991|FG000|Overall Study|Study Terminated By Sponsor|1417|||
13073590|NCT02524288|25276991|FG000|Overall Study|Subject Moved|32|||
13073591|NCT02524288|25276991|FG000|Overall Study|Withdrawal by Subject|76|||
13073592|NCT02524288|25276991|FG000|Overall Study|Pregnancy|22|||
13073593|NCT02524288|25276991|FG000|Overall Study|Physician Decision|2|||
13073594|NCT02275546|25277020|FG000|Treatment Period 2|Withdrawal by Subject|2|||
13073595|NCT02275546|25277021|FG001|Treatment Period 2|Withdrawal by Subject|1|||
13073596|NCT02275546|25277020|FG000|Treatment Period 2|Protocol Violation|0|||
13073597|NCT02275546|25277021|FG001|Treatment Period 2|Protocol Violation|1|||
13073598|NCT02077166|25277088|FG000|Overall Study|Death|6|||
13073599|NCT02077166|25277089|FG001|Overall Study|Death|7|||
13073600|NCT02077166|25277090|FG002|Overall Study|Death|5|||
13073601|NCT02077166|25277091|FG003|Overall Study|Death|6|||
13073602|NCT02077166|25277092|FG004|Overall Study|Death|4|||
13073603|NCT02077166|25277093|FG005|Overall Study|Death|32|||
13073604|NCT02077166|25277094|FG006|Overall Study|Death|22|||
13073605|NCT02077166|25277088|FG000|Overall Study|Study Closure by Sponsor|3|||
13073606|NCT02077166|25277089|FG001|Overall Study|Study Closure by Sponsor|0|||
13073607|NCT02077166|25277090|FG002|Overall Study|Study Closure by Sponsor|2|||
13073608|NCT02077166|25277091|FG003|Overall Study|Study Closure by Sponsor|2|||
13073609|NCT02077166|25277092|FG004|Overall Study|Study Closure by Sponsor|2|||
13073610|NCT02077166|25277093|FG005|Overall Study|Study Closure by Sponsor|12|||
13073611|NCT02077166|25277094|FG006|Overall Study|Study Closure by Sponsor|4|||
13073612|NCT02077166|25277088|FG000|Overall Study|Lost to Follow-up|0|||
13073613|NCT02077166|25277089|FG001|Overall Study|Lost to Follow-up|0|||
13073614|NCT02077166|25277090|FG002|Overall Study|Lost to Follow-up|0|||
13073615|NCT02077166|25277091|FG003|Overall Study|Lost to Follow-up|0|||
13073616|NCT02077166|25277092|FG004|Overall Study|Lost to Follow-up|0|||
13073617|NCT02077166|25277093|FG005|Overall Study|Lost to Follow-up|1|||
13073618|NCT02077166|25277094|FG006|Overall Study|Lost to Follow-up|0|||
13073619|NCT02077166|25277088|FG000|Overall Study|Withdrawal by Subject|3|||
13073620|NCT02077166|25277089|FG001|Overall Study|Withdrawal by Subject|0|||
13073621|NCT02077166|25277090|FG002|Overall Study|Withdrawal by Subject|1|||
13073622|NCT02077166|25277091|FG003|Overall Study|Withdrawal by Subject|1|||
13073623|NCT02077166|25277092|FG004|Overall Study|Withdrawal by Subject|1|||
13073624|NCT02077166|25277093|FG005|Overall Study|Withdrawal by Subject|3|||
13073625|NCT02077166|25277094|FG006|Overall Study|Withdrawal by Subject|0|||
13073626|NCT02077166|25277088|FG000|Overall Study|Other, Not Specified|0|||
13073627|NCT02077166|25277089|FG001|Overall Study|Other, Not Specified|0|||
13073628|NCT02077166|25277090|FG002|Overall Study|Other, Not Specified|1|||
13073629|NCT02077166|25277091|FG003|Overall Study|Other, Not Specified|0|||
13073630|NCT02077166|25277092|FG004|Overall Study|Other, Not Specified|1|||
13073631|NCT02077166|25277093|FG005|Overall Study|Other, Not Specified|7|||
13073632|NCT02077166|25277094|FG006|Overall Study|Other, Not Specified|8|||
13073633|NCT01891344|25277153|FG000|Overall Study|Ongoing|6|||
13073634|NCT01891344|25277154|FG001|Overall Study|Ongoing|2|||
13073635|NCT01891344|25277155|FG002|Overall Study|Ongoing|0|||
13073636|NCT01891344|25277156|FG003|Overall Study|Ongoing|1|||
13073637|NCT01891344|25277157|FG004|Overall Study|Ongoing|4|||
13073638|NCT01891344|25277158|FG005|Overall Study|Ongoing|1|||
13073639|NCT01891344|25277159|FG006|Overall Study|Ongoing|0|||
13073640|NCT01891344|25277160|FG007|Overall Study|Ongoing|0|||
13073641|NCT01670656|25277203|FG000|Overall Study|Non-compliance with study drug|0|||
13073642|NCT01670656|25277204|FG001|Overall Study|Non-compliance with study drug|0|||
13073643|NCT01670656|25277205|FG002|Overall Study|Non-compliance with study drug|3|||
13073644|NCT01670656|25277206|FG003|Overall Study|Non-compliance with study drug|0|||
13073645|NCT01670656|25277207|FG004|Overall Study|Non-compliance with study drug|1|||
13073646|NCT01670656|25277203|FG000|Overall Study|Pregnancy|0|||
13073647|NCT01670656|25277204|FG001|Overall Study|Pregnancy|0|||
13073648|NCT01670656|25277205|FG002|Overall Study|Pregnancy|0|||
13073649|NCT01670656|25277206|FG003|Overall Study|Pregnancy|0|||
13073650|NCT01670656|25277207|FG004|Overall Study|Pregnancy|1|||
13073651|NCT01670656|25277203|FG000|Overall Study|Withdrawal by Subject|1|||
13073652|NCT01670656|25277204|FG001|Overall Study|Withdrawal by Subject|1|||
13073653|NCT01670656|25277205|FG002|Overall Study|Withdrawal by Subject|0|||
13073654|NCT01670656|25277206|FG003|Overall Study|Withdrawal by Subject|0|||
13073655|NCT01670656|25277207|FG004|Overall Study|Withdrawal by Subject|0|||
13073656|NCT01670656|25277203|FG000|Overall Study|Non-compliance with protocol|0|||
13073657|NCT01670656|25277204|FG001|Overall Study|Non-compliance with protocol|3|||
13073658|NCT01670656|25277205|FG002|Overall Study|Non-compliance with protocol|1|||
13073659|NCT01670656|25277206|FG003|Overall Study|Non-compliance with protocol|1|||
13073660|NCT01670656|25277207|FG004|Overall Study|Non-compliance with protocol|2|||
13073661|NCT01670656|25277203|FG000|Overall Study|Adverse Event|2|||
13073662|NCT01670656|25277204|FG001|Overall Study|Adverse Event|2|||
13073663|NCT01670656|25277205|FG002|Overall Study|Adverse Event|2|||
13073664|NCT01670656|25277206|FG003|Overall Study|Adverse Event|3|||
13073665|NCT01670656|25277207|FG004|Overall Study|Adverse Event|3|||
13073666|NCT01670656|25277203|FG000|Overall Study|Subject withdrew consent|0|||
13073667|NCT01670656|25277204|FG001|Overall Study|Subject withdrew consent|1|||
13073668|NCT01670656|25277205|FG002|Overall Study|Subject withdrew consent|2|||
13073669|NCT01670656|25277206|FG003|Overall Study|Subject withdrew consent|1|||
13073670|NCT01670656|25277207|FG004|Overall Study|Subject withdrew consent|1|||
13073671|NCT01670656|25277203|FG000|Overall Study|Lost to Follow-up|0|||
13073672|NCT01670656|25277204|FG001|Overall Study|Lost to Follow-up|0|||
13073673|NCT01670656|25277205|FG002|Overall Study|Lost to Follow-up|0|||
13073674|NCT01670656|25277206|FG003|Overall Study|Lost to Follow-up|0|||
13073675|NCT01670656|25277207|FG004|Overall Study|Lost to Follow-up|3|||
13073676|NCT01670656|25277203|FG000|Overall Study|Subject moved|0|||
13073677|NCT01670656|25277204|FG001|Overall Study|Subject moved|0|||
13073678|NCT01670656|25277205|FG002|Overall Study|Subject moved|0|||
13073679|NCT01670656|25277206|FG003|Overall Study|Subject moved|1|||
13073680|NCT01670656|25277207|FG004|Overall Study|Subject moved|0|||
13073681|NCT01501955|25277256|FG000|Overall Study|Withdrawal by Subject|1|||
13073682|NCT01501955|25277257|FG001|Overall Study|Withdrawal by Subject|0|||
13073683|NCT01501955|25277256|FG000|Overall Study|Adverse Event|1|||
13073684|NCT01501955|25277257|FG001|Overall Study|Adverse Event|3|||
13073685|NCT01181778|25277273|FG000|Overall Study|Physician Decision|48|||
13073686|NCT00778999|25277346|FG000|Overall Study|Discontinuation: no embryo transfer|14|||
13073687|NCT00778999|25277347|FG001|Overall Study|Discontinuation: no embryo transfer|14|||
13073688|NCT00778999|25277346|FG000|Overall Study|Did not receive recFSH|14|||
13073689|NCT00778999|25277347|FG001|Overall Study|Did not receive recFSH|20|||
13073690|NCT00620464|25277362|FG000|Overall Study|Adverse Event|15|||
13073691|NCT00620464|25277363|FG001|Overall Study|Adverse Event|17|||
13073692|NCT00620464|25277362|FG000|Overall Study|Lost to Follow-up|1|||
13073693|NCT00620464|25277363|FG001|Overall Study|Lost to Follow-up|1|||
13073694|NCT00620464|25277362|FG000|Overall Study|Planning Pregnancy|1|||
13073695|NCT00620464|25277363|FG001|Overall Study|Planning Pregnancy|4|||
13073696|NCT00620464|25277362|FG000|Overall Study|Personal|2|||
13073697|NCT00620464|25277363|FG001|Overall Study|Personal|2|||
13073698|NCT00620464|25277362|FG000|Overall Study|Used prohibited medication|1|||
13073699|NCT00620464|25277363|FG001|Overall Study|Used prohibited medication|0|||
13073700|NCT00620035|25277375|FG000|Overall Study|Adverse Event|106|||
13073701|NCT00620035|25277375|FG000|Overall Study|Withdrawal of Informed Consent|1|||
13073702|NCT00620035|25277375|FG000|Overall Study|Other Reason|38|||
13130237|NCT02846532|25973584|FG001|Overall Study|Withdrawal by Subject|2|||
13130238|NCT02846532|25973585|FG002|Overall Study|Withdrawal by Subject|0|||
13130239|NCT02846415|25973602|FG000|Overall Study|Lost to Follow-up|2|||
13130240|NCT02846415|25973603|FG001|Overall Study|Lost to Follow-up|0|||
13130241|NCT02846415|25973602|FG000|Overall Study|Withdrawal by Subject|1|||
13130242|NCT02846415|25973603|FG001|Overall Study|Withdrawal by Subject|1|||
13130243|NCT02846324|25973646|FG000|Overall Study|Other|1|||
13130244|NCT02846324|25973647|FG001|Overall Study|Other|0|||
13130245|NCT02846324|25973648|FG002|Overall Study|Other|0|||
13130246|NCT02846324|25973649|FG003|Overall Study|Other|0|||
13130247|NCT02846324|25973646|FG000|Overall Study|Withdrawal by Subject|1|||
13130248|NCT02846324|25973647|FG001|Overall Study|Withdrawal by Subject|0|||
13130249|NCT02846324|25973648|FG002|Overall Study|Withdrawal by Subject|4|||
13130250|NCT02846324|25973649|FG003|Overall Study|Withdrawal by Subject|0|||
13130251|NCT02845375|25973670|FG000|Overall Study|upper airway obstruction|1|||
13130252|NCT02845375|25973671|FG001|Overall Study|upper airway obstruction|2|||
13130253|NCT02845375|25973672|FG002|Overall Study|upper airway obstruction|1|||
13130254|NCT02845336|25973703|FG000|Overall Study|Lost to Follow-up|3|||
13130255|NCT02845336|25973704|FG001|Overall Study|Lost to Follow-up|1|||
13130256|NCT02845336|25973703|FG000|Overall Study|Inability to get medication|2|||
13130257|NCT02845336|25973704|FG001|Overall Study|Inability to get medication|0|||
13130258|NCT02844946|25973729|FG000|Overall Study|Lost to Follow-up|7|||
13130259|NCT02844946|25973730|FG001|Overall Study|Lost to Follow-up|0|||
13130260|NCT02844920|25973737|FG000|Overall Study|Lost to Follow-up|2|||
13130261|NCT02844543|25973746|FG000|Overall Study|Withdrawal by Subject|4|||
13130262|NCT02844543|25973746|FG000|Overall Study|Did not meet eligibility criteria|1|||
13130263|NCT02844439|25973783|FG000|Overall Study|Withdrawal by Subject|1|||
13130264|NCT02844439|25973783|FG000|Overall Study|Lost to Follow-up|2|||
13130265|NCT02844439|25973783|FG000|Overall Study|Termination by Sponsor|4|||
13130266|NCT02844439|25973783|FG000|Overall Study|Death|28|||
13130267|NCT02844439|25973783|FG000|Overall Study|Other|5|||
13130268|NCT02843659|25973858|FG000|Overall Study|Subject Withdrew Consent|0|||
13130269|NCT02843659|25973859|FG001|Overall Study|Subject Withdrew Consent|0|||
13130270|NCT02843659|25973860|FG002|Overall Study|Subject Withdrew Consent|1|||
13130271|NCT02843659|25973858|FG000|Overall Study|Administrative Reason by Sponsor|4|||
13130272|NCT02843659|25973859|FG001|Overall Study|Administrative Reason by Sponsor|5|||
13130273|NCT02843659|25973860|FG002|Overall Study|Administrative Reason by Sponsor|4|||
13130274|NCT02843659|25973858|FG000|Overall Study|Adverse Event|0|||
13130275|NCT02843659|25973859|FG001|Overall Study|Adverse Event|1|||
13130276|NCT02843659|25973860|FG002|Overall Study|Adverse Event|0|||
13130277|NCT02843178|25973911|FG000|Overall Study|Lost to Follow-up|8|||
13130278|NCT02843178|25973912|FG001|Overall Study|Lost to Follow-up|8|||
13130279|NCT02843178|25973913|FG002|Overall Study|Lost to Follow-up|6|||
13130280|NCT02843178|25973914|FG003|Overall Study|Lost to Follow-up|3|||
13130281|NCT02843178|25973911|FG000|Overall Study|Withdrawal by Subject|0|||
13130282|NCT02843178|25973912|FG001|Overall Study|Withdrawal by Subject|0|||
13133717|NCT02765165|25988893|FG002|Treatment Period|Study terminated|0|||
13073703|NCT03943147|25277397|FG000|Open-Label MMF Run-in (Part A)|Other reasons|4|||
13073704|NCT03943147|25277398|FG001|Open-Label MMF Run-in (Part A)|Other reasons|0|||
13073705|NCT03943147|25277397|FG000|Open-Label MMF Run-in (Part A)|Adverse Event|1|||
13073706|NCT03943147|25277398|FG001|Open-Label MMF Run-in (Part A)|Adverse Event|0|||
13073707|NCT03943147|25277397|FG000|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|1|||
13073708|NCT03943147|25277398|FG001|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|0|||
13073709|NCT03943147|25277397|FG000|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|1|||
13073710|NCT03943147|25277398|FG001|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|0|||
13073711|NCT03943147|25277397|FG000|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|3|||
13073712|NCT03943147|25277398|FG001|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|0|||
13073713|NCT03943147|25277397|FG000|Blinded Treatment (Part B)|Study terminated by sponsor|3|||
13073714|NCT03943147|25277398|FG001|Blinded Treatment (Part B)|Study terminated by sponsor|0|||
13073715|NCT03730987|25277453|FG000|Overall Study|Lost to Follow-up|2|||
13073716|NCT03730987|25277454|FG001|Overall Study|Lost to Follow-up|0|||
13073717|NCT03730987|25277455|FG002|Overall Study|Lost to Follow-up|2|||
13073718|NCT03730987|25277456|FG003|Overall Study|Lost to Follow-up|0|||
13073719|NCT03722576|25277466|FG000|Overall Study|Withdrawal by Subject|3|||
13073720|NCT03722576|25277466|FG000|Overall Study|Adverse Event|2|||
13073721|NCT03722576|25277466|FG000|Overall Study|Physician Decision|1|||
13073722|NCT03722576|25277466|FG000|Overall Study|Lost to Follow-up|1|||
13073723|NCT03655054|25277475|FG000|Overall Study|Lost to Follow-up|1|||
13073724|NCT03556891|25277484|FG000|Overall Study|Adverse Event|4|||
13073725|NCT03556891|25277484|FG000|Overall Study|MRI Need|3|||
13073726|NCT03556891|25277484|FG000|Overall Study|Device Failure|1|||
13073727|NCT03556891|25277484|FG000|Overall Study|Death|1|||
13073728|NCT03556891|25277484|FG000|Overall Study|Lost to Follow-up|1|||
13073729|NCT03556891|25277484|FG000|Overall Study|Missing at random|1|||
13073730|NCT03556891|25277484|FG000|Overall Study|Missing due to COVID|1|||
13073731|NCT03556891|25277484|FG000|Overall Study|Protocol Violation|1|||
13073732|NCT02843074|25277571|FG000|Overall Study|Withdrawal by Subject|5|||
13073733|NCT02843074|25277571|FG000|Overall Study|Progressive disease|1|||
13073734|NCT02843074|25277571|FG000|Overall Study|Physician Decision|1|||
13073735|NCT02843074|25277571|FG000|Overall Study|Lost to Follow-up|1|||
13073736|NCT02843074|25277571|FG000|Overall Study|Death|9|||
13073737|NCT02727998|25277586|FG000|Overall Study|Lost to Follow-up|3|||
13073738|NCT02727998|25277587|FG001|Overall Study|Lost to Follow-up|3|||
13073739|NCT02727998|25277586|FG000|Overall Study|Withdrawal by Subject|0|||
13073740|NCT02727998|25277587|FG001|Overall Study|Withdrawal by Subject|1|||
13073741|NCT02499120|25277623|FG000|Overall Study|Death|45|||
13073742|NCT02499120|25277624|FG001|Overall Study|Death|42|||
13073743|NCT02499120|25277623|FG000|Overall Study|Lost to Follow-up|1|||
13073744|NCT02499120|25277624|FG001|Overall Study|Lost to Follow-up|2|||
13073745|NCT02499120|25277623|FG000|Overall Study|Participant refused further follow-up|1|||
13073746|NCT02499120|25277624|FG001|Overall Study|Participant refused further follow-up|0|||
13073747|NCT02499120|25277623|FG000|Overall Study|Withdrawal by Subject|2|||
13073748|NCT02499120|25277624|FG001|Overall Study|Withdrawal by Subject|5|||
13073749|NCT02499120|25277623|FG000|Overall Study|Other|1|||
13073750|NCT02499120|25277624|FG001|Overall Study|Other|0|||
13073751|NCT02499120|25277623|FG000|Overall Study|Ongoing on study|15|||
13073752|NCT02499120|25277624|FG001|Overall Study|Ongoing on study|11|||
13073753|NCT01405963|25277665|FG000|Overall Study|Moved Away|2|||
13073754|NCT01405963|25277666|FG001|Overall Study|Moved Away|0|||
13073755|NCT01405963|25277665|FG000|Overall Study|Adverse Event|0|||
13073756|NCT01405963|25277666|FG001|Overall Study|Adverse Event|1|||
13073757|NCT01405963|25277665|FG000|Overall Study|Lost to Follow-up|0|||
13073758|NCT01405963|25277666|FG001|Overall Study|Lost to Follow-up|1|||
13073759|NCT00210249|25277672|FG000|Overall Study|Lost to Follow-up|5|||
13073760|NCT00210249|25277672|FG000|Overall Study|Protocol Violation|11|||
13073761|NCT03626168|25277719|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
13073762|NCT03626168|25277720|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
13073763|NCT03626168|25277719|FG000|First Intervention (4 Weeks)|Began a medication that precluded participation|0|||
13073764|NCT03626168|25277720|FG001|First Intervention (4 Weeks)|Began a medication that precluded participation|1|||
13073765|NCT03626168|25277719|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
13073766|NCT03626168|25277720|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
13073767|NCT04579393|25277780|FG000|Overall Study|Withdrawal by Subject|2|||
13073768|NCT04579393|25277781|FG001|Overall Study|Withdrawal by Subject|2|||
13485130|NCT03033069|27031606|FG003|Overall Study|Reason not Specified|1|||
13485131|NCT02587598|27031748|FG000|Overall Study|Death|4|||
13485132|NCT02587598|27031749|FG001|Overall Study|Death|8|||
13485133|NCT02587598|27031750|FG002|Overall Study|Death|4|||
13485134|NCT02587598|27031751|FG003|Overall Study|Death|16|||
13485135|NCT02587598|27031752|FG004|Overall Study|Death|9|||
13485136|NCT02587598|27031753|FG005|Overall Study|Death|4|||
13485137|NCT02587598|27031754|FG006|Overall Study|Death|6|||
13485138|NCT02587598|27031755|FG007|Overall Study|Death|7|||
13485139|NCT02587598|27031756|FG008|Overall Study|Death|9|||
13485140|NCT02587598|27031757|FG009|Overall Study|Death|1|||
13485141|NCT02587598|27031758|FG010|Overall Study|Death|3|||
13485142|NCT02587598|27031748|FG000|Overall Study|Study Terminated by the Sponsor|0|||
13485143|NCT02587598|27031749|FG001|Overall Study|Study Terminated by the Sponsor|1|||
13485144|NCT02587598|27031750|FG002|Overall Study|Study Terminated by the Sponsor|0|||
13485145|NCT02587598|27031751|FG003|Overall Study|Study Terminated by the Sponsor|3|||
13485146|NCT02587598|27031752|FG004|Overall Study|Study Terminated by the Sponsor|0|||
13485147|NCT02587598|27031753|FG005|Overall Study|Study Terminated by the Sponsor|1|||
13485148|NCT02587598|27031754|FG006|Overall Study|Study Terminated by the Sponsor|0|||
13485149|NCT02587598|27031755|FG007|Overall Study|Study Terminated by the Sponsor|0|||
13485150|NCT02587598|27031756|FG008|Overall Study|Study Terminated by the Sponsor|0|||
13485151|NCT02587598|27031757|FG009|Overall Study|Study Terminated by the Sponsor|1|||
13485152|NCT02587598|27031758|FG010|Overall Study|Study Terminated by the Sponsor|6|||
13485153|NCT02587598|27031748|FG000|Overall Study|Reason for study withdrawal not specified|0|||
13485154|NCT02587598|27031749|FG001|Overall Study|Reason for study withdrawal not specified|1|||
13485155|NCT02587598|27031750|FG002|Overall Study|Reason for study withdrawal not specified|0|||
13485156|NCT02587598|27031751|FG003|Overall Study|Reason for study withdrawal not specified|0|||
13485157|NCT02587598|27031752|FG004|Overall Study|Reason for study withdrawal not specified|0|||
13485158|NCT02587598|27031753|FG005|Overall Study|Reason for study withdrawal not specified|0|||
13485159|NCT02587598|27031754|FG006|Overall Study|Reason for study withdrawal not specified|0|||
13485160|NCT02587598|27031755|FG007|Overall Study|Reason for study withdrawal not specified|0|||
13485161|NCT02587598|27031756|FG008|Overall Study|Reason for study withdrawal not specified|0|||
13485162|NCT02587598|27031757|FG009|Overall Study|Reason for study withdrawal not specified|0|||
13485163|NCT02587598|27031758|FG010|Overall Study|Reason for study withdrawal not specified|0|||
13485164|NCT02587598|27031748|FG000|Overall Study|Withdrawal by Subject|0|||
13485165|NCT02587598|27031749|FG001|Overall Study|Withdrawal by Subject|1|||
13485166|NCT02587598|27031750|FG002|Overall Study|Withdrawal by Subject|0|||
13485167|NCT02587598|27031751|FG003|Overall Study|Withdrawal by Subject|2|||
13485168|NCT02587598|27031752|FG004|Overall Study|Withdrawal by Subject|3|||
13485169|NCT02587598|27031753|FG005|Overall Study|Withdrawal by Subject|1|||
13485170|NCT02587598|27031754|FG006|Overall Study|Withdrawal by Subject|0|||
13485171|NCT02587598|27031755|FG007|Overall Study|Withdrawal by Subject|0|||
13485172|NCT02587598|27031756|FG008|Overall Study|Withdrawal by Subject|0|||
13485173|NCT02587598|27031757|FG009|Overall Study|Withdrawal by Subject|1|||
13485174|NCT02587598|27031758|FG010|Overall Study|Withdrawal by Subject|2|||
13485175|NCT02587598|27031748|FG000|Overall Study|Physician Decision|0|||
13485176|NCT02587598|27031749|FG001|Overall Study|Physician Decision|0|||
13485177|NCT02587598|27031750|FG002|Overall Study|Physician Decision|0|||
13485178|NCT02587598|27031751|FG003|Overall Study|Physician Decision|0|||
13485179|NCT02587598|27031752|FG004|Overall Study|Physician Decision|0|||
13485180|NCT02587598|27031753|FG005|Overall Study|Physician Decision|0|||
13485181|NCT02587598|27031754|FG006|Overall Study|Physician Decision|0|||
13485182|NCT02587598|27031755|FG007|Overall Study|Physician Decision|0|||
13485183|NCT02587598|27031756|FG008|Overall Study|Physician Decision|0|||
13485184|NCT02587598|27031757|FG009|Overall Study|Physician Decision|0|||
13485185|NCT02587598|27031758|FG010|Overall Study|Physician Decision|3|||
13485186|NCT02485574|27031770|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4|||
13485187|NCT01460160|27031787|FG000|Treatment Phase|Lack of Efficacy|3|||
13485188|NCT01460160|27031787|FG000|Treatment Phase|Study Drug Toxicity|2|||
13485189|NCT01460160|27031787|FG000|Treatment Phase|Adverse Event|8|||
13485190|NCT01460160|27031787|FG000|Treatment Phase|Withdrawal by Subject|4|||
13485191|NCT01460160|27031787|FG000|Treatment Phase|Death|2|||
13485192|NCT01460160|27031787|FG000|Treatment Phase|Other reasons|9|||
13485193|NCT01460160|27031787|FG000|Follow-up Phase|Withdrawal by Subject|4|||
13485194|NCT01460160|27031787|FG000|Follow-up Phase|Death|14|||
13485195|NCT01460160|27031787|FG000|Follow-up Phase|Lost to Follow-up|7|||
13485196|NCT01460160|27031787|FG000|Follow-up Phase|Follow-up no longer required per protocol|70|||
13485197|NCT01460160|27031787|FG000|Follow-up Phase|Other and not reported reasons|5|||
13485198|NCT01170702|27031838|FG000|Overall Study|Exclusion criteria met after consent|1|||
13485199|NCT01170702|27031839|FG001|Overall Study|Exclusion criteria met after consent|2|||
13485200|NCT01170702|27031840|FG002|Overall Study|Exclusion criteria met after consent|0|||
13485201|NCT01170702|27031841|FG003|Overall Study|Exclusion criteria met after consent|2|||
13485202|NCT01018563|27031860|FG000|Overall Study|Termination of the study by Sponsor|2|||
13485203|NCT01018563|27031861|FG001|Overall Study|Termination of the study by Sponsor|1|||
13485204|NCT00805961|27031870|FG000|Modality Therapy|Withdrawal by Subject|1|||
13485205|NCT00805961|27031870|FG000|Modality Therapy|Adverse Event|1|||
13485206|NCT00805961|27031870|FG000|Modality Therapy|Disease Progression|2|||
13485207|NCT00805961|27031870|FG000|Treatment-Free Interval|Adverse Event|3|||
13485208|NCT00805961|27031870|FG000|Treatment-Free Interval|Intercurrent Illness|2|||
13485209|NCT00805961|27031870|FG000|Treatment-Free Interval|Physician Decision|1|||
13485210|NCT00805961|27031870|FG000|Treatment-Free Interval|Lack of Efficacy|1|||
13485211|NCT00805961|27031870|FG000|Maintenance Treatment|Lack of Efficacy|13|||
13485212|NCT00805961|27031870|FG000|Maintenance Treatment|Intercurrent Illness|7|||
13485213|NCT00805961|27031870|FG000|Maintenance Treatment|Adverse Event|6|||
13485214|NCT00805961|27031870|FG000|Maintenance Treatment|Withdrawal by Subject|5|||
13485215|NCT00805961|27031870|FG000|Maintenance Treatment|Symptomatic Deterioration|2|||
13485216|NCT00805961|27031870|FG000|Maintenance Treatment|Withdrawn Consent|1|||
13487978|NCT01111565|27041933|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0|||
13487979|NCT01111565|27041934|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0|||
13073769|NCT04579393|25277780|FG000|Overall Study|Death|1|||
13073770|NCT04579393|25277781|FG001|Overall Study|Death|3|||
13073771|NCT04325906|25277836|FG000|Overall Study|Withdrawal by Subject|2|||
13073772|NCT04325906|25277837|FG001|Overall Study|Withdrawal by Subject|0|||
13130283|NCT02843178|25973913|FG002|Overall Study|Withdrawal by Subject|1|||
13130284|NCT02843178|25973914|FG003|Overall Study|Withdrawal by Subject|1|||
13130285|NCT02842866|25973929|FG000|Overall Study|Serious Adverse Event|0|||
13130286|NCT02842866|25973930|FG001|Overall Study|Serious Adverse Event|1|||
13130287|NCT02842866|25973929|FG000|Overall Study|Protocol Violation|4|||
13130288|NCT02842866|25973930|FG001|Overall Study|Protocol Violation|2|||
13130289|NCT02842866|25973929|FG000|Overall Study|Lost to Follow-up|2|||
13130290|NCT02842866|25973930|FG001|Overall Study|Lost to Follow-up|0|||
13130291|NCT02842866|25973929|FG000|Overall Study|Withdrawal by Subject|1|||
13130292|NCT02842866|25973930|FG001|Overall Study|Withdrawal by Subject|0|||
13130293|NCT02842853|25973963|FG000|Overall Study|Non-compliance with the protocol|3|||
13130294|NCT02842853|25973964|FG001|Overall Study|Non-compliance with the protocol|7|||
13130295|NCT02842853|25973965|FG002|Overall Study|Non-compliance with the protocol|2|||
13130296|NCT02842853|25973966|FG003|Overall Study|Non-compliance with the protocol|5|||
13130297|NCT02842853|25973963|FG000|Overall Study|Subject met exclusion criteria|0|||
13130298|NCT02842853|25973964|FG001|Overall Study|Subject met exclusion criteria|1|||
13130299|NCT02842853|25973965|FG002|Overall Study|Subject met exclusion criteria|0|||
13130300|NCT02842853|25973966|FG003|Overall Study|Subject met exclusion criteria|0|||
13130301|NCT02842853|25973963|FG000|Overall Study|Withdrawal by Subject|11|||
13130302|NCT02842853|25973964|FG001|Overall Study|Withdrawal by Subject|13|||
13130303|NCT02842853|25973965|FG002|Overall Study|Withdrawal by Subject|9|||
13130304|NCT02842853|25973966|FG003|Overall Study|Withdrawal by Subject|8|||
13130305|NCT02842853|25973963|FG000|Overall Study|Lost to Follow-up|9|||
13130306|NCT02842853|25973964|FG001|Overall Study|Lost to Follow-up|13|||
13130307|NCT02842853|25973965|FG002|Overall Study|Lost to Follow-up|10|||
13130308|NCT02842853|25973966|FG003|Overall Study|Lost to Follow-up|11|||
13130309|NCT02842736|25973986|FG000|Overall Study|Lost to Follow-up|13|||
13130310|NCT02842736|25973986|FG000|Overall Study|Intervention for menstrual bleeding|17|||
13130311|NCT02842736|25973986|FG000|Overall Study|Withdrawal by Subject|4|||
13130312|NCT02842736|25973986|FG000|Overall Study|Pregnancy|3|||
13130313|NCT02842736|25973986|FG000|Overall Study|Hysterectomy for fibroids|2|||
13130314|NCT02842736|25973986|FG000|Overall Study|Hysterectomy for uterine prolapse|1|||
13130315|NCT02842736|25973986|FG000|Overall Study|IUD: Mirena|1|||
13130316|NCT02842151|25973994|FG000|Overall Study|Adverse Event|1|||
13130317|NCT02842151|25973994|FG000|Overall Study|Subject moved too far away|1|||
13130318|NCT02842073|25974004|FG000|Overall Study|Withdrawal by Subject|1|||
13130319|NCT02841787|25974028|FG000|Overall Study|Lost to Follow-up|1|||
13130320|NCT02841787|25974029|FG001|Overall Study|Lost to Follow-up|0|||
13130321|NCT02841787|25974030|FG002|Overall Study|Lost to Follow-up|0|||
13130322|NCT02841787|25974028|FG000|Overall Study|Symptoms dropped below threshold|1|||
13130323|NCT02841787|25974029|FG001|Overall Study|Symptoms dropped below threshold|0|||
13130324|NCT02841787|25974030|FG002|Overall Study|Symptoms dropped below threshold|0|||
13130325|NCT02841787|25974028|FG000|Overall Study|Withdrawal by Subject|1|||
13130326|NCT02841787|25974029|FG001|Overall Study|Withdrawal by Subject|4|||
13130327|NCT02841787|25974030|FG002|Overall Study|Withdrawal by Subject|0|||
13130328|NCT02841709|25974054|FG000|5th Intervention|Adverse Event|2|||
13130329|NCT02841709|25974055|FG001|5th Intervention|Adverse Event|0|||
13130330|NCT02841709|25974056|FG002|5th Intervention|Adverse Event|0|||
13130331|NCT02841709|25974057|FG003|5th Intervention|Adverse Event|0|||
13130332|NCT02841709|25974058|FG004|5th Intervention|Adverse Event|2|||
13130333|NCT02841280|25974079|FG000|Overall Study|Adverse Event|2|||
13130334|NCT02841280|25974080|FG001|Overall Study|Adverse Event|1|||
13130335|NCT02841280|25974079|FG000|Overall Study|Death|1|||
13130336|NCT02841280|25974080|FG001|Overall Study|Death|0|||
13130337|NCT02841280|25974079|FG000|Overall Study|Lost to Follow-up|2|||
13130338|NCT02841280|25974080|FG001|Overall Study|Lost to Follow-up|2|||
13130339|NCT02841280|25974079|FG000|Overall Study|Withdrawal by Subject|7|||
13130340|NCT02841280|25974080|FG001|Overall Study|Withdrawal by Subject|3|||
13130341|NCT02841280|25974079|FG000|Overall Study|Stop Point: BP above threshold|2|||
13130342|NCT02841280|25974080|FG001|Overall Study|Stop Point: BP above threshold|0|||
13130343|NCT02840721|25974101|FG000|Treatment Period|Adverse Event|1|||
13130344|NCT02840721|25974101|FG000|Follow-Up|Lack of Efficacy|1|||
13130345|NCT02840721|25974101|FG000|Follow-Up|Withdrawal by Subject|4|||
13130346|NCT02840721|25974101|FG000|Follow-Up|Withdrawal of Consent|2|||
13130347|NCT02840474|25974144|FG000|Overall Study|Lost to Follow-up|1|||
13130348|NCT02840474|25974145|FG001|Overall Study|Lost to Follow-up|0|||
13487980|NCT01111565|27041935|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0|||
13073773|NCT04203667|25277865|FG000|Overall Study|Withdrawal by Subject|1|||
13073774|NCT04203667|25277865|FG000|Overall Study|Lost to Follow-up|1|||
13073775|NCT04203667|25277865|FG000|Overall Study|Death|1|||
13073776|NCT04203667|25277865|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1|||
13073777|NCT03679884|25277949|FG000|Overall Study|Other|12|||
13073778|NCT03679884|25277950|FG001|Overall Study|Other|12|||
13073779|NCT03679884|25277951|FG002|Overall Study|Other|12|||
13073780|NCT03679884|25277952|FG003|Overall Study|Other|7|||
13073781|NCT03679884|25277953|FG004|Overall Study|Other|8|||
13073782|NCT03679884|25277949|FG000|Overall Study|Lack of Efficacy|15|||
13073783|NCT03679884|25277950|FG001|Overall Study|Lack of Efficacy|29|||
13073784|NCT03679884|25277951|FG002|Overall Study|Lack of Efficacy|13|||
13073785|NCT03679884|25277952|FG003|Overall Study|Lack of Efficacy|29|||
13073786|NCT03679884|25277953|FG004|Overall Study|Lack of Efficacy|10|||
13073787|NCT03679884|25277949|FG000|Overall Study|Death|1|||
13073788|NCT03679884|25277950|FG001|Overall Study|Death|0|||
13073789|NCT03679884|25277951|FG002|Overall Study|Death|0|||
13073790|NCT03679884|25277952|FG003|Overall Study|Death|0|||
13073791|NCT03679884|25277953|FG004|Overall Study|Death|0|||
13073792|NCT03679884|25277949|FG000|Overall Study|Adverse Event|2|||
13073793|NCT03679884|25277950|FG001|Overall Study|Adverse Event|10|||
13073794|NCT03679884|25277951|FG002|Overall Study|Adverse Event|9|||
13073795|NCT03679884|25277952|FG003|Overall Study|Adverse Event|6|||
13073796|NCT03679884|25277953|FG004|Overall Study|Adverse Event|6|||
13073797|NCT03679884|25277949|FG000|Overall Study|Withdrawal by Subject|12|||
13073798|NCT03679884|25277950|FG001|Overall Study|Withdrawal by Subject|23|||
13073799|NCT03679884|25277951|FG002|Overall Study|Withdrawal by Subject|8|||
13073800|NCT03679884|25277952|FG003|Overall Study|Withdrawal by Subject|8|||
13073801|NCT03679884|25277953|FG004|Overall Study|Withdrawal by Subject|9|||
13073802|NCT03679884|25277949|FG000|Overall Study|Lost to Follow-up|1|||
13073803|NCT03679884|25277950|FG001|Overall Study|Lost to Follow-up|4|||
13073804|NCT03679884|25277951|FG002|Overall Study|Lost to Follow-up|2|||
13073805|NCT03679884|25277952|FG003|Overall Study|Lost to Follow-up|0|||
13073806|NCT03679884|25277953|FG004|Overall Study|Lost to Follow-up|3|||
13073807|NCT03653026|25277992|FG000|Part 1: Placebo-controlled Period|Adverse Event|5|||
13073808|NCT03653026|25277993|FG001|Part 1: Placebo-controlled Period|Adverse Event|6|||
13073809|NCT03653026|25277994|FG002|Part 1: Placebo-controlled Period|Adverse Event|0|||
13073810|NCT03653026|25277995|FG003|Part 1: Placebo-controlled Period|Adverse Event|0|||
13073811|NCT03653026|25277992|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6|||
13073812|NCT03653026|25277993|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4|||
13073813|NCT03653026|25277994|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
13073814|NCT03653026|25277995|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
13073815|NCT03653026|25277992|FG000|Part 1: Placebo-controlled Period|Other|0|||
13073816|NCT03653026|25277993|FG001|Part 1: Placebo-controlled Period|Other|3|||
13073817|NCT03653026|25277994|FG002|Part 1: Placebo-controlled Period|Other|0|||
13073818|NCT03653026|25277995|FG003|Part 1: Placebo-controlled Period|Other|0|||
13073819|NCT03653026|25277992|FG000|Part 2: Open-label Extension|Adverse Event|0|||
13073820|NCT03653026|25277993|FG001|Part 2: Open-label Extension|Adverse Event|0|||
13073821|NCT03653026|25277994|FG002|Part 2: Open-label Extension|Adverse Event|1|||
13073822|NCT03653026|25277995|FG003|Part 2: Open-label Extension|Adverse Event|1|||
13073823|NCT03653026|25277992|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
13073824|NCT03653026|25277993|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
13073825|NCT03653026|25277994|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1|||
13073826|NCT03653026|25277995|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2|||
13073827|NCT03653026|25277992|FG000|Part 2: Open-label Extension|Other|0|||
13073828|NCT03653026|25277993|FG001|Part 2: Open-label Extension|Other|0|||
13073829|NCT03653026|25277994|FG002|Part 2: Open-label Extension|Other|1|||
13073830|NCT03653026|25277995|FG003|Part 2: Open-label Extension|Other|2|||
13073831|NCT03553498|25278021|FG000|Overall Study|Missing primary outcome|1|||
13073832|NCT03553498|25278022|FG001|Overall Study|Missing primary outcome|2|||
13073833|NCT03530293|25278045|FG000|Pre-randomization|Adverse Event|12|||
13073834|NCT03530293|25278046|FG001|Pre-randomization|Adverse Event|0|||
13073835|NCT03530293|25278047|FG002|Pre-randomization|Adverse Event|0|||
13073836|NCT03530293|25278045|FG000|Pre-randomization|Protocol Violation|2|||
13073837|NCT03530293|25278046|FG001|Pre-randomization|Protocol Violation|0|||
13073838|NCT03530293|25278047|FG002|Pre-randomization|Protocol Violation|0|||
13073839|NCT03530293|25278045|FG000|Pre-randomization|Study Terminated by Sponsor|5|||
13073840|NCT03530293|25278046|FG001|Pre-randomization|Study Terminated by Sponsor|0|||
13073841|NCT03530293|25278047|FG002|Pre-randomization|Study Terminated by Sponsor|0|||
13073842|NCT03530293|25278045|FG000|Pre-randomization|Withdrawal by Subject|5|||
13073843|NCT03530293|25278046|FG001|Pre-randomization|Withdrawal by Subject|0|||
13073844|NCT03530293|25278047|FG002|Pre-randomization|Withdrawal by Subject|0|||
13073845|NCT03530293|25278045|FG000|Randomized Withdrawal Period / Follow-up|Adverse Event|0|||
13073846|NCT03530293|25278046|FG001|Randomized Withdrawal Period / Follow-up|Adverse Event|2|||
13073847|NCT03530293|25278047|FG002|Randomized Withdrawal Period / Follow-up|Adverse Event|4|||
13130349|NCT02840461|25974166|FG000|Overall Study|Adverse Event|1|||
13073848|NCT03530293|25278045|FG000|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
13073849|NCT03530293|25278046|FG001|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
13073850|NCT03530293|25278047|FG002|Randomized Withdrawal Period / Follow-up|Protocol Violation|1|||
13073851|NCT03530293|25278045|FG000|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|0|||
13073852|NCT03530293|25278046|FG001|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|3|||
13073853|NCT03530293|25278047|FG002|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|2|||
13073854|NCT03530293|25278045|FG000|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
13073855|NCT03530293|25278046|FG001|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|2|||
13073856|NCT03530293|25278047|FG002|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
13073857|NCT03530293|25278045|FG000|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|0|||
13073858|NCT03530293|25278046|FG001|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
13073859|NCT03530293|25278047|FG002|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
13073860|NCT03505749|25278078|FG000|Overall Study|Lost to Follow-up|7|||
13073861|NCT03505749|25278079|FG001|Overall Study|Lost to Follow-up|11|||
13073862|NCT03505749|25278078|FG000|Overall Study|Withdrawal by Subject|6|||
13073863|NCT03505749|25278079|FG001|Overall Study|Withdrawal by Subject|0|||
13073864|NCT03505749|25278078|FG000|Overall Study|Discharged from treatment|3|||
13073865|NCT03505749|25278079|FG001|Overall Study|Discharged from treatment|6|||
13073866|NCT03249376|25278112|FG000|Overall Study|Adverse Event|11|||
13073867|NCT03249376|25278113|FG001|Overall Study|Adverse Event|5|||
13073868|NCT03249376|25278112|FG000|Overall Study|Lack of Efficacy|2|||
13073869|NCT03249376|25278113|FG001|Overall Study|Lack of Efficacy|4|||
13073870|NCT03249376|25278112|FG000|Overall Study|Protocol Violation|3|||
13073871|NCT03249376|25278113|FG001|Overall Study|Protocol Violation|2|||
13073872|NCT03249376|25278112|FG000|Overall Study|Physician Decision|0|||
13073873|NCT03249376|25278113|FG001|Overall Study|Physician Decision|2|||
13073874|NCT03249376|25278112|FG000|Overall Study|Withdrawal by Subject|3|||
13073875|NCT03249376|25278113|FG001|Overall Study|Withdrawal by Subject|9|||
13073876|NCT03249376|25278112|FG000|Overall Study|LTFU|2|||
13073877|NCT03249376|25278113|FG001|Overall Study|LTFU|1|||
13073878|NCT03137381|25278140|FG000|Overall Study|Adverse Event|3|||
13073879|NCT03137381|25278141|FG001|Overall Study|Adverse Event|0|||
13073880|NCT03137381|25278142|FG002|Overall Study|Adverse Event|2|||
13073881|NCT03137381|25278143|FG003|Overall Study|Adverse Event|0|||
13073882|NCT03137381|25278140|FG000|Overall Study|Lost to Follow-up|2|||
13073883|NCT03137381|25278141|FG001|Overall Study|Lost to Follow-up|1|||
13073884|NCT03137381|25278142|FG002|Overall Study|Lost to Follow-up|1|||
13073885|NCT03137381|25278143|FG003|Overall Study|Lost to Follow-up|0|||
13073886|NCT03137381|25278140|FG000|Overall Study|Protocol deviation|1|||
13073887|NCT03137381|25278141|FG001|Overall Study|Protocol deviation|1|||
13073888|NCT03137381|25278142|FG002|Overall Study|Protocol deviation|0|||
13073889|NCT03137381|25278143|FG003|Overall Study|Protocol deviation|1|||
13073890|NCT03137381|25278140|FG000|Overall Study|Withdrawal by Investigator|0|||
13073891|NCT03137381|25278141|FG001|Overall Study|Withdrawal by Investigator|1|||
13073892|NCT03137381|25278142|FG002|Overall Study|Withdrawal by Investigator|1|||
13073893|NCT03137381|25278143|FG003|Overall Study|Withdrawal by Investigator|0|||
13073894|NCT03137381|25278140|FG000|Overall Study|Withdrawal by Subject|3|||
13073895|NCT03137381|25278141|FG001|Overall Study|Withdrawal by Subject|4|||
13073896|NCT03137381|25278142|FG002|Overall Study|Withdrawal by Subject|3|||
13073897|NCT03137381|25278143|FG003|Overall Study|Withdrawal by Subject|0|||
13073898|NCT03137381|25278140|FG000|Overall Study|Pregnancy|0|||
13073899|NCT03137381|25278141|FG001|Overall Study|Pregnancy|0|||
13073900|NCT03137381|25278142|FG002|Overall Study|Pregnancy|1|||
13073901|NCT03137381|25278143|FG003|Overall Study|Pregnancy|0|||
13130350|NCT02840461|25974167|FG001|Overall Study|Adverse Event|5|||
13130351|NCT02840461|25974168|FG002|Overall Study|Adverse Event|3|||
13130352|NCT02840461|25974166|FG000|Overall Study|Lost to Follow-up|10|||
13130353|NCT02840461|25974167|FG001|Overall Study|Lost to Follow-up|7|||
13130354|NCT02840461|25974168|FG002|Overall Study|Lost to Follow-up|6|||
13130355|NCT02840461|25974166|FG000|Overall Study|Non-Comliance with Dosing Requirements|0|||
13130356|NCT02840461|25974167|FG001|Overall Study|Non-Comliance with Dosing Requirements|1|||
13130357|NCT02840461|25974168|FG002|Overall Study|Non-Comliance with Dosing Requirements|0|||
13130358|NCT02840461|25974166|FG000|Overall Study|Protocol Violation|2|||
13130359|NCT02840461|25974167|FG001|Overall Study|Protocol Violation|3|||
13130360|NCT02840461|25974168|FG002|Overall Study|Protocol Violation|1|||
13130361|NCT02840461|25974166|FG000|Overall Study|Withdrawal by Subject|10|||
13130362|NCT02840461|25974167|FG001|Overall Study|Withdrawal by Subject|6|||
13130363|NCT02840461|25974168|FG002|Overall Study|Withdrawal by Subject|2|||
13130364|NCT02840461|25974166|FG000|Overall Study|Worsening of Symptom & Kit Error|0|||
13130365|NCT02840461|25974167|FG001|Overall Study|Worsening of Symptom & Kit Error|0|||
13130366|NCT02840461|25974168|FG002|Overall Study|Worsening of Symptom & Kit Error|2|||
13130367|NCT02840253|25974175|FG000|Overall Study|Unsuccessful block|4|||
13130368|NCT02839876|25974244|FG000|Overall Study|Protocol Violation|10|||
13130369|NCT02839876|25974245|FG001|Overall Study|Protocol Violation|11|||
13130370|NCT02839798|25974253|FG000|Overall Study|Withdrawal by Subject|2|||
13073902|NCT03118570|25278248|FG000|Overall Study|Adverse Event|2|||
13073903|NCT03118570|25278249|FG001|Overall Study|Adverse Event|0|||
13073904|NCT03118570|25278250|FG002|Overall Study|Adverse Event|0|||
13073905|NCT03118570|25278251|FG003|Overall Study|Adverse Event|0|||
13073906|NCT03118570|25278252|FG004|Overall Study|Adverse Event|3|||
13073907|NCT03118570|25278248|FG000|Overall Study|Withdrawal by Subject|0|||
13073908|NCT03118570|25278249|FG001|Overall Study|Withdrawal by Subject|1|||
13073909|NCT03118570|25278250|FG002|Overall Study|Withdrawal by Subject|4|||
13073910|NCT03118570|25278251|FG003|Overall Study|Withdrawal by Subject|0|||
13073911|NCT03118570|25278252|FG004|Overall Study|Withdrawal by Subject|1|||
13073912|NCT03118570|25278248|FG000|Overall Study|Lost to Follow-up|2|||
13073913|NCT03118570|25278249|FG001|Overall Study|Lost to Follow-up|3|||
13073914|NCT03118570|25278250|FG002|Overall Study|Lost to Follow-up|1|||
13073915|NCT03118570|25278251|FG003|Overall Study|Lost to Follow-up|0|||
13073916|NCT03118570|25278252|FG004|Overall Study|Lost to Follow-up|1|||
13073917|NCT03118570|25278248|FG000|Overall Study|Other, Not Specified|1|||
13073918|NCT03118570|25278249|FG001|Overall Study|Other, Not Specified|3|||
13073919|NCT03118570|25278250|FG002|Overall Study|Other, Not Specified|0|||
13073920|NCT03118570|25278251|FG003|Overall Study|Other, Not Specified|0|||
13073921|NCT03118570|25278252|FG004|Overall Study|Other, Not Specified|0|||
13073922|NCT04905498|25278271|FG000|Overall Study|Lost to Follow-up|0|||
13073923|NCT04905498|25278272|FG001|Overall Study|Lost to Follow-up|2|||
13073924|NCT04905498|25278271|FG000|Overall Study|COVID lockdown|1|||
13073925|NCT04905498|25278272|FG001|Overall Study|COVID lockdown|0|||
13073926|NCT04889222|25278280|FG000|Overall Study|Did not meet eligibility criteria|8|||
13073927|NCT04889222|25278280|FG000|Overall Study|Failure to place intravenous or arterial line|3|||
13073928|NCT04889222|25278280|FG000|Overall Study|Did not proceed due to time constraints|5|||
13073929|NCT04702997|25278293|FG000|Overall Study|Withdrawal by Subject|1|||
13073930|NCT04702997|25278294|FG001|Overall Study|Withdrawal by Subject|1|||
13073931|NCT04112173|25278336|FG000|Overall Study|Study terminated due to COVID-19 pandemic|1|||
13073932|NCT04016714|25278367|FG000|Overall Study|Death|1|||
13073933|NCT04016714|25278368|FG001|Overall Study|Death|0|||
13073934|NCT04016714|25278367|FG000|Overall Study|Lost to Follow-up|3|||
13073935|NCT04016714|25278368|FG001|Overall Study|Lost to Follow-up|1|||
13073936|NCT04016714|25278367|FG000|Overall Study|Physician Decision|3|||
13073937|NCT04016714|25278368|FG001|Overall Study|Physician Decision|3|||
13073938|NCT04016714|25278367|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
13073939|NCT04016714|25278368|FG001|Overall Study|Withdrawal by Parent/Guardian|12|||
13073940|NCT03922308|25278479|FG000|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
13073941|NCT03922308|25278480|FG001|Overall Study|Not Meeting Confirmatory Inclusion Criteria|1|||
13073942|NCT03922308|25278481|FG002|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
13073943|NCT03922308|25278479|FG000|Overall Study|Lost to Follow-up|1|||
13073944|NCT03922308|25278480|FG001|Overall Study|Lost to Follow-up|0|||
13073945|NCT03922308|25278481|FG002|Overall Study|Lost to Follow-up|0|||
13073946|NCT03922308|25278479|FG000|Overall Study|Reason not Specified|0|||
13073947|NCT03922308|25278480|FG001|Overall Study|Reason not Specified|2|||
13073948|NCT03922308|25278481|FG002|Overall Study|Reason not Specified|1|||
13073949|NCT03687502|25278550|FG000|Overall Study|IV was removed prior to radiology visit for ultrasound|1|||
13073950|NCT03687502|25278550|FG000|Overall Study|Lumason not available|1|||
13073951|NCT03607994|25278565|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
13073952|NCT03607994|25278566|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
13073953|NCT03112603|25278618|FG000|End of Randomization Period|Lost to Follow-up|1|||
13073954|NCT03112603|25278619|FG001|End of Randomization Period|Lost to Follow-up|0|||
13073955|NCT03112603|25278620|FG002|End of Randomization Period|Lost to Follow-up|0|||
13073956|NCT03112603|25278618|FG000|End of Randomization Period|Subject/Guardian Decision|4|||
13073957|NCT03112603|25278619|FG001|End of Randomization Period|Subject/Guardian Decision|11|||
13073958|NCT03112603|25278620|FG002|End of Randomization Period|Subject/Guardian Decision|0|||
13073959|NCT03112603|25278618|FG000|End of Randomization Period|Physician Decision|4|||
13073960|NCT03112603|25278619|FG001|End of Randomization Period|Physician Decision|14|||
13073961|NCT03112603|25278620|FG002|End of Randomization Period|Physician Decision|0|||
13073962|NCT03112603|25278618|FG000|End of Randomization Period|Failure to meet protocol continuation criteria|4|||
13073963|NCT03112603|25278619|FG001|End of Randomization Period|Failure to meet protocol continuation criteria|5|||
13073964|NCT03112603|25278620|FG002|End of Randomization Period|Failure to meet protocol continuation criteria|0|||
13073965|NCT03112603|25278618|FG000|End of Randomization Period|Death|8|||
13073966|NCT03112603|25278619|FG001|End of Randomization Period|Death|7|||
13073967|NCT03112603|25278620|FG002|End of Randomization Period|Death|0|||
13073968|NCT03112603|25278618|FG000|End of Randomization Period|Disease Relapse|9|||
13073969|NCT03112603|25278619|FG001|End of Randomization Period|Disease Relapse|7|||
13073970|NCT03112603|25278620|FG002|End of Randomization Period|Disease Relapse|0|||
13073971|NCT03112603|25278618|FG000|End of Randomization Period|Lack of Efficacy|24|||
13073972|NCT03112603|25278619|FG001|End of Randomization Period|Lack of Efficacy|70|||
13222318|NCT01807221|26286043|FG003|Overall Study|Progressive disease|0|||
13073973|NCT03112603|25278620|FG002|End of Randomization Period|Lack of Efficacy|0|||
13073974|NCT03112603|25278618|FG000|End of Randomization Period|Adverse Event|28|||
13073975|NCT03112603|25278619|FG001|End of Randomization Period|Adverse Event|8|||
13073976|NCT03112603|25278620|FG002|End of Randomization Period|Adverse Event|0|||
13073977|NCT03112603|25278618|FG000|End of Randomization Period|Ongoing Treatment|83|||
13073978|NCT03112603|25278619|FG001|End of Randomization Period|Ongoing Treatment|42|||
13073979|NCT03112603|25278620|FG002|End of Randomization Period|Ongoing Treatment|0|||
13073980|NCT03112603|25278618|FG000|End of Cross Over Period|Death|0|||
13073981|NCT03112603|25278619|FG001|End of Cross Over Period|Death|0|||
13073982|NCT03112603|25278620|FG002|End of Cross Over Period|Death|1|||
13073983|NCT03112603|25278618|FG000|End of Cross Over Period|Subject/Guardian Decision|0|||
13073984|NCT03112603|25278619|FG001|End of Cross Over Period|Subject/Guardian Decision|0|||
13073985|NCT03112603|25278620|FG002|End of Cross Over Period|Subject/Guardian Decision|3|||
13073986|NCT03112603|25278618|FG000|End of Cross Over Period|Physician Decision|0|||
13073987|NCT03112603|25278619|FG001|End of Cross Over Period|Physician Decision|0|||
13073988|NCT03112603|25278620|FG002|End of Cross Over Period|Physician Decision|3|||
13073989|NCT03112603|25278618|FG000|End of Cross Over Period|Lack of Efficacy|0|||
13073990|NCT03112603|25278619|FG001|End of Cross Over Period|Lack of Efficacy|0|||
13073991|NCT03112603|25278620|FG002|End of Cross Over Period|Lack of Efficacy|4|||
13073992|NCT03112603|25278618|FG000|End of Cross Over Period|Adverse Event|0|||
13073993|NCT03112603|25278619|FG001|End of Cross Over Period|Adverse Event|0|||
13073994|NCT03112603|25278620|FG002|End of Cross Over Period|Adverse Event|4|||
13073995|NCT03112603|25278618|FG000|End of Cross Over Period|Treatment Ongoing|0|||
13073996|NCT03112603|25278619|FG001|End of Cross Over Period|Treatment Ongoing|0|||
13073997|NCT03112603|25278620|FG002|End of Cross Over Period|Treatment Ongoing|46|||
13130371|NCT02839746|25974269|FG000|Overall Study|Not met selection criteria|12|||
13130372|NCT02839681|25974280|FG000|Overall Study|Death|2|||
13130373|NCT02839330|25974322|FG000|Overall Study|Adverse Event|0|||
13130374|NCT02839330|25974323|FG001|Overall Study|Adverse Event|1|||
13130375|NCT02839330|25974324|FG002|Overall Study|Adverse Event|2|||
13130376|NCT02839330|25974325|FG003|Overall Study|Adverse Event|2|||
13130377|NCT02839330|25974322|FG000|Overall Study|Death|4|||
13130378|NCT02839330|25974323|FG001|Overall Study|Death|6|||
13130379|NCT02839330|25974324|FG002|Overall Study|Death|1|||
13130380|NCT02839330|25974325|FG003|Overall Study|Death|1|||
13130381|NCT02839330|25974322|FG000|Overall Study|Withdrawal by Subject|27|||
13130382|NCT02839330|25974323|FG001|Overall Study|Withdrawal by Subject|19|||
13130383|NCT02839330|25974324|FG002|Overall Study|Withdrawal by Subject|11|||
13130384|NCT02839330|25974325|FG003|Overall Study|Withdrawal by Subject|13|||
13130385|NCT02839330|25974322|FG000|Overall Study|Lost to Follow-up|22|||
13130386|NCT02839330|25974323|FG001|Overall Study|Lost to Follow-up|27|||
13130387|NCT02839330|25974324|FG002|Overall Study|Lost to Follow-up|29|||
13130388|NCT02839330|25974325|FG003|Overall Study|Lost to Follow-up|25|||
13130389|NCT02839330|25974322|FG000|Overall Study|Administrative Reason|0|||
13130390|NCT02839330|25974323|FG001|Overall Study|Administrative Reason|0|||
13130391|NCT02839330|25974324|FG002|Overall Study|Administrative Reason|0|||
13130392|NCT02839330|25974325|FG003|Overall Study|Administrative Reason|1|||
13130393|NCT02839330|25974322|FG000|Overall Study|Protocol Violation|1|||
13130394|NCT02839330|25974323|FG001|Overall Study|Protocol Violation|2|||
13130395|NCT02839330|25974324|FG002|Overall Study|Protocol Violation|2|||
13130396|NCT02839330|25974325|FG003|Overall Study|Protocol Violation|3|||
13130397|NCT02839330|25974322|FG000|Overall Study|Other reason, not specified|4|||
13130398|NCT02839330|25974323|FG001|Overall Study|Other reason, not specified|3|||
13130399|NCT02839330|25974324|FG002|Overall Study|Other reason, not specified|3|||
13130400|NCT02839330|25974325|FG003|Overall Study|Other reason, not specified|6|||
13130401|NCT02839200|25974376|FG000|Overall Study|Withdrawal by Subject|2|||
13130402|NCT02839200|25974377|FG001|Overall Study|Withdrawal by Subject|0|||
13130403|NCT02839200|25974378|FG002|Overall Study|Withdrawal by Subject|1|||
13130404|NCT02839200|25974379|FG003|Overall Study|Withdrawal by Subject|0|||
13130405|NCT02839200|25974380|FG004|Overall Study|Withdrawal by Subject|0|||
13130406|NCT02839200|25974381|FG005|Overall Study|Withdrawal by Subject|1|||
13130407|NCT02839200|25974376|FG000|Overall Study|Lost to Follow-up|2|||
13130408|NCT02839200|25974377|FG001|Overall Study|Lost to Follow-up|0|||
13130409|NCT02839200|25974378|FG002|Overall Study|Lost to Follow-up|0|||
13130410|NCT02839200|25974379|FG003|Overall Study|Lost to Follow-up|0|||
13130411|NCT02839200|25974380|FG004|Overall Study|Lost to Follow-up|1|||
13130412|NCT02839200|25974381|FG005|Overall Study|Lost to Follow-up|0|||
13130413|NCT02839200|25974376|FG000|Overall Study|Adverse Event|0|||
13130414|NCT02839200|25974377|FG001|Overall Study|Adverse Event|0|||
13130415|NCT02839200|25974378|FG002|Overall Study|Adverse Event|0|||
13130416|NCT02839200|25974379|FG003|Overall Study|Adverse Event|0|||
13130417|NCT02839200|25974380|FG004|Overall Study|Adverse Event|1|||
13130418|NCT02839200|25974381|FG005|Overall Study|Adverse Event|0|||
13130419|NCT02839200|25974376|FG000|Overall Study|Randomized in error|0|||
13130420|NCT02839200|25974377|FG001|Overall Study|Randomized in error|1|||
13130421|NCT02839200|25974378|FG002|Overall Study|Randomized in error|0|||
13130422|NCT02839200|25974379|FG003|Overall Study|Randomized in error|0|||
13073998|NCT02903368|25278647|FG000|Overall Study|Adverse Event|3|||
13073999|NCT02903368|25278648|FG001|Overall Study|Adverse Event|0|||
13074000|NCT02903368|25278647|FG000|Overall Study|Withdrawal by Subject|1|||
13074001|NCT02903368|25278648|FG001|Overall Study|Withdrawal by Subject|0|||
13074002|NCT02895360|25278715|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4|||
13074003|NCT02895360|25278716|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
13074004|NCT02895360|25278717|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
13074005|NCT02895360|25278718|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
13074006|NCT02895360|25278719|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
13074007|NCT02895360|25278720|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
13074008|NCT02895360|25278715|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
13074009|NCT02895360|25278716|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3|||
13074010|NCT02895360|25278717|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
13074011|NCT02895360|25278718|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
13074012|NCT02895360|25278719|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
13074013|NCT02895360|25278720|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
13074014|NCT02895360|25278715|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
13074015|NCT02895360|25278716|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
13074016|NCT02895360|25278717|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2|||
13074017|NCT02895360|25278718|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
13074018|NCT02895360|25278719|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
13074019|NCT02895360|25278720|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
13074020|NCT02895360|25278715|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
13074021|NCT02895360|25278716|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
13074022|NCT02895360|25278717|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7|||
13074023|NCT02895360|25278718|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
13074024|NCT02895360|25278719|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
13074025|NCT02895360|25278720|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
13074026|NCT02895360|25278715|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
13074027|NCT02895360|25278716|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
13074028|NCT02895360|25278717|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
13074029|NCT02895360|25278718|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4|||
13074030|NCT02895360|25278719|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
13074031|NCT02895360|25278720|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
13074032|NCT02895360|25278715|FG000|Phase 2a|Adverse Event|0|||
13074033|NCT02895360|25278716|FG001|Phase 2a|Adverse Event|0|||
13074034|NCT02895360|25278717|FG002|Phase 2a|Adverse Event|0|||
13074035|NCT02895360|25278718|FG003|Phase 2a|Adverse Event|0|||
13074036|NCT02895360|25278719|FG004|Phase 2a|Adverse Event|0|||
13074037|NCT02895360|25278720|FG005|Phase 2a|Adverse Event|1|||
13074038|NCT02895360|25278715|FG000|Phase 2a|Progressive disease|0|||
13074039|NCT02895360|25278716|FG001|Phase 2a|Progressive disease|0|||
13074040|NCT02895360|25278717|FG002|Phase 2a|Progressive disease|0|||
13074041|NCT02895360|25278718|FG003|Phase 2a|Progressive disease|0|||
13074042|NCT02895360|25278719|FG004|Phase 2a|Progressive disease|11|||
13074043|NCT02895360|25278720|FG005|Phase 2a|Progressive disease|11|||
13074044|NCT02763579|25278735|FG000|Overall Study|Death|101|||
13074045|NCT02763579|25278736|FG001|Overall Study|Death|132|||
13074046|NCT02763579|25278735|FG000|Overall Study|Lost to Follow-up|3|||
13074047|NCT02763579|25278736|FG001|Overall Study|Lost to Follow-up|1|||
13074048|NCT02763579|25278735|FG000|Overall Study|Withdrawal by Subject|18|||
13074049|NCT02763579|25278736|FG001|Overall Study|Withdrawal by Subject|9|||
13074050|NCT02763579|25278735|FG000|Overall Study|Physician Decision|2|||
13074051|NCT02763579|25278736|FG001|Overall Study|Physician Decision|0|||
13074052|NCT02763579|25278735|FG000|Overall Study|On-going in study|77|||
13074053|NCT02763579|25278736|FG001|Overall Study|On-going in study|60|||
13074054|NCT02737826|25278771|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0|||
13074055|NCT02737826|25278772|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12|||
13074056|NCT02737826|25278773|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14|||
13074057|NCT02657889|25278864|FG000|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
13074058|NCT02657889|25278865|FG001|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
13074059|NCT02657889|25278866|FG002|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
13074060|NCT02657889|25278867|FG003|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
13074061|NCT02657889|25278864|FG000|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|2|||
13074062|NCT02657889|25278865|FG001|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
13074063|NCT02657889|25278866|FG002|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
13074064|NCT02657889|25278867|FG003|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
13074065|NCT02657889|25278864|FG000|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
13074066|NCT02657889|25278865|FG001|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|1|||
13074067|NCT02657889|25278866|FG002|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
13074068|NCT02657889|25278867|FG003|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
13074069|NCT02657889|25278864|FG000|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
13074070|NCT02657889|25278865|FG001|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|1|||
13074071|NCT02657889|25278866|FG002|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
13074072|NCT02657889|25278867|FG003|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
13074073|NCT02657889|25278864|FG000|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
13074074|NCT02657889|25278865|FG001|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
13074075|NCT02657889|25278866|FG002|Phase 2: (Up to a Maximum of 54 Months)|Death|30|||
13074076|NCT02657889|25278867|FG003|Phase 2: (Up to a Maximum of 54 Months)|Death|42|||
13074077|NCT02657889|25278864|FG000|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
13074078|NCT02657889|25278865|FG001|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
13074079|NCT02657889|25278866|FG002|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|5|||
13074080|NCT02657889|25278867|FG003|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|2|||
13074081|NCT02657889|25278864|FG000|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
13074082|NCT02657889|25278865|FG001|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
13074083|NCT02657889|25278866|FG002|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|8|||
13074084|NCT02657889|25278867|FG003|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|2|||
13074085|NCT02657889|25278864|FG000|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
13074086|NCT02657889|25278865|FG001|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
13074087|NCT02657889|25278866|FG002|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
13074088|NCT02657889|25278867|FG003|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
13074089|NCT02657889|25278864|FG000|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
13074090|NCT02657889|25278865|FG001|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
13074091|NCT02657889|25278866|FG002|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|6|||
13074092|NCT02657889|25278867|FG003|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|1|||
13074093|NCT02657889|25278864|FG000|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
13074094|NCT02657889|25278865|FG001|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
13074095|NCT02657889|25278866|FG002|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
13074096|NCT02657889|25278867|FG003|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|1|||
13074097|NCT02657889|25278864|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
13074098|NCT02657889|25278865|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
13074099|NCT02657889|25278866|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participant request|2|||
13074100|NCT02657889|25278867|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participant request|1|||
13074101|NCT02657889|25278864|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
13074102|NCT02657889|25278865|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
13074103|NCT02657889|25278866|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
13074104|NCT02657889|25278867|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|4|||
13074105|NCT02646982|25278922|FG000|Overall Study|Adverse Event|1|||
13074106|NCT02646982|25278923|FG001|Overall Study|Adverse Event|1|||
13074107|NCT02646982|25278922|FG000|Overall Study|Withdrawal by Subject|2|||
13074108|NCT02646982|25278923|FG001|Overall Study|Withdrawal by Subject|1|||
13074109|NCT02499835|25278983|FG000|Overall Study|Withdrawal by Subject|1|||
13074110|NCT02499835|25278984|FG001|Overall Study|Withdrawal by Subject|0|||
13074111|NCT02499835|25278985|FG002|Overall Study|Withdrawal by Subject|0|||
13074112|NCT02499835|25278986|FG003|Overall Study|Withdrawal by Subject|1|||
13074113|NCT02499835|25278983|FG000|Overall Study|Physician Decision|0|||
13074114|NCT02499835|25278984|FG001|Overall Study|Physician Decision|3|||
13074115|NCT02499835|25278985|FG002|Overall Study|Physician Decision|18|||
13074116|NCT02499835|25278986|FG003|Overall Study|Physician Decision|7|||
13074117|NCT02499835|25278983|FG000|Overall Study|Adverse Event|0|||
13074118|NCT02499835|25278984|FG001|Overall Study|Adverse Event|0|||
13074119|NCT02499835|25278985|FG002|Overall Study|Adverse Event|0|||
13074120|NCT02499835|25278986|FG003|Overall Study|Adverse Event|1|||
13074121|NCT02499835|25278983|FG000|Overall Study|Disease progression|2|||
13074122|NCT02499835|25278984|FG001|Overall Study|Disease progression|1|||
13074123|NCT02499835|25278985|FG002|Overall Study|Disease progression|0|||
13074124|NCT02499835|25278986|FG003|Overall Study|Disease progression|7|||
13074125|NCT02358031|25279121|FG000|Overall Study|Death|226|||
13074126|NCT02358031|25279122|FG001|Overall Study|Death|204|||
13074127|NCT02358031|25279123|FG002|Overall Study|Death|249|||
13074128|NCT02358031|25279121|FG000|Overall Study|Lost to Follow-up|0|||
13074129|NCT02358031|25279122|FG001|Overall Study|Lost to Follow-up|1|||
13074130|NCT02358031|25279123|FG002|Overall Study|Lost to Follow-up|1|||
13074131|NCT02358031|25279121|FG000|Overall Study|Withdrawal by Subject|14|||
13074132|NCT02358031|25279122|FG001|Overall Study|Withdrawal by Subject|12|||
13074133|NCT02358031|25279123|FG002|Overall Study|Withdrawal by Subject|17|||
13074134|NCT02358031|25279121|FG000|Overall Study|Ongoing in Study|61|||
13074135|NCT02358031|25279122|FG001|Overall Study|Ongoing in Study|64|||
13074136|NCT02358031|25279123|FG002|Overall Study|Ongoing in Study|33|||
13074137|NCT02250664|25279141|FG000|Overall Study|Lost to Follow-up|18|||
13074138|NCT02250664|25279142|FG001|Overall Study|Lost to Follow-up|28|||
13074139|NCT02250664|25279143|FG002|Overall Study|Lost to Follow-up|33|||
13074140|NCT02250664|25279141|FG000|Overall Study|Personal Reasons|7|||
13074141|NCT02250664|25279142|FG001|Overall Study|Personal Reasons|8|||
13074142|NCT02250664|25279143|FG002|Overall Study|Personal Reasons|14|||
13074143|NCT02250664|25279141|FG000|Overall Study|Adverse Event|6|||
13074144|NCT02250664|25279142|FG001|Overall Study|Adverse Event|3|||
13074145|NCT02250664|25279143|FG002|Overall Study|Adverse Event|8|||
13074146|NCT02250664|25279141|FG000|Overall Study|Incarcerated|2|||
13074147|NCT02250664|25279142|FG001|Overall Study|Incarcerated|1|||
13074148|NCT02250664|25279143|FG002|Overall Study|Incarcerated|2|||
13074149|NCT02250664|25279141|FG000|Overall Study|Withdrawal by Subject|0|||
13074150|NCT02250664|25279142|FG001|Overall Study|Withdrawal by Subject|1|||
13074151|NCT02250664|25279143|FG002|Overall Study|Withdrawal by Subject|2|||
13074152|NCT02250664|25279141|FG000|Overall Study|Death|0|||
13074153|NCT02250664|25279142|FG001|Overall Study|Death|1|||
13074154|NCT02250664|25279143|FG002|Overall Study|Death|1|||
13074155|NCT02250664|25279141|FG000|Overall Study|Physician Decision|1|||
13074156|NCT02250664|25279142|FG001|Overall Study|Physician Decision|3|||
13074157|NCT02250664|25279143|FG002|Overall Study|Physician Decision|1|||
13074158|NCT02250664|25279141|FG000|Overall Study|Protocol Violation|1|||
13074159|NCT02250664|25279142|FG001|Overall Study|Protocol Violation|0|||
13074160|NCT02250664|25279143|FG002|Overall Study|Protocol Violation|1|||
13074161|NCT02250664|25279141|FG000|Overall Study|Reason unknown|1|||
13074162|NCT02250664|25279142|FG001|Overall Study|Reason unknown|0|||
13074163|NCT02250664|25279143|FG002|Overall Study|Reason unknown|0|||
13074164|NCT02250534|25279161|FG000|Overall Study|Lost to Follow-up|18|||
13074165|NCT02250534|25279162|FG001|Overall Study|Lost to Follow-up|28|||
13074166|NCT02250534|25279163|FG002|Overall Study|Lost to Follow-up|33|||
13074167|NCT02250534|25279161|FG000|Overall Study|Personal reasons|7|||
13074168|NCT02250534|25279162|FG001|Overall Study|Personal reasons|8|||
13074169|NCT02250534|25279163|FG002|Overall Study|Personal reasons|14|||
13074170|NCT02250534|25279161|FG000|Overall Study|Adverse Event|6|||
13074171|NCT02250534|25279162|FG001|Overall Study|Adverse Event|3|||
13074172|NCT02250534|25279163|FG002|Overall Study|Adverse Event|8|||
13074173|NCT02250534|25279161|FG000|Overall Study|incarcerated|2|||
13074174|NCT02250534|25279162|FG001|Overall Study|incarcerated|1|||
13074175|NCT02250534|25279163|FG002|Overall Study|incarcerated|2|||
13074176|NCT02250534|25279161|FG000|Overall Study|Withdrawal by Subject|0|||
13074177|NCT02250534|25279162|FG001|Overall Study|Withdrawal by Subject|1|||
13074178|NCT02250534|25279163|FG002|Overall Study|Withdrawal by Subject|2|||
13074179|NCT02250534|25279161|FG000|Overall Study|Death|0|||
13074180|NCT02250534|25279162|FG001|Overall Study|Death|1|||
13074181|NCT02250534|25279163|FG002|Overall Study|Death|1|||
13074182|NCT02250534|25279161|FG000|Overall Study|Physician Decision|1|||
13074183|NCT02250534|25279162|FG001|Overall Study|Physician Decision|3|||
13074184|NCT02250534|25279163|FG002|Overall Study|Physician Decision|1|||
13074185|NCT02250534|25279161|FG000|Overall Study|Protocol Violation|1|||
13074186|NCT02250534|25279162|FG001|Overall Study|Protocol Violation|0|||
13074187|NCT02250534|25279163|FG002|Overall Study|Protocol Violation|1|||
13074188|NCT02250534|25279161|FG000|Overall Study|Reason unknown|1|||
13074189|NCT02250534|25279162|FG001|Overall Study|Reason unknown|0|||
13074190|NCT02250534|25279163|FG002|Overall Study|Reason unknown|0|||
13074191|NCT01989104|25279217|FG000|Overall Study|Withdrawal by Subject|3|||
13074192|NCT01989104|25279218|FG001|Overall Study|Withdrawal by Subject|0|||
13074193|NCT01989104|25279219|FG002|Overall Study|Withdrawal by Subject|0|||
13074194|NCT01989104|25279220|FG003|Overall Study|Withdrawal by Subject|0|||
13074195|NCT01989104|25279221|FG004|Overall Study|Withdrawal by Subject|0|||
13074196|NCT03094416|25279380|FG000|Run-in|Screening failure|8|||
13074197|NCT03094416|25279380|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8|||
13074198|NCT03094416|25279380|FG000|Run-in|Withdrawal by Subject|3|||
13074199|NCT03094416|25279380|FG000|Treatment Period|Withdrawal by Subject|2|||
13130423|NCT02839200|25974380|FG004|Overall Study|Randomized in error|0|||
13130424|NCT02839200|25974381|FG005|Overall Study|Randomized in error|0|||
13130425|NCT02838901|25974416|FG000|Overall Study|Withdrawal by Subject|1|||
13130426|NCT02838901|25974417|FG001|Overall Study|Withdrawal by Subject|1|||
13130427|NCT02838901|25974416|FG000|Overall Study|Lost to Follow-up|1|||
13130428|NCT02838901|25974417|FG001|Overall Study|Lost to Follow-up|1|||
13130429|NCT02838628|25974456|FG000|Recurrence Follow-up Period|AK Recurrence|18|||
13130430|NCT02838628|25974457|FG001|Recurrence Follow-up Period|AK Recurrence|13|||
13130431|NCT02838628|25974456|FG000|Recurrence Follow-up Period|Adverse Event|1|||
13130432|NCT02838628|25974457|FG001|Recurrence Follow-up Period|Adverse Event|0|||
13130433|NCT02838628|25974456|FG000|Recurrence Follow-up Period|Non-compliance|0|||
13130434|NCT02838628|25974457|FG001|Recurrence Follow-up Period|Non-compliance|1|||
13130435|NCT02838628|25974456|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
13130436|NCT02838628|25974457|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2|||
13130437|NCT02838628|25974456|FG000|Recurrence Follow-up Period|Other un-specified|1|||
13130438|NCT02838628|25974457|FG001|Recurrence Follow-up Period|Other un-specified|1|||
13130439|NCT02838420|25974478|FG000|Overall Study|Ongoing in Study|113|||
13130440|NCT02838420|25974479|FG001|Overall Study|Ongoing in Study|45|||
13130441|NCT02838420|25974478|FG000|Overall Study|Lost to Follow-up|1|||
13130442|NCT02838420|25974479|FG001|Overall Study|Lost to Follow-up|0|||
13074200|NCT02736968|25279478|FG000|Overall Study|Lost to Follow-up|0|||
13074201|NCT02736968|25279479|FG001|Overall Study|Lost to Follow-up|0|||
13074202|NCT02736968|25279480|FG002|Overall Study|Lost to Follow-up|0|||
13074203|NCT02736968|25279481|FG003|Overall Study|Lost to Follow-up|0|||
13074204|NCT02736968|25279482|FG004|Overall Study|Lost to Follow-up|0|||
13074205|NCT02736968|25279483|FG005|Overall Study|Lost to Follow-up|0|||
13074206|NCT02736968|25279484|FG006|Overall Study|Lost to Follow-up|5|||
13074207|NCT02736968|25279485|FG007|Overall Study|Lost to Follow-up|2|||
13074208|NCT02736968|25279478|FG000|Overall Study|COVID-19 Pandemic|0|||
13074209|NCT02736968|25279479|FG001|Overall Study|COVID-19 Pandemic|0|||
13074210|NCT02736968|25279480|FG002|Overall Study|COVID-19 Pandemic|0|||
13074211|NCT02736968|25279481|FG003|Overall Study|COVID-19 Pandemic|0|||
13074212|NCT02736968|25279482|FG004|Overall Study|COVID-19 Pandemic|0|||
13074213|NCT02736968|25279483|FG005|Overall Study|COVID-19 Pandemic|0|||
13074214|NCT02736968|25279484|FG006|Overall Study|COVID-19 Pandemic|2|||
13074215|NCT02736968|25279485|FG007|Overall Study|COVID-19 Pandemic|0|||
13074216|NCT02736968|25279478|FG000|Overall Study|Withdrawal by Subject|0|||
13074217|NCT02736968|25279479|FG001|Overall Study|Withdrawal by Subject|0|||
13074218|NCT02736968|25279480|FG002|Overall Study|Withdrawal by Subject|0|||
13074219|NCT02736968|25279481|FG003|Overall Study|Withdrawal by Subject|0|||
13074220|NCT02736968|25279482|FG004|Overall Study|Withdrawal by Subject|0|||
13074221|NCT02736968|25279483|FG005|Overall Study|Withdrawal by Subject|0|||
13074222|NCT02736968|25279484|FG006|Overall Study|Withdrawal by Subject|1|||
13074223|NCT02736968|25279485|FG007|Overall Study|Withdrawal by Subject|0|||
13074224|NCT02607930|25279592|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25|||
13074225|NCT02607930|25279593|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19|||
13074226|NCT02607930|25279594|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
13074227|NCT02607930|25279595|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
13074228|NCT02607930|25279592|FG000|Double-Blinded Treatment Phase|Withdrew consent|14|||
13074229|NCT02607930|25279593|FG001|Double-Blinded Treatment Phase|Withdrew consent|18|||
13074230|NCT02607930|25279594|FG002|Double-Blinded Treatment Phase|Withdrew consent|0|||
13074231|NCT02607930|25279595|FG003|Double-Blinded Treatment Phase|Withdrew consent|0|||
13074232|NCT02607930|25279592|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6|||
13074233|NCT02607930|25279593|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3|||
13074234|NCT02607930|25279594|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0|||
13074235|NCT02607930|25279595|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0|||
13074236|NCT02607930|25279592|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3|||
13074237|NCT02607930|25279593|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5|||
13074238|NCT02607930|25279594|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
13074239|NCT02607930|25279595|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
13074240|NCT02607930|25279592|FG000|Double-Blinded Treatment Phase|Protocol Violation|2|||
13074241|NCT02607930|25279593|FG001|Double-Blinded Treatment Phase|Protocol Violation|3|||
13074242|NCT02607930|25279594|FG002|Double-Blinded Treatment Phase|Protocol Violation|0|||
13074243|NCT02607930|25279595|FG003|Double-Blinded Treatment Phase|Protocol Violation|0|||
13074244|NCT02607930|25279592|FG000|Double-Blinded Treatment Phase|Adverse Event|0|||
13074245|NCT02607930|25279593|FG001|Double-Blinded Treatment Phase|Adverse Event|4|||
13074246|NCT02607930|25279594|FG002|Double-Blinded Treatment Phase|Adverse Event|0|||
13074247|NCT02607930|25279595|FG003|Double-Blinded Treatment Phase|Adverse Event|0|||
13074248|NCT02607930|25279592|FG000|Double-Blinded Treatment Phase|Death|2|||
13074249|NCT02607930|25279593|FG001|Double-Blinded Treatment Phase|Death|1|||
13074250|NCT02607930|25279594|FG002|Double-Blinded Treatment Phase|Death|0|||
13074251|NCT02607930|25279595|FG003|Double-Blinded Treatment Phase|Death|0|||
13074252|NCT02607930|25279592|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2|||
13074253|NCT02607930|25279593|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0|||
13074254|NCT02607930|25279594|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0|||
13074255|NCT02607930|25279595|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0|||
13074256|NCT02607930|25279592|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
13074257|NCT02607930|25279593|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
13074258|NCT02607930|25279594|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15|||
13074259|NCT02607930|25279595|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10|||
13074260|NCT02607930|25279592|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
13074261|NCT02607930|25279593|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
13074262|NCT02607930|25279594|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10|||
13074263|NCT02607930|25279595|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13|||
13074264|NCT02607930|25279592|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
13074265|NCT02607930|25279593|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
13074266|NCT02607930|25279594|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2|||
13074267|NCT02607930|25279595|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5|||
13074268|NCT02607930|25279592|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
13133718|NCT02765165|25988894|FG003|Treatment Period|Study terminated|0|||
13485217|NCT03921424|27031929|FG000|Overall Study|Lost to Follow-up|0|||
13074269|NCT02607930|25279593|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
13074270|NCT02607930|25279594|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4|||
13074271|NCT02607930|25279595|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2|||
13074272|NCT02607930|25279592|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
13074273|NCT02607930|25279593|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
13074274|NCT02607930|25279594|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
13074275|NCT02607930|25279595|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
13074276|NCT02607930|25279592|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
13074277|NCT02607930|25279593|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
13074278|NCT02607930|25279594|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
13074279|NCT02607930|25279595|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
13074280|NCT02607930|25279592|FG000|Open-Label B/F/TAF Extension Phase|Death|0|||
13074281|NCT02607930|25279593|FG001|Open-Label B/F/TAF Extension Phase|Death|0|||
13074282|NCT02607930|25279594|FG002|Open-Label B/F/TAF Extension Phase|Death|0|||
13074283|NCT02607930|25279595|FG003|Open-Label B/F/TAF Extension Phase|Death|1|||
13074284|NCT02607930|25279592|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
13074285|NCT02607930|25279593|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
13074286|NCT02607930|25279594|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1|||
13074287|NCT02607930|25279595|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
13130443|NCT02838420|25974478|FG000|Overall Study|Withdrawal by Subject|3|||
13130444|NCT02838420|25974479|FG001|Overall Study|Withdrawal by Subject|4|||
13130445|NCT02838420|25974478|FG000|Overall Study|Death|8|||
13130446|NCT02838420|25974479|FG001|Overall Study|Death|13|||
13130447|NCT02838134|25974516|FG000|Overall Study|Lost to Follow-up|1|||
13130448|NCT02838134|25974517|FG001|Overall Study|Lost to Follow-up|2|||
13130449|NCT02838134|25974516|FG000|Overall Study|logistic problems|1|||
13130450|NCT02838134|25974517|FG001|Overall Study|logistic problems|1|||
13130451|NCT02838017|25974540|FG000|Overall Study|Lost to Follow-up|14|||
13130452|NCT02838017|25974541|FG001|Overall Study|Lost to Follow-up|11|||
13130453|NCT02837952|25974560|FG000|Overall Study|Adverse Event|0|||
13130454|NCT02837952|25974561|FG001|Overall Study|Adverse Event|1|||
13130455|NCT02837952|25974560|FG000|Overall Study|Withdrawal by Subject|4|||
13130456|NCT02837952|25974561|FG001|Overall Study|Withdrawal by Subject|5|||
13130457|NCT02837952|25974560|FG000|Overall Study|Medication Error|1|||
13130458|NCT02837952|25974561|FG001|Overall Study|Medication Error|0|||
13130459|NCT02837731|25974598|FG000|Allocation|Admitted to General Floor|3|||
13130460|NCT02837731|25974599|FG001|Allocation|Admitted to General Floor|4|||
13130461|NCT02837731|25974598|FG000|Allocation|Immediate surgery/withdrew|2|||
13130462|NCT02837731|25974599|FG001|Allocation|Immediate surgery/withdrew|0|||
13130463|NCT02837731|25974598|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1|||
13130464|NCT02837731|25974599|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0|||
13130465|NCT02837731|25974598|FG000|Allocation|Withdrawal by Subject|2|||
13130466|NCT02837731|25974599|FG001|Allocation|Withdrawal by Subject|0|||
13130467|NCT02837731|25974598|FG000|Allocation|Device not available|1|||
13130468|NCT02837731|25974599|FG001|Allocation|Device not available|0|||
13130469|NCT02837731|25974598|FG000|Allocation|Protocol not implemented|7|||
13130470|NCT02837731|25974599|FG001|Allocation|Protocol not implemented|0|||
13130471|NCT02837731|25974598|FG000|Allocation|Moribund/Do not resuscitate|2|||
13130472|NCT02837731|25974599|FG001|Allocation|Moribund/Do not resuscitate|0|||
13130473|NCT02837731|25974598|FG000|Allocation|Did not meet sepsis criteria|1|||
13130474|NCT02837731|25974599|FG001|Allocation|Did not meet sepsis criteria|2|||
13130475|NCT02837731|25974598|FG000|Allocation|Known aortic abnormalities|0|||
13130476|NCT02837731|25974599|FG001|Allocation|Known aortic abnormalities|1|||
13130477|NCT02836873|25974620|FG000|Overall Study|Protocol Violation|0|||
13130478|NCT02836873|25974621|FG001|Overall Study|Protocol Violation|1|||
13130479|NCT02836873|25974620|FG000|Overall Study|Adverse Event|1|||
13130480|NCT02836873|25974621|FG001|Overall Study|Adverse Event|4|||
13130481|NCT02836873|25974620|FG000|Overall Study|Withdrawal by Subject|2|||
13130482|NCT02836873|25974621|FG001|Overall Study|Withdrawal by Subject|2|||
13130483|NCT02836873|25974620|FG000|Overall Study|Lost to Follow-up|1|||
13130484|NCT02836873|25974621|FG001|Overall Study|Lost to Follow-up|3|||
13130485|NCT02836873|25974620|FG000|Overall Study|Physician Decision|0|||
13130486|NCT02836873|25974621|FG001|Overall Study|Physician Decision|1|||
13130487|NCT02836873|25974620|FG000|Overall Study|Other|1|||
13130488|NCT02836873|25974621|FG001|Overall Study|Other|0|||
13130489|NCT02836769|25974629|FG000|Overall Study|Lost to Follow-up|10|||
13130490|NCT02836769|25974629|FG000|Overall Study|Medical withdrawal|2|||
13130491|NCT02836769|25974629|FG000|Overall Study|Withdrawal by Subject|3|||
13130492|NCT02836652|25974648|FG000|Overall Study|Death|3|||
13130493|NCT02836652|25974649|FG001|Overall Study|Death|3|||
13130494|NCT02836652|25974648|FG000|Overall Study|Transplant/Explant|3|||
13130495|NCT02836652|25974649|FG001|Overall Study|Transplant/Explant|4|||
13130496|NCT02836652|25974648|FG000|Overall Study|Withdrawn|9|||
13130497|NCT02836652|25974649|FG001|Overall Study|Withdrawn|9|||
13130498|NCT02836652|25974648|FG000|Overall Study|Not on treatment regimen post-op day 15|3|||
13130499|NCT02836652|25974649|FG001|Overall Study|Not on treatment regimen post-op day 15|3|||
13074288|NCT02476201|25279605|FG000|Overall Study|Unable to program MPP|9|||
13074289|NCT02476201|25279605|FG000|Overall Study|Study echo not performed|5|||
13074290|NCT02476201|25279605|FG000|Overall Study|Adverse Event|4|||
13074291|NCT02476201|25279605|FG000|Overall Study|Death|2|||
13074292|NCT02476201|25279605|FG000|Overall Study|Lost to Follow-up|2|||
13074293|NCT02476201|25279605|FG000|Overall Study|MPP programmed to OFF|2|||
13074294|NCT02476201|25279605|FG000|Overall Study|Withdrawal by Subject|1|||
13074295|NCT02476201|25279605|FG000|Overall Study|Unsuccessful implant|1|||
13074296|NCT01399658|25279611|FG000|Overall Study|Ineligible|1|||
13074297|NCT01399658|25279611|FG000|Overall Study|Machine Technical Issue|3|||
13074298|NCT01399658|25279611|FG000|Overall Study|Standard of Care better than protocol therapy|1|||
13074299|NCT01399658|25279611|FG000|Overall Study|No reason given|1|||
13074300|NCT00919893|25279867|FG000|Overall Study|Protocol Violation|19|||
13074301|NCT00919893|25279868|FG001|Overall Study|Protocol Violation|9|||
13074302|NCT00909753|25279963|FG000|Period: Washout of 28 Days|Protocol Violation|2|||
13074303|NCT00909753|25279964|FG001|Period: Washout of 28 Days|Protocol Violation|3|||
13074304|NCT00909753|25279963|FG000|Period: Second Intervention|Protocol Violation|1|||
13074305|NCT00909753|25279964|FG001|Period: Second Intervention|Protocol Violation|0|||
13074306|NCT00909610|25280001|FG000|Period: First Intervention|Adverse Event|0|||
13074307|NCT00909610|25280002|FG001|Period: First Intervention|Adverse Event|1|||
13074308|NCT00909610|25280001|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3|||
13074309|NCT00909610|25280002|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6|||
13074310|NCT00909610|25280001|FG000|Period: Second Intervention|Adverse Event|1|||
13074311|NCT00909610|25280002|FG001|Period: Second Intervention|Adverse Event|0|||
13074312|NCT00905606|25280063|FG000|Period 1|Adverse Event|0|||
13074313|NCT00905606|25280064|FG001|Period 1|Adverse Event|1|||
13074314|NCT00905606|25280063|FG000|Washout|Withdrawal by Subject|1|||
13074315|NCT00905606|25280064|FG001|Washout|Withdrawal by Subject|0|||
13074316|NCT00905567|25280079|FG000|Washout|Withdrawal by Subject|0|||
13074317|NCT00905567|25280080|FG001|Washout|Withdrawal by Subject|1|||
13074318|NCT00905346|25280095|FG000|Period 1|Withdrawal by Subject|1|||
13074319|NCT00905346|25280096|FG001|Period 1|Withdrawal by Subject|0|||
13074320|NCT00905164|25280111|FG000|Period 1|Protocol Violation|0|||
13074321|NCT00905164|25280112|FG001|Period 1|Protocol Violation|1|||
13074322|NCT00890591|25280136|FG000|Overall Study|Lack of Efficacy|20|||
13074323|NCT00890409|25280151|FG000|Overall Study|Lost to Follow-up|20|||
13074324|NCT00890409|25280152|FG001|Overall Study|Lost to Follow-up|21|||
13074325|NCT00888355|25280219|FG000|Overall Study|Adverse Event|10|||
13074326|NCT00888355|25280220|FG001|Overall Study|Adverse Event|0|||
13074327|NCT00888355|25280221|FG002|Overall Study|Adverse Event|3|||
13074328|NCT00888355|25280222|FG003|Overall Study|Adverse Event|3|||
13074329|NCT00888355|25280219|FG000|Overall Study|Lack of Efficacy|9|||
13074330|NCT00888355|25280220|FG001|Overall Study|Lack of Efficacy|2|||
13074331|NCT00888355|25280221|FG002|Overall Study|Lack of Efficacy|5|||
13074332|NCT00888355|25280222|FG003|Overall Study|Lack of Efficacy|2|||
13074333|NCT00888355|25280219|FG000|Overall Study|Lost to Follow-up|0|||
13074334|NCT00888355|25280220|FG001|Overall Study|Lost to Follow-up|2|||
13074335|NCT00888355|25280221|FG002|Overall Study|Lost to Follow-up|2|||
13074336|NCT00888355|25280222|FG003|Overall Study|Lost to Follow-up|0|||
13074337|NCT00888355|25280219|FG000|Overall Study|Protocol Violation|3|||
13074338|NCT00888355|25280220|FG001|Overall Study|Protocol Violation|2|||
13074339|NCT00888355|25280221|FG002|Overall Study|Protocol Violation|1|||
13074340|NCT00888355|25280222|FG003|Overall Study|Protocol Violation|2|||
13074341|NCT00888355|25280219|FG000|Overall Study|Withdrawal by Subject|0|||
13074342|NCT00888355|25280220|FG001|Overall Study|Withdrawal by Subject|3|||
13074343|NCT00888355|25280221|FG002|Overall Study|Withdrawal by Subject|1|||
13074344|NCT00888355|25280222|FG003|Overall Study|Withdrawal by Subject|3|||
13074345|NCT00887250|25280252|FG000|Overall Study|Adverse Event|3|||
13074346|NCT00887250|25280253|FG001|Overall Study|Adverse Event|0|||
13074347|NCT00887250|25280254|FG002|Overall Study|Adverse Event|7|||
13074348|NCT00887250|25280252|FG000|Overall Study|Lack of Efficacy|9|||
13074349|NCT00887250|25280253|FG001|Overall Study|Lack of Efficacy|6|||
13074350|NCT00887250|25280254|FG002|Overall Study|Lack of Efficacy|1|||
13074351|NCT00887250|25280252|FG000|Overall Study|Lost to Follow-up|2|||
13074352|NCT00887250|25280253|FG001|Overall Study|Lost to Follow-up|3|||
13074353|NCT00887250|25280254|FG002|Overall Study|Lost to Follow-up|1|||
13074354|NCT00887250|25280252|FG000|Overall Study|Protocol Violation|2|||
13074355|NCT00887250|25280253|FG001|Overall Study|Protocol Violation|2|||
13074356|NCT00887250|25280254|FG002|Overall Study|Protocol Violation|1|||
13074357|NCT00887250|25280252|FG000|Overall Study|Withdrawal by Subject|2|||
13074358|NCT00887250|25280253|FG001|Overall Study|Withdrawal by Subject|1|||
13074359|NCT00887250|25280254|FG002|Overall Study|Withdrawal by Subject|2|||
13074360|NCT00887250|25280252|FG000|Overall Study|Patient uncooperative|0|||
13074361|NCT00887250|25280253|FG001|Overall Study|Patient uncooperative|0|||
13074362|NCT00887250|25280254|FG002|Overall Study|Patient uncooperative|1|||
13074363|NCT00886600|25280289|FG000|Double-blind Monotherapy|Adverse Event|1|||
13074364|NCT00886600|25280290|FG001|Double-blind Monotherapy|Adverse Event|1|||
13074365|NCT00886600|25280291|FG002|Double-blind Monotherapy|Adverse Event|1|||
13074366|NCT00886600|25280292|FG003|Double-blind Monotherapy|Adverse Event|1|||
13074367|NCT00886600|25280289|FG000|Double-blind Monotherapy|Protocol Violation|0|||
13074368|NCT00886600|25280290|FG001|Double-blind Monotherapy|Protocol Violation|0|||
13074369|NCT00886600|25280291|FG002|Double-blind Monotherapy|Protocol Violation|0|||
13074370|NCT00886600|25280292|FG003|Double-blind Monotherapy|Protocol Violation|1|||
13074371|NCT00886600|25280289|FG000|Double-blind Monotherapy|Withdrawal by Subject|1|||
13074372|NCT00886600|25280290|FG001|Double-blind Monotherapy|Withdrawal by Subject|0|||
13074373|NCT00886600|25280291|FG002|Double-blind Monotherapy|Withdrawal by Subject|0|||
13074374|NCT00886600|25280292|FG003|Double-blind Monotherapy|Withdrawal by Subject|0|||
13074375|NCT00886600|25280289|FG000|Combination Therapy Period|Adverse Event|0|||
13074376|NCT00886600|25280290|FG001|Combination Therapy Period|Adverse Event|0|||
13074377|NCT00886600|25280291|FG002|Combination Therapy Period|Adverse Event|1|||
13074378|NCT00886600|25280292|FG003|Combination Therapy Period|Adverse Event|0|||
13074379|NCT00886600|25280289|FG000|Combination Therapy Period|Protocol Violation|0|||
13074380|NCT00886600|25280290|FG001|Combination Therapy Period|Protocol Violation|0|||
13074381|NCT00886600|25280291|FG002|Combination Therapy Period|Protocol Violation|1|||
13074382|NCT00886600|25280292|FG003|Combination Therapy Period|Protocol Violation|0|||
13074383|NCT00882440|25280337|FG000|Overall Study|Adverse Event|2|||
13074384|NCT00882440|25280338|FG001|Overall Study|Adverse Event|2|||
13074385|NCT00882440|25280339|FG002|Overall Study|Adverse Event|2|||
13074386|NCT00882440|25280340|FG003|Overall Study|Adverse Event|1|||
13074387|NCT00882440|25280341|FG004|Overall Study|Adverse Event|1|||
13074388|NCT00882440|25280342|FG005|Overall Study|Adverse Event|4|||
13074389|NCT00882440|25280343|FG006|Overall Study|Adverse Event|2|||
13074390|NCT00882440|25280337|FG000|Overall Study|Lack of Efficacy|3|||
13074391|NCT00882440|25280338|FG001|Overall Study|Lack of Efficacy|5|||
13074392|NCT00882440|25280339|FG002|Overall Study|Lack of Efficacy|2|||
13074393|NCT00882440|25280340|FG003|Overall Study|Lack of Efficacy|0|||
13074394|NCT00882440|25280341|FG004|Overall Study|Lack of Efficacy|0|||
13074395|NCT00882440|25280342|FG005|Overall Study|Lack of Efficacy|3|||
13074396|NCT00882440|25280343|FG006|Overall Study|Lack of Efficacy|0|||
13074397|NCT00882440|25280337|FG000|Overall Study|Lost to Follow-up|2|||
13074398|NCT00882440|25280338|FG001|Overall Study|Lost to Follow-up|0|||
13074399|NCT00882440|25280339|FG002|Overall Study|Lost to Follow-up|1|||
13074400|NCT00882440|25280340|FG003|Overall Study|Lost to Follow-up|1|||
13074401|NCT00882440|25280341|FG004|Overall Study|Lost to Follow-up|1|||
13074402|NCT00882440|25280342|FG005|Overall Study|Lost to Follow-up|0|||
13074403|NCT00882440|25280343|FG006|Overall Study|Lost to Follow-up|1|||
13074404|NCT00882440|25280337|FG000|Overall Study|Protocol Violation|0|||
13074405|NCT00882440|25280338|FG001|Overall Study|Protocol Violation|0|||
13074406|NCT00882440|25280339|FG002|Overall Study|Protocol Violation|1|||
13074407|NCT00882440|25280340|FG003|Overall Study|Protocol Violation|1|||
13074408|NCT00882440|25280341|FG004|Overall Study|Protocol Violation|1|||
13074409|NCT00882440|25280342|FG005|Overall Study|Protocol Violation|0|||
13074410|NCT00882440|25280343|FG006|Overall Study|Protocol Violation|0|||
13074411|NCT00882440|25280337|FG000|Overall Study|Withdrawal by Subject|2|||
13074412|NCT00882440|25280338|FG001|Overall Study|Withdrawal by Subject|1|||
13074413|NCT00882440|25280339|FG002|Overall Study|Withdrawal by Subject|1|||
13074414|NCT00882440|25280340|FG003|Overall Study|Withdrawal by Subject|0|||
13074415|NCT00882440|25280341|FG004|Overall Study|Withdrawal by Subject|6|||
13074416|NCT00882440|25280342|FG005|Overall Study|Withdrawal by Subject|0|||
13074417|NCT00882440|25280343|FG006|Overall Study|Withdrawal by Subject|1|||
13074418|NCT00882440|25280337|FG000|Overall Study|Patient Uncooperative|2|||
13074419|NCT00882440|25280338|FG001|Overall Study|Patient Uncooperative|0|||
13074420|NCT00882440|25280339|FG002|Overall Study|Patient Uncooperative|0|||
13074421|NCT00882440|25280340|FG003|Overall Study|Patient Uncooperative|0|||
13074422|NCT00882440|25280341|FG004|Overall Study|Patient Uncooperative|1|||
13074423|NCT00882440|25280342|FG005|Overall Study|Patient Uncooperative|0|||
13074424|NCT00882440|25280343|FG006|Overall Study|Patient Uncooperative|0|||
13130500|NCT02836613|25974668|FG000|Overall Study|Accidental drowning|1|||
13130501|NCT02836613|25974669|FG001|Overall Study|Accidental drowning|0|||
13130502|NCT02836613|25974668|FG000|Overall Study|Lost to Follow-up|0|||
13130503|NCT02836613|25974669|FG001|Overall Study|Lost to Follow-up|1|||
13130504|NCT02836613|25974668|FG000|Overall Study|Withdrawal by Subject|0|||
13130505|NCT02836613|25974669|FG001|Overall Study|Withdrawal by Subject|2|||
13130506|NCT02836496|25974690|FG000|Overall Study|Adverse Event|2|||
13130507|NCT02836496|25974691|FG001|Overall Study|Adverse Event|1|||
13130508|NCT02836496|25974690|FG000|Overall Study|Withdrawal by Subject|0|||
13222319|NCT01807221|26286044|FG004|Overall Study|Progressive disease|0|||
13130509|NCT02836496|25974691|FG001|Overall Study|Withdrawal by Subject|1|||
13130510|NCT02836249|25974714|FG000|Overall Study|Randomized but Never Treated|0|||
13130511|NCT02836249|25974715|FG001|Overall Study|Randomized but Never Treated|1|||
13130512|NCT02836249|25974714|FG000|Overall Study|Pregnancy|2|||
13130513|NCT02836249|25974715|FG001|Overall Study|Pregnancy|0|||
13130514|NCT02836249|25974714|FG000|Overall Study|Withdrew Consent|0|||
13130515|NCT02836249|25974715|FG001|Overall Study|Withdrew Consent|1|||
13130516|NCT02836249|25974714|FG000|Overall Study|Lost to Follow-up|0|||
13074425|NCT00870688|25280362|FG000|Overall Study|Lost to Follow-up|2|||
13074426|NCT00870688|25280362|FG000|Overall Study|Death, Unrelated|1|||
13074427|NCT00870688|25280362|FG000|Overall Study|Granules in the Stools|1|||
13074428|NCT00869128|25280369|FG000|Overall Study|lack of Compliance|6|||
13074429|NCT00869128|25280370|FG001|Overall Study|lack of Compliance|6|||
13074430|NCT00859521|25280385|FG000|Washout|Withdrawal by Subject|0|||
13074431|NCT00859521|25280386|FG001|Washout|Withdrawal by Subject|1|||
13074432|NCT00859430|25280401|FG000|First Intervention|Withdrawal by Subject|0|||
13074433|NCT00859430|25280402|FG001|First Intervention|Withdrawal by Subject|1|||
13074434|NCT00858702|25280417|FG000|Overall Study|Lack of Efficacy|1|||
13074435|NCT00858702|25280418|FG001|Overall Study|Lack of Efficacy|0|||
13074436|NCT00858702|25280417|FG000|Overall Study|Protocol Violation|1|||
13074437|NCT00858702|25280418|FG001|Overall Study|Protocol Violation|1|||
13074438|NCT00858702|25280417|FG000|Overall Study|Other|2|||
13074439|NCT00858702|25280418|FG001|Overall Study|Other|1|||
13074440|NCT00858702|25280417|FG000|Overall Study|Withdrawal by Subject|1|||
13074441|NCT00858702|25280418|FG001|Overall Study|Withdrawal by Subject|0|||
13074442|NCT00857285|25280429|FG000|Overall Study|Adverse Event|4|||
13074443|NCT00857285|25280430|FG001|Overall Study|Adverse Event|2|||
13074444|NCT00857285|25280429|FG000|Overall Study|Lack of Efficacy|0|||
13074445|NCT00857285|25280430|FG001|Overall Study|Lack of Efficacy|2|||
13074446|NCT00857285|25280429|FG000|Overall Study|Protocol Violation|3|||
13074447|NCT00857285|25280430|FG001|Overall Study|Protocol Violation|1|||
13074448|NCT00857285|25280429|FG000|Overall Study|Withdrawal by Subject|4|||
13074449|NCT00857285|25280430|FG001|Overall Study|Withdrawal by Subject|0|||
13074450|NCT00857285|25280429|FG000|Overall Study|Randomization criteria not met|1|||
13074451|NCT00857285|25280430|FG001|Overall Study|Randomization criteria not met|1|||
13074452|NCT00850174|25280471|FG000|Washout: One Week|Withdrawal by Subject|0|||
13074453|NCT00850174|25280472|FG001|Washout: One Week|Withdrawal by Subject|2|||
13074454|NCT00850174|25280471|FG000|Second Intervention|Withdrawal by Subject|1|||
13074455|NCT00850174|25280472|FG001|Second Intervention|Withdrawal by Subject|0|||
13074456|NCT00849797|25280509|FG000|First Intervention|bad veins|1|||
13074457|NCT00849797|25280510|FG001|First Intervention|bad veins|0|||
13074458|NCT00849797|25280509|FG000|First Intervention|Adverse Event|0|||
13074459|NCT00849797|25280510|FG001|First Intervention|Adverse Event|1|||
13074460|NCT00849797|25280509|FG000|Washout: One Week|Withdrawal by Subject|0|||
13074461|NCT00849797|25280510|FG001|Washout: One Week|Withdrawal by Subject|2|||
13074462|NCT00841815|25280541|FG000|Washout|Withdrawal by Subject|0|||
13074463|NCT00841815|25280542|FG001|Washout|Withdrawal by Subject|1|||
13074464|NCT00841698|25280557|FG000|First Intervention|Withdrawal by Subject|1|||
13074465|NCT00841698|25280558|FG001|First Intervention|Withdrawal by Subject|0|||
13074466|NCT00841659|25280573|FG000|Washout: 2 Weeks|Protocol Violation|1|||
13074467|NCT00841659|25280574|FG001|Washout: 2 Weeks|Protocol Violation|0|||
13074468|NCT00841542|25280589|FG000|Period 1|Adverse Event|1|||
13074469|NCT00841542|25280590|FG001|Period 1|Adverse Event|0|||
13074470|NCT00840879|25280605|FG000|Second Intervention|Withdrawal by Subject|1|||
13074471|NCT00840879|25280606|FG001|Second Intervention|Withdrawal by Subject|0|||
13074472|NCT00840632|25280665|FG000|First Intervention|Withdrawal by Subject|0|||
13074473|NCT00840632|25280666|FG001|First Intervention|Withdrawal by Subject|1|||
13074474|NCT00840632|25280665|FG000|Washout|Withdrawal by Subject|1|||
13074475|NCT00840632|25280666|FG001|Washout|Withdrawal by Subject|1|||
13074476|NCT00840411|25280697|FG000|First Intervention|Adverse Event|1|||
13074477|NCT00840411|25280698|FG001|First Intervention|Adverse Event|0|||
13074478|NCT00840411|25280697|FG000|Washout|Withdrawal by Subject|1|||
13074479|NCT00840411|25280698|FG001|Washout|Withdrawal by Subject|0|||
13074480|NCT00840216|25280729|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
13074481|NCT00840216|25280730|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
13074482|NCT00840203|25280751|FG000|First Intervention|Protocol Violation|1|||
13074483|NCT00840203|25280752|FG001|First Intervention|Protocol Violation|1|||
13074484|NCT00840203|25280751|FG000|Washout|Protocol Violation|1|||
13074485|NCT00840203|25280752|FG001|Washout|Protocol Violation|0|||
13074486|NCT00840073|25280793|FG000|Second Intervention|Missed 72 hour blood draw|1|||
13074487|NCT00840073|25280794|FG001|Second Intervention|Missed 72 hour blood draw|1|||
13074488|NCT00838630|25280825|FG000|First Intervention|Adverse Event|1|||
13074489|NCT00838630|25280826|FG001|First Intervention|Adverse Event|0|||
13074490|NCT00838630|25280825|FG000|Washout: 7 Days|Protocol Violation|1|||
13074491|NCT00838630|25280826|FG001|Washout: 7 Days|Protocol Violation|0|||
13074492|NCT00838279|25280841|FG000|Washout|Protocol Violation|1|||
13074493|NCT00838279|25280842|FG001|Washout|Protocol Violation|0|||
13074494|NCT00838279|25280841|FG000|Washout|Withdrawal by Subject|0|||
13074495|NCT00838279|25280842|FG001|Washout|Withdrawal by Subject|1|||
13074496|NCT00836901|25280879|FG000|First Intervention|Withdrawal by Subject|1|||
13074497|NCT00836901|25280880|FG001|First Intervention|Withdrawal by Subject|0|||
13074498|NCT00836706|25280895|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
13074499|NCT00836706|25280896|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
13074500|NCT00836472|25280917|FG000|Washout|Adverse Event|1|||
13074501|NCT00836472|25280918|FG001|Washout|Adverse Event|2|||
13074502|NCT00836472|25280917|FG000|Washout|Withdrawal by Subject|1|||
13074503|NCT00836472|25280918|FG001|Washout|Withdrawal by Subject|1|||
13074504|NCT00836056|25280933|FG000|First Intervention|Adverse Event|1|||
13074505|NCT00836056|25280934|FG001|First Intervention|Adverse Event|0|||
13074506|NCT00835991|25280971|FG000|First Intervention|Adverse Event|0|||
13074507|NCT00835991|25280972|FG001|First Intervention|Adverse Event|1|||
13074508|NCT00835991|25280971|FG000|Washout|Protocol Violation|0|||
13074509|NCT00835991|25280972|FG001|Washout|Protocol Violation|2|||
13074510|NCT00835991|25280971|FG000|Washout|Withdrawal by Subject|3|||
13074511|NCT00835991|25280972|FG001|Washout|Withdrawal by Subject|1|||
13074512|NCT00835796|25280987|FG000|First Intervention|Withdrawal by Subject|0|||
13074513|NCT00835796|25280988|FG001|First Intervention|Withdrawal by Subject|1|||
13074514|NCT00835705|25281009|FG000|First Intervention|Difficulty with vein|1|||
13074515|NCT00835705|25281010|FG001|First Intervention|Difficulty with vein|0|||
13074516|NCT00835705|25281009|FG000|Second Intervention|Difficulty with vein|1|||
13074517|NCT00835705|25281010|FG001|Second Intervention|Difficulty with vein|0|||
13074518|NCT00835692|25281025|FG000|First Intervention|Withdrawal by Subject|1|||
13074519|NCT00835692|25281026|FG001|First Intervention|Withdrawal by Subject|0|||
13074520|NCT00835666|25281041|FG000|Washout|Protocol Violation|1|||
13074521|NCT00835666|25281042|FG001|Washout|Protocol Violation|0|||
13074522|NCT00835666|25281041|FG000|Washout|Withdrawal by Subject|1|||
13074523|NCT00835666|25281042|FG001|Washout|Withdrawal by Subject|0|||
13074524|NCT00835640|25281057|FG000|Second Intervention|Protocol Violation|1|||
13074525|NCT00835640|25281058|FG001|Second Intervention|Protocol Violation|0|||
13074526|NCT00835575|25281105|FG000|Washout of 14 Days|Withdrawal by Subject|1|||
13074527|NCT00835575|25281106|FG001|Washout of 14 Days|Withdrawal by Subject|0|||
13074528|NCT00835549|25281121|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
13074529|NCT00835549|25281122|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
13074530|NCT00835536|25281135|FG000|Washout of 5 Weeks|Withdrawal by Subject|1|||
13074531|NCT00835536|25281136|FG001|Washout of 5 Weeks|Withdrawal by Subject|0|||
13074532|NCT00835406|25281187|FG000|Period: First Intervention|Adverse Event|0|||
13074533|NCT00835406|25281188|FG001|Period: First Intervention|Adverse Event|1|||
13074534|NCT00835406|25281187|FG000|Period: First Intervention|Withdrawal by Subject|2|||
13074535|NCT00835406|25281188|FG001|Period: First Intervention|Withdrawal by Subject|0|||
13074536|NCT00835406|25281187|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0|||
13074537|NCT00835406|25281188|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2|||
13074538|NCT00835367|25281215|FG000|Washout|Adverse Event|2|||
13074539|NCT00835367|25281216|FG001|Washout|Adverse Event|0|||
13074540|NCT00835367|25281215|FG000|Washout|Withdrawal by Subject|1|||
13074541|NCT00835367|25281216|FG001|Washout|Withdrawal by Subject|0|||
13074542|NCT00835367|25281215|FG000|Second Intervention|Adverse Event|1|||
13074543|NCT00835367|25281216|FG001|Second Intervention|Adverse Event|1|||
13074544|NCT00835354|25281231|FG000|First Intervention|Adverse Event|0|||
13074545|NCT00835354|25281232|FG001|First Intervention|Adverse Event|1|||
13130517|NCT02836249|25974715|FG001|Overall Study|Lost to Follow-up|1|||
13130518|NCT02836249|25974714|FG000|Overall Study|Still on Study|121|||
13130519|NCT02836249|25974715|FG001|Overall Study|Still on Study|55|||
13130520|NCT02836236|25974736|FG000|Overall Study|Randomized but Never Treated|1|||
13130521|NCT02836236|25974737|FG001|Overall Study|Randomized but Never Treated|0|||
13130522|NCT02836236|25974736|FG000|Overall Study|Withdrew Consent|2|||
13130523|NCT02836236|25974737|FG001|Overall Study|Withdrew Consent|0|||
13130524|NCT02836236|25974736|FG000|Overall Study|Adverse Event|0|||
13130525|NCT02836236|25974737|FG001|Overall Study|Adverse Event|1|||
13130526|NCT02836236|25974736|FG000|Overall Study|Investigator's Discretion|1|||
13130527|NCT02836236|25974737|FG001|Overall Study|Investigator's Discretion|0|||
13130528|NCT02836236|25974736|FG000|Overall Study|Still on Study|101|||
13130529|NCT02836236|25974737|FG001|Overall Study|Still on Study|49|||
13130530|NCT02835820|25974788|FG000|Overall Study|Baseline Screen Failure|0|||
13130531|NCT02835820|25974789|FG001|Overall Study|Baseline Screen Failure|3|||
13130532|NCT02835690|25974853|FG000|Overall Study|Death|12|||
13130533|NCT02835690|25974854|FG001|Overall Study|Death|11|||
13130534|NCT02835690|25974855|FG002|Overall Study|Death|13|||
13130535|NCT02835690|25974853|FG000|Overall Study|Transferred to Extension Study|2|||
13130536|NCT02835690|25974854|FG001|Overall Study|Transferred to Extension Study|2|||
13130537|NCT02835690|25974855|FG002|Overall Study|Transferred to Extension Study|1|||
13130538|NCT02835690|25974853|FG000|Overall Study|Did Not Continue on Extension Study|0|||
13130539|NCT02835690|25974854|FG001|Overall Study|Did Not Continue on Extension Study|0|||
13130540|NCT02835690|25974855|FG002|Overall Study|Did Not Continue on Extension Study|1|||
13130541|NCT02835690|25974853|FG000|Overall Study|Not Treated|0|||
13130542|NCT02835690|25974854|FG001|Overall Study|Not Treated|2|||
13130543|NCT02835690|25974855|FG002|Overall Study|Not Treated|0|||
13130544|NCT02847637|25975010|FG000|Overall Study|Withdrawal by Subject|0|||
13130545|NCT02847637|25975011|FG001|Overall Study|Withdrawal by Subject|1|||
13130546|NCT02847637|25975012|FG002|Overall Study|Withdrawal by Subject|1|||
13130547|NCT02847637|25975013|FG003|Overall Study|Withdrawal by Subject|0|||
13130548|NCT02847637|25975010|FG000|Overall Study|Lost to Follow-up|1|||
13130549|NCT02847637|25975011|FG001|Overall Study|Lost to Follow-up|1|||
13130550|NCT02847637|25975012|FG002|Overall Study|Lost to Follow-up|0|||
13130551|NCT02847637|25975013|FG003|Overall Study|Lost to Follow-up|0|||
13130552|NCT02835495|25975044|FG000|Overall Study|Cancer diagnosis prior intervention|1|||
13074546|NCT00835263|25281263|FG000|Second Intervention|Adverse Event|1|||
13074547|NCT00835263|25281264|FG001|Second Intervention|Adverse Event|0|||
13074548|NCT00835211|25281279|FG000|First Intervention|Withdrawal by Subject|0|||
13074549|NCT00835211|25281280|FG001|First Intervention|Withdrawal by Subject|1|||
13074550|NCT00835211|25281279|FG000|Washout: 7 Days|Adverse Event|2|||
13074551|NCT00835211|25281280|FG001|Washout: 7 Days|Adverse Event|1|||
13074552|NCT00835211|25281279|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
13074553|NCT00835211|25281280|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
13074554|NCT00835172|25281295|FG000|Washout|Protocol Violation|0|||
13074555|NCT00835172|25281296|FG001|Washout|Protocol Violation|1|||
13074556|NCT00835081|25281325|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
13074557|NCT00835081|25281326|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
13074558|NCT00835042|25281353|FG000|First Intervention|Withdrawal by Subject|3|||
13074559|NCT00835042|25281354|FG001|First Intervention|Withdrawal by Subject|0|||
13074560|NCT00835042|25281353|FG000|First Intervention|Adverse Event|1|||
13074561|NCT00835042|25281354|FG001|First Intervention|Adverse Event|2|||
13074562|NCT00835042|25281353|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
13074563|NCT00835042|25281354|FG001|Washout of 21 Days|Withdrawal by Subject|2|||
13074564|NCT00834873|25281435|FG000|First Intervention|Adverse Event|0|||
13074565|NCT00834873|25281436|FG001|First Intervention|Adverse Event|1|||
13074566|NCT00834795|25281451|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
13074567|NCT00834795|25281452|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
13074568|NCT00834795|25281451|FG000|Second Intervention|Adverse Event|1|||
13074569|NCT00834795|25281452|FG001|Second Intervention|Adverse Event|0|||
13074570|NCT00834756|25281467|FG000|First Intervention|Adverse Event|1|||
13074571|NCT00834756|25281468|FG001|First Intervention|Adverse Event|0|||
13074572|NCT00834756|25281467|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
13074573|NCT00834756|25281468|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
13074574|NCT00834743|25281483|FG000|Second Intervention|Withdrawal by Subject|1|||
13074575|NCT00834743|25281484|FG001|Second Intervention|Withdrawal by Subject|0|||
13074576|NCT00834717|25281499|FG000|First Intervention|Adverse Event|1|||
13074577|NCT00834717|25281500|FG001|First Intervention|Adverse Event|0|||
13074578|NCT00834717|25281499|FG000|First Intervention|Withdrawal by Subject|0|||
13074579|NCT00834717|25281500|FG001|First Intervention|Withdrawal by Subject|1|||
13074580|NCT00834639|25281515|FG000|Second Intervention|Physician Decision|0|||
13074581|NCT00834639|25281516|FG001|Second Intervention|Physician Decision|2|||
13074582|NCT00834613|25281531|FG000|First Intervention|Protocol Violation|1|||
13074583|NCT00834613|25281532|FG001|First Intervention|Protocol Violation|0|||
13074584|NCT00834587|25281553|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
13074585|NCT00834587|25281554|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
13074586|NCT00834522|25281617|FG000|Washout|Adverse Event|1|||
13074587|NCT00834522|25281618|FG001|Washout|Adverse Event|0|||
13074588|NCT00834522|25281617|FG000|Washout|Withdrawal by Subject|2|||
13074589|NCT00834522|25281618|FG001|Washout|Withdrawal by Subject|1|||
13074590|NCT00834444|25281633|FG000|First Intervention|Adverse Event|1|||
13074591|NCT00834444|25281634|FG001|First Intervention|Adverse Event|0|||
13074592|NCT00834444|25281633|FG000|First Intervention|Intolerance to Venopuncture|0|||
13074593|NCT00834444|25281634|FG001|First Intervention|Intolerance to Venopuncture|1|||
13074594|NCT00834444|25281633|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
13074595|NCT00834444|25281634|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
13074596|NCT00834444|25281633|FG000|Second Intervention|Adverse Event|1|||
13074597|NCT00834444|25281634|FG001|Second Intervention|Adverse Event|0|||
13074598|NCT00834431|25281649|FG000|First Intervention|Adverse Event|0|||
13074599|NCT00834431|25281650|FG001|First Intervention|Adverse Event|1|||
13074600|NCT00834431|25281649|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
13074601|NCT00834431|25281650|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
13074602|NCT00834418|25281663|FG000|Overall Study|Adverse Event|0|||
13074603|NCT00834418|25281664|FG001|Overall Study|Adverse Event|2|||
13074604|NCT00834340|25281693|FG000|Washout|Adverse Event|1|||
13074605|NCT00834340|25281694|FG001|Washout|Adverse Event|0|||
13074606|NCT00834340|25281693|FG000|Washout|Withdrawal by Subject|1|||
13074607|NCT00834340|25281694|FG001|Washout|Withdrawal by Subject|0|||
13074608|NCT00834249|25281731|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
13074609|NCT00834249|25281732|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
13074610|NCT00834249|25281731|FG000|Second Intervention|Adverse Event|1|||
13074611|NCT00834249|25281732|FG001|Second Intervention|Adverse Event|0|||
13074612|NCT00834067|25281791|FG000|Washout of 21 Days|Protocol Violation|0|||
13074613|NCT00834067|25281792|FG001|Washout of 21 Days|Protocol Violation|1|||
13074614|NCT00833937|25281807|FG000|Washout|Withdrawal by Subject|1|||
13074615|NCT00833937|25281808|FG001|Washout|Withdrawal by Subject|0|||
13074616|NCT00830336|25281871|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
13074617|NCT00830336|25281872|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
13074618|NCT00830258|25281887|FG000|First Intervention|Adverse Event|1|||
13074619|NCT00830258|25281888|FG001|First Intervention|Adverse Event|0|||
13074620|NCT00830258|25281887|FG000|Washout: 7 Days|Protocol Violation|1|||
13074621|NCT00830258|25281888|FG001|Washout: 7 Days|Protocol Violation|0|||
13074622|NCT00830219|25281903|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
13074623|NCT00830219|25281904|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
13074624|NCT00830206|25281919|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
13074625|NCT00830206|25281920|FG001|Washout: 21 Days|Withdrawal by Subject|1|||
13074626|NCT00830024|25281935|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
13074627|NCT00830024|25281936|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
13074628|NCT00829998|25281951|FG000|Washout|Adverse Event|0|||
13074629|NCT00829998|25281952|FG001|Washout|Adverse Event|1|||
13074630|NCT00829868|25281967|FG000|Washout|Physician Decision|1|||
13074631|NCT00829868|25281968|FG001|Washout|Physician Decision|0|||
13074632|NCT00829790|25281983|FG000|Washout of 14 Days|Withdrawal by Subject|0|||
13074633|NCT00829790|25281984|FG001|Washout of 14 Days|Withdrawal by Subject|1|||
13074634|NCT00829764|25281999|FG000|First Intervention|Adverse Event|1|||
13074635|NCT00829764|25282000|FG001|First Intervention|Adverse Event|0|||
13074636|NCT00829764|25281999|FG000|First Intervention|Withdrawal by Subject|1|||
13074637|NCT00829764|25282000|FG001|First Intervention|Withdrawal by Subject|1|||
13074638|NCT00829712|25282015|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
13074639|NCT00829712|25282016|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
13074640|NCT00829673|25282045|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
13074641|NCT00829673|25282046|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
13074642|NCT00829530|25282065|FG000|First Intervention|Adverse Event|0|||
13074643|NCT00829530|25282066|FG001|First Intervention|Adverse Event|1|||
13074644|NCT00829530|25282065|FG000|First Intervention|Intolerance to Venopuncture|0|||
13074645|NCT00829530|25282066|FG001|First Intervention|Intolerance to Venopuncture|1|||
13074646|NCT00829530|25282065|FG000|Second Intervention|Intolerance to Venopuncture|1|||
13074647|NCT00829530|25282066|FG001|Second Intervention|Intolerance to Venopuncture|0|||
13074648|NCT00829504|25282081|FG000|First Intervention|Adverse Event|1|||
13074649|NCT00829504|25282082|FG001|First Intervention|Adverse Event|0|||
13074650|NCT00829504|25282081|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
13074651|NCT00829504|25282082|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
13074652|NCT00829504|25282081|FG000|Second Intervention|Physician Decision|1|||
13074653|NCT00829504|25282082|FG001|Second Intervention|Physician Decision|0|||
13074654|NCT00829452|25282101|FG000|First Intervention|Withdrawal by Subject|0|||
13074655|NCT00829452|25282102|FG001|First Intervention|Withdrawal by Subject|1|||
13074656|NCT00829452|25282101|FG000|Washout of 42 Days|Withdrawal by Subject|0|||
13074657|NCT00829452|25282102|FG001|Washout of 42 Days|Withdrawal by Subject|1|||
13074658|NCT00829452|25282101|FG000|Second Intervention|Physician Decision|0|||
13074659|NCT00829452|25282102|FG001|Second Intervention|Physician Decision|1|||
13074660|NCT00829426|25282117|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
13074661|NCT00829426|25282118|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
13074662|NCT00829309|25282133|FG000|Washout: 7 Days|Protocol Violation|1|||
13074663|NCT00829309|25282134|FG001|Washout: 7 Days|Protocol Violation|0|||
13074664|NCT00828321|25282153|FG000|Washout of 42 Days|Withdrawal by Subject|2|||
13074665|NCT00828321|25282154|FG001|Washout of 42 Days|Withdrawal by Subject|0|||
13074666|NCT00828321|25282153|FG000|Second Intervention|Protocol Violation|0|||
13074667|NCT00828321|25282154|FG001|Second Intervention|Protocol Violation|1|||
13130553|NCT02835495|25975045|FG001|Overall Study|Cancer diagnosis prior intervention|0|||
13130554|NCT02835495|25975044|FG000|Overall Study|Declined in-person follow-up visit|4|||
13130555|NCT02835495|25975045|FG001|Overall Study|Declined in-person follow-up visit|2|||
13130556|NCT02835339|25975062|FG000|Overall Study|Did not receive allocated intervention|13|||
13130557|NCT02835339|25975063|FG001|Overall Study|Did not receive allocated intervention|16|||
13130558|NCT02835092|25975081|FG000|Overall Study|Withdrawal by Subject|3|||
13130559|NCT02835092|25975082|FG001|Overall Study|Withdrawal by Subject|6|||
13130560|NCT02835092|25975083|FG002|Overall Study|Withdrawal by Subject|3|||
13130561|NCT02835092|25975081|FG000|Overall Study|Lost to Follow-up|0|||
13130562|NCT02835092|25975082|FG001|Overall Study|Lost to Follow-up|2|||
13130563|NCT02835092|25975083|FG002|Overall Study|Lost to Follow-up|0|||
13130564|NCT02834819|25975110|FG000|Overall Study|Did not complete 7 day follow up call.|5|||
13130565|NCT02834819|25975111|FG001|Overall Study|Did not complete 7 day follow up call.|0|||
13130566|NCT02834390|25975142|FG000|Induction Phase|Progressive disease|0|||
13130567|NCT02834390|25975143|FG001|Induction Phase|Progressive disease|1|||
13130568|NCT02834390|25975142|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2|||
13130569|NCT02834390|25975143|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0|||
13130570|NCT02834390|25975142|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0|||
13130571|NCT02834390|25975143|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1|||
13130572|NCT02834390|25975142|FG000|Consolidation Phase|Physician Decision|1|||
13130573|NCT02834390|25975143|FG001|Consolidation Phase|Physician Decision|1|||
13130574|NCT02834247|25975183|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1|||
13130575|NCT02834247|25975184|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2|||
13130576|NCT02834247|25975185|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0|||
13130577|NCT02834247|25975186|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0|||
13130578|NCT02834247|25975183|FG000|Dose Escalation Phase|Death|5|||
13130579|NCT02834247|25975184|FG001|Dose Escalation Phase|Death|6|||
13130580|NCT02834247|25975185|FG002|Dose Escalation Phase|Death|5|||
13130581|NCT02834247|25975186|FG003|Dose Escalation Phase|Death|0|||
13130582|NCT02834247|25975183|FG000|Dose Escalation Phase|Lost to Follow-up|0|||
13130583|NCT02834247|25975184|FG001|Dose Escalation Phase|Lost to Follow-up|1|||
13074668|NCT00806403|25282173|FG000|Overall Study|Death|4|||
13074669|NCT00806403|25282174|FG001|Overall Study|Death|3|||
13074670|NCT00796523|25282259|FG000|Overall Study|Lost to Follow-up|9|||
13074671|NCT00796523|25282260|FG001|Overall Study|Lost to Follow-up|7|||
13074672|NCT00794924|25282271|FG000|Overall Study|Lost to Follow-up|6|||
13074673|NCT00794924|25282272|FG001|Overall Study|Lost to Follow-up|8|||
13074674|NCT00794924|25282271|FG000|Overall Study|Withdrawal by Subject|48|||
13074675|NCT00794924|25282272|FG001|Overall Study|Withdrawal by Subject|60|||
13074676|NCT00794924|25282271|FG000|Overall Study|Adverse Event|6|||
13074677|NCT00794924|25282272|FG001|Overall Study|Adverse Event|2|||
13074678|NCT00794677|25282299|FG000|First Intervention|Withdrawal by Subject|2|||
13074679|NCT00794677|25282300|FG001|First Intervention|Withdrawal by Subject|0|||
13074680|NCT00792116|25282317|FG000|Overall Study|Lost to Follow-up|0|||
13074681|NCT00792116|25282318|FG001|Overall Study|Lost to Follow-up|1|||
13074682|NCT00792116|25282317|FG000|Overall Study|Discontnued intervention|1|||
13074683|NCT00792116|25282318|FG001|Overall Study|Discontnued intervention|0|||
13074684|NCT00756574|25282359|FG000|Overall Study|Withdrawal by Subject|9|||
13074685|NCT00756574|25282360|FG001|Overall Study|Withdrawal by Subject|7|||
13074686|NCT00756574|25282359|FG000|Overall Study|Lost to Follow-up|4|||
13074687|NCT00756574|25282360|FG001|Overall Study|Lost to Follow-up|4|||
13074688|NCT00740480|25282374|FG000|Overall Study|Adverse Event|1|||
13074689|NCT00740480|25282374|FG000|Overall Study|Physician Decision|1|||
13074690|NCT00724698|25282379|FG000|Overall Study|Adverse Event|9|||
13074691|NCT00724698|25282379|FG000|Overall Study|Failure of Therapy|4|||
13074692|NCT00724698|25282379|FG000|Overall Study|Poor Compliance|16|||
13074693|NCT00724698|25282379|FG000|Overall Study|Lost to Follow-up|36|||
13074694|NCT00724698|25282379|FG000|Overall Study|No Info|25|||
13074695|NCT00711555|25282388|FG000|Overall Study|Adverse Event|3|||
13074696|NCT00676494|25282396|FG000|Overall Study|Missed Visit|8|||
13074697|NCT00676494|25282396|FG000|Overall Study|Withdrawal by Subject|6|||
13074698|NCT00674440|25282403|FG000|Overall Study|consented but not scanned (Withdrawn due to genetics)|1|||
13074699|NCT00674440|25282403|FG000|Overall Study|did not have surgery, so unevaluable|7|||
13074700|NCT00674440|25282403|FG000|Overall Study|had atypical histology or had second PET scan after initial surgery - not counted twice|3|||
13074701|NCT00659061|25282433|FG000|Overall Study|Migration due to political unrest|21|||
13074702|NCT00659061|25282434|FG001|Overall Study|Migration due to political unrest|15|||
13074703|NCT00581477|25282464|FG000|Overall Study|Physician Decision|2|||
13074704|NCT00529152|25282497|FG000|Overall Study|Adverse Event|2|||
13074705|NCT00529152|25282497|FG000|Overall Study|Withdrawal by Subject|2|||
13074706|NCT00529152|25282497|FG000|Overall Study|Lost to Follow-up|1|||
13074707|NCT00526227|25282506|FG000|Overall Study|Device not implanted|1|||
13074708|NCT00526227|25282506|FG000|Overall Study|Death|1|||
13074709|NCT00495131|25282551|FG000|Overall Study|Adverse Event|6|||
13074710|NCT00495131|25282552|FG001|Overall Study|Adverse Event|2|||
13074711|NCT00495131|25282551|FG000|Overall Study|Lack of Efficacy|0|||
13074712|NCT00495131|25282552|FG001|Overall Study|Lack of Efficacy|2|||
13074713|NCT00495131|25282551|FG000|Overall Study|Lost to Follow-up|0|||
13074714|NCT00495131|25282552|FG001|Overall Study|Lost to Follow-up|2|||
13074715|NCT00495131|25282551|FG000|Overall Study|Withdrawal by Subject|1|||
13074716|NCT00495131|25282552|FG001|Overall Study|Withdrawal by Subject|0|||
13074717|NCT00484419|25282630|FG000|Overall Study|Adverse Event|3|||
13074718|NCT00484419|25282631|FG001|Overall Study|Adverse Event|0|||
13074719|NCT00484419|25282632|FG002|Overall Study|Adverse Event|0|||
13222320|NCT01807221|26286045|FG005|Overall Study|Progressive disease|0|||
13222321|NCT01807221|26286040|FG000|Overall Study|Death|7|||
13222322|NCT01807221|26286041|FG001|Overall Study|Death|9|||
13074720|NCT00484419|25282630|FG000|Overall Study|Lost to Follow-up|1|||
13074721|NCT00484419|25282631|FG001|Overall Study|Lost to Follow-up|0|||
13074722|NCT00484419|25282632|FG002|Overall Study|Lost to Follow-up|2|||
13074723|NCT00484419|25282630|FG000|Overall Study|Withdrawal by Subject|3|||
13074724|NCT00484419|25282631|FG001|Overall Study|Withdrawal by Subject|1|||
13074725|NCT00484419|25282632|FG002|Overall Study|Withdrawal by Subject|1|||
13074726|NCT00484419|25282630|FG000|Overall Study|subject met discontinuation criteria|2|||
13074727|NCT00484419|25282631|FG001|Overall Study|subject met discontinuation criteria|2|||
13074728|NCT00484419|25282632|FG002|Overall Study|subject met discontinuation criteria|4|||
13222323|NCT01807221|26286042|FG002|Overall Study|Death|4|||
13074729|NCT00484419|25282630|FG000|Overall Study|required restricted medication|1|||
13074730|NCT00484419|25282631|FG001|Overall Study|required restricted medication|0|||
13074731|NCT00484419|25282632|FG002|Overall Study|required restricted medication|1|||
13074732|NCT00484419|25282630|FG000|Overall Study|Physician Decision|1|||
13074733|NCT00484419|25282631|FG001|Overall Study|Physician Decision|1|||
13074734|NCT00484419|25282632|FG002|Overall Study|Physician Decision|1|||
13074735|NCT00484419|25282630|FG000|Overall Study|subject unable to receive medication|1|||
13074736|NCT00484419|25282631|FG001|Overall Study|subject unable to receive medication|0|||
13074737|NCT00484419|25282632|FG002|Overall Study|subject unable to receive medication|0|||
13074738|NCT00484419|25282630|FG000|Overall Study|subject relocated|0|||
13222324|NCT01807221|26286043|FG003|Overall Study|Death|2|||
13222325|NCT01807221|26286044|FG004|Overall Study|Death|1|||
13074739|NCT00484419|25282631|FG001|Overall Study|subject relocated|1|||
13074740|NCT00484419|25282632|FG002|Overall Study|subject relocated|0|||
13074741|NCT00484419|25282630|FG000|Overall Study|sponsor decision, randomized in error|0|||
13074742|NCT00484419|25282631|FG001|Overall Study|sponsor decision, randomized in error|0|||
13074743|NCT00484419|25282632|FG002|Overall Study|sponsor decision, randomized in error|2|||
13130584|NCT02834247|25975185|FG002|Dose Escalation Phase|Lost to Follow-up|0|||
13130585|NCT02834247|25975186|FG003|Dose Escalation Phase|Lost to Follow-up|0|||
13130586|NCT02834247|25975183|FG000|Dose Escalation Phase|Withdrawal by Subject|2|||
13130587|NCT02834247|25975184|FG001|Dose Escalation Phase|Withdrawal by Subject|2|||
13130588|NCT02834247|25975185|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
13130589|NCT02834247|25975186|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
13130590|NCT02834247|25975183|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0|||
13130591|NCT02834247|25975184|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0|||
13130592|NCT02834247|25975185|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0|||
13130593|NCT02834247|25975186|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7|||
13130594|NCT02834247|25975183|FG000|Dose Expansion Phase|Death|0|||
13130595|NCT02834247|25975184|FG001|Dose Expansion Phase|Death|0|||
13130596|NCT02834247|25975185|FG002|Dose Expansion Phase|Death|0|||
13130597|NCT02834247|25975186|FG003|Dose Expansion Phase|Death|8|||
13130598|NCT02834247|25975183|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
13130599|NCT02834247|25975184|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
13130600|NCT02834247|25975185|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
13130601|NCT02834247|25975186|FG003|Dose Expansion Phase|Lost to Follow-up|1|||
13130602|NCT02834247|25975183|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
13130603|NCT02834247|25975184|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
13130604|NCT02834247|25975185|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
13130605|NCT02834247|25975186|FG003|Dose Expansion Phase|Withdrawal by Subject|1|||
13130606|NCT02833974|25975217|FG000|Overall Study|Lost to Follow-up|1|||
13130607|NCT02833974|25975218|FG001|Overall Study|Lost to Follow-up|0|||
13130608|NCT02833974|25975217|FG000|Overall Study|Adverse Event|0|||
13130609|NCT02833974|25975218|FG001|Overall Study|Adverse Event|3|||
13130610|NCT02833948|25975249|FG000|Overall Study|Death|2|||
13130611|NCT02833948|25975250|FG001|Overall Study|Death|3|||
13130612|NCT02833948|25975249|FG000|Overall Study|were not scanned|8|||
13130613|NCT02833948|25975250|FG001|Overall Study|were not scanned|13|||
13130614|NCT02833948|25975249|FG000|Overall Study|scans could not be evaluated|5|||
13130615|NCT02833948|25975250|FG001|Overall Study|scans could not be evaluated|2|||
13130616|NCT02833844|25975285|FG000|Double-Blind Period|Withdrawal by Subject|2|||
13130617|NCT02833844|25975286|FG001|Double-Blind Period|Withdrawal by Subject|3|||
13130618|NCT02833844|25975285|FG000|Double-Blind Period|Protocol Violation|0|||
13130619|NCT02833844|25975286|FG001|Double-Blind Period|Protocol Violation|4|||
13130620|NCT02833844|25975285|FG000|Open-Label Period|Death|0|||
13130621|NCT02833844|25975286|FG001|Open-Label Period|Death|2|||
13130622|NCT02833844|25975285|FG000|Open-Label Period|Lost to Follow-up|1|||
13130623|NCT02833844|25975286|FG001|Open-Label Period|Lost to Follow-up|0|||
13130624|NCT02833844|25975285|FG000|Open-Label Period|Withdrawal by Subject|1|||
13130625|NCT02833844|25975286|FG001|Open-Label Period|Withdrawal by Subject|0|||
13130626|NCT02833350|25975509|FG000|Overall Study|Adverse Event|0|||
13130627|NCT02833350|25975510|FG001|Overall Study|Adverse Event|3|||
13130628|NCT02833350|25975511|FG002|Overall Study|Adverse Event|4|||
13130629|NCT02833350|25975512|FG003|Overall Study|Adverse Event|4|||
13130630|NCT02833350|25975513|FG004|Overall Study|Adverse Event|1|||
13130631|NCT02833350|25975514|FG005|Overall Study|Adverse Event|0|||
13130632|NCT02833350|25975515|FG006|Overall Study|Adverse Event|1|||
13130633|NCT02833350|25975509|FG000|Overall Study|Death|0|||
13130634|NCT02833350|25975510|FG001|Overall Study|Death|0|||
13130635|NCT02833350|25975511|FG002|Overall Study|Death|1|||
13130636|NCT02833350|25975512|FG003|Overall Study|Death|0|||
13130637|NCT02833350|25975513|FG004|Overall Study|Death|0|||
13130638|NCT02833350|25975514|FG005|Overall Study|Death|0|||
13130639|NCT02833350|25975515|FG006|Overall Study|Death|0|||
13130640|NCT02833350|25975509|FG000|Overall Study|Lack of Efficacy|0|||
13130641|NCT02833350|25975510|FG001|Overall Study|Lack of Efficacy|2|||
13130642|NCT02833350|25975511|FG002|Overall Study|Lack of Efficacy|1|||
13130643|NCT02833350|25975512|FG003|Overall Study|Lack of Efficacy|4|||
13130644|NCT02833350|25975513|FG004|Overall Study|Lack of Efficacy|0|||
13130645|NCT02833350|25975514|FG005|Overall Study|Lack of Efficacy|1|||
13130646|NCT02833350|25975515|FG006|Overall Study|Lack of Efficacy|1|||
13130647|NCT02833350|25975509|FG000|Overall Study|Lost to Follow-up|0|||
13130648|NCT02833350|25975510|FG001|Overall Study|Lost to Follow-up|1|||
13130649|NCT02833350|25975511|FG002|Overall Study|Lost to Follow-up|0|||
13130650|NCT02833350|25975512|FG003|Overall Study|Lost to Follow-up|0|||
13130651|NCT02833350|25975513|FG004|Overall Study|Lost to Follow-up|0|||
13130652|NCT02833350|25975514|FG005|Overall Study|Lost to Follow-up|0|||
13130653|NCT02833350|25975515|FG006|Overall Study|Lost to Follow-up|1|||
13130654|NCT02833350|25975509|FG000|Overall Study|Withdrawal by Subject|3|||
13130655|NCT02833350|25975510|FG001|Overall Study|Withdrawal by Subject|3|||
13130656|NCT02833350|25975511|FG002|Overall Study|Withdrawal by Subject|2|||
13074744|NCT00440531|25282668|FG000|Overall Study|Adverse Event|1|||
13074745|NCT00440531|25282669|FG001|Overall Study|Adverse Event|0|||
13074746|NCT00440531|25282670|FG002|Overall Study|Adverse Event|2|||
13074747|NCT00440531|25282668|FG000|Overall Study|Withdrawal by Subject|2|||
13074748|NCT00440531|25282669|FG001|Overall Study|Withdrawal by Subject|0|||
13074749|NCT00440531|25282670|FG002|Overall Study|Withdrawal by Subject|0|||
13074750|NCT00440531|25282668|FG000|Overall Study|Protocol Violation|1|||
13074751|NCT00440531|25282669|FG001|Overall Study|Protocol Violation|2|||
13074752|NCT00440531|25282670|FG002|Overall Study|Protocol Violation|0|||
13074753|NCT00440531|25282668|FG000|Overall Study|Lost to Follow-up|4|||
13074754|NCT00440531|25282669|FG001|Overall Study|Lost to Follow-up|3|||
13074755|NCT00440531|25282670|FG002|Overall Study|Lost to Follow-up|5|||
13074756|NCT00440531|25282668|FG000|Overall Study|see pre-assignment details|2|||
13074757|NCT00440531|25282669|FG001|Overall Study|see pre-assignment details|0|||
13074758|NCT00440531|25282670|FG002|Overall Study|see pre-assignment details|0|||
13074759|NCT00439738|25282693|FG000|Overall Study|Withdrawal by Subject|16|||
13074760|NCT00439738|25282694|FG001|Overall Study|Withdrawal by Subject|13|||
13074761|NCT00439738|25282693|FG000|Overall Study|Adverse Event|6|||
13074762|NCT00439738|25282694|FG001|Overall Study|Adverse Event|4|||
13074763|NCT00439738|25282693|FG000|Overall Study|Lost to Follow-up|5|||
13074764|NCT00439738|25282694|FG001|Overall Study|Lost to Follow-up|6|||
13074765|NCT00439738|25282693|FG000|Overall Study|Protocol Violation|6|||
13074766|NCT00439738|25282694|FG001|Overall Study|Protocol Violation|3|||
13074767|NCT00439738|25282693|FG000|Overall Study|Lack of Efficacy|2|||
13074768|NCT00439738|25282694|FG001|Overall Study|Lack of Efficacy|2|||
13074769|NCT00439738|25282693|FG000|Overall Study|Abnormal Lab Values|1|||
13074770|NCT00439738|25282694|FG001|Overall Study|Abnormal Lab Values|0|||
13074771|NCT00430950|25282732|FG000|Overall Study|Adverse Event|7|||
13074772|NCT00430950|25282733|FG001|Overall Study|Adverse Event|6|||
13074773|NCT00430950|25282732|FG000|Overall Study|Withdrawal by Subject|1|||
13074774|NCT00430950|25282733|FG001|Overall Study|Withdrawal by Subject|0|||
13074775|NCT00430950|25282732|FG000|Overall Study|concomitant medication,etc.|5|||
13074776|NCT00430950|25282733|FG001|Overall Study|concomitant medication,etc.|7|||
13074777|NCT00430508|25282780|FG000|Overall Study|Adverse Event|2|||
13074778|NCT00430508|25282781|FG001|Overall Study|Adverse Event|3|||
13074779|NCT00430508|25282782|FG002|Overall Study|Adverse Event|5|||
13074780|NCT00430508|25282783|FG003|Overall Study|Adverse Event|3|||
13074781|NCT00430508|25282780|FG000|Overall Study|Withdrawal by Subject|0|||
13074782|NCT00430508|25282781|FG001|Overall Study|Withdrawal by Subject|1|||
13074783|NCT00430508|25282782|FG002|Overall Study|Withdrawal by Subject|1|||
13074784|NCT00430508|25282783|FG003|Overall Study|Withdrawal by Subject|1|||
13074785|NCT00430508|25282780|FG000|Overall Study|responder at visit 4|0|||
13074786|NCT00430508|25282781|FG001|Overall Study|responder at visit 4|0|||
13074787|NCT00430508|25282782|FG002|Overall Study|responder at visit 4|2|||
13074788|NCT00430508|25282783|FG003|Overall Study|responder at visit 4|0|||
13074789|NCT00430508|25282780|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0|||
13074790|NCT00430508|25282781|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
13074791|NCT00430508|25282782|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2|||
13074792|NCT00430508|25282783|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
13074793|NCT00430508|25282780|FG000|Overall Study|Other|1|||
13074794|NCT00430508|25282781|FG001|Overall Study|Other|1|||
13074795|NCT00430508|25282782|FG002|Overall Study|Other|3|||
13074796|NCT00430508|25282783|FG003|Overall Study|Other|0|||
13074797|NCT00430092|25282798|FG000|Overall Study|Adverse Event|0|||
13074798|NCT00430092|25282799|FG001|Overall Study|Adverse Event|0|||
13074799|NCT00430092|25282800|FG002|Overall Study|Adverse Event|1|||
13074800|NCT00430092|25282798|FG000|Overall Study|Lack of Efficacy|5|||
13074801|NCT00430092|25282799|FG001|Overall Study|Lack of Efficacy|2|||
13074802|NCT00430092|25282800|FG002|Overall Study|Lack of Efficacy|54|||
13074803|NCT00430092|25282798|FG000|Overall Study|Lost to Follow-up|1|||
13074804|NCT00430092|25282799|FG001|Overall Study|Lost to Follow-up|0|||
13074805|NCT00430092|25282800|FG002|Overall Study|Lost to Follow-up|0|||
13074806|NCT00430092|25282798|FG000|Overall Study|Protocol Violation|0|||
13074807|NCT00430092|25282799|FG001|Overall Study|Protocol Violation|1|||
13074808|NCT00430092|25282800|FG002|Overall Study|Protocol Violation|1|||
13074809|NCT00430092|25282798|FG000|Overall Study|Withdrawal by Subject|0|||
13074810|NCT00430092|25282799|FG001|Overall Study|Withdrawal by Subject|1|||
13074811|NCT00430092|25282800|FG002|Overall Study|Withdrawal by Subject|1|||
13485218|NCT03921424|27031930|FG001|Overall Study|Lost to Follow-up|1|||
13074812|NCT00429923|25282815|FG000|Overall Study|Adverse Event|0|||
13074813|NCT00429923|25282816|FG001|Overall Study|Adverse Event|2|||
13074814|NCT00429923|25282817|FG002|Overall Study|Adverse Event|3|||
13074815|NCT00429923|25282815|FG000|Overall Study|Lack of Efficacy|4|||
13074816|NCT00429923|25282816|FG001|Overall Study|Lack of Efficacy|1|||
13074817|NCT00429923|25282817|FG002|Overall Study|Lack of Efficacy|33|||
13074818|NCT00429923|25282815|FG000|Overall Study|Lost to Follow-up|0|||
13074819|NCT00429923|25282816|FG001|Overall Study|Lost to Follow-up|0|||
13074820|NCT00429923|25282817|FG002|Overall Study|Lost to Follow-up|2|||
13074821|NCT00429923|25282815|FG000|Overall Study|Withdrew Consent|1|||
13074822|NCT00429923|25282816|FG001|Overall Study|Withdrew Consent|0|||
13074823|NCT00429923|25282817|FG002|Overall Study|Withdrew Consent|1|||
13074824|NCT00429923|25282815|FG000|Overall Study|Early Termination|0|||
13074825|NCT00429923|25282816|FG001|Overall Study|Early Termination|1|||
13074826|NCT00429923|25282817|FG002|Overall Study|Early Termination|0|||
13074827|NCT00425100|25282856|FG000|Overall Study|Adverse Event|36|||
13074828|NCT00425100|25282856|FG000|Overall Study|Lack of Efficacy|4|||
13074829|NCT00425100|25282856|FG000|Overall Study|Lost to Follow-up|2|||
13074830|NCT00425100|25282856|FG000|Overall Study|Protocol Violation|4|||
13074831|NCT00425100|25282856|FG000|Overall Study|Withdrawal by Subject|7|||
13074832|NCT00415623|25282887|FG000|Overall Study|Adverse Event|3|||
13074833|NCT00415623|25282888|FG001|Overall Study|Adverse Event|4|||
13074834|NCT00415623|25282887|FG000|Overall Study|Death|1|||
13074835|NCT00415623|25282888|FG001|Overall Study|Death|0|||
13074836|NCT00415623|25282887|FG000|Overall Study|Withdrawal by Subject|1|||
13074837|NCT00415623|25282888|FG001|Overall Study|Withdrawal by Subject|1|||
13074838|NCT00412932|25282899|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1|||
13074839|NCT00412932|25282899|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2|||
13074840|NCT00412932|25282899|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1|||
13074841|NCT00412932|25282899|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2|||
13074842|NCT00412932|25282899|FG000|Olmesartan (Olm) 20 mg|Other|1|||
13074843|NCT00412932|25282899|FG000|Olmesartan 40 mg|Adverse Event|4|||
13074844|NCT00412932|25282899|FG000|Olmesartan 40 mg|Lack of Efficacy|3|||
13074845|NCT00412932|25282899|FG000|Olmesartan 40 mg|Withdrawal by Subject|1|||
13074846|NCT00412932|25282899|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3|||
13074847|NCT00412932|25282899|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3|||
13074848|NCT00412932|25282899|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1|||
13074849|NCT00412932|25282899|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
13130657|NCT02833350|25975512|FG003|Overall Study|Withdrawal by Subject|0|||
13130658|NCT02833350|25975513|FG004|Overall Study|Withdrawal by Subject|2|||
13130659|NCT02833350|25975514|FG005|Overall Study|Withdrawal by Subject|0|||
13130660|NCT02833350|25975515|FG006|Overall Study|Withdrawal by Subject|2|||
13130661|NCT02833077|25975534|FG000|Overall Study|Adverse Event|1|||
13130662|NCT02833077|25975535|FG001|Overall Study|Adverse Event|2|||
13130663|NCT02833077|25975534|FG000|Overall Study|Lost to Follow-up|10|||
13130664|NCT02833077|25975535|FG001|Overall Study|Lost to Follow-up|1|||
13130665|NCT02833077|25975534|FG000|Overall Study|Personal Reasons|6|||
13130666|NCT02833077|25975535|FG001|Overall Study|Personal Reasons|4|||
13130667|NCT02833077|25975534|FG000|Overall Study|Protocol Deviation|0|||
13130668|NCT02833077|25975535|FG001|Overall Study|Protocol Deviation|1|||
13130669|NCT02832622|25975550|FG000|Overall Study|MPP not programmed|1259|||
13130670|NCT02832622|25975550|FG000|Overall Study|Withdrawal by Subject|123|||
13130671|NCT02832622|25975550|FG000|Overall Study|Death|119|||
13130672|NCT02832622|25975550|FG000|Overall Study|Unsuccessful CRT implant|93|||
13130673|NCT02832622|25975550|FG000|Overall Study|Lost to Follow-up|45|||
13130674|NCT02832622|25975550|FG000|Overall Study|Patient non-compliance|42|||
13130675|NCT02832622|25975550|FG000|Overall Study|Withdrawal by other reasons|25|||
13130676|NCT02832622|25975550|FG000|Overall Study|System explant|24|||
13130677|NCT02832622|25975550|FG000|Overall Study|Physician Decision|6|||
13130678|NCT02832375|25975567|FG000|Overall Study|Lost to Follow-up|1|||
13130679|NCT02832375|25975568|FG001|Overall Study|Lost to Follow-up|0|||
13130680|NCT02832375|25975567|FG000|Overall Study|Withdrawal of Consent|1|||
13130681|NCT02832375|25975568|FG001|Overall Study|Withdrawal of Consent|0|||
13130682|NCT02832063|25975593|FG000|Overall Study|Adverse Event|2|||
13130683|NCT02832063|25975594|FG001|Overall Study|Adverse Event|1|||
13130684|NCT02832063|25975593|FG000|Overall Study|Physician Decision|5|||
13130685|NCT02832063|25975594|FG001|Overall Study|Physician Decision|7|||
13130686|NCT02832063|25975593|FG000|Overall Study|Lost to Follow-up|15|||
13130687|NCT02832063|25975594|FG001|Overall Study|Lost to Follow-up|8|||
13130688|NCT02832063|25975593|FG000|Overall Study|Withdrawal by Subject|10|||
13130689|NCT02832063|25975594|FG001|Overall Study|Withdrawal by Subject|21|||
13130690|NCT02832063|25975593|FG000|Overall Study|Other|2|||
13130691|NCT02832063|25975594|FG001|Overall Study|Other|1|||
13130692|NCT02832037|25975632|FG000|Overall Study|Administrative reasons|0|||
13130693|NCT02832037|25975633|FG001|Overall Study|Administrative reasons|0|||
13130694|NCT02832037|25975634|FG002|Overall Study|Administrative reasons|1|||
13130695|NCT02832037|25975635|FG003|Overall Study|Administrative reasons|0|||
13130696|NCT02832037|25975636|FG004|Overall Study|Administrative reasons|0|||
13130697|NCT02832037|25975632|FG000|Overall Study|Protocol Violation|3|||
13130698|NCT02832037|25975633|FG001|Overall Study|Protocol Violation|0|||
13130699|NCT02832037|25975634|FG002|Overall Study|Protocol Violation|4|||
13130700|NCT02832037|25975635|FG003|Overall Study|Protocol Violation|1|||
13130701|NCT02832037|25975636|FG004|Overall Study|Protocol Violation|2|||
13130702|NCT02832037|25975632|FG000|Overall Study|Lost to Follow-up|2|||
13130703|NCT02832037|25975633|FG001|Overall Study|Lost to Follow-up|0|||
13130704|NCT02832037|25975634|FG002|Overall Study|Lost to Follow-up|3|||
13130705|NCT02832037|25975635|FG003|Overall Study|Lost to Follow-up|0|||
13130706|NCT02832037|25975636|FG004|Overall Study|Lost to Follow-up|5|||
13130707|NCT02832037|25975632|FG000|Overall Study|Withdrawal by Subject|9|||
13074850|NCT00397254|25282920|FG000|Overall Study|Lost to Follow-up|2|||
13074851|NCT00397254|25282921|FG001|Overall Study|Lost to Follow-up|2|||
13074852|NCT00338104|25282981|FG000|Overall Study|Protocol Violation|2|||
13074853|NCT00338104|25282982|FG001|Overall Study|Protocol Violation|1|||
13074854|NCT00338104|25282983|FG002|Overall Study|Protocol Violation|3|||
13074855|NCT00326183|25283024|FG000|Overall Study|Lost to Follow-up|104|||
13074856|NCT00326183|25283025|FG001|Overall Study|Lost to Follow-up|56|||
13074857|NCT00326183|25283024|FG000|Overall Study|Protocol Violation|6|||
13074858|NCT00326183|25283025|FG001|Overall Study|Protocol Violation|3|||
13074859|NCT00326183|25283024|FG000|Overall Study|Withdrawal by Subject|35|||
13074860|NCT00326183|25283025|FG001|Overall Study|Withdrawal by Subject|7|||
13074861|NCT00326183|25283024|FG000|Overall Study|Subject Moved|7|||
13074862|NCT00326183|25283025|FG001|Overall Study|Subject Moved|4|||
13074863|NCT00326183|25283024|FG000|Overall Study|Other|47|||
13074864|NCT00326183|25283025|FG001|Overall Study|Other|13|||
13074865|NCT00326183|25283024|FG000|Overall Study|Adverse Event|1|||
13074866|NCT00326183|25283025|FG001|Overall Study|Adverse Event|0|||
13074867|NCT00318656|25283080|FG000|Overall Study|Took Avandamet instead of Glim/Met|0|||
13074868|NCT00318656|25283081|FG001|Overall Study|Took Avandamet instead of Glim/Met|1|||
13074869|NCT00318656|25283080|FG000|Overall Study|Did not receive any treatment|0|||
13074870|NCT00318656|25283081|FG001|Overall Study|Did not receive any treatment|1|||
13074871|NCT00303498|25283106|FG000|Run-In-Phase (10 Weeks)|Adverse Event|5|||
13074872|NCT00303498|25283107|FG001|Run-In-Phase (10 Weeks)|Adverse Event|1|||
13074873|NCT00303498|25283106|FG000|Run-In-Phase (10 Weeks)|Physician Decision|0|||
13074874|NCT00303498|25283107|FG001|Run-In-Phase (10 Weeks)|Physician Decision|1|||
13074875|NCT00303498|25283106|FG000|Run-In-Phase (10 Weeks)|Withdrawal by Subject|5|||
13074876|NCT00303498|25283107|FG001|Run-In-Phase (10 Weeks)|Withdrawal by Subject|0|||
13074877|NCT00303498|25283106|FG000|Run-In-Phase (10 Weeks)|Sponsor Decision|6|||
13074878|NCT00303498|25283107|FG001|Run-In-Phase (10 Weeks)|Sponsor Decision|3|||
13074879|NCT00303498|25283106|FG000|Run-In-Phase (10 Weeks)|Other|4|||
13074880|NCT00303498|25283107|FG001|Run-In-Phase (10 Weeks)|Other|1|||
13074881|NCT00303498|25283106|FG000|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|3|||
13074882|NCT00303498|25283107|FG001|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|2|||
13074883|NCT00303498|25283106|FG000|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|1|||
13074884|NCT00303498|25283107|FG001|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|0|||
13074885|NCT00303498|25283106|FG000|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|1|||
13074886|NCT00303498|25283107|FG001|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|0|||
13074887|NCT00303498|25283106|FG000|Maintenance Phase (24 Weeks)|Death|1|||
13074888|NCT00303498|25283107|FG001|Maintenance Phase (24 Weeks)|Death|0|||
13074889|NCT00303498|25283106|FG000|Maintenance Phase (24 Weeks)|Adverse Event|2|||
13074890|NCT00303498|25283107|FG001|Maintenance Phase (24 Weeks)|Adverse Event|1|||
13074891|NCT00303498|25283106|FG000|Maintenance Phase (24 Weeks)|Physician Decision|1|||
13074892|NCT00303498|25283107|FG001|Maintenance Phase (24 Weeks)|Physician Decision|0|||
13074893|NCT00303498|25283106|FG000|Maintenance Phase (24 Weeks)|Withdrawal by Subject|3|||
13074894|NCT00303498|25283107|FG001|Maintenance Phase (24 Weeks)|Withdrawal by Subject|4|||
13074895|NCT00303498|25283106|FG000|Maintenance Phase (24 Weeks)|Sponsor Decision|4|||
13074896|NCT00303498|25283107|FG001|Maintenance Phase (24 Weeks)|Sponsor Decision|0|||
13074897|NCT00303498|25283106|FG000|Maintenance Phase (24 Weeks)|Other|1|||
13074898|NCT00303498|25283107|FG001|Maintenance Phase (24 Weeks)|Other|0|||
13074899|NCT00303498|25283106|FG000|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|1|||
13074900|NCT00303498|25283107|FG001|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|2|||
13074901|NCT00303498|25283106|FG000|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|0|||
13074902|NCT00303498|25283107|FG001|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|1|||
13074903|NCT00301262|25283272|FG000|Double Blind Phase (DB)|Adverse Event|1|||
13074904|NCT00301262|25283273|FG001|Double Blind Phase (DB)|Adverse Event|0|||
13074905|NCT00301262|25283272|FG000|Double Blind Phase (DB)|Lack of Efficacy|0|||
13074906|NCT00301262|25283273|FG001|Double Blind Phase (DB)|Lack of Efficacy|1|||
13074907|NCT00301262|25283272|FG000|Double Blind Phase (DB)|Lost to Follow-up|3|||
13074908|NCT00301262|25283273|FG001|Double Blind Phase (DB)|Lost to Follow-up|3|||
13074909|NCT00301262|25283272|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5|||
13074910|NCT00301262|25283273|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5|||
13074911|NCT00301262|25283272|FG000|Double Blind Phase (DB)|Other|1|||
13074912|NCT00301262|25283273|FG001|Double Blind Phase (DB)|Other|4|||
13074913|NCT00301262|25283272|FG000|Open Label Phase (OL)|Adverse Event|1|||
13074914|NCT00301262|25283273|FG001|Open Label Phase (OL)|Adverse Event|0|||
13074915|NCT00301262|25283272|FG000|Open Label Phase (OL)|Lost to Follow-up|1|||
13074916|NCT00301262|25283273|FG001|Open Label Phase (OL)|Lost to Follow-up|2|||
13074917|NCT00301262|25283272|FG000|Open Label Phase (OL)|Other|2|||
13074918|NCT00301262|25283273|FG001|Open Label Phase (OL)|Other|0|||
13074919|NCT00283868|25283292|FG000|Overall Study|Lost to Follow-up|7|||
13074920|NCT00283868|25283293|FG001|Overall Study|Lost to Follow-up|8|||
13074921|NCT00282867|25283317|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
13074922|NCT00282867|25283318|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
13074923|NCT00282867|25283319|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0|||
13074924|NCT00271544|25283342|FG000|Overall Study|Subjects did not receive a 4196 lead|7|||
13074925|NCT00271544|25283342|FG000|Overall Study|Model 4196 lead not attempted|9|||
13074926|NCT00271544|25283342|FG000|Overall Study|Implant not attempted|4|||
13130708|NCT02832037|25975633|FG001|Overall Study|Withdrawal by Subject|8|||
13130709|NCT02832037|25975634|FG002|Overall Study|Withdrawal by Subject|0|||
13130710|NCT02832037|25975635|FG003|Overall Study|Withdrawal by Subject|4|||
13130711|NCT02832037|25975636|FG004|Overall Study|Withdrawal by Subject|8|||
13130712|NCT02832037|25975632|FG000|Overall Study|Adverse Event|5|||
13130713|NCT02832037|25975633|FG001|Overall Study|Adverse Event|4|||
13130714|NCT02832037|25975634|FG002|Overall Study|Adverse Event|0|||
13130715|NCT02832037|25975635|FG003|Overall Study|Adverse Event|2|||
13130716|NCT02832037|25975636|FG004|Overall Study|Adverse Event|4|||
13130717|NCT02831855|25975699|FG000|Open Label Phase (24 Weeks)|Adverse Event|39|||
13130718|NCT02831855|25975700|FG001|Open Label Phase (24 Weeks)|Adverse Event|0|||
13130719|NCT02831855|25975701|FG002|Open Label Phase (24 Weeks)|Adverse Event|0|||
13130720|NCT02831855|25975699|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8|||
13130721|NCT02831855|25975700|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
13130722|NCT02831855|25975701|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
13130723|NCT02831855|25975699|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7|||
13130724|NCT02831855|25975700|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
13130725|NCT02831855|25975701|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
13130726|NCT02831855|25975699|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2|||
13130727|NCT02831855|25975700|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
13130728|NCT02831855|25975701|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
13130729|NCT02831855|25975699|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5|||
13130730|NCT02831855|25975700|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0|||
13130731|NCT02831855|25975701|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0|||
13130732|NCT02831855|25975699|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6|||
13130733|NCT02831855|25975700|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
13130734|NCT02831855|25975701|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
13130735|NCT02831855|25975699|FG000|Open Label Phase (24 Weeks)|Other|4|||
13130736|NCT02831855|25975700|FG001|Open Label Phase (24 Weeks)|Other|0|||
13130737|NCT02831855|25975701|FG002|Open Label Phase (24 Weeks)|Other|0|||
13130738|NCT02831855|25975699|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0|||
13130739|NCT02831855|25975700|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6|||
13130740|NCT02831855|25975701|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6|||
13130741|NCT02831855|25975699|FG000|Double Blind Phase (24 Weeks)|Death|0|||
13130742|NCT02831855|25975700|FG001|Double Blind Phase (24 Weeks)|Death|0|||
13130743|NCT02831855|25975701|FG002|Double Blind Phase (24 Weeks)|Death|2|||
13130744|NCT02831855|25975699|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0|||
13130745|NCT02831855|25975700|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
13130746|NCT02831855|25975701|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
13130747|NCT02831855|25975699|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0|||
13130748|NCT02831855|25975700|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1|||
13130749|NCT02831855|25975701|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0|||
13130750|NCT02831855|25975699|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0|||
13130751|NCT02831855|25975700|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5|||
13130752|NCT02831855|25975701|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2|||
13130753|NCT02831855|25975699|FG000|Double Blind Phase (24 Weeks)|Other|0|||
13130754|NCT02831855|25975700|FG001|Double Blind Phase (24 Weeks)|Other|2|||
13130755|NCT02831855|25975701|FG002|Double Blind Phase (24 Weeks)|Other|5|||
13130756|NCT02831855|25975699|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0|||
13130757|NCT02831855|25975700|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6|||
13130758|NCT02831855|25975701|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1|||
13130759|NCT02831855|25975699|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0|||
13130760|NCT02831855|25975700|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5|||
13130761|NCT02831855|25975701|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2|||
13130762|NCT02831855|25975699|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
13130763|NCT02831855|25975700|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3|||
13130764|NCT02831855|25975701|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
13130765|NCT02831764|25975770|FG000|Overall Study|Protocol specific withdrawal criteria|0|||
13130766|NCT02831764|25975771|FG001|Overall Study|Protocol specific withdrawal criteria|2|||
13130767|NCT02831764|25975770|FG000|Overall Study|Withdrawal by Subject|7|||
13130768|NCT02831764|25975771|FG001|Overall Study|Withdrawal by Subject|6|||
13130769|NCT02831764|25975770|FG000|Overall Study|Physician Decision|2|||
13130770|NCT02831764|25975771|FG001|Overall Study|Physician Decision|2|||
13130771|NCT02831764|25975770|FG000|Overall Study|Lost to Follow-up|6|||
13130772|NCT02831764|25975771|FG001|Overall Study|Lost to Follow-up|5|||
13130773|NCT02831764|25975770|FG000|Overall Study|Adverse Event|8|||
13130774|NCT02831764|25975771|FG001|Overall Study|Adverse Event|5|||
13074927|NCT00235326|25283353|FG000|Overall Study|Lost to Follow-up|746|||
13074928|NCT00235326|25283354|FG001|Overall Study|Lost to Follow-up|1400|||
13074929|NCT00232141|25283429|FG000|Overall Study|Adverse Event|9|||
13074930|NCT00232141|25283430|FG001|Overall Study|Adverse Event|4|||
13074931|NCT00232141|25283429|FG000|Overall Study|Lack of Efficacy|0|||
13074932|NCT00232141|25283430|FG001|Overall Study|Lack of Efficacy|3|||
13074933|NCT00232141|25283429|FG000|Overall Study|Lost to Follow-up|9|||
13074934|NCT00232141|25283430|FG001|Overall Study|Lost to Follow-up|6|||
13074935|NCT00232141|25283429|FG000|Overall Study|Other|8|||
13074936|NCT00232141|25283430|FG001|Overall Study|Other|10|||
13074937|NCT00232141|25283429|FG000|Overall Study|Withdrawal by Subject|5|||
13074938|NCT00232141|25283430|FG001|Overall Study|Withdrawal by Subject|3|||
13074939|NCT00224003|25283452|FG000|Overall Study|Adverse Event|1|||
13074940|NCT00224003|25283452|FG000|Overall Study|Protocol Violation|2|||
13074941|NCT00224003|25283452|FG000|Overall Study|Withdrawal by Subject|1|||
13074942|NCT00224003|25283452|FG000|Overall Study|unk|3|||
13074943|NCT00162942|25283507|FG000|Overall Study|Adverse Event|10|||
13074944|NCT00162942|25283508|FG001|Overall Study|Adverse Event|6|||
13074945|NCT00162942|25283507|FG000|Overall Study|Death|1|||
13074946|NCT00162942|25283508|FG001|Overall Study|Death|0|||
13074947|NCT00162942|25283507|FG000|Overall Study|Withdrawal by Subject|3|||
13074948|NCT00162942|25283508|FG001|Overall Study|Withdrawal by Subject|6|||
13074949|NCT00162942|25283507|FG000|Overall Study|Physician Decision|1|||
13074950|NCT00162942|25283508|FG001|Overall Study|Physician Decision|0|||
13074951|NCT00162942|25283507|FG000|Overall Study|Enter Open-Label Study|76|||
13074952|NCT00162942|25283508|FG001|Overall Study|Enter Open-Label Study|35|||
13074953|NCT00162942|25283507|FG000|Overall Study|Alternate Therapy|6|||
13074954|NCT00162942|25283508|FG001|Overall Study|Alternate Therapy|2|||
13074955|NCT00162942|25283507|FG000|Overall Study|Lack of Efficacy|1|||
13074956|NCT00162942|25283508|FG001|Overall Study|Lack of Efficacy|0|||
13074957|NCT00162942|25283507|FG000|Overall Study|Flare During Active Treatment|7|||
13074958|NCT00162942|25283508|FG001|Overall Study|Flare During Active Treatment|3|||
13074959|NCT00162942|25283507|FG000|Overall Study|2 or more consecutive treatments missed|1|||
13074960|NCT00162942|25283508|FG001|Overall Study|2 or more consecutive treatments missed|0|||
13074961|NCT00126776|25283543|FG000|Overall Study|follow up complete on all patients|0|||
13074962|NCT00126776|25283544|FG001|Overall Study|follow up complete on all patients|0|||
13074963|NCT00120042|25283562|FG000|Overall Study|all completed protocl|0|||
13074964|NCT00120042|25283563|FG001|Overall Study|all completed protocl|0|||
13074965|NCT00120042|25283564|FG002|Overall Study|all completed protocl|0|||
13074966|NCT03520413|25283587|FG000|Overall Study|Lost to Follow-up|1|||
13074967|NCT03520413|25283588|FG001|Overall Study|Lost to Follow-up|1|||
13074968|NCT03520413|25283587|FG000|Overall Study|Withdrawal by Subject|1|||
13074969|NCT03520413|25283588|FG001|Overall Study|Withdrawal by Subject|2|||
13074970|NCT03520413|25283587|FG000|Overall Study|Death|0|||
13074971|NCT03520413|25283588|FG001|Overall Study|Death|1|||
13074972|NCT03520413|25283587|FG000|Overall Study|Physician Decision|3|||
13074973|NCT03520413|25283588|FG001|Overall Study|Physician Decision|3|||
13074974|NCT03520413|25283587|FG000|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
13074975|NCT03520413|25283588|FG001|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
13074976|NCT03513068|25283607|FG000|Overall Study|Death|1|||
13074977|NCT03513068|25283608|FG001|Overall Study|Death|0|||
13074978|NCT03513068|25283607|FG000|Overall Study|Withdrawal by Subject|4|||
13074979|NCT03513068|25283608|FG001|Overall Study|Withdrawal by Subject|6|||
13074980|NCT03507127|25283631|FG000|Overall Study|Withdrawal by Subject|1|||
13074981|NCT03507127|25283632|FG001|Overall Study|Withdrawal by Subject|0|||
13074982|NCT03507127|25283631|FG000|Overall Study|Unable to meet smoking abstinence criterion|1|||
13074983|NCT03507127|25283632|FG001|Overall Study|Unable to meet smoking abstinence criterion|1|||
13074984|NCT03502811|25283639|FG000|Overall Study|Death|157|||
13074985|NCT03502811|25283639|FG000|Overall Study|Withdrawal by Subject|105|||
13074986|NCT03502811|25283639|FG000|Overall Study|Lost to Follow-up|26|||
13074987|NCT03502811|25283639|FG000|Overall Study|No Visits (Missed)|31|||
13074988|NCT03530995|25283720|FG000|Part 1 Period 3|Withdrawal by Subject|2|||
13074989|NCT03530995|25283721|FG001|Part 1 Period 3|Withdrawal by Subject|0|||
13074990|NCT03530995|25283720|FG000|Part 1 Period 3|Protocol Violation|1|||
13074991|NCT03530995|25283721|FG001|Part 1 Period 3|Protocol Violation|0|||
13074992|NCT03530995|25283720|FG000|Part 1 Period 4|Physician Decision|1|||
13074993|NCT03530995|25283721|FG001|Part 1 Period 4|Physician Decision|0|||
13074994|NCT03530995|25283720|FG000|Part 1 Period 4|Withdrawal by Subject|1|||
13074995|NCT03530995|25283721|FG001|Part 1 Period 4|Withdrawal by Subject|0|||
13074996|NCT03072459|25283748|FG000|Overall Study|Device revised/removed|1|||
13074997|NCT03072459|25283748|FG000|Overall Study|Subject not able to return|1|||
13074998|NCT03019406|25283836|FG000|ETP: Ongoing From Week 26|Ongoing|6|||
13074999|NCT03019406|25283837|FG001|ETP: Ongoing From Week 26|Ongoing|5|||
13075000|NCT03019406|25283838|FG002|ETP: Ongoing From Week 26|Ongoing|5|||
13075001|NCT03019406|25283839|FG003|ETP: Ongoing From Week 26|Ongoing|3|||
13075002|NCT02874144|25283860|FG000|Overall Study|Lost to Follow-up|3|||
13075003|NCT02874144|25283861|FG001|Overall Study|Lost to Follow-up|5|||
13130775|NCT02831764|25975770|FG000|Overall Study|Lack of Efficacy|2|||
13075004|NCT02611830|25283895|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9|||
13075005|NCT02611830|25283896|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
13075006|NCT02611830|25283897|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
13075007|NCT02611830|25283898|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
13075008|NCT02611830|25283895|FG000|OL Induction Phase|Significant Protocol Deviation|4|||
13075009|NCT02611830|25283896|FG001|OL Induction Phase|Significant Protocol Deviation|0|||
13075010|NCT02611830|25283897|FG002|OL Induction Phase|Significant Protocol Deviation|0|||
13075011|NCT02611830|25283898|FG003|OL Induction Phase|Significant Protocol Deviation|0|||
13075012|NCT02611830|25283895|FG000|OL Induction Phase|Voluntary Withdrawal|5|||
13075013|NCT02611830|25283896|FG001|OL Induction Phase|Voluntary Withdrawal|0|||
13075014|NCT02611830|25283897|FG002|OL Induction Phase|Voluntary Withdrawal|0|||
13075015|NCT02611830|25283898|FG003|OL Induction Phase|Voluntary Withdrawal|0|||
13075016|NCT02611830|25283895|FG000|OL Induction Phase|Lack of Efficacy|9|||
13075017|NCT02611830|25283896|FG001|OL Induction Phase|Lack of Efficacy|0|||
13075018|NCT02611830|25283897|FG002|OL Induction Phase|Lack of Efficacy|0|||
13075019|NCT02611830|25283898|FG003|OL Induction Phase|Lack of Efficacy|0|||
13075020|NCT02611830|25283895|FG000|OL Induction Phase|Reason not specified|3|||
13075021|NCT02611830|25283896|FG001|OL Induction Phase|Reason not specified|0|||
13075022|NCT02611830|25283897|FG002|OL Induction Phase|Reason not specified|0|||
13075023|NCT02611830|25283898|FG003|OL Induction Phase|Reason not specified|0|||
13075024|NCT02611830|25283895|FG000|Maintenance Phase|Lack of Efficacy|0|||
13075025|NCT02611830|25283896|FG001|Maintenance Phase|Lack of Efficacy|29|||
13075026|NCT02611830|25283897|FG002|Maintenance Phase|Lack of Efficacy|18|||
13075027|NCT02611830|25283898|FG003|Maintenance Phase|Lack of Efficacy|6|||
13075028|NCT02611830|25283895|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0|||
13075029|NCT02611830|25283896|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
13075030|NCT02611830|25283897|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
13075031|NCT02611830|25283898|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2|||
13075032|NCT02611830|25283895|FG000|Maintenance Phase|Significant Protocol Deviation|0|||
13075033|NCT02611830|25283896|FG001|Maintenance Phase|Significant Protocol Deviation|0|||
13075034|NCT02611830|25283897|FG002|Maintenance Phase|Significant Protocol Deviation|1|||
13075035|NCT02611830|25283898|FG003|Maintenance Phase|Significant Protocol Deviation|1|||
13075036|NCT02611830|25283895|FG000|Maintenance Phase|Lost to Follow-up|0|||
13075037|NCT02611830|25283896|FG001|Maintenance Phase|Lost to Follow-up|0|||
13075038|NCT02611830|25283897|FG002|Maintenance Phase|Lost to Follow-up|0|||
13075039|NCT02611830|25283898|FG003|Maintenance Phase|Lost to Follow-up|1|||
13075040|NCT02611830|25283895|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
13075041|NCT02611830|25283896|FG001|Maintenance Phase|Voluntary Withdrawal|1|||
13075042|NCT02611830|25283897|FG002|Maintenance Phase|Voluntary Withdrawal|2|||
13075043|NCT02611830|25283898|FG003|Maintenance Phase|Voluntary Withdrawal|5|||
13075044|NCT02611830|25283895|FG000|Maintenance Phase|Pregnancy|0|||
13075045|NCT02611830|25283896|FG001|Maintenance Phase|Pregnancy|0|||
13075046|NCT02611830|25283897|FG002|Maintenance Phase|Pregnancy|1|||
13075047|NCT02611830|25283898|FG003|Maintenance Phase|Pregnancy|0|||
13075048|NCT02611830|25283895|FG000|Maintenance Phase|Reason not specified|0|||
13075049|NCT02611830|25283896|FG001|Maintenance Phase|Reason not specified|1|||
13075050|NCT02611830|25283897|FG002|Maintenance Phase|Reason not specified|4|||
13075051|NCT02611830|25283898|FG003|Maintenance Phase|Reason not specified|0|||
13075052|NCT02611817|25283921|FG000|Open-label Induction Phase|Reason not Specified|9|||
13075053|NCT02611817|25283922|FG001|Open-label Induction Phase|Reason not Specified|0|||
13075054|NCT02611817|25283923|FG002|Open-label Induction Phase|Reason not Specified|0|||
13075055|NCT02611817|25283921|FG000|Open-label Induction Phase|Lack of Efficacy|8|||
13075056|NCT02611817|25283922|FG001|Open-label Induction Phase|Lack of Efficacy|0|||
13075057|NCT02611817|25283923|FG002|Open-label Induction Phase|Lack of Efficacy|0|||
13075058|NCT02611817|25283921|FG000|Open-label Induction Phase|Pregnancy|1|||
13075059|NCT02611817|25283922|FG001|Open-label Induction Phase|Pregnancy|0|||
13075060|NCT02611817|25283923|FG002|Open-label Induction Phase|Pregnancy|0|||
13075061|NCT02611817|25283921|FG000|Open-label Induction Phase|Withdrawal by Subject|9|||
13075062|NCT02611817|25283922|FG001|Open-label Induction Phase|Withdrawal by Subject|0|||
13075063|NCT02611817|25283923|FG002|Open-label Induction Phase|Withdrawal by Subject|0|||
13075064|NCT02611817|25283921|FG000|Open-label Induction Phase|Lost to Follow-up|2|||
13075065|NCT02611817|25283922|FG001|Open-label Induction Phase|Lost to Follow-up|0|||
13075066|NCT02611817|25283923|FG002|Open-label Induction Phase|Lost to Follow-up|0|||
13075067|NCT02611817|25283921|FG000|Open-label Induction Phase|Protocol Violation|5|||
13075068|NCT02611817|25283922|FG001|Open-label Induction Phase|Protocol Violation|0|||
13075069|NCT02611817|25283923|FG002|Open-label Induction Phase|Protocol Violation|0|||
13075070|NCT02611817|25283921|FG000|Open-label Induction Phase|Adverse Event|16|||
13075071|NCT02611817|25283922|FG001|Open-label Induction Phase|Adverse Event|0|||
13075072|NCT02611817|25283923|FG002|Open-label Induction Phase|Adverse Event|0|||
13075073|NCT02611817|25283921|FG000|Double-blind Maintenance Phase|Adverse Event|0|||
13075074|NCT02611817|25283922|FG001|Double-blind Maintenance Phase|Adverse Event|12|||
13075075|NCT02611817|25283923|FG002|Double-blind Maintenance Phase|Adverse Event|11|||
13075076|NCT02611817|25283921|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0|||
13075077|NCT02611817|25283922|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1|||
13075078|NCT02611817|25283923|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0|||
13075079|NCT02611817|25283921|FG000|Double-blind Maintenance Phase|Reason not Specified|0|||
13075080|NCT02611817|25283922|FG001|Double-blind Maintenance Phase|Reason not Specified|1|||
13075081|NCT02611817|25283923|FG002|Double-blind Maintenance Phase|Reason not Specified|2|||
13075082|NCT02611817|25283921|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0|||
13075083|NCT02611817|25283922|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43|||
13075084|NCT02611817|25283923|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78|||
13075085|NCT02611817|25283921|FG000|Double-blind Maintenance Phase|Pregnancy|0|||
13075086|NCT02611817|25283922|FG001|Double-blind Maintenance Phase|Pregnancy|0|||
13075087|NCT02611817|25283923|FG002|Double-blind Maintenance Phase|Pregnancy|1|||
13075088|NCT02611817|25283921|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0|||
13075089|NCT02611817|25283922|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5|||
13075090|NCT02611817|25283923|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14|||
13075091|NCT02611817|25283921|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0|||
13075092|NCT02611817|25283922|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0|||
13075093|NCT02611817|25283923|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1|||
13075094|NCT02557139|25283966|FG000|Overall Study|Significant liver elevation|1|||
13075095|NCT02557139|25283967|FG001|Overall Study|Significant liver elevation|0|||
13075096|NCT02557139|25283968|FG002|Overall Study|Significant liver elevation|1|||
13075097|NCT02557139|25283966|FG000|Overall Study|Withdrawal by Subject|1|||
13075098|NCT02557139|25283967|FG001|Overall Study|Withdrawal by Subject|0|||
13075099|NCT02557139|25283968|FG002|Overall Study|Withdrawal by Subject|0|||
13075100|NCT02557139|25283966|FG000|Overall Study|Illness of prohibited medication|0|||
13075101|NCT02557139|25283967|FG001|Overall Study|Illness of prohibited medication|0|||
13075102|NCT02557139|25283968|FG002|Overall Study|Illness of prohibited medication|1|||
13075103|NCT02186847|25283989|FG000|Overall Study|Protocol Violation|3|||
13075104|NCT02186847|25283990|FG001|Overall Study|Protocol Violation|0|||
13075105|NCT02101034|25284032|FG000|Overall Study|Enrolled but did not start treatment|0|||
13075106|NCT02101034|25284033|FG001|Overall Study|Enrolled but did not start treatment|0|||
13075107|NCT02101034|25284034|FG002|Overall Study|Enrolled but did not start treatment|1|||
13075108|NCT02101034|25284035|FG003|Overall Study|Enrolled but did not start treatment|0|||
13075109|NCT02101034|25284036|FG004|Overall Study|Enrolled but did not start treatment|0|||
13075110|NCT01865617|25284162|FG000|Overall Study|Death|27|||
13075111|NCT01865617|25284163|FG001|Overall Study|Death|3|||
13075112|NCT01865617|25284164|FG002|Overall Study|Death|1|||
13075113|NCT01865617|25284165|FG003|Overall Study|Death|1|||
13075114|NCT01865617|25284166|FG004|Overall Study|Death|5|||
13075115|NCT01865617|25284167|FG005|Overall Study|Death|1|||
13075116|NCT01865617|25284168|FG006|Overall Study|Death|11|||
13075117|NCT01865617|25284169|FG007|Overall Study|Death|1|||
13075118|NCT01865617|25284170|FG008|Overall Study|Death|11|||
13075119|NCT01865617|25284171|FG009|Overall Study|Death|3|||
13075120|NCT01865617|25284172|FG010|Overall Study|Death|32|||
13075121|NCT01865617|25284173|FG011|Overall Study|Death|6|||
13075122|NCT01865617|25284174|FG012|Overall Study|Death|13|||
13075123|NCT01865617|25284162|FG000|Overall Study|Lost to Follow-up|2|||
13075124|NCT01865617|25284163|FG001|Overall Study|Lost to Follow-up|0|||
13075125|NCT01865617|25284164|FG002|Overall Study|Lost to Follow-up|0|||
13075126|NCT01865617|25284165|FG003|Overall Study|Lost to Follow-up|0|||
13075127|NCT01865617|25284166|FG004|Overall Study|Lost to Follow-up|0|||
13075128|NCT01865617|25284167|FG005|Overall Study|Lost to Follow-up|0|||
13075129|NCT01865617|25284168|FG006|Overall Study|Lost to Follow-up|0|||
13075130|NCT01865617|25284169|FG007|Overall Study|Lost to Follow-up|0|||
13075131|NCT01865617|25284170|FG008|Overall Study|Lost to Follow-up|0|||
13075132|NCT01865617|25284171|FG009|Overall Study|Lost to Follow-up|0|||
13075133|NCT01865617|25284172|FG010|Overall Study|Lost to Follow-up|0|||
13075134|NCT01865617|25284173|FG011|Overall Study|Lost to Follow-up|0|||
13075135|NCT01865617|25284174|FG012|Overall Study|Lost to Follow-up|0|||
13075136|NCT01865617|25284162|FG000|Overall Study|Withdrawal by Subject|1|||
13075137|NCT01865617|25284163|FG001|Overall Study|Withdrawal by Subject|0|||
13075138|NCT01865617|25284164|FG002|Overall Study|Withdrawal by Subject|0|||
13075139|NCT01865617|25284165|FG003|Overall Study|Withdrawal by Subject|0|||
13075140|NCT01865617|25284166|FG004|Overall Study|Withdrawal by Subject|0|||
13075141|NCT01865617|25284167|FG005|Overall Study|Withdrawal by Subject|0|||
13075142|NCT01865617|25284168|FG006|Overall Study|Withdrawal by Subject|0|||
13075143|NCT01865617|25284169|FG007|Overall Study|Withdrawal by Subject|0|||
13075144|NCT01865617|25284170|FG008|Overall Study|Withdrawal by Subject|0|||
13075145|NCT01865617|25284171|FG009|Overall Study|Withdrawal by Subject|0|||
13075146|NCT01865617|25284172|FG010|Overall Study|Withdrawal by Subject|0|||
13075147|NCT01865617|25284173|FG011|Overall Study|Withdrawal by Subject|0|||
13075148|NCT01865617|25284174|FG012|Overall Study|Withdrawal by Subject|0|||
13075149|NCT01865617|25284162|FG000|Overall Study|Patient proceeded to new therapy|0|||
13075150|NCT01865617|25284163|FG001|Overall Study|Patient proceeded to new therapy|0|||
13075151|NCT01865617|25284164|FG002|Overall Study|Patient proceeded to new therapy|0|||
13075152|NCT01865617|25284165|FG003|Overall Study|Patient proceeded to new therapy|0|||
13075153|NCT01865617|25284166|FG004|Overall Study|Patient proceeded to new therapy|2|||
13075154|NCT01865617|25284167|FG005|Overall Study|Patient proceeded to new therapy|0|||
13075155|NCT01865617|25284168|FG006|Overall Study|Patient proceeded to new therapy|0|||
13075156|NCT01865617|25284169|FG007|Overall Study|Patient proceeded to new therapy|0|||
13075157|NCT01865617|25284170|FG008|Overall Study|Patient proceeded to new therapy|0|||
13075158|NCT01865617|25284171|FG009|Overall Study|Patient proceeded to new therapy|0|||
13075159|NCT01865617|25284172|FG010|Overall Study|Patient proceeded to new therapy|0|||
13075160|NCT01865617|25284173|FG011|Overall Study|Patient proceeded to new therapy|0|||
13075161|NCT01865617|25284174|FG012|Overall Study|Patient proceeded to new therapy|0|||
13075162|NCT01865617|25284162|FG000|Overall Study|Other|0|||
13075163|NCT01865617|25284163|FG001|Overall Study|Other|0|||
13075164|NCT01865617|25284164|FG002|Overall Study|Other|0|||
13075165|NCT01865617|25284165|FG003|Overall Study|Other|0|||
13075166|NCT01865617|25284166|FG004|Overall Study|Other|0|||
13075167|NCT01865617|25284167|FG005|Overall Study|Other|0|||
13075168|NCT01865617|25284168|FG006|Overall Study|Other|1|||
13075169|NCT01865617|25284169|FG007|Overall Study|Other|0|||
13075170|NCT01865617|25284170|FG008|Overall Study|Other|0|||
13075171|NCT01865617|25284171|FG009|Overall Study|Other|0|||
13075172|NCT01865617|25284172|FG010|Overall Study|Other|0|||
13075173|NCT01865617|25284173|FG011|Overall Study|Other|0|||
13075174|NCT01865617|25284174|FG012|Overall Study|Other|0|||
13130776|NCT02831764|25975771|FG001|Overall Study|Lack of Efficacy|2|||
13130777|NCT02831764|25975770|FG000|Overall Study|Protocol Violation|5|||
13130778|NCT02831764|25975771|FG001|Overall Study|Protocol Violation|2|||
13130779|NCT02831764|25975770|FG000|Overall Study|Ongoing at the time of the analysis|330|||
13130780|NCT02831764|25975771|FG001|Overall Study|Ongoing at the time of the analysis|335|||
13130781|NCT02831673|25975840|FG000|Overall Study|Adverse Event|6|||
13130782|NCT02831673|25975841|FG001|Overall Study|Adverse Event|4|||
13130783|NCT02831673|25975840|FG000|Overall Study|Lack of Efficacy|3|||
13130784|NCT02831673|25975841|FG001|Overall Study|Lack of Efficacy|1|||
13130785|NCT02831673|25975840|FG000|Overall Study|Protocol Violation|5|||
13130786|NCT02831673|25975841|FG001|Overall Study|Protocol Violation|4|||
13130787|NCT02831673|25975840|FG000|Overall Study|Protocol Withdrawal Criterion Met|1|||
13130788|NCT02831673|25975841|FG001|Overall Study|Protocol Withdrawal Criterion Met|6|||
13130789|NCT02831673|25975840|FG000|Overall Study|Lost to Follow-up|9|||
13130790|NCT02831673|25975841|FG001|Overall Study|Lost to Follow-up|6|||
13130791|NCT02831673|25975840|FG000|Overall Study|Physician Decision|6|||
13130792|NCT02831673|25975841|FG001|Overall Study|Physician Decision|3|||
13130793|NCT02831673|25975840|FG000|Overall Study|Withdrawal by Subject|6|||
13130794|NCT02831673|25975841|FG001|Overall Study|Withdrawal by Subject|4|||
13130795|NCT02831673|25975840|FG000|Overall Study|Ongoing at Week 48 primary analysis.|320|||
13130796|NCT02831673|25975841|FG001|Overall Study|Ongoing at Week 48 primary analysis.|330|||
13130797|NCT02831387|25975866|FG000|Overall Study|Withdrawal by Subject|1|||
13130798|NCT02831387|25975867|FG001|Overall Study|Withdrawal by Subject|1|||
13130799|NCT02831387|25975866|FG000|Overall Study|Discontinued due to stock recovery|0|||
13130800|NCT02831387|25975867|FG001|Overall Study|Discontinued due to stock recovery|1|||
13130801|NCT02830893|25975886|FG000|Overall Study|Relocation to out of the country|1|||
13130802|NCT02830893|25975887|FG001|Overall Study|Relocation to out of the country|0|||
13130803|NCT02830893|25975886|FG000|Overall Study|Lost to Follow-up|0|||
13130804|NCT02830893|25975887|FG001|Overall Study|Lost to Follow-up|2|||
13130805|NCT02830893|25975886|FG000|Overall Study|Discharged to SNF, no transportation.|0|||
13130806|NCT02830893|25975887|FG001|Overall Study|Discharged to SNF, no transportation.|1|||
13130807|NCT02830880|25975898|FG000|Overall Study|Adverse reaction to chemotherapy|1|||
13130808|NCT02830880|25975898|FG000|Overall Study|Death|1|||
13130809|NCT02830880|25975898|FG000|Overall Study|Physician Decision|1|||
13130810|NCT02830776|25975905|FG000|Overall Study|Lost to Follow-up|1|||
13130811|NCT02830087|25975986|FG000|Overall Study|No study staff to follow-up patients|4|||
13130812|NCT02830087|25975987|FG001|Overall Study|No study staff to follow-up patients|4|||
13130813|NCT02830087|25975988|FG002|Overall Study|No study staff to follow-up patients|4|||
13130814|NCT02830087|25975989|FG003|Overall Study|No study staff to follow-up patients|3|||
13130815|NCT02830087|25975990|FG004|Overall Study|No study staff to follow-up patients|3|||
13130816|NCT02830087|25975991|FG005|Overall Study|No study staff to follow-up patients|3|||
13130817|NCT02829996|25976019|FG000|Overall Study|Withdrawal by Subject|1|||
13130818|NCT02829996|25976020|FG001|Overall Study|Withdrawal by Subject|0|||
13130819|NCT02829996|25976021|FG002|Overall Study|Withdrawal by Subject|0|||
13130820|NCT02829996|25976022|FG003|Overall Study|Withdrawal by Subject|0|||
13130821|NCT02829996|25976023|FG004|Overall Study|Withdrawal by Subject|0|||
13130822|NCT02829944|25976080|FG000|Overall Study|Physician Decision|0|||
13130823|NCT02829944|25976081|FG001|Overall Study|Physician Decision|1|||
13130824|NCT02829944|25976080|FG000|Overall Study|Screen Failure|2|||
13130825|NCT02829944|25976081|FG001|Overall Study|Screen Failure|2|||
13130826|NCT02829944|25976080|FG000|Overall Study|Inadequate Neuraxial Block|1|||
13130827|NCT02829944|25976081|FG001|Overall Study|Inadequate Neuraxial Block|1|||
13075175|NCT04604184|25284249|FG000|Overall Study|Adverse Event|5|||
13075176|NCT04604184|25284250|FG001|Overall Study|Adverse Event|5|||
13075177|NCT04604184|25284249|FG000|Overall Study|Death|2|||
13075178|NCT04604184|25284250|FG001|Overall Study|Death|1|||
13075179|NCT04604184|25284249|FG000|Overall Study|Withdrawal by Subject|1|||
13075180|NCT04604184|25284250|FG001|Overall Study|Withdrawal by Subject|3|||
13075181|NCT04604184|25284249|FG000|Overall Study|Not treated|2|||
13075182|NCT04604184|25284250|FG001|Overall Study|Not treated|2|||
13075183|NCT04604184|25284249|FG000|Overall Study|Due to sponsor decision|9|||
13075184|NCT04604184|25284250|FG001|Overall Study|Due to sponsor decision|7|||
13075185|NCT04604184|25284249|FG000|Overall Study|Physician Decision|0|||
13075186|NCT04604184|25284250|FG001|Overall Study|Physician Decision|1|||
13075187|NCT04604184|25284249|FG000|Overall Study|Transfer to healthcare|1|||
13075188|NCT04604184|25284250|FG001|Overall Study|Transfer to healthcare|0|||
13075189|NCT04368429|25284281|FG000|Overall Study|Adverse Event|1|||
13075190|NCT04368429|25284282|FG001|Overall Study|Adverse Event|0|||
13075191|NCT03865316|25284304|FG000|Overall Study|Procedure Cancelled|4|||
13075192|NCT03865316|25284304|FG000|Overall Study|Equipment failure|4|||
13075193|NCT03688555|25284338|FG000|Treatment Period|Adverse Event|0|||
13075194|NCT03688555|25284339|FG001|Treatment Period|Adverse Event|0|||
13075195|NCT03688555|25284340|FG002|Treatment Period|Adverse Event|1|||
13075196|NCT03248531|25284521|FG000|Overall Study|Adverse Event|0|||
13075197|NCT03248531|25284522|FG001|Overall Study|Adverse Event|0|||
13075198|NCT03248531|25284523|FG002|Overall Study|Adverse Event|1|||
13075199|NCT03248531|25284521|FG000|Overall Study|Lost to Follow-up|1|||
13075200|NCT03248531|25284522|FG001|Overall Study|Lost to Follow-up|0|||
13075201|NCT03248531|25284523|FG002|Overall Study|Lost to Follow-up|5|||
13075202|NCT03248531|25284521|FG000|Overall Study|Withdrawal by Subject|3|||
13075203|NCT03248531|25284522|FG001|Overall Study|Withdrawal by Subject|3|||
13075204|NCT03248531|25284523|FG002|Overall Study|Withdrawal by Subject|2|||
13075205|NCT03248531|25284521|FG000|Overall Study|Sponsor Request|0|||
13075206|NCT03248531|25284522|FG001|Overall Study|Sponsor Request|2|||
13075207|NCT03248531|25284523|FG002|Overall Study|Sponsor Request|0|||
13075208|NCT03205605|25284541|FG000|Overall Study|Withdrawal by Subject|1|||
13075209|NCT02234323|25284556|FG000|All Enrolled|Not Treated: Completed study in database|2|||
13075210|NCT02234323|25284556|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2|||
13075211|NCT02234323|25284556|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1|||
13075212|NCT02234323|25284556|FG000|All Treated|Death|1|||
13075213|NCT02234323|25284556|FG000|All Treated|Physician Decision|5|||
13075214|NCT02234323|25284556|FG000|All Treated|Lack of Efficacy|3|||
13075215|NCT02234323|25284556|FG000|All Treated|Exceeded lab value limit|2|||
13075216|NCT02234323|25284556|FG000|All Treated|Other|7|||
13075217|NCT02220855|25284566|FG000|Overall Study|Adverse Event|8|||
13075218|NCT02220855|25284566|FG000|Overall Study|Disease Progression|5|||
13075219|NCT02220855|25284566|FG000|Overall Study|Withdrawal by Subject|1|||
13075220|NCT01791595|25284665|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1|||
13075221|NCT01791595|25284666|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
13075222|NCT01791595|25284667|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
13075223|NCT01791595|25284668|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
13075224|NCT01791595|25284669|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
13075225|NCT01791595|25284670|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
13075226|NCT01791595|25284671|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
13075227|NCT01791595|25284665|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2|||
13075228|NCT01791595|25284666|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
13075229|NCT01791595|25284667|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
13075230|NCT01791595|25284668|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
13075231|NCT01791595|25284669|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
13075232|NCT01791595|25284670|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
13075233|NCT01791595|25284671|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
13075234|NCT01791595|25284665|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
13075235|NCT01791595|25284666|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5|||
13075236|NCT01791595|25284667|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
13075237|NCT01791595|25284668|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
13075238|NCT01791595|25284669|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
13075239|NCT01791595|25284670|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
13075240|NCT01791595|25284671|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
13075241|NCT01791595|25284665|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
13075242|NCT01791595|25284666|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
13075243|NCT01791595|25284667|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1|||
13075244|NCT01791595|25284668|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
13075245|NCT01791595|25284669|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
13075246|NCT01791595|25284670|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
13075247|NCT01791595|25284671|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
13075248|NCT01791595|25284665|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
13075249|NCT01791595|25284666|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
13075250|NCT01791595|25284667|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6|||
13075251|NCT01791595|25284668|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
13075252|NCT01791595|25284669|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
13075253|NCT01791595|25284670|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
13075254|NCT01791595|25284671|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
13075255|NCT01791595|25284665|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
13075256|NCT01791595|25284666|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
13075257|NCT01791595|25284667|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1|||
13075258|NCT01791595|25284668|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
13075259|NCT01791595|25284669|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
13075260|NCT01791595|25284670|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
13075261|NCT01791595|25284671|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
13075262|NCT01791595|25284665|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
13075263|NCT01791595|25284666|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
13075264|NCT01791595|25284667|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
13075265|NCT01791595|25284668|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2|||
13075266|NCT01791595|25284669|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
13075267|NCT01791595|25284670|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
13075268|NCT01791595|25284671|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
13075269|NCT01791595|25284665|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
13075270|NCT01791595|25284666|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
13075271|NCT01791595|25284667|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
13075272|NCT01791595|25284668|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2|||
13075273|NCT01791595|25284669|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
13075274|NCT01791595|25284670|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
13075275|NCT01791595|25284671|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
13075276|NCT01791595|25284665|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
13075277|NCT01791595|25284666|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
13075278|NCT01791595|25284667|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
13075279|NCT01791595|25284668|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
13075280|NCT01791595|25284669|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4|||
13075281|NCT01791595|25284670|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
13075282|NCT01791595|25284671|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
13075283|NCT01791595|25284665|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
13075284|NCT01791595|25284666|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
13075285|NCT01791595|25284667|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
13075286|NCT01791595|25284668|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
13075287|NCT01791595|25284669|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5|||
13075288|NCT01791595|25284670|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
13075289|NCT01791595|25284671|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
13075290|NCT01791595|25284665|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
13075291|NCT01791595|25284666|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
13075292|NCT01791595|25284667|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
13075293|NCT01791595|25284668|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
13075294|NCT01791595|25284669|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1|||
13075295|NCT01791595|25284670|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
13075296|NCT01791595|25284671|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
13075297|NCT01791595|25284665|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
13075298|NCT01791595|25284666|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
13075299|NCT01791595|25284667|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
13075300|NCT01791595|25284668|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
13075301|NCT01791595|25284669|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1|||
13075302|NCT01791595|25284670|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
13075303|NCT01791595|25284671|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
13075304|NCT01791595|25284665|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
13075305|NCT01791595|25284666|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
13075306|NCT01791595|25284667|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
13075307|NCT01791595|25284668|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
13075308|NCT01791595|25284669|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
13075309|NCT01791595|25284670|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5|||
13075310|NCT01791595|25284671|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
13075311|NCT01791595|25284665|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
13075312|NCT01791595|25284666|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
13075313|NCT01791595|25284667|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
13075314|NCT01791595|25284668|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
13075315|NCT01791595|25284669|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
13075316|NCT01791595|25284670|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3|||
13075317|NCT01791595|25284671|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
13075318|NCT01791595|25284665|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
13075319|NCT01791595|25284666|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
13075320|NCT01791595|25284667|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
13075321|NCT01791595|25284668|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
13075322|NCT01791595|25284669|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
13075323|NCT01791595|25284670|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
13075324|NCT01791595|25284671|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1|||
13075325|NCT01791595|25284665|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
13075326|NCT01791595|25284666|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
13075327|NCT01791595|25284667|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
13075328|NCT01791595|25284668|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
13075329|NCT01791595|25284669|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
13075330|NCT01791595|25284670|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
13075331|NCT01791595|25284671|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6|||
13075332|NCT01791595|25284665|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
13075333|NCT01791595|25284666|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
13075334|NCT01791595|25284667|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
13075335|NCT01791595|25284668|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
13075336|NCT01791595|25284669|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
13075337|NCT01791595|25284670|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
13075338|NCT01791595|25284671|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2|||
13075339|NCT01791595|25284665|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
13075340|NCT01791595|25284666|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
13075341|NCT01791595|25284667|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
13075342|NCT01791595|25284668|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
13075343|NCT01791595|25284669|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
13075344|NCT01791595|25284670|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
13075345|NCT01791595|25284671|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1|||
13075346|NCT01192776|25284738|FG000|Overall Study|Death|8|||
13075347|NCT01192776|25284739|FG001|Overall Study|Death|15|||
13075348|NCT01192776|25284740|FG002|Overall Study|Death|18|||
13075349|NCT01192776|25284741|FG003|Overall Study|Death|15|||
13075350|NCT01192776|25284738|FG000|Overall Study|Lost to Follow-up|3|||
13075351|NCT01192776|25284739|FG001|Overall Study|Lost to Follow-up|6|||
13075352|NCT01192776|25284740|FG002|Overall Study|Lost to Follow-up|3|||
13075353|NCT01192776|25284741|FG003|Overall Study|Lost to Follow-up|5|||
13130828|NCT02829944|25976080|FG000|Overall Study|Withdrawal by Subject|2|||
13130829|NCT02829944|25976081|FG001|Overall Study|Withdrawal by Subject|1|||
13130830|NCT02829944|25976080|FG000|Overall Study|Catheter Displacement|1|||
13130831|NCT02829944|25976081|FG001|Overall Study|Catheter Displacement|0|||
13130832|NCT02829944|25976080|FG000|Overall Study|Catheter broke|0|||
13130833|NCT02829944|25976081|FG001|Overall Study|Catheter broke|1|||
13130834|NCT02829944|25976080|FG000|Overall Study|Staff unavailable|0|||
13130835|NCT02829944|25976081|FG001|Overall Study|Staff unavailable|1|||
13130836|NCT02829918|25976088|FG000|Overall Study|Death|2|||
13130837|NCT02829918|25976088|FG000|Overall Study|Withdrawal by Subject|4|||
13130838|NCT02829918|25976088|FG000|Overall Study|Adverse Event|1|||
13130839|NCT02829918|25976088|FG000|Overall Study|Progression|1|||
13130840|NCT02829775|25976095|FG000|Overall Study|Death|1|||
13130841|NCT02829775|25976095|FG000|Overall Study|Withdrawal by Subject|3|||
13130842|NCT02829775|25976095|FG000|Overall Study|Disease remission|1|||
13130843|NCT02829138|25976112|FG000|Overall Study|Withdrawal by Subject|1|||
13130844|NCT02829138|25976113|FG001|Overall Study|Withdrawal by Subject|0|||
13133596|NCT02767570|25988488|FG000|Overall Study|Withdrawal by Subject|1|||
13133597|NCT02767570|25988489|FG001|Overall Study|Withdrawal by Subject|3|||
13133598|NCT02767570|25988488|FG000|Overall Study|Unrelated medical issue|1|||
13133599|NCT02767570|25988489|FG001|Overall Study|Unrelated medical issue|1|||
13133600|NCT02767570|25988488|FG000|Overall Study|Received intra-articular injection|0|||
13133601|NCT02767570|25988489|FG001|Overall Study|Received intra-articular injection|1|||
13133602|NCT02767323|25988518|FG000|Overall Study|Withdrawal by Subject|17|||
13133603|NCT02767323|25988519|FG001|Overall Study|Withdrawal by Subject|5|||
13133604|NCT02767323|25988520|FG002|Overall Study|Withdrawal by Subject|13|||
13133605|NCT02767323|25988521|FG003|Overall Study|Withdrawal by Subject|0|||
13307561|NCT01284959|26528989|FG000|Overall Study|Withdrawal by Subject|1|||
13075354|NCT03392883|25284806|FG000|Overall Study|Lost to Follow-up|122|||
13075355|NCT03392883|25284807|FG001|Overall Study|Lost to Follow-up|13|||
13075356|NCT03392883|25284808|FG002|Overall Study|Lost to Follow-up|9|||
13075357|NCT03392883|25284806|FG000|Overall Study|Death|4|||
13075358|NCT03392883|25284807|FG001|Overall Study|Death|0|||
13075359|NCT03392883|25284808|FG002|Overall Study|Death|0|||
13075360|NCT03392883|25284806|FG000|Overall Study|Lack of Efficacy|29|||
13075361|NCT03392883|25284807|FG001|Overall Study|Lack of Efficacy|0|||
13075362|NCT03392883|25284808|FG002|Overall Study|Lack of Efficacy|0|||
13075363|NCT03392883|25284806|FG000|Overall Study|Withdrawal by Subject|180|||
13075364|NCT03392883|25284807|FG001|Overall Study|Withdrawal by Subject|0|||
13075365|NCT03392883|25284808|FG002|Overall Study|Withdrawal by Subject|0|||
13075366|NCT03392883|25284806|FG000|Overall Study|Adverse Event|1|||
13075367|NCT03392883|25284807|FG001|Overall Study|Adverse Event|0|||
13075368|NCT03392883|25284808|FG002|Overall Study|Adverse Event|0|||
13075369|NCT03376789|25284827|FG000|Overall Study|Withdrawal by Subject|3|||
13075370|NCT03376789|25284828|FG001|Overall Study|Withdrawal by Subject|5|||
13075371|NCT03376789|25284827|FG000|Overall Study|Protocol Violation|0|||
13075372|NCT03376789|25284828|FG001|Overall Study|Protocol Violation|1|||
13075373|NCT03376789|25284827|FG000|Overall Study|Adverse Event|0|||
13075374|NCT03376789|25284828|FG001|Overall Study|Adverse Event|1|||
13075375|NCT03376789|25284827|FG000|Overall Study|Lost to Follow-up|1|||
13075376|NCT03376789|25284828|FG001|Overall Study|Lost to Follow-up|1|||
13075377|NCT03376789|25284827|FG000|Overall Study|Per sponsor due to noncompliance|1|||
13075378|NCT03376789|25284828|FG001|Overall Study|Per sponsor due to noncompliance|0|||
13075379|NCT03376789|25284827|FG000|Overall Study|Subject off study medication|0|||
13075380|NCT03376789|25284828|FG001|Overall Study|Subject off study medication|1|||
13075381|NCT03345004|25284907|FG000|Overall Study|Physician Decision|1|||
13075382|NCT03345004|25284908|FG001|Overall Study|Physician Decision|0|||
13075383|NCT03345004|25284907|FG000|Overall Study|Withdrawal by Subject|0|||
13075384|NCT03345004|25284908|FG001|Overall Study|Withdrawal by Subject|1|||
13075385|NCT03307967|25284973|FG000|Overall Study|Lost to Follow-up|4|||
13075386|NCT03288129|25284994|FG000|Overall Study|Adverse Event|10|||
13075387|NCT03288129|25284994|FG000|Overall Study|Lost to Follow-up|3|||
13075388|NCT03288129|25284994|FG000|Overall Study|Withdrawal by Subject|3|||
13075389|NCT03288129|25284994|FG000|Overall Study|Withdrawal of consent/assent|1|||
13075390|NCT03288129|25284994|FG000|Overall Study|Other|5|||
13075391|NCT03241225|25285029|FG000|Overall Study|Lost to Follow-up|2|||
13075392|NCT03241225|25285030|FG001|Overall Study|Lost to Follow-up|1|||
13075393|NCT03241225|25285029|FG000|Overall Study|Protocol Violation|4|||
13075394|NCT03241225|25285030|FG001|Overall Study|Protocol Violation|1|||
13075395|NCT03241225|25285029|FG000|Overall Study|Withdrawal by Subject|1|||
13075396|NCT03241225|25285030|FG001|Overall Study|Withdrawal by Subject|0|||
13075397|NCT03225846|25285125|FG000|Overall Study|Adverse Event|0|||
13075398|NCT03225846|25285126|FG001|Overall Study|Adverse Event|0|||
13075399|NCT03225846|25285127|FG002|Overall Study|Adverse Event|0|||
13075400|NCT03225846|25285128|FG003|Overall Study|Adverse Event|0|||
13075401|NCT03225846|25285129|FG004|Overall Study|Adverse Event|0|||
13075402|NCT03225846|25285130|FG005|Overall Study|Adverse Event|0|||
13075403|NCT03225846|25285131|FG006|Overall Study|Adverse Event|6|||
13075404|NCT03225846|25285125|FG000|Overall Study|Withdrawal by Subject|0|||
13075405|NCT03225846|25285126|FG001|Overall Study|Withdrawal by Subject|1|||
13075406|NCT03225846|25285127|FG002|Overall Study|Withdrawal by Subject|0|||
13075407|NCT03225846|25285128|FG003|Overall Study|Withdrawal by Subject|0|||
13075408|NCT03225846|25285129|FG004|Overall Study|Withdrawal by Subject|0|||
13075409|NCT03225846|25285130|FG005|Overall Study|Withdrawal by Subject|0|||
13075410|NCT03225846|25285131|FG006|Overall Study|Withdrawal by Subject|0|||
13075411|NCT03225846|25285125|FG000|Overall Study|Death|0|||
13075412|NCT03225846|25285126|FG001|Overall Study|Death|1|||
13075413|NCT03225846|25285127|FG002|Overall Study|Death|0|||
13075414|NCT03225846|25285128|FG003|Overall Study|Death|0|||
13075415|NCT03225846|25285129|FG004|Overall Study|Death|0|||
13075416|NCT03225846|25285130|FG005|Overall Study|Death|0|||
13075417|NCT03225846|25285131|FG006|Overall Study|Death|0|||
13075418|NCT03225846|25285125|FG000|Overall Study|Patient did not wish to comply with IC/EC|0|||
13075419|NCT03225846|25285126|FG001|Overall Study|Patient did not wish to comply with IC/EC|0|||
13075420|NCT03225846|25285127|FG002|Overall Study|Patient did not wish to comply with IC/EC|1|||
13075421|NCT03225846|25285128|FG003|Overall Study|Patient did not wish to comply with IC/EC|0|||
13075422|NCT03225846|25285129|FG004|Overall Study|Patient did not wish to comply with IC/EC|0|||
13075423|NCT03225846|25285130|FG005|Overall Study|Patient did not wish to comply with IC/EC|0|||
13075424|NCT03225846|25285131|FG006|Overall Study|Patient did not wish to comply with IC/EC|0|||
13075425|NCT03225846|25285125|FG000|Overall Study|Patient decision|0|||
13075426|NCT03225846|25285126|FG001|Overall Study|Patient decision|0|||
13075427|NCT03225846|25285127|FG002|Overall Study|Patient decision|0|||
13075428|NCT03225846|25285128|FG003|Overall Study|Patient decision|0|||
13075429|NCT03225846|25285129|FG004|Overall Study|Patient decision|0|||
13075430|NCT03225846|25285130|FG005|Overall Study|Patient decision|0|||
13075431|NCT03225846|25285131|FG006|Overall Study|Patient decision|1|||
13075432|NCT03191903|25285217|FG000|Overall Study|Withdrawal by Subject|6|||
13075433|NCT03191903|25285218|FG001|Overall Study|Withdrawal by Subject|5|||
13075434|NCT03191903|25285219|FG002|Overall Study|Withdrawal by Subject|4|||
13075435|NCT03191903|25285217|FG000|Overall Study|Adverse Event|1|||
13075436|NCT03191903|25285218|FG001|Overall Study|Adverse Event|0|||
13075437|NCT03191903|25285219|FG002|Overall Study|Adverse Event|0|||
13130845|NCT02828644|25976127|FG000|Overall Study|Lost to Follow-up|23|||
13130846|NCT02828644|25976128|FG001|Overall Study|Lost to Follow-up|22|||
13130847|NCT02828436|25976137|FG000|Period 1|Did Not Meet Inclusion Criteria|0|||
13130848|NCT02828436|25976138|FG001|Period 1|Did Not Meet Inclusion Criteria|3|||
13130849|NCT02828436|25976137|FG000|Period 1|Lost to Follow-up|0|||
13130850|NCT02828436|25976138|FG001|Period 1|Lost to Follow-up|1|||
13130851|NCT02828436|25976137|FG000|Period 2|Withdrawal by Subject|4|||
13130852|NCT02828436|25976138|FG001|Period 2|Withdrawal by Subject|0|||
13130853|NCT02828436|25976137|FG000|Period 2|Did Not Meet Inclusion Criteria|3|||
13130854|NCT02828436|25976138|FG001|Period 2|Did Not Meet Inclusion Criteria|0|||
13130855|NCT02828436|25976137|FG000|Period 2|Lost to Follow-up|1|||
13130856|NCT02828436|25976138|FG001|Period 2|Lost to Follow-up|0|||
13130857|NCT02828241|25976155|FG000|Overall Study|Adverse Event|7|||
13130858|NCT02828241|25976156|FG001|Overall Study|Adverse Event|2|||
13130859|NCT02828241|25976155|FG000|Overall Study|Protocol Violation|1|||
13130860|NCT02828241|25976156|FG001|Overall Study|Protocol Violation|0|||
13130861|NCT02828124|25976279|FG000|Overall Study|Disease Progression|1|||
13130862|NCT02828124|25976280|FG001|Overall Study|Disease Progression|2|||
13130863|NCT02828124|25976281|FG002|Overall Study|Disease Progression|1|||
13130864|NCT02828124|25976282|FG003|Overall Study|Disease Progression|4|||
13130865|NCT02828124|25976279|FG000|Overall Study|AE Unrelated to Study Drug|0|||
13130866|NCT02828124|25976280|FG001|Overall Study|AE Unrelated to Study Drug|0|||
13130867|NCT02828124|25976281|FG002|Overall Study|AE Unrelated to Study Drug|0|||
13130868|NCT02828124|25976282|FG003|Overall Study|AE Unrelated to Study Drug|1|||
13130869|NCT02828124|25976279|FG000|Overall Study|Subject Withdrew Consent|0|||
13130870|NCT02828124|25976280|FG001|Overall Study|Subject Withdrew Consent|0|||
13130871|NCT02828124|25976281|FG002|Overall Study|Subject Withdrew Consent|0|||
13130872|NCT02828124|25976282|FG003|Overall Study|Subject Withdrew Consent|1|||
13130873|NCT02828111|25976356|FG000|Overall Study|Withdrawal by Subject|0|||
13130874|NCT02828111|25976357|FG001|Overall Study|Withdrawal by Subject|0|||
13130875|NCT02828111|25976358|FG002|Overall Study|Withdrawal by Subject|2|||
13130876|NCT02828111|25976359|FG003|Overall Study|Withdrawal by Subject|0|||
13130877|NCT02828111|25976360|FG004|Overall Study|Withdrawal by Subject|0|||
13130878|NCT02828111|25976356|FG000|Overall Study|Lost to Follow-up|0|||
13130879|NCT02828111|25976357|FG001|Overall Study|Lost to Follow-up|0|||
13130880|NCT02828111|25976358|FG002|Overall Study|Lost to Follow-up|0|||
13130881|NCT02828111|25976359|FG003|Overall Study|Lost to Follow-up|1|||
13130882|NCT02828111|25976360|FG004|Overall Study|Lost to Follow-up|1|||
13130883|NCT02828020|25976399|FG000|Treatment Period|Adverse Event|3|||
13130884|NCT02828020|25976400|FG001|Treatment Period|Adverse Event|1|||
13130885|NCT02828020|25976401|FG002|Treatment Period|Adverse Event|1|||
13130886|NCT02828020|25976399|FG000|Treatment Period|Withdrawal of Consent|10|||
13130887|NCT02828020|25976400|FG001|Treatment Period|Withdrawal of Consent|14|||
13130888|NCT02828020|25976401|FG002|Treatment Period|Withdrawal of Consent|9|||
13130889|NCT02828020|25976399|FG000|Treatment Period|Lost to Follow-up|21|||
13130890|NCT02828020|25976400|FG001|Treatment Period|Lost to Follow-up|24|||
13130891|NCT02828020|25976401|FG002|Treatment Period|Lost to Follow-up|18|||
13130892|NCT02828020|25976399|FG000|Treatment Period|Lack of Qualifying Event|44|||
13130893|NCT02828020|25976400|FG001|Treatment Period|Lack of Qualifying Event|53|||
13130894|NCT02828020|25976401|FG002|Treatment Period|Lack of Qualifying Event|43|||
13130895|NCT02828020|25976399|FG000|Treatment Period|Pregnancy|0|||
13130896|NCT02828020|25976400|FG001|Treatment Period|Pregnancy|2|||
13130897|NCT02828020|25976401|FG002|Treatment Period|Pregnancy|0|||
13130898|NCT02828020|25976399|FG000|Treatment Period|Protocol Violation|2|||
13130899|NCT02828020|25976400|FG001|Treatment Period|Protocol Violation|4|||
13130900|NCT02828020|25976401|FG002|Treatment Period|Protocol Violation|7|||
13130901|NCT02828020|25976399|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
13130902|NCT02828020|25976400|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
13130903|NCT02828020|25976401|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
13130904|NCT02828020|25976399|FG000|Safety Follow-up Period|Withdrawal of Consent|10|||
13130905|NCT02828020|25976400|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
13130906|NCT02828020|25976401|FG002|Safety Follow-up Period|Withdrawal of Consent|7|||
13130907|NCT02828020|25976399|FG000|Safety Follow-up Period|Lost to Follow-up|9|||
13130908|NCT02828020|25976400|FG001|Safety Follow-up Period|Lost to Follow-up|8|||
13130909|NCT02828020|25976401|FG002|Safety Follow-up Period|Lost to Follow-up|11|||
13130910|NCT02828020|25976399|FG000|Safety Follow-up Period|Protocol Violation|0|||
13130911|NCT02828020|25976400|FG001|Safety Follow-up Period|Protocol Violation|2|||
13130912|NCT02828020|25976401|FG002|Safety Follow-up Period|Protocol Violation|1|||
13130913|NCT02828020|25976399|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1|||
13130914|NCT02828020|25976400|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
13075438|NCT03186794|25285241|FG000|Overall Study|Physician Decision|2|||
13075439|NCT03186794|25285241|FG000|Overall Study|Withdrawal due to COVID-19 pandemic closure|2|||
13075440|NCT04697069|25285280|FG000|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|0|||
13075441|NCT04697069|25285281|FG001|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|1|||
13075442|NCT04697069|25285280|FG000|Overall Study|Study termination|2|||
13075443|NCT04697069|25285281|FG001|Overall Study|Study termination|1|||
13075444|NCT04173507|25285324|FG000|Overall Study|On Treatment|3|||
13075445|NCT04173507|25285324|FG000|Overall Study|Adverse Event|3|||
13075446|NCT04173507|25285324|FG000|Overall Study|Progression/Relapse|34|||
13075447|NCT04173507|25285324|FG000|Overall Study|Death|2|||
13075448|NCT04148287|25285336|FG000|Overall Study|Death|2|||
13075449|NCT03935594|25285357|FG000|Overall Study|Physician Decision|3|||
13075450|NCT03278106|25285400|FG000|Overall Study|No protocol treatment|1|||
13075451|NCT03227757|25285407|FG000|Overall Study|Death|7|||
13075452|NCT03227757|25285407|FG000|Overall Study|Withdrawal|5|||
13075453|NCT03227757|25285407|FG000|Overall Study|Missed visits|4|||
13075454|NCT02937818|25285566|FG000|Overall Study|Participants decision|1|||
13075455|NCT02937818|25285567|FG001|Overall Study|Participants decision|0|||
13075456|NCT02937818|25285568|FG002|Overall Study|Participants decision|1|||
13075457|NCT02937818|25285569|FG003|Overall Study|Participants decision|1|||
13075458|NCT02937818|25285566|FG000|Overall Study|Adverse Event|2|||
13075459|NCT02937818|25285567|FG001|Overall Study|Adverse Event|4|||
13075460|NCT02937818|25285568|FG002|Overall Study|Adverse Event|1|||
13075461|NCT02937818|25285569|FG003|Overall Study|Adverse Event|1|||
13075462|NCT02937818|25285566|FG000|Overall Study|Disease progression|17|||
13075463|NCT02937818|25285567|FG001|Overall Study|Disease progression|14|||
13075464|NCT02937818|25285568|FG002|Overall Study|Disease progression|7|||
13075465|NCT02937818|25285569|FG003|Overall Study|Disease progression|18|||
13075466|NCT02937818|25285566|FG000|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|1|||
13075467|NCT02937818|25285567|FG001|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|2|||
13075468|NCT02937818|25285568|FG002|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|0|||
13075469|NCT02937818|25285569|FG003|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|0|||
13075470|NCT02937818|25285566|FG000|Overall Study|Condition under investigation worsened|0|||
13075471|NCT02937818|25285567|FG001|Overall Study|Condition under investigation worsened|0|||
13075472|NCT02937818|25285568|FG002|Overall Study|Condition under investigation worsened|1|||
13075473|NCT02937818|25285569|FG003|Overall Study|Condition under investigation worsened|0|||
13075474|NCT02937818|25285566|FG000|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|0|||
13075475|NCT02937818|25285567|FG001|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|0|||
13075476|NCT02937818|25285568|FG002|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|0|||
13075477|NCT02937818|25285569|FG003|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|1|||
13075478|NCT02794246|25285597|FG000|Overall Study|Withdrawal by Subject|2|||
13075479|NCT02794246|25285597|FG000|Overall Study|Physician Decision|4|||
13075480|NCT02453282|25285686|FG000|Overall Study|Death|275|||
13075481|NCT02453282|25285687|FG001|Overall Study|Death|277|||
13075482|NCT02453282|25285688|FG002|Overall Study|Death|296|||
13075483|NCT02453282|25285686|FG000|Overall Study|Lost to Follow-up|1|||
13075484|NCT02453282|25285687|FG001|Overall Study|Lost to Follow-up|0|||
13075485|NCT02453282|25285688|FG002|Overall Study|Lost to Follow-up|2|||
13075486|NCT02453282|25285686|FG000|Overall Study|Withdrawal by Subject|12|||
13075487|NCT02453282|25285687|FG001|Overall Study|Withdrawal by Subject|10|||
13075488|NCT02453282|25285688|FG002|Overall Study|Withdrawal by Subject|11|||
13075489|NCT02453282|25285686|FG000|Overall Study|Participants ongoing at data cut-off|85|||
13075490|NCT02453282|25285687|FG001|Overall Study|Participants ongoing at data cut-off|84|||
13075491|NCT02453282|25285688|FG002|Overall Study|Participants ongoing at data cut-off|62|||
13075492|NCT02453282|25285686|FG000|Overall Study|Other|1|||
13075493|NCT02453282|25285687|FG001|Overall Study|Other|1|||
13075494|NCT02453282|25285688|FG002|Overall Study|Other|1|||
13075495|NCT01938001|25285742|FG000|Overall Study|Withdrawal by Subject|25|||
13075496|NCT01938001|25285743|FG001|Overall Study|Withdrawal by Subject|17|||
13075497|NCT01938001|25285742|FG000|Overall Study|Non-compliant|1|||
13075498|NCT01938001|25285743|FG001|Overall Study|Non-compliant|0|||
13075499|NCT01938001|25285742|FG000|Overall Study|Participant Moved|0|||
13075500|NCT01938001|25285743|FG001|Overall Study|Participant Moved|1|||
13075501|NCT01938001|25285742|FG000|Overall Study|Lost to Follow-up|1|||
13075502|NCT01938001|25285743|FG001|Overall Study|Lost to Follow-up|3|||
13075503|NCT01938001|25285742|FG000|Overall Study|Death|16|||
13075504|NCT01938001|25285743|FG001|Overall Study|Death|26|||
13075505|NCT04289051|25285788|FG000|Overall Study|Lost to Follow-up|0|||
13075506|NCT04289051|25285789|FG001|Overall Study|Lost to Follow-up|0|||
13075507|NCT04289051|25285790|FG002|Overall Study|Lost to Follow-up|2|||
13075508|NCT04210180|25285799|FG000|Overall Study|Withdrawal by Subject|2|||
13075509|NCT03675308|25285911|FG000|Overall Study|Adverse Event|3|||
13075510|NCT03675308|25285912|FG001|Overall Study|Adverse Event|2|||
13075511|NCT03675308|25285911|FG000|Overall Study|Withdrawal by Subject|6|||
13075512|NCT03675308|25285912|FG001|Overall Study|Withdrawal by Subject|4|||
13075513|NCT03675308|25285911|FG000|Overall Study|Lost to Follow-up|3|||
13075514|NCT03675308|25285912|FG001|Overall Study|Lost to Follow-up|0|||
13075515|NCT03675308|25285911|FG000|Overall Study|Lack of Efficacy|1|||
13075516|NCT03675308|25285912|FG001|Overall Study|Lack of Efficacy|1|||
13075517|NCT03675308|25285911|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1|||
13075518|NCT03675308|25285912|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2|||
13075519|NCT03675308|25285911|FG000|Overall Study|Other|0|||
13075520|NCT03675308|25285912|FG001|Overall Study|Other|1|||
13075521|NCT03573817|25285945|FG000|Overall Study|Adverse Event|0|||
13075522|NCT03573817|25285946|FG001|Overall Study|Adverse Event|2|||
13075523|NCT03573817|25285945|FG000|Overall Study|Protocol Violation|0|||
13075524|NCT03573817|25285946|FG001|Overall Study|Protocol Violation|1|||
13075525|NCT03573817|25285945|FG000|Overall Study|Withdrawal by Subject|1|||
13075526|NCT03573817|25285946|FG001|Overall Study|Withdrawal by Subject|1|||
13130915|NCT02828020|25976401|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
13130916|NCT02827708|25976485|FG000|Overall Study|Lost to Follow-up|3|||
13130917|NCT02827708|25976486|FG001|Overall Study|Lost to Follow-up|1|||
13130918|NCT02827708|25976485|FG000|Overall Study|Withdrawal by Subject|1|||
13130919|NCT02827708|25976486|FG001|Overall Study|Withdrawal by Subject|2|||
13130920|NCT02827708|25976485|FG000|Overall Study|Death|1|||
13130921|NCT02827708|25976486|FG001|Overall Study|Death|2|||
13130922|NCT02827500|25976509|FG000|Overall Study|Death|7|||
13130923|NCT02827500|25976510|FG001|Overall Study|Death|3|||
13130924|NCT02827500|25976509|FG000|Overall Study|Lost to Follow-up|1|||
13130925|NCT02827500|25976510|FG001|Overall Study|Lost to Follow-up|1|||
13130926|NCT02827500|25976509|FG000|Overall Study|Withdrawal by Subject|3|||
13130927|NCT02827500|25976510|FG001|Overall Study|Withdrawal by Subject|1|||
13130928|NCT02827500|25976509|FG000|Overall Study|Missing primary endpoint data|3|||
13130929|NCT02827500|25976510|FG001|Overall Study|Missing primary endpoint data|1|||
13130930|NCT02827500|25976509|FG000|Overall Study|Other|5|||
13130931|NCT02827500|25976510|FG001|Overall Study|Other|1|||
13130932|NCT02826798|25976573|FG000|Overall Study|Withdrawal by Subject|0|||
13130933|NCT02826798|25976574|FG001|Overall Study|Withdrawal by Subject|1|||
13130934|NCT02826798|25976575|FG002|Overall Study|Withdrawal by Subject|0|||
13130935|NCT02826798|25976576|FG003|Overall Study|Withdrawal by Subject|1|||
13130936|NCT02826798|25976577|FG004|Overall Study|Withdrawal by Subject|0|||
13130937|NCT02826603|25976609|FG000|Overall Study|Adverse Event|17|||
13130938|NCT02826603|25976610|FG001|Overall Study|Adverse Event|9|||
13130939|NCT02826603|25976609|FG000|Overall Study|Lack of Efficacy|4|||
13130940|NCT02826603|25976610|FG001|Overall Study|Lack of Efficacy|9|||
13130941|NCT02826603|25976609|FG000|Overall Study|Lost to Follow-up|13|||
13130942|NCT02826603|25976610|FG001|Overall Study|Lost to Follow-up|12|||
13130943|NCT02826603|25976609|FG000|Overall Study|Noncompliance with treatment|0|||
13130944|NCT02826603|25976610|FG001|Overall Study|Noncompliance with treatment|2|||
13130945|NCT02826603|25976609|FG000|Overall Study|Physician Decision|1|||
13130946|NCT02826603|25976610|FG001|Overall Study|Physician Decision|7|||
13130947|NCT02826603|25976609|FG000|Overall Study|Pregnancy|1|||
13130948|NCT02826603|25976610|FG001|Overall Study|Pregnancy|2|||
13130949|NCT02826603|25976609|FG000|Overall Study|Protocol Violation|3|||
13130950|NCT02826603|25976610|FG001|Overall Study|Protocol Violation|3|||
13130951|NCT02826603|25976609|FG000|Overall Study|Withdrawal by Subject|20|||
13130952|NCT02826603|25976610|FG001|Overall Study|Withdrawal by Subject|19|||
13130953|NCT02826603|25976609|FG000|Overall Study|Death|2|||
13130954|NCT02826603|25976610|FG001|Overall Study|Death|0|||
13130955|NCT02826603|25976609|FG000|Overall Study|New therapy for study indication|0|||
13130956|NCT02826603|25976610|FG001|Overall Study|New therapy for study indication|1|||
13130957|NCT02826421|25976635|FG000|Overall Study|Adverse Event|1|||
13130958|NCT02826421|25976636|FG001|Overall Study|Adverse Event|0|||
13130959|NCT02826421|25976637|FG002|Overall Study|Adverse Event|0|||
13130960|NCT02826421|25976638|FG003|Overall Study|Adverse Event|1|||
13130961|NCT02826421|25976635|FG000|Overall Study|Withdrawal by Subject|1|||
13130962|NCT02826421|25976636|FG001|Overall Study|Withdrawal by Subject|3|||
13130963|NCT02826421|25976637|FG002|Overall Study|Withdrawal by Subject|1|||
13130964|NCT02826421|25976638|FG003|Overall Study|Withdrawal by Subject|1|||
13130965|NCT02826421|25976635|FG000|Overall Study|Reason not given|1|||
13130966|NCT02826421|25976636|FG001|Overall Study|Reason not given|0|||
13130967|NCT02826421|25976637|FG002|Overall Study|Reason not given|1|||
13130968|NCT02826421|25976638|FG003|Overall Study|Reason not given|0|||
13130969|NCT02825992|25976652|FG000|Overall Study|Withdrawal by Subject|4|||
13130970|NCT02825992|25976652|FG000|Overall Study|Lost to Follow-up|2|||
13130971|NCT02825992|25976652|FG000|Overall Study|Procedure terminated|2|||
13130972|NCT02825550|25976660|FG000|Overall Study|Physician Decision|1|||
13130973|NCT02825420|25976691|FG000|Overall Study|Death|30|||
13130974|NCT02825420|25976692|FG001|Overall Study|Death|12|||
13130975|NCT02825420|25976691|FG000|Overall Study|Progressive disease|6|||
13130976|NCT02825420|25976692|FG001|Overall Study|Progressive disease|1|||
13130977|NCT02825420|25976691|FG000|Overall Study|Lost to Follow-up|2|||
13130978|NCT02825420|25976692|FG001|Overall Study|Lost to Follow-up|2|||
13130979|NCT02825420|25976691|FG000|Overall Study|Withdrawal by Subject|1|||
13075527|NCT02919683|25286070|FG000|Post-Surgery Follow-Up|Death|2|||
13075528|NCT02919683|25286071|FG001|Post-Surgery Follow-Up|Death|2|||
13075529|NCT02919683|25286070|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1|||
13075530|NCT02919683|25286071|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0|||
13075531|NCT02790138|25286102|FG000|Overall Study|Adverse Event|5|||
13075532|NCT02790138|25286103|FG001|Overall Study|Adverse Event|2|||
13075533|NCT02790138|25286102|FG000|Overall Study|Significant Protocol Deviation|0|||
13075534|NCT02790138|25286103|FG001|Overall Study|Significant Protocol Deviation|1|||
13075535|NCT02790138|25286102|FG000|Overall Study|Lost to Follow-up|1|||
13075536|NCT02790138|25286103|FG001|Overall Study|Lost to Follow-up|0|||
13075537|NCT02790138|25286102|FG000|Overall Study|Voluntary Withdrawal|8|||
13075538|NCT02790138|25286103|FG001|Overall Study|Voluntary Withdrawal|9|||
13075539|NCT02790138|25286102|FG000|Overall Study|Lack of Efficacy|6|||
13075540|NCT02790138|25286103|FG001|Overall Study|Lack of Efficacy|7|||
13075541|NCT02790138|25286102|FG000|Overall Study|Reason not Specified|1|||
13075542|NCT02790138|25286103|FG001|Overall Study|Reason not Specified|0|||
13075543|NCT02514239|25286281|FG000|Overall Study|Refused to continue trial medication|0|||
13075544|NCT02514239|25286282|FG001|Overall Study|Refused to continue trial medication|0|||
13075545|NCT02514239|25286283|FG002|Overall Study|Refused to continue trial medication|0|||
13075546|NCT02514239|25286284|FG003|Overall Study|Refused to continue trial medication|0|||
13075547|NCT02514239|25286285|FG004|Overall Study|Refused to continue trial medication|0|||
13075548|NCT02514239|25286286|FG005|Overall Study|Refused to continue trial medication|0|||
13075549|NCT02514239|25286287|FG006|Overall Study|Refused to continue trial medication|0|||
13075550|NCT02514239|25286288|FG007|Overall Study|Refused to continue trial medication|0|||
13075551|NCT02514239|25286289|FG008|Overall Study|Refused to continue trial medication|0|||
13075552|NCT02514239|25286290|FG009|Overall Study|Refused to continue trial medication|1|||
13075553|NCT02514239|25286281|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
13075554|NCT02514239|25286282|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
13075555|NCT02514239|25286283|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
13075556|NCT02514239|25286284|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
13075557|NCT02514239|25286285|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
13075558|NCT02514239|25286286|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
13075559|NCT02514239|25286287|FG006|Overall Study|Dose-limiting toxicity (DLT)|0|||
13075560|NCT02514239|25286288|FG007|Overall Study|Dose-limiting toxicity (DLT)|0|||
13075561|NCT02514239|25286289|FG008|Overall Study|Dose-limiting toxicity (DLT)|1|||
13075562|NCT02514239|25286290|FG009|Overall Study|Dose-limiting toxicity (DLT)|2|||
13075563|NCT02514239|25286281|FG000|Overall Study|Not treated|0|||
13075564|NCT02514239|25286282|FG001|Overall Study|Not treated|1|||
13075565|NCT02514239|25286283|FG002|Overall Study|Not treated|0|||
13075566|NCT02514239|25286284|FG003|Overall Study|Not treated|0|||
13075567|NCT02514239|25286285|FG004|Overall Study|Not treated|0|||
13075568|NCT02514239|25286286|FG005|Overall Study|Not treated|0|||
13075569|NCT02514239|25286287|FG006|Overall Study|Not treated|0|||
13075570|NCT02514239|25286288|FG007|Overall Study|Not treated|0|||
13075571|NCT02514239|25286289|FG008|Overall Study|Not treated|0|||
13075572|NCT02514239|25286290|FG009|Overall Study|Not treated|0|||
13075573|NCT02514239|25286281|FG000|Overall Study|Other Adverse Events|2|||
13075574|NCT02514239|25286282|FG001|Overall Study|Other Adverse Events|0|||
13075575|NCT02514239|25286283|FG002|Overall Study|Other Adverse Events|0|||
13075576|NCT02514239|25286284|FG003|Overall Study|Other Adverse Events|1|||
13075577|NCT02514239|25286285|FG004|Overall Study|Other Adverse Events|0|||
13075578|NCT02514239|25286286|FG005|Overall Study|Other Adverse Events|1|||
13075579|NCT02514239|25286287|FG006|Overall Study|Other Adverse Events|0|||
13075580|NCT02514239|25286288|FG007|Overall Study|Other Adverse Events|1|||
13075581|NCT02514239|25286289|FG008|Overall Study|Other Adverse Events|2|||
13075582|NCT02514239|25286290|FG009|Overall Study|Other Adverse Events|0|||
13075583|NCT02514239|25286281|FG000|Overall Study|Progressive disease|3|||
13075584|NCT02514239|25286282|FG001|Overall Study|Progressive disease|3|||
13075585|NCT02514239|25286283|FG002|Overall Study|Progressive disease|2|||
13075586|NCT02514239|25286284|FG003|Overall Study|Progressive disease|2|||
13075587|NCT02514239|25286285|FG004|Overall Study|Progressive disease|3|||
13075588|NCT02514239|25286286|FG005|Overall Study|Progressive disease|3|||
13075589|NCT02514239|25286287|FG006|Overall Study|Progressive disease|4|||
13075590|NCT02514239|25286288|FG007|Overall Study|Progressive disease|2|||
13075591|NCT02514239|25286289|FG008|Overall Study|Progressive disease|5|||
13075592|NCT02514239|25286290|FG009|Overall Study|Progressive disease|0|||
13075593|NCT02109172|25286375|FG000|Overall Study|Withdrawal by Subject|1|||
13075594|NCT02109172|25286376|FG001|Overall Study|Withdrawal by Subject|0|||
13075595|NCT02109172|25286377|FG002|Overall Study|Withdrawal by Subject|0|||
13075596|NCT02109172|25286378|FG003|Overall Study|Withdrawal by Subject|1|||
13075597|NCT02109172|25286379|FG004|Overall Study|Withdrawal by Subject|0|||
13075598|NCT02109172|25286380|FG005|Overall Study|Withdrawal by Subject|0|||
13075599|NCT02109172|25286375|FG000|Overall Study|Adverse Event|0|||
13075600|NCT02109172|25286376|FG001|Overall Study|Adverse Event|0|||
13075601|NCT02109172|25286377|FG002|Overall Study|Adverse Event|1|||
13075602|NCT02109172|25286378|FG003|Overall Study|Adverse Event|0|||
13075603|NCT02109172|25286379|FG004|Overall Study|Adverse Event|0|||
13075604|NCT02109172|25286380|FG005|Overall Study|Adverse Event|1|||
13075605|NCT02109172|25286375|FG000|Overall Study|Death|0|||
13075606|NCT02109172|25286376|FG001|Overall Study|Death|0|||
13075607|NCT02109172|25286377|FG002|Overall Study|Death|0|||
13075608|NCT02109172|25286378|FG003|Overall Study|Death|0|||
13075609|NCT02109172|25286379|FG004|Overall Study|Death|1|||
13075610|NCT02109172|25286380|FG005|Overall Study|Death|0|||
13075611|NCT00799396|25286478|FG000|Clopidogrel Treatment|Adverse Event|6|||
13075612|NCT00799396|25286478|FG000|Clopidogrel Treatment|Physician Decision|5|||
13075613|NCT00799396|25286478|FG000|Clopidogrel Treatment|Withdrawal by Subject|2|||
13075614|NCT00799396|25286478|FG000|Clopidogrel Plus Aspirin|Adverse Event|2|||
13075615|NCT00799396|25286478|FG000|Clopidogrel Plus Aspirin|Physician Decision|4|||
13075616|NCT00069238|25286488|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9|||
13075617|NCT00069238|25286489|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
13075618|NCT00069238|25286490|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
13075619|NCT00069238|25286488|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
13075620|NCT00069238|25286489|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2|||
13075621|NCT00069238|25286490|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
13075622|NCT00069238|25286488|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
13075623|NCT00069238|25286489|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
13075624|NCT00069238|25286490|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2|||
13130980|NCT02825420|25976692|FG001|Overall Study|Withdrawal by Subject|1|||
13130981|NCT02825420|25976691|FG000|Overall Study|Protocol amendment not signed|1|||
13130982|NCT02825420|25976692|FG001|Overall Study|Protocol amendment not signed|1|||
13130983|NCT02825420|25976691|FG000|Overall Study|Physician Decision|1|||
13130984|NCT02825420|25976692|FG001|Overall Study|Physician Decision|0|||
13130985|NCT02825420|25976691|FG000|Overall Study|Did not receive PLD|2|||
13130986|NCT02825420|25976692|FG001|Overall Study|Did not receive PLD|0|||
13130987|NCT02825251|25976885|FG000|Overall Study|Adverse Event|0|||
13130988|NCT02825251|25976886|FG001|Overall Study|Adverse Event|1|||
13130989|NCT02825251|25976885|FG000|Overall Study|Lost to Follow-up|0|||
13130990|NCT02825251|25976886|FG001|Overall Study|Lost to Follow-up|1|||
13130991|NCT02825251|25976885|FG000|Overall Study|Withdrawal by Subject|1|||
13130992|NCT02825251|25976886|FG001|Overall Study|Withdrawal by Subject|4|||
13130993|NCT02825251|25976885|FG000|Overall Study|Unclassified|2|||
13130994|NCT02825251|25976886|FG001|Overall Study|Unclassified|0|||
13130995|NCT02825043|25976893|FG000|Overall Study|Lost to Follow-up|4|||
13130996|NCT02824627|25976910|FG000|Overall Study|Adverse Event|1|||
13130997|NCT02824627|25976911|FG001|Overall Study|Adverse Event|2|||
13130998|NCT02824627|25976910|FG000|Overall Study|Lost to Follow-up|2|||
13130999|NCT02824627|25976911|FG001|Overall Study|Lost to Follow-up|1|||
13131000|NCT02824562|25976925|FG000|Overall Study|Lost to Follow-up|3|||
13131001|NCT02824562|25976926|FG001|Overall Study|Lost to Follow-up|4|||
13131002|NCT02824562|25976925|FG000|Overall Study|Death|0|||
13131003|NCT02824562|25976926|FG001|Overall Study|Death|1|||
13131004|NCT02824432|25977007|FG000|Overall Study|Major Protocol Deviation|1|||
13131005|NCT02824432|25977008|FG001|Overall Study|Major Protocol Deviation|0|||
13131006|NCT02824224|25977033|FG000|Overall Study|Discontinued, IUS expulsion|0|||
13131007|NCT02824224|25977034|FG001|Overall Study|Discontinued, IUS expulsion|1|||
13131008|NCT02824224|25977033|FG000|Overall Study|Did not show up for allocation visit|2|||
13131009|NCT02824224|25977034|FG001|Overall Study|Did not show up for allocation visit|0|||
13131010|NCT02823964|25977040|FG000|Overall Study|Adverse Event|2|||
13131011|NCT02823964|25977040|FG000|Overall Study|Physician Decision|1|||
13131012|NCT02823964|25977040|FG000|Overall Study|Lack of Efficacy|1|||
13131013|NCT02823964|25977040|FG000|Overall Study|Withdrawal by Subject|1|||
13131014|NCT02823574|25977127|FG000|Pre-Treatment Period|Adverse Event Unrelated to Study drug|1|||
13131015|NCT02823574|25977128|FG001|Pre-Treatment Period|Adverse Event Unrelated to Study drug|0|||
13131016|NCT02823574|25977129|FG002|Pre-Treatment Period|Adverse Event Unrelated to Study drug|0|||
13131017|NCT02823574|25977130|FG003|Pre-Treatment Period|Adverse Event Unrelated to Study drug|0|||
13131018|NCT02823574|25977127|FG000|Pre-Treatment Period|Disease progression|0|||
13131019|NCT02823574|25977128|FG001|Pre-Treatment Period|Disease progression|0|||
13131020|NCT02823574|25977129|FG002|Pre-Treatment Period|Disease progression|1|||
13131021|NCT02823574|25977130|FG003|Pre-Treatment Period|Disease progression|0|||
13131022|NCT02823574|25977127|FG000|Treatment Period|Poor/Non Compliance|1|||
13131023|NCT02823574|25977128|FG001|Treatment Period|Poor/Non Compliance|0|||
13131024|NCT02823574|25977129|FG002|Treatment Period|Poor/Non Compliance|0|||
13131025|NCT02823574|25977130|FG003|Treatment Period|Poor/Non Compliance|1|||
13131026|NCT02823574|25977127|FG000|Treatment Period|Maximum Clinical Benefit|1|||
13131027|NCT02823574|25977128|FG001|Treatment Period|Maximum Clinical Benefit|0|||
13131028|NCT02823574|25977129|FG002|Treatment Period|Maximum Clinical Benefit|2|||
13131029|NCT02823574|25977130|FG003|Treatment Period|Maximum Clinical Benefit|0|||
13131030|NCT02823574|25977127|FG000|Treatment Period|Lost to Follow-up|1|||
13131031|NCT02823574|25977128|FG001|Treatment Period|Lost to Follow-up|0|||
13131032|NCT02823574|25977129|FG002|Treatment Period|Lost to Follow-up|0|||
13075625|NCT03138499|25286513|FG000|Overall Study|Lost to Follow-up|1|||
13075626|NCT03138499|25286514|FG001|Overall Study|Lost to Follow-up|0|||
13075627|NCT03138499|25286513|FG000|Overall Study|Participants withdrew consent|1|||
13075628|NCT03138499|25286514|FG001|Overall Study|Participants withdrew consent|0|||
13075629|NCT03138499|25286513|FG000|Overall Study|Participant discontinued study before treatment|0|||
13075630|NCT03138499|25286514|FG001|Overall Study|Participant discontinued study before treatment|1|||
13075631|NCT03138499|25286513|FG000|Overall Study|Disease Progression|2|||
13075632|NCT03138499|25286514|FG001|Overall Study|Disease Progression|6|||
13075633|NCT03138499|25286513|FG000|Overall Study|Study drug toxicity|2|||
13075634|NCT03138499|25286514|FG001|Overall Study|Study drug toxicity|2|||
13075635|NCT03138499|25286513|FG000|Overall Study|Participant request to discontinue study treatment|1|||
13075636|NCT03138499|25286514|FG001|Overall Study|Participant request to discontinue study treatment|1|||
13075637|NCT03138499|25286513|FG000|Overall Study|Other reasons|2|||
13075638|NCT03138499|25286514|FG001|Overall Study|Other reasons|0|||
13075639|NCT04466384|25286580|FG000|First Phase|Protocol Violation|1|||
13075640|NCT04466384|25286581|FG001|First Phase|Protocol Violation|0|||
13075641|NCT04466384|25286580|FG000|First Phase|Missing data|1|||
13075642|NCT04466384|25286581|FG001|First Phase|Missing data|0|||
13075643|NCT04466384|25286580|FG000|Cross Over Phase|Physician Decision|1|||
13075644|NCT04466384|25286581|FG001|Cross Over Phase|Physician Decision|0|||
13075645|NCT04466384|25286580|FG000|Cross Over Phase|Withdrawal by Subject|0|||
13075646|NCT04466384|25286581|FG001|Cross Over Phase|Withdrawal by Subject|1|||
13075647|NCT04428645|25286593|FG000|Second at Home Period (8 Weeks)|Withdrawal by Subject|1|||
13075648|NCT04157751|25286635|FG000|Overall Study|Withdrawal by Subject|12|||
13075649|NCT04157751|25286636|FG001|Overall Study|Withdrawal by Subject|17|||
13075650|NCT04157751|25286635|FG000|Overall Study|Lost to Follow-up|6|||
13075651|NCT04157751|25286636|FG001|Overall Study|Lost to Follow-up|2|||
13075652|NCT04157751|25286635|FG000|Overall Study|Adverse Event|34|||
13075653|NCT04157751|25286636|FG001|Overall Study|Adverse Event|23|||
13075654|NCT04157751|25286635|FG000|Overall Study|Not treated|1|||
13075655|NCT04157751|25286636|FG001|Overall Study|Not treated|5|||
13075656|NCT04157751|25286635|FG000|Overall Study|Other reason not stated above|10|||
13075657|NCT04157751|25286636|FG001|Overall Study|Other reason not stated above|10|||
13075658|NCT04086121|25286711|FG000|Overall Study|Other than listed|8|||
13075659|NCT04086121|25286711|FG000|Overall Study|Withdrawal by Subject|3|||
13075660|NCT04086121|25286711|FG000|Overall Study|Lost to Follow-up|2|||
13075661|NCT04086121|25286711|FG000|Overall Study|Adverse Event|1|||
13075662|NCT03965962|25286796|FG000|Overall Study|Adverse Event|1|||
13075663|NCT03965962|25286797|FG001|Overall Study|Adverse Event|0|||
13075664|NCT03965962|25286798|FG002|Overall Study|Adverse Event|0|||
13075665|NCT03965962|25286799|FG003|Overall Study|Adverse Event|0|||
13075666|NCT03965962|25286796|FG000|Overall Study|Protocol Violation|21|||
13075667|NCT03965962|25286797|FG001|Overall Study|Protocol Violation|4|||
13075668|NCT03965962|25286798|FG002|Overall Study|Protocol Violation|10|||
13075669|NCT03965962|25286799|FG003|Overall Study|Protocol Violation|5|||
13075670|NCT03965962|25286796|FG000|Overall Study|Lost to Follow-up|0|||
13075671|NCT03965962|25286797|FG001|Overall Study|Lost to Follow-up|1|||
13075672|NCT03965962|25286798|FG002|Overall Study|Lost to Follow-up|0|||
13075673|NCT03965962|25286799|FG003|Overall Study|Lost to Follow-up|0|||
13075674|NCT03965962|25286796|FG000|Overall Study|Withdrawal by Subject|3|||
13075675|NCT03965962|25286797|FG001|Overall Study|Withdrawal by Subject|0|||
13075676|NCT03965962|25286798|FG002|Overall Study|Withdrawal by Subject|0|||
13075677|NCT03965962|25286799|FG003|Overall Study|Withdrawal by Subject|1|||
13075683|NCT02576847|25286856|FG000|Overall Study|Adverse Event|27|||
13075684|NCT02576847|25286856|FG000|Overall Study|Lost to Follow-up|22|||
13075685|NCT02576847|25286856|FG000|Overall Study|Physician Decision|1|||
13075686|NCT02576847|25286856|FG000|Overall Study|Pregnancy|1|||
13075687|NCT02576847|25286856|FG000|Overall Study|Protocol Violation|3|||
13075688|NCT02576847|25286856|FG000|Overall Study|Withdrawal by Subject|78|||
13075689|NCT02576847|25286856|FG000|Overall Study|Other|5|||
13075690|NCT02425891|25286894|FG000|Overall Study|Death|333|||
13075691|NCT02425891|25286895|FG001|Overall Study|Death|314|||
13075692|NCT02425891|25286894|FG000|Overall Study|Lost to Follow-up|4|||
13075693|NCT02425891|25286895|FG001|Overall Study|Lost to Follow-up|6|||
13075694|NCT02425891|25286894|FG000|Overall Study|Non-Compliance|1|||
13075695|NCT02425891|25286895|FG001|Overall Study|Non-Compliance|1|||
13075696|NCT02425891|25286894|FG000|Overall Study|Accidentally randomized screen failure participant|0|||
13075697|NCT02425891|25286895|FG001|Overall Study|Accidentally randomized screen failure participant|1|||
13075698|NCT02425891|25286894|FG000|Overall Study|Physician Decision|0|||
13075699|NCT02425891|25286895|FG001|Overall Study|Physician Decision|1|||
13075700|NCT02425891|25286894|FG000|Overall Study|Protocol Violation|1|||
13075701|NCT02425891|25286895|FG001|Overall Study|Protocol Violation|1|||
13075702|NCT02425891|25286894|FG000|Overall Study|Study Terminated By Sponsor|85|||
13075703|NCT02425891|25286895|FG001|Overall Study|Study Terminated By Sponsor|95|||
13075704|NCT02425891|25286894|FG000|Overall Study|Withdrawal by Subject|27|||
13075705|NCT02425891|25286895|FG001|Overall Study|Withdrawal by Subject|32|||
13075706|NCT02315703|25287038|FG000|Overall Study|Adverse Event|0|||
13075707|NCT02315703|25287039|FG001|Overall Study|Adverse Event|0|||
13075708|NCT02315703|25287040|FG002|Overall Study|Adverse Event|0|||
13075709|NCT02315703|25287041|FG003|Overall Study|Adverse Event|1|||
13075710|NCT02315703|25287042|FG004|Overall Study|Adverse Event|1|||
13075711|NCT02315703|25287043|FG005|Overall Study|Adverse Event|0|||
13075712|NCT02315703|25287044|FG006|Overall Study|Adverse Event|1|||
13075713|NCT02315703|25287045|FG007|Overall Study|Adverse Event|0|||
13075714|NCT02315703|25287038|FG000|Overall Study|Lost to Follow-up|1|||
13075715|NCT02315703|25287039|FG001|Overall Study|Lost to Follow-up|5|||
13075716|NCT02315703|25287040|FG002|Overall Study|Lost to Follow-up|3|||
13075717|NCT02315703|25287041|FG003|Overall Study|Lost to Follow-up|3|||
13075718|NCT02315703|25287042|FG004|Overall Study|Lost to Follow-up|2|||
13075719|NCT02315703|25287043|FG005|Overall Study|Lost to Follow-up|1|||
13075720|NCT02315703|25287044|FG006|Overall Study|Lost to Follow-up|2|||
13075721|NCT02315703|25287045|FG007|Overall Study|Lost to Follow-up|2|||
13075722|NCT02315703|25287038|FG000|Overall Study|Pregnancy|0|||
13075723|NCT02315703|25287039|FG001|Overall Study|Pregnancy|0|||
13075724|NCT02315703|25287040|FG002|Overall Study|Pregnancy|0|||
13075725|NCT02315703|25287041|FG003|Overall Study|Pregnancy|0|||
13075726|NCT02315703|25287042|FG004|Overall Study|Pregnancy|0|||
13075727|NCT02315703|25287043|FG005|Overall Study|Pregnancy|0|||
13075728|NCT02315703|25287044|FG006|Overall Study|Pregnancy|0|||
13075729|NCT02315703|25287045|FG007|Overall Study|Pregnancy|1|||
13075730|NCT02315703|25287038|FG000|Overall Study|Withdrawal by Subject|1|||
13075731|NCT02315703|25287039|FG001|Overall Study|Withdrawal by Subject|3|||
13075732|NCT02315703|25287040|FG002|Overall Study|Withdrawal by Subject|0|||
13075733|NCT02315703|25287041|FG003|Overall Study|Withdrawal by Subject|3|||
13075734|NCT02315703|25287042|FG004|Overall Study|Withdrawal by Subject|4|||
13075735|NCT02315703|25287043|FG005|Overall Study|Withdrawal by Subject|1|||
13075736|NCT02315703|25287044|FG006|Overall Study|Withdrawal by Subject|1|||
13075737|NCT02315703|25287045|FG007|Overall Study|Withdrawal by Subject|2|||
13075738|NCT02315703|25287038|FG000|Overall Study|Physician Decision|0|||
13075739|NCT02315703|25287039|FG001|Overall Study|Physician Decision|0|||
13075740|NCT02315703|25287040|FG002|Overall Study|Physician Decision|0|||
13075741|NCT02315703|25287041|FG003|Overall Study|Physician Decision|0|||
13075742|NCT02315703|25287042|FG004|Overall Study|Physician Decision|0|||
13075743|NCT02315703|25287043|FG005|Overall Study|Physician Decision|2|||
13075744|NCT02315703|25287044|FG006|Overall Study|Physician Decision|1|||
13075745|NCT02315703|25287045|FG007|Overall Study|Physician Decision|0|||
13075746|NCT02315703|25287038|FG000|Overall Study|Other|4|||
13075747|NCT02315703|25287039|FG001|Overall Study|Other|2|||
13075748|NCT02315703|25287040|FG002|Overall Study|Other|2|||
13075749|NCT02315703|25287041|FG003|Overall Study|Other|2|||
13075750|NCT02315703|25287042|FG004|Overall Study|Other|1|||
13075751|NCT02315703|25287043|FG005|Overall Study|Other|2|||
13075752|NCT02315703|25287044|FG006|Overall Study|Other|8|||
13075753|NCT02315703|25287045|FG007|Overall Study|Other|2|||
13075754|NCT02167945|25287077|FG000|Overall Study|Adverse Event|16|||
13075755|NCT02167945|25287077|FG000|Overall Study|Withdrew Consent|42|||
13075756|NCT02167945|25287077|FG000|Overall Study|Lost to Follow-up|122|||
13075757|NCT02167945|25287077|FG000|Overall Study|COVID-19 logistical restrictions|6|||
13075758|NCT02167945|25287077|FG000|Overall Study|Other, not specified|63|||
13075759|NCT02128763|25287126|FG000|Overall Study|Death|1|||
13075760|NCT02128763|25287127|FG001|Overall Study|Death|0|||
13075761|NCT02128763|25287126|FG000|Overall Study|Lost to Follow-up|19|||
13075762|NCT02128763|25287127|FG001|Overall Study|Lost to Follow-up|16|||
13075763|NCT01991977|25287147|FG000|Overall Study|Withdrew prior to receiving treatment|7|||
13075764|NCT01991977|25287147|FG000|Overall Study|Withdrew after start of treatment|5|||
13075765|NCT01903733|25287225|FG000|Overall Study|Death|23|||
13075766|NCT01903733|25287226|FG001|Overall Study|Death|54|||
13075767|NCT01903733|25287227|FG002|Overall Study|Death|30|||
13075768|NCT01903733|25287228|FG003|Overall Study|Death|98|||
13075769|NCT01903733|25287225|FG000|Overall Study|Participant refused further follow-up|35|||
13075770|NCT01903733|25287226|FG001|Overall Study|Participant refused further follow-up|38|||
13075771|NCT01903733|25287227|FG002|Overall Study|Participant refused further follow-up|13|||
13075772|NCT01903733|25287228|FG003|Overall Study|Participant refused further follow-up|9|||
13075773|NCT01903733|25287225|FG000|Overall Study|Lost to Follow-up|18|||
13075774|NCT01903733|25287226|FG001|Overall Study|Lost to Follow-up|19|||
13075775|NCT01903733|25287227|FG002|Overall Study|Lost to Follow-up|6|||
13075776|NCT01903733|25287228|FG003|Overall Study|Lost to Follow-up|9|||
13075777|NCT01903733|25287225|FG000|Overall Study|Other|10|||
13075778|NCT01903733|25287226|FG001|Overall Study|Other|15|||
13075779|NCT01903733|25287227|FG002|Overall Study|Other|12|||
13075780|NCT01903733|25287228|FG003|Overall Study|Other|3|||
13075781|NCT01903733|25287225|FG000|Overall Study|Missing|2|||
13075782|NCT01903733|25287226|FG001|Overall Study|Missing|0|||
13075783|NCT01903733|25287227|FG002|Overall Study|Missing|0|||
13075784|NCT01903733|25287228|FG003|Overall Study|Missing|0|||
13075785|NCT01903733|25287225|FG000|Overall Study|Investigator request|18|||
13075786|NCT01903733|25287226|FG001|Overall Study|Investigator request|0|||
13075787|NCT01903733|25287227|FG002|Overall Study|Investigator request|0|||
13075788|NCT01903733|25287228|FG003|Overall Study|Investigator request|0|||
13075789|NCT01575548|25287243|FG000|Overall Study|Adverse Event|15|||
13075790|NCT01575548|25287244|FG001|Overall Study|Adverse Event|2|||
13075791|NCT01575548|25287243|FG000|Overall Study|Disease progression|12|||
13075792|NCT01575548|25287244|FG001|Overall Study|Disease progression|25|||
13075793|NCT01575548|25287243|FG000|Overall Study|Death|1|||
13075794|NCT01575548|25287244|FG001|Overall Study|Death|0|||
13075795|NCT01575548|25287243|FG000|Overall Study|Other complicating disease|1|||
13075796|NCT01575548|25287244|FG001|Overall Study|Other complicating disease|0|||
13075797|NCT01575548|25287243|FG000|Overall Study|Withdrawal by Subject|7|||
13075798|NCT01575548|25287244|FG001|Overall Study|Withdrawal by Subject|3|||
13075799|NCT01575548|25287243|FG000|Overall Study|Noncompliance|1|||
13075800|NCT01575548|25287244|FG001|Overall Study|Noncompliance|0|||
13075801|NCT01575548|25287243|FG000|Overall Study|Anticipated surgery|0|||
13075802|NCT01575548|25287244|FG001|Overall Study|Anticipated surgery|1|||
13075803|NCT01575548|25287243|FG000|Overall Study|Never started protocol therapy|3|||
13075804|NCT01575548|25287244|FG001|Overall Study|Never started protocol therapy|2|||
13075805|NCT01236547|25287281|FG000|Overall Study|Protocol Violation|0|||
13075806|NCT01236547|25287282|FG001|Overall Study|Protocol Violation|1|||
13075807|NCT01236547|25287283|FG002|Overall Study|Protocol Violation|1|||
13075808|NCT01236547|25287284|FG003|Overall Study|Protocol Violation|6|||
13075809|NCT01236547|25287285|FG004|Overall Study|Protocol Violation|12|||
13075810|NCT00919763|25287304|FG000|Overall Study|Adverse Event|7|||
13075811|NCT00919763|25287305|FG001|Overall Study|Adverse Event|1|||
13075812|NCT00919763|25287304|FG000|Overall Study|Lost to Follow-up|1|||
13075813|NCT00919763|25287305|FG001|Overall Study|Lost to Follow-up|0|||
13075814|NCT00919763|25287304|FG000|Overall Study|Protocol Violation|1|||
13075815|NCT00919763|25287305|FG001|Overall Study|Protocol Violation|1|||
13075816|NCT00919763|25287304|FG000|Overall Study|Withdrawal by Subject|3|||
13075817|NCT00919763|25287305|FG001|Overall Study|Withdrawal by Subject|1|||
13075818|NCT00919763|25287304|FG000|Overall Study|Non-compliance|0|||
13075819|NCT00919763|25287305|FG001|Overall Study|Non-compliance|1|||
13075820|NCT00238420|25287342|FG000|Overall Study|Protocol Violation|1|||
13075821|NCT00238420|25287343|FG001|Overall Study|Protocol Violation|1|||
13131033|NCT02823574|25977130|FG003|Treatment Period|Lost to Follow-up|0|||
13131034|NCT02823574|25977127|FG000|Treatment Period|Participant withdrew consent|2|||
13131035|NCT02823574|25977128|FG001|Treatment Period|Participant withdrew consent|0|||
13131036|NCT02823574|25977129|FG002|Treatment Period|Participant withdrew consent|0|||
13131037|NCT02823574|25977130|FG003|Treatment Period|Participant withdrew consent|0|||
13131038|NCT02823574|25977127|FG000|Treatment Period|Participant request to discontinue|4|||
13131039|NCT02823574|25977128|FG001|Treatment Period|Participant request to discontinue|0|||
13131040|NCT02823574|25977129|FG002|Treatment Period|Participant request to discontinue|2|||
13131041|NCT02823574|25977130|FG003|Treatment Period|Participant request to discontinue|3|||
13131042|NCT02823574|25977127|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10|||
13131043|NCT02823574|25977128|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2|||
13131044|NCT02823574|25977129|FG002|Treatment Period|Adverse Event unrelated to to study Drug|8|||
13131045|NCT02823574|25977130|FG003|Treatment Period|Adverse Event unrelated to to study Drug|1|||
13131046|NCT02823574|25977127|FG000|Treatment Period|Study Drug Toxicity|7|||
13131047|NCT02823574|25977128|FG001|Treatment Period|Study Drug Toxicity|2|||
13131048|NCT02823574|25977129|FG002|Treatment Period|Study Drug Toxicity|13|||
13131049|NCT02823574|25977130|FG003|Treatment Period|Study Drug Toxicity|3|||
13131050|NCT02823574|25977127|FG000|Treatment Period|Disease Progression|112|||
13131051|NCT02823574|25977128|FG001|Treatment Period|Disease Progression|60|||
13131052|NCT02823574|25977129|FG002|Treatment Period|Disease Progression|80|||
13131053|NCT02823574|25977130|FG003|Treatment Period|Disease Progression|41|||
13131054|NCT02823574|25977127|FG000|Treatment Period|participant no longer meets study criteria|0|||
13131055|NCT02823574|25977128|FG001|Treatment Period|participant no longer meets study criteria|0|||
13131056|NCT02823574|25977129|FG002|Treatment Period|participant no longer meets study criteria|1|||
13131057|NCT02823574|25977130|FG003|Treatment Period|participant no longer meets study criteria|0|||
13131058|NCT02823574|25977127|FG000|Treatment Period|Death|0|||
13131059|NCT02823574|25977128|FG001|Treatment Period|Death|0|||
13131060|NCT02823574|25977129|FG002|Treatment Period|Death|2|||
13131061|NCT02823574|25977130|FG003|Treatment Period|Death|1|||
13131062|NCT02823574|25977127|FG000|Treatment Period|Other reasons|1|||
13131063|NCT02823574|25977128|FG001|Treatment Period|Other reasons|2|||
13131064|NCT02823574|25977129|FG002|Treatment Period|Other reasons|0|||
13131065|NCT02823574|25977130|FG003|Treatment Period|Other reasons|1|||
13131066|NCT02823470|25977149|FG000|Overall Study|Adverse Event|1|||
13131067|NCT02823470|25977150|FG001|Overall Study|Adverse Event|0|||
13131068|NCT02823470|25977149|FG000|Overall Study|Study terminated by sponsor|8|||
13131069|NCT02823470|25977150|FG001|Overall Study|Study terminated by sponsor|15|||
13075822|NCT04189588|25287497|FG000|Overall Study|Death|0|||
13075823|NCT04189588|25287498|FG001|Overall Study|Death|1|||
13075824|NCT04189588|25287497|FG000|Overall Study|Lost to Follow-up|0|||
13075825|NCT04189588|25287498|FG001|Overall Study|Lost to Follow-up|1|||
13075826|NCT04115748|25287702|FG000|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
13075827|NCT04115748|25287703|FG001|Main Study (Up to 16 Weeks)|Study terminated by sponsor|16|||
13075828|NCT04115748|25287704|FG002|Main Study (Up to 16 Weeks)|Study terminated by sponsor|7|||
13075829|NCT04115748|25287705|FG003|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
13075830|NCT04115748|25287706|FG004|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
13075831|NCT04115748|25287707|FG005|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
13075832|NCT04115748|25287708|FG006|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
13075833|NCT04115748|25287709|FG007|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
13075834|NCT04115748|25287710|FG008|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
13075835|NCT04115748|25287711|FG009|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
13075836|NCT04115748|25287702|FG000|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
13075837|NCT04115748|25287703|FG001|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
13075838|NCT04115748|25287704|FG002|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
13075839|NCT04115748|25287705|FG003|Main Study (Up to 16 Weeks)|Withdrew consent|1|||
13075840|NCT04115748|25287706|FG004|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
13075841|NCT04115748|25287707|FG005|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
13075842|NCT04115748|25287708|FG006|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
13075843|NCT04115748|25287709|FG007|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
13075844|NCT04115748|25287710|FG008|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
13075845|NCT04115748|25287711|FG009|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
13075846|NCT04115748|25287702|FG000|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
13075847|NCT04115748|25287703|FG001|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
13075848|NCT04115748|25287704|FG002|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
13075849|NCT04115748|25287705|FG003|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
13075850|NCT04115748|25287706|FG004|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|4|||
13075851|NCT04115748|25287707|FG005|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|3|||
13075852|NCT04115748|25287708|FG006|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
13075853|NCT04115748|25287709|FG007|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
13075854|NCT04115748|25287710|FG008|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
13075855|NCT04115748|25287711|FG009|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|2|||
13075856|NCT04115748|25287702|FG000|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
13075857|NCT04115748|25287703|FG001|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
13075858|NCT04115748|25287704|FG002|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
13075859|NCT04115748|25287705|FG003|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
13075860|NCT04115748|25287706|FG004|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
13075861|NCT04115748|25287707|FG005|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
13075862|NCT04115748|25287708|FG006|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
13075863|NCT04115748|25287709|FG007|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
13075864|NCT04115748|25287710|FG008|LTE (After 16 Weeks to Week 50)|Adverse Event|1|||
13075865|NCT04115748|25287711|FG009|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
13075866|NCT04044664|25287750|FG000|Stage 1|Adverse Event|3|||
13075867|NCT04044664|25287751|FG001|Stage 1|Adverse Event|3|||
13075868|NCT04044664|25287752|FG002|Stage 1|Adverse Event|1|||
13075869|NCT04044664|25287750|FG000|Stage 1|Lost to Follow-up|3|||
13075870|NCT04044664|25287751|FG001|Stage 1|Lost to Follow-up|2|||
13075871|NCT04044664|25287752|FG002|Stage 1|Lost to Follow-up|2|||
13075872|NCT04044664|25287750|FG000|Stage 1|Withdrawal by Subject|9|||
13075873|NCT04044664|25287751|FG001|Stage 1|Withdrawal by Subject|1|||
13075874|NCT04044664|25287752|FG002|Stage 1|Withdrawal by Subject|0|||
13075875|NCT04044664|25287750|FG000|Stage 1|noncompliance, personal reason|2|||
13075876|NCT04044664|25287751|FG001|Stage 1|noncompliance, personal reason|0|||
13075877|NCT04044664|25287752|FG002|Stage 1|noncompliance, personal reason|0|||
13075878|NCT04044664|25287750|FG000|Stage 1|randomization error|0|||
13075879|NCT04044664|25287751|FG001|Stage 1|randomization error|1|||
13075880|NCT04044664|25287752|FG002|Stage 1|randomization error|0|||
13075881|NCT04044664|25287750|FG000|Stage 2|Adverse Event|2|||
13075882|NCT04044664|25287751|FG001|Stage 2|Adverse Event|0|||
13075883|NCT04044664|25287752|FG002|Stage 2|Adverse Event|0|||
13075884|NCT04044664|25287750|FG000|Stage 2|Lost to Follow-up|3|||
13075885|NCT04044664|25287751|FG001|Stage 2|Lost to Follow-up|2|||
13075886|NCT04044664|25287752|FG002|Stage 2|Lost to Follow-up|1|||
13075887|NCT04044664|25287750|FG000|Stage 2|Withdrawal by Subject|3|||
13075888|NCT04044664|25287751|FG001|Stage 2|Withdrawal by Subject|0|||
13075889|NCT04044664|25287752|FG002|Stage 2|Withdrawal by Subject|0|||
13075890|NCT04044664|25287750|FG000|Stage 2|protocol deviation|1|||
13075891|NCT04044664|25287751|FG001|Stage 2|protocol deviation|0|||
13075892|NCT04044664|25287752|FG002|Stage 2|protocol deviation|0|||
13075893|NCT04032093|25287850|FG000|Overall Study|Lost to Follow-up|7|||
13075894|NCT04032093|25287851|FG001|Overall Study|Lost to Follow-up|7|||
13075895|NCT04032093|25287852|FG002|Overall Study|Lost to Follow-up|6|||
13075896|NCT04032093|25287853|FG003|Overall Study|Lost to Follow-up|10|||
13075897|NCT04032093|25287854|FG004|Overall Study|Lost to Follow-up|13|||
13075898|NCT04032093|25287855|FG005|Overall Study|Lost to Follow-up|7|||
13075899|NCT04032093|25287856|FG006|Overall Study|Lost to Follow-up|7|||
13075900|NCT04032093|25287857|FG007|Overall Study|Lost to Follow-up|5|||
13075901|NCT04032093|25287858|FG008|Overall Study|Lost to Follow-up|9|||
13075902|NCT04032093|25287859|FG009|Overall Study|Lost to Follow-up|12|||
13075903|NCT04032093|25287850|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
13075904|NCT04032093|25287851|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
13075905|NCT04032093|25287852|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
13075906|NCT04032093|25287853|FG003|Overall Study|No Longer Meets Eligibility Criteria|2|||
13075907|NCT04032093|25287854|FG004|Overall Study|No Longer Meets Eligibility Criteria|1|||
13075908|NCT04032093|25287855|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
13075909|NCT04032093|25287856|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
13075910|NCT04032093|25287857|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
13075911|NCT04032093|25287858|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
13075912|NCT04032093|25287859|FG009|Overall Study|No Longer Meets Eligibility Criteria|1|||
13075913|NCT04032093|25287850|FG000|Overall Study|Other|1|||
13075914|NCT04032093|25287851|FG001|Overall Study|Other|0|||
13222326|NCT01807221|26286045|FG005|Overall Study|Death|6|||
13222327|NCT01807221|26286040|FG000|Overall Study|Physician Decision|2|||
13222328|NCT01807221|26286041|FG001|Overall Study|Physician Decision|1|||
13222329|NCT01807221|26286042|FG002|Overall Study|Physician Decision|0|||
13222330|NCT01807221|26286043|FG003|Overall Study|Physician Decision|0|||
13222331|NCT01807221|26286044|FG004|Overall Study|Physician Decision|0|||
13222332|NCT01807221|26286045|FG005|Overall Study|Physician Decision|0|||
13222333|NCT01807221|26286040|FG000|Overall Study|Adverse Event|33|||
13222334|NCT01807221|26286041|FG001|Overall Study|Adverse Event|22|||
13222335|NCT01807221|26286042|FG002|Overall Study|Adverse Event|26|||
13222336|NCT01807221|26286043|FG003|Overall Study|Adverse Event|25|||
13222337|NCT01807221|26286044|FG004|Overall Study|Adverse Event|18|||
13222338|NCT01807221|26286045|FG005|Overall Study|Adverse Event|21|||
13222339|NCT01807221|26286040|FG000|Overall Study|Protocol Violation|0|||
13222340|NCT01807221|26286041|FG001|Overall Study|Protocol Violation|2|||
13222341|NCT01807221|26286042|FG002|Overall Study|Protocol Violation|1|||
13222342|NCT01807221|26286043|FG003|Overall Study|Protocol Violation|2|||
13222343|NCT01807221|26286044|FG004|Overall Study|Protocol Violation|0|||
13222344|NCT01807221|26286045|FG005|Overall Study|Protocol Violation|1|||
13222345|NCT01807221|26286040|FG000|Overall Study|Non-compliance|1|||
13222346|NCT01807221|26286041|FG001|Overall Study|Non-compliance|2|||
13222347|NCT01807221|26286042|FG002|Overall Study|Non-compliance|0|||
13222348|NCT01807221|26286043|FG003|Overall Study|Non-compliance|1|||
13222349|NCT01807221|26286044|FG004|Overall Study|Non-compliance|0|||
13222350|NCT01807221|26286045|FG005|Overall Study|Non-compliance|0|||
13222351|NCT01807221|26286040|FG000|Overall Study|Logistical difficulties|0|||
13222352|NCT01807221|26286041|FG001|Overall Study|Logistical difficulties|1|||
13222353|NCT01807221|26286042|FG002|Overall Study|Logistical difficulties|0|||
13222354|NCT01807221|26286043|FG003|Overall Study|Logistical difficulties|0|||
13222355|NCT01807221|26286044|FG004|Overall Study|Logistical difficulties|1|||
13222356|NCT01807221|26286045|FG005|Overall Study|Logistical difficulties|0|||
13222357|NCT01807221|26286040|FG000|Overall Study|Withdrawal by Subject|33|||
13393340|NCT00665925|26783411|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
13075915|NCT04032093|25287852|FG002|Overall Study|Other|0|||
13075916|NCT04032093|25287853|FG003|Overall Study|Other|1|||
13075917|NCT04032093|25287854|FG004|Overall Study|Other|1|||
13075918|NCT04032093|25287855|FG005|Overall Study|Other|0|||
13075919|NCT04032093|25287856|FG006|Overall Study|Other|0|||
13075920|NCT04032093|25287857|FG007|Overall Study|Other|0|||
13075921|NCT04032093|25287858|FG008|Overall Study|Other|0|||
13075922|NCT04032093|25287859|FG009|Overall Study|Other|1|||
13075923|NCT04032093|25287850|FG000|Overall Study|Withdrawal by Subject|1|||
13075924|NCT04032093|25287851|FG001|Overall Study|Withdrawal by Subject|3|||
13075925|NCT04032093|25287852|FG002|Overall Study|Withdrawal by Subject|2|||
13075926|NCT04032093|25287853|FG003|Overall Study|Withdrawal by Subject|2|||
13075927|NCT04032093|25287854|FG004|Overall Study|Withdrawal by Subject|3|||
13075928|NCT04032093|25287855|FG005|Overall Study|Withdrawal by Subject|0|||
13075929|NCT04032093|25287856|FG006|Overall Study|Withdrawal by Subject|0|||
13075930|NCT04032093|25287857|FG007|Overall Study|Withdrawal by Subject|0|||
13222358|NCT01807221|26286041|FG001|Overall Study|Withdrawal by Subject|15|||
13222359|NCT01807221|26286042|FG002|Overall Study|Withdrawal by Subject|8|||
13222360|NCT01807221|26286043|FG003|Overall Study|Withdrawal by Subject|14|||
13222361|NCT01807221|26286044|FG004|Overall Study|Withdrawal by Subject|16|||
13222362|NCT01807221|26286045|FG005|Overall Study|Withdrawal by Subject|13|||
13222363|NCT01807221|26286040|FG000|Overall Study|Sponsor decision|2|||
13222364|NCT01807221|26286041|FG001|Overall Study|Sponsor decision|0|||
13222365|NCT01807221|26286042|FG002|Overall Study|Sponsor decision|1|||
13222366|NCT01807221|26286043|FG003|Overall Study|Sponsor decision|1|||
13075931|NCT04032093|25287858|FG008|Overall Study|Withdrawal by Subject|0|||
13075932|NCT04032093|25287859|FG009|Overall Study|Withdrawal by Subject|0|||
13075933|NCT04032093|25287850|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
13075934|NCT04032093|25287851|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
13075935|NCT04032093|25287852|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
13075936|NCT04032093|25287853|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
13075937|NCT04032093|25287854|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
13075938|NCT04032093|25287855|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
13075939|NCT04032093|25287856|FG006|Overall Study|Withdrawal by Parent/Guardian|3|||
13075940|NCT04032093|25287857|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
13075941|NCT04032093|25287858|FG008|Overall Study|Withdrawal by Parent/Guardian|2|||
13075942|NCT04032093|25287859|FG009|Overall Study|Withdrawal by Parent/Guardian|3|||
13075943|NCT04032093|25287850|FG000|Overall Study|Adverse Event|0|||
13075944|NCT04032093|25287851|FG001|Overall Study|Adverse Event|0|||
13075945|NCT04032093|25287852|FG002|Overall Study|Adverse Event|0|||
13075946|NCT04032093|25287853|FG003|Overall Study|Adverse Event|0|||
13075947|NCT04032093|25287854|FG004|Overall Study|Adverse Event|0|||
13075948|NCT04032093|25287855|FG005|Overall Study|Adverse Event|0|||
13075949|NCT04032093|25287856|FG006|Overall Study|Adverse Event|0|||
13075950|NCT04032093|25287857|FG007|Overall Study|Adverse Event|0|||
13075951|NCT04032093|25287858|FG008|Overall Study|Adverse Event|0|||
13075952|NCT04032093|25287859|FG009|Overall Study|Adverse Event|1|||
13075953|NCT04032093|25287850|FG000|Overall Study|Physician Decision|0|||
13075954|NCT04032093|25287851|FG001|Overall Study|Physician Decision|0|||
13075955|NCT04032093|25287852|FG002|Overall Study|Physician Decision|0|||
13075956|NCT04032093|25287853|FG003|Overall Study|Physician Decision|0|||
13075957|NCT04032093|25287854|FG004|Overall Study|Physician Decision|0|||
13075958|NCT04032093|25287855|FG005|Overall Study|Physician Decision|1|||
13075959|NCT04032093|25287856|FG006|Overall Study|Physician Decision|0|||
13075960|NCT04032093|25287857|FG007|Overall Study|Physician Decision|0|||
13075961|NCT04032093|25287858|FG008|Overall Study|Physician Decision|0|||
13075962|NCT04032093|25287859|FG009|Overall Study|Physician Decision|0|||
13075963|NCT03994731|25287897|FG000|Pegloticase + IMM Period|Death|2|||
13075964|NCT03994731|25287898|FG001|Pegloticase + IMM Period|Death|0|||
13075965|NCT03994731|25287897|FG000|Pegloticase + IMM Period|Lost to Follow-up|3|||
13075966|NCT03994731|25287898|FG001|Pegloticase + IMM Period|Lost to Follow-up|6|||
13075967|NCT03994731|25287897|FG000|Pegloticase + IMM Period|Withdrawal by Subject|15|||
13075968|NCT03994731|25287898|FG001|Pegloticase + IMM Period|Withdrawal by Subject|9|||
13075969|NCT03924622|25288119|FG000|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|2|||
13075970|NCT03924622|25288120|FG001|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
13075971|NCT03924622|25288121|FG002|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
13075972|NCT03924622|25288122|FG003|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|4|||
13075973|NCT03924622|25288123|FG004|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
13075974|NCT03924622|25288124|FG005|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
13131070|NCT02822794|25977219|FG000|Overall Study|Withdrew Consent|1|||
13131071|NCT02822794|25977220|FG001|Overall Study|Withdrew Consent|0|||
13131072|NCT02822235|25977280|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144|||
13131073|NCT02822235|25977281|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107|||
13131074|NCT02822235|25977280|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2|||
13222367|NCT01807221|26286044|FG004|Overall Study|Sponsor decision|0|||
13222368|NCT01807221|26286045|FG005|Overall Study|Sponsor decision|0|||
13222369|NCT01807221|26286040|FG000|Overall Study|Lost to Follow-up|1|||
13131075|NCT02822235|25977281|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0|||
13131076|NCT02822235|25977280|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0|||
13131077|NCT02822235|25977281|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1|||
13131078|NCT02822235|25977280|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4|||
13131079|NCT02822235|25977281|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0|||
13131080|NCT02822235|25977280|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1|||
13131081|NCT02822235|25977281|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0|||
13131082|NCT02822235|25977280|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6|||
13131083|NCT02822235|25977281|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1|||
13131084|NCT02822222|25977336|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1|||
13131085|NCT02822222|25977337|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0|||
13131086|NCT02821962|25977382|FG000|Overall Study|Lost to Follow-up|2|||
13131087|NCT02821962|25977383|FG001|Overall Study|Lost to Follow-up|0|||
13131088|NCT02821910|25977464|FG000|Overall Study|Withdrawal by Subject|0|||
13131089|NCT02821910|25977465|FG001|Overall Study|Withdrawal by Subject|0|||
13131090|NCT02821910|25977466|FG002|Overall Study|Withdrawal by Subject|1|||
13131091|NCT02821910|25977467|FG003|Overall Study|Withdrawal by Subject|0|||
13131092|NCT02821910|25977468|FG004|Overall Study|Withdrawal by Subject|0|||
13222370|NCT01807221|26286041|FG001|Overall Study|Lost to Follow-up|0|||
13075975|NCT03576716|25288199|FG000|Overall Study|Withdrawal by Subject|0|||
13075976|NCT03576716|25288200|FG001|Overall Study|Withdrawal by Subject|1|||
13075977|NCT03367819|25288243|FG000|Overall Study|Adverse Event|4|||
13075978|NCT03367819|25288244|FG001|Overall Study|Adverse Event|4|||
13075979|NCT03367819|25288243|FG000|Overall Study|Progressive Disease|15|||
13075980|NCT03367819|25288244|FG001|Overall Study|Progressive Disease|13|||
13075981|NCT03367819|25288243|FG000|Overall Study|Withdrawal by Subject|1|||
13075982|NCT03367819|25288244|FG001|Overall Study|Withdrawal by Subject|0|||
13075983|NCT03367819|25288243|FG000|Overall Study|Other|4|||
13075984|NCT03367819|25288244|FG001|Overall Study|Other|2|||
13075985|NCT03182868|25288292|FG000|Overall Study|Protocol Violation|3|||
13075986|NCT03182868|25288293|FG001|Overall Study|Protocol Violation|0|||
13075987|NCT03182868|25288294|FG002|Overall Study|Protocol Violation|4|||
13075988|NCT03182868|25288295|FG003|Overall Study|Protocol Violation|1|||
13075989|NCT03182868|25288296|FG004|Overall Study|Protocol Violation|8|||
13075990|NCT03077620|25288320|FG000|Overall Study|Unable to place lumbar catheter|1|||
13075991|NCT03077620|25288321|FG001|Overall Study|Unable to place lumbar catheter|0|||
13075992|NCT03077620|25288322|FG002|Overall Study|Unable to place lumbar catheter|1|||
13075993|NCT03077620|25288323|FG003|Overall Study|Unable to place lumbar catheter|0|||
13075994|NCT03077620|25288320|FG000|Overall Study|Withdrawal by Subject|0|||
13075995|NCT03077620|25288321|FG001|Overall Study|Withdrawal by Subject|1|||
13075996|NCT03077620|25288322|FG002|Overall Study|Withdrawal by Subject|0|||
13075997|NCT03077620|25288323|FG003|Overall Study|Withdrawal by Subject|0|||
13075998|NCT03077620|25288320|FG000|Overall Study|Physician Decision|0|||
13075999|NCT03077620|25288321|FG001|Overall Study|Physician Decision|0|||
13076000|NCT03077620|25288322|FG002|Overall Study|Physician Decision|1|||
13076001|NCT03077620|25288323|FG003|Overall Study|Physician Decision|0|||
13076002|NCT02536794|25288388|FG000|Reached 1st Response Assessment|Adverse Event|2|||
13076003|NCT02536794|25288388|FG000|Reached 1st Response Assessment|Progressive Disease|2|||
13076004|NCT02536794|25288388|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1|||
13076005|NCT02536794|25288388|FG000|Reached 1st Response Assessment|Protocol Violation|1|||
13076006|NCT02536794|25288388|FG000|Continued Treatment After 1st Response|Progressive disease|7|||
13076007|NCT02536794|25288388|FG000|Continued Treatment After 1st Response|Adverse Event|1|||
13076008|NCT01936857|25288545|FG000|Overall Study|Sent to prison or 06 center|11|||
13076009|NCT01936857|25288546|FG001|Overall Study|Sent to prison or 06 center|12|||
13076010|NCT01936857|25288545|FG000|Overall Study|Lost to Follow-up|10|||
13076011|NCT01936857|25288546|FG001|Overall Study|Lost to Follow-up|7|||
13076012|NCT01936857|25288545|FG000|Overall Study|Death|7|||
13076013|NCT01936857|25288546|FG001|Overall Study|Death|3|||
13076014|NCT01936857|25288545|FG000|Overall Study|Moved|2|||
13076015|NCT01936857|25288546|FG001|Overall Study|Moved|1|||
13076016|NCT01936857|25288545|FG000|Overall Study|Withdrawal by Subject|1|||
13076017|NCT01936857|25288546|FG001|Overall Study|Withdrawal by Subject|0|||
13076018|NCT01936857|25288545|FG000|Overall Study|Side effect of medication|1|||
13076019|NCT01936857|25288546|FG001|Overall Study|Side effect of medication|0|||
13076020|NCT01936857|25288545|FG000|Overall Study|Other|2|||
13076021|NCT01936857|25288546|FG001|Overall Study|Other|2|||
13076022|NCT01715285|25288591|FG000|Treatment Period|Adverse Event|60|||
13076023|NCT01715285|25288592|FG001|Treatment Period|Adverse Event|33|||
13076024|NCT01715285|25288593|FG002|Treatment Period|Adverse Event|0|||
13076025|NCT01715285|25288591|FG000|Treatment Period|Lost to Follow-up|3|||
13076026|NCT01715285|25288592|FG001|Treatment Period|Lost to Follow-up|2|||
13076027|NCT01715285|25288593|FG002|Treatment Period|Lost to Follow-up|0|||
13076028|NCT01715285|25288591|FG000|Treatment Period|Death|36|||
13076029|NCT01715285|25288592|FG001|Treatment Period|Death|23|||
13076030|NCT01715285|25288593|FG002|Treatment Period|Death|0|||
13076031|NCT01715285|25288591|FG000|Treatment Period|Noncompliance With Study Drug|4|||
13076032|NCT01715285|25288592|FG001|Treatment Period|Noncompliance With Study Drug|2|||
13076033|NCT01715285|25288593|FG002|Treatment Period|Noncompliance With Study Drug|0|||
13076034|NCT01715285|25288591|FG000|Treatment Period|Progressive Disease|254|||
13076035|NCT01715285|25288592|FG001|Treatment Period|Progressive Disease|388|||
13076036|NCT01715285|25288593|FG002|Treatment Period|Progressive Disease|0|||
13076037|NCT01715285|25288591|FG000|Treatment Period|Withdrawal Of Consent|52|||
13076038|NCT01715285|25288592|FG001|Treatment Period|Withdrawal Of Consent|47|||
13076039|NCT01715285|25288593|FG002|Treatment Period|Withdrawal Of Consent|0|||
13076040|NCT01715285|25288591|FG000|Treatment Period|Physician Decision|21|||
13076041|NCT01715285|25288592|FG001|Treatment Period|Physician Decision|23|||
13076042|NCT01715285|25288593|FG002|Treatment Period|Physician Decision|0|||
13076043|NCT01715285|25288591|FG000|Treatment Period|Ongoing|157|||
13076044|NCT01715285|25288592|FG001|Treatment Period|Ongoing|0|||
13076045|NCT01715285|25288593|FG002|Treatment Period|Ongoing|0|||
13076046|NCT01715285|25288591|FG000|Treatment Period|Other|10|||
13076047|NCT01715285|25288592|FG001|Treatment Period|Other|12|||
13076048|NCT01715285|25288593|FG002|Treatment Period|Other|0|||
13076049|NCT01715285|25288591|FG000|Treatment Period|Placebo Cross-over|0|||
13076050|NCT01715285|25288592|FG001|Treatment Period|Placebo Cross-over|72|||
13076051|NCT01715285|25288593|FG002|Treatment Period|Placebo Cross-over|0|||
13076052|NCT01715285|25288591|FG000|Open-label (OL) Extension Phase|Ongoing|157|||
13076053|NCT01715285|25288592|FG001|Open-label (OL) Extension Phase|Ongoing|0|||
13076054|NCT01715285|25288593|FG002|Open-label (OL) Extension Phase|Ongoing|72|||
13131093|NCT02821910|25977469|FG005|Overall Study|Withdrawal by Subject|1|||
13131094|NCT02821910|25977464|FG000|Overall Study|Other than specified|1|||
13131095|NCT02821910|25977465|FG001|Overall Study|Other than specified|0|||
13131096|NCT02821910|25977466|FG002|Overall Study|Other than specified|1|||
13131097|NCT02821910|25977467|FG003|Overall Study|Other than specified|0|||
13131098|NCT02821910|25977468|FG004|Overall Study|Other than specified|0|||
13131099|NCT02821910|25977469|FG005|Overall Study|Other than specified|0|||
13131100|NCT02821819|25977476|FG000|Overall Study|Protocol Violation|1|||
13131101|NCT02821715|25977527|FG000|Overall Study|Protocol Violation|1|||
13131102|NCT02821715|25977528|FG001|Overall Study|Protocol Violation|0|||
13131103|NCT02821715|25977529|FG002|Overall Study|Protocol Violation|0|||
13131104|NCT02821715|25977530|FG003|Overall Study|Protocol Violation|0|||
13131105|NCT02821715|25977531|FG004|Overall Study|Protocol Violation|0|||
13131106|NCT02821715|25977532|FG005|Overall Study|Protocol Violation|0|||
13131107|NCT02821416|25977547|FG000|Overall Study|Adverse Event|0|||
13131108|NCT02821416|25977548|FG001|Overall Study|Adverse Event|1|||
13131109|NCT02821416|25977547|FG000|Overall Study|Withdrawal by Subject|2|||
13131110|NCT02821416|25977548|FG001|Overall Study|Withdrawal by Subject|0|||
13131111|NCT02821416|25977547|FG000|Overall Study|Lost to Follow-up|1|||
13131112|NCT02821416|25977548|FG001|Overall Study|Lost to Follow-up|0|||
13131113|NCT02820844|25977773|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1|||
13131114|NCT02820844|25977774|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3|||
13131115|NCT02820844|25977775|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
13131116|NCT02820844|25977776|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
13131117|NCT02820844|25977777|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
13131118|NCT02820844|25977778|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
13131119|NCT02820844|25977773|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1|||
13131120|NCT02820844|25977774|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2|||
13131121|NCT02820844|25977775|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
13131122|NCT02820844|25977776|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
13131123|NCT02820844|25977777|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
13131124|NCT02820844|25977778|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
13131125|NCT02820844|25977773|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
13131126|NCT02820844|25977774|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3|||
13131127|NCT02820844|25977775|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
13131128|NCT02820844|25977776|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
13131129|NCT02820844|25977777|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
13131130|NCT02820844|25977778|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
13131131|NCT02820844|25977773|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2|||
13131132|NCT02820844|25977774|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1|||
13131133|NCT02820844|25977775|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
13131134|NCT02820844|25977776|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
13131135|NCT02820844|25977777|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
13131136|NCT02820844|25977778|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
13131137|NCT02820844|25977773|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1|||
13131138|NCT02820844|25977774|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
13131139|NCT02820844|25977775|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
13131140|NCT02820844|25977776|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
13131141|NCT02820844|25977777|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
13131142|NCT02820844|25977778|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
13222371|NCT01807221|26286042|FG002|Overall Study|Lost to Follow-up|2|||
13131143|NCT02820844|25977773|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
13131144|NCT02820844|25977774|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
13131145|NCT02820844|25977775|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1|||
13131146|NCT02820844|25977776|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2|||
13131147|NCT02820844|25977777|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
13131148|NCT02820844|25977778|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
13131149|NCT02820844|25977773|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
13131150|NCT02820844|25977774|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
13131151|NCT02820844|25977775|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1|||
13131152|NCT02820844|25977776|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
13131153|NCT02820844|25977777|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
13131154|NCT02820844|25977778|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
13131155|NCT02820844|25977773|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
13131156|NCT02820844|25977774|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
13131157|NCT02820844|25977775|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7|||
13076055|NCT04209725|25288621|FG000|Overall Study|Adverse Event|1|||
13076056|NCT04185909|25288635|FG000|Overall Study|Lost to Follow-up|1|||
13076057|NCT04076943|25288649|FG000|Overall Study|Withdrawal by Subject|12|||
13076058|NCT04076943|25288649|FG000|Overall Study|Adverse Event|1|||
13076059|NCT04076943|25288649|FG000|Overall Study|Progressive Disease|2|||
13076060|NCT04076943|25288649|FG000|Overall Study|Death|13|||
13076061|NCT04076943|25288649|FG000|Overall Study|Other than specified|6|||
13076062|NCT03332498|25288693|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0|||
13076063|NCT03332498|25288694|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0|||
13076064|NCT03332498|25288695|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2|||
13076065|NCT02900976|25288709|FG000|Overall Study|Adverse Event|0|||
13076066|NCT02900976|25288710|FG001|Overall Study|Adverse Event|1|||
13076067|NCT02900976|25288709|FG000|Overall Study|Physician Decision|0|||
13076068|NCT02900976|25288710|FG001|Overall Study|Physician Decision|2|||
13076069|NCT02900976|25288709|FG000|Overall Study|Progressive disease|0|||
13076070|NCT02900976|25288710|FG001|Overall Study|Progressive disease|6|||
13076071|NCT02720185|25288771|FG000|Overall Study|Lost to Follow-up|1|||
13076072|NCT02710669|25288795|FG000|Overall Study|Physician Decision|2|||
13076073|NCT02710669|25288796|FG001|Overall Study|Physician Decision|1|||
13076074|NCT02710669|25288797|FG002|Overall Study|Physician Decision|0|||
13076075|NCT02710669|25288795|FG000|Overall Study|Institutional delays (including COVID)|2|||
13076076|NCT02710669|25288796|FG001|Overall Study|Institutional delays (including COVID)|2|||
13076077|NCT02710669|25288797|FG002|Overall Study|Institutional delays (including COVID)|0|||
13076078|NCT02710669|25288795|FG000|Overall Study|arrived in afib/aflutter|10|||
13076079|NCT02710669|25288796|FG001|Overall Study|arrived in afib/aflutter|8|||
13076080|NCT02710669|25288797|FG002|Overall Study|arrived in afib/aflutter|2|||
13076081|NCT02684461|25288832|FG000|Overall Study|Adverse Event|1|||
13076082|NCT02684461|25288833|FG001|Overall Study|Adverse Event|0|||
13076083|NCT02684461|25288834|FG002|Overall Study|Adverse Event|0|||
13076084|NCT02684461|25288832|FG000|Overall Study|Lack of Efficacy|1|||
13076085|NCT02684461|25288833|FG001|Overall Study|Lack of Efficacy|2|||
13076086|NCT02684461|25288834|FG002|Overall Study|Lack of Efficacy|0|||
13076087|NCT01295944|25288893|FG000|Overall Study|Switched to alternative treatment|1|||
13076088|NCT01295944|25288893|FG000|Overall Study|Ineligible|9|||
13076089|NCT01295944|25288893|FG000|Overall Study|Withdrawal by Subject|4|||
13076090|NCT01295944|25288893|FG000|Overall Study|Participant chose to be treated in Peru|1|||
13076091|NCT01295944|25288893|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1|||
13076092|NCT01295944|25288893|FG000|Overall Study|Participant was diagnosed with stage 1 infiltrated ductal carcinoma of the right breast(10/03/2013).|1|||
13076093|NCT01295944|25288893|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1|||
13076094|NCT01285557|25288920|FG000|Overall Study|Death|173|||
13076095|NCT01285557|25288921|FG001|Overall Study|Death|90|||
13076096|NCT01285557|25288920|FG000|Overall Study|Lost to Follow-up|6|||
13076097|NCT01285557|25288921|FG001|Overall Study|Lost to Follow-up|2|||
13076098|NCT01285557|25288920|FG000|Overall Study|Withdrew Consent|6|||
13076099|NCT01285557|25288921|FG001|Overall Study|Withdrew Consent|1|||
13076100|NCT01285557|25288920|FG000|Overall Study|Sponsor Study Termination|23|||
13076101|NCT01285557|25288921|FG001|Overall Study|Sponsor Study Termination|13|||
13076102|NCT01285557|25288920|FG000|Overall Study|Randomized but not treated|1|||
13076103|NCT01285557|25288921|FG001|Overall Study|Randomized but not treated|1|||
13076104|NCT01285557|25288920|FG000|Overall Study|Study follow-up ongoing|28|||
13076105|NCT01285557|25288921|FG001|Overall Study|Study follow-up ongoing|14|||
13076106|NCT01285557|25288920|FG000|Overall Study|Sponsor Decision|2|||
13076107|NCT01285557|25288921|FG001|Overall Study|Sponsor Decision|1|||
13076108|NCT00964002|25289041|FG000|Overall Study|Protocol Violation|8|||
13076109|NCT00790218|25289085|FG000|Overall Study|Death|1|||
13076110|NCT00790218|25289086|FG001|Overall Study|Death|0|||
13076111|NCT00790218|25289087|FG002|Overall Study|Death|0|||
13076112|NCT05340751|25289188|FG000|Overall Study|Physician Decision|3|||
13076113|NCT05021081|25289268|FG000|Phase 2|Subject enrolled in error|1|||
13076114|NCT05021081|25289269|FG001|Phase 2|Subject enrolled in error|1|||
13076115|NCT05021081|25289270|FG002|Phase 2|Subject enrolled in error|0|||
13076116|NCT04649164|25289329|FG000|Overall Study|Withdrawal by Subject|1|||
13076117|NCT04649164|25289330|FG001|Overall Study|Withdrawal by Subject|1|||
13076118|NCT04649164|25289331|FG002|Overall Study|Withdrawal by Subject|2|||
13076119|NCT04649164|25289329|FG000|Overall Study|Participant's care recipient expired|0|||
13076120|NCT04649164|25289330|FG001|Overall Study|Participant's care recipient expired|0|||
13076121|NCT04649164|25289331|FG002|Overall Study|Participant's care recipient expired|2|||
13076122|NCT04640311|25289477|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
13076123|NCT04640311|25289478|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
13076124|NCT04640311|25289479|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
13076125|NCT04640311|25289480|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
13076126|NCT04640311|25289481|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
13076127|NCT04640311|25289482|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
13076128|NCT04640311|25289483|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
13076129|NCT04640311|25289484|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
13076130|NCT04640311|25289485|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
13076131|NCT04640311|25289486|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
13076132|NCT04640311|25289487|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
13076133|NCT04640311|25289488|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
13076134|NCT04640311|25289489|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
13076135|NCT04640311|25289477|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
13076136|NCT04640311|25289478|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|1|||
13076137|NCT04640311|25289479|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
13076138|NCT04640311|25289480|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
13076139|NCT04640311|25289481|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
13076140|NCT04640311|25289482|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
13076141|NCT04640311|25289483|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
13076142|NCT04640311|25289484|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
13076143|NCT04640311|25289485|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
13076144|NCT04640311|25289486|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
13076145|NCT04640311|25289487|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
13076146|NCT04640311|25289488|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
13076147|NCT04640311|25289489|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
13076148|NCT04640311|25289477|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
13076149|NCT04640311|25289478|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|1|||
13076150|NCT04640311|25289479|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
13076151|NCT04640311|25289480|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
13076152|NCT04640311|25289481|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
13076153|NCT04640311|25289482|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
13076154|NCT04640311|25289483|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
13076155|NCT04640311|25289484|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
13076156|NCT04640311|25289485|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
13076157|NCT04640311|25289486|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
13076158|NCT04640311|25289487|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
13076159|NCT04640311|25289488|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
13076160|NCT04640311|25289489|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
13076161|NCT04640311|25289477|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|3|||
13076162|NCT04640311|25289478|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|5|||
13076163|NCT04640311|25289479|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|6|||
13076164|NCT04640311|25289480|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
13076165|NCT04640311|25289481|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
13076166|NCT04640311|25289482|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
13076167|NCT04640311|25289483|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
13076168|NCT04640311|25289484|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
13076169|NCT04640311|25289485|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
13076170|NCT04640311|25289486|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
13076171|NCT04640311|25289487|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
13076172|NCT04640311|25289488|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
13076173|NCT04640311|25289489|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
13076174|NCT04640311|25289477|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
13076175|NCT04640311|25289478|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
13076176|NCT04640311|25289479|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|2|||
13076177|NCT04640311|25289480|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
13076178|NCT04640311|25289481|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
13076179|NCT04640311|25289482|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
13076180|NCT04640311|25289483|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
13076181|NCT04640311|25289484|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
13076182|NCT04640311|25289485|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
13076183|NCT04640311|25289486|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
13076184|NCT04640311|25289487|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
13076185|NCT04640311|25289488|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
13076186|NCT04640311|25289489|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
13076187|NCT04640311|25289477|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
13076188|NCT04640311|25289478|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
13076189|NCT04640311|25289479|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
13076190|NCT04640311|25289480|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
13076191|NCT04640311|25289481|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
13076192|NCT04640311|25289482|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
13076193|NCT04640311|25289483|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
13076194|NCT04640311|25289484|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
13076195|NCT04640311|25289485|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
13076196|NCT04640311|25289486|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
13076197|NCT04640311|25289487|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
13076198|NCT04640311|25289488|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
13076199|NCT04640311|25289489|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
13076200|NCT04640311|25289477|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
13076201|NCT04640311|25289478|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
13076202|NCT04640311|25289479|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
13076203|NCT04640311|25289480|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
13076204|NCT04640311|25289481|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
13076205|NCT04640311|25289482|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
13076206|NCT04640311|25289483|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
13076207|NCT04640311|25289484|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
13076208|NCT04640311|25289485|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|2|||
13076209|NCT04640311|25289486|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
13076210|NCT04640311|25289487|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
13076211|NCT04640311|25289488|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
13076212|NCT04640311|25289489|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
13076213|NCT04640311|25289477|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
13076214|NCT04640311|25289478|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
13076215|NCT04640311|25289479|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
13076216|NCT04640311|25289480|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
13076217|NCT04640311|25289481|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
13076218|NCT04640311|25289482|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
13076219|NCT04640311|25289483|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
13076220|NCT04640311|25289484|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
13076221|NCT04640311|25289485|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
13076222|NCT04640311|25289486|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
13076223|NCT04640311|25289487|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
13076224|NCT04640311|25289488|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
13076225|NCT04640311|25289489|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
13076226|NCT04640311|25289477|FG000|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
13076227|NCT04640311|25289478|FG001|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
13076228|NCT04640311|25289479|FG002|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
13076229|NCT04640311|25289480|FG003|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
13076230|NCT04640311|25289481|FG004|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
13076231|NCT04640311|25289482|FG005|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
13076232|NCT04640311|25289483|FG006|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
13076233|NCT04640311|25289484|FG007|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
13076234|NCT04640311|25289485|FG008|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
13076235|NCT04640311|25289486|FG009|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
13076236|NCT04640311|25289487|FG010|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
13076237|NCT04640311|25289488|FG011|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|1|||
13076238|NCT04640311|25289489|FG012|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
13076239|NCT04601194|25289522|FG000|Overall Study|Lost to Follow-up|7|||
13076240|NCT04476043|25289607|FG000|Overall Study|Withdrawal by Subject|1|||
13076241|NCT04476043|25289608|FG001|Overall Study|Withdrawal by Subject|3|||
13076242|NCT04476043|25289609|FG002|Overall Study|Withdrawal by Subject|4|||
13076243|NCT04476043|25289610|FG003|Overall Study|Withdrawal by Subject|1|||
13076244|NCT04476043|25289607|FG000|Overall Study|Lost to Follow-up|1|||
13076245|NCT04476043|25289608|FG001|Overall Study|Lost to Follow-up|1|||
13076246|NCT04476043|25289609|FG002|Overall Study|Lost to Follow-up|2|||
13076247|NCT04476043|25289610|FG003|Overall Study|Lost to Follow-up|1|||
13076248|NCT04476043|25289607|FG000|Overall Study|Adverse Event|2|||
13076249|NCT04476043|25289608|FG001|Overall Study|Adverse Event|0|||
13076250|NCT04476043|25289609|FG002|Overall Study|Adverse Event|1|||
13076251|NCT04476043|25289610|FG003|Overall Study|Adverse Event|0|||
13076252|NCT04476043|25289607|FG000|Overall Study|Protocol Violation|0|||
13076253|NCT04476043|25289608|FG001|Overall Study|Protocol Violation|1|||
13076254|NCT04476043|25289609|FG002|Overall Study|Protocol Violation|0|||
13076255|NCT04476043|25289610|FG003|Overall Study|Protocol Violation|0|||
13076256|NCT04439175|25289618|FG000|Overall Study|Never started treatment|4|||
13076257|NCT04439175|25289618|FG000|Overall Study|Ineligible|5|||
13076258|NCT04439175|25289618|FG000|Overall Study|Adverse Event|6|||
13076259|NCT04439175|25289618|FG000|Overall Study|Death|4|||
13076260|NCT04439175|25289618|FG000|Overall Study|Disease progression|44|||
13076261|NCT04439175|25289618|FG000|Overall Study|Withdrawal by Subject|4|||
13076262|NCT04439175|25289618|FG000|Overall Study|Alternative Therapy|1|||
13076263|NCT04439175|25289618|FG000|Overall Study|Other|2|||
13076264|NCT04364737|25289708|FG000|Overall Study|Withdrawal by Subject|4|||
13076265|NCT04364737|25289709|FG001|Overall Study|Withdrawal by Subject|9|||
13076266|NCT04364737|25289708|FG000|Overall Study|Lost to Follow-up|1|||
13076267|NCT04364737|25289709|FG001|Overall Study|Lost to Follow-up|1|||
13076268|NCT04294719|25289752|FG000|Overall Study|Withdrawal by Subject|1|||
13076269|NCT04245449|25289762|FG000|Overall Study|COVID shutdown|7|||
13076270|NCT04227704|25289837|FG000|Overall Study|due to anesthesia being changed to general anesthesia|0|||
13076271|NCT04227704|25289838|FG001|Overall Study|due to anesthesia being changed to general anesthesia|1|||
13076272|NCT04227704|25289839|FG002|Overall Study|due to anesthesia being changed to general anesthesia|0|||
13076273|NCT04227704|25289837|FG000|Overall Study|due to C/S being cancelled|1|||
13076274|NCT04227704|25289838|FG001|Overall Study|due to C/S being cancelled|0|||
13076275|NCT04227704|25289839|FG002|Overall Study|due to C/S being cancelled|0|||
13076276|NCT04191967|25289893|FG000|Screening & Thermocoagulation (Ablation)|Not considered candidates for thermocoagulation|86|||
13076277|NCT04191967|25289893|FG000|12 Month Follow-up|Pathology results for 12 month treatment efficacy not available for these participants|4|||
13076278|NCT04147195|25289967|FG000|Overall Study|Adverse Event|0|||
13076279|NCT04147195|25289968|FG001|Overall Study|Adverse Event|3|||
13076280|NCT04147195|25289967|FG000|Overall Study|Study Terminated by Sponsor|4|||
13076281|NCT04147195|25289968|FG001|Overall Study|Study Terminated by Sponsor|2|||
13076282|NCT04147195|25289967|FG000|Overall Study|Withdrawal by Subject|0|||
13076283|NCT04147195|25289968|FG001|Overall Study|Withdrawal by Subject|1|||
13076284|NCT03950674|25290019|FG000|Overall Study|Death|3|||
13076285|NCT03950674|25290020|FG001|Overall Study|Death|7|||
13076286|NCT03950674|25290019|FG000|Overall Study|Ongoing in Study|22|||
13076287|NCT03950674|25290020|FG001|Overall Study|Ongoing in Study|8|||
13076288|NCT03908476|25290081|FG000|Overall Study|Death|3|||
13076289|NCT03908476|25290082|FG001|Overall Study|Death|0|||
13076290|NCT03908476|25290081|FG000|Overall Study|Lost to Follow-up|3|||
13076291|NCT03908476|25290082|FG001|Overall Study|Lost to Follow-up|1|||
13076292|NCT03908476|25290081|FG000|Overall Study|Withdrawal by Subject|7|||
13076293|NCT03908476|25290082|FG001|Overall Study|Withdrawal by Subject|1|||
13076294|NCT03908476|25290081|FG000|Overall Study|Physician Decision|2|||
13076295|NCT03908476|25290082|FG001|Overall Study|Physician Decision|0|||
13076296|NCT03908476|25290081|FG000|Overall Study|System Explanted and not Replaced|4|||
13076297|NCT03908476|25290082|FG001|Overall Study|System Explanted and not Replaced|0|||
13076298|NCT03908476|25290081|FG000|Overall Study|Intrathecal Pump|1|||
13076299|NCT03908476|25290082|FG001|Overall Study|Intrathecal Pump|0|||
13076300|NCT03908476|25290081|FG000|Overall Study|Patient Has Requested an Explant of the Device|1|||
13076301|NCT03908476|25290082|FG001|Overall Study|Patient Has Requested an Explant of the Device|0|||
13076302|NCT03796195|25290091|FG000|Overall Study|Study closed early|1|||
13076303|NCT03745989|25290147|FG000|Overall Study|Death|3|||
13076304|NCT03745989|25290148|FG001|Overall Study|Death|7|||
13076305|NCT03745989|25290149|FG002|Overall Study|Death|4|||
13076306|NCT03745989|25290147|FG000|Overall Study|Lost to Follow-up|0|||
13076307|NCT03745989|25290148|FG001|Overall Study|Lost to Follow-up|2|||
13076308|NCT03745989|25290149|FG002|Overall Study|Lost to Follow-up|0|||
13076309|NCT03745989|25290147|FG000|Overall Study|Sponsor Decision|0|||
13076310|NCT03745989|25290148|FG001|Overall Study|Sponsor Decision|2|||
13076311|NCT03745989|25290149|FG002|Overall Study|Sponsor Decision|8|||
13076312|NCT03745989|25290147|FG000|Overall Study|Withdrawal by Subject|0|||
13076313|NCT03745989|25290148|FG001|Overall Study|Withdrawal by Subject|1|||
13076314|NCT03745989|25290149|FG002|Overall Study|Withdrawal by Subject|3|||
13076315|NCT03644927|25290325|FG000|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|1|||
13076316|NCT03644927|25290326|FG001|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|0|||
13076317|NCT03635983|25290369|FG000|Pre-Treatment Period|Not yet treated at the time of database lock|1|||
13076318|NCT03635983|25290370|FG001|Pre-Treatment Period|Not yet treated at the time of database lock|0|||
13076319|NCT03635983|25290369|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
13076320|NCT03635983|25290370|FG001|Pre-Treatment Period|Withdrawal by Subject|7|||
13133719|NCT02765165|25988895|FG004|Treatment Period|Study terminated|0|||
13076321|NCT03635983|25290369|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
13076322|NCT03635983|25290370|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
13076323|NCT03635983|25290369|FG000|Pre-Treatment Period|Other reasons|1|||
13076324|NCT03635983|25290370|FG001|Pre-Treatment Period|Other reasons|2|||
13076325|NCT03635983|25290369|FG000|Pre-Treatment Period|Disease Progression|0|||
13076326|NCT03635983|25290370|FG001|Pre-Treatment Period|Disease Progression|1|||
13076327|NCT03635983|25290369|FG000|Pre-Treatment Period|Adverse Event unrelated to Study drug|1|||
13076328|NCT03635983|25290370|FG001|Pre-Treatment Period|Adverse Event unrelated to Study drug|0|||
13076329|NCT03635983|25290369|FG000|Treatment Period|Completed treatment period|13|||
13076330|NCT03635983|25290370|FG001|Treatment Period|Completed treatment period|20|||
13076331|NCT03635983|25290369|FG000|Treatment Period|Participant request to discontinue Study treatment|5|||
13076332|NCT03635983|25290370|FG001|Treatment Period|Participant request to discontinue Study treatment|5|||
13076333|NCT03635983|25290369|FG000|Treatment Period|Withdrawal by Subject|2|||
13076334|NCT03635983|25290370|FG001|Treatment Period|Withdrawal by Subject|4|||
13076335|NCT03635983|25290369|FG000|Treatment Period|Death|3|||
13076336|NCT03635983|25290370|FG001|Treatment Period|Death|4|||
13076337|NCT03635983|25290369|FG000|Treatment Period|Poor/Non-compliance|1|||
13076338|NCT03635983|25290370|FG001|Treatment Period|Poor/Non-compliance|0|||
13076339|NCT03635983|25290369|FG000|Treatment Period|Participant no longer meets Study criteria|0|||
13076340|NCT03635983|25290370|FG001|Treatment Period|Participant no longer meets Study criteria|2|||
13076341|NCT03635983|25290369|FG000|Treatment Period|Other reasons|5|||
13076342|NCT03635983|25290370|FG001|Treatment Period|Other reasons|2|||
13076343|NCT03635983|25290369|FG000|Treatment Period|Disease progression|184|||
13076344|NCT03635983|25290370|FG001|Treatment Period|Disease progression|168|||
13076345|NCT03635983|25290369|FG000|Treatment Period|Study drug toxicity|26|||
13076346|NCT03635983|25290370|FG001|Treatment Period|Study drug toxicity|29|||
13076347|NCT03635983|25290369|FG000|Treatment Period|Adverse event unrelated to Study drug|10|||
13076348|NCT03635983|25290370|FG001|Treatment Period|Adverse event unrelated to Study drug|11|||
13076349|NCT03635983|25290369|FG000|Treatment Period|Maximum clinical benefit|3|||
13076350|NCT03635983|25290370|FG001|Treatment Period|Maximum clinical benefit|2|||
13076351|NCT03602586|25290379|FG000|Overall Study|Withdrawal by Subject|3|||
13076352|NCT03536884|25290418|FG000|Initial Treatment Period Week 0-16|Adverse Event|8|||
13076353|NCT03536884|25290419|FG001|Initial Treatment Period Week 0-16|Adverse Event|6|||
13076354|NCT03536884|25290420|FG002|Initial Treatment Period Week 0-16|Adverse Event|0|||
13076355|NCT03536884|25290421|FG003|Initial Treatment Period Week 0-16|Adverse Event|0|||
13076356|NCT03536884|25290422|FG004|Initial Treatment Period Week 0-16|Adverse Event|0|||
13076357|NCT03536884|25290418|FG000|Initial Treatment Period Week 0-16|Lost to Follow-up|0|||
13076358|NCT03536884|25290419|FG001|Initial Treatment Period Week 0-16|Lost to Follow-up|3|||
13076359|NCT03536884|25290420|FG002|Initial Treatment Period Week 0-16|Lost to Follow-up|0|||
13076360|NCT03536884|25290421|FG003|Initial Treatment Period Week 0-16|Lost to Follow-up|0|||
13076361|NCT03536884|25290422|FG004|Initial Treatment Period Week 0-16|Lost to Follow-up|0|||
13076362|NCT03536884|25290418|FG000|Initial Treatment Period Week 0-16|Withdrawal by Subject|3|||
13076363|NCT03536884|25290419|FG001|Initial Treatment Period Week 0-16|Withdrawal by Subject|4|||
13076364|NCT03536884|25290420|FG002|Initial Treatment Period Week 0-16|Withdrawal by Subject|0|||
13076365|NCT03536884|25290421|FG003|Initial Treatment Period Week 0-16|Withdrawal by Subject|0|||
13076366|NCT03536884|25290422|FG004|Initial Treatment Period Week 0-16|Withdrawal by Subject|0|||
13076367|NCT03536884|25290418|FG000|Initial Treatment Period Week 0-16|Unblinding was reason for dropout|0|||
13076368|NCT03536884|25290419|FG001|Initial Treatment Period Week 0-16|Unblinding was reason for dropout|1|||
13076369|NCT03536884|25290420|FG002|Initial Treatment Period Week 0-16|Unblinding was reason for dropout|0|||
13076370|NCT03536884|25290421|FG003|Initial Treatment Period Week 0-16|Unblinding was reason for dropout|0|||
13076371|NCT03536884|25290422|FG004|Initial Treatment Period Week 0-16|Unblinding was reason for dropout|0|||
13076372|NCT03536884|25290418|FG000|Initial Treatment Period Week 0-16|Withdrawn by Investigator for abnormal lab values|0|||
13076373|NCT03536884|25290419|FG001|Initial Treatment Period Week 0-16|Withdrawn by Investigator for abnormal lab values|1|||
13076374|NCT03536884|25290420|FG002|Initial Treatment Period Week 0-16|Withdrawn by Investigator for abnormal lab values|0|||
13076375|NCT03536884|25290421|FG003|Initial Treatment Period Week 0-16|Withdrawn by Investigator for abnormal lab values|0|||
13076376|NCT03536884|25290422|FG004|Initial Treatment Period Week 0-16|Withdrawn by Investigator for abnormal lab values|0|||
13076377|NCT03536884|25290418|FG000|Initial Treatment Period Week 0-16|Unable to attend visits|0|||
13076378|NCT03536884|25290419|FG001|Initial Treatment Period Week 0-16|Unable to attend visits|1|||
13076379|NCT03536884|25290420|FG002|Initial Treatment Period Week 0-16|Unable to attend visits|0|||
13076380|NCT03536884|25290421|FG003|Initial Treatment Period Week 0-16|Unable to attend visits|0|||
13076381|NCT03536884|25290422|FG004|Initial Treatment Period Week 0-16|Unable to attend visits|0|||
13076382|NCT03536884|25290418|FG000|Maintenance Treatment Period Week 16-48|Death|0|||
13076383|NCT03536884|25290419|FG001|Maintenance Treatment Period Week 16-48|Death|0|||
13076384|NCT03536884|25290420|FG002|Maintenance Treatment Period Week 16-48|Death|1|||
13076385|NCT03536884|25290421|FG003|Maintenance Treatment Period Week 16-48|Death|0|||
13076386|NCT03536884|25290422|FG004|Maintenance Treatment Period Week 16-48|Death|1|||
13076387|NCT03536884|25290418|FG000|Maintenance Treatment Period Week 16-48|Adverse Event|0|||
13076388|NCT03536884|25290419|FG001|Maintenance Treatment Period Week 16-48|Adverse Event|0|||
13076389|NCT03536884|25290420|FG002|Maintenance Treatment Period Week 16-48|Adverse Event|1|||
13076390|NCT03536884|25290421|FG003|Maintenance Treatment Period Week 16-48|Adverse Event|3|||
13076391|NCT03536884|25290422|FG004|Maintenance Treatment Period Week 16-48|Adverse Event|3|||
13076392|NCT03536884|25290418|FG000|Maintenance Treatment Period Week 16-48|Lack of Efficacy|0|||
13076393|NCT03536884|25290419|FG001|Maintenance Treatment Period Week 16-48|Lack of Efficacy|0|||
13076394|NCT03536884|25290420|FG002|Maintenance Treatment Period Week 16-48|Lack of Efficacy|0|||
13076395|NCT03536884|25290421|FG003|Maintenance Treatment Period Week 16-48|Lack of Efficacy|1|||
13076396|NCT03536884|25290422|FG004|Maintenance Treatment Period Week 16-48|Lack of Efficacy|4|||
13076397|NCT03536884|25290418|FG000|Maintenance Treatment Period Week 16-48|Lost to Follow-up|0|||
13076398|NCT03536884|25290419|FG001|Maintenance Treatment Period Week 16-48|Lost to Follow-up|0|||
13076399|NCT03536884|25290420|FG002|Maintenance Treatment Period Week 16-48|Lost to Follow-up|1|||
13076400|NCT03536884|25290421|FG003|Maintenance Treatment Period Week 16-48|Lost to Follow-up|2|||
13076401|NCT03536884|25290422|FG004|Maintenance Treatment Period Week 16-48|Lost to Follow-up|8|||
13076402|NCT03536884|25290418|FG000|Maintenance Treatment Period Week 16-48|Withdrawal by Subject|0|||
13076403|NCT03536884|25290419|FG001|Maintenance Treatment Period Week 16-48|Withdrawal by Subject|0|||
13076404|NCT03536884|25290420|FG002|Maintenance Treatment Period Week 16-48|Withdrawal by Subject|7|||
13076405|NCT03536884|25290421|FG003|Maintenance Treatment Period Week 16-48|Withdrawal by Subject|3|||
13076406|NCT03536884|25290422|FG004|Maintenance Treatment Period Week 16-48|Withdrawal by Subject|12|||
13076407|NCT03536884|25290418|FG000|Maintenance Treatment Period Week 16-48|Unable to come back for study visits|0|||
13076408|NCT03536884|25290419|FG001|Maintenance Treatment Period Week 16-48|Unable to come back for study visits|0|||
13076409|NCT03536884|25290420|FG002|Maintenance Treatment Period Week 16-48|Unable to come back for study visits|0|||
13076410|NCT03536884|25290421|FG003|Maintenance Treatment Period Week 16-48|Unable to come back for study visits|0|||
13076411|NCT03536884|25290422|FG004|Maintenance Treatment Period Week 16-48|Unable to come back for study visits|1|||
13076412|NCT03414684|25290508|FG000|First-course Treatment|Complete response|0|||
13076413|NCT03414684|25290509|FG001|First-course Treatment|Complete response|1|||
13076414|NCT03414684|25290508|FG000|First-course Treatment|Intercurrent illness|1|||
13076415|NCT03414684|25290509|FG001|First-course Treatment|Intercurrent illness|0|||
13076416|NCT03414684|25290508|FG000|First-course Treatment|Progressive Disease|31|||
13076417|NCT03414684|25290509|FG001|First-course Treatment|Progressive Disease|32|||
13076418|NCT03414684|25290508|FG000|First-course Treatment|Adverse Event|1|||
13076419|NCT03414684|25290509|FG001|First-course Treatment|Adverse Event|2|||
13076420|NCT03414684|25290508|FG000|First-course Treatment|Physician Decision|0|||
13076421|NCT03414684|25290509|FG001|First-course Treatment|Physician Decision|1|||
13076422|NCT03414684|25290508|FG000|First-course Treatment|Withdrawal by Subject|0|||
13076423|NCT03414684|25290509|FG001|First-course Treatment|Withdrawal by Subject|1|||
13076424|NCT03414684|25290508|FG000|First-course Treatment|"Patient proceeded with chest wall excision"|1|||
13076425|NCT03414684|25290509|FG001|First-course Treatment|"Patient proceeded with chest wall excision"|0|||
13076426|NCT03414684|25290508|FG000|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|0|||
13076427|NCT03414684|25290509|FG001|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|1|||
13076428|NCT03414684|25290508|FG000|First-course Treatment|Still on treatment|3|||
13076429|NCT03414684|25290509|FG001|First-course Treatment|Still on treatment|0|||
13076430|NCT03414684|25290508|FG000|First-course Treatment|Never started protocol therapy|2|||
13076431|NCT03414684|25290509|FG001|First-course Treatment|Never started protocol therapy|1|||
13076432|NCT03414684|25290508|FG000|Crossover Treatment|Progressive disease|0|||
13076433|NCT03414684|25290509|FG001|Crossover Treatment|Progressive disease|12|||
13076434|NCT03414684|25290508|FG000|Crossover Treatment|Adverse Event|0|||
13076435|NCT03414684|25290509|FG001|Crossover Treatment|Adverse Event|3|||
13076436|NCT03414684|25290508|FG000|Crossover Treatment|Physician Decision|0|||
13076437|NCT03414684|25290509|FG001|Crossover Treatment|Physician Decision|1|||
13076438|NCT03414684|25290508|FG000|Crossover Treatment|Still on treatment|0|||
13076439|NCT03414684|25290509|FG001|Crossover Treatment|Still on treatment|2|||
13076448|NCT03361306|25290606|FG000|Overall Study|Death|5|||
13076449|NCT03361306|25290606|FG000|Overall Study|Still On Study (on study treatment)|3|||
13076450|NCT03361306|25290606|FG000|Overall Study|Still On Study (in follow up)|7|||
13076451|NCT03299049|25290732|FG000|Overall Study|On-going|486|||
13076452|NCT03299049|25290733|FG001|Overall Study|On-going|481|||
13076453|NCT03299049|25290732|FG000|Overall Study|Withdrawal by Subject|6|||
13076454|NCT03299049|25290733|FG001|Overall Study|Withdrawal by Subject|21|||
13076455|NCT03299049|25290732|FG000|Overall Study|Physician Decision|5|||
13076456|NCT03299049|25290733|FG001|Overall Study|Physician Decision|1|||
13076457|NCT03299049|25290732|FG000|Overall Study|Lost to Follow-up|2|||
13076458|NCT03299049|25290733|FG001|Overall Study|Lost to Follow-up|0|||
13076459|NCT03299049|25290732|FG000|Overall Study|Pregnancy|1|||
13076460|NCT03299049|25290733|FG001|Overall Study|Pregnancy|3|||
13076461|NCT03299049|25290732|FG000|Overall Study|Protocol Violation|1|||
13076462|NCT03299049|25290733|FG001|Overall Study|Protocol Violation|1|||
13076463|NCT03299049|25290732|FG000|Overall Study|Lack of Efficacy|9|||
13076464|NCT03299049|25290733|FG001|Overall Study|Lack of Efficacy|3|||
13076465|NCT03299049|25290732|FG000|Overall Study|Adverse Event|12|||
13076466|NCT03299049|25290733|FG001|Overall Study|Adverse Event|13|||
13076467|NCT03206073|25290776|FG000|Overall Study|Participant Noncompliance|0|||
13076468|NCT03206073|25290777|FG001|Overall Study|Participant Noncompliance|1|||
13076469|NCT03206073|25290778|FG002|Overall Study|Participant Noncompliance|0|||
13076470|NCT03206073|25290779|FG003|Overall Study|Participant Noncompliance|0|||
13076471|NCT03206073|25290776|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1|||
13076472|NCT03206073|25290777|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0|||
13076473|NCT03206073|25290778|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0|||
13076474|NCT03206073|25290779|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0|||
13076475|NCT03206073|25290776|FG000|Overall Study|Death|0|||
13076476|NCT03206073|25290777|FG001|Overall Study|Death|0|||
13076477|NCT03206073|25290778|FG002|Overall Study|Death|1|||
13076478|NCT03206073|25290779|FG003|Overall Study|Death|0|||
13076479|NCT03206073|25290776|FG000|Overall Study|Taken off active treatment|0|||
13076480|NCT03206073|25290777|FG001|Overall Study|Taken off active treatment|0|||
13076481|NCT03206073|25290778|FG002|Overall Study|Taken off active treatment|3|||
13076482|NCT03206073|25290779|FG003|Overall Study|Taken off active treatment|0|||
13076483|NCT03110562|25290792|FG000|Overall Study|Withdrawal by Subject|37|||
13076484|NCT03110562|25290793|FG001|Overall Study|Withdrawal by Subject|35|||
13076485|NCT03110562|25290792|FG000|Overall Study|Death|47|||
13076486|NCT03110562|25290793|FG001|Overall Study|Death|61|||
13076487|NCT03110562|25290792|FG000|Overall Study|Lost to Follow-up|7|||
13076488|NCT03110562|25290793|FG001|Overall Study|Lost to Follow-up|6|||
13076489|NCT03110562|25290792|FG000|Overall Study|Other|2|||
13076490|NCT03110562|25290793|FG001|Overall Study|Other|1|||
13076491|NCT03110562|25290792|FG000|Overall Study|Randomized but never treated|0|||
13076492|NCT03110562|25290793|FG001|Overall Study|Randomized but never treated|3|||
13076493|NCT03110562|25290792|FG000|Overall Study|Ongoing|102|||
13076494|NCT03110562|25290793|FG001|Overall Study|Ongoing|101|||
13076495|NCT03106779|25290806|FG000|Overall Study|Lack of Efficacy|33|||
13076496|NCT03106779|25290807|FG001|Overall Study|Lack of Efficacy|24|||
13076497|NCT03106779|25290806|FG000|Overall Study|Adverse Event|8|||
13076498|NCT03106779|25290807|FG001|Overall Study|Adverse Event|16|||
13076499|NCT03106779|25290806|FG000|Overall Study|Physician Decision|10|||
13076500|NCT03106779|25290807|FG001|Overall Study|Physician Decision|6|||
13076501|NCT03106779|25290806|FG000|Overall Study|Patient/guardian decision|4|||
13076502|NCT03106779|25290807|FG001|Overall Study|Patient/guardian decision|3|||
13076503|NCT03106779|25290806|FG000|Overall Study|Progressive disease|1|||
13076504|NCT03106779|25290807|FG001|Overall Study|Progressive disease|3|||
13076505|NCT03106779|25290806|FG000|Overall Study|Lost to Follow-up|1|||
13076506|NCT03106779|25290807|FG001|Overall Study|Lost to Follow-up|2|||
13076507|NCT03106779|25290806|FG000|Overall Study|Death|1|||
13076508|NCT03106779|25290807|FG001|Overall Study|Death|0|||
13076509|NCT03106779|25290806|FG000|Overall Study|Protocol Violation|1|||
13076510|NCT03106779|25290807|FG001|Overall Study|Protocol Violation|0|||
13076511|NCT03106779|25290806|FG000|Overall Study|Not treated|1|||
13076512|NCT03106779|25290807|FG001|Overall Study|Not treated|0|||
13076513|NCT03064126|25290893|FG000|Overall Study|Death|6|||
13076514|NCT03064126|25290894|FG001|Overall Study|Death|2|||
13076515|NCT03064126|25290895|FG002|Overall Study|Death|2|||
13076516|NCT03064126|25290896|FG003|Overall Study|Death|1|||
13076517|NCT03064126|25290893|FG000|Overall Study|Investigator Discretion|1|||
13076518|NCT03064126|25290894|FG001|Overall Study|Investigator Discretion|0|||
13076519|NCT03064126|25290895|FG002|Overall Study|Investigator Discretion|0|||
13076520|NCT03064126|25290896|FG003|Overall Study|Investigator Discretion|0|||
13076521|NCT03064126|25290893|FG000|Overall Study|Withdrawal by Subject|7|||
13076522|NCT03064126|25290894|FG001|Overall Study|Withdrawal by Subject|4|||
13076523|NCT03064126|25290895|FG002|Overall Study|Withdrawal by Subject|0|||
13076524|NCT03064126|25290896|FG003|Overall Study|Withdrawal by Subject|0|||
13076525|NCT03064126|25290893|FG000|Overall Study|Subject moved|1|||
13076526|NCT03064126|25290894|FG001|Overall Study|Subject moved|0|||
13076527|NCT03064126|25290895|FG002|Overall Study|Subject moved|0|||
13076528|NCT03064126|25290896|FG003|Overall Study|Subject moved|0|||
13076529|NCT03064126|25290893|FG000|Overall Study|Protocol Violation|11|||
13076530|NCT03064126|25290894|FG001|Overall Study|Protocol Violation|1|||
13076531|NCT03064126|25290895|FG002|Overall Study|Protocol Violation|1|||
13076532|NCT03064126|25290896|FG003|Overall Study|Protocol Violation|0|||
13076533|NCT03004183|25290923|FG000|Overall Study|Adverse Event|7|||
13076534|NCT03004183|25290923|FG000|Overall Study|Lost to Follow-up|1|||
13076535|NCT03004183|25290923|FG000|Overall Study|Physician Decision|40|||
13076536|NCT03004183|25290923|FG000|Overall Study|Withdrawal by Subject|1|||
13076537|NCT03004183|25290923|FG000|Overall Study|COVID-19|1|||
13076666|NCT02941926|25291112|FG000|Overall Study|Progressive disease|1109|||
13076667|NCT02941926|25291112|FG000|Overall Study|Adverse Event|504|||
13076668|NCT02941926|25291112|FG000|Overall Study|Subject/guardian decision|127|||
13076669|NCT02941926|25291112|FG000|Overall Study|Physician Decision|112|||
13076670|NCT02941926|25291112|FG000|Overall Study|Death|46|||
13076671|NCT02941926|25291112|FG000|Overall Study|Protocol deviation|34|||
13076672|NCT02941926|25291112|FG000|Overall Study|Lost to Follow-up|8|||
13076673|NCT02941926|25291112|FG000|Overall Study|Technical problems|5|||
13076674|NCT02938520|25291244|FG000|Overall Study|On-going at the time of analysis|258|||
13076675|NCT02938520|25291245|FG001|Overall Study|On-going at the time of analysis|261|||
13076676|NCT02938520|25291244|FG000|Overall Study|Physician Decision|2|||
13076677|NCT02938520|25291245|FG001|Overall Study|Physician Decision|5|||
13076678|NCT02938520|25291244|FG000|Overall Study|Lost to Follow-up|2|||
13076679|NCT02938520|25291245|FG001|Overall Study|Lost to Follow-up|2|||
13076680|NCT02938520|25291244|FG000|Overall Study|Withdrawal by Subject|7|||
13076681|NCT02938520|25291245|FG001|Overall Study|Withdrawal by Subject|7|||
13076682|NCT02938520|25291244|FG000|Overall Study|Protocol Violation|0|||
13076683|NCT02938520|25291245|FG001|Overall Study|Protocol Violation|1|||
13076684|NCT02938520|25291244|FG000|Overall Study|Lack of Efficacy|5|||
13076685|NCT02938520|25291245|FG001|Overall Study|Lack of Efficacy|3|||
13076686|NCT02938520|25291244|FG000|Overall Study|Adverse Event|9|||
13076687|NCT02938520|25291245|FG001|Overall Study|Adverse Event|4|||
13076688|NCT02925338|25291424|FG000|Overall Study|Death|0|||
13076689|NCT02925338|25291425|FG001|Overall Study|Death|2|||
13076690|NCT02925338|25291426|FG002|Overall Study|Death|1|||
13076691|NCT02925338|25291427|FG003|Overall Study|Death|0|||
13076692|NCT02925338|25291428|FG004|Overall Study|Death|0|||
13076693|NCT02925338|25291424|FG000|Overall Study|Lost to Follow-up|30|||
13076694|NCT02925338|25291425|FG001|Overall Study|Lost to Follow-up|10|||
13076695|NCT02925338|25291426|FG002|Overall Study|Lost to Follow-up|1|||
13076696|NCT02925338|25291427|FG003|Overall Study|Lost to Follow-up|16|||
13076697|NCT02925338|25291428|FG004|Overall Study|Lost to Follow-up|3|||
13076698|NCT02925338|25291424|FG000|Overall Study|Withdrawal by Subject|3|||
13076699|NCT02925338|25291425|FG001|Overall Study|Withdrawal by Subject|0|||
13076700|NCT02925338|25291426|FG002|Overall Study|Withdrawal by Subject|3|||
13076701|NCT02925338|25291427|FG003|Overall Study|Withdrawal by Subject|2|||
13076702|NCT02925338|25291428|FG004|Overall Study|Withdrawal by Subject|2|||
13076703|NCT02925338|25291424|FG000|Overall Study|Missing|38|||
13076704|NCT02925338|25291425|FG001|Overall Study|Missing|27|||
13076705|NCT02925338|25291426|FG002|Overall Study|Missing|0|||
13076706|NCT02925338|25291427|FG003|Overall Study|Missing|3|||
13076707|NCT02925338|25291428|FG004|Overall Study|Missing|2|||
13076708|NCT02925338|25291424|FG000|Overall Study|Participant's Decision|11|||
13076709|NCT02925338|25291425|FG001|Overall Study|Participant's Decision|7|||
13076710|NCT02925338|25291426|FG002|Overall Study|Participant's Decision|3|||
13076711|NCT02925338|25291427|FG003|Overall Study|Participant's Decision|8|||
13076712|NCT02925338|25291428|FG004|Overall Study|Participant's Decision|1|||
13076713|NCT02925338|25291424|FG000|Overall Study|Treatment Discontinuation|144|||
13076714|NCT02925338|25291425|FG001|Overall Study|Treatment Discontinuation|65|||
13076715|NCT02925338|25291426|FG002|Overall Study|Treatment Discontinuation|56|||
13076716|NCT02925338|25291427|FG003|Overall Study|Treatment Discontinuation|131|||
13076717|NCT02925338|25291428|FG004|Overall Study|Treatment Discontinuation|22|||
13076718|NCT02913482|25291474|FG000|Overall Study|Death|0|||
13076719|NCT02913482|25291475|FG001|Overall Study|Death|2|||
13076720|NCT02913482|25291476|FG002|Overall Study|Death|2|||
13076721|NCT02913482|25291474|FG000|Overall Study|Progressive Disease|1|||
13076722|NCT02913482|25291475|FG001|Overall Study|Progressive Disease|1|||
13076723|NCT02913482|25291476|FG002|Overall Study|Progressive Disease|1|||
13076724|NCT02904954|25291495|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1|||
13076725|NCT02904954|25291496|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1|||
13076726|NCT02904954|25291495|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1|||
13076727|NCT02904954|25291496|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0|||
13076728|NCT02904954|25291495|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2|||
13076729|NCT02904954|25291496|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3|||
13076730|NCT02904954|25291495|FG000|Adjuvant Durvalumab|Recurrence|2|||
13076731|NCT02904954|25291496|FG001|Adjuvant Durvalumab|Recurrence|0|||
13076732|NCT02904954|25291495|FG000|Adjuvant Durvalumab|Adverse Event|2|||
13076733|NCT02904954|25291496|FG001|Adjuvant Durvalumab|Adverse Event|6|||
13076734|NCT02904954|25291495|FG000|Adjuvant Durvalumab|Participant wishes|12|||
13076735|NCT02904954|25291496|FG001|Adjuvant Durvalumab|Participant wishes|7|||
13076736|NCT02904954|25291495|FG000|Adjuvant Durvalumab|Physician Decision|2|||
13076737|NCT02904954|25291496|FG001|Adjuvant Durvalumab|Physician Decision|1|||
13076738|NCT02904954|25291495|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1|||
13076739|NCT02904954|25291496|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0|||
13076740|NCT02904954|25291495|FG000|Adjuvant Durvalumab|Death|0|||
13076741|NCT02904954|25291496|FG001|Adjuvant Durvalumab|Death|1|||
13076742|NCT02904954|25291495|FG000|Adjuvant Durvalumab|Prostate cancer|1|||
13076743|NCT02904954|25291496|FG001|Adjuvant Durvalumab|Prostate cancer|0|||
13076744|NCT02893930|25291505|FG000|Overall Study|Adverse Event|3|||
13076745|NCT02893930|25291505|FG000|Overall Study|Death|1|||
13076746|NCT02893930|25291505|FG000|Overall Study|Disease progression|5|||
13076747|NCT02893930|25291505|FG000|Overall Study|Withdrawal by Subject|2|||
13076748|NCT02893930|25291505|FG000|Overall Study|Physician Decision|1|||
13076749|NCT02893930|25291505|FG000|Overall Study|Ineligible|1|||
13076750|NCT02728076|25291511|FG000|Overall Study|Physician Decision|4|||
13076751|NCT02696616|25291649|FG000|Overall Study|Adverse Event|0|||
13076752|NCT02696616|25291650|FG001|Overall Study|Adverse Event|1|||
13076753|NCT02696616|25291651|FG002|Overall Study|Adverse Event|0|||
13076754|NCT02696616|25291652|FG003|Overall Study|Adverse Event|0|||
13076755|NCT02696616|25291653|FG004|Overall Study|Adverse Event|0|||
13076756|NCT02696616|25291654|FG005|Overall Study|Adverse Event|0|||
13076757|NCT02696616|25291655|FG006|Overall Study|Adverse Event|0|||
13076758|NCT02658812|25291664|FG000|Overall Study|Disease Progression|7|||
13076759|NCT02658812|25291664|FG000|Overall Study|Unrelated to study treatment|1|||
13076760|NCT02658812|25291664|FG000|Overall Study|Adverse Event|1|||
13076761|NCT02470091|25291690|FG000|Overall Study|Withdrawal by Subject|1|||
13076762|NCT02470091|25291691|FG001|Overall Study|Withdrawal by Subject|0|||
13076763|NCT02470091|25291690|FG000|Overall Study|Ineligible|0|||
13076764|NCT02470091|25291691|FG001|Overall Study|Ineligible|2|||
13076765|NCT02467270|25291751|FG000|Overall Study|Participants Never Treated|0|||
13076766|NCT02467270|25291752|FG001|Overall Study|Participants Never Treated|1|||
13076767|NCT02467270|25291753|FG002|Overall Study|Participants Never Treated|0|||
13076768|NCT02467270|25291751|FG000|Overall Study|Ongoing|50|||
13076769|NCT02467270|25291752|FG001|Overall Study|Ongoing|41|||
13076770|NCT02467270|25291753|FG002|Overall Study|Ongoing|43|||
13076771|NCT02467270|25291751|FG000|Overall Study|Adverse Event|16|||
13076772|NCT02467270|25291752|FG001|Overall Study|Adverse Event|15|||
13076773|NCT02467270|25291753|FG002|Overall Study|Adverse Event|14|||
13076774|NCT02467270|25291751|FG000|Overall Study|Progressive Disease|7|||
13076775|NCT02467270|25291752|FG001|Overall Study|Progressive Disease|7|||
13076776|NCT02467270|25291753|FG002|Overall Study|Progressive Disease|4|||
13076777|NCT02467270|25291751|FG000|Overall Study|Death|2|||
13076778|NCT02467270|25291752|FG001|Overall Study|Death|0|||
13076779|NCT02467270|25291753|FG002|Overall Study|Death|2|||
13076780|NCT02467270|25291751|FG000|Overall Study|Lack of Efficacy|12|||
13076781|NCT02467270|25291752|FG001|Overall Study|Lack of Efficacy|18|||
13076782|NCT02467270|25291753|FG002|Overall Study|Lack of Efficacy|23|||
13076783|NCT02467270|25291751|FG000|Overall Study|Non-compliance With Study Drug|0|||
13076784|NCT02467270|25291752|FG001|Overall Study|Non-compliance With Study Drug|2|||
13076785|NCT02467270|25291753|FG002|Overall Study|Non-compliance With Study Drug|1|||
13076786|NCT02467270|25291751|FG000|Overall Study|Lost to Follow-up|2|||
13076787|NCT02467270|25291752|FG001|Overall Study|Lost to Follow-up|1|||
13076788|NCT02467270|25291753|FG002|Overall Study|Lost to Follow-up|0|||
13393341|NCT00665925|26783412|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
13076789|NCT02467270|25291751|FG000|Overall Study|Pregnancy|0|||
13076790|NCT02467270|25291752|FG001|Overall Study|Pregnancy|1|||
13076791|NCT02467270|25291753|FG002|Overall Study|Pregnancy|0|||
13076792|NCT02467270|25291751|FG000|Overall Study|Physician Decision|0|||
13076793|NCT02467270|25291752|FG001|Overall Study|Physician Decision|4|||
13076794|NCT02467270|25291753|FG002|Overall Study|Physician Decision|1|||
13076795|NCT02467270|25291751|FG000|Overall Study|Withdrawal by Subject|4|||
13076796|NCT02467270|25291752|FG001|Overall Study|Withdrawal by Subject|3|||
13076797|NCT02467270|25291753|FG002|Overall Study|Withdrawal by Subject|5|||
13076798|NCT02467270|25291751|FG000|Overall Study|Reason not Specified|1|||
13076799|NCT02467270|25291752|FG001|Overall Study|Reason not Specified|2|||
13076800|NCT02467270|25291753|FG002|Overall Study|Reason not Specified|1|||
13076801|NCT02396381|25291815|FG000|Overall Study|Adverse Event|3|||
13076802|NCT02396381|25291816|FG001|Overall Study|Adverse Event|2|||
13076803|NCT02396381|25291815|FG000|Overall Study|Withdrawal by Subject|33|||
13076804|NCT02396381|25291816|FG001|Overall Study|Withdrawal by Subject|24|||
13076805|NCT02396381|25291815|FG000|Overall Study|Lost to Follow-up|49|||
13076806|NCT02396381|25291816|FG001|Overall Study|Lost to Follow-up|31|||
13076807|NCT02396381|25291815|FG000|Overall Study|Protocol Violation|1|||
13076808|NCT02396381|25291816|FG001|Overall Study|Protocol Violation|0|||
13076809|NCT02396381|25291815|FG000|Overall Study|Site terminated by sponsor|7|||
13076810|NCT02396381|25291816|FG001|Overall Study|Site terminated by sponsor|8|||
13076811|NCT02396381|25291815|FG000|Overall Study|Physician Decision|5|||
13076812|NCT02396381|25291816|FG001|Overall Study|Physician Decision|5|||
13076813|NCT02396381|25291815|FG000|Overall Study|Pregnancy|2|||
13076814|NCT02396381|25291816|FG001|Overall Study|Pregnancy|0|||
13076815|NCT02396381|25291815|FG000|Overall Study|Non-compliance with study procedures|1|||
13076816|NCT02396381|25291816|FG001|Overall Study|Non-compliance with study procedures|0|||
13076817|NCT02396381|25291815|FG000|Overall Study|Moved out of town/state|1|||
13076818|NCT02396381|25291816|FG001|Overall Study|Moved out of town/state|3|||
13076819|NCT02396381|25291815|FG000|Overall Study|Could not complete visit|1|||
13076820|NCT02396381|25291816|FG001|Overall Study|Could not complete visit|0|||
13076821|NCT02396381|25291815|FG000|Overall Study|Possible conflict of interest|1|||
13076822|NCT02396381|25291816|FG001|Overall Study|Possible conflict of interest|0|||
13076823|NCT02396381|25291815|FG000|Overall Study|Randomization/Screening Error|3|||
13076824|NCT02396381|25291816|FG001|Overall Study|Randomization/Screening Error|1|||
13076825|NCT02359864|25291891|FG000|Overall Study|Withdrawal by Subject|1|||
13076826|NCT02359864|25291892|FG001|Overall Study|Withdrawal by Subject|0|||
13076827|NCT02352948|25291967|FG000|Overall Study|Death|47|||
13076828|NCT02352948|25291968|FG001|Overall Study|Death|48|||
13076829|NCT02352948|25291969|FG002|Overall Study|Death|114|||
13076830|NCT02352948|25291970|FG003|Overall Study|Death|74|||
13076831|NCT02352948|25291971|FG004|Overall Study|Death|77|||
13076832|NCT02352948|25291972|FG005|Overall Study|Death|44|||
13076833|NCT02352948|25291967|FG000|Overall Study|Lost to Follow-up|1|||
13076834|NCT02352948|25291968|FG001|Overall Study|Lost to Follow-up|0|||
13076835|NCT02352948|25291969|FG002|Overall Study|Lost to Follow-up|2|||
13076836|NCT02352948|25291970|FG003|Overall Study|Lost to Follow-up|1|||
13076837|NCT02352948|25291971|FG004|Overall Study|Lost to Follow-up|2|||
13076838|NCT02352948|25291972|FG005|Overall Study|Lost to Follow-up|1|||
13076839|NCT02352948|25291967|FG000|Overall Study|Withdrawal by Subject|1|||
13076840|NCT02352948|25291968|FG001|Overall Study|Withdrawal by Subject|10|||
13076841|NCT02352948|25291969|FG002|Overall Study|Withdrawal by Subject|11|||
13076842|NCT02352948|25291970|FG003|Overall Study|Withdrawal by Subject|23|||
13076843|NCT02352948|25291971|FG004|Overall Study|Withdrawal by Subject|9|||
13076844|NCT02352948|25291972|FG005|Overall Study|Withdrawal by Subject|4|||
13076845|NCT02352948|25291967|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
13076846|NCT02352948|25291968|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
13076847|NCT02352948|25291969|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
13076848|NCT02352948|25291970|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
13076849|NCT02352948|25291971|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
13076850|NCT02352948|25291972|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
13076851|NCT02352948|25291967|FG000|Overall Study|Other|0|||
13076852|NCT02352948|25291968|FG001|Overall Study|Other|0|||
13076853|NCT02352948|25291969|FG002|Overall Study|Other|2|||
13076854|NCT02352948|25291970|FG003|Overall Study|Other|0|||
13076855|NCT02352948|25291971|FG004|Overall Study|Other|0|||
13076856|NCT02352948|25291972|FG005|Overall Study|Other|0|||
13076857|NCT02339740|25291985|FG000|Overall Study|Death|1|||
13076858|NCT02339740|25291986|FG001|Overall Study|Death|0|||
13076859|NCT02339740|25291985|FG000|Overall Study|Physician Decision|0|||
13076860|NCT02339740|25291986|FG001|Overall Study|Physician Decision|2|||
13076861|NCT02339740|25291985|FG000|Overall Study|Withdrawal by Subject|5|||
13076862|NCT02339740|25291986|FG001|Overall Study|Withdrawal by Subject|1|||
13076863|NCT02339740|25291985|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3|||
13076864|NCT02339740|25291986|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1|||
13076865|NCT02336815|25292020|FG000|Overall Study|Disease Progression|45|||
13076866|NCT02336815|25292021|FG001|Overall Study|Disease Progression|70|||
13076867|NCT02336815|25292020|FG000|Overall Study|Adverse Event|18|||
13076868|NCT02336815|25292021|FG001|Overall Study|Adverse Event|39|||
13076869|NCT02336815|25292020|FG000|Overall Study|Physician Decision|11|||
13076870|NCT02336815|25292021|FG001|Overall Study|Physician Decision|4|||
13076871|NCT02336815|25292020|FG000|Overall Study|Withdrawal by Subject|3|||
13076872|NCT02336815|25292021|FG001|Overall Study|Withdrawal by Subject|2|||
13076873|NCT02336815|25292020|FG000|Overall Study|Lost to Follow-up|1|||
13076874|NCT02336815|25292021|FG001|Overall Study|Lost to Follow-up|3|||
13076875|NCT02336815|25292020|FG000|Overall Study|Other|1|||
13076876|NCT02336815|25292021|FG001|Overall Study|Other|5|||
13076877|NCT02314247|25292051|FG000|Overall Study|Adverse Event|2|||
13076878|NCT02314247|25292052|FG001|Overall Study|Adverse Event|1|||
13076879|NCT02314247|25292053|FG002|Overall Study|Adverse Event|0|||
13076880|NCT02314247|25292051|FG000|Overall Study|Withdrawal by Subject|1|||
13076881|NCT02314247|25292052|FG001|Overall Study|Withdrawal by Subject|3|||
13076882|NCT02314247|25292053|FG002|Overall Study|Withdrawal by Subject|1|||
13076883|NCT02314247|25292051|FG000|Overall Study|Progression of Disease|6|||
13076884|NCT02314247|25292052|FG001|Overall Study|Progression of Disease|2|||
13076885|NCT02314247|25292053|FG002|Overall Study|Progression of Disease|0|||
13076886|NCT02213133|25292123|FG000|Overall Study|Participant discontinued study therapy|2|||
13076887|NCT02213133|25292124|FG001|Overall Study|Participant discontinued study therapy|0|||
13076888|NCT02213133|25292125|FG002|Overall Study|Participant discontinued study therapy|0|||
13076889|NCT02213133|25292123|FG000|Overall Study|Participant withdrew informed consent|2|||
13076890|NCT02213133|25292124|FG001|Overall Study|Participant withdrew informed consent|1|||
13076891|NCT02213133|25292125|FG002|Overall Study|Participant withdrew informed consent|2|||
13076892|NCT02213133|25292123|FG000|Overall Study|Disease progression|11|||
13076893|NCT02213133|25292124|FG001|Overall Study|Disease progression|2|||
13076894|NCT02213133|25292125|FG002|Overall Study|Disease progression|0|||
13076895|NCT02213133|25292123|FG000|Overall Study|Adverse Event (AE)|1|||
13076896|NCT02213133|25292124|FG001|Overall Study|Adverse Event (AE)|0|||
13076897|NCT02213133|25292125|FG002|Overall Study|Adverse Event (AE)|0|||
13076898|NCT02213133|25292123|FG000|Overall Study|Death|16|||
13076899|NCT02213133|25292124|FG001|Overall Study|Death|2|||
13076900|NCT02213133|25292125|FG002|Overall Study|Death|1|||
13076901|NCT02213133|25292123|FG000|Overall Study|Other|5|||
13076902|NCT02213133|25292124|FG001|Overall Study|Other|0|||
13076903|NCT02213133|25292125|FG002|Overall Study|Other|0|||
13076904|NCT02181738|25292183|FG000|Overall Study|Death|1|||
13076905|NCT02181738|25292184|FG001|Overall Study|Death|1|||
13076906|NCT02181738|25292185|FG002|Overall Study|Death|6|||
13076907|NCT02181738|25292186|FG003|Overall Study|Death|1|||
13076908|NCT02181738|25292183|FG000|Overall Study|Subject Withdrew Consent|1|||
13076909|NCT02181738|25292184|FG001|Overall Study|Subject Withdrew Consent|3|||
13076910|NCT02181738|25292185|FG002|Overall Study|Subject Withdrew Consent|2|||
13076911|NCT02181738|25292186|FG003|Overall Study|Subject Withdrew Consent|1|||
13076912|NCT02181738|25292183|FG000|Overall Study|Lost to Follow-up|0|||
13076913|NCT02181738|25292184|FG001|Overall Study|Lost to Follow-up|4|||
13076914|NCT02181738|25292185|FG002|Overall Study|Lost to Follow-up|2|||
13076915|NCT02181738|25292186|FG003|Overall Study|Lost to Follow-up|0|||
13076916|NCT02181738|25292183|FG000|Overall Study|Patient Return to Home Country|0|||
13076917|NCT02181738|25292184|FG001|Overall Study|Patient Return to Home Country|1|||
13076918|NCT02181738|25292185|FG002|Overall Study|Patient Return to Home Country|0|||
13076919|NCT02181738|25292186|FG003|Overall Study|Patient Return to Home Country|0|||
13076920|NCT02146833|25292200|FG000|Overall Study|Death|10|||
13076921|NCT02146833|25292200|FG000|Overall Study|No longer consented to study treatment|1|||
13076922|NCT02143414|25292227|FG000|Induction|Adverse Event|1|||
13076923|NCT02143414|25292228|FG001|Induction|Adverse Event|2|||
13076924|NCT02143414|25292227|FG000|Induction|Death|1|||
13076925|NCT02143414|25292228|FG001|Induction|Death|2|||
13076926|NCT02143414|25292227|FG000|Induction|Patient refusal|1|||
13076927|NCT02143414|25292228|FG001|Induction|Patient refusal|1|||
13076928|NCT02143414|25292227|FG000|Induction|Refractory|1|||
13076929|NCT02143414|25292228|FG001|Induction|Refractory|0|||
13076930|NCT02143414|25292227|FG000|Induction|Began alternative treatment|1|||
13076931|NCT02143414|25292228|FG001|Induction|Began alternative treatment|0|||
13076932|NCT02143414|25292227|FG000|Induction|Ineligible for postremission|5|||
13076933|NCT02143414|25292228|FG001|Induction|Ineligible for postremission|1|||
13076934|NCT02143414|25292227|FG000|Post-remission|Adverse Event|0|||
13076935|NCT02143414|25292228|FG001|Post-remission|Adverse Event|2|||
13076936|NCT02143414|25292227|FG000|Post-remission|Disease progression/relapse|5|||
13076937|NCT02143414|25292228|FG001|Post-remission|Disease progression/relapse|0|||
13076938|NCT02143414|25292227|FG000|Maintenance|Adverse Event|4|||
13076939|NCT02143414|25292228|FG001|Maintenance|Adverse Event|6|||
13076940|NCT02143414|25292227|FG000|Maintenance|Disease progression/relapse|3|||
13076941|NCT02143414|25292228|FG001|Maintenance|Disease progression/relapse|2|||
13076942|NCT02143414|25292227|FG000|Maintenance|Patient refusal|2|||
13076943|NCT02143414|25292228|FG001|Maintenance|Patient refusal|1|||
13076944|NCT02143414|25292227|FG000|Maintenance|Physician Decision|1|||
13076945|NCT02143414|25292228|FG001|Maintenance|Physician Decision|0|||
13076946|NCT02143414|25292227|FG000|Maintenance|Death|0|||
13076947|NCT02143414|25292228|FG001|Maintenance|Death|1|||
13076948|NCT02143414|25292227|FG000|Maintenance|On protocol treatment|0|||
13076949|NCT02143414|25292228|FG001|Maintenance|On protocol treatment|6|||
13076950|NCT02138786|25292251|FG000|Overall Study|Adverse Event|0|||
13076951|NCT02138786|25292252|FG001|Overall Study|Adverse Event|2|||
13076952|NCT02138786|25292253|FG002|Overall Study|Adverse Event|1|||
13076953|NCT02138786|25292251|FG000|Overall Study|Death|1|||
13076954|NCT02138786|25292252|FG001|Overall Study|Death|7|||
13076955|NCT02138786|25292253|FG002|Overall Study|Death|2|||
13076956|NCT02138786|25292251|FG000|Overall Study|Disease Progression|1|||
13076957|NCT02138786|25292252|FG001|Overall Study|Disease Progression|1|||
13076958|NCT02138786|25292253|FG002|Overall Study|Disease Progression|3|||
13076959|NCT02138786|25292251|FG000|Overall Study|Withdrawal by Subject|1|||
13076960|NCT02138786|25292252|FG001|Overall Study|Withdrawal by Subject|2|||
13076961|NCT02138786|25292253|FG002|Overall Study|Withdrawal by Subject|0|||
13076962|NCT02138786|25292251|FG000|Overall Study|Patient's Wish|0|||
13076963|NCT02138786|25292252|FG001|Overall Study|Patient's Wish|2|||
13076964|NCT02138786|25292253|FG002|Overall Study|Patient's Wish|0|||
13076965|NCT02138786|25292251|FG000|Overall Study|Sponsor Terminated Study|0|||
13076966|NCT02138786|25292252|FG001|Overall Study|Sponsor Terminated Study|1|||
13076967|NCT02138786|25292253|FG002|Overall Study|Sponsor Terminated Study|1|||
13076968|NCT02138786|25292251|FG000|Overall Study|Non-Compliance|0|||
13076969|NCT02138786|25292252|FG001|Overall Study|Non-Compliance|0|||
13076970|NCT02138786|25292253|FG002|Overall Study|Non-Compliance|1|||
13133720|NCT02765165|25988896|FG005|Treatment Period|Study terminated|1|||
13077109|NCT02091960|25292294|FG000|Overall Study|Death|7|||
13077110|NCT02091960|25292294|FG000|Overall Study|Withdrawal by Subject|1|||
13077111|NCT02091960|25292294|FG000|Overall Study|Miscellaneous Reasons|31|||
13077112|NCT02091960|25292294|FG000|Overall Study|On Study at Data Cut-off|12|||
13077113|NCT02088541|25292341|FG000|Overall Study|Adverse Event|3|||
13077114|NCT02088541|25292342|FG001|Overall Study|Adverse Event|0|||
13077115|NCT02088541|25292343|FG002|Overall Study|Adverse Event|3|||
13077116|NCT02088541|25292344|FG003|Overall Study|Adverse Event|3|||
13077117|NCT02088541|25292345|FG004|Overall Study|Adverse Event|0|||
13077118|NCT02088541|25292341|FG000|Overall Study|Death|51|||
13077119|NCT02088541|25292342|FG001|Overall Study|Death|21|||
13077120|NCT02088541|25292343|FG002|Overall Study|Death|85|||
13077121|NCT02088541|25292344|FG003|Overall Study|Death|28|||
13077122|NCT02088541|25292345|FG004|Overall Study|Death|38|||
13077123|NCT02088541|25292341|FG000|Overall Study|Lost to Follow-up|2|||
13077124|NCT02088541|25292342|FG001|Overall Study|Lost to Follow-up|0|||
13077125|NCT02088541|25292343|FG002|Overall Study|Lost to Follow-up|1|||
13077126|NCT02088541|25292344|FG003|Overall Study|Lost to Follow-up|0|||
13077127|NCT02088541|25292345|FG004|Overall Study|Lost to Follow-up|0|||
13077128|NCT02088541|25292341|FG000|Overall Study|Physician Decision|2|||
13077129|NCT02088541|25292342|FG001|Overall Study|Physician Decision|1|||
13077130|NCT02088541|25292343|FG002|Overall Study|Physician Decision|2|||
13077131|NCT02088541|25292344|FG003|Overall Study|Physician Decision|0|||
13077132|NCT02088541|25292345|FG004|Overall Study|Physician Decision|2|||
13077133|NCT02088541|25292341|FG000|Overall Study|Disease progression|7|||
13077134|NCT02088541|25292342|FG001|Overall Study|Disease progression|1|||
13077135|NCT02088541|25292343|FG002|Overall Study|Disease progression|2|||
13077136|NCT02088541|25292344|FG003|Overall Study|Disease progression|3|||
13077137|NCT02088541|25292345|FG004|Overall Study|Disease progression|1|||
13077138|NCT02088541|25292341|FG000|Overall Study|Study terminated by sponsor|1|||
13077139|NCT02088541|25292342|FG001|Overall Study|Study terminated by sponsor|1|||
13077140|NCT02088541|25292343|FG002|Overall Study|Study terminated by sponsor|12|||
13077141|NCT02088541|25292344|FG003|Overall Study|Study terminated by sponsor|2|||
13077142|NCT02088541|25292345|FG004|Overall Study|Study terminated by sponsor|6|||
13077143|NCT02088541|25292341|FG000|Overall Study|Withdrawal by Subject|3|||
13077144|NCT02088541|25292342|FG001|Overall Study|Withdrawal by Subject|2|||
13077145|NCT02088541|25292343|FG002|Overall Study|Withdrawal by Subject|9|||
13077146|NCT02088541|25292344|FG003|Overall Study|Withdrawal by Subject|7|||
13077147|NCT02088541|25292345|FG004|Overall Study|Withdrawal by Subject|10|||
13077148|NCT02088541|25292341|FG000|Overall Study|Other|2|||
13077149|NCT02088541|25292342|FG001|Overall Study|Other|1|||
13077150|NCT02088541|25292343|FG002|Overall Study|Other|3|||
13077151|NCT02088541|25292344|FG003|Overall Study|Other|1|||
13077152|NCT02088541|25292345|FG004|Overall Study|Other|1|||
13077153|NCT02025985|25292419|FG000|Overall Study|Consent withdrawn|0|||
13077154|NCT02025985|25292420|FG001|Overall Study|Consent withdrawn|0|||
13077155|NCT02025985|25292421|FG002|Overall Study|Consent withdrawn|1|||
13077156|NCT02025985|25292422|FG003|Overall Study|Consent withdrawn|0|||
13077157|NCT02025985|25292423|FG004|Overall Study|Consent withdrawn|0|||
13077158|NCT02025985|25292419|FG000|Overall Study|Termination of study by Sponsor|4|||
13077159|NCT02025985|25292420|FG001|Overall Study|Termination of study by Sponsor|3|||
13077160|NCT02025985|25292421|FG002|Overall Study|Termination of study by Sponsor|1|||
13077161|NCT02025985|25292422|FG003|Overall Study|Termination of study by Sponsor|1|||
13077162|NCT02025985|25292423|FG004|Overall Study|Termination of study by Sponsor|3|||
13077163|NCT02025985|25292419|FG000|Overall Study|Death|21|||
13077164|NCT02025985|25292420|FG001|Overall Study|Death|20|||
13077165|NCT02025985|25292421|FG002|Overall Study|Death|23|||
13077166|NCT02025985|25292422|FG003|Overall Study|Death|20|||
13077167|NCT02025985|25292423|FG004|Overall Study|Death|17|||
13077168|NCT01986348|25292458|FG000|Overall Study|Death|8|||
13077169|NCT01986348|25292459|FG001|Overall Study|Death|22|||
13077170|NCT01986348|25292460|FG002|Overall Study|Death|10|||
13077171|NCT01986348|25292461|FG003|Overall Study|Death|21|||
13077172|NCT01986348|25292458|FG000|Overall Study|Lost to Follow-up|0|||
13077173|NCT01986348|25292459|FG001|Overall Study|Lost to Follow-up|0|||
13077174|NCT01986348|25292460|FG002|Overall Study|Lost to Follow-up|0|||
13077175|NCT01986348|25292461|FG003|Overall Study|Lost to Follow-up|2|||
13077176|NCT01986348|25292458|FG000|Overall Study|Physician Decision|0|||
13077177|NCT01986348|25292459|FG001|Overall Study|Physician Decision|0|||
13077178|NCT01986348|25292460|FG002|Overall Study|Physician Decision|0|||
13077179|NCT01986348|25292461|FG003|Overall Study|Physician Decision|1|||
13077180|NCT01986348|25292458|FG000|Overall Study|Progressive Disease|0|||
13077181|NCT01986348|25292459|FG001|Overall Study|Progressive Disease|0|||
13077182|NCT01986348|25292460|FG002|Overall Study|Progressive Disease|2|||
13077183|NCT01986348|25292461|FG003|Overall Study|Progressive Disease|0|||
13077184|NCT01986348|25292458|FG000|Overall Study|Withdrawal by Participant|0|||
13077185|NCT01986348|25292459|FG001|Overall Study|Withdrawal by Participant|1|||
13077186|NCT01986348|25292460|FG002|Overall Study|Withdrawal by Participant|2|||
13077187|NCT01986348|25292461|FG003|Overall Study|Withdrawal by Participant|1|||
13077188|NCT01986348|25292458|FG000|Overall Study|Study Terminated by Sponsor|0|||
13077189|NCT01986348|25292459|FG001|Overall Study|Study Terminated by Sponsor|0|||
13077190|NCT01986348|25292460|FG002|Overall Study|Study Terminated by Sponsor|0|||
13077191|NCT01986348|25292461|FG003|Overall Study|Study Terminated by Sponsor|3|||
13077192|NCT01986348|25292458|FG000|Overall Study|Other-unspecified|0|||
13077193|NCT01986348|25292459|FG001|Overall Study|Other-unspecified|1|||
13077194|NCT01986348|25292460|FG002|Overall Study|Other-unspecified|0|||
13077195|NCT01986348|25292461|FG003|Overall Study|Other-unspecified|2|||
13077196|NCT01970865|25292937|FG000|Overall Study|Death|3|||
13077197|NCT01970865|25292938|FG001|Overall Study|Death|1|||
13077198|NCT01970865|25292939|FG002|Overall Study|Death|3|||
13077199|NCT01970865|25292940|FG003|Overall Study|Death|4|||
13077200|NCT01970865|25292941|FG004|Overall Study|Death|6|||
13077201|NCT01970865|25292942|FG005|Overall Study|Death|3|||
13077202|NCT01970865|25292943|FG006|Overall Study|Death|1|||
13077203|NCT01970865|25292944|FG007|Overall Study|Death|3|||
13077204|NCT01970865|25292945|FG008|Overall Study|Death|2|||
13077205|NCT01970865|25292946|FG009|Overall Study|Death|1|||
13077206|NCT01970865|25292947|FG010|Overall Study|Death|1|||
13077207|NCT01970865|25292948|FG011|Overall Study|Death|4|||
13077208|NCT01970865|25292949|FG012|Overall Study|Death|14|||
13077209|NCT01970865|25292950|FG013|Overall Study|Death|19|||
13077210|NCT01970865|25292951|FG014|Overall Study|Death|15|||
13077211|NCT01970865|25292952|FG015|Overall Study|Death|10|||
13077212|NCT01970865|25292953|FG016|Overall Study|Death|1|||
13077213|NCT01970865|25292937|FG000|Overall Study|Lost to Follow-up|0|||
13077214|NCT01970865|25292938|FG001|Overall Study|Lost to Follow-up|0|||
13077215|NCT01970865|25292939|FG002|Overall Study|Lost to Follow-up|0|||
13077216|NCT01970865|25292940|FG003|Overall Study|Lost to Follow-up|1|||
13077217|NCT01970865|25292941|FG004|Overall Study|Lost to Follow-up|1|||
13077218|NCT01970865|25292942|FG005|Overall Study|Lost to Follow-up|0|||
13077219|NCT01970865|25292943|FG006|Overall Study|Lost to Follow-up|0|||
13077220|NCT01970865|25292944|FG007|Overall Study|Lost to Follow-up|0|||
13077221|NCT01970865|25292945|FG008|Overall Study|Lost to Follow-up|0|||
13077222|NCT01970865|25292946|FG009|Overall Study|Lost to Follow-up|0|||
13077223|NCT01970865|25292947|FG010|Overall Study|Lost to Follow-up|0|||
13077224|NCT01970865|25292948|FG011|Overall Study|Lost to Follow-up|0|||
13077225|NCT01970865|25292949|FG012|Overall Study|Lost to Follow-up|1|||
13077226|NCT01970865|25292950|FG013|Overall Study|Lost to Follow-up|0|||
13077227|NCT01970865|25292951|FG014|Overall Study|Lost to Follow-up|0|||
13077228|NCT01970865|25292952|FG015|Overall Study|Lost to Follow-up|0|||
13077229|NCT01970865|25292953|FG016|Overall Study|Lost to Follow-up|0|||
13077230|NCT01970865|25292937|FG000|Overall Study|Withdrawal by Subject|0|||
13077231|NCT01970865|25292938|FG001|Overall Study|Withdrawal by Subject|0|||
13077232|NCT01970865|25292939|FG002|Overall Study|Withdrawal by Subject|0|||
13077233|NCT01970865|25292940|FG003|Overall Study|Withdrawal by Subject|1|||
13077234|NCT01970865|25292941|FG004|Overall Study|Withdrawal by Subject|2|||
13077235|NCT01970865|25292942|FG005|Overall Study|Withdrawal by Subject|0|||
13077236|NCT01970865|25292943|FG006|Overall Study|Withdrawal by Subject|0|||
13077237|NCT01970865|25292944|FG007|Overall Study|Withdrawal by Subject|0|||
13077238|NCT01970865|25292945|FG008|Overall Study|Withdrawal by Subject|0|||
13077239|NCT01970865|25292946|FG009|Overall Study|Withdrawal by Subject|0|||
13077240|NCT01970865|25292947|FG010|Overall Study|Withdrawal by Subject|0|||
13077241|NCT01970865|25292948|FG011|Overall Study|Withdrawal by Subject|1|||
13077242|NCT01970865|25292949|FG012|Overall Study|Withdrawal by Subject|2|||
13077243|NCT01970865|25292950|FG013|Overall Study|Withdrawal by Subject|5|||
13077244|NCT01970865|25292951|FG014|Overall Study|Withdrawal by Subject|2|||
13077245|NCT01970865|25292952|FG015|Overall Study|Withdrawal by Subject|7|||
13077246|NCT01970865|25292953|FG016|Overall Study|Withdrawal by Subject|0|||
13077247|NCT01970865|25292937|FG000|Overall Study|Other|0|||
13077248|NCT01970865|25292938|FG001|Overall Study|Other|0|||
13077249|NCT01970865|25292939|FG002|Overall Study|Other|0|||
13077250|NCT01970865|25292940|FG003|Overall Study|Other|1|||
13077251|NCT01970865|25292941|FG004|Overall Study|Other|0|||
13077252|NCT01970865|25292942|FG005|Overall Study|Other|0|||
13077253|NCT01970865|25292943|FG006|Overall Study|Other|0|||
13077254|NCT01970865|25292944|FG007|Overall Study|Other|0|||
13077255|NCT01970865|25292945|FG008|Overall Study|Other|0|||
13077256|NCT01970865|25292946|FG009|Overall Study|Other|0|||
13077257|NCT01970865|25292947|FG010|Overall Study|Other|0|||
13077258|NCT01970865|25292948|FG011|Overall Study|Other|0|||
13077259|NCT01970865|25292949|FG012|Overall Study|Other|0|||
13077260|NCT01970865|25292950|FG013|Overall Study|Other|1|||
13077261|NCT01970865|25292951|FG014|Overall Study|Other|0|||
13077262|NCT01970865|25292952|FG015|Overall Study|Other|1|||
13077263|NCT01970865|25292953|FG016|Overall Study|Other|0|||
13077264|NCT01970865|25292937|FG000|Overall Study|Study ongoing|0|||
13077265|NCT01970865|25292938|FG001|Overall Study|Study ongoing|2|||
13077266|NCT01970865|25292939|FG002|Overall Study|Study ongoing|0|||
13077267|NCT01970865|25292940|FG003|Overall Study|Study ongoing|6|||
13077268|NCT01970865|25292941|FG004|Overall Study|Study ongoing|8|||
13077269|NCT01970865|25292942|FG005|Overall Study|Study ongoing|0|||
13077270|NCT01970865|25292943|FG006|Overall Study|Study ongoing|2|||
13077271|NCT01970865|25292944|FG007|Overall Study|Study ongoing|0|||
13077272|NCT01970865|25292945|FG008|Overall Study|Study ongoing|1|||
13077273|NCT01970865|25292946|FG009|Overall Study|Study ongoing|3|||
13077274|NCT01970865|25292947|FG010|Overall Study|Study ongoing|29|||
13077275|NCT01970865|25292948|FG011|Overall Study|Study ongoing|22|||
13077276|NCT01970865|25292949|FG012|Overall Study|Study ongoing|43|||
13077277|NCT01970865|25292950|FG013|Overall Study|Study ongoing|41|||
13077278|NCT01970865|25292951|FG014|Overall Study|Study ongoing|29|||
13077279|NCT01970865|25292952|FG015|Overall Study|Study ongoing|29|||
13077280|NCT01970865|25292953|FG016|Overall Study|Study ongoing|2|||
13077281|NCT01937117|25292977|FG000|Overall Study|Disease Progression|7|||
13077282|NCT01937117|25292977|FG000|Overall Study|Physician Decision|4|||
13077283|NCT01937117|25292977|FG000|Overall Study|Adverse Event|2|||
13077284|NCT01607905|25293231|FG000|Overall Study|Withdrawal by participant|7|||
13077285|NCT01607905|25293232|FG001|Overall Study|Withdrawal by participant|2|||
13077286|NCT01607905|25293233|FG002|Overall Study|Withdrawal by participant|4|||
13077287|NCT01607905|25293234|FG003|Overall Study|Withdrawal by participant|6|||
13077288|NCT01607905|25293235|FG004|Overall Study|Withdrawal by participant|0|||
13077289|NCT01607905|25293236|FG005|Overall Study|Withdrawal by participant|4|||
13077290|NCT01607905|25293237|FG006|Overall Study|Withdrawal by participant|12|||
13077291|NCT01607905|25293231|FG000|Overall Study|Incidence or severity of AEs|5|||
13077292|NCT01607905|25293232|FG001|Overall Study|Incidence or severity of AEs|1|||
13077293|NCT01607905|25293233|FG002|Overall Study|Incidence or severity of AEs|1|||
13077294|NCT01607905|25293234|FG003|Overall Study|Incidence or severity of AEs|3|||
13077295|NCT01607905|25293235|FG004|Overall Study|Incidence or severity of AEs|0|||
13077296|NCT01607905|25293236|FG005|Overall Study|Incidence or severity of AEs|2|||
13077297|NCT01607905|25293237|FG006|Overall Study|Incidence or severity of AEs|8|||
13077298|NCT01607905|25293231|FG000|Overall Study|Disease progression|44|||
13077299|NCT01607905|25293232|FG001|Overall Study|Disease progression|16|||
13077300|NCT01607905|25293233|FG002|Overall Study|Disease progression|15|||
13077301|NCT01607905|25293234|FG003|Overall Study|Disease progression|11|||
13077302|NCT01607905|25293235|FG004|Overall Study|Disease progression|6|||
13077303|NCT01607905|25293236|FG005|Overall Study|Disease progression|7|||
13077304|NCT01607905|25293237|FG006|Overall Study|Disease progression|21|||
13077305|NCT01607905|25293231|FG000|Overall Study|Non-compliance with study procedures|0|||
13077306|NCT01607905|25293232|FG001|Overall Study|Non-compliance with study procedures|0|||
13077307|NCT01607905|25293233|FG002|Overall Study|Non-compliance with study procedures|0|||
13077308|NCT01607905|25293234|FG003|Overall Study|Non-compliance with study procedures|0|||
13077309|NCT01607905|25293235|FG004|Overall Study|Non-compliance with study procedures|0|||
13077310|NCT01607905|25293236|FG005|Overall Study|Non-compliance with study procedures|0|||
13077311|NCT01607905|25293237|FG006|Overall Study|Non-compliance with study procedures|1|||
13077312|NCT01607905|25293231|FG000|Overall Study|Death|1|||
13077313|NCT01607905|25293232|FG001|Overall Study|Death|1|||
13077314|NCT01607905|25293233|FG002|Overall Study|Death|1|||
13077315|NCT01607905|25293234|FG003|Overall Study|Death|1|||
13077316|NCT01607905|25293235|FG004|Overall Study|Death|0|||
13077317|NCT01607905|25293236|FG005|Overall Study|Death|0|||
13077318|NCT01607905|25293237|FG006|Overall Study|Death|3|||
13077319|NCT01607905|25293231|FG000|Overall Study|Other treatments become available|1|||
13077320|NCT01607905|25293232|FG001|Overall Study|Other treatments become available|0|||
13077321|NCT01607905|25293233|FG002|Overall Study|Other treatments become available|0|||
13077322|NCT01607905|25293234|FG003|Overall Study|Other treatments become available|0|||
13077323|NCT01607905|25293235|FG004|Overall Study|Other treatments become available|0|||
13077324|NCT01607905|25293236|FG005|Overall Study|Other treatments become available|0|||
13077325|NCT01607905|25293237|FG006|Overall Study|Other treatments become available|1|||
13077326|NCT01607905|25293231|FG000|Overall Study|Investigator discretion|0|||
13077327|NCT01607905|25293232|FG001|Overall Study|Investigator discretion|0|||
13077328|NCT01607905|25293233|FG002|Overall Study|Investigator discretion|0|||
13077329|NCT01607905|25293234|FG003|Overall Study|Investigator discretion|0|||
13077330|NCT01607905|25293235|FG004|Overall Study|Investigator discretion|0|||
13077331|NCT01607905|25293236|FG005|Overall Study|Investigator discretion|1|||
13077332|NCT01607905|25293237|FG006|Overall Study|Investigator discretion|0|||
13077333|NCT01607905|25293231|FG000|Overall Study|Other|1|||
13077334|NCT01607905|25293232|FG001|Overall Study|Other|0|||
13077335|NCT01607905|25293233|FG002|Overall Study|Other|0|||
13077336|NCT01607905|25293234|FG003|Overall Study|Other|0|||
13077337|NCT01607905|25293235|FG004|Overall Study|Other|0|||
13077338|NCT01607905|25293236|FG005|Overall Study|Other|0|||
13077339|NCT01607905|25293237|FG006|Overall Study|Other|1|||
13077340|NCT01607905|25293231|FG000|Overall Study|Randomized but not treated|1|||
13077341|NCT01607905|25293232|FG001|Overall Study|Randomized but not treated|0|||
13077342|NCT01607905|25293233|FG002|Overall Study|Randomized but not treated|0|||
13077343|NCT01607905|25293234|FG003|Overall Study|Randomized but not treated|0|||
13077344|NCT01607905|25293235|FG004|Overall Study|Randomized but not treated|1|||
13077345|NCT01607905|25293236|FG005|Overall Study|Randomized but not treated|1|||
13077346|NCT01607905|25293237|FG006|Overall Study|Randomized but not treated|0|||
13077347|NCT01607892|25293395|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
13077348|NCT01607892|25293396|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
13077349|NCT01607892|25293397|FG002|Overall Study|Need of treatment not allowed per protocol|0|||
13077350|NCT01607892|25293398|FG003|Overall Study|Need of treatment not allowed per protocol|1|||
13077351|NCT01607892|25293399|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
13077352|NCT01607892|25293395|FG000|Overall Study|Death|4|||
13077353|NCT01607892|25293396|FG001|Overall Study|Death|2|||
13077354|NCT01607892|25293397|FG002|Overall Study|Death|8|||
13077355|NCT01607892|25293398|FG003|Overall Study|Death|10|||
13077356|NCT01607892|25293399|FG004|Overall Study|Death|3|||
13077357|NCT01607892|25293395|FG000|Overall Study|Investigator discretion|2|||
13077358|NCT01607892|25293396|FG001|Overall Study|Investigator discretion|4|||
13077359|NCT01607892|25293397|FG002|Overall Study|Investigator discretion|4|||
13077360|NCT01607892|25293398|FG003|Overall Study|Investigator discretion|8|||
13077361|NCT01607892|25293399|FG004|Overall Study|Investigator discretion|0|||
13077362|NCT01607892|25293395|FG000|Overall Study|Other treatments became available|1|||
13077363|NCT01607892|25293396|FG001|Overall Study|Other treatments became available|1|||
13077364|NCT01607892|25293397|FG002|Overall Study|Other treatments became available|0|||
13077365|NCT01607892|25293398|FG003|Overall Study|Other treatments became available|0|||
13077366|NCT01607892|25293399|FG004|Overall Study|Other treatments became available|2|||
13077367|NCT01607892|25293395|FG000|Overall Study|Intercurrent illness|1|||
13077368|NCT01607892|25293396|FG001|Overall Study|Intercurrent illness|0|||
13077369|NCT01607892|25293397|FG002|Overall Study|Intercurrent illness|0|||
13077370|NCT01607892|25293398|FG003|Overall Study|Intercurrent illness|3|||
13077371|NCT01607892|25293399|FG004|Overall Study|Intercurrent illness|0|||
13077372|NCT01607892|25293395|FG000|Overall Study|Non-Compliance with study procedures|0|||
13077373|NCT01607892|25293396|FG001|Overall Study|Non-Compliance with study procedures|0|||
13077374|NCT01607892|25293397|FG002|Overall Study|Non-Compliance with study procedures|1|||
13077375|NCT01607892|25293398|FG003|Overall Study|Non-Compliance with study procedures|0|||
13077376|NCT01607892|25293399|FG004|Overall Study|Non-Compliance with study procedures|0|||
13077377|NCT01607892|25293395|FG000|Overall Study|Consent withdrawn by participant|9|||
13077378|NCT01607892|25293396|FG001|Overall Study|Consent withdrawn by participant|4|||
13077379|NCT01607892|25293397|FG002|Overall Study|Consent withdrawn by participant|24|||
13077380|NCT01607892|25293398|FG003|Overall Study|Consent withdrawn by participant|14|||
13077381|NCT01607892|25293399|FG004|Overall Study|Consent withdrawn by participant|4|||
13077382|NCT01607892|25293395|FG000|Overall Study|Disease progression|38|||
13077383|NCT01607892|25293396|FG001|Overall Study|Disease progression|13|||
13077384|NCT01607892|25293397|FG002|Overall Study|Disease progression|37|||
13077385|NCT01607892|25293398|FG003|Overall Study|Disease progression|57|||
13077386|NCT01607892|25293399|FG004|Overall Study|Disease progression|9|||
13077387|NCT01607892|25293395|FG000|Overall Study|Incidence or severity of Adverse events|3|||
13077388|NCT01607892|25293396|FG001|Overall Study|Incidence or severity of Adverse events|3|||
13077389|NCT01607892|25293397|FG002|Overall Study|Incidence or severity of Adverse events|7|||
13077390|NCT01607892|25293398|FG003|Overall Study|Incidence or severity of Adverse events|2|||
13077391|NCT01607892|25293399|FG004|Overall Study|Incidence or severity of Adverse events|6|||
13077392|NCT01602666|25293418|FG000|Induction Chemotherapy|Death|2|||
13077393|NCT01602666|25293419|FG001|Induction Chemotherapy|Death|1|||
13077394|NCT01602666|25293418|FG000|Induction Chemotherapy|Lack of Efficacy|16|||
13077395|NCT01602666|25293419|FG001|Induction Chemotherapy|Lack of Efficacy|7|||
13077396|NCT01602666|25293418|FG000|Induction Chemotherapy|Physician Decision|12|||
13077397|NCT01602666|25293419|FG001|Induction Chemotherapy|Physician Decision|5|||
13077398|NCT01602666|25293418|FG000|Induction Chemotherapy|Withdrawal by Subject|0|||
13077399|NCT01602666|25293419|FG001|Induction Chemotherapy|Withdrawal by Subject|2|||
13077400|NCT01602666|25293418|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5|||
13077401|NCT01602666|25293419|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6|||
13077402|NCT01602666|25293418|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2|||
13077403|NCT01602666|25293419|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3|||
13077404|NCT01602666|25293418|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4|||
13077405|NCT01602666|25293419|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5|||
13077406|NCT01602666|25293418|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2|||
13077407|NCT01602666|25293419|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3|||
13077408|NCT01602666|25293418|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4|||
13077409|NCT01602666|25293419|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0|||
13077410|NCT01602666|25293418|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0|||
13077411|NCT01602666|25293419|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14|||
13077412|NCT01602666|25293418|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0|||
13077413|NCT01602666|25293419|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9|||
13077414|NCT01554956|25293452|FG000|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
13077415|NCT01554956|25293453|FG001|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|1|||
13077416|NCT01554956|25293454|FG002|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
13077417|NCT01554956|25293452|FG000|Part 2 (Continuation Segment)|Withdrawal by Subject|0|||
13077418|NCT01554956|25293453|FG001|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
13077419|NCT01554956|25293454|FG002|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
13077420|NCT01554956|25293452|FG000|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|2|||
13077421|NCT01554956|25293453|FG001|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|4|||
13077422|NCT01554956|25293454|FG002|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|0|||
13077423|NCT01553149|25293477|FG000|Overall Study|Adverse Event|0|||
13077424|NCT01553149|25293478|FG001|Overall Study|Adverse Event|9|||
13077425|NCT01553149|25293477|FG000|Overall Study|Physician Decision|5|||
13077426|NCT01553149|25293478|FG001|Overall Study|Physician Decision|10|||
13077427|NCT01553149|25293477|FG000|Overall Study|Ineligible|0|||
13077428|NCT01553149|25293478|FG001|Overall Study|Ineligible|1|||
13077450|NCT01371981|25293609|FG000|Overall Study|Adverse Event|12|||
13077451|NCT01371981|25293610|FG001|Overall Study|Adverse Event|17|||
13077452|NCT01371981|25293611|FG002|Overall Study|Adverse Event|0|||
13077453|NCT01371981|25293612|FG003|Overall Study|Adverse Event|4|||
13077454|NCT01371981|25293613|FG004|Overall Study|Adverse Event|1|||
13077455|NCT01371981|25293614|FG005|Overall Study|Adverse Event|0|||
13077456|NCT01371981|25293609|FG000|Overall Study|Death|22|||
13077457|NCT01371981|25293610|FG001|Overall Study|Death|16|||
13077458|NCT01371981|25293611|FG002|Overall Study|Death|0|||
13077459|NCT01371981|25293612|FG003|Overall Study|Death|0|||
13077460|NCT01371981|25293613|FG004|Overall Study|Death|2|||
13077461|NCT01371981|25293614|FG005|Overall Study|Death|2|||
13077462|NCT01371981|25293609|FG000|Overall Study|Lack of Efficacy|69|||
13077463|NCT01371981|25293610|FG001|Overall Study|Lack of Efficacy|61|||
13077464|NCT01371981|25293611|FG002|Overall Study|Lack of Efficacy|4|||
13077465|NCT01371981|25293612|FG003|Overall Study|Lack of Efficacy|8|||
13077466|NCT01371981|25293613|FG004|Overall Study|Lack of Efficacy|5|||
13077467|NCT01371981|25293614|FG005|Overall Study|Lack of Efficacy|0|||
13077468|NCT01371981|25293609|FG000|Overall Study|Physician Decision|48|||
13077469|NCT01371981|25293610|FG001|Overall Study|Physician Decision|63|||
13077470|NCT01371981|25293611|FG002|Overall Study|Physician Decision|1|||
13077471|NCT01371981|25293612|FG003|Overall Study|Physician Decision|7|||
13077472|NCT01371981|25293613|FG004|Overall Study|Physician Decision|14|||
13077473|NCT01371981|25293614|FG005|Overall Study|Physician Decision|3|||
13077474|NCT01371981|25293609|FG000|Overall Study|Withdrawal by Subject|12|||
13077475|NCT01371981|25293610|FG001|Overall Study|Withdrawal by Subject|19|||
13077476|NCT01371981|25293611|FG002|Overall Study|Withdrawal by Subject|1|||
13077477|NCT01371981|25293612|FG003|Overall Study|Withdrawal by Subject|2|||
13077478|NCT01371981|25293613|FG004|Overall Study|Withdrawal by Subject|10|||
13077479|NCT01371981|25293614|FG005|Overall Study|Withdrawal by Subject|3|||
13077480|NCT01371981|25293609|FG000|Overall Study|Ineligible|19|||
13077481|NCT01371981|25293610|FG001|Overall Study|Ineligible|13|||
13077482|NCT01371981|25293611|FG002|Overall Study|Ineligible|0|||
13077483|NCT01371981|25293612|FG003|Overall Study|Ineligible|0|||
13077484|NCT01371981|25293613|FG004|Overall Study|Ineligible|0|||
13077485|NCT01371981|25293614|FG005|Overall Study|Ineligible|4|||
13077486|NCT01371981|25293609|FG000|Overall Study|Did not start treatment|2|||
13077487|NCT01371981|25293610|FG001|Overall Study|Did not start treatment|3|||
13077488|NCT01371981|25293611|FG002|Overall Study|Did not start treatment|0|||
13077489|NCT01371981|25293612|FG003|Overall Study|Did not start treatment|0|||
13077490|NCT01371981|25293613|FG004|Overall Study|Did not start treatment|0|||
13077491|NCT01371981|25293614|FG005|Overall Study|Did not start treatment|2|||
13077492|NCT01349959|25293627|FG000|Overall Study|Adverse Event|7|||
13077493|NCT01295125|25293658|FG000|Overall Study|Study stopped prematurely|9|||
13077496|NCT01207492|25293684|FG000|Overall Study|Still on study|1|||
13077497|NCT01207492|25293684|FG000|Overall Study|Withdrawal by Subject|9|||
13077498|NCT01207492|25293684|FG000|Overall Study|Physician Decision|1|||
13077499|NCT01207492|25293684|FG000|Overall Study|Progressive disease|3|||
13077500|NCT01207492|25293684|FG000|Overall Study|Toxicity|1|||
13077501|NCT00980460|25293721|FG000|Overall Study|Death|0|||
13077502|NCT00980460|25293722|FG001|Overall Study|Death|0|||
13077503|NCT00980460|25293723|FG002|Overall Study|Death|1|||
13077504|NCT00980460|25293724|FG003|Overall Study|Death|2|||
13077505|NCT00980460|25293725|FG004|Overall Study|Death|1|||
13077506|NCT00980460|25293721|FG000|Overall Study|Lack of Efficacy|0|||
13077507|NCT00980460|25293722|FG001|Overall Study|Lack of Efficacy|0|||
13077508|NCT00980460|25293723|FG002|Overall Study|Lack of Efficacy|10|||
13077509|NCT00980460|25293724|FG003|Overall Study|Lack of Efficacy|6|||
13077510|NCT00980460|25293725|FG004|Overall Study|Lack of Efficacy|8|||
13077511|NCT00980460|25293721|FG000|Overall Study|Lost to Follow-up|0|||
13077512|NCT00980460|25293722|FG001|Overall Study|Lost to Follow-up|0|||
13077513|NCT00980460|25293723|FG002|Overall Study|Lost to Follow-up|0|||
13077514|NCT00980460|25293724|FG003|Overall Study|Lost to Follow-up|1|||
13077515|NCT00980460|25293725|FG004|Overall Study|Lost to Follow-up|0|||
13077516|NCT00980460|25293721|FG000|Overall Study|Physician Decision|0|||
13077517|NCT00980460|25293722|FG001|Overall Study|Physician Decision|0|||
13077518|NCT00980460|25293723|FG002|Overall Study|Physician Decision|11|||
13077519|NCT00980460|25293724|FG003|Overall Study|Physician Decision|5|||
13077520|NCT00980460|25293725|FG004|Overall Study|Physician Decision|3|||
13077521|NCT00980460|25293721|FG000|Overall Study|Withdrawal by Subject|0|||
13077522|NCT00980460|25293722|FG001|Overall Study|Withdrawal by Subject|0|||
13077523|NCT00980460|25293723|FG002|Overall Study|Withdrawal by Subject|1|||
13077524|NCT00980460|25293724|FG003|Overall Study|Withdrawal by Subject|0|||
13077525|NCT00980460|25293725|FG004|Overall Study|Withdrawal by Subject|0|||
13077526|NCT00980460|25293721|FG000|Overall Study|Ineligible|0|||
13077527|NCT00980460|25293722|FG001|Overall Study|Ineligible|2|||
13077528|NCT00980460|25293723|FG002|Overall Study|Ineligible|3|||
13077529|NCT00980460|25293724|FG003|Overall Study|Ineligible|1|||
13077530|NCT00980460|25293725|FG004|Overall Study|Ineligible|4|||
13077531|NCT00980460|25293721|FG000|Overall Study|Refusal of further therapy|0|||
13077532|NCT00980460|25293722|FG001|Overall Study|Refusal of further therapy|2|||
13077533|NCT00980460|25293723|FG002|Overall Study|Refusal of further therapy|3|||
13077534|NCT00980460|25293724|FG003|Overall Study|Refusal of further therapy|2|||
13077535|NCT00980460|25293725|FG004|Overall Study|Refusal of further therapy|0|||
13077536|NCT00980460|25293721|FG000|Overall Study|No therapy within 42 days of resection|0|||
13077537|NCT00980460|25293722|FG001|Overall Study|No therapy within 42 days of resection|0|||
13077538|NCT00980460|25293723|FG002|Overall Study|No therapy within 42 days of resection|3|||
13077539|NCT00980460|25293724|FG003|Overall Study|No therapy within 42 days of resection|1|||
13077540|NCT00980460|25293725|FG004|Overall Study|No therapy within 42 days of resection|0|||
13077541|NCT00980460|25293721|FG000|Overall Study|No transplant by protocol timepoints|0|||
13077542|NCT00980460|25293722|FG001|Overall Study|No transplant by protocol timepoints|0|||
13077543|NCT00980460|25293723|FG002|Overall Study|No transplant by protocol timepoints|3|||
13077544|NCT00980460|25293724|FG003|Overall Study|No transplant by protocol timepoints|0|||
13077545|NCT00980460|25293725|FG004|Overall Study|No transplant by protocol timepoints|0|||
13077546|NCT00602641|25293744|FG000|Overall Study|Never started protocol therapy|6|||
13077547|NCT00602641|25293745|FG001|Overall Study|Never started protocol therapy|2|||
13077548|NCT00602641|25293744|FG000|Overall Study|Still on treatment at time of analysis|8|||
13077549|NCT00602641|25293745|FG001|Overall Study|Still on treatment at time of analysis|15|||
13077550|NCT00602641|25293744|FG000|Overall Study|Adverse Event|62|||
13077551|NCT00602641|25293745|FG001|Overall Study|Adverse Event|53|||
13077552|NCT00602641|25293744|FG000|Overall Study|Disease progression|38|||
13077553|NCT00602641|25293745|FG001|Overall Study|Disease progression|55|||
13077554|NCT00602641|25293744|FG000|Overall Study|Death|6|||
13077555|NCT00602641|25293745|FG001|Overall Study|Death|5|||
13077556|NCT00602641|25293744|FG000|Overall Study|Withdrawal by Subject|15|||
13077557|NCT00602641|25293745|FG001|Overall Study|Withdrawal by Subject|12|||
13077558|NCT00602641|25293744|FG000|Overall Study|Alternative therapy|5|||
13077559|NCT00602641|25293745|FG001|Overall Study|Alternative therapy|2|||
13077560|NCT00602641|25293744|FG000|Overall Study|Other Complicating Disease|5|||
13077561|NCT00602641|25293745|FG001|Overall Study|Other Complicating Disease|2|||
13077562|NCT00602641|25293744|FG000|Overall Study|Physician Decision|5|||
13077563|NCT00602641|25293745|FG001|Overall Study|Physician Decision|4|||
13077564|NCT00602641|25293744|FG000|Overall Study|Administrative Closure|1|||
13077565|NCT00602641|25293745|FG001|Overall Study|Administrative Closure|1|||
13077566|NCT00602641|25293744|FG000|Overall Study|Other|3|||
13077567|NCT00602641|25293745|FG001|Overall Study|Other|1|||
13077588|NCT00494234|25293793|FG000|Overall Study|Lack of Efficacy|12|||
13077589|NCT00494234|25293794|FG001|Overall Study|Lack of Efficacy|9|||
13077590|NCT00494234|25293793|FG000|Overall Study|Withdrawal by Subject|1|||
13077591|NCT00494234|25293794|FG001|Overall Study|Withdrawal by Subject|0|||
13077592|NCT00494234|25293793|FG000|Overall Study|Death|2|||
13077593|NCT00494234|25293794|FG001|Overall Study|Death|1|||
13077594|NCT00458536|25293800|FG000|Overall Study|Disease progression prior to treatment|7|||
13077595|NCT00458536|25293800|FG000|Overall Study|Unable to make vaccine|3|||
13077596|NCT00458536|25293800|FG000|Overall Study|No measurable disease after surgery|2|||
13077597|NCT00458536|25293800|FG000|Overall Study|Did not have renal cell carcinoma|2|||
13077598|NCT00458536|25293800|FG000|Overall Study|Patient did not have surgery|1|||
13077599|NCT00458536|25293800|FG000|Overall Study|Ineligible due to toxicity|1|||
13077600|NCT00458536|25293800|FG000|Overall Study|Withdrawal by Subject|1|||
13077601|NCT00458536|25293800|FG000|Overall Study|Progressive disease during treatment|2|||
13077602|NCT00389610|25293813|FG000|Overall Study|Disease Progression|0|||
13077603|NCT00389610|25293814|FG001|Overall Study|Disease Progression|19|||
13077604|NCT00389610|25293813|FG000|Overall Study|Death|0|||
13077605|NCT00389610|25293814|FG001|Overall Study|Death|1|||
13077606|NCT00389610|25293813|FG000|Overall Study|Physician Decision|0|||
13077607|NCT00389610|25293814|FG001|Overall Study|Physician Decision|1|||
13077608|NCT00389610|25293813|FG000|Overall Study|Withdrawal by Subject|0|||
13077609|NCT00389610|25293814|FG001|Overall Study|Withdrawal by Subject|1|||
13131158|NCT02820844|25977776|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2|||
13131159|NCT02820844|25977777|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
13131160|NCT02820844|25977778|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
13131161|NCT02820844|25977773|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
13131162|NCT02820844|25977774|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
13131163|NCT02820844|25977775|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
13131164|NCT02820844|25977776|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
13131165|NCT02820844|25977777|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2|||
13131166|NCT02820844|25977778|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
13131167|NCT02820844|25977773|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
13131168|NCT02820844|25977774|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
13131169|NCT02820844|25977775|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
13131170|NCT02820844|25977776|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
13131171|NCT02820844|25977777|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
13131172|NCT02820844|25977778|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1|||
13131173|NCT02820597|25977788|FG000|Overall Study|Lost to Follow-up|12|||
13131174|NCT02820298|25977809|FG000|Overall Study|Withdrawal by Subject|0|||
13131175|NCT02820298|25977810|FG001|Overall Study|Withdrawal by Subject|1|||
13131176|NCT02820298|25977809|FG000|Overall Study|Physician Decision|1|||
13131177|NCT02820298|25977810|FG001|Overall Study|Physician Decision|0|||
13131178|NCT02820298|25977809|FG000|Overall Study|Protocol Violation|0|||
13131179|NCT02820298|25977810|FG001|Overall Study|Protocol Violation|1|||
13131180|NCT02820038|25977925|FG000|Overall Study|Lost to Follow-up|7|||
13131181|NCT02820038|25977926|FG001|Overall Study|Lost to Follow-up|11|||
13131182|NCT02820038|25977927|FG002|Overall Study|Lost to Follow-up|2|||
13131183|NCT02820038|25977928|FG003|Overall Study|Lost to Follow-up|9|||
13131184|NCT02820038|25977925|FG000|Overall Study|Withdrawal by Subject|3|||
13131185|NCT02820038|25977926|FG001|Overall Study|Withdrawal by Subject|14|||
13131186|NCT02820038|25977927|FG002|Overall Study|Withdrawal by Subject|3|||
13131187|NCT02820038|25977928|FG003|Overall Study|Withdrawal by Subject|13|||
13131188|NCT02819804|25977934|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1|||
13131189|NCT02819726|25978055|FG000|Part A (All Participants)|Lost to Follow-up|0|||
13131190|NCT02819726|25978056|FG001|Part A (All Participants)|Lost to Follow-up|1|||
13131191|NCT02819726|25978057|FG002|Part A (All Participants)|Lost to Follow-up|0|||
13131192|NCT02819726|25978058|FG003|Part A (All Participants)|Lost to Follow-up|0|||
13131193|NCT02819726|25978055|FG000|Part A (All Participants)|Withdrawal by Subject|3|||
13131194|NCT02819726|25978056|FG001|Part A (All Participants)|Withdrawal by Subject|5|||
13131195|NCT02819726|25978057|FG002|Part A (All Participants)|Withdrawal by Subject|6|||
13131196|NCT02819726|25978058|FG003|Part A (All Participants)|Withdrawal by Subject|0|||
13131197|NCT02819726|25978055|FG000|Part A (All Participants)|Protocol non-compliance|3|||
13131198|NCT02819726|25978056|FG001|Part A (All Participants)|Protocol non-compliance|4|||
13131199|NCT02819726|25978057|FG002|Part A (All Participants)|Protocol non-compliance|5|||
13131200|NCT02819726|25978058|FG003|Part A (All Participants)|Protocol non-compliance|0|||
13131201|NCT02819726|25978055|FG000|Part B (All Participants)|Lost to Follow-up|1|||
13131202|NCT02819726|25978056|FG001|Part B (All Participants)|Lost to Follow-up|1|||
13077610|NCT02971137|25295235|FG000|Overall Study|Lost to Follow-up|44|||
13077611|NCT02971137|25295236|FG001|Overall Study|Lost to Follow-up|56|||
13077612|NCT04088500|25297539|FG000|Overall Study|Reason unknown|1|||
13077613|NCT04088500|25297539|FG000|Overall Study|Participant withdrew consent|1|||
13077614|NCT04088500|25297539|FG000|Overall Study|Disease progression|3|||
13077615|NCT02643303|25298223|FG000|Overall Study|Progressive Disease|4|||
13077616|NCT02643303|25298224|FG001|Overall Study|Progressive Disease|4|||
13077617|NCT02643303|25298225|FG002|Overall Study|Progressive Disease|1|||
13077618|NCT02643303|25298226|FG003|Overall Study|Progressive Disease|12|||
13077619|NCT02643303|25298227|FG004|Overall Study|Progressive Disease|6|||
13077620|NCT02643303|25298228|FG005|Overall Study|Progressive Disease|4|||
13077621|NCT02643303|25298229|FG006|Overall Study|Progressive Disease|8|||
13077622|NCT02643303|25298230|FG007|Overall Study|Progressive Disease|2|||
13077623|NCT02643303|25298231|FG008|Overall Study|Progressive Disease|6|||
13077624|NCT02643303|25298223|FG000|Overall Study|Adverse Event|0|||
13077625|NCT02643303|25298224|FG001|Overall Study|Adverse Event|1|||
13077626|NCT02643303|25298225|FG002|Overall Study|Adverse Event|0|||
13077627|NCT02643303|25298226|FG003|Overall Study|Adverse Event|0|||
13077628|NCT02643303|25298227|FG004|Overall Study|Adverse Event|1|||
13077629|NCT02643303|25298228|FG005|Overall Study|Adverse Event|0|||
13077630|NCT02643303|25298229|FG006|Overall Study|Adverse Event|0|||
13077631|NCT02643303|25298230|FG007|Overall Study|Adverse Event|0|||
13077632|NCT02643303|25298231|FG008|Overall Study|Adverse Event|0|||
13077633|NCT02643303|25298223|FG000|Overall Study|Withdrawal by Subject|0|||
13077634|NCT02643303|25298224|FG001|Overall Study|Withdrawal by Subject|0|||
13077635|NCT02643303|25298225|FG002|Overall Study|Withdrawal by Subject|0|||
13077636|NCT02643303|25298226|FG003|Overall Study|Withdrawal by Subject|1|||
13077637|NCT02643303|25298227|FG004|Overall Study|Withdrawal by Subject|0|||
13077638|NCT02643303|25298228|FG005|Overall Study|Withdrawal by Subject|0|||
13077639|NCT02643303|25298229|FG006|Overall Study|Withdrawal by Subject|1|||
13077640|NCT02643303|25298230|FG007|Overall Study|Withdrawal by Subject|1|||
13077641|NCT02643303|25298231|FG008|Overall Study|Withdrawal by Subject|1|||
13077642|NCT02703272|25298515|FG000|Overall Study|Death|4|||
13077643|NCT02703272|25298516|FG001|Overall Study|Death|9|||
13077644|NCT02703272|25298517|FG002|Overall Study|Death|19|||
13077645|NCT02703272|25298518|FG003|Overall Study|Death|10|||
13077646|NCT02703272|25298515|FG000|Overall Study|Withdrawal by Subject|0|||
13077647|NCT02703272|25298516|FG001|Overall Study|Withdrawal by Subject|0|||
13077648|NCT02703272|25298517|FG002|Overall Study|Withdrawal by Subject|4|||
13077649|NCT02703272|25298518|FG003|Overall Study|Withdrawal by Subject|2|||
13077650|NCT02703272|25298515|FG000|Overall Study|Study Terminated by Sponsor|6|||
13077651|NCT02703272|25298516|FG001|Overall Study|Study Terminated by Sponsor|1|||
13077652|NCT02703272|25298517|FG002|Overall Study|Study Terminated by Sponsor|12|||
13077653|NCT02703272|25298518|FG003|Overall Study|Study Terminated by Sponsor|4|||
13077654|NCT02703272|25298515|FG000|Overall Study|Other|1|||
13077655|NCT02703272|25298516|FG001|Overall Study|Other|0|||
13077656|NCT02703272|25298517|FG002|Overall Study|Other|0|||
13077657|NCT02703272|25298518|FG003|Overall Study|Other|0|||
13077658|NCT02605993|25298624|FG000|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
13077659|NCT02605993|25298625|FG001|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
13077660|NCT02605993|25298626|FG002|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|1|||
13077661|NCT02605993|25298627|FG003|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
13077662|NCT04327271|25299244|FG000|Overall Study|Death|1|||
13077663|NCT04327271|25299245|FG001|Overall Study|Death|0|||
13077664|NCT04327271|25299244|FG000|Overall Study|Withdrawal by Subject|1|||
13077665|NCT04327271|25299245|FG001|Overall Study|Withdrawal by Subject|0|||
13077666|NCT04327271|25299244|FG000|Overall Study|randomization error (data capture)|4|||
13077667|NCT04327271|25299245|FG001|Overall Study|randomization error (data capture)|3|||
13077668|NCT04799158|25300423|FG000|Run-In Period|Adverse Event|6|||
13077669|NCT04799158|25300424|FG001|Run-In Period|Adverse Event|0|||
13077670|NCT04799158|25300425|FG002|Run-In Period|Adverse Event|0|||
13077671|NCT04799158|25300426|FG003|Run-In Period|Adverse Event|0|||
13077672|NCT04799158|25300427|FG004|Run-In Period|Adverse Event|0|||
13077673|NCT04799158|25300423|FG000|Run-In Period|Lost to Follow-up|4|||
13077674|NCT04799158|25300424|FG001|Run-In Period|Lost to Follow-up|0|||
13077675|NCT04799158|25300425|FG002|Run-In Period|Lost to Follow-up|0|||
13077676|NCT04799158|25300426|FG003|Run-In Period|Lost to Follow-up|0|||
13077677|NCT04799158|25300427|FG004|Run-In Period|Lost to Follow-up|0|||
13077678|NCT04799158|25300423|FG000|Run-In Period|Significant Protocol Deviation|1|||
13077679|NCT04799158|25300424|FG001|Run-In Period|Significant Protocol Deviation|0|||
13077680|NCT04799158|25300425|FG002|Run-In Period|Significant Protocol Deviation|0|||
13077681|NCT04799158|25300426|FG003|Run-In Period|Significant Protocol Deviation|0|||
13077682|NCT04799158|25300427|FG004|Run-In Period|Significant Protocol Deviation|0|||
13077683|NCT04799158|25300423|FG000|Run-In Period|Withdrawal by Subject|11|||
13077684|NCT04799158|25300424|FG001|Run-In Period|Withdrawal by Subject|0|||
13077685|NCT04799158|25300425|FG002|Run-In Period|Withdrawal by Subject|0|||
13077686|NCT04799158|25300426|FG003|Run-In Period|Withdrawal by Subject|0|||
13077687|NCT04799158|25300427|FG004|Run-In Period|Withdrawal by Subject|0|||
13077688|NCT04799158|25300423|FG000|Run-In Period|Miscellaneous|3|||
13077689|NCT04799158|25300424|FG001|Run-In Period|Miscellaneous|0|||
13077690|NCT04799158|25300425|FG002|Run-In Period|Miscellaneous|0|||
13077691|NCT04799158|25300426|FG003|Run-In Period|Miscellaneous|0|||
13077692|NCT04799158|25300427|FG004|Run-In Period|Miscellaneous|0|||
13077693|NCT04799158|25300423|FG000|Run-In Period|Did not meet On-Demand Eligibility Criteria|226|||
13077694|NCT04799158|25300424|FG001|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
13077695|NCT04799158|25300425|FG002|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
13077696|NCT04799158|25300426|FG003|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
13077697|NCT04799158|25300427|FG004|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
13077698|NCT04799158|25300423|FG000|On-Demand Treatment Period|Adverse Event|0|||
13077699|NCT04799158|25300424|FG001|On-Demand Treatment Period|Adverse Event|1|||
13077700|NCT04799158|25300425|FG002|On-Demand Treatment Period|Adverse Event|0|||
13077701|NCT04799158|25300426|FG003|On-Demand Treatment Period|Adverse Event|0|||
13077702|NCT04799158|25300427|FG004|On-Demand Treatment Period|Adverse Event|1|||
13077703|NCT04799158|25300423|FG000|On-Demand Treatment Period|Lost to Follow-up|0|||
13077704|NCT04799158|25300424|FG001|On-Demand Treatment Period|Lost to Follow-up|0|||
13077705|NCT04799158|25300425|FG002|On-Demand Treatment Period|Lost to Follow-up|0|||
13077706|NCT04799158|25300426|FG003|On-Demand Treatment Period|Lost to Follow-up|0|||
13077707|NCT04799158|25300427|FG004|On-Demand Treatment Period|Lost to Follow-up|1|||
13077708|NCT04799158|25300423|FG000|On-Demand Treatment Period|Significant Protocol Deviation|0|||
13077709|NCT04799158|25300424|FG001|On-Demand Treatment Period|Significant Protocol Deviation|0|||
13077710|NCT04799158|25300425|FG002|On-Demand Treatment Period|Significant Protocol Deviation|0|||
13077711|NCT04799158|25300426|FG003|On-Demand Treatment Period|Significant Protocol Deviation|1|||
13077712|NCT04799158|25300427|FG004|On-Demand Treatment Period|Significant Protocol Deviation|0|||
13077713|NCT04799158|25300423|FG000|On-Demand Treatment Period|Withdrawal by Subject|0|||
13077714|NCT04799158|25300424|FG001|On-Demand Treatment Period|Withdrawal by Subject|0|||
13077715|NCT04799158|25300425|FG002|On-Demand Treatment Period|Withdrawal by Subject|0|||
13077716|NCT04799158|25300426|FG003|On-Demand Treatment Period|Withdrawal by Subject|1|||
13077717|NCT04799158|25300427|FG004|On-Demand Treatment Period|Withdrawal by Subject|0|||
13077718|NCT04799158|25300423|FG000|On-Demand Treatment Period|Lack of Efficacy|0|||
13077719|NCT04799158|25300424|FG001|On-Demand Treatment Period|Lack of Efficacy|0|||
13077720|NCT04799158|25300425|FG002|On-Demand Treatment Period|Lack of Efficacy|0|||
13077721|NCT04799158|25300426|FG003|On-Demand Treatment Period|Lack of Efficacy|0|||
13077722|NCT04799158|25300427|FG004|On-Demand Treatment Period|Lack of Efficacy|1|||
13077723|NCT04799158|25300423|FG000|On-Demand Treatment Period|Miscellaneous|0|||
13077724|NCT04799158|25300424|FG001|On-Demand Treatment Period|Miscellaneous|0|||
13077725|NCT04799158|25300425|FG002|On-Demand Treatment Period|Miscellaneous|0|||
13077726|NCT04799158|25300426|FG003|On-Demand Treatment Period|Miscellaneous|0|||
13077727|NCT04799158|25300427|FG004|On-Demand Treatment Period|Miscellaneous|1|||
13131203|NCT02819726|25978057|FG002|Part B (All Participants)|Lost to Follow-up|2|||
13131204|NCT02819726|25978058|FG003|Part B (All Participants)|Lost to Follow-up|2|||
13131205|NCT02819726|25978055|FG000|Part B (All Participants)|Withdrawal by Subject|2|||
13131206|NCT02819726|25978056|FG001|Part B (All Participants)|Withdrawal by Subject|1|||
13131207|NCT02819726|25978057|FG002|Part B (All Participants)|Withdrawal by Subject|1|||
13131208|NCT02819726|25978058|FG003|Part B (All Participants)|Withdrawal by Subject|0|||
13131209|NCT02819726|25978055|FG000|Part B (All Participants)|Protocol non-compliance|0|||
13131210|NCT02819726|25978056|FG001|Part B (All Participants)|Protocol non-compliance|0|||
13222372|NCT01807221|26286043|FG003|Overall Study|Lost to Follow-up|1|||
13222373|NCT01807221|26286044|FG004|Overall Study|Lost to Follow-up|0|||
13222374|NCT01807221|26286045|FG005|Overall Study|Lost to Follow-up|0|||
13222375|NCT01807182|26286054|FG000|Overall Study|Death|1|||
13222376|NCT01807182|26286054|FG000|Overall Study|New therapy|1|||
13222377|NCT01807182|26286054|FG000|Overall Study|Moved to hospice care|1|||
13222378|NCT01807156|26286061|FG000|Overall Study|Physician Decision|1|||
13131211|NCT02819726|25978057|FG002|Part B (All Participants)|Protocol non-compliance|1|||
13131212|NCT02819726|25978058|FG003|Part B (All Participants)|Protocol non-compliance|0|||
13131213|NCT02819518|25978134|FG000|Overall Study|Death|9|||
13131214|NCT02819518|25978135|FG001|Overall Study|Death|11|||
13131215|NCT02819518|25978136|FG002|Overall Study|Death|9|||
13131216|NCT02819518|25978137|FG003|Overall Study|Death|447|||
13131217|NCT02819518|25978138|FG004|Overall Study|Death|233|||
13131218|NCT02819518|25978134|FG000|Overall Study|Withdrawal by Subject|0|||
13131219|NCT02819518|25978135|FG001|Overall Study|Withdrawal by Subject|0|||
13131220|NCT02819518|25978136|FG002|Overall Study|Withdrawal by Subject|0|||
13131221|NCT02819518|25978137|FG003|Overall Study|Withdrawal by Subject|21|||
13131222|NCT02819518|25978138|FG004|Overall Study|Withdrawal by Subject|6|||
13131223|NCT02819518|25978134|FG000|Overall Study|Ongoing in Study|2|||
13222379|NCT01807117|26286080|FG000|Overall Study|Physician Decision|2|||
13222380|NCT01807117|26286080|FG000|Overall Study|Disease diagnosis not a study disease|1|||
13222381|NCT01807065|26286095|FG000|Overall Study|Receive no sip-T due to IV access|1|||
13077728|NCT04651218|25300458|FG000|Overall Study|Withdrawal by Subject|0|||
13077729|NCT04651218|25300459|FG001|Overall Study|Withdrawal by Subject|2|||
13077730|NCT04516746|25300526|FG000|Overall Study|Ongoing in the study at clinical DCO for the primary analysis.|21090|||
13077731|NCT04516746|25300527|FG001|Overall Study|Ongoing in the study at clinical DCO for the primary analysis.|10305|||
13077732|NCT04516746|25300526|FG000|Overall Study|Withdrawal by Subject|362|||
13077733|NCT04516746|25300527|FG001|Overall Study|Withdrawal by Subject|408|||
13077734|NCT04516746|25300526|FG000|Overall Study|Lost to Follow-up|157|||
13077735|NCT04516746|25300527|FG001|Overall Study|Lost to Follow-up|86|||
13077736|NCT04516746|25300526|FG000|Overall Study|Protocol deviation|18|||
13077737|NCT04516746|25300527|FG001|Overall Study|Protocol deviation|7|||
13077738|NCT04516746|25300526|FG000|Overall Study|Death|8|||
13077739|NCT04516746|25300527|FG001|Overall Study|Death|7|||
13077740|NCT04516746|25300526|FG000|Overall Study|Physician Decision|0|||
13077741|NCT04516746|25300527|FG001|Overall Study|Physician Decision|2|||
13077742|NCT04516746|25300526|FG000|Overall Study|Other|0|||
13077743|NCT04516746|25300527|FG001|Overall Study|Other|1|||
13077744|NCT04343651|25300564|FG000|Overall Study|Physician Decision|2|||
13077745|NCT04343651|25300565|FG001|Overall Study|Physician Decision|1|||
13077746|NCT04343651|25300564|FG000|Overall Study|Lost to Follow-up|2|||
13077747|NCT04343651|25300565|FG001|Overall Study|Lost to Follow-up|1|||
13077748|NCT04343651|25300564|FG000|Overall Study|Protocol Violation|4|||
13077749|NCT04343651|25300565|FG001|Overall Study|Protocol Violation|6|||
13077750|NCT04343651|25300564|FG000|Overall Study|Missing|3|||
13077751|NCT04343651|25300565|FG001|Overall Study|Missing|9|||
13077752|NCT04343651|25300564|FG000|Overall Study|Withdrawal by Subject|0|||
13077753|NCT04343651|25300565|FG001|Overall Study|Withdrawal by Subject|4|||
13077754|NCT04343651|25300564|FG000|Overall Study|Death|0|||
13077755|NCT04343651|25300565|FG001|Overall Study|Death|1|||
13077756|NCT04343651|25300564|FG000|Overall Study|Did not start treatment|1|||
13077757|NCT04343651|25300565|FG001|Overall Study|Did not start treatment|1|||
13077758|NCT04343651|25300564|FG000|Overall Study|Patient did not complete visits 3-6|0|||
13077759|NCT04343651|25300565|FG001|Overall Study|Patient did not complete visits 3-6|1|||
13077760|NCT04185220|25300589|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0|||
13077761|NCT04185220|25300590|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1|||
13077762|NCT04185220|25300589|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0|||
13077763|NCT04185220|25300590|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1|||
13077767|NCT03913130|25300644|FG000|Overall Study|Sponsor Decision|1|||
13077768|NCT03658304|25300672|FG000|Overall Study|participants still on follow up|8|||
13077769|NCT03575325|25300689|FG000|Overall Study|Death|1|||
13077770|NCT03488472|25300713|FG000|Overall Study|disease progression additional mets|1|||
13077771|NCT03370276|25300737|FG000|Overall Study|Death|0|||
13077772|NCT03370276|25300738|FG001|Overall Study|Death|2|||
13077773|NCT03370276|25300739|FG002|Overall Study|Death|5|||
13077774|NCT03316950|25300802|FG000|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|1|||
13077775|NCT03316950|25300803|FG001|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|2|||
13077776|NCT03316950|25300804|FG002|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|3|||
13077777|NCT03316950|25300805|FG003|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|0|||
13077778|NCT03316950|25300802|FG000|Initial Intervention (1 to 3 Months)|Physician Decision|2|||
13077779|NCT03316950|25300803|FG001|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
13077780|NCT03316950|25300804|FG002|Initial Intervention (1 to 3 Months)|Physician Decision|1|||
13077781|NCT03316950|25300805|FG003|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
13077782|NCT03316950|25300802|FG000|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
13077783|NCT03316950|25300803|FG001|Initial Intervention (1 to 3 Months)|Lost to Follow-up|2|||
13077784|NCT03316950|25300804|FG002|Initial Intervention (1 to 3 Months)|Lost to Follow-up|5|||
13077785|NCT03316950|25300805|FG003|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
13077786|NCT02964273|25300872|FG000|Phase A: Double-blind Period (12 Months)|Adverse Events|1|||
13077787|NCT02964273|25300873|FG001|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
13077788|NCT02964273|25300874|FG002|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
13077789|NCT02964273|25300875|FG003|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
13077790|NCT02964273|25300872|FG000|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
13077791|NCT02964273|25300873|FG001|Phase A: Double-blind Period (12 Months)|Physician Decision|2|||
13077792|NCT02964273|25300874|FG002|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
13077793|NCT02964273|25300875|FG003|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
13077794|NCT02964273|25300872|FG000|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|3|||
13077795|NCT02964273|25300873|FG001|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|1|||
13077796|NCT02964273|25300874|FG002|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
13077797|NCT02964273|25300875|FG003|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
13077798|NCT02964273|25300872|FG000|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
13077799|NCT02964273|25300873|FG001|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
13077800|NCT02964273|25300874|FG002|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
13077801|NCT02964273|25300875|FG003|Phase B: Open-label Period (24 Months)|Adverse Events|2|||
13077802|NCT02964273|25300872|FG000|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
13077803|NCT02964273|25300873|FG001|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
13077804|NCT02964273|25300874|FG002|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|4|||
13077805|NCT02964273|25300875|FG003|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|3|||
13077806|NCT02964273|25300872|FG000|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
13077807|NCT02964273|25300873|FG001|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
13077808|NCT02964273|25300874|FG002|Phase B: Open-label Period (24 Months)|Reason Not Specified|2|||
13077809|NCT02964273|25300875|FG003|Phase B: Open-label Period (24 Months)|Reason Not Specified|1|||
13077810|NCT02908672|25300914|FG000|Overall Study|Death|112|||
13077811|NCT02908672|25300915|FG001|Overall Study|Death|93|||
13077812|NCT02908672|25300914|FG000|Overall Study|Lost to Follow-up|3|||
13077813|NCT02908672|25300915|FG001|Overall Study|Lost to Follow-up|3|||
13077814|NCT02908672|25300914|FG000|Overall Study|Other|2|||
13077815|NCT02908672|25300915|FG001|Overall Study|Other|0|||
13077816|NCT02908672|25300914|FG000|Overall Study|Protocol Violation|1|||
13077817|NCT02908672|25300915|FG001|Overall Study|Protocol Violation|1|||
13077818|NCT02908672|25300914|FG000|Overall Study|Withdrawal by Subject|13|||
13077819|NCT02908672|25300915|FG001|Overall Study|Withdrawal by Subject|18|||
13077820|NCT02908672|25300914|FG000|Overall Study|Study is ongoing|124|||
13077821|NCT02908672|25300915|FG001|Overall Study|Study is ongoing|141|||
13077822|NCT02908672|25300914|FG000|Overall Study|Discontinued the study during run-in|3|||
13077823|NCT02908672|25300915|FG001|Overall Study|Discontinued the study during run-in|0|||
13077844|NCT02755103|25300997|FG000|Overall Study|Lost to Follow-up|17|||
13077845|NCT02755103|25300998|FG001|Overall Study|Lost to Follow-up|15|||
13077846|NCT02755103|25300997|FG000|Overall Study|Death|0|||
13077847|NCT02755103|25300998|FG001|Overall Study|Death|1|||
13077848|NCT02755103|25300997|FG000|Overall Study|Physician Decision|0|||
13077849|NCT02755103|25300998|FG001|Overall Study|Physician Decision|1|||
13077850|NCT02755103|25300997|FG000|Overall Study|Pregnancy|0|||
13077851|NCT02755103|25300998|FG001|Overall Study|Pregnancy|1|||
13077852|NCT02755103|25300997|FG000|Overall Study|Withdrawal by Subject|3|||
13077853|NCT02755103|25300998|FG001|Overall Study|Withdrawal by Subject|0|||
13077859|NCT02636725|25301019|FG000|Baseline|Adverse Event|1|||
13077860|NCT02636725|25301019|FG000|Baseline|Lack of Efficacy|2|||
13131224|NCT02819518|25978135|FG001|Overall Study|Ongoing in Study|3|||
13131225|NCT02819518|25978136|FG002|Overall Study|Ongoing in Study|1|||
13131226|NCT02819518|25978137|FG003|Overall Study|Ongoing in Study|98|||
13131227|NCT02819518|25978138|FG004|Overall Study|Ongoing in Study|42|||
13131228|NCT02819440|25978167|FG000|Overall Study|Adverse Event|3|||
13131229|NCT02819440|25978168|FG001|Overall Study|Adverse Event|1|||
13131230|NCT02819440|25978167|FG000|Overall Study|Lost to Follow-up|1|||
13131231|NCT02819440|25978168|FG001|Overall Study|Lost to Follow-up|3|||
13131232|NCT02819440|25978167|FG000|Overall Study|Withdrawal by Subject|9|||
13131233|NCT02819440|25978168|FG001|Overall Study|Withdrawal by Subject|8|||
13131234|NCT02819310|25978174|FG000|Overall Study|Withdrawal by Subject|37|||
13131235|NCT02819310|25978174|FG000|Overall Study|Lost to Follow-up|16|||
13131236|NCT02819310|25978174|FG000|Overall Study|Adverse Event|13|||
13077861|NCT02576574|25301107|FG000|Overall Study|still ongoing|65|||
13077862|NCT02576574|25301108|FG001|Overall Study|still ongoing|66|||
13077863|NCT02576574|25301109|FG002|Overall Study|still ongoing|73|||
13077864|NCT02576574|25301107|FG000|Overall Study|Randomized, not treated|5|||
13077865|NCT02576574|25301108|FG001|Overall Study|Randomized, not treated|4|||
13077866|NCT02576574|25301109|FG002|Overall Study|Randomized, not treated|26|||
13077867|NCT02484443|25301120|FG000|Overall Study|Lack of Efficacy|28|||
13077868|NCT02484443|25301120|FG000|Overall Study|Physician Decision|2|||
13077869|NCT02484443|25301120|FG000|Overall Study|Ineligible|2|||
13077870|NCT02454517|25301143|FG000|Overall Study|Withdrawal by Subject|3|||
13077871|NCT02454517|25301144|FG001|Overall Study|Withdrawal by Subject|0|||
13077872|NCT02454517|25301143|FG000|Overall Study|Lost to Follow-up|4|||
13077873|NCT02454517|25301144|FG001|Overall Study|Lost to Follow-up|7|||
13077874|NCT02454517|25301143|FG000|Overall Study|Discontinued Active surveillance and underwent treatment|1|||
13077875|NCT02454517|25301144|FG001|Overall Study|Discontinued Active surveillance and underwent treatment|2|||
13077876|NCT02446600|25301176|FG000|Overall Study|Never treated|20|||
13077877|NCT02446600|25301177|FG001|Overall Study|Never treated|2|||
13077878|NCT02446600|25301178|FG002|Overall Study|Never treated|6|||
13077879|NCT02446600|25301179|FG003|Overall Study|Never treated|0|||
13077880|NCT02446600|25301176|FG000|Overall Study|Withdrawal by Subject|19|||
13077881|NCT02446600|25301177|FG001|Overall Study|Withdrawal by Subject|5|||
13077882|NCT02446600|25301178|FG002|Overall Study|Withdrawal by Subject|17|||
13077883|NCT02446600|25301179|FG003|Overall Study|Withdrawal by Subject|0|||
13077884|NCT02446600|25301176|FG000|Overall Study|Ineligible|1|||
13077885|NCT02446600|25301177|FG001|Overall Study|Ineligible|4|||
13077886|NCT02446600|25301178|FG002|Overall Study|Ineligible|4|||
13077887|NCT02446600|25301179|FG003|Overall Study|Ineligible|1|||
13077888|NCT02446600|25301176|FG000|Overall Study|Duplicate Enrollment|0|||
13077889|NCT02446600|25301177|FG001|Overall Study|Duplicate Enrollment|1|||
13077890|NCT02446600|25301178|FG002|Overall Study|Duplicate Enrollment|0|||
13077891|NCT02446600|25301179|FG003|Overall Study|Duplicate Enrollment|0|||
13077892|NCT02440464|25301219|FG000|Overall Study|Withdrawal by Subject|3|||
13077893|NCT02440464|25301220|FG001|Overall Study|Withdrawal by Subject|2|||
13077894|NCT02425644|25301241|FG000|Overall Study|Lost to Follow-up|2|||
13077895|NCT02425644|25301242|FG001|Overall Study|Lost to Follow-up|3|||
13077896|NCT02425644|25301241|FG000|Overall Study|Withdrawal by Subject|41|||
13077897|NCT02425644|25301242|FG001|Overall Study|Withdrawal by Subject|36|||
13077898|NCT02425644|25301241|FG000|Overall Study|Lack of Efficacy|3|||
13077899|NCT02425644|25301242|FG001|Overall Study|Lack of Efficacy|10|||
13077900|NCT02425644|25301241|FG000|Overall Study|Adverse Event|13|||
13077901|NCT02425644|25301242|FG001|Overall Study|Adverse Event|3|||
13077902|NCT02425644|25301241|FG000|Overall Study|Death|0|||
13077903|NCT02425644|25301242|FG001|Overall Study|Death|2|||
13077904|NCT02425644|25301241|FG000|Overall Study|Other|18|||
13077905|NCT02425644|25301242|FG001|Overall Study|Other|17|||
13077906|NCT02393859|25301272|FG000|Overall Study|Decision by Sponsor|1|||
13077907|NCT02393859|25301273|FG001|Overall Study|Decision by Sponsor|1|||
13077908|NCT02393859|25301272|FG000|Overall Study|Withdrawal by Subject|5|||
13077909|NCT02393859|25301273|FG001|Overall Study|Withdrawal by Subject|2|||
13077910|NCT02393859|25301272|FG000|Overall Study|Death|16|||
13077911|NCT02393859|25301273|FG001|Overall Study|Death|8|||
13077912|NCT02393859|25301272|FG000|Overall Study|Continuing Study|32|||
13077913|NCT02393859|25301273|FG001|Overall Study|Continuing Study|43|||
13077924|NCT02186834|25301309|FG000|Dose Escalation|Death|0|||
13077925|NCT02186834|25301310|FG001|Dose Escalation|Death|0|||
13077926|NCT02186834|25301311|FG002|Dose Escalation|Death|0|||
13077927|NCT02186834|25301312|FG003|Dose Escalation|Death|1|||
13077928|NCT02186834|25301313|FG004|Dose Escalation|Death|0|||
13077929|NCT02186834|25301314|FG005|Dose Escalation|Death|0|||
13077930|NCT02186834|25301309|FG000|Treatment at RP2D|Died prior to treatment|0|||
13077931|NCT02186834|25301310|FG001|Treatment at RP2D|Died prior to treatment|0|||
13077932|NCT02186834|25301311|FG002|Treatment at RP2D|Died prior to treatment|0|||
13077933|NCT02186834|25301312|FG003|Treatment at RP2D|Died prior to treatment|0|||
13077934|NCT02186834|25301313|FG004|Treatment at RP2D|Died prior to treatment|0|||
13077935|NCT02186834|25301314|FG005|Treatment at RP2D|Died prior to treatment|1|||
13077992|NCT02065869|25301378|FG000|Overall Study|Death|7|||
13077993|NCT02065869|25301378|FG000|Overall Study|Disease relapse|16|||
13077994|NCT02065869|25301378|FG000|Overall Study|Lost to Follow-up|4|||
13077995|NCT02065869|25301378|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
13077996|NCT02065869|25301378|FG000|Overall Study|Withdrawal by Subject|1|||
13077997|NCT02063724|25301386|FG000|Overall Study|Disease progression|1|||
13077998|NCT01979536|25301405|FG000|Overall Study|Physician Decision|2|||
13077999|NCT01979536|25301406|FG001|Overall Study|Physician Decision|3|||
13078000|NCT01979536|25301405|FG000|Overall Study|Withdrawal by Subject|0|||
13078001|NCT01979536|25301406|FG001|Overall Study|Withdrawal by Subject|1|||
13078002|NCT01979536|25301405|FG000|Overall Study|Refusal|0|||
13078003|NCT01979536|25301406|FG001|Overall Study|Refusal|1|||
13078004|NCT01979536|25301405|FG000|Overall Study|Relapse|0|||
13078005|NCT01979536|25301406|FG001|Overall Study|Relapse|1|||
13078006|NCT01979536|25301405|FG000|Overall Study|Study terminated by Sponsor|0|||
13078007|NCT01979536|25301406|FG001|Overall Study|Study terminated by Sponsor|1|||
13078008|NCT01979536|25301405|FG000|Overall Study|Did not start treatment|0|||
13078009|NCT01979536|25301406|FG001|Overall Study|Did not start treatment|1|||
13078013|NCT01856192|25301470|FG000|Overall Study|Adverse Event|12|||
13078014|NCT01856192|25301471|FG001|Overall Study|Adverse Event|4|||
13393342|NCT00665925|26783413|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
13078015|NCT01856192|25301470|FG000|Overall Study|Alternative therapy|0|||
13078016|NCT01856192|25301471|FG001|Overall Study|Alternative therapy|3|||
13078017|NCT01856192|25301470|FG000|Overall Study|Death|3|||
13078018|NCT01856192|25301471|FG001|Overall Study|Death|5|||
13078019|NCT01856192|25301470|FG000|Overall Study|Lack of Efficacy|0|||
13078020|NCT01856192|25301471|FG001|Overall Study|Lack of Efficacy|5|||
13078021|NCT01856192|25301470|FG000|Overall Study|Withdrawal by Subject|1|||
13078022|NCT01856192|25301471|FG001|Overall Study|Withdrawal by Subject|1|||
13078023|NCT01856192|25301470|FG000|Overall Study|Other diseases|1|||
13078024|NCT01856192|25301471|FG001|Overall Study|Other diseases|0|||
13078025|NCT01856192|25301470|FG000|Overall Study|Never started treatment|7|||
13078026|NCT01856192|25301471|FG001|Overall Study|Never started treatment|5|||
13078027|NCT01856192|25301470|FG000|Overall Study|Path ineligible|20|||
13078028|NCT01856192|25301471|FG001|Overall Study|Path ineligible|34|||
13078029|NCT01856192|25301470|FG000|Overall Study|Non-path ineligible|2|||
13078030|NCT01856192|25301471|FG001|Overall Study|Non-path ineligible|2|||
13078031|NCT01856192|25301470|FG000|Overall Study|Physician Decision|1|||
13078032|NCT01856192|25301471|FG001|Overall Study|Physician Decision|1|||
13078033|NCT01856192|25301470|FG000|Overall Study|Suspicion of progressive disease|1|||
13078034|NCT01856192|25301471|FG001|Overall Study|Suspicion of progressive disease|0|||
13078035|NCT01856192|25301470|FG000|Overall Study|Non-compliance|1|||
13078036|NCT01856192|25301471|FG001|Overall Study|Non-compliance|0|||
13078037|NCT01339910|25301553|FG000|Overall Study|Withdrawal by Subject|1|||
13078038|NCT01339910|25301554|FG001|Overall Study|Withdrawal by Subject|0|||
13078039|NCT01339910|25301553|FG000|Overall Study|Physician Decision|1|||
13078040|NCT01339910|25301554|FG001|Overall Study|Physician Decision|0|||
13078041|NCT01339910|25301553|FG000|Overall Study|Disease relapse|1|||
13078042|NCT01339910|25301554|FG001|Overall Study|Disease relapse|4|||
13078043|NCT01247324|25301592|FG000|Overall Study|Death|1|||
13078044|NCT01247324|25301593|FG001|Overall Study|Death|0|||
13078045|NCT01247324|25301592|FG000|Overall Study|Physician Decision|0|||
13078046|NCT01247324|25301593|FG001|Overall Study|Physician Decision|1|||
13078047|NCT01247324|25301592|FG000|Overall Study|Non-compliance with study drug|3|||
13078048|NCT01247324|25301593|FG001|Overall Study|Non-compliance with study drug|0|||
13078049|NCT01247324|25301592|FG000|Overall Study|Lack of Efficacy|12|||
13078050|NCT01247324|25301593|FG001|Overall Study|Lack of Efficacy|8|||
13078051|NCT01247324|25301592|FG000|Overall Study|Non-compliance|2|||
13078052|NCT01247324|25301593|FG001|Overall Study|Non-compliance|0|||
13078053|NCT01247324|25301592|FG000|Overall Study|Pregnancy|2|||
13078054|NCT01247324|25301593|FG001|Overall Study|Pregnancy|3|||
13078055|NCT01247324|25301592|FG000|Overall Study|Protocol Violation|1|||
13078056|NCT01247324|25301593|FG001|Overall Study|Protocol Violation|2|||
13078057|NCT01247324|25301592|FG000|Overall Study|Reason not specified|11|||
13078058|NCT01247324|25301593|FG001|Overall Study|Reason not specified|8|||
13078059|NCT01247324|25301592|FG000|Overall Study|Consent withdrawn by participant|13|||
13078060|NCT01247324|25301593|FG001|Overall Study|Consent withdrawn by participant|8|||
13078061|NCT01247324|25301592|FG000|Overall Study|Adverse Event|25|||
13078062|NCT01247324|25301593|FG001|Overall Study|Adverse Event|13|||
13078063|NCT01247324|25301592|FG000|Overall Study|Lost to Follow-up|1|||
13078064|NCT01247324|25301593|FG001|Overall Study|Lost to Follow-up|1|||
13078065|NCT01147653|25301692|FG000|Year 2|Withdrawal by Subject|2|||
13078066|NCT01147653|25301693|FG001|Year 2|Withdrawal by Subject|3|||
13078067|NCT01141712|25301714|FG000|Overall Study|Disease progression|3|||
13078068|NCT01002742|25301755|FG000|Overall Study|Determined to be ineligible|0|||
13078069|NCT01002742|25301756|FG001|Overall Study|Determined to be ineligible|1|||
13078070|NCT00849147|25301773|FG000|Overall Study|Withdrawal by Subject|1|||
13078071|NCT00849147|25301773|FG000|Overall Study|Protocol Violation|2|||
13078072|NCT00849147|25301773|FG000|Overall Study|Disease Relapse/Progression|2|||
13078073|NCT00770809|25301791|FG000|Overall Study|Adverse Event|9|||
13078074|NCT00770809|25301792|FG001|Overall Study|Adverse Event|1|||
13078075|NCT00770809|25301793|FG002|Overall Study|Adverse Event|12|||
13078076|NCT00770809|25301791|FG000|Overall Study|Death|1|||
13078077|NCT00770809|25301792|FG001|Overall Study|Death|0|||
13078078|NCT00770809|25301793|FG002|Overall Study|Death|0|||
13078079|NCT00770809|25301791|FG000|Overall Study|Withdrawal by Subject|3|||
13078080|NCT00770809|25301792|FG001|Overall Study|Withdrawal by Subject|3|||
13078081|NCT00770809|25301793|FG002|Overall Study|Withdrawal by Subject|7|||
13078082|NCT00770809|25301791|FG000|Overall Study|Progression|2|||
13078083|NCT00770809|25301792|FG001|Overall Study|Progression|2|||
13078084|NCT00770809|25301793|FG002|Overall Study|Progression|0|||
13078085|NCT00770809|25301791|FG000|Overall Study|Complicating illness|0|||
13078086|NCT00770809|25301792|FG001|Overall Study|Complicating illness|0|||
13078087|NCT00770809|25301793|FG002|Overall Study|Complicating illness|1|||
13078088|NCT00770809|25301791|FG000|Overall Study|Other Medical Reasons|2|||
13078089|NCT00770809|25301792|FG001|Overall Study|Other Medical Reasons|4|||
13078090|NCT00770809|25301793|FG002|Overall Study|Other Medical Reasons|3|||
13131237|NCT02819310|25978174|FG000|Overall Study|Lack of Efficacy|5|||
13131238|NCT02819310|25978174|FG000|Overall Study|Physician Decision|8|||
13131239|NCT02819310|25978174|FG000|Overall Study|Protocol Violation|30|||
13131240|NCT02819297|25978187|FG000|Overall Study|Withdrawal by Subject|25|||
13131241|NCT02819297|25978188|FG001|Overall Study|Withdrawal by Subject|13|||
13131242|NCT02819297|25978187|FG000|Overall Study|Lost to Follow-up|12|||
13131243|NCT02819297|25978188|FG001|Overall Study|Lost to Follow-up|14|||
13131244|NCT02819297|25978187|FG000|Overall Study|Adverse Event|12|||
13078161|NCT00408005|25301954|FG000|Induction|Adverse Event|19|||
13078162|NCT00408005|25301955|FG001|Induction|Adverse Event|3|||
13078163|NCT00408005|25301956|FG002|Induction|Adverse Event|0|||
13078164|NCT00408005|25301957|FG003|Induction|Adverse Event|0|||
13078165|NCT00408005|25301958|FG004|Induction|Adverse Event|0|||
13078166|NCT00408005|25301959|FG005|Induction|Adverse Event|0|||
13078167|NCT00408005|25301960|FG006|Induction|Adverse Event|0|||
13078168|NCT00408005|25301961|FG007|Induction|Adverse Event|0|||
13078169|NCT00408005|25301954|FG000|Induction|Death|6|||
13078170|NCT00408005|25301955|FG001|Induction|Death|0|||
13078171|NCT00408005|25301956|FG002|Induction|Death|0|||
13078172|NCT00408005|25301957|FG003|Induction|Death|0|||
13078173|NCT00408005|25301958|FG004|Induction|Death|0|||
13078174|NCT00408005|25301959|FG005|Induction|Death|0|||
13078175|NCT00408005|25301960|FG006|Induction|Death|0|||
13078176|NCT00408005|25301961|FG007|Induction|Death|0|||
13078177|NCT00408005|25301954|FG000|Induction|Physician Decision|83|||
13078178|NCT00408005|25301955|FG001|Induction|Physician Decision|9|||
13078179|NCT00408005|25301956|FG002|Induction|Physician Decision|0|||
13078180|NCT00408005|25301957|FG003|Induction|Physician Decision|0|||
13222382|NCT01807065|26286096|FG001|Overall Study|Receive no sip-T due to IV access|1|||
13222383|NCT01806961|26286102|FG000|Overall Study|sponsor decision|16|||
13222384|NCT01806896|26286137|FG000|Overall Study|Adverse Event|2|||
13222385|NCT01806896|26286138|FG001|Overall Study|Adverse Event|0|||
13222386|NCT01806896|26286137|FG000|Overall Study|Other|1|||
13222387|NCT01806896|26286138|FG001|Overall Study|Other|0|||
13222388|NCT01806779|26286159|FG000|Overall Study|Physician Decision|2|||
13222389|NCT01806779|26286160|FG001|Overall Study|Physician Decision|0|||
13222390|NCT01806779|26286161|FG002|Overall Study|Physician Decision|1|||
13222391|NCT01806779|26286159|FG000|Overall Study|Lack of Efficacy|1|||
13222392|NCT01806779|26286160|FG001|Overall Study|Lack of Efficacy|1|||
13222393|NCT01806779|26286161|FG002|Overall Study|Lack of Efficacy|0|||
13222394|NCT01806779|26286159|FG000|Overall Study|Lost to Follow-up|19|||
13222395|NCT01806779|26286160|FG001|Overall Study|Lost to Follow-up|20|||
13222396|NCT01806779|26286161|FG002|Overall Study|Lost to Follow-up|0|||
13222397|NCT01806779|26286159|FG000|Overall Study|Withdrawal by Subject|20|||
13222398|NCT01806779|26286160|FG001|Overall Study|Withdrawal by Subject|23|||
13078181|NCT00408005|25301958|FG004|Induction|Physician Decision|0|||
13078182|NCT00408005|25301959|FG005|Induction|Physician Decision|0|||
13078183|NCT00408005|25301960|FG006|Induction|Physician Decision|0|||
13078184|NCT00408005|25301961|FG007|Induction|Physician Decision|0|||
13078185|NCT00408005|25301954|FG000|Induction|Withdrawal by Subject|2|||
13078186|NCT00408005|25301955|FG001|Induction|Withdrawal by Subject|4|||
13078187|NCT00408005|25301956|FG002|Induction|Withdrawal by Subject|0|||
13078188|NCT00408005|25301957|FG003|Induction|Withdrawal by Subject|0|||
13078189|NCT00408005|25301958|FG004|Induction|Withdrawal by Subject|0|||
13078190|NCT00408005|25301959|FG005|Induction|Withdrawal by Subject|0|||
13078191|NCT00408005|25301960|FG006|Induction|Withdrawal by Subject|0|||
13078192|NCT00408005|25301961|FG007|Induction|Withdrawal by Subject|0|||
13078193|NCT00408005|25301954|FG000|Induction|Ineligible|33|||
13078194|NCT00408005|25301955|FG001|Induction|Ineligible|14|||
13078195|NCT00408005|25301956|FG002|Induction|Ineligible|0|||
13078196|NCT00408005|25301957|FG003|Induction|Ineligible|0|||
13078197|NCT00408005|25301958|FG004|Induction|Ineligible|0|||
13078198|NCT00408005|25301959|FG005|Induction|Ineligible|0|||
13078199|NCT00408005|25301960|FG006|Induction|Ineligible|0|||
13078200|NCT00408005|25301961|FG007|Induction|Ineligible|0|||
13078201|NCT00408005|25301954|FG000|Induction|Refusal of Further Protocol Therapy|225|||
13078202|NCT00408005|25301955|FG001|Induction|Refusal of Further Protocol Therapy|44|||
13078203|NCT00408005|25301956|FG002|Induction|Refusal of Further Protocol Therapy|0|||
13078204|NCT00408005|25301957|FG003|Induction|Refusal of Further Protocol Therapy|0|||
13078205|NCT00408005|25301958|FG004|Induction|Refusal of Further Protocol Therapy|0|||
13078206|NCT00408005|25301959|FG005|Induction|Refusal of Further Protocol Therapy|0|||
13078207|NCT00408005|25301960|FG006|Induction|Refusal of Further Protocol Therapy|0|||
13078208|NCT00408005|25301961|FG007|Induction|Refusal of Further Protocol Therapy|0|||
13078209|NCT00408005|25301954|FG000|Induction|Entered another COG therapeutic protocol|4|||
13078210|NCT00408005|25301955|FG001|Induction|Entered another COG therapeutic protocol|0|||
13078211|NCT00408005|25301956|FG002|Induction|Entered another COG therapeutic protocol|0|||
13078212|NCT00408005|25301957|FG003|Induction|Entered another COG therapeutic protocol|0|||
13078213|NCT00408005|25301958|FG004|Induction|Entered another COG therapeutic protocol|0|||
13078214|NCT00408005|25301959|FG005|Induction|Entered another COG therapeutic protocol|0|||
13078215|NCT00408005|25301960|FG006|Induction|Entered another COG therapeutic protocol|0|||
13078216|NCT00408005|25301961|FG007|Induction|Entered another COG therapeutic protocol|0|||
13078217|NCT00408005|25301954|FG000|Induction|Patient transferred Tx to Non-COG Site|3|||
13078218|NCT00408005|25301955|FG001|Induction|Patient transferred Tx to Non-COG Site|2|||
13078219|NCT00408005|25301956|FG002|Induction|Patient transferred Tx to Non-COG Site|0|||
13078220|NCT00408005|25301957|FG003|Induction|Patient transferred Tx to Non-COG Site|0|||
13078221|NCT00408005|25301958|FG004|Induction|Patient transferred Tx to Non-COG Site|0|||
13078222|NCT00408005|25301959|FG005|Induction|Patient transferred Tx to Non-COG Site|0|||
13078223|NCT00408005|25301960|FG006|Induction|Patient transferred Tx to Non-COG Site|0|||
13078224|NCT00408005|25301961|FG007|Induction|Patient transferred Tx to Non-COG Site|0|||
13222399|NCT01806779|26286161|FG002|Overall Study|Withdrawal by Subject|22|||
13222400|NCT01806740|26286172|FG000|Overall Study|Withdrawal by Subject|4|||
13222401|NCT01806740|26286172|FG000|Overall Study|Physician Decision|1|||
13222402|NCT01806740|26286172|FG000|Overall Study|Patient's refusal of treatment|1|||
13222403|NCT01806714|26286189|FG000|Overall Study|No functioning phone number|200|||
13078225|NCT00408005|25301954|FG000|Induction|Identified as Philadelphia Chr. Positive|6|||
13078226|NCT00408005|25301955|FG001|Induction|Identified as Philadelphia Chr. Positive|0|||
13078227|NCT00408005|25301956|FG002|Induction|Identified as Philadelphia Chr. Positive|0|||
13078228|NCT00408005|25301957|FG003|Induction|Identified as Philadelphia Chr. Positive|0|||
13078229|NCT00408005|25301958|FG004|Induction|Identified as Philadelphia Chr. Positive|0|||
13078230|NCT00408005|25301959|FG005|Induction|Identified as Philadelphia Chr. Positive|0|||
13078231|NCT00408005|25301960|FG006|Induction|Identified as Philadelphia Chr. Positive|0|||
13078232|NCT00408005|25301961|FG007|Induction|Identified as Philadelphia Chr. Positive|0|||
13078233|NCT00408005|25301954|FG000|Induction|Progressive Disease|0|||
13078234|NCT00408005|25301955|FG001|Induction|Progressive Disease|1|||
13078235|NCT00408005|25301956|FG002|Induction|Progressive Disease|0|||
13078236|NCT00408005|25301957|FG003|Induction|Progressive Disease|0|||
13078237|NCT00408005|25301958|FG004|Induction|Progressive Disease|0|||
13078238|NCT00408005|25301959|FG005|Induction|Progressive Disease|0|||
13078239|NCT00408005|25301960|FG006|Induction|Progressive Disease|0|||
13078240|NCT00408005|25301961|FG007|Induction|Progressive Disease|0|||
13078241|NCT00408005|25301954|FG000|Induction|Inevaluable|18|||
13078242|NCT00408005|25301955|FG001|Induction|Inevaluable|14|||
13078243|NCT00408005|25301956|FG002|Induction|Inevaluable|0|||
13078244|NCT00408005|25301957|FG003|Induction|Inevaluable|0|||
13078245|NCT00408005|25301958|FG004|Induction|Inevaluable|0|||
13078246|NCT00408005|25301959|FG005|Induction|Inevaluable|0|||
13078247|NCT00408005|25301960|FG006|Induction|Inevaluable|0|||
13078248|NCT00408005|25301961|FG007|Induction|Inevaluable|0|||
13078249|NCT00408005|25301954|FG000|Induction|Failed to Complete Randomization|3|||
13078250|NCT00408005|25301955|FG001|Induction|Failed to Complete Randomization|2|||
13078251|NCT00408005|25301956|FG002|Induction|Failed to Complete Randomization|0|||
13078252|NCT00408005|25301957|FG003|Induction|Failed to Complete Randomization|0|||
13078253|NCT00408005|25301958|FG004|Induction|Failed to Complete Randomization|0|||
13078254|NCT00408005|25301959|FG005|Induction|Failed to Complete Randomization|0|||
13078255|NCT00408005|25301960|FG006|Induction|Failed to Complete Randomization|0|||
13078256|NCT00408005|25301961|FG007|Induction|Failed to Complete Randomization|0|||
13078257|NCT00408005|25301954|FG000|Induction|Protocol Deviation|3|||
13078258|NCT00408005|25301955|FG001|Induction|Protocol Deviation|1|||
13078259|NCT00408005|25301956|FG002|Induction|Protocol Deviation|0|||
13078260|NCT00408005|25301957|FG003|Induction|Protocol Deviation|0|||
13078261|NCT00408005|25301958|FG004|Induction|Protocol Deviation|0|||
13078262|NCT00408005|25301959|FG005|Induction|Protocol Deviation|0|||
13078263|NCT00408005|25301960|FG006|Induction|Protocol Deviation|0|||
13078264|NCT00408005|25301961|FG007|Induction|Protocol Deviation|0|||
13078265|NCT00408005|25301954|FG000|Induction|Hematopoietic Stem Cell Transplantation|1|||
13078266|NCT00408005|25301955|FG001|Induction|Hematopoietic Stem Cell Transplantation|0|||
13078267|NCT00408005|25301956|FG002|Induction|Hematopoietic Stem Cell Transplantation|0|||
13078268|NCT00408005|25301957|FG003|Induction|Hematopoietic Stem Cell Transplantation|0|||
13078269|NCT00408005|25301958|FG004|Induction|Hematopoietic Stem Cell Transplantation|0|||
13078270|NCT00408005|25301959|FG005|Induction|Hematopoietic Stem Cell Transplantation|0|||
13078271|NCT00408005|25301960|FG006|Induction|Hematopoietic Stem Cell Transplantation|0|||
13078272|NCT00408005|25301961|FG007|Induction|Hematopoietic Stem Cell Transplantation|0|||
13078273|NCT00408005|25301954|FG000|Induction|Recurrent leukemia|1|||
13078274|NCT00408005|25301955|FG001|Induction|Recurrent leukemia|0|||
13078275|NCT00408005|25301956|FG002|Induction|Recurrent leukemia|0|||
13078276|NCT00408005|25301957|FG003|Induction|Recurrent leukemia|0|||
13078277|NCT00408005|25301958|FG004|Induction|Recurrent leukemia|0|||
13078278|NCT00408005|25301959|FG005|Induction|Recurrent leukemia|0|||
13078279|NCT00408005|25301960|FG006|Induction|Recurrent leukemia|0|||
13078280|NCT00408005|25301961|FG007|Induction|Recurrent leukemia|0|||
13078281|NCT00408005|25301954|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
13078282|NCT00408005|25301955|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
13078283|NCT00408005|25301956|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7|||
13078284|NCT00408005|25301957|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4|||
13078285|NCT00408005|25301958|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8|||
13078286|NCT00408005|25301959|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12|||
13078287|NCT00408005|25301960|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
13078288|NCT00408005|25301961|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
13078289|NCT00408005|25301954|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
13078290|NCT00408005|25301955|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
13078291|NCT00408005|25301956|FG002|Post Induction Therapy by Tx Assignment|Death|3|||
13078292|NCT00408005|25301957|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
13078293|NCT00408005|25301958|FG004|Post Induction Therapy by Tx Assignment|Death|5|||
13078294|NCT00408005|25301959|FG005|Post Induction Therapy by Tx Assignment|Death|5|||
13078295|NCT00408005|25301960|FG006|Post Induction Therapy by Tx Assignment|Death|3|||
13078296|NCT00408005|25301961|FG007|Post Induction Therapy by Tx Assignment|Death|1|||
13078297|NCT00408005|25301954|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
13078298|NCT00408005|25301955|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
13078299|NCT00408005|25301956|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2|||
13078300|NCT00408005|25301957|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
13078301|NCT00408005|25301958|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1|||
13078302|NCT00408005|25301959|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
13078303|NCT00408005|25301960|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
13078304|NCT00408005|25301961|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
13078305|NCT00408005|25301954|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
13078306|NCT00408005|25301955|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
13078307|NCT00408005|25301956|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24|||
13078308|NCT00408005|25301957|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19|||
13078309|NCT00408005|25301958|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27|||
13078310|NCT00408005|25301959|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45|||
13078311|NCT00408005|25301960|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10|||
13078312|NCT00408005|25301961|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4|||
13078313|NCT00408005|25301954|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
13078314|NCT00408005|25301955|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
13078315|NCT00408005|25301956|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
13078316|NCT00408005|25301957|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
13078317|NCT00408005|25301958|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
13078318|NCT00408005|25301959|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2|||
13078319|NCT00408005|25301960|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
13078320|NCT00408005|25301961|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
13078321|NCT00408005|25301954|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
13078322|NCT00408005|25301955|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
13078323|NCT00408005|25301956|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27|||
13078324|NCT00408005|25301957|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10|||
13078325|NCT00408005|25301958|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36|||
13078326|NCT00408005|25301959|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16|||
13078327|NCT00408005|25301960|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4|||
13078328|NCT00408005|25301961|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2|||
13078329|NCT00408005|25301954|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
13078330|NCT00408005|25301955|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
13078331|NCT00408005|25301956|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
13078332|NCT00408005|25301957|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
13078333|NCT00408005|25301958|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1|||
13078334|NCT00408005|25301959|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
13078335|NCT00408005|25301960|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
13078336|NCT00408005|25301961|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
13078337|NCT00408005|25301954|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
13078338|NCT00408005|25301955|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
13078339|NCT00408005|25301956|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3|||
13078340|NCT00408005|25301957|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
13078341|NCT00408005|25301958|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
13078342|NCT00408005|25301959|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
13078343|NCT00408005|25301960|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
13078344|NCT00408005|25301961|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
13078345|NCT00408005|25301954|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
13078346|NCT00408005|25301955|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
13078347|NCT00408005|25301956|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
13078348|NCT00408005|25301957|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
13078349|NCT00408005|25301958|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1|||
13078350|NCT00408005|25301959|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
13078351|NCT00408005|25301960|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
13078352|NCT00408005|25301961|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
13078353|NCT00408005|25301954|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
13078354|NCT00408005|25301955|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
13078355|NCT00408005|25301956|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
13078356|NCT00408005|25301957|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
13078357|NCT00408005|25301958|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
13078358|NCT00408005|25301959|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1|||
13078359|NCT00408005|25301960|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
13078360|NCT00408005|25301961|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
13078361|NCT00408005|25301954|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
13078362|NCT00408005|25301955|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
13078363|NCT00408005|25301956|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
13078364|NCT00408005|25301957|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
13078365|NCT00408005|25301958|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
13078366|NCT00408005|25301959|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
13078367|NCT00408005|25301960|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
13078368|NCT00408005|25301961|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
13078369|NCT00408005|25301954|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
13078370|NCT00408005|25301955|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
13078371|NCT00408005|25301956|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
13078372|NCT00408005|25301957|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
13078373|NCT00408005|25301958|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1|||
13078374|NCT00408005|25301959|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2|||
13078375|NCT00408005|25301960|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
13078376|NCT00408005|25301961|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
13078377|NCT00408005|25301954|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
13078378|NCT00408005|25301955|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
13078379|NCT00408005|25301956|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13|||
13078380|NCT00408005|25301957|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7|||
13078381|NCT00408005|25301958|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49|||
13078382|NCT00408005|25301959|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15|||
13078383|NCT00408005|25301960|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1|||
13078384|NCT00408005|25301961|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
13078385|NCT00408005|25301954|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
13078386|NCT00408005|25301955|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
13078387|NCT00408005|25301956|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3|||
13078388|NCT00408005|25301957|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
13078389|NCT00408005|25301958|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
13078390|NCT00408005|25301959|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
13078391|NCT00408005|25301960|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
13078392|NCT00408005|25301961|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
13078393|NCT00406393|25301996|FG000|Overall Study|Did not undergo transplantation|2|||
13078394|NCT00406393|25301997|FG001|Overall Study|Did not undergo transplantation|1|||
13078395|NCT00075816|25302088|FG000|Overall Study|Did not undergo transplantation|14|||
13078396|NCT00075816|25302089|FG001|Overall Study|Did not undergo transplantation|11|||
13078429|NCT00026312|25302187|FG000|Overall Study|Adverse Event|0|||
13078430|NCT00026312|25302188|FG001|Overall Study|Adverse Event|32|||
13078431|NCT00026312|25302187|FG000|Overall Study|Death|1|||
13078432|NCT00026312|25302188|FG001|Overall Study|Death|7|||
13078433|NCT00026312|25302187|FG000|Overall Study|Lack of Efficacy|19|||
13078434|NCT00026312|25302188|FG001|Overall Study|Lack of Efficacy|114|||
13078435|NCT00026312|25302187|FG000|Overall Study|Lost to Follow-up|0|||
13078436|NCT00026312|25302188|FG001|Overall Study|Lost to Follow-up|5|||
13078437|NCT00026312|25302187|FG000|Overall Study|Physician Decision|1|||
13078438|NCT00026312|25302188|FG001|Overall Study|Physician Decision|37|||
13078439|NCT00026312|25302187|FG000|Overall Study|Protocol Violation|0|||
13078440|NCT00026312|25302188|FG001|Overall Study|Protocol Violation|3|||
13078441|NCT00026312|25302187|FG000|Overall Study|Withdrawal by Subject|1|||
13078442|NCT00026312|25302188|FG001|Overall Study|Withdrawal by Subject|6|||
13078443|NCT00026312|25302187|FG000|Overall Study|Ineligible|4|||
13078444|NCT00026312|25302188|FG001|Overall Study|Ineligible|5|||
13078445|NCT00026312|25302187|FG000|Overall Study|Entry onto another COG study|0|||
13078446|NCT00026312|25302188|FG001|Overall Study|Entry onto another COG study|1|||
13078447|NCT00026312|25302187|FG000|Overall Study|Refusal by patient/parent/guardian|8|||
13078448|NCT00026312|25302188|FG001|Overall Study|Refusal by patient/parent/guardian|59|||
13131245|NCT02819297|25978188|FG001|Overall Study|Adverse Event|10|||
13131246|NCT02819297|25978187|FG000|Overall Study|Physician Decision|5|||
13131247|NCT02819297|25978188|FG001|Overall Study|Physician Decision|5|||
13131248|NCT02819297|25978187|FG000|Overall Study|Lack of Efficacy|5|||
13131249|NCT02819297|25978188|FG001|Overall Study|Lack of Efficacy|8|||
13131250|NCT02819297|25978187|FG000|Overall Study|Protocol Violation|1|||
13131251|NCT02819297|25978188|FG001|Overall Study|Protocol Violation|2|||
13131252|NCT02818998|25978224|FG000|Overall Study|Adverse Event|3|||
13131253|NCT02818998|25978225|FG001|Overall Study|Adverse Event|2|||
13131254|NCT02818998|25978226|FG002|Overall Study|Adverse Event|1|||
13131255|NCT02818998|25978224|FG000|Overall Study|Lost to Follow-up|4|||
13131256|NCT02818998|25978225|FG001|Overall Study|Lost to Follow-up|1|||
13131257|NCT02818998|25978226|FG002|Overall Study|Lost to Follow-up|2|||
13131258|NCT02818998|25978224|FG000|Overall Study|Withdrawal by sponsor|0|||
13131259|NCT02818998|25978225|FG001|Overall Study|Withdrawal by sponsor|1|||
13131260|NCT02818998|25978226|FG002|Overall Study|Withdrawal by sponsor|1|||
13131261|NCT02818998|25978224|FG000|Overall Study|Death|3|||
13131262|NCT02818998|25978225|FG001|Overall Study|Death|6|||
13131263|NCT02818998|25978226|FG002|Overall Study|Death|8|||
13131264|NCT02818998|25978224|FG000|Overall Study|Withdrawal by Subject|7|||
13131265|NCT02818998|25978225|FG001|Overall Study|Withdrawal by Subject|6|||
13131266|NCT02818998|25978226|FG002|Overall Study|Withdrawal by Subject|6|||
13131267|NCT02818998|25978224|FG000|Overall Study|Physician Decision|1|||
13131268|NCT02818998|25978225|FG001|Overall Study|Physician Decision|0|||
13131269|NCT02818998|25978226|FG002|Overall Study|Physician Decision|0|||
13131270|NCT02818920|25978232|FG000|Overall Study|Unresectable|4|||
13131271|NCT02818920|25978232|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1|||
13131272|NCT02818920|25978232|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8|||
13131273|NCT02818920|25978232|FG000|Overall Study|Adverse Event|3|||
13131274|NCT02818920|25978232|FG000|Overall Study|Developed Other Disease|1|||
13131275|NCT02818920|25978232|FG000|Overall Study|Refused Further Treatment|1|||
13131276|NCT02818777|25978262|FG000|Overall Study|Adverse Event|3|||
13131277|NCT02818036|25978277|FG000|Overall Study|head did not fit in fMRI scanner headres|1|||
13131278|NCT02818036|25978278|FG001|Overall Study|head did not fit in fMRI scanner headres|0|||
13131279|NCT02818036|25978277|FG000|Overall Study|Withdrawal by Subject|1|||
13131280|NCT02818036|25978278|FG001|Overall Study|Withdrawal by Subject|0|||
13131281|NCT02817906|25978293|FG000|Overall Study|Adverse Event|3|||
13131282|NCT02817906|25978294|FG001|Overall Study|Adverse Event|0|||
13131283|NCT02817906|25978293|FG000|Overall Study|Lack of Efficacy|1|||
13131284|NCT02817906|25978294|FG001|Overall Study|Lack of Efficacy|0|||
13131285|NCT02817906|25978293|FG000|Overall Study|Protocol Violation|1|||
13131286|NCT02817906|25978294|FG001|Overall Study|Protocol Violation|1|||
13131287|NCT02817906|25978293|FG000|Overall Study|Study Terminated by Sponsor|2|||
13131288|NCT02817906|25978294|FG001|Overall Study|Study Terminated by Sponsor|2|||
13131289|NCT02817906|25978293|FG000|Overall Study|Withdrawal by Subject|7|||
13131290|NCT02817906|25978294|FG001|Overall Study|Withdrawal by Subject|0|||
13131291|NCT02817906|25978293|FG000|Overall Study|Other|2|||
13131292|NCT02817906|25978294|FG001|Overall Study|Other|2|||
13131293|NCT02817841|25978323|FG000|Overall Study|Lost to Follow-up|287|||
13131294|NCT02817841|25978323|FG000|Overall Study|Withdrawal by Subject|183|||
13131295|NCT02817841|25978323|FG000|Overall Study|Adverse event not related to bleeding|131|||
13131296|NCT02817841|25978323|FG000|Overall Study|Adverse event related to bleeding|51|||
13078449|NCT02475681|25302851|FG000|Overall Study|Death|16|||
13078450|NCT02475681|25302852|FG001|Overall Study|Death|6|||
13078451|NCT02475681|25302853|FG002|Overall Study|Death|9|||
13078452|NCT02475681|25302851|FG000|Overall Study|Physician Decision|0|||
13078453|NCT02475681|25302852|FG001|Overall Study|Physician Decision|3|||
13078454|NCT02475681|25302853|FG002|Overall Study|Physician Decision|1|||
13078455|NCT02475681|25302851|FG000|Overall Study|Withdrawal by Subject|12|||
13078456|NCT02475681|25302852|FG001|Overall Study|Withdrawal by Subject|6|||
13078457|NCT02475681|25302853|FG002|Overall Study|Withdrawal by Subject|9|||
13078458|NCT02475681|25302851|FG000|Overall Study|Lost to Follow-up|2|||
13078459|NCT02475681|25302852|FG001|Overall Study|Lost to Follow-up|1|||
13078460|NCT02475681|25302853|FG002|Overall Study|Lost to Follow-up|3|||
13078461|NCT02475681|25302851|FG000|Overall Study|Ongoing in Study|0|||
13078462|NCT02475681|25302852|FG001|Overall Study|Ongoing in Study|163|||
13078463|NCT02475681|25302853|FG002|Overall Study|Ongoing in Study|157|||
13078464|NCT02475681|25302851|FG000|Overall Study|Reasons other than above listed|2|||
13078465|NCT02475681|25302852|FG001|Overall Study|Reasons other than above listed|0|||
13078466|NCT02475681|25302853|FG002|Overall Study|Reasons other than above listed|0|||
13078467|NCT02633293|25303154|FG000|Overall Study|Death|56|||
13078468|NCT02633293|25303154|FG000|Overall Study|Progressive Disease|12|||
13078469|NCT02633293|25303154|FG000|Overall Study|Adverse Event|29|||
13078470|NCT02633293|25303154|FG000|Overall Study|Withdrawal by Subject|41|||
13078471|NCT02633293|25303154|FG000|Overall Study|Protocol Violation|1|||
13078472|NCT02633293|25303154|FG000|Overall Study|Lost to Follow-up|1|||
13078473|NCT02633293|25303154|FG000|Overall Study|Study Terminated by Sponsor|24|||
13078474|NCT02633293|25303154|FG000|Overall Study|Withdrawal by Sponsor Prior to Dose Administration|1|||
13078475|NCT02633293|25303154|FG000|Overall Study|Lung Transplant|5|||
13078476|NCT02633293|25303154|FG000|Overall Study|Lack of Efficacy|2|||
13078477|NCT02633293|25303154|FG000|Overall Study|Principal Investigator Terminated Study Site|1|||
13078478|NCT03343301|25303286|FG000|Overall Study|Withdrawal by Subject|1|||
13078479|NCT03343301|25303287|FG001|Overall Study|Withdrawal by Subject|1|||
13078480|NCT03343301|25303286|FG000|Overall Study|Death|0|||
13078481|NCT03343301|25303287|FG001|Overall Study|Death|2|||
13078482|NCT03343301|25303286|FG000|Overall Study|Other|0|||
13078483|NCT03343301|25303287|FG001|Overall Study|Other|6|||
13078484|NCT03343301|25303286|FG000|Overall Study|Missing|2|||
13078485|NCT03343301|25303287|FG001|Overall Study|Missing|0|||
13078486|NCT04248465|25304255|FG000|Randomized-Controlled Period|Death|12|||
13078487|NCT04248465|25304256|FG001|Randomized-Controlled Period|Death|5|||
13078488|NCT04248465|25304255|FG000|Randomized-Controlled Period|Adverse Event|2|||
13078489|NCT04248465|25304256|FG001|Randomized-Controlled Period|Adverse Event|0|||
13078490|NCT04248465|25304255|FG000|Randomized-Controlled Period|Study Terminated by Sponsor|194|||
13078491|NCT04248465|25304256|FG001|Randomized-Controlled Period|Study Terminated by Sponsor|99|||
13078492|NCT04248465|25304255|FG000|Randomized-Controlled Period|Withdrawal by Subject|30|||
13078493|NCT04248465|25304256|FG001|Randomized-Controlled Period|Withdrawal by Subject|17|||
13078494|NCT04248465|25304255|FG000|Randomized-Controlled Period|Physician Decision|1|||
13078495|NCT04248465|25304256|FG001|Randomized-Controlled Period|Physician Decision|1|||
13078496|NCT04248465|25304255|FG000|Randomized-Controlled Period|Lost to Follow-up|1|||
13078497|NCT04248465|25304256|FG001|Randomized-Controlled Period|Lost to Follow-up|0|||
13078498|NCT04248465|25304255|FG000|Open-label Extension Period|Study Terminated by Sponsor|14|||
13078499|NCT04248465|25304256|FG001|Open-label Extension Period|Study Terminated by Sponsor|4|||
13078500|NCT04248465|25304255|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
13078501|NCT04248465|25304256|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
13078502|NCT04545619|25304512|FG000|Overall Study|due to equipment challenges|1|||
13078503|NCT04508621|25304537|FG000|Overall Study|Adverse Event|39|||
13078504|NCT04508621|25304538|FG001|Overall Study|Adverse Event|16|||
13078505|NCT04508621|25304537|FG000|Overall Study|Lack of Efficacy|2|||
13078506|NCT04508621|25304538|FG001|Overall Study|Lack of Efficacy|8|||
13078507|NCT04508621|25304537|FG000|Overall Study|Physician Decision|0|||
13078508|NCT04508621|25304538|FG001|Overall Study|Physician Decision|1|||
13078509|NCT04508621|25304537|FG000|Overall Study|Withdrawal by Subject|10|||
13078510|NCT04508621|25304538|FG001|Overall Study|Withdrawal by Subject|14|||
13078511|NCT04508621|25304537|FG000|Overall Study|Lost to Follow-up|12|||
13078512|NCT04508621|25304538|FG001|Overall Study|Lost to Follow-up|9|||
13078513|NCT04508621|25304537|FG000|Overall Study|COVID-19 related crisis|3|||
13078514|NCT04508621|25304538|FG001|Overall Study|COVID-19 related crisis|0|||
13078515|NCT04508621|25304537|FG000|Overall Study|Subject non-compliance|1|||
13078516|NCT04508621|25304538|FG001|Overall Study|Subject non-compliance|0|||
13078517|NCT04248933|25304669|FG000|Overall Study|Lost to Follow-up|9|||
13078518|NCT04248933|25304669|FG000|Overall Study|Withdrawal by Subject|2|||
13078519|NCT04068688|25304775|FG000|Overall Study|Lost to Follow-up|1|||
13078520|NCT04068688|25304776|FG001|Overall Study|Lost to Follow-up|1|||
13078521|NCT04068688|25304777|FG002|Overall Study|Lost to Follow-up|0|||
13078522|NCT04068688|25304778|FG003|Overall Study|Lost to Follow-up|0|||
13078523|NCT04068688|25304779|FG004|Overall Study|Lost to Follow-up|5|||
13078524|NCT04068688|25304780|FG005|Overall Study|Lost to Follow-up|5|||
13078525|NCT04068688|25304781|FG006|Overall Study|Lost to Follow-up|0|||
13078526|NCT04068688|25304782|FG007|Overall Study|Lost to Follow-up|0|||
13078527|NCT04068688|25304783|FG008|Overall Study|Lost to Follow-up|1|||
13078528|NCT04068688|25304784|FG009|Overall Study|Lost to Follow-up|0|||
13078529|NCT04068688|25304775|FG000|Overall Study|Withdrawal by Subject|1|||
13078530|NCT04068688|25304776|FG001|Overall Study|Withdrawal by Subject|1|||
13078531|NCT04068688|25304777|FG002|Overall Study|Withdrawal by Subject|0|||
13078532|NCT04068688|25304778|FG003|Overall Study|Withdrawal by Subject|0|||
13078533|NCT04068688|25304779|FG004|Overall Study|Withdrawal by Subject|0|||
13078534|NCT04068688|25304780|FG005|Overall Study|Withdrawal by Subject|0|||
13078535|NCT04068688|25304781|FG006|Overall Study|Withdrawal by Subject|0|||
13078536|NCT04068688|25304782|FG007|Overall Study|Withdrawal by Subject|0|||
13078537|NCT04068688|25304783|FG008|Overall Study|Withdrawal by Subject|0|||
13078538|NCT04068688|25304784|FG009|Overall Study|Withdrawal by Subject|0|||
13078539|NCT04068688|25304775|FG000|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
13078540|NCT04068688|25304776|FG001|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
13078541|NCT04068688|25304777|FG002|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
13078542|NCT04068688|25304778|FG003|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
13078543|NCT04068688|25304779|FG004|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
13078544|NCT04068688|25304780|FG005|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
13078545|NCT04068688|25304781|FG006|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
13078546|NCT04068688|25304782|FG007|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
13078547|NCT04068688|25304783|FG008|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
13078548|NCT04068688|25304784|FG009|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
13131297|NCT02817841|25978323|FG000|Overall Study|Pregnancy|32|||
13131298|NCT02817841|25978323|FG000|Overall Study|Pregnancy wish|17|||
13131299|NCT02817841|25978323|FG000|Overall Study|Other reasons|53|||
13131300|NCT02817841|25978323|FG000|Overall Study|Protocol Violation|94|||
13131301|NCT02817828|25978349|FG000|Overall Study|Lost to Follow-up|41|||
13131302|NCT02817828|25978349|FG000|Overall Study|Adverse event not related to bleeding|104|||
13131303|NCT02817828|25978349|FG000|Overall Study|Adverse event related to bleeding|53|||
13131304|NCT02817828|25978349|FG000|Overall Study|Protocol Violation|11|||
13131305|NCT02817828|25978349|FG000|Overall Study|Pregnancy|7|||
13131306|NCT02817828|25978349|FG000|Overall Study|Pregnancy wish|15|||
13131307|NCT02817828|25978349|FG000|Overall Study|Withdrawal by Subject|78|||
13131308|NCT02817828|25978349|FG000|Overall Study|Other|26|||
13131309|NCT02817776|25978361|FG000|Overall Study|Excluded|33|||
13131310|NCT02817776|25978361|FG000|Overall Study|Lost to Follow-up|20|||
13131311|NCT02817776|25978361|FG000|Overall Study|Withdrawal by Subject|33|||
13131312|NCT02817776|25978361|FG000|Overall Study|Death|2|||
13131313|NCT02817594|25978382|FG000|Overall Study|Withdrawal by Subject|1|||
13131314|NCT02817594|25978382|FG000|Overall Study|Other|1|||
13131315|NCT02817594|25978382|FG000|Overall Study|Did Not Receive Treatment|1|||
13131316|NCT02817555|25978405|FG000|Overall Study|Death|1|||
13131317|NCT02817555|25978406|FG001|Overall Study|Death|3|||
13131318|NCT02817555|25978405|FG000|Overall Study|moved away|1|||
13131319|NCT02817555|25978406|FG001|Overall Study|moved away|0|||
13131320|NCT02817555|25978405|FG000|Overall Study|transplant|1|||
13131321|NCT02817555|25978406|FG001|Overall Study|transplant|1|||
13131322|NCT02817555|25978405|FG000|Overall Study|changed to Peritoneal Dialysis|0|||
13131323|NCT02817555|25978406|FG001|Overall Study|changed to Peritoneal Dialysis|1|||
13131324|NCT02817516|25978454|FG000|Overall Study|Other|0|||
13131325|NCT02817516|25978455|FG001|Overall Study|Other|0|||
13131326|NCT02817516|25978456|FG002|Overall Study|Other|1|||
13131327|NCT02817516|25978457|FG003|Overall Study|Other|0|||
13131328|NCT02817087|25978482|FG000|Overall Study|Withdrawal by Subject|2|||
13131329|NCT02817087|25978483|FG001|Overall Study|Withdrawal by Subject|0|||
13131330|NCT02816398|25978492|FG000|Overall Study|Death|5|||
13131331|NCT02816398|25978492|FG000|Overall Study|Lack of Efficacy|8|||
13131332|NCT02816398|25978492|FG000|Overall Study|Lost to Follow-up|1|||
13131333|NCT02816138|25978507|FG000|Overall Study|Adverse Event|1|||
13131334|NCT02815735|25978525|FG000|First Intervention (4 Weeks)|Discomfort|1|||
13131335|NCT02815735|25978526|FG001|First Intervention (4 Weeks)|Discomfort|0|||
13131336|NCT02815735|25978525|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1|||
13131337|NCT02815735|25978526|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
13131338|NCT02815735|25978525|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0|||
13131339|NCT02815735|25978526|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1|||
13131340|NCT02815735|25978525|FG000|Second Intervention (4 Weeks)|Protocol Violation|1|||
13131341|NCT02815735|25978526|FG001|Second Intervention (4 Weeks)|Protocol Violation|0|||
13131342|NCT02815670|25978539|FG000|Overall Study|Prematurely discontinued of the trial|1|||
13131343|NCT02815540|25978547|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2|||
13131344|NCT02815397|25978556|FG000|Overall Study|Physician Decision|2|||
13131345|NCT02815293|25978574|FG000|Overall Study|Study termination by sponsor|10|||
13393343|NCT00665925|26783414|FG003|Overall Study|Severe Non-Compliance to Protocol|1|||
13078549|NCT03591107|25304902|FG000|Overall Study|Same patient in both arms|1|||
13078550|NCT03591107|25304903|FG001|Overall Study|Same patient in both arms|1|||
13078551|NCT03591107|25304902|FG000|Overall Study|Sought care at other clinics|0|||
13078552|NCT03591107|25304903|FG001|Overall Study|Sought care at other clinics|2|||
13078553|NCT03591107|25304902|FG000|Overall Study|Discharged from clinic|0|||
13078554|NCT03591107|25304903|FG001|Overall Study|Discharged from clinic|1|||
13078555|NCT03591107|25304902|FG000|Overall Study|Withdrawal by Subject|0|||
13078556|NCT03591107|25304903|FG001|Overall Study|Withdrawal by Subject|1|||
13078557|NCT03371732|25304964|FG000|Overall Study|Withdrawal by Subject|9|||
13078558|NCT03371732|25304965|FG001|Overall Study|Withdrawal by Subject|3|||
13078559|NCT03371732|25304964|FG000|Overall Study|Refusal to continue|3|||
13078560|NCT03371732|25304965|FG001|Overall Study|Refusal to continue|4|||
13078561|NCT03188666|25305052|FG000|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
13078562|NCT03188666|25305053|FG001|Period 1 (28 Weeks Double-blind)|Adverse Event|1|||
13078563|NCT03188666|25305054|FG002|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
13078564|NCT03188666|25305055|FG003|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
13078565|NCT03188666|25305052|FG000|Period 2 (28 Weeks Open-label)|Death|0|||
13078566|NCT03188666|25305053|FG001|Period 2 (28 Weeks Open-label)|Death|0|||
13078567|NCT03188666|25305054|FG002|Period 2 (28 Weeks Open-label)|Death|0|||
13078568|NCT03188666|25305055|FG003|Period 2 (28 Weeks Open-label)|Death|1|||
13078569|NCT03188666|25305052|FG000|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
13078570|NCT03188666|25305053|FG001|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
13078571|NCT03188666|25305054|FG002|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|2|||
13078572|NCT03188666|25305055|FG003|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
13078573|NCT03188666|25305052|FG000|Period 3 (20 Weeks Follow-up)|Death|0|||
13078574|NCT03188666|25305053|FG001|Period 3 (20 Weeks Follow-up)|Death|0|||
13078575|NCT03188666|25305054|FG002|Period 3 (20 Weeks Follow-up)|Death|1|||
13078576|NCT03188666|25305055|FG003|Period 3 (20 Weeks Follow-up)|Death|2|||
13078577|NCT02922023|25305070|FG000|Overall Study|Lost to Follow-up|2|||
13078578|NCT02922023|25305071|FG001|Overall Study|Lost to Follow-up|0|||
13078579|NCT02768870|25305081|FG000|Overall Study|Not Implanted with Device|2|||
13078580|NCT02768870|25305081|FG000|Overall Study|Death|1|||
13078581|NCT02768870|25305081|FG000|Overall Study|Reoperation|4|||
13078582|NCT02768870|25305081|FG000|Overall Study|On Study|19|||
13078583|NCT02329834|25305146|FG000|Overall Study|Physician Decision|1|||
13078584|NCT02329834|25305147|FG001|Overall Study|Physician Decision|0|||
13078585|NCT01905397|25305178|FG000|Overall Study|Death|0|||
13078586|NCT01905397|25305179|FG001|Overall Study|Death|1|||
13078587|NCT01905397|25305178|FG000|Overall Study|Withdrawal by Subject|2|||
13078588|NCT01905397|25305179|FG001|Overall Study|Withdrawal by Subject|0|||
13078589|NCT01905397|25305178|FG000|Overall Study|Surgery canceled/aborted|9|||
13078590|NCT01905397|25305179|FG001|Overall Study|Surgery canceled/aborted|5|||
13078591|NCT01905397|25305178|FG000|Overall Study|Incision < 7 cm|2|||
13078592|NCT01905397|25305179|FG001|Overall Study|Incision < 7 cm|0|||
13078593|NCT01905397|25305178|FG000|Overall Study|Wrong treatment|1|||
13078594|NCT01905397|25305179|FG001|Overall Study|Wrong treatment|1|||
13078595|NCT01905397|25305178|FG000|Overall Study|Device not applied|3|||
13078596|NCT01905397|25305179|FG001|Overall Study|Device not applied|0|||
13078597|NCT01905397|25305178|FG000|Overall Study|Dressing not applied in operating room|1|||
13078598|NCT01905397|25305179|FG001|Overall Study|Dressing not applied in operating room|0|||
13078599|NCT01905397|25305178|FG000|Overall Study|Wound vac turned off due to device alarm|1|||
13078600|NCT01905397|25305179|FG001|Overall Study|Wound vac turned off due to device alarm|0|||
13078601|NCT01362595|25305186|FG000|Overall Study|Screen failure|10|||
13078602|NCT01362595|25305186|FG000|Overall Study|Withdrawal by Subject|2|||
13078603|NCT01309672|25305196|FG000|Overall Study|Lack of Efficacy|20|||
13078604|NCT01309672|25305196|FG000|Overall Study|Other|9|||
13078605|NCT01309672|25305196|FG000|Overall Study|Adverse Event|5|||
13078606|NCT01309672|25305196|FG000|Overall Study|Withdrawal by Subject|3|||
13078607|NCT00660673|25305233|FG000|Overall Study|Adverse Event|84|||
13078608|NCT00660673|25305233|FG000|Overall Study|Lack of Efficacy|7|||
13078609|NCT00660673|25305233|FG000|Overall Study|Withdrawal by Subject|22|||
13078610|NCT00660673|25305233|FG000|Overall Study|Administrative|2|||
13078611|NCT00660673|25305233|FG000|Overall Study|Protocol Violation|2|||
13078612|NCT00591318|25305252|FG000|Overall Study|Lack of Efficacy|2|||
13078613|NCT00591318|25305253|FG001|Overall Study|Lack of Efficacy|0|||
13078614|NCT00591318|25305252|FG000|Overall Study|Adverse Event|2|||
13078615|NCT00591318|25305253|FG001|Overall Study|Adverse Event|0|||
13078616|NCT00382070|25305276|FG000|Overall Study|No follow up data mapped to Other|17|||
13078617|NCT00382070|25305277|FG001|Overall Study|No follow up data mapped to Other|19|||
13078618|NCT00382070|25305276|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7|||
13078619|NCT00382070|25305277|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0|||
13078620|NCT00382070|25305276|FG000|Overall Study|No clinical assessment|9|||
13078621|NCT00382070|25305277|FG001|Overall Study|No clinical assessment|11|||
13078622|NCT05101252|25306683|FG000|Overall Study|Unsatisfactory Test Article|1|||
13078623|NCT05101252|25306684|FG001|Overall Study|Unsatisfactory Test Article|0|||
13078624|NCT05101252|25306683|FG000|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
13078625|NCT05101252|25306684|FG001|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
13078626|NCT05101252|25306683|FG000|Overall Study|Withdrew Consent during study|0|||
13078627|NCT05101252|25306684|FG001|Overall Study|Withdrew Consent during study|1|||
13078628|NCT05101252|25306683|FG000|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
13078629|NCT05101252|25306684|FG001|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
13131346|NCT02815293|25978575|FG001|Overall Study|Study termination by sponsor|7|||
13131347|NCT02815293|25978576|FG002|Overall Study|Study termination by sponsor|0|||
13131348|NCT02815293|25978574|FG000|Overall Study|Participants not randomized|0|||
13131349|NCT02815293|25978575|FG001|Overall Study|Participants not randomized|0|||
13131350|NCT02815293|25978576|FG002|Overall Study|Participants not randomized|18|||
13131351|NCT02815293|25978574|FG000|Overall Study|Adverse Event|0|||
13131352|NCT02815293|25978575|FG001|Overall Study|Adverse Event|1|||
13131353|NCT02815293|25978576|FG002|Overall Study|Adverse Event|0|||
13131354|NCT02814838|25978615|FG000|Overall Study|3 agreed dates for the final visit missed|1|||
13131355|NCT02814838|25978616|FG001|Overall Study|3 agreed dates for the final visit missed|0|||
13131356|NCT02814838|25978615|FG000|Overall Study|Consent withdrawal|1|||
13131357|NCT02814838|25978616|FG001|Overall Study|Consent withdrawal|1|||
13131358|NCT02814643|25978645|FG000|Overall Study|Lost to Follow-up|0|||
13131359|NCT02814643|25978646|FG001|Overall Study|Lost to Follow-up|1|||
13131360|NCT02814643|25978645|FG000|Overall Study|Withdrawal by Subject|1|||
13131361|NCT02814643|25978646|FG001|Overall Study|Withdrawal by Subject|2|||
13131362|NCT02814565|25978677|FG000|Overall Study|Lack of Efficacy|0|||
13131363|NCT02814565|25978678|FG001|Overall Study|Lack of Efficacy|1|||
13131364|NCT02814565|25978677|FG000|Overall Study|Subject decision, caused by AE Influenza|1|||
13131365|NCT02814565|25978678|FG001|Overall Study|Subject decision, caused by AE Influenza|1|||
13131366|NCT02814175|25978725|FG000|Part 1|Adverse Event|2|||
13131367|NCT02814175|25978726|FG001|Part 1|Adverse Event|3|||
13131368|NCT02814175|25978727|FG002|Part 1|Adverse Event|0|||
13131369|NCT02814175|25978728|FG003|Part 1|Adverse Event|0|||
13131370|NCT02814175|25978729|FG004|Part 1|Adverse Event|0|||
13131371|NCT02814175|25978730|FG005|Part 1|Adverse Event|0|||
13131372|NCT02814175|25978725|FG000|Part 1|Withdrawal Consent|8|||
13131373|NCT02814175|25978726|FG001|Part 1|Withdrawal Consent|1|||
13131374|NCT02814175|25978727|FG002|Part 1|Withdrawal Consent|0|||
13131375|NCT02814175|25978728|FG003|Part 1|Withdrawal Consent|0|||
13131376|NCT02814175|25978729|FG004|Part 1|Withdrawal Consent|0|||
13131377|NCT02814175|25978730|FG005|Part 1|Withdrawal Consent|0|||
13131378|NCT02814175|25978725|FG000|Part 1|Lost to Follow-up|1|||
13131379|NCT02814175|25978726|FG001|Part 1|Lost to Follow-up|0|||
13131380|NCT02814175|25978727|FG002|Part 1|Lost to Follow-up|0|||
13131381|NCT02814175|25978728|FG003|Part 1|Lost to Follow-up|0|||
13131382|NCT02814175|25978729|FG004|Part 1|Lost to Follow-up|0|||
13131383|NCT02814175|25978730|FG005|Part 1|Lost to Follow-up|0|||
13131384|NCT02814175|25978725|FG000|Part 1|Lack of Efficacy|1|||
13131385|NCT02814175|25978726|FG001|Part 1|Lack of Efficacy|2|||
13131386|NCT02814175|25978727|FG002|Part 1|Lack of Efficacy|0|||
13131387|NCT02814175|25978728|FG003|Part 1|Lack of Efficacy|0|||
13131388|NCT02814175|25978729|FG004|Part 1|Lack of Efficacy|0|||
13131389|NCT02814175|25978730|FG005|Part 1|Lack of Efficacy|0|||
13131390|NCT02814175|25978725|FG000|Part 2|Adverse Event|0|||
13131391|NCT02814175|25978726|FG001|Part 2|Adverse Event|0|||
13131392|NCT02814175|25978727|FG002|Part 2|Adverse Event|0|||
13131393|NCT02814175|25978728|FG003|Part 2|Adverse Event|1|||
13131394|NCT02814175|25978729|FG004|Part 2|Adverse Event|1|||
13131395|NCT02814175|25978730|FG005|Part 2|Adverse Event|2|||
13131396|NCT02814175|25978725|FG000|Part 2|Withdrawal Consent|0|||
13131397|NCT02814175|25978726|FG001|Part 2|Withdrawal Consent|0|||
13131398|NCT02814175|25978727|FG002|Part 2|Withdrawal Consent|0|||
13131399|NCT02814175|25978728|FG003|Part 2|Withdrawal Consent|2|||
13131400|NCT02814175|25978729|FG004|Part 2|Withdrawal Consent|1|||
13131401|NCT02814175|25978730|FG005|Part 2|Withdrawal Consent|1|||
13131402|NCT02814175|25978725|FG000|Part 2|Lost to Follow-up|0|||
13131403|NCT02814175|25978726|FG001|Part 2|Lost to Follow-up|0|||
13131404|NCT02814175|25978727|FG002|Part 2|Lost to Follow-up|0|||
13131405|NCT02814175|25978728|FG003|Part 2|Lost to Follow-up|1|||
13131406|NCT02814175|25978729|FG004|Part 2|Lost to Follow-up|0|||
13131407|NCT02814175|25978730|FG005|Part 2|Lost to Follow-up|0|||
13131408|NCT02814175|25978725|FG000|Part 2|Lack of Efficacy|0|||
13131409|NCT02814175|25978726|FG001|Part 2|Lack of Efficacy|0|||
13131410|NCT02814175|25978727|FG002|Part 2|Lack of Efficacy|0|||
13131411|NCT02814175|25978728|FG003|Part 2|Lack of Efficacy|0|||
13131412|NCT02814175|25978729|FG004|Part 2|Lack of Efficacy|0|||
13131413|NCT02814175|25978730|FG005|Part 2|Lack of Efficacy|3|||
13131414|NCT02813694|25978747|FG000|Overall Study|Physician Decision|0|||
13131415|NCT02813694|25978748|FG001|Overall Study|Physician Decision|1|||
13131416|NCT02813694|25978747|FG000|Overall Study|Withdrawal by Subject|10|||
13131417|NCT02813694|25978748|FG001|Overall Study|Withdrawal by Subject|9|||
13131418|NCT02813694|25978747|FG000|Overall Study|Lost to Follow-up|1|||
13131419|NCT02813694|25978748|FG001|Overall Study|Lost to Follow-up|1|||
13131420|NCT02813694|25978747|FG000|Overall Study|Death|3|||
13131421|NCT02813694|25978748|FG001|Overall Study|Death|3|||
13078630|NCT04027608|25306761|FG000|Overall Study|Withdrawal by Subject|13|||
13078631|NCT04027608|25306762|FG001|Overall Study|Withdrawal by Subject|2|||
13078632|NCT04027608|25306761|FG000|Overall Study|Protocol Violation|2|||
13078633|NCT04027608|25306762|FG001|Overall Study|Protocol Violation|1|||
13078634|NCT04027608|25306761|FG000|Overall Study|Physician Decision|1|||
13078635|NCT04027608|25306762|FG001|Overall Study|Physician Decision|0|||
13078636|NCT04027608|25306761|FG000|Overall Study|Lost to Follow-up|20|||
13078637|NCT04027608|25306762|FG001|Overall Study|Lost to Follow-up|4|||
13078638|NCT03769194|25306889|FG000|Overall Study|Withdrawal by Subject|0|||
13078639|NCT03769194|25306890|FG001|Overall Study|Withdrawal by Subject|7|||
13078640|NCT03769194|25306891|FG002|Overall Study|Withdrawal by Subject|4|||
13078641|NCT03769194|25306892|FG003|Overall Study|Withdrawal by Subject|1|||
13078642|NCT03769194|25306889|FG000|Overall Study|moved from study area|0|||
13078643|NCT03769194|25306890|FG001|Overall Study|moved from study area|2|||
13078644|NCT03769194|25306891|FG002|Overall Study|moved from study area|1|||
13078645|NCT03769194|25306892|FG003|Overall Study|moved from study area|1|||
13078646|NCT03769194|25306889|FG000|Overall Study|Lost to Follow-up|3|||
13078647|NCT03769194|25306890|FG001|Overall Study|Lost to Follow-up|6|||
13078648|NCT03769194|25306891|FG002|Overall Study|Lost to Follow-up|3|||
13078649|NCT03769194|25306892|FG003|Overall Study|Lost to Follow-up|6|||
13078650|NCT03769194|25306889|FG000|Overall Study|other|1|||
13078651|NCT03769194|25306890|FG001|Overall Study|other|3|||
13078652|NCT03769194|25306891|FG002|Overall Study|other|0|||
13078653|NCT03769194|25306892|FG003|Overall Study|other|1|||
13078654|NCT03597347|25306962|FG000|Overall Study|Withdrawal by Subject|1|||
13078655|NCT03597347|25306963|FG001|Overall Study|Withdrawal by Subject|1|||
13078656|NCT03597347|25306964|FG002|Overall Study|Withdrawal by Subject|0|||
13078657|NCT03597347|25306962|FG000|Overall Study|Withdrawal due to Covid-19|3|||
13078658|NCT03597347|25306963|FG001|Overall Study|Withdrawal due to Covid-19|0|||
13078659|NCT03597347|25306964|FG002|Overall Study|Withdrawal due to Covid-19|0|||
13078660|NCT03597347|25306962|FG000|Overall Study|Sponsor decision to terminate study|3|||
13078661|NCT03597347|25306963|FG001|Overall Study|Sponsor decision to terminate study|2|||
13078662|NCT03597347|25306964|FG002|Overall Study|Sponsor decision to terminate study|4|||
13078663|NCT03323658|25307014|FG000|Overall Study|Adverse Event|0|||
13078664|NCT03323658|25307015|FG001|Overall Study|Adverse Event|1|||
13078665|NCT03323658|25307016|FG002|Overall Study|Adverse Event|0|||
13078666|NCT03043872|25307148|FG000|Overall Study|Withdrawal by Subject|6|||
13078667|NCT03043872|25307149|FG001|Overall Study|Withdrawal by Subject|6|||
13078668|NCT03043872|25307150|FG002|Overall Study|Withdrawal by Subject|15|||
13078669|NCT03043872|25307148|FG000|Overall Study|Lost to Follow-up|2|||
13078670|NCT03043872|25307149|FG001|Overall Study|Lost to Follow-up|1|||
13078671|NCT03043872|25307150|FG002|Overall Study|Lost to Follow-up|1|||
13078672|NCT03043872|25307148|FG000|Overall Study|Death|270|||
13078673|NCT03043872|25307149|FG001|Overall Study|Death|269|||
13078674|NCT03043872|25307150|FG002|Overall Study|Death|296|||
13078675|NCT03025880|25307198|FG000|Overall Study|Adverse Event|1|||
13078676|NCT03025880|25307199|FG001|Overall Study|Adverse Event|0|||
13078677|NCT03025880|25307198|FG000|Overall Study|Death|1|||
13078678|NCT03025880|25307199|FG001|Overall Study|Death|1|||
13078679|NCT03025880|25307198|FG000|Overall Study|Withdrawal by Subject|0|||
13078680|NCT03025880|25307199|FG001|Overall Study|Withdrawal by Subject|1|||
13078681|NCT03025880|25307198|FG000|Overall Study|Physician Decision|0|||
13078682|NCT03025880|25307199|FG001|Overall Study|Physician Decision|1|||
13078683|NCT03025880|25307198|FG000|Overall Study|Progressive Disease|12|||
13078684|NCT03025880|25307199|FG001|Overall Study|Progressive Disease|19|||
13078685|NCT03016975|25307233|FG000|At 30 Days Follow-up|Subject is a Screen failure|1|||
13078686|NCT03016975|25307234|FG001|At 30 Days Follow-up|Subject is a Screen failure|0|||
13078687|NCT03016975|25307235|FG002|At 30 Days Follow-up|Subject is a Screen failure|0|||
13078688|NCT03016975|25307233|FG000|At 6 Months Follow-up|Death|2|||
13078689|NCT03016975|25307234|FG001|At 6 Months Follow-up|Death|0|||
13078690|NCT03016975|25307235|FG002|At 6 Months Follow-up|Death|0|||
13078691|NCT03016975|25307233|FG000|At 6 Months Follow-up|Subject withdrawn by investigator|1|||
13078692|NCT03016975|25307234|FG001|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
13078693|NCT03016975|25307235|FG002|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
13078694|NCT03016975|25307233|FG000|At 6 Months Follow-up|Re-attempt procedure|1|||
13078695|NCT03016975|25307234|FG001|At 6 Months Follow-up|Re-attempt procedure|0|||
13078696|NCT03016975|25307235|FG002|At 6 Months Follow-up|Re-attempt procedure|0|||
13078697|NCT03016975|25307233|FG000|At 6 Months Follow-up|Aborted implant|1|||
13078698|NCT03016975|25307234|FG001|At 6 Months Follow-up|Aborted implant|0|||
13078699|NCT03016975|25307235|FG002|At 6 Months Follow-up|Aborted implant|0|||
13078700|NCT03016975|25307233|FG000|At 2 Year Follow-up|Death|1|||
13078701|NCT03016975|25307234|FG001|At 2 Year Follow-up|Death|0|||
13078702|NCT03016975|25307235|FG002|At 2 Year Follow-up|Death|0|||
13078703|NCT03016975|25307233|FG000|At 3 Year Follow-up|Death|1|||
13078704|NCT03016975|25307234|FG001|At 3 Year Follow-up|Death|0|||
13078705|NCT03016975|25307235|FG002|At 3 Year Follow-up|Death|0|||
13078706|NCT03016975|25307233|FG000|At 3 Year Follow-up|Withdrawal by Subject|1|||
13078707|NCT03016975|25307234|FG001|At 3 Year Follow-up|Withdrawal by Subject|0|||
13078708|NCT03016975|25307235|FG002|At 3 Year Follow-up|Withdrawal by Subject|0|||
13131422|NCT02813694|25978747|FG000|Overall Study|Randomized- did not receive study drug|2|||
13131423|NCT02813694|25978748|FG001|Overall Study|Randomized- did not receive study drug|0|||
13131424|NCT02813694|25978747|FG000|Overall Study|Patient hospitalized|1|||
13131425|NCT02813694|25978748|FG001|Overall Study|Patient hospitalized|0|||
13131426|NCT02813681|25978779|FG000|Overall Study|Physician Decision|5|||
13131427|NCT02813681|25978780|FG001|Overall Study|Physician Decision|5|||
13131428|NCT02813681|25978781|FG002|Overall Study|Physician Decision|0|||
13131429|NCT02813681|25978779|FG000|Overall Study|Lost to Follow-up|0|||
13131430|NCT02813681|25978780|FG001|Overall Study|Lost to Follow-up|1|||
13131431|NCT02813681|25978781|FG002|Overall Study|Lost to Follow-up|0|||
13131432|NCT02813577|25978799|FG000|Overall Study|Study terminated|4|||
13131433|NCT02813421|25978836|FG000|Overall Study|Withdrawal by Subject|1|||
13131434|NCT02813421|25978837|FG001|Overall Study|Withdrawal by Subject|2|||
13131435|NCT02813421|25978836|FG000|Overall Study|Lost to Follow-up|1|||
13131436|NCT02813421|25978837|FG001|Overall Study|Lost to Follow-up|1|||
13131437|NCT02812186|25978854|FG000|Period 1|Post randomization screen failure|5|||
13131438|NCT02812186|25978855|FG001|Period 1|Post randomization screen failure|9|||
13131439|NCT02812186|25978854|FG000|Period 1|nonevaluable data sets|6|||
13131440|NCT02812186|25978855|FG001|Period 1|nonevaluable data sets|6|||
13131441|NCT02811861|25978873|FG000|Overall Study|Radiological Disease Progression|123|||
13131442|NCT02811861|25978874|FG001|Overall Study|Radiological Disease Progression|97|||
13131443|NCT02811861|25978875|FG002|Overall Study|Radiological Disease Progression|174|||
13131444|NCT02811861|25978873|FG000|Overall Study|Clinical Disease Progression|20|||
13131445|NCT02811861|25978874|FG001|Overall Study|Clinical Disease Progression|19|||
13131446|NCT02811861|25978875|FG002|Overall Study|Clinical Disease Progression|22|||
13131447|NCT02811861|25978873|FG000|Overall Study|Adverse Event|63|||
13131448|NCT02811861|25978874|FG001|Overall Study|Adverse Event|60|||
13131449|NCT02811861|25978875|FG002|Overall Study|Adverse Event|41|||
13131450|NCT02811861|25978873|FG000|Overall Study|Lost to Follow-up|0|||
13131451|NCT02811861|25978874|FG001|Overall Study|Lost to Follow-up|0|||
13131452|NCT02811861|25978875|FG002|Overall Study|Lost to Follow-up|1|||
13131453|NCT02811861|25978873|FG000|Overall Study|Subject Choice|29|||
13131454|NCT02811861|25978874|FG001|Overall Study|Subject Choice|17|||
13131455|NCT02811861|25978875|FG002|Overall Study|Subject Choice|23|||
13131456|NCT02811861|25978873|FG000|Overall Study|Withdrawal by Subject|4|||
13131457|NCT02811861|25978874|FG001|Overall Study|Withdrawal by Subject|4|||
13131458|NCT02811861|25978875|FG002|Overall Study|Withdrawal by Subject|9|||
13131459|NCT02811861|25978873|FG000|Overall Study|Other|4|||
13131460|NCT02811861|25978874|FG001|Overall Study|Other|13|||
13131461|NCT02811861|25978875|FG002|Overall Study|Other|3|||
13131462|NCT02811861|25978873|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112|||
13131463|NCT02811861|25978874|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142|||
13131464|NCT02811861|25978875|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67|||
13131465|NCT02811861|25978873|FG000|Overall Study|Randomized but not treated|2|||
13131466|NCT02811861|25978874|FG001|Overall Study|Randomized but not treated|3|||
13131467|NCT02811861|25978875|FG002|Overall Study|Randomized but not treated|17|||
13131468|NCT02811640|25978881|FG000|Overall Study|Technology malfunction|2|||
13131469|NCT02811159|25978898|FG000|Treatment Course 1|Lost to Follow-up|1|||
13131470|NCT02810964|25978925|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1|||
13131471|NCT02810964|25978926|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2|||
13131472|NCT02810964|25978925|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1|||
13131473|NCT02810964|25978926|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0|||
13131474|NCT02810964|25978925|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0|||
13131475|NCT02810964|25978926|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1|||
13131476|NCT02810964|25978925|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1|||
13131477|NCT02810964|25978926|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0|||
13131478|NCT02810951|25978934|FG000|Overall Study|Adverse Event|1|||
13131479|NCT02810418|25979048|FG000|Arm A Dose Escalation|Adverse Event|2|||
13131480|NCT02810418|25979049|FG001|Arm A Dose Escalation|Adverse Event|1|||
13131481|NCT02810418|25979050|FG002|Arm A Dose Escalation|Adverse Event|0|||
13131482|NCT02810418|25979051|FG003|Arm A Dose Escalation|Adverse Event|0|||
13131483|NCT02810418|25979052|FG004|Arm A Dose Escalation|Adverse Event|0|||
13131484|NCT02810418|25979053|FG005|Arm A Dose Escalation|Adverse Event|0|||
13131485|NCT02810418|25979054|FG006|Arm A Dose Escalation|Adverse Event|0|||
13131486|NCT02810418|25979048|FG000|Dose Expansion|Adverse Event|0|||
13131487|NCT02810418|25979049|FG001|Dose Expansion|Adverse Event|1|||
13131488|NCT02810418|25979050|FG002|Dose Expansion|Adverse Event|1|||
13131489|NCT02810418|25979051|FG003|Dose Expansion|Adverse Event|0|||
13131490|NCT02810418|25979052|FG004|Dose Expansion|Adverse Event|0|||
13131491|NCT02810418|25979053|FG005|Dose Expansion|Adverse Event|0|||
13131492|NCT02810418|25979054|FG006|Dose Expansion|Adverse Event|0|||
13131493|NCT02810418|25979048|FG000|Dose Expansion|Physician Decision|0|||
13131494|NCT02810418|25979049|FG001|Dose Expansion|Physician Decision|0|||
13131495|NCT02810418|25979050|FG002|Dose Expansion|Physician Decision|2|||
13078709|NCT02746809|25307441|FG000|Enrollment|Inclusion Exclusion not met|9|||
13078710|NCT02746809|25307441|FG000|Enrollment|Withdrawal by Subject|1|||
13078711|NCT02746809|25307441|FG000|Enrollment|Study Closed to Enrollment|2|||
13078712|NCT02746809|25307441|FG000|Procedure|Death|1|||
13078713|NCT02746809|25307441|FG000|1-Month|Death|5|||
13078714|NCT02746809|25307441|FG000|6-Month|Death|2|||
13078715|NCT02746809|25307441|FG000|6-Month|Withdrawal by Subject|1|||
13078716|NCT02746809|25307441|FG000|12-Month|Death|3|||
13078717|NCT02746809|25307441|FG000|12-Month|Withdrawal by Subject|2|||
13078718|NCT02746809|25307441|FG000|24-Month|Death|1|||
13078719|NCT02746809|25307441|FG000|24-Month|Withdrawal by Subject|1|||
13078720|NCT02746809|25307441|FG000|36-Month|Death|8|||
13078721|NCT02746809|25307441|FG000|36-Month|Withdrawal by Subject|1|||
13078722|NCT02746809|25307441|FG000|48-Month|Death|7|||
13078723|NCT02746809|25307441|FG000|48-Month|Withdrawal by Subject|1|||
13078724|NCT02746809|25307441|FG000|60-Month|Death|1|||
13078725|NCT02746809|25307441|FG000|60-Month|Lost to Follow-up|2|||
13078726|NCT02733042|25307702|FG000|Treatment Period|Adverse Event|1|||
13078727|NCT02733042|25307703|FG001|Treatment Period|Adverse Event|0|||
13078728|NCT02733042|25307704|FG002|Treatment Period|Adverse Event|1|||
13078729|NCT02733042|25307705|FG003|Treatment Period|Adverse Event|1|||
13078730|NCT02733042|25307706|FG004|Treatment Period|Adverse Event|0|||
13078731|NCT02733042|25307707|FG005|Treatment Period|Adverse Event|0|||
13078732|NCT02733042|25307708|FG006|Treatment Period|Adverse Event|0|||
13078733|NCT02733042|25307709|FG007|Treatment Period|Adverse Event|0|||
13078734|NCT02733042|25307710|FG008|Treatment Period|Adverse Event|0|||
13078735|NCT02733042|25307711|FG009|Treatment Period|Adverse Event|0|||
13078736|NCT02733042|25307712|FG010|Treatment Period|Adverse Event|2|||
13078737|NCT02733042|25307713|FG011|Treatment Period|Adverse Event|2|||
13078738|NCT02733042|25307714|FG012|Treatment Period|Adverse Event|0|||
13078739|NCT02733042|25307715|FG013|Treatment Period|Adverse Event|2|||
13078740|NCT02733042|25307716|FG014|Treatment Period|Adverse Event|0|||
13078741|NCT02733042|25307717|FG015|Treatment Period|Adverse Event|0|||
13078742|NCT02733042|25307718|FG016|Treatment Period|Adverse Event|0|||
13078743|NCT02733042|25307719|FG017|Treatment Period|Adverse Event|1|||
13078744|NCT02733042|25307720|FG018|Treatment Period|Adverse Event|0|||
13078745|NCT02733042|25307702|FG000|Treatment Period|Progressive Disease|2|||
13078746|NCT02733042|25307703|FG001|Treatment Period|Progressive Disease|1|||
13078747|NCT02733042|25307704|FG002|Treatment Period|Progressive Disease|3|||
13078748|NCT02733042|25307705|FG003|Treatment Period|Progressive Disease|1|||
13078749|NCT02733042|25307706|FG004|Treatment Period|Progressive Disease|1|||
13078750|NCT02733042|25307707|FG005|Treatment Period|Progressive Disease|3|||
13078751|NCT02733042|25307708|FG006|Treatment Period|Progressive Disease|0|||
13078752|NCT02733042|25307709|FG007|Treatment Period|Progressive Disease|3|||
13078753|NCT02733042|25307710|FG008|Treatment Period|Progressive Disease|3|||
13078754|NCT02733042|25307711|FG009|Treatment Period|Progressive Disease|0|||
13078755|NCT02733042|25307712|FG010|Treatment Period|Progressive Disease|2|||
13078756|NCT02733042|25307713|FG011|Treatment Period|Progressive Disease|2|||
13078757|NCT02733042|25307714|FG012|Treatment Period|Progressive Disease|8|||
13078758|NCT02733042|25307715|FG013|Treatment Period|Progressive Disease|1|||
13078759|NCT02733042|25307716|FG014|Treatment Period|Progressive Disease|4|||
13078760|NCT02733042|25307717|FG015|Treatment Period|Progressive Disease|7|||
13078761|NCT02733042|25307718|FG016|Treatment Period|Progressive Disease|2|||
13078762|NCT02733042|25307719|FG017|Treatment Period|Progressive Disease|3|||
13078763|NCT02733042|25307720|FG018|Treatment Period|Progressive Disease|4|||
13078764|NCT02733042|25307702|FG000|Treatment Period|Withdrawal by Subject|0|||
13078765|NCT02733042|25307703|FG001|Treatment Period|Withdrawal by Subject|1|||
13078766|NCT02733042|25307704|FG002|Treatment Period|Withdrawal by Subject|2|||
13078767|NCT02733042|25307705|FG003|Treatment Period|Withdrawal by Subject|1|||
13078768|NCT02733042|25307706|FG004|Treatment Period|Withdrawal by Subject|0|||
13078769|NCT02733042|25307707|FG005|Treatment Period|Withdrawal by Subject|0|||
13078770|NCT02733042|25307708|FG006|Treatment Period|Withdrawal by Subject|0|||
13078771|NCT02733042|25307709|FG007|Treatment Period|Withdrawal by Subject|0|||
13078772|NCT02733042|25307710|FG008|Treatment Period|Withdrawal by Subject|1|||
13078773|NCT02733042|25307711|FG009|Treatment Period|Withdrawal by Subject|1|||
13078774|NCT02733042|25307712|FG010|Treatment Period|Withdrawal by Subject|0|||
13078775|NCT02733042|25307713|FG011|Treatment Period|Withdrawal by Subject|2|||
13078776|NCT02733042|25307714|FG012|Treatment Period|Withdrawal by Subject|1|||
13078777|NCT02733042|25307715|FG013|Treatment Period|Withdrawal by Subject|1|||
13078778|NCT02733042|25307716|FG014|Treatment Period|Withdrawal by Subject|0|||
13078779|NCT02733042|25307717|FG015|Treatment Period|Withdrawal by Subject|0|||
13078780|NCT02733042|25307718|FG016|Treatment Period|Withdrawal by Subject|0|||
13078781|NCT02733042|25307719|FG017|Treatment Period|Withdrawal by Subject|0|||
13078782|NCT02733042|25307720|FG018|Treatment Period|Withdrawal by Subject|0|||
13078783|NCT02733042|25307702|FG000|Treatment Period|Other|0|||
13078784|NCT02733042|25307703|FG001|Treatment Period|Other|0|||
13078785|NCT02733042|25307704|FG002|Treatment Period|Other|1|||
13078786|NCT02733042|25307705|FG003|Treatment Period|Other|0|||
13078787|NCT02733042|25307706|FG004|Treatment Period|Other|0|||
13078788|NCT02733042|25307707|FG005|Treatment Period|Other|0|||
13078789|NCT02733042|25307708|FG006|Treatment Period|Other|0|||
13078790|NCT02733042|25307709|FG007|Treatment Period|Other|0|||
13078791|NCT02733042|25307710|FG008|Treatment Period|Other|0|||
13078792|NCT02733042|25307711|FG009|Treatment Period|Other|1|||
13078793|NCT02733042|25307712|FG010|Treatment Period|Other|1|||
13078794|NCT02733042|25307713|FG011|Treatment Period|Other|0|||
13078795|NCT02733042|25307714|FG012|Treatment Period|Other|0|||
13078796|NCT02733042|25307715|FG013|Treatment Period|Other|0|||
13078797|NCT02733042|25307716|FG014|Treatment Period|Other|0|||
13078798|NCT02733042|25307717|FG015|Treatment Period|Other|1|||
13078799|NCT02733042|25307718|FG016|Treatment Period|Other|0|||
13078800|NCT02733042|25307719|FG017|Treatment Period|Other|1|||
13078801|NCT02733042|25307720|FG018|Treatment Period|Other|0|||
13078802|NCT02733042|25307702|FG000|Treatment Period|Ongoing on Assigned Treatment|0|||
13078803|NCT02733042|25307703|FG001|Treatment Period|Ongoing on Assigned Treatment|0|||
13078804|NCT02733042|25307704|FG002|Treatment Period|Ongoing on Assigned Treatment|0|||
13078805|NCT02733042|25307705|FG003|Treatment Period|Ongoing on Assigned Treatment|0|||
13078806|NCT02733042|25307706|FG004|Treatment Period|Ongoing on Assigned Treatment|3|||
13078807|NCT02733042|25307707|FG005|Treatment Period|Ongoing on Assigned Treatment|0|||
13078808|NCT02733042|25307708|FG006|Treatment Period|Ongoing on Assigned Treatment|0|||
13078809|NCT02733042|25307709|FG007|Treatment Period|Ongoing on Assigned Treatment|0|||
13078810|NCT02733042|25307710|FG008|Treatment Period|Ongoing on Assigned Treatment|0|||
13078811|NCT02733042|25307711|FG009|Treatment Period|Ongoing on Assigned Treatment|8|||
13078812|NCT02733042|25307712|FG010|Treatment Period|Ongoing on Assigned Treatment|4|||
13078813|NCT02733042|25307713|FG011|Treatment Period|Ongoing on Assigned Treatment|0|||
13078814|NCT02733042|25307714|FG012|Treatment Period|Ongoing on Assigned Treatment|0|||
13078815|NCT02733042|25307715|FG013|Treatment Period|Ongoing on Assigned Treatment|0|||
13078816|NCT02733042|25307716|FG014|Treatment Period|Ongoing on Assigned Treatment|0|||
13078817|NCT02733042|25307717|FG015|Treatment Period|Ongoing on Assigned Treatment|0|||
13078818|NCT02733042|25307718|FG016|Treatment Period|Ongoing on Assigned Treatment|0|||
13078819|NCT02733042|25307719|FG017|Treatment Period|Ongoing on Assigned Treatment|0|||
13078820|NCT02733042|25307720|FG018|Treatment Period|Ongoing on Assigned Treatment|1|||
13078821|NCT02733042|25307702|FG000|Treatment Period|Death|0|||
13078822|NCT02733042|25307703|FG001|Treatment Period|Death|0|||
13078823|NCT02733042|25307704|FG002|Treatment Period|Death|0|||
13078824|NCT02733042|25307705|FG003|Treatment Period|Death|0|||
13078825|NCT02733042|25307706|FG004|Treatment Period|Death|0|||
13078826|NCT02733042|25307707|FG005|Treatment Period|Death|0|||
13078827|NCT02733042|25307708|FG006|Treatment Period|Death|1|||
13078828|NCT02733042|25307709|FG007|Treatment Period|Death|0|||
13078829|NCT02733042|25307710|FG008|Treatment Period|Death|1|||
13078830|NCT02733042|25307711|FG009|Treatment Period|Death|0|||
13078831|NCT02733042|25307712|FG010|Treatment Period|Death|1|||
13078832|NCT02733042|25307713|FG011|Treatment Period|Death|0|||
13078833|NCT02733042|25307714|FG012|Treatment Period|Death|0|||
13078834|NCT02733042|25307715|FG013|Treatment Period|Death|0|||
13078835|NCT02733042|25307716|FG014|Treatment Period|Death|1|||
13078836|NCT02733042|25307717|FG015|Treatment Period|Death|2|||
13078837|NCT02733042|25307718|FG016|Treatment Period|Death|0|||
13078838|NCT02733042|25307719|FG017|Treatment Period|Death|0|||
13078839|NCT02733042|25307720|FG018|Treatment Period|Death|0|||
13078840|NCT02733042|25307702|FG000|Follow-up Period|Ongoing on Follow-up|2|||
13078841|NCT02733042|25307703|FG001|Follow-up Period|Ongoing on Follow-up|2|||
13078842|NCT02733042|25307704|FG002|Follow-up Period|Ongoing on Follow-up|4|||
13078843|NCT02733042|25307705|FG003|Follow-up Period|Ongoing on Follow-up|2|||
13078844|NCT02733042|25307706|FG004|Follow-up Period|Ongoing on Follow-up|0|||
13078845|NCT02733042|25307707|FG005|Follow-up Period|Ongoing on Follow-up|0|||
13078846|NCT02733042|25307708|FG006|Follow-up Period|Ongoing on Follow-up|0|||
13078847|NCT02733042|25307709|FG007|Follow-up Period|Ongoing on Follow-up|1|||
13078848|NCT02733042|25307710|FG008|Follow-up Period|Ongoing on Follow-up|0|||
13078849|NCT02733042|25307711|FG009|Follow-up Period|Ongoing on Follow-up|2|||
13078850|NCT02733042|25307712|FG010|Follow-up Period|Ongoing on Follow-up|4|||
13078851|NCT02733042|25307713|FG011|Follow-up Period|Ongoing on Follow-up|9|||
13078852|NCT02733042|25307714|FG012|Follow-up Period|Ongoing on Follow-up|1|||
13078853|NCT02733042|25307715|FG013|Follow-up Period|Ongoing on Follow-up|3|||
13078854|NCT02733042|25307716|FG014|Follow-up Period|Ongoing on Follow-up|0|||
13078855|NCT02733042|25307717|FG015|Follow-up Period|Ongoing on Follow-up|0|||
13078856|NCT02733042|25307718|FG016|Follow-up Period|Ongoing on Follow-up|0|||
13078857|NCT02733042|25307719|FG017|Follow-up Period|Ongoing on Follow-up|1|||
13078858|NCT02733042|25307720|FG018|Follow-up Period|Ongoing on Follow-up|0|||
13078859|NCT02733042|25307702|FG000|Follow-up Period|Death|1|||
13078860|NCT02733042|25307703|FG001|Follow-up Period|Death|1|||
13078861|NCT02733042|25307704|FG002|Follow-up Period|Death|2|||
13078862|NCT02733042|25307705|FG003|Follow-up Period|Death|0|||
13078863|NCT02733042|25307706|FG004|Follow-up Period|Death|1|||
13078864|NCT02733042|25307707|FG005|Follow-up Period|Death|2|||
13078865|NCT02733042|25307708|FG006|Follow-up Period|Death|0|||
13078866|NCT02733042|25307709|FG007|Follow-up Period|Death|3|||
13078867|NCT02733042|25307710|FG008|Follow-up Period|Death|3|||
13078868|NCT02733042|25307711|FG009|Follow-up Period|Death|0|||
13078869|NCT02733042|25307712|FG010|Follow-up Period|Death|0|||
13078870|NCT02733042|25307713|FG011|Follow-up Period|Death|0|||
13078871|NCT02733042|25307714|FG012|Follow-up Period|Death|8|||
13078872|NCT02733042|25307715|FG013|Follow-up Period|Death|1|||
13078873|NCT02733042|25307716|FG014|Follow-up Period|Death|1|||
13078874|NCT02733042|25307717|FG015|Follow-up Period|Death|4|||
13078875|NCT02733042|25307718|FG016|Follow-up Period|Death|0|||
13078876|NCT02733042|25307719|FG017|Follow-up Period|Death|1|||
13078877|NCT02733042|25307720|FG018|Follow-up Period|Death|2|||
13078878|NCT02733042|25307702|FG000|Follow-up Period|Other|0|||
13078879|NCT02733042|25307703|FG001|Follow-up Period|Other|0|||
13078880|NCT02733042|25307704|FG002|Follow-up Period|Other|0|||
13078881|NCT02733042|25307705|FG003|Follow-up Period|Other|1|||
13078882|NCT02733042|25307706|FG004|Follow-up Period|Other|0|||
13078883|NCT02733042|25307707|FG005|Follow-up Period|Other|0|||
13078884|NCT02733042|25307708|FG006|Follow-up Period|Other|0|||
13078885|NCT02733042|25307709|FG007|Follow-up Period|Other|0|||
13078886|NCT02733042|25307710|FG008|Follow-up Period|Other|0|||
13078887|NCT02733042|25307711|FG009|Follow-up Period|Other|0|||
13078888|NCT02733042|25307712|FG010|Follow-up Period|Other|0|||
13078889|NCT02733042|25307713|FG011|Follow-up Period|Other|0|||
13078890|NCT02733042|25307714|FG012|Follow-up Period|Other|0|||
13078891|NCT02733042|25307715|FG013|Follow-up Period|Other|0|||
13078892|NCT02733042|25307716|FG014|Follow-up Period|Other|0|||
13078893|NCT02733042|25307717|FG015|Follow-up Period|Other|0|||
13078894|NCT02733042|25307718|FG016|Follow-up Period|Other|0|||
13078895|NCT02733042|25307719|FG017|Follow-up Period|Other|0|||
13078896|NCT02733042|25307720|FG018|Follow-up Period|Other|0|||
13078897|NCT02733042|25307702|FG000|Follow-up Period|Withdrawal by Subject|0|||
13078898|NCT02733042|25307703|FG001|Follow-up Period|Withdrawal by Subject|0|||
13078899|NCT02733042|25307704|FG002|Follow-up Period|Withdrawal by Subject|0|||
13078900|NCT02733042|25307705|FG003|Follow-up Period|Withdrawal by Subject|0|||
13078901|NCT02733042|25307706|FG004|Follow-up Period|Withdrawal by Subject|0|||
13078902|NCT02733042|25307707|FG005|Follow-up Period|Withdrawal by Subject|0|||
13078903|NCT02733042|25307708|FG006|Follow-up Period|Withdrawal by Subject|0|||
13078904|NCT02733042|25307709|FG007|Follow-up Period|Withdrawal by Subject|0|||
13078905|NCT02733042|25307710|FG008|Follow-up Period|Withdrawal by Subject|1|||
13078906|NCT02733042|25307711|FG009|Follow-up Period|Withdrawal by Subject|0|||
13078907|NCT02733042|25307712|FG010|Follow-up Period|Withdrawal by Subject|1|||
13078908|NCT02733042|25307713|FG011|Follow-up Period|Withdrawal by Subject|0|||
13078909|NCT02733042|25307714|FG012|Follow-up Period|Withdrawal by Subject|0|||
13078910|NCT02733042|25307715|FG013|Follow-up Period|Withdrawal by Subject|0|||
13078911|NCT02733042|25307716|FG014|Follow-up Period|Withdrawal by Subject|0|||
13078912|NCT02733042|25307717|FG015|Follow-up Period|Withdrawal by Subject|1|||
13078913|NCT02733042|25307718|FG016|Follow-up Period|Withdrawal by Subject|0|||
13078914|NCT02733042|25307719|FG017|Follow-up Period|Withdrawal by Subject|0|||
13078915|NCT02733042|25307720|FG018|Follow-up Period|Withdrawal by Subject|0|||
13078916|NCT02581982|25307728|FG000|Overall Study|Lack of Efficacy|12|||
13078917|NCT02581982|25307728|FG000|Overall Study|Adverse Event|3|||
13078918|NCT02581982|25307728|FG000|Overall Study|Physician Decision|1|||
13078919|NCT02446899|25307759|FG000|Overall Study|Adverse Event|4|||
13078920|NCT02446899|25307760|FG001|Overall Study|Adverse Event|7|||
13078921|NCT02446899|25307759|FG000|Overall Study|Condition Under Investigation Worsened|1|||
13078922|NCT02446899|25307760|FG001|Overall Study|Condition Under Investigation Worsened|4|||
13078923|NCT02446899|25307759|FG000|Overall Study|Study Specific Withdrawal Criteria|1|||
13078924|NCT02446899|25307760|FG001|Overall Study|Study Specific Withdrawal Criteria|0|||
13078925|NCT02446899|25307759|FG000|Overall Study|Lack of Efficacy|2|||
13078926|NCT02446899|25307760|FG001|Overall Study|Lack of Efficacy|8|||
13078927|NCT02446899|25307759|FG000|Overall Study|Lost to Follow-up|1|||
13078928|NCT02446899|25307760|FG001|Overall Study|Lost to Follow-up|3|||
13078929|NCT02446899|25307759|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
13078930|NCT02446899|25307760|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
13078931|NCT02446899|25307759|FG000|Overall Study|Withdrawal by Subject|11|||
13078932|NCT02446899|25307760|FG001|Overall Study|Withdrawal by Subject|19|||
13078933|NCT02446899|25307759|FG000|Overall Study|Miscellaneous|5|||
13078934|NCT02446899|25307760|FG001|Overall Study|Miscellaneous|4|||
13078935|NCT02446899|25307759|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
13078936|NCT02446899|25307760|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
13078937|NCT02426658|25307801|FG000|Overall Study|Withdrawal by Subject|1|||
13078938|NCT02426658|25307801|FG000|Overall Study|Patient expired before treatment|2|||
13078939|NCT02356887|25307818|FG000|Overall Study|poor compliance|2|||
13078940|NCT02256631|25307938|FG000|Overall Study|Lost to Follow-up|1|||
13078941|NCT02256631|25307939|FG001|Overall Study|Lost to Follow-up|1|||
13078942|NCT02256631|25307940|FG002|Overall Study|Lost to Follow-up|0|||
13078943|NCT02256631|25307941|FG003|Overall Study|Lost to Follow-up|2|||
13078944|NCT02256631|25307942|FG004|Overall Study|Lost to Follow-up|0|||
13078945|NCT02256631|25307943|FG005|Overall Study|Lost to Follow-up|4|||
13078946|NCT02256631|25307944|FG006|Overall Study|Lost to Follow-up|1|||
13078947|NCT02256631|25307938|FG000|Overall Study|Withdrawal by Subject|0|||
13078948|NCT02256631|25307939|FG001|Overall Study|Withdrawal by Subject|0|||
13078949|NCT02256631|25307940|FG002|Overall Study|Withdrawal by Subject|0|||
13078950|NCT02256631|25307941|FG003|Overall Study|Withdrawal by Subject|1|||
13078951|NCT02256631|25307942|FG004|Overall Study|Withdrawal by Subject|1|||
13078952|NCT02256631|25307943|FG005|Overall Study|Withdrawal by Subject|0|||
13078953|NCT02256631|25307944|FG006|Overall Study|Withdrawal by Subject|1|||
13078954|NCT02256631|25307938|FG000|Overall Study|Unable to get to clinic|0|||
13078955|NCT02256631|25307939|FG001|Overall Study|Unable to get to clinic|2|||
13078956|NCT02256631|25307940|FG002|Overall Study|Unable to get to clinic|0|||
13078957|NCT02256631|25307941|FG003|Overall Study|Unable to get to clinic|1|||
13078958|NCT02256631|25307942|FG004|Overall Study|Unable to get to clinic|0|||
13078959|NCT02256631|25307943|FG005|Overall Study|Unable to get to clinic|1|||
13078960|NCT02256631|25307944|FG006|Overall Study|Unable to get to clinic|2|||
13078961|NCT01822522|25308036|FG000|Overall Study|Adverse Event|1|||
13078962|NCT01822522|25308037|FG001|Overall Study|Adverse Event|1|||
13078963|NCT01822522|25308038|FG002|Overall Study|Adverse Event|1|||
13078964|NCT01822522|25308039|FG003|Overall Study|Adverse Event|0|||
13078965|NCT01822522|25308040|FG004|Overall Study|Adverse Event|0|||
13078966|NCT01822522|25308041|FG005|Overall Study|Adverse Event|1|||
13078967|NCT01822522|25308036|FG000|Overall Study|Death|3|||
13078968|NCT01822522|25308037|FG001|Overall Study|Death|0|||
13078969|NCT01822522|25308038|FG002|Overall Study|Death|2|||
13078970|NCT01822522|25308039|FG003|Overall Study|Death|0|||
13078971|NCT01822522|25308040|FG004|Overall Study|Death|0|||
13078972|NCT01822522|25308041|FG005|Overall Study|Death|0|||
13078973|NCT01822522|25308036|FG000|Overall Study|Lost to Follow-up|0|||
13078974|NCT01822522|25308037|FG001|Overall Study|Lost to Follow-up|0|||
13078975|NCT01822522|25308038|FG002|Overall Study|Lost to Follow-up|1|||
13078976|NCT01822522|25308039|FG003|Overall Study|Lost to Follow-up|1|||
13078977|NCT01822522|25308040|FG004|Overall Study|Lost to Follow-up|0|||
13078978|NCT01822522|25308041|FG005|Overall Study|Lost to Follow-up|1|||
13078979|NCT01822522|25308036|FG000|Overall Study|Withdrawal by Subject|0|||
13078980|NCT01822522|25308037|FG001|Overall Study|Withdrawal by Subject|0|||
13078981|NCT01822522|25308038|FG002|Overall Study|Withdrawal by Subject|0|||
13078982|NCT01822522|25308039|FG003|Overall Study|Withdrawal by Subject|1|||
13078983|NCT01822522|25308040|FG004|Overall Study|Withdrawal by Subject|0|||
13078984|NCT01822522|25308041|FG005|Overall Study|Withdrawal by Subject|0|||
13078985|NCT01822522|25308036|FG000|Overall Study|Lack of Efficacy|0|||
13078986|NCT01822522|25308037|FG001|Overall Study|Lack of Efficacy|0|||
13078987|NCT01822522|25308038|FG002|Overall Study|Lack of Efficacy|0|||
13078988|NCT01822522|25308039|FG003|Overall Study|Lack of Efficacy|0|||
13078989|NCT01822522|25308040|FG004|Overall Study|Lack of Efficacy|0|||
13078990|NCT01822522|25308041|FG005|Overall Study|Lack of Efficacy|2|||
13078991|NCT01772472|25308060|FG000|Overall Study|Death|56|||
13078992|NCT01772472|25308061|FG001|Overall Study|Death|42|||
13078993|NCT01772472|25308060|FG000|Overall Study|Physician Decision|1|||
13078994|NCT01772472|25308061|FG001|Overall Study|Physician Decision|3|||
13078995|NCT01772472|25308060|FG000|Overall Study|Other|5|||
13078996|NCT01772472|25308061|FG001|Overall Study|Other|5|||
13078997|NCT01772472|25308060|FG000|Overall Study|Lost to Follow-up|12|||
13078998|NCT01772472|25308061|FG001|Overall Study|Lost to Follow-up|8|||
13078999|NCT01772472|25308060|FG000|Overall Study|Withdrawal by Subject|72|||
13079000|NCT01772472|25308061|FG001|Overall Study|Withdrawal by Subject|50|||
13079001|NCT01772472|25308060|FG000|Overall Study|Ongoing|597|||
13079002|NCT01772472|25308061|FG001|Overall Study|Ongoing|635|||
13079003|NCT01712659|25308112|FG000|Dose Escalation|Physician Decision|0|||
13079004|NCT01712659|25308113|FG001|Dose Escalation|Physician Decision|1|||
13079005|NCT01712659|25308114|FG002|Dose Escalation|Physician Decision|0|||
13079006|NCT01712659|25308115|FG003|Dose Escalation|Physician Decision|0|||
13079007|NCT01712659|25308116|FG004|Dose Escalation|Physician Decision|0|||
13079008|NCT01712659|25308112|FG000|Dose Escalation|Unable to take study drug|0|||
13079009|NCT01712659|25308113|FG001|Dose Escalation|Unable to take study drug|1|||
13079010|NCT01712659|25308114|FG002|Dose Escalation|Unable to take study drug|0|||
13079011|NCT01712659|25308115|FG003|Dose Escalation|Unable to take study drug|0|||
13079012|NCT01712659|25308116|FG004|Dose Escalation|Unable to take study drug|0|||
13079013|NCT01712659|25308112|FG000|Dose Expansion|Early disease progression|1|||
13079014|NCT01712659|25308113|FG001|Dose Expansion|Early disease progression|0|||
13079015|NCT01712659|25308114|FG002|Dose Expansion|Early disease progression|0|||
13079016|NCT01712659|25308115|FG003|Dose Expansion|Early disease progression|0|||
13079017|NCT01712659|25308116|FG004|Dose Expansion|Early disease progression|0|||
13079018|NCT01712659|25308112|FG000|Dose Expansion|Physician Decision|1|||
13079019|NCT01712659|25308113|FG001|Dose Expansion|Physician Decision|0|||
13079020|NCT01712659|25308114|FG002|Dose Expansion|Physician Decision|0|||
13079021|NCT01712659|25308115|FG003|Dose Expansion|Physician Decision|0|||
13079022|NCT01712659|25308116|FG004|Dose Expansion|Physician Decision|0|||
13079023|NCT01610713|25308179|FG000|Overall Study|Adverse Event|3|||
13079024|NCT01610713|25308180|FG001|Overall Study|Adverse Event|0|||
13079025|NCT01610713|25308179|FG000|Overall Study|Lack of Efficacy|1|||
13079026|NCT01610713|25308180|FG001|Overall Study|Lack of Efficacy|0|||
13079027|NCT01610713|25308179|FG000|Overall Study|low mood and poor motivation|1|||
13079028|NCT01610713|25308180|FG001|Overall Study|low mood and poor motivation|0|||
13079029|NCT01610713|25308179|FG000|Overall Study|adv. to use original dose/amitriptyline|1|||
13079030|NCT01610713|25308180|FG001|Overall Study|adv. to use original dose/amitriptyline|0|||
13079031|NCT01610713|25308179|FG000|Overall Study|Lost to Follow-up|0|||
13079032|NCT01610713|25308180|FG001|Overall Study|Lost to Follow-up|1|||
13079033|NCT01610687|25308193|FG000|Overall Study|Lack of Efficacy|26|||
13079034|NCT01610687|25308193|FG000|Overall Study|Adverse Event|18|||
13079035|NCT01610687|25308193|FG000|Overall Study|Moved out of area|6|||
13079036|NCT01610687|25308193|FG000|Overall Study|Withdrawal by Subject|7|||
13079037|NCT01610687|25308193|FG000|Overall Study|Lost to Follow-up|4|||
13079038|NCT01610687|25308193|FG000|Overall Study|Symptom control without study medication|2|||
13079039|NCT01610687|25308193|FG000|Overall Study|Unable to make journey|1|||
13079040|NCT01610687|25308193|FG000|Overall Study|Death|1|||
13079041|NCT01610687|25308193|FG000|Overall Study|Cannabis affecting job|1|||
13079042|NCT01610687|25308193|FG000|Overall Study|Felt more alter without study medication|1|||
13079043|NCT01606202|25308232|FG000|Overall Study|Adverse Event|5|||
13079044|NCT01606202|25308233|FG001|Overall Study|Adverse Event|0|||
13079045|NCT01606202|25308232|FG000|Overall Study|Withdrawal by Subject|2|||
13079046|NCT01606202|25308233|FG001|Overall Study|Withdrawal by Subject|1|||
13079047|NCT01606202|25308232|FG000|Overall Study|Personal problems|0|||
13079048|NCT01606202|25308233|FG001|Overall Study|Personal problems|1|||
13079049|NCT01606202|25308232|FG000|Overall Study|Problems with administration|0|||
13079050|NCT01606202|25308233|FG001|Overall Study|Problems with administration|1|||
13079051|NCT01606189|25308272|FG000|Second Intenvention (14-20 Days)|Adverse Event|0|||
13079052|NCT01606189|25308273|FG001|Second Intenvention (14-20 Days)|Adverse Event|0|||
13079053|NCT01606189|25308274|FG002|Second Intenvention (14-20 Days)|Adverse Event|0|||
13079054|NCT01606189|25308275|FG003|Second Intenvention (14-20 Days)|Adverse Event|0|||
13079055|NCT01606189|25308276|FG004|Second Intenvention (14-20 Days)|Adverse Event|0|||
13079056|NCT01606189|25308277|FG005|Second Intenvention (14-20 Days)|Adverse Event|1|||
13079057|NCT01606189|25308272|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
13079058|NCT01606189|25308273|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
13079059|NCT01606189|25308274|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
13079060|NCT01606189|25308275|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
13079061|NCT01606189|25308276|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
13079062|NCT01606189|25308277|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1|||
13079063|NCT01606176|25308318|FG000|Overall Study|Adverse Event|2|||
13079064|NCT01606176|25308319|FG001|Overall Study|Adverse Event|3|||
13079065|NCT01606176|25308318|FG000|Overall Study|Disease progression|1|||
13079066|NCT01606176|25308319|FG001|Overall Study|Disease progression|0|||
13079067|NCT01606176|25308318|FG000|Overall Study|Withdrawal by Subject|1|||
13079068|NCT01606176|25308319|FG001|Overall Study|Withdrawal by Subject|0|||
13079069|NCT01604265|25308360|FG000|Overall Study|Adverse Event|1|||
13079070|NCT01604265|25308361|FG001|Overall Study|Adverse Event|0|||
13079071|NCT01604265|25308360|FG000|Overall Study|Withdrawal by Subject|1|||
13079072|NCT01604265|25308361|FG001|Overall Study|Withdrawal by Subject|0|||
13079073|NCT01493960|25308430|FG000|Overall Study|Adverse Event|0|||
13079074|NCT01493960|25308431|FG001|Overall Study|Adverse Event|1|||
13079075|NCT01493960|25308430|FG000|Overall Study|Lack of Efficacy|15|||
13079076|NCT01493960|25308431|FG001|Overall Study|Lack of Efficacy|9|||
13079077|NCT01493960|25308430|FG000|Overall Study|Protocol Violation|3|||
13079078|NCT01493960|25308431|FG001|Overall Study|Protocol Violation|0|||
13079079|NCT01493960|25308430|FG000|Overall Study|Withdrawal by Subject|10|||
13079080|NCT01493960|25308431|FG001|Overall Study|Withdrawal by Subject|4|||
13079081|NCT01493960|25308430|FG000|Overall Study|Non-specified|4|||
13079082|NCT01493960|25308431|FG001|Overall Study|Non-specified|4|||
13079083|NCT00551460|25308472|FG000|Overall Study|Adverse Event|1|||
13079084|NCT00551460|25308472|FG000|Overall Study|Withdrawal by Subject|1|||
13079085|NCT00551460|25308472|FG000|Overall Study|Physician Decision|1|||
13079086|NCT00551460|25308472|FG000|Overall Study|Death|7|||
13079087|NCT00551460|25308472|FG000|Overall Study|Ineligible|4|||
13079088|NCT00551460|25308472|FG000|Overall Study|Not analyzable (did not start treatment)|4|||
13079089|NCT00492856|25308489|FG000|Induction|Adverse Event|2|||
13079090|NCT00492856|25308490|FG001|Induction|Adverse Event|0|||
13079091|NCT00492856|25308491|FG002|Induction|Adverse Event|0|||
13079092|NCT00492856|25308492|FG003|Induction|Adverse Event|0|||
13079093|NCT00492856|25308489|FG000|Induction|Withdrawal by Subject|1|||
13079094|NCT00492856|25308490|FG001|Induction|Withdrawal by Subject|0|||
13079095|NCT00492856|25308491|FG002|Induction|Withdrawal by Subject|0|||
13079096|NCT00492856|25308492|FG003|Induction|Withdrawal by Subject|0|||
13079097|NCT00492856|25308489|FG000|Induction|Death|3|||
13079098|NCT00492856|25308490|FG001|Induction|Death|0|||
13079099|NCT00492856|25308491|FG002|Induction|Death|0|||
13079100|NCT00492856|25308492|FG003|Induction|Death|0|||
13079101|NCT00492856|25308489|FG000|Consolidation|Adverse Event|6|||
13079102|NCT00492856|25308490|FG001|Consolidation|Adverse Event|0|||
13079103|NCT00492856|25308491|FG002|Consolidation|Adverse Event|0|||
13079104|NCT00492856|25308492|FG003|Consolidation|Adverse Event|0|||
13079105|NCT00492856|25308489|FG000|Consolidation|Not protocol specified|2|||
13079106|NCT00492856|25308490|FG001|Consolidation|Not protocol specified|0|||
13079107|NCT00492856|25308491|FG002|Consolidation|Not protocol specified|0|||
13079108|NCT00492856|25308492|FG003|Consolidation|Not protocol specified|0|||
13079109|NCT00492856|25308489|FG000|Consolidation|Lost to Follow-up|1|||
13079110|NCT00492856|25308490|FG001|Consolidation|Lost to Follow-up|0|||
13079111|NCT00492856|25308491|FG002|Consolidation|Lost to Follow-up|0|||
13079112|NCT00492856|25308492|FG003|Consolidation|Lost to Follow-up|0|||
13079113|NCT00492856|25308489|FG000|Post-consolidation|Adverse Event|0|||
13079114|NCT00492856|25308490|FG001|Post-consolidation|Adverse Event|4|||
13079115|NCT00492856|25308491|FG002|Post-consolidation|Adverse Event|0|||
13079116|NCT00492856|25308492|FG003|Post-consolidation|Adverse Event|1|||
13079117|NCT00492856|25308489|FG000|Post-consolidation|Withdrawal by Subject|0|||
13079118|NCT00492856|25308490|FG001|Post-consolidation|Withdrawal by Subject|4|||
13079119|NCT00492856|25308491|FG002|Post-consolidation|Withdrawal by Subject|0|||
13079120|NCT00492856|25308492|FG003|Post-consolidation|Withdrawal by Subject|0|||
13079121|NCT00492856|25308489|FG000|Post-consolidation|Death|0|||
13079122|NCT00492856|25308490|FG001|Post-consolidation|Death|1|||
13079123|NCT00492856|25308491|FG002|Post-consolidation|Death|0|||
13079124|NCT00492856|25308492|FG003|Post-consolidation|Death|0|||
13079125|NCT00492856|25308489|FG000|Post-consolidation|Not protocol specified|0|||
13079126|NCT00492856|25308490|FG001|Post-consolidation|Not protocol specified|1|||
13079127|NCT00492856|25308491|FG002|Post-consolidation|Not protocol specified|0|||
13079128|NCT00492856|25308492|FG003|Post-consolidation|Not protocol specified|0|||
13079129|NCT00492856|25308489|FG000|Post-consolidation|Lost to Follow-up|0|||
13079130|NCT00492856|25308490|FG001|Post-consolidation|Lost to Follow-up|2|||
13079131|NCT00492856|25308491|FG002|Post-consolidation|Lost to Follow-up|0|||
13079132|NCT00492856|25308492|FG003|Post-consolidation|Lost to Follow-up|0|||
13079133|NCT00492856|25308489|FG000|Post-consolidation|Observation Arm|0|||
13079134|NCT00492856|25308490|FG001|Post-consolidation|Observation Arm|0|||
13079135|NCT00492856|25308491|FG002|Post-consolidation|Observation Arm|27|||
13079136|NCT00492856|25308492|FG003|Post-consolidation|Observation Arm|0|||
13079137|NCT00352027|25308763|FG000|Overall Study|Progressive disease|3|||
13131496|NCT02810418|25979051|FG003|Dose Expansion|Physician Decision|0|||
13131497|NCT02810418|25979052|FG004|Dose Expansion|Physician Decision|0|||
13131498|NCT02810418|25979053|FG005|Dose Expansion|Physician Decision|0|||
13131499|NCT02810418|25979054|FG006|Dose Expansion|Physician Decision|0|||
13131500|NCT02810418|25979048|FG000|Arm B Dose Escalation|Adverse Event|0|||
13131501|NCT02810418|25979049|FG001|Arm B Dose Escalation|Adverse Event|0|||
13131502|NCT02810418|25979050|FG002|Arm B Dose Escalation|Adverse Event|0|||
13131503|NCT02810418|25979051|FG003|Arm B Dose Escalation|Adverse Event|0|||
13131504|NCT02810418|25979052|FG004|Arm B Dose Escalation|Adverse Event|1|||
13131505|NCT02810418|25979053|FG005|Arm B Dose Escalation|Adverse Event|2|||
13131506|NCT02810418|25979054|FG006|Arm B Dose Escalation|Adverse Event|0|||
13131507|NCT02810392|25979095|FG000|Overall Study|Subject too ill to continue|1|||
13131508|NCT02810392|25979096|FG001|Overall Study|Subject too ill to continue|0|||
13131509|NCT02810392|25979095|FG000|Overall Study|COVID 19 research restrictions|0|||
13131510|NCT02810392|25979096|FG001|Overall Study|COVID 19 research restrictions|1|||
13131511|NCT02810340|25979135|FG000|Overall Study|Withdrawal by Subject|1|||
13131512|NCT02810340|25979136|FG001|Overall Study|Withdrawal by Subject|0|||
13131513|NCT02810340|25979137|FG002|Overall Study|Withdrawal by Subject|0|||
13131514|NCT02810340|25979135|FG000|Overall Study|Incarceration|0|||
13131515|NCT02810340|25979136|FG001|Overall Study|Incarceration|1|||
13131516|NCT02810340|25979137|FG002|Overall Study|Incarceration|0|||
13131517|NCT02810340|25979135|FG000|Overall Study|Lost to Follow-up|0|||
13131518|NCT02810340|25979136|FG001|Overall Study|Lost to Follow-up|0|||
13131519|NCT02810340|25979137|FG002|Overall Study|Lost to Follow-up|1|||
13131520|NCT02809976|25979149|FG000|Overall Study|Lost to Follow-up|1|||
13131521|NCT02809976|25979149|FG000|Overall Study|Withdrawal by Subject|1|||
13131522|NCT02809833|25979225|FG000|Overall Study|Death|3|||
13131523|NCT02809833|25979225|FG000|Overall Study|Intolerance|54|||
13131524|NCT02809833|25979225|FG000|Overall Study|Lack of Efficacy|89|||
13131525|NCT02809833|25979225|FG000|Overall Study|Remission/Treatment No Longer Needed|3|||
13131526|NCT02809833|25979225|FG000|Overall Study|Noncompliance|1|||
13131527|NCT02809833|25979225|FG000|Overall Study|Withdrawal by Subject|34|||
13131528|NCT02809833|25979225|FG000|Overall Study|Lost to Follow-up|35|||
13131529|NCT02809833|25979225|FG000|Overall Study|Adverse Event (AE)|24|||
13131530|NCT02809833|25979225|FG000|Overall Study|Other|5|||
13131531|NCT02809833|25979225|FG000|Overall Study|Missing Information|52|||
13131532|NCT02809118|25979246|FG000|Overall Study|Withdrawal by Subject|0|||
13131533|NCT02809118|25979247|FG001|Overall Study|Withdrawal by Subject|1|||
13131534|NCT02809118|25979248|FG002|Overall Study|Withdrawal by Subject|1|||
13131535|NCT02809053|25979299|FG000|Overall Study|Death|0|||
13131536|NCT02809053|25979300|FG001|Overall Study|Death|1|||
13131537|NCT02809053|25979299|FG000|Overall Study|Lost to Follow-up|3|||
13131538|NCT02809053|25979300|FG001|Overall Study|Lost to Follow-up|1|||
13131539|NCT02809053|25979299|FG000|Overall Study|Withdrawal by Subject|2|||
13131540|NCT02809053|25979300|FG001|Overall Study|Withdrawal by Subject|3|||
13079138|NCT04577794|25310655|FG000|Overall Study|Adverse Event|1|||
13079139|NCT04577794|25310656|FG001|Overall Study|Adverse Event|1|||
13079140|NCT04465877|25310692|FG000|Overall Study|Noncompliant with study requirements|0|||
13393344|NCT00665925|26783411|FG000|Overall Study|Adverse Event|1|||
13079141|NCT04465877|25310693|FG001|Overall Study|Noncompliant with study requirements|0|||
13079142|NCT04465877|25310694|FG002|Overall Study|Noncompliant with study requirements|1|||
13079143|NCT04465877|25310695|FG003|Overall Study|Noncompliant with study requirements|0|||
13079144|NCT04426695|25311132|FG000|Overall Study|Death|2|||
13079145|NCT04426695|25311133|FG001|Overall Study|Death|0|||
13079146|NCT04426695|25311134|FG002|Overall Study|Death|1|||
13079147|NCT04426695|25311135|FG003|Overall Study|Death|27|||
13079148|NCT04426695|25311136|FG004|Overall Study|Death|25|||
13079149|NCT04426695|25311137|FG005|Overall Study|Death|21|||
13079150|NCT04426695|25311138|FG006|Overall Study|Death|42|||
13079151|NCT04426695|25311139|FG007|Overall Study|Death|23|||
13079152|NCT04426695|25311140|FG008|Overall Study|Death|37|||
13079153|NCT04426695|25311141|FG009|Overall Study|Death|14|||
13079154|NCT04426695|25311142|FG010|Overall Study|Death|8|||
13079155|NCT04426695|25311143|FG011|Overall Study|Death|7|||
13079156|NCT04426695|25311144|FG012|Overall Study|Death|13|||
13079157|NCT04426695|25311145|FG013|Overall Study|Death|25|||
13079158|NCT04426695|25311146|FG014|Overall Study|Death|19|||
13079159|NCT04426695|25311147|FG015|Overall Study|Death|7|||
13079160|NCT04426695|25311148|FG016|Overall Study|Death|8|||
13079161|NCT04426695|25311149|FG017|Overall Study|Death|4|||
13079162|NCT04426695|25311132|FG000|Overall Study|Lost to Follow-up|2|||
13079163|NCT04426695|25311133|FG001|Overall Study|Lost to Follow-up|4|||
13079164|NCT04426695|25311134|FG002|Overall Study|Lost to Follow-up|1|||
13079165|NCT04426695|25311135|FG003|Overall Study|Lost to Follow-up|19|||
13079166|NCT04426695|25311136|FG004|Overall Study|Lost to Follow-up|10|||
13079167|NCT04426695|25311137|FG005|Overall Study|Lost to Follow-up|14|||
13079168|NCT04426695|25311138|FG006|Overall Study|Lost to Follow-up|5|||
13079169|NCT04426695|25311139|FG007|Overall Study|Lost to Follow-up|14|||
13079170|NCT04426695|25311140|FG008|Overall Study|Lost to Follow-up|10|||
13079171|NCT04426695|25311141|FG009|Overall Study|Lost to Follow-up|11|||
13079172|NCT04426695|25311142|FG010|Overall Study|Lost to Follow-up|12|||
13079173|NCT04426695|25311143|FG011|Overall Study|Lost to Follow-up|6|||
13079174|NCT04426695|25311144|FG012|Overall Study|Lost to Follow-up|2|||
13079175|NCT04426695|25311145|FG013|Overall Study|Lost to Follow-up|2|||
13079176|NCT04426695|25311146|FG014|Overall Study|Lost to Follow-up|2|||
13079177|NCT04426695|25311147|FG015|Overall Study|Lost to Follow-up|0|||
13079178|NCT04426695|25311148|FG016|Overall Study|Lost to Follow-up|0|||
13079179|NCT04426695|25311149|FG017|Overall Study|Lost to Follow-up|0|||
13079180|NCT04426695|25311132|FG000|Overall Study|Participant Decision|1|||
13079181|NCT04426695|25311133|FG001|Overall Study|Participant Decision|2|||
13079182|NCT04426695|25311134|FG002|Overall Study|Participant Decision|2|||
13079183|NCT04426695|25311135|FG003|Overall Study|Participant Decision|12|||
13079184|NCT04426695|25311136|FG004|Overall Study|Participant Decision|18|||
13079185|NCT04426695|25311137|FG005|Overall Study|Participant Decision|22|||
13079186|NCT04426695|25311138|FG006|Overall Study|Participant Decision|13|||
13079187|NCT04426695|25311139|FG007|Overall Study|Participant Decision|13|||
13079188|NCT04426695|25311140|FG008|Overall Study|Participant Decision|10|||
13079189|NCT04426695|25311141|FG009|Overall Study|Participant Decision|15|||
13079190|NCT04426695|25311142|FG010|Overall Study|Participant Decision|16|||
13079191|NCT04426695|25311143|FG011|Overall Study|Participant Decision|17|||
13079192|NCT04426695|25311144|FG012|Overall Study|Participant Decision|2|||
13079193|NCT04426695|25311145|FG013|Overall Study|Participant Decision|1|||
13079194|NCT04426695|25311146|FG014|Overall Study|Participant Decision|2|||
13079195|NCT04426695|25311147|FG015|Overall Study|Participant Decision|0|||
13079196|NCT04426695|25311148|FG016|Overall Study|Participant Decision|0|||
13079197|NCT04426695|25311149|FG017|Overall Study|Participant Decision|0|||
13079198|NCT04426695|25311132|FG000|Overall Study|Adverse Event|0|||
13079199|NCT04426695|25311133|FG001|Overall Study|Adverse Event|0|||
13079200|NCT04426695|25311134|FG002|Overall Study|Adverse Event|0|||
13079201|NCT04426695|25311135|FG003|Overall Study|Adverse Event|0|||
13079202|NCT04426695|25311136|FG004|Overall Study|Adverse Event|0|||
13079203|NCT04426695|25311137|FG005|Overall Study|Adverse Event|0|||
13079204|NCT04426695|25311138|FG006|Overall Study|Adverse Event|0|||
13079205|NCT04426695|25311139|FG007|Overall Study|Adverse Event|1|||
13079206|NCT04426695|25311140|FG008|Overall Study|Adverse Event|0|||
13079207|NCT04426695|25311141|FG009|Overall Study|Adverse Event|0|||
13079208|NCT04426695|25311142|FG010|Overall Study|Adverse Event|1|||
13079209|NCT04426695|25311143|FG011|Overall Study|Adverse Event|1|||
13079210|NCT04426695|25311144|FG012|Overall Study|Adverse Event|0|||
13079211|NCT04426695|25311145|FG013|Overall Study|Adverse Event|0|||
13079212|NCT04426695|25311146|FG014|Overall Study|Adverse Event|0|||
13079213|NCT04426695|25311147|FG015|Overall Study|Adverse Event|0|||
13079214|NCT04426695|25311148|FG016|Overall Study|Adverse Event|0|||
13079215|NCT04426695|25311149|FG017|Overall Study|Adverse Event|0|||
13079216|NCT04426695|25311132|FG000|Overall Study|Sponsor Request|0|||
13079217|NCT04426695|25311133|FG001|Overall Study|Sponsor Request|0|||
13079218|NCT04426695|25311134|FG002|Overall Study|Sponsor Request|0|||
13079219|NCT04426695|25311135|FG003|Overall Study|Sponsor Request|0|||
13079220|NCT04426695|25311136|FG004|Overall Study|Sponsor Request|0|||
13079221|NCT04426695|25311137|FG005|Overall Study|Sponsor Request|0|||
13079222|NCT04426695|25311138|FG006|Overall Study|Sponsor Request|1|||
13079223|NCT04426695|25311139|FG007|Overall Study|Sponsor Request|0|||
13079224|NCT04426695|25311140|FG008|Overall Study|Sponsor Request|0|||
13079225|NCT04426695|25311141|FG009|Overall Study|Sponsor Request|0|||
13079226|NCT04426695|25311142|FG010|Overall Study|Sponsor Request|0|||
13079227|NCT04426695|25311143|FG011|Overall Study|Sponsor Request|0|||
13079228|NCT04426695|25311144|FG012|Overall Study|Sponsor Request|0|||
13079229|NCT04426695|25311145|FG013|Overall Study|Sponsor Request|0|||
13079230|NCT04426695|25311146|FG014|Overall Study|Sponsor Request|0|||
13079231|NCT04426695|25311147|FG015|Overall Study|Sponsor Request|0|||
13079232|NCT04426695|25311148|FG016|Overall Study|Sponsor Request|0|||
13079233|NCT04426695|25311149|FG017|Overall Study|Sponsor Request|0|||
13079234|NCT04426695|25311132|FG000|Overall Study|Physician Decision|0|||
13079235|NCT04426695|25311133|FG001|Overall Study|Physician Decision|0|||
13079236|NCT04426695|25311134|FG002|Overall Study|Physician Decision|0|||
13079237|NCT04426695|25311135|FG003|Overall Study|Physician Decision|0|||
13079238|NCT04426695|25311136|FG004|Overall Study|Physician Decision|0|||
13079239|NCT04426695|25311137|FG005|Overall Study|Physician Decision|0|||
13079240|NCT04426695|25311138|FG006|Overall Study|Physician Decision|0|||
13079241|NCT04426695|25311139|FG007|Overall Study|Physician Decision|0|||
13079242|NCT04426695|25311140|FG008|Overall Study|Physician Decision|0|||
13079243|NCT04426695|25311141|FG009|Overall Study|Physician Decision|1|||
13079244|NCT04426695|25311142|FG010|Overall Study|Physician Decision|0|||
13079245|NCT04426695|25311143|FG011|Overall Study|Physician Decision|0|||
13079246|NCT04426695|25311144|FG012|Overall Study|Physician Decision|1|||
13079247|NCT04426695|25311145|FG013|Overall Study|Physician Decision|0|||
13079248|NCT04426695|25311146|FG014|Overall Study|Physician Decision|0|||
13079249|NCT04426695|25311147|FG015|Overall Study|Physician Decision|0|||
13079250|NCT04426695|25311148|FG016|Overall Study|Physician Decision|0|||
13079251|NCT04426695|25311149|FG017|Overall Study|Physician Decision|0|||
13079252|NCT04426695|25311132|FG000|Overall Study|Randomized but Never Treated|3|||
13079253|NCT04426695|25311133|FG001|Overall Study|Randomized but Never Treated|1|||
13079254|NCT04426695|25311134|FG002|Overall Study|Randomized but Never Treated|0|||
13079255|NCT04426695|25311135|FG003|Overall Study|Randomized but Never Treated|4|||
13079256|NCT04426695|25311136|FG004|Overall Study|Randomized but Never Treated|5|||
13079257|NCT04426695|25311137|FG005|Overall Study|Randomized but Never Treated|5|||
13079258|NCT04426695|25311138|FG006|Overall Study|Randomized but Never Treated|4|||
13079259|NCT04426695|25311139|FG007|Overall Study|Randomized but Never Treated|6|||
13079260|NCT04426695|25311140|FG008|Overall Study|Randomized but Never Treated|6|||
13079261|NCT04426695|25311141|FG009|Overall Study|Randomized but Never Treated|3|||
13079262|NCT04426695|25311142|FG010|Overall Study|Randomized but Never Treated|3|||
13079263|NCT04426695|25311143|FG011|Overall Study|Randomized but Never Treated|6|||
13079264|NCT04426695|25311144|FG012|Overall Study|Randomized but Never Treated|1|||
13079265|NCT04426695|25311145|FG013|Overall Study|Randomized but Never Treated|2|||
13079266|NCT04426695|25311146|FG014|Overall Study|Randomized but Never Treated|0|||
13079267|NCT04426695|25311147|FG015|Overall Study|Randomized but Never Treated|0|||
13079268|NCT04426695|25311148|FG016|Overall Study|Randomized but Never Treated|0|||
13079269|NCT04426695|25311149|FG017|Overall Study|Randomized but Never Treated|0|||
13079270|NCT04267133|25311155|FG000|Overall Study|Withdrawal by Subject|1|||
13079271|NCT04267133|25311155|FG000|Overall Study|Adverse Event|4|||
13079272|NCT03018080|25311200|FG000|Overall Study|Death|11|||
13079273|NCT03018080|25311201|FG001|Overall Study|Death|19|||
13079274|NCT03018080|25311200|FG000|Overall Study|Still On Study (in follow up)|10|||
13079275|NCT03018080|25311201|FG001|Overall Study|Still On Study (in follow up)|0|||
13079276|NCT02993523|25311227|FG000|Overall Study|Withdrew Consent|0|||
13079277|NCT02993523|25311228|FG001|Overall Study|Withdrew Consent|0|||
13079278|NCT02993523|25311229|FG002|Overall Study|Withdrew Consent|2|||
13079279|NCT02993523|25311230|FG003|Overall Study|Withdrew Consent|9|||
13079280|NCT02993523|25311231|FG004|Overall Study|Withdrew Consent|0|||
13079281|NCT02993523|25311227|FG000|Overall Study|Lost to Follow-up|0|||
13079282|NCT02993523|25311228|FG001|Overall Study|Lost to Follow-up|0|||
13079283|NCT02993523|25311229|FG002|Overall Study|Lost to Follow-up|3|||
13079284|NCT02993523|25311230|FG003|Overall Study|Lost to Follow-up|6|||
13079285|NCT02993523|25311231|FG004|Overall Study|Lost to Follow-up|0|||
13079286|NCT02993523|25311227|FG000|Overall Study|Death|1|||
13079287|NCT02993523|25311228|FG001|Overall Study|Death|1|||
13079288|NCT02993523|25311229|FG002|Overall Study|Death|138|||
13079289|NCT02993523|25311230|FG003|Overall Study|Death|222|||
13079290|NCT02993523|25311231|FG004|Overall Study|Death|6|||
13079291|NCT02993523|25311227|FG000|Overall Study|Reason not Specified|0|||
13079292|NCT02993523|25311228|FG001|Overall Study|Reason not Specified|0|||
13079293|NCT02993523|25311229|FG002|Overall Study|Reason not Specified|1|||
13079294|NCT02993523|25311230|FG003|Overall Study|Reason not Specified|1|||
13079295|NCT02993523|25311231|FG004|Overall Study|Reason not Specified|0|||
13079296|NCT02980692|25311399|FG000|Double Blind Placebo Controlled Period|Adverse Event|1|||
13079297|NCT02980692|25311400|FG001|Double Blind Placebo Controlled Period|Adverse Event|2|||
13079298|NCT02980692|25311401|FG002|Double Blind Placebo Controlled Period|Adverse Event|1|||
13079299|NCT02980692|25311402|FG003|Double Blind Placebo Controlled Period|Adverse Event|2|||
13079300|NCT02980692|25311403|FG004|Double Blind Placebo Controlled Period|Adverse Event|0|||
13079301|NCT02980692|25311399|FG000|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
13079302|NCT02980692|25311400|FG001|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
13079303|NCT02980692|25311401|FG002|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
13079304|NCT02980692|25311402|FG003|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
13079305|NCT02980692|25311403|FG004|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
13079306|NCT02980692|25311399|FG000|Double Blind Placebo Controlled Period|Investigator Decision|0|||
13079307|NCT02980692|25311400|FG001|Double Blind Placebo Controlled Period|Investigator Decision|0|||
13079308|NCT02980692|25311401|FG002|Double Blind Placebo Controlled Period|Investigator Decision|0|||
13079309|NCT02980692|25311402|FG003|Double Blind Placebo Controlled Period|Investigator Decision|2|||
13079310|NCT02980692|25311403|FG004|Double Blind Placebo Controlled Period|Investigator Decision|0|||
13079311|NCT02980692|25311399|FG000|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
13079312|NCT02980692|25311400|FG001|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
13079313|NCT02980692|25311401|FG002|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
13079314|NCT02980692|25311402|FG003|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
13079315|NCT02980692|25311403|FG004|Double Blind Placebo Controlled Period|Withdrawal by Subject|4|||
13079316|NCT02980692|25311399|FG000|Double Blind Placebo Controlled Period|Protocol Violation|2|||
13079317|NCT02980692|25311400|FG001|Double Blind Placebo Controlled Period|Protocol Violation|0|||
13079318|NCT02980692|25311401|FG002|Double Blind Placebo Controlled Period|Protocol Violation|1|||
13079319|NCT02980692|25311402|FG003|Double Blind Placebo Controlled Period|Protocol Violation|0|||
13079320|NCT02980692|25311403|FG004|Double Blind Placebo Controlled Period|Protocol Violation|0|||
13079321|NCT02980692|25311399|FG000|Double Blind Placebo Controlled Period|Other|1|||
13079322|NCT02980692|25311400|FG001|Double Blind Placebo Controlled Period|Other|0|||
13079323|NCT02980692|25311401|FG002|Double Blind Placebo Controlled Period|Other|0|||
13079324|NCT02980692|25311402|FG003|Double Blind Placebo Controlled Period|Other|0|||
13079325|NCT02980692|25311403|FG004|Double Blind Placebo Controlled Period|Other|1|||
13079326|NCT02980692|25311399|FG000|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|9|||
13079327|NCT02980692|25311400|FG001|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|12|||
13079328|NCT02980692|25311401|FG002|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|13|||
13079329|NCT02980692|25311402|FG003|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
13079330|NCT02980692|25311403|FG004|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
13079331|NCT02980692|25311399|FG000|Double-blind Follow-up Period|Adverse Event|0|||
13079332|NCT02980692|25311400|FG001|Double-blind Follow-up Period|Adverse Event|0|||
13079333|NCT02980692|25311401|FG002|Double-blind Follow-up Period|Adverse Event|0|||
13079334|NCT02980692|25311402|FG003|Double-blind Follow-up Period|Adverse Event|1|||
13079335|NCT02980692|25311403|FG004|Double-blind Follow-up Period|Adverse Event|1|||
13079336|NCT02980692|25311399|FG000|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
13079337|NCT02980692|25311400|FG001|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|2|||
13079338|NCT02980692|25311401|FG002|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|1|||
13079339|NCT02980692|25311402|FG003|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
13079340|NCT02980692|25311403|FG004|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
13079341|NCT02980692|25311399|FG000|Double-blind Follow-up Period|Lost to Follow-up|0|||
13079342|NCT02980692|25311400|FG001|Double-blind Follow-up Period|Lost to Follow-up|0|||
13079343|NCT02980692|25311401|FG002|Double-blind Follow-up Period|Lost to Follow-up|1|||
13079344|NCT02980692|25311402|FG003|Double-blind Follow-up Period|Lost to Follow-up|0|||
13079345|NCT02980692|25311403|FG004|Double-blind Follow-up Period|Lost to Follow-up|0|||
13079346|NCT02980692|25311399|FG000|Double-blind Follow-up Period|Pregnancy|0|||
13079347|NCT02980692|25311400|FG001|Double-blind Follow-up Period|Pregnancy|0|||
13079348|NCT02980692|25311401|FG002|Double-blind Follow-up Period|Pregnancy|1|||
13079349|NCT02980692|25311402|FG003|Double-blind Follow-up Period|Pregnancy|1|||
13079350|NCT02980692|25311403|FG004|Double-blind Follow-up Period|Pregnancy|0|||
13079351|NCT02980692|25311399|FG000|Double-blind Follow-up Period|Withdrawal by Subject|0|||
13079352|NCT02980692|25311400|FG001|Double-blind Follow-up Period|Withdrawal by Subject|1|||
13079353|NCT02980692|25311401|FG002|Double-blind Follow-up Period|Withdrawal by Subject|0|||
13079354|NCT02980692|25311402|FG003|Double-blind Follow-up Period|Withdrawal by Subject|1|||
13079355|NCT02980692|25311403|FG004|Double-blind Follow-up Period|Withdrawal by Subject|1|||
13079356|NCT02980692|25311399|FG000|Double-blind Follow-up Period|Other|0|||
13079357|NCT02980692|25311400|FG001|Double-blind Follow-up Period|Other|0|||
13079358|NCT02980692|25311401|FG002|Double-blind Follow-up Period|Other|1|||
13079359|NCT02980692|25311402|FG003|Double-blind Follow-up Period|Other|1|||
13079360|NCT02980692|25311403|FG004|Double-blind Follow-up Period|Other|3|||
13079361|NCT02395666|25311424|FG000|Overall Study|Physician Decision|3|||
13079362|NCT02395666|25311425|FG001|Overall Study|Physician Decision|0|||
13079363|NCT02395666|25311424|FG000|Overall Study|Lost to Follow-up|1|||
13079364|NCT02395666|25311425|FG001|Overall Study|Lost to Follow-up|0|||
13079365|NCT02395666|25311424|FG000|Overall Study|Withdrawal by Subject|2|||
13079366|NCT02395666|25311425|FG001|Overall Study|Withdrawal by Subject|1|||
13079367|NCT01711541|25311470|FG000|Overall Study|Cancel prior to treatment|0|||
13079368|NCT01711541|25311471|FG001|Overall Study|Cancel prior to treatment|0|||
13079369|NCT01711541|25311472|FG002|Overall Study|Cancel prior to treatment|0|||
13079370|NCT01711541|25311473|FG003|Overall Study|Cancel prior to treatment|1|||
13079371|NCT01711541|25311474|FG004|Overall Study|Cancel prior to treatment|0|||
13079372|NCT01711541|25311470|FG000|Overall Study|Ineligible|0|||
13079373|NCT01711541|25311471|FG001|Overall Study|Ineligible|1|||
13079374|NCT01711541|25311472|FG002|Overall Study|Ineligible|0|||
13079375|NCT01711541|25311473|FG003|Overall Study|Ineligible|0|||
13079376|NCT01711541|25311474|FG004|Overall Study|Ineligible|0|||
13131541|NCT02809053|25979299|FG000|Overall Study|Disease Progression|2|||
13131542|NCT02809053|25979300|FG001|Overall Study|Disease Progression|1|||
13131543|NCT02808975|25979321|FG000|Overall Study|Adverse Event|3|||
13131544|NCT02808975|25979322|FG001|Overall Study|Adverse Event|4|||
13131545|NCT02808975|25979321|FG000|Overall Study|Withdrew consent|9|||
13131546|NCT02808975|25979322|FG001|Overall Study|Withdrew consent|8|||
13131547|NCT02808975|25979321|FG000|Overall Study|Lost to Follow-up|4|||
13131548|NCT02808975|25979322|FG001|Overall Study|Lost to Follow-up|6|||
13131549|NCT02808975|25979321|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1|||
13131550|NCT02808975|25979322|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0|||
13131551|NCT02808975|25979321|FG000|Overall Study|Other, not specified|5|||
13131552|NCT02808975|25979322|FG001|Overall Study|Other, not specified|1|||
13131553|NCT02808819|25979384|FG000|Overall Study|eg. no treatment efficacy on asthma|5|||
13131554|NCT02808819|25979385|FG001|Overall Study|eg. no treatment efficacy on asthma|4|||
13131555|NCT02808819|25979384|FG000|Overall Study|Withdrawal by Subject|10|||
13131556|NCT02808819|25979385|FG001|Overall Study|Withdrawal by Subject|13|||
13131557|NCT02808819|25979384|FG000|Overall Study|Site terminated by sponsor|2|||
13131558|NCT02808819|25979385|FG001|Overall Study|Site terminated by sponsor|0|||
13131559|NCT02808819|25979384|FG000|Overall Study|Pregnancy|1|||
13131560|NCT02808819|25979385|FG001|Overall Study|Pregnancy|0|||
13131561|NCT02808819|25979384|FG000|Overall Study|Lost to Follow-up|1|||
13131562|NCT02808819|25979385|FG001|Overall Study|Lost to Follow-up|6|||
13131563|NCT02808819|25979384|FG000|Overall Study|Protocol Violation|0|||
13131564|NCT02808819|25979385|FG001|Overall Study|Protocol Violation|1|||
13131565|NCT02808819|25979384|FG000|Overall Study|Development of study-specific withdrawal criteria|8|||
13222404|NCT01806714|26286190|FG001|Overall Study|No functioning phone number|170|||
13222405|NCT01806662|26286199|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4|||
13222406|NCT01806662|26286200|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0|||
13222407|NCT01806662|26286199|FG000|First Intervention (Weeks 0-16)|Adverse Event|0|||
13222408|NCT01806662|26286200|FG001|First Intervention (Weeks 0-16)|Adverse Event|1|||
13222409|NCT01806662|26286199|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2|||
13222410|NCT01806662|26286200|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3|||
13222411|NCT01806662|26286199|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0|||
13222412|NCT01806662|26286200|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1|||
13222413|NCT01806623|26286219|FG000|Overall Study|Withdrawal by Subject|1|||
13222414|NCT01806623|26286219|FG000|Overall Study|Adverse Event|1|||
13222415|NCT01806623|26286219|FG000|Overall Study|Did not meet the inclusion criteria|56|||
13222416|NCT01806597|26286266|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1|||
13222417|NCT01806597|26286267|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1|||
13222418|NCT01806597|26286268|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0|||
13222419|NCT01806597|26286269|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0|||
13222420|NCT01806597|26286270|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2|||
13222421|NCT01806597|26286271|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0|||
13222422|NCT01806597|26286266|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
13222423|NCT01806597|26286267|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
13222424|NCT01806597|26286268|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
13131566|NCT02808819|25979385|FG001|Overall Study|Development of study-specific withdrawal criteria|3|||
13131567|NCT02808819|25979384|FG000|Overall Study|Death|1|||
13131568|NCT02808819|25979385|FG001|Overall Study|Death|0|||
13131569|NCT02808819|25979384|FG000|Overall Study|Adverse Event|3|||
13131570|NCT02808819|25979385|FG001|Overall Study|Adverse Event|4|||
13131571|NCT02808429|25979439|FG000|Overall Study|Lost to Follow-up|1|||
13131572|NCT02808429|25979440|FG001|Overall Study|Lost to Follow-up|0|||
13131573|NCT02808429|25979441|FG002|Overall Study|Lost to Follow-up|0|||
13131574|NCT02808429|25979439|FG000|Overall Study|Protocol Violation|0|||
13131575|NCT02808429|25979440|FG001|Overall Study|Protocol Violation|1|||
13222425|NCT01806597|26286269|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
13393345|NCT00665925|26783412|FG001|Overall Study|Adverse Event|5|||
13079377|NCT05014919|25521189|FG000|Open-Label (12 Weeks)|Adverse Event|1|||
13079378|NCT05014919|25521190|FG001|Open-Label (12 Weeks)|Adverse Event|0|||
13079379|NCT05014919|25521191|FG002|Open-Label (12 Weeks)|Adverse Event|0|||
13079380|NCT05014919|25521189|FG000|Open-Label (12 Weeks)|Lack of Efficacy|1|||
13079381|NCT05014919|25521190|FG001|Open-Label (12 Weeks)|Lack of Efficacy|0|||
13079382|NCT05014919|25521191|FG002|Open-Label (12 Weeks)|Lack of Efficacy|0|||
13079383|NCT05014919|25521189|FG000|Open-Label (12 Weeks)|Withdrawal by Subject|2|||
13079384|NCT05014919|25521190|FG001|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
13079385|NCT05014919|25521191|FG002|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
13079386|NCT05014919|25521189|FG000|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|15|||
13079387|NCT05014919|25521190|FG001|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
13079388|NCT05014919|25521191|FG002|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
13079389|NCT05014919|25521189|FG000|Open-Label (12 Weeks)|Sponsor Decision|4|||
13079390|NCT05014919|25521190|FG001|Open-Label (12 Weeks)|Sponsor Decision|0|||
13079391|NCT05014919|25521191|FG002|Open-Label (12 Weeks)|Sponsor Decision|0|||
13079392|NCT05014919|25521189|FG000|Open-Label (12 Weeks)|Study Terminated by Sponsor|5|||
13079393|NCT05014919|25521190|FG001|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
13079394|NCT05014919|25521191|FG002|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
13079395|NCT05014919|25521189|FG000|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
13079396|NCT05014919|25521190|FG001|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
13079397|NCT05014919|25521191|FG002|Double-Blind (26 Weeks)|Study Terminated by Sponsor|1|||
13079398|NCT05014919|25521189|FG000|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
13222426|NCT01806597|26286270|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
13307562|NCT01284959|26528990|FG001|Overall Study|Withdrawal by Subject|0|||
13079399|NCT05014919|25521190|FG001|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
13079400|NCT05014919|25521191|FG002|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
13079401|NCT04490395|25521227|FG000|Overall Study|Lost to Follow-up|0|||
13079402|NCT04490395|25521228|FG001|Overall Study|Lost to Follow-up|1|||
13079403|NCT03843541|25521304|FG000|Overall Study|Adverse Event|4|||
13079404|NCT03843541|25521305|FG001|Overall Study|Adverse Event|2|||
13079405|NCT03843541|25521306|FG002|Overall Study|Adverse Event|3|||
13079406|NCT03843541|25521304|FG000|Overall Study|Death|1|||
13079407|NCT03843541|25521305|FG001|Overall Study|Death|0|||
13079408|NCT03843541|25521306|FG002|Overall Study|Death|0|||
13079409|NCT03843541|25521304|FG000|Overall Study|Lack of adherence to study medication|0|||
13079410|NCT03843541|25521305|FG001|Overall Study|Lack of adherence to study medication|0|||
13079411|NCT03843541|25521306|FG002|Overall Study|Lack of adherence to study medication|1|||
13079412|NCT03843541|25521304|FG000|Overall Study|Physician Decision|1|||
13079413|NCT03843541|25521305|FG001|Overall Study|Physician Decision|2|||
13079414|NCT03843541|25521306|FG002|Overall Study|Physician Decision|2|||
13079415|NCT03843541|25521304|FG000|Overall Study|Study subject withdrawal by parent or guardian|1|||
13079416|NCT03843541|25521305|FG001|Overall Study|Study subject withdrawal by parent or guardian|0|||
13079417|NCT03843541|25521306|FG002|Overall Study|Study subject withdrawal by parent or guardian|0|||
13079418|NCT03843541|25521304|FG000|Overall Study|Withdrawal by Subject|6|||
13079419|NCT03843541|25521305|FG001|Overall Study|Withdrawal by Subject|9|||
13079420|NCT03843541|25521306|FG002|Overall Study|Withdrawal by Subject|7|||
13079421|NCT03843541|25521304|FG000|Overall Study|Administration of rescue mucolytic|0|||
13079422|NCT03843541|25521305|FG001|Overall Study|Administration of rescue mucolytic|0|||
13079423|NCT03843541|25521306|FG002|Overall Study|Administration of rescue mucolytic|1|||
13079424|NCT03843541|25521304|FG000|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|2|||
13079425|NCT03843541|25521305|FG001|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|3|||
13079426|NCT03843541|25521306|FG002|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|0|||
13079427|NCT03188822|25521387|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6|||
13079428|NCT03188822|25521387|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1|||
13079429|NCT03180840|25521403|FG000|Overall Study|Withdrawal by Subject|1|||
13079430|NCT02988817|25521822|FG000|Overall Study|Withdrawal by Subject|1|||
13079431|NCT02988817|25521823|FG001|Overall Study|Withdrawal by Subject|0|||
13079432|NCT02988817|25521824|FG002|Overall Study|Withdrawal by Subject|0|||
13079433|NCT02988817|25521825|FG003|Overall Study|Withdrawal by Subject|1|||
13079434|NCT02988817|25521826|FG004|Overall Study|Withdrawal by Subject|3|||
13079435|NCT02988817|25521827|FG005|Overall Study|Withdrawal by Subject|1|||
13079436|NCT02988817|25521828|FG006|Overall Study|Withdrawal by Subject|2|||
13079437|NCT02988817|25521829|FG007|Overall Study|Withdrawal by Subject|1|||
13079438|NCT02988817|25521830|FG008|Overall Study|Withdrawal by Subject|1|||
13079439|NCT02988817|25521831|FG009|Overall Study|Withdrawal by Subject|1|||
13079440|NCT02988817|25521832|FG010|Overall Study|Withdrawal by Subject|1|||
13079441|NCT02988817|25521833|FG011|Overall Study|Withdrawal by Subject|12|||
13079442|NCT02988817|25521834|FG012|Overall Study|Withdrawal by Subject|6|||
13079443|NCT02988817|25521835|FG013|Overall Study|Withdrawal by Subject|6|||
13079444|NCT02988817|25521836|FG014|Overall Study|Withdrawal by Subject|4|||
13079445|NCT02988817|25521837|FG015|Overall Study|Withdrawal by Subject|5|||
13079446|NCT02988817|25521838|FG016|Overall Study|Withdrawal by Subject|4|||
13079447|NCT02988817|25521839|FG017|Overall Study|Withdrawal by Subject|11|||
13079448|NCT02988817|25521840|FG018|Overall Study|Withdrawal by Subject|4|||
13079449|NCT02988817|25521841|FG019|Overall Study|Withdrawal by Subject|2|||
13079450|NCT02988817|25521822|FG000|Overall Study|Death|0|||
13079451|NCT02988817|25521823|FG001|Overall Study|Death|1|||
13079452|NCT02988817|25521824|FG002|Overall Study|Death|3|||
13079453|NCT02988817|25521825|FG003|Overall Study|Death|1|||
13079454|NCT02988817|25521826|FG004|Overall Study|Death|6|||
13079455|NCT02988817|25521827|FG005|Overall Study|Death|10|||
13079456|NCT02988817|25521828|FG006|Overall Study|Death|1|||
13079457|NCT02988817|25521829|FG007|Overall Study|Death|2|||
13079458|NCT02988817|25521830|FG008|Overall Study|Death|1|||
13079459|NCT02988817|25521831|FG009|Overall Study|Death|5|||
13079460|NCT02988817|25521832|FG010|Overall Study|Death|1|||
13079461|NCT02988817|25521833|FG011|Overall Study|Death|8|||
13079462|NCT02988817|25521834|FG012|Overall Study|Death|9|||
13079463|NCT02988817|25521835|FG013|Overall Study|Death|17|||
13079464|NCT02988817|25521836|FG014|Overall Study|Death|18|||
13079465|NCT02988817|25521837|FG015|Overall Study|Death|30|||
13079466|NCT02988817|25521838|FG016|Overall Study|Death|17|||
13079467|NCT02988817|25521839|FG017|Overall Study|Death|38|||
13079468|NCT02988817|25521840|FG018|Overall Study|Death|14|||
13079469|NCT02988817|25521841|FG019|Overall Study|Death|16|||
13079470|NCT02988817|25521822|FG000|Overall Study|Other|0|||
13079471|NCT02988817|25521823|FG001|Overall Study|Other|0|||
13079472|NCT02988817|25521824|FG002|Overall Study|Other|0|||
13079473|NCT02988817|25521825|FG003|Overall Study|Other|1|||
13079474|NCT02988817|25521826|FG004|Overall Study|Other|1|||
13079475|NCT02988817|25521827|FG005|Overall Study|Other|0|||
13079476|NCT02988817|25521828|FG006|Overall Study|Other|0|||
13079477|NCT02988817|25521829|FG007|Overall Study|Other|0|||
13079478|NCT02988817|25521830|FG008|Overall Study|Other|0|||
13079479|NCT02988817|25521831|FG009|Overall Study|Other|0|||
13079480|NCT02988817|25521832|FG010|Overall Study|Other|0|||
13079481|NCT02988817|25521833|FG011|Overall Study|Other|0|||
13079482|NCT02988817|25521834|FG012|Overall Study|Other|0|||
13079483|NCT02988817|25521835|FG013|Overall Study|Other|0|||
13079484|NCT02988817|25521836|FG014|Overall Study|Other|0|||
13079485|NCT02988817|25521837|FG015|Overall Study|Other|1|||
13079486|NCT02988817|25521838|FG016|Overall Study|Other|0|||
13079487|NCT02988817|25521839|FG017|Overall Study|Other|0|||
13079488|NCT02988817|25521840|FG018|Overall Study|Other|0|||
13079489|NCT02988817|25521841|FG019|Overall Study|Other|0|||
13079490|NCT02988817|25521822|FG000|Overall Study|Lost to Follow-up|0|||
13079491|NCT02988817|25521823|FG001|Overall Study|Lost to Follow-up|0|||
13079492|NCT02988817|25521824|FG002|Overall Study|Lost to Follow-up|0|||
13079493|NCT02988817|25521825|FG003|Overall Study|Lost to Follow-up|0|||
13079494|NCT02988817|25521826|FG004|Overall Study|Lost to Follow-up|0|||
13079495|NCT02988817|25521827|FG005|Overall Study|Lost to Follow-up|0|||
13079496|NCT02988817|25521828|FG006|Overall Study|Lost to Follow-up|0|||
13079497|NCT02988817|25521829|FG007|Overall Study|Lost to Follow-up|0|||
13079498|NCT02988817|25521830|FG008|Overall Study|Lost to Follow-up|1|||
13079499|NCT02988817|25521831|FG009|Overall Study|Lost to Follow-up|0|||
13079500|NCT02988817|25521832|FG010|Overall Study|Lost to Follow-up|1|||
13079501|NCT02988817|25521833|FG011|Overall Study|Lost to Follow-up|1|||
13079502|NCT02988817|25521834|FG012|Overall Study|Lost to Follow-up|0|||
13079503|NCT02988817|25521835|FG013|Overall Study|Lost to Follow-up|0|||
13079504|NCT02988817|25521836|FG014|Overall Study|Lost to Follow-up|1|||
13079505|NCT02988817|25521837|FG015|Overall Study|Lost to Follow-up|1|||
13079506|NCT02988817|25521838|FG016|Overall Study|Lost to Follow-up|2|||
13079507|NCT02988817|25521839|FG017|Overall Study|Lost to Follow-up|3|||
13079508|NCT02988817|25521840|FG018|Overall Study|Lost to Follow-up|0|||
13079509|NCT02988817|25521841|FG019|Overall Study|Lost to Follow-up|0|||
13079510|NCT02988817|25521822|FG000|Overall Study|Sponsor decision|0|||
13079511|NCT02988817|25521823|FG001|Overall Study|Sponsor decision|0|||
13079512|NCT02988817|25521824|FG002|Overall Study|Sponsor decision|0|||
13079513|NCT02988817|25521825|FG003|Overall Study|Sponsor decision|0|||
13079514|NCT02988817|25521826|FG004|Overall Study|Sponsor decision|0|||
13079515|NCT02988817|25521827|FG005|Overall Study|Sponsor decision|0|||
13079516|NCT02988817|25521828|FG006|Overall Study|Sponsor decision|0|||
13079517|NCT02988817|25521829|FG007|Overall Study|Sponsor decision|0|||
13079518|NCT02988817|25521830|FG008|Overall Study|Sponsor decision|0|||
13079519|NCT02988817|25521831|FG009|Overall Study|Sponsor decision|0|||
13079520|NCT02988817|25521832|FG010|Overall Study|Sponsor decision|0|||
13079521|NCT02988817|25521833|FG011|Overall Study|Sponsor decision|1|||
13079522|NCT02988817|25521834|FG012|Overall Study|Sponsor decision|1|||
13079523|NCT02988817|25521835|FG013|Overall Study|Sponsor decision|2|||
13079524|NCT02988817|25521836|FG014|Overall Study|Sponsor decision|2|||
13079525|NCT02988817|25521837|FG015|Overall Study|Sponsor decision|6|||
13079526|NCT02988817|25521838|FG016|Overall Study|Sponsor decision|2|||
13079527|NCT02988817|25521839|FG017|Overall Study|Sponsor decision|3|||
13079528|NCT02988817|25521840|FG018|Overall Study|Sponsor decision|2|||
13079529|NCT02988817|25521841|FG019|Overall Study|Sponsor decision|7|||
13079530|NCT02988817|25521822|FG000|Overall Study|Physician Decision|0|||
13079531|NCT02988817|25521823|FG001|Overall Study|Physician Decision|0|||
13079532|NCT02988817|25521824|FG002|Overall Study|Physician Decision|0|||
13079533|NCT02988817|25521825|FG003|Overall Study|Physician Decision|0|||
13079534|NCT02988817|25521826|FG004|Overall Study|Physician Decision|0|||
13079535|NCT02988817|25521827|FG005|Overall Study|Physician Decision|0|||
13079536|NCT02988817|25521828|FG006|Overall Study|Physician Decision|0|||
13079537|NCT02988817|25521829|FG007|Overall Study|Physician Decision|0|||
13079538|NCT02988817|25521830|FG008|Overall Study|Physician Decision|0|||
13079539|NCT02988817|25521831|FG009|Overall Study|Physician Decision|0|||
13079540|NCT02988817|25521832|FG010|Overall Study|Physician Decision|0|||
13079541|NCT02988817|25521833|FG011|Overall Study|Physician Decision|0|||
13079542|NCT02988817|25521834|FG012|Overall Study|Physician Decision|0|||
13079543|NCT02988817|25521835|FG013|Overall Study|Physician Decision|0|||
13079544|NCT02988817|25521836|FG014|Overall Study|Physician Decision|0|||
13079545|NCT02988817|25521837|FG015|Overall Study|Physician Decision|1|||
13079546|NCT02988817|25521838|FG016|Overall Study|Physician Decision|0|||
13079547|NCT02988817|25521839|FG017|Overall Study|Physician Decision|0|||
13079548|NCT02988817|25521840|FG018|Overall Study|Physician Decision|1|||
13079549|NCT02988817|25521841|FG019|Overall Study|Physician Decision|1|||
13079550|NCT02538666|25521885|FG000|Pre-Treatment|Disease progression|1|||
13079551|NCT02538666|25521886|FG001|Pre-Treatment|Disease progression|0|||
13079552|NCT02538666|25521887|FG002|Pre-Treatment|Disease progression|0|||
13079553|NCT02538666|25521885|FG000|Pre-Treatment|no longer meets study criteria|1|||
13079554|NCT02538666|25521886|FG001|Pre-Treatment|no longer meets study criteria|0|||
13079555|NCT02538666|25521887|FG002|Pre-Treatment|no longer meets study criteria|0|||
13079556|NCT02538666|25521885|FG000|Pre-Treatment|Withdrew Consent|0|||
13079557|NCT02538666|25521886|FG001|Pre-Treatment|Withdrew Consent|1|||
13079558|NCT02538666|25521887|FG002|Pre-Treatment|Withdrew Consent|1|||
13079559|NCT02538666|25521885|FG000|Treatment|Disease progression|270|||
13079560|NCT02538666|25521886|FG001|Treatment|Disease progression|227|||
13079561|NCT02538666|25521887|FG002|Treatment|Disease progression|165|||
13079562|NCT02538666|25521885|FG000|Treatment|Study drug toxicity|1|||
13079563|NCT02538666|25521886|FG001|Treatment|Study drug toxicity|29|||
13079564|NCT02538666|25521887|FG002|Treatment|Study drug toxicity|92|||
13079565|NCT02538666|25521885|FG000|Treatment|Death|0|||
13079566|NCT02538666|25521886|FG001|Treatment|Death|2|||
13079567|NCT02538666|25521887|FG002|Treatment|Death|3|||
13079568|NCT02538666|25521885|FG000|Treatment|Adverse event unrelated to study drug|8|||
13079569|NCT02538666|25521886|FG001|Treatment|Adverse event unrelated to study drug|10|||
13079570|NCT02538666|25521887|FG002|Treatment|Adverse event unrelated to study drug|15|||
13079571|NCT02538666|25521885|FG000|Treatment|Participant request to discontinue study treatment|3|||
13079572|NCT02538666|25521886|FG001|Treatment|Participant request to discontinue study treatment|6|||
13079573|NCT02538666|25521887|FG002|Treatment|Participant request to discontinue study treatment|11|||
13079574|NCT02538666|25521885|FG000|Treatment|Participant withdrew consent|2|||
13079575|NCT02538666|25521886|FG001|Treatment|Participant withdrew consent|5|||
13079576|NCT02538666|25521887|FG002|Treatment|Participant withdrew consent|3|||
13079577|NCT02538666|25521885|FG000|Treatment|Lost to Follow-up|0|||
13079578|NCT02538666|25521886|FG001|Treatment|Lost to Follow-up|1|||
13079579|NCT02538666|25521887|FG002|Treatment|Lost to Follow-up|1|||
13079580|NCT02538666|25521885|FG000|Treatment|Maximum clinical benefit|4|||
13079581|NCT02538666|25521886|FG001|Treatment|Maximum clinical benefit|3|||
13079582|NCT02538666|25521887|FG002|Treatment|Maximum clinical benefit|4|||
13079583|NCT02538666|25521885|FG000|Treatment|Poor/non-compliance|0|||
13079584|NCT02538666|25521886|FG001|Treatment|Poor/non-compliance|1|||
13079585|NCT02538666|25521887|FG002|Treatment|Poor/non-compliance|0|||
13079586|NCT02538666|25521885|FG000|Treatment|Participant no longer meets study criteria|0|||
13079587|NCT02538666|25521886|FG001|Treatment|Participant no longer meets study criteria|2|||
13079588|NCT02538666|25521887|FG002|Treatment|Participant no longer meets study criteria|0|||
13079589|NCT02538666|25521885|FG000|Treatment|Administrative reason by sponsor|0|||
13079590|NCT02538666|25521886|FG001|Treatment|Administrative reason by sponsor|0|||
13079591|NCT02538666|25521887|FG002|Treatment|Administrative reason by sponsor|1|||
13079592|NCT02538666|25521885|FG000|Treatment|Other reasons|8|||
13079593|NCT02538666|25521886|FG001|Treatment|Other reasons|15|||
13079594|NCT02538666|25521887|FG002|Treatment|Other reasons|5|||
13079595|NCT02538666|25521885|FG000|Treatment|Not reported|2|||
13079596|NCT02538666|25521886|FG001|Treatment|Not reported|2|||
13079597|NCT02538666|25521887|FG002|Treatment|Not reported|2|||
13079598|NCT02440581|25521932|FG000|Overall Study|Death|0|||
13079599|NCT02440581|25521933|FG001|Overall Study|Death|0|||
13079600|NCT02440581|25521934|FG002|Overall Study|Death|7|||
13079601|NCT02440581|25521935|FG003|Overall Study|Death|5|||
13079602|NCT02440581|25521932|FG000|Overall Study|Transplanted|1|||
13079603|NCT02440581|25521933|FG001|Overall Study|Transplanted|0|||
13079604|NCT02440581|25521934|FG002|Overall Study|Transplanted|3|||
13079605|NCT02440581|25521935|FG003|Overall Study|Transplanted|2|||
13079606|NCT02440581|25521932|FG000|Overall Study|Withdrawal by Subject|4|||
13079607|NCT02440581|25521933|FG001|Overall Study|Withdrawal by Subject|11|||
13079608|NCT02440581|25521934|FG002|Overall Study|Withdrawal by Subject|3|||
13079609|NCT02440581|25521935|FG003|Overall Study|Withdrawal by Subject|7|||
13079610|NCT02407236|25522250|FG000|Induction Study (8 Weeks)|Adverse Event|3|||
13079611|NCT02407236|25522251|FG001|Induction Study (8 Weeks)|Adverse Event|0|||
13079612|NCT02407236|25522252|FG002|Induction Study (8 Weeks)|Adverse Event|1|||
13079613|NCT02407236|25522253|FG003|Induction Study (8 Weeks)|Adverse Event|0|||
13079614|NCT02407236|25522254|FG004|Induction Study (8 Weeks)|Adverse Event|0|||
13079615|NCT02407236|25522255|FG005|Induction Study (8 Weeks)|Adverse Event|0|||
13079616|NCT02407236|25522256|FG006|Induction Study (8 Weeks)|Adverse Event|0|||
13079617|NCT02407236|25522257|FG007|Induction Study (8 Weeks)|Adverse Event|0|||
13079618|NCT02407236|25522258|FG008|Induction Study (8 Weeks)|Adverse Event|0|||
13079619|NCT02407236|25522259|FG009|Induction Study (8 Weeks)|Adverse Event|0|||
13079620|NCT02407236|25522260|FG010|Induction Study (8 Weeks)|Adverse Event|0|||
13079621|NCT02407236|25522261|FG011|Induction Study (8 Weeks)|Adverse Event|0|||
13079622|NCT02407236|25522262|FG012|Induction Study (8 Weeks)|Adverse Event|0|||
13079623|NCT02407236|25522250|FG000|Induction Study (8 Weeks)|Death|0|||
13079624|NCT02407236|25522251|FG001|Induction Study (8 Weeks)|Death|0|||
13079625|NCT02407236|25522252|FG002|Induction Study (8 Weeks)|Death|1|||
13079626|NCT02407236|25522253|FG003|Induction Study (8 Weeks)|Death|0|||
13079627|NCT02407236|25522254|FG004|Induction Study (8 Weeks)|Death|0|||
13079628|NCT02407236|25522255|FG005|Induction Study (8 Weeks)|Death|0|||
13079629|NCT02407236|25522256|FG006|Induction Study (8 Weeks)|Death|0|||
13079630|NCT02407236|25522257|FG007|Induction Study (8 Weeks)|Death|0|||
13079631|NCT02407236|25522258|FG008|Induction Study (8 Weeks)|Death|0|||
13079632|NCT02407236|25522259|FG009|Induction Study (8 Weeks)|Death|0|||
13079633|NCT02407236|25522260|FG010|Induction Study (8 Weeks)|Death|0|||
13079634|NCT02407236|25522261|FG011|Induction Study (8 Weeks)|Death|0|||
13079635|NCT02407236|25522262|FG012|Induction Study (8 Weeks)|Death|0|||
13079636|NCT02407236|25522250|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17|||
13079637|NCT02407236|25522251|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9|||
13079638|NCT02407236|25522252|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7|||
13079639|NCT02407236|25522253|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
13079640|NCT02407236|25522254|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
13079641|NCT02407236|25522255|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
13079642|NCT02407236|25522256|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
13079643|NCT02407236|25522257|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
13079644|NCT02407236|25522258|FG008|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
13079645|NCT02407236|25522259|FG009|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
13079646|NCT02407236|25522260|FG010|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
13079647|NCT02407236|25522261|FG011|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
13079648|NCT02407236|25522262|FG012|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
13079649|NCT02407236|25522250|FG000|Induction Study (8 Weeks)|Lack of Efficacy|0|||
13079650|NCT02407236|25522251|FG001|Induction Study (8 Weeks)|Lack of Efficacy|0|||
13079651|NCT02407236|25522252|FG002|Induction Study (8 Weeks)|Lack of Efficacy|1|||
13079652|NCT02407236|25522253|FG003|Induction Study (8 Weeks)|Lack of Efficacy|0|||
13079653|NCT02407236|25522254|FG004|Induction Study (8 Weeks)|Lack of Efficacy|0|||
13079654|NCT02407236|25522255|FG005|Induction Study (8 Weeks)|Lack of Efficacy|0|||
13079655|NCT02407236|25522256|FG006|Induction Study (8 Weeks)|Lack of Efficacy|0|||
13079656|NCT02407236|25522257|FG007|Induction Study (8 Weeks)|Lack of Efficacy|0|||
13079657|NCT02407236|25522258|FG008|Induction Study (8 Weeks)|Lack of Efficacy|0|||
13079658|NCT02407236|25522259|FG009|Induction Study (8 Weeks)|Lack of Efficacy|0|||
13079659|NCT02407236|25522260|FG010|Induction Study (8 Weeks)|Lack of Efficacy|0|||
13079660|NCT02407236|25522261|FG011|Induction Study (8 Weeks)|Lack of Efficacy|0|||
13079661|NCT02407236|25522262|FG012|Induction Study (8 Weeks)|Lack of Efficacy|0|||
13079662|NCT02407236|25522250|FG000|Induction Study (8 Weeks)|Physician Decision|1|||
13079663|NCT02407236|25522251|FG001|Induction Study (8 Weeks)|Physician Decision|1|||
13079664|NCT02407236|25522252|FG002|Induction Study (8 Weeks)|Physician Decision|0|||
13079665|NCT02407236|25522253|FG003|Induction Study (8 Weeks)|Physician Decision|0|||
13079666|NCT02407236|25522254|FG004|Induction Study (8 Weeks)|Physician Decision|0|||
13079667|NCT02407236|25522255|FG005|Induction Study (8 Weeks)|Physician Decision|0|||
13079668|NCT02407236|25522256|FG006|Induction Study (8 Weeks)|Physician Decision|0|||
13079669|NCT02407236|25522257|FG007|Induction Study (8 Weeks)|Physician Decision|0|||
13079670|NCT02407236|25522258|FG008|Induction Study (8 Weeks)|Physician Decision|0|||
13079671|NCT02407236|25522259|FG009|Induction Study (8 Weeks)|Physician Decision|0|||
13079672|NCT02407236|25522260|FG010|Induction Study (8 Weeks)|Physician Decision|0|||
13079673|NCT02407236|25522261|FG011|Induction Study (8 Weeks)|Physician Decision|0|||
13079674|NCT02407236|25522262|FG012|Induction Study (8 Weeks)|Physician Decision|0|||
13079675|NCT02407236|25522250|FG000|Induction Study (8 Weeks)|Other|2|||
13079676|NCT02407236|25522251|FG001|Induction Study (8 Weeks)|Other|1|||
13079677|NCT02407236|25522252|FG002|Induction Study (8 Weeks)|Other|5|||
13079678|NCT02407236|25522253|FG003|Induction Study (8 Weeks)|Other|0|||
13079679|NCT02407236|25522254|FG004|Induction Study (8 Weeks)|Other|0|||
13079680|NCT02407236|25522255|FG005|Induction Study (8 Weeks)|Other|0|||
13079681|NCT02407236|25522256|FG006|Induction Study (8 Weeks)|Other|0|||
13079682|NCT02407236|25522257|FG007|Induction Study (8 Weeks)|Other|0|||
13079683|NCT02407236|25522258|FG008|Induction Study (8 Weeks)|Other|0|||
13079684|NCT02407236|25522259|FG009|Induction Study (8 Weeks)|Other|0|||
13079685|NCT02407236|25522260|FG010|Induction Study (8 Weeks)|Other|0|||
13079686|NCT02407236|25522261|FG011|Induction Study (8 Weeks)|Other|0|||
13079687|NCT02407236|25522262|FG012|Induction Study (8 Weeks)|Other|0|||
13079688|NCT02407236|25522250|FG000|Maintenance Study (44 Weeks)|Adverse Event|0|||
13079689|NCT02407236|25522251|FG001|Maintenance Study (44 Weeks)|Adverse Event|0|||
13079690|NCT02407236|25522252|FG002|Maintenance Study (44 Weeks)|Adverse Event|0|||
13079691|NCT02407236|25522253|FG003|Maintenance Study (44 Weeks)|Adverse Event|19|||
13079692|NCT02407236|25522254|FG004|Maintenance Study (44 Weeks)|Adverse Event|8|||
13079693|NCT02407236|25522255|FG005|Maintenance Study (44 Weeks)|Adverse Event|4|||
13079694|NCT02407236|25522256|FG006|Maintenance Study (44 Weeks)|Adverse Event|11|||
13079695|NCT02407236|25522257|FG007|Maintenance Study (44 Weeks)|Adverse Event|10|||
13079696|NCT02407236|25522258|FG008|Maintenance Study (44 Weeks)|Adverse Event|0|||
13079697|NCT02407236|25522259|FG009|Maintenance Study (44 Weeks)|Adverse Event|0|||
13079698|NCT02407236|25522260|FG010|Maintenance Study (44 Weeks)|Adverse Event|0|||
13079699|NCT02407236|25522261|FG011|Maintenance Study (44 Weeks)|Adverse Event|0|||
13079700|NCT02407236|25522262|FG012|Maintenance Study (44 Weeks)|Adverse Event|0|||
13079701|NCT02407236|25522250|FG000|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
13079702|NCT02407236|25522251|FG001|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
13079703|NCT02407236|25522252|FG002|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
13079704|NCT02407236|25522253|FG003|Maintenance Study (44 Weeks)|Lack of Efficacy|19|||
13079705|NCT02407236|25522254|FG004|Maintenance Study (44 Weeks)|Lack of Efficacy|9|||
13079706|NCT02407236|25522255|FG005|Maintenance Study (44 Weeks)|Lack of Efficacy|6|||
13079707|NCT02407236|25522256|FG006|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
13079708|NCT02407236|25522257|FG007|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
13079709|NCT02407236|25522258|FG008|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
13079710|NCT02407236|25522259|FG009|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
13079711|NCT02407236|25522260|FG010|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
13079712|NCT02407236|25522261|FG011|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
13079713|NCT02407236|25522262|FG012|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
13079714|NCT02407236|25522250|FG000|Maintenance Study (44 Weeks)|Other|0|||
13079715|NCT02407236|25522251|FG001|Maintenance Study (44 Weeks)|Other|0|||
13079716|NCT02407236|25522252|FG002|Maintenance Study (44 Weeks)|Other|0|||
13079717|NCT02407236|25522253|FG003|Maintenance Study (44 Weeks)|Other|5|||
13079718|NCT02407236|25522254|FG004|Maintenance Study (44 Weeks)|Other|7|||
13079719|NCT02407236|25522255|FG005|Maintenance Study (44 Weeks)|Other|8|||
13079720|NCT02407236|25522256|FG006|Maintenance Study (44 Weeks)|Other|4|||
13079721|NCT02407236|25522257|FG007|Maintenance Study (44 Weeks)|Other|6|||
13079722|NCT02407236|25522258|FG008|Maintenance Study (44 Weeks)|Other|0|||
13079723|NCT02407236|25522259|FG009|Maintenance Study (44 Weeks)|Other|0|||
13079724|NCT02407236|25522260|FG010|Maintenance Study (44 Weeks)|Other|0|||
13079725|NCT02407236|25522261|FG011|Maintenance Study (44 Weeks)|Other|0|||
13079726|NCT02407236|25522262|FG012|Maintenance Study (44 Weeks)|Other|0|||
13079727|NCT02407236|25522250|FG000|Maintenance Study (44 Weeks)|Death|0|||
13079728|NCT02407236|25522251|FG001|Maintenance Study (44 Weeks)|Death|0|||
13079729|NCT02407236|25522252|FG002|Maintenance Study (44 Weeks)|Death|0|||
13079730|NCT02407236|25522253|FG003|Maintenance Study (44 Weeks)|Death|0|||
13079731|NCT02407236|25522254|FG004|Maintenance Study (44 Weeks)|Death|0|||
13079732|NCT02407236|25522255|FG005|Maintenance Study (44 Weeks)|Death|0|||
13079733|NCT02407236|25522256|FG006|Maintenance Study (44 Weeks)|Death|0|||
13079734|NCT02407236|25522257|FG007|Maintenance Study (44 Weeks)|Death|1|||
13079735|NCT02407236|25522258|FG008|Maintenance Study (44 Weeks)|Death|0|||
13079736|NCT02407236|25522259|FG009|Maintenance Study (44 Weeks)|Death|0|||
13079737|NCT02407236|25522260|FG010|Maintenance Study (44 Weeks)|Death|0|||
13079738|NCT02407236|25522261|FG011|Maintenance Study (44 Weeks)|Death|0|||
13079739|NCT02407236|25522262|FG012|Maintenance Study (44 Weeks)|Death|0|||
13079740|NCT02407236|25522250|FG000|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
13079741|NCT02407236|25522251|FG001|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
13079742|NCT02407236|25522252|FG002|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
13079743|NCT02407236|25522253|FG003|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
13079744|NCT02407236|25522254|FG004|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
13079745|NCT02407236|25522255|FG005|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
13079746|NCT02407236|25522256|FG006|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
13079747|NCT02407236|25522257|FG007|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
13079748|NCT02407236|25522258|FG008|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
13079749|NCT02407236|25522259|FG009|Long-term Extension Period (176 Weeks)|Adverse Event|17|||
13079750|NCT02407236|25522260|FG010|Long-term Extension Period (176 Weeks)|Adverse Event|10|||
13079751|NCT02407236|25522261|FG011|Long-term Extension Period (176 Weeks)|Adverse Event|11|||
13079752|NCT02407236|25522262|FG012|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
13079753|NCT02407236|25522250|FG000|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
13079754|NCT02407236|25522251|FG001|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
13079755|NCT02407236|25522252|FG002|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
13079756|NCT02407236|25522253|FG003|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
13079757|NCT02407236|25522254|FG004|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
13079758|NCT02407236|25522255|FG005|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
13079759|NCT02407236|25522256|FG006|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
13079760|NCT02407236|25522257|FG007|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
13079761|NCT02407236|25522258|FG008|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
13079762|NCT02407236|25522259|FG009|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
13079763|NCT02407236|25522260|FG010|Long-term Extension Period (176 Weeks)|Lost to Follow-up|1|||
13079764|NCT02407236|25522261|FG011|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
13079765|NCT02407236|25522262|FG012|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
13079766|NCT02407236|25522250|FG000|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
13079767|NCT02407236|25522251|FG001|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
13079768|NCT02407236|25522252|FG002|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
13079769|NCT02407236|25522253|FG003|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
13079770|NCT02407236|25522254|FG004|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
13079771|NCT02407236|25522255|FG005|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
13079772|NCT02407236|25522256|FG006|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
13079773|NCT02407236|25522257|FG007|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
13079774|NCT02407236|25522258|FG008|Long-term Extension Period (176 Weeks)|Lack of Efficacy|9|||
13079775|NCT02407236|25522259|FG009|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
13079776|NCT02407236|25522260|FG010|Long-term Extension Period (176 Weeks)|Lack of Efficacy|12|||
13079777|NCT02407236|25522261|FG011|Long-term Extension Period (176 Weeks)|Lack of Efficacy|7|||
13079778|NCT02407236|25522262|FG012|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
13079779|NCT02407236|25522250|FG000|Long-term Extension Period (176 Weeks)|Other|0|||
13079780|NCT02407236|25522251|FG001|Long-term Extension Period (176 Weeks)|Other|0|||
13079781|NCT02407236|25522252|FG002|Long-term Extension Period (176 Weeks)|Other|0|||
13079782|NCT02407236|25522253|FG003|Long-term Extension Period (176 Weeks)|Other|0|||
13079783|NCT02407236|25522254|FG004|Long-term Extension Period (176 Weeks)|Other|0|||
13079784|NCT02407236|25522255|FG005|Long-term Extension Period (176 Weeks)|Other|0|||
13079785|NCT02407236|25522256|FG006|Long-term Extension Period (176 Weeks)|Other|0|||
13079786|NCT02407236|25522257|FG007|Long-term Extension Period (176 Weeks)|Other|0|||
13079787|NCT02407236|25522258|FG008|Long-term Extension Period (176 Weeks)|Other|63|||
13079788|NCT02407236|25522259|FG009|Long-term Extension Period (176 Weeks)|Other|19|||
13079789|NCT02407236|25522260|FG010|Long-term Extension Period (176 Weeks)|Other|19|||
13079790|NCT02407236|25522261|FG011|Long-term Extension Period (176 Weeks)|Other|55|||
13079791|NCT02407236|25522262|FG012|Long-term Extension Period (176 Weeks)|Other|6|||
13079792|NCT02337829|25522287|FG000|Overall Study|Death|0|||
13079793|NCT02337829|25522288|FG001|Overall Study|Death|1|||
13079794|NCT02337829|25522289|FG002|Overall Study|Death|0|||
13079795|NCT02337829|25522290|FG003|Overall Study|Death|0|||
13079796|NCT02337829|25522287|FG000|Overall Study|Study terminated by sponsor|12|||
13079797|NCT02337829|25522288|FG001|Overall Study|Study terminated by sponsor|10|||
13079798|NCT02337829|25522289|FG002|Overall Study|Study terminated by sponsor|5|||
13079799|NCT02337829|25522290|FG003|Overall Study|Study terminated by sponsor|6|||
13079800|NCT02337829|25522287|FG000|Overall Study|discontinued for other reasons|6|||
13079801|NCT02337829|25522288|FG001|Overall Study|discontinued for other reasons|3|||
13079802|NCT02337829|25522289|FG002|Overall Study|discontinued for other reasons|1|||
13079803|NCT02337829|25522290|FG003|Overall Study|discontinued for other reasons|4|||
13079804|NCT02308241|25522297|FG000|Overall Study|Withdrawal by Subject|3|||
13131576|NCT02808429|25979441|FG002|Overall Study|Protocol Violation|0|||
13131577|NCT02808429|25979439|FG000|Overall Study|Premature study termination by sponsor|2|||
13131578|NCT02808429|25979440|FG001|Overall Study|Premature study termination by sponsor|0|||
13131579|NCT02808429|25979441|FG002|Overall Study|Premature study termination by sponsor|1|||
13131580|NCT02808429|25979439|FG000|Overall Study|Relocation|0|||
13131581|NCT02808429|25979440|FG001|Overall Study|Relocation|0|||
13131582|NCT02808429|25979441|FG002|Overall Study|Relocation|1|||
13131583|NCT02808338|25979454|FG000|Screening|Screen Failure|10|||
13131584|NCT02808338|25979454|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1|||
13131585|NCT02808338|25979454|FG000|Overnight In-lab Polysomonography|Reason not given|1|||
13131586|NCT02808312|25979577|FG000|Overall Study|Enrolled but Never Treated|0|||
13131587|NCT02808312|25979578|FG001|Overall Study|Enrolled but Never Treated|0|||
13131588|NCT02808312|25979579|FG002|Overall Study|Enrolled but Never Treated|1|||
13131589|NCT02808312|25979580|FG003|Overall Study|Enrolled but Never Treated|0|||
13131590|NCT02808312|25979581|FG004|Overall Study|Enrolled but Never Treated|0|||
13131591|NCT02808143|25979597|FG000|Maintenance Phase|Disease recurrence|1|||
13131592|NCT02808143|25979598|FG001|Maintenance Phase|Disease recurrence|3|||
13079805|NCT01893138|25522344|FG000|Double-Blind Period|Withdrawal by Subject|1|||
13079806|NCT01893138|25522345|FG001|Double-Blind Period|Withdrawal by Subject|1|||
13079807|NCT01893138|25522344|FG000|Open Label - Unblinded Period|Lack of Efficacy|9|||
13079808|NCT01893138|25522345|FG001|Open Label - Unblinded Period|Lack of Efficacy|0|||
13079809|NCT01893138|25522344|FG000|Open Label - Unblinded Period|Lost to Follow-up|4|||
13079810|NCT01893138|25522345|FG001|Open Label - Unblinded Period|Lost to Follow-up|3|||
13079811|NCT01893138|25522344|FG000|Open Label - Unblinded Period|Withdrawal by Subject|18|||
13079812|NCT01893138|25522345|FG001|Open Label - Unblinded Period|Withdrawal by Subject|7|||
13079813|NCT01893138|25522344|FG000|Open Label - Unblinded Period|Adverse Event|1|||
13079814|NCT01893138|25522345|FG001|Open Label - Unblinded Period|Adverse Event|0|||
13079815|NCT00473343|25522390|FG000|Overall Study|Adverse Event|9|||
13079816|NCT00473343|25522390|FG000|Overall Study|Lost to Follow-up|8|||
13079817|NCT00473343|25522390|FG000|Overall Study|Treatment failure|27|||
13079818|NCT00473343|25522390|FG000|Overall Study|Withdrew consent|3|||
13079819|NCT00473343|25522390|FG000|Overall Study|Other un-specified reason|3|||
13131593|NCT02808143|25979597|FG000|Maintenance Phase|Disease progression|1|||
13131594|NCT02808143|25979598|FG001|Maintenance Phase|Disease progression|2|||
13131595|NCT02808143|25979597|FG000|Survival Follow-Up|Still in survival Follow-up|2|||
13131596|NCT02808143|25979598|FG001|Survival Follow-Up|Still in survival Follow-up|3|||
13131597|NCT02808143|25979597|FG000|Survival Follow-Up|Disease recurrence|0|||
13131598|NCT02808143|25979598|FG001|Survival Follow-Up|Disease recurrence|2|||
13131599|NCT02808143|25979597|FG000|Survival Follow-Up|Adverse Event|0|||
13131600|NCT02808143|25979598|FG001|Survival Follow-Up|Adverse Event|1|||
13131601|NCT02808143|25979597|FG000|Survival Follow-Up|Death|1|||
13131602|NCT02808143|25979598|FG001|Survival Follow-Up|Death|0|||
13131603|NCT02807948|25979606|FG000|Overall Study|Physician Decision|1|||
13131604|NCT02807948|25979607|FG001|Overall Study|Physician Decision|0|||
13131605|NCT02807857|25979655|FG000|Enrolled Set|Patients not suitable for follow-up.|551|||
13131606|NCT02807857|25979655|FG000|Follow-Up Set|Study Terminated By Sponsor|131|||
13131607|NCT02807857|25979655|FG000|Follow-Up Set|Withdrawal by Subject|8|||
13131608|NCT02807857|25979655|FG000|Follow-Up Set|Lost to Follow-up|7|||
13131609|NCT02807857|25979655|FG000|Follow-Up Set|Physician Decision|6|||
13131610|NCT02807857|25979655|FG000|Follow-Up Set|Adverse Event|3|||
13131611|NCT02807857|25979655|FG000|Follow-Up Set|Death|27|||
13131612|NCT02807857|25979655|FG000|Follow-Up Set|Relocation|2|||
13131613|NCT02807844|25980010|FG000|Overall Study|Physician Decision|0|||
13131614|NCT02807844|25980011|FG001|Overall Study|Physician Decision|0|||
13131615|NCT02807844|25980012|FG002|Overall Study|Physician Decision|0|||
13131616|NCT02807844|25980013|FG003|Overall Study|Physician Decision|0|||
13131617|NCT02807844|25980014|FG004|Overall Study|Physician Decision|0|||
13131618|NCT02807844|25980015|FG005|Overall Study|Physician Decision|0|||
13131619|NCT02807844|25980016|FG006|Overall Study|Physician Decision|3|||
13131620|NCT02807844|25980017|FG007|Overall Study|Physician Decision|0|||
13131621|NCT02807844|25980018|FG008|Overall Study|Physician Decision|1|||
13131622|NCT02807844|25980019|FG009|Overall Study|Physician Decision|2|||
13131623|NCT02807844|25980010|FG000|Overall Study|Death|0|||
13131624|NCT02807844|25980011|FG001|Overall Study|Death|0|||
13131625|NCT02807844|25980012|FG002|Overall Study|Death|2|||
13131626|NCT02807844|25980013|FG003|Overall Study|Death|4|||
13131627|NCT02807844|25980014|FG004|Overall Study|Death|1|||
13131628|NCT02807844|25980015|FG005|Overall Study|Death|2|||
13131629|NCT02807844|25980016|FG006|Overall Study|Death|1|||
13131630|NCT02807844|25980017|FG007|Overall Study|Death|2|||
13131631|NCT02807844|25980018|FG008|Overall Study|Death|0|||
13131632|NCT02807844|25980019|FG009|Overall Study|Death|1|||
13131633|NCT02807844|25980010|FG000|Overall Study|Withdrawal by Subject|0|||
13131634|NCT02807844|25980011|FG001|Overall Study|Withdrawal by Subject|0|||
13131635|NCT02807844|25980012|FG002|Overall Study|Withdrawal by Subject|2|||
13131636|NCT02807844|25980013|FG003|Overall Study|Withdrawal by Subject|1|||
13131637|NCT02807844|25980014|FG004|Overall Study|Withdrawal by Subject|1|||
13131638|NCT02807844|25980015|FG005|Overall Study|Withdrawal by Subject|0|||
13131639|NCT02807844|25980016|FG006|Overall Study|Withdrawal by Subject|1|||
13131640|NCT02807844|25980017|FG007|Overall Study|Withdrawal by Subject|0|||
13131641|NCT02807844|25980018|FG008|Overall Study|Withdrawal by Subject|0|||
13131642|NCT02807844|25980019|FG009|Overall Study|Withdrawal by Subject|0|||
13131643|NCT02807844|25980010|FG000|Overall Study|Progressive disease|5|||
13131644|NCT02807844|25980011|FG001|Overall Study|Progressive disease|12|||
13131645|NCT02807844|25980012|FG002|Overall Study|Progressive disease|8|||
13131646|NCT02807844|25980013|FG003|Overall Study|Progressive disease|8|||
13131647|NCT02807844|25980014|FG004|Overall Study|Progressive disease|3|||
13131648|NCT02807844|25980015|FG005|Overall Study|Progressive disease|8|||
13131649|NCT02807844|25980016|FG006|Overall Study|Progressive disease|14|||
13131650|NCT02807844|25980017|FG007|Overall Study|Progressive disease|17|||
13131651|NCT02807844|25980018|FG008|Overall Study|Progressive disease|19|||
13131652|NCT02807844|25980019|FG009|Overall Study|Progressive disease|15|||
13131653|NCT02807844|25980010|FG000|Overall Study|Adverse Event|1|||
13131654|NCT02807844|25980011|FG001|Overall Study|Adverse Event|0|||
13131655|NCT02807844|25980012|FG002|Overall Study|Adverse Event|0|||
13131656|NCT02807844|25980013|FG003|Overall Study|Adverse Event|0|||
13079820|NCT04685499|25664333|FG000|Overall Study|Study Terminated Early|1|||
13079821|NCT04059146|25767068|FG000|Overall Study|Withdrawal by Subject|0|||
13079822|NCT04059146|25767069|FG001|Overall Study|Withdrawal by Subject|1|||
13079823|NCT03969641|25767090|FG000|Overall Study|Lost to Follow-up|5|||
13079824|NCT03969641|25767091|FG001|Overall Study|Lost to Follow-up|3|||
13079825|NCT03969641|25767090|FG000|Overall Study|Withdrawal by Subject|1|||
13079826|NCT03969641|25767091|FG001|Overall Study|Withdrawal by Subject|2|||
13079827|NCT03969641|25767090|FG000|Overall Study|Found to be ineligible|1|||
13079828|NCT03969641|25767091|FG001|Overall Study|Found to be ineligible|1|||
13079829|NCT03969641|25767090|FG000|Overall Study|Intrauterine fetal demise (IUFD)|0|||
13079830|NCT03969641|25767091|FG001|Overall Study|Intrauterine fetal demise (IUFD)|2|||
13079831|NCT03969641|25767090|FG000|Overall Study|Spontaneous abortion (SAB)|2|||
13079832|NCT03969641|25767091|FG001|Overall Study|Spontaneous abortion (SAB)|1|||
13079833|NCT03969641|25767090|FG000|Overall Study|Elective termination|0|||
13079834|NCT03969641|25767091|FG001|Overall Study|Elective termination|1|||
13079835|NCT03721172|25767181|FG000|Placebo-controlled Phase|Adverse Event|7|||
13079836|NCT03721172|25767182|FG001|Placebo-controlled Phase|Adverse Event|7|||
13079837|NCT03721172|25767183|FG002|Placebo-controlled Phase|Adverse Event|0|||
13079838|NCT03721172|25767181|FG000|Placebo-controlled Phase|Lack of Efficacy|4|||
13079839|NCT03721172|25767182|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
13079840|NCT03721172|25767183|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
13079841|NCT03721172|25767181|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
13079842|NCT03721172|25767182|FG001|Placebo-controlled Phase|Non-compliance with study drug|1|||
13079843|NCT03721172|25767183|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
13079844|NCT03721172|25767181|FG000|Placebo-controlled Phase|Lost to Follow-up|15|||
13079845|NCT03721172|25767182|FG001|Placebo-controlled Phase|Lost to Follow-up|13|||
13079846|NCT03721172|25767183|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
13079847|NCT03721172|25767181|FG000|Placebo-controlled Phase|Withdrawal by Subject|23|||
13079848|NCT03721172|25767182|FG001|Placebo-controlled Phase|Withdrawal by Subject|18|||
13079849|NCT03721172|25767183|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
13079850|NCT03721172|25767181|FG000|Placebo-controlled Phase|Other|3|||
13079851|NCT03721172|25767182|FG001|Placebo-controlled Phase|Other|0|||
13079852|NCT03721172|25767183|FG002|Placebo-controlled Phase|Other|0|||
13079853|NCT03721172|25767181|FG000|Apremilast Extension Phase|Adverse Event|0|||
13079854|NCT03721172|25767182|FG001|Apremilast Extension Phase|Adverse Event|0|||
13079855|NCT03721172|25767183|FG002|Apremilast Extension Phase|Adverse Event|10|||
13079856|NCT03721172|25767181|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
13079857|NCT03721172|25767182|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
13079858|NCT03721172|25767183|FG002|Apremilast Extension Phase|Lack of Efficacy|2|||
13079859|NCT03721172|25767181|FG000|Apremilast Extension Phase|Non-compliance with study drug|0|||
13079860|NCT03721172|25767182|FG001|Apremilast Extension Phase|Non-compliance with study drug|0|||
13079861|NCT03721172|25767183|FG002|Apremilast Extension Phase|Non-compliance with study drug|1|||
13079862|NCT03721172|25767181|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
13079863|NCT03721172|25767182|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
13079864|NCT03721172|25767183|FG002|Apremilast Extension Phase|Lost to Follow-up|20|||
13079865|NCT03721172|25767181|FG000|Apremilast Extension Phase|Protocol Violation|0|||
13079866|NCT03721172|25767182|FG001|Apremilast Extension Phase|Protocol Violation|0|||
13079867|NCT03721172|25767183|FG002|Apremilast Extension Phase|Protocol Violation|1|||
13079868|NCT03721172|25767181|FG000|Apremilast Extension Phase|Physician Decision|0|||
13079869|NCT03721172|25767182|FG001|Apremilast Extension Phase|Physician Decision|0|||
13079870|NCT03721172|25767183|FG002|Apremilast Extension Phase|Physician Decision|1|||
13079871|NCT03721172|25767181|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
13079872|NCT03721172|25767182|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
13079873|NCT03721172|25767183|FG002|Apremilast Extension Phase|Withdrawal by Subject|21|||
13079874|NCT03721172|25767181|FG000|Apremilast Extension Phase|Other|0|||
13079875|NCT03721172|25767182|FG001|Apremilast Extension Phase|Other|0|||
13079876|NCT03721172|25767183|FG002|Apremilast Extension Phase|Other|3|||
13079877|NCT03721172|25767181|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
13079878|NCT03721172|25767182|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
13079879|NCT03721172|25767183|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7|||
13079880|NCT03662659|25767218|FG000|Pre-treatment|Participant no longer met study criteria|1|||
13079881|NCT03662659|25767219|FG001|Pre-treatment|Participant no longer met study criteria|1|||
13079882|NCT03662659|25767218|FG000|Pre-treatment|Other reasons|1|||
13079883|NCT03662659|25767219|FG001|Pre-treatment|Other reasons|0|||
13079884|NCT03662659|25767218|FG000|Treatment|Completed Treatment|0|||
13079885|NCT03662659|25767219|FG001|Treatment|Completed Treatment|3|||
13079886|NCT03662659|25767218|FG000|Treatment|Disease Progression|69|||
13079887|NCT03662659|25767219|FG001|Treatment|Disease Progression|78|||
13079888|NCT03662659|25767218|FG000|Treatment|Study Drug Toxicity|18|||
13079889|NCT03662659|25767219|FG001|Treatment|Study Drug Toxicity|8|||
13079890|NCT03662659|25767218|FG000|Treatment|Death|12|||
13079891|NCT03662659|25767219|FG001|Treatment|Death|7|||
13307563|NCT01284959|26528991|FG002|Overall Study|Withdrawal by Subject|0|||
13307564|NCT01284959|26528989|FG000|Overall Study|Adverse Event|0|||
13079892|NCT03662659|25767218|FG000|Treatment|Adverse Event unrelated to Study Drug|7|||
13079893|NCT03662659|25767219|FG001|Treatment|Adverse Event unrelated to Study Drug|4|||
13079894|NCT03662659|25767218|FG000|Treatment|Withdrawal by Subject|1|||
13079895|NCT03662659|25767219|FG001|Treatment|Withdrawal by Subject|1|||
13079896|NCT03662659|25767218|FG000|Treatment|Poor/Non-compliance|1|||
13079897|NCT03662659|25767219|FG001|Treatment|Poor/Non-compliance|0|||
13079898|NCT03662659|25767218|FG000|Treatment|Participant no longer meets study criteria|1|||
13079899|NCT03662659|25767219|FG001|Treatment|Participant no longer meets study criteria|0|||
13079900|NCT03662659|25767218|FG000|Treatment|Other reasons|6|||
13079901|NCT03662659|25767219|FG001|Treatment|Other reasons|5|||
13131657|NCT02807844|25980014|FG004|Overall Study|Adverse Event|1|||
13131658|NCT02807844|25980015|FG005|Overall Study|Adverse Event|1|||
13131659|NCT02807844|25980016|FG006|Overall Study|Adverse Event|1|||
13131660|NCT02807844|25980017|FG007|Overall Study|Adverse Event|1|||
13131661|NCT02807844|25980018|FG008|Overall Study|Adverse Event|1|||
13131662|NCT02807844|25980019|FG009|Overall Study|Adverse Event|2|||
13131663|NCT02807623|25980056|FG000|Overall Study|Lost to Follow-up|23|||
13131664|NCT02807623|25980057|FG001|Overall Study|Lost to Follow-up|18|||
13131665|NCT02807623|25980058|FG002|Overall Study|Lost to Follow-up|22|||
13131666|NCT02807623|25980056|FG000|Overall Study|Drug intolerance|0|||
13131667|NCT02807623|25980057|FG001|Overall Study|Drug intolerance|1|||
13131668|NCT02807623|25980058|FG002|Overall Study|Drug intolerance|0|||
13131669|NCT02807623|25980056|FG000|Overall Study|incomplete blood draw|0|||
13131670|NCT02807623|25980057|FG001|Overall Study|incomplete blood draw|2|||
13131671|NCT02807623|25980058|FG002|Overall Study|incomplete blood draw|1|||
13131672|NCT02807493|25980075|FG000|Overall Study|Adverse Event|5|||
13131673|NCT02807493|25980076|FG001|Overall Study|Adverse Event|2|||
13131674|NCT02807493|25980075|FG000|Overall Study|Lost to Follow-up|6|||
13131675|NCT02807493|25980076|FG001|Overall Study|Lost to Follow-up|0|||
13131676|NCT02807493|25980075|FG000|Overall Study|Physician Decision|4|||
13131677|NCT02807493|25980076|FG001|Overall Study|Physician Decision|1|||
13131678|NCT02807493|25980075|FG000|Overall Study|Protocol Violation|7|||
13131679|NCT02807493|25980076|FG001|Overall Study|Protocol Violation|0|||
13131680|NCT02807493|25980075|FG000|Overall Study|Withdrawal by Subject|17|||
13131681|NCT02807493|25980076|FG001|Overall Study|Withdrawal by Subject|10|||
13131682|NCT02807493|25980075|FG000|Overall Study|Other withdrawal|17|||
13131683|NCT02807493|25980076|FG001|Overall Study|Other withdrawal|0|||
13131684|NCT02807493|25980075|FG000|Overall Study|C-Section Prior to Stage 2 of Labor|31|||
13131685|NCT02807493|25980076|FG001|Overall Study|C-Section Prior to Stage 2 of Labor|39|||
13131686|NCT02807402|25980114|FG000|Overall Study|Failure to Return|1|||
13131687|NCT02807402|25980114|FG000|Overall Study|Death|3|||
13131688|NCT02807402|25980114|FG000|Overall Study|Other|2|||
13131689|NCT02807376|25980129|FG000|Overall Study|Intra-operative exclusion criteria|3|||
13131690|NCT02807376|25980130|FG001|Overall Study|Intra-operative exclusion criteria|0|||
13131691|NCT02807376|25980129|FG000|Overall Study|Lost to Follow-up|0|||
13131692|NCT02807376|25980130|FG001|Overall Study|Lost to Follow-up|1|||
13131693|NCT02807363|25980169|FG000|Dosing Period|Adverse Event|0|||
13131694|NCT02807363|25980170|FG001|Dosing Period|Adverse Event|1|||
13131695|NCT02807363|25980171|FG002|Dosing Period|Adverse Event|0|||
13131696|NCT02807363|25980172|FG003|Dosing Period|Adverse Event|0|||
13222427|NCT01806597|26286271|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
13222428|NCT01806597|26286266|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
13222429|NCT01806597|26286267|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1|||
13222430|NCT01806597|26286268|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
13222431|NCT01806597|26286269|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
13131697|NCT02807259|25980197|FG000|Baseline (3 Months)|migration, refusal, not available|77|||
13131698|NCT02807259|25980198|FG001|Baseline (3 Months)|migration, refusal, not available|112|||
13131699|NCT02807259|25980197|FG000|Midline (3 Months)|migration, refusal, not available|30|||
13131700|NCT02807259|25980198|FG001|Midline (3 Months)|migration, refusal, not available|34|||
13131701|NCT02807259|25980197|FG000|Endline (3 Months)|migration, refusal, not available|35|||
13131702|NCT02807259|25980198|FG001|Endline (3 Months)|migration, refusal, not available|87|||
13131703|NCT02806986|25980220|FG000|Treatment Stage 1|Adverse Event|1|||
13131704|NCT02806986|25980220|FG000|Treatment Stage 2|Adverse Event|3|||
13131705|NCT02806986|25980220|FG000|Treatment Stage 2|Withdrawal by Subject|2|||
13131706|NCT02806973|25980259|FG000|Period 1|Withdrawal by Subject|0|||
13131707|NCT02806973|25980260|FG001|Period 1|Withdrawal by Subject|2|||
13131708|NCT02806973|25980261|FG002|Period 1|Withdrawal by Subject|1|||
13131709|NCT02806973|25980262|FG003|Period 1|Withdrawal by Subject|1|||
13131710|NCT02806973|25980259|FG000|Period 1|Adverse Event|0|||
13131711|NCT02806973|25980260|FG001|Period 1|Adverse Event|0|||
13131712|NCT02806973|25980261|FG002|Period 1|Adverse Event|0|||
13131713|NCT02806973|25980262|FG003|Period 1|Adverse Event|1|||
13131714|NCT02806973|25980259|FG000|Period 3|Withdrawal by Subject|0|||
13131715|NCT02806973|25980260|FG001|Period 3|Withdrawal by Subject|0|||
13131716|NCT02806973|25980261|FG002|Period 3|Withdrawal by Subject|0|||
13131717|NCT02806973|25980262|FG003|Period 3|Withdrawal by Subject|3|||
13131718|NCT02806973|25980259|FG000|Period 3|Adverse Event|0|||
13222432|NCT01806597|26286270|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
13079902|NCT03530124|25767242|FG000|Overall Study|Withdrawal by Subject|0|||
13079903|NCT03530124|25767243|FG001|Overall Study|Withdrawal by Subject|1|||
13079904|NCT03530124|25767242|FG000|Overall Study|Protocol Violation|1|||
13079905|NCT03530124|25767243|FG001|Overall Study|Protocol Violation|0|||
13079906|NCT03530124|25767242|FG000|Overall Study|Discharged prior to study completion|1|||
13079907|NCT03530124|25767243|FG001|Overall Study|Discharged prior to study completion|0|||
13079908|NCT03385239|25767338|FG000|Overall Study|Voluntary Withdrawal|2|||
13079909|NCT03385239|25767339|FG001|Overall Study|Voluntary Withdrawal|3|||
13079910|NCT03385239|25767340|FG002|Overall Study|Voluntary Withdrawal|2|||
13079911|NCT03385239|25767341|FG003|Overall Study|Voluntary Withdrawal|3|||
13079912|NCT03385239|25767342|FG004|Overall Study|Voluntary Withdrawal|0|||
13079913|NCT03385239|25767338|FG000|Overall Study|Adverse Event|0|||
13079914|NCT03385239|25767339|FG001|Overall Study|Adverse Event|0|||
13079915|NCT03385239|25767340|FG002|Overall Study|Adverse Event|1|||
13079916|NCT03385239|25767341|FG003|Overall Study|Adverse Event|0|||
13079917|NCT03385239|25767342|FG004|Overall Study|Adverse Event|0|||
13079918|NCT03385239|25767338|FG000|Overall Study|Other|0|||
13079919|NCT03385239|25767339|FG001|Overall Study|Other|0|||
13079920|NCT03385239|25767340|FG002|Overall Study|Other|0|||
13079921|NCT03385239|25767341|FG003|Overall Study|Other|1|||
13079922|NCT03385239|25767342|FG004|Overall Study|Other|0|||
13079923|NCT03116347|25767435|FG000|Overall Study|Withdrawal by Subject|1|||
13079924|NCT03116347|25767436|FG001|Overall Study|Withdrawal by Subject|2|||
13079925|NCT03089606|25767451|FG000|Overall Study|Progression after Cycle 1|1|||
13079926|NCT03080935|25767468|FG000|Overall Study|Death|34|||
13079927|NCT03080935|25767469|FG001|Overall Study|Death|50|||
13079928|NCT03080935|25767468|FG000|Overall Study|Lost to Follow-up|5|||
13079929|NCT03080935|25767469|FG001|Overall Study|Lost to Follow-up|4|||
13079930|NCT03080935|25767468|FG000|Overall Study|Withdrawal by Subject|11|||
13079931|NCT03080935|25767469|FG001|Overall Study|Withdrawal by Subject|15|||
13079932|NCT03020160|25767541|FG000|Overall Study|Withdrawal by Subject|1|||
13079933|NCT03020160|25767542|FG001|Overall Study|Withdrawal by Subject|0|||
13079934|NCT02632409|25767567|FG000|Randomized|AE unrelated to study Drug|0|||
13079935|NCT02632409|25767568|FG001|Randomized|AE unrelated to study Drug|1|||
13079936|NCT02632409|25767567|FG000|Randomized|Participant withdrew consent|2|||
13079937|NCT02632409|25767568|FG001|Randomized|Participant withdrew consent|1|||
13079938|NCT02632409|25767567|FG000|Randomized|No Longer meets study criteria|5|||
13079939|NCT02632409|25767568|FG001|Randomized|No Longer meets study criteria|0|||
13079940|NCT02632409|25767567|FG000|Randomized|other reasons|1|||
13079941|NCT02632409|25767568|FG001|Randomized|other reasons|0|||
13079942|NCT02632409|25767567|FG000|Treatment Period|Ongoing Treatment|20|||
13079943|NCT02632409|25767568|FG001|Treatment Period|Ongoing Treatment|21|||
13079944|NCT02632409|25767567|FG000|Treatment Period|Disease Recurrence|147|||
13079945|NCT02632409|25767568|FG001|Treatment Period|Disease Recurrence|90|||
13079946|NCT02632409|25767567|FG000|Treatment Period|Study Drug Toxicity|8|||
13079947|NCT02632409|25767568|FG001|Treatment Period|Study Drug Toxicity|49|||
13079948|NCT02632409|25767567|FG000|Treatment Period|Death|1|||
13079949|NCT02632409|25767568|FG001|Treatment Period|Death|0|||
13079950|NCT02632409|25767567|FG000|Treatment Period|AE unrelated to study drug|15|||
13079951|NCT02632409|25767568|FG001|Treatment Period|AE unrelated to study drug|16|||
13079952|NCT02632409|25767567|FG000|Treatment Period|Request to discontinue treatment|4|||
13079953|NCT02632409|25767568|FG001|Treatment Period|Request to discontinue treatment|19|||
13079954|NCT02632409|25767567|FG000|Treatment Period|Participant withdrew consent|7|||
13079955|NCT02632409|25767568|FG001|Treatment Period|Participant withdrew consent|5|||
13079956|NCT02632409|25767567|FG000|Treatment Period|Lost to Follow-up|0|||
13079957|NCT02632409|25767568|FG001|Treatment Period|Lost to Follow-up|1|||
13079958|NCT02632409|25767567|FG000|Treatment Period|Maximum clinical benefit|1|||
13079959|NCT02632409|25767568|FG001|Treatment Period|Maximum clinical benefit|0|||
13079960|NCT02632409|25767567|FG000|Treatment Period|No longer meets study criteria|3|||
13079961|NCT02632409|25767568|FG001|Treatment Period|No longer meets study criteria|0|||
13079962|NCT02632409|25767567|FG000|Treatment Period|Administrative Reason by sponsor|0|||
13079963|NCT02632409|25767568|FG001|Treatment Period|Administrative Reason by sponsor|1|||
13079964|NCT02632409|25767567|FG000|Treatment Period|Other Reasons|10|||
13079965|NCT02632409|25767568|FG001|Treatment Period|Other Reasons|6|||
13079966|NCT02593110|25767611|FG000|Overall Study|Withdrawal by Subject|0|||
13079967|NCT02593110|25767612|FG001|Overall Study|Withdrawal by Subject|3|||
13079968|NCT02593110|25767613|FG002|Overall Study|Withdrawal by Subject|3|||
13079969|NCT02593110|25767614|FG003|Overall Study|Withdrawal by Subject|2|||
13079970|NCT02593110|25767611|FG000|Overall Study|Death|0|||
13079971|NCT02593110|25767612|FG001|Overall Study|Death|0|||
13079972|NCT02593110|25767613|FG002|Overall Study|Death|1|||
13079973|NCT02593110|25767614|FG003|Overall Study|Death|0|||
13079974|NCT02373813|25767678|FG000|Run-In Period|Other, Not Specified|5|||
13079975|NCT02373813|25767679|FG001|Run-In Period|Other, Not Specified|0|||
13079976|NCT02373813|25767680|FG002|Run-In Period|Other, Not Specified|0|||
13079977|NCT02373813|25767681|FG003|Run-In Period|Other, Not Specified|0|||
13079978|NCT02373813|25767678|FG000|Run-In Period|Withdrawal by Subject|16|||
13079979|NCT02373813|25767679|FG001|Run-In Period|Withdrawal by Subject|0|||
13079980|NCT02373813|25767680|FG002|Run-In Period|Withdrawal by Subject|0|||
13079981|NCT02373813|25767681|FG003|Run-In Period|Withdrawal by Subject|0|||
13079982|NCT02373813|25767678|FG000|Run-In Period|Decision by Sponsor|11|||
13079983|NCT02373813|25767679|FG001|Run-In Period|Decision by Sponsor|0|||
13079984|NCT02373813|25767680|FG002|Run-In Period|Decision by Sponsor|0|||
13079985|NCT02373813|25767681|FG003|Run-In Period|Decision by Sponsor|0|||
13079986|NCT02373813|25767678|FG000|Run-In Period|Protocol Violation|75|||
13079987|NCT02373813|25767679|FG001|Run-In Period|Protocol Violation|0|||
13079988|NCT02373813|25767680|FG002|Run-In Period|Protocol Violation|0|||
13079989|NCT02373813|25767681|FG003|Run-In Period|Protocol Violation|0|||
13079990|NCT02373813|25767678|FG000|Run-In Period|Lost to Follow-up|2|||
13079991|NCT02373813|25767679|FG001|Run-In Period|Lost to Follow-up|0|||
13079992|NCT02373813|25767680|FG002|Run-In Period|Lost to Follow-up|0|||
13079993|NCT02373813|25767681|FG003|Run-In Period|Lost to Follow-up|0|||
13079994|NCT02373813|25767678|FG000|Run-In Period|Adverse Event|3|||
13079995|NCT02373813|25767679|FG001|Run-In Period|Adverse Event|0|||
13079996|NCT02373813|25767680|FG002|Run-In Period|Adverse Event|0|||
13079997|NCT02373813|25767681|FG003|Run-In Period|Adverse Event|0|||
13079998|NCT02373813|25767678|FG000|Run-In Period|Noncompliance|1|||
13079999|NCT02373813|25767679|FG001|Run-In Period|Noncompliance|0|||
13080000|NCT02373813|25767680|FG002|Run-In Period|Noncompliance|0|||
13080001|NCT02373813|25767681|FG003|Run-In Period|Noncompliance|0|||
13080002|NCT02373813|25767678|FG000|Run-In Period|Ineligibility Determined|3|||
13080003|NCT02373813|25767679|FG001|Run-In Period|Ineligibility Determined|0|||
13080004|NCT02373813|25767680|FG002|Run-In Period|Ineligibility Determined|0|||
13080005|NCT02373813|25767681|FG003|Run-In Period|Ineligibility Determined|0|||
13080006|NCT02373813|25767678|FG000|Double-Blind Treatment Period|Decision by Sponsor|0|||
13080007|NCT02373813|25767679|FG001|Double-Blind Treatment Period|Decision by Sponsor|1|||
13080008|NCT02373813|25767680|FG002|Double-Blind Treatment Period|Decision by Sponsor|2|||
13080009|NCT02373813|25767681|FG003|Double-Blind Treatment Period|Decision by Sponsor|0|||
13080010|NCT02373813|25767678|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
13080011|NCT02373813|25767679|FG001|Double-Blind Treatment Period|Protocol Violation|2|||
13080012|NCT02373813|25767680|FG002|Double-Blind Treatment Period|Protocol Violation|0|||
13080013|NCT02373813|25767681|FG003|Double-Blind Treatment Period|Protocol Violation|0|||
13080014|NCT02373813|25767678|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
13080015|NCT02373813|25767679|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
13080016|NCT02373813|25767680|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
13080017|NCT02373813|25767681|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
13080018|NCT02373813|25767678|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
13080019|NCT02373813|25767679|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10|||
13080020|NCT02373813|25767680|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6|||
13080021|NCT02373813|25767681|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3|||
13080022|NCT02337686|25767691|FG000|Overall Study|Adverse Event|1|||
13080023|NCT02231749|25767714|FG000|Overall Study|Disease progression|229|||
13080024|NCT02231749|25767715|FG001|Overall Study|Disease progression|297|||
13080025|NCT02231749|25767714|FG000|Overall Study|Study Drug Toxicity|134|||
13080026|NCT02231749|25767715|FG001|Overall Study|Study Drug Toxicity|63|||
13080027|NCT02231749|25767714|FG000|Overall Study|Death|1|||
13080028|NCT02231749|25767715|FG001|Overall Study|Death|1|||
13080029|NCT02231749|25767714|FG000|Overall Study|AE unrelated to Study drug|32|||
13080030|NCT02231749|25767715|FG001|Overall Study|AE unrelated to Study drug|31|||
13080031|NCT02231749|25767714|FG000|Overall Study|Participant's request to discontinue|10|||
13080032|NCT02231749|25767715|FG001|Overall Study|Participant's request to discontinue|21|||
13080033|NCT02231749|25767714|FG000|Overall Study|Participant withdrew Consent|8|||
13080034|NCT02231749|25767715|FG001|Overall Study|Participant withdrew Consent|15|||
13080035|NCT02231749|25767714|FG000|Overall Study|Lost to Follow-up|1|||
13080036|NCT02231749|25767715|FG001|Overall Study|Lost to Follow-up|2|||
13080037|NCT02231749|25767714|FG000|Overall Study|Maximum Clinical Benefit|5|||
13080038|NCT02231749|25767715|FG001|Overall Study|Maximum Clinical Benefit|8|||
13080039|NCT02231749|25767714|FG000|Overall Study|Poor/Non-Compliance|0|||
13080040|NCT02231749|25767715|FG001|Overall Study|Poor/Non-Compliance|3|||
13080041|NCT02231749|25767714|FG000|Overall Study|Pregnancy|1|||
13080042|NCT02231749|25767715|FG001|Overall Study|Pregnancy|0|||
13080043|NCT02231749|25767714|FG000|Overall Study|other|0|||
13080044|NCT02231749|25767715|FG001|Overall Study|other|8|||
13080045|NCT02231749|25767714|FG000|Overall Study|No longer meets Study Criteria|1|||
13080046|NCT02231749|25767715|FG001|Overall Study|No longer meets Study Criteria|0|||
13080047|NCT01853748|25767781|FG000|Allocation|Withdrawal by Subject|1|||
13080048|NCT01853748|25767782|FG001|Allocation|Withdrawal by Subject|13|||
13080049|NCT01853748|25767781|FG000|Allocation|not sufficient to receive intervention|0|||
13080050|NCT01853748|25767782|FG001|Allocation|not sufficient to receive intervention|1|||
13080051|NCT01853748|25767781|FG000|Follow-Up|Withdrawal by Subject|7|||
13080052|NCT01853748|25767782|FG001|Follow-Up|Withdrawal by Subject|6|||
13080053|NCT01853748|25767781|FG000|Follow-Up|Adverse Event|67|||
13080054|NCT01853748|25767782|FG001|Follow-Up|Adverse Event|7|||
13131719|NCT02806973|25980260|FG001|Period 3|Adverse Event|0|||
13080055|NCT01853748|25767781|FG000|Follow-Up|not available for data collection|16|||
13080056|NCT01853748|25767782|FG001|Follow-Up|not available for data collection|4|||
13080057|NCT01575808|25767852|FG000|Overall Study|Death|2|||
13080058|NCT01575808|25767853|FG001|Overall Study|Death|0|||
13080059|NCT01575808|25767852|FG000|Overall Study|Withdrawal by Subject|1|||
13080060|NCT01575808|25767853|FG001|Overall Study|Withdrawal by Subject|0|||
13131720|NCT02806973|25980261|FG002|Period 3|Adverse Event|1|||
13131721|NCT02806973|25980262|FG003|Period 3|Adverse Event|0|||
13131722|NCT02806960|25980301|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3|||
13131723|NCT02806960|25980302|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3|||
13131724|NCT02806960|25980303|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3|||
13131725|NCT02806960|25980304|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3|||
13133606|NCT02767323|25988518|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
13133607|NCT02767323|25988519|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20|||
13133608|NCT02767323|25988520|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
13133609|NCT02767323|25988521|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0|||
13133610|NCT02766777|25988527|FG000|Overall Study|Adverse Event|12|||
13133611|NCT02766777|25988527|FG000|Overall Study|Lost to Follow-up|16|||
13133612|NCT02766777|25988527|FG000|Overall Study|Non-Compliance With Study Drug|1|||
13133613|NCT02766777|25988527|FG000|Overall Study|Protocol Violation|1|||
13133614|NCT02766777|25988527|FG000|Overall Study|Withdrawal by Subject|4|||
13133615|NCT02766608|25988617|FG000|Overall Study|Adverse Event|27|||
13133616|NCT02766608|25988618|FG001|Overall Study|Adverse Event|22|||
13133617|NCT02766608|25988619|FG002|Overall Study|Adverse Event|17|||
13133618|NCT02766608|25988620|FG003|Overall Study|Adverse Event|13|||
13133619|NCT02766608|25988621|FG004|Overall Study|Adverse Event|12|||
13133620|NCT02766608|25988617|FG000|Overall Study|Withdrawal by Subject|21|||
13133621|NCT02766608|25988618|FG001|Overall Study|Withdrawal by Subject|20|||
13133622|NCT02766608|25988619|FG002|Overall Study|Withdrawal by Subject|24|||
13133623|NCT02766608|25988620|FG003|Overall Study|Withdrawal by Subject|13|||
13133624|NCT02766608|25988621|FG004|Overall Study|Withdrawal by Subject|10|||
13133625|NCT02766608|25988617|FG000|Overall Study|Lack of Efficacy|16|||
13133626|NCT02766608|25988618|FG001|Overall Study|Lack of Efficacy|15|||
13133627|NCT02766608|25988619|FG002|Overall Study|Lack of Efficacy|32|||
13133628|NCT02766608|25988620|FG003|Overall Study|Lack of Efficacy|8|||
13133629|NCT02766608|25988621|FG004|Overall Study|Lack of Efficacy|2|||
13133630|NCT02766608|25988617|FG000|Overall Study|Lost to Follow-up|6|||
13133631|NCT02766608|25988618|FG001|Overall Study|Lost to Follow-up|3|||
13133632|NCT02766608|25988619|FG002|Overall Study|Lost to Follow-up|5|||
13133633|NCT02766608|25988620|FG003|Overall Study|Lost to Follow-up|2|||
13133634|NCT02766608|25988621|FG004|Overall Study|Lost to Follow-up|2|||
13133635|NCT02766608|25988617|FG000|Overall Study|Physician Decision|3|||
13133636|NCT02766608|25988618|FG001|Overall Study|Physician Decision|2|||
13133637|NCT02766608|25988619|FG002|Overall Study|Physician Decision|3|||
13133638|NCT02766608|25988620|FG003|Overall Study|Physician Decision|1|||
13133639|NCT02766608|25988621|FG004|Overall Study|Physician Decision|2|||
13133640|NCT02766608|25988617|FG000|Overall Study|Protocol disc criteria|3|||
13133641|NCT02766608|25988618|FG001|Overall Study|Protocol disc criteria|3|||
13133642|NCT02766608|25988619|FG002|Overall Study|Protocol disc criteria|4|||
13133643|NCT02766608|25988620|FG003|Overall Study|Protocol disc criteria|0|||
13133644|NCT02766608|25988621|FG004|Overall Study|Protocol disc criteria|0|||
13133645|NCT02766608|25988617|FG000|Overall Study|Protocol Violation|0|||
13133646|NCT02766608|25988618|FG001|Overall Study|Protocol Violation|4|||
13133647|NCT02766608|25988619|FG002|Overall Study|Protocol Violation|4|||
13133648|NCT02766608|25988620|FG003|Overall Study|Protocol Violation|0|||
13133649|NCT02766608|25988621|FG004|Overall Study|Protocol Violation|1|||
13133650|NCT02766608|25988617|FG000|Overall Study|Administrative Reasons|3|||
13133651|NCT02766608|25988618|FG001|Overall Study|Administrative Reasons|1|||
13133652|NCT02766608|25988619|FG002|Overall Study|Administrative Reasons|1|||
13133653|NCT02766608|25988620|FG003|Overall Study|Administrative Reasons|0|||
13133654|NCT02766608|25988621|FG004|Overall Study|Administrative Reasons|0|||
13133655|NCT02766478|25988640|FG000|Overall Study|Withdrawal by Subject|1|||
13133656|NCT02766478|25988641|FG001|Overall Study|Withdrawal by Subject|1|||
13133657|NCT02766400|25988654|FG000|Overall Study|Death|1|||
13133658|NCT02766400|25988655|FG001|Overall Study|Death|2|||
13133659|NCT02766400|25988654|FG000|Overall Study|Withdrawal by Subject|1|||
13133660|NCT02766400|25988655|FG001|Overall Study|Withdrawal by Subject|0|||
13133661|NCT02766283|25988681|FG000|Overall Study|Lost to Follow-up|27|||
13133662|NCT02766088|25988696|FG000|Overall Study|Sponsor study termination|498|||
13133663|NCT02766088|25988696|FG000|Overall Study|Migrated/moved from the study area|1|||
13133664|NCT02766088|25988696|FG000|Overall Study|Lost to Follow-up|5|||
13133665|NCT02766088|25988696|FG000|Overall Study|Other|1|||
13133666|NCT02766088|25988696|FG000|Overall Study|Death|1|||
13133667|NCT02766023|25988751|FG000|Overall Study|Lost to Follow-up|23|||
13133668|NCT02766023|25988752|FG001|Overall Study|Lost to Follow-up|11|||
13133669|NCT02766023|25988751|FG000|Overall Study|Pregnancy|1|||
13133670|NCT02766023|25988752|FG001|Overall Study|Pregnancy|0|||
13080061|NCT00000135|25767904|FG000|Overall Study|Death|27|||
13080062|NCT00000135|25767905|FG001|Overall Study|Death|14|||
13080065|NCT00000620|25768080|FG000|Overall Study|Death|86|||
13080066|NCT00000620|25768081|FG001|Overall Study|Death|67|||
13080067|NCT00000620|25768082|FG002|Overall Study|Death|112|||
13080068|NCT00000620|25768083|FG003|Overall Study|Death|126|||
13080069|NCT00000620|25768084|FG004|Overall Study|Death|64|||
13080070|NCT00000620|25768085|FG005|Overall Study|Death|77|||
13080071|NCT00000620|25768086|FG006|Overall Study|Death|91|||
13080072|NCT00000620|25768087|FG007|Overall Study|Death|95|||
13080073|NCT00000620|25768080|FG000|Overall Study|Lost to Follow-up|14|||
13080074|NCT00000620|25768081|FG001|Overall Study|Lost to Follow-up|14|||
13080075|NCT00000620|25768082|FG002|Overall Study|Lost to Follow-up|14|||
13080076|NCT00000620|25768083|FG003|Overall Study|Lost to Follow-up|14|||
13080077|NCT00000620|25768084|FG004|Overall Study|Lost to Follow-up|15|||
13080078|NCT00000620|25768085|FG005|Overall Study|Lost to Follow-up|15|||
13080079|NCT00000620|25768086|FG006|Overall Study|Lost to Follow-up|13|||
13080080|NCT00000620|25768087|FG007|Overall Study|Lost to Follow-up|14|||
13080081|NCT00000620|25768080|FG000|Overall Study|Withdrawal by Subject|40|||
13080082|NCT00000620|25768081|FG001|Overall Study|Withdrawal by Subject|27|||
13080083|NCT00000620|25768082|FG002|Overall Study|Withdrawal by Subject|28|||
13080084|NCT00000620|25768083|FG003|Overall Study|Withdrawal by Subject|27|||
13080085|NCT00000620|25768084|FG004|Overall Study|Withdrawal by Subject|30|||
13080086|NCT00000620|25768085|FG005|Overall Study|Withdrawal by Subject|32|||
13080087|NCT00000620|25768086|FG006|Overall Study|Withdrawal by Subject|32|||
13080088|NCT00000620|25768087|FG007|Overall Study|Withdrawal by Subject|21|||
13080089|NCT00000620|25768080|FG000|Overall Study|missed closeout visit|22|||
13080090|NCT00000620|25768081|FG001|Overall Study|missed closeout visit|28|||
13080091|NCT00000620|25768082|FG002|Overall Study|missed closeout visit|16|||
13080092|NCT00000620|25768083|FG003|Overall Study|missed closeout visit|11|||
13080093|NCT00000620|25768084|FG004|Overall Study|missed closeout visit|26|||
13080094|NCT00000620|25768085|FG005|Overall Study|missed closeout visit|28|||
13080095|NCT00000620|25768086|FG006|Overall Study|missed closeout visit|13|||
13080096|NCT00000620|25768087|FG007|Overall Study|missed closeout visit|16|||
13080097|NCT00001213|25768100|FG000|Overall Study|Death|18|||
13080136|NCT04847141|25768420|FG000|Overall Study|Adverse Event|1|||
13080137|NCT04847141|25768421|FG001|Overall Study|Adverse Event|0|||
13080138|NCT04847141|25768422|FG002|Overall Study|Adverse Event|1|||
13080139|NCT04847141|25768420|FG000|Overall Study|Withdrawal by Subject|2|||
13080140|NCT04847141|25768421|FG001|Overall Study|Withdrawal by Subject|4|||
13080141|NCT04847141|25768422|FG002|Overall Study|Withdrawal by Subject|3|||
13080142|NCT04847141|25768420|FG000|Overall Study|Lost to Follow-up|7|||
13080143|NCT04847141|25768421|FG001|Overall Study|Lost to Follow-up|5|||
13080144|NCT04847141|25768422|FG002|Overall Study|Lost to Follow-up|7|||
13080145|NCT04847141|25768420|FG000|Overall Study|Reason not Specified|0|||
13080146|NCT04847141|25768421|FG001|Overall Study|Reason not Specified|1|||
13080147|NCT04847141|25768422|FG002|Overall Study|Reason not Specified|0|||
13080148|NCT04540887|25768462|FG000|Overall Study|Withdrawal by Subject|2|||
13080149|NCT04294680|25768483|FG000|Overall Study|Withdrawal by Subject|2|||
13080150|NCT04294680|25768484|FG001|Overall Study|Withdrawal by Subject|1|||
13080151|NCT04294680|25768483|FG000|Overall Study|Follow-up visits completed outside of window|1|||
13080152|NCT04294680|25768484|FG001|Overall Study|Follow-up visits completed outside of window|0|||
13080153|NCT04142983|25768502|FG000|Overall Study|Lost to Follow-up|73|||
13080154|NCT04142983|25768502|FG000|Overall Study|Withdrawal by Subject|10|||
13080155|NCT04142983|25768502|FG000|Overall Study|Physician Decision|1|||
13080156|NCT04142983|25768502|FG000|Overall Study|Adverse Event|1|||
13080157|NCT04142983|25768502|FG000|Overall Study|No longer eligible|4|||
13080158|NCT04142983|25768502|FG000|Overall Study|Screen Failure|10|||
13080159|NCT04059549|25768543|FG000|Overall Study|Withdrawal by Subject|2|||
13080160|NCT04059549|25768544|FG001|Overall Study|Withdrawal by Subject|0|||
13080161|NCT04041570|25768583|FG000|Overall Study|Moved from Area|0|||
13080162|NCT04041570|25768584|FG001|Overall Study|Moved from Area|2|||
13080163|NCT03893825|25768601|FG000|Overall Study|Death|2|||
13080164|NCT03893825|25768602|FG001|Overall Study|Death|1|||
13080165|NCT03893825|25768601|FG000|Overall Study|Adverse Event|0|||
13080166|NCT03893825|25768602|FG001|Overall Study|Adverse Event|2|||
13080167|NCT03893825|25768601|FG000|Overall Study|Withdrawal by Subject|19|||
13080168|NCT03893825|25768602|FG001|Overall Study|Withdrawal by Subject|21|||
13080169|NCT03893825|25768601|FG000|Overall Study|Protocol deviation|1|||
13080170|NCT03893825|25768602|FG001|Overall Study|Protocol deviation|0|||
13080171|NCT03893825|25768601|FG000|Overall Study|Lost to Follow-up|10|||
13080172|NCT03893825|25768602|FG001|Overall Study|Lost to Follow-up|10|||
13080173|NCT03893825|25768601|FG000|Overall Study|Other than specified|7|||
13080174|NCT03893825|25768602|FG001|Overall Study|Other than specified|6|||
13080175|NCT03890666|25768644|FG000|Overall Study|Withdrawal by Subject|0|||
13080176|NCT03890666|25768645|FG001|Overall Study|Withdrawal by Subject|1|||
13080177|NCT03890666|25768644|FG000|Overall Study|Protocol deviation|1|||
13080178|NCT03890666|25768645|FG001|Overall Study|Protocol deviation|4|||
13080179|NCT03890666|25768644|FG000|Overall Study|Lost to Follow-up|2|||
13080063|NCT00000378|25767966|FG000|Overall Study|Lack of Efficacy|16|||
13080064|NCT00000378|25767967|FG001|Overall Study|Lack of Efficacy|14|||
13080098|NCT00001262|25768136|FG000|Overall Study|Death|10|||
13080099|NCT00001262|25768137|FG001|Overall Study|Death|11|||
13080100|NCT00001262|25768138|FG002|Overall Study|Death|0|||
13080101|NCT00001262|25768136|FG000|Overall Study|Withdrawal by Subject|0|||
13080102|NCT00001262|25768137|FG001|Overall Study|Withdrawal by Subject|3|||
13080103|NCT00001262|25768138|FG002|Overall Study|Withdrawal by Subject|0|||
13080104|NCT00001277|25768158|FG000|Overall Study|Adverse Event|0|||
13080105|NCT00001277|25768159|FG001|Overall Study|Adverse Event|0|||
13080106|NCT00001277|25768160|FG002|Overall Study|Adverse Event|1|||
13080107|NCT00001277|25768158|FG000|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
13080108|NCT00001277|25768159|FG001|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
13080109|NCT00001277|25768160|FG002|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|2|||
13080180|NCT03890666|25768645|FG001|Overall Study|Lost to Follow-up|5|||
13080181|NCT03890666|25768644|FG000|Overall Study|Other than specified|1|||
13080182|NCT03890666|25768645|FG001|Overall Study|Other than specified|8|||
13080183|NCT03879408|25768713|FG000|Overall Study|Lost to Follow-up|0|||
13080184|NCT03879408|25768714|FG001|Overall Study|Lost to Follow-up|3|||
13080185|NCT03879408|25768715|FG002|Overall Study|Lost to Follow-up|2|||
13080186|NCT03879408|25768716|FG003|Overall Study|Lost to Follow-up|1|||
13080187|NCT03879408|25768717|FG004|Overall Study|Lost to Follow-up|0|||
13080188|NCT03879408|25768713|FG000|Overall Study|Withdrawal by Subject|2|||
13080189|NCT03879408|25768714|FG001|Overall Study|Withdrawal by Subject|1|||
13080190|NCT03879408|25768715|FG002|Overall Study|Withdrawal by Subject|1|||
13080191|NCT03879408|25768716|FG003|Overall Study|Withdrawal by Subject|0|||
13080192|NCT03879408|25768717|FG004|Overall Study|Withdrawal by Subject|1|||
13080193|NCT03801031|25768748|FG000|Overall Study|Lost to Follow-up|1|||
13080194|NCT03801031|25768749|FG001|Overall Study|Lost to Follow-up|0|||
13080195|NCT03801031|25768748|FG000|Overall Study|Unable to comply|1|||
13080196|NCT03801031|25768749|FG001|Overall Study|Unable to comply|0|||
13080197|NCT03801031|25768748|FG000|Overall Study|Withdrawal by Subject|0|||
13080198|NCT03801031|25768749|FG001|Overall Study|Withdrawal by Subject|1|||
13131726|NCT02806947|25980339|FG000|Overall Study|Withdrawal by Subject|5|||
13131727|NCT02806947|25980340|FG001|Overall Study|Withdrawal by Subject|1|||
13131728|NCT02806726|25980349|FG000|Overall Study|Lost to Follow-up|1|||
13131729|NCT02806713|25980364|FG000|Overall Study|Urethral injury during procedure|1|||
13131730|NCT02806713|25980365|FG001|Overall Study|Urethral injury during procedure|0|||
13131731|NCT02806713|25980364|FG000|Overall Study|cancelled surgery|1|||
13131732|NCT02806713|25980365|FG001|Overall Study|cancelled surgery|2|||
13131733|NCT02806505|25980382|FG000|Overall Study|Adverse event/intercurrent illness|1|||
13131734|NCT02806505|25980383|FG001|Overall Study|Adverse event/intercurrent illness|3|||
13131735|NCT02806505|25980382|FG000|Overall Study|Death|4|||
13131736|NCT02806505|25980383|FG001|Overall Study|Death|0|||
13131737|NCT02806505|25980382|FG000|Overall Study|Did not cooperate/refused treatment|3|||
13131738|NCT02806505|25980383|FG001|Overall Study|Did not cooperate/refused treatment|3|||
13131739|NCT02806505|25980382|FG000|Overall Study|Failure to return|0|||
13131740|NCT02806505|25980383|FG001|Overall Study|Failure to return|1|||
13131741|NCT02806505|25980382|FG000|Overall Study|Insufficient therapeutic response|2|||
13131742|NCT02806505|25980383|FG001|Overall Study|Insufficient therapeutic response|4|||
13131743|NCT02806414|25980390|FG000|Overall Study|Lost to Follow-up|2|||
13131744|NCT02806232|25980456|FG000|Overall Study|Lost to Follow-up|1|||
13131745|NCT02806232|25980457|FG001|Overall Study|Lost to Follow-up|2|||
13131746|NCT02806232|25980458|FG002|Overall Study|Lost to Follow-up|1|||
13131747|NCT02806232|25980459|FG003|Overall Study|Lost to Follow-up|0|||
13131748|NCT02806232|25980460|FG004|Overall Study|Lost to Follow-up|0|||
13131749|NCT02806232|25980461|FG005|Overall Study|Lost to Follow-up|1|||
13131750|NCT02806232|25980462|FG006|Overall Study|Lost to Follow-up|0|||
13131751|NCT02806232|25980463|FG007|Overall Study|Lost to Follow-up|0|||
13080110|NCT00001566|25768220|FG000|Overall Study|patients' choice to discontinue protocol|3|||
13080111|NCT00001566|25768220|FG000|Overall Study|stopped after C3 due to symptomatic PD|1|||
13080112|NCT00001566|25768220|FG000|Overall Study|Death|13|||
13080113|NCT00001566|25768220|FG000|Overall Study|Lost to Follow-up|1|||
13080114|NCT00001566|25768220|FG000|Overall Study|unable to complete initial apheresis|1|||
13080115|NCT00001575|25768228|FG000|Overall Study|Screening failures-Ph I portion|22|||
13080116|NCT00001575|25768228|FG000|Overall Study|Withdrawn/deaths|23|||
13080117|NCT00001596|25768271|FG000|Overall Study|Death|1|||
13080118|NCT00001596|25768272|FG001|Overall Study|Death|0|||
13080119|NCT00001596|25768271|FG000|Overall Study|Withdrawal by Subject|3|||
13080120|NCT00001596|25768272|FG001|Overall Study|Withdrawal by Subject|1|||
13080121|NCT00001596|25768271|FG000|Overall Study|Study Termination|12|||
13080122|NCT00001596|25768272|FG001|Overall Study|Study Termination|9|||
13080123|NCT00001596|25768271|FG000|Overall Study|Adverse Event|1|||
13080124|NCT00001596|25768272|FG001|Overall Study|Adverse Event|0|||
13080125|NCT00001703|25768315|FG000|Overall Study|progressed disease|2|||
13080126|NCT00001703|25768315|FG000|Overall Study|No evidence of disease|1|||
13080127|NCT00001703|25768315|FG000|Overall Study|recurrent disease|2|||
13080128|NCT00001723|25768338|FG000|Overall Study|Lack of Efficacy|6|||
13080129|NCT00001723|25768339|FG001|Overall Study|Lack of Efficacy|7|||
13080130|NCT00001723|25768338|FG000|Overall Study|Lack of family interest|4|||
13080131|NCT00001723|25768339|FG001|Overall Study|Lack of family interest|5|||
13080132|NCT00001723|25768338|FG000|Overall Study|Lost to Follow-up|2|||
13080133|NCT00001723|25768339|FG001|Overall Study|Lost to Follow-up|2|||
13080134|NCT00001723|25768338|FG000|Overall Study|medication intolerance|1|||
13080135|NCT00001723|25768339|FG001|Overall Study|medication intolerance|2|||
13080217|NCT03357952|25769092|FG000|Overall Study|Withdrawal by Subject|0|||
13080218|NCT03357952|25769093|FG001|Overall Study|Withdrawal by Subject|1|||
13080219|NCT03357952|25769092|FG000|Overall Study|Sponsor Decision|9|||
13080220|NCT03357952|25769093|FG001|Overall Study|Sponsor Decision|0|||
13080221|NCT03276572|25769166|FG000|Overall Study|In follow-up|0|||
13080222|NCT03276572|25769167|FG001|Overall Study|In follow-up|0|||
13080223|NCT03276572|25769168|FG002|Overall Study|In follow-up|0|||
13080224|NCT03276572|25769169|FG003|Overall Study|In follow-up|0|||
13080225|NCT03276572|25769170|FG004|Overall Study|In follow-up|0|||
13080226|NCT03276572|25769171|FG005|Overall Study|In follow-up|1|||
13080227|NCT03276572|25769172|FG006|Overall Study|In follow-up|1|||
13080228|NCT03276572|25769166|FG000|Overall Study|Lost to Follow-up|0|||
13080229|NCT03276572|25769167|FG001|Overall Study|Lost to Follow-up|0|||
13080230|NCT03276572|25769168|FG002|Overall Study|Lost to Follow-up|0|||
13080231|NCT03276572|25769169|FG003|Overall Study|Lost to Follow-up|0|||
13080232|NCT03276572|25769170|FG004|Overall Study|Lost to Follow-up|0|||
13080233|NCT03276572|25769171|FG005|Overall Study|Lost to Follow-up|0|||
13080234|NCT03276572|25769172|FG006|Overall Study|Lost to Follow-up|1|||
13080235|NCT03090737|25769183|FG000|Overall Study|Other reasons|1|||
13080236|NCT03090737|25769183|FG000|Overall Study|Completed treatment as per protocol|17|||
13080237|NCT03090737|25769183|FG000|Overall Study|Maximum clinical benefit|2|||
13080238|NCT03090737|25769183|FG000|Overall Study|Adverse event unrelated to study drug|7|||
13080239|NCT03090737|25769183|FG000|Overall Study|Study drug toxicity|4|||
13080240|NCT03090737|25769183|FG000|Overall Study|Disease progression|98|||
13080241|NCT03055858|25769191|FG000|Overall Study|Death|9|||
13080242|NCT03055858|25769191|FG000|Overall Study|Withdrawal by Subject|11|||
13080243|NCT03055858|25769191|FG000|Overall Study|Lost to Follow-up|6|||
13080244|NCT03055858|25769191|FG000|Overall Study|Missed Follow-Up Visits|18|||
13080245|NCT03004976|25769259|FG000|Overall Study|Lost to Follow-up|7|||
13080246|NCT03004976|25769260|FG001|Overall Study|Lost to Follow-up|5|||
13080247|NCT03004976|25769259|FG000|Overall Study|Physician Decision|1|||
13080248|NCT03004976|25769260|FG001|Overall Study|Physician Decision|0|||
13080249|NCT03004976|25769259|FG000|Overall Study|Withdrawal by Subject|1|||
13080250|NCT03004976|25769260|FG001|Overall Study|Withdrawal by Subject|0|||
13080251|NCT03004976|25769259|FG000|Overall Study|Death|4|||
13080252|NCT03004976|25769260|FG001|Overall Study|Death|1|||
13080285|NCT02985866|25769361|FG000|Overall Study|Poor CGM data|1|||
13080286|NCT02985866|25769362|FG001|Overall Study|Poor CGM data|1|||
13080287|NCT02773849|25769376|FG000|Overall Study|Adverse Event|3|||
13080288|NCT02773849|25769376|FG000|Overall Study|Lack of Efficacy|89|||
13080289|NCT02773849|25769376|FG000|Overall Study|Withdrawal by Subject|1|||
13080290|NCT02773849|25769376|FG000|Overall Study|Withdrawal of Consent|1|||
13080291|NCT02762981|25769441|FG000|Overall Study|Adverse Event|2|||
13080292|NCT02762981|25769442|FG001|Overall Study|Adverse Event|3|||
13080293|NCT02762981|25769443|FG002|Overall Study|Adverse Event|1|||
13080294|NCT02762981|25769444|FG003|Overall Study|Adverse Event|1|||
13080295|NCT02762981|25769445|FG004|Overall Study|Adverse Event|3|||
13080296|NCT02762981|25769441|FG000|Overall Study|Physician Decision|0|||
13080297|NCT02762981|25769442|FG001|Overall Study|Physician Decision|1|||
13080298|NCT02762981|25769443|FG002|Overall Study|Physician Decision|0|||
13080299|NCT02762981|25769444|FG003|Overall Study|Physician Decision|0|||
13080300|NCT02762981|25769445|FG004|Overall Study|Physician Decision|1|||
13080301|NCT02762981|25769441|FG000|Overall Study|Disease progression|11|||
13080302|NCT02762981|25769442|FG001|Overall Study|Disease progression|23|||
13080303|NCT02762981|25769443|FG002|Overall Study|Disease progression|4|||
13080304|NCT02762981|25769444|FG003|Overall Study|Disease progression|10|||
13080305|NCT02762981|25769445|FG004|Overall Study|Disease progression|1|||
13080306|NCT02762981|25769441|FG000|Overall Study|Enrolled not treated|1|||
13080307|NCT02762981|25769442|FG001|Overall Study|Enrolled not treated|5|||
13080308|NCT02762981|25769443|FG002|Overall Study|Enrolled not treated|0|||
13080309|NCT02762981|25769444|FG003|Overall Study|Enrolled not treated|2|||
13080310|NCT02762981|25769445|FG004|Overall Study|Enrolled not treated|0|||
13080311|NCT02762981|25769441|FG000|Overall Study|Other|2|||
13080312|NCT02762981|25769442|FG001|Overall Study|Other|3|||
13080313|NCT02762981|25769443|FG002|Overall Study|Other|1|||
13080314|NCT02762981|25769444|FG003|Overall Study|Other|0|||
13080315|NCT02762981|25769445|FG004|Overall Study|Other|0|||
13080316|NCT02762981|25769441|FG000|Overall Study|Missing|1|||
13080317|NCT02762981|25769442|FG001|Overall Study|Missing|0|||
13080318|NCT02762981|25769443|FG002|Overall Study|Missing|0|||
13080319|NCT02762981|25769444|FG003|Overall Study|Missing|0|||
13080320|NCT02762981|25769445|FG004|Overall Study|Missing|0|||
13080321|NCT02762981|25769441|FG000|Overall Study|Withdrawal by Subject|0|||
13080322|NCT02762981|25769442|FG001|Overall Study|Withdrawal by Subject|5|||
13080323|NCT02762981|25769443|FG002|Overall Study|Withdrawal by Subject|1|||
13080324|NCT02762981|25769444|FG003|Overall Study|Withdrawal by Subject|3|||
13080325|NCT02762981|25769445|FG004|Overall Study|Withdrawal by Subject|0|||
13131752|NCT02806232|25980464|FG008|Overall Study|Lost to Follow-up|0|||
13131753|NCT02806232|25980456|FG000|Overall Study|Withdrawal by Subject|0|||
13131754|NCT02806232|25980457|FG001|Overall Study|Withdrawal by Subject|2|||
13131755|NCT02806232|25980458|FG002|Overall Study|Withdrawal by Subject|0|||
13131756|NCT02806232|25980459|FG003|Overall Study|Withdrawal by Subject|0|||
13131757|NCT02806232|25980460|FG004|Overall Study|Withdrawal by Subject|2|||
13131758|NCT02806232|25980461|FG005|Overall Study|Withdrawal by Subject|1|||
13131759|NCT02806232|25980462|FG006|Overall Study|Withdrawal by Subject|0|||
13131760|NCT02806232|25980463|FG007|Overall Study|Withdrawal by Subject|0|||
13131761|NCT02806232|25980464|FG008|Overall Study|Withdrawal by Subject|0|||
13131762|NCT02806024|25980479|FG000|Overall Study|Night Delivery|1|||
13131763|NCT02806024|25980480|FG001|Overall Study|Night Delivery|1|||
13131764|NCT02806024|25980479|FG000|Overall Study|DVT during antepartum admission|0|||
13131765|NCT02806024|25980480|FG001|Overall Study|DVT during antepartum admission|1|||
13131766|NCT02805972|25980507|FG000|Washout Period|Lost to Follow-up|3|||
13131767|NCT02805972|25980508|FG001|Washout Period|Lost to Follow-up|0|||
13131768|NCT02805907|25980527|FG000|Overall Study|Lost to Follow-up|3|||
13131769|NCT02805907|25980528|FG001|Overall Study|Lost to Follow-up|3|||
13131770|NCT02805790|25980559|FG000|Second Intervention (4 Weeks)|Physician Decision|0|||
13131771|NCT02805790|25980560|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
13131772|NCT02805660|25980661|FG000|Overall Study|Death|5|||
13131773|NCT02805660|25980662|FG001|Overall Study|Death|2|||
13131774|NCT02805660|25980663|FG002|Overall Study|Death|9|||
13080326|NCT02706873|25769555|FG000|Overall Study|Adverse Event|13|||
13080327|NCT02706873|25769556|FG001|Overall Study|Adverse Event|3|||
13080328|NCT02706873|25769557|FG002|Overall Study|Adverse Event|13|||
13080329|NCT02706873|25769558|FG003|Overall Study|Adverse Event|12|||
13080330|NCT02706873|25769555|FG000|Overall Study|Withdrawal by Subject|15|||
13080331|NCT02706873|25769556|FG001|Overall Study|Withdrawal by Subject|0|||
13080332|NCT02706873|25769557|FG002|Overall Study|Withdrawal by Subject|8|||
13080333|NCT02706873|25769558|FG003|Overall Study|Withdrawal by Subject|11|||
13080334|NCT02706873|25769555|FG000|Overall Study|Lost to Follow-up|3|||
13080335|NCT02706873|25769556|FG001|Overall Study|Lost to Follow-up|0|||
13080336|NCT02706873|25769557|FG002|Overall Study|Lost to Follow-up|4|||
13080337|NCT02706873|25769558|FG003|Overall Study|Lost to Follow-up|2|||
13080338|NCT02706873|25769555|FG000|Overall Study|Lack of Efficacy|10|||
13080339|NCT02706873|25769556|FG001|Overall Study|Lack of Efficacy|0|||
13080340|NCT02706873|25769557|FG002|Overall Study|Lack of Efficacy|0|||
13080341|NCT02706873|25769558|FG003|Overall Study|Lack of Efficacy|3|||
13080342|NCT02706873|25769555|FG000|Overall Study|Other|5|||
13080343|NCT02706873|25769556|FG001|Overall Study|Other|1|||
13080344|NCT02706873|25769557|FG002|Overall Study|Other|2|||
13080345|NCT02706873|25769558|FG003|Overall Study|Other|3|||
13080346|NCT02706873|25769555|FG000|Overall Study|Not Dosed|1|||
13080347|NCT02706873|25769556|FG001|Overall Study|Not Dosed|0|||
13080348|NCT02706873|25769557|FG002|Overall Study|Not Dosed|0|||
13080349|NCT02706873|25769558|FG003|Overall Study|Not Dosed|1|||
13080350|NCT02706873|25769555|FG000|Overall Study|Ongoing|0|||
13080351|NCT02706873|25769556|FG001|Overall Study|Ongoing|0|||
13080352|NCT02706873|25769557|FG002|Overall Study|Ongoing|0|||
13080353|NCT02706873|25769558|FG003|Overall Study|Ongoing|1|||
13080354|NCT02454933|25769570|FG000|Overall Study|Progressive disease|7|||
13080355|NCT02454933|25769571|FG001|Overall Study|Progressive disease|5|||
13080356|NCT02454933|25769570|FG000|Overall Study|Adverse Event|1|||
13080357|NCT02454933|25769571|FG001|Overall Study|Adverse Event|1|||
13080358|NCT02454933|25769570|FG000|Overall Study|Withdrawal by Subject|0|||
13080359|NCT02454933|25769571|FG001|Overall Study|Withdrawal by Subject|2|||
13080360|NCT02399215|25769581|FG000|Overall Study|bowel obstruction (unrelated to dis-ease)|1|||
13080361|NCT02399215|25769581|FG000|Overall Study|Withdrawal by Subject|1|||
13080362|NCT02393716|25769601|FG000|Overall Study|Death|29|||
13080363|NCT02393716|25769601|FG000|Overall Study|Withdrawal by Subject|8|||
13080364|NCT02393716|25769601|FG000|Overall Study|Device Explanted|8|||
13080365|NCT02393716|25769601|FG000|Overall Study|Missed visit|16|||
13080366|NCT02362464|25769610|FG000|Overall Study|Switched to alternative therapy|1|||
13080367|NCT02362464|25769610|FG000|Overall Study|Refused further treatment|1|||
13080368|NCT02362464|25769610|FG000|Overall Study|Physician Decision|4|||
13080369|NCT02255435|25769677|FG000|Overall Study|Patient's Limited Time Availability|0|||
13080370|NCT02255435|25769678|FG001|Overall Study|Patient's Limited Time Availability|0|||
13080371|NCT02255435|25769679|FG002|Overall Study|Patient's Limited Time Availability|0|||
13080372|NCT02255435|25769680|FG003|Overall Study|Patient's Limited Time Availability|0|||
13080373|NCT02255435|25769681|FG004|Overall Study|Patient's Limited Time Availability|0|||
13080374|NCT02255435|25769682|FG005|Overall Study|Patient's Limited Time Availability|0|||
13080375|NCT02255435|25769683|FG006|Overall Study|Patient's Limited Time Availability|0|||
13080376|NCT02255435|25769684|FG007|Overall Study|Patient's Limited Time Availability|1|||
13080377|NCT02255435|25769685|FG008|Overall Study|Patient's Limited Time Availability|0|||
13080378|NCT02255435|25769686|FG009|Overall Study|Patient's Limited Time Availability|0|||
13080379|NCT02255435|25769677|FG000|Overall Study|Withdrawal by Subject|0|||
13080380|NCT02255435|25769678|FG001|Overall Study|Withdrawal by Subject|0|||
13080381|NCT02255435|25769679|FG002|Overall Study|Withdrawal by Subject|0|||
13080382|NCT02255435|25769680|FG003|Overall Study|Withdrawal by Subject|0|||
13080383|NCT02255435|25769681|FG004|Overall Study|Withdrawal by Subject|0|||
13080384|NCT02255435|25769682|FG005|Overall Study|Withdrawal by Subject|0|||
13080385|NCT02255435|25769683|FG006|Overall Study|Withdrawal by Subject|0|||
13080386|NCT02255435|25769684|FG007|Overall Study|Withdrawal by Subject|0|||
13080387|NCT02255435|25769685|FG008|Overall Study|Withdrawal by Subject|1|||
13080388|NCT02255435|25769686|FG009|Overall Study|Withdrawal by Subject|4|||
13080389|NCT02255435|25769677|FG000|Overall Study|Administrative reasons|0|||
13080390|NCT02255435|25769678|FG001|Overall Study|Administrative reasons|0|||
13080391|NCT02255435|25769679|FG002|Overall Study|Administrative reasons|0|||
13080392|NCT02255435|25769680|FG003|Overall Study|Administrative reasons|0|||
13080393|NCT02255435|25769681|FG004|Overall Study|Administrative reasons|0|||
13080394|NCT02255435|25769682|FG005|Overall Study|Administrative reasons|0|||
13080395|NCT02255435|25769683|FG006|Overall Study|Administrative reasons|0|||
13080396|NCT02255435|25769684|FG007|Overall Study|Administrative reasons|0|||
13080397|NCT02255435|25769685|FG008|Overall Study|Administrative reasons|0|||
13080398|NCT02255435|25769686|FG009|Overall Study|Administrative reasons|2|||
13080399|NCT02075840|25769747|FG000|Overall Study|Withdrawal by Subject|13|||
13080400|NCT02075840|25769748|FG001|Overall Study|Withdrawal by Subject|22|||
13080401|NCT02075840|25769747|FG000|Overall Study|Reason not specified|1|||
13080402|NCT02075840|25769748|FG001|Overall Study|Reason not specified|0|||
13080403|NCT02075840|25769747|FG000|Overall Study|Adverse Event|0|||
13080404|NCT02075840|25769748|FG001|Overall Study|Adverse Event|2|||
13080405|NCT02075840|25769747|FG000|Overall Study|Death|35|||
13080406|NCT02075840|25769748|FG001|Overall Study|Death|40|||
13080407|NCT02075840|25769747|FG000|Overall Study|Lost to Follow-up|3|||
13080408|NCT02075840|25769748|FG001|Overall Study|Lost to Follow-up|2|||
13080409|NCT02075840|25769747|FG000|Overall Study|Physician Decision|1|||
13080410|NCT02075840|25769748|FG001|Overall Study|Physician Decision|3|||
13080411|NCT02075840|25769747|FG000|Overall Study|Ongoing at CCOD|99|||
13080412|NCT02075840|25769748|FG001|Overall Study|Ongoing at CCOD|82|||
13080413|NCT01925131|25769795|FG000|Overall Study|Death|0|||
13080414|NCT01925131|25769796|FG001|Overall Study|Death|0|||
13080415|NCT01925131|25769797|FG002|Overall Study|Death|1|||
13080416|NCT01925131|25769798|FG003|Overall Study|Death|0|||
13080417|NCT01925131|25769799|FG004|Overall Study|Death|0|||
13080418|NCT01925131|25769800|FG005|Overall Study|Death|0|||
13080419|NCT01925131|25769795|FG000|Overall Study|Progression/Relapse|1|||
13080420|NCT01925131|25769796|FG001|Overall Study|Progression/Relapse|1|||
13080421|NCT01925131|25769797|FG002|Overall Study|Progression/Relapse|4|||
13080422|NCT01925131|25769798|FG003|Overall Study|Progression/Relapse|0|||
13080423|NCT01925131|25769799|FG004|Overall Study|Progression/Relapse|0|||
13080424|NCT01925131|25769800|FG005|Overall Study|Progression/Relapse|1|||
13080425|NCT01925131|25769795|FG000|Overall Study|Patient Refusal|1|||
13080426|NCT01925131|25769796|FG001|Overall Study|Patient Refusal|0|||
13080427|NCT01925131|25769797|FG002|Overall Study|Patient Refusal|0|||
13080428|NCT01925131|25769798|FG003|Overall Study|Patient Refusal|0|||
13080429|NCT01925131|25769799|FG004|Overall Study|Patient Refusal|0|||
13080430|NCT01925131|25769800|FG005|Overall Study|Patient Refusal|0|||
13080431|NCT01925131|25769795|FG000|Overall Study|Adverse Event|0|||
13080432|NCT01925131|25769796|FG001|Overall Study|Adverse Event|0|||
13080433|NCT01925131|25769797|FG002|Overall Study|Adverse Event|2|||
13080434|NCT01925131|25769798|FG003|Overall Study|Adverse Event|0|||
13080435|NCT01925131|25769799|FG004|Overall Study|Adverse Event|1|||
13080436|NCT01925131|25769800|FG005|Overall Study|Adverse Event|3|||
13080437|NCT01925131|25769795|FG000|Overall Study|Other - Not Protocol Specified|3|||
13080438|NCT01925131|25769796|FG001|Overall Study|Other - Not Protocol Specified|1|||
13080439|NCT01925131|25769797|FG002|Overall Study|Other - Not Protocol Specified|2|||
13080440|NCT01925131|25769798|FG003|Overall Study|Other - Not Protocol Specified|5|||
13080441|NCT01925131|25769799|FG004|Overall Study|Other - Not Protocol Specified|10|||
13080442|NCT01925131|25769800|FG005|Overall Study|Other - Not Protocol Specified|6|||
13080443|NCT01902173|25769836|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1|||
13080444|NCT01902173|25769837|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
13080445|NCT01902173|25769838|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
13080446|NCT01902173|25769839|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
13080447|NCT01902173|25769840|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
13080448|NCT01902173|25769841|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
13080449|NCT01902173|25769836|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2|||
13080450|NCT01902173|25769837|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
13080451|NCT01902173|25769838|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
13080452|NCT01902173|25769839|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
13080453|NCT01902173|25769840|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
13080454|NCT01902173|25769841|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
13080455|NCT01902173|25769836|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
13080456|NCT01902173|25769837|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5|||
13080457|NCT01902173|25769838|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
13080458|NCT01902173|25769839|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
13080459|NCT01902173|25769840|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
13080460|NCT01902173|25769841|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
13080461|NCT01902173|25769836|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
13080462|NCT01902173|25769837|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1|||
13080463|NCT01902173|25769838|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
13080464|NCT01902173|25769839|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
13080465|NCT01902173|25769840|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
13080466|NCT01902173|25769841|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
13080467|NCT01902173|25769836|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
13080468|NCT01902173|25769837|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3|||
13080469|NCT01902173|25769838|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
13080470|NCT01902173|25769839|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
13080471|NCT01902173|25769840|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
13080472|NCT01902173|25769841|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
13080473|NCT01902173|25769836|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
13080474|NCT01902173|25769837|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
13080475|NCT01902173|25769838|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3|||
13080476|NCT01902173|25769839|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
13080477|NCT01902173|25769840|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
13080478|NCT01902173|25769841|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
13080479|NCT01902173|25769836|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
13080480|NCT01902173|25769837|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
13080481|NCT01902173|25769838|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1|||
13080482|NCT01902173|25769839|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
13080483|NCT01902173|25769840|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
13080484|NCT01902173|25769841|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
13080485|NCT01902173|25769836|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
13080486|NCT01902173|25769837|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
13080487|NCT01902173|25769838|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
13080488|NCT01902173|25769839|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1|||
13080489|NCT01902173|25769840|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
13393346|NCT00665925|26783413|FG002|Overall Study|Adverse Event|10|||
13080490|NCT01902173|25769841|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
13080491|NCT01902173|25769836|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
13080492|NCT01902173|25769837|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
13080493|NCT01902173|25769838|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
13080494|NCT01902173|25769839|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2|||
13080495|NCT01902173|25769840|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
13080496|NCT01902173|25769841|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
13080497|NCT01902173|25769836|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
13080498|NCT01902173|25769837|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
13080499|NCT01902173|25769838|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
13080500|NCT01902173|25769839|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
13080501|NCT01902173|25769840|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1|||
13080502|NCT01902173|25769841|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
13080503|NCT01902173|25769836|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
13080504|NCT01902173|25769837|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
13080505|NCT01902173|25769838|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
13080506|NCT01902173|25769839|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
13080507|NCT01902173|25769840|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2|||
13080508|NCT01902173|25769841|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
13080509|NCT01902173|25769836|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
13080510|NCT01902173|25769837|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
13080511|NCT01902173|25769838|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
13080512|NCT01902173|25769839|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
13080513|NCT01902173|25769840|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
13080514|NCT01902173|25769841|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1|||
13080515|NCT01902173|25769836|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
13080516|NCT01902173|25769837|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
13080517|NCT01902173|25769838|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
13080518|NCT01902173|25769839|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
13080519|NCT01902173|25769840|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
13080520|NCT01902173|25769841|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3|||
13080521|NCT01902173|25769836|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0|||
13080522|NCT01902173|25769837|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0|||
13080523|NCT01902173|25769838|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0|||
13080524|NCT01902173|25769839|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0|||
13080525|NCT01902173|25769840|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0|||
13080526|NCT01902173|25769841|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1|||
13080527|NCT01804816|25769855|FG000|No Acupuncture (Initial 5 Weeks)|Withdrawal by Subject|3|||
13080528|NCT01804816|25769855|FG000|Acupuncture (Second 5 Weeks)|Physician Decision|1|||
13080535|NCT01696968|25769921|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0|||
13080536|NCT01696968|25769922|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8|||
13080537|NCT01696968|25769921|FG000|Overall Study|Died Before Randomization|3|||
13080538|NCT01696968|25769922|FG001|Overall Study|Died Before Randomization|8|||
13080539|NCT01696968|25769921|FG000|Overall Study|Died Before ASU (Control)|278|||
13080540|NCT01696968|25769922|FG001|Overall Study|Died Before ASU (Control)|0|||
13080541|NCT01696968|25769921|FG000|Overall Study|Refused ASU (Control)|920|||
13080542|NCT01696968|25769922|FG001|Overall Study|Refused ASU (Control)|0|||
13080543|NCT01696968|25769921|FG000|Overall Study|Refused Screen (Lung Screening)|0|||
13080544|NCT01696968|25769922|FG001|Overall Study|Refused Screen (Lung Screening)|6796|||
13080545|NCT01682083|25769941|FG000|Overall Study|Lost to Follow-up|11|||
13080546|NCT01682083|25769942|FG001|Overall Study|Lost to Follow-up|18|||
13080547|NCT01682083|25769941|FG000|Overall Study|Withdrawal by Subject|31|||
13080548|NCT01682083|25769942|FG001|Overall Study|Withdrawal by Subject|40|||
13080549|NCT01682083|25769941|FG000|Overall Study|Death|60|||
13080550|NCT01682083|25769942|FG001|Overall Study|Death|93|||
13080551|NCT01682083|25769941|FG000|Overall Study|Physician Decision|5|||
13080552|NCT01682083|25769942|FG001|Overall Study|Physician Decision|4|||
13080553|NCT00819780|25769981|FG000|Overall Study|Did not receive study drug|3|||
13080554|NCT00819780|25769982|FG001|Overall Study|Did not receive study drug|4|||
13080555|NCT00819780|25769981|FG000|Overall Study|Still in treatment|25|||
13080556|NCT00819780|25769982|FG001|Overall Study|Still in treatment|17|||
13080557|NCT00777036|25770085|FG000|On Treatment|Reason Not Specified|4|||
13080558|NCT00777036|25770086|FG001|On Treatment|Reason Not Specified|7|||
13080559|NCT00777036|25770087|FG002|On Treatment|Reason Not Specified|12|||
13080560|NCT00777036|25770085|FG000|On Treatment|Failure to Meet Study Criteria|0|||
13080561|NCT00777036|25770086|FG001|On Treatment|Failure to Meet Study Criteria|1|||
13080562|NCT00777036|25770087|FG002|On Treatment|Failure to Meet Study Criteria|0|||
13080563|NCT00777036|25770085|FG000|On Treatment|Non-compliance with Study Drug|1|||
13080564|NCT00777036|25770086|FG001|On Treatment|Non-compliance with Study Drug|0|||
13080565|NCT00777036|25770087|FG002|On Treatment|Non-compliance with Study Drug|0|||
13080566|NCT00777036|25770085|FG000|On Treatment|Maximum Clinical Benefit|2|||
13080567|NCT00777036|25770086|FG001|On Treatment|Maximum Clinical Benefit|0|||
13080568|NCT00777036|25770087|FG002|On Treatment|Maximum Clinical Benefit|1|||
13080569|NCT00777036|25770085|FG000|On Treatment|Withdrawal by Subject|3|||
13080570|NCT00777036|25770086|FG001|On Treatment|Withdrawal by Subject|2|||
13080571|NCT00777036|25770087|FG002|On Treatment|Withdrawal by Subject|3|||
13080572|NCT00777036|25770085|FG000|On Treatment|Death|0|||
13080573|NCT00777036|25770086|FG001|On Treatment|Death|2|||
13080574|NCT00777036|25770087|FG002|On Treatment|Death|0|||
13080575|NCT00777036|25770085|FG000|On Treatment|Study Drug Toxicity|0|||
13080576|NCT00777036|25770086|FG001|On Treatment|Study Drug Toxicity|0|||
13080577|NCT00777036|25770087|FG002|On Treatment|Study Drug Toxicity|1|||
13080578|NCT00777036|25770085|FG000|On Treatment|Progressive Disease|5|||
13080579|NCT00777036|25770086|FG001|On Treatment|Progressive Disease|4|||
13080580|NCT00777036|25770087|FG002|On Treatment|Progressive Disease|6|||
13080581|NCT00777036|25770085|FG000|Follow-Up|Lost to Follow-up|1|||
13080582|NCT00777036|25770086|FG001|Follow-Up|Lost to Follow-up|0|||
13080583|NCT00777036|25770087|FG002|Follow-Up|Lost to Follow-up|0|||
13080584|NCT00777036|25770085|FG000|Follow-Up|Reason Not Specified|2|||
13080585|NCT00777036|25770086|FG001|Follow-Up|Reason Not Specified|0|||
13080586|NCT00777036|25770087|FG002|Follow-Up|Reason Not Specified|0|||
13080587|NCT00777036|25770085|FG000|Follow-Up|Withdrawal by Subject|1|||
13080588|NCT00777036|25770086|FG001|Follow-Up|Withdrawal by Subject|0|||
13080589|NCT00777036|25770087|FG002|Follow-Up|Withdrawal by Subject|4|||
13080590|NCT00777036|25770085|FG000|Follow-Up|Death|1|||
13080591|NCT00777036|25770086|FG001|Follow-Up|Death|8|||
13080592|NCT00777036|25770087|FG002|Follow-Up|Death|0|||
13080593|NCT00640133|25770114|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1|||
13080594|NCT00640133|25770115|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0|||
13080595|NCT00640133|25770114|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1|||
13080596|NCT00640133|25770115|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0|||
13080597|NCT00640133|25770114|FG000|Open Label Phase (Month 4-12)|Adverse Event|1|||
13080598|NCT00640133|25770115|FG001|Open Label Phase (Month 4-12)|Adverse Event|0|||
13080599|NCT00584233|25770121|FG000|Overall Study|Withdrawal by Subject|5|||
13080600|NCT00584233|25770121|FG000|Overall Study|Subjects did not complete both CT and MRI to be evaluated in results|13|||
13080601|NCT00001832|25770218|FG000|Apheresis Period|not able to manufacture treatment cells|60|||
13080602|NCT00001832|25770219|FG001|Apheresis Period|not able to manufacture treatment cells|0|||
13080603|NCT00001832|25770220|FG002|Apheresis Period|not able to manufacture treatment cells|0|||
13080604|NCT00001832|25770221|FG003|Apheresis Period|not able to manufacture treatment cells|0|||
13080605|NCT00001832|25770222|FG004|Apheresis Period|not able to manufacture treatment cells|0|||
13080606|NCT00001832|25770223|FG005|Apheresis Period|not able to manufacture treatment cells|0|||
13080607|NCT00001832|25770224|FG006|Apheresis Period|not able to manufacture treatment cells|0|||
13080608|NCT00001832|25770225|FG007|Apheresis Period|not able to manufacture treatment cells|0|||
13080609|NCT00001832|25770226|FG008|Apheresis Period|not able to manufacture treatment cells|0|||
13080610|NCT00001832|25770227|FG009|Apheresis Period|not able to manufacture treatment cells|0|||
13080611|NCT00001832|25770228|FG010|Apheresis Period|not able to manufacture treatment cells|0|||
13080612|NCT00001832|25770229|FG011|Apheresis Period|not able to manufacture treatment cells|0|||
13080613|NCT00001832|25770230|FG012|Apheresis Period|not able to manufacture treatment cells|0|||
13080614|NCT00001832|25770231|FG013|Apheresis Period|not able to manufacture treatment cells|0|||
13080615|NCT00001832|25770232|FG014|Apheresis Period|not able to manufacture treatment cells|0|||
13080616|NCT00001832|25770218|FG000|Treatment Period|Death during treatment|0|||
13080617|NCT00001832|25770219|FG001|Treatment Period|Death during treatment|0|||
13080618|NCT00001832|25770220|FG002|Treatment Period|Death during treatment|0|||
13080619|NCT00001832|25770221|FG003|Treatment Period|Death during treatment|0|||
13080620|NCT00001832|25770222|FG004|Treatment Period|Death during treatment|0|||
13080621|NCT00001832|25770223|FG005|Treatment Period|Death during treatment|1|||
13131775|NCT02805660|25980664|FG003|Overall Study|Death|5|||
13080622|NCT00001832|25770224|FG006|Treatment Period|Death during treatment|0|||
13080623|NCT00001832|25770225|FG007|Treatment Period|Death during treatment|0|||
13080624|NCT00001832|25770226|FG008|Treatment Period|Death during treatment|0|||
13080625|NCT00001832|25770227|FG009|Treatment Period|Death during treatment|0|||
13080626|NCT00001832|25770228|FG010|Treatment Period|Death during treatment|0|||
13080627|NCT00001832|25770229|FG011|Treatment Period|Death during treatment|0|||
13080628|NCT00001832|25770230|FG012|Treatment Period|Death during treatment|0|||
13080629|NCT00001832|25770231|FG013|Treatment Period|Death during treatment|0|||
13080630|NCT00001832|25770232|FG014|Treatment Period|Death during treatment|0|||
13080631|NCT00001832|25770218|FG000|Treatment Period|Not treated|0|||
13080632|NCT00001832|25770219|FG001|Treatment Period|Not treated|0|||
13080633|NCT00001832|25770220|FG002|Treatment Period|Not treated|0|||
13080634|NCT00001832|25770221|FG003|Treatment Period|Not treated|0|||
13080635|NCT00001832|25770222|FG004|Treatment Period|Not treated|0|||
13080636|NCT00001832|25770223|FG005|Treatment Period|Not treated|0|||
13080637|NCT00001832|25770224|FG006|Treatment Period|Not treated|0|||
13080638|NCT00001832|25770225|FG007|Treatment Period|Not treated|1|||
13080639|NCT00001832|25770226|FG008|Treatment Period|Not treated|0|||
13080640|NCT00001832|25770227|FG009|Treatment Period|Not treated|0|||
13080641|NCT00001832|25770228|FG010|Treatment Period|Not treated|0|||
13080642|NCT00001832|25770229|FG011|Treatment Period|Not treated|0|||
13080643|NCT00001832|25770230|FG012|Treatment Period|Not treated|0|||
13080644|NCT00001832|25770231|FG013|Treatment Period|Not treated|0|||
13080645|NCT00001832|25770232|FG014|Treatment Period|Not treated|0|||
13131776|NCT02805660|25980665|FG004|Overall Study|Death|0|||
13131777|NCT02805660|25980666|FG005|Overall Study|Death|14|||
13131778|NCT02805660|25980667|FG006|Overall Study|Death|12|||
13131779|NCT02805660|25980661|FG000|Overall Study|Lost to Follow-up|0|||
13131780|NCT02805660|25980662|FG001|Overall Study|Lost to Follow-up|1|||
13131781|NCT02805660|25980663|FG002|Overall Study|Lost to Follow-up|1|||
13131782|NCT02805660|25980664|FG003|Overall Study|Lost to Follow-up|2|||
13131783|NCT02805660|25980665|FG004|Overall Study|Lost to Follow-up|0|||
13131784|NCT02805660|25980666|FG005|Overall Study|Lost to Follow-up|0|||
13131785|NCT02805660|25980667|FG006|Overall Study|Lost to Follow-up|0|||
13131786|NCT02805660|25980661|FG000|Overall Study|Withdrawal by Subject|0|||
13131787|NCT02805660|25980662|FG001|Overall Study|Withdrawal by Subject|0|||
13131788|NCT02805660|25980663|FG002|Overall Study|Withdrawal by Subject|0|||
13131789|NCT02805660|25980664|FG003|Overall Study|Withdrawal by Subject|3|||
13131790|NCT02805660|25980665|FG004|Overall Study|Withdrawal by Subject|1|||
13131791|NCT02805660|25980666|FG005|Overall Study|Withdrawal by Subject|0|||
13131792|NCT02805660|25980667|FG006|Overall Study|Withdrawal by Subject|2|||
13131793|NCT02805660|25980661|FG000|Overall Study|Study terminated by Sponsor|0|||
13131794|NCT02805660|25980662|FG001|Overall Study|Study terminated by Sponsor|0|||
13131795|NCT02805660|25980663|FG002|Overall Study|Study terminated by Sponsor|1|||
13131796|NCT02805660|25980664|FG003|Overall Study|Study terminated by Sponsor|4|||
13131797|NCT02805660|25980665|FG004|Overall Study|Study terminated by Sponsor|2|||
13131798|NCT02805660|25980666|FG005|Overall Study|Study terminated by Sponsor|3|||
13131799|NCT02805660|25980667|FG006|Overall Study|Study terminated by Sponsor|1|||
13131800|NCT02805660|25980661|FG000|Overall Study|Miscellaneous|0|||
13131801|NCT02805660|25980662|FG001|Overall Study|Miscellaneous|1|||
13131802|NCT02805660|25980663|FG002|Overall Study|Miscellaneous|0|||
13131803|NCT02805660|25980664|FG003|Overall Study|Miscellaneous|4|||
13131804|NCT02805660|25980665|FG004|Overall Study|Miscellaneous|0|||
13131805|NCT02805660|25980666|FG005|Overall Study|Miscellaneous|6|||
13131806|NCT02805660|25980667|FG006|Overall Study|Miscellaneous|4|||
13131807|NCT02805309|25980712|FG000|Overall Study|Lost to Follow-up|2|||
13131808|NCT02805309|25980713|FG001|Overall Study|Lost to Follow-up|2|||
13131809|NCT02805309|25980714|FG002|Overall Study|Lost to Follow-up|2|||
13131810|NCT02805309|25980712|FG000|Overall Study|Post-Randomization Exclusion|0|||
13131811|NCT02805309|25980713|FG001|Overall Study|Post-Randomization Exclusion|2|||
13131812|NCT02805309|25980714|FG002|Overall Study|Post-Randomization Exclusion|1|||
13131813|NCT02804763|25980965|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1|||
13131814|NCT02804763|25980966|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
13131815|NCT02804763|25980967|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
13131816|NCT02804763|25980968|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
13131817|NCT02804763|25980965|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
13131818|NCT02804763|25980966|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
13131819|NCT02804763|25980967|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1|||
13131820|NCT02804763|25980968|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2|||
13131821|NCT02804763|25980965|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
13131822|NCT02804763|25980966|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1|||
13131823|NCT02804763|25980967|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
13131824|NCT02804763|25980968|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
13131825|NCT02804763|25980965|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2|||
13131826|NCT02804763|25980966|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0|||
13080646|NCT04868890|25773398|FG000|Overall Study|Death|2|||
13080647|NCT04868890|25773399|FG001|Overall Study|Death|1|||
13080648|NCT04868890|25773398|FG000|Overall Study|Withdrawal by Subject|1|||
13080649|NCT04868890|25773399|FG001|Overall Study|Withdrawal by Subject|5|||
13080650|NCT04676867|25773474|FG000|Overall Study|Screen failure|0|||
13080651|NCT04676867|25773475|FG001|Overall Study|Screen failure|0|||
13080652|NCT04676867|25773476|FG002|Overall Study|Screen failure|6|||
13080653|NCT04676867|25773477|FG003|Overall Study|Screen failure|2|||
13080654|NCT04676867|25773474|FG000|Overall Study|Death|0|||
13080655|NCT04676867|25773475|FG001|Overall Study|Death|0|||
13080656|NCT04676867|25773476|FG002|Overall Study|Death|1|||
13080657|NCT04676867|25773477|FG003|Overall Study|Death|0|||
13080658|NCT04676867|25773474|FG000|Overall Study|Withdrawal by Subject|2|||
13080659|NCT04676867|25773475|FG001|Overall Study|Withdrawal by Subject|2|||
13080660|NCT04676867|25773476|FG002|Overall Study|Withdrawal by Subject|4|||
13080661|NCT04676867|25773477|FG003|Overall Study|Withdrawal by Subject|4|||
13080662|NCT04676867|25773474|FG000|Overall Study|Lost to Follow-up|1|||
13080663|NCT04676867|25773475|FG001|Overall Study|Lost to Follow-up|0|||
13080664|NCT04676867|25773476|FG002|Overall Study|Lost to Follow-up|0|||
13080665|NCT04676867|25773477|FG003|Overall Study|Lost to Follow-up|0|||
13080666|NCT04617275|25773680|FG000|Treatment Period|Adverse Event|1|||
13080667|NCT04617275|25773681|FG001|Treatment Period|Adverse Event|6|||
13080668|NCT04617275|25773682|FG002|Treatment Period|Adverse Event|4|||
13080669|NCT04617275|25773683|FG003|Treatment Period|Adverse Event|6|||
13080670|NCT04617275|25773684|FG004|Treatment Period|Adverse Event|7|||
13080671|NCT04617275|25773685|FG005|Treatment Period|Adverse Event|8|||
13080672|NCT04617275|25773686|FG006|Treatment Period|Adverse Event|0|||
13080673|NCT04617275|25773687|FG007|Treatment Period|Adverse Event|12|||
13080674|NCT04617275|25773680|FG000|Treatment Period|Lost to Follow-up|0|||
13080675|NCT04617275|25773681|FG001|Treatment Period|Lost to Follow-up|0|||
13080676|NCT04617275|25773682|FG002|Treatment Period|Lost to Follow-up|2|||
13080677|NCT04617275|25773683|FG003|Treatment Period|Lost to Follow-up|0|||
13080678|NCT04617275|25773684|FG004|Treatment Period|Lost to Follow-up|0|||
13080679|NCT04617275|25773685|FG005|Treatment Period|Lost to Follow-up|3|||
13080680|NCT04617275|25773686|FG006|Treatment Period|Lost to Follow-up|0|||
13080681|NCT04617275|25773687|FG007|Treatment Period|Lost to Follow-up|2|||
13080682|NCT04617275|25773680|FG000|Treatment Period|No longer meets eligibility criteria|0|||
13080683|NCT04617275|25773681|FG001|Treatment Period|No longer meets eligibility criteria|0|||
13080684|NCT04617275|25773682|FG002|Treatment Period|No longer meets eligibility criteria|0|||
13080685|NCT04617275|25773683|FG003|Treatment Period|No longer meets eligibility criteria|1|||
13080686|NCT04617275|25773684|FG004|Treatment Period|No longer meets eligibility criteria|0|||
13080687|NCT04617275|25773685|FG005|Treatment Period|No longer meets eligibility criteria|0|||
13080688|NCT04617275|25773686|FG006|Treatment Period|No longer meets eligibility criteria|0|||
13080689|NCT04617275|25773687|FG007|Treatment Period|No longer meets eligibility criteria|0|||
13080690|NCT04617275|25773680|FG000|Treatment Period|Other|0|||
13080691|NCT04617275|25773681|FG001|Treatment Period|Other|1|||
13080692|NCT04617275|25773682|FG002|Treatment Period|Other|0|||
13080693|NCT04617275|25773683|FG003|Treatment Period|Other|0|||
13080694|NCT04617275|25773684|FG004|Treatment Period|Other|0|||
13080695|NCT04617275|25773685|FG005|Treatment Period|Other|0|||
13080696|NCT04617275|25773686|FG006|Treatment Period|Other|0|||
13080697|NCT04617275|25773687|FG007|Treatment Period|Other|0|||
13080698|NCT04617275|25773680|FG000|Treatment Period|Withdrawal by Subject|2|||
13080699|NCT04617275|25773681|FG001|Treatment Period|Withdrawal by Subject|0|||
13080700|NCT04617275|25773682|FG002|Treatment Period|Withdrawal by Subject|0|||
13080701|NCT04617275|25773683|FG003|Treatment Period|Withdrawal by Subject|2|||
13080702|NCT04617275|25773684|FG004|Treatment Period|Withdrawal by Subject|2|||
13080703|NCT04617275|25773685|FG005|Treatment Period|Withdrawal by Subject|0|||
13080704|NCT04617275|25773686|FG006|Treatment Period|Withdrawal by Subject|1|||
13080705|NCT04617275|25773687|FG007|Treatment Period|Withdrawal by Subject|2|||
13080706|NCT04617275|25773680|FG000|Follow-up Period|Adverse Event|1|||
13080707|NCT04617275|25773681|FG001|Follow-up Period|Adverse Event|1|||
13080708|NCT04617275|25773682|FG002|Follow-up Period|Adverse Event|2|||
13080709|NCT04617275|25773683|FG003|Follow-up Period|Adverse Event|3|||
13080710|NCT04617275|25773684|FG004|Follow-up Period|Adverse Event|4|||
13080711|NCT04617275|25773685|FG005|Follow-up Period|Adverse Event|3|||
13080712|NCT04617275|25773686|FG006|Follow-up Period|Adverse Event|0|||
13080713|NCT04617275|25773687|FG007|Follow-up Period|Adverse Event|3|||
13080714|NCT04617275|25773680|FG000|Follow-up Period|Lost to Follow-up|0|||
13080715|NCT04617275|25773681|FG001|Follow-up Period|Lost to Follow-up|1|||
13080716|NCT04617275|25773682|FG002|Follow-up Period|Lost to Follow-up|2|||
13080717|NCT04617275|25773683|FG003|Follow-up Period|Lost to Follow-up|0|||
13080718|NCT04617275|25773684|FG004|Follow-up Period|Lost to Follow-up|0|||
13080719|NCT04617275|25773685|FG005|Follow-up Period|Lost to Follow-up|4|||
13080720|NCT04617275|25773686|FG006|Follow-up Period|Lost to Follow-up|0|||
13080721|NCT04617275|25773687|FG007|Follow-up Period|Lost to Follow-up|3|||
13393347|NCT00665925|26783414|FG003|Overall Study|Adverse Event|5|||
13080722|NCT04617275|25773680|FG000|Follow-up Period|No longer meets eligibility criteria|0|||
13080723|NCT04617275|25773681|FG001|Follow-up Period|No longer meets eligibility criteria|0|||
13080724|NCT04617275|25773682|FG002|Follow-up Period|No longer meets eligibility criteria|0|||
13080725|NCT04617275|25773683|FG003|Follow-up Period|No longer meets eligibility criteria|1|||
13080726|NCT04617275|25773684|FG004|Follow-up Period|No longer meets eligibility criteria|0|||
13080727|NCT04617275|25773685|FG005|Follow-up Period|No longer meets eligibility criteria|0|||
13080728|NCT04617275|25773686|FG006|Follow-up Period|No longer meets eligibility criteria|0|||
13080729|NCT04617275|25773687|FG007|Follow-up Period|No longer meets eligibility criteria|0|||
13080730|NCT04617275|25773680|FG000|Follow-up Period|Other|0|||
13080731|NCT04617275|25773681|FG001|Follow-up Period|Other|1|||
13080732|NCT04617275|25773682|FG002|Follow-up Period|Other|0|||
13080733|NCT04617275|25773683|FG003|Follow-up Period|Other|0|||
13080734|NCT04617275|25773684|FG004|Follow-up Period|Other|0|||
13080735|NCT04617275|25773685|FG005|Follow-up Period|Other|0|||
13080736|NCT04617275|25773686|FG006|Follow-up Period|Other|0|||
13080737|NCT04617275|25773687|FG007|Follow-up Period|Other|0|||
13080738|NCT04617275|25773680|FG000|Follow-up Period|Withdrawal by Subject|2|||
13080739|NCT04617275|25773681|FG001|Follow-up Period|Withdrawal by Subject|0|||
13080740|NCT04617275|25773682|FG002|Follow-up Period|Withdrawal by Subject|0|||
13080741|NCT04617275|25773683|FG003|Follow-up Period|Withdrawal by Subject|2|||
13080742|NCT04617275|25773684|FG004|Follow-up Period|Withdrawal by Subject|2|||
13080743|NCT04617275|25773685|FG005|Follow-up Period|Withdrawal by Subject|0|||
13080744|NCT04617275|25773686|FG006|Follow-up Period|Withdrawal by Subject|1|||
13080745|NCT04617275|25773687|FG007|Follow-up Period|Withdrawal by Subject|2|||
13131827|NCT02804763|25980967|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
13131828|NCT02804763|25980968|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
13131829|NCT02804763|25980965|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4|||
13131830|NCT02804763|25980966|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0|||
13131831|NCT02804763|25980967|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
13131832|NCT02804763|25980968|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
13131833|NCT02804763|25980965|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
13131834|NCT02804763|25980966|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1|||
13131835|NCT02804763|25980967|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
13131836|NCT02804763|25980968|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
13131837|NCT02804750|25980989|FG000|Period 1|Adverse Event|0|||
13131838|NCT02804750|25980990|FG001|Period 1|Adverse Event|2|||
13131839|NCT02804750|25980989|FG000|Period 1|Withdrawal by Subject|0|||
13131840|NCT02804750|25980990|FG001|Period 1|Withdrawal by Subject|1|||
13131841|NCT02804750|25980989|FG000|Period 2|Adverse Event|1|||
13131842|NCT02804750|25980990|FG001|Period 2|Adverse Event|0|||
13131843|NCT02804750|25980989|FG000|Period 3|Adverse Event|0|||
13131844|NCT02804750|25980990|FG001|Period 3|Adverse Event|2|||
13131845|NCT02804750|25980989|FG000|Period 4|Adverse Event|0|||
13131846|NCT02804750|25980990|FG001|Period 4|Adverse Event|5|||
13131847|NCT02804399|25981042|FG000|Period 2|Adverse Event|0|||
13131848|NCT02804399|25981043|FG001|Period 2|Adverse Event|1|||
13131849|NCT02804178|25981049|FG000|Overall Study|Adverse Event|1|||
13131850|NCT02803580|25981090|FG000|Overall Study|Death|13|||
13131851|NCT02803580|25981090|FG000|Overall Study|Lost to Follow-up|19|||
13131852|NCT02803580|25981090|FG000|Overall Study|Withdrawal by Subject|3|||
13131853|NCT02803580|25981090|FG000|Overall Study|Inclusion in clinical trial|1|||
13131854|NCT02803138|25981106|FG000|Overall Study|Failure to return|38|||
13131855|NCT02803138|25981106|FG000|Overall Study|Insufficient virological response|2|||
13131856|NCT02803138|25981106|FG000|Overall Study|Withdrawn consent|1|||
13131857|NCT02803138|25981106|FG000|Overall Study|Death|1|||
13131858|NCT02803138|25981106|FG000|Overall Study|Other, not specified|28|||
13131859|NCT02802878|25981127|FG000|Overall Study|Withdrawal by Subject|3|||
13131860|NCT02802878|25981128|FG001|Overall Study|Withdrawal by Subject|3|||
13131861|NCT02802878|25981127|FG000|Overall Study|Protocol Violation|1|||
13131862|NCT02802878|25981128|FG001|Overall Study|Protocol Violation|0|||
13131863|NCT02802865|25981157|FG000|Overall Study|Pregnancy|1|||
13131864|NCT02802865|25981158|FG001|Overall Study|Pregnancy|1|||
13131865|NCT02802865|25981157|FG000|Overall Study|Ineliegible due to tuberculosis|0|||
13131866|NCT02802865|25981158|FG001|Overall Study|Ineliegible due to tuberculosis|1|||
13131867|NCT02802735|25981212|FG000|Overall Study|Withdrawal by Subject|0|||
13131868|NCT02802735|25981213|FG001|Overall Study|Withdrawal by Subject|1|||
13131869|NCT02802735|25981214|FG002|Overall Study|Withdrawal by Subject|0|||
13131870|NCT02802735|25981215|FG003|Overall Study|Withdrawal by Subject|0|||
13131871|NCT02802735|25981216|FG004|Overall Study|Withdrawal by Subject|0|||
13131872|NCT02802592|25981229|FG000|Overall Study|Study terminated due to loss of funding|4|||
13131873|NCT02802345|25981250|FG000|Overall Study|Not Treated|0|||
13131874|NCT02802345|25981251|FG001|Overall Study|Not Treated|1|||
13131875|NCT02802345|25981250|FG000|Overall Study|Adverse Event|28|||
13131876|NCT02802345|25981251|FG001|Overall Study|Adverse Event|20|||
13131877|NCT02802345|25981250|FG000|Overall Study|Withdrawal by Subject|3|||
13131878|NCT02802345|25981251|FG001|Overall Study|Withdrawal by Subject|3|||
13131879|NCT02802345|25981250|FG000|Overall Study|Protocol Violation|0|||
13080746|NCT04426630|25773726|FG000|Overall Study|Death|4|||
13080747|NCT04426630|25773726|FG000|Overall Study|Lost to Follow-up|2|||
13080748|NCT04211389|25773815|FG000|Overall Study|Adverse Event|1|||
13080749|NCT04211389|25773816|FG001|Overall Study|Adverse Event|2|||
13080750|NCT04211389|25773815|FG000|Overall Study|Lost to Follow-up|15|||
13080751|NCT04211389|25773816|FG001|Overall Study|Lost to Follow-up|7|||
13080752|NCT04211389|25773815|FG000|Overall Study|Protocol Violation|0|||
13080753|NCT04211389|25773816|FG001|Overall Study|Protocol Violation|1|||
13080754|NCT04211389|25773815|FG000|Overall Study|Withdrawal by Subject|10|||
13080755|NCT04211389|25773816|FG001|Overall Study|Withdrawal by Subject|11|||
13080756|NCT04211363|25773843|FG000|Overall Study|Adverse Event|5|||
13080757|NCT04211363|25773844|FG001|Overall Study|Adverse Event|2|||
13080758|NCT04211363|25773843|FG000|Overall Study|Physician Decision|0|||
13080759|NCT04211363|25773844|FG001|Overall Study|Physician Decision|1|||
13080760|NCT04211363|25773843|FG000|Overall Study|Protocol Violation|1|||
13080761|NCT04211363|25773844|FG001|Overall Study|Protocol Violation|0|||
13080762|NCT04211363|25773843|FG000|Overall Study|Pregnancy|1|||
13080763|NCT04211363|25773844|FG001|Overall Study|Pregnancy|0|||
13080764|NCT04211363|25773843|FG000|Overall Study|Lost to Follow-up|12|||
13080765|NCT04211363|25773844|FG001|Overall Study|Lost to Follow-up|4|||
13080766|NCT04211363|25773843|FG000|Overall Study|Withdrawal by Subject|11|||
13080767|NCT04211363|25773844|FG001|Overall Study|Withdrawal by Subject|11|||
13080768|NCT04211363|25773843|FG000|Overall Study|Other|1|||
13080769|NCT04211363|25773844|FG001|Overall Study|Other|2|||
13080770|NCT04102111|25773869|FG000|Overall Study|Withdrawal by Subject|2|||
13080771|NCT04102111|25773870|FG001|Overall Study|Withdrawal by Subject|3|||
13080772|NCT04102111|25773869|FG000|Overall Study|Adverse Event|1|||
13080773|NCT04102111|25773870|FG001|Overall Study|Adverse Event|1|||
13080774|NCT04102111|25773869|FG000|Overall Study|Study terminated by sponsor|1|||
13080775|NCT04102111|25773870|FG001|Overall Study|Study terminated by sponsor|3|||
13080776|NCT04066491|25773898|FG000|Overall Study|Treatment ongoing|2|||
13080777|NCT04066491|25773899|FG001|Overall Study|Treatment ongoing|72|||
13080778|NCT04066491|25773900|FG002|Overall Study|Treatment ongoing|66|||
13080779|NCT04066491|25773898|FG000|Overall Study|Treatment completed/discontinued and in follow-up,|2|||
13080780|NCT04066491|25773899|FG001|Overall Study|Treatment completed/discontinued and in follow-up,|39|||
13080781|NCT04066491|25773900|FG002|Overall Study|Treatment completed/discontinued and in follow-up,|41|||
13080782|NCT04066491|25773898|FG000|Overall Study|Randomized, not treated|0|||
13080783|NCT04066491|25773899|FG001|Overall Study|Randomized, not treated|0|||
13080784|NCT04066491|25773900|FG002|Overall Study|Randomized, not treated|2|||
13080785|NCT04044716|25773947|FG000|Overall Study|participant stopped treatment but submitted partial data.|1|||
13080786|NCT04044716|25773948|FG001|Overall Study|participant stopped treatment but submitted partial data.|0|||
13080787|NCT04044716|25773949|FG002|Overall Study|participant stopped treatment but submitted partial data.|0|||
13080788|NCT04044716|25773947|FG000|Overall Study|Lost to Follow-up|2|||
13080789|NCT04044716|25773948|FG001|Overall Study|Lost to Follow-up|3|||
13080790|NCT04044716|25773949|FG002|Overall Study|Lost to Follow-up|0|||
13080791|NCT03982368|25774027|FG000|Overall Study|Adverse Event|6|||
13080792|NCT03982368|25774028|FG001|Overall Study|Adverse Event|4|||
13080793|NCT03982368|25774029|FG002|Overall Study|Adverse Event|3|||
13080794|NCT03982368|25774027|FG000|Overall Study|Lost to Follow-up|2|||
13080795|NCT03982368|25774028|FG001|Overall Study|Lost to Follow-up|1|||
13080796|NCT03982368|25774029|FG002|Overall Study|Lost to Follow-up|0|||
13080797|NCT03982368|25774027|FG000|Overall Study|Withdrawal by Subject|1|||
13080798|NCT03982368|25774028|FG001|Overall Study|Withdrawal by Subject|2|||
13080799|NCT03982368|25774029|FG002|Overall Study|Withdrawal by Subject|0|||
13080800|NCT03982368|25774027|FG000|Overall Study|unknow|4|||
13080801|NCT03982368|25774028|FG001|Overall Study|unknow|0|||
13080802|NCT03982368|25774029|FG002|Overall Study|unknow|2|||
13080803|NCT03962491|25774048|FG000|Overall Study|Lost to Follow-up|4|||
13080804|NCT03962491|25774049|FG001|Overall Study|Lost to Follow-up|5|||
13080805|NCT03909971|25774102|FG000|Overall Study|Other Reasons Not Specified|0|||
13080806|NCT03909971|25774103|FG001|Overall Study|Other Reasons Not Specified|1|||
13080807|NCT03909971|25774102|FG000|Overall Study|Global Deterioration of Health Status|2|||
13080808|NCT03909971|25774103|FG001|Overall Study|Global Deterioration of Health Status|1|||
13080809|NCT03909971|25774102|FG000|Overall Study|Progressive Disease|6|||
13080810|NCT03909971|25774103|FG001|Overall Study|Progressive Disease|14|||
13080811|NCT03909971|25774102|FG000|Overall Study|Death|2|||
13080812|NCT03909971|25774103|FG001|Overall Study|Death|6|||
13080813|NCT03811912|25774140|FG000|Overall Study|Withdrew Consent|4|||
13080814|NCT03811912|25774141|FG001|Overall Study|Withdrew Consent|2|||
13080815|NCT03670602|25774322|FG000|Overall Study|Lost to Follow-up|1|||
13080816|NCT03670602|25774323|FG001|Overall Study|Lost to Follow-up|0|||
13080817|NCT03670602|25774322|FG000|Overall Study|Withdrawal by Subject|0|||
13080818|NCT03670602|25774323|FG001|Overall Study|Withdrawal by Subject|3|||
13080819|NCT03664674|25774346|FG000|Overall Study|Adverse Event|1|||
13080820|NCT03664674|25774347|FG001|Overall Study|Adverse Event|1|||
13080821|NCT03664674|25774346|FG000|Overall Study|Physician Decision|0|||
13080822|NCT03664674|25774347|FG001|Overall Study|Physician Decision|1|||
13080823|NCT03664674|25774346|FG000|Overall Study|Withdrawal by Subject|2|||
13080824|NCT03664674|25774347|FG001|Overall Study|Withdrawal by Subject|0|||
13080825|NCT03657797|25774378|FG000|Overall Study|Lost to Follow-up|0|||
13080826|NCT03657797|25774379|FG001|Overall Study|Lost to Follow-up|1|||
13080827|NCT03657797|25774380|FG002|Overall Study|Lost to Follow-up|1|||
13080828|NCT03657797|25774381|FG003|Overall Study|Lost to Follow-up|0|||
13080829|NCT03657797|25774378|FG000|Overall Study|Physician Decision|0|||
13080830|NCT03657797|25774379|FG001|Overall Study|Physician Decision|1|||
13080831|NCT03657797|25774380|FG002|Overall Study|Physician Decision|0|||
13080832|NCT03657797|25774381|FG003|Overall Study|Physician Decision|0|||
13080833|NCT03657797|25774378|FG000|Overall Study|Withdrawal by Subject|0|||
13080834|NCT03657797|25774379|FG001|Overall Study|Withdrawal by Subject|1|||
13080835|NCT03657797|25774380|FG002|Overall Study|Withdrawal by Subject|2|||
13080836|NCT03657797|25774381|FG003|Overall Study|Withdrawal by Subject|0|||
13080837|NCT03657797|25774378|FG000|Overall Study|Adverse Event|0|||
13080838|NCT03657797|25774379|FG001|Overall Study|Adverse Event|0|||
13080839|NCT03657797|25774380|FG002|Overall Study|Adverse Event|2|||
13080840|NCT03657797|25774381|FG003|Overall Study|Adverse Event|0|||
13080841|NCT03624036|25774404|FG000|Overall Study|Still on Study|5|||
13080842|NCT03624036|25774405|FG001|Overall Study|Still on Study|1|||
13080843|NCT03624036|25774406|FG002|Overall Study|Still on Study|3|||
13080844|NCT03624036|25774407|FG003|Overall Study|Still on Study|3|||
13080845|NCT03624036|25774404|FG000|Overall Study|Death|1|||
13080846|NCT03624036|25774405|FG001|Overall Study|Death|2|||
13080847|NCT03624036|25774406|FG002|Overall Study|Death|0|||
13080848|NCT03624036|25774407|FG003|Overall Study|Death|0|||
13080849|NCT03624036|25774404|FG000|Overall Study|Enrolled but Never Treated|1|||
13080850|NCT03624036|25774405|FG001|Overall Study|Enrolled but Never Treated|0|||
13080851|NCT03624036|25774406|FG002|Overall Study|Enrolled but Never Treated|0|||
13080852|NCT03624036|25774407|FG003|Overall Study|Enrolled but Never Treated|0|||
13131880|NCT02802345|25981251|FG001|Overall Study|Protocol Violation|1|||
13131881|NCT02802345|25981250|FG000|Overall Study|Other than listed|1|||
13131882|NCT02802345|25981251|FG001|Overall Study|Other than listed|5|||
13131883|NCT02802319|25981266|FG000|Overall Study|Physician Decision|2|||
13131884|NCT02802319|25981267|FG001|Overall Study|Physician Decision|1|||
13131885|NCT02802319|25981266|FG000|Overall Study|Lost to Follow-up|0|||
13131886|NCT02802319|25981267|FG001|Overall Study|Lost to Follow-up|4|||
13131887|NCT02801877|25981298|FG000|Overall Study|Lost to Follow-up|1|||
13131888|NCT02801877|25981299|FG001|Overall Study|Lost to Follow-up|1|||
13131889|NCT02801877|25981300|FG002|Overall Study|Lost to Follow-up|2|||
13131890|NCT02801877|25981301|FG003|Overall Study|Lost to Follow-up|0|||
13131891|NCT02801877|25981298|FG000|Overall Study|Never Started Treatment|2|||
13131892|NCT02801877|25981299|FG001|Overall Study|Never Started Treatment|0|||
13131893|NCT02801877|25981300|FG002|Overall Study|Never Started Treatment|4|||
13131894|NCT02801877|25981301|FG003|Overall Study|Never Started Treatment|0|||
13131895|NCT02801669|25981333|FG000|Overall Study|Death|66|||
13131896|NCT02801669|25981334|FG001|Overall Study|Death|69|||
13131897|NCT02801669|25981333|FG000|Overall Study|Withdrawal by Subject|81|||
13131898|NCT02801669|25981334|FG001|Overall Study|Withdrawal by Subject|77|||
13131899|NCT02801669|25981333|FG000|Overall Study|Other|4|||
13131900|NCT02801669|25981334|FG001|Overall Study|Other|6|||
13131901|NCT02801617|25981359|FG000|Overall Study|Protocol Violation|2|||
13131902|NCT02801617|25981360|FG001|Overall Study|Protocol Violation|6|||
13131903|NCT02801578|25981366|FG000|Overall Study|Adverse Event|2|||
13131904|NCT02801396|25981390|FG000|Period 1|Withdrawal by Subject|0|||
13131905|NCT02801396|25981391|FG001|Period 1|Withdrawal by Subject|0|||
13131906|NCT02801396|25981392|FG002|Period 1|Withdrawal by Subject|0|||
13131907|NCT02801396|25981393|FG003|Period 1|Withdrawal by Subject|0|||
13131908|NCT02801396|25981394|FG004|Period 1|Withdrawal by Subject|1|||
13131909|NCT02801396|25981395|FG005|Period 1|Withdrawal by Subject|0|||
13131910|NCT02800928|25981406|FG000|Overall Study|Withdrawal by Subject|1|||
13131911|NCT02800928|25981407|FG001|Overall Study|Withdrawal by Subject|1|||
13131912|NCT02800928|25981406|FG000|Overall Study|Protocol Violation|1|||
13131913|NCT02800928|25981407|FG001|Overall Study|Protocol Violation|1|||
13131914|NCT02800642|25981422|FG000|Overall Study|Death|3|||
13131915|NCT02800642|25981422|FG000|Overall Study|Other|10|||
13131916|NCT02800642|25981422|FG000|Overall Study|Physician Decision|2|||
13131917|NCT02800642|25981422|FG000|Overall Study|Adverse Event|6|||
13131918|NCT02800642|25981422|FG000|Overall Study|Withdrawal by Subject|3|||
13131919|NCT02800642|25981422|FG000|Overall Study|Lost to Follow-up|1|||
13131920|NCT02799784|25981431|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
13131921|NCT02799784|25981432|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
13131922|NCT02799784|25981431|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5|||
13131923|NCT02799784|25981432|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0|||
13131924|NCT02799784|25981431|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0|||
13131925|NCT02799784|25981432|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1|||
13131926|NCT02799784|25981431|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1|||
13131927|NCT02799784|25981432|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0|||
13131928|NCT02799784|25981431|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0|||
13080853|NCT03372941|25774460|FG000|Overall Study|Lost to Follow-up|2|||
13080854|NCT03372941|25774461|FG001|Overall Study|Lost to Follow-up|4|||
13080855|NCT03262116|25774516|FG000|Overall Study|Physician Decision|0|||
13080856|NCT03262116|25774517|FG001|Overall Study|Physician Decision|2|||
13080857|NCT03262116|25774518|FG002|Overall Study|Physician Decision|1|||
13080858|NCT03262116|25774519|FG003|Overall Study|Physician Decision|1|||
13080859|NCT03262116|25774520|FG004|Overall Study|Physician Decision|1|||
13080860|NCT03262116|25774521|FG005|Overall Study|Physician Decision|2|||
13080861|NCT03245840|25774555|FG000|Overall Study|Adverse Event|6|||
13393348|NCT00665925|26783411|FG000|Overall Study|Enrolled by mistake|0|||
13080862|NCT03245840|25774556|FG001|Overall Study|Adverse Event|0|||
13080863|NCT03245840|25774555|FG000|Overall Study|Death|2|||
13080864|NCT03245840|25774556|FG001|Overall Study|Death|0|||
13080865|NCT03245840|25774555|FG000|Overall Study|Withdrawal by Subject|31|||
13080866|NCT03245840|25774556|FG001|Overall Study|Withdrawal by Subject|1|||
13080867|NCT03245840|25774555|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
13080868|NCT03245840|25774556|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
13080869|NCT03245840|25774555|FG000|Overall Study|Physician Decision|4|||
13080870|NCT03245840|25774556|FG001|Overall Study|Physician Decision|1|||
13080871|NCT03245840|25774555|FG000|Overall Study|Study Terminated by Sponsor|56|||
13080872|NCT03245840|25774556|FG001|Overall Study|Study Terminated by Sponsor|6|||
13080873|NCT03245840|25774555|FG000|Overall Study|Site Terminated by Sponsor|4|||
13080874|NCT03245840|25774556|FG001|Overall Study|Site Terminated by Sponsor|0|||
13080875|NCT03245840|25774555|FG000|Overall Study|Lost to Follow-up|12|||
13080876|NCT03245840|25774556|FG001|Overall Study|Lost to Follow-up|2|||
13080877|NCT03245840|25774555|FG000|Overall Study|Pregnancy|2|||
13080878|NCT03245840|25774556|FG001|Overall Study|Pregnancy|0|||
13080879|NCT03245840|25774555|FG000|Overall Study|Non-Compliance with Study Drug|2|||
13080880|NCT03245840|25774556|FG001|Overall Study|Non-Compliance with Study Drug|0|||
13080881|NCT03245840|25774555|FG000|Overall Study|Not treated|1|||
13080882|NCT03245840|25774556|FG001|Overall Study|Not treated|1|||
13080883|NCT03194646|25774599|FG000|Overall Study|Adverse Event|24|||
13080884|NCT03194646|25774600|FG001|Overall Study|Adverse Event|25|||
13080885|NCT03194646|25774601|FG002|Overall Study|Adverse Event|14|||
13080886|NCT03194646|25774602|FG003|Overall Study|Adverse Event|17|||
13080887|NCT03194646|25774599|FG000|Overall Study|Lack of Efficacy|4|||
13080888|NCT03194646|25774600|FG001|Overall Study|Lack of Efficacy|2|||
13080889|NCT03194646|25774601|FG002|Overall Study|Lack of Efficacy|2|||
13080890|NCT03194646|25774602|FG003|Overall Study|Lack of Efficacy|12|||
13080891|NCT03194646|25774599|FG000|Overall Study|Lost to Follow-up|30|||
13080892|NCT03194646|25774600|FG001|Overall Study|Lost to Follow-up|22|||
13080893|NCT03194646|25774601|FG002|Overall Study|Lost to Follow-up|12|||
13080894|NCT03194646|25774602|FG003|Overall Study|Lost to Follow-up|35|||
13080895|NCT03194646|25774599|FG000|Overall Study|Non-compliance with study drug|4|||
13080896|NCT03194646|25774600|FG001|Overall Study|Non-compliance with study drug|0|||
13080897|NCT03194646|25774601|FG002|Overall Study|Non-compliance with study drug|1|||
13080898|NCT03194646|25774602|FG003|Overall Study|Non-compliance with study drug|1|||
13080899|NCT03194646|25774599|FG000|Overall Study|Other|87|||
13080900|NCT03194646|25774600|FG001|Overall Study|Other|67|||
13080901|NCT03194646|25774601|FG002|Overall Study|Other|34|||
13080902|NCT03194646|25774602|FG003|Overall Study|Other|31|||
13080903|NCT03194646|25774599|FG000|Overall Study|Physician Decision|7|||
13080904|NCT03194646|25774600|FG001|Overall Study|Physician Decision|9|||
13080905|NCT03194646|25774601|FG002|Overall Study|Physician Decision|5|||
13080906|NCT03194646|25774602|FG003|Overall Study|Physician Decision|4|||
13080907|NCT03194646|25774599|FG000|Overall Study|Pregnancy|4|||
13080908|NCT03194646|25774600|FG001|Overall Study|Pregnancy|5|||
13080909|NCT03194646|25774601|FG002|Overall Study|Pregnancy|1|||
13080910|NCT03194646|25774602|FG003|Overall Study|Pregnancy|2|||
13080911|NCT03194646|25774599|FG000|Overall Study|Protocol Violation|4|||
13080912|NCT03194646|25774600|FG001|Overall Study|Protocol Violation|2|||
13080913|NCT03194646|25774601|FG002|Overall Study|Protocol Violation|1|||
13080914|NCT03194646|25774602|FG003|Overall Study|Protocol Violation|1|||
13080915|NCT03194646|25774599|FG000|Overall Study|Site terminated by sponsor|0|||
13080916|NCT03194646|25774600|FG001|Overall Study|Site terminated by sponsor|0|||
13080917|NCT03194646|25774601|FG002|Overall Study|Site terminated by sponsor|2|||
13080918|NCT03194646|25774602|FG003|Overall Study|Site terminated by sponsor|0|||
13080919|NCT03194646|25774599|FG000|Overall Study|Study terminated by sponsor|60|||
13080920|NCT03194646|25774600|FG001|Overall Study|Study terminated by sponsor|61|||
13080921|NCT03194646|25774601|FG002|Overall Study|Study terminated by sponsor|30|||
13080922|NCT03194646|25774602|FG003|Overall Study|Study terminated by sponsor|34|||
13080923|NCT03194646|25774599|FG000|Overall Study|Withdrawal by Subject|74|||
13080924|NCT03194646|25774600|FG001|Overall Study|Withdrawal by Subject|75|||
13080925|NCT03194646|25774601|FG002|Overall Study|Withdrawal by Subject|36|||
13080926|NCT03194646|25774602|FG003|Overall Study|Withdrawal by Subject|131|||
13080927|NCT03194646|25774599|FG000|Overall Study|Missing|4|||
13080928|NCT03194646|25774600|FG001|Overall Study|Missing|0|||
13080929|NCT03194646|25774601|FG002|Overall Study|Missing|1|||
13080930|NCT03194646|25774602|FG003|Overall Study|Missing|12|||
13080931|NCT03048578|25774615|FG000|Overall Study|Withdrawal by Subject|5|||
13080932|NCT03048578|25774616|FG001|Overall Study|Withdrawal by Subject|6|||
13080933|NCT03048578|25774615|FG000|Overall Study|Lost to Follow-up|22|||
13080934|NCT03048578|25774616|FG001|Overall Study|Lost to Follow-up|10|||
13080935|NCT03048578|25774615|FG000|Overall Study|Adverse Event|1|||
13080936|NCT03048578|25774616|FG001|Overall Study|Adverse Event|2|||
13080937|NCT03048578|25774615|FG000|Overall Study|Terminated|3|||
13080938|NCT03048578|25774616|FG001|Overall Study|Terminated|2|||
13131929|NCT02799784|25981432|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1|||
13131930|NCT02799784|25981431|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0|||
13131931|NCT02799784|25981432|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1|||
13131932|NCT02799745|25981469|FG000|Overall Study|Participant moved out of state|1|||
13131933|NCT02799745|25981470|FG001|Overall Study|Participant moved out of state|0|||
13131934|NCT02799745|25981469|FG000|Overall Study|Discontinued due to planned surgery|1|||
13131935|NCT02799745|25981470|FG001|Overall Study|Discontinued due to planned surgery|0|||
13131936|NCT02799745|25981469|FG000|Overall Study|Withdrawal by Subject|16|||
13131937|NCT02799745|25981470|FG001|Overall Study|Withdrawal by Subject|25|||
13131938|NCT02799745|25981469|FG000|Overall Study|Protocol Deviation|4|||
13131939|NCT02799745|25981470|FG001|Overall Study|Protocol Deviation|5|||
13131940|NCT02799745|25981469|FG000|Overall Study|Progressive Disease|28|||
13131941|NCT02799745|25981470|FG001|Overall Study|Progressive Disease|38|||
13131942|NCT02799745|25981469|FG000|Overall Study|Lost to Follow-up|3|||
13131943|NCT02799745|25981470|FG001|Overall Study|Lost to Follow-up|2|||
13131944|NCT02799745|25981469|FG000|Overall Study|Death|3|||
13131945|NCT02799745|25981470|FG001|Overall Study|Death|0|||
13131946|NCT02799745|25981469|FG000|Overall Study|Adverse Event|0|||
13131947|NCT02799745|25981470|FG001|Overall Study|Adverse Event|1|||
13131948|NCT02799472|25981535|FG000|Overall Study|Withdrawal by Subject|2|||
13131949|NCT02799472|25981536|FG001|Overall Study|Withdrawal by Subject|4|||
13131950|NCT02799472|25981535|FG000|Overall Study|Lack of Efficacy|2|||
13131951|NCT02799472|25981536|FG001|Overall Study|Lack of Efficacy|0|||
13131952|NCT02799472|25981535|FG000|Overall Study|Lost to Follow-up|0|||
13131953|NCT02799472|25981536|FG001|Overall Study|Lost to Follow-up|1|||
13131954|NCT02799381|25981561|FG000|Overall Study|Withdrew consent|3|||
13131955|NCT02799381|25981562|FG001|Overall Study|Withdrew consent|2|||
13131956|NCT02799381|25981561|FG000|Overall Study|Adverse Event|0|||
13131957|NCT02799381|25981562|FG001|Overall Study|Adverse Event|1|||
13131958|NCT02799381|25981561|FG000|Overall Study|Participant did not take any study drug|1|||
13131959|NCT02799381|25981562|FG001|Overall Study|Participant did not take any study drug|0|||
13131960|NCT02799082|25981603|FG000|Overall Study|Refused second PDT or withdraw consent|4|||
13131961|NCT02799082|25981604|FG001|Overall Study|Refused second PDT or withdraw consent|3|||
13131962|NCT02799082|25981603|FG000|Overall Study|Protocol Violation|0|||
13131963|NCT02799082|25981604|FG001|Overall Study|Protocol Violation|1|||
13131964|NCT02799069|25981724|FG000|Overall Study|Adverse Event|0|||
13131965|NCT02799069|25981725|FG001|Overall Study|Adverse Event|2|||
13131966|NCT02799069|25981726|FG002|Overall Study|Adverse Event|2|||
13131967|NCT02799069|25981724|FG000|Overall Study|Lack of Efficacy|2|||
13131968|NCT02799069|25981725|FG001|Overall Study|Lack of Efficacy|0|||
13131969|NCT02799069|25981726|FG002|Overall Study|Lack of Efficacy|0|||
13131970|NCT02799069|25981724|FG000|Overall Study|Lost to Follow-up|1|||
13131971|NCT02799069|25981725|FG001|Overall Study|Lost to Follow-up|1|||
13131972|NCT02799069|25981726|FG002|Overall Study|Lost to Follow-up|0|||
13131973|NCT02799069|25981724|FG000|Overall Study|Withdrawal by Subject|4|||
13131974|NCT02799069|25981725|FG001|Overall Study|Withdrawal by Subject|4|||
13131975|NCT02799069|25981726|FG002|Overall Study|Withdrawal by Subject|3|||
13131976|NCT02799069|25981724|FG000|Overall Study|Protocol Violation|1|||
13131977|NCT02799069|25981725|FG001|Overall Study|Protocol Violation|0|||
13131978|NCT02799069|25981726|FG002|Overall Study|Protocol Violation|2|||
13131979|NCT02798861|25981733|FG000|Overall Study|Lost to Follow-up|22|||
13131980|NCT02798861|25981733|FG000|Overall Study|Withdrawal by Subject|1|||
13131981|NCT02798835|25981778|FG000|Overall Study|Protocol Violation|0|||
13131982|NCT02798835|25981779|FG001|Overall Study|Protocol Violation|0|||
13131983|NCT02798835|25981780|FG002|Overall Study|Protocol Violation|3|||
13131984|NCT02798315|25981796|FG000|Overall Study|Failure to return|1|||
13131985|NCT02798211|25981880|FG000|Period 1|Adverse Event|1|||
13131986|NCT02798211|25981881|FG001|Period 1|Adverse Event|1|||
13131987|NCT02798211|25981882|FG002|Period 1|Adverse Event|0|||
13131988|NCT02798211|25981883|FG003|Period 1|Adverse Event|0|||
13131989|NCT02798211|25981884|FG004|Period 1|Adverse Event|0|||
13131990|NCT02798211|25981885|FG005|Period 1|Adverse Event|0|||
13131991|NCT02798211|25981880|FG000|Period 1|Lost to Follow-up|2|||
13131992|NCT02798211|25981881|FG001|Period 1|Lost to Follow-up|1|||
13131993|NCT02798211|25981882|FG002|Period 1|Lost to Follow-up|0|||
13131994|NCT02798211|25981883|FG003|Period 1|Lost to Follow-up|0|||
13131995|NCT02798211|25981884|FG004|Period 1|Lost to Follow-up|0|||
13131996|NCT02798211|25981885|FG005|Period 1|Lost to Follow-up|0|||
13131997|NCT02798211|25981880|FG000|Period 1|Protocol Violation|0|||
13131998|NCT02798211|25981881|FG001|Period 1|Protocol Violation|0|||
13131999|NCT02798211|25981882|FG002|Period 1|Protocol Violation|2|||
13132000|NCT02798211|25981883|FG003|Period 1|Protocol Violation|0|||
13080939|NCT02951767|25774683|FG000|Overall Study|Ongoing at data cutoff 04 July 2016|54|||
13080940|NCT02951767|25774683|FG000|Overall Study|Withdrawal by Subject|5|||
13080941|NCT02951767|25774683|FG000|Overall Study|Death|59|||
13080942|NCT02951767|25774683|FG000|Overall Study|Lost to Follow-up|1|||
13080943|NCT02923180|25774695|FG000|Overall Study|Off Study Due to Detectable PSA|13|||
13080944|NCT02923180|25774695|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13|||
13080945|NCT02899299|25774720|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
13080946|NCT02899299|25774721|FG001|Pre-treatment|Participant request to discontinue study treatment|3|||
13080947|NCT02899299|25774720|FG000|Pre-treatment|Participant withdrew consent|1|||
13080948|NCT02899299|25774721|FG001|Pre-treatment|Participant withdrew consent|11|||
13080949|NCT02899299|25774720|FG000|Pre-treatment|Participant no longer meets study criteria|2|||
13080950|NCT02899299|25774721|FG001|Pre-treatment|Participant no longer meets study criteria|3|||
13080951|NCT02899299|25774720|FG000|Pre-treatment|Not reported|0|||
13080952|NCT02899299|25774721|FG001|Pre-treatment|Not reported|1|||
13080953|NCT02899299|25774720|FG000|Treatment|Disease Progression|182|||
13080954|NCT02899299|25774721|FG001|Treatment|Disease Progression|44|||
13080955|NCT02899299|25774720|FG000|Treatment|Study Drug Toxicity|59|||
13080956|NCT02899299|25774721|FG001|Treatment|Study Drug Toxicity|24|||
13080957|NCT02899299|25774720|FG000|Treatment|Adverse Event unrelated to Study Drug|12|||
13080958|NCT02899299|25774721|FG001|Treatment|Adverse Event unrelated to Study Drug|9|||
13080959|NCT02899299|25774720|FG000|Treatment|Participant request to discontinue Study treatment|4|||
13080960|NCT02899299|25774721|FG001|Treatment|Participant request to discontinue Study treatment|10|||
13080961|NCT02899299|25774720|FG000|Treatment|Participant withdrew consent|6|||
13080962|NCT02899299|25774721|FG001|Treatment|Participant withdrew consent|3|||
13080963|NCT02899299|25774720|FG000|Treatment|Lost to Follow-up|0|||
13080964|NCT02899299|25774721|FG001|Treatment|Lost to Follow-up|1|||
13080965|NCT02899299|25774720|FG000|Treatment|Maximum Clinical Benefit|10|||
13080966|NCT02899299|25774721|FG001|Treatment|Maximum Clinical Benefit|2|||
13080967|NCT02899299|25774720|FG000|Treatment|Poor/Non-compliance|1|||
13080968|NCT02899299|25774721|FG001|Treatment|Poor/Non-compliance|0|||
13080969|NCT02899299|25774720|FG000|Treatment|Participant no longer meets Study criteria|4|||
13080970|NCT02899299|25774721|FG001|Treatment|Participant no longer meets Study criteria|0|||
13080971|NCT02899299|25774720|FG000|Treatment|Administrative reason by Sponsor|2|||
13080972|NCT02899299|25774721|FG001|Treatment|Administrative reason by Sponsor|0|||
13080973|NCT02899299|25774720|FG000|Treatment|Other reasons|11|||
13080974|NCT02899299|25774721|FG001|Treatment|Other reasons|2|||
13080975|NCT02899299|25774720|FG000|Treatment|Not reported: Includes participants who achieved max duration of treatment|4|||
13080976|NCT02899299|25774721|FG001|Treatment|Not reported: Includes participants who achieved max duration of treatment|189|||
13080977|NCT02821000|25774762|FG000|Overall Study|Death|44|||
13080978|NCT02821000|25774762|FG000|Overall Study|Withdrawal by Subject|1|||
13080979|NCT02821000|25774762|FG000|Overall Study|Ongoing in Study|58|||
13080980|NCT02609503|25774828|FG000|Overall Study|Adverse Event|1|||
13080981|NCT02609503|25774828|FG000|Overall Study|Death|1|||
13080982|NCT02609503|25774828|FG000|Overall Study|Withdrawal by Subject|1|||
13080983|NCT02609503|25774828|FG000|Overall Study|Disease progression|1|||
13080984|NCT02604511|25774839|FG000|Overall Study|Adverse Event|3|||
13080985|NCT02604511|25774839|FG000|Overall Study|Disease Progression|4|||
13080986|NCT02604511|25774839|FG000|Overall Study|Withdrawal by Subject|3|||
13080987|NCT02604511|25774839|FG000|Overall Study|Participant ineligible|1|||
13080988|NCT02604511|25774839|FG000|Overall Study|Intercurrent illness|1|||
13080989|NCT02506244|25774858|FG000|Overall Study|Did not undergo active monitoring|458|||
13080990|NCT02506244|25774859|FG001|Overall Study|Did not undergo active monitoring|459|||
13080991|NCT02506244|25774860|FG002|Overall Study|Did not undergo active monitoring|0|||
13080992|NCT02445391|25774884|FG000|Overall Study|No active protocol treatment|3|||
13080993|NCT02445391|25774885|FG001|Overall Study|No active protocol treatment|0|||
13080994|NCT02445391|25774886|FG002|Overall Study|No active protocol treatment|0|||
13080995|NCT02445391|25774884|FG000|Overall Study|Adverse Event|0|||
13080996|NCT02445391|25774885|FG001|Overall Study|Adverse Event|21|||
13080997|NCT02445391|25774886|FG002|Overall Study|Adverse Event|12|||
13080998|NCT02445391|25774884|FG000|Overall Study|Alternative therapy|0|||
13080999|NCT02445391|25774885|FG001|Overall Study|Alternative therapy|0|||
13081000|NCT02445391|25774886|FG002|Overall Study|Alternative therapy|1|||
13081001|NCT02445391|25774884|FG000|Overall Study|Disease progression|0|||
13081002|NCT02445391|25774885|FG001|Overall Study|Disease progression|7|||
13081003|NCT02445391|25774886|FG002|Overall Study|Disease progression|22|||
13081004|NCT02445391|25774884|FG000|Overall Study|Complicating disease|0|||
13081005|NCT02445391|25774885|FG001|Overall Study|Complicating disease|2|||
13081006|NCT02445391|25774886|FG002|Overall Study|Complicating disease|1|||
13081007|NCT02445391|25774884|FG000|Overall Study|Withdrawal by Subject|0|||
13081008|NCT02445391|25774885|FG001|Overall Study|Withdrawal by Subject|4|||
13081009|NCT02445391|25774886|FG002|Overall Study|Withdrawal by Subject|9|||
13081010|NCT02445391|25774884|FG000|Overall Study|Financial issue|0|||
13081011|NCT02445391|25774885|FG001|Overall Study|Financial issue|0|||
13081012|NCT02445391|25774886|FG002|Overall Study|Financial issue|2|||
13081013|NCT02445391|25774884|FG000|Overall Study|Still on treatment|0|||
13081014|NCT02445391|25774885|FG001|Overall Study|Still on treatment|7|||
13081015|NCT02445391|25774886|FG002|Overall Study|Still on treatment|16|||
13081016|NCT02445391|25774884|FG000|Overall Study|Not start protocol therapy|0|||
13081017|NCT02445391|25774885|FG001|Overall Study|Not start protocol therapy|12|||
13081018|NCT02445391|25774886|FG002|Overall Study|Not start protocol therapy|9|||
13081019|NCT02396199|25774892|FG000|Overall Study|Lost to Follow-up|1|||
13081020|NCT02396199|25774892|FG000|Overall Study|Death|4|||
13081021|NCT02357134|25774981|FG000|Overall Study|Lost to Follow-up|1|||
13081022|NCT02357134|25774982|FG001|Overall Study|Lost to Follow-up|0|||
13081023|NCT02357134|25774983|FG002|Overall Study|Lost to Follow-up|0|||
13081024|NCT02357134|25774984|FG003|Overall Study|Lost to Follow-up|0|||
13081025|NCT02232737|25775002|FG000|Overall Study|Lost to Follow-up|18|||
13081026|NCT02232737|25775003|FG001|Overall Study|Lost to Follow-up|28|||
13081027|NCT02232737|25775004|FG002|Overall Study|Lost to Follow-up|33|||
13081028|NCT02232737|25775002|FG000|Overall Study|Personal reasons|7|||
13081029|NCT02232737|25775003|FG001|Overall Study|Personal reasons|8|||
13081030|NCT02232737|25775004|FG002|Overall Study|Personal reasons|14|||
13081031|NCT02232737|25775002|FG000|Overall Study|Adverse Event|6|||
13081032|NCT02232737|25775003|FG001|Overall Study|Adverse Event|3|||
13081033|NCT02232737|25775004|FG002|Overall Study|Adverse Event|8|||
13081034|NCT02232737|25775002|FG000|Overall Study|Incarcerated|2|||
13081035|NCT02232737|25775003|FG001|Overall Study|Incarcerated|1|||
13081036|NCT02232737|25775004|FG002|Overall Study|Incarcerated|2|||
13081037|NCT02232737|25775002|FG000|Overall Study|Withdrawal by Subject|0|||
13081038|NCT02232737|25775003|FG001|Overall Study|Withdrawal by Subject|1|||
13081039|NCT02232737|25775004|FG002|Overall Study|Withdrawal by Subject|2|||
13081040|NCT02232737|25775002|FG000|Overall Study|Death|0|||
13081041|NCT02232737|25775003|FG001|Overall Study|Death|1|||
13081042|NCT02232737|25775004|FG002|Overall Study|Death|1|||
13081043|NCT02232737|25775002|FG000|Overall Study|Physician Decision|1|||
13081044|NCT02232737|25775003|FG001|Overall Study|Physician Decision|3|||
13081045|NCT02232737|25775004|FG002|Overall Study|Physician Decision|1|||
13081046|NCT02232737|25775002|FG000|Overall Study|Protocol Violation|1|||
13081047|NCT02232737|25775003|FG001|Overall Study|Protocol Violation|0|||
13081048|NCT02232737|25775004|FG002|Overall Study|Protocol Violation|1|||
13081049|NCT02232737|25775002|FG000|Overall Study|Reason unknown|1|||
13081050|NCT02232737|25775003|FG001|Overall Study|Reason unknown|0|||
13081051|NCT02232737|25775004|FG002|Overall Study|Reason unknown|0|||
13081052|NCT02227147|25775034|FG000|Controlled Treatment Period|Adverse Event|4|||
13081053|NCT02227147|25775035|FG001|Controlled Treatment Period|Adverse Event|3|||
13081054|NCT02227147|25775034|FG000|Controlled Treatment Period|Other|2|||
13081055|NCT02227147|25775035|FG001|Controlled Treatment Period|Other|0|||
13081056|NCT02227147|25775034|FG000|Follow-up Period|Other|3|||
13081057|NCT02227147|25775035|FG001|Follow-up Period|Other|5|||
13081058|NCT02108652|25775058|FG000|Overall Study|Death|226|||
13081059|NCT02108652|25775058|FG000|Overall Study|Lost to Follow-up|2|||
13081060|NCT02108652|25775058|FG000|Overall Study|Withdrawal by Subject|8|||
13081061|NCT02108652|25775058|FG000|Overall Study|Ongoing at data cutoff 04 July 2016|74|||
13081062|NCT01998633|25775136|FG000|Overall Study|Death|1|||
13081063|NCT01964430|25775153|FG000|Overall Study|Adverse Event|71|||
13081064|NCT01964430|25775154|FG001|Overall Study|Adverse Event|37|||
13081065|NCT01964430|25775153|FG000|Overall Study|Withdrawal by Subject|36|||
13081066|NCT01964430|25775154|FG001|Overall Study|Withdrawal by Subject|27|||
13081067|NCT01964430|25775153|FG000|Overall Study|Death|1|||
13081068|NCT01964430|25775154|FG001|Overall Study|Death|3|||
13081069|NCT01964430|25775153|FG000|Overall Study|Protocol Deviation|0|||
13081070|NCT01964430|25775154|FG001|Overall Study|Protocol Deviation|1|||
13081071|NCT01964430|25775153|FG000|Overall Study|Physician Decision|5|||
13081072|NCT01964430|25775154|FG001|Overall Study|Physician Decision|4|||
13081073|NCT01964430|25775153|FG000|Overall Study|Disease Relapse|28|||
13081074|NCT01964430|25775154|FG001|Overall Study|Disease Relapse|38|||
13081075|NCT01964430|25775153|FG000|Overall Study|Miscellaneous|1|||
13081076|NCT01964430|25775154|FG001|Overall Study|Miscellaneous|3|||
13081077|NCT01964430|25775153|FG000|Overall Study|Randomized but not Treated|3|||
13081078|NCT01964430|25775154|FG001|Overall Study|Randomized but not Treated|11|||
13081079|NCT01879072|25775160|FG000|Overall Study|Withdrawal by Subject|121|||
13081080|NCT01879072|25775160|FG000|Overall Study|Not Transplanted|30|||
13132001|NCT02798211|25981884|FG004|Period 1|Protocol Violation|0|||
13132002|NCT02798211|25981885|FG005|Period 1|Protocol Violation|0|||
13132003|NCT02798211|25981880|FG000|Period 1|Withdrawal by Subject|1|||
13132004|NCT02798211|25981881|FG001|Period 1|Withdrawal by Subject|1|||
13132005|NCT02798211|25981882|FG002|Period 1|Withdrawal by Subject|0|||
13132006|NCT02798211|25981883|FG003|Period 1|Withdrawal by Subject|0|||
13132007|NCT02798211|25981884|FG004|Period 1|Withdrawal by Subject|0|||
13132008|NCT02798211|25981885|FG005|Period 1|Withdrawal by Subject|0|||
13132009|NCT02798211|25981880|FG000|Period 1|Death|0|||
13132010|NCT02798211|25981881|FG001|Period 1|Death|0|||
13132011|NCT02798211|25981882|FG002|Period 1|Death|1|||
13132012|NCT02798211|25981883|FG003|Period 1|Death|0|||
13132013|NCT02798211|25981884|FG004|Period 1|Death|0|||
13132014|NCT02798211|25981885|FG005|Period 1|Death|0|||
13081081|NCT01809691|25775179|FG000|Overall Study|Currently on Treatment|192|||
13081082|NCT01809691|25775180|FG001|Overall Study|Currently on Treatment|100|||
13081083|NCT01809691|25775179|FG000|Overall Study|No Protocol Treatment|10|||
13081084|NCT01809691|25775180|FG001|Overall Study|No Protocol Treatment|11|||
13081085|NCT01809691|25775179|FG000|Overall Study|Adverse Event|80|||
13081086|NCT01809691|25775180|FG001|Overall Study|Adverse Event|21|||
13081087|NCT01809691|25775179|FG000|Overall Study|Disease Progression|226|||
13081088|NCT01809691|25775180|FG001|Overall Study|Disease Progression|372|||
13081089|NCT01809691|25775179|FG000|Overall Study|Death|26|||
13081090|NCT01809691|25775180|FG001|Overall Study|Death|13|||
13081091|NCT01809691|25775179|FG000|Overall Study|Participant Refusal|70|||
13081092|NCT01809691|25775180|FG001|Overall Study|Participant Refusal|72|||
13081093|NCT01809691|25775179|FG000|Overall Study|Other, Not Specified|34|||
13081094|NCT01809691|25775180|FG001|Overall Study|Other, Not Specified|52|||
13081095|NCT01740427|25775220|FG000|Overall Study|Ongoing|45|||
13081096|NCT01740427|25775221|FG001|Overall Study|Ongoing|5|||
13081097|NCT01740427|25775220|FG000|Overall Study|Objective Progression or Relapse|281|||
13081098|NCT01740427|25775221|FG001|Overall Study|Objective Progression or Relapse|171|||
13081099|NCT01740427|25775220|FG000|Overall Study|Adverse Event|31|||
13081100|NCT01740427|25775221|FG001|Overall Study|Adverse Event|9|||
13081101|NCT01740427|25775220|FG000|Overall Study|Global Deterioration of Health Status|28|||
13081102|NCT01740427|25775221|FG001|Overall Study|Global Deterioration of Health Status|12|||
13081103|NCT01740427|25775220|FG000|Overall Study|Participant Refused Continued Treatment|26|||
13081104|NCT01740427|25775221|FG001|Overall Study|Participant Refused Continued Treatment|15|||
13081105|NCT01740427|25775220|FG000|Overall Study|Unspecified reasons|15|||
13081106|NCT01740427|25775221|FG001|Overall Study|Unspecified reasons|4|||
13081107|NCT01740427|25775220|FG000|Overall Study|Death|10|||
13081108|NCT01740427|25775221|FG001|Overall Study|Death|3|||
13081109|NCT01740427|25775220|FG000|Overall Study|Protocol Violation|5|||
13081110|NCT01740427|25775221|FG001|Overall Study|Protocol Violation|3|||
13081111|NCT01740427|25775220|FG000|Overall Study|Lost to Follow-up|2|||
13081112|NCT01740427|25775221|FG001|Overall Study|Lost to Follow-up|0|||
13081113|NCT01740427|25775220|FG000|Overall Study|Site Terminated by Sponsor|1|||
13081114|NCT01740427|25775221|FG001|Overall Study|Site Terminated by Sponsor|0|||
13081115|NCT01723774|25775271|FG000|Neoadjuvant|Ki67 > 10%|4|||
13081116|NCT01723774|25775272|FG001|Neoadjuvant|Ki67 > 10%|0|||
13081117|NCT01723774|25775273|FG002|Neoadjuvant|Ki67 > 10%|10|||
13081118|NCT01723774|25775274|FG003|Neoadjuvant|Ki67 > 10%|0|||
13081119|NCT01723774|25775271|FG000|Neoadjuvant|Withdrawal by Subject|3|||
13081120|NCT01723774|25775272|FG001|Neoadjuvant|Withdrawal by Subject|1|||
13081121|NCT01723774|25775273|FG002|Neoadjuvant|Withdrawal by Subject|0|||
13081122|NCT01723774|25775274|FG003|Neoadjuvant|Withdrawal by Subject|0|||
13081123|NCT01723774|25775271|FG000|Neoadjuvant|Disease progression|0|||
13081124|NCT01723774|25775272|FG001|Neoadjuvant|Disease progression|1|||
13081125|NCT01723774|25775273|FG002|Neoadjuvant|Disease progression|1|||
13081126|NCT01723774|25775274|FG003|Neoadjuvant|Disease progression|0|||
13081127|NCT01723774|25775271|FG000|Neoadjuvant|Adverse Event|0|||
13081128|NCT01723774|25775272|FG001|Neoadjuvant|Adverse Event|1|||
13081129|NCT01723774|25775273|FG002|Neoadjuvant|Adverse Event|2|||
13081130|NCT01723774|25775274|FG003|Neoadjuvant|Adverse Event|0|||
13081131|NCT01723774|25775271|FG000|Neoadjuvant|High estradiol|0|||
13081132|NCT01723774|25775272|FG001|Neoadjuvant|High estradiol|1|||
13081133|NCT01723774|25775273|FG002|Neoadjuvant|High estradiol|0|||
13081134|NCT01723774|25775274|FG003|Neoadjuvant|High estradiol|0|||
13081135|NCT01723774|25775271|FG000|Adjuvant|Still on active treatment|0|||
13081136|NCT01723774|25775272|FG001|Adjuvant|Still on active treatment|0|||
13081137|NCT01723774|25775273|FG002|Adjuvant|Still on active treatment|0|||
13081138|NCT01723774|25775274|FG003|Adjuvant|Still on active treatment|1|||
13081139|NCT01661881|25775282|FG000|Overall Study|Disease Progression|1|||
13081140|NCT01610557|25775321|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
13081141|NCT01610557|25775322|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1|||
13081142|NCT01610557|25775323|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
13081143|NCT01610557|25775324|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
13081144|NCT01610557|25775325|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
13081145|NCT01610557|25775321|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
13081146|NCT01610557|25775322|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
13081147|NCT01610557|25775323|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
13081148|NCT01610557|25775324|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
13081149|NCT01610557|25775325|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3|||
13081150|NCT01186016|25775412|FG000|Overall Study|Withdrawal by Subject|46|||
13081151|NCT01186016|25775413|FG001|Overall Study|Withdrawal by Subject|29|||
13081152|NCT01081912|25775424|FG000|Conversion/Titration|Adverse Event|47|||
13081153|NCT01081912|25775425|FG001|Conversion/Titration|Adverse Event|0|||
13081154|NCT01081912|25775426|FG002|Conversion/Titration|Adverse Event|0|||
13081155|NCT01081912|25775424|FG000|Conversion/Titration|Lack of Efficacy|17|||
13081156|NCT01081912|25775425|FG001|Conversion/Titration|Lack of Efficacy|0|||
13081157|NCT01081912|25775426|FG002|Conversion/Titration|Lack of Efficacy|0|||
13081158|NCT01081912|25775424|FG000|Conversion/Titration|Lost to Follow-up|5|||
13081159|NCT01081912|25775425|FG001|Conversion/Titration|Lost to Follow-up|0|||
13081160|NCT01081912|25775426|FG002|Conversion/Titration|Lost to Follow-up|0|||
13081161|NCT01081912|25775424|FG000|Conversion/Titration|Physician Decision|2|||
13081162|NCT01081912|25775425|FG001|Conversion/Titration|Physician Decision|0|||
13081163|NCT01081912|25775426|FG002|Conversion/Titration|Physician Decision|0|||
13081164|NCT01081912|25775424|FG000|Conversion/Titration|Protocol Violation|67|||
13081165|NCT01081912|25775425|FG001|Conversion/Titration|Protocol Violation|0|||
13081166|NCT01081912|25775426|FG002|Conversion/Titration|Protocol Violation|0|||
13081167|NCT01081912|25775424|FG000|Conversion/Titration|Withdrawal by Subject|23|||
13081168|NCT01081912|25775425|FG001|Conversion/Titration|Withdrawal by Subject|0|||
13081169|NCT01081912|25775426|FG002|Conversion/Titration|Withdrawal by Subject|0|||
13081170|NCT01081912|25775424|FG000|Conversion/Titration|Non-Compliance|47|||
13081171|NCT01081912|25775425|FG001|Conversion/Titration|Non-Compliance|0|||
13081172|NCT01081912|25775426|FG002|Conversion/Titration|Non-Compliance|0|||
13081173|NCT01081912|25775424|FG000|Maintenance Treatment|Adverse Event|0|||
13081174|NCT01081912|25775425|FG001|Maintenance Treatment|Adverse Event|2|||
13081175|NCT01081912|25775426|FG002|Maintenance Treatment|Adverse Event|12|||
13081176|NCT01081912|25775424|FG000|Maintenance Treatment|Lack of Efficacy|0|||
13081177|NCT01081912|25775425|FG001|Maintenance Treatment|Lack of Efficacy|14|||
13081178|NCT01081912|25775426|FG002|Maintenance Treatment|Lack of Efficacy|64|||
13081179|NCT01081912|25775424|FG000|Maintenance Treatment|Lost to Follow-up|0|||
13081180|NCT01081912|25775425|FG001|Maintenance Treatment|Lost to Follow-up|1|||
13081181|NCT01081912|25775426|FG002|Maintenance Treatment|Lost to Follow-up|0|||
13081182|NCT01081912|25775424|FG000|Maintenance Treatment|Physician Decision|0|||
13081183|NCT01081912|25775425|FG001|Maintenance Treatment|Physician Decision|0|||
13081184|NCT01081912|25775426|FG002|Maintenance Treatment|Physician Decision|1|||
13081185|NCT01081912|25775424|FG000|Maintenance Treatment|Protocol Violation|0|||
13081186|NCT01081912|25775425|FG001|Maintenance Treatment|Protocol Violation|1|||
13081187|NCT01081912|25775426|FG002|Maintenance Treatment|Protocol Violation|2|||
13081188|NCT01081912|25775424|FG000|Maintenance Treatment|Withdrawal by Subject|0|||
13081189|NCT01081912|25775425|FG001|Maintenance Treatment|Withdrawal by Subject|5|||
13081190|NCT01081912|25775426|FG002|Maintenance Treatment|Withdrawal by Subject|5|||
13081191|NCT01081912|25775424|FG000|Maintenance Treatment|Non-Compliance|0|||
13081192|NCT01081912|25775425|FG001|Maintenance Treatment|Non-Compliance|4|||
13081193|NCT01081912|25775426|FG002|Maintenance Treatment|Non-Compliance|7|||
13081194|NCT01081912|25775424|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
13081195|NCT01081912|25775425|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
13081196|NCT01081912|25775426|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1|||
13081197|NCT01030523|25775445|FG000|Overall Study|Death|1|||
13081198|NCT01030523|25775446|FG001|Overall Study|Death|0|||
13081199|NCT01030523|25775445|FG000|Overall Study|Lost to Follow-up|4|||
13081200|NCT01030523|25775446|FG001|Overall Study|Lost to Follow-up|4|||
13081201|NCT01030523|25775445|FG000|Overall Study|Implant failure|1|||
13081202|NCT01030523|25775446|FG001|Overall Study|Implant failure|0|||
13081203|NCT01030523|25775445|FG000|Overall Study|Withdrawal by Subject|0|||
13081204|NCT01030523|25775446|FG001|Overall Study|Withdrawal by Subject|1|||
13081205|NCT00912223|25775464|FG000|Overall Study|Withdrawal by Subject|1|||
13081206|NCT00912223|25775464|FG000|Overall Study|Not transplanted|1|||
13081207|NCT00912223|25775464|FG000|Overall Study|Transformed disease|1|||
13081208|NCT00745420|25775483|FG000|Overall Study|Ineligible|1|||
13081209|NCT00580047|25775513|FG000|Overall Study|Lost to Follow-up|1|||
13081210|NCT00580047|25775514|FG001|Overall Study|Lost to Follow-up|1|||
13081211|NCT00580047|25775515|FG002|Overall Study|Lost to Follow-up|0|||
13081212|NCT00580047|25775513|FG000|Overall Study|Withdrawal by Subject|1|||
13081213|NCT00580047|25775514|FG001|Overall Study|Withdrawal by Subject|1|||
13081214|NCT00580047|25775515|FG002|Overall Study|Withdrawal by Subject|2|||
13081215|NCT00580047|25775513|FG000|Overall Study|Withdrawal by Subject|1|||
13081216|NCT00580047|25775514|FG001|Overall Study|Withdrawal by Subject|0|||
13081217|NCT00580047|25775515|FG002|Overall Study|Withdrawal by Subject|0|||
13081218|NCT00547339|25775566|FG000|Overall Study|Physician Decision|0|||
13081219|NCT00547339|25775567|FG001|Overall Study|Physician Decision|0|||
13081220|NCT00547339|25775568|FG002|Overall Study|Physician Decision|1|||
13081221|NCT00547339|25775569|FG003|Overall Study|Physician Decision|0|||
13081222|NCT00492050|25775577|FG000|Overall Study|Adverse Event|1|||
13081223|NCT00492050|25775577|FG000|Overall Study|Lack of Efficacy|1|||
13081224|NCT00492050|25775577|FG000|Overall Study|Withdrawal by Subject|3|||
13081225|NCT00492050|25775577|FG000|Overall Study|Unable to collect SCT|2|||
13081226|NCT00492050|25775577|FG000|Overall Study|Progressive Disease|2|||
13081227|NCT00489307|25775600|FG000|Overall Study|Death|1|||
13081228|NCT00489307|25775601|FG001|Overall Study|Death|1|||
13081229|NCT00489307|25775600|FG000|Overall Study|Lost to Follow-up|2|||
13081230|NCT00489307|25775601|FG001|Overall Study|Lost to Follow-up|2|||
13081231|NCT00489307|25775600|FG000|Overall Study|Physician Decision|1|||
13081232|NCT00489307|25775601|FG001|Overall Study|Physician Decision|0|||
13081233|NCT00489307|25775600|FG000|Overall Study|Withdrawal by Subject|2|||
13133671|NCT02766023|25988751|FG000|Overall Study|Adverse Event|1|||
13081234|NCT00489307|25775601|FG001|Overall Study|Withdrawal by Subject|4|||
13081235|NCT00489307|25775600|FG000|Overall Study|Hospitalization unrelated to treatment|10|||
13081236|NCT00489307|25775601|FG001|Overall Study|Hospitalization unrelated to treatment|7|||
13081237|NCT00489307|25775600|FG000|Overall Study|Surgery after assignment|1|||
13081238|NCT00489307|25775601|FG001|Overall Study|Surgery after assignment|0|||
13081239|NCT00489307|25775600|FG000|Overall Study|Did not fill up the forms|2|||
13081240|NCT00489307|25775601|FG001|Overall Study|Did not fill up the forms|1|||
13081241|NCT00489307|25775600|FG000|Overall Study|Patient or family refusal|5|||
13081242|NCT00489307|25775601|FG001|Overall Study|Patient or family refusal|9|||
13132015|NCT02798211|25981880|FG000|Period 1|Withdrawal of Informed Consent|2|||
13132016|NCT02798211|25981881|FG001|Period 1|Withdrawal of Informed Consent|7|||
13132017|NCT02798211|25981882|FG002|Period 1|Withdrawal of Informed Consent|3|||
13132018|NCT02798211|25981883|FG003|Period 1|Withdrawal of Informed Consent|0|||
13132019|NCT02798211|25981884|FG004|Period 1|Withdrawal of Informed Consent|0|||
13132020|NCT02798211|25981885|FG005|Period 1|Withdrawal of Informed Consent|0|||
13132021|NCT02798211|25981880|FG000|Period 2|Withdrawal by Subject|2|||
13132022|NCT02798211|25981881|FG001|Period 2|Withdrawal by Subject|0|||
13132023|NCT02798211|25981882|FG002|Period 2|Withdrawal by Subject|0|||
13132024|NCT02798211|25981883|FG003|Period 2|Withdrawal by Subject|0|||
13132025|NCT02798211|25981884|FG004|Period 2|Withdrawal by Subject|2|||
13132026|NCT02798211|25981885|FG005|Period 2|Withdrawal by Subject|2|||
13132027|NCT02798211|25981880|FG000|Period 2|Adverse Event|5|||
13132028|NCT02798211|25981881|FG001|Period 2|Adverse Event|0|||
13132029|NCT02798211|25981882|FG002|Period 2|Adverse Event|0|||
13132030|NCT02798211|25981883|FG003|Period 2|Adverse Event|0|||
13132031|NCT02798211|25981884|FG004|Period 2|Adverse Event|1|||
13132032|NCT02798211|25981885|FG005|Period 2|Adverse Event|0|||
13132033|NCT02798211|25981880|FG000|Period 2|Lack of Efficacy|1|||
13132034|NCT02798211|25981881|FG001|Period 2|Lack of Efficacy|0|||
13132035|NCT02798211|25981882|FG002|Period 2|Lack of Efficacy|0|||
13132036|NCT02798211|25981883|FG003|Period 2|Lack of Efficacy|1|||
13132037|NCT02798211|25981884|FG004|Period 2|Lack of Efficacy|0|||
13132038|NCT02798211|25981885|FG005|Period 2|Lack of Efficacy|1|||
13132039|NCT02798211|25981880|FG000|Period 2|Lost to Follow-up|3|||
13132040|NCT02798211|25981881|FG001|Period 2|Lost to Follow-up|0|||
13132041|NCT02798211|25981882|FG002|Period 2|Lost to Follow-up|0|||
13132042|NCT02798211|25981883|FG003|Period 2|Lost to Follow-up|0|||
13132043|NCT02798211|25981884|FG004|Period 2|Lost to Follow-up|2|||
13132044|NCT02798211|25981885|FG005|Period 2|Lost to Follow-up|0|||
13132045|NCT02798211|25981880|FG000|Period 2|Physician Decision|1|||
13132046|NCT02798211|25981881|FG001|Period 2|Physician Decision|0|||
13132047|NCT02798211|25981882|FG002|Period 2|Physician Decision|0|||
13132048|NCT02798211|25981883|FG003|Period 2|Physician Decision|1|||
13132049|NCT02798211|25981884|FG004|Period 2|Physician Decision|1|||
13132050|NCT02798211|25981885|FG005|Period 2|Physician Decision|0|||
13132051|NCT02798211|25981880|FG000|Period 2|Pregnancy|0|||
13132052|NCT02798211|25981881|FG001|Period 2|Pregnancy|0|||
13132053|NCT02798211|25981882|FG002|Period 2|Pregnancy|0|||
13132054|NCT02798211|25981883|FG003|Period 2|Pregnancy|2|||
13132055|NCT02798211|25981884|FG004|Period 2|Pregnancy|0|||
13132056|NCT02798211|25981885|FG005|Period 2|Pregnancy|0|||
13132057|NCT02798211|25981880|FG000|Period 2|Technical problems|1|||
13132058|NCT02798211|25981881|FG001|Period 2|Technical problems|0|||
13132059|NCT02798211|25981882|FG002|Period 2|Technical problems|0|||
13132060|NCT02798211|25981883|FG003|Period 2|Technical problems|1|||
13132061|NCT02798211|25981884|FG004|Period 2|Technical problems|0|||
13132062|NCT02798211|25981885|FG005|Period 2|Technical problems|0|||
13132063|NCT02798211|25981880|FG000|Period 2|Withdrawal of Informed Consent|1|||
13132064|NCT02798211|25981881|FG001|Period 2|Withdrawal of Informed Consent|0|||
13132065|NCT02798211|25981882|FG002|Period 2|Withdrawal of Informed Consent|0|||
13132066|NCT02798211|25981883|FG003|Period 2|Withdrawal of Informed Consent|2|||
13132067|NCT02798211|25981884|FG004|Period 2|Withdrawal of Informed Consent|2|||
13132068|NCT02798211|25981885|FG005|Period 2|Withdrawal of Informed Consent|3|||
13132069|NCT02797951|25981893|FG000|Overall Study|Adverse Event|4|||
13132070|NCT02797951|25981893|FG000|Overall Study|Death|1|||
13132071|NCT02797951|25981893|FG000|Overall Study|Lack of Efficacy|19|||
13132072|NCT02797951|25981893|FG000|Overall Study|Lost to Follow-up|4|||
13132073|NCT02797951|25981893|FG000|Overall Study|Physician Decision|6|||
13132074|NCT02797951|25981893|FG000|Overall Study|Withdrawal by Subject|15|||
13132075|NCT02797808|25981908|FG000|Overall Study|Withdrawal by Subject|1|||
13132076|NCT02797808|25981909|FG001|Overall Study|Withdrawal by Subject|1|||
13132077|NCT02797808|25981908|FG000|Overall Study|Physician Decision|6|||
13132078|NCT02797808|25981909|FG001|Overall Study|Physician Decision|2|||
13132079|NCT02797678|25981929|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25|||
13132080|NCT02797678|25981930|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
13132081|NCT02797678|25981931|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
13132082|NCT02797678|25981932|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
13132083|NCT02797678|25981929|FG000|First Intervention (5 Nights)|study/device use non-compliance|0|||
13132084|NCT02797678|25981930|FG001|First Intervention (5 Nights)|study/device use non-compliance|1|||
13081243|NCT04980456|25777358|FG000|Period 1 (Approximately 30 Days)|Adverse Event|2|||
13081244|NCT04980456|25777359|FG001|Period 1 (Approximately 30 Days)|Adverse Event|0|||
13081245|NCT04980456|25777358|FG000|Period 1 (Approximately 30 Days)|Lost to Follow-up|0|||
13081246|NCT04980456|25777359|FG001|Period 1 (Approximately 30 Days)|Lost to Follow-up|1|||
13081247|NCT04980456|25777358|FG000|Period 1 (Approximately 30 Days)|Withdrawal by Subject|1|||
13081248|NCT04980456|25777359|FG001|Period 1 (Approximately 30 Days)|Withdrawal by Subject|2|||
13081249|NCT04980456|25777358|FG000|Period 2 (Approximately 30 Days)|Adverse Event|0|||
13081250|NCT04980456|25777359|FG001|Period 2 (Approximately 30 Days)|Adverse Event|1|||
13081251|NCT04829214|25777380|FG000|Follow-up and Efficacy Analysis|Withdrawal by Subject|5|||
13081252|NCT04829214|25777381|FG001|Follow-up and Efficacy Analysis|Withdrawal by Subject|3|||
13081253|NCT04829214|25777380|FG000|Follow-up and Efficacy Analysis|Lost to Follow-up|2|||
13081254|NCT04829214|25777381|FG001|Follow-up and Efficacy Analysis|Lost to Follow-up|1|||
13081255|NCT04797637|25777398|FG000|Overall Study|Lost to Follow-up|23|||
13081256|NCT04797637|25777399|FG001|Overall Study|Lost to Follow-up|32|||
13081257|NCT04797637|25777398|FG000|Overall Study|Withdrawal by Subject|0|||
13081258|NCT04797637|25777399|FG001|Overall Study|Withdrawal by Subject|1|||
13081259|NCT04093752|25777473|FG000|Overall Study|Adverse Event|7|||
13081260|NCT04093752|25777474|FG001|Overall Study|Adverse Event|19|||
13081261|NCT04093752|25777475|FG002|Overall Study|Adverse Event|18|||
13081262|NCT04093752|25777476|FG003|Overall Study|Adverse Event|4|||
13081263|NCT04093752|25777473|FG000|Overall Study|Withdrawal by Subject|6|||
13081264|NCT04093752|25777474|FG001|Overall Study|Withdrawal by Subject|6|||
13081265|NCT04093752|25777475|FG002|Overall Study|Withdrawal by Subject|8|||
13081266|NCT04093752|25777476|FG003|Overall Study|Withdrawal by Subject|20|||
13081267|NCT04093752|25777473|FG000|Overall Study|Lost to Follow-up|2|||
13081268|NCT04093752|25777474|FG001|Overall Study|Lost to Follow-up|1|||
13081269|NCT04093752|25777475|FG002|Overall Study|Lost to Follow-up|1|||
13081270|NCT04093752|25777476|FG003|Overall Study|Lost to Follow-up|1|||
13081271|NCT04093752|25777473|FG000|Overall Study|Death|0|||
13081272|NCT04093752|25777474|FG001|Overall Study|Death|0|||
13081273|NCT04093752|25777475|FG002|Overall Study|Death|1|||
13081274|NCT04093752|25777476|FG003|Overall Study|Death|2|||
13081275|NCT04093752|25777473|FG000|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
13081276|NCT04093752|25777474|FG001|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
13081277|NCT04093752|25777475|FG002|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
13081278|NCT04093752|25777476|FG003|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
13081279|NCT04093752|25777473|FG000|Overall Study|Covid 19|0|||
13081280|NCT04093752|25777474|FG001|Overall Study|Covid 19|0|||
13081281|NCT04093752|25777475|FG002|Overall Study|Covid 19|0|||
13081282|NCT04093752|25777476|FG003|Overall Study|Covid 19|1|||
13081283|NCT04093752|25777473|FG000|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
13081284|NCT04093752|25777474|FG001|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
13081285|NCT04093752|25777475|FG002|Overall Study|Participant Thought there were Too Many Adverse Events|1|||
13081286|NCT04093752|25777476|FG003|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
13081287|NCT04093752|25777473|FG000|Overall Study|Participant was Reluctant to Follow-up|1|||
13081288|NCT04093752|25777474|FG001|Overall Study|Participant was Reluctant to Follow-up|0|||
13081289|NCT04093752|25777475|FG002|Overall Study|Participant was Reluctant to Follow-up|0|||
13081290|NCT04093752|25777476|FG003|Overall Study|Participant was Reluctant to Follow-up|0|||
13081291|NCT04093752|25777473|FG000|Overall Study|Participant Did Not Come for the Visit|1|||
13081292|NCT04093752|25777474|FG001|Overall Study|Participant Did Not Come for the Visit|0|||
13222433|NCT01806597|26286271|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
13222434|NCT01806597|26286266|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3|||
13222435|NCT01806597|26286267|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
13222436|NCT01806597|26286268|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
13222437|NCT01806597|26286269|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
13222438|NCT01806597|26286270|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
13222439|NCT01806597|26286271|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
13081293|NCT04093752|25777475|FG002|Overall Study|Participant Did Not Come for the Visit|0|||
13081294|NCT04093752|25777476|FG003|Overall Study|Participant Did Not Come for the Visit|0|||
13081295|NCT03667690|25777602|FG000|Overall Study|Adverse Event|0|||
13081296|NCT03667690|25777603|FG001|Overall Study|Adverse Event|3|||
13081297|NCT03667690|25777602|FG000|Overall Study|Death|22|||
13081298|NCT03667690|25777603|FG001|Overall Study|Death|21|||
13081299|NCT03667690|25777602|FG000|Overall Study|Lost to Follow-up|4|||
13081300|NCT03667690|25777603|FG001|Overall Study|Lost to Follow-up|5|||
13081301|NCT03667690|25777602|FG000|Overall Study|Withdrawal by Subject|7|||
13081302|NCT03667690|25777603|FG001|Overall Study|Withdrawal by Subject|8|||
13081303|NCT03667690|25777602|FG000|Overall Study|Subject could not return for additional investigational product|1|||
13081304|NCT03667690|25777603|FG001|Overall Study|Subject could not return for additional investigational product|0|||
13081305|NCT03667690|25777602|FG000|Overall Study|Subject discharged to hospice care|2|||
13081306|NCT03667690|25777603|FG001|Overall Study|Subject discharged to hospice care|0|||
13081307|NCT03667690|25777602|FG000|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|1|||
13081308|NCT03667690|25777603|FG001|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|0|||
13081309|NCT03667690|25777602|FG000|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|2|||
13081310|NCT03667690|25777603|FG001|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|1|||
13081311|NCT03667690|25777602|FG000|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
13081312|NCT03667690|25777603|FG001|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
13081313|NCT03667690|25777602|FG000|Overall Study|Subject was dropped due to exclusion criterion number 9|1|||
13081314|NCT03667690|25777603|FG001|Overall Study|Subject was dropped due to exclusion criterion number 9|0|||
13081315|NCT03667690|25777602|FG000|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|0|||
13081316|NCT03667690|25777603|FG001|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|1|||
13081317|NCT03601637|25777644|FG000|Overall Study|Withdrawal of Consent (not due to adverse event)|0|||
13081318|NCT03601637|25777645|FG001|Overall Study|Withdrawal of Consent (not due to adverse event)|1|||
13081319|NCT03601637|25777644|FG000|Overall Study|Adverse Event|1|||
13081320|NCT03601637|25777645|FG001|Overall Study|Adverse Event|1|||
13081321|NCT03601637|25777644|FG000|Overall Study|Other|0|||
13081322|NCT03601637|25777645|FG001|Overall Study|Other|1|||
13081323|NCT02393248|25777988|FG000|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
13081324|NCT02393248|25777989|FG001|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
13081325|NCT02393248|25777990|FG002|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
13081326|NCT02393248|25777991|FG003|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
13081327|NCT02393248|25777992|FG004|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
13081328|NCT02393248|25777993|FG005|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
13081329|NCT02393248|25777994|FG006|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
13081330|NCT02393248|25777995|FG007|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
13081331|NCT02393248|25777996|FG008|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
13081332|NCT02393248|25777997|FG009|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
13081333|NCT02393248|25777998|FG010|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
13081334|NCT02393248|25777999|FG011|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
13081335|NCT02393248|25778000|FG012|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
13081336|NCT02393248|25778001|FG013|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
13081337|NCT02393248|25778002|FG014|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
13081338|NCT02393248|25778003|FG015|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
13081339|NCT02393248|25778004|FG016|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
13081340|NCT02393248|25778005|FG017|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
13081341|NCT02393248|25778006|FG018|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
13081342|NCT02393248|25778007|FG019|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
13081343|NCT02393248|25778008|FG020|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
13081344|NCT02393248|25778009|FG021|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
13081345|NCT02393248|25778010|FG022|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
13081346|NCT02393248|25778011|FG023|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
13081347|NCT02393248|25778012|FG024|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
13081348|NCT02393248|25777988|FG000|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
13081349|NCT02393248|25777989|FG001|Part 1: Monotherapy Dose Escalation|Disease Progression|1|||
13081350|NCT02393248|25777990|FG002|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
13081351|NCT02393248|25777991|FG003|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
13081352|NCT02393248|25777992|FG004|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
13081353|NCT02393248|25777993|FG005|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
13081354|NCT02393248|25777994|FG006|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
13081355|NCT02393248|25777995|FG007|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
13081356|NCT02393248|25777996|FG008|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
13081357|NCT02393248|25777997|FG009|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
13081358|NCT02393248|25777998|FG010|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
13081359|NCT02393248|25777999|FG011|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
13081360|NCT02393248|25778000|FG012|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
13081361|NCT02393248|25778001|FG013|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
13081362|NCT02393248|25778002|FG014|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
13081363|NCT02393248|25778003|FG015|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
13081364|NCT02393248|25778004|FG016|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
13081365|NCT02393248|25778005|FG017|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
13081366|NCT02393248|25778006|FG018|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
13081367|NCT02393248|25778007|FG019|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
13081368|NCT02393248|25778008|FG020|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
13222440|NCT01806597|26286266|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0|||
13081369|NCT02393248|25778009|FG021|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
13081370|NCT02393248|25778010|FG022|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
13081371|NCT02393248|25778011|FG023|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
13081372|NCT02393248|25778012|FG024|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
13081373|NCT02393248|25777988|FG000|Part 1: Monotherapy Dose Escalation|Death|2|||
13081374|NCT02393248|25777989|FG001|Part 1: Monotherapy Dose Escalation|Death|2|||
13081375|NCT02393248|25777990|FG002|Part 1: Monotherapy Dose Escalation|Death|3|||
13081376|NCT02393248|25777991|FG003|Part 1: Monotherapy Dose Escalation|Death|6|||
13081377|NCT02393248|25777992|FG004|Part 1: Monotherapy Dose Escalation|Death|6|||
13081378|NCT02393248|25777993|FG005|Part 1: Monotherapy Dose Escalation|Death|6|||
13081379|NCT02393248|25777994|FG006|Part 1: Monotherapy Dose Escalation|Death|5|||
13081380|NCT02393248|25777995|FG007|Part 1: Monotherapy Dose Escalation|Death|8|||
13081381|NCT02393248|25777996|FG008|Part 1: Monotherapy Dose Escalation|Death|4|||
13081382|NCT02393248|25777997|FG009|Part 1: Monotherapy Dose Escalation|Death|2|||
13081383|NCT02393248|25777998|FG010|Part 1: Monotherapy Dose Escalation|Death|0|||
13081384|NCT02393248|25777999|FG011|Part 1: Monotherapy Dose Escalation|Death|0|||
13081385|NCT02393248|25778000|FG012|Part 1: Monotherapy Dose Escalation|Death|0|||
13081386|NCT02393248|25778001|FG013|Part 1: Monotherapy Dose Escalation|Death|0|||
13081387|NCT02393248|25778002|FG014|Part 1: Monotherapy Dose Escalation|Death|0|||
13081388|NCT02393248|25778003|FG015|Part 1: Monotherapy Dose Escalation|Death|0|||
13081389|NCT02393248|25778004|FG016|Part 1: Monotherapy Dose Escalation|Death|0|||
13081390|NCT02393248|25778005|FG017|Part 1: Monotherapy Dose Escalation|Death|0|||
13081391|NCT02393248|25778006|FG018|Part 1: Monotherapy Dose Escalation|Death|0|||
13081392|NCT02393248|25778007|FG019|Part 1: Monotherapy Dose Escalation|Death|0|||
13081393|NCT02393248|25778008|FG020|Part 1: Monotherapy Dose Escalation|Death|0|||
13081394|NCT02393248|25778009|FG021|Part 1: Monotherapy Dose Escalation|Death|0|||
13081395|NCT02393248|25778010|FG022|Part 1: Monotherapy Dose Escalation|Death|0|||
13081396|NCT02393248|25778011|FG023|Part 1: Monotherapy Dose Escalation|Death|0|||
13081397|NCT02393248|25778012|FG024|Part 1: Monotherapy Dose Escalation|Death|0|||
13081398|NCT02393248|25777988|FG000|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|1|||
13081399|NCT02393248|25777989|FG001|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
13081400|NCT02393248|25777990|FG002|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
13081401|NCT02393248|25777991|FG003|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
13081402|NCT02393248|25777992|FG004|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
13081403|NCT02393248|25777993|FG005|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
13081404|NCT02393248|25777994|FG006|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
13081405|NCT02393248|25777995|FG007|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
13081406|NCT02393248|25777996|FG008|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
13081407|NCT02393248|25777997|FG009|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
13081408|NCT02393248|25777998|FG010|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
13081409|NCT02393248|25777999|FG011|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
13081410|NCT02393248|25778000|FG012|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
13081411|NCT02393248|25778001|FG013|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
13081412|NCT02393248|25778002|FG014|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
13081413|NCT02393248|25778003|FG015|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
13081414|NCT02393248|25778004|FG016|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
13081415|NCT02393248|25778005|FG017|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
13081416|NCT02393248|25778006|FG018|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
13081417|NCT02393248|25778007|FG019|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
13081418|NCT02393248|25778008|FG020|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
13081419|NCT02393248|25778009|FG021|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
13081420|NCT02393248|25778010|FG022|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
13081421|NCT02393248|25778011|FG023|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
13081422|NCT02393248|25778012|FG024|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
13081423|NCT02393248|25777988|FG000|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
13081424|NCT02393248|25777989|FG001|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
13081425|NCT02393248|25777990|FG002|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
13081426|NCT02393248|25777991|FG003|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
13081427|NCT02393248|25777992|FG004|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
13081428|NCT02393248|25777993|FG005|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
13081429|NCT02393248|25777994|FG006|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
13081430|NCT02393248|25777995|FG007|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
13081431|NCT02393248|25777996|FG008|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
13081432|NCT02393248|25777997|FG009|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|1|||
13081433|NCT02393248|25777998|FG010|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
13081434|NCT02393248|25777999|FG011|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
13081435|NCT02393248|25778000|FG012|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
13081436|NCT02393248|25778001|FG013|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
13081437|NCT02393248|25778002|FG014|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
13081438|NCT02393248|25778003|FG015|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
13081439|NCT02393248|25778004|FG016|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
13081440|NCT02393248|25778005|FG017|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
13081441|NCT02393248|25778006|FG018|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
13081442|NCT02393248|25778007|FG019|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
13081443|NCT02393248|25778008|FG020|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
13081444|NCT02393248|25778009|FG021|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
13081445|NCT02393248|25778010|FG022|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
13081446|NCT02393248|25778011|FG023|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
13081447|NCT02393248|25778012|FG024|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
13081448|NCT02393248|25777988|FG000|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
13081449|NCT02393248|25777989|FG001|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
13081450|NCT02393248|25777990|FG002|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
13081451|NCT02393248|25777991|FG003|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
13081452|NCT02393248|25777992|FG004|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
13081453|NCT02393248|25777993|FG005|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
13081454|NCT02393248|25777994|FG006|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|1|||
13081455|NCT02393248|25777995|FG007|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
13081456|NCT02393248|25777996|FG008|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
13081457|NCT02393248|25777997|FG009|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
13081458|NCT02393248|25777998|FG010|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
13081459|NCT02393248|25777999|FG011|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
13081460|NCT02393248|25778000|FG012|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
13081461|NCT02393248|25778001|FG013|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
13081462|NCT02393248|25778002|FG014|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
13081463|NCT02393248|25778003|FG015|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
13081464|NCT02393248|25778004|FG016|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
13081465|NCT02393248|25778005|FG017|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
13081466|NCT02393248|25778006|FG018|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
13081467|NCT02393248|25778007|FG019|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
13081468|NCT02393248|25778008|FG020|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
13081469|NCT02393248|25778009|FG021|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
13081470|NCT02393248|25778010|FG022|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
13081471|NCT02393248|25778011|FG023|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
13081472|NCT02393248|25778012|FG024|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
13081473|NCT02393248|25777988|FG000|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
13081474|NCT02393248|25777989|FG001|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
13081475|NCT02393248|25777990|FG002|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
13081476|NCT02393248|25777991|FG003|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
13081477|NCT02393248|25777992|FG004|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
13081478|NCT02393248|25777993|FG005|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
13081479|NCT02393248|25777994|FG006|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
13081480|NCT02393248|25777995|FG007|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
13081481|NCT02393248|25777996|FG008|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
13081482|NCT02393248|25777997|FG009|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
13081483|NCT02393248|25777998|FG010|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
13081484|NCT02393248|25777999|FG011|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|13|||
13081485|NCT02393248|25778000|FG012|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|1|||
13081486|NCT02393248|25778001|FG013|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|2|||
13081487|NCT02393248|25778002|FG014|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|3|||
13081488|NCT02393248|25778003|FG015|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
13081489|NCT02393248|25778004|FG016|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
13081490|NCT02393248|25778005|FG017|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
13081491|NCT02393248|25778006|FG018|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
13081492|NCT02393248|25778007|FG019|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
13081493|NCT02393248|25778008|FG020|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
13081494|NCT02393248|25778009|FG021|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
13081495|NCT02393248|25778010|FG022|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
13081496|NCT02393248|25778011|FG023|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
13081497|NCT02393248|25778012|FG024|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
13081498|NCT02393248|25777988|FG000|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
13081499|NCT02393248|25777989|FG001|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
13081500|NCT02393248|25777990|FG002|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
13081501|NCT02393248|25777991|FG003|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
13081502|NCT02393248|25777992|FG004|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
13081503|NCT02393248|25777993|FG005|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
13081504|NCT02393248|25777994|FG006|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
13081505|NCT02393248|25777995|FG007|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
13081506|NCT02393248|25777996|FG008|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
13081507|NCT02393248|25777997|FG009|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
13081508|NCT02393248|25777998|FG010|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
13081509|NCT02393248|25777999|FG011|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
13081510|NCT02393248|25778000|FG012|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
13081511|NCT02393248|25778001|FG013|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
13081512|NCT02393248|25778002|FG014|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
13081513|NCT02393248|25778003|FG015|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
13081514|NCT02393248|25778004|FG016|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
13081515|NCT02393248|25778005|FG017|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
13081516|NCT02393248|25778006|FG018|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
13081517|NCT02393248|25778007|FG019|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
13081518|NCT02393248|25778008|FG020|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
13081519|NCT02393248|25778009|FG021|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
13081520|NCT02393248|25778010|FG022|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
13081521|NCT02393248|25778011|FG023|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
13081522|NCT02393248|25778012|FG024|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
13081523|NCT02393248|25777988|FG000|Part 2: Monotherapy Dose Expansion|Death|0|||
13081524|NCT02393248|25777989|FG001|Part 2: Monotherapy Dose Expansion|Death|0|||
13081525|NCT02393248|25777990|FG002|Part 2: Monotherapy Dose Expansion|Death|0|||
13081526|NCT02393248|25777991|FG003|Part 2: Monotherapy Dose Expansion|Death|0|||
13081527|NCT02393248|25777992|FG004|Part 2: Monotherapy Dose Expansion|Death|0|||
13081528|NCT02393248|25777993|FG005|Part 2: Monotherapy Dose Expansion|Death|0|||
13081529|NCT02393248|25777994|FG006|Part 2: Monotherapy Dose Expansion|Death|0|||
13081530|NCT02393248|25777995|FG007|Part 2: Monotherapy Dose Expansion|Death|0|||
13081531|NCT02393248|25777996|FG008|Part 2: Monotherapy Dose Expansion|Death|0|||
13081532|NCT02393248|25777997|FG009|Part 2: Monotherapy Dose Expansion|Death|0|||
13081533|NCT02393248|25777998|FG010|Part 2: Monotherapy Dose Expansion|Death|3|||
13081534|NCT02393248|25777999|FG011|Part 2: Monotherapy Dose Expansion|Death|29|||
13081535|NCT02393248|25778000|FG012|Part 2: Monotherapy Dose Expansion|Death|4|||
13081536|NCT02393248|25778001|FG013|Part 2: Monotherapy Dose Expansion|Death|15|||
13081537|NCT02393248|25778002|FG014|Part 2: Monotherapy Dose Expansion|Death|2|||
13081538|NCT02393248|25778003|FG015|Part 2: Monotherapy Dose Expansion|Death|0|||
13081539|NCT02393248|25778004|FG016|Part 2: Monotherapy Dose Expansion|Death|0|||
13081540|NCT02393248|25778005|FG017|Part 2: Monotherapy Dose Expansion|Death|0|||
13081541|NCT02393248|25778006|FG018|Part 2: Monotherapy Dose Expansion|Death|0|||
13081542|NCT02393248|25778007|FG019|Part 2: Monotherapy Dose Expansion|Death|0|||
13081543|NCT02393248|25778008|FG020|Part 2: Monotherapy Dose Expansion|Death|0|||
13081544|NCT02393248|25778009|FG021|Part 2: Monotherapy Dose Expansion|Death|0|||
13081545|NCT02393248|25778010|FG022|Part 2: Monotherapy Dose Expansion|Death|0|||
13081546|NCT02393248|25778011|FG023|Part 2: Monotherapy Dose Expansion|Death|0|||
13081547|NCT02393248|25778012|FG024|Part 2: Monotherapy Dose Expansion|Death|0|||
13081548|NCT02393248|25777988|FG000|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
13081549|NCT02393248|25777989|FG001|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
13081550|NCT02393248|25777990|FG002|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
13081551|NCT02393248|25777991|FG003|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
13081552|NCT02393248|25777992|FG004|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
13081553|NCT02393248|25777993|FG005|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
13081554|NCT02393248|25777994|FG006|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
13081555|NCT02393248|25777995|FG007|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
13081556|NCT02393248|25777996|FG008|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
13081557|NCT02393248|25777997|FG009|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
13081558|NCT02393248|25777998|FG010|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
13081559|NCT02393248|25777999|FG011|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|1|||
13081560|NCT02393248|25778000|FG012|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
13081561|NCT02393248|25778001|FG013|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|3|||
13081562|NCT02393248|25778002|FG014|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
13081563|NCT02393248|25778003|FG015|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
13081564|NCT02393248|25778004|FG016|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
13081565|NCT02393248|25778005|FG017|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
13081566|NCT02393248|25778006|FG018|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
13081567|NCT02393248|25778007|FG019|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
13081568|NCT02393248|25778008|FG020|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
13081569|NCT02393248|25778009|FG021|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
13081570|NCT02393248|25778010|FG022|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
13081571|NCT02393248|25778011|FG023|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
13081572|NCT02393248|25778012|FG024|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
13081573|NCT02393248|25777988|FG000|Part 3: Combination Therapy|Withdrawal by Subject|0|||
13081574|NCT02393248|25777989|FG001|Part 3: Combination Therapy|Withdrawal by Subject|0|||
13081575|NCT02393248|25777990|FG002|Part 3: Combination Therapy|Withdrawal by Subject|0|||
13081576|NCT02393248|25777991|FG003|Part 3: Combination Therapy|Withdrawal by Subject|0|||
13081577|NCT02393248|25777992|FG004|Part 3: Combination Therapy|Withdrawal by Subject|0|||
13081578|NCT02393248|25777993|FG005|Part 3: Combination Therapy|Withdrawal by Subject|0|||
13081579|NCT02393248|25777994|FG006|Part 3: Combination Therapy|Withdrawal by Subject|0|||
13081580|NCT02393248|25777995|FG007|Part 3: Combination Therapy|Withdrawal by Subject|0|||
13081581|NCT02393248|25777996|FG008|Part 3: Combination Therapy|Withdrawal by Subject|0|||
13081582|NCT02393248|25777997|FG009|Part 3: Combination Therapy|Withdrawal by Subject|0|||
13081583|NCT02393248|25777998|FG010|Part 3: Combination Therapy|Withdrawal by Subject|0|||
13081584|NCT02393248|25777999|FG011|Part 3: Combination Therapy|Withdrawal by Subject|0|||
13081585|NCT02393248|25778000|FG012|Part 3: Combination Therapy|Withdrawal by Subject|0|||
13081586|NCT02393248|25778001|FG013|Part 3: Combination Therapy|Withdrawal by Subject|0|||
13081587|NCT02393248|25778002|FG014|Part 3: Combination Therapy|Withdrawal by Subject|0|||
13081588|NCT02393248|25778003|FG015|Part 3: Combination Therapy|Withdrawal by Subject|0|||
13081589|NCT02393248|25778004|FG016|Part 3: Combination Therapy|Withdrawal by Subject|0|||
13081590|NCT02393248|25778005|FG017|Part 3: Combination Therapy|Withdrawal by Subject|0|||
13081591|NCT02393248|25778006|FG018|Part 3: Combination Therapy|Withdrawal by Subject|1|||
13081592|NCT02393248|25778007|FG019|Part 3: Combination Therapy|Withdrawal by Subject|0|||
13081593|NCT02393248|25778008|FG020|Part 3: Combination Therapy|Withdrawal by Subject|2|||
13081594|NCT02393248|25778009|FG021|Part 3: Combination Therapy|Withdrawal by Subject|1|||
13081595|NCT02393248|25778010|FG022|Part 3: Combination Therapy|Withdrawal by Subject|0|||
13081596|NCT02393248|25778011|FG023|Part 3: Combination Therapy|Withdrawal by Subject|1|||
13081597|NCT02393248|25778012|FG024|Part 3: Combination Therapy|Withdrawal by Subject|0|||
13081598|NCT02393248|25777988|FG000|Part 3: Combination Therapy|Death|0|||
13081599|NCT02393248|25777989|FG001|Part 3: Combination Therapy|Death|0|||
13081600|NCT02393248|25777990|FG002|Part 3: Combination Therapy|Death|0|||
13081601|NCT02393248|25777991|FG003|Part 3: Combination Therapy|Death|0|||
13081602|NCT02393248|25777992|FG004|Part 3: Combination Therapy|Death|0|||
13081603|NCT02393248|25777993|FG005|Part 3: Combination Therapy|Death|0|||
13081604|NCT02393248|25777994|FG006|Part 3: Combination Therapy|Death|0|||
13081605|NCT02393248|25777995|FG007|Part 3: Combination Therapy|Death|0|||
13081606|NCT02393248|25777996|FG008|Part 3: Combination Therapy|Death|0|||
13081607|NCT02393248|25777997|FG009|Part 3: Combination Therapy|Death|0|||
13081608|NCT02393248|25777998|FG010|Part 3: Combination Therapy|Death|0|||
13081609|NCT02393248|25777999|FG011|Part 3: Combination Therapy|Death|0|||
13081610|NCT02393248|25778000|FG012|Part 3: Combination Therapy|Death|0|||
13081611|NCT02393248|25778001|FG013|Part 3: Combination Therapy|Death|0|||
13081612|NCT02393248|25778002|FG014|Part 3: Combination Therapy|Death|0|||
13081613|NCT02393248|25778003|FG015|Part 3: Combination Therapy|Death|1|||
13081614|NCT02393248|25778004|FG016|Part 3: Combination Therapy|Death|7|||
13081615|NCT02393248|25778005|FG017|Part 3: Combination Therapy|Death|5|||
13081616|NCT02393248|25778006|FG018|Part 3: Combination Therapy|Death|5|||
13081617|NCT02393248|25778007|FG019|Part 3: Combination Therapy|Death|3|||
13081618|NCT02393248|25778008|FG020|Part 3: Combination Therapy|Death|7|||
13081619|NCT02393248|25778009|FG021|Part 3: Combination Therapy|Death|5|||
13081620|NCT02393248|25778010|FG022|Part 3: Combination Therapy|Death|6|||
13081621|NCT02393248|25778011|FG023|Part 3: Combination Therapy|Death|3|||
13081622|NCT02393248|25778012|FG024|Part 3: Combination Therapy|Death|0|||
13081623|NCT02393248|25777988|FG000|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
13081624|NCT02393248|25777989|FG001|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
13081625|NCT02393248|25777990|FG002|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
13081626|NCT02393248|25777991|FG003|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
13081627|NCT02393248|25777992|FG004|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
13081628|NCT02393248|25777993|FG005|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
13081629|NCT02393248|25777994|FG006|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
13081630|NCT02393248|25777995|FG007|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
13081631|NCT02393248|25777996|FG008|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
13081632|NCT02393248|25777997|FG009|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
13081633|NCT02393248|25777998|FG010|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
13081634|NCT02393248|25777999|FG011|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
13133672|NCT02766023|25988752|FG001|Overall Study|Adverse Event|0|||
13393349|NCT00665925|26783412|FG001|Overall Study|Enrolled by mistake|0|||
13081635|NCT02393248|25778000|FG012|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
13081636|NCT02393248|25778001|FG013|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
13081637|NCT02393248|25778002|FG014|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
13081638|NCT02393248|25778003|FG015|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
13081639|NCT02393248|25778004|FG016|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
13081640|NCT02393248|25778005|FG017|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
13081641|NCT02393248|25778006|FG018|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
13081642|NCT02393248|25778007|FG019|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
13081643|NCT02393248|25778008|FG020|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
13081644|NCT02393248|25778009|FG021|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
13081645|NCT02393248|25778010|FG022|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
13081646|NCT02393248|25778011|FG023|Part 3: Combination Therapy|Study Terminated by Sponsor|2|||
13081647|NCT02393248|25778012|FG024|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
13081648|NCT02393248|25777988|FG000|Part 3: Combination Therapy|Disease Progression|0|||
13081649|NCT02393248|25777989|FG001|Part 3: Combination Therapy|Disease Progression|0|||
13081650|NCT02393248|25777990|FG002|Part 3: Combination Therapy|Disease Progression|0|||
13081651|NCT02393248|25777991|FG003|Part 3: Combination Therapy|Disease Progression|0|||
13081652|NCT02393248|25777992|FG004|Part 3: Combination Therapy|Disease Progression|0|||
13081653|NCT02393248|25777993|FG005|Part 3: Combination Therapy|Disease Progression|0|||
13081654|NCT02393248|25777994|FG006|Part 3: Combination Therapy|Disease Progression|0|||
13081655|NCT02393248|25777995|FG007|Part 3: Combination Therapy|Disease Progression|0|||
13081656|NCT02393248|25777996|FG008|Part 3: Combination Therapy|Disease Progression|0|||
13081657|NCT02393248|25777997|FG009|Part 3: Combination Therapy|Disease Progression|0|||
13081658|NCT02393248|25777998|FG010|Part 3: Combination Therapy|Disease Progression|0|||
13081659|NCT02393248|25777999|FG011|Part 3: Combination Therapy|Disease Progression|0|||
13081660|NCT02393248|25778000|FG012|Part 3: Combination Therapy|Disease Progression|0|||
13081661|NCT02393248|25778001|FG013|Part 3: Combination Therapy|Disease Progression|0|||
13081662|NCT02393248|25778002|FG014|Part 3: Combination Therapy|Disease Progression|0|||
13081663|NCT02393248|25778003|FG015|Part 3: Combination Therapy|Disease Progression|0|||
13081664|NCT02393248|25778004|FG016|Part 3: Combination Therapy|Disease Progression|0|||
13081665|NCT02393248|25778005|FG017|Part 3: Combination Therapy|Disease Progression|0|||
13081666|NCT02393248|25778006|FG018|Part 3: Combination Therapy|Disease Progression|0|||
13081667|NCT02393248|25778007|FG019|Part 3: Combination Therapy|Disease Progression|0|||
13081668|NCT02393248|25778008|FG020|Part 3: Combination Therapy|Disease Progression|2|||
13081669|NCT02393248|25778009|FG021|Part 3: Combination Therapy|Disease Progression|1|||
13081670|NCT02393248|25778010|FG022|Part 3: Combination Therapy|Disease Progression|0|||
13081671|NCT02393248|25778011|FG023|Part 3: Combination Therapy|Disease Progression|0|||
13081672|NCT02393248|25778012|FG024|Part 3: Combination Therapy|Disease Progression|0|||
13081673|NCT02393248|25777988|FG000|Part 3: Combination Therapy|Lost to Follow-up|0|||
13081674|NCT02393248|25777989|FG001|Part 3: Combination Therapy|Lost to Follow-up|0|||
13081675|NCT02393248|25777990|FG002|Part 3: Combination Therapy|Lost to Follow-up|0|||
13081676|NCT02393248|25777991|FG003|Part 3: Combination Therapy|Lost to Follow-up|0|||
13081677|NCT02393248|25777992|FG004|Part 3: Combination Therapy|Lost to Follow-up|0|||
13081678|NCT02393248|25777993|FG005|Part 3: Combination Therapy|Lost to Follow-up|0|||
13081679|NCT02393248|25777994|FG006|Part 3: Combination Therapy|Lost to Follow-up|0|||
13081680|NCT02393248|25777995|FG007|Part 3: Combination Therapy|Lost to Follow-up|0|||
13081681|NCT02393248|25777996|FG008|Part 3: Combination Therapy|Lost to Follow-up|0|||
13081682|NCT02393248|25777997|FG009|Part 3: Combination Therapy|Lost to Follow-up|0|||
13081683|NCT02393248|25777998|FG010|Part 3: Combination Therapy|Lost to Follow-up|0|||
13081684|NCT02393248|25777999|FG011|Part 3: Combination Therapy|Lost to Follow-up|0|||
13081685|NCT02393248|25778000|FG012|Part 3: Combination Therapy|Lost to Follow-up|0|||
13081686|NCT02393248|25778001|FG013|Part 3: Combination Therapy|Lost to Follow-up|0|||
13081687|NCT02393248|25778002|FG014|Part 3: Combination Therapy|Lost to Follow-up|0|||
13081688|NCT02393248|25778003|FG015|Part 3: Combination Therapy|Lost to Follow-up|0|||
13081689|NCT02393248|25778004|FG016|Part 3: Combination Therapy|Lost to Follow-up|0|||
13081690|NCT02393248|25778005|FG017|Part 3: Combination Therapy|Lost to Follow-up|0|||
13081691|NCT02393248|25778006|FG018|Part 3: Combination Therapy|Lost to Follow-up|0|||
13081692|NCT02393248|25778007|FG019|Part 3: Combination Therapy|Lost to Follow-up|0|||
13081693|NCT02393248|25778008|FG020|Part 3: Combination Therapy|Lost to Follow-up|1|||
13081694|NCT02393248|25778009|FG021|Part 3: Combination Therapy|Lost to Follow-up|1|||
13081695|NCT02393248|25778010|FG022|Part 3: Combination Therapy|Lost to Follow-up|0|||
13081696|NCT02393248|25778011|FG023|Part 3: Combination Therapy|Lost to Follow-up|0|||
13081697|NCT02393248|25778012|FG024|Part 3: Combination Therapy|Lost to Follow-up|0|||
13081698|NCT02393248|25777988|FG000|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
13081699|NCT02393248|25777989|FG001|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
13081700|NCT02393248|25777990|FG002|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
13081701|NCT02393248|25777991|FG003|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
13133721|NCT02765165|25988897|FG006|Treatment Period|Study terminated|2|||
13081702|NCT02393248|25777992|FG004|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
13081703|NCT02393248|25777993|FG005|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
13081704|NCT02393248|25777994|FG006|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
13081705|NCT02393248|25777995|FG007|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
13081706|NCT02393248|25777996|FG008|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
13081707|NCT02393248|25777997|FG009|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
13081708|NCT02393248|25777998|FG010|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
13081709|NCT02393248|25777999|FG011|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
13081710|NCT02393248|25778000|FG012|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
13081711|NCT02393248|25778001|FG013|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
13081712|NCT02393248|25778002|FG014|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
13081713|NCT02393248|25778003|FG015|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
13081714|NCT02393248|25778004|FG016|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
13081715|NCT02393248|25778005|FG017|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
13081716|NCT02393248|25778006|FG018|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
13081717|NCT02393248|25778007|FG019|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
13081718|NCT02393248|25778008|FG020|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|1|||
13081719|NCT02393248|25778009|FG021|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
13081720|NCT02393248|25778010|FG022|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
13081721|NCT02393248|25778011|FG023|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
13081722|NCT02393248|25778012|FG024|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
13081723|NCT02393248|25777988|FG000|Part 3: Combination Therapy|Adverse Event|0|||
13081724|NCT02393248|25777989|FG001|Part 3: Combination Therapy|Adverse Event|0|||
13081725|NCT02393248|25777990|FG002|Part 3: Combination Therapy|Adverse Event|0|||
13081726|NCT02393248|25777991|FG003|Part 3: Combination Therapy|Adverse Event|0|||
13081727|NCT02393248|25777992|FG004|Part 3: Combination Therapy|Adverse Event|0|||
13081728|NCT02393248|25777993|FG005|Part 3: Combination Therapy|Adverse Event|0|||
13081729|NCT02393248|25777994|FG006|Part 3: Combination Therapy|Adverse Event|0|||
13081730|NCT02393248|25777995|FG007|Part 3: Combination Therapy|Adverse Event|0|||
13081731|NCT02393248|25777996|FG008|Part 3: Combination Therapy|Adverse Event|0|||
13081732|NCT02393248|25777997|FG009|Part 3: Combination Therapy|Adverse Event|0|||
13081733|NCT02393248|25777998|FG010|Part 3: Combination Therapy|Adverse Event|0|||
13081734|NCT02393248|25777999|FG011|Part 3: Combination Therapy|Adverse Event|0|||
13081735|NCT02393248|25778000|FG012|Part 3: Combination Therapy|Adverse Event|0|||
13081736|NCT02393248|25778001|FG013|Part 3: Combination Therapy|Adverse Event|0|||
13081737|NCT02393248|25778002|FG014|Part 3: Combination Therapy|Adverse Event|0|||
13081738|NCT02393248|25778003|FG015|Part 3: Combination Therapy|Adverse Event|0|||
13081739|NCT02393248|25778004|FG016|Part 3: Combination Therapy|Adverse Event|0|||
13081740|NCT02393248|25778005|FG017|Part 3: Combination Therapy|Adverse Event|0|||
13081741|NCT02393248|25778006|FG018|Part 3: Combination Therapy|Adverse Event|0|||
13081742|NCT02393248|25778007|FG019|Part 3: Combination Therapy|Adverse Event|0|||
13081743|NCT02393248|25778008|FG020|Part 3: Combination Therapy|Adverse Event|0|||
13081744|NCT02393248|25778009|FG021|Part 3: Combination Therapy|Adverse Event|0|||
13081745|NCT02393248|25778010|FG022|Part 3: Combination Therapy|Adverse Event|0|||
13081746|NCT02393248|25778011|FG023|Part 3: Combination Therapy|Adverse Event|1|||
13081747|NCT02393248|25778012|FG024|Part 3: Combination Therapy|Adverse Event|0|||
13081748|NCT02393248|25777988|FG000|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
13081749|NCT02393248|25777989|FG001|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
13081750|NCT02393248|25777990|FG002|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
13081751|NCT02393248|25777991|FG003|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
13081752|NCT02393248|25777992|FG004|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
13081753|NCT02393248|25777993|FG005|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
13081754|NCT02393248|25777994|FG006|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
13081755|NCT02393248|25777995|FG007|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
13081756|NCT02393248|25777996|FG008|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
13081757|NCT02393248|25777997|FG009|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
13081758|NCT02393248|25777998|FG010|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
13081759|NCT02393248|25777999|FG011|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
13081760|NCT02393248|25778000|FG012|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
13081761|NCT02393248|25778001|FG013|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
13081762|NCT02393248|25778002|FG014|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
13081763|NCT02393248|25778003|FG015|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
13081764|NCT02393248|25778004|FG016|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
13081765|NCT02393248|25778005|FG017|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
13081766|NCT02393248|25778006|FG018|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
13081767|NCT02393248|25778007|FG019|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
13081768|NCT02393248|25778008|FG020|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
13081769|NCT02393248|25778009|FG021|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
13081770|NCT02393248|25778010|FG022|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
13081771|NCT02393248|25778011|FG023|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|1|||
13081772|NCT02393248|25778012|FG024|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
13132085|NCT02797678|25981931|FG002|First Intervention (5 Nights)|study/device use non-compliance|0|||
13132086|NCT02797678|25981932|FG003|First Intervention (5 Nights)|study/device use non-compliance|0|||
13132087|NCT02797678|25981929|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0|||
13132088|NCT02797678|25981930|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0|||
13132089|NCT02797678|25981931|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1|||
13132090|NCT02797678|25981932|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0|||
13132091|NCT02797522|25982072|FG000|Overall Study|Study Terminated by Sponsor|0|||
13132092|NCT02797522|25982073|FG001|Overall Study|Study Terminated by Sponsor|0|||
13132093|NCT02797522|25982074|FG002|Overall Study|Study Terminated by Sponsor|0|||
13132094|NCT02797522|25982075|FG003|Overall Study|Study Terminated by Sponsor|0|||
13132095|NCT02797522|25982076|FG004|Overall Study|Study Terminated by Sponsor|0|||
13132096|NCT02797522|25982077|FG005|Overall Study|Study Terminated by Sponsor|0|||
13132097|NCT02797522|25982078|FG006|Overall Study|Study Terminated by Sponsor|0|||
13132098|NCT02797522|25982079|FG007|Overall Study|Study Terminated by Sponsor|4|||
13132099|NCT02797522|25982080|FG008|Overall Study|Study Terminated by Sponsor|2|||
13132100|NCT02797522|25982081|FG009|Overall Study|Study Terminated by Sponsor|4|||
13132101|NCT02797522|25982082|FG010|Overall Study|Study Terminated by Sponsor|1|||
13132102|NCT02797171|25982163|FG000|Overall Study|Lost to Follow-up|2|||
13132103|NCT02797171|25982164|FG001|Overall Study|Lost to Follow-up|0|||
13132104|NCT02797171|25982165|FG002|Overall Study|Lost to Follow-up|2|||
13132105|NCT02797171|25982166|FG003|Overall Study|Lost to Follow-up|1|||
13132106|NCT02797171|25982167|FG004|Overall Study|Lost to Follow-up|2|||
13132107|NCT02797171|25982168|FG005|Overall Study|Lost to Follow-up|0|||
13132108|NCT02797171|25982163|FG000|Overall Study|Withdrawal by Subject|1|||
13132109|NCT02797171|25982164|FG001|Overall Study|Withdrawal by Subject|1|||
13132110|NCT02797171|25982165|FG002|Overall Study|Withdrawal by Subject|0|||
13132111|NCT02797171|25982166|FG003|Overall Study|Withdrawal by Subject|0|||
13132112|NCT02797171|25982167|FG004|Overall Study|Withdrawal by Subject|0|||
13132113|NCT02797171|25982168|FG005|Overall Study|Withdrawal by Subject|0|||
13132114|NCT02797171|25982163|FG000|Overall Study|Protocol Violation|1|||
13132115|NCT02797171|25982164|FG001|Overall Study|Protocol Violation|0|||
13132116|NCT02797171|25982165|FG002|Overall Study|Protocol Violation|0|||
13132117|NCT02797171|25982166|FG003|Overall Study|Protocol Violation|0|||
13132118|NCT02797171|25982167|FG004|Overall Study|Protocol Violation|0|||
13132119|NCT02797171|25982168|FG005|Overall Study|Protocol Violation|0|||
13132120|NCT02797171|25982163|FG000|Overall Study|Participant unable to adhere|0|||
13132121|NCT02797171|25982164|FG001|Overall Study|Participant unable to adhere|1|||
13132122|NCT02797171|25982165|FG002|Overall Study|Participant unable to adhere|0|||
13132123|NCT02797171|25982166|FG003|Overall Study|Participant unable to adhere|0|||
13132124|NCT02797171|25982167|FG004|Overall Study|Participant unable to adhere|0|||
13132125|NCT02797171|25982168|FG005|Overall Study|Participant unable to adhere|0|||
13132126|NCT02797171|25982163|FG000|Overall Study|Not Randomized|0|||
13132127|NCT02797171|25982164|FG001|Overall Study|Not Randomized|0|||
13132128|NCT02797171|25982165|FG002|Overall Study|Not Randomized|0|||
13132129|NCT02797171|25982166|FG003|Overall Study|Not Randomized|0|||
13132130|NCT02797171|25982167|FG004|Overall Study|Not Randomized|0|||
13132131|NCT02797171|25982168|FG005|Overall Study|Not Randomized|1|||
13132132|NCT02797132|25982222|FG000|Part A (15 Days)|Adverse Event|1|||
13132133|NCT02797132|25982222|FG000|Part B (24 Weeks)|Adverse Event|3|||
13132134|NCT02797080|25982228|FG000|Overall Study|Lost to Follow-up|1|||
13132135|NCT02797080|25982228|FG000|Overall Study|Withdrawal by Subject|1|||
13132136|NCT02796963|25982303|FG000|Overall Study|Lost to Follow-up|89|||
13132137|NCT02796963|25982304|FG001|Overall Study|Lost to Follow-up|76|||
13132138|NCT02796963|25982305|FG002|Overall Study|Lost to Follow-up|69|||
13132139|NCT02796963|25982306|FG003|Overall Study|Lost to Follow-up|72|||
13132140|NCT02796755|25982323|FG000|Overall Study|Adverse Event|2|||
13132141|NCT02796755|25982324|FG001|Overall Study|Adverse Event|0|||
13132142|NCT02796677|25982361|FG000|Overall Study|Adverse Event|11|||
13132143|NCT02796677|25982362|FG001|Overall Study|Adverse Event|22|||
13132144|NCT02796677|25982363|FG002|Overall Study|Adverse Event|14|||
13132145|NCT02796677|25982364|FG003|Overall Study|Adverse Event|14|||
13081773|NCT01593254|25778026|FG000|Treatment Period|Treatment Failure|1|||
13081774|NCT01593254|25778027|FG001|Treatment Period|Treatment Failure|2|||
13081775|NCT01593254|25778026|FG000|Treatment Period|Pregnancy|0|||
13081776|NCT01593254|25778027|FG001|Treatment Period|Pregnancy|1|||
13081777|NCT01593254|25778026|FG000|Treatment Period|Poor/Non-Compliance|2|||
13081778|NCT01593254|25778027|FG001|Treatment Period|Poor/Non-Compliance|1|||
13081779|NCT01593254|25778026|FG000|Treatment Period|Maximum clinical benefit|1|||
13081780|NCT01593254|25778027|FG001|Treatment Period|Maximum clinical benefit|0|||
13081781|NCT01593254|25778026|FG000|Treatment Period|Subject withdrew consent|0|||
13081782|NCT01593254|25778027|FG001|Treatment Period|Subject withdrew consent|5|||
13081783|NCT01593254|25778026|FG000|Treatment Period|Subject Request to Discontinue|1|||
13081784|NCT01593254|25778027|FG001|Treatment Period|Subject Request to Discontinue|1|||
13081785|NCT01593254|25778026|FG000|Treatment Period|AE unrelated to Study Drug|0|||
13081786|NCT01593254|25778027|FG001|Treatment Period|AE unrelated to Study Drug|1|||
13081787|NCT01593254|25778026|FG000|Treatment Period|Death|2|||
13081788|NCT01593254|25778027|FG001|Treatment Period|Death|1|||
13081789|NCT01593254|25778026|FG000|Treatment Period|Study Drug Toxicity|3|||
13081790|NCT01593254|25778027|FG001|Treatment Period|Study Drug Toxicity|9|||
13081791|NCT01593254|25778026|FG000|Treatment Period|Disease Progression|1|||
13081792|NCT01593254|25778027|FG001|Treatment Period|Disease Progression|6|||
13081793|NCT01593254|25778026|FG000|Treatment Period|Did Not Achieve RCC|0|||
13081794|NCT01593254|25778027|FG001|Treatment Period|Did Not Achieve RCC|1|||
13081795|NCT01593254|25778026|FG000|Treatment Period|Patient Refused to Return|0|||
13081796|NCT01593254|25778027|FG001|Treatment Period|Patient Refused to Return|1|||
13081797|NCT01593254|25778026|FG000|Treatment Period|No Response|1|||
13081798|NCT01593254|25778027|FG001|Treatment Period|No Response|0|||
13081799|NCT01593254|25778026|FG000|Treatment Period|T315I MUTATION|0|||
13081800|NCT01593254|25778027|FG001|Treatment Period|T315I MUTATION|1|||
13081801|NCT01593254|25778026|FG000|Treatment Period|Investigator Decision|2|||
13081802|NCT01593254|25778027|FG001|Treatment Period|Investigator Decision|1|||
13081803|NCT01593254|25778026|FG000|Follow-Up Period|Withdrawal by Subject|0|||
13081804|NCT01593254|25778027|FG001|Follow-Up Period|Withdrawal by Subject|2|||
13081805|NCT01593254|25778026|FG000|Follow-Up Period|Non-Compliance|1|||
13081806|NCT01593254|25778027|FG001|Follow-Up Period|Non-Compliance|0|||
13081807|NCT01593254|25778026|FG000|Follow-Up Period|Death|2|||
13081808|NCT01593254|25778027|FG001|Follow-Up Period|Death|2|||
13081809|NCT01593254|25778026|FG000|Follow-Up Period|Subject request to Discontinue|0|||
13081810|NCT01593254|25778027|FG001|Follow-Up Period|Subject request to Discontinue|1|||
13081811|NCT01593254|25778026|FG000|Follow-Up Period|Pregnancy|0|||
13081812|NCT01593254|25778027|FG001|Follow-Up Period|Pregnancy|1|||
13081813|NCT01593254|25778026|FG000|Follow-Up Period|Study Drug Toxicity|0|||
13081814|NCT01593254|25778027|FG001|Follow-Up Period|Study Drug Toxicity|1|||
13081815|NCT01593254|25778026|FG000|Follow-Up Period|Patient refused to return|0|||
13081816|NCT01593254|25778027|FG001|Follow-Up Period|Patient refused to return|1|||
13081817|NCT01593254|25778026|FG000|Follow-Up Period|Fundus Hemorrhage|0|||
13081818|NCT01593254|25778027|FG001|Follow-Up Period|Fundus Hemorrhage|1|||
13081819|NCT01593254|25778026|FG000|Follow-Up Period|Disease Progression|0|||
13081820|NCT01593254|25778027|FG001|Follow-Up Period|Disease Progression|1|||
13081821|NCT01593254|25778026|FG000|Follow-Up Period|Study Drug Side Effects|0|||
13081822|NCT01593254|25778027|FG001|Follow-Up Period|Study Drug Side Effects|1|||
13081823|NCT01005914|25778039|FG000|Overall Study|Adverse Event|4|||
13081824|NCT01005914|25778039|FG000|Overall Study|Death|4|||
13081825|NCT01005914|25778039|FG000|Overall Study|Lack of Efficacy|1|||
13081826|NCT01005914|25778039|FG000|Overall Study|Withdrawal by Subject|1|||
13081827|NCT00312728|25778050|FG000|Overall Study|Progressive disease|53|||
13081828|NCT00312728|25778050|FG000|Overall Study|Adverse Event|32|||
13081829|NCT00312728|25778050|FG000|Overall Study|Withdrawal by Subject|10|||
13081830|NCT00312728|25778050|FG000|Overall Study|Required non-protocol cancer treatment|2|||
13081831|NCT00312728|25778050|FG000|Overall Study|Protocol Violation|2|||
13081832|NCT00312728|25778050|FG000|Overall Study|Other|10|||
13081833|NCT00312728|25778050|FG000|Overall Study|Other|1|||
13132146|NCT02796677|25982361|FG000|Overall Study|Protocol Violation|7|||
13132147|NCT02796677|25982362|FG001|Overall Study|Protocol Violation|5|||
13132148|NCT02796677|25982363|FG002|Overall Study|Protocol Violation|4|||
13132149|NCT02796677|25982364|FG003|Overall Study|Protocol Violation|8|||
13132150|NCT02796677|25982361|FG000|Overall Study|Lost to Follow-up|1|||
13132151|NCT02796677|25982362|FG001|Overall Study|Lost to Follow-up|5|||
13132152|NCT02796677|25982363|FG002|Overall Study|Lost to Follow-up|2|||
13132153|NCT02796677|25982364|FG003|Overall Study|Lost to Follow-up|2|||
13132154|NCT02796677|25982361|FG000|Overall Study|Lack of Efficacy|7|||
13132155|NCT02796677|25982362|FG001|Overall Study|Lack of Efficacy|9|||
13132156|NCT02796677|25982363|FG002|Overall Study|Lack of Efficacy|14|||
13132157|NCT02796677|25982364|FG003|Overall Study|Lack of Efficacy|20|||
13132158|NCT02796677|25982361|FG000|Overall Study|Withdrawal by Subject|4|||
13132159|NCT02796677|25982362|FG001|Overall Study|Withdrawal by Subject|14|||
13132160|NCT02796677|25982363|FG002|Overall Study|Withdrawal by Subject|6|||
13132161|NCT02796677|25982364|FG003|Overall Study|Withdrawal by Subject|7|||
13081834|NCT05594173|25779545|FG000|Overall Study|Adverse Event|1|||
13081835|NCT05594173|25779545|FG000|Overall Study|COVID-19 Pandemic|2|||
13081836|NCT05405244|25779570|FG000|Washout (2 Weeks)|Lost to Follow-up|0|||
13081837|NCT05405244|25779571|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
13081838|NCT05405244|25779570|FG000|Washout (2 Weeks)|Adverse Event|2|||
13081839|NCT05405244|25779571|FG001|Washout (2 Weeks)|Adverse Event|0|||
13081840|NCT05405244|25779570|FG000|Washout (2 Weeks)|Withdrawal by Subject|2|||
13081841|NCT05405244|25779571|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
13081842|NCT05283499|25779606|FG000|Overall Study|Did not receive intervention|1|||
13081843|NCT05283499|25779607|FG001|Overall Study|Did not receive intervention|2|||
13081844|NCT05271175|25779733|FG000|One Week Follow up|Lost to Follow-up|10|||
13081845|NCT05271175|25779734|FG001|One Week Follow up|Lost to Follow-up|7|||
13081846|NCT05271175|25779735|FG002|One Week Follow up|Lost to Follow-up|5|||
13081847|NCT05271175|25779733|FG000|One Month Follow up|Lost to Follow-up|12|||
13081848|NCT05271175|25779734|FG001|One Month Follow up|Lost to Follow-up|7|||
13081849|NCT05271175|25779735|FG002|One Month Follow up|Lost to Follow-up|9|||
13081850|NCT05271175|25779733|FG000|Six Months Follow up|Lost to Follow-up|8|||
13081851|NCT05271175|25779734|FG001|Six Months Follow up|Lost to Follow-up|2|||
13081852|NCT05271175|25779735|FG002|Six Months Follow up|Lost to Follow-up|2|||
13081853|NCT05000164|25779741|FG000|Overall Study|Adverse Event|1|||
13081854|NCT05000164|25779741|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
13081855|NCT05000164|25779741|FG000|Overall Study|Lens Discomfort|3|||
13081856|NCT05000164|25779741|FG000|Overall Study|Withdrew Consent during Study|2|||
13081857|NCT05000164|25779741|FG000|Overall Study|Subject Withdrawn by PI|2|||
13081858|NCT05000164|25779741|FG000|Overall Study|Other Fractured Test Article|1|||
13081859|NCT04647721|25779756|FG000|Overall Study|Withdrawal by Subject|0|||
13081860|NCT04647721|25779757|FG001|Overall Study|Withdrawal by Subject|2|||
13081861|NCT04647721|25779756|FG000|Overall Study|Lost to Follow-up|2|||
13081862|NCT04647721|25779757|FG001|Overall Study|Lost to Follow-up|0|||
13081863|NCT03761797|25779877|FG000|Overall Study|Changing hospital|11|||
13081864|NCT03761797|25779877|FG000|Overall Study|Improvement/remission|6|||
13081865|NCT03761797|25779877|FG000|Overall Study|Withdrawal by Subject|19|||
13081866|NCT03761797|25779877|FG000|Overall Study|Lost to Follow-up|33|||
13081867|NCT03761797|25779877|FG000|Overall Study|Adverse Event|37|||
13081868|NCT03761797|25779877|FG000|Overall Study|Case report form (CRF) not collected|5|||
13081869|NCT03761797|25779877|FG000|Overall Study|No patient visit after entry|13|||
13081870|NCT03761797|25779877|FG000|Overall Study|Switch to other diabetes medication|10|||
13081871|NCT03761797|25779877|FG000|Overall Study|Prevention for recurrence of cystitis|1|||
13081872|NCT03761797|25779877|FG000|Overall Study|Postoperative therapy of esophageal cancer|1|||
13081873|NCT03761797|25779877|FG000|Overall Study|Insufficient effectives|2|||
13081874|NCT03761797|25779877|FG000|Overall Study|Excessive alcohol intake|1|||
13081875|NCT03493854|25779902|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3|||
13081876|NCT03493854|25779903|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5|||
13081877|NCT03493854|25779902|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
13081878|NCT03493854|25779903|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
13081879|NCT03493854|25779902|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0|||
13081880|NCT03493854|25779903|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1|||
13081881|NCT03493854|25779902|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1|||
13081882|NCT03493854|25779903|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2|||
13081883|NCT03493854|25779902|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
13081884|NCT03493854|25779903|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
13081885|NCT03493854|25779902|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
13081886|NCT03493854|25779903|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2|||
13081887|NCT03493854|25779902|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
13081888|NCT03493854|25779903|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0|||
13081889|NCT03493854|25779902|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Ongoing Adjuvant Treatment|229|||
13081890|NCT03493854|25779903|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Ongoing Adjuvant Treatment|228|||
13081891|NCT03493854|25779902|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|2|||
13081892|NCT03493854|25779903|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|2|||
13081893|NCT03493854|25779902|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0|||
13081894|NCT03493854|25779903|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|1|||
13081895|NCT03493854|25779902|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|3|||
13081896|NCT03493854|25779903|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0|||
13081897|NCT03493854|25779902|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Protocol Violation|1|||
13081898|NCT03493854|25779903|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Protocol Violation|0|||
13081899|NCT03493854|25779902|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
13081900|NCT03493854|25779903|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|0|||
13081901|NCT03493854|25779902|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|5|||
13081902|NCT03493854|25779903|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|3|||
13081903|NCT03493854|25779902|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|1|||
13081904|NCT03493854|25779903|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|1|||
13081905|NCT03493854|25779902|FG000|Treatment-Free Follow-Up (up to 3 Years)|Ongoing in Follow-Up|18|||
13081906|NCT03493854|25779903|FG001|Treatment-Free Follow-Up (up to 3 Years)|Ongoing in Follow-Up|16|||
13132162|NCT02796677|25982361|FG000|Overall Study|Progressive disease|6|||
13132163|NCT02796677|25982362|FG001|Overall Study|Progressive disease|15|||
13132164|NCT02796677|25982363|FG002|Overall Study|Progressive disease|13|||
13132165|NCT02796677|25982364|FG003|Overall Study|Progressive disease|18|||
13132166|NCT02796677|25982361|FG000|Overall Study|Reason not mentioned|2|||
13132167|NCT02796677|25982362|FG001|Overall Study|Reason not mentioned|3|||
13132168|NCT02796677|25982363|FG002|Overall Study|Reason not mentioned|0|||
13132169|NCT02796677|25982364|FG003|Overall Study|Reason not mentioned|5|||
13132170|NCT02796664|25982387|FG000|Overall Study|Withdrawal by Subject|0|||
13132171|NCT02796664|25982388|FG001|Overall Study|Withdrawal by Subject|3|||
13132172|NCT02796664|25982387|FG000|Overall Study|Noncompliance|1|||
13132173|NCT02796664|25982388|FG001|Overall Study|Noncompliance|1|||
13132174|NCT02796664|25982387|FG000|Overall Study|Death|0|||
13132175|NCT02796664|25982388|FG001|Overall Study|Death|1|||
13132176|NCT02796651|25982419|FG000|Overall Study|Adverse Event|6|||
13132177|NCT02796651|25982419|FG000|Overall Study|Lost to Follow-up|1|||
13132178|NCT02796651|25982419|FG000|Overall Study|Withdrawal by Subject|4|||
13132179|NCT02796651|25982419|FG000|Overall Study|Protocol Violation|4|||
13132180|NCT02796651|25982419|FG000|Overall Study|Lack of Efficacy|1|||
13132181|NCT02796651|25982419|FG000|Overall Study|Other|10|||
13132182|NCT02796560|25982434|FG000|Overall Study|Adverse Event|2|||
13132183|NCT02796560|25982435|FG001|Overall Study|Adverse Event|0|||
13132184|NCT02796560|25982434|FG000|Overall Study|Withdrawal by Subject|2|||
13132185|NCT02796560|25982435|FG001|Overall Study|Withdrawal by Subject|2|||
13132186|NCT02796391|25982472|FG000|Overall Study|Lost to Follow-up|2|||
13132187|NCT02796391|25982473|FG001|Overall Study|Lost to Follow-up|2|||
13132188|NCT02796391|25982474|FG002|Overall Study|Lost to Follow-up|13|||
13132189|NCT02796391|25982475|FG003|Overall Study|Lost to Follow-up|8|||
13132190|NCT02796391|25982476|FG004|Overall Study|Lost to Follow-up|14|||
13132191|NCT02796391|25982477|FG005|Overall Study|Lost to Follow-up|13|||
13132192|NCT02796391|25982472|FG000|Overall Study|COVID|0|||
13132193|NCT02796391|25982473|FG001|Overall Study|COVID|0|||
13132194|NCT02796391|25982474|FG002|Overall Study|COVID|5|||
13132195|NCT02796391|25982475|FG003|Overall Study|COVID|5|||
13132196|NCT02796391|25982476|FG004|Overall Study|COVID|2|||
13132197|NCT02796391|25982477|FG005|Overall Study|COVID|4|||
13222441|NCT01806597|26286267|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1|||
13222442|NCT01806597|26286268|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0|||
13222443|NCT01806597|26286269|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0|||
13222444|NCT01806597|26286270|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0|||
13222445|NCT01806597|26286271|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0|||
13222446|NCT01806597|26286266|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9|||
13222447|NCT01806597|26286267|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6|||
13222448|NCT01806597|26286268|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4|||
13132198|NCT02796391|25982472|FG000|Overall Study|Participant did not like study cigarettes|0|||
13132199|NCT02796391|25982473|FG001|Overall Study|Participant did not like study cigarettes|0|||
13132200|NCT02796391|25982474|FG002|Overall Study|Participant did not like study cigarettes|3|||
13132201|NCT02796391|25982475|FG003|Overall Study|Participant did not like study cigarettes|0|||
13132202|NCT02796391|25982476|FG004|Overall Study|Participant did not like study cigarettes|0|||
13132203|NCT02796391|25982477|FG005|Overall Study|Participant did not like study cigarettes|0|||
13132204|NCT02796391|25982472|FG000|Overall Study|Withdrawal by Subject|1|||
13132205|NCT02796391|25982473|FG001|Overall Study|Withdrawal by Subject|1|||
13132206|NCT02796391|25982474|FG002|Overall Study|Withdrawal by Subject|4|||
13132207|NCT02796391|25982475|FG003|Overall Study|Withdrawal by Subject|3|||
13132208|NCT02796391|25982476|FG004|Overall Study|Withdrawal by Subject|4|||
13132209|NCT02796391|25982477|FG005|Overall Study|Withdrawal by Subject|3|||
13132210|NCT02796391|25982472|FG000|Overall Study|Adverse Event|0|||
13132211|NCT02796391|25982473|FG001|Overall Study|Adverse Event|0|||
13132212|NCT02796391|25982474|FG002|Overall Study|Adverse Event|0|||
13132213|NCT02796391|25982475|FG003|Overall Study|Adverse Event|1|||
13132214|NCT02796391|25982476|FG004|Overall Study|Adverse Event|0|||
13132215|NCT02796391|25982477|FG005|Overall Study|Adverse Event|0|||
13132216|NCT02796391|25982472|FG000|Overall Study|Protocol Violation|0|||
13132217|NCT02796391|25982473|FG001|Overall Study|Protocol Violation|0|||
13132218|NCT02796391|25982474|FG002|Overall Study|Protocol Violation|0|||
13132219|NCT02796391|25982475|FG003|Overall Study|Protocol Violation|1|||
13132220|NCT02796391|25982476|FG004|Overall Study|Protocol Violation|0|||
13132221|NCT02796391|25982477|FG005|Overall Study|Protocol Violation|0|||
13132222|NCT02795832|25982530|FG000|Overall Study|Adverse Event|0|||
13132223|NCT02795832|25982531|FG001|Overall Study|Adverse Event|0|||
13132224|NCT02795832|25982532|FG002|Overall Study|Adverse Event|0|||
13132225|NCT02795832|25982533|FG003|Overall Study|Adverse Event|0|||
13132226|NCT02795832|25982534|FG004|Overall Study|Adverse Event|0|||
13222449|NCT01806597|26286269|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3|||
13081907|NCT03176784|25779938|FG000|Overall Study|Lost to Follow-up|77|||
13081908|NCT03176784|25779939|FG001|Overall Study|Lost to Follow-up|79|||
13081909|NCT03176784|25779940|FG002|Overall Study|Lost to Follow-up|79|||
13081910|NCT03176784|25779941|FG003|Overall Study|Lost to Follow-up|49|||
13081911|NCT03176784|25779938|FG000|Overall Study|Withdrawal by Subject|28|||
13081912|NCT03176784|25779939|FG001|Overall Study|Withdrawal by Subject|34|||
13081913|NCT03176784|25779940|FG002|Overall Study|Withdrawal by Subject|34|||
13081914|NCT03176784|25779941|FG003|Overall Study|Withdrawal by Subject|21|||
13081915|NCT02657434|25780088|FG000|Overall Study|On-Going in Study|77|||
13081916|NCT02657434|25780089|FG001|Overall Study|On-Going in Study|91|||
13081917|NCT02657434|25780088|FG000|Overall Study|Death|177|||
13081918|NCT02657434|25780089|FG001|Overall Study|Death|183|||
13081919|NCT02657434|25780088|FG000|Overall Study|Lost to Follow-up|2|||
13081920|NCT02657434|25780089|FG001|Overall Study|Lost to Follow-up|2|||
13081921|NCT02657434|25780088|FG000|Overall Study|Randomization by Error|2|||
13081922|NCT02657434|25780089|FG001|Overall Study|Randomization by Error|0|||
13081923|NCT02657434|25780088|FG000|Overall Study|Withdrawal by Subject|27|||
13081924|NCT02657434|25780089|FG001|Overall Study|Withdrawal by Subject|16|||
13081925|NCT02657434|25780088|FG000|Overall Study|Protocol Violation|1|||
13081926|NCT02657434|25780089|FG001|Overall Study|Protocol Violation|0|||
13081927|NCT02606461|25780153|FG000|Period 1: Double-blinded Period|Randomized but no treatment|0|||
13081928|NCT02606461|25780154|FG001|Period 1: Double-blinded Period|Randomized but no treatment|0|||
13081929|NCT02606461|25780155|FG002|Period 1: Double-blinded Period|Randomized but no treatment|1|||
13081930|NCT02606461|25780156|FG003|Period 1: Double-blinded Period|Randomized but no treatment|0|||
13081931|NCT02606461|25780157|FG004|Period 1: Double-blinded Period|Randomized but no treatment|0|||
13081932|NCT02606461|25780158|FG005|Period 1: Double-blinded Period|Randomized but no treatment|0|||
13081933|NCT02593123|25780189|FG000|Overall Study|Physician Decision|2|||
13081934|NCT02593123|25780190|FG001|Overall Study|Physician Decision|1|||
13081935|NCT02593123|25780189|FG000|Overall Study|Relapse|1|||
13081936|NCT02593123|25780190|FG001|Overall Study|Relapse|1|||
13081937|NCT02527434|25780258|FG000|Overall Study|Lost to Follow-up|2|||
13081938|NCT02527434|25780259|FG001|Overall Study|Lost to Follow-up|2|||
13081939|NCT02527434|25780260|FG002|Overall Study|Lost to Follow-up|0|||
13081940|NCT02527434|25780258|FG000|Overall Study|Death|19|||
13081941|NCT02527434|25780259|FG001|Overall Study|Death|6|||
13081942|NCT02527434|25780260|FG002|Overall Study|Death|17|||
13081943|NCT02527434|25780258|FG000|Overall Study|Withdrawal by Subject|5|||
13081944|NCT02527434|25780259|FG001|Overall Study|Withdrawal by Subject|3|||
13081945|NCT02527434|25780260|FG002|Overall Study|Withdrawal by Subject|3|||
13081946|NCT02527434|25780258|FG000|Overall Study|Reason Not Specified|1|||
13081947|NCT02527434|25780259|FG001|Overall Study|Reason Not Specified|0|||
13081948|NCT02527434|25780260|FG002|Overall Study|Reason Not Specified|0|||
13081949|NCT02527434|25780258|FG000|Overall Study|Site closure|1|||
13081950|NCT02527434|25780259|FG001|Overall Study|Site closure|0|||
13081951|NCT02527434|25780260|FG002|Overall Study|Site closure|0|||
13081952|NCT02493426|25780273|FG000|Overall Study|Withdrawal by Subject|0|||
13081953|NCT02493426|25780274|FG001|Overall Study|Withdrawal by Subject|1|||
13081954|NCT02197572|25780293|FG000|Overall Study|Progressive Disease|28|||
13081955|NCT02197572|25780293|FG000|Overall Study|Withdrawal by Subject|9|||
13081956|NCT02197572|25780293|FG000|Overall Study|Adverse Event|3|||
13081957|NCT02197572|25780293|FG000|Overall Study|Reason Not Specified|4|||
13081958|NCT01446016|25780302|FG000|Overall Study|Lost to Follow-up|3|||
13081959|NCT01446016|25780302|FG000|Overall Study|Withdrawal by Subject|1|||
13081960|NCT01446016|25780302|FG000|Overall Study|Toxicity|3|||
13081961|NCT01028716|25780319|FG000|Overall Study|Physician Decision|1|||
13081962|NCT05244122|25780356|FG000|Overall Study|Withdrawal by Subject|318|||
13081963|NCT05200455|25780363|FG000|Overall Study|These patients were not implanted with intracranial electrodes for clinical reasons .|4|||
13081964|NCT05096312|25780382|FG000|Overall Study|Lost to Follow-up|2|||
13081965|NCT05096312|25780383|FG001|Overall Study|Lost to Follow-up|4|||
13081966|NCT05096312|25780382|FG000|Overall Study|Adverse Event|1|||
13081967|NCT05096312|25780383|FG001|Overall Study|Adverse Event|0|||
13081968|NCT05091528|25780412|FG000|Overall Study|Study Termination by Sponsor|0|||
13081969|NCT05091528|25780413|FG001|Overall Study|Study Termination by Sponsor|1|||
13081970|NCT05091528|25780414|FG002|Overall Study|Study Termination by Sponsor|0|||
13081971|NCT05091528|25780415|FG003|Overall Study|Study Termination by Sponsor|1|||
13081972|NCT05085665|25780421|FG000|Overall Study|Physician Decision|2|||
13081973|NCT05050318|25780439|FG000|Overall Study|Protocol Deviation|1|||
13081974|NCT05050318|25780440|FG001|Overall Study|Protocol Deviation|0|||
13081975|NCT05050318|25780441|FG002|Overall Study|Protocol Deviation|0|||
13081976|NCT05017493|25780460|FG000|Overall Study|Withdrawal by Subject|26|||
13081977|NCT05017493|25780461|FG001|Overall Study|Withdrawal by Subject|0|||
13081978|NCT05017493|25780460|FG000|Overall Study|Physician Decision|15|||
13081979|NCT05017493|25780461|FG001|Overall Study|Physician Decision|0|||
13081980|NCT05017493|25780460|FG000|Overall Study|Protocol Violation|81|||
13081981|NCT05017493|25780461|FG001|Overall Study|Protocol Violation|0|||
13081982|NCT05002985|25780478|FG000|Overall Study|Withdrawal by Subject|1|||
13081983|NCT05002972|25780502|FG000|Overall Study|Withdrawal by Subject|2|||
13081984|NCT04993339|25780519|FG000|Overall Study|Lost to Follow-up|0|||
13081985|NCT04993339|25780520|FG001|Overall Study|Lost to Follow-up|1|||
13081986|NCT04993339|25780519|FG000|Overall Study|no MRI scan|3|||
13081987|NCT04993339|25780520|FG001|Overall Study|no MRI scan|1|||
13081988|NCT04980040|25780533|FG000|Overall Study|Violated the Inclusion Criteria|260|||
13081989|NCT04980040|25780533|FG000|Overall Study|Violated the Administration & Dosage|225|||
13081990|NCT04980040|25780533|FG000|Overall Study|Lost to Safety-Follow-up|4|||
13081991|NCT04980040|25780533|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3|||
13081992|NCT04974697|25780547|FG000|Overall Study|Unsatisfactory lens fitting due to test article|1|||
13081993|NCT04974697|25780547|FG000|Overall Study|Lens discomfort|1|||
13081994|NCT04960228|25780560|FG000|Overall Study|Withdrawal by Subject|216|||
13081995|NCT04960228|25780561|FG001|Overall Study|Withdrawal by Subject|35|||
13081996|NCT04960228|25780560|FG000|Overall Study|Failed attention check|69|||
13081997|NCT04960228|25780561|FG001|Overall Study|Failed attention check|148|||
13081998|NCT04960228|25780560|FG000|Overall Study|Flagged for response quality by Dynata|3|||
13081999|NCT04960228|25780561|FG001|Overall Study|Flagged for response quality by Dynata|3|||
13082000|NCT04952701|25780569|FG000|Control Lens|Physician Decision|4|||
13082001|NCT04952701|25780569|FG000|Test Lens|Physician Decision|1|||
13082002|NCT04947436|25780590|FG000|Overall Study|Lost to Follow-up|3|||
13082003|NCT04947436|25780591|FG001|Overall Study|Lost to Follow-up|7|||
13082004|NCT04947436|25780592|FG002|Overall Study|Lost to Follow-up|5|||
13082005|NCT04947436|25780590|FG000|Overall Study|Death|1|||
13082006|NCT04947436|25780591|FG001|Overall Study|Death|1|||
13082007|NCT04947436|25780592|FG002|Overall Study|Death|1|||
13132227|NCT02795832|25982535|FG005|Overall Study|Adverse Event|3|||
13132228|NCT02795767|25982694|FG000|Overall Study|Received Commercial Emicizumab|1|||
13132229|NCT02795767|25982695|FG001|Overall Study|Received Commercial Emicizumab|0|||
13132230|NCT02795767|25982696|FG002|Overall Study|Received Commercial Emicizumab|0|||
13132231|NCT02794974|25982717|FG000|Overall Study|Physician Decision|0|||
13132232|NCT02794974|25982718|FG001|Overall Study|Physician Decision|1|||
13132233|NCT02794883|25982748|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0|||
13132234|NCT02794883|25982749|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0|||
13132235|NCT02794883|25982750|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1|||
13132236|NCT02794883|25982748|FG000|Pre-Surgical Treatment|Progressive Disease|0|||
13132237|NCT02794883|25982749|FG001|Pre-Surgical Treatment|Progressive Disease|1|||
13132238|NCT02794883|25982750|FG002|Pre-Surgical Treatment|Progressive Disease|0|||
13132239|NCT02794883|25982748|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1|||
13132240|NCT02794883|25982749|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4|||
13132241|NCT02794883|25982750|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0|||
13132242|NCT02794883|25982748|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1|||
13132243|NCT02794883|25982749|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
13132244|NCT02794883|25982750|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
13132245|NCT02794883|25982748|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
13132246|NCT02794883|25982749|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6|||
13132247|NCT02794883|25982750|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
13132248|NCT02794883|25982748|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0|||
13132249|NCT02794883|25982749|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
13132250|NCT02794883|25982750|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
13132251|NCT02794883|25982748|FG000|Follow-up Period (up to 2 Years)|Death|12|||
13132252|NCT02794883|25982749|FG001|Follow-up Period (up to 2 Years)|Death|10|||
13132253|NCT02794883|25982750|FG002|Follow-up Period (up to 2 Years)|Death|10|||
13132254|NCT02794870|25982783|FG000|Overall Study|Withdrawal by Subject|2|||
13132255|NCT02794870|25982784|FG001|Overall Study|Withdrawal by Subject|0|||
13132256|NCT02794480|25982811|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
13132257|NCT02794480|25982812|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
13132258|NCT02794480|25982813|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1|||
13132259|NCT02794480|25982814|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
13132260|NCT02794480|25982811|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
13132261|NCT02794480|25982812|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
13132262|NCT02794480|25982813|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1|||
13132263|NCT02794480|25982814|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
13132264|NCT02794480|25982811|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
13132265|NCT02794480|25982812|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
13132266|NCT02794480|25982813|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
13132267|NCT02794480|25982814|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2|||
13132268|NCT02794480|25982811|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
13132269|NCT02794480|25982812|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2|||
13132270|NCT02794480|25982813|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
13132271|NCT02794480|25982814|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
13132272|NCT02794480|25982811|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
13082008|NCT04942925|25780608|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
13082009|NCT04942925|25780609|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
13082010|NCT04942925|25780608|FG000|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
13082011|NCT04942925|25780609|FG001|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
13082012|NCT04919317|25780670|FG000|Hospitalization and Wound Follow-up|Protocol Violation|0|||
13082013|NCT04919317|25780671|FG001|Hospitalization and Wound Follow-up|Protocol Violation|5|||
13082014|NCT04919317|25780670|FG000|SF-36 Quality of Life Survey Completion|Lost to Follow-up|12|||
13082015|NCT04919317|25780671|FG001|SF-36 Quality of Life Survey Completion|Lost to Follow-up|6|||
13082016|NCT04919161|25780710|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1|||
13082017|NCT04919161|25780711|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0|||
13082018|NCT04919161|25780710|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0|||
13082019|NCT04919161|25780711|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1|||
13082020|NCT04919161|25780710|FG000|Overall Study|Acute ankle sprain after session 1|0|||
13082021|NCT04919161|25780711|FG001|Overall Study|Acute ankle sprain after session 1|1|||
13082022|NCT04908488|25780727|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
13082023|NCT04908488|25780728|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
13082024|NCT04908488|25780727|FG000|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
13082025|NCT04908488|25780728|FG001|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
13082026|NCT04899232|25780776|FG000|Screening Period|Physician Decision|1|||
13082027|NCT04899232|25780777|FG001|Screening Period|Physician Decision|0|||
13082028|NCT04899232|25780778|FG002|Screening Period|Physician Decision|0|||
13082029|NCT04899232|25780776|FG000|Screening Period|Withdrawal by Subject|1|||
13082030|NCT04899232|25780777|FG001|Screening Period|Withdrawal by Subject|0|||
13082031|NCT04899232|25780778|FG002|Screening Period|Withdrawal by Subject|0|||
13082032|NCT04899232|25780776|FG000|Screening Period|Participant discharged before receiving intervention|3|||
13082033|NCT04899232|25780777|FG001|Screening Period|Participant discharged before receiving intervention|0|||
13082034|NCT04899232|25780778|FG002|Screening Period|Participant discharged before receiving intervention|0|||
13082035|NCT04889625|25780789|FG000|Period 1|Subject did not meet eligibility criteria and was enrolled by error|2|||
13082036|NCT04889625|25780790|FG001|Period 1|Subject did not meet eligibility criteria and was enrolled by error|1|||
13082037|NCT04889625|25780789|FG000|Period 1|Subject out of window|0|||
13082038|NCT04889625|25780790|FG001|Period 1|Subject out of window|1|||
13082039|NCT04889625|25780789|FG000|Period 1|Wrong add power dispensed|0|||
13082040|NCT04889625|25780790|FG001|Period 1|Wrong add power dispensed|1|||
13082041|NCT04889625|25780789|FG000|Period 1|Discontinued due to fitting guide error|1|||
13082042|NCT04889625|25780790|FG001|Period 1|Discontinued due to fitting guide error|1|||
13082043|NCT04889625|25780789|FG000|Period 2|Test article no longer available|1|||
13082044|NCT04889625|25780790|FG001|Period 2|Test article no longer available|0|||
13082045|NCT04889625|25780789|FG000|Period 2|Incorrect lens dispensed|1|||
13082046|NCT04889625|25780790|FG001|Period 2|Incorrect lens dispensed|0|||
13082047|NCT04889625|25780789|FG000|Period 2|Wrong add power dispensed|0|||
13082048|NCT04889625|25780790|FG001|Period 2|Wrong add power dispensed|1|||
13082049|NCT04885296|25780803|FG000|Period 1|Covid-19 Related|1|||
13082050|NCT04885296|25780804|FG001|Period 1|Covid-19 Related|0|||
13082051|NCT04885296|25780803|FG000|Period 1|Adverse Event|0|||
13082052|NCT04885296|25780804|FG001|Period 1|Adverse Event|1|||
13082053|NCT04885296|25780803|FG000|Period 1|Withdrawal by Subject|1|||
13082054|NCT04885296|25780804|FG001|Period 1|Withdrawal by Subject|1|||
13082055|NCT04885296|25780803|FG000|Period 1|Test Article No Longer Available|1|||
13082056|NCT04885296|25780804|FG001|Period 1|Test Article No Longer Available|0|||
13082057|NCT04885296|25780803|FG000|Period 1|Dispensed Study lens in Error|1|||
13082058|NCT04885296|25780804|FG001|Period 1|Dispensed Study lens in Error|0|||
13082059|NCT04885296|25780803|FG000|Period 1|Lost to Follow-up|1|||
13082060|NCT04885296|25780804|FG001|Period 1|Lost to Follow-up|0|||
13082061|NCT04885296|25780803|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
13082062|NCT04885296|25780804|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
13082063|NCT04883541|25780823|FG000|Overall Study|Not attending regular yoga class|16|||
13082064|NCT04883541|25780824|FG001|Overall Study|Not attending regular yoga class|0|||
13082065|NCT04883541|25780823|FG000|Overall Study|Not attending the pregnancy school|0|||
13082066|NCT04883541|25780824|FG001|Overall Study|Not attending the pregnancy school|9|||
13082067|NCT04882995|25780839|FG000|Overall Study|Withdrawal by Subject|1|||
13082068|NCT04882995|25780840|FG001|Overall Study|Withdrawal by Subject|2|||
13082069|NCT04882995|25780839|FG000|Overall Study|Protocol Violation|4|||
13082070|NCT04882995|25780840|FG001|Overall Study|Protocol Violation|4|||
13082071|NCT04882995|25780839|FG000|Overall Study|Surgery postponed due to COVID|1|||
13082072|NCT04882995|25780840|FG001|Overall Study|Surgery postponed due to COVID|1|||
13082073|NCT04876274|25780859|FG000|Overall Study|Lost to Follow-up|9|||
13082074|NCT04876274|25780860|FG001|Overall Study|Lost to Follow-up|12|||
13082075|NCT04865354|25780876|FG000|First Wear Period (8 Days)|Withdrawal by Subject|1|||
13082076|NCT04865354|25780877|FG001|First Wear Period (8 Days)|Withdrawal by Subject|0|||
13082077|NCT04865354|25780876|FG000|First Wear Period (8 Days)|Lost to Follow-up|0|||
13082078|NCT04865354|25780877|FG001|First Wear Period (8 Days)|Lost to Follow-up|1|||
13082079|NCT04865354|25780876|FG000|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|1|||
13082080|NCT04865354|25780877|FG001|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|0|||
13082081|NCT04860518|25780890|FG000|Overall Study|Screen Failure, patient was not dosed|1|||
13082082|NCT04860518|25780891|FG001|Overall Study|Screen Failure, patient was not dosed|1|||
13082083|NCT04860258|25781027|FG000|Overall Study|Withdrawal by Subject|0|||
13082084|NCT04860258|25781028|FG001|Overall Study|Withdrawal by Subject|0|||
13082085|NCT04860258|25781029|FG002|Overall Study|Withdrawal by Subject|4|||
13082086|NCT04860258|25781030|FG003|Overall Study|Withdrawal by Subject|1|||
13082087|NCT04860258|25781031|FG004|Overall Study|Withdrawal by Subject|4|||
13082088|NCT04860258|25781032|FG005|Overall Study|Withdrawal by Subject|1|||
13082089|NCT04860258|25781033|FG006|Overall Study|Withdrawal by Subject|0|||
13082090|NCT04854707|25781071|FG000|Overall Study|Lack of Efficacy|78|||
13082091|NCT04854707|25781072|FG001|Overall Study|Lack of Efficacy|59|||
13082092|NCT04854707|25781073|FG002|Overall Study|Lack of Efficacy|30|||
13082093|NCT04851314|25781090|FG000|Overall Study|Unable to complete research set-up procedures|0|||
13082094|NCT04851314|25781091|FG001|Overall Study|Unable to complete research set-up procedures|2|||
13082095|NCT04851314|25781090|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3|||
13082096|NCT04851314|25781091|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2|||
13082097|NCT04849780|25781114|FG000|Period 1|Covid-19 Related|1|||
13082098|NCT04849780|25781115|FG001|Period 1|Covid-19 Related|0|||
13082099|NCT04849780|25781114|FG000|Period 1|Subject no longer meet eligibility criteria|3|||
13082100|NCT04849780|25781115|FG001|Period 1|Subject no longer meet eligibility criteria|0|||
13082101|NCT04849780|25781114|FG000|Period 2|Subject no longer meet eligibility criteria|2|||
13082102|NCT04849780|25781115|FG001|Period 2|Subject no longer meet eligibility criteria|0|||
13082103|NCT04848662|25781136|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1|||
13082104|NCT04848662|25781137|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0|||
13082105|NCT04841577|25781176|FG000|Overall Study|Adverse Event|5|||
13082106|NCT04841577|25781177|FG001|Overall Study|Adverse Event|10|||
13082107|NCT04841577|25781176|FG000|Overall Study|Lost to Follow-up|8|||
13082108|NCT04841577|25781177|FG001|Overall Study|Lost to Follow-up|7|||
13082109|NCT04841577|25781176|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
13082110|NCT04841577|25781177|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|8|||
13082111|NCT04841577|25781176|FG000|Overall Study|Other|0|||
13082112|NCT04841577|25781177|FG001|Overall Study|Other|1|||
13082113|NCT04837807|25781190|FG000|First Sequence (Week 1)|Withdrawal by Subject|0|||
13082114|NCT04837807|25781191|FG001|First Sequence (Week 1)|Withdrawal by Subject|1|||
13082115|NCT04823494|25781206|FG000|Overall Study|Programming software malfunction.|1|||
13082116|NCT04823494|25781207|FG001|Overall Study|Programming software malfunction.|0|||
13082117|NCT04823494|25781206|FG000|Overall Study|Withdrawal by Subject|1|||
13082118|NCT04823494|25781207|FG001|Overall Study|Withdrawal by Subject|0|||
13082119|NCT04823494|25781206|FG000|Overall Study|Devices lost|0|||
13082120|NCT04823494|25781207|FG001|Overall Study|Devices lost|1|||
13082121|NCT04822701|25781224|FG000|Overall Study|Not treated|2|||
13082122|NCT04822701|25781225|FG001|Overall Study|Not treated|0|||
13082123|NCT04822701|25781224|FG000|Overall Study|Lost to Follow-up|1|||
13082124|NCT04822701|25781225|FG001|Overall Study|Lost to Follow-up|0|||
13082125|NCT04822701|25781224|FG000|Overall Study|Withdrawal by Subject|1|||
13082126|NCT04822701|25781225|FG001|Overall Study|Withdrawal by Subject|0|||
13082127|NCT04821245|25781233|FG000|Overall Study|Withdrawal by Subject|3|||
13082128|NCT04821245|25781233|FG000|Overall Study|Physician Decision|1|||
13082129|NCT04821245|25781233|FG000|Overall Study|Protocol Violation|5|||
13082130|NCT04820491|25781256|FG000|Overall Study|Withdrawal by Subject|1|||
13082131|NCT04820491|25781257|FG001|Overall Study|Withdrawal by Subject|0|||
13082132|NCT04810221|25781266|FG000|Overall Study|Physician Decision|3|||
13082133|NCT04799782|25781277|FG000|Washout|Physician Decision|2|||
13082134|NCT04799782|25781278|FG001|Washout|Physician Decision|0|||
13082135|NCT04799782|25781277|FG000|Washout|Withdrawal by Subject|0|||
13082136|NCT04799782|25781278|FG001|Washout|Withdrawal by Subject|2|||
13082137|NCT04799782|25781277|FG000|Washout|Lost to Follow-up|0|||
13082138|NCT04799782|25781278|FG001|Washout|Lost to Follow-up|1|||
13082139|NCT04794751|25781289|FG000|Period 1|incorrect fitting guide was used to fit subject|2|||
13082140|NCT04794751|25781290|FG001|Period 1|incorrect fitting guide was used to fit subject|1|||
13082141|NCT04794751|25781289|FG000|Period 1|Subject no longer meets eligibility criteria|0|||
13082142|NCT04794751|25781290|FG001|Period 1|Subject no longer meets eligibility criteria|1|||
13082143|NCT04794751|25781289|FG000|Period 1|Protocol Violation|0|||
13082144|NCT04794751|25781290|FG001|Period 1|Protocol Violation|2|||
13082145|NCT04794751|25781289|FG000|Period 1|Withdrawal by Subject|0|||
13082146|NCT04794751|25781290|FG001|Period 1|Withdrawal by Subject|1|||
13082147|NCT04794751|25781289|FG000|Period 2|Withdrawal by Subject|0|||
13082148|NCT04794751|25781290|FG001|Period 2|Withdrawal by Subject|1|||
13082149|NCT04794751|25781289|FG000|Period 2|incorrect fitting guide was used to fit subject|0|||
13082150|NCT04794751|25781290|FG001|Period 2|incorrect fitting guide was used to fit subject|2|||
13082151|NCT04794751|25781289|FG000|Period 2|Protocol Violation|1|||
13082152|NCT04794751|25781290|FG001|Period 2|Protocol Violation|0|||
13082153|NCT04794270|25781309|FG000|Period 1|Non Compliance|1|||
13082154|NCT04794270|25781310|FG001|Period 1|Non Compliance|0|||
13082155|NCT04794270|25781309|FG000|Period 1|Adverse Event|1|||
13082156|NCT04794270|25781310|FG001|Period 1|Adverse Event|0|||
13082157|NCT04794270|25781309|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
13082158|NCT04794270|25781310|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
13082159|NCT04784897|25781379|FG000|Overall Study|Death|4|||
13082160|NCT04784897|25781380|FG001|Overall Study|Death|2|||
13082161|NCT04784897|25781381|FG002|Overall Study|Death|1|||
13082162|NCT04784897|25781379|FG000|Overall Study|Withdrawal by Subject|0|||
13082163|NCT04784897|25781380|FG001|Overall Study|Withdrawal by Subject|0|||
13082164|NCT04784897|25781381|FG002|Overall Study|Withdrawal by Subject|1|||
13082165|NCT04779879|25781530|FG000|Part A: Up to Day 29|ongoing in the study|8|||
13082166|NCT04779879|25781531|FG001|Part A: Up to Day 29|ongoing in the study|22|||
13082167|NCT04779879|25781532|FG002|Part A: Up to Day 29|ongoing in the study|0|||
13082168|NCT04779879|25781533|FG003|Part A: Up to Day 29|ongoing in the study|0|||
13082169|NCT04779879|25781534|FG004|Part A: Up to Day 29|ongoing in the study|0|||
13082170|NCT04779879|25781535|FG005|Part A: Up to Day 29|ongoing in the study|0|||
13082171|NCT04779879|25781530|FG000|Part B: Up to Day 29|Ongoing in the study|0|||
13082172|NCT04779879|25781531|FG001|Part B: Up to Day 29|Ongoing in the study|0|||
13082173|NCT04779879|25781532|FG002|Part B: Up to Day 29|Ongoing in the study|84|||
13082174|NCT04779879|25781533|FG003|Part B: Up to Day 29|Ongoing in the study|82|||
13082175|NCT04779879|25781534|FG004|Part B: Up to Day 29|Ongoing in the study|0|||
13082176|NCT04779879|25781535|FG005|Part B: Up to Day 29|Ongoing in the study|0|||
13082177|NCT04779879|25781530|FG000|Part B: Up to Day 29|Randomized, but did not receive treatment|0|||
13082178|NCT04779879|25781531|FG001|Part B: Up to Day 29|Randomized, but did not receive treatment|0|||
13082179|NCT04779879|25781532|FG002|Part B: Up to Day 29|Randomized, but did not receive treatment|0|||
13082180|NCT04779879|25781533|FG003|Part B: Up to Day 29|Randomized, but did not receive treatment|1|||
13082181|NCT04779879|25781534|FG004|Part B: Up to Day 29|Randomized, but did not receive treatment|0|||
13082182|NCT04779879|25781535|FG005|Part B: Up to Day 29|Randomized, but did not receive treatment|0|||
13082183|NCT04779879|25781530|FG000|Part C: Up to Day 29|Ongoing in the study|0|||
13082184|NCT04779879|25781531|FG001|Part C: Up to Day 29|Ongoing in the study|0|||
13082185|NCT04779879|25781532|FG002|Part C: Up to Day 29|Ongoing in the study|0|||
13082186|NCT04779879|25781533|FG003|Part C: Up to Day 29|Ongoing in the study|0|||
13082187|NCT04779879|25781534|FG004|Part C: Up to Day 29|Ongoing in the study|78|||
13082188|NCT04779879|25781535|FG005|Part C: Up to Day 29|Ongoing in the study|77|||
13082189|NCT04779879|25781530|FG000|Part C: Up to Day 29|Death|0|||
13082190|NCT04779879|25781531|FG001|Part C: Up to Day 29|Death|0|||
13082191|NCT04779879|25781532|FG002|Part C: Up to Day 29|Death|0|||
13082192|NCT04779879|25781533|FG003|Part C: Up to Day 29|Death|0|||
13082193|NCT04779879|25781534|FG004|Part C: Up to Day 29|Death|0|||
13082194|NCT04779879|25781535|FG005|Part C: Up to Day 29|Death|1|||
13082195|NCT04779879|25781530|FG000|Part C: Up to Day 29|Withdrawal by Subject|0|||
13082196|NCT04779879|25781531|FG001|Part C: Up to Day 29|Withdrawal by Subject|0|||
13082197|NCT04779879|25781532|FG002|Part C: Up to Day 29|Withdrawal by Subject|0|||
13082198|NCT04779879|25781533|FG003|Part C: Up to Day 29|Withdrawal by Subject|0|||
13082199|NCT04779879|25781534|FG004|Part C: Up to Day 29|Withdrawal by Subject|1|||
13082200|NCT04779879|25781535|FG005|Part C: Up to Day 29|Withdrawal by Subject|0|||
13082201|NCT04764669|25781586|FG000|Overall Study|Adverse Event|1|||
13082202|NCT04764669|25781587|FG001|Overall Study|Adverse Event|0|||
13082203|NCT04764669|25781588|FG002|Overall Study|Adverse Event|1|||
13082204|NCT04764669|25781589|FG003|Overall Study|Adverse Event|0|||
13082205|NCT04764669|25781586|FG000|Overall Study|Subject Choice|0|||
13082206|NCT04764669|25781587|FG001|Overall Study|Subject Choice|0|||
13082207|NCT04764669|25781588|FG002|Overall Study|Subject Choice|1|||
13082208|NCT04764669|25781589|FG003|Overall Study|Subject Choice|0|||
13082209|NCT04764669|25781586|FG000|Overall Study|Withdrawal by Subject|2|||
13082210|NCT04764669|25781587|FG001|Overall Study|Withdrawal by Subject|0|||
13082211|NCT04764669|25781588|FG002|Overall Study|Withdrawal by Subject|0|||
13082212|NCT04764669|25781589|FG003|Overall Study|Withdrawal by Subject|0|||
13082213|NCT04755595|25781596|FG000|Overall Study|Lost to Follow-up|1|||
13082214|NCT04749745|25781605|FG000|Overall Study|Withdrawal by Subject|1|||
13082215|NCT04749745|25781606|FG001|Overall Study|Withdrawal by Subject|0|||
13082216|NCT04748341|25781623|FG000|Overall Study|Lost to Follow-up|1|||
13082217|NCT04748341|25781624|FG001|Overall Study|Lost to Follow-up|1|||
13082218|NCT04741503|25781660|FG000|Initial Enrollment|Failed to meet screening criteria|0|||
13082219|NCT04741503|25781661|FG001|Initial Enrollment|Failed to meet screening criteria|0|||
13082220|NCT04741503|25781662|FG002|Initial Enrollment|Failed to meet screening criteria|767|||
13082221|NCT04741503|25781660|FG000|Initial Enrollment|Overquotas removed|0|||
13082222|NCT04741503|25781661|FG001|Initial Enrollment|Overquotas removed|0|||
13082223|NCT04741503|25781662|FG002|Initial Enrollment|Overquotas removed|186|||
13082224|NCT04741503|25781660|FG000|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|23|||
13082225|NCT04741503|25781661|FG001|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|17|||
13082226|NCT04741503|25781662|FG002|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|0|||
13082227|NCT04737278|25781741|FG000|Overall Study|Lost to Follow-up|1|||
13082228|NCT04737278|25781742|FG001|Overall Study|Lost to Follow-up|1|||
13082229|NCT04737278|25781741|FG000|Overall Study|Withdrawal by Subject|1|||
13082230|NCT04737278|25781742|FG001|Overall Study|Withdrawal by Subject|0|||
13082231|NCT04737278|25781741|FG000|Overall Study|Protocol Violation|1|||
13082232|NCT04737278|25781742|FG001|Overall Study|Protocol Violation|1|||
13082233|NCT04737278|25781741|FG000|Overall Study|failure to complete questionnaire|1|||
13082234|NCT04737278|25781742|FG001|Overall Study|failure to complete questionnaire|1|||
13082235|NCT04734873|25781769|FG000|Overall Study|Lost to Follow-up|1|||
13082236|NCT04734873|25781770|FG001|Overall Study|Lost to Follow-up|3|||
13082237|NCT04734873|25781771|FG002|Overall Study|Lost to Follow-up|2|||
13082238|NCT04734873|25781769|FG000|Overall Study|Randomized but not dosed|1|||
13082239|NCT04734873|25781770|FG001|Overall Study|Randomized but not dosed|0|||
13082240|NCT04734873|25781771|FG002|Overall Study|Randomized but not dosed|1|||
13082241|NCT04732338|25781786|FG000|Overall Study|Lost to Follow-up|3|||
13082242|NCT04732338|25781787|FG001|Overall Study|Lost to Follow-up|3|||
13082243|NCT04728802|25781806|FG000|Overall Study|Withdrawal by Subject|4|||
13082244|NCT04728802|25781807|FG001|Overall Study|Withdrawal by Subject|20|||
13082245|NCT04728802|25781806|FG000|Overall Study|Physician Decision|7|||
13082246|NCT04728802|25781807|FG001|Overall Study|Physician Decision|7|||
13082247|NCT04728802|25781806|FG000|Overall Study|Protocol Violation|10|||
13082248|NCT04728802|25781807|FG001|Overall Study|Protocol Violation|4|||
13082249|NCT04728802|25781806|FG000|Overall Study|Transfer|1|||
13082250|NCT04728802|25781807|FG001|Overall Study|Transfer|0|||
13082251|NCT04728802|25781806|FG000|Overall Study|Death|4|||
13082252|NCT04728802|25781807|FG001|Overall Study|Death|5|||
13082253|NCT04728802|25781806|FG000|Overall Study|Other|3|||
13082254|NCT04728802|25781807|FG001|Overall Study|Other|0|||
13082255|NCT04727749|25781838|FG000|Overall Study|Lost to Follow-up|10|||
13082256|NCT04727749|25781839|FG001|Overall Study|Lost to Follow-up|3|||
13082257|NCT04725500|25781851|FG000|Screening|Screen Failure|26|||
13082258|NCT04725500|25781851|FG000|Screening|Withdrawal by Subject|1|||
13082259|NCT04725500|25781851|FG000|2 Week Take Home|Screen Fail|5|||
13082260|NCT04724733|25781872|FG000|Overall Study|Lost to Follow-up|1|||
13082261|NCT04724733|25781873|FG001|Overall Study|Lost to Follow-up|1|||
13082262|NCT04724733|25781874|FG002|Overall Study|Lost to Follow-up|1|||
13082263|NCT04716426|25781895|FG000|Overall Study|Vaccination|1|||
13082264|NCT04716426|25781896|FG001|Overall Study|Vaccination|1|||
13082265|NCT04716426|25781895|FG000|Overall Study|Contamination|1|||
13082266|NCT04716426|25781896|FG001|Overall Study|Contamination|0|||
13082267|NCT04715932|25782029|FG000|Overall Study|Lost to Follow-up|1|||
13082268|NCT04715932|25782030|FG001|Overall Study|Lost to Follow-up|0|||
13082269|NCT04713748|25782038|FG000|Overall Study|Not enough kits allocated|35|||
13082270|NCT04709835|25782095|FG000|Overall Study|Withdrawal by Subject|0|||
13082271|NCT04709835|25782096|FG001|Overall Study|Withdrawal by Subject|1|||
13082272|NCT04709835|25782097|FG002|Overall Study|Withdrawal by Subject|0|||
13082273|NCT04706416|25782124|FG000|Overall Study|Lost to Follow-up|2|||
13082274|NCT04706416|25782125|FG001|Overall Study|Lost to Follow-up|0|||
13082275|NCT04702984|25782133|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1|||
13082276|NCT04701658|25782141|FG000|Overall Study|Lost to Follow-up|6|||
13082277|NCT04698993|25782164|FG000|Overall Study|PCR results not accessible|2|||
13082278|NCT04698993|25782165|FG001|Overall Study|PCR results not accessible|7|||
13082279|NCT04698993|25782164|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1|||
13082280|NCT04698993|25782165|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0|||
13082281|NCT04684394|25782194|FG000|Overall Study|Death|1|||
13082282|NCT04684394|25782195|FG001|Overall Study|Death|2|||
13082283|NCT04684394|25782194|FG000|Overall Study|Lost to Follow-up|1|||
13082284|NCT04684394|25782195|FG001|Overall Study|Lost to Follow-up|0|||
13082285|NCT04684394|25782194|FG000|Overall Study|Withdrawal by Subject|2|||
13082286|NCT04684394|25782195|FG001|Overall Study|Withdrawal by Subject|0|||
13082287|NCT04684394|25782194|FG000|Overall Study|Study discontinued per Sponsor decision|25|||
13082288|NCT04684394|25782195|FG001|Overall Study|Study discontinued per Sponsor decision|13|||
13082289|NCT04676412|25782212|FG000|Overall Study|Death|17|||
13082290|NCT04676412|25782213|FG001|Overall Study|Death|23|||
13082291|NCT04676412|25782212|FG000|Overall Study|Withdrawal by Subject|0|||
13082292|NCT04676412|25782213|FG001|Overall Study|Withdrawal by Subject|2|||
13082293|NCT04676412|25782212|FG000|Overall Study|Participants ongoing|32|||
13082294|NCT04676412|25782213|FG001|Overall Study|Participants ongoing|33|||
13082295|NCT04674644|25782220|FG000|Overall Study|with missing data|37|||
13082296|NCT04668989|25782231|FG000|First Intervention|Covid-19 related self-isolation|0|||
13082297|NCT04668989|25782232|FG001|First Intervention|Covid-19 related self-isolation|1|||
13082298|NCT04668989|25782231|FG000|Second Intervention|Adverse Event|0|||
13082299|NCT04668989|25782232|FG001|Second Intervention|Adverse Event|1|||
13082300|NCT04668950|25782245|FG000|Overall Study|Started medication more than 7 days after symptom onset|18|||
13082301|NCT04668950|25782246|FG001|Overall Study|Started medication more than 7 days after symptom onset|14|||
13133722|NCT02765165|25988891|FG000|Post-treatment Follow-up|Death|1|||
13082302|NCT04668950|25782245|FG000|Overall Study|Could not confirm started study medication|15|||
13082303|NCT04668950|25782246|FG001|Overall Study|Could not confirm started study medication|15|||
13082304|NCT04668950|25782245|FG000|Overall Study|Could not confirm baseline status|6|||
13082305|NCT04668950|25782246|FG001|Overall Study|Could not confirm baseline status|2|||
13082306|NCT04668950|25782245|FG000|Overall Study|Drop out and did not start medication|15|||
13082307|NCT04668950|25782246|FG001|Overall Study|Drop out and did not start medication|17|||
13082308|NCT04668950|25782245|FG000|Overall Study|Deteriorated at or before baseline assessment|6|||
13082309|NCT04668950|25782246|FG001|Overall Study|Deteriorated at or before baseline assessment|9|||
13082310|NCT04668950|25782245|FG000|Overall Study|Other|2|||
13082311|NCT04668950|25782246|FG001|Overall Study|Other|4|||
13082312|NCT04668274|25782301|FG000|Part 1 Study Period 1|Adverse Event|3|||
13082313|NCT04668274|25782302|FG001|Part 1 Study Period 1|Adverse Event|0|||
13082314|NCT04668274|25782303|FG002|Part 1 Study Period 1|Adverse Event|0|||
13082315|NCT04668274|25782304|FG003|Part 1 Study Period 1|Adverse Event|0|||
13082316|NCT04668274|25782301|FG000|Part 1 Study Period 1|Withdrawal by Subject|2|||
13082317|NCT04668274|25782302|FG001|Part 1 Study Period 1|Withdrawal by Subject|0|||
13082318|NCT04668274|25782303|FG002|Part 1 Study Period 1|Withdrawal by Subject|0|||
13082319|NCT04668274|25782304|FG003|Part 1 Study Period 1|Withdrawal by Subject|0|||
13082320|NCT04668274|25782301|FG000|Part 1 Study Period 2|Other|0|||
13082321|NCT04668274|25782302|FG001|Part 1 Study Period 2|Other|1|||
13082322|NCT04668274|25782303|FG002|Part 1 Study Period 2|Other|0|||
13082323|NCT04668274|25782304|FG003|Part 1 Study Period 2|Other|0|||
13082324|NCT04668274|25782301|FG000|Part 1 Study Period 3|Adverse Event|0|||
13082325|NCT04668274|25782302|FG001|Part 1 Study Period 3|Adverse Event|0|||
13082326|NCT04668274|25782303|FG002|Part 1 Study Period 3|Adverse Event|1|||
13082327|NCT04668274|25782304|FG003|Part 1 Study Period 3|Adverse Event|0|||
13082328|NCT04668274|25782301|FG000|Part 1 Study Period 3|Other|0|||
13082329|NCT04668274|25782302|FG001|Part 1 Study Period 3|Other|0|||
13082330|NCT04668274|25782303|FG002|Part 1 Study Period 3|Other|2|||
13082331|NCT04668274|25782304|FG003|Part 1 Study Period 3|Other|0|||
13082332|NCT04668274|25782301|FG000|Part 2 Study Period 4|Other|0|||
13082333|NCT04668274|25782302|FG001|Part 2 Study Period 4|Other|0|||
13082334|NCT04668274|25782303|FG002|Part 2 Study Period 4|Other|0|||
13082335|NCT04668274|25782304|FG003|Part 2 Study Period 4|Other|1|||
13082336|NCT04666441|25782467|FG000|Overall Study|Lost to Follow-up|1|||
13082337|NCT04666441|25782468|FG001|Overall Study|Lost to Follow-up|4|||
13082338|NCT04666441|25782469|FG002|Overall Study|Lost to Follow-up|1|||
13082339|NCT04666441|25782470|FG003|Overall Study|Lost to Follow-up|3|||
13082340|NCT04666441|25782471|FG004|Overall Study|Lost to Follow-up|0|||
13082341|NCT04666441|25782472|FG005|Overall Study|Lost to Follow-up|2|||
13082342|NCT04666441|25782473|FG006|Overall Study|Lost to Follow-up|2|||
13082343|NCT04666441|25782474|FG007|Overall Study|Lost to Follow-up|2|||
13082344|NCT04666441|25782467|FG000|Overall Study|Subject Decision|1|||
13082345|NCT04666441|25782468|FG001|Overall Study|Subject Decision|1|||
13082346|NCT04666441|25782469|FG002|Overall Study|Subject Decision|3|||
13082347|NCT04666441|25782470|FG003|Overall Study|Subject Decision|1|||
13082348|NCT04666441|25782471|FG004|Overall Study|Subject Decision|0|||
13082349|NCT04666441|25782472|FG005|Overall Study|Subject Decision|1|||
13082350|NCT04666441|25782473|FG006|Overall Study|Subject Decision|3|||
13082351|NCT04666441|25782474|FG007|Overall Study|Subject Decision|2|||
13082352|NCT04664855|25782493|FG000|Overall Study|Withdrawal by Subject|0|||
13082353|NCT04664855|25782494|FG001|Overall Study|Withdrawal by Subject|2|||
13132273|NCT02794480|25982812|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
13132274|NCT02794480|25982813|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
13132275|NCT02794480|25982814|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
13132276|NCT02794103|25982825|FG000|Overall Study|Loss to follow up due to high sedation|3|||
13132277|NCT02793947|25982842|FG000|Overall Study|Death|1|||
13132278|NCT02793947|25982843|FG001|Overall Study|Death|0|||
13132279|NCT02793947|25982842|FG000|Overall Study|Physician Decision|1|||
13132280|NCT02793947|25982843|FG001|Overall Study|Physician Decision|5|||
13132281|NCT02793622|25982882|FG000|Overall Study|Lost to Follow-up|31|||
13132282|NCT02793622|25982883|FG001|Overall Study|Lost to Follow-up|19|||
13132283|NCT02793622|25982882|FG000|Overall Study|Withdrawal by Subject|21|||
13132284|NCT02793622|25982883|FG001|Overall Study|Withdrawal by Subject|17|||
13132285|NCT02793622|25982882|FG000|Overall Study|Adverse Event|0|||
13132286|NCT02793622|25982883|FG001|Overall Study|Adverse Event|1|||
13132287|NCT02793622|25982882|FG000|Overall Study|Protocol Violation|1|||
13132288|NCT02793622|25982883|FG001|Overall Study|Protocol Violation|5|||
13132289|NCT02793232|25983093|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
13132290|NCT02793232|25983094|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
13132291|NCT02793232|25983095|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
13132292|NCT02793232|25983096|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
13132293|NCT02793232|25983097|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
13132294|NCT02793232|25983098|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
13132295|NCT02793232|25983099|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
13082354|NCT04664400|25782503|FG000|Overall Study|Withdrawal by Subject|2|||
13082355|NCT04664153|25782572|FG000|Overall Study|Lack of Efficacy|0|||
13082356|NCT04664153|25782573|FG001|Overall Study|Lack of Efficacy|0|||
13082357|NCT04664153|25782574|FG002|Overall Study|Lack of Efficacy|1|||
13082358|NCT04664153|25782575|FG003|Overall Study|Lack of Efficacy|0|||
13082359|NCT04664153|25782572|FG000|Overall Study|Physician Decision|0|||
13082360|NCT04664153|25782573|FG001|Overall Study|Physician Decision|0|||
13082361|NCT04664153|25782574|FG002|Overall Study|Physician Decision|1|||
13082362|NCT04664153|25782575|FG003|Overall Study|Physician Decision|0|||
13082363|NCT04664153|25782572|FG000|Overall Study|Withdrawal by Subject|3|||
13082364|NCT04664153|25782573|FG001|Overall Study|Withdrawal by Subject|2|||
13082365|NCT04664153|25782574|FG002|Overall Study|Withdrawal by Subject|1|||
13082366|NCT04664153|25782575|FG003|Overall Study|Withdrawal by Subject|2|||
13082367|NCT04664153|25782572|FG000|Overall Study|Other|0|||
13082368|NCT04664153|25782573|FG001|Overall Study|Other|1|||
13082369|NCT04664153|25782574|FG002|Overall Study|Other|0|||
13082370|NCT04664153|25782575|FG003|Overall Study|Other|0|||
13082371|NCT04664153|25782572|FG000|Overall Study|Adverse Event|4|||
13082372|NCT04664153|25782573|FG001|Overall Study|Adverse Event|0|||
13082373|NCT04664153|25782574|FG002|Overall Study|Adverse Event|1|||
13082374|NCT04664153|25782575|FG003|Overall Study|Adverse Event|0|||
13082375|NCT04663295|25782594|FG000|Run-in Period|Withdrawal by Subject|3|||
13082376|NCT04663295|25782594|FG000|Overall Study Period|Pregnancy|1|||
13082377|NCT04663295|25782594|FG000|Overall Study Period|Withdrawn by Parent/Guardian|1|||
13082378|NCT04658784|25782627|FG000|6-month Follow-up|Lost to Follow-up|2|||
13082379|NCT04658784|25782628|FG001|6-month Follow-up|Lost to Follow-up|5|||
13082380|NCT04656691|25782635|FG000|Overall Study|Adverse Event|1|||
13082381|NCT04651114|25782647|FG000|Overall Study|Withdrawal by Subject|8|||
13082382|NCT04646109|25782713|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0|||
13082383|NCT04646109|25782714|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6|||
13082384|NCT04641299|25782760|FG000|Overall Study|Adverse Event|0|||
13082385|NCT04641299|25782761|FG001|Overall Study|Adverse Event|0|||
13082386|NCT04641299|25782762|FG002|Overall Study|Adverse Event|2|||
13082387|NCT04641299|25782763|FG003|Overall Study|Adverse Event|0|||
13082388|NCT04641299|25782760|FG000|Overall Study|Lost to Follow-up|0|||
13082389|NCT04641299|25782761|FG001|Overall Study|Lost to Follow-up|1|||
13082390|NCT04641299|25782762|FG002|Overall Study|Lost to Follow-up|0|||
13082391|NCT04641299|25782763|FG003|Overall Study|Lost to Follow-up|0|||
13082392|NCT04641299|25782760|FG000|Overall Study|Withdrawal by Subject|1|||
13082393|NCT04641299|25782761|FG001|Overall Study|Withdrawal by Subject|0|||
13082394|NCT04641299|25782762|FG002|Overall Study|Withdrawal by Subject|0|||
13082395|NCT04641299|25782763|FG003|Overall Study|Withdrawal by Subject|0|||
13082396|NCT04641299|25782760|FG000|Overall Study|Reason not given|1|||
13082397|NCT04641299|25782761|FG001|Overall Study|Reason not given|0|||
13082398|NCT04641299|25782762|FG002|Overall Study|Reason not given|0|||
13082399|NCT04641299|25782763|FG003|Overall Study|Reason not given|0|||
13082400|NCT04640168|25782862|FG000|Overall Study|Withdrawal by Subject|8|||
13082401|NCT04640168|25782863|FG001|Overall Study|Withdrawal by Subject|7|||
13082402|NCT04640168|25782862|FG000|Overall Study|Lost to Follow-up|1|||
13082403|NCT04640168|25782863|FG001|Overall Study|Lost to Follow-up|0|||
13082404|NCT04640168|25782862|FG000|Overall Study|Enrolled but not treated|12|||
13082405|NCT04640168|25782863|FG001|Overall Study|Enrolled but not treated|12|||
13082406|NCT04633642|25782886|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1|||
13082407|NCT04633642|25782887|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2|||
13082408|NCT04633564|25782900|FG000|Period 1|Adverse Event|28|||
13082409|NCT04633564|25782901|FG001|Period 1|Adverse Event|19|||
13082410|NCT04633564|25782900|FG000|Period 1|Death|8|||
13082411|NCT04633564|25782901|FG001|Period 1|Death|7|||
13082412|NCT04633564|25782900|FG000|Period 1|Lost to Follow-up|3|||
13082413|NCT04633564|25782901|FG001|Period 1|Lost to Follow-up|5|||
13082414|NCT04633564|25782900|FG000|Period 1|Physician Decision|4|||
13082415|NCT04633564|25782901|FG001|Period 1|Physician Decision|12|||
13082416|NCT04633564|25782900|FG000|Period 1|Protocol Violation|0|||
13082417|NCT04633564|25782901|FG001|Period 1|Protocol Violation|1|||
13082418|NCT04633564|25782900|FG000|Period 1|Withdrawal by Subject|10|||
13222450|NCT01806597|26286270|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1|||
13082419|NCT04633564|25782901|FG001|Period 1|Withdrawal by Subject|8|||
13082420|NCT04633564|25782900|FG000|Period 1|Progressive disease|47|||
13082421|NCT04633564|25782901|FG001|Period 1|Progressive disease|51|||
13082422|NCT04633564|25782900|FG000|Period 1|Terminated by Sponsor|8|||
13082423|NCT04633564|25782901|FG001|Period 1|Terminated by Sponsor|6|||
13082424|NCT04633564|25782900|FG000|Period 2|Adverse Event|3|||
13082425|NCT04633564|25782901|FG001|Period 2|Adverse Event|4|||
13082426|NCT04633564|25782900|FG000|Period 2|Death|0|||
13082427|NCT04633564|25782901|FG001|Period 2|Death|2|||
13082428|NCT04633564|25782900|FG000|Period 2|Lost to Follow-up|0|||
13082429|NCT04633564|25782901|FG001|Period 2|Lost to Follow-up|1|||
13082430|NCT04633564|25782900|FG000|Period 2|Physician Decision|2|||
13082431|NCT04633564|25782901|FG001|Period 2|Physician Decision|4|||
13082432|NCT04633564|25782900|FG000|Period 2|Withdrawal by Subject|5|||
13082433|NCT04633564|25782901|FG001|Period 2|Withdrawal by Subject|1|||
13082434|NCT04633564|25782900|FG000|Period 2|Progressive Disease|74|||
13082435|NCT04633564|25782901|FG001|Period 2|Progressive Disease|82|||
13082436|NCT04633564|25782900|FG000|Period 2|Terminated by Sponsor|9|||
13082437|NCT04633564|25782901|FG001|Period 2|Terminated by Sponsor|3|||
13082438|NCT04625972|25782914|FG000|Overall Study|Physician Decision|1|||
13082439|NCT04625972|25782915|FG001|Overall Study|Physician Decision|0|||
13082440|NCT04625972|25782914|FG000|Overall Study|Protocol Violation|0|||
13082441|NCT04625972|25782915|FG001|Overall Study|Protocol Violation|1|||
13082442|NCT04625972|25782914|FG000|Overall Study|Ongoing in Study|741|||
13082443|NCT04625972|25782915|FG001|Overall Study|Ongoing in Study|369|||
13082444|NCT04625972|25782914|FG000|Overall Study|Lost to Follow-up|2|||
13082445|NCT04625972|25782915|FG001|Overall Study|Lost to Follow-up|0|||
13082446|NCT04625972|25782914|FG000|Overall Study|"Includes participants who discontinued early with reason other selected."|5|||
13082447|NCT04625972|25782915|FG001|Overall Study|"Includes participants who discontinued early with reason other selected."|2|||
13082448|NCT04625972|25782914|FG000|Overall Study|Withdrawal by Subject|7|||
13082449|NCT04625972|25782915|FG001|Overall Study|Withdrawal by Subject|3|||
13082450|NCT04623242|25783023|FG000|Overall Study|Withdrawal by Subject|7|||
13082451|NCT04623242|25783024|FG001|Overall Study|Withdrawal by Subject|12|||
13082452|NCT04623242|25783025|FG002|Overall Study|Withdrawal by Subject|5|||
13082453|NCT04623242|25783026|FG003|Overall Study|Withdrawal by Subject|7|||
13082454|NCT04623242|25783027|FG004|Overall Study|Withdrawal by Subject|0|||
13082455|NCT04623242|25783023|FG000|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|6|||
13082456|NCT04623242|25783024|FG001|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|4|||
13082457|NCT04623242|25783025|FG002|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|5|||
13082458|NCT04623242|25783026|FG003|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|3|||
13082459|NCT04623242|25783027|FG004|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|0|||
13082460|NCT04623242|25783023|FG000|Overall Study|Subject unblinded to mutation status|0|||
13082461|NCT04623242|25783024|FG001|Overall Study|Subject unblinded to mutation status|0|||
13082462|NCT04623242|25783025|FG002|Overall Study|Subject unblinded to mutation status|0|||
13082463|NCT04623242|25783026|FG003|Overall Study|Subject unblinded to mutation status|13|||
13082464|NCT04623242|25783027|FG004|Overall Study|Subject unblinded to mutation status|0|||
13082465|NCT04619992|25783042|FG000|Overall Study|Withdrawal by Subject|1|||
13082466|NCT04619992|25783043|FG001|Overall Study|Withdrawal by Subject|0|||
13082467|NCT04617860|25783075|FG000|Overall Study|Adverse Event|0|||
13082468|NCT04617860|25783076|FG001|Overall Study|Adverse Event|2|||
13082469|NCT04617860|25783077|FG002|Overall Study|Adverse Event|2|||
13082470|NCT04617860|25783075|FG000|Overall Study|Withdrawal by Subject|0|||
13082471|NCT04617860|25783076|FG001|Overall Study|Withdrawal by Subject|0|||
13082472|NCT04617860|25783077|FG002|Overall Study|Withdrawal by Subject|2|||
13082473|NCT04617860|25783075|FG000|Overall Study|Physician Decision|0|||
13082474|NCT04617860|25783076|FG001|Overall Study|Physician Decision|1|||
13082475|NCT04617860|25783077|FG002|Overall Study|Physician Decision|0|||
13082476|NCT04617860|25783075|FG000|Overall Study|Sponsor Decision|0|||
13082477|NCT04617860|25783076|FG001|Overall Study|Sponsor Decision|3|||
13082478|NCT04617860|25783077|FG002|Overall Study|Sponsor Decision|1|||
13082479|NCT04617860|25783075|FG000|Overall Study|Termination of Study by Sponsor|8|||
13082480|NCT04617860|25783076|FG001|Overall Study|Termination of Study by Sponsor|4|||
13082481|NCT04617860|25783077|FG002|Overall Study|Termination of Study by Sponsor|13|||
13082482|NCT04617847|25783101|FG000|Overall Study|Withdrawal by Subject|1|||
13082483|NCT04617847|25783102|FG001|Overall Study|Withdrawal by Subject|0|||
13082484|NCT04617847|25783101|FG000|Overall Study|Adverse Event|0|||
13082485|NCT04617847|25783102|FG001|Overall Study|Adverse Event|2|||
13082486|NCT04617847|25783101|FG000|Overall Study|Death|0|||
13082487|NCT04617847|25783102|FG001|Overall Study|Death|1|||
13082488|NCT04617847|25783101|FG000|Overall Study|Termination of Study by Sponsor|2|||
13082489|NCT04617847|25783102|FG001|Overall Study|Termination of Study by Sponsor|21|||
13082490|NCT04615507|25783117|FG000|Period 1|Covid-19 exposure|2|||
13082491|NCT04615507|25783118|FG001|Period 1|Covid-19 exposure|1|||
13082492|NCT04615507|25783117|FG000|Period 2|Covid-19 exposure|0|||
13082493|NCT04615507|25783118|FG001|Period 2|Covid-19 exposure|1|||
13082494|NCT04615507|25783117|FG000|Period 2|Protocol Violation|1|||
13082495|NCT04615507|25783118|FG001|Period 2|Protocol Violation|0|||
13082496|NCT04615507|25783117|FG000|Period 2|Withdrawal by Subject|1|||
13082497|NCT04615507|25783118|FG001|Period 2|Withdrawal by Subject|0|||
13082498|NCT04615507|25783117|FG000|Period 2|Adverse Event|0|||
13082499|NCT04615507|25783118|FG001|Period 2|Adverse Event|1|||
13082500|NCT04615507|25783117|FG000|Period 3|Covid-19 exposure|0|||
13082501|NCT04615507|25783118|FG001|Period 3|Covid-19 exposure|1|||
13082502|NCT04608500|25783143|FG000|Overall Study|Adverse Event|2|||
13082503|NCT04608500|25783144|FG001|Overall Study|Adverse Event|0|||
13082504|NCT04608500|25783143|FG000|Overall Study|Lost to Follow-up|15|||
13082505|NCT04608500|25783144|FG001|Overall Study|Lost to Follow-up|9|||
13082506|NCT04608500|25783143|FG000|Overall Study|Participant request|11|||
13082507|NCT04608500|25783144|FG001|Overall Study|Participant request|7|||
13082508|NCT04608500|25783143|FG000|Overall Study|Protocol Violation|1|||
13082509|NCT04608500|25783144|FG001|Overall Study|Protocol Violation|0|||
13082510|NCT04608500|25783143|FG000|Overall Study|Other|6|||
13082511|NCT04608500|25783144|FG001|Overall Study|Other|2|||
13082512|NCT04606199|25783172|FG000|Overall Study|Withdrawal by Subject|2|||
13082513|NCT04605588|25783185|FG000|Overall Study|Withdrawal by Subject|1|||
13082514|NCT04605588|25783186|FG001|Overall Study|Withdrawal by Subject|0|||
13082515|NCT04602000|25783285|FG000|Overall Study|Withdrawal by Subject|3|||
13082516|NCT04602000|25783286|FG001|Overall Study|Withdrawal by Subject|6|||
13082517|NCT04602000|25783287|FG002|Overall Study|Withdrawal by Subject|3|||
13082518|NCT04602000|25783288|FG003|Overall Study|Withdrawal by Subject|27|||
13082519|NCT04602000|25783289|FG004|Overall Study|Withdrawal by Subject|39|||
13082520|NCT04602000|25783285|FG000|Overall Study|Physician Decision|1|||
13082521|NCT04602000|25783286|FG001|Overall Study|Physician Decision|0|||
13082522|NCT04602000|25783287|FG002|Overall Study|Physician Decision|0|||
13082523|NCT04602000|25783288|FG003|Overall Study|Physician Decision|2|||
13082524|NCT04602000|25783289|FG004|Overall Study|Physician Decision|2|||
13082525|NCT04602000|25783285|FG000|Overall Study|Death|0|||
13082526|NCT04602000|25783286|FG001|Overall Study|Death|1|||
13082527|NCT04602000|25783287|FG002|Overall Study|Death|0|||
13082528|NCT04602000|25783288|FG003|Overall Study|Death|1|||
13082529|NCT04602000|25783289|FG004|Overall Study|Death|2|||
13082530|NCT04602000|25783285|FG000|Overall Study|Lost to Follow-up|0|||
13082531|NCT04602000|25783286|FG001|Overall Study|Lost to Follow-up|0|||
13082532|NCT04602000|25783287|FG002|Overall Study|Lost to Follow-up|0|||
13082533|NCT04602000|25783288|FG003|Overall Study|Lost to Follow-up|3|||
13082534|NCT04602000|25783289|FG004|Overall Study|Lost to Follow-up|4|||
13082535|NCT04602000|25783285|FG000|Overall Study|Other|4|||
13082536|NCT04602000|25783286|FG001|Overall Study|Other|1|||
13082537|NCT04602000|25783287|FG002|Overall Study|Other|2|||
13082538|NCT04602000|25783288|FG003|Overall Study|Other|5|||
13082539|NCT04602000|25783289|FG004|Overall Study|Other|4|||
13082540|NCT04602000|25783285|FG000|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
13082541|NCT04602000|25783286|FG001|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
13082542|NCT04602000|25783287|FG002|Overall Study|Completed Treatment Period but not entered into Follow-up Period|1|||
13082543|NCT04602000|25783288|FG003|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
13082544|NCT04602000|25783289|FG004|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
13082545|NCT04601103|25783316|FG000|Overall Study|Needed crown & cleaning|0|||
13082546|NCT04601103|25783317|FG001|Overall Study|Needed crown & cleaning|0|||
13082547|NCT04601103|25783318|FG002|Overall Study|Needed crown & cleaning|1|||
13082548|NCT04601103|25783316|FG000|Overall Study|study was terminated|18|||
13082549|NCT04601103|25783317|FG001|Overall Study|study was terminated|18|||
13082550|NCT04601103|25783318|FG002|Overall Study|study was terminated|16|||
13082551|NCT04599803|25783331|FG000|Overall Study|Withdrawal by Subject|5|||
13082552|NCT04599803|25783331|FG000|Overall Study|Lost to Follow-up|26|||
13082553|NCT04590027|25783348|FG000|Overall Study|Lost to Follow-up|17|||
13082554|NCT04590027|25783349|FG001|Overall Study|Lost to Follow-up|14|||
13082555|NCT04590027|25783348|FG000|Overall Study|Protocol Violation|0|||
13082556|NCT04590027|25783349|FG001|Overall Study|Protocol Violation|3|||
13082557|NCT04587453|25783388|FG000|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|0|||
13082558|NCT04587453|25783389|FG001|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|1|||
13082559|NCT04585646|25783445|FG000|First Intervention|Physician Decision|1|||
13082560|NCT04585646|25783446|FG001|First Intervention|Physician Decision|0|||
13082561|NCT04585646|25783445|FG000|First Intervention|Lost to Follow-up|0|||
13082562|NCT04585646|25783446|FG001|First Intervention|Lost to Follow-up|3|||
13082563|NCT04585646|25783445|FG000|First Intervention|Withdrawal by Subject|0|||
13082564|NCT04585646|25783446|FG001|First Intervention|Withdrawal by Subject|1|||
13082565|NCT04584788|25783452|FG000|Overall Study|Physician Decision|8|||
13082566|NCT04584788|25783452|FG000|Overall Study|Withdrawal by Subject|1|||
13082567|NCT04584788|25783452|FG000|Overall Study|Adverse Event|3|||
13082568|NCT04584645|25783483|FG000|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18995|||
13082569|NCT04584645|25783484|FG001|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18906|||
13082570|NCT04584346|25783501|FG000|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|0|||
13082571|NCT04584346|25783502|FG001|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|1|||
13082572|NCT04580303|25783537|FG000|Overall Study|Adverse Event|0|||
13082573|NCT04580303|25783538|FG001|Overall Study|Adverse Event|1|||
13082574|NCT04580303|25783539|FG002|Overall Study|Adverse Event|0|||
13082575|NCT04580303|25783540|FG003|Overall Study|Adverse Event|0|||
13082576|NCT04580303|25783537|FG000|Overall Study|Withdrawal by Subject|0|||
13082577|NCT04580303|25783538|FG001|Overall Study|Withdrawal by Subject|0|||
13082578|NCT04580303|25783539|FG002|Overall Study|Withdrawal by Subject|1|||
13082579|NCT04580303|25783540|FG003|Overall Study|Withdrawal by Subject|0|||
13082580|NCT04578457|25783562|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2|||
13082581|NCT04578457|25783562|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2|||
13082582|NCT04578457|25783562|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2|||
13082583|NCT04578457|25783562|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2|||
13082584|NCT04577183|25783568|FG000|Overall Study|Death|1|||
13082585|NCT04577183|25783568|FG000|Overall Study|Withdrawal by Subject|3|||
13082586|NCT04577183|25783568|FG000|Overall Study|Early termination|2|||
13082587|NCT04575038|25783587|FG000|Overall Study|Withdrawal by Subject|1|||
13082588|NCT04575038|25783588|FG001|Overall Study|Withdrawal by Subject|1|||
13082589|NCT04574999|25783611|FG000|Overall Study|Adverse Event|1|||
13082590|NCT04574999|25783612|FG001|Overall Study|Adverse Event|0|||
13082591|NCT04574999|25783611|FG000|Overall Study|Lack of Efficacy|2|||
13082592|NCT04574999|25783612|FG001|Overall Study|Lack of Efficacy|3|||
13082593|NCT04574999|25783611|FG000|Overall Study|Protocol Violation|1|||
13082594|NCT04574999|25783612|FG001|Overall Study|Protocol Violation|0|||
13082595|NCT04574999|25783611|FG000|Overall Study|Withdrawal by Subject|2|||
13082596|NCT04574999|25783612|FG001|Overall Study|Withdrawal by Subject|2|||
13082597|NCT04574999|25783611|FG000|Overall Study|Lost to Follow-up|1|||
13082598|NCT04574999|25783612|FG001|Overall Study|Lost to Follow-up|0|||
13082599|NCT04574999|25783611|FG000|Overall Study|Personal problems|1|||
13082600|NCT04574999|25783612|FG001|Overall Study|Personal problems|0|||
13082601|NCT04574999|25783611|FG000|Overall Study|Previous planned surgery|1|||
13082602|NCT04574999|25783612|FG001|Overall Study|Previous planned surgery|0|||
13082603|NCT04572997|25783664|FG000|Overall Study|Adverse Event|1|||
13082604|NCT04571515|25783717|FG000|Overall Study|Physician Decision|0|||
13082605|NCT04571515|25783718|FG001|Overall Study|Physician Decision|0|||
13082606|NCT04571515|25783719|FG002|Overall Study|Physician Decision|0|||
13082607|NCT04571515|25783720|FG003|Overall Study|Physician Decision|0|||
13082608|NCT04571515|25783721|FG004|Overall Study|Physician Decision|1|||
13082609|NCT04571515|25783717|FG000|Overall Study|Withdrawal by Subject|0|||
13082610|NCT04571515|25783718|FG001|Overall Study|Withdrawal by Subject|0|||
13082611|NCT04571515|25783719|FG002|Overall Study|Withdrawal by Subject|0|||
13082612|NCT04571515|25783720|FG003|Overall Study|Withdrawal by Subject|0|||
13082613|NCT04571515|25783721|FG004|Overall Study|Withdrawal by Subject|1|||
13082614|NCT04571515|25783717|FG000|Overall Study|insufficient pain|1|||
13082615|NCT04571515|25783718|FG001|Overall Study|insufficient pain|0|||
13082616|NCT04571515|25783719|FG002|Overall Study|insufficient pain|0|||
13082617|NCT04571515|25783720|FG003|Overall Study|insufficient pain|0|||
13082618|NCT04571515|25783721|FG004|Overall Study|insufficient pain|1|||
13082619|NCT04565249|25783744|FG000|Overall Study|Death|0|||
13082620|NCT04565249|25783745|FG001|Overall Study|Death|0|||
13082621|NCT04565249|25783746|FG002|Overall Study|Death|0|||
13082622|NCT04565249|25783747|FG003|Overall Study|Death|1|||
13082623|NCT04562155|25783802|FG000|Overall Study|COVID-19 pandemic|0|||
13082624|NCT04562155|25783803|FG001|Overall Study|COVID-19 pandemic|0|||
13082625|NCT04562155|25783804|FG002|Overall Study|COVID-19 pandemic|0|||
13082626|NCT04562155|25783805|FG003|Overall Study|COVID-19 pandemic|1|||
13082627|NCT04562155|25783802|FG000|Overall Study|Adverse Event|7|||
13082628|NCT04562155|25783803|FG001|Overall Study|Adverse Event|3|||
13082629|NCT04562155|25783804|FG002|Overall Study|Adverse Event|8|||
13082630|NCT04562155|25783805|FG003|Overall Study|Adverse Event|1|||
13082631|NCT04562155|25783802|FG000|Overall Study|Withdrawal by Subject|3|||
13082632|NCT04562155|25783803|FG001|Overall Study|Withdrawal by Subject|6|||
13082633|NCT04562155|25783804|FG002|Overall Study|Withdrawal by Subject|3|||
13082634|NCT04562155|25783805|FG003|Overall Study|Withdrawal by Subject|3|||
13082635|NCT04562155|25783802|FG000|Overall Study|Participant personal reason|1|||
13082636|NCT04562155|25783803|FG001|Overall Study|Participant personal reason|0|||
13082637|NCT04562155|25783804|FG002|Overall Study|Participant personal reason|2|||
13082638|NCT04562155|25783805|FG003|Overall Study|Participant personal reason|1|||
13082639|NCT04559698|25783834|FG000|Overall Study|Lost to Follow-up|14|||
13082640|NCT04559698|25783835|FG001|Overall Study|Lost to Follow-up|15|||
13082641|NCT04559698|25783834|FG000|Overall Study|Withdrawal by Subject|0|||
13082642|NCT04559698|25783835|FG001|Overall Study|Withdrawal by Subject|1|||
13082643|NCT04558125|25783842|FG000|Overall Study|Death|1|||
13082644|NCT04557371|25783875|FG000|Overall Study|Covid-19-related|0|||
13082645|NCT04557371|25783876|FG001|Overall Study|Covid-19-related|1|||
13082646|NCT04557371|25783877|FG002|Overall Study|Covid-19-related|0|||
13082647|NCT04557371|25783875|FG000|Overall Study|Withdrawal by Subject|0|||
13082648|NCT04557371|25783876|FG001|Overall Study|Withdrawal by Subject|1|||
13082649|NCT04557371|25783877|FG002|Overall Study|Withdrawal by Subject|0|||
13082650|NCT04557371|25783875|FG000|Overall Study|Adverse Event|1|||
13082651|NCT04557371|25783876|FG001|Overall Study|Adverse Event|0|||
13082652|NCT04557371|25783877|FG002|Overall Study|Adverse Event|0|||
13082653|NCT04555096|25783890|FG000|Overall Study|Death|4|||
13082654|NCT04555096|25783891|FG001|Overall Study|Death|4|||
13082655|NCT04555096|25783890|FG000|Overall Study|Withdrawal by Subject|1|||
13082656|NCT04555096|25783891|FG001|Overall Study|Withdrawal by Subject|0|||
13082657|NCT04555096|25783890|FG000|Overall Study|Other|0|||
13082658|NCT04555096|25783891|FG001|Overall Study|Other|1|||
13082659|NCT04553913|25783900|FG000|Overall Study|patient's block resolved prior to PACU|1|||
13082660|NCT04553913|25783900|FG000|Overall Study|did not use the device properly|5|||
13082661|NCT04551898|25783975|FG000|Overall Study|Participant randomized but did not receive study drug|0|||
13082662|NCT04551898|25783976|FG001|Overall Study|Participant randomized but did not receive study drug|1|||
13082663|NCT04551898|25783977|FG002|Overall Study|Participant randomized but did not receive study drug|3|||
13082664|NCT04551898|25783978|FG003|Overall Study|Participant randomized but did not receive study drug|1|||
13082665|NCT04551898|25783975|FG000|Overall Study|Withdrawal by Subject|5|||
13082666|NCT04551898|25783976|FG001|Overall Study|Withdrawal by Subject|1|||
13082667|NCT04551898|25783977|FG002|Overall Study|Withdrawal by Subject|2|||
13082668|NCT04551898|25783978|FG003|Overall Study|Withdrawal by Subject|2|||
13082669|NCT04551898|25783975|FG000|Overall Study|Lost to Follow-up|2|||
13082670|NCT04551898|25783976|FG001|Overall Study|Lost to Follow-up|1|||
13082671|NCT04551898|25783977|FG002|Overall Study|Lost to Follow-up|2|||
13082672|NCT04551898|25783978|FG003|Overall Study|Lost to Follow-up|2|||
13082673|NCT04551898|25783975|FG000|Overall Study|Death|1|||
13082674|NCT04551898|25783976|FG001|Overall Study|Death|0|||
13082675|NCT04551898|25783977|FG002|Overall Study|Death|0|||
13082676|NCT04551898|25783978|FG003|Overall Study|Death|0|||
13082677|NCT04551898|25783975|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
13082678|NCT04551898|25783976|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
13082679|NCT04551898|25783977|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1|||
13082680|NCT04551898|25783978|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
13082681|NCT04547023|25784045|FG000|Overall Study|Did Not Receive Intervention|3|||
13082682|NCT04547023|25784046|FG001|Overall Study|Did Not Receive Intervention|2|||
13082683|NCT04547023|25784045|FG000|Overall Study|Lost to Follow-up|1|||
13082684|NCT04547023|25784046|FG001|Overall Study|Lost to Follow-up|1|||
13082685|NCT04546724|25784099|FG000|Overall Study|Withdrawal by Subject|37|||
13082686|NCT04546724|25784100|FG001|Overall Study|Withdrawal by Subject|10|||
13082687|NCT04546724|25784099|FG000|Overall Study|Adverse Event|1|||
13082688|NCT04546724|25784100|FG001|Overall Study|Adverse Event|1|||
13082689|NCT04546724|25784099|FG000|Overall Study|Lost to Follow-up|30|||
13082690|NCT04546724|25784100|FG001|Overall Study|Lost to Follow-up|10|||
13082691|NCT04546724|25784099|FG000|Overall Study|Physician Decision|4|||
13082692|NCT04546724|25784100|FG001|Overall Study|Physician Decision|1|||
13082693|NCT04546724|25784099|FG000|Overall Study|Subject Moved|2|||
13082694|NCT04546724|25784100|FG001|Overall Study|Subject Moved|0|||
13082695|NCT04546724|25784099|FG000|Overall Study|Subject Praticipating in another trial|0|||
13082696|NCT04546724|25784100|FG001|Overall Study|Subject Praticipating in another trial|1|||
13082697|NCT04546724|25784099|FG000|Overall Study|"subjects did not have a Day29 or later visits . These subjects were considered as Not completed."|49|||
13082698|NCT04546724|25784100|FG001|Overall Study|"subjects did not have a Day29 or later visits . These subjects were considered as Not completed."|12|||
13082699|NCT04545567|25784151|FG000|Overall Study|tested positive for SARS-co-V2|1|||
13082700|NCT04545567|25784152|FG001|Overall Study|tested positive for SARS-co-V2|1|||
13082701|NCT04545567|25784151|FG000|Overall Study|Withdrawal by Subject|0|||
13082702|NCT04545567|25784152|FG001|Overall Study|Withdrawal by Subject|1|||
13082703|NCT04542694|25784187|FG000|Overall Study|The need for prohibited therapy|2|||
13082704|NCT04542694|25784188|FG001|Overall Study|The need for prohibited therapy|0|||
13082705|NCT04542694|25784187|FG000|Overall Study|Adverse Event|1|||
13082706|NCT04542694|25784188|FG001|Overall Study|Adverse Event|0|||
13082707|NCT04542694|25784187|FG000|Overall Study|Protocol Violation|1|||
13082708|NCT04542694|25784188|FG001|Overall Study|Protocol Violation|0|||
13082709|NCT04539275|25784229|FG000|Overall Study|Death|2|||
13082710|NCT04539275|25784230|FG001|Overall Study|Death|4|||
13082711|NCT04539275|25784229|FG000|Overall Study|Lost to Follow-up|1|||
13082712|NCT04539275|25784230|FG001|Overall Study|Lost to Follow-up|1|||
13082713|NCT04539275|25784229|FG000|Overall Study|Withdrawal by Subject|3|||
13082714|NCT04539275|25784230|FG001|Overall Study|Withdrawal by Subject|0|||
13082715|NCT04539262|25784501|FG000|Overall Study|Adverse Event|0|||
13082716|NCT04539262|25784502|FG001|Overall Study|Adverse Event|0|||
13082717|NCT04539262|25784503|FG002|Overall Study|Adverse Event|1|||
13082718|NCT04539262|25784504|FG003|Overall Study|Adverse Event|0|||
13082719|NCT04539262|25784505|FG004|Overall Study|Adverse Event|0|||
13082720|NCT04539262|25784506|FG005|Overall Study|Adverse Event|0|||
13082721|NCT04539262|25784507|FG006|Overall Study|Adverse Event|0|||
13082722|NCT04539262|25784508|FG007|Overall Study|Adverse Event|0|||
13082723|NCT04539262|25784501|FG000|Overall Study|Withdrew Consent|0|||
13082724|NCT04539262|25784502|FG001|Overall Study|Withdrew Consent|0|||
13082725|NCT04539262|25784503|FG002|Overall Study|Withdrew Consent|0|||
13082726|NCT04539262|25784504|FG003|Overall Study|Withdrew Consent|1|||
13082727|NCT04539262|25784505|FG004|Overall Study|Withdrew Consent|0|||
13082728|NCT04539262|25784506|FG005|Overall Study|Withdrew Consent|0|||
13082729|NCT04539262|25784507|FG006|Overall Study|Withdrew Consent|0|||
13082730|NCT04539262|25784508|FG007|Overall Study|Withdrew Consent|0|||
13082731|NCT04539262|25784501|FG000|Overall Study|Randomized, Not treated|0|||
13082732|NCT04539262|25784502|FG001|Overall Study|Randomized, Not treated|1|||
13082733|NCT04539262|25784503|FG002|Overall Study|Randomized, Not treated|0|||
13082734|NCT04539262|25784504|FG003|Overall Study|Randomized, Not treated|0|||
13082735|NCT04539262|25784505|FG004|Overall Study|Randomized, Not treated|0|||
13082736|NCT04539262|25784506|FG005|Overall Study|Randomized, Not treated|0|||
13082737|NCT04539262|25784507|FG006|Overall Study|Randomized, Not treated|1|||
13082738|NCT04539262|25784508|FG007|Overall Study|Randomized, Not treated|0|||
13082739|NCT04538170|25784525|FG000|Overall Study|Withdrawal by Subject|104|||
13082740|NCT04538170|25784526|FG001|Overall Study|Withdrawal by Subject|210|||
13082741|NCT04537949|25784617|FG000|Overall Study|personal reasons not related to the IMP|1|||
13082742|NCT04537949|25784618|FG001|Overall Study|personal reasons not related to the IMP|0|||
13082743|NCT04537949|25784619|FG002|Overall Study|personal reasons not related to the IMP|0|||
13082744|NCT04537949|25784620|FG003|Overall Study|personal reasons not related to the IMP|0|||
13082745|NCT04537949|25784621|FG004|Overall Study|personal reasons not related to the IMP|0|||
13082746|NCT04537949|25784622|FG005|Overall Study|personal reasons not related to the IMP|0|||
13082747|NCT04537949|25784623|FG006|Overall Study|personal reasons not related to the IMP|0|||
13082748|NCT04537949|25784624|FG007|Overall Study|personal reasons not related to the IMP|0|||
13082749|NCT04537806|25784641|FG000|Overall Study|Randomized but not treated|1|||
13082750|NCT04537806|25784642|FG001|Overall Study|Randomized but not treated|0|||
13082751|NCT04537806|25784641|FG000|Overall Study|Adverse Event|1|||
13082752|NCT04537806|25784642|FG001|Overall Study|Adverse Event|1|||
13082753|NCT04537234|25784673|FG000|Overall Study|Withdrawal by Subject|2|||
13082754|NCT04537234|25784674|FG001|Overall Study|Withdrawal by Subject|0|||
13082755|NCT04537078|25784713|FG000|Overall Study|Protocol Violation|3|||
13082756|NCT04537078|25784714|FG001|Overall Study|Protocol Violation|2|||
13082757|NCT04537078|25784713|FG000|Overall Study|Lost to Follow-up|1|||
13082758|NCT04537078|25784714|FG001|Overall Study|Lost to Follow-up|0|||
13082759|NCT04537078|25784713|FG000|Overall Study|Withdrawal by Subject|0|||
13082760|NCT04537078|25784714|FG001|Overall Study|Withdrawal by Subject|1|||
13082761|NCT04535947|25784749|FG000|Overall Study|Adverse Event|1|||
13082762|NCT04535947|25784750|FG001|Overall Study|Adverse Event|4|||
13082763|NCT04535947|25784749|FG000|Overall Study|Other reasons not specified|2|||
13082764|NCT04535947|25784750|FG001|Overall Study|Other reasons not specified|0|||
13082765|NCT04535947|25784749|FG000|Overall Study|Withdrawal by Subject|1|||
13082766|NCT04535947|25784750|FG001|Overall Study|Withdrawal by Subject|1|||
13082767|NCT04534491|25784761|FG000|Overall Study|Not completed end-of-study interview|24|||
13082768|NCT04534491|25784761|FG000|Overall Study|Non-users|70|||
13082769|NCT04534491|25784761|FG000|Overall Study|Non-verifiable users|58|||
13082770|NCT04533204|25784776|FG000|Overall Study|Unable to understand training instructions|1|||
13082771|NCT04533204|25784777|FG001|Overall Study|Unable to understand training instructions|1|||
13082772|NCT04532164|25784790|FG000|Overall Study|Adverse Event|1|||
13082773|NCT04532164|25784790|FG000|Overall Study|Protocol Violation|5|||
13082774|NCT04532164|25784790|FG000|Overall Study|Lost to Follow-up|1|||
13082775|NCT04532164|25784790|FG000|Overall Study|Found to be Ineligible|3|||
13082776|NCT04532164|25784790|FG000|Overall Study|Withdrawal by Subject|14|||
13082777|NCT04532099|25784812|FG000|First Wear Period (30 Days)|Withdrawal by Subject|1|||
13082778|NCT04532099|25784813|FG001|First Wear Period (30 Days)|Withdrawal by Subject|0|||
13082779|NCT04532099|25784814|FG002|First Wear Period (30 Days)|Withdrawal by Subject|0|||
13082780|NCT04531813|25784820|FG000|Overall Study|Protocol Violation|1|||
13082781|NCT04531813|25784820|FG000|Overall Study|Withdrawal by Subject|1|||
13082782|NCT04531540|25784829|FG000|Overall Study|Adverse Event|1|||
13082783|NCT04531540|25784829|FG000|Overall Study|Protocol Violation|3|||
13082784|NCT04531540|25784829|FG000|Overall Study|Withdrawal by Subject|4|||
13082785|NCT04531540|25784829|FG000|Overall Study|Found to be Ineligible|1|||
13082786|NCT04531527|25784836|FG000|Overall Study|Found to be Ineligible|3|||
13082787|NCT04531098|25784863|FG000|Stage I|Adverse Event|0|||
13082788|NCT04531098|25784864|FG001|Stage I|Adverse Event|0|||
13082789|NCT04531098|25784865|FG002|Stage I|Adverse Event|3|||
13082790|NCT04531098|25784863|FG000|Stage I|Protocol Violation|0|||
13082791|NCT04531098|25784864|FG001|Stage I|Protocol Violation|0|||
13082792|NCT04531098|25784865|FG002|Stage I|Protocol Violation|5|||
13082793|NCT04531098|25784863|FG000|Stage I|Withdrawal by Subject|0|||
13082794|NCT04531098|25784864|FG001|Stage I|Withdrawal by Subject|5|||
13082795|NCT04531098|25784865|FG002|Stage I|Withdrawal by Subject|10|||
13222451|NCT01806597|26286271|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0|||
13222452|NCT01806597|26286266|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12|||
13222453|NCT01806597|26286267|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5|||
13222454|NCT01806597|26286268|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3|||
13222455|NCT01806597|26286269|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1|||
13222456|NCT01806597|26286270|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
13222457|NCT01806597|26286271|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
13222458|NCT01806597|26286266|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2|||
13082796|NCT04531098|25784863|FG000|Stage II|Adverse Event|1|||
13082797|NCT04531098|25784864|FG001|Stage II|Adverse Event|2|||
13082798|NCT04531098|25784865|FG002|Stage II|Adverse Event|0|||
13082799|NCT04531098|25784863|FG000|Stage II|Protocol Violation|1|||
13222459|NCT01806597|26286267|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
13222460|NCT01806597|26286268|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
13222461|NCT01806597|26286269|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
13222462|NCT01806597|26286270|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
13222463|NCT01806597|26286271|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
13082800|NCT04531098|25784864|FG001|Stage II|Protocol Violation|2|||
13082801|NCT04531098|25784865|FG002|Stage II|Protocol Violation|0|||
13082802|NCT04531098|25784863|FG000|Stage II|Withdrawal by Subject|3|||
13082803|NCT04531098|25784864|FG001|Stage II|Withdrawal by Subject|1|||
13082804|NCT04531098|25784865|FG002|Stage II|Withdrawal by Subject|0|||
13082805|NCT04531098|25784863|FG000|Stage II|Moved from study area|8|||
13082806|NCT04531098|25784864|FG001|Stage II|Moved from study area|5|||
13082807|NCT04531098|25784865|FG002|Stage II|Moved from study area|0|||
13082808|NCT04529850|25784872|FG000|Overall Study|Death|2|||
13082809|NCT04529850|25784872|FG000|Overall Study|Physician Decision|1|||
13082810|NCT04529850|25784872|FG000|Overall Study|Withdrawal by Subject|2|||
13082811|NCT04529109|25784881|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
13082812|NCT04529109|25784882|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
13082813|NCT04529096|25784909|FG000|Overall Study|Adverse Event|6|||
13082814|NCT04529096|25784910|FG001|Overall Study|Adverse Event|1|||
13082815|NCT04529096|25784909|FG000|Overall Study|Lack of Efficacy|1|||
13082816|NCT04529096|25784910|FG001|Overall Study|Lack of Efficacy|0|||
13082817|NCT04529096|25784909|FG000|Overall Study|Lost to Follow-up|1|||
13082818|NCT04529096|25784910|FG001|Overall Study|Lost to Follow-up|1|||
13082819|NCT04529096|25784909|FG000|Overall Study|Non-Compliance With Study Drug|0|||
13082820|NCT04529096|25784910|FG001|Overall Study|Non-Compliance With Study Drug|1|||
13082821|NCT04529096|25784909|FG000|Overall Study|Physician Decision|1|||
13082822|NCT04529096|25784910|FG001|Overall Study|Physician Decision|3|||
13082823|NCT04529096|25784909|FG000|Overall Study|Withdrawal by Subject|5|||
13082824|NCT04529096|25784910|FG001|Overall Study|Withdrawal by Subject|0|||
13082825|NCT04528641|25785111|FG000|Overall Study|Withdrawal by Subject|0|||
13082826|NCT04528641|25785112|FG001|Overall Study|Withdrawal by Subject|0|||
13082827|NCT04528641|25785113|FG002|Overall Study|Withdrawal by Subject|0|||
13082828|NCT04528641|25785114|FG003|Overall Study|Withdrawal by Subject|1|||
13082829|NCT04528641|25785115|FG004|Overall Study|Withdrawal by Subject|0|||
13082830|NCT04528641|25785116|FG005|Overall Study|Withdrawal by Subject|1|||
13082831|NCT04527978|25785132|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
13082832|NCT04527978|25785133|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
13082833|NCT04527471|25785146|FG000|Overall Study|Adverse Event|1|||
13082834|NCT04527471|25785147|FG001|Overall Study|Adverse Event|0|||
13082835|NCT04527471|25785146|FG000|Overall Study|Lost to Follow-up|1|||
13082836|NCT04527471|25785147|FG001|Overall Study|Lost to Follow-up|0|||
13082837|NCT04526574|25785182|FG000|Overall Study|Protocol Violation|3|||
13082838|NCT04526574|25785183|FG001|Overall Study|Protocol Violation|1|||
13082839|NCT04526574|25785182|FG000|Overall Study|Withdrawal by Subject|12|||
13082840|NCT04526574|25785183|FG001|Overall Study|Withdrawal by Subject|9|||
13082841|NCT04526574|25785182|FG000|Overall Study|Other|1|||
13082842|NCT04526574|25785183|FG001|Overall Study|Other|2|||
13082843|NCT04526574|25785182|FG000|Overall Study|Adverse Event|1|||
13082844|NCT04526574|25785183|FG001|Overall Study|Adverse Event|1|||
13082845|NCT04526574|25785182|FG000|Overall Study|Death|2|||
13082846|NCT04526574|25785183|FG001|Overall Study|Death|3|||
13082847|NCT04526574|25785182|FG000|Overall Study|Lost to Follow-up|9|||
13082848|NCT04526574|25785183|FG001|Overall Study|Lost to Follow-up|9|||
13082849|NCT04526574|25785182|FG000|Overall Study|No longer meets eligibility criteria|8|||
13082850|NCT04526574|25785183|FG001|Overall Study|No longer meets eligibility criteria|8|||
13082851|NCT04523831|25785202|FG000|Overall Study|Lost to Follow-up|15|||
13082852|NCT04523831|25785203|FG001|Overall Study|Lost to Follow-up|17|||
13082853|NCT04523831|25785202|FG000|Overall Study|Death|0|||
13082854|NCT04523831|25785203|FG001|Overall Study|Death|3|||
13082855|NCT04523831|25785202|FG000|Overall Study|Adverse Event|2|||
13082856|NCT04523831|25785203|FG001|Overall Study|Adverse Event|0|||
13082857|NCT04521777|25785214|FG000|Overall Study|Death|2|||
13082858|NCT04521777|25785214|FG000|Overall Study|Withdrawal by Subject|2|||
13082859|NCT04516759|25785245|FG000|Overall Study|Withdrawal by Subject|1|||
13082860|NCT04516759|25785246|FG001|Overall Study|Withdrawal by Subject|1|||
13082861|NCT04516759|25785245|FG000|Overall Study|Other|0|||
13082862|NCT04516759|25785246|FG001|Overall Study|Other|1|||
13082863|NCT04516291|25785321|FG000|Treatment Period (24 Weeks)|Other|1|||
13082864|NCT04516291|25785322|FG001|Treatment Period (24 Weeks)|Other|0|||
13082865|NCT04516291|25785323|FG002|Treatment Period (24 Weeks)|Other|0|||
13082866|NCT04516291|25785324|FG003|Treatment Period (24 Weeks)|Other|2|||
13082867|NCT04516291|25785325|FG004|Treatment Period (24 Weeks)|Other|2|||
13082868|NCT04516291|25785326|FG005|Treatment Period (24 Weeks)|Other|4|||
13082869|NCT04516291|25785327|FG006|Treatment Period (24 Weeks)|Other|2|||
13082870|NCT04516291|25785328|FG007|Treatment Period (24 Weeks)|Other|0|||
13082871|NCT04516291|25785321|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
13082872|NCT04516291|25785322|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
13082873|NCT04516291|25785323|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
13082874|NCT04516291|25785324|FG003|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
13082875|NCT04516291|25785325|FG004|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
13082876|NCT04516291|25785326|FG005|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
13082877|NCT04516291|25785327|FG006|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
13082878|NCT04516291|25785328|FG007|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
13082879|NCT04516291|25785321|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
13082880|NCT04516291|25785322|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
13082881|NCT04516291|25785323|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
13082882|NCT04516291|25785324|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
13082883|NCT04516291|25785325|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
13082884|NCT04516291|25785326|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
13082885|NCT04516291|25785327|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
13082886|NCT04516291|25785328|FG007|Treatment Period (24 Weeks)|Protocol Violation|0|||
13082887|NCT04516291|25785321|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
13082888|NCT04516291|25785322|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|1|||
13082889|NCT04516291|25785323|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
13082890|NCT04516291|25785324|FG003|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
13082891|NCT04516291|25785325|FG004|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
13082892|NCT04516291|25785326|FG005|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
13082893|NCT04516291|25785327|FG006|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
13082894|NCT04516291|25785328|FG007|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
13082895|NCT04516291|25785321|FG000|Treatment Period (24 Weeks)|Adverse Event|1|||
13082896|NCT04516291|25785322|FG001|Treatment Period (24 Weeks)|Adverse Event|2|||
13082897|NCT04516291|25785323|FG002|Treatment Period (24 Weeks)|Adverse Event|3|||
13082898|NCT04516291|25785324|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
13082899|NCT04516291|25785325|FG004|Treatment Period (24 Weeks)|Adverse Event|9|||
13082900|NCT04516291|25785326|FG005|Treatment Period (24 Weeks)|Adverse Event|4|||
13082901|NCT04516291|25785327|FG006|Treatment Period (24 Weeks)|Adverse Event|7|||
13082902|NCT04516291|25785328|FG007|Treatment Period (24 Weeks)|Adverse Event|14|||
13082903|NCT04516291|25785321|FG000|Follow-up Period (12 Weeks)|Other|0|||
13082904|NCT04516291|25785322|FG001|Follow-up Period (12 Weeks)|Other|1|||
13082905|NCT04516291|25785323|FG002|Follow-up Period (12 Weeks)|Other|0|||
13082906|NCT04516291|25785324|FG003|Follow-up Period (12 Weeks)|Other|2|||
13082907|NCT04516291|25785325|FG004|Follow-up Period (12 Weeks)|Other|0|||
13082908|NCT04516291|25785326|FG005|Follow-up Period (12 Weeks)|Other|0|||
13082909|NCT04516291|25785327|FG006|Follow-up Period (12 Weeks)|Other|0|||
13082910|NCT04516291|25785328|FG007|Follow-up Period (12 Weeks)|Other|0|||
13082911|NCT04516291|25785321|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
13082912|NCT04516291|25785322|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
13082913|NCT04516291|25785323|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
13082914|NCT04516291|25785324|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
13082915|NCT04516291|25785325|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
13082916|NCT04516291|25785326|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
13082917|NCT04516291|25785327|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
13082918|NCT04516291|25785328|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
13082919|NCT04516291|25785321|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
13082920|NCT04516291|25785322|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
13082921|NCT04516291|25785323|FG002|Follow-up Period (12 Weeks)|Adverse Event|1|||
13082922|NCT04516291|25785324|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
13082923|NCT04516291|25785325|FG004|Follow-up Period (12 Weeks)|Adverse Event|1|||
13082924|NCT04516291|25785326|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
13082925|NCT04516291|25785327|FG006|Follow-up Period (12 Weeks)|Adverse Event|0|||
13082926|NCT04516291|25785328|FG007|Follow-up Period (12 Weeks)|Adverse Event|0|||
13132296|NCT02793232|25983100|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
13132297|NCT02793232|25983101|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
13132298|NCT02793128|25983117|FG000|Overall Study|Death|4|||
13132299|NCT02793128|25983117|FG000|Overall Study|Withdrawal by Subject|2|||
13132300|NCT02793128|25983117|FG000|Overall Study|Physician Decision|1|||
13132301|NCT02793128|25983117|FG000|Overall Study|Comorbid conditions and noncompliance|1|||
13132302|NCT02793128|25983117|FG000|Overall Study|Patient elected nephroureterectomy|1|||
13132303|NCT02792959|25983178|FG000|Overall Study|Protocol Violation|1|||
13132304|NCT02792829|25983309|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0|||
13132305|NCT02792829|25983310|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1|||
13132306|NCT02792829|25983311|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0|||
13132307|NCT02792829|25983312|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0|||
13132308|NCT02792829|25983313|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0|||
13132309|NCT02792829|25983314|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0|||
13132310|NCT02792829|25983315|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0|||
13132311|NCT02792829|25983316|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0|||
13132312|NCT02792829|25983309|FG000|Treatment Period 2|Adverse Event|0|||
13082927|NCT04512482|25785341|FG000|Second Intervention (1 Day)|Protocol Violation|2|||
13082928|NCT04512482|25785342|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
13082929|NCT04512001|25785355|FG000|Overall Study|Adverse Event|14|||
13082930|NCT04512001|25785356|FG001|Overall Study|Adverse Event|10|||
13082931|NCT04512001|25785355|FG000|Overall Study|Death|0|||
13082932|NCT04512001|25785356|FG001|Overall Study|Death|2|||
13082933|NCT04512001|25785355|FG000|Overall Study|Withdrawal by Subject|16|||
13082934|NCT04512001|25785356|FG001|Overall Study|Withdrawal by Subject|9|||
13082935|NCT04512001|25785355|FG000|Overall Study|Discontinued treatment prior to Week 24|4|||
13082936|NCT04512001|25785356|FG001|Overall Study|Discontinued treatment prior to Week 24|4|||
13082937|NCT04512001|25785355|FG000|Overall Study|Withdrawal By Sponsor's Decision|1|||
13082938|NCT04512001|25785356|FG001|Overall Study|Withdrawal By Sponsor's Decision|0|||
13082939|NCT04512001|25785355|FG000|Overall Study|Subject Did Not Meet Eligibility At Week 24|0|||
13082940|NCT04512001|25785356|FG001|Overall Study|Subject Did Not Meet Eligibility At Week 24|1|||
13082941|NCT04507867|25785419|FG000|Overall Study|Death|7|||
13082942|NCT04507867|25785420|FG001|Overall Study|Death|1|||
13082943|NCT04507776|25785434|FG000|Overall Study|Participants did not meet the entrance criteria|201|||
13082944|NCT04507763|25785447|FG000|Overall Study|Participants did not meet entrance criteria|201|||
13082945|NCT04504032|25785488|FG000|Overall Study|Adverse Event|1|||
13082946|NCT04504032|25785489|FG001|Overall Study|Adverse Event|2|||
13082947|NCT04504032|25785488|FG000|Overall Study|Lost to Follow-up|6|||
13082948|NCT04504032|25785489|FG001|Overall Study|Lost to Follow-up|9|||
13082949|NCT04504032|25785488|FG000|Overall Study|Protocol Violation|2|||
13082950|NCT04504032|25785489|FG001|Overall Study|Protocol Violation|0|||
13082951|NCT04504032|25785488|FG000|Overall Study|Study terminated by sponsor|1|||
13082952|NCT04504032|25785489|FG001|Overall Study|Study terminated by sponsor|2|||
13082953|NCT04504032|25785488|FG000|Overall Study|Withdrawal by Subject|9|||
13082954|NCT04504032|25785489|FG001|Overall Study|Withdrawal by Subject|11|||
13082955|NCT04504032|25785488|FG000|Overall Study|Disease progression prior to dosing|15|||
13082956|NCT04504032|25785489|FG001|Overall Study|Disease progression prior to dosing|3|||
13082957|NCT04504032|25785488|FG000|Overall Study|Drug supply issues|1|||
13082958|NCT04504032|25785489|FG001|Overall Study|Drug supply issues|1|||
13082959|NCT04504032|25785488|FG000|Overall Study|Progressed to moderate/severe COVID-19|1|||
13082960|NCT04504032|25785489|FG001|Overall Study|Progressed to moderate/severe COVID-19|0|||
13082961|NCT04502979|25785504|FG000|Overall Study|Lost to Follow-up|1|||
13082962|NCT04502979|25785505|FG001|Overall Study|Lost to Follow-up|3|||
13082963|NCT04502979|25785504|FG000|Overall Study|Withdrawal by Subject|2|||
13082964|NCT04502979|25785505|FG001|Overall Study|Withdrawal by Subject|1|||
13082965|NCT04501952|25785538|FG000|Overall Study|Adverse Event|0|||
13082966|NCT04501952|25785539|FG001|Overall Study|Adverse Event|3|||
13082967|NCT04501952|25785538|FG000|Overall Study|Investigator's Discretion|0|||
13082968|NCT04501952|25785539|FG001|Overall Study|Investigator's Discretion|1|||
13082969|NCT04501952|25785538|FG000|Overall Study|Protocol Violation|1|||
13082970|NCT04501952|25785539|FG001|Overall Study|Protocol Violation|1|||
13082971|NCT04501952|25785538|FG000|Overall Study|Withdrew Consent|5|||
13082972|NCT04501952|25785539|FG001|Overall Study|Withdrew Consent|4|||
13082973|NCT04501952|25785538|FG000|Overall Study|Lost to Follow-up|7|||
13082974|NCT04501952|25785539|FG001|Overall Study|Lost to Follow-up|2|||
13082975|NCT04501952|25785538|FG000|Overall Study|Randomized and Never Treated|13|||
13082976|NCT04501952|25785539|FG001|Overall Study|Randomized and Never Treated|9|||
13082977|NCT04498832|25785570|FG000|Overall Study|Adverse Event|1|||
13082978|NCT04498832|25785571|FG001|Overall Study|Adverse Event|3|||
13082979|NCT04498832|25785570|FG000|Overall Study|Withdrawal by Subject|0|||
13082980|NCT04498832|25785571|FG001|Overall Study|Withdrawal by Subject|1|||
13082981|NCT04498403|25785584|FG000|Overall Study|Adverse Event|1|||
13082982|NCT04498403|25785585|FG001|Overall Study|Adverse Event|0|||
13082983|NCT04498403|25785584|FG000|Overall Study|Study Terminated By Sponsor|29|||
13082984|NCT04498403|25785585|FG001|Overall Study|Study Terminated By Sponsor|10|||
13082985|NCT04498169|25785598|FG000|Study Completion|Adverse Event|1|||
13082986|NCT04498169|25785599|FG001|Study Completion|Adverse Event|1|||
13082987|NCT04497948|25785613|FG000|Overall Study|Death|2|||
13082988|NCT04495829|25785622|FG000|Overall Study|Lost to Follow-up|2|||
13082989|NCT04495829|25785622|FG000|Overall Study|Inclusion criterion not met|3|||
13082990|NCT04495374|25785645|FG000|Overall Study|Protocol Violation|2|||
13082991|NCT04495374|25785646|FG001|Overall Study|Protocol Violation|1|||
13082992|NCT04495283|25785698|FG000|Overall Study|Physician Decision|0|||
13082993|NCT04495283|25785699|FG001|Overall Study|Physician Decision|0|||
13082994|NCT04495283|25785700|FG002|Overall Study|Physician Decision|1|||
13082995|NCT04495283|25785698|FG000|Overall Study|Withdrawal by Subject|0|||
13082996|NCT04495283|25785699|FG001|Overall Study|Withdrawal by Subject|1|||
13082997|NCT04495283|25785700|FG002|Overall Study|Withdrawal by Subject|1|||
13082998|NCT04495283|25785698|FG000|Overall Study|Other|1|||
13082999|NCT04495283|25785699|FG001|Overall Study|Other|0|||
13083000|NCT04495283|25785700|FG002|Overall Study|Other|1|||
13083001|NCT04493931|25785975|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1|||
13083002|NCT04493931|25785976|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
13132313|NCT02792829|25983310|FG001|Treatment Period 2|Adverse Event|0|||
13083003|NCT04493931|25785977|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
13083004|NCT04493931|25785978|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
13083005|NCT04493931|25785979|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
13083006|NCT04493931|25785980|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
13083007|NCT04493931|25785981|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
13083008|NCT04493931|25785975|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
13083009|NCT04493931|25785976|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2|||
13083010|NCT04493931|25785977|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
13083011|NCT04493931|25785978|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
13083012|NCT04493931|25785979|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
13083013|NCT04493931|25785980|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
13083014|NCT04493931|25785981|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
13083015|NCT04493931|25785975|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
13083016|NCT04493931|25785976|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1|||
13083017|NCT04493931|25785977|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
13083018|NCT04493931|25785978|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
13083019|NCT04493931|25785979|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
13083020|NCT04493931|25785980|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
13083021|NCT04493931|25785981|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
13083022|NCT04493931|25785975|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
13083023|NCT04493931|25785976|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
13083024|NCT04493931|25785977|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1|||
13083025|NCT04493931|25785978|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
13083026|NCT04493931|25785979|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
13083027|NCT04493931|25785980|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
13083028|NCT04493931|25785981|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
13083029|NCT04492475|25786166|FG000|Overall Study|Enrolled but not treated|8|||
13083030|NCT04492475|25786167|FG001|Overall Study|Enrolled but not treated|8|||
13083031|NCT04492475|25786166|FG000|Overall Study|Withdrawal by Subject|4|||
13083032|NCT04492475|25786167|FG001|Overall Study|Withdrawal by Subject|0|||
13083033|NCT04492475|25786166|FG000|Overall Study|Became ineligible after enrollment|2|||
13083034|NCT04492475|25786167|FG001|Overall Study|Became ineligible after enrollment|0|||
13083035|NCT04491994|25786180|FG000|Overall Study|Withdrawal by Subject|10|||
13083036|NCT04491994|25786181|FG001|Overall Study|Withdrawal by Subject|5|||
13083037|NCT04491994|25786180|FG000|Overall Study|developed fever > 3 days|4|||
13083038|NCT04491994|25786181|FG001|Overall Study|developed fever > 3 days|1|||
13083039|NCT04491994|25786180|FG000|Overall Study|Protocol Violation|11|||
13083040|NCT04491994|25786181|FG001|Overall Study|Protocol Violation|2|||
13083041|NCT04491994|25786180|FG000|Overall Study|Lost to Follow-up|4|||
13083042|NCT04491994|25786181|FG001|Overall Study|Lost to Follow-up|3|||
13083043|NCT04490499|25786188|FG000|Overall Study|Withdrawal by Subject|2|||
13083044|NCT04486235|25786204|FG000|Overall Study|Pregnancy|1|||
13083045|NCT04486235|25786205|FG001|Overall Study|Pregnancy|0|||
13083046|NCT04486235|25786204|FG000|Overall Study|Lost to Follow-up|1|||
13083047|NCT04486235|25786205|FG001|Overall Study|Lost to Follow-up|0|||
13083048|NCT04484857|25786212|FG000|Overall Study|Adverse Event|2|||
13083049|NCT04484857|25786212|FG000|Overall Study|Death|10|||
13083050|NCT04484857|25786212|FG000|Overall Study|Withdrawal by Subject|3|||
13083051|NCT04484857|25786212|FG000|Overall Study|Transferred/Relocation|5|||
13083052|NCT04484857|25786212|FG000|Overall Study|Kidney Transplant|7|||
13083053|NCT04484857|25786212|FG000|Overall Study|Other than specified|4|||
13083054|NCT04484857|25786212|FG000|Overall Study|Participants continued an Optional Extension of Roxadustat Treatment|216|||
13083055|NCT04483011|25786247|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
13083056|NCT04483011|25786248|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
13083057|NCT04482647|25786255|FG000|Overall Study|Time constraints|2|||
13083058|NCT04482647|25786255|FG000|Overall Study|Health issues|1|||
13083059|NCT04482647|25786255|FG000|Overall Study|Death in the family|1|||
13083060|NCT04482647|25786255|FG000|Overall Study|Disliked the intervention|1|||
13083061|NCT04482647|25786255|FG000|Overall Study|No reasons specified|7|||
13083062|NCT04482439|25786272|FG000|Overall Study|Lost to Follow-up|1|||
13083063|NCT04482439|25786272|FG000|Overall Study|Unrelated illness|1|||
13083064|NCT04476784|25786288|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1|||
13083065|NCT04476784|25786289|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0|||
13083066|NCT04476108|25786316|FG000|Overall Study|Adverse Event|4|||
13083067|NCT04476108|25786317|FG001|Overall Study|Adverse Event|1|||
13083068|NCT04476108|25786316|FG000|Overall Study|Lost to Follow-up|1|||
13083069|NCT04476108|25786317|FG001|Overall Study|Lost to Follow-up|0|||
13083070|NCT04476108|25786316|FG000|Overall Study|Inadvertent Enrollment|1|||
13083071|NCT04476108|25786317|FG001|Overall Study|Inadvertent Enrollment|0|||
13083072|NCT04476108|25786316|FG000|Overall Study|Protocol Violation|1|||
13083073|NCT04476108|25786317|FG001|Overall Study|Protocol Violation|1|||
13083074|NCT04476108|25786316|FG000|Overall Study|Withdrawal by Subject|1|||
13083075|NCT04476108|25786317|FG001|Overall Study|Withdrawal by Subject|1|||
13083076|NCT04475588|25786358|FG000|Overall Study|Adverse Event|2|||
13083077|NCT04475588|25786359|FG001|Overall Study|Adverse Event|0|||
13083078|NCT04474405|25786395|FG000|Overall Study|Withdrawal by Subject|0|||
13083079|NCT04474405|25786396|FG001|Overall Study|Withdrawal by Subject|0|||
13083080|NCT04474405|25786397|FG002|Overall Study|Withdrawal by Subject|1|||
13083081|NCT04474405|25786398|FG003|Overall Study|Withdrawal by Subject|0|||
13083082|NCT04474405|25786399|FG004|Overall Study|Withdrawal by Subject|1|||
13083083|NCT04474405|25786400|FG005|Overall Study|Withdrawal by Subject|0|||
13083084|NCT04474405|25786395|FG000|Overall Study|Other|0|||
13083085|NCT04474405|25786396|FG001|Overall Study|Other|0|||
13083086|NCT04474405|25786397|FG002|Overall Study|Other|0|||
13083087|NCT04474405|25786398|FG003|Overall Study|Other|0|||
13083088|NCT04474405|25786399|FG004|Overall Study|Other|3|||
13083089|NCT04474405|25786400|FG005|Overall Study|Other|0|||
13083090|NCT04474197|25786434|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
13083091|NCT04474197|25786435|FG001|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
13083092|NCT04474197|25786436|FG002|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
13083093|NCT04474197|25786437|FG003|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
13083094|NCT04471935|25786445|FG000|Overall Study|Withdrawal by Subject|1|||
13083095|NCT04471935|25786445|FG000|Overall Study|Deemed ineligible to participate|1|||
13083096|NCT04470622|25786466|FG000|Overall Study|Withdrawal by Subject|0|||
13083097|NCT04470622|25786467|FG001|Overall Study|Withdrawal by Subject|1|||
13083098|NCT04470622|25786466|FG000|Overall Study|Screen Failure|0|||
13083099|NCT04470622|25786467|FG001|Overall Study|Screen Failure|1|||
13083100|NCT04470622|25786466|FG000|Overall Study|Death|0|||
13083101|NCT04470622|25786467|FG001|Overall Study|Death|1|||
13083102|NCT04468347|25786500|FG000|Overall Study|Withdrawal by Subject|0|||
13083103|NCT04468347|25786501|FG001|Overall Study|Withdrawal by Subject|1|||
13083104|NCT04468347|25786502|FG002|Overall Study|Withdrawal by Subject|3|||
13083105|NCT04468347|25786503|FG003|Overall Study|Withdrawal by Subject|3|||
13083106|NCT04468347|25786500|FG000|Overall Study|Lost to Follow-up|0|||
13083107|NCT04468347|25786501|FG001|Overall Study|Lost to Follow-up|0|||
13083108|NCT04468347|25786502|FG002|Overall Study|Lost to Follow-up|1|||
13083109|NCT04468347|25786503|FG003|Overall Study|Lost to Follow-up|1|||
13083110|NCT04468347|25786500|FG000|Overall Study|Physician Decision|1|||
13083111|NCT04468347|25786501|FG001|Overall Study|Physician Decision|0|||
13083112|NCT04468347|25786502|FG002|Overall Study|Physician Decision|2|||
13083113|NCT04468347|25786503|FG003|Overall Study|Physician Decision|0|||
13083114|NCT04468347|25786500|FG000|Overall Study|Protocol Violation|1|||
13083115|NCT04468347|25786501|FG001|Overall Study|Protocol Violation|0|||
13083116|NCT04468347|25786502|FG002|Overall Study|Protocol Violation|0|||
13083117|NCT04468347|25786503|FG003|Overall Study|Protocol Violation|0|||
13083118|NCT04465630|25786510|FG000|Overall Study|Sponsor Decision to terminate the study|54|||
13083119|NCT04465630|25786510|FG000|Overall Study|Screen failure|8|||
13083120|NCT04465630|25786510|FG000|Overall Study|Baseline failure|16|||
13083121|NCT04465422|25786525|FG000|Overall Study|Lost to Follow-up|0|||
13083122|NCT04465422|25786526|FG001|Overall Study|Lost to Follow-up|2|||
13083123|NCT04465396|25786633|FG000|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
13083124|NCT04465396|25786634|FG001|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
13083125|NCT04465396|25786635|FG002|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
13083126|NCT04465396|25786636|FG003|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
13083127|NCT04465357|25786660|FG000|Overall Study|Adverse Event|2|||
13083128|NCT04465357|25786660|FG000|Overall Study|Lack of Efficacy|1|||
13083129|NCT04465357|25786660|FG000|Overall Study|Lost to Follow-up|2|||
13083130|NCT04465357|25786660|FG000|Overall Study|Withdrawal by Subject|6|||
13083131|NCT04465357|25786660|FG000|Overall Study|Protocol specified withdrawal criterion met|2|||
13083132|NCT04461795|25786679|FG000|Overall Study|Lost to Follow-up|2|||
13083133|NCT04461795|25786679|FG000|Overall Study|Withdrawal by Subject|2|||
13083134|NCT04461795|25786679|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1|||
13083135|NCT04461015|25786692|FG000|Overall Study|IV access lost during the study|0|||
13083136|NCT04461015|25786693|FG001|Overall Study|IV access lost during the study|1|||
13083137|NCT04461015|25786692|FG000|Overall Study|Withdrawal by Subject|0|||
13083138|NCT04461015|25786693|FG001|Overall Study|Withdrawal by Subject|1|||
13083139|NCT04459598|25786722|FG000|Overall Study|Adverse Event|1|||
13083140|NCT04459598|25786723|FG001|Overall Study|Adverse Event|1|||
13083141|NCT04456686|25786754|FG000|Overall Study|Adverse Event|2|||
13083142|NCT04456686|25786755|FG001|Overall Study|Adverse Event|1|||
13083143|NCT04456686|25786754|FG000|Overall Study|Lack of Efficacy|3|||
13083144|NCT04456686|25786755|FG001|Overall Study|Lack of Efficacy|1|||
13083145|NCT04456686|25786754|FG000|Overall Study|Withdrew consent|3|||
13083146|NCT04456686|25786755|FG001|Overall Study|Withdrew consent|1|||
13083147|NCT04456686|25786754|FG000|Overall Study|Physician Decision|2|||
13083148|NCT04456686|25786755|FG001|Overall Study|Physician Decision|2|||
13083149|NCT04456686|25786754|FG000|Overall Study|Withdrawal by Subject|5|||
13083150|NCT04456686|25786755|FG001|Overall Study|Withdrawal by Subject|1|||
13083151|NCT04456686|25786754|FG000|Overall Study|Protocol Violation|0|||
13083152|NCT04456686|25786755|FG001|Overall Study|Protocol Violation|1|||
13083153|NCT04454567|25786798|FG000|Overall Study|Study Terminated by Sponsor|1|||
13083154|NCT04454567|25786799|FG001|Overall Study|Study Terminated by Sponsor|1|||
13083155|NCT04451330|25786818|FG000|Overall Study|Adverse Event|1|||
13083156|NCT04451330|25786819|FG001|Overall Study|Adverse Event|2|||
13083157|NCT04451330|25786818|FG000|Overall Study|Lost to Follow-up|5|||
13083158|NCT04451330|25786819|FG001|Overall Study|Lost to Follow-up|0|||
13083159|NCT04451330|25786818|FG000|Overall Study|Withdrawal by Subject|3|||
13083160|NCT04451330|25786819|FG001|Overall Study|Withdrawal by Subject|1|||
13083161|NCT04451330|25786818|FG000|Overall Study|Withdrawal by parent/guardian|1|||
13083162|NCT04451330|25786819|FG001|Overall Study|Withdrawal by parent/guardian|0|||
13083163|NCT04451330|25786818|FG000|Overall Study|Other than specified|0|||
13083164|NCT04451330|25786819|FG001|Overall Study|Other than specified|1|||
13083165|NCT04450381|25786826|FG000|Overall Study|Protocol Violation|4|||
13083166|NCT04450381|25786826|FG000|Overall Study|Wrong device setting|2|||
13083167|NCT04449341|25786841|FG000|Overall Study|Protocol Violation|1|||
13083168|NCT04449341|25786842|FG001|Overall Study|Protocol Violation|0|||
13083169|NCT04448756|25786911|FG000|Overall Study|Adverse Event|0|||
13083170|NCT04448756|25786912|FG001|Overall Study|Adverse Event|1|||
13083171|NCT04448756|25786913|FG002|Overall Study|Adverse Event|0|||
13083172|NCT04448756|25786911|FG000|Overall Study|Participant unable to attend Day 60 visit|1|||
13083173|NCT04448756|25786912|FG001|Overall Study|Participant unable to attend Day 60 visit|0|||
13083174|NCT04448756|25786913|FG002|Overall Study|Participant unable to attend Day 60 visit|0|||
13083175|NCT04448756|25786911|FG000|Overall Study|Withdrawal by Subject|0|||
13083176|NCT04448756|25786912|FG001|Overall Study|Withdrawal by Subject|3|||
13083177|NCT04448756|25786913|FG002|Overall Study|Withdrawal by Subject|1|||
13083178|NCT04448756|25786911|FG000|Overall Study|Death|2|||
13083179|NCT04448756|25786912|FG001|Overall Study|Death|1|||
13083180|NCT04448756|25786913|FG002|Overall Study|Death|0|||
13083181|NCT04448561|25787000|FG000|Overall Study|Noncompliance|1|||
13083182|NCT04448561|25787001|FG001|Overall Study|Noncompliance|0|||
13083183|NCT04447417|25787042|FG000|Overall Study|Withdrawal by Subject|1|||
13083184|NCT04447417|25787043|FG001|Overall Study|Withdrawal by Subject|0|||
13083185|NCT04447417|25787042|FG000|Overall Study|Failure to meet inclusion criteria|1|||
13083186|NCT04447417|25787043|FG001|Overall Study|Failure to meet inclusion criteria|0|||
13083187|NCT04447417|25787042|FG000|Overall Study|Lost to Follow-up|1|||
13083188|NCT04447417|25787043|FG001|Overall Study|Lost to Follow-up|0|||
13083189|NCT04447404|25787062|FG000|Overall Study|Death|2|||
13083190|NCT04447404|25787063|FG001|Overall Study|Death|0|||
13083191|NCT04439344|25787071|FG000|Overall Study|Never started threapy|3|||
13083192|NCT04439344|25787071|FG000|Overall Study|Ineligible|3|||
13083193|NCT04439344|25787071|FG000|Overall Study|Adverse Event|13|||
13083194|NCT04439344|25787071|FG000|Overall Study|Death|2|||
13083195|NCT04439344|25787071|FG000|Overall Study|Disease progression|29|||
13083196|NCT04439344|25787071|FG000|Overall Study|Withdrawal by Subject|2|||
13083197|NCT04439344|25787071|FG000|Overall Study|Alternative therapy|1|||
13083198|NCT04439279|25787079|FG000|Overall Study|Adverse Event|7|||
13083199|NCT04439279|25787079|FG000|Overall Study|Death|4|||
13083200|NCT04439279|25787079|FG000|Overall Study|Disease progression|17|||
13083201|NCT04439279|25787079|FG000|Overall Study|Complicating disease|3|||
13083202|NCT04439279|25787079|FG000|Overall Study|Withdrawal by Subject|2|||
13083203|NCT04439279|25787079|FG000|Overall Study|Ineligible|1|||
13083204|NCT04439279|25787079|FG000|Overall Study|Treatment still ongoing|1|||
13083205|NCT04439266|25787087|FG000|Overall Study|Ineligible|1|||
13083206|NCT04439266|25787087|FG000|Overall Study|Adverse Event|1|||
13083207|NCT04439266|25787087|FG000|Overall Study|Death|1|||
13083208|NCT04439266|25787087|FG000|Overall Study|Disease progression|1|||
13083209|NCT04439266|25787087|FG000|Overall Study|Still on treatment|1|||
13083210|NCT04439253|25787095|FG000|Overall Study|Adverse Event|1|||
13083211|NCT04439253|25787095|FG000|Overall Study|Disease progression|2|||
13083212|NCT04439253|25787095|FG000|Overall Study|Complicating disease|1|||
13083213|NCT04439240|25787103|FG000|Overall Study|Ineligible|2|||
13083214|NCT04439240|25787103|FG000|Overall Study|Never started treatment|2|||
13083215|NCT04439240|25787103|FG000|Overall Study|Adverse Event|12|||
13083216|NCT04439240|25787103|FG000|Overall Study|Death|2|||
13083217|NCT04439240|25787103|FG000|Overall Study|Disease progression|25|||
13083218|NCT04439240|25787103|FG000|Overall Study|Other diseases|2|||
13083219|NCT04439240|25787103|FG000|Overall Study|Withdrawal by Subject|3|||
13083220|NCT04439240|25787103|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1|||
13083221|NCT04439240|25787103|FG000|Overall Study|Symptomatic decline|1|||
13083222|NCT04439240|25787103|FG000|Overall Study|Pogression of the lymphadenopathy|1|||
13083223|NCT04439240|25787103|FG000|Overall Study|Clinical progression|1|||
13083224|NCT04439214|25787111|FG000|Overall Study|Adverse Event|13|||
13083225|NCT04439214|25787111|FG000|Overall Study|Disease progression|16|||
13083226|NCT04439214|25787111|FG000|Overall Study|Death|1|||
13083227|NCT04439214|25787111|FG000|Overall Study|Withdrawal by Subject|2|||
13083228|NCT04439214|25787111|FG000|Overall Study|Declining health|1|||
13132314|NCT02792829|25983311|FG002|Treatment Period 2|Adverse Event|0|||
13083229|NCT04439214|25787111|FG000|Overall Study|Still receiving treatment at the time of the analysis|9|||
13083230|NCT04439214|25787111|FG000|Overall Study|Ineligible|5|||
13083231|NCT04439123|25787119|FG000|Overall Study|Adverse Event|11|||
13083232|NCT04439123|25787119|FG000|Overall Study|Death|1|||
13083233|NCT04439123|25787119|FG000|Overall Study|Disease progression|19|||
13083234|NCT04439123|25787119|FG000|Overall Study|Withdrawal by Subject|2|||
13083235|NCT04439123|25787119|FG000|Overall Study|Still on treatment|2|||
13083236|NCT04439110|25787127|FG000|Overall Study|Ineligible|2|||
13083237|NCT04439110|25787127|FG000|Overall Study|Adverse Event|4|||
13083238|NCT04439110|25787127|FG000|Overall Study|Death|2|||
13083239|NCT04439110|25787127|FG000|Overall Study|Disease proression|25|||
13083240|NCT04439110|25787127|FG000|Overall Study|Withdrawal by Subject|1|||
13083241|NCT04439110|25787127|FG000|Overall Study|Alternative therapy|1|||
13083242|NCT04439110|25787127|FG000|Overall Study|Other complicating disease|1|||
13083243|NCT04439110|25787127|FG000|Overall Study|Personal reasons|1|||
13083244|NCT04439110|25787127|FG000|Overall Study|Still on treatment|1|||
13083245|NCT04438785|25787156|FG000|Overall Study|change of weight, give up intervention|2|||
13083246|NCT04438785|25787157|FG001|Overall Study|change of weight, give up intervention|10|||
13083247|NCT04438499|25787163|FG000|Overall Study|Lack of Efficacy|2|||
13083248|NCT04435665|25787210|FG000|Overall Study|Lost to Follow-up|0|||
13083249|NCT04435665|25787211|FG001|Overall Study|Lost to Follow-up|0|||
13083250|NCT04435665|25787212|FG002|Overall Study|Lost to Follow-up|0|||
13083251|NCT04435665|25787213|FG003|Overall Study|Lost to Follow-up|1|||
13083252|NCT04435184|25787254|FG000|Overall Study|follow-up blood draws missing|3|||
13083253|NCT04435184|25787255|FG001|Overall Study|follow-up blood draws missing|5|||
13083254|NCT04432376|25787276|FG000|Double-blind Treatment Period|Adverse Event|2|||
13083255|NCT04432376|25787277|FG001|Double-blind Treatment Period|Adverse Event|6|||
13083256|NCT04432376|25787278|FG002|Double-blind Treatment Period|Adverse Event|0|||
13083257|NCT04432376|25787276|FG000|Double-blind Treatment Period|Lost to Follow-up|2|||
13083258|NCT04432376|25787277|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
13083259|NCT04432376|25787278|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
13083260|NCT04432376|25787276|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
13083261|NCT04432376|25787277|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
13083262|NCT04432376|25787278|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
13083263|NCT04432376|25787276|FG000|Double-blind Treatment Period|Protocol Violation|0|||
13083264|NCT04432376|25787277|FG001|Double-blind Treatment Period|Protocol Violation|1|||
13083265|NCT04432376|25787278|FG002|Double-blind Treatment Period|Protocol Violation|0|||
13083266|NCT04432376|25787276|FG000|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
13083267|NCT04432376|25787277|FG001|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|1|||
13083268|NCT04432376|25787278|FG002|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
13083269|NCT04428502|25787289|FG000|Overall Study|Did not meet entrance criteria|14|||
13083270|NCT04428424|25787298|FG000|Overall Study|Does not meet entrance criteria|132|||
13083271|NCT04428424|25787298|FG000|Overall Study|Lost to Follow-up|115|||
13083272|NCT04428411|25787327|FG000|Overall Study|Lost to Follow-up|114|||
13083273|NCT04427501|25787452|FG000|Overall Study|Death|0|||
13083274|NCT04427501|25787453|FG001|Overall Study|Death|0|||
13083275|NCT04427501|25787454|FG002|Overall Study|Death|0|||
13083276|NCT04427501|25787455|FG003|Overall Study|Death|0|||
13083277|NCT04427501|25787456|FG004|Overall Study|Death|0|||
13083278|NCT04427501|25787457|FG005|Overall Study|Death|15|||
13083279|NCT04427501|25787458|FG006|Overall Study|Death|0|||
13083280|NCT04427501|25787459|FG007|Overall Study|Death|0|||
13083281|NCT04427501|25787460|FG008|Overall Study|Death|0|||
13083282|NCT04427501|25787461|FG009|Overall Study|Death|0|||
13083283|NCT04427501|25787452|FG000|Overall Study|Lost to Follow-up|5|||
13083284|NCT04427501|25787453|FG001|Overall Study|Lost to Follow-up|1|||
13083285|NCT04427501|25787454|FG002|Overall Study|Lost to Follow-up|2|||
13083286|NCT04427501|25787455|FG003|Overall Study|Lost to Follow-up|0|||
13083287|NCT04427501|25787456|FG004|Overall Study|Lost to Follow-up|2|||
13083288|NCT04427501|25787457|FG005|Overall Study|Lost to Follow-up|11|||
13083289|NCT04427501|25787458|FG006|Overall Study|Lost to Follow-up|10|||
13083290|NCT04427501|25787459|FG007|Overall Study|Lost to Follow-up|10|||
13083291|NCT04427501|25787460|FG008|Overall Study|Lost to Follow-up|2|||
13083292|NCT04427501|25787461|FG009|Overall Study|Lost to Follow-up|5|||
13083293|NCT04427501|25787452|FG000|Overall Study|Physician Decision|0|||
13083294|NCT04427501|25787453|FG001|Overall Study|Physician Decision|3|||
13083295|NCT04427501|25787454|FG002|Overall Study|Physician Decision|0|||
13083296|NCT04427501|25787455|FG003|Overall Study|Physician Decision|0|||
13083297|NCT04427501|25787456|FG004|Overall Study|Physician Decision|0|||
13083298|NCT04427501|25787457|FG005|Overall Study|Physician Decision|0|||
13083299|NCT04427501|25787458|FG006|Overall Study|Physician Decision|2|||
13083300|NCT04427501|25787459|FG007|Overall Study|Physician Decision|0|||
13083301|NCT04427501|25787460|FG008|Overall Study|Physician Decision|0|||
13083302|NCT04427501|25787461|FG009|Overall Study|Physician Decision|0|||
13083303|NCT04427501|25787452|FG000|Overall Study|Withdrawal by Subject|9|||
13083304|NCT04427501|25787453|FG001|Overall Study|Withdrawal by Subject|2|||
13083305|NCT04427501|25787454|FG002|Overall Study|Withdrawal by Subject|2|||
13083306|NCT04427501|25787455|FG003|Overall Study|Withdrawal by Subject|3|||
13083307|NCT04427501|25787456|FG004|Overall Study|Withdrawal by Subject|7|||
13083308|NCT04427501|25787457|FG005|Overall Study|Withdrawal by Subject|25|||
13083309|NCT04427501|25787458|FG006|Overall Study|Withdrawal by Subject|15|||
13083310|NCT04427501|25787459|FG007|Overall Study|Withdrawal by Subject|7|||
13083311|NCT04427501|25787460|FG008|Overall Study|Withdrawal by Subject|4|||
13083312|NCT04427501|25787461|FG009|Overall Study|Withdrawal by Subject|1|||
13083313|NCT04427501|25787452|FG000|Overall Study|Other - as reported by the investigator|1|||
13083314|NCT04427501|25787453|FG001|Overall Study|Other - as reported by the investigator|0|||
13083315|NCT04427501|25787454|FG002|Overall Study|Other - as reported by the investigator|0|||
13083316|NCT04427501|25787455|FG003|Overall Study|Other - as reported by the investigator|0|||
13083317|NCT04427501|25787456|FG004|Overall Study|Other - as reported by the investigator|0|||
13083318|NCT04427501|25787457|FG005|Overall Study|Other - as reported by the investigator|6|||
13083319|NCT04427501|25787458|FG006|Overall Study|Other - as reported by the investigator|6|||
13083320|NCT04427501|25787459|FG007|Overall Study|Other - as reported by the investigator|0|||
13083321|NCT04427501|25787460|FG008|Overall Study|Other - as reported by the investigator|0|||
13083322|NCT04427501|25787461|FG009|Overall Study|Other - as reported by the investigator|0|||
13083323|NCT04426318|25787494|FG000|Overall Study|failed attention checks and had their data removed from analyses|2|||
13083324|NCT04426318|25787495|FG001|Overall Study|failed attention checks and had their data removed from analyses|2|||
13083325|NCT04425863|25787525|FG000|Overall Study|Death|0|||
13083326|NCT04425863|25787526|FG001|Overall Study|Death|0|||
13083327|NCT04425863|25787527|FG002|Overall Study|Death|1|||
13083328|NCT04425252|25787550|FG000|Overall Study|Withdrawal by Subject|2|||
13083329|NCT04425252|25787551|FG001|Overall Study|Withdrawal by Subject|1|||
13083330|NCT04425252|25787550|FG000|Overall Study|Lost to Follow-up|1|||
13083331|NCT04425252|25787551|FG001|Overall Study|Lost to Follow-up|0|||
13083332|NCT04425252|25787550|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
13083333|NCT04425252|25787551|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
13083334|NCT04422990|25787569|FG000|Overall Study|Withdrawal by Subject|0|||
13083335|NCT04422990|25787570|FG001|Overall Study|Withdrawal by Subject|1|||
13083336|NCT04422990|25787569|FG000|Overall Study|Travel|3|||
13083337|NCT04422990|25787570|FG001|Overall Study|Travel|0|||
13083338|NCT04422561|25787583|FG000|Overall Study|Lost to Follow-up|25|||
13083339|NCT04422561|25787584|FG001|Overall Study|Lost to Follow-up|11|||
13083340|NCT04421027|25787641|FG000|Treatment Period|Adverse Event|5|||
13083341|NCT04421027|25787642|FG001|Treatment Period|Adverse Event|3|||
13083342|NCT04421027|25787643|FG002|Treatment Period|Adverse Event|0|||
13083343|NCT04421027|25787644|FG003|Treatment Period|Adverse Event|0|||
13083344|NCT04421027|25787641|FG000|Treatment Period|Death|98|||
13083345|NCT04421027|25787642|FG001|Treatment Period|Death|61|||
13083346|NCT04421027|25787643|FG002|Treatment Period|Death|0|||
13083347|NCT04421027|25787644|FG003|Treatment Period|Death|0|||
13083348|NCT04421027|25787641|FG000|Treatment Period|Lost to Follow-up|22|||
13083349|NCT04421027|25787642|FG001|Treatment Period|Lost to Follow-up|20|||
13083350|NCT04421027|25787643|FG002|Treatment Period|Lost to Follow-up|0|||
13083351|NCT04421027|25787644|FG003|Treatment Period|Lost to Follow-up|0|||
13083352|NCT04421027|25787641|FG000|Treatment Period|Other-Unknown|15|||
13083353|NCT04421027|25787642|FG001|Treatment Period|Other-Unknown|9|||
13083354|NCT04421027|25787643|FG002|Treatment Period|Other-Unknown|0|||
13083355|NCT04421027|25787644|FG003|Treatment Period|Other-Unknown|0|||
13083356|NCT04421027|25787641|FG000|Treatment Period|Physician Decision|1|||
13083357|NCT04421027|25787642|FG001|Treatment Period|Physician Decision|1|||
13083358|NCT04421027|25787643|FG002|Treatment Period|Physician Decision|0|||
13083359|NCT04421027|25787644|FG003|Treatment Period|Physician Decision|0|||
13083360|NCT04421027|25787641|FG000|Treatment Period|Withdrawal by Subject|7|||
13083361|NCT04421027|25787642|FG001|Treatment Period|Withdrawal by Subject|12|||
13083362|NCT04421027|25787643|FG002|Treatment Period|Withdrawal by Subject|0|||
13083363|NCT04421027|25787644|FG003|Treatment Period|Withdrawal by Subject|0|||
13083364|NCT04421027|25787641|FG000|Treatment Period|Randomized Not Dosed|9|||
13083365|NCT04421027|25787642|FG001|Treatment Period|Randomized Not Dosed|14|||
13083366|NCT04421027|25787643|FG002|Treatment Period|Randomized Not Dosed|0|||
13083367|NCT04421027|25787644|FG003|Treatment Period|Randomized Not Dosed|0|||
13083368|NCT04421027|25787641|FG000|Follow-Up Period|Adverse Event|0|||
13083369|NCT04421027|25787642|FG001|Follow-Up Period|Adverse Event|0|||
13083370|NCT04421027|25787643|FG002|Follow-Up Period|Adverse Event|0|||
13083371|NCT04421027|25787644|FG003|Follow-Up Period|Adverse Event|3|||
13083372|NCT04421027|25787641|FG000|Follow-Up Period|Death|0|||
13083373|NCT04421027|25787642|FG001|Follow-Up Period|Death|0|||
13083374|NCT04421027|25787643|FG002|Follow-Up Period|Death|16|||
13083375|NCT04421027|25787644|FG003|Follow-Up Period|Death|17|||
13083376|NCT04421027|25787641|FG000|Follow-Up Period|Lost to Follow-up|0|||
13083377|NCT04421027|25787642|FG001|Follow-Up Period|Lost to Follow-up|0|||
13083378|NCT04421027|25787643|FG002|Follow-Up Period|Lost to Follow-up|7|||
13083379|NCT04421027|25787644|FG003|Follow-Up Period|Lost to Follow-up|7|||
13083380|NCT04421027|25787641|FG000|Follow-Up Period|Protocol Deviation|0|||
13132315|NCT02792829|25983312|FG003|Treatment Period 2|Adverse Event|0|||
13083381|NCT04421027|25787642|FG001|Follow-Up Period|Protocol Deviation|0|||
13083382|NCT04421027|25787643|FG002|Follow-Up Period|Protocol Deviation|1|||
13083383|NCT04421027|25787644|FG003|Follow-Up Period|Protocol Deviation|0|||
13083384|NCT04421027|25787641|FG000|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
13083385|NCT04421027|25787642|FG001|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
13083386|NCT04421027|25787643|FG002|Follow-Up Period|Still in hospital on ventilator at end of study|1|||
13083387|NCT04421027|25787644|FG003|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
13083388|NCT04421027|25787641|FG000|Follow-Up Period|Left message, participant did not call back|0|||
13083389|NCT04421027|25787642|FG001|Follow-Up Period|Left message, participant did not call back|0|||
13083390|NCT04421027|25787643|FG002|Follow-Up Period|Left message, participant did not call back|0|||
13083391|NCT04421027|25787644|FG003|Follow-Up Period|Left message, participant did not call back|1|||
13083392|NCT04421027|25787641|FG000|Follow-Up Period|Participant died|0|||
13083393|NCT04421027|25787642|FG001|Follow-Up Period|Participant died|0|||
13083394|NCT04421027|25787643|FG002|Follow-Up Period|Participant died|0|||
13083395|NCT04421027|25787644|FG003|Follow-Up Period|Participant died|1|||
13083396|NCT04421027|25787641|FG000|Follow-Up Period|Participant was alive but did not respond to calls|0|||
13083397|NCT04421027|25787642|FG001|Follow-Up Period|Participant was alive but did not respond to calls|0|||
13083398|NCT04421027|25787643|FG002|Follow-Up Period|Participant was alive but did not respond to calls|0|||
13083399|NCT04421027|25787644|FG003|Follow-Up Period|Participant was alive but did not respond to calls|1|||
13083400|NCT04419311|25787687|FG000|Overall Study|Lost to Follow-up|1|||
13083401|NCT04419311|25787688|FG001|Overall Study|Lost to Follow-up|0|||
13083402|NCT04413552|25787897|FG000|Overall Study|Adverse Event|0|||
13083403|NCT04413552|25787898|FG001|Overall Study|Adverse Event|0|||
13083404|NCT04413552|25787899|FG002|Overall Study|Adverse Event|0|||
13083405|NCT04413552|25787900|FG003|Overall Study|Adverse Event|0|||
13083406|NCT04413552|25787901|FG004|Overall Study|Adverse Event|0|||
13083407|NCT04413552|25787902|FG005|Overall Study|Adverse Event|0|||
13083408|NCT04413552|25787903|FG006|Overall Study|Adverse Event|1|||
13083409|NCT04413552|25787904|FG007|Overall Study|Adverse Event|0|||
13083410|NCT04413552|25787905|FG008|Overall Study|Adverse Event|0|||
13083411|NCT04413552|25787906|FG009|Overall Study|Adverse Event|0|||
13083412|NCT04412707|25787924|FG000|Cycle 1|Death|0|||
13083413|NCT04412707|25787925|FG001|Cycle 1|Death|3|||
13083414|NCT04412707|25787924|FG000|Cycle 1|Disease progression|1|||
13083415|NCT04412707|25787925|FG001|Cycle 1|Disease progression|2|||
13083416|NCT04412707|25787924|FG000|Cycle 2|Death|0|||
13083417|NCT04412707|25787925|FG001|Cycle 2|Death|1|||
13083418|NCT04412707|25787924|FG000|Cycle 2|Disease progression|3|||
13083419|NCT04412707|25787925|FG001|Cycle 2|Disease progression|0|||
13083420|NCT04412707|25787924|FG000|Cycle 3 to End of Study (EOS)|Death|1|||
13083421|NCT04412707|25787925|FG001|Cycle 3 to End of Study (EOS)|Death|3|||
13083422|NCT04412707|25787924|FG000|Cycle 3 to End of Study (EOS)|Disease progression|4|||
13083423|NCT04412707|25787925|FG001|Cycle 3 to End of Study (EOS)|Disease progression|2|||
13083424|NCT04412707|25787924|FG000|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|4|||
13083425|NCT04412707|25787925|FG001|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|2|||
13083426|NCT04412707|25787924|FG000|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|1|||
13083427|NCT04412707|25787925|FG001|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|0|||
13083428|NCT04411680|25787962|FG000|Treatment Period|Adverse Event|3|||
13083429|NCT04411680|25787963|FG001|Treatment Period|Adverse Event|0|||
13083430|NCT04411680|25787962|FG000|Treatment Period|Discharged from hospital|18|||
13083431|NCT04411680|25787963|FG001|Treatment Period|Discharged from hospital|7|||
13083432|NCT04411680|25787962|FG000|Treatment Period|Missed 1 or more doses|8|||
13083433|NCT04411680|25787963|FG001|Treatment Period|Missed 1 or more doses|0|||
13083434|NCT04411680|25787962|FG000|Treatment Period|Transferred to another hospital|0|||
13083435|NCT04411680|25787963|FG001|Treatment Period|Transferred to another hospital|1|||
13083436|NCT04411680|25787962|FG000|Follow up Period|Withdrawal by Subject|2|||
13083437|NCT04411680|25787963|FG001|Follow up Period|Withdrawal by Subject|0|||
13083438|NCT04411680|25787962|FG000|Follow up Period|Lost to Follow-up|5|||
13083439|NCT04411680|25787963|FG001|Follow up Period|Lost to Follow-up|6|||
13083440|NCT04411680|25787962|FG000|Follow up Period|Death|11|||
13083441|NCT04411680|25787963|FG001|Follow up Period|Death|8|||
13083442|NCT04411667|25787980|FG000|Overall Study|Physician Decision|1|||
13083443|NCT04411667|25787981|FG001|Overall Study|Physician Decision|0|||
13083444|NCT04411628|25788019|FG000|Overall Study|Withdrawal by Subject|1|||
13083445|NCT04411628|25788020|FG001|Overall Study|Withdrawal by Subject|1|||
13083446|NCT04411628|25788021|FG002|Overall Study|Withdrawal by Subject|2|||
13083447|NCT04411628|25788022|FG003|Overall Study|Withdrawal by Subject|0|||
13083448|NCT04411628|25788019|FG000|Overall Study|Lost to Follow-up|0|||
13083449|NCT04411628|25788020|FG001|Overall Study|Lost to Follow-up|1|||
13083450|NCT04411628|25788021|FG002|Overall Study|Lost to Follow-up|0|||
13083451|NCT04411628|25788022|FG003|Overall Study|Lost to Follow-up|0|||
13083452|NCT04410198|25788029|FG000|Overall Study|Death|10|||
13083453|NCT04410198|25788029|FG000|Overall Study|Withdrawal by Subject|7|||
13083454|NCT04410198|25788029|FG000|Overall Study|Transferred/Relocation|4|||
13083455|NCT04410198|25788029|FG000|Overall Study|Kidney Transplant|9|||
13083456|NCT04410198|25788029|FG000|Overall Study|Adverse Event|4|||
13083457|NCT04410198|25788029|FG000|Overall Study|Physician Decision|2|||
13083458|NCT04410198|25788029|FG000|Overall Study|Other than specified|1|||
13083459|NCT04407507|25788046|FG000|Overall Study|Withdrawal by Subject|0|||
13083460|NCT04407507|25788047|FG001|Overall Study|Withdrawal by Subject|1|||
13083461|NCT04406194|25788066|FG000|Period 1|Withdrawal by Subject|0|||
13083462|NCT04406194|25788067|FG001|Period 1|Withdrawal by Subject|1|||
13083463|NCT04405570|25788102|FG000|Overall Study|Adverse Event|0|||
13083464|NCT04405570|25788103|FG001|Overall Study|Adverse Event|1|||
13083465|NCT04405570|25788104|FG002|Overall Study|Adverse Event|1|||
13083466|NCT04405570|25788105|FG003|Overall Study|Adverse Event|1|||
13083467|NCT04405570|25788102|FG000|Overall Study|Lost to Follow-up|0|||
13083468|NCT04405570|25788103|FG001|Overall Study|Lost to Follow-up|1|||
13083469|NCT04405570|25788104|FG002|Overall Study|Lost to Follow-up|0|||
13083470|NCT04405570|25788105|FG003|Overall Study|Lost to Follow-up|0|||
13083471|NCT04405570|25788102|FG000|Overall Study|Physician Decision|0|||
13083472|NCT04405570|25788103|FG001|Overall Study|Physician Decision|0|||
13083473|NCT04405570|25788104|FG002|Overall Study|Physician Decision|1|||
13083474|NCT04405570|25788105|FG003|Overall Study|Physician Decision|0|||
13083475|NCT04405570|25788102|FG000|Overall Study|Withdrawal by Subject|0|||
13083476|NCT04405570|25788103|FG001|Overall Study|Withdrawal by Subject|1|||
13083477|NCT04405570|25788104|FG002|Overall Study|Withdrawal by Subject|1|||
13083478|NCT04405570|25788105|FG003|Overall Study|Withdrawal by Subject|0|||
13083479|NCT04405570|25788102|FG000|Overall Study|Randomized not dosed|0|||
13083480|NCT04405570|25788103|FG001|Overall Study|Randomized not dosed|2|||
13083481|NCT04405570|25788104|FG002|Overall Study|Randomized not dosed|0|||
13083482|NCT04405570|25788105|FG003|Overall Study|Randomized not dosed|0|||
13083483|NCT04404725|25788114|FG000|First Intervention|Withdrawal by Subject|0|||
13083484|NCT04404725|25788115|FG001|First Intervention|Withdrawal by Subject|2|||
13083485|NCT04404725|25788114|FG000|Second Intervention|Adverse Event|1|||
13083486|NCT04404725|25788115|FG001|Second Intervention|Adverse Event|1|||
13083487|NCT04404725|25788114|FG000|Second Intervention|Withdrawal by Subject|0|||
13083488|NCT04404725|25788115|FG001|Second Intervention|Withdrawal by Subject|1|||
13083489|NCT04404010|25788132|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1|||
13083490|NCT04404010|25788133|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0|||
13083491|NCT04403399|25788150|FG000|Period 2|Physician Decision|0|||
13083492|NCT04403399|25788151|FG001|Period 2|Physician Decision|1|||
13083493|NCT04402866|25788186|FG000|Overall Study|Discontinued Prior to Treatment|0|||
13083494|NCT04402866|25788187|FG001|Overall Study|Discontinued Prior to Treatment|0|||
13083495|NCT04402866|25788188|FG002|Overall Study|Discontinued Prior to Treatment|0|||
13083496|NCT04402866|25788189|FG003|Overall Study|Discontinued Prior to Treatment|0|||
13083497|NCT04402866|25788190|FG004|Overall Study|Discontinued Prior to Treatment|2|||
13083498|NCT04402866|25788191|FG005|Overall Study|Discontinued Prior to Treatment|3|||
13083499|NCT04402866|25788186|FG000|Overall Study|Adverse Event|2|||
13083500|NCT04402866|25788187|FG001|Overall Study|Adverse Event|1|||
13083501|NCT04402866|25788188|FG002|Overall Study|Adverse Event|0|||
13083502|NCT04402866|25788189|FG003|Overall Study|Adverse Event|0|||
13083503|NCT04402866|25788190|FG004|Overall Study|Adverse Event|13|||
13083504|NCT04402866|25788191|FG005|Overall Study|Adverse Event|8|||
13083505|NCT04402866|25788186|FG000|Overall Study|Miscellaneous|0|||
13083506|NCT04402866|25788187|FG001|Overall Study|Miscellaneous|0|||
13083507|NCT04402866|25788188|FG002|Overall Study|Miscellaneous|1|||
13083508|NCT04402866|25788189|FG003|Overall Study|Miscellaneous|0|||
13083509|NCT04402866|25788190|FG004|Overall Study|Miscellaneous|0|||
13083510|NCT04402866|25788191|FG005|Overall Study|Miscellaneous|0|||
13083511|NCT04402866|25788186|FG000|Overall Study|Lost to Follow-up|0|||
13083512|NCT04402866|25788187|FG001|Overall Study|Lost to Follow-up|0|||
13083513|NCT04402866|25788188|FG002|Overall Study|Lost to Follow-up|0|||
13083514|NCT04402866|25788189|FG003|Overall Study|Lost to Follow-up|0|||
13083515|NCT04402866|25788190|FG004|Overall Study|Lost to Follow-up|0|||
13083516|NCT04402866|25788191|FG005|Overall Study|Lost to Follow-up|1|||
13083517|NCT04402866|25788186|FG000|Overall Study|Withdrawal by Subject|0|||
13083518|NCT04402866|25788187|FG001|Overall Study|Withdrawal by Subject|0|||
13083519|NCT04402866|25788188|FG002|Overall Study|Withdrawal by Subject|0|||
13083520|NCT04402866|25788189|FG003|Overall Study|Withdrawal by Subject|0|||
13083521|NCT04402866|25788190|FG004|Overall Study|Withdrawal by Subject|0|||
13083522|NCT04402866|25788191|FG005|Overall Study|Withdrawal by Subject|2|||
13083523|NCT04401579|25788292|FG000|Overall Study|Death|23|||
13083524|NCT04401579|25788293|FG001|Overall Study|Death|36|||
13083525|NCT04401579|25788292|FG000|Overall Study|Lost to Follow-up|40|||
13083526|NCT04401579|25788293|FG001|Overall Study|Lost to Follow-up|41|||
13083527|NCT04401579|25788292|FG000|Overall Study|Withdrawal by Subject|8|||
13083528|NCT04401579|25788293|FG001|Overall Study|Withdrawal by Subject|16|||
13083529|NCT04401579|25788292|FG000|Overall Study|Physician Decision|1|||
13083530|NCT04401579|25788293|FG001|Overall Study|Physician Decision|2|||
13083531|NCT04401579|25788292|FG000|Overall Study|Became ineligible after enrollment|1|||
13083532|NCT04401579|25788293|FG001|Overall Study|Became ineligible after enrollment|1|||
13083533|NCT04401579|25788292|FG000|Overall Study|Enrolled but treatment not administered|7|||
13083534|NCT04401579|25788293|FG001|Overall Study|Enrolled but treatment not administered|9|||
13083535|NCT04401579|25788292|FG000|Overall Study|Adverse Event|2|||
13083536|NCT04401579|25788293|FG001|Overall Study|Adverse Event|1|||
13083537|NCT04401579|25788292|FG000|Overall Study|Scheduling error|1|||
13083538|NCT04401579|25788293|FG001|Overall Study|Scheduling error|2|||
13083539|NCT04401579|25788292|FG000|Overall Study|Transferred to another hospital|1|||
13083540|NCT04401579|25788293|FG001|Overall Study|Transferred to another hospital|2|||
13083541|NCT04401423|25788322|FG000|Overall Study|Withdrawal by Subject|3|||
13083542|NCT04401423|25788323|FG001|Overall Study|Withdrawal by Subject|1|||
13083543|NCT04401423|25788322|FG000|Overall Study|Physician Decision|2|||
13083544|NCT04401423|25788323|FG001|Overall Study|Physician Decision|1|||
13132316|NCT02792829|25983313|FG004|Treatment Period 2|Adverse Event|1|||
13132317|NCT02792829|25983314|FG005|Treatment Period 2|Adverse Event|0|||
13132318|NCT02792829|25983315|FG006|Treatment Period 2|Adverse Event|1|||
13132319|NCT02792829|25983316|FG007|Treatment Period 2|Adverse Event|1|||
13132320|NCT02792829|25983309|FG000|Treatment Period 2|Use of proscribed medications|0|||
13132321|NCT02792829|25983310|FG001|Treatment Period 2|Use of proscribed medications|0|||
13132322|NCT02792829|25983311|FG002|Treatment Period 2|Use of proscribed medications|0|||
13132323|NCT02792829|25983312|FG003|Treatment Period 2|Use of proscribed medications|0|||
13132324|NCT02792829|25983313|FG004|Treatment Period 2|Use of proscribed medications|0|||
13132325|NCT02792829|25983314|FG005|Treatment Period 2|Use of proscribed medications|0|||
13132326|NCT02792829|25983315|FG006|Treatment Period 2|Use of proscribed medications|0|||
13132327|NCT02792829|25983316|FG007|Treatment Period 2|Use of proscribed medications|1|||
13132328|NCT02792777|25983336|FG000|Overall Study|Withdrawal by Subject|2|||
13132329|NCT02792777|25983337|FG001|Overall Study|Withdrawal by Subject|0|||
13132330|NCT02792777|25983336|FG000|Overall Study|Recording malfunction|2|||
13132331|NCT02792777|25983337|FG001|Overall Study|Recording malfunction|0|||
13132332|NCT02792777|25983336|FG000|Overall Study|Later determined to be ineligible|2|||
13132333|NCT02792777|25983337|FG001|Overall Study|Later determined to be ineligible|0|||
13132334|NCT02792777|25983336|FG000|Overall Study|Participant interviewed twice|1|||
13132335|NCT02792777|25983337|FG001|Overall Study|Participant interviewed twice|0|||
13132336|NCT02792699|25983428|FG000|Overall Study|Adverse Event|1|||
13132337|NCT02792699|25983429|FG001|Overall Study|Adverse Event|2|||
13132338|NCT02792699|25983430|FG002|Overall Study|Adverse Event|4|||
13132339|NCT02792699|25983428|FG000|Overall Study|Withdrawal by Subject|4|||
13132340|NCT02792699|25983429|FG001|Overall Study|Withdrawal by Subject|4|||
13132341|NCT02792699|25983430|FG002|Overall Study|Withdrawal by Subject|3|||
13132342|NCT02792699|25983428|FG000|Overall Study|Lost to Follow-up|0|||
13132343|NCT02792699|25983429|FG001|Overall Study|Lost to Follow-up|1|||
13132344|NCT02792699|25983430|FG002|Overall Study|Lost to Follow-up|2|||
13132345|NCT02792699|25983428|FG000|Overall Study|Physician Decision|2|||
13132346|NCT02792699|25983429|FG001|Overall Study|Physician Decision|0|||
13132347|NCT02792699|25983430|FG002|Overall Study|Physician Decision|0|||
13132348|NCT02792699|25983428|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
13132349|NCT02792699|25983429|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3|||
13132350|NCT02792699|25983430|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
13132351|NCT02792699|25983428|FG000|Overall Study|Other|1|||
13132352|NCT02792699|25983429|FG001|Overall Study|Other|0|||
13132353|NCT02792699|25983430|FG002|Overall Study|Other|0|||
13132354|NCT02792517|25983446|FG000|Overall Study|Withdrawal by Subject|10|||
13132355|NCT02792517|25983446|FG000|Overall Study|Decision by Sponsor|7|||
13132356|NCT02792517|25983446|FG000|Overall Study|Lost to Follow-up|3|||
13132357|NCT02792504|25983460|FG000|Overall Study|Lost to Follow-up|24|||
13132358|NCT02792504|25983460|FG000|Overall Study|Violated inclusion/exclusion criteria|6|||
13132359|NCT02792231|25983530|FG000|Overall Study|Patient/guardian decision|32|||
13132360|NCT02792231|25983531|FG001|Overall Study|Patient/guardian decision|42|||
13132361|NCT02792231|25983530|FG000|Overall Study|Adverse Event|15|||
13132362|NCT02792231|25983531|FG001|Overall Study|Adverse Event|11|||
13132363|NCT02792231|25983530|FG000|Overall Study|Physician Decision|14|||
13132364|NCT02792231|25983531|FG001|Overall Study|Physician Decision|12|||
13132365|NCT02792231|25983530|FG000|Overall Study|Lack of Efficacy|7|||
13132366|NCT02792231|25983531|FG001|Overall Study|Lack of Efficacy|9|||
13132367|NCT02792231|25983530|FG000|Overall Study|Lost to Follow-up|9|||
13132368|NCT02792231|25983531|FG001|Overall Study|Lost to Follow-up|5|||
13132369|NCT02792231|25983530|FG000|Overall Study|Pregnancy|1|||
13132370|NCT02792231|25983531|FG001|Overall Study|Pregnancy|3|||
13132371|NCT02792231|25983530|FG000|Overall Study|Non-compliance with study treatment|2|||
13132372|NCT02792231|25983531|FG001|Overall Study|Non-compliance with study treatment|1|||
13132373|NCT02792231|25983530|FG000|Overall Study|Protocol deviation|2|||
13132374|NCT02792231|25983531|FG001|Overall Study|Protocol deviation|0|||
13132375|NCT02792231|25983530|FG000|Overall Study|Technical problems|0|||
13132376|NCT02792231|25983531|FG001|Overall Study|Technical problems|1|||
13132377|NCT02792218|25983601|FG000|Overall Study|Patient/guardian decision|15|||
13132378|NCT02792218|25983602|FG001|Overall Study|Patient/guardian decision|42|||
13132379|NCT02792218|25983601|FG000|Overall Study|Adverse Event|15|||
13083545|NCT04401293|25788348|FG000|Overall Study|Withdrawal by Subject|1|||
13083546|NCT04401293|25788349|FG001|Overall Study|Withdrawal by Subject|3|||
13083547|NCT04401202|25788370|FG000|Overall Study|Lost to Follow-up|2|||
13083548|NCT04401202|25788371|FG001|Overall Study|Lost to Follow-up|2|||
13083549|NCT04401202|25788370|FG000|Overall Study|Adverse Event|0|||
13083550|NCT04401202|25788371|FG001|Overall Study|Adverse Event|1|||
13083551|NCT04401202|25788370|FG000|Overall Study|Hospitalized|4|||
13083552|NCT04401202|25788371|FG001|Overall Study|Hospitalized|1|||
13083553|NCT04400682|25788390|FG000|Period 1|Withdrawal by Subject|1|||
13083554|NCT04400682|25788391|FG001|Period 1|Withdrawal by Subject|4|||
13083555|NCT04399356|25788410|FG000|Overall Study|Lost to Follow-up|1|||
13083556|NCT04399356|25788411|FG001|Overall Study|Lost to Follow-up|1|||
13083557|NCT04399356|25788410|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1|||
13083558|NCT04399356|25788411|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2|||
13083559|NCT04399356|25788410|FG000|Overall Study|Withdrawal by Subject|1|||
13083560|NCT04399356|25788411|FG001|Overall Study|Withdrawal by Subject|0|||
13083561|NCT04399161|25788429|FG000|Overall Study|Withdrawal by Subject|1|||
13083562|NCT04399161|25788430|FG001|Overall Study|Withdrawal by Subject|0|||
13083563|NCT04399161|25788431|FG002|Overall Study|Withdrawal by Subject|2|||
13083564|NCT04399161|25788429|FG000|Overall Study|Protocol Violation|1|||
13083565|NCT04399161|25788430|FG001|Overall Study|Protocol Violation|2|||
13083566|NCT04399161|25788431|FG002|Overall Study|Protocol Violation|0|||
13083567|NCT04399122|25788446|FG000|Overall Study|Lost to Follow-up|2|||
13083568|NCT04399122|25788447|FG001|Overall Study|Lost to Follow-up|0|||
13083569|NCT04399122|25788446|FG000|Overall Study|Withdrawal by Subject|1|||
13083570|NCT04399122|25788447|FG001|Overall Study|Withdrawal by Subject|0|||
13083571|NCT04398732|25788464|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50|||
13083572|NCT04398134|25788551|FG000|Overall Study|Adverse Event|0|||
13083573|NCT04398134|25788552|FG001|Overall Study|Adverse Event|0|||
13083574|NCT04398134|25788553|FG002|Overall Study|Adverse Event|1|||
13083575|NCT04398134|25788554|FG003|Overall Study|Adverse Event|0|||
13083576|NCT04398134|25788551|FG000|Overall Study|Withdrawal by Subject|2|||
13083577|NCT04398134|25788552|FG001|Overall Study|Withdrawal by Subject|0|||
13083578|NCT04398134|25788553|FG002|Overall Study|Withdrawal by Subject|0|||
13083579|NCT04398134|25788554|FG003|Overall Study|Withdrawal by Subject|1|||
13083580|NCT04398134|25788551|FG000|Overall Study|Study Terminated by Sponsor|30|||
13083581|NCT04398134|25788552|FG001|Overall Study|Study Terminated by Sponsor|11|||
13083582|NCT04398134|25788553|FG002|Overall Study|Study Terminated by Sponsor|32|||
13083583|NCT04398134|25788554|FG003|Overall Study|Study Terminated by Sponsor|11|||
13083584|NCT04398030|25788577|FG000|Treatment Period 1 (1 Week)|Withdrawal by Subject|0|||
13083585|NCT04398030|25788578|FG001|Treatment Period 1 (1 Week)|Withdrawal by Subject|1|||
13083586|NCT04398030|25788577|FG000|Treatment Period 2 (1 Week)|Physician Decision|1|||
13083587|NCT04398030|25788578|FG001|Treatment Period 2 (1 Week)|Physician Decision|0|||
13083588|NCT04397757|25788641|FG000|Overall Study|Death|3|||
13083589|NCT04397757|25788642|FG001|Overall Study|Death|11|||
13083590|NCT04397757|25788641|FG000|Overall Study|Withdrawal by Subject|2|||
13083591|NCT04397757|25788642|FG001|Overall Study|Withdrawal by Subject|0|||
13083592|NCT04397757|25788641|FG000|Overall Study|Lost to Follow-up|4|||
13083593|NCT04397757|25788642|FG001|Overall Study|Lost to Follow-up|3|||
13083594|NCT04397718|25788669|FG000|Overall Study|Death|7|||
13083595|NCT04397718|25788670|FG001|Overall Study|Death|11|||
13083596|NCT04397718|25788669|FG000|Overall Study|Lost to Follow-up|0|||
13083597|NCT04397718|25788670|FG001|Overall Study|Lost to Follow-up|4|||
13083598|NCT04397445|25788706|FG000|Overall Study|Withdrawal by Subject|1|||
13083599|NCT04397445|25788707|FG001|Overall Study|Withdrawal by Subject|0|||
13083600|NCT04397445|25788708|FG002|Overall Study|Withdrawal by Subject|0|||
13083601|NCT04397445|25788709|FG003|Overall Study|Withdrawal by Subject|0|||
13083602|NCT04396639|25788721|FG000|Overall Study|Withdrawal by Subject|1|||
13083603|NCT04396639|25788721|FG000|Overall Study|Other|1|||
13083604|NCT04393493|25788780|FG000|First 4 Days of Intervention|Early improvement|5|||
13083605|NCT04393493|25788781|FG001|First 4 Days of Intervention|Early improvement|7|||
13083606|NCT04391842|25788788|FG000|Overall Study|Withdrawal by Subject|2|||
13083607|NCT04390191|25788817|FG000|Overall Study|Withdrawal by Subject|1|||
13083608|NCT04390191|25788818|FG001|Overall Study|Withdrawal by Subject|0|||
13083609|NCT04389840|25788851|FG000|Overall Study|Adverse Event|0|||
13083610|NCT04389840|25788852|FG001|Overall Study|Adverse Event|0|||
13083611|NCT04389840|25788853|FG002|Overall Study|Adverse Event|0|||
13083612|NCT04389840|25788854|FG003|Overall Study|Adverse Event|1|||
13083613|NCT04389840|25788855|FG004|Overall Study|Adverse Event|0|||
13083614|NCT04389840|25788856|FG005|Overall Study|Adverse Event|0|||
13083615|NCT04389840|25788851|FG000|Overall Study|Subject request and prohibited concomitant medication|2|||
13083616|NCT04389840|25788852|FG001|Overall Study|Subject request and prohibited concomitant medication|0|||
13083617|NCT04389840|25788853|FG002|Overall Study|Subject request and prohibited concomitant medication|0|||
13083618|NCT04389840|25788854|FG003|Overall Study|Subject request and prohibited concomitant medication|0|||
13083619|NCT04389840|25788855|FG004|Overall Study|Subject request and prohibited concomitant medication|1|||
13132380|NCT02792218|25983602|FG001|Overall Study|Adverse Event|14|||
13083620|NCT04389840|25788856|FG005|Overall Study|Subject request and prohibited concomitant medication|0|||
13083621|NCT04389840|25788851|FG000|Overall Study|Death|0|||
13083622|NCT04389840|25788852|FG001|Overall Study|Death|1|||
13083623|NCT04389840|25788853|FG002|Overall Study|Death|0|||
13083624|NCT04389840|25788854|FG003|Overall Study|Death|0|||
13083625|NCT04389840|25788855|FG004|Overall Study|Death|0|||
13083626|NCT04389840|25788856|FG005|Overall Study|Death|0|||
13083627|NCT04387136|25788873|FG000|Overall Study|Protocol Deviation by SOC staff|1|||
13083628|NCT04387136|25788874|FG001|Overall Study|Protocol Deviation by SOC staff|2|||
13083629|NCT04386902|25788880|FG000|Overall Study|Withdrawal by Subject|5|||
13083630|NCT04386902|25788880|FG000|Overall Study|Technical problems in the recording|5|||
13083631|NCT04385199|25788905|FG000|Overall Study|Withdrawal by Subject|1|||
13083632|NCT04385199|25788906|FG001|Overall Study|Withdrawal by Subject|0|||
13083633|NCT04384523|25788945|FG000|Overall Study|Lost to Follow-up|0|||
13083634|NCT04384523|25788946|FG001|Overall Study|Lost to Follow-up|0|||
13083635|NCT04384523|25788947|FG002|Overall Study|Lost to Follow-up|0|||
13083636|NCT04384523|25788948|FG003|Overall Study|Lost to Follow-up|0|||
13083637|NCT04384523|25788949|FG004|Overall Study|Lost to Follow-up|0|||
13083638|NCT04384523|25788950|FG005|Overall Study|Lost to Follow-up|1|||
13083639|NCT04384523|25788945|FG000|Overall Study|Protocol Violation|0|||
13083640|NCT04384523|25788946|FG001|Overall Study|Protocol Violation|1|||
13083641|NCT04384523|25788947|FG002|Overall Study|Protocol Violation|0|||
13083642|NCT04384523|25788948|FG003|Overall Study|Protocol Violation|0|||
13083643|NCT04384523|25788949|FG004|Overall Study|Protocol Violation|0|||
13083644|NCT04384523|25788950|FG005|Overall Study|Protocol Violation|0|||
13083645|NCT04384523|25788945|FG000|Overall Study|Withdrawal by Subject|1|||
13083646|NCT04384523|25788946|FG001|Overall Study|Withdrawal by Subject|0|||
13083647|NCT04384523|25788947|FG002|Overall Study|Withdrawal by Subject|0|||
13083648|NCT04384523|25788948|FG003|Overall Study|Withdrawal by Subject|0|||
13083649|NCT04384523|25788949|FG004|Overall Study|Withdrawal by Subject|0|||
13083650|NCT04384523|25788950|FG005|Overall Study|Withdrawal by Subject|0|||
13083651|NCT04384107|25788981|FG000|Overall Study|Withdrawal By Parent/Guardian|8|||
13083652|NCT04384107|25788982|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
13083653|NCT04384107|25788981|FG000|Overall Study|Lost to Follow-up|1|||
13083654|NCT04384107|25788982|FG001|Overall Study|Lost to Follow-up|0|||
13083655|NCT04382651|25789006|FG000|Overall Study|Death|26|||
13083656|NCT04382651|25789007|FG001|Overall Study|Death|23|||
13083657|NCT04382651|25789006|FG000|Overall Study|Lost to Follow-up|3|||
13083658|NCT04382651|25789007|FG001|Overall Study|Lost to Follow-up|4|||
13083659|NCT04382651|25789006|FG000|Overall Study|Withdrawal by Subject|2|||
13083660|NCT04382651|25789007|FG001|Overall Study|Withdrawal by Subject|0|||
13083661|NCT04382651|25789006|FG000|Overall Study|Physician Decision|0|||
13083662|NCT04382651|25789007|FG001|Overall Study|Physician Decision|1|||
13083663|NCT04382586|25789040|FG000|Overall Study|Death|3|||
13083664|NCT04382586|25789041|FG001|Overall Study|Death|4|||
13083665|NCT04382586|25789040|FG000|Overall Study|Lost to Follow-up|11|||
13083666|NCT04382586|25789041|FG001|Overall Study|Lost to Follow-up|8|||
13083667|NCT04382586|25789040|FG000|Overall Study|Withdrawal by Subject|3|||
13083668|NCT04382586|25789041|FG001|Overall Study|Withdrawal by Subject|1|||
13083669|NCT04382586|25789040|FG000|Overall Study|Physician Decision|0|||
13083670|NCT04382586|25789041|FG001|Overall Study|Physician Decision|3|||
13083671|NCT04382066|25789137|FG000|Overall Study|Adverse Event|1|||
13083672|NCT04382066|25789138|FG001|Overall Study|Adverse Event|0|||
13083673|NCT04382066|25789139|FG002|Overall Study|Adverse Event|0|||
13083674|NCT04382066|25789137|FG000|Overall Study|Death|1|||
13083675|NCT04382066|25789138|FG001|Overall Study|Death|0|||
13083676|NCT04382066|25789139|FG002|Overall Study|Death|1|||
13083677|NCT04382053|25789161|FG000|Overall Study|Death|6|||
13083678|NCT04382053|25789162|FG001|Overall Study|Death|8|||
13083679|NCT04382053|25789161|FG000|Overall Study|Lost to Follow-up|0|||
13083680|NCT04382053|25789162|FG001|Overall Study|Lost to Follow-up|2|||
13083681|NCT04382053|25789161|FG000|Overall Study|Protocol Deviation|1|||
13083682|NCT04382053|25789162|FG001|Overall Study|Protocol Deviation|2|||
13083683|NCT04382053|25789161|FG000|Overall Study|Withdrawal by Subject|2|||
13083684|NCT04382053|25789162|FG001|Overall Study|Withdrawal by Subject|1|||
13083685|NCT04381988|25789177|FG000|Overall Study|The study was terminated|4|||
13083686|NCT04381988|25789178|FG001|Overall Study|The study was terminated|0|||
13083687|NCT04380961|25789247|FG000|Overall Study|Lost to Follow-up|17|||
13083688|NCT04380961|25789248|FG001|Overall Study|Lost to Follow-up|11|||
13083689|NCT04380961|25789247|FG000|Overall Study|Withdrawal by Subject|3|||
13083690|NCT04380961|25789248|FG001|Overall Study|Withdrawal by Subject|0|||
13083691|NCT04380961|25789247|FG000|Overall Study|Death|22|||
13083692|NCT04380961|25789248|FG001|Overall Study|Death|16|||
13083693|NCT04380961|25789247|FG000|Overall Study|Other|1|||
13083694|NCT04380961|25789248|FG001|Overall Study|Other|0|||
13083695|NCT04380961|25789247|FG000|Overall Study|Randomized but Not Treated|1|||
13083696|NCT04380961|25789248|FG001|Overall Study|Randomized but Not Treated|2|||
13083697|NCT04380688|25789295|FG000|Overall Study|Death|2|||
13083698|NCT04380688|25789296|FG001|Overall Study|Death|2|||
13083699|NCT04380688|25789295|FG000|Overall Study|Lost to Follow-up|2|||
13083700|NCT04380688|25789296|FG001|Overall Study|Lost to Follow-up|4|||
13083701|NCT04380688|25789295|FG000|Overall Study|Withdrawal by Subject|3|||
13083702|NCT04380688|25789296|FG001|Overall Study|Withdrawal by Subject|3|||
13083703|NCT04380142|25789344|FG000|LD/CD Stabilization Period|Adverse Event|3|||
13083704|NCT04380142|25789345|FG001|LD/CD Stabilization Period|Adverse Event|0|||
13083705|NCT04380142|25789346|FG002|LD/CD Stabilization Period|Adverse Event|0|||
13083706|NCT04380142|25789344|FG000|LD/CD Stabilization Period|Withdrawal by Subject|4|||
13083707|NCT04380142|25789345|FG001|LD/CD Stabilization Period|Withdrawal by Subject|0|||
13083708|NCT04380142|25789346|FG002|LD/CD Stabilization Period|Withdrawal by Subject|0|||
13083709|NCT04380142|25789344|FG000|LD/CD Stabilization Period|Lost to Follow-up|1|||
13083710|NCT04380142|25789345|FG001|LD/CD Stabilization Period|Lost to Follow-up|0|||
13083711|NCT04380142|25789346|FG002|LD/CD Stabilization Period|Lost to Follow-up|0|||
13083712|NCT04380142|25789344|FG000|LD/CD Stabilization Period|Lack of Efficacy|1|||
13083713|NCT04380142|25789345|FG001|LD/CD Stabilization Period|Lack of Efficacy|0|||
13083714|NCT04380142|25789346|FG002|LD/CD Stabilization Period|Lack of Efficacy|0|||
13083715|NCT04380142|25789344|FG000|LD/CD Stabilization Period|Difficulty With Drug Delivery System|2|||
13083716|NCT04380142|25789345|FG001|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
13083717|NCT04380142|25789346|FG002|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
13083718|NCT04380142|25789344|FG000|LD/CD Stabilization Period|Other, Not Specified|18|||
13083719|NCT04380142|25789345|FG001|LD/CD Stabilization Period|Other, Not Specified|0|||
13083720|NCT04380142|25789346|FG002|LD/CD Stabilization Period|Other, Not Specified|0|||
13083721|NCT04380142|25789344|FG000|Double-Blind Treatment Period|Adverse Event|0|||
13083722|NCT04380142|25789345|FG001|Double-Blind Treatment Period|Adverse Event|1|||
13083723|NCT04380142|25789346|FG002|Double-Blind Treatment Period|Adverse Event|14|||
13083724|NCT04380142|25789344|FG000|Double-Blind Treatment Period|Withdrew Consent|0|||
13083725|NCT04380142|25789345|FG001|Double-Blind Treatment Period|Withdrew Consent|3|||
13083726|NCT04380142|25789346|FG002|Double-Blind Treatment Period|Withdrew Consent|6|||
13083727|NCT04380142|25789344|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
13083728|NCT04380142|25789345|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
13083729|NCT04380142|25789346|FG002|Double-Blind Treatment Period|Lack of Efficacy|2|||
13083730|NCT04380142|25789344|FG000|Double-Blind Treatment Period|Difficulty With Drug Delivery System|0|||
13083731|NCT04380142|25789345|FG001|Double-Blind Treatment Period|Difficulty With Drug Delivery System|1|||
13083732|NCT04380142|25789346|FG002|Double-Blind Treatment Period|Difficulty With Drug Delivery System|3|||
13083733|NCT04380142|25789344|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
13083734|NCT04380142|25789345|FG001|Double-Blind Treatment Period|Other, Not Specified|0|||
13083735|NCT04380142|25789346|FG002|Double-Blind Treatment Period|Other, Not Specified|1|||
13083736|NCT04380142|25789344|FG000|Double-Blind Treatment Period|Did Not Receive Study Drug|0|||
13083737|NCT04380142|25789345|FG001|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
13083738|NCT04380142|25789346|FG002|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
13083739|NCT04378270|25789358|FG000|Overall Study|Lack of Efficacy|1|||
13083740|NCT04378270|25789358|FG000|Overall Study|Withdrawal by Subject|1|||
13083741|NCT04378270|25789358|FG000|Overall Study|Screen Failure|1|||
13083742|NCT04378270|25789358|FG000|Overall Study|University Required, Research Covid Shut Down|2|||
13083743|NCT04377308|25789381|FG000|Overall Study|Withdrawal by Subject|0|||
13083744|NCT04377308|25789382|FG001|Overall Study|Withdrawal by Subject|1|||
13083745|NCT04376060|25789398|FG000|Overall Study|Physician Decision|1|||
13083746|NCT04375878|25789445|FG000|Crossover First and Second Interventions|Withdrawal by Subject|1|||
13083747|NCT04375878|25789446|FG001|Crossover First and Second Interventions|Withdrawal by Subject|1|||
13083748|NCT04375878|25789447|FG002|Crossover First and Second Interventions|Withdrawal by Subject|0|||
13083749|NCT04375878|25789448|FG003|Crossover First and Second Interventions|Withdrawal by Subject|0|||
13083750|NCT04375878|25789449|FG004|Crossover First and Second Interventions|Withdrawal by Subject|0|||
13083751|NCT04375878|25789450|FG005|Crossover First and Second Interventions|Withdrawal by Subject|0|||
13083752|NCT04375878|25789445|FG000|Crossover First and Second Interventions|Adverse Event|0|||
13083753|NCT04375878|25789446|FG001|Crossover First and Second Interventions|Adverse Event|0|||
13083754|NCT04375878|25789447|FG002|Crossover First and Second Interventions|Adverse Event|1|||
13083755|NCT04375878|25789448|FG003|Crossover First and Second Interventions|Adverse Event|0|||
13083756|NCT04375878|25789449|FG004|Crossover First and Second Interventions|Adverse Event|0|||
13083757|NCT04375878|25789450|FG005|Crossover First and Second Interventions|Adverse Event|0|||
13083758|NCT04375878|25789445|FG000|Extension Phase|Withdrawal by Subject|0|||
13083759|NCT04375878|25789446|FG001|Extension Phase|Withdrawal by Subject|0|||
13083760|NCT04375878|25789447|FG002|Extension Phase|Withdrawal by Subject|0|||
13083761|NCT04375878|25789448|FG003|Extension Phase|Withdrawal by Subject|0|||
13083762|NCT04375878|25789449|FG004|Extension Phase|Withdrawal by Subject|1|||
13083763|NCT04375878|25789450|FG005|Extension Phase|Withdrawal by Subject|0|||
13083764|NCT04372186|25789475|FG000|Overall Study|Death|24|||
13083765|NCT04372186|25789476|FG001|Overall Study|Death|11|||
13083766|NCT04372186|25789475|FG000|Overall Study|Transferred to a different facility for care|0|||
13083767|NCT04372186|25789476|FG001|Overall Study|Transferred to a different facility for care|2|||
13083768|NCT04370028|25789495|FG000|Overall Study|Withdrawal by Subject|695|||
13083769|NCT04370028|25789495|FG000|Overall Study|Protocol Violation|9|||
13083770|NCT04370028|25789495|FG000|Overall Study|Adverse Event|3|||
13083771|NCT04369950|25789522|FG000|Overall Study|Protocol Violation|2|||
13083772|NCT04369950|25789523|FG001|Overall Study|Protocol Violation|2|||
13083773|NCT04369742|25789588|FG000|Overall Study|Lost to Follow-Up (Day 14)|7|||
13083774|NCT04369742|25789589|FG001|Overall Study|Lost to Follow-Up (Day 14)|4|||
13083775|NCT04369742|25789588|FG000|Overall Study|Lost to Follow-Up (Day 30)|7|||
13083776|NCT04369742|25789589|FG001|Overall Study|Lost to Follow-Up (Day 30)|7|||
13083777|NCT04369430|25789626|FG000|Overall Study|Adverse Event|2|||
13083778|NCT04369430|25789627|FG001|Overall Study|Adverse Event|3|||
13083779|NCT04369430|25789626|FG000|Overall Study|Death|1|||
13083780|NCT04369430|25789627|FG001|Overall Study|Death|0|||
13083781|NCT04369430|25789626|FG000|Overall Study|Withdrawal by Subject|4|||
13083782|NCT04369430|25789627|FG001|Overall Study|Withdrawal by Subject|3|||
13083783|NCT04369430|25789626|FG000|Overall Study|COVID concern, Sponsor's decision|2|||
13083784|NCT04369430|25789627|FG001|Overall Study|COVID concern, Sponsor's decision|1|||
13083785|NCT04369430|25789626|FG000|Overall Study|Lost to Follow-up|0|||
13083786|NCT04369430|25789627|FG001|Overall Study|Lost to Follow-up|1|||
13083787|NCT04366349|25789704|FG000|Overall Study|Withdrawal by Subject|1|||
13083788|NCT04366349|25789705|FG001|Overall Study|Withdrawal by Subject|0|||
13083789|NCT04366349|25789706|FG002|Overall Study|Withdrawal by Subject|0|||
13083790|NCT04366349|25789707|FG003|Overall Study|Withdrawal by Subject|0|||
13083791|NCT04366349|25789708|FG004|Overall Study|Withdrawal by Subject|0|||
13083792|NCT04366349|25789709|FG005|Overall Study|Withdrawal by Subject|0|||
13083793|NCT04365699|25789730|FG000|Overall Study|Death|2|||
13083794|NCT04365699|25789731|FG001|Overall Study|Death|5|||
13083795|NCT04365699|25789732|FG002|Overall Study|Death|15|||
13083796|NCT04364984|25789765|FG000|Overall Study|Death|2|||
13083797|NCT04364984|25789766|FG001|Overall Study|Death|2|||
13083798|NCT04364984|25789767|FG002|Overall Study|Death|0|||
13083799|NCT04363736|25789802|FG000|Overall Study|Withdrawal by Subject|1|||
13083800|NCT04363736|25789803|FG001|Overall Study|Withdrawal by Subject|0|||
13083801|NCT04363736|25789802|FG000|Overall Study|Lost to Follow-up|10|||
13083802|NCT04363736|25789803|FG001|Overall Study|Lost to Follow-up|7|||
13083803|NCT04363736|25789802|FG000|Overall Study|Death|8|||
13083804|NCT04363736|25789803|FG001|Overall Study|Death|6|||
13083805|NCT04362176|25789854|FG000|Overall Study|Lost to Follow-up|5|||
13083806|NCT04362176|25789855|FG001|Overall Study|Lost to Follow-up|8|||
13083807|NCT04362176|25789854|FG000|Overall Study|Withdrawn (Participant/PI withdrew consent)|8|||
13083808|NCT04362176|25789855|FG001|Overall Study|Withdrawn (Participant/PI withdrew consent)|6|||
13083809|NCT04362137|25789896|FG000|Overall Study|Death|9|||
13083810|NCT04362137|25789897|FG001|Overall Study|Death|3|||
13083811|NCT04362137|25789896|FG000|Overall Study|Patient decision|6|||
13083812|NCT04362137|25789897|FG001|Overall Study|Patient decision|3|||
13083813|NCT04362137|25789896|FG000|Overall Study|Adverse Event|1|||
13083814|NCT04362137|25789897|FG001|Overall Study|Adverse Event|0|||
13083815|NCT04362137|25789896|FG000|Overall Study|Lost to Follow-up|1|||
13083816|NCT04362137|25789897|FG001|Overall Study|Lost to Follow-up|0|||
13083817|NCT04362137|25789896|FG000|Overall Study|Protocol deviation|1|||
13083818|NCT04362137|25789897|FG001|Overall Study|Protocol deviation|0|||
13083819|NCT04360187|25789960|FG000|Double-Blind Treatment|Adverse Event|9|||
13083820|NCT04360187|25789961|FG001|Double-Blind Treatment|Adverse Event|11|||
13083821|NCT04360187|25789960|FG000|Double-Blind Treatment|Lack of Efficacy|7|||
13083822|NCT04360187|25789961|FG001|Double-Blind Treatment|Lack of Efficacy|2|||
13083823|NCT04360187|25789960|FG000|Double-Blind Treatment|Physician Decision|1|||
13083824|NCT04360187|25789961|FG001|Double-Blind Treatment|Physician Decision|0|||
13083825|NCT04360187|25789960|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
13083826|NCT04360187|25789961|FG001|Double-Blind Treatment|Withdrawal by Subject|2|||
13083827|NCT04360187|25789960|FG000|Double-Blind Treatment|Withdrawal By Parent/Guardian|2|||
13083828|NCT04360187|25789961|FG001|Double-Blind Treatment|Withdrawal By Parent/Guardian|0|||
13083829|NCT04360187|25789960|FG000|Follow-Up|Lost to Follow-up|1|||
13083830|NCT04360187|25789961|FG001|Follow-Up|Lost to Follow-up|0|||
13083831|NCT04359901|25789974|FG000|Overall Study|Withdrawal by Subject|0|||
13083832|NCT04359901|25789975|FG001|Overall Study|Withdrawal by Subject|1|||
13083833|NCT04359901|25789974|FG000|Overall Study|Death|6|||
13083834|NCT04359901|25789975|FG001|Overall Study|Death|2|||
13083835|NCT04359771|25789990|FG000|Overall Study|Lack of Efficacy|2|||
13083836|NCT04359771|25789991|FG001|Overall Study|Lack of Efficacy|2|||
13083837|NCT04358549|25790011|FG000|Overall Study|Adverse Event|0|||
13083838|NCT04358549|25790012|FG001|Overall Study|Adverse Event|1|||
13083839|NCT04358549|25790011|FG000|Overall Study|Death|1|||
13083840|NCT04358549|25790012|FG001|Overall Study|Death|0|||
13083841|NCT04358549|25790011|FG000|Overall Study|Lost to Follow-up|2|||
13083842|NCT04358549|25790012|FG001|Overall Study|Lost to Follow-up|1|||
13083843|NCT04358549|25790011|FG000|Overall Study|Withdrawal by Subject|6|||
13083844|NCT04358549|25790012|FG001|Overall Study|Withdrawal by Subject|6|||
13083845|NCT04358549|25790011|FG000|Overall Study|Start remdesivir|1|||
13083846|NCT04358549|25790012|FG001|Overall Study|Start remdesivir|0|||
13083847|NCT04358081|25790040|FG000|Treatment Phase of Study|Withdrawal by Subject|0|||
13083848|NCT04358081|25790041|FG001|Treatment Phase of Study|Withdrawal by Subject|1|||
13083849|NCT04358081|25790042|FG002|Treatment Phase of Study|Withdrawal by Subject|1|||
13083850|NCT04358081|25790040|FG000|Treatment Phase of Study|Adverse Event|1|||
13083851|NCT04358081|25790041|FG001|Treatment Phase of Study|Adverse Event|0|||
13083852|NCT04358081|25790042|FG002|Treatment Phase of Study|Adverse Event|1|||
13083853|NCT04358081|25790040|FG000|Treatment Phase of Study|Physician Decision|2|||
13083854|NCT04358081|25790041|FG001|Treatment Phase of Study|Physician Decision|0|||
13083855|NCT04358081|25790042|FG002|Treatment Phase of Study|Physician Decision|1|||
13083856|NCT04358081|25790040|FG000|Treatment Phase of Study|Protocol Violation|1|||
13083857|NCT04358081|25790041|FG001|Treatment Phase of Study|Protocol Violation|0|||
13083858|NCT04358081|25790042|FG002|Treatment Phase of Study|Protocol Violation|0|||
13083859|NCT04358081|25790040|FG000|Study Completion Phase|Death|0|||
13083860|NCT04358081|25790041|FG001|Study Completion Phase|Death|0|||
13083861|NCT04358081|25790042|FG002|Study Completion Phase|Death|1|||
13083862|NCT04358081|25790040|FG000|Study Completion Phase|Lost to Follow-up|1|||
13083863|NCT04358081|25790041|FG001|Study Completion Phase|Lost to Follow-up|0|||
13083864|NCT04358081|25790042|FG002|Study Completion Phase|Lost to Follow-up|1|||
13083865|NCT04358068|25790079|FG000|Overall Study|Did not initiate study treatment|2|||
13083866|NCT04358068|25790080|FG001|Overall Study|Did not initiate study treatment|2|||
13083867|NCT04357782|25790119|FG000|Overall Study|Discharged from hospital|1|||
13083868|NCT04357782|25790120|FG001|Overall Study|Discharged from hospital|0|||
13083869|NCT04357782|25790119|FG000|Overall Study|Death|0|||
13083870|NCT04357782|25790120|FG001|Overall Study|Death|2|||
13083871|NCT04356937|25790149|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0|||
13083872|NCT04356937|25790150|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1|||
13083873|NCT04356573|25790165|FG000|Overall Study|Didn't Qualify|1|||
13083874|NCT04356573|25790166|FG001|Overall Study|Didn't Qualify|0|||
13083875|NCT04355767|25790189|FG000|Overall Study|Withdrawal by Subject|2|||
13083876|NCT04355767|25790190|FG001|Overall Study|Withdrawal by Subject|2|||
13083877|NCT04355767|25790189|FG000|Overall Study|Death|5|||
13083878|NCT04355767|25790190|FG001|Overall Study|Death|1|||
13083879|NCT04355663|25790220|FG000|Overall Study|Physician Decision|2|||
13083880|NCT04355663|25790221|FG001|Overall Study|Physician Decision|7|||
13083881|NCT04355663|25790222|FG002|Overall Study|Physician Decision|0|||
13083882|NCT04355663|25790220|FG000|Overall Study|Adverse Event|0|||
13083883|NCT04355663|25790221|FG001|Overall Study|Adverse Event|0|||
13083884|NCT04355663|25790222|FG002|Overall Study|Adverse Event|1|||
13083885|NCT04355663|25790220|FG000|Overall Study|Withdrawal by Subject|0|||
13083886|NCT04355663|25790221|FG001|Overall Study|Withdrawal by Subject|8|||
13083887|NCT04355663|25790222|FG002|Overall Study|Withdrawal by Subject|3|||
13083888|NCT04353817|25790239|FG000|Overall Study|Adverse Event|0|||
13083889|NCT04353817|25790240|FG001|Overall Study|Adverse Event|1|||
13083890|NCT04353596|25790267|FG000|Overall Study|Protocol Violation|4|||
13083891|NCT04353596|25790268|FG001|Overall Study|Protocol Violation|4|||
13083892|NCT04353596|25790267|FG000|Overall Study|no evidence of recent SARS-CoV-2|1|||
13083893|NCT04353596|25790268|FG001|Overall Study|no evidence of recent SARS-CoV-2|3|||
13083894|NCT04353037|25790303|FG000|Overall Study|Lost to Follow-up|0|||
13083895|NCT04353037|25790304|FG001|Overall Study|Lost to Follow-up|1|||
13083896|NCT04353037|25790305|FG002|Overall Study|Lost to Follow-up|2|||
13083897|NCT04353037|25790306|FG003|Overall Study|Lost to Follow-up|3|||
13083898|NCT04353037|25790303|FG000|Overall Study|Withdrawal by Subject|0|||
13083899|NCT04353037|25790304|FG001|Overall Study|Withdrawal by Subject|2|||
13083900|NCT04353037|25790305|FG002|Overall Study|Withdrawal by Subject|3|||
13083901|NCT04353037|25790306|FG003|Overall Study|Withdrawal by Subject|5|||
13083902|NCT04353037|25790303|FG000|Overall Study|Adverse Event|0|||
13083903|NCT04353037|25790304|FG001|Overall Study|Adverse Event|0|||
13083904|NCT04353037|25790305|FG002|Overall Study|Adverse Event|2|||
13083905|NCT04353037|25790306|FG003|Overall Study|Adverse Event|0|||
13083906|NCT04353037|25790303|FG000|Overall Study|Exposure Change|0|||
13083907|NCT04353037|25790304|FG001|Overall Study|Exposure Change|0|||
13083908|NCT04353037|25790305|FG002|Overall Study|Exposure Change|0|||
13083909|NCT04353037|25790306|FG003|Overall Study|Exposure Change|2|||
13083910|NCT04352127|25790321|FG000|Overall Study|Unable to obtain readings|4|||
13083911|NCT04352127|25790322|FG001|Overall Study|Unable to obtain readings|1|||
13083912|NCT04351269|25790343|FG000|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|70|||
13083913|NCT04351269|25790344|FG001|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|32|||
13083914|NCT04351269|25790345|FG002|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|29|||
13083915|NCT04351269|25790343|FG000|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
13083916|NCT04351269|25790344|FG001|Overall Study|CanGaroo Envelope used during a previous procedure|1|||
13083917|NCT04351269|25790345|FG002|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
13083918|NCT04351269|25790343|FG000|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
13083919|NCT04351269|25790344|FG001|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
13083920|NCT04351269|25790345|FG002|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|0|||
13083921|NCT04351269|25790343|FG000|Overall Study|Subjects followed long-term at different health care system|0|||
13083922|NCT04351269|25790344|FG001|Overall Study|Subjects followed long-term at different health care system|4|||
13083923|NCT04351269|25790345|FG002|Overall Study|Subjects followed long-term at different health care system|0|||
13083924|NCT04351269|25790343|FG000|Overall Study|Lost to Follow-up|1|||
13083925|NCT04351269|25790344|FG001|Overall Study|Lost to Follow-up|3|||
13083926|NCT04351269|25790345|FG002|Overall Study|Lost to Follow-up|0|||
13083927|NCT04350788|25790393|FG000|Overall Study|Lost to Follow-up|6|||
13083928|NCT04350788|25790394|FG001|Overall Study|Lost to Follow-up|2|||
13083929|NCT04350788|25790393|FG000|Overall Study|Withdrawal by Subject|2|||
13083930|NCT04350788|25790394|FG001|Overall Study|Withdrawal by Subject|4|||
13083931|NCT04350788|25790393|FG000|Overall Study|Protocol Violation|4|||
13083932|NCT04350788|25790394|FG001|Overall Study|Protocol Violation|0|||
13083933|NCT04349917|25790418|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0|||
13083934|NCT04349917|25790419|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1|||
13083935|NCT04349917|25790418|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0|||
13083936|NCT04349917|25790419|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1|||
13083937|NCT04348851|25790510|FG000|Post-Test 1|Withdrawal by Subject|0|||
13083938|NCT04348851|25790511|FG001|Post-Test 1|Withdrawal by Subject|1|||
13083939|NCT04348851|25790512|FG002|Post-Test 1|Withdrawal by Subject|0|||
13083940|NCT04348851|25790513|FG003|Post-Test 1|Withdrawal by Subject|0|||
13083941|NCT04348851|25790510|FG000|Post-Test 1|Lost to Follow-up|0|||
13083942|NCT04348851|25790511|FG001|Post-Test 1|Lost to Follow-up|1|||
13083943|NCT04348851|25790512|FG002|Post-Test 1|Lost to Follow-up|0|||
13083944|NCT04348851|25790513|FG003|Post-Test 1|Lost to Follow-up|0|||
13083945|NCT04348851|25790510|FG000|Post-Test 2|Stroke survivor death|0|||
13083946|NCT04348851|25790511|FG001|Post-Test 2|Stroke survivor death|1|||
13083947|NCT04348851|25790512|FG002|Post-Test 2|Stroke survivor death|0|||
13083948|NCT04348851|25790513|FG003|Post-Test 2|Stroke survivor death|1|||
13083949|NCT04348656|25790558|FG000|Overall Study|Withdrawal by Subject|2|||
13083950|NCT04348656|25790559|FG001|Overall Study|Withdrawal by Subject|0|||
13083951|NCT04348656|25790558|FG000|Overall Study|Lost to Follow-up|11|||
13083952|NCT04348656|25790559|FG001|Overall Study|Lost to Follow-up|6|||
13083953|NCT04348500|25790584|FG000|Overall Study|Death|2|||
13083954|NCT04348500|25790585|FG001|Overall Study|Death|2|||
13083955|NCT04348500|25790584|FG000|Overall Study|Withdrawn by subject due to dementia|0|||
13083956|NCT04348500|25790585|FG001|Overall Study|Withdrawn by subject due to dementia|1|||
13083957|NCT04347954|25790633|FG000|Overall Study|Did not present to study site for allocated intervention|3|||
13083958|NCT04347954|25790634|FG001|Overall Study|Did not present to study site for allocated intervention|0|||
13083959|NCT04347954|25790635|FG002|Overall Study|Did not present to study site for allocated intervention|3|||
13083960|NCT04347954|25790633|FG000|Overall Study|Lost to Follow-up|0|||
13083961|NCT04347954|25790634|FG001|Overall Study|Lost to Follow-up|1|||
13083962|NCT04347954|25790635|FG002|Overall Study|Lost to Follow-up|0|||
13083963|NCT04346628|25790662|FG000|Overall Study|Lost to Follow-up|4|||
13083964|NCT04346628|25790663|FG001|Overall Study|Lost to Follow-up|4|||
13083965|NCT04346628|25790662|FG000|Overall Study|Withdrew (had personal reasons)|2|||
13083966|NCT04346628|25790663|FG001|Overall Study|Withdrew (had personal reasons)|5|||
13083967|NCT04346628|25790662|FG000|Overall Study|Withdrew (medication intolerant)|0|||
13083968|NCT04346628|25790663|FG001|Overall Study|Withdrew (medication intolerant)|3|||
13083969|NCT04346628|25790662|FG000|Overall Study|Withdrew (declined intervention)|0|||
13083970|NCT04346628|25790663|FG001|Overall Study|Withdrew (declined intervention)|1|||
13083971|NCT04346199|25790710|FG000|Overall Study|Death|8|||
13083972|NCT04346199|25790711|FG001|Overall Study|Death|9|||
13083973|NCT04346199|25790710|FG000|Overall Study|Lost to Follow-up|0|||
13083974|NCT04346199|25790711|FG001|Overall Study|Lost to Follow-up|1|||
13083975|NCT04346199|25790710|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2|||
13083976|NCT04346199|25790711|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0|||
13083977|NCT04346199|25790710|FG000|Overall Study|Withdrawal by Subject|5|||
13083978|NCT04346199|25790711|FG001|Overall Study|Withdrawal by Subject|1|||
13083979|NCT04345653|25790720|FG000|Overall Study|Withdrawal by Subject|2|||
13083980|NCT04345367|25790781|FG000|Overall Study|Other|3|||
13083981|NCT04345367|25790782|FG001|Overall Study|Other|4|||
13083982|NCT04345367|25790781|FG000|Overall Study|Medication Error Without Associated Adverse Event|1|||
13083983|NCT04345367|25790782|FG001|Overall Study|Medication Error Without Associated Adverse Event|0|||
13083984|NCT04345367|25790781|FG000|Overall Study|Withdrawal by Subject|11|||
13083985|NCT04345367|25790782|FG001|Overall Study|Withdrawal by Subject|11|||
13083986|NCT04345367|25790781|FG000|Overall Study|Protocol Violation|4|||
13083987|NCT04345367|25790782|FG001|Overall Study|Protocol Violation|3|||
13083988|NCT04345367|25790781|FG000|Overall Study|Lost to Follow-up|2|||
13083989|NCT04345367|25790782|FG001|Overall Study|Lost to Follow-up|4|||
13083990|NCT04345367|25790781|FG000|Overall Study|Lack of Efficacy|2|||
13083991|NCT04345367|25790782|FG001|Overall Study|Lack of Efficacy|0|||
13083992|NCT04345367|25790781|FG000|Overall Study|Death|2|||
13083993|NCT04345367|25790782|FG001|Overall Study|Death|0|||
13083994|NCT04345367|25790781|FG000|Overall Study|Adverse Event|10|||
13083995|NCT04345367|25790782|FG001|Overall Study|Adverse Event|9|||
13083996|NCT04343976|25790803|FG000|Overall Study|Withdrawal by Subject|0|||
13083997|NCT04343976|25790804|FG001|Overall Study|Withdrawal by Subject|1|||
13083998|NCT04343261|25790812|FG000|Overall Study|Adverse Event|1|||
13083999|NCT04343261|25790812|FG000|Overall Study|received inadequate amount of antibodies|7|||
13084000|NCT04342897|25790837|FG000|Overall Study|Death|7|||
13084001|NCT04342897|25790838|FG001|Overall Study|Death|4|||
13084002|NCT04342897|25790837|FG000|Overall Study|Lost to Follow-up|6|||
13084003|NCT04342897|25790838|FG001|Overall Study|Lost to Follow-up|6|||
13084004|NCT04342897|25790837|FG000|Overall Study|Withdrawal by Subject|1|||
13084005|NCT04342897|25790838|FG001|Overall Study|Withdrawal by Subject|2|||
13084006|NCT04342689|25790855|FG000|Overall Study|Withdrawal by Subject|32|||
13084007|NCT04342689|25790856|FG001|Overall Study|Withdrawal by Subject|33|||
13084008|NCT04342689|25790855|FG000|Overall Study|Lost to Follow-up|10|||
13084009|NCT04342689|25790856|FG001|Overall Study|Lost to Follow-up|12|||
13084010|NCT04340557|25790877|FG000|Overall Study|Transferred to ICU and/or death|1|||
13084011|NCT04340557|25790878|FG001|Overall Study|Transferred to ICU and/or death|2|||
13084012|NCT04339972|25790893|FG000|Overall Study|Scheduling Issues|3|||
13084013|NCT04339972|25790894|FG001|Overall Study|Scheduling Issues|3|||
13084014|NCT04339972|25790893|FG000|Overall Study|dropout|1|||
13084015|NCT04339972|25790894|FG001|Overall Study|dropout|1|||
13084016|NCT04339972|25790893|FG000|Overall Study|Technical issues|1|||
13084017|NCT04339972|25790894|FG001|Overall Study|Technical issues|0|||
13084018|NCT04339972|25790893|FG000|Overall Study|Claustraphobia|0|||
13084019|NCT04339972|25790894|FG001|Overall Study|Claustraphobia|1|||
13084020|NCT04339296|25790909|FG000|Overall Study|Refuse to participate after allocation|1|||
13084021|NCT04339296|25790910|FG001|Overall Study|Refuse to participate after allocation|1|||
13084022|NCT04339296|25790909|FG000|Overall Study|Withdrew after completion of baseline|2|||
13084023|NCT04339296|25790910|FG001|Overall Study|Withdrew after completion of baseline|1|||
13084024|NCT04339296|25790909|FG000|Overall Study|Lost to Follow-up|0|||
13084025|NCT04339296|25790910|FG001|Overall Study|Lost to Follow-up|4|||
13084026|NCT04339296|25790909|FG000|Overall Study|Discontinued intervention|5|||
13084027|NCT04339296|25790910|FG001|Overall Study|Discontinued intervention|3|||
13084028|NCT04336475|25790923|FG000|Overall Study|pain|1|||
13084029|NCT04336475|25790924|FG001|Overall Study|pain|0|||
13084030|NCT04336475|25790923|FG000|Overall Study|upper respiratory infection|1|||
13084031|NCT04336475|25790924|FG001|Overall Study|upper respiratory infection|0|||
13084032|NCT04336475|25790923|FG000|Overall Study|Lost to Follow-up|0|||
13084033|NCT04336475|25790924|FG001|Overall Study|Lost to Follow-up|2|||
13084034|NCT04335929|25790938|FG000|Overall Study|Lost to Follow-up|10|||
13084035|NCT04335812|25790967|FG000|Overall Study|Withdrawal by Subject|1|||
13084036|NCT04335812|25790968|FG001|Overall Study|Withdrawal by Subject|3|||
13084037|NCT04335812|25790967|FG000|Overall Study|Lost to Follow-up|12|||
13084038|NCT04335812|25790968|FG001|Overall Study|Lost to Follow-up|12|||
13084039|NCT04335812|25790967|FG000|Overall Study|Did not engage in the intervention|22|||
13084040|NCT04335812|25790968|FG001|Overall Study|Did not engage in the intervention|18|||
13084041|NCT04335136|25791013|FG000|Overall Study|Death|8|||
13084042|NCT04335136|25791014|FG001|Overall Study|Death|4|||
13084043|NCT04335136|25791013|FG000|Overall Study|Lost to Follow-up|2|||
13084044|NCT04335136|25791014|FG001|Overall Study|Lost to Follow-up|0|||
13084045|NCT04335136|25791013|FG000|Overall Study|Protocol Violation|1|||
13084046|NCT04335136|25791014|FG001|Overall Study|Protocol Violation|0|||
13084047|NCT04335136|25791013|FG000|Overall Study|Withdrawal by Subject|1|||
13084048|NCT04335136|25791014|FG001|Overall Study|Withdrawal by Subject|1|||
13084049|NCT04335136|25791013|FG000|Overall Study|Health-threatening condition|0|||
13084050|NCT04335136|25791014|FG001|Overall Study|Health-threatening condition|1|||
13084051|NCT04335136|25791013|FG000|Overall Study|Adverse Event|0|||
13084052|NCT04335136|25791014|FG001|Overall Study|Adverse Event|1|||
13084053|NCT04335136|25791013|FG000|Overall Study|Erroneously randomized|2|||
13084054|NCT04335136|25791014|FG001|Overall Study|Erroneously randomized|0|||
13084055|NCT04334460|25791041|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4|||
13084056|NCT04334460|25791042|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1|||
13084057|NCT04334460|25791041|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4|||
13084058|NCT04334460|25791042|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1|||
13084059|NCT04334148|25791059|FG000|Overall Study|positive nasal swab at baseline|0|||
13084060|NCT04334148|25791060|FG001|Overall Study|positive nasal swab at baseline|1|||
13084061|NCT04333199|25791087|FG000|Evaluated Patients|Lost to Follow-up|0|||
13084062|NCT04333199|25791088|FG001|Evaluated Patients|Lost to Follow-up|1|||
13084063|NCT04333199|25791089|FG002|Evaluated Patients|Lost to Follow-up|2|||
13084064|NCT04332419|25791096|FG000|Overall Study|Withdrawal by Subject|1|||
13084065|NCT04332107|25791123|FG000|Day 3|Lost to Follow-up|23|||
13084066|NCT04332107|25791124|FG001|Day 3|Lost to Follow-up|14|||
13084067|NCT04332107|25791123|FG000|Day 3|Missing outcome data|3|||
13084068|NCT04332107|25791124|FG001|Day 3|Missing outcome data|6|||
13084069|NCT04332107|25791123|FG000|Day 14|Lost to Follow-up|13|||
13084070|NCT04332107|25791124|FG001|Day 14|Lost to Follow-up|4|||
13084071|NCT04332107|25791123|FG000|Day 14|Missing outcome data|4|||
13084072|NCT04332107|25791124|FG001|Day 14|Missing outcome data|4|||
13084073|NCT04332107|25791123|FG000|Day 21|Lost to Follow-up|10|||
13084074|NCT04332107|25791124|FG001|Day 21|Lost to Follow-up|2|||
13084075|NCT04331899|25791145|FG000|Trial Period (28 Days)|Withdrawal by Subject|2|||
13084076|NCT04331899|25791146|FG001|Trial Period (28 Days)|Withdrawal by Subject|2|||
13084077|NCT04330157|25791157|FG000|Overall Study|Protocol Violation|4|||
13084078|NCT04330157|25791157|FG000|Overall Study|Not extubated within 24 h postoperatively|3|||
13084079|NCT04329923|25791194|FG000|Overall Study|Withdrawal by Subject|1|||
13084080|NCT04329923|25791195|FG001|Overall Study|Withdrawal by Subject|4|||
13084081|NCT04329923|25791196|FG002|Overall Study|Withdrawal by Subject|1|||
13084082|NCT04329923|25791197|FG003|Overall Study|Withdrawal by Subject|1|||
13084083|NCT04329923|25791198|FG004|Overall Study|Withdrawal by Subject|1|||
13084084|NCT04329923|25791199|FG005|Overall Study|Withdrawal by Subject|1|||
13084085|NCT04329923|25791194|FG000|Overall Study|early termination of study|0|||
13084086|NCT04329923|25791195|FG001|Overall Study|early termination of study|0|||
13084087|NCT04329923|25791196|FG002|Overall Study|early termination of study|0|||
13084088|NCT04329923|25791197|FG003|Overall Study|early termination of study|0|||
13084089|NCT04329923|25791198|FG004|Overall Study|early termination of study|1|||
13084090|NCT04329923|25791199|FG005|Overall Study|early termination of study|2|||
13084091|NCT04329923|25791194|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0|||
13084092|NCT04329923|25791195|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0|||
13084093|NCT04329923|25791196|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0|||
13084094|NCT04329923|25791197|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0|||
13084095|NCT04329923|25791198|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0|||
13084096|NCT04329923|25791199|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2|||
13084097|NCT04328467|25791235|FG000|Overall Study|Did not meet inclusion criteria after randomization|4|||
13084098|NCT04328467|25791236|FG001|Overall Study|Did not meet inclusion criteria after randomization|2|||
13084099|NCT04328467|25791237|FG002|Overall Study|Did not meet inclusion criteria after randomization|1|||
13084100|NCT04328077|25791276|FG000|Overall Study|Lost to Follow-up|0|||
13084101|NCT04328077|25791277|FG001|Overall Study|Lost to Follow-up|1|||
13084102|NCT04328077|25791278|FG002|Overall Study|Lost to Follow-up|0|||
13084103|NCT04328077|25791279|FG003|Overall Study|Lost to Follow-up|0|||
13084104|NCT04328077|25791276|FG000|Overall Study|Withdrawal by Subject|0|||
13084105|NCT04328077|25791277|FG001|Overall Study|Withdrawal by Subject|1|||
13084106|NCT04328077|25791278|FG002|Overall Study|Withdrawal by Subject|1|||
13084107|NCT04328077|25791279|FG003|Overall Study|Withdrawal by Subject|3|||
13084108|NCT04327986|25791297|FG000|Overall Study|Physician Decision|2|||
13084109|NCT04327986|25791298|FG001|Overall Study|Physician Decision|0|||
13084110|NCT04327986|25791299|FG002|Overall Study|Physician Decision|0|||
13084111|NCT04327986|25791297|FG000|Overall Study|Death|1|||
13084112|NCT04327986|25791298|FG001|Overall Study|Death|0|||
13084113|NCT04327986|25791299|FG002|Overall Study|Death|0|||
13132381|NCT02792218|25983601|FG000|Overall Study|Lost to Follow-up|10|||
13132382|NCT02792218|25983602|FG001|Overall Study|Lost to Follow-up|5|||
13132383|NCT02792218|25983601|FG000|Overall Study|Lack of Efficacy|1|||
13132384|NCT02792218|25983602|FG001|Overall Study|Lack of Efficacy|12|||
13132385|NCT02792218|25983601|FG000|Overall Study|Physician Decision|4|||
13132386|NCT02792218|25983602|FG001|Overall Study|Physician Decision|4|||
13132387|NCT02792218|25983601|FG000|Overall Study|Protocol deviation|3|||
13132388|NCT02792218|25983602|FG001|Overall Study|Protocol deviation|2|||
13132389|NCT02792218|25983601|FG000|Overall Study|New therapy for study indication|0|||
13132390|NCT02792218|25983602|FG001|Overall Study|New therapy for study indication|1|||
13132391|NCT02792218|25983601|FG000|Overall Study|Non-compliance with study treatment|0|||
13132392|NCT02792218|25983602|FG001|Overall Study|Non-compliance with study treatment|1|||
13132393|NCT02792218|25983601|FG000|Overall Study|Pregnancy|1|||
13132394|NCT02792218|25983602|FG001|Overall Study|Pregnancy|0|||
13132395|NCT02792192|25983671|FG000|Overall Study|Death|1|||
13132396|NCT02792192|25983672|FG001|Overall Study|Death|0|||
13132397|NCT02792192|25983673|FG002|Overall Study|Death|0|||
13132398|NCT02792192|25983674|FG003|Overall Study|Death|0|||
13132399|NCT02792192|25983671|FG000|Overall Study|Informed Consent Withdrawn|4|||
13132400|NCT02792192|25983672|FG001|Overall Study|Informed Consent Withdrawn|0|||
13132401|NCT02792192|25983673|FG002|Overall Study|Informed Consent Withdrawn|0|||
13132402|NCT02792192|25983674|FG003|Overall Study|Informed Consent Withdrawn|0|||
13132403|NCT02792192|25983671|FG000|Overall Study|Physician Decision|1|||
13132404|NCT02792192|25983672|FG001|Overall Study|Physician Decision|0|||
13132405|NCT02792192|25983673|FG002|Overall Study|Physician Decision|0|||
13132406|NCT02792192|25983674|FG003|Overall Study|Physician Decision|0|||
13132407|NCT02792192|25983671|FG000|Overall Study|Progressive Disease|0|||
13132408|NCT02792192|25983672|FG001|Overall Study|Progressive Disease|1|||
13132409|NCT02792192|25983673|FG002|Overall Study|Progressive Disease|0|||
13132410|NCT02792192|25983674|FG003|Overall Study|Progressive Disease|0|||
13132411|NCT02792192|25983671|FG000|Overall Study|Study Terminated By Sponsor|6|||
13132412|NCT02792192|25983672|FG001|Overall Study|Study Terminated By Sponsor|10|||
13132413|NCT02792192|25983673|FG002|Overall Study|Study Terminated By Sponsor|0|||
13084114|NCT04327388|25791398|FG000|Overall Study|Adverse Event|17|||
13084115|NCT04327388|25791399|FG001|Overall Study|Adverse Event|18|||
13084116|NCT04327388|25791400|FG002|Overall Study|Adverse Event|9|||
13084117|NCT04327388|25791398|FG000|Overall Study|Other|1|||
13084118|NCT04327388|25791399|FG001|Overall Study|Other|2|||
13084119|NCT04327388|25791400|FG002|Overall Study|Other|0|||
13084120|NCT04327388|25791398|FG000|Overall Study|Randomized and not treated|2|||
13084121|NCT04327388|25791399|FG001|Overall Study|Randomized and not treated|0|||
13084122|NCT04327388|25791400|FG002|Overall Study|Randomized and not treated|2|||
13084123|NCT04323800|25791419|FG000|Overall Study|Withdrawal by Subject|4|||
13084124|NCT04323800|25791420|FG001|Overall Study|Withdrawal by Subject|4|||
13084125|NCT04323800|25791419|FG000|Overall Study|Incomplete transfusion|1|||
13084126|NCT04323800|25791420|FG001|Overall Study|Incomplete transfusion|0|||
13084127|NCT04323800|25791419|FG000|Overall Study|Other|0|||
13084128|NCT04323800|25791420|FG001|Overall Study|Other|1|||
13084129|NCT04323800|25791419|FG000|Overall Study|Positive RT-PCR at transfusion|1|||
13084130|NCT04323800|25791420|FG001|Overall Study|Positive RT-PCR at transfusion|1|||
13084131|NCT04322682|25791441|FG000|Overall Study|Withdrawal by Subject|33|||
13084132|NCT04322682|25791442|FG001|Overall Study|Withdrawal by Subject|47|||
13084133|NCT04322682|25791441|FG000|Overall Study|Death|5|||
13084134|NCT04322682|25791442|FG001|Overall Study|Death|9|||
13084135|NCT04322682|25791441|FG000|Overall Study|Lost to Follow-up|4|||
13084136|NCT04322682|25791442|FG001|Overall Study|Lost to Follow-up|8|||
13084137|NCT04322682|25791441|FG000|Overall Study|Admitted to Hospital and Intubated|1|||
13084138|NCT04322682|25791442|FG001|Overall Study|Admitted to Hospital and Intubated|0|||
13084139|NCT04322526|25791455|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
13084140|NCT04322526|25791456|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
13084141|NCT04322526|25791455|FG000|Washout (1 Week)|Lost to Follow-up|1|||
13084142|NCT04322526|25791456|FG001|Washout (1 Week)|Lost to Follow-up|2|||
13084143|NCT04321460|25791495|FG000|Overall Study|Participants who had no defecation or no data about it|1|||
13084144|NCT04321460|25791496|FG001|Overall Study|Participants who had no defecation or no data about it|1|||
13084145|NCT04320745|25791506|FG000|Overall Study|Adverse Event|26|||
13084146|NCT04320745|25791506|FG000|Overall Study|Withdrawal by Subject|4|||
13084147|NCT04320745|25791506|FG000|Overall Study|Lost to Follow-up|12|||
13084148|NCT04320745|25791506|FG000|Overall Study|Protocol Deviation|2|||
13084149|NCT04320745|25791506|FG000|Overall Study|Non-compliance With Study Drug|2|||
13084150|NCT04320745|25791506|FG000|Overall Study|Reason Not Specified|1|||
13084151|NCT04320615|25791547|FG000|Overall Study|Withdrawal by Subject|4|||
13084152|NCT04320615|25791548|FG001|Overall Study|Withdrawal by Subject|10|||
13084153|NCT04320615|25791547|FG000|Overall Study|Physician Decision|2|||
13084154|NCT04320615|25791548|FG001|Overall Study|Physician Decision|0|||
13084155|NCT04320615|25791547|FG000|Overall Study|Other|2|||
13084156|NCT04320615|25791548|FG001|Overall Study|Other|0|||
13084157|NCT04320615|25791547|FG000|Overall Study|Lost to Follow-up|5|||
13084158|NCT04320615|25791548|FG001|Overall Study|Lost to Follow-up|23|||
13084159|NCT04320615|25791547|FG000|Overall Study|Death|35|||
13084160|NCT04320615|25791548|FG001|Overall Study|Death|71|||
13084161|NCT04319159|25791598|FG000|Overall Study|Screening failure|13|||
13084162|NCT04319159|25791598|FG000|Overall Study|Re-screening due to COVID-19 implications|2|||
13084163|NCT04319159|25791598|FG000|Overall Study|Withdrawal by Subject|1|||
13084164|NCT04318535|25791639|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
13084165|NCT04318535|25791640|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1|||
13084166|NCT04318535|25791641|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
13084167|NCT04318093|25791658|FG000|Overall Study|Adverse Event|2|||
13084168|NCT04318093|25791659|FG001|Overall Study|Adverse Event|2|||
13084169|NCT04318093|25791658|FG000|Overall Study|Participant withdrew consent|1|||
13084170|NCT04318093|25791659|FG001|Overall Study|Participant withdrew consent|0|||
13084171|NCT04318093|25791658|FG000|Overall Study|Other reasons|0|||
13084172|NCT04318093|25791659|FG001|Overall Study|Other reasons|1|||
13084173|NCT04317690|25791727|FG000|Overall Study|did not have complete information for primary outcome|0|||
13084174|NCT04317690|25791728|FG001|Overall Study|did not have complete information for primary outcome|4|||
13084175|NCT04317690|25791729|FG002|Overall Study|did not have complete information for primary outcome|0|||
13084176|NCT04317690|25791730|FG003|Overall Study|did not have complete information for primary outcome|2|||
13084177|NCT04317690|25791731|FG004|Overall Study|did not have complete information for primary outcome|0|||
13084178|NCT04317040|25791772|FG000|Overall Study|Lost to Follow-up|2|||
13084179|NCT04317040|25791773|FG001|Overall Study|Lost to Follow-up|0|||
13084180|NCT04317040|25791772|FG000|Overall Study|Death|16|||
13084181|NCT04317040|25791773|FG001|Overall Study|Death|18|||
13084182|NCT04317040|25791772|FG000|Overall Study|Withdrawal by Subject|0|||
13084183|NCT04317040|25791773|FG001|Overall Study|Withdrawal by Subject|1|||
13084184|NCT04317040|25791772|FG000|Overall Study|Incomplete assessments|0|||
13084185|NCT04317040|25791773|FG001|Overall Study|Incomplete assessments|1|||
13084186|NCT04315298|25792289|FG000|Overall Study|Withdrawal by Subject|0|||
13084187|NCT04315298|25792290|FG001|Overall Study|Withdrawal by Subject|0|||
13084188|NCT04315298|25792291|FG002|Overall Study|Withdrawal by Subject|0|||
13084189|NCT04315298|25792292|FG003|Overall Study|Withdrawal by Subject|2|||
13084190|NCT04315298|25792293|FG004|Overall Study|Withdrawal by Subject|2|||
13084191|NCT04315298|25792294|FG005|Overall Study|Withdrawal by Subject|2|||
13084192|NCT04315298|25792295|FG006|Overall Study|Withdrawal by Subject|0|||
13084193|NCT04315298|25792296|FG007|Overall Study|Withdrawal by Subject|1|||
13084194|NCT04315298|25792297|FG008|Overall Study|Withdrawal by Subject|1|||
13084195|NCT04315298|25792298|FG009|Overall Study|Withdrawal by Subject|1|||
13084196|NCT04315298|25792299|FG010|Overall Study|Withdrawal by Subject|0|||
13084197|NCT04315298|25792300|FG011|Overall Study|Withdrawal by Subject|0|||
13084198|NCT04315298|25792301|FG012|Overall Study|Withdrawal by Subject|0|||
13084199|NCT04315298|25792302|FG013|Overall Study|Withdrawal by Subject|0|||
13084200|NCT04315298|25792303|FG014|Overall Study|Withdrawal by Subject|0|||
13084201|NCT04315298|25792304|FG015|Overall Study|Withdrawal by Subject|0|||
13084202|NCT04315298|25792305|FG016|Overall Study|Withdrawal by Subject|0|||
13084203|NCT04315298|25792306|FG017|Overall Study|Withdrawal by Subject|0|||
13084204|NCT04315298|25792307|FG018|Overall Study|Withdrawal by Subject|0|||
13084205|NCT04315298|25792289|FG000|Overall Study|Physician Decision|0|||
13084206|NCT04315298|25792290|FG001|Overall Study|Physician Decision|0|||
13084207|NCT04315298|25792291|FG002|Overall Study|Physician Decision|0|||
13084208|NCT04315298|25792292|FG003|Overall Study|Physician Decision|0|||
13084209|NCT04315298|25792293|FG004|Overall Study|Physician Decision|1|||
13084210|NCT04315298|25792294|FG005|Overall Study|Physician Decision|0|||
13084211|NCT04315298|25792295|FG006|Overall Study|Physician Decision|0|||
13084212|NCT04315298|25792296|FG007|Overall Study|Physician Decision|0|||
13084213|NCT04315298|25792297|FG008|Overall Study|Physician Decision|0|||
13084214|NCT04315298|25792298|FG009|Overall Study|Physician Decision|0|||
13084215|NCT04315298|25792299|FG010|Overall Study|Physician Decision|0|||
13084216|NCT04315298|25792300|FG011|Overall Study|Physician Decision|0|||
13084217|NCT04315298|25792301|FG012|Overall Study|Physician Decision|0|||
13084218|NCT04315298|25792302|FG013|Overall Study|Physician Decision|0|||
13084219|NCT04315298|25792303|FG014|Overall Study|Physician Decision|0|||
13084220|NCT04315298|25792304|FG015|Overall Study|Physician Decision|0|||
13084221|NCT04315298|25792305|FG016|Overall Study|Physician Decision|0|||
13084222|NCT04315298|25792306|FG017|Overall Study|Physician Decision|0|||
13084223|NCT04315298|25792307|FG018|Overall Study|Physician Decision|0|||
13084224|NCT04315298|25792289|FG000|Overall Study|Lost to Follow-up|5|||
13084225|NCT04315298|25792290|FG001|Overall Study|Lost to Follow-up|10|||
13084226|NCT04315298|25792291|FG002|Overall Study|Lost to Follow-up|6|||
13084227|NCT04315298|25792292|FG003|Overall Study|Lost to Follow-up|8|||
13084228|NCT04315298|25792293|FG004|Overall Study|Lost to Follow-up|12|||
13084229|NCT04315298|25792294|FG005|Overall Study|Lost to Follow-up|13|||
13084230|NCT04315298|25792295|FG006|Overall Study|Lost to Follow-up|9|||
13084231|NCT04315298|25792296|FG007|Overall Study|Lost to Follow-up|16|||
13084232|NCT04315298|25792297|FG008|Overall Study|Lost to Follow-up|14|||
13084233|NCT04315298|25792298|FG009|Overall Study|Lost to Follow-up|0|||
13084234|NCT04315298|25792299|FG010|Overall Study|Lost to Follow-up|2|||
13084235|NCT04315298|25792300|FG011|Overall Study|Lost to Follow-up|1|||
13084236|NCT04315298|25792301|FG012|Overall Study|Lost to Follow-up|0|||
13084237|NCT04315298|25792302|FG013|Overall Study|Lost to Follow-up|0|||
13084238|NCT04315298|25792303|FG014|Overall Study|Lost to Follow-up|0|||
13084239|NCT04315298|25792304|FG015|Overall Study|Lost to Follow-up|2|||
13084240|NCT04315298|25792305|FG016|Overall Study|Lost to Follow-up|0|||
13084241|NCT04315298|25792306|FG017|Overall Study|Lost to Follow-up|0|||
13084242|NCT04315298|25792307|FG018|Overall Study|Lost to Follow-up|0|||
13084243|NCT04315298|25792289|FG000|Overall Study|Death|24|||
13084244|NCT04315298|25792290|FG001|Overall Study|Death|60|||
13084245|NCT04315298|25792291|FG002|Overall Study|Death|49|||
13084246|NCT04315298|25792292|FG003|Overall Study|Death|59|||
13084247|NCT04315298|25792293|FG004|Overall Study|Death|70|||
13084248|NCT04315298|25792294|FG005|Overall Study|Death|114|||
13084249|NCT04315298|25792295|FG006|Overall Study|Death|9|||
13084250|NCT04315298|25792296|FG007|Overall Study|Death|12|||
13084251|NCT04315298|25792297|FG008|Overall Study|Death|21|||
13084252|NCT04315298|25792298|FG009|Overall Study|Death|16|||
13084253|NCT04315298|25792299|FG010|Overall Study|Death|40|||
13084254|NCT04315298|25792300|FG011|Overall Study|Death|40|||
13084255|NCT04315298|25792301|FG012|Overall Study|Death|3|||
13084256|NCT04315298|25792302|FG013|Overall Study|Death|4|||
13084257|NCT04315298|25792303|FG014|Overall Study|Death|6|||
13084258|NCT04315298|25792304|FG015|Overall Study|Death|4|||
13084259|NCT04315298|25792305|FG016|Overall Study|Death|3|||
13084260|NCT04315298|25792306|FG017|Overall Study|Death|1|||
13084261|NCT04315298|25792307|FG018|Overall Study|Death|0|||
13084262|NCT04314284|25792348|FG000|Overall Study|Withdrawal by Subject|4|||
13084263|NCT04314284|25792349|FG001|Overall Study|Withdrawal by Subject|7|||
13084264|NCT04314284|25792348|FG000|Overall Study|Consented but did not complete survey|0|||
13084265|NCT04314284|25792349|FG001|Overall Study|Consented but did not complete survey|6|||
13084266|NCT04314037|25792426|FG000|Treatment Period 2|Adverse Event|1|||
13084267|NCT04314037|25792427|FG001|Treatment Period 2|Adverse Event|0|||
13084268|NCT04314037|25792426|FG000|Treatment Period 3|Protocol Violation|1|||
13084269|NCT04314037|25792427|FG001|Treatment Period 3|Protocol Violation|0|||
13084270|NCT04314037|25792426|FG000|Treatment Period 3|Adverse Event|0|||
13084271|NCT04314037|25792427|FG001|Treatment Period 3|Adverse Event|1|||
13084272|NCT04311177|25792460|FG000|Overall Study|Adverse Event|3|||
13084273|NCT04311177|25792461|FG001|Overall Study|Adverse Event|1|||
13084274|NCT04311177|25792460|FG000|Overall Study|Physician Decision|4|||
13084275|NCT04311177|25792461|FG001|Overall Study|Physician Decision|3|||
13084276|NCT04311177|25792460|FG000|Overall Study|Withdrawal by Subject|1|||
13084277|NCT04311177|25792461|FG001|Overall Study|Withdrawal by Subject|0|||
13084278|NCT04308668|25792490|FG000|Overall Study|Lost to Follow-up|32|||
13084279|NCT04308668|25792491|FG001|Overall Study|Lost to Follow-up|38|||
13084280|NCT04308668|25792490|FG000|Overall Study|Withdrawal by Subject|4|||
13084281|NCT04308668|25792491|FG001|Overall Study|Withdrawal by Subject|4|||
13084282|NCT04308239|25792520|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2|||
13084283|NCT04308239|25792521|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1|||
13084284|NCT04308239|25792520|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1|||
13084285|NCT04308239|25792521|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2|||
13084286|NCT04308239|25792520|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1|||
13084287|NCT04308239|25792521|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2|||
13084288|NCT04308239|25792520|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0|||
13084289|NCT04308239|25792521|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2|||
13084290|NCT04307940|25792563|FG000|Overall Study|Adverse Event|1|||
13084291|NCT04307940|25792564|FG001|Overall Study|Adverse Event|0|||
13084292|NCT04307940|25792565|FG002|Overall Study|Adverse Event|0|||
13084293|NCT04307940|25792563|FG000|Overall Study|Withdrawal by Subject|2|||
13084294|NCT04307940|25792564|FG001|Overall Study|Withdrawal by Subject|3|||
13084295|NCT04307940|25792565|FG002|Overall Study|Withdrawal by Subject|1|||
13084296|NCT04307940|25792563|FG000|Overall Study|Lost to Follow-up|2|||
13084297|NCT04307940|25792564|FG001|Overall Study|Lost to Follow-up|0|||
13084298|NCT04307940|25792565|FG002|Overall Study|Lost to Follow-up|1|||
13084299|NCT04302545|25792600|FG000|Overall Study|Lost to Follow-up|3|||
13084300|NCT04302545|25792601|FG001|Overall Study|Lost to Follow-up|4|||
13084301|NCT04297241|25792617|FG000|Overall Study|Withdrawal by Subject|1|||
13084302|NCT04297241|25792617|FG000|Overall Study|Adverse Event|1|||
13084303|NCT04297241|25792617|FG000|Overall Study|Physician Decision|3|||
13084304|NCT04295356|25792648|FG000|Overall Study|Physician Decision|1|||
13084305|NCT04295356|25792649|FG001|Overall Study|Physician Decision|0|||
13084306|NCT04295356|25792648|FG000|Overall Study|Lost to Follow-up|0|||
13084307|NCT04295356|25792649|FG001|Overall Study|Lost to Follow-up|3|||
13084308|NCT04295356|25792648|FG000|Overall Study|Protocol Violation|0|||
13084309|NCT04295356|25792649|FG001|Overall Study|Protocol Violation|1|||
13084310|NCT04292899|25792672|FG000|Overall Study|Death|21|||
13084311|NCT04292899|25792673|FG001|Overall Study|Death|28|||
13084312|NCT04292899|25792674|FG002|Overall Study|Death|188|||
13084313|NCT04292899|25792675|FG003|Overall Study|Death|371|||
13084314|NCT04292899|25792672|FG000|Overall Study|Lost to Follow-up|8|||
13084315|NCT04292899|25792673|FG001|Overall Study|Lost to Follow-up|4|||
13084316|NCT04292899|25792674|FG002|Overall Study|Lost to Follow-up|22|||
13084317|NCT04292899|25792675|FG003|Overall Study|Lost to Follow-up|235|||
13084318|NCT04292899|25792672|FG000|Overall Study|Withdrew consent|1|||
13084319|NCT04292899|25792673|FG001|Overall Study|Withdrew consent|0|||
13084320|NCT04292899|25792674|FG002|Overall Study|Withdrew consent|11|||
13084321|NCT04292899|25792675|FG003|Overall Study|Withdrew consent|32|||
13084322|NCT04292899|25792672|FG000|Overall Study|Adverse Event|2|||
13084323|NCT04292899|25792673|FG001|Overall Study|Adverse Event|1|||
13084324|NCT04292899|25792674|FG002|Overall Study|Adverse Event|2|||
13084325|NCT04292899|25792675|FG003|Overall Study|Adverse Event|2|||
13084326|NCT04292899|25792672|FG000|Overall Study|Investigator's Discretion|0|||
13084327|NCT04292899|25792673|FG001|Overall Study|Investigator's Discretion|0|||
13084328|NCT04292899|25792674|FG002|Overall Study|Investigator's Discretion|0|||
13084329|NCT04292899|25792675|FG003|Overall Study|Investigator's Discretion|3|||
13084330|NCT04292899|25792672|FG000|Overall Study|Non-compliance With Study Drug|0|||
13084331|NCT04292899|25792673|FG001|Overall Study|Non-compliance With Study Drug|0|||
13084332|NCT04292899|25792674|FG002|Overall Study|Non-compliance With Study Drug|0|||
13084333|NCT04292899|25792675|FG003|Overall Study|Non-compliance With Study Drug|1|||
13084334|NCT04292899|25792672|FG000|Overall Study|Protocol Violation|0|||
13084335|NCT04292899|25792673|FG001|Overall Study|Protocol Violation|0|||
13084336|NCT04292899|25792674|FG002|Overall Study|Protocol Violation|0|||
13084337|NCT04292899|25792675|FG003|Overall Study|Protocol Violation|1|||
13084338|NCT04292730|25792700|FG000|Overall Study|Lost to Follow-up|8|||
13084339|NCT04292730|25792701|FG001|Overall Study|Lost to Follow-up|12|||
13084340|NCT04292730|25792702|FG002|Overall Study|Lost to Follow-up|12|||
13084341|NCT04292730|25792703|FG003|Overall Study|Lost to Follow-up|48|||
13084342|NCT04292730|25792700|FG000|Overall Study|Death|2|||
13084343|NCT04292730|25792701|FG001|Overall Study|Death|2|||
13084344|NCT04292730|25792702|FG002|Overall Study|Death|4|||
13084345|NCT04292730|25792703|FG003|Overall Study|Death|12|||
13084346|NCT04292730|25792700|FG000|Overall Study|Withdrew Consent|2|||
13084347|NCT04292730|25792701|FG001|Overall Study|Withdrew Consent|2|||
13084348|NCT04292730|25792702|FG002|Overall Study|Withdrew Consent|5|||
13084349|NCT04292730|25792703|FG003|Overall Study|Withdrew Consent|6|||
13084350|NCT04292730|25792700|FG000|Overall Study|Non-Compliance with Study Drug|0|||
13084351|NCT04292730|25792701|FG001|Overall Study|Non-Compliance with Study Drug|1|||
13084352|NCT04292730|25792702|FG002|Overall Study|Non-Compliance with Study Drug|0|||
13084353|NCT04292730|25792703|FG003|Overall Study|Non-Compliance with Study Drug|0|||
13084354|NCT04292730|25792700|FG000|Overall Study|Protocol Violation|0|||
13084355|NCT04292730|25792701|FG001|Overall Study|Protocol Violation|0|||
13084356|NCT04292730|25792702|FG002|Overall Study|Protocol Violation|1|||
13084357|NCT04292730|25792703|FG003|Overall Study|Protocol Violation|0|||
13084358|NCT04292730|25792700|FG000|Overall Study|Randomized but not Treated|8|||
13084359|NCT04292730|25792701|FG001|Overall Study|Randomized but not Treated|4|||
13084360|NCT04292730|25792702|FG002|Overall Study|Randomized but not Treated|0|||
13084361|NCT04292730|25792703|FG003|Overall Study|Randomized but not Treated|14|||
13084362|NCT04292535|25792902|FG000|Overall Study|Withdrawal by Subject|0|||
13084363|NCT04292535|25792903|FG001|Overall Study|Withdrawal by Subject|0|||
13084364|NCT04292535|25792904|FG002|Overall Study|Withdrawal by Subject|0|||
13084365|NCT04292535|25792905|FG003|Overall Study|Withdrawal by Subject|0|||
13084366|NCT04292535|25792906|FG004|Overall Study|Withdrawal by Subject|0|||
13084367|NCT04292535|25792907|FG005|Overall Study|Withdrawal by Subject|0|||
13084368|NCT04292535|25792908|FG006|Overall Study|Withdrawal by Subject|0|||
13084369|NCT04292535|25792909|FG007|Overall Study|Withdrawal by Subject|1|||
13084370|NCT04292535|25792910|FG008|Overall Study|Withdrawal by Subject|0|||
13084371|NCT04292535|25792911|FG009|Overall Study|Withdrawal by Subject|0|||
13084372|NCT04292535|25792912|FG010|Overall Study|Withdrawal by Subject|0|||
13084373|NCT04292535|25792913|FG011|Overall Study|Withdrawal by Subject|0|||
13084374|NCT04292535|25792914|FG012|Overall Study|Withdrawal by Subject|0|||
13084375|NCT04292535|25792915|FG013|Overall Study|Withdrawal by Subject|0|||
13084376|NCT04292535|25792902|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
13084377|NCT04292535|25792903|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
13084378|NCT04292535|25792904|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
13084379|NCT04292535|25792905|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
13084380|NCT04292535|25792906|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
13084381|NCT04292535|25792907|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
13084382|NCT04292535|25792908|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
13084383|NCT04292535|25792909|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
13084384|NCT04292535|25792910|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
13084385|NCT04292535|25792911|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
13084386|NCT04292535|25792912|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
13084387|NCT04292535|25792913|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
13084388|NCT04292535|25792914|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
13084389|NCT04292535|25792915|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
13084390|NCT04292535|25792902|FG000|Overall Study|Report of Dizziness|0|||
13084391|NCT04292535|25792903|FG001|Overall Study|Report of Dizziness|0|||
13084392|NCT04292535|25792904|FG002|Overall Study|Report of Dizziness|0|||
13084393|NCT04292535|25792905|FG003|Overall Study|Report of Dizziness|0|||
13084394|NCT04292535|25792906|FG004|Overall Study|Report of Dizziness|0|||
13084395|NCT04292535|25792907|FG005|Overall Study|Report of Dizziness|0|||
13084396|NCT04292535|25792908|FG006|Overall Study|Report of Dizziness|0|||
13084397|NCT04292535|25792909|FG007|Overall Study|Report of Dizziness|0|||
13084398|NCT04292535|25792910|FG008|Overall Study|Report of Dizziness|0|||
13084399|NCT04292535|25792911|FG009|Overall Study|Report of Dizziness|0|||
13084400|NCT04292535|25792912|FG010|Overall Study|Report of Dizziness|0|||
13084401|NCT04292535|25792913|FG011|Overall Study|Report of Dizziness|0|||
13084402|NCT04292535|25792914|FG012|Overall Study|Report of Dizziness|0|||
13084403|NCT04292535|25792915|FG013|Overall Study|Report of Dizziness|1|||
13084404|NCT04292535|25792902|FG000|Overall Study|Equipment Failure|0|||
13084405|NCT04292535|25792903|FG001|Overall Study|Equipment Failure|0|||
13084406|NCT04292535|25792904|FG002|Overall Study|Equipment Failure|0|||
13084407|NCT04292535|25792905|FG003|Overall Study|Equipment Failure|0|||
13084408|NCT04292535|25792906|FG004|Overall Study|Equipment Failure|0|||
13084409|NCT04292535|25792907|FG005|Overall Study|Equipment Failure|0|||
13084410|NCT04292535|25792908|FG006|Overall Study|Equipment Failure|0|||
13084411|NCT04292535|25792909|FG007|Overall Study|Equipment Failure|0|||
13084412|NCT04292535|25792910|FG008|Overall Study|Equipment Failure|0|||
13084413|NCT04292535|25792911|FG009|Overall Study|Equipment Failure|0|||
13084414|NCT04292535|25792912|FG010|Overall Study|Equipment Failure|0|||
13084415|NCT04292535|25792913|FG011|Overall Study|Equipment Failure|1|||
13084416|NCT04292535|25792914|FG012|Overall Study|Equipment Failure|0|||
13084417|NCT04292535|25792915|FG013|Overall Study|Equipment Failure|0|||
13084418|NCT04292171|25792936|FG000|Overall Study|Pharmacy error|2|||
13084419|NCT04292171|25792937|FG001|Overall Study|Pharmacy error|0|||
13084420|NCT04292171|25792936|FG000|Overall Study|Delivered prior to procedure|0|||
13084421|NCT04292171|25792937|FG001|Overall Study|Delivered prior to procedure|1|||
13084422|NCT04289623|25792976|FG000|Wave 1 Emails|Email was not delivered|268|||
13084423|NCT04289623|25792977|FG001|Wave 1 Emails|Email was not delivered|257|||
13084424|NCT04289623|25792978|FG002|Wave 1 Emails|Email was not delivered|0|||
13084425|NCT04289623|25792979|FG003|Wave 1 Emails|Email was not delivered|0|||
13084426|NCT04289623|25792980|FG004|Wave 1 Emails|Email was not delivered|0|||
13084427|NCT04289623|25792981|FG005|Wave 1 Emails|Email was not delivered|0|||
13084428|NCT04287517|25793002|FG000|Overall Study|Withdrawal by Subject|1|||
13084429|NCT04287517|25793003|FG001|Overall Study|Withdrawal by Subject|1|||
13084430|NCT04285229|25793045|FG000|Overall Study|Adverse Event|1|||
13084431|NCT04285229|25793046|FG001|Overall Study|Adverse Event|2|||
13084432|NCT04285229|25793045|FG000|Overall Study|Withdrawal by Subject|1|||
13084433|NCT04285229|25793046|FG001|Overall Study|Withdrawal by Subject|0|||
13084434|NCT04285229|25793045|FG000|Overall Study|Sponsor Decision|1|||
13084435|NCT04285229|25793046|FG001|Overall Study|Sponsor Decision|0|||
13084436|NCT04284813|25793054|FG000|Overall Study|Withdrawal by Subject|1|||
13084437|NCT04280705|25793151|FG000|Overall Study|Enrolled but not treated|4|||
13084438|NCT04280705|25793152|FG001|Overall Study|Enrolled but not treated|10|||
13084439|NCT04280705|25793151|FG000|Overall Study|Physician Decision|1|||
13084440|NCT04280705|25793152|FG001|Overall Study|Physician Decision|0|||
13084441|NCT04280705|25793151|FG000|Overall Study|Withdrawal by Subject|7|||
13084442|NCT04280705|25793152|FG001|Overall Study|Withdrawal by Subject|9|||
13084443|NCT04280705|25793151|FG000|Overall Study|Adverse Event|0|||
13084444|NCT04280705|25793152|FG001|Overall Study|Adverse Event|4|||
13084445|NCT04280705|25793151|FG000|Overall Study|Transferred to another hospital|1|||
13084446|NCT04280705|25793152|FG001|Overall Study|Transferred to another hospital|1|||
13084447|NCT04276207|25793167|FG000|Period 1|Withdrawal by Subject|0|||
13084448|NCT04276207|25793168|FG001|Period 1|Withdrawal by Subject|1|||
13084449|NCT04275336|25793207|FG000|Overall Study|First venipuncture failed|4|||
13084450|NCT04275336|25793208|FG001|Overall Study|First venipuncture failed|6|||
13084451|NCT04275336|25793209|FG002|Overall Study|First venipuncture failed|5|||
13084452|NCT04275336|25793207|FG000|Overall Study|Unscheduled venipuncture|9|||
13084453|NCT04275336|25793208|FG001|Overall Study|Unscheduled venipuncture|13|||
13084454|NCT04275336|25793209|FG002|Overall Study|Unscheduled venipuncture|7|||
13084455|NCT04275336|25793207|FG000|Overall Study|Failed specimen of saliva|4|||
13084456|NCT04275336|25793208|FG001|Overall Study|Failed specimen of saliva|3|||
13084457|NCT04275336|25793209|FG002|Overall Study|Failed specimen of saliva|4|||
13084458|NCT04274686|25793222|FG000|Overall Study|Physician Decision|1|||
13084459|NCT04274686|25793223|FG001|Overall Study|Physician Decision|0|||
13084460|NCT04274192|25793248|FG000|Overall Study|Protocol Violation|1|||
13084461|NCT04274192|25793249|FG001|Overall Study|Protocol Violation|0|||
13084462|NCT04273217|25793364|FG000|Overall Study|Lost to Follow-up|0|||
13084463|NCT04273217|25793365|FG001|Overall Study|Lost to Follow-up|0|||
13084464|NCT04273217|25793366|FG002|Overall Study|Lost to Follow-up|0|||
13084465|NCT04273217|25793367|FG003|Overall Study|Lost to Follow-up|0|||
13084466|NCT04273217|25793368|FG004|Overall Study|Lost to Follow-up|0|||
13084467|NCT04273217|25793369|FG005|Overall Study|Lost to Follow-up|1|||
13084468|NCT04273217|25793364|FG000|Overall Study|Participant non-compliance|0|||
13084469|NCT04273217|25793365|FG001|Overall Study|Participant non-compliance|0|||
13084470|NCT04273217|25793366|FG002|Overall Study|Participant non-compliance|0|||
13084471|NCT04273217|25793367|FG003|Overall Study|Participant non-compliance|0|||
13084472|NCT04273217|25793368|FG004|Overall Study|Participant non-compliance|1|||
13084473|NCT04273217|25793369|FG005|Overall Study|Participant non-compliance|0|||
13084474|NCT04273217|25793364|FG000|Overall Study|Positive urine drug screen|1|||
13084475|NCT04273217|25793365|FG001|Overall Study|Positive urine drug screen|0|||
13084476|NCT04273217|25793366|FG002|Overall Study|Positive urine drug screen|1|||
13084477|NCT04273217|25793367|FG003|Overall Study|Positive urine drug screen|0|||
13084478|NCT04273217|25793368|FG004|Overall Study|Positive urine drug screen|0|||
13084479|NCT04273217|25793369|FG005|Overall Study|Positive urine drug screen|1|||
13084480|NCT04272775|25793396|FG000|Overall Study|Study Terminated by Sponsor|1|||
13084481|NCT04272775|25793397|FG001|Overall Study|Study Terminated by Sponsor|0|||
13084482|NCT04272775|25793396|FG000|Overall Study|Protocol Violation|0|||
13084483|NCT04272775|25793397|FG001|Overall Study|Protocol Violation|1|||
13084484|NCT04272775|25793396|FG000|Overall Study|Symptomatic Deterioration|1|||
13084485|NCT04272775|25793397|FG001|Overall Study|Symptomatic Deterioration|1|||
13084486|NCT04272775|25793396|FG000|Overall Study|Withdrawal by Subject|1|||
13084487|NCT04272775|25793397|FG001|Overall Study|Withdrawal by Subject|2|||
13084488|NCT04272775|25793396|FG000|Overall Study|Adverse Event|1|||
13084489|NCT04272775|25793397|FG001|Overall Study|Adverse Event|2|||
13084490|NCT04272775|25793396|FG000|Overall Study|Progressive Disease|3|||
13084491|NCT04272775|25793397|FG001|Overall Study|Progressive Disease|1|||
13084492|NCT04271605|25793406|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5|||
13084493|NCT04268316|25793433|FG000|Overall Study|Withdrawal by Subject|2|||
13084494|NCT04268316|25793434|FG001|Overall Study|Withdrawal by Subject|1|||
13084495|NCT04268316|25793435|FG002|Overall Study|Withdrawal by Subject|0|||
13133723|NCT02765165|25988892|FG001|Post-treatment Follow-up|Death|2|||
13084496|NCT04263142|25793703|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0|||
13084497|NCT04263142|25793704|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0|||
13084498|NCT04263142|25793705|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0|||
13084499|NCT04263142|25793706|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0|||
13084500|NCT04263142|25793707|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1|||
13084501|NCT04263142|25793703|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0|||
13084502|NCT04263142|25793704|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0|||
13084503|NCT04263142|25793705|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0|||
13084504|NCT04263142|25793706|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0|||
13084505|NCT04263142|25793707|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1|||
13084506|NCT04259346|25793724|FG000|Overall Study|Lost to Follow-up|1|||
13084507|NCT04259346|25793725|FG001|Overall Study|Lost to Follow-up|3|||
13084508|NCT04259346|25793724|FG000|Overall Study|Protocol Violation|1|||
13084509|NCT04259346|25793725|FG001|Overall Study|Protocol Violation|0|||
13084510|NCT04259346|25793724|FG000|Overall Study|Withdrawal by Subject|1|||
13084511|NCT04259346|25793725|FG001|Overall Study|Withdrawal by Subject|0|||
13084512|NCT04259346|25793724|FG000|Overall Study|Adverse Event|1|||
13084513|NCT04259346|25793725|FG001|Overall Study|Adverse Event|1|||
13084514|NCT04258995|25793756|FG000|Overall Study|Lost to Follow-up|1|||
13084515|NCT04258995|25793757|FG001|Overall Study|Lost to Follow-up|1|||
13084516|NCT04256785|25793788|FG000|Overall Study|Adverse Event|8|||
13084517|NCT04256785|25793789|FG001|Overall Study|Adverse Event|6|||
13084518|NCT04256785|25793788|FG000|Overall Study|Lack of Efficacy|3|||
13084519|NCT04256785|25793789|FG001|Overall Study|Lack of Efficacy|4|||
13084520|NCT04256785|25793788|FG000|Overall Study|Lost to Follow-up|7|||
13084521|NCT04256785|25793789|FG001|Overall Study|Lost to Follow-up|7|||
13084522|NCT04256785|25793788|FG000|Overall Study|Protocol Violation|1|||
13084523|NCT04256785|25793789|FG001|Overall Study|Protocol Violation|0|||
13084524|NCT04256785|25793788|FG000|Overall Study|Withdrawal by Subject|4|||
13084525|NCT04256785|25793789|FG001|Overall Study|Withdrawal by Subject|1|||
13084526|NCT04256785|25793788|FG000|Overall Study|Surgery or quarantined due to Covid-19|5|||
13084527|NCT04256785|25793789|FG001|Overall Study|Surgery or quarantined due to Covid-19|7|||
13084528|NCT04253236|25793820|FG000|Overall Study|Adverse Event|1|||
13084529|NCT04253236|25793821|FG001|Overall Study|Adverse Event|0|||
13084530|NCT04253236|25793820|FG000|Overall Study|Safety Concerns|1|||
13084531|NCT04253236|25793821|FG001|Overall Study|Safety Concerns|0|||
13084532|NCT04253236|25793820|FG000|Overall Study|Study Terminated by Sponsor|1|||
13084533|NCT04253236|25793821|FG001|Overall Study|Study Terminated by Sponsor|0|||
13084534|NCT04252586|25793841|FG000|Overall Study|Withdrawal by parent/guardian|3|||
13084535|NCT04252586|25793841|FG000|Overall Study|Adverse Event|1|||
13084536|NCT04252586|25793841|FG000|Overall Study|Death|2|||
13084537|NCT04252586|25793841|FG000|Overall Study|Study terminated by sponsor|4|||
13084538|NCT04252586|25793841|FG000|Overall Study|Sponsor request|10|||
13084539|NCT04252586|25793841|FG000|Overall Study|Did not complete treatment period|1|||
13084540|NCT04249336|25793872|FG000|Overall Study|Lost to Follow-up|3|||
13084541|NCT04249336|25793873|FG001|Overall Study|Lost to Follow-up|3|||
13084542|NCT04249336|25793874|FG002|Overall Study|Lost to Follow-up|3|||
13084543|NCT04249336|25793875|FG003|Overall Study|Lost to Follow-up|3|||
13084544|NCT04247828|25793885|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9|||
13084545|NCT04247061|25793897|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6|||
13084546|NCT04247061|25793897|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2|||
13084547|NCT04247061|25793897|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1|||
13084548|NCT04245709|25793905|FG000|Overall Study|Adverse Event|13|||
13084549|NCT04245709|25793905|FG000|Overall Study|Risk of travel during COVID19 pandemic|1|||
13084550|NCT04245202|25793948|FG000|Overall Study|Lack of Efficacy|10|||
13084551|NCT04245202|25793949|FG001|Overall Study|Lack of Efficacy|1|||
13084552|NCT04241133|25793962|FG000|Overall Study|COVID19 Precautions|14|||
13084553|NCT04241133|25793963|FG001|Overall Study|COVID19 Precautions|34|||
13084556|NCT04238663|25794078|FG000|Overall Study|Lost to Follow-up|0|||
13084557|NCT04238663|25794079|FG001|Overall Study|Lost to Follow-up|1|||
13084558|NCT04238663|25794080|FG002|Overall Study|Lost to Follow-up|0|||
13084559|NCT04238650|25794109|FG000|Overall Study|Withdrawal by Subject|0|||
13084560|NCT04238650|25794110|FG001|Overall Study|Withdrawal by Subject|1|||
13084561|NCT04237792|25794208|FG000|Treatment (Day 1)|Adverse Event|1|||
13084562|NCT04237792|25794209|FG001|Treatment (Day 1)|Adverse Event|0|||
13084563|NCT04237792|25794210|FG002|Treatment (Day 1)|Adverse Event|0|||
13084564|NCT04237792|25794211|FG003|Treatment (Day 1)|Adverse Event|0|||
13084565|NCT04237792|25794212|FG004|Treatment (Day 1)|Adverse Event|1|||
13084566|NCT04237792|25794213|FG005|Treatment (Day 1)|Adverse Event|1|||
13084567|NCT04237792|25794208|FG000|Treatment (Day 1)|Other|0|||
13084568|NCT04237792|25794209|FG001|Treatment (Day 1)|Other|0|||
13084569|NCT04237792|25794210|FG002|Treatment (Day 1)|Other|1|||
13084570|NCT04237792|25794211|FG003|Treatment (Day 1)|Other|0|||
13084571|NCT04237792|25794212|FG004|Treatment (Day 1)|Other|0|||
13084572|NCT04237792|25794213|FG005|Treatment (Day 1)|Other|1|||
13084573|NCT04237792|25794208|FG000|Treatment (Day 1)|Not treated|1|||
13084574|NCT04237792|25794209|FG001|Treatment (Day 1)|Not treated|1|||
13084575|NCT04237792|25794210|FG002|Treatment (Day 1)|Not treated|2|||
13084576|NCT04237792|25794211|FG003|Treatment (Day 1)|Not treated|1|||
13084577|NCT04237792|25794212|FG004|Treatment (Day 1)|Not treated|0|||
13084578|NCT04237792|25794213|FG005|Treatment (Day 1)|Not treated|1|||
13084579|NCT04236141|25794262|FG000|Overall Study|Death|11|||
13084580|NCT04236141|25794263|FG001|Overall Study|Death|9|||
13084581|NCT04236141|25794262|FG000|Overall Study|Withdrawal by Participant|1|||
13084582|NCT04236141|25794263|FG001|Overall Study|Withdrawal by Participant|0|||
13084583|NCT04236141|25794262|FG000|Overall Study|Reason not Specified|1|||
13084584|NCT04236141|25794263|FG001|Overall Study|Reason not Specified|0|||
13084585|NCT04233580|25794282|FG000|Overall Study|Adverse Event|3|||
13084586|NCT04233580|25794283|FG001|Overall Study|Adverse Event|3|||
13084587|NCT04233580|25794282|FG000|Overall Study|Withdrawal by Subject|2|||
13084588|NCT04233580|25794283|FG001|Overall Study|Withdrawal by Subject|1|||
13084589|NCT04232943|25794355|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
13084590|NCT04232943|25794356|FG001|Overall Study|Enrolled but Treatment not Administered|3|||
13084591|NCT04232943|25794357|FG002|Overall Study|Enrolled but Treatment not Administered|2|||
13084592|NCT04232943|25794355|FG000|Overall Study|Withdrawal by Subject|1|||
13084593|NCT04232943|25794356|FG001|Overall Study|Withdrawal by Subject|1|||
13084594|NCT04232943|25794357|FG002|Overall Study|Withdrawal by Subject|0|||
13084595|NCT04232540|25794382|FG000|Overall Study|Lost to Follow-up|1|||
13084596|NCT04232540|25794383|FG001|Overall Study|Lost to Follow-up|0|||
13084597|NCT04230876|25794406|FG000|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
13084598|NCT04230876|25794407|FG001|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
13084599|NCT04230213|25794472|FG000|TP1: Week 0 (Day 1) to Week 10|Other|8|||
13084600|NCT04230213|25794473|FG001|TP1: Week 0 (Day 1) to Week 10|Other|0|||
13084601|NCT04230213|25794474|FG002|TP1: Week 0 (Day 1) to Week 10|Other|0|||
13084602|NCT04230213|25794472|FG000|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|7|||
13084603|NCT04230213|25794473|FG001|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
13084604|NCT04230213|25794474|FG002|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
13084605|NCT04230213|25794472|FG000|TP1: Week 0 (Day 1) to Week 10|Physician Decision|3|||
13084606|NCT04230213|25794473|FG001|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
13084607|NCT04230213|25794474|FG002|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
13084608|NCT04230213|25794472|FG000|TP2: Week 10 to Week 16|Other|0|||
13084609|NCT04230213|25794473|FG001|TP2: Week 10 to Week 16|Other|2|||
13084610|NCT04230213|25794474|FG002|TP2: Week 10 to Week 16|Other|1|||
13084611|NCT04230213|25794472|FG000|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
13084612|NCT04230213|25794473|FG001|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
13084613|NCT04230213|25794474|FG002|TP2: Week 10 to Week 16|Withdrawal by Subject|2|||
13084614|NCT04230213|25794472|FG000|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
13084615|NCT04230213|25794473|FG001|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
13084616|NCT04230213|25794474|FG002|TP3: Week 16 to Week 22|Lost to Follow-up|1|||
13084617|NCT04230213|25794472|FG000|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
13084618|NCT04230213|25794473|FG001|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
13084619|NCT04230213|25794474|FG002|TP3: Week 16 to Week 22|Withdrawal by Subject|2|||
13084620|NCT04230213|25794472|FG000|TP3: Week 16 to Week 22|Physician Decision|0|||
13084621|NCT04230213|25794473|FG001|TP3: Week 16 to Week 22|Physician Decision|0|||
13084622|NCT04230213|25794474|FG002|TP3: Week 16 to Week 22|Physician Decision|1|||
13084623|NCT04230213|25794472|FG000|TP3: Week 16 to Week 22|Other|0|||
13084624|NCT04230213|25794473|FG001|TP3: Week 16 to Week 22|Other|1|||
13084625|NCT04230213|25794474|FG002|TP3: Week 16 to Week 22|Other|3|||
13084626|NCT04230213|25794472|FG000|TP4: Week 22 to Week 32|Other|0|||
13084627|NCT04230213|25794473|FG001|TP4: Week 22 to Week 32|Other|5|||
13084628|NCT04230213|25794474|FG002|TP4: Week 22 to Week 32|Other|5|||
13084629|NCT04230213|25794472|FG000|TP4: Week 22 to Week 32|Withdrawal by Subject|0|||
13084630|NCT04230213|25794473|FG001|TP4: Week 22 to Week 32|Withdrawal by Subject|1|||
13084631|NCT04230213|25794474|FG002|TP4: Week 22 to Week 32|Withdrawal by Subject|2|||
13084632|NCT04230213|25794472|FG000|TP4: Week 22 to Week 32|Physician Decision|0|||
13084633|NCT04230213|25794473|FG001|TP4: Week 22 to Week 32|Physician Decision|2|||
13084634|NCT04230213|25794474|FG002|TP4: Week 22 to Week 32|Physician Decision|1|||
13084635|NCT04230213|25794472|FG000|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
13084636|NCT04230213|25794473|FG001|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
13084637|NCT04230213|25794474|FG002|Follow up: Week 32 to Week 36|Withdrawal by Subject|1|||
13084638|NCT04230213|25794472|FG000|Follow up: Week 32 to Week 36|Other|0|||
13084639|NCT04230213|25794473|FG001|Follow up: Week 32 to Week 36|Other|1|||
13084640|NCT04230213|25794474|FG002|Follow up: Week 32 to Week 36|Other|1|||
13084641|NCT04228302|25794573|FG000|Overall Study|Adverse Event|0|||
13084642|NCT04228302|25794574|FG001|Overall Study|Adverse Event|0|||
13084643|NCT04228302|25794575|FG002|Overall Study|Adverse Event|0|||
13084644|NCT04228302|25794576|FG003|Overall Study|Adverse Event|0|||
13084645|NCT04228302|25794577|FG004|Overall Study|Adverse Event|1|||
13084646|NCT04228302|25794578|FG005|Overall Study|Adverse Event|0|||
13084647|NCT04227340|25794613|FG000|Overall Study|Withdrawal by Subject|3|||
13084648|NCT04223830|25794622|FG000|Overall Study|Lost to Follow-up|9|||
13084649|NCT04223830|25794622|FG000|Overall Study|Adverse Event|1|||
13084650|NCT04223791|25794649|FG000|Overall Study|Lost to Follow-up|0|||
13084651|NCT04223791|25794650|FG001|Overall Study|Lost to Follow-up|4|||
13084652|NCT04223791|25794649|FG000|Overall Study|Physician Decision|5|||
13084653|NCT04223791|25794650|FG001|Overall Study|Physician Decision|1|||
13084654|NCT04223791|25794649|FG000|Overall Study|Protocol Violation|1|||
13084655|NCT04223791|25794650|FG001|Overall Study|Protocol Violation|1|||
13084656|NCT04223791|25794649|FG000|Overall Study|Withdrawal by Subject|10|||
13084657|NCT04223791|25794650|FG001|Overall Study|Withdrawal by Subject|12|||
13084658|NCT04223791|25794649|FG000|Overall Study|Pregnancy|1|||
13084659|NCT04223791|25794650|FG001|Overall Study|Pregnancy|1|||
13084660|NCT04223791|25794649|FG000|Overall Study|Ongoing in Study|305|||
13084661|NCT04223791|25794650|FG001|Overall Study|Ongoing in Study|302|||
13084662|NCT04223687|25794695|FG000|Overall Study|Missing primary outcome|1|||
13084663|NCT04223687|25794696|FG001|Overall Study|Missing primary outcome|0|||
13084664|NCT04223232|25794727|FG000|Overall Study|Withdrawal by Subject|1|||
13084665|NCT04222725|25794750|FG000|Overall Study|Adverse Event|0|||
13084666|NCT04222725|25794751|FG001|Overall Study|Adverse Event|1|||
13084667|NCT04222725|25794752|FG002|Overall Study|Adverse Event|0|||
13084668|NCT04222725|25794753|FG003|Overall Study|Adverse Event|0|||
13084669|NCT04222699|25794762|FG000|Overall Study|Lost to Follow-up|2|||
13084670|NCT04218695|25794795|FG000|Overall Study|Adverse Event|1|||
13084671|NCT04218695|25794796|FG001|Overall Study|Adverse Event|0|||
13084672|NCT04218110|25794823|FG000|Overall Study|Withdrawal by Subject|0|||
13084673|NCT04218110|25794824|FG001|Overall Study|Withdrawal by Subject|0|||
13084674|NCT04218110|25794825|FG002|Overall Study|Withdrawal by Subject|0|||
13084675|NCT04218110|25794826|FG003|Overall Study|Withdrawal by Subject|1|||
13084676|NCT04214600|25794841|FG000|Overall Study|Lost to Follow-up|9|||
13084677|NCT04214600|25794842|FG001|Overall Study|Lost to Follow-up|14|||
13084678|NCT04213989|25794867|FG000|Overall Study|Withdrawal by Subject|3|||
13084679|NCT04213989|25794868|FG001|Overall Study|Withdrawal by Subject|2|||
13084680|NCT04213989|25794867|FG000|Overall Study|Physician Decision|1|||
13084681|NCT04213989|25794868|FG001|Overall Study|Physician Decision|0|||
13084682|NCT04213989|25794867|FG000|Overall Study|Lost to Follow-up|0|||
13084683|NCT04213989|25794868|FG001|Overall Study|Lost to Follow-up|4|||
13084684|NCT04210310|25794881|FG000|Overall Study|Lost to Follow-up|32|||
13084685|NCT04210310|25794882|FG001|Overall Study|Lost to Follow-up|1|||
13084686|NCT04209530|25794903|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4|||
13084687|NCT04209530|25794904|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2|||
13084688|NCT04209530|25794903|FG000|Overall Study|Withdrawal by Subject|0|||
13084689|NCT04209530|25794904|FG001|Overall Study|Withdrawal by Subject|1|||
13084690|NCT04209400|25794931|FG000|Overall Study|Withdrawal by Subject|0|||
13084691|NCT04209400|25794932|FG001|Overall Study|Withdrawal by Subject|1|||
13084692|NCT04208750|25794945|FG000|Overall Study|Lost to Follow-up|16|||
13084693|NCT04208750|25794946|FG001|Overall Study|Lost to Follow-up|15|||
13084694|NCT04207840|25794973|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
13084695|NCT04207840|25794974|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
13084696|NCT04207840|25794975|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1|||
13084697|NCT04207840|25794973|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
13084698|NCT04207840|25794974|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
13084699|NCT04207840|25794975|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1|||
13084700|NCT04206384|25794982|FG000|Overall Study|Withdrawal by Subject|8|||
13084701|NCT04206384|25794982|FG000|Overall Study|Adverse Event|2|||
13084702|NCT04206293|25795027|FG000|Overall Study|Consent withdrawal|1|||
13084703|NCT04206085|25795045|FG000|Overall Study|Lost to Follow-up|0|||
13084704|NCT04206085|25795046|FG001|Overall Study|Lost to Follow-up|1|||
13084705|NCT04206085|25795047|FG002|Overall Study|Lost to Follow-up|0|||
13084706|NCT04206085|25795045|FG000|Overall Study|Lost to Follow-up|0|||
13084707|NCT04206085|25795046|FG001|Overall Study|Lost to Follow-up|0|||
13084708|NCT04206085|25795047|FG002|Overall Study|Lost to Follow-up|1|||
13084709|NCT04202497|25795095|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1|||
13084710|NCT04202497|25795096|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
13084711|NCT04202497|25795097|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
13084712|NCT04202497|25795098|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
13084713|NCT04195893|25795143|FG000|Second Intervention|Withdrawal by Subject|1|||
13084714|NCT04195893|25795144|FG001|Second Intervention|Withdrawal by Subject|0|||
13132414|NCT02792192|25983674|FG003|Overall Study|Study Terminated By Sponsor|0|||
13132415|NCT02792062|25983725|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1|||
13132416|NCT02792062|25983726|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
13132417|NCT02792062|25983727|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
13132418|NCT02792062|25983728|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
13222464|NCT01806597|26286266|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
13222465|NCT01806597|26286267|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
13222466|NCT01806597|26286268|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
13222467|NCT01806597|26286269|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
13222468|NCT01806597|26286270|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
13222469|NCT01806597|26286271|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
13222470|NCT01806597|26286266|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2|||
13222471|NCT01806597|26286267|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
13222472|NCT01806597|26286268|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
13222473|NCT01806597|26286269|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
13222474|NCT01806597|26286270|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
13222475|NCT01806597|26286271|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
13222476|NCT01806597|26286266|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
13222477|NCT01806597|26286267|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
13222478|NCT01806597|26286268|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
13222479|NCT01806597|26286269|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
13222480|NCT01806597|26286270|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
13222481|NCT01806597|26286271|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
13222482|NCT01806597|26286266|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10|||
13222483|NCT01806597|26286267|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
13222484|NCT01806597|26286268|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6|||
13222485|NCT01806597|26286269|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
13222486|NCT01806597|26286270|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
13222487|NCT01806597|26286271|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
13222488|NCT01806597|26286266|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
13222489|NCT01806597|26286267|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
13222490|NCT01806597|26286268|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
13222491|NCT01806597|26286269|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
13222492|NCT01806597|26286270|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
13222493|NCT01806597|26286271|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
13222494|NCT01806597|26286266|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1|||
13084715|NCT04195581|25795220|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4|||
13084716|NCT04195581|25795220|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5|||
13084717|NCT04195581|25795220|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1|||
13084718|NCT04195581|25795220|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1|||
13084719|NCT04195581|25795220|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3|||
13084720|NCT04195581|25795220|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2|||
13084721|NCT04194489|25795231|FG000|Overall Study|Withdrawal by Subject|5|||
13084722|NCT04194489|25795231|FG000|Overall Study|Lost to Follow-up|48|||
13084723|NCT04194151|25795288|FG000|Overall Study|Physician Decision|1|||
13084724|NCT04194151|25795289|FG001|Overall Study|Physician Decision|1|||
13084725|NCT04194151|25795290|FG002|Overall Study|Physician Decision|1|||
13084726|NCT04194151|25795291|FG003|Overall Study|Physician Decision|1|||
13084727|NCT04194151|25795292|FG004|Overall Study|Physician Decision|0|||
13084728|NCT04194151|25795293|FG005|Overall Study|Physician Decision|1|||
13084729|NCT04194151|25795288|FG000|Overall Study|Monitorization problem|0|||
13084730|NCT04194151|25795289|FG001|Overall Study|Monitorization problem|1|||
13084731|NCT04194151|25795290|FG002|Overall Study|Monitorization problem|0|||
13084732|NCT04194151|25795291|FG003|Overall Study|Monitorization problem|0|||
13084733|NCT04194151|25795292|FG004|Overall Study|Monitorization problem|0|||
13084734|NCT04194151|25795293|FG005|Overall Study|Monitorization problem|0|||
13084735|NCT04194008|25795307|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19|||
13084736|NCT04194008|25795307|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6|||
13084737|NCT04194008|25795307|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2|||
13084738|NCT04194008|25795307|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3|||
13084739|NCT04194008|25795307|FG000|Treatment Phase With Nerivio|Missing data|4|||
13084740|NCT04194008|25795307|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1|||
13084741|NCT04191148|25795337|FG000|Overall Study|Withdrawal by Subject|1|||
13084742|NCT04191148|25795338|FG001|Overall Study|Withdrawal by Subject|0|||
13084743|NCT04191148|25795337|FG000|Overall Study|Adverse Event|1|||
13084744|NCT04191148|25795338|FG001|Overall Study|Adverse Event|0|||
13084745|NCT04189952|25795351|FG000|Follow-up Period|Death|1|||
13084746|NCT04189952|25795351|FG000|Follow-up Period|Withdrawal by Subject|1|||
13084747|NCT04189224|25795372|FG000|Period 2|Adverse Event|0|||
13084748|NCT04189224|25795373|FG001|Period 2|Adverse Event|1|||
13084749|NCT04189081|25795394|FG000|Overall Study|Lost to Follow-up|1|||
13084750|NCT04189081|25795395|FG001|Overall Study|Lost to Follow-up|0|||
13084751|NCT04189081|25795396|FG002|Overall Study|Lost to Follow-up|0|||
13084752|NCT04189081|25795394|FG000|Overall Study|Withdrawal by Subject|0|||
13084753|NCT04189081|25795395|FG001|Overall Study|Withdrawal by Subject|0|||
13084754|NCT04189081|25795396|FG002|Overall Study|Withdrawal by Subject|1|||
13084755|NCT04187989|25795443|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6|||
13084756|NCT04187989|25795444|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8|||
13084757|NCT04187989|25795443|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
13084758|NCT04187989|25795444|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
13084759|NCT04186806|25795539|FG000|Period 1: 7 Days|Adverse Event|1|||
13084760|NCT04186806|25795540|FG001|Period 1: 7 Days|Adverse Event|0|||
13084761|NCT04182880|25795553|FG000|Overall Study|Pregnancy|1|||
13084762|NCT04182880|25795554|FG001|Overall Study|Pregnancy|0|||
13084763|NCT04179838|25795579|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
13084764|NCT04179838|25795580|FG001|First Intervention (1 Day)|Withdrawal by Subject|3|||
13084765|NCT04179838|25795579|FG000|Second Intervention (1 Day)|Protocol Violation|0|||
13084766|NCT04179838|25795580|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
13084767|NCT04179786|25795589|FG000|Overall Study|Withdrawal by Subject|8|||
13084768|NCT04179721|25795612|FG000|Overall Study|COVID-19 Related Lost of Followup|11|||
13084769|NCT04179721|25795613|FG001|Overall Study|COVID-19 Related Lost of Followup|13|||
13084770|NCT04179721|25795612|FG000|Overall Study|Lost to Follow-up|0|||
13084771|NCT04179721|25795613|FG001|Overall Study|Lost to Follow-up|1|||
13084772|NCT04179461|25795622|FG000|Overall Study|Lost to Follow-up|4|||
13084773|NCT04178967|25795701|FG000|Overall Study|Adverse Event|4|||
13084774|NCT04178967|25795702|FG001|Overall Study|Adverse Event|6|||
13084775|NCT04178967|25795701|FG000|Overall Study|Due to Epidemic/Pandemic|0|||
13084776|NCT04178967|25795702|FG001|Overall Study|Due to Epidemic/Pandemic|1|||
13084777|NCT04178967|25795701|FG000|Overall Study|Lack of Efficacy|3|||
13084778|NCT04178967|25795702|FG001|Overall Study|Lack of Efficacy|1|||
13084779|NCT04178967|25795701|FG000|Overall Study|Protocol Violation|0|||
13084780|NCT04178967|25795702|FG001|Overall Study|Protocol Violation|7|||
13084781|NCT04178967|25795701|FG000|Overall Study|Withdrawal by Subject|8|||
13084782|NCT04178967|25795702|FG001|Overall Study|Withdrawal by Subject|7|||
13084783|NCT04178967|25795701|FG000|Overall Study|Lost to Follow-up|2|||
13084784|NCT04178967|25795702|FG001|Overall Study|Lost to Follow-up|0|||
13084785|NCT04178720|25795720|FG000|Overall Study|Withdrawal by Subject|2|||
13084786|NCT04178720|25795721|FG001|Overall Study|Withdrawal by Subject|0|||
13084787|NCT04178720|25795720|FG000|Overall Study|Relocation|0|||
13084788|NCT04178720|25795721|FG001|Overall Study|Relocation|1|||
13084789|NCT04178590|25795831|FG000|Overall Study|Pregnancy|1|||
13084790|NCT04178590|25795831|FG000|Overall Study|Lost to Follow-up|1|||
13084791|NCT04177862|25795854|FG000|Overall Study|Protocol Violation|2|||
13084792|NCT04177862|25795855|FG001|Overall Study|Protocol Violation|7|||
13084793|NCT04175808|25795909|FG000|Part A|Miscellaneous|2|||
13084794|NCT04175808|25795910|FG001|Part A|Miscellaneous|0|||
13084795|NCT04175808|25795911|FG002|Part A|Miscellaneous|0|||
13084796|NCT04175808|25795912|FG003|Part A|Miscellaneous|0|||
13084797|NCT04175808|25795913|FG004|Part A|Miscellaneous|0|||
13084798|NCT04175808|25795914|FG005|Part A|Miscellaneous|0|||
13084799|NCT04175808|25795915|FG006|Part A|Miscellaneous|0|||
13084800|NCT04175392|25795938|FG000|Overall Study|Withdrawal by Subject|3|||
13084801|NCT04175392|25795939|FG001|Overall Study|Withdrawal by Subject|2|||
13084802|NCT04173741|25795952|FG000|Overall Study|IVC measurement cannot be done|1|||
13084803|NCT04173741|25795953|FG001|Overall Study|IVC measurement cannot be done|1|||
13084804|NCT04173572|25795986|FG000|Overall Study|Withdrawal by Subject|1|||
13084805|NCT04173572|25795987|FG001|Overall Study|Withdrawal by Subject|5|||
13084806|NCT04173572|25795986|FG000|Overall Study|Lost to Follow-up|3|||
13084807|NCT04173572|25795987|FG001|Overall Study|Lost to Follow-up|1|||
13084808|NCT04172831|25796012|FG000|Overall Study|Adverse Event|21|||
13084809|NCT04172831|25796013|FG001|Overall Study|Adverse Event|9|||
13084810|NCT04172831|25796012|FG000|Overall Study|Lack of Efficacy|2|||
13084811|NCT04172831|25796013|FG001|Overall Study|Lack of Efficacy|8|||
13084812|NCT04172831|25796012|FG000|Overall Study|Physician Decision|0|||
13084813|NCT04172831|25796013|FG001|Overall Study|Physician Decision|1|||
13084814|NCT04172831|25796012|FG000|Overall Study|Withdrawal by Subject|12|||
13084815|NCT04172831|25796013|FG001|Overall Study|Withdrawal by Subject|11|||
13084816|NCT04172831|25796012|FG000|Overall Study|Lost to Follow-up|4|||
13084817|NCT04172831|25796013|FG001|Overall Study|Lost to Follow-up|9|||
13084818|NCT04172831|25796012|FG000|Overall Study|COVID-19 related crisis|3|||
13084819|NCT04172831|25796013|FG001|Overall Study|COVID-19 related crisis|3|||
13084820|NCT04172831|25796012|FG000|Overall Study|Subject non-compliance|1|||
13084821|NCT04172831|25796013|FG001|Overall Study|Subject non-compliance|1|||
13084822|NCT04172831|25796012|FG000|Overall Study|Family emergency|1|||
13084823|NCT04172831|25796013|FG001|Overall Study|Family emergency|0|||
13084824|NCT04171414|25796024|FG000|Overall Study|Death|1|||
13084825|NCT04171414|25796024|FG000|Overall Study|Withdrawal by Subject|1|||
13084826|NCT04170686|25796053|FG000|Screening|Physician Decision|12|||
13084827|NCT04170686|25796054|FG001|Screening|Physician Decision|13|||
13084828|NCT04170686|25796053|FG000|Randomization and Treatment|Lost to Follow-up|26|||
13084829|NCT04170686|25796054|FG001|Randomization and Treatment|Lost to Follow-up|15|||
13084830|NCT04169373|25796137|FG000|Overall Study|Adverse Event|1|||
13084831|NCT04169373|25796138|FG001|Overall Study|Adverse Event|0|||
13084832|NCT04169373|25796139|FG002|Overall Study|Adverse Event|1|||
13084833|NCT04169373|25796140|FG003|Overall Study|Adverse Event|2|||
13084834|NCT04169373|25796137|FG000|Overall Study|Withdrawal by Subject|2|||
13084835|NCT04169373|25796138|FG001|Overall Study|Withdrawal by Subject|0|||
13084836|NCT04169373|25796139|FG002|Overall Study|Withdrawal by Subject|5|||
13084837|NCT04169373|25796140|FG003|Overall Study|Withdrawal by Subject|6|||
13084838|NCT04169373|25796137|FG000|Overall Study|Lost to Follow-up|1|||
13084839|NCT04169373|25796138|FG001|Overall Study|Lost to Follow-up|1|||
13084840|NCT04169373|25796139|FG002|Overall Study|Lost to Follow-up|0|||
13084841|NCT04169373|25796140|FG003|Overall Study|Lost to Follow-up|1|||
13084842|NCT04169373|25796137|FG000|Overall Study|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
13084843|NCT04169373|25796138|FG001|Overall Study|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|1|||
13084844|NCT04169373|25796139|FG002|Overall Study|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
13084845|NCT04169373|25796140|FG003|Overall Study|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
13084846|NCT04169373|25796137|FG000|Overall Study|Other|1|||
13084847|NCT04169373|25796138|FG001|Overall Study|Other|3|||
13084848|NCT04169373|25796139|FG002|Overall Study|Other|3|||
13084849|NCT04169373|25796140|FG003|Overall Study|Other|5|||
13084850|NCT04169061|25796146|FG000|Overall Study|Adverse Event|2|||
13084851|NCT04169061|25796146|FG000|Overall Study|Death|1|||
13084852|NCT04169061|25796146|FG000|Overall Study|Withdrawal by Subject|1|||
13084853|NCT04169061|25796146|FG000|Overall Study|Protocol Violation|1|||
13084854|NCT04168190|25796216|FG000|Overall Study|Lost to Follow-up|0|||
13084855|NCT04168190|25796217|FG001|Overall Study|Lost to Follow-up|1|||
13084856|NCT04168190|25796218|FG002|Overall Study|Lost to Follow-up|0|||
13084857|NCT04168190|25796219|FG003|Overall Study|Lost to Follow-up|7|||
13084858|NCT04168190|25796220|FG004|Overall Study|Lost to Follow-up|5|||
13084859|NCT04168190|25796216|FG000|Overall Study|Withdrawal by Subject|1|||
13084860|NCT04168190|25796217|FG001|Overall Study|Withdrawal by Subject|0|||
13084861|NCT04168190|25796218|FG002|Overall Study|Withdrawal by Subject|0|||
13084862|NCT04168190|25796219|FG003|Overall Study|Withdrawal by Subject|2|||
13084863|NCT04168190|25796220|FG004|Overall Study|Withdrawal by Subject|4|||
13084864|NCT04168190|25796216|FG000|Overall Study|Death|0|||
13084865|NCT04168190|25796217|FG001|Overall Study|Death|0|||
13084866|NCT04168190|25796218|FG002|Overall Study|Death|0|||
13084867|NCT04168190|25796219|FG003|Overall Study|Death|1|||
13084868|NCT04168190|25796220|FG004|Overall Study|Death|0|||
13084869|NCT04167670|25796244|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1|||
13084870|NCT04167670|25796245|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7|||
13084871|NCT04167670|25796246|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4|||
13084872|NCT04167670|25796244|FG000|Overall Study|Significant protocol deviation|3|||
13084873|NCT04167670|25796245|FG001|Overall Study|Significant protocol deviation|1|||
13084874|NCT04167670|25796246|FG002|Overall Study|Significant protocol deviation|0|||
13084875|NCT04167670|25796244|FG000|Overall Study|Lost to Follow-up|0|||
13084876|NCT04167670|25796245|FG001|Overall Study|Lost to Follow-up|3|||
13084877|NCT04167670|25796246|FG002|Overall Study|Lost to Follow-up|3|||
13084878|NCT04167670|25796244|FG000|Overall Study|Voluntary Withdrawal|0|||
13084879|NCT04167670|25796245|FG001|Overall Study|Voluntary Withdrawal|1|||
13084880|NCT04167670|25796246|FG002|Overall Study|Voluntary Withdrawal|1|||
13084881|NCT04167670|25796244|FG000|Overall Study|Withdrawal of Consent|4|||
13084882|NCT04167670|25796245|FG001|Overall Study|Withdrawal of Consent|1|||
13084883|NCT04167670|25796246|FG002|Overall Study|Withdrawal of Consent|3|||
13084884|NCT04167670|25796244|FG000|Overall Study|Miscellaneous|7|||
13084885|NCT04167670|25796245|FG001|Overall Study|Miscellaneous|5|||
13084886|NCT04167670|25796246|FG002|Overall Study|Miscellaneous|3|||
13084887|NCT04167085|25796273|FG000|Baseline|Withdrawal by Subject|2|||
13084888|NCT04167085|25796274|FG001|Baseline|Withdrawal by Subject|1|||
13084889|NCT04167085|25796273|FG000|Washout (1 Month)|Withdrawal by Subject|1|||
13084890|NCT04167085|25796274|FG001|Washout (1 Month)|Withdrawal by Subject|0|||
13084891|NCT04166630|25796301|FG000|Overall Study|Withdrawal by Subject|0|||
13084892|NCT04166630|25796302|FG001|Overall Study|Withdrawal by Subject|1|||
13084893|NCT04165824|25796309|FG000|Overall Study|Adverse Event|23|||
13084894|NCT04165824|25796309|FG000|Overall Study|Physician Decision|1|||
13084895|NCT04165824|25796309|FG000|Overall Study|Withdrawal by Subject|17|||
13084896|NCT04165824|25796309|FG000|Overall Study|Other|5|||
13084897|NCT04165031|25796358|FG000|Overall Study|Adverse Event|1|||
13084898|NCT04165031|25796359|FG001|Overall Study|Adverse Event|1|||
13084899|NCT04165031|25796360|FG002|Overall Study|Adverse Event|0|||
13084900|NCT04165031|25796361|FG003|Overall Study|Adverse Event|0|||
13084901|NCT04165031|25796362|FG004|Overall Study|Adverse Event|0|||
13084902|NCT04165031|25796363|FG005|Overall Study|Adverse Event|0|||
13084903|NCT04165031|25796358|FG000|Overall Study|Withdrawal by Subject|0|||
13084904|NCT04165031|25796359|FG001|Overall Study|Withdrawal by Subject|0|||
13084905|NCT04165031|25796360|FG002|Overall Study|Withdrawal by Subject|1|||
13084906|NCT04165031|25796361|FG003|Overall Study|Withdrawal by Subject|0|||
13084907|NCT04165031|25796362|FG004|Overall Study|Withdrawal by Subject|0|||
13084908|NCT04165031|25796363|FG005|Overall Study|Withdrawal by Subject|0|||
13084909|NCT04164758|25796381|FG000|Overall Study|COVID-19 withdrawal of consent|1|||
13084910|NCT04164758|25796382|FG001|Overall Study|COVID-19 withdrawal of consent|0|||
13084911|NCT04164758|25796383|FG002|Overall Study|COVID-19 withdrawal of consent|0|||
13084912|NCT04164758|25796381|FG000|Overall Study|Adverse Event|0|||
13084913|NCT04164758|25796382|FG001|Overall Study|Adverse Event|1|||
13084914|NCT04164758|25796383|FG002|Overall Study|Adverse Event|0|||
13084915|NCT04162795|25796399|FG000|Overall Study|Other|16|||
13084916|NCT04162795|25796399|FG000|Overall Study|Screen failures|10|||
13084917|NCT04162769|25796449|FG000|Double-blind Treatment (12-Week)|Adverse Event|2|||
13084918|NCT04162769|25796450|FG001|Double-blind Treatment (12-Week)|Adverse Event|5|||
13084919|NCT04162769|25796451|FG002|Double-blind Treatment (12-Week)|Adverse Event|0|||
13084920|NCT04162769|25796452|FG003|Double-blind Treatment (12-Week)|Adverse Event|0|||
13084921|NCT04162769|25796449|FG000|Double-blind Treatment (12-Week)|Withdrawal by Subject|4|||
13084922|NCT04162769|25796450|FG001|Double-blind Treatment (12-Week)|Withdrawal by Subject|3|||
13084923|NCT04162769|25796451|FG002|Double-blind Treatment (12-Week)|Withdrawal by Subject|2|||
13084924|NCT04162769|25796452|FG003|Double-blind Treatment (12-Week)|Withdrawal by Subject|0|||
13084925|NCT04162769|25796449|FG000|Double-blind Treatment (12-Week)|Physician Decision|1|||
13084926|NCT04162769|25796450|FG001|Double-blind Treatment (12-Week)|Physician Decision|0|||
13084927|NCT04162769|25796451|FG002|Double-blind Treatment (12-Week)|Physician Decision|0|||
13084928|NCT04162769|25796452|FG003|Double-blind Treatment (12-Week)|Physician Decision|0|||
13084929|NCT04162769|25796449|FG000|Double-blind Treatment (12-Week)|Lost to Follow-up|5|||
13084930|NCT04162769|25796450|FG001|Double-blind Treatment (12-Week)|Lost to Follow-up|1|||
13084931|NCT04162769|25796451|FG002|Double-blind Treatment (12-Week)|Lost to Follow-up|6|||
13084932|NCT04162769|25796452|FG003|Double-blind Treatment (12-Week)|Lost to Follow-up|0|||
13084933|NCT04162769|25796449|FG000|Double-blind Treatment (12-Week)|Protocol deviation|1|||
13084934|NCT04162769|25796450|FG001|Double-blind Treatment (12-Week)|Protocol deviation|1|||
13084935|NCT04162769|25796451|FG002|Double-blind Treatment (12-Week)|Protocol deviation|0|||
13084936|NCT04162769|25796452|FG003|Double-blind Treatment (12-Week)|Protocol deviation|0|||
13084937|NCT04162769|25796449|FG000|Double-blind Treatment (12-Week)|Other|0|||
13084938|NCT04162769|25796450|FG001|Double-blind Treatment (12-Week)|Other|1|||
13084939|NCT04162769|25796451|FG002|Double-blind Treatment (12-Week)|Other|1|||
13084940|NCT04162769|25796452|FG003|Double-blind Treatment (12-Week)|Other|0|||
13084941|NCT04162769|25796449|FG000|OLE Period (52-Week)|Adverse Event|0|||
13084942|NCT04162769|25796450|FG001|OLE Period (52-Week)|Adverse Event|0|||
13084943|NCT04162769|25796451|FG002|OLE Period (52-Week)|Adverse Event|0|||
13084944|NCT04162769|25796452|FG003|OLE Period (52-Week)|Adverse Event|5|||
13084945|NCT04162769|25796449|FG000|OLE Period (52-Week)|Withdrawal by Subject|0|||
13084946|NCT04162769|25796450|FG001|OLE Period (52-Week)|Withdrawal by Subject|0|||
13084947|NCT04162769|25796451|FG002|OLE Period (52-Week)|Withdrawal by Subject|0|||
13084948|NCT04162769|25796452|FG003|OLE Period (52-Week)|Withdrawal by Subject|10|||
13084949|NCT04162769|25796449|FG000|OLE Period (52-Week)|Physician Decision|0|||
13084950|NCT04162769|25796450|FG001|OLE Period (52-Week)|Physician Decision|0|||
13084951|NCT04162769|25796451|FG002|OLE Period (52-Week)|Physician Decision|0|||
13084952|NCT04162769|25796452|FG003|OLE Period (52-Week)|Physician Decision|1|||
13084953|NCT04162769|25796449|FG000|OLE Period (52-Week)|Lost to Follow-up|0|||
13084954|NCT04162769|25796450|FG001|OLE Period (52-Week)|Lost to Follow-up|0|||
13084955|NCT04162769|25796451|FG002|OLE Period (52-Week)|Lost to Follow-up|0|||
13084956|NCT04162769|25796452|FG003|OLE Period (52-Week)|Lost to Follow-up|9|||
13084957|NCT04162769|25796449|FG000|OLE Period (52-Week)|Protocol deviation|0|||
13084958|NCT04162769|25796450|FG001|OLE Period (52-Week)|Protocol deviation|0|||
13084959|NCT04162769|25796451|FG002|OLE Period (52-Week)|Protocol deviation|0|||
13084960|NCT04162769|25796452|FG003|OLE Period (52-Week)|Protocol deviation|2|||
13084961|NCT04161807|25796466|FG000|Overall Study|Withdrawal by Subject|2|||
13084962|NCT04161807|25796466|FG000|Overall Study|Performed only 1 treatment|2|||
13084963|NCT04161144|25796483|FG000|Overall Study|Withdrawal by Subject|0|||
13084964|NCT04161144|25796484|FG001|Overall Study|Withdrawal by Subject|1|||
13084965|NCT04161144|25796483|FG000|Overall Study|Protocol Violation|1|||
13084966|NCT04161144|25796484|FG001|Overall Study|Protocol Violation|0|||
13084967|NCT04161131|25796505|FG000|Overall Study|Ineligible|2|||
13084968|NCT04161131|25796505|FG000|Overall Study|Lost to Follow-up|4|||
13084969|NCT04161079|25796527|FG000|Clinical Investigation 2010-040|Adverse Event|1|||
13084970|NCT04160988|25796537|FG000|Overall Study|poor image quality|28|||
13084971|NCT04160091|25796580|FG000|Overall Study|Terminated by Sponsor|7|||
13084972|NCT04160091|25796581|FG001|Overall Study|Terminated by Sponsor|3|||
13084973|NCT04160091|25796582|FG002|Overall Study|Terminated by Sponsor|5|||
13084974|NCT04160091|25796583|FG003|Overall Study|Terminated by Sponsor|2|||
13084975|NCT04160091|25796580|FG000|Overall Study|Noncompliance|0|||
13084976|NCT04160091|25796581|FG001|Overall Study|Noncompliance|0|||
13084977|NCT04160091|25796582|FG002|Overall Study|Noncompliance|0|||
13084978|NCT04160091|25796583|FG003|Overall Study|Noncompliance|1|||
13084979|NCT04160091|25796580|FG000|Overall Study|Withdrawal by Subject|0|||
13084980|NCT04160091|25796581|FG001|Overall Study|Withdrawal by Subject|0|||
13084981|NCT04160091|25796582|FG002|Overall Study|Withdrawal by Subject|0|||
13084982|NCT04160091|25796583|FG003|Overall Study|Withdrawal by Subject|1|||
13084983|NCT04157738|25796604|FG000|Overall Study|Moved out of state|0|||
13084984|NCT04157738|25796605|FG001|Overall Study|Moved out of state|2|||
13084985|NCT04157738|25796604|FG000|Overall Study|Did not show up to the Follow-up appointment|1|||
13084986|NCT04157738|25796605|FG001|Overall Study|Did not show up to the Follow-up appointment|0|||
13084987|NCT04156646|25796728|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0|||
13084988|NCT04156646|25796729|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1|||
13084989|NCT04156399|25796736|FG000|Overall Study|hospitalization unrelated to acupuncture|1|||
13084990|NCT04156399|25796736|FG000|Overall Study|study suspension due to COVID pandemic|3|||
13084991|NCT04155047|25796749|FG000|Overall Study|Adverse Event|1|||
13084992|NCT04155047|25796750|FG001|Overall Study|Adverse Event|0|||
13084993|NCT04155047|25796749|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1|||
13084994|NCT04155047|25796750|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0|||
13084995|NCT04154605|25796763|FG000|Overall Study|Procedure Canceled|1|||
13084996|NCT04154605|25796764|FG001|Overall Study|Procedure Canceled|1|||
13084997|NCT04154605|25796763|FG000|Overall Study|Missed follow up|1|||
13084998|NCT04154605|25796764|FG001|Overall Study|Missed follow up|1|||
13084999|NCT04154605|25796763|FG000|Overall Study|Withdrawal by Subject|1|||
13085000|NCT04154605|25796764|FG001|Overall Study|Withdrawal by Subject|0|||
13085001|NCT04154293|25796791|FG000|Overall Study|Withdrawal by Subject|2|||
13085002|NCT04154293|25796792|FG001|Overall Study|Withdrawal by Subject|3|||
13085003|NCT04154293|25796793|FG002|Overall Study|Withdrawal by Subject|1|||
13085004|NCT04154293|25796791|FG000|Overall Study|Physician Decision|0|||
13085005|NCT04154293|25796792|FG001|Overall Study|Physician Decision|0|||
13085006|NCT04154293|25796793|FG002|Overall Study|Physician Decision|1|||
13085007|NCT04153188|25796819|FG000|Overall Study|Lost to Follow-up|1|||
13085008|NCT04153188|25796820|FG001|Overall Study|Lost to Follow-up|1|||
13085009|NCT04153188|25796819|FG000|Overall Study|Withdrawal by Subject|2|||
13085010|NCT04153188|25796820|FG001|Overall Study|Withdrawal by Subject|0|||
13085011|NCT04153188|25796819|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0|||
13085012|NCT04153188|25796820|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1|||
13085013|NCT04152083|25796845|FG000|Overall Study|Lost to Follow-up|2|||
13085014|NCT04152083|25796846|FG001|Overall Study|Lost to Follow-up|1|||
13085015|NCT04152083|25796845|FG000|Overall Study|Adverse Event|1|||
13085016|NCT04152083|25796846|FG001|Overall Study|Adverse Event|0|||
13085017|NCT04152083|25796845|FG000|Overall Study|Randomized but not treated|3|||
13085018|NCT04152083|25796846|FG001|Overall Study|Randomized but not treated|2|||
13085019|NCT04150341|25796879|FG000|Overall Study|Physician Decision|0|||
13085020|NCT04150341|25796880|FG001|Overall Study|Physician Decision|0|||
13085021|NCT04150341|25796881|FG002|Overall Study|Physician Decision|1|||
13085022|NCT04150341|25796882|FG003|Overall Study|Physician Decision|0|||
13085023|NCT04150341|25796883|FG004|Overall Study|Physician Decision|0|||
13085024|NCT04150341|25796884|FG005|Overall Study|Physician Decision|0|||
13085025|NCT04150341|25796879|FG000|Overall Study|Adverse Event|0|||
13085026|NCT04150341|25796880|FG001|Overall Study|Adverse Event|0|||
13085027|NCT04150341|25796881|FG002|Overall Study|Adverse Event|0|||
13085028|NCT04150341|25796882|FG003|Overall Study|Adverse Event|0|||
13085029|NCT04150341|25796883|FG004|Overall Study|Adverse Event|1|||
13085030|NCT04150341|25796884|FG005|Overall Study|Adverse Event|0|||
13085031|NCT04150250|25796921|FG000|Overall Study|Lost to Follow-up|0|||
13085032|NCT04150250|25796922|FG001|Overall Study|Lost to Follow-up|2|||
13085033|NCT04150068|25796943|FG000|Maintenance Period (Week 26 Analysis)|Still on study|24|||
13085034|NCT04150068|25796944|FG001|Maintenance Period (Week 26 Analysis)|Still on study|12|||
13085035|NCT04150068|25796945|FG002|Maintenance Period (Week 26 Analysis)|Still on study|35|||
13085036|NCT04150068|25796943|FG000|Maintenance Period (Week 26 Analysis)|Death|0|||
13085037|NCT04150068|25796944|FG001|Maintenance Period (Week 26 Analysis)|Death|0|||
13085038|NCT04150068|25796945|FG002|Maintenance Period (Week 26 Analysis)|Death|1|||
13085039|NCT04149353|25796952|FG000|Overall Study|Study terminated|1|||
13085040|NCT04147715|25797264|FG000|Overall Study|Adverse Event|0|||
13085041|NCT04147715|25797265|FG001|Overall Study|Adverse Event|0|||
13085042|NCT04147715|25797266|FG002|Overall Study|Adverse Event|0|||
13085043|NCT04147715|25797267|FG003|Overall Study|Adverse Event|0|||
13085044|NCT04147715|25797268|FG004|Overall Study|Adverse Event|0|||
13085045|NCT04147715|25797269|FG005|Overall Study|Adverse Event|0|||
13085046|NCT04147715|25797270|FG006|Overall Study|Adverse Event|0|||
13085047|NCT04147715|25797271|FG007|Overall Study|Adverse Event|2|||
13085048|NCT04147715|25797272|FG008|Overall Study|Adverse Event|1|||
13085049|NCT04147715|25797273|FG009|Overall Study|Adverse Event|0|||
13085050|NCT04147715|25797274|FG010|Overall Study|Adverse Event|0|||
13085051|NCT04147715|25797275|FG011|Overall Study|Adverse Event|0|||
13085052|NCT04147611|25797288|FG000|Overall Study|Physician Decision|0|||
13085053|NCT04147611|25797289|FG001|Overall Study|Physician Decision|1|||
13085054|NCT04146467|25797328|FG000|Overall Study|Adverse Event|0|||
13085055|NCT04146467|25797329|FG001|Overall Study|Adverse Event|1|||
13085056|NCT04146467|25797328|FG000|Overall Study|Lost to Follow-up|0|||
13085057|NCT04146467|25797329|FG001|Overall Study|Lost to Follow-up|2|||
13085058|NCT04144166|25797340|FG000|Overall Study|Discharged before study start|1|||
13085059|NCT04144166|25797340|FG000|Overall Study|Pregnancy|1|||
13085060|NCT04144166|25797340|FG000|Overall Study|Nail polish could not be removed from finger|1|||
13085061|NCT04142450|25797351|FG000|Overall Study|Screen Failure|1|||
13085062|NCT04142450|25797351|FG000|Overall Study|Lost to Follow-up|1|||
13085063|NCT04142242|25797390|FG000|Overall Study|Non-compliance with the protocol|1|||
13085064|NCT04142242|25797391|FG001|Overall Study|Non-compliance with the protocol|0|||
13085065|NCT04142242|25797392|FG002|Overall Study|Non-compliance with the protocol|0|||
13085066|NCT04142242|25797393|FG003|Overall Study|Non-compliance with the protocol|0|||
13085067|NCT04142242|25797394|FG004|Overall Study|Non-compliance with the protocol|0|||
13085068|NCT04142242|25797395|FG005|Overall Study|Non-compliance with the protocol|1|||
13085069|NCT04142242|25797390|FG000|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0|||
13085070|NCT04142242|25797391|FG001|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|1|||
13085071|NCT04142242|25797392|FG002|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0|||
13085072|NCT04142242|25797393|FG003|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0|||
13085073|NCT04142242|25797394|FG004|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0|||
13085074|NCT04142242|25797395|FG005|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0|||
13085075|NCT04142242|25797390|FG000|Overall Study|Ongoing|0|||
13085076|NCT04142242|25797391|FG001|Overall Study|Ongoing|0|||
13085077|NCT04142242|25797392|FG002|Overall Study|Ongoing|31|||
13085078|NCT04142242|25797393|FG003|Overall Study|Ongoing|39|||
13085079|NCT04142242|25797394|FG004|Overall Study|Ongoing|0|||
13085080|NCT04142242|25797395|FG005|Overall Study|Ongoing|0|||
13085081|NCT04142216|25797422|FG000|Overall Study|Hospitalization|0|||
13085082|NCT04142216|25797423|FG001|Overall Study|Hospitalization|2|||
13085083|NCT04142216|25797422|FG000|Overall Study|Death|3|||
13085084|NCT04142216|25797423|FG001|Overall Study|Death|1|||
13085085|NCT04142216|25797422|FG000|Overall Study|Referral to another hemodialysis unit|3|||
13085086|NCT04142216|25797423|FG001|Overall Study|Referral to another hemodialysis unit|2|||
13085087|NCT04142216|25797422|FG000|Overall Study|Use of clove|0|||
13085088|NCT04142216|25797423|FG001|Overall Study|Use of clove|1|||
13085089|NCT04140890|25797456|FG000|Overall Study|Withdrawal by Subject|0|||
13085090|NCT04140890|25797457|FG001|Overall Study|Withdrawal by Subject|1|||
13085091|NCT04140292|25797478|FG000|Overall Study|Restriction on outpatient visits due to COVID-19.|4|||
13085092|NCT04140292|25797479|FG001|Overall Study|Restriction on outpatient visits due to COVID-19.|16|||
13085093|NCT04139018|25797494|FG000|Overall Study|Screen fail|1|||
13085094|NCT04139018|25797495|FG001|Overall Study|Screen fail|0|||
13085095|NCT04139018|25797494|FG000|Overall Study|Withdrawal by Subject|2|||
13085096|NCT04139018|25797495|FG001|Overall Study|Withdrawal by Subject|0|||
13085097|NCT04139018|25797494|FG000|Overall Study|Lost to Follow-up|0|||
13085098|NCT04139018|25797495|FG001|Overall Study|Lost to Follow-up|1|||
13085099|NCT04138810|25797508|FG000|Overall Study|Withdrawal by Subject|0|||
13085100|NCT04138810|25797509|FG001|Overall Study|Withdrawal by Subject|1|||
13085101|NCT04138810|25797508|FG000|Overall Study|Subject cancelled surgery|1|||
13085102|NCT04138810|25797509|FG001|Overall Study|Subject cancelled surgery|0|||
13085103|NCT04138043|25797551|FG000|Overall Study|Withdrawal by Subject|0|||
13085104|NCT04138043|25797552|FG001|Overall Study|Withdrawal by Subject|1|||
13085105|NCT04136444|25797587|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0|||
13085106|NCT04136444|25797588|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1|||
13085107|NCT04135937|25797594|FG000|Overall Study|Lost to Follow-up|2|||
13085108|NCT04135937|25797594|FG000|Overall Study|Withdrawal by Subject|1|||
13085109|NCT04133519|25797621|FG000|Overall Study|Withdrawal by Subject|5|||
13085110|NCT04133519|25797622|FG001|Overall Study|Withdrawal by Subject|4|||
13085111|NCT04133519|25797621|FG000|Overall Study|Protocol Violation|0|||
13085112|NCT04133519|25797622|FG001|Overall Study|Protocol Violation|1|||
13085113|NCT04133519|25797621|FG000|Overall Study|Never started treatment|1|||
13085114|NCT04133519|25797622|FG001|Overall Study|Never started treatment|1|||
13085115|NCT04132336|25797744|FG000|Overall Study|Investigator Decision|0|||
13085116|NCT04132336|25797745|FG001|Overall Study|Investigator Decision|1|||
13085117|NCT04132336|25797746|FG002|Overall Study|Investigator Decision|0|||
13085118|NCT04132336|25797747|FG003|Overall Study|Investigator Decision|0|||
13085119|NCT04132336|25797748|FG004|Overall Study|Investigator Decision|0|||
13085120|NCT04132336|25797749|FG005|Overall Study|Investigator Decision|0|||
13085121|NCT04132336|25797750|FG006|Overall Study|Investigator Decision|0|||
13085122|NCT04131556|25797783|FG000|Overall Study|Adverse Event|1|||
13085123|NCT04131556|25797783|FG000|Overall Study|Withdrawal by Subject|1|||
13085124|NCT04130919|25797831|FG000|Blinded Treatment Phase|Study terminated by sponsor|1|||
13085125|NCT04130919|25797832|FG001|Blinded Treatment Phase|Study terminated by sponsor|1|||
13085126|NCT04130919|25797833|FG002|Blinded Treatment Phase|Study terminated by sponsor|1|||
13085127|NCT04130919|25797834|FG003|Blinded Treatment Phase|Study terminated by sponsor|0|||
13085128|NCT04130919|25797835|FG004|Blinded Treatment Phase|Study terminated by sponsor|0|||
13085129|NCT04130919|25797836|FG005|Blinded Treatment Phase|Study terminated by sponsor|0|||
13085130|NCT04130919|25797831|FG000|Blinded Treatment Phase|Adverse Event|0|||
13085131|NCT04130919|25797832|FG001|Blinded Treatment Phase|Adverse Event|0|||
13085132|NCT04130919|25797833|FG002|Blinded Treatment Phase|Adverse Event|1|||
13085133|NCT04130919|25797834|FG003|Blinded Treatment Phase|Adverse Event|0|||
13085134|NCT04130919|25797835|FG004|Blinded Treatment Phase|Adverse Event|0|||
13085135|NCT04130919|25797836|FG005|Blinded Treatment Phase|Adverse Event|0|||
13085136|NCT04130919|25797831|FG000|Blinded Treatment Phase|Disease worsening|0|||
13085137|NCT04130919|25797832|FG001|Blinded Treatment Phase|Disease worsening|0|||
13085138|NCT04130919|25797833|FG002|Blinded Treatment Phase|Disease worsening|1|||
13085139|NCT04130919|25797834|FG003|Blinded Treatment Phase|Disease worsening|0|||
13085140|NCT04130919|25797835|FG004|Blinded Treatment Phase|Disease worsening|0|||
13085141|NCT04130919|25797836|FG005|Blinded Treatment Phase|Disease worsening|0|||
13085142|NCT04130919|25797831|FG000|Blinded Treatment Phase|Investigator's decision|0|||
13085143|NCT04130919|25797832|FG001|Blinded Treatment Phase|Investigator's decision|1|||
13085144|NCT04130919|25797833|FG002|Blinded Treatment Phase|Investigator's decision|0|||
13085145|NCT04130919|25797834|FG003|Blinded Treatment Phase|Investigator's decision|0|||
13085146|NCT04130919|25797835|FG004|Blinded Treatment Phase|Investigator's decision|0|||
13085147|NCT04130919|25797836|FG005|Blinded Treatment Phase|Investigator's decision|0|||
13085148|NCT04130919|25797831|FG000|Blinded Treatment Phase|Withdrew consent|1|||
13085149|NCT04130919|25797832|FG001|Blinded Treatment Phase|Withdrew consent|0|||
13085150|NCT04130919|25797833|FG002|Blinded Treatment Phase|Withdrew consent|0|||
13085151|NCT04130919|25797834|FG003|Blinded Treatment Phase|Withdrew consent|0|||
13085152|NCT04130919|25797835|FG004|Blinded Treatment Phase|Withdrew consent|0|||
13085153|NCT04130919|25797836|FG005|Blinded Treatment Phase|Withdrew consent|0|||
13085154|NCT04130919|25797831|FG000|Open-label Treatment Phase|Withdrew consent|0|||
13085155|NCT04130919|25797832|FG001|Open-label Treatment Phase|Withdrew consent|0|||
13085156|NCT04130919|25797833|FG002|Open-label Treatment Phase|Withdrew consent|0|||
13085157|NCT04130919|25797834|FG003|Open-label Treatment Phase|Withdrew consent|1|||
13085158|NCT04130919|25797835|FG004|Open-label Treatment Phase|Withdrew consent|1|||
13085159|NCT04130919|25797836|FG005|Open-label Treatment Phase|Withdrew consent|1|||
13085160|NCT04130919|25797831|FG000|Open-label Treatment Phase|Disease worsening|0|||
13085161|NCT04130919|25797832|FG001|Open-label Treatment Phase|Disease worsening|0|||
13085162|NCT04130919|25797833|FG002|Open-label Treatment Phase|Disease worsening|0|||
13085163|NCT04130919|25797834|FG003|Open-label Treatment Phase|Disease worsening|1|||
13085164|NCT04130919|25797835|FG004|Open-label Treatment Phase|Disease worsening|0|||
13085165|NCT04130919|25797836|FG005|Open-label Treatment Phase|Disease worsening|1|||
13085166|NCT04130919|25797831|FG000|Open-label Treatment Phase|Investigator's decision|0|||
13085167|NCT04130919|25797832|FG001|Open-label Treatment Phase|Investigator's decision|0|||
13085168|NCT04130919|25797833|FG002|Open-label Treatment Phase|Investigator's decision|0|||
13085169|NCT04130919|25797834|FG003|Open-label Treatment Phase|Investigator's decision|1|||
13085170|NCT04130919|25797835|FG004|Open-label Treatment Phase|Investigator's decision|0|||
13085171|NCT04130919|25797836|FG005|Open-label Treatment Phase|Investigator's decision|0|||
13085172|NCT04130919|25797831|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
13085173|NCT04130919|25797832|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
13085174|NCT04130919|25797833|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
13085175|NCT04130919|25797834|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
13085176|NCT04130919|25797835|FG004|Open-label Treatment Phase|Lost to Follow-up|0|||
13085177|NCT04130919|25797836|FG005|Open-label Treatment Phase|Lost to Follow-up|1|||
13085178|NCT04130919|25797831|FG000|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
13085179|NCT04130919|25797832|FG001|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
13085180|NCT04130919|25797833|FG002|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
13085181|NCT04130919|25797834|FG003|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
13085182|NCT04130919|25797835|FG004|Open-label Treatment Phase|MCS response not achieved at open-label week 10|1|||
13085183|NCT04130919|25797836|FG005|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
13085184|NCT04129346|25797875|FG000|Overall Study|Death|1|||
13085185|NCT04129346|25797876|FG001|Overall Study|Death|0|||
13085186|NCT04128696|25797939|FG000|Overall Study|Lost to Follow-up|0|||
13085187|NCT04128696|25797940|FG001|Overall Study|Lost to Follow-up|1|||
13085188|NCT04128696|25797939|FG000|Overall Study|Withdrawal by Subject|8|||
13085189|NCT04128696|25797940|FG001|Overall Study|Withdrawal by Subject|5|||
13085190|NCT04128696|25797939|FG000|Overall Study|In Follow-up|47|||
13085191|NCT04128696|25797940|FG001|Overall Study|In Follow-up|51|||
13085192|NCT04128696|25797939|FG000|Overall Study|On Study Treatment (pembrolizumab) All participants discontinued feladilimab/placebo|52|||
13085193|NCT04128696|25797940|FG001|Overall Study|On Study Treatment (pembrolizumab) All participants discontinued feladilimab/placebo|62|||
13085194|NCT04128293|25798151|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
13085195|NCT04128293|25798152|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
13085196|NCT04128293|25798153|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
13085197|NCT04128293|25798154|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
13085198|NCT04128267|25798161|FG000|Overall Study|Withdrawal by Subject|6|||
13085199|NCT04128267|25798161|FG000|Overall Study|Death|2|||
13085200|NCT04128267|25798161|FG000|Overall Study|Disease progression|1|||
13085201|NCT04128267|25798161|FG000|Overall Study|Participant had other medical issues|4|||
13085202|NCT04128267|25798161|FG000|Overall Study|Participant failed to respond to multiple attempts to contact|2|||
13085203|NCT04128007|25798186|FG000|Overall Study|Withdrawal by Subject|9|||
13085204|NCT04128007|25798187|FG001|Overall Study|Withdrawal by Subject|6|||
13085205|NCT04128007|25798186|FG000|Overall Study|Protocol Violation|1|||
13085206|NCT04128007|25798187|FG001|Overall Study|Protocol Violation|0|||
13085207|NCT04128007|25798186|FG000|Overall Study|Lost to Follow-up|8|||
13085208|NCT04128007|25798187|FG001|Overall Study|Lost to Follow-up|7|||
13085209|NCT04128007|25798186|FG000|Overall Study|Adverse Event|5|||
13085210|NCT04128007|25798187|FG001|Overall Study|Adverse Event|2|||
13085211|NCT04128007|25798186|FG000|Overall Study|Not reported|0|||
13085212|NCT04128007|25798187|FG001|Overall Study|Not reported|2|||
13085213|NCT04126343|25798246|FG000|Overall Study|Adverse Event|0|||
13085214|NCT04126343|25798247|FG001|Overall Study|Adverse Event|0|||
13085215|NCT04126343|25798248|FG002|Overall Study|Adverse Event|0|||
13085216|NCT04126343|25798249|FG003|Overall Study|Adverse Event|0|||
13085217|NCT04126343|25798250|FG004|Overall Study|Adverse Event|0|||
13085218|NCT04126343|25798251|FG005|Overall Study|Adverse Event|1|||
13085219|NCT04126343|25798246|FG000|Overall Study|Withdrawal by Subject|0|||
13085220|NCT04126343|25798247|FG001|Overall Study|Withdrawal by Subject|0|||
13085221|NCT04126343|25798248|FG002|Overall Study|Withdrawal by Subject|0|||
13085222|NCT04126343|25798249|FG003|Overall Study|Withdrawal by Subject|1|||
13085223|NCT04126343|25798250|FG004|Overall Study|Withdrawal by Subject|0|||
13085224|NCT04126343|25798251|FG005|Overall Study|Withdrawal by Subject|0|||
13085225|NCT04126343|25798246|FG000|Overall Study|Related to COVID-19 pandemic|3|||
13085226|NCT04126343|25798247|FG001|Overall Study|Related to COVID-19 pandemic|4|||
13085227|NCT04126343|25798248|FG002|Overall Study|Related to COVID-19 pandemic|3|||
13085228|NCT04126343|25798249|FG003|Overall Study|Related to COVID-19 pandemic|3|||
13085229|NCT04126343|25798250|FG004|Overall Study|Related to COVID-19 pandemic|3|||
13085230|NCT04126343|25798251|FG005|Overall Study|Related to COVID-19 pandemic|3|||
13085231|NCT04126174|25798268|FG000|Overall Study|Lost to Follow-up|3|||
13085232|NCT04126174|25798269|FG001|Overall Study|Lost to Follow-up|3|||
13085233|NCT04124952|25798285|FG000|Overall Study|Lost to Follow-up|1|||
13085234|NCT04124926|25798323|FG000|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|3|||
13085235|NCT04124926|25798324|FG001|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|7|||
13085236|NCT04124926|25798325|FG002|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
13085237|NCT04124926|25798326|FG003|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
13085238|NCT04124926|25798327|FG004|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
13085239|NCT04124926|25798323|FG000|Healing Phase|Protocol Violation|0|||
13085240|NCT04124926|25798324|FG001|Healing Phase|Protocol Violation|1|||
13085241|NCT04124926|25798325|FG002|Healing Phase|Protocol Violation|0|||
13085242|NCT04124926|25798326|FG003|Healing Phase|Protocol Violation|0|||
13085243|NCT04124926|25798327|FG004|Healing Phase|Protocol Violation|0|||
13085244|NCT04124926|25798323|FG000|Healing Phase|Lost to Follow-up|5|||
13085245|NCT04124926|25798324|FG001|Healing Phase|Lost to Follow-up|4|||
13085246|NCT04124926|25798325|FG002|Healing Phase|Lost to Follow-up|0|||
13085247|NCT04124926|25798326|FG003|Healing Phase|Lost to Follow-up|0|||
13085248|NCT04124926|25798327|FG004|Healing Phase|Lost to Follow-up|0|||
13085249|NCT04124926|25798323|FG000|Healing Phase|Voluntary Withdrawal|10|||
13085250|NCT04124926|25798324|FG001|Healing Phase|Voluntary Withdrawal|7|||
13085251|NCT04124926|25798325|FG002|Healing Phase|Voluntary Withdrawal|0|||
13085252|NCT04124926|25798326|FG003|Healing Phase|Voluntary Withdrawal|0|||
13085253|NCT04124926|25798327|FG004|Healing Phase|Voluntary Withdrawal|0|||
13085254|NCT04124926|25798323|FG000|Healing Phase|Withdrawal of Consent|5|||
13085255|NCT04124926|25798324|FG001|Healing Phase|Withdrawal of Consent|3|||
13085256|NCT04124926|25798325|FG002|Healing Phase|Withdrawal of Consent|0|||
13085257|NCT04124926|25798326|FG003|Healing Phase|Withdrawal of Consent|0|||
13085258|NCT04124926|25798327|FG004|Healing Phase|Withdrawal of Consent|0|||
13085259|NCT04124926|25798323|FG000|Healing Phase|Miscellaneous|8|||
13085260|NCT04124926|25798324|FG001|Healing Phase|Miscellaneous|7|||
13085261|NCT04124926|25798325|FG002|Healing Phase|Miscellaneous|0|||
13085262|NCT04124926|25798326|FG003|Healing Phase|Miscellaneous|0|||
13085263|NCT04124926|25798327|FG004|Healing Phase|Miscellaneous|0|||
13085264|NCT04124926|25798323|FG000|Healing Phase|Randomized but not Treated|0|||
13085265|NCT04124926|25798324|FG001|Healing Phase|Randomized but not Treated|3|||
13085266|NCT04124926|25798325|FG002|Healing Phase|Randomized but not Treated|0|||
13085267|NCT04124926|25798326|FG003|Healing Phase|Randomized but not Treated|0|||
13085268|NCT04124926|25798327|FG004|Healing Phase|Randomized but not Treated|0|||
13085269|NCT04124926|25798323|FG000|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
13085270|NCT04124926|25798324|FG001|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
13085271|NCT04124926|25798325|FG002|Maintenance Phase|Pretreatment Event, AE, or SAE|3|||
13085272|NCT04124926|25798326|FG003|Maintenance Phase|Pretreatment Event, AE, or SAE|5|||
13085273|NCT04124926|25798327|FG004|Maintenance Phase|Pretreatment Event, AE, or SAE|4|||
13085274|NCT04124926|25798323|FG000|Maintenance Phase|Protocol Violation|0|||
13085275|NCT04124926|25798324|FG001|Maintenance Phase|Protocol Violation|0|||
13085276|NCT04124926|25798325|FG002|Maintenance Phase|Protocol Violation|3|||
13085277|NCT04124926|25798326|FG003|Maintenance Phase|Protocol Violation|0|||
13085278|NCT04124926|25798327|FG004|Maintenance Phase|Protocol Violation|0|||
13085279|NCT04124926|25798323|FG000|Maintenance Phase|Lost to Follow-up|0|||
13085280|NCT04124926|25798324|FG001|Maintenance Phase|Lost to Follow-up|0|||
13085281|NCT04124926|25798325|FG002|Maintenance Phase|Lost to Follow-up|7|||
13085282|NCT04124926|25798326|FG003|Maintenance Phase|Lost to Follow-up|8|||
13085283|NCT04124926|25798327|FG004|Maintenance Phase|Lost to Follow-up|9|||
13085284|NCT04124926|25798323|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
13085285|NCT04124926|25798324|FG001|Maintenance Phase|Voluntary Withdrawal|0|||
13085286|NCT04124926|25798325|FG002|Maintenance Phase|Voluntary Withdrawal|3|||
13085287|NCT04124926|25798326|FG003|Maintenance Phase|Voluntary Withdrawal|6|||
13085288|NCT04124926|25798327|FG004|Maintenance Phase|Voluntary Withdrawal|5|||
13085289|NCT04124926|25798323|FG000|Maintenance Phase|Pregnancy|0|||
13085290|NCT04124926|25798324|FG001|Maintenance Phase|Pregnancy|0|||
13085291|NCT04124926|25798325|FG002|Maintenance Phase|Pregnancy|0|||
13085292|NCT04124926|25798326|FG003|Maintenance Phase|Pregnancy|1|||
13085293|NCT04124926|25798327|FG004|Maintenance Phase|Pregnancy|0|||
13085294|NCT04124926|25798323|FG000|Maintenance Phase|Lack of Efficacy|0|||
13085295|NCT04124926|25798324|FG001|Maintenance Phase|Lack of Efficacy|0|||
13085296|NCT04124926|25798325|FG002|Maintenance Phase|Lack of Efficacy|0|||
13085297|NCT04124926|25798326|FG003|Maintenance Phase|Lack of Efficacy|0|||
13085298|NCT04124926|25798327|FG004|Maintenance Phase|Lack of Efficacy|1|||
13085299|NCT04124926|25798323|FG000|Maintenance Phase|Withdrawal of Consent|0|||
13085300|NCT04124926|25798324|FG001|Maintenance Phase|Withdrawal of Consent|0|||
13085301|NCT04124926|25798325|FG002|Maintenance Phase|Withdrawal of Consent|5|||
13085302|NCT04124926|25798326|FG003|Maintenance Phase|Withdrawal of Consent|5|||
13085303|NCT04124926|25798327|FG004|Maintenance Phase|Withdrawal of Consent|5|||
13085304|NCT04124926|25798323|FG000|Maintenance Phase|Miscellaneous|0|||
13085305|NCT04124926|25798324|FG001|Maintenance Phase|Miscellaneous|0|||
13085306|NCT04124926|25798325|FG002|Maintenance Phase|Miscellaneous|1|||
13085307|NCT04124926|25798326|FG003|Maintenance Phase|Miscellaneous|2|||
13085308|NCT04124926|25798327|FG004|Maintenance Phase|Miscellaneous|4|||
13085309|NCT04124926|25798323|FG000|Maintenance Phase|Randomized but not Treated|0|||
13085310|NCT04124926|25798324|FG001|Maintenance Phase|Randomized but not Treated|0|||
13085311|NCT04124926|25798325|FG002|Maintenance Phase|Randomized but not Treated|2|||
13085312|NCT04124926|25798326|FG003|Maintenance Phase|Randomized but not Treated|2|||
13085313|NCT04124926|25798327|FG004|Maintenance Phase|Randomized but not Treated|0|||
13085314|NCT04123665|25798356|FG000|Overall Study|Withdrawal by Subject|7|||
13085315|NCT04123665|25798357|FG001|Overall Study|Withdrawal by Subject|0|||
13085316|NCT04123665|25798356|FG000|Overall Study|Lost to Follow-up|1|||
13085317|NCT04123665|25798357|FG001|Overall Study|Lost to Follow-up|0|||
13085318|NCT04123405|25798422|FG000|Overall Study|Adverse Event|1|||
13085319|NCT04123405|25798423|FG001|Overall Study|Adverse Event|2|||
13085320|NCT04123405|25798424|FG002|Overall Study|Adverse Event|3|||
13085321|NCT04123405|25798425|FG003|Overall Study|Adverse Event|3|||
13085322|NCT04123405|25798422|FG000|Overall Study|Exclusion criteria met|1|||
13085323|NCT04123405|25798423|FG001|Overall Study|Exclusion criteria met|2|||
13085324|NCT04123405|25798424|FG002|Overall Study|Exclusion criteria met|0|||
13085325|NCT04123405|25798425|FG003|Overall Study|Exclusion criteria met|2|||
13085326|NCT04123405|25798422|FG000|Overall Study|Withdrawal by Subject|1|||
13085327|NCT04123405|25798423|FG001|Overall Study|Withdrawal by Subject|3|||
13085328|NCT04123405|25798424|FG002|Overall Study|Withdrawal by Subject|0|||
13085329|NCT04123405|25798425|FG003|Overall Study|Withdrawal by Subject|2|||
13085330|NCT04123405|25798422|FG000|Overall Study|Contact to subject lost|0|||
13085331|NCT04123405|25798423|FG001|Overall Study|Contact to subject lost|0|||
13085332|NCT04123405|25798424|FG002|Overall Study|Contact to subject lost|0|||
13085333|NCT04123405|25798425|FG003|Overall Study|Contact to subject lost|1|||
13085334|NCT04123405|25798422|FG000|Overall Study|screening failure|1|||
13085335|NCT04123405|25798423|FG001|Overall Study|screening failure|0|||
13085336|NCT04123405|25798424|FG002|Overall Study|screening failure|0|||
13085337|NCT04123405|25798425|FG003|Overall Study|screening failure|0|||
13085338|NCT04123067|25798444|FG000|Overall Study|Lost to Follow-up|0|||
13085339|NCT04123067|25798445|FG001|Overall Study|Lost to Follow-up|1|||
13085340|NCT04122534|25798452|FG000|Overall Study|Lost to Follow-up|4|||
13085341|NCT04118166|25798461|FG000|Overall Study|Adverse Event|1|||
13085342|NCT04117607|25798657|FG000|Overall Study|Early Termination|0|||
13085343|NCT04117607|25798658|FG001|Overall Study|Early Termination|1|||
13085344|NCT04117607|25798659|FG002|Overall Study|Early Termination|0|||
13085345|NCT04117607|25798660|FG003|Overall Study|Early Termination|0|||
13085346|NCT04117607|25798661|FG004|Overall Study|Early Termination|0|||
13085347|NCT04117607|25798662|FG005|Overall Study|Early Termination|0|||
13085348|NCT04117607|25798663|FG006|Overall Study|Early Termination|1|||
13085349|NCT04117607|25798664|FG007|Overall Study|Early Termination|0|||
13085350|NCT04117607|25798665|FG008|Overall Study|Early Termination|0|||
13085351|NCT04117607|25798666|FG009|Overall Study|Early Termination|0|||
13085352|NCT04117607|25798667|FG010|Overall Study|Early Termination|0|||
13085353|NCT04117607|25798668|FG011|Overall Study|Early Termination|0|||
13085354|NCT04117607|25798669|FG012|Overall Study|Early Termination|0|||
13085355|NCT04117607|25798670|FG013|Overall Study|Early Termination|0|||
13085356|NCT04116229|25798703|FG000|Overall Study|Met exclusion criteria during screeneing on day of study visit.|2|||
13085357|NCT04116229|25798704|FG001|Overall Study|Met exclusion criteria during screeneing on day of study visit.|3|||
13085358|NCT04116229|25798703|FG000|Overall Study|Scheduling not possible.|0|||
13085359|NCT04116229|25798704|FG001|Overall Study|Scheduling not possible.|1|||
13085360|NCT04115839|25798995|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
13085361|NCT04115839|25798996|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13|||
13085362|NCT04115839|25798997|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
13085363|NCT04115839|25798998|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
13085364|NCT04115839|25798999|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
13085365|NCT04115839|25799000|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
13085366|NCT04115839|25799001|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
13085367|NCT04115839|25798995|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2|||
13085368|NCT04115839|25798996|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1|||
13085369|NCT04115839|25798997|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3|||
13085370|NCT04115839|25798998|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
13085371|NCT04115839|25798999|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
13085372|NCT04115839|25799000|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
13085373|NCT04115839|25799001|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
13085374|NCT04115839|25798995|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2|||
13085375|NCT04115839|25798996|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0|||
13085376|NCT04115839|25798997|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0|||
13085377|NCT04115839|25798998|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0|||
13085378|NCT04115839|25798999|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0|||
13085379|NCT04115839|25799000|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0|||
13085380|NCT04115839|25799001|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0|||
13085381|NCT04115839|25798995|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
13085382|NCT04115839|25798996|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
13085383|NCT04115839|25798997|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1|||
13085384|NCT04115839|25798998|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
13085385|NCT04115839|25798999|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
13085386|NCT04115839|25799000|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
13085387|NCT04115839|25799001|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
13085388|NCT04115839|25798995|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
13085389|NCT04115839|25798996|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
13085390|NCT04115839|25798997|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
13085391|NCT04115839|25798998|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17|||
13085392|NCT04115839|25798999|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19|||
13085393|NCT04115839|25799000|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10|||
13085394|NCT04115839|25799001|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8|||
13085395|NCT04115839|25798995|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
13085396|NCT04115839|25798996|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
13085397|NCT04115839|25798997|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
13085398|NCT04115839|25798998|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
13085399|NCT04115839|25798999|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
13085400|NCT04115839|25799000|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
13085401|NCT04115839|25799001|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
13085402|NCT04115358|25799112|FG000|Overall Study|exfoliation|0|||
13085403|NCT04115358|25799113|FG001|Overall Study|exfoliation|0|||
13085404|NCT04115358|25799114|FG002|Overall Study|exfoliation|1|||
13085405|NCT04113746|25799139|FG000|Overall Study|Lost to Follow-up|4|||
13085406|NCT04113746|25799140|FG001|Overall Study|Lost to Follow-up|4|||
13085407|NCT04113694|25799154|FG000|Overall Study|Adverse Event|2|||
13085408|NCT04113694|25799154|FG000|Overall Study|Lost to Follow-up|2|||
13085409|NCT04113694|25799154|FG000|Overall Study|Withdrawal by Subject|6|||
13085410|NCT04113694|25799154|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1|||
13085411|NCT04112303|25799164|FG000|Overall Study|Death|1|||
13132419|NCT02792062|25983729|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
13132420|NCT02792062|25983730|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
13132421|NCT02791893|25983752|FG000|Blinded Phase|Lost to Follow-up|2|||
13132422|NCT02791893|25983753|FG001|Blinded Phase|Lost to Follow-up|2|||
13132423|NCT02791893|25983752|FG000|Blinded Phase|Withdrawal by Subject|1|||
13132424|NCT02791893|25983753|FG001|Blinded Phase|Withdrawal by Subject|2|||
13085412|NCT04110314|25799195|FG000|Overall Study|Did not meet inclusion criteria|35255|||
13085413|NCT04110314|25799196|FG001|Overall Study|Did not meet inclusion criteria|35104|||
13085414|NCT04110314|25799197|FG002|Overall Study|Did not meet inclusion criteria|35636|||
13085415|NCT04110314|25799198|FG003|Overall Study|Did not meet inclusion criteria|35135|||
13085416|NCT04110314|25799199|FG004|Overall Study|Did not meet inclusion criteria|35247|||
13085417|NCT04110314|25799200|FG005|Overall Study|Did not meet inclusion criteria|35727|||
13085418|NCT04110145|25799248|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
13085419|NCT04110145|25799249|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
13085420|NCT04110145|25799250|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
13085421|NCT04110145|25799251|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1|||
13085422|NCT04110145|25799252|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
13085423|NCT04109391|25799276|FG000|Overall Study|Adverse Event|2|||
13085424|NCT04109391|25799277|FG001|Overall Study|Adverse Event|2|||
13085425|NCT04109391|25799278|FG002|Overall Study|Adverse Event|0|||
13085426|NCT04109391|25799276|FG000|Overall Study|Withdrawal by Subject|2|||
13085427|NCT04109391|25799277|FG001|Overall Study|Withdrawal by Subject|0|||
13085428|NCT04109391|25799278|FG002|Overall Study|Withdrawal by Subject|0|||
13085429|NCT04109391|25799276|FG000|Overall Study|Pregnancy|1|||
13085430|NCT04109391|25799277|FG001|Overall Study|Pregnancy|0|||
13085431|NCT04109391|25799278|FG002|Overall Study|Pregnancy|0|||
13085432|NCT04109391|25799276|FG000|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|3|||
13085433|NCT04109391|25799277|FG001|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|1|||
13085434|NCT04109391|25799278|FG002|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|0|||
13085435|NCT04109391|25799276|FG000|Overall Study|Lost to Follow-up|0|||
13085436|NCT04109391|25799277|FG001|Overall Study|Lost to Follow-up|0|||
13085437|NCT04109391|25799278|FG002|Overall Study|Lost to Follow-up|1|||
13085438|NCT04109391|25799276|FG000|Overall Study|Lack of Efficacy|2|||
13085439|NCT04109391|25799277|FG001|Overall Study|Lack of Efficacy|2|||
13085440|NCT04109391|25799278|FG002|Overall Study|Lack of Efficacy|3|||
13085441|NCT04109222|25799296|FG000|Overall Study|Adverse Event|1|||
13085442|NCT04109222|25799297|FG001|Overall Study|Adverse Event|0|||
13085443|NCT04109222|25799298|FG002|Overall Study|Adverse Event|0|||
13085444|NCT04109118|25799319|FG000|Overall Study|Lost to Follow-up|3|||
13085445|NCT04106817|25799343|FG000|Overall Study|Lost to Follow-up|1|||
13085446|NCT04106817|25799344|FG001|Overall Study|Lost to Follow-up|0|||
13085447|NCT04106817|25799345|FG002|Overall Study|Lost to Follow-up|0|||
13085448|NCT04105998|25799368|FG000|Second Study Day|Altered frequency and times of measurements on both study days|2|||
13085449|NCT04105998|25799369|FG001|Second Study Day|Altered frequency and times of measurements on both study days|0|||
13085450|NCT04105972|25799388|FG000|Overall Study|Adverse Event|2|||
13085451|NCT04105972|25799389|FG001|Overall Study|Adverse Event|1|||
13085452|NCT04105218|25799418|FG000|Overall Study|Withdrawal by Subject|3|||
13085453|NCT04105218|25799419|FG001|Overall Study|Withdrawal by Subject|2|||
13085454|NCT04105218|25799418|FG000|Overall Study|Study was terminated; unable to complete study visits|1|||
13085455|NCT04105218|25799419|FG001|Overall Study|Study was terminated; unable to complete study visits|3|||
13085456|NCT04105218|25799418|FG000|Overall Study|Failed screening tests|2|||
13085457|NCT04105218|25799419|FG001|Overall Study|Failed screening tests|1|||
13085458|NCT04102540|25799436|FG000|Overall Study|Withdrawn by PI|2|||
13085459|NCT04102540|25799436|FG000|Overall Study|Lost to Follow-up|6|||
13085460|NCT04102501|25799451|FG000|Overall Study|Withdrawal by Subject|7|||
13085461|NCT04102501|25799452|FG001|Overall Study|Withdrawal by Subject|9|||
13085462|NCT04102501|25799451|FG000|Overall Study|Adverse Event|1|||
13085463|NCT04102501|25799452|FG001|Overall Study|Adverse Event|3|||
13085464|NCT04102345|25799479|FG000|Overall Study|Withdrawal by Subject|1|||
13085465|NCT04102345|25799480|FG001|Overall Study|Withdrawal by Subject|0|||
13085466|NCT04099277|25799493|FG000|Overall Study|Physician Decision|1|||
13085467|NCT04099277|25799493|FG000|Overall Study|Withdrawal by Subject|1|||
13085468|NCT04098809|25799526|FG000|Overall Study|Withdrawal by Subject|1|||
13085469|NCT04098809|25799527|FG001|Overall Study|Withdrawal by Subject|3|||
13085470|NCT04098809|25799526|FG000|Overall Study|Physician Decision|2|||
13085471|NCT04098809|25799527|FG001|Overall Study|Physician Decision|1|||
13085472|NCT04098458|25799552|FG000|Overall Study|Death|1|||
13085473|NCT04098458|25799552|FG000|Overall Study|did not meet study inclusion criteria|3|||
13085474|NCT04098367|25799583|FG000|Overall Study|Adverse Event|0|||
13085475|NCT04098367|25799584|FG001|Overall Study|Adverse Event|0|||
13085476|NCT04098367|25799585|FG002|Overall Study|Adverse Event|1|||
13085477|NCT04098367|25799583|FG000|Overall Study|Lost to Follow-up|1|||
13085478|NCT04098367|25799584|FG001|Overall Study|Lost to Follow-up|5|||
13085479|NCT04098367|25799585|FG002|Overall Study|Lost to Follow-up|2|||
13085480|NCT04098367|25799583|FG000|Overall Study|Withdrawal by Subject|0|||
13085481|NCT04098367|25799584|FG001|Overall Study|Withdrawal by Subject|0|||
13085482|NCT04098367|25799585|FG002|Overall Study|Withdrawal by Subject|1|||
13085483|NCT04098367|25799583|FG000|Overall Study|Sick . Could not attend visit|1|||
13485219|NCT03921424|27031929|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
13085484|NCT04098367|25799584|FG001|Overall Study|Sick . Could not attend visit|0|||
13085485|NCT04098367|25799585|FG002|Overall Study|Sick . Could not attend visit|0|||
13085486|NCT04097925|25799594|FG000|Overall Study|Withdrawal by Subject|1|||
13085487|NCT04096365|25799604|FG000|Overall Study|Adverse Event|1|||
13085488|NCT04095858|25799625|FG000|Overall Study|Death|1|||
13085489|NCT04095858|25799626|FG001|Overall Study|Death|0|||
13085490|NCT04095858|25799625|FG000|Overall Study|Study terminated by Sponsor|2|||
13085491|NCT04095858|25799626|FG001|Overall Study|Study terminated by Sponsor|4|||
13085492|NCT04095286|25799674|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
13085493|NCT04095286|25799675|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1|||
13085494|NCT04095286|25799676|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
13085495|NCT04095286|25799677|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
13085496|NCT04095286|25799678|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
13085497|NCT04095286|25799679|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
13085498|NCT04095286|25799674|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1|||
13085499|NCT04095286|25799675|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
13085500|NCT04095286|25799676|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
13085501|NCT04095286|25799677|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
13085502|NCT04095286|25799678|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
13085503|NCT04095286|25799679|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
13085504|NCT04095286|25799674|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
13085505|NCT04095286|25799675|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
13085506|NCT04095286|25799676|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1|||
13085507|NCT04095286|25799677|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
13085508|NCT04095286|25799678|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
13085509|NCT04095286|25799679|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
13085510|NCT04095286|25799674|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
13085511|NCT04095286|25799675|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
13085512|NCT04095286|25799676|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2|||
13085513|NCT04095286|25799677|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
13085514|NCT04095286|25799678|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
13085515|NCT04095286|25799679|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
13085516|NCT04095286|25799674|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
13085517|NCT04095286|25799675|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
13085518|NCT04095286|25799676|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
13085519|NCT04095286|25799677|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
13085520|NCT04095286|25799678|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1|||
13085521|NCT04095286|25799679|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
13085522|NCT04094883|25799688|FG000|Overall Study|Withdrawal by Subject|1|||
13085523|NCT04094870|25799716|FG000|Overall Study|Lost to Follow-up|1|||
13085524|NCT04094870|25799717|FG001|Overall Study|Lost to Follow-up|1|||
13085525|NCT04093414|25799772|FG000|3 Month Follow up|Physician Decision|0|||
13085526|NCT04093414|25799773|FG001|3 Month Follow up|Physician Decision|1|||
13085527|NCT04093414|25799772|FG000|6month Follow up|Physician Decision|1|||
13085528|NCT04093414|25799773|FG001|6month Follow up|Physician Decision|3|||
13085529|NCT04093258|25799786|FG000|Period 2|Subject no longer meets the eligibility criteria|1|||
13085530|NCT04093258|25799787|FG001|Period 2|Subject no longer meets the eligibility criteria|0|||
13085531|NCT04091659|25799802|FG000|Overall Study|Protocol Violation|3|||
13085532|NCT04091659|25799803|FG001|Overall Study|Protocol Violation|0|||
13085533|NCT04091659|25799802|FG000|Overall Study|Lost to Follow-up|0|||
13085534|NCT04091659|25799803|FG001|Overall Study|Lost to Follow-up|1|||
13085535|NCT04091581|25799816|FG000|Overall Study|Lost to Follow-up|0|||
13085536|NCT04091581|25799817|FG001|Overall Study|Lost to Follow-up|1|||
13085537|NCT04091360|25799921|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
13085538|NCT04091360|25799922|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
13085539|NCT04091360|25799923|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
13085540|NCT04091360|25799924|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
13085541|NCT04091360|25799925|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
13085542|NCT04091360|25799926|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
13085543|NCT04091360|25799927|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
13085544|NCT04091360|25799928|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
13085545|NCT04091360|25799929|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
13085546|NCT04091360|25799930|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
13085547|NCT04091360|25799921|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
13085548|NCT04091360|25799922|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
13085549|NCT04091360|25799923|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
13085550|NCT04091360|25799924|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
13085551|NCT04091360|25799925|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
13085552|NCT04091360|25799926|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
13085553|NCT04091360|25799927|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
13085554|NCT04091360|25799928|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
13085555|NCT04091360|25799929|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
13085556|NCT04091360|25799930|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
13085557|NCT04091360|25799921|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
13085558|NCT04091360|25799922|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
13085559|NCT04091360|25799923|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
13085560|NCT04091360|25799924|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
13085561|NCT04091360|25799925|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
13085562|NCT04091360|25799926|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
13085563|NCT04091360|25799927|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
13085564|NCT04091360|25799928|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
13085565|NCT04091360|25799929|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
13085566|NCT04091360|25799930|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
13085567|NCT04091087|25799959|FG000|Overall Study|Not treated|1|||
13085568|NCT04091087|25799960|FG001|Overall Study|Not treated|0|||
13085569|NCT04091087|25799959|FG000|Overall Study|Adverse Event|4|||
13085570|NCT04091087|25799960|FG001|Overall Study|Adverse Event|4|||
13085571|NCT04091087|25799959|FG000|Overall Study|Protocol Violation|0|||
13085572|NCT04091087|25799960|FG001|Overall Study|Protocol Violation|1|||
13085573|NCT04091087|25799959|FG000|Overall Study|Withdrawal by Subject|5|||
13085574|NCT04091087|25799960|FG001|Overall Study|Withdrawal by Subject|2|||
13085575|NCT04090242|25799997|FG000|Overall Study|Withdrawal by Subject|1|||
13085576|NCT04090242|25799998|FG001|Overall Study|Withdrawal by Subject|0|||
13085577|NCT04090164|25800012|FG000|Overall Study|incomplete data on file|245|||
13085578|NCT04090164|25800013|FG001|Overall Study|incomplete data on file|0|||
13085579|NCT04089761|25800030|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14|||
13085580|NCT04089761|25800030|FG000|"Run In Phase"|Lost to Follow-up|1|||
13085581|NCT04089761|25800030|FG000|"Treatment Phase"|No evaluable data|5|||
13085582|NCT04089761|25800030|FG000|"Treatment Phase"|Lost to Follow-up|1|||
13085583|NCT04087720|25800039|FG000|Overall Study|Withdrawal by Subject|2|||
13085584|NCT04087720|25800039|FG000|Overall Study|Withdrawal by Subject - COVID-19 Concerns|3|||
13085585|NCT04086641|25800066|FG000|Foot 1 (Two Week Utilization)|COVID-19|1|||
13085586|NCT04086641|25800067|FG001|Foot 1 (Two Week Utilization)|COVID-19|2|||
13085587|NCT04086472|25800119|FG000|Overall Study|Lost to Follow-up|1|||
13085588|NCT04086472|25800120|FG001|Overall Study|Lost to Follow-up|0|||
13085589|NCT04086472|25800121|FG002|Overall Study|Lost to Follow-up|0|||
13085590|NCT04086472|25800122|FG003|Overall Study|Lost to Follow-up|0|||
13085591|NCT04086472|25800123|FG004|Overall Study|Lost to Follow-up|1|||
13085592|NCT04086472|25800119|FG000|Overall Study|Physician Decision|0|||
13085593|NCT04086472|25800120|FG001|Overall Study|Physician Decision|1|||
13085594|NCT04086472|25800121|FG002|Overall Study|Physician Decision|1|||
13085595|NCT04086472|25800122|FG003|Overall Study|Physician Decision|0|||
13085596|NCT04086472|25800123|FG004|Overall Study|Physician Decision|0|||
13085597|NCT04086472|25800119|FG000|Overall Study|Withdrawal by Subject|1|||
13085598|NCT04086472|25800120|FG001|Overall Study|Withdrawal by Subject|1|||
13085599|NCT04086472|25800121|FG002|Overall Study|Withdrawal by Subject|1|||
13085600|NCT04086472|25800122|FG003|Overall Study|Withdrawal by Subject|0|||
13085601|NCT04086472|25800123|FG004|Overall Study|Withdrawal by Subject|0|||
13085602|NCT04086472|25800119|FG000|Overall Study|Various reasons|2|||
13085603|NCT04086472|25800120|FG001|Overall Study|Various reasons|0|||
13085604|NCT04086472|25800121|FG002|Overall Study|Various reasons|0|||
13085605|NCT04086472|25800122|FG003|Overall Study|Various reasons|3|||
13085606|NCT04086472|25800123|FG004|Overall Study|Various reasons|1|||
13085607|NCT04085601|25800166|FG000|Overall Study|Lost to Follow-up|1|||
13085608|NCT04085601|25800167|FG001|Overall Study|Lost to Follow-up|0|||
13085609|NCT04085601|25800166|FG000|Overall Study|Death|1|||
13085610|NCT04085601|25800167|FG001|Overall Study|Death|1|||
13085611|NCT04085367|25800184|FG000|Overall Study|Adverse Event|1|||
13085612|NCT04085367|25800185|FG001|Overall Study|Adverse Event|1|||
13085613|NCT04085367|25800184|FG000|Overall Study|Withdrawal by Subject|13|||
13085614|NCT04085367|25800185|FG001|Overall Study|Withdrawal by Subject|4|||
13085615|NCT04085367|25800184|FG000|Overall Study|Lost to Follow-up|3|||
13085616|NCT04085367|25800185|FG001|Overall Study|Lost to Follow-up|1|||
13085617|NCT04085367|25800184|FG000|Overall Study|Other unspecified|2|||
13085618|NCT04085367|25800185|FG001|Overall Study|Other unspecified|1|||
13085619|NCT04085367|25800184|FG000|Overall Study|Status Unknown|1|||
13085620|NCT04085367|25800185|FG001|Overall Study|Status Unknown|1|||
13085621|NCT04085289|25800204|FG000|Overall Study|Withdrawal by Subject|0|||
13085622|NCT04085289|25800205|FG001|Overall Study|Withdrawal by Subject|0|||
13085623|NCT04085289|25800206|FG002|Overall Study|Withdrawal by Subject|1|||
13085624|NCT04084769|25800263|FG000|Overall Study|Protocol Violation|1|||
13085625|NCT04084769|25800264|FG001|Overall Study|Protocol Violation|3|||
13085626|NCT04084769|25800265|FG002|Overall Study|Protocol Violation|0|||
13085627|NCT04084769|25800266|FG003|Overall Study|Protocol Violation|1|||
13085628|NCT04084769|25800263|FG000|Overall Study|Withdrawal by Subject|0|||
13085629|NCT04084769|25800264|FG001|Overall Study|Withdrawal by Subject|1|||
13085630|NCT04084769|25800265|FG002|Overall Study|Withdrawal by Subject|0|||
13085631|NCT04084769|25800266|FG003|Overall Study|Withdrawal by Subject|0|||
13085632|NCT04084769|25800263|FG000|Overall Study|Withdrawal by parent/guardian|1|||
13085633|NCT04084769|25800264|FG001|Overall Study|Withdrawal by parent/guardian|0|||
13085634|NCT04084769|25800265|FG002|Overall Study|Withdrawal by parent/guardian|0|||
13085635|NCT04084769|25800266|FG003|Overall Study|Withdrawal by parent/guardian|1|||
13085636|NCT04084769|25800263|FG000|Overall Study|Lost to Follow-up|2|||
13085637|NCT04084769|25800264|FG001|Overall Study|Lost to Follow-up|0|||
13085638|NCT04084769|25800265|FG002|Overall Study|Lost to Follow-up|0|||
13085639|NCT04084769|25800266|FG003|Overall Study|Lost to Follow-up|0|||
13085640|NCT04082663|25800275|FG000|Overall Study|Adverse Event|6|||
13085641|NCT04082663|25800275|FG000|Overall Study|Lost to Follow-up|1|||
13085642|NCT04080752|25800306|FG000|Overall Study|Adverse Event|2|||
13085643|NCT04080752|25800307|FG001|Overall Study|Adverse Event|3|||
13085644|NCT04080752|25800306|FG000|Overall Study|Lack of Efficacy|1|||
13085645|NCT04080752|25800307|FG001|Overall Study|Lack of Efficacy|0|||
13085646|NCT04080752|25800306|FG000|Overall Study|Lost to Follow-up|1|||
13085647|NCT04080752|25800307|FG001|Overall Study|Lost to Follow-up|0|||
13085648|NCT04080752|25800306|FG000|Overall Study|Pregnancy|0|||
13085649|NCT04080752|25800307|FG001|Overall Study|Pregnancy|1|||
13085650|NCT04080752|25800306|FG000|Overall Study|Withdrawal by Subject|7|||
13085651|NCT04080752|25800307|FG001|Overall Study|Withdrawal by Subject|0|||
13085652|NCT04080752|25800306|FG000|Overall Study|Non-Compliance with Study Drug|0|||
13085653|NCT04080752|25800307|FG001|Overall Study|Non-Compliance with Study Drug|1|||
13085654|NCT04080752|25800306|FG000|Overall Study|Other|2|||
13085655|NCT04080752|25800307|FG001|Overall Study|Other|1|||
13085656|NCT04080297|25800332|FG000|Overall Study|Adverse Event|1|||
13085657|NCT04080297|25800333|FG001|Overall Study|Adverse Event|3|||
13085658|NCT04080297|25800332|FG000|Overall Study|concurrent illness|1|||
13085659|NCT04080297|25800333|FG001|Overall Study|concurrent illness|0|||
13085660|NCT04079842|25800341|FG000|Overall Study|Request of subject|2|||
13085661|NCT04079842|25800341|FG000|Overall Study|Unable to draw Arterial samples|1|||
13085662|NCT04079816|25800349|FG000|Overall Study|Request of Subject|2|||
13085663|NCT04079816|25800349|FG000|Overall Study|Unable to draw samples|1|||
13085664|NCT04079803|25800400|FG000|Overall Study|Withdrawal by Subject|0|||
13085665|NCT04079803|25800401|FG001|Overall Study|Withdrawal by Subject|0|||
13085666|NCT04079803|25800402|FG002|Overall Study|Withdrawal by Subject|1|||
13085667|NCT04079790|25800553|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1|||
13085668|NCT04079790|25800554|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
13085669|NCT04079790|25800555|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
13085670|NCT04079790|25800556|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
13085671|NCT04079790|25800553|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
13085672|NCT04079790|25800554|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
13085673|NCT04079790|25800555|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1|||
13085674|NCT04079790|25800556|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
13085675|NCT04079790|25800553|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
13085676|NCT04079790|25800554|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
13085677|NCT04079790|25800555|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2|||
13085678|NCT04079790|25800556|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
13085679|NCT04079114|25800565|FG000|Overall Study|Study prematuely terminated.|166|||
13085680|NCT04078126|25800590|FG000|Washout|Study put on hold due to COVID-19|0|||
13085681|NCT04078126|25800591|FG001|Washout|Study put on hold due to COVID-19|2|||
13085682|NCT04078126|25800590|FG000|Period 2|Study put on hold due to COVID-19|1|||
13085683|NCT04078126|25800591|FG001|Period 2|Study put on hold due to COVID-19|1|||
13085684|NCT04076917|25800597|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49|||
13085685|NCT04076917|25800597|FG000|Overall Study|Study closure|13|||
13085686|NCT04076917|25800597|FG000|Overall Study|Physician Decision|3|||
13085687|NCT04076917|25800597|FG000|Overall Study|Death|1|||
13085688|NCT04076917|25800597|FG000|Overall Study|Lost to Follow-up|1|||
13085689|NCT04076917|25800597|FG000|Overall Study|Withdrawal by Subject|1|||
13085690|NCT04076917|25800597|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1|||
13085691|NCT04075604|25800648|FG000|Overall Study|Adverse Event|0|||
13085692|NCT04075604|25800649|FG001|Overall Study|Adverse Event|0|||
13085693|NCT04075604|25800650|FG002|Overall Study|Adverse Event|3|||
13085694|NCT04075604|25800648|FG000|Overall Study|Participant request to discontinue study treatment|0|||
13085695|NCT04075604|25800649|FG001|Overall Study|Participant request to discontinue study treatment|0|||
13085696|NCT04075604|25800650|FG002|Overall Study|Participant request to discontinue study treatment|1|||
13085697|NCT04075604|25800648|FG000|Overall Study|Participant withdrew consent|0|||
13085698|NCT04075604|25800649|FG001|Overall Study|Participant withdrew consent|0|||
13085699|NCT04075604|25800650|FG002|Overall Study|Participant withdrew consent|1|||
13085700|NCT04075604|25800648|FG000|Overall Study|Other reasons|1|||
13085701|NCT04075604|25800649|FG001|Overall Study|Other reasons|0|||
13085702|NCT04075604|25800650|FG002|Overall Study|Other reasons|0|||
13085703|NCT04075604|25800648|FG000|Overall Study|Disease progression|0|||
13085704|NCT04075604|25800649|FG001|Overall Study|Disease progression|1|||
13085705|NCT04075604|25800650|FG002|Overall Study|Disease progression|0|||
13085706|NCT04075604|25800648|FG000|Overall Study|Study drug toxicity|0|||
13085707|NCT04075604|25800649|FG001|Overall Study|Study drug toxicity|5|||
13085708|NCT04075604|25800650|FG002|Overall Study|Study drug toxicity|1|||
13085709|NCT04075513|25800685|FG000|Overall Study|Withdrawal by Subject|2|||
13085710|NCT04075513|25800686|FG001|Overall Study|Withdrawal by Subject|2|||
13085711|NCT04075513|25800685|FG000|Overall Study|Lack of Efficacy|1|||
13085712|NCT04075513|25800686|FG001|Overall Study|Lack of Efficacy|0|||
13085713|NCT04075513|25800685|FG000|Overall Study|Lost to Follow-up|4|||
13085714|NCT04075513|25800686|FG001|Overall Study|Lost to Follow-up|2|||
13085715|NCT04075513|25800685|FG000|Overall Study|Switch to insulin pump|1|||
13085716|NCT04075513|25800686|FG001|Overall Study|Switch to insulin pump|0|||
13085717|NCT04074161|25800796|FG000|Overall Study|Withdrawal by Subject|2|||
13085718|NCT04074161|25800797|FG001|Overall Study|Withdrawal by Subject|4|||
13085719|NCT04074161|25800798|FG002|Overall Study|Withdrawal by Subject|1|||
13085720|NCT04074161|25800796|FG000|Overall Study|Lost to Follow-up|4|||
13085721|NCT04074161|25800797|FG001|Overall Study|Lost to Follow-up|5|||
13085722|NCT04074161|25800798|FG002|Overall Study|Lost to Follow-up|3|||
13085723|NCT04073407|25800811|FG000|Part 1|Withdrawal by Subject|1|||
13085724|NCT04073407|25800812|FG001|Part 1|Withdrawal by Subject|0|||
13085725|NCT04073407|25800811|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4|||
13085726|NCT04073407|25800812|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1|||
13085727|NCT04073407|25800811|FG000|Part 2|Withdrawal by Subject|0|||
13085728|NCT04073407|25800812|FG001|Part 2|Withdrawal by Subject|1|||
13085729|NCT04073368|25800855|FG000|Overall Study|Adverse Event|2|||
13085730|NCT04073368|25800856|FG001|Overall Study|Adverse Event|0|||
13085731|NCT04073368|25800857|FG002|Overall Study|Adverse Event|1|||
13085732|NCT04073368|25800858|FG003|Overall Study|Adverse Event|1|||
13085733|NCT04073368|25800855|FG000|Overall Study|Withdrawal by Subject|2|||
13085734|NCT04073368|25800856|FG001|Overall Study|Withdrawal by Subject|2|||
13085735|NCT04073368|25800857|FG002|Overall Study|Withdrawal by Subject|1|||
13085736|NCT04073368|25800858|FG003|Overall Study|Withdrawal by Subject|1|||
13085737|NCT04073368|25800855|FG000|Overall Study|Lost to Follow-up|1|||
13085738|NCT04073368|25800856|FG001|Overall Study|Lost to Follow-up|1|||
13085739|NCT04073368|25800857|FG002|Overall Study|Lost to Follow-up|1|||
13085740|NCT04073368|25800858|FG003|Overall Study|Lost to Follow-up|0|||
13085741|NCT04073368|25800855|FG000|Overall Study|Protocol Violation|0|||
13085742|NCT04073368|25800856|FG001|Overall Study|Protocol Violation|1|||
13085743|NCT04073368|25800857|FG002|Overall Study|Protocol Violation|0|||
13085744|NCT04073368|25800858|FG003|Overall Study|Protocol Violation|0|||
13085745|NCT04073368|25800855|FG000|Overall Study|Subject noncompliance|7|||
13085746|NCT04073368|25800856|FG001|Overall Study|Subject noncompliance|4|||
13085747|NCT04073368|25800857|FG002|Overall Study|Subject noncompliance|0|||
13085748|NCT04073368|25800858|FG003|Overall Study|Subject noncompliance|0|||
13085749|NCT04073186|25800869|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1|||
13085750|NCT04073186|25800869|FG000|First Wearing Cycle|Withdrawal by Subject|1|||
13085751|NCT04073186|25800869|FG000|First Wearing Cycle|Protocol Violation|1|||
13085752|NCT04073186|25800869|FG000|First Wearing Cycle|Lens Discomfort|2|||
13085753|NCT04073186|25800869|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1|||
13085754|NCT04073186|25800869|FG000|Second Wearing Cycle|Adverse Event|1|||
13085755|NCT04072159|25800884|FG000|Overall Study|Lost to Follow-up|6|||
13085756|NCT04072159|25800885|FG001|Overall Study|Lost to Follow-up|6|||
13085757|NCT04072159|25800884|FG000|Overall Study|Withdrawal by Subject|2|||
13085758|NCT04072159|25800885|FG001|Overall Study|Withdrawal by Subject|0|||
13085759|NCT04071301|25800891|FG000|Overall Study|Withdrawal by Subject|6|||
13085760|NCT04071301|25800891|FG000|Overall Study|Death|1|||
13085761|NCT04071158|25800958|FG000|Overall Study|Lost to Follow-up|1|||
13085762|NCT04071158|25800959|FG001|Overall Study|Lost to Follow-up|2|||
13085763|NCT04071158|25800960|FG002|Overall Study|Lost to Follow-up|3|||
13085764|NCT04071158|25800961|FG003|Overall Study|Lost to Follow-up|3|||
13085765|NCT04071158|25800962|FG004|Overall Study|Lost to Follow-up|5|||
13085766|NCT04071158|25800958|FG000|Overall Study|Randomized but not treated|2|||
13085767|NCT04071158|25800959|FG001|Overall Study|Randomized but not treated|2|||
13085768|NCT04071158|25800960|FG002|Overall Study|Randomized but not treated|0|||
13085769|NCT04071158|25800961|FG003|Overall Study|Randomized but not treated|0|||
13085770|NCT04071158|25800962|FG004|Overall Study|Randomized but not treated|0|||
13085771|NCT04070326|25801017|FG000|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|1|||
13085772|NCT04070326|25801018|FG001|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|0|||
13085773|NCT04069715|25801053|FG000|Overall Study|Lost to Follow-up|1|||
13085774|NCT04069715|25801054|FG001|Overall Study|Lost to Follow-up|1|||
13085775|NCT04069715|25801053|FG000|Overall Study|Physician Decision|1|||
13085776|NCT04069715|25801054|FG001|Overall Study|Physician Decision|1|||
13085777|NCT04069715|25801053|FG000|Overall Study|Withdrawal by Subject|3|||
13085778|NCT04069715|25801054|FG001|Overall Study|Withdrawal by Subject|3|||
13085779|NCT04068181|25801141|FG000|Overall Study|Withdrawal by Subject|2|||
13085780|NCT04068181|25801142|FG001|Overall Study|Withdrawal by Subject|0|||
13085781|NCT04068181|25801143|FG002|Overall Study|Withdrawal by Subject|0|||
13085782|NCT04068181|25801144|FG003|Overall Study|Withdrawal by Subject|0|||
13085783|NCT04068181|25801141|FG000|Overall Study|Lost to Follow-up|1|||
13085784|NCT04068181|25801142|FG001|Overall Study|Lost to Follow-up|0|||
13085785|NCT04068181|25801143|FG002|Overall Study|Lost to Follow-up|0|||
13085786|NCT04068181|25801144|FG003|Overall Study|Lost to Follow-up|0|||
13085787|NCT04068181|25801141|FG000|Overall Study|Death|8|||
13085788|NCT04068181|25801142|FG001|Overall Study|Death|8|||
13085789|NCT04068181|25801143|FG002|Overall Study|Death|4|||
13085790|NCT04068181|25801144|FG003|Overall Study|Death|2|||
13085791|NCT04068181|25801141|FG000|Overall Study|Continuing Study|16|||
13085792|NCT04068181|25801142|FG001|Overall Study|Continuing Study|7|||
13085793|NCT04068181|25801143|FG002|Overall Study|Continuing Study|11|||
13085794|NCT04068181|25801144|FG003|Overall Study|Continuing Study|13|||
13085795|NCT04067518|25801161|FG000|Overall Study|Screen Failures|0|||
13085796|NCT04067518|25801162|FG001|Overall Study|Screen Failures|1|||
13085797|NCT04067518|25801161|FG000|Overall Study|Enrolled but not Treated|0|||
13085798|NCT04067518|25801162|FG001|Overall Study|Enrolled but not Treated|1|||
13085799|NCT04067518|25801161|FG000|Overall Study|Adverse Events|0|||
13085800|NCT04067518|25801162|FG001|Overall Study|Adverse Events|2|||
13085801|NCT04067518|25801161|FG000|Overall Study|Ongoing|3|||
13085802|NCT04067518|25801162|FG001|Overall Study|Ongoing|21|||
13085803|NCT04067492|25801369|FG000|Overall Study|Lost to Follow-up|0|||
13085804|NCT04067492|25801370|FG001|Overall Study|Lost to Follow-up|0|||
13085805|NCT04067492|25801371|FG002|Overall Study|Lost to Follow-up|0|||
13085806|NCT04067492|25801372|FG003|Overall Study|Lost to Follow-up|0|||
13085807|NCT04067492|25801373|FG004|Overall Study|Lost to Follow-up|0|||
13085808|NCT04067492|25801374|FG005|Overall Study|Lost to Follow-up|1|||
13085809|NCT04067492|25801369|FG000|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
13085810|NCT04067492|25801370|FG001|Overall Study|closure of city borders because of COVID-19 quarantine|1|||
13085811|NCT04067492|25801371|FG002|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
13085812|NCT04067492|25801372|FG003|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
13085813|NCT04067492|25801373|FG004|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
13085814|NCT04067492|25801374|FG005|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
13085815|NCT04067492|25801369|FG000|Overall Study|COVID-19 epidemiological situation|0|||
13085816|NCT04067492|25801370|FG001|Overall Study|COVID-19 epidemiological situation|0|||
13085817|NCT04067492|25801371|FG002|Overall Study|COVID-19 epidemiological situation|0|||
13085818|NCT04067492|25801372|FG003|Overall Study|COVID-19 epidemiological situation|1|||
13085819|NCT04067492|25801373|FG004|Overall Study|COVID-19 epidemiological situation|0|||
13085820|NCT04067492|25801374|FG005|Overall Study|COVID-19 epidemiological situation|0|||
13085821|NCT04067401|25801401|FG000|Overall Study|Withdrawal by Subject|7|||
13085822|NCT04067401|25801402|FG001|Overall Study|Withdrawal by Subject|0|||
13085823|NCT04067401|25801401|FG000|Overall Study|no data provided|1|||
13085824|NCT04067401|25801402|FG001|Overall Study|no data provided|0|||
13085825|NCT04067141|25801451|FG000|First Intervention|Withdrawal by Subject|0|||
13085826|NCT04067141|25801452|FG001|First Intervention|Withdrawal by Subject|1|||
13085827|NCT04067141|25801451|FG000|Second Intervention|Adverse Event|0|||
13085828|NCT04067141|25801452|FG001|Second Intervention|Adverse Event|2|||
13085829|NCT04067050|25801559|FG000|One Month|Lost to Follow-up|4|||
13085830|NCT04067050|25801560|FG001|One Month|Lost to Follow-up|0|||
13085831|NCT04067050|25801559|FG000|Two Month|Lost to Follow-up|1|||
13085832|NCT04067050|25801560|FG001|Two Month|Lost to Follow-up|0|||
13085833|NCT04067050|25801559|FG000|Two Month|Adverse Event|1|||
13085834|NCT04067050|25801560|FG001|Two Month|Adverse Event|0|||
13085835|NCT04067011|25801580|FG000|Overall Study|Not Treated|8|||
13085836|NCT04067011|25801581|FG001|Overall Study|Not Treated|7|||
13085837|NCT04067011|25801582|FG002|Overall Study|Not Treated|5|||
13085838|NCT04067011|25801580|FG000|Overall Study|Adverse Event|2|||
13085839|NCT04067011|25801581|FG001|Overall Study|Adverse Event|1|||
13085840|NCT04067011|25801582|FG002|Overall Study|Adverse Event|0|||
13085841|NCT04067011|25801580|FG000|Overall Study|Withdrawal by Subject|6|||
13085842|NCT04067011|25801581|FG001|Overall Study|Withdrawal by Subject|2|||
13085843|NCT04067011|25801582|FG002|Overall Study|Withdrawal by Subject|1|||
13085844|NCT04067011|25801580|FG000|Overall Study|Lost to Follow-up|0|||
13085845|NCT04067011|25801581|FG001|Overall Study|Lost to Follow-up|0|||
13085846|NCT04067011|25801582|FG002|Overall Study|Lost to Follow-up|1|||
13085847|NCT04067011|25801580|FG000|Overall Study|Physician Decision|1|||
13085848|NCT04067011|25801581|FG001|Overall Study|Physician Decision|1|||
13085849|NCT04067011|25801582|FG002|Overall Study|Physician Decision|0|||
13085850|NCT04067011|25801580|FG000|Overall Study|Other Reasons|2|||
13085851|NCT04067011|25801581|FG001|Overall Study|Other Reasons|0|||
13085852|NCT04067011|25801582|FG002|Overall Study|Other Reasons|1|||
13085853|NCT04067011|25801580|FG000|Overall Study|Missing|0|||
13085854|NCT04067011|25801581|FG001|Overall Study|Missing|2|||
13085855|NCT04067011|25801582|FG002|Overall Study|Missing|0|||
13085856|NCT04063657|25801627|FG000|Overall Study|Lost to Follow-up|1|||
13085857|NCT04063657|25801628|FG001|Overall Study|Lost to Follow-up|0|||
13085858|NCT04060654|25801634|FG000|Overall Study|Withdrawal by Subject|1|||
13085859|NCT04060654|25801634|FG000|Overall Study|Lost to Follow-up|5|||
13085860|NCT04059094|25801702|FG000|Overall Study|Adverse Event|0|||
13085861|NCT04059094|25801703|FG001|Overall Study|Adverse Event|0|||
13085862|NCT04059094|25801704|FG002|Overall Study|Adverse Event|0|||
13085863|NCT04059094|25801705|FG003|Overall Study|Adverse Event|0|||
13085864|NCT04059094|25801706|FG004|Overall Study|Adverse Event|1|||
13085865|NCT04059094|25801702|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
13085866|NCT04059094|25801703|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2|||
13085867|NCT04059094|25801704|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
13085868|NCT04059094|25801705|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
13085869|NCT04059094|25801706|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
13085870|NCT04058353|25801728|FG000|Overall Study|Adverse Event|2|||
13085871|NCT04058353|25801729|FG001|Overall Study|Adverse Event|1|||
13085872|NCT04058353|25801728|FG000|Overall Study|Physician Decision|1|||
13085873|NCT04058353|25801729|FG001|Overall Study|Physician Decision|0|||
13085874|NCT04058353|25801728|FG000|Overall Study|Other|1|||
13085875|NCT04058353|25801729|FG001|Overall Study|Other|0|||
13085876|NCT04057573|25801796|FG000|24-Week Double-Blind Period|Adverse Event|2|||
13085877|NCT04057573|25801797|FG001|24-Week Double-Blind Period|Adverse Event|0|||
13085878|NCT04057573|25801798|FG002|24-Week Double-Blind Period|Adverse Event|0|||
13085879|NCT04057573|25801799|FG003|24-Week Double-Blind Period|Adverse Event|0|||
13085880|NCT04057573|25801796|FG000|24-Week Double-Blind Period|Lack of Efficacy|0|||
13085881|NCT04057573|25801797|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
13085882|NCT04057573|25801798|FG002|24-Week Double-Blind Period|Lack of Efficacy|0|||
13085883|NCT04057573|25801799|FG003|24-Week Double-Blind Period|Lack of Efficacy|0|||
13085884|NCT04057573|25801796|FG000|24-Week Double-Blind Period|Lost to Follow-up|11|||
13085885|NCT04057573|25801797|FG001|24-Week Double-Blind Period|Lost to Follow-up|6|||
13085886|NCT04057573|25801798|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
13085887|NCT04057573|25801799|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
13085888|NCT04057573|25801796|FG000|24-Week Double-Blind Period|Physician Decision|1|||
13085889|NCT04057573|25801797|FG001|24-Week Double-Blind Period|Physician Decision|0|||
13085890|NCT04057573|25801798|FG002|24-Week Double-Blind Period|Physician Decision|0|||
13085891|NCT04057573|25801799|FG003|24-Week Double-Blind Period|Physician Decision|0|||
13085892|NCT04057573|25801796|FG000|24-Week Double-Blind Period|Pregnancy|1|||
13085893|NCT04057573|25801797|FG001|24-Week Double-Blind Period|Pregnancy|0|||
13085894|NCT04057573|25801798|FG002|24-Week Double-Blind Period|Pregnancy|0|||
13085895|NCT04057573|25801799|FG003|24-Week Double-Blind Period|Pregnancy|0|||
13085896|NCT04057573|25801796|FG000|24-Week Double-Blind Period|Withdrawal by Subject|10|||
13085897|NCT04057573|25801797|FG001|24-Week Double-Blind Period|Withdrawal by Subject|8|||
13085898|NCT04057573|25801798|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
13085899|NCT04057573|25801799|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
13085900|NCT04057573|25801796|FG000|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|3|||
13085901|NCT04057573|25801797|FG001|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|1|||
13085902|NCT04057573|25801798|FG002|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
13085903|NCT04057573|25801799|FG003|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
13085904|NCT04057573|25801796|FG000|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|1|||
13085905|NCT04057573|25801797|FG001|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
13085906|NCT04057573|25801798|FG002|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
13085907|NCT04057573|25801799|FG003|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
13085908|NCT04057573|25801796|FG000|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
13085909|NCT04057573|25801797|FG001|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|1|||
13085910|NCT04057573|25801798|FG002|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
13085911|NCT04057573|25801799|FG003|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
13085912|NCT04057573|25801796|FG000|24-Week Double-Blind Period|Not Treated|1|||
13085913|NCT04057573|25801797|FG001|24-Week Double-Blind Period|Not Treated|0|||
13085914|NCT04057573|25801798|FG002|24-Week Double-Blind Period|Not Treated|0|||
13085915|NCT04057573|25801799|FG003|24-Week Double-Blind Period|Not Treated|0|||
13085916|NCT04057573|25801796|FG000|28-Week Treatment Extension Period|Adverse Event|0|||
13085917|NCT04057573|25801797|FG001|28-Week Treatment Extension Period|Adverse Event|0|||
13085918|NCT04057573|25801798|FG002|28-Week Treatment Extension Period|Adverse Event|1|||
13085919|NCT04057573|25801799|FG003|28-Week Treatment Extension Period|Adverse Event|0|||
13085920|NCT04057573|25801796|FG000|28-Week Treatment Extension Period|Lack of Efficacy|0|||
13085921|NCT04057573|25801797|FG001|28-Week Treatment Extension Period|Lack of Efficacy|0|||
13085922|NCT04057573|25801798|FG002|28-Week Treatment Extension Period|Lack of Efficacy|1|||
13085923|NCT04057573|25801799|FG003|28-Week Treatment Extension Period|Lack of Efficacy|0|||
13085924|NCT04057573|25801796|FG000|28-Week Treatment Extension Period|Lost to Follow-up|0|||
13085925|NCT04057573|25801797|FG001|28-Week Treatment Extension Period|Lost to Follow-up|0|||
13085926|NCT04057573|25801798|FG002|28-Week Treatment Extension Period|Lost to Follow-up|9|||
13085927|NCT04057573|25801799|FG003|28-Week Treatment Extension Period|Lost to Follow-up|10|||
13085928|NCT04057573|25801796|FG000|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
13085929|NCT04057573|25801797|FG001|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
13085930|NCT04057573|25801798|FG002|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
13085931|NCT04057573|25801799|FG003|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
13085932|NCT04057573|25801796|FG000|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
13085933|NCT04057573|25801797|FG001|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
13085934|NCT04057573|25801798|FG002|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|1|||
13085935|NCT04057573|25801799|FG003|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
13085936|NCT04057196|25801818|FG000|Overall Study|Withdrawal by Subject|3|||
13085937|NCT04057196|25801818|FG000|Overall Study|Death|3|||
13085938|NCT04054765|25801873|FG000|Baseline|Withdrawal by Subject|5|||
13085939|NCT04054765|25801874|FG001|Baseline|Withdrawal by Subject|3|||
13085940|NCT04054765|25801873|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8|||
13085941|NCT04054765|25801874|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3|||
13085942|NCT04054765|25801873|FG000|3-month Follow up|Withdrawal by Subject|0|||
13085943|NCT04054765|25801874|FG001|3-month Follow up|Withdrawal by Subject|3|||
13085944|NCT04054765|25801873|FG000|6-month Follow up|Lost to Follow-up|32|||
13085945|NCT04054765|25801874|FG001|6-month Follow up|Lost to Follow-up|32|||
13085946|NCT04054193|25801882|FG000|Cycle 1|Physician Decision|1|||
13085947|NCT04054193|25801882|FG000|Cycle 1|Consent withdrawn by parent/guardian|1|||
13085948|NCT04054193|25801882|FG000|Cycle 1|Allocated but not treated|3|||
13085949|NCT04054193|25801882|FG000|Cycles 2-3|Physician Decision|2|||
13085950|NCT04054193|25801882|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2|||
13085951|NCT04054193|25801882|FG000|Cycles 2-3|Various reasons|17|||
13085952|NCT04054011|25801892|FG000|Overall Study|COVID|3|||
13085953|NCT04053465|25801907|FG000|Overall Study|Withdrawal by Subject|4|||
13085954|NCT04053465|25801908|FG001|Overall Study|Withdrawal by Subject|4|||
13085955|NCT04053023|25802077|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1|||
13085956|NCT04053023|25802078|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0|||
13085957|NCT04052620|25802113|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1|||
13085958|NCT04052620|25802114|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0|||
13085959|NCT04052620|25802113|FG000|Overall Study|Withdrawal by Subject|1|||
13085960|NCT04052620|25802114|FG001|Overall Study|Withdrawal by Subject|0|||
13085961|NCT04052620|25802113|FG000|Overall Study|Lost to Follow-up|1|||
13085962|NCT04052620|25802114|FG001|Overall Study|Lost to Follow-up|1|||
13085963|NCT04052620|25802113|FG000|Overall Study|Adverse Event|1|||
13085964|NCT04052620|25802114|FG001|Overall Study|Adverse Event|0|||
13085965|NCT04052620|25802113|FG000|Overall Study|Subject did not meet study Criteria|0|||
13085966|NCT04052620|25802114|FG001|Overall Study|Subject did not meet study Criteria|1|||
13085967|NCT04052620|25802113|FG000|Overall Study|Screened failure, randomized by mistake|0|||
13085968|NCT04052620|25802114|FG001|Overall Study|Screened failure, randomized by mistake|1|||
13085969|NCT04052620|25802113|FG000|Overall Study|Personal reasons|2|||
13085970|NCT04052620|25802114|FG001|Overall Study|Personal reasons|4|||
13085971|NCT04052620|25802113|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1|||
13085972|NCT04052620|25802114|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0|||
13085973|NCT04052425|25802181|FG000|24-Week Double-blind Period|Adverse Event|0|||
13085974|NCT04052425|25802182|FG001|24-Week Double-blind Period|Adverse Event|1|||
13085975|NCT04052425|25802183|FG002|24-Week Double-blind Period|Adverse Event|0|||
13085976|NCT04052425|25802184|FG003|24-Week Double-blind Period|Adverse Event|0|||
13085977|NCT04052425|25802181|FG000|24-Week Double-blind Period|Lack of Efficacy|0|||
13085978|NCT04052425|25802182|FG001|24-Week Double-blind Period|Lack of Efficacy|1|||
13085979|NCT04052425|25802183|FG002|24-Week Double-blind Period|Lack of Efficacy|0|||
13085980|NCT04052425|25802184|FG003|24-Week Double-blind Period|Lack of Efficacy|0|||
13085981|NCT04052425|25802181|FG000|24-Week Double-blind Period|Lost to Follow-up|14|||
13085982|NCT04052425|25802182|FG001|24-Week Double-blind Period|Lost to Follow-up|7|||
13085983|NCT04052425|25802183|FG002|24-Week Double-blind Period|Lost to Follow-up|0|||
13085984|NCT04052425|25802184|FG003|24-Week Double-blind Period|Lost to Follow-up|0|||
13085985|NCT04052425|25802181|FG000|24-Week Double-blind Period|Physician Decision|1|||
13085986|NCT04052425|25802182|FG001|24-Week Double-blind Period|Physician Decision|0|||
13085987|NCT04052425|25802183|FG002|24-Week Double-blind Period|Physician Decision|0|||
13085988|NCT04052425|25802184|FG003|24-Week Double-blind Period|Physician Decision|0|||
13085989|NCT04052425|25802181|FG000|24-Week Double-blind Period|Protocol Violation|1|||
13085990|NCT04052425|25802182|FG001|24-Week Double-blind Period|Protocol Violation|0|||
13085991|NCT04052425|25802183|FG002|24-Week Double-blind Period|Protocol Violation|0|||
13085992|NCT04052425|25802184|FG003|24-Week Double-blind Period|Protocol Violation|0|||
13085993|NCT04052425|25802181|FG000|24-Week Double-blind Period|Withdrawal by Subject|9|||
13085994|NCT04052425|25802182|FG001|24-Week Double-blind Period|Withdrawal by Subject|10|||
13085995|NCT04052425|25802183|FG002|24-Week Double-blind Period|Withdrawal by Subject|0|||
13085996|NCT04052425|25802184|FG003|24-Week Double-blind Period|Withdrawal by Subject|0|||
13085997|NCT04052425|25802181|FG000|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|3|||
13085998|NCT04052425|25802182|FG001|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
13085999|NCT04052425|25802183|FG002|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
13086000|NCT04052425|25802184|FG003|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
13086001|NCT04052425|25802181|FG000|28-Week Treatment-Extension Period|Adverse Event|0|||
13086002|NCT04052425|25802182|FG001|28-Week Treatment-Extension Period|Adverse Event|0|||
13086003|NCT04052425|25802183|FG002|28-Week Treatment-Extension Period|Adverse Event|1|||
13086004|NCT04052425|25802184|FG003|28-Week Treatment-Extension Period|Adverse Event|0|||
13086005|NCT04052425|25802181|FG000|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
13086006|NCT04052425|25802182|FG001|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
13086007|NCT04052425|25802183|FG002|28-Week Treatment-Extension Period|Lack of Efficacy|1|||
13086008|NCT04052425|25802184|FG003|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
13086009|NCT04052425|25802181|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
13086010|NCT04052425|25802182|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
13086011|NCT04052425|25802183|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
13086012|NCT04052425|25802184|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|1|||
13086013|NCT04052425|25802181|FG000|28-Week Treatment-Extension Period|Physician Decision|0|||
13086014|NCT04052425|25802182|FG001|28-Week Treatment-Extension Period|Physician Decision|0|||
13086015|NCT04052425|25802183|FG002|28-Week Treatment-Extension Period|Physician Decision|0|||
13086016|NCT04052425|25802184|FG003|28-Week Treatment-Extension Period|Physician Decision|1|||
13086017|NCT04052425|25802181|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
13086018|NCT04052425|25802182|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
13086019|NCT04052425|25802183|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|10|||
13086020|NCT04052425|25802184|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|7|||
13086021|NCT04052425|25802181|FG000|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
13086022|NCT04052425|25802182|FG001|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
13086023|NCT04052425|25802183|FG002|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|1|||
13086024|NCT04052425|25802184|FG003|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
13086025|NCT04052425|25802181|FG000|28-Week Treatment-Extension Period|Participant Moved|0|||
13086026|NCT04052425|25802182|FG001|28-Week Treatment-Extension Period|Participant Moved|0|||
13086027|NCT04052425|25802183|FG002|28-Week Treatment-Extension Period|Participant Moved|1|||
13086028|NCT04052425|25802184|FG003|28-Week Treatment-Extension Period|Participant Moved|1|||
13086029|NCT04052204|25802202|FG000|Overall Study|Death|1|||
13086030|NCT04052204|25802203|FG001|Overall Study|Death|0|||
13086031|NCT04052204|25802204|FG002|Overall Study|Death|0|||
13086032|NCT04052204|25802202|FG000|Overall Study|Progressive disease|1|||
13086033|NCT04052204|25802203|FG001|Overall Study|Progressive disease|0|||
13086034|NCT04052204|25802204|FG002|Overall Study|Progressive disease|0|||
13086035|NCT04052204|25802202|FG000|Overall Study|Other|1|||
13086036|NCT04052204|25802203|FG001|Overall Study|Other|0|||
13086037|NCT04052204|25802204|FG002|Overall Study|Other|0|||
13086038|NCT04052139|25802249|FG000|Overall Study|Lost to Follow-up|2|||
13086039|NCT04052139|25802250|FG001|Overall Study|Lost to Follow-up|0|||
13086040|NCT04052139|25802251|FG002|Overall Study|Lost to Follow-up|0|||
13086041|NCT04052139|25802249|FG000|Overall Study|Withdrawal by Subject|1|||
13086042|NCT04052139|25802250|FG001|Overall Study|Withdrawal by Subject|0|||
13086043|NCT04052139|25802251|FG002|Overall Study|Withdrawal by Subject|0|||
13086044|NCT04051944|25802264|FG000|Overall Study|Study ending|1|||
13086045|NCT04051944|25802265|FG001|Overall Study|Study ending|1|||
13086046|NCT04051944|25802264|FG000|Overall Study|Early study termination by participant|1|||
13086047|NCT04051944|25802265|FG001|Overall Study|Early study termination by participant|0|||
13086048|NCT04051944|25802264|FG000|Overall Study|Withdrawal by Subject|2|||
13086049|NCT04051944|25802265|FG001|Overall Study|Withdrawal by Subject|2|||
13086050|NCT04051944|25802264|FG000|Overall Study|Lack of Efficacy|3|||
13086051|NCT04051944|25802265|FG001|Overall Study|Lack of Efficacy|0|||
13086052|NCT04051944|25802264|FG000|Overall Study|Adverse event, non- fatal|1|||
13086053|NCT04051944|25802265|FG001|Overall Study|Adverse event, non- fatal|1|||
13086054|NCT04050865|25802282|FG000|Overall Study|Adverse Event|1|||
13086055|NCT04050865|25802283|FG001|Overall Study|Adverse Event|0|||
13086056|NCT04050865|25802282|FG000|Overall Study|no insert|1|||
13086057|NCT04050865|25802283|FG001|Overall Study|no insert|0|||
13086058|NCT04050865|25802282|FG000|Overall Study|Only 1 insert|2|||
13086059|NCT04050865|25802283|FG001|Overall Study|Only 1 insert|3|||
13086060|NCT04050865|25802282|FG000|Overall Study|Physician Decision|0|||
13086061|NCT04050865|25802283|FG001|Overall Study|Physician Decision|1|||
13086062|NCT04050865|25802282|FG000|Overall Study|Withdrawal by Subject|0|||
13086063|NCT04050865|25802283|FG001|Overall Study|Withdrawal by Subject|1|||
13086064|NCT04050722|25802306|FG000|Overall Study|Withdrawal by Subject|1|||
13086065|NCT04050722|25802307|FG001|Overall Study|Withdrawal by Subject|0|||
13086066|NCT04050618|25802452|FG000|First Intervention|Withdrawal by Subject|2|||
13086067|NCT04050618|25802453|FG001|First Intervention|Withdrawal by Subject|0|||
13086068|NCT04050618|25802452|FG000|Second Intervention|Withdrawal by Subject|1|||
13086069|NCT04050618|25802453|FG001|Second Intervention|Withdrawal by Subject|0|||
13086070|NCT04050371|25802470|FG000|Overall Study|Withdrawal by Subject|1|||
13086071|NCT04050371|25802471|FG001|Overall Study|Withdrawal by Subject|0|||
13132425|NCT02791893|25983752|FG000|Open Label Phase|Lost to Follow-up|3|||
13132426|NCT02791893|25983753|FG001|Open Label Phase|Lost to Follow-up|0|||
13132427|NCT02791893|25983752|FG000|Open Label Phase|Withdrawal by Subject|0|||
13132428|NCT02791893|25983753|FG001|Open Label Phase|Withdrawal by Subject|2|||
13132429|NCT02791763|25983880|FG000|Overall Study|Protocol Violation|0|||
13132430|NCT02791763|25983881|FG001|Overall Study|Protocol Violation|0|||
13132431|NCT02791763|25983882|FG002|Overall Study|Protocol Violation|1|||
13132432|NCT02791763|25983880|FG000|Overall Study|Withdrawal by Subject|5|||
13132433|NCT02791763|25983881|FG001|Overall Study|Withdrawal by Subject|1|||
13132434|NCT02791763|25983882|FG002|Overall Study|Withdrawal by Subject|0|||
13132435|NCT02791763|25983880|FG000|Overall Study|Physician Decision|0|||
13132436|NCT02791763|25983881|FG001|Overall Study|Physician Decision|1|||
13132437|NCT02791763|25983882|FG002|Overall Study|Physician Decision|0|||
13132438|NCT02791763|25983880|FG000|Overall Study|Needs maintenance/changes in dialysis|16|||
13132439|NCT02791763|25983881|FG001|Overall Study|Needs maintenance/changes in dialysis|19|||
13132440|NCT02791763|25983882|FG002|Overall Study|Needs maintenance/changes in dialysis|5|||
13132441|NCT02791763|25983880|FG000|Overall Study|Cancer event|1|||
13132442|NCT02791763|25983881|FG001|Overall Study|Cancer event|3|||
13132443|NCT02791763|25983882|FG002|Overall Study|Cancer event|0|||
13132444|NCT02791763|25983880|FG000|Overall Study|Participant had renal transplant|3|||
13132445|NCT02791763|25983881|FG001|Overall Study|Participant had renal transplant|0|||
13132446|NCT02791763|25983882|FG002|Overall Study|Participant had renal transplant|0|||
13132447|NCT02791763|25983880|FG000|Overall Study|Met hemoglobin stopping criteria|1|||
13132448|NCT02791763|25983881|FG001|Overall Study|Met hemoglobin stopping criteria|0|||
13132449|NCT02791763|25983882|FG002|Overall Study|Met hemoglobin stopping criteria|0|||
13132450|NCT02791763|25983880|FG000|Overall Study|Adverse Event|12|||
13132451|NCT02791763|25983881|FG001|Overall Study|Adverse Event|13|||
13132452|NCT02791763|25983882|FG002|Overall Study|Adverse Event|7|||
13132453|NCT02791659|25983895|FG000|Overall Study|Protocol Violation|0|||
13132454|NCT02791659|25983896|FG001|Overall Study|Protocol Violation|1|||
13132455|NCT02791516|25983913|FG000|Overall Study|Withdrawal by Subject|1|||
13132456|NCT02791516|25983914|FG001|Overall Study|Withdrawal by Subject|1|||
13132457|NCT02791490|25983939|FG000|Overall Study|Lost to Follow-up|1|||
13132458|NCT02791490|25983940|FG001|Overall Study|Lost to Follow-up|2|||
13132459|NCT02791490|25983939|FG000|Overall Study|Withdrawal by Subject|2|||
13132460|NCT02791490|25983940|FG001|Overall Study|Withdrawal by Subject|6|||
13132461|NCT02791438|25983973|FG000|Treatment Period|Adverse Event|1|||
13132462|NCT02791438|25983974|FG001|Treatment Period|Adverse Event|0|||
13132463|NCT02791438|25983973|FG000|Treatment Period|Withdrawal by Subject|0|||
13132464|NCT02791438|25983974|FG001|Treatment Period|Withdrawal by Subject|1|||
13132465|NCT02791438|25983973|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
13132466|NCT02791438|25983974|FG001|Treatment Period|Withdrawal by Parent/Guardian|0|||
13132467|NCT02791269|25983995|FG000|Overall Study|Lost to Follow-up|0|||
13132468|NCT02791269|25983996|FG001|Overall Study|Lost to Follow-up|1|||
13132469|NCT02791191|25984037|FG000|Overall Study|Adverse Event|2|||
13132470|NCT02791191|25984038|FG001|Overall Study|Adverse Event|4|||
13132471|NCT02791191|25984039|FG002|Overall Study|Adverse Event|5|||
13132472|NCT02791191|25984037|FG000|Overall Study|Lack of Efficacy|0|||
13132473|NCT02791191|25984038|FG001|Overall Study|Lack of Efficacy|1|||
13132474|NCT02791191|25984039|FG002|Overall Study|Lack of Efficacy|0|||
13132475|NCT02791191|25984037|FG000|Overall Study|Study Drug Non-Compliance|0|||
13132476|NCT02791191|25984038|FG001|Overall Study|Study Drug Non-Compliance|2|||
13132477|NCT02791191|25984039|FG002|Overall Study|Study Drug Non-Compliance|0|||
13132478|NCT02791191|25984037|FG000|Overall Study|Site Closed by Sponsor|1|||
13132479|NCT02791191|25984038|FG001|Overall Study|Site Closed by Sponsor|1|||
13132480|NCT02791191|25984039|FG002|Overall Study|Site Closed by Sponsor|3|||
13132481|NCT02791191|25984037|FG000|Overall Study|Progressive Disease|1|||
13132482|NCT02791191|25984038|FG001|Overall Study|Progressive Disease|0|||
13132483|NCT02791191|25984039|FG002|Overall Study|Progressive Disease|0|||
13132484|NCT02791191|25984037|FG000|Overall Study|Study Terminated by Sponsor|29|||
13132485|NCT02791191|25984038|FG001|Overall Study|Study Terminated by Sponsor|101|||
13132486|NCT02791191|25984039|FG002|Overall Study|Study Terminated by Sponsor|109|||
13132487|NCT02791191|25984037|FG000|Overall Study|Withdrawal by Subject|3|||
13132488|NCT02791191|25984038|FG001|Overall Study|Withdrawal by Subject|1|||
13132489|NCT02791191|25984039|FG002|Overall Study|Withdrawal by Subject|3|||
13132490|NCT02791191|25984037|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2|||
13132491|NCT02791191|25984038|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1|||
13132492|NCT02791191|25984039|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0|||
13086072|NCT04049578|25802483|FG000|Overall Study|Physician Decision|1|||
13086073|NCT04049552|25802493|FG000|Overall Study|Lost to Follow-up|1|||
13086074|NCT04048681|25802510|FG000|Overall Study|family emergency|0|||
13086075|NCT04048681|25802511|FG001|Overall Study|family emergency|0|||
13086076|NCT04048681|25802512|FG002|Overall Study|family emergency|0|||
13086077|NCT04048681|25802513|FG003|Overall Study|family emergency|1|||
13086078|NCT04048681|25802514|FG004|Overall Study|family emergency|0|||
13086079|NCT04048382|25802539|FG000|3-Month Follow Up|Enrolled but did not complete survey|2|||
13086080|NCT04048382|25802540|FG001|3-Month Follow Up|Enrolled but did not complete survey|0|||
13086081|NCT04048382|25802539|FG000|3-Month Follow Up|Withdrawal by Subject|0|||
13086082|NCT04048382|25802540|FG001|3-Month Follow Up|Withdrawal by Subject|1|||
13086083|NCT04048382|25802539|FG000|6-Month Follow up|Enrolled but did not complete survey|2|||
13086084|NCT04048382|25802540|FG001|6-Month Follow up|Enrolled but did not complete survey|0|||
13086085|NCT04047446|25802573|FG000|Overall Study|Physician Decision|1|||
13086086|NCT04047446|25802574|FG001|Overall Study|Physician Decision|0|||
13086087|NCT04046939|25802651|FG000|Primary Assessment Period|Adverse Event|1|||
13086088|NCT04046939|25802652|FG001|Primary Assessment Period|Adverse Event|0|||
13086089|NCT04046939|25802653|FG002|Primary Assessment Period|Adverse Event|0|||
13086090|NCT04046939|25802654|FG003|Primary Assessment Period|Adverse Event|0|||
13086091|NCT04046939|25802651|FG000|Primary Assessment Period|Withdrawal by Subject|1|||
13086092|NCT04046939|25802652|FG001|Primary Assessment Period|Withdrawal by Subject|0|||
13086093|NCT04046939|25802653|FG002|Primary Assessment Period|Withdrawal by Subject|1|||
13086094|NCT04046939|25802654|FG003|Primary Assessment Period|Withdrawal by Subject|0|||
13086095|NCT04046939|25802651|FG000|Primary Assessment Period|Physician Decision|0|||
13086096|NCT04046939|25802652|FG001|Primary Assessment Period|Physician Decision|0|||
13086097|NCT04046939|25802653|FG002|Primary Assessment Period|Physician Decision|1|||
13086098|NCT04046939|25802654|FG003|Primary Assessment Period|Physician Decision|0|||
13086099|NCT04046939|25802651|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1|||
13086100|NCT04046939|25802652|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0|||
13086101|NCT04046939|25802653|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0|||
13086102|NCT04046939|25802654|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1|||
13086103|NCT04046341|25802668|FG000|Overall Study|Lost to Follow-up|2|||
13086104|NCT04046341|25802668|FG000|Overall Study|Withdrawal by Subject|1|||
13086105|NCT04046250|25802683|FG000|Overall Study|Death|0|||
13086106|NCT04046250|25802684|FG001|Overall Study|Death|1|||
13086107|NCT04046250|25802683|FG000|Overall Study|Withdrawal by Subject|3|||
13086108|NCT04046250|25802684|FG001|Overall Study|Withdrawal by Subject|3|||
13086109|NCT04044352|25802731|FG000|Overall Study|Lost to Follow-up|9|||
13086110|NCT04044352|25802731|FG000|Overall Study|Withdrawal by Subject|2|||
13086111|NCT04043962|25802742|FG000|Post-Treatment|Declined due to lack of time/interest or could not be reached|3|||
13086112|NCT04043962|25802742|FG000|Post-Treatment|Withdrawal by Subject|5|||
13086113|NCT04043962|25802742|FG000|Follow-up|Declined due to lack of time/interest or could not be reached|7|||
13086114|NCT04043728|25802763|FG000|Overall Study|Lost to Follow-up|1|||
13086115|NCT04043728|25802764|FG001|Overall Study|Lost to Follow-up|2|||
13086116|NCT04043728|25802765|FG002|Overall Study|Lost to Follow-up|0|||
13086117|NCT04043416|25802806|FG000|Washout|Change in health condition|0|||
13086118|NCT04043416|25802807|FG001|Washout|Change in health condition|1|||
13086119|NCT04043143|25802836|FG000|Overall Study|Lost to Follow-up|5|||
13086120|NCT04043143|25802837|FG001|Overall Study|Lost to Follow-up|5|||
13086121|NCT04043143|25802836|FG000|Overall Study|screen failure|1|||
13086122|NCT04043143|25802837|FG001|Overall Study|screen failure|0|||
13086123|NCT04042103|25802853|FG000|Overall Study|Lost to Follow-up|1|||
13086124|NCT04042103|25802853|FG000|Overall Study|Withdrawal by Subject|1|||
13086125|NCT04041700|25802890|FG000|Overall Study|Pregnancy|1|||
13086126|NCT04041700|25802890|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1|||
13086127|NCT04041440|25802905|FG000|Overall Study|Withdrawal by Subject|0|||
13086128|NCT04041440|25802906|FG001|Overall Study|Withdrawal by Subject|1|||
13086129|NCT04041440|25802905|FG000|Overall Study|Lost to Follow-up|0|||
13086130|NCT04041440|25802906|FG001|Overall Study|Lost to Follow-up|1|||
13086131|NCT04041414|25802931|FG000|Overall Study|Lost to Follow-up|1|||
13086132|NCT04041414|25802932|FG001|Overall Study|Lost to Follow-up|2|||
13086133|NCT04040933|25803017|FG000|Overall Study|Protocol Violation|1|||
13086134|NCT04040933|25803017|FG000|Overall Study|Withdrawal by Subject|2|||
13086135|NCT04039919|25803107|FG000|Treatment Period 1|Withdrawal by Subject|1|||
13086136|NCT04039919|25803108|FG001|Treatment Period 1|Withdrawal by Subject|0|||
13086137|NCT04039919|25803109|FG002|Treatment Period 1|Withdrawal by Subject|0|||
13086138|NCT04039919|25803110|FG003|Treatment Period 1|Withdrawal by Subject|0|||
13086139|NCT04039919|25803111|FG004|Treatment Period 1|Withdrawal by Subject|0|||
13086140|NCT04039919|25803107|FG000|Treatment Period 1|Sponsor's decision|0|||
13086141|NCT04039919|25803108|FG001|Treatment Period 1|Sponsor's decision|0|||
13086142|NCT04039919|25803109|FG002|Treatment Period 1|Sponsor's decision|0|||
13086143|NCT04039919|25803110|FG003|Treatment Period 1|Sponsor's decision|0|||
13086144|NCT04039919|25803111|FG004|Treatment Period 1|Sponsor's decision|16|||
13086145|NCT04039919|25803107|FG000|Treatment Period 5|Withdrawal by Subject|1|||
13086146|NCT04039919|25803108|FG001|Treatment Period 5|Withdrawal by Subject|0|||
13086147|NCT04039919|25803109|FG002|Treatment Period 5|Withdrawal by Subject|0|||
13086148|NCT04039919|25803110|FG003|Treatment Period 5|Withdrawal by Subject|0|||
13086149|NCT04039919|25803111|FG004|Treatment Period 5|Withdrawal by Subject|0|||
13086150|NCT04037748|25803132|FG000|Treatment Period 1|Withdrawal by Subject|3|||
13086151|NCT04037748|25803133|FG001|Treatment Period 1|Withdrawal by Subject|0|||
13086152|NCT04037748|25803132|FG000|Treatment Period 1|Adverse Event|1|||
13086153|NCT04037748|25803133|FG001|Treatment Period 1|Adverse Event|1|||
13086154|NCT04037748|25803132|FG000|Treatment Period 1|Protocol Violation|4|||
13086155|NCT04037748|25803133|FG001|Treatment Period 1|Protocol Violation|5|||
13086156|NCT04037748|25803132|FG000|Treatment Period 2|Adverse Event|0|||
13086157|NCT04037748|25803133|FG001|Treatment Period 2|Adverse Event|1|||
13086158|NCT04037748|25803132|FG000|Treatment Period 2|Protocol Violation|2|||
13086159|NCT04037748|25803133|FG001|Treatment Period 2|Protocol Violation|0|||
13086160|NCT04036110|25803166|FG000|Overall Study|Lost to Follow-up|3|||
13086161|NCT04036110|25803167|FG001|Overall Study|Lost to Follow-up|2|||
13086162|NCT04036110|25803168|FG002|Overall Study|Lost to Follow-up|1|||
13086163|NCT04036110|25803166|FG000|Overall Study|Study Suspended|4|||
13086164|NCT04036110|25803167|FG001|Overall Study|Study Suspended|5|||
13086165|NCT04036110|25803168|FG002|Overall Study|Study Suspended|1|||
13086166|NCT04035577|25803188|FG000|Overall Study|Lost to Follow-up|1|||
13086167|NCT04035577|25803188|FG000|Overall Study|Withdrawal by Subject|1|||
13086168|NCT04035564|25803217|FG000|Overall Study|Protocol Violation|1|||
13086169|NCT04035564|25803218|FG001|Overall Study|Protocol Violation|2|||
13086170|NCT04035564|25803217|FG000|Overall Study|No laboratory available|2|||
13086171|NCT04035564|25803218|FG001|Overall Study|No laboratory available|2|||
13086172|NCT04035564|25803217|FG000|Overall Study|Guardian declined consent|1|||
13086173|NCT04035564|25803218|FG001|Overall Study|Guardian declined consent|2|||
13086174|NCT04035473|25803241|FG000|Screening/Baseline|Death|0|||
13086175|NCT04035473|25803242|FG001|Screening/Baseline|Death|1|||
13086176|NCT04035473|25803241|FG000|Screening/Baseline|Adverse Event|0|||
13086177|NCT04035473|25803242|FG001|Screening/Baseline|Adverse Event|1|||
13086178|NCT04035473|25803241|FG000|Follow-up Period|Adverse Event|2|||
13086179|NCT04035473|25803242|FG001|Follow-up Period|Adverse Event|0|||
13086180|NCT04034238|25803282|FG000|Dose Escalation Phase|Withdrawal by Subject|1|||
13086181|NCT04034238|25803283|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
13086182|NCT04034238|25803284|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
13086183|NCT04034238|25803285|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
13086184|NCT04034238|25803282|FG000|Dose Escalation Phase|Screen failures|0|||
13086185|NCT04034238|25803283|FG001|Dose Escalation Phase|Screen failures|0|||
13086186|NCT04034238|25803284|FG002|Dose Escalation Phase|Screen failures|0|||
13086187|NCT04034238|25803285|FG003|Dose Escalation Phase|Screen failures|2|||
13086188|NCT04034238|25803282|FG000|Dose Expansion Phase|Not treated due to study hold.|0|||
13086189|NCT04034238|25803283|FG001|Dose Expansion Phase|Not treated due to study hold.|0|||
13086190|NCT04034238|25803284|FG002|Dose Expansion Phase|Not treated due to study hold.|0|||
13086191|NCT04034238|25803285|FG003|Dose Expansion Phase|Not treated due to study hold.|1|||
13086192|NCT04034238|25803282|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
13086193|NCT04034238|25803283|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
13086194|NCT04034238|25803284|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1|||
13086195|NCT04034238|25803285|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
13086196|NCT04033432|25803295|FG000|Overall Study|Progressive Disease|8|||
13086197|NCT04033432|25803295|FG000|Overall Study|Adverse Event|4|||
13086198|NCT04033432|25803295|FG000|Overall Study|Death|1|||
13086199|NCT04032977|25803316|FG000|Overall Study|Withdrawal by Subject|6|||
13086200|NCT04032977|25803317|FG001|Overall Study|Withdrawal by Subject|1|||
13086201|NCT04032977|25803316|FG000|Overall Study|Lost to Follow-up|2|||
13086202|NCT04032977|25803317|FG001|Overall Study|Lost to Follow-up|7|||
13086203|NCT04032977|25803316|FG000|Overall Study|Pregnancy|1|||
13086204|NCT04032977|25803317|FG001|Overall Study|Pregnancy|0|||
13086205|NCT04032652|25803332|FG000|Overall Study|The study was terminated and the PI has|1|||
13086206|NCT04032652|25803333|FG001|Overall Study|The study was terminated and the PI has|1|||
13086207|NCT04032613|25803348|FG000|Overall Study|Did not complete post-program assessment|5|||
13086208|NCT04032613|25803349|FG001|Overall Study|Did not complete post-program assessment|2|||
13086209|NCT04032171|25803408|FG000|Overall Study|Study Termination|1|||
13086210|NCT04032171|25803409|FG001|Overall Study|Study Termination|0|||
13086211|NCT04032158|25803468|FG000|Overall Study|Study Termination|2|||
13086212|NCT04032158|25803469|FG001|Overall Study|Study Termination|1|||
13086213|NCT04031404|25803486|FG000|Baseline|Lost to Follow-up|0|||
13086214|NCT04031404|25803487|FG001|Baseline|Lost to Follow-up|1|||
13086215|NCT04031404|25803486|FG000|Baseline|Did not meet full inclusion/exclusion.|2|||
13086216|NCT04031404|25803487|FG001|Baseline|Did not meet full inclusion/exclusion.|4|||
13086217|NCT04031404|25803486|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1|||
13086218|NCT04031404|25803487|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3|||
13086219|NCT04031404|25803486|FG000|Pre-randomization|Disqualified by TMS safety screening|1|||
13086220|NCT04031404|25803487|FG001|Pre-randomization|Disqualified by TMS safety screening|0|||
13086221|NCT04031404|25803486|FG000|Washout (5 Day Min)|Lost to Follow-up|1|||
13086222|NCT04031404|25803487|FG001|Washout (5 Day Min)|Lost to Follow-up|0|||
13086223|NCT04030598|25803529|FG000|Overall Study|Voluntary Withdrawal|0|||
13086224|NCT04030598|25803530|FG001|Overall Study|Voluntary Withdrawal|1|||
13086225|NCT04030598|25803531|FG002|Overall Study|Voluntary Withdrawal|0|||
13086226|NCT04030247|25803550|FG000|Overall Study|Withdrawal by Subject|4|||
13086227|NCT04030247|25803550|FG000|Overall Study|Lost to Follow-up|13|||
13086228|NCT04029961|25803571|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1|||
13086229|NCT04029961|25803572|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0|||
13086230|NCT04029961|25803571|FG000|Overall Study|Change in Treatment Course|0|||
13086231|NCT04029961|25803572|FG001|Overall Study|Change in Treatment Course|1|||
13086232|NCT04029519|25803582|FG000|Overall Study|Protocol Violation|1|||
13086233|NCT04029519|25803582|FG000|Overall Study|Withdrawal by Subject|3|||
13086234|NCT04029519|25803582|FG000|Overall Study|Lost to Follow-up|1|||
13086235|NCT04027686|25803611|FG000|Overall Study|Lost to Follow-up|2|||
13086236|NCT04027686|25803612|FG001|Overall Study|Lost to Follow-up|0|||
13086237|NCT04027686|25803611|FG000|Overall Study|Withdrawal by Subject|0|||
13086238|NCT04027686|25803612|FG001|Overall Study|Withdrawal by Subject|1|||
13086239|NCT04026568|25803625|FG000|Overall Study|study terminated|0|||
13086240|NCT04026568|25803626|FG001|Overall Study|study terminated|1|||
13086241|NCT04025684|25803713|FG000|Overall Study|Withdrawal by Subject|1|||
13086242|NCT04025684|25803714|FG001|Overall Study|Withdrawal by Subject|1|||
13086243|NCT04025684|25803715|FG002|Overall Study|Withdrawal by Subject|0|||
13086244|NCT04025684|25803716|FG003|Overall Study|Withdrawal by Subject|0|||
13086245|NCT04025684|25803713|FG000|Overall Study|Multiple reasons|1|||
13086246|NCT04025684|25803714|FG001|Overall Study|Multiple reasons|3|||
13086247|NCT04025684|25803715|FG002|Overall Study|Multiple reasons|0|||
13086248|NCT04025684|25803716|FG003|Overall Study|Multiple reasons|1|||
13086249|NCT04025632|25803748|FG000|Overall Study|Adverse Event|1|||
13086250|NCT04025632|25803749|FG001|Overall Study|Adverse Event|1|||
13086251|NCT04025632|25803748|FG000|Overall Study|Withdrawal by Subject|1|||
13086252|NCT04025632|25803749|FG001|Overall Study|Withdrawal by Subject|1|||
13086253|NCT04025632|25803748|FG000|Overall Study|Study Terminated by Sponsor|10|||
13086254|NCT04025632|25803749|FG001|Overall Study|Study Terminated by Sponsor|9|||
13086255|NCT04025632|25803748|FG000|Overall Study|Physician Decision|3|||
13086256|NCT04025632|25803749|FG001|Overall Study|Physician Decision|1|||
13086257|NCT04024891|25803774|FG000|Overall Study|Pregnancy|0|||
13086258|NCT04024891|25803775|FG001|Overall Study|Pregnancy|1|||
13086259|NCT04024228|25803814|FG000|Overall Study|Adverse Event|1|||
13086260|NCT04024228|25803815|FG001|Overall Study|Adverse Event|0|||
13086261|NCT04024228|25803814|FG000|Overall Study|Protocol Deviation|0|||
13086262|NCT04024228|25803815|FG001|Overall Study|Protocol Deviation|2|||
13086263|NCT04024228|25803814|FG000|Overall Study|Withdrawal by Subject|3|||
13086264|NCT04024228|25803815|FG001|Overall Study|Withdrawal by Subject|4|||
13086265|NCT04023994|25803903|FG000|Overall Study|Lost to Follow-up|0|||
13086266|NCT04023994|25803904|FG001|Overall Study|Lost to Follow-up|1|||
13086267|NCT04023994|25803905|FG002|Overall Study|Lost to Follow-up|2|||
13086268|NCT04023994|25803906|FG003|Overall Study|Lost to Follow-up|0|||
13086269|NCT04023994|25803907|FG004|Overall Study|Lost to Follow-up|0|||
13086270|NCT04023994|25803908|FG005|Overall Study|Lost to Follow-up|0|||
13086271|NCT04023994|25803903|FG000|Overall Study|Withdrawal by Subject|0|||
13086272|NCT04023994|25803904|FG001|Overall Study|Withdrawal by Subject|0|||
13086273|NCT04023994|25803905|FG002|Overall Study|Withdrawal by Subject|0|||
13086274|NCT04023994|25803906|FG003|Overall Study|Withdrawal by Subject|1|||
13086275|NCT04023994|25803907|FG004|Overall Study|Withdrawal by Subject|0|||
13086276|NCT04023994|25803908|FG005|Overall Study|Withdrawal by Subject|0|||
13086277|NCT04023682|25803920|FG000|Overall Study|Clinical schedules did not allow continued participation|6|||
13086278|NCT04022733|25803933|FG000|Overall Study|conversion to open surgery|3|||
13086279|NCT04022733|25803934|FG001|Overall Study|conversion to open surgery|2|||
13086280|NCT04022733|25803933|FG000|Overall Study|bradycardia|0|||
13086281|NCT04022733|25803934|FG001|Overall Study|bradycardia|1|||
13086282|NCT04021524|25803949|FG000|Overall Study|Change in surgical intervention|0|||
13086283|NCT04021524|25803950|FG001|Overall Study|Change in surgical intervention|1|||
13086284|NCT04021290|25804013|FG000|Overall Study|Adverse Event|4|||
13086285|NCT04021290|25804014|FG001|Overall Study|Adverse Event|3|||
13086286|NCT04021290|25804013|FG000|Overall Study|Lack of Efficacy|0|||
13086287|NCT04021290|25804014|FG001|Overall Study|Lack of Efficacy|3|||
13086288|NCT04021290|25804013|FG000|Overall Study|Lost to Follow-up|2|||
13086289|NCT04021290|25804014|FG001|Overall Study|Lost to Follow-up|1|||
13086290|NCT04021290|25804013|FG000|Overall Study|Death|1|||
13086291|NCT04021290|25804014|FG001|Overall Study|Death|0|||
13086292|NCT04021290|25804013|FG000|Overall Study|Physician Decision|1|||
13086293|NCT04021290|25804014|FG001|Overall Study|Physician Decision|2|||
13086294|NCT04021290|25804013|FG000|Overall Study|Withdrawal by Subject|1|||
13086295|NCT04021290|25804014|FG001|Overall Study|Withdrawal by Subject|5|||
13086296|NCT04021290|25804013|FG000|Overall Study|Ongoing|89|||
13086297|NCT04021290|25804014|FG001|Overall Study|Ongoing|0|||
13086298|NCT04021290|25804013|FG000|Overall Study|Protocol Deviation|5|||
13086299|NCT04021290|25804014|FG001|Overall Study|Protocol Deviation|4|||
13086300|NCT04019054|25804043|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0|||
13086301|NCT04019054|25804044|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1|||
13086302|NCT04019054|25804043|FG000|Overall Study|Withdrawal by Subject|3|||
13086303|NCT04019054|25804044|FG001|Overall Study|Withdrawal by Subject|1|||
13086304|NCT04018612|25804109|FG000|Overall Study|Withdrawal by Subject|1|||
13086305|NCT04018612|25804110|FG001|Overall Study|Withdrawal by Subject|0|||
13086306|NCT04018612|25804111|FG002|Overall Study|Withdrawal by Subject|1|||
13086307|NCT04018066|25804122|FG000|Overall Study|participants started taking medications during the study period|3|||
13086308|NCT04018066|25804122|FG000|Overall Study|participant dropped out due to schedule conflicts.|1|||
13086309|NCT04017611|25804128|FG000|Overall Study|Withdrawn prior to completion|1|||
13086310|NCT04016779|25804183|FG000|Overall Study|Adverse Event|9|||
13086311|NCT04016779|25804184|FG001|Overall Study|Adverse Event|17|||
13086312|NCT04016779|25804183|FG000|Overall Study|Lack of Efficacy|4|||
13086313|NCT04016779|25804184|FG001|Overall Study|Lack of Efficacy|1|||
13086314|NCT04016779|25804183|FG000|Overall Study|Lost to Follow-up|5|||
13086315|NCT04016779|25804184|FG001|Overall Study|Lost to Follow-up|14|||
13086316|NCT04016779|25804183|FG000|Overall Study|Physician Decision|1|||
13086317|NCT04016779|25804184|FG001|Overall Study|Physician Decision|3|||
13086318|NCT04016779|25804183|FG000|Overall Study|Withdrawal by Subject|6|||
13086319|NCT04016779|25804184|FG001|Overall Study|Withdrawal by Subject|8|||
13086320|NCT04016779|25804183|FG000|Overall Study|Non-compliance with Study Drug|2|||
13086321|NCT04016779|25804184|FG001|Overall Study|Non-compliance with Study Drug|3|||
13086322|NCT04016779|25804183|FG000|Overall Study|Other, Multiple categories|17|||
13086323|NCT04016779|25804184|FG001|Overall Study|Other, Multiple categories|17|||
13086324|NCT04016311|25804201|FG000|Overall Study|Withdrawal by Subject|1|||
13086325|NCT04016311|25804202|FG001|Overall Study|Withdrawal by Subject|0|||
13086326|NCT04015518|25804271|FG000|Overall Study|Adverse Event|6|||
13086327|NCT04015518|25804272|FG001|Overall Study|Adverse Event|1|||
13086328|NCT04015518|25804273|FG002|Overall Study|Adverse Event|1|||
13086329|NCT04015518|25804274|FG003|Overall Study|Adverse Event|3|||
13086330|NCT04015518|25804275|FG004|Overall Study|Adverse Event|3|||
13086331|NCT04015518|25804271|FG000|Overall Study|Lack of Efficacy|1|||
13086332|NCT04015518|25804272|FG001|Overall Study|Lack of Efficacy|0|||
13086333|NCT04015518|25804273|FG002|Overall Study|Lack of Efficacy|1|||
13086334|NCT04015518|25804274|FG003|Overall Study|Lack of Efficacy|0|||
13086335|NCT04015518|25804275|FG004|Overall Study|Lack of Efficacy|4|||
13086336|NCT04015518|25804271|FG000|Overall Study|Lost to Follow-up|0|||
13086337|NCT04015518|25804272|FG001|Overall Study|Lost to Follow-up|0|||
13086338|NCT04015518|25804273|FG002|Overall Study|Lost to Follow-up|0|||
13086339|NCT04015518|25804274|FG003|Overall Study|Lost to Follow-up|0|||
13086340|NCT04015518|25804275|FG004|Overall Study|Lost to Follow-up|1|||
13086341|NCT04015518|25804271|FG000|Overall Study|Withdrawal by Subject|0|||
13086342|NCT04015518|25804272|FG001|Overall Study|Withdrawal by Subject|1|||
13086343|NCT04015518|25804273|FG002|Overall Study|Withdrawal by Subject|0|||
13086344|NCT04015518|25804274|FG003|Overall Study|Withdrawal by Subject|1|||
13086345|NCT04015518|25804275|FG004|Overall Study|Withdrawal by Subject|1|||
13086346|NCT04015518|25804271|FG000|Overall Study|Patient did not come for consecutive visits|0|||
13086347|NCT04015518|25804272|FG001|Overall Study|Patient did not come for consecutive visits|1|||
13086348|NCT04015518|25804273|FG002|Overall Study|Patient did not come for consecutive visits|0|||
13086349|NCT04015518|25804274|FG003|Overall Study|Patient did not come for consecutive visits|0|||
13086350|NCT04015518|25804275|FG004|Overall Study|Patient did not come for consecutive visits|0|||
13086351|NCT04015518|25804271|FG000|Overall Study|not willing to travel due to Covid-19|0|||
13086352|NCT04015518|25804272|FG001|Overall Study|not willing to travel due to Covid-19|0|||
13086353|NCT04015518|25804273|FG002|Overall Study|not willing to travel due to Covid-19|1|||
13086354|NCT04015518|25804274|FG003|Overall Study|not willing to travel due to Covid-19|0|||
13086355|NCT04015518|25804275|FG004|Overall Study|not willing to travel due to Covid-19|0|||
13086356|NCT04015518|25804271|FG000|Overall Study|Patient wants to discontinue treatment|0|||
13086357|NCT04015518|25804272|FG001|Overall Study|Patient wants to discontinue treatment|0|||
13086358|NCT04015518|25804273|FG002|Overall Study|Patient wants to discontinue treatment|0|||
13086359|NCT04015518|25804274|FG003|Overall Study|Patient wants to discontinue treatment|1|||
13086360|NCT04015518|25804275|FG004|Overall Study|Patient wants to discontinue treatment|0|||
13086361|NCT04015518|25804271|FG000|Overall Study|Difficult for patient to come to the hospital|0|||
13086362|NCT04015518|25804272|FG001|Overall Study|Difficult for patient to come to the hospital|0|||
13086363|NCT04015518|25804273|FG002|Overall Study|Difficult for patient to come to the hospital|0|||
13086364|NCT04015518|25804274|FG003|Overall Study|Difficult for patient to come to the hospital|0|||
13086365|NCT04015518|25804275|FG004|Overall Study|Difficult for patient to come to the hospital|1|||
13086366|NCT04015518|25804271|FG000|Overall Study|Pregnancy|0|||
13086367|NCT04015518|25804272|FG001|Overall Study|Pregnancy|0|||
13086368|NCT04015518|25804273|FG002|Overall Study|Pregnancy|0|||
13086369|NCT04015518|25804274|FG003|Overall Study|Pregnancy|0|||
13086370|NCT04015518|25804275|FG004|Overall Study|Pregnancy|1|||
13086371|NCT04015518|25804271|FG000|Overall Study|Personal reasons|1|||
13086372|NCT04015518|25804272|FG001|Overall Study|Personal reasons|0|||
13086373|NCT04015518|25804273|FG002|Overall Study|Personal reasons|0|||
13086374|NCT04015518|25804274|FG003|Overall Study|Personal reasons|0|||
13086375|NCT04015518|25804275|FG004|Overall Study|Personal reasons|1|||
13086376|NCT04015518|25804271|FG000|Overall Study|Withdrew consent|1|||
13086377|NCT04015518|25804272|FG001|Overall Study|Withdrew consent|0|||
13086378|NCT04015518|25804273|FG002|Overall Study|Withdrew consent|0|||
13086379|NCT04015518|25804274|FG003|Overall Study|Withdrew consent|0|||
13086380|NCT04015518|25804275|FG004|Overall Study|Withdrew consent|0|||
13086381|NCT04015518|25804271|FG000|Overall Study|Prostate carcinoma|1|||
13086382|NCT04015518|25804272|FG001|Overall Study|Prostate carcinoma|0|||
13086383|NCT04015518|25804273|FG002|Overall Study|Prostate carcinoma|0|||
13086384|NCT04015518|25804274|FG003|Overall Study|Prostate carcinoma|0|||
13086385|NCT04015518|25804275|FG004|Overall Study|Prostate carcinoma|0|||
13086386|NCT04015518|25804271|FG000|Overall Study|Could not keep appointments due to work|1|||
13086387|NCT04015518|25804272|FG001|Overall Study|Could not keep appointments due to work|0|||
13086388|NCT04015518|25804273|FG002|Overall Study|Could not keep appointments due to work|0|||
13086389|NCT04015518|25804274|FG003|Overall Study|Could not keep appointments due to work|0|||
13086390|NCT04015518|25804275|FG004|Overall Study|Could not keep appointments due to work|0|||
13086391|NCT04015232|25804352|FG000|Overall Study|Withdrawal by Subject|7|||
13086392|NCT04015232|25804353|FG001|Overall Study|Withdrawal by Subject|4|||
13086393|NCT04015232|25804352|FG000|Overall Study|Protocol Violation|1|||
13086394|NCT04015232|25804353|FG001|Overall Study|Protocol Violation|0|||
13086395|NCT04015232|25804352|FG000|Overall Study|Medical Grounds|3|||
13086396|NCT04015232|25804353|FG001|Overall Study|Medical Grounds|3|||
13086397|NCT04014075|25804364|FG000|Overall Study|Progressive Disease|39|||
13086398|NCT04014075|25804364|FG000|Overall Study|Adverse Event|9|||
13086399|NCT04014075|25804364|FG000|Overall Study|Clinical Progression|2|||
13086400|NCT04014075|25804364|FG000|Overall Study|Death|2|||
13086401|NCT04014075|25804364|FG000|Overall Study|Withdrawal by Subject|2|||
13086402|NCT04014075|25804364|FG000|Overall Study|Miscellaneous|1|||
13086403|NCT04014075|25804364|FG000|Overall Study|Physician Decision|1|||
13086404|NCT04014062|25804409|FG000|Period I: Dosing|Medical Grounds|4|||
13086405|NCT04014062|25804410|FG001|Period I: Dosing|Medical Grounds|5|||
13086406|NCT04014062|25804409|FG000|Period I: Dosing|Withdrawal by Subject|3|||
13086407|NCT04014062|25804410|FG001|Period I: Dosing|Withdrawal by Subject|1|||
13086408|NCT04013529|25804431|FG000|Overall Study|Withdrawal by Subject|1|||
13086409|NCT04013529|25804432|FG001|Overall Study|Withdrawal by Subject|1|||
13086410|NCT04013191|25804465|FG000|Overall Study|Adverse Event|1|||
13086411|NCT04013191|25804466|FG001|Overall Study|Adverse Event|0|||
13086412|NCT04011735|25804501|FG000|Overall Study|Withdrawal by Subject|1|||
13086413|NCT04011735|25804502|FG001|Overall Study|Withdrawal by Subject|0|||
13086414|NCT04011735|25804503|FG002|Overall Study|Withdrawal by Subject|1|||
13086415|NCT04011735|25804501|FG000|Overall Study|Met exclusion criteria after study entry|0|||
13086416|NCT04011735|25804502|FG001|Overall Study|Met exclusion criteria after study entry|1|||
13086417|NCT04011735|25804503|FG002|Overall Study|Met exclusion criteria after study entry|0|||
13086418|NCT04009824|25804591|FG000|Overall Study|COVID-19 pandemic restriction/closure|2|||
13086419|NCT04009824|25804592|FG001|Overall Study|COVID-19 pandemic restriction/closure|3|||
13086420|NCT04009824|25804593|FG002|Overall Study|COVID-19 pandemic restriction/closure|5|||
13086421|NCT04009824|25804594|FG003|Overall Study|COVID-19 pandemic restriction/closure|2|||
13086422|NCT04009824|25804595|FG004|Overall Study|COVID-19 pandemic restriction/closure|3|||
13086423|NCT04009629|25804614|FG000|Overall Study|Withdrawal by Subject|2|||
13086424|NCT04009629|25804615|FG001|Overall Study|Withdrawal by Subject|0|||
13086425|NCT04009577|25804661|FG000|Core Study|Adverse Event|1|||
13086426|NCT04009577|25804662|FG001|Core Study|Adverse Event|0|||
13086427|NCT04009577|25804663|FG002|Core Study|Adverse Event|2|||
13086428|NCT04009577|25804664|FG003|Core Study|Adverse Event|4|||
13086429|NCT04009577|25804661|FG000|Core Study|Withdrawal by Subject|0|||
13086430|NCT04009577|25804662|FG001|Core Study|Withdrawal by Subject|0|||
13086431|NCT04009577|25804663|FG002|Core Study|Withdrawal by Subject|2|||
13086432|NCT04009577|25804664|FG003|Core Study|Withdrawal by Subject|0|||
13086433|NCT04009577|25804661|FG000|Core Study|Other|0|||
13086434|NCT04009577|25804662|FG001|Core Study|Other|0|||
13086435|NCT04009577|25804663|FG002|Core Study|Other|0|||
13086436|NCT04009577|25804664|FG003|Core Study|Other|1|||
13086437|NCT04009577|25804661|FG000|Extension Phase|Adverse Event|0|||
13086438|NCT04009577|25804662|FG001|Extension Phase|Adverse Event|0|||
13086439|NCT04009577|25804663|FG002|Extension Phase|Adverse Event|0|||
13086440|NCT04009577|25804664|FG003|Extension Phase|Adverse Event|1|||
13086441|NCT04009577|25804661|FG000|Extension Phase|Inadequate therapeutic effect|0|||
13086442|NCT04009577|25804662|FG001|Extension Phase|Inadequate therapeutic effect|0|||
13086443|NCT04009577|25804663|FG002|Extension Phase|Inadequate therapeutic effect|1|||
13086444|NCT04009577|25804664|FG003|Extension Phase|Inadequate therapeutic effect|0|||
13086445|NCT04009577|25804661|FG000|Extension Phase|Withdrawal by Subject|0|||
13086446|NCT04009577|25804662|FG001|Extension Phase|Withdrawal by Subject|0|||
13086447|NCT04009577|25804663|FG002|Extension Phase|Withdrawal by Subject|1|||
13086448|NCT04009577|25804664|FG003|Extension Phase|Withdrawal by Subject|0|||
13086449|NCT04009577|25804661|FG000|Extension Phase|Not Treated|0|||
13086450|NCT04009577|25804662|FG001|Extension Phase|Not Treated|0|||
13086451|NCT04009577|25804663|FG002|Extension Phase|Not Treated|2|||
13086452|NCT04009577|25804664|FG003|Extension Phase|Not Treated|0|||
13086453|NCT04007367|25804694|FG000|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|43|||
13086454|NCT04007367|25804695|FG001|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
13086455|NCT04007367|25804696|FG002|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
13086456|NCT04007367|25804694|FG000|Open-Label Phase (8-Weeks)|Adverse Event|2|||
13086457|NCT04007367|25804695|FG001|Open-Label Phase (8-Weeks)|Adverse Event|0|||
13086458|NCT04007367|25804696|FG002|Open-Label Phase (8-Weeks)|Adverse Event|0|||
13086459|NCT04007367|25804694|FG000|Open-Label Phase (8-Weeks)|Withdrawal by Participant|2|||
13086460|NCT04007367|25804695|FG001|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
13086461|NCT04007367|25804696|FG002|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
13086462|NCT04007367|25804694|FG000|Open-Label Phase (8-Weeks)|Non-compliance|1|||
13086463|NCT04007367|25804695|FG001|Open-Label Phase (8-Weeks)|Non-compliance|0|||
13086464|NCT04007367|25804696|FG002|Open-Label Phase (8-Weeks)|Non-compliance|0|||
13086465|NCT04007367|25804694|FG000|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
13086466|NCT04007367|25804695|FG001|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
13086467|NCT04007367|25804696|FG002|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|2|||
13086468|NCT04007159|25804713|FG000|Induction Phase|(missed study visits)|16|||
13086469|NCT04007159|25804713|FG000|Induction Phase|Withdrawal by Subject|4|||
13086470|NCT04007159|25804713|FG000|Induction Phase|Adverse Event|2|||
13086471|NCT04007159|25804713|FG000|Challenge Phase|missed study visits|3|||
13086472|NCT04007107|25804723|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
13086473|NCT04007107|25804724|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1|||
13086474|NCT04007107|25804725|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
13086475|NCT04007107|25804726|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
13086476|NCT04006366|25804734|FG000|Overall Study|Withdrawal by Subject|1|||
13086477|NCT04006171|25804776|FG000|Overall Study|Withdrawal by Subject|8|||
13086478|NCT04006171|25804777|FG001|Overall Study|Withdrawal by Subject|7|||
13086479|NCT04006171|25804776|FG000|Overall Study|missing serum samples|2|||
13086480|NCT04006171|25804777|FG001|Overall Study|missing serum samples|2|||
13086481|NCT04006171|25804776|FG000|Overall Study|insufficient sample volume|2|||
13086482|NCT04006171|25804777|FG001|Overall Study|insufficient sample volume|3|||
13086483|NCT04006145|25804790|FG000|Overall Study|Lost to Follow-up|0|||
13086484|NCT04006145|25804791|FG001|Overall Study|Lost to Follow-up|1|||
13086485|NCT04006145|25804790|FG000|Overall Study|Other|1|||
13086486|NCT04006145|25804791|FG001|Overall Study|Other|2|||
13086487|NCT04005885|25804838|FG000|First Intervention|Withdrawal by Subject|1|||
13086488|NCT04005885|25804839|FG001|First Intervention|Withdrawal by Subject|1|||
13086489|NCT04005885|25804838|FG000|Second Intervention|Withdrawal by Subject|0|||
13086490|NCT04005885|25804839|FG001|Second Intervention|Withdrawal by Subject|2|||
13086491|NCT04005755|25804874|FG000|Overall Study|Adverse Event|6|||
13086492|NCT04005755|25804874|FG000|Overall Study|Physician Decision|3|||
13086493|NCT04005755|25804874|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4|||
13086494|NCT04005755|25804874|FG000|Overall Study|Withdrawal by Subject|3|||
13086495|NCT04005755|25804874|FG000|Overall Study|Lost to Follow-up|1|||
13086496|NCT04004260|25804903|FG000|Overall Study|Withdrawal by Subject|7|||
13086497|NCT04004260|25804904|FG001|Overall Study|Withdrawal by Subject|3|||
13086498|NCT04004260|25804903|FG000|Overall Study|Lost to Follow-up|22|||
13086499|NCT04004260|25804904|FG001|Overall Study|Lost to Follow-up|12|||
13086500|NCT04004260|25804903|FG000|Overall Study|Did not engage in intervention|13|||
13086501|NCT04004260|25804904|FG001|Overall Study|Did not engage in intervention|17|||
13086502|NCT04004208|25804938|FG000|Overall Study|Withdrawal by parent/guardian|1|||
13086503|NCT04004208|25804939|FG001|Overall Study|Withdrawal by parent/guardian|1|||
13086504|NCT04004208|25804938|FG000|Overall Study|Death|3|||
13086505|NCT04004208|25804939|FG001|Overall Study|Death|0|||
13086506|NCT04004208|25804938|FG000|Overall Study|COVID-19 pandemic|1|||
13086507|NCT04004208|25804939|FG001|Overall Study|COVID-19 pandemic|0|||
13086508|NCT04004208|25804938|FG000|Overall Study|Physician Decision|1|||
13086509|NCT04004208|25804939|FG001|Overall Study|Physician Decision|0|||
13086510|NCT04004208|25804938|FG000|Overall Study|Adverse Event|1|||
13086511|NCT04004208|25804939|FG001|Overall Study|Adverse Event|1|||
13086512|NCT04003623|25804962|FG000|Overall Study|Withdrawal by Subject|1|||
13086513|NCT04003623|25804963|FG001|Overall Study|Withdrawal by Subject|0|||
13086514|NCT04003610|25805005|FG000|Overall Study|Lost to Follow-up|0|||
13086515|NCT04003610|25805006|FG001|Overall Study|Lost to Follow-up|1|||
13086516|NCT04003610|25805007|FG002|Overall Study|Lost to Follow-up|0|||
13086517|NCT04003610|25805005|FG000|Overall Study|Death|0|||
13086518|NCT04003610|25805006|FG001|Overall Study|Death|0|||
13086519|NCT04003610|25805007|FG002|Overall Study|Death|3|||
13086520|NCT04003610|25805005|FG000|Overall Study|Study Terminated by Sponsor|0|||
13086521|NCT04003610|25805006|FG001|Overall Study|Study Terminated by Sponsor|0|||
13086522|NCT04003610|25805007|FG002|Overall Study|Study Terminated by Sponsor|3|||
13132493|NCT02790606|25984056|FG000|Overall Study|Death|27|||
13086523|NCT04003155|25805074|FG000|Double-Blind (DB) Period (12 Weeks)|Adverse Event|9|||
13086524|NCT04003155|25805075|FG001|Double-Blind (DB) Period (12 Weeks)|Adverse Event|8|||
13086525|NCT04003155|25805076|FG002|Double-Blind (DB) Period (12 Weeks)|Adverse Event|5|||
13086526|NCT04003155|25805077|FG003|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
13086527|NCT04003155|25805078|FG004|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
13086528|NCT04003155|25805074|FG000|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|3|||
13086529|NCT04003155|25805075|FG001|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
13086530|NCT04003155|25805076|FG002|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
13086531|NCT04003155|25805077|FG003|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
13086532|NCT04003155|25805078|FG004|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
13086533|NCT04003155|25805074|FG000|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|1|||
13086534|NCT04003155|25805075|FG001|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
13086535|NCT04003155|25805076|FG002|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
13086536|NCT04003155|25805077|FG003|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
13086537|NCT04003155|25805078|FG004|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
13086538|NCT04003155|25805074|FG000|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|9|||
13086539|NCT04003155|25805075|FG001|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|12|||
13086540|NCT04003155|25805076|FG002|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
13086541|NCT04003155|25805077|FG003|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
13086542|NCT04003155|25805078|FG004|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
13086543|NCT04003155|25805074|FG000|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|1|||
13086544|NCT04003155|25805075|FG001|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|7|||
13086545|NCT04003155|25805076|FG002|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|3|||
13086546|NCT04003155|25805077|FG003|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
13086547|NCT04003155|25805078|FG004|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
13086548|NCT04003155|25805074|FG000|Extension Period (EP) (40 Weeks)|Adverse Event|0|||
13086549|NCT04003155|25805075|FG001|Extension Period (EP) (40 Weeks)|Adverse Event|5|||
13086550|NCT04003155|25805076|FG002|Extension Period (EP) (40 Weeks)|Adverse Event|4|||
13086551|NCT04003155|25805077|FG003|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
13086552|NCT04003155|25805078|FG004|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
13086553|NCT04003155|25805074|FG000|Extension Period (EP) (40 Weeks)|Lost to Follow-up|0|||
13086554|NCT04003155|25805075|FG001|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
13086555|NCT04003155|25805076|FG002|Extension Period (EP) (40 Weeks)|Lost to Follow-up|3|||
13086556|NCT04003155|25805077|FG003|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
13086557|NCT04003155|25805078|FG004|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
13086558|NCT04003155|25805074|FG000|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|0|||
13086559|NCT04003155|25805075|FG001|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|12|||
13086560|NCT04003155|25805076|FG002|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|7|||
13086561|NCT04003155|25805077|FG003|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|9|||
13086562|NCT04003155|25805078|FG004|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|5|||
13086563|NCT04003155|25805074|FG000|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
13086564|NCT04003155|25805075|FG001|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
13086565|NCT04003155|25805076|FG002|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
13086566|NCT04003155|25805077|FG003|Extension Period (EP) (40 Weeks)|Miscellaneous|2|||
13086567|NCT04003155|25805078|FG004|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
13086568|NCT04002960|25805084|FG000|Overall Study|Withdrawn prior to Completion|2|||
13086569|NCT04002648|25805099|FG000|Overall Study|Lost to Follow-up|2|||
13086570|NCT04002648|25805100|FG001|Overall Study|Lost to Follow-up|0|||
13086571|NCT04000815|25805124|FG000|Overall Study|Lost to Follow-up|9|||
13086572|NCT04000815|25805125|FG001|Overall Study|Lost to Follow-up|2|||
13086573|NCT04000815|25805126|FG002|Overall Study|Lost to Follow-up|3|||
13086574|NCT04000815|25805124|FG000|Overall Study|Withdrawal by Subject|4|||
13086575|NCT04000815|25805125|FG001|Overall Study|Withdrawal by Subject|3|||
13086576|NCT04000815|25805126|FG002|Overall Study|Withdrawal by Subject|2|||
13086577|NCT04000815|25805124|FG000|Overall Study|Right ovarian cyst occured|1|||
13086578|NCT04000815|25805125|FG001|Overall Study|Right ovarian cyst occured|0|||
13086579|NCT04000815|25805126|FG002|Overall Study|Right ovarian cyst occured|0|||
13086580|NCT04000815|25805124|FG000|Overall Study|Hypertension occured on follow up|0|||
13086581|NCT04000815|25805125|FG001|Overall Study|Hypertension occured on follow up|0|||
13086582|NCT04000815|25805126|FG002|Overall Study|Hypertension occured on follow up|2|||
13086583|NCT04000581|25805159|FG000|Overall Study|Withdrawal by Subject|0|||
13086584|NCT04000581|25805160|FG001|Overall Study|Withdrawal by Subject|1|||
13086585|NCT04000165|25805180|FG000|Overall Study|Physician Decision|1|||
13086586|NCT04000165|25805180|FG000|Overall Study|Withdrawal by Subject|1|||
13086587|NCT04000009|25805186|FG000|Overall Study|Adverse Event|13|||
13086588|NCT04000009|25805186|FG000|Overall Study|Lack of Efficacy|7|||
13086589|NCT04000009|25805186|FG000|Overall Study|Lost to Follow-up|8|||
13086590|NCT04000009|25805186|FG000|Overall Study|Noncompliance with study drug|4|||
13086591|NCT04000009|25805186|FG000|Overall Study|Physician Decision|1|||
13086592|NCT04000009|25805186|FG000|Overall Study|Use of prohibited medication|3|||
13086593|NCT04000009|25805186|FG000|Overall Study|Pregnancy|1|||
13086594|NCT04000009|25805186|FG000|Overall Study|Withdrawal by Subject|22|||
13086595|NCT04000009|25805186|FG000|Overall Study|Study terminated by sponsor|98|||
13086596|NCT04000009|25805186|FG000|Overall Study|Not further specified|8|||
13086597|NCT03999892|25805192|FG000|Overall Study|Lost to Follow-up|1|||
13086598|NCT03999554|25805245|FG000|Overall Study|Lost to Follow-up|4|||
13086599|NCT03999554|25805246|FG001|Overall Study|Lost to Follow-up|5|||
13086600|NCT03999554|25805247|FG002|Overall Study|Lost to Follow-up|4|||
13086601|NCT03999554|25805248|FG003|Overall Study|Lost to Follow-up|5|||
13086602|NCT03999554|25805249|FG004|Overall Study|Lost to Follow-up|8|||
13086603|NCT03999554|25805245|FG000|Overall Study|Protocol Violation|0|||
13086604|NCT03999554|25805246|FG001|Overall Study|Protocol Violation|0|||
13086605|NCT03999554|25805247|FG002|Overall Study|Protocol Violation|5|||
13086606|NCT03999554|25805248|FG003|Overall Study|Protocol Violation|0|||
13086607|NCT03999554|25805249|FG004|Overall Study|Protocol Violation|0|||
13086608|NCT03999554|25805245|FG000|Overall Study|Pregnancy|0|||
13086609|NCT03999554|25805246|FG001|Overall Study|Pregnancy|0|||
13086610|NCT03999554|25805247|FG002|Overall Study|Pregnancy|1|||
13086611|NCT03999554|25805248|FG003|Overall Study|Pregnancy|0|||
13086612|NCT03999554|25805249|FG004|Overall Study|Pregnancy|0|||
13086613|NCT03999554|25805245|FG000|Overall Study|Withdrawal by Subject|2|||
13086614|NCT03999554|25805246|FG001|Overall Study|Withdrawal by Subject|2|||
13086615|NCT03999554|25805247|FG002|Overall Study|Withdrawal by Subject|2|||
13086616|NCT03999554|25805248|FG003|Overall Study|Withdrawal by Subject|1|||
13086617|NCT03999554|25805249|FG004|Overall Study|Withdrawal by Subject|1|||
13086618|NCT03999554|25805245|FG000|Overall Study|failure to comply with protocol requirements|0|||
13086619|NCT03999554|25805246|FG001|Overall Study|failure to comply with protocol requirements|0|||
13086620|NCT03999554|25805247|FG002|Overall Study|failure to comply with protocol requirements|0|||
13086621|NCT03999554|25805248|FG003|Overall Study|failure to comply with protocol requirements|1|||
13086622|NCT03999554|25805249|FG004|Overall Study|failure to comply with protocol requirements|0|||
13086623|NCT03998189|25805270|FG000|Overall Study|Lack of Efficacy|0|||
13086624|NCT03998189|25805271|FG001|Overall Study|Lack of Efficacy|1|||
13086625|NCT03997825|25805282|FG000|Overall Study|Death|3|||
13086626|NCT03997825|25805282|FG000|Overall Study|Lost to Follow-up|10|||
13086627|NCT03997825|25805282|FG000|Overall Study|Withdrawal by Subject|3|||
13086628|NCT03997825|25805282|FG000|Overall Study|Refused participation|1|||
13086629|NCT03996694|25805321|FG000|First Washout (7 Days)|positive urine drug screen|0|||
13086630|NCT03996694|25805322|FG001|First Washout (7 Days)|positive urine drug screen|0|||
13086631|NCT03996694|25805323|FG002|First Washout (7 Days)|positive urine drug screen|1|||
13086632|NCT03996694|25805324|FG003|First Washout (7 Days)|positive urine drug screen|0|||
13086633|NCT03996694|25805325|FG004|First Washout (7 Days)|positive urine drug screen|0|||
13086634|NCT03996694|25805326|FG005|First Washout (7 Days)|positive urine drug screen|0|||
13086635|NCT03996694|25805321|FG000|First Washout (7 Days)|Adverse Event|0|||
13086636|NCT03996694|25805322|FG001|First Washout (7 Days)|Adverse Event|1|||
13086637|NCT03996694|25805323|FG002|First Washout (7 Days)|Adverse Event|0|||
13086638|NCT03996694|25805324|FG003|First Washout (7 Days)|Adverse Event|0|||
13086639|NCT03996694|25805325|FG004|First Washout (7 Days)|Adverse Event|0|||
13086640|NCT03996694|25805326|FG005|First Washout (7 Days)|Adverse Event|0|||
13086641|NCT03996694|25805321|FG000|First Washout (7 Days)|Lost to Follow-up|0|||
13086642|NCT03996694|25805322|FG001|First Washout (7 Days)|Lost to Follow-up|0|||
13086643|NCT03996694|25805323|FG002|First Washout (7 Days)|Lost to Follow-up|1|||
13086644|NCT03996694|25805324|FG003|First Washout (7 Days)|Lost to Follow-up|0|||
13086645|NCT03996694|25805325|FG004|First Washout (7 Days)|Lost to Follow-up|0|||
13086646|NCT03996694|25805326|FG005|First Washout (7 Days)|Lost to Follow-up|0|||
13086647|NCT03996694|25805321|FG000|Third Washout (7 Days)|Withdrawal by Subject|0|||
13086648|NCT03996694|25805322|FG001|Third Washout (7 Days)|Withdrawal by Subject|0|||
13086649|NCT03996694|25805323|FG002|Third Washout (7 Days)|Withdrawal by Subject|0|||
13086650|NCT03996694|25805324|FG003|Third Washout (7 Days)|Withdrawal by Subject|0|||
13086651|NCT03996694|25805325|FG004|Third Washout (7 Days)|Withdrawal by Subject|1|||
13086652|NCT03996694|25805326|FG005|Third Washout (7 Days)|Withdrawal by Subject|0|||
13086653|NCT03995784|25805349|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1|||
13086654|NCT03995355|25805372|FG000|Overall Study|Adverse Event|1|||
13086655|NCT03995355|25805373|FG001|Overall Study|Adverse Event|0|||
13086656|NCT03995355|25805372|FG000|Overall Study|Withdrawal by Subject|1|||
13086657|NCT03995355|25805373|FG001|Overall Study|Withdrawal by Subject|0|||
13086658|NCT03995355|25805372|FG000|Overall Study|Scheduling Issues|0|||
13086659|NCT03995355|25805373|FG001|Overall Study|Scheduling Issues|1|||
13086660|NCT03994120|25805396|FG000|Overall Study|Lost to Follow-up|3|||
13086661|NCT03994120|25805397|FG001|Overall Study|Lost to Follow-up|1|||
13086662|NCT03993392|25805410|FG000|Overall Study|Withdrawal by Subject|3|||
13086663|NCT03993392|25805410|FG000|Overall Study|Lost to Follow-up|2|||
13086664|NCT03993392|25805410|FG000|Overall Study|Did not meet Day 1 check-in criteria|1|||
13086665|NCT03993379|25805441|FG000|Overall Study|The study was terminated early due to business decision.|0|||
13086666|NCT03993379|25805442|FG001|Overall Study|The study was terminated early due to business decision.|2|||
13086667|NCT03993379|25805443|FG002|Overall Study|The study was terminated early due to business decision.|0|||
13086668|NCT03993379|25805444|FG003|Overall Study|The study was terminated early due to business decision.|0|||
13086669|NCT03993379|25805441|FG000|Overall Study|Withdrawal by Subject|0|||
13086670|NCT03993379|25805442|FG001|Overall Study|Withdrawal by Subject|1|||
13086671|NCT03993379|25805443|FG002|Overall Study|Withdrawal by Subject|0|||
13086672|NCT03993379|25805444|FG003|Overall Study|Withdrawal by Subject|0|||
13086673|NCT03993288|25805467|FG000|Overall Study|Lost to Follow-up|2|||
13086674|NCT03993288|25805468|FG001|Overall Study|Lost to Follow-up|1|||
13086675|NCT03993288|25805467|FG000|Overall Study|non-compliance to the inclusion criteria|0|||
13086676|NCT03993288|25805468|FG001|Overall Study|non-compliance to the inclusion criteria|1|||
13086677|NCT03993288|25805467|FG000|Overall Study|wrong randomization|0|||
13086678|NCT03993288|25805468|FG001|Overall Study|wrong randomization|1|||
13086679|NCT03993288|25805467|FG000|Overall Study|improper enrollment|0|||
13086680|NCT03993288|25805468|FG001|Overall Study|improper enrollment|1|||
13086681|NCT03993288|25805467|FG000|Overall Study|prescribed with prohibited concomitant therapy|1|||
13086682|NCT03993288|25805468|FG001|Overall Study|prescribed with prohibited concomitant therapy|0|||
13086683|NCT03993288|25805467|FG000|Overall Study|developed SAE|2|||
13086684|NCT03993288|25805468|FG001|Overall Study|developed SAE|0|||
13086685|NCT03993288|25805467|FG000|Overall Study|consent withdrawal|1|||
13086686|NCT03993288|25805468|FG001|Overall Study|consent withdrawal|0|||
13086687|NCT03993288|25805467|FG000|Overall Study|did not follow the treatment schedule|1|||
13086688|NCT03993288|25805468|FG001|Overall Study|did not follow the treatment schedule|0|||
13086689|NCT03993288|25805467|FG000|Overall Study|did not follow the treatment regimen|1|||
13086690|NCT03993288|25805468|FG001|Overall Study|did not follow the treatment regimen|0|||
13086691|NCT03993288|25805467|FG000|Overall Study|Adverse Event|1|||
13086692|NCT03993288|25805468|FG001|Overall Study|Adverse Event|0|||
13086693|NCT03993288|25805467|FG000|Overall Study|Withdrawal by Subject|1|||
13086694|NCT03993288|25805468|FG001|Overall Study|Withdrawal by Subject|1|||
13132494|NCT02790606|25984056|FG000|Overall Study|Lost to Follow-up|4|||
13132495|NCT02790606|25984056|FG000|Overall Study|Physician Decision|3|||
13132496|NCT02790606|25984056|FG000|Overall Study|Withdrawal by Subject|1|||
13132497|NCT02790437|25984090|FG000|Overall Study|Patient graft failure - nephrectomy|1|||
13132498|NCT02790437|25984091|FG001|Overall Study|Patient graft failure - nephrectomy|0|||
13132499|NCT02790437|25984090|FG000|Overall Study|Adverse Event|1|||
13132500|NCT02790437|25984091|FG001|Overall Study|Adverse Event|0|||
13132501|NCT02790437|25984090|FG000|Overall Study|Withdrawal by Subject|1|||
13132502|NCT02790437|25984091|FG001|Overall Study|Withdrawal by Subject|0|||
13132503|NCT02790073|25984099|FG000|Overall Study|Death|1|||
13132504|NCT02790073|25984099|FG000|Overall Study|Withdrawal from HD|1|||
13132505|NCT02790073|25984099|FG000|Overall Study|Withdrawal by Subject|1|||
13132506|NCT02789657|25984125|FG000|Overall Study|Withdrawal by Subject|2|||
13132507|NCT02789657|25984126|FG001|Overall Study|Withdrawal by Subject|0|||
13132508|NCT02789657|25984127|FG002|Overall Study|Withdrawal by Subject|0|||
13132509|NCT02789657|25984128|FG003|Overall Study|Withdrawal by Subject|0|||
13132510|NCT02789176|25984163|FG000|Overall Study|Death|0|||
13132511|NCT02789176|25984164|FG001|Overall Study|Death|0|||
13132512|NCT02789176|25984165|FG002|Overall Study|Death|3|||
13132513|NCT02789176|25984166|FG003|Overall Study|Death|0|||
13132514|NCT02789176|25984163|FG000|Overall Study|Withdrawal by Subject|0|||
13132515|NCT02789176|25984164|FG001|Overall Study|Withdrawal by Subject|0|||
13132516|NCT02789176|25984165|FG002|Overall Study|Withdrawal by Subject|1|||
13132517|NCT02789176|25984166|FG003|Overall Study|Withdrawal by Subject|0|||
13132518|NCT02789176|25984163|FG000|Overall Study|Lost to Follow-up|8|||
13132519|NCT02789176|25984164|FG001|Overall Study|Lost to Follow-up|2|||
13132520|NCT02789176|25984165|FG002|Overall Study|Lost to Follow-up|6|||
13132521|NCT02789176|25984166|FG003|Overall Study|Lost to Follow-up|1|||
13132522|NCT02789137|25984208|FG000|Overall Study|Dropped out/Died|58|||
13132523|NCT02789111|25984223|FG000|Overall Study|Withdrawal by Subject|1|||
13132524|NCT02789111|25984224|FG001|Overall Study|Withdrawal by Subject|4|||
13132525|NCT02788747|25984302|FG000|Overall Study|Adverse Event|1|||
13132526|NCT02788747|25984303|FG001|Overall Study|Adverse Event|0|||
13132527|NCT02788747|25984304|FG002|Overall Study|Adverse Event|0|||
13132528|NCT02788656|25984331|FG000|Overall Study|Withdrawal by Subject|1|||
13132529|NCT02788656|25984332|FG001|Overall Study|Withdrawal by Subject|0|||
13132530|NCT02788513|25984370|FG000|Overall Study|Withdrawal by Subject|3|||
13132531|NCT02788513|25984371|FG001|Overall Study|Withdrawal by Subject|0|||
13132532|NCT02788513|25984372|FG002|Overall Study|Withdrawal by Subject|2|||
13132533|NCT02788513|25984373|FG003|Overall Study|Withdrawal by Subject|3|||
13132534|NCT02788513|25984374|FG004|Overall Study|Withdrawal by Subject|1|||
13132535|NCT02788513|25984370|FG000|Overall Study|Lost to Follow-up|1|||
13132536|NCT02788513|25984371|FG001|Overall Study|Lost to Follow-up|0|||
13132537|NCT02788513|25984372|FG002|Overall Study|Lost to Follow-up|0|||
13132538|NCT02788513|25984373|FG003|Overall Study|Lost to Follow-up|0|||
13132539|NCT02788513|25984374|FG004|Overall Study|Lost to Follow-up|1|||
13132540|NCT02788513|25984370|FG000|Overall Study|Adverse Event|5|||
13132541|NCT02788513|25984371|FG001|Overall Study|Adverse Event|8|||
13086695|NCT03991494|25805496|FG000|Overall Study|Progressive Disease|4|||
13086696|NCT03990649|25805525|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
13086697|NCT03990649|25805526|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1|||
13086698|NCT03990649|25805527|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
13086699|NCT03990649|25805525|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
13086700|NCT03990649|25805526|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1|||
13086701|NCT03990649|25805527|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
13086702|NCT03990649|25805525|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2|||
13086703|NCT03990649|25805526|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
13086704|NCT03990649|25805527|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
13086705|NCT03990649|25805525|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
13086706|NCT03990649|25805526|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
13086707|NCT03990649|25805527|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0|||
13086708|NCT03990649|25805525|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
13086709|NCT03990649|25805526|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
13086710|NCT03990649|25805527|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1|||
13086711|NCT03990649|25805525|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
13086712|NCT03990649|25805526|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
13086713|NCT03990649|25805527|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2|||
13086714|NCT03990649|25805525|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
13086715|NCT03990649|25805526|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
13086716|NCT03990649|25805527|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1|||
13086717|NCT03990389|25805550|FG000|Overall Study|Lost to Follow-up|3|||
13086718|NCT03990389|25805551|FG001|Overall Study|Lost to Follow-up|0|||
13086719|NCT03989232|25805584|FG000|Overall Study|Lost to Follow-up|3|||
13086720|NCT03989232|25805585|FG001|Overall Study|Lost to Follow-up|10|||
13086721|NCT03989232|25805584|FG000|Overall Study|Withdrawal by Subject|6|||
13086722|NCT03989232|25805585|FG001|Overall Study|Withdrawal by Subject|6|||
13086723|NCT03989232|25805584|FG000|Overall Study|Death|1|||
13086724|NCT03989232|25805585|FG001|Overall Study|Death|2|||
13086725|NCT03988907|25805624|FG000|Overall Study|Unable to complete visit|0|||
13086726|NCT03988907|25805625|FG001|Overall Study|Unable to complete visit|1|||
13086727|NCT03988842|25805642|FG000|Overall Study|Death|1|||
13086728|NCT03988803|25805657|FG000|Period 2|Prematurely discontinued from medication|2|||
13086729|NCT03988803|25805657|FG000|Period 2|Adverse Event|1|||
13086730|NCT03988166|25805670|FG000|Overall Study|Lost to Follow-up|2|||
13086731|NCT03988166|25805670|FG000|Overall Study|Death|1|||
13086732|NCT03988088|25805689|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
13086733|NCT03988088|25805690|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1|||
13086734|NCT03988088|25805691|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
13086735|NCT03988088|25805692|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
13086736|NCT03988088|25805689|FG000|Open-Label Addendum|Lost to Follow-up|0|||
13086737|NCT03988088|25805690|FG001|Open-Label Addendum|Lost to Follow-up|0|||
13086738|NCT03988088|25805691|FG002|Open-Label Addendum|Lost to Follow-up|1|||
13086739|NCT03988088|25805692|FG003|Open-Label Addendum|Lost to Follow-up|0|||
13086740|NCT03988023|25805707|FG000|Overall Study|Non-compliance|3|||
13086741|NCT03988023|25805708|FG001|Overall Study|Non-compliance|0|||
13086742|NCT03988023|25805707|FG000|Overall Study|Withdrawal by Subject|39|||
13086743|NCT03988023|25805708|FG001|Overall Study|Withdrawal by Subject|37|||
13086744|NCT03988023|25805707|FG000|Overall Study|Adverse Event|0|||
13086745|NCT03988023|25805708|FG001|Overall Study|Adverse Event|2|||
13086746|NCT03988023|25805707|FG000|Overall Study|Physician Decision|0|||
13086747|NCT03988023|25805708|FG001|Overall Study|Physician Decision|1|||
13086748|NCT03988023|25805707|FG000|Overall Study|Lost to Follow-up|5|||
13086749|NCT03988023|25805708|FG001|Overall Study|Lost to Follow-up|8|||
13086750|NCT03988023|25805707|FG000|Overall Study|Sponsor decision to terminate follow up|10|||
13086751|NCT03988023|25805708|FG001|Overall Study|Sponsor decision to terminate follow up|12|||
13086752|NCT03988023|25805707|FG000|Overall Study|Lack of Efficacy|3|||
13086753|NCT03988023|25805708|FG001|Overall Study|Lack of Efficacy|1|||
13086754|NCT03988023|25805707|FG000|Overall Study|COVID-19 pandemic|225|||
13086755|NCT03988023|25805708|FG001|Overall Study|COVID-19 pandemic|227|||
13086756|NCT03987932|25805750|FG000|Overall Study|Lost to Follow-up|2|||
13086757|NCT03987932|25805751|FG001|Overall Study|Lost to Follow-up|1|||
13086758|NCT03987932|25805752|FG002|Overall Study|Lost to Follow-up|1|||
13086759|NCT03987932|25805750|FG000|Overall Study|Non-study related elective surgery|0|||
13086760|NCT03987932|25805751|FG001|Overall Study|Non-study related elective surgery|0|||
13086761|NCT03987932|25805752|FG002|Overall Study|Non-study related elective surgery|1|||
13086762|NCT03987620|25805773|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43|||
13086763|NCT03987620|25805774|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41|||
13086764|NCT03987620|25805773|FG000|Overall Study|Adverse Event|3|||
13086765|NCT03987620|25805774|FG001|Overall Study|Adverse Event|0|||
13086766|NCT03987620|25805773|FG000|Overall Study|Lost to Follow-up|1|||
13086767|NCT03987620|25805774|FG001|Overall Study|Lost to Follow-up|2|||
13086768|NCT03987620|25805773|FG000|Overall Study|Physician Decision|0|||
13086769|NCT03987620|25805774|FG001|Overall Study|Physician Decision|1|||
13086770|NCT03987620|25805773|FG000|Overall Study|Pregnancy|1|||
13086771|NCT03987620|25805774|FG001|Overall Study|Pregnancy|0|||
13086772|NCT03987620|25805773|FG000|Overall Study|Withdrawal by Subject|7|||
13086773|NCT03987620|25805774|FG001|Overall Study|Withdrawal by Subject|1|||
13086774|NCT03987620|25805773|FG000|Overall Study|Other|2|||
13086775|NCT03987620|25805774|FG001|Overall Study|Other|5|||
13086776|NCT03987191|25805799|FG000|Overall Study|COVID-19 related research disruption|0|||
13086777|NCT03987191|25805800|FG001|Overall Study|COVID-19 related research disruption|2|||
13086778|NCT03987074|25805833|FG000|Overall Study|Withdrew Consent|1|||
13086779|NCT03987074|25805834|FG001|Overall Study|Withdrew Consent|1|||
13086780|NCT03987074|25805835|FG002|Overall Study|Withdrew Consent|0|||
13086781|NCT03987074|25805836|FG003|Overall Study|Withdrew Consent|2|||
13086782|NCT03987074|25805837|FG004|Overall Study|Withdrew Consent|1|||
13086783|NCT03987074|25805833|FG000|Overall Study|Adverse Event|2|||
13086784|NCT03987074|25805834|FG001|Overall Study|Adverse Event|1|||
13086785|NCT03987074|25805835|FG002|Overall Study|Adverse Event|0|||
13086786|NCT03987074|25805836|FG003|Overall Study|Adverse Event|0|||
13086787|NCT03987074|25805837|FG004|Overall Study|Adverse Event|1|||
13086788|NCT03987074|25805833|FG000|Overall Study|Lost to Follow-up|0|||
13086789|NCT03987074|25805834|FG001|Overall Study|Lost to Follow-up|0|||
13086790|NCT03987074|25805835|FG002|Overall Study|Lost to Follow-up|1|||
13086791|NCT03987074|25805836|FG003|Overall Study|Lost to Follow-up|1|||
13086792|NCT03987074|25805837|FG004|Overall Study|Lost to Follow-up|0|||
13086793|NCT03987074|25805833|FG000|Overall Study|Investigator's Discretion|0|||
13086794|NCT03987074|25805834|FG001|Overall Study|Investigator's Discretion|0|||
13086795|NCT03987074|25805835|FG002|Overall Study|Investigator's Discretion|0|||
13086796|NCT03987074|25805836|FG003|Overall Study|Investigator's Discretion|1|||
13086797|NCT03987074|25805837|FG004|Overall Study|Investigator's Discretion|0|||
13086798|NCT03986866|25805856|FG000|Overall Study|Withdrawal by Subject|0|||
13086799|NCT03986866|25805857|FG001|Overall Study|Withdrawal by Subject|3|||
13086800|NCT03986866|25805856|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
13086801|NCT03986866|25805857|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
13086802|NCT03984825|25805973|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2|||
13086803|NCT03984825|25805973|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1|||
13086804|NCT03984825|25805973|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3|||
13086805|NCT03984812|25806292|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
13086806|NCT03984812|25806293|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
13086807|NCT03984812|25806294|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1|||
13086808|NCT03984812|25806295|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
13086809|NCT03984812|25806296|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
13086810|NCT03984812|25806297|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
13086811|NCT03984812|25806298|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
13086812|NCT03984812|25806299|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
13086813|NCT03984812|25806300|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
13086814|NCT03984812|25806301|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
13086815|NCT03984812|25806302|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
13086816|NCT03984305|25806341|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19|||
13086817|NCT03984305|25806342|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15|||
13086818|NCT03984305|25806341|FG000|Overall Study|Withdrawal by Subject|3|||
13086819|NCT03984305|25806342|FG001|Overall Study|Withdrawal by Subject|3|||
13086820|NCT03984305|25806341|FG000|Overall Study|Lost to Follow-up|1|||
13086821|NCT03984305|25806342|FG001|Overall Study|Lost to Follow-up|0|||
13086822|NCT03983317|25806351|FG000|Overall Study|Physician Decision|5|||
13086823|NCT03982433|25806364|FG000|Overall Study|Lost to Follow-up|1|||
13086824|NCT03982069|25806393|FG000|Overall Study|Lost to Follow-up|5|||
13086825|NCT03982069|25806394|FG001|Overall Study|Lost to Follow-up|5|||
13086826|NCT03982069|25806395|FG002|Overall Study|Lost to Follow-up|3|||
13086827|NCT03982069|25806396|FG003|Overall Study|Lost to Follow-up|5|||
13086828|NCT03982069|25806393|FG000|Overall Study|Physician Decision|0|||
13086829|NCT03982069|25806394|FG001|Overall Study|Physician Decision|1|||
13086830|NCT03982069|25806395|FG002|Overall Study|Physician Decision|0|||
13086831|NCT03982069|25806396|FG003|Overall Study|Physician Decision|0|||
13086832|NCT03982069|25806393|FG000|Overall Study|Withdrawal by Subject|2|||
13086833|NCT03982069|25806394|FG001|Overall Study|Withdrawal by Subject|1|||
13086834|NCT03982069|25806395|FG002|Overall Study|Withdrawal by Subject|5|||
13086835|NCT03982069|25806396|FG003|Overall Study|Withdrawal by Subject|2|||
13086836|NCT03982069|25806393|FG000|Overall Study|Specimen loss|3|||
13086837|NCT03982069|25806394|FG001|Overall Study|Specimen loss|3|||
13086838|NCT03982069|25806395|FG002|Overall Study|Specimen loss|1|||
13086839|NCT03982069|25806396|FG003|Overall Study|Specimen loss|1|||
13086840|NCT03981861|25806406|FG000|Overall Study|Withdrawal by Subject|3|||
13086841|NCT03981822|25806479|FG000|Overall Study|Lost to Follow-up|0|||
13086842|NCT03981822|25806480|FG001|Overall Study|Lost to Follow-up|1|||
13086843|NCT03981822|25806481|FG002|Overall Study|Lost to Follow-up|1|||
13086844|NCT03981822|25806482|FG003|Overall Study|Lost to Follow-up|0|||
13086845|NCT03981822|25806483|FG004|Overall Study|Lost to Follow-up|6|||
13086846|NCT03981822|25806484|FG005|Overall Study|Lost to Follow-up|4|||
13086847|NCT03981822|25806485|FG006|Overall Study|Lost to Follow-up|4|||
13086848|NCT03981822|25806486|FG007|Overall Study|Lost to Follow-up|2|||
13086849|NCT03981822|25806479|FG000|Overall Study|Withdrawal by Subject|0|||
13086850|NCT03981822|25806480|FG001|Overall Study|Withdrawal by Subject|1|||
13086851|NCT03981822|25806481|FG002|Overall Study|Withdrawal by Subject|0|||
13086852|NCT03981822|25806482|FG003|Overall Study|Withdrawal by Subject|0|||
13086853|NCT03981822|25806483|FG004|Overall Study|Withdrawal by Subject|0|||
13086854|NCT03981822|25806484|FG005|Overall Study|Withdrawal by Subject|1|||
13086855|NCT03981822|25806485|FG006|Overall Study|Withdrawal by Subject|0|||
13086856|NCT03981822|25806486|FG007|Overall Study|Withdrawal by Subject|2|||
13086857|NCT03981822|25806479|FG000|Overall Study|COVID-19 Related|0|||
13086858|NCT03981822|25806480|FG001|Overall Study|COVID-19 Related|0|||
13086859|NCT03981822|25806481|FG002|Overall Study|COVID-19 Related|0|||
13086860|NCT03981822|25806482|FG003|Overall Study|COVID-19 Related|0|||
13086861|NCT03981822|25806483|FG004|Overall Study|COVID-19 Related|2|||
13086862|NCT03981822|25806484|FG005|Overall Study|COVID-19 Related|1|||
13086863|NCT03981822|25806485|FG006|Overall Study|COVID-19 Related|2|||
13086864|NCT03981822|25806486|FG007|Overall Study|COVID-19 Related|1|||
13086865|NCT03980938|25806499|FG000|Treatment Period 1|Study Terminated|1|||
13086866|NCT03980938|25806500|FG001|Treatment Period 1|Study Terminated|1|||
13086867|NCT03980938|25806499|FG000|Treatment Period 2|Study Terminated|2|||
13086868|NCT03980938|25806500|FG001|Treatment Period 2|Study Terminated|2|||
13086869|NCT03980808|25806515|FG000|Overall Study|Lost to Follow-up|2|||
13086870|NCT03980808|25806516|FG001|Overall Study|Lost to Follow-up|2|||
13086871|NCT03980522|25806555|FG000|Treatment Period|Adverse Event|1|||
13086872|NCT03980522|25806556|FG001|Treatment Period|Adverse Event|0|||
13086873|NCT03980522|25806557|FG002|Treatment Period|Adverse Event|0|||
13086874|NCT03980522|25806558|FG003|Treatment Period|Adverse Event|0|||
13086875|NCT03980522|25806559|FG004|Treatment Period|Adverse Event|0|||
13086876|NCT03979820|25806586|FG000|Overall Study|Protocol Violation|1|||
13086877|NCT03979820|25806587|FG001|Overall Study|Protocol Violation|0|||
13086878|NCT03979820|25806588|FG002|Overall Study|Protocol Violation|0|||
13086879|NCT03979820|25806589|FG003|Overall Study|Protocol Violation|0|||
13086880|NCT03979820|25806586|FG000|Overall Study|Withdrawal by Subject|0|||
13086881|NCT03979820|25806587|FG001|Overall Study|Withdrawal by Subject|0|||
13086882|NCT03979820|25806588|FG002|Overall Study|Withdrawal by Subject|1|||
13086883|NCT03979820|25806589|FG003|Overall Study|Withdrawal by Subject|0|||
13086884|NCT03979820|25806586|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5|||
13086885|NCT03979820|25806587|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
13086886|NCT03979820|25806588|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
13086887|NCT03979820|25806589|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10|||
13086888|NCT03979638|25806627|FG000|Period 1|Physician Decision|1|||
13086889|NCT03979638|25806628|FG001|Period 1|Physician Decision|1|||
13086890|NCT03979638|25806627|FG000|Period 1|Withdrawal by Subject|4|||
13086891|NCT03979638|25806628|FG001|Period 1|Withdrawal by Subject|3|||
13086892|NCT03979638|25806627|FG000|Period 1|Study terminated by Sponsor|1|||
13086893|NCT03979638|25806628|FG001|Period 1|Study terminated by Sponsor|3|||
13086894|NCT03979638|25806627|FG000|Period 1|Protocol Violation|1|||
13086895|NCT03979638|25806628|FG001|Period 1|Protocol Violation|0|||
13086896|NCT03979638|25806627|FG000|Period 2|Study terminated by Sponsor|1|||
13086897|NCT03979638|25806628|FG001|Period 2|Study terminated by Sponsor|1|||
13086898|NCT03979274|25806657|FG000|Treatment Period 2|Withdrawal by Subject|0|||
13086899|NCT03979274|25806658|FG001|Treatment Period 2|Withdrawal by Subject|1|||
13086900|NCT03978832|25806682|FG000|Overall Study|Adverse Event|1|||
13086901|NCT03978832|25806682|FG000|Overall Study|Lost to Follow-up|1|||
13086902|NCT03978832|25806682|FG000|Overall Study|Withdrawal by Subject|6|||
13086903|NCT03978832|25806682|FG000|Overall Study|Physician Decision|2|||
13086904|NCT03978832|25806682|FG000|Overall Study|did not pass screening criteria|44|||
13086905|NCT03978091|25806805|FG000|Overall Study|Lost to Follow-up|0|||
13086906|NCT03978091|25806806|FG001|Overall Study|Lost to Follow-up|0|||
13086907|NCT03978091|25806807|FG002|Overall Study|Lost to Follow-up|1|||
13086908|NCT03978091|25806808|FG003|Overall Study|Lost to Follow-up|0|||
13086909|NCT03978091|25806809|FG004|Overall Study|Lost to Follow-up|0|||
13086910|NCT03978091|25806810|FG005|Overall Study|Lost to Follow-up|0|||
13086911|NCT03978091|25806805|FG000|Overall Study|Withdrawal by Subject|0|||
13086912|NCT03978091|25806806|FG001|Overall Study|Withdrawal by Subject|0|||
13086913|NCT03978091|25806807|FG002|Overall Study|Withdrawal by Subject|0|||
13086914|NCT03978091|25806808|FG003|Overall Study|Withdrawal by Subject|1|||
13086915|NCT03978091|25806809|FG004|Overall Study|Withdrawal by Subject|1|||
13086916|NCT03978091|25806810|FG005|Overall Study|Withdrawal by Subject|0|||
13086917|NCT03977727|25806861|FG000|Second Treatment|Lost to Follow-up|0|||
13086918|NCT03977727|25806862|FG001|Second Treatment|Lost to Follow-up|3|||
13086919|NCT03977454|25806883|FG000|Overall Study|immediate postoperative revision|2|||
13086920|NCT03977454|25806884|FG001|Overall Study|immediate postoperative revision|2|||
13086921|NCT03977155|25806934|FG000|Overall Study|Adverse Event|3|||
13086922|NCT03977155|25806935|FG001|Overall Study|Adverse Event|0|||
13086923|NCT03977155|25806936|FG002|Overall Study|Adverse Event|0|||
13086924|NCT03977155|25806934|FG000|Overall Study|Lost to Follow-up|0|||
13086925|NCT03977155|25806935|FG001|Overall Study|Lost to Follow-up|1|||
13086926|NCT03977155|25806936|FG002|Overall Study|Lost to Follow-up|0|||
13086927|NCT03977155|25806934|FG000|Overall Study|Withdrawal by Subject|1|||
13086928|NCT03977155|25806935|FG001|Overall Study|Withdrawal by Subject|1|||
13086929|NCT03977155|25806936|FG002|Overall Study|Withdrawal by Subject|2|||
13086930|NCT03977155|25806934|FG000|Overall Study|Participant was unable to come in for the Visit|1|||
13086931|NCT03977155|25806935|FG001|Overall Study|Participant was unable to come in for the Visit|0|||
13086932|NCT03977155|25806936|FG002|Overall Study|Participant was unable to come in for the Visit|0|||
13086933|NCT03976648|25806949|FG000|Overall Study|Adverse Event|0|||
13086934|NCT03976648|25806950|FG001|Overall Study|Adverse Event|2|||
13086935|NCT03976648|25806949|FG000|Overall Study|Study terminated by sponsor|21|||
13086936|NCT03976648|25806950|FG001|Overall Study|Study terminated by sponsor|8|||
13086937|NCT03976466|25806965|FG000|Overall Study|Lost to Follow-up|1|||
13086938|NCT03976466|25806966|FG001|Overall Study|Lost to Follow-up|3|||
13086939|NCT03976401|25807027|FG000|Overall Study|Adverse Event|2|||
13086940|NCT03976401|25807028|FG001|Overall Study|Adverse Event|0|||
13086941|NCT03976401|25807029|FG002|Overall Study|Adverse Event|4|||
13086942|NCT03976401|25807030|FG003|Overall Study|Adverse Event|1|||
13086943|NCT03976401|25807031|FG004|Overall Study|Adverse Event|1|||
13086944|NCT03976401|25807032|FG005|Overall Study|Adverse Event|0|||
13086945|NCT03976401|25807027|FG000|Overall Study|Withdrawal by Subject|0|||
13086946|NCT03976401|25807028|FG001|Overall Study|Withdrawal by Subject|1|||
13086947|NCT03976401|25807029|FG002|Overall Study|Withdrawal by Subject|0|||
13086948|NCT03976401|25807030|FG003|Overall Study|Withdrawal by Subject|0|||
13086949|NCT03976401|25807031|FG004|Overall Study|Withdrawal by Subject|0|||
13086950|NCT03976401|25807032|FG005|Overall Study|Withdrawal by Subject|1|||
13086951|NCT03976401|25807027|FG000|Overall Study|Physician Decision|0|||
13086952|NCT03976401|25807028|FG001|Overall Study|Physician Decision|0|||
13086953|NCT03976401|25807029|FG002|Overall Study|Physician Decision|1|||
13086954|NCT03976401|25807030|FG003|Overall Study|Physician Decision|0|||
13086955|NCT03976401|25807031|FG004|Overall Study|Physician Decision|0|||
13086956|NCT03976401|25807032|FG005|Overall Study|Physician Decision|0|||
13086957|NCT03976401|25807027|FG000|Overall Study|Lost to Follow-up|1|||
13086958|NCT03976401|25807028|FG001|Overall Study|Lost to Follow-up|2|||
13086959|NCT03976401|25807029|FG002|Overall Study|Lost to Follow-up|0|||
13086960|NCT03976401|25807030|FG003|Overall Study|Lost to Follow-up|0|||
13086961|NCT03976401|25807031|FG004|Overall Study|Lost to Follow-up|0|||
13086962|NCT03976401|25807032|FG005|Overall Study|Lost to Follow-up|0|||
13086963|NCT03976401|25807027|FG000|Overall Study|Protocol Violation|0|||
13086964|NCT03976401|25807028|FG001|Overall Study|Protocol Violation|1|||
13086965|NCT03976401|25807029|FG002|Overall Study|Protocol Violation|0|||
13086966|NCT03976401|25807030|FG003|Overall Study|Protocol Violation|0|||
13086967|NCT03976401|25807031|FG004|Overall Study|Protocol Violation|0|||
13086968|NCT03976401|25807032|FG005|Overall Study|Protocol Violation|0|||
13086969|NCT03976401|25807027|FG000|Overall Study|Withdrew Consent|0|||
13086970|NCT03976401|25807028|FG001|Overall Study|Withdrew Consent|0|||
13086971|NCT03976401|25807029|FG002|Overall Study|Withdrew Consent|0|||
13086972|NCT03976401|25807030|FG003|Overall Study|Withdrew Consent|1|||
13086973|NCT03976401|25807031|FG004|Overall Study|Withdrew Consent|0|||
13086974|NCT03976401|25807032|FG005|Overall Study|Withdrew Consent|0|||
13086975|NCT03975920|25807073|FG000|Overall Study|Lost to Follow-up|1|||
13086976|NCT03975920|25807074|FG001|Overall Study|Lost to Follow-up|2|||
13086977|NCT03975920|25807073|FG000|Overall Study|Protocol Violation|1|||
13086978|NCT03975920|25807074|FG001|Overall Study|Protocol Violation|1|||
13086979|NCT03975920|25807073|FG000|Overall Study|Did not complete survey|2|||
13086980|NCT03975920|25807074|FG001|Overall Study|Did not complete survey|1|||
13086981|NCT03974334|25807084|FG000|Overall Study|Lost to Follow-up|1|||
13086982|NCT03972137|25807108|FG000|Overall Study|Lost to Follow-up|2|||
13086983|NCT03972137|25807108|FG000|Overall Study|Withdrawal by Subject|4|||
13086984|NCT03970824|25807138|FG000|Overall Study|Withdrawal by Subject|1|||
13086985|NCT03970824|25807139|FG001|Overall Study|Withdrawal by Subject|1|||
13086986|NCT03970824|25807140|FG002|Overall Study|Withdrawal by Subject|3|||
13086987|NCT03970824|25807138|FG000|Overall Study|Lost to Follow-up|0|||
13086988|NCT03970824|25807139|FG001|Overall Study|Lost to Follow-up|2|||
13086989|NCT03970824|25807140|FG002|Overall Study|Lost to Follow-up|1|||
13086990|NCT03970824|25807138|FG000|Overall Study|Adverse Event|1|||
13086991|NCT03970824|25807139|FG001|Overall Study|Adverse Event|0|||
13086992|NCT03970824|25807140|FG002|Overall Study|Adverse Event|0|||
13086993|NCT03970733|25807158|FG000|Overall Study|Withdrawal by Subject|0|||
13086994|NCT03970733|25807159|FG001|Overall Study|Withdrawal by Subject|5|||
13086995|NCT03970733|25807160|FG002|Overall Study|Withdrawal by Subject|1|||
13086996|NCT03970733|25807158|FG000|Overall Study|e.g.: moved from study area|1|||
13086997|NCT03970733|25807159|FG001|Overall Study|e.g.: moved from study area|0|||
13086998|NCT03970733|25807160|FG002|Overall Study|e.g.: moved from study area|0|||
13086999|NCT03970733|25807158|FG000|Overall Study|Lost to Follow-up|2|||
13087000|NCT03970733|25807159|FG001|Overall Study|Lost to Follow-up|1|||
13087001|NCT03970733|25807160|FG002|Overall Study|Lost to Follow-up|1|||
13087002|NCT03970733|25807158|FG000|Overall Study|Other|1|||
13087003|NCT03970733|25807159|FG001|Overall Study|Other|0|||
13087004|NCT03970733|25807160|FG002|Overall Study|Other|0|||
13087005|NCT03970395|25807183|FG000|Overall Study|Withdrawal by Subject|3|||
13087006|NCT03970395|25807184|FG001|Overall Study|Withdrawal by Subject|4|||
13087007|NCT03970395|25807183|FG000|Overall Study|Lost to Follow-up|4|||
13087008|NCT03970395|25807184|FG001|Overall Study|Lost to Follow-up|8|||
13087009|NCT03969719|25807238|FG000|Overall Study|Other reasons not specified|1|||
13087010|NCT03969719|25807239|FG001|Overall Study|Other reasons not specified|1|||
13087011|NCT03969719|25807240|FG002|Overall Study|Other reasons not specified|3|||
13087012|NCT03969719|25807238|FG000|Overall Study|Withdrawal by Subject|2|||
13087013|NCT03969719|25807239|FG001|Overall Study|Withdrawal by Subject|3|||
13087014|NCT03969719|25807240|FG002|Overall Study|Withdrawal by Subject|2|||
13087015|NCT03969719|25807238|FG000|Overall Study|Protocol Violation|1|||
13087016|NCT03969719|25807239|FG001|Overall Study|Protocol Violation|2|||
13087017|NCT03969719|25807240|FG002|Overall Study|Protocol Violation|0|||
13087018|NCT03969719|25807238|FG000|Overall Study|Adverse Event|0|||
13087019|NCT03969719|25807239|FG001|Overall Study|Adverse Event|2|||
13087020|NCT03969719|25807240|FG002|Overall Study|Adverse Event|0|||
13087021|NCT03969719|25807238|FG000|Overall Study|Lost to Follow-up|0|||
13087022|NCT03969719|25807239|FG001|Overall Study|Lost to Follow-up|1|||
13087023|NCT03969719|25807240|FG002|Overall Study|Lost to Follow-up|0|||
13087024|NCT03969589|25807257|FG000|Overall Study|Lost to Follow-up|3|||
13087025|NCT03969589|25807258|FG001|Overall Study|Lost to Follow-up|2|||
13087026|NCT03969589|25807257|FG000|Overall Study|Declined Follow-Up|0|||
13087027|NCT03969589|25807258|FG001|Overall Study|Declined Follow-Up|1|||
13087028|NCT03968978|25807281|FG000|Overall Study|Adverse Event|1|||
13087029|NCT03968978|25807282|FG001|Overall Study|Adverse Event|0|||
13087030|NCT03968159|25807313|FG000|Overall Study|Adverse Event|4|||
13087031|NCT03968159|25807314|FG001|Overall Study|Adverse Event|4|||
13087032|NCT03968159|25807313|FG000|Overall Study|Lost to Follow-up|1|||
13087033|NCT03968159|25807314|FG001|Overall Study|Lost to Follow-up|1|||
13087034|NCT03968159|25807313|FG000|Overall Study|Use of prohibited medication|0|||
13087035|NCT03968159|25807314|FG001|Overall Study|Use of prohibited medication|1|||
13087036|NCT03968159|25807313|FG000|Overall Study|Protocol Violation|2|||
13087037|NCT03968159|25807314|FG001|Overall Study|Protocol Violation|2|||
13087038|NCT03968159|25807313|FG000|Overall Study|Withdrawal by Subject|4|||
13087039|NCT03968159|25807314|FG001|Overall Study|Withdrawal by Subject|6|||
13087040|NCT03968159|25807313|FG000|Overall Study|Lack of Efficacy|0|||
13087041|NCT03968159|25807314|FG001|Overall Study|Lack of Efficacy|1|||
13087042|NCT03968159|25807313|FG000|Overall Study|Not further specified|2|||
13087043|NCT03968159|25807314|FG001|Overall Study|Not further specified|0|||
13087044|NCT03967444|25807327|FG000|Overall Study|Lost to Follow-up|1|||
13087045|NCT03967444|25807328|FG001|Overall Study|Lost to Follow-up|2|||
13087046|NCT03966911|25807343|FG000|Overall Study|Adverse Event|1|||
13087047|NCT03966911|25807344|FG001|Overall Study|Adverse Event|1|||
13087048|NCT03966911|25807343|FG000|Overall Study|Withdrawal by Subject|8|||
13087049|NCT03966911|25807344|FG001|Overall Study|Withdrawal by Subject|2|||
13087050|NCT03966911|25807343|FG000|Overall Study|Unable to complete study visits due to COVID-19|0|||
13087051|NCT03966911|25807344|FG001|Overall Study|Unable to complete study visits due to COVID-19|13|||
13087052|NCT03966885|25807363|FG000|Overall Study|Death|1|||
13087053|NCT03966885|25807364|FG001|Overall Study|Death|0|||
13087054|NCT03966885|25807363|FG000|Overall Study|Lost to Follow-up|1|||
13087055|NCT03966885|25807364|FG001|Overall Study|Lost to Follow-up|2|||
13087056|NCT03966885|25807363|FG000|Overall Study|Not post-assessed. Study ended early due to COVID-19|20|||
13087057|NCT03966885|25807364|FG001|Overall Study|Not post-assessed. Study ended early due to COVID-19|16|||
13087058|NCT03966885|25807363|FG000|Overall Study|Moved from study area.|0|||
13087059|NCT03966885|25807364|FG001|Overall Study|Moved from study area.|2|||
13087060|NCT03966365|25807389|FG000|Overall Study|Protocol Violation|1|||
13087061|NCT03966365|25807390|FG001|Overall Study|Protocol Violation|0|||
13087062|NCT03965403|25807403|FG000|Overall Study|Subject not meeting eligibility criteria|1|||
13087063|NCT03965351|25807426|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
13087064|NCT03965351|25807427|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
13087065|NCT03965351|25807426|FG000|Second Intervention (4 Weeks)|Adverse Event|0|||
13087066|NCT03965351|25807427|FG001|Second Intervention (4 Weeks)|Adverse Event|1|||
13087067|NCT03965052|25807452|FG000|Overall Study|Protocol Violation|1|||
13087068|NCT03965052|25807453|FG001|Overall Study|Protocol Violation|0|||
13087069|NCT03964974|25807466|FG000|Overall Study|Lost to Follow-up|3|||
13087070|NCT03964974|25807467|FG001|Overall Study|Lost to Follow-up|2|||
13087071|NCT03964974|25807466|FG000|Overall Study|Withdrawal by Subject|0|||
13087072|NCT03964974|25807467|FG001|Overall Study|Withdrawal by Subject|3|||
13087073|NCT03963401|25807670|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
13087074|NCT03963401|25807671|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
13087075|NCT03963401|25807672|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
13087076|NCT03963401|25807673|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
13087077|NCT03963401|25807674|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
13087078|NCT03963401|25807675|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
13087079|NCT03963401|25807670|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
13087080|NCT03963401|25807671|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
13087081|NCT03963401|25807672|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
13087082|NCT03963401|25807673|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
13087083|NCT03963401|25807674|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
13087084|NCT03963401|25807675|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
13087085|NCT03963401|25807670|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
13087086|NCT03963401|25807671|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
13087087|NCT03963401|25807672|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
13087088|NCT03963401|25807673|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
13087089|NCT03963401|25807674|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
13087090|NCT03963401|25807675|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0|||
13087091|NCT03963401|25807670|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
13087092|NCT03963401|25807671|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1|||
13087093|NCT03963401|25807672|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
13087094|NCT03963401|25807673|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
13087095|NCT03963401|25807674|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
13087096|NCT03963401|25807675|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
13087097|NCT03963401|25807670|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6|||
13087098|NCT03963401|25807671|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
13087099|NCT03963401|25807672|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2|||
13087100|NCT03963401|25807673|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0|||
13087101|NCT03963401|25807674|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4|||
13087102|NCT03963401|25807675|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
13087103|NCT03963401|25807670|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
13087104|NCT03963401|25807671|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
13087105|NCT03963401|25807672|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
13087106|NCT03963401|25807673|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
13087107|NCT03963401|25807674|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
13087108|NCT03963401|25807675|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
13087109|NCT03963401|25807670|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
13087110|NCT03963401|25807671|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
13087111|NCT03963401|25807672|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1|||
13087112|NCT03963401|25807673|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
13087113|NCT03963401|25807674|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
13087114|NCT03963401|25807675|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
13087115|NCT03963401|25807670|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1|||
13087116|NCT03963401|25807671|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
13087117|NCT03963401|25807672|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
13087118|NCT03963401|25807673|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
13087119|NCT03963401|25807674|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
13087120|NCT03963401|25807675|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
13087121|NCT03963401|25807670|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4|||
13087122|NCT03963401|25807671|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
13087123|NCT03963401|25807672|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
13087124|NCT03963401|25807673|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
13087125|NCT03963401|25807674|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
13087126|NCT03963401|25807675|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
13087127|NCT03963401|25807670|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1|||
13087128|NCT03963401|25807671|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
13087129|NCT03963401|25807672|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
13087130|NCT03963401|25807673|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
13087131|NCT03963401|25807674|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
13087132|NCT03963401|25807675|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
13087133|NCT03963401|25807670|FG000|Extension Period (Week 17 - Week 52)|Other|1|||
13087134|NCT03963401|25807671|FG001|Extension Period (Week 17 - Week 52)|Other|1|||
13087135|NCT03963401|25807672|FG002|Extension Period (Week 17 - Week 52)|Other|0|||
13087136|NCT03963401|25807673|FG003|Extension Period (Week 17 - Week 52)|Other|1|||
13087137|NCT03963401|25807674|FG004|Extension Period (Week 17 - Week 52)|Other|1|||
13087138|NCT03963401|25807675|FG005|Extension Period (Week 17 - Week 52)|Other|1|||
13087139|NCT03963232|25807713|FG000|Overall Study|Adverse Event|0|||
13087140|NCT03963232|25807714|FG001|Overall Study|Adverse Event|6|||
13087141|NCT03963232|25807713|FG000|Overall Study|Protocol Violation|1|||
13087142|NCT03963232|25807714|FG001|Overall Study|Protocol Violation|1|||
13087143|NCT03963232|25807713|FG000|Overall Study|Pregnancy|2|||
13087144|NCT03963232|25807714|FG001|Overall Study|Pregnancy|1|||
13087145|NCT03963232|25807713|FG000|Overall Study|Withdrawal by Subject|13|||
13087146|NCT03963232|25807714|FG001|Overall Study|Withdrawal by Subject|5|||
13087147|NCT03963232|25807713|FG000|Overall Study|Physician Decision|1|||
13087148|NCT03963232|25807714|FG001|Overall Study|Physician Decision|3|||
13087149|NCT03962790|25807729|FG000|Period 1|Adverse Event|0|||
13087150|NCT03962790|25807730|FG001|Period 1|Adverse Event|1|||
13087151|NCT03962790|25807729|FG000|Period 1|Failed to meet all eligibility criteria|1|||
13087152|NCT03962790|25807730|FG001|Period 1|Failed to meet all eligibility criteria|1|||
13087153|NCT03962790|25807729|FG000|Period 1|No Longer Meets Eligibility Criteria|1|||
13087154|NCT03962790|25807730|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
13087155|NCT03962790|25807729|FG000|Period 1|Withdrawal by Subject|1|||
13087156|NCT03962790|25807730|FG001|Period 1|Withdrawal by Subject|0|||
13087157|NCT03962738|25807823|FG000|Overall Study|Protocol Deviation|3|||
13087158|NCT03962738|25807824|FG001|Overall Study|Protocol Deviation|0|||
13087159|NCT03962738|25807825|FG002|Overall Study|Protocol Deviation|1|||
13087160|NCT03962738|25807826|FG003|Overall Study|Protocol Deviation|1|||
13087161|NCT03962738|25807823|FG000|Overall Study|Withdrawal by Subject|4|||
13087162|NCT03962738|25807824|FG001|Overall Study|Withdrawal by Subject|0|||
13087163|NCT03962738|25807825|FG002|Overall Study|Withdrawal by Subject|0|||
13087164|NCT03962738|25807826|FG003|Overall Study|Withdrawal by Subject|0|||
13087165|NCT03962738|25807823|FG000|Overall Study|Lost to Follow-up|0|||
13087166|NCT03962738|25807824|FG001|Overall Study|Lost to Follow-up|0|||
13087167|NCT03962738|25807825|FG002|Overall Study|Lost to Follow-up|1|||
13087168|NCT03962738|25807826|FG003|Overall Study|Lost to Follow-up|0|||
13087169|NCT03962101|25807836|FG000|Overall Study|Adverse Event|1|||
13087170|NCT03962101|25807836|FG000|Overall Study|Physician Decision|2|||
13087171|NCT03962101|25807836|FG000|Overall Study|Not related to medical events|1|||
13087172|NCT03961529|25807860|FG000|Overall Study|Adverse Event|13|||
13087173|NCT03961529|25807861|FG001|Overall Study|Adverse Event|5|||
13087174|NCT03961529|25807862|FG002|Overall Study|Adverse Event|2|||
13087175|NCT03961529|25807860|FG000|Overall Study|Withdrawal by Subject|17|||
13087176|NCT03961529|25807861|FG001|Overall Study|Withdrawal by Subject|2|||
13087177|NCT03961529|25807862|FG002|Overall Study|Withdrawal by Subject|1|||
13087178|NCT03961529|25807860|FG000|Overall Study|Withdrawal by parent/guardian|0|||
13087179|NCT03961529|25807861|FG001|Overall Study|Withdrawal by parent/guardian|7|||
13087180|NCT03961529|25807862|FG002|Overall Study|Withdrawal by parent/guardian|0|||
13087181|NCT03961529|25807860|FG000|Overall Study|Physician Decision|2|||
13087182|NCT03961529|25807861|FG001|Overall Study|Physician Decision|1|||
13087183|NCT03961529|25807862|FG002|Overall Study|Physician Decision|1|||
13087184|NCT03961529|25807860|FG000|Overall Study|Lost to Follow-up|2|||
13087185|NCT03961529|25807861|FG001|Overall Study|Lost to Follow-up|1|||
13087186|NCT03961529|25807862|FG002|Overall Study|Lost to Follow-up|0|||
13087187|NCT03961529|25807860|FG000|Overall Study|Lack of Efficacy|2|||
13087188|NCT03961529|25807861|FG001|Overall Study|Lack of Efficacy|0|||
13087189|NCT03961529|25807862|FG002|Overall Study|Lack of Efficacy|1|||
13087190|NCT03961529|25807860|FG000|Overall Study|Other|6|||
13087191|NCT03961529|25807861|FG001|Overall Study|Other|1|||
13087192|NCT03961529|25807862|FG002|Overall Study|Other|0|||
13087193|NCT03961308|25807879|FG000|Overall Study|Withdrawal by Subject|1|||
13087194|NCT03961308|25807880|FG001|Overall Study|Withdrawal by Subject|0|||
13087195|NCT03961308|25807879|FG000|Overall Study|Other|1|||
13087196|NCT03961308|25807880|FG001|Overall Study|Other|0|||
13087197|NCT03961308|25807879|FG000|Overall Study|Lost to Follow-up|0|||
13087198|NCT03961308|25807880|FG001|Overall Study|Lost to Follow-up|1|||
13087199|NCT03961308|25807879|FG000|Overall Study|Adverse Event|0|||
13087200|NCT03961308|25807880|FG001|Overall Study|Adverse Event|1|||
13087201|NCT03961204|25807896|FG000|Overall Study|Withdrawal by Subject|2|||
13087202|NCT03961204|25807896|FG000|Overall Study|Lost to Follow-up|3|||
13087203|NCT03961204|25807896|FG000|Overall Study|Other|1|||
13087204|NCT03961204|25807896|FG000|Overall Study|Missing|1|||
13087205|NCT03959423|25807917|FG000|Overall Study|Withdrawal by Subject|2|||
13087206|NCT03959423|25807918|FG001|Overall Study|Withdrawal by Subject|3|||
13087207|NCT03959423|25807917|FG000|Overall Study|Physician Decision|0|||
13087208|NCT03959423|25807918|FG001|Overall Study|Physician Decision|1|||
13087209|NCT03959423|25807917|FG000|Overall Study|Lost to Follow-up|1|||
13087210|NCT03959423|25807918|FG001|Overall Study|Lost to Follow-up|0|||
13087211|NCT03959423|25807917|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
13087212|NCT03959423|25807918|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
13087213|NCT03959137|25807924|FG000|Overall Study|Protocol Violation|6|||
13087214|NCT03958955|25807943|FG000|Overall Study|Adverse Event|1|||
13087215|NCT03958656|25807974|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0|||
13087216|NCT03958656|25807975|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1|||
13087217|NCT03958656|25807976|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0|||
13087218|NCT03958656|25807977|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0|||
13087219|NCT03958656|25807974|FG000|Overall Study|No longer meets eligibility criteria|0|||
13087220|NCT03958656|25807975|FG001|Overall Study|No longer meets eligibility criteria|0|||
13087221|NCT03958656|25807976|FG002|Overall Study|No longer meets eligibility criteria|1|||
13087222|NCT03958656|25807977|FG003|Overall Study|No longer meets eligibility criteria|0|||
13087223|NCT03958656|25807974|FG000|Overall Study|Started anti-cancer treatment|0|||
13087224|NCT03958656|25807975|FG001|Overall Study|Started anti-cancer treatment|0|||
13087225|NCT03958656|25807976|FG002|Overall Study|Started anti-cancer treatment|1|||
13087226|NCT03958656|25807977|FG003|Overall Study|Started anti-cancer treatment|0|||
13087227|NCT03958331|25808003|FG000|Overall Study|Withdrawal by Subject|3|||
13087228|NCT03958331|25808004|FG001|Overall Study|Withdrawal by Subject|1|||
13087229|NCT03958331|25808005|FG002|Overall Study|Withdrawal by Subject|5|||
13087230|NCT03958331|25808003|FG000|Overall Study|Weaned from medicine|2|||
13087231|NCT03958331|25808004|FG001|Overall Study|Weaned from medicine|0|||
13087232|NCT03958331|25808005|FG002|Overall Study|Weaned from medicine|0|||
13087233|NCT03958331|25808003|FG000|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|2|||
13087234|NCT03958331|25808004|FG001|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|1|||
13087235|NCT03958331|25808005|FG002|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|12|||
13087236|NCT03958149|25808022|FG000|Overall Study|Withdrawal by Subject|0|||
13087237|NCT03958149|25808023|FG001|Overall Study|Withdrawal by Subject|1|||
13087238|NCT03956862|25808052|FG000|Overall Study|Lost to Follow-up|1|||
13087239|NCT03956862|25808053|FG001|Overall Study|Lost to Follow-up|1|||
13087240|NCT03956862|25808052|FG000|Overall Study|Withdrawal by Subject|1|||
13087241|NCT03956862|25808053|FG001|Overall Study|Withdrawal by Subject|1|||
13087242|NCT03956615|25808060|FG000|Overall Study|No multiple myeloma confirmed|2|||
13087243|NCT03956615|25808060|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1|||
13087244|NCT03956615|25808060|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2|||
13087245|NCT03956615|25808060|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2|||
13087246|NCT03956550|25808102|FG000|Overall Study|Sponsor decision|65|||
13087247|NCT03956550|25808103|FG001|Overall Study|Sponsor decision|66|||
13087248|NCT03956550|25808104|FG002|Overall Study|Sponsor decision|64|||
13087249|NCT03956550|25808102|FG000|Overall Study|Adverse Event|0|||
13087250|NCT03956550|25808103|FG001|Overall Study|Adverse Event|1|||
13087251|NCT03956550|25808104|FG002|Overall Study|Adverse Event|0|||
13087252|NCT03956550|25808102|FG000|Overall Study|Withdrawal by Subject|5|||
13087253|NCT03956550|25808103|FG001|Overall Study|Withdrawal by Subject|5|||
13087254|NCT03956550|25808104|FG002|Overall Study|Withdrawal by Subject|6|||
13087255|NCT03956225|25808120|FG000|Overall Study|Lack of Efficacy|1|||
13087256|NCT03956225|25808121|FG001|Overall Study|Lack of Efficacy|1|||
13087257|NCT03956225|25808120|FG000|Overall Study|Lost to Follow-up|0|||
13087258|NCT03956225|25808121|FG001|Overall Study|Lost to Follow-up|1|||
13087259|NCT03956225|25808120|FG000|Overall Study|Withdrawal by Subject|2|||
13087260|NCT03956225|25808121|FG001|Overall Study|Withdrawal by Subject|1|||
13087261|NCT03956225|25808120|FG000|Overall Study|Other Reasons|2|||
13087262|NCT03956225|25808121|FG001|Overall Study|Other Reasons|1|||
13087263|NCT03955471|25808153|FG000|Overall Study|Death|22|||
13087264|NCT03955471|25808153|FG000|Overall Study|Lost to Follow-up|1|||
13087265|NCT03955471|25808153|FG000|Overall Study|Withdrawal by Subject|6|||
13087266|NCT03955471|25808153|FG000|Overall Study|Sponsor Decision to Terminate Study|11|||
13087267|NCT03954834|25808207|FG000|Overall Study|Adverse Event|1|||
13087268|NCT03954834|25808208|FG001|Overall Study|Adverse Event|3|||
13087269|NCT03954834|25808209|FG002|Overall Study|Adverse Event|1|||
13087270|NCT03954834|25808210|FG003|Overall Study|Adverse Event|1|||
13087271|NCT03954834|25808207|FG000|Overall Study|Death|0|||
13087272|NCT03954834|25808208|FG001|Overall Study|Death|0|||
13087273|NCT03954834|25808209|FG002|Overall Study|Death|0|||
13087274|NCT03954834|25808210|FG003|Overall Study|Death|1|||
13087275|NCT03954834|25808207|FG000|Overall Study|Physician Decision|0|||
13087276|NCT03954834|25808208|FG001|Overall Study|Physician Decision|1|||
13087277|NCT03954834|25808209|FG002|Overall Study|Physician Decision|0|||
13087278|NCT03954834|25808210|FG003|Overall Study|Physician Decision|2|||
13087279|NCT03954834|25808207|FG000|Overall Study|Protocol Violation|1|||
13087280|NCT03954834|25808208|FG001|Overall Study|Protocol Violation|0|||
13087281|NCT03954834|25808209|FG002|Overall Study|Protocol Violation|0|||
13087282|NCT03954834|25808210|FG003|Overall Study|Protocol Violation|1|||
13087283|NCT03954834|25808207|FG000|Overall Study|Withdrawal by Subject|2|||
13087284|NCT03954834|25808208|FG001|Overall Study|Withdrawal by Subject|3|||
13087285|NCT03954834|25808209|FG002|Overall Study|Withdrawal by Subject|13|||
13087286|NCT03954834|25808210|FG003|Overall Study|Withdrawal by Subject|6|||
13087287|NCT03954834|25808207|FG000|Overall Study|Participant left the country|0|||
13087288|NCT03954834|25808208|FG001|Overall Study|Participant left the country|0|||
13087289|NCT03954834|25808209|FG002|Overall Study|Participant left the country|1|||
13087290|NCT03954834|25808210|FG003|Overall Study|Participant left the country|0|||
13087291|NCT03954834|25808207|FG000|Overall Study|Lost to Follow-up|3|||
13087292|NCT03954834|25808208|FG001|Overall Study|Lost to Follow-up|2|||
13087293|NCT03954834|25808209|FG002|Overall Study|Lost to Follow-up|3|||
13087294|NCT03954834|25808210|FG003|Overall Study|Lost to Follow-up|5|||
13087295|NCT03954444|25808228|FG000|Overall Study|Withdrawal by Subject|5|||
13087296|NCT03954444|25808229|FG001|Overall Study|Withdrawal by Subject|5|||
13087297|NCT03954444|25808230|FG002|Overall Study|Withdrawal by Subject|5|||
13087298|NCT03954444|25808228|FG000|Overall Study|Adverse Event|1|||
13087299|NCT03954444|25808229|FG001|Overall Study|Adverse Event|3|||
13087300|NCT03954444|25808230|FG002|Overall Study|Adverse Event|2|||
13087301|NCT03954444|25808228|FG000|Overall Study|Protocol Violation|0|||
13087302|NCT03954444|25808229|FG001|Overall Study|Protocol Violation|3|||
13087303|NCT03954444|25808230|FG002|Overall Study|Protocol Violation|5|||
13087304|NCT03954444|25808228|FG000|Overall Study|Use of prohibited therapy|1|||
13087305|NCT03954444|25808229|FG001|Overall Study|Use of prohibited therapy|1|||
13087306|NCT03954444|25808230|FG002|Overall Study|Use of prohibited therapy|2|||
13087307|NCT03954444|25808228|FG000|Overall Study|Lost to Follow-up|1|||
13087308|NCT03954444|25808229|FG001|Overall Study|Lost to Follow-up|0|||
13087309|NCT03954444|25808230|FG002|Overall Study|Lost to Follow-up|1|||
13087310|NCT03954444|25808228|FG000|Overall Study|Non-compliant with study drug application|2|||
13087311|NCT03954444|25808229|FG001|Overall Study|Non-compliant with study drug application|2|||
13087312|NCT03954444|25808230|FG002|Overall Study|Non-compliant with study drug application|0|||
13087313|NCT03954444|25808228|FG000|Overall Study|Administrative reasons|0|||
13087314|NCT03954444|25808229|FG001|Overall Study|Administrative reasons|0|||
13087315|NCT03954444|25808230|FG002|Overall Study|Administrative reasons|1|||
13087316|NCT03954444|25808228|FG000|Overall Study|Miscellaneous|3|||
13087317|NCT03954444|25808229|FG001|Overall Study|Miscellaneous|2|||
13087318|NCT03954444|25808230|FG002|Overall Study|Miscellaneous|1|||
13087319|NCT03953820|25808248|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1|||
13087320|NCT03953820|25808249|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
13087321|NCT03953820|25808250|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
13087322|NCT03953820|25808248|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1|||
13087323|NCT03953820|25808249|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
13087324|NCT03953820|25808250|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
13087325|NCT03953183|25808293|FG000|Overall Study|Physician Decision|0|||
13087326|NCT03953183|25808294|FG001|Overall Study|Physician Decision|1|||
13087327|NCT03953183|25808293|FG000|Overall Study|Withdrawal by Subject|0|||
13087328|NCT03953183|25808294|FG001|Overall Study|Withdrawal by Subject|1|||
13087329|NCT03952650|25808332|FG000|Overall Study|TRAVEL|0|||
13087330|NCT03952650|25808333|FG001|Overall Study|TRAVEL|4|||
13087331|NCT03952650|25808334|FG002|Overall Study|TRAVEL|0|||
13087332|NCT03952650|25808335|FG003|Overall Study|TRAVEL|4|||
13087333|NCT03952650|25808336|FG004|Overall Study|TRAVEL|0|||
13087334|NCT03952650|25808337|FG005|Overall Study|TRAVEL|3|||
13087335|NCT03952650|25808338|FG006|Overall Study|TRAVEL|2|||
13087336|NCT03952650|25808332|FG000|Overall Study|Withdrawal by Subject|0|||
13087337|NCT03952650|25808333|FG001|Overall Study|Withdrawal by Subject|2|||
13087338|NCT03952650|25808334|FG002|Overall Study|Withdrawal by Subject|0|||
13087339|NCT03952650|25808335|FG003|Overall Study|Withdrawal by Subject|3|||
13087340|NCT03952650|25808336|FG004|Overall Study|Withdrawal by Subject|0|||
13087341|NCT03952650|25808337|FG005|Overall Study|Withdrawal by Subject|1|||
13087342|NCT03952650|25808338|FG006|Overall Study|Withdrawal by Subject|1|||
13087343|NCT03952650|25808332|FG000|Overall Study|Lost to Follow-up|0|||
13087344|NCT03952650|25808333|FG001|Overall Study|Lost to Follow-up|1|||
13087345|NCT03952650|25808334|FG002|Overall Study|Lost to Follow-up|0|||
13087346|NCT03952650|25808335|FG003|Overall Study|Lost to Follow-up|0|||
13087347|NCT03952650|25808336|FG004|Overall Study|Lost to Follow-up|0|||
13087348|NCT03952650|25808337|FG005|Overall Study|Lost to Follow-up|1|||
13087349|NCT03952650|25808338|FG006|Overall Study|Lost to Follow-up|1|||
13087350|NCT03952650|25808332|FG000|Overall Study|Received wrong vaccine and travelled|0|||
13087351|NCT03952650|25808333|FG001|Overall Study|Received wrong vaccine and travelled|0|||
13087352|NCT03952650|25808334|FG002|Overall Study|Received wrong vaccine and travelled|0|||
13087353|NCT03952650|25808335|FG003|Overall Study|Received wrong vaccine and travelled|0|||
13087354|NCT03952650|25808336|FG004|Overall Study|Received wrong vaccine and travelled|0|||
13087355|NCT03952650|25808337|FG005|Overall Study|Received wrong vaccine and travelled|1|||
13087356|NCT03952650|25808338|FG006|Overall Study|Received wrong vaccine and travelled|0|||
13087357|NCT03952650|25808332|FG000|Overall Study|Unable to make study visit|0|||
13087358|NCT03952650|25808333|FG001|Overall Study|Unable to make study visit|0|||
13087359|NCT03952650|25808334|FG002|Overall Study|Unable to make study visit|0|||
13087360|NCT03952650|25808335|FG003|Overall Study|Unable to make study visit|0|||
13087361|NCT03952650|25808336|FG004|Overall Study|Unable to make study visit|0|||
13087362|NCT03952650|25808337|FG005|Overall Study|Unable to make study visit|1|||
13087363|NCT03952650|25808338|FG006|Overall Study|Unable to make study visit|0|||
13087364|NCT03952143|25808369|FG000|Lead-In Period|Adverse Event|2|||
13087365|NCT03952143|25808370|FG001|Lead-In Period|Adverse Event|0|||
13087366|NCT03952143|25808371|FG002|Lead-In Period|Adverse Event|0|||
13087367|NCT03952143|25808369|FG000|Lead-In Period|Lack of Efficacy|2|||
13087368|NCT03952143|25808370|FG001|Lead-In Period|Lack of Efficacy|0|||
13087369|NCT03952143|25808371|FG002|Lead-In Period|Lack of Efficacy|0|||
13087370|NCT03952143|25808369|FG000|Lead-In Period|Physician Decision|5|||
13087371|NCT03952143|25808370|FG001|Lead-In Period|Physician Decision|0|||
13087372|NCT03952143|25808371|FG002|Lead-In Period|Physician Decision|0|||
13087373|NCT03952143|25808369|FG000|Lead-In Period|Protocol Violation|5|||
13087374|NCT03952143|25808370|FG001|Lead-In Period|Protocol Violation|0|||
13087375|NCT03952143|25808371|FG002|Lead-In Period|Protocol Violation|0|||
13087376|NCT03952143|25808369|FG000|Lead-In Period|Withdrawal by Subject|19|||
13087377|NCT03952143|25808370|FG001|Lead-In Period|Withdrawal by Subject|0|||
13087378|NCT03952143|25808371|FG002|Lead-In Period|Withdrawal by Subject|0|||
13087379|NCT03952143|25808369|FG000|Treatment Period|Adverse Event|0|||
13087380|NCT03952143|25808370|FG001|Treatment Period|Adverse Event|0|||
13087381|NCT03952143|25808371|FG002|Treatment Period|Adverse Event|1|||
13087382|NCT03952143|25808369|FG000|Treatment Period|Lost to Follow-up|0|||
13087383|NCT03952143|25808370|FG001|Treatment Period|Lost to Follow-up|2|||
13087384|NCT03952143|25808371|FG002|Treatment Period|Lost to Follow-up|0|||
13087385|NCT03952143|25808369|FG000|Treatment Period|Physician Decision|0|||
13087386|NCT03952143|25808370|FG001|Treatment Period|Physician Decision|0|||
13087387|NCT03952143|25808371|FG002|Treatment Period|Physician Decision|2|||
13087388|NCT03952143|25808369|FG000|Treatment Period|Protocol Violation|0|||
13087389|NCT03952143|25808370|FG001|Treatment Period|Protocol Violation|0|||
13087390|NCT03952143|25808371|FG002|Treatment Period|Protocol Violation|1|||
13087391|NCT03952143|25808369|FG000|Treatment Period|Withdrawal by Subject|0|||
13087392|NCT03952143|25808370|FG001|Treatment Period|Withdrawal by Subject|5|||
13087393|NCT03952143|25808371|FG002|Treatment Period|Withdrawal by Subject|26|||
13087394|NCT03952143|25808369|FG000|Treatment Period|Due to COVID 19 restrictions|0|||
13087395|NCT03952143|25808370|FG001|Treatment Period|Due to COVID 19 restrictions|2|||
13087396|NCT03952143|25808371|FG002|Treatment Period|Due to COVID 19 restrictions|5|||
13087397|NCT03952143|25808369|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0|||
13087398|NCT03952143|25808370|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0|||
13087399|NCT03952143|25808371|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1|||
13087400|NCT03951805|25808426|FG000|Overall Study|Adverse Event|1|||
13087401|NCT03951805|25808427|FG001|Overall Study|Adverse Event|0|||
13087402|NCT03951805|25808428|FG002|Overall Study|Adverse Event|0|||
13087403|NCT03951805|25808429|FG003|Overall Study|Adverse Event|0|||
13087404|NCT03951766|25808451|FG000|Treatment Phase|Lost to Follow-up|1|||
13087405|NCT03951766|25808451|FG000|Follow-up Phase|Lost to Follow-up|10|||
13087406|NCT03950856|25808514|FG000|Overall Study|Death|1|||
13087407|NCT03950856|25808515|FG001|Overall Study|Death|2|||
13087408|NCT03950856|25808516|FG002|Overall Study|Death|0|||
13087409|NCT03950856|25808517|FG003|Overall Study|Death|0|||
13087410|NCT03950856|25808514|FG000|Overall Study|Lost to Follow-up|5|||
13087411|NCT03950856|25808515|FG001|Overall Study|Lost to Follow-up|6|||
13087412|NCT03950856|25808516|FG002|Overall Study|Lost to Follow-up|8|||
13087413|NCT03950856|25808517|FG003|Overall Study|Lost to Follow-up|2|||
13087414|NCT03950856|25808514|FG000|Overall Study|Protocol Violation|2|||
13087415|NCT03950856|25808515|FG001|Overall Study|Protocol Violation|0|||
13087416|NCT03950856|25808516|FG002|Overall Study|Protocol Violation|0|||
13087417|NCT03950856|25808517|FG003|Overall Study|Protocol Violation|1|||
13087418|NCT03950856|25808514|FG000|Overall Study|Withdrawal by Subject|4|||
13087419|NCT03950856|25808515|FG001|Overall Study|Withdrawal by Subject|1|||
13087420|NCT03950856|25808516|FG002|Overall Study|Withdrawal by Subject|3|||
13087421|NCT03950856|25808517|FG003|Overall Study|Withdrawal by Subject|1|||
13087422|NCT03950856|25808514|FG000|Overall Study|Unable to phone|7|||
13087423|NCT03950856|25808515|FG001|Overall Study|Unable to phone|6|||
13087424|NCT03950856|25808516|FG002|Overall Study|Unable to phone|7|||
13087425|NCT03950856|25808517|FG003|Overall Study|Unable to phone|2|||
13087426|NCT03950622|25808552|FG000|Overall Study|Withdrawal by Subject|1|||
13087427|NCT03950622|25808553|FG001|Overall Study|Withdrawal by Subject|0|||
13087428|NCT03950622|25808552|FG000|Overall Study|Protocol Deviation|0|||
13087429|NCT03950622|25808553|FG001|Overall Study|Protocol Deviation|1|||
13087430|NCT03950622|25808552|FG000|Overall Study|Physician Decision|1|||
13087431|NCT03950622|25808553|FG001|Overall Study|Physician Decision|0|||
13087432|NCT03950622|25808552|FG000|Overall Study|Lost to Follow-up|5|||
13087433|NCT03950622|25808553|FG001|Overall Study|Lost to Follow-up|5|||
13087434|NCT03950622|25808552|FG000|Overall Study|Death|1|||
13087435|NCT03950622|25808553|FG001|Overall Study|Death|1|||
13087436|NCT03948581|25808570|FG000|Overall Study|Lost to Follow-up|0|||
13087437|NCT03948581|25808571|FG001|Overall Study|Lost to Follow-up|1|||
13087438|NCT03948334|25808600|FG000|Overall Study|Adverse Event|1|||
13087439|NCT03948334|25808601|FG001|Overall Study|Adverse Event|4|||
13087440|NCT03948334|25808600|FG000|Overall Study|Lack of Efficacy|2|||
13087441|NCT03948334|25808601|FG001|Overall Study|Lack of Efficacy|0|||
13087442|NCT03948334|25808600|FG000|Overall Study|Lost to Follow-up|1|||
13087443|NCT03948334|25808601|FG001|Overall Study|Lost to Follow-up|0|||
13087444|NCT03948334|25808600|FG000|Overall Study|Physician Decision|1|||
13087445|NCT03948334|25808601|FG001|Overall Study|Physician Decision|0|||
13087446|NCT03948334|25808600|FG000|Overall Study|Pregnancy|0|||
13087447|NCT03948334|25808601|FG001|Overall Study|Pregnancy|1|||
13087448|NCT03948334|25808600|FG000|Overall Study|Protocol Deviation|1|||
13087449|NCT03948334|25808601|FG001|Overall Study|Protocol Deviation|0|||
13087450|NCT03948334|25808600|FG000|Overall Study|Study terminated by Sponsor|50|||
13087451|NCT03948334|25808601|FG001|Overall Study|Study terminated by Sponsor|51|||
13087452|NCT03948334|25808600|FG000|Overall Study|Subject Decision /Guardian Decision|4|||
13087453|NCT03948334|25808601|FG001|Overall Study|Subject Decision /Guardian Decision|7|||
13087454|NCT03946124|25808607|FG000|Overall Study|Withdrawal by Subject|19|||
13087455|NCT03945981|25808630|FG000|Overall Study|Lost to Follow-up|12|||
13087456|NCT03945981|25808630|FG000|Overall Study|Physician Decision|4|||
13087457|NCT03945981|25808630|FG000|Overall Study|Withdrawal by Subject|6|||
13087458|NCT03945981|25808630|FG000|Overall Study|Protocol Violation|1|||
13087459|NCT03944707|25808657|FG000|Overall Study|Adverse Event|0|||
13087460|NCT03944707|25808658|FG001|Overall Study|Adverse Event|2|||
13087461|NCT03944707|25808657|FG000|Overall Study|Study terminated by sponsor|12|||
13087462|NCT03944707|25808658|FG001|Overall Study|Study terminated by sponsor|7|||
13087463|NCT03944707|25808657|FG000|Overall Study|Subject decision|0|||
13087464|NCT03944707|25808658|FG001|Overall Study|Subject decision|1|||
13087465|NCT03943290|25808763|FG000|Overall Study|Sponsor Terminated Study|6|||
13087466|NCT03943290|25808764|FG001|Overall Study|Sponsor Terminated Study|1|||
13087467|NCT03943290|25808765|FG002|Overall Study|Sponsor Terminated Study|11|||
13087468|NCT03943290|25808766|FG003|Overall Study|Sponsor Terminated Study|6|||
13087469|NCT03943290|25808767|FG004|Overall Study|Sponsor Terminated Study|7|||
13087470|NCT03943290|25808768|FG005|Overall Study|Sponsor Terminated Study|6|||
13087471|NCT03943290|25808769|FG006|Overall Study|Sponsor Terminated Study|6|||
13087472|NCT03943290|25808770|FG007|Overall Study|Sponsor Terminated Study|7|||
13087473|NCT03943290|25808771|FG008|Overall Study|Sponsor Terminated Study|8|||
13087474|NCT03943290|25808763|FG000|Overall Study|Lost to Follow-up|1|||
13087475|NCT03943290|25808764|FG001|Overall Study|Lost to Follow-up|0|||
13087476|NCT03943290|25808765|FG002|Overall Study|Lost to Follow-up|1|||
13087477|NCT03943290|25808766|FG003|Overall Study|Lost to Follow-up|0|||
13087478|NCT03943290|25808767|FG004|Overall Study|Lost to Follow-up|0|||
13087479|NCT03943290|25808768|FG005|Overall Study|Lost to Follow-up|0|||
13087480|NCT03943290|25808769|FG006|Overall Study|Lost to Follow-up|0|||
13087481|NCT03943290|25808770|FG007|Overall Study|Lost to Follow-up|1|||
13087482|NCT03943290|25808771|FG008|Overall Study|Lost to Follow-up|0|||
13087483|NCT03943290|25808763|FG000|Overall Study|Withdrawal by Subject|0|||
13087484|NCT03943290|25808764|FG001|Overall Study|Withdrawal by Subject|0|||
13087485|NCT03943290|25808765|FG002|Overall Study|Withdrawal by Subject|1|||
13087486|NCT03943290|25808766|FG003|Overall Study|Withdrawal by Subject|0|||
13087487|NCT03943290|25808767|FG004|Overall Study|Withdrawal by Subject|0|||
13087488|NCT03943290|25808768|FG005|Overall Study|Withdrawal by Subject|0|||
13087489|NCT03943290|25808769|FG006|Overall Study|Withdrawal by Subject|0|||
13087490|NCT03943290|25808770|FG007|Overall Study|Withdrawal by Subject|0|||
13087491|NCT03943290|25808771|FG008|Overall Study|Withdrawal by Subject|0|||
13087492|NCT03943095|25808822|FG000|Overall Study|Incorrectly dispensed wrong box kit|0|||
13087493|NCT03943095|25808823|FG001|Overall Study|Incorrectly dispensed wrong box kit|1|||
13087494|NCT03943095|25808822|FG000|Overall Study|Withdrawal by Subject|1|||
13087495|NCT03943095|25808823|FG001|Overall Study|Withdrawal by Subject|0|||
13087496|NCT03942042|25808861|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0|||
13087497|NCT03942042|25808862|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1|||
13087498|NCT03942042|25808861|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1|||
13087499|NCT03942042|25808862|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0|||
13087500|NCT03941483|25808889|FG000|Overall Study|Miscellaneous|2|||
13087501|NCT03941483|25808890|FG001|Overall Study|Miscellaneous|3|||
13087502|NCT03941483|25808891|FG002|Overall Study|Miscellaneous|0|||
13087503|NCT03941483|25808889|FG000|Overall Study|Study Terminated by Sponsor|1|||
13087504|NCT03941483|25808890|FG001|Overall Study|Study Terminated by Sponsor|0|||
13087505|NCT03941483|25808891|FG002|Overall Study|Study Terminated by Sponsor|0|||
13087506|NCT03941483|25808889|FG000|Overall Study|Withdrawal by Subject|1|||
13087507|NCT03941483|25808890|FG001|Overall Study|Withdrawal by Subject|4|||
13087508|NCT03941483|25808891|FG002|Overall Study|Withdrawal by Subject|1|||
13087509|NCT03941483|25808889|FG000|Overall Study|Lost to Follow-up|2|||
13087510|NCT03941483|25808890|FG001|Overall Study|Lost to Follow-up|1|||
13087511|NCT03941483|25808891|FG002|Overall Study|Lost to Follow-up|8|||
13087512|NCT03941483|25808889|FG000|Overall Study|Death|3|||
13087513|NCT03941483|25808890|FG001|Overall Study|Death|2|||
13087514|NCT03941483|25808891|FG002|Overall Study|Death|6|||
13087515|NCT03939312|25808902|FG000|OL Treatment Period (40 Weeks)|Withdrawal Criteria at Visit 1|43|||
13087516|NCT03939312|25808902|FG000|OL Treatment Period (40 Weeks)|Adverse Event|25|||
13087517|NCT03939312|25808902|FG000|OL Treatment Period (40 Weeks)|Lack of Efficacy|4|||
13087518|NCT03939312|25808902|FG000|OL Treatment Period (40 Weeks)|Withdrawal by Subject|35|||
13087519|NCT03939312|25808902|FG000|OL Treatment Period (40 Weeks)|Lost to Follow-up|19|||
13087520|NCT03939312|25808902|FG000|OL Treatment Period (40 Weeks)|Pregnancy|3|||
13087521|NCT03939312|25808902|FG000|OL Treatment Period (40 Weeks)|Protocol Deviation|16|||
13087522|NCT03939312|25808902|FG000|OL Treatment Period (40 Weeks)|Non-compliance With Study Drug|4|||
13087523|NCT03939312|25808902|FG000|OL Treatment Period (40 Weeks)|Site Terminated by Sponsor|3|||
13087524|NCT03939312|25808902|FG000|OL Treatment Period (40 Weeks)|Reason Not Specified|22|||
13087525|NCT03939312|25808902|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Withdrawal by Subject|12|||
13087526|NCT03939312|25808902|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Lost to Follow-up|4|||
13087527|NCT03938857|25809009|FG000|Overall Study|Physician Decision|1|||
13087528|NCT03938857|25809010|FG001|Overall Study|Physician Decision|0|||
13087529|NCT03938857|25809011|FG002|Overall Study|Physician Decision|0|||
13087530|NCT03938857|25809012|FG003|Overall Study|Physician Decision|0|||
13087531|NCT03938545|25809051|FG000|Overall Study|Lost to Follow-up|0|||
13087532|NCT03938545|25809052|FG001|Overall Study|Lost to Follow-up|0|||
13087533|NCT03938545|25809053|FG002|Overall Study|Lost to Follow-up|0|||
13087534|NCT03938545|25809054|FG003|Overall Study|Lost to Follow-up|1|||
13087535|NCT03938545|25809051|FG000|Overall Study|Non-compliance with study drug|0|||
13087536|NCT03938545|25809052|FG001|Overall Study|Non-compliance with study drug|0|||
13087537|NCT03938545|25809053|FG002|Overall Study|Non-compliance with study drug|1|||
13087538|NCT03938545|25809054|FG003|Overall Study|Non-compliance with study drug|0|||
13087539|NCT03938545|25809051|FG000|Overall Study|Pregnancy|1|||
13087540|NCT03938545|25809052|FG001|Overall Study|Pregnancy|0|||
13087541|NCT03938545|25809053|FG002|Overall Study|Pregnancy|0|||
13087542|NCT03938545|25809054|FG003|Overall Study|Pregnancy|0|||
13087543|NCT03938545|25809051|FG000|Overall Study|Study terminated by sponsor|6|||
13087544|NCT03938545|25809052|FG001|Overall Study|Study terminated by sponsor|4|||
13087545|NCT03938545|25809053|FG002|Overall Study|Study terminated by sponsor|2|||
13087546|NCT03938545|25809054|FG003|Overall Study|Study terminated by sponsor|4|||
13087547|NCT03938545|25809051|FG000|Overall Study|Withdrawal by Subject|0|||
13087548|NCT03938545|25809052|FG001|Overall Study|Withdrawal by Subject|1|||
13087549|NCT03938545|25809053|FG002|Overall Study|Withdrawal by Subject|0|||
13087550|NCT03938545|25809054|FG003|Overall Study|Withdrawal by Subject|0|||
13087551|NCT03938545|25809051|FG000|Overall Study|Adverse Event|1|||
13087552|NCT03938545|25809052|FG001|Overall Study|Adverse Event|0|||
13087553|NCT03938545|25809053|FG002|Overall Study|Adverse Event|0|||
13087554|NCT03938545|25809054|FG003|Overall Study|Adverse Event|0|||
13087555|NCT03937908|25809073|FG000|Overall Study|Study discontinuation due to pandemic restrictions|0|||
13087556|NCT03937908|25809074|FG001|Overall Study|Study discontinuation due to pandemic restrictions|1|||
13132542|NCT02788513|25984372|FG002|Overall Study|Adverse Event|4|||
13132543|NCT02788513|25984373|FG003|Overall Study|Adverse Event|2|||
13132544|NCT02788513|25984374|FG004|Overall Study|Adverse Event|2|||
13132545|NCT02788513|25984370|FG000|Overall Study|Protocol Violation|0|||
13132546|NCT02788513|25984371|FG001|Overall Study|Protocol Violation|0|||
13132547|NCT02788513|25984372|FG002|Overall Study|Protocol Violation|1|||
13132548|NCT02788513|25984373|FG003|Overall Study|Protocol Violation|1|||
13132549|NCT02788513|25984374|FG004|Overall Study|Protocol Violation|0|||
13132550|NCT02788513|25984370|FG000|Overall Study|Subject decided to stop taking treatment|0|||
13132551|NCT02788513|25984371|FG001|Overall Study|Subject decided to stop taking treatment|0|||
13132552|NCT02788513|25984372|FG002|Overall Study|Subject decided to stop taking treatment|1|||
13132553|NCT02788513|25984373|FG003|Overall Study|Subject decided to stop taking treatment|0|||
13132554|NCT02788513|25984374|FG004|Overall Study|Subject decided to stop taking treatment|0|||
13132555|NCT02788513|25984370|FG000|Overall Study|Decision by the study team|0|||
13132556|NCT02788513|25984371|FG001|Overall Study|Decision by the study team|0|||
13132557|NCT02788513|25984372|FG002|Overall Study|Decision by the study team|0|||
13132558|NCT02788513|25984373|FG003|Overall Study|Decision by the study team|0|||
13132559|NCT02788513|25984374|FG004|Overall Study|Decision by the study team|1|||
13132560|NCT02788474|25984394|FG000|Double Blind Treatment Period|Not treated|1|||
13132561|NCT02788474|25984395|FG001|Double Blind Treatment Period|Not treated|0|||
13132562|NCT02788474|25984394|FG000|Double Blind Treatment Period|Patient's refusal|3|||
13132563|NCT02788474|25984395|FG001|Double Blind Treatment Period|Patient's refusal|0|||
13132564|NCT02788474|25984394|FG000|Double Blind Treatment Period|Adverse Event|6|||
13132565|NCT02788474|25984395|FG001|Double Blind Treatment Period|Adverse Event|4|||
13132566|NCT02788474|25984394|FG000|Open Label Treatment Period|Adverse Event|29|||
13132567|NCT02788474|25984395|FG001|Open Label Treatment Period|Adverse Event|9|||
13132568|NCT02788474|25984394|FG000|Open Label Treatment Period|Other than reason specified|1|||
13132569|NCT02788474|25984395|FG001|Open Label Treatment Period|Other than reason specified|0|||
13132570|NCT02788474|25984394|FG000|Open Label Treatment Period|Patient's refusal|1|||
13132571|NCT02788474|25984395|FG001|Open Label Treatment Period|Patient's refusal|3|||
13132572|NCT02788474|25984394|FG000|Open Label Treatment Period|Non-compliance|1|||
13132573|NCT02788474|25984395|FG001|Open Label Treatment Period|Non-compliance|0|||
13132574|NCT02788357|25984414|FG000|Overall Study|Lost to Follow-up|3|||
13132575|NCT02788357|25984415|FG001|Overall Study|Lost to Follow-up|0|||
13132576|NCT02788279|25984456|FG000|Overall Study|Death|62|||
13132577|NCT02788279|25984457|FG001|Overall Study|Death|136|||
13132578|NCT02788279|25984458|FG002|Overall Study|Death|72|||
13132579|NCT02788279|25984456|FG000|Overall Study|Withdrawal by Subject|10|||
13087557|NCT03937778|25809083|FG000|Overall Study|Withdrawal by Subject|1|||
13087558|NCT03937778|25809083|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1|||
13087559|NCT03937479|25809191|FG000|Overall Study|Adverse Event|2|||
13087560|NCT03937479|25809192|FG001|Overall Study|Adverse Event|3|||
13087561|NCT03937479|25809193|FG002|Overall Study|Adverse Event|0|||
13087562|NCT03937479|25809194|FG003|Overall Study|Adverse Event|0|||
13087563|NCT03937479|25809195|FG004|Overall Study|Adverse Event|1|||
13087564|NCT03937479|25809191|FG000|Overall Study|Withdrawal by Subject|3|||
13087565|NCT03937479|25809192|FG001|Overall Study|Withdrawal by Subject|5|||
13087566|NCT03937479|25809193|FG002|Overall Study|Withdrawal by Subject|2|||
13087567|NCT03937479|25809194|FG003|Overall Study|Withdrawal by Subject|2|||
13087568|NCT03937479|25809195|FG004|Overall Study|Withdrawal by Subject|1|||
13087569|NCT03937479|25809191|FG000|Overall Study|Protocol Violation|5|||
13087570|NCT03937479|25809192|FG001|Overall Study|Protocol Violation|6|||
13087571|NCT03937479|25809193|FG002|Overall Study|Protocol Violation|4|||
13087572|NCT03937479|25809194|FG003|Overall Study|Protocol Violation|3|||
13087573|NCT03937479|25809195|FG004|Overall Study|Protocol Violation|2|||
13087574|NCT03937479|25809191|FG000|Overall Study|Lost to Follow-up|0|||
13087575|NCT03937479|25809192|FG001|Overall Study|Lost to Follow-up|1|||
13087576|NCT03937479|25809193|FG002|Overall Study|Lost to Follow-up|0|||
13087577|NCT03937479|25809194|FG003|Overall Study|Lost to Follow-up|1|||
13087578|NCT03937479|25809195|FG004|Overall Study|Lost to Follow-up|0|||
13087579|NCT03937479|25809191|FG000|Overall Study|Physician Decision|0|||
13087580|NCT03937479|25809192|FG001|Overall Study|Physician Decision|0|||
13087581|NCT03937479|25809193|FG002|Overall Study|Physician Decision|1|||
13087582|NCT03937479|25809194|FG003|Overall Study|Physician Decision|0|||
13087583|NCT03937479|25809195|FG004|Overall Study|Physician Decision|1|||
13087584|NCT03936244|25809268|FG000|Overall Study|Lost to Follow-up|5|||
13087585|NCT03936244|25809269|FG001|Overall Study|Lost to Follow-up|1|||
13087586|NCT03936244|25809268|FG000|Overall Study|Physician Decision|7|||
13087587|NCT03936244|25809269|FG001|Overall Study|Physician Decision|3|||
13087588|NCT03935126|25809285|FG000|Overall Study|Study termination by sponsor|3|||
13087589|NCT03934541|25809340|FG000|Overall Study|Study Terminated by Sponsor|0|||
13087590|NCT03934541|25809341|FG001|Overall Study|Study Terminated by Sponsor|1|||
13087591|NCT03934541|25809342|FG002|Overall Study|Study Terminated by Sponsor|0|||
13087592|NCT03934541|25809343|FG003|Overall Study|Study Terminated by Sponsor|0|||
13087593|NCT03933462|25809368|FG000|Overall Study|Adverse Event|2|||
13087594|NCT03933462|25809369|FG001|Overall Study|Adverse Event|0|||
13087595|NCT03933449|25809398|FG000|Overall Study|Adverse Event|6|||
13087596|NCT03933449|25809399|FG001|Overall Study|Adverse Event|4|||
13087597|NCT03933449|25809398|FG000|Overall Study|Death|36|||
13087598|NCT03933449|25809399|FG001|Overall Study|Death|51|||
13087599|NCT03933449|25809398|FG000|Overall Study|Ongoing in Study|20|||
13087600|NCT03933449|25809399|FG001|Overall Study|Ongoing in Study|6|||
13087601|NCT03931785|25809426|FG000|Overall Study|Lost to Follow-up|4|||
13087602|NCT03931785|25809427|FG001|Overall Study|Lost to Follow-up|1|||
13087603|NCT03931785|25809428|FG002|Overall Study|Lost to Follow-up|4|||
13087604|NCT03931785|25809429|FG003|Overall Study|Lost to Follow-up|3|||
13087605|NCT03931785|25809426|FG000|Overall Study|Adverse Event|1|||
13087606|NCT03931785|25809427|FG001|Overall Study|Adverse Event|0|||
13087607|NCT03931785|25809428|FG002|Overall Study|Adverse Event|3|||
13087608|NCT03931785|25809429|FG003|Overall Study|Adverse Event|4|||
13087609|NCT03931785|25809426|FG000|Overall Study|Protocol Violation|0|||
13087610|NCT03931785|25809427|FG001|Overall Study|Protocol Violation|1|||
13087611|NCT03931785|25809428|FG002|Overall Study|Protocol Violation|0|||
13087612|NCT03931785|25809429|FG003|Overall Study|Protocol Violation|0|||
13087613|NCT03931785|25809426|FG000|Overall Study|Noncompliance With Study drug|0|||
13087614|NCT03931785|25809427|FG001|Overall Study|Noncompliance With Study drug|1|||
13087615|NCT03931785|25809428|FG002|Overall Study|Noncompliance With Study drug|0|||
13087616|NCT03931785|25809429|FG003|Overall Study|Noncompliance With Study drug|0|||
13087617|NCT03931785|25809426|FG000|Overall Study|Other Not specified|0|||
13087618|NCT03931785|25809427|FG001|Overall Study|Other Not specified|2|||
13087619|NCT03931785|25809428|FG002|Overall Study|Other Not specified|2|||
13087620|NCT03931785|25809429|FG003|Overall Study|Other Not specified|2|||
13087621|NCT03931785|25809426|FG000|Overall Study|Withdrawal by Subject|0|||
13087622|NCT03931785|25809427|FG001|Overall Study|Withdrawal by Subject|2|||
13087623|NCT03931785|25809428|FG002|Overall Study|Withdrawal by Subject|4|||
13087624|NCT03931785|25809429|FG003|Overall Study|Withdrawal by Subject|1|||
13087625|NCT03931785|25809426|FG000|Overall Study|Pregnancy|0|||
13087626|NCT03931785|25809427|FG001|Overall Study|Pregnancy|0|||
13087627|NCT03931785|25809428|FG002|Overall Study|Pregnancy|0|||
13087628|NCT03931785|25809429|FG003|Overall Study|Pregnancy|1|||
13087629|NCT03931330|25809437|FG000|Overall Study|Physician Decision|1|||
13087630|NCT03929562|25809453|FG000|From Baseline to 1 Month Follow Up|Lost to Follow-up|2|||
13087631|NCT03929562|25809454|FG001|From Baseline to 1 Month Follow Up|Lost to Follow-up|1|||
13087632|NCT03929562|25809453|FG000|From Baseline to 1 Month Follow Up|Withdrawal by Subject|2|||
13087633|NCT03929562|25809454|FG001|From Baseline to 1 Month Follow Up|Withdrawal by Subject|0|||
13087634|NCT03929562|25809453|FG000|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|2|||
13087635|NCT03929562|25809454|FG001|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|0|||
13087636|NCT03928821|25809533|FG000|Overall Study|Death|0|||
13087637|NCT03928821|25809534|FG001|Overall Study|Death|1|||
13087638|NCT03928821|25809535|FG002|Overall Study|Death|0|||
13087639|NCT03928821|25809536|FG003|Overall Study|Death|0|||
13087640|NCT03928821|25809533|FG000|Overall Study|Lost to Follow-up|0|||
13087641|NCT03928821|25809534|FG001|Overall Study|Lost to Follow-up|2|||
13087642|NCT03928821|25809535|FG002|Overall Study|Lost to Follow-up|3|||
13087643|NCT03928821|25809536|FG003|Overall Study|Lost to Follow-up|0|||
13087644|NCT03928821|25809533|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
13087645|NCT03928821|25809534|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
13087646|NCT03928821|25809535|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
13087647|NCT03928821|25809536|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
13087648|NCT03927950|25809543|FG000|Overall Study|Adverse Event|9|||
13087649|NCT03927911|25809588|FG000|Overall Study|problems with eDiary|0|||
13087650|NCT03927911|25809589|FG001|Overall Study|problems with eDiary|1|||
13087651|NCT03927911|25809590|FG002|Overall Study|problems with eDiary|0|||
13087652|NCT03927911|25809591|FG003|Overall Study|problems with eDiary|1|||
13087653|NCT03927911|25809592|FG004|Overall Study|problems with eDiary|0|||
13087654|NCT03927911|25809593|FG005|Overall Study|problems with eDiary|4|||
13087655|NCT03927911|25809588|FG000|Overall Study|Adverse Event|0|||
13087656|NCT03927911|25809589|FG001|Overall Study|Adverse Event|0|||
13087657|NCT03927911|25809590|FG002|Overall Study|Adverse Event|0|||
13087658|NCT03927911|25809591|FG003|Overall Study|Adverse Event|0|||
13087659|NCT03927911|25809592|FG004|Overall Study|Adverse Event|0|||
13087660|NCT03927911|25809593|FG005|Overall Study|Adverse Event|1|||
13087661|NCT03927911|25809588|FG000|Overall Study|not treated -study terminated by sponsor|0|||
13087662|NCT03927911|25809589|FG001|Overall Study|not treated -study terminated by sponsor|1|||
13136335|NCT02724878|25998453|FG000|Overall Study|not started|1|||
13136336|NCT02724839|25998495|FG000|Overall Study|Withdrawal by Subject|1|||
13136337|NCT02724839|25998496|FG001|Overall Study|Withdrawal by Subject|1|||
13087663|NCT03927911|25809590|FG002|Overall Study|not treated -study terminated by sponsor|0|||
13087664|NCT03927911|25809591|FG003|Overall Study|not treated -study terminated by sponsor|0|||
13087665|NCT03927911|25809592|FG004|Overall Study|not treated -study terminated by sponsor|0|||
13087666|NCT03927911|25809593|FG005|Overall Study|not treated -study terminated by sponsor|0|||
13087667|NCT03927911|25809588|FG000|Overall Study|Surgery cancelled|0|||
13087668|NCT03927911|25809589|FG001|Overall Study|Surgery cancelled|0|||
13087669|NCT03927911|25809590|FG002|Overall Study|Surgery cancelled|0|||
13087670|NCT03927911|25809591|FG003|Overall Study|Surgery cancelled|1|||
13087671|NCT03927911|25809592|FG004|Overall Study|Surgery cancelled|0|||
13087672|NCT03927911|25809593|FG005|Overall Study|Surgery cancelled|1|||
13087673|NCT03927911|25809588|FG000|Overall Study|Protocol Violation|0|||
13087674|NCT03927911|25809589|FG001|Overall Study|Protocol Violation|0|||
13087675|NCT03927911|25809590|FG002|Overall Study|Protocol Violation|0|||
13087676|NCT03927911|25809591|FG003|Overall Study|Protocol Violation|0|||
13087677|NCT03927911|25809592|FG004|Overall Study|Protocol Violation|0|||
13087678|NCT03927911|25809593|FG005|Overall Study|Protocol Violation|1|||
13087679|NCT03927846|25809614|FG000|Overall Study|Lost to Follow-up|10|||
13087680|NCT03927846|25809615|FG001|Overall Study|Lost to Follow-up|11|||
13087681|NCT03927144|25809628|FG000|Overall Study|Adverse Event|9|||
13087682|NCT03927144|25809629|FG001|Overall Study|Adverse Event|5|||
13087683|NCT03927144|25809628|FG000|Overall Study|Lost to Follow-up|3|||
13087684|NCT03927144|25809629|FG001|Overall Study|Lost to Follow-up|2|||
13087685|NCT03927144|25809628|FG000|Overall Study|New Therapy for Study Indication|0|||
13087686|NCT03927144|25809629|FG001|Overall Study|New Therapy for Study Indication|1|||
13087687|NCT03927144|25809628|FG000|Overall Study|No Longer Clinically Benefiting|4|||
13087688|NCT03927144|25809629|FG001|Overall Study|No Longer Clinically Benefiting|4|||
13087689|NCT03927144|25809628|FG000|Overall Study|Physician Decision|2|||
13087690|NCT03927144|25809629|FG001|Overall Study|Physician Decision|8|||
13087691|NCT03927144|25809628|FG000|Overall Study|Protocol Violation|2|||
13087692|NCT03927144|25809629|FG001|Overall Study|Protocol Violation|2|||
13087693|NCT03927144|25809628|FG000|Overall Study|Withdrawal by Subject|16|||
13087694|NCT03927144|25809629|FG001|Overall Study|Withdrawal by Subject|40|||
13087695|NCT03926169|25809671|FG000|Period A|Adverse Event|2|||
13087696|NCT03926169|25809672|FG001|Period A|Adverse Event|2|||
13087697|NCT03926169|25809673|FG002|Period A|Adverse Event|1|||
13087698|NCT03926169|25809671|FG000|Period A|Withdrawal by Subject|2|||
13087699|NCT03926169|25809672|FG001|Period A|Withdrawal by Subject|2|||
13087700|NCT03926169|25809673|FG002|Period A|Withdrawal by Subject|2|||
13087701|NCT03926169|25809671|FG000|Period A|Lost to Follow-up|3|||
13087702|NCT03926169|25809672|FG001|Period A|Lost to Follow-up|1|||
13087703|NCT03926169|25809673|FG002|Period A|Lost to Follow-up|0|||
13087704|NCT03926169|25809671|FG000|Period A|Lack of Efficacy|0|||
13087705|NCT03926169|25809672|FG001|Period A|Lack of Efficacy|2|||
13087706|NCT03926169|25809673|FG002|Period A|Lack of Efficacy|2|||
13087707|NCT03926169|25809671|FG000|Period A|COVID-19 Infection|0|||
13136338|NCT02724839|25998497|FG002|Overall Study|Withdrawal by Subject|0|||
13136339|NCT02724839|25998495|FG000|Overall Study|Lost to Follow-up|0|||
13087708|NCT03926169|25809672|FG001|Period A|COVID-19 Infection|1|||
13087709|NCT03926169|25809673|FG002|Period A|COVID-19 Infection|0|||
13087710|NCT03926169|25809671|FG000|Period A|COVID-19 Logistical Restrictions|0|||
13087711|NCT03926169|25809672|FG001|Period A|COVID-19 Logistical Restrictions|2|||
13087712|NCT03926169|25809673|FG002|Period A|COVID-19 Logistical Restrictions|1|||
13087713|NCT03926169|25809671|FG000|Period A|Other, Not Specified|1|||
13087714|NCT03926169|25809672|FG001|Period A|Other, Not Specified|0|||
13087715|NCT03926169|25809673|FG002|Period A|Other, Not Specified|0|||
13087716|NCT03926169|25809671|FG000|Period B|Adverse Event|3|||
13087717|NCT03926169|25809672|FG001|Period B|Adverse Event|1|||
13087718|NCT03926169|25809673|FG002|Period B|Adverse Event|1|||
13087719|NCT03926169|25809671|FG000|Period B|Withdrawal by Subject|1|||
13087720|NCT03926169|25809672|FG001|Period B|Withdrawal by Subject|3|||
13087721|NCT03926169|25809673|FG002|Period B|Withdrawal by Subject|0|||
13087722|NCT03926169|25809671|FG000|Period B|Lack of Efficacy|3|||
13087723|NCT03926169|25809672|FG001|Period B|Lack of Efficacy|1|||
13087724|NCT03926169|25809673|FG002|Period B|Lack of Efficacy|1|||
13087725|NCT03926169|25809671|FG000|Period B|Lost to Follow-up|1|||
13087726|NCT03926169|25809672|FG001|Period B|Lost to Follow-up|1|||
13087727|NCT03926169|25809673|FG002|Period B|Lost to Follow-up|4|||
13087728|NCT03926169|25809671|FG000|Period B|Other, Not Specified|62|||
13087729|NCT03926169|25809672|FG001|Period B|Other, Not Specified|57|||
13087730|NCT03926169|25809673|FG002|Period B|Other, Not Specified|65|||
13087731|NCT03923933|25809698|FG000|Overall Study|Lost to Follow-up|1|||
13087732|NCT03923933|25809699|FG001|Overall Study|Lost to Follow-up|0|||
13087733|NCT03923933|25809698|FG000|Overall Study|Withdrawal by Subject|0|||
13087734|NCT03923933|25809699|FG001|Overall Study|Withdrawal by Subject|1|||
13087735|NCT03923530|25809711|FG000|Overall Study|Withdrawal by Subject|1|||
13087736|NCT03923530|25809711|FG000|Overall Study|screen failure|3|||
13087737|NCT03922945|25809759|FG000|Overall Study|Adverse Event|1|||
13087738|NCT03922945|25809760|FG001|Overall Study|Adverse Event|1|||
13087739|NCT03922945|25809761|FG002|Overall Study|Adverse Event|2|||
13087740|NCT03922945|25809759|FG000|Overall Study|Lost to Follow-up|13|||
13087741|NCT03922945|25809760|FG001|Overall Study|Lost to Follow-up|9|||
13087742|NCT03922945|25809761|FG002|Overall Study|Lost to Follow-up|20|||
13087743|NCT03922945|25809759|FG000|Overall Study|Lack of Efficacy|2|||
13087744|NCT03922945|25809760|FG001|Overall Study|Lack of Efficacy|0|||
13087745|NCT03922945|25809761|FG002|Overall Study|Lack of Efficacy|1|||
13087746|NCT03922945|25809759|FG000|Overall Study|Protocol Non-Compliance|0|||
13087747|NCT03922945|25809760|FG001|Overall Study|Protocol Non-Compliance|0|||
13087748|NCT03922945|25809761|FG002|Overall Study|Protocol Non-Compliance|1|||
13087749|NCT03922945|25809759|FG000|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|10|||
13087750|NCT03922945|25809760|FG001|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|6|||
13087751|NCT03922945|25809761|FG002|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|14|||
13087752|NCT03922945|25809759|FG000|Overall Study|All Other Personal Reasons|1|||
13087753|NCT03922945|25809760|FG001|Overall Study|All Other Personal Reasons|1|||
13087754|NCT03922945|25809761|FG002|Overall Study|All Other Personal Reasons|2|||
13087755|NCT03922477|25809780|FG000|Overall Study|Death|9|||
13087756|NCT03922477|25809780|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1|||
13087757|NCT03922477|25809780|FG000|Overall Study|Physician Decision|1|||
13087758|NCT03922477|25809780|FG000|Overall Study|Withdrawal by Subject|2|||
13087759|NCT03921723|25809850|FG000|Period 2 (4 Days)|Withdrawal by Subject|3|||
13087760|NCT03921723|25809850|FG000|Period 3 (4 Days)|Withdrawal by Subject|1|||
13087761|NCT03921528|25809905|FG000|Overall Study|Withdrawal by Subject|0|||
13087762|NCT03921528|25809906|FG001|Overall Study|Withdrawal by Subject|1|||
13087763|NCT03921528|25809907|FG002|Overall Study|Withdrawal by Subject|0|||
13087764|NCT03921528|25809908|FG003|Overall Study|Withdrawal by Subject|0|||
13087765|NCT03921528|25809909|FG004|Overall Study|Withdrawal by Subject|0|||
13087766|NCT03921151|25809924|FG000|Overall Study|Withdrawal by Subject|11|||
13087767|NCT03921151|25809925|FG001|Overall Study|Withdrawal by Subject|16|||
13087768|NCT03920670|25809938|FG000|Overall Study|Protocol Violation|2|||
13087769|NCT03920670|25809939|FG001|Overall Study|Protocol Violation|2|||
13087770|NCT03920670|25809938|FG000|Overall Study|Adverse Event|1|||
13087771|NCT03920670|25809939|FG001|Overall Study|Adverse Event|0|||
13087772|NCT03920293|25809962|FG000|Overall Study|Withdrawal by Subject|2|||
13087773|NCT03920293|25809963|FG001|Overall Study|Withdrawal by Subject|1|||
13087774|NCT03920293|25809962|FG000|Overall Study|Physician Decision|1|||
13087775|NCT03920293|25809963|FG001|Overall Study|Physician Decision|2|||
13087776|NCT03920293|25809962|FG000|Overall Study|Adverse Event|0|||
13087777|NCT03920293|25809963|FG001|Overall Study|Adverse Event|2|||
13087778|NCT03920293|25809962|FG000|Overall Study|Sponsor Decision|0|||
13087779|NCT03920293|25809963|FG001|Overall Study|Sponsor Decision|1|||
13087780|NCT03920293|25809962|FG000|Overall Study|Death|2|||
13087781|NCT03920293|25809963|FG001|Overall Study|Death|0|||
13087782|NCT03920293|25809962|FG000|Overall Study|Protocol Violation|1|||
13087783|NCT03920293|25809963|FG001|Overall Study|Protocol Violation|0|||
13087784|NCT03920293|25809962|FG000|Overall Study|Noncompliance|1|||
13087785|NCT03920293|25809963|FG001|Overall Study|Noncompliance|0|||
13087786|NCT03920280|25809981|FG000|Overall Study|Adverse Event|2|||
13087787|NCT03920280|25809982|FG001|Overall Study|Adverse Event|3|||
13087788|NCT03920280|25809981|FG000|Overall Study|Lost to Follow-up|0|||
13087789|NCT03920280|25809982|FG001|Overall Study|Lost to Follow-up|1|||
13087790|NCT03920280|25809981|FG000|Overall Study|Withdrawal by Subject|1|||
13087791|NCT03920280|25809982|FG001|Overall Study|Withdrawal by Subject|1|||
13087792|NCT03920280|25809981|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0|||
13087793|NCT03920280|25809982|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1|||
13087794|NCT03920215|25810017|FG000|Overall Study|Lost to Follow-up|1|||
13087795|NCT03920215|25810018|FG001|Overall Study|Lost to Follow-up|2|||
13087796|NCT03920215|25810019|FG002|Overall Study|Lost to Follow-up|0|||
13087797|NCT03920215|25810020|FG003|Overall Study|Lost to Follow-up|0|||
13087798|NCT03920215|25810017|FG000|Overall Study|Death|0|||
13087799|NCT03920215|25810018|FG001|Overall Study|Death|0|||
13087800|NCT03920215|25810019|FG002|Overall Study|Death|0|||
13087801|NCT03920215|25810020|FG003|Overall Study|Death|1|||
13087802|NCT03918239|25810051|FG000|Overall Study|Lost to Follow-up|3|||
13087803|NCT03918239|25810052|FG001|Overall Study|Lost to Follow-up|1|||
13087804|NCT03918239|25810051|FG000|Overall Study|Pregnancy|0|||
13087805|NCT03918239|25810052|FG001|Overall Study|Pregnancy|2|||
13087806|NCT03918239|25810051|FG000|Overall Study|Withdrawal by Subject|3|||
13087807|NCT03918239|25810052|FG001|Overall Study|Withdrawal by Subject|3|||
13087808|NCT03918239|25810051|FG000|Overall Study|positive urine drug screening results|4|||
13087809|NCT03918239|25810052|FG001|Overall Study|positive urine drug screening results|1|||
13087810|NCT03917823|25810073|FG000|Overall Study|Lost to Follow-up|1|||
13087811|NCT03917823|25810074|FG001|Overall Study|Lost to Follow-up|1|||
13087812|NCT03917823|25810073|FG000|Overall Study|Withdrawal by Subject|0|||
13087813|NCT03917823|25810074|FG001|Overall Study|Withdrawal by Subject|1|||
13087814|NCT03917654|25810137|FG000|Year 1|Withdrawal by Subject|1|||
13087815|NCT03917654|25810138|FG001|Year 1|Withdrawal by Subject|0|||
13087816|NCT03917654|25810139|FG002|Year 1|Withdrawal by Subject|0|||
13087817|NCT03917654|25810140|FG003|Year 1|Withdrawal by Subject|0|||
13087818|NCT03917654|25810141|FG004|Year 1|Withdrawal by Subject|0|||
13087819|NCT03917654|25810142|FG005|Year 1|Withdrawal by Subject|1|||
13087820|NCT03917654|25810143|FG006|Year 1|Withdrawal by Subject|6|||
13087821|NCT03917654|25810144|FG007|Year 1|Withdrawal by Subject|2|||
13087822|NCT03917654|25810145|FG008|Year 1|Withdrawal by Subject|5|||
13087823|NCT03917654|25810146|FG009|Year 1|Withdrawal by Subject|3|||
13087824|NCT03917654|25810147|FG010|Year 1|Withdrawal by Subject|1|||
13087825|NCT03917654|25810148|FG011|Year 1|Withdrawal by Subject|0|||
13087826|NCT03917654|25810137|FG000|Year 1|Travel|0|||
13087827|NCT03917654|25810138|FG001|Year 1|Travel|1|||
13087828|NCT03917654|25810139|FG002|Year 1|Travel|1|||
13087829|NCT03917654|25810140|FG003|Year 1|Travel|0|||
13087830|NCT03917654|25810141|FG004|Year 1|Travel|4|||
13087831|NCT03917654|25810142|FG005|Year 1|Travel|4|||
13087832|NCT03917654|25810143|FG006|Year 1|Travel|10|||
13087833|NCT03917654|25810144|FG007|Year 1|Travel|8|||
13087834|NCT03917654|25810145|FG008|Year 1|Travel|2|||
13087835|NCT03917654|25810146|FG009|Year 1|Travel|5|||
13087836|NCT03917654|25810147|FG010|Year 1|Travel|3|||
13087837|NCT03917654|25810148|FG011|Year 1|Travel|3|||
13087838|NCT03917654|25810137|FG000|Year 1|Subject moved away from site|0|||
13087839|NCT03917654|25810138|FG001|Year 1|Subject moved away from site|1|||
13087840|NCT03917654|25810139|FG002|Year 1|Subject moved away from site|0|||
13087841|NCT03917654|25810140|FG003|Year 1|Subject moved away from site|0|||
13087842|NCT03917654|25810141|FG004|Year 1|Subject moved away from site|0|||
13087843|NCT03917654|25810142|FG005|Year 1|Subject moved away from site|0|||
13087844|NCT03917654|25810143|FG006|Year 1|Subject moved away from site|1|||
13087845|NCT03917654|25810144|FG007|Year 1|Subject moved away from site|2|||
13087846|NCT03917654|25810145|FG008|Year 1|Subject moved away from site|1|||
13087847|NCT03917654|25810146|FG009|Year 1|Subject moved away from site|0|||
13087848|NCT03917654|25810147|FG010|Year 1|Subject moved away from site|0|||
13087849|NCT03917654|25810148|FG011|Year 1|Subject moved away from site|3|||
13087850|NCT03917654|25810137|FG000|Year 1|Spouse/Family member request|0|||
13087851|NCT03917654|25810138|FG001|Year 1|Spouse/Family member request|0|||
13087852|NCT03917654|25810139|FG002|Year 1|Spouse/Family member request|1|||
13087853|NCT03917654|25810140|FG003|Year 1|Spouse/Family member request|0|||
13087854|NCT03917654|25810141|FG004|Year 1|Spouse/Family member request|1|||
13087855|NCT03917654|25810142|FG005|Year 1|Spouse/Family member request|0|||
13087856|NCT03917654|25810143|FG006|Year 1|Spouse/Family member request|0|||
13087857|NCT03917654|25810144|FG007|Year 1|Spouse/Family member request|2|||
13087858|NCT03917654|25810145|FG008|Year 1|Spouse/Family member request|0|||
13087859|NCT03917654|25810146|FG009|Year 1|Spouse/Family member request|0|||
13087860|NCT03917654|25810147|FG010|Year 1|Spouse/Family member request|0|||
13087861|NCT03917654|25810148|FG011|Year 1|Spouse/Family member request|1|||
13087862|NCT03917654|25810137|FG000|Year 1|Death|0|||
13087863|NCT03917654|25810138|FG001|Year 1|Death|0|||
13087864|NCT03917654|25810139|FG002|Year 1|Death|0|||
13087865|NCT03917654|25810140|FG003|Year 1|Death|0|||
13087866|NCT03917654|25810141|FG004|Year 1|Death|0|||
13087867|NCT03917654|25810142|FG005|Year 1|Death|0|||
13087868|NCT03917654|25810143|FG006|Year 1|Death|0|||
13087869|NCT03917654|25810144|FG007|Year 1|Death|0|||
13087870|NCT03917654|25810145|FG008|Year 1|Death|1|||
13087871|NCT03917654|25810146|FG009|Year 1|Death|1|||
13087872|NCT03917654|25810147|FG010|Year 1|Death|0|||
13087873|NCT03917654|25810148|FG011|Year 1|Death|0|||
13087874|NCT03917654|25810137|FG000|Year 1|Lost to Follow-up|0|||
13087875|NCT03917654|25810138|FG001|Year 1|Lost to Follow-up|0|||
13087876|NCT03917654|25810139|FG002|Year 1|Lost to Follow-up|0|||
13087877|NCT03917654|25810140|FG003|Year 1|Lost to Follow-up|0|||
13087878|NCT03917654|25810141|FG004|Year 1|Lost to Follow-up|0|||
13087879|NCT03917654|25810142|FG005|Year 1|Lost to Follow-up|0|||
13087880|NCT03917654|25810143|FG006|Year 1|Lost to Follow-up|2|||
13087881|NCT03917654|25810144|FG007|Year 1|Lost to Follow-up|0|||
13087882|NCT03917654|25810145|FG008|Year 1|Lost to Follow-up|0|||
13087883|NCT03917654|25810146|FG009|Year 1|Lost to Follow-up|0|||
13087884|NCT03917654|25810147|FG010|Year 1|Lost to Follow-up|0|||
13087885|NCT03917654|25810148|FG011|Year 1|Lost to Follow-up|0|||
13087886|NCT03917654|25810137|FG000|Year 1|Missed visits|0|||
13087887|NCT03917654|25810138|FG001|Year 1|Missed visits|0|||
13087888|NCT03917654|25810139|FG002|Year 1|Missed visits|0|||
13087889|NCT03917654|25810140|FG003|Year 1|Missed visits|0|||
13087890|NCT03917654|25810141|FG004|Year 1|Missed visits|0|||
13087891|NCT03917654|25810142|FG005|Year 1|Missed visits|0|||
13087892|NCT03917654|25810143|FG006|Year 1|Missed visits|0|||
13087893|NCT03917654|25810144|FG007|Year 1|Missed visits|0|||
13087894|NCT03917654|25810145|FG008|Year 1|Missed visits|0|||
13087895|NCT03917654|25810146|FG009|Year 1|Missed visits|0|||
13087896|NCT03917654|25810147|FG010|Year 1|Missed visits|1|||
13087897|NCT03917654|25810148|FG011|Year 1|Missed visits|1|||
13087898|NCT03917654|25810137|FG000|Year 1|Pregnancy|0|||
13087899|NCT03917654|25810138|FG001|Year 1|Pregnancy|0|||
13087900|NCT03917654|25810139|FG002|Year 1|Pregnancy|0|||
13087901|NCT03917654|25810140|FG003|Year 1|Pregnancy|0|||
13087902|NCT03917654|25810141|FG004|Year 1|Pregnancy|0|||
13087903|NCT03917654|25810142|FG005|Year 1|Pregnancy|0|||
13087904|NCT03917654|25810143|FG006|Year 1|Pregnancy|0|||
13087905|NCT03917654|25810144|FG007|Year 1|Pregnancy|1|||
13087906|NCT03917654|25810145|FG008|Year 1|Pregnancy|0|||
13087907|NCT03917654|25810146|FG009|Year 1|Pregnancy|1|||
13087908|NCT03917654|25810147|FG010|Year 1|Pregnancy|0|||
13087909|NCT03917654|25810148|FG011|Year 1|Pregnancy|0|||
13087910|NCT03917654|25810137|FG000|Year 2|Travel|1|||
13087911|NCT03917654|25810138|FG001|Year 2|Travel|0|||
13087912|NCT03917654|25810139|FG002|Year 2|Travel|0|||
13087913|NCT03917654|25810140|FG003|Year 2|Travel|0|||
13087914|NCT03917654|25810141|FG004|Year 2|Travel|1|||
13087915|NCT03917654|25810142|FG005|Year 2|Travel|1|||
13087916|NCT03917654|25810143|FG006|Year 2|Travel|2|||
13087917|NCT03917654|25810144|FG007|Year 2|Travel|1|||
13087918|NCT03917654|25810145|FG008|Year 2|Travel|0|||
13087919|NCT03917654|25810146|FG009|Year 2|Travel|1|||
13087920|NCT03917654|25810147|FG010|Year 2|Travel|0|||
13087921|NCT03917654|25810148|FG011|Year 2|Travel|1|||
13087922|NCT03917654|25810137|FG000|Year 2|Married|1|||
13087923|NCT03917654|25810138|FG001|Year 2|Married|0|||
13087924|NCT03917654|25810139|FG002|Year 2|Married|0|||
13087925|NCT03917654|25810140|FG003|Year 2|Married|0|||
13087926|NCT03917654|25810141|FG004|Year 2|Married|0|||
13087927|NCT03917654|25810142|FG005|Year 2|Married|0|||
13087928|NCT03917654|25810143|FG006|Year 2|Married|1|||
13087929|NCT03917654|25810144|FG007|Year 2|Married|1|||
13087930|NCT03917654|25810145|FG008|Year 2|Married|0|||
13087931|NCT03917654|25810146|FG009|Year 2|Married|0|||
13087932|NCT03917654|25810147|FG010|Year 2|Married|0|||
13087933|NCT03917654|25810148|FG011|Year 2|Married|0|||
13087934|NCT03917654|25810137|FG000|Year 2|Subject moved away from site|1|||
13087935|NCT03917654|25810138|FG001|Year 2|Subject moved away from site|0|||
13087936|NCT03917654|25810139|FG002|Year 2|Subject moved away from site|0|||
13087937|NCT03917654|25810140|FG003|Year 2|Subject moved away from site|0|||
13087938|NCT03917654|25810141|FG004|Year 2|Subject moved away from site|1|||
13087939|NCT03917654|25810142|FG005|Year 2|Subject moved away from site|0|||
13087940|NCT03917654|25810143|FG006|Year 2|Subject moved away from site|2|||
13087941|NCT03917654|25810144|FG007|Year 2|Subject moved away from site|3|||
13087942|NCT03917654|25810145|FG008|Year 2|Subject moved away from site|0|||
13087943|NCT03917654|25810146|FG009|Year 2|Subject moved away from site|2|||
13087944|NCT03917654|25810147|FG010|Year 2|Subject moved away from site|0|||
13087945|NCT03917654|25810148|FG011|Year 2|Subject moved away from site|1|||
13087946|NCT03917654|25810137|FG000|Year 2|Year 2 Screening failure|0|||
13087947|NCT03917654|25810138|FG001|Year 2|Year 2 Screening failure|1|||
13087948|NCT03917654|25810139|FG002|Year 2|Year 2 Screening failure|0|||
13087949|NCT03917654|25810140|FG003|Year 2|Year 2 Screening failure|0|||
13087950|NCT03917654|25810141|FG004|Year 2|Year 2 Screening failure|2|||
13087951|NCT03917654|25810142|FG005|Year 2|Year 2 Screening failure|0|||
13087952|NCT03917654|25810143|FG006|Year 2|Year 2 Screening failure|4|||
13087953|NCT03917654|25810144|FG007|Year 2|Year 2 Screening failure|3|||
13087954|NCT03917654|25810145|FG008|Year 2|Year 2 Screening failure|10|||
13087955|NCT03917654|25810146|FG009|Year 2|Year 2 Screening failure|2|||
13087956|NCT03917654|25810147|FG010|Year 2|Year 2 Screening failure|1|||
13087957|NCT03917654|25810148|FG011|Year 2|Year 2 Screening failure|1|||
13087958|NCT03917654|25810137|FG000|Year 2|Death|0|||
13087959|NCT03917654|25810138|FG001|Year 2|Death|0|||
13087960|NCT03917654|25810139|FG002|Year 2|Death|0|||
13087961|NCT03917654|25810140|FG003|Year 2|Death|0|||
13087962|NCT03917654|25810141|FG004|Year 2|Death|0|||
13087963|NCT03917654|25810142|FG005|Year 2|Death|1|||
13087964|NCT03917654|25810143|FG006|Year 2|Death|0|||
13087965|NCT03917654|25810144|FG007|Year 2|Death|0|||
13087966|NCT03917654|25810145|FG008|Year 2|Death|1|||
13087967|NCT03917654|25810146|FG009|Year 2|Death|1|||
13087968|NCT03917654|25810147|FG010|Year 2|Death|0|||
13087969|NCT03917654|25810148|FG011|Year 2|Death|0|||
13087970|NCT03917654|25810137|FG000|Year 2|Withdrawal by Subject|0|||
13087971|NCT03917654|25810138|FG001|Year 2|Withdrawal by Subject|0|||
13087972|NCT03917654|25810139|FG002|Year 2|Withdrawal by Subject|0|||
13087973|NCT03917654|25810140|FG003|Year 2|Withdrawal by Subject|0|||
13087974|NCT03917654|25810141|FG004|Year 2|Withdrawal by Subject|0|||
13087975|NCT03917654|25810142|FG005|Year 2|Withdrawal by Subject|0|||
13087976|NCT03917654|25810143|FG006|Year 2|Withdrawal by Subject|3|||
13087977|NCT03917654|25810144|FG007|Year 2|Withdrawal by Subject|0|||
13087978|NCT03917654|25810145|FG008|Year 2|Withdrawal by Subject|2|||
13087979|NCT03917654|25810146|FG009|Year 2|Withdrawal by Subject|5|||
13087980|NCT03917654|25810147|FG010|Year 2|Withdrawal by Subject|0|||
13087981|NCT03917654|25810148|FG011|Year 2|Withdrawal by Subject|0|||
13087982|NCT03917654|25810137|FG000|Year 2|Spouse/family member request|0|||
13087983|NCT03917654|25810138|FG001|Year 2|Spouse/family member request|0|||
13087984|NCT03917654|25810139|FG002|Year 2|Spouse/family member request|0|||
13087985|NCT03917654|25810140|FG003|Year 2|Spouse/family member request|0|||
13087986|NCT03917654|25810141|FG004|Year 2|Spouse/family member request|0|||
13087987|NCT03917654|25810142|FG005|Year 2|Spouse/family member request|0|||
13087988|NCT03917654|25810143|FG006|Year 2|Spouse/family member request|1|||
13087989|NCT03917654|25810144|FG007|Year 2|Spouse/family member request|0|||
13087990|NCT03917654|25810145|FG008|Year 2|Spouse/family member request|0|||
13087991|NCT03917654|25810146|FG009|Year 2|Spouse/family member request|0|||
13087992|NCT03917654|25810147|FG010|Year 2|Spouse/family member request|0|||
13087993|NCT03917654|25810148|FG011|Year 2|Spouse/family member request|0|||
13087994|NCT03917654|25810137|FG000|Year 2|Lost to Follow-up|0|||
13087995|NCT03917654|25810138|FG001|Year 2|Lost to Follow-up|0|||
13087996|NCT03917654|25810139|FG002|Year 2|Lost to Follow-up|0|||
13087997|NCT03917654|25810140|FG003|Year 2|Lost to Follow-up|0|||
13087998|NCT03917654|25810141|FG004|Year 2|Lost to Follow-up|0|||
13087999|NCT03917654|25810142|FG005|Year 2|Lost to Follow-up|0|||
13088000|NCT03917654|25810143|FG006|Year 2|Lost to Follow-up|1|||
13088001|NCT03917654|25810144|FG007|Year 2|Lost to Follow-up|0|||
13088002|NCT03917654|25810145|FG008|Year 2|Lost to Follow-up|1|||
13088003|NCT03917654|25810146|FG009|Year 2|Lost to Follow-up|0|||
13088004|NCT03917654|25810147|FG010|Year 2|Lost to Follow-up|0|||
13088005|NCT03917654|25810148|FG011|Year 2|Lost to Follow-up|1|||
13088006|NCT03917654|25810137|FG000|Year 2|Adverse Event|0|||
13088007|NCT03917654|25810138|FG001|Year 2|Adverse Event|0|||
13088008|NCT03917654|25810139|FG002|Year 2|Adverse Event|0|||
13088009|NCT03917654|25810140|FG003|Year 2|Adverse Event|0|||
13088010|NCT03917654|25810141|FG004|Year 2|Adverse Event|0|||
13088011|NCT03917654|25810142|FG005|Year 2|Adverse Event|0|||
13088012|NCT03917654|25810143|FG006|Year 2|Adverse Event|0|||
13088013|NCT03917654|25810144|FG007|Year 2|Adverse Event|0|||
13088014|NCT03917654|25810145|FG008|Year 2|Adverse Event|0|||
13088015|NCT03917654|25810146|FG009|Year 2|Adverse Event|1|||
13088016|NCT03917654|25810147|FG010|Year 2|Adverse Event|0|||
13088017|NCT03917654|25810148|FG011|Year 2|Adverse Event|0|||
13088018|NCT03917472|25810189|FG000|Overall Study|Physician Decision|4|||
13088019|NCT03917472|25810190|FG001|Overall Study|Physician Decision|0|||
13088020|NCT03917472|25810189|FG000|Overall Study|Adverse Event|3|||
13088021|NCT03917472|25810190|FG001|Overall Study|Adverse Event|1|||
13088022|NCT03917472|25810189|FG000|Overall Study|Death|7|||
13088023|NCT03917472|25810190|FG001|Overall Study|Death|5|||
13088024|NCT03917472|25810189|FG000|Overall Study|Withdrawal by Subject|11|||
13088025|NCT03917472|25810190|FG001|Overall Study|Withdrawal by Subject|4|||
13088026|NCT03917472|25810189|FG000|Overall Study|Lost to Follow-up|10|||
13088027|NCT03917472|25810190|FG001|Overall Study|Lost to Follow-up|5|||
13088028|NCT03914950|25810202|FG000|Overall Study|Physician Decision|54|||
13088029|NCT03914417|25810209|FG000|Overall Study|Withdrawal by Subject|2|||
13088030|NCT03913377|25810232|FG000|Period 1|Test Article no longer available|0|||
13088031|NCT03913377|25810233|FG001|Period 1|Test Article no longer available|1|||
13088032|NCT03913377|25810234|FG002|Period 1|Test Article no longer available|0|||
13088033|NCT03913377|25810232|FG000|Period 1|No Longer Meets Eligibility Criteria|0|||
13088034|NCT03913377|25810233|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
13088035|NCT03913377|25810234|FG002|Period 1|No Longer Meets Eligibility Criteria|1|||
13088036|NCT03912337|25810257|FG000|Overall Study|Withdrawal of Consent From Study|1|||
13088037|NCT03912337|25810258|FG001|Overall Study|Withdrawal of Consent From Study|0|||
13088038|NCT03912337|25810257|FG000|Overall Study|Lost to Follow-up|1|||
13088039|NCT03912337|25810258|FG001|Overall Study|Lost to Follow-up|1|||
13088040|NCT03912259|25810321|FG000|Overall Study|Adverse Event (AE)|2|||
13088041|NCT03912259|25810322|FG001|Overall Study|Adverse Event (AE)|4|||
13088042|NCT03912259|25810321|FG000|Overall Study|Lack of Efficacy|4|||
13088043|NCT03912259|25810322|FG001|Overall Study|Lack of Efficacy|1|||
13088044|NCT03912259|25810321|FG000|Overall Study|Withdrawal by Subject|11|||
13088045|NCT03912259|25810322|FG001|Overall Study|Withdrawal by Subject|1|||
13088046|NCT03911960|25810348|FG000|Overall Study|Lost to Follow-up|5|||
13088047|NCT03911960|25810349|FG001|Overall Study|Lost to Follow-up|3|||
13088048|NCT03911843|25810366|FG000|Overall Study|Adverse Event|2|||
13088049|NCT03911843|25810367|FG001|Overall Study|Adverse Event|0|||
13088050|NCT03911843|25810366|FG000|Overall Study|Protocol Violation|2|||
13088051|NCT03911843|25810367|FG001|Overall Study|Protocol Violation|0|||
13088052|NCT03911843|25810366|FG000|Overall Study|Lost to Follow-up|0|||
13088053|NCT03911843|25810367|FG001|Overall Study|Lost to Follow-up|1|||
13088054|NCT03911401|25810391|FG000|Overall Study|Adverse Event|1|||
13088055|NCT03911401|25810392|FG001|Overall Study|Adverse Event|2|||
13088056|NCT03911401|25810393|FG002|Overall Study|Adverse Event|5|||
13088057|NCT03911401|25810391|FG000|Overall Study|Lack of Efficacy|1|||
13088058|NCT03911401|25810392|FG001|Overall Study|Lack of Efficacy|1|||
13088059|NCT03911401|25810393|FG002|Overall Study|Lack of Efficacy|8|||
13088060|NCT03911401|25810391|FG000|Overall Study|Physician Decision|0|||
13088061|NCT03911401|25810392|FG001|Overall Study|Physician Decision|0|||
13088062|NCT03911401|25810393|FG002|Overall Study|Physician Decision|1|||
13088063|NCT03911401|25810391|FG000|Overall Study|Withdrawal by Subject|1|||
13088064|NCT03911401|25810392|FG001|Overall Study|Withdrawal by Subject|2|||
13222495|NCT01806597|26286267|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
13088065|NCT03911401|25810393|FG002|Overall Study|Withdrawal by Subject|0|||
13088066|NCT03911401|25810391|FG000|Overall Study|Withdrawal by parent/guardian|4|||
13088067|NCT03911401|25810392|FG001|Overall Study|Withdrawal by parent/guardian|4|||
13088068|NCT03911401|25810393|FG002|Overall Study|Withdrawal by parent/guardian|11|||
13088069|NCT03909295|25810399|FG000|Overall Study|Adverse Event|2|||
13088070|NCT03909295|25810399|FG000|Overall Study|Study terminated by sponsor|50|||
13088071|NCT03909100|25810414|FG000|Overall Study|Protocol Deviation|2|||
13088072|NCT03909100|25810414|FG000|Overall Study|Technical Problems|4|||
13088073|NCT03909100|25810414|FG000|Overall Study|Withdrawal by Subject|4|||
13088074|NCT03909100|25810414|FG000|Overall Study|Lost to Follow-up|1|||
13088075|NCT03909100|25810414|FG000|Overall Study|Reason not Specified|4|||
13088076|NCT03908970|25810431|FG000|Overall Study|Adverse Event|7|||
13088077|NCT03908970|25810432|FG001|Overall Study|Adverse Event|21|||
13088078|NCT03908970|25810431|FG000|Overall Study|Physician Decision|1|||
13088079|NCT03908970|25810432|FG001|Overall Study|Physician Decision|4|||
13088080|NCT03908970|25810431|FG000|Overall Study|Withdrawal by Subject|9|||
13088081|NCT03908970|25810432|FG001|Overall Study|Withdrawal by Subject|22|||
13088082|NCT03907683|25810438|FG000|Overall Study|Pregnancy|1|||
13088083|NCT03907683|25810438|FG000|Overall Study|Withdrawal by Subject|1|||
13088084|NCT03907280|25810458|FG000|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
13088085|NCT03907280|25810459|FG001|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|1|||
13088086|NCT03907280|25810460|FG002|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
13088087|NCT03907072|25810505|FG000|Overall Study|Study Terminated by Sponsor|2|||
13088088|NCT03907072|25810506|FG001|Overall Study|Study Terminated by Sponsor|2|||
13088089|NCT03907072|25810507|FG002|Overall Study|Study Terminated by Sponsor|2|||
13088090|NCT03905863|25810526|FG000|Overall Study|Adverse Event|2|||
13088091|NCT03905863|25810527|FG001|Overall Study|Adverse Event|4|||
13088092|NCT03905863|25810526|FG000|Overall Study|Withdrawal by Subject|2|||
13088093|NCT03905863|25810527|FG001|Overall Study|Withdrawal by Subject|2|||
13088094|NCT03905863|25810526|FG000|Overall Study|Physician Decision|0|||
13088095|NCT03905863|25810527|FG001|Overall Study|Physician Decision|3|||
13088096|NCT03905863|25810526|FG000|Overall Study|Lost to Follow-up|1|||
13088097|NCT03905863|25810527|FG001|Overall Study|Lost to Follow-up|0|||
13088098|NCT03905863|25810526|FG000|Overall Study|Protocol Violation|0|||
13088099|NCT03905863|25810527|FG001|Overall Study|Protocol Violation|2|||
13088100|NCT03905863|25810526|FG000|Overall Study|Death|0|||
13088101|NCT03905863|25810527|FG001|Overall Study|Death|1|||
13088102|NCT03905642|25810538|FG000|Overall Study|Withdrawal by Subject|3|||
13088103|NCT03905642|25810538|FG000|Overall Study|Pregnancy|1|||
13088104|NCT03905642|25810538|FG000|Overall Study|Adverse Event|1|||
13088105|NCT03905642|25810538|FG000|Overall Study|Lack of Efficacy|1|||
13088106|NCT03905642|25810538|FG000|Overall Study|Completed study but not 24 of 28 days|2|||
13088107|NCT03905135|25810567|FG000|Dose Escalation|Adverse Event|1|||
13088108|NCT03905135|25810568|FG001|Dose Escalation|Adverse Event|1|||
13088109|NCT03905135|25810567|FG000|Dose Escalation|Progressive disease|3|||
13088110|NCT03905135|25810568|FG001|Dose Escalation|Progressive disease|1|||
13088111|NCT03905135|25810567|FG000|Dose Escalation|Intercurrent illness|1|||
13088112|NCT03905135|25810568|FG001|Dose Escalation|Intercurrent illness|0|||
13088113|NCT03905096|25810595|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1|||
13088114|NCT03905096|25810596|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0|||
13088115|NCT03904420|25810609|FG000|Overall Study|Study terminated|2|||
13088116|NCT03904420|25810610|FG001|Overall Study|Study terminated|2|||
13088117|NCT03903822|25810861|FG000|Treatment Phase (6 Weeks)|Adverse Event|3|||
13088118|NCT03903822|25810862|FG001|Treatment Phase (6 Weeks)|Adverse Event|3|||
13088119|NCT03903822|25810863|FG002|Treatment Phase (6 Weeks)|Adverse Event|1|||
13088120|NCT03903822|25810864|FG003|Treatment Phase (6 Weeks)|Adverse Event|1|||
13088121|NCT03903822|25810865|FG004|Treatment Phase (6 Weeks)|Adverse Event|1|||
13088122|NCT03903822|25810866|FG005|Treatment Phase (6 Weeks)|Adverse Event|6|||
13088123|NCT03903822|25810867|FG006|Treatment Phase (6 Weeks)|Adverse Event|1|||
13088124|NCT03903822|25810868|FG007|Treatment Phase (6 Weeks)|Adverse Event|0|||
13088125|NCT03903822|25810861|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
13088126|NCT03903822|25810862|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
13088127|NCT03903822|25810863|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
13088128|NCT03903822|25810864|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
13088129|NCT03903822|25810865|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
13088130|NCT03903822|25810866|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
13088131|NCT03903822|25810867|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
13088132|NCT03903822|25810868|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
13088133|NCT03903822|25810861|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
13088134|NCT03903822|25810862|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
13088135|NCT03903822|25810863|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
13088136|NCT03903822|25810864|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
13088137|NCT03903822|25810865|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
13088138|NCT03903822|25810866|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
13088139|NCT03903822|25810867|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
13088140|NCT03903822|25810868|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
13088141|NCT03903822|25810861|FG000|Treatment Phase (6 Weeks)|Physician Decision|0|||
13088142|NCT03903822|25810862|FG001|Treatment Phase (6 Weeks)|Physician Decision|2|||
13088143|NCT03903822|25810863|FG002|Treatment Phase (6 Weeks)|Physician Decision|0|||
13088144|NCT03903822|25810864|FG003|Treatment Phase (6 Weeks)|Physician Decision|0|||
13088145|NCT03903822|25810865|FG004|Treatment Phase (6 Weeks)|Physician Decision|0|||
13088146|NCT03903822|25810866|FG005|Treatment Phase (6 Weeks)|Physician Decision|0|||
13088147|NCT03903822|25810867|FG006|Treatment Phase (6 Weeks)|Physician Decision|0|||
13088148|NCT03903822|25810868|FG007|Treatment Phase (6 Weeks)|Physician Decision|0|||
13088149|NCT03903822|25810861|FG000|Treatment Phase (6 Weeks)|Pregnancy|0|||
13088150|NCT03903822|25810862|FG001|Treatment Phase (6 Weeks)|Pregnancy|0|||
13088151|NCT03903822|25810863|FG002|Treatment Phase (6 Weeks)|Pregnancy|0|||
13088152|NCT03903822|25810864|FG003|Treatment Phase (6 Weeks)|Pregnancy|1|||
13088153|NCT03903822|25810865|FG004|Treatment Phase (6 Weeks)|Pregnancy|1|||
13088154|NCT03903822|25810866|FG005|Treatment Phase (6 Weeks)|Pregnancy|0|||
13088155|NCT03903822|25810867|FG006|Treatment Phase (6 Weeks)|Pregnancy|0|||
13088156|NCT03903822|25810868|FG007|Treatment Phase (6 Weeks)|Pregnancy|0|||
13088157|NCT03903822|25810861|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0|||
13088158|NCT03903822|25810862|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0|||
13088159|NCT03903822|25810863|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0|||
13088160|NCT03903822|25810864|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1|||
13088161|NCT03903822|25810865|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0|||
13088162|NCT03903822|25810866|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0|||
13088163|NCT03903822|25810867|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0|||
13088164|NCT03903822|25810868|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0|||
13088165|NCT03903822|25810861|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
13088166|NCT03903822|25810862|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4|||
13088167|NCT03903822|25810863|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
13088168|NCT03903822|25810864|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
13088169|NCT03903822|25810865|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1|||
13088170|NCT03903822|25810866|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
13088171|NCT03903822|25810867|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
13088172|NCT03903822|25810868|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
13088173|NCT03903822|25810861|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2|||
13088174|NCT03903822|25810862|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
13088175|NCT03903822|25810863|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
13088176|NCT03903822|25810864|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
13088177|NCT03903822|25810865|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
13088178|NCT03903822|25810866|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1|||
13088179|NCT03903822|25810867|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
13088180|NCT03903822|25810868|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
13088181|NCT03903822|25810861|FG000|Treatment Phase (6 Weeks)|Other|2|||
13088182|NCT03903822|25810862|FG001|Treatment Phase (6 Weeks)|Other|1|||
13088183|NCT03903822|25810863|FG002|Treatment Phase (6 Weeks)|Other|0|||
13088184|NCT03903822|25810864|FG003|Treatment Phase (6 Weeks)|Other|0|||
13088185|NCT03903822|25810865|FG004|Treatment Phase (6 Weeks)|Other|1|||
13088186|NCT03903822|25810866|FG005|Treatment Phase (6 Weeks)|Other|1|||
13088187|NCT03903822|25810867|FG006|Treatment Phase (6 Weeks)|Other|0|||
13088188|NCT03903822|25810868|FG007|Treatment Phase (6 Weeks)|Other|0|||
13088189|NCT03903822|25810861|FG000|Follow up Phase (4 Weeks)|Adverse Event|3|||
13088190|NCT03903822|25810862|FG001|Follow up Phase (4 Weeks)|Adverse Event|2|||
13088191|NCT03903822|25810863|FG002|Follow up Phase (4 Weeks)|Adverse Event|1|||
13088192|NCT03903822|25810864|FG003|Follow up Phase (4 Weeks)|Adverse Event|1|||
13088193|NCT03903822|25810865|FG004|Follow up Phase (4 Weeks)|Adverse Event|0|||
13088194|NCT03903822|25810866|FG005|Follow up Phase (4 Weeks)|Adverse Event|5|||
13088195|NCT03903822|25810867|FG006|Follow up Phase (4 Weeks)|Adverse Event|1|||
13088196|NCT03903822|25810868|FG007|Follow up Phase (4 Weeks)|Adverse Event|0|||
13088197|NCT03903822|25810861|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
13088198|NCT03903822|25810862|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
13088199|NCT03903822|25810863|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
13088200|NCT03903822|25810864|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
13088201|NCT03903822|25810865|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1|||
13088202|NCT03903822|25810866|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
13088203|NCT03903822|25810867|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
13088204|NCT03903822|25810868|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
13088205|NCT03903822|25810861|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2|||
13088206|NCT03903822|25810862|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
13088207|NCT03903822|25810863|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
13088208|NCT03903822|25810864|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
13088209|NCT03903822|25810865|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
13088210|NCT03903822|25810866|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
13088211|NCT03903822|25810867|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1|||
13088212|NCT03903822|25810868|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3|||
13088213|NCT03903822|25810861|FG000|Follow up Phase (4 Weeks)|Pregnancy|0|||
13088214|NCT03903822|25810862|FG001|Follow up Phase (4 Weeks)|Pregnancy|0|||
13088215|NCT03903822|25810863|FG002|Follow up Phase (4 Weeks)|Pregnancy|0|||
13088216|NCT03903822|25810864|FG003|Follow up Phase (4 Weeks)|Pregnancy|1|||
13088217|NCT03903822|25810865|FG004|Follow up Phase (4 Weeks)|Pregnancy|1|||
13088218|NCT03903822|25810866|FG005|Follow up Phase (4 Weeks)|Pregnancy|0|||
13088219|NCT03903822|25810867|FG006|Follow up Phase (4 Weeks)|Pregnancy|0|||
13088220|NCT03903822|25810868|FG007|Follow up Phase (4 Weeks)|Pregnancy|0|||
13088221|NCT03903822|25810861|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
13088222|NCT03903822|25810862|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5|||
13088223|NCT03903822|25810863|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
13088224|NCT03903822|25810864|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
13088225|NCT03903822|25810865|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
13088226|NCT03903822|25810866|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
13088227|NCT03903822|25810867|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
13088228|NCT03903822|25810868|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
13088229|NCT03903822|25810861|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
13088230|NCT03903822|25810862|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
13088231|NCT03903822|25810863|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
13088232|NCT03903822|25810864|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
13088233|NCT03903822|25810865|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
13088234|NCT03903822|25810866|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1|||
13088235|NCT03903822|25810867|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
13088236|NCT03903822|25810868|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
13088237|NCT03903822|25810861|FG000|Follow up Phase (4 Weeks)|Other|1|||
13088238|NCT03903822|25810862|FG001|Follow up Phase (4 Weeks)|Other|1|||
13088239|NCT03903822|25810863|FG002|Follow up Phase (4 Weeks)|Other|0|||
13088240|NCT03903822|25810864|FG003|Follow up Phase (4 Weeks)|Other|0|||
13088241|NCT03903822|25810865|FG004|Follow up Phase (4 Weeks)|Other|0|||
13088242|NCT03903822|25810866|FG005|Follow up Phase (4 Weeks)|Other|0|||
13088243|NCT03903822|25810867|FG006|Follow up Phase (4 Weeks)|Other|0|||
13088244|NCT03903822|25810868|FG007|Follow up Phase (4 Weeks)|Other|0|||
13088245|NCT03903159|25810877|FG000|Overall Study|Discharged with Staff Approval|2|||
13088246|NCT03903159|25810877|FG000|Overall Study|Discharged at Staff Request|2|||
13088247|NCT03903159|25810877|FG000|Overall Study|Discharged Against Staff Advice|1|||
13088248|NCT03902613|25810883|FG000|Overall Study|Physician Decision|1|||
13088249|NCT03902574|25810904|FG000|Overall Study|Urinary drug test was positive on Day 20|0|||
13088250|NCT03902574|25810905|FG001|Overall Study|Urinary drug test was positive on Day 20|0|||
13088251|NCT03902574|25810906|FG002|Overall Study|Urinary drug test was positive on Day 20|1|||
13088252|NCT03902392|25810921|FG000|Overall Study|Lost to Follow-up|7|||
13088253|NCT03902392|25810922|FG001|Overall Study|Lost to Follow-up|7|||
13088254|NCT03900728|25810943|FG000|Overall Study|No text responses|0|||
13088255|NCT03900728|25810944|FG001|Overall Study|No text responses|0|||
13088256|NCT03900728|25810945|FG002|Overall Study|No text responses|4|||
13088257|NCT03900416|25811070|FG000|Six Week Follow-up|Lost to Follow-up|1|||
13088258|NCT03900416|25811071|FG001|Six Week Follow-up|Lost to Follow-up|0|||
13088259|NCT03900416|25811070|FG000|Six Week Follow-up|Withdrawal by Subject|1|||
13088260|NCT03900416|25811071|FG001|Six Week Follow-up|Withdrawal by Subject|0|||
13088261|NCT03900416|25811070|FG000|Twelve Week Follow-up|Lost to Follow-up|0|||
13088262|NCT03900416|25811071|FG001|Twelve Week Follow-up|Lost to Follow-up|2|||
13088263|NCT03900416|25811070|FG000|Twelve Week Follow-up|Withdrawal by Subject|0|||
13088264|NCT03900416|25811071|FG001|Twelve Week Follow-up|Withdrawal by Subject|1|||
13088265|NCT03900416|25811070|FG000|Twelve Week Follow-up|Adverse Event|1|||
13088266|NCT03900416|25811071|FG001|Twelve Week Follow-up|Adverse Event|1|||
13088267|NCT03900416|25811070|FG000|Six Month Follow-up|Lost to Follow-up|4|||
13088268|NCT03900416|25811071|FG001|Six Month Follow-up|Lost to Follow-up|3|||
13088269|NCT03900416|25811070|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
13088270|NCT03900416|25811071|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
13088271|NCT03899064|25811079|FG000|Overall Study|Lost to Follow-up|1|||
13088272|NCT03899064|25811079|FG000|Overall Study|Protocol Violation|2|||
13088273|NCT03899064|25811079|FG000|Overall Study|Withdrawal by Subject|2|||
13088274|NCT03899064|25811079|FG000|Overall Study|Other|2|||
13088275|NCT03898063|25811096|FG000|Overall Study|Withdrawal by Subject|10|||
13088276|NCT03898063|25811097|FG001|Overall Study|Withdrawal by Subject|8|||
13088277|NCT03897179|25811103|FG000|Overall Study|Withdrawal by Subject|1|||
13088278|NCT03896477|25811172|FG000|Overall Study|Met Ineligibility Criteria During the Study|1|||
13088279|NCT03896477|25811173|FG001|Overall Study|Met Ineligibility Criteria During the Study|1|||
13088280|NCT03896477|25811174|FG002|Overall Study|Met Ineligibility Criteria During the Study|2|||
13088281|NCT03896477|25811172|FG000|Overall Study|Parent Requested Withdrawal|8|||
13088282|NCT03896477|25811173|FG001|Overall Study|Parent Requested Withdrawal|12|||
13088283|NCT03896477|25811174|FG002|Overall Study|Parent Requested Withdrawal|9|||
13088284|NCT03896477|25811172|FG000|Overall Study|Adverse Event|0|||
13088285|NCT03896477|25811173|FG001|Overall Study|Adverse Event|0|||
13088286|NCT03896477|25811174|FG002|Overall Study|Adverse Event|1|||
13088287|NCT03896477|25811172|FG000|Overall Study|Death|1|||
13088288|NCT03896477|25811173|FG001|Overall Study|Death|0|||
13088289|NCT03896477|25811174|FG002|Overall Study|Death|0|||
13088290|NCT03896477|25811172|FG000|Overall Study|Other|5|||
13088291|NCT03896477|25811173|FG001|Overall Study|Other|6|||
13088292|NCT03896477|25811174|FG002|Overall Study|Other|7|||
13088293|NCT03896477|25811172|FG000|Overall Study|Lost to Follow-up|2|||
13088294|NCT03896477|25811173|FG001|Overall Study|Lost to Follow-up|1|||
13088295|NCT03896477|25811174|FG002|Overall Study|Lost to Follow-up|1|||
13088296|NCT03896295|25811278|FG000|Overall Study|Adverse Event|0|||
13088297|NCT03896295|25811279|FG001|Overall Study|Adverse Event|1|||
13088298|NCT03896295|25811278|FG000|Overall Study|COVID-19|7|||
13088299|NCT03896295|25811279|FG001|Overall Study|COVID-19|29|||
13088300|NCT03896022|25811301|FG000|Overall Study|Withdrawal by Subject|1|||
13088301|NCT03896022|25811302|FG001|Overall Study|Withdrawal by Subject|0|||
13088302|NCT03896022|25811303|FG002|Overall Study|Withdrawal by Subject|0|||
13088303|NCT03896022|25811301|FG000|Overall Study|Did not have procedure|3|||
13088304|NCT03896022|25811302|FG001|Overall Study|Did not have procedure|0|||
13088305|NCT03896022|25811303|FG002|Overall Study|Did not have procedure|0|||
13088306|NCT03895840|25811314|FG000|Overall Study|Withdrawal by Subject|21|||
13088307|NCT03895372|25811495|FG000|Investigational Treatment Period|Adverse Event|1|||
13088308|NCT03895372|25811496|FG001|Investigational Treatment Period|Adverse Event|0|||
13088309|NCT03895372|25811497|FG002|Investigational Treatment Period|Adverse Event|0|||
13088310|NCT03895372|25811498|FG003|Investigational Treatment Period|Adverse Event|0|||
13088311|NCT03895372|25811499|FG004|Investigational Treatment Period|Adverse Event|0|||
13088312|NCT03895372|25811500|FG005|Investigational Treatment Period|Adverse Event|0|||
13088313|NCT03895372|25811501|FG006|Investigational Treatment Period|Adverse Event|4|||
13088314|NCT03895372|25811502|FG007|Investigational Treatment Period|Adverse Event|3|||
13088315|NCT03895372|25811495|FG000|Investigational Treatment Period|Lack of Efficacy|1|||
13088316|NCT03895372|25811496|FG001|Investigational Treatment Period|Lack of Efficacy|0|||
13088317|NCT03895372|25811497|FG002|Investigational Treatment Period|Lack of Efficacy|0|||
13088318|NCT03895372|25811498|FG003|Investigational Treatment Period|Lack of Efficacy|0|||
13088319|NCT03895372|25811499|FG004|Investigational Treatment Period|Lack of Efficacy|0|||
13088320|NCT03895372|25811500|FG005|Investigational Treatment Period|Lack of Efficacy|0|||
13088321|NCT03895372|25811501|FG006|Investigational Treatment Period|Lack of Efficacy|0|||
13088322|NCT03895372|25811502|FG007|Investigational Treatment Period|Lack of Efficacy|0|||
13088323|NCT03895372|25811495|FG000|Investigational Treatment Period|Lost to Follow-up|0|||
13088324|NCT03895372|25811496|FG001|Investigational Treatment Period|Lost to Follow-up|0|||
13088325|NCT03895372|25811497|FG002|Investigational Treatment Period|Lost to Follow-up|0|||
13088326|NCT03895372|25811498|FG003|Investigational Treatment Period|Lost to Follow-up|0|||
13088327|NCT03895372|25811499|FG004|Investigational Treatment Period|Lost to Follow-up|0|||
13088328|NCT03895372|25811500|FG005|Investigational Treatment Period|Lost to Follow-up|0|||
13088329|NCT03895372|25811501|FG006|Investigational Treatment Period|Lost to Follow-up|1|||
13088330|NCT03895372|25811502|FG007|Investigational Treatment Period|Lost to Follow-up|0|||
13088331|NCT03895372|25811495|FG000|Investigational Treatment Period|Other|0|||
13088332|NCT03895372|25811496|FG001|Investigational Treatment Period|Other|0|||
13088333|NCT03895372|25811497|FG002|Investigational Treatment Period|Other|0|||
13088334|NCT03895372|25811498|FG003|Investigational Treatment Period|Other|0|||
13088335|NCT03895372|25811499|FG004|Investigational Treatment Period|Other|0|||
13088336|NCT03895372|25811500|FG005|Investigational Treatment Period|Other|1|||
13088337|NCT03895372|25811501|FG006|Investigational Treatment Period|Other|0|||
13088338|NCT03895372|25811502|FG007|Investigational Treatment Period|Other|2|||
13088339|NCT03895372|25811495|FG000|Investigational Treatment Period|Protocol Violation|0|||
13088340|NCT03895372|25811496|FG001|Investigational Treatment Period|Protocol Violation|0|||
13088341|NCT03895372|25811497|FG002|Investigational Treatment Period|Protocol Violation|0|||
13088342|NCT03895372|25811498|FG003|Investigational Treatment Period|Protocol Violation|1|||
13088343|NCT03895372|25811499|FG004|Investigational Treatment Period|Protocol Violation|0|||
13088344|NCT03895372|25811500|FG005|Investigational Treatment Period|Protocol Violation|0|||
13088345|NCT03895372|25811501|FG006|Investigational Treatment Period|Protocol Violation|0|||
13088346|NCT03895372|25811502|FG007|Investigational Treatment Period|Protocol Violation|0|||
13088347|NCT03895372|25811495|FG000|Investigational Treatment Period|Withdrawal by Subject|2|||
13088348|NCT03895372|25811496|FG001|Investigational Treatment Period|Withdrawal by Subject|3|||
13088349|NCT03895372|25811497|FG002|Investigational Treatment Period|Withdrawal by Subject|1|||
13088350|NCT03895372|25811498|FG003|Investigational Treatment Period|Withdrawal by Subject|1|||
13088351|NCT03895372|25811499|FG004|Investigational Treatment Period|Withdrawal by Subject|0|||
13088352|NCT03895372|25811500|FG005|Investigational Treatment Period|Withdrawal by Subject|1|||
13088353|NCT03895372|25811501|FG006|Investigational Treatment Period|Withdrawal by Subject|3|||
13088354|NCT03895372|25811502|FG007|Investigational Treatment Period|Withdrawal by Subject|0|||
13088355|NCT03895372|25811495|FG000|Extension Treatment Period|Adverse Event|0|||
13088356|NCT03895372|25811496|FG001|Extension Treatment Period|Adverse Event|1|||
13088357|NCT03895372|25811497|FG002|Extension Treatment Period|Adverse Event|0|||
13088358|NCT03895372|25811498|FG003|Extension Treatment Period|Adverse Event|1|||
13088359|NCT03895372|25811499|FG004|Extension Treatment Period|Adverse Event|0|||
13088360|NCT03895372|25811500|FG005|Extension Treatment Period|Adverse Event|0|||
13088361|NCT03895372|25811501|FG006|Extension Treatment Period|Adverse Event|3|||
13088362|NCT03895372|25811502|FG007|Extension Treatment Period|Adverse Event|3|||
13088363|NCT03895372|25811495|FG000|Extension Treatment Period|Other|1|||
13088364|NCT03895372|25811496|FG001|Extension Treatment Period|Other|3|||
13088365|NCT03895372|25811497|FG002|Extension Treatment Period|Other|0|||
13088366|NCT03895372|25811498|FG003|Extension Treatment Period|Other|0|||
13088367|NCT03895372|25811499|FG004|Extension Treatment Period|Other|1|||
13088368|NCT03895372|25811500|FG005|Extension Treatment Period|Other|0|||
13088369|NCT03895372|25811501|FG006|Extension Treatment Period|Other|0|||
13088370|NCT03895372|25811502|FG007|Extension Treatment Period|Other|2|||
13088371|NCT03895372|25811495|FG000|Extension Treatment Period|Pregnancy|0|||
13088372|NCT03895372|25811496|FG001|Extension Treatment Period|Pregnancy|0|||
13088373|NCT03895372|25811497|FG002|Extension Treatment Period|Pregnancy|0|||
13088374|NCT03895372|25811498|FG003|Extension Treatment Period|Pregnancy|0|||
13088375|NCT03895372|25811499|FG004|Extension Treatment Period|Pregnancy|1|||
13088376|NCT03895372|25811500|FG005|Extension Treatment Period|Pregnancy|0|||
13088377|NCT03895372|25811501|FG006|Extension Treatment Period|Pregnancy|0|||
13088378|NCT03895372|25811502|FG007|Extension Treatment Period|Pregnancy|0|||
13088379|NCT03895372|25811495|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
13088380|NCT03895372|25811496|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
13088381|NCT03895372|25811497|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
13088382|NCT03895372|25811498|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
13088383|NCT03895372|25811499|FG004|Extension Treatment Period|Withdrawal by Subject|1|||
13088384|NCT03895372|25811500|FG005|Extension Treatment Period|Withdrawal by Subject|1|||
13088385|NCT03895372|25811501|FG006|Extension Treatment Period|Withdrawal by Subject|1|||
13088386|NCT03895372|25811502|FG007|Extension Treatment Period|Withdrawal by Subject|1|||
13088387|NCT03895034|25811508|FG000|Overall Study|Lost to Follow-up|2|||
13088388|NCT03894969|25811589|FG000|Overall Study|Adverse Event|0|||
13088389|NCT03894969|25811590|FG001|Overall Study|Adverse Event|2|||
13088390|NCT03894969|25811591|FG002|Overall Study|Adverse Event|0|||
13088391|NCT03894969|25811592|FG003|Overall Study|Adverse Event|1|||
13088392|NCT03894969|25811593|FG004|Overall Study|Adverse Event|2|||
13088393|NCT03894969|25811589|FG000|Overall Study|Lost to Follow-up|3|||
13088394|NCT03894969|25811590|FG001|Overall Study|Lost to Follow-up|1|||
13088395|NCT03894969|25811591|FG002|Overall Study|Lost to Follow-up|1|||
13088396|NCT03894969|25811592|FG003|Overall Study|Lost to Follow-up|0|||
13088397|NCT03894969|25811593|FG004|Overall Study|Lost to Follow-up|0|||
13088398|NCT03894969|25811589|FG000|Overall Study|Withdrawal by Subject|2|||
13088399|NCT03894969|25811590|FG001|Overall Study|Withdrawal by Subject|1|||
13088400|NCT03894969|25811591|FG002|Overall Study|Withdrawal by Subject|3|||
13088401|NCT03894969|25811592|FG003|Overall Study|Withdrawal by Subject|4|||
13088402|NCT03894969|25811593|FG004|Overall Study|Withdrawal by Subject|8|||
13088403|NCT03894969|25811589|FG000|Overall Study|Other|0|||
13088404|NCT03894969|25811590|FG001|Overall Study|Other|0|||
13088405|NCT03894969|25811591|FG002|Overall Study|Other|0|||
13088406|NCT03894969|25811592|FG003|Overall Study|Other|0|||
13088407|NCT03894969|25811593|FG004|Overall Study|Other|3|||
13088408|NCT03894969|25811589|FG000|Overall Study|Unsolicited Non-Serious Advers Event|0|||
13088409|NCT03894969|25811590|FG001|Overall Study|Unsolicited Non-Serious Advers Event|0|||
13088410|NCT03894969|25811591|FG002|Overall Study|Unsolicited Non-Serious Advers Event|0|||
13088411|NCT03894969|25811592|FG003|Overall Study|Unsolicited Non-Serious Advers Event|2|||
13088412|NCT03894969|25811593|FG004|Overall Study|Unsolicited Non-Serious Advers Event|1|||
13088413|NCT03894969|25811589|FG000|Overall Study|Solicited Adverse Event|0|||
13088414|NCT03894969|25811590|FG001|Overall Study|Solicited Adverse Event|1|||
13088415|NCT03894969|25811591|FG002|Overall Study|Solicited Adverse Event|0|||
13088416|NCT03894969|25811592|FG003|Overall Study|Solicited Adverse Event|0|||
13088417|NCT03894969|25811593|FG004|Overall Study|Solicited Adverse Event|0|||
13088418|NCT03894813|25811614|FG000|Overall Study|Adverse Event|1|||
13088419|NCT03894813|25811615|FG001|Overall Study|Adverse Event|1|||
13088420|NCT03894813|25811614|FG000|Overall Study|Lack of Efficacy|3|||
13088421|NCT03894813|25811615|FG001|Overall Study|Lack of Efficacy|3|||
13088422|NCT03894813|25811614|FG000|Overall Study|Lost to Follow-up|1|||
13088423|NCT03894813|25811615|FG001|Overall Study|Lost to Follow-up|0|||
13088424|NCT03894813|25811614|FG000|Overall Study|Pregnancy|2|||
13088425|NCT03894813|25811615|FG001|Overall Study|Pregnancy|1|||
13088426|NCT03894813|25811614|FG000|Overall Study|Protocol Violation|3|||
13088427|NCT03894813|25811615|FG001|Overall Study|Protocol Violation|7|||
13088428|NCT03894813|25811614|FG000|Overall Study|Withdrawal by Subject|1|||
13088429|NCT03894813|25811615|FG001|Overall Study|Withdrawal by Subject|3|||
13088430|NCT03894813|25811614|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0|||
13088431|NCT03894813|25811615|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1|||
13088432|NCT03894540|25811718|FG000|Overall Study|Adverse Event|0|||
13088433|NCT03894540|25811719|FG001|Overall Study|Adverse Event|0|||
13088434|NCT03894540|25811720|FG002|Overall Study|Adverse Event|0|||
13088435|NCT03894540|25811721|FG003|Overall Study|Adverse Event|0|||
13088436|NCT03894540|25811722|FG004|Overall Study|Adverse Event|1|||
13088437|NCT03894540|25811723|FG005|Overall Study|Adverse Event|0|||
13088438|NCT03894540|25811718|FG000|Overall Study|Withdrawal by Subject|0|||
13088439|NCT03894540|25811719|FG001|Overall Study|Withdrawal by Subject|0|||
13088440|NCT03894540|25811720|FG002|Overall Study|Withdrawal by Subject|0|||
13088441|NCT03894540|25811721|FG003|Overall Study|Withdrawal by Subject|0|||
13088442|NCT03894540|25811722|FG004|Overall Study|Withdrawal by Subject|1|||
13088443|NCT03894540|25811723|FG005|Overall Study|Withdrawal by Subject|0|||
13088444|NCT03894540|25811718|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
13088445|NCT03894540|25811719|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
13088446|NCT03894540|25811720|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1|||
13088447|NCT03894540|25811721|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
13088448|NCT03894540|25811722|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2|||
13088449|NCT03894540|25811723|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
13088450|NCT03894540|25811718|FG000|Overall Study|Progressive Disease Clinical|1|||
13088451|NCT03894540|25811719|FG001|Overall Study|Progressive Disease Clinical|1|||
13088452|NCT03894540|25811720|FG002|Overall Study|Progressive Disease Clinical|0|||
13088453|NCT03894540|25811721|FG003|Overall Study|Progressive Disease Clinical|1|||
13088454|NCT03894540|25811722|FG004|Overall Study|Progressive Disease Clinical|5|||
13088455|NCT03894540|25811723|FG005|Overall Study|Progressive Disease Clinical|1|||
13088456|NCT03894540|25811718|FG000|Overall Study|Study termination by sponsor|0|||
13088457|NCT03894540|25811719|FG001|Overall Study|Study termination by sponsor|0|||
13088458|NCT03894540|25811720|FG002|Overall Study|Study termination by sponsor|0|||
13088459|NCT03894540|25811721|FG003|Overall Study|Study termination by sponsor|0|||
13088460|NCT03894540|25811722|FG004|Overall Study|Study termination by sponsor|2|||
13088461|NCT03894540|25811723|FG005|Overall Study|Study termination by sponsor|0|||
13088462|NCT03893565|25811876|FG000|Double-blind Induction Phase (10 Weeks)|Other|1|||
13088463|NCT03893565|25811877|FG001|Double-blind Induction Phase (10 Weeks)|Other|3|||
13088464|NCT03893565|25811878|FG002|Double-blind Induction Phase (10 Weeks)|Other|0|||
13088465|NCT03893565|25811879|FG003|Double-blind Induction Phase (10 Weeks)|Other|0|||
13088466|NCT03893565|25811880|FG004|Double-blind Induction Phase (10 Weeks)|Other|1|||
13088467|NCT03893565|25811881|FG005|Double-blind Induction Phase (10 Weeks)|Other|0|||
13088468|NCT03893565|25811882|FG006|Double-blind Induction Phase (10 Weeks)|Other|0|||
13088469|NCT03893565|25811883|FG007|Double-blind Induction Phase (10 Weeks)|Other|0|||
13088470|NCT03893565|25811884|FG008|Double-blind Induction Phase (10 Weeks)|Other|0|||
13088471|NCT03893565|25811876|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
13088472|NCT03893565|25811877|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1|||
13088473|NCT03893565|25811878|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
13088474|NCT03893565|25811879|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
13088475|NCT03893565|25811880|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
13088476|NCT03893565|25811881|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
13088477|NCT03893565|25811882|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
13088478|NCT03893565|25811883|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
13088479|NCT03893565|25811884|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
13088480|NCT03893565|25811876|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
13088481|NCT03893565|25811877|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2|||
13088482|NCT03893565|25811878|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
13088483|NCT03893565|25811879|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1|||
13088484|NCT03893565|25811880|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
13088485|NCT03893565|25811881|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
13088486|NCT03893565|25811882|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
13088487|NCT03893565|25811883|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
13088488|NCT03893565|25811884|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
13088489|NCT03893565|25811876|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
13088490|NCT03893565|25811877|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1|||
13088491|NCT03893565|25811878|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
13088492|NCT03893565|25811879|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6|||
13088493|NCT03893565|25811880|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
13088494|NCT03893565|25811881|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
13088495|NCT03893565|25811882|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
13088496|NCT03893565|25811883|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
13088497|NCT03893565|25811884|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
13088498|NCT03893565|25811876|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
13088499|NCT03893565|25811877|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
13088500|NCT03893565|25811878|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9|||
13088501|NCT03893565|25811879|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
13088502|NCT03893565|25811880|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6|||
13088503|NCT03893565|25811881|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
13088504|NCT03893565|25811882|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
13088505|NCT03893565|25811883|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
13088506|NCT03893565|25811884|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
13088507|NCT03893565|25811876|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
13088508|NCT03893565|25811877|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2|||
13088509|NCT03893565|25811878|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
13088510|NCT03893565|25811879|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
13088511|NCT03893565|25811880|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
13088512|NCT03893565|25811881|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
13088513|NCT03893565|25811882|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
13088514|NCT03893565|25811883|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
13088515|NCT03893565|25811884|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
13088516|NCT03893565|25811876|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
13088517|NCT03893565|25811877|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
13088518|NCT03893565|25811878|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
13088519|NCT03893565|25811879|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1|||
13088520|NCT03893565|25811880|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
13088521|NCT03893565|25811881|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
13088522|NCT03893565|25811882|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
13088523|NCT03893565|25811883|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
13088524|NCT03893565|25811884|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
13088525|NCT03893565|25811876|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
13088526|NCT03893565|25811877|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2|||
13088527|NCT03893565|25811878|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
13088528|NCT03893565|25811879|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
13088529|NCT03893565|25811880|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
13088530|NCT03893565|25811881|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
13088531|NCT03893565|25811882|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
13088532|NCT03893565|25811883|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
13088533|NCT03893565|25811884|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
13088534|NCT03893565|25811876|FG000|Double-blind Extended Treatment(20weeks)|Other|0|||
13088535|NCT03893565|25811877|FG001|Double-blind Extended Treatment(20weeks)|Other|0|||
13088536|NCT03893565|25811878|FG002|Double-blind Extended Treatment(20weeks)|Other|0|||
13088537|NCT03893565|25811879|FG003|Double-blind Extended Treatment(20weeks)|Other|0|||
13088538|NCT03893565|25811880|FG004|Double-blind Extended Treatment(20weeks)|Other|0|||
13088539|NCT03893565|25811881|FG005|Double-blind Extended Treatment(20weeks)|Other|1|||
13088540|NCT03893565|25811882|FG006|Double-blind Extended Treatment(20weeks)|Other|1|||
13088541|NCT03893565|25811883|FG007|Double-blind Extended Treatment(20weeks)|Other|0|||
13088542|NCT03893565|25811884|FG008|Double-blind Extended Treatment(20weeks)|Other|0|||
13088543|NCT03893565|25811876|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
13088544|NCT03893565|25811877|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
13088545|NCT03893565|25811878|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
13088546|NCT03893565|25811879|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
13088547|NCT03893565|25811880|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
13088548|NCT03893565|25811881|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
13088549|NCT03893565|25811882|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1|||
13088550|NCT03893565|25811883|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
13088551|NCT03893565|25811884|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
13088552|NCT03893565|25811876|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
13088553|NCT03893565|25811877|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
13088554|NCT03893565|25811878|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
13088555|NCT03893565|25811879|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
13088556|NCT03893565|25811880|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
13088557|NCT03893565|25811881|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
13088558|NCT03893565|25811882|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
13088559|NCT03893565|25811883|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
13088560|NCT03893565|25811884|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
13088561|NCT03893565|25811876|FG000|Open-label Induction Phase (10 Weeks)|Other|0|||
13088562|NCT03893565|25811877|FG001|Open-label Induction Phase (10 Weeks)|Other|0|||
13088563|NCT03893565|25811878|FG002|Open-label Induction Phase (10 Weeks)|Other|0|||
13088564|NCT03893565|25811879|FG003|Open-label Induction Phase (10 Weeks)|Other|0|||
13088565|NCT03893565|25811880|FG004|Open-label Induction Phase (10 Weeks)|Other|0|||
13088566|NCT03893565|25811881|FG005|Open-label Induction Phase (10 Weeks)|Other|0|||
13088567|NCT03893565|25811882|FG006|Open-label Induction Phase (10 Weeks)|Other|0|||
13088568|NCT03893565|25811883|FG007|Open-label Induction Phase (10 Weeks)|Other|3|||
13088569|NCT03893565|25811884|FG008|Open-label Induction Phase (10 Weeks)|Other|0|||
13088570|NCT03893565|25811876|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
13088571|NCT03893565|25811877|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
13088572|NCT03893565|25811878|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
13088573|NCT03893565|25811879|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
13088574|NCT03893565|25811880|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
13088575|NCT03893565|25811881|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
13088576|NCT03893565|25811882|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
13088577|NCT03893565|25811883|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5|||
13088578|NCT03893565|25811884|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
13088579|NCT03893565|25811876|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
13088580|NCT03893565|25811877|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
13088581|NCT03893565|25811878|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
13088582|NCT03893565|25811879|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
13088583|NCT03893565|25811880|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
13088584|NCT03893565|25811881|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
13088585|NCT03893565|25811882|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
13088586|NCT03893565|25811883|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15|||
13088587|NCT03893565|25811884|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
13088588|NCT03893565|25811876|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
13088589|NCT03893565|25811877|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
13088590|NCT03893565|25811878|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
13088591|NCT03893565|25811879|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
13088592|NCT03893565|25811880|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
13088593|NCT03893565|25811881|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
13088594|NCT03893565|25811882|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
13088595|NCT03893565|25811883|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7|||
13088596|NCT03893565|25811884|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
13088597|NCT03893565|25811876|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
13088598|NCT03893565|25811877|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
13088599|NCT03893565|25811878|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
13088600|NCT03893565|25811879|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
13088601|NCT03893565|25811880|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
13088602|NCT03893565|25811881|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
13088603|NCT03893565|25811882|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
13088604|NCT03893565|25811883|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
13088605|NCT03893565|25811884|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4|||
13088606|NCT03892889|25811891|FG000|Overall Study|Adverse Event|17|||
13088607|NCT03892889|25811891|FG000|Overall Study|Lack of Efficacy|1|||
13088608|NCT03892889|25811891|FG000|Overall Study|Lost to Follow-up|46|||
13088609|NCT03892889|25811891|FG000|Overall Study|Non-compliance with study drug|22|||
13088610|NCT03892889|25811891|FG000|Overall Study|Pregnancy|1|||
13088611|NCT03892889|25811891|FG000|Overall Study|Protocol Deviation|3|||
13088612|NCT03892889|25811891|FG000|Overall Study|Withdrawal by Subject|50|||
13088613|NCT03892889|25811891|FG000|Overall Study|Withdrawal by Caregiver|1|||
13088614|NCT03892889|25811891|FG000|Overall Study|Study Terminated by Sponsor|50|||
13088615|NCT03892889|25811891|FG000|Overall Study|Physician Decision|8|||
13088616|NCT03892889|25811891|FG000|Overall Study|Reason not Specified|5|||
13088617|NCT03892707|25811927|FG000|Overall Study|Screen failure|6|||
13088618|NCT03892707|25811928|FG001|Overall Study|Screen failure|0|||
13088619|NCT03892707|25811927|FG000|Overall Study|Pain resolution|0|||
13088620|NCT03892707|25811928|FG001|Overall Study|Pain resolution|4|||
13088621|NCT03892707|25811927|FG000|Overall Study|Withdrawal by Subject|0|||
13088622|NCT03892707|25811928|FG001|Overall Study|Withdrawal by Subject|1|||
13088623|NCT03892707|25811927|FG000|Overall Study|Other (long business trip)|0|||
13088624|NCT03892707|25811928|FG001|Overall Study|Other (long business trip)|1|||
13088625|NCT03892564|25811936|FG000|Overall Study|Withdrawal by Subject|2|||
13088626|NCT03891862|25811955|FG000|Open-label Period|Adverse Event|2|||
13088627|NCT03891862|25811956|FG001|Open-label Period|Adverse Event|0|||
13088628|NCT03891862|25811957|FG002|Open-label Period|Adverse Event|0|||
13088629|NCT03891862|25811955|FG000|Open-label Period|Protocol Violation|5|||
13088630|NCT03891862|25811956|FG001|Open-label Period|Protocol Violation|0|||
13088631|NCT03891862|25811957|FG002|Open-label Period|Protocol Violation|0|||
13088632|NCT03891862|25811955|FG000|Open-label Period|Withdrawal by Subject|6|||
13088633|NCT03891862|25811956|FG001|Open-label Period|Withdrawal by Subject|0|||
13088634|NCT03891862|25811957|FG002|Open-label Period|Withdrawal by Subject|0|||
13088635|NCT03891862|25811955|FG000|Open-label Period|Death|1|||
13088636|NCT03891862|25811956|FG001|Open-label Period|Death|0|||
13088637|NCT03891862|25811957|FG002|Open-label Period|Death|0|||
13088638|NCT03891862|25811955|FG000|Open-label Period|Lost to Follow-up|2|||
13088639|NCT03891862|25811956|FG001|Open-label Period|Lost to Follow-up|0|||
13088640|NCT03891862|25811957|FG002|Open-label Period|Lost to Follow-up|0|||
13088641|NCT03891862|25811955|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0|||
13088642|NCT03891862|25811956|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1|||
13088643|NCT03891862|25811957|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1|||
13088644|NCT03891862|25811955|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0|||
13088645|NCT03891862|25811956|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2|||
13088646|NCT03891862|25811957|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1|||
13088647|NCT03891862|25811955|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0|||
13088648|NCT03891862|25811956|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1|||
13088649|NCT03891862|25811957|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2|||
13088650|NCT03891862|25811955|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
13088651|NCT03891862|25811956|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2|||
13088652|NCT03891862|25811957|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
13088653|NCT03891641|25811976|FG000|Overall Study|Study Stoppage Due to COVID-19|2|||
13088654|NCT03891641|25811977|FG001|Overall Study|Study Stoppage Due to COVID-19|2|||
13088655|NCT03891264|25811984|FG000|Overall Study|Adverse Event|1|||
13088656|NCT03891264|25811984|FG000|Overall Study|Withdrawal by Subject|2|||
13088657|NCT03891264|25811984|FG000|Overall Study|Physician Decision|2|||
13088658|NCT03890367|25812025|FG000|Overall Study|Withdrawal by parent/guardian|1|||
13088659|NCT03890367|25812026|FG001|Overall Study|Withdrawal by parent/guardian|3|||
13088660|NCT03890367|25812027|FG002|Overall Study|Withdrawal by parent/guardian|0|||
13088661|NCT03890367|25812025|FG000|Overall Study|Protocol deviation|2|||
13088662|NCT03890367|25812026|FG001|Overall Study|Protocol deviation|2|||
13088663|NCT03890367|25812027|FG002|Overall Study|Protocol deviation|1|||
13088664|NCT03890367|25812025|FG000|Overall Study|Lost to Follow-up|1|||
13088665|NCT03890367|25812026|FG001|Overall Study|Lost to Follow-up|1|||
13088666|NCT03890367|25812027|FG002|Overall Study|Lost to Follow-up|0|||
13088667|NCT03889886|25812066|FG000|Overall Study|Other|0|||
13088668|NCT03889886|25812067|FG001|Overall Study|Other|1|||
13088669|NCT03889886|25812068|FG002|Overall Study|Other|0|||
13088670|NCT03889886|25812069|FG003|Overall Study|Other|1|||
13088671|NCT03889886|25812066|FG000|Overall Study|Withdrawal by Subject|0|||
13088672|NCT03889886|25812067|FG001|Overall Study|Withdrawal by Subject|0|||
13088673|NCT03889886|25812068|FG002|Overall Study|Withdrawal by Subject|1|||
13088674|NCT03889886|25812069|FG003|Overall Study|Withdrawal by Subject|0|||
13088675|NCT03889886|25812066|FG000|Overall Study|Adverse Event|0|||
13088676|NCT03889886|25812067|FG001|Overall Study|Adverse Event|0|||
13088677|NCT03889886|25812068|FG002|Overall Study|Adverse Event|0|||
13088678|NCT03889886|25812069|FG003|Overall Study|Adverse Event|6|||
13088679|NCT03889704|25812077|FG000|Overall Study|Study terminated due to pandemic|1|||
13088680|NCT03888482|25812092|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0|||
13088681|NCT03888482|25812093|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1|||
13088682|NCT03888482|25812092|FG000|Second Wear (8 -1/+2 Days)|Other|1|||
13088683|NCT03888482|25812093|FG001|Second Wear (8 -1/+2 Days)|Other|0|||
13088684|NCT03888391|25812105|FG000|Overall Study|Lost to Follow-up|15|||
13088685|NCT03888235|25812147|FG000|Overall Study|Lost to Follow-up|1|||
13088686|NCT03888235|25812148|FG001|Overall Study|Lost to Follow-up|1|||
13088687|NCT03888235|25812149|FG002|Overall Study|Lost to Follow-up|0|||
13088688|NCT03887442|25812170|FG000|Overall Study|Adverse Event|1|||
13088689|NCT03887442|25812171|FG001|Overall Study|Adverse Event|0|||
13088690|NCT03886493|25812187|FG000|Overall Study|Adverse Event|1|||
13088691|NCT03886220|25812200|FG000|Treatment Period|Discontinued study drug during the treatment period|5|||
13088692|NCT03886220|25812201|FG001|Treatment Period|Discontinued study drug during the treatment period|12|||
13088693|NCT03886220|25812200|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
13088694|NCT03886220|25812201|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
13088695|NCT03886220|25812200|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
13088696|NCT03886220|25812201|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
13088697|NCT03885726|25812267|FG000|Overall Study|Staffing issues/lost interest|1|||
13088698|NCT03885726|25812267|FG000|Overall Study|Early discharge from hospital|3|||
13088699|NCT03885661|25812280|FG000|Overall Study|Withdrawal by Subject|0|||
13088700|NCT03885661|25812281|FG001|Overall Study|Withdrawal by Subject|1|||
13088701|NCT03885661|25812280|FG000|Overall Study|Unwilling to undergo required study procedure|1|||
13088702|NCT03885661|25812281|FG001|Overall Study|Unwilling to undergo required study procedure|0|||
13088703|NCT03885596|25812320|FG000|Overall Study|Withdrawal by Subject|2|||
13088704|NCT03885596|25812321|FG001|Overall Study|Withdrawal by Subject|1|||
13088705|NCT03885596|25812322|FG002|Overall Study|Withdrawal by Subject|0|||
13088706|NCT03885596|25812323|FG003|Overall Study|Withdrawal by Subject|0|||
13088707|NCT03883477|25812348|FG000|Overall Study|Death|1|||
13088708|NCT03883477|25812349|FG001|Overall Study|Death|0|||
13088709|NCT03883477|25812348|FG000|Overall Study|Protocol Violation|0|||
13088710|NCT03883477|25812349|FG001|Overall Study|Protocol Violation|1|||
13088711|NCT03883386|25812364|FG000|First Assignment|Lost to Follow-up|1|||
13088712|NCT03883386|25812365|FG001|First Assignment|Lost to Follow-up|0|||
13088713|NCT03883386|25812364|FG000|First Assignment|Withdrawal by Subject|1|||
13088714|NCT03883386|25812365|FG001|First Assignment|Withdrawal by Subject|1|||
13088715|NCT03883113|25812418|FG000|Overall Study|Physician Decision|4|||
13088716|NCT03883113|25812419|FG001|Overall Study|Physician Decision|2|||
13088717|NCT03883113|25812418|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9|||
13088718|NCT03883113|25812419|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7|||
13088719|NCT03883113|25812418|FG000|Overall Study|Pregnancy|1|||
13088720|NCT03883113|25812419|FG001|Overall Study|Pregnancy|0|||
13088721|NCT03883113|25812418|FG000|Overall Study|Adverse Event|0|||
13088722|NCT03883113|25812419|FG001|Overall Study|Adverse Event|1|||
13088723|NCT03883113|25812418|FG000|Overall Study|Withdrawal by Subject|1|||
13088724|NCT03883113|25812419|FG001|Overall Study|Withdrawal by Subject|2|||
13088725|NCT03883113|25812418|FG000|Overall Study|Lost to Follow-up|1|||
13088726|NCT03883113|25812419|FG001|Overall Study|Lost to Follow-up|0|||
13088727|NCT03882801|25812438|FG000|Period 1|Adverse Event|0|||
13088728|NCT03882801|25812439|FG001|Period 1|Adverse Event|1|||
13088729|NCT03882801|25812438|FG000|Period 1|Non-compliance with study drug|1|||
13088730|NCT03882801|25812439|FG001|Period 1|Non-compliance with study drug|1|||
13088731|NCT03882801|25812438|FG000|Period 1|Never treated with study drug|1|||
13088732|NCT03882801|25812439|FG001|Period 1|Never treated with study drug|0|||
13088733|NCT03882801|25812438|FG000|Washout Period|Physician Decision|0|||
13088734|NCT03882801|25812439|FG001|Washout Period|Physician Decision|1|||
13088735|NCT03882801|25812438|FG000|Period 2|Non-compliance with study drug|0|||
13088736|NCT03882801|25812439|FG001|Period 2|Non-compliance with study drug|1|||
13088737|NCT03882424|25812469|FG000|Overall Study|Lost to Follow-up|3|||
13088738|NCT03882424|25812470|FG001|Overall Study|Lost to Follow-up|0|||
13088739|NCT03882424|25812471|FG002|Overall Study|Lost to Follow-up|0|||
13088740|NCT03882424|25812469|FG000|Overall Study|schedule conflict|1|||
13088741|NCT03882424|25812470|FG001|Overall Study|schedule conflict|0|||
13088742|NCT03882424|25812471|FG002|Overall Study|schedule conflict|0|||
13088743|NCT03882047|25812519|FG000|Overall Study|Adverse Event|0|||
13088744|NCT03882047|25812520|FG001|Overall Study|Adverse Event|2|||
13088745|NCT03882047|25812521|FG002|Overall Study|Adverse Event|2|||
13088746|NCT03882047|25812519|FG000|Overall Study|Treatment Failure|3|||
13088747|NCT03882047|25812520|FG001|Overall Study|Treatment Failure|3|||
13088748|NCT03882047|25812521|FG002|Overall Study|Treatment Failure|12|||
13088749|NCT03882047|25812519|FG000|Overall Study|Lost to Follow-up|0|||
13088750|NCT03882047|25812520|FG001|Overall Study|Lost to Follow-up|1|||
13088751|NCT03882047|25812521|FG002|Overall Study|Lost to Follow-up|0|||
13088752|NCT03882047|25812519|FG000|Overall Study|Did Not Wish to Continue|1|||
13088753|NCT03882047|25812520|FG001|Overall Study|Did Not Wish to Continue|4|||
13088754|NCT03882047|25812521|FG002|Overall Study|Did Not Wish to Continue|1|||
13088755|NCT03882047|25812519|FG000|Overall Study|Noncompliance With Protocol|2|||
13088756|NCT03882047|25812520|FG001|Overall Study|Noncompliance With Protocol|0|||
13088757|NCT03882047|25812521|FG002|Overall Study|Noncompliance With Protocol|0|||
13088758|NCT03882047|25812519|FG000|Overall Study|Did Not Meet Eligibility|0|||
13088759|NCT03882047|25812520|FG001|Overall Study|Did Not Meet Eligibility|0|||
13088760|NCT03882047|25812521|FG002|Overall Study|Did Not Meet Eligibility|1|||
13088761|NCT03880266|25812596|FG000|Overall Study|Withdrawal by Subject|0|||
13088762|NCT03880266|25812597|FG001|Overall Study|Withdrawal by Subject|1|||
13088763|NCT03880266|25812598|FG002|Overall Study|Withdrawal by Subject|1|||
13088764|NCT03880266|25812599|FG003|Overall Study|Withdrawal by Subject|0|||
13088765|NCT03880266|25812600|FG004|Overall Study|Withdrawal by Subject|0|||
13088766|NCT03880266|25812601|FG005|Overall Study|Withdrawal by Subject|0|||
13088767|NCT03880266|25812602|FG006|Overall Study|Withdrawal by Subject|0|||
13088768|NCT03880266|25812603|FG007|Overall Study|Withdrawal by Subject|0|||
13088769|NCT03880227|25812634|FG000|First Visit|Withdrawal by Subject|1|||
13088770|NCT03880227|25812635|FG001|First Visit|Withdrawal by Subject|0|||
13088771|NCT03880227|25812636|FG002|First Visit|Withdrawal by Subject|0|||
13088772|NCT03880227|25812637|FG003|First Visit|Withdrawal by Subject|0|||
13088773|NCT03880227|25812634|FG000|1 Week Washout/ Delay|Lost to Follow-up|0|||
13088774|NCT03880227|25812635|FG001|1 Week Washout/ Delay|Lost to Follow-up|1|||
13088775|NCT03880227|25812636|FG002|1 Week Washout/ Delay|Lost to Follow-up|0|||
13088776|NCT03880227|25812637|FG003|1 Week Washout/ Delay|Lost to Follow-up|0|||
13088777|NCT03880227|25812634|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0|||
13088778|NCT03880227|25812635|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0|||
13088779|NCT03880227|25812636|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2|||
13088780|NCT03880227|25812637|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0|||
13088781|NCT03880227|25812634|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
13088782|NCT03880227|25812635|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
13088783|NCT03880227|25812636|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1|||
13088784|NCT03880227|25812637|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
13088785|NCT03879772|25812690|FG000|Overall Study|Adverse Event|2|||
13088786|NCT03879772|25812691|FG001|Overall Study|Adverse Event|2|||
13088787|NCT03879772|25812692|FG002|Overall Study|Adverse Event|3|||
13088788|NCT03879772|25812693|FG003|Overall Study|Adverse Event|4|||
13088789|NCT03879772|25812694|FG004|Overall Study|Adverse Event|3|||
13088790|NCT03879772|25812690|FG000|Overall Study|Treatment Failure|1|||
13088791|NCT03879772|25812691|FG001|Overall Study|Treatment Failure|0|||
13088792|NCT03879772|25812692|FG002|Overall Study|Treatment Failure|0|||
13088793|NCT03879772|25812693|FG003|Overall Study|Treatment Failure|2|||
13088794|NCT03879772|25812694|FG004|Overall Study|Treatment Failure|1|||
13088795|NCT03879772|25812690|FG000|Overall Study|Lost to Follow-up|0|||
13088796|NCT03879772|25812691|FG001|Overall Study|Lost to Follow-up|0|||
13088797|NCT03879772|25812692|FG002|Overall Study|Lost to Follow-up|0|||
13088798|NCT03879772|25812693|FG003|Overall Study|Lost to Follow-up|0|||
13088799|NCT03879772|25812694|FG004|Overall Study|Lost to Follow-up|1|||
13088800|NCT03879772|25812690|FG000|Overall Study|Withdrawal by Subject|0|||
13088801|NCT03879772|25812691|FG001|Overall Study|Withdrawal by Subject|1|||
13088802|NCT03879772|25812692|FG002|Overall Study|Withdrawal by Subject|3|||
13088803|NCT03879772|25812693|FG003|Overall Study|Withdrawal by Subject|1|||
13088804|NCT03879772|25812694|FG004|Overall Study|Withdrawal by Subject|1|||
13088805|NCT03879772|25812690|FG000|Overall Study|Protocol Violation|0|||
13088806|NCT03879772|25812691|FG001|Overall Study|Protocol Violation|0|||
13088807|NCT03879772|25812692|FG002|Overall Study|Protocol Violation|3|||
13088808|NCT03879772|25812693|FG003|Overall Study|Protocol Violation|1|||
13088809|NCT03879772|25812694|FG004|Overall Study|Protocol Violation|2|||
13088810|NCT03879772|25812690|FG000|Overall Study|Did Not Meet Entry Requirements|1|||
13088811|NCT03879772|25812691|FG001|Overall Study|Did Not Meet Entry Requirements|0|||
13088812|NCT03879772|25812692|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
13088813|NCT03879772|25812693|FG003|Overall Study|Did Not Meet Entry Requirements|0|||
13088814|NCT03879772|25812694|FG004|Overall Study|Did Not Meet Entry Requirements|0|||
13132580|NCT02788279|25984457|FG001|Overall Study|Withdrawal by Subject|15|||
13132581|NCT02788279|25984458|FG002|Overall Study|Withdrawal by Subject|5|||
13132582|NCT02788279|25984456|FG000|Overall Study|Lost to Follow-up|0|||
13132583|NCT02788279|25984457|FG001|Overall Study|Lost to Follow-up|3|||
13132584|NCT02788279|25984458|FG002|Overall Study|Lost to Follow-up|2|||
13132585|NCT02788279|25984456|FG000|Overall Study|Sponsor decision|18|||
13132586|NCT02788279|25984457|FG001|Overall Study|Sponsor decision|29|||
13132587|NCT02788279|25984458|FG002|Overall Study|Sponsor decision|11|||
13132588|NCT02788201|25984501|FG000|Overall Study|Death|1|||
13132589|NCT02788201|25984502|FG001|Overall Study|Death|1|||
13132590|NCT02788201|25984503|FG002|Overall Study|Death|1|||
13088815|NCT03878758|25812719|FG000|Overall Study|Withdrawal by Subject|1|||
13088816|NCT03878758|25812719|FG000|Overall Study|Protocol defined|2|||
13088817|NCT03878758|25812719|FG000|Overall Study|Improper consent documentation|1|||
13088818|NCT03878602|25812742|FG000|Overall Study|cord blood donation|7|||
13088819|NCT03878602|25812743|FG001|Overall Study|cord blood donation|1|||
13088820|NCT03878602|25812742|FG000|Overall Study|incomplete data collection|2|||
13088821|NCT03878602|25812743|FG001|Overall Study|incomplete data collection|0|||
13088822|NCT03878160|25812800|FG000|Overall Study|Lost to Follow-up|1|||
13088823|NCT03878160|25812801|FG001|Overall Study|Lost to Follow-up|1|||
13088824|NCT03878160|25812802|FG002|Overall Study|Lost to Follow-up|1|||
13088825|NCT03878160|25812800|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1|||
13088826|NCT03878160|25812801|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
13088827|NCT03878160|25812802|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
13088828|NCT03878108|25812831|FG000|Overall Study|Adverse Event|1|||
13088829|NCT03878108|25812832|FG001|Overall Study|Adverse Event|0|||
13088830|NCT03877237|25812851|FG000|Overall Study|Adverse Event|1|||
13088831|NCT03877237|25812852|FG001|Overall Study|Adverse Event|2|||
13088832|NCT03877237|25812851|FG000|Overall Study|Death|3|||
13088833|NCT03877237|25812852|FG001|Overall Study|Death|2|||
13088834|NCT03877237|25812851|FG000|Overall Study|Physician Decision|1|||
13088835|NCT03877237|25812852|FG001|Overall Study|Physician Decision|0|||
13088836|NCT03877237|25812851|FG000|Overall Study|Withdrawal by Subject|0|||
13088837|NCT03877237|25812852|FG001|Overall Study|Withdrawal by Subject|2|||
13088838|NCT03877224|25812871|FG000|Overall Study|Death|3|||
13088839|NCT03877224|25812872|FG001|Overall Study|Death|2|||
13088840|NCT03877224|25812871|FG000|Overall Study|Withdrawal by Subject|1|||
13088841|NCT03877224|25812872|FG001|Overall Study|Withdrawal by Subject|6|||
13088842|NCT03877224|25812871|FG000|Overall Study|Participant is alive, just unable to come for visits|1|||
13088843|NCT03877224|25812872|FG001|Overall Study|Participant is alive, just unable to come for visits|0|||
13088844|NCT03876743|25812947|FG000|Overall Study|Lost to Follow-up|6|||
13088845|NCT03876743|25812948|FG001|Overall Study|Lost to Follow-up|4|||
13088846|NCT03876743|25812949|FG002|Overall Study|Lost to Follow-up|4|||
13088847|NCT03876743|25812950|FG003|Overall Study|Lost to Follow-up|7|||
13088848|NCT03875508|25812963|FG000|Overall Study|Adverse Event|1|||
13088849|NCT03875508|25812963|FG000|Overall Study|Lost to Follow-up|8|||
13088850|NCT03875508|25812963|FG000|Overall Study|Lack of Efficacy|1|||
13088851|NCT03875508|25812963|FG000|Overall Study|Other, not specified|2|||
13088852|NCT03875482|25812984|FG000|Overall Study|Adverse Event|0|||
13088853|NCT03875482|25812985|FG001|Overall Study|Adverse Event|1|||
13088854|NCT03875482|25812984|FG000|Overall Study|Withdrew consent|5|||
13088855|NCT03875482|25812985|FG001|Overall Study|Withdrew consent|6|||
13088856|NCT03875482|25812984|FG000|Overall Study|Lost to Follow-up|8|||
13088857|NCT03875482|25812985|FG001|Overall Study|Lost to Follow-up|2|||
13088858|NCT03875482|25812984|FG000|Overall Study|Lack of Efficacy|0|||
13088859|NCT03875482|25812985|FG001|Overall Study|Lack of Efficacy|11|||
13088860|NCT03875313|25813043|FG000|Overall Study|Withdrawal by Subject|1|||
13088861|NCT03875313|25813044|FG001|Overall Study|Withdrawal by Subject|3|||
13088862|NCT03875313|25813045|FG002|Overall Study|Withdrawal by Subject|0|||
13088863|NCT03875313|25813046|FG003|Overall Study|Withdrawal by Subject|0|||
13088864|NCT03875313|25813047|FG004|Overall Study|Withdrawal by Subject|0|||
13088865|NCT03875313|25813043|FG000|Overall Study|Death|0|||
13088866|NCT03875313|25813044|FG001|Overall Study|Death|0|||
13088867|NCT03875313|25813045|FG002|Overall Study|Death|0|||
13088868|NCT03875313|25813046|FG003|Overall Study|Death|0|||
13088869|NCT03875313|25813047|FG004|Overall Study|Death|1|||
13088870|NCT03875313|25813043|FG000|Overall Study|Lost to Follow-up|0|||
13088871|NCT03875313|25813044|FG001|Overall Study|Lost to Follow-up|0|||
13088872|NCT03875313|25813045|FG002|Overall Study|Lost to Follow-up|0|||
13088873|NCT03875313|25813046|FG003|Overall Study|Lost to Follow-up|0|||
13088874|NCT03875313|25813047|FG004|Overall Study|Lost to Follow-up|1|||
13088875|NCT03875313|25813043|FG000|Overall Study|Study Termination by Sponsor|0|||
13088876|NCT03875313|25813044|FG001|Overall Study|Study Termination by Sponsor|1|||
13088877|NCT03875313|25813045|FG002|Overall Study|Study Termination by Sponsor|1|||
13088878|NCT03875313|25813046|FG003|Overall Study|Study Termination by Sponsor|0|||
13088879|NCT03875313|25813047|FG004|Overall Study|Study Termination by Sponsor|1|||
13088880|NCT03875313|25813043|FG000|Overall Study|New Anticancer Treatment|0|||
13088881|NCT03875313|25813044|FG001|Overall Study|New Anticancer Treatment|1|||
13088882|NCT03875313|25813045|FG002|Overall Study|New Anticancer Treatment|2|||
13088883|NCT03875313|25813046|FG003|Overall Study|New Anticancer Treatment|1|||
13088884|NCT03875313|25813047|FG004|Overall Study|New Anticancer Treatment|0|||
13088885|NCT03875313|25813043|FG000|Overall Study|Other, Not Specified|2|||
13088886|NCT03875313|25813044|FG001|Overall Study|Other, Not Specified|11|||
13088887|NCT03875313|25813045|FG002|Overall Study|Other, Not Specified|3|||
13088888|NCT03875313|25813046|FG003|Overall Study|Other, Not Specified|3|||
13088889|NCT03875313|25813047|FG004|Overall Study|Other, Not Specified|1|||
13088890|NCT03875118|25813062|FG000|Overall Study|Withdrawal by Subject|4|||
13222496|NCT01806597|26286268|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
13088891|NCT03875118|25813063|FG001|Overall Study|Withdrawal by Subject|4|||
13088892|NCT03874013|25813084|FG000|Overall Study|Adverse Event|0|||
13088893|NCT03874013|25813085|FG001|Overall Study|Adverse Event|1|||
13088894|NCT03873987|25813102|FG000|Overall Study|Adverse Event|1|||
13088895|NCT03873987|25813103|FG001|Overall Study|Adverse Event|0|||
13088896|NCT03873987|25813102|FG000|Overall Study|staff was unable to start a new IV line|1|||
13088897|NCT03873987|25813103|FG001|Overall Study|staff was unable to start a new IV line|0|||
13088898|NCT03873987|25813102|FG000|Overall Study|Lost to Follow-up|0|||
13088899|NCT03873987|25813103|FG001|Overall Study|Lost to Follow-up|1|||
13088900|NCT03872843|25813120|FG000|Overall Study|Lost to Follow-up|5|||
13088901|NCT03872843|25813121|FG001|Overall Study|Lost to Follow-up|7|||
13088902|NCT03870997|25813149|FG000|Overall Study|Did not complete mid-study/final survey|10544|||
13088903|NCT03870997|25813150|FG001|Overall Study|Did not complete mid-study/final survey|10431|||
13088904|NCT03870997|25813151|FG002|Overall Study|Did not complete mid-study/final survey|10978|||
13088905|NCT03870997|25813152|FG003|Overall Study|Did not complete mid-study/final survey|10947|||
13088906|NCT03870997|25813153|FG004|Overall Study|Did not complete mid-study/final survey|10588|||
13088907|NCT03870997|25813154|FG005|Overall Study|Did not complete mid-study/final survey|10531|||
13088908|NCT03870555|25813229|FG000|Period 3 (2 Days)|Adverse Event|1|||
13088909|NCT03870555|25813230|FG001|Period 3 (2 Days)|Adverse Event|0|||
13088910|NCT03870555|25813231|FG002|Period 3 (2 Days)|Adverse Event|0|||
13088911|NCT03870477|25813241|FG000|Overall Study|Early Study Termination|1|||
13088912|NCT03869684|25813262|FG000|Overall Study|Adverse Event|0|||
13088913|NCT03869684|25813263|FG001|Overall Study|Adverse Event|3|||
13088914|NCT03869684|25813264|FG002|Overall Study|Adverse Event|1|||
13088915|NCT03869684|25813262|FG000|Overall Study|Withdrawal by Subject|1|||
13088916|NCT03869684|25813263|FG001|Overall Study|Withdrawal by Subject|0|||
13088917|NCT03869684|25813264|FG002|Overall Study|Withdrawal by Subject|0|||
13088918|NCT03869684|25813262|FG000|Overall Study|Lost to Follow-up|1|||
13088919|NCT03869684|25813263|FG001|Overall Study|Lost to Follow-up|0|||
13088920|NCT03869684|25813264|FG002|Overall Study|Lost to Follow-up|0|||
13088921|NCT03869684|25813262|FG000|Overall Study|Study prematurely terminated by sponsor|0|||
13088922|NCT03869684|25813263|FG001|Overall Study|Study prematurely terminated by sponsor|0|||
13088923|NCT03869684|25813264|FG002|Overall Study|Study prematurely terminated by sponsor|2|||
13088924|NCT03869333|25813351|FG000|Overall Study|Lost to Follow-up|1|||
13088925|NCT03869333|25813352|FG001|Overall Study|Lost to Follow-up|0|||
13088926|NCT03869333|25813353|FG002|Overall Study|Lost to Follow-up|0|||
13088927|NCT03869333|25813354|FG003|Overall Study|Lost to Follow-up|0|||
13088928|NCT03869333|25813351|FG000|Overall Study|Pregnancy|1|||
13088929|NCT03869333|25813352|FG001|Overall Study|Pregnancy|0|||
13088930|NCT03869333|25813353|FG002|Overall Study|Pregnancy|0|||
13088931|NCT03869333|25813354|FG003|Overall Study|Pregnancy|0|||
13088932|NCT03869333|25813351|FG000|Overall Study|Physician Decision|0|||
13088933|NCT03869333|25813352|FG001|Overall Study|Physician Decision|1|||
13088934|NCT03869333|25813353|FG002|Overall Study|Physician Decision|0|||
13088935|NCT03869333|25813354|FG003|Overall Study|Physician Decision|0|||
13088936|NCT03868631|25813373|FG000|Baseline to Week 6|Adverse Event|0|||
13088937|NCT03868631|25813374|FG001|Baseline to Week 6|Adverse Event|3|||
13088938|NCT03868631|25813373|FG000|Baseline to Week 6|Protocol Violation|1|||
13088939|NCT03868631|25813374|FG001|Baseline to Week 6|Protocol Violation|1|||
13088940|NCT03868631|25813373|FG000|Baseline to Week 6|Withdrawal by Subject|3|||
13088941|NCT03868631|25813374|FG001|Baseline to Week 6|Withdrawal by Subject|0|||
13088942|NCT03868631|25813373|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2|||
13088943|NCT03868631|25813374|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0|||
13088944|NCT03868631|25813373|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1|||
13088945|NCT03868631|25813374|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0|||
13088946|NCT03868631|25813373|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
13088947|NCT03868631|25813374|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
13088948|NCT03868059|25813405|FG000|Overall Study|Adverse Event|3|||
13088949|NCT03868059|25813405|FG000|Overall Study|Lost to Follow-up|3|||
13088950|NCT03868059|25813405|FG000|Overall Study|Withdrawal by Subject|6|||
13088951|NCT03867760|25813430|FG000|Overall Study|Lost to Follow-up|2|||
13088952|NCT03867760|25813431|FG001|Overall Study|Lost to Follow-up|3|||
13088953|NCT03867760|25813430|FG000|Overall Study|Withdrawal by Subject|1|||
13088954|NCT03867760|25813431|FG001|Overall Study|Withdrawal by Subject|2|||
13088955|NCT03867760|25813430|FG000|Overall Study|subject could not meet study logistics|3|||
13088956|NCT03867760|25813431|FG001|Overall Study|subject could not meet study logistics|3|||
13088957|NCT03866473|25813456|FG000|Phase 1|Death|1|||
13088958|NCT03866473|25813457|FG001|Phase 1|Death|0|||
13088959|NCT03866473|25813456|FG000|Phase 2|Death|0|||
13088960|NCT03866473|25813457|FG001|Phase 2|Death|2|||
13088961|NCT03866473|25813456|FG000|Phase 2|Dropped|1|||
13088962|NCT03866473|25813457|FG001|Phase 2|Dropped|1|||
13088963|NCT03866473|25813456|FG000|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|1|||
13088964|NCT03866473|25813457|FG001|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|0|||
13088965|NCT03865953|25813498|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2|||
13132591|NCT02788201|25984504|FG003|Overall Study|Death|1|||
13088966|NCT03865953|25813499|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
13088967|NCT03865953|25813498|FG000|First Intervention (4 Weeks)|Protocol Violation|0|||
13088968|NCT03865953|25813499|FG001|First Intervention (4 Weeks)|Protocol Violation|1|||
13088969|NCT03865953|25813498|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0|||
13088970|NCT03865953|25813499|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2|||
13088971|NCT03865732|25813516|FG000|Overall Study|Adverse Event|0|||
13088972|NCT03865732|25813517|FG001|Overall Study|Adverse Event|1|||
13088973|NCT03865407|25813540|FG000|Overall Study|Adverse Event|1|||
13088974|NCT03865407|25813541|FG001|Overall Study|Adverse Event|0|||
13088975|NCT03865407|25813540|FG000|Overall Study|Withdrawal by Subject|1|||
13088976|NCT03865407|25813541|FG001|Overall Study|Withdrawal by Subject|0|||
13088977|NCT03865407|25813540|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1|||
13088978|NCT03865407|25813541|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0|||
13088979|NCT03865381|25813551|FG000|Overall Study|Protocol Violation/Non-Compliance|3|||
13088980|NCT03865381|25813551|FG000|Overall Study|Withdrawal by Subject|2|||
13088981|NCT03864900|25813574|FG000|Overall Study|Withdrawal by Subject|1|||
13088982|NCT03864900|25813575|FG001|Overall Study|Withdrawal by Subject|1|||
13088983|NCT03864900|25813574|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2|||
13088984|NCT03864900|25813575|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5|||
13088985|NCT03864653|25813582|FG000|Overall Study|Withdrawal by Subject|1|||
13088986|NCT03864627|25813598|FG000|Overall Study|Adverse Event|0|||
13088987|NCT03864627|25813599|FG001|Overall Study|Adverse Event|1|||
13088988|NCT03864627|25813598|FG000|Overall Study|Lack of Efficacy|0|||
13088989|NCT03864627|25813599|FG001|Overall Study|Lack of Efficacy|1|||
13088990|NCT03864627|25813598|FG000|Overall Study|Lost to Follow-up|0|||
13088991|NCT03864627|25813599|FG001|Overall Study|Lost to Follow-up|1|||
13088992|NCT03864627|25813598|FG000|Overall Study|Withdrawal by Subject|4|||
13088993|NCT03864627|25813599|FG001|Overall Study|Withdrawal by Subject|8|||
13088994|NCT03864627|25813598|FG000|Overall Study|Study terminated by sponsor|0|||
13088995|NCT03864627|25813599|FG001|Overall Study|Study terminated by sponsor|1|||
13088996|NCT03864341|25813607|FG000|Overall Study|Withdrawal by Subject|1|||
13088997|NCT03863834|25813614|FG000|Overall Study|Lost to Follow-up|3|||
13088998|NCT03863353|25813629|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24|||
13088999|NCT03863353|25813630|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20|||
13089000|NCT03862625|25813649|FG000|Overall Study|Lost to Follow-up|0|||
13089001|NCT03862625|25813650|FG001|Overall Study|Lost to Follow-up|1|||
13089002|NCT03861936|25813701|FG000|Overall Study|Withdrawal by Subject|4|||
13089003|NCT03861936|25813702|FG001|Overall Study|Withdrawal by Subject|1|||
13089004|NCT03861936|25813703|FG002|Overall Study|Withdrawal by Subject|3|||
13089005|NCT03861936|25813701|FG000|Overall Study|Lost to Follow-up|5|||
13089006|NCT03861936|25813702|FG001|Overall Study|Lost to Follow-up|3|||
13089007|NCT03861936|25813703|FG002|Overall Study|Lost to Follow-up|3|||
13089008|NCT03861936|25813701|FG000|Overall Study|Physician Decision|0|||
13089009|NCT03861936|25813702|FG001|Overall Study|Physician Decision|1|||
13089010|NCT03861936|25813703|FG002|Overall Study|Physician Decision|0|||
13089011|NCT03861936|25813701|FG000|Overall Study|Protocol Deviation|0|||
13089012|NCT03861936|25813702|FG001|Overall Study|Protocol Deviation|0|||
13089013|NCT03861936|25813703|FG002|Overall Study|Protocol Deviation|1|||
13089014|NCT03861936|25813701|FG000|Overall Study|Reason not Specified|5|||
13089015|NCT03861936|25813702|FG001|Overall Study|Reason not Specified|5|||
13089016|NCT03861936|25813703|FG002|Overall Study|Reason not Specified|3|||
13089017|NCT03861559|25813756|FG000|Overall Study|Adverse Event|0|||
13089018|NCT03861559|25813757|FG001|Overall Study|Adverse Event|2|||
13089019|NCT03861559|25813756|FG000|Overall Study|Treatment failure|0|||
13089020|NCT03861559|25813757|FG001|Overall Study|Treatment failure|2|||
13089021|NCT03861559|25813756|FG000|Overall Study|Noncompliance|1|||
13089022|NCT03861559|25813757|FG001|Overall Study|Noncompliance|1|||
13089023|NCT03861559|25813756|FG000|Overall Study|Did not meet eligibility requirements|1|||
13089024|NCT03861559|25813757|FG001|Overall Study|Did not meet eligibility requirements|0|||
13089025|NCT03861052|25813824|FG000|Overall Study|Adverse Event|1|||
13089026|NCT03861052|25813825|FG001|Overall Study|Adverse Event|1|||
13089027|NCT03861052|25813826|FG002|Overall Study|Adverse Event|2|||
13089028|NCT03861052|25813827|FG003|Overall Study|Adverse Event|4|||
13089029|NCT03861052|25813824|FG000|Overall Study|Lost to Follow-up|0|||
13089030|NCT03861052|25813825|FG001|Overall Study|Lost to Follow-up|0|||
13089031|NCT03861052|25813826|FG002|Overall Study|Lost to Follow-up|0|||
13089032|NCT03861052|25813827|FG003|Overall Study|Lost to Follow-up|1|||
13089033|NCT03861052|25813824|FG000|Overall Study|Physician Decision|0|||
13089034|NCT03861052|25813825|FG001|Overall Study|Physician Decision|1|||
13089035|NCT03861052|25813826|FG002|Overall Study|Physician Decision|0|||
13089036|NCT03861052|25813827|FG003|Overall Study|Physician Decision|0|||
13089037|NCT03861052|25813824|FG000|Overall Study|Withdrawal by Subject|2|||
13089038|NCT03861052|25813825|FG001|Overall Study|Withdrawal by Subject|5|||
13089039|NCT03861052|25813826|FG002|Overall Study|Withdrawal by Subject|3|||
13089040|NCT03861052|25813827|FG003|Overall Study|Withdrawal by Subject|0|||
13089041|NCT03861052|25813824|FG000|Overall Study|Relocation to other city|1|||
13089042|NCT03861052|25813825|FG001|Overall Study|Relocation to other city|0|||
13089043|NCT03861052|25813826|FG002|Overall Study|Relocation to other city|0|||
13089044|NCT03861052|25813827|FG003|Overall Study|Relocation to other city|0|||
13089045|NCT03860259|25813862|FG000|Overall Study|Lost to Follow-up|5|||
13089046|NCT03860259|25813863|FG001|Overall Study|Lost to Follow-up|5|||
13089047|NCT03860259|25813862|FG000|Overall Study|Protocol Violation|1|||
13089048|NCT03860259|25813863|FG001|Overall Study|Protocol Violation|0|||
13089049|NCT03859323|25814079|FG000|Overall Study|Lost to Follow-up|0|||
13089050|NCT03859323|25814080|FG001|Overall Study|Lost to Follow-up|0|||
13089051|NCT03859323|25814081|FG002|Overall Study|Lost to Follow-up|0|||
13089052|NCT03859323|25814082|FG003|Overall Study|Lost to Follow-up|0|||
13089053|NCT03859323|25814083|FG004|Overall Study|Lost to Follow-up|0|||
13089054|NCT03859323|25814084|FG005|Overall Study|Lost to Follow-up|0|||
13089055|NCT03859323|25814085|FG006|Overall Study|Lost to Follow-up|1|||
13089056|NCT03859323|25814086|FG007|Overall Study|Lost to Follow-up|0|||
13307565|NCT01284959|26528990|FG001|Overall Study|Adverse Event|0|||
13089057|NCT03859323|25814087|FG008|Overall Study|Lost to Follow-up|0|||
13089058|NCT03859323|25814088|FG009|Overall Study|Lost to Follow-up|0|||
13089059|NCT03859323|25814089|FG010|Overall Study|Lost to Follow-up|0|||
13089060|NCT03859323|25814090|FG011|Overall Study|Lost to Follow-up|0|||
13089061|NCT03859323|25814091|FG012|Overall Study|Lost to Follow-up|0|||
13089062|NCT03859323|25814079|FG000|Overall Study|Withdrawal by Subject|0|||
13089063|NCT03859323|25814080|FG001|Overall Study|Withdrawal by Subject|0|||
13089064|NCT03859323|25814081|FG002|Overall Study|Withdrawal by Subject|1|||
13089065|NCT03859323|25814082|FG003|Overall Study|Withdrawal by Subject|0|||
13089066|NCT03859323|25814083|FG004|Overall Study|Withdrawal by Subject|0|||
13089067|NCT03859323|25814084|FG005|Overall Study|Withdrawal by Subject|1|||
13089068|NCT03859323|25814085|FG006|Overall Study|Withdrawal by Subject|0|||
13089069|NCT03859323|25814086|FG007|Overall Study|Withdrawal by Subject|0|||
13089070|NCT03859323|25814087|FG008|Overall Study|Withdrawal by Subject|0|||
13089071|NCT03859323|25814088|FG009|Overall Study|Withdrawal by Subject|1|||
13089072|NCT03859323|25814089|FG010|Overall Study|Withdrawal by Subject|1|||
13089073|NCT03859323|25814090|FG011|Overall Study|Withdrawal by Subject|2|||
13089074|NCT03859323|25814091|FG012|Overall Study|Withdrawal by Subject|1|||
13089075|NCT03859323|25814079|FG000|Overall Study|Pregnancy|0|||
13089076|NCT03859323|25814080|FG001|Overall Study|Pregnancy|0|||
13089077|NCT03859323|25814081|FG002|Overall Study|Pregnancy|0|||
13089078|NCT03859323|25814082|FG003|Overall Study|Pregnancy|0|||
13089079|NCT03859323|25814083|FG004|Overall Study|Pregnancy|0|||
13089080|NCT03859323|25814084|FG005|Overall Study|Pregnancy|0|||
13089081|NCT03859323|25814085|FG006|Overall Study|Pregnancy|0|||
13089082|NCT03859323|25814086|FG007|Overall Study|Pregnancy|0|||
13089083|NCT03859323|25814087|FG008|Overall Study|Pregnancy|0|||
13089084|NCT03859323|25814088|FG009|Overall Study|Pregnancy|1|||
13089085|NCT03859323|25814089|FG010|Overall Study|Pregnancy|0|||
13089086|NCT03859323|25814090|FG011|Overall Study|Pregnancy|0|||
13089087|NCT03859323|25814091|FG012|Overall Study|Pregnancy|0|||
13089088|NCT03857841|25814114|FG000|Overall Study|Death|1|||
13089089|NCT03857841|25814115|FG001|Overall Study|Death|0|||
13089090|NCT03857841|25814116|FG002|Overall Study|Death|0|||
13089091|NCT03857841|25814117|FG003|Overall Study|Death|0|||
13089092|NCT03857841|25814114|FG000|Overall Study|Study Terminated by Sponsor|1|||
13089093|NCT03857841|25814115|FG001|Overall Study|Study Terminated by Sponsor|0|||
13089094|NCT03857841|25814116|FG002|Overall Study|Study Terminated by Sponsor|0|||
13089095|NCT03857841|25814117|FG003|Overall Study|Study Terminated by Sponsor|0|||
13089096|NCT03855228|25814176|FG000|Overall Study|Adverse Event|2|||
13089097|NCT03855228|25814177|FG001|Overall Study|Adverse Event|4|||
13089098|NCT03855228|25814178|FG002|Overall Study|Adverse Event|4|||
13089099|NCT03855228|25814179|FG003|Overall Study|Adverse Event|8|||
13089100|NCT03855228|25814176|FG000|Overall Study|Treatment Failure|1|||
13089101|NCT03855228|25814177|FG001|Overall Study|Treatment Failure|2|||
13089102|NCT03855228|25814178|FG002|Overall Study|Treatment Failure|1|||
13089103|NCT03855228|25814179|FG003|Overall Study|Treatment Failure|8|||
13089104|NCT03855228|25814176|FG000|Overall Study|Lost to Follow-up|0|||
13089105|NCT03855228|25814177|FG001|Overall Study|Lost to Follow-up|0|||
13089106|NCT03855228|25814178|FG002|Overall Study|Lost to Follow-up|0|||
13089107|NCT03855228|25814179|FG003|Overall Study|Lost to Follow-up|1|||
13089108|NCT03855228|25814176|FG000|Overall Study|Protocol Violation|0|||
13089109|NCT03855228|25814177|FG001|Overall Study|Protocol Violation|1|||
13089110|NCT03855228|25814178|FG002|Overall Study|Protocol Violation|2|||
13089111|NCT03855228|25814179|FG003|Overall Study|Protocol Violation|1|||
13089112|NCT03855228|25814176|FG000|Overall Study|Did Not Meet Entry Requirements|0|||
13089113|NCT03855228|25814177|FG001|Overall Study|Did Not Meet Entry Requirements|2|||
13089114|NCT03855228|25814178|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
13089115|NCT03855228|25814179|FG003|Overall Study|Did Not Meet Entry Requirements|1|||
13089116|NCT03855189|25814278|FG000|Overall Study|Adverse Event|5|||
13089117|NCT03855189|25814279|FG001|Overall Study|Adverse Event|2|||
13089118|NCT03855189|25814280|FG002|Overall Study|Adverse Event|4|||
13089119|NCT03855189|25814278|FG000|Overall Study|Treatment Failure|1|||
13089120|NCT03855189|25814279|FG001|Overall Study|Treatment Failure|1|||
13089121|NCT03855189|25814280|FG002|Overall Study|Treatment Failure|2|||
13089122|NCT03855189|25814278|FG000|Overall Study|Noncompliance with Protocol|0|||
13089123|NCT03855189|25814279|FG001|Overall Study|Noncompliance with Protocol|1|||
13089124|NCT03855189|25814280|FG002|Overall Study|Noncompliance with Protocol|0|||
13089125|NCT03855189|25814278|FG000|Overall Study|Did Not Return|4|||
13089126|NCT03855189|25814279|FG001|Overall Study|Did Not Return|3|||
13089127|NCT03855189|25814280|FG002|Overall Study|Did Not Return|0|||
13089128|NCT03853551|25814286|FG000|Overall Study|Death|2|||
13089129|NCT03853551|25814286|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7|||
13089130|NCT03853291|25814319|FG000|Overall Study|Lost to Follow-up|1|||
13089131|NCT03853291|25814320|FG001|Overall Study|Lost to Follow-up|2|||
13089132|NCT03853291|25814321|FG002|Overall Study|Lost to Follow-up|0|||
13089133|NCT03853291|25814322|FG003|Overall Study|Lost to Follow-up|0|||
13089134|NCT03853291|25814323|FG004|Overall Study|Lost to Follow-up|0|||
13089135|NCT03853291|25814324|FG005|Overall Study|Lost to Follow-up|0|||
13307566|NCT01284959|26528991|FG002|Overall Study|Adverse Event|1|||
13089136|NCT03853291|25814319|FG000|Overall Study|Determined to be ineligible|1|||
13089137|NCT03853291|25814320|FG001|Overall Study|Determined to be ineligible|1|||
13089138|NCT03853291|25814321|FG002|Overall Study|Determined to be ineligible|0|||
13089139|NCT03853291|25814322|FG003|Overall Study|Determined to be ineligible|0|||
13089140|NCT03853291|25814323|FG004|Overall Study|Determined to be ineligible|0|||
13089141|NCT03853291|25814324|FG005|Overall Study|Determined to be ineligible|0|||
13089142|NCT03853213|25814347|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1|||
13089143|NCT03853213|25814348|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0|||
13089144|NCT03853213|25814347|FG000|Overall Study|Other (e.g., too busy)|0|||
13089145|NCT03853213|25814348|FG001|Overall Study|Other (e.g., too busy)|2|||
13089146|NCT03853148|25814479|FG000|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
13089147|NCT03853148|25814480|FG001|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
13089148|NCT03853148|25814481|FG002|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
13089149|NCT03853148|25814482|FG003|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
13089170|NCT03851094|25814623|FG000|Overall Study|Withdrawal by Subject|0|||
13089171|NCT03851094|25814624|FG001|Overall Study|Withdrawal by Subject|1|||
13089172|NCT03851094|25814623|FG000|Overall Study|Participant lost device|0|||
13089173|NCT03851094|25814624|FG001|Overall Study|Participant lost device|1|||
13089174|NCT03851094|25814623|FG000|Overall Study|Participant returned device|0|||
13089175|NCT03851094|25814624|FG001|Overall Study|Participant returned device|2|||
13089176|NCT03851016|25814641|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
13089177|NCT03851016|25814642|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
13089178|NCT03850509|25814669|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2|||
13089179|NCT03850509|25814670|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1|||
13089180|NCT03850496|25814700|FG000|Overall Study|Withdrawal by Subject|1|||
13089181|NCT03850496|25814701|FG001|Overall Study|Withdrawal by Subject|0|||
13089182|NCT03850496|25814702|FG002|Overall Study|Withdrawal by Subject|0|||
13089183|NCT03850496|25814700|FG000|Overall Study|Lost to Follow-up|0|||
13089184|NCT03850496|25814701|FG001|Overall Study|Lost to Follow-up|1|||
13089185|NCT03850496|25814702|FG002|Overall Study|Lost to Follow-up|4|||
13089186|NCT03850444|25814735|FG000|Overall Study|Adverse Event|12|||
13089187|NCT03850444|25814736|FG001|Overall Study|Adverse Event|9|||
13089188|NCT03850444|25814735|FG000|Overall Study|Death|38|||
13089189|NCT03850444|25814736|FG001|Overall Study|Death|64|||
13089190|NCT03850444|25814735|FG000|Overall Study|Lost to Follow-up|0|||
13089191|NCT03850444|25814736|FG001|Overall Study|Lost to Follow-up|1|||
13089192|NCT03850444|25814735|FG000|Overall Study|Withdrawal by Subject|0|||
13089193|NCT03850444|25814736|FG001|Overall Study|Withdrawal by Subject|1|||
13089194|NCT03850444|25814735|FG000|Overall Study|Ongoing in Study|78|||
13089195|NCT03850444|25814736|FG001|Overall Study|Ongoing in Study|59|||
13089196|NCT03850093|25814781|FG000|Overall Study|Withdrawal by Subject|1|||
13089197|NCT03850093|25814782|FG001|Overall Study|Withdrawal by Subject|0|||
13089198|NCT03850093|25814783|FG002|Overall Study|Withdrawal by Subject|2|||
13089199|NCT03849300|25814850|FG000|Overall Study|move out to different area|1|||
13089200|NCT03849300|25814851|FG001|Overall Study|move out to different area|3|||
13089201|NCT03849300|25814852|FG002|Overall Study|move out to different area|1|||
13089202|NCT03849300|25814853|FG003|Overall Study|move out to different area|4|||
13089203|NCT03849300|25814850|FG000|Overall Study|scheduling/transportation conflict|4|||
13089204|NCT03849300|25814851|FG001|Overall Study|scheduling/transportation conflict|4|||
13089205|NCT03849300|25814852|FG002|Overall Study|scheduling/transportation conflict|3|||
13089206|NCT03849300|25814853|FG003|Overall Study|scheduling/transportation conflict|2|||
13089207|NCT03848949|25814868|FG000|Overall Study|Lost to Follow-up|5|||
13089208|NCT03848949|25814869|FG001|Overall Study|Lost to Follow-up|7|||
13089209|NCT03848832|25814903|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
13089210|NCT03848832|25814904|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
13089211|NCT03848832|25814905|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1|||
13089212|NCT03848832|25814903|FG000|Overall Study|Withdrawal by Subject|0|||
13089213|NCT03848832|25814904|FG001|Overall Study|Withdrawal by Subject|0|||
13089214|NCT03848832|25814905|FG002|Overall Study|Withdrawal by Subject|1|||
13089215|NCT03848832|25814903|FG000|Overall Study|Withdrawal (Covid-19)|0|||
13089216|NCT03848832|25814904|FG001|Overall Study|Withdrawal (Covid-19)|2|||
13089217|NCT03848832|25814905|FG002|Overall Study|Withdrawal (Covid-19)|0|||
13089218|NCT03848832|25814903|FG000|Overall Study|Physician Decision|2|||
13089219|NCT03848832|25814904|FG001|Overall Study|Physician Decision|1|||
13089220|NCT03848832|25814905|FG002|Overall Study|Physician Decision|3|||
13089221|NCT03848832|25814903|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
13089222|NCT03848832|25814904|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
13089223|NCT03848832|25814905|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1|||
13089224|NCT03848832|25814903|FG000|Overall Study|Adverse Event|1|||
13089225|NCT03848832|25814904|FG001|Overall Study|Adverse Event|0|||
13089226|NCT03848832|25814905|FG002|Overall Study|Adverse Event|0|||
13089227|NCT03848416|25814929|FG000|Overall Study|Withdrawal by Subject|1|||
13089228|NCT03848416|25814930|FG001|Overall Study|Withdrawal by Subject|0|||
13089229|NCT03848416|25814931|FG002|Overall Study|Withdrawal by Subject|0|||
13089230|NCT03848416|25814929|FG000|Overall Study|Death|0|||
13089231|NCT03848416|25814930|FG001|Overall Study|Death|0|||
13089232|NCT03848416|25814931|FG002|Overall Study|Death|1|||
13089233|NCT03847987|25814961|FG000|Overall Study|Lost to Follow-up|1|||
13089234|NCT03847987|25814962|FG001|Overall Study|Lost to Follow-up|0|||
13089235|NCT03847987|25814961|FG000|Overall Study|Adverse Event|2|||
13089236|NCT03847987|25814962|FG001|Overall Study|Adverse Event|0|||
13089237|NCT03847974|25814969|FG000|Overall Study|relocated out of region|3|||
13089238|NCT03847974|25814969|FG000|Overall Study|Withdrawal by Subject|2|||
13089239|NCT03847974|25814969|FG000|Overall Study|Adverse Event|1|||
13089240|NCT03847610|25814975|FG000|Overall Study|Withdrawal by Subject|1|||
13089241|NCT03846453|25815069|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465|||
13089242|NCT03846453|25815070|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
13089243|NCT03846453|25815071|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
13089244|NCT03846453|25815069|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3|||
13089245|NCT03846453|25815070|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
13089246|NCT03846453|25815071|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
13089247|NCT03846453|25815069|FG000|Placebo Run-in (14 Days)|Physician Decision|1|||
13089248|NCT03846453|25815070|FG001|Placebo Run-in (14 Days)|Physician Decision|0|||
13089249|NCT03846453|25815071|FG002|Placebo Run-in (14 Days)|Physician Decision|0|||
13089250|NCT03846453|25815069|FG000|Placebo Run-in (14 Days)|Other|2|||
13089251|NCT03846453|25815070|FG001|Placebo Run-in (14 Days)|Other|0|||
13089252|NCT03846453|25815071|FG002|Placebo Run-in (14 Days)|Other|0|||
13089253|NCT03846453|25815069|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0|||
13089254|NCT03846453|25815070|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16|||
13089255|NCT03846453|25815071|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8|||
13089256|NCT03846453|25815069|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0|||
13089257|NCT03846453|25815070|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6|||
13089258|NCT03846453|25815071|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5|||
13089259|NCT03846453|25815069|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0|||
13307567|NCT01284634|26529034|FG000|Overall Study|Adverse Event|1|||
13089260|NCT03846453|25815070|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2|||
13089261|NCT03846453|25815071|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4|||
13089262|NCT03846453|25815069|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0|||
13089263|NCT03846453|25815070|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2|||
13089264|NCT03846453|25815071|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4|||
13089265|NCT03846453|25815069|FG000|Randomized Treatment Period (Days 57±3)|Other|0|||
13089266|NCT03846453|25815070|FG001|Randomized Treatment Period (Days 57±3)|Other|1|||
13089267|NCT03846453|25815071|FG002|Randomized Treatment Period (Days 57±3)|Other|4|||
13089268|NCT03846219|25815255|FG000|Overall Study|Withdrawal by Subject|3|||
13089269|NCT03846219|25815256|FG001|Overall Study|Withdrawal by Subject|2|||
13089270|NCT03846219|25815257|FG002|Overall Study|Withdrawal by Subject|2|||
13089271|NCT03846219|25815255|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0|||
13089272|NCT03846219|25815256|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2|||
13089273|NCT03846219|25815257|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1|||
13089274|NCT03846219|25815255|FG000|Overall Study|Physician Decision|0|||
13089275|NCT03846219|25815256|FG001|Overall Study|Physician Decision|0|||
13089276|NCT03846219|25815257|FG002|Overall Study|Physician Decision|2|||
13089277|NCT03845296|25815276|FG000|Overall Study|On Treatment|2|||
13089278|NCT03845296|25815277|FG001|Overall Study|On Treatment|1|||
13089279|NCT03845296|25815276|FG000|Overall Study|Adverse Event|4|||
13089280|NCT03845296|25815277|FG001|Overall Study|Adverse Event|11|||
13089281|NCT03845296|25815276|FG000|Overall Study|Refusal unrelated to adverse event|0|||
13089282|NCT03845296|25815277|FG001|Overall Study|Refusal unrelated to adverse event|1|||
13089283|NCT03845296|25815276|FG000|Overall Study|Progression/relapse|14|||
13089284|NCT03845296|25815277|FG001|Overall Study|Progression/relapse|18|||
13089285|NCT03845296|25815276|FG000|Overall Study|Death|4|||
13089286|NCT03845296|25815277|FG001|Overall Study|Death|0|||
13089287|NCT03845296|25815276|FG000|Overall Study|Other - not protocol specified|1|||
13089288|NCT03845296|25815277|FG001|Overall Study|Other - not protocol specified|3|||
13089289|NCT03844945|25815300|FG000|Overall Study|Adverse Event|1|||
13089290|NCT03844945|25815301|FG001|Overall Study|Adverse Event|1|||
13089291|NCT03844945|25815302|FG002|Overall Study|Adverse Event|4|||
13089292|NCT03844945|25815303|FG003|Overall Study|Adverse Event|0|||
13089293|NCT03844945|25815300|FG000|Overall Study|Withdrawal by Subject|0|||
13089294|NCT03844945|25815301|FG001|Overall Study|Withdrawal by Subject|0|||
13089295|NCT03844945|25815302|FG002|Overall Study|Withdrawal by Subject|1|||
13089296|NCT03844945|25815303|FG003|Overall Study|Withdrawal by Subject|0|||
13089297|NCT03844945|25815300|FG000|Overall Study|Lack of Efficacy|0|||
13089298|NCT03844945|25815301|FG001|Overall Study|Lack of Efficacy|0|||
13089299|NCT03844945|25815302|FG002|Overall Study|Lack of Efficacy|0|||
13089300|NCT03844945|25815303|FG003|Overall Study|Lack of Efficacy|1|||
13089301|NCT03843632|25815398|FG000|Overall Study|Withdrawal by Subject|1|||
13089302|NCT03843632|25815399|FG001|Overall Study|Withdrawal by Subject|0|||
13089303|NCT03843632|25815400|FG002|Overall Study|Withdrawal by Subject|0|||
13089304|NCT03843632|25815401|FG003|Overall Study|Withdrawal by Subject|0|||
13089305|NCT03841331|25815428|FG000|Overall Study|Withdrawal by Subject|4|||
13089306|NCT03841331|25815429|FG001|Overall Study|Withdrawal by Subject|9|||
13089307|NCT03841331|25815428|FG000|Overall Study|Lost to Follow-up|5|||
13089308|NCT03841331|25815429|FG001|Overall Study|Lost to Follow-up|1|||
13089309|NCT03840811|25815456|FG000|Overall Study|Lost to Follow-up|0|||
13089310|NCT03840811|25815457|FG001|Overall Study|Lost to Follow-up|0|||
13089311|NCT03840811|25815458|FG002|Overall Study|Lost to Follow-up|1|||
13089312|NCT03840174|25815503|FG000|Overall Study|Withdrawal by Subject|1|||
13089313|NCT03840174|25815504|FG001|Overall Study|Withdrawal by Subject|0|||
13089314|NCT03840174|25815505|FG002|Overall Study|Withdrawal by Subject|0|||
13089315|NCT03840174|25815506|FG003|Overall Study|Withdrawal by Subject|0|||
13089316|NCT03840135|25815539|FG000|Overall Study|Protocol Violation|6|||
13089317|NCT03840135|25815540|FG001|Overall Study|Protocol Violation|1|||
13089318|NCT03840135|25815539|FG000|Overall Study|Withdrawal by Subject|1|||
13089319|NCT03840135|25815540|FG001|Overall Study|Withdrawal by Subject|0|||
13089320|NCT03839940|25815597|FG000|Overall Study|Withdrawal by Subject|3|||
13089321|NCT03839940|25815598|FG001|Overall Study|Withdrawal by Subject|0|||
13089322|NCT03839940|25815597|FG000|Overall Study|Protocol Violation|0|||
13089323|NCT03839940|25815598|FG001|Overall Study|Protocol Violation|1|||
13089324|NCT03839940|25815597|FG000|Overall Study|No Post-Baseline Pain Score Data|1|||
13089325|NCT03839940|25815598|FG001|Overall Study|No Post-Baseline Pain Score Data|1|||
13089326|NCT03839693|25815622|FG000|Overall Study|Lost to Follow-up|0|||
13089327|NCT03839693|25815623|FG001|Overall Study|Lost to Follow-up|2|||
13089328|NCT03839693|25815624|FG002|Overall Study|Lost to Follow-up|2|||
13089329|NCT03839693|25815622|FG000|Overall Study|Withdrawal by Subject|1|||
13089330|NCT03839693|25815623|FG001|Overall Study|Withdrawal by Subject|0|||
13089331|NCT03839693|25815624|FG002|Overall Study|Withdrawal by Subject|2|||
13089332|NCT03839693|25815622|FG000|Overall Study|subject moved out of the area|1|||
13089333|NCT03839693|25815623|FG001|Overall Study|subject moved out of the area|0|||
13089334|NCT03839693|25815624|FG002|Overall Study|subject moved out of the area|0|||
13089335|NCT03839641|25815649|FG000|Overall Study|Withdrawal by Subject|1|||
13089336|NCT03839641|25815650|FG001|Overall Study|Withdrawal by Subject|1|||
13089337|NCT03839628|25815657|FG000|Overall Study|Withdrawal by Subject|1|||
13089338|NCT03839355|25815674|FG000|Overall Study|Withdrawal by Subject|1|||
13089339|NCT03839355|25815675|FG001|Overall Study|Withdrawal by Subject|0|||
13089340|NCT03839212|25815683|FG000|Overall Study|COVID-19 related suspension of research activities.|4|||
13089341|NCT03838731|25815712|FG000|Overall Study|Pregnancy|0|||
13089342|NCT03838731|25815713|FG001|Overall Study|Pregnancy|1|||
13089343|NCT03838731|25815712|FG000|Overall Study|Withdrawal of consent|1|||
13089344|NCT03838731|25815713|FG001|Overall Study|Withdrawal of consent|0|||
13089345|NCT03838198|25815741|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
13089346|NCT03838198|25815742|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
13089347|NCT03838198|25815743|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1|||
13089348|NCT03838198|25815744|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
13089349|NCT03838198|25815741|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
13089350|NCT03838198|25815742|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
13089351|NCT03838198|25815743|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
13089352|NCT03838198|25815744|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
13089353|NCT03837743|25815762|FG000|Overall Study|Adverse Event|1|||
13089354|NCT03837743|25815762|FG000|Overall Study|Withdrawal by Subject|2|||
13089355|NCT03837028|25815796|FG000|Overall Study|Lost to Follow-up|4|||
13089356|NCT03837028|25815797|FG001|Overall Study|Lost to Follow-up|0|||
13089357|NCT03837028|25815798|FG002|Overall Study|Lost to Follow-up|2|||
13089358|NCT03837028|25815799|FG003|Overall Study|Lost to Follow-up|0|||
13089359|NCT03837028|25815796|FG000|Overall Study|Withdrawal by Subject|12|||
13089360|NCT03837028|25815797|FG001|Overall Study|Withdrawal by Subject|11|||
13089361|NCT03837028|25815798|FG002|Overall Study|Withdrawal by Subject|11|||
13089362|NCT03837028|25815799|FG003|Overall Study|Withdrawal by Subject|7|||
13089363|NCT03836729|25815913|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1|||
13089364|NCT03836677|25815932|FG000|Period 1|Adverse Event|0|||
13089365|NCT03836677|25815933|FG001|Period 1|Adverse Event|1|||
13089366|NCT03836677|25815932|FG000|Period 2|Severe non-compliance to protocol|1|||
13089367|NCT03836677|25815933|FG001|Period 2|Severe non-compliance to protocol|0|||
13089368|NCT03836664|25815950|FG000|Overall Study|Didn't complete forms and lost drug|3|||
13089369|NCT03836664|25815951|FG001|Overall Study|Didn't complete forms and lost drug|3|||
13089370|NCT03835975|25816011|FG000|Overall Study|Lost to Follow-up|1|||
13089371|NCT03835975|25816012|FG001|Overall Study|Lost to Follow-up|1|||
13089372|NCT03835975|25816013|FG002|Overall Study|Lost to Follow-up|0|||
13089373|NCT03835975|25816014|FG003|Overall Study|Lost to Follow-up|0|||
13089374|NCT03835975|25816015|FG004|Overall Study|Lost to Follow-up|0|||
13089375|NCT03835975|25816011|FG000|Overall Study|No longer met eligibility criteria|0|||
13089376|NCT03835975|25816012|FG001|Overall Study|No longer met eligibility criteria|1|||
13089377|NCT03835975|25816013|FG002|Overall Study|No longer met eligibility criteria|0|||
13089378|NCT03835975|25816014|FG003|Overall Study|No longer met eligibility criteria|0|||
13089379|NCT03835975|25816015|FG004|Overall Study|No longer met eligibility criteria|0|||
13089380|NCT03835975|25816011|FG000|Overall Study|Protocol Violation|1|||
13089381|NCT03835975|25816012|FG001|Overall Study|Protocol Violation|1|||
13089382|NCT03835975|25816013|FG002|Overall Study|Protocol Violation|2|||
13089383|NCT03835975|25816014|FG003|Overall Study|Protocol Violation|0|||
13089384|NCT03835975|25816015|FG004|Overall Study|Protocol Violation|0|||
13089385|NCT03835975|25816011|FG000|Overall Study|Withdrawal by Subject|1|||
13089386|NCT03835975|25816012|FG001|Overall Study|Withdrawal by Subject|0|||
13089387|NCT03835975|25816013|FG002|Overall Study|Withdrawal by Subject|1|||
13089388|NCT03835975|25816014|FG003|Overall Study|Withdrawal by Subject|1|||
13089389|NCT03835975|25816015|FG004|Overall Study|Withdrawal by Subject|0|||
13089390|NCT03835481|25816110|FG000|Double-blind Period|Other not stated below|0|||
13089391|NCT03835481|25816111|FG001|Double-blind Period|Other not stated below|0|||
13089392|NCT03835481|25816112|FG002|Double-blind Period|Other not stated below|0|||
13089393|NCT03835481|25816113|FG003|Double-blind Period|Other not stated below|1|||
13089394|NCT03835481|25816114|FG004|Double-blind Period|Other not stated below|1|||
13089395|NCT03835481|25816110|FG000|Double-blind Period|Termination of treatment by sponsor|0|||
13089396|NCT03835481|25816111|FG001|Double-blind Period|Termination of treatment by sponsor|0|||
13089397|NCT03835481|25816112|FG002|Double-blind Period|Termination of treatment by sponsor|0|||
13089398|NCT03835481|25816113|FG003|Double-blind Period|Termination of treatment by sponsor|0|||
13089399|NCT03835481|25816114|FG004|Double-blind Period|Termination of treatment by sponsor|35|||
13089400|NCT03835481|25816110|FG000|Double-blind Period|Withdrawal by Subject|0|||
13089401|NCT03835481|25816111|FG001|Double-blind Period|Withdrawal by Subject|0|||
13089402|NCT03835481|25816112|FG002|Double-blind Period|Withdrawal by Subject|1|||
13089403|NCT03835481|25816113|FG003|Double-blind Period|Withdrawal by Subject|0|||
13089404|NCT03835481|25816114|FG004|Double-blind Period|Withdrawal by Subject|5|||
13089405|NCT03835481|25816110|FG000|Double-blind Period|Lost to Follow-up|0|||
13089406|NCT03835481|25816111|FG001|Double-blind Period|Lost to Follow-up|0|||
13089407|NCT03835481|25816112|FG002|Double-blind Period|Lost to Follow-up|0|||
13089408|NCT03835481|25816113|FG003|Double-blind Period|Lost to Follow-up|1|||
13089409|NCT03835481|25816114|FG004|Double-blind Period|Lost to Follow-up|0|||
13307568|NCT01284634|26529035|FG001|Overall Study|Adverse Event|0|||
13307569|NCT01284634|26529036|FG002|Overall Study|Adverse Event|2|||
13089410|NCT03835481|25816110|FG000|Double-blind Period|Protocol Violation|0|||
13089411|NCT03835481|25816111|FG001|Double-blind Period|Protocol Violation|2|||
13089412|NCT03835481|25816112|FG002|Double-blind Period|Protocol Violation|0|||
13089413|NCT03835481|25816113|FG003|Double-blind Period|Protocol Violation|1|||
13089414|NCT03835481|25816114|FG004|Double-blind Period|Protocol Violation|0|||
13089415|NCT03835481|25816110|FG000|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
13089416|NCT03835481|25816111|FG001|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
13089417|NCT03835481|25816112|FG002|Open Label Period (After Week 12)|Termination of treatment by Sponsor|23|||
13089418|NCT03835481|25816113|FG003|Open Label Period (After Week 12)|Termination of treatment by Sponsor|31|||
13089419|NCT03835481|25816114|FG004|Open Label Period (After Week 12)|Termination of treatment by Sponsor|35|||
13089420|NCT03835481|25816110|FG000|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
13089421|NCT03835481|25816111|FG001|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
13089422|NCT03835481|25816112|FG002|Open Label Period (After Week 12)|Withdrawal by Subject|7|||
13089423|NCT03835481|25816113|FG003|Open Label Period (After Week 12)|Withdrawal by Subject|9|||
13089424|NCT03835481|25816114|FG004|Open Label Period (After Week 12)|Withdrawal by Subject|1|||
13089425|NCT03835481|25816110|FG000|Open Label Period (After Week 12)|Lost to Follow-up|0|||
13089426|NCT03835481|25816111|FG001|Open Label Period (After Week 12)|Lost to Follow-up|0|||
13089427|NCT03835481|25816112|FG002|Open Label Period (After Week 12)|Lost to Follow-up|4|||
13089428|NCT03835481|25816113|FG003|Open Label Period (After Week 12)|Lost to Follow-up|3|||
13089429|NCT03835481|25816114|FG004|Open Label Period (After Week 12)|Lost to Follow-up|0|||
13089430|NCT03835481|25816110|FG000|Open Label Period (After Week 12)|Adverse Event|0|||
13089431|NCT03835481|25816111|FG001|Open Label Period (After Week 12)|Adverse Event|0|||
13089432|NCT03835481|25816112|FG002|Open Label Period (After Week 12)|Adverse Event|1|||
13089433|NCT03835481|25816113|FG003|Open Label Period (After Week 12)|Adverse Event|1|||
13089434|NCT03835481|25816114|FG004|Open Label Period (After Week 12)|Adverse Event|0|||
13089435|NCT03835481|25816110|FG000|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
13089436|NCT03835481|25816111|FG001|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
13089437|NCT03835481|25816112|FG002|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
13089438|NCT03835481|25816113|FG003|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|1|||
13089439|NCT03835481|25816114|FG004|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
13089440|NCT03835481|25816110|FG000|Open Label Period (After Week 12)|Other not stated above|0|||
13089441|NCT03835481|25816111|FG001|Open Label Period (After Week 12)|Other not stated above|0|||
13089442|NCT03835481|25816112|FG002|Open Label Period (After Week 12)|Other not stated above|0|||
13089443|NCT03835481|25816113|FG003|Open Label Period (After Week 12)|Other not stated above|1|||
13089444|NCT03835481|25816114|FG004|Open Label Period (After Week 12)|Other not stated above|1|||
13089445|NCT03835221|25816161|FG000|Methafilcon A|Withdrawal by Subject|1|||
13089446|NCT03834623|25816182|FG000|Overall Study|Progression|0|||
13089447|NCT03834623|25816183|FG001|Overall Study|Progression|1|||
13089448|NCT03834350|25816195|FG000|Overall Study|Withdrawal by Subject|1|||
13089453|NCT03833661|25816253|FG000|Overall Study|Treatment ongoing|9|||
13089454|NCT03832738|25816309|FG000|Overall Study|Withdrawal by Subject|6|||
13089455|NCT03832738|25816310|FG001|Overall Study|Withdrawal by Subject|7|||
13089456|NCT03832738|25816311|FG002|Overall Study|Withdrawal by Subject|16|||
13089457|NCT03832738|25816309|FG000|Overall Study|Physician Decision|0|||
13089458|NCT03832738|25816310|FG001|Overall Study|Physician Decision|1|||
13089459|NCT03832738|25816311|FG002|Overall Study|Physician Decision|2|||
13089460|NCT03832738|25816309|FG000|Overall Study|Adverse Event|2|||
13089461|NCT03832738|25816310|FG001|Overall Study|Adverse Event|3|||
13089462|NCT03832738|25816311|FG002|Overall Study|Adverse Event|1|||
13089463|NCT03832738|25816309|FG000|Overall Study|Pregnancy|0|||
13089464|NCT03832738|25816310|FG001|Overall Study|Pregnancy|1|||
13089465|NCT03832738|25816311|FG002|Overall Study|Pregnancy|0|||
13132592|NCT02788201|25984505|FG004|Overall Study|Death|0|||
13132593|NCT02788201|25984506|FG005|Overall Study|Death|1|||
13132594|NCT02788201|25984501|FG000|Overall Study|Ineligible|0|||
13132595|NCT02788201|25984502|FG001|Overall Study|Ineligible|0|||
13132596|NCT02788201|25984503|FG002|Overall Study|Ineligible|0|||
13132597|NCT02788201|25984504|FG003|Overall Study|Ineligible|0|||
13132598|NCT02788201|25984505|FG004|Overall Study|Ineligible|0|||
13132599|NCT02788201|25984506|FG005|Overall Study|Ineligible|1|||
13132600|NCT02788201|25984501|FG000|Overall Study|Withdrawal by Subject|0|||
13132601|NCT02788201|25984502|FG001|Overall Study|Withdrawal by Subject|0|||
13132602|NCT02788201|25984503|FG002|Overall Study|Withdrawal by Subject|0|||
13132603|NCT02788201|25984504|FG003|Overall Study|Withdrawal by Subject|0|||
13132604|NCT02788201|25984505|FG004|Overall Study|Withdrawal by Subject|0|||
13132605|NCT02788201|25984506|FG005|Overall Study|Withdrawal by Subject|1|||
13132606|NCT02788175|25984513|FG000|Overall Study|Protocol Violation|3|||
13132607|NCT02788175|25984513|FG000|Overall Study|Withdrawal by Subject|4|||
13089466|NCT03832387|25816346|FG000|Overall Study|Protocol Violation|2|||
13089467|NCT03832387|25816347|FG001|Overall Study|Protocol Violation|6|||
13089468|NCT03832387|25816346|FG000|Overall Study|EXCLUSION CRITERIA|3|||
13089469|NCT03832387|25816347|FG001|Overall Study|EXCLUSION CRITERIA|1|||
13089470|NCT03832322|25816362|FG000|Overall Study|Failed cecal intubation in 2nd exam|3|||
13089471|NCT03832322|25816363|FG001|Overall Study|Failed cecal intubation in 2nd exam|1|||
13089472|NCT03831945|25816378|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
13089473|NCT03831945|25816379|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
13089474|NCT03831945|25816378|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
13089475|NCT03831945|25816379|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
13089476|NCT03831945|25816378|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2|||
13089477|NCT03831945|25816379|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1|||
13089478|NCT03831880|25816470|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0|||
13089479|NCT03831880|25816471|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1|||
13089480|NCT03831880|25816470|FG000|Period 2 (12 Weeks)|Protocol Deviation|0|||
13089481|NCT03831880|25816471|FG001|Period 2 (12 Weeks)|Protocol Deviation|1|||
13089482|NCT03831282|25816477|FG000|Overall Study|Could not place sensor|1|||
13089483|NCT03831191|25816554|FG000|Induction Period (16 Weeks)|Adverse Event|2|||
13089484|NCT03831191|25816555|FG001|Induction Period (16 Weeks)|Adverse Event|1|||
13089485|NCT03831191|25816556|FG002|Induction Period (16 Weeks)|Adverse Event|3|||
13089486|NCT03831191|25816557|FG003|Induction Period (16 Weeks)|Adverse Event|4|||
13089487|NCT03831191|25816558|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
13089488|NCT03831191|25816559|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
13089489|NCT03831191|25816560|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
13089490|NCT03831191|25816561|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
13089491|NCT03831191|25816562|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
13089492|NCT03831191|25816563|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
13089493|NCT03831191|25816564|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
13089494|NCT03831191|25816565|FG011|Induction Period (16 Weeks)|Adverse Event|0|||
13089495|NCT03831191|25816566|FG012|Induction Period (16 Weeks)|Adverse Event|0|||
13089496|NCT03831191|25816567|FG013|Induction Period (16 Weeks)|Adverse Event|0|||
13089497|NCT03831191|25816568|FG014|Induction Period (16 Weeks)|Adverse Event|0|||
13089498|NCT03831191|25816554|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2|||
13089499|NCT03831191|25816555|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3|||
13089500|NCT03831191|25816556|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
13089501|NCT03831191|25816557|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
13089502|NCT03831191|25816558|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
13089503|NCT03831191|25816559|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
13089504|NCT03831191|25816560|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
13089505|NCT03831191|25816561|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
13089506|NCT03831191|25816562|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0|||
13089507|NCT03831191|25816563|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0|||
13089508|NCT03831191|25816564|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0|||
13089509|NCT03831191|25816565|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0|||
13089510|NCT03831191|25816566|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0|||
13089511|NCT03831191|25816567|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0|||
13089512|NCT03831191|25816568|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0|||
13089513|NCT03831191|25816554|FG000|Induction Period (16 Weeks)|Pregnancy|0|||
13089514|NCT03831191|25816555|FG001|Induction Period (16 Weeks)|Pregnancy|0|||
13089515|NCT03831191|25816556|FG002|Induction Period (16 Weeks)|Pregnancy|1|||
13089516|NCT03831191|25816557|FG003|Induction Period (16 Weeks)|Pregnancy|0|||
13089517|NCT03831191|25816558|FG004|Induction Period (16 Weeks)|Pregnancy|0|||
13089518|NCT03831191|25816559|FG005|Induction Period (16 Weeks)|Pregnancy|0|||
13089519|NCT03831191|25816560|FG006|Induction Period (16 Weeks)|Pregnancy|0|||
13089520|NCT03831191|25816561|FG007|Induction Period (16 Weeks)|Pregnancy|0|||
13089521|NCT03831191|25816562|FG008|Induction Period (16 Weeks)|Pregnancy|0|||
13089522|NCT03831191|25816563|FG009|Induction Period (16 Weeks)|Pregnancy|0|||
13089523|NCT03831191|25816564|FG010|Induction Period (16 Weeks)|Pregnancy|0|||
13089524|NCT03831191|25816565|FG011|Induction Period (16 Weeks)|Pregnancy|0|||
13089525|NCT03831191|25816566|FG012|Induction Period (16 Weeks)|Pregnancy|0|||
13089526|NCT03831191|25816567|FG013|Induction Period (16 Weeks)|Pregnancy|0|||
13089527|NCT03831191|25816568|FG014|Induction Period (16 Weeks)|Pregnancy|0|||
13089528|NCT03831191|25816554|FG000|Induction Period (16 Weeks)|Protocol Violation|0|||
13089529|NCT03831191|25816555|FG001|Induction Period (16 Weeks)|Protocol Violation|0|||
13089530|NCT03831191|25816556|FG002|Induction Period (16 Weeks)|Protocol Violation|0|||
13089531|NCT03831191|25816557|FG003|Induction Period (16 Weeks)|Protocol Violation|2|||
13089532|NCT03831191|25816558|FG004|Induction Period (16 Weeks)|Protocol Violation|0|||
13089533|NCT03831191|25816559|FG005|Induction Period (16 Weeks)|Protocol Violation|0|||
13089534|NCT03831191|25816560|FG006|Induction Period (16 Weeks)|Protocol Violation|0|||
13133724|NCT02765165|25988893|FG002|Post-treatment Follow-up|Death|1|||
13089535|NCT03831191|25816561|FG007|Induction Period (16 Weeks)|Protocol Violation|0|||
13089536|NCT03831191|25816562|FG008|Induction Period (16 Weeks)|Protocol Violation|0|||
13089537|NCT03831191|25816563|FG009|Induction Period (16 Weeks)|Protocol Violation|0|||
13089538|NCT03831191|25816564|FG010|Induction Period (16 Weeks)|Protocol Violation|0|||
13089539|NCT03831191|25816565|FG011|Induction Period (16 Weeks)|Protocol Violation|0|||
13089540|NCT03831191|25816566|FG012|Induction Period (16 Weeks)|Protocol Violation|0|||
13089541|NCT03831191|25816567|FG013|Induction Period (16 Weeks)|Protocol Violation|0|||
13089542|NCT03831191|25816568|FG014|Induction Period (16 Weeks)|Protocol Violation|0|||
13089543|NCT03831191|25816554|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7|||
13089544|NCT03831191|25816555|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
13089545|NCT03831191|25816556|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
13089546|NCT03831191|25816557|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
13089547|NCT03831191|25816558|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
13089548|NCT03831191|25816559|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
13089549|NCT03831191|25816560|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
13089550|NCT03831191|25816561|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
13089551|NCT03831191|25816562|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
13089552|NCT03831191|25816563|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
13089553|NCT03831191|25816564|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
13089554|NCT03831191|25816565|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
13089555|NCT03831191|25816566|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
13089556|NCT03831191|25816567|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
13089557|NCT03831191|25816568|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
13089558|NCT03831191|25816554|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12|||
13089559|NCT03831191|25816555|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15|||
13089560|NCT03831191|25816556|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16|||
13089561|NCT03831191|25816557|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13|||
13089562|NCT03831191|25816558|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
13089563|NCT03831191|25816559|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
13089564|NCT03831191|25816560|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
13089565|NCT03831191|25816561|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
13089566|NCT03831191|25816562|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
13089567|NCT03831191|25816563|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
13089568|NCT03831191|25816564|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
13089569|NCT03831191|25816565|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
13089570|NCT03831191|25816566|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
13089571|NCT03831191|25816567|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
13089572|NCT03831191|25816568|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
13089573|NCT03831191|25816554|FG000|Induction Period (16 Weeks)|Sponsor Decision|0|||
13089574|NCT03831191|25816555|FG001|Induction Period (16 Weeks)|Sponsor Decision|0|||
13089575|NCT03831191|25816556|FG002|Induction Period (16 Weeks)|Sponsor Decision|0|||
13089576|NCT03831191|25816557|FG003|Induction Period (16 Weeks)|Sponsor Decision|1|||
13089577|NCT03831191|25816558|FG004|Induction Period (16 Weeks)|Sponsor Decision|0|||
13089578|NCT03831191|25816559|FG005|Induction Period (16 Weeks)|Sponsor Decision|0|||
13089579|NCT03831191|25816560|FG006|Induction Period (16 Weeks)|Sponsor Decision|0|||
13089580|NCT03831191|25816561|FG007|Induction Period (16 Weeks)|Sponsor Decision|0|||
13089581|NCT03831191|25816562|FG008|Induction Period (16 Weeks)|Sponsor Decision|0|||
13089582|NCT03831191|25816563|FG009|Induction Period (16 Weeks)|Sponsor Decision|0|||
13089583|NCT03831191|25816564|FG010|Induction Period (16 Weeks)|Sponsor Decision|0|||
13089584|NCT03831191|25816565|FG011|Induction Period (16 Weeks)|Sponsor Decision|0|||
13089585|NCT03831191|25816566|FG012|Induction Period (16 Weeks)|Sponsor Decision|0|||
13089586|NCT03831191|25816567|FG013|Induction Period (16 Weeks)|Sponsor Decision|0|||
13089587|NCT03831191|25816568|FG014|Induction Period (16 Weeks)|Sponsor Decision|0|||
13089588|NCT03831191|25816554|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
13089589|NCT03831191|25816555|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
13089590|NCT03831191|25816556|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
13089591|NCT03831191|25816557|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
13089592|NCT03831191|25816558|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
13089593|NCT03831191|25816559|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5|||
13089594|NCT03831191|25816560|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2|||
13089595|NCT03831191|25816561|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
13089596|NCT03831191|25816562|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8|||
13089597|NCT03831191|25816563|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
13089598|NCT03831191|25816564|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
13089599|NCT03831191|25816565|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7|||
13089600|NCT03831191|25816566|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
13089601|NCT03831191|25816567|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
13089602|NCT03831191|25816568|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6|||
13089603|NCT03831191|25816554|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
13089604|NCT03831191|25816555|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
13089605|NCT03831191|25816556|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
13089606|NCT03831191|25816557|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
13089607|NCT03831191|25816558|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
13089608|NCT03831191|25816559|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
13089609|NCT03831191|25816560|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
13089610|NCT03831191|25816561|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
13089611|NCT03831191|25816562|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
13089612|NCT03831191|25816563|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
13089613|NCT03831191|25816564|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
13089614|NCT03831191|25816565|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
13089615|NCT03831191|25816566|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
13089616|NCT03831191|25816567|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
13089617|NCT03831191|25816568|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
13089618|NCT03831191|25816554|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
13089619|NCT03831191|25816555|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
13089620|NCT03831191|25816556|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
13089621|NCT03831191|25816557|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
13089622|NCT03831191|25816558|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
13089623|NCT03831191|25816559|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
13089624|NCT03831191|25816560|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
13089625|NCT03831191|25816561|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
13089626|NCT03831191|25816562|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
13089627|NCT03831191|25816563|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
13089628|NCT03831191|25816564|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
13089629|NCT03831191|25816565|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
13089630|NCT03831191|25816566|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
13089631|NCT03831191|25816567|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
13089632|NCT03831191|25816568|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
13089633|NCT03830892|25816585|FG000|Overall Study|Physician Decision|2|||
13089634|NCT03830892|25816586|FG001|Overall Study|Physician Decision|3|||
13089635|NCT03830892|25816585|FG000|Overall Study|Study terminated due to COVID|4|||
13089636|NCT03830892|25816586|FG001|Overall Study|Study terminated due to COVID|0|||
13089637|NCT03830892|25816585|FG000|Overall Study|Protocol Violation|0|||
13089638|NCT03830892|25816586|FG001|Overall Study|Protocol Violation|1|||
13089639|NCT03830892|25816585|FG000|Overall Study|Withdrawal by Subject|0|||
13089640|NCT03830892|25816586|FG001|Overall Study|Withdrawal by Subject|2|||
13089641|NCT03830281|25816624|FG000|Lead-in Period (2 Weeks)|Adverse Event|2|||
13089642|NCT03830281|25816625|FG001|Lead-in Period (2 Weeks)|Adverse Event|0|||
13089643|NCT03830281|25816624|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6|||
13089644|NCT03830281|25816625|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0|||
13089645|NCT03830281|25816624|FG000|Lead-in Period (2 Weeks)|Physician Decision|2|||
13089646|NCT03830281|25816625|FG001|Lead-in Period (2 Weeks)|Physician Decision|0|||
13089647|NCT03830281|25816624|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29|||
13089648|NCT03830281|25816625|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0|||
13089649|NCT03830281|25816624|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
13089650|NCT03830281|25816625|FG001|Treatment Period (16 Weeks)|Adverse Event|7|||
13089651|NCT03830281|25816624|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4|||
13089652|NCT03830281|25816625|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3|||
13089653|NCT03830281|25816624|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1|||
13089654|NCT03830281|25816625|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1|||
13089655|NCT03830281|25816624|FG000|Treatment Period (16 Weeks)|Physician Decision|1|||
13089656|NCT03830281|25816625|FG001|Treatment Period (16 Weeks)|Physician Decision|0|||
13089657|NCT03830281|25816624|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5|||
13089658|NCT03830281|25816625|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6|||
13089659|NCT03829228|25816634|FG000|Overall Study|Protocol Violation|1|||
13089660|NCT03828747|25816656|FG000|Double-Blind Treatment Period|Adverse Event|6|||
13089661|NCT03828747|25816657|FG001|Double-Blind Treatment Period|Adverse Event|6|||
13089662|NCT03828747|25816656|FG000|Double-Blind Treatment Period|Death|1|||
13089663|NCT03828747|25816657|FG001|Double-Blind Treatment Period|Death|2|||
13089664|NCT03828747|25816656|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
13089665|NCT03828747|25816657|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
13089666|NCT03828747|25816656|FG000|Double-Blind Treatment Period|Withdrawal by Subject|19|||
13089667|NCT03828747|25816657|FG001|Double-Blind Treatment Period|Withdrawal by Subject|21|||
13089668|NCT03828747|25816656|FG000|Double-Blind Treatment Period|Physician Decision|0|||
13089669|NCT03828747|25816657|FG001|Double-Blind Treatment Period|Physician Decision|3|||
13089670|NCT03828747|25816656|FG000|Double-Blind Treatment Period|Various reasons|5|||
13089671|NCT03828747|25816657|FG001|Double-Blind Treatment Period|Various reasons|3|||
13307570|NCT01284634|26529037|FG003|Overall Study|Adverse Event|1|||
13089672|NCT03828747|25816656|FG000|Open-Label Extension|Continuing on Study|77|||
13089673|NCT03828747|25816657|FG001|Open-Label Extension|Continuing on Study|72|||
13089674|NCT03828747|25816656|FG000|Open-Label Extension|Adverse Event|3|||
13089675|NCT03828747|25816657|FG001|Open-Label Extension|Adverse Event|4|||
13089676|NCT03828747|25816656|FG000|Open-Label Extension|Death|0|||
13089677|NCT03828747|25816657|FG001|Open-Label Extension|Death|2|||
13089678|NCT03828747|25816656|FG000|Open-Label Extension|Lost to Follow-up|4|||
13089679|NCT03828747|25816657|FG001|Open-Label Extension|Lost to Follow-up|0|||
13089680|NCT03828747|25816656|FG000|Open-Label Extension|Withdrawal by Subject|19|||
13089681|NCT03828747|25816657|FG001|Open-Label Extension|Withdrawal by Subject|16|||
13089682|NCT03828747|25816656|FG000|Open-Label Extension|Various reasons|1|||
13089683|NCT03828747|25816657|FG001|Open-Label Extension|Various reasons|1|||
13089684|NCT03828617|25816696|FG000|Overall Study|Lost to Follow-up|22|||
13089685|NCT03828617|25816697|FG001|Overall Study|Lost to Follow-up|12|||
13089686|NCT03828617|25816698|FG002|Overall Study|Lost to Follow-up|23|||
13089687|NCT03828617|25816699|FG003|Overall Study|Lost to Follow-up|7|||
13089688|NCT03828617|25816696|FG000|Overall Study|No longer met eligibility criteria|0|||
13089689|NCT03828617|25816697|FG001|Overall Study|No longer met eligibility criteria|1|||
13089690|NCT03828617|25816698|FG002|Overall Study|No longer met eligibility criteria|1|||
13089691|NCT03828617|25816699|FG003|Overall Study|No longer met eligibility criteria|3|||
13089692|NCT03828617|25816696|FG000|Overall Study|Protocol Violation|0|||
13089693|NCT03828617|25816697|FG001|Overall Study|Protocol Violation|2|||
13089694|NCT03828617|25816698|FG002|Overall Study|Protocol Violation|0|||
13089695|NCT03828617|25816699|FG003|Overall Study|Protocol Violation|0|||
13089696|NCT03828617|25816696|FG000|Overall Study|Withdrawal by Subject|2|||
13089697|NCT03828617|25816697|FG001|Overall Study|Withdrawal by Subject|0|||
13089698|NCT03828617|25816698|FG002|Overall Study|Withdrawal by Subject|2|||
13089699|NCT03828617|25816699|FG003|Overall Study|Withdrawal by Subject|0|||
13089700|NCT03828539|25816718|FG000|Overall Study|Adverse Event|3|||
13089701|NCT03828539|25816719|FG001|Overall Study|Adverse Event|12|||
13089702|NCT03828539|25816718|FG000|Overall Study|Patient's/guardian's decision|3|||
13089703|NCT03828539|25816719|FG001|Overall Study|Patient's/guardian's decision|5|||
13089704|NCT03828539|25816718|FG000|Overall Study|Lost to Follow-up|4|||
13089705|NCT03828539|25816719|FG001|Overall Study|Lost to Follow-up|2|||
13089706|NCT03828539|25816718|FG000|Overall Study|Protocol Violation|3|||
13089707|NCT03828539|25816719|FG001|Overall Study|Protocol Violation|2|||
13089708|NCT03828539|25816718|FG000|Overall Study|Withdrawal of informed consent|2|||
13089709|NCT03828539|25816719|FG001|Overall Study|Withdrawal of informed consent|1|||
13089710|NCT03828539|25816718|FG000|Overall Study|New therapy for study indication|1|||
13089711|NCT03828539|25816719|FG001|Overall Study|New therapy for study indication|0|||
13089712|NCT03828487|25816725|FG000|Overall Study|Physician Decision|1|||
13089713|NCT03828383|25816744|FG000|Overall Study|Lost to Follow-up|3|||
13089714|NCT03828383|25816745|FG001|Overall Study|Lost to Follow-up|2|||
13089715|NCT03828383|25816744|FG000|Overall Study|Withdrawal by Subject|4|||
13089716|NCT03828383|25816745|FG001|Overall Study|Withdrawal by Subject|5|||
13089717|NCT03827564|25816758|FG000|Overall Study|Discontinued due to Study Termination|1|||
13089718|NCT03827564|25816759|FG001|Overall Study|Discontinued due to Study Termination|0|||
13089719|NCT03827473|25816780|FG000|Overall Study|Withdrawal by Subject|1|||
13089720|NCT03827473|25816781|FG001|Overall Study|Withdrawal by Subject|0|||
13089721|NCT03827395|25816812|FG000|Overall Study|Lost to Follow-up|1|||
13089722|NCT03827395|25816813|FG001|Overall Study|Lost to Follow-up|0|||
13089723|NCT03827395|25816812|FG000|Overall Study|Protocol Violation|1|||
13089724|NCT03827395|25816813|FG001|Overall Study|Protocol Violation|0|||
13089725|NCT03827395|25816812|FG000|Overall Study|Became ineligible after enrollment|1|||
13089726|NCT03827395|25816813|FG001|Overall Study|Became ineligible after enrollment|2|||
13089727|NCT03826914|25816828|FG000|Overall Study|Withdrawal by Subject|1|||
13089728|NCT03826914|25816829|FG001|Overall Study|Withdrawal by Subject|1|||
13089729|NCT03826667|25816845|FG000|Overall Study|Protocol deviation|21|||
13089730|NCT03826186|25816872|FG000|Overall Study|Protocol Violation|2|||
13089731|NCT03826186|25816873|FG001|Overall Study|Protocol Violation|0|||
13089732|NCT03826186|25816872|FG000|Overall Study|Withdrawal by Subject|1|||
13089733|NCT03826186|25816873|FG001|Overall Study|Withdrawal by Subject|0|||
13089734|NCT03825341|25816920|FG000|Overall Study|Withdrawal by Subject|0|||
13089735|NCT03825341|25816921|FG001|Overall Study|Withdrawal by Subject|1|||
13089736|NCT03825042|25816938|FG000|Overall Study|Adverse Event|1|||
13089737|NCT03825042|25816939|FG001|Overall Study|Adverse Event|0|||
13089738|NCT03825042|25816938|FG000|Overall Study|Withdrawal by Subject|1|||
13089739|NCT03825042|25816939|FG001|Overall Study|Withdrawal by Subject|0|||
13089740|NCT03824912|25816969|FG000|Overall Study|Lost to Follow-up|18|||
13089741|NCT03824912|25816970|FG001|Overall Study|Lost to Follow-up|15|||
13089742|NCT03824912|25816971|FG002|Overall Study|Lost to Follow-up|8|||
13089743|NCT03824912|25816969|FG000|Overall Study|Negative Baseline Culture Result|118|||
13089744|NCT03824912|25816970|FG001|Overall Study|Negative Baseline Culture Result|112|||
13089745|NCT03824912|25816971|FG002|Overall Study|Negative Baseline Culture Result|57|||
13089746|NCT03824912|25816969|FG000|Overall Study|Non-Compliance with Study Drug|0|||
13089747|NCT03824912|25816970|FG001|Overall Study|Non-Compliance with Study Drug|0|||
13089748|NCT03824912|25816971|FG002|Overall Study|Non-Compliance with Study Drug|1|||
13089749|NCT03824912|25816969|FG000|Overall Study|Protocol Violation|1|||
13089750|NCT03824912|25816970|FG001|Overall Study|Protocol Violation|4|||
13089751|NCT03824912|25816971|FG002|Overall Study|Protocol Violation|1|||
13089752|NCT03824912|25816969|FG000|Overall Study|Withdrawal by Subject|3|||
13089753|NCT03824912|25816970|FG001|Overall Study|Withdrawal by Subject|2|||
13089754|NCT03824912|25816971|FG002|Overall Study|Withdrawal by Subject|1|||
13089755|NCT03824912|25816969|FG000|Overall Study|Participation in another study|0|||
13089756|NCT03824912|25816970|FG001|Overall Study|Participation in another study|1|||
13089757|NCT03824912|25816971|FG002|Overall Study|Participation in another study|0|||
13089758|NCT03824704|25816981|FG000|Overall Study|Study Terminated by Sponsor|1|||
13089759|NCT03824236|25817024|FG000|Overall Study|Lost to Follow-up|0|||
13089760|NCT03824236|25817025|FG001|Overall Study|Lost to Follow-up|0|||
13089761|NCT03824236|25817026|FG002|Overall Study|Lost to Follow-up|1|||
13089762|NCT03823703|25817068|FG000|Overall Study|Sponsor request|0|||
13089763|NCT03823703|25817069|FG001|Overall Study|Sponsor request|3|||
13089764|NCT03823703|25817070|FG002|Overall Study|Sponsor request|4|||
13089765|NCT03823703|25817068|FG000|Overall Study|Adverse Event|3|||
13089766|NCT03823703|25817069|FG001|Overall Study|Adverse Event|1|||
13089767|NCT03823703|25817070|FG002|Overall Study|Adverse Event|0|||
13089768|NCT03823703|25817068|FG000|Overall Study|Withdrawal by Subject|0|||
13089769|NCT03823703|25817069|FG001|Overall Study|Withdrawal by Subject|1|||
13089770|NCT03823703|25817070|FG002|Overall Study|Withdrawal by Subject|0|||
13089771|NCT03823391|25817095|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
13089772|NCT03823391|25817096|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
13089773|NCT03823391|25817095|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1|||
13089774|NCT03823391|25817096|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0|||
13089775|NCT03823378|25817231|FG000|Overall Study|Adverse Event|2|||
13089776|NCT03823378|25817232|FG001|Overall Study|Adverse Event|2|||
13089777|NCT03823378|25817233|FG002|Overall Study|Adverse Event|0|||
13089778|NCT03823378|25817234|FG003|Overall Study|Adverse Event|0|||
13089779|NCT03823378|25817235|FG004|Overall Study|Adverse Event|0|||
13089780|NCT03823378|25817236|FG005|Overall Study|Adverse Event|0|||
13089781|NCT03823378|25817231|FG000|Overall Study|Lost to Follow-up|0|||
13089782|NCT03823378|25817232|FG001|Overall Study|Lost to Follow-up|1|||
13089783|NCT03823378|25817233|FG002|Overall Study|Lost to Follow-up|0|||
13089784|NCT03823378|25817234|FG003|Overall Study|Lost to Follow-up|0|||
13089785|NCT03823378|25817235|FG004|Overall Study|Lost to Follow-up|1|||
13089786|NCT03823378|25817236|FG005|Overall Study|Lost to Follow-up|0|||
13089787|NCT03823378|25817231|FG000|Overall Study|Withdrawal by Subject|0|||
13089788|NCT03823378|25817232|FG001|Overall Study|Withdrawal by Subject|1|||
13089789|NCT03823378|25817233|FG002|Overall Study|Withdrawal by Subject|4|||
13089790|NCT03823378|25817234|FG003|Overall Study|Withdrawal by Subject|2|||
13089791|NCT03823378|25817235|FG004|Overall Study|Withdrawal by Subject|0|||
13089792|NCT03823378|25817236|FG005|Overall Study|Withdrawal by Subject|1|||
13089793|NCT03823378|25817231|FG000|Overall Study|Other, not specified|19|||
13089794|NCT03823378|25817232|FG001|Overall Study|Other, not specified|12|||
13089795|NCT03823378|25817233|FG002|Overall Study|Other, not specified|6|||
13089796|NCT03823378|25817234|FG003|Overall Study|Other, not specified|8|||
13089797|NCT03823378|25817235|FG004|Overall Study|Other, not specified|17|||
13089798|NCT03823378|25817236|FG005|Overall Study|Other, not specified|7|||
13089799|NCT03823287|25817278|FG000|Overall Study|Withdrawal by Subject|7|||
13089800|NCT03823287|25817279|FG001|Overall Study|Withdrawal by Subject|6|||
13089801|NCT03823287|25817278|FG000|Overall Study|Death|4|||
13089802|NCT03823287|25817279|FG001|Overall Study|Death|1|||
13089803|NCT03823287|25817278|FG000|Overall Study|Lost to Follow-up|2|||
13089804|NCT03823287|25817279|FG001|Overall Study|Lost to Follow-up|3|||
13089805|NCT03823287|25817278|FG000|Overall Study|Physician Decision|2|||
13089806|NCT03823287|25817279|FG001|Overall Study|Physician Decision|1|||
13089807|NCT03823287|25817278|FG000|Overall Study|Adverse Event|0|||
13089808|NCT03823287|25817279|FG001|Overall Study|Adverse Event|3|||
13089809|NCT03823287|25817278|FG000|Overall Study|Ongoing in the study at Primary Completion Date|319|||
13089810|NCT03823287|25817279|FG001|Overall Study|Ongoing in the study at Primary Completion Date|323|||
13089811|NCT03822884|25817327|FG000|Overall Study|Withdrawal by Subject|0|||
13089812|NCT03822884|25817328|FG001|Overall Study|Withdrawal by Subject|0|||
13089813|NCT03822884|25817329|FG002|Overall Study|Withdrawal by Subject|0|||
13089814|NCT03822884|25817330|FG003|Overall Study|Withdrawal by Subject|0|||
13089815|NCT03822884|25817331|FG004|Overall Study|Withdrawal by Subject|1|||
13089816|NCT03822884|25817332|FG005|Overall Study|Withdrawal by Subject|0|||
13089817|NCT03822416|25817349|FG000|Overall Study|Lost to Follow-up|1|||
13089818|NCT03822416|25817350|FG001|Overall Study|Lost to Follow-up|0|||
13089819|NCT03822416|25817349|FG000|Overall Study|Withdrawal by Subject|0|||
13089820|NCT03822416|25817350|FG001|Overall Study|Withdrawal by Subject|1|||
13089821|NCT03822182|25817371|FG000|Overall Study|Protocol Violation|0|||
13089822|NCT03822182|25817372|FG001|Overall Study|Protocol Violation|1|||
13089823|NCT03822182|25817373|FG002|Overall Study|Protocol Violation|1|||
13132608|NCT02788175|25984513|FG000|Overall Study|Ineligible prior to study agent|6|||
13089824|NCT03821064|25817404|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1|||
13089825|NCT03820024|25817417|FG000|Overall Study|Physician Decision|1|||
13089826|NCT03820024|25817418|FG001|Overall Study|Physician Decision|2|||
13089827|NCT03819634|25817424|FG000|Overall Study|Physician Decision|2|||
13089828|NCT03819218|25817437|FG000|Overall Study|Protocol Violation|1|||
13089829|NCT03818399|25817444|FG000|Overall Study|Lost to Follow-up|11|||
13089830|NCT03818399|25817444|FG000|Overall Study|Withdrawal by Subject|1|||
13089831|NCT03818399|25817444|FG000|Overall Study|Protocol Violation|2|||
13089832|NCT03818321|25817457|FG000|Overall Study|Withdrawal by Subject|1|||
13089833|NCT03818321|25817458|FG001|Overall Study|Withdrawal by Subject|2|||
13089834|NCT03817879|25817471|FG000|Overall Study|Drop out|5|||
13089835|NCT03817879|25817472|FG001|Overall Study|Drop out|12|||
13089836|NCT03817879|25817471|FG000|Overall Study|Withdrawal by Subject|0|||
13089837|NCT03817879|25817472|FG001|Overall Study|Withdrawal by Subject|1|||
13089838|NCT03817853|25817491|FG000|Induction Phase|Adverse Event|5|||
13089839|NCT03817853|25817492|FG001|Induction Phase|Adverse Event|0|||
13089840|NCT03817853|25817493|FG002|Induction Phase|Adverse Event|0|||
13089841|NCT03817853|25817491|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3|||
13089842|NCT03817853|25817492|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
13089843|NCT03817853|25817493|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
13089844|NCT03817853|25817491|FG000|Induction Phase|Physician Decision|2|||
13089845|NCT03817853|25817492|FG001|Induction Phase|Physician Decision|0|||
13089846|NCT03817853|25817493|FG002|Induction Phase|Physician Decision|0|||
13089847|NCT03817853|25817491|FG000|Induction Phase|Progressive Disease|4|||
13089848|NCT03817853|25817492|FG001|Induction Phase|Progressive Disease|0|||
13089849|NCT03817853|25817493|FG002|Induction Phase|Progressive Disease|0|||
13089850|NCT03817853|25817491|FG000|Induction Phase|Withdrawal by Subject|3|||
13089851|NCT03817853|25817492|FG001|Induction Phase|Withdrawal by Subject|0|||
13089852|NCT03817853|25817493|FG002|Induction Phase|Withdrawal by Subject|0|||
13089853|NCT03817853|25817491|FG000|Induction Phase|Continuing on Study|34|||
13089854|NCT03817853|25817492|FG001|Induction Phase|Continuing on Study|0|||
13089855|NCT03817853|25817493|FG002|Induction Phase|Continuing on Study|0|||
13089856|NCT03817853|25817491|FG000|Maintenance/ Follow-up Phase|Adverse Event|0|||
13089857|NCT03817853|25817492|FG001|Maintenance/ Follow-up Phase|Adverse Event|1|||
13089858|NCT03817853|25817493|FG002|Maintenance/ Follow-up Phase|Adverse Event|0|||
13089859|NCT03817853|25817491|FG000|Maintenance/ Follow-up Phase|Death|0|||
13089860|NCT03817853|25817492|FG001|Maintenance/ Follow-up Phase|Death|1|||
13089861|NCT03817853|25817493|FG002|Maintenance/ Follow-up Phase|Death|1|||
13089862|NCT03817853|25817491|FG000|Maintenance/ Follow-up Phase|Progressive Disease|0|||
13089863|NCT03817853|25817492|FG001|Maintenance/ Follow-up Phase|Progressive Disease|1|||
13089864|NCT03817853|25817493|FG002|Maintenance/ Follow-up Phase|Progressive Disease|3|||
13089865|NCT03817853|25817491|FG000|Maintenance/ Follow-up Phase|Withdrawal by Subject|0|||
13089866|NCT03817853|25817492|FG001|Maintenance/ Follow-up Phase|Withdrawal by Subject|1|||
13089867|NCT03817853|25817493|FG002|Maintenance/ Follow-up Phase|Withdrawal by Subject|0|||
13089868|NCT03817853|25817491|FG000|Maintenance/ Follow-up Phase|Continuing on Study|0|||
13089869|NCT03817853|25817492|FG001|Maintenance/ Follow-up Phase|Continuing on Study|52|||
13089870|NCT03817853|25817493|FG002|Maintenance/ Follow-up Phase|Continuing on Study|2|||
13089871|NCT03817528|25817499|FG000|Overall Study|Withdrawal by Subject|1|||
13089872|NCT03817528|25817499|FG000|Overall Study|Adverse Event|2|||
13089873|NCT03816761|25817610|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
13089874|NCT03816761|25817611|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
13089875|NCT03816761|25817612|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
13089876|NCT03816761|25817613|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
13089877|NCT03816761|25817614|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
13089878|NCT03816761|25817615|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1|||
13089879|NCT03816761|25817610|FG000|Second Treatment Period (7 Days)|Unclassified|0|||
13089880|NCT03816761|25817611|FG001|Second Treatment Period (7 Days)|Unclassified|0|||
13089881|NCT03816761|25817612|FG002|Second Treatment Period (7 Days)|Unclassified|0|||
13089882|NCT03816761|25817613|FG003|Second Treatment Period (7 Days)|Unclassified|1|||
13089883|NCT03816761|25817614|FG004|Second Treatment Period (7 Days)|Unclassified|0|||
13089884|NCT03816761|25817615|FG005|Second Treatment Period (7 Days)|Unclassified|0|||
13089885|NCT03815175|25817659|FG000|Overall Study|Subject Lost to Follow-up|6|||
13089886|NCT03815175|25817659|FG000|Overall Study|Subject Withdrew Consent|48|||
13089887|NCT03815175|25817659|FG000|Overall Study|Subject Withdrawn by Physician/Site|10|||
13089888|NCT03815175|25817659|FG000|Overall Study|Death|86|||
13089889|NCT03815175|25817659|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1|||
13089890|NCT03815175|25817659|FG000|Overall Study|Subject Discontinued by Sponsor|2|||
13089891|NCT03815175|25817659|FG000|Overall Study|Other Status Change Reason|1|||
13089892|NCT03815175|25817659|FG000|Overall Study|Missed Visit|12|||
13089893|NCT03814590|25817940|FG000|Overall Study|Adverse Event|0|||
13089894|NCT03814590|25817941|FG001|Overall Study|Adverse Event|0|||
13089895|NCT03814590|25817942|FG002|Overall Study|Adverse Event|0|||
13089896|NCT03814590|25817943|FG003|Overall Study|Adverse Event|0|||
13089897|NCT03814590|25817944|FG004|Overall Study|Adverse Event|0|||
13089898|NCT03814590|25817945|FG005|Overall Study|Adverse Event|1|||
13089899|NCT03814590|25817946|FG006|Overall Study|Adverse Event|1|||
13089900|NCT03814590|25817947|FG007|Overall Study|Adverse Event|1|||
13089901|NCT03814590|25817948|FG008|Overall Study|Adverse Event|0|||
13089902|NCT03814590|25817949|FG009|Overall Study|Adverse Event|0|||
13089903|NCT03814590|25817950|FG010|Overall Study|Adverse Event|1|||
13089904|NCT03814590|25817951|FG011|Overall Study|Adverse Event|0|||
13089905|NCT03814590|25817952|FG012|Overall Study|Adverse Event|3|||
13089906|NCT03814590|25817953|FG013|Overall Study|Adverse Event|0|||
13089907|NCT03814590|25817940|FG000|Overall Study|Lost to Follow-up|0|||
13089908|NCT03814590|25817941|FG001|Overall Study|Lost to Follow-up|2|||
13089909|NCT03814590|25817942|FG002|Overall Study|Lost to Follow-up|1|||
13089910|NCT03814590|25817943|FG003|Overall Study|Lost to Follow-up|0|||
13089911|NCT03814590|25817944|FG004|Overall Study|Lost to Follow-up|1|||
13089912|NCT03814590|25817945|FG005|Overall Study|Lost to Follow-up|1|||
13089913|NCT03814590|25817946|FG006|Overall Study|Lost to Follow-up|1|||
13089914|NCT03814590|25817947|FG007|Overall Study|Lost to Follow-up|1|||
13089915|NCT03814590|25817948|FG008|Overall Study|Lost to Follow-up|0|||
13089916|NCT03814590|25817949|FG009|Overall Study|Lost to Follow-up|0|||
13089917|NCT03814590|25817950|FG010|Overall Study|Lost to Follow-up|1|||
13089918|NCT03814590|25817951|FG011|Overall Study|Lost to Follow-up|0|||
13089919|NCT03814590|25817952|FG012|Overall Study|Lost to Follow-up|0|||
13089920|NCT03814590|25817953|FG013|Overall Study|Lost to Follow-up|1|||
13089921|NCT03814590|25817940|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
13089922|NCT03814590|25817941|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
13089923|NCT03814590|25817942|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
13089924|NCT03814590|25817943|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
13089925|NCT03814590|25817944|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
13089926|NCT03814590|25817945|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
13089927|NCT03814590|25817946|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
13089928|NCT03814590|25817947|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
13089929|NCT03814590|25817948|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
13089930|NCT03814590|25817949|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1|||
13089931|NCT03814590|25817950|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
13089932|NCT03814590|25817951|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
13089933|NCT03814590|25817952|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
13089934|NCT03814590|25817953|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
13089935|NCT03814590|25817940|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
13089936|NCT03814590|25817941|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
13089937|NCT03814590|25817942|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
13089938|NCT03814590|25817943|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
13089939|NCT03814590|25817944|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
13089940|NCT03814590|25817945|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
13089941|NCT03814590|25817946|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
13089942|NCT03814590|25817947|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
13089943|NCT03814590|25817948|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
13089944|NCT03814590|25817949|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
13089945|NCT03814590|25817950|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
13089946|NCT03814590|25817951|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
13089947|NCT03814590|25817952|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
13089948|NCT03814590|25817953|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
13089949|NCT03814590|25817940|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
13089950|NCT03814590|25817941|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
13089951|NCT03814590|25817942|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
13089952|NCT03814590|25817943|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
13089953|NCT03814590|25817944|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
13089954|NCT03814590|25817945|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
13089955|NCT03814590|25817946|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
13089956|NCT03814590|25817947|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
13089957|NCT03814590|25817948|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
13089958|NCT03814590|25817949|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
13089959|NCT03814590|25817950|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
13089960|NCT03814590|25817951|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
13089961|NCT03814590|25817952|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
13089962|NCT03814590|25817953|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
13089963|NCT03814590|25817940|FG000|Overall Study|UNKNOWN REASON|0|||
13089964|NCT03814590|25817941|FG001|Overall Study|UNKNOWN REASON|0|||
13089965|NCT03814590|25817942|FG002|Overall Study|UNKNOWN REASON|0|||
13089966|NCT03814590|25817943|FG003|Overall Study|UNKNOWN REASON|0|||
13089967|NCT03814590|25817944|FG004|Overall Study|UNKNOWN REASON|0|||
13089968|NCT03814590|25817945|FG005|Overall Study|UNKNOWN REASON|0|||
13089969|NCT03814590|25817946|FG006|Overall Study|UNKNOWN REASON|0|||
13089970|NCT03814590|25817947|FG007|Overall Study|UNKNOWN REASON|1|||
13089971|NCT03814590|25817948|FG008|Overall Study|UNKNOWN REASON|0|||
13089972|NCT03814590|25817949|FG009|Overall Study|UNKNOWN REASON|0|||
13089973|NCT03814590|25817950|FG010|Overall Study|UNKNOWN REASON|0|||
13089974|NCT03814590|25817951|FG011|Overall Study|UNKNOWN REASON|0|||
13089975|NCT03814590|25817952|FG012|Overall Study|UNKNOWN REASON|0|||
13089976|NCT03814590|25817953|FG013|Overall Study|UNKNOWN REASON|0|||
13089977|NCT03812679|25817962|FG000|Overall Study|Adverse Event|2|||
13089978|NCT03812679|25817962|FG000|Overall Study|Missed >4 consecutive therapy days|1|||
13089979|NCT03812679|25817962|FG000|Overall Study|Renal transplant|1|||
13089980|NCT03812679|25817962|FG000|Overall Study|Withdrawal by Subject|1|||
13089981|NCT03812679|25817962|FG000|Overall Study|Termination of study|2|||
13089982|NCT03812679|25817962|FG000|Overall Study|Water device replacement|1|||
13089983|NCT03812510|25817993|FG000|Overall Study|Lost to Follow-up|39|||
13089984|NCT03812510|25817993|FG000|Overall Study|Withdrawal by Subject|42|||
13089985|NCT03812510|25817993|FG000|Overall Study|Physician Decision|2|||
13089986|NCT03812510|25817993|FG000|Overall Study|Study Terminated by Sponsor|9|||
13089987|NCT03812510|25817993|FG000|Overall Study|Did Not Start Study Medication|55|||
13089988|NCT03812510|25817993|FG000|Overall Study|Adverse Event|5|||
13089989|NCT03812380|25818024|FG000|Overall Study|Protocol Violation|3|||
13089990|NCT03812380|25818025|FG001|Overall Study|Protocol Violation|3|||
13089991|NCT03812380|25818024|FG000|Overall Study|Withdrawal by Subject|5|||
13089992|NCT03812380|25818025|FG001|Overall Study|Withdrawal by Subject|4|||
13089993|NCT03812380|25818024|FG000|Overall Study|Early termination of study|14|||
13089994|NCT03812380|25818025|FG001|Overall Study|Early termination of study|14|||
13089995|NCT03811834|25818075|FG000|Period 1 ( 7 Days)|Adverse Event|1|||
13089996|NCT03811093|25818092|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0|||
13089997|NCT03811093|25818093|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4|||
13089998|NCT03811093|25818092|FG000|Overall Study|Unable to measure body fat percentage|2|||
13089999|NCT03811093|25818093|FG001|Overall Study|Unable to measure body fat percentage|0|||
13090012|NCT03810183|25818151|FG000|Overall Study|Study terminated by Sponsor|2|||
13090013|NCT03810183|25818152|FG001|Overall Study|Study terminated by Sponsor|1|||
13090014|NCT03810014|25818187|FG000|Overall Study|Pregnancy|2|||
13090015|NCT03810014|25818188|FG001|Overall Study|Pregnancy|2|||
13090016|NCT03810014|25818189|FG002|Overall Study|Pregnancy|0|||
13090017|NCT03810014|25818190|FG003|Overall Study|Pregnancy|2|||
13090018|NCT03809611|25818208|FG000|Overall Study|Withdrawal by Subject|1|||
13090019|NCT03809611|25818209|FG001|Overall Study|Withdrawal by Subject|1|||
13090020|NCT03809104|25818220|FG000|Overall Study|Withdrawal by Subject|3|||
13090021|NCT03809039|25818358|FG000|Part 1|Withdrawal by Subject|1|||
13090022|NCT03809039|25818359|FG001|Part 1|Withdrawal by Subject|0|||
13090023|NCT03809039|25818360|FG002|Part 1|Withdrawal by Subject|0|||
13090024|NCT03809039|25818361|FG003|Part 1|Withdrawal by Subject|1|||
13090025|NCT03809039|25818362|FG004|Part 1|Withdrawal by Subject|0|||
13090026|NCT03809039|25818363|FG005|Part 1|Withdrawal by Subject|0|||
13090027|NCT03809039|25818364|FG006|Part 1|Withdrawal by Subject|0|||
13090028|NCT03809039|25818365|FG007|Part 1|Withdrawal by Subject|0|||
13090029|NCT03809039|25818366|FG008|Part 1|Withdrawal by Subject|0|||
13090030|NCT03809039|25818358|FG000|Part 3|Withdrawn by study termination|0|||
13090031|NCT03809039|25818359|FG001|Part 3|Withdrawn by study termination|0|||
13090032|NCT03809039|25818360|FG002|Part 3|Withdrawn by study termination|0|||
13090033|NCT03809039|25818361|FG003|Part 3|Withdrawn by study termination|0|||
13090034|NCT03809039|25818362|FG004|Part 3|Withdrawn by study termination|0|||
13090035|NCT03809039|25818363|FG005|Part 3|Withdrawn by study termination|0|||
13090036|NCT03809039|25818364|FG006|Part 3|Withdrawn by study termination|0|||
13090037|NCT03809039|25818365|FG007|Part 3|Withdrawn by study termination|2|||
13090038|NCT03809039|25818366|FG008|Part 3|Withdrawn by study termination|6|||
13090039|NCT03808688|25818381|FG000|Overall Study|Adverse Event|13|||
13090040|NCT03808688|25818382|FG001|Overall Study|Adverse Event|17|||
13090041|NCT03808688|25818381|FG000|Overall Study|Lack of Efficacy|2|||
13090042|NCT03808688|25818382|FG001|Overall Study|Lack of Efficacy|0|||
13090043|NCT03808688|25818381|FG000|Overall Study|Lost to Follow-up|0|||
13090044|NCT03808688|25818382|FG001|Overall Study|Lost to Follow-up|2|||
13090045|NCT03808688|25818381|FG000|Overall Study|Withdrawal by Subject|1|||
13090046|NCT03808688|25818382|FG001|Overall Study|Withdrawal by Subject|0|||
13090047|NCT03808688|25818381|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1|||
13090048|NCT03808688|25818382|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0|||
13090049|NCT03808688|25818381|FG000|Overall Study|IOP Too High|1|||
13090050|NCT03808688|25818382|FG001|Overall Study|IOP Too High|1|||
13090051|NCT03808688|25818381|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0|||
13090052|NCT03808688|25818382|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1|||
13090053|NCT03808688|25818381|FG000|Overall Study|Visit Out of Window|0|||
13090054|NCT03808688|25818382|FG001|Overall Study|Visit Out of Window|1|||
13090055|NCT03808688|25818381|FG000|Overall Study|Medication Non-Compliance|0|||
13090056|NCT03808688|25818382|FG001|Overall Study|Medication Non-Compliance|1|||
13090057|NCT03808545|25818423|FG000|Overall Study|Withdrawal by Subject|1|||
13090058|NCT03808545|25818424|FG001|Overall Study|Withdrawal by Subject|1|||
13090059|NCT03808298|25818499|FG000|Overall Study|Adverse Event|3|||
13090060|NCT03808298|25818499|FG000|Overall Study|Physician Decision|1|||
13090061|NCT03808298|25818499|FG000|Overall Study|Withdrawal by Subject|1|||
13090062|NCT03808298|25818499|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3|||
13090063|NCT03807843|25818518|FG000|Overall Study|Lost to Follow-up|1|||
13090064|NCT03807843|25818519|FG001|Overall Study|Lost to Follow-up|0|||
13090065|NCT03807739|25818546|FG000|Overall Study|Adverse Event|1|||
13090066|NCT03807739|25818547|FG001|Overall Study|Adverse Event|0|||
13090067|NCT03807739|25818548|FG002|Overall Study|Adverse Event|0|||
13090068|NCT03807739|25818549|FG003|Overall Study|Adverse Event|0|||
13090069|NCT03807739|25818546|FG000|Overall Study|Withdrawal by Subject|1|||
13090070|NCT03807739|25818547|FG001|Overall Study|Withdrawal by Subject|0|||
13090071|NCT03807739|25818548|FG002|Overall Study|Withdrawal by Subject|0|||
13090072|NCT03807739|25818549|FG003|Overall Study|Withdrawal by Subject|0|||
13090073|NCT03807700|25818579|FG000|Overall Study|Withdrawal by Subject|2|||
13090074|NCT03807700|25818580|FG001|Overall Study|Withdrawal by Subject|1|||
13090075|NCT03806231|25818615|FG000|Overall Study|Physician Decision|1|||
13090076|NCT03806231|25818616|FG001|Overall Study|Physician Decision|0|||
13090077|NCT03806231|25818615|FG000|Overall Study|Withdrawal by Subject|1|||
13090078|NCT03806231|25818616|FG001|Overall Study|Withdrawal by Subject|0|||
13090079|NCT03806127|25818641|FG000|Overall Study|Withdrawal by Subject|4|||
13090080|NCT03806127|25818642|FG001|Overall Study|Withdrawal by Subject|5|||
13090081|NCT03806127|25818641|FG000|Overall Study|Protocol Violation|3|||
13090082|NCT03806127|25818642|FG001|Overall Study|Protocol Violation|1|||
13090083|NCT03806127|25818641|FG000|Overall Study|Adverse Event|3|||
13090084|NCT03806127|25818642|FG001|Overall Study|Adverse Event|0|||
13090085|NCT03806127|25818641|FG000|Overall Study|Unable to Complete Procedures|0|||
13090086|NCT03806127|25818642|FG001|Overall Study|Unable to Complete Procedures|1|||
13090087|NCT03806127|25818641|FG000|Overall Study|Pregnancy|0|||
13090088|NCT03806127|25818642|FG001|Overall Study|Pregnancy|1|||
13090089|NCT03806127|25818641|FG000|Overall Study|Lost to Follow-up|5|||
13090090|NCT03806127|25818642|FG001|Overall Study|Lost to Follow-up|1|||
13090091|NCT03806127|25818641|FG000|Overall Study|Physician Decision|1|||
13090092|NCT03806127|25818642|FG001|Overall Study|Physician Decision|1|||
13090093|NCT03806127|25818641|FG000|Overall Study|Could Not Come Due to Covid|1|||
13090094|NCT03806127|25818642|FG001|Overall Study|Could Not Come Due to Covid|0|||
13090095|NCT03806127|25818641|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1|||
13090096|NCT03806127|25818642|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0|||
13090097|NCT03806127|25818641|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1|||
13090098|NCT03806127|25818642|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0|||
13090099|NCT03806127|25818641|FG000|Overall Study|Covid 19 Restrictions|2|||
13090100|NCT03806127|25818642|FG001|Overall Study|Covid 19 Restrictions|0|||
13090101|NCT03806127|25818641|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0|||
13090102|NCT03806127|25818642|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1|||
13090103|NCT03806127|25818641|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0|||
13090104|NCT03806127|25818642|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1|||
13090105|NCT03805971|25818657|FG000|Overall Study|Withdrawal by Subject|1|||
13090106|NCT03805971|25818657|FG000|Overall Study|Protocol Violation|2|||
13090107|NCT03805438|25818677|FG000|Overall Study|Lack of Efficacy|1|||
13090108|NCT03805438|25818677|FG000|Overall Study|Protocol Violation|1|||
13090109|NCT03804918|25818684|FG000|Overall Study|Participant did not use the app|1|||
13090110|NCT03804879|25818719|FG000|Overall Study|Adverse Event|3|||
13090111|NCT03804879|25818720|FG001|Overall Study|Adverse Event|0|||
13090112|NCT03804879|25818719|FG000|Overall Study|Study Terminated By Sponsor|10|||
13090113|NCT03804879|25818720|FG001|Overall Study|Study Terminated By Sponsor|12|||
13090114|NCT03804879|25818719|FG000|Overall Study|Withdrawal by Subject|3|||
13090115|NCT03804879|25818720|FG001|Overall Study|Withdrawal by Subject|1|||
13090116|NCT03804710|25818782|FG000|Overall Study|Adverse Event|0|||
13090117|NCT03804710|25818783|FG001|Overall Study|Adverse Event|3|||
13090118|NCT03804710|25818782|FG000|Overall Study|Withdrawal by Subject|2|||
13090119|NCT03804710|25818783|FG001|Overall Study|Withdrawal by Subject|1|||
13090120|NCT03804710|25818782|FG000|Overall Study|Other|0|||
13090121|NCT03804710|25818783|FG001|Overall Study|Other|1|||
13090122|NCT03803475|25818793|FG000|Overall Study|Physician Decision|1|||
13090123|NCT03803059|25818810|FG000|Overall Study|Protocol Violation|2|||
13090124|NCT03803059|25818810|FG000|Overall Study|Lost to Follow-up|1|||
13090125|NCT03802994|25818853|FG000|Overall Study|Lost to Follow-up|0|||
13090126|NCT03802994|25818854|FG001|Overall Study|Lost to Follow-up|2|||
13090127|NCT03802994|25818855|FG002|Overall Study|Lost to Follow-up|3|||
13090128|NCT03802994|25818856|FG003|Overall Study|Lost to Follow-up|2|||
13090129|NCT03802994|25818857|FG004|Overall Study|Lost to Follow-up|2|||
13090130|NCT03802916|25818874|FG000|Overall Study|Adverse Event|0|||
13090131|NCT03802916|25818875|FG001|Overall Study|Adverse Event|1|||
13090132|NCT03802916|25818874|FG000|Overall Study|Withdrawal by Subject|0|||
13090133|NCT03802916|25818875|FG001|Overall Study|Withdrawal by Subject|1|||
13090146|NCT03801928|25819144|FG000|Overall Study|Adverse Event|1|||
13090147|NCT03801928|25819145|FG001|Overall Study|Adverse Event|0|||
13090148|NCT03801928|25819146|FG002|Overall Study|Adverse Event|1|||
13090149|NCT03801928|25819147|FG003|Overall Study|Adverse Event|2|||
13090150|NCT03801928|25819148|FG004|Overall Study|Adverse Event|0|||
13090151|NCT03801928|25819149|FG005|Overall Study|Adverse Event|2|||
13090152|NCT03801928|25819144|FG000|Overall Study|Lack of Efficacy|0|||
13090153|NCT03801928|25819145|FG001|Overall Study|Lack of Efficacy|0|||
13090154|NCT03801928|25819146|FG002|Overall Study|Lack of Efficacy|1|||
13090155|NCT03801928|25819147|FG003|Overall Study|Lack of Efficacy|0|||
13090156|NCT03801928|25819148|FG004|Overall Study|Lack of Efficacy|0|||
13090157|NCT03801928|25819149|FG005|Overall Study|Lack of Efficacy|0|||
13090158|NCT03801928|25819144|FG000|Overall Study|Lost to Follow-up|5|||
13090159|NCT03801928|25819145|FG001|Overall Study|Lost to Follow-up|1|||
13090160|NCT03801928|25819146|FG002|Overall Study|Lost to Follow-up|1|||
13090161|NCT03801928|25819147|FG003|Overall Study|Lost to Follow-up|4|||
13090162|NCT03801928|25819148|FG004|Overall Study|Lost to Follow-up|4|||
13090163|NCT03801928|25819149|FG005|Overall Study|Lost to Follow-up|2|||
13090164|NCT03801928|25819144|FG000|Overall Study|Withdrawal by Subject|0|||
13090165|NCT03801928|25819145|FG001|Overall Study|Withdrawal by Subject|0|||
13090166|NCT03801928|25819146|FG002|Overall Study|Withdrawal by Subject|2|||
13090167|NCT03801928|25819147|FG003|Overall Study|Withdrawal by Subject|1|||
13090168|NCT03801928|25819148|FG004|Overall Study|Withdrawal by Subject|0|||
13090169|NCT03801928|25819149|FG005|Overall Study|Withdrawal by Subject|0|||
13090170|NCT03801928|25819144|FG000|Overall Study|Other|0|||
13090171|NCT03801928|25819145|FG001|Overall Study|Other|2|||
13090172|NCT03801928|25819146|FG002|Overall Study|Other|0|||
13090173|NCT03801928|25819147|FG003|Overall Study|Other|1|||
13090174|NCT03801928|25819148|FG004|Overall Study|Other|0|||
13090175|NCT03801928|25819149|FG005|Overall Study|Other|1|||
13090176|NCT03801148|25819184|FG000|Period 1 (2 Days)|Adverse Event|1|||
13090177|NCT03801148|25819185|FG001|Period 1 (2 Days)|Adverse Event|1|||
13090178|NCT03801148|25819186|FG002|Period 1 (2 Days)|Adverse Event|0|||
13090179|NCT03801148|25819187|FG003|Period 1 (2 Days)|Adverse Event|0|||
13090180|NCT03801148|25819184|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
13090181|NCT03801148|25819185|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
13090182|NCT03801148|25819186|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
13090183|NCT03801148|25819187|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1|||
13090184|NCT03801148|25819184|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
13090185|NCT03801148|25819185|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
13090186|NCT03801148|25819186|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
13090187|NCT03801148|25819187|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
13090188|NCT03801148|25819184|FG000|Follow-Up (12 Days)|Lost to Follow-up|0|||
13090189|NCT03801148|25819185|FG001|Follow-Up (12 Days)|Lost to Follow-up|1|||
13090190|NCT03801148|25819186|FG002|Follow-Up (12 Days)|Lost to Follow-up|1|||
13090191|NCT03801148|25819187|FG003|Follow-Up (12 Days)|Lost to Follow-up|0|||
13090192|NCT03800173|25819227|FG000|Overall Study|Lost to Follow-up|0|||
13090193|NCT03800173|25819228|FG001|Overall Study|Lost to Follow-up|0|||
13090194|NCT03800173|25819229|FG002|Overall Study|Lost to Follow-up|0|||
13090195|NCT03800173|25819230|FG003|Overall Study|Lost to Follow-up|0|||
13090196|NCT03800173|25819231|FG004|Overall Study|Lost to Follow-up|1|||
13090197|NCT03799952|25819262|FG000|Overall Study|Program was too easy, discontinued|1|||
13090198|NCT03799952|25819263|FG001|Overall Study|Program was too easy, discontinued|0|||
13090199|NCT03799952|25819262|FG000|Overall Study|Lost to Follow-up|0|||
13090200|NCT03799952|25819263|FG001|Overall Study|Lost to Follow-up|2|||
13090201|NCT03799718|25819278|FG000|Overall Study|Adverse Event|2|||
13090202|NCT03799627|25819539|FG000|Overall Study|Adverse Event|1|||
13090203|NCT03799627|25819540|FG001|Overall Study|Adverse Event|2|||
13090204|NCT03799627|25819541|FG002|Overall Study|Adverse Event|0|||
13090205|NCT03799627|25819542|FG003|Overall Study|Adverse Event|0|||
13090206|NCT03799627|25819543|FG004|Overall Study|Adverse Event|2|||
13090207|NCT03799627|25819544|FG005|Overall Study|Adverse Event|5|||
13090208|NCT03799627|25819545|FG006|Overall Study|Adverse Event|0|||
13090209|NCT03799627|25819546|FG007|Overall Study|Adverse Event|2|||
13090210|NCT03799627|25819547|FG008|Overall Study|Adverse Event|0|||
13090211|NCT03799627|25819539|FG000|Overall Study|Physician Decision|2|||
13090212|NCT03799627|25819540|FG001|Overall Study|Physician Decision|2|||
13090213|NCT03799627|25819541|FG002|Overall Study|Physician Decision|0|||
13090214|NCT03799627|25819542|FG003|Overall Study|Physician Decision|0|||
13090215|NCT03799627|25819543|FG004|Overall Study|Physician Decision|2|||
13090216|NCT03799627|25819544|FG005|Overall Study|Physician Decision|2|||
13090217|NCT03799627|25819545|FG006|Overall Study|Physician Decision|0|||
13090218|NCT03799627|25819546|FG007|Overall Study|Physician Decision|0|||
13090219|NCT03799627|25819547|FG008|Overall Study|Physician Decision|0|||
13090220|NCT03799627|25819539|FG000|Overall Study|Withdrawal by Subject|1|||
13090221|NCT03799627|25819540|FG001|Overall Study|Withdrawal by Subject|1|||
13090222|NCT03799627|25819541|FG002|Overall Study|Withdrawal by Subject|0|||
13090223|NCT03799627|25819542|FG003|Overall Study|Withdrawal by Subject|2|||
13090224|NCT03799627|25819543|FG004|Overall Study|Withdrawal by Subject|0|||
13090225|NCT03799627|25819544|FG005|Overall Study|Withdrawal by Subject|3|||
13090226|NCT03799627|25819545|FG006|Overall Study|Withdrawal by Subject|0|||
13090227|NCT03799627|25819546|FG007|Overall Study|Withdrawal by Subject|0|||
13090228|NCT03799627|25819547|FG008|Overall Study|Withdrawal by Subject|0|||
13090229|NCT03799627|25819539|FG000|Overall Study|Lack of Efficacy|0|||
13090230|NCT03799627|25819540|FG001|Overall Study|Lack of Efficacy|0|||
13090231|NCT03799627|25819541|FG002|Overall Study|Lack of Efficacy|0|||
13090232|NCT03799627|25819542|FG003|Overall Study|Lack of Efficacy|1|||
13090233|NCT03799627|25819543|FG004|Overall Study|Lack of Efficacy|0|||
13090234|NCT03799627|25819544|FG005|Overall Study|Lack of Efficacy|0|||
13090235|NCT03799627|25819545|FG006|Overall Study|Lack of Efficacy|0|||
13090236|NCT03799627|25819546|FG007|Overall Study|Lack of Efficacy|0|||
13090237|NCT03799627|25819547|FG008|Overall Study|Lack of Efficacy|0|||
13090238|NCT03799627|25819539|FG000|Overall Study|Lost to Follow-up|0|||
13090239|NCT03799627|25819540|FG001|Overall Study|Lost to Follow-up|0|||
13090240|NCT03799627|25819541|FG002|Overall Study|Lost to Follow-up|0|||
13090241|NCT03799627|25819542|FG003|Overall Study|Lost to Follow-up|0|||
13090242|NCT03799627|25819543|FG004|Overall Study|Lost to Follow-up|0|||
13090243|NCT03799627|25819544|FG005|Overall Study|Lost to Follow-up|0|||
13090244|NCT03799627|25819545|FG006|Overall Study|Lost to Follow-up|1|||
13090245|NCT03799627|25819546|FG007|Overall Study|Lost to Follow-up|0|||
13090246|NCT03799627|25819547|FG008|Overall Study|Lost to Follow-up|1|||
13090247|NCT03799627|25819539|FG000|Overall Study|Death|0|||
13090248|NCT03799627|25819540|FG001|Overall Study|Death|0|||
13090249|NCT03799627|25819541|FG002|Overall Study|Death|0|||
13090250|NCT03799627|25819542|FG003|Overall Study|Death|1|||
13090251|NCT03799627|25819543|FG004|Overall Study|Death|0|||
13090252|NCT03799627|25819544|FG005|Overall Study|Death|0|||
13090253|NCT03799627|25819545|FG006|Overall Study|Death|0|||
13090254|NCT03799627|25819546|FG007|Overall Study|Death|0|||
13090255|NCT03799627|25819547|FG008|Overall Study|Death|0|||
13090256|NCT03799627|25819539|FG000|Overall Study|Study Drug Put on Hold|1|||
13090257|NCT03799627|25819540|FG001|Overall Study|Study Drug Put on Hold|0|||
13090258|NCT03799627|25819541|FG002|Overall Study|Study Drug Put on Hold|0|||
13090259|NCT03799627|25819542|FG003|Overall Study|Study Drug Put on Hold|0|||
13090260|NCT03799627|25819543|FG004|Overall Study|Study Drug Put on Hold|0|||
13090261|NCT03799627|25819544|FG005|Overall Study|Study Drug Put on Hold|0|||
13090262|NCT03799627|25819545|FG006|Overall Study|Study Drug Put on Hold|0|||
13090263|NCT03799627|25819546|FG007|Overall Study|Study Drug Put on Hold|0|||
13090264|NCT03799627|25819547|FG008|Overall Study|Study Drug Put on Hold|0|||
13090265|NCT03799627|25819539|FG000|Overall Study|Due to Urgent Safety Measures Letter|1|||
13090266|NCT03799627|25819540|FG001|Overall Study|Due to Urgent Safety Measures Letter|2|||
13090267|NCT03799627|25819541|FG002|Overall Study|Due to Urgent Safety Measures Letter|0|||
13090268|NCT03799627|25819542|FG003|Overall Study|Due to Urgent Safety Measures Letter|2|||
13090269|NCT03799627|25819543|FG004|Overall Study|Due to Urgent Safety Measures Letter|1|||
13090270|NCT03799627|25819544|FG005|Overall Study|Due to Urgent Safety Measures Letter|0|||
13090271|NCT03799627|25819545|FG006|Overall Study|Due to Urgent Safety Measures Letter|0|||
13090272|NCT03799627|25819546|FG007|Overall Study|Due to Urgent Safety Measures Letter|0|||
13090273|NCT03799627|25819547|FG008|Overall Study|Due to Urgent Safety Measures Letter|0|||
13090274|NCT03799627|25819539|FG000|Overall Study|Kidney Transplantation|1|||
13090275|NCT03799627|25819540|FG001|Overall Study|Kidney Transplantation|0|||
13090276|NCT03799627|25819541|FG002|Overall Study|Kidney Transplantation|0|||
13090277|NCT03799627|25819542|FG003|Overall Study|Kidney Transplantation|1|||
13090278|NCT03799627|25819543|FG004|Overall Study|Kidney Transplantation|1|||
13090279|NCT03799627|25819544|FG005|Overall Study|Kidney Transplantation|0|||
13090280|NCT03799627|25819545|FG006|Overall Study|Kidney Transplantation|0|||
13090281|NCT03799627|25819546|FG007|Overall Study|Kidney Transplantation|0|||
13090282|NCT03799627|25819547|FG008|Overall Study|Kidney Transplantation|0|||
13090283|NCT03799627|25819539|FG000|Overall Study|Participant Was on Rescue Epogen|0|||
13090284|NCT03799627|25819540|FG001|Overall Study|Participant Was on Rescue Epogen|1|||
13090285|NCT03799627|25819541|FG002|Overall Study|Participant Was on Rescue Epogen|0|||
13090286|NCT03799627|25819542|FG003|Overall Study|Participant Was on Rescue Epogen|0|||
13090287|NCT03799627|25819543|FG004|Overall Study|Participant Was on Rescue Epogen|0|||
13090288|NCT03799627|25819544|FG005|Overall Study|Participant Was on Rescue Epogen|0|||
13090289|NCT03799627|25819545|FG006|Overall Study|Participant Was on Rescue Epogen|1|||
13090290|NCT03799627|25819546|FG007|Overall Study|Participant Was on Rescue Epogen|0|||
13090291|NCT03799627|25819547|FG008|Overall Study|Participant Was on Rescue Epogen|1|||
13090292|NCT03799627|25819539|FG000|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
13090293|NCT03799627|25819540|FG001|Overall Study|Placed on Dose Hold Until End of Treatment|1|||
13090294|NCT03799627|25819541|FG002|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
13090295|NCT03799627|25819542|FG003|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
13090296|NCT03799627|25819543|FG004|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
13090297|NCT03799627|25819544|FG005|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
13090298|NCT03799627|25819545|FG006|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
13090299|NCT03799627|25819546|FG007|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
13090300|NCT03799627|25819547|FG008|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
13090301|NCT03799627|25819539|FG000|Overall Study|Met Exclusion Criteria|0|||
13090302|NCT03799627|25819540|FG001|Overall Study|Met Exclusion Criteria|0|||
13090303|NCT03799627|25819541|FG002|Overall Study|Met Exclusion Criteria|0|||
13090304|NCT03799627|25819542|FG003|Overall Study|Met Exclusion Criteria|1|||
13090305|NCT03799627|25819543|FG004|Overall Study|Met Exclusion Criteria|0|||
13090306|NCT03799627|25819544|FG005|Overall Study|Met Exclusion Criteria|0|||
13090307|NCT03799627|25819545|FG006|Overall Study|Met Exclusion Criteria|0|||
13090308|NCT03799627|25819546|FG007|Overall Study|Met Exclusion Criteria|0|||
13090309|NCT03799627|25819547|FG008|Overall Study|Met Exclusion Criteria|0|||
13090310|NCT03799627|25819539|FG000|Overall Study|Investigational Product Noncompliance|0|||
13090311|NCT03799627|25819540|FG001|Overall Study|Investigational Product Noncompliance|0|||
13090312|NCT03799627|25819541|FG002|Overall Study|Investigational Product Noncompliance|0|||
13090313|NCT03799627|25819542|FG003|Overall Study|Investigational Product Noncompliance|1|||
13090314|NCT03799627|25819543|FG004|Overall Study|Investigational Product Noncompliance|0|||
13090315|NCT03799627|25819544|FG005|Overall Study|Investigational Product Noncompliance|0|||
13090316|NCT03799627|25819545|FG006|Overall Study|Investigational Product Noncompliance|0|||
13090317|NCT03799627|25819546|FG007|Overall Study|Investigational Product Noncompliance|0|||
13090318|NCT03799627|25819547|FG008|Overall Study|Investigational Product Noncompliance|0|||
13090319|NCT03799627|25819539|FG000|Overall Study|Participant Relocation|0|||
13090320|NCT03799627|25819540|FG001|Overall Study|Participant Relocation|0|||
13090321|NCT03799627|25819541|FG002|Overall Study|Participant Relocation|0|||
13090322|NCT03799627|25819542|FG003|Overall Study|Participant Relocation|1|||
13090323|NCT03799627|25819543|FG004|Overall Study|Participant Relocation|0|||
13090324|NCT03799627|25819544|FG005|Overall Study|Participant Relocation|1|||
13090325|NCT03799627|25819545|FG006|Overall Study|Participant Relocation|0|||
13090326|NCT03799627|25819546|FG007|Overall Study|Participant Relocation|0|||
13090327|NCT03799627|25819547|FG008|Overall Study|Participant Relocation|0|||
13090328|NCT03799627|25819539|FG000|Overall Study|Eurofin Issue|0|||
13090329|NCT03799627|25819540|FG001|Overall Study|Eurofin Issue|0|||
13090330|NCT03799627|25819541|FG002|Overall Study|Eurofin Issue|0|||
13090331|NCT03799627|25819542|FG003|Overall Study|Eurofin Issue|0|||
13090332|NCT03799627|25819543|FG004|Overall Study|Eurofin Issue|1|||
13090333|NCT03799627|25819544|FG005|Overall Study|Eurofin Issue|0|||
13090334|NCT03799627|25819545|FG006|Overall Study|Eurofin Issue|0|||
13090335|NCT03799627|25819546|FG007|Overall Study|Eurofin Issue|0|||
13090336|NCT03799627|25819547|FG008|Overall Study|Eurofin Issue|0|||
13090337|NCT03799627|25819539|FG000|Overall Study|Noncompliance with Site Instructions|0|||
13090338|NCT03799627|25819540|FG001|Overall Study|Noncompliance with Site Instructions|0|||
13090339|NCT03799627|25819541|FG002|Overall Study|Noncompliance with Site Instructions|0|||
13090340|NCT03799627|25819542|FG003|Overall Study|Noncompliance with Site Instructions|0|||
13090341|NCT03799627|25819543|FG004|Overall Study|Noncompliance with Site Instructions|1|||
13090342|NCT03799627|25819544|FG005|Overall Study|Noncompliance with Site Instructions|0|||
13090343|NCT03799627|25819545|FG006|Overall Study|Noncompliance with Site Instructions|0|||
13090344|NCT03799627|25819546|FG007|Overall Study|Noncompliance with Site Instructions|0|||
13090345|NCT03799627|25819547|FG008|Overall Study|Noncompliance with Site Instructions|0|||
13090346|NCT03799627|25819539|FG000|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
13090347|NCT03799627|25819540|FG001|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
13090348|NCT03799627|25819541|FG002|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
13090349|NCT03799627|25819542|FG003|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
13090350|NCT03799627|25819543|FG004|Overall Study|Participant's Last Dose Prior to End of Treatment|1|||
13090351|NCT03799627|25819544|FG005|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
13090352|NCT03799627|25819545|FG006|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
13090353|NCT03799627|25819546|FG007|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
13090354|NCT03799627|25819547|FG008|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
13090355|NCT03799627|25819539|FG000|Overall Study|Changes In Hemoglobin Values|1|||
13090356|NCT03799627|25819540|FG001|Overall Study|Changes In Hemoglobin Values|2|||
13090357|NCT03799627|25819541|FG002|Overall Study|Changes In Hemoglobin Values|1|||
13090358|NCT03799627|25819542|FG003|Overall Study|Changes In Hemoglobin Values|0|||
13090359|NCT03799627|25819543|FG004|Overall Study|Changes In Hemoglobin Values|0|||
13090360|NCT03799627|25819544|FG005|Overall Study|Changes In Hemoglobin Values|2|||
13090361|NCT03799627|25819545|FG006|Overall Study|Changes In Hemoglobin Values|1|||
13090362|NCT03799627|25819546|FG007|Overall Study|Changes In Hemoglobin Values|0|||
13090363|NCT03799627|25819547|FG008|Overall Study|Changes In Hemoglobin Values|1|||
13090364|NCT03799211|25819570|FG000|Overall Study|Lost to Follow-up|2|||
13090365|NCT03799211|25819571|FG001|Overall Study|Lost to Follow-up|13|||
13090366|NCT03799211|25819570|FG000|Overall Study|Withdrawal by Subject|2|||
13090367|NCT03799211|25819571|FG001|Overall Study|Withdrawal by Subject|0|||
13090368|NCT03799198|25819612|FG000|Overall Study|Lost to Follow-up|4|||
13090369|NCT03799198|25819613|FG001|Overall Study|Lost to Follow-up|8|||
13090370|NCT03799198|25819612|FG000|Overall Study|Death|0|||
13090371|NCT03799198|25819613|FG001|Overall Study|Death|1|||
13090372|NCT03798717|25819658|FG000|Overall Study|Failed Screening|0|||
13090373|NCT03798717|25819659|FG001|Overall Study|Failed Screening|0|||
13090374|NCT03798717|25819660|FG002|Overall Study|Failed Screening|0|||
13090375|NCT03798717|25819661|FG003|Overall Study|Failed Screening|0|||
13090376|NCT03798717|25819662|FG004|Overall Study|Failed Screening|0|||
13090377|NCT03798717|25819663|FG005|Overall Study|Failed Screening|1|||
13090378|NCT03798717|25819658|FG000|Overall Study|Physician Decision|1|||
13090379|NCT03798717|25819659|FG001|Overall Study|Physician Decision|0|||
13090380|NCT03798717|25819660|FG002|Overall Study|Physician Decision|1|||
13090381|NCT03798717|25819661|FG003|Overall Study|Physician Decision|0|||
13090382|NCT03798717|25819662|FG004|Overall Study|Physician Decision|0|||
13090383|NCT03798717|25819663|FG005|Overall Study|Physician Decision|0|||
13090384|NCT03798717|25819658|FG000|Overall Study|Withdrawal by Subject|0|||
13090385|NCT03798717|25819659|FG001|Overall Study|Withdrawal by Subject|0|||
13090386|NCT03798717|25819660|FG002|Overall Study|Withdrawal by Subject|0|||
13090387|NCT03798717|25819661|FG003|Overall Study|Withdrawal by Subject|1|||
13090388|NCT03798717|25819662|FG004|Overall Study|Withdrawal by Subject|0|||
13090389|NCT03798717|25819663|FG005|Overall Study|Withdrawal by Subject|0|||
13090390|NCT03798717|25819658|FG000|Overall Study|Lost to Follow-up|1|||
13090391|NCT03798717|25819659|FG001|Overall Study|Lost to Follow-up|0|||
13090392|NCT03798717|25819660|FG002|Overall Study|Lost to Follow-up|0|||
13090393|NCT03798717|25819661|FG003|Overall Study|Lost to Follow-up|1|||
13090394|NCT03798717|25819662|FG004|Overall Study|Lost to Follow-up|0|||
13090395|NCT03798717|25819663|FG005|Overall Study|Lost to Follow-up|0|||
13090396|NCT03798717|25819658|FG000|Overall Study|Adverse Event|0|||
13090397|NCT03798717|25819659|FG001|Overall Study|Adverse Event|1|||
13090398|NCT03798717|25819660|FG002|Overall Study|Adverse Event|0|||
13090399|NCT03798717|25819661|FG003|Overall Study|Adverse Event|0|||
13090400|NCT03798717|25819662|FG004|Overall Study|Adverse Event|0|||
13090401|NCT03798717|25819663|FG005|Overall Study|Adverse Event|0|||
13090402|NCT03798717|25819658|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
13090403|NCT03798717|25819659|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
13090404|NCT03798717|25819660|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
13090405|NCT03798717|25819661|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
13090406|NCT03798717|25819662|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1|||
13090407|NCT03798717|25819663|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
13090408|NCT03798483|25819686|FG000|Overall Study|Lost to Follow-up|2|||
13090409|NCT03798366|25819707|FG000|Overall Study|Lost to Follow-up|0|||
13090410|NCT03798366|25819708|FG001|Overall Study|Lost to Follow-up|1|||
13090411|NCT03797144|25819744|FG000|Enrollment|Protocol Violation|4|||
13090412|NCT03797144|25819745|FG001|Enrollment|Protocol Violation|1|||
13090413|NCT03797144|25819744|FG000|Surgery|Protocol Violation|1|||
13090414|NCT03797144|25819745|FG001|Surgery|Protocol Violation|0|||
13090415|NCT03797144|25819744|FG000|3 Month|Early termination cut-off date|2|||
13090416|NCT03797144|25819745|FG001|3 Month|Early termination cut-off date|0|||
13090417|NCT03797144|25819744|FG000|12 Month|Early termination cut-off date|8|||
13090418|NCT03797144|25819745|FG001|12 Month|Early termination cut-off date|9|||
13090419|NCT03797144|25819744|FG000|24 Month|Early termination cut-off date|1|||
13090420|NCT03797144|25819745|FG001|24 Month|Early termination cut-off date|1|||
13090421|NCT03796728|25819759|FG000|Overall Study|Lost to Follow-up|8|||
13090422|NCT03796728|25819759|FG000|Overall Study|Reason not Specified|16|||
13090423|NCT03796676|25819898|FG000|Overall Study|Adverse Event|2|||
13090424|NCT03796676|25819899|FG001|Overall Study|Adverse Event|1|||
13090425|NCT03796676|25819900|FG002|Overall Study|Adverse Event|2|||
13090426|NCT03796676|25819898|FG000|Overall Study|Lost to Follow-up|2|||
13090427|NCT03796676|25819899|FG001|Overall Study|Lost to Follow-up|1|||
13090428|NCT03796676|25819900|FG002|Overall Study|Lost to Follow-up|0|||
13090429|NCT03796676|25819898|FG000|Overall Study|Protocol Violation|0|||
13090430|NCT03796676|25819899|FG001|Overall Study|Protocol Violation|0|||
13090431|NCT03796676|25819900|FG002|Overall Study|Protocol Violation|1|||
13090432|NCT03796676|25819898|FG000|Overall Study|Withdrawal by Subject|1|||
13090433|NCT03796676|25819899|FG001|Overall Study|Withdrawal by Subject|1|||
13090434|NCT03796676|25819900|FG002|Overall Study|Withdrawal by Subject|0|||
13090435|NCT03796676|25819898|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1|||
13090436|NCT03796676|25819899|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
13090437|NCT03796676|25819900|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
13090438|NCT03796039|25819933|FG000|Overall Study|Death|2|||
13090439|NCT03796039|25819934|FG001|Overall Study|Death|1|||
13090440|NCT03796039|25819933|FG000|Overall Study|Withdrawal by Subject|7|||
13090441|NCT03796039|25819934|FG001|Overall Study|Withdrawal by Subject|4|||
13090442|NCT03794089|25819971|FG000|Overall Study|Lost to Follow-up|4|||
13090443|NCT03794089|25819972|FG001|Overall Study|Lost to Follow-up|1|||
13090444|NCT03794089|25819971|FG000|Overall Study|Withdrawal by Subject|2|||
13090445|NCT03794089|25819972|FG001|Overall Study|Withdrawal by Subject|0|||
13090446|NCT03793556|25820021|FG000|Overall Study|Withdrawal by Subject|12|||
13090447|NCT03793556|25820022|FG001|Overall Study|Withdrawal by Subject|1|||
13090448|NCT03793556|25820021|FG000|Overall Study|Lost to Follow-up|1|||
13090449|NCT03793556|25820022|FG001|Overall Study|Lost to Follow-up|1|||
13090450|NCT03792672|25820049|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1|||
13090451|NCT03792672|25820050|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
13090452|NCT03792672|25820051|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
13090453|NCT03792672|25820052|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2|||
13090454|NCT03792672|25820053|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
13090455|NCT03792672|25820054|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
13090456|NCT03792672|25820049|FG000|Washout Period 3 (10 Days)|Physician Decision|0|||
13090457|NCT03792672|25820050|FG001|Washout Period 3 (10 Days)|Physician Decision|0|||
13090458|NCT03792672|25820051|FG002|Washout Period 3 (10 Days)|Physician Decision|1|||
13090459|NCT03792672|25820052|FG003|Washout Period 3 (10 Days)|Physician Decision|0|||
13090460|NCT03792672|25820053|FG004|Washout Period 3 (10 Days)|Physician Decision|0|||
13090461|NCT03792672|25820054|FG005|Washout Period 3 (10 Days)|Physician Decision|0|||
13090462|NCT03792672|25820049|FG000|Treatment Period 4 (2 Days)|Other|1|||
13090463|NCT03792672|25820050|FG001|Treatment Period 4 (2 Days)|Other|0|||
13090464|NCT03792672|25820051|FG002|Treatment Period 4 (2 Days)|Other|0|||
13090465|NCT03792672|25820052|FG003|Treatment Period 4 (2 Days)|Other|0|||
13090466|NCT03792672|25820053|FG004|Treatment Period 4 (2 Days)|Other|0|||
13090467|NCT03792672|25820054|FG005|Treatment Period 4 (2 Days)|Other|0|||
13090468|NCT03792477|25820086|FG000|Overall Study|Adverse Event|0|||
13090469|NCT03792477|25820087|FG001|Overall Study|Adverse Event|0|||
13090470|NCT03792477|25820088|FG002|Overall Study|Adverse Event|0|||
13090471|NCT03792477|25820089|FG003|Overall Study|Adverse Event|1|||
13090472|NCT03792477|25820090|FG004|Overall Study|Adverse Event|0|||
13090473|NCT03792477|25820086|FG000|Overall Study|Lost to Follow-up|0|||
13090474|NCT03792477|25820087|FG001|Overall Study|Lost to Follow-up|0|||
13090475|NCT03792477|25820088|FG002|Overall Study|Lost to Follow-up|2|||
13090476|NCT03792477|25820089|FG003|Overall Study|Lost to Follow-up|0|||
13090477|NCT03792477|25820090|FG004|Overall Study|Lost to Follow-up|0|||
13090478|NCT03792477|25820086|FG000|Overall Study|Other|0|||
13090479|NCT03792477|25820087|FG001|Overall Study|Other|0|||
13090480|NCT03792477|25820088|FG002|Overall Study|Other|0|||
13090481|NCT03792477|25820089|FG003|Overall Study|Other|0|||
13090482|NCT03792477|25820090|FG004|Overall Study|Other|1|||
13090483|NCT03791398|25820105|FG000|Overall Study|Progression of Disease Under Study|2|||
13090484|NCT03791398|25820106|FG001|Overall Study|Progression of Disease Under Study|0|||
13090485|NCT03791398|25820107|FG002|Overall Study|Progression of Disease Under Study|0|||
13090486|NCT03790917|25820119|FG000|Overall Study|Death|1|||
13090487|NCT03789292|25820146|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7|||
13090488|NCT03789292|25820147|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8|||
13090489|NCT03789292|25820148|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0|||
13090490|NCT03789292|25820146|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2|||
13090491|NCT03789292|25820147|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
13090492|NCT03789292|25820148|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
13090493|NCT03789292|25820146|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1|||
13090494|NCT03789292|25820147|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
13090495|NCT03789292|25820148|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
13090496|NCT03789292|25820146|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
13090497|NCT03789292|25820147|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
13090498|NCT03789292|25820148|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0|||
13090499|NCT03789292|25820146|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9|||
13090500|NCT03789292|25820147|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8|||
13090501|NCT03789292|25820148|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0|||
13090502|NCT03789292|25820146|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1|||
13090503|NCT03789292|25820147|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
13090504|NCT03789292|25820148|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
13090505|NCT03789292|25820146|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
13090506|NCT03789292|25820147|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2|||
13090507|NCT03789292|25820148|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
13090508|NCT03789292|25820146|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
13090509|NCT03789292|25820147|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
13090510|NCT03789292|25820148|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6|||
13090511|NCT03789292|25820146|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
13090512|NCT03789292|25820147|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
13090513|NCT03789292|25820148|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1|||
13090514|NCT03789292|25820146|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1|||
13090515|NCT03789292|25820147|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
13090516|NCT03789292|25820148|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
13090517|NCT03789292|25820146|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9|||
13090518|NCT03789292|25820147|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
13090519|NCT03789292|25820148|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
13090520|NCT03789292|25820146|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1|||
13090521|NCT03789292|25820147|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
13090522|NCT03789292|25820148|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
13090523|NCT03789292|25820146|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2|||
13090524|NCT03789292|25820147|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1|||
13090525|NCT03789292|25820148|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0|||
13090526|NCT03789110|25820158|FG000|Overall Study|Adverse Event|2|||
13090527|NCT03789110|25820158|FG000|Overall Study|Physician Decision|1|||
13090528|NCT03789110|25820158|FG000|Overall Study|Withdrawal by Subject|2|||
13090529|NCT03789110|25820158|FG000|Overall Study|Lack of Efficacy|22|||
13090530|NCT03789110|25820158|FG000|Overall Study|still on treatment|3|||
13090531|NCT03788967|25820228|FG000|Overall Study|Lost to Follow-up|14|||
13090532|NCT03788967|25820229|FG001|Overall Study|Lost to Follow-up|10|||
13090533|NCT03788967|25820228|FG000|Overall Study|Participant Non-Compliance/Uncooperativeness|3|||
13090534|NCT03788967|25820229|FG001|Overall Study|Participant Non-Compliance/Uncooperativeness|6|||
13090535|NCT03788967|25820228|FG000|Overall Study|Participant Withdrawal of Consent|13|||
13090536|NCT03788967|25820229|FG001|Overall Study|Participant Withdrawal of Consent|5|||
13090537|NCT03788967|25820228|FG000|Overall Study|Adverse Event|1|||
13090538|NCT03788967|25820229|FG001|Overall Study|Adverse Event|1|||
13090539|NCT03788967|25820228|FG000|Overall Study|COVID-19|1|||
13090540|NCT03788967|25820229|FG001|Overall Study|COVID-19|2|||
13090541|NCT03787615|25820236|FG000|Overall Study|Withdrawal by Subject|2|||
13090542|NCT03787615|25820236|FG000|Overall Study|Lost to Follow-up|2|||
13132609|NCT02787863|25984598|FG000|Overall Study|Death|1|||
13132610|NCT02787863|25984599|FG001|Overall Study|Death|0|||
13132611|NCT02787863|25984600|FG002|Overall Study|Death|1|||
13132612|NCT02787863|25984601|FG003|Overall Study|Death|0|||
13132613|NCT02787863|25984602|FG004|Overall Study|Death|0|||
13132614|NCT02787863|25984603|FG005|Overall Study|Death|0|||
13132615|NCT02787863|25984604|FG006|Overall Study|Death|0|||
13132616|NCT02787863|25984605|FG007|Overall Study|Death|0|||
13132617|NCT02787863|25984598|FG000|Overall Study|Withdrawal by Subject|0|||
13132618|NCT02787863|25984599|FG001|Overall Study|Withdrawal by Subject|1|||
13132619|NCT02787863|25984600|FG002|Overall Study|Withdrawal by Subject|1|||
13132620|NCT02787863|25984601|FG003|Overall Study|Withdrawal by Subject|0|||
13132621|NCT02787863|25984602|FG004|Overall Study|Withdrawal by Subject|0|||
13132622|NCT02787863|25984603|FG005|Overall Study|Withdrawal by Subject|0|||
13132623|NCT02787863|25984604|FG006|Overall Study|Withdrawal by Subject|0|||
13132624|NCT02787863|25984605|FG007|Overall Study|Withdrawal by Subject|0|||
13133673|NCT02766023|25988751|FG000|Overall Study|Withdrawal by Subject|4|||
13133674|NCT02766023|25988752|FG001|Overall Study|Withdrawal by Subject|5|||
13090543|NCT03787303|25820246|FG000|Overall Study|Death|1|||
13090544|NCT03787303|25820246|FG000|Overall Study|Premature Termination of Study|1|||
13090545|NCT03787212|25820255|FG000|Period 1|Study Termination|2|||
13090546|NCT03787212|25820256|FG001|Period 1|Study Termination|2|||
13090547|NCT03786718|25820273|FG000|Overall Study|Lost to Follow-up|3|||
13090548|NCT03786718|25820273|FG000|Overall Study|Withdrawal by Subject|1|||
13090549|NCT03786718|25820273|FG000|Overall Study|Did not use the intervention|2|||
13090550|NCT03786718|25820273|FG000|Overall Study|diagnosis changed from type 2 to type 1|1|||
13090551|NCT03785548|25820288|FG000|Overall Study|age > 80|1|||
13090552|NCT03785548|25820289|FG001|Overall Study|age > 80|0|||
13090553|NCT03785548|25820288|FG000|Overall Study|no Postop queries|1|||
13090554|NCT03785548|25820289|FG001|Overall Study|no Postop queries|0|||
13090555|NCT03784963|25820328|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12|||
13090556|NCT03784963|25820329|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10|||
13090557|NCT03784963|25820330|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1|||
13090558|NCT03784963|25820331|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0|||
13090559|NCT03783962|25820364|FG000|Overall Study|Lost to Follow-up|3|||
13090560|NCT03783962|25820365|FG001|Overall Study|Lost to Follow-up|6|||
13090561|NCT03783962|25820364|FG000|Overall Study|Protocol Violation|0|||
13090562|NCT03783962|25820365|FG001|Overall Study|Protocol Violation|1|||
13090563|NCT03783923|25820390|FG000|Placebo-Controlled Period (26 Weeks)|Study Terminated|3|||
13090564|NCT03783923|25820391|FG001|Placebo-Controlled Period (26 Weeks)|Study Terminated|2|||
13090565|NCT03783923|25820390|FG000|Placebo-Controlled Period (26 Weeks)|Adverse Event|1|||
13090566|NCT03783923|25820391|FG001|Placebo-Controlled Period (26 Weeks)|Adverse Event|0|||
13090567|NCT03783923|25820390|FG000|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
13090568|NCT03783923|25820391|FG001|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
13090569|NCT03783923|25820390|FG000|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
13090570|NCT03783923|25820391|FG001|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
13090571|NCT03783923|25820390|FG000|Open-Label Extension (26 Weeks)|Study Terminated|0|||
13090572|NCT03783923|25820391|FG001|Open-Label Extension (26 Weeks)|Study Terminated|1|||
13090573|NCT03783780|25820398|FG000|Overall Study|Withdrawn prior to completion|1|||
13090574|NCT03783702|25820459|FG000|Overall Study|Lost to Follow-up|6|||
13090575|NCT03783702|25820460|FG001|Overall Study|Lost to Follow-up|8|||
13090576|NCT03783702|25820459|FG000|Overall Study|Protocol Violation|1|||
13090577|NCT03783702|25820460|FG001|Overall Study|Protocol Violation|3|||
13090578|NCT03783039|25820483|FG000|Overall Study|Death|2|||
13090579|NCT03783039|25820484|FG001|Overall Study|Death|1|||
13090580|NCT03782571|25820513|FG000|Period 1|Withdrawal by Subject|1|||
13090581|NCT03782571|25820514|FG001|Period 1|Withdrawal by Subject|0|||
13090582|NCT03782571|25820515|FG002|Period 1|Withdrawal by Subject|0|||
13090583|NCT03782571|25820516|FG003|Period 1|Withdrawal by Subject|0|||
13090584|NCT03782571|25820513|FG000|Period 3|Subject Unable to Attend V5|1|||
13090585|NCT03782571|25820514|FG001|Period 3|Subject Unable to Attend V5|0|||
13090586|NCT03782571|25820515|FG002|Period 3|Subject Unable to Attend V5|0|||
13090587|NCT03782571|25820516|FG003|Period 3|Subject Unable to Attend V5|0|||
13090588|NCT03782571|25820513|FG000|Period 3|Adverse Event|1|||
13090589|NCT03782571|25820514|FG001|Period 3|Adverse Event|0|||
13090590|NCT03782571|25820515|FG002|Period 3|Adverse Event|0|||
13090591|NCT03782571|25820516|FG003|Period 3|Adverse Event|0|||
13090592|NCT03781375|25820534|FG000|Double-blind Phase|Adverse Event|0|||
13090593|NCT03781375|25820535|FG001|Double-blind Phase|Adverse Event|1|||
13090594|NCT03781375|25820534|FG000|Double-blind Phase|Lack of Response|6|||
13090595|NCT03781375|25820535|FG001|Double-blind Phase|Lack of Response|2|||
13090596|NCT03781375|25820534|FG000|Double-blind Phase|Other|1|||
13090597|NCT03781375|25820535|FG001|Double-blind Phase|Other|3|||
13090598|NCT03781375|25820534|FG000|Open-label Phase|Protocol Issues|0|||
13090599|NCT03781375|25820535|FG001|Open-label Phase|Protocol Issues|1|||
13090600|NCT03781375|25820534|FG000|Open-label Phase|Suboptimal Clinical Response|1|||
13090601|NCT03781375|25820535|FG001|Open-label Phase|Suboptimal Clinical Response|0|||
13090602|NCT03781375|25820534|FG000|Open-label Phase|Other|2|||
13090603|NCT03781375|25820535|FG001|Open-label Phase|Other|2|||
13090604|NCT03781336|25820562|FG000|Overall Study|Withdrawal by Subject|2|||
13090605|NCT03781336|25820563|FG001|Overall Study|Withdrawal by Subject|2|||
13090606|NCT03780959|25820585|FG000|Part 1|Adverse Event|1|||
13090607|NCT03780959|25820586|FG001|Part 1|Adverse Event|0|||
13090608|NCT03780959|25820587|FG002|Part 1|Adverse Event|0|||
13090609|NCT03780959|25820585|FG000|Part 1|Withdrawal by Subject|1|||
13090610|NCT03780959|25820586|FG001|Part 1|Withdrawal by Subject|0|||
13090611|NCT03780959|25820587|FG002|Part 1|Withdrawal by Subject|0|||
13090612|NCT03780959|25820585|FG000|Part 1|Withdrawal by Parent/Guardian|1|||
13090613|NCT03780959|25820586|FG001|Part 1|Withdrawal by Parent/Guardian|0|||
13090614|NCT03780959|25820587|FG002|Part 1|Withdrawal by Parent/Guardian|0|||
13090615|NCT03780959|25820585|FG000|Part 1|Response Status|2|||
13090616|NCT03780959|25820586|FG001|Part 1|Response Status|0|||
13090617|NCT03780959|25820587|FG002|Part 1|Response Status|0|||
13090618|NCT03780959|25820585|FG000|Part 2|Withdrawal by Parent/Guardian|0|||
13090619|NCT03780959|25820586|FG001|Part 2|Withdrawal by Parent/Guardian|1|||
13090620|NCT03780959|25820587|FG002|Part 2|Withdrawal by Parent/Guardian|0|||
13090621|NCT03780959|25820585|FG000|Part 2|Response Status|0|||
13090622|NCT03780959|25820586|FG001|Part 2|Response Status|18|||
13090623|NCT03780959|25820587|FG002|Part 2|Response Status|6|||
13090624|NCT03780400|25820597|FG000|Overall Study|Lost to Follow-up|5|||
13090625|NCT03780400|25820597|FG000|Overall Study|Withdrawal by Subject|2|||
13090626|NCT03780244|25820644|FG000|Overall Study|Lost to Follow-up|1|||
13090627|NCT03780244|25820645|FG001|Overall Study|Lost to Follow-up|0|||
13090628|NCT03779503|25820672|FG000|First Intervention|Adverse Event|0|||
13090629|NCT03779503|25820673|FG001|First Intervention|Adverse Event|1|||
13090630|NCT03779503|25820672|FG000|First Intervention|Withdrawal by Subject|1|||
13090631|NCT03779503|25820673|FG001|First Intervention|Withdrawal by Subject|0|||
13090632|NCT03777917|25820694|FG000|Overall Study|Withdrawal by Subject|1|||
13090633|NCT03777917|25820695|FG001|Overall Study|Withdrawal by Subject|0|||
13090634|NCT03777917|25820694|FG000|Overall Study|Physician Decision|1|||
13090635|NCT03777917|25820695|FG001|Overall Study|Physician Decision|0|||
13090636|NCT03777917|25820694|FG000|Overall Study|Lost to Follow-up|6|||
13090637|NCT03777917|25820695|FG001|Overall Study|Lost to Follow-up|2|||
13090638|NCT03777917|25820694|FG000|Overall Study|Other|1|||
13090639|NCT03777917|25820695|FG001|Overall Study|Other|0|||
13090640|NCT03777059|25820742|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
13090641|NCT03777059|25820743|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9|||
13090642|NCT03777059|25820744|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4|||
13090643|NCT03777059|25820745|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
13090644|NCT03777059|25820742|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
13090645|NCT03777059|25820743|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
13090646|NCT03777059|25820744|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
13090647|NCT03777059|25820745|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
13090648|NCT03777059|25820742|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
13090649|NCT03777059|25820743|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9|||
13090650|NCT03777059|25820744|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
13090651|NCT03777059|25820745|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10|||
13090652|NCT03777059|25820742|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
13090653|NCT03777059|25820743|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
13090654|NCT03777059|25820744|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4|||
13090655|NCT03777059|25820745|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5|||
13090656|NCT03777059|25820742|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
13090657|NCT03777059|25820743|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1|||
13090658|NCT03777059|25820744|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
13090659|NCT03777059|25820745|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
13090660|NCT03777059|25820742|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4|||
13090661|NCT03777059|25820743|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5|||
13090662|NCT03777059|25820744|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7|||
13090663|NCT03777059|25820745|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8|||
13090664|NCT03777059|25820742|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
13090665|NCT03777059|25820743|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2|||
13090666|NCT03777059|25820744|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
13090667|NCT03777059|25820745|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1|||
13090668|NCT03777059|25820742|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
13090669|NCT03777059|25820743|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3|||
13090670|NCT03777059|25820744|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4|||
13090671|NCT03777059|25820745|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
13090672|NCT03777059|25820742|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
13090673|NCT03777059|25820743|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1|||
13090674|NCT03777059|25820744|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
13090675|NCT03777059|25820745|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3|||
13090676|NCT03777059|25820742|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
13090677|NCT03777059|25820743|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
13090678|NCT03777059|25820744|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
13090679|NCT03777059|25820745|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
13090680|NCT03777059|25820742|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
13090681|NCT03777059|25820743|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
13090682|NCT03777059|25820744|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
13090683|NCT03777059|25820745|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
13090684|NCT03776175|25820788|FG000|Treatment Period (42 Days)|Adverse Event|0|||
13090685|NCT03776175|25820789|FG001|Treatment Period (42 Days)|Adverse Event|1|||
13090686|NCT03776175|25820790|FG002|Treatment Period (42 Days)|Adverse Event|1|||
13090687|NCT03776175|25820791|FG003|Treatment Period (42 Days)|Adverse Event|0|||
13090688|NCT03776175|25820788|FG000|Treatment Period (42 Days)|Lost to Follow-up|0|||
13090689|NCT03776175|25820789|FG001|Treatment Period (42 Days)|Lost to Follow-up|0|||
13090690|NCT03776175|25820790|FG002|Treatment Period (42 Days)|Lost to Follow-up|0|||
13090691|NCT03776175|25820791|FG003|Treatment Period (42 Days)|Lost to Follow-up|2|||
13090692|NCT03776175|25820788|FG000|Treatment Period (42 Days)|Participants screened at other site|0|||
13090693|NCT03776175|25820789|FG001|Treatment Period (42 Days)|Participants screened at other site|2|||
13090694|NCT03776175|25820790|FG002|Treatment Period (42 Days)|Participants screened at other site|0|||
13090695|NCT03776175|25820791|FG003|Treatment Period (42 Days)|Participants screened at other site|0|||
13090696|NCT03776175|25820788|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1|||
13090697|NCT03776175|25820789|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2|||
13090698|NCT03776175|25820790|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3|||
13090699|NCT03776175|25820791|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0|||
13090700|NCT03776175|25820788|FG000|Treatment Period (42 Days)|Unable to attend study visits|0|||
13090701|NCT03776175|25820789|FG001|Treatment Period (42 Days)|Unable to attend study visits|2|||
13090702|NCT03776175|25820790|FG002|Treatment Period (42 Days)|Unable to attend study visits|0|||
13090703|NCT03776175|25820791|FG003|Treatment Period (42 Days)|Unable to attend study visits|0|||
13090704|NCT03776175|25820788|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
13090705|NCT03776175|25820789|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
13090706|NCT03776175|25820790|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
13090707|NCT03776175|25820791|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2|||
13090708|NCT03775681|25820798|FG000|Overall Study|Physician Decision|3|||
13090709|NCT03774823|25820831|FG000|Overall Study|Withdrawal by Subject|1|||
13090710|NCT03774823|25820832|FG001|Overall Study|Withdrawal by Subject|1|||
13090711|NCT03774576|25820847|FG000|Period 2|Adverse Event|1|||
13090712|NCT03774433|25820854|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14|||
13090713|NCT03773796|25820879|FG000|Overall Study|Adverse Event|1|||
13090714|NCT03773796|25820879|FG000|Overall Study|Withdrawal by Subject|1|||
13090715|NCT03773796|25820879|FG000|Overall Study|Lack of Efficacy|1|||
13090716|NCT03773484|25820885|FG000|Post-intervention|5 clinicians were excluded from analysis due to lack of prescribing data|5|||
13090717|NCT03773133|25820892|FG000|Overall Study|Screen Failure|8|||
13090718|NCT03772587|25820998|FG000|Overall Study|COVID-19|0|||
13090719|NCT03772587|25820999|FG001|Overall Study|COVID-19|0|||
13090720|NCT03772587|25821000|FG002|Overall Study|COVID-19|1|||
13090721|NCT03772587|25821001|FG003|Overall Study|COVID-19|1|||
13090722|NCT03772587|25821002|FG004|Overall Study|COVID-19|0|||
13090723|NCT03772587|25820998|FG000|Overall Study|Withdrawal by Subject|1|||
13090724|NCT03772587|25820999|FG001|Overall Study|Withdrawal by Subject|0|||
13090725|NCT03772587|25821000|FG002|Overall Study|Withdrawal by Subject|0|||
13090726|NCT03772587|25821001|FG003|Overall Study|Withdrawal by Subject|0|||
13090727|NCT03772587|25821002|FG004|Overall Study|Withdrawal by Subject|0|||
13090728|NCT03772522|25821030|FG000|Pre-intervention|Withdrawal by Subject|3|||
13090729|NCT03772522|25821031|FG001|Pre-intervention|Withdrawal by Subject|4|||
13090730|NCT03772522|25821030|FG000|Intervention|Withdrawal by Subject|1|||
13090731|NCT03772522|25821031|FG001|Intervention|Withdrawal by Subject|0|||
13090732|NCT03772522|25821030|FG000|Post-intervention Follow-up|Lost to Follow-up|1|||
13090733|NCT03772522|25821031|FG001|Post-intervention Follow-up|Lost to Follow-up|0|||
13090734|NCT03772327|25821054|FG000|Overall Study|Lost to Follow-up|3|||
13090735|NCT03772327|25821055|FG001|Overall Study|Lost to Follow-up|4|||
13090736|NCT03772327|25821054|FG000|Overall Study|Withdrawal by Subject|2|||
13090737|NCT03772327|25821055|FG001|Overall Study|Withdrawal by Subject|3|||
13090738|NCT03772041|25821076|FG000|Overall Study|Adverse Event|8|||
13090739|NCT03772041|25821077|FG001|Overall Study|Adverse Event|3|||
13090740|NCT03772041|25821076|FG000|Overall Study|Withdrawal by Subject|0|||
13090741|NCT03772041|25821077|FG001|Overall Study|Withdrawal by Subject|2|||
13090742|NCT03772041|25821076|FG000|Overall Study|Protocol Violation|4|||
13090743|NCT03772041|25821077|FG001|Overall Study|Protocol Violation|2|||
13090744|NCT03772041|25821076|FG000|Overall Study|Physician Decision|2|||
13090745|NCT03772041|25821077|FG001|Overall Study|Physician Decision|3|||
13090746|NCT03771963|25821091|FG000|Overall Study|Lost to Follow-up|22|||
13090747|NCT03771963|25821091|FG000|Overall Study|Withdrawal of Consent|10|||
13090748|NCT03771664|25821150|FG000|Overall Study|Adverse Event|1|||
13090749|NCT03771664|25821151|FG001|Overall Study|Adverse Event|0|||
13090750|NCT03771664|25821150|FG000|Overall Study|Lost to Follow-up|1|||
13090751|NCT03771664|25821151|FG001|Overall Study|Lost to Follow-up|0|||
13090752|NCT03771664|25821150|FG000|Overall Study|Withdrawal by Participant|1|||
13090753|NCT03771664|25821151|FG001|Overall Study|Withdrawal by Participant|4|||
13090754|NCT03771664|25821150|FG000|Overall Study|Randomized but not Treated|0|||
13090755|NCT03771664|25821151|FG001|Overall Study|Randomized but not Treated|1|||
13090756|NCT03771352|25821159|FG000|Overall Study|Screen failure|2|||
13090757|NCT03771352|25821159|FG000|Overall Study|Withdrawal by Subject|2|||
13090758|NCT03770728|25821202|FG000|Overall Study|Adverse Event|1|||
13090759|NCT03770728|25821203|FG001|Overall Study|Adverse Event|0|||
13090760|NCT03770728|25821204|FG002|Overall Study|Adverse Event|1|||
13090761|NCT03770728|25821205|FG003|Overall Study|Adverse Event|0|||
13090762|NCT03770728|25821202|FG000|Overall Study|Poor compliance to protocol|0|||
13090763|NCT03770728|25821203|FG001|Overall Study|Poor compliance to protocol|0|||
13090764|NCT03770728|25821204|FG002|Overall Study|Poor compliance to protocol|1|||
13090765|NCT03770728|25821205|FG003|Overall Study|Poor compliance to protocol|0|||
13090766|NCT03770728|25821202|FG000|Overall Study|Withdrawal by Subject|13|||
13090767|NCT03770728|25821203|FG001|Overall Study|Withdrawal by Subject|8|||
13090768|NCT03770728|25821204|FG002|Overall Study|Withdrawal by Subject|9|||
13090769|NCT03770728|25821205|FG003|Overall Study|Withdrawal by Subject|13|||
13090770|NCT03770728|25821202|FG000|Overall Study|Other than specified|24|||
13090771|NCT03770728|25821203|FG001|Overall Study|Other than specified|23|||
13090772|NCT03770728|25821204|FG002|Overall Study|Other than specified|21|||
13090773|NCT03770728|25821205|FG003|Overall Study|Other than specified|22|||
13090774|NCT03769896|25821261|FG000|Open-label Phase|Lack of Efficacy|5|||
13090775|NCT03769896|25821262|FG001|Open-label Phase|Lack of Efficacy|0|||
13090776|NCT03769896|25821261|FG000|Open-label Phase|Adverse Event|3|||
13090777|NCT03769896|25821262|FG001|Open-label Phase|Adverse Event|0|||
13090778|NCT03769896|25821261|FG000|Open-label Phase|Withdrawal by Subject|1|||
13090779|NCT03769896|25821262|FG001|Open-label Phase|Withdrawal by Subject|0|||
13090780|NCT03769753|25821268|FG000|Overall Study|Not Treated|6|||
13090781|NCT03769753|25821268|FG000|Overall Study|Inevaluable - No Evidence of Disease|1|||
13090782|NCT03769090|25821302|FG000|Overall Study|Randomized and did not receive randomized study treatment|1|||
13090783|NCT03769090|25821303|FG001|Overall Study|Randomized and did not receive randomized study treatment|2|||
13090784|NCT03769090|25821304|FG002|Overall Study|Randomized and did not receive randomized study treatment|2|||
13090785|NCT03769090|25821302|FG000|Overall Study|Withdrawal by Subject|52|||
13090786|NCT03769090|25821303|FG001|Overall Study|Withdrawal by Subject|62|||
13090787|NCT03769090|25821304|FG002|Overall Study|Withdrawal by Subject|74|||
13090788|NCT03769090|25821302|FG000|Overall Study|Death|4|||
13090789|NCT03769090|25821303|FG001|Overall Study|Death|2|||
13090790|NCT03769090|25821304|FG002|Overall Study|Death|2|||
13090791|NCT03769090|25821302|FG000|Overall Study|Adverse Event|7|||
13090792|NCT03769090|25821303|FG001|Overall Study|Adverse Event|7|||
13090793|NCT03769090|25821304|FG002|Overall Study|Adverse Event|8|||
13090794|NCT03769090|25821302|FG000|Overall Study|A single severe exacerbation event lasting >20 days|0|||
13090795|NCT03769090|25821303|FG001|Overall Study|A single severe exacerbation event lasting >20 days|1|||
13090796|NCT03769090|25821304|FG002|Overall Study|A single severe exacerbation event lasting >20 days|2|||
13090797|NCT03769090|25821302|FG000|Overall Study|>= 3 severe exacerbation events within a 3 month period|1|||
13090798|NCT03769090|25821303|FG001|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
13090799|NCT03769090|25821304|FG002|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
13090800|NCT03769090|25821302|FG000|Overall Study|>= 5 total severe exacerbation events|0|||
13090801|NCT03769090|25821303|FG001|Overall Study|>= 5 total severe exacerbation events|1|||
13090802|NCT03769090|25821304|FG002|Overall Study|>= 5 total severe exacerbation events|1|||
13090803|NCT03769090|25821302|FG000|Overall Study|Protocol Violation|5|||
13090804|NCT03769090|25821303|FG001|Overall Study|Protocol Violation|6|||
13090805|NCT03769090|25821304|FG002|Overall Study|Protocol Violation|8|||
13090806|NCT03769090|25821302|FG000|Overall Study|Pregnancy|1|||
13090807|NCT03769090|25821303|FG001|Overall Study|Pregnancy|0|||
13090808|NCT03769090|25821304|FG002|Overall Study|Pregnancy|3|||
13090809|NCT03769090|25821302|FG000|Overall Study|Lost to Follow-up|19|||
13090810|NCT03769090|25821303|FG001|Overall Study|Lost to Follow-up|25|||
13090811|NCT03769090|25821304|FG002|Overall Study|Lost to Follow-up|21|||
13090812|NCT03769090|25821302|FG000|Overall Study|Condition under investigation worsened|2|||
13090813|NCT03769090|25821303|FG001|Overall Study|Condition under investigation worsened|0|||
13090814|NCT03769090|25821304|FG002|Overall Study|Condition under investigation worsened|1|||
13090815|NCT03769090|25821302|FG000|Overall Study|Lack of Efficacy|1|||
13090816|NCT03769090|25821303|FG001|Overall Study|Lack of Efficacy|2|||
13090817|NCT03769090|25821304|FG002|Overall Study|Lack of Efficacy|2|||
13090818|NCT03769090|25821302|FG000|Overall Study|Other reasons|8|||
13090819|NCT03769090|25821303|FG001|Overall Study|Other reasons|12|||
13090820|NCT03769090|25821304|FG002|Overall Study|Other reasons|15|||
13090821|NCT03768726|25821353|FG000|Treatment Phase|Adverse Event|2|||
13090822|NCT03768726|25821354|FG001|Treatment Phase|Adverse Event|2|||
13090823|NCT03768726|25821353|FG000|Treatment Phase|Lost to Follow-up|1|||
13090824|NCT03768726|25821354|FG001|Treatment Phase|Lost to Follow-up|0|||
13090825|NCT03768726|25821353|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2|||
13090826|NCT03768726|25821354|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0|||
13090827|NCT03768726|25821353|FG000|Treatment Phase|Withdrawal by Subject|3|||
13090828|NCT03768726|25821354|FG001|Treatment Phase|Withdrawal by Subject|1|||
13090829|NCT03768726|25821353|FG000|Follow-Up|Adverse Event|2|||
13090830|NCT03768726|25821354|FG001|Follow-Up|Adverse Event|2|||
13090831|NCT03768726|25821353|FG000|Follow-Up|Withdrawal By Parent/Guardian|1|||
13136340|NCT02724839|25998496|FG001|Overall Study|Lost to Follow-up|3|||
13136341|NCT02724839|25998497|FG002|Overall Study|Lost to Follow-up|2|||
13136342|NCT02724839|25998495|FG000|Overall Study|Physician Decision|0|||
13136343|NCT02724839|25998496|FG001|Overall Study|Physician Decision|0|||
13136344|NCT02724839|25998497|FG002|Overall Study|Physician Decision|3|||
13136345|NCT02724644|25998532|FG000|Overall Study|Adverse Event|7|||
13090832|NCT03768726|25821354|FG001|Follow-Up|Withdrawal By Parent/Guardian|1|||
13090833|NCT03768726|25821353|FG000|Follow-Up|Withdrawal by Subject|2|||
13090834|NCT03768726|25821354|FG001|Follow-Up|Withdrawal by Subject|0|||
13090835|NCT03768726|25821353|FG000|Follow-Up|Other|1|||
13090836|NCT03768726|25821354|FG001|Follow-Up|Other|0|||
13090837|NCT03768206|25821370|FG000|Overall Study|Lost to Follow-up|2|||
13090838|NCT03768206|25821371|FG001|Overall Study|Lost to Follow-up|1|||
13090839|NCT03768206|25821370|FG000|Overall Study|Withdrawal by Subject|0|||
13090840|NCT03768206|25821371|FG001|Overall Study|Withdrawal by Subject|1|||
13090841|NCT03768089|25821510|FG000|Part A|Lost to Follow-up|0|||
13090842|NCT03768089|25821511|FG001|Part A|Lost to Follow-up|0|||
13090843|NCT03768089|25821512|FG002|Part A|Lost to Follow-up|0|||
13090844|NCT03768089|25821513|FG003|Part A|Lost to Follow-up|0|||
13090845|NCT03768089|25821514|FG004|Part A|Lost to Follow-up|1|||
13090846|NCT03768089|25821515|FG005|Part A|Lost to Follow-up|0|||
13090847|NCT03768089|25821516|FG006|Part A|Lost to Follow-up|0|||
13090848|NCT03768089|25821517|FG007|Part A|Lost to Follow-up|0|||
13090849|NCT03768089|25821518|FG008|Part A|Lost to Follow-up|0|||
13090850|NCT03768089|25821519|FG009|Part A|Lost to Follow-up|0|||
13090851|NCT03768089|25821520|FG010|Part A|Lost to Follow-up|0|||
13090852|NCT03768089|25821521|FG011|Part A|Lost to Follow-up|0|||
13090853|NCT03768089|25821522|FG012|Part A|Lost to Follow-up|0|||
13090854|NCT03768089|25821523|FG013|Part A|Lost to Follow-up|0|||
13090855|NCT03768089|25821524|FG014|Part A|Lost to Follow-up|0|||
13090856|NCT03768089|25821525|FG015|Part A|Lost to Follow-up|0|||
13090857|NCT03768089|25821526|FG016|Part A|Lost to Follow-up|0|||
13090858|NCT03768089|25821527|FG017|Part A|Lost to Follow-up|0|||
13090859|NCT03768089|25821510|FG000|Part C|Randomized, Never Dosed|0|||
13090860|NCT03768089|25821511|FG001|Part C|Randomized, Never Dosed|0|||
13090861|NCT03768089|25821512|FG002|Part C|Randomized, Never Dosed|0|||
13090862|NCT03768089|25821513|FG003|Part C|Randomized, Never Dosed|0|||
13090863|NCT03768089|25821514|FG004|Part C|Randomized, Never Dosed|0|||
13090864|NCT03768089|25821515|FG005|Part C|Randomized, Never Dosed|0|||
13090865|NCT03768089|25821516|FG006|Part C|Randomized, Never Dosed|0|||
13090866|NCT03768089|25821517|FG007|Part C|Randomized, Never Dosed|0|||
13090867|NCT03768089|25821518|FG008|Part C|Randomized, Never Dosed|0|||
13090868|NCT03768089|25821519|FG009|Part C|Randomized, Never Dosed|0|||
13090869|NCT03768089|25821520|FG010|Part C|Randomized, Never Dosed|0|||
13090870|NCT03768089|25821521|FG011|Part C|Randomized, Never Dosed|0|||
13090871|NCT03768089|25821522|FG012|Part C|Randomized, Never Dosed|0|||
13090872|NCT03768089|25821523|FG013|Part C|Randomized, Never Dosed|0|||
13090873|NCT03768089|25821524|FG014|Part C|Randomized, Never Dosed|1|||
13090874|NCT03768089|25821525|FG015|Part C|Randomized, Never Dosed|0|||
13090875|NCT03768089|25821526|FG016|Part C|Randomized, Never Dosed|0|||
13090876|NCT03768089|25821527|FG017|Part C|Randomized, Never Dosed|0|||
13090877|NCT03767894|25821538|FG000|Overall Study|Withdrawal by Subject|1|||
13090878|NCT03766646|25821551|FG000|Overall Study|Withdrawal by Subject|1|||
13090879|NCT03766646|25821552|FG001|Overall Study|Withdrawal by Subject|0|||
13090880|NCT03766646|25821551|FG000|Overall Study|Protocol Violation|0|||
13090881|NCT03766646|25821552|FG001|Overall Study|Protocol Violation|3|||
13090882|NCT03765164|25821569|FG000|Pre-intervention|Withdrawal by Subject|5|||
13090883|NCT03765164|25821570|FG001|Pre-intervention|Withdrawal by Subject|6|||
13090884|NCT03765138|25821578|FG000|Overall Study|Lost to Follow-up|1|||
13090885|NCT03764813|25821609|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
13090886|NCT03764813|25821610|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
13090887|NCT03764813|25821611|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
13090888|NCT03764813|25821612|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
13090889|NCT03764631|25821639|FG000|Overall Study|Personal Reasons|3|||
13090890|NCT03764631|25821640|FG001|Overall Study|Personal Reasons|2|||
13090891|NCT03764631|25821639|FG000|Overall Study|Switching Therapy|3|||
13090892|NCT03764631|25821640|FG001|Overall Study|Switching Therapy|3|||
13090893|NCT03764631|25821639|FG000|Overall Study|Adverse Event|0|||
13136346|NCT02724644|25998533|FG001|Overall Study|Adverse Event|1|||
13136347|NCT02724644|25998532|FG000|Overall Study|Lost to Follow-up|6|||
13136348|NCT02724644|25998533|FG001|Overall Study|Lost to Follow-up|2|||
13136349|NCT02724644|25998532|FG000|Overall Study|Withdrawal by Subject|7|||
13136350|NCT02724644|25998533|FG001|Overall Study|Withdrawal by Subject|1|||
13136351|NCT02724644|25998532|FG000|Overall Study|Administrative|1|||
13136352|NCT02724644|25998533|FG001|Overall Study|Administrative|0|||
13136353|NCT02724592|25998552|FG000|Overall Study|Lost to Follow-up|4|||
13136354|NCT02724592|25998553|FG001|Overall Study|Lost to Follow-up|1|||
13136355|NCT02724462|25998568|FG000|3 Month Follow-up Survey|Lost to Follow-up|171|||
13090894|NCT03764631|25821640|FG001|Overall Study|Adverse Event|1|||
13090895|NCT03764631|25821639|FG000|Overall Study|Lost to Follow-up|33|||
13090896|NCT03764631|25821640|FG001|Overall Study|Lost to Follow-up|41|||
13090897|NCT03764631|25821639|FG000|Overall Study|No data as study site was closed|2|||
13090898|NCT03764631|25821640|FG001|Overall Study|No data as study site was closed|6|||
13136356|NCT02724462|25998569|FG001|3 Month Follow-up Survey|Lost to Follow-up|151|||
13136357|NCT02724462|25998568|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
13204568|NCT01972529|26229306|FG002|Overall Study|Participant Choice|0|||
13136358|NCT02724462|25998569|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
13136359|NCT02724462|25998568|FG000|6 Month Follow-up Survey|Lost to Follow-up|156|||
13136360|NCT02724462|25998569|FG001|6 Month Follow-up Survey|Lost to Follow-up|123|||
13136361|NCT02724462|25998568|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
13136362|NCT02724462|25998569|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
13136363|NCT02724462|25998568|FG000|12 Month Follow-up Survey|Lost to Follow-up|174|||
13136364|NCT02724462|25998569|FG001|12 Month Follow-up Survey|Lost to Follow-up|134|||
13136365|NCT02724462|25998568|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
13136366|NCT02724462|25998569|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
13136367|NCT02724111|25998596|FG000|Overall Study|Protocol Violation|2|||
13136368|NCT02724111|25998597|FG001|Overall Study|Protocol Violation|5|||
13136369|NCT02724020|25998633|FG000|Overall Study|Death|16|||
13136370|NCT02724020|25998634|FG001|Overall Study|Death|18|||
13136371|NCT02724020|25998635|FG002|Overall Study|Death|19|||
13136372|NCT02724020|25998633|FG000|Overall Study|Lost to Follow-up|0|||
13136373|NCT02724020|25998634|FG001|Overall Study|Lost to Follow-up|3|||
13136374|NCT02724020|25998635|FG002|Overall Study|Lost to Follow-up|0|||
13136375|NCT02724020|25998633|FG000|Overall Study|Site Terminated by Sponsor|15|||
13136376|NCT02724020|25998634|FG001|Overall Study|Site Terminated by Sponsor|8|||
13136377|NCT02724020|25998635|FG002|Overall Study|Site Terminated by Sponsor|8|||
13136378|NCT02724020|25998633|FG000|Overall Study|Withdrawal by Subject|1|||
13136379|NCT02724020|25998634|FG001|Overall Study|Withdrawal by Subject|3|||
13136380|NCT02724020|25998635|FG002|Overall Study|Withdrawal by Subject|5|||
13204569|NCT01972529|26229307|FG003|Overall Study|Participant Choice|0|||
13204570|NCT01972529|26229304|FG000|Overall Study|Withdrawl of Consent|1|||
13204571|NCT01972529|26229305|FG001|Overall Study|Withdrawl of Consent|2|||
13204572|NCT01972529|26229306|FG002|Overall Study|Withdrawl of Consent|0|||
13204573|NCT01972529|26229307|FG003|Overall Study|Withdrawl of Consent|1|||
13204574|NCT01972529|26229304|FG000|Overall Study|Other|0|||
13204575|NCT01972529|26229305|FG001|Overall Study|Other|0|||
13204576|NCT01972529|26229306|FG002|Overall Study|Other|0|||
13204577|NCT01972529|26229307|FG003|Overall Study|Other|2|||
13204578|NCT01972529|26229304|FG000|Overall Study|Not treated|0|||
13204579|NCT01972529|26229305|FG001|Overall Study|Not treated|1|||
13204580|NCT01972529|26229306|FG002|Overall Study|Not treated|2|||
13204581|NCT01972529|26229307|FG003|Overall Study|Not treated|1|||
13204582|NCT01972464|26229328|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2|||
13204583|NCT01972464|26229329|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3|||
13204584|NCT01972464|26229328|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1|||
13204585|NCT01972464|26229329|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0|||
13204586|NCT01972464|26229328|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0|||
13204587|NCT01972464|26229329|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1|||
13204588|NCT01972464|26229328|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
13204589|NCT01972464|26229329|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
13204590|NCT01972438|26229388|FG000|Baseline-Month 3 Crossover Period|Death|1|||
13204591|NCT01972438|26229389|FG001|Baseline-Month 3 Crossover Period|Death|0|||
13204592|NCT01972438|26229388|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1|||
13204593|NCT01972438|26229389|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0|||
13204594|NCT01972438|26229388|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0|||
13204595|NCT01972438|26229389|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1|||
13204596|NCT01972438|26229388|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1|||
13204597|NCT01972438|26229389|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2|||
13204598|NCT01972438|26229388|FG000|Months 3-6 Crossover Period|Early Study Closure|0|||
13204599|NCT01972438|26229389|FG001|Months 3-6 Crossover Period|Early Study Closure|1|||
13204600|NCT01972438|26229388|FG000|Months 6-12 Study Period|Death|1|||
13204601|NCT01972438|26229389|FG001|Months 6-12 Study Period|Death|0|||
13204602|NCT01972438|26229388|FG000|Months 6-12 Study Period|Early Study Closure|2|||
13204603|NCT01972438|26229389|FG001|Months 6-12 Study Period|Early Study Closure|2|||
13204604|NCT01972438|26229388|FG000|Post Month 12 Study Period|Early Study Closure|3|||
13204605|NCT01972438|26229389|FG001|Post Month 12 Study Period|Early Study Closure|4|||
13204606|NCT01972308|26229412|FG000|Overall Study|Withdrawal by Subject|0|||
13204607|NCT01972308|26229413|FG001|Overall Study|Withdrawal by Subject|1|||
13204608|NCT01972308|26229412|FG000|Overall Study|Lost to Follow-up|4|||
13204609|NCT01972308|26229413|FG001|Overall Study|Lost to Follow-up|6|||
13204610|NCT01972308|26229412|FG000|Overall Study|Death|4|||
13204611|NCT01972308|26229413|FG001|Overall Study|Death|1|||
13204612|NCT01972152|26229455|FG000|First Treatment Visit|Lost to Follow-up|0|||
13204613|NCT01972152|26229456|FG001|First Treatment Visit|Lost to Follow-up|1|||
13204614|NCT01972152|26229457|FG002|First Treatment Visit|Lost to Follow-up|0|||
13204615|NCT01972152|26229458|FG003|First Treatment Visit|Lost to Follow-up|0|||
13204616|NCT01972152|26229459|FG004|First Treatment Visit|Lost to Follow-up|0|||
13204617|NCT01972152|26229460|FG005|First Treatment Visit|Lost to Follow-up|0|||
13204618|NCT01972152|26229455|FG000|Second Treatment Visit|Protocol Violation|0|||
13136381|NCT02723864|25998708|FG000|Overall Study|Refused further treatment|1|||
13136382|NCT02723864|25998709|FG001|Overall Study|Refused further treatment|0|||
13136383|NCT02723864|25998710|FG002|Overall Study|Refused further treatment|0|||
13136384|NCT02723864|25998711|FG003|Overall Study|Refused further treatment|0|||
13136385|NCT02723864|25998712|FG004|Overall Study|Refused further treatment|1|||
13136386|NCT02723864|25998713|FG005|Overall Study|Refused further treatment|2|||
13136387|NCT02723864|25998714|FG006|Overall Study|Refused further treatment|0|||
13136388|NCT02723864|25998708|FG000|Overall Study|Exceed treatment hold time|0|||
13136389|NCT02723864|25998709|FG001|Overall Study|Exceed treatment hold time|1|||
13136390|NCT02723864|25998710|FG002|Overall Study|Exceed treatment hold time|0|||
13136391|NCT02723864|25998711|FG003|Overall Study|Exceed treatment hold time|0|||
13136392|NCT02723864|25998712|FG004|Overall Study|Exceed treatment hold time|0|||
13136393|NCT02723864|25998713|FG005|Overall Study|Exceed treatment hold time|0|||
13136394|NCT02723864|25998714|FG006|Overall Study|Exceed treatment hold time|0|||
13136395|NCT02723864|25998708|FG000|Overall Study|Clinical progression|0|||
13136396|NCT02723864|25998709|FG001|Overall Study|Clinical progression|0|||
13136397|NCT02723864|25998710|FG002|Overall Study|Clinical progression|1|||
13136398|NCT02723864|25998711|FG003|Overall Study|Clinical progression|0|||
13136399|NCT02723864|25998712|FG004|Overall Study|Clinical progression|0|||
13136400|NCT02723864|25998713|FG005|Overall Study|Clinical progression|3|||
13136401|NCT02723864|25998714|FG006|Overall Study|Clinical progression|1|||
13136402|NCT02723864|25998708|FG000|Overall Study|Physician Decision|0|||
13136403|NCT02723864|25998709|FG001|Overall Study|Physician Decision|0|||
13136404|NCT02723864|25998710|FG002|Overall Study|Physician Decision|0|||
13136405|NCT02723864|25998711|FG003|Overall Study|Physician Decision|0|||
13136406|NCT02723864|25998712|FG004|Overall Study|Physician Decision|0|||
13136407|NCT02723864|25998713|FG005|Overall Study|Physician Decision|0|||
13136408|NCT02723864|25998714|FG006|Overall Study|Physician Decision|1|||
13136409|NCT02723864|25998708|FG000|Overall Study|Changes in patient condition|0|||
13136410|NCT02723864|25998709|FG001|Overall Study|Changes in patient condition|0|||
13136411|NCT02723864|25998710|FG002|Overall Study|Changes in patient condition|0|||
13136412|NCT02723864|25998711|FG003|Overall Study|Changes in patient condition|0|||
13136413|NCT02723864|25998712|FG004|Overall Study|Changes in patient condition|0|||
13136414|NCT02723864|25998713|FG005|Overall Study|Changes in patient condition|1|||
13136415|NCT02723864|25998714|FG006|Overall Study|Changes in patient condition|0|||
13136416|NCT02723864|25998708|FG000|Overall Study|Patient choice|0|||
13136417|NCT02723864|25998709|FG001|Overall Study|Patient choice|0|||
13136418|NCT02723864|25998710|FG002|Overall Study|Patient choice|0|||
13136419|NCT02723864|25998711|FG003|Overall Study|Patient choice|0|||
13136420|NCT02723864|25998712|FG004|Overall Study|Patient choice|0|||
13136421|NCT02723864|25998713|FG005|Overall Study|Patient choice|1|||
13136422|NCT02723864|25998714|FG006|Overall Study|Patient choice|0|||
13136423|NCT02723864|25998708|FG000|Overall Study|Adverse Event|0|||
13136424|NCT02723864|25998709|FG001|Overall Study|Adverse Event|0|||
13136425|NCT02723864|25998710|FG002|Overall Study|Adverse Event|0|||
13136426|NCT02723864|25998711|FG003|Overall Study|Adverse Event|0|||
13136427|NCT02723864|25998712|FG004|Overall Study|Adverse Event|0|||
13136428|NCT02723864|25998713|FG005|Overall Study|Adverse Event|1|||
13136429|NCT02723864|25998714|FG006|Overall Study|Adverse Event|0|||
13136430|NCT02723864|25998708|FG000|Overall Study|Started new treatment|0|||
13136431|NCT02723864|25998709|FG001|Overall Study|Started new treatment|0|||
13136432|NCT02723864|25998710|FG002|Overall Study|Started new treatment|0|||
13136433|NCT02723864|25998711|FG003|Overall Study|Started new treatment|0|||
13136434|NCT02723864|25998712|FG004|Overall Study|Started new treatment|0|||
13136435|NCT02723864|25998713|FG005|Overall Study|Started new treatment|1|||
13136436|NCT02723864|25998714|FG006|Overall Study|Started new treatment|0|||
13136437|NCT02723864|25998708|FG000|Overall Study|Switched to alternative treatment|0|||
13136438|NCT02723864|25998709|FG001|Overall Study|Switched to alternative treatment|0|||
13136439|NCT02723864|25998710|FG002|Overall Study|Switched to alternative treatment|0|||
13136440|NCT02723864|25998711|FG003|Overall Study|Switched to alternative treatment|0|||
13136441|NCT02723864|25998712|FG004|Overall Study|Switched to alternative treatment|0|||
13136442|NCT02723864|25998713|FG005|Overall Study|Switched to alternative treatment|1|||
13136443|NCT02723864|25998714|FG006|Overall Study|Switched to alternative treatment|0|||
13136444|NCT02723864|25998708|FG000|Overall Study|Late determination of ineligibility|0|||
13136445|NCT02723864|25998709|FG001|Overall Study|Late determination of ineligibility|0|||
13136446|NCT02723864|25998710|FG002|Overall Study|Late determination of ineligibility|0|||
13136447|NCT02723864|25998711|FG003|Overall Study|Late determination of ineligibility|0|||
13136448|NCT02723864|25998712|FG004|Overall Study|Late determination of ineligibility|0|||
13136449|NCT02723864|25998713|FG005|Overall Study|Late determination of ineligibility|1|||
13136450|NCT02723864|25998714|FG006|Overall Study|Late determination of ineligibility|0|||
13136451|NCT02723786|25998738|FG000|Overall Study|Lost to Follow-up|1|||
13136452|NCT02723630|25998786|FG000|Intervention Period 1|Adverse Event|1|||
13136453|NCT02723630|25998787|FG001|Intervention Period 1|Adverse Event|0|||
13136454|NCT02723630|25998788|FG002|Intervention Period 1|Adverse Event|0|||
13136455|NCT02723630|25998789|FG003|Intervention Period 1|Adverse Event|0|||
13136456|NCT02723630|25998790|FG004|Intervention Period 1|Adverse Event|0|||
13136457|NCT02723630|25998791|FG005|Intervention Period 1|Adverse Event|0|||
13136458|NCT02723630|25998786|FG000|Intervention Period 3|consumption of restricted item|0|||
13136459|NCT02723630|25998787|FG001|Intervention Period 3|consumption of restricted item|1|||
13136460|NCT02723630|25998788|FG002|Intervention Period 3|consumption of restricted item|0|||
13136461|NCT02723630|25998789|FG003|Intervention Period 3|consumption of restricted item|0|||
13136462|NCT02723630|25998790|FG004|Intervention Period 3|consumption of restricted item|0|||
13136463|NCT02723630|25998791|FG005|Intervention Period 3|consumption of restricted item|0|||
13136464|NCT02723591|25998924|FG000|Overall Study|Adverse Event|48|||
13136465|NCT02723591|25998925|FG001|Overall Study|Adverse Event|40|||
13136466|NCT02723591|25998924|FG000|Overall Study|Death|2|||
13136467|NCT02723591|25998925|FG001|Overall Study|Death|2|||
13136468|NCT02723591|25998924|FG000|Overall Study|Lack of Efficacy|4|||
13136469|NCT02723591|25998925|FG001|Overall Study|Lack of Efficacy|3|||
13136470|NCT02723591|25998924|FG000|Overall Study|Lost to Follow-up|1|||
13136471|NCT02723591|25998925|FG001|Overall Study|Lost to Follow-up|7|||
13136472|NCT02723591|25998924|FG000|Overall Study|Protocol Violation|20|||
13136473|NCT02723591|25998925|FG001|Overall Study|Protocol Violation|23|||
13136474|NCT02723591|25998924|FG000|Overall Study|Withdrawal by Subject|4|||
13136475|NCT02723591|25998925|FG001|Overall Study|Withdrawal by Subject|8|||
13136476|NCT02723591|25998924|FG000|Overall Study|Randomized but Never Received StudyDrug|12|||
13136477|NCT02723591|25998925|FG001|Overall Study|Randomized but Never Received StudyDrug|12|||
13136478|NCT02723591|25998924|FG000|Overall Study|Miscellaneous|5|||
13136479|NCT02723591|25998925|FG001|Overall Study|Miscellaneous|6|||
13136480|NCT02723344|25998952|FG000|Overall Study|Lost to Follow-up|0|||
13136481|NCT02723344|25998953|FG001|Overall Study|Lost to Follow-up|4|||
13136482|NCT02723201|25999019|FG000|Second Intervention Period|Protocol Violation|1|||
13136483|NCT02723201|25999020|FG001|Second Intervention Period|Protocol Violation|0|||
13136484|NCT02723201|25999021|FG002|Second Intervention Period|Protocol Violation|0|||
13136485|NCT02723201|25999019|FG000|Second Intervention Period|Adverse Event|1|||
13136486|NCT02723201|25999020|FG001|Second Intervention Period|Adverse Event|0|||
13136487|NCT02723201|25999021|FG002|Second Intervention Period|Adverse Event|0|||
13136488|NCT02723188|25999042|FG000|Overall Study|Withdrawal by Subject|1|||
13136489|NCT02723188|25999043|FG001|Overall Study|Withdrawal by Subject|0|||
13136490|NCT02723188|25999044|FG002|Overall Study|Withdrawal by Subject|0|||
13136491|NCT02723175|25999091|FG000|Overall Study|Lost to 1 Month Follow Up|3|||
13136492|NCT02723175|25999092|FG001|Overall Study|Lost to 1 Month Follow Up|2|||
13136493|NCT02723175|25999091|FG000|Overall Study|Lost to 3 Month Follow Up|1|||
13136494|NCT02723175|25999092|FG001|Overall Study|Lost to 3 Month Follow Up|1|||
13136495|NCT02723084|25999110|FG000|Overall Study|Withdrawal by Subject|1|||
13136496|NCT02723084|25999111|FG001|Overall Study|Withdrawal by Subject|1|||
13136497|NCT02723084|25999110|FG000|Overall Study|Lost to Follow-up|3|||
13136498|NCT02723084|25999111|FG001|Overall Study|Lost to Follow-up|0|||
13136499|NCT02723006|25999144|FG000|Overall Study|Withdrawal by Subject|0|||
13136500|NCT02723006|25999145|FG001|Overall Study|Withdrawal by Subject|1|||
13136501|NCT02723006|25999146|FG002|Overall Study|Withdrawal by Subject|1|||
13136502|NCT02723006|25999144|FG000|Overall Study|Study Terminated by Sponsor|1|||
13136503|NCT02723006|25999145|FG001|Overall Study|Study Terminated by Sponsor|6|||
13136504|NCT02723006|25999146|FG002|Overall Study|Study Terminated by Sponsor|6|||
13136505|NCT02722967|25999164|FG000|Overall Study|Adverse Event|1|||
13136506|NCT02722967|25999165|FG001|Overall Study|Adverse Event|0|||
13136507|NCT02722967|25999166|FG002|Overall Study|Adverse Event|0|||
13136508|NCT02722967|25999164|FG000|Overall Study|Lost to Follow-up|0|||
13136509|NCT02722967|25999165|FG001|Overall Study|Lost to Follow-up|1|||
13136510|NCT02722967|25999166|FG002|Overall Study|Lost to Follow-up|0|||
13136511|NCT02722967|25999164|FG000|Overall Study|Non-compliance with patch wearing|2|||
13136512|NCT02722967|25999165|FG001|Overall Study|Non-compliance with patch wearing|1|||
13136513|NCT02722967|25999166|FG002|Overall Study|Non-compliance with patch wearing|1|||
13136514|NCT02722967|25999164|FG000|Overall Study|Withdrawal by Subject|1|||
13136515|NCT02722967|25999165|FG001|Overall Study|Withdrawal by Subject|0|||
13136516|NCT02722967|25999166|FG002|Overall Study|Withdrawal by Subject|1|||
13136517|NCT02722967|25999164|FG000|Overall Study|Physician Decision|1|||
13136518|NCT02722967|25999165|FG001|Overall Study|Physician Decision|0|||
13136519|NCT02722967|25999166|FG002|Overall Study|Physician Decision|0|||
13136520|NCT02722967|25999164|FG000|Overall Study|Non-adherence of the patch to the skin|0|||
13136521|NCT02722967|25999165|FG001|Overall Study|Non-adherence of the patch to the skin|0|||
13136522|NCT02722967|25999166|FG002|Overall Study|Non-adherence of the patch to the skin|2|||
13136523|NCT02722928|25999187|FG000|Overall Study|Standard CT was not as required per prot|5|||
13136524|NCT02722928|25999188|FG001|Overall Study|Standard CT was not as required per prot|13|||
13136525|NCT02722928|25999187|FG000|Overall Study|Required Intraoperative MRI|5|||
13136526|NCT02722928|25999188|FG001|Overall Study|Required Intraoperative MRI|7|||
13136527|NCT02722499|25999209|FG000|Overall Study|Lost to Follow-up|2|||
13136528|NCT02722499|25999210|FG001|Overall Study|Lost to Follow-up|0|||
13136529|NCT02722499|25999211|FG002|Overall Study|Lost to Follow-up|1|||
13136530|NCT02722304|25999277|FG000|Overall Study|Study Terminated by Sponsor|1|||
13136531|NCT02722304|25999278|FG001|Overall Study|Study Terminated by Sponsor|0|||
13136532|NCT02722304|25999279|FG002|Overall Study|Study Terminated by Sponsor|2|||
13136533|NCT02722304|25999280|FG003|Overall Study|Study Terminated by Sponsor|1|||
13136534|NCT02722304|25999281|FG004|Overall Study|Study Terminated by Sponsor|1|||
13136535|NCT02722304|25999277|FG000|Overall Study|Other|0|||
13136536|NCT02722304|25999278|FG001|Overall Study|Other|0|||
13136537|NCT02722304|25999279|FG002|Overall Study|Other|0|||
13136538|NCT02722304|25999280|FG003|Overall Study|Other|1|||
13136539|NCT02722304|25999281|FG004|Overall Study|Other|1|||
13136540|NCT02722278|25999296|FG000|Overall Study|Withdrawal by Subject|5|||
13136541|NCT02722278|25999297|FG001|Overall Study|Withdrawal by Subject|3|||
13136542|NCT02722278|25999296|FG000|Overall Study|Adverse Event|4|||
13136543|NCT02722278|25999297|FG001|Overall Study|Adverse Event|1|||
13136544|NCT02722278|25999296|FG000|Overall Study|Lost to Follow-up|2|||
13136545|NCT02722278|25999297|FG001|Overall Study|Lost to Follow-up|0|||
13136546|NCT02722278|25999296|FG000|Overall Study|Protocol Violation|1|||
13136547|NCT02722278|25999297|FG001|Overall Study|Protocol Violation|0|||
13136548|NCT02722278|25999296|FG000|Overall Study|High PSA pre-study/ not eligible|0|||
13090899|NCT03764475|25821663|FG000|Overall Study|Adverse Event|11|||
13090900|NCT03764475|25821664|FG001|Overall Study|Adverse Event|2|||
13090901|NCT03764475|25821663|FG000|Overall Study|Lost to Follow-up|24|||
13090902|NCT03764475|25821664|FG001|Overall Study|Lost to Follow-up|10|||
13090903|NCT03764475|25821663|FG000|Overall Study|Withdrawal by Subject|26|||
13090904|NCT03764475|25821664|FG001|Overall Study|Withdrawal by Subject|10|||
13090905|NCT03764475|25821663|FG000|Overall Study|Lack of Efficacy|3|||
13090906|NCT03764475|25821664|FG001|Overall Study|Lack of Efficacy|0|||
13090907|NCT03764475|25821663|FG000|Overall Study|COVID-19 Disruption|2|||
13090908|NCT03764475|25821664|FG001|Overall Study|COVID-19 Disruption|0|||
13090909|NCT03764072|25821749|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
13090910|NCT03764072|25821750|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
13090911|NCT03764072|25821751|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
13090912|NCT03764072|25821752|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
13090913|NCT03764072|25821753|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
13090914|NCT03764072|25821754|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
13090915|NCT03764072|25821749|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
13090916|NCT03764072|25821750|FG001|Overall Study|Withdrawal of consent (for other reason)|0|||
13090917|NCT03764072|25821751|FG002|Overall Study|Withdrawal of consent (for other reason)|0|||
13090918|NCT03764072|25821752|FG003|Overall Study|Withdrawal of consent (for other reason)|0|||
13090919|NCT03764072|25821753|FG004|Overall Study|Withdrawal of consent (for other reason)|0|||
13090920|NCT03764072|25821754|FG005|Overall Study|Withdrawal of consent (for other reason)|1|||
13090921|NCT03764072|25821749|FG000|Overall Study|Lost to Follow-up|0|||
13090922|NCT03764072|25821750|FG001|Overall Study|Lost to Follow-up|0|||
13090923|NCT03764072|25821751|FG002|Overall Study|Lost to Follow-up|0|||
13090924|NCT03764072|25821752|FG003|Overall Study|Lost to Follow-up|0|||
13090925|NCT03764072|25821753|FG004|Overall Study|Lost to Follow-up|1|||
13090926|NCT03764072|25821754|FG005|Overall Study|Lost to Follow-up|0|||
13090927|NCT03763877|25821857|FG000|Overall Study|Withdrawal by Subject|3|||
13090928|NCT03763877|25821858|FG001|Overall Study|Withdrawal by Subject|1|||
13090929|NCT03763877|25821859|FG002|Overall Study|Withdrawal by Subject|3|||
13090930|NCT03763877|25821860|FG003|Overall Study|Withdrawal by Subject|4|||
13090931|NCT03763877|25821857|FG000|Overall Study|Adverse Event|1|||
13090932|NCT03763877|25821858|FG001|Overall Study|Adverse Event|1|||
13090933|NCT03763877|25821859|FG002|Overall Study|Adverse Event|3|||
13090934|NCT03763877|25821860|FG003|Overall Study|Adverse Event|1|||
13090935|NCT03763877|25821857|FG000|Overall Study|Protocol Violation|1|||
13090936|NCT03763877|25821858|FG001|Overall Study|Protocol Violation|1|||
13090937|NCT03763877|25821859|FG002|Overall Study|Protocol Violation|0|||
13090938|NCT03763877|25821860|FG003|Overall Study|Protocol Violation|0|||
13090939|NCT03763877|25821857|FG000|Overall Study|Lost to Follow-up|0|||
13090940|NCT03763877|25821858|FG001|Overall Study|Lost to Follow-up|1|||
13090941|NCT03763877|25821859|FG002|Overall Study|Lost to Follow-up|1|||
13090942|NCT03763877|25821860|FG003|Overall Study|Lost to Follow-up|0|||
13090943|NCT03762681|25821989|FG000|Part 1|Withdrawal by Subject|0|||
13090944|NCT03762681|25821990|FG001|Part 1|Withdrawal by Subject|0|||
13090945|NCT03762681|25821991|FG002|Part 1|Withdrawal by Subject|0|||
13090946|NCT03762681|25821992|FG003|Part 1|Withdrawal by Subject|1|||
13090947|NCT03762681|25821993|FG004|Part 1|Withdrawal by Subject|0|||
13090948|NCT03762681|25821994|FG005|Part 1|Withdrawal by Subject|0|||
13090949|NCT03762681|25821995|FG006|Part 1|Withdrawal by Subject|0|||
13090950|NCT03762681|25821996|FG007|Part 1|Withdrawal by Subject|0|||
13090951|NCT03762681|25821989|FG000|Part 2a|Pandemic Travel Restrictions|0|||
13090952|NCT03762681|25821990|FG001|Part 2a|Pandemic Travel Restrictions|0|||
13136549|NCT02722278|25999297|FG001|Overall Study|High PSA pre-study/ not eligible|1|||
13090953|NCT03762681|25821991|FG002|Part 2a|Pandemic Travel Restrictions|0|||
13090954|NCT03762681|25821992|FG003|Part 2a|Pandemic Travel Restrictions|0|||
13136550|NCT02722278|25999296|FG000|Overall Study|Subject declined after tx assignment|0|||
13090955|NCT03762681|25821993|FG004|Part 2a|Pandemic Travel Restrictions|0|||
13090956|NCT03762681|25821994|FG005|Part 2a|Pandemic Travel Restrictions|0|||
13090957|NCT03762681|25821995|FG006|Part 2a|Pandemic Travel Restrictions|0|||
13090958|NCT03762681|25821996|FG007|Part 2a|Pandemic Travel Restrictions|1|||
13090959|NCT03762668|25822009|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0|||
13090960|NCT03762668|25822010|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1|||
13090961|NCT03762616|25822018|FG000|Overall Study|Protocol Violation|2|||
13090962|NCT03762265|25822124|FG000|BT Period: Weeks 1 to 37|Adverse Event|7|||
13090963|NCT03762265|25822125|FG001|BT Period: Weeks 1 to 37|Adverse Event|2|||
13090964|NCT03762265|25822124|FG000|BT Period: Weeks 1 to 37|Lack of Efficacy|1|||
13090965|NCT03762265|25822125|FG001|BT Period: Weeks 1 to 37|Lack of Efficacy|0|||
13090966|NCT03762265|25822124|FG000|BT Period: Weeks 1 to 37|Physician Decision|1|||
13090967|NCT03762265|25822125|FG001|BT Period: Weeks 1 to 37|Physician Decision|0|||
13090968|NCT03762265|25822124|FG000|BT Period: Weeks 1 to 37|Required prohibited medication|2|||
13090969|NCT03762265|25822125|FG001|BT Period: Weeks 1 to 37|Required prohibited medication|0|||
13090970|NCT03762265|25822124|FG000|BT Period: Weeks 1 to 37|Withdrawal by Subject|4|||
13090971|NCT03762265|25822125|FG001|BT Period: Weeks 1 to 37|Withdrawal by Subject|0|||
13136551|NCT02722278|25999297|FG001|Overall Study|Subject declined after tx assignment|1|||
13136552|NCT02722278|25999296|FG000|Overall Study|Site closure not study related|0|||
13136553|NCT02722278|25999297|FG001|Overall Study|Site closure not study related|1|||
13136554|NCT02722148|25999306|FG000|Overall Study|Lost to Follow-up|2|||
13136555|NCT02722148|25999306|FG000|Overall Study|Non compliant with treatment regimen|3|||
13136556|NCT02722044|25999335|FG000|Overall Study|Adverse Event|2|||
13136557|NCT02722044|25999335|FG000|Overall Study|Physician Decision|1|||
13136558|NCT02722044|25999335|FG000|Overall Study|Withdrawal by Subject|1|||
13136559|NCT02722044|25999335|FG000|Overall Study|Did Not Meet Criteria at Week 14|1|||
13136560|NCT02721966|25999385|FG000|Overall Study|Protocol Violation|1|||
13136561|NCT02721966|25999386|FG001|Overall Study|Protocol Violation|0|||
13136562|NCT02721966|25999387|FG002|Overall Study|Protocol Violation|0|||
13136563|NCT02721966|25999388|FG003|Overall Study|Protocol Violation|0|||
13136564|NCT02721966|25999389|FG004|Overall Study|Protocol Violation|0|||
13136565|NCT02721966|25999385|FG000|Overall Study|Withdrawal by Subject|9|||
13136566|NCT02721966|25999386|FG001|Overall Study|Withdrawal by Subject|2|||
13136567|NCT02721966|25999387|FG002|Overall Study|Withdrawal by Subject|3|||
13136568|NCT02721966|25999388|FG003|Overall Study|Withdrawal by Subject|7|||
13136569|NCT02721966|25999389|FG004|Overall Study|Withdrawal by Subject|0|||
13136570|NCT02721966|25999385|FG000|Overall Study|Adverse Event|4|||
13136571|NCT02721966|25999386|FG001|Overall Study|Adverse Event|4|||
13136572|NCT02721966|25999387|FG002|Overall Study|Adverse Event|3|||
13136573|NCT02721966|25999388|FG003|Overall Study|Adverse Event|0|||
13136574|NCT02721966|25999389|FG004|Overall Study|Adverse Event|0|||
13136575|NCT02721966|25999385|FG000|Overall Study|Death|1|||
13136576|NCT02721966|25999386|FG001|Overall Study|Death|0|||
13136577|NCT02721966|25999387|FG002|Overall Study|Death|0|||
13136578|NCT02721966|25999388|FG003|Overall Study|Death|0|||
13136579|NCT02721966|25999389|FG004|Overall Study|Death|0|||
13136580|NCT02721966|25999385|FG000|Overall Study|Lack of Efficacy|7|||
13136581|NCT02721966|25999386|FG001|Overall Study|Lack of Efficacy|4|||
13136582|NCT02721966|25999387|FG002|Overall Study|Lack of Efficacy|0|||
13136583|NCT02721966|25999388|FG003|Overall Study|Lack of Efficacy|0|||
13136584|NCT02721966|25999389|FG004|Overall Study|Lack of Efficacy|0|||
13136585|NCT02721966|25999385|FG000|Overall Study|Lost to Follow-up|0|||
13136586|NCT02721966|25999386|FG001|Overall Study|Lost to Follow-up|0|||
13136587|NCT02721966|25999387|FG002|Overall Study|Lost to Follow-up|3|||
13136588|NCT02721966|25999388|FG003|Overall Study|Lost to Follow-up|0|||
13136589|NCT02721966|25999389|FG004|Overall Study|Lost to Follow-up|0|||
13136590|NCT02721966|25999385|FG000|Overall Study|Physician Decision|1|||
13136591|NCT02721966|25999386|FG001|Overall Study|Physician Decision|1|||
13136592|NCT02721966|25999387|FG002|Overall Study|Physician Decision|0|||
13136593|NCT02721966|25999388|FG003|Overall Study|Physician Decision|0|||
13136594|NCT02721966|25999389|FG004|Overall Study|Physician Decision|0|||
13136595|NCT02721966|25999385|FG000|Overall Study|Pregnancy|1|||
13090972|NCT03762265|25822124|FG000|BT Period: Weeks 1 to 37|Other|0|||
13090973|NCT03762265|25822125|FG001|BT Period: Weeks 1 to 37|Other|1|||
13090974|NCT03762265|25822124|FG000|OLE Period: Weeks 37 to 61|Adverse Event|1|||
13090975|NCT03762265|25822125|FG001|OLE Period: Weeks 37 to 61|Adverse Event|2|||
13090976|NCT03762265|25822124|FG000|OLE Period: Weeks 37 to 61|Lack of Efficacy|3|||
13090977|NCT03762265|25822125|FG001|OLE Period: Weeks 37 to 61|Lack of Efficacy|2|||
13090978|NCT03762265|25822124|FG000|OLE Period: Weeks 37 to 61|Non-compliance with study drug|1|||
13090979|NCT03762265|25822125|FG001|OLE Period: Weeks 37 to 61|Non-compliance with study drug|0|||
13090980|NCT03762265|25822124|FG000|OLE Period: Weeks 37 to 61|Study terminated by sponsor|8|||
13090981|NCT03762265|25822125|FG001|OLE Period: Weeks 37 to 61|Study terminated by sponsor|10|||
13090982|NCT03762265|25822124|FG000|OLE Period: Weeks 37 to 61|Withdrawal by Subject|3|||
13136596|NCT02721966|25999386|FG001|Overall Study|Pregnancy|0|||
13136597|NCT02721966|25999387|FG002|Overall Study|Pregnancy|0|||
13136598|NCT02721966|25999388|FG003|Overall Study|Pregnancy|0|||
13136599|NCT02721966|25999389|FG004|Overall Study|Pregnancy|0|||
13136600|NCT02721966|25999385|FG000|Overall Study|Did not continue to period 2|5|||
13136601|NCT02721966|25999386|FG001|Overall Study|Did not continue to period 2|12|||
13136602|NCT02721966|25999387|FG002|Overall Study|Did not continue to period 2|0|||
13136603|NCT02721966|25999388|FG003|Overall Study|Did not continue to period 2|0|||
13222497|NCT01806597|26286269|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
13222498|NCT01806597|26286270|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
13222499|NCT01806597|26286271|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
13222500|NCT01806597|26286266|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
13222501|NCT01806597|26286267|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
13222502|NCT01806597|26286268|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
13222503|NCT01806597|26286269|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
13222504|NCT01806597|26286270|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
13222505|NCT01806597|26286271|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5|||
13136604|NCT02721966|25999389|FG004|Overall Study|Did not continue to period 2|5|||
13136605|NCT02721875|25999409|FG000|Overall Study|Progressive disease/relapse|1|||
13136606|NCT02721875|25999410|FG001|Overall Study|Progressive disease/relapse|0|||
13136607|NCT02721355|25999429|FG000|Overall Study|Lost to Follow-up|6|||
13136608|NCT02721355|25999430|FG001|Overall Study|Lost to Follow-up|1|||
13136609|NCT02721251|25999469|FG000|Overall Study|Withdrawal by Subject|8|||
13136610|NCT02721251|25999470|FG001|Overall Study|Withdrawal by Subject|7|||
13136611|NCT02721251|25999471|FG002|Overall Study|Withdrawal by Subject|9|||
13136612|NCT02721251|25999469|FG000|Overall Study|poor adherence|2|||
13136613|NCT02721251|25999470|FG001|Overall Study|poor adherence|2|||
13136614|NCT02721251|25999471|FG002|Overall Study|poor adherence|2|||
13136615|NCT02721147|25999516|FG000|Overall Study|Lost to Follow-up|2|||
13136616|NCT02721147|25999517|FG001|Overall Study|Lost to Follow-up|0|||
13136617|NCT02721147|25999518|FG002|Overall Study|Lost to Follow-up|0|||
13136618|NCT02720757|25999529|FG000|Overall Study|Other reason|5|||
13136619|NCT02720757|25999529|FG000|Overall Study|Loss of contact|4|||
13136620|NCT02720757|25999529|FG000|Overall Study|Informed consent withdrawal|1|||
13136621|NCT02720757|25999529|FG000|Overall Study|Patients wish to withdraw|2|||
13136622|NCT02720757|25999529|FG000|Overall Study|Missing|3|||
13136623|NCT02720757|25999529|FG000|Overall Study|General exclusion|3|||
13136624|NCT02720536|25999562|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11|||
13136625|NCT02720536|25999562|FG000|Overall Study|PR - pregnancy|2|||
13136626|NCT02720536|25999562|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2|||
13136627|NCT02720536|25999562|FG000|Overall Study|PR - death|1|||
13136628|NCT02720536|25999562|FG000|Overall Study|PR - adverse event|1|||
13136629|NCT02720536|25999562|FG000|Overall Study|PR - abnormal lab value(s)|1|||
13136630|NCT02720536|25999562|FG000|Overall Study|PR- unwilling to comply with procedures|1|||
13136631|NCT02720523|25999635|FG000|Period 1: Placebo-controlled Period|Adverse Event|0|||
13136632|NCT02720523|25999636|FG001|Period 1: Placebo-controlled Period|Adverse Event|0|||
13136633|NCT02720523|25999637|FG002|Period 1: Placebo-controlled Period|Adverse Event|1|||
13136634|NCT02720523|25999638|FG003|Period 1: Placebo-controlled Period|Adverse Event|5|||
13136635|NCT02720523|25999639|FG004|Period 1: Placebo-controlled Period|Adverse Event|0|||
13136636|NCT02720523|25999640|FG005|Period 1: Placebo-controlled Period|Adverse Event|0|||
13136637|NCT02720523|25999641|FG006|Period 1: Placebo-controlled Period|Adverse Event|0|||
13136638|NCT02720523|25999635|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1|||
13136639|NCT02720523|25999636|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
13136640|NCT02720523|25999637|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
13136641|NCT02720523|25999638|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
13136642|NCT02720523|25999639|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
13136643|NCT02720523|25999640|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
13136644|NCT02720523|25999641|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
13136645|NCT02720523|25999635|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1|||
13136646|NCT02720523|25999636|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
13136647|NCT02720523|25999637|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
13136648|NCT02720523|25999638|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
13136649|NCT02720523|25999639|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
13136650|NCT02720523|25999640|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
13136651|NCT02720523|25999641|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
13136652|NCT02720523|25999635|FG000|Period 1: Placebo-controlled Period|Other|0|||
13136653|NCT02720523|25999636|FG001|Period 1: Placebo-controlled Period|Other|0|||
13136654|NCT02720523|25999637|FG002|Period 1: Placebo-controlled Period|Other|1|||
13136655|NCT02720523|25999638|FG003|Period 1: Placebo-controlled Period|Other|1|||
13136656|NCT02720523|25999639|FG004|Period 1: Placebo-controlled Period|Other|0|||
13136657|NCT02720523|25999640|FG005|Period 1: Placebo-controlled Period|Other|0|||
13136658|NCT02720523|25999641|FG006|Period 1: Placebo-controlled Period|Other|0|||
13136659|NCT02720523|25999635|FG000|Period 2: Long-term Extension Period|Ongoing|0|||
13136660|NCT02720523|25999636|FG001|Period 2: Long-term Extension Period|Ongoing|0|||
13136661|NCT02720523|25999637|FG002|Period 2: Long-term Extension Period|Ongoing|0|||
13136662|NCT02720523|25999638|FG003|Period 2: Long-term Extension Period|Ongoing|0|||
13136663|NCT02720523|25999639|FG004|Period 2: Long-term Extension Period|Ongoing|57|||
13136664|NCT02720523|25999640|FG005|Period 2: Long-term Extension Period|Ongoing|54|||
13222506|NCT01806597|26286266|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
13222507|NCT01806597|26286267|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
13222508|NCT01806597|26286268|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
13222509|NCT01806597|26286269|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
13222510|NCT01806597|26286270|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
13222511|NCT01806597|26286271|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2|||
13222512|NCT01806597|26286266|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
13222513|NCT01806597|26286267|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
13222514|NCT01806597|26286268|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
13222515|NCT01806597|26286269|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
13222516|NCT01806597|26286270|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
13222517|NCT01806597|26286271|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2|||
13222518|NCT01806597|26286266|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
13222519|NCT01806597|26286267|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
13222520|NCT01806597|26286268|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
13222521|NCT01806597|26286269|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
13222522|NCT01806597|26286270|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
13222523|NCT01806597|26286271|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2|||
13393350|NCT00665925|26783413|FG002|Overall Study|Enrolled by mistake|0|||
13136665|NCT02720523|25999641|FG006|Period 2: Long-term Extension Period|Ongoing|45|||
13136666|NCT02720523|25999635|FG000|Period 2: Long-term Extension Period|Adverse Event|0|||
13136667|NCT02720523|25999636|FG001|Period 2: Long-term Extension Period|Adverse Event|0|||
13136668|NCT02720523|25999637|FG002|Period 2: Long-term Extension Period|Adverse Event|0|||
13136669|NCT02720523|25999638|FG003|Period 2: Long-term Extension Period|Adverse Event|0|||
13136670|NCT02720523|25999639|FG004|Period 2: Long-term Extension Period|Adverse Event|4|||
13136671|NCT02720523|25999640|FG005|Period 2: Long-term Extension Period|Adverse Event|7|||
13136672|NCT02720523|25999641|FG006|Period 2: Long-term Extension Period|Adverse Event|11|||
13136673|NCT02720523|25999635|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
13136674|NCT02720523|25999636|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
13136675|NCT02720523|25999637|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
13136676|NCT02720523|25999638|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
13136677|NCT02720523|25999639|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2|||
13136678|NCT02720523|25999640|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
13136679|NCT02720523|25999641|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
13136680|NCT02720523|25999635|FG000|Period 2: Long-term Extension Period|Other|0|||
13136681|NCT02720523|25999636|FG001|Period 2: Long-term Extension Period|Other|0|||
13136682|NCT02720523|25999637|FG002|Period 2: Long-term Extension Period|Other|0|||
13136683|NCT02720523|25999638|FG003|Period 2: Long-term Extension Period|Other|0|||
13136684|NCT02720523|25999639|FG004|Period 2: Long-term Extension Period|Other|2|||
13136685|NCT02720523|25999640|FG005|Period 2: Long-term Extension Period|Other|0|||
13136686|NCT02720523|25999641|FG006|Period 2: Long-term Extension Period|Other|3|||
13136687|NCT02720510|25999666|FG000|Overall Study|Study Terminated by the sponsor|2|||
13136688|NCT02720510|25999667|FG001|Overall Study|Study Terminated by the sponsor|0|||
13136689|NCT02720510|25999666|FG000|Overall Study|Adverse Event|0|||
13136690|NCT02720510|25999667|FG001|Overall Study|Adverse Event|1|||
13136691|NCT02720510|25999666|FG000|Overall Study|Physician Decision|1|||
13136692|NCT02720510|25999667|FG001|Overall Study|Physician Decision|2|||
13136693|NCT02720484|25999677|FG000|Treatment on Study|Adverse Event|1|||
13136694|NCT02720484|25999677|FG000|Treatment on Study|Withdrawal by Subject|1|||
13136695|NCT02720484|25999677|FG000|Treatment on Study|Progressive Disease|4|||
13136696|NCT02720484|25999677|FG000|Follow Up for 2 Years|Withdrawal by Subject|1|||
13136697|NCT02720484|25999677|FG000|Follow Up for 2 Years|Death|3|||
13136698|NCT02720484|25999677|FG000|Follow Up for 2 Years|Lost to Follow-up|2|||
13136699|NCT02720198|25999710|FG000|Overall Study|Withdrawal by Subject|0|||
13136700|NCT02720198|25999711|FG001|Overall Study|Withdrawal by Subject|1|||
13136701|NCT02720081|25999774|FG000|Overall Study|Adverse Event|0|||
13136702|NCT02720081|25999775|FG001|Overall Study|Adverse Event|3|||
13136703|NCT02720081|25999774|FG000|Overall Study|Protocol Violation|4|||
13136704|NCT02720081|25999775|FG001|Overall Study|Protocol Violation|1|||
13136705|NCT02720042|25999792|FG000|Overall Study|Death|3|||
13136706|NCT02720042|25999792|FG000|Overall Study|Lost to Follow-up|4|||
13136707|NCT02720042|25999792|FG000|Overall Study|Withdrawal by Subject|1|||
13136708|NCT02720042|25999792|FG000|Overall Study|Physician Decision|3|||
13136709|NCT02720042|25999792|FG000|Overall Study|Phasix Mesh explanted|1|||
13136710|NCT02720042|25999792|FG000|Overall Study|unable due to non-study-related illness|3|||
13136711|NCT02719743|25999935|FG000|Overall Study|Consent withdrawal|0|||
13136712|NCT02719743|25999936|FG001|Overall Study|Consent withdrawal|2|||
13136713|NCT02719743|25999937|FG002|Overall Study|Consent withdrawal|0|||
13136714|NCT02719743|25999938|FG003|Overall Study|Consent withdrawal|1|||
13136715|NCT02719743|25999939|FG004|Overall Study|Consent withdrawal|0|||
13136716|NCT02719743|25999935|FG000|Overall Study|Migrated/moved from study area|0|||
13136717|NCT02719743|25999936|FG001|Overall Study|Migrated/moved from study area|0|||
13136718|NCT02719743|25999937|FG002|Overall Study|Migrated/moved from study area|0|||
13136719|NCT02719743|25999938|FG003|Overall Study|Migrated/moved from study area|0|||
13136720|NCT02719743|25999939|FG004|Overall Study|Migrated/moved from study area|2|||
13136721|NCT02719743|25999935|FG000|Overall Study|Lost to Follow-up|1|||
13136722|NCT02719743|25999936|FG001|Overall Study|Lost to Follow-up|1|||
13136723|NCT02719743|25999937|FG002|Overall Study|Lost to Follow-up|0|||
13136724|NCT02719743|25999938|FG003|Overall Study|Lost to Follow-up|0|||
13136725|NCT02719743|25999939|FG004|Overall Study|Lost to Follow-up|0|||
13136726|NCT02719691|25999978|FG000|Overall Study|Physician Decision|0|||
13136727|NCT02719691|25999979|FG001|Overall Study|Physician Decision|0|||
13136728|NCT02719691|25999980|FG002|Overall Study|Physician Decision|1|||
13136729|NCT02719691|25999981|FG003|Overall Study|Physician Decision|0|||
13136730|NCT02719691|25999982|FG004|Overall Study|Physician Decision|0|||
13136731|NCT02719691|25999983|FG005|Overall Study|Physician Decision|0|||
13136732|NCT02719691|25999984|FG006|Overall Study|Physician Decision|0|||
13136733|NCT02719691|25999978|FG000|Overall Study|Withdrawal by Subject|0|||
13136734|NCT02719691|25999979|FG001|Overall Study|Withdrawal by Subject|0|||
13136735|NCT02719691|25999980|FG002|Overall Study|Withdrawal by Subject|0|||
13136736|NCT02719691|25999981|FG003|Overall Study|Withdrawal by Subject|0|||
13136737|NCT02719691|25999982|FG004|Overall Study|Withdrawal by Subject|0|||
13136738|NCT02719691|25999983|FG005|Overall Study|Withdrawal by Subject|1|||
13136739|NCT02719691|25999984|FG006|Overall Study|Withdrawal by Subject|0|||
13136740|NCT02719353|26000021|FG000|First Intervention|Physician Decision|0|||
13136741|NCT02719353|26000022|FG001|First Intervention|Physician Decision|1|||
13136742|NCT02719171|26000129|FG000|Overall Study|Adverse Event|1|||
13136743|NCT02719171|26000130|FG001|Overall Study|Adverse Event|2|||
13136744|NCT02719171|26000131|FG002|Overall Study|Adverse Event|0|||
13136745|NCT02719171|26000132|FG003|Overall Study|Adverse Event|0|||
13136746|NCT02719171|26000133|FG004|Overall Study|Adverse Event|2|||
13136747|NCT02719171|26000129|FG000|Overall Study|Lost to Follow-up|0|||
13136748|NCT02719171|26000130|FG001|Overall Study|Lost to Follow-up|0|||
13136749|NCT02719171|26000131|FG002|Overall Study|Lost to Follow-up|1|||
13136750|NCT02719171|26000132|FG003|Overall Study|Lost to Follow-up|0|||
13136751|NCT02719171|26000133|FG004|Overall Study|Lost to Follow-up|0|||
13136752|NCT02719171|26000129|FG000|Overall Study|Subject Withdrawal|0|||
13136753|NCT02719171|26000130|FG001|Overall Study|Subject Withdrawal|2|||
13136754|NCT02719171|26000131|FG002|Overall Study|Subject Withdrawal|2|||
13136755|NCT02719171|26000132|FG003|Overall Study|Subject Withdrawal|1|||
13136756|NCT02719171|26000133|FG004|Overall Study|Subject Withdrawal|0|||
13136757|NCT02719171|26000129|FG000|Overall Study|Other|0|||
13136758|NCT02719171|26000130|FG001|Overall Study|Other|0|||
13136759|NCT02719171|26000131|FG002|Overall Study|Other|0|||
13136760|NCT02719171|26000132|FG003|Overall Study|Other|1|||
13136761|NCT02719171|26000133|FG004|Overall Study|Other|0|||
13136762|NCT02719028|26000168|FG000|Overall Study|Adverse Event|2|||
13136763|NCT02719028|26000169|FG001|Overall Study|Adverse Event|1|||
13136764|NCT02719028|26000170|FG002|Overall Study|Adverse Event|4|||
13136765|NCT02719028|26000171|FG003|Overall Study|Adverse Event|8|||
13136766|NCT02719028|26000168|FG000|Overall Study|Physician Decision|0|||
13136767|NCT02719028|26000169|FG001|Overall Study|Physician Decision|1|||
13136768|NCT02719028|26000170|FG002|Overall Study|Physician Decision|1|||
13136769|NCT02719028|26000171|FG003|Overall Study|Physician Decision|1|||
13136770|NCT02719028|26000168|FG000|Overall Study|Use of prohibited medication|0|||
13136771|NCT02719028|26000169|FG001|Overall Study|Use of prohibited medication|0|||
13136772|NCT02719028|26000170|FG002|Overall Study|Use of prohibited medication|1|||
13136773|NCT02719028|26000171|FG003|Overall Study|Use of prohibited medication|0|||
13136774|NCT02719028|26000168|FG000|Overall Study|Protocol Violation|0|||
13136775|NCT02719028|26000169|FG001|Overall Study|Protocol Violation|0|||
13136776|NCT02719028|26000170|FG002|Overall Study|Protocol Violation|0|||
13136777|NCT02719028|26000171|FG003|Overall Study|Protocol Violation|1|||
13136778|NCT02718898|26000216|FG000|Blinded Treatment Period|Adverse Event|5|||
13136779|NCT02718898|26000217|FG001|Blinded Treatment Period|Adverse Event|1|||
13136780|NCT02718898|26000218|FG002|Blinded Treatment Period|Adverse Event|0|||
13136781|NCT02718898|26000219|FG003|Blinded Treatment Period|Adverse Event|0|||
13136782|NCT02718898|26000220|FG004|Blinded Treatment Period|Adverse Event|0|||
13136783|NCT02718898|26000221|FG005|Blinded Treatment Period|Adverse Event|0|||
13136784|NCT02718898|26000222|FG006|Blinded Treatment Period|Adverse Event|0|||
13136785|NCT02718898|26000216|FG000|Blinded Treatment Period|Physician Decision|1|||
13136786|NCT02718898|26000217|FG001|Blinded Treatment Period|Physician Decision|0|||
13136787|NCT02718898|26000218|FG002|Blinded Treatment Period|Physician Decision|0|||
13136788|NCT02718898|26000219|FG003|Blinded Treatment Period|Physician Decision|0|||
13136789|NCT02718898|26000220|FG004|Blinded Treatment Period|Physician Decision|0|||
13136790|NCT02718898|26000221|FG005|Blinded Treatment Period|Physician Decision|0|||
13136791|NCT02718898|26000222|FG006|Blinded Treatment Period|Physician Decision|0|||
13136792|NCT02718898|26000216|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
13136793|NCT02718898|26000217|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
13136794|NCT02718898|26000218|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
13136795|NCT02718898|26000219|FG003|Blinded Treatment Period|Lack of Efficacy|0|||
13136796|NCT02718898|26000220|FG004|Blinded Treatment Period|Lack of Efficacy|0|||
13136797|NCT02718898|26000221|FG005|Blinded Treatment Period|Lack of Efficacy|0|||
13136798|NCT02718898|26000222|FG006|Blinded Treatment Period|Lack of Efficacy|0|||
13136799|NCT02718898|26000216|FG000|Blinded Treatment Period|Lost to Follow-up|2|||
13136800|NCT02718898|26000217|FG001|Blinded Treatment Period|Lost to Follow-up|0|||
13136801|NCT02718898|26000218|FG002|Blinded Treatment Period|Lost to Follow-up|0|||
13136802|NCT02718898|26000219|FG003|Blinded Treatment Period|Lost to Follow-up|0|||
13136803|NCT02718898|26000220|FG004|Blinded Treatment Period|Lost to Follow-up|0|||
13136804|NCT02718898|26000221|FG005|Blinded Treatment Period|Lost to Follow-up|0|||
13136805|NCT02718898|26000222|FG006|Blinded Treatment Period|Lost to Follow-up|0|||
13136806|NCT02718898|26000216|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0|||
13136807|NCT02718898|26000217|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0|||
13136808|NCT02718898|26000218|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1|||
13136809|NCT02718898|26000219|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1|||
13136810|NCT02718898|26000220|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0|||
13136811|NCT02718898|26000221|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0|||
13136812|NCT02718898|26000222|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0|||
13136813|NCT02718898|26000216|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
13136814|NCT02718898|26000217|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
13136815|NCT02718898|26000218|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
13136816|NCT02718898|26000219|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2|||
13136817|NCT02718898|26000220|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
13136818|NCT02718898|26000221|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
13136819|NCT02718898|26000222|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
13136820|NCT02718898|26000216|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
13136821|NCT02718898|26000217|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
13136822|NCT02718898|26000218|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
13136823|NCT02718898|26000219|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3|||
13136824|NCT02718898|26000220|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
13136825|NCT02718898|26000221|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
13136826|NCT02718898|26000222|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
13136827|NCT02718898|26000216|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
13136828|NCT02718898|26000217|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
13136829|NCT02718898|26000218|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1|||
13136830|NCT02718898|26000219|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2|||
13136831|NCT02718898|26000220|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
13136832|NCT02718898|26000221|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
13136833|NCT02718898|26000222|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
13136834|NCT02718898|26000216|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
13136835|NCT02718898|26000217|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
13136836|NCT02718898|26000218|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
13136837|NCT02718898|26000219|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1|||
13136838|NCT02718898|26000220|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
13136839|NCT02718898|26000221|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
13136840|NCT02718898|26000222|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
13136841|NCT02718898|26000216|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
13136842|NCT02718898|26000217|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
13136843|NCT02718898|26000218|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
13136844|NCT02718898|26000219|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1|||
13136845|NCT02718898|26000220|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
13136846|NCT02718898|26000221|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
13136847|NCT02718898|26000222|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
13136848|NCT02718898|26000216|FG000|Post Treatment Follow-up Period|Adverse Event|0|||
13136849|NCT02718898|26000217|FG001|Post Treatment Follow-up Period|Adverse Event|0|||
13136850|NCT02718898|26000218|FG002|Post Treatment Follow-up Period|Adverse Event|0|||
13136851|NCT02718898|26000219|FG003|Post Treatment Follow-up Period|Adverse Event|0|||
13136852|NCT02718898|26000220|FG004|Post Treatment Follow-up Period|Adverse Event|0|||
13136853|NCT02718898|26000221|FG005|Post Treatment Follow-up Period|Adverse Event|1|||
13136854|NCT02718898|26000222|FG006|Post Treatment Follow-up Period|Adverse Event|1|||
13136855|NCT02718898|26000216|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0|||
13136856|NCT02718898|26000217|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0|||
13136857|NCT02718898|26000218|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0|||
13136858|NCT02718898|26000219|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0|||
13136859|NCT02718898|26000220|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1|||
13136860|NCT02718898|26000221|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5|||
13136861|NCT02718898|26000222|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1|||
13136862|NCT02718898|26000216|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
13136863|NCT02718898|26000217|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
13136864|NCT02718898|26000218|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
13136865|NCT02718898|26000219|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
13136866|NCT02718898|26000220|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
13136867|NCT02718898|26000221|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5|||
13136868|NCT02718898|26000222|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3|||
13136869|NCT02718625|26000245|FG000|Overall Study|Adverse Event|0|||
13136870|NCT02718625|26000246|FG001|Overall Study|Adverse Event|1|||
13136871|NCT02718625|26000245|FG000|Overall Study|Termination of Study by Sponsor|0|||
13136872|NCT02718625|26000246|FG001|Overall Study|Termination of Study by Sponsor|1|||
13136873|NCT02718417|26000359|FG000|Chemotherapy Phase (CP)|Adverse Event|9|||
13136874|NCT02718417|26000360|FG001|Chemotherapy Phase (CP)|Adverse Event|14|||
13136875|NCT02718417|26000361|FG002|Chemotherapy Phase (CP)|Adverse Event|13|||
13136876|NCT02718417|26000359|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5|||
13136877|NCT02718417|26000360|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4|||
13136878|NCT02718417|26000361|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1|||
13136879|NCT02718417|26000359|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3|||
13136880|NCT02718417|26000360|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2|||
13136881|NCT02718417|26000361|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1|||
13136882|NCT02718417|26000359|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4|||
13136883|NCT02718417|26000360|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2|||
13136884|NCT02718417|26000361|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1|||
13136885|NCT02718417|26000359|FG000|Chemotherapy Phase (CP)|Physician's decision|5|||
13136886|NCT02718417|26000360|FG001|Chemotherapy Phase (CP)|Physician's decision|0|||
13136887|NCT02718417|26000361|FG002|Chemotherapy Phase (CP)|Physician's decision|4|||
13136888|NCT02718417|26000359|FG000|Chemotherapy Phase (CP)|Progressive disease|11|||
13136889|NCT02718417|26000360|FG001|Chemotherapy Phase (CP)|Progressive disease|7|||
13136890|NCT02718417|26000361|FG002|Chemotherapy Phase (CP)|Progressive disease|10|||
13136891|NCT02718417|26000359|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13|||
13136892|NCT02718417|26000360|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8|||
13136893|NCT02718417|26000361|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15|||
13136894|NCT02718417|26000359|FG000|Chemotherapy Phase (CP)|Other|2|||
13136895|NCT02718417|26000360|FG001|Chemotherapy Phase (CP)|Other|0|||
13136896|NCT02718417|26000361|FG002|Chemotherapy Phase (CP)|Other|1|||
13136897|NCT02718417|26000359|FG000|Maintenance Phase (MP)|Adverse Event|21|||
13136898|NCT02718417|26000360|FG001|Maintenance Phase (MP)|Adverse Event|26|||
13136899|NCT02718417|26000361|FG002|Maintenance Phase (MP)|Adverse Event|0|||
13136900|NCT02718417|26000359|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1|||
13136901|NCT02718417|26000360|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1|||
13136902|NCT02718417|26000361|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0|||
13136903|NCT02718417|26000359|FG000|Maintenance Phase (MP)|Global deterioration of health status|5|||
13136904|NCT02718417|26000360|FG001|Maintenance Phase (MP)|Global deterioration of health status|3|||
13136905|NCT02718417|26000361|FG002|Maintenance Phase (MP)|Global deterioration of health status|0|||
13136906|NCT02718417|26000359|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
13136907|NCT02718417|26000360|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1|||
13136908|NCT02718417|26000361|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
13136909|NCT02718417|26000359|FG000|Maintenance Phase (MP)|Physician's decision|6|||
13136910|NCT02718417|26000360|FG001|Maintenance Phase (MP)|Physician's decision|7|||
13136911|NCT02718417|26000361|FG002|Maintenance Phase (MP)|Physician's decision|0|||
13136912|NCT02718417|26000359|FG000|Maintenance Phase (MP)|Progressive disease|100|||
13136913|NCT02718417|26000360|FG001|Maintenance Phase (MP)|Progressive disease|88|||
13136914|NCT02718417|26000361|FG002|Maintenance Phase (MP)|Progressive disease|0|||
13136915|NCT02718417|26000359|FG000|Maintenance Phase (MP)|Other|2|||
13136916|NCT02718417|26000360|FG001|Maintenance Phase (MP)|Other|1|||
13136917|NCT02718417|26000361|FG002|Maintenance Phase (MP)|Other|0|||
13136918|NCT02718417|26000359|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17|||
13136919|NCT02718417|26000360|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20|||
13136920|NCT02718417|26000361|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0|||
13136921|NCT02718417|26000359|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114|||
13136922|NCT02718417|26000360|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140|||
13136923|NCT02718417|26000361|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0|||
13136924|NCT02718417|26000359|FG000|Observation Phase (OP)|Adverse Event|0|||
13136925|NCT02718417|26000360|FG001|Observation Phase (OP)|Adverse Event|0|||
13136926|NCT02718417|26000361|FG002|Observation Phase (OP)|Adverse Event|1|||
13136927|NCT02718417|26000359|FG000|Observation Phase (OP)|Death leading to discontinuation|0|||
13136928|NCT02718417|26000360|FG001|Observation Phase (OP)|Death leading to discontinuation|0|||
13136929|NCT02718417|26000361|FG002|Observation Phase (OP)|Death leading to discontinuation|2|||
13136930|NCT02718417|26000359|FG000|Observation Phase (OP)|Lost to Follow-up|0|||
13136931|NCT02718417|26000360|FG001|Observation Phase (OP)|Lost to Follow-up|0|||
13136932|NCT02718417|26000361|FG002|Observation Phase (OP)|Lost to Follow-up|1|||
13136933|NCT02718417|26000359|FG000|Observation Phase (OP)|Physician Decision|0|||
13136934|NCT02718417|26000360|FG001|Observation Phase (OP)|Physician Decision|0|||
13136935|NCT02718417|26000361|FG002|Observation Phase (OP)|Physician Decision|9|||
13136936|NCT02718417|26000359|FG000|Observation Phase (OP)|Progressive disease|0|||
13136937|NCT02718417|26000360|FG001|Observation Phase (OP)|Progressive disease|0|||
13136938|NCT02718417|26000361|FG002|Observation Phase (OP)|Progressive disease|92|||
13136939|NCT02718417|26000359|FG000|Observation Phase (OP)|Study terminated by sponsor|0|||
13136940|NCT02718417|26000360|FG001|Observation Phase (OP)|Study terminated by sponsor|0|||
13136941|NCT02718417|26000361|FG002|Observation Phase (OP)|Study terminated by sponsor|135|||
13136942|NCT02718417|26000359|FG000|Observation Phase (OP)|Withdrawal by Subject|0|||
13136943|NCT02718417|26000360|FG001|Observation Phase (OP)|Withdrawal by Subject|0|||
13136944|NCT02718417|26000361|FG002|Observation Phase (OP)|Withdrawal by Subject|34|||
13136945|NCT02718417|26000359|FG000|Observation Phase (OP)|Global deterioration of health status|0|||
13136946|NCT02718417|26000360|FG001|Observation Phase (OP)|Global deterioration of health status|0|||
13136947|NCT02718417|26000361|FG002|Observation Phase (OP)|Global deterioration of health status|1|||
13136948|NCT02718417|26000359|FG000|Observation Phase (OP)|Other|0|||
13136949|NCT02718417|26000360|FG001|Observation Phase (OP)|Other|0|||
13136950|NCT02718417|26000361|FG002|Observation Phase (OP)|Other|7|||
13136951|NCT02718417|26000359|FG000|Follow-up Phase|Adverse Event|3|||
13136952|NCT02718417|26000360|FG001|Follow-up Phase|Adverse Event|1|||
13136953|NCT02718417|26000361|FG002|Follow-up Phase|Adverse Event|1|||
13136954|NCT02718417|26000359|FG000|Follow-up Phase|Other|4|||
13136955|NCT02718417|26000360|FG001|Follow-up Phase|Other|6|||
13136956|NCT02718417|26000361|FG002|Follow-up Phase|Other|4|||
13136957|NCT02718417|26000359|FG000|Follow-up Phase|Withdrawal by Subject|19|||
13136958|NCT02718417|26000360|FG001|Follow-up Phase|Withdrawal by Subject|17|||
13136959|NCT02718417|26000361|FG002|Follow-up Phase|Withdrawal by Subject|5|||
13136960|NCT02718417|26000359|FG000|Follow-up Phase|Study terminated by sponsor|100|||
13136961|NCT02718417|26000360|FG001|Follow-up Phase|Study terminated by sponsor|138|||
13136962|NCT02718417|26000361|FG002|Follow-up Phase|Study terminated by sponsor|6|||
13136963|NCT02718417|26000359|FG000|Follow-up Phase|Lost to Follow-up|2|||
13136964|NCT02718417|26000360|FG001|Follow-up Phase|Lost to Follow-up|3|||
13136965|NCT02718417|26000361|FG002|Follow-up Phase|Lost to Follow-up|0|||
13136966|NCT02718417|26000359|FG000|Follow-up Phase|Death leading to discontinuation|7|||
13136967|NCT02718417|26000360|FG001|Follow-up Phase|Death leading to discontinuation|7|||
13136968|NCT02718417|26000361|FG002|Follow-up Phase|Death leading to discontinuation|3|||
13136969|NCT02718417|26000359|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20|||
13136970|NCT02718417|26000360|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17|||
13136971|NCT02718417|26000361|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11|||
13136972|NCT02718417|26000359|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
13136973|NCT02718417|26000360|FG001|Long-term Follow-up Phase|Lost to Follow-up|4|||
13136974|NCT02718417|26000361|FG002|Long-term Follow-up Phase|Lost to Follow-up|3|||
13136975|NCT02718417|26000359|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105|||
13136976|NCT02718417|26000360|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80|||
13136977|NCT02718417|26000361|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112|||
13136978|NCT02718417|26000359|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6|||
13136979|NCT02718417|26000360|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9|||
13136980|NCT02718417|26000361|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9|||
13136981|NCT02718417|26000359|FG000|Long-term Follow-up Phase|Other|0|||
13136982|NCT02718417|26000360|FG001|Long-term Follow-up Phase|Other|2|||
13136983|NCT02718417|26000361|FG002|Long-term Follow-up Phase|Other|0|||
13136984|NCT02718326|26000402|FG000|Overall Study|Adverse Event|4|||
13136985|NCT02718326|26000403|FG001|Overall Study|Adverse Event|9|||
13136986|NCT02718326|26000404|FG002|Overall Study|Adverse Event|0|||
13136987|NCT02718326|26000402|FG000|Overall Study|Death|8|||
13136988|NCT02718326|26000403|FG001|Overall Study|Death|1|||
13136989|NCT02718326|26000404|FG002|Overall Study|Death|2|||
13136990|NCT02718326|26000402|FG000|Overall Study|Withdrawal by Subject|4|||
13136991|NCT02718326|26000403|FG001|Overall Study|Withdrawal by Subject|9|||
13136992|NCT02718326|26000404|FG002|Overall Study|Withdrawal by Subject|6|||
13136993|NCT02718326|26000402|FG000|Overall Study|Lost to Follow-up|18|||
13136994|NCT02718326|26000403|FG001|Overall Study|Lost to Follow-up|5|||
13136995|NCT02718326|26000404|FG002|Overall Study|Lost to Follow-up|14|||
13136996|NCT02718326|26000402|FG000|Overall Study|Protocol Deviation|1|||
13136997|NCT02718326|26000403|FG001|Overall Study|Protocol Deviation|0|||
13136998|NCT02718326|26000404|FG002|Overall Study|Protocol Deviation|0|||
13136999|NCT02718326|26000402|FG000|Overall Study|Pregnancy|1|||
13137000|NCT02718326|26000403|FG001|Overall Study|Pregnancy|0|||
13137001|NCT02718326|26000404|FG002|Overall Study|Pregnancy|0|||
13137002|NCT02718131|26000439|FG000|Overall Study|Withdrawal by Subject|1|||
13137003|NCT02718131|26000440|FG001|Overall Study|Withdrawal by Subject|0|||
13137004|NCT02718131|26000439|FG000|Overall Study|Adverse Event|1|||
13137005|NCT02718131|26000440|FG001|Overall Study|Adverse Event|0|||
13137006|NCT02718131|26000439|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1|||
13137007|NCT02718131|26000440|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0|||
13137008|NCT02717832|26000449|FG000|Overall Study|Inability to place IV|3|||
13137009|NCT02717754|26000496|FG000|Overall Study|Incorrect Infusion Duration|0|||
13137010|NCT02717754|26000497|FG001|Overall Study|Incorrect Infusion Duration|0|||
13137011|NCT02717754|26000498|FG002|Overall Study|Incorrect Infusion Duration|0|||
13137012|NCT02717754|26000499|FG003|Overall Study|Incorrect Infusion Duration|10|||
13137013|NCT02717754|26000500|FG004|Overall Study|Incorrect Infusion Duration|20|||
13137014|NCT02717754|26000501|FG005|Overall Study|Incorrect Infusion Duration|20|||
13137015|NCT02717546|26000515|FG000|Overall Study|Lost to Follow-up|12|||
13137016|NCT02717494|26000562|FG000|First Intervention (Step 1)|Lost to Follow-up|4|||
13137017|NCT02717494|26000563|FG001|First Intervention (Step 1)|Lost to Follow-up|7|||
13137018|NCT02717494|26000564|FG002|First Intervention (Step 1)|Lost to Follow-up|3|||
13137019|NCT02717494|26000562|FG000|First Intervention (Step 1)|Withdrawal by Subject|2|||
13137020|NCT02717494|26000563|FG001|First Intervention (Step 1)|Withdrawal by Subject|0|||
13137021|NCT02717494|26000564|FG002|First Intervention (Step 1)|Withdrawal by Subject|1|||
13137022|NCT02717494|26000562|FG000|First Intervention (Step 1)|Death|0|||
13137023|NCT02717494|26000563|FG001|First Intervention (Step 1)|Death|0|||
13137024|NCT02717494|26000564|FG002|First Intervention (Step 1)|Death|1|||
13137025|NCT02717494|26000562|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
13137026|NCT02717494|26000563|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
13137027|NCT02717494|26000564|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4|||
13137028|NCT02717195|26000609|FG000|Prospective Confirmation (PC) Period|Adverse Event|19|||
13137029|NCT02717195|26000610|FG001|Prospective Confirmation (PC) Period|Adverse Event|7|||
13137030|NCT02717195|26000611|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
13137031|NCT02717195|26000612|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
13137032|NCT02717195|26000613|FG004|Prospective Confirmation (PC) Period|Adverse Event|0|||
13137033|NCT02717195|26000609|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
13137034|NCT02717195|26000610|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1|||
13137035|NCT02717195|26000611|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
13137036|NCT02717195|26000612|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
13137037|NCT02717195|26000613|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
13137038|NCT02717195|26000609|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7|||
13137039|NCT02717195|26000610|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1|||
13137040|NCT02717195|26000611|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
13137041|NCT02717195|26000612|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
13137042|NCT02717195|26000613|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
13137043|NCT02717195|26000609|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3|||
13137044|NCT02717195|26000610|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1|||
13137045|NCT02717195|26000611|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
13137046|NCT02717195|26000612|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
13137047|NCT02717195|26000613|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0|||
13137048|NCT02717195|26000609|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43|||
13137049|NCT02717195|26000610|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12|||
13137050|NCT02717195|26000611|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
13137051|NCT02717195|26000612|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
13137052|NCT02717195|26000613|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
13137053|NCT02717195|26000609|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9|||
13137054|NCT02717195|26000610|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4|||
13137055|NCT02717195|26000611|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
13137056|NCT02717195|26000612|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
13137057|NCT02717195|26000613|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
13137058|NCT02717195|26000609|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189|||
13137059|NCT02717195|26000610|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75|||
13137060|NCT02717195|26000611|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
13137061|NCT02717195|26000612|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
13137062|NCT02717195|26000613|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
13137063|NCT02717195|26000609|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
13137064|NCT02717195|26000610|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
13137065|NCT02717195|26000611|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
13137066|NCT02717195|26000612|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
13137067|NCT02717195|26000613|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
13137068|NCT02717195|26000609|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1|||
13137069|NCT02717195|26000610|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
13137070|NCT02717195|26000611|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
13137071|NCT02717195|26000612|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
13137072|NCT02717195|26000613|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
13137073|NCT02717195|26000609|FG000|Prospective Confirmation (PC) Period|Technical error|1|||
13137074|NCT02717195|26000610|FG001|Prospective Confirmation (PC) Period|Technical error|0|||
13137075|NCT02717195|26000611|FG002|Prospective Confirmation (PC) Period|Technical error|0|||
13137076|NCT02717195|26000612|FG003|Prospective Confirmation (PC) Period|Technical error|0|||
13137077|NCT02717195|26000613|FG004|Prospective Confirmation (PC) Period|Technical error|0|||
13137078|NCT02717195|26000609|FG000|Prospective Confirmation (PC) Period|Patient decision|5|||
13137079|NCT02717195|26000610|FG001|Prospective Confirmation (PC) Period|Patient decision|2|||
13137080|NCT02717195|26000611|FG002|Prospective Confirmation (PC) Period|Patient decision|0|||
13137081|NCT02717195|26000612|FG003|Prospective Confirmation (PC) Period|Patient decision|0|||
13137082|NCT02717195|26000613|FG004|Prospective Confirmation (PC) Period|Patient decision|0|||
13137083|NCT02717195|26000609|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1|||
13137084|NCT02717195|26000610|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
13137085|NCT02717195|26000611|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
13137086|NCT02717195|26000612|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
13137087|NCT02717195|26000613|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
13137088|NCT02717195|26000609|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1|||
13137089|NCT02717195|26000610|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0|||
13137090|NCT02717195|26000611|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0|||
13137091|NCT02717195|26000612|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0|||
13137092|NCT02717195|26000613|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0|||
13137093|NCT02717195|26000609|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
13137094|NCT02717195|26000610|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1|||
13137095|NCT02717195|26000611|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
13137096|NCT02717195|26000612|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
13137097|NCT02717195|26000613|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
13137098|NCT02717195|26000609|FG000|Prospective Confirmation (PC) Period|Investigator decision|2|||
13137099|NCT02717195|26000610|FG001|Prospective Confirmation (PC) Period|Investigator decision|1|||
13137100|NCT02717195|26000611|FG002|Prospective Confirmation (PC) Period|Investigator decision|0|||
13137101|NCT02717195|26000612|FG003|Prospective Confirmation (PC) Period|Investigator decision|0|||
13137102|NCT02717195|26000613|FG004|Prospective Confirmation (PC) Period|Investigator decision|0|||
13137103|NCT02717195|26000609|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
13137104|NCT02717195|26000610|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1|||
13137105|NCT02717195|26000611|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
13137106|NCT02717195|26000612|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
13137107|NCT02717195|26000613|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
13137108|NCT02717195|26000609|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1|||
13137109|NCT02717195|26000610|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
13137110|NCT02717195|26000611|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
13137111|NCT02717195|26000612|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
13137112|NCT02717195|26000613|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
13137113|NCT02717195|26000609|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
13137114|NCT02717195|26000610|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1|||
13137115|NCT02717195|26000611|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
13137116|NCT02717195|26000612|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
13137117|NCT02717195|26000613|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
13137118|NCT02717195|26000609|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1|||
13137119|NCT02717195|26000610|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0|||
13090983|NCT03762265|25822125|FG001|OLE Period: Weeks 37 to 61|Withdrawal by Subject|2|||
13090984|NCT03762265|25822124|FG000|LTE Period: Weeks 61 to 109|Lack of Efficacy|0|||
13090985|NCT03762265|25822125|FG001|LTE Period: Weeks 61 to 109|Lack of Efficacy|1|||
13090986|NCT03762265|25822124|FG000|LTE Period: Weeks 61 to 109|Study terminated by sponsor|28|||
13090987|NCT03762265|25822125|FG001|LTE Period: Weeks 61 to 109|Study terminated by sponsor|25|||
13090988|NCT03762265|25822124|FG000|LTE Period: Weeks 61 to 109|Withdrawal by Subject|0|||
13090989|NCT03762265|25822125|FG001|LTE Period: Weeks 61 to 109|Withdrawal by Subject|2|||
13090990|NCT03762265|25822124|FG000|LTE Period: Weeks 61 to 109|Other|1|||
13137120|NCT02717195|26000611|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0|||
13137121|NCT02717195|26000612|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0|||
13137122|NCT02717195|26000613|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0|||
13137123|NCT02717195|26000609|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0|||
13137124|NCT02717195|26000610|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1|||
13137125|NCT02717195|26000611|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0|||
13137126|NCT02717195|26000612|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0|||
13137127|NCT02717195|26000613|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0|||
13137128|NCT02717195|26000609|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1|||
13137129|NCT02717195|26000610|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
13137130|NCT02717195|26000611|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
13137131|NCT02717195|26000612|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
13137132|NCT02717195|26000613|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
13137133|NCT02717195|26000609|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1|||
13137134|NCT02717195|26000610|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
13137135|NCT02717195|26000611|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
13137136|NCT02717195|26000612|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
13137137|NCT02717195|26000613|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
13137138|NCT02717195|26000609|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0|||
13137139|NCT02717195|26000610|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0|||
13137140|NCT02717195|26000611|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10|||
13137141|NCT02717195|26000612|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11|||
13137142|NCT02717195|26000613|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8|||
13137143|NCT02717195|26000609|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
13137144|NCT02717195|26000610|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
13137145|NCT02717195|26000611|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6|||
13137146|NCT02717195|26000612|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9|||
13137147|NCT02717195|26000613|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2|||
13137148|NCT02717195|26000609|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
13137149|NCT02717195|26000610|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
13137150|NCT02717195|26000611|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4|||
13137151|NCT02717195|26000612|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3|||
13137152|NCT02717195|26000613|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2|||
13137153|NCT02717195|26000609|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
13137154|NCT02717195|26000610|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
13137155|NCT02717195|26000611|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
13137156|NCT02717195|26000612|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
13137157|NCT02717195|26000613|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
13137158|NCT02717195|26000609|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
13137159|NCT02717195|26000610|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
13137160|NCT02717195|26000611|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14|||
13137161|NCT02717195|26000612|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13|||
13137162|NCT02717195|26000613|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8|||
13137163|NCT02717195|26000609|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
13137164|NCT02717195|26000610|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
13137165|NCT02717195|26000611|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
13137166|NCT02717195|26000612|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3|||
13137167|NCT02717195|26000613|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2|||
13137168|NCT02717195|26000609|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
13137169|NCT02717195|26000610|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
13137170|NCT02717195|26000611|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1|||
13137171|NCT02717195|26000612|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
13137172|NCT02717195|26000613|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
13137173|NCT02717195|26000609|FG000|Double-blind Treatment (DBT) Period|Patient decision|0|||
13137174|NCT02717195|26000610|FG001|Double-blind Treatment (DBT) Period|Patient decision|0|||
13137175|NCT02717195|26000611|FG002|Double-blind Treatment (DBT) Period|Patient decision|0|||
13137176|NCT02717195|26000612|FG003|Double-blind Treatment (DBT) Period|Patient decision|2|||
13137177|NCT02717195|26000613|FG004|Double-blind Treatment (DBT) Period|Patient decision|2|||
13137178|NCT02717195|26000609|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0|||
13137179|NCT02717195|26000610|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0|||
13137180|NCT02717195|26000611|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0|||
13137181|NCT02717195|26000612|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1|||
13137182|NCT02717195|26000613|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1|||
13222524|NCT01806597|26286266|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
13393351|NCT00665925|26783414|FG003|Overall Study|Enrolled by mistake|1|||
13137183|NCT02717195|26000609|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0|||
13137184|NCT02717195|26000610|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0|||
13137185|NCT02717195|26000611|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0|||
13137186|NCT02717195|26000612|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0|||
13137187|NCT02717195|26000613|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1|||
13137188|NCT02717195|26000609|FG000|Double-blind Treatment (DBT) Period|Change of residence|0|||
13137189|NCT02717195|26000610|FG001|Double-blind Treatment (DBT) Period|Change of residence|0|||
13137190|NCT02717195|26000611|FG002|Double-blind Treatment (DBT) Period|Change of residence|0|||
13137191|NCT02717195|26000612|FG003|Double-blind Treatment (DBT) Period|Change of residence|1|||
13137192|NCT02717195|26000613|FG004|Double-blind Treatment (DBT) Period|Change of residence|1|||
13137193|NCT02717195|26000609|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
13137194|NCT02717195|26000610|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
13137195|NCT02717195|26000611|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
13137196|NCT02717195|26000612|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
13137197|NCT02717195|26000613|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1|||
13137198|NCT02717195|26000609|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
13137199|NCT02717195|26000610|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
13137200|NCT02717195|26000611|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1|||
13137201|NCT02717195|26000612|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
13137202|NCT02717195|26000613|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
13137203|NCT02717195|26000609|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
13137204|NCT02717195|26000610|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
13137205|NCT02717195|26000611|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
13137206|NCT02717195|26000612|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
13137207|NCT02717195|26000613|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
13137208|NCT02717130|26000619|FG000|Overall Study|Withdrawal by Subject|1|||
13137209|NCT02717130|26000619|FG000|Overall Study|Adverse Event|1|||
13137210|NCT02717130|26000619|FG000|Overall Study|Physician Decision|1|||
13137211|NCT02717130|26000619|FG000|Overall Study|Study Closure|4|||
13137212|NCT02716987|26000702|FG000|Overall Study|Ligand synthesis failure|0|||
13137213|NCT02716987|26000703|FG001|Overall Study|Ligand synthesis failure|0|||
13137214|NCT02716987|26000704|FG002|Overall Study|Ligand synthesis failure|1|||
13137215|NCT02716987|26000705|FG003|Overall Study|Ligand synthesis failure|0|||
13137216|NCT02716987|26000706|FG004|Overall Study|Ligand synthesis failure|0|||
13137217|NCT02716987|26000707|FG005|Overall Study|Ligand synthesis failure|0|||
13137218|NCT02716987|26000702|FG000|Overall Study|Withdrawal by Subject|0|||
13137219|NCT02716987|26000703|FG001|Overall Study|Withdrawal by Subject|0|||
13137220|NCT02716987|26000704|FG002|Overall Study|Withdrawal by Subject|0|||
13137221|NCT02716987|26000705|FG003|Overall Study|Withdrawal by Subject|0|||
13137222|NCT02716987|26000706|FG004|Overall Study|Withdrawal by Subject|1|||
13137223|NCT02716987|26000707|FG005|Overall Study|Withdrawal by Subject|1|||
13137224|NCT02716896|26000732|FG000|Overall Study|Physician Decision|0|||
13137225|NCT02716896|26000733|FG001|Overall Study|Physician Decision|1|||
13137226|NCT02716779|26000787|FG000|Monotherapy|Adverse Event|0|||
13137227|NCT02716779|26000788|FG001|Monotherapy|Adverse Event|1|||
13137228|NCT02716779|26000789|FG002|Monotherapy|Adverse Event|1|||
13137229|NCT02716779|26000787|FG000|Combination Therapy|Adverse Event|0|||
13137230|NCT02716779|26000788|FG001|Combination Therapy|Adverse Event|2|||
13137231|NCT02716779|26000789|FG002|Combination Therapy|Adverse Event|1|||
13137232|NCT02716584|26000820|FG000|Overall Study|Lost to Follow-up|8|||
13137233|NCT02716584|26000821|FG001|Overall Study|Lost to Follow-up|5|||
13137234|NCT02716298|26000839|FG000|First Intervention (1 Month)|Lens discomfort|1|||
13137235|NCT02716298|26000840|FG001|First Intervention (1 Month)|Lens discomfort|1|||
13137236|NCT02716194|26000928|FG000|Period 1 - ADVATE|Withdrawal by Subject|1|||
13137237|NCT02716194|26000929|FG001|Period 1 - ADVATE|Withdrawal by Subject|1|||
13137238|NCT02716194|26000930|FG002|Period 1 - ADVATE|Withdrawal by Subject|0|||
13137239|NCT02715804|26000957|FG000|Overall Study|Death|222|||
13137240|NCT02715804|26000958|FG001|Overall Study|Death|106|||
13137241|NCT02715804|26000957|FG000|Overall Study|Withdrawal by Subject|5|||
13137242|NCT02715804|26000958|FG001|Overall Study|Withdrawal by Subject|4|||
13137243|NCT02715804|26000957|FG000|Overall Study|Other than specified|2|||
13137244|NCT02715804|26000958|FG001|Overall Study|Other than specified|3|||
13137245|NCT02715765|26000979|FG000|Overall Study|Study Termination|3|||
13137246|NCT02715765|26000980|FG001|Overall Study|Study Termination|0|||
13137247|NCT02715765|26000981|FG002|Overall Study|Study Termination|0|||
13137248|NCT02715726|26001036|FG000|Overall Study|Adverse Event|2|||
13137249|NCT02715726|26001037|FG001|Overall Study|Adverse Event|6|||
13137250|NCT02715726|26001036|FG000|Overall Study|Protocol Violation|1|||
13137251|NCT02715726|26001037|FG001|Overall Study|Protocol Violation|0|||
13137252|NCT02715726|26001036|FG000|Overall Study|Death|2|||
13137253|NCT02715726|26001037|FG001|Overall Study|Death|1|||
13137254|NCT02715726|26001036|FG000|Overall Study|Participant moved|1|||
13137255|NCT02715726|26001037|FG001|Overall Study|Participant moved|3|||
13137256|NCT02715726|26001036|FG000|Overall Study|Other than specified above|11|||
13137257|NCT02715726|26001037|FG001|Overall Study|Other than specified above|15|||
13137258|NCT02715726|26001036|FG000|Overall Study|Randomized but not treated|1|||
13137259|NCT02715726|26001037|FG001|Overall Study|Randomized but not treated|2|||
13137260|NCT02715258|26001060|FG000|Overall Study|Withdrawal by Subject|6|||
13137261|NCT02715258|26001061|FG001|Overall Study|Withdrawal by Subject|1|||
13137262|NCT02715258|26001060|FG000|Overall Study|Lost to Follow-up|7|||
13137263|NCT02715258|26001061|FG001|Overall Study|Lost to Follow-up|1|||
13137264|NCT02715258|26001060|FG000|Overall Study|Terminated by Sponsor|0|||
13137265|NCT02715258|26001061|FG001|Overall Study|Terminated by Sponsor|1|||
13137266|NCT02715258|26001060|FG000|Overall Study|Death|0|||
13137267|NCT02715258|26001061|FG001|Overall Study|Death|1|||
13137268|NCT02715258|26001060|FG000|Overall Study|Subject non-compliant|1|||
13137269|NCT02715258|26001061|FG001|Overall Study|Subject non-compliant|1|||
13137270|NCT02715258|26001060|FG000|Overall Study|GCP violation|2|||
13137271|NCT02715258|26001061|FG001|Overall Study|GCP violation|1|||
13137272|NCT02714868|26001084|FG000|Overall Study|Withdrawal by Subject|3|||
13137273|NCT02714868|26001085|FG001|Overall Study|Withdrawal by Subject|0|||
13137274|NCT02714868|26001084|FG000|Overall Study|PI withdrawal safety risk self/others|1|||
13137275|NCT02714868|26001085|FG001|Overall Study|PI withdrawal safety risk self/others|0|||
13137276|NCT02714868|26001084|FG000|Overall Study|PI withdraw did not meet inclusion|1|||
13137277|NCT02714868|26001085|FG001|Overall Study|PI withdraw did not meet inclusion|0|||
13137278|NCT02714595|26001338|FG000|Overall Study|Lost to Follow-up|1|||
13137279|NCT02714595|26001339|FG001|Overall Study|Lost to Follow-up|0|||
13137280|NCT02714595|26001338|FG000|Overall Study|Withdrawal by Subject|1|||
13137281|NCT02714595|26001339|FG001|Overall Study|Withdrawal by Subject|2|||
13137282|NCT02714595|26001338|FG000|Overall Study|Lack of Efficacy|0|||
13137283|NCT02714595|26001339|FG001|Overall Study|Lack of Efficacy|1|||
13137284|NCT02714595|26001338|FG000|Overall Study|Death|30|||
13137285|NCT02714595|26001339|FG001|Overall Study|Death|9|||
13137286|NCT02714595|26001338|FG000|Overall Study|Other-Miscellaneous|0|||
13137287|NCT02714595|26001339|FG001|Overall Study|Other-Miscellaneous|1|||
13137288|NCT02714569|26001496|FG000|Part A Second Intervention|Withdrawal by Subject|0|||
13137289|NCT02714569|26001497|FG001|Part A Second Intervention|Withdrawal by Subject|1|||
13137290|NCT02714569|26001498|FG002|Part A Second Intervention|Withdrawal by Subject|0|||
13137291|NCT02714569|26001499|FG003|Part A Second Intervention|Withdrawal by Subject|0|||
13137292|NCT02714569|26001500|FG004|Part A Second Intervention|Withdrawal by Subject|0|||
13137293|NCT02714569|26001501|FG005|Part A Second Intervention|Withdrawal by Subject|0|||
13137294|NCT02714569|26001502|FG006|Part A Second Intervention|Withdrawal by Subject|0|||
13137295|NCT02714569|26001503|FG007|Part A Second Intervention|Withdrawal by Subject|0|||
13137296|NCT02714569|26001504|FG008|Part A Second Intervention|Withdrawal by Subject|0|||
13137297|NCT02714569|26001505|FG009|Part A Second Intervention|Withdrawal by Subject|0|||
13137298|NCT02714569|26001506|FG010|Part A Second Intervention|Withdrawal by Subject|0|||
13137299|NCT02714569|26001496|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
13137300|NCT02714569|26001497|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
13137301|NCT02714569|26001498|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
13137302|NCT02714569|26001499|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1|||
13137303|NCT02714569|26001500|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
13137304|NCT02714569|26001501|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
13137305|NCT02714569|26001502|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
13137306|NCT02714569|26001503|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
13137307|NCT02714569|26001504|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
13137308|NCT02714569|26001505|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
13137309|NCT02714569|26001506|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
13137310|NCT02714569|26001496|FG000|Part A Third Intervention|Adverse Event|0|||
13137311|NCT02714569|26001497|FG001|Part A Third Intervention|Adverse Event|0|||
13137312|NCT02714569|26001498|FG002|Part A Third Intervention|Adverse Event|1|||
13137313|NCT02714569|26001499|FG003|Part A Third Intervention|Adverse Event|0|||
13137314|NCT02714569|26001500|FG004|Part A Third Intervention|Adverse Event|0|||
13137315|NCT02714569|26001501|FG005|Part A Third Intervention|Adverse Event|0|||
13137316|NCT02714569|26001502|FG006|Part A Third Intervention|Adverse Event|0|||
13137317|NCT02714569|26001503|FG007|Part A Third Intervention|Adverse Event|0|||
13137318|NCT02714569|26001504|FG008|Part A Third Intervention|Adverse Event|0|||
13137319|NCT02714569|26001505|FG009|Part A Third Intervention|Adverse Event|0|||
13137320|NCT02714569|26001506|FG010|Part A Third Intervention|Adverse Event|0|||
13137321|NCT02714569|26001496|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
13137322|NCT02714569|26001497|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
13137323|NCT02714569|26001498|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
13137324|NCT02714569|26001499|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
13137325|NCT02714569|26001500|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
13137326|NCT02714569|26001501|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
13137327|NCT02714569|26001502|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
13137328|NCT02714569|26001503|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
13137329|NCT02714569|26001504|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
13137330|NCT02714569|26001505|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
13137331|NCT02714569|26001506|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
13137332|NCT02714569|26001496|FG000|Part B (Overall)|Lost to Follow-up|0|||
13137333|NCT02714569|26001497|FG001|Part B (Overall)|Lost to Follow-up|0|||
13137334|NCT02714569|26001498|FG002|Part B (Overall)|Lost to Follow-up|0|||
13137335|NCT02714569|26001499|FG003|Part B (Overall)|Lost to Follow-up|0|||
13137336|NCT02714569|26001500|FG004|Part B (Overall)|Lost to Follow-up|0|||
13137337|NCT02714569|26001501|FG005|Part B (Overall)|Lost to Follow-up|0|||
13137338|NCT02714569|26001502|FG006|Part B (Overall)|Lost to Follow-up|1|||
13137339|NCT02714569|26001503|FG007|Part B (Overall)|Lost to Follow-up|0|||
13137340|NCT02714569|26001504|FG008|Part B (Overall)|Lost to Follow-up|0|||
13137341|NCT02714569|26001505|FG009|Part B (Overall)|Lost to Follow-up|0|||
13137342|NCT02714569|26001506|FG010|Part B (Overall)|Lost to Follow-up|0|||
13137343|NCT02714569|26001496|FG000|Part B (Overall)|Withdrawal by Subject|0|||
13137344|NCT02714569|26001497|FG001|Part B (Overall)|Withdrawal by Subject|0|||
13137345|NCT02714569|26001498|FG002|Part B (Overall)|Withdrawal by Subject|0|||
13137346|NCT02714569|26001499|FG003|Part B (Overall)|Withdrawal by Subject|0|||
13137347|NCT02714569|26001500|FG004|Part B (Overall)|Withdrawal by Subject|0|||
13137348|NCT02714569|26001501|FG005|Part B (Overall)|Withdrawal by Subject|0|||
13137349|NCT02714569|26001502|FG006|Part B (Overall)|Withdrawal by Subject|0|||
13137350|NCT02714569|26001503|FG007|Part B (Overall)|Withdrawal by Subject|1|||
13137351|NCT02714569|26001504|FG008|Part B (Overall)|Withdrawal by Subject|0|||
13137352|NCT02714569|26001505|FG009|Part B (Overall)|Withdrawal by Subject|1|||
13137353|NCT02714569|26001506|FG010|Part B (Overall)|Withdrawal by Subject|0|||
13137354|NCT02714569|26001496|FG000|Part B (Overall)|Adverse Event|0|||
13137355|NCT02714569|26001497|FG001|Part B (Overall)|Adverse Event|0|||
13137356|NCT02714569|26001498|FG002|Part B (Overall)|Adverse Event|0|||
13137357|NCT02714569|26001499|FG003|Part B (Overall)|Adverse Event|0|||
13137358|NCT02714569|26001500|FG004|Part B (Overall)|Adverse Event|0|||
13137359|NCT02714569|26001501|FG005|Part B (Overall)|Adverse Event|0|||
13137360|NCT02714569|26001502|FG006|Part B (Overall)|Adverse Event|0|||
13137361|NCT02714569|26001503|FG007|Part B (Overall)|Adverse Event|0|||
13137362|NCT02714569|26001504|FG008|Part B (Overall)|Adverse Event|0|||
13137363|NCT02714569|26001505|FG009|Part B (Overall)|Adverse Event|1|||
13137364|NCT02714569|26001506|FG010|Part B (Overall)|Adverse Event|0|||
13137365|NCT02714426|26001529|FG000|Overall Study|Withdrawal by Subject|2|||
13137366|NCT02714426|26001530|FG001|Overall Study|Withdrawal by Subject|2|||
13137367|NCT02714218|26001585|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
13137368|NCT02714218|26001586|FG001|Pre-Treatment Period|Participant no longer meets study criteria|1|||
13137369|NCT02714218|26001587|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
13137370|NCT02714218|26001585|FG000|Pre-Treatment Period|Other reasons|0|||
13137371|NCT02714218|26001586|FG001|Pre-Treatment Period|Other reasons|1|||
13137372|NCT02714218|26001587|FG002|Pre-Treatment Period|Other reasons|0|||
13137373|NCT02714218|26001585|FG000|Treatment Period|Disease Progression|55|||
13137374|NCT02714218|26001586|FG001|Treatment Period|Disease Progression|52|||
13137375|NCT02714218|26001587|FG002|Treatment Period|Disease Progression|14|||
13137376|NCT02714218|26001585|FG000|Treatment Period|Study drug toxicity|46|||
13137377|NCT02714218|26001586|FG001|Treatment Period|Study drug toxicity|70|||
13137378|NCT02714218|26001587|FG002|Treatment Period|Study drug toxicity|6|||
13137379|NCT02714218|26001585|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
13137380|NCT02714218|26001586|FG001|Treatment Period|Adverse event unrelated to study drug|6|||
13137381|NCT02714218|26001587|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
13137382|NCT02714218|26001585|FG000|Treatment Period|Request to discontinue treatment|1|||
13137383|NCT02714218|26001586|FG001|Treatment Period|Request to discontinue treatment|4|||
13137384|NCT02714218|26001587|FG002|Treatment Period|Request to discontinue treatment|1|||
13137385|NCT02714218|26001585|FG000|Treatment Period|Participant withdrew consent|2|||
13137386|NCT02714218|26001586|FG001|Treatment Period|Participant withdrew consent|2|||
13137387|NCT02714218|26001587|FG002|Treatment Period|Participant withdrew consent|0|||
13137388|NCT02714218|26001585|FG000|Treatment Period|Maximum clinical benefit|4|||
13137389|NCT02714218|26001586|FG001|Treatment Period|Maximum clinical benefit|2|||
13137390|NCT02714218|26001587|FG002|Treatment Period|Maximum clinical benefit|0|||
13137391|NCT02714218|26001585|FG000|Treatment Period|Administrative reason by sponsor|2|||
13137392|NCT02714218|26001586|FG001|Treatment Period|Administrative reason by sponsor|1|||
13137393|NCT02714218|26001587|FG002|Treatment Period|Administrative reason by sponsor|0|||
13137394|NCT02714218|26001585|FG000|Treatment Period|Other reasons|6|||
13137395|NCT02714218|26001586|FG001|Treatment Period|Other reasons|6|||
13137396|NCT02714218|26001587|FG002|Treatment Period|Other reasons|0|||
13137397|NCT02714218|26001585|FG000|Treatment Period|Completed treatment as per protocol|36|||
13137398|NCT02714218|26001586|FG001|Treatment Period|Completed treatment as per protocol|27|||
13137399|NCT02714218|26001587|FG002|Treatment Period|Completed treatment as per protocol|3|||
13137400|NCT02714218|26001585|FG000|Treatment Period|Not reported|9|||
13137401|NCT02714218|26001586|FG001|Treatment Period|Not reported|6|||
13137402|NCT02714218|26001587|FG002|Treatment Period|Not reported|0|||
13137403|NCT02714153|26001597|FG000|Overall Study|Death|1|||
13137404|NCT02714062|26001651|FG000|Overall Study|Adverse Event|0|||
13137405|NCT02714062|26001652|FG001|Overall Study|Adverse Event|0|||
13137406|NCT02714062|26001653|FG002|Overall Study|Adverse Event|2|||
13137407|NCT02714062|26001651|FG000|Overall Study|Withdrawal by Subject|1|||
13137408|NCT02714062|26001652|FG001|Overall Study|Withdrawal by Subject|0|||
13137409|NCT02714062|26001653|FG002|Overall Study|Withdrawal by Subject|1|||
13137410|NCT02714062|26001651|FG000|Overall Study|Protocol Violation|0|||
13137411|NCT02714062|26001652|FG001|Overall Study|Protocol Violation|1|||
13137412|NCT02714062|26001653|FG002|Overall Study|Protocol Violation|0|||
13137413|NCT02713828|26001669|FG000|Overall Study|Death|2|||
13137414|NCT02713828|26001670|FG001|Overall Study|Death|0|||
13137415|NCT02713828|26001669|FG000|Overall Study|Withdrawal by Subject|1|||
13137416|NCT02713828|26001670|FG001|Overall Study|Withdrawal by Subject|0|||
13137417|NCT02713828|26001669|FG000|Overall Study|study terminated but patient allowed to|2|||
13137418|NCT02713828|26001670|FG001|Overall Study|study terminated but patient allowed to|0|||
13137419|NCT02713789|26001715|FG000|Overall Study|Lost to Follow-up|0|||
13137420|NCT02713789|26001716|FG001|Overall Study|Lost to Follow-up|1|||
13137421|NCT02713789|26001717|FG002|Overall Study|Lost to Follow-up|1|||
13137422|NCT02713594|26001734|FG000|Overall Study|Withdrawal by Subject|32|||
13137423|NCT02713594|26001735|FG001|Overall Study|Withdrawal by Subject|22|||
13137424|NCT02713594|26001734|FG000|Overall Study|Lost to Follow-up|358|||
13137425|NCT02713594|26001735|FG001|Overall Study|Lost to Follow-up|374|||
13137426|NCT02713542|26001748|FG000|Overall Study|Use of prohibited medication|14|||
13137427|NCT02713542|26001749|FG001|Overall Study|Use of prohibited medication|5|||
13137428|NCT02713542|26001748|FG000|Overall Study|Withdrawal by Subject|4|||
13137429|NCT02713542|26001749|FG001|Overall Study|Withdrawal by Subject|1|||
13137430|NCT02713490|26001770|FG000|Overall Study|Withdrawal by Subject|2|||
13137431|NCT02713490|26001771|FG001|Overall Study|Withdrawal by Subject|1|||
13137432|NCT02713490|26001770|FG000|Overall Study|Did not receive study drug|1|||
13137433|NCT02713490|26001771|FG001|Overall Study|Did not receive study drug|0|||
13137434|NCT02713490|26001770|FG000|Overall Study|Met exclusion criteria|0|||
13137435|NCT02713490|26001771|FG001|Overall Study|Met exclusion criteria|1|||
13137436|NCT02713243|26001793|FG000|Overall Study|Abnormal laboratory value(s)#|1|||
13137437|NCT02713243|26001794|FG001|Overall Study|Abnormal laboratory value(s)#|0|||
13137438|NCT02713243|26001793|FG000|Overall Study|Administrative problems|0|||
13137439|NCT02713243|26001794|FG001|Overall Study|Administrative problems|1|||
13137440|NCT02713243|26001793|FG000|Overall Study|Protocol deviation|0|||
13137441|NCT02713243|26001794|FG001|Overall Study|Protocol deviation|1|||
13137442|NCT02713204|26001866|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1|||
13137443|NCT02713204|26001867|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0|||
13137444|NCT02713204|26001868|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1|||
13137445|NCT02713204|26001869|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0|||
13137446|NCT02713204|26001870|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0|||
13137447|NCT02713204|26001871|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0|||
13137448|NCT02713204|26001872|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0|||
13137449|NCT02713204|26001873|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0|||
13137450|NCT02713204|26001866|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
13137451|NCT02713204|26001867|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
13137452|NCT02713204|26001868|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
13137453|NCT02713204|26001869|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
13137454|NCT02713204|26001870|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
13137455|NCT02713204|26001871|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
13137456|NCT02713204|26001872|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
13137457|NCT02713204|26001873|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
13137458|NCT02713204|26001866|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
13137459|NCT02713204|26001867|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
13137460|NCT02713204|26001868|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
13137461|NCT02713204|26001869|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
13137462|NCT02713204|26001870|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
13137463|NCT02713204|26001871|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
13137464|NCT02713204|26001872|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
13137465|NCT02713204|26001873|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
13137466|NCT02713204|26001866|FG000|From Week 12 up to Week 36|Adverse Event|1|||
13137467|NCT02713204|26001867|FG001|From Week 12 up to Week 36|Adverse Event|0|||
13137468|NCT02713204|26001868|FG002|From Week 12 up to Week 36|Adverse Event|0|||
13137469|NCT02713204|26001869|FG003|From Week 12 up to Week 36|Adverse Event|1|||
13137470|NCT02713204|26001870|FG004|From Week 12 up to Week 36|Adverse Event|1|||
13137471|NCT02713204|26001871|FG005|From Week 12 up to Week 36|Adverse Event|0|||
13137472|NCT02713204|26001872|FG006|From Week 12 up to Week 36|Adverse Event|2|||
13137473|NCT02713204|26001873|FG007|From Week 12 up to Week 36|Adverse Event|1|||
13137474|NCT02713204|26001866|FG000|From Week 12 up to Week 36|Death|0|||
13137475|NCT02713204|26001867|FG001|From Week 12 up to Week 36|Death|0|||
13137476|NCT02713204|26001868|FG002|From Week 12 up to Week 36|Death|0|||
13137477|NCT02713204|26001869|FG003|From Week 12 up to Week 36|Death|1|||
13137478|NCT02713204|26001870|FG004|From Week 12 up to Week 36|Death|0|||
13137479|NCT02713204|26001871|FG005|From Week 12 up to Week 36|Death|1|||
13137480|NCT02713204|26001872|FG006|From Week 12 up to Week 36|Death|0|||
13137481|NCT02713204|26001873|FG007|From Week 12 up to Week 36|Death|3|||
13137482|NCT02713204|26001866|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
13137483|NCT02713204|26001867|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
13137484|NCT02713204|26001868|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
13137485|NCT02713204|26001869|FG003|From Week 12 up to Week 36|Lost to Follow-up|2|||
13137486|NCT02713204|26001870|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
13137487|NCT02713204|26001871|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
13137488|NCT02713204|26001872|FG006|From Week 12 up to Week 36|Lost to Follow-up|0|||
13137489|NCT02713204|26001873|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
13137490|NCT02713204|26001866|FG000|From Week 12 up to Week 36|Participant Re-located|0|||
13137491|NCT02713204|26001867|FG001|From Week 12 up to Week 36|Participant Re-located|0|||
13137492|NCT02713204|26001868|FG002|From Week 12 up to Week 36|Participant Re-located|0|||
13137493|NCT02713204|26001869|FG003|From Week 12 up to Week 36|Participant Re-located|0|||
13137494|NCT02713204|26001870|FG004|From Week 12 up to Week 36|Participant Re-located|1|||
13137495|NCT02713204|26001871|FG005|From Week 12 up to Week 36|Participant Re-located|0|||
13137496|NCT02713204|26001872|FG006|From Week 12 up to Week 36|Participant Re-located|0|||
13137497|NCT02713204|26001873|FG007|From Week 12 up to Week 36|Participant Re-located|0|||
13137498|NCT02712996|26001930|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0|||
13137499|NCT02712996|26001931|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1|||
13137500|NCT02712983|26002189|FG000|Treatment Phase|Adverse Event|3|||
13137501|NCT02712983|26002190|FG001|Treatment Phase|Adverse Event|1|||
13137502|NCT02712983|26002191|FG002|Treatment Phase|Adverse Event|1|||
13137503|NCT02712983|26002192|FG003|Treatment Phase|Adverse Event|4|||
13137504|NCT02712983|26002193|FG004|Treatment Phase|Adverse Event|3|||
13137505|NCT02712983|26002194|FG005|Treatment Phase|Adverse Event|0|||
13137506|NCT02712983|26002195|FG006|Treatment Phase|Adverse Event|6|||
13137507|NCT02712983|26002196|FG007|Treatment Phase|Adverse Event|6|||
13137508|NCT02712983|26002197|FG008|Treatment Phase|Adverse Event|1|||
13137509|NCT02712983|26002189|FG000|Treatment Phase|Protocol Deviation|0|||
13137510|NCT02712983|26002190|FG001|Treatment Phase|Protocol Deviation|0|||
13137511|NCT02712983|26002191|FG002|Treatment Phase|Protocol Deviation|0|||
13137512|NCT02712983|26002192|FG003|Treatment Phase|Protocol Deviation|2|||
13137513|NCT02712983|26002193|FG004|Treatment Phase|Protocol Deviation|0|||
13137514|NCT02712983|26002194|FG005|Treatment Phase|Protocol Deviation|0|||
13137515|NCT02712983|26002195|FG006|Treatment Phase|Protocol Deviation|1|||
13137516|NCT02712983|26002196|FG007|Treatment Phase|Protocol Deviation|0|||
13137517|NCT02712983|26002197|FG008|Treatment Phase|Protocol Deviation|0|||
13137518|NCT02712983|26002189|FG000|Treatment Phase|Technical Problems|0|||
13137519|NCT02712983|26002190|FG001|Treatment Phase|Technical Problems|0|||
13137520|NCT02712983|26002191|FG002|Treatment Phase|Technical Problems|0|||
13137521|NCT02712983|26002192|FG003|Treatment Phase|Technical Problems|0|||
13137522|NCT02712983|26002193|FG004|Treatment Phase|Technical Problems|0|||
13137523|NCT02712983|26002194|FG005|Treatment Phase|Technical Problems|0|||
13137524|NCT02712983|26002195|FG006|Treatment Phase|Technical Problems|1|||
13137525|NCT02712983|26002196|FG007|Treatment Phase|Technical Problems|0|||
13137526|NCT02712983|26002197|FG008|Treatment Phase|Technical Problems|0|||
13137527|NCT02712983|26002189|FG000|Treatment Phase|Physician Decision|0|||
13137528|NCT02712983|26002190|FG001|Treatment Phase|Physician Decision|0|||
13137529|NCT02712983|26002191|FG002|Treatment Phase|Physician Decision|0|||
13137530|NCT02712983|26002192|FG003|Treatment Phase|Physician Decision|0|||
13137531|NCT02712983|26002193|FG004|Treatment Phase|Physician Decision|0|||
13137532|NCT02712983|26002194|FG005|Treatment Phase|Physician Decision|0|||
13137533|NCT02712983|26002195|FG006|Treatment Phase|Physician Decision|0|||
13137534|NCT02712983|26002196|FG007|Treatment Phase|Physician Decision|1|||
13137535|NCT02712983|26002197|FG008|Treatment Phase|Physician Decision|1|||
13137536|NCT02712983|26002189|FG000|Treatment Phase|Subject Decision|2|||
13137537|NCT02712983|26002190|FG001|Treatment Phase|Subject Decision|0|||
13137538|NCT02712983|26002191|FG002|Treatment Phase|Subject Decision|0|||
13137539|NCT02712983|26002192|FG003|Treatment Phase|Subject Decision|2|||
13137540|NCT02712983|26002193|FG004|Treatment Phase|Subject Decision|1|||
13137541|NCT02712983|26002194|FG005|Treatment Phase|Subject Decision|0|||
13137542|NCT02712983|26002195|FG006|Treatment Phase|Subject Decision|1|||
13137543|NCT02712983|26002196|FG007|Treatment Phase|Subject Decision|2|||
13137544|NCT02712983|26002197|FG008|Treatment Phase|Subject Decision|0|||
13137545|NCT02712983|26002189|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
13137546|NCT02712983|26002190|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
13137547|NCT02712983|26002191|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
13137548|NCT02712983|26002192|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
13137549|NCT02712983|26002193|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
13137550|NCT02712983|26002194|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
13137551|NCT02712983|26002195|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
13137552|NCT02712983|26002196|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
13137553|NCT02712983|26002197|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
13137554|NCT02712983|26002189|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
13137555|NCT02712983|26002190|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
13137556|NCT02712983|26002191|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
13137557|NCT02712983|26002192|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1|||
13137558|NCT02712983|26002193|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
13137559|NCT02712983|26002194|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
13137560|NCT02712983|26002195|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
13137561|NCT02712983|26002196|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
13137562|NCT02712983|26002197|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
13137563|NCT02712983|26002189|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
13137564|NCT02712983|26002190|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
13137565|NCT02712983|26002191|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
13137566|NCT02712983|26002192|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
13137567|NCT02712983|26002193|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
13137568|NCT02712983|26002194|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
13137569|NCT02712983|26002195|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
13137570|NCT02712983|26002196|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
13137571|NCT02712983|26002197|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
13137572|NCT02712788|26002212|FG000|Overall Study|Physician Decision|1|||
13137573|NCT02712788|26002213|FG001|Overall Study|Physician Decision|0|||
13137574|NCT02712788|26002212|FG000|Overall Study|Protocol Violation|1|||
13137575|NCT02712788|26002213|FG001|Overall Study|Protocol Violation|0|||
13137576|NCT02712554|26002338|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0|||
13137577|NCT02712554|26002339|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13|||
13137578|NCT02712554|26002338|FG000|Part B: Qualification Phase|Sponsor Decision|0|||
13137579|NCT02712554|26002339|FG001|Part B: Qualification Phase|Sponsor Decision|4|||
13137580|NCT02712554|26002338|FG000|Part B: Qualification Phase|Withdrawal by Subject|0|||
13137581|NCT02712554|26002339|FG001|Part B: Qualification Phase|Withdrawal by Subject|3|||
13137582|NCT02712554|26002338|FG000|Part B: Qualification Phase|Adverse Event|0|||
13137583|NCT02712554|26002339|FG001|Part B: Qualification Phase|Adverse Event|1|||
13137584|NCT02712554|26002338|FG000|Part B: Treatment Phase|Adverse Event|0|||
13137585|NCT02712554|26002339|FG001|Part B: Treatment Phase|Adverse Event|1|||
13137586|NCT02712554|26002338|FG000|Part B: Treatment Phase|Withdrawal by Subject|0|||
13137587|NCT02712554|26002339|FG001|Part B: Treatment Phase|Withdrawal by Subject|1|||
13137588|NCT02712554|26002338|FG000|Part B: Treatment Phase|Other|0|||
13137589|NCT02712554|26002339|FG001|Part B: Treatment Phase|Other|1|||
13090991|NCT03762265|25822125|FG001|LTE Period: Weeks 61 to 109|Other|0|||
13090992|NCT03762200|25822136|FG000|Overall Study|Death|2|||
13090993|NCT03761147|25822149|FG000|Overall Study|Withdrawal by Subject|6|||
13090994|NCT03761147|25822150|FG001|Overall Study|Withdrawal by Subject|1|||
13090995|NCT03761147|25822149|FG000|Overall Study|Adverse Event|1|||
13090996|NCT03761147|25822150|FG001|Overall Study|Adverse Event|3|||
13090997|NCT03760666|25822195|FG000|Overall Study|Adverse Event|2|||
13090998|NCT03760666|25822196|FG001|Overall Study|Adverse Event|4|||
13090999|NCT03760666|25822197|FG002|Overall Study|Adverse Event|1|||
13091000|NCT03760666|25822195|FG000|Overall Study|AML Disease Progression|3|||
13091001|NCT03760666|25822196|FG001|Overall Study|AML Disease Progression|3|||
13091002|NCT03760666|25822197|FG002|Overall Study|AML Disease Progression|0|||
13091003|NCT03760666|25822195|FG000|Overall Study|Physician Decision|0|||
13091004|NCT03760666|25822196|FG001|Overall Study|Physician Decision|3|||
13091005|NCT03760666|25822197|FG002|Overall Study|Physician Decision|0|||
13091006|NCT03760666|25822195|FG000|Overall Study|Withdrawal by Subject|0|||
13091007|NCT03760666|25822196|FG001|Overall Study|Withdrawal by Subject|1|||
13091008|NCT03760666|25822197|FG002|Overall Study|Withdrawal by Subject|0|||
13091009|NCT03760510|25822216|FG000|Overall Study|Not ventilated for 24 hours|105|||
13091010|NCT03760510|25822217|FG001|Overall Study|Not ventilated for 24 hours|97|||
13091011|NCT03760250|25822224|FG000|Overall Study|Withdrawal by Subject|1|||
13091012|NCT03760250|25822224|FG000|Overall Study|Physician Decision|1|||
13091013|NCT03760185|25822235|FG000|Overall Study|Lost to Follow-up|1|||
13091014|NCT03760185|25822236|FG001|Overall Study|Lost to Follow-up|1|||
13091015|NCT03760146|25822319|FG000|Overall Study|Adverse Event|11|||
13137590|NCT02712424|26002354|FG000|Overall Study|Lost to Follow-up|34|||
13137591|NCT02712424|26002355|FG001|Overall Study|Lost to Follow-up|32|||
13137592|NCT02712398|26002370|FG000|Overall Study|Withdrawal by Subject|6|||
13137593|NCT02712398|26002370|FG000|Overall Study|Lost to Follow-up|6|||
13091016|NCT03760146|25822320|FG001|Overall Study|Adverse Event|8|||
13091017|NCT03760146|25822321|FG002|Overall Study|Adverse Event|0|||
13091018|NCT03760146|25822322|FG003|Overall Study|Adverse Event|0|||
13137594|NCT02712398|26002370|FG000|Overall Study|Sponsor Decision|1|||
13137595|NCT02712398|26002370|FG000|Overall Study|Physician Decision|1|||
13137596|NCT02712398|26002370|FG000|Overall Study|Death|2|||
13137597|NCT02712398|26002370|FG000|Overall Study|Re-operation|21|||
13137598|NCT02712333|26002395|FG000|First Period|Withdrawal by Subject|3|||
13137599|NCT02712333|26002396|FG001|First Period|Withdrawal by Subject|2|||
13137600|NCT02712320|26002406|FG000|Overall Study|Lost to Follow-up|1|||
13137601|NCT02712320|26002406|FG000|Overall Study|Withdrawal by Subject|1|||
13137602|NCT02712320|26002406|FG000|Overall Study|Transferred to another facility|1|||
13137603|NCT02712320|26002406|FG000|Overall Study|Treating with the prohibited medications|2|||
13137604|NCT02712008|26002453|FG000|Baseline (Day 1) up to Week 12|Death|3|||
13137605|NCT02712008|26002454|FG001|Baseline (Day 1) up to Week 12|Death|0|||
13137606|NCT02712008|26002455|FG002|Baseline (Day 1) up to Week 12|Death|0|||
13137607|NCT02712008|26002456|FG003|Baseline (Day 1) up to Week 12|Death|0|||
13137608|NCT02712008|26002457|FG004|Baseline (Day 1) up to Week 12|Death|0|||
13137609|NCT02712008|26002458|FG005|Baseline (Day 1) up to Week 12|Death|0|||
13137610|NCT02712008|26002459|FG006|Baseline (Day 1) up to Week 12|Death|0|||
13137611|NCT02712008|26002460|FG007|Baseline (Day 1) up to Week 12|Death|0|||
13137612|NCT02712008|26002453|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
13137613|NCT02712008|26002454|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2|||
13137614|NCT02712008|26002455|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
13137615|NCT02712008|26002456|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
13137616|NCT02712008|26002457|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
13137617|NCT02712008|26002458|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
13137618|NCT02712008|26002459|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
13137619|NCT02712008|26002460|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
13137620|NCT02712008|26002453|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
13137621|NCT02712008|26002454|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
13137622|NCT02712008|26002455|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2|||
13137623|NCT02712008|26002456|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
13137624|NCT02712008|26002457|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
13137625|NCT02712008|26002458|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
13137626|NCT02712008|26002459|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
13137627|NCT02712008|26002460|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
13137628|NCT02712008|26002453|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
13137629|NCT02712008|26002454|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
13137630|NCT02712008|26002455|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1|||
13137631|NCT02712008|26002456|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
13137632|NCT02712008|26002457|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
13137633|NCT02712008|26002458|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
13137634|NCT02712008|26002459|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
13137635|NCT02712008|26002460|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
13137636|NCT02712008|26002453|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
13137637|NCT02712008|26002454|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1|||
13137638|NCT02712008|26002455|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
13137639|NCT02712008|26002456|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
13137640|NCT02712008|26002457|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
13137641|NCT02712008|26002458|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
13137642|NCT02712008|26002459|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
13137643|NCT02712008|26002460|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
13137644|NCT02712008|26002453|FG000|From Week 12 up to Week 36|Adverse Event|0|||
13137645|NCT02712008|26002454|FG001|From Week 12 up to Week 36|Adverse Event|0|||
13137646|NCT02712008|26002455|FG002|From Week 12 up to Week 36|Adverse Event|0|||
13137647|NCT02712008|26002456|FG003|From Week 12 up to Week 36|Adverse Event|0|||
13137648|NCT02712008|26002457|FG004|From Week 12 up to Week 36|Adverse Event|1|||
13137649|NCT02712008|26002458|FG005|From Week 12 up to Week 36|Adverse Event|0|||
13137650|NCT02712008|26002459|FG006|From Week 12 up to Week 36|Adverse Event|0|||
13137651|NCT02712008|26002460|FG007|From Week 12 up to Week 36|Adverse Event|2|||
13137652|NCT02712008|26002453|FG000|From Week 12 up to Week 36|Death|1|||
13137653|NCT02712008|26002454|FG001|From Week 12 up to Week 36|Death|0|||
13137654|NCT02712008|26002455|FG002|From Week 12 up to Week 36|Death|0|||
13137655|NCT02712008|26002456|FG003|From Week 12 up to Week 36|Death|0|||
13137656|NCT02712008|26002457|FG004|From Week 12 up to Week 36|Death|0|||
13137657|NCT02712008|26002458|FG005|From Week 12 up to Week 36|Death|0|||
13137658|NCT02712008|26002459|FG006|From Week 12 up to Week 36|Death|1|||
13137659|NCT02712008|26002460|FG007|From Week 12 up to Week 36|Death|0|||
13137660|NCT02712008|26002453|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
13137661|NCT02712008|26002454|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
13137662|NCT02712008|26002455|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
13137663|NCT02712008|26002456|FG003|From Week 12 up to Week 36|Lost to Follow-up|1|||
13137664|NCT02712008|26002457|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
13137665|NCT02712008|26002458|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
13137666|NCT02712008|26002459|FG006|From Week 12 up to Week 36|Lost to Follow-up|1|||
13137667|NCT02712008|26002460|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
13137668|NCT02712008|26002453|FG000|From Week 12 up to Week 36|Physician Decision|0|||
13137669|NCT02712008|26002454|FG001|From Week 12 up to Week 36|Physician Decision|0|||
13137670|NCT02712008|26002455|FG002|From Week 12 up to Week 36|Physician Decision|0|||
13137671|NCT02712008|26002456|FG003|From Week 12 up to Week 36|Physician Decision|1|||
13137672|NCT02712008|26002457|FG004|From Week 12 up to Week 36|Physician Decision|1|||
13137673|NCT02712008|26002458|FG005|From Week 12 up to Week 36|Physician Decision|0|||
13137674|NCT02712008|26002459|FG006|From Week 12 up to Week 36|Physician Decision|0|||
13137675|NCT02712008|26002460|FG007|From Week 12 up to Week 36|Physician Decision|0|||
13137676|NCT02712008|26002453|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0|||
13137677|NCT02712008|26002454|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0|||
13137678|NCT02712008|26002455|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0|||
13137679|NCT02712008|26002456|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0|||
13137680|NCT02712008|26002457|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0|||
13137681|NCT02712008|26002458|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0|||
13137682|NCT02712008|26002459|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3|||
13137683|NCT02712008|26002460|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2|||
13137684|NCT02711995|26002484|FG000|Washout (90 Days)|Conflicting medication|1|||
13137685|NCT02711956|26002575|FG000|Overall Study|Adverse Event|0|||
13137686|NCT02711956|26002576|FG001|Overall Study|Adverse Event|0|||
13137687|NCT02711956|26002577|FG002|Overall Study|Adverse Event|0|||
13137688|NCT02711956|26002578|FG003|Overall Study|Adverse Event|1|||
13137689|NCT02711956|26002579|FG004|Overall Study|Adverse Event|2|||
13137690|NCT02711956|26002580|FG005|Overall Study|Adverse Event|0|||
13137691|NCT02711956|26002581|FG006|Overall Study|Adverse Event|0|||
13137692|NCT02711956|26002582|FG007|Overall Study|Adverse Event|1|||
13137693|NCT02711956|26002583|FG008|Overall Study|Adverse Event|1|||
13137694|NCT02711956|26002584|FG009|Overall Study|Adverse Event|1|||
13137695|NCT02711956|26002585|FG010|Overall Study|Adverse Event|1|||
13137696|NCT02711956|26002586|FG011|Overall Study|Adverse Event|0|||
13137697|NCT02711956|26002587|FG012|Overall Study|Adverse Event|0|||
13137698|NCT02711956|26002588|FG013|Overall Study|Adverse Event|0|||
13137699|NCT02711956|26002589|FG014|Overall Study|Adverse Event|2|||
13137700|NCT02711956|26002575|FG000|Overall Study|Physician Decision|0|||
13137701|NCT02711956|26002576|FG001|Overall Study|Physician Decision|0|||
13137702|NCT02711956|26002577|FG002|Overall Study|Physician Decision|0|||
13137703|NCT02711956|26002578|FG003|Overall Study|Physician Decision|2|||
13137704|NCT02711956|26002579|FG004|Overall Study|Physician Decision|0|||
13137705|NCT02711956|26002580|FG005|Overall Study|Physician Decision|0|||
13137706|NCT02711956|26002581|FG006|Overall Study|Physician Decision|0|||
13137707|NCT02711956|26002582|FG007|Overall Study|Physician Decision|0|||
13137708|NCT02711956|26002583|FG008|Overall Study|Physician Decision|0|||
13137709|NCT02711956|26002584|FG009|Overall Study|Physician Decision|0|||
13137710|NCT02711956|26002585|FG010|Overall Study|Physician Decision|0|||
13137711|NCT02711956|26002586|FG011|Overall Study|Physician Decision|0|||
13137712|NCT02711956|26002587|FG012|Overall Study|Physician Decision|0|||
13137713|NCT02711956|26002588|FG013|Overall Study|Physician Decision|0|||
13137714|NCT02711956|26002589|FG014|Overall Study|Physician Decision|0|||
13137715|NCT02711956|26002575|FG000|Overall Study|Withdrawal by Subject|0|||
13137716|NCT02711956|26002576|FG001|Overall Study|Withdrawal by Subject|0|||
13137717|NCT02711956|26002577|FG002|Overall Study|Withdrawal by Subject|0|||
13137718|NCT02711956|26002578|FG003|Overall Study|Withdrawal by Subject|0|||
13137719|NCT02711956|26002579|FG004|Overall Study|Withdrawal by Subject|0|||
13137720|NCT02711956|26002580|FG005|Overall Study|Withdrawal by Subject|0|||
13137721|NCT02711956|26002581|FG006|Overall Study|Withdrawal by Subject|1|||
13137722|NCT02711956|26002582|FG007|Overall Study|Withdrawal by Subject|0|||
13137723|NCT02711956|26002583|FG008|Overall Study|Withdrawal by Subject|0|||
13137724|NCT02711956|26002584|FG009|Overall Study|Withdrawal by Subject|0|||
13137725|NCT02711956|26002585|FG010|Overall Study|Withdrawal by Subject|0|||
13137726|NCT02711956|26002586|FG011|Overall Study|Withdrawal by Subject|1|||
13137727|NCT02711956|26002587|FG012|Overall Study|Withdrawal by Subject|6|||
13137728|NCT02711956|26002588|FG013|Overall Study|Withdrawal by Subject|0|||
13137729|NCT02711956|26002589|FG014|Overall Study|Withdrawal by Subject|1|||
13137730|NCT02711956|26002575|FG000|Overall Study|Clinical progression|1|||
13137731|NCT02711956|26002576|FG001|Overall Study|Clinical progression|0|||
13137732|NCT02711956|26002577|FG002|Overall Study|Clinical progression|0|||
13137733|NCT02711956|26002578|FG003|Overall Study|Clinical progression|0|||
13137734|NCT02711956|26002579|FG004|Overall Study|Clinical progression|0|||
13137735|NCT02711956|26002580|FG005|Overall Study|Clinical progression|0|||
13137736|NCT02711956|26002581|FG006|Overall Study|Clinical progression|1|||
13137737|NCT02711956|26002582|FG007|Overall Study|Clinical progression|0|||
13137738|NCT02711956|26002583|FG008|Overall Study|Clinical progression|1|||
13137739|NCT02711956|26002584|FG009|Overall Study|Clinical progression|0|||
13137740|NCT02711956|26002585|FG010|Overall Study|Clinical progression|0|||
13137741|NCT02711956|26002586|FG011|Overall Study|Clinical progression|2|||
13137742|NCT02711956|26002587|FG012|Overall Study|Clinical progression|4|||
13137743|NCT02711956|26002588|FG013|Overall Study|Clinical progression|1|||
13137744|NCT02711956|26002589|FG014|Overall Study|Clinical progression|1|||
13137745|NCT02711956|26002575|FG000|Overall Study|Radiographic progression|1|||
13137746|NCT02711956|26002576|FG001|Overall Study|Radiographic progression|1|||
13137747|NCT02711956|26002577|FG002|Overall Study|Radiographic progression|2|||
13137748|NCT02711956|26002578|FG003|Overall Study|Radiographic progression|0|||
13137749|NCT02711956|26002579|FG004|Overall Study|Radiographic progression|1|||
13137750|NCT02711956|26002580|FG005|Overall Study|Radiographic progression|0|||
13137751|NCT02711956|26002581|FG006|Overall Study|Radiographic progression|0|||
13137752|NCT02711956|26002582|FG007|Overall Study|Radiographic progression|0|||
13137753|NCT02711956|26002583|FG008|Overall Study|Radiographic progression|2|||
13137754|NCT02711956|26002584|FG009|Overall Study|Radiographic progression|1|||
13137755|NCT02711956|26002585|FG010|Overall Study|Radiographic progression|0|||
13137756|NCT02711956|26002586|FG011|Overall Study|Radiographic progression|5|||
13137757|NCT02711956|26002587|FG012|Overall Study|Radiographic progression|3|||
13137758|NCT02711956|26002588|FG013|Overall Study|Radiographic progression|0|||
13137759|NCT02711956|26002589|FG014|Overall Study|Radiographic progression|1|||
13137760|NCT02711956|26002575|FG000|Overall Study|PSA progression with clinical progression|0|||
13137761|NCT02711956|26002576|FG001|Overall Study|PSA progression with clinical progression|0|||
13137762|NCT02711956|26002577|FG002|Overall Study|PSA progression with clinical progression|0|||
13137763|NCT02711956|26002578|FG003|Overall Study|PSA progression with clinical progression|0|||
13137764|NCT02711956|26002579|FG004|Overall Study|PSA progression with clinical progression|1|||
13137765|NCT02711956|26002580|FG005|Overall Study|PSA progression with clinical progression|0|||
13137766|NCT02711956|26002581|FG006|Overall Study|PSA progression with clinical progression|0|||
13137767|NCT02711956|26002582|FG007|Overall Study|PSA progression with clinical progression|0|||
13137768|NCT02711956|26002583|FG008|Overall Study|PSA progression with clinical progression|0|||
13137769|NCT02711956|26002584|FG009|Overall Study|PSA progression with clinical progression|0|||
13137770|NCT02711956|26002585|FG010|Overall Study|PSA progression with clinical progression|0|||
13137771|NCT02711956|26002586|FG011|Overall Study|PSA progression with clinical progression|0|||
13137772|NCT02711956|26002587|FG012|Overall Study|PSA progression with clinical progression|1|||
13137773|NCT02711956|26002588|FG013|Overall Study|PSA progression with clinical progression|1|||
13137774|NCT02711956|26002589|FG014|Overall Study|PSA progression with clinical progression|0|||
13137775|NCT02711956|26002575|FG000|Overall Study|PSA progression with radiographic progression|0|||
13137776|NCT02711956|26002576|FG001|Overall Study|PSA progression with radiographic progression|1|||
13137777|NCT02711956|26002577|FG002|Overall Study|PSA progression with radiographic progression|0|||
13137778|NCT02711956|26002578|FG003|Overall Study|PSA progression with radiographic progression|0|||
13137779|NCT02711956|26002579|FG004|Overall Study|PSA progression with radiographic progression|0|||
13137780|NCT02711956|26002580|FG005|Overall Study|PSA progression with radiographic progression|2|||
13137781|NCT02711956|26002581|FG006|Overall Study|PSA progression with radiographic progression|2|||
13137782|NCT02711956|26002582|FG007|Overall Study|PSA progression with radiographic progression|1|||
13137783|NCT02711956|26002583|FG008|Overall Study|PSA progression with radiographic progression|0|||
13137784|NCT02711956|26002584|FG009|Overall Study|PSA progression with radiographic progression|1|||
13137785|NCT02711956|26002585|FG010|Overall Study|PSA progression with radiographic progression|0|||
13137786|NCT02711956|26002586|FG011|Overall Study|PSA progression with radiographic progression|1|||
13137787|NCT02711956|26002587|FG012|Overall Study|PSA progression with radiographic progression|2|||
13137788|NCT02711956|26002588|FG013|Overall Study|PSA progression with radiographic progression|3|||
13137789|NCT02711956|26002589|FG014|Overall Study|PSA progression with radiographic progression|3|||
13137790|NCT02711800|26002600|FG000|Overall Study|Lost to Follow-up|1|||
13137791|NCT02711800|26002600|FG000|Overall Study|Withdrawal by Subject|1|||
13137792|NCT02711553|26002644|FG000|Overall Study|Withdrawal by Subject|2|||
13137793|NCT02711553|26002645|FG001|Overall Study|Withdrawal by Subject|1|||
13137794|NCT02711553|26002646|FG002|Overall Study|Withdrawal by Subject|1|||
13137795|NCT02711553|26002647|FG003|Overall Study|Withdrawal by Subject|0|||
13137796|NCT02711553|26002644|FG000|Overall Study|Lost to Follow-up|3|||
13137797|NCT02711553|26002645|FG001|Overall Study|Lost to Follow-up|3|||
13137798|NCT02711553|26002646|FG002|Overall Study|Lost to Follow-up|6|||
13137799|NCT02711553|26002647|FG003|Overall Study|Lost to Follow-up|3|||
13137800|NCT02711553|26002644|FG000|Overall Study|On Study Treatment at Study Conclusion|1|||
13137801|NCT02711553|26002645|FG001|Overall Study|On Study Treatment at Study Conclusion|1|||
13137802|NCT02711553|26002646|FG002|Overall Study|On Study Treatment at Study Conclusion|3|||
13137803|NCT02711553|26002647|FG003|Overall Study|On Study Treatment at Study Conclusion|1|||
13137804|NCT02711345|26002862|FG000|Overall Study|Adverse Event|0|||
13137805|NCT02711345|26002863|FG001|Overall Study|Adverse Event|0|||
13137806|NCT02711345|26002864|FG002|Overall Study|Adverse Event|0|||
13137807|NCT02711345|26002865|FG003|Overall Study|Adverse Event|1|||
13137808|NCT02711345|26002866|FG004|Overall Study|Adverse Event|1|||
13137809|NCT02711345|26002867|FG005|Overall Study|Adverse Event|2|||
13137810|NCT02711345|26002868|FG006|Overall Study|Adverse Event|1|||
13137811|NCT02711345|26002869|FG007|Overall Study|Adverse Event|0|||
13137812|NCT02711345|26002870|FG008|Overall Study|Adverse Event|0|||
13137813|NCT02711345|26002871|FG009|Overall Study|Adverse Event|2|||
13137814|NCT02711345|26002862|FG000|Overall Study|Physician Decision|0|||
13137815|NCT02711345|26002863|FG001|Overall Study|Physician Decision|0|||
13137816|NCT02711345|26002864|FG002|Overall Study|Physician Decision|1|||
13137817|NCT02711345|26002865|FG003|Overall Study|Physician Decision|0|||
13137818|NCT02711345|26002866|FG004|Overall Study|Physician Decision|0|||
13137819|NCT02711345|26002867|FG005|Overall Study|Physician Decision|0|||
13137820|NCT02711345|26002868|FG006|Overall Study|Physician Decision|0|||
13137821|NCT02711345|26002869|FG007|Overall Study|Physician Decision|0|||
13137822|NCT02711345|26002870|FG008|Overall Study|Physician Decision|1|||
13137823|NCT02711345|26002871|FG009|Overall Study|Physician Decision|0|||
13137824|NCT02711345|26002862|FG000|Overall Study|Progressive disease|1|||
13137825|NCT02711345|26002863|FG001|Overall Study|Progressive disease|3|||
13137826|NCT02711345|26002864|FG002|Overall Study|Progressive disease|5|||
13137827|NCT02711345|26002865|FG003|Overall Study|Progressive disease|3|||
13137828|NCT02711345|26002866|FG004|Overall Study|Progressive disease|7|||
13137829|NCT02711345|26002867|FG005|Overall Study|Progressive disease|2|||
13137830|NCT02711345|26002868|FG006|Overall Study|Progressive disease|8|||
13137831|NCT02711345|26002869|FG007|Overall Study|Progressive disease|4|||
13137832|NCT02711345|26002870|FG008|Overall Study|Progressive disease|5|||
13137833|NCT02711345|26002871|FG009|Overall Study|Progressive disease|6|||
13137834|NCT02711345|26002862|FG000|Overall Study|Subject/guardian decision|0|||
13137835|NCT02711345|26002863|FG001|Overall Study|Subject/guardian decision|0|||
13137836|NCT02711345|26002864|FG002|Overall Study|Subject/guardian decision|0|||
13137837|NCT02711345|26002865|FG003|Overall Study|Subject/guardian decision|0|||
13137838|NCT02711345|26002866|FG004|Overall Study|Subject/guardian decision|0|||
13091019|NCT03760146|25822323|FG004|Overall Study|Adverse Event|0|||
13091020|NCT03760146|25822324|FG005|Overall Study|Adverse Event|0|||
13091021|NCT03760146|25822319|FG000|Overall Study|Death|1|||
13091022|NCT03760146|25822320|FG001|Overall Study|Death|0|||
13091023|NCT03760146|25822321|FG002|Overall Study|Death|0|||
13091024|NCT03760146|25822322|FG003|Overall Study|Death|0|||
13091025|NCT03760146|25822323|FG004|Overall Study|Death|0|||
13091026|NCT03760146|25822324|FG005|Overall Study|Death|0|||
13091027|NCT03760146|25822319|FG000|Overall Study|Lost to Follow-up|41|||
13091028|NCT03760146|25822320|FG001|Overall Study|Lost to Follow-up|28|||
13091029|NCT03760146|25822321|FG002|Overall Study|Lost to Follow-up|9|||
13091030|NCT03760146|25822322|FG003|Overall Study|Lost to Follow-up|2|||
13091031|NCT03760146|25822323|FG004|Overall Study|Lost to Follow-up|14|||
13091032|NCT03760146|25822324|FG005|Overall Study|Lost to Follow-up|8|||
13091033|NCT03760146|25822319|FG000|Overall Study|No longer met eligibility criteria|3|||
13091034|NCT03760146|25822320|FG001|Overall Study|No longer met eligibility criteria|9|||
13091035|NCT03760146|25822321|FG002|Overall Study|No longer met eligibility criteria|0|||
13091036|NCT03760146|25822322|FG003|Overall Study|No longer met eligibility criteria|0|||
13091037|NCT03760146|25822323|FG004|Overall Study|No longer met eligibility criteria|1|||
13091038|NCT03760146|25822324|FG005|Overall Study|No longer met eligibility criteria|0|||
13091039|NCT03760146|25822319|FG000|Overall Study|Protocol Violation|21|||
13091040|NCT03760146|25822320|FG001|Overall Study|Protocol Violation|13|||
13091041|NCT03760146|25822321|FG002|Overall Study|Protocol Violation|1|||
13091042|NCT03760146|25822322|FG003|Overall Study|Protocol Violation|0|||
13091043|NCT03760146|25822323|FG004|Overall Study|Protocol Violation|1|||
13091044|NCT03760146|25822324|FG005|Overall Study|Protocol Violation|0|||
13091045|NCT03760146|25822319|FG000|Overall Study|Withdrawal by Subject|19|||
13091046|NCT03760146|25822320|FG001|Overall Study|Withdrawal by Subject|20|||
13091047|NCT03760146|25822321|FG002|Overall Study|Withdrawal by Subject|1|||
13091048|NCT03760146|25822322|FG003|Overall Study|Withdrawal by Subject|0|||
13091049|NCT03760146|25822323|FG004|Overall Study|Withdrawal by Subject|1|||
13091050|NCT03760146|25822324|FG005|Overall Study|Withdrawal by Subject|0|||
13091051|NCT03760081|25822360|FG000|Overall Study|Miscellaneous|0|||
13091052|NCT03760081|25822361|FG001|Overall Study|Miscellaneous|1|||
13091053|NCT03760081|25822360|FG000|Overall Study|Progressive Disease|5|||
13091054|NCT03760081|25822361|FG001|Overall Study|Progressive Disease|10|||
13091055|NCT03760081|25822360|FG000|Overall Study|Death|1|||
13091056|NCT03760081|25822361|FG001|Overall Study|Death|1|||
13091057|NCT03760068|25822386|FG000|Overall Study|Withdrawal by Subject|7|||
13091058|NCT03760068|25822387|FG001|Overall Study|Withdrawal by Subject|8|||
13091059|NCT03760068|25822386|FG000|Overall Study|Adverse Event|1|||
13091060|NCT03760068|25822387|FG001|Overall Study|Adverse Event|2|||
13091061|NCT03760068|25822386|FG000|Overall Study|Administrative Decision by Sponsor|0|||
13137839|NCT02711345|26002867|FG005|Overall Study|Subject/guardian decision|2|||
13137840|NCT02711345|26002868|FG006|Overall Study|Subject/guardian decision|3|||
13091062|NCT03760068|25822387|FG001|Overall Study|Administrative Decision by Sponsor|2|||
13091063|NCT03760068|25822386|FG000|Overall Study|Physician Decision|1|||
13091064|NCT03760068|25822387|FG001|Overall Study|Physician Decision|2|||
13091065|NCT03760068|25822386|FG000|Overall Study|Lost to Follow-up|4|||
13137841|NCT02711345|26002869|FG007|Overall Study|Subject/guardian decision|1|||
13137842|NCT02711345|26002870|FG008|Overall Study|Subject/guardian decision|0|||
13137843|NCT02711345|26002871|FG009|Overall Study|Subject/guardian decision|4|||
13137844|NCT02711345|26002862|FG000|Overall Study|Death|1|||
13137845|NCT02711345|26002863|FG001|Overall Study|Death|0|||
13137846|NCT02711345|26002864|FG002|Overall Study|Death|0|||
13137847|NCT02711345|26002865|FG003|Overall Study|Death|0|||
13137848|NCT02711345|26002866|FG004|Overall Study|Death|0|||
13137849|NCT02711345|26002867|FG005|Overall Study|Death|0|||
13137850|NCT02711345|26002868|FG006|Overall Study|Death|0|||
13137851|NCT02711345|26002869|FG007|Overall Study|Death|1|||
13137852|NCT02711345|26002870|FG008|Overall Study|Death|0|||
13137853|NCT02711345|26002871|FG009|Overall Study|Death|0|||
13137854|NCT02711306|26002890|FG000|Overall Study|Withdrawal by Subject|2|||
13137855|NCT02711306|26002891|FG001|Overall Study|Withdrawal by Subject|2|||
13137856|NCT02711137|26002999|FG000|Overall Study|Death|1|||
13137857|NCT02711137|26003000|FG001|Overall Study|Death|4|||
13137858|NCT02711137|26003001|FG002|Overall Study|Death|5|||
13137859|NCT02711137|26003002|FG003|Overall Study|Death|5|||
13137860|NCT02711137|26003003|FG004|Overall Study|Death|3|||
13137861|NCT02711137|26003004|FG005|Overall Study|Death|1|||
13137862|NCT02711137|26003005|FG006|Overall Study|Death|61|||
13137863|NCT02711137|26003006|FG007|Overall Study|Death|3|||
13137864|NCT02711137|26003007|FG008|Overall Study|Death|0|||
13137865|NCT02711137|26003008|FG009|Overall Study|Death|1|||
13137866|NCT02711137|26003009|FG010|Overall Study|Death|1|||
13137867|NCT02711137|26003010|FG011|Overall Study|Death|1|||
13137868|NCT02711137|26003011|FG012|Overall Study|Death|0|||
13137869|NCT02711137|26003012|FG013|Overall Study|Death|0|||
13137870|NCT02711137|26003013|FG014|Overall Study|Death|0|||
13137871|NCT02711137|26002999|FG000|Overall Study|Study Terminated by Sponsor|0|||
13137872|NCT02711137|26003000|FG001|Overall Study|Study Terminated by Sponsor|0|||
13137873|NCT02711137|26003001|FG002|Overall Study|Study Terminated by Sponsor|1|||
13137874|NCT02711137|26003002|FG003|Overall Study|Study Terminated by Sponsor|0|||
13137875|NCT02711137|26003003|FG004|Overall Study|Study Terminated by Sponsor|0|||
13137876|NCT02711137|26003004|FG005|Overall Study|Study Terminated by Sponsor|0|||
13137877|NCT02711137|26003005|FG006|Overall Study|Study Terminated by Sponsor|1|||
13137878|NCT02711137|26003006|FG007|Overall Study|Study Terminated by Sponsor|0|||
13137879|NCT02711137|26003007|FG008|Overall Study|Study Terminated by Sponsor|0|||
13137880|NCT02711137|26003008|FG009|Overall Study|Study Terminated by Sponsor|0|||
13137881|NCT02711137|26003009|FG010|Overall Study|Study Terminated by Sponsor|0|||
13137882|NCT02711137|26003010|FG011|Overall Study|Study Terminated by Sponsor|0|||
13137883|NCT02711137|26003011|FG012|Overall Study|Study Terminated by Sponsor|0|||
13137884|NCT02711137|26003012|FG013|Overall Study|Study Terminated by Sponsor|0|||
13137885|NCT02711137|26003013|FG014|Overall Study|Study Terminated by Sponsor|0|||
13137886|NCT02711137|26002999|FG000|Overall Study|Physician Decision|1|||
13137887|NCT02711137|26003000|FG001|Overall Study|Physician Decision|0|||
13137888|NCT02711137|26003001|FG002|Overall Study|Physician Decision|2|||
13137889|NCT02711137|26003002|FG003|Overall Study|Physician Decision|1|||
13137890|NCT02711137|26003003|FG004|Overall Study|Physician Decision|1|||
13137891|NCT02711137|26003004|FG005|Overall Study|Physician Decision|0|||
13137892|NCT02711137|26003005|FG006|Overall Study|Physician Decision|12|||
13137893|NCT02711137|26003006|FG007|Overall Study|Physician Decision|2|||
13137894|NCT02711137|26003007|FG008|Overall Study|Physician Decision|1|||
13137895|NCT02711137|26003008|FG009|Overall Study|Physician Decision|1|||
13137896|NCT02711137|26003009|FG010|Overall Study|Physician Decision|3|||
13137897|NCT02711137|26003010|FG011|Overall Study|Physician Decision|2|||
13137898|NCT02711137|26003011|FG012|Overall Study|Physician Decision|1|||
13137899|NCT02711137|26003012|FG013|Overall Study|Physician Decision|1|||
13137900|NCT02711137|26003013|FG014|Overall Study|Physician Decision|2|||
13137901|NCT02711137|26002999|FG000|Overall Study|Other|0|||
13137902|NCT02711137|26003000|FG001|Overall Study|Other|1|||
13137903|NCT02711137|26003001|FG002|Overall Study|Other|0|||
13137904|NCT02711137|26003002|FG003|Overall Study|Other|0|||
13137905|NCT02711137|26003003|FG004|Overall Study|Other|0|||
13137906|NCT02711137|26003004|FG005|Overall Study|Other|0|||
13137907|NCT02711137|26003005|FG006|Overall Study|Other|3|||
13137908|NCT02711137|26003006|FG007|Overall Study|Other|0|||
13137909|NCT02711137|26003007|FG008|Overall Study|Other|0|||
13137910|NCT02711137|26003008|FG009|Overall Study|Other|0|||
13137911|NCT02711137|26003009|FG010|Overall Study|Other|0|||
13137912|NCT02711137|26003010|FG011|Overall Study|Other|0|||
13137913|NCT02711137|26003011|FG012|Overall Study|Other|0|||
13137914|NCT02711137|26003012|FG013|Overall Study|Other|0|||
13137915|NCT02711137|26003013|FG014|Overall Study|Other|1|||
13137916|NCT02711137|26002999|FG000|Overall Study|Withdrawal by Subject|1|||
13137917|NCT02711137|26003000|FG001|Overall Study|Withdrawal by Subject|0|||
13137918|NCT02711137|26003001|FG002|Overall Study|Withdrawal by Subject|0|||
13137919|NCT02711137|26003002|FG003|Overall Study|Withdrawal by Subject|1|||
13137920|NCT02711137|26003003|FG004|Overall Study|Withdrawal by Subject|1|||
13137921|NCT02711137|26003004|FG005|Overall Study|Withdrawal by Subject|0|||
13137922|NCT02711137|26003005|FG006|Overall Study|Withdrawal by Subject|7|||
13137923|NCT02711137|26003006|FG007|Overall Study|Withdrawal by Subject|0|||
13137924|NCT02711137|26003007|FG008|Overall Study|Withdrawal by Subject|0|||
13137925|NCT02711137|26003008|FG009|Overall Study|Withdrawal by Subject|0|||
13137926|NCT02711137|26003009|FG010|Overall Study|Withdrawal by Subject|0|||
13137927|NCT02711137|26003010|FG011|Overall Study|Withdrawal by Subject|0|||
13137928|NCT02711137|26003011|FG012|Overall Study|Withdrawal by Subject|0|||
13137929|NCT02711137|26003012|FG013|Overall Study|Withdrawal by Subject|1|||
13137930|NCT02711137|26003013|FG014|Overall Study|Withdrawal by Subject|0|||
13137931|NCT02711137|26002999|FG000|Overall Study|Lost to Follow-up|1|||
13137932|NCT02711137|26003000|FG001|Overall Study|Lost to Follow-up|0|||
13137933|NCT02711137|26003001|FG002|Overall Study|Lost to Follow-up|0|||
13137934|NCT02711137|26003002|FG003|Overall Study|Lost to Follow-up|0|||
13137935|NCT02711137|26003003|FG004|Overall Study|Lost to Follow-up|0|||
13137936|NCT02711137|26003004|FG005|Overall Study|Lost to Follow-up|0|||
13137937|NCT02711137|26003005|FG006|Overall Study|Lost to Follow-up|2|||
13137938|NCT02711137|26003006|FG007|Overall Study|Lost to Follow-up|0|||
13137939|NCT02711137|26003007|FG008|Overall Study|Lost to Follow-up|0|||
13137940|NCT02711137|26003008|FG009|Overall Study|Lost to Follow-up|0|||
13137941|NCT02711137|26003009|FG010|Overall Study|Lost to Follow-up|0|||
13137942|NCT02711137|26003010|FG011|Overall Study|Lost to Follow-up|0|||
13137943|NCT02711137|26003011|FG012|Overall Study|Lost to Follow-up|0|||
13137944|NCT02711137|26003012|FG013|Overall Study|Lost to Follow-up|0|||
13137945|NCT02711137|26003013|FG014|Overall Study|Lost to Follow-up|0|||
13137946|NCT02710422|26003036|FG000|Overall Study|Termination of study|9|||
13137947|NCT02710422|26003037|FG001|Overall Study|Termination of study|9|||
13137948|NCT02710292|26003047|FG000|Period 1, First 10 Days of Wear|Adverse Event|0|||
13137949|NCT02710292|26003048|FG001|Period 1, First 10 Days of Wear|Adverse Event|1|||
13137950|NCT02710292|26003047|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1|||
13137951|NCT02710292|26003048|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2|||
13137952|NCT02710214|26003087|FG000|Overall Study|Lost to Follow-up|1|||
13137953|NCT02710214|26003088|FG001|Overall Study|Lost to Follow-up|0|||
13137954|NCT02710214|26003087|FG000|Overall Study|Lack of Efficacy|0|||
13137955|NCT02710214|26003088|FG001|Overall Study|Lack of Efficacy|1|||
13137956|NCT02710214|26003087|FG000|Overall Study|Death|0|||
13137957|NCT02710214|26003088|FG001|Overall Study|Death|1|||
13137958|NCT02710136|26003118|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1|||
13137959|NCT02710136|26003119|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0|||
13137960|NCT02710071|26003133|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3|||
13137961|NCT02710071|26003134|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4|||
13137962|NCT02710071|26003133|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1|||
13137963|NCT02710071|26003134|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
13137964|NCT02710045|26003170|FG000|Overall Study|Death|1|||
13137965|NCT02710045|26003171|FG001|Overall Study|Death|2|||
13137966|NCT02710045|26003172|FG002|Overall Study|Death|0|||
13137967|NCT02710045|26003170|FG000|Overall Study|Withdrawal by Subject|6|||
13137968|NCT02710045|26003171|FG001|Overall Study|Withdrawal by Subject|6|||
13137969|NCT02710045|26003172|FG002|Overall Study|Withdrawal by Subject|2|||
13137970|NCT02710045|26003170|FG000|Overall Study|Protocol Violation|1|||
13137971|NCT02710045|26003171|FG001|Overall Study|Protocol Violation|2|||
13137972|NCT02710045|26003172|FG002|Overall Study|Protocol Violation|3|||
13137973|NCT02710045|26003170|FG000|Overall Study|Lost to Follow-up|3|||
13137974|NCT02710045|26003171|FG001|Overall Study|Lost to Follow-up|6|||
13137975|NCT02710045|26003172|FG002|Overall Study|Lost to Follow-up|7|||
13137976|NCT02710045|26003170|FG000|Overall Study|Physician Decision|0|||
13137977|NCT02710045|26003171|FG001|Overall Study|Physician Decision|0|||
13137978|NCT02710045|26003172|FG002|Overall Study|Physician Decision|1|||
13137979|NCT02710045|26003170|FG000|Overall Study|Poor Attendance|0|||
13137980|NCT02710045|26003171|FG001|Overall Study|Poor Attendance|1|||
13137981|NCT02710045|26003172|FG002|Overall Study|Poor Attendance|0|||
13137982|NCT02709889|26003271|FG000|Overall Study|Withdrawal by Subject|11|||
13137983|NCT02709889|26003272|FG001|Overall Study|Withdrawal by Subject|10|||
13137984|NCT02709889|26003273|FG002|Overall Study|Withdrawal by Subject|2|||
13137985|NCT02709889|26003274|FG003|Overall Study|Withdrawal by Subject|12|||
13137986|NCT02709889|26003271|FG000|Overall Study|Death|25|||
13137987|NCT02709889|26003272|FG001|Overall Study|Death|38|||
13137988|NCT02709889|26003273|FG002|Overall Study|Death|4|||
13137989|NCT02709889|26003274|FG003|Overall Study|Death|44|||
13137990|NCT02709889|26003271|FG000|Overall Study|Physician Decision|1|||
13137991|NCT02709889|26003272|FG001|Overall Study|Physician Decision|2|||
13137992|NCT02709889|26003273|FG002|Overall Study|Physician Decision|3|||
13137993|NCT02709889|26003274|FG003|Overall Study|Physician Decision|5|||
13137994|NCT02709889|26003271|FG000|Overall Study|Lost to Follow-up|2|||
13137995|NCT02709889|26003272|FG001|Overall Study|Lost to Follow-up|0|||
13137996|NCT02709889|26003273|FG002|Overall Study|Lost to Follow-up|0|||
13137997|NCT02709889|26003274|FG003|Overall Study|Lost to Follow-up|4|||
13137998|NCT02709889|26003271|FG000|Overall Study|Study Terminated by Sponsor|4|||
13137999|NCT02709889|26003272|FG001|Overall Study|Study Terminated by Sponsor|6|||
13222525|NCT01806597|26286267|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
13138000|NCT02709889|26003273|FG002|Overall Study|Study Terminated by Sponsor|2|||
13138001|NCT02709889|26003274|FG003|Overall Study|Study Terminated by Sponsor|17|||
13138002|NCT02709889|26003271|FG000|Overall Study|Other, Not Specified|0|||
13138003|NCT02709889|26003272|FG001|Overall Study|Other, Not Specified|1|||
13138004|NCT02709889|26003273|FG002|Overall Study|Other, Not Specified|1|||
13138005|NCT02709889|26003274|FG003|Overall Study|Other, Not Specified|6|||
13138006|NCT02709785|26003304|FG000|Overall Study|Withdrawal by Subject|1|||
13138007|NCT02709785|26003305|FG001|Overall Study|Withdrawal by Subject|2|||
13138008|NCT02709785|26003306|FG002|Overall Study|Withdrawal by Subject|1|||
13138009|NCT02709746|26003442|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4|||
13138010|NCT02709746|26003443|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
13138011|NCT02709746|26003444|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
13138012|NCT02709746|26003445|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
13138013|NCT02709746|26003446|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
13138014|NCT02709746|26003442|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14|||
13138015|NCT02709746|26003443|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
13138016|NCT02709746|26003444|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
13138017|NCT02709746|26003445|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
13138018|NCT02709746|26003446|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
13138019|NCT02709746|26003442|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12|||
13138020|NCT02709746|26003443|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
13138021|NCT02709746|26003444|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
13138022|NCT02709746|26003445|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
13138023|NCT02709746|26003446|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
13138024|NCT02709746|26003442|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7|||
13138025|NCT02709746|26003443|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
13138026|NCT02709746|26003444|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
13138027|NCT02709746|26003445|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
13138028|NCT02709746|26003446|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
13138029|NCT02709746|26003442|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2|||
13138030|NCT02709746|26003443|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
13138031|NCT02709746|26003444|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
13138032|NCT02709746|26003445|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
13138033|NCT02709746|26003446|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
13138034|NCT02709746|26003442|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12|||
13138035|NCT02709746|26003443|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
13138036|NCT02709746|26003444|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
13138037|NCT02709746|26003445|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
13138038|NCT02709746|26003446|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
13138039|NCT02709746|26003442|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7|||
13138040|NCT02709746|26003443|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
13138041|NCT02709746|26003444|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
13138042|NCT02709746|26003445|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
13138043|NCT02709746|26003446|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
13138044|NCT02709746|26003442|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7|||
13138045|NCT02709746|26003443|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
13138046|NCT02709746|26003444|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
13138047|NCT02709746|26003445|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
13138048|NCT02709746|26003446|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
13138049|NCT02709746|26003442|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103|||
13138050|NCT02709746|26003443|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
13138051|NCT02709746|26003444|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
13138052|NCT02709746|26003445|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
13138053|NCT02709746|26003446|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
13138054|NCT02709746|26003442|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
13138055|NCT02709746|26003443|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1|||
13138056|NCT02709746|26003444|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
13138057|NCT02709746|26003445|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
13138058|NCT02709746|26003446|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2|||
13138059|NCT02709746|26003442|FG000|Phase B (Double-blind Treatment Period)|Other|0|||
13138060|NCT02709746|26003443|FG001|Phase B (Double-blind Treatment Period)|Other|6|||
13138061|NCT02709746|26003444|FG002|Phase B (Double-blind Treatment Period)|Other|5|||
13138062|NCT02709746|26003445|FG003|Phase B (Double-blind Treatment Period)|Other|6|||
13138063|NCT02709746|26003446|FG004|Phase B (Double-blind Treatment Period)|Other|7|||
13138064|NCT02709746|26003442|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
13138065|NCT02709746|26003443|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
13138066|NCT02709746|26003444|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4|||
13138067|NCT02709746|26003445|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
13138068|NCT02709746|26003446|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
13138069|NCT02709746|26003442|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
13138070|NCT02709746|26003443|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3|||
13138071|NCT02709746|26003444|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
13138072|NCT02709746|26003445|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1|||
13138073|NCT02709746|26003446|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2|||
13138074|NCT02709746|26003442|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0|||
13138075|NCT02709746|26003443|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4|||
13138076|NCT02709746|26003444|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8|||
13138077|NCT02709746|26003445|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5|||
13138078|NCT02709746|26003446|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2|||
13138079|NCT02709746|26003442|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0|||
13138080|NCT02709746|26003443|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
13138081|NCT02709746|26003444|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
13138082|NCT02709746|26003445|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
13138083|NCT02709746|26003446|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1|||
13138084|NCT02709746|26003442|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
13138085|NCT02709746|26003443|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
13138086|NCT02709746|26003444|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1|||
13138087|NCT02709746|26003445|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
13091066|NCT03760068|25822387|FG001|Overall Study|Lost to Follow-up|9|||
13091067|NCT03760068|25822386|FG000|Overall Study|Subject Moved Out of State|1|||
13091068|NCT03760068|25822387|FG001|Overall Study|Subject Moved Out of State|0|||
13091069|NCT03759600|25822403|FG000|Overall Study|Ongoing at Data Cut-off|16|||
13091070|NCT03759600|25822403|FG000|Overall Study|Adverse Event|1|||
13138088|NCT02709746|26003446|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
13138089|NCT02709746|26003442|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
13138090|NCT02709746|26003443|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4|||
13138091|NCT02709746|26003444|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
13138092|NCT02709746|26003445|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
13138093|NCT02709746|26003446|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
13138094|NCT02709655|26003544|FG000|Single-Blind Phase (4 Weeks)|Adverse Event|2|||
13138095|NCT02709655|26003545|FG001|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
13138096|NCT02709655|26003546|FG002|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
13138097|NCT02709655|26003547|FG003|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
13138098|NCT02709655|26003548|FG004|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
13138099|NCT02709655|26003544|FG000|Single-Blind Phase (4 Weeks)|Lack of Efficacy|8|||
13138100|NCT02709655|26003545|FG001|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
13138101|NCT02709655|26003546|FG002|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
13138102|NCT02709655|26003547|FG003|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
13222526|NCT01806597|26286268|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
13222527|NCT01806597|26286269|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
13222528|NCT01806597|26286270|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
13222529|NCT01806597|26286271|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1|||
13222530|NCT01806584|26286290|FG000|Overall Study|Adverse Event|2|||
13222531|NCT01806584|26286291|FG001|Overall Study|Adverse Event|1|||
13222532|NCT01806584|26286290|FG000|Overall Study|Death|1|||
13222533|NCT01806584|26286291|FG001|Overall Study|Death|0|||
13222534|NCT01806584|26286290|FG000|Overall Study|Lost to Follow-up|0|||
13222535|NCT01806584|26286291|FG001|Overall Study|Lost to Follow-up|2|||
13222536|NCT01806584|26286290|FG000|Overall Study|Study terminated by sponsor|9|||
13222537|NCT01806584|26286291|FG001|Overall Study|Study terminated by sponsor|14|||
13222538|NCT01806584|26286290|FG000|Overall Study|Withdrawal by Subject|1|||
13222539|NCT01806584|26286291|FG001|Overall Study|Withdrawal by Subject|1|||
13222540|NCT01806584|26286290|FG000|Overall Study|Other unspecified|1|||
13222541|NCT01806584|26286291|FG001|Overall Study|Other unspecified|0|||
13091071|NCT03759600|25822403|FG000|Overall Study|Progressive Disease|3|||
13091072|NCT03759587|25822418|FG000|Overall Study|Ongoing|19|||
13091073|NCT03759366|25822437|FG000|Primary Evaluation Period (26 Weeks)|Ongoing during the Primary Evaluation Period|1|||
13091074|NCT03759366|25822437|FG000|Extension Period (Up to 208 Weeks)|Ongoing during the Extension Period|10|||
13091075|NCT03759340|25822448|FG000|Overall Study|Adverse Event|2|||
13091076|NCT03759340|25822448|FG000|Overall Study|Lost to Follow-up|1|||
13091077|NCT03759340|25822448|FG000|Overall Study|Withdrawal by Subject|15|||
13091078|NCT03759340|25822448|FG000|Overall Study|Study Terminated by Sponsor|38|||
13091079|NCT03759041|25822469|FG000|Overall Study|Withdrawal by Subject|4|||
13091080|NCT03759041|25822470|FG001|Overall Study|Withdrawal by Subject|10|||
13091081|NCT03759041|25822471|FG002|Overall Study|Withdrawal by Subject|10|||
13138103|NCT02709655|26003548|FG004|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
13138104|NCT02709655|26003544|FG000|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|3|||
13138105|NCT02709655|26003545|FG001|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
13138106|NCT02709655|26003546|FG002|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
13138107|NCT02709655|26003547|FG003|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
13138108|NCT02709655|26003548|FG004|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
13138109|NCT02709655|26003544|FG000|Single-Blind Phase (4 Weeks)|Protocol Violation|3|||
13138110|NCT02709655|26003545|FG001|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
13138111|NCT02709655|26003546|FG002|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
13138112|NCT02709655|26003547|FG003|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
13138113|NCT02709655|26003548|FG004|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
13138114|NCT02709655|26003544|FG000|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|15|||
13138115|NCT02709655|26003545|FG001|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
13138116|NCT02709655|26003546|FG002|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
13138117|NCT02709655|26003547|FG003|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
13138118|NCT02709655|26003548|FG004|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
13138119|NCT02709655|26003544|FG000|Single-Blind Phase (4 Weeks)|Lost to Follow-up|1|||
13138120|NCT02709655|26003545|FG001|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
13138121|NCT02709655|26003546|FG002|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
13138122|NCT02709655|26003547|FG003|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
13138123|NCT02709655|26003548|FG004|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
13138124|NCT02709655|26003544|FG000|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|85|||
13138125|NCT02709655|26003545|FG001|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
13138126|NCT02709655|26003546|FG002|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
13138127|NCT02709655|26003547|FG003|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
13138128|NCT02709655|26003548|FG004|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
13138129|NCT02709655|26003544|FG000|Single-Blind Phase (4 Weeks)|Other than specified|20|||
13138130|NCT02709655|26003545|FG001|Single-Blind Phase (4 Weeks)|Other than specified|0|||
13138131|NCT02709655|26003546|FG002|Single-Blind Phase (4 Weeks)|Other than specified|0|||
13138132|NCT02709655|26003547|FG003|Single-Blind Phase (4 Weeks)|Other than specified|0|||
13138133|NCT02709655|26003548|FG004|Single-Blind Phase (4 Weeks)|Other than specified|0|||
13138134|NCT02709655|26003544|FG000|Single-Blind Phase (4 Weeks)|Enrolled but not treated|6|||
13091082|NCT03759041|25822469|FG000|Overall Study|Adverse Event|1|||
13091083|NCT03759041|25822470|FG001|Overall Study|Adverse Event|3|||
13091084|NCT03759041|25822471|FG002|Overall Study|Adverse Event|4|||
13091085|NCT03759041|25822469|FG000|Overall Study|Lack of Efficacy|0|||
13091086|NCT03759041|25822470|FG001|Overall Study|Lack of Efficacy|0|||
13091087|NCT03759041|25822471|FG002|Overall Study|Lack of Efficacy|1|||
13091088|NCT03759041|25822469|FG000|Overall Study|Study Terminated by Sponsor|15|||
13091089|NCT03759041|25822470|FG001|Overall Study|Study Terminated by Sponsor|16|||
13091090|NCT03759041|25822471|FG002|Overall Study|Study Terminated by Sponsor|10|||
13091091|NCT03759041|25822469|FG000|Overall Study|Other reason for discontinuation|0|||
13091092|NCT03759041|25822470|FG001|Overall Study|Other reason for discontinuation|2|||
13091093|NCT03759041|25822471|FG002|Overall Study|Other reason for discontinuation|1|||
13091094|NCT03759041|25822469|FG000|Overall Study|Lost to Follow-up|7|||
13091095|NCT03759041|25822470|FG001|Overall Study|Lost to Follow-up|2|||
13091096|NCT03759041|25822471|FG002|Overall Study|Lost to Follow-up|2|||
13091097|NCT03759041|25822469|FG000|Overall Study|Subjects did not have a discontinuation page completed|0|||
13091098|NCT03759041|25822470|FG001|Overall Study|Subjects did not have a discontinuation page completed|1|||
13091099|NCT03759041|25822471|FG002|Overall Study|Subjects did not have a discontinuation page completed|0|||
13091100|NCT03758443|25822519|FG000|Induction Period|Adverse Event|2|||
13091101|NCT03758443|25822520|FG001|Induction Period|Adverse Event|4|||
13091102|NCT03758443|25822521|FG002|Induction Period|Adverse Event|2|||
13091103|NCT03758443|25822522|FG003|Induction Period|Adverse Event|3|||
13091104|NCT03758443|25822519|FG000|Induction Period|Physician Decision|1|||
13091105|NCT03758443|25822520|FG001|Induction Period|Physician Decision|1|||
13091106|NCT03758443|25822521|FG002|Induction Period|Physician Decision|3|||
13091107|NCT03758443|25822522|FG003|Induction Period|Physician Decision|0|||
13091108|NCT03758443|25822519|FG000|Induction Period|Protocol Violation|0|||
13091109|NCT03758443|25822520|FG001|Induction Period|Protocol Violation|0|||
13091110|NCT03758443|25822521|FG002|Induction Period|Protocol Violation|0|||
13091111|NCT03758443|25822522|FG003|Induction Period|Protocol Violation|1|||
13091112|NCT03758443|25822519|FG000|Induction Period|Withdrawal by Subject|3|||
13091113|NCT03758443|25822520|FG001|Induction Period|Withdrawal by Subject|2|||
13091114|NCT03758443|25822521|FG002|Induction Period|Withdrawal by Subject|2|||
13091115|NCT03758443|25822522|FG003|Induction Period|Withdrawal by Subject|4|||
13091116|NCT03758443|25822519|FG000|Extended Induction Period|Adverse Event|1|||
13091117|NCT03758443|25822520|FG001|Extended Induction Period|Adverse Event|1|||
13091118|NCT03758443|25822521|FG002|Extended Induction Period|Adverse Event|0|||
13091119|NCT03758443|25822522|FG003|Extended Induction Period|Adverse Event|1|||
13091120|NCT03758443|25822519|FG000|Extended Induction Period|Lost to Follow-up|1|||
13091121|NCT03758443|25822520|FG001|Extended Induction Period|Lost to Follow-up|0|||
13091122|NCT03758443|25822521|FG002|Extended Induction Period|Lost to Follow-up|0|||
13091123|NCT03758443|25822522|FG003|Extended Induction Period|Lost to Follow-up|0|||
13091124|NCT03758443|25822519|FG000|Extended Induction Period|Physician Decision|2|||
13091125|NCT03758443|25822520|FG001|Extended Induction Period|Physician Decision|1|||
13091126|NCT03758443|25822521|FG002|Extended Induction Period|Physician Decision|2|||
13091127|NCT03758443|25822522|FG003|Extended Induction Period|Physician Decision|2|||
13091128|NCT03758443|25822519|FG000|Extended Induction Period|Protocol Violation|0|||
13091129|NCT03758443|25822520|FG001|Extended Induction Period|Protocol Violation|0|||
13091130|NCT03758443|25822521|FG002|Extended Induction Period|Protocol Violation|0|||
13091131|NCT03758443|25822522|FG003|Extended Induction Period|Protocol Violation|1|||
13091132|NCT03758443|25822519|FG000|Extended Induction Period|Withdrawal by Subject|8|||
13091133|NCT03758443|25822520|FG001|Extended Induction Period|Withdrawal by Subject|1|||
13091134|NCT03758443|25822521|FG002|Extended Induction Period|Withdrawal by Subject|7|||
13091135|NCT03758443|25822522|FG003|Extended Induction Period|Withdrawal by Subject|3|||
13091136|NCT03758443|25822519|FG000|Extended Induction Period|Miscellaneous|1|||
13091137|NCT03758443|25822520|FG001|Extended Induction Period|Miscellaneous|0|||
13091138|NCT03758443|25822521|FG002|Extended Induction Period|Miscellaneous|0|||
13091139|NCT03758443|25822522|FG003|Extended Induction Period|Miscellaneous|0|||
13091140|NCT03758443|25822519|FG000|Maintenance Period|Adverse Event|1|||
13091141|NCT03758443|25822520|FG001|Maintenance Period|Adverse Event|2|||
13091142|NCT03758443|25822521|FG002|Maintenance Period|Adverse Event|0|||
13091143|NCT03758443|25822522|FG003|Maintenance Period|Adverse Event|0|||
13091144|NCT03758443|25822519|FG000|Maintenance Period|Lost to Follow-up|0|||
13091145|NCT03758443|25822520|FG001|Maintenance Period|Lost to Follow-up|0|||
13091146|NCT03758443|25822521|FG002|Maintenance Period|Lost to Follow-up|0|||
13091147|NCT03758443|25822522|FG003|Maintenance Period|Lost to Follow-up|1|||
13091148|NCT03758443|25822519|FG000|Maintenance Period|Persistent Loss of Response During Maintenance|3|||
13091149|NCT03758443|25822520|FG001|Maintenance Period|Persistent Loss of Response During Maintenance|1|||
13091150|NCT03758443|25822521|FG002|Maintenance Period|Persistent Loss of Response During Maintenance|2|||
13091151|NCT03758443|25822522|FG003|Maintenance Period|Persistent Loss of Response During Maintenance|0|||
13091152|NCT03758443|25822519|FG000|Maintenance Period|Protocol Violation|0|||
13091153|NCT03758443|25822520|FG001|Maintenance Period|Protocol Violation|1|||
13091154|NCT03758443|25822521|FG002|Maintenance Period|Protocol Violation|0|||
13091155|NCT03758443|25822522|FG003|Maintenance Period|Protocol Violation|0|||
13091156|NCT03758443|25822519|FG000|Maintenance Period|Study Terminated by Sponsor|11|||
13091157|NCT03758443|25822520|FG001|Maintenance Period|Study Terminated by Sponsor|16|||
13091158|NCT03758443|25822521|FG002|Maintenance Period|Study Terminated by Sponsor|9|||
13091159|NCT03758443|25822522|FG003|Maintenance Period|Study Terminated by Sponsor|11|||
13091160|NCT03758443|25822519|FG000|Maintenance Period|Withdrawal by Subject|1|||
13091161|NCT03758443|25822520|FG001|Maintenance Period|Withdrawal by Subject|0|||
13091162|NCT03758443|25822521|FG002|Maintenance Period|Withdrawal by Subject|1|||
13091163|NCT03758443|25822522|FG003|Maintenance Period|Withdrawal by Subject|1|||
13091164|NCT03758443|25822519|FG000|Maintenance Period|Miscellaneous|0|||
13091165|NCT03758443|25822520|FG001|Maintenance Period|Miscellaneous|0|||
13091166|NCT03758443|25822521|FG002|Maintenance Period|Miscellaneous|1|||
13091167|NCT03758443|25822522|FG003|Maintenance Period|Miscellaneous|0|||
13091168|NCT03757988|25822542|FG000|Overall Study|Withdrawal by Subject|1|||
13091169|NCT03757715|25822557|FG000|Overall Study|Lost to Follow-up|4|||
13091170|NCT03757715|25822558|FG001|Overall Study|Lost to Follow-up|9|||
13091171|NCT03757715|25822557|FG000|Overall Study|Withdrawal by Subject|1|||
13091172|NCT03757715|25822558|FG001|Overall Study|Withdrawal by Subject|1|||
13091173|NCT03757234|25822606|FG000|Overall Study|Adverse Event|0|||
13091174|NCT03757234|25822607|FG001|Overall Study|Adverse Event|0|||
13091175|NCT03757234|25822608|FG002|Overall Study|Adverse Event|0|||
13091176|NCT03757234|25822609|FG003|Overall Study|Adverse Event|0|||
13091177|NCT03757234|25822610|FG004|Overall Study|Adverse Event|1|||
13138135|NCT02709655|26003545|FG001|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
13138136|NCT02709655|26003546|FG002|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
13138137|NCT02709655|26003547|FG003|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
13138138|NCT02709655|26003548|FG004|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
13138139|NCT02709655|26003544|FG000|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
13138140|NCT02709655|26003545|FG001|Double-Blind Phase (8 Weeks)|Adverse Event|1|||
13222542|NCT01806545|26286320|FG000|Overall Study|Adverse Event|2|||
13091178|NCT03757234|25822606|FG000|Overall Study|Lost to Follow-up|1|||
13091179|NCT03757234|25822607|FG001|Overall Study|Lost to Follow-up|0|||
13091180|NCT03757234|25822608|FG002|Overall Study|Lost to Follow-up|0|||
13091181|NCT03757234|25822609|FG003|Overall Study|Lost to Follow-up|0|||
13091182|NCT03757234|25822610|FG004|Overall Study|Lost to Follow-up|1|||
13091183|NCT03757234|25822606|FG000|Overall Study|Withdrawal by Subject|1|||
13091184|NCT03757234|25822607|FG001|Overall Study|Withdrawal by Subject|1|||
13091185|NCT03757234|25822608|FG002|Overall Study|Withdrawal by Subject|0|||
13091186|NCT03757234|25822609|FG003|Overall Study|Withdrawal by Subject|1|||
13138141|NCT02709655|26003546|FG002|Double-Blind Phase (8 Weeks)|Adverse Event|2|||
13138142|NCT02709655|26003547|FG003|Double-Blind Phase (8 Weeks)|Adverse Event|3|||
13138143|NCT02709655|26003548|FG004|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
13138144|NCT02709655|26003544|FG000|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
13138145|NCT02709655|26003545|FG001|Double-Blind Phase (8 Weeks)|Lack of Efficacy|2|||
13138146|NCT02709655|26003546|FG002|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
13138147|NCT02709655|26003547|FG003|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
13138148|NCT02709655|26003548|FG004|Double-Blind Phase (8 Weeks)|Lack of Efficacy|1|||
13138149|NCT02709655|26003544|FG000|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|0|||
13138150|NCT02709655|26003545|FG001|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
13138151|NCT02709655|26003546|FG002|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|3|||
13138152|NCT02709655|26003547|FG003|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|6|||
13138153|NCT02709655|26003548|FG004|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
13138154|NCT02709655|26003544|FG000|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
13138155|NCT02709655|26003545|FG001|Double-Blind Phase (8 Weeks)|Protocol Violation|1|||
13138156|NCT02709655|26003546|FG002|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
13138157|NCT02709655|26003547|FG003|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
13138158|NCT02709655|26003548|FG004|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
13138159|NCT02709655|26003544|FG000|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|0|||
13138160|NCT02709655|26003545|FG001|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
13138161|NCT02709655|26003546|FG002|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
13138162|NCT02709655|26003547|FG003|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
13138163|NCT02709655|26003548|FG004|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|1|||
13138164|NCT02709655|26003544|FG000|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
13138165|NCT02709655|26003545|FG001|Double-Blind Phase (8 Weeks)|Lost to Follow-up|1|||
13138166|NCT02709655|26003546|FG002|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
13138167|NCT02709655|26003547|FG003|Double-Blind Phase (8 Weeks)|Lost to Follow-up|2|||
13138168|NCT02709655|26003548|FG004|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
13138169|NCT02709655|26003544|FG000|Double-Blind Phase (8 Weeks)|Other than specified|0|||
13138170|NCT02709655|26003545|FG001|Double-Blind Phase (8 Weeks)|Other than specified|5|||
13138171|NCT02709655|26003546|FG002|Double-Blind Phase (8 Weeks)|Other than specified|7|||
13138172|NCT02709655|26003547|FG003|Double-Blind Phase (8 Weeks)|Other than specified|5|||
13138173|NCT02709655|26003548|FG004|Double-Blind Phase (8 Weeks)|Other than specified|2|||
13138174|NCT02709577|26003569|FG000|Overall Study|non-accommodating anatomy|0|||
13138175|NCT02709577|26003570|FG001|Overall Study|non-accommodating anatomy|1|||
13138176|NCT02709577|26003571|FG002|Overall Study|non-accommodating anatomy|0|||
13138177|NCT02709577|26003572|FG003|Overall Study|non-accommodating anatomy|0|||
13138178|NCT02709577|26003569|FG000|Overall Study|procedural complication|0|||
13138179|NCT02709577|26003570|FG001|Overall Study|procedural complication|1|||
13138180|NCT02709577|26003571|FG002|Overall Study|procedural complication|0|||
13138181|NCT02709577|26003572|FG003|Overall Study|procedural complication|0|||
13138182|NCT02709577|26003569|FG000|Overall Study|Withdrawal by Subject|2|||
13138183|NCT02709577|26003570|FG001|Overall Study|Withdrawal by Subject|3|||
13138184|NCT02709577|26003571|FG002|Overall Study|Withdrawal by Subject|2|||
13138185|NCT02709577|26003572|FG003|Overall Study|Withdrawal by Subject|0|||
13204619|NCT01972152|26229456|FG001|Second Treatment Visit|Protocol Violation|1|||
13204620|NCT01972152|26229457|FG002|Second Treatment Visit|Protocol Violation|0|||
13204621|NCT01972152|26229458|FG003|Second Treatment Visit|Protocol Violation|0|||
13204622|NCT01972152|26229459|FG004|Second Treatment Visit|Protocol Violation|0|||
13204623|NCT01972152|26229460|FG005|Second Treatment Visit|Protocol Violation|0|||
13204624|NCT01972074|26229477|FG000|Overall Study|Adverse Event|4|||
13204625|NCT01972074|26229478|FG001|Overall Study|Adverse Event|1|||
13204626|NCT01972074|26229479|FG002|Overall Study|Adverse Event|0|||
13204627|NCT01972074|26229477|FG000|Overall Study|Lack of Efficacy|1|||
13204628|NCT01972074|26229478|FG001|Overall Study|Lack of Efficacy|1|||
13204629|NCT01972074|26229479|FG002|Overall Study|Lack of Efficacy|0|||
13204630|NCT01972074|26229477|FG000|Overall Study|Lost to Follow-up|0|||
13204631|NCT01972074|26229478|FG001|Overall Study|Lost to Follow-up|1|||
13204632|NCT01972074|26229479|FG002|Overall Study|Lost to Follow-up|1|||
13204633|NCT01972074|26229477|FG000|Overall Study|Withdrawal by Subject|1|||
13204634|NCT01972074|26229478|FG001|Overall Study|Withdrawal by Subject|1|||
13204635|NCT01972074|26229479|FG002|Overall Study|Withdrawal by Subject|1|||
13204636|NCT01972074|26229477|FG000|Overall Study|Scanner Unavailable|0|||
13204637|NCT01972074|26229478|FG001|Overall Study|Scanner Unavailable|0|||
13204638|NCT01972074|26229479|FG002|Overall Study|Scanner Unavailable|1|||
13204639|NCT01971723|26229516|FG000|Overall Study|Withdrawal by Subject|1|||
13204640|NCT01971723|26229517|FG001|Overall Study|Withdrawal by Subject|1|||
13204641|NCT01971723|26229516|FG000|Overall Study|Protocol Violation|1|||
13204642|NCT01971723|26229517|FG001|Overall Study|Protocol Violation|2|||
13204643|NCT01971645|26229538|FG000|Overall Study|Adverse Event|1|||
13204644|NCT01971645|26229539|FG001|Overall Study|Adverse Event|0|||
13204645|NCT01971645|26229540|FG002|Overall Study|Adverse Event|0|||
13204646|NCT01971645|26229538|FG000|Overall Study|Lost to Follow-up|1|||
13138186|NCT02709538|26003590|FG000|Overall Study|Adverse Event|13|||
13138187|NCT02709538|26003591|FG001|Overall Study|Adverse Event|2|||
13138188|NCT02709538|26003592|FG002|Overall Study|Adverse Event|3|||
13138189|NCT02709538|26003590|FG000|Overall Study|Lack of Efficacy|1|||
13138190|NCT02709538|26003591|FG001|Overall Study|Lack of Efficacy|0|||
13138191|NCT02709538|26003592|FG002|Overall Study|Lack of Efficacy|0|||
13138192|NCT02709538|26003590|FG000|Overall Study|Lost to Follow-up|24|||
13138193|NCT02709538|26003591|FG001|Overall Study|Lost to Follow-up|8|||
13138194|NCT02709538|26003592|FG002|Overall Study|Lost to Follow-up|4|||
13138195|NCT02709538|26003590|FG000|Overall Study|Physician Decision|1|||
13138196|NCT02709538|26003591|FG001|Overall Study|Physician Decision|0|||
13138197|NCT02709538|26003592|FG002|Overall Study|Physician Decision|0|||
13138198|NCT02709538|26003590|FG000|Overall Study|Withdrawal by Subject|40|||
13138199|NCT02709538|26003591|FG001|Overall Study|Withdrawal by Subject|7|||
13138200|NCT02709538|26003592|FG002|Overall Study|Withdrawal by Subject|4|||
13138201|NCT02709538|26003590|FG000|Overall Study|Non-compliance with study procedures|5|||
13138202|NCT02709538|26003591|FG001|Overall Study|Non-compliance with study procedures|0|||
13138203|NCT02709538|26003592|FG002|Overall Study|Non-compliance with study procedures|0|||
13138204|NCT02709538|26003590|FG000|Overall Study|Non-compliance with study drug|2|||
13138205|NCT02709538|26003591|FG001|Overall Study|Non-compliance with study drug|0|||
13138206|NCT02709538|26003592|FG002|Overall Study|Non-compliance with study drug|0|||
13138207|NCT02709538|26003590|FG000|Overall Study|Protocol deviation|10|||
13138208|NCT02709538|26003591|FG001|Overall Study|Protocol deviation|4|||
13138209|NCT02709538|26003592|FG002|Overall Study|Protocol deviation|4|||
13138210|NCT02709538|26003590|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1|||
13138211|NCT02709538|26003591|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
13138212|NCT02709538|26003592|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
13138213|NCT02709538|26003590|FG000|Overall Study|Other|16|||
13138214|NCT02709538|26003591|FG001|Overall Study|Other|7|||
13138215|NCT02709538|26003592|FG002|Overall Study|Other|5|||
13138216|NCT02709486|26003793|FG000|Overall Study|Adverse Event|2|||
13138217|NCT02709486|26003794|FG001|Overall Study|Adverse Event|5|||
13138218|NCT02709486|26003795|FG002|Overall Study|Adverse Event|3|||
13138219|NCT02709486|26003793|FG000|Overall Study|Death|0|||
13138220|NCT02709486|26003794|FG001|Overall Study|Death|0|||
13138221|NCT02709486|26003795|FG002|Overall Study|Death|2|||
13138222|NCT02709486|26003793|FG000|Overall Study|Insufficient clinical response|7|||
13138223|NCT02709486|26003794|FG001|Overall Study|Insufficient clinical response|3|||
13138224|NCT02709486|26003795|FG002|Overall Study|Insufficient clinical response|3|||
13138225|NCT02709486|26003793|FG000|Overall Study|Lost to Follow-up|3|||
13138226|NCT02709486|26003794|FG001|Overall Study|Lost to Follow-up|2|||
13138227|NCT02709486|26003795|FG002|Overall Study|Lost to Follow-up|2|||
13138228|NCT02709486|26003793|FG000|Overall Study|Other|0|||
13138229|NCT02709486|26003794|FG001|Overall Study|Other|2|||
13138230|NCT02709486|26003795|FG002|Overall Study|Other|3|||
13138231|NCT02709486|26003793|FG000|Overall Study|Withdrawal by Subject|32|||
13138232|NCT02709486|26003794|FG001|Overall Study|Withdrawal by Subject|22|||
13138233|NCT02709486|26003795|FG002|Overall Study|Withdrawal by Subject|32|||
13138234|NCT02709369|26003831|FG000|Overall Study|Lost to Follow-up|15|||
13138235|NCT02709369|26003831|FG000|Overall Study|Withdrawal by Subject|10|||
13138236|NCT02709369|26003831|FG000|Overall Study|Did not received intervention|2|||
13138237|NCT02709330|26003846|FG000|Overall Study|Death|5|||
13138238|NCT02709330|26003847|FG001|Overall Study|Death|0|||
13138239|NCT02709330|26003846|FG000|Overall Study|Lost to Follow-up|2|||
13138240|NCT02709330|26003847|FG001|Overall Study|Lost to Follow-up|0|||
13138241|NCT02709330|26003846|FG000|Overall Study|Physician Decision|2|||
13138242|NCT02709330|26003847|FG001|Overall Study|Physician Decision|0|||
13138243|NCT02709330|26003846|FG000|Overall Study|Withdrawal by Subject|4|||
13138244|NCT02709330|26003847|FG001|Overall Study|Withdrawal by Subject|0|||
13138245|NCT02709109|26003878|FG000|Treatment Period 1 (28 Days)|Adverse Event|3|||
13138246|NCT02709109|26003879|FG001|Treatment Period 1 (28 Days)|Adverse Event|3|||
13138247|NCT02709109|26003880|FG002|Treatment Period 1 (28 Days)|Adverse Event|1|||
13138248|NCT02709109|26003881|FG003|Treatment Period 1 (28 Days)|Adverse Event|0|||
13138249|NCT02709109|26003878|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
13138250|NCT02709109|26003879|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2|||
13138251|NCT02709109|26003880|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
13138252|NCT02709109|26003881|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
13138253|NCT02709109|26003878|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1|||
13138254|NCT02709109|26003879|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
13138255|NCT02709109|26003880|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
13138256|NCT02709109|26003881|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
13138257|NCT02709109|26003878|FG000|Washout Period (28 Days)|Other|2|||
13138258|NCT02709109|26003879|FG001|Washout Period (28 Days)|Other|2|||
13138259|NCT02709109|26003880|FG002|Washout Period (28 Days)|Other|3|||
13138260|NCT02709109|26003881|FG003|Washout Period (28 Days)|Other|0|||
13204647|NCT01971645|26229539|FG001|Overall Study|Lost to Follow-up|0|||
13138261|NCT02709109|26003878|FG000|Treatment Period 2 (28 Days)|Adverse Event|2|||
13138262|NCT02709109|26003879|FG001|Treatment Period 2 (28 Days)|Adverse Event|3|||
13138263|NCT02709109|26003880|FG002|Treatment Period 2 (28 Days)|Adverse Event|0|||
13138264|NCT02709109|26003881|FG003|Treatment Period 2 (28 Days)|Adverse Event|0|||
13138265|NCT02709109|26003878|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0|||
13138266|NCT02709109|26003879|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1|||
13138267|NCT02709109|26003880|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1|||
13138268|NCT02709109|26003881|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0|||
13138269|NCT02709109|26003878|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
13138270|NCT02709109|26003879|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
13138271|NCT02709109|26003880|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1|||
13138272|NCT02709109|26003881|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
13138273|NCT02709109|26003878|FG000|Treatment Period 2 (28 Days)|Other|0|||
13138274|NCT02709109|26003879|FG001|Treatment Period 2 (28 Days)|Other|0|||
13138275|NCT02709109|26003880|FG002|Treatment Period 2 (28 Days)|Other|1|||
13138276|NCT02709109|26003881|FG003|Treatment Period 2 (28 Days)|Other|0|||
13138277|NCT02709096|26003894|FG000|Overall Study|non-compliance|1|||
13138278|NCT02709096|26003895|FG001|Overall Study|non-compliance|1|||
13138279|NCT02709083|26003908|FG000|Overall Study|Original PI left institution|7|||
13138280|NCT02709005|26003943|FG000|Overall Study|Lost to Follow-up|1|||
13138281|NCT02709005|26003944|FG001|Overall Study|Lost to Follow-up|1|||
13138282|NCT02709005|26003943|FG000|Overall Study|Withdrawal by Subject|3|||
13138283|NCT02709005|26003944|FG001|Overall Study|Withdrawal by Subject|0|||
13138284|NCT02708966|26003993|FG000|Overall Study|Lost to Follow-up|2|||
13138285|NCT02708966|26003994|FG001|Overall Study|Lost to Follow-up|2|||
13138286|NCT02708524|26004053|FG000|Overall Study|Adverse Event|0|||
13138287|NCT02708524|26004054|FG001|Overall Study|Adverse Event|1|||
13138288|NCT02708524|26004055|FG002|Overall Study|Adverse Event|0|||
13138289|NCT02708524|26004056|FG003|Overall Study|Adverse Event|0|||
13138290|NCT02708524|26004053|FG000|Overall Study|Lens Discomfort|1|||
13138291|NCT02708524|26004054|FG001|Overall Study|Lens Discomfort|0|||
13138292|NCT02708524|26004055|FG002|Overall Study|Lens Discomfort|1|||
13138293|NCT02708524|26004056|FG003|Overall Study|Lens Discomfort|0|||
13138294|NCT02708524|26004053|FG000|Overall Study|Lost to Follow-up|1|||
13138295|NCT02708524|26004054|FG001|Overall Study|Lost to Follow-up|1|||
13138296|NCT02708524|26004055|FG002|Overall Study|Lost to Follow-up|1|||
13138297|NCT02708524|26004056|FG003|Overall Study|Lost to Follow-up|0|||
13138298|NCT02708524|26004053|FG000|Overall Study|Protocol Violation|0|||
13138299|NCT02708524|26004054|FG001|Overall Study|Protocol Violation|1|||
13138300|NCT02708524|26004055|FG002|Overall Study|Protocol Violation|0|||
13138301|NCT02708524|26004056|FG003|Overall Study|Protocol Violation|0|||
13138302|NCT02708524|26004053|FG000|Overall Study|Withdrawal by Subject|1|||
13138303|NCT02708524|26004054|FG001|Overall Study|Withdrawal by Subject|1|||
13138304|NCT02708524|26004055|FG002|Overall Study|Withdrawal by Subject|0|||
13138305|NCT02708524|26004056|FG003|Overall Study|Withdrawal by Subject|0|||
13138306|NCT02708524|26004053|FG000|Overall Study|Dispensed incorrect study lens|0|||
13138307|NCT02708524|26004054|FG001|Overall Study|Dispensed incorrect study lens|1|||
13138308|NCT02708524|26004055|FG002|Overall Study|Dispensed incorrect study lens|1|||
13138309|NCT02708524|26004056|FG003|Overall Study|Dispensed incorrect study lens|0|||
13138310|NCT02708524|26004053|FG000|Overall Study|Did not wear lens at final visit|0|||
13138311|NCT02708524|26004054|FG001|Overall Study|Did not wear lens at final visit|1|||
13138312|NCT02708524|26004055|FG002|Overall Study|Did not wear lens at final visit|0|||
13138313|NCT02708524|26004056|FG003|Overall Study|Did not wear lens at final visit|0|||
13138314|NCT02708524|26004053|FG000|Overall Study|Subject lost study lens|1|||
13138315|NCT02708524|26004054|FG001|Overall Study|Subject lost study lens|0|||
13138316|NCT02708524|26004055|FG002|Overall Study|Subject lost study lens|0|||
13138317|NCT02708524|26004056|FG003|Overall Study|Subject lost study lens|0|||
13138318|NCT02708498|26004107|FG000|Overall Study|Death|20|||
13138319|NCT02708498|26004108|FG001|Overall Study|Death|19|||
13138320|NCT02708498|26004109|FG002|Overall Study|Death|0|||
13138321|NCT02708498|26004110|FG003|Overall Study|Death|0|||
13138322|NCT02708498|26004111|FG004|Overall Study|Death|1|||
13138323|NCT02708498|26004112|FG005|Overall Study|Death|0|||
13138324|NCT02708498|26004113|FG006|Overall Study|Death|0|||
13138325|NCT02708498|26004114|FG007|Overall Study|Death|0|||
13138326|NCT02708498|26004107|FG000|Overall Study|Unknown reason, missing data|0|||
13138327|NCT02708498|26004108|FG001|Overall Study|Unknown reason, missing data|0|||
13138328|NCT02708498|26004109|FG002|Overall Study|Unknown reason, missing data|62|||
13138329|NCT02708498|26004110|FG003|Overall Study|Unknown reason, missing data|51|||
13138330|NCT02708498|26004111|FG004|Overall Study|Unknown reason, missing data|195|||
13138331|NCT02708498|26004112|FG005|Overall Study|Unknown reason, missing data|132|||
13138332|NCT02708498|26004113|FG006|Overall Study|Unknown reason, missing data|0|||
13138333|NCT02708498|26004114|FG007|Overall Study|Unknown reason, missing data|0|||
13138334|NCT02708485|26004129|FG000|Overall Study|Withdrawal by Subject|3|||
13138335|NCT02708485|26004130|FG001|Overall Study|Withdrawal by Subject|2|||
13138336|NCT02708355|26004151|FG000|Overall Study|Adverse Event|1|||
13138337|NCT02708355|26004152|FG001|Overall Study|Adverse Event|0|||
13138338|NCT02708355|26004153|FG002|Overall Study|Adverse Event|0|||
13138339|NCT02708277|26004172|FG000|Overall Study|Lost to Follow-up|7|||
13138340|NCT02708277|26004173|FG001|Overall Study|Lost to Follow-up|4|||
13138341|NCT02708121|26004189|FG000|Overall Study|Withdrawn by Study Team|1|||
13138342|NCT02708121|26004190|FG001|Overall Study|Withdrawn by Study Team|1|||
13138343|NCT02708121|26004189|FG000|Overall Study|Withdrawal by Subject|0|||
13138344|NCT02708121|26004190|FG001|Overall Study|Withdrawal by Subject|4|||
13138345|NCT02708095|26004221|FG000|Overall Study|Adverse Event|4|||
13138346|NCT02708095|26004222|FG001|Overall Study|Adverse Event|10|||
13138347|NCT02708095|26004223|FG002|Overall Study|Adverse Event|11|||
13138348|NCT02708095|26004221|FG000|Overall Study|Lack of Efficacy|9|||
13138349|NCT02708095|26004222|FG001|Overall Study|Lack of Efficacy|3|||
13138350|NCT02708095|26004223|FG002|Overall Study|Lack of Efficacy|0|||
13138351|NCT02708095|26004221|FG000|Overall Study|Lost to Follow-up|2|||
13138352|NCT02708095|26004222|FG001|Overall Study|Lost to Follow-up|0|||
13138353|NCT02708095|26004223|FG002|Overall Study|Lost to Follow-up|0|||
13138354|NCT02708095|26004221|FG000|Overall Study|Physician Decision|2|||
13138355|NCT02708095|26004222|FG001|Overall Study|Physician Decision|3|||
13138356|NCT02708095|26004223|FG002|Overall Study|Physician Decision|2|||
13138357|NCT02708095|26004221|FG000|Overall Study|Protocol Violation|0|||
13138358|NCT02708095|26004222|FG001|Overall Study|Protocol Violation|0|||
13138359|NCT02708095|26004223|FG002|Overall Study|Protocol Violation|1|||
13138360|NCT02708095|26004221|FG000|Overall Study|Withdrawal by Subject|5|||
13138361|NCT02708095|26004222|FG001|Overall Study|Withdrawal by Subject|3|||
13138362|NCT02708095|26004223|FG002|Overall Study|Withdrawal by Subject|4|||
13138363|NCT02707991|26004238|FG000|Overall Study|Protocol Violation|1|||
13138364|NCT02707991|26004239|FG001|Overall Study|Protocol Violation|0|||
13138365|NCT02707991|26004238|FG000|Overall Study|Became ineligible|0|||
13138366|NCT02707991|26004239|FG001|Overall Study|Became ineligible|1|||
13138367|NCT02707965|26004322|FG000|Overall Study|Withdrawal by Subject|0|||
13138368|NCT02707965|26004323|FG001|Overall Study|Withdrawal by Subject|0|||
13138369|NCT02707965|26004324|FG002|Overall Study|Withdrawal by Subject|1|||
13138370|NCT02707965|26004325|FG003|Overall Study|Withdrawal by Subject|0|||
13138371|NCT02707965|26004326|FG004|Overall Study|Withdrawal by Subject|0|||
13138372|NCT02707965|26004327|FG005|Overall Study|Withdrawal by Subject|0|||
13138373|NCT02707965|26004328|FG006|Overall Study|Withdrawal by Subject|0|||
13138374|NCT02707965|26004329|FG007|Overall Study|Withdrawal by Subject|2|||
13138375|NCT02707965|26004330|FG008|Overall Study|Withdrawal by Subject|0|||
13138376|NCT02707965|26004331|FG009|Overall Study|Withdrawal by Subject|0|||
13138377|NCT02707965|26004332|FG010|Overall Study|Withdrawal by Subject|0|||
13138378|NCT02707965|26004333|FG011|Overall Study|Withdrawal by Subject|0|||
13138379|NCT02707965|26004334|FG012|Overall Study|Withdrawal by Subject|0|||
13138380|NCT02707965|26004335|FG013|Overall Study|Withdrawal by Subject|0|||
13138381|NCT02707965|26004336|FG014|Overall Study|Withdrawal by Subject|0|||
13138382|NCT02707965|26004337|FG015|Overall Study|Withdrawal by Subject|0|||
13138383|NCT02707965|26004322|FG000|Overall Study|PI decisions|0|||
13138384|NCT02707965|26004323|FG001|Overall Study|PI decisions|0|||
13138385|NCT02707965|26004324|FG002|Overall Study|PI decisions|0|||
13138386|NCT02707965|26004325|FG003|Overall Study|PI decisions|0|||
13138387|NCT02707965|26004326|FG004|Overall Study|PI decisions|0|||
13138388|NCT02707965|26004327|FG005|Overall Study|PI decisions|0|||
13138389|NCT02707965|26004328|FG006|Overall Study|PI decisions|0|||
13138390|NCT02707965|26004329|FG007|Overall Study|PI decisions|0|||
13138391|NCT02707965|26004330|FG008|Overall Study|PI decisions|0|||
13138392|NCT02707965|26004331|FG009|Overall Study|PI decisions|0|||
13138393|NCT02707965|26004332|FG010|Overall Study|PI decisions|0|||
13138394|NCT02707965|26004333|FG011|Overall Study|PI decisions|0|||
13138395|NCT02707965|26004334|FG012|Overall Study|PI decisions|0|||
13138396|NCT02707965|26004335|FG013|Overall Study|PI decisions|0|||
13138397|NCT02707965|26004336|FG014|Overall Study|PI decisions|2|||
13138398|NCT02707965|26004337|FG015|Overall Study|PI decisions|0|||
13138399|NCT02707965|26004322|FG000|Overall Study|Protocol deviation|1|||
13138400|NCT02707965|26004323|FG001|Overall Study|Protocol deviation|1|||
13138401|NCT02707965|26004324|FG002|Overall Study|Protocol deviation|0|||
13138402|NCT02707965|26004325|FG003|Overall Study|Protocol deviation|0|||
13138403|NCT02707965|26004326|FG004|Overall Study|Protocol deviation|0|||
13138404|NCT02707965|26004327|FG005|Overall Study|Protocol deviation|0|||
13138405|NCT02707965|26004328|FG006|Overall Study|Protocol deviation|0|||
13138406|NCT02707965|26004329|FG007|Overall Study|Protocol deviation|1|||
13138407|NCT02707965|26004330|FG008|Overall Study|Protocol deviation|0|||
13138408|NCT02707965|26004331|FG009|Overall Study|Protocol deviation|0|||
13138409|NCT02707965|26004332|FG010|Overall Study|Protocol deviation|0|||
13138410|NCT02707965|26004333|FG011|Overall Study|Protocol deviation|0|||
13138411|NCT02707965|26004334|FG012|Overall Study|Protocol deviation|0|||
13138412|NCT02707965|26004335|FG013|Overall Study|Protocol deviation|0|||
13138413|NCT02707965|26004336|FG014|Overall Study|Protocol deviation|0|||
13138414|NCT02707965|26004337|FG015|Overall Study|Protocol deviation|0|||
13138415|NCT02707952|26004369|FG000|Overall Study|Adverse Event|1|||
13138416|NCT02707952|26004370|FG001|Overall Study|Adverse Event|0|||
13138417|NCT02707952|26004371|FG002|Overall Study|Adverse Event|0|||
13138418|NCT02707952|26004372|FG003|Overall Study|Adverse Event|0|||
13138419|NCT02707952|26004369|FG000|Overall Study|Lost to Follow-up|1|||
13138420|NCT02707952|26004370|FG001|Overall Study|Lost to Follow-up|0|||
13138421|NCT02707952|26004371|FG002|Overall Study|Lost to Follow-up|0|||
13138422|NCT02707952|26004372|FG003|Overall Study|Lost to Follow-up|0|||
13138423|NCT02707952|26004369|FG000|Overall Study|Withdrawal by Subject|0|||
13138424|NCT02707952|26004370|FG001|Overall Study|Withdrawal by Subject|1|||
13138425|NCT02707952|26004371|FG002|Overall Study|Withdrawal by Subject|2|||
13138426|NCT02707952|26004372|FG003|Overall Study|Withdrawal by Subject|0|||
13138427|NCT02707861|26004395|FG000|Overall Study|Went onto commercial drug|30|||
13138428|NCT02707861|26004396|FG001|Overall Study|Went onto commercial drug|23|||
13138429|NCT02707861|26004395|FG000|Overall Study|Adverse Event|2|||
13138430|NCT02707861|26004396|FG001|Overall Study|Adverse Event|3|||
13138431|NCT02707861|26004395|FG000|Overall Study|Death|5|||
13138432|NCT02707861|26004396|FG001|Overall Study|Death|2|||
13138433|NCT02707861|26004395|FG000|Overall Study|Lack of Efficacy|0|||
13138434|NCT02707861|26004396|FG001|Overall Study|Lack of Efficacy|2|||
13138435|NCT02707861|26004395|FG000|Overall Study|Physician Decision|1|||
13138436|NCT02707861|26004396|FG001|Overall Study|Physician Decision|4|||
13138437|NCT02707861|26004395|FG000|Overall Study|Withdrawal by Subject|2|||
13138438|NCT02707861|26004396|FG001|Overall Study|Withdrawal by Subject|1|||
13138439|NCT02707861|26004395|FG000|Overall Study|Lost to Follow-up|1|||
13138440|NCT02707861|26004396|FG001|Overall Study|Lost to Follow-up|3|||
13138441|NCT02707757|26004409|FG000|Overall Study|Protocol Violation|3|||
13138442|NCT02707757|26004410|FG001|Overall Study|Protocol Violation|2|||
13138443|NCT02707757|26004409|FG000|Overall Study|Withdrawal by Subject|2|||
13138444|NCT02707757|26004410|FG001|Overall Study|Withdrawal by Subject|0|||
13138445|NCT02707757|26004409|FG000|Overall Study|Death|0|||
13138446|NCT02707757|26004410|FG001|Overall Study|Death|1|||
13138447|NCT02707757|26004409|FG000|Overall Study|Adverse Event|6|||
13138448|NCT02707757|26004410|FG001|Overall Study|Adverse Event|4|||
13138449|NCT02707757|26004409|FG000|Overall Study|Renal transplant/elective operation|1|||
13138450|NCT02707757|26004410|FG001|Overall Study|Renal transplant/elective operation|5|||
13138451|NCT02707640|26004435|FG000|Overall Study|Adverse Event|4|||
13138452|NCT02707640|26004436|FG001|Overall Study|Adverse Event|2|||
13138453|NCT02707640|26004435|FG000|Overall Study|Death|1|||
13138454|NCT02707640|26004436|FG001|Overall Study|Death|2|||
13138455|NCT02707640|26004435|FG000|Overall Study|Physician Decision|2|||
13138456|NCT02707640|26004436|FG001|Overall Study|Physician Decision|0|||
13138457|NCT02707640|26004435|FG000|Overall Study|Withdrawal by Subject|0|||
13138458|NCT02707640|26004436|FG001|Overall Study|Withdrawal by Subject|1|||
13138459|NCT02707640|26004435|FG000|Overall Study|Participant's Personal Decision|1|||
13138460|NCT02707640|26004436|FG001|Overall Study|Participant's Personal Decision|2|||
13138461|NCT02707640|26004435|FG000|Overall Study|Sponsor Discretion|1|||
13138462|NCT02707640|26004436|FG001|Overall Study|Sponsor Discretion|0|||
13138463|NCT02707601|26004457|FG000|Overall Study|Death|0|||
13138464|NCT02707601|26004458|FG001|Overall Study|Death|1|||
13138465|NCT02707601|26004457|FG000|Overall Study|Lack of Efficacy|0|||
13138466|NCT02707601|26004458|FG001|Overall Study|Lack of Efficacy|1|||
13138467|NCT02707601|26004457|FG000|Overall Study|Investigator's Discretion|1|||
13138468|NCT02707601|26004458|FG001|Overall Study|Investigator's Discretion|0|||
13138469|NCT02707601|26004457|FG000|Overall Study|Withdrew Consent|0|||
13138470|NCT02707601|26004458|FG001|Overall Study|Withdrew Consent|1|||
13138471|NCT02707601|26004457|FG000|Overall Study|Lost to Follow-up|1|||
13138472|NCT02707601|26004458|FG001|Overall Study|Lost to Follow-up|1|||
13138473|NCT02707601|26004457|FG000|Overall Study|Participants Randomized but Not Treated|2|||
13138474|NCT02707601|26004458|FG001|Overall Study|Participants Randomized but Not Treated|0|||
13138475|NCT02707055|26004473|FG000|Phase 1|Withdrawal by Subject|1|||
13138476|NCT02707055|26004474|FG001|Phase 1|Withdrawal by Subject|2|||
13138477|NCT02707055|26004473|FG000|Phase 1|Physician Decision|0|||
13138478|NCT02707055|26004474|FG001|Phase 1|Physician Decision|1|||
13138479|NCT02707055|26004473|FG000|Phase 2|Adverse Event|1|||
13222543|NCT01806545|26286321|FG001|Overall Study|Adverse Event|3|||
13138480|NCT02707055|26004474|FG001|Phase 2|Adverse Event|2|||
13138481|NCT02706951|26004516|FG000|Overall Study|Adverse Event|1|||
13138482|NCT02706951|26004517|FG001|Overall Study|Adverse Event|5|||
13138483|NCT02706951|26004518|FG002|Overall Study|Adverse Event|3|||
13138484|NCT02706951|26004516|FG000|Overall Study|Withdrawal by Subject|11|||
13138485|NCT02706951|26004517|FG001|Overall Study|Withdrawal by Subject|6|||
13138486|NCT02706951|26004518|FG002|Overall Study|Withdrawal by Subject|6|||
13138487|NCT02706951|26004516|FG000|Overall Study|Lost to Follow-up|0|||
13138488|NCT02706951|26004517|FG001|Overall Study|Lost to Follow-up|4|||
13138489|NCT02706951|26004518|FG002|Overall Study|Lost to Follow-up|1|||
13138490|NCT02706951|26004516|FG000|Overall Study|Other|2|||
13138491|NCT02706951|26004517|FG001|Overall Study|Other|1|||
13138492|NCT02706951|26004518|FG002|Overall Study|Other|0|||
13138493|NCT02706938|26004534|FG000|First Period, 6 Weeks|Adverse Event|8|||
13138494|NCT02706938|26004535|FG001|First Period, 6 Weeks|Adverse Event|0|||
13138495|NCT02706938|26004534|FG000|First Period, 6 Weeks|Lost to Follow-up|2|||
13138496|NCT02706938|26004535|FG001|First Period, 6 Weeks|Lost to Follow-up|2|||
13138497|NCT02706938|26004534|FG000|First Period, 6 Weeks|Withdrawal by Subject|1|||
13138498|NCT02706938|26004535|FG001|First Period, 6 Weeks|Withdrawal by Subject|0|||
13138499|NCT02706938|26004534|FG000|Second Period, 6 Weeks|Adverse Event|0|||
13138500|NCT02706938|26004535|FG001|Second Period, 6 Weeks|Adverse Event|7|||
13138501|NCT02706938|26004534|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0|||
13138502|NCT02706938|26004535|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3|||
13138503|NCT02706899|26004564|FG000|Overall Study|Withdrawal by Subject|1|||
13138504|NCT02706899|26004565|FG001|Overall Study|Withdrawal by Subject|0|||
13138505|NCT02706899|26004564|FG000|Overall Study|Death|8|||
13138506|NCT02706899|26004565|FG001|Overall Study|Death|0|||
13138507|NCT02706899|26004564|FG000|Overall Study|Study Termination by Sponsor|4|||
13138508|NCT02706899|26004565|FG001|Overall Study|Study Termination by Sponsor|6|||
13138509|NCT02706886|26004706|FG000|Part A: SAD Period|Withdrawal by Subject|0|||
13138510|NCT02706886|26004707|FG001|Part A: SAD Period|Withdrawal by Subject|0|||
13138511|NCT02706886|26004708|FG002|Part A: SAD Period|Withdrawal by Subject|0|||
13138512|NCT02706886|26004709|FG003|Part A: SAD Period|Withdrawal by Subject|2|||
13138513|NCT02706886|26004710|FG004|Part A: SAD Period|Withdrawal by Subject|0|||
13138514|NCT02706886|26004711|FG005|Part A: SAD Period|Withdrawal by Subject|0|||
13138515|NCT02706886|26004712|FG006|Part A: SAD Period|Withdrawal by Subject|0|||
13138516|NCT02706886|26004713|FG007|Part A: SAD Period|Withdrawal by Subject|0|||
13138517|NCT02706886|26004714|FG008|Part A: SAD Period|Withdrawal by Subject|0|||
13138518|NCT02706847|26004756|FG000|Day 1 to Week 12|Adverse Event|2|||
13138519|NCT02706847|26004757|FG001|Day 1 to Week 12|Adverse Event|2|||
13138520|NCT02706847|26004758|FG002|Day 1 to Week 12|Adverse Event|1|||
13138521|NCT02706847|26004759|FG003|Day 1 to Week 12|Adverse Event|12|||
13138522|NCT02706847|26004756|FG000|Day 1 to Week 12|Withdrawal by Subject|2|||
13138523|NCT02706847|26004757|FG001|Day 1 to Week 12|Withdrawal by Subject|1|||
13138524|NCT02706847|26004758|FG002|Day 1 to Week 12|Withdrawal by Subject|4|||
13138525|NCT02706847|26004759|FG003|Day 1 to Week 12|Withdrawal by Subject|2|||
13138526|NCT02706847|26004756|FG000|Day 1 to Week 12|Lost to Follow-up|2|||
13138527|NCT02706847|26004757|FG001|Day 1 to Week 12|Lost to Follow-up|1|||
13138528|NCT02706847|26004758|FG002|Day 1 to Week 12|Lost to Follow-up|0|||
13138529|NCT02706847|26004759|FG003|Day 1 to Week 12|Lost to Follow-up|0|||
13138530|NCT02706847|26004756|FG000|Day 1 to Week 12|Other|4|||
13138531|NCT02706847|26004757|FG001|Day 1 to Week 12|Other|4|||
13138532|NCT02706847|26004758|FG002|Day 1 to Week 12|Other|2|||
13138533|NCT02706847|26004759|FG003|Day 1 to Week 12|Other|2|||
13138534|NCT02706847|26004756|FG000|Day 1 to Week 12|Randomized in Error|0|||
13138535|NCT02706847|26004757|FG001|Day 1 to Week 12|Randomized in Error|0|||
13138536|NCT02706847|26004758|FG002|Day 1 to Week 12|Randomized in Error|1|||
13138537|NCT02706847|26004759|FG003|Day 1 to Week 12|Randomized in Error|0|||
13138538|NCT02706847|26004756|FG000|Week 12 to Week 24|Adverse Event|1|||
13091187|NCT03757234|25822610|FG004|Overall Study|Withdrawal by Subject|2|||
13091188|NCT03757234|25822606|FG000|Overall Study|Other|1|||
13091189|NCT03757234|25822607|FG001|Overall Study|Other|1|||
13091190|NCT03757234|25822608|FG002|Overall Study|Other|0|||
13091191|NCT03757234|25822609|FG003|Overall Study|Other|0|||
13091192|NCT03757234|25822610|FG004|Overall Study|Other|0|||
13091193|NCT03756883|25822635|FG000|Overall Study|Adverse Event|2|||
13091194|NCT03756883|25822636|FG001|Overall Study|Adverse Event|2|||
13091195|NCT03756883|25822637|FG002|Overall Study|Adverse Event|2|||
13091196|NCT03756883|25822635|FG000|Overall Study|Lack of Efficacy|0|||
13091197|NCT03756883|25822636|FG001|Overall Study|Lack of Efficacy|1|||
13091198|NCT03756883|25822637|FG002|Overall Study|Lack of Efficacy|2|||
13091199|NCT03756883|25822635|FG000|Overall Study|Lost to Follow-up|3|||
13138539|NCT02706847|26004757|FG001|Week 12 to Week 24|Adverse Event|2|||
13138540|NCT02706847|26004758|FG002|Week 12 to Week 24|Adverse Event|2|||
13138541|NCT02706847|26004759|FG003|Week 12 to Week 24|Adverse Event|5|||
13138542|NCT02706847|26004756|FG000|Week 12 to Week 24|Withdrawal by Subject|1|||
13138543|NCT02706847|26004757|FG001|Week 12 to Week 24|Withdrawal by Subject|0|||
13138544|NCT02706847|26004758|FG002|Week 12 to Week 24|Withdrawal by Subject|1|||
13138545|NCT02706847|26004759|FG003|Week 12 to Week 24|Withdrawal by Subject|4|||
13138546|NCT02706847|26004756|FG000|Week 12 to Week 24|Lost to Follow-up|0|||
13138547|NCT02706847|26004757|FG001|Week 12 to Week 24|Lost to Follow-up|0|||
13138548|NCT02706847|26004758|FG002|Week 12 to Week 24|Lost to Follow-up|0|||
13091200|NCT03756883|25822636|FG001|Overall Study|Lost to Follow-up|3|||
13091201|NCT03756883|25822637|FG002|Overall Study|Lost to Follow-up|0|||
13091202|NCT03756883|25822635|FG000|Overall Study|Protocol Violation|2|||
13091203|NCT03756883|25822636|FG001|Overall Study|Protocol Violation|0|||
13091204|NCT03756883|25822637|FG002|Overall Study|Protocol Violation|1|||
13138549|NCT02706847|26004759|FG003|Week 12 to Week 24|Lost to Follow-up|1|||
13138550|NCT02706847|26004756|FG000|Week 12 to Week 24|Other|1|||
13138551|NCT02706847|26004757|FG001|Week 12 to Week 24|Other|0|||
13138552|NCT02706847|26004758|FG002|Week 12 to Week 24|Other|1|||
13138553|NCT02706847|26004759|FG003|Week 12 to Week 24|Other|4|||
13138554|NCT02706834|26004935|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
13138555|NCT02706834|26004936|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
13138556|NCT02706834|26004937|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
13138557|NCT02706834|26004938|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
13138558|NCT02706834|26004939|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
13138559|NCT02706834|26004940|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
13138560|NCT02706834|26004941|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
13138561|NCT02706834|26004942|FG007|Overall Study|Pretreatment Event/Adverse Event|0|||
13138562|NCT02706834|26004943|FG008|Overall Study|Pretreatment Event/Adverse Event|0|||
13138563|NCT02706834|26004944|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
13138564|NCT02706834|26004945|FG010|Overall Study|Pretreatment Event/Adverse Event|1|||
13138565|NCT02706834|26004935|FG000|Overall Study|Lost to Follow-up|0|||
13138566|NCT02706834|26004936|FG001|Overall Study|Lost to Follow-up|0|||
13138567|NCT02706834|26004937|FG002|Overall Study|Lost to Follow-up|1|||
13138568|NCT02706834|26004938|FG003|Overall Study|Lost to Follow-up|0|||
13138569|NCT02706834|26004939|FG004|Overall Study|Lost to Follow-up|0|||
13138570|NCT02706834|26004940|FG005|Overall Study|Lost to Follow-up|0|||
13138571|NCT02706834|26004941|FG006|Overall Study|Lost to Follow-up|0|||
13138572|NCT02706834|26004942|FG007|Overall Study|Lost to Follow-up|0|||
13138573|NCT02706834|26004943|FG008|Overall Study|Lost to Follow-up|0|||
13138574|NCT02706834|26004944|FG009|Overall Study|Lost to Follow-up|0|||
13138575|NCT02706834|26004945|FG010|Overall Study|Lost to Follow-up|0|||
13138576|NCT02706834|26004935|FG000|Overall Study|Voluntary Withdrawal|1|||
13138577|NCT02706834|26004936|FG001|Overall Study|Voluntary Withdrawal|0|||
13138578|NCT02706834|26004937|FG002|Overall Study|Voluntary Withdrawal|0|||
13138579|NCT02706834|26004938|FG003|Overall Study|Voluntary Withdrawal|0|||
13138580|NCT02706834|26004939|FG004|Overall Study|Voluntary Withdrawal|0|||
13138581|NCT02706834|26004940|FG005|Overall Study|Voluntary Withdrawal|0|||
13138582|NCT02706834|26004941|FG006|Overall Study|Voluntary Withdrawal|0|||
13138583|NCT02706834|26004942|FG007|Overall Study|Voluntary Withdrawal|0|||
13138584|NCT02706834|26004943|FG008|Overall Study|Voluntary Withdrawal|0|||
13138585|NCT02706834|26004944|FG009|Overall Study|Voluntary Withdrawal|1|||
13138586|NCT02706834|26004945|FG010|Overall Study|Voluntary Withdrawal|0|||
13138587|NCT02706834|26004935|FG000|Overall Study|Other Reason Not Specified|1|||
13138588|NCT02706834|26004936|FG001|Overall Study|Other Reason Not Specified|0|||
13138589|NCT02706834|26004937|FG002|Overall Study|Other Reason Not Specified|0|||
13138590|NCT02706834|26004938|FG003|Overall Study|Other Reason Not Specified|0|||
13138591|NCT02706834|26004939|FG004|Overall Study|Other Reason Not Specified|1|||
13138592|NCT02706834|26004940|FG005|Overall Study|Other Reason Not Specified|0|||
13138593|NCT02706834|26004941|FG006|Overall Study|Other Reason Not Specified|0|||
13138594|NCT02706834|26004942|FG007|Overall Study|Other Reason Not Specified|0|||
13138595|NCT02706834|26004943|FG008|Overall Study|Other Reason Not Specified|0|||
13138596|NCT02706834|26004944|FG009|Overall Study|Other Reason Not Specified|0|||
13138597|NCT02706834|26004945|FG010|Overall Study|Other Reason Not Specified|0|||
13138598|NCT02706717|26005016|FG000|Overall Study|Withdrawal by Subject|1|||
13138599|NCT02706717|26005017|FG001|Overall Study|Withdrawal by Subject|8|||
13138600|NCT02706717|26005016|FG000|Overall Study|Lost to Follow-up|0|||
13138601|NCT02706717|26005017|FG001|Overall Study|Lost to Follow-up|1|||
13138602|NCT02706717|26005016|FG000|Overall Study|Physician Decision|0|||
13138603|NCT02706717|26005017|FG001|Overall Study|Physician Decision|1|||
13138604|NCT02706717|26005016|FG000|Overall Study|Death|0|||
13138605|NCT02706717|26005017|FG001|Overall Study|Death|1|||
13138606|NCT02706691|26005026|FG000|Overall Study|Adverse Event|1|||
13138607|NCT02706483|26005032|FG000|Overall Study|Adverse Event|97|||
13138608|NCT02706483|26005032|FG000|Overall Study|Death|1|||
13138609|NCT02706483|26005032|FG000|Overall Study|Lack of Efficacy|39|||
13138610|NCT02706483|26005032|FG000|Overall Study|Lost to Follow-up|101|||
13138611|NCT02706483|26005032|FG000|Overall Study|Non-compliance with study drug|15|||
13138612|NCT02706483|26005032|FG000|Overall Study|Physician Decision|6|||
13138613|NCT02706483|26005032|FG000|Overall Study|Pregnancy|6|||
13138614|NCT02706483|26005032|FG000|Overall Study|Protocol Violation|18|||
13138615|NCT02706483|26005032|FG000|Overall Study|Withdrawal by Subject|136|||
13138616|NCT02706483|26005032|FG000|Overall Study|Non-compliance with visits|6|||
13138617|NCT02706483|26005032|FG000|Overall Study|Site closure|4|||
13138618|NCT02706483|26005032|FG000|Overall Study|Subject moved|1|||
13138619|NCT02706405|26005167|FG000|Overall Study|Death|3|||
13138620|NCT02706405|26005168|FG001|Overall Study|Death|2|||
13138621|NCT02706405|26005169|FG002|Overall Study|Death|0|||
13138622|NCT02706405|26005170|FG003|Overall Study|Death|1|||
13138623|NCT02706405|26005171|FG004|Overall Study|Death|0|||
13138624|NCT02706405|26005172|FG005|Overall Study|Death|0|||
13138625|NCT02706405|26005173|FG006|Overall Study|Death|3|||
13138626|NCT02706405|26005174|FG007|Overall Study|Death|4|||
13138627|NCT02706405|26005167|FG000|Overall Study|Disease progression|0|||
13138628|NCT02706405|26005168|FG001|Overall Study|Disease progression|0|||
13138629|NCT02706405|26005169|FG002|Overall Study|Disease progression|0|||
13138630|NCT02706405|26005170|FG003|Overall Study|Disease progression|0|||
13138631|NCT02706405|26005171|FG004|Overall Study|Disease progression|0|||
13138632|NCT02706405|26005172|FG005|Overall Study|Disease progression|0|||
13138633|NCT02706405|26005173|FG006|Overall Study|Disease progression|0|||
13138634|NCT02706405|26005174|FG007|Overall Study|Disease progression|1|||
13138635|NCT02706405|26005167|FG000|Overall Study|Pt moved to new therapy|0|||
13138636|NCT02706405|26005168|FG001|Overall Study|Pt moved to new therapy|0|||
13138637|NCT02706405|26005169|FG002|Overall Study|Pt moved to new therapy|0|||
13138638|NCT02706405|26005170|FG003|Overall Study|Pt moved to new therapy|0|||
13138639|NCT02706405|26005171|FG004|Overall Study|Pt moved to new therapy|0|||
13138640|NCT02706405|26005172|FG005|Overall Study|Pt moved to new therapy|1|||
13138641|NCT02706405|26005173|FG006|Overall Study|Pt moved to new therapy|0|||
13138642|NCT02706405|26005174|FG007|Overall Study|Pt moved to new therapy|1|||
13138643|NCT02706405|26005167|FG000|Overall Study|Physician Decision|1|||
13138644|NCT02706405|26005168|FG001|Overall Study|Physician Decision|0|||
13138645|NCT02706405|26005169|FG002|Overall Study|Physician Decision|0|||
13138646|NCT02706405|26005170|FG003|Overall Study|Physician Decision|0|||
13138647|NCT02706405|26005171|FG004|Overall Study|Physician Decision|0|||
13138648|NCT02706405|26005172|FG005|Overall Study|Physician Decision|0|||
13138649|NCT02706405|26005173|FG006|Overall Study|Physician Decision|0|||
13138650|NCT02706405|26005174|FG007|Overall Study|Physician Decision|0|||
13138651|NCT02706392|26005237|FG000|Overall Study|Death|1|||
13138652|NCT02706392|26005238|FG001|Overall Study|Death|0|||
13138653|NCT02706392|26005239|FG002|Overall Study|Death|2|||
13138654|NCT02706392|26005240|FG003|Overall Study|Death|2|||
13138655|NCT02706392|26005241|FG004|Overall Study|Death|5|||
13138656|NCT02706392|26005242|FG005|Overall Study|Death|2|||
13138657|NCT02706327|26005272|FG000|Overall Study|Lost to Follow-up|1|||
13138658|NCT02706327|26005273|FG001|Overall Study|Lost to Follow-up|1|||
13138659|NCT02706327|26005274|FG002|Overall Study|Lost to Follow-up|2|||
13138660|NCT02705755|26005342|FG000|Part A (6 Days)|Adverse Event|1|||
13138661|NCT02705755|26005343|FG001|Part A (6 Days)|Adverse Event|0|||
13138662|NCT02705755|26005344|FG002|Part A (6 Days)|Adverse Event|0|||
13138663|NCT02705755|26005345|FG003|Part A (6 Days)|Adverse Event|0|||
13138664|NCT02705755|26005342|FG000|Part A (6 Days)|Physician Decision|3|||
13138665|NCT02705755|26005343|FG001|Part A (6 Days)|Physician Decision|0|||
13138666|NCT02705755|26005344|FG002|Part A (6 Days)|Physician Decision|0|||
13138667|NCT02705755|26005345|FG003|Part A (6 Days)|Physician Decision|0|||
13138668|NCT02705755|26005342|FG000|Part A (6 Days)|Withdrawal by Subject|1|||
13138669|NCT02705755|26005343|FG001|Part A (6 Days)|Withdrawal by Subject|0|||
13138670|NCT02705755|26005344|FG002|Part A (6 Days)|Withdrawal by Subject|0|||
13138671|NCT02705755|26005345|FG003|Part A (6 Days)|Withdrawal by Subject|0|||
13138672|NCT02705755|26005342|FG000|Part C (20 Weeks)|Physician Decision|0|||
13138673|NCT02705755|26005343|FG001|Part C (20 Weeks)|Physician Decision|0|||
13138674|NCT02705755|26005344|FG002|Part C (20 Weeks)|Physician Decision|0|||
13138675|NCT02705755|26005345|FG003|Part C (20 Weeks)|Physician Decision|2|||
13138676|NCT02705755|26005342|FG000|Part C (20 Weeks)|Adverse Event|0|||
13138677|NCT02705755|26005343|FG001|Part C (20 Weeks)|Adverse Event|0|||
13138678|NCT02705755|26005344|FG002|Part C (20 Weeks)|Adverse Event|0|||
13138679|NCT02705755|26005345|FG003|Part C (20 Weeks)|Adverse Event|6|||
13138680|NCT02705755|26005342|FG000|Part C (20 Weeks)|Withdrawal by Subject|0|||
13138681|NCT02705755|26005343|FG001|Part C (20 Weeks)|Withdrawal by Subject|0|||
13138682|NCT02705755|26005344|FG002|Part C (20 Weeks)|Withdrawal by Subject|0|||
13138683|NCT02705755|26005345|FG003|Part C (20 Weeks)|Withdrawal by Subject|2|||
13138684|NCT02705716|26005362|FG000|Overall Study|Adverse Event|0|||
13138685|NCT02705716|26005363|FG001|Overall Study|Adverse Event|1|||
13138686|NCT02705716|26005362|FG000|Overall Study|Protocol Violation|3|||
13138687|NCT02705716|26005363|FG001|Overall Study|Protocol Violation|0|||
13138688|NCT02705716|26005362|FG000|Overall Study|Withdrawal of Consent|1|||
13138689|NCT02705716|26005363|FG001|Overall Study|Withdrawal of Consent|1|||
13138690|NCT02705625|26005402|FG000|Overall Study|Protocol Violation|1|||
13138691|NCT02705625|26005403|FG001|Overall Study|Protocol Violation|0|||
13138692|NCT02705625|26005404|FG002|Overall Study|Protocol Violation|0|||
13138693|NCT02705625|26005402|FG000|Overall Study|Adverse Event|6|||
13138694|NCT02705625|26005403|FG001|Overall Study|Adverse Event|5|||
13138695|NCT02705625|26005404|FG002|Overall Study|Adverse Event|2|||
13138696|NCT02705625|26005402|FG000|Overall Study|Death|0|||
13138697|NCT02705625|26005403|FG001|Overall Study|Death|0|||
13138698|NCT02705625|26005404|FG002|Overall Study|Death|1|||
13138699|NCT02705625|26005402|FG000|Overall Study|Withdrawal by Subject|1|||
13138700|NCT02705625|26005403|FG001|Overall Study|Withdrawal by Subject|4|||
13138701|NCT02705625|26005404|FG002|Overall Study|Withdrawal by Subject|5|||
13138702|NCT02705625|26005402|FG000|Overall Study|Lost to Follow-up|0|||
13138703|NCT02705625|26005403|FG001|Overall Study|Lost to Follow-up|0|||
13138704|NCT02705625|26005404|FG002|Overall Study|Lost to Follow-up|1|||
13138705|NCT02705625|26005402|FG000|Overall Study|Non-compliance|0|||
13138706|NCT02705625|26005403|FG001|Overall Study|Non-compliance|1|||
13138707|NCT02705625|26005404|FG002|Overall Study|Non-compliance|1|||
13138708|NCT02705625|26005402|FG000|Overall Study|Overdosing|0|||
13138709|NCT02705625|26005403|FG001|Overall Study|Overdosing|0|||
13138710|NCT02705625|26005404|FG002|Overall Study|Overdosing|1|||
13138711|NCT02705586|26005410|FG000|Overall Study|Health Issues|2|||
13138712|NCT02705586|26005410|FG000|Overall Study|Transportation Difficulties|5|||
13138713|NCT02705586|26005410|FG000|Overall Study|Vacation/Planned Absence|1|||
13138714|NCT02705105|26005449|FG000|Treatment|Objective Disease Progression|1|||
13138715|NCT02705105|26005450|FG001|Treatment|Objective Disease Progression|50|||
13138716|NCT02705105|26005449|FG000|Treatment|Withdrawal by Subject|3|||
13138717|NCT02705105|26005450|FG001|Treatment|Withdrawal by Subject|5|||
13138718|NCT02705105|26005449|FG000|Treatment|Adverse Event|0|||
13138719|NCT02705105|26005450|FG001|Treatment|Adverse Event|17|||
13138720|NCT02705105|26005449|FG000|Treatment|Clinical Disease Progression|0|||
13138721|NCT02705105|26005450|FG001|Treatment|Clinical Disease Progression|32|||
13138722|NCT02705105|26005449|FG000|Treatment|Physician Decision|0|||
13138723|NCT02705105|26005450|FG001|Treatment|Physician Decision|3|||
13138724|NCT02705105|26005449|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0|||
13138725|NCT02705105|26005450|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2|||
13138726|NCT02705105|26005449|FG000|Follow-Up|Death|3|||
13138727|NCT02705105|26005450|FG001|Follow-Up|Death|68|||
13138728|NCT02705105|26005449|FG000|Follow-Up|Withdrawal by Subject|1|||
13138729|NCT02705105|26005450|FG001|Follow-Up|Withdrawal by Subject|14|||
13138730|NCT02705105|26005449|FG000|Follow-Up|Study Terminated|0|||
13138731|NCT02705105|26005450|FG001|Follow-Up|Study Terminated|26|||
13138732|NCT02705105|26005449|FG000|Follow-Up|Discontinued per Amendment 3|0|||
13138733|NCT02705105|26005450|FG001|Follow-Up|Discontinued per Amendment 3|2|||
13138734|NCT02704689|26005469|FG000|Overall Study|Physician Decision|1|||
13138735|NCT02704689|26005469|FG000|Overall Study|Study device not implanted|2|||
13138736|NCT02704143|26005480|FG000|Overall Study|disease progression|10|||
13138737|NCT02704130|26005515|FG000|Overall Study|Physician Decision|5|||
13138738|NCT02704130|26005516|FG001|Overall Study|Physician Decision|3|||
13138739|NCT02704091|26005543|FG000|Overall Study|Adverse Event|4|||
13138740|NCT02704091|26005544|FG001|Overall Study|Adverse Event|3|||
13138741|NCT02704091|26005543|FG000|Overall Study|Protocol Violation|5|||
13138742|NCT02704091|26005544|FG001|Overall Study|Protocol Violation|3|||
13138743|NCT02704091|26005543|FG000|Overall Study|Consent withdrawn|4|||
13138744|NCT02704091|26005544|FG001|Overall Study|Consent withdrawn|4|||
13138745|NCT02704091|26005543|FG000|Overall Study|Lost to Follow-up|13|||
13138746|NCT02704091|26005544|FG001|Overall Study|Lost to Follow-up|5|||
13138747|NCT02704091|26005543|FG000|Overall Study|Other|2|||
13138748|NCT02704091|26005544|FG001|Overall Study|Other|8|||
13138749|NCT02703636|26005557|FG000|Overall Study|Adverse Event|14|||
13138750|NCT02703636|26005557|FG000|Overall Study|Study stopped by sponsor|1|||
13138751|NCT02703636|26005557|FG000|Overall Study|Withdrawal by Subject|1|||
13138752|NCT02703532|26005605|FG000|Overall Study|Withdrawal by Subject|0|||
13138753|NCT02703532|26005606|FG001|Overall Study|Withdrawal by Subject|1|||
13138754|NCT02703532|26005607|FG002|Overall Study|Withdrawal by Subject|0|||
13138755|NCT02703532|26005608|FG003|Overall Study|Withdrawal by Subject|1|||
13138756|NCT02703532|26005605|FG000|Overall Study|Lost to Follow-up|2|||
13138757|NCT02703532|26005606|FG001|Overall Study|Lost to Follow-up|0|||
13138758|NCT02703532|26005607|FG002|Overall Study|Lost to Follow-up|2|||
13138759|NCT02703532|26005608|FG003|Overall Study|Lost to Follow-up|0|||
13138760|NCT02703454|26005623|FG000|Overall Study|Not treated|1|||
13138761|NCT02703454|26005624|FG001|Overall Study|Not treated|3|||
13138762|NCT02703454|26005623|FG000|Overall Study|Withdrawal by Subject|4|||
13138763|NCT02703454|26005624|FG001|Overall Study|Withdrawal by Subject|3|||
13138764|NCT02703454|26005623|FG000|Overall Study|Lost to Follow-up|1|||
13138765|NCT02703454|26005624|FG001|Overall Study|Lost to Follow-up|2|||
13138766|NCT02703454|26005623|FG000|Overall Study|Study discontinuation|5|||
13138767|NCT02703454|26005624|FG001|Overall Study|Study discontinuation|8|||
13138768|NCT02703337|26005653|FG000|Period One (Part A)|Withdrawal by Subject|0|||
13138769|NCT02703337|26005654|FG001|Period One (Part A)|Withdrawal by Subject|0|||
13138770|NCT02703337|26005655|FG002|Period One (Part A)|Withdrawal by Subject|0|||
13138771|NCT02703337|26005656|FG003|Period One (Part A)|Withdrawal by Subject|0|||
13138772|NCT02703337|26005657|FG004|Period One (Part A)|Withdrawal by Subject|1|||
13138773|NCT02703337|26005658|FG005|Period One (Part A)|Withdrawal by Subject|0|||
13138774|NCT02703337|26005659|FG006|Period One (Part A)|Withdrawal by Subject|0|||
13138775|NCT02703337|26005660|FG007|Period One (Part A)|Withdrawal by Subject|0|||
13138776|NCT02703324|26005676|FG000|Period Two|Withdrawal by Subject|0|||
13138777|NCT02703324|26005677|FG001|Period Two|Withdrawal by Subject|0|||
13138778|NCT02703324|26005678|FG002|Period Two|Withdrawal by Subject|1|||
13138779|NCT02703324|26005679|FG003|Period Two|Withdrawal by Subject|0|||
13138780|NCT02703324|26005680|FG004|Period Two|Withdrawal by Subject|0|||
13138781|NCT02703324|26005681|FG005|Period Two|Withdrawal by Subject|0|||
13138782|NCT02703311|26005699|FG000|Overall Study|Death|5|||
13138783|NCT02703311|26005699|FG000|Overall Study|Withdrawal by Subject|3|||
13138784|NCT02703259|26005722|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1|||
13138785|NCT02703259|26005723|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4|||
13138786|NCT02703259|26005722|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1|||
13138787|NCT02703259|26005723|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2|||
13138788|NCT02703259|26005722|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
13138789|NCT02703259|26005723|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
13138790|NCT02702609|26005746|FG000|Overall Study|Lost to Follow-up|8|||
13138791|NCT02702609|26005747|FG001|Overall Study|Lost to Follow-up|4|||
13138792|NCT02702609|26005746|FG000|Overall Study|Physician Decision|1|||
13138793|NCT02702609|26005747|FG001|Overall Study|Physician Decision|0|||
13138794|NCT02702518|26005762|FG000|Overall Study|Lost to Follow-up|3|||
13138795|NCT02702518|26005763|FG001|Overall Study|Lost to Follow-up|4|||
13138796|NCT02702401|26005791|FG000|Overall Study|Death|242|||
13138797|NCT02702401|26005792|FG001|Overall Study|Death|125|||
13138798|NCT02702401|26005791|FG000|Overall Study|Withdrawal by Subject|15|||
13138799|NCT02702401|26005792|FG001|Overall Study|Withdrawal by Subject|5|||
13138800|NCT02702401|26005791|FG000|Overall Study|Sponsor Decision|19|||
13138801|NCT02702401|26005792|FG001|Overall Study|Sponsor Decision|3|||
13138802|NCT02702401|26005791|FG000|Overall Study|Physician Decision|1|||
13138803|NCT02702401|26005792|FG001|Overall Study|Physician Decision|2|||
13138804|NCT02702401|26005791|FG000|Overall Study|Lost to Follow-up|1|||
13138805|NCT02702401|26005792|FG001|Overall Study|Lost to Follow-up|0|||
13138806|NCT02702388|26005850|FG000|Overall Study|Disease Progression|18|||
13138807|NCT02702388|26005851|FG001|Overall Study|Disease Progression|25|||
13138808|NCT02702388|26005850|FG000|Overall Study|Withdrawal by Subject|9|||
13138809|NCT02702388|26005851|FG001|Overall Study|Withdrawal by Subject|7|||
13138810|NCT02702388|26005850|FG000|Overall Study|Adverse Event|11|||
13138811|NCT02702388|26005851|FG001|Overall Study|Adverse Event|15|||
13138812|NCT02702388|26005850|FG000|Overall Study|Other|2|||
13138813|NCT02702388|26005851|FG001|Overall Study|Other|4|||
13138814|NCT02702193|26005882|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1|||
13138815|NCT02702193|26005883|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0|||
13138816|NCT02702193|26005882|FG000|4 Month Follow up|Withdrawal by Subject|1|||
13138817|NCT02702193|26005883|FG001|4 Month Follow up|Withdrawal by Subject|0|||
13138818|NCT02702193|26005882|FG000|4 Month Follow up|Lost to Follow-up|17|||
13138819|NCT02702193|26005883|FG001|4 Month Follow up|Lost to Follow-up|18|||
13138820|NCT02702193|26005882|FG000|8 Month Follow up|Withdrawal by Subject|1|||
13138821|NCT02702193|26005883|FG001|8 Month Follow up|Withdrawal by Subject|0|||
13138822|NCT02702193|26005882|FG000|8 Month Follow up|Lost to Follow-up|14|||
13138823|NCT02702193|26005883|FG001|8 Month Follow up|Lost to Follow-up|18|||
13138824|NCT02702193|26005882|FG000|12 Month Follow up|Withdrawal by Subject|1|||
13138825|NCT02702193|26005883|FG001|12 Month Follow up|Withdrawal by Subject|0|||
13138826|NCT02702193|26005882|FG000|12 Month Follow up|Lost to Follow-up|16|||
13138827|NCT02702193|26005883|FG001|12 Month Follow up|Lost to Follow-up|18|||
13138828|NCT02702011|26005906|FG000|Overall Study|Withdrawal by Subject|0|||
13138829|NCT02702011|26005907|FG001|Overall Study|Withdrawal by Subject|1|||
13138830|NCT02702011|26005908|FG002|Overall Study|Withdrawal by Subject|0|||
13138831|NCT02702011|26005909|FG003|Overall Study|Withdrawal by Subject|0|||
13138832|NCT02701985|26005957|FG000|Overall Study|Withdrawal by Subject|1|||
13138833|NCT02701985|26005958|FG001|Overall Study|Withdrawal by Subject|1|||
13138834|NCT02701985|26005957|FG000|Overall Study|Lost to Follow-up|1|||
13138835|NCT02701985|26005958|FG001|Overall Study|Lost to Follow-up|0|||
13138836|NCT02701985|26005957|FG000|Overall Study|Death|1|||
13138837|NCT02701985|26005958|FG001|Overall Study|Death|0|||
13138838|NCT02701985|26005957|FG000|Overall Study|Adverse Event|0|||
13138839|NCT02701985|26005958|FG001|Overall Study|Adverse Event|5|||
13138840|NCT02701777|26005995|FG000|Overall Study|Some subjects did not like the stimulation.|4|||
13138841|NCT02701777|26005996|FG001|Overall Study|Some subjects did not like the stimulation.|0|||
13138842|NCT02701777|26005997|FG002|Overall Study|Some subjects did not like the stimulation.|0|||
13138843|NCT02701777|26005998|FG003|Overall Study|Some subjects did not like the stimulation.|2|||
13138844|NCT02701777|26005995|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
13138845|NCT02701777|26005996|FG001|Overall Study|Some subjects were unable to commit to the training study.|3|||
13138846|NCT02701777|26005997|FG002|Overall Study|Some subjects were unable to commit to the training study.|4|||
13138847|NCT02701777|26005998|FG003|Overall Study|Some subjects were unable to commit to the training study.|0|||
13138848|NCT02701764|26006025|FG000|Overall Study|Lost to Follow-up|0|||
13138849|NCT02701764|26006026|FG001|Overall Study|Lost to Follow-up|1|||
13138850|NCT02701634|26006061|FG000|Overall Study|Adverse Event|2|||
13138851|NCT02701634|26006062|FG001|Overall Study|Adverse Event|3|||
13138852|NCT02701634|26006061|FG000|Overall Study|Death|1|||
13138853|NCT02701634|26006062|FG001|Overall Study|Death|0|||
13138854|NCT02701634|26006061|FG000|Overall Study|Investigator's Discretion|7|||
13138855|NCT02701634|26006062|FG001|Overall Study|Investigator's Discretion|4|||
13138856|NCT02701634|26006061|FG000|Overall Study|Study terminated by Sponsor|15|||
13138857|NCT02701634|26006062|FG001|Overall Study|Study terminated by Sponsor|17|||
13138858|NCT02701634|26006061|FG000|Overall Study|Withdrew Consent|6|||
13138859|NCT02701634|26006062|FG001|Overall Study|Withdrew Consent|7|||
13138860|NCT02701634|26006061|FG000|Overall Study|Randomized but not treated|1|||
13138861|NCT02701634|26006062|FG001|Overall Study|Randomized but not treated|0|||
13138862|NCT02701413|26006083|FG000|Overall Study|Withdrawal by Subject|7|||
13138863|NCT02701413|26006084|FG001|Overall Study|Withdrawal by Subject|11|||
13138864|NCT02701361|26006133|FG000|Overall Study|Lost to Follow-up|5|||
13138865|NCT02701361|26006134|FG001|Overall Study|Lost to Follow-up|2|||
13138866|NCT02701361|26006135|FG002|Overall Study|Lost to Follow-up|1|||
13138867|NCT02701361|26006133|FG000|Overall Study|Withdrawal by Subject|4|||
13138868|NCT02701361|26006134|FG001|Overall Study|Withdrawal by Subject|0|||
13138869|NCT02701361|26006135|FG002|Overall Study|Withdrawal by Subject|0|||
13138870|NCT02701361|26006133|FG000|Overall Study|timed out in rehab center|0|||
13138871|NCT02701361|26006134|FG001|Overall Study|timed out in rehab center|1|||
13138872|NCT02701361|26006135|FG002|Overall Study|timed out in rehab center|0|||
13138873|NCT02701361|26006133|FG000|Overall Study|incarceration|0|||
13138874|NCT02701361|26006134|FG001|Overall Study|incarceration|0|||
13138875|NCT02701361|26006135|FG002|Overall Study|incarceration|1|||
13138876|NCT02701296|26006158|FG000|Overall Study|Incomplete Data|0|||
13138877|NCT02701296|26006159|FG001|Overall Study|Incomplete Data|2|||
13138878|NCT02701283|26006217|FG000|Overall Study|Death|25|||
13138879|NCT02701283|26006218|FG001|Overall Study|Death|29|||
13138880|NCT02701283|26006219|FG002|Overall Study|Death|19|||
13138881|NCT02701283|26006217|FG000|Overall Study|Lost to Follow-up|3|||
13138882|NCT02701283|26006218|FG001|Overall Study|Lost to Follow-up|8|||
13138883|NCT02701283|26006219|FG002|Overall Study|Lost to Follow-up|1|||
13138884|NCT02701283|26006217|FG000|Overall Study|Withdrawal by Subject|12|||
13138885|NCT02701283|26006218|FG001|Overall Study|Withdrawal by Subject|41|||
13138886|NCT02701283|26006219|FG002|Overall Study|Withdrawal by Subject|1|||
13138887|NCT02701283|26006217|FG000|Overall Study|Missed 2-year visit|22|||
13138888|NCT02701283|26006218|FG001|Overall Study|Missed 2-year visit|27|||
13138889|NCT02701283|26006219|FG002|Overall Study|Missed 2-year visit|0|||
13138890|NCT02701283|26006217|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7|||
13138891|NCT02701283|26006218|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57|||
13138892|NCT02701283|26006219|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0|||
13138893|NCT02701192|26006237|FG000|Overall Study|Protocol Violation|2|||
13138894|NCT02701192|26006237|FG000|Overall Study|Lost to Follow-up|4|||
13138895|NCT02700997|26006243|FG000|Overall Study|Did not undergo CT imaging|1|||
13138896|NCT02700997|26006243|FG000|Overall Study|No CT measurement - pelvic calcification|1|||
13138897|NCT02700984|26006299|FG000|Overall Study|Death|2|||
13138898|NCT02700984|26006300|FG001|Overall Study|Death|1|||
13138899|NCT02700984|26006299|FG000|Overall Study|Lost to Follow-up|2|||
13138900|NCT02700984|26006300|FG001|Overall Study|Lost to Follow-up|1|||
13138901|NCT02700984|26006299|FG000|Overall Study|Physician Decision|0|||
13138902|NCT02700984|26006300|FG001|Overall Study|Physician Decision|1|||
13138903|NCT02700984|26006299|FG000|Overall Study|Withdrawal by Subject|8|||
13138904|NCT02700984|26006300|FG001|Overall Study|Withdrawal by Subject|9|||
13138905|NCT02700984|26006299|FG000|Overall Study|Reason not specified|3|||
13138906|NCT02700984|26006300|FG001|Overall Study|Reason not specified|2|||
13138907|NCT02700919|26006368|FG000|Overall Study|Physician Decision|1|||
13138908|NCT02700919|26006369|FG001|Overall Study|Physician Decision|0|||
13138909|NCT02700919|26006370|FG002|Overall Study|Physician Decision|0|||
13138910|NCT02700919|26006368|FG000|Overall Study|Protocol Violation|1|||
13138911|NCT02700919|26006369|FG001|Overall Study|Protocol Violation|0|||
13138912|NCT02700919|26006370|FG002|Overall Study|Protocol Violation|0|||
13138913|NCT02700919|26006368|FG000|Overall Study|Adverse Event|1|||
13138914|NCT02700919|26006369|FG001|Overall Study|Adverse Event|3|||
13138915|NCT02700919|26006370|FG002|Overall Study|Adverse Event|1|||
13138916|NCT02700919|26006368|FG000|Overall Study|Withdrawal by Subject|5|||
13138917|NCT02700919|26006369|FG001|Overall Study|Withdrawal by Subject|8|||
13138918|NCT02700919|26006370|FG002|Overall Study|Withdrawal by Subject|2|||
13138919|NCT02700919|26006368|FG000|Overall Study|Lost to Follow-up|2|||
13138920|NCT02700919|26006369|FG001|Overall Study|Lost to Follow-up|0|||
13138921|NCT02700919|26006370|FG002|Overall Study|Lost to Follow-up|0|||
13138922|NCT02700919|26006368|FG000|Overall Study|Other|2|||
13138923|NCT02700919|26006369|FG001|Overall Study|Other|1|||
13138924|NCT02700919|26006370|FG002|Overall Study|Other|1|||
13138925|NCT02700815|26006421|FG000|Overall Study|Adverse Event|0|||
13138926|NCT02700815|26006422|FG001|Overall Study|Adverse Event|6|||
13138927|NCT02700815|26006423|FG002|Overall Study|Adverse Event|2|||
13138928|NCT02700815|26006424|FG003|Overall Study|Adverse Event|3|||
13138929|NCT02700815|26006421|FG000|Overall Study|Lack of Efficacy|0|||
13138930|NCT02700815|26006422|FG001|Overall Study|Lack of Efficacy|0|||
13138931|NCT02700815|26006423|FG002|Overall Study|Lack of Efficacy|1|||
13138932|NCT02700815|26006424|FG003|Overall Study|Lack of Efficacy|2|||
13138933|NCT02700815|26006421|FG000|Overall Study|Lost to Follow-up|1|||
13138934|NCT02700815|26006422|FG001|Overall Study|Lost to Follow-up|0|||
13138935|NCT02700815|26006423|FG002|Overall Study|Lost to Follow-up|0|||
13138936|NCT02700815|26006424|FG003|Overall Study|Lost to Follow-up|1|||
13138937|NCT02700815|26006421|FG000|Overall Study|Refusal to continue medication|0|||
13138938|NCT02700815|26006422|FG001|Overall Study|Refusal to continue medication|1|||
13138939|NCT02700815|26006423|FG002|Overall Study|Refusal to continue medication|0|||
13138940|NCT02700815|26006424|FG003|Overall Study|Refusal to continue medication|1|||
13138941|NCT02700815|26006421|FG000|Overall Study|Withdrawal by Subject|0|||
13138942|NCT02700815|26006422|FG001|Overall Study|Withdrawal by Subject|0|||
13138943|NCT02700815|26006423|FG002|Overall Study|Withdrawal by Subject|1|||
13138944|NCT02700815|26006424|FG003|Overall Study|Withdrawal by Subject|0|||
13138945|NCT02700698|26006437|FG000|Overall Study|Withdrawal by Subject|1|||
13138946|NCT02700698|26006438|FG001|Overall Study|Withdrawal by Subject|0|||
13138947|NCT02700412|26006448|FG000|Overall Study|Adverse Event|6|||
13138948|NCT02700412|26006448|FG000|Overall Study|Death|1|||
13138949|NCT02700412|26006448|FG000|Overall Study|Lack of Efficacy|19|||
13138950|NCT02700412|26006448|FG000|Overall Study|Protocol Violation|5|||
13138951|NCT02700412|26006448|FG000|Overall Study|Withdrawal by Subject|2|||
13138952|NCT02699996|26006471|FG000|Overall Study|Withdrawal by Subject|5|||
13138953|NCT02699996|26006472|FG001|Overall Study|Withdrawal by Subject|2|||
13138954|NCT02699983|26006539|FG000|Overall Study|Withdrawal by Subject|1|||
13138955|NCT02699983|26006540|FG001|Overall Study|Withdrawal by Subject|0|||
13138956|NCT02699892|26006547|FG000|Overall Study|Other|36|||
13138957|NCT02699866|26006557|FG000|Overall Study|Withdrawal by Subject|3|||
13138958|NCT02699866|26006557|FG000|Overall Study|Physician Decision|2|||
13138959|NCT02699866|26006557|FG000|Overall Study|Adverse Event|3|||
13138960|NCT02699749|26006834|FG000|Overall Study|Other|0|||
13138961|NCT02699749|26006835|FG001|Overall Study|Other|0|||
13138962|NCT02699749|26006836|FG002|Overall Study|Other|2|||
13138963|NCT02699749|26006837|FG003|Overall Study|Other|0|||
13138964|NCT02699749|26006838|FG004|Overall Study|Other|0|||
13138965|NCT02699749|26006839|FG005|Overall Study|Other|1|||
13138966|NCT02699749|26006840|FG006|Overall Study|Other|1|||
13138967|NCT02699749|26006841|FG007|Overall Study|Other|0|||
13138968|NCT02699749|26006842|FG008|Overall Study|Other|0|||
13138969|NCT02699749|26006843|FG009|Overall Study|Other|0|||
13138970|NCT02699749|26006844|FG010|Overall Study|Other|1|||
13138971|NCT02699749|26006845|FG011|Overall Study|Other|0|||
13138972|NCT02699749|26006846|FG012|Overall Study|Other|0|||
13138973|NCT02699749|26006847|FG013|Overall Study|Other|0|||
13138974|NCT02699749|26006834|FG000|Overall Study|Progressive Disease|3|||
13138975|NCT02699749|26006835|FG001|Overall Study|Progressive Disease|3|||
13138976|NCT02699749|26006836|FG002|Overall Study|Progressive Disease|14|||
13138977|NCT02699749|26006837|FG003|Overall Study|Progressive Disease|3|||
13138978|NCT02699749|26006838|FG004|Overall Study|Progressive Disease|3|||
13138979|NCT02699749|26006839|FG005|Overall Study|Progressive Disease|7|||
13138980|NCT02699749|26006840|FG006|Overall Study|Progressive Disease|5|||
13138981|NCT02699749|26006841|FG007|Overall Study|Progressive Disease|5|||
13138982|NCT02699749|26006842|FG008|Overall Study|Progressive Disease|6|||
13138983|NCT02699749|26006843|FG009|Overall Study|Progressive Disease|6|||
13138984|NCT02699749|26006844|FG010|Overall Study|Progressive Disease|5|||
13138985|NCT02699749|26006845|FG011|Overall Study|Progressive Disease|4|||
13138986|NCT02699749|26006846|FG012|Overall Study|Progressive Disease|3|||
13138987|NCT02699749|26006847|FG013|Overall Study|Progressive Disease|5|||
13138988|NCT02699749|26006834|FG000|Overall Study|Death|0|||
13138989|NCT02699749|26006835|FG001|Overall Study|Death|0|||
13138990|NCT02699749|26006836|FG002|Overall Study|Death|0|||
13138991|NCT02699749|26006837|FG003|Overall Study|Death|0|||
13138992|NCT02699749|26006838|FG004|Overall Study|Death|0|||
13138993|NCT02699749|26006839|FG005|Overall Study|Death|0|||
13138994|NCT02699749|26006840|FG006|Overall Study|Death|0|||
13138995|NCT02699749|26006841|FG007|Overall Study|Death|0|||
13138996|NCT02699749|26006842|FG008|Overall Study|Death|0|||
13138997|NCT02699749|26006843|FG009|Overall Study|Death|0|||
13138998|NCT02699749|26006844|FG010|Overall Study|Death|0|||
13138999|NCT02699749|26006845|FG011|Overall Study|Death|0|||
13139000|NCT02699749|26006846|FG012|Overall Study|Death|0|||
13139001|NCT02699749|26006847|FG013|Overall Study|Death|1|||
13139002|NCT02699749|26006834|FG000|Overall Study|Lost to Follow-up|0|||
13139003|NCT02699749|26006835|FG001|Overall Study|Lost to Follow-up|0|||
13139004|NCT02699749|26006836|FG002|Overall Study|Lost to Follow-up|0|||
13139005|NCT02699749|26006837|FG003|Overall Study|Lost to Follow-up|0|||
13139006|NCT02699749|26006838|FG004|Overall Study|Lost to Follow-up|0|||
13139007|NCT02699749|26006839|FG005|Overall Study|Lost to Follow-up|1|||
13139008|NCT02699749|26006840|FG006|Overall Study|Lost to Follow-up|0|||
13139009|NCT02699749|26006841|FG007|Overall Study|Lost to Follow-up|1|||
13139010|NCT02699749|26006842|FG008|Overall Study|Lost to Follow-up|0|||
13139011|NCT02699749|26006843|FG009|Overall Study|Lost to Follow-up|0|||
13139012|NCT02699749|26006844|FG010|Overall Study|Lost to Follow-up|0|||
13139013|NCT02699749|26006845|FG011|Overall Study|Lost to Follow-up|0|||
13139014|NCT02699749|26006846|FG012|Overall Study|Lost to Follow-up|0|||
13139015|NCT02699749|26006847|FG013|Overall Study|Lost to Follow-up|0|||
13139016|NCT02699684|26006860|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
13139017|NCT02699684|26006861|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0|||
13139018|NCT02699593|26006872|FG000|Period 1|Unsatisfactory Visual Response|0|||
13139019|NCT02699593|26006873|FG001|Period 1|Unsatisfactory Visual Response|1|||
13139020|NCT02699593|26006872|FG000|Period 1|Torn Contact Len|4|||
13139021|NCT02699593|26006873|FG001|Period 1|Torn Contact Len|3|||
13139022|NCT02699593|26006872|FG000|Period 1|Protocol Violation|0|||
13139023|NCT02699593|26006873|FG001|Period 1|Protocol Violation|1|||
13139024|NCT02699593|26006872|FG000|Period 1|Withdrawal by Subject|0|||
13139025|NCT02699593|26006873|FG001|Period 1|Withdrawal by Subject|1|||
13139026|NCT02699593|26006872|FG000|Period 1|Adverse Event|1|||
13139027|NCT02699593|26006873|FG001|Period 1|Adverse Event|1|||
13139028|NCT02699593|26006872|FG000|Period 2|Adverse Event|1|||
13139029|NCT02699593|26006873|FG001|Period 2|Adverse Event|1|||
13139030|NCT02699593|26006872|FG000|Period 2|Lost Contact Lens|0|||
13139031|NCT02699593|26006873|FG001|Period 2|Lost Contact Lens|1|||
13139032|NCT02699593|26006872|FG000|Period 2|Torn Contact Lens|1|||
13139033|NCT02699593|26006873|FG001|Period 2|Torn Contact Lens|0|||
13139034|NCT02699463|26006886|FG000|Overall Study|Lost to Follow-up|11|||
13139035|NCT02699463|26006887|FG001|Overall Study|Lost to Follow-up|8|||
13139036|NCT02699463|26006886|FG000|Overall Study|Withdrawal by Subject|4|||
13139037|NCT02699463|26006887|FG001|Overall Study|Withdrawal by Subject|1|||
13139038|NCT02699450|26007032|FG000|Overall Study|Death|2|||
13139039|NCT02699450|26007033|FG001|Overall Study|Death|1|||
13139040|NCT02699450|26007034|FG002|Overall Study|Death|2|||
13139041|NCT02699450|26007032|FG000|Overall Study|Met Criteria for Study Exit|0|||
13139042|NCT02699450|26007033|FG001|Overall Study|Met Criteria for Study Exit|0|||
13139043|NCT02699450|26007034|FG002|Overall Study|Met Criteria for Study Exit|1|||
13139044|NCT02699450|26007032|FG000|Overall Study|Protocol Violation|4|||
13139045|NCT02699450|26007033|FG001|Overall Study|Protocol Violation|3|||
13139046|NCT02699450|26007034|FG002|Overall Study|Protocol Violation|5|||
13139047|NCT02699450|26007032|FG000|Overall Study|Lost to Follow-up|3|||
13139048|NCT02699450|26007033|FG001|Overall Study|Lost to Follow-up|0|||
13139049|NCT02699450|26007034|FG002|Overall Study|Lost to Follow-up|5|||
13139050|NCT02699450|26007032|FG000|Overall Study|Physician Decision|2|||
13139051|NCT02699450|26007033|FG001|Overall Study|Physician Decision|0|||
13139052|NCT02699450|26007034|FG002|Overall Study|Physician Decision|0|||
13091205|NCT03756883|25822635|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
13091206|NCT03756883|25822636|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
13091207|NCT03756883|25822637|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2|||
13091208|NCT03756883|25822635|FG000|Overall Study|Withdrawal by Subject|4|||
13091209|NCT03756883|25822636|FG001|Overall Study|Withdrawal by Subject|1|||
13091210|NCT03756883|25822637|FG002|Overall Study|Withdrawal by Subject|0|||
13091211|NCT03756883|25822635|FG000|Overall Study|Other Reasons|2|||
13091212|NCT03756883|25822636|FG001|Overall Study|Other Reasons|4|||
13091213|NCT03756883|25822637|FG002|Overall Study|Other Reasons|0|||
13091214|NCT03756571|25822672|FG000|Overall Study|Lost to Follow-up|1|||
13091215|NCT03756571|25822673|FG001|Overall Study|Lost to Follow-up|1|||
13091216|NCT03756285|25822690|FG000|Overall Study|Lost to Follow-up|0|||
13091217|NCT03756285|25822691|FG001|Overall Study|Lost to Follow-up|1|||
13091218|NCT03756285|25822690|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0|||
13091219|NCT03756285|25822691|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1|||
13091220|NCT03756285|25822690|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
13091221|NCT03756285|25822691|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
13091222|NCT03756129|25822810|FG000|Overall Study|Adverse Event|1|||
13091223|NCT03756129|25822811|FG001|Overall Study|Adverse Event|1|||
13091224|NCT03756129|25822812|FG002|Overall Study|Adverse Event|0|||
13091225|NCT03756129|25822813|FG003|Overall Study|Adverse Event|2|||
13091226|NCT03756129|25822814|FG004|Overall Study|Adverse Event|0|||
13091227|NCT03756129|25822815|FG005|Overall Study|Adverse Event|0|||
13091228|NCT03756129|25822810|FG000|Overall Study|Withdrawal by Subject|2|||
13091229|NCT03756129|25822811|FG001|Overall Study|Withdrawal by Subject|1|||
13091230|NCT03756129|25822812|FG002|Overall Study|Withdrawal by Subject|3|||
13139053|NCT02699450|26007032|FG000|Overall Study|Withdrawal by Subject|3|||
13139054|NCT02699450|26007033|FG001|Overall Study|Withdrawal by Subject|1|||
13139055|NCT02699450|26007034|FG002|Overall Study|Withdrawal by Subject|2|||
13139056|NCT02699450|26007032|FG000|Overall Study|Adverse Event|1|||
13139057|NCT02699450|26007033|FG001|Overall Study|Adverse Event|0|||
13139058|NCT02699450|26007034|FG002|Overall Study|Adverse Event|0|||
13139059|NCT02699125|26007048|FG000|Placebo|Lost to Follow-up|2|||
13139060|NCT02699125|26007049|FG001|Placebo|Lost to Follow-up|0|||
13139061|NCT02699125|26007048|FG000|Placebo|Protocol Violation|1|||
13139062|NCT02699125|26007049|FG001|Placebo|Protocol Violation|0|||
13139063|NCT02699125|26007048|FG000|Placebo|Withdrawal by Subject|0|||
13139064|NCT02699125|26007049|FG001|Placebo|Withdrawal by Subject|4|||
13139065|NCT02699125|26007048|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7|||
13139066|NCT02699125|26007049|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
13139067|NCT02699099|26007150|FG000|Overall Study|Adverse Event|1|||
13139068|NCT02699099|26007151|FG001|Overall Study|Adverse Event|0|||
13139069|NCT02699099|26007152|FG002|Overall Study|Adverse Event|2|||
13139070|NCT02699099|26007150|FG000|Overall Study|Lost to Follow-up|0|||
13139071|NCT02699099|26007151|FG001|Overall Study|Lost to Follow-up|1|||
13139072|NCT02699099|26007152|FG002|Overall Study|Lost to Follow-up|0|||
13139073|NCT02699099|26007150|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7|||
13139074|NCT02699099|26007151|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
13139075|NCT02699099|26007152|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4|||
13139076|NCT02698891|26007165|FG000|Overall Study|Withdrawal by Subject|2|||
13139077|NCT02698891|26007165|FG000|Overall Study|deemed ineligible|1|||
13139078|NCT02698891|26007165|FG000|Overall Study|Adverse Event|9|||
13139079|NCT02698865|26007180|FG000|Overall Study|Other|11|||
13139080|NCT02698865|26007181|FG001|Overall Study|Other|11|||
13139081|NCT02698865|26007180|FG000|Overall Study|Withdrawal by Subject|20|||
13139082|NCT02698865|26007181|FG001|Overall Study|Withdrawal by Subject|16|||
13139083|NCT02698865|26007180|FG000|Overall Study|Physician Decision|0|||
13139084|NCT02698865|26007181|FG001|Overall Study|Physician Decision|4|||
13139085|NCT02698865|26007180|FG000|Overall Study|Lost to Follow-up|4|||
13139086|NCT02698865|26007181|FG001|Overall Study|Lost to Follow-up|2|||
13139087|NCT02698826|26007189|FG000|Overall Study|Death|13|||
13139088|NCT02698826|26007189|FG000|Overall Study|Adverse Event|1|||
13139089|NCT02698787|26007205|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0|||
13139090|NCT02698787|26007206|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1|||
13139091|NCT02698475|26007225|FG000|Main Study Period|Lack of Efficacy|1|||
13139092|NCT02698475|26007225|FG000|Main Study Period|Protocol Violation|2|||
13139093|NCT02698475|26007225|FG000|Long-Term Extension Period|Lost to Follow-up|1|||
13139094|NCT02698475|26007225|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1|||
13139095|NCT02698475|26007225|FG000|Long-Term Extension Period|Withdrawal by Subject|3|||
13139096|NCT02698475|26007225|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22|||
13139097|NCT02698475|26007225|FG000|Long-Term Extension Period|Other|1|||
13139098|NCT02698436|26007270|FG000|Overall Study|Adverse Event|1|||
13139099|NCT02698436|26007271|FG001|Overall Study|Adverse Event|0|||
13139100|NCT02698436|26007270|FG000|Overall Study|Withdrawal by Subject|3|||
13139101|NCT02698436|26007271|FG001|Overall Study|Withdrawal by Subject|3|||
13139102|NCT02698436|26007270|FG000|Overall Study|Lost to Follow-up|2|||
13139103|NCT02698436|26007271|FG001|Overall Study|Lost to Follow-up|4|||
13139104|NCT02698436|26007270|FG000|Overall Study|Non-compliance with study regimen|1|||
13139105|NCT02698436|26007271|FG001|Overall Study|Non-compliance with study regimen|0|||
13139106|NCT02698423|26007286|FG000|Overall Study|Lost to Follow-up|19|||
13139107|NCT02698423|26007287|FG001|Overall Study|Lost to Follow-up|24|||
13139108|NCT02698410|26007308|FG000|Overall Study|Adverse Event|2|||
13139109|NCT02698410|26007308|FG000|Overall Study|Withdrawal by Subject|1|||
13139110|NCT02698410|26007308|FG000|Overall Study|Other|1|||
13139111|NCT02698371|26007432|FG000|All Participants Flow|Lost to Follow-up|3|||
13139112|NCT02698371|26007432|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3|||
13139113|NCT02698371|26007432|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3|||
13139114|NCT02698371|26007432|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3|||
13139115|NCT02698371|26007432|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3|||
13139116|NCT02698371|26007432|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3|||
13139117|NCT02698371|26007432|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2|||
13139118|NCT02698241|26007439|FG000|Overall Study|Inclusion/exclusion criteria not met|4|||
13139119|NCT02698241|26007439|FG000|Overall Study|Screening not met|7|||
13139120|NCT02698241|26007439|FG000|Overall Study|Withdrawal by Subject|7|||
13139121|NCT02698241|26007439|FG000|Overall Study|Physician Decision|2|||
13139122|NCT02698241|26007439|FG000|Overall Study|Subject underwent system modification|2|||
13139123|NCT02698241|26007439|FG000|Overall Study|Lost to Follow-up|3|||
13139124|NCT02698241|26007439|FG000|Overall Study|Subject on inodrip not safe to continue|6|||
13139125|NCT02698241|26007439|FG000|Overall Study|geographic and licensing issue|1|||
13139126|NCT02698241|26007439|FG000|Overall Study|Death|2|||
13139127|NCT02698189|26007473|FG000|Overall Study|Physician Decision|3|||
13139128|NCT02698189|26007474|FG001|Overall Study|Physician Decision|0|||
13139129|NCT02698189|26007473|FG000|Overall Study|Progressive disease|0|||
13139130|NCT02698189|26007474|FG001|Overall Study|Progressive disease|5|||
13139131|NCT02698189|26007473|FG000|Overall Study|Study terminated by sponsor|0|||
13139132|NCT02698189|26007474|FG001|Overall Study|Study terminated by sponsor|1|||
13139133|NCT02698176|26007520|FG000|Overall Study|Progressive disease|4|||
13139134|NCT02698176|26007521|FG001|Overall Study|Progressive disease|3|||
13139135|NCT02698176|26007522|FG002|Overall Study|Progressive disease|1|||
13139136|NCT02698176|26007523|FG003|Overall Study|Progressive disease|0|||
13139137|NCT02698176|26007520|FG000|Overall Study|Adverse Event|2|||
13139138|NCT02698176|26007521|FG001|Overall Study|Adverse Event|0|||
13139139|NCT02698176|26007522|FG002|Overall Study|Adverse Event|0|||
13139140|NCT02698176|26007523|FG003|Overall Study|Adverse Event|0|||
13139141|NCT02698176|26007520|FG000|Overall Study|Clinical progression|3|||
13139142|NCT02698176|26007521|FG001|Overall Study|Clinical progression|0|||
13139143|NCT02698176|26007522|FG002|Overall Study|Clinical progression|0|||
13139144|NCT02698176|26007523|FG003|Overall Study|Clinical progression|0|||
13139145|NCT02697916|26007548|FG000|Overall Study|Death|357|||
13139146|NCT02697916|26007549|FG001|Overall Study|Death|315|||
13139147|NCT02697916|26007548|FG000|Overall Study|Withdrawal by Subject|221|||
13139148|NCT02697916|26007549|FG001|Overall Study|Withdrawal by Subject|393|||
13139149|NCT02697773|26007738|FG000|Overall Study|Adverse Event|2|||
13139150|NCT02697773|26007739|FG001|Overall Study|Adverse Event|1|||
13139151|NCT02697773|26007740|FG002|Overall Study|Adverse Event|2|||
13139152|NCT02697773|26007738|FG000|Overall Study|Death|0|||
13139153|NCT02697773|26007739|FG001|Overall Study|Death|0|||
13139154|NCT02697773|26007740|FG002|Overall Study|Death|2|||
13139155|NCT02697773|26007738|FG000|Overall Study|Lack of Efficacy|4|||
13139156|NCT02697773|26007739|FG001|Overall Study|Lack of Efficacy|6|||
13139157|NCT02697773|26007740|FG002|Overall Study|Lack of Efficacy|6|||
13139158|NCT02697773|26007738|FG000|Overall Study|Lost to Follow-up|5|||
13139159|NCT02697773|26007739|FG001|Overall Study|Lost to Follow-up|5|||
13139160|NCT02697773|26007740|FG002|Overall Study|Lost to Follow-up|7|||
13139161|NCT02697773|26007738|FG000|Overall Study|Other|15|||
13139162|NCT02697773|26007739|FG001|Overall Study|Other|11|||
13139163|NCT02697773|26007740|FG002|Overall Study|Other|10|||
13139164|NCT02697773|26007738|FG000|Overall Study|Protocol Violation|1|||
13139165|NCT02697773|26007739|FG001|Overall Study|Protocol Violation|1|||
13139166|NCT02697773|26007740|FG002|Overall Study|Protocol Violation|0|||
13139167|NCT02697773|26007738|FG000|Overall Study|Withdrawal by Subject|10|||
13139168|NCT02697773|26007739|FG001|Overall Study|Withdrawal by Subject|13|||
13139169|NCT02697773|26007740|FG002|Overall Study|Withdrawal by Subject|13|||
13139170|NCT02697773|26007738|FG000|Overall Study|Randomized but not treated|1|||
13139171|NCT02697773|26007739|FG001|Overall Study|Randomized but not treated|1|||
13139172|NCT02697773|26007740|FG002|Overall Study|Randomized but not treated|0|||
13204648|NCT01971645|26229540|FG002|Overall Study|Lost to Follow-up|1|||
13204649|NCT01971645|26229538|FG000|Overall Study|Protocol Violation|0|||
13204650|NCT01971645|26229539|FG001|Overall Study|Protocol Violation|0|||
13204651|NCT01971645|26229540|FG002|Overall Study|Protocol Violation|1|||
13204652|NCT01971567|26229569|FG000|Overall Study|Withdrawal by Subject|3|||
13204653|NCT01971567|26229570|FG001|Overall Study|Withdrawal by Subject|2|||
13204654|NCT01971567|26229569|FG000|Overall Study|Lost to Follow-up|1|||
13204655|NCT01971567|26229570|FG001|Overall Study|Lost to Follow-up|0|||
13204656|NCT01971554|26229617|FG000|Overall Study|Lost to Follow-up|1|||
13204657|NCT01971554|26229618|FG001|Overall Study|Lost to Follow-up|0|||
13204658|NCT01971554|26229619|FG002|Overall Study|Lost to Follow-up|0|||
13204659|NCT01971554|26229620|FG003|Overall Study|Lost to Follow-up|0|||
13204660|NCT01971476|26229707|FG000|Cohort 1: 2 to <12 Years|Other not defined|3|||
13204661|NCT01971476|26229708|FG001|Cohort 1: 2 to <12 Years|Other not defined|3|||
13204662|NCT01971476|26229709|FG002|Cohort 1: 2 to <12 Years|Other not defined|6|||
13204663|NCT01971476|26229707|FG000|Cohort 2: 12 to <18 Years|Other not defined|6|||
13204664|NCT01971476|26229708|FG001|Cohort 2: 12 to <18 Years|Other not defined|3|||
13204665|NCT01971476|26229709|FG002|Cohort 2: 12 to <18 Years|Other not defined|0|||
13204666|NCT01971476|26229707|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0|||
13204667|NCT01971476|26229708|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1|||
13204668|NCT01971476|26229709|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0|||
13204669|NCT01971346|26229723|FG000|Overall Study|Protocol Violation|3|||
13204670|NCT01971346|26229723|FG000|Overall Study|Lost to Follow-up|2|||
13204671|NCT01971346|26229723|FG000|Overall Study|Withdrawal by Subject|2|||
13204672|NCT01971346|26229723|FG000|Overall Study|Physician Decision|1|||
13204673|NCT01971203|26229742|FG000|Overall Study|Protocol Violation|3|||
13204674|NCT01971203|26229743|FG001|Overall Study|Protocol Violation|2|||
13204675|NCT01971203|26229742|FG000|Overall Study|Withdrawal by Subject|5|||
13204676|NCT01971203|26229743|FG001|Overall Study|Withdrawal by Subject|6|||
13204677|NCT01971203|26229742|FG000|Overall Study|Adverse Event|1|||
13204678|NCT01971203|26229743|FG001|Overall Study|Adverse Event|0|||
13204679|NCT01970995|26229773|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
13204680|NCT01970995|26229774|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
13204681|NCT01970995|26229775|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
13204682|NCT01970995|26229773|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
13204683|NCT01970995|26229774|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0|||
13204684|NCT01970995|26229775|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
13204685|NCT01970982|26229803|FG000|Overall Study|Withdrawal by Subject|0|||
13204686|NCT01970982|26229804|FG001|Overall Study|Withdrawal by Subject|0|||
13204687|NCT01970982|26229805|FG002|Overall Study|Withdrawal by Subject|2|||
13204688|NCT01970878|26229844|FG000|Overall Study|Withdrawal by Subject|11|||
13204689|NCT01970878|26229845|FG001|Overall Study|Withdrawal by Subject|10|||
13204690|NCT01970878|26229846|FG002|Overall Study|Withdrawal by Subject|14|||
13204691|NCT01970878|26229847|FG003|Overall Study|Withdrawal by Subject|7|||
13204692|NCT01970878|26229844|FG000|Overall Study|Lost to Follow-up|1|||
13204693|NCT01970878|26229845|FG001|Overall Study|Lost to Follow-up|3|||
13204694|NCT01970878|26229846|FG002|Overall Study|Lost to Follow-up|2|||
13204695|NCT01970878|26229847|FG003|Overall Study|Lost to Follow-up|4|||
13204696|NCT01970878|26229844|FG000|Overall Study|Administrative Reasons|1|||
13204697|NCT01970878|26229845|FG001|Overall Study|Administrative Reasons|0|||
13204698|NCT01970878|26229846|FG002|Overall Study|Administrative Reasons|0|||
13204699|NCT01970878|26229847|FG003|Overall Study|Administrative Reasons|4|||
13204700|NCT01970878|26229844|FG000|Overall Study|Lack of Efficacy|2|||
13204701|NCT01970878|26229845|FG001|Overall Study|Lack of Efficacy|1|||
13204702|NCT01970878|26229846|FG002|Overall Study|Lack of Efficacy|2|||
13204703|NCT01970878|26229847|FG003|Overall Study|Lack of Efficacy|0|||
13204704|NCT01970878|26229844|FG000|Overall Study|Adverse Event|12|||
13204705|NCT01970878|26229845|FG001|Overall Study|Adverse Event|7|||
13139173|NCT02697734|26007829|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4|||
13139174|NCT02697734|26007830|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0|||
13139175|NCT02697734|26007829|FG000|Core Phase - up to Week 48|Adverse Event|1|||
13139176|NCT02697734|26007830|FG001|Core Phase - up to Week 48|Adverse Event|2|||
13139177|NCT02697734|26007829|FG000|Core Phase - up to Week 48|Physician Decision|1|||
13139178|NCT02697734|26007830|FG001|Core Phase - up to Week 48|Physician Decision|0|||
13139179|NCT02697734|26007829|FG000|Optional Extension Phase|Adverse Event|5|||
13139180|NCT02697734|26007830|FG001|Optional Extension Phase|Adverse Event|1|||
13139181|NCT02697734|26007829|FG000|Optional Extension Phase|Physician Decision|0|||
13139182|NCT02697734|26007830|FG001|Optional Extension Phase|Physician Decision|1|||
13139183|NCT02697617|26007851|FG000|Overall Study|Withdrawal by Subject|0|||
13139184|NCT02697617|26007852|FG001|Overall Study|Withdrawal by Subject|2|||
13139185|NCT02697617|26007851|FG000|Overall Study|Pregnancy|1|||
13139186|NCT02697617|26007852|FG001|Overall Study|Pregnancy|0|||
13139187|NCT02697591|26007986|FG000|Overall Study|Lost to Follow-up|0|||
13139188|NCT02697591|26007987|FG001|Overall Study|Lost to Follow-up|0|||
13139189|NCT02697591|26007988|FG002|Overall Study|Lost to Follow-up|0|||
13139190|NCT02697591|26007989|FG003|Overall Study|Lost to Follow-up|0|||
13139191|NCT02697591|26007990|FG004|Overall Study|Lost to Follow-up|0|||
13139192|NCT02697591|26007991|FG005|Overall Study|Lost to Follow-up|1|||
13139193|NCT02697591|26007992|FG006|Overall Study|Lost to Follow-up|1|||
13139194|NCT02697591|26007993|FG007|Overall Study|Lost to Follow-up|0|||
13139195|NCT02697591|26007994|FG008|Overall Study|Lost to Follow-up|0|||
13139196|NCT02697591|26007995|FG009|Overall Study|Lost to Follow-up|1|||
13139197|NCT02697591|26007986|FG000|Overall Study|Withdrawal by Subject|1|||
13139198|NCT02697591|26007987|FG001|Overall Study|Withdrawal by Subject|1|||
13139199|NCT02697591|26007988|FG002|Overall Study|Withdrawal by Subject|2|||
13139200|NCT02697591|26007989|FG003|Overall Study|Withdrawal by Subject|1|||
13139201|NCT02697591|26007990|FG004|Overall Study|Withdrawal by Subject|7|||
13139202|NCT02697591|26007991|FG005|Overall Study|Withdrawal by Subject|6|||
13139203|NCT02697591|26007992|FG006|Overall Study|Withdrawal by Subject|9|||
13139204|NCT02697591|26007993|FG007|Overall Study|Withdrawal by Subject|1|||
13139205|NCT02697591|26007994|FG008|Overall Study|Withdrawal by Subject|6|||
13139206|NCT02697591|26007995|FG009|Overall Study|Withdrawal by Subject|10|||
13139207|NCT02697591|26007986|FG000|Overall Study|Physician Decision|1|||
13139208|NCT02697591|26007987|FG001|Overall Study|Physician Decision|0|||
13139209|NCT02697591|26007988|FG002|Overall Study|Physician Decision|0|||
13139210|NCT02697591|26007989|FG003|Overall Study|Physician Decision|0|||
13139211|NCT02697591|26007990|FG004|Overall Study|Physician Decision|1|||
13139212|NCT02697591|26007991|FG005|Overall Study|Physician Decision|2|||
13139213|NCT02697591|26007992|FG006|Overall Study|Physician Decision|0|||
13139214|NCT02697591|26007993|FG007|Overall Study|Physician Decision|0|||
13139215|NCT02697591|26007994|FG008|Overall Study|Physician Decision|1|||
13139216|NCT02697591|26007995|FG009|Overall Study|Physician Decision|1|||
13139217|NCT02697591|26007986|FG000|Overall Study|Death|2|||
13139218|NCT02697591|26007987|FG001|Overall Study|Death|3|||
13139219|NCT02697591|26007988|FG002|Overall Study|Death|1|||
13139220|NCT02697591|26007989|FG003|Overall Study|Death|1|||
13139221|NCT02697591|26007990|FG004|Overall Study|Death|4|||
13139222|NCT02697591|26007991|FG005|Overall Study|Death|5|||
13139223|NCT02697591|26007992|FG006|Overall Study|Death|3|||
13139224|NCT02697591|26007993|FG007|Overall Study|Death|1|||
13139225|NCT02697591|26007994|FG008|Overall Study|Death|1|||
13139226|NCT02697591|26007995|FG009|Overall Study|Death|5|||
13139227|NCT02697591|26007986|FG000|Overall Study|Reason not Specified|0|||
13139228|NCT02697591|26007987|FG001|Overall Study|Reason not Specified|0|||
13139229|NCT02697591|26007988|FG002|Overall Study|Reason not Specified|0|||
13139230|NCT02697591|26007989|FG003|Overall Study|Reason not Specified|1|||
13139231|NCT02697591|26007990|FG004|Overall Study|Reason not Specified|1|||
13091231|NCT03756129|25822813|FG003|Overall Study|Withdrawal by Subject|1|||
13091232|NCT03756129|25822814|FG004|Overall Study|Withdrawal by Subject|1|||
13091233|NCT03756129|25822815|FG005|Overall Study|Withdrawal by Subject|3|||
13091234|NCT03756129|25822810|FG000|Overall Study|Lost to Follow-up|0|||
13091235|NCT03756129|25822811|FG001|Overall Study|Lost to Follow-up|0|||
13091236|NCT03756129|25822812|FG002|Overall Study|Lost to Follow-up|0|||
13091237|NCT03756129|25822813|FG003|Overall Study|Lost to Follow-up|0|||
13091238|NCT03756129|25822814|FG004|Overall Study|Lost to Follow-up|0|||
13091239|NCT03756129|25822815|FG005|Overall Study|Lost to Follow-up|1|||
13091240|NCT03756129|25822810|FG000|Overall Study|Physician Decision|0|||
13091241|NCT03756129|25822811|FG001|Overall Study|Physician Decision|0|||
13091242|NCT03756129|25822812|FG002|Overall Study|Physician Decision|0|||
13091243|NCT03756129|25822813|FG003|Overall Study|Physician Decision|0|||
13091244|NCT03756129|25822814|FG004|Overall Study|Physician Decision|0|||
13091245|NCT03756129|25822815|FG005|Overall Study|Physician Decision|1|||
13091246|NCT03755882|25822824|FG000|Period 1|Protocol Violation|1|||
13091247|NCT03755882|25822825|FG001|Period 1|Protocol Violation|0|||
13091248|NCT03755882|25822824|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3|||
13139232|NCT02697591|26007991|FG005|Overall Study|Reason not Specified|2|||
13139233|NCT02697591|26007992|FG006|Overall Study|Reason not Specified|3|||
13091249|NCT03755882|25822825|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0|||
13091250|NCT03755661|25822846|FG000|Overall Study|Lost to Follow-up|1|||
13091251|NCT03755661|25822847|FG001|Overall Study|Lost to Follow-up|0|||
13091252|NCT03754582|25822879|FG000|Treatment Phase|Adverse Event|0|||
13091253|NCT03754582|25822880|FG001|Treatment Phase|Adverse Event|1|||
13091254|NCT03754582|25822881|FG002|Treatment Phase|Adverse Event|0|||
13091255|NCT03754582|25822879|FG000|Follow-up Phase|Other|0|||
13091256|NCT03754582|25822880|FG001|Follow-up Phase|Other|0|||
13091257|NCT03754582|25822881|FG002|Follow-up Phase|Other|1|||
13091258|NCT03753763|25822908|FG000|Overall Study|Adverse Event|2|||
13091259|NCT03753763|25822909|FG001|Overall Study|Adverse Event|0|||
13091260|NCT03753763|25822908|FG000|Overall Study|Withdrawal by Subject|3|||
13091261|NCT03753763|25822909|FG001|Overall Study|Withdrawal by Subject|1|||
13091262|NCT03753763|25822908|FG000|Overall Study|clinical deterioration|1|||
13091263|NCT03753763|25822909|FG001|Overall Study|clinical deterioration|0|||
13091264|NCT03753542|25822922|FG000|Overall Study|Lost to Follow-up|9|||
13091265|NCT03753542|25822923|FG001|Overall Study|Lost to Follow-up|14|||
13139234|NCT02697591|26007993|FG007|Overall Study|Reason not Specified|1|||
13139235|NCT02697591|26007994|FG008|Overall Study|Reason not Specified|1|||
13139236|NCT02697591|26007995|FG009|Overall Study|Reason not Specified|3|||
13139237|NCT02697435|26008010|FG000|Overall Study|Withdrawal by Subject|1|||
13139238|NCT02697435|26008011|FG001|Overall Study|Withdrawal by Subject|0|||
13139239|NCT02697435|26008010|FG000|Overall Study|Physician Decision|0|||
13139240|NCT02697435|26008011|FG001|Overall Study|Physician Decision|4|||
13139241|NCT02696902|26008051|FG000|Overall Study|Lost to Follow-up|0|||
13139242|NCT02696902|26008052|FG001|Overall Study|Lost to Follow-up|1|||
13139243|NCT02696902|26008053|FG002|Overall Study|Lost to Follow-up|1|||
13139244|NCT02696902|26008051|FG000|Overall Study|Withdrawal by Subject|0|||
13139245|NCT02696902|26008052|FG001|Overall Study|Withdrawal by Subject|0|||
13139246|NCT02696902|26008053|FG002|Overall Study|Withdrawal by Subject|1|||
13139247|NCT02696902|26008051|FG000|Overall Study|Death|19|||
13139248|NCT02696902|26008052|FG001|Overall Study|Death|3|||
13139249|NCT02696902|26008053|FG002|Overall Study|Death|24|||
13139250|NCT02696902|26008051|FG000|Overall Study|Participant not fit post-randomization|0|||
13139251|NCT02696902|26008052|FG001|Overall Study|Participant not fit post-randomization|0|||
13139252|NCT02696902|26008053|FG002|Overall Study|Participant not fit post-randomization|1|||
13139253|NCT02696902|26008051|FG000|Overall Study|Participant not eligible (negative PCR)|0|||
13139254|NCT02696902|26008052|FG001|Overall Study|Participant not eligible (negative PCR)|0|||
13139255|NCT02696902|26008053|FG002|Overall Study|Participant not eligible (negative PCR)|1|||
13139256|NCT02696902|26008051|FG000|Overall Study|Principal investigator's decision|1|||
13139257|NCT02696902|26008052|FG001|Overall Study|Principal investigator's decision|0|||
13139258|NCT02696902|26008053|FG002|Overall Study|Principal investigator's decision|0|||
13139259|NCT02696902|26008051|FG000|Overall Study|Sponsor's decision|1|||
13139260|NCT02696902|26008052|FG001|Overall Study|Sponsor's decision|0|||
13139261|NCT02696902|26008053|FG002|Overall Study|Sponsor's decision|0|||
13139262|NCT02696902|26008051|FG000|Overall Study|Transferred to other hospital|1|||
13139263|NCT02696902|26008052|FG001|Overall Study|Transferred to other hospital|0|||
13139264|NCT02696902|26008053|FG002|Overall Study|Transferred to other hospital|0|||
13139265|NCT02696850|26008070|FG000|Overall Study|Withdrawal by Subject|3|||
13139266|NCT02696850|26008071|FG001|Overall Study|Withdrawal by Subject|3|||
13139267|NCT02696850|26008070|FG000|Overall Study|Lost to Follow-up|8|||
13139268|NCT02696850|26008071|FG001|Overall Study|Lost to Follow-up|5|||
13139269|NCT02696798|26008174|FG000|Blinded Treatment Dosing Period|Adverse Event|2|||
13139270|NCT02696798|26008175|FG001|Blinded Treatment Dosing Period|Adverse Event|9|||
13139271|NCT02696798|26008176|FG002|Blinded Treatment Dosing Period|Adverse Event|2|||
13139272|NCT02696798|26008174|FG000|Blinded Treatment Dosing Period|Death|0|||
13139273|NCT02696798|26008175|FG001|Blinded Treatment Dosing Period|Death|0|||
13139274|NCT02696798|26008176|FG002|Blinded Treatment Dosing Period|Death|1|||
13139275|NCT02696798|26008174|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2|||
13139276|NCT02696798|26008175|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
13139277|NCT02696798|26008176|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
13139278|NCT02696798|26008174|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
13139279|NCT02696798|26008175|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1|||
13139280|NCT02696798|26008176|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
13139281|NCT02696798|26008174|FG000|Blinded Treatment Dosing Period|Physician Decision|0|||
13139282|NCT02696798|26008175|FG001|Blinded Treatment Dosing Period|Physician Decision|1|||
13139283|NCT02696798|26008176|FG002|Blinded Treatment Dosing Period|Physician Decision|0|||
13139284|NCT02696798|26008174|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7|||
13139285|NCT02696798|26008175|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3|||
13139286|NCT02696798|26008176|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4|||
13139287|NCT02696798|26008174|FG000|Extended Treatment Period|Adverse Event|1|||
13139288|NCT02696798|26008175|FG001|Extended Treatment Period|Adverse Event|4|||
13139289|NCT02696798|26008176|FG002|Extended Treatment Period|Adverse Event|5|||
13204706|NCT01970878|26229846|FG002|Overall Study|Adverse Event|4|||
13091266|NCT03752528|25822944|FG000|Part A|Lost to Follow-up|1|||
13139290|NCT02696798|26008174|FG000|Extended Treatment Period|Lack of Efficacy|7|||
13139291|NCT02696798|26008175|FG001|Extended Treatment Period|Lack of Efficacy|2|||
13139292|NCT02696798|26008176|FG002|Extended Treatment Period|Lack of Efficacy|2|||
13139293|NCT02696798|26008174|FG000|Extended Treatment Period|Lost to Follow-up|1|||
13139294|NCT02696798|26008175|FG001|Extended Treatment Period|Lost to Follow-up|0|||
13139295|NCT02696798|26008176|FG002|Extended Treatment Period|Lost to Follow-up|0|||
13139296|NCT02696798|26008174|FG000|Extended Treatment Period|Physician Decision|0|||
13139297|NCT02696798|26008175|FG001|Extended Treatment Period|Physician Decision|1|||
13139298|NCT02696798|26008176|FG002|Extended Treatment Period|Physician Decision|0|||
13139299|NCT02696798|26008174|FG000|Extended Treatment Period|Withdrawal by Subject|3|||
13139300|NCT02696798|26008175|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
13139301|NCT02696798|26008176|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
13139302|NCT02696798|26008174|FG000|Post-treatment Follow-up Period|Adverse Event|2|||
13139303|NCT02696798|26008175|FG001|Post-treatment Follow-up Period|Adverse Event|12|||
13139304|NCT02696798|26008176|FG002|Post-treatment Follow-up Period|Adverse Event|6|||
13139305|NCT02696798|26008174|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0|||
13139306|NCT02696798|26008175|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1|||
13139307|NCT02696798|26008176|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1|||
13139308|NCT02696798|26008174|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1|||
13139309|NCT02696798|26008175|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2|||
13139310|NCT02696798|26008176|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0|||
13139311|NCT02696798|26008174|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2|||
13139312|NCT02696798|26008175|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8|||
13139313|NCT02696798|26008176|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12|||
13139314|NCT02696798|26008174|FG000|Post-treatment Follow-up Period|Physician Decision|0|||
13139315|NCT02696798|26008175|FG001|Post-treatment Follow-up Period|Physician Decision|2|||
13139316|NCT02696798|26008176|FG002|Post-treatment Follow-up Period|Physician Decision|0|||
13139317|NCT02696798|26008174|FG000|Post-treatment Follow-up Period|No progressive improvement|0|||
13139318|NCT02696798|26008175|FG001|Post-treatment Follow-up Period|No progressive improvement|1|||
13139319|NCT02696798|26008176|FG002|Post-treatment Follow-up Period|No progressive improvement|0|||
13139320|NCT02696785|26008307|FG000|Blinded Treatment Period|Adverse Event|0|||
13139321|NCT02696785|26008308|FG001|Blinded Treatment Period|Adverse Event|1|||
13139322|NCT02696785|26008309|FG002|Blinded Treatment Period|Adverse Event|3|||
13139323|NCT02696785|26008310|FG003|Blinded Treatment Period|Adverse Event|0|||
13139324|NCT02696785|26008307|FG000|Blinded Treatment Period|Withdrawal by Subject|0|||
13139325|NCT02696785|26008308|FG001|Blinded Treatment Period|Withdrawal by Subject|1|||
13139326|NCT02696785|26008309|FG002|Blinded Treatment Period|Withdrawal by Subject|1|||
13139327|NCT02696785|26008310|FG003|Blinded Treatment Period|Withdrawal by Subject|2|||
13139328|NCT02696785|26008307|FG000|Blinded Treatment Period|Lack of Efficacy|0|||
13091267|NCT03752528|25822944|FG000|Part A|Protocol Violation|1|||
13091268|NCT03752528|25822944|FG000|Part B|Protocol Violation|1|||
13091269|NCT03752528|25822944|FG000|Part B|Study terminated by sponsor|3|||
13091270|NCT03752151|25822952|FG000|Overall Study|Withdrawal by Subject|1|||
13091271|NCT03752151|25822952|FG000|Overall Study|Protocol Violation|1|||
13091272|NCT03751657|25822994|FG000|Overall Study|Physician Decision|0|||
13091273|NCT03751657|25822995|FG001|Overall Study|Physician Decision|1|||
13091274|NCT03751657|25822994|FG000|Overall Study|Withdrawal by Subject|1|||
13091275|NCT03751657|25822995|FG001|Overall Study|Withdrawal by Subject|1|||
13091276|NCT03751657|25822994|FG000|Overall Study|Lost to Follow-up|2|||
13091277|NCT03751657|25822995|FG001|Overall Study|Lost to Follow-up|1|||
13091278|NCT03751631|25823025|FG000|Overall Study|Withdrawal by Subject|0|||
13091279|NCT03751631|25823026|FG001|Overall Study|Withdrawal by Subject|0|||
13091280|NCT03751631|25823027|FG002|Overall Study|Withdrawal by Subject|1|||
13091281|NCT03751631|25823028|FG003|Overall Study|Withdrawal by Subject|1|||
13091282|NCT03751631|25823029|FG004|Overall Study|Withdrawal by Subject|0|||
13091283|NCT03751631|25823030|FG005|Overall Study|Withdrawal by Subject|0|||
13091284|NCT03751280|25823070|FG000|Overall Study|Adverse Event|0|||
13139329|NCT02696785|26008308|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
13139330|NCT02696785|26008309|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
13139331|NCT02696785|26008310|FG003|Blinded Treatment Period|Lack of Efficacy|1|||
13139332|NCT02696785|26008307|FG000|Blinded Treatment Period|Screen Failure|1|||
13139333|NCT02696785|26008308|FG001|Blinded Treatment Period|Screen Failure|0|||
13139334|NCT02696785|26008309|FG002|Blinded Treatment Period|Screen Failure|0|||
13139335|NCT02696785|26008310|FG003|Blinded Treatment Period|Screen Failure|0|||
13139336|NCT02696785|26008307|FG000|Washout Period|Withdrawal by Subject|0|||
13139337|NCT02696785|26008308|FG001|Washout Period|Withdrawal by Subject|1|||
13139338|NCT02696785|26008309|FG002|Washout Period|Withdrawal by Subject|0|||
13139339|NCT02696785|26008310|FG003|Washout Period|Withdrawal by Subject|0|||
13139340|NCT02696785|26008307|FG000|Washout Period|Lack of Efficacy|0|||
13139341|NCT02696785|26008308|FG001|Washout Period|Lack of Efficacy|1|||
13091285|NCT03751280|25823071|FG001|Overall Study|Adverse Event|1|||
13091286|NCT03751280|25823070|FG000|Overall Study|Lost to Follow-up|3|||
13091287|NCT03751280|25823071|FG001|Overall Study|Lost to Follow-up|5|||
13139342|NCT02696785|26008309|FG002|Washout Period|Lack of Efficacy|0|||
13139343|NCT02696785|26008310|FG003|Washout Period|Lack of Efficacy|0|||
13139344|NCT02696785|26008307|FG000|Extended Treatment Period|Adverse Event|2|||
13139345|NCT02696785|26008308|FG001|Extended Treatment Period|Adverse Event|3|||
13139346|NCT02696785|26008309|FG002|Extended Treatment Period|Adverse Event|2|||
13139347|NCT02696785|26008310|FG003|Extended Treatment Period|Adverse Event|1|||
13139348|NCT02696785|26008307|FG000|Extended Treatment Period|Lack of Efficacy|0|||
13139349|NCT02696785|26008308|FG001|Extended Treatment Period|Lack of Efficacy|1|||
13139350|NCT02696785|26008309|FG002|Extended Treatment Period|Lack of Efficacy|0|||
13139351|NCT02696785|26008310|FG003|Extended Treatment Period|Lack of Efficacy|0|||
13139352|NCT02696785|26008307|FG000|Extended Treatment Period|Withdrawal by Subject|1|||
13139353|NCT02696785|26008308|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
13139354|NCT02696785|26008309|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
13139355|NCT02696785|26008310|FG003|Extended Treatment Period|Withdrawal by Subject|5|||
13139356|NCT02696785|26008307|FG000|Follow-up Period|Adverse Event|0|||
13139357|NCT02696785|26008308|FG001|Follow-up Period|Adverse Event|0|||
13139358|NCT02696785|26008309|FG002|Follow-up Period|Adverse Event|8|||
13139359|NCT02696785|26008310|FG003|Follow-up Period|Adverse Event|2|||
13139360|NCT02696785|26008307|FG000|Follow-up Period|Lost to Follow-up|0|||
13139361|NCT02696785|26008308|FG001|Follow-up Period|Lost to Follow-up|0|||
13139362|NCT02696785|26008309|FG002|Follow-up Period|Lost to Follow-up|0|||
13139363|NCT02696785|26008310|FG003|Follow-up Period|Lost to Follow-up|1|||
13139364|NCT02696785|26008307|FG000|Follow-up Period|Lack of Efficacy|0|||
13139365|NCT02696785|26008308|FG001|Follow-up Period|Lack of Efficacy|0|||
13139366|NCT02696785|26008309|FG002|Follow-up Period|Lack of Efficacy|0|||
13139367|NCT02696785|26008310|FG003|Follow-up Period|Lack of Efficacy|1|||
13139368|NCT02696785|26008307|FG000|Follow-up Period|Withdrawal by Subject|1|||
13139369|NCT02696785|26008308|FG001|Follow-up Period|Withdrawal by Subject|0|||
13139370|NCT02696785|26008309|FG002|Follow-up Period|Withdrawal by Subject|5|||
13139371|NCT02696785|26008310|FG003|Follow-up Period|Withdrawal by Subject|4|||
13139372|NCT02696434|26008335|FG000|Overall Study|Adverse Event|3|||
13139373|NCT02696434|26008336|FG001|Overall Study|Adverse Event|1|||
13139374|NCT02696434|26008335|FG000|Overall Study|Lost to Follow-up|5|||
13139375|NCT02696434|26008336|FG001|Overall Study|Lost to Follow-up|4|||
13139376|NCT02696434|26008335|FG000|Overall Study|Withdrawal by Subject|14|||
13139377|NCT02696434|26008336|FG001|Overall Study|Withdrawal by Subject|12|||
13139378|NCT02696434|26008335|FG000|Overall Study|Physician Decision|0|||
13139379|NCT02696434|26008336|FG001|Overall Study|Physician Decision|1|||
13139380|NCT02696317|26008353|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2|||
13139381|NCT02696317|26008354|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4|||
13139382|NCT02696317|26008353|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1|||
13139383|NCT02696317|26008354|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0|||
13139384|NCT02696226|26008377|FG000|Overall Study|Study terminated - lack of enrollment|1|||
13139385|NCT02696226|26008378|FG001|Overall Study|Study terminated - lack of enrollment|0|||
13139386|NCT02696226|26008379|FG002|Overall Study|Study terminated - lack of enrollment|2|||
13139387|NCT02696226|26008380|FG003|Overall Study|Study terminated - lack of enrollment|0|||
13139388|NCT02696096|26008392|FG000|Overall Study|ruled out at screening|1|||
13139389|NCT02696096|26008392|FG000|Overall Study|did not attend second fMRI|1|||
13139390|NCT02695719|26008417|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
13139391|NCT02695719|26008418|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
13139392|NCT02695719|26008417|FG000|Overall Study|Significant Protocol Deviation|0|||
13139393|NCT02695719|26008418|FG001|Overall Study|Significant Protocol Deviation|1|||
13139394|NCT02695719|26008417|FG000|Overall Study|Voluntary Withdrawal|1|||
13139395|NCT02695719|26008418|FG001|Overall Study|Voluntary Withdrawal|0|||
13139396|NCT02695628|26008426|FG000|Overall Study|Withdrawal by Subject|1|||
13139397|NCT02695537|26008436|FG000|Overall Study|Adverse Event|3|||
13139398|NCT02695537|26008436|FG000|Overall Study|Lack of Efficacy|28|||
13139399|NCT02695537|26008436|FG000|Overall Study|Withdrawal by Subject|4|||
13139400|NCT02695537|26008436|FG000|Overall Study|Protocol Violation|3|||
13139401|NCT02695524|26008463|FG000|Overall Study|Lost to Follow-up|3|||
13139402|NCT02695524|26008464|FG001|Overall Study|Lost to Follow-up|2|||
13139403|NCT02695524|26008463|FG000|Overall Study|Death|0|||
13091288|NCT03751280|25823070|FG000|Overall Study|Physician Decision|0|||
13091289|NCT03751280|25823071|FG001|Overall Study|Physician Decision|2|||
13091290|NCT03751280|25823070|FG000|Overall Study|Protocol Violation|0|||
13091291|NCT03751280|25823071|FG001|Overall Study|Protocol Violation|2|||
13091292|NCT03751280|25823070|FG000|Overall Study|Withdrawal by Subject|5|||
13091293|NCT03751280|25823071|FG001|Overall Study|Withdrawal by Subject|2|||
13091294|NCT03751098|25823090|FG000|Overall Study|Withdrawal by Subject|0|||
13091295|NCT03751098|25823091|FG001|Overall Study|Withdrawal by Subject|1|||
13091296|NCT03751020|25823196|FG000|Overall Study|Withdrawal by Subject|2|||
13091297|NCT03751020|25823197|FG001|Overall Study|Withdrawal by Subject|0|||
13132625|NCT02787408|25984621|FG000|Overall Study|Death|16|||
13139404|NCT02695524|26008464|FG001|Overall Study|Death|1|||
13139405|NCT02695420|26008497|FG000|Overall Study|Death|0|||
13139406|NCT02695420|26008498|FG001|Overall Study|Death|1|||
13091298|NCT03751020|25823198|FG002|Overall Study|Withdrawal by Subject|0|||
13091299|NCT03751020|25823196|FG000|Overall Study|Lost to Follow-up|7|||
13091300|NCT03751020|25823197|FG001|Overall Study|Lost to Follow-up|4|||
13091301|NCT03751020|25823198|FG002|Overall Study|Lost to Follow-up|10|||
13091302|NCT03750955|25823221|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
13091303|NCT03750955|25823222|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
13091304|NCT03750955|25823221|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
13091305|NCT03750955|25823222|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
13091306|NCT03750695|25823236|FG000|Overall Study|Lost to Follow-up|0|||
13091307|NCT03750695|25823237|FG001|Overall Study|Lost to Follow-up|1|||
13091308|NCT03750552|25823258|FG000|Overall Study|Adverse Event|5|||
13091309|NCT03750552|25823259|FG001|Overall Study|Adverse Event|1|||
13091310|NCT03750552|25823258|FG000|Overall Study|Withdrawal by Subject|1|||
13091311|NCT03750552|25823259|FG001|Overall Study|Withdrawal by Subject|1|||
13091312|NCT03750552|25823258|FG000|Overall Study|Other|2|||
13091313|NCT03750552|25823259|FG001|Overall Study|Other|0|||
13091314|NCT03750240|25823267|FG000|Overall Study|Technical Difficulties|2|||
13091315|NCT03749109|25823369|FG000|Overall Study|Adverse Event|2|||
13091316|NCT03749109|25823370|FG001|Overall Study|Adverse Event|0|||
13091317|NCT03748823|25823411|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
13091318|NCT03748823|25823412|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
13091319|NCT03748823|25823411|FG000|Extension Period|Withdrawal by Subject|1|||
13091320|NCT03748823|25823412|FG001|Extension Period|Withdrawal by Subject|2|||
13091321|NCT03748823|25823411|FG000|Extension Period|Death|0|||
13091322|NCT03748823|25823412|FG001|Extension Period|Death|1|||
13091323|NCT03748823|25823411|FG000|Extension Period|Protocol Violation|1|||
13091324|NCT03748823|25823412|FG001|Extension Period|Protocol Violation|0|||
13091325|NCT03748823|25823411|FG000|Extension Period|Ongoing in the Extension Period|41|||
13091326|NCT03748823|25823412|FG001|Extension Period|Ongoing in the Extension Period|84|||
13091327|NCT03748706|25823425|FG000|Overall Study|Lost to Follow-up|1|||
13091328|NCT03747302|25823440|FG000|Overall Study|Withdrawal by Subject|1|||
13091329|NCT03747302|25823441|FG001|Overall Study|Withdrawal by Subject|2|||
13132626|NCT02787408|25984621|FG000|Overall Study|Withdrawal by Subject|1|||
13132627|NCT02787408|25984621|FG000|Overall Study|Non-implanted patient exited post 6 month follow-up visit per protocol|1|||
13132628|NCT02787304|25984680|FG000|Overall Study|Adverse Event|9|||
13132629|NCT02787304|25984681|FG001|Overall Study|Adverse Event|3|||
13132630|NCT02787304|25984682|FG002|Overall Study|Adverse Event|8|||
13132631|NCT02787304|25984683|FG003|Overall Study|Adverse Event|1|||
13132632|NCT02787304|25984680|FG000|Overall Study|Withdrawal by Subject|1|||
13132633|NCT02787304|25984681|FG001|Overall Study|Withdrawal by Subject|4|||
13132634|NCT02787304|25984682|FG002|Overall Study|Withdrawal by Subject|0|||
13132635|NCT02787304|25984683|FG003|Overall Study|Withdrawal by Subject|0|||
13132636|NCT02787304|25984680|FG000|Overall Study|Lost to Follow-up|1|||
13132637|NCT02787304|25984681|FG001|Overall Study|Lost to Follow-up|0|||
13132638|NCT02787304|25984682|FG002|Overall Study|Lost to Follow-up|0|||
13132639|NCT02787304|25984683|FG003|Overall Study|Lost to Follow-up|1|||
13132640|NCT02787304|25984680|FG000|Overall Study|Noncompliance with study drug|0|||
13132641|NCT02787304|25984681|FG001|Overall Study|Noncompliance with study drug|0|||
13132642|NCT02787304|25984682|FG002|Overall Study|Noncompliance with study drug|1|||
13132643|NCT02787304|25984683|FG003|Overall Study|Noncompliance with study drug|0|||
13132644|NCT02787304|25984680|FG000|Overall Study|Physician Decision|0|||
13132645|NCT02787304|25984681|FG001|Overall Study|Physician Decision|0|||
13139407|NCT02695420|26008499|FG002|Overall Study|Death|0|||
13139408|NCT02695420|26008500|FG003|Overall Study|Death|0|||
13139409|NCT02695329|26008519|FG000|Overall Study|Adverse Event|1|||
13139410|NCT02695329|26008520|FG001|Overall Study|Adverse Event|0|||
13139411|NCT02695329|26008519|FG000|Overall Study|Poor X-ray quality for measurement|4|||
13139412|NCT02695329|26008520|FG001|Overall Study|Poor X-ray quality for measurement|5|||
13139413|NCT02694978|26008539|FG000|Overall Study|Adverse Event|10|||
13139414|NCT02694978|26008540|FG001|Overall Study|Adverse Event|9|||
13139415|NCT02694978|26008539|FG000|Overall Study|Withdrawal by Subject|22|||
13139416|NCT02694978|26008540|FG001|Overall Study|Withdrawal by Subject|19|||
13139417|NCT02694978|26008539|FG000|Overall Study|Lost to Follow-up|14|||
13139418|NCT02694978|26008540|FG001|Overall Study|Lost to Follow-up|17|||
13139419|NCT02694978|26008539|FG000|Overall Study|Death|4|||
13139420|NCT02694978|26008540|FG001|Overall Study|Death|1|||
13139421|NCT02694978|26008539|FG000|Overall Study|Other-Decision of Participant|6|||
13139422|NCT02694978|26008540|FG001|Overall Study|Other-Decision of Participant|1|||
13139423|NCT02694978|26008539|FG000|Overall Study|Other-Investigator's decision|1|||
13139424|NCT02694978|26008540|FG001|Overall Study|Other-Investigator's decision|0|||
13139425|NCT02694978|26008539|FG000|Overall Study|Other-Unable to be reached|0|||
13139426|NCT02694978|26008540|FG001|Overall Study|Other-Unable to be reached|1|||
13139427|NCT02694978|26008539|FG000|Overall Study|Other-Protocol noncompliant|2|||
13132646|NCT02787304|25984682|FG002|Overall Study|Physician Decision|1|||
13132647|NCT02787304|25984683|FG003|Overall Study|Physician Decision|0|||
13132648|NCT02787304|25984680|FG000|Overall Study|Study terminated by sponsor|25|||
13139428|NCT02694978|26008540|FG001|Overall Study|Other-Protocol noncompliant|1|||
13139429|NCT02694978|26008539|FG000|Overall Study|Other-Personal reasons|3|||
13139430|NCT02694978|26008540|FG001|Overall Study|Other-Personal reasons|3|||
13139431|NCT02694978|26008539|FG000|Overall Study|Other-Withdrew prior to dosing|9|||
13139432|NCT02694978|26008540|FG001|Overall Study|Other-Withdrew prior to dosing|8|||
13139433|NCT02694757|26008546|FG000|Overall Study|Lack of Efficacy|3|||
13139434|NCT02694744|26008561|FG000|Overall Study|Adverse Event|2|||
13139435|NCT02694744|26008562|FG001|Overall Study|Adverse Event|1|||
13139436|NCT02694744|26008561|FG000|Overall Study|Withdrawal by Subject|2|||
13139437|NCT02694744|26008562|FG001|Overall Study|Withdrawal by Subject|1|||
13139438|NCT02694744|26008561|FG000|Overall Study|Physician Decision|1|||
13139439|NCT02694744|26008562|FG001|Overall Study|Physician Decision|2|||
13139440|NCT02694744|26008561|FG000|Overall Study|Lost to Follow-up|1|||
13139441|NCT02694744|26008562|FG001|Overall Study|Lost to Follow-up|0|||
13139442|NCT02694744|26008561|FG000|Overall Study|Taking potassium supplement: exclusion 6|0|||
13139443|NCT02694744|26008562|FG001|Overall Study|Taking potassium supplement: exclusion 6|1|||
13139444|NCT02694718|26008574|FG000|Overall Study|Death|1|||
13139445|NCT02694718|26008574|FG000|Overall Study|Withdrawal by Subject|1|||
13139446|NCT02694562|26008585|FG000|Overall Study|Death|8|||
13139447|NCT02694562|26008585|FG000|Overall Study|Protocol Violation|4|||
13139448|NCT02694562|26008585|FG000|Overall Study|Lost to Follow-up|3|||
13139449|NCT02694562|26008585|FG000|Overall Study|Screen Failure|2|||
13139450|NCT02694562|26008585|FG000|Overall Study|Physician Decision|1|||
13139451|NCT02694549|26008593|FG000|Overall Study|screen failures|2|||
13139452|NCT02694536|26008604|FG000|Overall Study|Progressive Disease|40|||
13139453|NCT02694536|26008604|FG000|Overall Study|Lost to Follow-up|1|||
13139454|NCT02694536|26008604|FG000|Overall Study|Study Drug-Related Adverse Event|1|||
13139455|NCT02694536|26008604|FG000|Overall Study|Withdrawal by Subject|8|||
13139456|NCT02694536|26008604|FG000|Overall Study|Death|8|||
13139457|NCT02694536|26008604|FG000|Overall Study|Other|22|||
13139458|NCT02694523|26008640|FG000|Part A|Adverse Event|7|||
13139459|NCT02694523|26008641|FG001|Part A|Adverse Event|3|||
13139460|NCT02694523|26008642|FG002|Part A|Adverse Event|0|||
13139461|NCT02694523|26008643|FG003|Part A|Adverse Event|0|||
13139462|NCT02694523|26008644|FG004|Part A|Adverse Event|0|||
13139463|NCT02694523|26008645|FG005|Part A|Adverse Event|0|||
13139464|NCT02694523|26008646|FG006|Part A|Adverse Event|0|||
13139465|NCT02694523|26008640|FG000|Part A|Protocol Violation|1|||
13139466|NCT02694523|26008641|FG001|Part A|Protocol Violation|0|||
13139467|NCT02694523|26008642|FG002|Part A|Protocol Violation|0|||
13139468|NCT02694523|26008643|FG003|Part A|Protocol Violation|0|||
13139469|NCT02694523|26008644|FG004|Part A|Protocol Violation|0|||
13139470|NCT02694523|26008645|FG005|Part A|Protocol Violation|0|||
13139471|NCT02694523|26008646|FG006|Part A|Protocol Violation|0|||
13139472|NCT02694523|26008640|FG000|Part A|Lost to Follow-up|1|||
13139473|NCT02694523|26008641|FG001|Part A|Lost to Follow-up|2|||
13139474|NCT02694523|26008642|FG002|Part A|Lost to Follow-up|0|||
13139475|NCT02694523|26008643|FG003|Part A|Lost to Follow-up|0|||
13139476|NCT02694523|26008644|FG004|Part A|Lost to Follow-up|0|||
13139477|NCT02694523|26008645|FG005|Part A|Lost to Follow-up|0|||
13139478|NCT02694523|26008646|FG006|Part A|Lost to Follow-up|0|||
13139479|NCT02694523|26008640|FG000|Part A|Withdrawal by Subject|3|||
13139480|NCT02694523|26008641|FG001|Part A|Withdrawal by Subject|1|||
13139481|NCT02694523|26008642|FG002|Part A|Withdrawal by Subject|0|||
13139482|NCT02694523|26008643|FG003|Part A|Withdrawal by Subject|0|||
13139483|NCT02694523|26008644|FG004|Part A|Withdrawal by Subject|0|||
13139484|NCT02694523|26008645|FG005|Part A|Withdrawal by Subject|0|||
13139485|NCT02694523|26008646|FG006|Part A|Withdrawal by Subject|0|||
13139486|NCT02694523|26008640|FG000|Part A|Other|1|||
13139487|NCT02694523|26008641|FG001|Part A|Other|1|||
13139488|NCT02694523|26008642|FG002|Part A|Other|0|||
13139489|NCT02694523|26008643|FG003|Part A|Other|0|||
13139490|NCT02694523|26008644|FG004|Part A|Other|0|||
13139491|NCT02694523|26008645|FG005|Part A|Other|0|||
13139492|NCT02694523|26008646|FG006|Part A|Other|0|||
13139493|NCT02694523|26008640|FG000|Part B|Adverse Event|0|||
13139494|NCT02694523|26008641|FG001|Part B|Adverse Event|0|||
13139495|NCT02694523|26008642|FG002|Part B|Adverse Event|7|||
13139496|NCT02694523|26008643|FG003|Part B|Adverse Event|1|||
13139497|NCT02694523|26008644|FG004|Part B|Adverse Event|1|||
13139498|NCT02694523|26008645|FG005|Part B|Adverse Event|2|||
13139499|NCT02694523|26008646|FG006|Part B|Adverse Event|0|||
13139500|NCT02694523|26008640|FG000|Part B|Protocol Violation|0|||
13139501|NCT02694523|26008641|FG001|Part B|Protocol Violation|0|||
13139502|NCT02694523|26008642|FG002|Part B|Protocol Violation|1|||
13139503|NCT02694523|26008643|FG003|Part B|Protocol Violation|0|||
13139504|NCT02694523|26008644|FG004|Part B|Protocol Violation|0|||
13139505|NCT02694523|26008645|FG005|Part B|Protocol Violation|0|||
13139506|NCT02694523|26008646|FG006|Part B|Protocol Violation|0|||
13139507|NCT02694523|26008640|FG000|Part B|Lost to Follow-up|0|||
13139508|NCT02694523|26008641|FG001|Part B|Lost to Follow-up|0|||
13139509|NCT02694523|26008642|FG002|Part B|Lost to Follow-up|2|||
13139510|NCT02694523|26008643|FG003|Part B|Lost to Follow-up|3|||
13139511|NCT02694523|26008644|FG004|Part B|Lost to Follow-up|2|||
13139512|NCT02694523|26008645|FG005|Part B|Lost to Follow-up|0|||
13139513|NCT02694523|26008646|FG006|Part B|Lost to Follow-up|1|||
13139514|NCT02694523|26008640|FG000|Part B|Withdrawal by Subject|0|||
13139515|NCT02694523|26008641|FG001|Part B|Withdrawal by Subject|0|||
13139516|NCT02694523|26008642|FG002|Part B|Withdrawal by Subject|9|||
13139517|NCT02694523|26008643|FG003|Part B|Withdrawal by Subject|0|||
13139518|NCT02694523|26008644|FG004|Part B|Withdrawal by Subject|1|||
13139519|NCT02694523|26008645|FG005|Part B|Withdrawal by Subject|3|||
13139520|NCT02694523|26008646|FG006|Part B|Withdrawal by Subject|0|||
13139521|NCT02694523|26008640|FG000|Part B|Other|0|||
13139522|NCT02694523|26008641|FG001|Part B|Other|0|||
13139523|NCT02694523|26008642|FG002|Part B|Other|1|||
13139524|NCT02694523|26008643|FG003|Part B|Other|0|||
13139525|NCT02694523|26008644|FG004|Part B|Other|0|||
13139526|NCT02694523|26008645|FG005|Part B|Other|0|||
13139527|NCT02694523|26008646|FG006|Part B|Other|1|||
13139528|NCT02694328|26008665|FG000|Overall Study|Adverse Event|27|||
13139529|NCT02694328|26008666|FG001|Overall Study|Adverse Event|33|||
13139530|NCT02694328|26008665|FG000|Overall Study|Withdrawal by Subject|27|||
13139531|NCT02694328|26008666|FG001|Overall Study|Withdrawal by Subject|23|||
13139532|NCT02694328|26008665|FG000|Overall Study|Lost to Follow-up|26|||
13139533|NCT02694328|26008666|FG001|Overall Study|Lost to Follow-up|22|||
13139534|NCT02694328|26008665|FG000|Overall Study|Noncompliant with study drug|11|||
13139535|NCT02694328|26008666|FG001|Overall Study|Noncompliant with study drug|8|||
13139536|NCT02694328|26008665|FG000|Overall Study|Incarceration|1|||
13139537|NCT02694328|26008666|FG001|Overall Study|Incarceration|1|||
13139538|NCT02694328|26008665|FG000|Overall Study|Lack of Efficacy|1|||
13139539|NCT02694328|26008666|FG001|Overall Study|Lack of Efficacy|2|||
13139540|NCT02694328|26008665|FG000|Overall Study|Pregnancy|1|||
13139541|NCT02694328|26008666|FG001|Overall Study|Pregnancy|1|||
13139542|NCT02694328|26008665|FG000|Overall Study|Protocol Violation|6|||
13139543|NCT02694328|26008666|FG001|Overall Study|Protocol Violation|5|||
13139544|NCT02694328|26008665|FG000|Overall Study|Abnormal Laboratory Value|0|||
13139545|NCT02694328|26008666|FG001|Overall Study|Abnormal Laboratory Value|3|||
13139546|NCT02693834|26008677|FG000|Baseline Measurement|Withdrawal by Subject|1|||
13139547|NCT02693834|26008678|FG001|Baseline Measurement|Withdrawal by Subject|0|||
13139548|NCT02693834|26008677|FG000|Baseline Measurement|Adverse Event|1|||
13139549|NCT02693834|26008678|FG001|Baseline Measurement|Adverse Event|0|||
13139550|NCT02693834|26008677|FG000|Week 2 Practice|Adverse Event|0|||
13139551|NCT02693834|26008678|FG001|Week 2 Practice|Adverse Event|1|||
13139552|NCT02693743|26008691|FG000|Overall Study|Physician Decision|1|||
13139553|NCT02693743|26008692|FG001|Overall Study|Physician Decision|0|||
13139554|NCT02693691|26008701|FG000|Primary Endpoint Analysis (First 12M)|Death|30|||
13139555|NCT02693691|26008701|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12|||
13139556|NCT02693691|26008701|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7|||
13139557|NCT02693691|26008701|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1|||
13139558|NCT02693691|26008701|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12|||
13139559|NCT02693691|26008701|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11|||
13139560|NCT02693691|26008701|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1|||
13139561|NCT02693418|26008734|FG000|Overall Study|Lost to Follow-up|1|||
13139562|NCT02693418|26008735|FG001|Overall Study|Lost to Follow-up|2|||
13139563|NCT02693418|26008736|FG002|Overall Study|Lost to Follow-up|0|||
13139564|NCT02693418|26008737|FG003|Overall Study|Lost to Follow-up|0|||
13139565|NCT02693418|26008738|FG004|Overall Study|Lost to Follow-up|0|||
13139566|NCT02693418|26008734|FG000|Overall Study|Menses during study period|0|||
13139567|NCT02693418|26008735|FG001|Overall Study|Menses during study period|0|||
13139568|NCT02693418|26008736|FG002|Overall Study|Menses during study period|2|||
13139569|NCT02693418|26008737|FG003|Overall Study|Menses during study period|0|||
13139570|NCT02693418|26008738|FG004|Overall Study|Menses during study period|0|||
13139571|NCT02693171|26008747|FG000|Overall Study|Adverse Event|1|||
13139572|NCT02693171|26008747|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
13139573|NCT02693119|26008886|FG000|Open-Label Period|Withdrawal by Subject|0|||
13139574|NCT02693119|26008887|FG001|Open-Label Period|Withdrawal by Subject|1|||
13139575|NCT02693106|26008899|FG000|Overall Study|No time|3|||
13139576|NCT02693002|26008918|FG000|Overall Study|Withdrawal by Subject|1|||
13139577|NCT02693002|26008919|FG001|Overall Study|Withdrawal by Subject|0|||
13139578|NCT02692716|26008966|FG000|Overall Study|Lost to Follow-up|2|||
13139579|NCT02692716|26008967|FG001|Overall Study|Lost to Follow-up|5|||
13139580|NCT02692716|26008966|FG000|Overall Study|Withdrawal by Subject|3|||
13139581|NCT02692716|26008967|FG001|Overall Study|Withdrawal by Subject|1|||
13139582|NCT02692703|26008975|FG000|Overall Study|Lost to Follow-up|1|||
13139583|NCT02692703|26008975|FG000|Overall Study|Other|1|||
13139584|NCT02692586|26008982|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1|||
13139585|NCT02692586|26008982|FG000|Overall Study|Received adjunctive thrombolytics|2|||
13139586|NCT02692560|26009009|FG000|Overall Study|Withdrawal by Subject|0|||
13139587|NCT02692560|26009010|FG001|Overall Study|Withdrawal by Subject|6|||
13139588|NCT02692482|26009029|FG000|Overall Study|Death|2|||
13139589|NCT02692482|26009030|FG001|Overall Study|Death|2|||
13139590|NCT02692482|26009029|FG000|Overall Study|Withdrawal by Subject|1|||
13139591|NCT02692482|26009030|FG001|Overall Study|Withdrawal by Subject|2|||
13139592|NCT02692417|26009047|FG000|Overall Study|Withdrawal by Subject|5|||
13139593|NCT02692417|26009048|FG001|Overall Study|Withdrawal by Subject|1|||
13139594|NCT02692417|26009047|FG000|Overall Study|Adverse Event|1|||
13139595|NCT02692417|26009048|FG001|Overall Study|Adverse Event|0|||
13139596|NCT02692235|26009063|FG000|Overall Study|Withdrawal by Subject|2|||
13139597|NCT02692235|26009064|FG001|Overall Study|Withdrawal by Subject|1|||
13139598|NCT02692235|26009063|FG000|Overall Study|Adverse Event|1|||
13139599|NCT02692235|26009064|FG001|Overall Study|Adverse Event|2|||
13139600|NCT02692040|26009206|FG000|Overall Study|Protocol Violation|0|||
13139601|NCT02692040|26009207|FG001|Overall Study|Protocol Violation|0|||
13139602|NCT02692040|26009208|FG002|Overall Study|Protocol Violation|0|||
13139603|NCT02692040|26009209|FG003|Overall Study|Protocol Violation|0|||
13139604|NCT02692040|26009210|FG004|Overall Study|Protocol Violation|0|||
13139605|NCT02692040|26009211|FG005|Overall Study|Protocol Violation|0|||
13139606|NCT02692040|26009212|FG006|Overall Study|Protocol Violation|0|||
13139607|NCT02692040|26009213|FG007|Overall Study|Protocol Violation|0|||
13139608|NCT02692040|26009214|FG008|Overall Study|Protocol Violation|0|||
13139609|NCT02692040|26009215|FG009|Overall Study|Protocol Violation|0|||
13139610|NCT02692040|26009216|FG010|Overall Study|Protocol Violation|0|||
13139611|NCT02692040|26009217|FG011|Overall Study|Protocol Violation|0|||
13139612|NCT02692040|26009218|FG012|Overall Study|Protocol Violation|1|||
13139613|NCT02692040|26009219|FG013|Overall Study|Protocol Violation|0|||
13139614|NCT02692040|26009220|FG014|Overall Study|Protocol Violation|0|||
13139615|NCT02692040|26009221|FG015|Overall Study|Protocol Violation|0|||
13139616|NCT02692040|26009222|FG016|Overall Study|Protocol Violation|0|||
13139617|NCT02692040|26009206|FG000|Overall Study|Adverse Event|0|||
13139618|NCT02692040|26009207|FG001|Overall Study|Adverse Event|0|||
13139619|NCT02692040|26009208|FG002|Overall Study|Adverse Event|0|||
13139620|NCT02692040|26009209|FG003|Overall Study|Adverse Event|0|||
13139621|NCT02692040|26009210|FG004|Overall Study|Adverse Event|0|||
13139622|NCT02692040|26009211|FG005|Overall Study|Adverse Event|0|||
13139623|NCT02692040|26009212|FG006|Overall Study|Adverse Event|0|||
13139624|NCT02692040|26009213|FG007|Overall Study|Adverse Event|0|||
13139625|NCT02692040|26009214|FG008|Overall Study|Adverse Event|0|||
13139626|NCT02692040|26009215|FG009|Overall Study|Adverse Event|0|||
13139627|NCT02692040|26009216|FG010|Overall Study|Adverse Event|0|||
13139628|NCT02692040|26009217|FG011|Overall Study|Adverse Event|0|||
13139629|NCT02692040|26009218|FG012|Overall Study|Adverse Event|0|||
13139630|NCT02692040|26009219|FG013|Overall Study|Adverse Event|3|||
13139631|NCT02692040|26009220|FG014|Overall Study|Adverse Event|1|||
13139632|NCT02692040|26009221|FG015|Overall Study|Adverse Event|1|||
13139633|NCT02692040|26009222|FG016|Overall Study|Adverse Event|0|||
13139634|NCT02691936|26009249|FG000|Overall Study|Withdrawal by Subject|2|||
13139635|NCT02691936|26009250|FG001|Overall Study|Withdrawal by Subject|5|||
13139636|NCT02691741|26009286|FG000|Overall Study|Adverse Event|0|||
13139637|NCT02691741|26009287|FG001|Overall Study|Adverse Event|2|||
13139638|NCT02691741|26009286|FG000|Overall Study|Lost to Follow-up|1|||
13139639|NCT02691741|26009287|FG001|Overall Study|Lost to Follow-up|0|||
13139640|NCT02691741|26009286|FG000|Overall Study|Physician Decision|0|||
13139641|NCT02691741|26009287|FG001|Overall Study|Physician Decision|1|||
13139642|NCT02691741|26009286|FG000|Overall Study|Withdrawal by Subject|0|||
13139643|NCT02691741|26009287|FG001|Overall Study|Withdrawal by Subject|4|||
13139644|NCT02691702|26009605|FG000|Overall Study|Adverse Event|1|||
13139645|NCT02691702|26009606|FG001|Overall Study|Adverse Event|0|||
13139646|NCT02691702|26009607|FG002|Overall Study|Adverse Event|0|||
13139647|NCT02691702|26009608|FG003|Overall Study|Adverse Event|0|||
13139648|NCT02691702|26009609|FG004|Overall Study|Adverse Event|0|||
13139649|NCT02691702|26009610|FG005|Overall Study|Adverse Event|0|||
13139650|NCT02691702|26009611|FG006|Overall Study|Adverse Event|0|||
13139651|NCT02691702|26009612|FG007|Overall Study|Adverse Event|0|||
13139652|NCT02691702|26009613|FG008|Overall Study|Adverse Event|1|||
13139653|NCT02691702|26009614|FG009|Overall Study|Adverse Event|0|||
13139654|NCT02691702|26009615|FG010|Overall Study|Adverse Event|1|||
13139655|NCT02691702|26009605|FG000|Overall Study|Lost to Follow-up|0|||
13139656|NCT02691702|26009606|FG001|Overall Study|Lost to Follow-up|0|||
13139657|NCT02691702|26009607|FG002|Overall Study|Lost to Follow-up|1|||
13139658|NCT02691702|26009608|FG003|Overall Study|Lost to Follow-up|0|||
13139659|NCT02691702|26009609|FG004|Overall Study|Lost to Follow-up|0|||
13139660|NCT02691702|26009610|FG005|Overall Study|Lost to Follow-up|2|||
13139661|NCT02691702|26009611|FG006|Overall Study|Lost to Follow-up|0|||
13139662|NCT02691702|26009612|FG007|Overall Study|Lost to Follow-up|0|||
13139663|NCT02691702|26009613|FG008|Overall Study|Lost to Follow-up|0|||
13139664|NCT02691702|26009614|FG009|Overall Study|Lost to Follow-up|0|||
13139665|NCT02691702|26009615|FG010|Overall Study|Lost to Follow-up|1|||
13139666|NCT02691702|26009605|FG000|Overall Study|Withdrawal by Subject|1|||
13139667|NCT02691702|26009606|FG001|Overall Study|Withdrawal by Subject|1|||
13139668|NCT02691702|26009607|FG002|Overall Study|Withdrawal by Subject|0|||
13139669|NCT02691702|26009608|FG003|Overall Study|Withdrawal by Subject|0|||
13139670|NCT02691702|26009609|FG004|Overall Study|Withdrawal by Subject|0|||
13139671|NCT02691702|26009610|FG005|Overall Study|Withdrawal by Subject|1|||
13139672|NCT02691702|26009611|FG006|Overall Study|Withdrawal by Subject|2|||
13139673|NCT02691702|26009612|FG007|Overall Study|Withdrawal by Subject|0|||
13139674|NCT02691702|26009613|FG008|Overall Study|Withdrawal by Subject|0|||
13139675|NCT02691702|26009614|FG009|Overall Study|Withdrawal by Subject|0|||
13139676|NCT02691702|26009615|FG010|Overall Study|Withdrawal by Subject|0|||
13139677|NCT02691702|26009605|FG000|Overall Study|Other|0|||
13139678|NCT02691702|26009606|FG001|Overall Study|Other|0|||
13139679|NCT02691702|26009607|FG002|Overall Study|Other|0|||
13139680|NCT02691702|26009608|FG003|Overall Study|Other|0|||
13139681|NCT02691702|26009609|FG004|Overall Study|Other|0|||
13139682|NCT02691702|26009610|FG005|Overall Study|Other|0|||
13139683|NCT02691702|26009611|FG006|Overall Study|Other|1|||
13139684|NCT02691702|26009612|FG007|Overall Study|Other|0|||
13139685|NCT02691702|26009613|FG008|Overall Study|Other|1|||
13139686|NCT02691702|26009614|FG009|Overall Study|Other|0|||
13139687|NCT02691702|26009615|FG010|Overall Study|Other|0|||
13139688|NCT02691702|26009605|FG000|Overall Study|Protocol Violation|0|||
13139689|NCT02691702|26009606|FG001|Overall Study|Protocol Violation|0|||
13139690|NCT02691702|26009607|FG002|Overall Study|Protocol Violation|0|||
13139691|NCT02691702|26009608|FG003|Overall Study|Protocol Violation|0|||
13139692|NCT02691702|26009609|FG004|Overall Study|Protocol Violation|0|||
13139693|NCT02691702|26009610|FG005|Overall Study|Protocol Violation|0|||
13139694|NCT02691702|26009611|FG006|Overall Study|Protocol Violation|0|||
13139695|NCT02691702|26009612|FG007|Overall Study|Protocol Violation|0|||
13139696|NCT02691702|26009613|FG008|Overall Study|Protocol Violation|0|||
13139697|NCT02691702|26009614|FG009|Overall Study|Protocol Violation|2|||
13139698|NCT02691702|26009615|FG010|Overall Study|Protocol Violation|0|||
13139699|NCT02691572|26009628|FG000|Overall Study|Withdrawal by Subject|1|||
13139700|NCT02691572|26009629|FG001|Overall Study|Withdrawal by Subject|0|||
13139701|NCT02691572|26009628|FG000|Overall Study|Protocol Violation|0|||
13139702|NCT02691572|26009629|FG001|Overall Study|Protocol Violation|1|||
13139703|NCT02691507|26009766|FG000|Overall Study|Missed Visit 3|0|||
13139704|NCT02691507|26009767|FG001|Overall Study|Missed Visit 3|1|||
13139705|NCT02691494|26009803|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
13139706|NCT02691494|26009804|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
13139707|NCT02691494|26009805|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
13139708|NCT02691494|26009803|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
13139709|NCT02691494|26009804|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
13139710|NCT02691494|26009805|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
13139711|NCT02691494|26009803|FG000|Post-Treatment Follow-Up Period|Other|2|||
13139712|NCT02691494|26009804|FG001|Post-Treatment Follow-Up Period|Other|1|||
13139713|NCT02691494|26009805|FG002|Post-Treatment Follow-Up Period|Other|1|||
13139714|NCT02691494|26009803|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
13139715|NCT02691494|26009804|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
13139716|NCT02691494|26009805|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3|||
13139717|NCT02691494|26009803|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
13139718|NCT02691494|26009804|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1|||
13139719|NCT02691494|26009805|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
13139720|NCT02691468|26009820|FG000|Overall Study|Bronchial blocker use|2|||
13139721|NCT02691468|26009821|FG001|Overall Study|Bronchial blocker use|1|||
13139722|NCT02691468|26009820|FG000|Overall Study|Lost to Follow-up|2|||
13139723|NCT02691468|26009821|FG001|Overall Study|Lost to Follow-up|1|||
13139724|NCT02691468|26009820|FG000|Overall Study|Failure to advance FOB|2|||
13139725|NCT02691468|26009821|FG001|Overall Study|Failure to advance FOB|0|||
13139726|NCT02691455|26009916|FG000|Overall Study|Withdrawal by Subject|1|||
13139727|NCT02691455|26009917|FG001|Overall Study|Withdrawal by Subject|2|||
13139728|NCT02691455|26009916|FG000|Overall Study|Lost to Follow-up|15|||
13139729|NCT02691455|26009917|FG001|Overall Study|Lost to Follow-up|15|||
13139730|NCT02691247|26009944|FG000|Overall Study|Withdrawal by Subject|1|||
13139731|NCT02691247|26009945|FG001|Overall Study|Withdrawal by Subject|2|||
13139732|NCT02691247|26009946|FG002|Overall Study|Withdrawal by Subject|2|||
13139733|NCT02691247|26009944|FG000|Overall Study|Lost to Follow-up|2|||
13139734|NCT02691247|26009945|FG001|Overall Study|Lost to Follow-up|0|||
13139735|NCT02691247|26009946|FG002|Overall Study|Lost to Follow-up|1|||
13139736|NCT02691013|26009967|FG000|Overall Study|Withdrawal by Subject|3|||
13139737|NCT02691013|26009968|FG001|Overall Study|Withdrawal by Subject|0|||
13139738|NCT02690974|26009981|FG000|Overall Study|Adverse Event|16|||
13139739|NCT02690974|26009981|FG000|Overall Study|Death|9|||
13139740|NCT02690974|26009981|FG000|Overall Study|Subject/guardian decision|4|||
13139741|NCT02690974|26009981|FG000|Overall Study|Lost to Follow-up|3|||
13139742|NCT02690974|26009981|FG000|Overall Study|Withdrawal of Informed Consent|3|||
13139743|NCT02690974|26009981|FG000|Overall Study|Physician Decision|2|||
13139744|NCT02690974|26009981|FG000|Overall Study|Non-compliance with study treatment|1|||
13139745|NCT02690974|26009981|FG000|Overall Study|Protocol-defined stopping criteria|1|||
13139746|NCT02690974|26009981|FG000|Overall Study|Protocol Deviation|1|||
13139747|NCT02690727|26009994|FG000|Overall Study|Adverse Event|2|||
13139748|NCT02690727|26009995|FG001|Overall Study|Adverse Event|2|||
13139749|NCT02690714|26010016|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1|||
13139750|NCT02690714|26010016|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1|||
13139751|NCT02690701|26010088|FG000|Treatment Period 1|Adverse Event|2|||
13139752|NCT02690701|26010089|FG001|Treatment Period 1|Adverse Event|2|||
13139753|NCT02690701|26010088|FG000|Treatment Period 1|Withdrawal by Subject|0|||
13139754|NCT02690701|26010089|FG001|Treatment Period 1|Withdrawal by Subject|1|||
13139755|NCT02690701|26010088|FG000|Treatment Period 2|Adverse Event|2|||
13139756|NCT02690701|26010089|FG001|Treatment Period 2|Adverse Event|0|||
13139757|NCT02690701|26010088|FG000|Treatment Period 2|Lack of Efficacy|1|||
13139758|NCT02690701|26010089|FG001|Treatment Period 2|Lack of Efficacy|0|||
13139759|NCT02690701|26010088|FG000|Treatment Period 2|Lost to Follow-up|0|||
13139760|NCT02690701|26010089|FG001|Treatment Period 2|Lost to Follow-up|2|||
13139761|NCT02690701|26010088|FG000|Treatment Period 2|Withdrawal by Subject|0|||
13139762|NCT02690701|26010089|FG001|Treatment Period 2|Withdrawal by Subject|2|||
13139763|NCT02690701|26010088|FG000|Treatment Period 2|Protocol Violation|0|||
13139764|NCT02690701|26010089|FG001|Treatment Period 2|Protocol Violation|1|||
13139765|NCT02690649|26010108|FG000|Overall Study|Withdrawal by Subject|1|||
13139766|NCT02690649|26010109|FG001|Overall Study|Withdrawal by Subject|1|||
13139767|NCT02690649|26010108|FG000|Overall Study|Protocol Violation|0|||
13139768|NCT02690649|26010109|FG001|Overall Study|Protocol Violation|3|||
13139769|NCT02690207|26010118|FG000|Overall Study|Lost to Follow-up|48|||
13139770|NCT02690207|26010118|FG000|Overall Study|Withdrawal by Subject|46|||
13139771|NCT02690207|26010118|FG000|Overall Study|Protocol Violation|2|||
13139772|NCT02690207|26010118|FG000|Overall Study|Serious adverse event|110|||
13139773|NCT02690207|26010118|FG000|Overall Study|Non-serious Adverse Event|18|||
13139774|NCT02690207|26010118|FG000|Overall Study|Migrated/moved from study area|5|||
13139775|NCT02690207|26010118|FG000|Overall Study|Suspected HZ Episode|1|||
13139776|NCT02690207|26010118|FG000|Overall Study|Other reasons for withdrawal|23|||
13139777|NCT02690194|26010171|FG000|Overall Study|Withdrawal by Subject|1|||
13139778|NCT02690194|26010172|FG001|Overall Study|Withdrawal by Subject|4|||
13139779|NCT02690194|26010173|FG002|Overall Study|Withdrawal by Subject|0|||
13139780|NCT02689804|26010206|FG000|Overall Study|Withdrawal by Subject|2|||
13139781|NCT02689804|26010207|FG001|Overall Study|Withdrawal by Subject|0|||
13139782|NCT02689518|26010215|FG000|Overall Study|Withdrawal by Subject|3|||
13139783|NCT02689492|26010231|FG000|Overall Study|Lost to Follow-up|61|||
13139784|NCT02689492|26010231|FG000|Overall Study|Withdrawal by Subject|11|||
13139785|NCT02689492|26010231|FG000|Overall Study|Death|9|||
13139786|NCT02689492|26010231|FG000|Overall Study|Physician Decision|2|||
13139787|NCT02689492|26010231|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1|||
13139788|NCT02689492|26010231|FG000|Overall Study|Withdrawal/ Physician's Decision|1|||
13139789|NCT02689492|26010231|FG000|Overall Study|Other than listed|1|||
13139790|NCT02689349|26010254|FG000|Overall Study|Not implanted|4|||
13139791|NCT02689349|26010255|FG001|Overall Study|Not implanted|0|||
13139792|NCT02689349|26010254|FG000|Overall Study|Withdrawal by Subject|9|||
13139793|NCT02689349|26010255|FG001|Overall Study|Withdrawal by Subject|0|||
13139794|NCT02689284|26010295|FG000|Overall Study|Adverse Event|1|||
13139795|NCT02689284|26010296|FG001|Overall Study|Adverse Event|8|||
13139796|NCT02689284|26010295|FG000|Overall Study|Death|0|||
13139797|NCT02689284|26010296|FG001|Overall Study|Death|1|||
13139798|NCT02689284|26010295|FG000|Overall Study|Physician Decision|1|||
13139799|NCT02689284|26010296|FG001|Overall Study|Physician Decision|2|||
13139800|NCT02689284|26010295|FG000|Overall Study|Withdrawal by Subject|0|||
13139801|NCT02689284|26010296|FG001|Overall Study|Withdrawal by Subject|1|||
13139802|NCT02689284|26010295|FG000|Overall Study|progression of cancer|1|||
13139803|NCT02689284|26010296|FG001|Overall Study|progression of cancer|72|||
13139804|NCT02689284|26010295|FG000|Overall Study|decreased heart function|0|||
13139805|NCT02689284|26010296|FG001|Overall Study|decreased heart function|1|||
13139806|NCT02689284|26010295|FG000|Overall Study|concern for anemia|0|||
13139807|NCT02689284|26010296|FG001|Overall Study|concern for anemia|1|||
13139808|NCT02689284|26010295|FG000|Overall Study|no measurable cancer for evaluation|0|||
13139809|NCT02689284|26010296|FG001|Overall Study|no measurable cancer for evaluation|1|||
13139810|NCT02689219|26010315|FG000|Overall Study|Death|1|||
13139811|NCT02689219|26010316|FG001|Overall Study|Death|1|||
13139812|NCT02689219|26010315|FG000|Overall Study|Disease Progression|10|||
13139813|NCT02689219|26010316|FG001|Overall Study|Disease Progression|6|||
13139814|NCT02689206|26010536|FG000|Overall Study|Adverse Event|0|||
13139815|NCT02689206|26010537|FG001|Overall Study|Adverse Event|0|||
13139816|NCT02689206|26010538|FG002|Overall Study|Adverse Event|1|||
13139817|NCT02689206|26010539|FG003|Overall Study|Adverse Event|0|||
13139818|NCT02689206|26010540|FG004|Overall Study|Adverse Event|2|||
13139819|NCT02689206|26010536|FG000|Overall Study|Protocol Violation|1|||
13139820|NCT02689206|26010537|FG001|Overall Study|Protocol Violation|0|||
13139821|NCT02689206|26010538|FG002|Overall Study|Protocol Violation|0|||
13139822|NCT02689206|26010539|FG003|Overall Study|Protocol Violation|1|||
13139823|NCT02689206|26010540|FG004|Overall Study|Protocol Violation|2|||
13204707|NCT01970878|26229847|FG003|Overall Study|Adverse Event|3|||
13139824|NCT02689206|26010536|FG000|Overall Study|Other: Reached stopping criteria|0|||
13139825|NCT02689206|26010537|FG001|Overall Study|Other: Reached stopping criteria|1|||
13139826|NCT02689206|26010538|FG002|Overall Study|Other: Reached stopping criteria|2|||
13139827|NCT02689206|26010539|FG003|Overall Study|Other: Reached stopping criteria|3|||
13139828|NCT02689206|26010540|FG004|Overall Study|Other: Reached stopping criteria|4|||
13139829|NCT02689206|26010536|FG000|Overall Study|Physician Decision|1|||
13139830|NCT02689206|26010537|FG001|Overall Study|Physician Decision|0|||
13139831|NCT02689206|26010538|FG002|Overall Study|Physician Decision|0|||
13139832|NCT02689206|26010539|FG003|Overall Study|Physician Decision|0|||
13139833|NCT02689206|26010540|FG004|Overall Study|Physician Decision|0|||
13139834|NCT02689206|26010536|FG000|Overall Study|Withdrawal by Subject|1|||
13139835|NCT02689206|26010537|FG001|Overall Study|Withdrawal by Subject|0|||
13139836|NCT02689206|26010538|FG002|Overall Study|Withdrawal by Subject|1|||
13139837|NCT02689206|26010539|FG003|Overall Study|Withdrawal by Subject|0|||
13139838|NCT02689206|26010540|FG004|Overall Study|Withdrawal by Subject|0|||
13139839|NCT02689076|26010565|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172|||
13222544|NCT01806545|26286320|FG000|Overall Study|Lost to Follow-up|1|||
13222545|NCT01806545|26286321|FG001|Overall Study|Lost to Follow-up|0|||
13222546|NCT01806545|26286320|FG000|Overall Study|Withdrawal by Subject|3|||
13091330|NCT03746483|25823464|FG000|Overall Study|Adverse Event|0|||
13091331|NCT03746483|25823465|FG001|Overall Study|Adverse Event|1|||
13091332|NCT03746483|25823464|FG000|Overall Study|Lack of Efficacy|3|||
13222547|NCT01806545|26286321|FG001|Overall Study|Withdrawal by Subject|2|||
13222548|NCT01806506|26286334|FG000|Overall Study|Lost to Follow-up|2|||
13222549|NCT01806506|26286335|FG001|Overall Study|Lost to Follow-up|1|||
13222550|NCT01806389|26286351|FG000|Overall Study|Withdrawal by Subject|4|||
13222551|NCT01806298|26286363|FG000|Overall Study|Adverse Event|3|||
13222552|NCT01806298|26286363|FG000|Overall Study|Protocol Non-compliance|1|||
13222553|NCT01806298|26286363|FG000|Overall Study|Withdrawal by Subject|1|||
13222554|NCT01806298|26286363|FG000|Overall Study|Other|5|||
13222555|NCT01806168|26286396|FG000|Overall Study|Adverse Event|1|||
13222556|NCT01806168|26286397|FG001|Overall Study|Adverse Event|0|||
13222557|NCT01806168|26286398|FG002|Overall Study|Adverse Event|0|||
13222558|NCT01806168|26286396|FG000|Overall Study|Withdrawal by Subject|0|||
13222559|NCT01806168|26286397|FG001|Overall Study|Withdrawal by Subject|1|||
13222560|NCT01806168|26286398|FG002|Overall Study|Withdrawal by Subject|2|||
13222561|NCT01806168|26286396|FG000|Overall Study|Protocol Violation|0|||
13222562|NCT01806168|26286397|FG001|Overall Study|Protocol Violation|0|||
13222563|NCT01806168|26286398|FG002|Overall Study|Protocol Violation|1|||
13222564|NCT01806064|26286439|FG000|Overall Study|Randomized Not Enrolled|0|||
13222565|NCT01806064|26286440|FG001|Overall Study|Randomized Not Enrolled|0|||
13222566|NCT01806064|26286441|FG002|Overall Study|Randomized Not Enrolled|0|||
13222567|NCT01806064|26286442|FG003|Overall Study|Randomized Not Enrolled|1|||
13222568|NCT01806064|26286443|FG004|Overall Study|Randomized Not Enrolled|2|||
13222569|NCT01806051|26286451|FG000|Overall Study|Withdrawal by Subject|6|||
13222570|NCT01805180|26286482|FG000|Lead-in Donor Phase|screen failure|1|||
13222571|NCT01805180|26286483|FG001|Lead-in Donor Phase|screen failure|0|||
13222572|NCT01805180|26286484|FG002|Lead-in Donor Phase|screen failure|0|||
13222573|NCT01805037|26286501|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0|||
13222574|NCT01805037|26286502|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2|||
13222575|NCT01805037|26286501|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0|||
13222576|NCT01805037|26286502|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2|||
13091333|NCT03746483|25823465|FG001|Overall Study|Lack of Efficacy|2|||
13091334|NCT03746483|25823464|FG000|Overall Study|Lost to Follow-up|1|||
13091335|NCT03746483|25823465|FG001|Overall Study|Lost to Follow-up|0|||
13091336|NCT03746483|25823464|FG000|Overall Study|Protocol Violation|2|||
13091337|NCT03746483|25823465|FG001|Overall Study|Protocol Violation|0|||
13139840|NCT02689076|26010566|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213|||
13139841|NCT02689076|26010567|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0|||
13139842|NCT02689076|26010565|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3|||
13139843|NCT02689076|26010566|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1|||
13139844|NCT02689076|26010567|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0|||
13139845|NCT02689076|26010565|FG000|Overall Study|Did not have an HIE match|2|||
13139846|NCT02689076|26010566|FG001|Overall Study|Did not have an HIE match|0|||
13139847|NCT02689076|26010567|FG002|Overall Study|Did not have an HIE match|0|||
13139848|NCT02689076|26010565|FG000|Overall Study|Death during non-VA encounter|2|||
13139849|NCT02689076|26010566|FG001|Overall Study|Death during non-VA encounter|5|||
13139850|NCT02689076|26010567|FG002|Overall Study|Death during non-VA encounter|0|||
13139851|NCT02689076|26010565|FG000|Overall Study|Provider declined to participate after participant assignment|1|||
13222577|NCT01805037|26286501|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0|||
13222578|NCT01805037|26286502|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1|||
13091338|NCT03746405|25823478|FG000|Overall Study|Withdrawal by Subject|3|||
13139852|NCT02689076|26010566|FG001|Overall Study|Provider declined to participate after participant assignment|1|||
13139853|NCT02689076|26010567|FG002|Overall Study|Provider declined to participate after participant assignment|0|||
13139854|NCT02689076|26010565|FG000|Overall Study|Participant no longer active in VA system|1|||
13139855|NCT02689076|26010566|FG001|Overall Study|Participant no longer active in VA system|0|||
13139856|NCT02689076|26010567|FG002|Overall Study|Participant no longer active in VA system|0|||
13139857|NCT02689076|26010565|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
13139858|NCT02689076|26010566|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2|||
13139859|NCT02689076|26010567|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
13139860|NCT02688933|26010594|FG000|Overall Study|Adverse Event|3|||
13139861|NCT02688933|26010595|FG001|Overall Study|Adverse Event|1|||
13139862|NCT02688933|26010594|FG000|Overall Study|Lack of Efficacy|2|||
13139863|NCT02688933|26010595|FG001|Overall Study|Lack of Efficacy|2|||
13139864|NCT02688933|26010594|FG000|Overall Study|Poor compliance to protocol|7|||
13139865|NCT02688933|26010595|FG001|Overall Study|Poor compliance to protocol|4|||
13139866|NCT02688933|26010594|FG000|Overall Study|Hypoglycemia|2|||
13139867|NCT02688933|26010595|FG001|Overall Study|Hypoglycemia|0|||
13139868|NCT02688933|26010594|FG000|Overall Study|Other than Specified|14|||
13139869|NCT02688933|26010595|FG001|Overall Study|Other than Specified|25|||
13139870|NCT02688933|26010594|FG000|Overall Study|Lost to Follow-up|1|||
13139871|NCT02688933|26010595|FG001|Overall Study|Lost to Follow-up|5|||
13139872|NCT02688764|26010650|FG000|Overall Study|Adverse Event|3|||
13139873|NCT02688764|26010651|FG001|Overall Study|Adverse Event|3|||
13139874|NCT02688764|26010650|FG000|Overall Study|AE/Kidney transplant|1|||
13139875|NCT02688764|26010651|FG001|Overall Study|AE/Kidney transplant|0|||
13139876|NCT02688764|26010650|FG000|Overall Study|AE/Lack of efficacy|1|||
13139877|NCT02688764|26010651|FG001|Overall Study|AE/Lack of efficacy|0|||
13139878|NCT02688764|26010650|FG000|Overall Study|AE/Non-compl.|1|||
13139879|NCT02688764|26010651|FG001|Overall Study|AE/Non-compl.|0|||
13139880|NCT02688764|26010650|FG000|Overall Study|AE/Non-compl./Withd. parent|0|||
13139881|NCT02688764|26010651|FG001|Overall Study|AE/Non-compl./Withd. parent|1|||
13139882|NCT02688764|26010650|FG000|Overall Study|AE/Other|0|||
13139883|NCT02688764|26010651|FG001|Overall Study|AE/Other|1|||
13139884|NCT02688764|26010650|FG000|Overall Study|AE/Physician decision|1|||
13139885|NCT02688764|26010651|FG001|Overall Study|AE/Physician decision|0|||
13139886|NCT02688764|26010650|FG000|Overall Study|AE/Withd. parent|3|||
13139887|NCT02688764|26010651|FG001|Overall Study|AE/Withd. parent|0|||
13139888|NCT02688764|26010650|FG000|Overall Study|AE/Withd. parent/Withd. subject|1|||
13139889|NCT02688764|26010651|FG001|Overall Study|AE/Withd. parent/Withd. subject|1|||
13139890|NCT02688764|26010650|FG000|Overall Study|AE/Withd. subject|1|||
13139891|NCT02688764|26010651|FG001|Overall Study|AE/Withd. subject|0|||
13139892|NCT02688764|26010650|FG000|Overall Study|Kidney transplant|10|||
13139893|NCT02688764|26010651|FG001|Overall Study|Kidney transplant|4|||
13139894|NCT02688764|26010650|FG000|Overall Study|Lack of Efficacy|3|||
13139895|NCT02688764|26010651|FG001|Overall Study|Lack of Efficacy|2|||
13139896|NCT02688764|26010650|FG000|Overall Study|Lack of efficacy/Physician decision|0|||
13139897|NCT02688764|26010651|FG001|Overall Study|Lack of efficacy/Physician decision|1|||
13139898|NCT02688764|26010650|FG000|Overall Study|Non-compliance with study drug|4|||
13139899|NCT02688764|26010651|FG001|Overall Study|Non-compliance with study drug|0|||
13139900|NCT02688764|26010650|FG000|Overall Study|Non-compl./Physician decision|2|||
13139901|NCT02688764|26010651|FG001|Overall Study|Non-compl./Physician decision|0|||
13139902|NCT02688764|26010650|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
13139903|NCT02688764|26010651|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
13139904|NCT02688764|26010650|FG000|Overall Study|Non-compl./Withd. subject|0|||
13139905|NCT02688764|26010651|FG001|Overall Study|Non-compl./Withd. subject|2|||
13139906|NCT02688764|26010650|FG000|Overall Study|Phosphorus level outside safe range|0|||
13139907|NCT02688764|26010651|FG001|Overall Study|Phosphorus level outside safe range|1|||
13139908|NCT02688764|26010650|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1|||
13139909|NCT02688764|26010651|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0|||
13139910|NCT02688764|26010650|FG000|Overall Study|Study drug taste/Withd. parent|1|||
13139911|NCT02688764|26010651|FG001|Overall Study|Study drug taste/Withd. parent|0|||
13139912|NCT02688764|26010650|FG000|Overall Study|Subject moving out|2|||
13139913|NCT02688764|26010651|FG001|Overall Study|Subject moving out|0|||
13139914|NCT02688764|26010650|FG000|Overall Study|Subject taken off dialysis|1|||
13139915|NCT02688764|26010651|FG001|Overall Study|Subject taken off dialysis|0|||
13139916|NCT02688764|26010650|FG000|Overall Study|Withdrawal by parent|3|||
13139917|NCT02688764|26010651|FG001|Overall Study|Withdrawal by parent|0|||
13139918|NCT02688647|26010768|FG000|Initial Treatment Period (24 Weeks)|Death|0|||
13139919|NCT02688647|26010769|FG001|Initial Treatment Period (24 Weeks)|Death|1|||
13139920|NCT02688647|26010768|FG000|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|0|||
13139921|NCT02688647|26010769|FG001|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|5|||
13139922|NCT02688647|26010768|FG000|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|1|||
13139923|NCT02688647|26010769|FG001|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|0|||
13139924|NCT02688647|26010768|FG000|Post Switch Treatment Period (72 Weeks)|Death|7|||
13139925|NCT02688647|26010769|FG001|Post Switch Treatment Period (72 Weeks)|Death|2|||
13139926|NCT02688647|26010768|FG000|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|1|||
13139927|NCT02688647|26010769|FG001|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|0|||
13139928|NCT02688647|26010768|FG000|Post Switch Treatment Period (72 Weeks)|Other|10|||
13139929|NCT02688647|26010769|FG001|Post Switch Treatment Period (72 Weeks)|Other|6|||
13139930|NCT02688647|26010768|FG000|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|10|||
13139931|NCT02688647|26010769|FG001|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|6|||
13139932|NCT02688621|26010792|FG000|Overall Study|Pregnancy|1|||
13139933|NCT02688621|26010793|FG001|Overall Study|Pregnancy|3|||
13139934|NCT02688621|26010792|FG000|Overall Study|Lost to Follow-up|38|||
13139935|NCT02688621|26010793|FG001|Overall Study|Lost to Follow-up|15|||
13139936|NCT02688621|26010792|FG000|Overall Study|Withdrawal by Subject|1|||
13139937|NCT02688621|26010793|FG001|Overall Study|Withdrawal by Subject|0|||
13139938|NCT02688608|26010802|FG000|Overall Study|Lost to Follow-up|1|||
13139939|NCT02688530|26010857|FG000|Overall Study|Withdrawal by Subject|0|||
13139940|NCT02688530|26010858|FG001|Overall Study|Withdrawal by Subject|1|||
13139941|NCT02688530|26010859|FG002|Overall Study|Withdrawal by Subject|0|||
13139942|NCT02688530|26010860|FG003|Overall Study|Withdrawal by Subject|0|||
13139943|NCT02688530|26010857|FG000|Overall Study|Lost to Follow-up|0|||
13139944|NCT02688530|26010858|FG001|Overall Study|Lost to Follow-up|0|||
13139945|NCT02688530|26010859|FG002|Overall Study|Lost to Follow-up|2|||
13222579|NCT01805037|26286501|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0|||
13222580|NCT01805037|26286502|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1|||
13307571|NCT01284621|26529086|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
13091339|NCT03746405|25823479|FG001|Overall Study|Withdrawal by Subject|0|||
13091340|NCT03746405|25823478|FG000|Overall Study|technical difficulties|0|||
13091341|NCT03746405|25823479|FG001|Overall Study|technical difficulties|2|||
13091342|NCT03745937|25823603|FG000|Overall Study|Withdrawal by Subject|0|||
13091343|NCT03745937|25823604|FG001|Overall Study|Withdrawal by Subject|0|||
13091344|NCT03745937|25823605|FG002|Overall Study|Withdrawal by Subject|0|||
13091345|NCT03745937|25823606|FG003|Overall Study|Withdrawal by Subject|1|||
13091346|NCT03745937|25823603|FG000|Overall Study|Not-specifed|0|||
13091347|NCT03745937|25823604|FG001|Overall Study|Not-specifed|1|||
13091348|NCT03745937|25823605|FG002|Overall Study|Not-specifed|0|||
13091349|NCT03745937|25823606|FG003|Overall Study|Not-specifed|1|||
13091350|NCT03745768|25823629|FG000|Overall Study|discontinued study|2|||
13091351|NCT03745768|25823630|FG001|Overall Study|discontinued study|0|||
13091352|NCT03745222|25823678|FG000|Overall Study|Withdrawal by Subject|0|||
13091353|NCT03745222|25823679|FG001|Overall Study|Withdrawal by Subject|1|||
13091354|NCT03745222|25823680|FG002|Overall Study|Withdrawal by Subject|0|||
13091355|NCT03743038|25823704|FG000|Overall Study|Physician Decision|1|||
13091356|NCT03742271|25823710|FG000|Overall Study|Unsatisfactory Visual Response|1|||
13091357|NCT03742271|25823710|FG000|Overall Study|Withdrawal by Subject|3|||
13091358|NCT03742271|25823710|FG000|Overall Study|Lost to Follow-up|4|||
13091359|NCT03742271|25823710|FG000|Overall Study|Failed Insertion & removal|3|||
13139946|NCT02688530|26010860|FG003|Overall Study|Lost to Follow-up|0|||
13139947|NCT02688387|26011148|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
13139948|NCT02688387|26011149|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
13139949|NCT02688387|26011150|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1|||
13139950|NCT02688387|26011151|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
13139951|NCT02688387|26011152|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
13139952|NCT02688387|26011153|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
13091360|NCT03742271|25823710|FG000|Overall Study|Protocol Violation|1|||
13091361|NCT03741062|25823727|FG000|Overall Study|Protocol Violation|1|||
13139953|NCT02688387|26011154|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
13139954|NCT02688387|26011155|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
13139955|NCT02688387|26011156|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
13139956|NCT02688387|26011157|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
13139957|NCT02688387|26011158|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
13139958|NCT02688387|26011159|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
13139959|NCT02688387|26011160|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
13139960|NCT02688387|26011161|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
13139961|NCT02688387|26011162|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
13139962|NCT02688387|26011163|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
13139963|NCT02688387|26011164|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
13139964|NCT02688387|26011165|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
13139965|NCT02688387|26011166|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
13139966|NCT02688387|26011167|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
13139967|NCT02688387|26011168|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
13139968|NCT02688387|26011169|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
13139969|NCT02688387|26011148|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
13222581|NCT01805037|26286501|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0|||
13091362|NCT03741062|25823728|FG001|Overall Study|Protocol Violation|0|||
13139970|NCT02688387|26011149|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
13139971|NCT02688387|26011150|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
13139972|NCT02688387|26011151|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
13139973|NCT02688387|26011152|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
13139974|NCT02688387|26011153|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
13139975|NCT02688387|26011154|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
13139976|NCT02688387|26011155|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
13139977|NCT02688387|26011156|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
13139978|NCT02688387|26011157|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
13139979|NCT02688387|26011158|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
13139980|NCT02688387|26011159|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
13139981|NCT02688387|26011160|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
13139982|NCT02688387|26011161|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
13139983|NCT02688387|26011162|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
13139984|NCT02688387|26011163|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
13139985|NCT02688387|26011164|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
13139986|NCT02688387|26011165|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
13139987|NCT02688387|26011166|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
13139988|NCT02688387|26011167|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
13139989|NCT02688387|26011168|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
13139990|NCT02688387|26011169|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
13139991|NCT02688387|26011148|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
13139992|NCT02688387|26011149|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1|||
13139993|NCT02688387|26011150|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
13139994|NCT02688387|26011151|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
13139995|NCT02688387|26011152|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
13139996|NCT02688387|26011153|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
13139997|NCT02688387|26011154|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
13139998|NCT02688387|26011155|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
13139999|NCT02688387|26011156|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
13140000|NCT02688387|26011157|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
13140001|NCT02688387|26011158|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
13140002|NCT02688387|26011159|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
13140003|NCT02688387|26011160|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
13140004|NCT02688387|26011161|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
13140005|NCT02688387|26011162|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
13140006|NCT02688387|26011163|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
13140007|NCT02688387|26011164|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
13140008|NCT02688387|26011165|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
13140009|NCT02688387|26011166|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
13140010|NCT02688387|26011167|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
13140011|NCT02688387|26011168|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
13140012|NCT02688387|26011169|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
13140013|NCT02688387|26011148|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
13140014|NCT02688387|26011149|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
13140015|NCT02688387|26011150|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
13140016|NCT02688387|26011151|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
13140017|NCT02688387|26011152|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
13140018|NCT02688387|26011153|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
13140019|NCT02688387|26011154|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
13140020|NCT02688387|26011155|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
13140021|NCT02688387|26011156|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
13140022|NCT02688387|26011157|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
13140023|NCT02688387|26011158|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
13140024|NCT02688387|26011159|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
13140025|NCT02688387|26011160|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
13140026|NCT02688387|26011161|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
13140027|NCT02688387|26011162|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
13140028|NCT02688387|26011163|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
13140029|NCT02688387|26011164|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
13140030|NCT02688387|26011165|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
13140031|NCT02688387|26011166|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
13140032|NCT02688387|26011167|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
13140033|NCT02688387|26011168|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
13140034|NCT02688387|26011169|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
13140035|NCT02688387|26011148|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1|||
13140036|NCT02688387|26011149|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
13140037|NCT02688387|26011150|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
13140038|NCT02688387|26011151|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
13140039|NCT02688387|26011152|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
13140040|NCT02688387|26011153|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
13140041|NCT02688387|26011154|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
13140042|NCT02688387|26011155|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
13140043|NCT02688387|26011156|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
13140044|NCT02688387|26011157|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
13140045|NCT02688387|26011158|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
13140046|NCT02688387|26011159|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
13140047|NCT02688387|26011160|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
13140048|NCT02688387|26011161|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
13140049|NCT02688387|26011162|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
13140050|NCT02688387|26011163|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
13140051|NCT02688387|26011164|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
13140052|NCT02688387|26011165|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
13140053|NCT02688387|26011166|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
13140054|NCT02688387|26011167|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
13140055|NCT02688387|26011168|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
13140056|NCT02688387|26011169|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
13140057|NCT02688387|26011148|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
13140058|NCT02688387|26011149|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
13140059|NCT02688387|26011150|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
13140060|NCT02688387|26011151|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
13140061|NCT02688387|26011152|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
13140062|NCT02688387|26011153|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
13140063|NCT02688387|26011154|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
13140064|NCT02688387|26011155|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
13140065|NCT02688387|26011156|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
13140066|NCT02688387|26011157|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
13140067|NCT02688387|26011158|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1|||
13140068|NCT02688387|26011159|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
13140069|NCT02688387|26011160|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
13140070|NCT02688387|26011161|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
13140071|NCT02688387|26011162|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
13140072|NCT02688387|26011163|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
13140073|NCT02688387|26011164|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
13140074|NCT02688387|26011165|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
13140075|NCT02688387|26011166|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
13140076|NCT02688387|26011167|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
13140077|NCT02688387|26011168|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
13140078|NCT02688387|26011169|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
13140079|NCT02688387|26011148|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
13140080|NCT02688387|26011149|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
13140081|NCT02688387|26011150|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
13140082|NCT02688387|26011151|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
13140083|NCT02688387|26011152|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
13140084|NCT02688387|26011153|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
13140085|NCT02688387|26011154|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
13140086|NCT02688387|26011155|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
13140087|NCT02688387|26011156|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
13140088|NCT02688387|26011157|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
13140089|NCT02688387|26011158|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
13140090|NCT02688387|26011159|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
13140091|NCT02688387|26011160|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
13140092|NCT02688387|26011161|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
13140093|NCT02688387|26011162|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
13140094|NCT02688387|26011163|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
13140095|NCT02688387|26011164|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
13140096|NCT02688387|26011165|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
13140097|NCT02688387|26011166|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
13140098|NCT02688387|26011167|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
13140099|NCT02688387|26011168|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
13140100|NCT02688387|26011169|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
13140101|NCT02688387|26011148|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
13140102|NCT02688387|26011149|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
13140103|NCT02688387|26011150|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
13140104|NCT02688387|26011151|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
13140105|NCT02688387|26011152|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
13140106|NCT02688387|26011153|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
13140107|NCT02688387|26011154|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
13140108|NCT02688387|26011155|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
13140109|NCT02688387|26011156|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
13140110|NCT02688387|26011157|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
13140111|NCT02688387|26011158|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
13140112|NCT02688387|26011159|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
13140113|NCT02688387|26011160|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
13140114|NCT02688387|26011161|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
13140115|NCT02688387|26011162|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
13140116|NCT02688387|26011163|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
13140117|NCT02688387|26011164|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
13140118|NCT02688387|26011165|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
13140119|NCT02688387|26011166|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
13140120|NCT02688387|26011167|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
13140121|NCT02688387|26011168|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1|||
13140122|NCT02688387|26011169|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
13140123|NCT02688387|26011148|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
13140124|NCT02688387|26011149|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
13140125|NCT02688387|26011150|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
13140126|NCT02688387|26011151|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
13140127|NCT02688387|26011152|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
13140128|NCT02688387|26011153|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
13140129|NCT02688387|26011154|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
13140130|NCT02688387|26011155|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
13140131|NCT02688387|26011156|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
13140132|NCT02688387|26011157|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
13140133|NCT02688387|26011158|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
13140134|NCT02688387|26011159|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
13140135|NCT02688387|26011160|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
13140136|NCT02688387|26011161|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
13140137|NCT02688387|26011162|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
13140138|NCT02688387|26011163|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
13140139|NCT02688387|26011164|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
13140140|NCT02688387|26011165|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
13140141|NCT02688387|26011166|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
13140142|NCT02688387|26011167|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
13140143|NCT02688387|26011168|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
13140144|NCT02688387|26011169|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
13140145|NCT02688387|26011148|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
13140146|NCT02688387|26011149|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
13140147|NCT02688387|26011150|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
13091363|NCT03739866|25823836|FG000|Overall Study|Lost to Follow-up|0|||
13091364|NCT03739866|25823837|FG001|Overall Study|Lost to Follow-up|0|||
13091365|NCT03739866|25823838|FG002|Overall Study|Lost to Follow-up|0|||
13091366|NCT03739866|25823839|FG003|Overall Study|Lost to Follow-up|1|||
13091367|NCT03739866|25823840|FG004|Overall Study|Lost to Follow-up|0|||
13091368|NCT03739866|25823841|FG005|Overall Study|Lost to Follow-up|0|||
13091369|NCT03739866|25823842|FG006|Overall Study|Lost to Follow-up|0|||
13091370|NCT03739866|25823843|FG007|Overall Study|Lost to Follow-up|0|||
13091371|NCT03739866|25823836|FG000|Overall Study|Enrolled but not treated|0|||
13091372|NCT03739866|25823837|FG001|Overall Study|Enrolled but not treated|0|||
13091373|NCT03739866|25823838|FG002|Overall Study|Enrolled but not treated|1|||
13091374|NCT03739866|25823839|FG003|Overall Study|Enrolled but not treated|0|||
13091375|NCT03739866|25823840|FG004|Overall Study|Enrolled but not treated|1|||
13091376|NCT03739866|25823841|FG005|Overall Study|Enrolled but not treated|0|||
13091377|NCT03739866|25823842|FG006|Overall Study|Enrolled but not treated|0|||
13091378|NCT03739866|25823843|FG007|Overall Study|Enrolled but not treated|0|||
13091379|NCT03739528|25823880|FG000|Overall Study|Not treated|8|||
13091380|NCT03739528|25823881|FG001|Overall Study|Not treated|12|||
13091381|NCT03739528|25823880|FG000|Overall Study|Treatment and study discontinued|6|||
13091382|NCT03739528|25823881|FG001|Overall Study|Treatment and study discontinued|2|||
13091383|NCT03739528|25823880|FG000|Overall Study|Treatment discontinued + study completed|1|||
13091384|NCT03739528|25823881|FG001|Overall Study|Treatment discontinued + study completed|3|||
13091385|NCT03739242|25823924|FG000|Overall Study|Withdrawal by Subject|1|||
13091386|NCT03739242|25823925|FG001|Overall Study|Withdrawal by Subject|1|||
13091387|NCT03739242|25823924|FG000|Overall Study|Protocol Violation|0|||
13091388|NCT03739242|25823925|FG001|Overall Study|Protocol Violation|1|||
13091389|NCT03739203|25823946|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
13091390|NCT03739203|25823947|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|9|||
13091391|NCT03739203|25823948|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|13|||
13091392|NCT03739203|25823946|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
13091393|NCT03739203|25823947|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
13091394|NCT03739203|25823948|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
13091395|NCT03739203|25823946|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
13091396|NCT03739203|25823947|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
13091397|NCT03739203|25823948|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
13091398|NCT03739203|25823946|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
13091399|NCT03739203|25823947|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
13091400|NCT03739203|25823948|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|6|||
13091401|NCT03739203|25823946|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
13091402|NCT03739203|25823947|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
13091403|NCT03739203|25823948|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
13091404|NCT03739203|25823946|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
13091405|NCT03739203|25823947|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|3|||
13091406|NCT03739203|25823948|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
13091407|NCT03739203|25823946|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
13091408|NCT03739203|25823947|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
13091409|NCT03739203|25823948|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
13091410|NCT03739203|25823946|FG000|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|1|||
13091411|NCT03739203|25823947|FG001|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|2|||
13091412|NCT03739203|25823948|FG002|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|0|||
13091413|NCT03739203|25823946|FG000|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
13091414|NCT03739203|25823947|FG001|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
13091415|NCT03739203|25823948|FG002|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|2|||
13091416|NCT03739203|25823946|FG000|Safety Follow-Up Period (4 Weeks)|Death|1|||
13091417|NCT03739203|25823947|FG001|Safety Follow-Up Period (4 Weeks)|Death|0|||
13091418|NCT03739203|25823948|FG002|Safety Follow-Up Period (4 Weeks)|Death|0|||
13091419|NCT03739203|25823946|FG000|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
13091420|NCT03739203|25823947|FG001|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
13091421|NCT03739203|25823948|FG002|Safety Follow-Up Period (4 Weeks)|Reason not Specified|2|||
13091422|NCT03738865|25823969|FG000|Overall Study|Withdrawal by Subject|3|||
13091423|NCT03738865|25823970|FG001|Overall Study|Withdrawal by Subject|3|||
13091424|NCT03738865|25823969|FG000|Overall Study|Adverse Event|2|||
13091425|NCT03738865|25823970|FG001|Overall Study|Adverse Event|0|||
13140148|NCT02688387|26011151|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
13140149|NCT02688387|26011152|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
13140150|NCT02688387|26011153|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
13140151|NCT02688387|26011154|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
13140152|NCT02688387|26011155|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
13140153|NCT02688387|26011156|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
13140154|NCT02688387|26011157|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
13140155|NCT02688387|26011158|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
13140156|NCT02688387|26011159|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
13140157|NCT02688387|26011160|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
13140158|NCT02688387|26011161|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
13140159|NCT02688387|26011162|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
13140160|NCT02688387|26011163|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
13140161|NCT02688387|26011164|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
13140162|NCT02688387|26011165|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
13140163|NCT02688387|26011166|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
13140164|NCT02688387|26011167|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1|||
13140165|NCT02688387|26011168|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
13140166|NCT02688387|26011169|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
13140167|NCT02688192|26011193|FG000|Overall Study|Lost to Follow-up|11|||
13307572|NCT01284621|26529087|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
13140168|NCT02688192|26011194|FG001|Overall Study|Lost to Follow-up|5|||
13140169|NCT02688192|26011193|FG000|Overall Study|Physician Decision|1|||
13140170|NCT02688192|26011194|FG001|Overall Study|Physician Decision|0|||
13140171|NCT02688153|26011259|FG000|Overall Study|Death|7|||
13140172|NCT02688153|26011260|FG001|Overall Study|Death|5|||
13140173|NCT02688153|26011259|FG000|Overall Study|Withdrawal by Subject|4|||
13140174|NCT02688153|26011260|FG001|Overall Study|Withdrawal by Subject|2|||
13140175|NCT02688153|26011259|FG000|Overall Study|Valve Explant|1|||
13140176|NCT02688153|26011260|FG001|Overall Study|Valve Explant|0|||
13140177|NCT02688153|26011259|FG000|Overall Study|Conversion to Commercial Valve|3|||
13140178|NCT02688153|26011260|FG001|Overall Study|Conversion to Commercial Valve|0|||
13140179|NCT02688088|26011295|FG000|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
13140180|NCT02688088|26011296|FG001|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|1|||
13140181|NCT02688088|26011297|FG002|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
13140182|NCT02688088|26011298|FG003|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
13140183|NCT02688088|26011299|FG004|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
13140184|NCT02688088|26011295|FG000|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
13140185|NCT02688088|26011296|FG001|Abemaciclib + Drug Cocktail - Period 2|Death|1|||
13140186|NCT02688088|26011297|FG002|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
13140187|NCT02688088|26011298|FG003|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
13140188|NCT02688088|26011299|FG004|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
13140189|NCT02688088|26011295|FG000|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
13140190|NCT02688088|26011296|FG001|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|3|||
13140191|NCT02688088|26011297|FG002|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
13140192|NCT02688088|26011298|FG003|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
13140193|NCT02688088|26011299|FG004|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
13140194|NCT02688088|26011295|FG000|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
13140195|NCT02688088|26011296|FG001|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|2|||
13140196|NCT02688088|26011297|FG002|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
13140197|NCT02688088|26011298|FG003|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
13140198|NCT02688088|26011299|FG004|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
13140199|NCT02688088|26011295|FG000|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
13140200|NCT02688088|26011296|FG001|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
13140201|NCT02688088|26011297|FG002|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|7|||
13140202|NCT02688088|26011298|FG003|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
13140203|NCT02688088|26011299|FG004|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
13140204|NCT02688088|26011295|FG000|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
13140205|NCT02688088|26011296|FG001|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
13140206|NCT02688088|26011297|FG002|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|1|||
13140207|NCT02688088|26011298|FG003|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
13140208|NCT02688088|26011299|FG004|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
13140209|NCT02688088|26011295|FG000|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
13140210|NCT02688088|26011296|FG001|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
13140211|NCT02688088|26011297|FG002|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
13140212|NCT02688088|26011298|FG003|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|7|||
13140213|NCT02688088|26011299|FG004|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
13140214|NCT02688088|26011295|FG000|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
13140215|NCT02688088|26011296|FG001|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
13140216|NCT02688088|26011297|FG002|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
13140217|NCT02688088|26011298|FG003|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|1|||
13140218|NCT02688088|26011299|FG004|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
13140219|NCT02688088|26011295|FG000|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
13140220|NCT02688088|26011296|FG001|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
13140221|NCT02688088|26011297|FG002|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
13140222|NCT02688088|26011298|FG003|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
13140223|NCT02688088|26011299|FG004|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|18|||
13140224|NCT02687919|26011334|FG000|Overall Study|Withdrawal by Subject|6|||
13140225|NCT02687919|26011335|FG001|Overall Study|Withdrawal by Subject|6|||
13140226|NCT02687919|26011334|FG000|Overall Study|Protocol Violation|2|||
13140227|NCT02687919|26011335|FG001|Overall Study|Protocol Violation|0|||
13140228|NCT02687815|26011354|FG000|Overall Study|Lost to Follow-up|2|||
13140229|NCT02687815|26011355|FG001|Overall Study|Lost to Follow-up|4|||
13140230|NCT02687815|26011354|FG000|Overall Study|Withdrawal by Subject|2|||
13140231|NCT02687815|26011355|FG001|Overall Study|Withdrawal by Subject|4|||
13140232|NCT02687711|26011394|FG000|Overall Study|Adverse Event|89|||
13140233|NCT02687711|26011394|FG000|Overall Study|Lack of Efficacy|70|||
13140234|NCT02687711|26011394|FG000|Overall Study|Lost to Follow-up|20|||
13140235|NCT02687711|26011394|FG000|Overall Study|Consent withdrawn|15|||
13204708|NCT01970878|26229844|FG000|Overall Study|Protocol Specified Criteria|10|||
13140236|NCT02687711|26011394|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1|||
13140237|NCT02687711|26011394|FG000|Overall Study|Too expensive|4|||
13140238|NCT02687711|26011394|FG000|Overall Study|Participant moved abroad|1|||
13140239|NCT02687711|26011394|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1|||
13140240|NCT02687711|26011394|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1|||
13140241|NCT02687711|26011394|FG000|Overall Study|Disliked taste|1|||
13140242|NCT02687711|26011394|FG000|Overall Study|Low mood|1|||
13140243|NCT02687711|26011394|FG000|Overall Study|Side effects|1|||
13140244|NCT02687711|26011394|FG000|Overall Study|Change of Hospital|1|||
13140245|NCT02687711|26011394|FG000|Overall Study|Liver Encephalopathy|1|||
13140246|NCT02687711|26011394|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1|||
13140247|NCT02687711|26011394|FG000|Overall Study|Withdrawn due to intake interruption|1|||
13140248|NCT02687711|26011394|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1|||
13140249|NCT02687711|26011394|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1|||
13140250|NCT02687711|26011394|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1|||
13140251|NCT02687581|26011417|FG000|Overall Study|Withdrawal by Subject|1|||
13140252|NCT02687581|26011418|FG001|Overall Study|Withdrawal by Subject|0|||
13140253|NCT02687581|26011419|FG002|Overall Study|Withdrawal by Subject|0|||
13140254|NCT02687581|26011420|FG003|Overall Study|Withdrawal by Subject|1|||
13140255|NCT02687581|26011417|FG000|Overall Study|Lost to Follow-up|2|||
13140256|NCT02687581|26011418|FG001|Overall Study|Lost to Follow-up|2|||
13140257|NCT02687581|26011419|FG002|Overall Study|Lost to Follow-up|0|||
13140258|NCT02687581|26011420|FG003|Overall Study|Lost to Follow-up|0|||
13140259|NCT02687581|26011417|FG000|Overall Study|the device is too small for the patient.|1|||
13140260|NCT02687581|26011418|FG001|Overall Study|the device is too small for the patient.|0|||
13140261|NCT02687581|26011419|FG002|Overall Study|the device is too small for the patient.|0|||
13140262|NCT02687581|26011420|FG003|Overall Study|the device is too small for the patient.|0|||
13140263|NCT02687542|26011508|FG000|Overall Study|Medication error without associated AEs|0|||
13140264|NCT02687542|26011509|FG001|Overall Study|Medication error without associated AEs|0|||
13140265|NCT02687542|26011510|FG002|Overall Study|Medication error without associated AEs|0|||
13140266|NCT02687542|26011511|FG003|Overall Study|Medication error without associated AEs|0|||
13140267|NCT02687542|26011512|FG004|Overall Study|Medication error without associated AEs|1|||
13140268|NCT02687542|26011508|FG000|Overall Study|Lost to Follow-up|0|||
13140269|NCT02687542|26011509|FG001|Overall Study|Lost to Follow-up|0|||
13140270|NCT02687542|26011510|FG002|Overall Study|Lost to Follow-up|0|||
13140271|NCT02687542|26011511|FG003|Overall Study|Lost to Follow-up|0|||
13140272|NCT02687542|26011512|FG004|Overall Study|Lost to Follow-up|1|||
13140273|NCT02687542|26011508|FG000|Overall Study|Protocol Violation|0|||
13140274|NCT02687542|26011509|FG001|Overall Study|Protocol Violation|1|||
13140275|NCT02687542|26011510|FG002|Overall Study|Protocol Violation|0|||
13140276|NCT02687542|26011511|FG003|Overall Study|Protocol Violation|0|||
13140277|NCT02687542|26011512|FG004|Overall Study|Protocol Violation|0|||
13140278|NCT02687542|26011508|FG000|Overall Study|Other|5|||
13140279|NCT02687542|26011509|FG001|Overall Study|Other|9|||
13140280|NCT02687542|26011510|FG002|Overall Study|Other|10|||
13140281|NCT02687542|26011511|FG003|Overall Study|Other|6|||
13140282|NCT02687542|26011512|FG004|Overall Study|Other|5|||
13140283|NCT02687542|26011508|FG000|Overall Study|Adverse Event|3|||
13140284|NCT02687542|26011509|FG001|Overall Study|Adverse Event|1|||
13140285|NCT02687542|26011510|FG002|Overall Study|Adverse Event|3|||
13091426|NCT03738865|25823969|FG000|Overall Study|Physician Decision|0|||
13091427|NCT03738865|25823970|FG001|Overall Study|Physician Decision|1|||
13091428|NCT03738475|25824014|FG000|Overall Study|Participant Non-Compliance|1|||
13091429|NCT03738475|25824015|FG001|Overall Study|Participant Non-Compliance|0|||
13091430|NCT03738241|25824358|FG000|Overall Study|Withdrawal by Subject|0|||
13091431|NCT03738241|25824359|FG001|Overall Study|Withdrawal by Subject|0|||
13091432|NCT03738241|25824360|FG002|Overall Study|Withdrawal by Subject|0|||
13091433|NCT03738241|25824361|FG003|Overall Study|Withdrawal by Subject|0|||
13091434|NCT03738241|25824362|FG004|Overall Study|Withdrawal by Subject|0|||
13091435|NCT03738241|25824363|FG005|Overall Study|Withdrawal by Subject|0|||
13091436|NCT03738241|25824364|FG006|Overall Study|Withdrawal by Subject|0|||
13091437|NCT03738241|25824365|FG007|Overall Study|Withdrawal by Subject|0|||
13091438|NCT03738241|25824366|FG008|Overall Study|Withdrawal by Subject|0|||
13091439|NCT03738241|25824367|FG009|Overall Study|Withdrawal by Subject|1|||
13091440|NCT03738241|25824358|FG000|Overall Study|Physician Decision|0|||
13091441|NCT03738241|25824359|FG001|Overall Study|Physician Decision|0|||
13091442|NCT03738241|25824360|FG002|Overall Study|Physician Decision|0|||
13091443|NCT03738241|25824361|FG003|Overall Study|Physician Decision|0|||
13091444|NCT03738241|25824362|FG004|Overall Study|Physician Decision|0|||
13091445|NCT03738241|25824363|FG005|Overall Study|Physician Decision|0|||
13091446|NCT03738241|25824364|FG006|Overall Study|Physician Decision|0|||
13091447|NCT03738241|25824365|FG007|Overall Study|Physician Decision|0|||
13091448|NCT03738241|25824366|FG008|Overall Study|Physician Decision|1|||
13091449|NCT03738241|25824367|FG009|Overall Study|Physician Decision|0|||
13091450|NCT03738241|25824358|FG000|Overall Study|Adverse Event|1|||
13091451|NCT03738241|25824359|FG001|Overall Study|Adverse Event|0|||
13091452|NCT03738241|25824360|FG002|Overall Study|Adverse Event|0|||
13091453|NCT03738241|25824361|FG003|Overall Study|Adverse Event|0|||
13091454|NCT03738241|25824362|FG004|Overall Study|Adverse Event|0|||
13091455|NCT03738241|25824363|FG005|Overall Study|Adverse Event|0|||
13091456|NCT03738241|25824364|FG006|Overall Study|Adverse Event|0|||
13091457|NCT03738241|25824365|FG007|Overall Study|Adverse Event|0|||
13091458|NCT03738241|25824366|FG008|Overall Study|Adverse Event|0|||
13091459|NCT03738241|25824367|FG009|Overall Study|Adverse Event|0|||
13091460|NCT03738215|25824388|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
13091461|NCT03738215|25824389|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|1|||
13091462|NCT03738215|25824390|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
13091463|NCT03738215|25824388|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
13091464|NCT03738215|25824389|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
13091465|NCT03738215|25824390|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
13091466|NCT03738215|25824388|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
13091467|NCT03738215|25824389|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
13091468|NCT03738215|25824390|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|18|||
13091469|NCT03738215|25824388|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|13|||
13091470|NCT03738215|25824389|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|11|||
13091471|NCT03738215|25824390|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|9|||
13091472|NCT03738215|25824388|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
13091473|NCT03738215|25824389|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
13091474|NCT03738215|25824390|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
13091475|NCT03738215|25824388|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
13091476|NCT03738215|25824389|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
13091477|NCT03738215|25824390|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|5|||
13091478|NCT03738215|25824388|FG000|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
13091479|NCT03738215|25824389|FG001|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
13091480|NCT03738215|25824390|FG002|Safety Follow Up Period (4 Weeks)|Adverse Event|1|||
13091481|NCT03738215|25824388|FG000|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
13091482|NCT03738215|25824389|FG001|Safety Follow Up Period (4 Weeks)|Reason Not Specified|2|||
13091483|NCT03738215|25824390|FG002|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
13091484|NCT03738215|25824388|FG000|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
13091485|NCT03738215|25824389|FG001|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
13091486|NCT03738215|25824390|FG002|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|3|||
13091487|NCT03738215|25824388|FG000|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
13091488|NCT03738215|25824389|FG001|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
13091489|NCT03738215|25824390|FG002|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|4|||
13091490|NCT03737110|25824509|FG000|Run-in (RI) Period|Lack of Efficacy|3|||
13091491|NCT03737110|25824510|FG001|Run-in (RI) Period|Lack of Efficacy|0|||
13091492|NCT03737110|25824511|FG002|Run-in (RI) Period|Lack of Efficacy|0|||
13091493|NCT03737110|25824509|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3|||
13140286|NCT02687542|26011511|FG003|Overall Study|Adverse Event|2|||
13140287|NCT02687542|26011512|FG004|Overall Study|Adverse Event|9|||
13140288|NCT02687542|26011508|FG000|Overall Study|Withdrawal by Subject|0|||
13140289|NCT02687542|26011509|FG001|Overall Study|Withdrawal by Subject|1|||
13140290|NCT02687542|26011510|FG002|Overall Study|Withdrawal by Subject|1|||
13140291|NCT02687542|26011511|FG003|Overall Study|Withdrawal by Subject|2|||
13140292|NCT02687542|26011512|FG004|Overall Study|Withdrawal by Subject|4|||
13140293|NCT02687451|26011563|FG000|Overall Study|Withdrawal by Subject|1|||
13140294|NCT02687451|26011564|FG001|Overall Study|Withdrawal by Subject|0|||
13140295|NCT02687451|26011565|FG002|Overall Study|Withdrawal by Subject|0|||
13140296|NCT02687451|26011566|FG003|Overall Study|Withdrawal by Subject|0|||
13140297|NCT02687451|26011567|FG004|Overall Study|Withdrawal by Subject|0|||
13140298|NCT02687451|26011568|FG005|Overall Study|Withdrawal by Subject|1|||
13140299|NCT02687191|26011721|FG000|Overall Study|Death|0|||
13140300|NCT02687191|26011722|FG001|Overall Study|Death|1|||
13140301|NCT02687191|26011723|FG002|Overall Study|Death|1|||
13140302|NCT02687191|26011724|FG003|Overall Study|Death|0|||
13140303|NCT02687191|26011725|FG004|Overall Study|Death|1|||
13140304|NCT02687191|26011726|FG005|Overall Study|Death|1|||
13140305|NCT02687191|26011721|FG000|Overall Study|Withdrawal by Subject|0|||
13140306|NCT02687191|26011722|FG001|Overall Study|Withdrawal by Subject|0|||
13140307|NCT02687191|26011723|FG002|Overall Study|Withdrawal by Subject|0|||
13140308|NCT02687191|26011724|FG003|Overall Study|Withdrawal by Subject|1|||
13140309|NCT02687191|26011725|FG004|Overall Study|Withdrawal by Subject|0|||
13140310|NCT02687191|26011726|FG005|Overall Study|Withdrawal by Subject|0|||
13140311|NCT02687035|26011745|FG000|Overall Study|Withdrawal by Subject|1|||
13140312|NCT02687035|26011745|FG000|Overall Study|Death|87|||
13140313|NCT02687035|26011745|FG000|Overall Study|Lost to Follow-up|1|||
13140314|NCT02687035|26011745|FG000|Overall Study|Missed Visit|87|||
13140315|NCT02687035|26011745|FG000|Overall Study|Did not receive Study Device|8|||
13140316|NCT02686164|26011757|FG000|Overall Study|Adverse Event|1|||
13140317|NCT02686164|26011757|FG000|Overall Study|Withdrawal of consent|1|||
13140318|NCT02686164|26011757|FG000|Overall Study|Clinical progression|1|||
13140319|NCT02686034|26011800|FG000|Run-In Period 1|Eligibility|12|||
13140320|NCT02686034|26011801|FG001|Run-In Period 1|Eligibility|10|||
13140321|NCT02686034|26011800|FG000|Run-In Period 1|Withdrawal by Subject|4|||
13140322|NCT02686034|26011801|FG001|Run-In Period 1|Withdrawal by Subject|3|||
13140323|NCT02686034|26011800|FG000|Run-In Period 1|Lost to Follow-up|4|||
13140324|NCT02686034|26011801|FG001|Run-In Period 1|Lost to Follow-up|4|||
13140325|NCT02686034|26011800|FG000|Randomized Controlled Period 2|Lost to Follow-up|1|||
13140326|NCT02686034|26011801|FG001|Randomized Controlled Period 2|Lost to Follow-up|2|||
13140327|NCT02686034|26011800|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3|||
13140328|NCT02686034|26011801|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0|||
13140329|NCT02686034|26011800|FG000|Randomized Controlled Period 2|Adverse Event|0|||
13140330|NCT02686034|26011801|FG001|Randomized Controlled Period 2|Adverse Event|2|||
13140331|NCT02686034|26011800|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1|||
13140332|NCT02686034|26011801|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0|||
13140333|NCT02686034|26011800|FG000|Open Label Period 3|Lost to Follow-up|0|||
13140334|NCT02686034|26011801|FG001|Open Label Period 3|Lost to Follow-up|1|||
13140335|NCT02685995|26011814|FG000|Overall Study|Insertion of immediately puncturable graft.|1|||
13140336|NCT02685995|26011815|FG001|Overall Study|Insertion of immediately puncturable graft.|1|||
13140337|NCT02685488|26011836|FG000|Overall Study|Withdrawal by Subject|0|||
13140338|NCT02685488|26011837|FG001|Overall Study|Withdrawal by Subject|1|||
13140339|NCT02685202|26011845|FG000|Overall Study|Lost to Follow-up|9|||
13140340|NCT02685072|26011894|FG000|Treatment Period|Lost to Follow-up|12|||
13140341|NCT02685072|26011895|FG001|Treatment Period|Lost to Follow-up|6|||
13140342|NCT02685072|26011894|FG000|Treatment Period|Withdrawal by Subject|1|||
13140343|NCT02685072|26011895|FG001|Treatment Period|Withdrawal by Subject|3|||
13140344|NCT02685072|26011894|FG000|1-Month Follow-Up|Withdrawal by Subject|1|||
13140345|NCT02685072|26011895|FG001|1-Month Follow-Up|Withdrawal by Subject|0|||
13140346|NCT02685033|26011928|FG000|Overall Study|Withdrawal of Consent|0|||
13140347|NCT02685033|26011929|FG001|Overall Study|Withdrawal of Consent|1|||
13140348|NCT02685033|26011928|FG000|Overall Study|Lost to Follow-up|2|||
13140349|NCT02685033|26011929|FG001|Overall Study|Lost to Follow-up|1|||
13140350|NCT02685033|26011928|FG000|Overall Study|Adverse Event|1|||
13140351|NCT02685033|26011929|FG001|Overall Study|Adverse Event|0|||
13140352|NCT02684981|26011975|FG000|Overall Study|Permanently discontinued the treatment|157|||
13140353|NCT02684981|26011976|FG001|Overall Study|Permanently discontinued the treatment|161|||
13140354|NCT02684981|26011977|FG002|Overall Study|Permanently discontinued the treatment|110|||
13140355|NCT02684981|26011975|FG000|Overall Study|Other|83|||
13140356|NCT02684981|26011976|FG001|Overall Study|Other|49|||
13140357|NCT02684981|26011977|FG002|Overall Study|Other|17|||
13140358|NCT02684617|26012013|FG000|Overall Study|Adverse Event|1|||
13140359|NCT02684617|26012014|FG001|Overall Study|Adverse Event|0|||
13140360|NCT02684617|26012015|FG002|Overall Study|Adverse Event|1|||
13140361|NCT02684617|26012013|FG000|Overall Study|Death|8|||
13140362|NCT02684617|26012014|FG001|Overall Study|Death|16|||
13140363|NCT02684617|26012015|FG002|Overall Study|Death|28|||
13140364|NCT02684617|26012013|FG000|Overall Study|Withdrawal by Subject|2|||
13140365|NCT02684617|26012014|FG001|Overall Study|Withdrawal by Subject|0|||
13140366|NCT02684617|26012015|FG002|Overall Study|Withdrawal by Subject|4|||
13140367|NCT02684617|26012013|FG000|Overall Study|Screen Failure|1|||
13140368|NCT02684617|26012014|FG001|Overall Study|Screen Failure|0|||
13140369|NCT02684617|26012015|FG002|Overall Study|Screen Failure|2|||
13140370|NCT02684617|26012013|FG000|Overall Study|Study Terminated by Sponsor|6|||
13140371|NCT02684617|26012014|FG001|Overall Study|Study Terminated by Sponsor|1|||
13140372|NCT02684617|26012015|FG002|Overall Study|Study Terminated by Sponsor|5|||
13140373|NCT02684370|26012070|FG000|Part A|Adverse Event|2|||
13140374|NCT02684370|26012071|FG001|Part A|Adverse Event|0|||
13140375|NCT02684370|26012072|FG002|Part A|Adverse Event|1|||
13140376|NCT02684370|26012073|FG003|Part A|Adverse Event|0|||
13140377|NCT02684370|26012074|FG004|Part A|Adverse Event|0|||
13140378|NCT02684370|26012075|FG005|Part A|Adverse Event|0|||
13140379|NCT02684370|26012070|FG000|Part A|Lost to Follow-up|1|||
13140380|NCT02684370|26012071|FG001|Part A|Lost to Follow-up|1|||
13140381|NCT02684370|26012072|FG002|Part A|Lost to Follow-up|0|||
13140382|NCT02684370|26012073|FG003|Part A|Lost to Follow-up|0|||
13140383|NCT02684370|26012074|FG004|Part A|Lost to Follow-up|0|||
13140384|NCT02684370|26012075|FG005|Part A|Lost to Follow-up|0|||
13140385|NCT02684370|26012070|FG000|Part A|Subject Withdrawal|1|||
13307573|NCT01284621|26529088|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
13140386|NCT02684370|26012071|FG001|Part A|Subject Withdrawal|0|||
13140387|NCT02684370|26012072|FG002|Part A|Subject Withdrawal|3|||
13140388|NCT02684370|26012073|FG003|Part A|Subject Withdrawal|0|||
13140389|NCT02684370|26012074|FG004|Part A|Subject Withdrawal|0|||
13140390|NCT02684370|26012075|FG005|Part A|Subject Withdrawal|0|||
13140391|NCT02684370|26012070|FG000|Part A|Other|0|||
13140392|NCT02684370|26012071|FG001|Part A|Other|0|||
13140393|NCT02684370|26012072|FG002|Part A|Other|1|||
13140394|NCT02684370|26012073|FG003|Part A|Other|0|||
13140395|NCT02684370|26012074|FG004|Part A|Other|0|||
13140396|NCT02684370|26012075|FG005|Part A|Other|0|||
13140397|NCT02684370|26012070|FG000|Part B|Adverse Event|0|||
13140398|NCT02684370|26012071|FG001|Part B|Adverse Event|0|||
13140399|NCT02684370|26012072|FG002|Part B|Adverse Event|0|||
13140400|NCT02684370|26012073|FG003|Part B|Adverse Event|0|||
13140401|NCT02684370|26012074|FG004|Part B|Adverse Event|2|||
13140402|NCT02684370|26012075|FG005|Part B|Adverse Event|1|||
13140403|NCT02684370|26012070|FG000|Part B|Lost to Follow-up|0|||
13140404|NCT02684370|26012071|FG001|Part B|Lost to Follow-up|0|||
13140405|NCT02684370|26012072|FG002|Part B|Lost to Follow-up|0|||
13140406|NCT02684370|26012073|FG003|Part B|Lost to Follow-up|1|||
13140407|NCT02684370|26012074|FG004|Part B|Lost to Follow-up|2|||
13140408|NCT02684370|26012075|FG005|Part B|Lost to Follow-up|5|||
13140409|NCT02684370|26012070|FG000|Part B|Subject Withdrawal|0|||
13140410|NCT02684370|26012071|FG001|Part B|Subject Withdrawal|0|||
13140411|NCT02684370|26012072|FG002|Part B|Subject Withdrawal|0|||
13140412|NCT02684370|26012073|FG003|Part B|Subject Withdrawal|1|||
13140413|NCT02684370|26012074|FG004|Part B|Subject Withdrawal|1|||
13140414|NCT02684370|26012075|FG005|Part B|Subject Withdrawal|2|||
13140415|NCT02684357|26012136|FG000|Part A|Adverse Event (Worsening of Disease)|1|||
13140416|NCT02684357|26012137|FG001|Part A|Adverse Event (Worsening of Disease)|0|||
13140417|NCT02684357|26012138|FG002|Part A|Adverse Event (Worsening of Disease)|0|||
13140418|NCT02684357|26012139|FG003|Part A|Adverse Event (Worsening of Disease)|0|||
13140419|NCT02684357|26012140|FG004|Part A|Adverse Event (Worsening of Disease)|0|||
13140420|NCT02684357|26012141|FG005|Part A|Adverse Event (Worsening of Disease)|0|||
13140421|NCT02684357|26012136|FG000|Part A|Lost to Follow-up|0|||
13140422|NCT02684357|26012137|FG001|Part A|Lost to Follow-up|2|||
13140423|NCT02684357|26012138|FG002|Part A|Lost to Follow-up|2|||
13140424|NCT02684357|26012139|FG003|Part A|Lost to Follow-up|0|||
13140425|NCT02684357|26012140|FG004|Part A|Lost to Follow-up|0|||
13140426|NCT02684357|26012141|FG005|Part A|Lost to Follow-up|0|||
13140427|NCT02684357|26012136|FG000|Part A|Withdrawal by Subject|3|||
13140428|NCT02684357|26012137|FG001|Part A|Withdrawal by Subject|0|||
13140429|NCT02684357|26012138|FG002|Part A|Withdrawal by Subject|0|||
13140430|NCT02684357|26012139|FG003|Part A|Withdrawal by Subject|0|||
13140431|NCT02684357|26012140|FG004|Part A|Withdrawal by Subject|0|||
13140432|NCT02684357|26012141|FG005|Part A|Withdrawal by Subject|0|||
13140433|NCT02684357|26012136|FG000|Part A|Other|0|||
13140434|NCT02684357|26012137|FG001|Part A|Other|1|||
13140435|NCT02684357|26012138|FG002|Part A|Other|0|||
13140436|NCT02684357|26012139|FG003|Part A|Other|0|||
13140437|NCT02684357|26012140|FG004|Part A|Other|0|||
13140438|NCT02684357|26012141|FG005|Part A|Other|0|||
13140439|NCT02684357|26012136|FG000|Part B|Adverse Event (Other)|0|||
13140440|NCT02684357|26012137|FG001|Part B|Adverse Event (Other)|0|||
13140441|NCT02684357|26012138|FG002|Part B|Adverse Event (Other)|0|||
13140442|NCT02684357|26012139|FG003|Part B|Adverse Event (Other)|1|||
13140443|NCT02684357|26012140|FG004|Part B|Adverse Event (Other)|1|||
13140444|NCT02684357|26012141|FG005|Part B|Adverse Event (Other)|1|||
13140445|NCT02684357|26012136|FG000|Part B|Lost to Follow-up|0|||
13140446|NCT02684357|26012137|FG001|Part B|Lost to Follow-up|0|||
13140447|NCT02684357|26012138|FG002|Part B|Lost to Follow-up|0|||
13140448|NCT02684357|26012139|FG003|Part B|Lost to Follow-up|1|||
13140449|NCT02684357|26012140|FG004|Part B|Lost to Follow-up|1|||
13140450|NCT02684357|26012141|FG005|Part B|Lost to Follow-up|7|||
13140451|NCT02684357|26012136|FG000|Part B|Withdrawal by Subject|0|||
13140452|NCT02684357|26012137|FG001|Part B|Withdrawal by Subject|0|||
13140453|NCT02684357|26012138|FG002|Part B|Withdrawal by Subject|0|||
13140454|NCT02684357|26012139|FG003|Part B|Withdrawal by Subject|0|||
13140455|NCT02684357|26012140|FG004|Part B|Withdrawal by Subject|2|||
13140456|NCT02684357|26012141|FG005|Part B|Withdrawal by Subject|4|||
13140457|NCT02684357|26012136|FG000|Part B|Other|0|||
13140458|NCT02684357|26012137|FG001|Part B|Other|0|||
13140459|NCT02684357|26012138|FG002|Part B|Other|0|||
13140460|NCT02684357|26012139|FG003|Part B|Other|1|||
13140461|NCT02684357|26012140|FG004|Part B|Other|0|||
13140462|NCT02684357|26012141|FG005|Part B|Other|1|||
13140463|NCT02684344|26012154|FG000|Overall Study|Withdrawal by Subject|0|||
13140464|NCT02684344|26012155|FG001|Overall Study|Withdrawal by Subject|1|||
13140465|NCT02684279|26012180|FG000|Overall Study|Adverse Event|87|||
13140466|NCT02684279|26012180|FG000|Overall Study|Lack of Efficacy|4|||
13140467|NCT02684279|26012180|FG000|Overall Study|Lost to Follow-up|61|||
13140468|NCT02684279|26012180|FG000|Overall Study|Protocol Violation|6|||
13140469|NCT02684279|26012180|FG000|Overall Study|Pregnancy|8|||
13140470|NCT02684279|26012180|FG000|Overall Study|Withdrawal by Subject|92|||
13140471|NCT02684279|26012180|FG000|Overall Study|non-compliance with study drug|9|||
13140472|NCT02684279|26012180|FG000|Overall Study|non compliance with study visits|2|||
13140473|NCT02684279|26012180|FG000|Overall Study|subject to have surgery|1|||
13140474|NCT02684279|26012180|FG000|Overall Study|family emergency|1|||
13140475|NCT02684279|26012180|FG000|Overall Study|Site closures|7|||
13140476|NCT02684279|26012180|FG000|Overall Study|Physician Decision|1|||
13204709|NCT01970878|26229845|FG001|Overall Study|Protocol Specified Criteria|4|||
13204710|NCT01970878|26229846|FG002|Overall Study|Protocol Specified Criteria|3|||
13204711|NCT01970878|26229847|FG003|Overall Study|Protocol Specified Criteria|6|||
13204712|NCT01970878|26229844|FG000|Overall Study|Physician Decision|0|||
13204713|NCT01970878|26229845|FG001|Overall Study|Physician Decision|1|||
13204714|NCT01970878|26229846|FG002|Overall Study|Physician Decision|1|||
13204715|NCT01970878|26229847|FG003|Overall Study|Physician Decision|0|||
13204716|NCT01970878|26229844|FG000|Overall Study|No Completion Status|0|||
13204717|NCT01970878|26229845|FG001|Overall Study|No Completion Status|1|||
13204718|NCT01970878|26229846|FG002|Overall Study|No Completion Status|0|||
13204719|NCT01970878|26229847|FG003|Overall Study|No Completion Status|0|||
13204720|NCT01970592|26229854|FG000|Overall Study|Withdrawal by Subject|4|||
13204721|NCT01970592|26229854|FG000|Overall Study|Physician Decision|1|||
13204722|NCT01970592|26229854|FG000|Overall Study|Adverse Event|1|||
13204723|NCT01970540|26229893|FG000|Overall Study|Non-treatment-related AE|0|||
13204724|NCT01970540|26229894|FG001|Overall Study|Non-treatment-related AE|0|||
13204725|NCT01970540|26229895|FG002|Overall Study|Non-treatment-related AE|1|||
13204726|NCT01970540|26229893|FG000|Overall Study|Progressive disease|55|||
13204727|NCT01970540|26229894|FG001|Overall Study|Progressive disease|23|||
13204728|NCT01970540|26229895|FG002|Overall Study|Progressive disease|10|||
13204729|NCT01970540|26229893|FG000|Overall Study|Treatment delay over protocol|0|||
13204730|NCT01970540|26229894|FG001|Overall Study|Treatment delay over protocol|0|||
13204731|NCT01970540|26229895|FG002|Overall Study|Treatment delay over protocol|1|||
13204732|NCT01970540|26229893|FG000|Overall Study|Physician Decision|7|||
13204733|NCT01970540|26229894|FG001|Overall Study|Physician Decision|2|||
13204734|NCT01970540|26229895|FG002|Overall Study|Physician Decision|0|||
13204735|NCT01970540|26229893|FG000|Overall Study|Clinical progression|0|||
13204736|NCT01970540|26229894|FG001|Overall Study|Clinical progression|1|||
13204737|NCT01970540|26229895|FG002|Overall Study|Clinical progression|1|||
13204738|NCT01970540|26229893|FG000|Overall Study|End of study|2|||
13204739|NCT01970540|26229894|FG001|Overall Study|End of study|0|||
13204740|NCT01970540|26229895|FG002|Overall Study|End of study|2|||
13204741|NCT01970540|26229893|FG000|Overall Study|Adverse Event|0|||
13204742|NCT01970540|26229894|FG001|Overall Study|Adverse Event|2|||
13204743|NCT01970540|26229895|FG002|Overall Study|Adverse Event|1|||
13204744|NCT01970540|26229893|FG000|Overall Study|Treatment-related AE|4|||
13204745|NCT01970540|26229894|FG001|Overall Study|Treatment-related AE|0|||
13204746|NCT01970540|26229895|FG002|Overall Study|Treatment-related AE|2|||
13204747|NCT01970540|26229893|FG000|Overall Study|Withdrawal by Subject|4|||
13204748|NCT01970540|26229894|FG001|Overall Study|Withdrawal by Subject|0|||
13204749|NCT01970540|26229895|FG002|Overall Study|Withdrawal by Subject|1|||
13204750|NCT01970540|26229893|FG000|Overall Study|Clinical deterioration|1|||
13204751|NCT01970540|26229894|FG001|Overall Study|Clinical deterioration|0|||
13204752|NCT01970540|26229895|FG002|Overall Study|Clinical deterioration|0|||
13204753|NCT01970527|26229913|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1|||
13204754|NCT01970527|26229914|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0|||
13204755|NCT01970527|26229913|FG000|Treatment|Disease progression|0|||
13204756|NCT01970527|26229914|FG001|Treatment|Disease progression|1|||
13204757|NCT01970527|26229913|FG000|Treatment|Participant did not tolerate Ipilimumab|0|||
13204758|NCT01970527|26229914|FG001|Treatment|Participant did not tolerate Ipilimumab|1|||
13204759|NCT01970527|26229913|FG000|Treatment|Death|0|||
13204760|NCT01970527|26229914|FG001|Treatment|Death|1|||
13204761|NCT01970527|26229913|FG000|Follow-up Clinic Visit|Disease progression|1|||
13204762|NCT01970527|26229914|FG001|Follow-up Clinic Visit|Disease progression|1|||
13204763|NCT01970527|26229913|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0|||
13204764|NCT01970527|26229914|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1|||
13204765|NCT01970527|26229913|FG000|Follow-up Clinic Visit|Lost to Follow-up|0|||
13204766|NCT01970527|26229914|FG001|Follow-up Clinic Visit|Lost to Follow-up|1|||
13204767|NCT01970501|26229933|FG000|Overall Study|Discontinuation of study by sponsor|16|||
13204768|NCT01970501|26229934|FG001|Overall Study|Discontinuation of study by sponsor|14|||
13204769|NCT01970501|26229933|FG000|Overall Study|Withdrawal by Subject|6|||
13204770|NCT01970501|26229934|FG001|Overall Study|Withdrawal by Subject|7|||
13204771|NCT01970501|26229933|FG000|Overall Study|Adverse Event|2|||
13204772|NCT01970501|26229934|FG001|Overall Study|Adverse Event|4|||
13204773|NCT01970501|26229933|FG000|Overall Study|Death|1|||
13204774|NCT01970501|26229934|FG001|Overall Study|Death|3|||
13204775|NCT01970501|26229933|FG000|Overall Study|Physician Decision|2|||
13204776|NCT01970501|26229934|FG001|Overall Study|Physician Decision|0|||
13204777|NCT01970488|26230009|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1|||
13204778|NCT01970488|26230010|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2|||
13204779|NCT01970488|26230011|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0|||
13204780|NCT01970488|26230012|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0|||
13204781|NCT01970488|26230013|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0|||
13204782|NCT01970488|26230009|FG000|Part 1: Through Week 16|Protocol Violation|1|||
13204783|NCT01970488|26230010|FG001|Part 1: Through Week 16|Protocol Violation|2|||
13140477|NCT02684097|26012203|FG000|Overall Study|Lack of Efficacy|13|||
13140478|NCT02684097|26012204|FG001|Overall Study|Lack of Efficacy|6|||
13140479|NCT02683941|26012241|FG000|Double-blind Phase|Adverse Event|0|||
13140480|NCT02683941|26012242|FG001|Double-blind Phase|Adverse Event|1|||
13140481|NCT02683941|26012241|FG000|Double-blind Phase|Withdrawal by Subject|4|||
13140482|NCT02683941|26012242|FG001|Double-blind Phase|Withdrawal by Subject|2|||
13140483|NCT02683941|26012241|FG000|Double-blind Phase|Lost to Follow-up|1|||
13140484|NCT02683941|26012242|FG001|Double-blind Phase|Lost to Follow-up|0|||
13140485|NCT02683941|26012241|FG000|Double-blind Phase|Disease Progression|5|||
13140486|NCT02683941|26012242|FG001|Double-blind Phase|Disease Progression|2|||
13140487|NCT02683941|26012241|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
13140488|NCT02683941|26012242|FG001|Open-label Treatment Phase|Withdrawal by Subject|2|||
13140489|NCT02683941|26012241|FG000|Open-label Treatment Phase|Disease Progression|1|||
13140490|NCT02683941|26012242|FG001|Open-label Treatment Phase|Disease Progression|2|||
13140491|NCT02683941|26012241|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18|||
13140492|NCT02683941|26012242|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9|||
13140493|NCT02683941|26012241|FG000|Open-label Treatment Phase|Other|1|||
13140494|NCT02683941|26012242|FG001|Open-label Treatment Phase|Other|0|||
13140495|NCT02683941|26012241|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3|||
13140496|NCT02683941|26012242|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3|||
13140497|NCT02683941|26012241|FG000|Open-label Follow-up Phase|Lost to Follow-up|1|||
13140498|NCT02683941|26012242|FG001|Open-label Follow-up Phase|Lost to Follow-up|0|||
13140499|NCT02683941|26012241|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6|||
13140500|NCT02683941|26012242|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4|||
13140501|NCT02683941|26012241|FG000|Open-label Follow-up Phase|Other|8|||
13140502|NCT02683941|26012242|FG001|Open-label Follow-up Phase|Other|1|||
13140503|NCT02683876|26012257|FG000|Overall Study|samples damaged during shipping|2|||
13140504|NCT02683876|26012258|FG001|Overall Study|samples damaged during shipping|0|||
13140505|NCT02683785|26012305|FG000|Overall Study|Withdrawal by Subject|1|||
13140506|NCT02683785|26012306|FG001|Overall Study|Withdrawal by Subject|1|||
13140507|NCT02683785|26012305|FG000|Overall Study|Lost to Follow-up|0|||
13140508|NCT02683785|26012306|FG001|Overall Study|Lost to Follow-up|1|||
13140509|NCT02683785|26012305|FG000|Overall Study|Adverse Event|0|||
13140510|NCT02683785|26012306|FG001|Overall Study|Adverse Event|2|||
13140511|NCT02683746|26012341|FG000|Overall Study|Adverse Event|3|||
13140512|NCT02683746|26012342|FG001|Overall Study|Adverse Event|2|||
13140513|NCT02683746|26012341|FG000|Overall Study|Lost to Follow-up|5|||
13140514|NCT02683746|26012342|FG001|Overall Study|Lost to Follow-up|6|||
13140515|NCT02683746|26012341|FG000|Overall Study|Withdrawal by Subject|6|||
13140516|NCT02683746|26012342|FG001|Overall Study|Withdrawal by Subject|5|||
13140517|NCT02683746|26012341|FG000|Overall Study|Physician Decision|2|||
13140518|NCT02683746|26012342|FG001|Overall Study|Physician Decision|1|||
13140519|NCT02683668|26012361|FG000|Period 2|Withdrawal by Subject|0|||
13140520|NCT02683668|26012362|FG001|Period 2|Withdrawal by Subject|1|||
13140521|NCT02683668|26012363|FG002|Period 2|Withdrawal by Subject|0|||
13140522|NCT02683525|26012379|FG000|Overall Study|Lost to Follow-up|1|||
13140523|NCT02683525|26012379|FG000|Overall Study|Physician Decision|1|||
13140524|NCT02683525|26012379|FG000|Overall Study|Disease Progression|6|||
13140525|NCT02683187|26012389|FG000|Overall Study|Failed IV access|3|||
13140526|NCT02683187|26012389|FG000|Overall Study|Withdrawal by Subject|5|||
13140527|NCT02683109|26012407|FG000|Overall Study|Adverse Event|1|||
13140528|NCT02683109|26012408|FG001|Overall Study|Adverse Event|0|||
13140529|NCT02682927|26012573|FG000|Overall Study|Adverse Event|0|||
13140530|NCT02682927|26012574|FG001|Overall Study|Adverse Event|0|||
13140531|NCT02682927|26012575|FG002|Overall Study|Adverse Event|5|||
13140532|NCT02682927|26012576|FG003|Overall Study|Adverse Event|1|||
13140533|NCT02682927|26012577|FG004|Overall Study|Adverse Event|0|||
13140534|NCT02682927|26012578|FG005|Overall Study|Adverse Event|2|||
13140535|NCT02682927|26012573|FG000|Overall Study|Death|0|||
13140536|NCT02682927|26012574|FG001|Overall Study|Death|0|||
13140537|NCT02682927|26012575|FG002|Overall Study|Death|0|||
13140538|NCT02682927|26012576|FG003|Overall Study|Death|1|||
13140539|NCT02682927|26012577|FG004|Overall Study|Death|0|||
13140540|NCT02682927|26012578|FG005|Overall Study|Death|0|||
13140541|NCT02682927|26012573|FG000|Overall Study|Lack of Efficacy|1|||
13140542|NCT02682927|26012574|FG001|Overall Study|Lack of Efficacy|0|||
13140543|NCT02682927|26012575|FG002|Overall Study|Lack of Efficacy|0|||
13140544|NCT02682927|26012576|FG003|Overall Study|Lack of Efficacy|1|||
13140545|NCT02682927|26012577|FG004|Overall Study|Lack of Efficacy|0|||
13140546|NCT02682927|26012578|FG005|Overall Study|Lack of Efficacy|0|||
13140547|NCT02682927|26012573|FG000|Overall Study|Other|0|||
13140548|NCT02682927|26012574|FG001|Overall Study|Other|0|||
13140549|NCT02682927|26012575|FG002|Overall Study|Other|0|||
13140550|NCT02682927|26012576|FG003|Overall Study|Other|2|||
13140551|NCT02682927|26012577|FG004|Overall Study|Other|0|||
13140552|NCT02682927|26012578|FG005|Overall Study|Other|0|||
13140553|NCT02682927|26012573|FG000|Overall Study|Withdrawal by Subject|2|||
13140554|NCT02682927|26012574|FG001|Overall Study|Withdrawal by Subject|0|||
13140555|NCT02682927|26012575|FG002|Overall Study|Withdrawal by Subject|1|||
13140556|NCT02682927|26012576|FG003|Overall Study|Withdrawal by Subject|0|||
13140557|NCT02682927|26012577|FG004|Overall Study|Withdrawal by Subject|1|||
13140558|NCT02682927|26012578|FG005|Overall Study|Withdrawal by Subject|1|||
13140559|NCT02682823|26012628|FG000|Overall Study|Withdrawal by Subject|0|||
13140560|NCT02682823|26012629|FG001|Overall Study|Withdrawal by Subject|0|||
13140561|NCT02682823|26012630|FG002|Overall Study|Withdrawal by Subject|1|||
13140562|NCT02682823|26012631|FG003|Overall Study|Withdrawal by Subject|0|||
13140563|NCT02682823|26012632|FG004|Overall Study|Withdrawal by Subject|1|||
13140564|NCT02682823|26012628|FG000|Overall Study|Protocol Deviation|0|||
13140565|NCT02682823|26012629|FG001|Overall Study|Protocol Deviation|1|||
13140566|NCT02682823|26012630|FG002|Overall Study|Protocol Deviation|0|||
13140567|NCT02682823|26012631|FG003|Overall Study|Protocol Deviation|0|||
13140568|NCT02682823|26012632|FG004|Overall Study|Protocol Deviation|0|||
13140569|NCT02682823|26012628|FG000|Overall Study|Adverse Event|0|||
13140570|NCT02682823|26012629|FG001|Overall Study|Adverse Event|0|||
13140571|NCT02682823|26012630|FG002|Overall Study|Adverse Event|0|||
13140572|NCT02682823|26012631|FG003|Overall Study|Adverse Event|1|||
13140573|NCT02682823|26012632|FG004|Overall Study|Adverse Event|0|||
13140574|NCT02682784|26012659|FG000|Overall Study|Withdrawal by Subject|0|||
13140575|NCT02682784|26012660|FG001|Overall Study|Withdrawal by Subject|2|||
13140576|NCT02682784|26012661|FG002|Overall Study|Withdrawal by Subject|1|||
13140577|NCT02682784|26012662|FG003|Overall Study|Withdrawal by Subject|2|||
13140578|NCT02682784|26012659|FG000|Overall Study|Physician Decision|1|||
13140579|NCT02682784|26012660|FG001|Overall Study|Physician Decision|0|||
13140580|NCT02682784|26012661|FG002|Overall Study|Physician Decision|1|||
13140581|NCT02682784|26012662|FG003|Overall Study|Physician Decision|1|||
13140582|NCT02682602|26012686|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1|||
13140583|NCT02682602|26012687|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0|||
13140584|NCT02682602|26012686|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3|||
13140585|NCT02682602|26012687|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0|||
13140586|NCT02682264|26012700|FG000|Overall Study|Withdrawal by Subject|56|||
13140587|NCT02682264|26012701|FG001|Overall Study|Withdrawal by Subject|45|||
13140588|NCT02682264|26012700|FG000|Overall Study|Lost to Follow-up|49|||
13140589|NCT02682264|26012701|FG001|Overall Study|Lost to Follow-up|41|||
13140590|NCT02682264|26012700|FG000|Overall Study|Lack of Efficacy|14|||
13140591|NCT02682264|26012701|FG001|Overall Study|Lack of Efficacy|16|||
13140592|NCT02682264|26012700|FG000|Overall Study|Withdrawal by Parent|6|||
13140593|NCT02682264|26012701|FG001|Overall Study|Withdrawal by Parent|7|||
13140594|NCT02682264|26012700|FG000|Overall Study|Adverse Event|9|||
13140595|NCT02682264|26012701|FG001|Overall Study|Adverse Event|0|||
13140596|NCT02682264|26012700|FG000|Overall Study|Noncompliance with study drug|1|||
13140597|NCT02682264|26012701|FG001|Overall Study|Noncompliance with study drug|4|||
13140598|NCT02682264|26012700|FG000|Overall Study|Pregnancy|1|||
13140599|NCT02682264|26012701|FG001|Overall Study|Pregnancy|2|||
13140600|NCT02682264|26012700|FG000|Overall Study|Recovery|1|||
13140601|NCT02682264|26012701|FG001|Overall Study|Recovery|2|||
13140602|NCT02682264|26012700|FG000|Overall Study|Progressive Disease|1|||
13140603|NCT02682264|26012701|FG001|Overall Study|Progressive Disease|0|||
13140604|NCT02682264|26012700|FG000|Overall Study|Technical Problems|0|||
13140605|NCT02682264|26012701|FG001|Overall Study|Technical Problems|1|||
13140606|NCT02682264|26012700|FG000|Overall Study|Moved abroad and unable to continue|0|||
13140607|NCT02682264|26012701|FG001|Overall Study|Moved abroad and unable to continue|3|||
13140608|NCT02682264|26012700|FG000|Overall Study|Stopped test article application|0|||
13140609|NCT02682264|26012701|FG001|Overall Study|Stopped test article application|1|||
13140610|NCT02681523|26012709|FG000|Overall Study|Adverse Event|1|||
13140611|NCT02681523|26012709|FG000|Overall Study|Patient Non-compliance|1|||
13140612|NCT02681510|26012718|FG000|Overall Study|Withdrawal by Subject|1|||
13140613|NCT02681510|26012718|FG000|Overall Study|Lost to Follow-up|9|||
13140614|NCT02681094|26012744|FG000|1 -Modified Enrolled Participants Set|Participant decision|7|||
13140615|NCT02681094|26012745|FG001|1 -Modified Enrolled Participants Set|Participant decision|10|||
13140616|NCT02681094|26012746|FG002|1 -Modified Enrolled Participants Set|Participant decision|9|||
13140617|NCT02681094|26012744|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10|||
13140618|NCT02681094|26012745|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4|||
13140619|NCT02681094|26012746|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1|||
13140620|NCT02681094|26012744|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2|||
13140621|NCT02681094|26012745|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0|||
13140622|NCT02681094|26012746|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1|||
13140623|NCT02681094|26012744|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1|||
13140624|NCT02681094|26012745|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5|||
13140625|NCT02681094|26012746|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14|||
13140626|NCT02681094|26012744|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11|||
13140627|NCT02681094|26012745|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13|||
13140628|NCT02681094|26012746|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20|||
13140629|NCT02681094|26012744|FG000|1 -Modified Enrolled Participants Set|Other|6|||
13140630|NCT02681094|26012745|FG001|1 -Modified Enrolled Participants Set|Other|6|||
13140631|NCT02681094|26012746|FG002|1 -Modified Enrolled Participants Set|Other|7|||
13140632|NCT02681094|26012744|FG000|1 -Modified Enrolled Participants Set|No treatment given|0|||
13140633|NCT02681094|26012745|FG001|1 -Modified Enrolled Participants Set|No treatment given|1|||
13140634|NCT02681094|26012746|FG002|1 -Modified Enrolled Participants Set|No treatment given|1|||
13140635|NCT02681094|26012744|FG000|2 - Enrolled Participants Set|Participant decision|7|||
13140636|NCT02681094|26012745|FG001|2 - Enrolled Participants Set|Participant decision|10|||
13140637|NCT02681094|26012746|FG002|2 - Enrolled Participants Set|Participant decision|9|||
13140638|NCT02681094|26012744|FG000|2 - Enrolled Participants Set|Adverse Event|10|||
13140639|NCT02681094|26012745|FG001|2 - Enrolled Participants Set|Adverse Event|4|||
13140640|NCT02681094|26012746|FG002|2 - Enrolled Participants Set|Adverse Event|1|||
13140641|NCT02681094|26012744|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2|||
13140642|NCT02681094|26012745|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0|||
13091494|NCT03737110|25824510|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
13091495|NCT03737110|25824511|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
13091496|NCT03737110|25824509|FG000|Run-in (RI) Period|Adverse Event|4|||
13091497|NCT03737110|25824510|FG001|Run-in (RI) Period|Adverse Event|0|||
13091498|NCT03737110|25824511|FG002|Run-in (RI) Period|Adverse Event|0|||
13091499|NCT03737110|25824509|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
13091500|NCT03737110|25824510|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1|||
13091501|NCT03737110|25824511|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
13091502|NCT03737110|25824509|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
13091503|NCT03737110|25824510|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
13091504|NCT03737110|25824511|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
13091505|NCT03736967|25824630|FG000|Overall Study|Withdrawal by Subject|26|||
13091506|NCT03736967|25824631|FG001|Overall Study|Withdrawal by Subject|25|||
13091507|NCT03736967|25824632|FG002|Overall Study|Withdrawal by Subject|23|||
13091508|NCT03736967|25824633|FG003|Overall Study|Withdrawal by Subject|26|||
13091509|NCT03736967|25824630|FG000|Overall Study|Lost to Follow-up|3|||
13091510|NCT03736967|25824631|FG001|Overall Study|Lost to Follow-up|2|||
13091511|NCT03736967|25824632|FG002|Overall Study|Lost to Follow-up|1|||
13091512|NCT03736967|25824633|FG003|Overall Study|Lost to Follow-up|1|||
13091513|NCT03736967|25824630|FG000|Overall Study|Physician Decision|1|||
13091514|NCT03736967|25824631|FG001|Overall Study|Physician Decision|0|||
13091515|NCT03736967|25824632|FG002|Overall Study|Physician Decision|0|||
13091516|NCT03736967|25824633|FG003|Overall Study|Physician Decision|1|||
13091517|NCT03736967|25824630|FG000|Overall Study|Adverse Event|0|||
13091518|NCT03736967|25824631|FG001|Overall Study|Adverse Event|1|||
13091519|NCT03736967|25824632|FG002|Overall Study|Adverse Event|0|||
13091520|NCT03736967|25824633|FG003|Overall Study|Adverse Event|1|||
13091521|NCT03736967|25824630|FG000|Overall Study|Death|0|||
13091522|NCT03736967|25824631|FG001|Overall Study|Death|0|||
13091523|NCT03736967|25824632|FG002|Overall Study|Death|0|||
13091524|NCT03736967|25824633|FG003|Overall Study|Death|1|||
13091525|NCT03736967|25824630|FG000|Overall Study|Randomized but never treated|1|||
13140643|NCT02681094|26012746|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1|||
13140644|NCT02681094|26012744|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1|||
13140645|NCT02681094|26012745|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5|||
13140646|NCT02681094|26012746|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14|||
13140647|NCT02681094|26012744|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14|||
13140648|NCT02681094|26012745|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15|||
13140649|NCT02681094|26012746|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21|||
13140650|NCT02681094|26012744|FG000|2 - Enrolled Participants Set|Other|6|||
13140651|NCT02681094|26012745|FG001|2 - Enrolled Participants Set|Other|6|||
13140652|NCT02681094|26012746|FG002|2 - Enrolled Participants Set|Other|7|||
13140653|NCT02681094|26012744|FG000|2 - Enrolled Participants Set|No treatment given|0|||
13140654|NCT02681094|26012745|FG001|2 - Enrolled Participants Set|No treatment given|1|||
13140655|NCT02681094|26012746|FG002|2 - Enrolled Participants Set|No treatment given|1|||
13140656|NCT02680847|26012791|FG000|Overall Study|Other|2|||
13140657|NCT02680847|26012792|FG001|Overall Study|Other|0|||
13140658|NCT02680847|26012793|FG002|Overall Study|Other|0|||
13140659|NCT02680847|26012791|FG000|Overall Study|No longer met eligibility criteria|2|||
13140660|NCT02680847|26012792|FG001|Overall Study|No longer met eligibility criteria|2|||
13140661|NCT02680847|26012793|FG002|Overall Study|No longer met eligibility criteria|0|||
13140662|NCT02680847|26012791|FG000|Overall Study|Unwilling to participate in study|1|||
13091526|NCT03736967|25824631|FG001|Overall Study|Randomized but never treated|0|||
13091527|NCT03736967|25824632|FG002|Overall Study|Randomized but never treated|0|||
13091528|NCT03736967|25824633|FG003|Overall Study|Randomized but never treated|0|||
13140663|NCT02680847|26012792|FG001|Overall Study|Unwilling to participate in study|1|||
13140664|NCT02680847|26012793|FG002|Overall Study|Unwilling to participate in study|0|||
13140665|NCT02680847|26012791|FG000|Overall Study|Lack of Efficacy|0|||
13140666|NCT02680847|26012792|FG001|Overall Study|Lack of Efficacy|0|||
13140667|NCT02680847|26012793|FG002|Overall Study|Lack of Efficacy|2|||
13140668|NCT02680847|26012791|FG000|Overall Study|Adverse Event|0|||
13140669|NCT02680847|26012792|FG001|Overall Study|Adverse Event|0|||
13140670|NCT02680847|26012793|FG002|Overall Study|Adverse Event|1|||
13140671|NCT02680834|26012810|FG000|Overall Study|Physician Decision|5|||
13140672|NCT02680834|26012811|FG001|Overall Study|Physician Decision|2|||
13140673|NCT02680834|26012810|FG000|Overall Study|Withdrawal by Subject|6|||
13140674|NCT02680834|26012811|FG001|Overall Study|Withdrawal by Subject|0|||
13140675|NCT02680834|26012810|FG000|Overall Study|Lost to Follow-up|0|||
13140676|NCT02680834|26012811|FG001|Overall Study|Lost to Follow-up|1|||
13140677|NCT02680756|26012866|FG000|Overall Study|Adverse Event|10|||
13140678|NCT02680756|26012867|FG001|Overall Study|Adverse Event|2|||
13140679|NCT02680756|26012866|FG000|Overall Study|Lost to Follow-up|7|||
13140680|NCT02680756|26012867|FG001|Overall Study|Lost to Follow-up|6|||
13140681|NCT02680756|26012866|FG000|Overall Study|Withdrawal by Subject|5|||
13140682|NCT02680756|26012867|FG001|Overall Study|Withdrawal by Subject|5|||
13140683|NCT02680756|26012866|FG000|Overall Study|Physician Decision|4|||
13140684|NCT02680756|26012867|FG001|Overall Study|Physician Decision|1|||
13140685|NCT02680756|26012866|FG000|Overall Study|Hb ≤7.5 g/dL|0|||
13140686|NCT02680756|26012867|FG001|Overall Study|Hb ≤7.5 g/dL|2|||
13140687|NCT02680756|26012866|FG000|Overall Study|Blood transfusion for any reason|0|||
13140688|NCT02680756|26012867|FG001|Overall Study|Blood transfusion for any reason|1|||
13140689|NCT02680756|26012866|FG000|Overall Study|Death|1|||
13140690|NCT02680756|26012867|FG001|Overall Study|Death|0|||
13140691|NCT02680756|26012866|FG000|Overall Study|Protocol Violation|1|||
13140692|NCT02680756|26012867|FG001|Overall Study|Protocol Violation|0|||
13140693|NCT02680756|26012866|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1|||
13140694|NCT02680756|26012867|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0|||
13140695|NCT02680756|26012866|FG000|Overall Study|None of above or not recorded|3|||
13140696|NCT02680756|26012867|FG001|Overall Study|None of above or not recorded|2|||
13140697|NCT02680665|26012875|FG000|Overall Study|No visit after the first prescription|5|||
13140698|NCT02680639|26012900|FG000|Screening Period|Screen Failure|7|||
13140699|NCT02680639|26012901|FG001|Screening Period|Screen Failure|0|||
13140700|NCT02680639|26012902|FG002|Screening Period|Screen Failure|0|||
13140701|NCT02680574|26012927|FG000|Overall Study|Death|137|||
13140702|NCT02680574|26012928|FG001|Overall Study|Death|137|||
13140703|NCT02680574|26012927|FG000|Overall Study|Withdrawal by Subject|17|||
13140704|NCT02680574|26012928|FG001|Overall Study|Withdrawal by Subject|9|||
13140705|NCT02680574|26012927|FG000|Overall Study|Lost to Follow-up|4|||
13140706|NCT02680574|26012928|FG001|Overall Study|Lost to Follow-up|6|||
13140707|NCT02680041|26012939|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8|||
13140708|NCT02680041|26012939|FG000|Overall Study|Lost to Follow-up|2|||
13140709|NCT02680002|26013074|FG000|Overall Study|Lost to Follow-up|5|||
13140710|NCT02680002|26013075|FG001|Overall Study|Lost to Follow-up|1|||
13140711|NCT02680002|26013076|FG002|Overall Study|Lost to Follow-up|4|||
13140712|NCT02680002|26013077|FG003|Overall Study|Lost to Follow-up|2|||
13140713|NCT02680002|26013078|FG004|Overall Study|Lost to Follow-up|0|||
13140714|NCT02680002|26013079|FG005|Overall Study|Lost to Follow-up|2|||
13140715|NCT02680002|26013074|FG000|Overall Study|Physician Decision|5|||
13140716|NCT02680002|26013075|FG001|Overall Study|Physician Decision|1|||
13140717|NCT02680002|26013076|FG002|Overall Study|Physician Decision|1|||
13140718|NCT02680002|26013077|FG003|Overall Study|Physician Decision|1|||
13140719|NCT02680002|26013078|FG004|Overall Study|Physician Decision|1|||
13140720|NCT02680002|26013079|FG005|Overall Study|Physician Decision|1|||
13140721|NCT02680002|26013074|FG000|Overall Study|Protocol Violation|1|||
13140722|NCT02680002|26013075|FG001|Overall Study|Protocol Violation|0|||
13140723|NCT02680002|26013076|FG002|Overall Study|Protocol Violation|1|||
13140724|NCT02680002|26013077|FG003|Overall Study|Protocol Violation|0|||
13140725|NCT02680002|26013078|FG004|Overall Study|Protocol Violation|1|||
13140726|NCT02680002|26013079|FG005|Overall Study|Protocol Violation|2|||
13140727|NCT02680002|26013074|FG000|Overall Study|Withdrawal by Subject|0|||
13140728|NCT02680002|26013075|FG001|Overall Study|Withdrawal by Subject|0|||
13140729|NCT02680002|26013076|FG002|Overall Study|Withdrawal by Subject|1|||
13140730|NCT02680002|26013077|FG003|Overall Study|Withdrawal by Subject|0|||
13140731|NCT02680002|26013078|FG004|Overall Study|Withdrawal by Subject|2|||
13140732|NCT02680002|26013079|FG005|Overall Study|Withdrawal by Subject|2|||
13140733|NCT02680002|26013074|FG000|Overall Study|Missed Visit 8 (Day 201)|2|||
13140734|NCT02680002|26013075|FG001|Overall Study|Missed Visit 8 (Day 201)|1|||
13140735|NCT02680002|26013076|FG002|Overall Study|Missed Visit 8 (Day 201)|3|||
13140736|NCT02680002|26013077|FG003|Overall Study|Missed Visit 8 (Day 201)|1|||
13140737|NCT02680002|26013078|FG004|Overall Study|Missed Visit 8 (Day 201)|5|||
13140738|NCT02680002|26013079|FG005|Overall Study|Missed Visit 8 (Day 201)|0|||
13140739|NCT02680002|26013074|FG000|Overall Study|Other|0|||
13140740|NCT02680002|26013075|FG001|Overall Study|Other|1|||
13140741|NCT02680002|26013076|FG002|Overall Study|Other|0|||
13140742|NCT02680002|26013077|FG003|Overall Study|Other|0|||
13140743|NCT02680002|26013078|FG004|Overall Study|Other|1|||
13140744|NCT02680002|26013079|FG005|Overall Study|Other|0|||
13140745|NCT02680002|26013074|FG000|Overall Study|Adverse Event|0|||
13140746|NCT02680002|26013075|FG001|Overall Study|Adverse Event|0|||
13140747|NCT02680002|26013076|FG002|Overall Study|Adverse Event|0|||
13140748|NCT02680002|26013077|FG003|Overall Study|Adverse Event|0|||
13140749|NCT02680002|26013078|FG004|Overall Study|Adverse Event|1|||
13140750|NCT02680002|26013079|FG005|Overall Study|Adverse Event|2|||
13140751|NCT02679755|26013119|FG000|Overall Study|Death|0|||
13140752|NCT02679755|26013120|FG001|Overall Study|Death|3|||
13140753|NCT02679755|26013119|FG000|Overall Study|Global deterioration of health status|1|||
13140754|NCT02679755|26013120|FG001|Overall Study|Global deterioration of health status|8|||
13140755|NCT02679755|26013119|FG000|Overall Study|Lost to Follow-up|1|||
13140756|NCT02679755|26013120|FG001|Overall Study|Lost to Follow-up|0|||
13140757|NCT02679755|26013119|FG000|Overall Study|Objective progression or relapse|24|||
13140758|NCT02679755|26013120|FG001|Overall Study|Objective progression or relapse|83|||
13140759|NCT02679755|26013119|FG000|Overall Study|Not defined|0|||
13140760|NCT02679755|26013120|FG001|Overall Study|Not defined|2|||
13140761|NCT02679755|26013119|FG000|Overall Study|Withdrawal by participant|6|||
13140762|NCT02679755|26013120|FG001|Overall Study|Withdrawal by participant|3|||
13140763|NCT02679755|26013119|FG000|Overall Study|Adverse Event|1|||
13140764|NCT02679755|26013120|FG001|Overall Study|Adverse Event|4|||
13140765|NCT02679755|26013119|FG000|Overall Study|Adverse events not related to study drug|1|||
13140766|NCT02679755|26013120|FG001|Overall Study|Adverse events not related to study drug|2|||
13140767|NCT02679729|26013252|FG000|Overall Study|Lost to Follow-up|0|||
13140768|NCT02679729|26013253|FG001|Overall Study|Lost to Follow-up|1|||
13140769|NCT02679729|26013254|FG002|Overall Study|Lost to Follow-up|0|||
13140770|NCT02679729|26013255|FG003|Overall Study|Lost to Follow-up|0|||
13140771|NCT02679729|26013256|FG004|Overall Study|Lost to Follow-up|1|||
13140772|NCT02679729|26013257|FG005|Overall Study|Lost to Follow-up|0|||
13140773|NCT02679729|26013258|FG006|Overall Study|Lost to Follow-up|0|||
13140774|NCT02679729|26013259|FG007|Overall Study|Lost to Follow-up|0|||
13140775|NCT02679729|26013260|FG008|Overall Study|Lost to Follow-up|0|||
13140776|NCT02679729|26013252|FG000|Overall Study|Participant decision|0|||
13140777|NCT02679729|26013253|FG001|Overall Study|Participant decision|1|||
13140778|NCT02679729|26013254|FG002|Overall Study|Participant decision|0|||
13140779|NCT02679729|26013255|FG003|Overall Study|Participant decision|0|||
13140780|NCT02679729|26013256|FG004|Overall Study|Participant decision|0|||
13140781|NCT02679729|26013257|FG005|Overall Study|Participant decision|0|||
13140782|NCT02679729|26013258|FG006|Overall Study|Participant decision|1|||
13140783|NCT02679729|26013259|FG007|Overall Study|Participant decision|0|||
13140784|NCT02679729|26013260|FG008|Overall Study|Participant decision|0|||
13140785|NCT02679573|26013283|FG000|Overall Study|Adverse Event|13|||
13140786|NCT02679573|26013284|FG001|Overall Study|Adverse Event|6|||
13140787|NCT02679573|26013283|FG000|Overall Study|Lack of Efficacy|12|||
13140788|NCT02679573|26013284|FG001|Overall Study|Lack of Efficacy|15|||
13140789|NCT02679573|26013283|FG000|Overall Study|Could not complete required study visits|6|||
13140790|NCT02679573|26013284|FG001|Overall Study|Could not complete required study visits|2|||
13140791|NCT02679573|26013283|FG000|Overall Study|Withdrawal by Subject|2|||
13140792|NCT02679573|26013284|FG001|Overall Study|Withdrawal by Subject|9|||
13140793|NCT02679573|26013283|FG000|Overall Study|Death|2|||
13140794|NCT02679573|26013284|FG001|Overall Study|Death|0|||
13140795|NCT02679573|26013283|FG000|Overall Study|Physician Decision|2|||
13140796|NCT02679573|26013284|FG001|Overall Study|Physician Decision|4|||
13140797|NCT02679573|26013283|FG000|Overall Study|Lost to Follow-up|0|||
13140798|NCT02679573|26013284|FG001|Overall Study|Lost to Follow-up|3|||
13140799|NCT02679287|26013319|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2|||
13140800|NCT02679287|26013320|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1|||
13140801|NCT02679287|26013319|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2|||
13140802|NCT02679287|26013320|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3|||
13140803|NCT02679287|26013319|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0|||
13140804|NCT02679287|26013320|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1|||
13140805|NCT02679287|26013319|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0|||
13140806|NCT02679287|26013320|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1|||
13140807|NCT02679287|26013319|FG000|Period 2|Work/Scheduling Conflict|1|||
13140808|NCT02679287|26013320|FG001|Period 2|Work/Scheduling Conflict|0|||
13140809|NCT02679287|26013319|FG000|Period 2|Disliked Mobile System|2|||
13140810|NCT02679287|26013320|FG001|Period 2|Disliked Mobile System|0|||
13140811|NCT02679287|26013319|FG000|Period 3|Work/Scheduling Conflict|0|||
13140812|NCT02679287|26013320|FG001|Period 3|Work/Scheduling Conflict|1|||
13140813|NCT02679274|26013357|FG000|Overall Study|Withdrawal by Subject|1|||
13140814|NCT02679274|26013358|FG001|Overall Study|Withdrawal by Subject|0|||
13140815|NCT02679235|26013367|FG000|Overall Study|Withdrawal by Subject|3|||
13140816|NCT02679235|26013367|FG000|Overall Study|Adverse Event|1|||
13140817|NCT02679222|26013386|FG000|Overall Study|No time for project|1|||
13140818|NCT02679079|26013428|FG000|Overall Study|Adverse Event|2|||
13140819|NCT02679079|26013429|FG001|Overall Study|Adverse Event|0|||
13140820|NCT02679079|26013430|FG002|Overall Study|Adverse Event|2|||
13140821|NCT02679079|26013428|FG000|Overall Study|Protocol Violation|0|||
13140822|NCT02679079|26013429|FG001|Overall Study|Protocol Violation|1|||
13140823|NCT02679079|26013430|FG002|Overall Study|Protocol Violation|0|||
13140824|NCT02679079|26013428|FG000|Overall Study|Withdrawal by Subject|2|||
13140825|NCT02679079|26013429|FG001|Overall Study|Withdrawal by Subject|1|||
13140826|NCT02679079|26013430|FG002|Overall Study|Withdrawal by Subject|0|||
13140827|NCT02678923|26013451|FG000|Overall Study|Protocol Deviation (Not Dosed)|1|||
13140828|NCT02678923|26013452|FG001|Overall Study|Protocol Deviation (Not Dosed)|3|||
13140829|NCT02678923|26013451|FG000|Overall Study|Withdrawal by Subject|3|||
13140830|NCT02678923|26013452|FG001|Overall Study|Withdrawal by Subject|2|||
13140831|NCT02678923|26013451|FG000|Overall Study|Lost to Follow-up|1|||
13140832|NCT02678923|26013452|FG001|Overall Study|Lost to Follow-up|0|||
13140833|NCT02678923|26013451|FG000|Overall Study|Did Not Return for Study Visits|1|||
13140834|NCT02678923|26013452|FG001|Overall Study|Did Not Return for Study Visits|0|||
13140835|NCT02678676|26013467|FG000|Overall Study|Death|619|||
13140836|NCT02678676|26013468|FG001|Overall Study|Death|649|||
13140837|NCT02678676|26013467|FG000|Overall Study|Withdrawal by Subject|13|||
13140838|NCT02678676|26013468|FG001|Overall Study|Withdrawal by Subject|5|||
13140839|NCT02678676|26013467|FG000|Overall Study|Lost to Follow-up|171|||
13140840|NCT02678676|26013468|FG001|Overall Study|Lost to Follow-up|151|||
13140841|NCT02678676|26013467|FG000|Overall Study|Unconfirmed for lost to follow-up|85|||
13140842|NCT02678676|26013468|FG001|Overall Study|Unconfirmed for lost to follow-up|67|||
13140843|NCT02678416|26013492|FG000|Part 1|Withdrawal by Subject|1|||
13140844|NCT02678416|26013492|FG000|Part 2|Adverse Event|2|||
13140845|NCT02678416|26013492|FG000|Part 2|Withdrawal by Subject|1|||
13140846|NCT02678390|26013513|FG000|AE (1 Day)|Withdrawal by Subject|0|||
13140847|NCT02678390|26013514|FG001|AE (1 Day)|Withdrawal by Subject|1|||
13140848|NCT02678351|26013523|FG000|Overall Study|Withdrawal by Subject|1|||
13140849|NCT02678286|26013560|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2|||
13140850|NCT02678286|26013561|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1|||
13140851|NCT02678286|26013560|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0|||
13140852|NCT02678286|26013561|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1|||
13140853|NCT02678286|26013560|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1|||
13140854|NCT02678286|26013561|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0|||
13140855|NCT02678286|26013560|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3|||
13140856|NCT02678286|26013561|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2|||
13140857|NCT02678286|26013560|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
13140858|NCT02678286|26013561|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
13140859|NCT02678247|26013596|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0|||
13140860|NCT02678247|26013597|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2|||
13140861|NCT02678247|26013596|FG000|First Intervention (7 Weeks)|Adverse Event|1|||
13140862|NCT02678247|26013597|FG001|First Intervention (7 Weeks)|Adverse Event|2|||
13140863|NCT02678247|26013596|FG000|First Intervention (7 Weeks)|Physician Decision|1|||
13140864|NCT02678247|26013597|FG001|First Intervention (7 Weeks)|Physician Decision|0|||
13140865|NCT02678247|26013596|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
13140866|NCT02678247|26013597|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
13140867|NCT02678247|26013596|FG000|Second Intervention (7 Weeks)|Adverse Event|2|||
13140868|NCT02678247|26013597|FG001|Second Intervention (7 Weeks)|Adverse Event|1|||
13140869|NCT02678247|26013596|FG000|Second Intervention (7 Weeks)|Physician Decision|1|||
13140870|NCT02678247|26013597|FG001|Second Intervention (7 Weeks)|Physician Decision|0|||
13140871|NCT02678000|26013649|FG000|PART 2|Adverse Event|0|||
13140872|NCT02678000|26013650|FG001|PART 2|Adverse Event|0|||
13140873|NCT02678000|26013651|FG002|PART 2|Adverse Event|2|||
13140874|NCT02678000|26013652|FG003|PART 2|Adverse Event|1|||
13140875|NCT02678000|26013653|FG004|PART 2|Adverse Event|0|||
13140876|NCT02678000|26013649|FG000|PART 2|Withdrawal by Subject|0|||
13140877|NCT02678000|26013650|FG001|PART 2|Withdrawal by Subject|0|||
13140878|NCT02678000|26013651|FG002|PART 2|Withdrawal by Subject|1|||
13140879|NCT02678000|26013652|FG003|PART 2|Withdrawal by Subject|0|||
13140880|NCT02678000|26013653|FG004|PART 2|Withdrawal by Subject|0|||
13140881|NCT02677987|26013694|FG000|Overall Study|Withdrawal by Subject|3|||
13140882|NCT02677987|26013695|FG001|Overall Study|Withdrawal by Subject|0|||
13140883|NCT02677987|26013694|FG000|Overall Study|Lost to Follow-up|1|||
13140884|NCT02677987|26013695|FG001|Overall Study|Lost to Follow-up|0|||
13140885|NCT02677844|26013735|FG000|Period 3|Withdrawal by Subject|0|||
13140886|NCT02677844|26013736|FG001|Period 3|Withdrawal by Subject|0|||
13140887|NCT02677844|26013737|FG002|Period 3|Withdrawal by Subject|0|||
13140888|NCT02677844|26013738|FG003|Period 3|Withdrawal by Subject|1|||
13140889|NCT02677844|26013739|FG004|Period 3|Withdrawal by Subject|0|||
13140890|NCT02677844|26013740|FG005|Period 3|Withdrawal by Subject|0|||
13140891|NCT02677844|26013741|FG006|Period 3|Withdrawal by Subject|0|||
13140892|NCT02677714|26013759|FG000|Overall Study|Withdrawal by Subject|2|||
13140893|NCT02677714|26013760|FG001|Overall Study|Withdrawal by Subject|0|||
13140894|NCT02677324|26013775|FG000|Overall Study|Disease Progression|6|||
13140895|NCT02677324|26013775|FG000|Overall Study|Inability to Swallow pills|1|||
13140896|NCT02677324|26013775|FG000|Overall Study|Non-compliance|1|||
13140897|NCT02677324|26013775|FG000|Overall Study|Lack of Efficacy|1|||
13140898|NCT02677324|26013775|FG000|Overall Study|Medical insurance coverage|1|||
13140899|NCT02677324|26013775|FG000|Overall Study|Adverse Event|1|||
13140900|NCT02677324|26013775|FG000|Overall Study|IgM Myeloma diagnosis|1|||
13140901|NCT02677220|26013783|FG000|Overall Study|Adverse Event|1|||
13140902|NCT02677116|26013881|FG000|Overall Study|Adverse Event|0|||
13140903|NCT02677116|26013882|FG001|Overall Study|Adverse Event|1|||
13140904|NCT02677116|26013883|FG002|Overall Study|Adverse Event|0|||
13140905|NCT02677116|26013884|FG003|Overall Study|Adverse Event|0|||
13140906|NCT02677116|26013885|FG004|Overall Study|Adverse Event|0|||
13140907|NCT02677116|26013886|FG005|Overall Study|Adverse Event|1|||
13140908|NCT02677116|26013887|FG006|Overall Study|Adverse Event|1|||
13140909|NCT02677116|26013888|FG007|Overall Study|Adverse Event|0|||
13140910|NCT02677116|26013889|FG008|Overall Study|Adverse Event|0|||
13140911|NCT02677116|26013881|FG000|Overall Study|Physician Decision|0|||
13140912|NCT02677116|26013882|FG001|Overall Study|Physician Decision|2|||
13140913|NCT02677116|26013883|FG002|Overall Study|Physician Decision|3|||
13140914|NCT02677116|26013884|FG003|Overall Study|Physician Decision|2|||
13140915|NCT02677116|26013885|FG004|Overall Study|Physician Decision|1|||
13140916|NCT02677116|26013886|FG005|Overall Study|Physician Decision|3|||
13140917|NCT02677116|26013887|FG006|Overall Study|Physician Decision|1|||
13140918|NCT02677116|26013888|FG007|Overall Study|Physician Decision|1|||
13140919|NCT02677116|26013889|FG008|Overall Study|Physician Decision|2|||
13140920|NCT02677116|26013881|FG000|Overall Study|Withdrawal by parent or guardian|2|||
13140921|NCT02677116|26013882|FG001|Overall Study|Withdrawal by parent or guardian|1|||
13140922|NCT02677116|26013883|FG002|Overall Study|Withdrawal by parent or guardian|0|||
13140923|NCT02677116|26013884|FG003|Overall Study|Withdrawal by parent or guardian|1|||
13140924|NCT02677116|26013885|FG004|Overall Study|Withdrawal by parent or guardian|0|||
13140925|NCT02677116|26013886|FG005|Overall Study|Withdrawal by parent or guardian|0|||
13140926|NCT02677116|26013887|FG006|Overall Study|Withdrawal by parent or guardian|2|||
13140927|NCT02677116|26013888|FG007|Overall Study|Withdrawal by parent or guardian|1|||
13140928|NCT02677116|26013889|FG008|Overall Study|Withdrawal by parent or guardian|0|||
13140929|NCT02677116|26013881|FG000|Overall Study|Withdrawal by Subject|1|||
13140930|NCT02677116|26013882|FG001|Overall Study|Withdrawal by Subject|0|||
13140931|NCT02677116|26013883|FG002|Overall Study|Withdrawal by Subject|0|||
13140932|NCT02677116|26013884|FG003|Overall Study|Withdrawal by Subject|0|||
13140933|NCT02677116|26013885|FG004|Overall Study|Withdrawal by Subject|0|||
13140934|NCT02677116|26013886|FG005|Overall Study|Withdrawal by Subject|0|||
13140935|NCT02677116|26013887|FG006|Overall Study|Withdrawal by Subject|0|||
13140936|NCT02677116|26013888|FG007|Overall Study|Withdrawal by Subject|0|||
13140937|NCT02677116|26013889|FG008|Overall Study|Withdrawal by Subject|0|||
13140938|NCT02676895|26013940|FG000|Overall Study|Administrative reason|1|||
13140939|NCT02676895|26013941|FG001|Overall Study|Administrative reason|0|||
13140940|NCT02676895|26013942|FG002|Overall Study|Administrative reason|0|||
13140941|NCT02676895|26013940|FG000|Overall Study|Protocol Violation|1|||
13140942|NCT02676895|26013941|FG001|Overall Study|Protocol Violation|0|||
13140943|NCT02676895|26013942|FG002|Overall Study|Protocol Violation|0|||
13140944|NCT02676895|26013940|FG000|Overall Study|Adverse Event|0|||
13140945|NCT02676895|26013941|FG001|Overall Study|Adverse Event|3|||
13140946|NCT02676895|26013942|FG002|Overall Study|Adverse Event|1|||
13140947|NCT02676895|26013940|FG000|Overall Study|Lost to Follow-up|0|||
13140948|NCT02676895|26013941|FG001|Overall Study|Lost to Follow-up|0|||
13140949|NCT02676895|26013942|FG002|Overall Study|Lost to Follow-up|1|||
13140950|NCT02676895|26013940|FG000|Overall Study|Withdrawal by Subject|0|||
13140951|NCT02676895|26013941|FG001|Overall Study|Withdrawal by Subject|0|||
13140952|NCT02676895|26013942|FG002|Overall Study|Withdrawal by Subject|1|||
13140953|NCT02676882|26013955|FG000|Overall Study|Adverse Event|1|||
13140954|NCT02676882|26013956|FG001|Overall Study|Adverse Event|0|||
13140955|NCT02676882|26013955|FG000|Overall Study|Lost to Follow-up|1|||
13140956|NCT02676882|26013956|FG001|Overall Study|Lost to Follow-up|0|||
13140957|NCT02676882|26013955|FG000|Overall Study|Withdrawal by Subject|1|||
13140958|NCT02676882|26013956|FG001|Overall Study|Withdrawal by Subject|2|||
13140959|NCT02676778|26014009|FG000|Overall Study|Disease Progression|7|||
13140960|NCT02676778|26014010|FG001|Overall Study|Disease Progression|3|||
13140961|NCT02676778|26014011|FG002|Overall Study|Disease Progression|1|||
13140962|NCT02676778|26014009|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1|||
13140963|NCT02676778|26014010|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1|||
13140964|NCT02676778|26014011|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0|||
13140965|NCT02676778|26014009|FG000|Overall Study|Withdrawal by Subject|3|||
13140966|NCT02676778|26014010|FG001|Overall Study|Withdrawal by Subject|2|||
13140967|NCT02676778|26014011|FG002|Overall Study|Withdrawal by Subject|0|||
13140968|NCT02676778|26014009|FG000|Overall Study|Other|4|||
13140969|NCT02676778|26014010|FG001|Overall Study|Other|3|||
13140970|NCT02676778|26014011|FG002|Overall Study|Other|0|||
13140971|NCT02676778|26014009|FG000|Overall Study|Adverse Event|2|||
13140972|NCT02676778|26014010|FG001|Overall Study|Adverse Event|3|||
13140973|NCT02676778|26014011|FG002|Overall Study|Adverse Event|0|||
13140974|NCT02676765|26014030|FG000|Overall Study|Lost to Follow-up|0|||
13140975|NCT02676765|26014031|FG001|Overall Study|Lost to Follow-up|1|||
13140976|NCT02676466|26014122|FG000|Overall Study|Death|0|||
13140977|NCT02676466|26014123|FG001|Overall Study|Death|2|||
13140978|NCT02676466|26014124|FG002|Overall Study|Death|1|||
13140979|NCT02676466|26014125|FG003|Overall Study|Death|0|||
13140980|NCT02676466|26014126|FG004|Overall Study|Death|0|||
13140981|NCT02676466|26014127|FG005|Overall Study|Death|0|||
13140982|NCT02676466|26014128|FG006|Overall Study|Death|0|||
13140983|NCT02676466|26014129|FG007|Overall Study|Death|0|||
13140984|NCT02676466|26014122|FG000|Overall Study|Withdrawal by Subject|4|||
13140985|NCT02676466|26014123|FG001|Overall Study|Withdrawal by Subject|3|||
13140986|NCT02676466|26014124|FG002|Overall Study|Withdrawal by Subject|1|||
13140987|NCT02676466|26014125|FG003|Overall Study|Withdrawal by Subject|0|||
13140988|NCT02676466|26014126|FG004|Overall Study|Withdrawal by Subject|3|||
13140989|NCT02676466|26014127|FG005|Overall Study|Withdrawal by Subject|1|||
13140990|NCT02676466|26014128|FG006|Overall Study|Withdrawal by Subject|1|||
13140991|NCT02676466|26014129|FG007|Overall Study|Withdrawal by Subject|1|||
13140992|NCT02675998|26014156|FG000|8-Week Treatment Period|Adverse Event|6|||
13140993|NCT02675998|26014157|FG001|8-Week Treatment Period|Adverse Event|5|||
13140994|NCT02675998|26014158|FG002|8-Week Treatment Period|Adverse Event|6|||
13140995|NCT02675998|26014159|FG003|8-Week Treatment Period|Adverse Event|0|||
13140996|NCT02675998|26014156|FG000|8-Week Treatment Period|Withdrawal by Subject|3|||
13140997|NCT02675998|26014157|FG001|8-Week Treatment Period|Withdrawal by Subject|3|||
13140998|NCT02675998|26014158|FG002|8-Week Treatment Period|Withdrawal by Subject|3|||
13140999|NCT02675998|26014159|FG003|8-Week Treatment Period|Withdrawal by Subject|0|||
13141000|NCT02675998|26014156|FG000|8-Week Treatment Period|Lack of Efficacy|2|||
13141001|NCT02675998|26014157|FG001|8-Week Treatment Period|Lack of Efficacy|5|||
13141002|NCT02675998|26014158|FG002|8-Week Treatment Period|Lack of Efficacy|3|||
13141003|NCT02675998|26014159|FG003|8-Week Treatment Period|Lack of Efficacy|0|||
13141004|NCT02675998|26014156|FG000|8-Week Treatment Period|Physician Decision|1|||
13141005|NCT02675998|26014157|FG001|8-Week Treatment Period|Physician Decision|0|||
13141006|NCT02675998|26014158|FG002|8-Week Treatment Period|Physician Decision|2|||
13141007|NCT02675998|26014159|FG003|8-Week Treatment Period|Physician Decision|0|||
13141008|NCT02675998|26014156|FG000|8-Week Treatment Period|GI side Effects|1|||
13141009|NCT02675998|26014157|FG001|8-Week Treatment Period|GI side Effects|4|||
13141010|NCT02675998|26014158|FG002|8-Week Treatment Period|GI side Effects|2|||
13141011|NCT02675998|26014159|FG003|8-Week Treatment Period|GI side Effects|0|||
13141012|NCT02675998|26014156|FG000|8-Week Treatment Period|Protocol Violation|1|||
13141013|NCT02675998|26014157|FG001|8-Week Treatment Period|Protocol Violation|1|||
13141014|NCT02675998|26014158|FG002|8-Week Treatment Period|Protocol Violation|1|||
13141015|NCT02675998|26014159|FG003|8-Week Treatment Period|Protocol Violation|0|||
13141016|NCT02675998|26014156|FG000|8-Week Treatment Period|Other|3|||
13141017|NCT02675998|26014157|FG001|8-Week Treatment Period|Other|1|||
13141018|NCT02675998|26014158|FG002|8-Week Treatment Period|Other|2|||
13141019|NCT02675998|26014159|FG003|8-Week Treatment Period|Other|0|||
13141020|NCT02675998|26014156|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0|||
13141021|NCT02675998|26014157|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
13141022|NCT02675998|26014158|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
13141023|NCT02675998|26014159|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3|||
13141024|NCT02675998|26014156|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0|||
13141025|NCT02675998|26014157|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0|||
13141026|NCT02675998|26014158|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1|||
13141027|NCT02675998|26014159|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3|||
13141028|NCT02675998|26014156|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
13141029|NCT02675998|26014157|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
13141030|NCT02675998|26014158|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
13141031|NCT02675998|26014159|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1|||
13141032|NCT02675998|26014156|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1|||
13141033|NCT02675998|26014157|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0|||
13141034|NCT02675998|26014158|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0|||
13141035|NCT02675998|26014159|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0|||
13141036|NCT02675998|26014156|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
13141037|NCT02675998|26014157|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
13141038|NCT02675998|26014158|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
13141039|NCT02675998|26014159|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1|||
13141040|NCT02675907|26014196|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
13141041|NCT02675907|26014197|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
13141042|NCT02675907|26014196|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
13141043|NCT02675907|26014197|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
13141044|NCT02675907|26014196|FG000|Study Overall|Lack of Efficacy|1|||
13141045|NCT02675907|26014197|FG001|Study Overall|Lack of Efficacy|0|||
13141046|NCT02675907|26014196|FG000|Study Overall|Withdrawal by Subject|2|||
13141047|NCT02675907|26014197|FG001|Study Overall|Withdrawal by Subject|2|||
13141048|NCT02675907|26014196|FG000|Study Overall|Lost to Follow-up|0|||
13141049|NCT02675907|26014197|FG001|Study Overall|Lost to Follow-up|2|||
13141050|NCT02675634|26014212|FG000|Test Period 1|Adverse Event|0|||
13141051|NCT02675634|26014213|FG001|Test Period 1|Adverse Event|1|||
13141052|NCT02675634|26014214|FG002|Test Period 1|Adverse Event|0|||
13141053|NCT02675634|26014215|FG003|Test Period 1|Adverse Event|1|||
13141054|NCT02675634|26014216|FG004|Test Period 1|Adverse Event|0|||
13141055|NCT02675634|26014217|FG005|Test Period 1|Adverse Event|0|||
13141056|NCT02675634|26014212|FG000|Test Period 1|Device deficiency that did not lead to A|0|||
13141057|NCT02675634|26014213|FG001|Test Period 1|Device deficiency that did not lead to A|0|||
13141058|NCT02675634|26014214|FG002|Test Period 1|Device deficiency that did not lead to A|1|||
13141059|NCT02675634|26014215|FG003|Test Period 1|Device deficiency that did not lead to A|0|||
13141060|NCT02675634|26014216|FG004|Test Period 1|Device deficiency that did not lead to A|0|||
13141061|NCT02675634|26014217|FG005|Test Period 1|Device deficiency that did not lead to A|0|||
13141062|NCT02675634|26014212|FG000|Test Period 2|Lack of Efficacy|1|||
13141063|NCT02675634|26014213|FG001|Test Period 2|Lack of Efficacy|0|||
13141064|NCT02675634|26014214|FG002|Test Period 2|Lack of Efficacy|0|||
13141065|NCT02675634|26014215|FG003|Test Period 2|Lack of Efficacy|0|||
13141066|NCT02675634|26014216|FG004|Test Period 2|Lack of Efficacy|0|||
13141067|NCT02675634|26014217|FG005|Test Period 2|Lack of Efficacy|0|||
13141068|NCT02675634|26014212|FG000|Test Period 2|Adverse Event|0|||
13141069|NCT02675634|26014213|FG001|Test Period 2|Adverse Event|0|||
13141070|NCT02675634|26014214|FG002|Test Period 2|Adverse Event|0|||
13141071|NCT02675634|26014215|FG003|Test Period 2|Adverse Event|0|||
13141072|NCT02675634|26014216|FG004|Test Period 2|Adverse Event|0|||
13141073|NCT02675634|26014217|FG005|Test Period 2|Adverse Event|1|||
13141074|NCT02675517|26014228|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8|||
13141075|NCT02675517|26014228|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151|||
13141076|NCT02675426|26014279|FG000|Overall Study|Adverse Event|6|||
13141077|NCT02675426|26014280|FG001|Overall Study|Adverse Event|2|||
13141078|NCT02675426|26014281|FG002|Overall Study|Adverse Event|9|||
13141079|NCT02675426|26014279|FG000|Overall Study|Withdrawal by Subject|3|||
13141080|NCT02675426|26014280|FG001|Overall Study|Withdrawal by Subject|5|||
13141081|NCT02675426|26014281|FG002|Overall Study|Withdrawal by Subject|5|||
13141082|NCT02675426|26014279|FG000|Overall Study|Lost to Follow-up|1|||
13141083|NCT02675426|26014280|FG001|Overall Study|Lost to Follow-up|0|||
13091529|NCT03736785|25824668|FG000|Overall Study|Adverse Event|1|||
13091530|NCT03736785|25824669|FG001|Overall Study|Adverse Event|1|||
13091531|NCT03736785|25824670|FG002|Overall Study|Adverse Event|1|||
13091532|NCT03736785|25824668|FG000|Overall Study|Death|1|||
13091533|NCT03736785|25824669|FG001|Overall Study|Death|0|||
13091534|NCT03736785|25824670|FG002|Overall Study|Death|1|||
13091535|NCT03736785|25824668|FG000|Overall Study|Lost to Follow-up|0|||
13091536|NCT03736785|25824669|FG001|Overall Study|Lost to Follow-up|2|||
13091537|NCT03736785|25824670|FG002|Overall Study|Lost to Follow-up|3|||
13091538|NCT03736785|25824668|FG000|Overall Study|Non compliance with study drug|1|||
13091539|NCT03736785|25824669|FG001|Overall Study|Non compliance with study drug|1|||
13091540|NCT03736785|25824670|FG002|Overall Study|Non compliance with study drug|0|||
13091541|NCT03736785|25824668|FG000|Overall Study|Physician Decision|0|||
13091542|NCT03736785|25824669|FG001|Overall Study|Physician Decision|1|||
13091543|NCT03736785|25824670|FG002|Overall Study|Physician Decision|1|||
13091544|NCT03736785|25824668|FG000|Overall Study|Protocol Violation|1|||
13091545|NCT03736785|25824669|FG001|Overall Study|Protocol Violation|4|||
13091546|NCT03736785|25824670|FG002|Overall Study|Protocol Violation|3|||
13091547|NCT03736785|25824668|FG000|Overall Study|Sponsor Decision|1|||
13091548|NCT03736785|25824669|FG001|Overall Study|Sponsor Decision|0|||
13091549|NCT03736785|25824670|FG002|Overall Study|Sponsor Decision|0|||
13091550|NCT03736785|25824668|FG000|Overall Study|Unknown/Missing data|3|||
13091551|NCT03736785|25824669|FG001|Overall Study|Unknown/Missing data|2|||
13091552|NCT03736785|25824670|FG002|Overall Study|Unknown/Missing data|1|||
13091553|NCT03736785|25824668|FG000|Overall Study|Withdrawal by Subject|9|||
13091554|NCT03736785|25824669|FG001|Overall Study|Withdrawal by Subject|6|||
13091555|NCT03736785|25824670|FG002|Overall Study|Withdrawal by Subject|4|||
13141084|NCT02675426|26014281|FG002|Overall Study|Lost to Follow-up|2|||
13141085|NCT02675426|26014279|FG000|Overall Study|Other|3|||
13141086|NCT02675426|26014280|FG001|Overall Study|Other|1|||
13141087|NCT02675426|26014281|FG002|Overall Study|Other|2|||
13141088|NCT02675231|26014325|FG000|Overall Study|Withdrawal by Subject|1|||
13141089|NCT02675231|26014326|FG001|Overall Study|Withdrawal by Subject|3|||
13141090|NCT02675231|26014327|FG002|Overall Study|Withdrawal by Subject|1|||
13141091|NCT02675231|26014325|FG000|Overall Study|Lost to Follow-up|2|||
13141092|NCT02675231|26014326|FG001|Overall Study|Lost to Follow-up|2|||
13091556|NCT03736031|25824689|FG000|Overall Study|Death|2|||
13091557|NCT03736031|25824690|FG001|Overall Study|Death|4|||
13091558|NCT03736031|25824689|FG000|Overall Study|Lost to Follow-up|21|||
13091559|NCT03736031|25824690|FG001|Overall Study|Lost to Follow-up|2|||
13091560|NCT03736031|25824689|FG000|Overall Study|Withdrawal by Subject|9|||
13091561|NCT03736031|25824690|FG001|Overall Study|Withdrawal by Subject|0|||
13091562|NCT03735498|25824697|FG000|Overall Study|Withdrawal by Subject|5|||
13091563|NCT03735498|25824697|FG000|Overall Study|one participant only completed 5 of 6 sessions|1|||
13091564|NCT03734991|25824718|FG000|Overall Study|Adverse Event|4|||
13091565|NCT03734991|25824719|FG001|Overall Study|Adverse Event|0|||
13091566|NCT03734991|25824718|FG000|Overall Study|Lost to Follow-up|4|||
13091567|NCT03734991|25824719|FG001|Overall Study|Lost to Follow-up|0|||
13091568|NCT03734991|25824718|FG000|Overall Study|Physician Decision|0|||
13091569|NCT03734991|25824719|FG001|Overall Study|Physician Decision|1|||
13091570|NCT03734991|25824718|FG000|Overall Study|Pregnancy|1|||
13091571|NCT03734991|25824719|FG001|Overall Study|Pregnancy|0|||
13091572|NCT03734991|25824718|FG000|Overall Study|Withdrawal by Subject|6|||
13091573|NCT03734991|25824719|FG001|Overall Study|Withdrawal by Subject|3|||
13091574|NCT03734991|25824718|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49|||
13091575|NCT03734991|25824719|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41|||
13091576|NCT03734991|25824718|FG000|Overall Study|Other|2|||
13091577|NCT03734991|25824719|FG001|Overall Study|Other|2|||
13091578|NCT03734679|25824731|FG000|Overall Study|Missed Visit|1|||
13091579|NCT03733899|25824764|FG000|Period 1|Protocol Violation|0|||
13091580|NCT03733899|25824765|FG001|Period 1|Protocol Violation|0|||
13091581|NCT03733899|25824766|FG002|Period 1|Protocol Violation|0|||
13091582|NCT03733899|25824767|FG003|Period 1|Protocol Violation|0|||
13091583|NCT03733899|25824768|FG004|Period 1|Protocol Violation|0|||
13091584|NCT03733899|25824769|FG005|Period 1|Protocol Violation|1|||
13091585|NCT03733899|25824764|FG000|Period 2|Unscuccessful Treatment|0|||
13091586|NCT03733899|25824765|FG001|Period 2|Unscuccessful Treatment|1|||
13091587|NCT03733899|25824766|FG002|Period 2|Unscuccessful Treatment|0|||
13091588|NCT03733899|25824767|FG003|Period 2|Unscuccessful Treatment|0|||
13091589|NCT03733899|25824768|FG004|Period 2|Unscuccessful Treatment|0|||
13091590|NCT03733899|25824769|FG005|Period 2|Unscuccessful Treatment|0|||
13091591|NCT03733899|25824764|FG000|Period 3|Withdrawal by Subject|1|||
13091592|NCT03733899|25824765|FG001|Period 3|Withdrawal by Subject|0|||
13091593|NCT03733899|25824766|FG002|Period 3|Withdrawal by Subject|0|||
13091594|NCT03733899|25824767|FG003|Period 3|Withdrawal by Subject|0|||
13091595|NCT03733899|25824768|FG004|Period 3|Withdrawal by Subject|0|||
13091596|NCT03733899|25824769|FG005|Period 3|Withdrawal by Subject|0|||
13091597|NCT03733470|25824782|FG000|Overall Study|PI Decision|1|||
13091598|NCT03733470|25824783|FG001|Overall Study|PI Decision|1|||
13091599|NCT03733444|25824909|FG000|Overall Study|Adverse Event|8|||
13141093|NCT02675231|26014327|FG002|Overall Study|Lost to Follow-up|2|||
13141094|NCT02675231|26014325|FG000|Overall Study|On study treatment/follow up|23|||
13141095|NCT02675231|26014326|FG001|Overall Study|On study treatment/follow up|31|||
13141096|NCT02675231|26014327|FG002|Overall Study|On study treatment/follow up|23|||
13141097|NCT02675075|26014367|FG000|Overall Study|Lost to Follow-up|3|||
13141098|NCT02675075|26014368|FG001|Overall Study|Lost to Follow-up|0|||
13141099|NCT02674854|26014386|FG000|Overall Study|Adverse Event|17|||
13141100|NCT02674854|26014387|FG001|Overall Study|Adverse Event|15|||
13141101|NCT02674854|26014388|FG002|Overall Study|Adverse Event|5|||
13141102|NCT02674854|26014386|FG000|Overall Study|Withdrawal by Subject|1|||
13141103|NCT02674854|26014387|FG001|Overall Study|Withdrawal by Subject|5|||
13141104|NCT02674854|26014388|FG002|Overall Study|Withdrawal by Subject|4|||
13141105|NCT02674854|26014386|FG000|Overall Study|No-compliant subject|1|||
13141106|NCT02674854|26014387|FG001|Overall Study|No-compliant subject|0|||
13141107|NCT02674854|26014388|FG002|Overall Study|No-compliant subject|1|||
13141108|NCT02674854|26014386|FG000|Overall Study|Lost to Follow-up|1|||
13141109|NCT02674854|26014387|FG001|Overall Study|Lost to Follow-up|0|||
13141110|NCT02674854|26014388|FG002|Overall Study|Lost to Follow-up|2|||
13141111|NCT02674854|26014386|FG000|Overall Study|Lack of Efficacy|0|||
13141112|NCT02674854|26014387|FG001|Overall Study|Lack of Efficacy|3|||
13141113|NCT02674854|26014388|FG002|Overall Study|Lack of Efficacy|0|||
13141114|NCT02674854|26014386|FG000|Overall Study|Disallowed Concurrent Medication|2|||
13141115|NCT02674854|26014387|FG001|Overall Study|Disallowed Concurrent Medication|2|||
13141116|NCT02674854|26014388|FG002|Overall Study|Disallowed Concurrent Medication|0|||
13141117|NCT02674854|26014386|FG000|Overall Study|Protocol Violation|1|||
13141118|NCT02674854|26014387|FG001|Overall Study|Protocol Violation|1|||
13141119|NCT02674854|26014388|FG002|Overall Study|Protocol Violation|2|||
13307574|NCT01284621|26529089|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
13091600|NCT03733444|25824910|FG001|Overall Study|Adverse Event|10|||
13091601|NCT03733444|25824911|FG002|Overall Study|Adverse Event|5|||
13141120|NCT02674854|26014386|FG000|Overall Study|Death|0|||
13141121|NCT02674854|26014387|FG001|Overall Study|Death|1|||
13141122|NCT02674854|26014388|FG002|Overall Study|Death|0|||
13091602|NCT03733444|25824909|FG000|Overall Study|Death|20|||
13091603|NCT03733444|25824910|FG001|Overall Study|Death|19|||
13141123|NCT02674854|26014386|FG000|Overall Study|Subject missed V6.2|1|||
13141124|NCT02674854|26014387|FG001|Overall Study|Subject missed V6.2|0|||
13141125|NCT02674854|26014388|FG002|Overall Study|Subject missed V6.2|0|||
13141126|NCT02674750|26014412|FG000|Overall Study|Death|4|||
13141127|NCT02674750|26014413|FG001|Overall Study|Death|5|||
13141128|NCT02674750|26014414|FG002|Overall Study|Death|8|||
13141129|NCT02674750|26014412|FG000|Overall Study|Lost to Follow-up|0|||
13141130|NCT02674750|26014413|FG001|Overall Study|Lost to Follow-up|8|||
13141131|NCT02674750|26014414|FG002|Overall Study|Lost to Follow-up|0|||
13141132|NCT02674750|26014412|FG000|Overall Study|Lack of Efficacy|1|||
13141133|NCT02674750|26014413|FG001|Overall Study|Lack of Efficacy|17|||
13141134|NCT02674750|26014414|FG002|Overall Study|Lack of Efficacy|3|||
13141135|NCT02674750|26014412|FG000|Overall Study|Withdrawal by Subject|0|||
13141136|NCT02674750|26014413|FG001|Overall Study|Withdrawal by Subject|7|||
13141137|NCT02674750|26014414|FG002|Overall Study|Withdrawal by Subject|1|||
13141138|NCT02674750|26014412|FG000|Overall Study|Other|0|||
13141139|NCT02674750|26014413|FG001|Overall Study|Other|8|||
13141140|NCT02674750|26014414|FG002|Overall Study|Other|0|||
13141141|NCT02674685|26014430|FG000|Overall Study|Protocol Violation|4|||
13141142|NCT02674633|26014457|FG000|Overall Study|Lost to Follow-up|3|||
13141143|NCT02674633|26014458|FG001|Overall Study|Lost to Follow-up|2|||
13141144|NCT02674633|26014457|FG000|Overall Study|Physician Decision|1|||
13141145|NCT02674633|26014458|FG001|Overall Study|Physician Decision|0|||
13141146|NCT02674633|26014457|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
13141147|NCT02674633|26014458|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
13141148|NCT02674568|26014483|FG000|Overall Study|Withdrawal by Subject|5|||
13141149|NCT02674568|26014483|FG000|Overall Study|Death|303|||
13141150|NCT02674568|26014483|FG000|Overall Study|Physician Decision|2|||
13141151|NCT02674568|26014483|FG000|Overall Study|Lost to Follow-up|9|||
13141152|NCT02674568|26014483|FG000|Overall Study|Other, Not Specified|20|||
13141153|NCT02674477|26014500|FG000|Overall Study|Protocol Violation|8|||
13141154|NCT02674477|26014501|FG001|Overall Study|Protocol Violation|2|||
13141155|NCT02674399|26014544|FG000|Overall Study|Lost to Follow-up|2|||
13141156|NCT02674399|26014545|FG001|Overall Study|Lost to Follow-up|0|||
13141157|NCT02674386|26014608|FG000|Overall Study|Lost to Follow-up|0|||
13141158|NCT02674386|26014609|FG001|Overall Study|Lost to Follow-up|1|||
13141159|NCT02674386|26014610|FG002|Overall Study|Lost to Follow-up|1|||
13141160|NCT02674386|26014608|FG000|Overall Study|Withdrawal by Subject|0|||
13141161|NCT02674386|26014609|FG001|Overall Study|Withdrawal by Subject|4|||
13141162|NCT02674386|26014610|FG002|Overall Study|Withdrawal by Subject|0|||
13141163|NCT02674386|26014608|FG000|Overall Study|Other|0|||
13141164|NCT02674386|26014609|FG001|Overall Study|Other|1|||
13141165|NCT02674386|26014610|FG002|Overall Study|Other|0|||
13141166|NCT02674386|26014608|FG000|Overall Study|Enrolled but not evaluated|0|||
13141167|NCT02674386|26014609|FG001|Overall Study|Enrolled but not evaluated|4|||
13141168|NCT02674386|26014610|FG002|Overall Study|Enrolled but not evaluated|0|||
13141169|NCT02674334|26014625|FG000|Overall Study|Lost to Follow-up|5|||
13141170|NCT02674334|26014626|FG001|Overall Study|Lost to Follow-up|3|||
13141171|NCT02674334|26014625|FG000|Overall Study|participant difficulty breathing|1|||
13141172|NCT02674334|26014626|FG001|Overall Study|participant difficulty breathing|0|||
13141173|NCT02674334|26014625|FG000|Overall Study|NIRS not recording|1|||
13141174|NCT02674334|26014626|FG001|Overall Study|NIRS not recording|0|||
13141175|NCT02674204|26014667|FG000|Overall Study|Adverse Event|1|||
13141176|NCT02674204|26014668|FG001|Overall Study|Adverse Event|0|||
13141177|NCT02673697|26014683|FG000|Overall Study|Adverse Event|2|||
13141178|NCT02673697|26014684|FG001|Overall Study|Adverse Event|0|||
13141179|NCT02673697|26014683|FG000|Overall Study|Death|32|||
13141180|NCT02673697|26014684|FG001|Overall Study|Death|24|||
13141181|NCT02673697|26014683|FG000|Overall Study|Lost to Follow-up|5|||
13141182|NCT02673697|26014684|FG001|Overall Study|Lost to Follow-up|2|||
13141183|NCT02673697|26014683|FG000|Overall Study|Physician Decision|2|||
13141184|NCT02673697|26014684|FG001|Overall Study|Physician Decision|1|||
13141185|NCT02673697|26014683|FG000|Overall Study|Withdrawal by Subject|10|||
13141186|NCT02673697|26014684|FG001|Overall Study|Withdrawal by Subject|7|||
13141187|NCT02673697|26014683|FG000|Overall Study|Change subj medical status|1|||
13141188|NCT02673697|26014684|FG001|Overall Study|Change subj medical status|2|||
13141189|NCT02673697|26014683|FG000|Overall Study|Explant|10|||
13141190|NCT02673697|26014684|FG001|Overall Study|Explant|5|||
13141191|NCT02673697|26014683|FG000|Overall Study|Sponsor Decision to stop follow up|391|||
13141192|NCT02673697|26014684|FG001|Overall Study|Sponsor Decision to stop follow up|416|||
13141193|NCT02673684|26014703|FG000|Overall Study|Study not completed d/t loss of funding|9|||
13141194|NCT02673684|26014704|FG001|Overall Study|Study not completed d/t loss of funding|8|||
13141195|NCT02673619|26014807|FG000|Overall Study|Lost to Follow-up|1|||
13141196|NCT02673619|26014808|FG001|Overall Study|Lost to Follow-up|0|||
13141197|NCT02673619|26014809|FG002|Overall Study|Lost to Follow-up|0|||
13141198|NCT02673619|26014810|FG003|Overall Study|Lost to Follow-up|0|||
13141199|NCT02673619|26014807|FG000|Overall Study|Withdrawal by Subject|1|||
13141200|NCT02673619|26014808|FG001|Overall Study|Withdrawal by Subject|1|||
13141201|NCT02673619|26014809|FG002|Overall Study|Withdrawal by Subject|1|||
13141202|NCT02673619|26014810|FG003|Overall Study|Withdrawal by Subject|0|||
13141203|NCT02673619|26014807|FG000|Overall Study|Adverse Event|0|||
13141204|NCT02673619|26014808|FG001|Overall Study|Adverse Event|0|||
13141205|NCT02673619|26014809|FG002|Overall Study|Adverse Event|1|||
13141206|NCT02673619|26014810|FG003|Overall Study|Adverse Event|0|||
13141207|NCT02673619|26014807|FG000|Overall Study|Lack of Efficacy|0|||
13141208|NCT02673619|26014808|FG001|Overall Study|Lack of Efficacy|0|||
13141209|NCT02673619|26014809|FG002|Overall Study|Lack of Efficacy|1|||
13141210|NCT02673619|26014810|FG003|Overall Study|Lack of Efficacy|0|||
13141211|NCT02673515|26014831|FG000|Overall Study|Lack of motivation|2|||
13141212|NCT02673515|26014832|FG001|Overall Study|Lack of motivation|1|||
13141213|NCT02673489|26014852|FG000|Treatment Period|Lost to Follow-up|3|||
13141214|NCT02673489|26014853|FG001|Treatment Period|Lost to Follow-up|0|||
13141215|NCT02673489|26014852|FG000|Treatment Period|Participant request to discontinue|1|||
13141216|NCT02673489|26014853|FG001|Treatment Period|Participant request to discontinue|1|||
13141217|NCT02673489|26014852|FG000|Treatment Period|Participant moved to another province|1|||
13141218|NCT02673489|26014853|FG001|Treatment Period|Participant moved to another province|0|||
13141219|NCT02673489|26014852|FG000|Treatment Period|Participant was incarcerated|0|||
13141220|NCT02673489|26014853|FG001|Treatment Period|Participant was incarcerated|1|||
13141221|NCT02673489|26014852|FG000|Treatment Period|Adverse Event|0|||
13141222|NCT02673489|26014853|FG001|Treatment Period|Adverse Event|1|||
13141223|NCT02673489|26014852|FG000|Follow Up Period|Unable to return for week 24 follow-up|0|||
13141224|NCT02673489|26014853|FG001|Follow Up Period|Unable to return for week 24 follow-up|1|||
13141225|NCT02673489|26014852|FG000|Follow Up Period|Unable to return for follow-up|0|||
13141226|NCT02673489|26014853|FG001|Follow Up Period|Unable to return for follow-up|1|||
13141227|NCT02672852|26014894|FG000|Part A1|Disease Worsening|1|||
13141228|NCT02672852|26014895|FG001|Part A1|Disease Worsening|0|||
13141229|NCT02672852|26014896|FG002|Part A1|Disease Worsening|0|||
13141230|NCT02672852|26014897|FG003|Part A1|Disease Worsening|0|||
13141231|NCT02672852|26014898|FG004|Part A1|Disease Worsening|0|||
13141232|NCT02672852|26014899|FG005|Part A1|Disease Worsening|0|||
13141233|NCT02672852|26014900|FG006|Part A1|Disease Worsening|0|||
13141234|NCT02672852|26014894|FG000|Part A1|Adverse Event|0|||
13141235|NCT02672852|26014895|FG001|Part A1|Adverse Event|1|||
13141236|NCT02672852|26014896|FG002|Part A1|Adverse Event|0|||
13141237|NCT02672852|26014897|FG003|Part A1|Adverse Event|0|||
13141238|NCT02672852|26014898|FG004|Part A1|Adverse Event|0|||
13141239|NCT02672852|26014899|FG005|Part A1|Adverse Event|0|||
13141240|NCT02672852|26014900|FG006|Part A1|Adverse Event|0|||
13141241|NCT02672852|26014894|FG000|Part A1|Lost to Follow-up|1|||
13141242|NCT02672852|26014895|FG001|Part A1|Lost to Follow-up|2|||
13091604|NCT03733444|25824911|FG002|Overall Study|Death|11|||
13091605|NCT03733444|25824909|FG000|Overall Study|Lost to Follow-up|3|||
13091606|NCT03733444|25824910|FG001|Overall Study|Lost to Follow-up|0|||
13091607|NCT03733444|25824911|FG002|Overall Study|Lost to Follow-up|1|||
13091608|NCT03733444|25824909|FG000|Overall Study|Lack of Efficacy|0|||
13091609|NCT03733444|25824910|FG001|Overall Study|Lack of Efficacy|1|||
13091610|NCT03733444|25824911|FG002|Overall Study|Lack of Efficacy|1|||
13091611|NCT03733444|25824909|FG000|Overall Study|Physician Decision|2|||
13091612|NCT03733444|25824910|FG001|Overall Study|Physician Decision|1|||
13091613|NCT03733444|25824911|FG002|Overall Study|Physician Decision|0|||
13091614|NCT03733444|25824909|FG000|Overall Study|Protocol Violation|2|||
13091615|NCT03733444|25824910|FG001|Overall Study|Protocol Violation|1|||
13091616|NCT03733444|25824911|FG002|Overall Study|Protocol Violation|0|||
13091617|NCT03733444|25824909|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
13091618|NCT03733444|25824910|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
13091619|NCT03733444|25824911|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|2|||
13091620|NCT03733444|25824909|FG000|Overall Study|Study Terminated by Sponsor|203|||
13091621|NCT03733444|25824910|FG001|Overall Study|Study Terminated by Sponsor|209|||
13091622|NCT03733444|25824911|FG002|Overall Study|Study Terminated by Sponsor|221|||
13091623|NCT03733444|25824909|FG000|Overall Study|Withdrawal by Subject|19|||
13091624|NCT03733444|25824910|FG001|Overall Study|Withdrawal by Subject|18|||
13091625|NCT03733444|25824911|FG002|Overall Study|Withdrawal by Subject|16|||
13091626|NCT03733444|25824909|FG000|Overall Study|Miscellaneous|1|||
13091627|NCT03733444|25824910|FG001|Overall Study|Miscellaneous|0|||
13091628|NCT03733444|25824911|FG002|Overall Study|Miscellaneous|1|||
13091629|NCT03733444|25824909|FG000|Overall Study|Not Treated|1|||
13091630|NCT03733444|25824910|FG001|Overall Study|Not Treated|2|||
13091631|NCT03733444|25824911|FG002|Overall Study|Not Treated|1|||
13091632|NCT03733301|25825001|FG000|Overall Study|Screen Fail|1|||
13091633|NCT03733301|25825002|FG001|Overall Study|Screen Fail|0|||
13091634|NCT03733301|25825003|FG002|Overall Study|Screen Fail|0|||
13091635|NCT03733301|25825001|FG000|Overall Study|Non-compliance|1|||
13091636|NCT03733301|25825002|FG001|Overall Study|Non-compliance|0|||
13091637|NCT03733301|25825003|FG002|Overall Study|Non-compliance|0|||
13091638|NCT03733301|25825001|FG000|Overall Study|Lack of Efficacy|2|||
13091639|NCT03733301|25825002|FG001|Overall Study|Lack of Efficacy|3|||
13091640|NCT03733301|25825003|FG002|Overall Study|Lack of Efficacy|0|||
13141243|NCT02672852|26014896|FG002|Part A1|Lost to Follow-up|0|||
13141244|NCT02672852|26014897|FG003|Part A1|Lost to Follow-up|0|||
13141245|NCT02672852|26014898|FG004|Part A1|Lost to Follow-up|0|||
13141246|NCT02672852|26014899|FG005|Part A1|Lost to Follow-up|0|||
13141247|NCT02672852|26014900|FG006|Part A1|Lost to Follow-up|0|||
13141248|NCT02672852|26014894|FG000|Part A1|Withdrawal by Subject|1|||
13141249|NCT02672852|26014895|FG001|Part A1|Withdrawal by Subject|1|||
13141250|NCT02672852|26014896|FG002|Part A1|Withdrawal by Subject|0|||
13141251|NCT02672852|26014897|FG003|Part A1|Withdrawal by Subject|0|||
13141252|NCT02672852|26014898|FG004|Part A1|Withdrawal by Subject|0|||
13141253|NCT02672852|26014899|FG005|Part A1|Withdrawal by Subject|0|||
13141254|NCT02672852|26014900|FG006|Part A1|Withdrawal by Subject|0|||
13141255|NCT02672852|26014894|FG000|Part A2|Disease worsening|0|||
13141256|NCT02672852|26014895|FG001|Part A2|Disease worsening|0|||
13141257|NCT02672852|26014896|FG002|Part A2|Disease worsening|1|||
13141258|NCT02672852|26014897|FG003|Part A2|Disease worsening|0|||
13141259|NCT02672852|26014898|FG004|Part A2|Disease worsening|0|||
13141260|NCT02672852|26014899|FG005|Part A2|Disease worsening|0|||
13141261|NCT02672852|26014900|FG006|Part A2|Disease worsening|0|||
13141262|NCT02672852|26014894|FG000|Part A2|Adverse Event|0|||
13141263|NCT02672852|26014895|FG001|Part A2|Adverse Event|0|||
13141264|NCT02672852|26014896|FG002|Part A2|Adverse Event|3|||
13141265|NCT02672852|26014897|FG003|Part A2|Adverse Event|0|||
13141266|NCT02672852|26014898|FG004|Part A2|Adverse Event|0|||
13141267|NCT02672852|26014899|FG005|Part A2|Adverse Event|0|||
13141268|NCT02672852|26014900|FG006|Part A2|Adverse Event|0|||
13141269|NCT02672852|26014894|FG000|Part A2|Lost to Follow-up|0|||
13141270|NCT02672852|26014895|FG001|Part A2|Lost to Follow-up|0|||
13141271|NCT02672852|26014896|FG002|Part A2|Lost to Follow-up|2|||
13141272|NCT02672852|26014897|FG003|Part A2|Lost to Follow-up|0|||
13141273|NCT02672852|26014898|FG004|Part A2|Lost to Follow-up|0|||
13141274|NCT02672852|26014899|FG005|Part A2|Lost to Follow-up|0|||
13141275|NCT02672852|26014900|FG006|Part A2|Lost to Follow-up|0|||
13141276|NCT02672852|26014894|FG000|Part A2|Withdrawal by Subject|0|||
13141277|NCT02672852|26014895|FG001|Part A2|Withdrawal by Subject|0|||
13141278|NCT02672852|26014896|FG002|Part A2|Withdrawal by Subject|1|||
13141279|NCT02672852|26014897|FG003|Part A2|Withdrawal by Subject|0|||
13141280|NCT02672852|26014898|FG004|Part A2|Withdrawal by Subject|0|||
13141281|NCT02672852|26014899|FG005|Part A2|Withdrawal by Subject|0|||
13141282|NCT02672852|26014900|FG006|Part A2|Withdrawal by Subject|0|||
13141283|NCT02672852|26014894|FG000|Part A2|Other|0|||
13141284|NCT02672852|26014895|FG001|Part A2|Other|0|||
13141285|NCT02672852|26014896|FG002|Part A2|Other|3|||
13141286|NCT02672852|26014897|FG003|Part A2|Other|0|||
13141287|NCT02672852|26014898|FG004|Part A2|Other|0|||
13141288|NCT02672852|26014899|FG005|Part A2|Other|0|||
13141289|NCT02672852|26014900|FG006|Part A2|Other|0|||
13141290|NCT02672852|26014894|FG000|Part A2|Not entered in Part B|0|||
13141291|NCT02672852|26014895|FG001|Part A2|Not entered in Part B|0|||
13141292|NCT02672852|26014896|FG002|Part A2|Not entered in Part B|0|||
13141293|NCT02672852|26014897|FG003|Part A2|Not entered in Part B|4|||
13141294|NCT02672852|26014898|FG004|Part A2|Not entered in Part B|0|||
13141295|NCT02672852|26014899|FG005|Part A2|Not entered in Part B|0|||
13141296|NCT02672852|26014900|FG006|Part A2|Not entered in Part B|0|||
13141297|NCT02672852|26014894|FG000|Part B|Disease worsening|0|||
13141298|NCT02672852|26014895|FG001|Part B|Disease worsening|0|||
13141299|NCT02672852|26014896|FG002|Part B|Disease worsening|0|||
13141300|NCT02672852|26014897|FG003|Part B|Disease worsening|0|||
13141301|NCT02672852|26014898|FG004|Part B|Disease worsening|1|||
13141302|NCT02672852|26014899|FG005|Part B|Disease worsening|0|||
13141303|NCT02672852|26014900|FG006|Part B|Disease worsening|1|||
13141304|NCT02672852|26014894|FG000|Part B|Worsening pre-existing condition|0|||
13141305|NCT02672852|26014895|FG001|Part B|Worsening pre-existing condition|0|||
13141306|NCT02672852|26014896|FG002|Part B|Worsening pre-existing condition|0|||
13141307|NCT02672852|26014897|FG003|Part B|Worsening pre-existing condition|0|||
13141308|NCT02672852|26014898|FG004|Part B|Worsening pre-existing condition|0|||
13141309|NCT02672852|26014899|FG005|Part B|Worsening pre-existing condition|1|||
13141310|NCT02672852|26014900|FG006|Part B|Worsening pre-existing condition|0|||
13141311|NCT02672852|26014894|FG000|Part B|Other adverse event|0|||
13141312|NCT02672852|26014895|FG001|Part B|Other adverse event|0|||
13141313|NCT02672852|26014896|FG002|Part B|Other adverse event|0|||
13141314|NCT02672852|26014897|FG003|Part B|Other adverse event|0|||
13141315|NCT02672852|26014898|FG004|Part B|Other adverse event|3|||
13141316|NCT02672852|26014899|FG005|Part B|Other adverse event|5|||
13141317|NCT02672852|26014900|FG006|Part B|Other adverse event|1|||
13141318|NCT02672852|26014894|FG000|Part B|Lost to Follow-up|0|||
13141319|NCT02672852|26014895|FG001|Part B|Lost to Follow-up|0|||
13141320|NCT02672852|26014896|FG002|Part B|Lost to Follow-up|0|||
13141321|NCT02672852|26014897|FG003|Part B|Lost to Follow-up|0|||
13141322|NCT02672852|26014898|FG004|Part B|Lost to Follow-up|3|||
13141323|NCT02672852|26014899|FG005|Part B|Lost to Follow-up|4|||
13141324|NCT02672852|26014900|FG006|Part B|Lost to Follow-up|1|||
13141325|NCT02672852|26014894|FG000|Part B|Withdrawal by Subject|0|||
13141326|NCT02672852|26014895|FG001|Part B|Withdrawal by Subject|0|||
13141327|NCT02672852|26014896|FG002|Part B|Withdrawal by Subject|0|||
13141328|NCT02672852|26014897|FG003|Part B|Withdrawal by Subject|0|||
13141329|NCT02672852|26014898|FG004|Part B|Withdrawal by Subject|5|||
13141330|NCT02672852|26014899|FG005|Part B|Withdrawal by Subject|0|||
13141331|NCT02672852|26014900|FG006|Part B|Withdrawal by Subject|7|||
13141332|NCT02672852|26014894|FG000|Part B|Other|0|||
13141333|NCT02672852|26014895|FG001|Part B|Other|0|||
13141334|NCT02672852|26014896|FG002|Part B|Other|0|||
13141335|NCT02672852|26014897|FG003|Part B|Other|0|||
13141336|NCT02672852|26014898|FG004|Part B|Other|4|||
13141337|NCT02672852|26014899|FG005|Part B|Other|1|||
13141338|NCT02672852|26014900|FG006|Part B|Other|2|||
13141339|NCT02672553|26014967|FG000|Overall Study|Death|3|||
13141340|NCT02672553|26014968|FG001|Overall Study|Death|5|||
13141341|NCT02672553|26014967|FG000|Overall Study|Valve Explant|1|||
13141342|NCT02672553|26014968|FG001|Overall Study|Valve Explant|0|||
13141343|NCT02672553|26014967|FG000|Overall Study|Conversion to Commercial Valve|3|||
13141344|NCT02672553|26014968|FG001|Overall Study|Conversion to Commercial Valve|0|||
13141345|NCT02672553|26014967|FG000|Overall Study|Withdrawal by Subject|3|||
13141346|NCT02672553|26014968|FG001|Overall Study|Withdrawal by Subject|3|||
13091641|NCT03733301|25825001|FG000|Overall Study|Adverse Event|0|||
13091642|NCT03733301|25825002|FG001|Overall Study|Adverse Event|1|||
13091643|NCT03733301|25825003|FG002|Overall Study|Adverse Event|3|||
13091644|NCT03733301|25825001|FG000|Overall Study|Withdrawal by Subject|3|||
13091645|NCT03733301|25825002|FG001|Overall Study|Withdrawal by Subject|5|||
13091646|NCT03733301|25825003|FG002|Overall Study|Withdrawal by Subject|1|||
13091647|NCT03732534|25825009|FG000|Overall Study|Study terminated by Sponsor|6|||
13091648|NCT03732248|25825032|FG000|Overall Study|Withdrawal by Subject|1|||
13091649|NCT03732248|25825033|FG001|Overall Study|Withdrawal by Subject|0|||
13091650|NCT03731182|25825058|FG000|Overall Study|Lost to Follow-up|2|||
13091651|NCT03731182|25825059|FG001|Overall Study|Lost to Follow-up|0|||
13091652|NCT03731182|25825058|FG000|Overall Study|Physician Decision|1|||
13091653|NCT03731182|25825059|FG001|Overall Study|Physician Decision|0|||
13091654|NCT03731182|25825058|FG000|Overall Study|Withdrawal By Parent/Guardian|2|||
13091655|NCT03731182|25825059|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
13091656|NCT03730961|25825102|FG000|Overall Study|Adverse Event|0|||
13091657|NCT03730961|25825103|FG001|Overall Study|Adverse Event|1|||
13091658|NCT03730103|25825122|FG000|Overall Study|Did not meet inclusion criteria|0|||
13091659|NCT03730103|25825123|FG001|Overall Study|Did not meet inclusion criteria|5|||
13091660|NCT03730012|25825156|FG000|Overall Study|Adverse Event|0|||
13091661|NCT03730012|25825157|FG001|Overall Study|Adverse Event|1|||
13091662|NCT03730012|25825156|FG000|Overall Study|Lack of Efficacy|1|||
13091663|NCT03730012|25825157|FG001|Overall Study|Lack of Efficacy|5|||
13091664|NCT03730012|25825156|FG000|Overall Study|Withdrawal by Subject|0|||
13091665|NCT03730012|25825157|FG001|Overall Study|Withdrawal by Subject|1|||
13141347|NCT02672553|26014967|FG000|Overall Study|Intraoperative screen failure|2|||
13141348|NCT02672553|26014968|FG001|Overall Study|Intraoperative screen failure|0|||
13141349|NCT02672423|26015008|FG000|Period 1|Adverse Event|0|||
13141350|NCT02672423|26015009|FG001|Period 1|Adverse Event|0|||
13141351|NCT02672423|26015010|FG002|Period 1|Adverse Event|0|||
13141352|NCT02672423|26015011|FG003|Period 1|Adverse Event|0|||
13141353|NCT02672423|26015012|FG004|Period 1|Adverse Event|1|||
13141354|NCT02672423|26015013|FG005|Period 1|Adverse Event|0|||
13141355|NCT02672423|26015014|FG006|Period 1|Adverse Event|0|||
13141356|NCT02672423|26015015|FG007|Period 1|Adverse Event|0|||
13141357|NCT02672423|26015016|FG008|Period 1|Adverse Event|0|||
13141358|NCT02672423|26015017|FG009|Period 1|Adverse Event|0|||
13141359|NCT02672423|26015008|FG000|Period 2|Withdrawal by Subject|0|||
13141360|NCT02672423|26015009|FG001|Period 2|Withdrawal by Subject|0|||
13141361|NCT02672423|26015010|FG002|Period 2|Withdrawal by Subject|1|||
13141362|NCT02672423|26015011|FG003|Period 2|Withdrawal by Subject|0|||
13141363|NCT02672423|26015012|FG004|Period 2|Withdrawal by Subject|0|||
13141364|NCT02672423|26015013|FG005|Period 2|Withdrawal by Subject|0|||
13141365|NCT02672423|26015014|FG006|Period 2|Withdrawal by Subject|0|||
13141366|NCT02672423|26015015|FG007|Period 2|Withdrawal by Subject|0|||
13141367|NCT02672423|26015016|FG008|Period 2|Withdrawal by Subject|0|||
13141368|NCT02672423|26015017|FG009|Period 2|Withdrawal by Subject|0|||
13141369|NCT02672423|26015008|FG000|Period 3|Withdrawal by Subject|0|||
13141370|NCT02672423|26015009|FG001|Period 3|Withdrawal by Subject|0|||
13141371|NCT02672423|26015010|FG002|Period 3|Withdrawal by Subject|0|||
13141372|NCT02672423|26015011|FG003|Period 3|Withdrawal by Subject|0|||
13141373|NCT02672423|26015012|FG004|Period 3|Withdrawal by Subject|0|||
13141374|NCT02672423|26015013|FG005|Period 3|Withdrawal by Subject|0|||
13141375|NCT02672423|26015014|FG006|Period 3|Withdrawal by Subject|0|||
13091666|NCT03730012|25825156|FG000|Overall Study|Miscellaneous|2|||
13091667|NCT03730012|25825157|FG001|Overall Study|Miscellaneous|1|||
13091668|NCT03728140|25825172|FG000|Overall Study|Abnormal embryo transfer operation|10|||
13091669|NCT03728140|25825173|FG001|Overall Study|Abnormal embryo transfer operation|7|||
13141376|NCT02672423|26015015|FG007|Period 3|Withdrawal by Subject|1|||
13141377|NCT02672423|26015016|FG008|Period 3|Withdrawal by Subject|0|||
13141378|NCT02672423|26015017|FG009|Period 3|Withdrawal by Subject|0|||
13141379|NCT02672423|26015008|FG000|Period 3|Physician Decision|0|||
13141380|NCT02672423|26015009|FG001|Period 3|Physician Decision|0|||
13141381|NCT02672423|26015010|FG002|Period 3|Physician Decision|0|||
13141382|NCT02672423|26015011|FG003|Period 3|Physician Decision|0|||
13141383|NCT02672423|26015012|FG004|Period 3|Physician Decision|0|||
13141384|NCT02672423|26015013|FG005|Period 3|Physician Decision|1|||
13141385|NCT02672423|26015014|FG006|Period 3|Physician Decision|0|||
13141386|NCT02672423|26015015|FG007|Period 3|Physician Decision|0|||
13141387|NCT02672423|26015016|FG008|Period 3|Physician Decision|0|||
13141388|NCT02672423|26015017|FG009|Period 3|Physician Decision|0|||
13141389|NCT02671760|26015047|FG000|Overall Study|Lost to Follow-up|0|||
13141390|NCT02671760|26015048|FG001|Overall Study|Lost to Follow-up|1|||
13141391|NCT02671760|26015049|FG002|Overall Study|Lost to Follow-up|0|||
13141392|NCT02671500|26015063|FG000|Overall Study|Lack of Efficacy|12|||
13141393|NCT02671500|26015063|FG000|Overall Study|Lost to Follow-up|2|||
13141394|NCT02671461|26015096|FG000|Treatment|Adverse Event|0|||
13141395|NCT02671461|26015097|FG001|Treatment|Adverse Event|0|||
13141396|NCT02671461|26015098|FG002|Treatment|Adverse Event|1|||
13141397|NCT02671461|26015096|FG000|Treatment|Administrative Reason by Sponsor|1|||
13141398|NCT02671461|26015097|FG001|Treatment|Administrative Reason by Sponsor|3|||
13141399|NCT02671461|26015098|FG002|Treatment|Administrative Reason by Sponsor|4|||
13141400|NCT02671461|26015096|FG000|Treatment|Randomized, not treated|1|||
13141401|NCT02671461|26015097|FG001|Treatment|Randomized, not treated|0|||
13141402|NCT02671461|26015098|FG002|Treatment|Randomized, not treated|0|||
13141403|NCT02671461|26015096|FG000|Follow-up|Withdrawal by Subject|1|||
13141404|NCT02671461|26015097|FG001|Follow-up|Withdrawal by Subject|0|||
13141405|NCT02671461|26015098|FG002|Follow-up|Withdrawal by Subject|0|||
13141406|NCT02671461|26015096|FG000|Follow-up|Lost to Follow-up|0|||
13141407|NCT02671461|26015097|FG001|Follow-up|Lost to Follow-up|0|||
13141408|NCT02671461|26015098|FG002|Follow-up|Lost to Follow-up|1|||
13141409|NCT02671461|26015096|FG000|Follow-up|Administrative Reason by Sponsor|0|||
13141410|NCT02671461|26015097|FG001|Follow-up|Administrative Reason by Sponsor|1|||
13141411|NCT02671461|26015098|FG002|Follow-up|Administrative Reason by Sponsor|0|||
13141412|NCT02671422|26015104|FG000|Overall Study|Lost to Follow-up|1|||
13141413|NCT02671422|26015104|FG000|Overall Study|Adverse Event|68|||
13141414|NCT02671422|26015104|FG000|Overall Study|Lack of Efficacy|1|||
13141415|NCT02671422|26015104|FG000|Overall Study|Lost to Follow-up|4|||
13141416|NCT02671422|26015104|FG000|Overall Study|Withdrawal by Subject|7|||
13141417|NCT02671422|26015104|FG000|Overall Study|Progressive Disease|156|||
13141418|NCT02671422|26015104|FG000|Overall Study|Worsening of Disease|4|||
13141419|NCT02671422|26015104|FG000|Overall Study|Sponsor decision|5|||
13141420|NCT02671422|26015104|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8|||
13141421|NCT02671422|26015104|FG000|Overall Study|Not treated with Vargatef®|3|||
13141422|NCT02671422|26015104|FG000|Overall Study|Other not defined above|3|||
13141423|NCT02671266|26015123|FG000|Overall Study|Withdrawal by Subject|1|||
13141424|NCT02671266|26015124|FG001|Overall Study|Withdrawal by Subject|1|||
13141425|NCT02670928|26015155|FG000|Overall Study|Adverse Event|3|||
13141426|NCT02670928|26015156|FG001|Overall Study|Adverse Event|1|||
13141427|NCT02670928|26015155|FG000|Overall Study|Withdrawal by Subject|4|||
13141428|NCT02670928|26015156|FG001|Overall Study|Withdrawal by Subject|0|||
13141429|NCT02670928|26015155|FG000|Overall Study|Lost to Follow-up|1|||
13141430|NCT02670928|26015156|FG001|Overall Study|Lost to Follow-up|0|||
13141431|NCT02670928|26015155|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2|||
13141432|NCT02670928|26015156|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0|||
13141433|NCT02670915|26015411|FG000|Overall Study|Withdrawal by Subject|0|||
13141434|NCT02670915|26015412|FG001|Overall Study|Withdrawal by Subject|1|||
13141435|NCT02670915|26015413|FG002|Overall Study|Withdrawal by Subject|4|||
13141436|NCT02670915|26015411|FG000|Overall Study|Withdrawal by parent/guardian|4|||
13141437|NCT02670915|26015412|FG001|Overall Study|Withdrawal by parent/guardian|4|||
13141438|NCT02670915|26015413|FG002|Overall Study|Withdrawal by parent/guardian|1|||
13141439|NCT02670915|26015411|FG000|Overall Study|Unclassified|0|||
13141440|NCT02670915|26015412|FG001|Overall Study|Unclassified|3|||
13141441|NCT02670915|26015413|FG002|Overall Study|Unclassified|0|||
13141442|NCT02670551|26015434|FG000|Overall Study|Adverse Event|4|||
13141443|NCT02670551|26015435|FG001|Overall Study|Adverse Event|7|||
13141444|NCT02670551|26015436|FG002|Overall Study|Adverse Event|9|||
13141445|NCT02670551|26015434|FG000|Overall Study|Lack of Efficacy|2|||
13141446|NCT02670551|26015435|FG001|Overall Study|Lack of Efficacy|0|||
13141447|NCT02670551|26015436|FG002|Overall Study|Lack of Efficacy|3|||
13141448|NCT02670551|26015434|FG000|Overall Study|Withdrawal of Consent|6|||
13141449|NCT02670551|26015435|FG001|Overall Study|Withdrawal of Consent|3|||
13141450|NCT02670551|26015436|FG002|Overall Study|Withdrawal of Consent|8|||
13141451|NCT02670551|26015434|FG000|Overall Study|Lost to Follow-up|5|||
13141452|NCT02670551|26015435|FG001|Overall Study|Lost to Follow-up|7|||
13141453|NCT02670551|26015436|FG002|Overall Study|Lost to Follow-up|6|||
13141454|NCT02670551|26015434|FG000|Overall Study|Protocol Violation|1|||
13141455|NCT02670551|26015435|FG001|Overall Study|Protocol Violation|0|||
13141456|NCT02670551|26015436|FG002|Overall Study|Protocol Violation|0|||
13141457|NCT02670551|26015434|FG000|Overall Study|Noncompliance with study drug|3|||
13141458|NCT02670551|26015435|FG001|Overall Study|Noncompliance with study drug|3|||
13141459|NCT02670551|26015436|FG002|Overall Study|Noncompliance with study drug|2|||
13141460|NCT02670551|26015434|FG000|Overall Study|Other Miscellaneous Reasons|2|||
13141461|NCT02670551|26015435|FG001|Overall Study|Other Miscellaneous Reasons|3|||
13141462|NCT02670551|26015436|FG002|Overall Study|Other Miscellaneous Reasons|3|||
13141463|NCT02670551|26015434|FG000|Overall Study|Did Not Receive Treatment|5|||
13141464|NCT02670551|26015435|FG001|Overall Study|Did Not Receive Treatment|3|||
13141465|NCT02670551|26015436|FG002|Overall Study|Did Not Receive Treatment|0|||
13141466|NCT02670538|26015457|FG000|Overall Study|Withdrawal of Consent|8|||
13141467|NCT02670538|26015458|FG001|Overall Study|Withdrawal of Consent|6|||
13141468|NCT02670538|26015459|FG002|Overall Study|Withdrawal of Consent|5|||
13141469|NCT02670538|26015457|FG000|Overall Study|Lost to Follow-up|8|||
13141470|NCT02670538|26015458|FG001|Overall Study|Lost to Follow-up|12|||
13141471|NCT02670538|26015459|FG002|Overall Study|Lost to Follow-up|7|||
13141472|NCT02670538|26015457|FG000|Overall Study|Adverse Event|5|||
13141473|NCT02670538|26015458|FG001|Overall Study|Adverse Event|5|||
13141474|NCT02670538|26015459|FG002|Overall Study|Adverse Event|11|||
13141475|NCT02670538|26015457|FG000|Overall Study|Lack of Efficacy|7|||
13141476|NCT02670538|26015458|FG001|Overall Study|Lack of Efficacy|1|||
13141477|NCT02670538|26015459|FG002|Overall Study|Lack of Efficacy|2|||
13141478|NCT02670538|26015457|FG000|Overall Study|Protocol Violation|3|||
13141479|NCT02670538|26015458|FG001|Overall Study|Protocol Violation|4|||
13141480|NCT02670538|26015459|FG002|Overall Study|Protocol Violation|1|||
13141481|NCT02670538|26015457|FG000|Overall Study|Noncompliance with Study Drug|1|||
13141482|NCT02670538|26015458|FG001|Overall Study|Noncompliance with Study Drug|3|||
13141483|NCT02670538|26015459|FG002|Overall Study|Noncompliance with Study Drug|2|||
13141484|NCT02670538|26015457|FG000|Overall Study|Other Miscellaneous Reasons|0|||
13141485|NCT02670538|26015458|FG001|Overall Study|Other Miscellaneous Reasons|1|||
13141486|NCT02670538|26015459|FG002|Overall Study|Other Miscellaneous Reasons|2|||
13141487|NCT02670473|26015514|FG000|Overall Study|Withdrawal by Subject|1|||
13141488|NCT02670382|26015531|FG000|Placebo lead-in Phase|Withdrawal by Subject|2|||
13141489|NCT02670382|26015532|FG001|Placebo lead-in Phase|Withdrawal by Subject|1|||
13141490|NCT02670330|26015549|FG000|Overall Study|Protocol Deviation|1|||
13141491|NCT02670330|26015550|FG001|Overall Study|Protocol Deviation|0|||
13141492|NCT02670330|26015549|FG000|Overall Study|Study Terminated By Sponsor|36|||
13141493|NCT02670330|26015550|FG001|Overall Study|Study Terminated By Sponsor|43|||
13141494|NCT02670330|26015549|FG000|Overall Study|Adverse Event|1|||
13141495|NCT02670330|26015550|FG001|Overall Study|Adverse Event|3|||
13141496|NCT02670330|26015549|FG000|Overall Study|Withdrawal by Subject|34|||
13141497|NCT02670330|26015550|FG001|Overall Study|Withdrawal by Subject|29|||
13141498|NCT02670330|26015549|FG000|Overall Study|Lost to Follow-up|3|||
13141499|NCT02670330|26015550|FG001|Overall Study|Lost to Follow-up|2|||
13141500|NCT02670122|26015563|FG000|Overall Study|Lost to Follow-up|4|||
13141501|NCT02670083|26015613|FG000|Overall Study|Adverse Event|16|||
13141502|NCT02670083|26015614|FG001|Overall Study|Adverse Event|13|||
13141503|NCT02670083|26015613|FG000|Overall Study|Death|4|||
13141504|NCT02670083|26015614|FG001|Overall Study|Death|6|||
13141505|NCT02670083|26015613|FG000|Overall Study|Lost to Follow-up|2|||
13141506|NCT02670083|26015614|FG001|Overall Study|Lost to Follow-up|2|||
13141507|NCT02670083|26015613|FG000|Overall Study|Multiple Reasons|9|||
13141508|NCT02670083|26015614|FG001|Overall Study|Multiple Reasons|9|||
13141509|NCT02670083|26015613|FG000|Overall Study|Physician Decision|0|||
13141510|NCT02670083|26015614|FG001|Overall Study|Physician Decision|2|||
13141511|NCT02670083|26015613|FG000|Overall Study|Study Terminated By Sponsor|257|||
13141512|NCT02670083|26015614|FG001|Overall Study|Study Terminated By Sponsor|254|||
13141513|NCT02670083|26015613|FG000|Overall Study|Symptomatic Deterioration|0|||
13141514|NCT02670083|26015614|FG001|Overall Study|Symptomatic Deterioration|2|||
13141515|NCT02670083|26015613|FG000|Overall Study|Withdrawal by Subject|32|||
13141516|NCT02670083|26015614|FG001|Overall Study|Withdrawal by Subject|31|||
13141517|NCT02670083|26015613|FG000|Overall Study|Non-Compliance With Study Drug|1|||
13141518|NCT02670083|26015614|FG001|Overall Study|Non-Compliance With Study Drug|0|||
13141519|NCT02669940|26015674|FG000|Overall Study|Failure to return|0|||
13141520|NCT02669940|26015675|FG001|Overall Study|Failure to return|3|||
13141521|NCT02669940|26015674|FG000|Overall Study|Insufficient follow-up data|1|||
13141522|NCT02669940|26015675|FG001|Overall Study|Insufficient follow-up data|0|||
13141523|NCT02669862|26015698|FG000|Overall Study|Lost to Follow-up|0|||
13141524|NCT02669862|26015699|FG001|Overall Study|Lost to Follow-up|2|||
13141525|NCT02669862|26015700|FG002|Overall Study|Lost to Follow-up|1|||
13141526|NCT02669862|26015698|FG000|Overall Study|Withdrawal by Subject|2|||
13141527|NCT02669862|26015699|FG001|Overall Study|Withdrawal by Subject|2|||
13141528|NCT02669862|26015700|FG002|Overall Study|Withdrawal by Subject|3|||
13141529|NCT02669862|26015698|FG000|Overall Study|moved|0|||
13141530|NCT02669862|26015699|FG001|Overall Study|moved|1|||
13141531|NCT02669862|26015700|FG002|Overall Study|moved|0|||
13141532|NCT02669862|26015698|FG000|Overall Study|Protocol Violation|0|||
13141533|NCT02669862|26015699|FG001|Overall Study|Protocol Violation|0|||
13141534|NCT02669862|26015700|FG002|Overall Study|Protocol Violation|1|||
13141535|NCT02669849|26015730|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
13141536|NCT02669849|26015731|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
13141537|NCT02669849|26015732|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3|||
13141538|NCT02669849|26015730|FG000|Overall Study|Lost to Follow-up|1|||
13141539|NCT02669849|26015731|FG001|Overall Study|Lost to Follow-up|0|||
13141540|NCT02669849|26015732|FG002|Overall Study|Lost to Follow-up|3|||
13141541|NCT02669849|26015730|FG000|Overall Study|Death|1|||
13141542|NCT02669849|26015731|FG001|Overall Study|Death|1|||
13141543|NCT02669849|26015732|FG002|Overall Study|Death|2|||
13141544|NCT02669849|26015730|FG000|Overall Study|Study terminated by sponsor|16|||
13141545|NCT02669849|26015731|FG001|Overall Study|Study terminated by sponsor|1|||
13141546|NCT02669849|26015732|FG002|Overall Study|Study terminated by sponsor|14|||
13141547|NCT02669849|26015730|FG000|Overall Study|Other|0|||
13141548|NCT02669849|26015731|FG001|Overall Study|Other|0|||
13141549|NCT02669849|26015732|FG002|Overall Study|Other|2|||
13141550|NCT02669758|26015738|FG000|Overall Study|Withdrawal by Subject|43|||
13141551|NCT02669758|26015738|FG000|Overall Study|Lost to Follow-up|19|||
13141552|NCT02669758|26015738|FG000|Overall Study|Adverse Event|16|||
13141553|NCT02669758|26015738|FG000|Overall Study|Non-Compliance with Study Drug|8|||
13141554|NCT02669758|26015738|FG000|Overall Study|Lack of Efficacy|5|||
13141555|NCT02669758|26015738|FG000|Overall Study|Pregnancy|1|||
13141556|NCT02669758|26015738|FG000|Overall Study|Study noncompliance|1|||
13141557|NCT02669758|26015738|FG000|Overall Study|Protocol Violation|1|||
13141558|NCT02669667|26015854|FG000|Overall Study|Lost to Follow-up|0|||
13141559|NCT02669667|26015855|FG001|Overall Study|Lost to Follow-up|0|||
13141560|NCT02669667|26015856|FG002|Overall Study|Lost to Follow-up|0|||
13141561|NCT02669667|26015857|FG003|Overall Study|Lost to Follow-up|0|||
13141562|NCT02669667|26015858|FG004|Overall Study|Lost to Follow-up|0|||
13141563|NCT02669667|26015859|FG005|Overall Study|Lost to Follow-up|1|||
13141564|NCT02669667|26015860|FG006|Overall Study|Lost to Follow-up|0|||
13141565|NCT02669433|26015884|FG000|Overall Study|Protocol Violation|0|||
13141566|NCT02669433|26015885|FG001|Overall Study|Protocol Violation|4|||
13141567|NCT02669433|26015886|FG002|Overall Study|Protocol Violation|1|||
13141568|NCT02669433|26015884|FG000|Overall Study|Disease Progression|1|||
13141569|NCT02669433|26015885|FG001|Overall Study|Disease Progression|0|||
13141570|NCT02669433|26015886|FG002|Overall Study|Disease Progression|0|||
13141571|NCT02669433|26015884|FG000|Overall Study|Physician Decision|1|||
13141572|NCT02669433|26015885|FG001|Overall Study|Physician Decision|1|||
13141573|NCT02669433|26015886|FG002|Overall Study|Physician Decision|0|||
13141574|NCT02669433|26015884|FG000|Overall Study|Adverse Event|6|||
13141575|NCT02669433|26015885|FG001|Overall Study|Adverse Event|7|||
13141576|NCT02669433|26015886|FG002|Overall Study|Adverse Event|10|||
13141577|NCT02669433|26015884|FG000|Overall Study|Sponsor Termination|1|||
13141578|NCT02669433|26015885|FG001|Overall Study|Sponsor Termination|0|||
13141579|NCT02669433|26015886|FG002|Overall Study|Sponsor Termination|1|||
13141580|NCT02669433|26015884|FG000|Overall Study|Withdrawal by Subject|5|||
13141581|NCT02669433|26015885|FG001|Overall Study|Withdrawal by Subject|1|||
13141582|NCT02669433|26015886|FG002|Overall Study|Withdrawal by Subject|0|||
13141583|NCT02669433|26015884|FG000|Overall Study|Withdrawal by Caregiver|1|||
13141584|NCT02669433|26015885|FG001|Overall Study|Withdrawal by Caregiver|0|||
13141585|NCT02669433|26015886|FG002|Overall Study|Withdrawal by Caregiver|2|||
13141586|NCT02669433|26015884|FG000|Overall Study|Death|0|||
13141587|NCT02669433|26015885|FG001|Overall Study|Death|1|||
13141588|NCT02669433|26015886|FG002|Overall Study|Death|1|||
13141589|NCT02669407|26015905|FG000|Overall Study|Physician Decision|3|||
13141590|NCT02669264|26016071|FG000|Overall Study|Death|5|||
13141591|NCT02669264|26016072|FG001|Overall Study|Death|5|||
13141592|NCT02669264|26016073|FG002|Overall Study|Death|3|||
13141593|NCT02669264|26016074|FG003|Overall Study|Death|3|||
13141594|NCT02669264|26016075|FG004|Overall Study|Death|3|||
13141595|NCT02669264|26016076|FG005|Overall Study|Death|6|||
13141596|NCT02669264|26016077|FG006|Overall Study|Death|3|||
13141597|NCT02669264|26016071|FG000|Overall Study|Withdrawal by Subject|0|||
13141598|NCT02669264|26016072|FG001|Overall Study|Withdrawal by Subject|1|||
13141599|NCT02669264|26016073|FG002|Overall Study|Withdrawal by Subject|0|||
13141600|NCT02669264|26016074|FG003|Overall Study|Withdrawal by Subject|0|||
13141601|NCT02669264|26016075|FG004|Overall Study|Withdrawal by Subject|1|||
13141602|NCT02669264|26016076|FG005|Overall Study|Withdrawal by Subject|0|||
13141603|NCT02669264|26016077|FG006|Overall Study|Withdrawal by Subject|0|||
13141604|NCT02669264|26016071|FG000|Overall Study|Lost to Follow-up|0|||
13141605|NCT02669264|26016072|FG001|Overall Study|Lost to Follow-up|0|||
13141606|NCT02669264|26016073|FG002|Overall Study|Lost to Follow-up|0|||
13141607|NCT02669264|26016074|FG003|Overall Study|Lost to Follow-up|0|||
13141608|NCT02669264|26016075|FG004|Overall Study|Lost to Follow-up|1|||
13141609|NCT02669264|26016076|FG005|Overall Study|Lost to Follow-up|0|||
13141610|NCT02669264|26016077|FG006|Overall Study|Lost to Follow-up|0|||
13141611|NCT02669264|26016071|FG000|Overall Study|Miscellaneous|0|||
13141612|NCT02669264|26016072|FG001|Overall Study|Miscellaneous|0|||
13141613|NCT02669264|26016073|FG002|Overall Study|Miscellaneous|0|||
13141614|NCT02669264|26016074|FG003|Overall Study|Miscellaneous|0|||
13141615|NCT02669264|26016075|FG004|Overall Study|Miscellaneous|0|||
13141616|NCT02669264|26016076|FG005|Overall Study|Miscellaneous|0|||
13141617|NCT02669264|26016077|FG006|Overall Study|Miscellaneous|2|||
13204784|NCT01970488|26230011|FG002|Part 1: Through Week 16|Protocol Violation|0|||
13204785|NCT01970488|26230012|FG003|Part 1: Through Week 16|Protocol Violation|0|||
13204786|NCT01970488|26230013|FG004|Part 1: Through Week 16|Protocol Violation|0|||
13204787|NCT01970488|26230009|FG000|Part 1: Through Week 16|Adverse Event|6|||
13204788|NCT01970488|26230010|FG001|Part 1: Through Week 16|Adverse Event|5|||
13204789|NCT01970488|26230011|FG002|Part 1: Through Week 16|Adverse Event|0|||
13204790|NCT01970488|26230012|FG003|Part 1: Through Week 16|Adverse Event|0|||
13204791|NCT01970488|26230013|FG004|Part 1: Through Week 16|Adverse Event|0|||
13204792|NCT01970488|26230009|FG000|Part 1: Through Week 16|Withdrawal by Subject|3|||
13204793|NCT01970488|26230010|FG001|Part 1: Through Week 16|Withdrawal by Subject|2|||
13204794|NCT01970488|26230011|FG002|Part 1: Through Week 16|Withdrawal by Subject|0|||
13204795|NCT01970488|26230012|FG003|Part 1: Through Week 16|Withdrawal by Subject|0|||
13204796|NCT01970488|26230013|FG004|Part 1: Through Week 16|Withdrawal by Subject|0|||
13204797|NCT01970488|26230009|FG000|Part 1: Through Week 16|Lost to Follow-up|0|||
13204798|NCT01970488|26230010|FG001|Part 1: Through Week 16|Lost to Follow-up|2|||
13204799|NCT01970488|26230011|FG002|Part 1: Through Week 16|Lost to Follow-up|0|||
13204800|NCT01970488|26230012|FG003|Part 1: Through Week 16|Lost to Follow-up|0|||
13204801|NCT01970488|26230013|FG004|Part 1: Through Week 16|Lost to Follow-up|0|||
13204802|NCT01970488|26230009|FG000|Part 2: Post Week 16|Physician Decision|0|||
13204803|NCT01970488|26230010|FG001|Part 2: Post Week 16|Physician Decision|0|||
13204804|NCT01970488|26230011|FG002|Part 2: Post Week 16|Physician Decision|0|||
13204805|NCT01970488|26230012|FG003|Part 2: Post Week 16|Physician Decision|0|||
13204806|NCT01970488|26230013|FG004|Part 2: Post Week 16|Physician Decision|1|||
13204807|NCT01970488|26230009|FG000|Part 2: Post Week 16|Non-compliance|0|||
13204808|NCT01970488|26230010|FG001|Part 2: Post Week 16|Non-compliance|0|||
13204809|NCT01970488|26230011|FG002|Part 2: Post Week 16|Non-compliance|1|||
13204810|NCT01970488|26230012|FG003|Part 2: Post Week 16|Non-compliance|0|||
13204811|NCT01970488|26230013|FG004|Part 2: Post Week 16|Non-compliance|0|||
13204812|NCT01970488|26230009|FG000|Part 2: Post Week 16|Lack of Efficacy|0|||
13204813|NCT01970488|26230010|FG001|Part 2: Post Week 16|Lack of Efficacy|0|||
13204814|NCT01970488|26230011|FG002|Part 2: Post Week 16|Lack of Efficacy|2|||
13204815|NCT01970488|26230012|FG003|Part 2: Post Week 16|Lack of Efficacy|3|||
13204816|NCT01970488|26230013|FG004|Part 2: Post Week 16|Lack of Efficacy|1|||
13204817|NCT01970488|26230009|FG000|Part 2: Post Week 16|Adverse Event|0|||
13204818|NCT01970488|26230010|FG001|Part 2: Post Week 16|Adverse Event|0|||
13204819|NCT01970488|26230011|FG002|Part 2: Post Week 16|Adverse Event|5|||
13204820|NCT01970488|26230012|FG003|Part 2: Post Week 16|Adverse Event|1|||
13204821|NCT01970488|26230013|FG004|Part 2: Post Week 16|Adverse Event|1|||
13204822|NCT01970488|26230009|FG000|Part 2: Post Week 16|Withdrawal by Subject|0|||
13204823|NCT01970488|26230010|FG001|Part 2: Post Week 16|Withdrawal by Subject|0|||
13204824|NCT01970488|26230011|FG002|Part 2: Post Week 16|Withdrawal by Subject|8|||
13204825|NCT01970488|26230012|FG003|Part 2: Post Week 16|Withdrawal by Subject|3|||
13204826|NCT01970488|26230013|FG004|Part 2: Post Week 16|Withdrawal by Subject|3|||
13204827|NCT01970488|26230009|FG000|Part 2: Post Week 16|Lost to Follow-up|0|||
13204828|NCT01970488|26230010|FG001|Part 2: Post Week 16|Lost to Follow-up|0|||
13204829|NCT01970488|26230011|FG002|Part 2: Post Week 16|Lost to Follow-up|1|||
13204830|NCT01970488|26230012|FG003|Part 2: Post Week 16|Lost to Follow-up|1|||
13204831|NCT01970488|26230013|FG004|Part 2: Post Week 16|Lost to Follow-up|2|||
13204832|NCT01970475|26230038|FG000|Overall Study|Withdrawal by Subject|11|||
13204833|NCT01970475|26230039|FG001|Overall Study|Withdrawal by Subject|6|||
13204834|NCT01970475|26230038|FG000|Overall Study|Adverse Event|7|||
13204835|NCT01970475|26230039|FG001|Overall Study|Adverse Event|3|||
13204836|NCT01970475|26230038|FG000|Overall Study|Lost to Follow-up|2|||
13204837|NCT01970475|26230039|FG001|Overall Study|Lost to Follow-up|2|||
13204838|NCT01970475|26230038|FG000|Overall Study|Protocol Violation|1|||
13204839|NCT01970475|26230039|FG001|Overall Study|Protocol Violation|0|||
13204840|NCT01970462|26230058|FG000|Overall Study|Lost to Follow-up|0|||
13204841|NCT01970462|26230059|FG001|Overall Study|Lost to Follow-up|2|||
13204842|NCT01970397|26230076|FG000|Overall Study|Adverse Event|0|||
13204843|NCT01970397|26230077|FG001|Overall Study|Adverse Event|1|||
13204844|NCT01970397|26230076|FG000|Overall Study|Lost to Follow-up|0|||
13204845|NCT01970397|26230077|FG001|Overall Study|Lost to Follow-up|1|||
13204846|NCT01970397|26230076|FG000|Overall Study|Personal Reasons|1|||
13204847|NCT01970397|26230077|FG001|Overall Study|Personal Reasons|2|||
13204848|NCT01970397|26230076|FG000|Overall Study|Protocol Violation|1|||
13204849|NCT01970397|26230077|FG001|Overall Study|Protocol Violation|1|||
13204850|NCT01970371|26230110|FG000|Overall Study|Death|8|||
13204851|NCT01970371|26230111|FG001|Overall Study|Death|13|||
13204852|NCT01970371|26230112|FG002|Overall Study|Death|12|||
13204853|NCT01970371|26230110|FG000|Overall Study|Lost to Follow-up|0|||
13204854|NCT01970371|26230111|FG001|Overall Study|Lost to Follow-up|0|||
13204855|NCT01970371|26230112|FG002|Overall Study|Lost to Follow-up|1|||
13204856|NCT01970241|26230159|FG000|Overall Study|Withdrawal by Subject|2|||
13204857|NCT01970241|26230160|FG001|Overall Study|Withdrawal by Subject|0|||
13204858|NCT01970241|26230159|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15|||
13141618|NCT02669121|26016096|FG000|Overall Study|Adverse Event|4|||
13141619|NCT02669121|26016097|FG001|Overall Study|Adverse Event|5|||
13141620|NCT02669121|26016096|FG000|Overall Study|Lost to Follow-up|15|||
13141621|NCT02669121|26016097|FG001|Overall Study|Lost to Follow-up|27|||
13141622|NCT02669121|26016096|FG000|Overall Study|Withdrawal by Subject|132|||
13141623|NCT02669121|26016097|FG001|Overall Study|Withdrawal by Subject|140|||
13141624|NCT02669121|26016096|FG000|Overall Study|Pregnancy|0|||
13141625|NCT02669121|26016097|FG001|Overall Study|Pregnancy|1|||
13141626|NCT02669121|26016096|FG000|Overall Study|Discharged from US Military Active Service|117|||
13141627|NCT02669121|26016097|FG001|Overall Study|Discharged from US Military Active Service|91|||
13141628|NCT02669121|26016096|FG000|Overall Study|Reason not Specified|22|||
13141629|NCT02669121|26016097|FG001|Overall Study|Reason not Specified|18|||
13141630|NCT02669095|26016112|FG000|Overall Study|Adverse Event|1|||
13141631|NCT02669095|26016113|FG001|Overall Study|Adverse Event|0|||
13141632|NCT02669095|26016112|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
13141633|NCT02669095|26016113|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
13141634|NCT02669095|26016112|FG000|Overall Study|Torn Lens|0|||
13141635|NCT02669095|26016113|FG001|Overall Study|Torn Lens|1|||
13141636|NCT02669095|26016112|FG000|Overall Study|Visit 5 assessments not completed|0|||
13141637|NCT02669095|26016113|FG001|Overall Study|Visit 5 assessments not completed|1|||
13141638|NCT02669082|26016127|FG000|Overall Study|Adverse Event|1|||
13141639|NCT02669043|26016133|FG000|Overall Study|Didn't meet I/E criteria|4|||
13141640|NCT02669017|26016283|FG000|Overall Study|Death|1|||
13141641|NCT02669017|26016284|FG001|Overall Study|Death|2|||
13141642|NCT02669017|26016285|FG002|Overall Study|Death|2|||
13141643|NCT02669017|26016286|FG003|Overall Study|Death|3|||
13141644|NCT02669017|26016287|FG004|Overall Study|Death|8|||
13141645|NCT02669017|26016288|FG005|Overall Study|Death|18|||
13141646|NCT02669017|26016289|FG006|Overall Study|Death|10|||
13141647|NCT02669017|26016290|FG007|Overall Study|Death|47|||
13141648|NCT02669017|26016291|FG008|Overall Study|Death|20|||
13141649|NCT02669017|26016283|FG000|Overall Study|Withdrawal by Subject|0|||
13141650|NCT02669017|26016284|FG001|Overall Study|Withdrawal by Subject|0|||
13141651|NCT02669017|26016285|FG002|Overall Study|Withdrawal by Subject|0|||
13141652|NCT02669017|26016286|FG003|Overall Study|Withdrawal by Subject|1|||
13141653|NCT02669017|26016287|FG004|Overall Study|Withdrawal by Subject|2|||
13141654|NCT02669017|26016288|FG005|Overall Study|Withdrawal by Subject|0|||
13141655|NCT02669017|26016289|FG006|Overall Study|Withdrawal by Subject|0|||
13141656|NCT02669017|26016290|FG007|Overall Study|Withdrawal by Subject|2|||
13141657|NCT02669017|26016291|FG008|Overall Study|Withdrawal by Subject|2|||
13141658|NCT02669017|26016283|FG000|Overall Study|Lost to Follow-up|0|||
13141659|NCT02669017|26016284|FG001|Overall Study|Lost to Follow-up|0|||
13141660|NCT02669017|26016285|FG002|Overall Study|Lost to Follow-up|0|||
13141661|NCT02669017|26016286|FG003|Overall Study|Lost to Follow-up|0|||
13141662|NCT02669017|26016287|FG004|Overall Study|Lost to Follow-up|0|||
13141663|NCT02669017|26016288|FG005|Overall Study|Lost to Follow-up|0|||
13141664|NCT02669017|26016289|FG006|Overall Study|Lost to Follow-up|0|||
13141665|NCT02669017|26016290|FG007|Overall Study|Lost to Follow-up|0|||
13141666|NCT02669017|26016291|FG008|Overall Study|Lost to Follow-up|1|||
13141667|NCT02669017|26016283|FG000|Overall Study|Miscellaneous|0|||
13141668|NCT02669017|26016284|FG001|Overall Study|Miscellaneous|0|||
13141669|NCT02669017|26016285|FG002|Overall Study|Miscellaneous|0|||
13141670|NCT02669017|26016286|FG003|Overall Study|Miscellaneous|0|||
13141671|NCT02669017|26016287|FG004|Overall Study|Miscellaneous|2|||
13141672|NCT02669017|26016288|FG005|Overall Study|Miscellaneous|1|||
13141673|NCT02669017|26016289|FG006|Overall Study|Miscellaneous|1|||
13141674|NCT02669017|26016290|FG007|Overall Study|Miscellaneous|13|||
13141675|NCT02669017|26016291|FG008|Overall Study|Miscellaneous|2|||
13141676|NCT02668692|26016308|FG000|Overall Study|Adverse Event|1|||
13141677|NCT02668692|26016309|FG001|Overall Study|Adverse Event|0|||
13141678|NCT02668640|26016322|FG000|Overall Study|Lost to Follow-up|13|||
13141679|NCT02668640|26016322|FG000|Overall Study|Other, not specified|1|||
13141680|NCT02668393|26016336|FG000|Overall Study|Progressive disease|6|||
13141681|NCT02668393|26016337|FG001|Overall Study|Progressive disease|3|||
13141682|NCT02668393|26016336|FG000|Overall Study|Adverse Event|0|||
13141683|NCT02668393|26016337|FG001|Overall Study|Adverse Event|2|||
13141684|NCT02668393|26016336|FG000|Overall Study|Withdrawal from the trial|0|||
13141685|NCT02668393|26016337|FG001|Overall Study|Withdrawal from the trial|1|||
13141686|NCT02668393|26016336|FG000|Overall Study|Lack of benefit and side effects|1|||
13141687|NCT02668393|26016337|FG001|Overall Study|Lack of benefit and side effects|0|||
13141688|NCT02668302|26016350|FG000|Overall Study|Withdrawal by Subject|1|||
13141689|NCT02668302|26016351|FG001|Overall Study|Withdrawal by Subject|0|||
13141690|NCT02668185|26016368|FG000|First Intervention (4 Weeks)|Physician Decision|2|||
13141691|NCT02668185|26016369|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
13141692|NCT02668185|26016368|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
13141693|NCT02668185|26016369|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
13141694|NCT02668185|26016368|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
13141695|NCT02668185|26016369|FG001|Washout Period (2 Weeks)|Physician Decision|2|||
13141696|NCT02668185|26016368|FG000|Second Intervention (4 Weeks)|Physician Decision|1|||
13141697|NCT02668185|26016369|FG001|Second Intervention (4 Weeks)|Physician Decision|3|||
13141698|NCT02667912|26016428|FG000|Overall Study|Death|3|||
13141699|NCT02667912|26016429|FG001|Overall Study|Death|1|||
13141700|NCT02667912|26016428|FG000|Overall Study|Withdrawal by Subject|1|||
13141701|NCT02667912|26016429|FG001|Overall Study|Withdrawal by Subject|2|||
13141702|NCT02667912|26016428|FG000|Overall Study|Withdrawal by Subject|1|||
13141703|NCT02667912|26016429|FG001|Overall Study|Withdrawal by Subject|0|||
13141704|NCT02667626|26016450|FG000|Overall Study|Withdrawal by Subject|0|||
13141705|NCT02667626|26016451|FG001|Overall Study|Withdrawal by Subject|1|||
13141706|NCT02667457|26016482|FG000|Overall Study|Withdrawal by Subject|1|||
13141707|NCT02667457|26016483|FG001|Overall Study|Withdrawal by Subject|0|||
13141708|NCT02667457|26016482|FG000|Overall Study|Other Reason|0|||
13141709|NCT02667457|26016483|FG001|Overall Study|Other Reason|2|||
13141710|NCT02667301|26016491|FG000|Overall Study|Adverse Event|1|||
13141711|NCT02667301|26016491|FG000|Overall Study|Lack of Efficacy|1|||
13141712|NCT02667288|26016498|FG000|Overall Study|Protocol Violation|5|||
13141713|NCT02667288|26016498|FG000|Overall Study|Lost to Follow-up|3|||
13141714|NCT02667288|26016498|FG000|Overall Study|Withdrawal by Subject|5|||
13141715|NCT02667275|26016513|FG000|Overall Study|Protocol Violation|11|||
13141716|NCT02667275|26016514|FG001|Overall Study|Protocol Violation|7|||
13141717|NCT02667275|26016513|FG000|Overall Study|Lost to Follow-up|0|||
13141718|NCT02667275|26016514|FG001|Overall Study|Lost to Follow-up|2|||
13141719|NCT02667275|26016513|FG000|Overall Study|Withdrawal by Subject|0|||
13141720|NCT02667275|26016514|FG001|Overall Study|Withdrawal by Subject|5|||
13141721|NCT02667275|26016513|FG000|Overall Study|Discontinued early without completing|0|||
13141722|NCT02667275|26016514|FG001|Overall Study|Discontinued early without completing|1|||
13141723|NCT02667236|26016529|FG000|Overall Study|Adverse Event|1|||
13141724|NCT02667236|26016530|FG001|Overall Study|Adverse Event|1|||
13141725|NCT02667236|26016529|FG000|Overall Study|Withdrawal by Subject|2|||
13141726|NCT02667236|26016530|FG001|Overall Study|Withdrawal by Subject|0|||
13141727|NCT02667119|26016555|FG000|Overall Study|Lost to Follow-up|3|||
13141728|NCT02667119|26016556|FG001|Overall Study|Lost to Follow-up|0|||
13141729|NCT02666664|26016627|FG000|Overall Study|Physician Decision|0|||
13141730|NCT02666664|26016628|FG001|Overall Study|Physician Decision|1|||
13141731|NCT02666664|26016627|FG000|Overall Study|Protocol Violation|0|||
13141732|NCT02666664|26016628|FG001|Overall Study|Protocol Violation|2|||
13141733|NCT02666664|26016627|FG000|Overall Study|Other|0|||
13141734|NCT02666664|26016628|FG001|Overall Study|Other|1|||
13141735|NCT02666664|26016627|FG000|Overall Study|Adverse Event|12|||
13141736|NCT02666664|26016628|FG001|Overall Study|Adverse Event|37|||
13141737|NCT02666664|26016627|FG000|Overall Study|Withdrawal by participant|23|||
13141738|NCT02666664|26016628|FG001|Overall Study|Withdrawal by participant|40|||
13141739|NCT02666664|26016627|FG000|Overall Study|Sponsor decision|0|||
13141740|NCT02666664|26016628|FG001|Overall Study|Sponsor decision|1|||
13141741|NCT02666664|26016627|FG000|Overall Study|Lost to Follow-up|1|||
13141742|NCT02666664|26016628|FG001|Overall Study|Lost to Follow-up|2|||
13141743|NCT02666430|26016661|FG000|Period 1|Lost to Follow-up|1|||
13141744|NCT02666430|26016662|FG001|Period 1|Lost to Follow-up|0|||
13141745|NCT02666430|26016661|FG000|Period 1|Adverse Event|0|||
13141746|NCT02666430|26016662|FG001|Period 1|Adverse Event|1|||
13141747|NCT02666430|26016661|FG000|Period 2|Withdrawal by Subject|1|||
13141748|NCT02666430|26016662|FG001|Period 2|Withdrawal by Subject|4|||
13141749|NCT02666430|26016661|FG000|Period 3|Lost to Follow-up|1|||
13141750|NCT02666430|26016662|FG001|Period 3|Lost to Follow-up|0|||
13141751|NCT02666222|26016672|FG000|Overall Study|Death|2|||
13141752|NCT02665689|26016699|FG000|Overall Study|Adverse Event|1|||
13141753|NCT02665689|26016700|FG001|Overall Study|Adverse Event|0|||
13141754|NCT02665689|26016699|FG000|Overall Study|Trial termination|1|||
13141755|NCT02665689|26016700|FG001|Overall Study|Trial termination|1|||
13141756|NCT02665689|26016699|FG000|Overall Study|Lost to Follow-up|0|||
13141757|NCT02665689|26016700|FG001|Overall Study|Lost to Follow-up|1|||
13141758|NCT02665455|26016706|FG000|Overall Study|Withdrawal by Subject|6|||
13091670|NCT03727841|25825204|FG000|Overall Study|Physician Decision|3|||
13091671|NCT03727841|25825205|FG001|Overall Study|Physician Decision|1|||
13091672|NCT03727347|25825229|FG000|Overall Study|Withdrawal by Subject|2|||
13091673|NCT03727347|25825229|FG000|Overall Study|Lost to Follow-up|1|||
13091674|NCT03726996|25825239|FG000|Overall Study|Parent's decision|2|||
13091675|NCT03726996|25825239|FG000|Overall Study|Study early termination|2|||
13091676|NCT03726879|25825278|FG000|Overall Study|Death|6|||
13091677|NCT03726879|25825279|FG001|Overall Study|Death|4|||
13091678|NCT03726879|25825278|FG000|Overall Study|Physician Decision|0|||
13091679|NCT03726879|25825279|FG001|Overall Study|Physician Decision|2|||
13091680|NCT03726879|25825278|FG000|Overall Study|Protocol Violation|0|||
13091681|NCT03726879|25825279|FG001|Overall Study|Protocol Violation|1|||
13091682|NCT03726879|25825278|FG000|Overall Study|Withdrawal by Subject|5|||
13091683|NCT03726879|25825279|FG001|Overall Study|Withdrawal by Subject|5|||
13091684|NCT03726879|25825278|FG000|Overall Study|TSH result is unstable|0|||
13141759|NCT02665455|26016706|FG000|Overall Study|Lost to Follow-up|1|||
13091685|NCT03726879|25825279|FG001|Overall Study|TSH result is unstable|1|||
13091686|NCT03726879|25825278|FG000|Overall Study|Continuing on Study|215|||
13091687|NCT03726879|25825279|FG001|Overall Study|Continuing on Study|215|||
13091688|NCT03725982|25825315|FG000|First Intervention|Withdrawal by Subject|0|||
13091689|NCT03725982|25825316|FG001|First Intervention|Withdrawal by Subject|1|||
13091690|NCT03725982|25825315|FG000|First Intervention|Physician Decision|1|||
13091691|NCT03725982|25825316|FG001|First Intervention|Physician Decision|1|||
13091692|NCT03725852|25825346|FG000|Overall Study|Death|1|||
13091693|NCT03725852|25825347|FG001|Overall Study|Death|0|||
13091694|NCT03725852|25825346|FG000|Overall Study|Withdrawal by Subject|1|||
13091695|NCT03725852|25825347|FG001|Overall Study|Withdrawal by Subject|0|||
13091696|NCT03725852|25825346|FG000|Overall Study|Travel restrictions due to COVID-19|2|||
13091697|NCT03725852|25825347|FG001|Overall Study|Travel restrictions due to COVID-19|0|||
13091698|NCT03725722|25825390|FG000|Overall Study|Lack of Efficacy|2|||
13091699|NCT03725722|25825391|FG001|Overall Study|Lack of Efficacy|1|||
13091700|NCT03725722|25825392|FG002|Overall Study|Lack of Efficacy|2|||
13091701|NCT03725722|25825393|FG003|Overall Study|Lack of Efficacy|0|||
13091702|NCT03725722|25825394|FG004|Overall Study|Lack of Efficacy|2|||
13091703|NCT03725722|25825390|FG000|Overall Study|Adverse Event|2|||
13091704|NCT03725722|25825391|FG001|Overall Study|Adverse Event|2|||
13091705|NCT03725722|25825392|FG002|Overall Study|Adverse Event|1|||
13091706|NCT03725722|25825393|FG003|Overall Study|Adverse Event|0|||
13091707|NCT03725722|25825394|FG004|Overall Study|Adverse Event|6|||
13091708|NCT03725722|25825390|FG000|Overall Study|Withdrawal by Subject|4|||
13091709|NCT03725722|25825391|FG001|Overall Study|Withdrawal by Subject|1|||
13091710|NCT03725722|25825392|FG002|Overall Study|Withdrawal by Subject|0|||
13091711|NCT03725722|25825393|FG003|Overall Study|Withdrawal by Subject|4|||
13091712|NCT03725722|25825394|FG004|Overall Study|Withdrawal by Subject|4|||
13091713|NCT03725722|25825390|FG000|Overall Study|Lost to Follow-up|3|||
13091714|NCT03725722|25825391|FG001|Overall Study|Lost to Follow-up|1|||
13091715|NCT03725722|25825392|FG002|Overall Study|Lost to Follow-up|2|||
13091716|NCT03725722|25825393|FG003|Overall Study|Lost to Follow-up|2|||
13091717|NCT03725722|25825394|FG004|Overall Study|Lost to Follow-up|1|||
13091718|NCT03725722|25825390|FG000|Overall Study|Personal reasons|0|||
13091719|NCT03725722|25825391|FG001|Overall Study|Personal reasons|0|||
13091720|NCT03725722|25825392|FG002|Overall Study|Personal reasons|1|||
13091721|NCT03725722|25825393|FG003|Overall Study|Personal reasons|0|||
13091722|NCT03725722|25825394|FG004|Overall Study|Personal reasons|1|||
13091723|NCT03725722|25825390|FG000|Overall Study|COVID-19 situation|0|||
13091724|NCT03725722|25825391|FG001|Overall Study|COVID-19 situation|1|||
13141760|NCT02665455|26016706|FG000|Overall Study|Adverse Event|1|||
13141761|NCT02665455|26016706|FG000|Overall Study|Protocol Violation|1|||
13141762|NCT02665338|26016721|FG000|Overall Study|Withdrawal by Subject|0|||
13141763|NCT02665338|26016722|FG001|Overall Study|Withdrawal by Subject|1|||
13141764|NCT02665286|26016749|FG000|Overall Study|Lost to Follow-up|3|||
13141765|NCT02665286|26016750|FG001|Overall Study|Lost to Follow-up|2|||
13141766|NCT02665286|26016751|FG002|Overall Study|Lost to Follow-up|1|||
13141767|NCT02665052|26016779|FG000|Overall Study|Lost to Follow-up|1|||
13141768|NCT02665052|26016780|FG001|Overall Study|Lost to Follow-up|0|||
13141769|NCT02665052|26016781|FG002|Overall Study|Lost to Follow-up|0|||
13141770|NCT02665052|26016782|FG003|Overall Study|Lost to Follow-up|0|||
13141771|NCT02665052|26016779|FG000|Overall Study|Withdrawal by Subject|1|||
13141772|NCT02665052|26016780|FG001|Overall Study|Withdrawal by Subject|1|||
13141773|NCT02665052|26016781|FG002|Overall Study|Withdrawal by Subject|0|||
13141774|NCT02665052|26016782|FG003|Overall Study|Withdrawal by Subject|5|||
13141775|NCT02665052|26016779|FG000|Overall Study|Adverse Event|1|||
13141776|NCT02665052|26016780|FG001|Overall Study|Adverse Event|1|||
13141777|NCT02665052|26016781|FG002|Overall Study|Adverse Event|0|||
13141778|NCT02665052|26016782|FG003|Overall Study|Adverse Event|0|||
13141779|NCT02664441|26016816|FG000|Randomization|Withdrawal by Subject|0|||
13141780|NCT02664441|26016817|FG001|Randomization|Withdrawal by Subject|1|||
13141781|NCT02664441|26016816|FG000|36-week Randomized Trial|Adverse Event|2|||
13141782|NCT02664441|26016817|FG001|36-week Randomized Trial|Adverse Event|0|||
13141783|NCT02664441|26016816|FG000|36-week Randomized Trial|Lost to Follow-up|1|||
13141784|NCT02664441|26016817|FG001|36-week Randomized Trial|Lost to Follow-up|0|||
13141785|NCT02664441|26016816|FG000|36-week Randomized Trial|Withdrawal by Subject|0|||
13091725|NCT03725722|25825392|FG002|Overall Study|COVID-19 situation|0|||
13091726|NCT03725722|25825393|FG003|Overall Study|COVID-19 situation|0|||
13091727|NCT03725722|25825394|FG004|Overall Study|COVID-19 situation|0|||
13091728|NCT03725085|25825404|FG000|Overall Study|Lost to Follow-up|2|||
13091729|NCT03724981|25825415|FG000|First Device|Protocol Violation|1|||
13091730|NCT03724981|25825416|FG001|First Device|Protocol Violation|1|||
13091731|NCT03724968|25825437|FG000|Overall Study|Insurance issues|0|||
13091732|NCT03724968|25825438|FG001|Overall Study|Insurance issues|1|||
13141786|NCT02664441|26016817|FG001|36-week Randomized Trial|Withdrawal by Subject|3|||
13141787|NCT02664441|26016816|FG000|18-week Open Label Extension|Adverse Event|1|||
13141788|NCT02664441|26016817|FG001|18-week Open Label Extension|Adverse Event|0|||
13141789|NCT02664441|26016816|FG000|18-week Open Label Extension|Physician Decision|1|||
13141790|NCT02664441|26016817|FG001|18-week Open Label Extension|Physician Decision|0|||
13141791|NCT02664441|26016816|FG000|18-week Open Label Extension|Death|1|||
13141792|NCT02664441|26016817|FG001|18-week Open Label Extension|Death|0|||
13141793|NCT02664441|26016816|FG000|18-week Open Label Extension|Lost to Follow-up|0|||
13141794|NCT02664441|26016817|FG001|18-week Open Label Extension|Lost to Follow-up|1|||
13141795|NCT02664415|26016852|FG000|Overall Study|Adverse Event|1|||
13141796|NCT02664415|26016853|FG001|Overall Study|Adverse Event|0|||
13141797|NCT02664272|26016861|FG000|Overall Study|Fluoroscopic images not made available|2|||
13141798|NCT02663895|26016878|FG000|Overall Study|Adverse Event|3|||
13141799|NCT02663895|26016878|FG000|Overall Study|Physician Decision|2|||
13141800|NCT02663895|26016878|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1|||
13141801|NCT02663895|26016878|FG000|Overall Study|Withdrawal by Subject|1|||
13141802|NCT02663882|26016897|FG000|Overall Study|Lost to Follow-up|4|||
13141803|NCT02663882|26016898|FG001|Overall Study|Lost to Follow-up|2|||
13141804|NCT02663817|26016906|FG000|Overall Study|Screen failure|2|||
13141805|NCT02663687|26016974|FG000|Overall Study|Adverse Event|1|||
13141806|NCT02663687|26016975|FG001|Overall Study|Adverse Event|0|||
13141807|NCT02663687|26016976|FG002|Overall Study|Adverse Event|0|||
13141808|NCT02663687|26016977|FG003|Overall Study|Adverse Event|0|||
13141809|NCT02663687|26016978|FG004|Overall Study|Adverse Event|0|||
13141810|NCT02663687|26016974|FG000|Overall Study|Other|1|||
13141811|NCT02663687|26016975|FG001|Overall Study|Other|0|||
13141812|NCT02663687|26016976|FG002|Overall Study|Other|1|||
13141813|NCT02663687|26016977|FG003|Overall Study|Other|0|||
13141814|NCT02663687|26016978|FG004|Overall Study|Other|0|||
13141815|NCT02663674|26017247|FG000|Overall Study|Lost to Follow-up|5|||
13141816|NCT02663674|26017248|FG001|Overall Study|Lost to Follow-up|4|||
13141817|NCT02663674|26017247|FG000|Overall Study|Withdrawal by Subject|1|||
13141818|NCT02663674|26017248|FG001|Overall Study|Withdrawal by Subject|4|||
13141819|NCT02663674|26017247|FG000|Overall Study|Physician Decision|1|||
13141820|NCT02663674|26017248|FG001|Overall Study|Physician Decision|1|||
13141821|NCT02663674|26017247|FG000|Overall Study|Other Event (Health Related)|0|||
13141822|NCT02663674|26017248|FG001|Overall Study|Other Event (Health Related)|1|||
13141823|NCT02663453|26017277|FG000|Overall Study|Death|4|||
13141824|NCT02663453|26017278|FG001|Overall Study|Death|4|||
13141825|NCT02663453|26017277|FG000|Overall Study|Withdrawal by Subject|1|||
13141826|NCT02663453|26017278|FG001|Overall Study|Withdrawal by Subject|0|||
13141827|NCT02663271|26017287|FG000|Overall Study|Withdrawal by Subject|5|||
13141828|NCT02663271|26017287|FG000|Overall Study|Lack of Efficacy|1|||
13141829|NCT02663128|26017312|FG000|Period 2|Physician Decision|0|||
13141830|NCT02663128|26017313|FG001|Period 2|Physician Decision|0|||
13141831|NCT02663128|26017314|FG002|Period 2|Physician Decision|0|||
13141832|NCT02663128|26017315|FG003|Period 2|Physician Decision|0|||
13141833|NCT02663128|26017316|FG004|Period 2|Physician Decision|1|||
13141834|NCT02663128|26017317|FG005|Period 2|Physician Decision|0|||
13141835|NCT02662764|26017379|FG000|Overall Study|Adverse Event|6|||
13141836|NCT02662764|26017379|FG000|Overall Study|Lack of Efficacy|8|||
13141837|NCT02662764|26017379|FG000|Overall Study|Protocol Violation|1|||
13141838|NCT02662764|26017379|FG000|Overall Study|Withdrawal by Subject|5|||
13141839|NCT02662764|26017379|FG000|Overall Study|Device failure|4|||
13141840|NCT02662764|26017379|FG000|Overall Study|Patient changed treatment|1|||
13141841|NCT02662764|26017379|FG000|Overall Study|Patient discharged prior to 24 hrs|5|||
13141842|NCT02662582|26017440|FG000|Treatment Period 1 (14 Days)|Adverse Event|3|||
13141843|NCT02662582|26017441|FG001|Treatment Period 1 (14 Days)|Adverse Event|2|||
13141844|NCT02662582|26017440|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0|||
13141845|NCT02662582|26017441|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1|||
13141846|NCT02662582|26017440|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1|||
13141847|NCT02662582|26017441|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0|||
13141848|NCT02662582|26017440|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
13141849|NCT02662582|26017441|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
13141850|NCT02662569|26017552|FG000|Overall Study|Withdrawal by Subject|6|||
13141851|NCT02662569|26017553|FG001|Overall Study|Withdrawal by Subject|1|||
13141852|NCT02662569|26017554|FG002|Overall Study|Withdrawal by Subject|6|||
13141853|NCT02662569|26017555|FG003|Overall Study|Withdrawal by Subject|4|||
13141854|NCT02662569|26017552|FG000|Overall Study|Lost to Follow-up|1|||
13141855|NCT02662569|26017553|FG001|Overall Study|Lost to Follow-up|0|||
13141856|NCT02662569|26017554|FG002|Overall Study|Lost to Follow-up|0|||
13141857|NCT02662569|26017555|FG003|Overall Study|Lost to Follow-up|0|||
13141858|NCT02662556|26017564|FG000|Overall Study|Adverse Event|4|||
13141859|NCT02662556|26017564|FG000|Overall Study|Lack of Efficacy|4|||
13141860|NCT02661815|26017591|FG000|Overall Study|Withdrawal by Subject|1|||
13141861|NCT02661815|26017592|FG001|Overall Study|Withdrawal by Subject|0|||
13141862|NCT02661815|26017593|FG002|Overall Study|Withdrawal by Subject|0|||
13141863|NCT02661815|26017594|FG003|Overall Study|Withdrawal by Subject|0|||
13141864|NCT02661594|26017617|FG000|Overall Study|Protocol Violation|1|||
13141865|NCT02661594|26017618|FG001|Overall Study|Protocol Violation|0|||
13141866|NCT02661594|26017619|FG002|Overall Study|Protocol Violation|1|||
13141867|NCT02661594|26017620|FG003|Overall Study|Protocol Violation|0|||
13141868|NCT02661490|26017773|FG000|Overall Study|Lost to Follow-up|0|||
13141869|NCT02661490|26017774|FG001|Overall Study|Lost to Follow-up|1|||
13141870|NCT02661490|26017775|FG002|Overall Study|Lost to Follow-up|0|||
13141871|NCT02661490|26017776|FG003|Overall Study|Lost to Follow-up|0|||
13141872|NCT02661490|26017777|FG004|Overall Study|Lost to Follow-up|2|||
13141873|NCT02661490|26017773|FG000|Overall Study|Withdrawal by Subject|2|||
13141874|NCT02661490|26017774|FG001|Overall Study|Withdrawal by Subject|0|||
13141875|NCT02661490|26017775|FG002|Overall Study|Withdrawal by Subject|2|||
13141876|NCT02661490|26017776|FG003|Overall Study|Withdrawal by Subject|0|||
13141877|NCT02661490|26017777|FG004|Overall Study|Withdrawal by Subject|0|||
13141878|NCT02661490|26017773|FG000|Overall Study|Death|1|||
13141879|NCT02661490|26017774|FG001|Overall Study|Death|1|||
13141880|NCT02661490|26017775|FG002|Overall Study|Death|0|||
13141881|NCT02661490|26017776|FG003|Overall Study|Death|1|||
13141882|NCT02661490|26017777|FG004|Overall Study|Death|0|||
13141883|NCT02661490|26017773|FG000|Overall Study|Reason not Specified|0|||
13141884|NCT02661490|26017774|FG001|Overall Study|Reason not Specified|0|||
13141885|NCT02661490|26017775|FG002|Overall Study|Reason not Specified|0|||
13141886|NCT02661490|26017776|FG003|Overall Study|Reason not Specified|0|||
13141887|NCT02661490|26017777|FG004|Overall Study|Reason not Specified|1|||
13141888|NCT02661217|26017799|FG000|Overall Study|Physician Decision|12|||
13141889|NCT02661217|26017800|FG001|Overall Study|Physician Decision|15|||
13141890|NCT02661217|26017799|FG000|Overall Study|Lost to Follow-up|1|||
13141891|NCT02661217|26017800|FG001|Overall Study|Lost to Follow-up|4|||
13141892|NCT02661217|26017799|FG000|Overall Study|Protocol Deviation|0|||
13141893|NCT02661217|26017800|FG001|Overall Study|Protocol Deviation|4|||
13141894|NCT02661217|26017799|FG000|Overall Study|Non-compliance with study treatment|5|||
13141895|NCT02661217|26017800|FG001|Overall Study|Non-compliance with study treatment|5|||
13141896|NCT02661217|26017799|FG000|Overall Study|Death|21|||
13141897|NCT02661217|26017800|FG001|Overall Study|Death|15|||
13141898|NCT02661217|26017799|FG000|Overall Study|Adverse Event|10|||
13141899|NCT02661217|26017800|FG001|Overall Study|Adverse Event|8|||
13141900|NCT02661217|26017799|FG000|Overall Study|Withdrawal by Subject|15|||
13141901|NCT02661217|26017800|FG001|Overall Study|Withdrawal by Subject|19|||
13141902|NCT02661217|26017799|FG000|Overall Study|Did not enter follow-up epoch|7|||
13141903|NCT02661217|26017800|FG001|Overall Study|Did not enter follow-up epoch|10|||
13141904|NCT02661217|26017799|FG000|Overall Study|Death - no study drug received|1|||
13141905|NCT02661217|26017800|FG001|Overall Study|Death - no study drug received|2|||
13141906|NCT02661217|26017799|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3|||
13141907|NCT02661217|26017800|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1|||
13141908|NCT02661178|26018111|FG000|Part 1|Protocol Violation|1|||
13141909|NCT02661178|26018112|FG001|Part 1|Protocol Violation|0|||
13141910|NCT02661178|26018113|FG002|Part 1|Protocol Violation|0|||
13141911|NCT02661178|26018114|FG003|Part 1|Protocol Violation|0|||
13141912|NCT02661178|26018115|FG004|Part 1|Protocol Violation|0|||
13141913|NCT02661178|26018116|FG005|Part 1|Protocol Violation|0|||
13141914|NCT02661178|26018117|FG006|Part 1|Protocol Violation|0|||
13141915|NCT02661178|26018118|FG007|Part 1|Protocol Violation|0|||
13141916|NCT02661178|26018119|FG008|Part 1|Protocol Violation|0|||
13141917|NCT02661178|26018120|FG009|Part 1|Protocol Violation|0|||
13141918|NCT02661178|26018121|FG010|Part 1|Protocol Violation|0|||
13141919|NCT02661178|26018122|FG011|Part 1|Protocol Violation|0|||
13141920|NCT02661178|26018123|FG012|Part 1|Protocol Violation|0|||
13141921|NCT02661178|26018124|FG013|Part 1|Protocol Violation|0|||
13141922|NCT02661178|26018125|FG014|Part 1|Protocol Violation|0|||
13141923|NCT02661061|26018140|FG000|Overall Study|Lack of Efficacy|1|||
13141924|NCT02661061|26018141|FG001|Overall Study|Lack of Efficacy|1|||
13141925|NCT02661061|26018140|FG000|Overall Study|Withdrawal by Subject|1|||
13141926|NCT02661061|26018141|FG001|Overall Study|Withdrawal by Subject|1|||
13141927|NCT02660983|26018161|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1|||
13141928|NCT02660983|26018162|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5|||
13141929|NCT02660983|26018161|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15|||
13141930|NCT02660983|26018162|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12|||
13141931|NCT02660983|26018161|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8|||
13141932|NCT02660983|26018162|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9|||
13141933|NCT02660983|26018161|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
13141934|NCT02660983|26018162|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
13141935|NCT02660983|26018161|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1|||
13141936|NCT02660983|26018162|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4|||
13141937|NCT02660983|26018161|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1|||
13141938|NCT02660983|26018162|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3|||
13141939|NCT02660983|26018161|FG000|Open Label Extension Phase (24 Weeks)|Other|0|||
13141940|NCT02660983|26018162|FG001|Open Label Extension Phase (24 Weeks)|Other|1|||
13141941|NCT02660944|26018181|FG000|Overall Study|Adverse Event|3|||
13141942|NCT02660944|26018182|FG001|Overall Study|Adverse Event|4|||
13141943|NCT02660944|26018181|FG000|Overall Study|Physician Decision|3|||
13141944|NCT02660944|26018182|FG001|Overall Study|Physician Decision|1|||
13141945|NCT02660944|26018181|FG000|Overall Study|Withdrawal by Subject|5|||
13141946|NCT02660944|26018182|FG001|Overall Study|Withdrawal by Subject|3|||
13141947|NCT02660944|26018181|FG000|Overall Study|Lost to Follow-up|4|||
13141948|NCT02660944|26018182|FG001|Overall Study|Lost to Follow-up|1|||
13141949|NCT02660944|26018181|FG000|Overall Study|Subject schedule|0|||
13141950|NCT02660944|26018182|FG001|Overall Study|Subject schedule|1|||
13141951|NCT02660944|26018181|FG000|Overall Study|Exclusion criteria met|2|||
13141952|NCT02660944|26018182|FG001|Overall Study|Exclusion criteria met|0|||
13141953|NCT02660580|26018301|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
13141954|NCT02660580|26018302|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
13141955|NCT02660580|26018303|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
13141956|NCT02660580|26018304|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
13141957|NCT02660580|26018305|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
13141958|NCT02660580|26018301|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3|||
13141959|NCT02660580|26018302|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1|||
13141960|NCT02660580|26018303|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
13141961|NCT02660580|26018304|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
13141962|NCT02660580|26018305|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
13141963|NCT02660580|26018301|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1|||
13141964|NCT02660580|26018302|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
13141965|NCT02660580|26018303|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
13141966|NCT02660580|26018304|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
13141967|NCT02660580|26018305|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
13141968|NCT02660580|26018301|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
13141969|NCT02660580|26018302|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2|||
13141970|NCT02660580|26018303|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
13141971|NCT02660580|26018304|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
13141972|NCT02660580|26018305|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
13141973|NCT02660580|26018301|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2|||
13141974|NCT02660580|26018302|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9|||
13141975|NCT02660580|26018303|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
13141976|NCT02660580|26018304|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
13141977|NCT02660580|26018305|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
13141978|NCT02660580|26018301|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1|||
13141979|NCT02660580|26018302|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4|||
13141980|NCT02660580|26018303|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
13141981|NCT02660580|26018304|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
13141982|NCT02660580|26018305|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
13141983|NCT02660580|26018301|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1|||
13141984|NCT02660580|26018302|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2|||
13141985|NCT02660580|26018303|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
13141986|NCT02660580|26018304|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
13141987|NCT02660580|26018305|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
13141988|NCT02660580|26018301|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
13141989|NCT02660580|26018302|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
13141990|NCT02660580|26018303|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2|||
13141991|NCT02660580|26018304|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
13141992|NCT02660580|26018305|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1|||
13141993|NCT02660580|26018301|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
13141994|NCT02660580|26018302|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
13141995|NCT02660580|26018303|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
13141996|NCT02660580|26018304|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
13141997|NCT02660580|26018305|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
13141998|NCT02660580|26018301|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
13141999|NCT02660580|26018302|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
13142000|NCT02660580|26018303|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4|||
13142001|NCT02660580|26018304|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
13142002|NCT02660580|26018305|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
13142003|NCT02660580|26018301|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
13142004|NCT02660580|26018302|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
13142005|NCT02660580|26018303|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8|||
13142006|NCT02660580|26018304|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6|||
13142007|NCT02660580|26018305|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4|||
13142008|NCT02660580|26018301|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
13142009|NCT02660580|26018302|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
13142010|NCT02660580|26018303|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3|||
13142011|NCT02660580|26018304|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
13142012|NCT02660580|26018305|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
13142013|NCT02660580|26018301|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
13142014|NCT02660580|26018302|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
13142015|NCT02660580|26018303|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
13142016|NCT02660580|26018304|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
13142017|NCT02660580|26018305|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
13142018|NCT02660489|26018332|FG000|Overall Study|Lost to Follow-up|1|||
13142019|NCT02660489|26018333|FG001|Overall Study|Lost to Follow-up|1|||
13142020|NCT02660489|26018332|FG000|Overall Study|Adverse Event|1|||
13142021|NCT02660489|26018333|FG001|Overall Study|Adverse Event|3|||
13142022|NCT02660489|26018332|FG000|Overall Study|no rhinovirus infection|4|||
13142023|NCT02660489|26018333|FG001|Overall Study|no rhinovirus infection|4|||
13142024|NCT02660359|26018375|FG000|Overall Study|Protocol Deviation|0|||
13142025|NCT02660359|26018376|FG001|Overall Study|Protocol Deviation|0|||
13142026|NCT02660359|26018377|FG002|Overall Study|Protocol Deviation|1|||
13142027|NCT02660359|26018375|FG000|Overall Study|Sponsor Decision to Terminate Study|73|||
13142028|NCT02660359|26018376|FG001|Overall Study|Sponsor Decision to Terminate Study|75|||
13142029|NCT02660359|26018377|FG002|Overall Study|Sponsor Decision to Terminate Study|71|||
13142030|NCT02660359|26018375|FG000|Overall Study|Lack of Efficacy|1|||
13142031|NCT02660359|26018376|FG001|Overall Study|Lack of Efficacy|1|||
13142032|NCT02660359|26018377|FG002|Overall Study|Lack of Efficacy|1|||
13142033|NCT02660359|26018375|FG000|Overall Study|Adverse Event|0|||
13142034|NCT02660359|26018376|FG001|Overall Study|Adverse Event|1|||
13142035|NCT02660359|26018377|FG002|Overall Study|Adverse Event|0|||
13142036|NCT02660359|26018375|FG000|Overall Study|Other|2|||
13142037|NCT02660359|26018376|FG001|Overall Study|Other|1|||
13142038|NCT02660359|26018377|FG002|Overall Study|Other|3|||
13142039|NCT02660359|26018375|FG000|Overall Study|Withdrawal by Subject|7|||
13142040|NCT02660359|26018376|FG001|Overall Study|Withdrawal by Subject|5|||
13142041|NCT02660359|26018377|FG002|Overall Study|Withdrawal by Subject|8|||
13142042|NCT02660359|26018375|FG000|Overall Study|Lost to Follow-up|3|||
13142043|NCT02660359|26018376|FG001|Overall Study|Lost to Follow-up|3|||
13142044|NCT02660359|26018377|FG002|Overall Study|Lost to Follow-up|0|||
13142045|NCT02660242|26018433|FG000|Glucose Tabs|Lost to Follow-up|1|||
13142046|NCT02660242|26018433|FG000|Glucagon Injection|Lost to Follow-up|1|||
13142047|NCT02660229|26018452|FG000|Overall Study|Adverse Event|2|||
13142048|NCT02660229|26018453|FG001|Overall Study|Adverse Event|0|||
13142049|NCT02660229|26018452|FG000|Overall Study|Withdrawal by Subject|0|||
13142050|NCT02660229|26018453|FG001|Overall Study|Withdrawal by Subject|1|||
13091733|NCT03724968|25825437|FG000|Overall Study|Study closed|0|||
13091734|NCT03724968|25825438|FG001|Overall Study|Study closed|1|||
13142051|NCT02660138|26018498|FG000|Overall Study|Adverse Event|0|||
13091735|NCT03724812|25825462|FG000|Overall Study|Missed Visit|1|||
13091736|NCT03724812|25825462|FG000|Overall Study|Death|2|||
13091737|NCT03724812|25825462|FG000|Overall Study|Withdrawal by Subject|1|||
13091738|NCT03723915|25825473|FG000|Screening|Failed to meet screening requirements.|2|||
13091739|NCT03723915|25825473|FG000|On Treatment|Failed to meet treatment requirements|2|||
13091740|NCT03723590|25825485|FG000|Overall Study|Withdrawal by Subject|3|||
13091741|NCT03723070|25825495|FG000|Overall Study|Lost to Follow-up|2|||
13091742|NCT03723070|25825495|FG000|Overall Study|Physician Decision|1|||
13091743|NCT03723070|25825495|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6|||
13091744|NCT03722784|25825544|FG000|Overall Study|Withdrawal by Subject|1|||
13091745|NCT03722784|25825545|FG001|Overall Study|Withdrawal by Subject|0|||
13091746|NCT03722784|25825544|FG000|Overall Study|Physician Decision|1|||
13091747|NCT03722784|25825545|FG001|Overall Study|Physician Decision|1|||
13091748|NCT03722784|25825544|FG000|Overall Study|Protocol Violation|0|||
13091749|NCT03722784|25825545|FG001|Overall Study|Protocol Violation|1|||
13091750|NCT03722524|25825555|FG000|Overall Study|Protocol Violation|86|||
13091751|NCT03722524|25825555|FG000|Overall Study|Adverse Event|7|||
13091752|NCT03722524|25825555|FG000|Overall Study|Lost to Follow-up|1|||
13091753|NCT03722524|25825555|FG000|Overall Study|Reason is not stated|1|||
13091754|NCT03722524|25825555|FG000|Overall Study|Physician Decision|1|||
13091755|NCT03722524|25825555|FG000|Overall Study|Patient's decision (refusal to continue participation)|3|||
13091756|NCT03722446|25825578|FG000|Overall Study|Protocol Violation|15|||
13091757|NCT03722446|25825579|FG001|Overall Study|Protocol Violation|2|||
13091758|NCT03722264|25825591|FG000|Overall Study|Physician Decision|3|||
13091759|NCT03722238|25825682|FG000|Overall Study|Protocol Violation|1|||
13091760|NCT03722238|25825683|FG001|Overall Study|Protocol Violation|0|||
13091761|NCT03722238|25825682|FG000|Overall Study|Physician Decision|1|||
13142052|NCT02660138|26018499|FG001|Overall Study|Adverse Event|3|||
13142053|NCT02660138|26018500|FG002|Overall Study|Adverse Event|2|||
13091762|NCT03722238|25825683|FG001|Overall Study|Physician Decision|0|||
13091763|NCT03722238|25825682|FG000|Overall Study|Death|1|||
13142054|NCT02660138|26018498|FG000|Overall Study|Lack of Efficacy|1|||
13142055|NCT02660138|26018499|FG001|Overall Study|Lack of Efficacy|2|||
13142056|NCT02660138|26018500|FG002|Overall Study|Lack of Efficacy|1|||
13142057|NCT02660138|26018498|FG000|Overall Study|Withdrawal by Subject|7|||
13142058|NCT02660138|26018499|FG001|Overall Study|Withdrawal by Subject|6|||
13142059|NCT02660138|26018500|FG002|Overall Study|Withdrawal by Subject|6|||
13142060|NCT02660138|26018498|FG000|Overall Study|Lost to Follow-up|4|||
13142061|NCT02660138|26018499|FG001|Overall Study|Lost to Follow-up|4|||
13142062|NCT02660138|26018500|FG002|Overall Study|Lost to Follow-up|1|||
13142063|NCT02660138|26018498|FG000|Overall Study|Sponsor Decision to Terminate Study|57|||
13142064|NCT02660138|26018499|FG001|Overall Study|Sponsor Decision to Terminate Study|57|||
13142065|NCT02660138|26018500|FG002|Overall Study|Sponsor Decision to Terminate Study|62|||
13142066|NCT02660138|26018498|FG000|Overall Study|Other|1|||
13142067|NCT02660138|26018499|FG001|Overall Study|Other|1|||
13142068|NCT02660138|26018500|FG002|Overall Study|Other|0|||
13142069|NCT02660138|26018498|FG000|Overall Study|Not treated|0|||
13142070|NCT02660138|26018499|FG001|Overall Study|Not treated|1|||
13142071|NCT02660138|26018500|FG002|Overall Study|Not treated|0|||
13142072|NCT02660086|26018535|FG000|Overall Study- 12-month|Withdrawal by Subject|5|||
13142073|NCT02660086|26018536|FG001|Overall Study- 12-month|Withdrawal by Subject|5|||
13142074|NCT02660086|26018535|FG000|Overall Study- 12-month|Left full-time employment|12|||
13142075|NCT02660086|26018536|FG001|Overall Study- 12-month|Left full-time employment|20|||
13142076|NCT02660086|26018535|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8|||
13142077|NCT02660086|26018536|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4|||
13142078|NCT02660086|26018535|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1|||
13142079|NCT02660086|26018536|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0|||
13142080|NCT02660086|26018535|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17|||
13142081|NCT02660086|26018536|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8|||
13142082|NCT02660086|26018535|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9|||
13142083|NCT02660086|26018536|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16|||
13142084|NCT02659943|26018623|FG000|Overall Study|Switched to alternative treatment|1|||
13142085|NCT02659943|26018624|FG001|Overall Study|Switched to alternative treatment|1|||
13142086|NCT02659943|26018625|FG002|Overall Study|Switched to alternative treatment|0|||
13142087|NCT02659943|26018626|FG003|Overall Study|Switched to alternative treatment|2|||
13142088|NCT02659943|26018627|FG004|Overall Study|Switched to alternative treatment|1|||
13142089|NCT02659943|26018628|FG005|Overall Study|Switched to alternative treatment|0|||
13142090|NCT02659943|26018629|FG006|Overall Study|Switched to alternative treatment|1|||
13142091|NCT02659943|26018623|FG000|Overall Study|Disease progression on study|0|||
13142092|NCT02659943|26018624|FG001|Overall Study|Disease progression on study|1|||
13142093|NCT02659943|26018625|FG002|Overall Study|Disease progression on study|1|||
13142094|NCT02659943|26018626|FG003|Overall Study|Disease progression on study|1|||
13142095|NCT02659943|26018627|FG004|Overall Study|Disease progression on study|1|||
13142096|NCT02659943|26018628|FG005|Overall Study|Disease progression on study|4|||
13142097|NCT02659943|26018629|FG006|Overall Study|Disease progression on study|0|||
13142098|NCT02659943|26018623|FG000|Overall Study|Patient's condition per principal investigator|0|||
13142099|NCT02659943|26018624|FG001|Overall Study|Patient's condition per principal investigator|0|||
13142100|NCT02659943|26018625|FG002|Overall Study|Patient's condition per principal investigator|0|||
13142101|NCT02659943|26018626|FG003|Overall Study|Patient's condition per principal investigator|0|||
13142102|NCT02659943|26018627|FG004|Overall Study|Patient's condition per principal investigator|0|||
13142103|NCT02659943|26018628|FG005|Overall Study|Patient's condition per principal investigator|1|||
13142104|NCT02659943|26018629|FG006|Overall Study|Patient's condition per principal investigator|0|||
13142105|NCT02659943|26018623|FG000|Overall Study|Ineligible|0|||
13142106|NCT02659943|26018624|FG001|Overall Study|Ineligible|0|||
13142107|NCT02659943|26018625|FG002|Overall Study|Ineligible|0|||
13142108|NCT02659943|26018626|FG003|Overall Study|Ineligible|0|||
13142109|NCT02659943|26018627|FG004|Overall Study|Ineligible|0|||
13142110|NCT02659943|26018628|FG005|Overall Study|Ineligible|0|||
13142111|NCT02659943|26018629|FG006|Overall Study|Ineligible|1|||
13142112|NCT02659943|26018623|FG000|Overall Study|No longer meets eligibility|0|||
13142113|NCT02659943|26018624|FG001|Overall Study|No longer meets eligibility|0|||
13142114|NCT02659943|26018625|FG002|Overall Study|No longer meets eligibility|0|||
13142115|NCT02659943|26018626|FG003|Overall Study|No longer meets eligibility|0|||
13142116|NCT02659943|26018627|FG004|Overall Study|No longer meets eligibility|0|||
13142117|NCT02659943|26018628|FG005|Overall Study|No longer meets eligibility|0|||
13142118|NCT02659943|26018629|FG006|Overall Study|No longer meets eligibility|1|||
13142119|NCT02659943|26018623|FG000|Overall Study|No treatment, per protocol|0|||
13142120|NCT02659943|26018624|FG001|Overall Study|No treatment, per protocol|0|||
13142121|NCT02659943|26018625|FG002|Overall Study|No treatment, per protocol|0|||
13142122|NCT02659943|26018626|FG003|Overall Study|No treatment, per protocol|0|||
13142123|NCT02659943|26018627|FG004|Overall Study|No treatment, per protocol|0|||
13142124|NCT02659943|26018628|FG005|Overall Study|No treatment, per protocol|0|||
13142125|NCT02659943|26018629|FG006|Overall Study|No treatment, per protocol|3|||
13142126|NCT02659631|26018792|FG000|Overall Study|Lost to Follow-up|0|||
13142127|NCT02659631|26018793|FG001|Overall Study|Lost to Follow-up|0|||
13142128|NCT02659631|26018794|FG002|Overall Study|Lost to Follow-up|2|||
13142129|NCT02659631|26018795|FG003|Overall Study|Lost to Follow-up|0|||
13142130|NCT02659631|26018796|FG004|Overall Study|Lost to Follow-up|0|||
13142131|NCT02659631|26018797|FG005|Overall Study|Lost to Follow-up|1|||
13142132|NCT02659631|26018798|FG006|Overall Study|Lost to Follow-up|0|||
13142133|NCT02659631|26018799|FG007|Overall Study|Lost to Follow-up|0|||
13142134|NCT02659631|26018800|FG008|Overall Study|Lost to Follow-up|0|||
13142135|NCT02659631|26018801|FG009|Overall Study|Lost to Follow-up|0|||
13142136|NCT02659631|26018792|FG000|Overall Study|Withdrawal prior to treatment|0|||
13142137|NCT02659631|26018793|FG001|Overall Study|Withdrawal prior to treatment|0|||
13142138|NCT02659631|26018794|FG002|Overall Study|Withdrawal prior to treatment|0|||
13142139|NCT02659631|26018795|FG003|Overall Study|Withdrawal prior to treatment|0|||
13142140|NCT02659631|26018796|FG004|Overall Study|Withdrawal prior to treatment|1|||
13142141|NCT02659631|26018797|FG005|Overall Study|Withdrawal prior to treatment|0|||
13142142|NCT02659631|26018798|FG006|Overall Study|Withdrawal prior to treatment|0|||
13142143|NCT02659631|26018799|FG007|Overall Study|Withdrawal prior to treatment|0|||
13142144|NCT02659631|26018800|FG008|Overall Study|Withdrawal prior to treatment|0|||
13142145|NCT02659631|26018801|FG009|Overall Study|Withdrawal prior to treatment|0|||
13142146|NCT02659631|26018792|FG000|Overall Study|Participant refused further follow-up|0|||
13142147|NCT02659631|26018793|FG001|Overall Study|Participant refused further follow-up|0|||
13142148|NCT02659631|26018794|FG002|Overall Study|Participant refused further follow-up|0|||
13142149|NCT02659631|26018795|FG003|Overall Study|Participant refused further follow-up|1|||
13142150|NCT02659631|26018796|FG004|Overall Study|Participant refused further follow-up|0|||
13142151|NCT02659631|26018797|FG005|Overall Study|Participant refused further follow-up|0|||
13142152|NCT02659631|26018798|FG006|Overall Study|Participant refused further follow-up|0|||
13142153|NCT02659631|26018799|FG007|Overall Study|Participant refused further follow-up|0|||
13142154|NCT02659631|26018800|FG008|Overall Study|Participant refused further follow-up|1|||
13142155|NCT02659631|26018801|FG009|Overall Study|Participant refused further follow-up|0|||
13142156|NCT02659631|26018792|FG000|Overall Study|Death (follow-up phase)|1|||
13142157|NCT02659631|26018793|FG001|Overall Study|Death (follow-up phase)|2|||
13142158|NCT02659631|26018794|FG002|Overall Study|Death (follow-up phase)|1|||
13142159|NCT02659631|26018795|FG003|Overall Study|Death (follow-up phase)|1|||
13142160|NCT02659631|26018796|FG004|Overall Study|Death (follow-up phase)|3|||
13142161|NCT02659631|26018797|FG005|Overall Study|Death (follow-up phase)|2|||
13142162|NCT02659631|26018798|FG006|Overall Study|Death (follow-up phase)|0|||
13142163|NCT02659631|26018799|FG007|Overall Study|Death (follow-up phase)|3|||
13142164|NCT02659631|26018800|FG008|Overall Study|Death (follow-up phase)|1|||
13142165|NCT02659631|26018801|FG009|Overall Study|Death (follow-up phase)|0|||
13142166|NCT02659631|26018792|FG000|Overall Study|Death (treatment phase)|0|||
13142167|NCT02659631|26018793|FG001|Overall Study|Death (treatment phase)|0|||
13142168|NCT02659631|26018794|FG002|Overall Study|Death (treatment phase)|0|||
13142169|NCT02659631|26018795|FG003|Overall Study|Death (treatment phase)|0|||
13142170|NCT02659631|26018796|FG004|Overall Study|Death (treatment phase)|1|||
13142171|NCT02659631|26018797|FG005|Overall Study|Death (treatment phase)|0|||
13142172|NCT02659631|26018798|FG006|Overall Study|Death (treatment phase)|1|||
13142173|NCT02659631|26018799|FG007|Overall Study|Death (treatment phase)|0|||
13142174|NCT02659631|26018800|FG008|Overall Study|Death (treatment phase)|0|||
13142175|NCT02659631|26018801|FG009|Overall Study|Death (treatment phase)|0|||
13142176|NCT02659150|26018812|FG000|Subject Enrollment|Physician Decision|3|||
13142177|NCT02659150|26018812|FG000|Subject Enrollment|Withdrawal by Subject|2|||
13142178|NCT02659150|26018812|FG000|Baseline Imaging|Withdrawal by Subject|1|||
13142179|NCT02659150|26018812|FG000|Baseline Imaging|Physician Decision|1|||
13142180|NCT02659150|26018812|FG000|Study Drug Dosing|Adverse Event|1|||
13142181|NCT02659098|26018843|FG000|Overall Study|Withdrawal by Subject|7|||
13142182|NCT02659059|26018871|FG000|Overall Study|Completed|1|||
13142183|NCT02659059|26018872|FG001|Overall Study|Completed|0|||
13142184|NCT02659059|26018871|FG000|Overall Study|Other reasons|8|||
13142185|NCT02659059|26018872|FG001|Overall Study|Other reasons|2|||
13142186|NCT02659059|26018871|FG000|Overall Study|Disease Progression|120|||
13142187|NCT02659059|26018872|FG001|Overall Study|Disease Progression|16|||
13142188|NCT02659059|26018871|FG000|Overall Study|Study Drug toxicity|37|||
13142189|NCT02659059|26018872|FG001|Overall Study|Study Drug toxicity|9|||
13142190|NCT02659059|26018871|FG000|Overall Study|Death|2|||
13142191|NCT02659059|26018872|FG001|Overall Study|Death|1|||
13142192|NCT02659059|26018871|FG000|Overall Study|Adverse Event unrelated to Study drug|22|||
13142193|NCT02659059|26018872|FG001|Overall Study|Adverse Event unrelated to Study drug|4|||
13142194|NCT02659059|26018871|FG000|Overall Study|Participant request to discontinue study treatment|5|||
13142195|NCT02659059|26018872|FG001|Overall Study|Participant request to discontinue study treatment|0|||
13142196|NCT02659059|26018871|FG000|Overall Study|Participant withdrew consent|4|||
13142197|NCT02659059|26018872|FG001|Overall Study|Participant withdrew consent|0|||
13142198|NCT02659059|26018871|FG000|Overall Study|Lost to Follow-up|1|||
13142199|NCT02659059|26018872|FG001|Overall Study|Lost to Follow-up|0|||
13142200|NCT02658734|26018893|FG000|Overall Study|Adverse Event|2|||
13142201|NCT02658734|26018893|FG000|Overall Study|Death|4|||
13142202|NCT02658734|26018893|FG000|Overall Study|Lost to Follow-up|7|||
13142203|NCT02658734|26018893|FG000|Overall Study|Withdrawal of Consent|16|||
13142204|NCT02658734|26018893|FG000|Overall Study|Disease Progression|28|||
13142205|NCT02658630|26018903|FG000|Overall Study|Withdrawal by Subject|4|||
13142206|NCT02658448|26018911|FG000|Overall Study|Lost to Follow-up|1|||
13142207|NCT02658175|26018932|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1|||
13142208|NCT02658175|26018933|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
13142209|NCT02658175|26018934|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
13142210|NCT02658175|26018932|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6|||
13142211|NCT02658175|26018933|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2|||
13142212|NCT02658175|26018934|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0|||
13142213|NCT02658175|26018932|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8|||
13142214|NCT02658175|26018933|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5|||
13142215|NCT02658175|26018934|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0|||
13142216|NCT02658175|26018932|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1|||
13142217|NCT02658175|26018933|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
13142218|NCT02658175|26018934|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
13142219|NCT02658175|26018932|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4|||
13142220|NCT02658175|26018933|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0|||
13142221|NCT02658175|26018934|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1|||
13142222|NCT02658175|26018932|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7|||
13142223|NCT02658175|26018933|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
13142224|NCT02658175|26018934|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
13142225|NCT02658175|26018932|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1|||
13142226|NCT02658175|26018933|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0|||
13142227|NCT02658175|26018934|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1|||
13142228|NCT02658175|26018932|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8|||
13142229|NCT02658175|26018933|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2|||
13142230|NCT02658175|26018934|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0|||
13142231|NCT02658175|26018932|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
13142232|NCT02658175|26018933|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
13142233|NCT02658175|26018934|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1|||
13142234|NCT02658175|26018932|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1|||
13222582|NCT01805037|26286502|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10|||
13142235|NCT02658175|26018933|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
13142236|NCT02658175|26018934|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
13142237|NCT02658149|26018955|FG000|Overall Study|Physician Decision|1|||
13142238|NCT02658149|26018956|FG001|Overall Study|Physician Decision|0|||
13142239|NCT02658084|26018972|FG000|Overall Study|Withdrawal by Subject|1|||
13142240|NCT02658084|26018973|FG001|Overall Study|Withdrawal by Subject|0|||
13142241|NCT02658084|26018972|FG000|Overall Study|Study Termination|1|||
13142242|NCT02658084|26018973|FG001|Overall Study|Study Termination|0|||
13142243|NCT02658019|26018984|FG000|Overall Study|Adverse Event|1|||
13142244|NCT02657408|26019015|FG000|Overall Study|Adverse Event|3|||
13142245|NCT02657408|26019016|FG001|Overall Study|Adverse Event|7|||
13142246|NCT02657369|26019026|FG000|Overall Study|Death|27|||
13142247|NCT02657369|26019026|FG000|Overall Study|Study terminated by sponsor|7|||
13142248|NCT02657343|26019071|FG000|Overall Study|Death|0|||
13142249|NCT02657343|26019072|FG001|Overall Study|Death|2|||
13142250|NCT02657343|26019073|FG002|Overall Study|Death|0|||
13142251|NCT02657343|26019074|FG003|Overall Study|Death|0|||
13142252|NCT02657343|26019075|FG004|Overall Study|Death|0|||
13142253|NCT02657343|26019076|FG005|Overall Study|Death|0|||
13142254|NCT02657343|26019071|FG000|Overall Study|Patient went to hospice|1|||
13142255|NCT02657343|26019072|FG001|Overall Study|Patient went to hospice|0|||
13142256|NCT02657343|26019073|FG002|Overall Study|Patient went to hospice|0|||
13142257|NCT02657343|26019074|FG003|Overall Study|Patient went to hospice|0|||
13142258|NCT02657343|26019075|FG004|Overall Study|Patient went to hospice|0|||
13142259|NCT02657343|26019076|FG005|Overall Study|Patient went to hospice|0|||
13142260|NCT02657343|26019071|FG000|Overall Study|Withdrawal by Subject|0|||
13142261|NCT02657343|26019072|FG001|Overall Study|Withdrawal by Subject|0|||
13142262|NCT02657343|26019073|FG002|Overall Study|Withdrawal by Subject|0|||
13142263|NCT02657343|26019074|FG003|Overall Study|Withdrawal by Subject|0|||
13142264|NCT02657343|26019075|FG004|Overall Study|Withdrawal by Subject|1|||
13142265|NCT02657343|26019076|FG005|Overall Study|Withdrawal by Subject|0|||
13142266|NCT02657031|26019097|FG000|Overall Study|Adverse Event|1|||
13142267|NCT02657031|26019098|FG001|Overall Study|Adverse Event|2|||
13142268|NCT02656693|26019191|FG000|Overall Study|Pregnancy|1|||
13142269|NCT02656693|26019192|FG001|Overall Study|Pregnancy|1|||
13142270|NCT02656693|26019193|FG002|Overall Study|Pregnancy|1|||
13142271|NCT02656693|26019191|FG000|Overall Study|Bariatric surgery|0|||
13142272|NCT02656693|26019192|FG001|Overall Study|Bariatric surgery|1|||
13142273|NCT02656693|26019193|FG002|Overall Study|Bariatric surgery|2|||
13142274|NCT02656680|26019214|FG000|Overall Study|Lost to Follow-up|0|||
13142275|NCT02656680|26019215|FG001|Overall Study|Lost to Follow-up|1|||
13142276|NCT02656329|26019245|FG000|Overall Study|Lost to Follow-up|2|||
13142277|NCT02656329|26019246|FG001|Overall Study|Lost to Follow-up|3|||
13142278|NCT02656329|26019245|FG000|Overall Study|Withdrawal by Subject|7|||
13142279|NCT02656329|26019246|FG001|Overall Study|Withdrawal by Subject|6|||
13142280|NCT02656329|26019245|FG000|Overall Study|Study termination by Sponsor|150|||
13142281|NCT02656329|26019246|FG001|Overall Study|Study termination by Sponsor|142|||
13142282|NCT02656329|26019245|FG000|Overall Study|Other than specified above|5|||
13142283|NCT02656329|26019246|FG001|Overall Study|Other than specified above|6|||
13142284|NCT02656290|26019253|FG000|Overall Study|Subjects Remain On Study|26|||
13142285|NCT02656173|26019296|FG000|Overall Study|Deviation from the Eligible Criteria|3|||
13142286|NCT02656173|26019297|FG001|Overall Study|Deviation from the Eligible Criteria|2|||
13142287|NCT02656173|26019296|FG000|Overall Study|Adverse Event|7|||
13142288|NCT02656173|26019297|FG001|Overall Study|Adverse Event|5|||
13142289|NCT02656173|26019296|FG000|Overall Study|Withdrawal by Subject|1|||
13142290|NCT02656173|26019297|FG001|Overall Study|Withdrawal by Subject|3|||
13142291|NCT02656173|26019296|FG000|Overall Study|Protocol Violation|0|||
13142292|NCT02656173|26019297|FG001|Overall Study|Protocol Violation|1|||
13142293|NCT02656173|26019296|FG000|Overall Study|Miscellaneous|2|||
13142294|NCT02656173|26019297|FG001|Overall Study|Miscellaneous|0|||
13142295|NCT02656017|26019336|FG000|Overall Study|Study burden|3|||
13142296|NCT02656017|26019337|FG001|Overall Study|Study burden|3|||
13142297|NCT02656017|26019336|FG000|Overall Study|Adverse Event|2|||
13142298|NCT02656017|26019337|FG001|Overall Study|Adverse Event|1|||
13142299|NCT02656017|26019336|FG000|Overall Study|Unable/unwilling to take study medication|2|||
13142300|NCT02656017|26019337|FG001|Overall Study|Unable/unwilling to take study medication|1|||
13142301|NCT02656017|26019336|FG000|Overall Study|Began Tolvaptan|1|||
13142302|NCT02656017|26019337|FG001|Overall Study|Began Tolvaptan|1|||
13142303|NCT02656017|26019336|FG000|Overall Study|Withdrawal by Subject|1|||
13142304|NCT02656017|26019337|FG001|Overall Study|Withdrawal by Subject|0|||
13142305|NCT02655887|26019353|FG000|Overall Study|Lost to Follow-up|3|||
13142306|NCT02655887|26019353|FG000|Overall Study|Death|4|||
13142307|NCT02655887|26019353|FG000|Overall Study|Withdrawal by Subject|3|||
13142308|NCT02655887|26019353|FG000|Overall Study|Missed 12-month follow-up visit|4|||
13142309|NCT02655679|26019441|FG000|Overall Study|Adverse Event|0|||
13142310|NCT02655679|26019442|FG001|Overall Study|Adverse Event|1|||
13142311|NCT02655679|26019443|FG002|Overall Study|Adverse Event|0|||
13142312|NCT02655679|26019444|FG003|Overall Study|Adverse Event|0|||
13142313|NCT02655679|26019445|FG004|Overall Study|Adverse Event|0|||
13142314|NCT02655679|26019441|FG000|Overall Study|Withdrawal by Subject|1|||
13142315|NCT02655679|26019442|FG001|Overall Study|Withdrawal by Subject|1|||
13142316|NCT02655679|26019443|FG002|Overall Study|Withdrawal by Subject|0|||
13142317|NCT02655679|26019444|FG003|Overall Study|Withdrawal by Subject|3|||
13142318|NCT02655679|26019445|FG004|Overall Study|Withdrawal by Subject|1|||
13142319|NCT02655679|26019441|FG000|Overall Study|Inability to Comply with the Protocol|1|||
13142320|NCT02655679|26019442|FG001|Overall Study|Inability to Comply with the Protocol|0|||
13142321|NCT02655679|26019443|FG002|Overall Study|Inability to Comply with the Protocol|0|||
13142322|NCT02655679|26019444|FG003|Overall Study|Inability to Comply with the Protocol|0|||
13142323|NCT02655679|26019445|FG004|Overall Study|Inability to Comply with the Protocol|0|||
13142324|NCT02655679|26019441|FG000|Overall Study|Lost to Follow-up|0|||
13142325|NCT02655679|26019442|FG001|Overall Study|Lost to Follow-up|1|||
13142326|NCT02655679|26019443|FG002|Overall Study|Lost to Follow-up|1|||
13142327|NCT02655679|26019444|FG003|Overall Study|Lost to Follow-up|1|||
13142328|NCT02655679|26019445|FG004|Overall Study|Lost to Follow-up|0|||
13142329|NCT02655679|26019441|FG000|Overall Study|Other Miscellaneous Reasons|1|||
13142330|NCT02655679|26019442|FG001|Overall Study|Other Miscellaneous Reasons|0|||
13142331|NCT02655679|26019443|FG002|Overall Study|Other Miscellaneous Reasons|0|||
13142332|NCT02655679|26019444|FG003|Overall Study|Other Miscellaneous Reasons|0|||
13142333|NCT02655679|26019445|FG004|Overall Study|Other Miscellaneous Reasons|0|||
13142334|NCT02655666|26019461|FG000|Overall Study|Sponsor stopped this clinical research.|12|||
13142335|NCT02655419|26019586|FG000|Overall Study|Enrolled but not treated|1|||
13142336|NCT02655419|26019587|FG001|Overall Study|Enrolled but not treated|5|||
13142337|NCT02655419|26019586|FG000|Overall Study|Withdrawal by Subject|4|||
13142338|NCT02655419|26019587|FG001|Overall Study|Withdrawal by Subject|1|||
13142339|NCT02655419|26019586|FG000|Overall Study|Other|0|||
13142340|NCT02655419|26019587|FG001|Overall Study|Other|1|||
13142341|NCT02655237|26019632|FG000|Overall Study|Adverse Event|10|||
13142342|NCT02655237|26019633|FG001|Overall Study|Adverse Event|7|||
13142343|NCT02655237|26019632|FG000|Overall Study|Protocol Deviation|2|||
13142344|NCT02655237|26019633|FG001|Overall Study|Protocol Deviation|0|||
13142345|NCT02655237|26019632|FG000|Overall Study|Withdrawal by Participant|1|||
13142346|NCT02655237|26019633|FG001|Overall Study|Withdrawal by Participant|2|||
13142347|NCT02655237|26019632|FG000|Overall Study|Lack of Efficacy|0|||
13142348|NCT02655237|26019633|FG001|Overall Study|Lack of Efficacy|1|||
13142349|NCT02655237|26019632|FG000|Overall Study|Recovery Leading to Surgery|2|||
13142350|NCT02655237|26019633|FG001|Overall Study|Recovery Leading to Surgery|1|||
13091764|NCT03722238|25825683|FG001|Overall Study|Death|0|||
13091765|NCT03722238|25825682|FG000|Overall Study|Lost to Follow-up|6|||
13091766|NCT03722238|25825683|FG001|Overall Study|Lost to Follow-up|0|||
13091767|NCT03722238|25825682|FG000|Overall Study|Partial missing data|44|||
13091768|NCT03722238|25825683|FG001|Overall Study|Partial missing data|1|||
13091769|NCT03722238|25825682|FG000|Overall Study|Withdrawal by Subject|2|||
13091770|NCT03722238|25825683|FG001|Overall Study|Withdrawal by Subject|0|||
13091771|NCT03722238|25825682|FG000|Overall Study|Other|4|||
13091772|NCT03722238|25825683|FG001|Overall Study|Other|0|||
13091773|NCT03722238|25825682|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2|||
13091774|NCT03722238|25825683|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0|||
13091775|NCT03722238|25825682|FG000|Overall Study|Did not meet risk classification group criteria|90|||
13091776|NCT03722238|25825683|FG001|Overall Study|Did not meet risk classification group criteria|0|||
13091777|NCT03722238|25825682|FG000|Overall Study|Did not sign consent|17|||
13091778|NCT03722238|25825683|FG001|Overall Study|Did not sign consent|0|||
13091779|NCT03722238|25825682|FG000|Overall Study|Other eligibility criteria not met pre-consent|22|||
13091780|NCT03722238|25825683|FG001|Overall Study|Other eligibility criteria not met pre-consent|0|||
13091781|NCT03722238|25825682|FG000|Overall Study|Not willing to purchase study medication|142|||
13091782|NCT03722238|25825683|FG001|Overall Study|Not willing to purchase study medication|0|||
13091783|NCT03722238|25825682|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133|||
13091784|NCT03722238|25825683|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0|||
13091785|NCT03722030|25825756|FG000|Overall Study|Withdrawal by Subject|1|||
13091786|NCT03722030|25825757|FG001|Overall Study|Withdrawal by Subject|0|||
13091787|NCT03721705|25825774|FG000|Overall Study|Adverse Event|2|||
13091788|NCT03721705|25825775|FG001|Overall Study|Adverse Event|0|||
13142351|NCT02655237|26019632|FG000|Overall Study|Reduction of Hemoglobin Concentration|1|||
13142352|NCT02655237|26019633|FG001|Overall Study|Reduction of Hemoglobin Concentration|0|||
13142353|NCT02655237|26019632|FG000|Overall Study|Randomized but Not Treated|1|||
13142354|NCT02655237|26019633|FG001|Overall Study|Randomized but Not Treated|0|||
13142355|NCT02655224|26019670|FG000|Overall Study|Adverse Event|1|||
13142356|NCT02655224|26019671|FG001|Overall Study|Adverse Event|1|||
13142357|NCT02654977|26019678|FG000|Overall Study|Death|1|||
13142358|NCT02654977|26019678|FG000|Overall Study|Lost to Follow-up|1|||
13142359|NCT02654977|26019678|FG000|Overall Study|Adverse Event|1|||
13142360|NCT02654977|26019678|FG000|Overall Study|Withdrawal by Subject|1|||
13142361|NCT02654977|26019678|FG000|Overall Study|Lack of Efficacy|3|||
13142362|NCT02654717|26019691|FG000|Overall Study|Adverse Event|2|||
13142363|NCT02654717|26019692|FG001|Overall Study|Adverse Event|2|||
13142364|NCT02654717|26019691|FG000|Overall Study|Protocol Violation|1|||
13142365|NCT02654717|26019692|FG001|Overall Study|Protocol Violation|2|||
13142366|NCT02654717|26019691|FG000|Overall Study|Withdrawal by Subject|0|||
13142367|NCT02654717|26019692|FG001|Overall Study|Withdrawal by Subject|1|||
13142368|NCT02654717|26019691|FG000|Overall Study|Non-permitted medication|3|||
13142369|NCT02654717|26019692|FG001|Overall Study|Non-permitted medication|0|||
13142370|NCT02654145|26019701|FG000|Overall Study|Lack of Efficacy|1|||
13142371|NCT02654145|26019701|FG000|Overall Study|Protocol Violation|1|||
13142372|NCT02654145|26019701|FG000|Overall Study|Withdrawal by Subject|5|||
13142373|NCT02654054|26019737|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
13142374|NCT02654054|26019738|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
13142375|NCT02654054|26019739|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
13142376|NCT02654054|26019737|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
13142377|NCT02654054|26019738|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
13142378|NCT02654054|26019739|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
13142379|NCT02654054|26019737|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
13142380|NCT02654054|26019738|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
13142381|NCT02654054|26019739|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
13142382|NCT02654054|26019737|FG000|Post-Treatment Follow-Up Period|Other|1|||
13142383|NCT02654054|26019738|FG001|Post-Treatment Follow-Up Period|Other|0|||
13142384|NCT02654054|26019739|FG002|Post-Treatment Follow-Up Period|Other|4|||
13142385|NCT02654054|26019737|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
13142386|NCT02654054|26019738|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
13142387|NCT02654054|26019739|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4|||
13142388|NCT02654002|26019893|FG000|Overall Study|Adverse Event|0|||
13142389|NCT02654002|26019894|FG001|Overall Study|Adverse Event|0|||
13142390|NCT02654002|26019895|FG002|Overall Study|Adverse Event|0|||
13142391|NCT02654002|26019896|FG003|Overall Study|Adverse Event|0|||
13142392|NCT02654002|26019897|FG004|Overall Study|Adverse Event|0|||
13142393|NCT02654002|26019898|FG005|Overall Study|Adverse Event|0|||
13142394|NCT02654002|26019899|FG006|Overall Study|Adverse Event|1|||
13142395|NCT02654002|26019900|FG007|Overall Study|Adverse Event|0|||
13142396|NCT02654002|26019901|FG008|Overall Study|Adverse Event|0|||
13142397|NCT02654002|26019893|FG000|Overall Study|Withdrew Consent|0|||
13142398|NCT02654002|26019894|FG001|Overall Study|Withdrew Consent|0|||
13142399|NCT02654002|26019895|FG002|Overall Study|Withdrew Consent|0|||
13142400|NCT02654002|26019896|FG003|Overall Study|Withdrew Consent|0|||
13142401|NCT02654002|26019897|FG004|Overall Study|Withdrew Consent|0|||
13142402|NCT02654002|26019898|FG005|Overall Study|Withdrew Consent|1|||
13142403|NCT02654002|26019899|FG006|Overall Study|Withdrew Consent|0|||
13142404|NCT02654002|26019900|FG007|Overall Study|Withdrew Consent|1|||
13142405|NCT02654002|26019901|FG008|Overall Study|Withdrew Consent|0|||
13142406|NCT02653664|26019925|FG000|Post-Treatment|Withdrawal by Subject|6|||
13142407|NCT02653664|26019926|FG001|Post-Treatment|Withdrawal by Subject|5|||
13142408|NCT02653664|26019927|FG002|Post-Treatment|Withdrawal by Subject|7|||
13142409|NCT02653664|26019925|FG000|Post-Treatment|Lost to Follow-up|8|||
13142410|NCT02653664|26019926|FG001|Post-Treatment|Lost to Follow-up|1|||
13142411|NCT02653664|26019927|FG002|Post-Treatment|Lost to Follow-up|7|||
13142412|NCT02653664|26019925|FG000|3 Month Follow-Up|Withdrawal by Subject|9|||
13142413|NCT02653664|26019926|FG001|3 Month Follow-Up|Withdrawal by Subject|5|||
13142414|NCT02653664|26019927|FG002|3 Month Follow-Up|Withdrawal by Subject|9|||
13142415|NCT02653664|26019925|FG000|3 Month Follow-Up|Lost to Follow-up|9|||
13142416|NCT02653664|26019926|FG001|3 Month Follow-Up|Lost to Follow-up|8|||
13142417|NCT02653664|26019927|FG002|3 Month Follow-Up|Lost to Follow-up|16|||
13142418|NCT02653664|26019925|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
13142419|NCT02653664|26019926|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
13142420|NCT02653664|26019927|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
13142421|NCT02653664|26019925|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3|||
13142422|NCT02653664|26019926|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
13142423|NCT02653664|26019927|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
13142424|NCT02653664|26019925|FG000|6 Month Follow-Up|Withdrawal by Subject|13|||
13142425|NCT02653664|26019926|FG001|6 Month Follow-Up|Withdrawal by Subject|7|||
13142426|NCT02653664|26019927|FG002|6 Month Follow-Up|Withdrawal by Subject|14|||
13142427|NCT02653664|26019925|FG000|6 Month Follow-Up|Lost to Follow-up|10|||
13142428|NCT02653664|26019926|FG001|6 Month Follow-Up|Lost to Follow-up|11|||
13142429|NCT02653664|26019927|FG002|6 Month Follow-Up|Lost to Follow-up|9|||
13142430|NCT02653664|26019925|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
13142431|NCT02653664|26019926|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
13142432|NCT02653664|26019927|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
13142433|NCT02653664|26019925|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0|||
13142434|NCT02653664|26019926|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1|||
13142435|NCT02653664|26019927|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0|||
13142436|NCT02653625|26019938|FG000|Overall Study|Adverse Event|1|||
13142437|NCT02653625|26019938|FG000|Overall Study|Non-compliance with Study Drug|1|||
13142438|NCT02653625|26019938|FG000|Overall Study|Protocol Violation|1|||
13142439|NCT02653625|26019938|FG000|Overall Study|Suspected Drug Induced Liver Injury|1|||
13142440|NCT02653495|26019959|FG000|Overall Study|Lost to Follow-up|2|||
13142441|NCT02653495|26019960|FG001|Overall Study|Lost to Follow-up|0|||
13142442|NCT02653495|26019959|FG000|Overall Study|Screening Failure|10|||
13142443|NCT02653495|26019960|FG001|Overall Study|Screening Failure|0|||
13142444|NCT02653482|26019993|FG000|Overall Study|Death|1|||
13142445|NCT02653482|26019994|FG001|Overall Study|Death|1|||
13142446|NCT02653326|26020013|FG000|Overall Study|Lost to Follow-up|10|||
13142447|NCT02653326|26020014|FG001|Overall Study|Lost to Follow-up|7|||
13142448|NCT02653300|26020022|FG000|Overall Study|Withdrawal by Subject|2|||
13142449|NCT02653170|26020052|FG000|Overall Study|Withdrawal by Subject|3|||
13142450|NCT02653170|26020053|FG001|Overall Study|Withdrawal by Subject|8|||
13142451|NCT02653170|26020054|FG002|Overall Study|Withdrawal by Subject|3|||
13142452|NCT02653170|26020052|FG000|Overall Study|withdrawn by study team|2|||
13142453|NCT02653170|26020053|FG001|Overall Study|withdrawn by study team|4|||
13142454|NCT02653170|26020054|FG002|Overall Study|withdrawn by study team|5|||
13142455|NCT02653170|26020052|FG000|Overall Study|Lost to Follow-up|12|||
13142456|NCT02653170|26020053|FG001|Overall Study|Lost to Follow-up|4|||
13142457|NCT02653170|26020054|FG002|Overall Study|Lost to Follow-up|10|||
13142458|NCT02652767|26020082|FG000|Overall Study|Death|2|||
13142459|NCT02652767|26020082|FG000|Overall Study|Lost to Follow-up|1|||
13142460|NCT02652767|26020082|FG000|Overall Study|Withdrawal by Subject|1|||
13142461|NCT02652624|26020101|FG000|Randomized Phase|Pregnancy|3|||
13142462|NCT02652624|26020102|FG001|Randomized Phase|Pregnancy|1|||
13142463|NCT02652624|26020101|FG000|Randomized Phase|Investigator's Discretion|0|||
13142464|NCT02652624|26020102|FG001|Randomized Phase|Investigator's Discretion|2|||
13142465|NCT02652624|26020101|FG000|Randomized Phase|Death|0|||
13142466|NCT02652624|26020102|FG001|Randomized Phase|Death|1|||
13142467|NCT02652624|26020101|FG000|Randomized Phase|Lost to Follow-up|0|||
13142468|NCT02652624|26020102|FG001|Randomized Phase|Lost to Follow-up|1|||
13142469|NCT02652624|26020101|FG000|Extension Phase|Lost to Follow-up|3|||
13142470|NCT02652624|26020102|FG001|Extension Phase|Lost to Follow-up|1|||
13142471|NCT02652624|26020101|FG000|Extension Phase|Pregnancy|1|||
13142472|NCT02652624|26020102|FG001|Extension Phase|Pregnancy|1|||
13142473|NCT02652624|26020101|FG000|Extension Phase|Adverse Event|0|||
13142474|NCT02652624|26020102|FG001|Extension Phase|Adverse Event|1|||
13142475|NCT02652624|26020101|FG000|Extension Phase|Withdrew Consent|0|||
13142476|NCT02652624|26020102|FG001|Extension Phase|Withdrew Consent|1|||
13142477|NCT02652442|26020116|FG000|Centrifugation - Distance|Lost to Follow-up|1|||
13204859|NCT01970241|26230160|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8|||
13204860|NCT01970007|26230169|FG000|Overall Study|Death|5|||
13204861|NCT01970007|26230169|FG000|Overall Study|Withdrawal by Subject|23|||
13204862|NCT01970007|26230169|FG000|Overall Study|Lost to Follow-up|24|||
13204863|NCT01970007|26230169|FG000|Overall Study|"Other endpoint"|3|||
13204864|NCT01969851|26230199|FG000|Overall Study|Adverse Event|0|||
13204865|NCT01969851|26230200|FG001|Overall Study|Adverse Event|0|||
13204866|NCT01969851|26230201|FG002|Overall Study|Adverse Event|3|||
13204867|NCT01969851|26230199|FG000|Overall Study|Lack of Efficacy|0|||
13204868|NCT01969851|26230200|FG001|Overall Study|Lack of Efficacy|3|||
13204869|NCT01969851|26230201|FG002|Overall Study|Lack of Efficacy|1|||
13204870|NCT01969851|26230199|FG000|Overall Study|Withdrawal by Subject|1|||
13204871|NCT01969851|26230200|FG001|Overall Study|Withdrawal by Subject|0|||
13204872|NCT01969851|26230201|FG002|Overall Study|Withdrawal by Subject|1|||
13204873|NCT01969851|26230199|FG000|Overall Study|No effective dose in Titration period|0|||
13204874|NCT01969851|26230200|FG001|Overall Study|No effective dose in Titration period|0|||
13204875|NCT01969851|26230201|FG002|Overall Study|No effective dose in Titration period|1|||
13204876|NCT01969851|26230199|FG000|Overall Study|Sponsor decision|0|||
13204877|NCT01969851|26230200|FG001|Overall Study|Sponsor decision|0|||
13204878|NCT01969851|26230201|FG002|Overall Study|Sponsor decision|1|||
13204879|NCT01969799|26230228|FG000|Overall Study|Adverse Event|0|||
13204880|NCT01969799|26230229|FG001|Overall Study|Adverse Event|1|||
13204881|NCT01969799|26230228|FG000|Overall Study|Death|16|||
13204882|NCT01969799|26230229|FG001|Overall Study|Death|11|||
13204883|NCT01969799|26230228|FG000|Overall Study|Lost to Follow-up|0|||
13204884|NCT01969799|26230229|FG001|Overall Study|Lost to Follow-up|2|||
13204885|NCT01969799|26230228|FG000|Overall Study|Physician Decision|1|||
13204886|NCT01969799|26230229|FG001|Overall Study|Physician Decision|0|||
13204887|NCT01969721|26230260|FG000|Overall Study|Adverse Event|3|||
13204888|NCT01969721|26230261|FG001|Overall Study|Adverse Event|8|||
13204889|NCT01969721|26230262|FG002|Overall Study|Adverse Event|3|||
13204890|NCT01969721|26230263|FG003|Overall Study|Adverse Event|2|||
13204891|NCT01969721|26230260|FG000|Overall Study|Lack of Efficacy|0|||
13204892|NCT01969721|26230261|FG001|Overall Study|Lack of Efficacy|0|||
13204893|NCT01969721|26230262|FG002|Overall Study|Lack of Efficacy|1|||
13204894|NCT01969721|26230263|FG003|Overall Study|Lack of Efficacy|0|||
13204895|NCT01969721|26230260|FG000|Overall Study|Non compliant with protocol|1|||
13204896|NCT01969721|26230261|FG001|Overall Study|Non compliant with protocol|1|||
13204897|NCT01969721|26230262|FG002|Overall Study|Non compliant with protocol|0|||
13204898|NCT01969721|26230263|FG003|Overall Study|Non compliant with protocol|2|||
13204899|NCT01969721|26230260|FG000|Overall Study|Other not defined above|0|||
13204900|NCT01969721|26230261|FG001|Overall Study|Other not defined above|2|||
13204901|NCT01969721|26230262|FG002|Overall Study|Other not defined above|0|||
13204902|NCT01969721|26230263|FG003|Overall Study|Other not defined above|0|||
13204903|NCT01969721|26230260|FG000|Overall Study|Discontinued during washout periods.|0|||
13204904|NCT01969721|26230261|FG001|Overall Study|Discontinued during washout periods.|1|||
13204905|NCT01969721|26230262|FG002|Overall Study|Discontinued during washout periods.|1|||
13204906|NCT01969721|26230263|FG003|Overall Study|Discontinued during washout periods.|2|||
13204907|NCT01969565|26230271|FG000|Overall Study|Withdrawal by Subject|1|||
13204908|NCT01969500|26230290|FG000|Overall Study|Death|0|||
13204909|NCT01969500|26230291|FG001|Overall Study|Death|1|||
13204910|NCT01969500|26230290|FG000|Overall Study|extended hospitalization|1|||
13204911|NCT01969500|26230291|FG001|Overall Study|extended hospitalization|1|||
13204912|NCT01969084|26230312|FG000|Overall Study|Adverse Event|0|||
13204913|NCT01969084|26230313|FG001|Overall Study|Adverse Event|1|||
13204914|NCT01969058|26230362|FG000|Overall Study|Withdrawal by Subject|2|||
13204915|NCT01969058|26230363|FG001|Overall Study|Withdrawal by Subject|0|||
13204916|NCT01969058|26230362|FG000|Overall Study|Adverse Event|1|||
13204917|NCT01969058|26230363|FG001|Overall Study|Adverse Event|0|||
13204918|NCT01968980|26230430|FG000|Overall Study|Death|0|||
13204919|NCT01968980|26230431|FG001|Overall Study|Death|1|||
13204920|NCT01968980|26230430|FG000|Overall Study|Adverse Event|1|||
13204921|NCT01968980|26230431|FG001|Overall Study|Adverse Event|3|||
13204922|NCT01968980|26230430|FG000|Overall Study|Does not meet entry criteria|1|||
13204923|NCT01968980|26230431|FG001|Overall Study|Does not meet entry criteria|3|||
13204924|NCT01968980|26230430|FG000|Overall Study|Withdrawal by Subject|13|||
13204925|NCT01968980|26230431|FG001|Overall Study|Withdrawal by Subject|5|||
13204926|NCT01968980|26230430|FG000|Overall Study|Other unspecified|1|||
13204927|NCT01968980|26230431|FG001|Overall Study|Other unspecified|2|||
13142478|NCT02652260|26020159|FG000|Overall Study|Pregnancy|0|||
13142479|NCT02652260|26020160|FG001|Overall Study|Pregnancy|1|||
13142480|NCT02652260|26020159|FG000|Overall Study|Withdrawal by Subject|0|||
13142481|NCT02652260|26020160|FG001|Overall Study|Withdrawal by Subject|1|||
13142482|NCT02652156|26020196|FG000|Overall Study|Physician Decision|1|||
13142483|NCT02652156|26020197|FG001|Overall Study|Physician Decision|0|||
13142484|NCT02652156|26020198|FG002|Overall Study|Physician Decision|0|||
13142485|NCT02652130|26020205|FG000|Overall Study|Death|1|||
13142486|NCT02651987|26020253|FG000|Overall Study|Adverse Event|2|||
13142487|NCT02651987|26020254|FG001|Overall Study|Adverse Event|2|||
13142488|NCT02651987|26020253|FG000|Overall Study|Consent Withdrawn|2|||
13142489|NCT02651987|26020254|FG001|Overall Study|Consent Withdrawn|0|||
13142490|NCT02651987|26020253|FG000|Overall Study|Local PD|0|||
13142491|NCT02651987|26020254|FG001|Overall Study|Local PD|2|||
13142492|NCT02651987|26020253|FG000|Overall Study|Investigator Decision|1|||
13142493|NCT02651987|26020254|FG001|Overall Study|Investigator Decision|1|||
13142494|NCT02651922|26020273|FG000|Overall Study|due to exclusion criteria|2|||
13142495|NCT02651688|26020348|FG000|Overall Study|Non-compliance|0|||
13142496|NCT02651688|26020349|FG001|Overall Study|Non-compliance|0|||
13142497|NCT02651688|26020350|FG002|Overall Study|Non-compliance|1|||
13142498|NCT02651688|26020348|FG000|Overall Study|Principal Investigator (PI) decision|0|||
13142499|NCT02651688|26020349|FG001|Overall Study|Principal Investigator (PI) decision|2|||
13142500|NCT02651688|26020350|FG002|Overall Study|Principal Investigator (PI) decision|0|||
13142501|NCT02651688|26020348|FG000|Overall Study|Lost to Follow-up|1|||
13142502|NCT02651688|26020349|FG001|Overall Study|Lost to Follow-up|3|||
13142503|NCT02651688|26020350|FG002|Overall Study|Lost to Follow-up|0|||
13142504|NCT02651688|26020348|FG000|Overall Study|Withdrawal by Subject|1|||
13142505|NCT02651688|26020349|FG001|Overall Study|Withdrawal by Subject|0|||
13142506|NCT02651688|26020350|FG002|Overall Study|Withdrawal by Subject|2|||
13142507|NCT02651467|26020379|FG000|Overall Study|Withdrawal by Subject|0|||
13142508|NCT02651467|26020380|FG001|Overall Study|Withdrawal by Subject|0|||
13142509|NCT02651467|26020381|FG002|Overall Study|Withdrawal by Subject|2|||
13142510|NCT02651467|26020379|FG000|Overall Study|Other (Not specified)|1|||
13142511|NCT02651467|26020380|FG001|Overall Study|Other (Not specified)|0|||
13142512|NCT02651467|26020381|FG002|Overall Study|Other (Not specified)|2|||
13142513|NCT02651220|26020405|FG000|Overall Study|Adverse Event|1|||
13142514|NCT02651220|26020406|FG001|Overall Study|Adverse Event|5|||
13142515|NCT02651220|26020407|FG002|Overall Study|Adverse Event|1|||
13142516|NCT02651220|26020405|FG000|Overall Study|Lost to Follow-up|8|||
13142517|NCT02651220|26020406|FG001|Overall Study|Lost to Follow-up|14|||
13142518|NCT02651220|26020407|FG002|Overall Study|Lost to Follow-up|14|||
13142519|NCT02651220|26020405|FG000|Overall Study|Non-Compliance with Study Drug|4|||
13142520|NCT02651220|26020406|FG001|Overall Study|Non-Compliance with Study Drug|0|||
13142521|NCT02651220|26020407|FG002|Overall Study|Non-Compliance with Study Drug|1|||
13142522|NCT02651220|26020405|FG000|Overall Study|Pregnancy|1|||
13142523|NCT02651220|26020406|FG001|Overall Study|Pregnancy|0|||
13142524|NCT02651220|26020407|FG002|Overall Study|Pregnancy|1|||
13142525|NCT02651220|26020405|FG000|Overall Study|Protocol Violation|0|||
13142526|NCT02651220|26020406|FG001|Overall Study|Protocol Violation|0|||
13142527|NCT02651220|26020407|FG002|Overall Study|Protocol Violation|1|||
13142528|NCT02651220|26020405|FG000|Overall Study|Withdrawal by Subject|5|||
13142529|NCT02651220|26020406|FG001|Overall Study|Withdrawal by Subject|6|||
13142530|NCT02651220|26020407|FG002|Overall Study|Withdrawal by Subject|8|||
13142531|NCT02651220|26020405|FG000|Overall Study|Miscellaneous|4|||
13142532|NCT02651220|26020406|FG001|Overall Study|Miscellaneous|1|||
13142533|NCT02651220|26020407|FG002|Overall Study|Miscellaneous|2|||
13142534|NCT02651220|26020405|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
13142535|NCT02651220|26020406|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
13091789|NCT03721705|25825774|FG000|Overall Study|Withdrawal by Subject|4|||
13091790|NCT03721705|25825775|FG001|Overall Study|Withdrawal by Subject|10|||
13091791|NCT03721705|25825774|FG000|Overall Study|No Suitable Study Partner|1|||
13091792|NCT03721705|25825775|FG001|Overall Study|No Suitable Study Partner|0|||
13091793|NCT03721705|25825774|FG000|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|3|||
13091794|NCT03721705|25825775|FG001|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|7|||
13091795|NCT03721705|25825774|FG000|Overall Study|Death|0|||
13091796|NCT03721705|25825775|FG001|Overall Study|Death|1|||
13091797|NCT03720847|25825796|FG000|Washout|Physician Decision|1|||
13091798|NCT03720847|25825797|FG001|Washout|Physician Decision|2|||
13091799|NCT03720652|25825850|FG000|Overall Study|Withdrawal by Subject|2|||
13091800|NCT03720652|25825851|FG001|Overall Study|Withdrawal by Subject|7|||
13142536|NCT02651220|26020407|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
13142537|NCT02651194|26020415|FG000|Overall Study|Lost to Follow-up|3|||
13142538|NCT02651194|26020415|FG000|Overall Study|Other|2|||
13142539|NCT02651155|26020438|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
13142540|NCT02651155|26020439|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
13142541|NCT02651155|26020438|FG000|Overall Study|Voluntary Withdrawal|5|||
13142542|NCT02651155|26020439|FG001|Overall Study|Voluntary Withdrawal|0|||
13142543|NCT02651116|26020476|FG000|Overall Study|Adverse Event|0|||
13142544|NCT02651116|26020477|FG001|Overall Study|Adverse Event|1|||
13142545|NCT02651116|26020476|FG000|Overall Study|No Longer Willing To Participate In Study|1|||
13142546|NCT02651116|26020477|FG001|Overall Study|No Longer Willing To Participate In Study|0|||
13142547|NCT02650921|26020527|FG000|Overall Study|Withdrawal by Subject|4|||
13142548|NCT02650921|26020527|FG000|Overall Study|Lost to Follow-up|2|||
13142549|NCT02650921|26020527|FG000|Overall Study|Adverse Event|1|||
13142550|NCT02650921|26020527|FG000|Overall Study|Due to Medical Condition|1|||
13142551|NCT02650466|26020535|FG000|Overall Study|Physician Decision|1|||
13142552|NCT02650466|26020535|FG000|Overall Study|Withdrawal by Subject|5|||
13142553|NCT02650466|26020535|FG000|Overall Study|Lost to Follow-up|1|||
13142554|NCT02650128|26020544|FG000|Overall Study|Death|2|||
13142555|NCT02649894|26020571|FG000|Overall Study|Adverse Event|1|||
13142556|NCT02649894|26020572|FG001|Overall Study|Adverse Event|0|||
13142557|NCT02649894|26020571|FG000|Overall Study|Physician Decision|0|||
13142558|NCT02649894|26020572|FG001|Overall Study|Physician Decision|1|||
13142559|NCT02649894|26020571|FG000|Overall Study|Withdrawal by Subject|5|||
13142560|NCT02649894|26020572|FG001|Overall Study|Withdrawal by Subject|2|||
13142561|NCT02649894|26020571|FG000|Overall Study|Lost to Follow-up|2|||
13142562|NCT02649894|26020572|FG001|Overall Study|Lost to Follow-up|1|||
13142563|NCT02649894|26020571|FG000|Overall Study|Death|30|||
13142564|NCT02649894|26020572|FG001|Overall Study|Death|7|||
13142565|NCT02649894|26020571|FG000|Overall Study|Other, not specified|6|||
13142566|NCT02649894|26020572|FG001|Overall Study|Other, not specified|0|||
13142567|NCT02649634|26020635|FG000|Overall Study|Withdrawal by Subject|3|||
13142568|NCT02649634|26020636|FG001|Overall Study|Withdrawal by Subject|5|||
13142569|NCT02649634|26020635|FG000|Overall Study|Lost to Follow-up|0|||
13142570|NCT02649634|26020636|FG001|Overall Study|Lost to Follow-up|1|||
13091801|NCT03720652|25825850|FG000|Overall Study|Lost to Follow-up|0|||
13091802|NCT03720652|25825851|FG001|Overall Study|Lost to Follow-up|4|||
13091803|NCT03720470|25826010|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
13091804|NCT03720470|25826011|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
13091805|NCT03720470|25826012|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
13091806|NCT03720470|25826013|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
13091807|NCT03720470|25826014|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8|||
13142571|NCT02649439|26020663|FG000|Overall Study|Switched to alternative treatment|6|||
13142572|NCT02649439|26020664|FG001|Overall Study|Switched to alternative treatment|4|||
13142573|NCT02649439|26020663|FG000|Overall Study|Patient decision|1|||
13142574|NCT02649439|26020664|FG001|Overall Study|Patient decision|0|||
13142575|NCT02649439|26020663|FG000|Overall Study|Patient going out of country|1|||
13142576|NCT02649439|26020664|FG001|Overall Study|Patient going out of country|0|||
13142577|NCT02649439|26020663|FG000|Overall Study|To start finasteride|1|||
13142578|NCT02649439|26020664|FG001|Overall Study|To start finasteride|0|||
13142579|NCT02649439|26020663|FG000|Overall Study|Physician Decision|1|||
13142580|NCT02649439|26020664|FG001|Overall Study|Physician Decision|0|||
13142581|NCT02649439|26020663|FG000|Overall Study|Disease progression on study|12|||
13142582|NCT02649439|26020664|FG001|Overall Study|Disease progression on study|13|||
13142583|NCT02649439|26020663|FG000|Overall Study|Refused further treatment|1|||
13142584|NCT02649439|26020664|FG001|Overall Study|Refused further treatment|0|||
13142585|NCT02649439|26020663|FG000|Overall Study|Refused further follow up|2|||
13142586|NCT02649439|26020664|FG001|Overall Study|Refused further follow up|7|||
13142587|NCT02649439|26020663|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1|||
13142588|NCT02649439|26020664|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0|||
13142589|NCT02649439|26020663|FG000|Overall Study|No treatment, per protocol|1|||
13142590|NCT02649439|26020664|FG001|Overall Study|No treatment, per protocol|0|||
13142591|NCT02649439|26020663|FG000|Overall Study|PSA DT makes ineligible|0|||
13142592|NCT02649439|26020664|FG001|Overall Study|PSA DT makes ineligible|1|||
13142593|NCT02649439|26020663|FG000|Overall Study|Rising PSA No Mets|0|||
13142594|NCT02649439|26020664|FG001|Overall Study|Rising PSA No Mets|1|||
13142595|NCT02649439|26020663|FG000|Overall Study|Rising PSA|0|||
13142596|NCT02649439|26020664|FG001|Overall Study|Rising PSA|1|||
13142597|NCT02649439|26020663|FG000|Overall Study|Signed follow up protocol|0|||
13142598|NCT02649439|26020664|FG001|Overall Study|Signed follow up protocol|1|||
13142599|NCT02649231|26020691|FG000|Overall Study|Adverse Event|0|||
13142600|NCT02649231|26020692|FG001|Overall Study|Adverse Event|0|||
13142601|NCT02649231|26020693|FG002|Overall Study|Adverse Event|0|||
13142602|NCT02649231|26020694|FG003|Overall Study|Adverse Event|1|||
13142603|NCT02649231|26020691|FG000|Overall Study|Lost to Follow-up|2|||
13142604|NCT02649231|26020692|FG001|Overall Study|Lost to Follow-up|1|||
13142605|NCT02649231|26020693|FG002|Overall Study|Lost to Follow-up|1|||
13142606|NCT02649231|26020694|FG003|Overall Study|Lost to Follow-up|0|||
13142607|NCT02649231|26020691|FG000|Overall Study|Withdrawal by Subject|0|||
13142608|NCT02649231|26020692|FG001|Overall Study|Withdrawal by Subject|1|||
13142609|NCT02649231|26020693|FG002|Overall Study|Withdrawal by Subject|0|||
13142610|NCT02649231|26020694|FG003|Overall Study|Withdrawal by Subject|1|||
13142611|NCT02649231|26020691|FG000|Overall Study|Protocol Violation|2|||
13142612|NCT02649231|26020692|FG001|Overall Study|Protocol Violation|1|||
13142613|NCT02649231|26020693|FG002|Overall Study|Protocol Violation|1|||
13142614|NCT02649231|26020694|FG003|Overall Study|Protocol Violation|0|||
13142615|NCT02649218|26020703|FG000|Overall Study|Adverse Event|8|||
13142616|NCT02649218|26020703|FG000|Overall Study|Lack of Efficacy|8|||
13142617|NCT02649218|26020703|FG000|Overall Study|Pregnancy|3|||
13142618|NCT02649218|26020703|FG000|Overall Study|Protocol Violation|3|||
13142619|NCT02649218|26020703|FG000|Overall Study|Physician Decision|1|||
13142620|NCT02649218|26020703|FG000|Overall Study|Withdrawal by Subject|2|||
13142621|NCT02648932|26020720|FG000|Overall Study|No transplant|3|||
13142622|NCT02648932|26020721|FG001|Overall Study|No transplant|1|||
13142623|NCT02648724|26020813|FG000|Overall Study|Withdrawal by Subject|0|||
13142624|NCT02648724|26020814|FG001|Overall Study|Withdrawal by Subject|1|||
13142625|NCT02648724|26020815|FG002|Overall Study|Withdrawal by Subject|1|||
13142626|NCT02648724|26020816|FG003|Overall Study|Withdrawal by Subject|0|||
13142627|NCT02648724|26020817|FG004|Overall Study|Withdrawal by Subject|1|||
13142628|NCT02648724|26020818|FG005|Overall Study|Withdrawal by Subject|0|||
13142629|NCT02648724|26020819|FG006|Overall Study|Withdrawal by Subject|0|||
13142630|NCT02648724|26020813|FG000|Overall Study|Progressive disease|2|||
13142631|NCT02648724|26020814|FG001|Overall Study|Progressive disease|2|||
13142632|NCT02648724|26020815|FG002|Overall Study|Progressive disease|2|||
13142633|NCT02648724|26020816|FG003|Overall Study|Progressive disease|3|||
13142634|NCT02648724|26020817|FG004|Overall Study|Progressive disease|22|||
13142635|NCT02648724|26020818|FG005|Overall Study|Progressive disease|7|||
13142636|NCT02648724|26020819|FG006|Overall Study|Progressive disease|8|||
13142637|NCT02648724|26020813|FG000|Overall Study|Other reason (unknown)|1|||
13142638|NCT02648724|26020814|FG001|Overall Study|Other reason (unknown)|0|||
13142639|NCT02648724|26020815|FG002|Overall Study|Other reason (unknown)|0|||
13142640|NCT02648724|26020816|FG003|Overall Study|Other reason (unknown)|0|||
13142641|NCT02648724|26020817|FG004|Overall Study|Other reason (unknown)|0|||
13142642|NCT02648724|26020818|FG005|Overall Study|Other reason (unknown)|0|||
13142643|NCT02648724|26020819|FG006|Overall Study|Other reason (unknown)|0|||
13142644|NCT02648724|26020813|FG000|Overall Study|Protocol Violation|0|||
13142645|NCT02648724|26020814|FG001|Overall Study|Protocol Violation|0|||
13142646|NCT02648724|26020815|FG002|Overall Study|Protocol Violation|0|||
13142647|NCT02648724|26020816|FG003|Overall Study|Protocol Violation|0|||
13142648|NCT02648724|26020817|FG004|Overall Study|Protocol Violation|1|||
13142649|NCT02648724|26020818|FG005|Overall Study|Protocol Violation|0|||
13142650|NCT02648724|26020819|FG006|Overall Study|Protocol Violation|0|||
13142651|NCT02648724|26020813|FG000|Overall Study|Death|0|||
13142652|NCT02648724|26020814|FG001|Overall Study|Death|0|||
13142653|NCT02648724|26020815|FG002|Overall Study|Death|0|||
13142654|NCT02648724|26020816|FG003|Overall Study|Death|0|||
13142655|NCT02648724|26020817|FG004|Overall Study|Death|0|||
13142656|NCT02648724|26020818|FG005|Overall Study|Death|0|||
13142657|NCT02648724|26020819|FG006|Overall Study|Death|3|||
13142658|NCT02648724|26020813|FG000|Overall Study|Physician Decision|0|||
13142659|NCT02648724|26020814|FG001|Overall Study|Physician Decision|0|||
13142660|NCT02648724|26020815|FG002|Overall Study|Physician Decision|0|||
13142661|NCT02648724|26020816|FG003|Overall Study|Physician Decision|0|||
13142662|NCT02648724|26020817|FG004|Overall Study|Physician Decision|1|||
13142663|NCT02648724|26020818|FG005|Overall Study|Physician Decision|0|||
13142664|NCT02648724|26020819|FG006|Overall Study|Physician Decision|1|||
13142665|NCT02648724|26020813|FG000|Overall Study|Transferred to named patient program|0|||
13142666|NCT02648724|26020814|FG001|Overall Study|Transferred to named patient program|0|||
13142667|NCT02648724|26020815|FG002|Overall Study|Transferred to named patient program|0|||
13142668|NCT02648724|26020816|FG003|Overall Study|Transferred to named patient program|0|||
13142669|NCT02648724|26020817|FG004|Overall Study|Transferred to named patient program|0|||
13142670|NCT02648724|26020818|FG005|Overall Study|Transferred to named patient program|1|||
13142671|NCT02648724|26020819|FG006|Overall Study|Transferred to named patient program|0|||
13142672|NCT02648698|26020832|FG000|Overall Study|Protocol Violation|1|||
13142673|NCT02648698|26020833|FG001|Overall Study|Protocol Violation|5|||
13142674|NCT02648438|26020883|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
13142675|NCT02648438|26020884|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
13142676|NCT02648438|26020885|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
13142677|NCT02648438|26020883|FG000|Overall Study|Protocol Violation|2|||
13142678|NCT02648438|26020884|FG001|Overall Study|Protocol Violation|0|||
13142679|NCT02648438|26020885|FG002|Overall Study|Protocol Violation|0|||
13142680|NCT02648438|26020883|FG000|Overall Study|Withdrawal by Subject|1|||
13142681|NCT02648438|26020884|FG001|Overall Study|Withdrawal by Subject|1|||
13142682|NCT02648438|26020885|FG002|Overall Study|Withdrawal by Subject|0|||
13142683|NCT02648347|26020910|FG000|Overall Study|Death|174|||
13142684|NCT02648347|26020911|FG001|Overall Study|Death|167|||
13142685|NCT02648347|26020910|FG000|Overall Study|Withdrawal by Subject|16|||
13142686|NCT02648347|26020911|FG001|Overall Study|Withdrawal by Subject|9|||
13142687|NCT02648347|26020910|FG000|Overall Study|Lost to Follow-up|18|||
13142688|NCT02648347|26020911|FG001|Overall Study|Lost to Follow-up|21|||
13142689|NCT02648347|26020910|FG000|Overall Study|Missing|1|||
13142690|NCT02648347|26020911|FG001|Overall Study|Missing|0|||
13142691|NCT02648217|26020936|FG000|Overall Study|Adverse Event|0|||
13142692|NCT02648217|26020937|FG001|Overall Study|Adverse Event|1|||
13142693|NCT02648217|26020936|FG000|Overall Study|Lost to Follow-up|1|||
13142694|NCT02648217|26020937|FG001|Overall Study|Lost to Follow-up|1|||
13142695|NCT02648217|26020936|FG000|Overall Study|Withdrawal by Subject|4|||
13142696|NCT02648217|26020937|FG001|Overall Study|Withdrawal by Subject|3|||
13142697|NCT02648217|26020936|FG000|Overall Study|Unclassified|5|||
13142698|NCT02648217|26020937|FG001|Overall Study|Unclassified|0|||
13142699|NCT02648204|26021068|FG000|Overall Study|Withdrawal by Subject|12|||
13142700|NCT02648204|26021069|FG001|Overall Study|Withdrawal by Subject|8|||
13142701|NCT02648204|26021070|FG002|Overall Study|Withdrawal by Subject|2|||
13142702|NCT02648204|26021071|FG003|Overall Study|Withdrawal by Subject|6|||
13142703|NCT02648204|26021068|FG000|Overall Study|Lost to Follow-up|5|||
13142704|NCT02648204|26021069|FG001|Overall Study|Lost to Follow-up|8|||
13142705|NCT02648204|26021070|FG002|Overall Study|Lost to Follow-up|4|||
13142706|NCT02648204|26021071|FG003|Overall Study|Lost to Follow-up|6|||
13142707|NCT02648204|26021068|FG000|Overall Study|Missing follow-up information|4|||
13142708|NCT02648204|26021069|FG001|Overall Study|Missing follow-up information|4|||
13142709|NCT02648204|26021070|FG002|Overall Study|Missing follow-up information|4|||
13142710|NCT02648204|26021071|FG003|Overall Study|Missing follow-up information|2|||
13142711|NCT02648204|26021068|FG000|Overall Study|Death|1|||
13142712|NCT02648204|26021069|FG001|Overall Study|Death|1|||
13142713|NCT02648204|26021070|FG002|Overall Study|Death|2|||
13142714|NCT02648204|26021071|FG003|Overall Study|Death|2|||
13142715|NCT02648204|26021068|FG000|Overall Study|Adverse Event|0|||
13091808|NCT03720470|25826015|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6|||
13091809|NCT03720470|25826010|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
13091810|NCT03720470|25826011|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
13091811|NCT03720470|25826012|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
13091812|NCT03720470|25826013|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
13091813|NCT03720470|25826014|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
13091814|NCT03720470|25826015|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
13142716|NCT02648204|26021069|FG001|Overall Study|Adverse Event|0|||
13142717|NCT02648204|26021070|FG002|Overall Study|Adverse Event|1|||
13142718|NCT02648204|26021071|FG003|Overall Study|Adverse Event|0|||
13142719|NCT02647944|26021102|FG000|Overall Study|Withdrawal by Subject|0|||
13142720|NCT02647944|26021103|FG001|Overall Study|Withdrawal by Subject|3|||
13142721|NCT02647944|26021102|FG000|Overall Study|Adverse Event|2|||
13142722|NCT02647944|26021103|FG001|Overall Study|Adverse Event|0|||
13142723|NCT02647905|26021110|FG000|Overall Study|Lost to Follow-up|1|||
13142724|NCT02647905|26021110|FG000|Overall Study|Withdrawal by Subject|2|||
13142725|NCT02647866|26021201|FG000|Overall Study|Adverse Event|0|||
13142726|NCT02647866|26021202|FG001|Overall Study|Adverse Event|0|||
13142727|NCT02647866|26021203|FG002|Overall Study|Adverse Event|2|||
13142728|NCT02647866|26021204|FG003|Overall Study|Adverse Event|2|||
13142729|NCT02647866|26021205|FG004|Overall Study|Adverse Event|1|||
13142730|NCT02647866|26021201|FG000|Overall Study|Disease Worsening|3|||
13142731|NCT02647866|26021202|FG001|Overall Study|Disease Worsening|1|||
13142732|NCT02647866|26021203|FG002|Overall Study|Disease Worsening|0|||
13142733|NCT02647866|26021204|FG003|Overall Study|Disease Worsening|0|||
13142734|NCT02647866|26021205|FG004|Overall Study|Disease Worsening|1|||
13142735|NCT02647866|26021201|FG000|Overall Study|Withdrawal by Subject|1|||
13142736|NCT02647866|26021202|FG001|Overall Study|Withdrawal by Subject|1|||
13142737|NCT02647866|26021203|FG002|Overall Study|Withdrawal by Subject|2|||
13142738|NCT02647866|26021204|FG003|Overall Study|Withdrawal by Subject|4|||
13142739|NCT02647866|26021205|FG004|Overall Study|Withdrawal by Subject|4|||
13142740|NCT02647866|26021201|FG000|Overall Study|Physician Decision|0|||
13142741|NCT02647866|26021202|FG001|Overall Study|Physician Decision|1|||
13142742|NCT02647866|26021203|FG002|Overall Study|Physician Decision|1|||
13142743|NCT02647866|26021204|FG003|Overall Study|Physician Decision|0|||
13142744|NCT02647866|26021205|FG004|Overall Study|Physician Decision|2|||
13142745|NCT02647866|26021201|FG000|Overall Study|Death|0|||
13142746|NCT02647866|26021202|FG001|Overall Study|Death|1|||
13142747|NCT02647866|26021203|FG002|Overall Study|Death|0|||
13142748|NCT02647866|26021204|FG003|Overall Study|Death|0|||
13142749|NCT02647866|26021205|FG004|Overall Study|Death|0|||
13142750|NCT02647866|26021201|FG000|Overall Study|Subject moved to different country|1|||
13142751|NCT02647866|26021202|FG001|Overall Study|Subject moved to different country|0|||
13142752|NCT02647866|26021203|FG002|Overall Study|Subject moved to different country|0|||
13142753|NCT02647866|26021204|FG003|Overall Study|Subject moved to different country|0|||
13142754|NCT02647866|26021205|FG004|Overall Study|Subject moved to different country|0|||
13142755|NCT02647788|26021222|FG000|Overall Study|Lost to Follow-up|13|||
13142756|NCT02647788|26021223|FG001|Overall Study|Lost to Follow-up|11|||
13142757|NCT02647788|26021222|FG000|Overall Study|Did not want opiate|0|||
13142758|NCT02647788|26021223|FG001|Overall Study|Did not want opiate|1|||
13142759|NCT02647788|26021222|FG000|Overall Study|Withdrawal by Subject|1|||
13142760|NCT02647788|26021223|FG001|Overall Study|Withdrawal by Subject|0|||
13142761|NCT02647788|26021222|FG000|Overall Study|Felt itchy with assigned medication|1|||
13142762|NCT02647788|26021223|FG001|Overall Study|Felt itchy with assigned medication|0|||
13142763|NCT02647788|26021222|FG000|Overall Study|Felt nauseous with assigned medication|1|||
13142764|NCT02647788|26021223|FG001|Overall Study|Felt nauseous with assigned medication|1|||
13142765|NCT02647658|26021256|FG000|Overall Study|Consent refusal|15|||
13142766|NCT02647658|26021257|FG001|Overall Study|Consent refusal|24|||
13142767|NCT02647645|26021274|FG000|Overall Study|Lost to Follow-up|2|||
13142768|NCT02647645|26021275|FG001|Overall Study|Lost to Follow-up|1|||
13142769|NCT02647359|26021310|FG000|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|0|||
13142770|NCT02647359|26021311|FG001|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|1|||
13142771|NCT02647359|26021310|FG000|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|4|||
13142772|NCT02647359|26021311|FG001|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|0|||
13142773|NCT02647359|26021310|FG000|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|2|||
13142774|NCT02647359|26021311|FG001|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|1|||
13142775|NCT02647359|26021310|FG000|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|8|||
13142776|NCT02647359|26021311|FG001|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|3|||
13142777|NCT02647359|26021310|FG000|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|1|||
13142778|NCT02647359|26021311|FG001|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|0|||
13142779|NCT02647359|26021310|FG000|Open-Label Sub-Study (96 Weeks)|Other than specified|7|||
13142780|NCT02647359|26021311|FG001|Open-Label Sub-Study (96 Weeks)|Other than specified|4|||
13142781|NCT02647320|26021409|FG000|Overall Study|Adverse Event|0|||
13142782|NCT02647320|26021410|FG001|Overall Study|Adverse Event|1|||
13142783|NCT02647320|26021411|FG002|Overall Study|Adverse Event|3|||
13142784|NCT02647320|26021412|FG003|Overall Study|Adverse Event|2|||
13142785|NCT02647320|26021413|FG004|Overall Study|Adverse Event|1|||
13142786|NCT02647320|26021409|FG000|Overall Study|Protocol Violation|0|||
13142787|NCT02647320|26021410|FG001|Overall Study|Protocol Violation|0|||
13142788|NCT02647320|26021411|FG002|Overall Study|Protocol Violation|3|||
13142789|NCT02647320|26021412|FG003|Overall Study|Protocol Violation|0|||
13142790|NCT02647320|26021413|FG004|Overall Study|Protocol Violation|0|||
13142791|NCT02647320|26021409|FG000|Overall Study|Withdrawal by Subject|7|||
13142792|NCT02647320|26021410|FG001|Overall Study|Withdrawal by Subject|4|||
13142793|NCT02647320|26021411|FG002|Overall Study|Withdrawal by Subject|2|||
13142794|NCT02647320|26021412|FG003|Overall Study|Withdrawal by Subject|2|||
13142795|NCT02647320|26021413|FG004|Overall Study|Withdrawal by Subject|7|||
13142796|NCT02647320|26021409|FG000|Overall Study|Persistent hyperglycemia|0|||
13142797|NCT02647320|26021410|FG001|Overall Study|Persistent hyperglycemia|1|||
13142798|NCT02647320|26021411|FG002|Overall Study|Persistent hyperglycemia|1|||
13142799|NCT02647320|26021412|FG003|Overall Study|Persistent hyperglycemia|1|||
13142800|NCT02647320|26021413|FG004|Overall Study|Persistent hyperglycemia|1|||
13142801|NCT02647320|26021409|FG000|Overall Study|Study terminated by sponsor|1|||
13142802|NCT02647320|26021410|FG001|Overall Study|Study terminated by sponsor|1|||
13142803|NCT02647320|26021411|FG002|Overall Study|Study terminated by sponsor|1|||
13142804|NCT02647320|26021412|FG003|Overall Study|Study terminated by sponsor|1|||
13142805|NCT02647320|26021413|FG004|Overall Study|Study terminated by sponsor|2|||
13142806|NCT02647320|26021409|FG000|Overall Study|Reason not provided|0|||
13142807|NCT02647320|26021410|FG001|Overall Study|Reason not provided|0|||
13142808|NCT02647320|26021411|FG002|Overall Study|Reason not provided|1|||
13142809|NCT02647320|26021412|FG003|Overall Study|Reason not provided|0|||
13142810|NCT02647320|26021413|FG004|Overall Study|Reason not provided|2|||
13142811|NCT02647320|26021409|FG000|Overall Study|Lost to Follow-up|1|||
13142812|NCT02647320|26021410|FG001|Overall Study|Lost to Follow-up|1|||
13142813|NCT02647320|26021411|FG002|Overall Study|Lost to Follow-up|0|||
13142814|NCT02647320|26021412|FG003|Overall Study|Lost to Follow-up|0|||
13142815|NCT02647320|26021413|FG004|Overall Study|Lost to Follow-up|0|||
13142816|NCT02647320|26021409|FG000|Overall Study|Develop anemia|1|||
13142817|NCT02647320|26021410|FG001|Overall Study|Develop anemia|0|||
13142818|NCT02647320|26021411|FG002|Overall Study|Develop anemia|0|||
13142819|NCT02647320|26021412|FG003|Overall Study|Develop anemia|0|||
13142820|NCT02647320|26021413|FG004|Overall Study|Develop anemia|0|||
13142821|NCT02647320|26021409|FG000|Overall Study|Lack of Efficacy|0|||
13142822|NCT02647320|26021410|FG001|Overall Study|Lack of Efficacy|0|||
13142823|NCT02647320|26021411|FG002|Overall Study|Lack of Efficacy|0|||
13142824|NCT02647320|26021412|FG003|Overall Study|Lack of Efficacy|1|||
13142825|NCT02647320|26021413|FG004|Overall Study|Lack of Efficacy|0|||
13142826|NCT02647320|26021409|FG000|Overall Study|Disposition Missing Due to Fire at Site|2|||
13142827|NCT02647320|26021410|FG001|Overall Study|Disposition Missing Due to Fire at Site|3|||
13142828|NCT02647320|26021411|FG002|Overall Study|Disposition Missing Due to Fire at Site|4|||
13142829|NCT02647320|26021412|FG003|Overall Study|Disposition Missing Due to Fire at Site|3|||
13142830|NCT02647320|26021413|FG004|Overall Study|Disposition Missing Due to Fire at Site|4|||
13142831|NCT02647281|26021619|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
13142832|NCT02647281|26021620|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
13142833|NCT02647281|26021621|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
13204928|NCT01968967|26230508|FG000|Treatment Period|Other|22|||
13142834|NCT02647281|26021622|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
13142835|NCT02647281|26021623|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
13142836|NCT02647281|26021624|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
13142837|NCT02647281|26021625|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
13142838|NCT02647281|26021626|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
13142839|NCT02647281|26021627|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1|||
13142840|NCT02646891|26021782|FG000|Overall Study|Adverse Event|0|||
13142841|NCT02646891|26021783|FG001|Overall Study|Adverse Event|1|||
13142842|NCT02646891|26021784|FG002|Overall Study|Adverse Event|0|||
13142843|NCT02646891|26021785|FG003|Overall Study|Adverse Event|0|||
13142844|NCT02646891|26021786|FG004|Overall Study|Adverse Event|0|||
13142845|NCT02646891|26021787|FG005|Overall Study|Adverse Event|0|||
13142846|NCT02646891|26021788|FG006|Overall Study|Adverse Event|0|||
13142847|NCT02646891|26021789|FG007|Overall Study|Adverse Event|0|||
13142848|NCT02646891|26021790|FG008|Overall Study|Adverse Event|0|||
13142849|NCT02646891|26021791|FG009|Overall Study|Adverse Event|0|||
13142850|NCT02646891|26021782|FG000|Overall Study|Lost to Follow-up|0|||
13142851|NCT02646891|26021783|FG001|Overall Study|Lost to Follow-up|0|||
13142852|NCT02646891|26021784|FG002|Overall Study|Lost to Follow-up|0|||
13142853|NCT02646891|26021785|FG003|Overall Study|Lost to Follow-up|0|||
13142854|NCT02646891|26021786|FG004|Overall Study|Lost to Follow-up|0|||
13142855|NCT02646891|26021787|FG005|Overall Study|Lost to Follow-up|0|||
13142856|NCT02646891|26021788|FG006|Overall Study|Lost to Follow-up|2|||
13142857|NCT02646891|26021789|FG007|Overall Study|Lost to Follow-up|2|||
13142858|NCT02646891|26021790|FG008|Overall Study|Lost to Follow-up|2|||
13142859|NCT02646891|26021791|FG009|Overall Study|Lost to Follow-up|2|||
13142860|NCT02646891|26021782|FG000|Overall Study|Protocol Violation|0|||
13142861|NCT02646891|26021783|FG001|Overall Study|Protocol Violation|0|||
13142862|NCT02646891|26021784|FG002|Overall Study|Protocol Violation|0|||
13142863|NCT02646891|26021785|FG003|Overall Study|Protocol Violation|0|||
13142864|NCT02646891|26021786|FG004|Overall Study|Protocol Violation|0|||
13142865|NCT02646891|26021787|FG005|Overall Study|Protocol Violation|0|||
13142866|NCT02646891|26021788|FG006|Overall Study|Protocol Violation|1|||
13142867|NCT02646891|26021789|FG007|Overall Study|Protocol Violation|1|||
13142868|NCT02646891|26021790|FG008|Overall Study|Protocol Violation|0|||
13142869|NCT02646891|26021791|FG009|Overall Study|Protocol Violation|0|||
13142870|NCT02646891|26021782|FG000|Overall Study|Withdrawal by Subject|2|||
13142871|NCT02646891|26021783|FG001|Overall Study|Withdrawal by Subject|0|||
13142872|NCT02646891|26021784|FG002|Overall Study|Withdrawal by Subject|1|||
13142873|NCT02646891|26021785|FG003|Overall Study|Withdrawal by Subject|0|||
13142874|NCT02646891|26021786|FG004|Overall Study|Withdrawal by Subject|0|||
13142875|NCT02646891|26021787|FG005|Overall Study|Withdrawal by Subject|0|||
13142876|NCT02646891|26021788|FG006|Overall Study|Withdrawal by Subject|5|||
13142877|NCT02646891|26021789|FG007|Overall Study|Withdrawal by Subject|9|||
13142878|NCT02646891|26021790|FG008|Overall Study|Withdrawal by Subject|7|||
13142879|NCT02646891|26021791|FG009|Overall Study|Withdrawal by Subject|3|||
13142880|NCT02646891|26021782|FG000|Overall Study|Death|0|||
13142881|NCT02646891|26021783|FG001|Overall Study|Death|0|||
13142882|NCT02646891|26021784|FG002|Overall Study|Death|0|||
13142883|NCT02646891|26021785|FG003|Overall Study|Death|0|||
13142884|NCT02646891|26021786|FG004|Overall Study|Death|0|||
13142885|NCT02646891|26021787|FG005|Overall Study|Death|0|||
13142886|NCT02646891|26021788|FG006|Overall Study|Death|1|||
13393352|NCT00665925|26783411|FG000|Overall Study|Due to exclusion criteria|1|||
13091815|NCT03720470|25826010|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
13091816|NCT03720470|25826011|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
13091817|NCT03720470|25826012|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
13091818|NCT03720470|25826013|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
13091819|NCT03720470|25826014|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
13091820|NCT03720470|25826015|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
13091821|NCT03720470|25826010|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
13091822|NCT03720470|25826011|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
13091823|NCT03720470|25826012|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
13091824|NCT03720470|25826013|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
13091825|NCT03720470|25826014|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
13091826|NCT03720470|25826015|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
13091827|NCT03720470|25826010|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
13091828|NCT03720470|25826011|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
13091829|NCT03720470|25826012|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
13091830|NCT03720470|25826013|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
13091831|NCT03720470|25826014|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
13091832|NCT03720470|25826015|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1|||
13142887|NCT02646891|26021789|FG007|Overall Study|Death|1|||
13142888|NCT02646891|26021790|FG008|Overall Study|Death|1|||
13142889|NCT02646891|26021791|FG009|Overall Study|Death|0|||
13091833|NCT03720470|25826010|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5|||
13091834|NCT03720470|25826011|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
13091835|NCT03720470|25826012|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
13091836|NCT03720470|25826013|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9|||
13091837|NCT03720470|25826014|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3|||
13091838|NCT03720470|25826015|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6|||
13091839|NCT03720470|25826010|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
13091840|NCT03720470|25826011|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
13091841|NCT03720470|25826012|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
13091842|NCT03720470|25826013|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
13091843|NCT03720470|25826014|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
13091844|NCT03720470|25826015|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
13091845|NCT03720470|25826010|FG000|Treatment Period: First Part 16 Weeks|Other|1|||
13091846|NCT03720470|25826011|FG001|Treatment Period: First Part 16 Weeks|Other|0|||
13091847|NCT03720470|25826012|FG002|Treatment Period: First Part 16 Weeks|Other|0|||
13091848|NCT03720470|25826013|FG003|Treatment Period: First Part 16 Weeks|Other|1|||
13091849|NCT03720470|25826014|FG004|Treatment Period: First Part 16 Weeks|Other|2|||
13091850|NCT03720470|25826015|FG005|Treatment Period: First Part 16 Weeks|Other|2|||
13091851|NCT03720470|25826010|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
13091852|NCT03720470|25826011|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
13091853|NCT03720470|25826012|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
13091854|NCT03720470|25826013|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
13091855|NCT03720470|25826014|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
13091856|NCT03720470|25826015|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1|||
13091857|NCT03720470|25826010|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0|||
13091858|NCT03720470|25826011|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0|||
13091859|NCT03720470|25826012|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0|||
13142890|NCT02646618|26021900|FG000|Overall Study|Lost to Follow-up|10|||
13142891|NCT02646618|26021901|FG001|Overall Study|Lost to Follow-up|14|||
13142892|NCT02646566|26021949|FG000|Overall Study|Lost to Follow-up|5|||
13142893|NCT02646566|26021950|FG001|Overall Study|Lost to Follow-up|4|||
13142894|NCT02646566|26021951|FG002|Overall Study|Lost to Follow-up|5|||
13142895|NCT02646566|26021949|FG000|Overall Study|Treatment failure|1|||
13142896|NCT02646566|26021950|FG001|Overall Study|Treatment failure|0|||
13142897|NCT02646566|26021951|FG002|Overall Study|Treatment failure|0|||
13142898|NCT02646423|26021988|FG000|Overall Study|Adverse Event|5|||
13142899|NCT02646423|26021989|FG001|Overall Study|Adverse Event|7|||
13142900|NCT02646423|26021988|FG000|Overall Study|Ineligible|2|||
13142901|NCT02646423|26021989|FG001|Overall Study|Ineligible|1|||
13142902|NCT02646332|26022002|FG000|Overall Study|Lost to Follow-up|0|||
13142903|NCT02646332|26022003|FG001|Overall Study|Lost to Follow-up|3|||
13142904|NCT02646124|26022024|FG000|Overall Study|Lost to Follow-up|0|||
13142905|NCT02646124|26022025|FG001|Overall Study|Lost to Follow-up|2|||
13142906|NCT02645409|26022037|FG000|Overall Study|Withdrawal by Subject|3|||
13142907|NCT02645409|26022038|FG001|Overall Study|Withdrawal by Subject|0|||
13142908|NCT02645409|26022037|FG000|Overall Study|Physician Decision|1|||
13142909|NCT02645409|26022038|FG001|Overall Study|Physician Decision|0|||
13142910|NCT02644967|26022047|FG000|Overall Study|Death|26|||
13142911|NCT02644967|26022047|FG000|Overall Study|Physician Decision|1|||
13142912|NCT02644967|26022047|FG000|Overall Study|Withdrawal by Subject|2|||
13142913|NCT02644967|26022047|FG000|Overall Study|Protocol Violation|1|||
13142914|NCT02644967|26022047|FG000|Overall Study|Progressive Disease|1|||
13142915|NCT02644967|26022047|FG000|Overall Study|Study Terminated by Sponsor|4|||
13142916|NCT02644668|26022096|FG000|Overall Study|Adverse Event|2|||
13142917|NCT02644668|26022097|FG001|Overall Study|Adverse Event|0|||
13142918|NCT02644668|26022098|FG002|Overall Study|Adverse Event|1|||
13142919|NCT02644668|26022096|FG000|Overall Study|Protocol Violation|0|||
13142920|NCT02644668|26022097|FG001|Overall Study|Protocol Violation|0|||
13142921|NCT02644668|26022098|FG002|Overall Study|Protocol Violation|1|||
13142922|NCT02644668|26022096|FG000|Overall Study|Withdrawal by Subject|0|||
13142923|NCT02644668|26022097|FG001|Overall Study|Withdrawal by Subject|0|||
13142924|NCT02644668|26022098|FG002|Overall Study|Withdrawal by Subject|1|||
13142925|NCT02644356|26022110|FG000|Overall Study|Withdrawal by Subject|2|||
13142926|NCT02644343|26022116|FG000|Overall Study|Withdrawal by Subject|1|||
13142927|NCT02644122|26022126|FG000|Overall Study|Withdrawal by Subject|1|||
13142928|NCT02644109|26022139|FG000|Overall Study|Adverse Event|0|||
13142929|NCT02644109|26022140|FG001|Overall Study|Adverse Event|4|||
13142930|NCT02644096|26022153|FG000|Overall Study|Withdrawal by Subject|28|||
13142931|NCT02644096|26022154|FG001|Overall Study|Withdrawal by Subject|25|||
13142932|NCT02643693|26022172|FG000|Overall Study|Physician Decision|0|||
13142933|NCT02643693|26022173|FG001|Overall Study|Physician Decision|1|||
13142934|NCT02643693|26022174|FG002|Overall Study|Physician Decision|0|||
13142935|NCT02643693|26022175|FG003|Overall Study|Physician Decision|0|||
13142936|NCT02643693|26022176|FG004|Overall Study|Physician Decision|0|||
13142937|NCT02643693|26022177|FG005|Overall Study|Physician Decision|0|||
13142938|NCT02643693|26022172|FG000|Overall Study|Withdrawal by Subject|0|||
13142939|NCT02643693|26022173|FG001|Overall Study|Withdrawal by Subject|1|||
13142940|NCT02643693|26022174|FG002|Overall Study|Withdrawal by Subject|0|||
13142941|NCT02643693|26022175|FG003|Overall Study|Withdrawal by Subject|0|||
13142942|NCT02643693|26022176|FG004|Overall Study|Withdrawal by Subject|0|||
13142943|NCT02643693|26022177|FG005|Overall Study|Withdrawal by Subject|0|||
13142944|NCT02643693|26022172|FG000|Overall Study|Protocol Adherence Issues|2|||
13142945|NCT02643693|26022173|FG001|Overall Study|Protocol Adherence Issues|0|||
13142946|NCT02643693|26022174|FG002|Overall Study|Protocol Adherence Issues|1|||
13142947|NCT02643693|26022175|FG003|Overall Study|Protocol Adherence Issues|0|||
13142948|NCT02643693|26022176|FG004|Overall Study|Protocol Adherence Issues|0|||
13142949|NCT02643693|26022177|FG005|Overall Study|Protocol Adherence Issues|1|||
13142950|NCT02643628|26022198|FG000|Overall Study|Lost to Follow-up|1|||
13142951|NCT02643628|26022199|FG001|Overall Study|Lost to Follow-up|4|||
13142952|NCT02643628|26022198|FG000|Overall Study|Withdrawal by Subject|0|||
13142953|NCT02643628|26022199|FG001|Overall Study|Withdrawal by Subject|1|||
13142954|NCT02643628|26022198|FG000|Overall Study|Relocated out of state|0|||
13142955|NCT02643628|26022199|FG001|Overall Study|Relocated out of state|1|||
13142956|NCT02643472|26022230|FG000|Overall Study|Death|2|||
13142957|NCT02643472|26022231|FG001|Overall Study|Death|5|||
13142958|NCT02643472|26022230|FG000|Overall Study|Withdrawal by Subject|3|||
13142959|NCT02643472|26022231|FG001|Overall Study|Withdrawal by Subject|2|||
13142960|NCT02643472|26022230|FG000|Overall Study|Protocol Violation|0|||
13142961|NCT02643472|26022231|FG001|Overall Study|Protocol Violation|1|||
13142962|NCT02643472|26022230|FG000|Overall Study|Lost to Follow-up|22|||
13142963|NCT02643472|26022231|FG001|Overall Study|Lost to Follow-up|26|||
13142964|NCT02643420|26022264|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6|||
13142965|NCT02643420|26022265|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12|||
13142966|NCT02643420|26022264|FG000|Overall Study|Withdrawal by Subject|25|||
13142967|NCT02643420|26022265|FG001|Overall Study|Withdrawal by Subject|19|||
13142968|NCT02643420|26022264|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6|||
13142969|NCT02643420|26022265|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10|||
13142970|NCT02643420|26022264|FG000|Overall Study|Lost to Follow-up|6|||
13142971|NCT02643420|26022265|FG001|Overall Study|Lost to Follow-up|10|||
13142972|NCT02643420|26022264|FG000|Overall Study|Investigator Decision|2|||
13142973|NCT02643420|26022265|FG001|Overall Study|Investigator Decision|4|||
13142974|NCT02643420|26022264|FG000|Overall Study|Sponsor decision|1|||
13142975|NCT02643420|26022265|FG001|Overall Study|Sponsor decision|1|||
13142976|NCT02643420|26022264|FG000|Overall Study|Death|0|||
13142977|NCT02643420|26022265|FG001|Overall Study|Death|2|||
13142978|NCT02643420|26022264|FG000|Overall Study|Reason not Specified|8|||
13142979|NCT02643420|26022265|FG001|Overall Study|Reason not Specified|7|||
13142980|NCT02643394|26022280|FG000|Overall Study|Protocol Violation|4|||
13142981|NCT02643394|26022281|FG001|Overall Study|Protocol Violation|5|||
13142982|NCT02643355|26022300|FG000|Overall Study|Withdrawal by Subject|1|||
13142983|NCT02643355|26022301|FG001|Overall Study|Withdrawal by Subject|3|||
13142984|NCT02643355|26022300|FG000|Overall Study|Protocol Violation|0|||
13142985|NCT02643355|26022301|FG001|Overall Study|Protocol Violation|2|||
13142986|NCT02643251|26022316|FG000|Overall Study|Adverse Event|3|||
13142987|NCT02643251|26022317|FG001|Overall Study|Adverse Event|1|||
13142988|NCT02643251|26022316|FG000|Overall Study|Withdrawal by Subject|2|||
13142989|NCT02643251|26022317|FG001|Overall Study|Withdrawal by Subject|0|||
13142990|NCT02643251|26022316|FG000|Overall Study|Lost to Follow-up|4|||
13142991|NCT02643251|26022317|FG001|Overall Study|Lost to Follow-up|1|||
13142992|NCT02643251|26022316|FG000|Overall Study|Protocol Violation|1|||
13142993|NCT02643251|26022317|FG001|Overall Study|Protocol Violation|0|||
13142994|NCT02643251|26022316|FG000|Overall Study|PI Decision to terminate patient|1|||
13142995|NCT02643251|26022317|FG001|Overall Study|PI Decision to terminate patient|0|||
13142996|NCT02643082|26022337|FG000|Period 1|Adverse Event|1|||
13142997|NCT02643082|26022338|FG001|Period 1|Adverse Event|0|||
13142998|NCT02642679|26022346|FG000|Overall Study|Withdrawal by Subject|1|||
13091860|NCT03720470|25826013|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2|||
13091861|NCT03720470|25826014|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1|||
13091862|NCT03720470|25826015|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1|||
13091863|NCT03720470|25826010|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
13091864|NCT03720470|25826011|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
13091865|NCT03720470|25826012|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1|||
13091866|NCT03720470|25826013|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
13091867|NCT03720470|25826014|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
13142999|NCT02642679|26022346|FG000|Overall Study|Physician Decision|1|||
13143000|NCT02642679|26022346|FG000|Overall Study|Physician Decision|1|||
13143001|NCT02642653|26022385|FG000|Overall Study|Adverse Event|2|||
13143002|NCT02642653|26022386|FG001|Overall Study|Adverse Event|0|||
13091868|NCT03720470|25826015|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
13091869|NCT03720470|25826010|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
13091870|NCT03720470|25826011|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
13091871|NCT03720470|25826012|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
13091872|NCT03720470|25826013|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
13091873|NCT03720470|25826014|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
13091874|NCT03720470|25826015|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
13091875|NCT03720470|25826010|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0|||
13091876|NCT03720470|25826011|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0|||
13091877|NCT03720470|25826012|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0|||
13091878|NCT03720470|25826013|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0|||
13091879|NCT03720470|25826014|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0|||
13091880|NCT03720470|25826015|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1|||
13091881|NCT03720470|25826010|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
13091882|NCT03720470|25826011|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
13091883|NCT03720470|25826012|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1|||
13091884|NCT03720470|25826013|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
13091885|NCT03720470|25826014|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
13091886|NCT03720470|25826015|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
13091887|NCT03720470|25826010|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
13091888|NCT03720470|25826011|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1|||
13091889|NCT03720470|25826012|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
13091890|NCT03720470|25826013|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
13091891|NCT03720470|25826014|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
13091892|NCT03720470|25826015|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
13091893|NCT03720470|25826010|FG000|Treatment Period: Final 4 Weeks|Other|0|||
13091894|NCT03720470|25826011|FG001|Treatment Period: Final 4 Weeks|Other|1|||
13091895|NCT03720470|25826012|FG002|Treatment Period: Final 4 Weeks|Other|0|||
13143003|NCT02642614|26022431|FG000|Overall Study|Adverse Event|1|||
13143004|NCT02642614|26022432|FG001|Overall Study|Adverse Event|1|||
13143005|NCT02642614|26022433|FG002|Overall Study|Adverse Event|2|||
13143006|NCT02642614|26022434|FG003|Overall Study|Adverse Event|2|||
13143007|NCT02642614|26022431|FG000|Overall Study|Lost to Follow-up|1|||
13143008|NCT02642614|26022432|FG001|Overall Study|Lost to Follow-up|0|||
13143009|NCT02642614|26022433|FG002|Overall Study|Lost to Follow-up|0|||
13143010|NCT02642614|26022434|FG003|Overall Study|Lost to Follow-up|0|||
13143011|NCT02642614|26022431|FG000|Overall Study|Withdrawal by Subject|1|||
13143012|NCT02642614|26022432|FG001|Overall Study|Withdrawal by Subject|1|||
13143013|NCT02642614|26022433|FG002|Overall Study|Withdrawal by Subject|0|||
13143014|NCT02642614|26022434|FG003|Overall Study|Withdrawal by Subject|0|||
13143015|NCT02642432|26022442|FG000|Overall Study|Adverse Event|2|||
13143016|NCT02642432|26022442|FG000|Overall Study|Withdrew Consent|1|||
13143017|NCT02642432|26022442|FG000|Overall Study|Lost to Follow-up|2|||
13143018|NCT02642432|26022442|FG000|Overall Study|Other|3|||
13143019|NCT02642159|26022499|FG000|Overall Study|Randomized but not treated|1|||
13143020|NCT02642159|26022500|FG001|Overall Study|Randomized but not treated|0|||
13143021|NCT02642159|26022499|FG000|Overall Study|Adverse Event|10|||
13143022|NCT02642159|26022500|FG001|Overall Study|Adverse Event|4|||
13143023|NCT02642159|26022499|FG000|Overall Study|Withdrawal by Subject|9|||
13143024|NCT02642159|26022500|FG001|Overall Study|Withdrawal by Subject|1|||
13143025|NCT02642159|26022499|FG000|Overall Study|Poor compliance to study protocol|1|||
13143026|NCT02642159|26022500|FG001|Overall Study|Poor compliance to study protocol|0|||
13143027|NCT02642159|26022499|FG000|Overall Study|Other than specified above|10|||
13143028|NCT02642159|26022500|FG001|Overall Study|Other than specified above|3|||
13143029|NCT02641730|26022613|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
13143030|NCT02641730|26022614|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
13143031|NCT02641730|26022615|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
13143032|NCT02641730|26022616|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
13143033|NCT02641730|26022617|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
13143034|NCT02641730|26022613|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
13143035|NCT02641730|26022614|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
13143036|NCT02641730|26022615|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
13143037|NCT02641730|26022616|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5|||
13143038|NCT02641730|26022617|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4|||
13143039|NCT02641730|26022613|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
13143040|NCT02641730|26022614|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
13143041|NCT02641730|26022615|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
13143042|NCT02641730|26022616|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
13143043|NCT02641730|26022617|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
13143044|NCT02641730|26022613|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
13143045|NCT02641730|26022614|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
13204929|NCT01968967|26230509|FG001|Treatment Period|Other|22|||
13143046|NCT02641730|26022615|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
13143047|NCT02641730|26022616|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
13143048|NCT02641730|26022617|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
13143049|NCT02641730|26022613|FG000|After Controlled Period (Week 16 - 52)|Other|0|||
13143050|NCT02641730|26022614|FG001|After Controlled Period (Week 16 - 52)|Other|1|||
13143051|NCT02641730|26022615|FG002|After Controlled Period (Week 16 - 52)|Other|1|||
13143052|NCT02641730|26022616|FG003|After Controlled Period (Week 16 - 52)|Other|0|||
13143053|NCT02641730|26022617|FG004|After Controlled Period (Week 16 - 52)|Other|1|||
13143054|NCT02641730|26022613|FG000|Observational Period (Week 60 - Week 84)|Other|0|||
13143055|NCT02641730|26022614|FG001|Observational Period (Week 60 - Week 84)|Other|0|||
13143056|NCT02641730|26022615|FG002|Observational Period (Week 60 - Week 84)|Other|0|||
13143057|NCT02641730|26022616|FG003|Observational Period (Week 60 - Week 84)|Other|0|||
13143058|NCT02641730|26022617|FG004|Observational Period (Week 60 - Week 84)|Other|1|||
13143059|NCT02641587|26022647|FG000|Confinement Period|Adverse Event|1|||
13143060|NCT02641587|26022648|FG001|Confinement Period|Adverse Event|0|||
13143061|NCT02641587|26022647|FG000|Confinement Period|Withdrawal by Subject|2|||
13143062|NCT02641587|26022648|FG001|Confinement Period|Withdrawal by Subject|1|||
13143063|NCT02641587|26022647|FG000|Ambulatory Period|Withdrawal by Subject|1|||
13143064|NCT02641587|26022648|FG001|Ambulatory Period|Withdrawal by Subject|0|||
13143065|NCT02641392|26022666|FG000|Overall Study|Lost to Follow-up|0|||
13143066|NCT02641392|26022667|FG001|Overall Study|Lost to Follow-up|0|||
13143067|NCT02641392|26022668|FG002|Overall Study|Lost to Follow-up|2|||
13143068|NCT02641392|26022666|FG000|Overall Study|Withdrawal by Subject|0|||
13143069|NCT02641392|26022667|FG001|Overall Study|Withdrawal by Subject|0|||
13143070|NCT02641392|26022668|FG002|Overall Study|Withdrawal by Subject|17|||
13143071|NCT02641392|26022666|FG000|Overall Study|Adverse Event|0|||
13143072|NCT02641392|26022667|FG001|Overall Study|Adverse Event|1|||
13143073|NCT02641392|26022668|FG002|Overall Study|Adverse Event|25|||
13143074|NCT02641392|26022666|FG000|Overall Study|Study Terminated by Sponsor|4|||
13143075|NCT02641392|26022667|FG001|Overall Study|Study Terminated by Sponsor|12|||
13143076|NCT02641392|26022668|FG002|Overall Study|Study Terminated by Sponsor|144|||
13143077|NCT02641392|26022666|FG000|Overall Study|Lack of Efficacy|0|||
13143078|NCT02641392|26022667|FG001|Overall Study|Lack of Efficacy|0|||
13143079|NCT02641392|26022668|FG002|Overall Study|Lack of Efficacy|101|||
13143080|NCT02641392|26022666|FG000|Overall Study|Miscellaneous|0|||
13143081|NCT02641392|26022667|FG001|Overall Study|Miscellaneous|0|||
13143082|NCT02641392|26022668|FG002|Overall Study|Miscellaneous|3|||
13143083|NCT02641392|26022666|FG000|Overall Study|Death|0|||
13143084|NCT02641392|26022667|FG001|Overall Study|Death|0|||
13143085|NCT02641392|26022668|FG002|Overall Study|Death|1|||
13143086|NCT02641379|26022767|FG000|Overall Study|Exclusion criterion during screening|1|||
13143087|NCT02641379|26022768|FG001|Overall Study|Exclusion criterion during screening|0|||
13143088|NCT02641379|26022769|FG002|Overall Study|Exclusion criterion during screening|0|||
13143089|NCT02641379|26022770|FG003|Overall Study|Exclusion criterion during screening|1|||
13143090|NCT02641379|26022771|FG004|Overall Study|Exclusion criterion during screening|2|||
13143091|NCT02641379|26022772|FG005|Overall Study|Exclusion criterion during screening|0|||
13143092|NCT02641379|26022773|FG006|Overall Study|Exclusion criterion during screening|0|||
13143093|NCT02641379|26022774|FG007|Overall Study|Exclusion criterion during screening|0|||
13143094|NCT02641379|26022775|FG008|Overall Study|Exclusion criterion during screening|0|||
13143095|NCT02641379|26022776|FG009|Overall Study|Exclusion criterion during screening|0|||
13143096|NCT02641379|26022777|FG010|Overall Study|Exclusion criterion during screening|0|||
13143097|NCT02641379|26022767|FG000|Overall Study|Withdrawal of informed consent|0|||
13143098|NCT02641379|26022768|FG001|Overall Study|Withdrawal of informed consent|1|||
13143099|NCT02641379|26022769|FG002|Overall Study|Withdrawal of informed consent|0|||
13143100|NCT02641379|26022770|FG003|Overall Study|Withdrawal of informed consent|0|||
13143101|NCT02641379|26022771|FG004|Overall Study|Withdrawal of informed consent|0|||
13143102|NCT02641379|26022772|FG005|Overall Study|Withdrawal of informed consent|0|||
13143103|NCT02641379|26022773|FG006|Overall Study|Withdrawal of informed consent|0|||
13143104|NCT02641379|26022774|FG007|Overall Study|Withdrawal of informed consent|1|||
13143105|NCT02641379|26022775|FG008|Overall Study|Withdrawal of informed consent|0|||
13143106|NCT02641379|26022776|FG009|Overall Study|Withdrawal of informed consent|0|||
13143107|NCT02641379|26022777|FG010|Overall Study|Withdrawal of informed consent|0|||
13143108|NCT02641379|26022767|FG000|Overall Study|Adverse Event|7|||
13143109|NCT02641379|26022768|FG001|Overall Study|Adverse Event|8|||
13143110|NCT02641379|26022769|FG002|Overall Study|Adverse Event|2|||
13143111|NCT02641379|26022770|FG003|Overall Study|Adverse Event|2|||
13143112|NCT02641379|26022771|FG004|Overall Study|Adverse Event|5|||
13143113|NCT02641379|26022772|FG005|Overall Study|Adverse Event|1|||
13143114|NCT02641379|26022773|FG006|Overall Study|Adverse Event|5|||
13143115|NCT02641379|26022774|FG007|Overall Study|Adverse Event|0|||
13143116|NCT02641379|26022775|FG008|Overall Study|Adverse Event|1|||
13143117|NCT02641379|26022776|FG009|Overall Study|Adverse Event|1|||
13143118|NCT02641379|26022777|FG010|Overall Study|Adverse Event|5|||
13143119|NCT02641379|26022767|FG000|Overall Study|Lack of Efficacy|0|||
13143120|NCT02641379|26022768|FG001|Overall Study|Lack of Efficacy|0|||
13143121|NCT02641379|26022769|FG002|Overall Study|Lack of Efficacy|2|||
13143122|NCT02641379|26022770|FG003|Overall Study|Lack of Efficacy|0|||
13143123|NCT02641379|26022771|FG004|Overall Study|Lack of Efficacy|0|||
13143124|NCT02641379|26022772|FG005|Overall Study|Lack of Efficacy|2|||
13143125|NCT02641379|26022773|FG006|Overall Study|Lack of Efficacy|0|||
13143126|NCT02641379|26022774|FG007|Overall Study|Lack of Efficacy|5|||
13143127|NCT02641379|26022775|FG008|Overall Study|Lack of Efficacy|0|||
13143128|NCT02641379|26022776|FG009|Overall Study|Lack of Efficacy|0|||
13143129|NCT02641379|26022777|FG010|Overall Study|Lack of Efficacy|0|||
13143130|NCT02641379|26022767|FG000|Overall Study|Participant unable to attend study visit|4|||
13143131|NCT02641379|26022768|FG001|Overall Study|Participant unable to attend study visit|10|||
13143132|NCT02641379|26022769|FG002|Overall Study|Participant unable to attend study visit|1|||
13143133|NCT02641379|26022770|FG003|Overall Study|Participant unable to attend study visit|2|||
13143134|NCT02641379|26022771|FG004|Overall Study|Participant unable to attend study visit|5|||
13143135|NCT02641379|26022772|FG005|Overall Study|Participant unable to attend study visit|1|||
13143136|NCT02641379|26022773|FG006|Overall Study|Participant unable to attend study visit|1|||
13143137|NCT02641379|26022774|FG007|Overall Study|Participant unable to attend study visit|1|||
13143138|NCT02641379|26022775|FG008|Overall Study|Participant unable to attend study visit|0|||
13143139|NCT02641379|26022776|FG009|Overall Study|Participant unable to attend study visit|2|||
13143140|NCT02641379|26022777|FG010|Overall Study|Participant unable to attend study visit|0|||
13143141|NCT02641379|26022767|FG000|Overall Study|Participant's compliance|0|||
13143142|NCT02641379|26022768|FG001|Overall Study|Participant's compliance|1|||
13143143|NCT02641379|26022769|FG002|Overall Study|Participant's compliance|0|||
13143144|NCT02641379|26022770|FG003|Overall Study|Participant's compliance|1|||
13143145|NCT02641379|26022771|FG004|Overall Study|Participant's compliance|0|||
13143146|NCT02641379|26022772|FG005|Overall Study|Participant's compliance|2|||
13143147|NCT02641379|26022773|FG006|Overall Study|Participant's compliance|0|||
13143148|NCT02641379|26022774|FG007|Overall Study|Participant's compliance|0|||
13143149|NCT02641379|26022775|FG008|Overall Study|Participant's compliance|1|||
13143150|NCT02641379|26022776|FG009|Overall Study|Participant's compliance|1|||
13143151|NCT02641379|26022777|FG010|Overall Study|Participant's compliance|1|||
13143152|NCT02641379|26022767|FG000|Overall Study|Participant cannot be reached|4|||
13143153|NCT02641379|26022768|FG001|Overall Study|Participant cannot be reached|4|||
13143154|NCT02641379|26022769|FG002|Overall Study|Participant cannot be reached|0|||
13143155|NCT02641379|26022770|FG003|Overall Study|Participant cannot be reached|8|||
13143156|NCT02641379|26022771|FG004|Overall Study|Participant cannot be reached|2|||
13143157|NCT02641379|26022772|FG005|Overall Study|Participant cannot be reached|1|||
13143158|NCT02641379|26022773|FG006|Overall Study|Participant cannot be reached|0|||
13143159|NCT02641379|26022774|FG007|Overall Study|Participant cannot be reached|1|||
13143160|NCT02641379|26022775|FG008|Overall Study|Participant cannot be reached|0|||
13143161|NCT02641379|26022776|FG009|Overall Study|Participant cannot be reached|2|||
13143162|NCT02641379|26022777|FG010|Overall Study|Participant cannot be reached|1|||
13091896|NCT03720470|25826013|FG003|Treatment Period: Final 4 Weeks|Other|2|||
13091897|NCT03720470|25826014|FG004|Treatment Period: Final 4 Weeks|Other|1|||
13091898|NCT03720470|25826015|FG005|Treatment Period: Final 4 Weeks|Other|0|||
13091899|NCT03720210|25826024|FG000|Overall Study|Lost to Follow-up|1|||
13091900|NCT03719586|25826059|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8|||
13091901|NCT03719586|25826060|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7|||
13091902|NCT03719586|25826061|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4|||
13091903|NCT03719586|25826062|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0|||
13133675|NCT02766023|25988751|FG000|Overall Study|Physician Decision|1|||
13133676|NCT02766023|25988752|FG001|Overall Study|Physician Decision|0|||
13133677|NCT02766023|25988751|FG000|Overall Study|Not Eligible at Enrollment|0|||
13133678|NCT02766023|25988752|FG001|Overall Study|Not Eligible at Enrollment|1|||
13133679|NCT02765490|25988775|FG000|Overall Study|Lost to Follow-up|1|||
13133680|NCT02765490|25988776|FG001|Overall Study|Lost to Follow-up|1|||
13133681|NCT02765490|25988775|FG000|Overall Study|Other|0|||
13133682|NCT02765490|25988776|FG001|Overall Study|Other|1|||
13133683|NCT02765490|25988775|FG000|Overall Study|Death|0|||
13133684|NCT02765490|25988776|FG001|Overall Study|Death|1|||
13133685|NCT02765399|25988829|FG000|Overall Study|Nausea|1|||
13133686|NCT02765399|25988830|FG001|Overall Study|Nausea|0|||
13133687|NCT02765165|25988891|FG000|Treatment Period|Progressive disease|3|||
13133688|NCT02765165|25988892|FG001|Treatment Period|Progressive disease|2|||
13133689|NCT02765165|25988893|FG002|Treatment Period|Progressive disease|3|||
13133690|NCT02765165|25988894|FG003|Treatment Period|Progressive disease|3|||
13133691|NCT02765165|25988895|FG004|Treatment Period|Progressive disease|4|||
13133692|NCT02765165|25988896|FG005|Treatment Period|Progressive disease|2|||
13133693|NCT02765165|25988897|FG006|Treatment Period|Progressive disease|2|||
13133694|NCT02765165|25988891|FG000|Treatment Period|Physician Decision|0|||
13091904|NCT03718429|25826111|FG000|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
13091905|NCT03718429|25826112|FG001|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
13091906|NCT03718429|25826113|FG002|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
13143163|NCT02641379|26022767|FG000|Overall Study|PCR positive at Week 24|15|||
13143164|NCT02641379|26022768|FG001|Overall Study|PCR positive at Week 24|21|||
13143165|NCT02641379|26022769|FG002|Overall Study|PCR positive at Week 24|62|||
13143166|NCT02641379|26022770|FG003|Overall Study|PCR positive at Week 24|0|||
13143167|NCT02641379|26022771|FG004|Overall Study|PCR positive at Week 24|0|||
13143168|NCT02641379|26022772|FG005|Overall Study|PCR positive at Week 24|6|||
13143169|NCT02641379|26022773|FG006|Overall Study|PCR positive at Week 24|3|||
13143170|NCT02641379|26022774|FG007|Overall Study|PCR positive at Week 24|8|||
13143171|NCT02641379|26022775|FG008|Overall Study|PCR positive at Week 24|0|||
13143172|NCT02641379|26022776|FG009|Overall Study|PCR positive at Week 24|1|||
13143173|NCT02641379|26022777|FG010|Overall Study|PCR positive at Week 24|0|||
13143174|NCT02641379|26022767|FG000|Overall Study|PCR positive at follow up 2|1|||
13143175|NCT02641379|26022768|FG001|Overall Study|PCR positive at follow up 2|0|||
13143176|NCT02641379|26022769|FG002|Overall Study|PCR positive at follow up 2|0|||
13143177|NCT02641379|26022770|FG003|Overall Study|PCR positive at follow up 2|0|||
13143178|NCT02641379|26022771|FG004|Overall Study|PCR positive at follow up 2|0|||
13143179|NCT02641379|26022772|FG005|Overall Study|PCR positive at follow up 2|0|||
13143180|NCT02641379|26022773|FG006|Overall Study|PCR positive at follow up 2|0|||
13143181|NCT02641379|26022774|FG007|Overall Study|PCR positive at follow up 2|0|||
13143182|NCT02641379|26022775|FG008|Overall Study|PCR positive at follow up 2|0|||
13143183|NCT02641379|26022776|FG009|Overall Study|PCR positive at follow up 2|0|||
13143184|NCT02641379|26022777|FG010|Overall Study|PCR positive at follow up 2|0|||
13143185|NCT02641379|26022767|FG000|Overall Study|Participant showed relapse|1|||
13143186|NCT02641379|26022768|FG001|Overall Study|Participant showed relapse|0|||
13143187|NCT02641379|26022769|FG002|Overall Study|Participant showed relapse|0|||
13143188|NCT02641379|26022770|FG003|Overall Study|Participant showed relapse|0|||
13143189|NCT02641379|26022771|FG004|Overall Study|Participant showed relapse|0|||
13143190|NCT02641379|26022772|FG005|Overall Study|Participant showed relapse|0|||
13143191|NCT02641379|26022773|FG006|Overall Study|Participant showed relapse|1|||
13143192|NCT02641379|26022774|FG007|Overall Study|Participant showed relapse|0|||
13143193|NCT02641379|26022775|FG008|Overall Study|Participant showed relapse|0|||
13143194|NCT02641379|26022776|FG009|Overall Study|Participant showed relapse|0|||
13143195|NCT02641379|26022777|FG010|Overall Study|Participant showed relapse|0|||
13143196|NCT02641379|26022767|FG000|Overall Study|Participant stopped study/treatment|1|||
13143197|NCT02641379|26022768|FG001|Overall Study|Participant stopped study/treatment|3|||
13143198|NCT02641379|26022769|FG002|Overall Study|Participant stopped study/treatment|1|||
13143199|NCT02641379|26022770|FG003|Overall Study|Participant stopped study/treatment|0|||
13143200|NCT02641379|26022771|FG004|Overall Study|Participant stopped study/treatment|0|||
13143201|NCT02641379|26022772|FG005|Overall Study|Participant stopped study/treatment|1|||
13143202|NCT02641379|26022773|FG006|Overall Study|Participant stopped study/treatment|2|||
13143203|NCT02641379|26022774|FG007|Overall Study|Participant stopped study/treatment|0|||
13143204|NCT02641379|26022775|FG008|Overall Study|Participant stopped study/treatment|1|||
13143205|NCT02641379|26022776|FG009|Overall Study|Participant stopped study/treatment|0|||
13091907|NCT03718429|25826114|FG003|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
13091908|NCT03718143|25826132|FG000|Overall Study|Death|1|||
13091909|NCT03718143|25826133|FG001|Overall Study|Death|0|||
13091910|NCT03718143|25826134|FG002|Overall Study|Death|0|||
13091911|NCT03718143|25826132|FG000|Overall Study|Progression of Disease|1|||
13091912|NCT03718143|25826133|FG001|Overall Study|Progression of Disease|0|||
13091913|NCT03718143|25826134|FG002|Overall Study|Progression of Disease|0|||
13091914|NCT03718143|25826132|FG000|Overall Study|Withdrawal of Informed Consent|1|||
13091915|NCT03718143|25826133|FG001|Overall Study|Withdrawal of Informed Consent|2|||
13091916|NCT03718143|25826134|FG002|Overall Study|Withdrawal of Informed Consent|1|||
13091917|NCT03717480|25826151|FG000|Overall Study|Never received investigational product due to product viability limitations.|1|||
13091918|NCT03717064|25826177|FG000|Period 2|Adverse Event|1|||
13091919|NCT03717012|25826214|FG000|Overall Study|Due to trial termination|1|||
13091920|NCT03717012|25826215|FG001|Overall Study|Due to trial termination|2|||
13091921|NCT03717012|25826214|FG000|Overall Study|Protocol Violation|0|||
13091922|NCT03717012|25826215|FG001|Overall Study|Protocol Violation|2|||
13091923|NCT03717012|25826214|FG000|Overall Study|Adverse Event|0|||
13091924|NCT03717012|25826215|FG001|Overall Study|Adverse Event|1|||
13091925|NCT03717012|25826214|FG000|Overall Study|Lung transplant|0|||
13091926|NCT03717012|25826215|FG001|Overall Study|Lung transplant|1|||
13091927|NCT03716050|25826292|FG000|Overall Study|Lost to Follow-up|0|||
13091928|NCT03716050|25826293|FG001|Overall Study|Lost to Follow-up|0|||
13091929|NCT03716050|25826294|FG002|Overall Study|Lost to Follow-up|1|||
13143206|NCT02641379|26022777|FG010|Overall Study|Participant stopped study/treatment|0|||
13143207|NCT02641379|26022767|FG000|Overall Study|Therapy stopped due to misunderstanding|1|||
13143208|NCT02641379|26022768|FG001|Overall Study|Therapy stopped due to misunderstanding|0|||
13143209|NCT02641379|26022769|FG002|Overall Study|Therapy stopped due to misunderstanding|0|||
13143210|NCT02641379|26022770|FG003|Overall Study|Therapy stopped due to misunderstanding|0|||
13143211|NCT02641379|26022771|FG004|Overall Study|Therapy stopped due to misunderstanding|0|||
13143212|NCT02641379|26022772|FG005|Overall Study|Therapy stopped due to misunderstanding|0|||
13143213|NCT02641379|26022773|FG006|Overall Study|Therapy stopped due to misunderstanding|0|||
13143214|NCT02641379|26022774|FG007|Overall Study|Therapy stopped due to misunderstanding|0|||
13143215|NCT02641379|26022775|FG008|Overall Study|Therapy stopped due to misunderstanding|0|||
13143216|NCT02641379|26022776|FG009|Overall Study|Therapy stopped due to misunderstanding|0|||
13143217|NCT02641379|26022777|FG010|Overall Study|Therapy stopped due to misunderstanding|0|||
13143218|NCT02641379|26022767|FG000|Overall Study|Financial problems|0|||
13143219|NCT02641379|26022768|FG001|Overall Study|Financial problems|1|||
13143220|NCT02641379|26022769|FG002|Overall Study|Financial problems|0|||
13143221|NCT02641379|26022770|FG003|Overall Study|Financial problems|0|||
13143222|NCT02641379|26022771|FG004|Overall Study|Financial problems|0|||
13143223|NCT02641379|26022772|FG005|Overall Study|Financial problems|0|||
13143224|NCT02641379|26022773|FG006|Overall Study|Financial problems|0|||
13143225|NCT02641379|26022774|FG007|Overall Study|Financial problems|0|||
13143226|NCT02641379|26022775|FG008|Overall Study|Financial problems|0|||
13143227|NCT02641379|26022776|FG009|Overall Study|Financial problems|0|||
13143228|NCT02641379|26022777|FG010|Overall Study|Financial problems|0|||
13143229|NCT02641379|26022767|FG000|Overall Study|PCR positive at Week 68|0|||
13143230|NCT02641379|26022768|FG001|Overall Study|PCR positive at Week 68|1|||
13143231|NCT02641379|26022769|FG002|Overall Study|PCR positive at Week 68|0|||
13143232|NCT02641379|26022770|FG003|Overall Study|PCR positive at Week 68|0|||
13143233|NCT02641379|26022771|FG004|Overall Study|PCR positive at Week 68|0|||
13143234|NCT02641379|26022772|FG005|Overall Study|PCR positive at Week 68|0|||
13143235|NCT02641379|26022773|FG006|Overall Study|PCR positive at Week 68|0|||
13143236|NCT02641379|26022774|FG007|Overall Study|PCR positive at Week 68|0|||
13143237|NCT02641379|26022775|FG008|Overall Study|PCR positive at Week 68|0|||
13143238|NCT02641379|26022776|FG009|Overall Study|PCR positive at Week 68|0|||
13143239|NCT02641379|26022777|FG010|Overall Study|PCR positive at Week 68|0|||
13143240|NCT02641379|26022767|FG000|Overall Study|PCR positive at Week 48|0|||
13143241|NCT02641379|26022768|FG001|Overall Study|PCR positive at Week 48|1|||
13143242|NCT02641379|26022769|FG002|Overall Study|PCR positive at Week 48|0|||
13143243|NCT02641379|26022770|FG003|Overall Study|PCR positive at Week 48|0|||
13143244|NCT02641379|26022771|FG004|Overall Study|PCR positive at Week 48|0|||
13143245|NCT02641379|26022772|FG005|Overall Study|PCR positive at Week 48|0|||
13143246|NCT02641379|26022773|FG006|Overall Study|PCR positive at Week 48|0|||
13143247|NCT02641379|26022774|FG007|Overall Study|PCR positive at Week 48|0|||
13143248|NCT02641379|26022775|FG008|Overall Study|PCR positive at Week 48|0|||
13143249|NCT02641379|26022776|FG009|Overall Study|PCR positive at Week 48|0|||
13143250|NCT02641379|26022777|FG010|Overall Study|PCR positive at Week 48|0|||
13143251|NCT02641379|26022767|FG000|Overall Study|PCR not performed at Week 12|0|||
13143252|NCT02641379|26022768|FG001|Overall Study|PCR not performed at Week 12|0|||
13143253|NCT02641379|26022769|FG002|Overall Study|PCR not performed at Week 12|1|||
13143254|NCT02641379|26022770|FG003|Overall Study|PCR not performed at Week 12|0|||
13143255|NCT02641379|26022771|FG004|Overall Study|PCR not performed at Week 12|0|||
13143256|NCT02641379|26022772|FG005|Overall Study|PCR not performed at Week 12|0|||
13143257|NCT02641379|26022773|FG006|Overall Study|PCR not performed at Week 12|0|||
13143258|NCT02641379|26022774|FG007|Overall Study|PCR not performed at Week 12|0|||
13143259|NCT02641379|26022775|FG008|Overall Study|PCR not performed at Week 12|0|||
13143260|NCT02641379|26022776|FG009|Overall Study|PCR not performed at Week 12|0|||
13143261|NCT02641379|26022777|FG010|Overall Study|PCR not performed at Week 12|0|||
13143262|NCT02641379|26022767|FG000|Overall Study|No PCR at baseline|0|||
13143263|NCT02641379|26022768|FG001|Overall Study|No PCR at baseline|0|||
13143264|NCT02641379|26022769|FG002|Overall Study|No PCR at baseline|1|||
13143265|NCT02641379|26022770|FG003|Overall Study|No PCR at baseline|0|||
13143266|NCT02641379|26022771|FG004|Overall Study|No PCR at baseline|0|||
13143267|NCT02641379|26022772|FG005|Overall Study|No PCR at baseline|0|||
13143268|NCT02641379|26022773|FG006|Overall Study|No PCR at baseline|0|||
13143269|NCT02641379|26022774|FG007|Overall Study|No PCR at baseline|0|||
13143270|NCT02641379|26022775|FG008|Overall Study|No PCR at baseline|0|||
13143271|NCT02641379|26022776|FG009|Overall Study|No PCR at baseline|0|||
13143272|NCT02641379|26022777|FG010|Overall Study|No PCR at baseline|0|||
13143273|NCT02641379|26022767|FG000|Overall Study|PCR positive at Week 28|0|||
13143274|NCT02641379|26022768|FG001|Overall Study|PCR positive at Week 28|0|||
13143275|NCT02641379|26022769|FG002|Overall Study|PCR positive at Week 28|1|||
13143276|NCT02641379|26022770|FG003|Overall Study|PCR positive at Week 28|0|||
13143277|NCT02641379|26022771|FG004|Overall Study|PCR positive at Week 28|0|||
13143278|NCT02641379|26022772|FG005|Overall Study|PCR positive at Week 28|0|||
13143279|NCT02641379|26022773|FG006|Overall Study|PCR positive at Week 28|0|||
13143280|NCT02641379|26022774|FG007|Overall Study|PCR positive at Week 28|0|||
13143281|NCT02641379|26022775|FG008|Overall Study|PCR positive at Week 28|0|||
13143282|NCT02641379|26022776|FG009|Overall Study|PCR positive at Week 28|0|||
13143283|NCT02641379|26022777|FG010|Overall Study|PCR positive at Week 28|0|||
13143284|NCT02641379|26022767|FG000|Overall Study|PCR sample for Week 4 not drawn|0|||
13143285|NCT02641379|26022768|FG001|Overall Study|PCR sample for Week 4 not drawn|0|||
13143286|NCT02641379|26022769|FG002|Overall Study|PCR sample for Week 4 not drawn|0|||
13143287|NCT02641379|26022770|FG003|Overall Study|PCR sample for Week 4 not drawn|1|||
13143288|NCT02641379|26022771|FG004|Overall Study|PCR sample for Week 4 not drawn|0|||
13143289|NCT02641379|26022772|FG005|Overall Study|PCR sample for Week 4 not drawn|0|||
13143290|NCT02641379|26022773|FG006|Overall Study|PCR sample for Week 4 not drawn|0|||
13143291|NCT02641379|26022774|FG007|Overall Study|PCR sample for Week 4 not drawn|0|||
13143292|NCT02641379|26022775|FG008|Overall Study|PCR sample for Week 4 not drawn|0|||
13143293|NCT02641379|26022776|FG009|Overall Study|PCR sample for Week 4 not drawn|0|||
13143294|NCT02641379|26022777|FG010|Overall Study|PCR sample for Week 4 not drawn|0|||
13143295|NCT02641379|26022767|FG000|Overall Study|Inclusion criteria not fulfilled|0|||
13143296|NCT02641379|26022768|FG001|Overall Study|Inclusion criteria not fulfilled|0|||
13143297|NCT02641379|26022769|FG002|Overall Study|Inclusion criteria not fulfilled|0|||
13143298|NCT02641379|26022770|FG003|Overall Study|Inclusion criteria not fulfilled|1|||
13143299|NCT02641379|26022771|FG004|Overall Study|Inclusion criteria not fulfilled|0|||
13143300|NCT02641379|26022772|FG005|Overall Study|Inclusion criteria not fulfilled|0|||
13143301|NCT02641379|26022773|FG006|Overall Study|Inclusion criteria not fulfilled|0|||
13143302|NCT02641379|26022774|FG007|Overall Study|Inclusion criteria not fulfilled|0|||
13143303|NCT02641379|26022775|FG008|Overall Study|Inclusion criteria not fulfilled|0|||
13143304|NCT02641379|26022776|FG009|Overall Study|Inclusion criteria not fulfilled|0|||
13143305|NCT02641379|26022777|FG010|Overall Study|Inclusion criteria not fulfilled|0|||
13143306|NCT02641379|26022767|FG000|Overall Study|Baseline viral load unavailable|0|||
13143307|NCT02641379|26022768|FG001|Overall Study|Baseline viral load unavailable|0|||
13143308|NCT02641379|26022769|FG002|Overall Study|Baseline viral load unavailable|0|||
13143309|NCT02641379|26022770|FG003|Overall Study|Baseline viral load unavailable|1|||
13143310|NCT02641379|26022771|FG004|Overall Study|Baseline viral load unavailable|0|||
13143311|NCT02641379|26022772|FG005|Overall Study|Baseline viral load unavailable|0|||
13143312|NCT02641379|26022773|FG006|Overall Study|Baseline viral load unavailable|0|||
13143313|NCT02641379|26022774|FG007|Overall Study|Baseline viral load unavailable|0|||
13143314|NCT02641379|26022775|FG008|Overall Study|Baseline viral load unavailable|0|||
13143315|NCT02641379|26022776|FG009|Overall Study|Baseline viral load unavailable|0|||
13143316|NCT02641379|26022777|FG010|Overall Study|Baseline viral load unavailable|0|||
13143317|NCT02641379|26022767|FG000|Overall Study|Blood could not be drawn|0|||
13143318|NCT02641379|26022768|FG001|Overall Study|Blood could not be drawn|0|||
13143319|NCT02641379|26022769|FG002|Overall Study|Blood could not be drawn|0|||
13143320|NCT02641379|26022770|FG003|Overall Study|Blood could not be drawn|0|||
13143321|NCT02641379|26022771|FG004|Overall Study|Blood could not be drawn|1|||
13143322|NCT02641379|26022772|FG005|Overall Study|Blood could not be drawn|0|||
13143323|NCT02641379|26022773|FG006|Overall Study|Blood could not be drawn|0|||
13143324|NCT02641379|26022774|FG007|Overall Study|Blood could not be drawn|0|||
13143325|NCT02641379|26022775|FG008|Overall Study|Blood could not be drawn|0|||
13143326|NCT02641379|26022776|FG009|Overall Study|Blood could not be drawn|0|||
13143327|NCT02641379|26022777|FG010|Overall Study|Blood could not be drawn|0|||
13143328|NCT02641379|26022767|FG000|Overall Study|Protocol Violation|0|||
13143329|NCT02641379|26022768|FG001|Overall Study|Protocol Violation|0|||
13143330|NCT02641379|26022769|FG002|Overall Study|Protocol Violation|0|||
13143331|NCT02641379|26022770|FG003|Overall Study|Protocol Violation|0|||
13143332|NCT02641379|26022771|FG004|Overall Study|Protocol Violation|2|||
13143333|NCT02641379|26022772|FG005|Overall Study|Protocol Violation|0|||
13143334|NCT02641379|26022773|FG006|Overall Study|Protocol Violation|0|||
13143335|NCT02641379|26022774|FG007|Overall Study|Protocol Violation|0|||
13143336|NCT02641379|26022775|FG008|Overall Study|Protocol Violation|1|||
13143337|NCT02641379|26022776|FG009|Overall Study|Protocol Violation|0|||
13143338|NCT02641379|26022777|FG010|Overall Study|Protocol Violation|0|||
13143339|NCT02641379|26022767|FG000|Overall Study|Participation in sili rescue study|0|||
13143340|NCT02641379|26022768|FG001|Overall Study|Participation in sili rescue study|0|||
13143341|NCT02641379|26022769|FG002|Overall Study|Participation in sili rescue study|0|||
13143342|NCT02641379|26022770|FG003|Overall Study|Participation in sili rescue study|0|||
13143343|NCT02641379|26022771|FG004|Overall Study|Participation in sili rescue study|0|||
13143344|NCT02641379|26022772|FG005|Overall Study|Participation in sili rescue study|1|||
13143345|NCT02641379|26022773|FG006|Overall Study|Participation in sili rescue study|0|||
13143346|NCT02641379|26022774|FG007|Overall Study|Participation in sili rescue study|0|||
13143347|NCT02641379|26022775|FG008|Overall Study|Participation in sili rescue study|0|||
13143348|NCT02641379|26022776|FG009|Overall Study|Participation in sili rescue study|0|||
13143349|NCT02641379|26022777|FG010|Overall Study|Participation in sili rescue study|0|||
13143350|NCT02641379|26022767|FG000|Overall Study|Lost to Follow-up|0|||
13143351|NCT02641379|26022768|FG001|Overall Study|Lost to Follow-up|0|||
13143352|NCT02641379|26022769|FG002|Overall Study|Lost to Follow-up|0|||
13143353|NCT02641379|26022770|FG003|Overall Study|Lost to Follow-up|0|||
13143354|NCT02641379|26022771|FG004|Overall Study|Lost to Follow-up|0|||
13143355|NCT02641379|26022772|FG005|Overall Study|Lost to Follow-up|0|||
13143356|NCT02641379|26022773|FG006|Overall Study|Lost to Follow-up|0|||
13143357|NCT02641379|26022774|FG007|Overall Study|Lost to Follow-up|0|||
13143358|NCT02641379|26022775|FG008|Overall Study|Lost to Follow-up|1|||
13143359|NCT02641379|26022776|FG009|Overall Study|Lost to Follow-up|0|||
13143360|NCT02641379|26022777|FG010|Overall Study|Lost to Follow-up|0|||
13143361|NCT02641379|26022767|FG000|Overall Study|Source data not found|0|||
13143362|NCT02641379|26022768|FG001|Overall Study|Source data not found|0|||
13143363|NCT02641379|26022769|FG002|Overall Study|Source data not found|0|||
13143364|NCT02641379|26022770|FG003|Overall Study|Source data not found|0|||
13143365|NCT02641379|26022771|FG004|Overall Study|Source data not found|0|||
13143366|NCT02641379|26022772|FG005|Overall Study|Source data not found|1|||
13143367|NCT02641379|26022773|FG006|Overall Study|Source data not found|0|||
13143368|NCT02641379|26022774|FG007|Overall Study|Source data not found|0|||
13143369|NCT02641379|26022775|FG008|Overall Study|Source data not found|0|||
13143370|NCT02641379|26022776|FG009|Overall Study|Source data not found|0|||
13143371|NCT02641379|26022777|FG010|Overall Study|Source data not found|0|||
13143372|NCT02641379|26022767|FG000|Overall Study|Participant showed weight reduction|0|||
13143373|NCT02641379|26022768|FG001|Overall Study|Participant showed weight reduction|0|||
13143374|NCT02641379|26022769|FG002|Overall Study|Participant showed weight reduction|0|||
13143375|NCT02641379|26022770|FG003|Overall Study|Participant showed weight reduction|0|||
13143376|NCT02641379|26022771|FG004|Overall Study|Participant showed weight reduction|0|||
13143377|NCT02641379|26022772|FG005|Overall Study|Participant showed weight reduction|0|||
13143378|NCT02641379|26022773|FG006|Overall Study|Participant showed weight reduction|0|||
13143379|NCT02641379|26022774|FG007|Overall Study|Participant showed weight reduction|1|||
13143380|NCT02641379|26022775|FG008|Overall Study|Participant showed weight reduction|0|||
13143381|NCT02641379|26022776|FG009|Overall Study|Participant showed weight reduction|0|||
13143382|NCT02641379|26022777|FG010|Overall Study|Participant showed weight reduction|0|||
13143383|NCT02641379|26022767|FG000|Overall Study|Non-response Week 12|0|||
13143384|NCT02641379|26022768|FG001|Overall Study|Non-response Week 12|0|||
13143385|NCT02641379|26022769|FG002|Overall Study|Non-response Week 12|0|||
13143386|NCT02641379|26022770|FG003|Overall Study|Non-response Week 12|0|||
13143387|NCT02641379|26022771|FG004|Overall Study|Non-response Week 12|0|||
13143388|NCT02641379|26022772|FG005|Overall Study|Non-response Week 12|0|||
13143389|NCT02641379|26022773|FG006|Overall Study|Non-response Week 12|0|||
13143390|NCT02641379|26022774|FG007|Overall Study|Non-response Week 12|1|||
13143391|NCT02641379|26022775|FG008|Overall Study|Non-response Week 12|0|||
13143392|NCT02641379|26022776|FG009|Overall Study|Non-response Week 12|0|||
13143393|NCT02641379|26022777|FG010|Overall Study|Non-response Week 12|0|||
13143394|NCT02641379|26022767|FG000|Overall Study|No 2 Log drop at Week 12|0|||
13143395|NCT02641379|26022768|FG001|Overall Study|No 2 Log drop at Week 12|0|||
13143396|NCT02641379|26022769|FG002|Overall Study|No 2 Log drop at Week 12|0|||
13143397|NCT02641379|26022770|FG003|Overall Study|No 2 Log drop at Week 12|0|||
13143398|NCT02641379|26022771|FG004|Overall Study|No 2 Log drop at Week 12|0|||
13143399|NCT02641379|26022772|FG005|Overall Study|No 2 Log drop at Week 12|0|||
13143400|NCT02641379|26022773|FG006|Overall Study|No 2 Log drop at Week 12|0|||
13143401|NCT02641379|26022774|FG007|Overall Study|No 2 Log drop at Week 12|0|||
13143402|NCT02641379|26022775|FG008|Overall Study|No 2 Log drop at Week 12|0|||
13143403|NCT02641379|26022776|FG009|Overall Study|No 2 Log drop at Week 12|0|||
13143404|NCT02641379|26022777|FG010|Overall Study|No 2 Log drop at Week 12|1|||
13143405|NCT02641379|26022767|FG000|Overall Study|Negative PCR result|0|||
13143406|NCT02641379|26022768|FG001|Overall Study|Negative PCR result|0|||
13143407|NCT02641379|26022769|FG002|Overall Study|Negative PCR result|0|||
13143408|NCT02641379|26022770|FG003|Overall Study|Negative PCR result|0|||
13143409|NCT02641379|26022771|FG004|Overall Study|Negative PCR result|0|||
13143410|NCT02641379|26022772|FG005|Overall Study|Negative PCR result|0|||
13143411|NCT02641379|26022773|FG006|Overall Study|Negative PCR result|0|||
13143412|NCT02641379|26022774|FG007|Overall Study|Negative PCR result|0|||
13143413|NCT02641379|26022775|FG008|Overall Study|Negative PCR result|0|||
13143414|NCT02641379|26022776|FG009|Overall Study|Negative PCR result|1|||
13143415|NCT02641379|26022777|FG010|Overall Study|Negative PCR result|0|||
13143416|NCT02641379|26022767|FG000|Overall Study|Participant's PCR high|0|||
13143417|NCT02641379|26022768|FG001|Overall Study|Participant's PCR high|0|||
13143418|NCT02641379|26022769|FG002|Overall Study|Participant's PCR high|0|||
13143419|NCT02641379|26022770|FG003|Overall Study|Participant's PCR high|0|||
13143420|NCT02641379|26022771|FG004|Overall Study|Participant's PCR high|0|||
13143421|NCT02641379|26022772|FG005|Overall Study|Participant's PCR high|0|||
13143422|NCT02641379|26022773|FG006|Overall Study|Participant's PCR high|0|||
13143423|NCT02641379|26022774|FG007|Overall Study|Participant's PCR high|1|||
13143424|NCT02641379|26022775|FG008|Overall Study|Participant's PCR high|0|||
13143425|NCT02641379|26022776|FG009|Overall Study|Participant's PCR high|0|||
13143426|NCT02641379|26022777|FG010|Overall Study|Participant's PCR high|0|||
13143427|NCT02641379|26022767|FG000|Overall Study|Participant treated after Week 24|0|||
13143428|NCT02641379|26022768|FG001|Overall Study|Participant treated after Week 24|0|||
13143429|NCT02641379|26022769|FG002|Overall Study|Participant treated after Week 24|0|||
13143430|NCT02641379|26022770|FG003|Overall Study|Participant treated after Week 24|0|||
13143431|NCT02641379|26022771|FG004|Overall Study|Participant treated after Week 24|0|||
13143432|NCT02641379|26022772|FG005|Overall Study|Participant treated after Week 24|0|||
13143433|NCT02641379|26022773|FG006|Overall Study|Participant treated after Week 24|0|||
13143434|NCT02641379|26022774|FG007|Overall Study|Participant treated after Week 24|0|||
13143435|NCT02641379|26022775|FG008|Overall Study|Participant treated after Week 24|1|||
13143436|NCT02641379|26022776|FG009|Overall Study|Participant treated after Week 24|0|||
13143437|NCT02641379|26022777|FG010|Overall Study|Participant treated after Week 24|0|||
13143438|NCT02641379|26022767|FG000|Overall Study|Missing PCR result at Week 8|0|||
13143439|NCT02641379|26022768|FG001|Overall Study|Missing PCR result at Week 8|0|||
13143440|NCT02641379|26022769|FG002|Overall Study|Missing PCR result at Week 8|0|||
13143441|NCT02641379|26022770|FG003|Overall Study|Missing PCR result at Week 8|0|||
13143442|NCT02641379|26022771|FG004|Overall Study|Missing PCR result at Week 8|0|||
13143443|NCT02641379|26022772|FG005|Overall Study|Missing PCR result at Week 8|0|||
13143444|NCT02641379|26022773|FG006|Overall Study|Missing PCR result at Week 8|0|||
13143445|NCT02641379|26022774|FG007|Overall Study|Missing PCR result at Week 8|0|||
13143446|NCT02641379|26022775|FG008|Overall Study|Missing PCR result at Week 8|0|||
13143447|NCT02641379|26022776|FG009|Overall Study|Missing PCR result at Week 8|1|||
13143448|NCT02641379|26022777|FG010|Overall Study|Missing PCR result at Week 8|0|||
13143449|NCT02641379|26022767|FG000|Overall Study|PCR positive|0|||
13143450|NCT02641379|26022768|FG001|Overall Study|PCR positive|0|||
13143451|NCT02641379|26022769|FG002|Overall Study|PCR positive|0|||
13143452|NCT02641379|26022770|FG003|Overall Study|PCR positive|0|||
13143453|NCT02641379|26022771|FG004|Overall Study|PCR positive|0|||
13143454|NCT02641379|26022772|FG005|Overall Study|PCR positive|0|||
13143455|NCT02641379|26022773|FG006|Overall Study|PCR positive|1|||
13143456|NCT02641379|26022774|FG007|Overall Study|PCR positive|0|||
13143457|NCT02641379|26022775|FG008|Overall Study|PCR positive|0|||
13143458|NCT02641379|26022776|FG009|Overall Study|PCR positive|0|||
13143459|NCT02641379|26022777|FG010|Overall Study|PCR positive|0|||
13143460|NCT02641080|26022796|FG000|Overall Study|Physician Decision|2|||
13143461|NCT02641080|26022797|FG001|Overall Study|Physician Decision|0|||
13143462|NCT02641080|26022796|FG000|Overall Study|Withdrawal by Subject|0|||
13143463|NCT02641080|26022797|FG001|Overall Study|Withdrawal by Subject|1|||
13143464|NCT02641080|26022796|FG000|Overall Study|Rehab Center denied use of pumps|0|||
13143465|NCT02641080|26022797|FG001|Overall Study|Rehab Center denied use of pumps|3|||
13143466|NCT02641080|26022796|FG000|Overall Study|Lost to Follow-up|0|||
13143467|NCT02641080|26022797|FG001|Overall Study|Lost to Follow-up|3|||
13143468|NCT02640755|26022839|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0|||
13143469|NCT02640755|26022840|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1|||
13143470|NCT02640755|26022839|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1|||
13143471|NCT02640755|26022840|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0|||
13143472|NCT02640755|26022839|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1|||
13143473|NCT02640755|26022840|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0|||
13143474|NCT02640677|26022849|FG000|Overall Study|Lost to Follow-up|1|||
13143475|NCT02640677|26022849|FG000|Overall Study|Withdrawal by Subject|1|||
13143476|NCT02640612|26022879|FG000|Overall Study|Adverse Event|6|||
13143477|NCT02640612|26022880|FG001|Overall Study|Adverse Event|7|||
13143478|NCT02640612|26022881|FG002|Overall Study|Adverse Event|2|||
13143479|NCT02640612|26022879|FG000|Overall Study|Death|1|||
13143480|NCT02640612|26022880|FG001|Overall Study|Death|0|||
13143481|NCT02640612|26022881|FG002|Overall Study|Death|0|||
13143482|NCT02640612|26022879|FG000|Overall Study|Withdrawal by Subject|10|||
13143483|NCT02640612|26022880|FG001|Overall Study|Withdrawal by Subject|3|||
13143484|NCT02640612|26022881|FG002|Overall Study|Withdrawal by Subject|3|||
13143485|NCT02640612|26022879|FG000|Overall Study|Lost to Follow-up|4|||
13143486|NCT02640612|26022880|FG001|Overall Study|Lost to Follow-up|1|||
13143487|NCT02640612|26022881|FG002|Overall Study|Lost to Follow-up|1|||
13143488|NCT02640612|26022879|FG000|Overall Study|Protocol Violation|0|||
13143489|NCT02640612|26022880|FG001|Overall Study|Protocol Violation|2|||
13143490|NCT02640612|26022881|FG002|Overall Study|Protocol Violation|0|||
13143491|NCT02640612|26022879|FG000|Overall Study|Lack of Efficacy|1|||
13143492|NCT02640612|26022880|FG001|Overall Study|Lack of Efficacy|1|||
13143493|NCT02640612|26022881|FG002|Overall Study|Lack of Efficacy|0|||
13143494|NCT02640547|26022958|FG000|Overall Study|Failure to Return|1|||
13143495|NCT02640547|26022958|FG000|Overall Study|Withdrawal by Subject|1|||
13143496|NCT02640547|26022958|FG000|Overall Study|Death|6|||
13143497|NCT02640547|26022958|FG000|Overall Study|Miscellaneous|3|||
13143498|NCT02640482|26022975|FG000|Overall Study|Lost to Follow-up|3|||
13143499|NCT02640482|26022976|FG001|Overall Study|Lost to Follow-up|0|||
13143500|NCT02640404|26022991|FG000|Overall Study|Protocol Violation|1|||
13143501|NCT02640404|26022992|FG001|Overall Study|Protocol Violation|0|||
13143502|NCT02640404|26022991|FG000|Overall Study|Withdrawal by Subject|1|||
13143503|NCT02640404|26022992|FG001|Overall Study|Withdrawal by Subject|0|||
13143504|NCT02640235|26023019|FG000|Overall Study|Withdrawal by Subject|7|||
13143505|NCT02640235|26023020|FG001|Overall Study|Withdrawal by Subject|6|||
13143506|NCT02640235|26023019|FG000|Overall Study|Lost to Follow-up|4|||
13143507|NCT02640235|26023020|FG001|Overall Study|Lost to Follow-up|3|||
13143508|NCT02640235|26023019|FG000|Overall Study|Death|2|||
13143509|NCT02640235|26023020|FG001|Overall Study|Death|3|||
13143510|NCT02640235|26023019|FG000|Overall Study|Other|1|||
13143511|NCT02640235|26023020|FG001|Overall Study|Other|2|||
13143512|NCT02640157|26023047|FG000|Overall Study|Adverse Event|2|||
13143513|NCT02640157|26023048|FG001|Overall Study|Adverse Event|2|||
13143514|NCT02640157|26023049|FG002|Overall Study|Adverse Event|1|||
13143515|NCT02640157|26023047|FG000|Overall Study|Withdrew consent|2|||
13143516|NCT02640157|26023048|FG001|Overall Study|Withdrew consent|0|||
13143517|NCT02640157|26023049|FG002|Overall Study|Withdrew consent|2|||
13143518|NCT02640157|26023047|FG000|Overall Study|Lost to Follow-up|9|||
13143519|NCT02640157|26023048|FG001|Overall Study|Lost to Follow-up|2|||
13143520|NCT02640157|26023049|FG002|Overall Study|Lost to Follow-up|7|||
13143521|NCT02640157|26023047|FG000|Overall Study|Randomized in error; did not receive Tx|0|||
13143522|NCT02640157|26023048|FG001|Overall Study|Randomized in error; did not receive Tx|1|||
13143523|NCT02640157|26023049|FG002|Overall Study|Randomized in error; did not receive Tx|0|||
13143524|NCT02640053|26023076|FG000|Overall Study|Withdrawal by Subject|2|||
13143525|NCT02640053|26023077|FG001|Overall Study|Withdrawal by Subject|1|||
13143526|NCT02640053|26023076|FG000|Overall Study|Adverse Event|1|||
13143527|NCT02640053|26023077|FG001|Overall Study|Adverse Event|1|||
13143528|NCT02640053|26023076|FG000|Overall Study|Alternative Therapy|1|||
13143529|NCT02640053|26023077|FG001|Overall Study|Alternative Therapy|1|||
13143530|NCT02640053|26023076|FG000|Overall Study|Chemo regimen changed after 1st Rx|0|||
13143531|NCT02640053|26023077|FG001|Overall Study|Chemo regimen changed after 1st Rx|1|||
13143532|NCT02639559|26023122|FG000|Overall Study|Mobilization failure|0|||
13143533|NCT02639559|26023123|FG001|Overall Study|Mobilization failure|3|||
13143534|NCT02639559|26023122|FG000|Overall Study|Issues with vascular acess|1|||
13143535|NCT02639559|26023123|FG001|Overall Study|Issues with vascular acess|0|||
13143536|NCT02639546|26023240|FG000|Overall Study|Death|2|||
13143537|NCT02639546|26023241|FG001|Overall Study|Death|2|||
13143538|NCT02639546|26023242|FG002|Overall Study|Death|1|||
13143539|NCT02639546|26023243|FG003|Overall Study|Death|2|||
13143540|NCT02639546|26023244|FG004|Overall Study|Death|2|||
13143541|NCT02639546|26023245|FG005|Overall Study|Death|2|||
13143542|NCT02639546|26023246|FG006|Overall Study|Death|0|||
13143543|NCT02639546|26023247|FG007|Overall Study|Death|0|||
13143544|NCT02639546|26023240|FG000|Overall Study|Lost to Follow-up|0|||
13143545|NCT02639546|26023241|FG001|Overall Study|Lost to Follow-up|0|||
13143546|NCT02639546|26023242|FG002|Overall Study|Lost to Follow-up|1|||
13143547|NCT02639546|26023243|FG003|Overall Study|Lost to Follow-up|0|||
13143548|NCT02639546|26023244|FG004|Overall Study|Lost to Follow-up|1|||
13143549|NCT02639546|26023245|FG005|Overall Study|Lost to Follow-up|1|||
13143550|NCT02639546|26023246|FG006|Overall Study|Lost to Follow-up|0|||
13143551|NCT02639546|26023247|FG007|Overall Study|Lost to Follow-up|1|||
13143552|NCT02639546|26023240|FG000|Overall Study|PI, physician decision; no response to trt.|2|||
13143553|NCT02639546|26023241|FG001|Overall Study|PI, physician decision; no response to trt.|0|||
13143554|NCT02639546|26023242|FG002|Overall Study|PI, physician decision; no response to trt.|0|||
13143555|NCT02639546|26023243|FG003|Overall Study|PI, physician decision; no response to trt.|0|||
13143556|NCT02639546|26023244|FG004|Overall Study|PI, physician decision; no response to trt.|0|||
13143557|NCT02639546|26023245|FG005|Overall Study|PI, physician decision; no response to trt.|1|||
13143558|NCT02639546|26023246|FG006|Overall Study|PI, physician decision; no response to trt.|0|||
13143559|NCT02639546|26023247|FG007|Overall Study|PI, physician decision; no response to trt.|1|||
13143560|NCT02639546|26023240|FG000|Overall Study|Study Terminated By Sponsor|0|||
13143561|NCT02639546|26023241|FG001|Overall Study|Study Terminated By Sponsor|2|||
13143562|NCT02639546|26023242|FG002|Overall Study|Study Terminated By Sponsor|3|||
13143563|NCT02639546|26023243|FG003|Overall Study|Study Terminated By Sponsor|4|||
13143564|NCT02639546|26023244|FG004|Overall Study|Study Terminated By Sponsor|4|||
13143565|NCT02639546|26023245|FG005|Overall Study|Study Terminated By Sponsor|3|||
13143566|NCT02639546|26023246|FG006|Overall Study|Study Terminated By Sponsor|3|||
13143567|NCT02639546|26023247|FG007|Overall Study|Study Terminated By Sponsor|9|||
13143568|NCT02639546|26023240|FG000|Overall Study|Withdrawal by Subject|2|||
13143569|NCT02639546|26023241|FG001|Overall Study|Withdrawal by Subject|2|||
13143570|NCT02639546|26023242|FG002|Overall Study|Withdrawal by Subject|1|||
13143571|NCT02639546|26023243|FG003|Overall Study|Withdrawal by Subject|0|||
13143572|NCT02639546|26023244|FG004|Overall Study|Withdrawal by Subject|0|||
13143573|NCT02639546|26023245|FG005|Overall Study|Withdrawal by Subject|1|||
13143574|NCT02639546|26023246|FG006|Overall Study|Withdrawal by Subject|2|||
13143575|NCT02639546|26023247|FG007|Overall Study|Withdrawal by Subject|1|||
13143576|NCT02639390|26023270|FG000|Overall Study|Subject unable to comply with treatment schedule.|0|||
13143577|NCT02639390|26023271|FG001|Overall Study|Subject unable to comply with treatment schedule.|2|||
13143578|NCT02639338|26023294|FG000|Overall Study|Lost to Follow-up|2|||
13143579|NCT02639338|26023295|FG001|Overall Study|Lost to Follow-up|2|||
13143580|NCT02639338|26023294|FG000|Overall Study|Withdrew Consent|1|||
13143581|NCT02639338|26023295|FG001|Overall Study|Withdrew Consent|2|||
13143582|NCT02639338|26023294|FG000|Overall Study|Death|1|||
13143583|NCT02639338|26023295|FG001|Overall Study|Death|0|||
13143584|NCT02639338|26023294|FG000|Overall Study|Randomized but Not Treated|0|||
13143585|NCT02639338|26023295|FG001|Overall Study|Randomized but Not Treated|1|||
13143586|NCT02639247|26023318|FG000|Overall Study|Lost to Follow-up|2|||
13143587|NCT02639247|26023319|FG001|Overall Study|Lost to Follow-up|1|||
13143588|NCT02639247|26023318|FG000|Overall Study|Death|2|||
13143589|NCT02639247|26023319|FG001|Overall Study|Death|0|||
13143590|NCT02639247|26023318|FG000|Overall Study|Withdrew Consent|0|||
13143591|NCT02639247|26023319|FG001|Overall Study|Withdrew Consent|1|||
13143592|NCT02639247|26023318|FG000|Overall Study|Protocol Violation|1|||
13143593|NCT02639247|26023319|FG001|Overall Study|Protocol Violation|0|||
13143594|NCT02639182|26023359|FG000|Overall Study|Disease Progression|50|||
13143595|NCT02639182|26023360|FG001|Overall Study|Disease Progression|49|||
13143596|NCT02639182|26023359|FG000|Overall Study|Adverse Event|7|||
13143597|NCT02639182|26023360|FG001|Overall Study|Adverse Event|5|||
13143598|NCT02639182|26023359|FG000|Overall Study|Physician Decision|3|||
13143599|NCT02639182|26023360|FG001|Overall Study|Physician Decision|3|||
13143600|NCT02639182|26023359|FG000|Overall Study|Withdrew Consent|5|||
13143601|NCT02639182|26023360|FG001|Overall Study|Withdrew Consent|4|||
13143602|NCT02639182|26023359|FG000|Overall Study|Lost to Follow-up|0|||
13143603|NCT02639182|26023360|FG001|Overall Study|Lost to Follow-up|1|||
13091930|NCT03716050|25826295|FG003|Overall Study|Lost to Follow-up|0|||
13091931|NCT03716050|25826296|FG004|Overall Study|Lost to Follow-up|0|||
13091932|NCT03716050|25826297|FG005|Overall Study|Lost to Follow-up|0|||
13091933|NCT03716050|25826298|FG006|Overall Study|Lost to Follow-up|0|||
13091934|NCT03716050|25826299|FG007|Overall Study|Lost to Follow-up|0|||
13091935|NCT03716050|25826292|FG000|Overall Study|Physician Decision|0|||
13091936|NCT03716050|25826293|FG001|Overall Study|Physician Decision|0|||
13091937|NCT03716050|25826294|FG002|Overall Study|Physician Decision|0|||
13143604|NCT02639182|26023359|FG000|Overall Study|Study Closure|1|||
13143605|NCT02639182|26023360|FG001|Overall Study|Study Closure|2|||
13143606|NCT02639182|26023359|FG000|Overall Study|Sponsor Ended Study|0|||
13143607|NCT02639182|26023360|FG001|Overall Study|Sponsor Ended Study|1|||
13143608|NCT02639182|26023359|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1|||
13143609|NCT02639182|26023360|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1|||
13143610|NCT02639052|26023376|FG000|Overall Study|Lost to Follow-up|1|||
13143611|NCT02638948|26023474|FG000|Overall Study|Withdrawal by Subject|4|||
13143612|NCT02638948|26023475|FG001|Overall Study|Withdrawal by Subject|5|||
13143613|NCT02638948|26023476|FG002|Overall Study|Withdrawal by Subject|3|||
13143614|NCT02638948|26023477|FG003|Overall Study|Withdrawal by Subject|1|||
13143615|NCT02638948|26023474|FG000|Overall Study|Administrative Reason by Sponsor|0|||
13143616|NCT02638948|26023475|FG001|Overall Study|Administrative Reason by Sponsor|1|||
13143617|NCT02638948|26023476|FG002|Overall Study|Administrative Reason by Sponsor|0|||
13143618|NCT02638948|26023477|FG003|Overall Study|Administrative Reason by Sponsor|4|||
13143619|NCT02638948|26023474|FG000|Overall Study|Adverse Event|0|||
13143620|NCT02638948|26023475|FG001|Overall Study|Adverse Event|0|||
13143621|NCT02638948|26023476|FG002|Overall Study|Adverse Event|1|||
13143622|NCT02638948|26023477|FG003|Overall Study|Adverse Event|1|||
13143623|NCT02638948|26023474|FG000|Overall Study|Lack of Efficacy|1|||
13143624|NCT02638948|26023475|FG001|Overall Study|Lack of Efficacy|1|||
13143625|NCT02638948|26023476|FG002|Overall Study|Lack of Efficacy|0|||
13143626|NCT02638948|26023477|FG003|Overall Study|Lack of Efficacy|0|||
13143627|NCT02638948|26023474|FG000|Overall Study|Lost to Follow-up|0|||
13143628|NCT02638948|26023475|FG001|Overall Study|Lost to Follow-up|0|||
13143629|NCT02638948|26023476|FG002|Overall Study|Lost to Follow-up|1|||
13143630|NCT02638948|26023477|FG003|Overall Study|Lost to Follow-up|1|||
13143631|NCT02638948|26023474|FG000|Overall Study|Poor/Non-Compliance|0|||
13143632|NCT02638948|26023475|FG001|Overall Study|Poor/Non-Compliance|2|||
13143633|NCT02638948|26023476|FG002|Overall Study|Poor/Non-Compliance|1|||
13143634|NCT02638948|26023477|FG003|Overall Study|Poor/Non-Compliance|0|||
13143635|NCT02638948|26023474|FG000|Overall Study|Participant no longer met study criteria|0|||
13143636|NCT02638948|26023475|FG001|Overall Study|Participant no longer met study criteria|1|||
13143637|NCT02638948|26023476|FG002|Overall Study|Participant no longer met study criteria|0|||
13143638|NCT02638948|26023477|FG003|Overall Study|Participant no longer met study criteria|0|||
13143639|NCT02638948|26023474|FG000|Overall Study|Other than specified above|4|||
13143640|NCT02638948|26023475|FG001|Overall Study|Other than specified above|1|||
13143641|NCT02638948|26023476|FG002|Overall Study|Other than specified above|1|||
13143642|NCT02638948|26023477|FG003|Overall Study|Other than specified above|1|||
13143643|NCT02638623|26023500|FG000|Overall Study|Surgery timing|5|||
13143644|NCT02638623|26023501|FG001|Overall Study|Surgery timing|6|||
13143645|NCT02638623|26023500|FG000|Overall Study|Not given intervention|2|||
13143646|NCT02638623|26023501|FG001|Overall Study|Not given intervention|0|||
13143647|NCT02638493|26023540|FG000|Overall Study|Inability to provide semen samples|2|||
13143648|NCT02638493|26023541|FG001|Overall Study|Inability to provide semen samples|0|||
13485220|NCT03921424|27031930|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
13487981|NCT01111565|27041931|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58|||
13487982|NCT01111565|27041932|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
13487983|NCT01111565|27041933|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
13487984|NCT01111565|27041934|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
13143649|NCT02638493|26023542|FG002|Overall Study|Inability to provide semen samples|0|||
13143650|NCT02638337|26023631|FG000|Overall Study|Adverse Event|6|||
13143651|NCT02638337|26023632|FG001|Overall Study|Adverse Event|10|||
13485221|NCT03406078|27031981|FG000|Overall Study|Death|1|||
13485222|NCT03406078|27031982|FG001|Overall Study|Death|0|||
13485223|NCT03406078|27031981|FG000|Overall Study|Lost to Follow-up|0|||
13143652|NCT02638337|26023631|FG000|Overall Study|Protocol Violation|3|||
13143653|NCT02638337|26023632|FG001|Overall Study|Protocol Violation|0|||
13143654|NCT02638337|26023631|FG000|Overall Study|Withdrawal by Subject|13|||
13143655|NCT02638337|26023632|FG001|Overall Study|Withdrawal by Subject|16|||
13143656|NCT02638337|26023631|FG000|Overall Study|Lost to Follow-up|7|||
13143657|NCT02638337|26023632|FG001|Overall Study|Lost to Follow-up|7|||
13143658|NCT02638337|26023631|FG000|Overall Study|Other - Miscellaneous|4|||
13143659|NCT02638337|26023632|FG001|Overall Study|Other - Miscellaneous|3|||
13143660|NCT02638259|26023713|FG000|Treatment Period 1|Adverse Event|1|||
13143661|NCT02638259|26023714|FG001|Treatment Period 1|Adverse Event|5|||
13143662|NCT02638259|26023713|FG000|Treatment Period 1|Death|0|||
13143663|NCT02638259|26023714|FG001|Treatment Period 1|Death|1|||
13143664|NCT02638259|26023713|FG000|Treatment Period 1|Lack of Efficacy|0|||
13143665|NCT02638259|26023714|FG001|Treatment Period 1|Lack of Efficacy|1|||
13143666|NCT02638259|26023713|FG000|Treatment Period 1|Protocol Violation|0|||
13143667|NCT02638259|26023714|FG001|Treatment Period 1|Protocol Violation|3|||
13091938|NCT03716050|25826295|FG003|Overall Study|Physician Decision|1|||
13091939|NCT03716050|25826296|FG004|Overall Study|Physician Decision|0|||
13091940|NCT03716050|25826297|FG005|Overall Study|Physician Decision|0|||
13091941|NCT03716050|25826298|FG006|Overall Study|Physician Decision|0|||
13091942|NCT03716050|25826299|FG007|Overall Study|Physician Decision|0|||
13091943|NCT03716050|25826292|FG000|Overall Study|Protocol Violation|0|||
13091944|NCT03716050|25826293|FG001|Overall Study|Protocol Violation|0|||
13091945|NCT03716050|25826294|FG002|Overall Study|Protocol Violation|0|||
13091946|NCT03716050|25826295|FG003|Overall Study|Protocol Violation|1|||
13091947|NCT03716050|25826296|FG004|Overall Study|Protocol Violation|0|||
13091948|NCT03716050|25826297|FG005|Overall Study|Protocol Violation|0|||
13091949|NCT03716050|25826298|FG006|Overall Study|Protocol Violation|0|||
13091950|NCT03716050|25826299|FG007|Overall Study|Protocol Violation|2|||
13091951|NCT03716024|25826318|FG000|Overall Study|Randomized, not Treated|7|||
13091952|NCT03716024|25826319|FG001|Overall Study|Randomized, not Treated|8|||
13091953|NCT03716024|25826318|FG000|Overall Study|Adverse Event|1|||
13091954|NCT03716024|25826319|FG001|Overall Study|Adverse Event|2|||
13091955|NCT03716024|25826318|FG000|Overall Study|Treatment Failure|1|||
13091956|NCT03716024|25826319|FG001|Overall Study|Treatment Failure|0|||
13091957|NCT03716024|25826318|FG000|Overall Study|Lost to Follow-up|2|||
13091958|NCT03716024|25826319|FG001|Overall Study|Lost to Follow-up|6|||
13091959|NCT03716024|25826318|FG000|Overall Study|Withdrawal by Subject|0|||
13091960|NCT03716024|25826319|FG001|Overall Study|Withdrawal by Subject|1|||
13091961|NCT03716024|25826318|FG000|Overall Study|Missing Reason|0|||
13091962|NCT03716024|25826319|FG001|Overall Study|Missing Reason|1|||
13091963|NCT03715530|25826337|FG000|Overall Study|Lost to Follow-up|3|||
13091964|NCT03715530|25826338|FG001|Overall Study|Lost to Follow-up|1|||
13091965|NCT03715530|25826339|FG002|Overall Study|Lost to Follow-up|2|||
13091966|NCT03714815|25826365|FG000|Overall Study|Physician Decision|2|||
13091967|NCT03714815|25826365|FG000|Overall Study|Withdrawal by Subject|2|||
13091968|NCT03714815|25826365|FG000|Overall Study|Death|11|||
13091969|NCT03714672|25826424|FG000|Overall Study|Adverse Event|0|||
13091970|NCT03714672|25826425|FG001|Overall Study|Adverse Event|0|||
13091971|NCT03714672|25826426|FG002|Overall Study|Adverse Event|3|||
13091972|NCT03714672|25826427|FG003|Overall Study|Adverse Event|0|||
13091973|NCT03714672|25826424|FG000|Overall Study|Physician Decision|0|||
13091974|NCT03714672|25826425|FG001|Overall Study|Physician Decision|1|||
13091975|NCT03714672|25826426|FG002|Overall Study|Physician Decision|0|||
13091976|NCT03714672|25826427|FG003|Overall Study|Physician Decision|0|||
13091977|NCT03714672|25826424|FG000|Overall Study|Other Reason|1|||
13091978|NCT03714672|25826425|FG001|Overall Study|Other Reason|2|||
13091979|NCT03714672|25826426|FG002|Overall Study|Other Reason|1|||
13091980|NCT03714672|25826427|FG003|Overall Study|Other Reason|1|||
13091981|NCT03714672|25826424|FG000|Overall Study|Lost to Follow-up|1|||
13091982|NCT03714672|25826425|FG001|Overall Study|Lost to Follow-up|1|||
13091983|NCT03714672|25826426|FG002|Overall Study|Lost to Follow-up|0|||
13091984|NCT03714672|25826427|FG003|Overall Study|Lost to Follow-up|0|||
13091985|NCT03714022|25826484|FG000|Overall Study|Adverse Event|1|||
13091986|NCT03714022|25826485|FG001|Overall Study|Adverse Event|0|||
13091987|NCT03714022|25826484|FG000|Overall Study|Consent withdrawal|0|||
13091988|NCT03714022|25826485|FG001|Overall Study|Consent withdrawal|1|||
13091989|NCT03714022|25826484|FG000|Overall Study|Lost to Follow-up|3|||
13091990|NCT03714022|25826485|FG001|Overall Study|Lost to Follow-up|2|||
13091991|NCT03713684|25826532|FG000|Overall Study|Adverse Event|1|||
13091992|NCT03713684|25826533|FG001|Overall Study|Adverse Event|3|||
13091993|NCT03713684|25826534|FG002|Overall Study|Adverse Event|1|||
13091994|NCT03713684|25826535|FG003|Overall Study|Adverse Event|0|||
13143668|NCT02638259|26023713|FG000|Treatment Period 1|Withdrawal by Subject|4|||
13143669|NCT02638259|26023714|FG001|Treatment Period 1|Withdrawal by Subject|6|||
13143670|NCT02638259|26023713|FG000|Treatment Period 1|Withdrawn per sponsor decision|0|||
13143671|NCT02638259|26023714|FG001|Treatment Period 1|Withdrawn per sponsor decision|2|||
13091995|NCT03713684|25826532|FG000|Overall Study|Poor compliance to protocol|2|||
13091996|NCT03713684|25826533|FG001|Overall Study|Poor compliance to protocol|1|||
13091997|NCT03713684|25826534|FG002|Overall Study|Poor compliance to protocol|0|||
13091998|NCT03713684|25826535|FG003|Overall Study|Poor compliance to protocol|1|||
13091999|NCT03713684|25826532|FG000|Overall Study|Withdrawal by Subject|14|||
13092000|NCT03713684|25826533|FG001|Overall Study|Withdrawal by Subject|6|||
13092001|NCT03713684|25826534|FG002|Overall Study|Withdrawal by Subject|14|||
13092002|NCT03713684|25826535|FG003|Overall Study|Withdrawal by Subject|16|||
13092003|NCT03713684|25826532|FG000|Overall Study|Other than specified|69|||
13092004|NCT03713684|25826533|FG001|Overall Study|Other than specified|77|||
13092005|NCT03713684|25826534|FG002|Overall Study|Other than specified|73|||
13092006|NCT03713684|25826535|FG003|Overall Study|Other than specified|70|||
13092007|NCT03713320|25826575|FG000|Randomized Period|Adverse Event|1|||
13092008|NCT03713320|25826576|FG001|Randomized Period|Adverse Event|5|||
13092009|NCT03713320|25826577|FG002|Randomized Period|Adverse Event|0|||
13092010|NCT03713320|25826575|FG000|Randomized Period|Physician Decision|1|||
13092011|NCT03713320|25826576|FG001|Randomized Period|Physician Decision|1|||
13092012|NCT03713320|25826577|FG002|Randomized Period|Physician Decision|0|||
13092013|NCT03713320|25826575|FG000|Randomized Period|Withdrawal by Subject|4|||
13092014|NCT03713320|25826576|FG001|Randomized Period|Withdrawal by Subject|0|||
13143672|NCT02638259|26023713|FG000|Treatment Period 2|Adverse Event|5|||
13143673|NCT02638259|26023714|FG001|Treatment Period 2|Adverse Event|4|||
13143674|NCT02638259|26023713|FG000|Treatment Period 2|Withdrawal by Subject|1|||
13092015|NCT03713320|25826577|FG002|Randomized Period|Withdrawal by Subject|0|||
13092016|NCT03713320|25826575|FG000|Randomized Period|Participant decision|3|||
13092017|NCT03713320|25826576|FG001|Randomized Period|Participant decision|1|||
13092018|NCT03713320|25826577|FG002|Randomized Period|Participant decision|0|||
13092019|NCT03713320|25826575|FG000|Randomized Period|Study terminated by sponsor|6|||
13092020|NCT03713320|25826576|FG001|Randomized Period|Study terminated by sponsor|3|||
13092021|NCT03713320|25826577|FG002|Randomized Period|Study terminated by sponsor|0|||
13092022|NCT03713320|25826575|FG000|Cobomarsen Crossover Period|Physician Decision|0|||
13092023|NCT03713320|25826576|FG001|Cobomarsen Crossover Period|Physician Decision|0|||
13092024|NCT03713320|25826577|FG002|Cobomarsen Crossover Period|Physician Decision|2|||
13092025|NCT03713320|25826575|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
13092026|NCT03713320|25826576|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
13092027|NCT03713320|25826577|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5|||
13092028|NCT03713281|25826584|FG000|Overall Study|Lens handling difficuluties|2|||
13092029|NCT03713281|25826584|FG000|Overall Study|Subject was not dispensed enough lenses|1|||
13133725|NCT02765165|25988894|FG003|Post-treatment Follow-up|Death|1|||
13133726|NCT02765165|25988895|FG004|Post-treatment Follow-up|Death|1|||
13133727|NCT02765165|25988896|FG005|Post-treatment Follow-up|Death|1|||
13133728|NCT02765165|25988897|FG006|Post-treatment Follow-up|Death|0|||
13133729|NCT02765165|25988891|FG000|Post-treatment Follow-up|Lost to Follow-up|0|||
13133730|NCT02765165|25988892|FG001|Post-treatment Follow-up|Lost to Follow-up|0|||
13133731|NCT02765165|25988893|FG002|Post-treatment Follow-up|Lost to Follow-up|0|||
13133732|NCT02765165|25988894|FG003|Post-treatment Follow-up|Lost to Follow-up|1|||
13133733|NCT02765165|25988895|FG004|Post-treatment Follow-up|Lost to Follow-up|0|||
13133734|NCT02765165|25988896|FG005|Post-treatment Follow-up|Lost to Follow-up|0|||
13133735|NCT02765165|25988897|FG006|Post-treatment Follow-up|Lost to Follow-up|0|||
13133736|NCT02765165|25988891|FG000|Post-treatment Follow-up|Site terminated by sponsor|0|||
13133737|NCT02765165|25988892|FG001|Post-treatment Follow-up|Site terminated by sponsor|0|||
13133738|NCT02765165|25988893|FG002|Post-treatment Follow-up|Site terminated by sponsor|1|||
13133739|NCT02765165|25988894|FG003|Post-treatment Follow-up|Site terminated by sponsor|0|||
13133740|NCT02765165|25988895|FG004|Post-treatment Follow-up|Site terminated by sponsor|0|||
13133741|NCT02765165|25988896|FG005|Post-treatment Follow-up|Site terminated by sponsor|0|||
13133742|NCT02765165|25988897|FG006|Post-treatment Follow-up|Site terminated by sponsor|0|||
13133743|NCT02765165|25988891|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
13133744|NCT02765165|25988892|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
13133745|NCT02765165|25988893|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
13133746|NCT02765165|25988894|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
13133747|NCT02765165|25988895|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
13133748|NCT02765165|25988896|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
13133749|NCT02765165|25988897|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
13133750|NCT02765165|25988891|FG000|Post-treatment Follow-up|Withdrawal by Subject|0|||
13133751|NCT02765165|25988892|FG001|Post-treatment Follow-up|Withdrawal by Subject|1|||
13133752|NCT02765165|25988893|FG002|Post-treatment Follow-up|Withdrawal by Subject|0|||
13133753|NCT02765165|25988894|FG003|Post-treatment Follow-up|Withdrawal by Subject|0|||
13133754|NCT02765165|25988895|FG004|Post-treatment Follow-up|Withdrawal by Subject|0|||
13133755|NCT02765165|25988896|FG005|Post-treatment Follow-up|Withdrawal by Subject|0|||
13133756|NCT02765165|25988897|FG006|Post-treatment Follow-up|Withdrawal by Subject|0|||
13092030|NCT03713021|25826592|FG000|Overall Study|Did not have CT sim scan available|6|||
13092031|NCT03713021|25826592|FG000|Overall Study|Not eligible|4|||
13092032|NCT03713021|25826592|FG000|Overall Study|Issues with TraceIT markers|5|||
13092033|NCT03712930|25826610|FG000|Overall Study|Death|7|||
13092034|NCT03712930|25826610|FG000|Overall Study|Physician Decision|1|||
13092035|NCT03712930|25826610|FG000|Overall Study|Study Terminated by Sponsor|3|||
13092036|NCT03712930|25826610|FG000|Overall Study|Progressive Disease|2|||
13092037|NCT03712917|25826631|FG000|Overall Study|Pregnancy|0|||
13092038|NCT03712917|25826632|FG001|Overall Study|Pregnancy|0|||
13092039|NCT03712917|25826633|FG002|Overall Study|Pregnancy|1|||
13092040|NCT03712917|25826631|FG000|Overall Study|Adverse Event|0|||
13092041|NCT03712917|25826632|FG001|Overall Study|Adverse Event|4|||
13092042|NCT03712917|25826633|FG002|Overall Study|Adverse Event|3|||
13092043|NCT03712917|25826631|FG000|Overall Study|Lost to Follow-up|9|||
13092044|NCT03712917|25826632|FG001|Overall Study|Lost to Follow-up|4|||
13092045|NCT03712917|25826633|FG002|Overall Study|Lost to Follow-up|5|||
13092046|NCT03712787|25826672|FG000|Overall Study|Adverse Event|2|||
13143675|NCT02638259|26023714|FG001|Treatment Period 2|Withdrawal by Subject|7|||
13143676|NCT02638129|26023733|FG000|Overall Study|Study terminated|28|||
13143677|NCT02638129|26023734|FG001|Overall Study|Study terminated|30|||
13143678|NCT02638103|26023821|FG000|Overall Study|Adverse Event|13|||
13143679|NCT02638103|26023822|FG001|Overall Study|Adverse Event|12|||
13143680|NCT02638103|26023823|FG002|Overall Study|Adverse Event|19|||
13143681|NCT02638103|26023824|FG003|Overall Study|Adverse Event|12|||
13143682|NCT02638103|26023821|FG000|Overall Study|Withdrawal by Subject|43|||
13143683|NCT02638103|26023822|FG001|Overall Study|Withdrawal by Subject|53|||
13143684|NCT02638103|26023823|FG002|Overall Study|Withdrawal by Subject|30|||
13143685|NCT02638103|26023824|FG003|Overall Study|Withdrawal by Subject|61|||
13143686|NCT02638103|26023821|FG000|Overall Study|Protocol Violation|1|||
13143687|NCT02638103|26023822|FG001|Overall Study|Protocol Violation|2|||
13143688|NCT02638103|26023823|FG002|Overall Study|Protocol Violation|1|||
13143689|NCT02638103|26023824|FG003|Overall Study|Protocol Violation|4|||
13143690|NCT02638103|26023821|FG000|Overall Study|Pregnancy|2|||
13143691|NCT02638103|26023822|FG001|Overall Study|Pregnancy|3|||
13143692|NCT02638103|26023823|FG002|Overall Study|Pregnancy|0|||
13143693|NCT02638103|26023824|FG003|Overall Study|Pregnancy|1|||
13143694|NCT02638103|26023821|FG000|Overall Study|Non-compliance to Study Procedures|2|||
13143695|NCT02638103|26023822|FG001|Overall Study|Non-compliance to Study Procedures|1|||
13143696|NCT02638103|26023823|FG002|Overall Study|Non-compliance to Study Procedures|1|||
13143697|NCT02638103|26023824|FG003|Overall Study|Non-compliance to Study Procedures|1|||
13143698|NCT02638103|26023821|FG000|Overall Study|Lost to Follow-up|26|||
13143699|NCT02638103|26023822|FG001|Overall Study|Lost to Follow-up|33|||
13143700|NCT02638103|26023823|FG002|Overall Study|Lost to Follow-up|20|||
13143701|NCT02638103|26023824|FG003|Overall Study|Lost to Follow-up|37|||
13143702|NCT02638103|26023821|FG000|Overall Study|Lack of Efficacy|14|||
13143703|NCT02638103|26023822|FG001|Overall Study|Lack of Efficacy|10|||
13143704|NCT02638103|26023823|FG002|Overall Study|Lack of Efficacy|12|||
13143705|NCT02638103|26023824|FG003|Overall Study|Lack of Efficacy|22|||
13143706|NCT02638103|26023821|FG000|Overall Study|Other than specified|5|||
13143707|NCT02638103|26023822|FG001|Overall Study|Other than specified|4|||
13143708|NCT02638103|26023823|FG002|Overall Study|Other than specified|2|||
13143709|NCT02638103|26023824|FG003|Overall Study|Other than specified|4|||
13143710|NCT02638012|26023834|FG000|Overall Study|Lost to Follow-up|1|||
13143711|NCT02637895|26023853|FG000|Overall Study|Lost to Follow-up|4|||
13143712|NCT02637895|26023854|FG001|Overall Study|Lost to Follow-up|0|||
13143713|NCT02637895|26023853|FG000|Overall Study|Protocol Violation|0|||
13143714|NCT02637895|26023854|FG001|Overall Study|Protocol Violation|1|||
13143715|NCT02637895|26023853|FG000|Overall Study|Lack of Efficacy|1|||
13143716|NCT02637895|26023854|FG001|Overall Study|Lack of Efficacy|0|||
13143717|NCT02637895|26023853|FG000|Overall Study|Withdrawal by Subject|1|||
13143718|NCT02637895|26023854|FG001|Overall Study|Withdrawal by Subject|1|||
13143719|NCT02637895|26023853|FG000|Overall Study|Abnormal baseline lab|0|||
13143720|NCT02637895|26023854|FG001|Overall Study|Abnormal baseline lab|1|||
13143721|NCT02637856|26023874|FG000|Main Study (Baseline to Week 100)|Adverse Event|9|||
13143722|NCT02637856|26023875|FG001|Main Study (Baseline to Week 100)|Adverse Event|0|||
13143723|NCT02637856|26023874|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5|||
13143724|NCT02637856|26023875|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0|||
13143725|NCT02637856|26023874|FG000|Main Study (Baseline to Week 100)|Physician Decision|2|||
13143726|NCT02637856|26023875|FG001|Main Study (Baseline to Week 100)|Physician Decision|0|||
13143727|NCT02637856|26023874|FG000|Main Study (Baseline to Week 100)|Pregnancy|7|||
13143728|NCT02637856|26023875|FG001|Main Study (Baseline to Week 100)|Pregnancy|0|||
13143729|NCT02637856|26023874|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20|||
13143730|NCT02637856|26023875|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0|||
13092047|NCT03712787|25826673|FG001|Overall Study|Adverse Event|3|||
13204930|NCT01968967|26230510|FG002|Treatment Period|Other|0|||
13092048|NCT03712787|25826674|FG002|Overall Study|Adverse Event|0|||
13092049|NCT03712787|25826675|FG003|Overall Study|Adverse Event|4|||
13092050|NCT03712787|25826672|FG000|Overall Study|Withdrawal by Subject|4|||
13143731|NCT02637856|26023874|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2|||
13143732|NCT02637856|26023875|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0|||
13143733|NCT02637856|26023874|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164|||
13143734|NCT02637856|26023875|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0|||
13143735|NCT02637856|26023874|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1|||
13143736|NCT02637856|26023875|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0|||
13143737|NCT02637856|26023874|FG000|Main Study (Baseline to Week 100)|Incarceration|1|||
13143738|NCT02637856|26023875|FG001|Main Study (Baseline to Week 100)|Incarceration|0|||
13143739|NCT02637856|26023874|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2|||
13143740|NCT02637856|26023875|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0|||
13143741|NCT02637856|26023874|FG000|Main Study (Baseline to Week 100)|Site Closing|6|||
13092051|NCT03712787|25826673|FG001|Overall Study|Withdrawal by Subject|14|||
13092052|NCT03712787|25826674|FG002|Overall Study|Withdrawal by Subject|12|||
13092053|NCT03712787|25826675|FG003|Overall Study|Withdrawal by Subject|8|||
13092054|NCT03712787|25826672|FG000|Overall Study|Lost to Follow-up|1|||
13092055|NCT03712787|25826673|FG001|Overall Study|Lost to Follow-up|1|||
13092056|NCT03712787|25826674|FG002|Overall Study|Lost to Follow-up|2|||
13092057|NCT03712787|25826675|FG003|Overall Study|Lost to Follow-up|1|||
13143742|NCT02637856|26023875|FG001|Main Study (Baseline to Week 100)|Site Closing|0|||
13143743|NCT02637856|26023874|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0|||
13143744|NCT02637856|26023875|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1|||
13143745|NCT02637856|26023874|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0|||
13143746|NCT02637856|26023875|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3|||
13143747|NCT02637557|26023978|FG000|Overall Study|Adverse Event|3|||
13143748|NCT02637557|26023979|FG001|Overall Study|Adverse Event|1|||
13143749|NCT02637557|26023980|FG002|Overall Study|Adverse Event|3|||
13143750|NCT02637557|26023981|FG003|Overall Study|Adverse Event|3|||
13143751|NCT02637557|26023978|FG000|Overall Study|Lost to Follow-up|1|||
13143752|NCT02637557|26023979|FG001|Overall Study|Lost to Follow-up|1|||
13143753|NCT02637557|26023980|FG002|Overall Study|Lost to Follow-up|0|||
13143754|NCT02637557|26023981|FG003|Overall Study|Lost to Follow-up|1|||
13143755|NCT02637557|26023978|FG000|Overall Study|Physician Decision|1|||
13143756|NCT02637557|26023979|FG001|Overall Study|Physician Decision|0|||
13143757|NCT02637557|26023980|FG002|Overall Study|Physician Decision|0|||
13143758|NCT02637557|26023981|FG003|Overall Study|Physician Decision|0|||
13143759|NCT02637557|26023978|FG000|Overall Study|Protocol Violation|2|||
13143760|NCT02637557|26023979|FG001|Overall Study|Protocol Violation|0|||
13143761|NCT02637557|26023980|FG002|Overall Study|Protocol Violation|2|||
13143762|NCT02637557|26023981|FG003|Overall Study|Protocol Violation|1|||
13143763|NCT02637557|26023978|FG000|Overall Study|Withdrawal by Subject|1|||
13143764|NCT02637557|26023979|FG001|Overall Study|Withdrawal by Subject|3|||
13143765|NCT02637557|26023980|FG002|Overall Study|Withdrawal by Subject|4|||
13143766|NCT02637557|26023981|FG003|Overall Study|Withdrawal by Subject|2|||
13143767|NCT02637323|26023996|FG000|Overall Study|Lost to Follow-up|2|||
13143768|NCT02637323|26023997|FG001|Overall Study|Lost to Follow-up|0|||
13143769|NCT02637323|26023996|FG000|Overall Study|Protocol Violation|0|||
13143770|NCT02637323|26023997|FG001|Overall Study|Protocol Violation|1|||
13143771|NCT02637232|26024003|FG000|Overall Study|Lost to Follow-up|42|||
13143772|NCT02637232|26024003|FG000|Overall Study|Adverse Event|11|||
13143773|NCT02637232|26024003|FG000|Overall Study|patient 's decision|2|||
13143774|NCT02637141|26024045|FG000|Overall Study|Adverse Event|1|||
13143775|NCT02637141|26024046|FG001|Overall Study|Adverse Event|1|||
13143776|NCT02637141|26024047|FG002|Overall Study|Adverse Event|0|||
13143777|NCT02637141|26024045|FG000|Overall Study|Withdrawal by Subject|1|||
13143778|NCT02637141|26024046|FG001|Overall Study|Withdrawal by Subject|1|||
13143779|NCT02637141|26024047|FG002|Overall Study|Withdrawal by Subject|1|||
13143780|NCT02637076|26024076|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
13143781|NCT02637076|26024077|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
13143782|NCT02637076|26024076|FG000|Overall Study|Withdrawal by Subject|0|||
13143783|NCT02637076|26024077|FG001|Overall Study|Withdrawal by Subject|4|||
13143784|NCT02637063|26024113|FG000|Overall Study|Lost to Follow-up|3|||
13143785|NCT02637063|26024114|FG001|Overall Study|Lost to Follow-up|2|||
13143786|NCT02637063|26024115|FG002|Overall Study|Lost to Follow-up|3|||
13092058|NCT03712787|25826672|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
13092059|NCT03712787|25826673|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
13143787|NCT02637063|26024113|FG000|Overall Study|Withdrawal by Subject|2|||
13143788|NCT02637063|26024114|FG001|Overall Study|Withdrawal by Subject|2|||
13143789|NCT02637063|26024115|FG002|Overall Study|Withdrawal by Subject|3|||
13143790|NCT02637037|26024188|FG000|Overall Study|Positive drug screen at admission|1|||
13143791|NCT02637037|26024189|FG001|Overall Study|Positive drug screen at admission|0|||
13143792|NCT02637037|26024188|FG000|Overall Study|Withdrawal by Subject|2|||
13143793|NCT02637037|26024189|FG001|Overall Study|Withdrawal by Subject|1|||
13143794|NCT02637037|26024188|FG000|Overall Study|Adverse Event|1|||
13143795|NCT02637037|26024189|FG001|Overall Study|Adverse Event|0|||
13143796|NCT02636907|26024200|FG000|Autoinjector Assessment Period|Adverse Event|2|||
13143797|NCT02636907|26024200|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2|||
13143798|NCT02636907|26024200|FG000|Extension Phase|Adverse Event|2|||
13143799|NCT02636907|26024200|FG000|Extension Phase|Withdrawal by Subject|4|||
13143800|NCT02636907|26024200|FG000|Extension Phase|Physician Decision|1|||
13143801|NCT02636907|26024200|FG000|Extension Phase|Lost to Follow-up|2|||
13143802|NCT02636907|26024200|FG000|Extension Phase|Lack of Efficacy|1|||
13143803|NCT02636868|26024233|FG000|Overall Study|Death|0|||
13143804|NCT02636868|26024234|FG001|Overall Study|Death|1|||
13143805|NCT02636868|26024235|FG002|Overall Study|Death|2|||
13143806|NCT02636699|26024256|FG000|Overall Study|Adverse Event|4|||
13143807|NCT02636699|26024257|FG001|Overall Study|Adverse Event|0|||
13143808|NCT02636699|26024256|FG000|Overall Study|Lost to Follow-up|3|||
13143809|NCT02636699|26024257|FG001|Overall Study|Lost to Follow-up|3|||
13143810|NCT02636699|26024256|FG000|Overall Study|Non-compliance with the investigational product (IP)|2|||
13143811|NCT02636699|26024257|FG001|Overall Study|Non-compliance with the investigational product (IP)|0|||
13143812|NCT02636699|26024256|FG000|Overall Study|Physician Decision|0|||
13143813|NCT02636699|26024257|FG001|Overall Study|Physician Decision|1|||
13143814|NCT02636699|26024256|FG000|Overall Study|Withdrawal by Subject|13|||
13143815|NCT02636699|26024257|FG001|Overall Study|Withdrawal by Subject|6|||
13143816|NCT02636699|26024256|FG000|Overall Study|Other|3|||
13143817|NCT02636699|26024257|FG001|Overall Study|Other|1|||
13143818|NCT02636608|26024287|FG000|Overall Study|Failure to Return|4|||
13143819|NCT02636608|26024287|FG000|Overall Study|Insufficient Virological Response|1|||
13143820|NCT02636608|26024287|FG000|Overall Study|Death|3|||
13143821|NCT02636608|26024287|FG000|Overall Study|Other|2|||
13143822|NCT02636608|26024287|FG000|Overall Study|Did Not Receive Treatment|1|||
13143823|NCT02636595|26024295|FG000|Overall Study|Lost to Follow-up|1|||
13143824|NCT02636595|26024295|FG000|Overall Study|Other|1|||
13143825|NCT02636361|26024318|FG000|Period 4|Physician Decision|0|||
13143826|NCT02636361|26024319|FG001|Period 4|Physician Decision|0|||
13143827|NCT02636361|26024320|FG002|Period 4|Physician Decision|0|||
13143828|NCT02636361|26024321|FG003|Period 4|Physician Decision|1|||
13143829|NCT02636361|26024322|FG004|Period 4|Physician Decision|0|||
13143830|NCT02636283|26024343|FG000|Overall Study|Adverse Event|2|||
13143831|NCT02636283|26024344|FG001|Overall Study|Adverse Event|0|||
13143832|NCT02636283|26024343|FG000|Overall Study|Trial Terminated Prematurely|0|||
13143833|NCT02636283|26024344|FG001|Overall Study|Trial Terminated Prematurely|3|||
13143834|NCT02635984|26024371|FG000|Overall Study|Lost to Follow-up|2|||
13143835|NCT02635984|26024372|FG001|Overall Study|Lost to Follow-up|4|||
13143836|NCT02635984|26024371|FG000|Overall Study|Study Arm Closed|1|||
13143837|NCT02635984|26024372|FG001|Overall Study|Study Arm Closed|0|||
13143838|NCT02635776|26024393|FG000|Overall Study|Physician Decision|1|||
13143839|NCT02635776|26024394|FG001|Overall Study|Physician Decision|0|||
13143840|NCT02635776|26024393|FG000|Overall Study|Adverse Event|51|||
13143841|NCT02635776|26024394|FG001|Overall Study|Adverse Event|3|||
13143842|NCT02635776|26024393|FG000|Overall Study|Withdrawal by Subject|41|||
13143843|NCT02635776|26024394|FG001|Overall Study|Withdrawal by Subject|7|||
13143844|NCT02635776|26024393|FG000|Overall Study|Lost to Follow-up|4|||
13143845|NCT02635776|26024394|FG001|Overall Study|Lost to Follow-up|0|||
13143846|NCT02635776|26024393|FG000|Overall Study|Other reasons|5|||
13143847|NCT02635776|26024394|FG001|Overall Study|Other reasons|1|||
13143848|NCT02635737|26024407|FG000|Overall Study|Protocol Violation|1|||
13143849|NCT02635724|26024446|FG000|Overall Study|Withdrawal by Subject|0|||
13143850|NCT02635724|26024447|FG001|Overall Study|Withdrawal by Subject|1|||
13143851|NCT02635724|26024448|FG002|Overall Study|Withdrawal by Subject|0|||
13143852|NCT02635646|26024469|FG000|Overall Study|Lost to Follow-up|24|||
13143853|NCT02635646|26024470|FG001|Overall Study|Lost to Follow-up|25|||
13143854|NCT02635646|26024469|FG000|Overall Study|Pregnancy|1|||
13143855|NCT02635646|26024470|FG001|Overall Study|Pregnancy|1|||
13143856|NCT02635386|26024608|FG000|Overall Study|Pregnancy|2|||
13143857|NCT02635386|26024609|FG001|Overall Study|Pregnancy|0|||
13143858|NCT02635386|26024610|FG002|Overall Study|Pregnancy|0|||
13143859|NCT02635386|26024611|FG003|Overall Study|Pregnancy|0|||
13143860|NCT02635386|26024612|FG004|Overall Study|Pregnancy|2|||
13143861|NCT02635386|26024608|FG000|Overall Study|Withdrawal by Subject|1|||
13143862|NCT02635386|26024609|FG001|Overall Study|Withdrawal by Subject|1|||
13143863|NCT02635386|26024610|FG002|Overall Study|Withdrawal by Subject|0|||
13143864|NCT02635386|26024611|FG003|Overall Study|Withdrawal by Subject|1|||
13143865|NCT02635386|26024612|FG004|Overall Study|Withdrawal by Subject|0|||
13143866|NCT02635386|26024608|FG000|Overall Study|Physician Decision|0|||
13143867|NCT02635386|26024609|FG001|Overall Study|Physician Decision|1|||
13143868|NCT02635386|26024610|FG002|Overall Study|Physician Decision|0|||
13143869|NCT02635386|26024611|FG003|Overall Study|Physician Decision|0|||
13143870|NCT02635386|26024612|FG004|Overall Study|Physician Decision|0|||
13143871|NCT02635386|26024608|FG000|Overall Study|Moved Out of State|0|||
13143872|NCT02635386|26024609|FG001|Overall Study|Moved Out of State|1|||
13143873|NCT02635386|26024610|FG002|Overall Study|Moved Out of State|0|||
13143874|NCT02635386|26024611|FG003|Overall Study|Moved Out of State|0|||
13143875|NCT02635386|26024612|FG004|Overall Study|Moved Out of State|0|||
13143876|NCT02635386|26024608|FG000|Overall Study|Noncompliant|0|||
13143877|NCT02635386|26024609|FG001|Overall Study|Noncompliant|2|||
13143878|NCT02635386|26024610|FG002|Overall Study|Noncompliant|1|||
13143879|NCT02635386|26024611|FG003|Overall Study|Noncompliant|1|||
13143880|NCT02635386|26024612|FG004|Overall Study|Noncompliant|1|||
13143881|NCT02635386|26024608|FG000|Overall Study|side effects|0|||
13143882|NCT02635386|26024609|FG001|Overall Study|side effects|0|||
13143883|NCT02635386|26024610|FG002|Overall Study|side effects|1|||
13143884|NCT02635386|26024611|FG003|Overall Study|side effects|4|||
13143885|NCT02635386|26024612|FG004|Overall Study|side effects|6|||
13143886|NCT02635386|26024608|FG000|Overall Study|needed other major surgery|0|||
13143887|NCT02635386|26024609|FG001|Overall Study|needed other major surgery|1|||
13143888|NCT02635386|26024610|FG002|Overall Study|needed other major surgery|0|||
13143889|NCT02635386|26024611|FG003|Overall Study|needed other major surgery|0|||
13143890|NCT02635386|26024612|FG004|Overall Study|needed other major surgery|0|||
13143891|NCT02635386|26024608|FG000|Overall Study|Other medical problems not drug related|0|||
13143892|NCT02635386|26024609|FG001|Overall Study|Other medical problems not drug related|0|||
13143893|NCT02635386|26024610|FG002|Overall Study|Other medical problems not drug related|0|||
13143894|NCT02635386|26024611|FG003|Overall Study|Other medical problems not drug related|1|||
13143895|NCT02635386|26024612|FG004|Overall Study|Other medical problems not drug related|0|||
13143896|NCT02635347|26024648|FG000|Overall Study|Failed screening|20|||
13143897|NCT02635347|26024649|FG001|Overall Study|Failed screening|7|||
13092060|NCT03712787|25826674|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
13092061|NCT03712787|25826675|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
13092062|NCT03712787|25826672|FG000|Overall Study|COVID-19 Infection|0|||
13092063|NCT03712787|25826673|FG001|Overall Study|COVID-19 Infection|1|||
13092064|NCT03712787|25826674|FG002|Overall Study|COVID-19 Infection|0|||
13092065|NCT03712787|25826675|FG003|Overall Study|COVID-19 Infection|0|||
13092066|NCT03712787|25826672|FG000|Overall Study|Other, Not Specified|79|||
13092067|NCT03712787|25826673|FG001|Overall Study|Other, Not Specified|77|||
13092068|NCT03712787|25826674|FG002|Overall Study|Other, Not Specified|74|||
13092069|NCT03712787|25826675|FG003|Overall Study|Other, Not Specified|78|||
13092070|NCT03712449|25826708|FG000|Overall Study|Withdraw Consent|0|||
13092071|NCT03712449|25826709|FG001|Overall Study|Withdraw Consent|1|||
13092072|NCT03712345|25826748|FG000|Overall Study|Failure to meet randomization criteria|0|||
13092073|NCT03712345|25826749|FG001|Overall Study|Failure to meet randomization criteria|0|||
13092074|NCT03712345|25826750|FG002|Overall Study|Failure to meet randomization criteria|1|||
13092075|NCT03712280|25826777|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0|||
13092076|NCT03712280|25826778|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1|||
13092077|NCT03712280|25826779|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0|||
13092078|NCT03712280|25826780|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1|||
13092079|NCT03712280|25826777|FG000|Overall Study|Withdrawal by Participant or Caregiver|1|||
13092080|NCT03712280|25826778|FG001|Overall Study|Withdrawal by Participant or Caregiver|0|||
13092081|NCT03712280|25826779|FG002|Overall Study|Withdrawal by Participant or Caregiver|0|||
13092082|NCT03712280|25826780|FG003|Overall Study|Withdrawal by Participant or Caregiver|0|||
13092083|NCT03712280|25826777|FG000|Overall Study|Adverse Event|0|||
13092084|NCT03712280|25826778|FG001|Overall Study|Adverse Event|0|||
13092085|NCT03712280|25826779|FG002|Overall Study|Adverse Event|1|||
13092086|NCT03712280|25826780|FG003|Overall Study|Adverse Event|0|||
13092087|NCT03711266|25826789|FG000|Overall Study|Lost to Follow-up|10|||
13092088|NCT03711162|25826905|FG000|Overall Study|Adverse Event|5|||
13092089|NCT03711162|25826906|FG001|Overall Study|Adverse Event|2|||
13092090|NCT03711162|25826907|FG002|Overall Study|Adverse Event|4|||
13092091|NCT03711162|25826905|FG000|Overall Study|Death|11|||
13092092|NCT03711162|25826906|FG001|Overall Study|Death|7|||
13092093|NCT03711162|25826907|FG002|Overall Study|Death|8|||
13092094|NCT03711162|25826905|FG000|Overall Study|Lost to Follow-up|1|||
13092095|NCT03711162|25826906|FG001|Overall Study|Lost to Follow-up|0|||
13092096|NCT03711162|25826907|FG002|Overall Study|Lost to Follow-up|1|||
13092097|NCT03711162|25826905|FG000|Overall Study|Study Terminated by Sponsor|139|||
13092098|NCT03711162|25826906|FG001|Overall Study|Study Terminated by Sponsor|152|||
13092099|NCT03711162|25826907|FG002|Overall Study|Study Terminated by Sponsor|146|||
13092100|NCT03711162|25826905|FG000|Overall Study|Withdrawal by Subject|17|||
13092101|NCT03711162|25826906|FG001|Overall Study|Withdrawal by Subject|10|||
13092102|NCT03711162|25826907|FG002|Overall Study|Withdrawal by Subject|10|||
13092103|NCT03711162|25826905|FG000|Overall Study|Miscellaneous|1|||
13092104|NCT03711162|25826906|FG001|Overall Study|Miscellaneous|2|||
13092105|NCT03711162|25826907|FG002|Overall Study|Miscellaneous|2|||
13092106|NCT03711162|25826905|FG000|Overall Study|Not Treated|1|||
13092107|NCT03711162|25826906|FG001|Overall Study|Not Treated|0|||
13143898|NCT02635204|26024666|FG000|Overall Study|Adverse Event|1|||
13143899|NCT02635204|26024667|FG001|Overall Study|Adverse Event|0|||
13143900|NCT02635204|26024666|FG000|Overall Study|Lost to Follow-up|1|||
13143901|NCT02635204|26024667|FG001|Overall Study|Lost to Follow-up|1|||
13143902|NCT02634983|26024690|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2|||
13204931|NCT01968967|26230511|FG003|Treatment Period|Other|0|||
13092108|NCT03711162|25826907|FG002|Overall Study|Not Treated|1|||
13092109|NCT03711162|25826905|FG000|Overall Study|Physician Decision|0|||
13092110|NCT03711162|25826906|FG001|Overall Study|Physician Decision|2|||
13092111|NCT03711162|25826907|FG002|Overall Study|Physician Decision|0|||
13092112|NCT03711162|25826905|FG000|Overall Study|Lack of Efficacy|0|||
13092113|NCT03711162|25826906|FG001|Overall Study|Lack of Efficacy|0|||
13092114|NCT03711162|25826907|FG002|Overall Study|Lack of Efficacy|2|||
13092115|NCT03711162|25826905|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
13092116|NCT03711162|25826906|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
13092117|NCT03711162|25826907|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
13092118|NCT03710889|25826916|FG000|Overall Study|Adverse Event|2|||
13092119|NCT03710889|25826916|FG000|Overall Study|Protocol Deviation|1|||
13143903|NCT02634983|26024691|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0|||
13143904|NCT02634801|26024797|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2|||
13143905|NCT02634801|26024798|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20|||
13143906|NCT02634801|26024799|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0|||
13143907|NCT02634801|26024797|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
13143908|NCT02634801|26024798|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2|||
13143909|NCT02634801|26024799|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
13143910|NCT02634801|26024797|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2|||
13143911|NCT02634801|26024798|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
13143912|NCT02634801|26024799|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
13143913|NCT02634801|26024797|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
13143914|NCT02634801|26024798|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
13143915|NCT02634801|26024799|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1|||
13143916|NCT02634801|26024797|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0|||
13143917|NCT02634801|26024798|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8|||
13143918|NCT02634801|26024799|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3|||
13143919|NCT02634801|26024797|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
13143920|NCT02634801|26024798|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
13143921|NCT02634801|26024799|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1|||
13143922|NCT02634801|26024797|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1|||
13143923|NCT02634801|26024798|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
13143924|NCT02634801|26024799|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
13143925|NCT02634801|26024797|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
13143926|NCT02634801|26024798|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
13143927|NCT02634801|26024799|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
13143928|NCT02634801|26024797|FG000|Extension Period (Weeks 24 to 36)|Missing|1|||
13143929|NCT02634801|26024798|FG001|Extension Period (Weeks 24 to 36)|Missing|0|||
13143930|NCT02634801|26024799|FG002|Extension Period (Weeks 24 to 36)|Missing|0|||
13143931|NCT02634801|26024797|FG000|Follow-up Period|Lost to Follow-up|3|||
13143932|NCT02634801|26024798|FG001|Follow-up Period|Lost to Follow-up|1|||
13143933|NCT02634801|26024799|FG002|Follow-up Period|Lost to Follow-up|2|||
13143934|NCT02634801|26024797|FG000|Follow-up Period|Physician Decision|0|||
13143935|NCT02634801|26024798|FG001|Follow-up Period|Physician Decision|0|||
13143936|NCT02634801|26024799|FG002|Follow-up Period|Physician Decision|1|||
13143937|NCT02634801|26024797|FG000|Follow-up Period|Withdrawal by Subject|1|||
13143938|NCT02634801|26024798|FG001|Follow-up Period|Withdrawal by Subject|2|||
13143939|NCT02634801|26024799|FG002|Follow-up Period|Withdrawal by Subject|5|||
13143940|NCT02634801|26024797|FG000|Follow-up Period|Adverse Event|1|||
13143941|NCT02634801|26024798|FG001|Follow-up Period|Adverse Event|5|||
13143942|NCT02634801|26024799|FG002|Follow-up Period|Adverse Event|0|||
13143943|NCT02634788|26024878|FG000|Overall Study|Adverse Event|0|||
13143944|NCT02634788|26024879|FG001|Overall Study|Adverse Event|8|||
13143945|NCT02634788|26024880|FG002|Overall Study|Adverse Event|3|||
13143946|NCT02634788|26024881|FG003|Overall Study|Adverse Event|1|||
13143947|NCT02634788|26024878|FG000|Overall Study|Lack of Efficacy|4|||
13143948|NCT02634788|26024879|FG001|Overall Study|Lack of Efficacy|0|||
13143949|NCT02634788|26024880|FG002|Overall Study|Lack of Efficacy|1|||
13143950|NCT02634788|26024881|FG003|Overall Study|Lack of Efficacy|4|||
13143951|NCT02634788|26024878|FG000|Overall Study|Lost to Follow-up|0|||
13143952|NCT02634788|26024879|FG001|Overall Study|Lost to Follow-up|1|||
13143953|NCT02634788|26024880|FG002|Overall Study|Lost to Follow-up|0|||
13143954|NCT02634788|26024881|FG003|Overall Study|Lost to Follow-up|0|||
13143955|NCT02634788|26024878|FG000|Overall Study|Withdrawal by Subject|0|||
13143956|NCT02634788|26024879|FG001|Overall Study|Withdrawal by Subject|1|||
13143957|NCT02634788|26024880|FG002|Overall Study|Withdrawal by Subject|1|||
13143958|NCT02634788|26024881|FG003|Overall Study|Withdrawal by Subject|0|||
13143959|NCT02634606|26024891|FG000|Overall Study|unable to obtain the drug at start|13|||
13143960|NCT02634580|26024959|FG000|Double-blind Treatment Period|Subject Request|1|||
13143961|NCT02634580|26024960|FG001|Double-blind Treatment Period|Subject Request|0|||
13143962|NCT02634580|26024961|FG002|Double-blind Treatment Period|Subject Request|1|||
13143963|NCT02634580|26024962|FG003|Double-blind Treatment Period|Subject Request|1|||
13143964|NCT02634580|26024959|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
13143965|NCT02634580|26024960|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
13143966|NCT02634580|26024961|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
13143967|NCT02634580|26024962|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
13143968|NCT02634346|26024986|FG000|Overall Study|Withdrawal by Subject|8|||
13143969|NCT02634346|26024987|FG001|Overall Study|Withdrawal by Subject|9|||
13143970|NCT02634346|26024988|FG002|Overall Study|Withdrawal by Subject|8|||
13143971|NCT02634346|26024986|FG000|Overall Study|Adverse Event|2|||
13143972|NCT02634346|26024987|FG001|Overall Study|Adverse Event|2|||
13143973|NCT02634346|26024988|FG002|Overall Study|Adverse Event|7|||
13143974|NCT02634346|26024986|FG000|Overall Study|Lack of Efficacy|1|||
13143975|NCT02634346|26024987|FG001|Overall Study|Lack of Efficacy|2|||
13143976|NCT02634346|26024988|FG002|Overall Study|Lack of Efficacy|8|||
13143977|NCT02634346|26024986|FG000|Overall Study|Lost to Follow-up|1|||
13143978|NCT02634346|26024987|FG001|Overall Study|Lost to Follow-up|0|||
13143979|NCT02634346|26024988|FG002|Overall Study|Lost to Follow-up|0|||
13143980|NCT02634346|26024986|FG000|Overall Study|Protocol Violation|0|||
13143981|NCT02634346|26024987|FG001|Overall Study|Protocol Violation|1|||
13143982|NCT02634346|26024988|FG002|Overall Study|Protocol Violation|0|||
13143983|NCT02634333|26025004|FG000|Overall Study|Completed out of Window|3|||
13143984|NCT02634333|26025005|FG001|Overall Study|Completed out of Window|2|||
13143985|NCT02634333|26025004|FG000|Overall Study|Missed Visit|5|||
13143986|NCT02634333|26025005|FG001|Overall Study|Missed Visit|2|||
13143987|NCT02634333|26025004|FG000|Overall Study|Lost to Follow-up|12|||
13143988|NCT02634333|26025005|FG001|Overall Study|Lost to Follow-up|7|||
13143989|NCT02634333|26025004|FG000|Overall Study|Withdrawal by Subject|9|||
13143990|NCT02634333|26025005|FG001|Overall Study|Withdrawal by Subject|13|||
13143991|NCT02634333|26025004|FG000|Overall Study|Death|11|||
13143992|NCT02634333|26025005|FG001|Overall Study|Death|8|||
13143993|NCT02634320|26025016|FG000|Overall Study|Adverse Event|2|||
13143994|NCT02634320|26025016|FG000|Overall Study|Lost to Follow-up|3|||
13143995|NCT02634320|26025016|FG000|Overall Study|Moved out of area|2|||
13143996|NCT02634320|26025016|FG000|Overall Study|Out of window for study visits|1|||
13143997|NCT02634320|26025016|FG000|Overall Study|Protocol Violation|1|||
13143998|NCT02634320|26025016|FG000|Overall Study|Withdrawal by Subject|5|||
13143999|NCT02634320|26025016|FG000|Overall Study|Lack of Efficacy|2|||
13144000|NCT02634307|26025073|FG000|Overall Study|Adverse Event|50|||
13144001|NCT02634307|26025074|FG001|Overall Study|Adverse Event|24|||
13144002|NCT02634307|26025075|FG002|Overall Study|Adverse Event|14|||
13144003|NCT02634307|26025073|FG000|Overall Study|Lost to Follow-up|21|||
13144004|NCT02634307|26025074|FG001|Overall Study|Lost to Follow-up|5|||
13144005|NCT02634307|26025075|FG002|Overall Study|Lost to Follow-up|6|||
13144006|NCT02634307|26025073|FG000|Overall Study|Pregnancy|5|||
13144007|NCT02634307|26025074|FG001|Overall Study|Pregnancy|1|||
13144008|NCT02634307|26025075|FG002|Overall Study|Pregnancy|3|||
13144009|NCT02634307|26025073|FG000|Overall Study|Withdrawal by Subject|38|||
13144010|NCT02634307|26025074|FG001|Overall Study|Withdrawal by Subject|24|||
13144011|NCT02634307|26025075|FG002|Overall Study|Withdrawal by Subject|18|||
13144012|NCT02634307|26025073|FG000|Overall Study|Non-Compliance with Study Drug|0|||
13144013|NCT02634307|26025074|FG001|Overall Study|Non-Compliance with Study Drug|2|||
13144014|NCT02634307|26025075|FG002|Overall Study|Non-Compliance with Study Drug|2|||
13144015|NCT02634307|26025073|FG000|Overall Study|Lack of Efficacy|1|||
13144016|NCT02634307|26025074|FG001|Overall Study|Lack of Efficacy|5|||
13144017|NCT02634307|26025075|FG002|Overall Study|Lack of Efficacy|3|||
13144018|NCT02634307|26025073|FG000|Overall Study|Physician Decision|7|||
13144019|NCT02634307|26025074|FG001|Overall Study|Physician Decision|5|||
13144020|NCT02634307|26025075|FG002|Overall Study|Physician Decision|5|||
13144021|NCT02634307|26025073|FG000|Overall Study|Reason not Specified|3|||
13144022|NCT02634307|26025074|FG001|Overall Study|Reason not Specified|5|||
13144023|NCT02634307|26025075|FG002|Overall Study|Reason not Specified|10|||
13144024|NCT02634151|26025168|FG000|Overall Study|Withdrawal by Subject|1|||
13144025|NCT02634151|26025169|FG001|Overall Study|Withdrawal by Subject|0|||
13144026|NCT02634151|26025168|FG000|Overall Study|Non-Compliance|0|||
13144027|NCT02634151|26025169|FG001|Overall Study|Non-Compliance|1|||
13144028|NCT02634151|26025168|FG000|Overall Study|Other|0|||
13144029|NCT02634151|26025169|FG001|Overall Study|Other|1|||
13144030|NCT02633800|26025186|FG000|Overall Study|Death|3|||
13144031|NCT02633800|26025187|FG001|Overall Study|Death|3|||
13144032|NCT02633800|26025186|FG000|Overall Study|Reason not provided|1|||
13144033|NCT02633800|26025187|FG001|Overall Study|Reason not provided|0|||
13144034|NCT02633800|26025186|FG000|Overall Study|Radiologic(al) progression|23|||
13144035|NCT02633800|26025187|FG001|Overall Study|Radiologic(al) progression|23|||
13144036|NCT02633800|26025186|FG000|Overall Study|Clinical progression|3|||
13144037|NCT02633800|26025187|FG001|Overall Study|Clinical progression|6|||
13144038|NCT02633800|26025186|FG000|Overall Study|Study terminated by sponsor|6|||
13144039|NCT02633800|26025187|FG001|Overall Study|Study terminated by sponsor|5|||
13144040|NCT02633800|26025186|FG000|Overall Study|Adverse event, non-fatal|7|||
13144041|NCT02633800|26025187|FG001|Overall Study|Adverse event, non-fatal|2|||
13144042|NCT02633800|26025186|FG000|Overall Study|Withdrawal by Subject|0|||
13144043|NCT02633800|26025187|FG001|Overall Study|Withdrawal by Subject|3|||
13144044|NCT02633800|26025186|FG000|Overall Study|Patient Request|1|||
13144045|NCT02633800|26025187|FG001|Overall Study|Patient Request|1|||
13144046|NCT02633787|26025195|FG000|Overall Study|Withdrawal by Subject|1|||
13144047|NCT02633527|26025233|FG000|Overall Study|Failed to meet eligibility|0|||
13144048|NCT02633527|26025234|FG001|Overall Study|Failed to meet eligibility|1|||
13144049|NCT02633527|26025235|FG002|Overall Study|Failed to meet eligibility|1|||
13144050|NCT02633527|26025236|FG003|Overall Study|Failed to meet eligibility|0|||
13144051|NCT02633527|26025237|FG004|Overall Study|Failed to meet eligibility|1|||
13144052|NCT02633527|26025233|FG000|Overall Study|Adverse Event|0|||
13144053|NCT02633527|26025234|FG001|Overall Study|Adverse Event|4|||
13144054|NCT02633527|26025235|FG002|Overall Study|Adverse Event|3|||
13144055|NCT02633527|26025236|FG003|Overall Study|Adverse Event|1|||
13144056|NCT02633527|26025237|FG004|Overall Study|Adverse Event|5|||
13144057|NCT02633527|26025233|FG000|Overall Study|Lost to Follow-up|1|||
13144058|NCT02633527|26025234|FG001|Overall Study|Lost to Follow-up|2|||
13144059|NCT02633527|26025235|FG002|Overall Study|Lost to Follow-up|5|||
13144060|NCT02633527|26025236|FG003|Overall Study|Lost to Follow-up|5|||
13144061|NCT02633527|26025237|FG004|Overall Study|Lost to Follow-up|4|||
13144062|NCT02633527|26025233|FG000|Overall Study|Withdrawal by Subject|0|||
13144063|NCT02633527|26025234|FG001|Overall Study|Withdrawal by Subject|3|||
13144064|NCT02633527|26025235|FG002|Overall Study|Withdrawal by Subject|5|||
13144065|NCT02633527|26025236|FG003|Overall Study|Withdrawal by Subject|4|||
13144066|NCT02633527|26025237|FG004|Overall Study|Withdrawal by Subject|4|||
13144067|NCT02633527|26025233|FG000|Overall Study|Protocol Violation|0|||
13144068|NCT02633527|26025234|FG001|Overall Study|Protocol Violation|1|||
13144069|NCT02633527|26025235|FG002|Overall Study|Protocol Violation|1|||
13144070|NCT02633527|26025236|FG003|Overall Study|Protocol Violation|1|||
13144071|NCT02633527|26025237|FG004|Overall Study|Protocol Violation|1|||
13144072|NCT02633527|26025233|FG000|Overall Study|Physician Decision|0|||
13144073|NCT02633527|26025234|FG001|Overall Study|Physician Decision|0|||
13144074|NCT02633527|26025235|FG002|Overall Study|Physician Decision|0|||
13144075|NCT02633527|26025236|FG003|Overall Study|Physician Decision|0|||
13144076|NCT02633527|26025237|FG004|Overall Study|Physician Decision|1|||
13144077|NCT02633527|26025233|FG000|Overall Study|Administrative reason|1|||
13144078|NCT02633527|26025234|FG001|Overall Study|Administrative reason|0|||
13144079|NCT02633527|26025235|FG002|Overall Study|Administrative reason|0|||
13144080|NCT02633527|26025236|FG003|Overall Study|Administrative reason|1|||
13144081|NCT02633527|26025237|FG004|Overall Study|Administrative reason|0|||
13144082|NCT02633527|26025233|FG000|Overall Study|Multiple reasons|1|||
13144083|NCT02633527|26025234|FG001|Overall Study|Multiple reasons|0|||
13144084|NCT02633527|26025235|FG002|Overall Study|Multiple reasons|2|||
13144085|NCT02633527|26025236|FG003|Overall Study|Multiple reasons|2|||
13144086|NCT02633527|26025237|FG004|Overall Study|Multiple reasons|1|||
13144087|NCT02633501|26025275|FG000|Overall Study|Adverse Event|0|||
13144088|NCT02633501|26025276|FG001|Overall Study|Adverse Event|0|||
13144089|NCT02633501|26025277|FG002|Overall Study|Adverse Event|1|||
13144090|NCT02633501|26025278|FG003|Overall Study|Adverse Event|0|||
13144091|NCT02633501|26025279|FG004|Overall Study|Adverse Event|1|||
13092134|NCT03710161|25826980|FG000|Overall Study|Study halted due to COVID pandemic|3|||
13092135|NCT03710161|25826981|FG001|Overall Study|Study halted due to COVID pandemic|2|||
13092136|NCT03710083|25826990|FG000|Overall Study|Withdrawal by Subject|2|||
13092137|NCT03710083|25826990|FG000|Overall Study|Unsuccessful Procedure|1|||
13092138|NCT03709823|25827029|FG000|Overall Study|Adverse Event|0|||
13092139|NCT03709823|25827030|FG001|Overall Study|Adverse Event|0|||
13092140|NCT03709823|25827031|FG002|Overall Study|Adverse Event|1|||
13092141|NCT03709823|25827032|FG003|Overall Study|Adverse Event|0|||
13092142|NCT03709823|25827033|FG004|Overall Study|Adverse Event|0|||
13092143|NCT03709823|25827034|FG005|Overall Study|Adverse Event|0|||
13092144|NCT03709823|25827029|FG000|Overall Study|Lost to Follow-up|2|||
13092145|NCT03709823|25827030|FG001|Overall Study|Lost to Follow-up|2|||
13144092|NCT02633501|26025280|FG005|Overall Study|Adverse Event|1|||
13144093|NCT02633501|26025275|FG000|Overall Study|Withdrawal by Subject|2|||
13144094|NCT02633501|26025276|FG001|Overall Study|Withdrawal by Subject|1|||
13144095|NCT02633501|26025277|FG002|Overall Study|Withdrawal by Subject|2|||
13092146|NCT03709823|25827031|FG002|Overall Study|Lost to Follow-up|2|||
13092147|NCT03709823|25827032|FG003|Overall Study|Lost to Follow-up|1|||
13092148|NCT03709823|25827033|FG004|Overall Study|Lost to Follow-up|1|||
13092149|NCT03709823|25827034|FG005|Overall Study|Lost to Follow-up|0|||
13144096|NCT02633501|26025278|FG003|Overall Study|Withdrawal by Subject|2|||
13144097|NCT02633501|26025279|FG004|Overall Study|Withdrawal by Subject|1|||
13144098|NCT02633501|26025280|FG005|Overall Study|Withdrawal by Subject|3|||
13144099|NCT02633501|26025275|FG000|Overall Study|Various other reasons|0|||
13144100|NCT02633501|26025276|FG001|Overall Study|Various other reasons|2|||
13144101|NCT02633501|26025277|FG002|Overall Study|Various other reasons|4|||
13144102|NCT02633501|26025278|FG003|Overall Study|Various other reasons|1|||
13144103|NCT02633501|26025279|FG004|Overall Study|Various other reasons|7|||
13144104|NCT02633501|26025280|FG005|Overall Study|Various other reasons|11|||
13092150|NCT03709823|25827029|FG000|Overall Study|Withdrawal by Subject|1|||
13092151|NCT03709823|25827030|FG001|Overall Study|Withdrawal by Subject|3|||
13092152|NCT03709823|25827031|FG002|Overall Study|Withdrawal by Subject|0|||
13144105|NCT02633501|26025275|FG000|Overall Study|Lost to Follow-up|0|||
13144106|NCT02633501|26025276|FG001|Overall Study|Lost to Follow-up|0|||
13144107|NCT02633501|26025277|FG002|Overall Study|Lost to Follow-up|0|||
13144108|NCT02633501|26025278|FG003|Overall Study|Lost to Follow-up|1|||
13144109|NCT02633501|26025279|FG004|Overall Study|Lost to Follow-up|2|||
13144110|NCT02633501|26025280|FG005|Overall Study|Lost to Follow-up|0|||
13144111|NCT02633306|26025292|FG000|Overall Study|Withdrawal by Subject|3|||
13144112|NCT02633215|26025309|FG000|Overall Study|Lost to Follow-up|2|||
13144113|NCT02633215|26025310|FG001|Overall Study|Lost to Follow-up|3|||
13144114|NCT02633046|26025316|FG000|Overall Study|Adverse Event|8|||
13144115|NCT02633046|26025316|FG000|Overall Study|Physician Decision|7|||
13144116|NCT02633046|26025316|FG000|Overall Study|Withdrawal by Subject|8|||
13144117|NCT02633046|26025316|FG000|Overall Study|Increased proteinuria|2|||
13144118|NCT02633046|26025316|FG000|Overall Study|Participant decided not to continue with open label extension|1|||
13144119|NCT02633046|26025316|FG000|Overall Study|Mutual decision patient and physician|1|||
13144120|NCT02633020|26025345|FG000|Overall Study|Adverse Event|1|||
13144121|NCT02633020|26025346|FG001|Overall Study|Adverse Event|0|||
13144122|NCT02632838|26025367|FG000|Overall Study|Withdrawal by Subject|3|||
13144123|NCT02632838|26025368|FG001|Overall Study|Withdrawal by Subject|0|||
13144124|NCT02632838|26025367|FG000|Overall Study|Lost to Follow-up|0|||
13144125|NCT02632838|26025368|FG001|Overall Study|Lost to Follow-up|2|||
13144126|NCT02632786|26025393|FG000|Overall Study|Adverse Event|2|||
13144127|NCT02632786|26025394|FG001|Overall Study|Adverse Event|1|||
13144128|NCT02632786|26025393|FG000|Overall Study|Death|3|||
13144129|NCT02632786|26025394|FG001|Overall Study|Death|2|||
13144130|NCT02632786|26025393|FG000|Overall Study|Physician Decision|5|||
13144131|NCT02632786|26025394|FG001|Overall Study|Physician Decision|4|||
13144132|NCT02632786|26025393|FG000|Overall Study|Withdrawal by Subject|1|||
13144133|NCT02632786|26025394|FG001|Overall Study|Withdrawal by Subject|0|||
13144134|NCT02632747|26025409|FG000|Wash-out Period|Adverse Event|1|||
13144135|NCT02632747|26025410|FG001|Wash-out Period|Adverse Event|0|||
13144136|NCT02632552|26025439|FG000|Overall Study|Lost to Follow-up|14|||
13144137|NCT02632552|26025440|FG001|Overall Study|Lost to Follow-up|8|||
13144138|NCT02632552|26025439|FG000|Overall Study|Withdrawal by Subject|2|||
13144139|NCT02632552|26025440|FG001|Overall Study|Withdrawal by Subject|0|||
13144140|NCT02632552|26025439|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7|||
13144141|NCT02632552|26025440|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2|||
13144142|NCT02632110|26025928|FG000|Overall Study|Withdrawal by Subject|1|||
13144143|NCT02632110|26025929|FG001|Overall Study|Withdrawal by Subject|1|||
13144144|NCT02632110|26025930|FG002|Overall Study|Withdrawal by Subject|0|||
13144145|NCT02632110|26025931|FG003|Overall Study|Withdrawal by Subject|0|||
13144146|NCT02632110|26025932|FG004|Overall Study|Withdrawal by Subject|1|||
13144147|NCT02632110|26025933|FG005|Overall Study|Withdrawal by Subject|1|||
13144148|NCT02632110|26025934|FG006|Overall Study|Withdrawal by Subject|3|||
13144149|NCT02632110|26025935|FG007|Overall Study|Withdrawal by Subject|3|||
13144150|NCT02632110|26025936|FG008|Overall Study|Withdrawal by Subject|1|||
13144151|NCT02632110|26025937|FG009|Overall Study|Withdrawal by Subject|1|||
13144152|NCT02631876|26025968|FG000|Overall Study|Death|96|||
13144153|NCT02631876|26025969|FG001|Overall Study|Death|50|||
13144154|NCT02631876|26025968|FG000|Overall Study|Investigator's discretion|1|||
13144155|NCT02631876|26025969|FG001|Overall Study|Investigator's discretion|0|||
13144156|NCT02631876|26025968|FG000|Overall Study|Lost to Follow-up|2|||
13144157|NCT02631876|26025969|FG001|Overall Study|Lost to Follow-up|0|||
13144158|NCT02631876|26025968|FG000|Overall Study|Withdrawal by Subject|16|||
13092153|NCT03709823|25827032|FG003|Overall Study|Withdrawal by Subject|0|||
13144159|NCT02631876|26025969|FG001|Overall Study|Withdrawal by Subject|9|||
13144160|NCT02631876|26025968|FG000|Overall Study|Other than specified|4|||
13144161|NCT02631876|26025969|FG001|Overall Study|Other than specified|4|||
13144162|NCT02631850|26026020|FG000|Treatment Period|Lost to Follow-up|0|||
13144163|NCT02631850|26026021|FG001|Treatment Period|Lost to Follow-up|1|||
13144164|NCT02631850|26026022|FG002|Treatment Period|Lost to Follow-up|0|||
13144165|NCT02631850|26026023|FG003|Treatment Period|Lost to Follow-up|0|||
13144166|NCT02631850|26026020|FG000|Treatment Period|Protocol Violation|1|||
13144167|NCT02631850|26026021|FG001|Treatment Period|Protocol Violation|0|||
13144168|NCT02631850|26026022|FG002|Treatment Period|Protocol Violation|0|||
13144169|NCT02631850|26026023|FG003|Treatment Period|Protocol Violation|0|||
13144170|NCT02631850|26026020|FG000|Treatment Period|Withdrawal by Subject|0|||
13144171|NCT02631850|26026021|FG001|Treatment Period|Withdrawal by Subject|5|||
13144172|NCT02631850|26026022|FG002|Treatment Period|Withdrawal by Subject|2|||
13144173|NCT02631850|26026023|FG003|Treatment Period|Withdrawal by Subject|2|||
13144174|NCT02631850|26026020|FG000|Treatment Period|Adverse Event|1|||
13144175|NCT02631850|26026021|FG001|Treatment Period|Adverse Event|0|||
13144176|NCT02631850|26026022|FG002|Treatment Period|Adverse Event|2|||
13144177|NCT02631850|26026023|FG003|Treatment Period|Adverse Event|3|||
13144178|NCT02631850|26026020|FG000|Treatment Period|Family medical issue|1|||
13144179|NCT02631850|26026021|FG001|Treatment Period|Family medical issue|0|||
13144180|NCT02631850|26026022|FG002|Treatment Period|Family medical issue|0|||
13144181|NCT02631850|26026023|FG003|Treatment Period|Family medical issue|0|||
13144182|NCT02631850|26026020|FG000|6 Month Follow up|Lost to Follow-up|5|||
13144183|NCT02631850|26026021|FG001|6 Month Follow up|Lost to Follow-up|8|||
13144184|NCT02631850|26026022|FG002|6 Month Follow up|Lost to Follow-up|3|||
13144185|NCT02631850|26026023|FG003|6 Month Follow up|Lost to Follow-up|5|||
13144186|NCT02631850|26026020|FG000|6 Month Follow up|Withdrawal by Subject|1|||
13144187|NCT02631850|26026021|FG001|6 Month Follow up|Withdrawal by Subject|0|||
13144188|NCT02631850|26026022|FG002|6 Month Follow up|Withdrawal by Subject|0|||
13144189|NCT02631850|26026023|FG003|6 Month Follow up|Withdrawal by Subject|2|||
13144190|NCT02631850|26026020|FG000|6 Month Follow up|Adverse Event|1|||
13144191|NCT02631850|26026021|FG001|6 Month Follow up|Adverse Event|4|||
13144192|NCT02631850|26026022|FG002|6 Month Follow up|Adverse Event|1|||
13144193|NCT02631850|26026023|FG003|6 Month Follow up|Adverse Event|3|||
13144194|NCT02631850|26026020|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0|||
13144195|NCT02631850|26026021|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
13144196|NCT02631850|26026022|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2|||
13144197|NCT02631850|26026023|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
13144198|NCT02631746|26026036|FG000|Overall Study|Lack of Efficacy|3|||
13144199|NCT02631577|26026073|FG000|Overall Study|Death|1|||
13144200|NCT02631577|26026074|FG001|Overall Study|Death|7|||
13144201|NCT02631577|26026073|FG000|Overall Study|Withdrawal by Subject|0|||
13144202|NCT02631577|26026074|FG001|Overall Study|Withdrawal by Subject|3|||
13144203|NCT02631551|26026097|FG000|Overall Study|Adverse Event|1|||
13144204|NCT02631551|26026098|FG001|Overall Study|Adverse Event|2|||
13144205|NCT02631551|26026099|FG002|Overall Study|Adverse Event|4|||
13144206|NCT02631551|26026100|FG003|Overall Study|Adverse Event|0|||
13144207|NCT02631551|26026097|FG000|Overall Study|Lack of Efficacy|0|||
13144208|NCT02631551|26026098|FG001|Overall Study|Lack of Efficacy|0|||
13144209|NCT02631551|26026099|FG002|Overall Study|Lack of Efficacy|1|||
13144210|NCT02631551|26026100|FG003|Overall Study|Lack of Efficacy|0|||
13144211|NCT02631551|26026097|FG000|Overall Study|Lost to Follow-up|1|||
13144212|NCT02631551|26026098|FG001|Overall Study|Lost to Follow-up|2|||
13144213|NCT02631551|26026099|FG002|Overall Study|Lost to Follow-up|0|||
13144214|NCT02631551|26026100|FG003|Overall Study|Lost to Follow-up|3|||
13144215|NCT02631551|26026097|FG000|Overall Study|Withdrawal by Subject|2|||
13144216|NCT02631551|26026098|FG001|Overall Study|Withdrawal by Subject|2|||
13144217|NCT02631551|26026099|FG002|Overall Study|Withdrawal by Subject|0|||
13144218|NCT02631551|26026100|FG003|Overall Study|Withdrawal by Subject|5|||
13144219|NCT02631551|26026097|FG000|Overall Study|Protocol deviation|3|||
13144220|NCT02631551|26026098|FG001|Overall Study|Protocol deviation|6|||
13144221|NCT02631551|26026099|FG002|Overall Study|Protocol deviation|3|||
13144222|NCT02631551|26026100|FG003|Overall Study|Protocol deviation|0|||
13144223|NCT02631551|26026097|FG000|Overall Study|Non-compliance with study procedures|0|||
13144224|NCT02631551|26026098|FG001|Overall Study|Non-compliance with study procedures|0|||
13144225|NCT02631551|26026099|FG002|Overall Study|Non-compliance with study procedures|1|||
13144226|NCT02631551|26026100|FG003|Overall Study|Non-compliance with study procedures|1|||
13144227|NCT02631551|26026097|FG000|Overall Study|Non-compliance with study drug|1|||
13144228|NCT02631551|26026098|FG001|Overall Study|Non-compliance with study drug|0|||
13144229|NCT02631551|26026099|FG002|Overall Study|Non-compliance with study drug|0|||
13144230|NCT02631551|26026100|FG003|Overall Study|Non-compliance with study drug|0|||
13144231|NCT02631551|26026097|FG000|Overall Study|Other, specific reasons not collected|5|||
13144232|NCT02631551|26026098|FG001|Overall Study|Other, specific reasons not collected|7|||
13144233|NCT02631551|26026099|FG002|Overall Study|Other, specific reasons not collected|2|||
13144234|NCT02631551|26026100|FG003|Overall Study|Other, specific reasons not collected|2|||
13144235|NCT02631538|26026143|FG000|Treatment Period (Up to Week 52)|Adverse Event|1|||
13144236|NCT02631538|26026144|FG001|Treatment Period (Up to Week 52)|Adverse Event|5|||
13144237|NCT02631538|26026145|FG002|Treatment Period (Up to Week 52)|Adverse Event|2|||
13144238|NCT02631538|26026146|FG003|Treatment Period (Up to Week 52)|Adverse Event|2|||
13144239|NCT02631538|26026143|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
13144240|NCT02631538|26026144|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
13144241|NCT02631538|26026145|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2|||
13144242|NCT02631538|26026146|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5|||
13144243|NCT02631538|26026143|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
13144244|NCT02631538|26026144|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
13144245|NCT02631538|26026145|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
13144246|NCT02631538|26026146|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
13144247|NCT02631538|26026143|FG000|Treatment Period (Up to Week 52)|Physician Decision|1|||
13144248|NCT02631538|26026144|FG001|Treatment Period (Up to Week 52)|Physician Decision|0|||
13144249|NCT02631538|26026145|FG002|Treatment Period (Up to Week 52)|Physician Decision|0|||
13144250|NCT02631538|26026146|FG003|Treatment Period (Up to Week 52)|Physician Decision|1|||
13144251|NCT02631538|26026143|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
13144252|NCT02631538|26026144|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
13144253|NCT02631538|26026145|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1|||
13144254|NCT02631538|26026146|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
13144255|NCT02631538|26026143|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
13144256|NCT02631538|26026144|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
13144257|NCT02631538|26026145|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
13144258|NCT02631538|26026146|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
13144259|NCT02631148|26026165|FG000|Overall Study|8 were ineligible|8|||
13144260|NCT02631148|26026166|FG001|Overall Study|8 were ineligible|0|||
13144261|NCT02631148|26026165|FG000|Overall Study|Withdrawal by Subject|1|||
13144262|NCT02631148|26026166|FG001|Overall Study|Withdrawal by Subject|0|||
13144263|NCT02631148|26026165|FG000|Overall Study|PAH not available to study participant|1|||
13144264|NCT02631148|26026166|FG001|Overall Study|PAH not available to study participant|0|||
13144265|NCT02630966|26026189|FG000|Overall Study|Adverse Event|1|||
13144266|NCT02630966|26026190|FG001|Overall Study|Adverse Event|3|||
13144267|NCT02630966|26026189|FG000|Overall Study|Significant Protocol Deviation|0|||
13144268|NCT02630966|26026190|FG001|Overall Study|Significant Protocol Deviation|2|||
13144269|NCT02630966|26026189|FG000|Overall Study|Voluntary Withdrawal|1|||
13144270|NCT02630966|26026190|FG001|Overall Study|Voluntary Withdrawal|1|||
13144271|NCT02630966|26026189|FG000|Overall Study|Lack of Efficacy|0|||
13144272|NCT02630966|26026190|FG001|Overall Study|Lack of Efficacy|2|||
13144273|NCT02630706|26026307|FG000|Overall Study|Adverse Event|2|||
13144274|NCT02630706|26026308|FG001|Overall Study|Adverse Event|1|||
13144275|NCT02630706|26026309|FG002|Overall Study|Adverse Event|1|||
13144276|NCT02630706|26026307|FG000|Overall Study|Lost to Follow-up|0|||
13144277|NCT02630706|26026308|FG001|Overall Study|Lost to Follow-up|1|||
13144278|NCT02630706|26026309|FG002|Overall Study|Lost to Follow-up|2|||
13144279|NCT02630706|26026307|FG000|Overall Study|Physician Decision|1|||
13144280|NCT02630706|26026308|FG001|Overall Study|Physician Decision|1|||
13144281|NCT02630706|26026309|FG002|Overall Study|Physician Decision|0|||
13144282|NCT02630706|26026307|FG000|Overall Study|Pregnancy|0|||
13144283|NCT02630706|26026308|FG001|Overall Study|Pregnancy|1|||
13144284|NCT02630706|26026309|FG002|Overall Study|Pregnancy|0|||
13144285|NCT02630706|26026307|FG000|Overall Study|Withdrawal by Subject|4|||
13144286|NCT02630706|26026308|FG001|Overall Study|Withdrawal by Subject|5|||
13144287|NCT02630706|26026309|FG002|Overall Study|Withdrawal by Subject|7|||
13144288|NCT02630693|26026328|FG000|Overall Study|No receive treatment|0|||
13144289|NCT02630693|26026329|FG001|Overall Study|No receive treatment|1|||
13144290|NCT02630563|26026340|FG000|Overall Study|Administrative|1|||
13144291|NCT02630472|26026361|FG000|Overall Study|Physician Decision|10|||
13144292|NCT02630472|26026362|FG001|Overall Study|Physician Decision|0|||
13144293|NCT02630251|26026489|FG000|Overall Study|Physician Decision|0|||
13144294|NCT02630251|26026490|FG001|Overall Study|Physician Decision|0|||
13144295|NCT02630251|26026491|FG002|Overall Study|Physician Decision|1|||
13144296|NCT02630251|26026492|FG003|Overall Study|Physician Decision|0|||
13144297|NCT02630186|26026510|FG000|Overall Study|Withdrawal by Subject|1|||
13144298|NCT02629965|26026549|FG000|Period 1|Adverse Event|1|||
13144299|NCT02629965|26026550|FG001|Period 1|Adverse Event|0|||
13144300|NCT02629965|26026549|FG000|Period 1|Unexpected worsening of disease|2|||
13144301|NCT02629965|26026550|FG001|Period 1|Unexpected worsening of disease|0|||
13144302|NCT02629965|26026549|FG000|Period 1|Other than listed above|1|||
13144303|NCT02629965|26026550|FG001|Period 1|Other than listed above|2|||
13144304|NCT02629965|26026549|FG000|Period 2|Adverse Event|1|||
13144305|NCT02629965|26026550|FG001|Period 2|Adverse Event|0|||
13144306|NCT02629861|26026607|FG000|Overall Study|Adverse Event|7|||
13144307|NCT02629861|26026608|FG001|Overall Study|Adverse Event|5|||
13144308|NCT02629861|26026609|FG002|Overall Study|Adverse Event|4|||
13144309|NCT02629861|26026607|FG000|Overall Study|Withdrawal by Subject|5|||
13144310|NCT02629861|26026608|FG001|Overall Study|Withdrawal by Subject|8|||
13144311|NCT02629861|26026609|FG002|Overall Study|Withdrawal by Subject|13|||
13144312|NCT02629861|26026607|FG000|Overall Study|Protocol Violation|2|||
13144313|NCT02629861|26026608|FG001|Overall Study|Protocol Violation|3|||
13144314|NCT02629861|26026609|FG002|Overall Study|Protocol Violation|7|||
13144315|NCT02629861|26026607|FG000|Overall Study|Lost to Follow-up|12|||
13144316|NCT02629861|26026608|FG001|Overall Study|Lost to Follow-up|9|||
13144317|NCT02629861|26026609|FG002|Overall Study|Lost to Follow-up|4|||
13144318|NCT02629861|26026607|FG000|Overall Study|Other|1|||
13144319|NCT02629861|26026608|FG001|Overall Study|Other|1|||
13144320|NCT02629861|26026609|FG002|Overall Study|Other|0|||
13144321|NCT02629861|26026607|FG000|Overall Study|Pregnancy|2|||
13144322|NCT02629861|26026608|FG001|Overall Study|Pregnancy|1|||
13144323|NCT02629861|26026609|FG002|Overall Study|Pregnancy|0|||
13144324|NCT02629822|26026629|FG000|Base Study|Lost to Follow-up|2|||
13144325|NCT02629822|26026629|FG000|Base Study|Non-Compliance With Study Drug|1|||
13144326|NCT02629822|26026629|FG000|Extension Study|Adverse Event|1|||
13144327|NCT02629822|26026629|FG000|Extension Study|Lost to Follow-up|1|||
13144328|NCT02629159|26026689|FG000|Overall Study|Adverse Event|17|||
13144329|NCT02629159|26026690|FG001|Overall Study|Adverse Event|20|||
13144330|NCT02629159|26026691|FG002|Overall Study|Adverse Event|22|||
13144331|NCT02629159|26026689|FG000|Overall Study|Withdrawal by Subject|22|||
13144332|NCT02629159|26026690|FG001|Overall Study|Withdrawal by Subject|11|||
13144333|NCT02629159|26026691|FG002|Overall Study|Withdrawal by Subject|15|||
13144334|NCT02629159|26026689|FG000|Overall Study|Lost to Follow-up|7|||
13144335|NCT02629159|26026690|FG001|Overall Study|Lost to Follow-up|4|||
13144336|NCT02629159|26026691|FG002|Overall Study|Lost to Follow-up|5|||
13144337|NCT02629159|26026689|FG000|Overall Study|Lack of Efficacy|4|||
13144338|NCT02629159|26026690|FG001|Overall Study|Lack of Efficacy|0|||
13144339|NCT02629159|26026691|FG002|Overall Study|Lack of Efficacy|1|||
13144340|NCT02629159|26026689|FG000|Overall Study|Other|6|||
13144341|NCT02629159|26026690|FG001|Overall Study|Other|4|||
13144342|NCT02629159|26026691|FG002|Overall Study|Other|8|||
13144343|NCT02629133|26026712|FG000|Overall Study|Lost to Follow-up|3|||
13144344|NCT02629133|26026713|FG001|Overall Study|Lost to Follow-up|1|||
13144345|NCT02629133|26026712|FG000|Overall Study|Withdrawal by Subject|1|||
13144346|NCT02629133|26026713|FG001|Overall Study|Withdrawal by Subject|1|||
13144347|NCT02628938|26026737|FG000|Overall Study|Did not attend the follow up recall|2|||
13144348|NCT02628938|26026738|FG001|Overall Study|Did not attend the follow up recall|2|||
13144349|NCT02628938|26026739|FG002|Overall Study|Did not attend the follow up recall|1|||
13144350|NCT02628938|26026737|FG000|Overall Study|Failure to comply with the instructions|3|||
13144351|NCT02628938|26026738|FG001|Overall Study|Failure to comply with the instructions|0|||
13144352|NCT02628938|26026739|FG002|Overall Study|Failure to comply with the instructions|3|||
13144353|NCT02628873|26026756|FG000|Break (1 Hour)|Withdrawal by Subject|0|||
13144354|NCT02628873|26026757|FG001|Break (1 Hour)|Withdrawal by Subject|1|||
13144355|NCT02628873|26026756|FG000|Second Test (1 Hour)|Physician Decision|1|||
13144356|NCT02628873|26026757|FG001|Second Test (1 Hour)|Physician Decision|0|||
13144357|NCT02628769|26026798|FG000|First Intervention|Adverse Event|1|||
13144358|NCT02628769|26026799|FG001|First Intervention|Adverse Event|0|||
13144359|NCT02628769|26026798|FG000|First Intervention|Withdrawal by Subject|0|||
13144360|NCT02628769|26026799|FG001|First Intervention|Withdrawal by Subject|1|||
13144361|NCT02628769|26026798|FG000|Second Intervention|Adverse Event|2|||
13144362|NCT02628769|26026799|FG001|Second Intervention|Adverse Event|0|||
13144363|NCT02628769|26026798|FG000|Second Intervention|Physician Decision|0|||
13144364|NCT02628769|26026799|FG001|Second Intervention|Physician Decision|1|||
13144365|NCT02628743|26026825|FG000|Overall Study|Other|3|||
13144366|NCT02628743|26026825|FG000|Overall Study|Withdrawal by Subject|50|||
13144367|NCT02628743|26026825|FG000|Overall Study|Study Terminated by Sponsor|76|||
13144368|NCT02628743|26026825|FG000|Overall Study|Physician Decision|2|||
13144369|NCT02628600|26026844|FG000|Overall Study|Death|2|||
13144370|NCT02628600|26026845|FG001|Overall Study|Death|1|||
13144371|NCT02628600|26026844|FG000|Overall Study|Adverse Event|3|||
13144372|NCT02628600|26026845|FG001|Overall Study|Adverse Event|20|||
13144373|NCT02628600|26026844|FG000|Overall Study|Protocol Violation|0|||
13144374|NCT02628600|26026845|FG001|Overall Study|Protocol Violation|1|||
13144375|NCT02628600|26026844|FG000|Overall Study|Lack of Efficacy|2|||
13144376|NCT02628600|26026845|FG001|Overall Study|Lack of Efficacy|0|||
13144377|NCT02628600|26026844|FG000|Overall Study|Withdrawal by Subject|13|||
13144378|NCT02628600|26026845|FG001|Overall Study|Withdrawal by Subject|8|||
13144379|NCT02628600|26026844|FG000|Overall Study|Lost to Follow-up|1|||
13144380|NCT02628600|26026845|FG001|Overall Study|Lost to Follow-up|0|||
13144381|NCT02628600|26026844|FG000|Overall Study|Physician Decision|2|||
13144382|NCT02628600|26026845|FG001|Overall Study|Physician Decision|2|||
13144383|NCT02628600|26026844|FG000|Overall Study|Other not specified|1|||
13144384|NCT02628600|26026845|FG001|Overall Study|Other not specified|0|||
13144385|NCT02628418|26026873|FG000|Overall Study|Lost to Follow-up|1|||
13144386|NCT02628418|26026874|FG001|Overall Study|Lost to Follow-up|2|||
13144387|NCT02628028|26026941|FG000|Dosing Period|Withdrawal by Subject|0|||
13144388|NCT02628028|26026942|FG001|Dosing Period|Withdrawal by Subject|0|||
13144389|NCT02628028|26026943|FG002|Dosing Period|Withdrawal by Subject|1|||
13144390|NCT02628028|26026944|FG003|Dosing Period|Withdrawal by Subject|0|||
13144391|NCT02628028|26026945|FG004|Dosing Period|Withdrawal by Subject|2|||
13144392|NCT02628028|26026946|FG005|Dosing Period|Withdrawal by Subject|4|||
13144393|NCT02628028|26026947|FG006|Dosing Period|Withdrawal by Subject|1|||
13144394|NCT02628028|26026948|FG007|Dosing Period|Withdrawal by Subject|1|||
13144395|NCT02628028|26026941|FG000|Dosing Period|Adverse Event|0|||
13144396|NCT02628028|26026942|FG001|Dosing Period|Adverse Event|0|||
13144397|NCT02628028|26026943|FG002|Dosing Period|Adverse Event|0|||
13144398|NCT02628028|26026944|FG003|Dosing Period|Adverse Event|0|||
13144399|NCT02628028|26026945|FG004|Dosing Period|Adverse Event|2|||
13144400|NCT02628028|26026946|FG005|Dosing Period|Adverse Event|1|||
13144401|NCT02628028|26026947|FG006|Dosing Period|Adverse Event|3|||
13144402|NCT02628028|26026948|FG007|Dosing Period|Adverse Event|2|||
13144403|NCT02628028|26026941|FG000|Dosing Period|Death|0|||
13144404|NCT02628028|26026942|FG001|Dosing Period|Death|0|||
13144405|NCT02628028|26026943|FG002|Dosing Period|Death|0|||
13144406|NCT02628028|26026944|FG003|Dosing Period|Death|0|||
13144407|NCT02628028|26026945|FG004|Dosing Period|Death|0|||
13144408|NCT02628028|26026946|FG005|Dosing Period|Death|0|||
13144409|NCT02628028|26026947|FG006|Dosing Period|Death|0|||
13144410|NCT02628028|26026948|FG007|Dosing Period|Death|1|||
13144411|NCT02628028|26026941|FG000|Dosing Period|Lack of Efficacy|0|||
13144412|NCT02628028|26026942|FG001|Dosing Period|Lack of Efficacy|0|||
13144413|NCT02628028|26026943|FG002|Dosing Period|Lack of Efficacy|0|||
13144414|NCT02628028|26026944|FG003|Dosing Period|Lack of Efficacy|0|||
13144415|NCT02628028|26026945|FG004|Dosing Period|Lack of Efficacy|3|||
13144416|NCT02628028|26026946|FG005|Dosing Period|Lack of Efficacy|0|||
13144417|NCT02628028|26026947|FG006|Dosing Period|Lack of Efficacy|1|||
13144418|NCT02628028|26026948|FG007|Dosing Period|Lack of Efficacy|0|||
13144419|NCT02628028|26026941|FG000|Dosing Period|Study Terminated by Sponsor|0|||
13144420|NCT02628028|26026942|FG001|Dosing Period|Study Terminated by Sponsor|0|||
13144421|NCT02628028|26026943|FG002|Dosing Period|Study Terminated by Sponsor|0|||
13144422|NCT02628028|26026944|FG003|Dosing Period|Study Terminated by Sponsor|0|||
13144423|NCT02628028|26026945|FG004|Dosing Period|Study Terminated by Sponsor|7|||
13144424|NCT02628028|26026946|FG005|Dosing Period|Study Terminated by Sponsor|6|||
13144425|NCT02628028|26026947|FG006|Dosing Period|Study Terminated by Sponsor|7|||
13144426|NCT02628028|26026948|FG007|Dosing Period|Study Terminated by Sponsor|7|||
13092154|NCT03709823|25827033|FG004|Overall Study|Withdrawal by Subject|0|||
13092155|NCT03709823|25827034|FG005|Overall Study|Withdrawal by Subject|0|||
13092156|NCT03709823|25827029|FG000|Overall Study|Other, Not Specified|0|||
13092157|NCT03709823|25827030|FG001|Overall Study|Other, Not Specified|0|||
13092158|NCT03709823|25827031|FG002|Overall Study|Other, Not Specified|0|||
13092159|NCT03709823|25827032|FG003|Overall Study|Other, Not Specified|1|||
13092160|NCT03709823|25827033|FG004|Overall Study|Other, Not Specified|0|||
13092161|NCT03709823|25827034|FG005|Overall Study|Other, Not Specified|0|||
13092162|NCT03709654|25827067|FG000|Overall Study|Lost to Follow-up|1|||
13092163|NCT03709654|25827068|FG001|Overall Study|Lost to Follow-up|1|||
13092164|NCT03709654|25827067|FG000|Overall Study|Withdrawal by Subject|1|||
13092165|NCT03709654|25827068|FG001|Overall Study|Withdrawal by Subject|1|||
13092166|NCT03709654|25827067|FG000|Overall Study|Adverse Event|1|||
13092167|NCT03709654|25827068|FG001|Overall Study|Adverse Event|0|||
13092168|NCT03709576|25827082|FG000|Overall Study|progression prior to enrollment|1|||
13092169|NCT03708744|25827105|FG000|Overall Study|Withdrawal by Subject|0|||
13092170|NCT03708744|25827106|FG001|Overall Study|Withdrawal by Subject|0|||
13092171|NCT03708744|25827107|FG002|Overall Study|Withdrawal by Subject|1|||
13092172|NCT03708744|25827108|FG003|Overall Study|Withdrawal by Subject|0|||
13092173|NCT03708211|25827145|FG000|Overall Study|Progressive Disease|10|||
13092174|NCT03708211|25827146|FG001|Overall Study|Progressive Disease|7|||
13092175|NCT03708211|25827145|FG000|Overall Study|Withdrawal by Subject|0|||
13092176|NCT03708211|25827146|FG001|Overall Study|Withdrawal by Subject|1|||
13092177|NCT03708211|25827145|FG000|Overall Study|Other|2|||
13092178|NCT03708211|25827146|FG001|Overall Study|Other|0|||
13092179|NCT03707912|25827171|FG000|Overall Study|Violation of inclusion criteria|1|||
13092180|NCT03707912|25827172|FG001|Overall Study|Violation of inclusion criteria|0|||
13092181|NCT03707821|25827197|FG000|Overall Study|Protocol Violation|0|||
13092182|NCT03707821|25827198|FG001|Overall Study|Protocol Violation|1|||
13092183|NCT03707821|25827197|FG000|Overall Study|Unsatisfactory Visual Response|1|||
13092184|NCT03707821|25827198|FG001|Overall Study|Unsatisfactory Visual Response|0|||
13092185|NCT03707821|25827197|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
13092186|NCT03707821|25827198|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
13092187|NCT03707587|25827217|FG000|Overall Study|Death|0|||
13092188|NCT03707587|25827218|FG001|Overall Study|Death|1|||
13092189|NCT03707522|25827257|FG000|Overall Study|Lost to Follow-up|24|||
13092190|NCT03707522|25827258|FG001|Overall Study|Lost to Follow-up|27|||
13092191|NCT03707522|25827259|FG002|Overall Study|Lost to Follow-up|41|||
13092192|NCT03707522|25827260|FG003|Overall Study|Lost to Follow-up|36|||
13092193|NCT03706456|25827277|FG000|Overall Study|Lack of Efficacy|1|||
13092194|NCT03706456|25827277|FG000|Overall Study|Ongoing|21|||
13092195|NCT03706040|25827412|FG000|Period A (Week 0 to Week 16)|Adverse Event|3|||
13144427|NCT02628028|26026941|FG000|Dosing Period|Physician Decision|0|||
13144428|NCT02628028|26026942|FG001|Dosing Period|Physician Decision|0|||
13092196|NCT03706040|25827413|FG001|Period A (Week 0 to Week 16)|Adverse Event|2|||
13092197|NCT03706040|25827414|FG002|Period A (Week 0 to Week 16)|Adverse Event|1|||
13092198|NCT03706040|25827415|FG003|Period A (Week 0 to Week 16)|Adverse Event|0|||
13092199|NCT03706040|25827416|FG004|Period A (Week 0 to Week 16)|Adverse Event|0|||
13092200|NCT03706040|25827417|FG005|Period A (Week 0 to Week 16)|Adverse Event|0|||
13092201|NCT03706040|25827418|FG006|Period A (Week 0 to Week 16)|Adverse Event|0|||
13092202|NCT03706040|25827412|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3|||
13092203|NCT03706040|25827413|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5|||
13092204|NCT03706040|25827414|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4|||
13092205|NCT03706040|25827415|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
13144429|NCT02628028|26026943|FG002|Dosing Period|Physician Decision|0|||
13144430|NCT02628028|26026944|FG003|Dosing Period|Physician Decision|0|||
13144431|NCT02628028|26026945|FG004|Dosing Period|Physician Decision|0|||
13144432|NCT02628028|26026946|FG005|Dosing Period|Physician Decision|1|||
13144433|NCT02628028|26026947|FG006|Dosing Period|Physician Decision|0|||
13144434|NCT02628028|26026948|FG007|Dosing Period|Physician Decision|0|||
13144435|NCT02628028|26026941|FG000|Dosing Period|Site Terminated by Sponsor|0|||
13144436|NCT02628028|26026942|FG001|Dosing Period|Site Terminated by Sponsor|0|||
13144437|NCT02628028|26026943|FG002|Dosing Period|Site Terminated by Sponsor|0|||
13144438|NCT02628028|26026944|FG003|Dosing Period|Site Terminated by Sponsor|0|||
13144439|NCT02628028|26026945|FG004|Dosing Period|Site Terminated by Sponsor|0|||
13144440|NCT02628028|26026946|FG005|Dosing Period|Site Terminated by Sponsor|1|||
13144441|NCT02628028|26026947|FG006|Dosing Period|Site Terminated by Sponsor|1|||
13144442|NCT02628028|26026948|FG007|Dosing Period|Site Terminated by Sponsor|0|||
13144443|NCT02628028|26026941|FG000|Dosing Period|Lost to Follow-up|0|||
13144444|NCT02628028|26026942|FG001|Dosing Period|Lost to Follow-up|0|||
13144445|NCT02628028|26026943|FG002|Dosing Period|Lost to Follow-up|0|||
13144446|NCT02628028|26026944|FG003|Dosing Period|Lost to Follow-up|0|||
13144447|NCT02628028|26026945|FG004|Dosing Period|Lost to Follow-up|0|||
13144448|NCT02628028|26026946|FG005|Dosing Period|Lost to Follow-up|0|||
13144449|NCT02628028|26026947|FG006|Dosing Period|Lost to Follow-up|1|||
13144450|NCT02628028|26026948|FG007|Dosing Period|Lost to Follow-up|0|||
13144451|NCT02628028|26026941|FG000|Dosing Period|Other|0|||
13144452|NCT02628028|26026942|FG001|Dosing Period|Other|0|||
13144453|NCT02628028|26026943|FG002|Dosing Period|Other|0|||
13144454|NCT02628028|26026944|FG003|Dosing Period|Other|0|||
13144455|NCT02628028|26026945|FG004|Dosing Period|Other|2|||
13144456|NCT02628028|26026946|FG005|Dosing Period|Other|1|||
13144457|NCT02628028|26026947|FG006|Dosing Period|Other|2|||
13144458|NCT02628028|26026948|FG007|Dosing Period|Other|4|||
13144459|NCT02628028|26026941|FG000|Long-term Extension (LTE) Period|Adverse Event|0|||
13144460|NCT02628028|26026942|FG001|Long-term Extension (LTE) Period|Adverse Event|0|||
13144461|NCT02628028|26026943|FG002|Long-term Extension (LTE) Period|Adverse Event|0|||
13144462|NCT02628028|26026944|FG003|Long-term Extension (LTE) Period|Adverse Event|0|||
13144463|NCT02628028|26026945|FG004|Long-term Extension (LTE) Period|Adverse Event|0|||
13144464|NCT02628028|26026946|FG005|Long-term Extension (LTE) Period|Adverse Event|1|||
13144465|NCT02628028|26026947|FG006|Long-term Extension (LTE) Period|Adverse Event|0|||
13144466|NCT02628028|26026948|FG007|Long-term Extension (LTE) Period|Adverse Event|3|||
13144467|NCT02628028|26026941|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
13144468|NCT02628028|26026942|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
13144469|NCT02628028|26026943|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
13144470|NCT02628028|26026944|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
13144471|NCT02628028|26026945|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
13144472|NCT02628028|26026946|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2|||
13144473|NCT02628028|26026947|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
13144474|NCT02628028|26026948|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1|||
13144475|NCT02628028|26026941|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
13144476|NCT02628028|26026942|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
13144477|NCT02628028|26026943|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
13144478|NCT02628028|26026944|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
13144479|NCT02628028|26026945|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
13144480|NCT02628028|26026946|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52|||
13144481|NCT02628028|26026947|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
13144482|NCT02628028|26026948|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
13144483|NCT02628028|26026941|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
13144484|NCT02628028|26026942|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
13144485|NCT02628028|26026943|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
13144486|NCT02628028|26026944|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
13144487|NCT02628028|26026945|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
13144488|NCT02628028|26026946|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2|||
13144489|NCT02628028|26026947|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
13144490|NCT02628028|26026948|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
13204932|NCT01968967|26230512|FG004|Treatment Period|Other|0|||
13144491|NCT02628028|26026941|FG000|Long-term Extension (LTE) Period|Other|0|||
13144492|NCT02628028|26026942|FG001|Long-term Extension (LTE) Period|Other|0|||
13144493|NCT02628028|26026943|FG002|Long-term Extension (LTE) Period|Other|0|||
13144494|NCT02628028|26026944|FG003|Long-term Extension (LTE) Period|Other|0|||
13144495|NCT02628028|26026945|FG004|Long-term Extension (LTE) Period|Other|0|||
13144496|NCT02628028|26026946|FG005|Long-term Extension (LTE) Period|Other|3|||
13144497|NCT02628028|26026947|FG006|Long-term Extension (LTE) Period|Other|4|||
13144498|NCT02628028|26026948|FG007|Long-term Extension (LTE) Period|Other|3|||
13144499|NCT02627677|26027002|FG000|Overall Study|Adverse event (not progressive disease)|1|||
13144500|NCT02627677|26027003|FG001|Overall Study|Adverse event (not progressive disease)|4|||
13144501|NCT02627677|26027004|FG002|Overall Study|Adverse event (not progressive disease)|1|||
13144502|NCT02627677|26027002|FG000|Overall Study|Progressive disease|1|||
13144503|NCT02627677|26027003|FG001|Overall Study|Progressive disease|3|||
13144504|NCT02627677|26027004|FG002|Overall Study|Progressive disease|0|||
13144505|NCT02627677|26027002|FG000|Overall Study|Lack of Efficacy|1|||
13144506|NCT02627677|26027003|FG001|Overall Study|Lack of Efficacy|2|||
13144507|NCT02627677|26027004|FG002|Overall Study|Lack of Efficacy|0|||
13144508|NCT02627677|26027002|FG000|Overall Study|Lost to Follow-up|0|||
13144509|NCT02627677|26027003|FG001|Overall Study|Lost to Follow-up|0|||
13144510|NCT02627677|26027004|FG002|Overall Study|Lost to Follow-up|1|||
13144511|NCT02627677|26027002|FG000|Overall Study|Pregnancy|0|||
13144512|NCT02627677|26027003|FG001|Overall Study|Pregnancy|1|||
13144513|NCT02627677|26027004|FG002|Overall Study|Pregnancy|0|||
13144514|NCT02627677|26027002|FG000|Overall Study|Study Terminated by Sponsor|5|||
13144515|NCT02627677|26027003|FG001|Overall Study|Study Terminated by Sponsor|10|||
13144516|NCT02627677|26027004|FG002|Overall Study|Study Terminated by Sponsor|6|||
13144517|NCT02627677|26027002|FG000|Overall Study|Physician Decision|0|||
13144518|NCT02627677|26027003|FG001|Overall Study|Physician Decision|0|||
13144519|NCT02627677|26027004|FG002|Overall Study|Physician Decision|2|||
13144520|NCT02627677|26027002|FG000|Overall Study|Withdrawal by Subject|2|||
13144521|NCT02627677|26027003|FG001|Overall Study|Withdrawal by Subject|1|||
13144522|NCT02627677|26027004|FG002|Overall Study|Withdrawal by Subject|1|||
13144523|NCT02627677|26027002|FG000|Overall Study|Reason not Specified|0|||
13144524|NCT02627677|26027003|FG001|Overall Study|Reason not Specified|0|||
13144525|NCT02627677|26027004|FG002|Overall Study|Reason not Specified|1|||
13144526|NCT02627677|26027002|FG000|Overall Study|Randomized but not Treated|1|||
13144527|NCT02627677|26027003|FG001|Overall Study|Randomized but not Treated|0|||
13144528|NCT02627677|26027004|FG002|Overall Study|Randomized but not Treated|0|||
13144529|NCT02627495|26027010|FG000|Overall Study|Withdrawal by Subject|4|||
13144530|NCT02627144|26027020|FG000|Overall Study|Serious adverse event|32|||
13144531|NCT02627144|26027020|FG000|Overall Study|Cancer progression|171|||
13144532|NCT02627144|26027020|FG000|Overall Study|Death from cancer|20|||
13144533|NCT02627144|26027020|FG000|Overall Study|Death from other cause|8|||
13144534|NCT02627144|26027020|FG000|Overall Study|Refusal of treatment / poor cooperation|38|||
13144535|NCT02627144|26027020|FG000|Overall Study|Administrative reasons|65|||
13144536|NCT02627144|26027020|FG000|Overall Study|Lost to Follow-up|8|||
13144537|NCT02627144|26027020|FG000|Overall Study|Enrolled, not treated|6|||
13144538|NCT02627144|26027020|FG000|Overall Study|Other|17|||
13144539|NCT02626819|26027047|FG000|Overall Study|Lost to Follow-up|3|||
13144540|NCT02626819|26027048|FG001|Overall Study|Lost to Follow-up|2|||
13144541|NCT02626819|26027047|FG000|Overall Study|Withdrawal by Subject|1|||
13144542|NCT02626819|26027048|FG001|Overall Study|Withdrawal by Subject|0|||
13144543|NCT02626819|26027047|FG000|Overall Study|Diagnosed w/ catastrophic illness|0|||
13144544|NCT02626819|26027048|FG001|Overall Study|Diagnosed w/ catastrophic illness|1|||
13144545|NCT02626780|26027055|FG000|Overall Study|Withdrawal by Subject|3|||
13144546|NCT02626520|26027072|FG000|Overall Study|Physician Decision|1|||
13144547|NCT02626520|26027073|FG001|Overall Study|Physician Decision|1|||
13144548|NCT02626520|26027072|FG000|Overall Study|Adverse Event|0|||
13144549|NCT02626520|26027073|FG001|Overall Study|Adverse Event|4|||
13144550|NCT02626520|26027072|FG000|Overall Study|Lack of Efficacy|0|||
13144551|NCT02626520|26027073|FG001|Overall Study|Lack of Efficacy|2|||
13144552|NCT02626520|26027072|FG000|Overall Study|Did not start protocol therapy|0|||
13144553|NCT02626520|26027073|FG001|Overall Study|Did not start protocol therapy|2|||
13144554|NCT02626520|26027072|FG000|Overall Study|Study terminated|0|||
13144555|NCT02626520|26027073|FG001|Overall Study|Study terminated|1|||
13144556|NCT02626182|26027090|FG000|Overall Study|Adverse Event|2|||
13144557|NCT02626182|26027091|FG001|Overall Study|Adverse Event|0|||
13144558|NCT02626026|26027188|FG000|Overall Study|Randomized but Never Treated|0|||
13144559|NCT02626026|26027189|FG001|Overall Study|Randomized but Never Treated|0|||
13144560|NCT02626026|26027190|FG002|Overall Study|Randomized but Never Treated|0|||
13144561|NCT02626026|26027191|FG003|Overall Study|Randomized but Never Treated|0|||
13144562|NCT02626026|26027192|FG004|Overall Study|Randomized but Never Treated|1|||
13144563|NCT02626026|26027193|FG005|Overall Study|Randomized but Never Treated|0|||
13144564|NCT02626000|26027207|FG000|Overall Study|Decision by Sponsor|1|||
13144565|NCT02626000|26027207|FG000|Overall Study|Death|29|||
13144566|NCT02625974|26027322|FG000|Overall Study|Adverse Event|12|||
13144567|NCT02625974|26027323|FG001|Overall Study|Adverse Event|2|||
13144568|NCT02625974|26027322|FG000|Overall Study|Withdrawal by Subject|3|||
13144569|NCT02625974|26027323|FG001|Overall Study|Withdrawal by Subject|1|||
13144570|NCT02625974|26027322|FG000|Overall Study|positive parasitemia|1|||
13144571|NCT02625974|26027323|FG001|Overall Study|positive parasitemia|0|||
13144572|NCT02625974|26027322|FG000|Overall Study|non-compliance with study drug|0|||
13144573|NCT02625974|26027323|FG001|Overall Study|non-compliance with study drug|2|||
13144574|NCT02625974|26027322|FG000|Overall Study|Protocol Violation|0|||
13144575|NCT02625974|26027323|FG001|Overall Study|Protocol Violation|1|||
13144576|NCT02625922|26027343|FG000|Overall Study|Non-availability of IMP|1|||
13092206|NCT03706040|25827416|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
13092207|NCT03706040|25827417|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
13092208|NCT03706040|25827418|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
13092209|NCT03706040|25827412|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
13092210|NCT03706040|25827413|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
13092211|NCT03706040|25827414|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4|||
13092212|NCT03706040|25827415|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
13092213|NCT03706040|25827416|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
13092214|NCT03706040|25827417|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
13092215|NCT03706040|25827418|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
13092216|NCT03706040|25827412|FG000|Period A (Week 0 to Week 16)|Other|2|||
13092217|NCT03706040|25827413|FG001|Period A (Week 0 to Week 16)|Other|0|||
13092218|NCT03706040|25827414|FG002|Period A (Week 0 to Week 16)|Other|2|||
13092219|NCT03706040|25827415|FG003|Period A (Week 0 to Week 16)|Other|0|||
13092220|NCT03706040|25827416|FG004|Period A (Week 0 to Week 16)|Other|0|||
13092221|NCT03706040|25827417|FG005|Period A (Week 0 to Week 16)|Other|0|||
13092222|NCT03706040|25827418|FG006|Period A (Week 0 to Week 16)|Other|0|||
13092223|NCT03706040|25827412|FG000|Period B (Week 16 to Week 52)|Adverse Event|0|||
13092224|NCT03706040|25827413|FG001|Period B (Week 16 to Week 52)|Adverse Event|0|||
13092225|NCT03706040|25827414|FG002|Period B (Week 16 to Week 52)|Adverse Event|0|||
13092226|NCT03706040|25827415|FG003|Period B (Week 16 to Week 52)|Adverse Event|1|||
13092227|NCT03706040|25827416|FG004|Period B (Week 16 to Week 52)|Adverse Event|2|||
13092228|NCT03706040|25827417|FG005|Period B (Week 16 to Week 52)|Adverse Event|3|||
13092229|NCT03706040|25827418|FG006|Period B (Week 16 to Week 52)|Adverse Event|0|||
13092230|NCT03706040|25827412|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
13092231|NCT03706040|25827413|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
13092232|NCT03706040|25827414|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
13092233|NCT03706040|25827415|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3|||
13092234|NCT03706040|25827416|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2|||
13092235|NCT03706040|25827417|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1|||
13092236|NCT03706040|25827418|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10|||
13092237|NCT03706040|25827412|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
13092238|NCT03706040|25827413|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
13092239|NCT03706040|25827414|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
13092240|NCT03706040|25827415|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
13092241|NCT03706040|25827416|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
13092242|NCT03706040|25827417|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
13092243|NCT03706040|25827418|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
13092244|NCT03706040|25827412|FG000|Period B (Week 16 to Week 52)|Other|0|||
13092245|NCT03706040|25827413|FG001|Period B (Week 16 to Week 52)|Other|0|||
13092246|NCT03706040|25827414|FG002|Period B (Week 16 to Week 52)|Other|0|||
13092247|NCT03706040|25827415|FG003|Period B (Week 16 to Week 52)|Other|4|||
13092248|NCT03706040|25827416|FG004|Period B (Week 16 to Week 52)|Other|5|||
13092249|NCT03706040|25827417|FG005|Period B (Week 16 to Week 52)|Other|23|||
13092250|NCT03706040|25827418|FG006|Period B (Week 16 to Week 52)|Other|17|||
13132649|NCT02787304|25984681|FG001|Overall Study|Study terminated by sponsor|31|||
13132650|NCT02787304|25984682|FG002|Overall Study|Study terminated by sponsor|31|||
13132651|NCT02787304|25984683|FG003|Overall Study|Study terminated by sponsor|32|||
13132652|NCT02787083|25984698|FG000|Overall Study|Adverse Event|1|||
13132653|NCT02787083|25984699|FG001|Overall Study|Adverse Event|0|||
13132654|NCT02787083|25984698|FG000|Overall Study|Withdrawal by Subject|2|||
13132655|NCT02787083|25984699|FG001|Overall Study|Withdrawal by Subject|2|||
13132656|NCT02786953|25984728|FG000|Overall Study|Withdrawal by Subject|3|||
13132657|NCT02786953|25984729|FG001|Overall Study|Withdrawal by Subject|0|||
13132658|NCT02786953|25984728|FG000|Overall Study|Physician Decision|0|||
13132659|NCT02786953|25984729|FG001|Overall Study|Physician Decision|1|||
13132660|NCT02786927|25984738|FG000|Overall Study|Adverse Event|1|||
13132661|NCT02786927|25984738|FG000|Overall Study|Protocol Violation|4|||
13132662|NCT02786901|25984777|FG000|Overall Study|Adverse Event|1|||
13132663|NCT02786901|25984778|FG001|Overall Study|Adverse Event|1|||
13132664|NCT02786901|25984779|FG002|Overall Study|Adverse Event|2|||
13132665|NCT02786901|25984777|FG000|Overall Study|Physician Decision|1|||
13132666|NCT02786901|25984778|FG001|Overall Study|Physician Decision|0|||
13144577|NCT02625922|26027344|FG001|Overall Study|Non-availability of IMP|1|||
13144578|NCT02625922|26027343|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1|||
13092251|NCT03705793|25827435|FG000|Overall Study|Lost to Follow-up|3|||
13092252|NCT03705793|25827436|FG001|Overall Study|Lost to Follow-up|4|||
13092253|NCT03705793|25827435|FG000|Overall Study|Withdrawal by Subject|2|||
13092254|NCT03705793|25827436|FG001|Overall Study|Withdrawal by Subject|1|||
13092255|NCT03705494|25827457|FG000|Overall Study|Lost to Follow-up|2|||
13092256|NCT03705494|25827458|FG001|Overall Study|Lost to Follow-up|1|||
13092257|NCT03705494|25827457|FG000|Overall Study|Withdrawal by Subject|5|||
13092258|NCT03705494|25827458|FG001|Overall Study|Withdrawal by Subject|2|||
13092259|NCT03704636|25827464|FG000|Overall Study|Inadequate Venous Flow|3|||
13092260|NCT03704194|25827496|FG000|Overall Study|Withdrawal by Subject|0|||
13144579|NCT02625922|26027344|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1|||
13144580|NCT02625909|26027363|FG000|Overall Study|Death|2|||
13144581|NCT02625909|26027364|FG001|Overall Study|Death|0|||
13144582|NCT02625909|26027363|FG000|Overall Study|Lost to Follow-up|3|||
13144583|NCT02625909|26027364|FG001|Overall Study|Lost to Follow-up|5|||
13144584|NCT02625909|26027363|FG000|Overall Study|Lack of Efficacy|9|||
13144585|NCT02625909|26027364|FG001|Overall Study|Lack of Efficacy|2|||
13144586|NCT02625909|26027363|FG000|Overall Study|Reinfection|3|||
13144587|NCT02625909|26027364|FG001|Overall Study|Reinfection|2|||
13144588|NCT02625623|26027391|FG000|Overall Study|Participants randomized but not treated|9|||
13144589|NCT02625623|26027392|FG001|Overall Study|Participants randomized but not treated|1|||
13144590|NCT02625259|26027443|FG000|First Intervention (Day 1)|Other|0|||
13144591|NCT02625259|26027444|FG001|First Intervention (Day 1)|Other|0|||
13144592|NCT02625259|26027445|FG002|First Intervention (Day 1)|Other|1|||
13144593|NCT02625259|26027446|FG003|First Intervention (Day 1)|Other|0|||
13144594|NCT02625259|26027447|FG004|First Intervention (Day 1)|Other|0|||
13144595|NCT02625259|26027443|FG000|First Intervention (Day 1)|Adverse Event|2|||
13144596|NCT02625259|26027444|FG001|First Intervention (Day 1)|Adverse Event|1|||
13144597|NCT02625259|26027445|FG002|First Intervention (Day 1)|Adverse Event|0|||
13144598|NCT02625259|26027446|FG003|First Intervention (Day 1)|Adverse Event|0|||
13144599|NCT02625259|26027447|FG004|First Intervention (Day 1)|Adverse Event|0|||
13144600|NCT02625259|26027443|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
13144601|NCT02625259|26027444|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
13144602|NCT02625259|26027445|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
13144603|NCT02625259|26027446|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
13144604|NCT02625259|26027447|FG004|First Intervention (Day 1)|Withdrawal by Subject|0|||
13144605|NCT02625233|26027462|FG000|Overall Study|Adverse Event|2|||
13144606|NCT02625233|26027463|FG001|Overall Study|Adverse Event|0|||
13144607|NCT02625220|26027472|FG000|Overall Study|Adverse Event|2|||
13144608|NCT02625220|26027472|FG000|Overall Study|Lost to Follow-up|2|||
13144609|NCT02625220|26027472|FG000|Overall Study|Protocol Violation|1|||
13144610|NCT02625220|26027472|FG000|Overall Study|Study discontinued at site|2|||
13144611|NCT02624986|26027674|FG000|Overall Study|Death|0|||
13144612|NCT02624986|26027675|FG001|Overall Study|Death|1|||
13144613|NCT02624986|26027676|FG002|Overall Study|Death|2|||
13144614|NCT02624986|26027677|FG003|Overall Study|Death|2|||
13144615|NCT02624986|26027678|FG004|Overall Study|Death|2|||
13144616|NCT02624986|26027679|FG005|Overall Study|Death|0|||
13144617|NCT02624986|26027680|FG006|Overall Study|Death|0|||
13144618|NCT02624986|26027681|FG007|Overall Study|Death|1|||
13144619|NCT02624986|26027674|FG000|Overall Study|Study Terminated by Sponsor|1|||
13144620|NCT02624986|26027675|FG001|Overall Study|Study Terminated by Sponsor|1|||
13144621|NCT02624986|26027676|FG002|Overall Study|Study Terminated by Sponsor|0|||
13144622|NCT02624986|26027677|FG003|Overall Study|Study Terminated by Sponsor|1|||
13144623|NCT02624986|26027678|FG004|Overall Study|Study Terminated by Sponsor|2|||
13144624|NCT02624986|26027679|FG005|Overall Study|Study Terminated by Sponsor|2|||
13144625|NCT02624986|26027680|FG006|Overall Study|Study Terminated by Sponsor|4|||
13144626|NCT02624986|26027681|FG007|Overall Study|Study Terminated by Sponsor|3|||
13144627|NCT02624986|26027674|FG000|Overall Study|Progressive Disease|0|||
13144628|NCT02624986|26027675|FG001|Overall Study|Progressive Disease|1|||
13144629|NCT02624986|26027676|FG002|Overall Study|Progressive Disease|0|||
13144630|NCT02624986|26027677|FG003|Overall Study|Progressive Disease|0|||
13144631|NCT02624986|26027678|FG004|Overall Study|Progressive Disease|0|||
13144632|NCT02624986|26027679|FG005|Overall Study|Progressive Disease|0|||
13144633|NCT02624986|26027680|FG006|Overall Study|Progressive Disease|0|||
13144634|NCT02624986|26027681|FG007|Overall Study|Progressive Disease|0|||
13144635|NCT02624986|26027674|FG000|Overall Study|Protocol Violation|1|||
13144636|NCT02624986|26027675|FG001|Overall Study|Protocol Violation|0|||
13144637|NCT02624986|26027676|FG002|Overall Study|Protocol Violation|0|||
13144638|NCT02624986|26027677|FG003|Overall Study|Protocol Violation|0|||
13092261|NCT03704194|25827497|FG001|Overall Study|Withdrawal by Subject|1|||
13144639|NCT02624986|26027678|FG004|Overall Study|Protocol Violation|0|||
13144640|NCT02624986|26027679|FG005|Overall Study|Protocol Violation|0|||
13144641|NCT02624986|26027680|FG006|Overall Study|Protocol Violation|0|||
13144642|NCT02624986|26027681|FG007|Overall Study|Protocol Violation|0|||
13144643|NCT02624986|26027674|FG000|Overall Study|Withdrawal by Subject|0|||
13144644|NCT02624986|26027675|FG001|Overall Study|Withdrawal by Subject|0|||
13144645|NCT02624986|26027676|FG002|Overall Study|Withdrawal by Subject|0|||
13144646|NCT02624986|26027677|FG003|Overall Study|Withdrawal by Subject|0|||
13144647|NCT02624986|26027678|FG004|Overall Study|Withdrawal by Subject|0|||
13144648|NCT02624986|26027679|FG005|Overall Study|Withdrawal by Subject|0|||
13144649|NCT02624986|26027680|FG006|Overall Study|Withdrawal by Subject|0|||
13144650|NCT02624986|26027681|FG007|Overall Study|Withdrawal by Subject|1|||
13144651|NCT02624791|26027693|FG000|Overall Study|Withdrawal by Subject|2|||
13144652|NCT02624791|26027694|FG001|Overall Study|Withdrawal by Subject|0|||
13144653|NCT02624791|26027695|FG002|Overall Study|Withdrawal by Subject|0|||
13144654|NCT02624791|26027696|FG003|Overall Study|Withdrawal by Subject|0|||
13144655|NCT02624791|26027697|FG004|Overall Study|Withdrawal by Subject|0|||
13144656|NCT02624791|26027698|FG005|Overall Study|Withdrawal by Subject|0|||
13144657|NCT02624713|26027712|FG000|Overall Study|Lost to Follow-up|14|||
13144658|NCT02624713|26027713|FG001|Overall Study|Lost to Follow-up|0|||
13144659|NCT02624687|26027748|FG000|Overall Study|Withdrawal by Subject|1|||
13144660|NCT02624687|26027749|FG001|Overall Study|Withdrawal by Subject|1|||
13144661|NCT02624687|26027748|FG000|Overall Study|medical leave from work|0|||
13144662|NCT02624687|26027749|FG001|Overall Study|medical leave from work|1|||
13144663|NCT02624492|26027785|FG000|Overall Study|Adverse Event|2|||
13144664|NCT02624492|26027786|FG001|Overall Study|Adverse Event|2|||
13144665|NCT02624492|26027787|FG002|Overall Study|Adverse Event|2|||
13144666|NCT02624492|26027785|FG000|Overall Study|Progressive disease|0|||
13144667|NCT02624492|26027786|FG001|Overall Study|Progressive disease|2|||
13144668|NCT02624492|26027787|FG002|Overall Study|Progressive disease|3|||
13144669|NCT02624284|26027814|FG000|Overall Study|Withdrawal by Subject|3|||
13144670|NCT02624284|26027815|FG001|Overall Study|Withdrawal by Subject|6|||
13144671|NCT02624284|26027816|FG002|Overall Study|Withdrawal by Subject|3|||
13144672|NCT02624284|26027814|FG000|Overall Study|Protocol Violation|9|||
13144673|NCT02624284|26027815|FG001|Overall Study|Protocol Violation|10|||
13144674|NCT02624284|26027816|FG002|Overall Study|Protocol Violation|7|||
13144675|NCT02624284|26027814|FG000|Overall Study|Revealed exclusionary condition|2|||
13144676|NCT02624284|26027815|FG001|Overall Study|Revealed exclusionary condition|2|||
13144677|NCT02624284|26027816|FG002|Overall Study|Revealed exclusionary condition|0|||
13144678|NCT02624284|26027814|FG000|Overall Study|Adverse Event|0|||
13144679|NCT02624284|26027815|FG001|Overall Study|Adverse Event|0|||
13144680|NCT02624284|26027816|FG002|Overall Study|Adverse Event|1|||
13144681|NCT02624050|26027849|FG000|Overall Study|Physician Decision|4|||
13144682|NCT02624050|26027850|FG001|Overall Study|Physician Decision|0|||
13144683|NCT02624050|26027849|FG000|Overall Study|Protocol Violation|2|||
13144684|NCT02624050|26027850|FG001|Overall Study|Protocol Violation|0|||
13144685|NCT02623959|26027865|FG000|Overall Study|Progression|0|||
13144686|NCT02623959|26027866|FG001|Overall Study|Progression|1|||
13144687|NCT02623829|26027883|FG000|Overall Study|Lost to Follow-up|1|||
13144688|NCT02623829|26027884|FG001|Overall Study|Lost to Follow-up|1|||
13144689|NCT02623361|26027901|FG000|Overall Study|Protocol Violation|0|||
13144690|NCT02623361|26027902|FG001|Overall Study|Protocol Violation|1|||
13144691|NCT02623361|26027901|FG000|Overall Study|Withdrawal by Subject|0|||
13144692|NCT02623361|26027902|FG001|Overall Study|Withdrawal by Subject|1|||
13144693|NCT02623335|26027933|FG000|Overall Study|Death|8|||
13144694|NCT02623335|26027934|FG001|Overall Study|Death|7|||
13144695|NCT02623335|26027933|FG000|Overall Study|Lost to Follow-up|15|||
13144696|NCT02623335|26027934|FG001|Overall Study|Lost to Follow-up|23|||
13144697|NCT02623335|26027933|FG000|Overall Study|Withdrawal by Subject|2|||
13144698|NCT02623335|26027934|FG001|Overall Study|Withdrawal by Subject|5|||
13144699|NCT02623335|26027933|FG000|Overall Study|Protocol Violation|2|||
13144700|NCT02623335|26027934|FG001|Overall Study|Protocol Violation|1|||
13144701|NCT02623322|26027977|FG000|Overall Study|Lost to Follow-up|2|||
13144702|NCT02623322|26027978|FG001|Overall Study|Lost to Follow-up|1|||
13144703|NCT02623322|26027979|FG002|Overall Study|Lost to Follow-up|0|||
13144704|NCT02623218|26028017|FG000|Overall Study|Lost to Follow-up|0|||
13144705|NCT02623218|26028018|FG001|Overall Study|Lost to Follow-up|1|||
13144706|NCT02623218|26028019|FG002|Overall Study|Lost to Follow-up|0|||
13144707|NCT02623218|26028020|FG003|Overall Study|Lost to Follow-up|0|||
13144708|NCT02623218|26028021|FG004|Overall Study|Lost to Follow-up|0|||
13144709|NCT02622828|26028028|FG000|Overall Study|participant withdrew|3|||
13144710|NCT02622724|26028111|FG000|Overall Study|Death|51|||
13144711|NCT02622724|26028112|FG001|Overall Study|Death|53|||
13144712|NCT02622724|26028111|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4|||
13144713|NCT02622724|26028112|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7|||
13144714|NCT02622724|26028111|FG000|Overall Study|Early termination of study|38|||
13144715|NCT02622724|26028112|FG001|Overall Study|Early termination of study|43|||
13144716|NCT02622568|26028125|FG000|Overall Study|Lost to Follow-up|5|||
13144717|NCT02622568|26028126|FG001|Overall Study|Lost to Follow-up|5|||
13144718|NCT02622386|26028145|FG000|First Assignment|Withdrawal by Subject|3|||
13144719|NCT02622386|26028146|FG001|First Assignment|Withdrawal by Subject|2|||
13144720|NCT02622386|26028145|FG000|Washout|Withdrawal by Subject|4|||
13144721|NCT02622386|26028146|FG001|Washout|Withdrawal by Subject|4|||
13144722|NCT02622386|26028145|FG000|Second Assignment|Withdrawal by Subject|0|||
13144723|NCT02622386|26028146|FG001|Second Assignment|Withdrawal by Subject|2|||
13144724|NCT02622321|26028237|FG000|Overall Study|Withdrawal by Subject|2|||
13144725|NCT02622321|26028238|FG001|Overall Study|Withdrawal by Subject|0|||
13144726|NCT02622321|26028239|FG002|Overall Study|Withdrawal by Subject|0|||
13144727|NCT02622321|26028240|FG003|Overall Study|Withdrawal by Subject|0|||
13144728|NCT02622321|26028237|FG000|Overall Study|Death|0|||
13144729|NCT02622321|26028238|FG001|Overall Study|Death|0|||
13144730|NCT02622321|26028239|FG002|Overall Study|Death|1|||
13144731|NCT02622321|26028240|FG003|Overall Study|Death|0|||
13144732|NCT02622321|26028237|FG000|Overall Study|Physician Decision|1|||
13144733|NCT02622321|26028238|FG001|Overall Study|Physician Decision|0|||
13144734|NCT02622321|26028239|FG002|Overall Study|Physician Decision|0|||
13144735|NCT02622321|26028240|FG003|Overall Study|Physician Decision|0|||
13204933|NCT01968967|26230508|FG000|Treatment Period|Withdrawal by Subject|71|||
13204934|NCT01968967|26230509|FG001|Treatment Period|Withdrawal by Subject|61|||
13204935|NCT01968967|26230510|FG002|Treatment Period|Withdrawal by Subject|0|||
13204936|NCT01968967|26230511|FG003|Treatment Period|Withdrawal by Subject|0|||
13204937|NCT01968967|26230512|FG004|Treatment Period|Withdrawal by Subject|0|||
13204938|NCT01968967|26230508|FG000|Treatment Period|Did Not Meet Entrance Criteria|2|||
13204939|NCT01968967|26230509|FG001|Treatment Period|Did Not Meet Entrance Criteria|3|||
13204940|NCT01968967|26230510|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
13204941|NCT01968967|26230511|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
13204942|NCT01968967|26230512|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
13204943|NCT01968967|26230508|FG000|Treatment Period|Lost to Follow-up|26|||
13204944|NCT01968967|26230509|FG001|Treatment Period|Lost to Follow-up|31|||
13204945|NCT01968967|26230510|FG002|Treatment Period|Lost to Follow-up|0|||
13204946|NCT01968967|26230511|FG003|Treatment Period|Lost to Follow-up|0|||
13204947|NCT01968967|26230512|FG004|Treatment Period|Lost to Follow-up|0|||
13204948|NCT01968967|26230508|FG000|Treatment Period|Protocol Violation|1|||
13204949|NCT01968967|26230509|FG001|Treatment Period|Protocol Violation|2|||
13204950|NCT01968967|26230510|FG002|Treatment Period|Protocol Violation|0|||
13204951|NCT01968967|26230511|FG003|Treatment Period|Protocol Violation|0|||
13204952|NCT01968967|26230512|FG004|Treatment Period|Protocol Violation|0|||
13204953|NCT01968967|26230508|FG000|Treatment Period|Adverse Event|9|||
13485224|NCT03406078|27031982|FG001|Overall Study|Lost to Follow-up|1|||
13092262|NCT03704051|25827508|FG000|Overall Study|Withdrawal by Subject|4|||
13092263|NCT03704051|25827509|FG001|Overall Study|Withdrawal by Subject|0|||
13092264|NCT03703882|25827530|FG000|Overall Study|Adverse Event|1|||
13092265|NCT03703882|25827531|FG001|Overall Study|Adverse Event|0|||
13092266|NCT03703882|25827530|FG000|Overall Study|Lost to Follow-up|0|||
13092267|NCT03703882|25827531|FG001|Overall Study|Lost to Follow-up|2|||
13092268|NCT03703882|25827530|FG000|Overall Study|Non-compliance with study drug|0|||
13092269|NCT03703882|25827531|FG001|Overall Study|Non-compliance with study drug|1|||
13092270|NCT03703882|25827530|FG000|Overall Study|Physician Decision|0|||
13092271|NCT03703882|25827531|FG001|Overall Study|Physician Decision|1|||
13092272|NCT03703882|25827530|FG000|Overall Study|Progressive disease|1|||
13092273|NCT03703882|25827531|FG001|Overall Study|Progressive disease|0|||
13092274|NCT03703882|25827530|FG000|Overall Study|Withdrawal by parent/guardian|1|||
13092275|NCT03703882|25827531|FG001|Overall Study|Withdrawal by parent/guardian|0|||
13092276|NCT03703882|25827530|FG000|Overall Study|Starting another treatment|0|||
13092277|NCT03703882|25827531|FG001|Overall Study|Starting another treatment|1|||
13092278|NCT03703882|25827530|FG000|Overall Study|noncompliance with study procedures|0|||
13092279|NCT03703882|25827531|FG001|Overall Study|noncompliance with study procedures|1|||
13092280|NCT03703817|25827548|FG000|Overall Study|Not meeting eligibility criteria|7|||
13092281|NCT03703817|25827549|FG001|Overall Study|Not meeting eligibility criteria|4|||
13092282|NCT03703466|25827591|FG000|Overall Study|Death|2|||
13092283|NCT03703466|25827592|FG001|Overall Study|Death|1|||
13092284|NCT03703466|25827593|FG002|Overall Study|Death|0|||
13092285|NCT03703466|25827591|FG000|Overall Study|Protocol Violation|1|||
13092286|NCT03703466|25827592|FG001|Overall Study|Protocol Violation|0|||
13092287|NCT03703466|25827593|FG002|Overall Study|Protocol Violation|0|||
13092288|NCT03703466|25827591|FG000|Overall Study|Withdrawal by Subject|0|||
13092289|NCT03703466|25827592|FG001|Overall Study|Withdrawal by Subject|3|||
13092290|NCT03703466|25827593|FG002|Overall Study|Withdrawal by Subject|0|||
13092291|NCT03703466|25827591|FG000|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|1|||
13092292|NCT03703466|25827592|FG001|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|2|||
13092293|NCT03703466|25827593|FG002|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|2|||
13092294|NCT03703336|25827618|FG000|Overall Study|Parent withdrew consent|29|||
13092295|NCT03703336|25827619|FG001|Overall Study|Parent withdrew consent|8|||
13092296|NCT03703336|25827618|FG000|Overall Study|Migration|3|||
13092297|NCT03703336|25827619|FG001|Overall Study|Migration|3|||
13092298|NCT03703336|25827618|FG000|Overall Study|Protocol Violation|3|||
13204954|NCT01968967|26230509|FG001|Treatment Period|Adverse Event|8|||
13204955|NCT01968967|26230510|FG002|Treatment Period|Adverse Event|0|||
13204956|NCT01968967|26230511|FG003|Treatment Period|Adverse Event|0|||
13092299|NCT03703336|25827619|FG001|Overall Study|Protocol Violation|1|||
13204957|NCT01968967|26230512|FG004|Treatment Period|Adverse Event|0|||
13204958|NCT01968967|26230508|FG000|Treatment Period|Death|9|||
13204959|NCT01968967|26230509|FG001|Treatment Period|Death|2|||
13092300|NCT03703336|25827618|FG000|Overall Study|Physician Decision|2|||
13092301|NCT03703336|25827619|FG001|Overall Study|Physician Decision|0|||
13092302|NCT03703336|25827618|FG000|Overall Study|Adverse Event|0|||
13092303|NCT03703336|25827619|FG001|Overall Study|Adverse Event|2|||
13092304|NCT03703336|25827618|FG000|Overall Study|Lost to Follow-up|1|||
13092305|NCT03703336|25827619|FG001|Overall Study|Lost to Follow-up|0|||
13092306|NCT03702166|25827630|FG000|Overall Study|Lost to Follow-up|1|||
13092307|NCT03702166|25827630|FG000|Overall Study|Withdrawal by Subject|1|||
13144736|NCT02622113|26028259|FG000|Overall Study|Adverse Event|4|||
13144737|NCT02622113|26028260|FG001|Overall Study|Adverse Event|4|||
13144738|NCT02622113|26028259|FG000|Overall Study|Physician Decision|0|||
13144739|NCT02622113|26028260|FG001|Overall Study|Physician Decision|1|||
13144740|NCT02622113|26028259|FG000|Overall Study|Withdrawal by Subject|0|||
13144741|NCT02622113|26028260|FG001|Overall Study|Withdrawal by Subject|2|||
13144742|NCT02622113|26028259|FG000|Overall Study|Stopping Criteria|1|||
13144743|NCT02622113|26028260|FG001|Overall Study|Stopping Criteria|3|||
13144744|NCT02622074|26028365|FG000|Overall Study|Death|4|||
13144745|NCT02622074|26028366|FG001|Overall Study|Death|0|||
13144746|NCT02622074|26028367|FG002|Overall Study|Death|0|||
13144747|NCT02622074|26028368|FG003|Overall Study|Death|1|||
13144748|NCT02622074|26028369|FG004|Overall Study|Death|1|||
13144749|NCT02622074|26028370|FG005|Overall Study|Death|0|||
13144750|NCT02622074|26028365|FG000|Overall Study|Withdrawal by Subject|0|||
13144751|NCT02622074|26028366|FG001|Overall Study|Withdrawal by Subject|1|||
13144752|NCT02622074|26028367|FG002|Overall Study|Withdrawal by Subject|0|||
13144753|NCT02622074|26028368|FG003|Overall Study|Withdrawal by Subject|0|||
13144754|NCT02622074|26028369|FG004|Overall Study|Withdrawal by Subject|0|||
13144755|NCT02622074|26028370|FG005|Overall Study|Withdrawal by Subject|0|||
13144756|NCT02621931|26028429|FG000|Overall Study|Death|0|||
13144757|NCT02621931|26028430|FG001|Overall Study|Death|1|||
13144758|NCT02621931|26028431|FG002|Overall Study|Death|0|||
13144759|NCT02621931|26028429|FG000|Overall Study|Adverse Event|8|||
13144760|NCT02621931|26028430|FG001|Overall Study|Adverse Event|5|||
13144761|NCT02621931|26028431|FG002|Overall Study|Adverse Event|7|||
13144762|NCT02621931|26028429|FG000|Overall Study|Withdrawal by Subject|12|||
13144763|NCT02621931|26028430|FG001|Overall Study|Withdrawal by Subject|10|||
13144764|NCT02621931|26028431|FG002|Overall Study|Withdrawal by Subject|11|||
13144765|NCT02621931|26028429|FG000|Overall Study|Protocol Violation|2|||
13144766|NCT02621931|26028430|FG001|Overall Study|Protocol Violation|2|||
13144767|NCT02621931|26028431|FG002|Overall Study|Protocol Violation|2|||
13144768|NCT02621931|26028429|FG000|Overall Study|Pregnancy|2|||
13144769|NCT02621931|26028430|FG001|Overall Study|Pregnancy|0|||
13144770|NCT02621931|26028431|FG002|Overall Study|Pregnancy|0|||
13144771|NCT02621931|26028429|FG000|Overall Study|Noncompliance to study procedures|0|||
13144772|NCT02621931|26028430|FG001|Overall Study|Noncompliance to study procedures|1|||
13144773|NCT02621931|26028431|FG002|Overall Study|Noncompliance to study procedures|2|||
13144774|NCT02621931|26028429|FG000|Overall Study|Lost to Follow-up|8|||
13144775|NCT02621931|26028430|FG001|Overall Study|Lost to Follow-up|7|||
13144776|NCT02621931|26028431|FG002|Overall Study|Lost to Follow-up|10|||
13144777|NCT02621931|26028429|FG000|Overall Study|Lack of Efficacy|0|||
13144778|NCT02621931|26028430|FG001|Overall Study|Lack of Efficacy|0|||
13144779|NCT02621931|26028431|FG002|Overall Study|Lack of Efficacy|1|||
13144780|NCT02621931|26028429|FG000|Overall Study|Other|1|||
13144781|NCT02621931|26028430|FG001|Overall Study|Other|1|||
13144782|NCT02621931|26028431|FG002|Overall Study|Other|3|||
13144783|NCT02621606|26028467|FG000|Overall Study|Withdrawal by Subject|0|||
13144784|NCT02621606|26028468|FG001|Overall Study|Withdrawal by Subject|1|||
13144785|NCT02621606|26028469|FG002|Overall Study|Withdrawal by Subject|0|||
13144786|NCT02621424|26028494|FG000|Overall Study|Withdrawal by Subject|1|||
13144787|NCT02621424|26028495|FG001|Overall Study|Withdrawal by Subject|2|||
13144788|NCT02621073|26028510|FG000|Overall Study|Lost to Follow-up|0|||
13144789|NCT02621073|26028511|FG001|Overall Study|Lost to Follow-up|1|||
13144790|NCT02621073|26028510|FG000|Overall Study|Physician Decision|3|||
13144791|NCT02621073|26028511|FG001|Overall Study|Physician Decision|2|||
13144792|NCT02621047|26028634|FG000|Overall Study|Adverse Event|0|||
13144793|NCT02621047|26028635|FG001|Overall Study|Adverse Event|0|||
13144794|NCT02621047|26028636|FG002|Overall Study|Adverse Event|1|||
13144795|NCT02621034|26028659|FG000|Overall Study|Lost to Follow-up|3|||
13144796|NCT02621034|26028660|FG001|Overall Study|Lost to Follow-up|2|||
13144797|NCT02621034|26028661|FG002|Overall Study|Lost to Follow-up|5|||
13144798|NCT02620787|26028678|FG000|Overall Study|Adverse Event|1|||
13144799|NCT02620787|26028679|FG001|Overall Study|Adverse Event|0|||
13144800|NCT02620787|26028678|FG000|Overall Study|Eligibility Criteria Not Met|1|||
13144801|NCT02620787|26028679|FG001|Overall Study|Eligibility Criteria Not Met|0|||
13144802|NCT02620384|26028714|FG000|Overall Study|Adverse Event|2|||
13144803|NCT02620384|26028715|FG001|Overall Study|Adverse Event|1|||
13144804|NCT02620384|26028714|FG000|Overall Study|Discharged prior to 2nd dose|2|||
13144805|NCT02620384|26028715|FG001|Overall Study|Discharged prior to 2nd dose|5|||
13092308|NCT03702010|25827649|FG000|Follow-up (30days)|Lack of Efficacy|2|||
13144806|NCT02620384|26028714|FG000|Overall Study|Drug shortage prevented 2nd dose|0|||
13144807|NCT02620384|26028715|FG001|Overall Study|Drug shortage prevented 2nd dose|1|||
13144808|NCT02620020|26028750|FG000|Overall Study|Adverse Event|8|||
13144809|NCT02620020|26028751|FG001|Overall Study|Adverse Event|4|||
13144810|NCT02620020|26028752|FG002|Overall Study|Adverse Event|3|||
13144811|NCT02620020|26028753|FG003|Overall Study|Adverse Event|5|||
13144812|NCT02620020|26028750|FG000|Overall Study|Lost to Follow-up|4|||
13144813|NCT02620020|26028751|FG001|Overall Study|Lost to Follow-up|8|||
13144814|NCT02620020|26028752|FG002|Overall Study|Lost to Follow-up|1|||
13144815|NCT02620020|26028753|FG003|Overall Study|Lost to Follow-up|4|||
13144816|NCT02620020|26028750|FG000|Overall Study|Physician Decision|7|||
13144817|NCT02620020|26028751|FG001|Overall Study|Physician Decision|4|||
13144818|NCT02620020|26028752|FG002|Overall Study|Physician Decision|3|||
13144819|NCT02620020|26028753|FG003|Overall Study|Physician Decision|4|||
13144820|NCT02620020|26028750|FG000|Overall Study|Protocol Violation|5|||
13144821|NCT02620020|26028751|FG001|Overall Study|Protocol Violation|2|||
13144822|NCT02620020|26028752|FG002|Overall Study|Protocol Violation|1|||
13144823|NCT02620020|26028753|FG003|Overall Study|Protocol Violation|1|||
13144824|NCT02620020|26028750|FG000|Overall Study|Withdrawal by Subject|20|||
13144825|NCT02620020|26028751|FG001|Overall Study|Withdrawal by Subject|16|||
13144826|NCT02620020|26028752|FG002|Overall Study|Withdrawal by Subject|17|||
13144827|NCT02620020|26028753|FG003|Overall Study|Withdrawal by Subject|12|||
13144828|NCT02620020|26028750|FG000|Overall Study|Death|0|||
13144829|NCT02620020|26028751|FG001|Overall Study|Death|1|||
13144830|NCT02620020|26028752|FG002|Overall Study|Death|0|||
13144831|NCT02620020|26028753|FG003|Overall Study|Death|0|||
13144832|NCT02619812|26028780|FG000|Overall Study|Withdrawal by Subject|0|||
13144833|NCT02619812|26028781|FG001|Overall Study|Withdrawal by Subject|0|||
13092309|NCT03702010|25827650|FG001|Follow-up (30days)|Lack of Efficacy|2|||
13092310|NCT03701516|25827667|FG000|Period 1|Lost to Follow-up|0|||
13092311|NCT03701516|25827668|FG001|Period 1|Lost to Follow-up|1|||
13092312|NCT03701516|25827667|FG000|Period 1|Adverse Event|0|||
13092313|NCT03701516|25827668|FG001|Period 1|Adverse Event|2|||
13092314|NCT03701516|25827667|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2|||
13092315|NCT03701516|25827668|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
13092316|NCT03701516|25827667|FG000|Period 1|Non Compliance to Protocol|2|||
13092317|NCT03701516|25827668|FG001|Period 1|Non Compliance to Protocol|1|||
13092318|NCT03701516|25827667|FG000|Period 1|Withdrawal by Subject|0|||
13092319|NCT03701516|25827668|FG001|Period 1|Withdrawal by Subject|1|||
13092320|NCT03701516|25827667|FG000|Period 2|failed to meet all eligibility creiteria|1|||
13092321|NCT03701516|25827668|FG001|Period 2|failed to meet all eligibility creiteria|0|||
13092322|NCT03701516|25827667|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
13092323|NCT03701516|25827668|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
13092324|NCT03701074|25827681|FG000|Overall Study|Physician Decision|1|||
13092325|NCT03701074|25827682|FG001|Overall Study|Physician Decision|0|||
13144834|NCT02619812|26028782|FG002|Overall Study|Withdrawal by Subject|1|||
13144835|NCT02619812|26028783|FG003|Overall Study|Withdrawal by Subject|2|||
13144836|NCT02619682|26028789|FG000|Overall Study|Withdrawal by Subject|3|||
13144837|NCT02619682|26028789|FG000|Overall Study|Lack of Efficacy|8|||
13144838|NCT02619682|26028789|FG000|Overall Study|new secondary cancer|1|||
13144839|NCT02619682|26028789|FG000|Overall Study|post surgery complications|2|||
13144840|NCT02619617|26028802|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0|||
13144841|NCT02619617|26028803|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1|||
13144842|NCT02619617|26028802|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0|||
13144843|NCT02619617|26028803|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3|||
13144844|NCT02619175|26028824|FG000|Overall Study|Withdrawal by Subject|1|||
13144845|NCT02619175|26028825|FG001|Overall Study|Withdrawal by Subject|0|||
13144846|NCT02619175|26028824|FG000|Overall Study|foot pain|1|||
13144847|NCT02619175|26028825|FG001|Overall Study|foot pain|0|||
13144848|NCT02618967|26028959|FG000|Overall Study|Lost to Follow-up|0|||
13144849|NCT02618967|26028960|FG001|Overall Study|Lost to Follow-up|0|||
13144850|NCT02618967|26028961|FG002|Overall Study|Lost to Follow-up|1|||
13144851|NCT02618967|26028962|FG003|Overall Study|Lost to Follow-up|0|||
13144852|NCT02618967|26028963|FG004|Overall Study|Lost to Follow-up|2|||
13144853|NCT02618967|26028964|FG005|Overall Study|Lost to Follow-up|0|||
13144854|NCT02618967|26028965|FG006|Overall Study|Lost to Follow-up|0|||
13144855|NCT02618967|26028966|FG007|Overall Study|Lost to Follow-up|0|||
13144856|NCT02618967|26028959|FG000|Overall Study|Withdrawal by Subject|1|||
13144857|NCT02618967|26028960|FG001|Overall Study|Withdrawal by Subject|0|||
13144858|NCT02618967|26028961|FG002|Overall Study|Withdrawal by Subject|0|||
13144859|NCT02618967|26028962|FG003|Overall Study|Withdrawal by Subject|0|||
13144860|NCT02618967|26028963|FG004|Overall Study|Withdrawal by Subject|0|||
13144861|NCT02618967|26028964|FG005|Overall Study|Withdrawal by Subject|0|||
13144862|NCT02618967|26028965|FG006|Overall Study|Withdrawal by Subject|0|||
13144863|NCT02618967|26028966|FG007|Overall Study|Withdrawal by Subject|0|||
13144864|NCT02618928|26028999|FG000|Overall Study|Failure to Return|28|||
13144865|NCT02618928|26028999|FG000|Overall Study|Insufficient Virological Response|1|||
13092326|NCT03700892|25827703|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
13144866|NCT02618928|26028999|FG000|Overall Study|Withdrawal by Subject|2|||
13144867|NCT02618928|26028999|FG000|Overall Study|Death|3|||
13144868|NCT02618928|26028999|FG000|Overall Study|Other|11|||
13144869|NCT02618928|26028999|FG000|Overall Study|Missing|6|||
13144870|NCT02618928|26028999|FG000|Overall Study|Treatment Never Started|7|||
13144871|NCT02618759|26029022|FG000|Overall Study|Lost to Follow-up|0|||
13144872|NCT02618759|26029023|FG001|Overall Study|Lost to Follow-up|1|||
13144873|NCT02618759|26029022|FG000|Overall Study|Withdrawal by Subject|1|||
13144874|NCT02618759|26029023|FG001|Overall Study|Withdrawal by Subject|0|||
13144875|NCT02618759|26029022|FG000|Overall Study|Other Reasons|1|||
13144876|NCT02618759|26029023|FG001|Overall Study|Other Reasons|4|||
13144877|NCT02618616|26029054|FG000|Overall Study|Lack of Efficacy|4|||
13144878|NCT02618616|26029055|FG001|Overall Study|Lack of Efficacy|0|||
13144879|NCT02618616|26029054|FG000|Overall Study|Pregnancy|0|||
13144880|NCT02618616|26029055|FG001|Overall Study|Pregnancy|1|||
13144881|NCT02618616|26029054|FG000|Overall Study|Adverse Event|8|||
13144882|NCT02618616|26029055|FG001|Overall Study|Adverse Event|0|||
13144883|NCT02618616|26029054|FG000|Overall Study|Failure to comply with dosing/evaluation|1|||
13144884|NCT02618616|26029055|FG001|Overall Study|Failure to comply with dosing/evaluation|0|||
13144885|NCT02618616|26029054|FG000|Overall Study|Consent withdrawn by subject|8|||
13144886|NCT02618616|26029055|FG001|Overall Study|Consent withdrawn by subject|5|||
13144887|NCT02618616|26029054|FG000|Overall Study|Lost to Follow-up|0|||
13144888|NCT02618616|26029055|FG001|Overall Study|Lost to Follow-up|1|||
13144889|NCT02618382|26029064|FG000|Overall Study|Physician Decision|1|||
13144890|NCT02618382|26029064|FG000|Overall Study|Withdrawal by Subject|1|||
13144891|NCT02618382|26029064|FG000|Overall Study|Protocol Violation|1|||
13144892|NCT02617628|26029079|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62|||
13144893|NCT02617628|26029080|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61|||
13144894|NCT02617589|26029101|FG000|All Randomized|Request to discontinue study treatment|1|||
13144895|NCT02617589|26029102|FG001|All Randomized|Request to discontinue study treatment|3|||
13144896|NCT02617589|26029101|FG000|All Randomized|Participant Withdrew Consent|1|||
13144897|NCT02617589|26029102|FG001|All Randomized|Participant Withdrew Consent|2|||
13144898|NCT02617589|26029101|FG000|Treatment Period|Other Reasons|2|||
13144899|NCT02617589|26029102|FG001|Treatment Period|Other Reasons|2|||
13144900|NCT02617589|26029101|FG000|Treatment Period|Not reported|1|||
13144901|NCT02617589|26029102|FG001|Treatment Period|Not reported|0|||
13144902|NCT02617589|26029101|FG000|Treatment Period|Poor/Non compliance|1|||
13144903|NCT02617589|26029102|FG001|Treatment Period|Poor/Non compliance|1|||
13144904|NCT02617589|26029101|FG000|Treatment Period|Maximum Clinical Benefit|0|||
13144905|NCT02617589|26029102|FG001|Treatment Period|Maximum Clinical Benefit|2|||
13144906|NCT02617589|26029101|FG000|Treatment Period|Participant Withdrew Consent|2|||
13144907|NCT02617589|26029102|FG001|Treatment Period|Participant Withdrew Consent|6|||
13144908|NCT02617589|26029101|FG000|Treatment Period|Participant Request to discontinue|12|||
13144909|NCT02617589|26029102|FG001|Treatment Period|Participant Request to discontinue|20|||
13092327|NCT03700892|25827704|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1|||
13092328|NCT03700892|25827705|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
13092329|NCT03700736|25827735|FG000|Overall Study|Pregnancy|1|||
13092330|NCT03700736|25827736|FG001|Overall Study|Pregnancy|1|||
13092331|NCT03700736|25827735|FG000|Overall Study|Withdrawal by Subject|2|||
13092332|NCT03700736|25827736|FG001|Overall Study|Withdrawal by Subject|6|||
13092333|NCT03700671|25827755|FG000|Overall Study|Lack of Efficacy|1|||
13092334|NCT03700671|25827756|FG001|Overall Study|Lack of Efficacy|2|||
13092335|NCT03700385|25827763|FG000|Overall Study|Lost to Follow-up|1|||
13092336|NCT03700320|25827784|FG000|Overall Study|Adverse Event|5|||
13092337|NCT03700320|25827785|FG001|Overall Study|Adverse Event|31|||
13092338|NCT03700320|25827784|FG000|Overall Study|Lack of Efficacy|2|||
13092339|NCT03700320|25827785|FG001|Overall Study|Lack of Efficacy|5|||
13092340|NCT03700320|25827784|FG000|Overall Study|Withdrawal by Subject|29|||
13092341|NCT03700320|25827785|FG001|Overall Study|Withdrawal by Subject|75|||
13092342|NCT03700320|25827784|FG000|Overall Study|Lost to Follow-up|16|||
13092343|NCT03700320|25827785|FG001|Overall Study|Lost to Follow-up|23|||
13092344|NCT03700320|25827784|FG000|Overall Study|Pregnancy|2|||
13092345|NCT03700320|25827785|FG001|Overall Study|Pregnancy|4|||
13092346|NCT03700320|25827784|FG000|Overall Study|Protocol Deviation|7|||
13092347|NCT03700320|25827785|FG001|Overall Study|Protocol Deviation|31|||
13092348|NCT03700320|25827784|FG000|Overall Study|Non-compliance with Study Drug|1|||
13092349|NCT03700320|25827785|FG001|Overall Study|Non-compliance with Study Drug|3|||
13092350|NCT03700320|25827784|FG000|Overall Study|Reason not Specified|0|||
13092351|NCT03700320|25827785|FG001|Overall Study|Reason not Specified|1|||
13092352|NCT03699124|25827839|FG000|Overall Study|Adverse Event|6|||
13092353|NCT03699124|25827840|FG001|Overall Study|Adverse Event|5|||
13092354|NCT03699124|25827841|FG002|Overall Study|Adverse Event|2|||
13092355|NCT03699124|25827839|FG000|Overall Study|Death|0|||
13092356|NCT03699124|25827840|FG001|Overall Study|Death|2|||
13092357|NCT03699124|25827841|FG002|Overall Study|Death|0|||
13092358|NCT03699124|25827839|FG000|Overall Study|Lost to Follow-up|20|||
13092359|NCT03699124|25827840|FG001|Overall Study|Lost to Follow-up|16|||
13092360|NCT03699124|25827841|FG002|Overall Study|Lost to Follow-up|15|||
13092361|NCT03699124|25827839|FG000|Overall Study|Protocol Violation|1|||
13092362|NCT03699124|25827840|FG001|Overall Study|Protocol Violation|0|||
13092363|NCT03699124|25827841|FG002|Overall Study|Protocol Violation|0|||
13092364|NCT03699124|25827839|FG000|Overall Study|Withdrawal by Subject|13|||
13092365|NCT03699124|25827840|FG001|Overall Study|Withdrawal by Subject|14|||
13092366|NCT03699124|25827841|FG002|Overall Study|Withdrawal by Subject|13|||
13144910|NCT02617589|26029101|FG000|Treatment Period|Adverse event unrelated to study drug|15|||
13144911|NCT02617589|26029102|FG001|Treatment Period|Adverse event unrelated to study drug|9|||
13144912|NCT02617589|26029101|FG000|Treatment Period|Death|1|||
13144913|NCT02617589|26029102|FG001|Treatment Period|Death|1|||
13144914|NCT02617589|26029101|FG000|Treatment Period|Study Drug Toxicity|26|||
13144915|NCT02617589|26029102|FG001|Treatment Period|Study Drug Toxicity|20|||
13144916|NCT02617589|26029101|FG000|Treatment Period|Disease Progression|214|||
13144917|NCT02617589|26029102|FG001|Treatment Period|Disease Progression|137|||
13144918|NCT02617589|26029101|FG000|Treatment Period|Completed Treatment|0|||
13144919|NCT02617589|26029102|FG001|Treatment Period|Completed Treatment|76|||
13144920|NCT02616900|26029110|FG000|Overall Study|Lack of Efficacy|7|||
13144921|NCT02616900|26029110|FG000|Overall Study|Lost to Follow-up|2|||
13144922|NCT02616900|26029110|FG000|Overall Study|Protocol Violation|5|||
13144923|NCT02616900|26029110|FG000|Overall Study|Withdrawal by Subject|3|||
13144924|NCT02616900|26029110|FG000|Overall Study|Incomplete data|6|||
13144925|NCT02616783|26029137|FG000|Overall Study|Randomized but Not Treated|1|||
13144926|NCT02616783|26029138|FG001|Overall Study|Randomized but Not Treated|0|||
13144927|NCT02616783|26029137|FG000|Overall Study|Adverse Event|1|||
13144928|NCT02616783|26029138|FG001|Overall Study|Adverse Event|0|||
13144929|NCT02616783|26029137|FG000|Overall Study|Death|1|||
13144930|NCT02616783|26029138|FG001|Overall Study|Death|0|||
13144931|NCT02616783|26029137|FG000|Overall Study|Non-Compliance with Study Drug|1|||
13144932|NCT02616783|26029138|FG001|Overall Study|Non-Compliance with Study Drug|0|||
13144933|NCT02616783|26029137|FG000|Overall Study|Protocol Violation|1|||
13144934|NCT02616783|26029138|FG001|Overall Study|Protocol Violation|1|||
13144935|NCT02616783|26029137|FG000|Overall Study|Withdrew Consent|1|||
13144936|NCT02616783|26029138|FG001|Overall Study|Withdrew Consent|1|||
13144937|NCT02616614|26029162|FG000|Overall Study|Withdrawal by Subject|10|||
13144938|NCT02616614|26029163|FG001|Overall Study|Withdrawal by Subject|5|||
13144939|NCT02616614|26029164|FG002|Overall Study|Withdrawal by Subject|6|||
13144940|NCT02616614|26029162|FG000|Overall Study|Physician Decision|2|||
13144941|NCT02616614|26029163|FG001|Overall Study|Physician Decision|1|||
13144942|NCT02616614|26029164|FG002|Overall Study|Physician Decision|0|||
13144943|NCT02616614|26029162|FG000|Overall Study|Adverse Event|1|||
13144944|NCT02616614|26029163|FG001|Overall Study|Adverse Event|4|||
13144945|NCT02616614|26029164|FG002|Overall Study|Adverse Event|1|||
13144946|NCT02616614|26029162|FG000|Overall Study|Protocol Violation|0|||
13144947|NCT02616614|26029163|FG001|Overall Study|Protocol Violation|3|||
13144948|NCT02616614|26029164|FG002|Overall Study|Protocol Violation|1|||
13144949|NCT02616614|26029162|FG000|Overall Study|Prohibited Medication|12|||
13092367|NCT03699124|25827839|FG000|Overall Study|Other reasons|5|||
13092368|NCT03699124|25827840|FG001|Overall Study|Other reasons|3|||
13092369|NCT03699124|25827841|FG002|Overall Study|Other reasons|10|||
13092370|NCT03698591|25827860|FG000|Overall Study|Withdrawal by Subject|2|||
13092371|NCT03698591|25827861|FG001|Overall Study|Withdrawal by Subject|2|||
13092372|NCT03698591|25827860|FG000|Overall Study|Failed drug screen|1|||
13092373|NCT03698591|25827861|FG001|Overall Study|Failed drug screen|1|||
13092374|NCT03698591|25827860|FG000|Overall Study|Failed health screen|0|||
13092375|NCT03698591|25827861|FG001|Overall Study|Failed health screen|1|||
13092376|NCT03698591|25827860|FG000|Overall Study|Ineligible for financial compensation|1|||
13092377|NCT03698591|25827861|FG001|Overall Study|Ineligible for financial compensation|0|||
13092378|NCT03698591|25827860|FG000|Overall Study|Equipment Error|1|||
13092379|NCT03698591|25827861|FG001|Overall Study|Equipment Error|0|||
13092380|NCT03698591|25827860|FG000|Overall Study|Could not establish TMS dosage|0|||
13092381|NCT03698591|25827861|FG001|Overall Study|Could not establish TMS dosage|1|||
13092382|NCT03698331|25827884|FG000|Overall Study|Adverse Event|2|||
13092383|NCT03698331|25827885|FG001|Overall Study|Adverse Event|3|||
13092384|NCT03698331|25827884|FG000|Overall Study|Withdrawal by Subject|1|||
13092385|NCT03698331|25827885|FG001|Overall Study|Withdrawal by Subject|1|||
13092386|NCT03698331|25827884|FG000|Overall Study|Lost to Follow-up|0|||
13092387|NCT03698331|25827885|FG001|Overall Study|Lost to Follow-up|2|||
13092388|NCT03698331|25827884|FG000|Overall Study|Non-compliance with study drug|1|||
13092389|NCT03698331|25827885|FG001|Overall Study|Non-compliance with study drug|0|||
13092390|NCT03697993|25827911|FG000|Overall Study|Became Ineligible after Enrollment|1|||
13092391|NCT03697993|25827912|FG001|Overall Study|Became Ineligible after Enrollment|3|||
13092392|NCT03697993|25827911|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
13092393|NCT03697993|25827912|FG001|Overall Study|Enrolled but Treatment not Administered|1|||
13144950|NCT02616614|26029163|FG001|Overall Study|Prohibited Medication|9|||
13144951|NCT02616614|26029164|FG002|Overall Study|Prohibited Medication|5|||
13144952|NCT02616614|26029162|FG000|Overall Study|More than 3 applications missed|6|||
13092394|NCT03697993|25827911|FG000|Overall Study|Lost to Follow-up|3|||
13092395|NCT03697993|25827912|FG001|Overall Study|Lost to Follow-up|0|||
13092396|NCT03697993|25827911|FG000|Overall Study|Physician Decision|4|||
13092397|NCT03697993|25827912|FG001|Overall Study|Physician Decision|0|||
13092398|NCT03697993|25827911|FG000|Overall Study|Initial Urine Culture Negative|0|||
13092399|NCT03697993|25827912|FG001|Overall Study|Initial Urine Culture Negative|1|||
13092400|NCT03697460|25827923|FG000|Overall Study|Withdrawal by Subject|3|||
13144953|NCT02616614|26029163|FG001|Overall Study|More than 3 applications missed|8|||
13144954|NCT02616614|26029164|FG002|Overall Study|More than 3 applications missed|1|||
13144955|NCT02616614|26029162|FG000|Overall Study|Lost to Follow-up|31|||
13144956|NCT02616614|26029163|FG001|Overall Study|Lost to Follow-up|28|||
13144957|NCT02616614|26029164|FG002|Overall Study|Lost to Follow-up|13|||
13144958|NCT02616614|26029162|FG000|Overall Study|Pregnancy|2|||
13144959|NCT02616614|26029163|FG001|Overall Study|Pregnancy|0|||
13144960|NCT02616614|26029164|FG002|Overall Study|Pregnancy|1|||
13144961|NCT02616614|26029162|FG000|Overall Study|Other|1|||
13144962|NCT02616614|26029163|FG001|Overall Study|Other|2|||
13144963|NCT02616614|26029164|FG002|Overall Study|Other|1|||
13144964|NCT02616601|26029182|FG000|Overall Study|Withdrawal by Subject|4|||
13144965|NCT02616601|26029183|FG001|Overall Study|Withdrawal by Subject|4|||
13144966|NCT02616601|26029184|FG002|Overall Study|Withdrawal by Subject|3|||
13144967|NCT02616601|26029182|FG000|Overall Study|Adverse Event|2|||
13144968|NCT02616601|26029183|FG001|Overall Study|Adverse Event|0|||
13144969|NCT02616601|26029184|FG002|Overall Study|Adverse Event|2|||
13144970|NCT02616601|26029182|FG000|Overall Study|Death|1|||
13144971|NCT02616601|26029183|FG001|Overall Study|Death|0|||
13144972|NCT02616601|26029184|FG002|Overall Study|Death|0|||
13144973|NCT02616601|26029182|FG000|Overall Study|Lost to Follow-up|1|||
13144974|NCT02616601|26029183|FG001|Overall Study|Lost to Follow-up|0|||
13144975|NCT02616601|26029184|FG002|Overall Study|Lost to Follow-up|1|||
13144976|NCT02616601|26029182|FG000|Overall Study|Non-Compliance with Test Article|1|||
13144977|NCT02616601|26029183|FG001|Overall Study|Non-Compliance with Test Article|0|||
13144978|NCT02616601|26029184|FG002|Overall Study|Non-Compliance with Test Article|1|||
13144979|NCT02616393|26029228|FG000|Overall Study|Death|5|||
13144980|NCT02616393|26029229|FG001|Overall Study|Death|12|||
13144981|NCT02616393|26029230|FG002|Overall Study|Death|1|||
13144982|NCT02616393|26029228|FG000|Overall Study|Termination by Sponsor|4|||
13144983|NCT02616393|26029229|FG001|Overall Study|Termination by Sponsor|5|||
13144984|NCT02616393|26029230|FG002|Overall Study|Termination by Sponsor|2|||
13144985|NCT02616393|26029228|FG000|Overall Study|Other|3|||
13144986|NCT02616393|26029229|FG001|Overall Study|Other|0|||
13144987|NCT02616393|26029230|FG002|Overall Study|Other|0|||
13144988|NCT02616393|26029228|FG000|Overall Study|Withdrawal by Subject|1|||
13144989|NCT02616393|26029229|FG001|Overall Study|Withdrawal by Subject|1|||
13144990|NCT02616393|26029230|FG002|Overall Study|Withdrawal by Subject|0|||
13144991|NCT02616393|26029228|FG000|Overall Study|Lost to Follow-up|0|||
13144992|NCT02616393|26029229|FG001|Overall Study|Lost to Follow-up|2|||
13144993|NCT02616393|26029230|FG002|Overall Study|Lost to Follow-up|0|||
13144994|NCT02616380|26029245|FG000|Overall Study|Lost to Follow-up|1|||
13144995|NCT02616380|26029245|FG000|Overall Study|Other|2|||
13144996|NCT02616029|26029321|FG000|Overall Study|Adverse Event|1|||
13144997|NCT02616029|26029322|FG001|Overall Study|Adverse Event|0|||
13144998|NCT02616029|26029321|FG000|Overall Study|Death|0|||
13144999|NCT02616029|26029322|FG001|Overall Study|Death|1|||
13145000|NCT02616029|26029321|FG000|Overall Study|Protocol Violation|1|||
13145001|NCT02616029|26029322|FG001|Overall Study|Protocol Violation|0|||
13145002|NCT02616029|26029321|FG000|Overall Study|Withdrew Consent|1|||
13145003|NCT02616029|26029322|FG001|Overall Study|Withdrew Consent|0|||
13145004|NCT02616029|26029321|FG000|Overall Study|Enrolled and Never Treated|1|||
13145005|NCT02616029|26029322|FG001|Overall Study|Enrolled and Never Treated|1|||
13145006|NCT02615990|26029373|FG000|Overall Study|study terminated|1|||
13145007|NCT02615990|26029374|FG001|Overall Study|study terminated|1|||
13145008|NCT02615509|26029384|FG000|Overall Study|Lost to Follow-up|134|||
13145009|NCT02615509|26029384|FG000|Overall Study|Death|4|||
13145010|NCT02615509|26029384|FG000|Overall Study|Withdrawal by Subject|8|||
13145011|NCT02615470|26029401|FG000|Overall Study|Lost to Follow-up|21|||
13145012|NCT02615470|26029402|FG001|Overall Study|Lost to Follow-up|32|||
13145013|NCT02615249|26029411|FG000|Overall Study|Withdrawal by Subject|1|||
13145014|NCT02615171|26029436|FG000|Overall Study|Lost to Follow-up|2|||
13145015|NCT02615171|26029437|FG001|Overall Study|Lost to Follow-up|1|||
13145016|NCT02615145|26029522|FG000|Overall Study|Did Not Start Treatment|0|||
13145017|NCT02615145|26029523|FG001|Overall Study|Did Not Start Treatment|0|||
13145018|NCT02615145|26029524|FG002|Overall Study|Did Not Start Treatment|1|||
13145019|NCT02615145|26029525|FG003|Overall Study|Did Not Start Treatment|1|||
13145020|NCT02615145|26029522|FG000|Overall Study|Failure to Return|20|||
13092401|NCT03697252|25827946|FG000|Overall Study|Adverse Event|3|||
13145021|NCT02615145|26029523|FG001|Overall Study|Failure to Return|10|||
13145022|NCT02615145|26029524|FG002|Overall Study|Failure to Return|7|||
13145023|NCT02615145|26029525|FG003|Overall Study|Failure to Return|0|||
13145024|NCT02615145|26029522|FG000|Overall Study|Death|2|||
13145025|NCT02615145|26029523|FG001|Overall Study|Death|3|||
13145026|NCT02615145|26029524|FG002|Overall Study|Death|0|||
13145027|NCT02615145|26029525|FG003|Overall Study|Death|0|||
13145028|NCT02615145|26029522|FG000|Overall Study|Other, Not Specified|5|||
13145029|NCT02615145|26029523|FG001|Overall Study|Other, Not Specified|2|||
13145030|NCT02615145|26029524|FG002|Overall Study|Other, Not Specified|0|||
13145031|NCT02615145|26029525|FG003|Overall Study|Other, Not Specified|0|||
13145032|NCT02614898|26029542|FG000|Overall Study|Participated until study termination|10|||
13145033|NCT02614898|26029543|FG001|Overall Study|Participated until study termination|26|||
13145034|NCT02614898|26029542|FG000|Overall Study|Lost to Follow-up|0|||
13145035|NCT02614898|26029543|FG001|Overall Study|Lost to Follow-up|2|||
13145036|NCT02614898|26029542|FG000|Overall Study|Physician Decision|1|||
13145037|NCT02614898|26029543|FG001|Overall Study|Physician Decision|8|||
13145038|NCT02614898|26029542|FG000|Overall Study|Study Terminated by Sponsor|3|||
13145039|NCT02614898|26029543|FG001|Overall Study|Study Terminated by Sponsor|0|||
13145040|NCT02614898|26029542|FG000|Overall Study|Withdrawal by Subject|0|||
13145041|NCT02614898|26029543|FG001|Overall Study|Withdrawal by Subject|2|||
13145042|NCT02614898|26029542|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
13145043|NCT02614898|26029543|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
13145044|NCT02614898|26029542|FG000|Overall Study|Other-Additional Information Unavailable|0|||
13145045|NCT02614898|26029543|FG001|Overall Study|Other-Additional Information Unavailable|11|||
13145046|NCT02614898|26029542|FG000|Overall Study|Missing|0|||
13145047|NCT02614898|26029543|FG001|Overall Study|Missing|1|||
13145048|NCT02614859|26029564|FG000|Overall Study|Physician Decision|0|||
13145049|NCT02614859|26029565|FG001|Overall Study|Physician Decision|1|||
13145050|NCT02614794|26029604|FG000|Overall Study|On treatment|118|||
13145051|NCT02614794|26029605|FG001|Overall Study|On treatment|27|||
13145052|NCT02614794|26029604|FG000|Overall Study|In long term follow up|148|||
13145053|NCT02614794|26029605|FG001|Overall Study|In long term follow up|85|||
13092402|NCT03697252|25827947|FG001|Overall Study|Adverse Event|2|||
13092403|NCT03697252|25827946|FG000|Overall Study|Withdrawal by Subject|14|||
13092404|NCT03697252|25827947|FG001|Overall Study|Withdrawal by Subject|14|||
13092405|NCT03697252|25827946|FG000|Overall Study|Lost to Follow-up|0|||
13092406|NCT03697252|25827947|FG001|Overall Study|Lost to Follow-up|1|||
13092407|NCT03697252|25827946|FG000|Overall Study|Physician Decision|1|||
13092408|NCT03697252|25827947|FG001|Overall Study|Physician Decision|1|||
13092409|NCT03697252|25827946|FG000|Overall Study|Other|0|||
13092410|NCT03697252|25827947|FG001|Overall Study|Other|1|||
13092411|NCT03696576|25827984|FG000|Overall Study|Soreness of throat after therapy|1|||
13092412|NCT03696576|25827985|FG001|Overall Study|Soreness of throat after therapy|1|||
13092413|NCT03696576|25827984|FG000|Overall Study|Lost to Follow-up|2|||
13092414|NCT03696576|25827985|FG001|Overall Study|Lost to Follow-up|4|||
13092415|NCT03696342|25828008|FG000|Overall Study|Lost to Follow-up|1|||
13092416|NCT03696342|25828009|FG001|Overall Study|Lost to Follow-up|0|||
13092417|NCT03696108|25828030|FG000|Overall Study|Physician Decision|1|||
13092418|NCT03696108|25828031|FG001|Overall Study|Physician Decision|0|||
13092419|NCT03696108|25828030|FG000|Overall Study|Withdrawal by Subject|3|||
13092420|NCT03696108|25828031|FG001|Overall Study|Withdrawal by Subject|6|||
13092421|NCT03695393|25828058|FG000|Overall Study|Death|3|||
13092422|NCT03695393|25828059|FG001|Overall Study|Death|1|||
13092423|NCT03695393|25828058|FG000|Overall Study|Lost to Follow-up|0|||
13092424|NCT03695393|25828059|FG001|Overall Study|Lost to Follow-up|1|||
13092425|NCT03695367|25828080|FG000|Overall Study|Missed the Day 28 visit.|1|||
13092426|NCT03695367|25828081|FG001|Overall Study|Missed the Day 28 visit.|0|||
13092427|NCT03695367|25828080|FG000|Overall Study|Lost to Follow-up|0|||
13092428|NCT03695367|25828081|FG001|Overall Study|Lost to Follow-up|1|||
13092429|NCT03695367|25828080|FG000|Overall Study|Withdrawal by Subject|0|||
13092430|NCT03695367|25828081|FG001|Overall Study|Withdrawal by Subject|1|||
13092431|NCT03695367|25828080|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0|||
13145054|NCT02614794|26029604|FG000|Overall Study|Death|126|||
13145055|NCT02614794|26029605|FG001|Overall Study|Death|84|||
13145056|NCT02614794|26029604|FG000|Overall Study|Withdrawal by Subject|16|||
13145057|NCT02614794|26029605|FG001|Overall Study|Withdrawal by Subject|5|||
13145058|NCT02614794|26029604|FG000|Overall Study|Lost to Follow-up|2|||
13145059|NCT02614794|26029605|FG001|Overall Study|Lost to Follow-up|0|||
13145060|NCT02614794|26029604|FG000|Overall Study|Physician Decision|0|||
13145061|NCT02614794|26029605|FG001|Overall Study|Physician Decision|1|||
13145062|NCT02614729|26029630|FG000|Overall Study|Withdrawal by Subject|1|||
13145063|NCT02614729|26029631|FG001|Overall Study|Withdrawal by Subject|0|||
13145064|NCT02614703|26029644|FG000|Overall Study|Withdrawal by Subject|7|||
13145065|NCT02614703|26029645|FG001|Overall Study|Withdrawal by Subject|1|||
13145066|NCT02614560|26029667|FG000|Overall Study|Death|6|||
13145067|NCT02614560|26029668|FG001|Overall Study|Death|2|||
13145068|NCT02614287|26029709|FG000|Open Label (OL) Treatment Phase|Adverse Event|7|||
13092432|NCT03695367|25828081|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2|||
13092433|NCT03695094|25828121|FG000|Overall Study|Adverse Event|1|||
13145069|NCT02614287|26029710|FG001|Open Label (OL) Treatment Phase|Adverse Event|6|||
13145070|NCT02614287|26029709|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13|||
13145071|NCT02614287|26029710|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5|||
13145072|NCT02614287|26029709|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7|||
13145073|NCT02614287|26029710|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4|||
13145074|NCT02614287|26029709|FG000|Open Label (OL) Treatment Phase|Physician Decision|1|||
13145075|NCT02614287|26029710|FG001|Open Label (OL) Treatment Phase|Physician Decision|0|||
13145076|NCT02614287|26029709|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10|||
13145077|NCT02614287|26029710|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7|||
13145078|NCT02614287|26029709|FG000|Post Treatment Follow-up Phase|Adverse Event|1|||
13145079|NCT02614287|26029710|FG001|Post Treatment Follow-up Phase|Adverse Event|0|||
13145080|NCT02614287|26029709|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
13145081|NCT02614287|26029710|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
13145082|NCT02614287|26029709|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6|||
13145083|NCT02614287|26029710|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3|||
13145084|NCT02614261|26029768|FG000|Double-Blind Treatment Phase|Adverse Event|7|||
13145085|NCT02614261|26029769|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
13145086|NCT02614261|26029770|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
13145087|NCT02614261|26029771|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
13145088|NCT02614261|26029768|FG000|Double-Blind Treatment Phase|Lack of Efficacy|4|||
13145089|NCT02614261|26029769|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
13145090|NCT02614261|26029770|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
13145091|NCT02614261|26029771|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
13145092|NCT02614261|26029768|FG000|Double-Blind Treatment Phase|Lost to Follow-up|9|||
13145093|NCT02614261|26029769|FG001|Double-Blind Treatment Phase|Lost to Follow-up|4|||
13145094|NCT02614261|26029770|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
13145095|NCT02614261|26029771|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
13145096|NCT02614261|26029768|FG000|Double-Blind Treatment Phase|Physician Decision|2|||
13145097|NCT02614261|26029769|FG001|Double-Blind Treatment Phase|Physician Decision|1|||
13145098|NCT02614261|26029770|FG002|Double-Blind Treatment Phase|Physician Decision|1|||
13145099|NCT02614261|26029771|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
13145100|NCT02614261|26029768|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
13145101|NCT02614261|26029769|FG001|Double-Blind Treatment Phase|Pregnancy|2|||
13145102|NCT02614261|26029770|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
13145103|NCT02614261|26029771|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
13145104|NCT02614261|26029768|FG000|Double-Blind Treatment Phase|Protocol Violation|6|||
13145105|NCT02614261|26029769|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
13145106|NCT02614261|26029770|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
13145107|NCT02614261|26029771|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
13145108|NCT02614261|26029768|FG000|Double-Blind Treatment Phase|Screen failure|0|||
13145109|NCT02614261|26029769|FG001|Double-Blind Treatment Phase|Screen failure|1|||
13145110|NCT02614261|26029770|FG002|Double-Blind Treatment Phase|Screen failure|2|||
13145111|NCT02614261|26029771|FG003|Double-Blind Treatment Phase|Screen failure|0|||
13145112|NCT02614261|26029768|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|20|||
13145113|NCT02614261|26029769|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
13145114|NCT02614261|26029770|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|7|||
13145115|NCT02614261|26029771|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
13145116|NCT02614261|26029768|FG000|Open-Label Extension Phase|Adverse Event|23|||
13145117|NCT02614261|26029769|FG001|Open-Label Extension Phase|Adverse Event|12|||
13145118|NCT02614261|26029770|FG002|Open-Label Extension Phase|Adverse Event|11|||
13145119|NCT02614261|26029771|FG003|Open-Label Extension Phase|Adverse Event|0|||
13145120|NCT02614261|26029768|FG000|Open-Label Extension Phase|Lack of Efficacy|14|||
13145121|NCT02614261|26029769|FG001|Open-Label Extension Phase|Lack of Efficacy|12|||
13145122|NCT02614261|26029770|FG002|Open-Label Extension Phase|Lack of Efficacy|14|||
13145123|NCT02614261|26029771|FG003|Open-Label Extension Phase|Lack of Efficacy|0|||
13145124|NCT02614261|26029768|FG000|Open-Label Extension Phase|Lost to Follow-up|15|||
13145125|NCT02614261|26029769|FG001|Open-Label Extension Phase|Lost to Follow-up|7|||
13145126|NCT02614261|26029770|FG002|Open-Label Extension Phase|Lost to Follow-up|9|||
13145127|NCT02614261|26029771|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
13145128|NCT02614261|26029768|FG000|Open-Label Extension Phase|Physician Decision|2|||
13145129|NCT02614261|26029769|FG001|Open-Label Extension Phase|Physician Decision|0|||
13145130|NCT02614261|26029770|FG002|Open-Label Extension Phase|Physician Decision|0|||
13145131|NCT02614261|26029771|FG003|Open-Label Extension Phase|Physician Decision|0|||
13145132|NCT02614261|26029768|FG000|Open-Label Extension Phase|Pregnancy|1|||
13145133|NCT02614261|26029769|FG001|Open-Label Extension Phase|Pregnancy|2|||
13145134|NCT02614261|26029770|FG002|Open-Label Extension Phase|Pregnancy|1|||
13145135|NCT02614261|26029771|FG003|Open-Label Extension Phase|Pregnancy|0|||
13145136|NCT02614261|26029768|FG000|Open-Label Extension Phase|Protocol Violation|3|||
13145137|NCT02614261|26029769|FG001|Open-Label Extension Phase|Protocol Violation|4|||
13145138|NCT02614261|26029770|FG002|Open-Label Extension Phase|Protocol Violation|1|||
13145139|NCT02614261|26029771|FG003|Open-Label Extension Phase|Protocol Violation|0|||
13145140|NCT02614261|26029768|FG000|Open-Label Extension Phase|Withdrawal by Subject|30|||
13145141|NCT02614261|26029769|FG001|Open-Label Extension Phase|Withdrawal by Subject|18|||
13145142|NCT02614261|26029770|FG002|Open-Label Extension Phase|Withdrawal by Subject|18|||
13145143|NCT02614261|26029771|FG003|Open-Label Extension Phase|Withdrawal by Subject|0|||
13145144|NCT02614261|26029768|FG000|Follow-up Phase|Adverse Event|2|||
13145145|NCT02614261|26029769|FG001|Follow-up Phase|Adverse Event|0|||
13145146|NCT02614261|26029770|FG002|Follow-up Phase|Adverse Event|1|||
13145147|NCT02614261|26029771|FG003|Follow-up Phase|Adverse Event|0|||
13145148|NCT02614261|26029768|FG000|Follow-up Phase|Lost to Follow-up|12|||
13145149|NCT02614261|26029769|FG001|Follow-up Phase|Lost to Follow-up|5|||
13145150|NCT02614261|26029770|FG002|Follow-up Phase|Lost to Follow-up|2|||
13145151|NCT02614261|26029771|FG003|Follow-up Phase|Lost to Follow-up|0|||
13145152|NCT02614261|26029768|FG000|Follow-up Phase|Physician Decision|5|||
13145153|NCT02614261|26029769|FG001|Follow-up Phase|Physician Decision|1|||
13145154|NCT02614261|26029770|FG002|Follow-up Phase|Physician Decision|0|||
13145155|NCT02614261|26029771|FG003|Follow-up Phase|Physician Decision|0|||
13145156|NCT02614261|26029768|FG000|Follow-up Phase|Pregnancy|0|||
13145157|NCT02614261|26029769|FG001|Follow-up Phase|Pregnancy|1|||
13145158|NCT02614261|26029770|FG002|Follow-up Phase|Pregnancy|0|||
13145159|NCT02614261|26029771|FG003|Follow-up Phase|Pregnancy|0|||
13145160|NCT02614261|26029768|FG000|Follow-up Phase|Protocol Violation|1|||
13145161|NCT02614261|26029769|FG001|Follow-up Phase|Protocol Violation|0|||
13145162|NCT02614261|26029770|FG002|Follow-up Phase|Protocol Violation|0|||
13145163|NCT02614261|26029771|FG003|Follow-up Phase|Protocol Violation|0|||
13145164|NCT02614261|26029768|FG000|Follow-up Phase|Withdrawal by Subject|12|||
13145165|NCT02614261|26029769|FG001|Follow-up Phase|Withdrawal by Subject|4|||
13145166|NCT02614261|26029770|FG002|Follow-up Phase|Withdrawal by Subject|11|||
13145167|NCT02614261|26029771|FG003|Follow-up Phase|Withdrawal by Subject|0|||
13145168|NCT02614261|26029768|FG000|Israel Addendum|Withdrawal by Subject|0|||
13145169|NCT02614261|26029769|FG001|Israel Addendum|Withdrawal by Subject|0|||
13145170|NCT02614261|26029770|FG002|Israel Addendum|Withdrawal by Subject|0|||
13145171|NCT02614261|26029771|FG003|Israel Addendum|Withdrawal by Subject|4|||
13145172|NCT02614196|26029833|FG000|Double Blind Treatment Phase|Adverse Event|8|||
13145173|NCT02614196|26029834|FG001|Double Blind Treatment Phase|Adverse Event|5|||
13145174|NCT02614196|26029835|FG002|Double Blind Treatment Phase|Adverse Event|9|||
13145175|NCT02614196|26029836|FG003|Double Blind Treatment Phase|Adverse Event|0|||
13145176|NCT02614196|26029837|FG004|Double Blind Treatment Phase|Adverse Event|0|||
13145177|NCT02614196|26029838|FG005|Double Blind Treatment Phase|Adverse Event|0|||
13145178|NCT02614196|26029833|FG000|Double Blind Treatment Phase|Lack of Efficacy|6|||
13145179|NCT02614196|26029834|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
13145180|NCT02614196|26029835|FG002|Double Blind Treatment Phase|Lack of Efficacy|1|||
13145181|NCT02614196|26029836|FG003|Double Blind Treatment Phase|Lack of Efficacy|0|||
13145182|NCT02614196|26029837|FG004|Double Blind Treatment Phase|Lack of Efficacy|0|||
13145183|NCT02614196|26029838|FG005|Double Blind Treatment Phase|Lack of Efficacy|0|||
13145184|NCT02614196|26029833|FG000|Double Blind Treatment Phase|Lost to Follow-up|10|||
13145185|NCT02614196|26029834|FG001|Double Blind Treatment Phase|Lost to Follow-up|7|||
13145186|NCT02614196|26029835|FG002|Double Blind Treatment Phase|Lost to Follow-up|1|||
13145187|NCT02614196|26029836|FG003|Double Blind Treatment Phase|Lost to Follow-up|0|||
13145188|NCT02614196|26029837|FG004|Double Blind Treatment Phase|Lost to Follow-up|0|||
13145189|NCT02614196|26029838|FG005|Double Blind Treatment Phase|Lost to Follow-up|0|||
13145190|NCT02614196|26029833|FG000|Double Blind Treatment Phase|Physician Decision|4|||
13145191|NCT02614196|26029834|FG001|Double Blind Treatment Phase|Physician Decision|0|||
13222583|NCT01805037|26286501|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0|||
13222584|NCT01805037|26286502|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1|||
13222585|NCT01805037|26286501|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0|||
13222586|NCT01805037|26286502|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1|||
13222587|NCT01805037|26286501|FG000|Follow Up (up to 3 Years)|Death|0|||
13222588|NCT01805037|26286502|FG001|Follow Up (up to 3 Years)|Death|2|||
13222589|NCT01805037|26286501|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0|||
13222590|NCT01805037|26286502|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3|||
13222591|NCT01805037|26286501|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0|||
13222592|NCT01805037|26286502|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1|||
13222593|NCT01804946|26286531|FG000|Overall Study|Protocol Violation|1|||
13222594|NCT01804946|26286532|FG001|Overall Study|Protocol Violation|0|||
13222595|NCT01804946|26286531|FG000|Overall Study|Adverse Event|0|||
13222596|NCT01804946|26286532|FG001|Overall Study|Adverse Event|1|||
13222597|NCT01804946|26286531|FG000|Overall Study|Insufficient data available|0|||
13222598|NCT01804946|26286532|FG001|Overall Study|Insufficient data available|1|||
13222599|NCT01804946|26286531|FG000|Overall Study|Do not meet inclusion criteria|1|||
13222600|NCT01804946|26286532|FG001|Overall Study|Do not meet inclusion criteria|2|||
13145192|NCT02614196|26029835|FG002|Double Blind Treatment Phase|Physician Decision|2|||
13145193|NCT02614196|26029836|FG003|Double Blind Treatment Phase|Physician Decision|0|||
13145194|NCT02614196|26029837|FG004|Double Blind Treatment Phase|Physician Decision|0|||
13222601|NCT01804842|26286559|FG000|Overall Study|Adverse Event|1|||
13222602|NCT01804842|26286560|FG001|Overall Study|Adverse Event|1|||
13222603|NCT01804842|26286561|FG002|Overall Study|Adverse Event|0|||
13222604|NCT01804842|26286559|FG000|Overall Study|Lost to Follow-up|1|||
13222605|NCT01804842|26286560|FG001|Overall Study|Lost to Follow-up|0|||
13092434|NCT03695094|25828122|FG001|Overall Study|Adverse Event|1|||
13092435|NCT03695094|25828121|FG000|Overall Study|Withdrawal by Subject|1|||
13092436|NCT03695094|25828122|FG001|Overall Study|Withdrawal by Subject|0|||
13092437|NCT03694925|25828145|FG000|Overall Study|Inadequate laboratory testing|0|||
13092438|NCT03694925|25828146|FG001|Overall Study|Inadequate laboratory testing|3|||
13092439|NCT03694925|25828147|FG002|Overall Study|Inadequate laboratory testing|0|||
13092440|NCT03694821|25828186|FG000|Overall Study|Study terminated|4|||
13092441|NCT03694821|25828187|FG001|Overall Study|Study terminated|8|||
13092442|NCT03694821|25828188|FG002|Overall Study|Study terminated|4|||
13092443|NCT03694548|25828207|FG000|Part A Survey|Protocol Violation|3|||
13092444|NCT03694548|25828208|FG001|Part A Survey|Protocol Violation|3|||
13092445|NCT03694548|25828209|FG002|Part A Survey|Protocol Violation|0|||
13092446|NCT03694548|25828207|FG000|Part B Yoga Program|Protocol Violation|0|||
13092447|NCT03694548|25828208|FG001|Part B Yoga Program|Protocol Violation|0|||
13092448|NCT03694548|25828209|FG002|Part B Yoga Program|Protocol Violation|3|||
13092449|NCT03694548|25828207|FG000|Part B Yoga Program|Did not attend intervention|0|||
13092450|NCT03694548|25828208|FG001|Part B Yoga Program|Did not attend intervention|0|||
13092451|NCT03694548|25828209|FG002|Part B Yoga Program|Did not attend intervention|8|||
13092452|NCT03694353|25828216|FG000|Overall Study|Withdrawal by Subject|1|||
13092453|NCT03694353|25828216|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1|||
13092454|NCT03694327|25828233|FG000|Overall Study|Lost to Follow-up|13|||
13092455|NCT03694327|25828234|FG001|Overall Study|Lost to Follow-up|23|||
13092456|NCT03694275|25828264|FG000|Overall Study|Adverse Event|0|||
13092457|NCT03694275|25828265|FG001|Overall Study|Adverse Event|1|||
13092458|NCT03694275|25828264|FG000|Overall Study|Reason not Specified|0|||
13092459|NCT03694275|25828265|FG001|Overall Study|Reason not Specified|1|||
13092460|NCT03694210|25828278|FG000|Overall Study|Death|1|||
13092461|NCT03694210|25828278|FG000|Overall Study|Screen Failure|7|||
13092462|NCT03694197|25828316|FG000|Overall Study|Adverse Event|9|||
13092463|NCT03694197|25828316|FG000|Overall Study|Protocol became inconvenient to participate|1|||
13092464|NCT03694197|25828316|FG000|Overall Study|Physician Decision|4|||
13092465|NCT03694197|25828316|FG000|Overall Study|Study terminated by sponsor|1350|||
13092466|NCT03694197|25828316|FG000|Overall Study|Participant moved|5|||
13092467|NCT03694197|25828316|FG000|Overall Study|Participant withdrew consent|10|||
13092468|NCT03694197|25828316|FG000|Overall Study|Related to IMP administration|1|||
13092469|NCT03694197|25828316|FG000|Overall Study|Not disclosed|5|||
13092470|NCT03693989|25828345|FG000|Overall Study|Protocol Violation|3|||
13092471|NCT03693989|25828346|FG001|Overall Study|Protocol Violation|4|||
13092472|NCT03693950|25828371|FG000|Overall Study|Withdrawal by Subject|1|||
13092473|NCT03693950|25828372|FG001|Overall Study|Withdrawal by Subject|0|||
13092474|NCT03693625|25828387|FG000|Overall Study|Adverse Event|2|||
13092475|NCT03693625|25828388|FG001|Overall Study|Adverse Event|0|||
13092476|NCT03693625|25828387|FG000|Overall Study|Study Terminated By Sponsor|20|||
13092477|NCT03693625|25828388|FG001|Overall Study|Study Terminated By Sponsor|7|||
13092478|NCT03693625|25828387|FG000|Overall Study|Withdrawal by Subject|1|||
13092479|NCT03693625|25828388|FG001|Overall Study|Withdrawal by Subject|1|||
13092480|NCT03693612|25828680|FG000|Overall Study|Lost to Follow-up|0|||
13092481|NCT03693612|25828681|FG001|Overall Study|Lost to Follow-up|0|||
13092482|NCT03693612|25828682|FG002|Overall Study|Lost to Follow-up|0|||
13092483|NCT03693612|25828683|FG003|Overall Study|Lost to Follow-up|0|||
13092484|NCT03693612|25828684|FG004|Overall Study|Lost to Follow-up|1|||
13092485|NCT03693612|25828685|FG005|Overall Study|Lost to Follow-up|0|||
13092486|NCT03693612|25828686|FG006|Overall Study|Lost to Follow-up|0|||
13092487|NCT03693612|25828680|FG000|Overall Study|Withdrawal by Subject|0|||
13092488|NCT03693612|25828681|FG001|Overall Study|Withdrawal by Subject|0|||
13092489|NCT03693612|25828682|FG002|Overall Study|Withdrawal by Subject|1|||
13092490|NCT03693612|25828683|FG003|Overall Study|Withdrawal by Subject|0|||
13092491|NCT03693612|25828684|FG004|Overall Study|Withdrawal by Subject|2|||
13092492|NCT03693612|25828685|FG005|Overall Study|Withdrawal by Subject|0|||
13092493|NCT03693612|25828686|FG006|Overall Study|Withdrawal by Subject|0|||
13092494|NCT03693612|25828680|FG000|Overall Study|Study Terminated by Sponsor|0|||
13092495|NCT03693612|25828681|FG001|Overall Study|Study Terminated by Sponsor|1|||
13092496|NCT03693612|25828682|FG002|Overall Study|Study Terminated by Sponsor|0|||
13092497|NCT03693612|25828683|FG003|Overall Study|Study Terminated by Sponsor|0|||
13092498|NCT03693612|25828684|FG004|Overall Study|Study Terminated by Sponsor|3|||
13092499|NCT03693612|25828685|FG005|Overall Study|Study Terminated by Sponsor|0|||
13092500|NCT03693612|25828686|FG006|Overall Study|Study Terminated by Sponsor|0|||
13092501|NCT03693404|25828703|FG000|Overall Study|Withdrawal by Subject|1|||
13092502|NCT03693404|25828704|FG001|Overall Study|Withdrawal by Subject|0|||
13092503|NCT03693404|25828703|FG000|Overall Study|Lost to Follow-up|0|||
13092504|NCT03693404|25828704|FG001|Overall Study|Lost to Follow-up|5|||
13092505|NCT03693404|25828703|FG000|Overall Study|Excluded from Analysis|0|||
13222606|NCT01804842|26286561|FG002|Overall Study|Lost to Follow-up|0|||
13222607|NCT01804842|26286559|FG000|Overall Study|Non-Compliance|1|||
13145195|NCT02614196|26029838|FG005|Double Blind Treatment Phase|Physician Decision|0|||
13145196|NCT02614196|26029833|FG000|Double Blind Treatment Phase|Pregnancy|1|||
13092506|NCT03693404|25828704|FG001|Overall Study|Excluded from Analysis|1|||
13092507|NCT03693170|25828723|FG000|Overall Study|Disease Progression|48|||
13092508|NCT03693170|25828723|FG000|Overall Study|Adverse Event|16|||
13092509|NCT03693170|25828723|FG000|Overall Study|Physician Decision|6|||
13092510|NCT03693170|25828723|FG000|Overall Study|Protocol Violation|2|||
13092511|NCT03693170|25828723|FG000|Overall Study|Death|1|||
13145197|NCT02614196|26029834|FG001|Double Blind Treatment Phase|Pregnancy|2|||
13145198|NCT02614196|26029835|FG002|Double Blind Treatment Phase|Pregnancy|0|||
13145199|NCT02614196|26029836|FG003|Double Blind Treatment Phase|Pregnancy|0|||
13145200|NCT02614196|26029837|FG004|Double Blind Treatment Phase|Pregnancy|0|||
13145201|NCT02614196|26029838|FG005|Double Blind Treatment Phase|Pregnancy|0|||
13145202|NCT02614196|26029833|FG000|Double Blind Treatment Phase|Protocol Violation|5|||
13145203|NCT02614196|26029834|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
13145204|NCT02614196|26029835|FG002|Double Blind Treatment Phase|Protocol Violation|1|||
13145205|NCT02614196|26029836|FG003|Double Blind Treatment Phase|Protocol Violation|0|||
13145206|NCT02614196|26029837|FG004|Double Blind Treatment Phase|Protocol Violation|1|||
13145207|NCT02614196|26029838|FG005|Double Blind Treatment Phase|Protocol Violation|0|||
13145208|NCT02614196|26029833|FG000|Double Blind Treatment Phase|Terminated by sponsor|1|||
13145209|NCT02614196|26029834|FG001|Double Blind Treatment Phase|Terminated by sponsor|0|||
13145210|NCT02614196|26029835|FG002|Double Blind Treatment Phase|Terminated by sponsor|0|||
13145211|NCT02614196|26029836|FG003|Double Blind Treatment Phase|Terminated by sponsor|0|||
13145212|NCT02614196|26029837|FG004|Double Blind Treatment Phase|Terminated by sponsor|0|||
13145213|NCT02614196|26029838|FG005|Double Blind Treatment Phase|Terminated by sponsor|0|||
13145214|NCT02614196|26029833|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39|||
13145215|NCT02614196|26029834|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
13145216|NCT02614196|26029835|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14|||
13145217|NCT02614196|26029836|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4|||
13145218|NCT02614196|26029837|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0|||
13145219|NCT02614196|26029838|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0|||
13145220|NCT02614196|26029833|FG000|Double Blind Treatment Phase|Did not receive study drug|2|||
13145221|NCT02614196|26029834|FG001|Double Blind Treatment Phase|Did not receive study drug|2|||
13145222|NCT02614196|26029835|FG002|Double Blind Treatment Phase|Did not receive study drug|3|||
13145223|NCT02614196|26029836|FG003|Double Blind Treatment Phase|Did not receive study drug|0|||
13145224|NCT02614196|26029837|FG004|Double Blind Treatment Phase|Did not receive study drug|0|||
13145225|NCT02614196|26029838|FG005|Double Blind Treatment Phase|Did not receive study drug|0|||
13145226|NCT02614196|26029833|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8|||
13145227|NCT02614196|26029834|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
13145228|NCT02614196|26029835|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
13145229|NCT02614196|26029836|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
13145230|NCT02614196|26029837|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
13145231|NCT02614196|26029838|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
13145232|NCT02614196|26029833|FG000|Post Treatment Follow-up Phase|Pregnancy|2|||
13145233|NCT02614196|26029834|FG001|Post Treatment Follow-up Phase|Pregnancy|0|||
13145234|NCT02614196|26029835|FG002|Post Treatment Follow-up Phase|Pregnancy|0|||
13145235|NCT02614196|26029836|FG003|Post Treatment Follow-up Phase|Pregnancy|0|||
13145236|NCT02614196|26029837|FG004|Post Treatment Follow-up Phase|Pregnancy|0|||
13145237|NCT02614196|26029838|FG005|Post Treatment Follow-up Phase|Pregnancy|0|||
13145238|NCT02614196|26029833|FG000|Post Treatment Follow-up Phase|Protocol Violation|0|||
13145239|NCT02614196|26029834|FG001|Post Treatment Follow-up Phase|Protocol Violation|1|||
13145240|NCT02614196|26029835|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
13145241|NCT02614196|26029836|FG003|Post Treatment Follow-up Phase|Protocol Violation|0|||
13145242|NCT02614196|26029837|FG004|Post Treatment Follow-up Phase|Protocol Violation|1|||
13145243|NCT02614196|26029838|FG005|Post Treatment Follow-up Phase|Protocol Violation|0|||
13145244|NCT02614196|26029833|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10|||
13145245|NCT02614196|26029834|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
13145246|NCT02614196|26029835|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
13145247|NCT02614196|26029836|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
13145248|NCT02614196|26029837|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
13145249|NCT02614196|26029838|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
13145250|NCT02614183|26029885|FG000|Double Blind Treatment Phase|Adverse Event|10|||
13145251|NCT02614183|26029886|FG001|Double Blind Treatment Phase|Adverse Event|9|||
13222608|NCT01804842|26286560|FG001|Overall Study|Non-Compliance|1|||
13092512|NCT03693170|25828723|FG000|Overall Study|Non compliance with study drug|1|||
13092513|NCT03693170|25828723|FG000|Overall Study|Withdrawal by Subject|1|||
13092514|NCT03692910|25828765|FG000|Overall Study|Lost to Follow-up|4|||
13092515|NCT03692910|25828766|FG001|Overall Study|Lost to Follow-up|0|||
13092516|NCT03692910|25828767|FG002|Overall Study|Lost to Follow-up|0|||
13092517|NCT03692910|25828765|FG000|Overall Study|Withdrawal by Subject|2|||
13145252|NCT02614183|26029887|FG002|Double Blind Treatment Phase|Adverse Event|7|||
13145253|NCT02614183|26029885|FG000|Double Blind Treatment Phase|Lack of Efficacy|10|||
13145254|NCT02614183|26029886|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
13145255|NCT02614183|26029887|FG002|Double Blind Treatment Phase|Lack of Efficacy|2|||
13145256|NCT02614183|26029885|FG000|Double Blind Treatment Phase|Lost to Follow-up|18|||
13145257|NCT02614183|26029886|FG001|Double Blind Treatment Phase|Lost to Follow-up|9|||
13145258|NCT02614183|26029887|FG002|Double Blind Treatment Phase|Lost to Follow-up|5|||
13222609|NCT01804842|26286561|FG002|Overall Study|Non-Compliance|0|||
13145259|NCT02614183|26029885|FG000|Double Blind Treatment Phase|Physician Decision|7|||
13145260|NCT02614183|26029886|FG001|Double Blind Treatment Phase|Physician Decision|3|||
13145261|NCT02614183|26029887|FG002|Double Blind Treatment Phase|Physician Decision|2|||
13145262|NCT02614183|26029885|FG000|Double Blind Treatment Phase|Pregnancy|2|||
13145263|NCT02614183|26029886|FG001|Double Blind Treatment Phase|Pregnancy|1|||
13145264|NCT02614183|26029887|FG002|Double Blind Treatment Phase|Pregnancy|3|||
13145265|NCT02614183|26029885|FG000|Double Blind Treatment Phase|Protocol Violation|2|||
13145266|NCT02614183|26029886|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
13145267|NCT02614183|26029887|FG002|Double Blind Treatment Phase|Protocol Violation|2|||
13145268|NCT02614183|26029885|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33|||
13145269|NCT02614183|26029886|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
13145270|NCT02614183|26029887|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16|||
13145271|NCT02614183|26029885|FG000|Double Blind Treatment Phase|Did not receive study drug|1|||
13145272|NCT02614183|26029886|FG001|Double Blind Treatment Phase|Did not receive study drug|1|||
13145273|NCT02614183|26029887|FG002|Double Blind Treatment Phase|Did not receive study drug|2|||
13145274|NCT02614183|26029885|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
13145275|NCT02614183|26029886|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
13145276|NCT02614183|26029887|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
13145277|NCT02614183|26029885|FG000|Post Treatment Follow-up Phase|Physician Decision|5|||
13145278|NCT02614183|26029886|FG001|Post Treatment Follow-up Phase|Physician Decision|1|||
13145279|NCT02614183|26029887|FG002|Post Treatment Follow-up Phase|Physician Decision|2|||
13145280|NCT02614183|26029885|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
13145281|NCT02614183|26029886|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
13145282|NCT02614183|26029887|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
13145283|NCT02614183|26029885|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7|||
13145284|NCT02614183|26029886|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2|||
13145285|NCT02614183|26029887|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
13145286|NCT02614131|26029940|FG000|Overall Study|Withdrawal by Subject|1|||
13145287|NCT02614131|26029941|FG001|Overall Study|Withdrawal by Subject|0|||
13145288|NCT02614131|26029942|FG002|Overall Study|Withdrawal by Subject|0|||
13145289|NCT02614131|26029943|FG003|Overall Study|Withdrawal by Subject|0|||
13145290|NCT02614131|26029944|FG004|Overall Study|Withdrawal by Subject|0|||
13145291|NCT02614131|26029945|FG005|Overall Study|Withdrawal by Subject|0|||
13145292|NCT02614131|26029946|FG006|Overall Study|Withdrawal by Subject|0|||
13145293|NCT02614131|26029940|FG000|Overall Study|Adverse Event|0|||
13145294|NCT02614131|26029941|FG001|Overall Study|Adverse Event|0|||
13145295|NCT02614131|26029942|FG002|Overall Study|Adverse Event|0|||
13145296|NCT02614131|26029943|FG003|Overall Study|Adverse Event|0|||
13145297|NCT02614131|26029944|FG004|Overall Study|Adverse Event|0|||
13145298|NCT02614131|26029945|FG005|Overall Study|Adverse Event|0|||
13145299|NCT02614131|26029946|FG006|Overall Study|Adverse Event|1|||
13145300|NCT02614079|26029952|FG000|Overall Study|Withdrawal by Subject|1|||
13145301|NCT02614066|26029989|FG000|Overall Study|Initiated KTE-X19 and Died|5|||
13145302|NCT02614066|26029990|FG001|Overall Study|Initiated KTE-X19 and Died|12|||
13145303|NCT02614066|26029991|FG002|Overall Study|Initiated KTE-X19 and Died|11|||
13145304|NCT02614066|26029992|FG003|Overall Study|Initiated KTE-X19 and Died|20|||
13145305|NCT02614066|26029989|FG000|Overall Study|Full Consent Withdrawn|0|||
13145306|NCT02614066|26029990|FG001|Overall Study|Full Consent Withdrawn|1|||
13145307|NCT02614066|26029991|FG002|Overall Study|Full Consent Withdrawn|0|||
13145308|NCT02614066|26029992|FG003|Overall Study|Full Consent Withdrawn|3|||
13145309|NCT02614066|26029989|FG000|Overall Study|Lost to Follow-up|0|||
13145310|NCT02614066|26029990|FG001|Overall Study|Lost to Follow-up|1|||
13145311|NCT02614066|26029991|FG002|Overall Study|Lost to Follow-up|0|||
13145312|NCT02614066|26029992|FG003|Overall Study|Lost to Follow-up|0|||
13145313|NCT02614066|26029989|FG000|Overall Study|Still on-study|1|||
13145314|NCT02614066|26029990|FG001|Overall Study|Still on-study|9|||
13145315|NCT02614066|26029991|FG002|Overall Study|Still on-study|5|||
13145316|NCT02614066|26029992|FG003|Overall Study|Still on-study|32|||
13145317|NCT02614066|26029989|FG000|Overall Study|Enrolled But Did Not Initiate KTE-X19|0|||
13145318|NCT02614066|26029990|FG001|Overall Study|Enrolled But Did Not Initiate KTE-X19|5|||
13145319|NCT02614066|26029991|FG002|Overall Study|Enrolled But Did Not Initiate KTE-X19|4|||
13145320|NCT02614066|26029992|FG003|Overall Study|Enrolled But Did Not Initiate KTE-X19|16|||
13145321|NCT02613910|26030043|FG000|Overall Study|Termination of study|1|||
13145322|NCT02613884|26030051|FG000|Overall Study|Death|1|||
13145323|NCT02613884|26030051|FG000|Overall Study|Lost to Follow-up|1|||
13145324|NCT02613871|26030072|FG000|Overall Study|Death|2|||
13145325|NCT02613871|26030072|FG000|Overall Study|Withdrew Consent|1|||
13145326|NCT02613572|26030102|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1|||
13145327|NCT02613572|26030103|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
13145328|NCT02613572|26030104|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
13145329|NCT02613572|26030102|FG000|Phase II: Double-Blind Rand Plac Control|Death|0|||
13145330|NCT02613572|26030103|FG001|Phase II: Double-Blind Rand Plac Control|Death|1|||
13145331|NCT02613572|26030104|FG002|Phase II: Double-Blind Rand Plac Control|Death|0|||
13145332|NCT02613507|26030127|FG000|Overall Study|Disease Progression|237|||
13145333|NCT02613507|26030128|FG001|Overall Study|Disease Progression|109|||
13145334|NCT02613507|26030127|FG000|Overall Study|Study Drug Toxicity|15|||
13145335|NCT02613507|26030128|FG001|Overall Study|Study Drug Toxicity|14|||
13145336|NCT02613507|26030127|FG000|Overall Study|Death|3|||
13145337|NCT02613507|26030128|FG001|Overall Study|Death|0|||
13145338|NCT02613507|26030127|FG000|Overall Study|Adverse Event Unrelated to Study Drug|17|||
13145339|NCT02613507|26030128|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
13145340|NCT02613507|26030127|FG000|Overall Study|Request to Discontinue Study Treatment|8|||
13145341|NCT02613507|26030128|FG001|Overall Study|Request to Discontinue Study Treatment|17|||
13145342|NCT02613507|26030127|FG000|Overall Study|Participant Withdrew Consent|0|||
13145343|NCT02613507|26030128|FG001|Overall Study|Participant Withdrew Consent|2|||
13145344|NCT02613507|26030127|FG000|Overall Study|Lost to Follow-up|1|||
13145345|NCT02613507|26030128|FG001|Overall Study|Lost to Follow-up|0|||
13145346|NCT02613507|26030127|FG000|Overall Study|Maximum Clinical Benefit|4|||
13145347|NCT02613507|26030128|FG001|Overall Study|Maximum Clinical Benefit|10|||
13145348|NCT02613507|26030127|FG000|Overall Study|Brain Radiotherapy Activity Limited|1|||
13145349|NCT02613507|26030128|FG001|Overall Study|Brain Radiotherapy Activity Limited|0|||
13145350|NCT02613507|26030127|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
13145351|NCT02613507|26030128|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
13145352|NCT02613507|26030127|FG000|Overall Study|Randomized but not Treated|1|||
13145353|NCT02613507|26030128|FG001|Overall Study|Randomized but not Treated|10|||
13145354|NCT02613481|26030137|FG000|Overall Study|Lost to Follow-up|7|||
13145355|NCT02613481|26030137|FG000|Overall Study|Withdrawal by Subject|2|||
13145356|NCT02613403|26030193|FG000|Overall Study|Lost to Follow-up|0|||
13145357|NCT02613403|26030194|FG001|Overall Study|Lost to Follow-up|1|||
13145358|NCT02613403|26030195|FG002|Overall Study|Lost to Follow-up|0|||
13145359|NCT02613403|26030196|FG003|Overall Study|Lost to Follow-up|0|||
13145360|NCT02613403|26030197|FG004|Overall Study|Lost to Follow-up|0|||
13145361|NCT02613403|26030193|FG000|Overall Study|Withdrawal by Subject|2|||
13145362|NCT02613403|26030194|FG001|Overall Study|Withdrawal by Subject|0|||
13145363|NCT02613403|26030195|FG002|Overall Study|Withdrawal by Subject|0|||
13145364|NCT02613403|26030196|FG003|Overall Study|Withdrawal by Subject|0|||
13145365|NCT02613403|26030197|FG004|Overall Study|Withdrawal by Subject|0|||
13145366|NCT02613364|26030260|FG000|Overall Study|Other|19|||
13145367|NCT02613364|26030261|FG001|Overall Study|Other|29|||
13145368|NCT02613364|26030262|FG002|Overall Study|Other|17|||
13145369|NCT02613364|26030260|FG000|Overall Study|Too time consuming|21|||
13145370|NCT02613364|26030261|FG001|Overall Study|Too time consuming|26|||
13145371|NCT02613364|26030262|FG002|Overall Study|Too time consuming|26|||
13145372|NCT02613364|26030260|FG000|Overall Study|Withdrawal by Subject|13|||
13145373|NCT02613364|26030261|FG001|Overall Study|Withdrawal by Subject|18|||
13145374|NCT02613364|26030262|FG002|Overall Study|Withdrawal by Subject|17|||
13145375|NCT02613364|26030260|FG000|Overall Study|Medical|12|||
13145376|NCT02613364|26030261|FG001|Overall Study|Medical|13|||
13145377|NCT02613364|26030262|FG002|Overall Study|Medical|9|||
13145378|NCT02613364|26030260|FG000|Overall Study|Disliked Study Procedure|1|||
13145379|NCT02613364|26030261|FG001|Overall Study|Disliked Study Procedure|1|||
13145380|NCT02613364|26030262|FG002|Overall Study|Disliked Study Procedure|4|||
13145381|NCT02613364|26030260|FG000|Overall Study|Disliked Intervention|0|||
13145382|NCT02613364|26030261|FG001|Overall Study|Disliked Intervention|3|||
13145383|NCT02613364|26030262|FG002|Overall Study|Disliked Intervention|3|||
13145384|NCT02613221|26030276|FG000|Overall Study|Lack of efficacy (exacerbation)|50|||
13145385|NCT02613221|26030276|FG000|Overall Study|Adverse Event|2|||
13145386|NCT02613221|26030276|FG000|Overall Study|Voluntary Discontinuation|1|||
13145387|NCT02613221|26030276|FG000|Overall Study|Delayed Treatment|1|||
13145388|NCT02613221|26030276|FG000|Overall Study|Enrolled but Not Treated|1|||
13145389|NCT02613208|26030292|FG000|Overall Study|Withdrawal by Subject|1|||
13145390|NCT02613208|26030292|FG000|Overall Study|Change of address|2|||
13145391|NCT02613208|26030292|FG000|Overall Study|Physician Decision|2|||
13145392|NCT02613208|26030292|FG000|Overall Study|Lost to Follow-up|5|||
13145393|NCT02613208|26030292|FG000|Overall Study|Death|37|||
13145394|NCT02613182|26030298|FG000|Overall Study|Death|6|||
13145395|NCT02613182|26030298|FG000|Overall Study|Physician Decision|1|||
13145396|NCT02613182|26030298|FG000|Overall Study|Study Terminated by Sponsor|21|||
13145397|NCT02613182|26030298|FG000|Overall Study|Withdrawal by Subject|6|||
13145398|NCT02613169|26030317|FG000|Overall Study|Withdrawal by Subject|4|||
13145399|NCT02613169|26030318|FG001|Overall Study|Withdrawal by Subject|1|||
13145400|NCT02613169|26030317|FG000|Overall Study|Lost to Follow-up|0|||
13145401|NCT02613169|26030318|FG001|Overall Study|Lost to Follow-up|5|||
13145402|NCT02613169|26030317|FG000|Overall Study|HIV|0|||
13145403|NCT02613169|26030318|FG001|Overall Study|HIV|2|||
13145404|NCT02613169|26030317|FG000|Overall Study|No TB infection endpoint|14|||
13145405|NCT02613169|26030318|FG001|Overall Study|No TB infection endpoint|9|||
13145406|NCT02612909|26030399|FG000|Phase 2|Withdrawal by Subject|2|||
13145407|NCT02612909|26030400|FG001|Phase 2|Withdrawal by Subject|5|||
13145408|NCT02612909|26030401|FG002|Phase 2|Withdrawal by Subject|0|||
13145409|NCT02612909|26030402|FG003|Phase 2|Withdrawal by Subject|0|||
13145410|NCT02612909|26030403|FG004|Phase 2|Withdrawal by Subject|0|||
13145411|NCT02612909|26030399|FG000|Phase 2|Pregnancy|0|||
13145412|NCT02612909|26030400|FG001|Phase 2|Pregnancy|0|||
13145413|NCT02612909|26030401|FG002|Phase 2|Pregnancy|1|||
13145414|NCT02612909|26030402|FG003|Phase 2|Pregnancy|0|||
13145415|NCT02612909|26030403|FG004|Phase 2|Pregnancy|0|||
13145416|NCT02612909|26030399|FG000|Phase 3|Withdrawal by Subject|0|||
13145417|NCT02612909|26030400|FG001|Phase 3|Withdrawal by Subject|0|||
13145418|NCT02612909|26030401|FG002|Phase 3|Withdrawal by Subject|0|||
13145419|NCT02612909|26030402|FG003|Phase 3|Withdrawal by Subject|1|||
13092518|NCT03692910|25828766|FG001|Overall Study|Withdrawal by Subject|0|||
13092519|NCT03692910|25828767|FG002|Overall Study|Withdrawal by Subject|0|||
13092520|NCT03692871|25828792|FG000|Overall Study|Death|1|||
13092521|NCT03692871|25828793|FG001|Overall Study|Death|1|||
13092522|NCT03692871|25828792|FG000|Overall Study|Lost to Follow-up|24|||
13092523|NCT03692871|25828793|FG001|Overall Study|Lost to Follow-up|9|||
13092524|NCT03692871|25828792|FG000|Overall Study|Physician Decision|22|||
13092525|NCT03692871|25828793|FG001|Overall Study|Physician Decision|7|||
13092526|NCT03692871|25828792|FG000|Overall Study|Protocol Deviation|1|||
13092527|NCT03692871|25828793|FG001|Overall Study|Protocol Deviation|0|||
13092528|NCT03692871|25828792|FG000|Overall Study|Withdrawal by Parent/Guardian|77|||
13092529|NCT03692871|25828793|FG001|Overall Study|Withdrawal by Parent/Guardian|20|||
13092530|NCT03692676|25828820|FG000|Overall Study|exclude patients with prior use|4424|||
13092531|NCT03692676|25828821|FG001|Overall Study|exclude patients with prior use|24726|||
13092532|NCT03692676|25828822|FG002|Overall Study|exclude patients with prior use|0|||
13092533|NCT03692676|25828823|FG003|Overall Study|exclude patients with prior use|0|||
13092534|NCT03692676|25828820|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480|||
13092535|NCT03692676|25828821|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037|||
13092536|NCT03692676|25828822|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
13092537|NCT03692676|25828823|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
13092538|NCT03692676|25828820|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881|||
13092539|NCT03692676|25828821|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563|||
13092540|NCT03692676|25828822|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281|||
13092541|NCT03692676|25828823|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558|||
13092542|NCT03692676|25828820|FG000|Overall Study|exclude patients less than 18 years of age on index date|8|||
13092543|NCT03692676|25828821|FG001|Overall Study|exclude patients less than 18 years of age on index date|613|||
13092544|NCT03692676|25828822|FG002|Overall Study|exclude patients less than 18 years of age on index date|836|||
13092545|NCT03692676|25828823|FG003|Overall Study|exclude patients less than 18 years of age on index date|193|||
13092546|NCT03692676|25828820|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149|||
13092547|NCT03692676|25828821|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717|||
13092548|NCT03692676|25828822|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723|||
13092549|NCT03692676|25828823|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273|||
13092550|NCT03692676|25828820|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208|||
13092551|NCT03692676|25828821|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759|||
13092552|NCT03692676|25828822|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419|||
13092553|NCT03692676|25828823|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684|||
13092554|NCT03692676|25828820|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275|||
13092555|NCT03692676|25828821|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218|||
13092556|NCT03692676|25828822|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515|||
13092557|NCT03692676|25828823|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173|||
13092558|NCT03692676|25828820|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
13092559|NCT03692676|25828821|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
13092560|NCT03692676|25828822|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147|||
13132667|NCT02786901|25984779|FG002|Overall Study|Physician Decision|0|||
13145420|NCT02612909|26030403|FG004|Phase 3|Withdrawal by Subject|0|||
13145421|NCT02612779|26030420|FG000|Overall Study|Administrative reason by sponsor|4|||
13145422|NCT02612779|26030421|FG001|Overall Study|Administrative reason by sponsor|1|||
13145423|NCT02612779|26030420|FG000|Overall Study|No longer meet study criteria|0|||
13145424|NCT02612779|26030421|FG001|Overall Study|No longer meet study criteria|1|||
13092561|NCT03692676|25828823|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4|||
13092562|NCT03692676|25828820|FG000|Overall Study|exclude patients with prior use of same substances and device|0|||
13092563|NCT03692676|25828821|FG001|Overall Study|exclude patients with prior use of same substances and device|0|||
13092564|NCT03692676|25828822|FG002|Overall Study|exclude patients with prior use of same substances and device|3700|||
13092565|NCT03692676|25828823|FG003|Overall Study|exclude patients with prior use of same substances and device|0|||
13092566|NCT03692676|25828820|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
13145425|NCT02612779|26030420|FG000|Overall Study|Disease progression|29|||
13145426|NCT02612779|26030421|FG001|Overall Study|Disease progression|2|||
13145427|NCT02612779|26030420|FG000|Overall Study|Study drug toxicity|10|||
13145428|NCT02612779|26030421|FG001|Overall Study|Study drug toxicity|1|||
13145429|NCT02612779|26030420|FG000|Overall Study|Death|1|||
13145430|NCT02612779|26030421|FG001|Overall Study|Death|0|||
13145431|NCT02612779|26030420|FG000|Overall Study|Adverse event unrelated to study drug|5|||
13145432|NCT02612779|26030421|FG001|Overall Study|Adverse event unrelated to study drug|0|||
13145433|NCT02612779|26030420|FG000|Overall Study|Participant withdrew consent|4|||
13145434|NCT02612779|26030421|FG001|Overall Study|Participant withdrew consent|0|||
13145435|NCT02612779|26030420|FG000|Overall Study|Lost to Follow-up|1|||
13145436|NCT02612779|26030421|FG001|Overall Study|Lost to Follow-up|0|||
13145437|NCT02612779|26030420|FG000|Overall Study|Maximum clinical benefit|10|||
13145438|NCT02612779|26030421|FG001|Overall Study|Maximum clinical benefit|1|||
13145439|NCT02612779|26030420|FG000|Overall Study|Other reasons|4|||
13145440|NCT02612779|26030421|FG001|Overall Study|Other reasons|0|||
13145441|NCT02612727|26030436|FG000|Overall Study|Parent request|4|||
13145442|NCT02612727|26030437|FG001|Overall Study|Parent request|1|||
13145443|NCT02612727|26030436|FG000|Overall Study|Needed treatment incompatible with PT|1|||
13145444|NCT02612727|26030437|FG001|Overall Study|Needed treatment incompatible with PT|1|||
13145445|NCT02612727|26030436|FG000|Overall Study|Direct hyperbilirubinemia|0|||
13145446|NCT02612727|26030437|FG001|Overall Study|Direct hyperbilirubinemia|2|||
13145447|NCT02612623|26030460|FG000|Overall Study|Withdrawal by Subject|0|||
13145448|NCT02612623|26030461|FG001|Overall Study|Withdrawal by Subject|1|||
13145449|NCT02612623|26030462|FG002|Overall Study|Withdrawal by Subject|0|||
13145450|NCT02612623|26030463|FG003|Overall Study|Withdrawal by Subject|0|||
13145451|NCT02612623|26030460|FG000|Overall Study|Adverse Event|1|||
13145452|NCT02612623|26030461|FG001|Overall Study|Adverse Event|0|||
13145453|NCT02612623|26030462|FG002|Overall Study|Adverse Event|1|||
13145454|NCT02612623|26030463|FG003|Overall Study|Adverse Event|0|||
13145455|NCT02612610|26030718|FG000|Overall Study|Withdrawal by Subject|1|||
13145456|NCT02612610|26030719|FG001|Overall Study|Withdrawal by Subject|1|||
13145457|NCT02612610|26030720|FG002|Overall Study|Withdrawal by Subject|0|||
13145458|NCT02612610|26030721|FG003|Overall Study|Withdrawal by Subject|2|||
13145459|NCT02612610|26030718|FG000|Overall Study|Adverse Event|2|||
13145460|NCT02612610|26030719|FG001|Overall Study|Adverse Event|2|||
13145461|NCT02612610|26030720|FG002|Overall Study|Adverse Event|3|||
13145462|NCT02612610|26030721|FG003|Overall Study|Adverse Event|10|||
13145463|NCT02612610|26030718|FG000|Overall Study|Lost to Follow-up|0|||
13145464|NCT02612610|26030719|FG001|Overall Study|Lost to Follow-up|1|||
13145465|NCT02612610|26030720|FG002|Overall Study|Lost to Follow-up|0|||
13145466|NCT02612610|26030721|FG003|Overall Study|Lost to Follow-up|0|||
13145467|NCT02612610|26030718|FG000|Overall Study|Protocol Violation|0|||
13145468|NCT02612610|26030719|FG001|Overall Study|Protocol Violation|1|||
13145469|NCT02612610|26030720|FG002|Overall Study|Protocol Violation|1|||
13145470|NCT02612610|26030721|FG003|Overall Study|Protocol Violation|0|||
13145471|NCT02612610|26030718|FG000|Overall Study|Lack of Efficacy|1|||
13145472|NCT02612610|26030719|FG001|Overall Study|Lack of Efficacy|2|||
13145473|NCT02612610|26030720|FG002|Overall Study|Lack of Efficacy|0|||
13092567|NCT03692676|25828821|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
13092568|NCT03692676|25828822|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965|||
13092569|NCT03692676|25828823|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198|||
13092570|NCT03692676|25828820|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
13092571|NCT03692676|25828821|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
13092572|NCT03692676|25828822|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
13092573|NCT03692676|25828823|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223|||
13092574|NCT03692676|25828820|FG000|Overall Study|Other|0|||
13092575|NCT03692676|25828821|FG001|Overall Study|Other|805|||
13092576|NCT03692676|25828822|FG002|Overall Study|Other|758|||
13092577|NCT03692676|25828823|FG003|Overall Study|Other|277|||
13092578|NCT03692676|25828820|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
13145474|NCT02612610|26030721|FG003|Overall Study|Lack of Efficacy|1|||
13145475|NCT02612610|26030718|FG000|Overall Study|Physician Decision|0|||
13145476|NCT02612610|26030719|FG001|Overall Study|Physician Decision|1|||
13145477|NCT02612610|26030720|FG002|Overall Study|Physician Decision|0|||
13145478|NCT02612610|26030721|FG003|Overall Study|Physician Decision|0|||
13145479|NCT02612610|26030718|FG000|Overall Study|Noncompliance|1|||
13145480|NCT02612610|26030719|FG001|Overall Study|Noncompliance|0|||
13145481|NCT02612610|26030720|FG002|Overall Study|Noncompliance|0|||
13145482|NCT02612610|26030721|FG003|Overall Study|Noncompliance|0|||
13145483|NCT02612610|26030718|FG000|Overall Study|Cough Improvement|0|||
13145484|NCT02612610|26030719|FG001|Overall Study|Cough Improvement|0|||
13145485|NCT02612610|26030720|FG002|Overall Study|Cough Improvement|1|||
13145486|NCT02612610|26030721|FG003|Overall Study|Cough Improvement|0|||
13145487|NCT02612428|26030738|FG000|VTL-308|Death|14|||
13145488|NCT02612428|26030739|FG001|VTL-308|Death|16|||
13145489|NCT02612428|26030738|FG000|VTL-308|Withdrawal by Subject|0|||
13145490|NCT02612428|26030739|FG001|VTL-308|Withdrawal by Subject|1|||
13145491|NCT02612428|26030738|FG000|VTL-308E|Death|9|||
13145492|NCT02612428|26030739|FG001|VTL-308E|Death|7|||
13145493|NCT02612428|26030738|FG000|VTL-308E|Lost to Follow-up|2|||
13145494|NCT02612428|26030739|FG001|VTL-308E|Lost to Follow-up|0|||
13145495|NCT02612285|26030745|FG000|Overall Study|Withdrawal by Subject|1|||
13145496|NCT02612194|26030764|FG000|Overall Study|Death|5|||
13145497|NCT02612194|26030765|FG001|Overall Study|Death|0|||
13145498|NCT02612194|26030766|FG002|Overall Study|Death|2|||
13145499|NCT02612194|26030764|FG000|Overall Study|Early Study Termination|1|||
13145500|NCT02612194|26030765|FG001|Overall Study|Early Study Termination|0|||
13145501|NCT02612194|26030766|FG002|Overall Study|Early Study Termination|0|||
13145502|NCT02612155|26030793|FG000|Overall Study|Death|1|||
13145503|NCT02612155|26030794|FG001|Overall Study|Death|1|||
13145504|NCT02612155|26030793|FG000|Overall Study|Lost to Follow-up|2|||
13145505|NCT02612155|26030794|FG001|Overall Study|Lost to Follow-up|2|||
13145506|NCT02612077|26030806|FG000|Overall Study|Adverse Event|3|||
13145507|NCT02612077|26030806|FG000|Overall Study|Withdrawal by Subject|9|||
13145508|NCT02612077|26030806|FG000|Overall Study|Protocol Violation|28|||
13145509|NCT02612077|26030806|FG000|Overall Study|Lost to Follow-up|20|||
13145510|NCT02612077|26030806|FG000|Overall Study|Death|377|||
13145511|NCT02612077|26030806|FG000|Overall Study|Moved or Changed Medical Team|23|||
13145512|NCT02612077|26030806|FG000|Overall Study|Enrollment in a Clinical Trial|1|||
13145513|NCT02612077|26030806|FG000|Overall Study|Disease Progression|3|||
13145514|NCT02612077|26030806|FG000|Overall Study|Unknown reason|2|||
13145515|NCT02612064|26030823|FG000|Overall Study|Withdrawal by Subject|1|||
13145516|NCT02612064|26030824|FG001|Overall Study|Withdrawal by Subject|1|||
13145517|NCT02612064|26030823|FG000|Overall Study|Other|0|||
13145518|NCT02612064|26030824|FG001|Overall Study|Other|2|||
13145519|NCT02611882|26030848|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33|||
13145520|NCT02611882|26030849|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
13145521|NCT02611882|26030850|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
13145522|NCT02611778|26030912|FG000|Overall Study|Withdrawal by Subject|2|||
13145523|NCT02611778|26030913|FG001|Overall Study|Withdrawal by Subject|8|||
13145524|NCT02611778|26030912|FG000|Overall Study|Adverse Event|1|||
13145525|NCT02611778|26030913|FG001|Overall Study|Adverse Event|2|||
13145526|NCT02611778|26030912|FG000|Overall Study|Death|2|||
13145527|NCT02611778|26030913|FG001|Overall Study|Death|1|||
13145528|NCT02611778|26030912|FG000|Overall Study|Protocol Violation|1|||
13145529|NCT02611778|26030913|FG001|Overall Study|Protocol Violation|0|||
13145530|NCT02611778|26030912|FG000|Overall Study|Lost to Follow-up|3|||
13145531|NCT02611778|26030913|FG001|Overall Study|Lost to Follow-up|1|||
13145532|NCT02611778|26030912|FG000|Overall Study|Need for alternative treatment|1|||
13145533|NCT02611778|26030913|FG001|Overall Study|Need for alternative treatment|0|||
13145534|NCT02611778|26030912|FG000|Overall Study|Other Reason|2|||
13145535|NCT02611778|26030913|FG001|Overall Study|Other Reason|1|||
13145536|NCT02611752|26030952|FG000|Overall Study|Adverse Event|0|||
13145537|NCT02611752|26030953|FG001|Overall Study|Adverse Event|1|||
13145538|NCT02611479|26030959|FG000|Baseline Enrollment|Exited study|13|||
13145539|NCT02611479|26030959|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2|||
13145540|NCT02611479|26030959|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18|||
13145541|NCT02611479|26030959|FG000|Data Cleaning|No baseline function or pain metrics|2|||
13145542|NCT02611362|26030982|FG000|Overall Study|Withdrawal by Subject|7|||
13145543|NCT02611362|26030983|FG001|Overall Study|Withdrawal by Subject|2|||
13145544|NCT02611362|26030982|FG000|Overall Study|Lost to Follow-up|2|||
13145545|NCT02611362|26030983|FG001|Overall Study|Lost to Follow-up|4|||
13145546|NCT02610842|26030992|FG000|Overall Study|Lost to Follow-up|5|||
13145547|NCT02610816|26031022|FG000|Phase 1|Withdrawal by Subject|2|||
13145548|NCT02610816|26031023|FG001|Phase 1|Withdrawal by Subject|6|||
13145549|NCT02610816|26031024|FG002|Phase 1|Withdrawal by Subject|0|||
13145550|NCT02610816|26031025|FG003|Phase 1|Withdrawal by Subject|0|||
13145551|NCT02610816|26031022|FG000|Phase 1|Lost to Follow-up|2|||
13145552|NCT02610816|26031023|FG001|Phase 1|Lost to Follow-up|1|||
13145553|NCT02610816|26031024|FG002|Phase 1|Lost to Follow-up|0|||
13145554|NCT02610816|26031025|FG003|Phase 1|Lost to Follow-up|0|||
13145555|NCT02610816|26031022|FG000|Phase 1|Physician Decision|0|||
13145556|NCT02610816|26031023|FG001|Phase 1|Physician Decision|1|||
13145557|NCT02610816|26031024|FG002|Phase 1|Physician Decision|0|||
13145558|NCT02610816|26031025|FG003|Phase 1|Physician Decision|0|||
13145559|NCT02610816|26031022|FG000|Phase 2|Withdrawal by Subject|0|||
13145560|NCT02610816|26031023|FG001|Phase 2|Withdrawal by Subject|0|||
13145561|NCT02610816|26031024|FG002|Phase 2|Withdrawal by Subject|9|||
13145562|NCT02610816|26031025|FG003|Phase 2|Withdrawal by Subject|3|||
13145563|NCT02610816|26031022|FG000|Phase 2|Lost to Follow-up|0|||
13145564|NCT02610816|26031023|FG001|Phase 2|Lost to Follow-up|0|||
13145565|NCT02610816|26031024|FG002|Phase 2|Lost to Follow-up|2|||
13145566|NCT02610816|26031025|FG003|Phase 2|Lost to Follow-up|0|||
13145567|NCT02610816|26031022|FG000|Phase 2|Physician Decision|0|||
13145568|NCT02610816|26031023|FG001|Phase 2|Physician Decision|0|||
13145569|NCT02610816|26031024|FG002|Phase 2|Physician Decision|0|||
13145570|NCT02610816|26031025|FG003|Phase 2|Physician Decision|2|||
13145571|NCT02610816|26031022|FG000|Phase 2|Pregnancy|0|||
13145572|NCT02610816|26031023|FG001|Phase 2|Pregnancy|0|||
13145573|NCT02610816|26031024|FG002|Phase 2|Pregnancy|0|||
13145574|NCT02610816|26031025|FG003|Phase 2|Pregnancy|1|||
13145575|NCT02610777|26031090|FG000|Overall Study|Lost to Follow-up|1|||
13145576|NCT02610777|26031091|FG001|Overall Study|Lost to Follow-up|0|||
13145577|NCT02610777|26031090|FG000|Overall Study|Site Terminated by Sponsor|9|||
13092579|NCT03692676|25828821|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
13092580|NCT03692676|25828822|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
13092581|NCT03692676|25828823|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3|||
13092586|NCT03691948|25828863|FG000|Overall Study|Lost to Follow-up|1|||
13092587|NCT03691948|25828864|FG001|Overall Study|Lost to Follow-up|3|||
13092588|NCT03691831|25828885|FG000|Overall Study|Lost to Follow-up|16|||
13092589|NCT03691831|25828886|FG001|Overall Study|Lost to Follow-up|12|||
13132668|NCT02786901|25984777|FG000|Overall Study|Rescue Therapy Use|71|||
13145578|NCT02610777|26031091|FG001|Overall Study|Site Terminated by Sponsor|8|||
13145579|NCT02610777|26031090|FG000|Overall Study|Withdrawal by Subject|2|||
13145580|NCT02610777|26031091|FG001|Overall Study|Withdrawal by Subject|2|||
13145581|NCT02610777|26031090|FG000|Overall Study|Reason not Specified|0|||
13145582|NCT02610777|26031091|FG001|Overall Study|Reason not Specified|1|||
13145583|NCT02610777|26031090|FG000|Overall Study|Death|50|||
13145584|NCT02610777|26031091|FG001|Overall Study|Death|47|||
13145585|NCT02610725|26031099|FG000|Overall Study|Lost to Follow-up|197|||
13145586|NCT02610725|26031099|FG000|Overall Study|self-reported contraindication|9|||
13145587|NCT02610231|26031108|FG000|Overall Study|Withdrawal by Subject|27|||
13145588|NCT02610231|26031108|FG000|Overall Study|Adverse Event|20|||
13145589|NCT02610231|26031108|FG000|Overall Study|Death|5|||
13145590|NCT02610231|26031108|FG000|Overall Study|Surgery|2|||
13145591|NCT02610231|26031108|FG000|Overall Study|Physician Decision|1|||
13145592|NCT02610231|26031108|FG000|Overall Study|Non Compliance|2|||
13145593|NCT02610231|26031108|FG000|Overall Study|Other|3|||
13145594|NCT02610192|26031123|FG000|Overall Study|Received other treatment|8|||
13145595|NCT02610192|26031123|FG000|Overall Study|Physician Decision|1|||
13145596|NCT02610140|26031160|FG000|Randomization and Treatment Period|Radiological progression|23|||
13145597|NCT02610140|26031161|FG001|Randomization and Treatment Period|Radiological progression|15|||
13145598|NCT02610140|26031160|FG000|Randomization and Treatment Period|Progressive disease - radiological|54|||
13145599|NCT02610140|26031161|FG001|Randomization and Treatment Period|Progressive disease - radiological|23|||
13145600|NCT02610140|26031160|FG000|Randomization and Treatment Period|Protocol Violation|1|||
13145601|NCT02610140|26031161|FG001|Randomization and Treatment Period|Protocol Violation|0|||
13145602|NCT02610140|26031160|FG000|Randomization and Treatment Period|Physician Decision|0|||
13145603|NCT02610140|26031161|FG001|Randomization and Treatment Period|Physician Decision|1|||
13145604|NCT02610140|26031160|FG000|Randomization and Treatment Period|Lack of Efficacy|1|||
13145605|NCT02610140|26031161|FG001|Randomization and Treatment Period|Lack of Efficacy|0|||
13145606|NCT02610140|26031160|FG000|Randomization and Treatment Period|Death|7|||
13145607|NCT02610140|26031161|FG001|Randomization and Treatment Period|Death|1|||
13145608|NCT02610140|26031160|FG000|Randomization and Treatment Period|Withdrawal by Subject|12|||
13145609|NCT02610140|26031161|FG001|Randomization and Treatment Period|Withdrawal by Subject|12|||
13145610|NCT02610140|26031160|FG000|Randomization and Treatment Period|Adverse Event|44|||
13145611|NCT02610140|26031161|FG001|Randomization and Treatment Period|Adverse Event|13|||
13145612|NCT02610140|26031160|FG000|Randomization and Treatment Period|Progressive disease - clinical|12|||
13145613|NCT02610140|26031161|FG001|Randomization and Treatment Period|Progressive disease - clinical|5|||
13145614|NCT02610140|26031160|FG000|Randomization and Treatment Period|Ongoing but not completed|9|||
13145615|NCT02610140|26031161|FG001|Randomization and Treatment Period|Ongoing but not completed|2|||
13145616|NCT02610140|26031160|FG000|Randomization and Treatment Period|Not treated|3|||
13145617|NCT02610140|26031161|FG001|Randomization and Treatment Period|Not treated|10|||
13145618|NCT02610140|26031160|FG000|Safety Follow-up|Other|0|||
13145619|NCT02610140|26031161|FG001|Safety Follow-up|Other|2|||
13145620|NCT02610140|26031160|FG000|Safety Follow-up|Lost to Follow-up|1|||
13145621|NCT02610140|26031161|FG001|Safety Follow-up|Lost to Follow-up|0|||
13145622|NCT02610140|26031160|FG000|Safety Follow-up|No follow-up|5|||
13145623|NCT02610140|26031161|FG001|Safety Follow-up|No follow-up|3|||
13145624|NCT02610140|26031160|FG000|Safety Follow-up|Death|12|||
13145625|NCT02610140|26031161|FG001|Safety Follow-up|Death|2|||
13145626|NCT02610140|26031160|FG000|Safety Follow-up|Deterioration of general conditions|15|||
13145627|NCT02610140|26031161|FG001|Safety Follow-up|Deterioration of general conditions|5|||
13145628|NCT02610140|26031160|FG000|Safety Follow-up|Withdrawal by Subject|12|||
13145629|NCT02610140|26031161|FG001|Safety Follow-up|Withdrawal by Subject|12|||
13145630|NCT02610140|26031160|FG000|Active Follow-up|Progressive disease - radiological|30|||
13145631|NCT02610140|26031161|FG001|Active Follow-up|Progressive disease - radiological|22|||
13145632|NCT02610140|26031160|FG000|Active Follow-up|Death|8|||
13145633|NCT02610140|26031161|FG001|Active Follow-up|Death|1|||
13145634|NCT02610140|26031160|FG000|Active Follow-up|Withdrawal by Subject|4|||
13145635|NCT02610140|26031161|FG001|Active Follow-up|Withdrawal by Subject|0|||
13145636|NCT02610140|26031160|FG000|Active Follow-up|Progressive disease - clinical|1|||
13145637|NCT02610140|26031161|FG001|Active Follow-up|Progressive disease - clinical|2|||
13145638|NCT02610140|26031160|FG000|Active Follow-up|Deterioration of general conditions|1|||
13145639|NCT02610140|26031161|FG001|Active Follow-up|Deterioration of general conditions|0|||
13145640|NCT02610140|26031160|FG000|Active Follow-up|Ongoing but not completed|4|||
13145641|NCT02610140|26031161|FG001|Active Follow-up|Ongoing but not completed|1|||
13145642|NCT02610140|26031160|FG000|Long-term Follow-up|Death|86|||
13145643|NCT02610140|26031161|FG001|Long-term Follow-up|Death|44|||
13145644|NCT02610140|26031160|FG000|Long-term Follow-up|Withdrawal by Subject|6|||
13145645|NCT02610140|26031161|FG001|Long-term Follow-up|Withdrawal by Subject|3|||
13145646|NCT02610140|26031160|FG000|Long-term Follow-up|Lost to Follow-up|1|||
13145647|NCT02610140|26031161|FG001|Long-term Follow-up|Lost to Follow-up|2|||
13145648|NCT02610140|26031160|FG000|Long-term Follow-up|Ongoing but not completed|30|||
13145649|NCT02610140|26031161|FG001|Long-term Follow-up|Ongoing but not completed|17|||
13145650|NCT02609984|26031200|FG000|Overall Study|Death|29|||
13145651|NCT02609984|26031201|FG001|Overall Study|Death|26|||
13145652|NCT02609984|26031200|FG000|Overall Study|Participation Discontinued by Sponsor|12|||
13145653|NCT02609984|26031201|FG001|Overall Study|Participation Discontinued by Sponsor|10|||
13145654|NCT02609984|26031200|FG000|Overall Study|Lost to Follow-up|1|||
13145655|NCT02609984|26031201|FG001|Overall Study|Lost to Follow-up|2|||
13145656|NCT02609984|26031200|FG000|Overall Study|Withdrawal by Subject|0|||
13145657|NCT02609984|26031201|FG001|Overall Study|Withdrawal by Subject|1|||
13145658|NCT02609984|26031200|FG000|Overall Study|Disease Progression|2|||
13145659|NCT02609984|26031201|FG001|Overall Study|Disease Progression|0|||
13145660|NCT02609724|26031255|FG000|Overall Study|Death|2|||
13145661|NCT02609724|26031256|FG001|Overall Study|Death|0|||
13145662|NCT02609724|26031257|FG002|Overall Study|Death|1|||
13145663|NCT02609724|26031255|FG000|Overall Study|Withdrawal by Subject|1|||
13145664|NCT02609724|26031256|FG001|Overall Study|Withdrawal by Subject|2|||
13145665|NCT02609724|26031257|FG002|Overall Study|Withdrawal by Subject|3|||
13145666|NCT02609724|26031255|FG000|Overall Study|Illness|2|||
13145667|NCT02609724|26031256|FG001|Overall Study|Illness|1|||
13145668|NCT02609724|26031257|FG002|Overall Study|Illness|0|||
13145669|NCT02609672|26031298|FG000|Overall Study|Lost to Follow-up|3|||
13145670|NCT02609672|26031299|FG001|Overall Study|Lost to Follow-up|1|||
13145671|NCT02609659|26031309|FG000|Overall Study|Adverse Event|1|||
13145672|NCT02609659|26031309|FG000|Overall Study|Lost to Follow-up|6|||
13145673|NCT02609659|26031309|FG000|Overall Study|Other|1|||
13145674|NCT02609633|26031341|FG000|Overall Study|Consent Withdrawn|0|||
13145675|NCT02609633|26031342|FG001|Overall Study|Consent Withdrawn|1|||
13145676|NCT02609633|26031341|FG000|Overall Study|Protocol Deviation|1|||
13145677|NCT02609633|26031342|FG001|Overall Study|Protocol Deviation|0|||
13145678|NCT02609633|26031341|FG000|Overall Study|Non-Compliant with Study Procedures|2|||
13145679|NCT02609633|26031342|FG001|Overall Study|Non-Compliant with Study Procedures|0|||
13145680|NCT02609633|26031341|FG000|Overall Study|Reason not Specified|2|||
13145681|NCT02609633|26031342|FG001|Overall Study|Reason not Specified|1|||
13145682|NCT02609607|26031371|FG000|Overall Study|Lost to Follow-up|0|||
13145683|NCT02609607|26031372|FG001|Overall Study|Lost to Follow-up|1|||
13145684|NCT02609399|26031391|FG000|Influenza Season 2015-2016|Lost to Follow-up|3|||
13145685|NCT02609399|26031392|FG001|Influenza Season 2015-2016|Lost to Follow-up|2|||
13145686|NCT02609399|26031391|FG000|Influenza Season 2016-2017|Lost to Follow-up|8|||
13145687|NCT02609399|26031392|FG001|Influenza Season 2016-2017|Lost to Follow-up|5|||
13145688|NCT02609399|26031391|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1|||
13145689|NCT02609399|26031392|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0|||
13145690|NCT02609178|26031414|FG000|First Crown|Withdrawal by Subject|0|||
13145691|NCT02609178|26031415|FG001|First Crown|Withdrawal by Subject|0|||
13145692|NCT02609178|26031416|FG002|First Crown|Withdrawal by Subject|1|||
13145693|NCT02609178|26031417|FG003|First Crown|Withdrawal by Subject|1|||
13145694|NCT02609178|26031418|FG004|First Crown|Withdrawal by Subject|0|||
13145695|NCT02609178|26031419|FG005|First Crown|Withdrawal by Subject|0|||
13145696|NCT02608892|26031435|FG000|Overall Study|Lost to Follow-up|1|||
13092590|NCT03691831|25828885|FG000|Overall Study|Withdrawal by Subject|9|||
13092591|NCT03691831|25828886|FG001|Overall Study|Withdrawal by Subject|17|||
13092592|NCT03691831|25828885|FG000|Overall Study|Investigator Decision|2|||
13092593|NCT03691831|25828886|FG001|Overall Study|Investigator Decision|2|||
13092594|NCT03691779|25828916|FG000|Part B (24 Weeks)|Adverse Event|0|||
13092595|NCT03691779|25828917|FG001|Part B (24 Weeks)|Adverse Event|1|||
13092596|NCT03691779|25828916|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0|||
13092597|NCT03691779|25828917|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1|||
13092598|NCT03691571|25828939|FG000|Overall Study|Withdrawal by Subject|9|||
13092599|NCT03691571|25828940|FG001|Overall Study|Withdrawal by Subject|2|||
13092600|NCT03691428|25828961|FG000|Overall Study|Withdrawal by Subject|6|||
13092601|NCT03691428|25828962|FG001|Overall Study|Withdrawal by Subject|8|||
13092602|NCT03689855|25828969|FG000|Overall Study|Adverse Event|3|||
13092603|NCT03689855|25828969|FG000|Overall Study|Withdrawal by Subject|1|||
13092604|NCT03689452|25828992|FG000|Overall Study|Lost to Follow-up|1|||
13092605|NCT03689452|25828993|FG001|Overall Study|Lost to Follow-up|1|||
13092606|NCT03689374|25829055|FG000|Run-in Period (12 Weeks)|Run-in failure|526|||
13092607|NCT03689374|25829056|FG001|Run-in Period (12 Weeks)|Run-in failure|0|||
13092608|NCT03689374|25829057|FG002|Run-in Period (12 Weeks)|Run-in failure|0|||
13092609|NCT03689374|25829055|FG000|Treatment Period (Week 0 to 52)|Withdrawal by Subject|0|||
13092610|NCT03689374|25829056|FG001|Treatment Period (Week 0 to 52)|Withdrawal by Subject|10|||
13092611|NCT03689374|25829057|FG002|Treatment Period (Week 0 to 52)|Withdrawal by Subject|38|||
13092612|NCT03689374|25829055|FG000|Treatment Period (Week 0 to 52)|Lost to Follow-up|0|||
13092613|NCT03689374|25829056|FG001|Treatment Period (Week 0 to 52)|Lost to Follow-up|3|||
13092614|NCT03689374|25829057|FG002|Treatment Period (Week 0 to 52)|Lost to Follow-up|4|||
13092615|NCT03689374|25829055|FG000|Treatment Period (Week 0 to 52)|Death|0|||
13092616|NCT03689374|25829056|FG001|Treatment Period (Week 0 to 52)|Death|11|||
13092617|NCT03689374|25829057|FG002|Treatment Period (Week 0 to 52)|Death|1|||
13092618|NCT03688880|25829088|FG000|Overall Study|Withdrawal by Subject|0|||
13092619|NCT03688880|25829089|FG001|Overall Study|Withdrawal by Subject|2|||
13092620|NCT03688880|25829088|FG000|Overall Study|Use of non-permitted concurrent therapy|0|||
13092621|NCT03688880|25829089|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
13092622|NCT03688880|25829088|FG000|Overall Study|Lost to Follow-up|4|||
13092623|NCT03688880|25829089|FG001|Overall Study|Lost to Follow-up|7|||
13092624|NCT03688880|25829088|FG000|Overall Study|Adverse Event|0|||
13092625|NCT03688880|25829089|FG001|Overall Study|Adverse Event|2|||
13092626|NCT03688880|25829088|FG000|Overall Study|Device deficiencies|0|||
13092627|NCT03688880|25829089|FG001|Overall Study|Device deficiencies|2|||
13092628|NCT03688880|25829088|FG000|Overall Study|Other|10|||
13092629|NCT03688880|25829089|FG001|Overall Study|Other|16|||
13092630|NCT03688711|25829120|FG000|Overall Study|Withdrawal by Subject|0|||
13092631|NCT03688711|25829121|FG001|Overall Study|Withdrawal by Subject|1|||
13092632|NCT03688620|25829612|FG000|Overall Study|Other|0|||
13092633|NCT03688620|25829613|FG001|Overall Study|Other|0|||
13092634|NCT03688620|25829614|FG002|Overall Study|Other|1|||
13092635|NCT03688620|25829612|FG000|Overall Study|Unwilling to attend the scheduled visit|0|||
13092636|NCT03688620|25829613|FG001|Overall Study|Unwilling to attend the scheduled visit|1|||
13092637|NCT03688620|25829614|FG002|Overall Study|Unwilling to attend the scheduled visit|0|||
13092638|NCT03688620|25829612|FG000|Overall Study|Lost to Follow-up|16|||
13092639|NCT03688620|25829613|FG001|Overall Study|Lost to Follow-up|0|||
13092640|NCT03688620|25829614|FG002|Overall Study|Lost to Follow-up|1|||
13092641|NCT03688620|25829612|FG000|Overall Study|Withdrawal by Subject|0|||
13092642|NCT03688620|25829613|FG001|Overall Study|Withdrawal by Subject|0|||
13092643|NCT03688620|25829614|FG002|Overall Study|Withdrawal by Subject|6|||
13092644|NCT03688074|25829631|FG000|Overall Study|Adverse Event|0|||
13092645|NCT03688074|25829632|FG001|Overall Study|Adverse Event|1|||
13092646|NCT03688074|25829631|FG000|Overall Study|Other|1|||
13092647|NCT03688074|25829632|FG001|Overall Study|Other|0|||
13092648|NCT03687970|25829649|FG000|Overall Study|visit scheduling conflicts|2|||
13092649|NCT03687970|25829650|FG001|Overall Study|visit scheduling conflicts|0|||
13092650|NCT03687827|25829669|FG000|Treatment Period 1|Death|0|||
13092651|NCT03687827|25829670|FG001|Treatment Period 1|Death|1|||
13092652|NCT03687827|25829669|FG000|Treatment Period 1|Lost to Follow-up|2|||
13092653|NCT03687827|25829670|FG001|Treatment Period 1|Lost to Follow-up|2|||
13092654|NCT03687827|25829669|FG000|Treatment Period 1|Physician Decision|5|||
13092655|NCT03687827|25829670|FG001|Treatment Period 1|Physician Decision|2|||
13092656|NCT03687827|25829669|FG000|Treatment Period 1|Withdrawal by Subject|7|||
13092657|NCT03687827|25829670|FG001|Treatment Period 1|Withdrawal by Subject|3|||
13092658|NCT03687827|25829669|FG000|Treatment Period 2|Physician Decision|4|||
13092659|NCT03687827|25829670|FG001|Treatment Period 2|Physician Decision|1|||
13092660|NCT03687827|25829669|FG000|Treatment Period 2|Withdrawal by Subject|1|||
13092661|NCT03687827|25829670|FG001|Treatment Period 2|Withdrawal by Subject|2|||
13092662|NCT03687736|25829682|FG000|Overall Study|Lost to Follow-up|7|||
13092663|NCT03687736|25829682|FG000|Overall Study|Withdrawal by Subject|3|||
13092664|NCT03687372|25829703|FG000|Overall Study|Lost to Follow-up|12|||
13092665|NCT03687372|25829704|FG001|Overall Study|Lost to Follow-up|21|||
13092666|NCT03687372|25829703|FG000|Overall Study|Withdrawal by Subject|4|||
13092667|NCT03687372|25829704|FG001|Overall Study|Withdrawal by Subject|17|||
13092668|NCT03687372|25829703|FG000|Overall Study|Investigator Decision|1|||
13145697|NCT02608892|26031436|FG001|Overall Study|Lost to Follow-up|0|||
13145698|NCT02608879|26031465|FG000|Overall Study|Lost to Follow-up|1|||
13145699|NCT02608879|26031466|FG001|Overall Study|Lost to Follow-up|0|||
13145700|NCT02608879|26031467|FG002|Overall Study|Lost to Follow-up|0|||
13145701|NCT02608879|26031465|FG000|Overall Study|Did not meet continuation criteria|0|||
13145702|NCT02608879|26031466|FG001|Overall Study|Did not meet continuation criteria|0|||
13145703|NCT02608879|26031467|FG002|Overall Study|Did not meet continuation criteria|3|||
13145704|NCT02608476|26031492|FG000|Overall Study|Withdrawal by Subject|30|||
13092669|NCT03687372|25829704|FG001|Overall Study|Investigator Decision|1|||
13092670|NCT03687125|25829749|FG000|Overall Study|Progressive Disease|2|||
13092671|NCT03687125|25829750|FG001|Overall Study|Progressive Disease|1|||
13092672|NCT03687125|25829749|FG000|Overall Study|Protocol Violation|1|||
13092673|NCT03687125|25829750|FG001|Overall Study|Protocol Violation|0|||
13092674|NCT03686969|25829879|FG000|Overall Study|Study terminated|1|||
13092675|NCT03686969|25829880|FG001|Overall Study|Study terminated|0|||
13092676|NCT03686176|25829950|FG000|Overall Study|Procedure cancelled|1|||
13092677|NCT03686176|25829951|FG001|Overall Study|Procedure cancelled|0|||
13092678|NCT03686176|25829952|FG002|Overall Study|Procedure cancelled|0|||
13092679|NCT03686176|25829950|FG000|Overall Study|VR Malfunction|1|||
13092680|NCT03686176|25829951|FG001|Overall Study|VR Malfunction|0|||
13092681|NCT03686176|25829952|FG002|Overall Study|VR Malfunction|0|||
13092682|NCT03686033|25830014|FG000|Treatment Period 2 (1 Day)|Adverse Event|0|||
13092683|NCT03686033|25830015|FG001|Treatment Period 2 (1 Day)|Adverse Event|0|||
13092684|NCT03686033|25830016|FG002|Treatment Period 2 (1 Day)|Adverse Event|0|||
13092685|NCT03686033|25830017|FG003|Treatment Period 2 (1 Day)|Adverse Event|0|||
13092686|NCT03686033|25830018|FG004|Treatment Period 2 (1 Day)|Adverse Event|1|||
13092687|NCT03686033|25830019|FG005|Treatment Period 2 (1 Day)|Adverse Event|0|||
13092688|NCT03685708|25830043|FG000|Overall Study|Withdrawal by Subject|0|||
13092689|NCT03685708|25830044|FG001|Overall Study|Withdrawal by Subject|0|||
13092690|NCT03685708|25830045|FG002|Overall Study|Withdrawal by Subject|1|||
13092691|NCT03685708|25830043|FG000|Overall Study|Screen Fail|0|||
13092692|NCT03685708|25830044|FG001|Overall Study|Screen Fail|1|||
13092693|NCT03685708|25830045|FG002|Overall Study|Screen Fail|1|||
13092694|NCT03685708|25830043|FG000|Overall Study|COVID 19 Pandemic|1|||
13092695|NCT03685708|25830044|FG001|Overall Study|COVID 19 Pandemic|1|||
13092696|NCT03685708|25830045|FG002|Overall Study|COVID 19 Pandemic|6|||
13092697|NCT03685708|25830043|FG000|Overall Study|Disease Progression|0|||
13092698|NCT03685708|25830044|FG001|Overall Study|Disease Progression|0|||
13092699|NCT03685708|25830045|FG002|Overall Study|Disease Progression|1|||
13092700|NCT03685643|25830062|FG000|Overall Study|Lost to Follow-up|14|||
13092701|NCT03685643|25830063|FG001|Overall Study|Lost to Follow-up|22|||
13092702|NCT03685344|25830154|FG000|Overall Study|Withdrawal by Subject|1|||
13092703|NCT03685344|25830155|FG001|Overall Study|Withdrawal by Subject|1|||
13092704|NCT03685344|25830156|FG002|Overall Study|Withdrawal by Subject|2|||
13092705|NCT03685344|25830157|FG003|Overall Study|Withdrawal by Subject|0|||
13092706|NCT03685344|25830154|FG000|Overall Study|Physician Decision|1|||
13092707|NCT03685344|25830155|FG001|Overall Study|Physician Decision|1|||
13092708|NCT03685344|25830156|FG002|Overall Study|Physician Decision|5|||
13092709|NCT03685344|25830157|FG003|Overall Study|Physician Decision|0|||
13092710|NCT03685344|25830154|FG000|Overall Study|Death|1|||
13092711|NCT03685344|25830155|FG001|Overall Study|Death|1|||
13092712|NCT03685344|25830156|FG002|Overall Study|Death|0|||
13092713|NCT03685344|25830157|FG003|Overall Study|Death|0|||
13092714|NCT03684928|25830174|FG000|First Intervention|Lost to Follow-up|0|||
13092715|NCT03684928|25830175|FG001|First Intervention|Lost to Follow-up|1|||
13092716|NCT03684928|25830174|FG000|First Intervention|Withdrawal by Subject|0|||
13092717|NCT03684928|25830175|FG001|First Intervention|Withdrawal by Subject|2|||
13092718|NCT03684928|25830174|FG000|Second Intervention|Soft Tissue Injury|1|||
13145705|NCT02608476|26031493|FG001|Overall Study|Withdrawal by Subject|37|||
13145706|NCT02608476|26031492|FG000|Overall Study|Lost to Follow-up|24|||
13145707|NCT02608476|26031493|FG001|Overall Study|Lost to Follow-up|24|||
13145708|NCT02608476|26031492|FG000|Overall Study|Adverse Event|2|||
13145709|NCT02608476|26031493|FG001|Overall Study|Adverse Event|8|||
13145710|NCT02608476|26031492|FG000|Overall Study|Withdrawal by Parent/Guardian|5|||
13145711|NCT02608476|26031493|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
13145712|NCT02608476|26031492|FG000|Overall Study|Noncompliance with treatment|1|||
13145713|NCT02608476|26031493|FG001|Overall Study|Noncompliance with treatment|5|||
13145714|NCT02608476|26031492|FG000|Overall Study|Lack of Efficacy|3|||
13145715|NCT02608476|26031493|FG001|Overall Study|Lack of Efficacy|1|||
13145716|NCT02608476|26031492|FG000|Overall Study|Other|0|||
13145717|NCT02608476|26031493|FG001|Overall Study|Other|1|||
13145718|NCT02608476|26031492|FG000|Overall Study|Physician Decision|1|||
13145719|NCT02608476|26031493|FG001|Overall Study|Physician Decision|0|||
13145720|NCT02608476|26031492|FG000|Overall Study|Pregnancy|0|||
13145721|NCT02608476|26031493|FG001|Overall Study|Pregnancy|1|||
13145722|NCT02608476|26031492|FG000|Overall Study|Progressive disease|1|||
13145723|NCT02608476|26031493|FG001|Overall Study|Progressive disease|0|||
13145724|NCT02608450|26031518|FG000|Overall Study|Lost to Follow-up|39|||
13145725|NCT02608450|26031519|FG001|Overall Study|Lost to Follow-up|32|||
13145726|NCT02608450|26031518|FG000|Overall Study|Withdrawal by Subject|21|||
13145727|NCT02608450|26031519|FG001|Overall Study|Withdrawal by Subject|15|||
13145728|NCT02608450|26031518|FG000|Overall Study|Adverse Event|3|||
13145729|NCT02608450|26031519|FG001|Overall Study|Adverse Event|6|||
13145730|NCT02608450|26031518|FG000|Overall Study|Withdrawal by parent|2|||
13092719|NCT03684928|25830175|FG001|Second Intervention|Soft Tissue Injury|0|||
13092720|NCT03684642|25830208|FG000|Overall Study|Adverse Event|6|||
13092721|NCT03684642|25830209|FG001|Overall Study|Adverse Event|15|||
13092722|NCT03684642|25830210|FG002|Overall Study|Adverse Event|11|||
13092723|NCT03684642|25830208|FG000|Overall Study|Withdrawal by Subject|35|||
13092724|NCT03684642|25830209|FG001|Overall Study|Withdrawal by Subject|53|||
13092725|NCT03684642|25830210|FG002|Overall Study|Withdrawal by Subject|23|||
13092726|NCT03684642|25830208|FG000|Overall Study|Lack of Efficacy|0|||
13092727|NCT03684642|25830209|FG001|Overall Study|Lack of Efficacy|0|||
13092728|NCT03684642|25830210|FG002|Overall Study|Lack of Efficacy|1|||
13092729|NCT03684642|25830208|FG000|Overall Study|Poor compliance to protocol|0|||
13092730|NCT03684642|25830209|FG001|Overall Study|Poor compliance to protocol|4|||
13092731|NCT03684642|25830210|FG002|Overall Study|Poor compliance to protocol|1|||
13092732|NCT03684642|25830208|FG000|Overall Study|Other than specified|62|||
13092733|NCT03684642|25830209|FG001|Overall Study|Other than specified|60|||
13092734|NCT03684642|25830210|FG002|Overall Study|Other than specified|67|||
13092735|NCT03684642|25830208|FG000|Overall Study|Randomized and not treated|0|||
13092736|NCT03684642|25830209|FG001|Overall Study|Randomized and not treated|0|||
13092737|NCT03684642|25830210|FG002|Overall Study|Randomized and not treated|1|||
13092738|NCT03684642|25830208|FG000|Overall Study|Missing completion status but alive at last contact|0|||
13092739|NCT03684642|25830209|FG001|Overall Study|Missing completion status but alive at last contact|1|||
13092740|NCT03684642|25830210|FG002|Overall Study|Missing completion status but alive at last contact|2|||
13092741|NCT03684304|25830227|FG000|Overall Study|Lost to Follow-up|19|||
13092742|NCT03684304|25830228|FG001|Overall Study|Lost to Follow-up|17|||
13092743|NCT03684057|25830247|FG000|Overall Study|Withdrawal by Subject|4|||
13092744|NCT03684057|25830248|FG001|Overall Study|Withdrawal by Subject|5|||
13092745|NCT03684044|25830312|FG000|Overall Study|Adverse Event|3|||
13092746|NCT03684044|25830313|FG001|Overall Study|Adverse Event|0|||
13092747|NCT03684044|25830312|FG000|Overall Study|Death|4|||
13092748|NCT03684044|25830313|FG001|Overall Study|Death|7|||
13092749|NCT03684044|25830312|FG000|Overall Study|Lost to Follow-up|3|||
13092750|NCT03684044|25830313|FG001|Overall Study|Lost to Follow-up|2|||
13092751|NCT03684044|25830312|FG000|Overall Study|Patient Not Available|0|||
13092752|NCT03684044|25830313|FG001|Overall Study|Patient Not Available|2|||
13092753|NCT03684044|25830312|FG000|Overall Study|Physician Decision|1|||
13092754|NCT03684044|25830313|FG001|Overall Study|Physician Decision|0|||
13092755|NCT03684044|25830312|FG000|Overall Study|Withdrawal by Subject|11|||
13092756|NCT03684044|25830313|FG001|Overall Study|Withdrawal by Subject|9|||
13092757|NCT03683758|25830332|FG000|Overall Study|Non-study commitment conflict|1|||
13092758|NCT03683758|25830333|FG001|Overall Study|Non-study commitment conflict|3|||
13092759|NCT03683758|25830332|FG000|Overall Study|Illness preventing participation|1|||
13092760|NCT03683758|25830333|FG001|Overall Study|Illness preventing participation|0|||
13092761|NCT03683758|25830332|FG000|Overall Study|Adverse Event|1|||
13092762|NCT03683758|25830333|FG001|Overall Study|Adverse Event|0|||
13092763|NCT03683719|25830371|FG000|Overall Study|Lack of Efficacy|1|||
13092764|NCT03683719|25830372|FG001|Overall Study|Lack of Efficacy|3|||
13092765|NCT03683719|25830373|FG002|Overall Study|Lack of Efficacy|4|||
13092766|NCT03683719|25830374|FG003|Overall Study|Lack of Efficacy|0|||
13092767|NCT03683719|25830375|FG004|Overall Study|Lack of Efficacy|4|||
13092768|NCT03683719|25830371|FG000|Overall Study|Adverse Event|6|||
13092769|NCT03683719|25830372|FG001|Overall Study|Adverse Event|6|||
13092770|NCT03683719|25830373|FG002|Overall Study|Adverse Event|0|||
13092771|NCT03683719|25830374|FG003|Overall Study|Adverse Event|1|||
13092772|NCT03683719|25830375|FG004|Overall Study|Adverse Event|3|||
13092773|NCT03683719|25830371|FG000|Overall Study|Withdrawal by Subject|4|||
13092774|NCT03683719|25830372|FG001|Overall Study|Withdrawal by Subject|4|||
13092775|NCT03683719|25830373|FG002|Overall Study|Withdrawal by Subject|3|||
13092776|NCT03683719|25830374|FG003|Overall Study|Withdrawal by Subject|5|||
13092777|NCT03683719|25830375|FG004|Overall Study|Withdrawal by Subject|5|||
13092778|NCT03683719|25830371|FG000|Overall Study|Lost to Follow-up|1|||
13092779|NCT03683719|25830372|FG001|Overall Study|Lost to Follow-up|0|||
13092780|NCT03683719|25830373|FG002|Overall Study|Lost to Follow-up|0|||
13092781|NCT03683719|25830374|FG003|Overall Study|Lost to Follow-up|1|||
13092782|NCT03683719|25830375|FG004|Overall Study|Lost to Follow-up|1|||
13092783|NCT03683719|25830371|FG000|Overall Study|Other personal reasons|0|||
13092784|NCT03683719|25830372|FG001|Overall Study|Other personal reasons|0|||
13092785|NCT03683719|25830373|FG002|Overall Study|Other personal reasons|1|||
13092786|NCT03683719|25830374|FG003|Overall Study|Other personal reasons|0|||
13092787|NCT03683719|25830375|FG004|Overall Study|Other personal reasons|1|||
13092788|NCT03683576|25830426|FG000|Overall Study|Withdrawal by Subject|2|||
13145731|NCT02608450|26031519|FG001|Overall Study|Withdrawal by parent|3|||
13145732|NCT02608450|26031518|FG000|Overall Study|Lack of Efficacy|0|||
13145733|NCT02608450|26031519|FG001|Overall Study|Lack of Efficacy|3|||
13145734|NCT02608450|26031518|FG000|Overall Study|Noncompliance with study drug|0|||
13145735|NCT02608450|26031519|FG001|Overall Study|Noncompliance with study drug|2|||
13145736|NCT02608450|26031518|FG000|Overall Study|Physician Decision|0|||
13145737|NCT02608450|26031519|FG001|Overall Study|Physician Decision|1|||
13092789|NCT03683576|25830427|FG001|Overall Study|Withdrawal by Subject|0|||
13092790|NCT03683576|25830428|FG002|Overall Study|Withdrawal by Subject|8|||
13092791|NCT03683576|25830429|FG003|Overall Study|Withdrawal by Subject|3|||
13092792|NCT03683576|25830426|FG000|Overall Study|Adverse Event|3|||
13092793|NCT03683576|25830427|FG001|Overall Study|Adverse Event|0|||
13092794|NCT03683576|25830428|FG002|Overall Study|Adverse Event|0|||
13092795|NCT03683576|25830429|FG003|Overall Study|Adverse Event|4|||
13092796|NCT03683576|25830426|FG000|Overall Study|Lack of Efficacy|1|||
13092797|NCT03683576|25830427|FG001|Overall Study|Lack of Efficacy|0|||
13092798|NCT03683576|25830428|FG002|Overall Study|Lack of Efficacy|1|||
13092799|NCT03683576|25830429|FG003|Overall Study|Lack of Efficacy|1|||
13092800|NCT03683576|25830426|FG000|Overall Study|Lost to Follow-up|0|||
13092801|NCT03683576|25830427|FG001|Overall Study|Lost to Follow-up|1|||
13092802|NCT03683576|25830428|FG002|Overall Study|Lost to Follow-up|2|||
13092803|NCT03683576|25830429|FG003|Overall Study|Lost to Follow-up|0|||
13092804|NCT03683576|25830426|FG000|Overall Study|Other, Not Specified|0|||
13092805|NCT03683576|25830427|FG001|Overall Study|Other, Not Specified|2|||
13092806|NCT03683576|25830428|FG002|Overall Study|Other, Not Specified|0|||
13092807|NCT03683576|25830429|FG003|Overall Study|Other, Not Specified|0|||
13092808|NCT03683576|25830426|FG000|Overall Study|Protocol Violation|0|||
13092809|NCT03683576|25830427|FG001|Overall Study|Protocol Violation|1|||
13092810|NCT03683576|25830428|FG002|Overall Study|Protocol Violation|1|||
13092811|NCT03683576|25830429|FG003|Overall Study|Protocol Violation|0|||
13092812|NCT03682848|25830459|FG000|Overall Study|Withdrawal by Subject|2|||
13092813|NCT03682848|25830459|FG000|Overall Study|Site closed|5|||
13092814|NCT03682848|25830459|FG000|Overall Study|Protocol Deviation|1|||
13092815|NCT03682848|25830459|FG000|Overall Study|Adverse Event|1|||
13092816|NCT03682705|25830618|FG000|Overall Study|Adverse Event|1|||
13092817|NCT03682705|25830619|FG001|Overall Study|Adverse Event|1|||
13092818|NCT03682705|25830620|FG002|Overall Study|Adverse Event|1|||
13092819|NCT03682705|25830621|FG003|Overall Study|Adverse Event|0|||
13092820|NCT03682705|25830622|FG004|Overall Study|Adverse Event|1|||
13092821|NCT03682705|25830623|FG005|Overall Study|Adverse Event|1|||
13092822|NCT03682705|25830618|FG000|Overall Study|Withdrawal by Subject|1|||
13092823|NCT03682705|25830619|FG001|Overall Study|Withdrawal by Subject|3|||
13092824|NCT03682705|25830620|FG002|Overall Study|Withdrawal by Subject|2|||
13092825|NCT03682705|25830621|FG003|Overall Study|Withdrawal by Subject|4|||
13092826|NCT03682705|25830622|FG004|Overall Study|Withdrawal by Subject|0|||
13092827|NCT03682705|25830623|FG005|Overall Study|Withdrawal by Subject|1|||
13092828|NCT03682705|25830618|FG000|Overall Study|Other, not specified|0|||
13092829|NCT03682705|25830619|FG001|Overall Study|Other, not specified|0|||
13092830|NCT03682705|25830620|FG002|Overall Study|Other, not specified|0|||
13092831|NCT03682705|25830621|FG003|Overall Study|Other, not specified|1|||
13092832|NCT03682705|25830622|FG004|Overall Study|Other, not specified|2|||
13092833|NCT03682705|25830623|FG005|Overall Study|Other, not specified|0|||
13092834|NCT03682705|25830618|FG000|Overall Study|Lost to Follow-up|0|||
13092835|NCT03682705|25830619|FG001|Overall Study|Lost to Follow-up|0|||
13092836|NCT03682705|25830620|FG002|Overall Study|Lost to Follow-up|0|||
13092837|NCT03682705|25830621|FG003|Overall Study|Lost to Follow-up|0|||
13092838|NCT03682705|25830622|FG004|Overall Study|Lost to Follow-up|3|||
13092839|NCT03682705|25830623|FG005|Overall Study|Lost to Follow-up|0|||
13092840|NCT03682367|25830650|FG000|Overall Study|Protocol Violation|2|||
13092841|NCT03682367|25830651|FG001|Overall Study|Protocol Violation|1|||
13092842|NCT03682367|25830650|FG000|Overall Study|Closed Study Early|0|||
13092843|NCT03682367|25830651|FG001|Overall Study|Closed Study Early|3|||
13092844|NCT03682302|25830694|FG000|Overall Study|Lost to Follow-up|1|||
13092845|NCT03682302|25830695|FG001|Overall Study|Lost to Follow-up|2|||
13092846|NCT03682302|25830696|FG002|Overall Study|Lost to Follow-up|0|||
13092847|NCT03682302|25830697|FG003|Overall Study|Lost to Follow-up|1|||
13092848|NCT03682302|25830694|FG000|Overall Study|Study drug was not administered|0|||
13092849|NCT03682302|25830695|FG001|Overall Study|Study drug was not administered|0|||
13092850|NCT03682302|25830696|FG002|Overall Study|Study drug was not administered|1|||
13092851|NCT03682302|25830697|FG003|Overall Study|Study drug was not administered|1|||
13092852|NCT03682120|25830880|FG000|Overall Study|Lost to Follow-up|11|||
13092853|NCT03682120|25830881|FG001|Overall Study|Lost to Follow-up|4|||
13092854|NCT03682120|25830882|FG002|Overall Study|Lost to Follow-up|5|||
13092855|NCT03682120|25830883|FG003|Overall Study|Lost to Follow-up|2|||
13092856|NCT03682120|25830880|FG000|Overall Study|Physician Decision|1|||
13092857|NCT03682120|25830881|FG001|Overall Study|Physician Decision|0|||
13092858|NCT03682120|25830882|FG002|Overall Study|Physician Decision|0|||
13145738|NCT02608450|26031518|FG000|Overall Study|Pregnancy|0|||
13092859|NCT03682120|25830883|FG003|Overall Study|Physician Decision|0|||
13145739|NCT02608450|26031519|FG001|Overall Study|Pregnancy|1|||
13145740|NCT02608450|26031518|FG000|Overall Study|Progressive disease|1|||
13145741|NCT02608450|26031519|FG001|Overall Study|Progressive disease|0|||
13145742|NCT02608450|26031518|FG000|Overall Study|Multiple reasons|0|||
13145743|NCT02608450|26031519|FG001|Overall Study|Multiple reasons|2|||
13145744|NCT02608099|26031562|FG000|Overall Study|Ablation procedure not initiated|3|||
13145745|NCT02608099|26031563|FG001|Overall Study|Ablation procedure not initiated|2|||
13145746|NCT02607865|26031748|FG000|Overall Study|Lost to Follow-up|9|||
13145747|NCT02607865|26031749|FG001|Overall Study|Lost to Follow-up|7|||
13145748|NCT02607865|26031750|FG002|Overall Study|Lost to Follow-up|7|||
13145749|NCT02607865|26031751|FG003|Overall Study|Lost to Follow-up|5|||
13145750|NCT02607865|26031748|FG000|Overall Study|Withdrawal by Subject|18|||
13145751|NCT02607865|26031749|FG001|Overall Study|Withdrawal by Subject|18|||
13145752|NCT02607865|26031750|FG002|Overall Study|Withdrawal by Subject|17|||
13145753|NCT02607865|26031751|FG003|Overall Study|Withdrawal by Subject|8|||
13145754|NCT02607865|26031748|FG000|Overall Study|Death|5|||
13145755|NCT02607865|26031749|FG001|Overall Study|Death|4|||
13145756|NCT02607865|26031750|FG002|Overall Study|Death|1|||
13145757|NCT02607865|26031751|FG003|Overall Study|Death|3|||
13145758|NCT02607865|26031748|FG000|Overall Study|Unclassified|1|||
13145759|NCT02607865|26031749|FG001|Overall Study|Unclassified|1|||
13145760|NCT02607865|26031750|FG002|Overall Study|Unclassified|2|||
13145761|NCT02607865|26031751|FG003|Overall Study|Unclassified|0|||
13145762|NCT02607800|26031774|FG000|Overall Study|Lost to Follow-up|7|||
13145763|NCT02607800|26031775|FG001|Overall Study|Lost to Follow-up|10|||
13092860|NCT03682120|25830880|FG000|Overall Study|Withdrawal by Subject|1|||
13092861|NCT03682120|25830881|FG001|Overall Study|Withdrawal by Subject|2|||
13092862|NCT03682120|25830882|FG002|Overall Study|Withdrawal by Subject|3|||
13092863|NCT03682120|25830883|FG003|Overall Study|Withdrawal by Subject|0|||
13092864|NCT03682120|25830880|FG000|Overall Study|Death|0|||
13092865|NCT03682120|25830881|FG001|Overall Study|Death|1|||
13092866|NCT03682120|25830882|FG002|Overall Study|Death|0|||
13092867|NCT03682120|25830883|FG003|Overall Study|Death|0|||
13092868|NCT03682120|25830880|FG000|Overall Study|Enrolled but Treatment Not Administered|0|||
13092869|NCT03682120|25830881|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
13092870|NCT03682120|25830882|FG002|Overall Study|Enrolled but Treatment Not Administered|0|||
13092871|NCT03682120|25830883|FG003|Overall Study|Enrolled but Treatment Not Administered|0|||
13092872|NCT03682107|25831001|FG000|Overall Study|Withdrawal by Subject|0|||
13092873|NCT03682107|25831002|FG001|Overall Study|Withdrawal by Subject|1|||
13092874|NCT03682107|25831003|FG002|Overall Study|Withdrawal by Subject|0|||
13092875|NCT03682107|25831004|FG003|Overall Study|Withdrawal by Subject|0|||
13092876|NCT03682107|25831005|FG004|Overall Study|Withdrawal by Subject|0|||
13092877|NCT03681951|25831221|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1|||
13092878|NCT03681951|25831222|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
13092879|NCT03681951|25831223|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
13092880|NCT03681951|25831224|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
13092881|NCT03681951|25831225|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
13092882|NCT03681951|25831226|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
13092883|NCT03681951|25831227|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
13092884|NCT03681951|25831228|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
13092885|NCT03681951|25831221|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4|||
13092886|NCT03681951|25831222|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
13092887|NCT03681951|25831223|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
13092888|NCT03681951|25831224|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
13092889|NCT03681951|25831225|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
13092890|NCT03681951|25831226|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
13092891|NCT03681951|25831227|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
13092892|NCT03681951|25831228|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
13092893|NCT03681951|25831221|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3|||
13092894|NCT03681951|25831222|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
13092895|NCT03681951|25831223|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
13092896|NCT03681951|25831224|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
13092897|NCT03681951|25831225|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
13092898|NCT03681951|25831226|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
13092899|NCT03681951|25831227|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
13092900|NCT03681951|25831228|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
13092901|NCT03681691|25831277|FG000|Overall Study|COVID|1|||
13485225|NCT03406078|27031981|FG000|Overall Study|Withdrawal by Subject|5|||
13485226|NCT03406078|27031982|FG001|Overall Study|Withdrawal by Subject|2|||
13092902|NCT03681691|25831278|FG001|Overall Study|COVID|0|||
13145764|NCT02607800|26031774|FG000|Overall Study|Withdrew Consent|2|||
13145765|NCT02607800|26031775|FG001|Overall Study|Withdrew Consent|0|||
13145766|NCT02607800|26031774|FG000|Overall Study|Randomized/Enrolled but Not Treated|1|||
13145767|NCT02607800|26031775|FG001|Overall Study|Randomized/Enrolled but Not Treated|1|||
13145768|NCT02607735|26031803|FG000|Primary Study|Randomized but Never Treated|1|||
13145769|NCT02607735|26031804|FG001|Primary Study|Randomized but Never Treated|0|||
13145770|NCT02607735|26031805|FG002|Primary Study|Randomized but Never Treated|0|||
13145771|NCT02607735|26031803|FG000|Primary Study|Lost to Follow-up|4|||
13145772|NCT02607735|26031804|FG001|Primary Study|Lost to Follow-up|0|||
13145773|NCT02607735|26031805|FG002|Primary Study|Lost to Follow-up|0|||
13145774|NCT02607735|26031803|FG000|Primary Study|Withdrew Consent|2|||
13145775|NCT02607735|26031804|FG001|Primary Study|Withdrew Consent|0|||
13145776|NCT02607735|26031805|FG002|Primary Study|Withdrew Consent|0|||
13145777|NCT02607735|26031803|FG000|Deferred Treatment Substudy|Lost to Follow-up|0|||
13145778|NCT02607735|26031804|FG001|Deferred Treatment Substudy|Lost to Follow-up|0|||
13145779|NCT02607735|26031805|FG002|Deferred Treatment Substudy|Lost to Follow-up|4|||
13145780|NCT02607735|26031803|FG000|Deferred Treatment Substudy|Withdrew Consent|0|||
13145781|NCT02607735|26031804|FG001|Deferred Treatment Substudy|Withdrew Consent|0|||
13145782|NCT02607735|26031805|FG002|Deferred Treatment Substudy|Withdrew Consent|1|||
13145783|NCT02607306|26031935|FG000|Overall Study|Adverse Event|8|||
13145784|NCT02607306|26031936|FG001|Overall Study|Adverse Event|6|||
13145785|NCT02607306|26031937|FG002|Overall Study|Adverse Event|6|||
13145786|NCT02607306|26031935|FG000|Overall Study|Unclassified|1|||
13145787|NCT02607306|26031936|FG001|Overall Study|Unclassified|4|||
13145788|NCT02607306|26031937|FG002|Overall Study|Unclassified|0|||
13145789|NCT02607306|26031935|FG000|Overall Study|Withdrawal by Subject|8|||
13145790|NCT02607306|26031936|FG001|Overall Study|Withdrawal by Subject|10|||
13145791|NCT02607306|26031937|FG002|Overall Study|Withdrawal by Subject|2|||
13145792|NCT02607306|26031935|FG000|Overall Study|Lack of Efficacy|0|||
13145793|NCT02607306|26031936|FG001|Overall Study|Lack of Efficacy|1|||
13145794|NCT02607306|26031937|FG002|Overall Study|Lack of Efficacy|1|||
13145795|NCT02607306|26031935|FG000|Overall Study|Protocol Violation|4|||
13145796|NCT02607306|26031936|FG001|Overall Study|Protocol Violation|2|||
13145797|NCT02607306|26031937|FG002|Overall Study|Protocol Violation|1|||
13204960|NCT01968967|26230510|FG002|Treatment Period|Death|0|||
13204961|NCT01968967|26230511|FG003|Treatment Period|Death|0|||
13204962|NCT01968967|26230512|FG004|Treatment Period|Death|0|||
13204963|NCT01968967|26230508|FG000|Treatment Period|Randomized Not Treated|6|||
13204964|NCT01968967|26230509|FG001|Treatment Period|Randomized Not Treated|5|||
13204965|NCT01968967|26230510|FG002|Treatment Period|Randomized Not Treated|0|||
13204966|NCT01968967|26230511|FG003|Treatment Period|Randomized Not Treated|0|||
13204967|NCT01968967|26230512|FG004|Treatment Period|Randomized Not Treated|0|||
13204968|NCT01968967|26230508|FG000|Extension Period|Withdrew Consent|0|||
13204969|NCT01968967|26230509|FG001|Extension Period|Withdrew Consent|0|||
13204970|NCT01968967|26230510|FG002|Extension Period|Withdrew Consent|2|||
13204971|NCT01968967|26230511|FG003|Extension Period|Withdrew Consent|0|||
13204972|NCT01968967|26230512|FG004|Extension Period|Withdrew Consent|5|||
13204973|NCT01968954|26230583|FG000|Overall Study|Adverse Event|6|||
13204974|NCT01968954|26230584|FG001|Overall Study|Adverse Event|3|||
13204975|NCT01968954|26230583|FG000|Overall Study|Death|1|||
13204976|NCT01968954|26230584|FG001|Overall Study|Death|2|||
13204977|NCT01968954|26230583|FG000|Overall Study|Lost to Follow-up|6|||
13204978|NCT01968954|26230584|FG001|Overall Study|Lost to Follow-up|4|||
13204979|NCT01968954|26230583|FG000|Overall Study|Withdrawal by Subject|20|||
13204980|NCT01968954|26230584|FG001|Overall Study|Withdrawal by Subject|23|||
13204981|NCT01968954|26230583|FG000|Overall Study|Other|7|||
13204982|NCT01968954|26230584|FG001|Overall Study|Other|8|||
13204983|NCT01968954|26230583|FG000|Overall Study|Protocol Violation|0|||
13204984|NCT01968954|26230584|FG001|Overall Study|Protocol Violation|1|||
13204985|NCT01968954|26230583|FG000|Overall Study|Did not met inclusion criteria|0|||
13204986|NCT01968954|26230584|FG001|Overall Study|Did not met inclusion criteria|2|||
13204987|NCT01968811|26230591|FG000|Overall Study|Protocol Violation|4|||
13204988|NCT01968811|26230591|FG000|Overall Study|post op.ref. of subject to other hospita|1|||
13204989|NCT01968707|26230682|FG000|Overall Study|Did not meet treatment day baseline|49|||
13204990|NCT01968707|26230683|FG001|Overall Study|Did not meet treatment day baseline|12|||
13204991|NCT01968707|26230684|FG002|Overall Study|Did not meet treatment day baseline|41|||
13204992|NCT01968707|26230685|FG003|Overall Study|Did not meet treatment day baseline|44|||
13204993|NCT01968707|26230686|FG004|Overall Study|Did not meet treatment day baseline|36|||
13204994|NCT01968707|26230687|FG005|Overall Study|Did not meet treatment day baseline|11|||
13204995|NCT01968707|26230688|FG006|Overall Study|Did not meet treatment day baseline|34|||
13204996|NCT01968707|26230689|FG007|Overall Study|Did not meet treatment day baseline|35|||
13204997|NCT01968694|26230710|FG000|Washout (1 Month)|Lost to Follow-up|0|||
13204998|NCT01968694|26230711|FG001|Washout (1 Month)|Lost to Follow-up|1|||
13204999|NCT01968551|26230735|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
13205000|NCT01968551|26230736|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
13205001|NCT01968551|26230737|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0|||
13205002|NCT01968551|26230735|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
13205003|NCT01968551|26230736|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1|||
13145798|NCT02607280|26031950|FG000|Overall Study|Adverse Event|4|||
13145799|NCT02607280|26031951|FG001|Overall Study|Adverse Event|0|||
13145800|NCT02607280|26031950|FG000|Overall Study|Decrease in CrCl <15|0|||
13145801|NCT02607280|26031951|FG001|Overall Study|Decrease in CrCl <15|1|||
13145802|NCT02607228|26032052|FG000|Overall Study|Progressive Disease|4|||
13145803|NCT02607228|26032053|FG001|Overall Study|Progressive Disease|3|||
13145804|NCT02607228|26032054|FG002|Overall Study|Progressive Disease|1|||
13145805|NCT02607228|26032055|FG003|Overall Study|Progressive Disease|5|||
13145806|NCT02607228|26032056|FG004|Overall Study|Progressive Disease|4|||
13145807|NCT02607228|26032057|FG005|Overall Study|Progressive Disease|3|||
13145808|NCT02607228|26032058|FG006|Overall Study|Progressive Disease|1|||
13145809|NCT02607228|26032052|FG000|Overall Study|Adverse Event|1|||
13145810|NCT02607228|26032053|FG001|Overall Study|Adverse Event|0|||
13145811|NCT02607228|26032054|FG002|Overall Study|Adverse Event|1|||
13145812|NCT02607228|26032055|FG003|Overall Study|Adverse Event|0|||
13145813|NCT02607228|26032056|FG004|Overall Study|Adverse Event|1|||
13145814|NCT02607228|26032057|FG005|Overall Study|Adverse Event|1|||
13145815|NCT02607228|26032058|FG006|Overall Study|Adverse Event|1|||
13145816|NCT02607228|26032052|FG000|Overall Study|Investigator's Discretion|0|||
13145817|NCT02607228|26032053|FG001|Overall Study|Investigator's Discretion|0|||
13145818|NCT02607228|26032054|FG002|Overall Study|Investigator's Discretion|1|||
13145819|NCT02607228|26032055|FG003|Overall Study|Investigator's Discretion|0|||
13145820|NCT02607228|26032056|FG004|Overall Study|Investigator's Discretion|0|||
13145821|NCT02607228|26032057|FG005|Overall Study|Investigator's Discretion|1|||
13092903|NCT03681691|25831277|FG000|Overall Study|prolonged bleeding|1|||
13092904|NCT03681691|25831278|FG001|Overall Study|prolonged bleeding|0|||
13092905|NCT03681691|25831277|FG000|Overall Study|veins would not stay open during the PET scan.|0|||
13092906|NCT03681691|25831278|FG001|Overall Study|veins would not stay open during the PET scan.|1|||
13092907|NCT03681470|25831290|FG000|Overall Study|Lack of Efficacy|3|||
13092908|NCT03681470|25831290|FG000|Overall Study|Lost to Follow-up|1|||
13092909|NCT03681470|25831290|FG000|Overall Study|Protocol Violation|3|||
13092910|NCT03681470|25831290|FG000|Overall Study|Withdrawal by Subject|1|||
13092911|NCT03681405|25831319|FG000|Overall Study|Found to be ineligible after randomized|1|||
13092912|NCT03681405|25831320|FG001|Overall Study|Found to be ineligible after randomized|0|||
13092913|NCT03681353|25831332|FG000|Overall Study|Lost to Follow-up|2|||
13092914|NCT03681353|25831332|FG000|Overall Study|Withdrawal by Subject|3|||
13092915|NCT03681353|25831332|FG000|Overall Study|withdrawn by PI|2|||
13092916|NCT03681119|25831343|FG000|Overall Study|No specific reason|4|||
13092917|NCT03681119|25831344|FG001|Overall Study|No specific reason|0|||
13092918|NCT03681119|25831343|FG000|Overall Study|Sickness|2|||
13092919|NCT03681119|25831344|FG001|Overall Study|Sickness|0|||
13092920|NCT03681093|25831371|FG000|Overall Study|Subject decision|0|||
13092921|NCT03681093|25831372|FG001|Overall Study|Subject decision|2|||
13092922|NCT03681093|25831373|FG002|Overall Study|Subject decision|1|||
13092923|NCT03680911|25831388|FG000|At Home Treatment|Study Termination|3|||
13092924|NCT03680911|25831389|FG001|At Home Treatment|Study Termination|0|||
13092925|NCT03680911|25831388|FG000|At Home Treatment|Lost to Follow-up|0|||
13092926|NCT03680911|25831389|FG001|At Home Treatment|Lost to Follow-up|1|||
13092927|NCT03680911|25831388|FG000|At Home Treatment|Withdrawal by Subject|0|||
13092928|NCT03680911|25831389|FG001|At Home Treatment|Withdrawal by Subject|2|||
13092929|NCT03680911|25831388|FG000|Visit 3 (4 Month Follow up)|Study Termination|0|||
13092930|NCT03680911|25831389|FG001|Visit 3 (4 Month Follow up)|Study Termination|1|||
13092931|NCT03680742|25831396|FG000|Overall Study|Unsuccessful Implant Attempt|2|||
13092932|NCT03680521|25831418|FG000|Overall Study|Ongoing in long-term follow up|7|||
13092933|NCT03680521|25831419|FG001|Overall Study|Ongoing in long-term follow up|11|||
13092934|NCT03679767|25831467|FG000|Overall Study|Death|16|||
13092935|NCT03679767|25831468|FG001|Overall Study|Death|10|||
13092936|NCT03679767|25831469|FG002|Overall Study|Death|16|||
13092937|NCT03679767|25831470|FG003|Overall Study|Death|10|||
13092938|NCT03679767|25831467|FG000|Overall Study|Lost to Follow-up|1|||
13092939|NCT03679767|25831468|FG001|Overall Study|Lost to Follow-up|0|||
13092940|NCT03679767|25831469|FG002|Overall Study|Lost to Follow-up|1|||
13092941|NCT03679767|25831470|FG003|Overall Study|Lost to Follow-up|1|||
13092942|NCT03679767|25831467|FG000|Overall Study|Withdrawal by Subject|0|||
13092943|NCT03679767|25831468|FG001|Overall Study|Withdrawal by Subject|0|||
13092944|NCT03679767|25831469|FG002|Overall Study|Withdrawal by Subject|0|||
13092945|NCT03679767|25831470|FG003|Overall Study|Withdrawal by Subject|1|||
13092946|NCT03679767|25831467|FG000|Overall Study|Follow-up Completed|4|||
13092947|NCT03679767|25831468|FG001|Overall Study|Follow-up Completed|1|||
13092948|NCT03679767|25831469|FG002|Overall Study|Follow-up Completed|3|||
13092949|NCT03679767|25831470|FG003|Overall Study|Follow-up Completed|5|||
13092950|NCT03679767|25831467|FG000|Overall Study|Ongoing|14|||
13092951|NCT03679767|25831468|FG001|Overall Study|Ongoing|12|||
13092952|NCT03679767|25831469|FG002|Overall Study|Ongoing|9|||
13145822|NCT02607228|26032058|FG006|Overall Study|Investigator's Discretion|0|||
13145823|NCT02607228|26032052|FG000|Overall Study|Withdrew Consent|0|||
13145824|NCT02607228|26032053|FG001|Overall Study|Withdrew Consent|1|||
13145825|NCT02607228|26032054|FG002|Overall Study|Withdrew Consent|0|||
13145826|NCT02607228|26032055|FG003|Overall Study|Withdrew Consent|0|||
13145827|NCT02607228|26032056|FG004|Overall Study|Withdrew Consent|0|||
13145828|NCT02607228|26032057|FG005|Overall Study|Withdrew Consent|1|||
13145829|NCT02607228|26032058|FG006|Overall Study|Withdrew Consent|0|||
13145830|NCT02607228|26032052|FG000|Overall Study|Study Terminated by Sponsor|0|||
13145831|NCT02607228|26032053|FG001|Overall Study|Study Terminated by Sponsor|0|||
13145832|NCT02607228|26032054|FG002|Overall Study|Study Terminated by Sponsor|0|||
13145833|NCT02607228|26032055|FG003|Overall Study|Study Terminated by Sponsor|1|||
13145834|NCT02607228|26032056|FG004|Overall Study|Study Terminated by Sponsor|0|||
13145835|NCT02607228|26032057|FG005|Overall Study|Study Terminated by Sponsor|0|||
13145836|NCT02607228|26032058|FG006|Overall Study|Study Terminated by Sponsor|0|||
13145837|NCT02606877|26032079|FG000|Overall Study|Adverse Event|3|||
13145838|NCT02606877|26032080|FG001|Overall Study|Adverse Event|0|||
13145839|NCT02606877|26032079|FG000|Overall Study|Non-compliance with protocol|0|||
13145840|NCT02606877|26032080|FG001|Overall Study|Non-compliance with protocol|1|||
13145841|NCT02606877|26032079|FG000|Overall Study|Other than listed above|1|||
13145842|NCT02606877|26032080|FG001|Overall Study|Other than listed above|0|||
13145843|NCT02606643|26032097|FG000|Overall Study|did not meet inclusion criteria|1|||
13145844|NCT02606643|26032098|FG001|Overall Study|did not meet inclusion criteria|3|||
13145845|NCT02606279|26032117|FG000|Overall Study|Lost to Follow-up|0|||
13145846|NCT02606279|26032118|FG001|Overall Study|Lost to Follow-up|1|||
13145847|NCT02606253|26032187|FG000|Overall Study|Adverse Event|2|||
13145848|NCT02606253|26032188|FG001|Overall Study|Adverse Event|0|||
13145849|NCT02606253|26032189|FG002|Overall Study|Adverse Event|0|||
13145850|NCT02606253|26032187|FG000|Overall Study|Protocol Violation|2|||
13145851|NCT02606253|26032188|FG001|Overall Study|Protocol Violation|1|||
13145852|NCT02606253|26032189|FG002|Overall Study|Protocol Violation|0|||
13145853|NCT02606253|26032187|FG000|Overall Study|Physician Decision|1|||
13145854|NCT02606253|26032188|FG001|Overall Study|Physician Decision|1|||
13145855|NCT02606253|26032189|FG002|Overall Study|Physician Decision|0|||
13145856|NCT02605967|26032234|FG000|Overall Study|subject / guardian decision|1|||
13145857|NCT02605967|26032235|FG001|Overall Study|subject / guardian decision|2|||
13145858|NCT02605967|26032234|FG000|Overall Study|Physician Decision|10|||
13145859|NCT02605967|26032235|FG001|Overall Study|Physician Decision|1|||
13145860|NCT02605967|26032234|FG000|Overall Study|Death|4|||
13145861|NCT02605967|26032235|FG001|Overall Study|Death|2|||
13145862|NCT02605967|26032234|FG000|Overall Study|Adverse Event|1|||
13145863|NCT02605967|26032235|FG001|Overall Study|Adverse Event|0|||
13145864|NCT02605967|26032234|FG000|Overall Study|progressive disease|66|||
13145865|NCT02605967|26032235|FG001|Overall Study|progressive disease|35|||
13145866|NCT02605954|26032259|FG000|Overall Study|Adverse Event|5|||
13145867|NCT02605954|26032260|FG001|Overall Study|Adverse Event|1|||
13145868|NCT02605954|26032259|FG000|Overall Study|Investigator's Discretion|1|||
13145869|NCT02605954|26032260|FG001|Overall Study|Investigator's Discretion|0|||
13145870|NCT02605954|26032259|FG000|Overall Study|Non-Compliance with Study Drug|1|||
13145871|NCT02605954|26032260|FG001|Overall Study|Non-Compliance with Study Drug|0|||
13145872|NCT02605954|26032259|FG000|Overall Study|Withdrew Consent|2|||
13145873|NCT02605954|26032260|FG001|Overall Study|Withdrew Consent|2|||
13092953|NCT03679767|25831470|FG003|Overall Study|Ongoing|17|||
13092954|NCT03679741|25831493|FG000|Period 1|No longer meet eligibility criteria|1|||
13092955|NCT03679741|25831494|FG001|Period 1|No longer meet eligibility criteria|0|||
13092956|NCT03679741|25831493|FG000|Period 1|Lost to Follow-up|0|||
13092957|NCT03679741|25831494|FG001|Period 1|Lost to Follow-up|1|||
13092958|NCT03679741|25831493|FG000|Period 1|Adverse Event|1|||
13092959|NCT03679741|25831494|FG001|Period 1|Adverse Event|1|||
13092960|NCT03679741|25831493|FG000|Period 1|Withdrawal by Subject|0|||
13092961|NCT03679741|25831494|FG001|Period 1|Withdrawal by Subject|1|||
13092962|NCT03679741|25831493|FG000|Period 2|Adverse Event|2|||
13092963|NCT03679741|25831494|FG001|Period 2|Adverse Event|1|||
13092964|NCT03679741|25831493|FG000|Period 2|Withdrawal by Subject|1|||
13092965|NCT03679741|25831494|FG001|Period 2|Withdrawal by Subject|1|||
13092966|NCT03678870|25831513|FG000|Overall Study|prescribed non- protocol medications|10|||
13092967|NCT03678870|25831514|FG001|Overall Study|prescribed non- protocol medications|6|||
13092968|NCT03678870|25831513|FG000|Overall Study|Lost to Follow-up|3|||
13092969|NCT03678870|25831514|FG001|Overall Study|Lost to Follow-up|2|||
13092970|NCT03678285|25831526|FG000|Overall Study|Adverse Event|2|||
13092971|NCT03678285|25831526|FG000|Overall Study|Withdrawal by subject prior to start of workout|1|||
13092972|NCT03678285|25831526|FG000|Overall Study|Dehydrated prior to start of workout|1|||
13132669|NCT02786901|25984778|FG001|Overall Study|Rescue Therapy Use|49|||
13132670|NCT02786901|25984779|FG002|Overall Study|Rescue Therapy Use|33|||
13132671|NCT02786901|25984777|FG000|Overall Study|Subject Request/Lost to Follow up|1|||
13145874|NCT02605954|26032259|FG000|Overall Study|Lost to Follow-up|3|||
13145875|NCT02605954|26032260|FG001|Overall Study|Lost to Follow-up|0|||
13145876|NCT02605954|26032259|FG000|Overall Study|Randomized but not treated|0|||
13145877|NCT02605954|26032260|FG001|Overall Study|Randomized but not treated|1|||
13145878|NCT02605928|26032266|FG000|Overall Study|Model tuning phase|28|||
13145879|NCT02605928|26032266|FG000|Overall Study|Lack of Efficacy|5|||
13145880|NCT02605837|26032310|FG000|Overall Study|Adverse Event|3|||
13145881|NCT02605837|26032311|FG001|Overall Study|Adverse Event|1|||
13145882|NCT02605837|26032310|FG000|Overall Study|Non-Compliance with Study Drug|0|||
13145883|NCT02605837|26032311|FG001|Overall Study|Non-Compliance with Study Drug|1|||
13145884|NCT02605837|26032310|FG000|Overall Study|Withdrawal by Subject|8|||
13145885|NCT02605837|26032311|FG001|Overall Study|Withdrawal by Subject|8|||
13145886|NCT02605837|26032310|FG000|Overall Study|Physician Decision|0|||
13145887|NCT02605837|26032311|FG001|Overall Study|Physician Decision|1|||
13145888|NCT02605824|26032326|FG000|Overall Study|Physician Decision|1|||
13145889|NCT02605824|26032327|FG001|Overall Study|Physician Decision|0|||
13145890|NCT02605642|26032376|FG000|Overall Study|Other|11|||
13145891|NCT02605642|26032377|FG001|Overall Study|Other|1|||
13145892|NCT02605642|26032376|FG000|Overall Study|Participant non-compliance|2|||
13145893|NCT02605642|26032377|FG001|Overall Study|Participant non-compliance|4|||
13145894|NCT02605642|26032376|FG000|Overall Study|Physician Decision|10|||
13145895|NCT02605642|26032377|FG001|Overall Study|Physician Decision|0|||
13145896|NCT02605642|26032376|FG000|Overall Study|Lost to Follow-up|12|||
13145897|NCT02605642|26032377|FG001|Overall Study|Lost to Follow-up|1|||
13145898|NCT02605642|26032376|FG000|Overall Study|Adverse Event|14|||
13145899|NCT02605642|26032377|FG001|Overall Study|Adverse Event|2|||
13145900|NCT02605642|26032376|FG000|Overall Study|Withdrawal by Subject|23|||
13145901|NCT02605642|26032377|FG001|Overall Study|Withdrawal by Subject|2|||
13145902|NCT02605642|26032376|FG000|Overall Study|Lack of response|24|||
13145903|NCT02605642|26032377|FG001|Overall Study|Lack of response|11|||
13145904|NCT02605447|26032385|FG000|Overall Study|Death|66|||
13145905|NCT02605447|26032385|FG000|Overall Study|Physician Decision|1|||
13145906|NCT02605447|26032385|FG000|Overall Study|Lost to Follow-up|24|||
13145907|NCT02605447|26032385|FG000|Overall Study|Withdrawal by Subject|10|||
13145908|NCT02605447|26032385|FG000|Overall Study|Not disclosed|1|||
13145909|NCT02605174|26032461|FG000|Overall Study|Adverse Event|0|||
13145910|NCT02605174|26032462|FG001|Overall Study|Adverse Event|0|||
13145911|NCT02605174|26032463|FG002|Overall Study|Adverse Event|1|||
13145912|NCT02605174|26032464|FG003|Overall Study|Adverse Event|0|||
13145913|NCT02605174|26032465|FG004|Overall Study|Adverse Event|4|||
13145914|NCT02605174|26032466|FG005|Overall Study|Adverse Event|0|||
13145915|NCT02605174|26032467|FG006|Overall Study|Adverse Event|0|||
13145916|NCT02605174|26032461|FG000|Overall Study|Lost to Follow-up|20|||
13145917|NCT02605174|26032462|FG001|Overall Study|Lost to Follow-up|7|||
13145918|NCT02605174|26032463|FG002|Overall Study|Lost to Follow-up|27|||
13145919|NCT02605174|26032464|FG003|Overall Study|Lost to Follow-up|10|||
13145920|NCT02605174|26032465|FG004|Overall Study|Lost to Follow-up|20|||
13145921|NCT02605174|26032466|FG005|Overall Study|Lost to Follow-up|10|||
13145922|NCT02605174|26032467|FG006|Overall Study|Lost to Follow-up|29|||
13145923|NCT02605174|26032461|FG000|Overall Study|Protocol Violation|10|||
13145924|NCT02605174|26032462|FG001|Overall Study|Protocol Violation|4|||
13145925|NCT02605174|26032463|FG002|Overall Study|Protocol Violation|14|||
13145926|NCT02605174|26032464|FG003|Overall Study|Protocol Violation|6|||
13145927|NCT02605174|26032465|FG004|Overall Study|Protocol Violation|7|||
13145928|NCT02605174|26032466|FG005|Overall Study|Protocol Violation|7|||
13145929|NCT02605174|26032467|FG006|Overall Study|Protocol Violation|12|||
13145930|NCT02605174|26032461|FG000|Overall Study|Pregnancy|1|||
13145931|NCT02605174|26032462|FG001|Overall Study|Pregnancy|0|||
13145932|NCT02605174|26032463|FG002|Overall Study|Pregnancy|0|||
13145933|NCT02605174|26032464|FG003|Overall Study|Pregnancy|2|||
13145934|NCT02605174|26032465|FG004|Overall Study|Pregnancy|0|||
13145935|NCT02605174|26032466|FG005|Overall Study|Pregnancy|0|||
13145936|NCT02605174|26032467|FG006|Overall Study|Pregnancy|0|||
13145937|NCT02605174|26032461|FG000|Overall Study|Withdrawal by Subject|9|||
13145938|NCT02605174|26032462|FG001|Overall Study|Withdrawal by Subject|6|||
13145939|NCT02605174|26032463|FG002|Overall Study|Withdrawal by Subject|14|||
13145940|NCT02605174|26032464|FG003|Overall Study|Withdrawal by Subject|11|||
13145941|NCT02605174|26032465|FG004|Overall Study|Withdrawal by Subject|6|||
13145942|NCT02605174|26032466|FG005|Overall Study|Withdrawal by Subject|4|||
13145943|NCT02605174|26032467|FG006|Overall Study|Withdrawal by Subject|15|||
13145944|NCT02605174|26032461|FG000|Overall Study|Physician Decision|2|||
13145945|NCT02605174|26032462|FG001|Overall Study|Physician Decision|0|||
13145946|NCT02605174|26032463|FG002|Overall Study|Physician Decision|0|||
13145947|NCT02605174|26032464|FG003|Overall Study|Physician Decision|0|||
13145948|NCT02605174|26032465|FG004|Overall Study|Physician Decision|0|||
13145949|NCT02605174|26032466|FG005|Overall Study|Physician Decision|0|||
13145950|NCT02605174|26032467|FG006|Overall Study|Physician Decision|3|||
13145951|NCT02605174|26032461|FG000|Overall Study|Randomization Failure|22|||
13145952|NCT02605174|26032462|FG001|Overall Study|Randomization Failure|6|||
13145953|NCT02605174|26032463|FG002|Overall Study|Randomization Failure|20|||
13145954|NCT02605174|26032464|FG003|Overall Study|Randomization Failure|7|||
13145955|NCT02605174|26032465|FG004|Overall Study|Randomization Failure|16|||
13145956|NCT02605174|26032466|FG005|Overall Study|Randomization Failure|11|||
13145957|NCT02605174|26032467|FG006|Overall Study|Randomization Failure|30|||
13145958|NCT02605122|26032486|FG000|Overall Study|Withdrawal by Subject|4|||
13145959|NCT02605122|26032487|FG001|Overall Study|Withdrawal by Subject|1|||
13145960|NCT02605122|26032486|FG000|Overall Study|Lost to Follow-up|1|||
13145961|NCT02605122|26032487|FG001|Overall Study|Lost to Follow-up|1|||
13145962|NCT02604589|26032523|FG000|Overall Study|catheter dislodgement|0|||
13145963|NCT02604589|26032524|FG001|Overall Study|catheter dislodgement|0|||
13092973|NCT03678103|25831534|FG000|Overall Study|Withdrawn prior to completion|4|||
13092974|NCT03677934|25831585|FG000|Overall Study|Adverse Event|1|||
13092975|NCT03677934|25831586|FG001|Overall Study|Adverse Event|1|||
13092976|NCT03677934|25831585|FG000|Overall Study|Death|8|||
13092977|NCT03677934|25831586|FG001|Overall Study|Death|4|||
13092978|NCT03677934|25831585|FG000|Overall Study|Lost to Follow-up|3|||
13092979|NCT03677934|25831586|FG001|Overall Study|Lost to Follow-up|0|||
13092980|NCT03677934|25831585|FG000|Overall Study|Non-Compliance With Study Drug|1|||
13092981|NCT03677934|25831586|FG001|Overall Study|Non-Compliance With Study Drug|0|||
13092982|NCT03677934|25831585|FG000|Overall Study|Physician Decision|0|||
13092983|NCT03677934|25831586|FG001|Overall Study|Physician Decision|1|||
13092984|NCT03677934|25831585|FG000|Overall Study|Withdrawal by Subject|1|||
13092985|NCT03677934|25831586|FG001|Overall Study|Withdrawal by Subject|7|||
13092986|NCT03677869|25831599|FG000|Overall Study|Withdrawal by Subject|1|||
13092987|NCT03677401|25831630|FG000|Overall Study|Adverse Event|4|||
13092988|NCT03677401|25831631|FG001|Overall Study|Adverse Event|14|||
13092989|NCT03677401|25831630|FG000|Overall Study|Lack of Efficacy|3|||
13092990|NCT03677401|25831631|FG001|Overall Study|Lack of Efficacy|1|||
13092991|NCT03677401|25831630|FG000|Overall Study|Withdrawal by Subject|2|||
13092992|NCT03677401|25831631|FG001|Overall Study|Withdrawal by Subject|2|||
13092993|NCT03677401|25831630|FG000|Overall Study|Sponsor decision|0|||
13092994|NCT03677401|25831631|FG001|Overall Study|Sponsor decision|1|||
13092995|NCT03677401|25831630|FG000|Overall Study|Reason Unspecified|1|||
13092996|NCT03677401|25831631|FG001|Overall Study|Reason Unspecified|0|||
13092997|NCT03677375|25831637|FG000|Overall Study|Incomplete procedure|8|||
13092998|NCT03677375|25831637|FG000|Overall Study|Adverse Event|3|||
13092999|NCT03677375|25831637|FG000|Overall Study|Physician Decision|1|||
13093000|NCT03676634|25831645|FG000|Overall Study|Red blood cell loss|1|||
13093001|NCT03676634|25831645|FG000|Overall Study|Out-of-limit pulse|2|||
13093002|NCT03675776|25831666|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5|||
13093003|NCT03675776|25831667|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6|||
13093004|NCT03675776|25831668|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8|||
13093005|NCT03675776|25831666|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
13093006|NCT03675776|25831667|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
13093007|NCT03675776|25831668|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
13093008|NCT03674281|25831698|FG000|Overall Study|screen failure|2|||
13093009|NCT03674281|25831699|FG001|Overall Study|screen failure|0|||
13093010|NCT03674281|25831700|FG002|Overall Study|screen failure|0|||
13093011|NCT03674281|25831698|FG000|Overall Study|Withdrawal by Subject|1|||
13093012|NCT03674281|25831699|FG001|Overall Study|Withdrawal by Subject|3|||
13093013|NCT03674281|25831700|FG002|Overall Study|Withdrawal by Subject|3|||
13093014|NCT03674177|25831779|FG000|Overall Study|Lost to Follow-up|2|||
13093015|NCT03674177|25831780|FG001|Overall Study|Lost to Follow-up|1|||
13093016|NCT03674177|25831781|FG002|Overall Study|Lost to Follow-up|0|||
13093017|NCT03674177|25831782|FG003|Overall Study|Lost to Follow-up|2|||
13093018|NCT03673956|25831813|FG000|Overall Study|Lost to Follow-up|1|||
13093019|NCT03673956|25831814|FG001|Overall Study|Lost to Follow-up|0|||
13093020|NCT03673956|25831815|FG002|Overall Study|Lost to Follow-up|0|||
13093021|NCT03673956|25831816|FG003|Overall Study|Lost to Follow-up|0|||
13093022|NCT03673956|25831813|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1|||
13093023|NCT03673956|25831814|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
13093024|NCT03673956|25831815|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
13093025|NCT03673956|25831816|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
13093026|NCT03673670|25831882|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1|||
13093027|NCT03673670|25831883|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
13093028|NCT03673670|25831884|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
13093029|NCT03673670|25831885|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
13093030|NCT03673670|25831886|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
13093031|NCT03673670|25831887|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
13093032|NCT03673670|25831882|FG000|Treatment Period 1 (3 Days)|Physician Decision|0|||
13093033|NCT03673670|25831883|FG001|Treatment Period 1 (3 Days)|Physician Decision|0|||
13093034|NCT03673670|25831884|FG002|Treatment Period 1 (3 Days)|Physician Decision|1|||
13093035|NCT03673670|25831885|FG003|Treatment Period 1 (3 Days)|Physician Decision|0|||
13093036|NCT03673670|25831886|FG004|Treatment Period 1 (3 Days)|Physician Decision|0|||
13145964|NCT02604589|26032525|FG002|Overall Study|catheter dislodgement|1|||
13145965|NCT02604550|26032556|FG000|Overall Study|Lost to Follow-up|7|||
13093037|NCT03673670|25831887|FG005|Treatment Period 1 (3 Days)|Physician Decision|0|||
13093038|NCT03673670|25831882|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
13093039|NCT03673670|25831883|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
13093040|NCT03673670|25831884|FG002|Treatment Period 1 (3 Days)|Adverse Event|0|||
13093041|NCT03673670|25831885|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
13093042|NCT03673670|25831886|FG004|Treatment Period 1 (3 Days)|Adverse Event|0|||
13145966|NCT02604550|26032557|FG001|Overall Study|Lost to Follow-up|6|||
13145967|NCT02604550|26032556|FG000|Overall Study|Withdrawal by Subject|0|||
13145968|NCT02604550|26032557|FG001|Overall Study|Withdrawal by Subject|1|||
13145969|NCT02604550|26032556|FG000|Overall Study|Incomplete data using paper journal|18|||
13145970|NCT02604550|26032557|FG001|Overall Study|Incomplete data using paper journal|19|||
13145971|NCT02604407|26032578|FG000|Overall Study|Adverse Event|0|||
13145972|NCT02604407|26032579|FG001|Overall Study|Adverse Event|7|||
13145973|NCT02604407|26032580|FG002|Overall Study|Adverse Event|5|||
13145974|NCT02604407|26032578|FG000|Overall Study|Protocol Violation|2|||
13145975|NCT02604407|26032579|FG001|Overall Study|Protocol Violation|0|||
13145976|NCT02604407|26032580|FG002|Overall Study|Protocol Violation|0|||
13145977|NCT02604407|26032578|FG000|Overall Study|Withdrawal by Subject|3|||
13145978|NCT02604407|26032579|FG001|Overall Study|Withdrawal by Subject|3|||
13145979|NCT02604407|26032580|FG002|Overall Study|Withdrawal by Subject|5|||
13145980|NCT02604407|26032578|FG000|Overall Study|Lost to Follow-up|2|||
13145981|NCT02604407|26032579|FG001|Overall Study|Lost to Follow-up|1|||
13145982|NCT02604407|26032580|FG002|Overall Study|Lost to Follow-up|2|||
13145983|NCT02604407|26032578|FG000|Overall Study|Lack of Efficacy|1|||
13145984|NCT02604407|26032579|FG001|Overall Study|Lack of Efficacy|0|||
13145985|NCT02604407|26032580|FG002|Overall Study|Lack of Efficacy|0|||
13145986|NCT02604407|26032578|FG000|Overall Study|Other|3|||
13145987|NCT02604407|26032579|FG001|Overall Study|Other|1|||
13145988|NCT02604407|26032580|FG002|Overall Study|Other|4|||
13145989|NCT02604342|26032637|FG000|Overall Study|Death|32|||
13145990|NCT02604342|26032638|FG001|Overall Study|Death|16|||
13145991|NCT02604342|26032637|FG000|Overall Study|Progression of disease|1|||
13145992|NCT02604342|26032638|FG001|Overall Study|Progression of disease|0|||
13145993|NCT02604342|26032637|FG000|Overall Study|Withdrawal by Subject|5|||
13145994|NCT02604342|26032638|FG001|Overall Study|Withdrawal by Subject|6|||
13145995|NCT02604342|26032637|FG000|Overall Study|Other|1|||
13145996|NCT02604342|26032638|FG001|Overall Study|Other|0|||
13145997|NCT02604342|26032637|FG000|Overall Study|Study Termination by Sponsor|1|||
13145998|NCT02604342|26032638|FG001|Overall Study|Study Termination by Sponsor|0|||
13145999|NCT02604342|26032637|FG000|Overall Study|Lost to Follow-up|1|||
13146000|NCT02604342|26032638|FG001|Overall Study|Lost to Follow-up|1|||
13146001|NCT02604342|26032637|FG000|Overall Study|Physician Decision|2|||
13146002|NCT02604342|26032638|FG001|Overall Study|Physician Decision|0|||
13146003|NCT02604264|26032651|FG000|Intervention|Didn't use CVC for at least 21 days|200|||
13146004|NCT02604264|26032652|FG001|Intervention|Didn't use CVC for at least 21 days|242|||
13146005|NCT02604212|26032729|FG000|Overall Study|Study Terminated by Sponsor|2|||
13146006|NCT02604212|26032730|FG001|Overall Study|Study Terminated by Sponsor|1|||
13146007|NCT02604212|26032731|FG002|Overall Study|Study Terminated by Sponsor|3|||
13146008|NCT02604212|26032732|FG003|Overall Study|Study Terminated by Sponsor|3|||
13146009|NCT02604212|26032729|FG000|Overall Study|Withdrawal by Subject|0|||
13146010|NCT02604212|26032730|FG001|Overall Study|Withdrawal by Subject|0|||
13146011|NCT02604212|26032731|FG002|Overall Study|Withdrawal by Subject|1|||
13146012|NCT02604212|26032732|FG003|Overall Study|Withdrawal by Subject|0|||
13146013|NCT02604199|26032793|FG000|Overall Study|Pregnancy|0|||
13146014|NCT02604199|26032794|FG001|Overall Study|Pregnancy|0|||
13146015|NCT02604199|26032795|FG002|Overall Study|Pregnancy|0|||
13146016|NCT02604199|26032796|FG003|Overall Study|Pregnancy|1|||
13146017|NCT02604199|26032793|FG000|Overall Study|Study terminated by sponsor|0|||
13146018|NCT02604199|26032794|FG001|Overall Study|Study terminated by sponsor|2|||
13146019|NCT02604199|26032795|FG002|Overall Study|Study terminated by sponsor|0|||
13146020|NCT02604199|26032796|FG003|Overall Study|Study terminated by sponsor|2|||
13146021|NCT02604199|26032793|FG000|Overall Study|Withdrawal by Subject|0|||
13146022|NCT02604199|26032794|FG001|Overall Study|Withdrawal by Subject|1|||
13146023|NCT02604199|26032795|FG002|Overall Study|Withdrawal by Subject|0|||
13146024|NCT02604199|26032796|FG003|Overall Study|Withdrawal by Subject|0|||
13146025|NCT02604160|26032815|FG000|Overall Study|Protocol Violation|0|||
13146026|NCT02604160|26032816|FG001|Overall Study|Protocol Violation|1|||
13146027|NCT02604160|26032815|FG000|Overall Study|Physician Decision|0|||
13146028|NCT02604160|26032816|FG001|Overall Study|Physician Decision|1|||
13146029|NCT02604017|26032848|FG000|Overall Study|Withdrew Consent|0|||
13146030|NCT02604017|26032849|FG001|Overall Study|Withdrew Consent|2|||
13146031|NCT02604017|26032848|FG000|Overall Study|Lost to Follow-up|5|||
13146032|NCT02604017|26032849|FG001|Overall Study|Lost to Follow-up|6|||
13146033|NCT02604017|26032848|FG000|Overall Study|Other|1|||
13146034|NCT02604017|26032849|FG001|Overall Study|Other|0|||
13146035|NCT02603952|26032903|FG000|Overall Study|Withdrawal by Subject|1|||
13146036|NCT02603952|26032904|FG001|Overall Study|Withdrawal by Subject|0|||
13146037|NCT02603952|26032905|FG002|Overall Study|Withdrawal by Subject|0|||
13146038|NCT02603952|26032906|FG003|Overall Study|Withdrawal by Subject|0|||
13146039|NCT02603952|26032903|FG000|Overall Study|Received oseltamivir by error|0|||
13146040|NCT02603952|26032904|FG001|Overall Study|Received oseltamivir by error|0|||
13146041|NCT02603952|26032905|FG002|Overall Study|Received oseltamivir by error|0|||
13146042|NCT02603952|26032906|FG003|Overall Study|Received oseltamivir by error|1|||
13146043|NCT02603432|26032961|FG000|Overall Study|Ongoing|184|||
13146044|NCT02603432|26032962|FG001|Overall Study|Ongoing|144|||
13146045|NCT02603432|26032961|FG000|Overall Study|Adverse Event|1|||
13146046|NCT02603432|26032962|FG001|Overall Study|Adverse Event|0|||
13146047|NCT02603432|26032961|FG000|Overall Study|Death|144|||
13146048|NCT02603432|26032962|FG001|Overall Study|Death|177|||
13146049|NCT02603432|26032961|FG000|Overall Study|Lost to Follow-up|4|||
13146050|NCT02603432|26032962|FG001|Overall Study|Lost to Follow-up|6|||
13146051|NCT02603432|26032961|FG000|Overall Study|Progressive Disease|5|||
13146052|NCT02603432|26032962|FG001|Overall Study|Progressive Disease|5|||
13146053|NCT02603432|26032961|FG000|Overall Study|Withdrawal by Subject|9|||
13146054|NCT02603432|26032962|FG001|Overall Study|Withdrawal by Subject|17|||
13146055|NCT02603432|26032961|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
13146056|NCT02603432|26032962|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
13146057|NCT02603432|26032961|FG000|Overall Study|Other|0|||
13146058|NCT02603432|26032962|FG001|Overall Study|Other|1|||
13146059|NCT02603419|26033166|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
13146060|NCT02603419|26033167|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1|||
13146061|NCT02603419|26033168|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
13146062|NCT02603419|26033169|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
13146063|NCT02603419|26033170|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
13146064|NCT02603419|26033171|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
13146065|NCT02603419|26033166|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
13146066|NCT02603419|26033167|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
13146067|NCT02603419|26033168|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
13146068|NCT02603419|26033169|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
13146069|NCT02603419|26033170|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3|||
13146070|NCT02603419|26033171|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0|||
13146071|NCT02603419|26033166|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2|||
13146072|NCT02603419|26033167|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
13146073|NCT02603419|26033168|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3|||
13146074|NCT02603419|26033169|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
13146075|NCT02603419|26033170|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1|||
13146076|NCT02603419|26033171|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
13146077|NCT02603419|26033166|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
13146078|NCT02603419|26033167|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
13146079|NCT02603419|26033168|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
13146080|NCT02603419|26033169|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
13146081|NCT02603419|26033170|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1|||
13146082|NCT02603419|26033171|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
13146083|NCT02603419|26033166|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
13146084|NCT02603419|26033167|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1|||
13146085|NCT02603419|26033168|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
13146086|NCT02603419|26033169|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
13146087|NCT02603419|26033170|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
13146088|NCT02603419|26033171|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
13146089|NCT02603419|26033166|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2|||
13146090|NCT02603419|26033167|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
13146091|NCT02603419|26033168|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
13146092|NCT02603419|26033169|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
13146093|NCT02603419|26033170|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
13146094|NCT02603419|26033171|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
13146095|NCT02603419|26033166|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
13146096|NCT02603419|26033167|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
13146097|NCT02603419|26033168|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
13146098|NCT02603419|26033169|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2|||
13146099|NCT02603419|26033170|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
13146100|NCT02603419|26033171|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
13146101|NCT02603419|26033166|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
13146102|NCT02603419|26033167|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
13146103|NCT02603419|26033168|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
13146104|NCT02603419|26033169|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
13146105|NCT02603419|26033170|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
13146106|NCT02603419|26033171|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1|||
13146107|NCT02603419|26033166|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
13146108|NCT02603419|26033167|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
13146109|NCT02603419|26033168|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
13222610|NCT01804842|26286559|FG000|Overall Study|Personal Reason|0|||
13146110|NCT02603419|26033169|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
13146111|NCT02603419|26033170|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
13146112|NCT02603419|26033171|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1|||
13146113|NCT02603419|26033166|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
13146114|NCT02603419|26033167|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
13146115|NCT02603419|26033168|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
13146116|NCT02603419|26033169|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
13146117|NCT02603419|26033170|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
13146118|NCT02603419|26033171|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1|||
13146119|NCT02603393|26033204|FG000|Overall Study|Patient/guardian decision|32|||
13146120|NCT02603393|26033205|FG001|Overall Study|Patient/guardian decision|18|||
13146121|NCT02603393|26033204|FG000|Overall Study|Adverse Event|17|||
13146122|NCT02603393|26033205|FG001|Overall Study|Adverse Event|15|||
13146123|NCT02603393|26033204|FG000|Overall Study|Technical problems|4|||
13146124|NCT02603393|26033205|FG001|Overall Study|Technical problems|7|||
13146125|NCT02603393|26033204|FG000|Overall Study|Lack of Efficacy|7|||
13146126|NCT02603393|26033205|FG001|Overall Study|Lack of Efficacy|2|||
13146127|NCT02603393|26033204|FG000|Overall Study|Death|3|||
13146128|NCT02603393|26033205|FG001|Overall Study|Death|4|||
13146129|NCT02603393|26033204|FG000|Overall Study|Physician Decision|3|||
13146130|NCT02603393|26033205|FG001|Overall Study|Physician Decision|3|||
13146131|NCT02603393|26033204|FG000|Overall Study|Protocol deviation|2|||
13146132|NCT02603393|26033205|FG001|Overall Study|Protocol deviation|3|||
13146133|NCT02603393|26033204|FG000|Overall Study|Lost to Follow-up|1|||
13146134|NCT02603393|26033205|FG001|Overall Study|Lost to Follow-up|2|||
13146135|NCT02603393|26033204|FG000|Overall Study|Non-compliance with study treatment|1|||
13146136|NCT02603393|26033205|FG001|Overall Study|Non-compliance with study treatment|0|||
13146137|NCT02603393|26033204|FG000|Overall Study|Sponsor decision|1|||
13146138|NCT02603393|26033205|FG001|Overall Study|Sponsor decision|0|||
13146139|NCT02603172|26033356|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0|||
13146140|NCT02603172|26033357|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0|||
13146141|NCT02603172|26033358|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1|||
13146142|NCT02603172|26033359|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0|||
13146143|NCT02603172|26033360|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0|||
13146144|NCT02603172|26033361|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0|||
13146145|NCT02603172|26033362|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0|||
13146146|NCT02603172|26033363|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0|||
13146147|NCT02603120|26033390|FG000|Double-Blind Treatment Phase|Withdrew consent|4|||
13146148|NCT02603120|26033391|FG001|Double-Blind Treatment Phase|Withdrew consent|8|||
13146149|NCT02603120|26033390|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
13146150|NCT02603120|26033391|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
13146151|NCT02603120|26033390|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
13146152|NCT02603120|26033391|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
13146153|NCT02603120|26033390|FG000|Double-Blind Treatment Phase|Death|2|||
13146154|NCT02603120|26033391|FG001|Double-Blind Treatment Phase|Death|0|||
13146155|NCT02603120|26033390|FG000|Double-Blind Treatment Phase|Investigator's discretion|2|||
13146156|NCT02603120|26033391|FG001|Double-Blind Treatment Phase|Investigator's discretion|0|||
13146157|NCT02603120|26033390|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
13146158|NCT02603120|26033391|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
13146159|NCT02603120|26033390|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
13146160|NCT02603120|26033391|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
13146161|NCT02603120|26033390|FG000|Double-Blind Treatment Phase|Did not receive study drug|2|||
13146162|NCT02603120|26033391|FG001|Double-Blind Treatment Phase|Did not receive study drug|2|||
13146163|NCT02603120|26033390|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3|||
13146164|NCT02603120|26033391|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4|||
13146165|NCT02603120|26033390|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1|||
13146166|NCT02603120|26033391|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2|||
13146167|NCT02603120|26033390|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1|||
13146168|NCT02603120|26033391|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2|||
13146169|NCT02603120|26033390|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0|||
13146170|NCT02603120|26033391|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1|||
13146171|NCT02603120|26033390|FG000|OL Extension B/F/TAF Treatment Phase|Death|0|||
13146172|NCT02603120|26033391|FG001|OL Extension B/F/TAF Treatment Phase|Death|1|||
13146173|NCT02603120|26033390|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0|||
13146174|NCT02603120|26033391|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1|||
13146175|NCT02603107|26033410|FG000|Randomized Phase|Withdrew consent|8|||
13146176|NCT02603107|26033411|FG001|Randomized Phase|Withdrew consent|15|||
13222611|NCT01804842|26286560|FG001|Overall Study|Personal Reason|0|||
13222612|NCT01804842|26286561|FG002|Overall Study|Personal Reason|1|||
13146177|NCT02603107|26033410|FG000|Randomized Phase|Lost to Follow-up|1|||
13146178|NCT02603107|26033411|FG001|Randomized Phase|Lost to Follow-up|3|||
13146179|NCT02603107|26033410|FG000|Randomized Phase|Adverse Event|2|||
13146180|NCT02603107|26033411|FG001|Randomized Phase|Adverse Event|0|||
13146181|NCT02603107|26033410|FG000|Randomized Phase|Death|1|||
13146182|NCT02603107|26033411|FG001|Randomized Phase|Death|1|||
13146183|NCT02603107|26033410|FG000|Randomized Phase|Non-compliance with study drug|1|||
13146184|NCT02603107|26033411|FG001|Randomized Phase|Non-compliance with study drug|1|||
13146185|NCT02603107|26033410|FG000|Randomized Phase|Investigator's discretion|0|||
13146186|NCT02603107|26033411|FG001|Randomized Phase|Investigator's discretion|1|||
13146187|NCT02603107|26033410|FG000|Randomized Phase|Lack of Efficacy|1|||
13146188|NCT02603107|26033411|FG001|Randomized Phase|Lack of Efficacy|0|||
13146189|NCT02603107|26033410|FG000|Randomized Phase|Protocol Violation|1|||
13146190|NCT02603107|26033411|FG001|Randomized Phase|Protocol Violation|0|||
13146191|NCT02603107|26033410|FG000|Optional Extension Phase|Lost to Follow-up|3|||
13146192|NCT02603107|26033411|FG001|Optional Extension Phase|Lost to Follow-up|3|||
13146193|NCT02603107|26033410|FG000|Optional Extension Phase|Withdrew consent|3|||
13146194|NCT02603107|26033411|FG001|Optional Extension Phase|Withdrew consent|2|||
13146195|NCT02603107|26033410|FG000|Optional Extension Phase|Investigator's discretion|2|||
13146196|NCT02603107|26033411|FG001|Optional Extension Phase|Investigator's discretion|2|||
13146197|NCT02603107|26033410|FG000|Optional Extension Phase|Pregnancy|0|||
13146198|NCT02603107|26033411|FG001|Optional Extension Phase|Pregnancy|3|||
13146199|NCT02603107|26033410|FG000|Optional Extension Phase|Adverse Event|0|||
13146200|NCT02603107|26033411|FG001|Optional Extension Phase|Adverse Event|2|||
13146201|NCT02603107|26033410|FG000|Optional Extension Phase|Not treated in extension phase|0|||
13146202|NCT02603107|26033411|FG001|Optional Extension Phase|Not treated in extension phase|1|||
13146203|NCT02603107|26033410|FG000|Optional Extension Phase|Protocol Violation|1|||
13146204|NCT02603107|26033411|FG001|Optional Extension Phase|Protocol Violation|0|||
13146205|NCT02602288|26033428|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14|||
13146206|NCT02602288|26033429|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10|||
13146207|NCT02602288|26033428|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
13146208|NCT02602288|26033429|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
13146209|NCT02602288|26033428|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9|||
13146210|NCT02602288|26033429|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6|||
13146211|NCT02602288|26033428|FG000|12 Month Follow-up|Lost to Follow-up|0|||
13146212|NCT02602288|26033429|FG001|12 Month Follow-up|Lost to Follow-up|4|||
13146213|NCT02602288|26033428|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
13146214|NCT02602288|26033429|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
13146215|NCT02602080|26033474|FG000|Overall Study|Protocol Violation|6|||
13146216|NCT02602080|26033475|FG001|Overall Study|Protocol Violation|1|||
13146217|NCT02602080|26033476|FG002|Overall Study|Protocol Violation|3|||
13146218|NCT02601820|26033503|FG000|Early On-Treatment (T2)|Missing T2 Record|51|||
13146219|NCT02601820|26033503|FG000|Late On-Treatment (T3)|missing T3 Record|49|||
13146220|NCT02601820|26033503|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3|||
13146221|NCT02601820|26033503|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88|||
13146222|NCT02601625|26033564|FG000|Overall Study|Lost to Follow-up|0|||
13146223|NCT02601625|26033565|FG001|Overall Study|Lost to Follow-up|0|||
13146224|NCT02601625|26033566|FG002|Overall Study|Lost to Follow-up|1|||
13146225|NCT02601625|26033567|FG003|Overall Study|Lost to Follow-up|1|||
13146226|NCT02601573|26033610|FG000|Overall Study|Lost to Follow-up|0|||
13146227|NCT02601573|26033611|FG001|Overall Study|Lost to Follow-up|3|||
13146228|NCT02601573|26033612|FG002|Overall Study|Lost to Follow-up|1|||
13146229|NCT02601573|26033613|FG003|Overall Study|Lost to Follow-up|0|||
13146230|NCT02601573|26033614|FG004|Overall Study|Lost to Follow-up|2|||
13146231|NCT02601573|26033610|FG000|Overall Study|Withdrawal by Subject|0|||
13146232|NCT02601573|26033611|FG001|Overall Study|Withdrawal by Subject|1|||
13146233|NCT02601573|26033612|FG002|Overall Study|Withdrawal by Subject|0|||
13146234|NCT02601573|26033613|FG003|Overall Study|Withdrawal by Subject|1|||
13146235|NCT02601573|26033614|FG004|Overall Study|Withdrawal by Subject|0|||
13146236|NCT02601560|26033821|FG000|Overall Study|Other|0|||
13146237|NCT02601560|26033822|FG001|Overall Study|Other|0|||
13146238|NCT02601560|26033823|FG002|Overall Study|Other|0|||
13146239|NCT02601560|26033824|FG003|Overall Study|Other|0|||
13146240|NCT02601560|26033825|FG004|Overall Study|Other|0|||
13146241|NCT02601560|26033826|FG005|Overall Study|Other|0|||
13146242|NCT02601560|26033827|FG006|Overall Study|Other|1|||
13146243|NCT02601560|26033828|FG007|Overall Study|Other|0|||
13146244|NCT02601469|26033841|FG000|Overall Study|Enrolled in Error|1|||
13146245|NCT02601469|26033842|FG001|Overall Study|Enrolled in Error|0|||
13146246|NCT02601300|26033857|FG000|Induction Phase|Lack of Efficacy|2|||
13146247|NCT02601300|26033857|FG000|Induction Phase|Protocol Violation|1|||
13146248|NCT02601300|26033857|FG000|Extension Phase|Withdrawal by Subject|3|||
13146249|NCT02601300|26033857|FG000|Extension Phase|Adverse Event|4|||
13146250|NCT02601300|26033857|FG000|Extension Phase|Lack of Efficacy|10|||
13146251|NCT02601209|26033907|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
13146252|NCT02601209|26033908|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
13146253|NCT02601209|26033909|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
13146254|NCT02601209|26033910|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
13146255|NCT02601209|26033911|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
13146256|NCT02601209|26033912|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
13146257|NCT02601209|26033913|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
13146258|NCT02601209|26033914|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
13146259|NCT02601209|26033915|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
13146260|NCT02601209|26033907|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
13146261|NCT02601209|26033908|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
13146262|NCT02601209|26033909|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
13146263|NCT02601209|26033910|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
13146264|NCT02601209|26033911|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
13146265|NCT02601209|26033912|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2|||
13146266|NCT02601209|26033913|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
13146267|NCT02601209|26033914|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
13146268|NCT02601209|26033915|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
13146269|NCT02601027|26033938|FG000|Registration to Surgery|Withdrawal by Subject|20|||
13146270|NCT02601027|26033939|FG001|Registration to Surgery|Withdrawal by Subject|10|||
13146271|NCT02601001|26034013|FG000|Dosing Period 2|Adverse Event|0|||
13146272|NCT02601001|26034014|FG001|Dosing Period 2|Adverse Event|0|||
13146273|NCT02601001|26034015|FG002|Dosing Period 2|Adverse Event|0|||
13146274|NCT02601001|26034016|FG003|Dosing Period 2|Adverse Event|0|||
13146275|NCT02601001|26034017|FG004|Dosing Period 2|Adverse Event|0|||
13146276|NCT02601001|26034018|FG005|Dosing Period 2|Adverse Event|0|||
13146277|NCT02601001|26034019|FG006|Dosing Period 2|Adverse Event|1|||
13146278|NCT02600871|26034036|FG000|Overall Study|Lost to Follow-up|13|||
13146279|NCT02600871|26034037|FG001|Overall Study|Lost to Follow-up|10|||
13146280|NCT02600845|26034054|FG000|Overall Study|Reason Not Specified|3|||
13146281|NCT02600845|26034054|FG000|Overall Study|Non-compliance with Study Procedures|10|||
13146282|NCT02600845|26034054|FG000|Overall Study|Consent Withdrawal|5|||
13146283|NCT02600819|26034077|FG000|GEN Phase|Adverse Event|2|||
13146284|NCT02600819|26034078|FG001|GEN Phase|Adverse Event|0|||
13146285|NCT02600819|26034077|FG000|GEN Phase|Death|2|||
13146286|NCT02600819|26034078|FG001|GEN Phase|Death|0|||
13146287|NCT02600819|26034077|FG000|GEN Phase|Investigator's Discretion|4|||
13146288|NCT02600819|26034078|FG001|GEN Phase|Investigator's Discretion|0|||
13146289|NCT02600819|26034077|FG000|GEN Phase|Non-Compliance with Study Drug|1|||
13146290|NCT02600819|26034078|FG001|GEN Phase|Non-Compliance with Study Drug|0|||
13146291|NCT02600819|26034077|FG000|GEN Phase|Withdrew Consent|5|||
13146292|NCT02600819|26034078|FG001|GEN Phase|Withdrew Consent|0|||
13146293|NCT02600819|26034077|FG000|GEN Phase|Lost to Follow-up|2|||
13146294|NCT02600819|26034078|FG001|GEN Phase|Lost to Follow-up|0|||
13146295|NCT02600559|26034089|FG000|Overall Study|Withdrawal by Subject|3|||
13146296|NCT02600559|26034089|FG000|Overall Study|Lost to Follow-up|20|||
13146297|NCT02600351|26034132|FG000|Overall Study|Lack of Efficacy|3|||
13146298|NCT02600351|26034133|FG001|Overall Study|Lack of Efficacy|0|||
13146299|NCT02600351|26034134|FG002|Overall Study|Lack of Efficacy|5|||
13146300|NCT02600351|26034135|FG003|Overall Study|Lack of Efficacy|2|||
13146301|NCT02600351|26034132|FG000|Overall Study|Lost to Follow-up|1|||
13146302|NCT02600351|26034133|FG001|Overall Study|Lost to Follow-up|0|||
13146303|NCT02600351|26034134|FG002|Overall Study|Lost to Follow-up|0|||
13146304|NCT02600351|26034135|FG003|Overall Study|Lost to Follow-up|0|||
13146305|NCT02600351|26034132|FG000|Overall Study|Randomized but Not Treated|1|||
13146306|NCT02600351|26034133|FG001|Overall Study|Randomized but Not Treated|0|||
13146307|NCT02600351|26034134|FG002|Overall Study|Randomized but Not Treated|1|||
13146308|NCT02600351|26034135|FG003|Overall Study|Randomized but Not Treated|3|||
13146309|NCT02599961|26034147|FG000|Overall Study|Withdrawal by Subject|1|||
13146310|NCT02599961|26034147|FG000|Overall Study|Subject Non-Compliance|2|||
13146311|NCT02599961|26034147|FG000|Overall Study|Discontinuation of Study by Sponsor|9|||
13146312|NCT02599961|26034147|FG000|Overall Study|Other, Not Specified|3|||
13146313|NCT02599688|26034153|FG000|Overall Study|Lack of Efficacy|1|||
13146314|NCT02599688|26034153|FG000|Overall Study|Withdrawal by Subject|1|||
13146315|NCT02599688|26034153|FG000|Overall Study|Termination by Sponsor|2|||
13146316|NCT02599402|26034274|FG000|Overall Study|Disease progression|153|||
13146317|NCT02599402|26034274|FG000|Overall Study|Study drug toxicity|201|||
13146318|NCT02599402|26034274|FG000|Overall Study|Death|26|||
13146319|NCT02599402|26034274|FG000|Overall Study|Adverse Event unrelated to study drug|23|||
13146320|NCT02599402|26034274|FG000|Overall Study|Participant request to discontinue study treatment|13|||
13146321|NCT02599402|26034274|FG000|Overall Study|Participant withdrew consent|5|||
13146322|NCT02599402|26034274|FG000|Overall Study|Lost to Follow-up|1|||
13146323|NCT02599402|26034274|FG000|Overall Study|Maximum Clinical Benefit|7|||
13146324|NCT02599402|26034274|FG000|Overall Study|Poor/non-compliance|1|||
13146325|NCT02599402|26034274|FG000|Overall Study|Pregnancy|1|||
13146326|NCT02599402|26034274|FG000|Overall Study|Participant no longer met study criteria|7|||
13146327|NCT02599402|26034274|FG000|Overall Study|Other Reasons|95|||
13146328|NCT02599129|26034295|FG000|Overall Study|Lack of Efficacy|2|||
13146329|NCT02599129|26034296|FG001|Overall Study|Lack of Efficacy|2|||
13146330|NCT02599129|26034295|FG000|Overall Study|Lost to Follow-up|1|||
13146331|NCT02599129|26034296|FG001|Overall Study|Lost to Follow-up|0|||
13146332|NCT02599129|26034295|FG000|Overall Study|Withdrawal by Subject|2|||
13146333|NCT02599129|26034296|FG001|Overall Study|Withdrawal by Subject|1|||
13146334|NCT02598934|26034313|FG000|Overall Study|Adverse Event|11|||
13146335|NCT02598934|26034314|FG001|Overall Study|Adverse Event|13|||
13146336|NCT02598934|26034313|FG000|Overall Study|Failure to Return|3|||
13146337|NCT02598934|26034314|FG001|Overall Study|Failure to Return|3|||
13146338|NCT02598934|26034313|FG000|Overall Study|Withdrawal by Subject|2|||
13146339|NCT02598934|26034314|FG001|Overall Study|Withdrawal by Subject|3|||
13146340|NCT02598934|26034313|FG000|Overall Study|Administrative|2|||
13146341|NCT02598934|26034314|FG001|Overall Study|Administrative|1|||
13146342|NCT02598934|26034313|FG000|Overall Study|Protocol Violation|1|||
13146343|NCT02598934|26034314|FG001|Overall Study|Protocol Violation|2|||
13146344|NCT02598622|26034327|FG000|Overall Study|Withdrawal by Subject|3|||
13146345|NCT02598622|26034328|FG001|Overall Study|Withdrawal by Subject|0|||
13146346|NCT02598622|26034327|FG000|Overall Study|Physician Decision|3|||
13146347|NCT02598622|26034328|FG001|Overall Study|Physician Decision|0|||
13146348|NCT02598388|26034447|FG000|Overall Study|Lost to Follow-up|1|||
13146349|NCT02598388|26034448|FG001|Overall Study|Lost to Follow-up|0|||
13146350|NCT02598388|26034449|FG002|Overall Study|Lost to Follow-up|1|||
13146351|NCT02598388|26034450|FG003|Overall Study|Lost to Follow-up|0|||
13146352|NCT02598388|26034451|FG004|Overall Study|Lost to Follow-up|5|||
13222613|NCT01804673|26286579|FG000|Overall Study|Adverse Event|4|||
13222614|NCT01804673|26286579|FG000|Overall Study|Withdrawal by Subject|1|||
13222615|NCT01804673|26286579|FG000|Overall Study|Lack of Efficacy|9|||
13222616|NCT01804673|26286579|FG000|Overall Study|Change to Oral Therapy|37|||
13222617|NCT01804673|26286579|FG000|Overall Study|No Further Therapy Required|84|||
13222618|NCT01804673|26286579|FG000|Overall Study|Use of Prohibited Medication|1|||
13222619|NCT01804673|26286579|FG000|Overall Study|Other|4|||
13222620|NCT01804582|26286602|FG000|Overall Study|Lost to Follow-up|47|||
13222621|NCT01804582|26286603|FG001|Overall Study|Lost to Follow-up|56|||
13222622|NCT01804582|26286602|FG000|Overall Study|Physician Decision|2|||
13222623|NCT01804582|26286603|FG001|Overall Study|Physician Decision|0|||
13222624|NCT01804140|26286610|FG000|Overall Study|No sampling or biopsy procedures done|114|||
13222625|NCT01804049|26286627|FG000|Overall Study|Adverse Event|2|||
13222626|NCT01804049|26286628|FG001|Overall Study|Adverse Event|10|||
13222627|NCT01804049|26286627|FG000|Overall Study|Lost to Follow-up|2|||
13222628|NCT01804049|26286628|FG001|Overall Study|Lost to Follow-up|1|||
13222629|NCT01804049|26286627|FG000|Overall Study|Decreased interest/personal|4|||
13222630|NCT01804049|26286628|FG001|Overall Study|Decreased interest/personal|5|||
13222631|NCT01804049|26286627|FG000|Overall Study|Other health concerns|2|||
13222632|NCT01804049|26286628|FG001|Overall Study|Other health concerns|7|||
13222633|NCT01804049|26286627|FG000|Overall Study|Moved out of area|0|||
13222634|NCT01804049|26286628|FG001|Overall Study|Moved out of area|7|||
13222635|NCT01804049|26286627|FG000|Overall Study|other MD recommended|1|||
13222636|NCT01804049|26286628|FG001|Overall Study|other MD recommended|1|||
13222637|NCT01804049|26286627|FG000|Overall Study|Enrollment in dual studies|0|||
13222638|NCT01804049|26286628|FG001|Overall Study|Enrollment in dual studies|1|||
13222639|NCT01803880|26286672|FG000|Overall Study|Adverse Event|1|||
13222640|NCT01803880|26286673|FG001|Overall Study|Adverse Event|0|||
13222641|NCT01803880|26286674|FG002|Overall Study|Adverse Event|0|||
13222642|NCT01803880|26286672|FG000|Overall Study|Withdrawal by Subject|1|||
13222643|NCT01803880|26286673|FG001|Overall Study|Withdrawal by Subject|1|||
13222644|NCT01803880|26286674|FG002|Overall Study|Withdrawal by Subject|4|||
13222645|NCT01803880|26286672|FG000|Overall Study|Physician Decision|0|||
13222646|NCT01803880|26286673|FG001|Overall Study|Physician Decision|0|||
13222647|NCT01803880|26286674|FG002|Overall Study|Physician Decision|1|||
13222648|NCT01803880|26286672|FG000|Overall Study|Unable to return for follow-up visits|0|||
13222649|NCT01803880|26286673|FG001|Overall Study|Unable to return for follow-up visits|1|||
13222650|NCT01803880|26286674|FG002|Overall Study|Unable to return for follow-up visits|2|||
13222651|NCT01803880|26286672|FG000|Overall Study|Lost to Follow-up|1|||
13222652|NCT01803880|26286673|FG001|Overall Study|Lost to Follow-up|2|||
13222653|NCT01803880|26286674|FG002|Overall Study|Lost to Follow-up|3|||
13222654|NCT01803880|26286672|FG000|Overall Study|Protocol Violation|1|||
13222655|NCT01803880|26286673|FG001|Overall Study|Protocol Violation|0|||
13222656|NCT01803880|26286674|FG002|Overall Study|Protocol Violation|0|||
13222657|NCT01803880|26286672|FG000|Overall Study|Early study termination|0|||
13222658|NCT01803880|26286673|FG001|Overall Study|Early study termination|6|||
13222659|NCT01803880|26286674|FG002|Overall Study|Early study termination|5|||
13146353|NCT02598388|26034452|FG005|Overall Study|Lost to Follow-up|1|||
13146354|NCT02598388|26034453|FG006|Overall Study|Lost to Follow-up|2|||
13146355|NCT02598388|26034454|FG007|Overall Study|Lost to Follow-up|1|||
13146356|NCT02598388|26034455|FG008|Overall Study|Lost to Follow-up|0|||
13222660|NCT01803880|26286672|FG000|Overall Study|Incomplete data entry by sites|2|||
13146357|NCT02598388|26034456|FG009|Overall Study|Lost to Follow-up|0|||
13146358|NCT02598388|26034457|FG010|Overall Study|Lost to Follow-up|1|||
13146359|NCT02598388|26034458|FG011|Overall Study|Lost to Follow-up|0|||
13146360|NCT02598388|26034447|FG000|Overall Study|Withdrawal by Subject|0|||
13146361|NCT02598388|26034448|FG001|Overall Study|Withdrawal by Subject|0|||
13146362|NCT02598388|26034449|FG002|Overall Study|Withdrawal by Subject|0|||
13146363|NCT02598388|26034450|FG003|Overall Study|Withdrawal by Subject|0|||
13146364|NCT02598388|26034451|FG004|Overall Study|Withdrawal by Subject|2|||
13146365|NCT02598388|26034452|FG005|Overall Study|Withdrawal by Subject|0|||
13146366|NCT02598388|26034453|FG006|Overall Study|Withdrawal by Subject|2|||
13146367|NCT02598388|26034454|FG007|Overall Study|Withdrawal by Subject|0|||
13146368|NCT02598388|26034455|FG008|Overall Study|Withdrawal by Subject|0|||
13146369|NCT02598388|26034456|FG009|Overall Study|Withdrawal by Subject|1|||
13146370|NCT02598388|26034457|FG010|Overall Study|Withdrawal by Subject|0|||
13146371|NCT02598388|26034458|FG011|Overall Study|Withdrawal by Subject|0|||
13146372|NCT02598388|26034447|FG000|Overall Study|Other|0|||
13146373|NCT02598388|26034448|FG001|Overall Study|Other|0|||
13146374|NCT02598388|26034449|FG002|Overall Study|Other|1|||
13146375|NCT02598388|26034450|FG003|Overall Study|Other|0|||
13146376|NCT02598388|26034451|FG004|Overall Study|Other|3|||
13146377|NCT02598388|26034452|FG005|Overall Study|Other|0|||
13146378|NCT02598388|26034453|FG006|Overall Study|Other|1|||
13146379|NCT02598388|26034454|FG007|Overall Study|Other|0|||
13146380|NCT02598388|26034455|FG008|Overall Study|Other|0|||
13146381|NCT02598388|26034456|FG009|Overall Study|Other|0|||
13146382|NCT02598388|26034457|FG010|Overall Study|Other|0|||
13146383|NCT02598388|26034458|FG011|Overall Study|Other|0|||
13146384|NCT02598297|26034491|FG000|Overall Study|Study terminated by Sponsor|21|||
13146385|NCT02598297|26034492|FG001|Overall Study|Study terminated by Sponsor|23|||
13146386|NCT02598297|26034491|FG000|Overall Study|Adverse Event|1|||
13093043|NCT03673670|25831887|FG005|Treatment Period 1 (3 Days)|Adverse Event|1|||
13093044|NCT03673670|25831882|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
13093045|NCT03673670|25831883|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
13093046|NCT03673670|25831884|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
13093047|NCT03673670|25831885|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
13093048|NCT03673670|25831886|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
13093049|NCT03673670|25831887|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1|||
13093050|NCT03673670|25831882|FG000|Treatment Period 2 (3 Days)|Adverse Event|0|||
13093051|NCT03673670|25831883|FG001|Treatment Period 2 (3 Days)|Adverse Event|0|||
13093052|NCT03673670|25831884|FG002|Treatment Period 2 (3 Days)|Adverse Event|1|||
13093053|NCT03673670|25831885|FG003|Treatment Period 2 (3 Days)|Adverse Event|0|||
13093054|NCT03673670|25831886|FG004|Treatment Period 2 (3 Days)|Adverse Event|1|||
13093055|NCT03673670|25831887|FG005|Treatment Period 2 (3 Days)|Adverse Event|0|||
13093056|NCT03673670|25831882|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
13093057|NCT03673670|25831883|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
13093058|NCT03673670|25831884|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
13093059|NCT03673670|25831885|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
13093060|NCT03673670|25831886|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1|||
13093061|NCT03673670|25831887|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
13093062|NCT03673670|25831882|FG000|Treatment Period 3 (3 Days)|Adverse Event|0|||
13093063|NCT03673670|25831883|FG001|Treatment Period 3 (3 Days)|Adverse Event|0|||
13093064|NCT03673670|25831884|FG002|Treatment Period 3 (3 Days)|Adverse Event|0|||
13093065|NCT03673670|25831885|FG003|Treatment Period 3 (3 Days)|Adverse Event|0|||
13093066|NCT03673670|25831886|FG004|Treatment Period 3 (3 Days)|Adverse Event|1|||
13093067|NCT03673670|25831887|FG005|Treatment Period 3 (3 Days)|Adverse Event|0|||
13093068|NCT03673345|25831930|FG000|Overall Study|Lost to Follow-up|1|||
13093069|NCT03673345|25831931|FG001|Overall Study|Lost to Follow-up|0|||
13093070|NCT03673345|25831932|FG002|Overall Study|Lost to Follow-up|3|||
13093071|NCT03673345|25831933|FG003|Overall Study|Lost to Follow-up|3|||
13093072|NCT03673345|25831934|FG004|Overall Study|Lost to Follow-up|2|||
13093073|NCT03673345|25831935|FG005|Overall Study|Lost to Follow-up|1|||
13093074|NCT03673345|25831936|FG006|Overall Study|Lost to Follow-up|0|||
13093075|NCT03673345|25831937|FG007|Overall Study|Lost to Follow-up|0|||
13093076|NCT03673345|25831930|FG000|Overall Study|Withdrawal by Subject|1|||
13093077|NCT03673345|25831931|FG001|Overall Study|Withdrawal by Subject|0|||
13093078|NCT03673345|25831932|FG002|Overall Study|Withdrawal by Subject|4|||
13093079|NCT03673345|25831933|FG003|Overall Study|Withdrawal by Subject|2|||
13093080|NCT03673345|25831934|FG004|Overall Study|Withdrawal by Subject|0|||
13093081|NCT03673345|25831935|FG005|Overall Study|Withdrawal by Subject|0|||
13093082|NCT03673345|25831936|FG006|Overall Study|Withdrawal by Subject|0|||
13093083|NCT03673345|25831937|FG007|Overall Study|Withdrawal by Subject|0|||
13146387|NCT02598297|26034492|FG001|Overall Study|Adverse Event|1|||
13146388|NCT02598297|26034491|FG000|Overall Study|Physician Decision|1|||
13146389|NCT02598297|26034492|FG001|Overall Study|Physician Decision|0|||
13146390|NCT02598297|26034491|FG000|Overall Study|Subject/guardian decision|1|||
13146391|NCT02598297|26034492|FG001|Overall Study|Subject/guardian decision|0|||
13146392|NCT02598297|26034491|FG000|Overall Study|Followed for survival|1|||
13146393|NCT02598297|26034492|FG001|Overall Study|Followed for survival|0|||
13146394|NCT02598193|26034502|FG000|Overall Study|Adverse Event|13|||
13146395|NCT02598193|26034502|FG000|Overall Study|Withdrawal by Subject|1|||
13146396|NCT02598193|26034502|FG000|Overall Study|Listed in active lung transplant list|1|||
13146397|NCT02598193|26034502|FG000|Overall Study|Does not want to take Nintedanib|1|||
13146398|NCT02598128|26034519|FG000|Period A: Days -7 to -1|Adverse Event|1|||
13146399|NCT02598128|26034520|FG001|Period A: Days -7 to -1|Adverse Event|0|||
13146400|NCT02598128|26034521|FG002|Period A: Days -7 to -1|Adverse Event|0|||
13146401|NCT02598128|26034522|FG003|Period A: Days -7 to -1|Adverse Event|0|||
13146402|NCT02598076|26034543|FG000|Overall Study|Lost to Follow-up|2|||
13146403|NCT02598076|26034544|FG001|Overall Study|Lost to Follow-up|3|||
13146404|NCT02597946|26034555|FG000|Overall Study|Withdrawal by Subject|1|||
13146405|NCT02597946|26034555|FG000|Overall Study|Progressive disease|16|||
13146406|NCT02597946|26034555|FG000|Overall Study|Other than above|1|||
13146407|NCT02597933|26034590|FG000|Overall Study|Withdrawal by Subject|7|||
13146408|NCT02597933|26034591|FG001|Overall Study|Withdrawal by Subject|5|||
13146409|NCT02597933|26034590|FG000|Overall Study|Protocol Violation|2|||
13146410|NCT02597933|26034591|FG001|Overall Study|Protocol Violation|2|||
13146411|NCT02597933|26034590|FG000|Overall Study|Adverse Event|20|||
13146412|NCT02597933|26034591|FG001|Overall Study|Adverse Event|28|||
13146413|NCT02597933|26034590|FG000|Overall Study|Not treated|2|||
13146414|NCT02597933|26034591|FG001|Overall Study|Not treated|2|||
13146415|NCT02597933|26034590|FG000|Overall Study|Other than stated above|7|||
13146416|NCT02597933|26034591|FG001|Overall Study|Other than stated above|14|||
13146417|NCT02597920|26034624|FG000|Overall Study|Worsening of other pre-existing disease|0|||
13146418|NCT02597920|26034625|FG001|Overall Study|Worsening of other pre-existing disease|1|||
13146419|NCT02597920|26034626|FG002|Overall Study|Worsening of other pre-existing disease|0|||
13146420|NCT02597920|26034624|FG000|Overall Study|Other adverse event|20|||
13146421|NCT02597920|26034625|FG001|Overall Study|Other adverse event|30|||
13146422|NCT02597920|26034626|FG002|Overall Study|Other adverse event|0|||
13146423|NCT02597920|26034624|FG000|Overall Study|Lost to Follow-up|7|||
13146424|NCT02597920|26034625|FG001|Overall Study|Lost to Follow-up|9|||
13146425|NCT02597920|26034626|FG002|Overall Study|Lost to Follow-up|0|||
13146426|NCT02597920|26034624|FG000|Overall Study|Refuse to continue in the study|3|||
13146427|NCT02597920|26034625|FG001|Overall Study|Refuse to continue in the study|13|||
13146428|NCT02597920|26034626|FG002|Overall Study|Refuse to continue in the study|1|||
13146429|NCT02597920|26034624|FG000|Overall Study|Other than specified|10|||
13146430|NCT02597920|26034625|FG001|Overall Study|Other than specified|31|||
13146431|NCT02597920|26034626|FG002|Overall Study|Other than specified|5|||
13146432|NCT02597920|26034624|FG000|Overall Study|Other|1|||
13146433|NCT02597920|26034625|FG001|Overall Study|Other|0|||
13146434|NCT02597920|26034626|FG002|Overall Study|Other|0|||
13146435|NCT02597855|26034641|FG000|Overall Study|Lost to Follow-up|2|||
13146436|NCT02597855|26034642|FG001|Overall Study|Lost to Follow-up|1|||
13146437|NCT02597712|26034660|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2|||
13146438|NCT02597712|26034661|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0|||
13146439|NCT02597712|26034660|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1|||
13146440|NCT02597712|26034661|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0|||
13146441|NCT02597712|26034660|FG000|Overall Study|Recurrent metastatic prostate cancer|0|||
13146442|NCT02597712|26034661|FG001|Overall Study|Recurrent metastatic prostate cancer|1|||
13146443|NCT02597478|26034682|FG000|Overall Study|Withdrawal by Subject|2|||
13146444|NCT02597478|26034683|FG001|Overall Study|Withdrawal by Subject|0|||
13146445|NCT02597478|26034682|FG000|Overall Study|Change of opioid dose|1|||
13146446|NCT02597478|26034683|FG001|Overall Study|Change of opioid dose|0|||
13146447|NCT02597478|26034682|FG000|Overall Study|Insufficient exertional dyspnea|0|||
13146448|NCT02597478|26034683|FG001|Overall Study|Insufficient exertional dyspnea|1|||
13146449|NCT02597452|26034695|FG000|Overall Study|testing incomplete|30|||
13146450|NCT02597062|26034703|FG000|Overall Study|Ineligible|1|||
13146451|NCT02597049|26034751|FG000|Overall Study|Lost to Follow-up|0|||
13146452|NCT02597049|26034752|FG001|Overall Study|Lost to Follow-up|3|||
13146453|NCT02597049|26034753|FG002|Overall Study|Lost to Follow-up|2|||
13146454|NCT02597049|26034751|FG000|Overall Study|Withdrawal by Subject|2|||
13146455|NCT02597049|26034752|FG001|Overall Study|Withdrawal by Subject|2|||
13146456|NCT02597049|26034753|FG002|Overall Study|Withdrawal by Subject|1|||
13146457|NCT02597049|26034751|FG000|Overall Study|Adverse Event|2|||
13146458|NCT02597049|26034752|FG001|Overall Study|Adverse Event|0|||
13146459|NCT02597049|26034753|FG002|Overall Study|Adverse Event|0|||
13146460|NCT02597049|26034751|FG000|Overall Study|Death|2|||
13146461|NCT02597049|26034752|FG001|Overall Study|Death|0|||
13146462|NCT02597049|26034753|FG002|Overall Study|Death|0|||
13146463|NCT02597049|26034751|FG000|Overall Study|Noncompliant with Study Visits|1|||
13146464|NCT02597049|26034752|FG001|Overall Study|Noncompliant with Study Visits|0|||
13146465|NCT02597049|26034753|FG002|Overall Study|Noncompliant with Study Visits|0|||
13146466|NCT02596971|26034800|FG000|Overall Study|Death|5|||
13146467|NCT02596971|26034801|FG001|Overall Study|Death|1|||
13146468|NCT02596971|26034802|FG002|Overall Study|Death|5|||
13146469|NCT02596971|26034800|FG000|Overall Study|Withdrawal by Subject|5|||
13146470|NCT02596971|26034801|FG001|Overall Study|Withdrawal by Subject|1|||
13146471|NCT02596971|26034802|FG002|Overall Study|Withdrawal by Subject|4|||
13146472|NCT02596958|26034816|FG000|Overall Study|Serious Adverse Drug Reactions|44|||
13146473|NCT02596958|26034816|FG000|Overall Study|Cancer Progression|441|||
13146474|NCT02596958|26034816|FG000|Overall Study|Death From Cancer|112|||
13146475|NCT02596958|26034816|FG000|Overall Study|Death From Other Cause|33|||
13146476|NCT02596958|26034816|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61|||
13146477|NCT02596958|26034816|FG000|Overall Study|Administrative Reasons/Other|231|||
13146478|NCT02596958|26034816|FG000|Overall Study|Lost to Follow-up|33|||
13146479|NCT02596958|26034816|FG000|Overall Study|Missing|32|||
13146480|NCT02596958|26034816|FG000|Overall Study|Excluded Due to Second Line Treatment|9|||
13146481|NCT02596945|26034824|FG000|Overall Study|No documentation of study drug dosing|3|||
13146482|NCT02596945|26034824|FG000|Overall Study|Other|32|||
13146483|NCT02596945|26034824|FG000|Overall Study|Change to hemodialysis|15|||
13146484|NCT02596945|26034824|FG000|Overall Study|Other Erythropoietin stimulating agent|4|||
13146485|NCT02596945|26034824|FG000|Overall Study|Withdrawal by Subject|1|||
13146486|NCT02596945|26034824|FG000|Overall Study|Missing|1|||
13146487|NCT02596893|26034891|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61|||
13146488|NCT02596893|26034892|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56|||
13146489|NCT02596893|26034893|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48|||
13146490|NCT02596893|26034894|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58|||
13146491|NCT02596893|26034891|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11|||
13146492|NCT02596893|26034892|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
13146493|NCT02596893|26034893|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
13146494|NCT02596893|26034894|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12|||
13146495|NCT02596893|26034891|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
13146496|NCT02596893|26034892|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
13146497|NCT02596893|26034893|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
13146498|NCT02596893|26034894|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1|||
13146499|NCT02596893|26034891|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15|||
13146500|NCT02596893|26034892|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
13146501|NCT02596893|26034893|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
13146502|NCT02596893|26034894|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13|||
13146503|NCT02596893|26034891|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10|||
13146504|NCT02596893|26034892|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4|||
13146505|NCT02596893|26034893|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13|||
13146506|NCT02596893|26034894|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5|||
13146507|NCT02596893|26034891|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1|||
13146508|NCT02596893|26034892|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
13146509|NCT02596893|26034893|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0|||
13146510|NCT02596893|26034894|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
13146511|NCT02596893|26034891|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0|||
13146512|NCT02596893|26034892|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
13146513|NCT02596893|26034893|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
13146514|NCT02596893|26034894|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
13146515|NCT02596893|26034891|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
13146516|NCT02596893|26034892|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
13146517|NCT02596893|26034893|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1|||
13146518|NCT02596893|26034894|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2|||
13146519|NCT02596893|26034891|FG000|Overall Double-Blind Period Weeks 0-52|Death|0|||
13146520|NCT02596893|26034892|FG001|Overall Double-Blind Period Weeks 0-52|Death|0|||
13146521|NCT02596893|26034893|FG002|Overall Double-Blind Period Weeks 0-52|Death|1|||
13146522|NCT02596893|26034894|FG003|Overall Double-Blind Period Weeks 0-52|Death|0|||
13146523|NCT02596893|26034891|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
13093084|NCT03673345|25831930|FG000|Overall Study|Physician Decision|0|||
13093085|NCT03673345|25831931|FG001|Overall Study|Physician Decision|0|||
13093086|NCT03673345|25831932|FG002|Overall Study|Physician Decision|2|||
13093087|NCT03673345|25831933|FG003|Overall Study|Physician Decision|0|||
13093088|NCT03673345|25831934|FG004|Overall Study|Physician Decision|0|||
13093089|NCT03673345|25831935|FG005|Overall Study|Physician Decision|0|||
13093090|NCT03673345|25831936|FG006|Overall Study|Physician Decision|0|||
13093091|NCT03673345|25831937|FG007|Overall Study|Physician Decision|0|||
13093092|NCT03673098|25831971|FG000|Overall Study|Lost to Follow-up|2|||
13146524|NCT02596893|26034892|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
13146525|NCT02596893|26034893|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
13093093|NCT03673098|25831972|FG001|Overall Study|Lost to Follow-up|3|||
13093094|NCT03673098|25831971|FG000|Overall Study|Withdrawal by Subject|6|||
13093095|NCT03673098|25831972|FG001|Overall Study|Withdrawal by Subject|1|||
13093096|NCT03673098|25831971|FG000|Overall Study|Could not participate due to scheduling conflicts or health issues|2|||
13093097|NCT03673098|25831972|FG001|Overall Study|Could not participate due to scheduling conflicts or health issues|0|||
13093098|NCT03672396|25831997|FG000|Overall Study|Withdrawal by Subject|4|||
13093099|NCT03672396|25831997|FG000|Overall Study|Physician Decision|1|||
13093100|NCT03672396|25831997|FG000|Overall Study|Adverse Event|1|||
13093101|NCT03672097|25832008|FG000|Period 1|Withdrawal by Subject|2|||
13093102|NCT03672097|25832008|FG000|Period 1|Adverse Event|1|||
13093103|NCT03672097|25832008|FG000|Period 1|Did not receive treatment|1|||
13093104|NCT03672097|25832008|FG000|Period 2|Withdrawal by Subject|3|||
13093105|NCT03672097|25832008|FG000|Period 2|Other|1|||
13093106|NCT03672006|25832029|FG000|Overall Study|exclusion criteria met|0|||
13093107|NCT03672006|25832030|FG001|Overall Study|exclusion criteria met|1|||
13093108|NCT03671148|25832063|FG000|Overall Study|Adverse Event|3|||
13093109|NCT03671148|25832064|FG001|Overall Study|Adverse Event|2|||
13093110|NCT03671148|25832063|FG000|Overall Study|Withdrawal by Subject|8|||
13093111|NCT03671148|25832064|FG001|Overall Study|Withdrawal by Subject|2|||
13093112|NCT03671148|25832063|FG000|Overall Study|Lost to Follow-up|1|||
13093113|NCT03671148|25832064|FG001|Overall Study|Lost to Follow-up|2|||
13093114|NCT03671148|25832063|FG000|Overall Study|Lack of Efficacy|7|||
13093115|NCT03671148|25832064|FG001|Overall Study|Lack of Efficacy|2|||
13093116|NCT03671148|25832063|FG000|Overall Study|COVID-19 Logistical Restrictions|0|||
13093117|NCT03671148|25832064|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
13093118|NCT03671148|25832063|FG000|Overall Study|Other|1|||
13093119|NCT03671148|25832064|FG001|Overall Study|Other|0|||
13093120|NCT03671148|25832063|FG000|Overall Study|Incomplete Randomization Visit|1|||
13093121|NCT03671148|25832064|FG001|Overall Study|Incomplete Randomization Visit|0|||
13093122|NCT03670810|25832161|FG000|Main Study|Adverse Event|37|||
13093123|NCT03670810|25832162|FG001|Main Study|Adverse Event|38|||
13093124|NCT03670810|25832163|FG002|Main Study|Adverse Event|3|||
13093125|NCT03670810|25832164|FG003|Main Study|Adverse Event|4|||
13093126|NCT03670810|25832165|FG004|Main Study|Adverse Event|4|||
13093127|NCT03670810|25832166|FG005|Main Study|Adverse Event|5|||
13093128|NCT03670810|25832167|FG006|Main Study|Adverse Event|0|||
13093129|NCT03670810|25832168|FG007|Main Study|Adverse Event|0|||
13093130|NCT03670810|25832169|FG008|Main Study|Adverse Event|0|||
13093131|NCT03670810|25832161|FG000|Main Study|Lack of Efficacy|8|||
13093132|NCT03670810|25832162|FG001|Main Study|Lack of Efficacy|9|||
13093133|NCT03670810|25832163|FG002|Main Study|Lack of Efficacy|3|||
13093134|NCT03670810|25832164|FG003|Main Study|Lack of Efficacy|4|||
13093135|NCT03670810|25832165|FG004|Main Study|Lack of Efficacy|0|||
13093136|NCT03670810|25832166|FG005|Main Study|Lack of Efficacy|0|||
13093137|NCT03670810|25832167|FG006|Main Study|Lack of Efficacy|0|||
13093138|NCT03670810|25832168|FG007|Main Study|Lack of Efficacy|0|||
13093139|NCT03670810|25832169|FG008|Main Study|Lack of Efficacy|0|||
13093140|NCT03670810|25832161|FG000|Main Study|Lost to Follow-up|9|||
13093141|NCT03670810|25832162|FG001|Main Study|Lost to Follow-up|7|||
13093142|NCT03670810|25832163|FG002|Main Study|Lost to Follow-up|4|||
13093143|NCT03670810|25832164|FG003|Main Study|Lost to Follow-up|6|||
13093144|NCT03670810|25832165|FG004|Main Study|Lost to Follow-up|1|||
13093145|NCT03670810|25832166|FG005|Main Study|Lost to Follow-up|0|||
13093146|NCT03670810|25832167|FG006|Main Study|Lost to Follow-up|0|||
13093147|NCT03670810|25832168|FG007|Main Study|Lost to Follow-up|0|||
13093148|NCT03670810|25832169|FG008|Main Study|Lost to Follow-up|0|||
13093149|NCT03670810|25832161|FG000|Main Study|Non-compliance with Study Drug|0|||
13093150|NCT03670810|25832162|FG001|Main Study|Non-compliance with Study Drug|2|||
13093151|NCT03670810|25832163|FG002|Main Study|Non-compliance with Study Drug|3|||
13093152|NCT03670810|25832164|FG003|Main Study|Non-compliance with Study Drug|0|||
13093153|NCT03670810|25832165|FG004|Main Study|Non-compliance with Study Drug|0|||
13093154|NCT03670810|25832166|FG005|Main Study|Non-compliance with Study Drug|0|||
13093155|NCT03670810|25832167|FG006|Main Study|Non-compliance with Study Drug|0|||
13093156|NCT03670810|25832168|FG007|Main Study|Non-compliance with Study Drug|1|||
13093157|NCT03670810|25832169|FG008|Main Study|Non-compliance with Study Drug|0|||
13093158|NCT03670810|25832161|FG000|Main Study|Physician Decision|3|||
13093159|NCT03670810|25832162|FG001|Main Study|Physician Decision|0|||
13093160|NCT03670810|25832163|FG002|Main Study|Physician Decision|1|||
13093161|NCT03670810|25832164|FG003|Main Study|Physician Decision|0|||
13093162|NCT03670810|25832165|FG004|Main Study|Physician Decision|0|||
13093163|NCT03670810|25832166|FG005|Main Study|Physician Decision|0|||
13093164|NCT03670810|25832167|FG006|Main Study|Physician Decision|1|||
13093165|NCT03670810|25832168|FG007|Main Study|Physician Decision|1|||
13093166|NCT03670810|25832169|FG008|Main Study|Physician Decision|0|||
13093167|NCT03670810|25832161|FG000|Main Study|Pregnancy|1|||
13093168|NCT03670810|25832162|FG001|Main Study|Pregnancy|2|||
13093169|NCT03670810|25832163|FG002|Main Study|Pregnancy|0|||
13093170|NCT03670810|25832164|FG003|Main Study|Pregnancy|0|||
13093171|NCT03670810|25832165|FG004|Main Study|Pregnancy|0|||
13093172|NCT03670810|25832166|FG005|Main Study|Pregnancy|0|||
13093173|NCT03670810|25832167|FG006|Main Study|Pregnancy|0|||
13146526|NCT02596893|26034894|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2|||
13146527|NCT02596893|26034891|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66|||
13146528|NCT02596893|26034892|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76|||
13146529|NCT02596893|26034893|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69|||
13146530|NCT02596893|26034894|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70|||
13146531|NCT02596854|26034900|FG000|Overall Study|Withdrawn|8|||
13146532|NCT02596711|26034924|FG000|Overall Study|Lost to Follow-up|1|||
13146533|NCT02596711|26034925|FG001|Overall Study|Lost to Follow-up|2|||
13146534|NCT02596711|26034926|FG002|Overall Study|Lost to Follow-up|3|||
13146535|NCT02596620|26034939|FG000|Overall Study|Lost to Follow-up|1|||
13146536|NCT02596620|26034940|FG001|Overall Study|Lost to Follow-up|1|||
13146537|NCT02596230|26034977|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714|||
13146538|NCT02596230|26034978|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228|||
13146539|NCT02596230|26034979|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0|||
13146540|NCT02596230|26034980|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846|||
13146541|NCT02596230|26034981|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0|||
13146542|NCT02596230|26034977|FG000|Objective 2, One Year|Lost to Follow-up|0|||
13146543|NCT02596230|26034978|FG001|Objective 2, One Year|Lost to Follow-up|41|||
13146544|NCT02596230|26034979|FG002|Objective 2, One Year|Lost to Follow-up|41|||
13146545|NCT02596230|26034980|FG003|Objective 2, One Year|Lost to Follow-up|32|||
13146546|NCT02596230|26034981|FG004|Objective 2, One Year|Lost to Follow-up|46|||
13146547|NCT02596230|26034977|FG000|Objective 2, One Year|Withdrawal by Subject|0|||
13146548|NCT02596230|26034978|FG001|Objective 2, One Year|Withdrawal by Subject|11|||
13146549|NCT02596230|26034979|FG002|Objective 2, One Year|Withdrawal by Subject|14|||
13146550|NCT02596230|26034980|FG003|Objective 2, One Year|Withdrawal by Subject|5|||
13146551|NCT02596230|26034981|FG004|Objective 2, One Year|Withdrawal by Subject|2|||
13146552|NCT02596230|26034977|FG000|Objective 2, One Year|Adverse drug reaction|0|||
13146553|NCT02596230|26034978|FG001|Objective 2, One Year|Adverse drug reaction|1|||
13146554|NCT02596230|26034979|FG002|Objective 2, One Year|Adverse drug reaction|0|||
13146555|NCT02596230|26034980|FG003|Objective 2, One Year|Adverse drug reaction|0|||
13146556|NCT02596230|26034981|FG004|Objective 2, One Year|Adverse drug reaction|0|||
13146557|NCT02596230|26034977|FG000|Objective 2, One Year|Death|0|||
13146558|NCT02596230|26034978|FG001|Objective 2, One Year|Death|12|||
13146559|NCT02596230|26034979|FG002|Objective 2, One Year|Death|41|||
13146560|NCT02596230|26034980|FG003|Objective 2, One Year|Death|21|||
13146561|NCT02596230|26034981|FG004|Objective 2, One Year|Death|30|||
13146562|NCT02596230|26034977|FG000|Objective 2, One Year|Other|0|||
13146563|NCT02596230|26034978|FG001|Objective 2, One Year|Other|3|||
13146564|NCT02596230|26034979|FG002|Objective 2, One Year|Other|2|||
13146565|NCT02596230|26034980|FG003|Objective 2, One Year|Other|0|||
13146566|NCT02596230|26034981|FG004|Objective 2, One Year|Other|0|||
13146567|NCT02596009|26034997|FG000|Overall Study|Administrative problems|0|||
13146568|NCT02596009|26034998|FG001|Overall Study|Administrative problems|1|||
13146569|NCT02596009|26034999|FG002|Overall Study|Administrative problems|0|||
13146570|NCT02596009|26035000|FG003|Overall Study|Administrative problems|0|||
13146571|NCT02596009|26035001|FG004|Overall Study|Administrative problems|0|||
13146572|NCT02596009|26035002|FG005|Overall Study|Administrative problems|0|||
13146573|NCT02595970|26035018|FG000|Overall Study|Withdrawal by Subject|2|||
13146574|NCT02595970|26035018|FG000|Overall Study|Physician Decision|2|||
13146575|NCT02595970|26035018|FG000|Overall Study|Protocol Violation|4|||
13146576|NCT02595970|26035018|FG000|Overall Study|Adverse Event|5|||
13146577|NCT02595970|26035018|FG000|Overall Study|Lack of Efficacy|7|||
13146578|NCT02595749|26035041|FG000|Overall Study|Withdrawal by Subject|12|||
13146579|NCT02595749|26035042|FG001|Overall Study|Withdrawal by Subject|7|||
13146580|NCT02595723|26035060|FG000|First Washout (21 Days)|Withdrawal by Subject|1|||
13093174|NCT03670810|25832168|FG007|Main Study|Pregnancy|0|||
13093175|NCT03670810|25832169|FG008|Main Study|Pregnancy|0|||
13093176|NCT03670810|25832161|FG000|Main Study|Protocol Deviation|2|||
13093177|NCT03670810|25832162|FG001|Main Study|Protocol Deviation|12|||
13093178|NCT03670810|25832163|FG002|Main Study|Protocol Deviation|8|||
13093179|NCT03670810|25832164|FG003|Main Study|Protocol Deviation|4|||
13093180|NCT03670810|25832165|FG004|Main Study|Protocol Deviation|0|||
13093181|NCT03670810|25832166|FG005|Main Study|Protocol Deviation|0|||
13093182|NCT03670810|25832167|FG006|Main Study|Protocol Deviation|0|||
13093183|NCT03670810|25832168|FG007|Main Study|Protocol Deviation|0|||
13093184|NCT03670810|25832169|FG008|Main Study|Protocol Deviation|0|||
13093185|NCT03670810|25832161|FG000|Main Study|Withdrawal by Subject|21|||
13093186|NCT03670810|25832162|FG001|Main Study|Withdrawal by Subject|21|||
13146581|NCT02595723|26035061|FG001|First Washout (21 Days)|Withdrawal by Subject|0|||
13093187|NCT03670810|25832163|FG002|Main Study|Withdrawal by Subject|8|||
13146582|NCT02595723|26035062|FG002|First Washout (21 Days)|Withdrawal by Subject|0|||
13146583|NCT02595723|26035060|FG000|First Washout (21 Days)|Lost to Follow-up|1|||
13146584|NCT02595723|26035061|FG001|First Washout (21 Days)|Lost to Follow-up|0|||
13146585|NCT02595723|26035062|FG002|First Washout (21 Days)|Lost to Follow-up|0|||
13093188|NCT03670810|25832164|FG003|Main Study|Withdrawal by Subject|9|||
13093189|NCT03670810|25832165|FG004|Main Study|Withdrawal by Subject|5|||
13093190|NCT03670810|25832166|FG005|Main Study|Withdrawal by Subject|2|||
13093191|NCT03670810|25832167|FG006|Main Study|Withdrawal by Subject|1|||
13093192|NCT03670810|25832168|FG007|Main Study|Withdrawal by Subject|1|||
13093193|NCT03670810|25832169|FG008|Main Study|Withdrawal by Subject|0|||
13093194|NCT03670810|25832161|FG000|Main Study|Participant did not want to take the three other treatments|1|||
13093195|NCT03670810|25832162|FG001|Main Study|Participant did not want to take the three other treatments|0|||
13093196|NCT03670810|25832163|FG002|Main Study|Participant did not want to take the three other treatments|0|||
13093197|NCT03670810|25832164|FG003|Main Study|Participant did not want to take the three other treatments|0|||
13093198|NCT03670810|25832165|FG004|Main Study|Participant did not want to take the three other treatments|0|||
13093199|NCT03670810|25832166|FG005|Main Study|Participant did not want to take the three other treatments|0|||
13093200|NCT03670810|25832167|FG006|Main Study|Participant did not want to take the three other treatments|0|||
13093201|NCT03670810|25832168|FG007|Main Study|Participant did not want to take the three other treatments|0|||
13093202|NCT03670810|25832169|FG008|Main Study|Participant did not want to take the three other treatments|0|||
13093203|NCT03670810|25832161|FG000|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
13093204|NCT03670810|25832162|FG001|Main Study|Migraines more frequent-GP advised to re-start Topiramate|1|||
13093205|NCT03670810|25832163|FG002|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
13093206|NCT03670810|25832164|FG003|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
13093207|NCT03670810|25832165|FG004|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
13093208|NCT03670810|25832166|FG005|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
13093209|NCT03670810|25832167|FG006|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
13093210|NCT03670810|25832168|FG007|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
13093211|NCT03670810|25832169|FG008|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
13093212|NCT03670810|25832161|FG000|Main Study|Travel and Coronavirus issues|0|||
13093213|NCT03670810|25832162|FG001|Main Study|Travel and Coronavirus issues|0|||
13093214|NCT03670810|25832163|FG002|Main Study|Travel and Coronavirus issues|0|||
13093215|NCT03670810|25832164|FG003|Main Study|Travel and Coronavirus issues|1|||
13093216|NCT03670810|25832165|FG004|Main Study|Travel and Coronavirus issues|0|||
13093217|NCT03670810|25832166|FG005|Main Study|Travel and Coronavirus issues|0|||
13093218|NCT03670810|25832167|FG006|Main Study|Travel and Coronavirus issues|0|||
13093219|NCT03670810|25832168|FG007|Main Study|Travel and Coronavirus issues|0|||
13093220|NCT03670810|25832169|FG008|Main Study|Travel and Coronavirus issues|0|||
13093221|NCT03670810|25832161|FG000|Open Label Extension|Protocol Deviation|0|||
13093222|NCT03670810|25832162|FG001|Open Label Extension|Protocol Deviation|0|||
13093223|NCT03670810|25832163|FG002|Open Label Extension|Protocol Deviation|0|||
13093224|NCT03670810|25832164|FG003|Open Label Extension|Protocol Deviation|0|||
13093225|NCT03670810|25832165|FG004|Open Label Extension|Protocol Deviation|0|||
13093226|NCT03670810|25832166|FG005|Open Label Extension|Protocol Deviation|0|||
13093227|NCT03670810|25832167|FG006|Open Label Extension|Protocol Deviation|0|||
13093228|NCT03670810|25832168|FG007|Open Label Extension|Protocol Deviation|0|||
13093229|NCT03670810|25832169|FG008|Open Label Extension|Protocol Deviation|5|||
13093230|NCT03670810|25832161|FG000|Open Label Extension|Death|0|||
13093231|NCT03670810|25832162|FG001|Open Label Extension|Death|0|||
13093232|NCT03670810|25832163|FG002|Open Label Extension|Death|0|||
13093233|NCT03670810|25832164|FG003|Open Label Extension|Death|0|||
13093234|NCT03670810|25832165|FG004|Open Label Extension|Death|0|||
13093235|NCT03670810|25832166|FG005|Open Label Extension|Death|0|||
13093236|NCT03670810|25832167|FG006|Open Label Extension|Death|0|||
13093237|NCT03670810|25832168|FG007|Open Label Extension|Death|0|||
13093238|NCT03670810|25832169|FG008|Open Label Extension|Death|1|||
13093239|NCT03670810|25832161|FG000|Open Label Extension|COVID-19|0|||
13093240|NCT03670810|25832162|FG001|Open Label Extension|COVID-19|0|||
13093241|NCT03670810|25832163|FG002|Open Label Extension|COVID-19|0|||
13093242|NCT03670810|25832164|FG003|Open Label Extension|COVID-19|0|||
13093243|NCT03670810|25832165|FG004|Open Label Extension|COVID-19|0|||
13093244|NCT03670810|25832166|FG005|Open Label Extension|COVID-19|0|||
13093245|NCT03670810|25832167|FG006|Open Label Extension|COVID-19|0|||
13093246|NCT03670810|25832168|FG007|Open Label Extension|COVID-19|0|||
13093247|NCT03670810|25832169|FG008|Open Label Extension|COVID-19|1|||
13093248|NCT03670810|25832161|FG000|Open Label Extension|Lack of Efficacy|0|||
13093249|NCT03670810|25832162|FG001|Open Label Extension|Lack of Efficacy|0|||
13093250|NCT03670810|25832163|FG002|Open Label Extension|Lack of Efficacy|0|||
13093251|NCT03670810|25832164|FG003|Open Label Extension|Lack of Efficacy|0|||
13093252|NCT03670810|25832165|FG004|Open Label Extension|Lack of Efficacy|0|||
13093253|NCT03670810|25832166|FG005|Open Label Extension|Lack of Efficacy|0|||
13146586|NCT02595528|26035085|FG000|Overall Study|Withdrawal by Subject|1|||
13146587|NCT02595528|26035086|FG001|Overall Study|Withdrawal by Subject|2|||
13146588|NCT02595528|26035087|FG002|Overall Study|Withdrawal by Subject|1|||
13146589|NCT02595528|26035088|FG003|Overall Study|Withdrawal by Subject|3|||
13146590|NCT02595528|26035085|FG000|Overall Study|Lost to Follow-up|1|||
13146591|NCT02595528|26035086|FG001|Overall Study|Lost to Follow-up|1|||
13146592|NCT02595528|26035087|FG002|Overall Study|Lost to Follow-up|0|||
13146593|NCT02595528|26035088|FG003|Overall Study|Lost to Follow-up|1|||
13146594|NCT02595502|26035097|FG000|Period 1|Adverse Event|0|||
13146595|NCT02595502|26035098|FG001|Period 1|Adverse Event|1|||
13146596|NCT02595502|26035097|FG000|Period 1|Withdrawal by Subject|1|||
13146597|NCT02595502|26035098|FG001|Period 1|Withdrawal by Subject|0|||
13146598|NCT02595502|26035097|FG000|Period 1|Lost to Follow-up|0|||
13146599|NCT02595502|26035098|FG001|Period 1|Lost to Follow-up|1|||
13146600|NCT02595502|26035097|FG000|Period 2|Adverse Event|1|||
13146601|NCT02595502|26035098|FG001|Period 2|Adverse Event|1|||
13146602|NCT02595502|26035097|FG000|Period 2|Received incorrect lens at Period 1|0|||
13146603|NCT02595502|26035098|FG001|Period 2|Received incorrect lens at Period 1|1|||
13146604|NCT02595502|26035097|FG000|Period 3|Protocol Violation|0|||
13146605|NCT02595502|26035098|FG001|Period 3|Protocol Violation|1|||
13146606|NCT02595502|26035097|FG000|Period 3|Lost to Follow-up|1|||
13146607|NCT02595502|26035098|FG001|Period 3|Lost to Follow-up|0|||
13146608|NCT02595502|26035097|FG000|Period 3|Received Incorrect Treatment at period 3|0|||
13146609|NCT02595502|26035098|FG001|Period 3|Received Incorrect Treatment at period 3|1|||
13146610|NCT02595450|26035106|FG000|Overall Study|Unspecified (only completed 1 cycle)|73|||
13146611|NCT02595450|26035106|FG000|Overall Study|Enrolled, but not treated|8|||
13146612|NCT02595437|26035126|FG000|Triferic Via IV|Withdrawal by Subject|1|||
13146613|NCT02595398|26035143|FG000|Overall Study|Non-compliance|1|||
13146614|NCT02595398|26035144|FG001|Overall Study|Non-compliance|0|||
13146615|NCT02595398|26035143|FG000|Overall Study|Withdrawal by Subject|2|||
13146616|NCT02595398|26035144|FG001|Overall Study|Withdrawal by Subject|1|||
13146617|NCT02595398|26035143|FG000|Overall Study|Lost to Follow-up|1|||
13146618|NCT02595398|26035144|FG001|Overall Study|Lost to Follow-up|0|||
13146619|NCT02595073|26035159|FG000|Overall Study|Progressive Disease|0|||
13146620|NCT02595073|26035160|FG001|Overall Study|Progressive Disease|1|||
13146621|NCT02595073|26035159|FG000|Overall Study|Protocol Violation|2|||
13146622|NCT02595073|26035160|FG001|Overall Study|Protocol Violation|0|||
13146623|NCT02595008|26035173|FG000|Overall Study|Enrolled In Error|1|||
13146624|NCT02595008|26035174|FG001|Overall Study|Enrolled In Error|0|||
13146625|NCT02594735|26035200|FG000|Overall Study|Adverse Event|1|||
13146626|NCT02594163|26035223|FG000|Treatment Period|Progressive disease|2|||
13146627|NCT02594163|26035224|FG001|Treatment Period|Progressive disease|3|||
13146628|NCT02594163|26035223|FG000|Treatment Period|Adverse Event|1|||
13146629|NCT02594163|26035224|FG001|Treatment Period|Adverse Event|5|||
13146630|NCT02594163|26035223|FG000|Treatment Period|Physician Decision|1|||
13146631|NCT02594163|26035224|FG001|Treatment Period|Physician Decision|3|||
13146632|NCT02594163|26035223|FG000|Treatment Period|Study termination by sponsor|2|||
13146633|NCT02594163|26035224|FG001|Treatment Period|Study termination by sponsor|1|||
13146634|NCT02594163|26035223|FG000|Treatment Period|Other, Non-AE|1|||
13146635|NCT02594163|26035224|FG001|Treatment Period|Other, Non-AE|0|||
13146636|NCT02594163|26035223|FG000|Follow-up Period|Withdrawal by Subject|0|||
13146637|NCT02594163|26035224|FG001|Follow-up Period|Withdrawal by Subject|1|||
13146638|NCT02594163|26035223|FG000|Follow-up Period|Study Termination by Sponsor|6|||
13146639|NCT02594163|26035224|FG001|Follow-up Period|Study Termination by Sponsor|4|||
13146640|NCT02594163|26035223|FG000|Follow-up Period|Lost to Follow-up|1|||
13146641|NCT02594163|26035224|FG001|Follow-up Period|Lost to Follow-up|0|||
13146642|NCT02594163|26035223|FG000|Follow-up Period|Death|2|||
13146643|NCT02594163|26035224|FG001|Follow-up Period|Death|5|||
13146644|NCT02594163|26035223|FG000|Follow-up Period|Adverse Event|0|||
13146645|NCT02594163|26035224|FG001|Follow-up Period|Adverse Event|1|||
13146646|NCT02594163|26035223|FG000|Follow-up Period|Progressive Disease|2|||
13146647|NCT02594163|26035224|FG001|Follow-up Period|Progressive Disease|0|||
13146648|NCT02594163|26035223|FG000|Follow-up Period|Physician Decision|0|||
13146649|NCT02594163|26035224|FG001|Follow-up Period|Physician Decision|1|||
13146650|NCT02594098|26035291|FG000|Overall Study|Lack of Efficacy|17|||
13146651|NCT02594098|26035292|FG001|Overall Study|Lack of Efficacy|6|||
13146652|NCT02594098|26035291|FG000|Overall Study|Withdrawal by Subject|1|||
13146653|NCT02594098|26035292|FG001|Overall Study|Withdrawal by Subject|3|||
13146654|NCT02594098|26035291|FG000|Overall Study|Terminated participation|6|||
13146655|NCT02594098|26035292|FG001|Overall Study|Terminated participation|2|||
13146656|NCT02594098|26035291|FG000|Overall Study|Seek alternative treatment|2|||
13146657|NCT02594098|26035292|FG001|Overall Study|Seek alternative treatment|1|||
13146658|NCT02594098|26035291|FG000|Overall Study|Other|0|||
13146659|NCT02594098|26035292|FG001|Overall Study|Other|1|||
13146660|NCT02593864|26035299|FG000|Overall Study|Withdrawal by Subject|3|||
13146661|NCT02593864|26035299|FG000|Overall Study|Lost to Follow-up|3|||
13146662|NCT02593825|26035318|FG000|Intervention|Lost to Follow-up|10|||
13146663|NCT02593825|26035319|FG001|Intervention|Lost to Follow-up|12|||
13146664|NCT02593786|26035426|FG000|Overall Study|Disease progression|12|||
13146665|NCT02593786|26035427|FG001|Overall Study|Disease progression|16|||
13146666|NCT02593786|26035428|FG002|Overall Study|Disease progression|10|||
13146667|NCT02593786|26035429|FG003|Overall Study|Disease progression|7|||
13146668|NCT02593786|26035426|FG000|Overall Study|Study drug toxicity|1|||
13146669|NCT02593786|26035427|FG001|Overall Study|Study drug toxicity|0|||
13146670|NCT02593786|26035428|FG002|Overall Study|Study drug toxicity|0|||
13146671|NCT02593786|26035429|FG003|Overall Study|Study drug toxicity|0|||
13146672|NCT02593786|26035426|FG000|Overall Study|Adverse event unrelated to study drug|1|||
13146673|NCT02593786|26035427|FG001|Overall Study|Adverse event unrelated to study drug|1|||
13146674|NCT02593786|26035428|FG002|Overall Study|Adverse event unrelated to study drug|1|||
13146675|NCT02593786|26035429|FG003|Overall Study|Adverse event unrelated to study drug|0|||
13146676|NCT02593786|26035426|FG000|Overall Study|Participant request to discontinue study therapy|0|||
13146677|NCT02593786|26035427|FG001|Overall Study|Participant request to discontinue study therapy|2|||
13146678|NCT02593786|26035428|FG002|Overall Study|Participant request to discontinue study therapy|0|||
13146679|NCT02593786|26035429|FG003|Overall Study|Participant request to discontinue study therapy|0|||
13146680|NCT02593786|26035426|FG000|Overall Study|Other reasons|1|||
13146681|NCT02593786|26035427|FG001|Overall Study|Other reasons|1|||
13146682|NCT02593786|26035428|FG002|Overall Study|Other reasons|0|||
13146683|NCT02593786|26035429|FG003|Overall Study|Other reasons|5|||
13146684|NCT02593773|26035441|FG000|Overall Study|Voluntary Withdrawal|3|||
13146685|NCT02593773|26035441|FG000|Overall Study|Study Terminated by Sponsor|31|||
13146686|NCT02593773|26035441|FG000|Overall Study|Death|1|||
13146687|NCT02593539|26035468|FG000|Overall Study|Adverse Event|1|||
13146688|NCT02593318|26035487|FG000|Overall Study|Withdrawal by Subject|1|||
13146689|NCT02593318|26035488|FG001|Overall Study|Withdrawal by Subject|1|||
13146690|NCT02593305|26035511|FG000|Post 1|Comparison only group. No intervention.|0|||
13146691|NCT02593305|26035512|FG001|Post 1|Comparison only group. No intervention.|0|||
13146692|NCT02593305|26035513|FG002|Post 1|Comparison only group. No intervention.|10|||
13146693|NCT02593149|26035526|FG000|Run-In|Didn't use CVC for at least 21 days|36|||
13146694|NCT02593149|26035527|FG001|Run-In|Didn't use CVC for at least 21 days|38|||
13146695|NCT02593149|26035526|FG000|Intervention|Didn't use CVC for at least 21 day|116|||
13146696|NCT02593149|26035527|FG001|Intervention|Didn't use CVC for at least 21 day|115|||
13146697|NCT02593097|26035544|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
13146698|NCT02593097|26035545|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2|||
13146699|NCT02593097|26035544|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
13146700|NCT02593097|26035545|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
13146701|NCT02593097|26035544|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
13146702|NCT02593097|26035545|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
13146703|NCT02593097|26035544|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1|||
13146704|NCT02593097|26035545|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0|||
13146705|NCT02593097|26035544|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
13146706|NCT02593097|26035545|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
13146707|NCT02592876|26035576|FG000|Overall Study|Withdrawal by Subject|3|||
13146708|NCT02592876|26035577|FG001|Overall Study|Withdrawal by Subject|3|||
13146709|NCT02592876|26035576|FG000|Overall Study|Study Termination by Sponsor|32|||
13146710|NCT02592876|26035577|FG001|Overall Study|Study Termination by Sponsor|27|||
13146711|NCT02592876|26035576|FG000|Overall Study|Lost to Follow-up|0|||
13146712|NCT02592876|26035577|FG001|Overall Study|Lost to Follow-up|1|||
13146713|NCT02592876|26035576|FG000|Overall Study|Death|6|||
13146714|NCT02592876|26035577|FG001|Overall Study|Death|9|||
13205004|NCT01968551|26230737|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
13205005|NCT01968551|26230735|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
13205006|NCT01968551|26230736|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
13205007|NCT01968551|26230737|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3|||
13205008|NCT01968551|26230735|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
13205009|NCT01968551|26230736|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
13205010|NCT01968551|26230737|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2|||
13205011|NCT01968551|26230735|FG000|Extension Phase|Adverse Event|0|||
13205012|NCT01968551|26230736|FG001|Extension Phase|Adverse Event|0|||
13205013|NCT01968551|26230737|FG002|Extension Phase|Adverse Event|2|||
13205014|NCT01968551|26230735|FG000|Extension Phase|Death|0|||
13205015|NCT01968551|26230736|FG001|Extension Phase|Death|1|||
13205016|NCT01968551|26230737|FG002|Extension Phase|Death|0|||
13205017|NCT01968551|26230735|FG000|Extension Phase|Withdrew Consent|0|||
13205018|NCT01968551|26230736|FG001|Extension Phase|Withdrew Consent|0|||
13205019|NCT01968551|26230737|FG002|Extension Phase|Withdrew Consent|1|||
13205020|NCT01968551|26230735|FG000|Extension Phase|Lost to Follow-up|1|||
13205021|NCT01968551|26230736|FG001|Extension Phase|Lost to Follow-up|0|||
13205022|NCT01968551|26230737|FG002|Extension Phase|Lost to Follow-up|1|||
13205023|NCT01968434|26230754|FG000|Overall Study|Lost to Follow-up|3|||
13205024|NCT01968434|26230755|FG001|Overall Study|Lost to Follow-up|6|||
13205025|NCT01968226|26230761|FG000|Overall Study|[F-18] RDG-K5 was not available|2|||
13205026|NCT01968070|26230874|FG000|Period 1|Withdrawal by Subject|0|||
13205027|NCT01968070|26230875|FG001|Period 1|Withdrawal by Subject|1|||
13205028|NCT01968070|26230876|FG002|Period 1|Withdrawal by Subject|0|||
13205029|NCT01968070|26230877|FG003|Period 1|Withdrawal by Subject|0|||
13205030|NCT01968070|26230878|FG004|Period 1|Withdrawal by Subject|0|||
13205031|NCT01968070|26230879|FG005|Period 1|Withdrawal by Subject|0|||
13205032|NCT01968070|26230880|FG006|Period 1|Withdrawal by Subject|1|||
13205033|NCT01968070|26230881|FG007|Period 1|Withdrawal by Subject|0|||
13146715|NCT02592798|26035620|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1|||
13146716|NCT02592798|26035621|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0|||
13146717|NCT02592798|26035620|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0|||
13146718|NCT02592798|26035621|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1|||
13146719|NCT02592798|26035620|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1|||
13146720|NCT02592798|26035621|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3|||
13146721|NCT02592798|26035620|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1|||
13146722|NCT02592798|26035621|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2|||
13146723|NCT02592798|26035620|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3|||
13146724|NCT02592798|26035621|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2|||
13146725|NCT02592798|26035620|FG000|Double-Blind Period 2 (DB2)|Other reasons|1|||
13146726|NCT02592798|26035621|FG001|Double-Blind Period 2 (DB2)|Other reasons|0|||
13146727|NCT02592798|26035620|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1|||
13146728|NCT02592798|26035621|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0|||
13146729|NCT02592798|26035620|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1|||
13146730|NCT02592798|26035621|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0|||
13093254|NCT03670810|25832167|FG006|Open Label Extension|Lack of Efficacy|0|||
13093255|NCT03670810|25832168|FG007|Open Label Extension|Lack of Efficacy|0|||
13093256|NCT03670810|25832169|FG008|Open Label Extension|Lack of Efficacy|39|||
13093257|NCT03670810|25832161|FG000|Open Label Extension|Participant refused to comply with face mask use|0|||
13093258|NCT03670810|25832162|FG001|Open Label Extension|Participant refused to comply with face mask use|0|||
13093259|NCT03670810|25832163|FG002|Open Label Extension|Participant refused to comply with face mask use|0|||
13093260|NCT03670810|25832164|FG003|Open Label Extension|Participant refused to comply with face mask use|0|||
13093261|NCT03670810|25832165|FG004|Open Label Extension|Participant refused to comply with face mask use|0|||
13093262|NCT03670810|25832166|FG005|Open Label Extension|Participant refused to comply with face mask use|0|||
13093263|NCT03670810|25832167|FG006|Open Label Extension|Participant refused to comply with face mask use|0|||
13093264|NCT03670810|25832168|FG007|Open Label Extension|Participant refused to comply with face mask use|0|||
13093265|NCT03670810|25832169|FG008|Open Label Extension|Participant refused to comply with face mask use|1|||
13093266|NCT03670810|25832161|FG000|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
13093267|NCT03670810|25832162|FG001|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
13093268|NCT03670810|25832163|FG002|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
13093269|NCT03670810|25832164|FG003|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
13093270|NCT03670810|25832165|FG004|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
13093271|NCT03670810|25832166|FG005|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
13093272|NCT03670810|25832167|FG006|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
13146731|NCT02592798|26035620|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1|||
13146732|NCT02592798|26035621|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2|||
13146733|NCT02592798|26035620|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1|||
13146734|NCT02592798|26035621|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0|||
13146735|NCT02592798|26035620|FG000|Transition From DB2 to OLE|Other reasons|1|||
13146736|NCT02592798|26035621|FG001|Transition From DB2 to OLE|Other reasons|0|||
13146737|NCT02592798|26035620|FG000|Open Label Period (OLE)|Other reasons|0|||
13146738|NCT02592798|26035621|FG001|Open Label Period (OLE)|Other reasons|2|||
13146739|NCT02592798|26035620|FG000|Open Label Period (OLE)|Participant request to discontinue|1|||
13146740|NCT02592798|26035621|FG001|Open Label Period (OLE)|Participant request to discontinue|0|||
13146741|NCT02592798|26035620|FG000|Open Label Period (OLE)|Lost to Follow-up|0|||
13146742|NCT02592798|26035621|FG001|Open Label Period (OLE)|Lost to Follow-up|1|||
13146743|NCT02592798|26035620|FG000|Open Label Period (OLE)|Lack of Efficacy|3|||
13146744|NCT02592798|26035621|FG001|Open Label Period (OLE)|Lack of Efficacy|5|||
13146745|NCT02592798|26035620|FG000|Open Label Period (OLE)|Adverse Event|0|||
13146746|NCT02592798|26035621|FG001|Open Label Period (OLE)|Adverse Event|1|||
13146747|NCT02592551|26035655|FG000|Overall Study|Not evaluable|1|||
13146748|NCT02592551|26035656|FG001|Overall Study|Not evaluable|3|||
13146749|NCT02592551|26035657|FG002|Overall Study|Not evaluable|0|||
13146750|NCT02592447|26035672|FG000|Overall Study|Lost to Follow-up|1|||
13146751|NCT02592447|26035673|FG001|Overall Study|Lost to Follow-up|0|||
13146752|NCT02592447|26035672|FG000|Overall Study|Ineligible after randomization|1|||
13146753|NCT02592447|26035673|FG001|Overall Study|Ineligible after randomization|0|||
13146754|NCT02592447|26035672|FG000|Overall Study|Withdrawal by Subject|0|||
13146755|NCT02592447|26035673|FG001|Overall Study|Withdrawal by Subject|1|||
13146756|NCT02592434|26035793|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12|||
13146757|NCT02592434|26035794|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0|||
13146758|NCT02592434|26035795|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0|||
13146759|NCT02592434|26035793|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21|||
13146760|NCT02592434|26035794|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
13146761|NCT02592434|26035795|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
13146762|NCT02592434|26035793|FG000|Open-Label Phase (18 Weeks)|Other|3|||
13146763|NCT02592434|26035794|FG001|Open-Label Phase (18 Weeks)|Other|0|||
13146764|NCT02592434|26035795|FG002|Open-Label Phase (18 Weeks)|Other|0|||
13146765|NCT02592434|26035793|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4|||
13146766|NCT02592434|26035794|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
13146767|NCT02592434|26035795|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
13146768|NCT02592434|26035793|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0|||
13146769|NCT02592434|26035794|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2|||
13146770|NCT02592434|26035795|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2|||
13146771|NCT02592434|26035793|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0|||
13146772|NCT02592434|26035794|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22|||
13146773|NCT02592434|26035795|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44|||
13146774|NCT02592434|26035793|FG000|Double Blind Phase (26 Weeks)|Other|0|||
13146775|NCT02592434|26035794|FG001|Double Blind Phase (26 Weeks)|Other|1|||
13146776|NCT02592434|26035795|FG002|Double Blind Phase (26 Weeks)|Other|0|||
13146777|NCT02592434|26035793|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
13146778|NCT02592434|26035794|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
13146779|NCT02592434|26035795|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1|||
13146780|NCT02592434|26035793|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
13146781|NCT02592434|26035794|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1|||
13146782|NCT02592434|26035795|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
13146783|NCT02592434|26035793|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
13146784|NCT02592434|26035794|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1|||
13146785|NCT02592434|26035795|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
13146786|NCT02592018|26035812|FG000|Overall Study|Adverse Event|1|||
13146787|NCT02592018|26035812|FG000|Overall Study|Lost to Follow-up|1|||
13146788|NCT02591290|26035820|FG000|Overall Study|Withdrawal by Subject|2|||
13146789|NCT02591238|26035863|FG000|Overall Study|Pregnancy|1|||
13146790|NCT02591238|26035864|FG001|Overall Study|Pregnancy|0|||
13146791|NCT02591238|26035865|FG002|Overall Study|Pregnancy|0|||
13146792|NCT02591238|26035866|FG003|Overall Study|Pregnancy|0|||
13146793|NCT02591238|26035863|FG000|Overall Study|Withdrawal by Subject|0|||
13146794|NCT02591238|26035864|FG001|Overall Study|Withdrawal by Subject|0|||
13146795|NCT02591238|26035865|FG002|Overall Study|Withdrawal by Subject|0|||
13146796|NCT02591238|26035866|FG003|Overall Study|Withdrawal by Subject|1|||
13146797|NCT02591238|26035863|FG000|Overall Study|influenza|0|||
13146798|NCT02591238|26035864|FG001|Overall Study|influenza|0|||
13146799|NCT02591238|26035865|FG002|Overall Study|influenza|0|||
13146800|NCT02591238|26035866|FG003|Overall Study|influenza|1|||
13146801|NCT02591238|26035863|FG000|Overall Study|personal circumstances|0|||
13146802|NCT02591238|26035864|FG001|Overall Study|personal circumstances|0|||
13146803|NCT02591238|26035865|FG002|Overall Study|personal circumstances|0|||
13146804|NCT02591238|26035866|FG003|Overall Study|personal circumstances|1|||
13146805|NCT02591238|26035863|FG000|Overall Study|personal circumstances|0|||
13146806|NCT02591238|26035864|FG001|Overall Study|personal circumstances|1|||
13146807|NCT02591238|26035865|FG002|Overall Study|personal circumstances|0|||
13146808|NCT02591238|26035866|FG003|Overall Study|personal circumstances|0|||
13146809|NCT02590939|26035893|FG000|Overall Study|Withdrawal by Subject|3|||
13146810|NCT02590939|26035894|FG001|Overall Study|Withdrawal by Subject|1|||
13146811|NCT02590939|26035893|FG000|Overall Study|Failed the nociceptive test|2|||
13146812|NCT02590939|26035894|FG001|Overall Study|Failed the nociceptive test|1|||
13146813|NCT02590588|26035904|FG000|Overall Study|Adverse Event|1|||
13146814|NCT02590562|26035963|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6|||
13146815|NCT02590432|26036011|FG000|Open-label Treatment Period|Adverse Event|97|||
13146816|NCT02590432|26036012|FG001|Open-label Treatment Period|Adverse Event|79|||
13146817|NCT02590432|26036013|FG002|Open-label Treatment Period|Adverse Event|0|||
13146818|NCT02590432|26036014|FG003|Open-label Treatment Period|Adverse Event|0|||
13146819|NCT02590432|26036015|FG004|Open-label Treatment Period|Adverse Event|0|||
13146820|NCT02590432|26036016|FG005|Open-label Treatment Period|Adverse Event|0|||
13146821|NCT02590432|26036017|FG006|Open-label Treatment Period|Adverse Event|0|||
13146822|NCT02590432|26036018|FG007|Open-label Treatment Period|Adverse Event|0|||
13146823|NCT02590432|26036019|FG008|Open-label Treatment Period|Adverse Event|0|||
13146824|NCT02590432|26036011|FG000|Open-label Treatment Period|Lack of Efficacy|14|||
13146825|NCT02590432|26036012|FG001|Open-label Treatment Period|Lack of Efficacy|5|||
13146826|NCT02590432|26036013|FG002|Open-label Treatment Period|Lack of Efficacy|0|||
13146827|NCT02590432|26036014|FG003|Open-label Treatment Period|Lack of Efficacy|0|||
13146828|NCT02590432|26036015|FG004|Open-label Treatment Period|Lack of Efficacy|0|||
13146829|NCT02590432|26036016|FG005|Open-label Treatment Period|Lack of Efficacy|0|||
13146830|NCT02590432|26036017|FG006|Open-label Treatment Period|Lack of Efficacy|0|||
13146831|NCT02590432|26036018|FG007|Open-label Treatment Period|Lack of Efficacy|0|||
13146832|NCT02590432|26036019|FG008|Open-label Treatment Period|Lack of Efficacy|0|||
13146833|NCT02590432|26036011|FG000|Open-label Treatment Period|Withdrawal of Consent|43|||
13146834|NCT02590432|26036012|FG001|Open-label Treatment Period|Withdrawal of Consent|28|||
13146835|NCT02590432|26036013|FG002|Open-label Treatment Period|Withdrawal of Consent|0|||
13146836|NCT02590432|26036014|FG003|Open-label Treatment Period|Withdrawal of Consent|0|||
13146837|NCT02590432|26036015|FG004|Open-label Treatment Period|Withdrawal of Consent|0|||
13146838|NCT02590432|26036016|FG005|Open-label Treatment Period|Withdrawal of Consent|0|||
13146839|NCT02590432|26036017|FG006|Open-label Treatment Period|Withdrawal of Consent|0|||
13146840|NCT02590432|26036018|FG007|Open-label Treatment Period|Withdrawal of Consent|0|||
13146841|NCT02590432|26036019|FG008|Open-label Treatment Period|Withdrawal of Consent|0|||
13146842|NCT02590432|26036011|FG000|Open-label Treatment Period|Lost to Follow-up|51|||
13146843|NCT02590432|26036012|FG001|Open-label Treatment Period|Lost to Follow-up|29|||
13146844|NCT02590432|26036013|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
13146845|NCT02590432|26036014|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
13146846|NCT02590432|26036015|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
13146847|NCT02590432|26036016|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
13146848|NCT02590432|26036017|FG006|Open-label Treatment Period|Lost to Follow-up|0|||
13146849|NCT02590432|26036018|FG007|Open-label Treatment Period|Lost to Follow-up|0|||
13146850|NCT02590432|26036019|FG008|Open-label Treatment Period|Lost to Follow-up|0|||
13146851|NCT02590432|26036011|FG000|Open-label Treatment Period|Protocol Violation|10|||
13146852|NCT02590432|26036012|FG001|Open-label Treatment Period|Protocol Violation|4|||
13146853|NCT02590432|26036013|FG002|Open-label Treatment Period|Protocol Violation|0|||
13146854|NCT02590432|26036014|FG003|Open-label Treatment Period|Protocol Violation|0|||
13146855|NCT02590432|26036015|FG004|Open-label Treatment Period|Protocol Violation|0|||
13146856|NCT02590432|26036016|FG005|Open-label Treatment Period|Protocol Violation|0|||
13146857|NCT02590432|26036017|FG006|Open-label Treatment Period|Protocol Violation|0|||
13146858|NCT02590432|26036018|FG007|Open-label Treatment Period|Protocol Violation|0|||
13146859|NCT02590432|26036019|FG008|Open-label Treatment Period|Protocol Violation|0|||
13146860|NCT02590432|26036011|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7|||
13146861|NCT02590432|26036012|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1|||
13146862|NCT02590432|26036013|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0|||
13146863|NCT02590432|26036014|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0|||
13146864|NCT02590432|26036015|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0|||
13146865|NCT02590432|26036016|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0|||
13146866|NCT02590432|26036017|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0|||
13146867|NCT02590432|26036018|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0|||
13146868|NCT02590432|26036019|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0|||
13146869|NCT02590432|26036011|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10|||
13146870|NCT02590432|26036012|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6|||
13146871|NCT02590432|26036013|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
13146872|NCT02590432|26036014|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
13146873|NCT02590432|26036015|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
13146874|NCT02590432|26036016|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
13146875|NCT02590432|26036017|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
13146876|NCT02590432|26036018|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
13146877|NCT02590432|26036019|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
13146878|NCT02590432|26036011|FG000|Double-blind Treatment Period|Adverse Event|0|||
13146879|NCT02590432|26036012|FG001|Double-blind Treatment Period|Adverse Event|0|||
13146880|NCT02590432|26036013|FG002|Double-blind Treatment Period|Adverse Event|14|||
13146881|NCT02590432|26036014|FG003|Double-blind Treatment Period|Adverse Event|12|||
13146882|NCT02590432|26036015|FG004|Double-blind Treatment Period|Adverse Event|6|||
13146883|NCT02590432|26036016|FG005|Double-blind Treatment Period|Adverse Event|22|||
13146884|NCT02590432|26036017|FG006|Double-blind Treatment Period|Adverse Event|20|||
13146885|NCT02590432|26036018|FG007|Double-blind Treatment Period|Adverse Event|0|||
13146886|NCT02590432|26036019|FG008|Double-blind Treatment Period|Adverse Event|0|||
13146887|NCT02590432|26036011|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
13146888|NCT02590432|26036012|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
13146889|NCT02590432|26036013|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
13146890|NCT02590432|26036014|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
13146891|NCT02590432|26036015|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
13146892|NCT02590432|26036016|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
13146893|NCT02590432|26036017|FG006|Double-blind Treatment Period|Lack of Efficacy|0|||
13146894|NCT02590432|26036018|FG007|Double-blind Treatment Period|Lack of Efficacy|0|||
13146895|NCT02590432|26036019|FG008|Double-blind Treatment Period|Lack of Efficacy|0|||
13146896|NCT02590432|26036011|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
13146897|NCT02590432|26036012|FG001|Double-blind Treatment Period|Withdrawal of Consent|0|||
13146898|NCT02590432|26036013|FG002|Double-blind Treatment Period|Withdrawal of Consent|1|||
13146899|NCT02590432|26036014|FG003|Double-blind Treatment Period|Withdrawal of Consent|3|||
13146900|NCT02590432|26036015|FG004|Double-blind Treatment Period|Withdrawal of Consent|3|||
13146901|NCT02590432|26036016|FG005|Double-blind Treatment Period|Withdrawal of Consent|1|||
13146902|NCT02590432|26036017|FG006|Double-blind Treatment Period|Withdrawal of Consent|1|||
13146903|NCT02590432|26036018|FG007|Double-blind Treatment Period|Withdrawal of Consent|0|||
13146904|NCT02590432|26036019|FG008|Double-blind Treatment Period|Withdrawal of Consent|0|||
13146905|NCT02590432|26036011|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
13146906|NCT02590432|26036012|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
13146907|NCT02590432|26036013|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
13146908|NCT02590432|26036014|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
13146909|NCT02590432|26036015|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
13146910|NCT02590432|26036016|FG005|Double-blind Treatment Period|Lost to Follow-up|2|||
13146911|NCT02590432|26036017|FG006|Double-blind Treatment Period|Lost to Follow-up|0|||
13146912|NCT02590432|26036018|FG007|Double-blind Treatment Period|Lost to Follow-up|0|||
13146913|NCT02590432|26036019|FG008|Double-blind Treatment Period|Lost to Follow-up|0|||
13146914|NCT02590432|26036011|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
13146915|NCT02590432|26036012|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
13146916|NCT02590432|26036013|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
13146917|NCT02590432|26036014|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
13146918|NCT02590432|26036015|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
13146919|NCT02590432|26036016|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1|||
13146920|NCT02590432|26036017|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
13146921|NCT02590432|26036018|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
13146922|NCT02590432|26036019|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
13146923|NCT02590432|26036011|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
13146924|NCT02590432|26036012|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
13146925|NCT02590432|26036013|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
13146926|NCT02590432|26036014|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
13146927|NCT02590432|26036015|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
13146928|NCT02590432|26036016|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
13146929|NCT02590432|26036017|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
13146930|NCT02590432|26036018|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12|||
13146931|NCT02590432|26036019|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15|||
13146932|NCT02590432|26036011|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
13146933|NCT02590432|26036012|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
13146934|NCT02590432|26036013|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
13146935|NCT02590432|26036014|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
13146936|NCT02590432|26036015|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
13146937|NCT02590432|26036016|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
13146938|NCT02590432|26036017|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
13146939|NCT02590432|26036018|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1|||
13146940|NCT02590432|26036019|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
13146941|NCT02590432|26036011|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
13146942|NCT02590432|26036012|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
13146943|NCT02590432|26036013|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
13146944|NCT02590432|26036014|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
13146945|NCT02590432|26036015|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
13146946|NCT02590432|26036016|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
13093273|NCT03670810|25832168|FG007|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
13093274|NCT03670810|25832169|FG008|Open Label Extension|Taking medication too restrictive for lifestyle|1|||
13093275|NCT03670810|25832161|FG000|Open Label Extension|Withdrawal by Subject|0|||
13093276|NCT03670810|25832162|FG001|Open Label Extension|Withdrawal by Subject|0|||
13093277|NCT03670810|25832163|FG002|Open Label Extension|Withdrawal by Subject|0|||
13093278|NCT03670810|25832164|FG003|Open Label Extension|Withdrawal by Subject|0|||
13093279|NCT03670810|25832165|FG004|Open Label Extension|Withdrawal by Subject|0|||
13093280|NCT03670810|25832166|FG005|Open Label Extension|Withdrawal by Subject|0|||
13093281|NCT03670810|25832167|FG006|Open Label Extension|Withdrawal by Subject|0|||
13093282|NCT03670810|25832168|FG007|Open Label Extension|Withdrawal by Subject|0|||
13093283|NCT03670810|25832169|FG008|Open Label Extension|Withdrawal by Subject|46|||
13093284|NCT03670810|25832161|FG000|Open Label Extension|Participant didn't have disposition for OLE period|0|||
13093285|NCT03670810|25832162|FG001|Open Label Extension|Participant didn't have disposition for OLE period|0|||
13093286|NCT03670810|25832163|FG002|Open Label Extension|Participant didn't have disposition for OLE period|0|||
13093287|NCT03670810|25832164|FG003|Open Label Extension|Participant didn't have disposition for OLE period|0|||
13093288|NCT03670810|25832165|FG004|Open Label Extension|Participant didn't have disposition for OLE period|0|||
13093289|NCT03670810|25832166|FG005|Open Label Extension|Participant didn't have disposition for OLE period|0|||
13093290|NCT03670810|25832167|FG006|Open Label Extension|Participant didn't have disposition for OLE period|0|||
13093291|NCT03670810|25832168|FG007|Open Label Extension|Participant didn't have disposition for OLE period|0|||
13093292|NCT03670810|25832169|FG008|Open Label Extension|Participant didn't have disposition for OLE period|1|||
13146947|NCT02590432|26036017|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
13146948|NCT02590432|26036018|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3|||
13146949|NCT02590432|26036019|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1|||
13146950|NCT02590432|26036011|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
13146951|NCT02590432|26036012|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
13146952|NCT02590432|26036013|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
13146953|NCT02590432|26036014|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
13146954|NCT02590432|26036015|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
13146955|NCT02590432|26036016|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
13146956|NCT02590432|26036017|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
13146957|NCT02590432|26036018|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
13146958|NCT02590432|26036019|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1|||
13146959|NCT02590432|26036011|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
13146960|NCT02590432|26036012|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
13146961|NCT02590432|26036013|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
13146962|NCT02590432|26036014|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
13146963|NCT02590432|26036015|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
13146964|NCT02590432|26036016|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
13146965|NCT02590432|26036017|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
13146966|NCT02590432|26036018|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
13146967|NCT02590432|26036019|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1|||
13146968|NCT02590432|26036011|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
13146969|NCT02590432|26036012|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
13146970|NCT02590432|26036013|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
13146971|NCT02590432|26036014|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
13146972|NCT02590432|26036015|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
13146973|NCT02590432|26036016|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
13146974|NCT02590432|26036017|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
13146975|NCT02590432|26036018|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1|||
13146976|NCT02590432|26036019|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
13146977|NCT02590432|26036011|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
13146978|NCT02590432|26036012|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
13146979|NCT02590432|26036013|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
13146980|NCT02590432|26036014|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
13146981|NCT02590432|26036015|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
13146982|NCT02590432|26036016|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
13146983|NCT02590432|26036017|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
13146984|NCT02590432|26036018|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1|||
13146985|NCT02590432|26036019|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
13146986|NCT02590406|26036040|FG000|Overall Study|Adverse Event|1|||
13146987|NCT02590406|26036041|FG001|Overall Study|Adverse Event|0|||
13146988|NCT02590406|26036040|FG000|Overall Study|Saturometer malfunction|0|||
13146989|NCT02590406|26036041|FG001|Overall Study|Saturometer malfunction|1|||
13146990|NCT02590354|26036051|FG000|Phase 1|Active hepatitis B or C infection|1|||
13146991|NCT02590354|26036051|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1|||
13146992|NCT02590354|26036051|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75|||
13146993|NCT02590354|26036051|FG000|Phase 1|Subject does not want to participate|20|||
13146994|NCT02590354|26036051|FG000|Phase 1|Lost to Follow-up|1|||
13146995|NCT02590354|26036051|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2|||
13146996|NCT02590003|26036078|FG000|Overall Study|Death|1|||
13146997|NCT02590003|26036079|FG001|Overall Study|Death|2|||
13146998|NCT02589665|26036160|FG000|Induction Period|Did not receive drug|0|||
13146999|NCT02589665|26036161|FG001|Induction Period|Did not receive drug|0|||
13147000|NCT02589665|26036162|FG002|Induction Period|Did not receive drug|0|||
13147001|NCT02589665|26036163|FG003|Induction Period|Did not receive drug|1|||
13147002|NCT02589665|26036164|FG004|Induction Period|Did not receive drug|0|||
13147003|NCT02589665|26036165|FG005|Induction Period|Did not receive drug|0|||
13147004|NCT02589665|26036166|FG006|Induction Period|Did not receive drug|0|||
13147005|NCT02589665|26036167|FG007|Induction Period|Did not receive drug|0|||
13147006|NCT02589665|26036168|FG008|Induction Period|Did not receive drug|0|||
13147007|NCT02589665|26036169|FG009|Induction Period|Did not receive drug|0|||
13147008|NCT02589665|26036160|FG000|Induction Period|Adverse Event|3|||
13147009|NCT02589665|26036161|FG001|Induction Period|Adverse Event|0|||
13147010|NCT02589665|26036162|FG002|Induction Period|Adverse Event|2|||
13147011|NCT02589665|26036163|FG003|Induction Period|Adverse Event|2|||
13147012|NCT02589665|26036164|FG004|Induction Period|Adverse Event|0|||
13147013|NCT02589665|26036165|FG005|Induction Period|Adverse Event|0|||
13147014|NCT02589665|26036166|FG006|Induction Period|Adverse Event|0|||
13147015|NCT02589665|26036167|FG007|Induction Period|Adverse Event|0|||
13147016|NCT02589665|26036168|FG008|Induction Period|Adverse Event|0|||
13147017|NCT02589665|26036169|FG009|Induction Period|Adverse Event|0|||
13147018|NCT02589665|26036160|FG000|Induction Period|Withdrawal by Subject|0|||
13147019|NCT02589665|26036161|FG001|Induction Period|Withdrawal by Subject|1|||
13147020|NCT02589665|26036162|FG002|Induction Period|Withdrawal by Subject|0|||
13147021|NCT02589665|26036163|FG003|Induction Period|Withdrawal by Subject|1|||
13147022|NCT02589665|26036164|FG004|Induction Period|Withdrawal by Subject|0|||
13147023|NCT02589665|26036165|FG005|Induction Period|Withdrawal by Subject|0|||
13147024|NCT02589665|26036166|FG006|Induction Period|Withdrawal by Subject|0|||
13147025|NCT02589665|26036167|FG007|Induction Period|Withdrawal by Subject|0|||
13147026|NCT02589665|26036168|FG008|Induction Period|Withdrawal by Subject|0|||
13147027|NCT02589665|26036169|FG009|Induction Period|Withdrawal by Subject|0|||
13147028|NCT02589665|26036160|FG000|Induction Period|Protocol Violation|0|||
13147029|NCT02589665|26036161|FG001|Induction Period|Protocol Violation|1|||
13147030|NCT02589665|26036162|FG002|Induction Period|Protocol Violation|0|||
13147031|NCT02589665|26036163|FG003|Induction Period|Protocol Violation|0|||
13147032|NCT02589665|26036164|FG004|Induction Period|Protocol Violation|0|||
13147033|NCT02589665|26036165|FG005|Induction Period|Protocol Violation|0|||
13147034|NCT02589665|26036166|FG006|Induction Period|Protocol Violation|0|||
13147035|NCT02589665|26036167|FG007|Induction Period|Protocol Violation|0|||
13147036|NCT02589665|26036168|FG008|Induction Period|Protocol Violation|0|||
13147037|NCT02589665|26036169|FG009|Induction Period|Protocol Violation|0|||
13147038|NCT02589665|26036160|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
13147039|NCT02589665|26036161|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
13147040|NCT02589665|26036162|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
13147041|NCT02589665|26036163|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
13147042|NCT02589665|26036164|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7|||
13147043|NCT02589665|26036165|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41|||
13147044|NCT02589665|26036166|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39|||
13147045|NCT02589665|26036167|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
13147046|NCT02589665|26036168|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
13147047|NCT02589665|26036169|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
13147048|NCT02589665|26036160|FG000|Maintenance Period|Withdrawal by Subject|0|||
13147049|NCT02589665|26036161|FG001|Maintenance Period|Withdrawal by Subject|0|||
13147050|NCT02589665|26036162|FG002|Maintenance Period|Withdrawal by Subject|0|||
13147051|NCT02589665|26036163|FG003|Maintenance Period|Withdrawal by Subject|0|||
13147052|NCT02589665|26036164|FG004|Maintenance Period|Withdrawal by Subject|4|||
13147053|NCT02589665|26036165|FG005|Maintenance Period|Withdrawal by Subject|2|||
13147054|NCT02589665|26036166|FG006|Maintenance Period|Withdrawal by Subject|4|||
13147055|NCT02589665|26036167|FG007|Maintenance Period|Withdrawal by Subject|0|||
13147056|NCT02589665|26036168|FG008|Maintenance Period|Withdrawal by Subject|0|||
13147057|NCT02589665|26036169|FG009|Maintenance Period|Withdrawal by Subject|0|||
13147058|NCT02589665|26036160|FG000|Maintenance Period|Lack of Efficacy|0|||
13147059|NCT02589665|26036161|FG001|Maintenance Period|Lack of Efficacy|0|||
13147060|NCT02589665|26036162|FG002|Maintenance Period|Lack of Efficacy|0|||
13147061|NCT02589665|26036163|FG003|Maintenance Period|Lack of Efficacy|0|||
13147062|NCT02589665|26036164|FG004|Maintenance Period|Lack of Efficacy|2|||
13147063|NCT02589665|26036165|FG005|Maintenance Period|Lack of Efficacy|1|||
13147064|NCT02589665|26036166|FG006|Maintenance Period|Lack of Efficacy|0|||
13147065|NCT02589665|26036167|FG007|Maintenance Period|Lack of Efficacy|0|||
13147066|NCT02589665|26036168|FG008|Maintenance Period|Lack of Efficacy|0|||
13147067|NCT02589665|26036169|FG009|Maintenance Period|Lack of Efficacy|0|||
13147068|NCT02589665|26036160|FG000|Maintenance Period|Adverse Event|0|||
13147069|NCT02589665|26036161|FG001|Maintenance Period|Adverse Event|0|||
13147070|NCT02589665|26036162|FG002|Maintenance Period|Adverse Event|0|||
13147071|NCT02589665|26036163|FG003|Maintenance Period|Adverse Event|0|||
13093293|NCT03670810|25832161|FG000|Open Label Extension|Physician Decision|0|||
13093294|NCT03670810|25832162|FG001|Open Label Extension|Physician Decision|0|||
13093295|NCT03670810|25832163|FG002|Open Label Extension|Physician Decision|0|||
13093296|NCT03670810|25832164|FG003|Open Label Extension|Physician Decision|0|||
13093297|NCT03670810|25832165|FG004|Open Label Extension|Physician Decision|0|||
13093298|NCT03670810|25832166|FG005|Open Label Extension|Physician Decision|0|||
13093299|NCT03670810|25832167|FG006|Open Label Extension|Physician Decision|0|||
13093300|NCT03670810|25832168|FG007|Open Label Extension|Physician Decision|0|||
13093301|NCT03670810|25832169|FG008|Open Label Extension|Physician Decision|2|||
13093302|NCT03670810|25832161|FG000|Open Label Extension|Non-compliance with study drug|0|||
13093303|NCT03670810|25832162|FG001|Open Label Extension|Non-compliance with study drug|0|||
13093304|NCT03670810|25832163|FG002|Open Label Extension|Non-compliance with study drug|0|||
13093305|NCT03670810|25832164|FG003|Open Label Extension|Non-compliance with study drug|0|||
13093306|NCT03670810|25832165|FG004|Open Label Extension|Non-compliance with study drug|0|||
13093307|NCT03670810|25832166|FG005|Open Label Extension|Non-compliance with study drug|0|||
13147072|NCT02589665|26036164|FG004|Maintenance Period|Adverse Event|0|||
13147073|NCT02589665|26036165|FG005|Maintenance Period|Adverse Event|0|||
13147074|NCT02589665|26036166|FG006|Maintenance Period|Adverse Event|2|||
13147075|NCT02589665|26036167|FG007|Maintenance Period|Adverse Event|0|||
13147076|NCT02589665|26036168|FG008|Maintenance Period|Adverse Event|0|||
13147077|NCT02589665|26036169|FG009|Maintenance Period|Adverse Event|0|||
13147078|NCT02589665|26036160|FG000|Maintenance Period|Lost to Follow-up|0|||
13147079|NCT02589665|26036161|FG001|Maintenance Period|Lost to Follow-up|0|||
13147080|NCT02589665|26036162|FG002|Maintenance Period|Lost to Follow-up|0|||
13147081|NCT02589665|26036163|FG003|Maintenance Period|Lost to Follow-up|0|||
13147082|NCT02589665|26036164|FG004|Maintenance Period|Lost to Follow-up|0|||
13147083|NCT02589665|26036165|FG005|Maintenance Period|Lost to Follow-up|1|||
13147084|NCT02589665|26036166|FG006|Maintenance Period|Lost to Follow-up|0|||
13147085|NCT02589665|26036167|FG007|Maintenance Period|Lost to Follow-up|0|||
13147086|NCT02589665|26036168|FG008|Maintenance Period|Lost to Follow-up|0|||
13147087|NCT02589665|26036169|FG009|Maintenance Period|Lost to Follow-up|0|||
13147088|NCT02589665|26036160|FG000|Maintenance Period|Physician Decision|0|||
13147089|NCT02589665|26036161|FG001|Maintenance Period|Physician Decision|0|||
13147090|NCT02589665|26036162|FG002|Maintenance Period|Physician Decision|0|||
13147091|NCT02589665|26036163|FG003|Maintenance Period|Physician Decision|0|||
13147092|NCT02589665|26036164|FG004|Maintenance Period|Physician Decision|0|||
13147093|NCT02589665|26036165|FG005|Maintenance Period|Physician Decision|1|||
13147094|NCT02589665|26036166|FG006|Maintenance Period|Physician Decision|0|||
13147095|NCT02589665|26036167|FG007|Maintenance Period|Physician Decision|0|||
13147096|NCT02589665|26036168|FG008|Maintenance Period|Physician Decision|0|||
13147097|NCT02589665|26036169|FG009|Maintenance Period|Physician Decision|0|||
13147098|NCT02589665|26036160|FG000|Maintenance Period|Reason Not Collected|0|||
13147099|NCT02589665|26036161|FG001|Maintenance Period|Reason Not Collected|0|||
13147100|NCT02589665|26036162|FG002|Maintenance Period|Reason Not Collected|0|||
13147101|NCT02589665|26036163|FG003|Maintenance Period|Reason Not Collected|0|||
13147102|NCT02589665|26036164|FG004|Maintenance Period|Reason Not Collected|0|||
13147103|NCT02589665|26036165|FG005|Maintenance Period|Reason Not Collected|1|||
13147104|NCT02589665|26036166|FG006|Maintenance Period|Reason Not Collected|1|||
13147105|NCT02589665|26036167|FG007|Maintenance Period|Reason Not Collected|0|||
13147106|NCT02589665|26036168|FG008|Maintenance Period|Reason Not Collected|0|||
13147107|NCT02589665|26036169|FG009|Maintenance Period|Reason Not Collected|0|||
13147108|NCT02589665|26036160|FG000|Induction Extension Period|Adverse Event|0|||
13147109|NCT02589665|26036161|FG001|Induction Extension Period|Adverse Event|0|||
13147110|NCT02589665|26036162|FG002|Induction Extension Period|Adverse Event|0|||
13147111|NCT02589665|26036163|FG003|Induction Extension Period|Adverse Event|0|||
13147112|NCT02589665|26036164|FG004|Induction Extension Period|Adverse Event|0|||
13147113|NCT02589665|26036165|FG005|Induction Extension Period|Adverse Event|0|||
13147114|NCT02589665|26036166|FG006|Induction Extension Period|Adverse Event|0|||
13147115|NCT02589665|26036167|FG007|Induction Extension Period|Adverse Event|0|||
13147116|NCT02589665|26036168|FG008|Induction Extension Period|Adverse Event|4|||
13147117|NCT02589665|26036169|FG009|Induction Extension Period|Adverse Event|0|||
13147118|NCT02589665|26036160|FG000|Induction Extension Period|Lack of Efficacy|0|||
13147119|NCT02589665|26036161|FG001|Induction Extension Period|Lack of Efficacy|0|||
13147120|NCT02589665|26036162|FG002|Induction Extension Period|Lack of Efficacy|0|||
13147121|NCT02589665|26036163|FG003|Induction Extension Period|Lack of Efficacy|0|||
13147122|NCT02589665|26036164|FG004|Induction Extension Period|Lack of Efficacy|0|||
13147123|NCT02589665|26036165|FG005|Induction Extension Period|Lack of Efficacy|0|||
13147124|NCT02589665|26036166|FG006|Induction Extension Period|Lack of Efficacy|0|||
13147125|NCT02589665|26036167|FG007|Induction Extension Period|Lack of Efficacy|0|||
13147126|NCT02589665|26036168|FG008|Induction Extension Period|Lack of Efficacy|3|||
13147127|NCT02589665|26036169|FG009|Induction Extension Period|Lack of Efficacy|0|||
13147128|NCT02589665|26036160|FG000|Induction Extension Period|Withdrawal by Subject|0|||
13147129|NCT02589665|26036161|FG001|Induction Extension Period|Withdrawal by Subject|0|||
13147130|NCT02589665|26036162|FG002|Induction Extension Period|Withdrawal by Subject|0|||
13147131|NCT02589665|26036163|FG003|Induction Extension Period|Withdrawal by Subject|0|||
13147132|NCT02589665|26036164|FG004|Induction Extension Period|Withdrawal by Subject|0|||
13147133|NCT02589665|26036165|FG005|Induction Extension Period|Withdrawal by Subject|0|||
13147134|NCT02589665|26036166|FG006|Induction Extension Period|Withdrawal by Subject|0|||
13147135|NCT02589665|26036167|FG007|Induction Extension Period|Withdrawal by Subject|2|||
13147136|NCT02589665|26036168|FG008|Induction Extension Period|Withdrawal by Subject|3|||
13147137|NCT02589665|26036169|FG009|Induction Extension Period|Withdrawal by Subject|0|||
13147138|NCT02589665|26036160|FG000|Induction Extension Period|Physician Decision|0|||
13147139|NCT02589665|26036161|FG001|Induction Extension Period|Physician Decision|0|||
13147140|NCT02589665|26036162|FG002|Induction Extension Period|Physician Decision|0|||
13147141|NCT02589665|26036163|FG003|Induction Extension Period|Physician Decision|0|||
13147142|NCT02589665|26036164|FG004|Induction Extension Period|Physician Decision|0|||
13147143|NCT02589665|26036165|FG005|Induction Extension Period|Physician Decision|0|||
13147144|NCT02589665|26036166|FG006|Induction Extension Period|Physician Decision|0|||
13147145|NCT02589665|26036167|FG007|Induction Extension Period|Physician Decision|0|||
13147146|NCT02589665|26036168|FG008|Induction Extension Period|Physician Decision|1|||
13147147|NCT02589665|26036169|FG009|Induction Extension Period|Physician Decision|0|||
13147148|NCT02589665|26036160|FG000|Induction Extension Period|Reason Not Collected|0|||
13147149|NCT02589665|26036161|FG001|Induction Extension Period|Reason Not Collected|0|||
13147150|NCT02589665|26036162|FG002|Induction Extension Period|Reason Not Collected|0|||
13147151|NCT02589665|26036163|FG003|Induction Extension Period|Reason Not Collected|0|||
13147152|NCT02589665|26036164|FG004|Induction Extension Period|Reason Not Collected|0|||
13147153|NCT02589665|26036165|FG005|Induction Extension Period|Reason Not Collected|0|||
13147154|NCT02589665|26036166|FG006|Induction Extension Period|Reason Not Collected|0|||
13147155|NCT02589665|26036167|FG007|Induction Extension Period|Reason Not Collected|0|||
13147156|NCT02589665|26036168|FG008|Induction Extension Period|Reason Not Collected|1|||
13147157|NCT02589665|26036169|FG009|Induction Extension Period|Reason Not Collected|0|||
13147158|NCT02589665|26036160|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
13147159|NCT02589665|26036161|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
13147160|NCT02589665|26036162|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
13147161|NCT02589665|26036163|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
13147162|NCT02589665|26036164|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
13147163|NCT02589665|26036165|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
13147164|NCT02589665|26036166|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
13147165|NCT02589665|26036167|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
13147166|NCT02589665|26036168|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
13147167|NCT02589665|26036169|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57|||
13147168|NCT02589665|26036160|FG000|Maintenance Extension Period|Withdrawal by Subject|0|||
13147169|NCT02589665|26036161|FG001|Maintenance Extension Period|Withdrawal by Subject|0|||
13147170|NCT02589665|26036162|FG002|Maintenance Extension Period|Withdrawal by Subject|0|||
13147171|NCT02589665|26036163|FG003|Maintenance Extension Period|Withdrawal by Subject|0|||
13147172|NCT02589665|26036164|FG004|Maintenance Extension Period|Withdrawal by Subject|0|||
13147173|NCT02589665|26036165|FG005|Maintenance Extension Period|Withdrawal by Subject|0|||
13147174|NCT02589665|26036166|FG006|Maintenance Extension Period|Withdrawal by Subject|0|||
13147175|NCT02589665|26036167|FG007|Maintenance Extension Period|Withdrawal by Subject|0|||
13147176|NCT02589665|26036168|FG008|Maintenance Extension Period|Withdrawal by Subject|0|||
13147177|NCT02589665|26036169|FG009|Maintenance Extension Period|Withdrawal by Subject|4|||
13147178|NCT02589665|26036160|FG000|Maintenance Extension Period|Lack of Efficacy|0|||
13147179|NCT02589665|26036161|FG001|Maintenance Extension Period|Lack of Efficacy|0|||
13147180|NCT02589665|26036162|FG002|Maintenance Extension Period|Lack of Efficacy|0|||
13147181|NCT02589665|26036163|FG003|Maintenance Extension Period|Lack of Efficacy|0|||
13147182|NCT02589665|26036164|FG004|Maintenance Extension Period|Lack of Efficacy|0|||
13093308|NCT03670810|25832167|FG006|Open Label Extension|Non-compliance with study drug|0|||
13093309|NCT03670810|25832168|FG007|Open Label Extension|Non-compliance with study drug|0|||
13093310|NCT03670810|25832169|FG008|Open Label Extension|Non-compliance with study drug|5|||
13093311|NCT03670810|25832161|FG000|Open Label Extension|Pregnancy|0|||
13093312|NCT03670810|25832162|FG001|Open Label Extension|Pregnancy|0|||
13093313|NCT03670810|25832163|FG002|Open Label Extension|Pregnancy|0|||
13093314|NCT03670810|25832164|FG003|Open Label Extension|Pregnancy|0|||
13093315|NCT03670810|25832165|FG004|Open Label Extension|Pregnancy|0|||
13093316|NCT03670810|25832166|FG005|Open Label Extension|Pregnancy|0|||
13093317|NCT03670810|25832167|FG006|Open Label Extension|Pregnancy|0|||
13093318|NCT03670810|25832168|FG007|Open Label Extension|Pregnancy|0|||
13093319|NCT03670810|25832169|FG008|Open Label Extension|Pregnancy|3|||
13093320|NCT03670810|25832161|FG000|Open Label Extension|Adverse Event|0|||
13093321|NCT03670810|25832162|FG001|Open Label Extension|Adverse Event|0|||
13093322|NCT03670810|25832163|FG002|Open Label Extension|Adverse Event|0|||
13093323|NCT03670810|25832164|FG003|Open Label Extension|Adverse Event|0|||
13093324|NCT03670810|25832165|FG004|Open Label Extension|Adverse Event|0|||
13093325|NCT03670810|25832166|FG005|Open Label Extension|Adverse Event|0|||
13093326|NCT03670810|25832167|FG006|Open Label Extension|Adverse Event|0|||
13093327|NCT03670810|25832168|FG007|Open Label Extension|Adverse Event|0|||
13093328|NCT03670810|25832169|FG008|Open Label Extension|Adverse Event|24|||
13093329|NCT03670810|25832161|FG000|Open Label Extension|Participant wanted to become pregnant|0|||
13093330|NCT03670810|25832162|FG001|Open Label Extension|Participant wanted to become pregnant|0|||
13147183|NCT02589665|26036165|FG005|Maintenance Extension Period|Lack of Efficacy|0|||
13147184|NCT02589665|26036166|FG006|Maintenance Extension Period|Lack of Efficacy|0|||
13147185|NCT02589665|26036167|FG007|Maintenance Extension Period|Lack of Efficacy|0|||
13147186|NCT02589665|26036168|FG008|Maintenance Extension Period|Lack of Efficacy|0|||
13307575|NCT01284621|26529090|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1|||
13093331|NCT03670810|25832163|FG002|Open Label Extension|Participant wanted to become pregnant|0|||
13093332|NCT03670810|25832164|FG003|Open Label Extension|Participant wanted to become pregnant|0|||
13093333|NCT03670810|25832165|FG004|Open Label Extension|Participant wanted to become pregnant|0|||
13147187|NCT02589665|26036169|FG009|Maintenance Extension Period|Lack of Efficacy|4|||
13147188|NCT02589665|26036160|FG000|Maintenance Extension Period|Adverse Event|0|||
13147189|NCT02589665|26036161|FG001|Maintenance Extension Period|Adverse Event|0|||
13147190|NCT02589665|26036162|FG002|Maintenance Extension Period|Adverse Event|0|||
13147191|NCT02589665|26036163|FG003|Maintenance Extension Period|Adverse Event|0|||
13147192|NCT02589665|26036164|FG004|Maintenance Extension Period|Adverse Event|0|||
13147193|NCT02589665|26036165|FG005|Maintenance Extension Period|Adverse Event|0|||
13147194|NCT02589665|26036166|FG006|Maintenance Extension Period|Adverse Event|0|||
13147195|NCT02589665|26036167|FG007|Maintenance Extension Period|Adverse Event|0|||
13147196|NCT02589665|26036168|FG008|Maintenance Extension Period|Adverse Event|0|||
13147197|NCT02589665|26036169|FG009|Maintenance Extension Period|Adverse Event|2|||
13147198|NCT02589665|26036160|FG000|Maintenance Extension Period|Non-responder|0|||
13147199|NCT02589665|26036161|FG001|Maintenance Extension Period|Non-responder|0|||
13147200|NCT02589665|26036162|FG002|Maintenance Extension Period|Non-responder|0|||
13147201|NCT02589665|26036163|FG003|Maintenance Extension Period|Non-responder|0|||
13147202|NCT02589665|26036164|FG004|Maintenance Extension Period|Non-responder|0|||
13147203|NCT02589665|26036165|FG005|Maintenance Extension Period|Non-responder|0|||
13147204|NCT02589665|26036166|FG006|Maintenance Extension Period|Non-responder|0|||
13147205|NCT02589665|26036167|FG007|Maintenance Extension Period|Non-responder|0|||
13147206|NCT02589665|26036168|FG008|Maintenance Extension Period|Non-responder|0|||
13147207|NCT02589665|26036169|FG009|Maintenance Extension Period|Non-responder|1|||
13147208|NCT02589639|26036190|FG000|Overall Study|Lost to Follow-up|1|||
13147209|NCT02589639|26036191|FG001|Overall Study|Lost to Follow-up|0|||
13147210|NCT02589639|26036192|FG002|Overall Study|Lost to Follow-up|0|||
13147211|NCT02589639|26036190|FG000|Overall Study|Protocol Violation|1|||
13147212|NCT02589639|26036191|FG001|Overall Study|Protocol Violation|0|||
13147213|NCT02589639|26036192|FG002|Overall Study|Protocol Violation|0|||
13147214|NCT02589639|26036190|FG000|Overall Study|Patient withdrawal, not due to AE|3|||
13147215|NCT02589639|26036191|FG001|Overall Study|Patient withdrawal, not due to AE|0|||
13147216|NCT02589639|26036192|FG002|Overall Study|Patient withdrawal, not due to AE|0|||
13147217|NCT02589639|26036190|FG000|Overall Study|Adverse Event|4|||
13147218|NCT02589639|26036191|FG001|Overall Study|Adverse Event|5|||
13147219|NCT02589639|26036192|FG002|Overall Study|Adverse Event|3|||
13147220|NCT02589639|26036190|FG000|Overall Study|Other reason than specified above|1|||
13147221|NCT02589639|26036191|FG001|Overall Study|Other reason than specified above|2|||
13147222|NCT02589639|26036192|FG002|Overall Study|Other reason than specified above|1|||
13147223|NCT02589639|26036190|FG000|Overall Study|Not Treated|0|||
13147224|NCT02589639|26036191|FG001|Overall Study|Not Treated|3|||
13147225|NCT02589639|26036192|FG002|Overall Study|Not Treated|0|||
13147226|NCT02589626|26036207|FG000|Overall Study|Other than the reason specified|1|||
13147227|NCT02589626|26036208|FG001|Overall Study|Other than the reason specified|0|||
13147228|NCT02589626|26036207|FG000|Overall Study|Withdrawal by Subject|1|||
13147229|NCT02589626|26036208|FG001|Overall Study|Withdrawal by Subject|1|||
13147230|NCT02589626|26036207|FG000|Overall Study|Adverse Event|1|||
13147231|NCT02589626|26036208|FG001|Overall Study|Adverse Event|1|||
13147232|NCT02589405|26036214|FG000|Overall Study|Adverse Event|3|||
13147233|NCT02589405|26036214|FG000|Overall Study|Withdrawal by Subject|1|||
13147234|NCT02588833|26036240|FG000|Part 1|Withdrawal by Subject|1|||
13147235|NCT02588833|26036241|FG001|Part 1|Withdrawal by Subject|0|||
13093334|NCT03670810|25832166|FG005|Open Label Extension|Participant wanted to become pregnant|0|||
13147236|NCT02588833|26036240|FG000|Part 2A|Physician Decision|0|||
13147237|NCT02588833|26036241|FG001|Part 2A|Physician Decision|1|||
13147238|NCT02588833|26036240|FG000|Part 2A|Withdrawal by Subject|0|||
13147239|NCT02588833|26036241|FG001|Part 2A|Withdrawal by Subject|1|||
13147240|NCT02588833|26036240|FG000|Part 2B|Adverse Event|0|||
13147241|NCT02588833|26036241|FG001|Part 2B|Adverse Event|1|||
13147242|NCT02588833|26036240|FG000|Part 2C|Adverse Event|0|||
13147243|NCT02588833|26036241|FG001|Part 2C|Adverse Event|1|||
13147244|NCT02588833|26036240|FG000|Part 2C|Withdrawal by Subject|0|||
13093335|NCT03670810|25832167|FG006|Open Label Extension|Participant wanted to become pregnant|0|||
13093336|NCT03670810|25832168|FG007|Open Label Extension|Participant wanted to become pregnant|0|||
13093337|NCT03670810|25832169|FG008|Open Label Extension|Participant wanted to become pregnant|1|||
13093338|NCT03670810|25832161|FG000|Open Label Extension|Lost to Follow-up|0|||
13093339|NCT03670810|25832162|FG001|Open Label Extension|Lost to Follow-up|0|||
13093340|NCT03670810|25832163|FG002|Open Label Extension|Lost to Follow-up|0|||
13093341|NCT03670810|25832164|FG003|Open Label Extension|Lost to Follow-up|0|||
13147245|NCT02588833|26036241|FG001|Part 2C|Withdrawal by Subject|1|||
13147246|NCT02588833|26036240|FG000|Part 3 (Safety Follow-up)|Other|0|||
13093342|NCT03670810|25832165|FG004|Open Label Extension|Lost to Follow-up|0|||
13093343|NCT03670810|25832166|FG005|Open Label Extension|Lost to Follow-up|0|||
13093344|NCT03670810|25832167|FG006|Open Label Extension|Lost to Follow-up|0|||
13093345|NCT03670810|25832168|FG007|Open Label Extension|Lost to Follow-up|0|||
13093346|NCT03670810|25832169|FG008|Open Label Extension|Lost to Follow-up|23|||
13147247|NCT02588833|26036241|FG001|Part 3 (Safety Follow-up)|Other|2|||
13147248|NCT02588664|26036306|FG000|Overall Study|Death|56|||
13093347|NCT03670641|25832180|FG000|Overall Study|Lost to Follow-up|3|||
13093348|NCT03670537|25832186|FG000|Overall Study|Protocol Violation|1|||
13093349|NCT03669861|25832197|FG000|Overall Study|Disease Flare|5|||
13093350|NCT03669861|25832197|FG000|Overall Study|Lack of Efficacy|2|||
13093351|NCT03669588|25832220|FG000|Overall Study|Adverse Event|1|||
13147249|NCT02588664|26036307|FG001|Overall Study|Death|55|||
13147250|NCT02588664|26036306|FG000|Overall Study|Lost to Follow-up|1305|||
13147251|NCT02588664|26036307|FG001|Overall Study|Lost to Follow-up|990|||
13147252|NCT02588612|26036322|FG000|Overall Study|Physician Decision|1|||
13147253|NCT02588612|26036322|FG000|Overall Study|Leukapheresis did not yield enough cells|1|||
13147254|NCT02588612|26036322|FG000|Overall Study|Failed eligibility prior to chemotherapy|2|||
13147255|NCT02588612|26036322|FG000|Overall Study|Death prior to T-cell infusion|1|||
13147256|NCT02588339|26036334|FG000|Overall Study|Withdrawal by Subject|1|||
13147257|NCT02588339|26036334|FG000|Overall Study|GVHD Progression prior to treatment|2|||
13147258|NCT02588261|26036367|FG000|Overall Study|Study Terminated by Sponsor|157|||
13147259|NCT02588261|26036368|FG001|Overall Study|Study Terminated by Sponsor|142|||
13147260|NCT02588261|26036367|FG000|Overall Study|Protocol Deviation|1|||
13147261|NCT02588261|26036368|FG001|Overall Study|Protocol Deviation|0|||
13147262|NCT02588261|26036367|FG000|Overall Study|Death|1|||
13147263|NCT02588261|26036368|FG001|Overall Study|Death|2|||
13147264|NCT02588261|26036367|FG000|Overall Study|Withdrawal by Subject|12|||
13147265|NCT02588261|26036368|FG001|Overall Study|Withdrawal by Subject|8|||
13147266|NCT02588261|26036367|FG000|Overall Study|Noncompliance with Study Drug|0|||
13147267|NCT02588261|26036368|FG001|Overall Study|Noncompliance with Study Drug|1|||
13147268|NCT02588261|26036367|FG000|Overall Study|Miscellaneous|5|||
13147269|NCT02588261|26036368|FG001|Overall Study|Miscellaneous|4|||
13147270|NCT02588261|26036367|FG000|Overall Study|Progressive Disease|61|||
13147271|NCT02588261|26036368|FG001|Overall Study|Progressive Disease|82|||
13147272|NCT02588261|26036367|FG000|Overall Study|Adverse Event|29|||
13147273|NCT02588261|26036368|FG001|Overall Study|Adverse Event|24|||
13147274|NCT02588261|26036367|FG000|Overall Study|Lost to Follow-up|1|||
13093352|NCT03669588|25832221|FG001|Overall Study|Adverse Event|0|||
13093353|NCT03669588|25832220|FG000|Overall Study|Physician Decision|0|||
13093354|NCT03669588|25832221|FG001|Overall Study|Physician Decision|1|||
13093355|NCT03669588|25832220|FG000|Overall Study|Protocol Violation|1|||
13093356|NCT03669588|25832221|FG001|Overall Study|Protocol Violation|0|||
13147275|NCT02588261|26036368|FG001|Overall Study|Lost to Follow-up|0|||
13147276|NCT02588248|26036391|FG000|Overall Study|Physician Decision|4|||
13147277|NCT02588248|26036392|FG001|Overall Study|Physician Decision|3|||
13147278|NCT02588092|26036617|FG000|Overall Study|Death|4|||
13147279|NCT02588092|26036618|FG001|Overall Study|Death|3|||
13147280|NCT02588092|26036619|FG002|Overall Study|Death|3|||
13147281|NCT02588092|26036620|FG003|Overall Study|Death|3|||
13147282|NCT02588092|26036621|FG004|Overall Study|Death|2|||
13147283|NCT02588092|26036622|FG005|Overall Study|Death|2|||
13147284|NCT02588092|26036623|FG006|Overall Study|Death|2|||
13147285|NCT02588092|26036624|FG007|Overall Study|Death|1|||
13147286|NCT02588092|26036625|FG008|Overall Study|Death|5|||
13147287|NCT02588092|26036626|FG009|Overall Study|Death|2|||
13147288|NCT02588092|26036617|FG000|Overall Study|Withdrawal by Subject|0|||
13147289|NCT02588092|26036618|FG001|Overall Study|Withdrawal by Subject|0|||
13147290|NCT02588092|26036619|FG002|Overall Study|Withdrawal by Subject|0|||
13147291|NCT02588092|26036620|FG003|Overall Study|Withdrawal by Subject|0|||
13147292|NCT02588092|26036621|FG004|Overall Study|Withdrawal by Subject|0|||
13147293|NCT02588092|26036622|FG005|Overall Study|Withdrawal by Subject|1|||
13147294|NCT02588092|26036623|FG006|Overall Study|Withdrawal by Subject|1|||
13147295|NCT02588092|26036624|FG007|Overall Study|Withdrawal by Subject|2|||
13147296|NCT02588092|26036625|FG008|Overall Study|Withdrawal by Subject|0|||
13147297|NCT02588092|26036626|FG009|Overall Study|Withdrawal by Subject|0|||
13147298|NCT02588092|26036617|FG000|Overall Study|Started Another Treatment|0|||
13147299|NCT02588092|26036618|FG001|Overall Study|Started Another Treatment|0|||
13147300|NCT02588092|26036619|FG002|Overall Study|Started Another Treatment|0|||
13093357|NCT03669588|25832220|FG000|Overall Study|Sponsor Decision|1|||
13147301|NCT02588092|26036620|FG003|Overall Study|Started Another Treatment|0|||
13093358|NCT03669588|25832221|FG001|Overall Study|Sponsor Decision|1|||
13093359|NCT03669588|25832220|FG000|Overall Study|Withdrawal by Subject|1|||
13147302|NCT02588092|26036621|FG004|Overall Study|Started Another Treatment|1|||
13147303|NCT02588092|26036622|FG005|Overall Study|Started Another Treatment|0|||
13147304|NCT02588092|26036623|FG006|Overall Study|Started Another Treatment|0|||
13147305|NCT02588092|26036624|FG007|Overall Study|Started Another Treatment|1|||
13147306|NCT02588092|26036625|FG008|Overall Study|Started Another Treatment|0|||
13147307|NCT02588092|26036626|FG009|Overall Study|Started Another Treatment|0|||
13147308|NCT02588092|26036617|FG000|Overall Study|Sponsor Decision|0|||
13147309|NCT02588092|26036618|FG001|Overall Study|Sponsor Decision|0|||
13147310|NCT02588092|26036619|FG002|Overall Study|Sponsor Decision|0|||
13147311|NCT02588092|26036620|FG003|Overall Study|Sponsor Decision|0|||
13147312|NCT02588092|26036621|FG004|Overall Study|Sponsor Decision|0|||
13147313|NCT02588092|26036622|FG005|Overall Study|Sponsor Decision|0|||
13147314|NCT02588092|26036623|FG006|Overall Study|Sponsor Decision|0|||
13147315|NCT02588092|26036624|FG007|Overall Study|Sponsor Decision|0|||
13147316|NCT02588092|26036625|FG008|Overall Study|Sponsor Decision|1|||
13147317|NCT02588092|26036626|FG009|Overall Study|Sponsor Decision|1|||
13147318|NCT02587962|26036714|FG000|Overall Study|Adverse Event|0|||
13147319|NCT02587962|26036715|FG001|Overall Study|Adverse Event|0|||
13147320|NCT02587962|26036716|FG002|Overall Study|Adverse Event|1|||
13147321|NCT02587962|26036717|FG003|Overall Study|Adverse Event|0|||
13147322|NCT02587962|26036718|FG004|Overall Study|Adverse Event|0|||
13147323|NCT02587962|26036714|FG000|Overall Study|Withdrawal by Subject|0|||
13147324|NCT02587962|26036715|FG001|Overall Study|Withdrawal by Subject|0|||
13147325|NCT02587962|26036716|FG002|Overall Study|Withdrawal by Subject|1|||
13147326|NCT02587962|26036717|FG003|Overall Study|Withdrawal by Subject|1|||
13147327|NCT02587962|26036718|FG004|Overall Study|Withdrawal by Subject|4|||
13147328|NCT02587962|26036714|FG000|Overall Study|Radiological progression|2|||
13147329|NCT02587962|26036715|FG001|Overall Study|Radiological progression|2|||
13147330|NCT02587962|26036716|FG002|Overall Study|Radiological progression|2|||
13147331|NCT02587962|26036717|FG003|Overall Study|Radiological progression|5|||
13147332|NCT02587962|26036718|FG004|Overall Study|Radiological progression|10|||
13147333|NCT02587962|26036714|FG000|Overall Study|Clinical progression|0|||
13147334|NCT02587962|26036715|FG001|Overall Study|Clinical progression|1|||
13147335|NCT02587962|26036716|FG002|Overall Study|Clinical progression|2|||
13147336|NCT02587962|26036717|FG003|Overall Study|Clinical progression|0|||
13147337|NCT02587962|26036718|FG004|Overall Study|Clinical progression|1|||
13147338|NCT02587819|26036727|FG000|Overall Study|Adverse Event|1|||
13147339|NCT02587819|26036727|FG000|Overall Study|Lost to Follow-up|1|||
13147340|NCT02587234|26036744|FG000|Overall Study|Withdrawal by Subject|1|||
13147341|NCT02587234|26036745|FG001|Overall Study|Withdrawal by Subject|1|||
13147342|NCT02587234|26036744|FG000|Overall Study|Lost to Follow-up|0|||
13147343|NCT02587234|26036745|FG001|Overall Study|Lost to Follow-up|2|||
13147344|NCT02587221|26036796|FG000|Overall Study|Adverse Event|3|||
13147345|NCT02587221|26036797|FG001|Overall Study|Adverse Event|3|||
13147346|NCT02587221|26036796|FG000|Overall Study|Death|33|||
13147347|NCT02587221|26036797|FG001|Overall Study|Death|34|||
13147348|NCT02587221|26036796|FG000|Overall Study|Withdrawal by Subject|66|||
13147349|NCT02587221|26036797|FG001|Overall Study|Withdrawal by Subject|61|||
13147350|NCT02587221|26036796|FG000|Overall Study|Lost to Follow-up|21|||
13147351|NCT02587221|26036797|FG001|Overall Study|Lost to Follow-up|19|||
13147352|NCT02587221|26036796|FG000|Overall Study|Protocol Violation|6|||
13147353|NCT02587221|26036797|FG001|Overall Study|Protocol Violation|5|||
13147354|NCT02587221|26036796|FG000|Overall Study|Other Reason or Unspecified|2|||
13147355|NCT02587221|26036797|FG001|Overall Study|Other Reason or Unspecified|1|||
13147356|NCT02587143|26036810|FG000|Overall Study|Adverse Event|1|||
13147357|NCT02587143|26036811|FG001|Overall Study|Adverse Event|0|||
13147358|NCT02587065|26036827|FG000|Overall Study|Adverse Event|14|||
13147359|NCT02587065|26036827|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5|||
13147360|NCT02587065|26036827|FG000|Overall Study|Non-adherence to the Protocol|3|||
13147361|NCT02587065|26036827|FG000|Overall Study|Discontinuation of Study Medication|2|||
13147362|NCT02587065|26036827|FG000|Overall Study|Reason not Specified|3|||
13147363|NCT02586805|26036862|FG000|Overall Study|Withdrawal by Subject|3|||
13093360|NCT03669588|25832221|FG001|Overall Study|Withdrawal by Subject|4|||
13093361|NCT03669588|25832220|FG000|Overall Study|Rescue Therapy Needed|0|||
13093362|NCT03669588|25832221|FG001|Overall Study|Rescue Therapy Needed|1|||
13093363|NCT03669549|25832231|FG000|Overall Study|Adverse Event|4|||
13093364|NCT03669549|25832231|FG000|Overall Study|Withdrawal by Subject|1|||
13093365|NCT03669549|25832231|FG000|Overall Study|Study terminated by the Sponsor|1|||
13093366|NCT03669081|25832254|FG000|Overall Study|Data could not be validated|1|||
13093367|NCT03669081|25832255|FG001|Overall Study|Data could not be validated|1|||
13093368|NCT03668600|25832261|FG000|Overall Study|Study Terminated by the Sponsor|157|||
13093369|NCT03668600|25832261|FG000|Overall Study|Protocol Violation|1|||
13093370|NCT03668600|25832261|FG000|Overall Study|Pregnancy|1|||
13093371|NCT03668600|25832261|FG000|Overall Study|Lost to Follow-up|7|||
13093372|NCT03668600|25832261|FG000|Overall Study|Withdrawal by Subject|56|||
13093373|NCT03668600|25832261|FG000|Overall Study|Lack of Efficacy|7|||
13093374|NCT03668600|25832261|FG000|Overall Study|Adverse Event|1|||
13093375|NCT03667053|25832320|FG000|Overall Study|Withdrawal by Subject|1|||
13093376|NCT03667053|25832321|FG001|Overall Study|Withdrawal by Subject|0|||
13093377|NCT03667053|25832322|FG002|Overall Study|Withdrawal by Subject|0|||
13147364|NCT02586805|26036863|FG001|Overall Study|Withdrawal by Subject|1|||
13147365|NCT02586805|26036864|FG002|Overall Study|Withdrawal by Subject|1|||
13147366|NCT02586805|26036865|FG003|Overall Study|Withdrawal by Subject|2|||
13147367|NCT02586805|26036862|FG000|Overall Study|Adverse Event|2|||
13147368|NCT02586805|26036863|FG001|Overall Study|Adverse Event|0|||
13147369|NCT02586805|26036864|FG002|Overall Study|Adverse Event|1|||
13147370|NCT02586805|26036865|FG003|Overall Study|Adverse Event|0|||
13147371|NCT02586805|26036862|FG000|Overall Study|Lost to Follow-up|0|||
13147372|NCT02586805|26036863|FG001|Overall Study|Lost to Follow-up|0|||
13147373|NCT02586805|26036864|FG002|Overall Study|Lost to Follow-up|1|||
13147374|NCT02586805|26036865|FG003|Overall Study|Lost to Follow-up|0|||
13093378|NCT03666988|25832415|FG000|Part 1 (Up to 28 Months)|Adverse Event|0|||
13093379|NCT03666988|25832416|FG001|Part 1 (Up to 28 Months)|Adverse Event|1|||
13093380|NCT03666988|25832417|FG002|Part 1 (Up to 28 Months)|Adverse Event|3|||
13093381|NCT03666988|25832418|FG003|Part 1 (Up to 28 Months)|Adverse Event|0|||
13093382|NCT03666988|25832419|FG004|Part 1 (Up to 28 Months)|Adverse Event|0|||
13093383|NCT03666988|25832420|FG005|Part 1 (Up to 28 Months)|Adverse Event|0|||
13093384|NCT03666988|25832415|FG000|Part 1 (Up to 28 Months)|Other|0|||
13093385|NCT03666988|25832416|FG001|Part 1 (Up to 28 Months)|Other|1|||
13093386|NCT03666988|25832417|FG002|Part 1 (Up to 28 Months)|Other|1|||
13093387|NCT03666988|25832418|FG003|Part 1 (Up to 28 Months)|Other|0|||
13093388|NCT03666988|25832419|FG004|Part 1 (Up to 28 Months)|Other|0|||
13093389|NCT03666988|25832420|FG005|Part 1 (Up to 28 Months)|Other|0|||
13093390|NCT03666988|25832415|FG000|Part 1 (Up to 28 Months)|Disease Progression|2|||
13093391|NCT03666988|25832416|FG001|Part 1 (Up to 28 Months)|Disease Progression|14|||
13093392|NCT03666988|25832417|FG002|Part 1 (Up to 28 Months)|Disease Progression|7|||
13093393|NCT03666988|25832418|FG003|Part 1 (Up to 28 Months)|Disease Progression|0|||
13093394|NCT03666988|25832419|FG004|Part 1 (Up to 28 Months)|Disease Progression|0|||
13093395|NCT03666988|25832420|FG005|Part 1 (Up to 28 Months)|Disease Progression|0|||
13093396|NCT03666988|25832415|FG000|Part 1 (Up to 28 Months)|Physician Decision|0|||
13093397|NCT03666988|25832416|FG001|Part 1 (Up to 28 Months)|Physician Decision|0|||
13093398|NCT03666988|25832417|FG002|Part 1 (Up to 28 Months)|Physician Decision|1|||
13093399|NCT03666988|25832418|FG003|Part 1 (Up to 28 Months)|Physician Decision|0|||
13093400|NCT03666988|25832419|FG004|Part 1 (Up to 28 Months)|Physician Decision|0|||
13093401|NCT03666988|25832420|FG005|Part 1 (Up to 28 Months)|Physician Decision|0|||
13093402|NCT03666988|25832415|FG000|Part 1 (Up to 28 Months)|Withdrawal by Subject|1|||
13093403|NCT03666988|25832416|FG001|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
13093404|NCT03666988|25832417|FG002|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
13093405|NCT03666988|25832418|FG003|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
13093406|NCT03666988|25832419|FG004|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
13093407|NCT03666988|25832420|FG005|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
13093408|NCT03666858|25832439|FG000|Cohort 1|Adverse Event|1|||
13093409|NCT03666858|25832440|FG001|Cohort 1|Adverse Event|0|||
13093410|NCT03666858|25832439|FG000|Cohort 2|Adverse Event|0|||
13093411|NCT03666858|25832440|FG001|Cohort 2|Adverse Event|1|||
13093412|NCT03665441|25832465|FG000|Overall Study|survival follow up ongoing|23|||
13093413|NCT03665441|25832466|FG001|Overall Study|survival follow up ongoing|0|||
13093414|NCT03665441|25832465|FG000|Overall Study|Patients ongoing on treatment|9|||
13093415|NCT03665441|25832466|FG001|Overall Study|Patients ongoing on treatment|6|||
13093416|NCT03665441|25832465|FG000|Overall Study|Randomized but not treated|7|||
13093417|NCT03665441|25832466|FG001|Overall Study|Randomized but not treated|11|||
13093418|NCT03665038|25832502|FG000|Overall Study|Lost to Follow-up|0|||
13093419|NCT03665038|25832503|FG001|Overall Study|Lost to Follow-up|0|||
13093420|NCT03665038|25832504|FG002|Overall Study|Lost to Follow-up|1|||
13093421|NCT03664024|25832517|FG000|Overall Study|Follow-up discontinued by sponsor|34|||
13093422|NCT03664024|25832517|FG000|Overall Study|Lost to Follow-up|2|||
13093423|NCT03664024|25832517|FG000|Overall Study|Withdrawal by Subject|2|||
13093424|NCT03664024|25832517|FG000|Overall Study|Death|80|||
13093425|NCT03663582|25832551|FG000|Overall Study|Physician Decision|1|||
13093426|NCT03663569|25832564|FG000|Overall Study|Discontinuation of study|11|||
13093427|NCT03663569|25832564|FG000|Overall Study|Never taken Spiolto® Respimat®|1|||
13093428|NCT03663569|25832564|FG000|Overall Study|Deceased patient|6|||
13093429|NCT03663569|25832564|FG000|Overall Study|Lost to Follow-up|18|||
13093430|NCT03663569|25832564|FG000|Overall Study|Withdrawal of consent|5|||
13093431|NCT03663569|25832564|FG000|Overall Study|Patient's request|11|||
13093432|NCT03663569|25832564|FG000|Overall Study|Adverse Event|4|||
13093433|NCT03663569|25832564|FG000|Overall Study|Not come to second visit|3|||
13093434|NCT03663569|25832564|FG000|Overall Study|Not meet inclusion / exclusion criterion|3|||
13093435|NCT03663569|25832564|FG000|Overall Study|Serious adverse event|1|||
13093436|NCT03663179|25832579|FG000|Overall Study|Withdrawal by Subject|2|||
13093437|NCT03663179|25832580|FG001|Overall Study|Withdrawal by Subject|0|||
13093438|NCT03663179|25832579|FG000|Overall Study|Lost to Follow-up|1|||
13093439|NCT03663179|25832580|FG001|Overall Study|Lost to Follow-up|1|||
13093440|NCT03663179|25832579|FG000|Overall Study|Revealed exclusionary condition|1|||
13093441|NCT03663179|25832580|FG001|Overall Study|Revealed exclusionary condition|0|||
13147375|NCT02586805|26036862|FG000|Overall Study|Physician Decision|1|||
13147376|NCT02586805|26036863|FG001|Overall Study|Physician Decision|0|||
13147377|NCT02586805|26036864|FG002|Overall Study|Physician Decision|0|||
13147378|NCT02586805|26036865|FG003|Overall Study|Physician Decision|0|||
13147379|NCT02586727|26036880|FG000|Overall Study|Lost to Follow-up|1|||
13093442|NCT03662997|25832619|FG000|Overall Study|Adverse Event|0|||
13093443|NCT03662997|25832620|FG001|Overall Study|Adverse Event|2|||
13093444|NCT03662997|25832621|FG002|Overall Study|Adverse Event|0|||
13307576|NCT01284621|26529091|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
13093445|NCT03662997|25832622|FG003|Overall Study|Adverse Event|0|||
13093446|NCT03662789|25832647|FG000|Overall Study|Lost to Follow-up|1|||
13147380|NCT02586727|26036881|FG001|Overall Study|Lost to Follow-up|0|||
13147381|NCT02586506|26036889|FG000|Overall Study|Protocol Violation|6|||
13147382|NCT02586506|26036889|FG000|Overall Study|Lost to Follow-up|1|||
13147383|NCT02586506|26036889|FG000|Overall Study|Other Reason|2|||
13147384|NCT02586493|26036897|FG000|Overall Study|Adverse Event|4|||
13147385|NCT02586493|26036897|FG000|Overall Study|Protocol Violation|6|||
13147386|NCT02586493|26036897|FG000|Overall Study|Lost to Follow-up|1|||
13147387|NCT02586493|26036897|FG000|Overall Study|Withdrawal by Subject|1|||
13147388|NCT02586415|26036914|FG000|Overall Study|Death|13|||
13147389|NCT02586415|26036915|FG001|Overall Study|Death|23|||
13147390|NCT02586415|26036914|FG000|Overall Study|Lost to Follow-up|1|||
13147391|NCT02586415|26036915|FG001|Overall Study|Lost to Follow-up|2|||
13147392|NCT02586233|26036996|FG000|Overall Study|Randomized but did not receive treatment|0|||
13147393|NCT02586233|26036997|FG001|Overall Study|Randomized but did not receive treatment|1|||
13147394|NCT02586233|26036998|FG002|Overall Study|Randomized but did not receive treatment|0|||
13147395|NCT02586233|26036999|FG003|Overall Study|Randomized but did not receive treatment|0|||
13147396|NCT02586233|26037000|FG004|Overall Study|Randomized but did not receive treatment|0|||
13147397|NCT02586233|26037001|FG005|Overall Study|Randomized but did not receive treatment|2|||
13147398|NCT02586233|26037002|FG006|Overall Study|Randomized but did not receive treatment|2|||
13147399|NCT02586233|26036996|FG000|Overall Study|Death|0|||
13147400|NCT02586233|26036997|FG001|Overall Study|Death|1|||
13147401|NCT02586233|26036998|FG002|Overall Study|Death|0|||
13147402|NCT02586233|26036999|FG003|Overall Study|Death|0|||
13147403|NCT02586233|26037000|FG004|Overall Study|Death|2|||
13147404|NCT02586233|26037001|FG005|Overall Study|Death|0|||
13147405|NCT02586233|26037002|FG006|Overall Study|Death|0|||
13147406|NCT02586207|26037009|FG000|Overall Study|Physician Decision|1|||
13147407|NCT02586207|26037009|FG000|Overall Study|Withdrawal by Subject|1|||
13147408|NCT02586155|26037050|FG000|Overall Study|Adverse Event|2|||
13147409|NCT02586155|26037051|FG001|Overall Study|Adverse Event|3|||
13147410|NCT02586155|26037050|FG000|Overall Study|Withdrawal by Subject|31|||
13147411|NCT02586155|26037051|FG001|Overall Study|Withdrawal by Subject|24|||
13147412|NCT02586155|26037050|FG000|Overall Study|Lost to Follow-up|7|||
13147413|NCT02586155|26037051|FG001|Overall Study|Lost to Follow-up|13|||
13147414|NCT02586155|26037050|FG000|Overall Study|Death|61|||
13147415|NCT02586155|26037051|FG001|Overall Study|Death|72|||
13147416|NCT02586155|26037050|FG000|Overall Study|Other reasons|26|||
13147417|NCT02586155|26037051|FG001|Overall Study|Other reasons|15|||
13147418|NCT02586077|26037061|FG000|Overall Study|Withdrawal by Subject|1|||
13147419|NCT02586077|26037061|FG000|Overall Study|Physician Decision|4|||
13147420|NCT02586077|26037061|FG000|Overall Study|Lost to Follow-up|3|||
13147421|NCT02586064|26037114|FG000|Overall Study|Other Obligations|6|||
13147422|NCT02586064|26037115|FG001|Overall Study|Other Obligations|6|||
13147423|NCT02586064|26037114|FG000|Overall Study|Other|3|||
13147424|NCT02586064|26037115|FG001|Overall Study|Other|7|||
13147425|NCT02586064|26037114|FG000|Overall Study|Never Started|3|||
13147426|NCT02586064|26037115|FG001|Overall Study|Never Started|3|||
13147427|NCT02586064|26037114|FG000|Overall Study|Lost Interest|1|||
13147428|NCT02586064|26037115|FG001|Overall Study|Lost Interest|4|||
13147429|NCT02586064|26037114|FG000|Overall Study|Miscellaneous Life Issues|0|||
13147430|NCT02586064|26037115|FG001|Overall Study|Miscellaneous Life Issues|5|||
13147431|NCT02586064|26037114|FG000|Overall Study|Infrequent Attendance|2|||
13147432|NCT02586064|26037115|FG001|Overall Study|Infrequent Attendance|1|||
13147433|NCT02586064|26037114|FG000|Overall Study|Timed Out|2|||
13147434|NCT02586064|26037115|FG001|Overall Study|Timed Out|0|||
13147435|NCT02586064|26037114|FG000|Overall Study|AUD relapse|0|||
13147436|NCT02586064|26037115|FG001|Overall Study|AUD relapse|2|||
13147437|NCT02586064|26037114|FG000|Overall Study|Legal Issue|1|||
13147438|NCT02586064|26037115|FG001|Overall Study|Legal Issue|0|||
13147439|NCT02586025|26037152|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1|||
13147440|NCT02586025|26037153|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0|||
13147441|NCT02586025|26037152|FG000|Neoadjuvant Treatment|Death|1|||
13147442|NCT02586025|26037153|FG001|Neoadjuvant Treatment|Death|0|||
13147443|NCT02586025|26037152|FG000|Neoadjuvant Treatment|Adverse Event|1|||
13147444|NCT02586025|26037153|FG001|Neoadjuvant Treatment|Adverse Event|0|||
13147445|NCT02586025|26037152|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4|||
13147446|NCT02586025|26037153|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3|||
13147447|NCT02586025|26037152|FG000|Neoadjuvant Treatment|Physician Decision|2|||
13147448|NCT02586025|26037153|FG001|Neoadjuvant Treatment|Physician Decision|1|||
13147449|NCT02586025|26037152|FG000|Neoadjuvant Treatment|Progressive Disease|2|||
13147450|NCT02586025|26037153|FG001|Neoadjuvant Treatment|Progressive Disease|3|||
13147451|NCT02586025|26037152|FG000|Adjuvant Treatment|Remain in Adjuvant Treatment|133|||
13147452|NCT02586025|26037153|FG001|Adjuvant Treatment|Remain in Adjuvant Treatment|61|||
13147453|NCT02586025|26037152|FG000|Adjuvant Treatment|Withdrawal by Subject|5|||
13147454|NCT02586025|26037153|FG001|Adjuvant Treatment|Withdrawal by Subject|3|||
13147455|NCT02586025|26037152|FG000|Adjuvant Treatment|Physician Decision|0|||
13147456|NCT02586025|26037153|FG001|Adjuvant Treatment|Physician Decision|1|||
13147457|NCT02586025|26037152|FG000|Adjuvant Treatment|Recurrent Disease|1|||
13147458|NCT02586025|26037153|FG001|Adjuvant Treatment|Recurrent Disease|4|||
13147459|NCT02586025|26037152|FG000|Treatment-Free Follow-Up|Remain in Treatment-Free Follow-Up|56|||
13147460|NCT02586025|26037153|FG001|Treatment-Free Follow-Up|Remain in Treatment-Free Follow-Up|35|||
13147461|NCT02586012|26037171|FG000|Overall Study|Withdrawal by Subject|1|||
13147462|NCT02586012|26037172|FG001|Overall Study|Withdrawal by Subject|1|||
13147463|NCT02586012|26037173|FG002|Overall Study|Withdrawal by Subject|0|||
13147464|NCT02586012|26037174|FG003|Overall Study|Withdrawal by Subject|1|||
13147465|NCT02586012|26037175|FG004|Overall Study|Withdrawal by Subject|0|||
13147466|NCT02586012|26037176|FG005|Overall Study|Withdrawal by Subject|2|||
13147467|NCT02586012|26037171|FG000|Overall Study|Protocol Violation|0|||
13147468|NCT02586012|26037172|FG001|Overall Study|Protocol Violation|0|||
13147469|NCT02586012|26037173|FG002|Overall Study|Protocol Violation|0|||
13147470|NCT02586012|26037174|FG003|Overall Study|Protocol Violation|0|||
13147471|NCT02586012|26037175|FG004|Overall Study|Protocol Violation|0|||
13147472|NCT02586012|26037176|FG005|Overall Study|Protocol Violation|1|||
13147473|NCT02586012|26037171|FG000|Overall Study|study terminated|0|||
13147474|NCT02586012|26037172|FG001|Overall Study|study terminated|2|||
13147475|NCT02586012|26037173|FG002|Overall Study|study terminated|1|||
13147476|NCT02586012|26037174|FG003|Overall Study|study terminated|1|||
13147477|NCT02586012|26037175|FG004|Overall Study|study terminated|1|||
13147478|NCT02586012|26037176|FG005|Overall Study|study terminated|0|||
13147479|NCT02585999|26037183|FG000|Overall Study|Lost to Follow-up|1|||
13147480|NCT02585999|26037183|FG000|Overall Study|Protocol Violation|1|||
13147481|NCT02585960|26037261|FG000|PK/Safety Assessment Period|Physician Decision|0|||
13147482|NCT02585960|26037262|FG001|PK/Safety Assessment Period|Physician Decision|1|||
13147483|NCT02585960|26037263|FG002|PK/Safety Assessment Period|Physician Decision|0|||
13147484|NCT02585960|26037261|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1|||
13147485|NCT02585960|26037262|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2|||
13147486|NCT02585960|26037263|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5|||
13147487|NCT02585960|26037261|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
13147488|NCT02585960|26037262|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2|||
13147489|NCT02585960|26037263|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
13147490|NCT02585960|26037261|FG000|PK/Safety Assessment Period|Other|4|||
13147491|NCT02585960|26037262|FG001|PK/Safety Assessment Period|Other|4|||
13147492|NCT02585960|26037263|FG002|PK/Safety Assessment Period|Other|0|||
13147493|NCT02585960|26037261|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
13147494|NCT02585960|26037262|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1|||
13147495|NCT02585960|26037263|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
13147496|NCT02585960|26037261|FG000|PK/Safety Assessment Period|Screen Failure|0|||
13147497|NCT02585960|26037262|FG001|PK/Safety Assessment Period|Screen Failure|0|||
13147498|NCT02585960|26037263|FG002|PK/Safety Assessment Period|Screen Failure|1|||
13147499|NCT02585960|26037261|FG000|Prophylactic Treatment Period|Major protocol deviation|0|||
13147500|NCT02585960|26037262|FG001|Prophylactic Treatment Period|Major protocol deviation|4|||
13147501|NCT02585960|26037263|FG002|Prophylactic Treatment Period|Major protocol deviation|0|||
13147502|NCT02585960|26037261|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
13147503|NCT02585960|26037262|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1|||
13147504|NCT02585960|26037263|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
13147505|NCT02585934|26037291|FG000|Overall Study|Lost to Follow-up|2|||
13147506|NCT02585934|26037292|FG001|Overall Study|Lost to Follow-up|2|||
13147507|NCT02585934|26037291|FG000|Overall Study|Protocol Violation|14|||
13147508|NCT02585934|26037292|FG001|Overall Study|Protocol Violation|11|||
13147509|NCT02585934|26037291|FG000|Overall Study|Adverse Event|21|||
13147510|NCT02585934|26037292|FG001|Overall Study|Adverse Event|22|||
13147511|NCT02585934|26037291|FG000|Overall Study|Physician Decision|3|||
13147512|NCT02585934|26037292|FG001|Overall Study|Physician Decision|2|||
13147513|NCT02585934|26037291|FG000|Overall Study|Withdrawal by Subject|7|||
13147514|NCT02585934|26037292|FG001|Overall Study|Withdrawal by Subject|21|||
13147515|NCT02585934|26037291|FG000|Overall Study|Lack of Efficacy|2|||
13147516|NCT02585934|26037292|FG001|Overall Study|Lack of Efficacy|1|||
13147517|NCT02585934|26037291|FG000|Overall Study|Death|2|||
13147518|NCT02585934|26037292|FG001|Overall Study|Death|0|||
13147519|NCT02585934|26037291|FG000|Overall Study|Caregiver Withdrew Consent|7|||
13147520|NCT02585934|26037292|FG001|Overall Study|Caregiver Withdrew Consent|7|||
13147521|NCT02585934|26037291|FG000|Overall Study|Sponsor Termination|1|||
13147522|NCT02585934|26037292|FG001|Overall Study|Sponsor Termination|2|||
13147523|NCT02585934|26037291|FG000|Overall Study|Another Reason|10|||
13147524|NCT02585934|26037292|FG001|Overall Study|Another Reason|5|||
13147525|NCT02585830|26037299|FG000|Overall Study|Withdrawal by Subject|3|||
13147526|NCT02585778|26037424|FG000|Overall Study|Adverse Event|17|||
13147527|NCT02585778|26037425|FG001|Overall Study|Adverse Event|4|||
13147528|NCT02585778|26037424|FG000|Overall Study|Participant did not wish to continue|9|||
13147529|NCT02585778|26037425|FG001|Overall Study|Participant did not wish to continue|4|||
13147530|NCT02585778|26037424|FG000|Overall Study|Poor compliance to study protocol|0|||
13147531|NCT02585778|26037425|FG001|Overall Study|Poor compliance to study protocol|2|||
13147532|NCT02585778|26037424|FG000|Overall Study|Death|0|||
13147533|NCT02585778|26037425|FG001|Overall Study|Death|1|||
13147534|NCT02585778|26037424|FG000|Overall Study|Randomized but not treated|1|||
13147535|NCT02585778|26037425|FG001|Overall Study|Randomized but not treated|2|||
13147536|NCT02585778|26037424|FG000|Overall Study|Other than specified above|6|||
13147537|NCT02585778|26037425|FG001|Overall Study|Other than specified above|2|||
13147538|NCT02585713|26037442|FG000|Overall Study|Withdrew prior to treatment|2|||
13147539|NCT02585713|26037443|FG001|Overall Study|Withdrew prior to treatment|7|||
13147540|NCT02585713|26037442|FG000|Overall Study|Other|3|||
13147541|NCT02585713|26037443|FG001|Overall Study|Other|1|||
13147542|NCT02584959|26037508|FG000|Period 1|Withdrawn from study|3|||
13093447|NCT03662789|25832648|FG001|Overall Study|Lost to Follow-up|2|||
13093448|NCT03662789|25832647|FG000|Overall Study|Could not perform treadmill test|4|||
13093449|NCT03662789|25832648|FG001|Overall Study|Could not perform treadmill test|4|||
13093450|NCT03662789|25832647|FG000|Overall Study|Death|0|||
13093451|NCT03662789|25832648|FG001|Overall Study|Death|1|||
13093452|NCT03662750|25832655|FG000|Overall Study|Withdrawal by Subject|1|||
13093453|NCT03662334|25832698|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1|||
13093454|NCT03662334|25832699|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0|||
13093455|NCT03661983|25832713|FG000|Open Label Stabilization Phase|Adverse Event|5|||
13093456|NCT03661983|25832714|FG001|Open Label Stabilization Phase|Adverse Event|0|||
13093457|NCT03661983|25832715|FG002|Open Label Stabilization Phase|Adverse Event|0|||
13093458|NCT03661983|25832716|FG003|Open Label Stabilization Phase|Adverse Event|0|||
13093459|NCT03661983|25832713|FG000|Open Label Stabilization Phase|Lack of Efficacy|1|||
13093460|NCT03661983|25832714|FG001|Open Label Stabilization Phase|Lack of Efficacy|0|||
13093461|NCT03661983|25832715|FG002|Open Label Stabilization Phase|Lack of Efficacy|0|||
13093462|NCT03661983|25832716|FG003|Open Label Stabilization Phase|Lack of Efficacy|0|||
13093463|NCT03661983|25832713|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2|||
13147543|NCT02584959|26037509|FG001|Period 1|Withdrawn from study|4|||
13147544|NCT02584959|26037510|FG002|Period 1|Withdrawn from study|0|||
13147545|NCT02584959|26037508|FG000|Period 2|Withdrawn from study|6|||
13147546|NCT02584959|26037509|FG001|Period 2|Withdrawn from study|1|||
13147547|NCT02584959|26037510|FG002|Period 2|Withdrawn from study|2|||
13147548|NCT02584855|26037551|FG000|Open-Label Treatment Period|Lack of Efficacy|61|||
13147549|NCT02584855|26037552|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
13147550|NCT02584855|26037553|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
13147551|NCT02584855|26037554|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
13147552|NCT02584855|26037555|FG004|Open-Label Treatment Period|Lack of Efficacy|0|||
13147553|NCT02584855|26037556|FG005|Open-Label Treatment Period|Lack of Efficacy|0|||
13147554|NCT02584855|26037551|FG000|Open-Label Treatment Period|Withdrawal by Subject|21|||
13147555|NCT02584855|26037552|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
13147556|NCT02584855|26037553|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
13147557|NCT02584855|26037554|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
13147558|NCT02584855|26037555|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
13147559|NCT02584855|26037556|FG005|Open-Label Treatment Period|Withdrawal by Subject|0|||
13147560|NCT02584855|26037551|FG000|Open-Label Treatment Period|Adverse Event|14|||
13147561|NCT02584855|26037552|FG001|Open-Label Treatment Period|Adverse Event|0|||
13147562|NCT02584855|26037553|FG002|Open-Label Treatment Period|Adverse Event|0|||
13147563|NCT02584855|26037554|FG003|Open-Label Treatment Period|Adverse Event|0|||
13147564|NCT02584855|26037555|FG004|Open-Label Treatment Period|Adverse Event|0|||
13147565|NCT02584855|26037556|FG005|Open-Label Treatment Period|Adverse Event|0|||
13147566|NCT02584855|26037551|FG000|Open-Label Treatment Period|Death|2|||
13147567|NCT02584855|26037552|FG001|Open-Label Treatment Period|Death|0|||
13147568|NCT02584855|26037553|FG002|Open-Label Treatment Period|Death|0|||
13147569|NCT02584855|26037554|FG003|Open-Label Treatment Period|Death|0|||
13147570|NCT02584855|26037555|FG004|Open-Label Treatment Period|Death|0|||
13147571|NCT02584855|26037556|FG005|Open-Label Treatment Period|Death|0|||
13147572|NCT02584855|26037551|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
13147573|NCT02584855|26037552|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
13147574|NCT02584855|26037553|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
13147575|NCT02584855|26037554|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
13147576|NCT02584855|26037555|FG004|Open-Label Treatment Period|Lost to Follow-up|0|||
13147577|NCT02584855|26037556|FG005|Open-Label Treatment Period|Lost to Follow-up|0|||
13147578|NCT02584855|26037551|FG000|Open-Label Treatment Period|Protocol Violation|1|||
13147579|NCT02584855|26037552|FG001|Open-Label Treatment Period|Protocol Violation|0|||
13147580|NCT02584855|26037553|FG002|Open-Label Treatment Period|Protocol Violation|0|||
13147581|NCT02584855|26037554|FG003|Open-Label Treatment Period|Protocol Violation|0|||
13147582|NCT02584855|26037555|FG004|Open-Label Treatment Period|Protocol Violation|0|||
13222661|NCT01803880|26286673|FG001|Overall Study|Incomplete data entry by sites|0|||
13093464|NCT03661983|25832714|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
13147583|NCT02584855|26037556|FG005|Open-Label Treatment Period|Protocol Violation|0|||
13147584|NCT02584855|26037551|FG000|Open-Label Treatment Period|No PI Available|2|||
13147585|NCT02584855|26037552|FG001|Open-Label Treatment Period|No PI Available|0|||
13147586|NCT02584855|26037553|FG002|Open-Label Treatment Period|No PI Available|0|||
13147587|NCT02584855|26037554|FG003|Open-Label Treatment Period|No PI Available|0|||
13147588|NCT02584855|26037555|FG004|Open-Label Treatment Period|No PI Available|0|||
13147589|NCT02584855|26037556|FG005|Open-Label Treatment Period|No PI Available|0|||
13147590|NCT02584855|26037551|FG000|Open-Label Treatment Period|Sponsor Decision|1|||
13147591|NCT02584855|26037552|FG001|Open-Label Treatment Period|Sponsor Decision|0|||
13147592|NCT02584855|26037553|FG002|Open-Label Treatment Period|Sponsor Decision|0|||
13147593|NCT02584855|26037554|FG003|Open-Label Treatment Period|Sponsor Decision|0|||
13147594|NCT02584855|26037555|FG004|Open-Label Treatment Period|Sponsor Decision|0|||
13147595|NCT02584855|26037556|FG005|Open-Label Treatment Period|Sponsor Decision|0|||
13147596|NCT02584855|26037551|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
13147597|NCT02584855|26037552|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
13147598|NCT02584855|26037553|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2|||
13147599|NCT02584855|26037554|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
13147600|NCT02584855|26037555|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
13147601|NCT02584855|26037556|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
13147602|NCT02584855|26037551|FG000|Double-Blind Withdrawal Period|Adverse Event|0|||
13147603|NCT02584855|26037552|FG001|Double-Blind Withdrawal Period|Adverse Event|4|||
13147604|NCT02584855|26037553|FG002|Double-Blind Withdrawal Period|Adverse Event|0|||
13147605|NCT02584855|26037554|FG003|Double-Blind Withdrawal Period|Adverse Event|1|||
13147606|NCT02584855|26037555|FG004|Double-Blind Withdrawal Period|Adverse Event|0|||
13147607|NCT02584855|26037556|FG005|Double-Blind Withdrawal Period|Adverse Event|0|||
13147608|NCT02584855|26037551|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
13147609|NCT02584855|26037552|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10|||
13147610|NCT02584855|26037553|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
13147611|NCT02584855|26037554|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
13147612|NCT02584855|26037555|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
13147613|NCT02584855|26037556|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
13147614|NCT02584855|26037551|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
13147615|NCT02584855|26037552|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1|||
13147616|NCT02584855|26037553|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
13147617|NCT02584855|26037554|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
13147618|NCT02584855|26037555|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
13147619|NCT02584855|26037556|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
13147620|NCT02584855|26037551|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
13147621|NCT02584855|26037552|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
13147622|NCT02584855|26037553|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
13147623|NCT02584855|26037554|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
13147624|NCT02584855|26037555|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7|||
13147625|NCT02584855|26037556|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
13147626|NCT02584855|26037551|FG000|Post Treatment Follow-up Period|Protocol Violation|0|||
13147627|NCT02584855|26037552|FG001|Post Treatment Follow-up Period|Protocol Violation|0|||
13147628|NCT02584855|26037553|FG002|Post Treatment Follow-up Period|Protocol Violation|0|||
13147629|NCT02584855|26037554|FG003|Post Treatment Follow-up Period|Protocol Violation|0|||
13147630|NCT02584855|26037555|FG004|Post Treatment Follow-up Period|Protocol Violation|1|||
13093465|NCT03661983|25832715|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
13093466|NCT03661983|25832716|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
13093467|NCT03661983|25832713|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3|||
13093468|NCT03661983|25832714|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
13093469|NCT03661983|25832715|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
13093470|NCT03661983|25832716|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
13093471|NCT03661983|25832713|FG000|Double-blind Randomized Phase|Adverse Event|0|||
13093472|NCT03661983|25832714|FG001|Double-blind Randomized Phase|Adverse Event|1|||
13093473|NCT03661983|25832715|FG002|Double-blind Randomized Phase|Adverse Event|0|||
13093474|NCT03661983|25832716|FG003|Double-blind Randomized Phase|Adverse Event|0|||
13093475|NCT03661983|25832713|FG000|Double-blind Randomized Phase|Disease Relapse|0|||
13093476|NCT03661983|25832714|FG001|Double-blind Randomized Phase|Disease Relapse|0|||
13093477|NCT03661983|25832715|FG002|Double-blind Randomized Phase|Disease Relapse|0|||
13147631|NCT02584855|26037556|FG005|Post Treatment Follow-up Period|Protocol Violation|0|||
13147632|NCT02584660|26037579|FG000|Overall Study|Adverse Event|4|||
13147633|NCT02584660|26037580|FG001|Overall Study|Adverse Event|0|||
13147634|NCT02584660|26037579|FG000|Overall Study|Lost to Follow-up|3|||
13147635|NCT02584660|26037580|FG001|Overall Study|Lost to Follow-up|4|||
13147636|NCT02584660|26037579|FG000|Overall Study|Protocol Violation|0|||
13147637|NCT02584660|26037580|FG001|Overall Study|Protocol Violation|1|||
13147638|NCT02584660|26037579|FG000|Overall Study|Withdrawal by Subject|0|||
13147639|NCT02584660|26037580|FG001|Overall Study|Withdrawal by Subject|2|||
13147640|NCT02584660|26037579|FG000|Overall Study|Other|0|||
13147641|NCT02584660|26037580|FG001|Overall Study|Other|1|||
13147642|NCT02584634|26037639|FG000|Overall Study|Adverse Event|3|||
13147643|NCT02584634|26037640|FG001|Overall Study|Adverse Event|3|||
13147644|NCT02584634|26037639|FG000|Overall Study|Death|0|||
13147645|NCT02584634|26037640|FG001|Overall Study|Death|1|||
13147646|NCT02584634|26037639|FG000|Overall Study|Lost to Follow-up|0|||
13147647|NCT02584634|26037640|FG001|Overall Study|Lost to Follow-up|1|||
13147648|NCT02584634|26037639|FG000|Overall Study|Physician Decision|1|||
13147649|NCT02584634|26037640|FG001|Overall Study|Physician Decision|1|||
13147650|NCT02584634|26037639|FG000|Overall Study|Progressive disease|7|||
13147651|NCT02584634|26037640|FG001|Overall Study|Progressive disease|14|||
13147652|NCT02584634|26037639|FG000|Overall Study|Withdrawal by Subject|1|||
13147653|NCT02584634|26037640|FG001|Overall Study|Withdrawal by Subject|1|||
13147654|NCT02584634|26037639|FG000|Overall Study|Other|0|||
13147655|NCT02584634|26037640|FG001|Overall Study|Other|2|||
13147656|NCT02584634|26037639|FG000|Overall Study|Ongoing|0|||
13147657|NCT02584634|26037640|FG001|Overall Study|Ongoing|8|||
13147658|NCT02584504|26037704|FG000|Double-blind Treatment|Participant withdrew consent|0|||
13147659|NCT02584504|26037705|FG001|Double-blind Treatment|Participant withdrew consent|0|||
13147660|NCT02584504|26037706|FG002|Double-blind Treatment|Participant withdrew consent|1|||
13147661|NCT02584504|26037704|FG000|Double-blind Treatment|Adverse Event|0|||
13147662|NCT02584504|26037705|FG001|Double-blind Treatment|Adverse Event|1|||
13147663|NCT02584504|26037706|FG002|Double-blind Treatment|Adverse Event|0|||
13147664|NCT02584504|26037704|FG000|Double-blind Treatment|Family Matter|0|||
13147665|NCT02584504|26037705|FG001|Double-blind Treatment|Family Matter|1|||
13147666|NCT02584504|26037706|FG002|Double-blind Treatment|Family Matter|0|||
13147667|NCT02584504|26037704|FG000|Open-label Treatment|Participant withdrew consent|0|||
13147668|NCT02584504|26037705|FG001|Open-label Treatment|Participant withdrew consent|0|||
13147669|NCT02584504|26037706|FG002|Open-label Treatment|Participant withdrew consent|4|||
13147670|NCT02584504|26037704|FG000|Open-label Treatment|Adverse Event|2|||
13147671|NCT02584504|26037705|FG001|Open-label Treatment|Adverse Event|2|||
13147672|NCT02584504|26037706|FG002|Open-label Treatment|Adverse Event|3|||
13147673|NCT02584504|26037704|FG000|Open-label Treatment|Physician Decision|0|||
13147674|NCT02584504|26037705|FG001|Open-label Treatment|Physician Decision|1|||
13147675|NCT02584504|26037706|FG002|Open-label Treatment|Physician Decision|0|||
13147676|NCT02584504|26037704|FG000|Open-label Treatment|Entered but not treated|0|||
13147677|NCT02584504|26037705|FG001|Open-label Treatment|Entered but not treated|1|||
13147678|NCT02584504|26037706|FG002|Open-label Treatment|Entered but not treated|1|||
13147679|NCT02584452|26037741|FG000|Overall Study|Physician Decision|1|||
13147680|NCT02584452|26037742|FG001|Overall Study|Physician Decision|1|||
13147681|NCT02584452|26037741|FG000|Overall Study|Lost to Follow-up|1|||
13093478|NCT03661983|25832716|FG003|Double-blind Randomized Phase|Disease Relapse|6|||
13093479|NCT03661983|25832713|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
13093480|NCT03661983|25832714|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
13093481|NCT03661983|25832715|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
13093482|NCT03661983|25832716|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1|||
13093483|NCT03661983|25832713|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0|||
13093484|NCT03661983|25832714|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
13093485|NCT03661983|25832715|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
13093486|NCT03661983|25832716|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
13093487|NCT03660943|25832735|FG000|Overall Study|Adverse Event|5|||
13093488|NCT03660943|25832736|FG001|Overall Study|Adverse Event|3|||
13093489|NCT03660943|25832735|FG000|Overall Study|Death|0|||
13147682|NCT02584452|26037742|FG001|Overall Study|Lost to Follow-up|1|||
13147683|NCT02584257|26037764|FG000|Period 1|Withdrawal by Subject|0|||
13147684|NCT02584257|26037765|FG001|Period 1|Withdrawal by Subject|0|||
13147685|NCT02584257|26037766|FG002|Period 1|Withdrawal by Subject|0|||
13147686|NCT02584257|26037767|FG003|Period 1|Withdrawal by Subject|0|||
13147687|NCT02584257|26037768|FG004|Period 1|Withdrawal by Subject|0|||
13147688|NCT02584257|26037769|FG005|Period 1|Withdrawal by Subject|0|||
13147689|NCT02584257|26037770|FG006|Period 1|Withdrawal by Subject|1|||
13147690|NCT02584257|26037771|FG007|Period 1|Withdrawal by Subject|0|||
13147691|NCT02584257|26037772|FG008|Period 1|Withdrawal by Subject|0|||
13147692|NCT02584257|26037764|FG000|Period 2|Physician Decision|1|||
13147693|NCT02584257|26037765|FG001|Period 2|Physician Decision|0|||
13147694|NCT02584257|26037766|FG002|Period 2|Physician Decision|0|||
13147695|NCT02584257|26037767|FG003|Period 2|Physician Decision|0|||
13147696|NCT02584257|26037768|FG004|Period 2|Physician Decision|0|||
13147697|NCT02584257|26037769|FG005|Period 2|Physician Decision|0|||
13147698|NCT02584257|26037770|FG006|Period 2|Physician Decision|0|||
13147699|NCT02584257|26037771|FG007|Period 2|Physician Decision|0|||
13147700|NCT02584257|26037772|FG008|Period 2|Physician Decision|0|||
13147701|NCT02584257|26037764|FG000|Period 2|Adverse Event|0|||
13093490|NCT03660943|25832736|FG001|Overall Study|Death|2|||
13147702|NCT02584257|26037765|FG001|Period 2|Adverse Event|1|||
13147703|NCT02584257|26037766|FG002|Period 2|Adverse Event|0|||
13147704|NCT02584257|26037767|FG003|Period 2|Adverse Event|0|||
13147705|NCT02584257|26037768|FG004|Period 2|Adverse Event|0|||
13147706|NCT02584257|26037769|FG005|Period 2|Adverse Event|0|||
13147707|NCT02584257|26037770|FG006|Period 2|Adverse Event|0|||
13147708|NCT02584257|26037771|FG007|Period 2|Adverse Event|0|||
13147709|NCT02584257|26037772|FG008|Period 2|Adverse Event|0|||
13147710|NCT02583711|26037805|FG000|Overall Study|Withdrawal by Subject|0|||
13147711|NCT02583711|26037806|FG001|Overall Study|Withdrawal by Subject|10|||
13147712|NCT02583711|26037807|FG002|Overall Study|Withdrawal by Subject|0|||
13147713|NCT02583477|26037834|FG000|Overall Study|Adverse Event|0|||
13147714|NCT02583477|26037835|FG001|Overall Study|Adverse Event|2|||
13147715|NCT02583477|26037834|FG000|Overall Study|Death|1|||
13147716|NCT02583477|26037835|FG001|Overall Study|Death|16|||
13147717|NCT02583477|26037834|FG000|Overall Study|Study terminated|2|||
13147718|NCT02583477|26037835|FG001|Overall Study|Study terminated|2|||
13147719|NCT02583425|26037842|FG000|Screening|Did not meet entry criteria|12|||
13147720|NCT02583425|26037842|FG000|Baseline|Did not meet continued criteria|5|||
13147721|NCT02583425|26037842|FG000|Treatment Period|Adverse Event|1|||
13147722|NCT02583399|26037851|FG000|Overall Study|Able to be discharged|3|||
13147723|NCT02583399|26037851|FG000|Overall Study|Wanted to use a restricted medication|3|||
13147724|NCT02583256|26037952|FG000|Overall Study|Withdrawal by Subject|0|||
13147725|NCT02583256|26037953|FG001|Overall Study|Withdrawal by Subject|1|||
13147726|NCT02583256|26037954|FG002|Overall Study|Withdrawal by Subject|1|||
13147727|NCT02583256|26037955|FG003|Overall Study|Withdrawal by Subject|0|||
13147728|NCT02583256|26037952|FG000|Overall Study|Lost to Follow-up|1|||
13147729|NCT02583256|26037953|FG001|Overall Study|Lost to Follow-up|1|||
13147730|NCT02583256|26037954|FG002|Overall Study|Lost to Follow-up|0|||
13147731|NCT02583256|26037955|FG003|Overall Study|Lost to Follow-up|1|||
13147732|NCT02583256|26037952|FG000|Overall Study|Administrative/Other|2|||
13147733|NCT02583256|26037953|FG001|Overall Study|Administrative/Other|0|||
13147734|NCT02583256|26037954|FG002|Overall Study|Administrative/Other|1|||
13147735|NCT02583256|26037955|FG003|Overall Study|Administrative/Other|2|||
13147736|NCT02582983|26037962|FG000|Overall Study|Death|3|||
13147737|NCT02582983|26037962|FG000|Overall Study|Withdrawal by Subject|2|||
13147738|NCT02582983|26037962|FG000|Overall Study|Adverse Event|1|||
13147739|NCT02582866|26037970|FG000|Overall Study|Death|1|||
13147740|NCT02582866|26037970|FG000|Overall Study|Lack of Efficacy|2|||
13147741|NCT02582866|26037970|FG000|Overall Study|Lost to Follow-up|2|||
13147742|NCT02582866|26037970|FG000|Overall Study|Withdrawal by Subject|7|||
13147743|NCT02582866|26037970|FG000|Overall Study|Investigator decision|5|||
13147744|NCT02582866|26037970|FG000|Overall Study|Participant wants to get pregnant|1|||
13147745|NCT02582866|26037970|FG000|Overall Study|Pregnancy|2|||
13147746|NCT02582866|26037970|FG000|Overall Study|Sponsor decision|1|||
13147747|NCT02582866|26037970|FG000|Overall Study|Withdrawal due to personal reasons|1|||
13147748|NCT02582814|26038015|FG000|Overall Study|Study-specific withdrawal criteria|1|||
13147749|NCT02582814|26038016|FG001|Overall Study|Study-specific withdrawal criteria|0|||
13147750|NCT02582814|26038015|FG000|Overall Study|Withdrawal by Subject|4|||
13147751|NCT02582814|26038016|FG001|Overall Study|Withdrawal by Subject|3|||
13147752|NCT02582814|26038015|FG000|Overall Study|Adverse Event|4|||
13147753|NCT02582814|26038016|FG001|Overall Study|Adverse Event|4|||
13147754|NCT02582749|26038053|FG000|Overall Study|Study terminated by funder|5|||
13147755|NCT02582749|26038054|FG001|Overall Study|Study terminated by funder|10|||
13147756|NCT02582749|26038053|FG000|Overall Study|Withdrawal by Subject|0|||
13147757|NCT02582749|26038054|FG001|Overall Study|Withdrawal by Subject|1|||
13147758|NCT02582684|26038075|FG000|Overall Study|Unable to contact subject/parent|4|||
13147759|NCT02582684|26038075|FG000|Overall Study|Subject not able to get to clinic|10|||
13147760|NCT02582684|26038075|FG000|Overall Study|Subject withdrew consent|1|||
13147761|NCT02582684|26038075|FG000|Overall Study|Found to be ineligible after enrollment|2|||
13147762|NCT02582671|26038089|FG000|Overall Study|Failure to return|1|||
13147763|NCT02582671|26038089|FG000|Overall Study|Other, not specified|1|||
13147764|NCT02582658|26038109|FG000|Overall Study|Failure to Return|10|||
13147765|NCT02582658|26038109|FG000|Overall Study|Insufficient Virological Response|2|||
13147766|NCT02582658|26038109|FG000|Overall Study|Withdrawn Consent|1|||
13147767|NCT02582658|26038109|FG000|Overall Study|Death|1|||
13147768|NCT02582658|26038109|FG000|Overall Study|Not further specified|11|||
13147769|NCT02582632|26038124|FG000|Overall Study|Other|1|||
13147770|NCT02582515|26038137|FG000|Overall Study|Withdrawal by Subject|0|||
13147771|NCT02582515|26038138|FG001|Overall Study|Withdrawal by Subject|1|||
13147772|NCT02582255|26038156|FG000|Overall Study|Protocol Violation|0|||
13147773|NCT02582255|26038157|FG001|Overall Study|Protocol Violation|3|||
13147774|NCT02582242|26038204|FG000|Overall Study|Adverse Event|4|||
13147775|NCT02582242|26038205|FG001|Overall Study|Adverse Event|3|||
13147776|NCT02582242|26038204|FG000|Overall Study|Protocol Violation|3|||
13147777|NCT02582242|26038205|FG001|Overall Study|Protocol Violation|1|||
13307577|NCT01284491|26529099|FG000|Overall Study|Study termination|13|||
13147778|NCT02582242|26038204|FG000|Overall Study|Lost to Follow-up|0|||
13147779|NCT02582242|26038205|FG001|Overall Study|Lost to Follow-up|1|||
13147780|NCT02582242|26038204|FG000|Overall Study|Withdrawal by Subject|11|||
13147781|NCT02582242|26038205|FG001|Overall Study|Withdrawal by Subject|11|||
13147782|NCT02582242|26038204|FG000|Overall Study|Unclassified|2|||
13147783|NCT02582242|26038205|FG001|Overall Study|Unclassified|1|||
13147784|NCT02581995|26038221|FG000|Overall Study|Unspecified other|3|||
13147785|NCT02581995|26038221|FG000|Overall Study|Adverse Event|6|||
13147786|NCT02581995|26038221|FG000|Overall Study|Lost to Follow-up|5|||
13147787|NCT02581995|26038221|FG000|Overall Study|Withdrawal by participant|12|||
13147788|NCT02581995|26038221|FG000|Overall Study|Physician Decision|1|||
13147789|NCT02581995|26038221|FG000|Overall Study|Death|4|||
13147790|NCT02581930|26038229|FG000|Overall Study|Withdrawal by Subject|1|||
13147791|NCT02581930|26038229|FG000|Overall Study|patient declined further treatment|1|||
13147792|NCT02581891|26038259|FG000|Overall Study|Adverse Event|4|||
13147793|NCT02581891|26038260|FG001|Overall Study|Adverse Event|6|||
13147794|NCT02581891|26038259|FG000|Overall Study|Death|3|||
13147795|NCT02581891|26038260|FG001|Overall Study|Death|4|||
13147796|NCT02581891|26038259|FG000|Overall Study|Lost to Follow-up|1|||
13147797|NCT02581891|26038260|FG001|Overall Study|Lost to Follow-up|2|||
13147798|NCT02581891|26038259|FG000|Overall Study|Physician Decision|0|||
13147799|NCT02581891|26038260|FG001|Overall Study|Physician Decision|1|||
13147800|NCT02581891|26038259|FG000|Overall Study|Withdrawal by Subject|4|||
13147801|NCT02581891|26038260|FG001|Overall Study|Withdrawal by Subject|5|||
13147802|NCT02581891|26038259|FG000|Overall Study|Other Reasons|3|||
13147803|NCT02581891|26038260|FG001|Overall Study|Other Reasons|1|||
13147804|NCT02581891|26038259|FG000|Overall Study|Discontinued during followup|1|||
13147805|NCT02581891|26038260|FG001|Overall Study|Discontinued during followup|0|||
13147806|NCT02581488|26038281|FG000|Overall Study|Adverse Event|6|||
13147807|NCT02581488|26038282|FG001|Overall Study|Adverse Event|7|||
13147808|NCT02581488|26038281|FG000|Overall Study|Lost to Follow-up|1|||
13147809|NCT02581488|26038282|FG001|Overall Study|Lost to Follow-up|0|||
13147810|NCT02581488|26038281|FG000|Overall Study|Withdrawal by Subject|1|||
13147811|NCT02581488|26038282|FG001|Overall Study|Withdrawal by Subject|0|||
13147812|NCT02581488|26038281|FG000|Overall Study|Non-Compliance|1|||
13147813|NCT02581488|26038282|FG001|Overall Study|Non-Compliance|0|||
13147814|NCT02581488|26038281|FG000|Overall Study|Protocol Violation|0|||
13147815|NCT02581488|26038282|FG001|Overall Study|Protocol Violation|4|||
13147816|NCT02581410|26038317|FG000|Vaccination Phase|Adverse Event|2|||
13147817|NCT02581410|26038318|FG001|Vaccination Phase|Adverse Event|1|||
13147818|NCT02581410|26038317|FG000|Vaccination Phase|Withdrawal by Subject|0|||
13147819|NCT02581410|26038318|FG001|Vaccination Phase|Withdrawal by Subject|1|||
13147820|NCT02581410|26038317|FG000|Vaccination Phase|Migrated/moved from study area|0|||
13147821|NCT02581410|26038318|FG001|Vaccination Phase|Migrated/moved from study area|1|||
13147822|NCT02581410|26038317|FG000|End of Study Phase|Adverse Event|4|||
13147823|NCT02581410|26038318|FG001|End of Study Phase|Adverse Event|3|||
13147824|NCT02581410|26038317|FG000|End of Study Phase|Withdrawal by Subject|1|||
13147825|NCT02581410|26038318|FG001|End of Study Phase|Withdrawal by Subject|2|||
13147826|NCT02581410|26038317|FG000|End of Study Phase|Migrated/moved from study area|0|||
13147827|NCT02581410|26038318|FG001|End of Study Phase|Migrated/moved from study area|3|||
13147828|NCT02581410|26038317|FG000|End of Study Phase|Lost to Follow-up|0|||
13147829|NCT02581410|26038318|FG001|End of Study Phase|Lost to Follow-up|2|||
13093491|NCT03660943|25832735|FG000|Overall Study|Lost to Follow-up|7|||
13093492|NCT03660943|25832736|FG001|Overall Study|Lost to Follow-up|3|||
13093493|NCT03660943|25832735|FG000|Overall Study|Protocol Violation|3|||
13093494|NCT03660943|25832736|FG001|Overall Study|Protocol Violation|5|||
13093495|NCT03660943|25832735|FG000|Overall Study|Withdrawal by Subject|8|||
13093496|NCT03660943|25832736|FG001|Overall Study|Withdrawal by Subject|15|||
13093497|NCT03660943|25832735|FG000|Overall Study|Lack of Efficacy|9|||
13147830|NCT02581410|26038317|FG000|End of Study Phase|Other-transfer of subject not completed|0|||
13147831|NCT02581410|26038318|FG001|End of Study Phase|Other-transfer of subject not completed|1|||
13147832|NCT02581345|26038429|FG000|Part 1: up to Week 16|Adverse Event|3|||
13147833|NCT02581345|26038430|FG001|Part 1: up to Week 16|Adverse Event|8|||
13147834|NCT02581345|26038431|FG002|Part 1: up to Week 16|Adverse Event|0|||
13147835|NCT02581345|26038432|FG003|Part 1: up to Week 16|Adverse Event|0|||
13147836|NCT02581345|26038429|FG000|Part 1: up to Week 16|Physician Decision|2|||
13147837|NCT02581345|26038430|FG001|Part 1: up to Week 16|Physician Decision|4|||
13147838|NCT02581345|26038431|FG002|Part 1: up to Week 16|Physician Decision|0|||
13147839|NCT02581345|26038432|FG003|Part 1: up to Week 16|Physician Decision|0|||
13147840|NCT02581345|26038429|FG000|Part 1: up to Week 16|Withdrawal by Subject|4|||
13147841|NCT02581345|26038430|FG001|Part 1: up to Week 16|Withdrawal by Subject|7|||
13147842|NCT02581345|26038431|FG002|Part 1: up to Week 16|Withdrawal by Subject|0|||
13147843|NCT02581345|26038432|FG003|Part 1: up to Week 16|Withdrawal by Subject|0|||
13147844|NCT02581345|26038429|FG000|Part 1: up to Week 16|Lost to Follow-up|2|||
13147845|NCT02581345|26038430|FG001|Part 1: up to Week 16|Lost to Follow-up|0|||
13147846|NCT02581345|26038431|FG002|Part 1: up to Week 16|Lost to Follow-up|0|||
13147847|NCT02581345|26038432|FG003|Part 1: up to Week 16|Lost to Follow-up|0|||
13147848|NCT02581345|26038429|FG000|Part 1: up to Week 16|Unspecified Reason|3|||
13147849|NCT02581345|26038430|FG001|Part 1: up to Week 16|Unspecified Reason|3|||
13147850|NCT02581345|26038431|FG002|Part 1: up to Week 16|Unspecified Reason|0|||
13147851|NCT02581345|26038432|FG003|Part 1: up to Week 16|Unspecified Reason|0|||
13093498|NCT03660943|25832736|FG001|Overall Study|Lack of Efficacy|12|||
13147852|NCT02581345|26038429|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1|||
13147853|NCT02581345|26038430|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1|||
13147854|NCT02581345|26038431|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0|||
13147855|NCT02581345|26038432|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0|||
13147856|NCT02581345|26038429|FG000|Part 2: Week 17 to Week 47|Adverse Event|5|||
13147857|NCT02581345|26038430|FG001|Part 2: Week 17 to Week 47|Adverse Event|0|||
13147858|NCT02581345|26038431|FG002|Part 2: Week 17 to Week 47|Adverse Event|2|||
13147859|NCT02581345|26038432|FG003|Part 2: Week 17 to Week 47|Adverse Event|2|||
13147860|NCT02581345|26038429|FG000|Part 2: Week 17 to Week 47|Physician Decision|3|||
13147861|NCT02581345|26038430|FG001|Part 2: Week 17 to Week 47|Physician Decision|0|||
13147862|NCT02581345|26038431|FG002|Part 2: Week 17 to Week 47|Physician Decision|2|||
13147863|NCT02581345|26038432|FG003|Part 2: Week 17 to Week 47|Physician Decision|1|||
13147864|NCT02581345|26038429|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9|||
13147865|NCT02581345|26038430|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0|||
13147866|NCT02581345|26038431|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7|||
13147867|NCT02581345|26038432|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5|||
13147868|NCT02581345|26038429|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8|||
13147869|NCT02581345|26038430|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0|||
13147870|NCT02581345|26038431|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3|||
13147871|NCT02581345|26038432|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2|||
13147872|NCT02581345|26038429|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2|||
13147873|NCT02581345|26038430|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
13147874|NCT02581345|26038431|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
13147875|NCT02581345|26038432|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1|||
13147876|NCT02581345|26038429|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2|||
13147877|NCT02581345|26038430|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0|||
13147878|NCT02581345|26038431|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
13147879|NCT02581345|26038432|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
13147880|NCT02581202|26038473|FG000|Overall Study|Lack of Efficacy|2|||
13147881|NCT02581202|26038473|FG000|Overall Study|Withdrawal by Subject|4|||
13147882|NCT02581202|26038473|FG000|Overall Study|Lost to Follow-up|5|||
13147883|NCT02581202|26038473|FG000|Overall Study|Pregnancy|3|||
13147884|NCT02581189|26038489|FG000|Overall Study|Failure to return|36|||
13147885|NCT02581189|26038489|FG000|Overall Study|Withdrew consent|5|||
13147886|NCT02581189|26038489|FG000|Overall Study|Death|3|||
13147887|NCT02581189|26038489|FG000|Overall Study|Insufficient virological response|2|||
13147888|NCT02581189|26038489|FG000|Overall Study|Other, not specified|7|||
13093499|NCT03660943|25832735|FG000|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|4|||
13093500|NCT03660943|25832736|FG001|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|13|||
13093501|NCT03658889|25832772|FG000|Overall Study|Protocol Violation|2|||
13093502|NCT03658889|25832773|FG001|Overall Study|Protocol Violation|0|||
13093503|NCT03658876|25832786|FG000|Overall Study|Protocol Violation|3|||
13093504|NCT03658876|25832787|FG001|Overall Study|Protocol Violation|2|||
13093505|NCT03658876|25832786|FG000|Overall Study|Withdrawal by Subject|2|||
13093506|NCT03658876|25832787|FG001|Overall Study|Withdrawal by Subject|0|||
13093507|NCT03658876|25832786|FG000|Overall Study|Death|0|||
13093508|NCT03658876|25832787|FG001|Overall Study|Death|1|||
13093509|NCT03658876|25832786|FG000|Overall Study|Intercurrent illness|6|||
13093510|NCT03658876|25832787|FG001|Overall Study|Intercurrent illness|4|||
13093511|NCT03658876|25832786|FG000|Overall Study|Transplantation/other operation|1|||
13093512|NCT03658876|25832787|FG001|Overall Study|Transplantation/other operation|5|||
13093513|NCT03658811|25832796|FG000|Overall Study|Lost to Follow-up|3|||
13093514|NCT03657277|25832805|FG000|Overall Study|Physician Decision|2|||
13147889|NCT02581163|26038505|FG000|Overall Study|Failure to return|15|||
13147890|NCT02581163|26038505|FG000|Overall Study|Insufficient virological response|3|||
13147891|NCT02581163|26038505|FG000|Overall Study|Withdrew consent|1|||
13093515|NCT03657277|25832805|FG000|Overall Study|Lost to Follow-up|1|||
13093516|NCT03657277|25832805|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8|||
13093517|NCT03657095|25832826|FG000|Overall Study|Withdrawal by Subject|1|||
13093518|NCT03657095|25832827|FG001|Overall Study|Withdrawal by Subject|1|||
13093519|NCT03657095|25832826|FG000|Overall Study|Adverse Event|0|||
13093520|NCT03657095|25832827|FG001|Overall Study|Adverse Event|3|||
13093521|NCT03657095|25832826|FG000|Overall Study|Study Terminated by Sponsor|58|||
13093522|NCT03657095|25832827|FG001|Overall Study|Study Terminated by Sponsor|49|||
13093523|NCT03656874|25832844|FG000|Overall Study|Lost to Follow-up|3|||
13147892|NCT02581163|26038505|FG000|Overall Study|Death|1|||
13147893|NCT02581163|26038505|FG000|Overall Study|Other, not specified|9|||
13147894|NCT02580877|26038520|FG000|Overall Study|Withdrawal by Subject|1|||
13093524|NCT03656874|25832845|FG001|Overall Study|Lost to Follow-up|17|||
13093525|NCT03656692|25832854|FG000|Overall Study|Worsening of disease activity|2|||
13093526|NCT03656692|25832854|FG000|Overall Study|Physician Decision|1|||
13093527|NCT03655951|25833021|FG000|Overall Study|Lost to Follow-up|39|||
13093528|NCT03655951|25833022|FG001|Overall Study|Lost to Follow-up|20|||
13093529|NCT03655951|25833021|FG000|Overall Study|Withdrawal by Subject|0|||
13093530|NCT03655951|25833022|FG001|Overall Study|Withdrawal by Subject|1|||
13093531|NCT03655756|25833029|FG000|Overall Study|Death|1|||
13093532|NCT03655717|25833080|FG000|Overall Study|Withdrawal by Subject|4|||
13093533|NCT03655717|25833081|FG001|Overall Study|Withdrawal by Subject|8|||
13093534|NCT03655717|25833082|FG002|Overall Study|Withdrawal by Subject|1|||
13093535|NCT03655717|25833083|FG003|Overall Study|Withdrawal by Subject|0|||
13093536|NCT03655717|25833084|FG004|Overall Study|Withdrawal by Subject|0|||
13093537|NCT03655717|25833085|FG005|Overall Study|Withdrawal by Subject|1|||
13093538|NCT03655717|25833086|FG006|Overall Study|Withdrawal by Subject|3|||
13093539|NCT03655717|25833087|FG007|Overall Study|Withdrawal by Subject|1|||
13093540|NCT03655717|25833088|FG008|Overall Study|Withdrawal by Subject|2|||
13093541|NCT03655717|25833089|FG009|Overall Study|Withdrawal by Subject|0|||
13093542|NCT03655717|25833090|FG010|Overall Study|Withdrawal by Subject|0|||
13093543|NCT03655717|25833091|FG011|Overall Study|Withdrawal by Subject|1|||
13093544|NCT03655717|25833092|FG012|Overall Study|Withdrawal by Subject|0|||
13093545|NCT03655717|25833093|FG013|Overall Study|Withdrawal by Subject|3|||
13093546|NCT03655717|25833094|FG014|Overall Study|Withdrawal by Subject|0|||
13093547|NCT03655717|25833095|FG015|Overall Study|Withdrawal by Subject|1|||
13093548|NCT03655717|25833096|FG016|Overall Study|Withdrawal by Subject|0|||
13093549|NCT03655717|25833097|FG017|Overall Study|Withdrawal by Subject|0|||
13093550|NCT03655717|25833098|FG018|Overall Study|Withdrawal by Subject|1|||
13093551|NCT03655717|25833099|FG019|Overall Study|Withdrawal by Subject|0|||
13093552|NCT03655717|25833100|FG020|Overall Study|Withdrawal by Subject|0|||
13093553|NCT03655717|25833101|FG021|Overall Study|Withdrawal by Subject|1|||
13093554|NCT03655717|25833102|FG022|Overall Study|Withdrawal by Subject|2|||
13093555|NCT03655717|25833103|FG023|Overall Study|Withdrawal by Subject|1|||
13093556|NCT03655717|25833104|FG024|Overall Study|Withdrawal by Subject|1|||
13093557|NCT03655717|25833105|FG025|Overall Study|Withdrawal by Subject|0|||
13093558|NCT03655717|25833080|FG000|Overall Study|Physician Decision|3|||
13093559|NCT03655717|25833081|FG001|Overall Study|Physician Decision|3|||
13093560|NCT03655717|25833082|FG002|Overall Study|Physician Decision|0|||
13093561|NCT03655717|25833083|FG003|Overall Study|Physician Decision|0|||
13093562|NCT03655717|25833084|FG004|Overall Study|Physician Decision|0|||
13093563|NCT03655717|25833085|FG005|Overall Study|Physician Decision|0|||
13093564|NCT03655717|25833086|FG006|Overall Study|Physician Decision|0|||
13093565|NCT03655717|25833087|FG007|Overall Study|Physician Decision|0|||
13093566|NCT03655717|25833088|FG008|Overall Study|Physician Decision|0|||
13093567|NCT03655717|25833089|FG009|Overall Study|Physician Decision|1|||
13093568|NCT03655717|25833090|FG010|Overall Study|Physician Decision|0|||
13093569|NCT03655717|25833091|FG011|Overall Study|Physician Decision|0|||
13093570|NCT03655717|25833092|FG012|Overall Study|Physician Decision|0|||
13093571|NCT03655717|25833093|FG013|Overall Study|Physician Decision|0|||
13093572|NCT03655717|25833094|FG014|Overall Study|Physician Decision|0|||
13093573|NCT03655717|25833095|FG015|Overall Study|Physician Decision|0|||
13147895|NCT02580877|26038521|FG001|Overall Study|Withdrawal by Subject|3|||
13147896|NCT02580877|26038520|FG000|Overall Study|Adverse Event|0|||
13147897|NCT02580877|26038521|FG001|Overall Study|Adverse Event|1|||
13147898|NCT02580591|26038564|FG000|Overall Study|Adverse Event|0|||
13147899|NCT02580591|26038565|FG001|Overall Study|Adverse Event|1|||
13147900|NCT02580591|26038566|FG002|Overall Study|Adverse Event|2|||
13147901|NCT02580591|26038567|FG003|Overall Study|Adverse Event|5|||
13147902|NCT02580591|26038564|FG000|Overall Study|Protocol Violation|3|||
13147903|NCT02580591|26038565|FG001|Overall Study|Protocol Violation|2|||
13147904|NCT02580591|26038566|FG002|Overall Study|Protocol Violation|1|||
13147905|NCT02580591|26038567|FG003|Overall Study|Protocol Violation|1|||
13147906|NCT02580591|26038564|FG000|Overall Study|Lost to Follow-up|5|||
13147907|NCT02580591|26038565|FG001|Overall Study|Lost to Follow-up|3|||
13147908|NCT02580591|26038566|FG002|Overall Study|Lost to Follow-up|3|||
13147909|NCT02580591|26038567|FG003|Overall Study|Lost to Follow-up|1|||
13147910|NCT02580591|26038564|FG000|Overall Study|Withdrawal by Subject|6|||
13147911|NCT02580591|26038565|FG001|Overall Study|Withdrawal by Subject|1|||
13147912|NCT02580591|26038566|FG002|Overall Study|Withdrawal by Subject|2|||
13147913|NCT02580591|26038567|FG003|Overall Study|Withdrawal by Subject|3|||
13093574|NCT03655717|25833096|FG016|Overall Study|Physician Decision|0|||
13093575|NCT03655717|25833097|FG017|Overall Study|Physician Decision|0|||
13093576|NCT03655717|25833098|FG018|Overall Study|Physician Decision|0|||
13093577|NCT03655717|25833099|FG019|Overall Study|Physician Decision|1|||
13093578|NCT03655717|25833100|FG020|Overall Study|Physician Decision|0|||
13093579|NCT03655717|25833101|FG021|Overall Study|Physician Decision|0|||
13093580|NCT03655717|25833102|FG022|Overall Study|Physician Decision|0|||
13093581|NCT03655717|25833103|FG023|Overall Study|Physician Decision|1|||
13093582|NCT03655717|25833104|FG024|Overall Study|Physician Decision|0|||
13093583|NCT03655717|25833105|FG025|Overall Study|Physician Decision|0|||
13093584|NCT03655717|25833080|FG000|Overall Study|Lost to Follow-up|3|||
13093585|NCT03655717|25833081|FG001|Overall Study|Lost to Follow-up|1|||
13147914|NCT02580591|26038564|FG000|Overall Study|Not treated|1|||
13147915|NCT02580591|26038565|FG001|Overall Study|Not treated|1|||
13147916|NCT02580591|26038566|FG002|Overall Study|Not treated|0|||
13147917|NCT02580591|26038567|FG003|Overall Study|Not treated|0|||
13147918|NCT02580591|26038564|FG000|Overall Study|Other than specified|3|||
13147919|NCT02580591|26038565|FG001|Overall Study|Other than specified|2|||
13147920|NCT02580591|26038566|FG002|Overall Study|Other than specified|5|||
13147921|NCT02580591|26038567|FG003|Overall Study|Other than specified|2|||
13147922|NCT02580357|26038588|FG000|Overall Study|Lost to Follow-up|2|||
13147923|NCT02580357|26038589|FG001|Overall Study|Lost to Follow-up|0|||
13147924|NCT02580357|26038590|FG002|Overall Study|Lost to Follow-up|0|||
13147925|NCT02580357|26038588|FG000|Overall Study|Protocol Violation|1|||
13147926|NCT02580357|26038589|FG001|Overall Study|Protocol Violation|0|||
13147927|NCT02580357|26038590|FG002|Overall Study|Protocol Violation|0|||
13147928|NCT02580240|26038605|FG000|Overall Study|Physician Decision|2|||
13147929|NCT02580240|26038606|FG001|Overall Study|Physician Decision|0|||
13093586|NCT03655717|25833082|FG002|Overall Study|Lost to Follow-up|0|||
13093587|NCT03655717|25833083|FG003|Overall Study|Lost to Follow-up|1|||
13093588|NCT03655717|25833084|FG004|Overall Study|Lost to Follow-up|0|||
13093589|NCT03655717|25833085|FG005|Overall Study|Lost to Follow-up|1|||
13093590|NCT03655717|25833086|FG006|Overall Study|Lost to Follow-up|0|||
13093591|NCT03655717|25833087|FG007|Overall Study|Lost to Follow-up|0|||
13093592|NCT03655717|25833088|FG008|Overall Study|Lost to Follow-up|0|||
13093593|NCT03655717|25833089|FG009|Overall Study|Lost to Follow-up|0|||
13093594|NCT03655717|25833090|FG010|Overall Study|Lost to Follow-up|0|||
13093595|NCT03655717|25833091|FG011|Overall Study|Lost to Follow-up|1|||
13093596|NCT03655717|25833092|FG012|Overall Study|Lost to Follow-up|0|||
13093597|NCT03655717|25833093|FG013|Overall Study|Lost to Follow-up|0|||
13093598|NCT03655717|25833094|FG014|Overall Study|Lost to Follow-up|0|||
13093599|NCT03655717|25833095|FG015|Overall Study|Lost to Follow-up|0|||
13093600|NCT03655717|25833096|FG016|Overall Study|Lost to Follow-up|0|||
13093601|NCT03655717|25833097|FG017|Overall Study|Lost to Follow-up|0|||
13093602|NCT03655717|25833098|FG018|Overall Study|Lost to Follow-up|0|||
13093603|NCT03655717|25833099|FG019|Overall Study|Lost to Follow-up|0|||
13093604|NCT03655717|25833100|FG020|Overall Study|Lost to Follow-up|0|||
13093605|NCT03655717|25833101|FG021|Overall Study|Lost to Follow-up|0|||
13093606|NCT03655717|25833102|FG022|Overall Study|Lost to Follow-up|0|||
13093607|NCT03655717|25833103|FG023|Overall Study|Lost to Follow-up|0|||
13093608|NCT03655717|25833104|FG024|Overall Study|Lost to Follow-up|0|||
13093609|NCT03655717|25833105|FG025|Overall Study|Lost to Follow-up|0|||
13093610|NCT03655691|25833129|FG000|Overall Study|Adverse Event|0|||
13093611|NCT03655691|25833130|FG001|Overall Study|Adverse Event|0|||
13093612|NCT03655691|25833131|FG002|Overall Study|Adverse Event|1|||
13093613|NCT03655691|25833129|FG000|Overall Study|Lost to Follow-up|1|||
13093614|NCT03655691|25833130|FG001|Overall Study|Lost to Follow-up|1|||
13093615|NCT03655691|25833131|FG002|Overall Study|Lost to Follow-up|2|||
13093616|NCT03655691|25833129|FG000|Overall Study|Protocol Violation|0|||
13093617|NCT03655691|25833130|FG001|Overall Study|Protocol Violation|1|||
13093618|NCT03655691|25833131|FG002|Overall Study|Protocol Violation|0|||
13093619|NCT03655691|25833129|FG000|Overall Study|Withdrawal by Subject|1|||
13093620|NCT03655691|25833130|FG001|Overall Study|Withdrawal by Subject|1|||
13093621|NCT03655691|25833131|FG002|Overall Study|Withdrawal by Subject|0|||
13093622|NCT03655405|25833170|FG000|Overall Study|Death after initial data collection|4|||
13093623|NCT03655405|25833171|FG001|Overall Study|Death after initial data collection|2|||
13093624|NCT03655405|25833170|FG000|Overall Study|Died before initial data collection|1|||
13093625|NCT03655405|25833171|FG001|Overall Study|Died before initial data collection|2|||
13093626|NCT03655405|25833170|FG000|Overall Study|Protocol Violation|0|||
13147930|NCT02580058|26038681|FG000|Overall Study|Lost to Follow-up|4|||
13147931|NCT02580058|26038682|FG001|Overall Study|Lost to Follow-up|5|||
13147932|NCT02580058|26038683|FG002|Overall Study|Lost to Follow-up|4|||
13147933|NCT02580058|26038681|FG000|Overall Study|Ongoing|51|||
13147934|NCT02580058|26038682|FG001|Overall Study|Ongoing|55|||
13147935|NCT02580058|26038683|FG002|Overall Study|Ongoing|46|||
13147936|NCT02580058|26038681|FG000|Overall Study|Withdrawal by Subject|24|||
13147937|NCT02580058|26038682|FG001|Overall Study|Withdrawal by Subject|26|||
13147938|NCT02580058|26038683|FG002|Overall Study|Withdrawal by Subject|36|||
13147939|NCT02579928|26038696|FG000|Overall Study|Withdrawal by Subject|1|||
13147940|NCT02579928|26038697|FG001|Overall Study|Withdrawal by Subject|0|||
13147941|NCT02579863|26038724|FG000|Overall Study|Final Disposition Unknown|2|||
13147942|NCT02579863|26038725|FG001|Overall Study|Final Disposition Unknown|1|||
13147943|NCT02579863|26038724|FG000|Overall Study|Adverse Event|18|||
13147944|NCT02579863|26038725|FG001|Overall Study|Adverse Event|11|||
13147945|NCT02579863|26038724|FG000|Overall Study|Death|31|||
13147946|NCT02579863|26038725|FG001|Overall Study|Death|29|||
13147947|NCT02579863|26038724|FG000|Overall Study|Lost to Follow-up|2|||
13147948|NCT02579863|26038725|FG001|Overall Study|Lost to Follow-up|1|||
13147949|NCT02579863|26038724|FG000|Overall Study|Physician Decision|1|||
13093627|NCT03655405|25833171|FG001|Overall Study|Protocol Violation|1|||
13093628|NCT03655106|25833188|FG000|Overall Study|Withdrawal by Subject|3|||
13093629|NCT03655106|25833189|FG001|Overall Study|Withdrawal by Subject|2|||
13093630|NCT03655106|25833188|FG000|Overall Study|Lost to Follow-up|2|||
13147950|NCT02579863|26038725|FG001|Overall Study|Physician Decision|2|||
13147951|NCT02579863|26038724|FG000|Overall Study|Screen Failure|0|||
13147952|NCT02579863|26038725|FG001|Overall Study|Screen Failure|2|||
13147953|NCT02579863|26038724|FG000|Overall Study|Study Terminated at Selected Sites|82|||
13147954|NCT02579863|26038725|FG001|Overall Study|Study Terminated at Selected Sites|88|||
13147955|NCT02579863|26038724|FG000|Overall Study|Withdrawal by Subject|20|||
13147956|NCT02579863|26038725|FG001|Overall Study|Withdrawal by Subject|20|||
13147957|NCT02579772|26038746|FG000|Overall Study|Withdrawal by Subject|0|||
13147958|NCT02579772|26038747|FG001|Overall Study|Withdrawal by Subject|1|||
13147959|NCT02579772|26038746|FG000|Overall Study|Usage of additional antioxidants|1|||
13147960|NCT02579772|26038747|FG001|Overall Study|Usage of additional antioxidants|0|||
13147961|NCT02579772|26038746|FG000|Overall Study|flu-like illness, orthopedic trauma|1|||
13147962|NCT02579772|26038747|FG001|Overall Study|flu-like illness, orthopedic trauma|1|||
13093631|NCT03655106|25833189|FG001|Overall Study|Lost to Follow-up|1|||
13093632|NCT03655106|25833188|FG000|Overall Study|Duplicate Enrollment|1|||
13093633|NCT03655106|25833189|FG001|Overall Study|Duplicate Enrollment|1|||
13093634|NCT03655106|25833188|FG000|Overall Study|Protocol Violation|3|||
13093635|NCT03655106|25833189|FG001|Overall Study|Protocol Violation|0|||
13093636|NCT03654885|25833296|FG000|Overall Study|Randomized, Not Treated: Consent Withdrawn|5|||
13093637|NCT03654885|25833297|FG001|Overall Study|Randomized, Not Treated: Consent Withdrawn|3|||
13093638|NCT03654885|25833296|FG000|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|0|||
13093639|NCT03654885|25833297|FG001|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|3|||
13093640|NCT03654885|25833296|FG000|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|7|||
13093641|NCT03654885|25833297|FG001|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|1|||
13093642|NCT03654885|25833296|FG000|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|7|||
13093643|NCT03654885|25833297|FG001|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|1|||
13093644|NCT03654885|25833296|FG000|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|1|||
13093645|NCT03654885|25833297|FG001|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|0|||
13093646|NCT03654885|25833296|FG000|Overall Study|Adverse Event in Study Eye|3|||
13093647|NCT03654885|25833297|FG001|Overall Study|Adverse Event in Study Eye|0|||
13093648|NCT03654885|25833296|FG000|Overall Study|Consent Withdrawn|1|||
13093649|NCT03654885|25833297|FG001|Overall Study|Consent Withdrawn|0|||
13093650|NCT03654885|25833296|FG000|Overall Study|Death|3|||
13093651|NCT03654885|25833297|FG001|Overall Study|Death|1|||
13093652|NCT03654885|25833296|FG000|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|0|||
13093653|NCT03654885|25833297|FG001|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|1|||
13093654|NCT03654885|25833296|FG000|Overall Study|Lost to Follow-up|3|||
13093655|NCT03654885|25833297|FG001|Overall Study|Lost to Follow-up|3|||
13093656|NCT03654560|25833318|FG000|Overall Study|Death|3|||
13093657|NCT03654560|25833319|FG001|Overall Study|Death|1|||
13093658|NCT03654560|25833318|FG000|Overall Study|Lost to Follow-up|1|||
13093659|NCT03654560|25833319|FG001|Overall Study|Lost to Follow-up|0|||
13093660|NCT03654404|25833334|FG000|Overall Study|Death|1|||
13093661|NCT03654404|25833334|FG000|Overall Study|Lost to Follow-up|2|||
13093662|NCT03654404|25833334|FG000|Overall Study|Withdrawal by Subject|5|||
13093663|NCT03654326|25833355|FG000|Overall Study|Withdrawal by Subject|5|||
13093664|NCT03654326|25833356|FG001|Overall Study|Withdrawal by Subject|3|||
13093665|NCT03654326|25833355|FG000|Overall Study|Physician Decision|0|||
13093666|NCT03654326|25833356|FG001|Overall Study|Physician Decision|1|||
13093667|NCT03654326|25833355|FG000|Overall Study|Unable to adhere to study schedule|0|||
13093668|NCT03654326|25833356|FG001|Overall Study|Unable to adhere to study schedule|1|||
13093669|NCT03654326|25833355|FG000|Overall Study|Lost to Follow-up|1|||
13093670|NCT03654326|25833356|FG001|Overall Study|Lost to Follow-up|1|||
13093671|NCT03653429|25833375|FG000|Overall Study|Physician Decision|4|||
13093672|NCT03653429|25833376|FG001|Overall Study|Physician Decision|10|||
13147963|NCT02579759|26038801|FG000|Overall Study|Protocol Violation|2|||
13147964|NCT02579759|26038802|FG001|Overall Study|Protocol Violation|0|||
13147965|NCT02579759|26038803|FG002|Overall Study|Protocol Violation|0|||
13147966|NCT02579759|26038801|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0|||
13147967|NCT02579759|26038802|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1|||
13147968|NCT02579759|26038803|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0|||
13147969|NCT02579759|26038801|FG000|Overall Study|BfArM hold|13|||
13147970|NCT02579759|26038802|FG001|Overall Study|BfArM hold|12|||
13147971|NCT02579759|26038803|FG002|Overall Study|BfArM hold|12|||
13147972|NCT02579759|26038801|FG000|Overall Study|Sponsor stopped Dose 2|0|||
13147973|NCT02579759|26038802|FG001|Overall Study|Sponsor stopped Dose 2|41|||
13147974|NCT02579759|26038803|FG002|Overall Study|Sponsor stopped Dose 2|0|||
13147975|NCT02579759|26038801|FG000|Overall Study|Non compliance|0|||
13147976|NCT02579759|26038802|FG001|Overall Study|Non compliance|1|||
13147977|NCT02579759|26038803|FG002|Overall Study|Non compliance|0|||
13147978|NCT02579759|26038801|FG000|Overall Study|Pregnancy|0|||
13147979|NCT02579759|26038802|FG001|Overall Study|Pregnancy|1|||
13147980|NCT02579759|26038803|FG002|Overall Study|Pregnancy|0|||
13093673|NCT03653416|25833401|FG000|Overall Study|Protocol Violation|6|||
13093674|NCT03653416|25833402|FG001|Overall Study|Protocol Violation|1|||
13093675|NCT03653208|25833466|FG000|Overall Study|Withdrawal by Subject|0|||
13093676|NCT03653208|25833467|FG001|Overall Study|Withdrawal by Subject|0|||
13093677|NCT03653208|25833468|FG002|Overall Study|Withdrawal by Subject|0|||
13093678|NCT03653208|25833469|FG003|Overall Study|Withdrawal by Subject|0|||
13093679|NCT03653208|25833470|FG004|Overall Study|Withdrawal by Subject|1|||
13093680|NCT03653208|25833471|FG005|Overall Study|Withdrawal by Subject|0|||
13093681|NCT03653208|25833472|FG006|Overall Study|Withdrawal by Subject|0|||
13093682|NCT03653208|25833473|FG007|Overall Study|Withdrawal by Subject|1|||
13093683|NCT03653208|25833474|FG008|Overall Study|Withdrawal by Subject|1|||
13093684|NCT03652818|25833522|FG000|Overall Study|Adverse Event|1|||
13093685|NCT03652818|25833523|FG001|Overall Study|Adverse Event|0|||
13093686|NCT03652818|25833524|FG002|Overall Study|Adverse Event|0|||
13093687|NCT03652818|25833525|FG003|Overall Study|Adverse Event|0|||
13093688|NCT03652818|25833526|FG004|Overall Study|Adverse Event|0|||
13093689|NCT03652818|25833522|FG000|Overall Study|Physician Decision|1|||
13093690|NCT03652818|25833523|FG001|Overall Study|Physician Decision|0|||
13093691|NCT03652818|25833524|FG002|Overall Study|Physician Decision|0|||
13093692|NCT03652818|25833525|FG003|Overall Study|Physician Decision|0|||
13093693|NCT03652818|25833526|FG004|Overall Study|Physician Decision|0|||
13093694|NCT03652818|25833522|FG000|Overall Study|Lost to Follow-up|0|||
13093695|NCT03652818|25833523|FG001|Overall Study|Lost to Follow-up|1|||
13093696|NCT03652818|25833524|FG002|Overall Study|Lost to Follow-up|2|||
13093697|NCT03652818|25833525|FG003|Overall Study|Lost to Follow-up|1|||
13093698|NCT03652818|25833526|FG004|Overall Study|Lost to Follow-up|1|||
13093699|NCT03652675|25833553|FG000|Overall Study|Lost to Follow-up|4|||
13093700|NCT03652675|25833554|FG001|Overall Study|Lost to Follow-up|4|||
13093701|NCT03652662|25833573|FG000|Overall Study|Withdrawal by Subject|2|||
13093702|NCT03652662|25833574|FG001|Overall Study|Withdrawal by Subject|1|||
13093703|NCT03652662|25833573|FG000|Overall Study|Lost to Follow-up|1|||
13093704|NCT03652662|25833574|FG001|Overall Study|Lost to Follow-up|0|||
13093705|NCT03652610|25833607|FG000|Overall Study|Lost to Follow-up|1|||
13093706|NCT03652610|25833608|FG001|Overall Study|Lost to Follow-up|0|||
13093707|NCT03652610|25833607|FG000|Overall Study|Withdrawal by Subject|3|||
13093708|NCT03652610|25833608|FG001|Overall Study|Withdrawal by Subject|5|||
13093709|NCT03651622|25833668|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0|||
13093710|NCT03651622|25833669|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6|||
13093711|NCT03651622|25833670|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2|||
13093712|NCT03651622|25833668|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4|||
13093713|NCT03651622|25833669|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1|||
13093714|NCT03651622|25833670|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7|||
13093715|NCT03651622|25833668|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0|||
13093716|NCT03651622|25833669|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2|||
13093717|NCT03651622|25833670|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3|||
13093718|NCT03651622|25833668|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2|||
13093719|NCT03651622|25833669|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
13093720|NCT03651622|25833670|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
13093721|NCT03651622|25833668|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
13093722|NCT03651622|25833669|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
13093723|NCT03651622|25833670|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1|||
13093724|NCT03650556|25833680|FG000|Overall Study|Death|2|||
13093725|NCT03650556|25833680|FG000|Overall Study|Withdrawal by Subject|20|||
13093726|NCT03650556|25833680|FG000|Overall Study|Physician Decision|2|||
13093727|NCT03650556|25833680|FG000|Overall Study|Lost to Follow-up|8|||
13093728|NCT03650556|25833680|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4|||
13093729|NCT03650556|25833680|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1|||
13093730|NCT03650452|25833713|FG000|Overall Study|Physician Decision|1|||
13093731|NCT03650452|25833714|FG001|Overall Study|Physician Decision|0|||
13147981|NCT02579759|26038801|FG000|Overall Study|Inclusion/exclusion criteria|0|||
13147982|NCT02579759|26038802|FG001|Overall Study|Inclusion/exclusion criteria|0|||
13147983|NCT02579759|26038803|FG002|Overall Study|Inclusion/exclusion criteria|1|||
13147984|NCT02579759|26038801|FG000|Overall Study|Adverse Event|4|||
13147985|NCT02579759|26038802|FG001|Overall Study|Adverse Event|3|||
13147986|NCT02579759|26038803|FG002|Overall Study|Adverse Event|1|||
13147987|NCT02579759|26038801|FG000|Overall Study|Withdrawal by Subject|3|||
13147988|NCT02579759|26038802|FG001|Overall Study|Withdrawal by Subject|3|||
13093732|NCT03650452|25833713|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
13093733|NCT03650452|25833714|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
13093734|NCT03650452|25833713|FG000|Overall Study|Adverse Event|3|||
13093735|NCT03650452|25833714|FG001|Overall Study|Adverse Event|4|||
13093736|NCT03650452|25833713|FG000|Overall Study|Early Withdrawal from Study Treatment|3|||
13093737|NCT03650452|25833714|FG001|Overall Study|Early Withdrawal from Study Treatment|0|||
13093738|NCT03650400|25833749|FG000|Overall Study|Study terminated by sponsor|0|||
13093739|NCT03650400|25833750|FG001|Overall Study|Study terminated by sponsor|5|||
13147989|NCT02579759|26038803|FG002|Overall Study|Withdrawal by Subject|5|||
13093740|NCT03650387|25833776|FG000|Overall Study|Withdrawal by Subject|13|||
13093741|NCT03650387|25833776|FG000|Overall Study|Lost to Follow-up|12|||
13093742|NCT03650387|25833776|FG000|Overall Study|Adverse Event (Not related)|1|||
13093743|NCT03650387|25833776|FG000|Overall Study|Due to COVID-19 Pandemic|8|||
13093744|NCT03649477|25833806|FG000|Overall Study|Adverse Event|2|||
13093745|NCT03649477|25833807|FG001|Overall Study|Adverse Event|0|||
13093746|NCT03649477|25833808|FG002|Overall Study|Adverse Event|0|||
13132672|NCT02786901|25984778|FG001|Overall Study|Subject Request/Lost to Follow up|5|||
13132673|NCT02786901|25984779|FG002|Overall Study|Subject Request/Lost to Follow up|5|||
13132674|NCT02786901|25984777|FG000|Overall Study|Disallowed medication|1|||
13132675|NCT02786901|25984778|FG001|Overall Study|Disallowed medication|1|||
13132676|NCT02786901|25984779|FG002|Overall Study|Disallowed medication|0|||
13132677|NCT02786901|25984777|FG000|Overall Study|Randomized in error|2|||
13132678|NCT02786901|25984778|FG001|Overall Study|Randomized in error|0|||
13132679|NCT02786901|25984779|FG002|Overall Study|Randomized in error|1|||
13132680|NCT02786836|25984787|FG000|Overall Study|Death|1|||
13132681|NCT02786836|25984787|FG000|Overall Study|Lack of Efficacy|2|||
13132682|NCT02786836|25984787|FG000|Overall Study|Protocol Violation|3|||
13132683|NCT02786836|25984787|FG000|Overall Study|Withdrawal by Subject|3|||
13132684|NCT02786836|25984787|FG000|Overall Study|Liver Transplantation|2|||
13132685|NCT02786836|25984787|FG000|Overall Study|Device or Pharmacy Issues|3|||
13132686|NCT02786004|25984802|FG000|Overall Study|Withdrawal by Subject|0|||
13132687|NCT02786004|25984803|FG001|Overall Study|Withdrawal by Subject|1|||
13132688|NCT02785939|25984819|FG000|Overall Study|Progression|25|||
13132689|NCT02785939|25984820|FG001|Overall Study|Progression|8|||
13132690|NCT02785939|25984819|FG000|Overall Study|Adverse Event|3|||
13132691|NCT02785939|25984820|FG001|Overall Study|Adverse Event|1|||
13132692|NCT02785939|25984819|FG000|Overall Study|Death|1|||
13132693|NCT02785939|25984820|FG001|Overall Study|Death|0|||
13132694|NCT02785939|25984819|FG000|Overall Study|Refusal|1|||
13132695|NCT02785939|25984820|FG001|Overall Study|Refusal|0|||
13132696|NCT02785939|25984819|FG000|Overall Study|Deteriorating health|1|||
13132697|NCT02785939|25984820|FG001|Overall Study|Deteriorating health|0|||
13132698|NCT02785939|25984819|FG000|Overall Study|Not protocol specified|0|||
13132699|NCT02785939|25984820|FG001|Overall Study|Not protocol specified|1|||
13132700|NCT02785913|25984831|FG000|Overall Study|Adverse Event|5|||
13132701|NCT02785913|25984831|FG000|Overall Study|Death|2|||
13132702|NCT02785913|25984831|FG000|Overall Study|Progression|18|||
13132703|NCT02785913|25984831|FG000|Overall Study|Not protocol specified|1|||
13132704|NCT02785900|25984862|FG000|Overall Study|Study Termination by Sponsor|64|||
13132705|NCT02785900|25984863|FG001|Overall Study|Study Termination by Sponsor|81|||
13132706|NCT02785900|25984862|FG000|Overall Study|Death|46|||
13132707|NCT02785900|25984863|FG001|Overall Study|Death|32|||
13132708|NCT02785900|25984862|FG000|Overall Study|Withdrawal by Subject|4|||
13132709|NCT02785900|25984863|FG001|Overall Study|Withdrawal by Subject|8|||
13132710|NCT02785900|25984862|FG000|Overall Study|Physician Decision|3|||
13147990|NCT02579759|26038801|FG000|Overall Study|Lost to Follow-up|2|||
13147991|NCT02579759|26038802|FG001|Overall Study|Lost to Follow-up|2|||
13147992|NCT02579759|26038803|FG002|Overall Study|Lost to Follow-up|2|||
13147993|NCT02579629|26038860|FG000|Overall Study|Withdrawal by Subject|0|||
13147994|NCT02579629|26038861|FG001|Overall Study|Withdrawal by Subject|1|||
13147995|NCT02579629|26038862|FG002|Overall Study|Withdrawal by Subject|0|||
13147996|NCT02579629|26038860|FG000|Overall Study|Screen Failure|2|||
13147997|NCT02579629|26038861|FG001|Overall Study|Screen Failure|0|||
13147998|NCT02579629|26038862|FG002|Overall Study|Screen Failure|2|||
13147999|NCT02579616|26038875|FG000|Overall Study|Participants did not receive treatment|3|||
13148000|NCT02579603|26038891|FG000|Overall Study|Not treated|1|||
13148001|NCT02579603|26038892|FG001|Overall Study|Not treated|0|||
13148002|NCT02579603|26038891|FG000|Overall Study|Adverse Event|2|||
13148003|NCT02579603|26038892|FG001|Overall Study|Adverse Event|2|||
13148004|NCT02579603|26038891|FG000|Overall Study|Other than stated|1|||
13148005|NCT02579603|26038892|FG001|Overall Study|Other than stated|0|||
13148006|NCT02579382|26038998|FG000|Main Study Phase|Lost to Follow-up|0|||
13148007|NCT02579382|26038999|FG001|Main Study Phase|Lost to Follow-up|0|||
13148008|NCT02579382|26039000|FG002|Main Study Phase|Lost to Follow-up|2|||
13132711|NCT02785900|25984863|FG001|Overall Study|Physician Decision|2|||
13132712|NCT02785770|25984935|FG000|Intervention Period 2 (1 Day)|Adverse Event|0|||
13132713|NCT02785770|25984936|FG001|Intervention Period 2 (1 Day)|Adverse Event|1|||
13132714|NCT02785770|25984937|FG002|Intervention Period 2 (1 Day)|Adverse Event|0|||
13132715|NCT02785770|25984938|FG003|Intervention Period 2 (1 Day)|Adverse Event|0|||
13132716|NCT02785770|25984935|FG000|Intervention Period 2 (1 Day)|Family related obligations|0|||
13132717|NCT02785770|25984936|FG001|Intervention Period 2 (1 Day)|Family related obligations|0|||
13132718|NCT02785770|25984937|FG002|Intervention Period 2 (1 Day)|Family related obligations|1|||
13132719|NCT02785770|25984938|FG003|Intervention Period 2 (1 Day)|Family related obligations|0|||
13148009|NCT02579382|26039001|FG003|Main Study Phase|Lost to Follow-up|0|||
13148010|NCT02579382|26038998|FG000|Main Study Phase|Withdrew Consent|0|||
13148011|NCT02579382|26038999|FG001|Main Study Phase|Withdrew Consent|0|||
13148012|NCT02579382|26039000|FG002|Main Study Phase|Withdrew Consent|0|||
13148013|NCT02579382|26039001|FG003|Main Study Phase|Withdrew Consent|2|||
13148014|NCT02579382|26038998|FG000|Main Study Phase|Lack of Efficacy|0|||
13148015|NCT02579382|26038999|FG001|Main Study Phase|Lack of Efficacy|0|||
13148016|NCT02579382|26039000|FG002|Main Study Phase|Lack of Efficacy|0|||
13148017|NCT02579382|26039001|FG003|Main Study Phase|Lack of Efficacy|1|||
13148018|NCT02579382|26038998|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0|||
13148019|NCT02579382|26038999|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3|||
13093747|NCT03649412|25833973|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1|||
13093748|NCT03649412|25833974|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0|||
13093749|NCT03649412|25833973|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1|||
13093750|NCT03649412|25833974|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0|||
13093751|NCT03649412|25833973|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
13093752|NCT03649412|25833974|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
13093753|NCT03649412|25833973|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1|||
13093754|NCT03649412|25833974|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0|||
13093755|NCT03649412|25833973|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0|||
13093756|NCT03649412|25833974|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1|||
13093757|NCT03649412|25833973|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0|||
13093758|NCT03649412|25833974|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1|||
13093759|NCT03648983|25833982|FG000|Overall Study|Study was terminated due to PI departure|95|||
13093760|NCT03648879|25833990|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1|||
13093761|NCT03647709|25834008|FG000|Overall Study|Lost to Follow-up|5|||
13093762|NCT03647709|25834008|FG000|Overall Study|Physician Decision|6|||
13093763|NCT03647709|25834008|FG000|Overall Study|Withdrawal by Subject|3|||
13093764|NCT03647267|25834031|FG000|Overall Study|Lost to Follow-up|1|||
13093765|NCT03647267|25834032|FG001|Overall Study|Lost to Follow-up|0|||
13093766|NCT03646656|25834056|FG000|Overall Study|Lost to Follow-up|1|||
13093767|NCT03646656|25834057|FG001|Overall Study|Lost to Follow-up|0|||
13093768|NCT03646656|25834056|FG000|Overall Study|Withdrawal by Subject|2|||
13093769|NCT03646656|25834057|FG001|Overall Study|Withdrawal by Subject|0|||
13093770|NCT03646305|25834140|FG000|Overall Study|Lost to Follow-up|4|||
13093771|NCT03646305|25834141|FG001|Overall Study|Lost to Follow-up|2|||
13093772|NCT03646305|25834142|FG002|Overall Study|Lost to Follow-up|2|||
13093773|NCT03646305|25834143|FG003|Overall Study|Lost to Follow-up|1|||
13093774|NCT03646305|25834140|FG000|Overall Study|Withdrawal by Subject|1|||
13093775|NCT03646305|25834141|FG001|Overall Study|Withdrawal by Subject|0|||
13093776|NCT03646305|25834142|FG002|Overall Study|Withdrawal by Subject|0|||
13093777|NCT03646305|25834143|FG003|Overall Study|Withdrawal by Subject|1|||
13093778|NCT03645434|25834197|FG000|Period 1|Adverse Event|0|||
13093779|NCT03645434|25834198|FG001|Period 1|Adverse Event|0|||
13093780|NCT03645434|25834199|FG002|Period 1|Adverse Event|0|||
13093781|NCT03645434|25834200|FG003|Period 1|Adverse Event|1|||
13093782|NCT03645434|25834201|FG004|Period 1|Adverse Event|0|||
13093783|NCT03645434|25834202|FG005|Period 1|Adverse Event|0|||
13093784|NCT03645434|25834197|FG000|Period 1|COPD exacerbation|0|||
13093785|NCT03645434|25834198|FG001|Period 1|COPD exacerbation|0|||
13093786|NCT03645434|25834199|FG002|Period 1|COPD exacerbation|0|||
13148020|NCT02579382|26039000|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1|||
13148021|NCT02579382|26039001|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4|||
13148022|NCT02579382|26038998|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1|||
13148023|NCT02579382|26038999|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
13148024|NCT02579382|26039000|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2|||
13148025|NCT02579382|26039001|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
13148026|NCT02579382|26038998|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0|||
13148027|NCT02579382|26038999|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
13148028|NCT02579382|26039000|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
13148029|NCT02579382|26039001|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
13148030|NCT02579382|26038998|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
13148031|NCT02579382|26038999|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1|||
13148032|NCT02579382|26039000|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
13148033|NCT02579382|26039001|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
13148034|NCT02579382|26038998|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
13148035|NCT02579382|26038999|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1|||
13307578|NCT01284361|26529108|FG000|Overall Study|Withdrawal by Subject|1|||
13093787|NCT03645434|25834200|FG003|Period 1|COPD exacerbation|0|||
13093788|NCT03645434|25834201|FG004|Period 1|COPD exacerbation|1|||
13093789|NCT03645434|25834202|FG005|Period 1|COPD exacerbation|0|||
13093790|NCT03645421|25834279|FG000|Overall Study|Adverse Event|0|||
13093791|NCT03645421|25834280|FG001|Overall Study|Adverse Event|0|||
13093792|NCT03645421|25834281|FG002|Overall Study|Adverse Event|4|||
13093793|NCT03645421|25834282|FG003|Overall Study|Adverse Event|1|||
13148036|NCT02579382|26039000|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
13148037|NCT02579382|26039001|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
13148038|NCT02579382|26038998|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
13148039|NCT02579382|26038999|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1|||
13148040|NCT02579382|26039000|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
13148041|NCT02579382|26039001|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
13148042|NCT02579096|26039014|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10|||
13148043|NCT02579096|26039015|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6|||
13148044|NCT02579096|26039014|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2|||
13148045|NCT02579096|26039015|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1|||
13148046|NCT02579096|26039014|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32|||
13148047|NCT02579096|26039015|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36|||
13148048|NCT02579096|26039014|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9|||
13148049|NCT02579096|26039015|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4|||
13148050|NCT02579096|26039014|FG000|Phase 1, Weeks 0 - 24|Other reasons|4|||
13148051|NCT02579096|26039015|FG001|Phase 1, Weeks 0 - 24|Other reasons|3|||
13148052|NCT02579096|26039014|FG000|Phase 2, Weeks 25 - 48|Death|2|||
13093794|NCT03645421|25834279|FG000|Overall Study|Withdrawal by patient|0|||
13093795|NCT03645421|25834280|FG001|Overall Study|Withdrawal by patient|0|||
13093796|NCT03645421|25834281|FG002|Overall Study|Withdrawal by patient|0|||
13093797|NCT03645421|25834282|FG003|Overall Study|Withdrawal by patient|3|||
13093798|NCT03645421|25834279|FG000|Overall Study|Study specific withdrawal criteria|0|||
13093799|NCT03645421|25834280|FG001|Overall Study|Study specific withdrawal criteria|0|||
13093800|NCT03645421|25834281|FG002|Overall Study|Study specific withdrawal criteria|1|||
13093801|NCT03645421|25834282|FG003|Overall Study|Study specific withdrawal criteria|0|||
13093802|NCT03645395|25834345|FG000|Part 1 (Up to 6 Months)|Adverse Event|1|||
13093803|NCT03645395|25834346|FG001|Part 1 (Up to 6 Months)|Adverse Event|0|||
13093804|NCT03645395|25834347|FG002|Part 1 (Up to 6 Months)|Adverse Event|0|||
13093805|NCT03645395|25834348|FG003|Part 1 (Up to 6 Months)|Adverse Event|0|||
13093806|NCT03645395|25834345|FG000|Part 1 (Up to 6 Months)|Disease Progression|0|||
13093807|NCT03645395|25834346|FG001|Part 1 (Up to 6 Months)|Disease Progression|1|||
13093808|NCT03645395|25834347|FG002|Part 1 (Up to 6 Months)|Disease Progression|0|||
13093809|NCT03645395|25834348|FG003|Part 1 (Up to 6 Months)|Disease Progression|0|||
13093810|NCT03645395|25834345|FG000|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
13093811|NCT03645395|25834346|FG001|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
13093812|NCT03645395|25834347|FG002|Part 1 (Up to 6 Months)|Withdrawal by Subject|1|||
13093813|NCT03645395|25834348|FG003|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
13093814|NCT03645395|25834345|FG000|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|1|||
13093815|NCT03645395|25834346|FG001|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
13093816|NCT03645395|25834347|FG002|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
13093817|NCT03645395|25834348|FG003|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|0|||
13093818|NCT03645057|25834383|FG000|Randomization to Baseline|Lost to Follow-up|1|||
13093819|NCT03645057|25834384|FG001|Randomization to Baseline|Lost to Follow-up|0|||
13093820|NCT03645057|25834385|FG002|Randomization to Baseline|Lost to Follow-up|1|||
13093821|NCT03645057|25834386|FG003|Randomization to Baseline|Lost to Follow-up|0|||
13093822|NCT03645057|25834383|FG000|Baseline to Six Weeks|Withdrawal by Subject|1|||
13093823|NCT03645057|25834384|FG001|Baseline to Six Weeks|Withdrawal by Subject|0|||
13093824|NCT03645057|25834385|FG002|Baseline to Six Weeks|Withdrawal by Subject|1|||
13148053|NCT02579096|26039015|FG001|Phase 2, Weeks 25 - 48|Death|4|||
13148054|NCT02579096|26039014|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3|||
13148055|NCT02579096|26039015|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1|||
13148056|NCT02579096|26039014|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4|||
13148057|NCT02579096|26039015|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0|||
13148058|NCT02579096|26039014|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9|||
13148059|NCT02579096|26039015|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12|||
13148060|NCT02579096|26039014|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4|||
13148061|NCT02579096|26039015|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9|||
13148062|NCT02579096|26039014|FG000|Phase 2, Weeks 25 - 48|Other reasons|0|||
13148063|NCT02579096|26039015|FG001|Phase 2, Weeks 25 - 48|Other reasons|5|||
13148064|NCT02579096|26039014|FG000|Phase 3, Weeks 49 - 72|Death|3|||
13148065|NCT02579096|26039015|FG001|Phase 3, Weeks 49 - 72|Death|2|||
13148066|NCT02579096|26039014|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0|||
13148067|NCT02579096|26039015|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1|||
13148068|NCT02579096|26039014|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0|||
13148069|NCT02579096|26039015|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5|||
13148070|NCT02579096|26039014|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6|||
13148071|NCT02579096|26039015|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4|||
13307579|NCT01284361|26529108|FG000|Overall Study|Protocol Violation|5|||
13093825|NCT03645057|25834386|FG003|Baseline to Six Weeks|Withdrawal by Subject|0|||
13093826|NCT03645057|25834383|FG000|Baseline to Six Weeks|Lost to Follow-up|5|||
13093827|NCT03645057|25834384|FG001|Baseline to Six Weeks|Lost to Follow-up|2|||
13148072|NCT02579096|26039014|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10|||
13148073|NCT02579096|26039015|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5|||
13148074|NCT02579096|26039014|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0|||
13148075|NCT02579096|26039015|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1|||
13148076|NCT02579096|26039014|FG000|Phase 3, Weeks 49 - 72|Other reasons|3|||
13148077|NCT02579096|26039015|FG001|Phase 3, Weeks 49 - 72|Other reasons|0|||
13148078|NCT02578992|26039034|FG000|Overall Study|equipment not available or malfunction|3|||
13148079|NCT02578992|26039035|FG001|Overall Study|equipment not available or malfunction|3|||
13148080|NCT02578940|26039044|FG000|Overall Study|Screening failure|5|||
13148081|NCT02578940|26039044|FG000|Overall Study|Lost to Follow-up|1|||
13148082|NCT02578862|26039067|FG000|Overall Study|Withdrawal by Subject|0|||
13148083|NCT02578862|26039068|FG001|Overall Study|Withdrawal by Subject|1|||
13148084|NCT02578862|26039067|FG000|Overall Study|Unplanned unilateral procedure|0|||
13148085|NCT02578862|26039068|FG001|Overall Study|Unplanned unilateral procedure|1|||
13148086|NCT02578706|26039155|FG000|Overall Study|Withdrawal by Subject|1|||
13148087|NCT02578706|26039156|FG001|Overall Study|Withdrawal by Subject|0|||
13148088|NCT02578706|26039157|FG002|Overall Study|Withdrawal by Subject|0|||
13148089|NCT02578706|26039155|FG000|Overall Study|Lost to Follow-up|0|||
13148090|NCT02578706|26039156|FG001|Overall Study|Lost to Follow-up|4|||
13148091|NCT02578706|26039157|FG002|Overall Study|Lost to Follow-up|0|||
13148092|NCT02578706|26039155|FG000|Overall Study|Physician Decision|0|||
13148093|NCT02578706|26039156|FG001|Overall Study|Physician Decision|1|||
13148094|NCT02578706|26039157|FG002|Overall Study|Physician Decision|0|||
13148095|NCT02578316|26039183|FG000|Extension Phase|Progression of disease|6|||
13205034|NCT01968070|26230882|FG008|Period 1|Withdrawal by Subject|0|||
13205035|NCT01968070|26230883|FG009|Period 1|Withdrawal by Subject|0|||
13205036|NCT01968070|26230884|FG010|Period 1|Withdrawal by Subject|0|||
13205037|NCT01968070|26230885|FG011|Period 1|Withdrawal by Subject|0|||
13205038|NCT01968070|26230886|FG012|Period 1|Withdrawal by Subject|0|||
13205039|NCT01968070|26230887|FG013|Period 1|Withdrawal by Subject|0|||
13205040|NCT01968070|26230888|FG014|Period 1|Withdrawal by Subject|0|||
13205041|NCT01968070|26230889|FG015|Period 1|Withdrawal by Subject|1|||
13205042|NCT01968070|26230890|FG016|Period 1|Withdrawal by Subject|0|||
13205043|NCT01968070|26230891|FG017|Period 1|Withdrawal by Subject|0|||
13205044|NCT01968070|26230874|FG000|Period 1|Protocol Violation|0|||
13205045|NCT01968070|26230875|FG001|Period 1|Protocol Violation|0|||
13205046|NCT01968070|26230876|FG002|Period 1|Protocol Violation|0|||
13205047|NCT01968070|26230877|FG003|Period 1|Protocol Violation|1|||
13205048|NCT01968070|26230878|FG004|Period 1|Protocol Violation|1|||
13205049|NCT01968070|26230879|FG005|Period 1|Protocol Violation|0|||
13205050|NCT01968070|26230880|FG006|Period 1|Protocol Violation|0|||
13205051|NCT01968070|26230881|FG007|Period 1|Protocol Violation|0|||
13205052|NCT01968070|26230882|FG008|Period 1|Protocol Violation|0|||
13205053|NCT01968070|26230883|FG009|Period 1|Protocol Violation|0|||
13205054|NCT01968070|26230884|FG010|Period 1|Protocol Violation|0|||
13205055|NCT01968070|26230885|FG011|Period 1|Protocol Violation|0|||
13205056|NCT01968070|26230886|FG012|Period 1|Protocol Violation|0|||
13205057|NCT01968070|26230887|FG013|Period 1|Protocol Violation|0|||
13205058|NCT01968070|26230888|FG014|Period 1|Protocol Violation|0|||
13205059|NCT01968070|26230889|FG015|Period 1|Protocol Violation|0|||
13205060|NCT01968070|26230890|FG016|Period 1|Protocol Violation|0|||
13205061|NCT01968070|26230891|FG017|Period 1|Protocol Violation|0|||
13205062|NCT01968070|26230874|FG000|Period 1|Lost to Follow-up|0|||
13205063|NCT01968070|26230875|FG001|Period 1|Lost to Follow-up|0|||
13205064|NCT01968070|26230876|FG002|Period 1|Lost to Follow-up|0|||
13205065|NCT01968070|26230877|FG003|Period 1|Lost to Follow-up|1|||
13205066|NCT01968070|26230878|FG004|Period 1|Lost to Follow-up|0|||
13205067|NCT01968070|26230879|FG005|Period 1|Lost to Follow-up|0|||
13205068|NCT01968070|26230880|FG006|Period 1|Lost to Follow-up|0|||
13205069|NCT01968070|26230881|FG007|Period 1|Lost to Follow-up|0|||
13205070|NCT01968070|26230882|FG008|Period 1|Lost to Follow-up|0|||
13205071|NCT01968070|26230883|FG009|Period 1|Lost to Follow-up|0|||
13205072|NCT01968070|26230884|FG010|Period 1|Lost to Follow-up|0|||
13205073|NCT01968070|26230885|FG011|Period 1|Lost to Follow-up|0|||
13205074|NCT01968070|26230886|FG012|Period 1|Lost to Follow-up|0|||
13205075|NCT01968070|26230887|FG013|Period 1|Lost to Follow-up|0|||
13205076|NCT01968070|26230888|FG014|Period 1|Lost to Follow-up|0|||
13205077|NCT01968070|26230889|FG015|Period 1|Lost to Follow-up|0|||
13205078|NCT01968070|26230890|FG016|Period 1|Lost to Follow-up|0|||
13205079|NCT01968070|26230891|FG017|Period 1|Lost to Follow-up|0|||
13205080|NCT01968070|26230874|FG000|Period 1|Adverse Event|0|||
13205081|NCT01968070|26230875|FG001|Period 1|Adverse Event|0|||
13205082|NCT01968070|26230876|FG002|Period 1|Adverse Event|0|||
13205083|NCT01968070|26230877|FG003|Period 1|Adverse Event|0|||
13205084|NCT01968070|26230878|FG004|Period 1|Adverse Event|0|||
13205085|NCT01968070|26230879|FG005|Period 1|Adverse Event|0|||
13205086|NCT01968070|26230880|FG006|Period 1|Adverse Event|1|||
13205087|NCT01968070|26230881|FG007|Period 1|Adverse Event|0|||
13205088|NCT01968070|26230882|FG008|Period 1|Adverse Event|0|||
13148096|NCT02578186|26039192|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
13148097|NCT02578186|26039193|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
13148098|NCT02578186|26039192|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
13148099|NCT02578186|26039193|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
13148100|NCT02577887|26039202|FG000|Overall Study|Death|93|||
13148101|NCT02577887|26039202|FG000|Overall Study|Protocol Violation|125|||
13148102|NCT02577887|26039202|FG000|Overall Study|Withdrawal by Subject|80|||
13148103|NCT02577718|26039210|FG000|Overall Study|Death|6|||
13148104|NCT02577718|26039210|FG000|Overall Study|Withdrawal by Subject|2|||
13148105|NCT02577523|26039237|FG000|Overall Study|Adverse Event|1|||
13148106|NCT02577523|26039238|FG001|Overall Study|Adverse Event|1|||
13148107|NCT02577523|26039237|FG000|Overall Study|Lack of Efficacy|1|||
13148108|NCT02577523|26039238|FG001|Overall Study|Lack of Efficacy|1|||
13148109|NCT02577523|26039237|FG000|Overall Study|Withdrawal by Subject|1|||
13148110|NCT02577523|26039238|FG001|Overall Study|Withdrawal by Subject|0|||
13148111|NCT02577315|26039261|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
13148112|NCT02577315|26039262|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
13148113|NCT02577146|26039269|FG000|Overall Study|Lost to Follow-up|8|||
13148114|NCT02577146|26039269|FG000|Overall Study|Physician Decision|3|||
13148115|NCT02577146|26039269|FG000|Overall Study|Screen Failure|17|||
13148116|NCT02577107|26039288|FG000|Overall Study|Protocol deviation|0|||
13148117|NCT02577107|26039289|FG001|Overall Study|Protocol deviation|1|||
13093828|NCT03645057|25834385|FG002|Baseline to Six Weeks|Lost to Follow-up|5|||
13093829|NCT03645057|25834386|FG003|Baseline to Six Weeks|Lost to Follow-up|2|||
13093830|NCT03645057|25834383|FG000|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
13093831|NCT03645057|25834384|FG001|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
13093832|NCT03645057|25834385|FG002|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
13093833|NCT03645057|25834386|FG003|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
13093834|NCT03644550|25834397|FG000|Overall Study|Withdrawal by Subject|3|||
13093835|NCT03644550|25834397|FG000|Overall Study|Progressive disease|15|||
13093836|NCT03644173|25834421|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21|||
13093837|NCT03644173|25834421|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2|||
13093838|NCT03644173|25834421|FG000|Participants at the 1-month Follow up|Death|2|||
13093839|NCT03644173|25834421|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2|||
13093840|NCT03643952|25834444|FG000|Overall Study|Lack of Efficacy|1|||
13093841|NCT03643575|25834507|FG000|Washout: 7 Days|Withdrew consent due to illness|0|||
13093842|NCT03643575|25834508|FG001|Washout: 7 Days|Withdrew consent due to illness|0|||
13093843|NCT03643575|25834509|FG002|Washout: 7 Days|Withdrew consent due to illness|0|||
13093844|NCT03643575|25834510|FG003|Washout: 7 Days|Withdrew consent due to illness|1|||
13093845|NCT03643575|25834511|FG004|Washout: 7 Days|Withdrew consent due to illness|0|||
13093846|NCT03643575|25834512|FG005|Washout: 7 Days|Withdrew consent due to illness|0|||
13093847|NCT03643575|25834507|FG000|Washout: 7 Days|Adverse Event|1|||
13093848|NCT03643575|25834508|FG001|Washout: 7 Days|Adverse Event|0|||
13148118|NCT02577029|26039420|FG000|Overall Study|Adverse Event|1|||
13148119|NCT02577029|26039421|FG001|Overall Study|Adverse Event|0|||
13148120|NCT02577029|26039422|FG002|Overall Study|Adverse Event|2|||
13148121|NCT02577029|26039423|FG003|Overall Study|Adverse Event|0|||
13148122|NCT02577029|26039424|FG004|Overall Study|Adverse Event|1|||
13148123|NCT02577029|26039425|FG005|Overall Study|Adverse Event|0|||
13148124|NCT02577029|26039426|FG006|Overall Study|Adverse Event|0|||
13148125|NCT02577029|26039427|FG007|Overall Study|Adverse Event|0|||
13148126|NCT02577029|26039420|FG000|Overall Study|Withdrawal by Subject|0|||
13093849|NCT03643575|25834509|FG002|Washout: 7 Days|Adverse Event|0|||
13093850|NCT03643575|25834510|FG003|Washout: 7 Days|Adverse Event|0|||
13093851|NCT03643575|25834511|FG004|Washout: 7 Days|Adverse Event|0|||
13093852|NCT03643575|25834512|FG005|Washout: 7 Days|Adverse Event|0|||
13093853|NCT03643575|25834507|FG000|Washout: 7 Days|Non compliance check in|0|||
13093854|NCT03643575|25834508|FG001|Washout: 7 Days|Non compliance check in|1|||
13093855|NCT03643575|25834509|FG002|Washout: 7 Days|Non compliance check in|0|||
13093856|NCT03643575|25834510|FG003|Washout: 7 Days|Non compliance check in|0|||
13093857|NCT03643575|25834511|FG004|Washout: 7 Days|Non compliance check in|0|||
13093858|NCT03643575|25834512|FG005|Washout: 7 Days|Non compliance check in|0|||
13093859|NCT03643432|25834541|FG000|Overall Study|Lost to Follow-up|1|||
13093860|NCT03643432|25834542|FG001|Overall Study|Lost to Follow-up|0|||
13093861|NCT03643159|25834555|FG000|Overall Study|Adverse Event|1|||
13093862|NCT03643159|25834555|FG000|Overall Study|Withdrawal by Subject|1|||
13093863|NCT03642873|25834594|FG000|Third Intervention (1 Day)|Screen failure|0|||
13093864|NCT03642873|25834595|FG001|Third Intervention (1 Day)|Screen failure|0|||
13093865|NCT03642873|25834596|FG002|Third Intervention (1 Day)|Screen failure|0|||
13148127|NCT02577029|26039421|FG001|Overall Study|Withdrawal by Subject|0|||
13148128|NCT02577029|26039422|FG002|Overall Study|Withdrawal by Subject|0|||
13148129|NCT02577029|26039423|FG003|Overall Study|Withdrawal by Subject|0|||
13093866|NCT03642873|25834597|FG003|Third Intervention (1 Day)|Screen failure|0|||
13093867|NCT03642873|25834598|FG004|Third Intervention (1 Day)|Screen failure|1|||
13148130|NCT02577029|26039424|FG004|Overall Study|Withdrawal by Subject|0|||
13307580|NCT01284361|26529108|FG000|Overall Study|Adverse Event|1|||
13093868|NCT03642873|25834599|FG005|Third Intervention (1 Day)|Screen failure|0|||
13093869|NCT03642717|25834617|FG000|Overall Study|Lost to Follow-up|2|||
13093870|NCT03642717|25834617|FG000|Overall Study|Inclusion/exclusion criteria violation|33|||
13093871|NCT03642717|25834617|FG000|Overall Study|Taken study drug prior to contract date|3|||
13093872|NCT03642262|25834639|FG000|Period 1|Withdrawal by Subject|1|||
13093873|NCT03642262|25834640|FG001|Period 1|Withdrawal by Subject|1|||
13093874|NCT03642262|25834639|FG000|Period 1|Adverse Event|0|||
13093875|NCT03642262|25834640|FG001|Period 1|Adverse Event|1|||
13093876|NCT03641651|25834653|FG000|Overall Study|organizational issues at one study site|1|||
13093877|NCT03641508|25834670|FG000|First Injection|Lost to Follow-up|2|||
13093878|NCT03641508|25834671|FG001|First Injection|Lost to Follow-up|0|||
13093879|NCT03640559|25834684|FG000|Overall Study|Physician Decision|1|||
13093880|NCT03640559|25834685|FG001|Overall Study|Physician Decision|1|||
13093881|NCT03640559|25834684|FG000|Overall Study|Withdrawal by Subject|1|||
13093882|NCT03640559|25834685|FG001|Overall Study|Withdrawal by Subject|0|||
13093883|NCT03640507|25834715|FG000|Overall Study|Withdrawal by Subject|0|||
13093884|NCT03640507|25834716|FG001|Overall Study|Withdrawal by Subject|0|||
13093885|NCT03640507|25834717|FG002|Overall Study|Withdrawal by Subject|1|||
13093886|NCT03640052|25834740|FG000|Overall Study|Lost to Follow-up|0|||
13093887|NCT03640052|25834741|FG001|Overall Study|Lost to Follow-up|1|||
13093888|NCT03640052|25834742|FG002|Overall Study|Lost to Follow-up|0|||
13093889|NCT03640052|25834743|FG003|Overall Study|Lost to Follow-up|0|||
13093890|NCT03640052|25834744|FG004|Overall Study|Lost to Follow-up|0|||
13093891|NCT03639987|25834777|FG000|Overall Study|Study terminated by sponsor|26|||
13093892|NCT03639987|25834778|FG001|Overall Study|Study terminated by sponsor|25|||
13093893|NCT03639987|25834777|FG000|Overall Study|Lost to Follow-up|0|||
13093894|NCT03639987|25834778|FG001|Overall Study|Lost to Follow-up|1|||
13093895|NCT03639779|25834790|FG000|Overall Study|Lost to Follow-up|1|||
13093896|NCT03639675|25834797|FG000|Overall Study|Withdrawal by Subject|1|||
13093897|NCT03638635|25834832|FG000|Initial Hospitalization|Study terminated prematurely|0|||
13093898|NCT03638635|25834833|FG001|Initial Hospitalization|Study terminated prematurely|1|||
13093899|NCT03638635|25834832|FG000|Initial Hospitalization|Withdrawal by study personnel|0|||
13093900|NCT03638635|25834833|FG001|Initial Hospitalization|Withdrawal by study personnel|1|||
13093901|NCT03638635|25834832|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39|||
13093902|NCT03638635|25834833|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22|||
13093903|NCT03638258|25834890|FG000|Overall Study|Adverse Event|1|||
13093904|NCT03638258|25834891|FG001|Overall Study|Adverse Event|0|||
13093905|NCT03638258|25834892|FG002|Overall Study|Adverse Event|2|||
13093906|NCT03638258|25834890|FG000|Overall Study|Lost to Follow-up|2|||
13093907|NCT03638258|25834891|FG001|Overall Study|Lost to Follow-up|4|||
13093908|NCT03638258|25834892|FG002|Overall Study|Lost to Follow-up|5|||
13093909|NCT03638258|25834890|FG000|Overall Study|Pregnancy|0|||
13093910|NCT03638258|25834891|FG001|Overall Study|Pregnancy|0|||
13148131|NCT02577029|26039425|FG005|Overall Study|Withdrawal by Subject|1|||
13148132|NCT02577029|26039426|FG006|Overall Study|Withdrawal by Subject|0|||
13148133|NCT02577029|26039427|FG007|Overall Study|Withdrawal by Subject|0|||
13148134|NCT02577029|26039420|FG000|Overall Study|Sponsor Termination of the Study|9|||
13148135|NCT02577029|26039421|FG001|Overall Study|Sponsor Termination of the Study|2|||
13148136|NCT02577029|26039422|FG002|Overall Study|Sponsor Termination of the Study|5|||
13148137|NCT02577029|26039423|FG003|Overall Study|Sponsor Termination of the Study|12|||
13148138|NCT02577029|26039424|FG004|Overall Study|Sponsor Termination of the Study|10|||
13148139|NCT02577029|26039425|FG005|Overall Study|Sponsor Termination of the Study|12|||
13148140|NCT02577029|26039426|FG006|Overall Study|Sponsor Termination of the Study|12|||
13148141|NCT02577029|26039427|FG007|Overall Study|Sponsor Termination of the Study|12|||
13148142|NCT02577016|26039450|FG000|Overall Study|Adverse Event|2|||
13148143|NCT02577016|26039451|FG001|Overall Study|Adverse Event|1|||
13148144|NCT02577016|26039450|FG000|Overall Study|Physician Decision|0|||
13148145|NCT02577016|26039451|FG001|Overall Study|Physician Decision|1|||
13148146|NCT02577003|26039476|FG000|Overall Study|Adverse Event|2|||
13148147|NCT02577003|26039477|FG001|Overall Study|Adverse Event|4|||
13148148|NCT02577003|26039476|FG000|Overall Study|Withdrawal by Subject|0|||
13148149|NCT02577003|26039477|FG001|Overall Study|Withdrawal by Subject|1|||
13148150|NCT02576990|26039510|FG000|Overall Study|Death|29|||
13148151|NCT02576990|26039511|FG001|Overall Study|Death|18|||
13148152|NCT02576990|26039510|FG000|Overall Study|Physician Decision|1|||
13148153|NCT02576990|26039511|FG001|Overall Study|Physician Decision|0|||
13148154|NCT02576990|26039510|FG000|Overall Study|Screen failure|2|||
13148155|NCT02576990|26039511|FG001|Overall Study|Screen failure|0|||
13093911|NCT03638258|25834892|FG002|Overall Study|Pregnancy|1|||
13093912|NCT03638258|25834890|FG000|Overall Study|Protocol Violation|0|||
13093913|NCT03638258|25834891|FG001|Overall Study|Protocol Violation|0|||
13093914|NCT03638258|25834892|FG002|Overall Study|Protocol Violation|1|||
13093915|NCT03638258|25834890|FG000|Overall Study|Withdrawal by Subject|4|||
13093916|NCT03638258|25834891|FG001|Overall Study|Withdrawal by Subject|5|||
13148156|NCT02576990|26039510|FG000|Overall Study|Sponsor's decision|24|||
13222662|NCT01803880|26286674|FG002|Overall Study|Incomplete data entry by sites|0|||
13148157|NCT02576990|26039511|FG001|Overall Study|Sponsor's decision|4|||
13148158|NCT02576990|26039510|FG000|Overall Study|Withdrawal by Subject|0|||
13148159|NCT02576990|26039511|FG001|Overall Study|Withdrawal by Subject|2|||
13148160|NCT02576977|26039536|FG000|Overall Study|Adverse Event|13|||
13148161|NCT02576977|26039537|FG001|Overall Study|Adverse Event|2|||
13148162|NCT02576977|26039536|FG000|Overall Study|Death|73|||
13148163|NCT02576977|26039537|FG001|Overall Study|Death|60|||
13148164|NCT02576977|26039536|FG000|Overall Study|Screen failure|1|||
13148165|NCT02576977|26039537|FG001|Overall Study|Screen failure|0|||
13148166|NCT02576977|26039536|FG000|Overall Study|Study Terminated at Selected Sites|27|||
13148167|NCT02576977|26039537|FG001|Overall Study|Study Terminated at Selected Sites|50|||
13148168|NCT02576977|26039536|FG000|Overall Study|Withdrawal by Subject|11|||
13148169|NCT02576977|26039537|FG001|Overall Study|Withdrawal by Subject|11|||
13148170|NCT02576977|26039536|FG000|Overall Study|Final Disposition Unknown|0|||
13148171|NCT02576977|26039537|FG001|Overall Study|Final Disposition Unknown|1|||
13148172|NCT02576977|26039536|FG000|Overall Study|Lost to Follow-up|1|||
13148173|NCT02576977|26039537|FG001|Overall Study|Lost to Follow-up|0|||
13148174|NCT02576977|26039536|FG000|Overall Study|Progressive Disease|0|||
13148175|NCT02576977|26039537|FG001|Overall Study|Progressive Disease|1|||
13148176|NCT02576951|26039571|FG000|Overall Study|Lost to Follow-up|0|||
13148177|NCT02576951|26039572|FG001|Overall Study|Lost to Follow-up|0|||
13148178|NCT02576951|26039573|FG002|Overall Study|Lost to Follow-up|2|||
13148179|NCT02576951|26039574|FG003|Overall Study|Lost to Follow-up|2|||
13148180|NCT02576951|26039571|FG000|Overall Study|Withdrawal by Subject|1|||
13148181|NCT02576951|26039572|FG001|Overall Study|Withdrawal by Subject|0|||
13148182|NCT02576951|26039573|FG002|Overall Study|Withdrawal by Subject|0|||
13148183|NCT02576951|26039574|FG003|Overall Study|Withdrawal by Subject|2|||
13148184|NCT02576951|26039571|FG000|Overall Study|Protocol Violation|0|||
13148185|NCT02576951|26039572|FG001|Overall Study|Protocol Violation|0|||
13148186|NCT02576951|26039573|FG002|Overall Study|Protocol Violation|0|||
13148187|NCT02576951|26039574|FG003|Overall Study|Protocol Violation|1|||
13148188|NCT02576938|26039612|FG000|Overall Study|Adverse Event|5|||
13148189|NCT02576938|26039613|FG001|Overall Study|Adverse Event|3|||
13148190|NCT02576938|26039614|FG002|Overall Study|Adverse Event|6|||
13148191|NCT02576938|26039612|FG000|Overall Study|Protocol Violation|1|||
13148192|NCT02576938|26039613|FG001|Overall Study|Protocol Violation|1|||
13148193|NCT02576938|26039614|FG002|Overall Study|Protocol Violation|1|||
13148194|NCT02576938|26039612|FG000|Overall Study|Withdrawal by Subject|3|||
13148195|NCT02576938|26039613|FG001|Overall Study|Withdrawal by Subject|2|||
13148196|NCT02576938|26039614|FG002|Overall Study|Withdrawal by Subject|4|||
13148197|NCT02576938|26039612|FG000|Overall Study|Lack of Efficacy|9|||
13148198|NCT02576938|26039613|FG001|Overall Study|Lack of Efficacy|4|||
13148199|NCT02576938|26039614|FG002|Overall Study|Lack of Efficacy|0|||
13148200|NCT02576938|26039612|FG000|Overall Study|Lost to Follow-up|2|||
13148201|NCT02576938|26039613|FG001|Overall Study|Lost to Follow-up|0|||
13148202|NCT02576938|26039614|FG002|Overall Study|Lost to Follow-up|1|||
13148203|NCT02576938|26039612|FG000|Overall Study|Physician Decision|0|||
13148204|NCT02576938|26039613|FG001|Overall Study|Physician Decision|1|||
13148205|NCT02576938|26039614|FG002|Overall Study|Physician Decision|0|||
13148206|NCT02576938|26039612|FG000|Overall Study|Met Exclusion Criteria|0|||
13148207|NCT02576938|26039613|FG001|Overall Study|Met Exclusion Criteria|1|||
13148208|NCT02576938|26039614|FG002|Overall Study|Met Exclusion Criteria|0|||
13148209|NCT02576860|26039639|FG000|Overall Study|Adverse Event|6|||
13148210|NCT02576860|26039640|FG001|Overall Study|Adverse Event|6|||
13148211|NCT02576860|26039639|FG000|Overall Study|Lost to Follow-up|5|||
13148212|NCT02576860|26039640|FG001|Overall Study|Lost to Follow-up|7|||
13148213|NCT02576860|26039639|FG000|Overall Study|Physician Decision|0|||
13148214|NCT02576860|26039640|FG001|Overall Study|Physician Decision|1|||
13148215|NCT02576860|26039639|FG000|Overall Study|Protocol Violation|0|||
13148216|NCT02576860|26039640|FG001|Overall Study|Protocol Violation|2|||
13148217|NCT02576860|26039639|FG000|Overall Study|Withdrawal by Subject|13|||
13148218|NCT02576860|26039640|FG001|Overall Study|Withdrawal by Subject|8|||
13148219|NCT02576860|26039639|FG000|Overall Study|Disallowed medication|1|||
13148220|NCT02576860|26039640|FG001|Overall Study|Disallowed medication|0|||
13148221|NCT02576678|26039682|FG000|Overall Study|Adverse Event|0|||
13148222|NCT02576678|26039683|FG001|Overall Study|Adverse Event|0|||
13148223|NCT02576678|26039684|FG002|Overall Study|Adverse Event|2|||
13148224|NCT02576678|26039682|FG000|Overall Study|Withdrawal by Subject|3|||
13148225|NCT02576678|26039683|FG001|Overall Study|Withdrawal by Subject|1|||
13148226|NCT02576678|26039684|FG002|Overall Study|Withdrawal by Subject|2|||
13148227|NCT02576678|26039682|FG000|Overall Study|Lost to Follow-up|0|||
13148228|NCT02576678|26039683|FG001|Overall Study|Lost to Follow-up|0|||
13148229|NCT02576678|26039684|FG002|Overall Study|Lost to Follow-up|1|||
13148230|NCT02576678|26039682|FG000|Overall Study|Miscellaneous|2|||
13148231|NCT02576678|26039683|FG001|Overall Study|Miscellaneous|0|||
13148232|NCT02576678|26039684|FG002|Overall Study|Miscellaneous|0|||
13148233|NCT02576652|26039693|FG000|Overall Study|Withdrawal by Subject|2|||
13148234|NCT02576639|26039766|FG000|Overall Study|Withdrawal by Subject|1|||
13148235|NCT02576639|26039767|FG001|Overall Study|Withdrawal by Subject|2|||
13148236|NCT02576639|26039768|FG002|Overall Study|Withdrawal by Subject|1|||
13148237|NCT02576639|26039769|FG003|Overall Study|Withdrawal by Subject|0|||
13148238|NCT02576639|26039770|FG004|Overall Study|Withdrawal by Subject|1|||
13148239|NCT02576639|26039766|FG000|Overall Study|Adverse Event|1|||
13148240|NCT02576639|26039767|FG001|Overall Study|Adverse Event|0|||
13148241|NCT02576639|26039768|FG002|Overall Study|Adverse Event|1|||
13148242|NCT02576639|26039769|FG003|Overall Study|Adverse Event|1|||
13148243|NCT02576639|26039770|FG004|Overall Study|Adverse Event|2|||
13148244|NCT02576639|26039766|FG000|Overall Study|Physician Decision|0|||
13148245|NCT02576639|26039767|FG001|Overall Study|Physician Decision|0|||
13148246|NCT02576639|26039768|FG002|Overall Study|Physician Decision|0|||
13148247|NCT02576639|26039769|FG003|Overall Study|Physician Decision|0|||
13148248|NCT02576639|26039770|FG004|Overall Study|Physician Decision|1|||
13148249|NCT02576587|26039795|FG000|Baseline|Equipment failure|0|||
13148250|NCT02576587|26039796|FG001|Baseline|Equipment failure|1|||
13148251|NCT02576587|26039795|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25|||
13093917|NCT03638258|25834892|FG002|Overall Study|Withdrawal by Subject|12|||
13093918|NCT03638258|25834890|FG000|Overall Study|Lack of Efficacy|0|||
13093919|NCT03638258|25834891|FG001|Overall Study|Lack of Efficacy|0|||
13093920|NCT03638258|25834892|FG002|Overall Study|Lack of Efficacy|2|||
13132720|NCT02785770|25984935|FG000|Intervention Period 3 (1 Day)|Adverse Event|0|||
13132721|NCT02785770|25984936|FG001|Intervention Period 3 (1 Day)|Adverse Event|0|||
13132722|NCT02785770|25984937|FG002|Intervention Period 3 (1 Day)|Adverse Event|0|||
13132723|NCT02785770|25984938|FG003|Intervention Period 3 (1 Day)|Adverse Event|1|||
13132724|NCT02785588|25984954|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1|||
13132725|NCT02785588|25984954|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1|||
13132726|NCT02785458|25984969|FG000|1 Month|Withdrawal by Subject|2|||
13132727|NCT02785458|25984970|FG001|1 Month|Withdrawal by Subject|1|||
13132728|NCT02785458|25984969|FG000|1 Month|Lost to Follow-up|38|||
13132729|NCT02785458|25984970|FG001|1 Month|Lost to Follow-up|31|||
13132730|NCT02785458|25984969|FG000|1 Month|Deemed Ineligible|1|||
13132731|NCT02785458|25984970|FG001|1 Month|Deemed Ineligible|0|||
13132732|NCT02785458|25984969|FG000|1 Month|Completed Evaluation by Baseline|42|||
13132733|NCT02785458|25984970|FG001|1 Month|Completed Evaluation by Baseline|39|||
13132734|NCT02785458|25984969|FG000|1 Month|Partial Interview|0|||
13132735|NCT02785458|25984970|FG001|1 Month|Partial Interview|4|||
13132736|NCT02785458|25984969|FG000|3 Months|Withdrawal by Subject|3|||
13132737|NCT02785458|25984970|FG001|3 Months|Withdrawal by Subject|1|||
13132738|NCT02785458|25984969|FG000|3 Months|Lost to Follow-up|25|||
13132739|NCT02785458|25984970|FG001|3 Months|Lost to Follow-up|21|||
13132740|NCT02785458|25984969|FG000|3 Months|Completed Evaluation at 1 Month|100|||
13132741|NCT02785458|25984970|FG001|3 Months|Completed Evaluation at 1 Month|89|||
13132742|NCT02784834|25984976|FG000|Overall Study|Lack of Efficacy|1|||
13148252|NCT02576587|26039796|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0|||
13148253|NCT02576587|26039795|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92|||
13148254|NCT02576587|26039796|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0|||
13148255|NCT02576587|26039795|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0|||
13148256|NCT02576587|26039796|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155|||
13148257|NCT02576535|26039807|FG000|Overall Study|Withdrawal by Subject|2|||
13148258|NCT02576145|26039850|FG000|Overall Study|Adverse Event|1|||
13148259|NCT02576145|26039851|FG001|Overall Study|Adverse Event|0|||
13148260|NCT02576145|26039850|FG000|Overall Study|Withdrawal by Subject|1|||
13148261|NCT02576145|26039851|FG001|Overall Study|Withdrawal by Subject|0|||
13148262|NCT02576145|26039850|FG000|Overall Study|Acute rejection|1|||
13148263|NCT02576145|26039851|FG001|Overall Study|Acute rejection|0|||
13148264|NCT02576145|26039850|FG000|Overall Study|Tetanus Titers Decreased|0|||
13148265|NCT02576145|26039851|FG001|Overall Study|Tetanus Titers Decreased|1|||
13148266|NCT02576067|26039868|FG000|Overall Study|Death|0|||
13148267|NCT02576067|26039869|FG001|Overall Study|Death|1|||
13148268|NCT02576067|26039868|FG000|Overall Study|Lack of Efficacy|1|||
13148269|NCT02576067|26039869|FG001|Overall Study|Lack of Efficacy|0|||
13148270|NCT02576067|26039868|FG000|Overall Study|Lost to Follow-up|11|||
13148271|NCT02576067|26039869|FG001|Overall Study|Lost to Follow-up|0|||
13148272|NCT02576067|26039868|FG000|Overall Study|Withdrawal by Subject|11|||
13148273|NCT02576067|26039869|FG001|Overall Study|Withdrawal by Subject|2|||
13148274|NCT02576067|26039868|FG000|Overall Study|study closure of main CIRT trial)|0|||
13148275|NCT02576067|26039869|FG001|Overall Study|study closure of main CIRT trial)|8|||
13148276|NCT02576067|26039868|FG000|Overall Study|not randomized, failed run-in|7|||
13148277|NCT02576067|26039869|FG001|Overall Study|not randomized, failed run-in|0|||
13148278|NCT02576067|26039868|FG000|Overall Study|screen failure/ re-enrolled|0|||
13148279|NCT02576067|26039869|FG001|Overall Study|screen failure/ re-enrolled|25|||
13148280|NCT02576067|26039868|FG000|Overall Study|Physician Decision|4|||
13132743|NCT02784535|25984990|FG000|Overall Study|Adverse Event|1|||
13132744|NCT02784535|25984991|FG001|Overall Study|Adverse Event|0|||
13132745|NCT02784535|25984990|FG000|Overall Study|Withdrawal by Subject|0|||
13132746|NCT02784535|25984991|FG001|Overall Study|Withdrawal by Subject|1|||
13148281|NCT02576067|26039869|FG001|Overall Study|Physician Decision|0|||
13205089|NCT01968070|26230883|FG009|Period 1|Adverse Event|0|||
13148282|NCT02576054|26039886|FG000|Overall Study|Withdrawal by Subject|1|||
13148283|NCT02575950|26039920|FG000|Overall Study|Withdrawal by Subject|0|||
13148284|NCT02575950|26039921|FG001|Overall Study|Withdrawal by Subject|0|||
13148285|NCT02575950|26039922|FG002|Overall Study|Withdrawal by Subject|0|||
13148286|NCT02575950|26039923|FG003|Overall Study|Withdrawal by Subject|2|||
13148287|NCT02575950|26039920|FG000|Overall Study|Lost to Follow-up|0|||
13148288|NCT02575950|26039921|FG001|Overall Study|Lost to Follow-up|1|||
13148289|NCT02575950|26039922|FG002|Overall Study|Lost to Follow-up|0|||
13148290|NCT02575950|26039923|FG003|Overall Study|Lost to Follow-up|3|||
13148291|NCT02575911|26039943|FG000|Overall Study|Lost to Follow-up|1|||
13148292|NCT02575833|26039960|FG000|Overall Study|Withdrawal by Subject|0|||
13148293|NCT02575833|26039961|FG001|Overall Study|Withdrawal by Subject|1|||
13148294|NCT02575833|26039960|FG000|Overall Study|Lost to Follow-up|1|||
13148295|NCT02575833|26039961|FG001|Overall Study|Lost to Follow-up|0|||
13148296|NCT02575807|26040017|FG000|Overall Study|Death|8|||
13148297|NCT02575807|26040018|FG001|Overall Study|Death|3|||
13148298|NCT02575807|26040019|FG002|Overall Study|Death|7|||
13148299|NCT02575807|26040020|FG003|Overall Study|Death|0|||
13148300|NCT02575807|26040021|FG004|Overall Study|Death|1|||
13148301|NCT02575807|26040017|FG000|Overall Study|Study terminated by Sponsor|0|||
13148302|NCT02575807|26040018|FG001|Overall Study|Study terminated by Sponsor|1|||
13148303|NCT02575807|26040019|FG002|Overall Study|Study terminated by Sponsor|7|||
13148304|NCT02575807|26040020|FG003|Overall Study|Study terminated by Sponsor|0|||
13148305|NCT02575807|26040021|FG004|Overall Study|Study terminated by Sponsor|1|||
13148306|NCT02575807|26040017|FG000|Overall Study|Terminated due to FDA clinical hold|1|||
13148307|NCT02575807|26040018|FG001|Overall Study|Terminated due to FDA clinical hold|0|||
13148308|NCT02575807|26040019|FG002|Overall Study|Terminated due to FDA clinical hold|0|||
13148309|NCT02575807|26040020|FG003|Overall Study|Terminated due to FDA clinical hold|0|||
13148310|NCT02575807|26040021|FG004|Overall Study|Terminated due to FDA clinical hold|0|||
13148311|NCT02575807|26040017|FG000|Overall Study|Terminated due to physician decision|0|||
13148312|NCT02575807|26040018|FG001|Overall Study|Terminated due to physician decision|0|||
13148313|NCT02575807|26040019|FG002|Overall Study|Terminated due to physician decision|1|||
13148314|NCT02575807|26040020|FG003|Overall Study|Terminated due to physician decision|0|||
13148315|NCT02575807|26040021|FG004|Overall Study|Terminated due to physician decision|0|||
13148316|NCT02575807|26040017|FG000|Overall Study|Subject ineligible - medical implant|0|||
13148317|NCT02575807|26040018|FG001|Overall Study|Subject ineligible - medical implant|0|||
13148318|NCT02575807|26040019|FG002|Overall Study|Subject ineligible - medical implant|0|||
13148319|NCT02575807|26040020|FG003|Overall Study|Subject ineligible - medical implant|1|||
13148320|NCT02575807|26040021|FG004|Overall Study|Subject ineligible - medical implant|0|||
13148321|NCT02575807|26040017|FG000|Overall Study|Withdrawal by Subject|0|||
13148322|NCT02575807|26040018|FG001|Overall Study|Withdrawal by Subject|0|||
13148323|NCT02575807|26040019|FG002|Overall Study|Withdrawal by Subject|1|||
13148324|NCT02575807|26040020|FG003|Overall Study|Withdrawal by Subject|1|||
13148325|NCT02575807|26040021|FG004|Overall Study|Withdrawal by Subject|2|||
13148326|NCT02575365|26040033|FG000|Overall Study|Lost to Follow-up|4|||
13148327|NCT02575339|26040079|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1|||
13148328|NCT02575339|26040080|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0|||
13148329|NCT02575339|26040081|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0|||
13148330|NCT02575339|26040079|FG000|Study Treatment|Disease Progression|5|||
13148331|NCT02575339|26040080|FG001|Study Treatment|Disease Progression|2|||
13148332|NCT02575339|26040081|FG002|Study Treatment|Disease Progression|0|||
13148333|NCT02575339|26040079|FG000|Study Treatment|Adverse Event|1|||
13148334|NCT02575339|26040080|FG001|Study Treatment|Adverse Event|2|||
13148335|NCT02575339|26040081|FG002|Study Treatment|Adverse Event|0|||
13148336|NCT02575339|26040079|FG000|Follow up|Death|6|||
13148337|NCT02575339|26040080|FG001|Follow up|Death|2|||
13148338|NCT02575339|26040081|FG002|Follow up|Death|0|||
13148339|NCT02575339|26040079|FG000|Follow up|Study Terminated|0|||
13148340|NCT02575339|26040080|FG001|Follow up|Study Terminated|2|||
13148341|NCT02575339|26040081|FG002|Follow up|Study Terminated|0|||
13148342|NCT02575339|26040079|FG000|Follow up|Death due to progressive disease after coming off treatment early|1|||
13148343|NCT02575339|26040080|FG001|Follow up|Death due to progressive disease after coming off treatment early|0|||
13148344|NCT02575339|26040081|FG002|Follow up|Death due to progressive disease after coming off treatment early|0|||
13148345|NCT02575079|26040102|FG000|Overall Study|Death|3|||
13148346|NCT02575079|26040103|FG001|Overall Study|Death|0|||
13148347|NCT02575079|26040102|FG000|Overall Study|Withdrawal by Subject|3|||
13148348|NCT02575079|26040103|FG001|Overall Study|Withdrawal by Subject|0|||
13148349|NCT02574845|26040148|FG000|Overall Study|Consent withdrawn further participation|0|||
13148350|NCT02574845|26040149|FG001|Overall Study|Consent withdrawn further participation|0|||
13148351|NCT02574845|26040150|FG002|Overall Study|Consent withdrawn further participation|0|||
13148352|NCT02574845|26040151|FG003|Overall Study|Consent withdrawn further participation|0|||
13148353|NCT02574845|26040152|FG004|Overall Study|Consent withdrawn further participation|1|||
13148354|NCT02574845|26040153|FG005|Overall Study|Consent withdrawn further participation|0|||
13148355|NCT02574845|26040148|FG000|Overall Study|Adverse Event|0|||
13222663|NCT01803737|26286703|FG000|Overall Study|Lack of Time|1|||
13093921|NCT03637374|25834907|FG000|Overall Study|Death|2|||
13093922|NCT03637374|25834908|FG001|Overall Study|Death|0|||
13093923|NCT03636906|25834978|FG000|Overall Study|Adverse Event|0|||
13093924|NCT03636906|25834979|FG001|Overall Study|Adverse Event|0|||
13093925|NCT03636906|25834980|FG002|Overall Study|Adverse Event|1|||
13093926|NCT03636906|25834978|FG000|Overall Study|Lost to Follow-up|1|||
13093927|NCT03636906|25834979|FG001|Overall Study|Lost to Follow-up|0|||
13093928|NCT03636906|25834980|FG002|Overall Study|Lost to Follow-up|0|||
13093929|NCT03636906|25834978|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|2|||
13093930|NCT03636906|25834979|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|0|||
13093931|NCT03636906|25834980|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|1|||
13093932|NCT03636906|25834978|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
13093933|NCT03636906|25834979|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
13093934|NCT03636906|25834980|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|2|||
13093935|NCT03636906|25834978|FG000|Overall Study|Other|0|||
13093936|NCT03636906|25834979|FG001|Overall Study|Other|0|||
13093937|NCT03636906|25834980|FG002|Overall Study|Other|1|||
13093938|NCT03636893|25834993|FG000|Overall Study|Death|0|||
13093939|NCT03636893|25834994|FG001|Overall Study|Death|1|||
13093940|NCT03636893|25834993|FG000|Overall Study|Protocol Violation|0|||
13093941|NCT03636893|25834994|FG001|Overall Study|Protocol Violation|3|||
13093942|NCT03636893|25834993|FG000|Overall Study|Withdrawal by Subject|1|||
13093943|NCT03636893|25834994|FG001|Overall Study|Withdrawal by Subject|2|||
13093944|NCT03636893|25834993|FG000|Overall Study|Refusal to surgery|4|||
13093945|NCT03636893|25834994|FG001|Overall Study|Refusal to surgery|3|||
13093946|NCT03636893|25834993|FG000|Overall Study|Early surgery (for acute bleeding)|3|||
13093947|NCT03636893|25834994|FG001|Overall Study|Early surgery (for acute bleeding)|0|||
13093948|NCT03636893|25834993|FG000|Overall Study|Adverse Event|1|||
13093949|NCT03636893|25834994|FG001|Overall Study|Adverse Event|1|||
13093950|NCT03636269|25835015|FG000|Period 1: Double-blind Phase|Adverse Event|13|||
13093951|NCT03636269|25835016|FG001|Period 1: Double-blind Phase|Adverse Event|7|||
13093952|NCT03636269|25835017|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
13093953|NCT03636269|25835015|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
13093954|NCT03636269|25835016|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0|||
13093955|NCT03636269|25835017|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
13093956|NCT03636269|25835015|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2|||
13093957|NCT03636269|25835016|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
13093958|NCT03636269|25835017|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
13093959|NCT03636269|25835015|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5|||
13093960|NCT03636269|25835016|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1|||
13093961|NCT03636269|25835017|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0|||
13093962|NCT03636269|25835015|FG000|Period 1: Double-blind Phase|Other|6|||
13093963|NCT03636269|25835016|FG001|Period 1: Double-blind Phase|Other|3|||
13093964|NCT03636269|25835017|FG002|Period 1: Double-blind Phase|Other|0|||
13093965|NCT03636269|25835015|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1|||
13093966|NCT03636269|25835016|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0|||
13093967|NCT03636269|25835017|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
13093968|NCT03636269|25835015|FG000|Period 1: Double-blind Phase|Subject non-compliance|1|||
13093969|NCT03636269|25835016|FG001|Period 1: Double-blind Phase|Subject non-compliance|2|||
13093970|NCT03636269|25835017|FG002|Period 1: Double-blind Phase|Subject non-compliance|0|||
13093971|NCT03636269|25835015|FG000|Period 2: Open-label Phase|Adverse Event|0|||
13093972|NCT03636269|25835016|FG001|Period 2: Open-label Phase|Adverse Event|0|||
13093973|NCT03636269|25835017|FG002|Period 2: Open-label Phase|Adverse Event|21|||
13093974|NCT03636269|25835015|FG000|Period 2: Open-label Phase|Lack of Efficacy|0|||
13093975|NCT03636269|25835016|FG001|Period 2: Open-label Phase|Lack of Efficacy|0|||
13093976|NCT03636269|25835017|FG002|Period 2: Open-label Phase|Lack of Efficacy|2|||
13093977|NCT03636269|25835015|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
13093978|NCT03636269|25835016|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
13093979|NCT03636269|25835017|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2|||
13093980|NCT03636269|25835015|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0|||
13093981|NCT03636269|25835016|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0|||
13093982|NCT03636269|25835017|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11|||
13093983|NCT03636269|25835015|FG000|Period 2: Open-label Phase|Administrative|0|||
13093984|NCT03636269|25835016|FG001|Period 2: Open-label Phase|Administrative|0|||
13093985|NCT03636269|25835017|FG002|Period 2: Open-label Phase|Administrative|36|||
13093986|NCT03636269|25835015|FG000|Period 2: Open-label Phase|Other|0|||
13093987|NCT03636269|25835016|FG001|Period 2: Open-label Phase|Other|0|||
13093988|NCT03636269|25835017|FG002|Period 2: Open-label Phase|Other|9|||
13093989|NCT03636269|25835015|FG000|Period 2: Open-label Phase|Sponsor stopping study|0|||
13093990|NCT03636269|25835016|FG001|Period 2: Open-label Phase|Sponsor stopping study|0|||
13093991|NCT03636269|25835017|FG002|Period 2: Open-label Phase|Sponsor stopping study|313|||
13093992|NCT03635957|25835030|FG000|Run-In Period|Lost to Follow-up|1|||
13093993|NCT03635957|25835030|FG000|Pegloticase + IMM Period|Lack of Efficacy|3|||
13093994|NCT03635775|25835057|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
13093995|NCT03635775|25835058|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
13093996|NCT03635775|25835059|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
13093997|NCT03635775|25835060|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1|||
13093998|NCT03635424|25835083|FG000|Overall Study|Adverse Event|1|||
13093999|NCT03635424|25835083|FG000|Overall Study|Death|1|||
13094000|NCT03635424|25835083|FG000|Overall Study|Device not implanted|1|||
13094001|NCT03635320|25835096|FG000|Overall Study|not implanted the device|1|||
13094002|NCT03635320|25835097|FG001|Overall Study|not implanted the device|2|||
13094003|NCT03635320|25835096|FG000|Overall Study|Withdrawal by Subject|11|||
13094004|NCT03635320|25835097|FG001|Overall Study|Withdrawal by Subject|6|||
13094005|NCT03635190|25835112|FG000|Overall Study|Lost to Follow-up|4|||
13094006|NCT03635190|25835112|FG000|Overall Study|Death|3|||
13094007|NCT03635190|25835112|FG000|Overall Study|Withdrawal by Subject|1|||
13094008|NCT03635190|25835112|FG000|Overall Study|Patient moved and did not return for follow up|1|||
13094009|NCT03635099|25835229|FG000|Period 1|Adverse Event|1|||
13094010|NCT03635099|25835230|FG001|Period 1|Adverse Event|0|||
13094011|NCT03635099|25835231|FG002|Period 1|Adverse Event|0|||
13094012|NCT03635099|25835232|FG003|Period 1|Adverse Event|1|||
13094013|NCT03635099|25835233|FG004|Period 1|Adverse Event|0|||
13094014|NCT03635099|25835234|FG005|Period 1|Adverse Event|0|||
13094015|NCT03635099|25835235|FG006|Period 1|Adverse Event|0|||
13094016|NCT03635099|25835236|FG007|Period 1|Adverse Event|0|||
13094017|NCT03635099|25835229|FG000|Period 1|Protocol Violation|0|||
13094018|NCT03635099|25835230|FG001|Period 1|Protocol Violation|0|||
13094019|NCT03635099|25835231|FG002|Period 1|Protocol Violation|1|||
13094020|NCT03635099|25835232|FG003|Period 1|Protocol Violation|0|||
13094021|NCT03635099|25835233|FG004|Period 1|Protocol Violation|0|||
13094022|NCT03635099|25835234|FG005|Period 1|Protocol Violation|0|||
13094023|NCT03635099|25835235|FG006|Period 1|Protocol Violation|0|||
13094024|NCT03635099|25835236|FG007|Period 1|Protocol Violation|0|||
13094025|NCT03635099|25835229|FG000|Period 1|Lost to Follow-up|0|||
13094026|NCT03635099|25835230|FG001|Period 1|Lost to Follow-up|0|||
13094027|NCT03635099|25835231|FG002|Period 1|Lost to Follow-up|1|||
13148356|NCT02574845|26040149|FG001|Overall Study|Adverse Event|1|||
13148357|NCT02574845|26040150|FG002|Overall Study|Adverse Event|0|||
13148358|NCT02574845|26040151|FG003|Overall Study|Adverse Event|0|||
13148359|NCT02574845|26040152|FG004|Overall Study|Adverse Event|0|||
13148360|NCT02574845|26040153|FG005|Overall Study|Adverse Event|1|||
13148361|NCT02574637|26040270|FG000|Double-blind Period|Adverse Event|1|||
13148362|NCT02574637|26040271|FG001|Double-blind Period|Adverse Event|0|||
13148363|NCT02574637|26040272|FG002|Double-blind Period|Adverse Event|0|||
13148364|NCT02574637|26040273|FG003|Double-blind Period|Adverse Event|0|||
13148365|NCT02574637|26040274|FG004|Double-blind Period|Adverse Event|0|||
13148366|NCT02574637|26040275|FG005|Double-blind Period|Adverse Event|0|||
13148367|NCT02574637|26040276|FG006|Double-blind Period|Adverse Event|0|||
13148368|NCT02574637|26040277|FG007|Double-blind Period|Adverse Event|0|||
13148369|NCT02574637|26040278|FG008|Double-blind Period|Adverse Event|0|||
13148370|NCT02574637|26040279|FG009|Double-blind Period|Adverse Event|0|||
13148371|NCT02574637|26040270|FG000|Double-blind Period|Lack of Efficacy|0|||
13094028|NCT03635099|25835232|FG003|Period 1|Lost to Follow-up|2|||
13094029|NCT03635099|25835233|FG004|Period 1|Lost to Follow-up|1|||
13094030|NCT03635099|25835234|FG005|Period 1|Lost to Follow-up|0|||
13094031|NCT03635099|25835235|FG006|Period 1|Lost to Follow-up|1|||
13094032|NCT03635099|25835236|FG007|Period 1|Lost to Follow-up|2|||
13094033|NCT03635099|25835229|FG000|Period 1|Withdrawal by Subject|3|||
13094034|NCT03635099|25835230|FG001|Period 1|Withdrawal by Subject|3|||
13094035|NCT03635099|25835231|FG002|Period 1|Withdrawal by Subject|5|||
13094036|NCT03635099|25835232|FG003|Period 1|Withdrawal by Subject|2|||
13094037|NCT03635099|25835233|FG004|Period 1|Withdrawal by Subject|2|||
13094038|NCT03635099|25835234|FG005|Period 1|Withdrawal by Subject|0|||
13094039|NCT03635099|25835235|FG006|Period 1|Withdrawal by Subject|3|||
13094040|NCT03635099|25835236|FG007|Period 1|Withdrawal by Subject|0|||
13094041|NCT03635099|25835229|FG000|Period 1|History of suicidal ideation|0|||
13094042|NCT03635099|25835230|FG001|Period 1|History of suicidal ideation|0|||
13094043|NCT03635099|25835231|FG002|Period 1|History of suicidal ideation|1|||
13094044|NCT03635099|25835232|FG003|Period 1|History of suicidal ideation|0|||
13094045|NCT03635099|25835233|FG004|Period 1|History of suicidal ideation|0|||
13094046|NCT03635099|25835234|FG005|Period 1|History of suicidal ideation|0|||
13094047|NCT03635099|25835235|FG006|Period 1|History of suicidal ideation|0|||
13094048|NCT03635099|25835236|FG007|Period 1|History of suicidal ideation|0|||
13094049|NCT03635099|25835229|FG000|Period 1|pursue other treatment options|0|||
13094050|NCT03635099|25835230|FG001|Period 1|pursue other treatment options|0|||
13148372|NCT02574637|26040271|FG001|Double-blind Period|Lack of Efficacy|0|||
13148373|NCT02574637|26040272|FG002|Double-blind Period|Lack of Efficacy|2|||
13094051|NCT03635099|25835231|FG002|Period 1|pursue other treatment options|0|||
13094052|NCT03635099|25835232|FG003|Period 1|pursue other treatment options|0|||
13094053|NCT03635099|25835233|FG004|Period 1|pursue other treatment options|0|||
13094054|NCT03635099|25835234|FG005|Period 1|pursue other treatment options|1|||
13094055|NCT03635099|25835235|FG006|Period 1|pursue other treatment options|0|||
13094056|NCT03635099|25835236|FG007|Period 1|pursue other treatment options|0|||
13094057|NCT03635099|25835229|FG000|Not Eligible for Period 2|Pregnancy|0|||
13094058|NCT03635099|25835230|FG001|Not Eligible for Period 2|Pregnancy|0|||
13094059|NCT03635099|25835231|FG002|Not Eligible for Period 2|Pregnancy|0|||
13094060|NCT03635099|25835232|FG003|Not Eligible for Period 2|Pregnancy|1|||
13094061|NCT03635099|25835233|FG004|Not Eligible for Period 2|Pregnancy|0|||
13094062|NCT03635099|25835234|FG005|Not Eligible for Period 2|Pregnancy|0|||
13094063|NCT03635099|25835235|FG006|Not Eligible for Period 2|Pregnancy|0|||
13094064|NCT03635099|25835236|FG007|Not Eligible for Period 2|Pregnancy|0|||
13094065|NCT03635099|25835229|FG000|Not Eligible for Period 2|Withdrawal by Subject|1|||
13094066|NCT03635099|25835230|FG001|Not Eligible for Period 2|Withdrawal by Subject|0|||
13094067|NCT03635099|25835231|FG002|Not Eligible for Period 2|Withdrawal by Subject|0|||
13094068|NCT03635099|25835232|FG003|Not Eligible for Period 2|Withdrawal by Subject|0|||
13094069|NCT03635099|25835233|FG004|Not Eligible for Period 2|Withdrawal by Subject|0|||
13094070|NCT03635099|25835234|FG005|Not Eligible for Period 2|Withdrawal by Subject|0|||
13094071|NCT03635099|25835235|FG006|Not Eligible for Period 2|Withdrawal by Subject|0|||
13094072|NCT03635099|25835236|FG007|Not Eligible for Period 2|Withdrawal by Subject|0|||
13094073|NCT03635099|25835229|FG000|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
13094074|NCT03635099|25835230|FG001|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
13094075|NCT03635099|25835231|FG002|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
13094076|NCT03635099|25835232|FG003|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
13094077|NCT03635099|25835233|FG004|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
13094078|NCT03635099|25835234|FG005|Not Eligible for Period 2|Part II subjects did not have a period 2.|9|||
13094079|NCT03635099|25835235|FG006|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
13094080|NCT03635099|25835236|FG007|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
13094081|NCT03635099|25835229|FG000|Eligible for Period 2|Switch to higher dose at end of period 1|15|||
13094082|NCT03635099|25835230|FG001|Eligible for Period 2|Switch to higher dose at end of period 1|35|||
13094083|NCT03635099|25835231|FG002|Eligible for Period 2|Switch to higher dose at end of period 1|21|||
13148374|NCT02574637|26040273|FG003|Double-blind Period|Lack of Efficacy|0|||
13148375|NCT02574637|26040274|FG004|Double-blind Period|Lack of Efficacy|0|||
13148376|NCT02574637|26040275|FG005|Double-blind Period|Lack of Efficacy|0|||
13148377|NCT02574637|26040276|FG006|Double-blind Period|Lack of Efficacy|0|||
13148378|NCT02574637|26040277|FG007|Double-blind Period|Lack of Efficacy|0|||
13148379|NCT02574637|26040278|FG008|Double-blind Period|Lack of Efficacy|0|||
13148380|NCT02574637|26040279|FG009|Double-blind Period|Lack of Efficacy|0|||
13148381|NCT02574637|26040270|FG000|Double-blind Period|Protocol Deviation|1|||
13148382|NCT02574637|26040271|FG001|Double-blind Period|Protocol Deviation|0|||
13148383|NCT02574637|26040272|FG002|Double-blind Period|Protocol Deviation|0|||
13148384|NCT02574637|26040273|FG003|Double-blind Period|Protocol Deviation|0|||
13148385|NCT02574637|26040274|FG004|Double-blind Period|Protocol Deviation|0|||
13148386|NCT02574637|26040275|FG005|Double-blind Period|Protocol Deviation|0|||
13148387|NCT02574637|26040276|FG006|Double-blind Period|Protocol Deviation|0|||
13148388|NCT02574637|26040277|FG007|Double-blind Period|Protocol Deviation|0|||
13094084|NCT03635099|25835232|FG003|Eligible for Period 2|Switch to higher dose at end of period 1|25|||
13094085|NCT03635099|25835233|FG004|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
13094086|NCT03635099|25835234|FG005|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
13094087|NCT03635099|25835235|FG006|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
13094088|NCT03635099|25835236|FG007|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
13094089|NCT03635099|25835229|FG000|Period 2|Adverse Event|0|||
13094090|NCT03635099|25835230|FG001|Period 2|Adverse Event|0|||
13094091|NCT03635099|25835231|FG002|Period 2|Adverse Event|1|||
13094092|NCT03635099|25835232|FG003|Period 2|Adverse Event|0|||
13094093|NCT03635099|25835233|FG004|Period 2|Adverse Event|1|||
13094094|NCT03635099|25835234|FG005|Period 2|Adverse Event|0|||
13094095|NCT03635099|25835235|FG006|Period 2|Adverse Event|0|||
13094096|NCT03635099|25835236|FG007|Period 2|Adverse Event|0|||
13094097|NCT03635099|25835229|FG000|Period 2|Lost to Follow-up|0|||
13094098|NCT03635099|25835230|FG001|Period 2|Lost to Follow-up|0|||
13094099|NCT03635099|25835231|FG002|Period 2|Lost to Follow-up|1|||
13094100|NCT03635099|25835232|FG003|Period 2|Lost to Follow-up|0|||
13094101|NCT03635099|25835233|FG004|Period 2|Lost to Follow-up|4|||
13094102|NCT03635099|25835234|FG005|Period 2|Lost to Follow-up|0|||
13094103|NCT03635099|25835235|FG006|Period 2|Lost to Follow-up|0|||
13094104|NCT03635099|25835236|FG007|Period 2|Lost to Follow-up|0|||
13148389|NCT02574637|26040278|FG008|Double-blind Period|Protocol Deviation|0|||
13148390|NCT02574637|26040279|FG009|Double-blind Period|Protocol Deviation|0|||
13148391|NCT02574637|26040270|FG000|Double-blind Period|Non-Compliance With Study Drug|0|||
13094105|NCT03635099|25835229|FG000|Period 2|Withdrawal by Subject|0|||
13094106|NCT03635099|25835230|FG001|Period 2|Withdrawal by Subject|0|||
13094107|NCT03635099|25835231|FG002|Period 2|Withdrawal by Subject|7|||
13094108|NCT03635099|25835232|FG003|Period 2|Withdrawal by Subject|4|||
13094109|NCT03635099|25835233|FG004|Period 2|Withdrawal by Subject|7|||
13094110|NCT03635099|25835234|FG005|Period 2|Withdrawal by Subject|0|||
13094111|NCT03635099|25835235|FG006|Period 2|Withdrawal by Subject|0|||
13094112|NCT03635099|25835236|FG007|Period 2|Withdrawal by Subject|0|||
13094113|NCT03635086|25835307|FG000|Overall Study|Withdrawal of consent|0|||
13094114|NCT03635086|25835308|FG001|Overall Study|Withdrawal of consent|0|||
13094115|NCT03635086|25835309|FG002|Overall Study|Withdrawal of consent|1|||
13094116|NCT03635086|25835310|FG003|Overall Study|Withdrawal of consent|0|||
13094117|NCT03635086|25835311|FG004|Overall Study|Withdrawal of consent|0|||
13094118|NCT03635086|25835307|FG000|Overall Study|Adverse Event|0|||
13094119|NCT03635086|25835308|FG001|Overall Study|Adverse Event|1|||
13094120|NCT03635086|25835309|FG002|Overall Study|Adverse Event|0|||
13094121|NCT03635086|25835310|FG003|Overall Study|Adverse Event|0|||
13094122|NCT03635086|25835311|FG004|Overall Study|Adverse Event|0|||
13094123|NCT03635086|25835307|FG000|Overall Study|Lost to Follow-up|1|||
13094124|NCT03635086|25835308|FG001|Overall Study|Lost to Follow-up|0|||
13094125|NCT03635086|25835309|FG002|Overall Study|Lost to Follow-up|0|||
13094126|NCT03635086|25835310|FG003|Overall Study|Lost to Follow-up|0|||
13094127|NCT03635086|25835311|FG004|Overall Study|Lost to Follow-up|0|||
13094128|NCT03634800|25835319|FG000|Overall Study|Adverse Event|1|||
13094129|NCT03634800|25835319|FG000|Overall Study|Disease Progression|4|||
13094130|NCT03634800|25835319|FG000|Overall Study|Withdrawal by Subject|1|||
13148392|NCT02574637|26040271|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
13148393|NCT02574637|26040272|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
13148394|NCT02574637|26040273|FG003|Double-blind Period|Non-Compliance With Study Drug|1|||
13148395|NCT02574637|26040274|FG004|Double-blind Period|Non-Compliance With Study Drug|0|||
13148396|NCT02574637|26040275|FG005|Double-blind Period|Non-Compliance With Study Drug|0|||
13148397|NCT02574637|26040276|FG006|Double-blind Period|Non-Compliance With Study Drug|0|||
13148398|NCT02574637|26040277|FG007|Double-blind Period|Non-Compliance With Study Drug|0|||
13148399|NCT02574637|26040278|FG008|Double-blind Period|Non-Compliance With Study Drug|0|||
13148400|NCT02574637|26040279|FG009|Double-blind Period|Non-Compliance With Study Drug|0|||
13148401|NCT02574637|26040270|FG000|Double-blind Period|Study Terminated By Sponsor|1|||
13094131|NCT03634579|25835329|FG000|Overall Study|study termination|9|||
13094132|NCT03634085|25835349|FG000|Overall Study|Adverse Event|1|||
13094133|NCT03634085|25835350|FG001|Overall Study|Adverse Event|0|||
13094134|NCT03634085|25835349|FG000|Overall Study|Withdrawal by Subject|0|||
13094135|NCT03634085|25835350|FG001|Overall Study|Withdrawal by Subject|2|||
13094136|NCT03633929|25835360|FG000|Overall Study|Lost to Follow-up|1|||
13094137|NCT03633929|25835360|FG000|Overall Study|Did not login to software. Did not participate|3|||
13094138|NCT03633903|25835377|FG000|Overall Study|Withdrawal by Subject|1|||
13094139|NCT03633903|25835378|FG001|Overall Study|Withdrawal by Subject|2|||
13094140|NCT03633903|25835377|FG000|Overall Study|Lost to Follow-up|5|||
13094141|NCT03633903|25835378|FG001|Overall Study|Lost to Follow-up|5|||
13094142|NCT03633825|25835393|FG000|Enrollment|Did not post on network|5066|||
13094143|NCT03633825|25835394|FG001|Enrollment|Did not post on network|5080|||
13094144|NCT03633825|25835393|FG000|Enrollment|Post not classified as crisis|13967|||
13094145|NCT03633825|25835394|FG001|Enrollment|Post not classified as crisis|13757|||
13094146|NCT03633825|25835393|FG000|Follow up|Lost to Follow-up|478|||
13094147|NCT03633825|25835394|FG001|Follow up|Lost to Follow-up|450|||
13094148|NCT03633695|25835460|FG000|Overall Study|Lost to Follow-up|4|||
13094149|NCT03633695|25835461|FG001|Overall Study|Lost to Follow-up|5|||
13094150|NCT03633695|25835460|FG000|Overall Study|Discontinued|8|||
13094151|NCT03633695|25835461|FG001|Overall Study|Discontinued|4|||
13094152|NCT03633331|25835467|FG000|Overall Study|Withdrawal by Subject|1|||
13094153|NCT03633227|25835914|FG000|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
13094154|NCT03633227|25835915|FG001|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
13094155|NCT03633227|25835914|FG000|Double Blind (DB), up to Week 48|Death|2|||
13094156|NCT03633227|25835915|FG001|Double Blind (DB), up to Week 48|Death|1|||
13094157|NCT03633227|25835914|FG000|Double Blind (DB), up to Week 48|Adverse Event|0|||
13094158|NCT03633227|25835915|FG001|Double Blind (DB), up to Week 48|Adverse Event|1|||
13094159|NCT03633227|25835914|FG000|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|2|||
13094160|NCT03633227|25835915|FG001|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|1|||
13094161|NCT03633227|25835914|FG000|Double Blind (DB), up to Week 48|Physician Decision|1|||
13094162|NCT03633227|25835915|FG001|Double Blind (DB), up to Week 48|Physician Decision|0|||
13094163|NCT03633227|25835914|FG000|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|1|||
13094164|NCT03633227|25835915|FG001|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|0|||
13094165|NCT03633227|25835914|FG000|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|1|||
13094166|NCT03633227|25835915|FG001|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|0|||
13094167|NCT03633227|25835914|FG000|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|0|||
13094168|NCT03633227|25835915|FG001|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|2|||
13094169|NCT03633227|25835914|FG000|DB Extension, Week 48 up to 3 Years|Death|0|||
13094170|NCT03633227|25835915|FG001|DB Extension, Week 48 up to 3 Years|Death|1|||
13094171|NCT03633227|25835914|FG000|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|3|||
13094172|NCT03633227|25835915|FG001|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|2|||
13094173|NCT03633227|25835914|FG000|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|1|||
13094174|NCT03633227|25835915|FG001|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|0|||
13094175|NCT03633227|25835914|FG000|DB Extension, Week 48 up to 3 Years|Physician Decision|0|||
13094176|NCT03633227|25835915|FG001|DB Extension, Week 48 up to 3 Years|Physician Decision|1|||
13094177|NCT03631732|25835948|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3|||
13094178|NCT03631732|25835949|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0|||
13094179|NCT03631732|25835948|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1|||
13094180|NCT03631732|25835949|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2|||
13094181|NCT03631732|25835948|FG000|Randomized Phase Up to Week 24|Adverse Event|2|||
13094182|NCT03631732|25835949|FG001|Randomized Phase Up to Week 24|Adverse Event|0|||
13094183|NCT03631732|25835948|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1|||
13094184|NCT03631732|25835949|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0|||
13094185|NCT03631732|25835948|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6|||
13094186|NCT03631732|25835949|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1|||
13094187|NCT03631732|25835948|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
13094188|NCT03631732|25835949|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
13094189|NCT03631732|25835948|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4|||
13094190|NCT03631732|25835949|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1|||
13094191|NCT03631732|25835948|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1|||
13094192|NCT03631732|25835949|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0|||
13094193|NCT03631732|25835948|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1|||
13094194|NCT03631732|25835949|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0|||
13094195|NCT03631732|25835948|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1|||
13094196|NCT03631732|25835949|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0|||
13094197|NCT03631706|25835970|FG000|Overall Study|Randomized, not treated|1|||
13094198|NCT03631706|25835971|FG001|Overall Study|Randomized, not treated|0|||
13094199|NCT03631706|25835970|FG000|Overall Study|Treatment ongoing|26|||
13094200|NCT03631706|25835971|FG001|Overall Study|Treatment ongoing|57|||
13094201|NCT03631706|25835970|FG000|Overall Study|Off treatment (Treatment completed and discontinued) and in follow up)|65|||
13094202|NCT03631706|25835971|FG001|Overall Study|Off treatment (Treatment completed and discontinued) and in follow up)|41|||
13094203|NCT03631407|25836004|FG000|Overall Study|Withdrawal by Subject|3|||
13148402|NCT02574637|26040271|FG001|Double-blind Period|Study Terminated By Sponsor|1|||
13148403|NCT02574637|26040272|FG002|Double-blind Period|Study Terminated By Sponsor|5|||
13148404|NCT02574637|26040273|FG003|Double-blind Period|Study Terminated By Sponsor|2|||
13148405|NCT02574637|26040274|FG004|Double-blind Period|Study Terminated By Sponsor|2|||
13148406|NCT02574637|26040275|FG005|Double-blind Period|Study Terminated By Sponsor|0|||
13148407|NCT02574637|26040276|FG006|Double-blind Period|Study Terminated By Sponsor|0|||
13148408|NCT02574637|26040277|FG007|Double-blind Period|Study Terminated By Sponsor|0|||
13148409|NCT02574637|26040278|FG008|Double-blind Period|Study Terminated By Sponsor|0|||
13148410|NCT02574637|26040279|FG009|Double-blind Period|Study Terminated By Sponsor|0|||
13148411|NCT02574637|26040270|FG000|Double-blind Period|Reason Not Specified|0|||
13148412|NCT02574637|26040271|FG001|Double-blind Period|Reason Not Specified|0|||
13148413|NCT02574637|26040272|FG002|Double-blind Period|Reason Not Specified|0|||
13148414|NCT02574637|26040273|FG003|Double-blind Period|Reason Not Specified|1|||
13148415|NCT02574637|26040274|FG004|Double-blind Period|Reason Not Specified|0|||
13148416|NCT02574637|26040275|FG005|Double-blind Period|Reason Not Specified|0|||
13148417|NCT02574637|26040276|FG006|Double-blind Period|Reason Not Specified|0|||
13148418|NCT02574637|26040277|FG007|Double-blind Period|Reason Not Specified|0|||
13148419|NCT02574637|26040278|FG008|Double-blind Period|Reason Not Specified|0|||
13148420|NCT02574637|26040279|FG009|Double-blind Period|Reason Not Specified|0|||
13148421|NCT02574637|26040270|FG000|Open-label (OL) Period|Adverse Event|0|||
13148422|NCT02574637|26040271|FG001|Open-label (OL) Period|Adverse Event|0|||
13148423|NCT02574637|26040272|FG002|Open-label (OL) Period|Adverse Event|0|||
13148424|NCT02574637|26040273|FG003|Open-label (OL) Period|Adverse Event|0|||
13148425|NCT02574637|26040274|FG004|Open-label (OL) Period|Adverse Event|0|||
13148426|NCT02574637|26040275|FG005|Open-label (OL) Period|Adverse Event|0|||
13148427|NCT02574637|26040276|FG006|Open-label (OL) Period|Adverse Event|0|||
13148428|NCT02574637|26040277|FG007|Open-label (OL) Period|Adverse Event|0|||
13148429|NCT02574637|26040278|FG008|Open-label (OL) Period|Adverse Event|1|||
13148430|NCT02574637|26040279|FG009|Open-label (OL) Period|Adverse Event|0|||
13148431|NCT02574637|26040270|FG000|Open-label (OL) Period|Withdrawal by Subject|0|||
13148432|NCT02574637|26040271|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
13148433|NCT02574637|26040272|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
13148434|NCT02574637|26040273|FG003|Open-label (OL) Period|Withdrawal by Subject|0|||
13148435|NCT02574637|26040274|FG004|Open-label (OL) Period|Withdrawal by Subject|0|||
13148436|NCT02574637|26040275|FG005|Open-label (OL) Period|Withdrawal by Subject|1|||
13148437|NCT02574637|26040276|FG006|Open-label (OL) Period|Withdrawal by Subject|0|||
13148438|NCT02574637|26040277|FG007|Open-label (OL) Period|Withdrawal by Subject|0|||
13148439|NCT02574637|26040278|FG008|Open-label (OL) Period|Withdrawal by Subject|0|||
13148440|NCT02574637|26040279|FG009|Open-label (OL) Period|Withdrawal by Subject|1|||
13148441|NCT02574637|26040270|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0|||
13148442|NCT02574637|26040271|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0|||
13148443|NCT02574637|26040272|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0|||
13148444|NCT02574637|26040273|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0|||
13148445|NCT02574637|26040274|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0|||
13148446|NCT02574637|26040275|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1|||
13148447|NCT02574637|26040276|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2|||
13148448|NCT02574637|26040277|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1|||
13148449|NCT02574637|26040278|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1|||
13148450|NCT02574637|26040279|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0|||
13148451|NCT02574520|26040312|FG000|Overall Study|Not dosed|2|||
13148452|NCT02574520|26040313|FG001|Overall Study|Not dosed|0|||
13148453|NCT02574520|26040314|FG002|Overall Study|Not dosed|5|||
13148454|NCT02574520|26040315|FG003|Overall Study|Not dosed|4|||
13148455|NCT02574520|26040312|FG000|Overall Study|Adverse Event|0|||
13148456|NCT02574520|26040313|FG001|Overall Study|Adverse Event|0|||
13148457|NCT02574520|26040314|FG002|Overall Study|Adverse Event|0|||
13148458|NCT02574520|26040315|FG003|Overall Study|Adverse Event|1|||
13148459|NCT02574520|26040312|FG000|Overall Study|Withdrawal by Subject|0|||
13148460|NCT02574520|26040313|FG001|Overall Study|Withdrawal by Subject|0|||
13148461|NCT02574520|26040314|FG002|Overall Study|Withdrawal by Subject|0|||
13148462|NCT02574520|26040315|FG003|Overall Study|Withdrawal by Subject|1|||
13148463|NCT02574520|26040312|FG000|Overall Study|Other|0|||
13148464|NCT02574520|26040313|FG001|Overall Study|Other|0|||
13148465|NCT02574520|26040314|FG002|Overall Study|Other|0|||
13148466|NCT02574520|26040315|FG003|Overall Study|Other|2|||
13148467|NCT02574481|26040366|FG000|Overall Study|Withdrawal by Subject|6|||
13148468|NCT02574481|26040367|FG001|Overall Study|Withdrawal by Subject|4|||
13148469|NCT02574481|26040368|FG002|Overall Study|Withdrawal by Subject|1|||
13148470|NCT02574481|26040369|FG003|Overall Study|Withdrawal by Subject|0|||
13148471|NCT02574481|26040366|FG000|Overall Study|Adverse Event|2|||
13148472|NCT02574481|26040367|FG001|Overall Study|Adverse Event|0|||
13148473|NCT02574481|26040368|FG002|Overall Study|Adverse Event|0|||
13148474|NCT02574481|26040369|FG003|Overall Study|Adverse Event|0|||
13148475|NCT02574481|26040366|FG000|Overall Study|Visit Missed|12|||
13148476|NCT02574481|26040367|FG001|Overall Study|Visit Missed|4|||
13148477|NCT02574481|26040368|FG002|Overall Study|Visit Missed|2|||
13148478|NCT02574481|26040369|FG003|Overall Study|Visit Missed|0|||
13148479|NCT02574481|26040366|FG000|Overall Study|Other|1|||
13148480|NCT02574481|26040367|FG001|Overall Study|Other|0|||
13148481|NCT02574481|26040368|FG002|Overall Study|Other|0|||
13148482|NCT02574481|26040369|FG003|Overall Study|Other|0|||
13094204|NCT03631407|25836005|FG001|Overall Study|Withdrawal by Subject|2|||
13094205|NCT03631407|25836004|FG000|Overall Study|Sponsor Decision|0|||
13094206|NCT03631407|25836005|FG001|Overall Study|Sponsor Decision|2|||
13094207|NCT03631407|25836004|FG000|Overall Study|Death|16|||
13094208|NCT03631407|25836005|FG001|Overall Study|Death|16|||
13094209|NCT03631407|25836004|FG000|Overall Study|Randomized by mistake without study treatment|1|||
13094210|NCT03631407|25836005|FG001|Overall Study|Randomized by mistake without study treatment|0|||
13094211|NCT03631355|25836022|FG000|Overall Study|Lost to Follow-up|1|||
13094212|NCT03631355|25836023|FG001|Overall Study|Lost to Follow-up|2|||
13094213|NCT03630393|25836042|FG000|Overall Study|Death|1|||
13094214|NCT03630393|25836043|FG001|Overall Study|Death|0|||
13094215|NCT03630302|25836050|FG000|Surgery|hardware issue prevented LFP recordings|1|||
13148483|NCT02574481|26040366|FG000|Overall Study|Death|6|||
13148484|NCT02574481|26040367|FG001|Overall Study|Death|6|||
13148485|NCT02574481|26040368|FG002|Overall Study|Death|0|||
13148486|NCT02574481|26040369|FG003|Overall Study|Death|0|||
13148487|NCT02574312|26040392|FG000|3 Months Follow-up|Withdrawal by Subject|1|||
13094216|NCT03630302|25836050|FG000|3 Month Visit|Adverse Event|2|||
13094217|NCT03630302|25836050|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2|||
13148488|NCT02574312|26040393|FG001|3 Months Follow-up|Withdrawal by Subject|0|||
13148489|NCT02574260|26040401|FG000|Overall Study|Disease Progression|1|||
13148490|NCT02574247|26040423|FG000|Overall Study|Withdrawal by Subject|1|||
13148491|NCT02574247|26040424|FG001|Overall Study|Withdrawal by Subject|0|||
13148492|NCT02574247|26040425|FG002|Overall Study|Withdrawal by Subject|0|||
13148493|NCT02574247|26040423|FG000|Overall Study|Did not meet inclusion criteria|4|||
13148494|NCT02574247|26040424|FG001|Overall Study|Did not meet inclusion criteria|3|||
13148495|NCT02574247|26040425|FG002|Overall Study|Did not meet inclusion criteria|5|||
13148496|NCT02574078|26040531|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
13148497|NCT02574078|26040532|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
13148498|NCT02574078|26040533|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
13148499|NCT02574078|26040534|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
13148500|NCT02574078|26040535|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0|||
13148501|NCT02574078|26040536|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1|||
13094218|NCT03630120|25836093|FG000|Overall Study|Disease progression|0|||
13094219|NCT03630120|25836094|FG001|Overall Study|Disease progression|1|||
13094220|NCT03630120|25836095|FG002|Overall Study|Disease progression|1|||
13094221|NCT03630120|25836096|FG003|Overall Study|Disease progression|1|||
13094222|NCT03630016|25836102|FG000|Overall Study|Poor Sensor Placement|1|||
13094223|NCT03629886|25836126|FG000|Overall Study|Migrated / moved from the study area|0|||
13094224|NCT03629886|25836127|FG001|Overall Study|Migrated / moved from the study area|55|||
13094225|NCT03629886|25836126|FG000|Overall Study|Consent withdrawal, not due to an AE|0|||
13094226|NCT03629886|25836127|FG001|Overall Study|Consent withdrawal, not due to an AE|50|||
13094227|NCT03629886|25836126|FG000|Overall Study|Study vaccine not administrated|0|||
13094228|NCT03629886|25836127|FG001|Overall Study|Study vaccine not administrated|3|||
13094229|NCT03629886|25836126|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0|||
13094230|NCT03629886|25836127|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28|||
13094231|NCT03629886|25836126|FG000|Overall Study|Refused vaccination step of the study|0|||
13094232|NCT03629886|25836127|FG001|Overall Study|Refused vaccination step of the study|44|||
13094233|NCT03629249|25836169|FG000|Overall Study|Study terminated by sponsor|197|||
13094234|NCT03629249|25836170|FG001|Overall Study|Study terminated by sponsor|197|||
13094235|NCT03629249|25836171|FG002|Overall Study|Study terminated by sponsor|194|||
13094236|NCT03629249|25836169|FG000|Overall Study|Protocol deviation|0|||
13094237|NCT03629249|25836170|FG001|Overall Study|Protocol deviation|2|||
13094238|NCT03629249|25836171|FG002|Overall Study|Protocol deviation|5|||
13094239|NCT03629249|25836169|FG000|Overall Study|Subject decision|1|||
13094240|NCT03629249|25836170|FG001|Overall Study|Subject decision|1|||
13094241|NCT03629249|25836171|FG002|Overall Study|Subject decision|3|||
13094242|NCT03629249|25836169|FG000|Overall Study|Adverse Event|1|||
13094243|NCT03629249|25836170|FG001|Overall Study|Adverse Event|1|||
13094244|NCT03629249|25836171|FG002|Overall Study|Adverse Event|0|||
13094245|NCT03629249|25836169|FG000|Overall Study|Death|1|||
13148502|NCT02574078|26040537|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2|||
13148503|NCT02574078|26040538|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0|||
13148504|NCT02574078|26040539|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1|||
13148505|NCT02574078|26040540|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0|||
13148506|NCT02574078|26040541|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0|||
13148507|NCT02574078|26040542|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0|||
13148508|NCT02574078|26040543|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0|||
13148509|NCT02574078|26040531|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
13148510|NCT02574078|26040532|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
13148511|NCT02574078|26040533|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
13148512|NCT02574078|26040534|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
13148513|NCT02574078|26040535|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
13148514|NCT02574078|26040536|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
13148515|NCT02574078|26040537|FG006|Pre-Treatment Period|Participant withdrew consent|0|||
13148516|NCT02574078|26040538|FG007|Pre-Treatment Period|Participant withdrew consent|3|||
13148517|NCT02574078|26040539|FG008|Pre-Treatment Period|Participant withdrew consent|0|||
13148518|NCT02574078|26040540|FG009|Pre-Treatment Period|Participant withdrew consent|0|||
13148519|NCT02574078|26040541|FG010|Pre-Treatment Period|Participant withdrew consent|2|||
13148520|NCT02574078|26040542|FG011|Pre-Treatment Period|Participant withdrew consent|0|||
13148521|NCT02574078|26040543|FG012|Pre-Treatment Period|Participant withdrew consent|0|||
13148522|NCT02574078|26040531|FG000|Pre-Treatment Period|Other reasons|0|||
13148523|NCT02574078|26040532|FG001|Pre-Treatment Period|Other reasons|0|||
13148524|NCT02574078|26040533|FG002|Pre-Treatment Period|Other reasons|0|||
13148525|NCT02574078|26040534|FG003|Pre-Treatment Period|Other reasons|0|||
13148526|NCT02574078|26040535|FG004|Pre-Treatment Period|Other reasons|0|||
13148527|NCT02574078|26040536|FG005|Pre-Treatment Period|Other reasons|0|||
13148528|NCT02574078|26040537|FG006|Pre-Treatment Period|Other reasons|2|||
13148529|NCT02574078|26040538|FG007|Pre-Treatment Period|Other reasons|0|||
13148530|NCT02574078|26040539|FG008|Pre-Treatment Period|Other reasons|0|||
13148531|NCT02574078|26040540|FG009|Pre-Treatment Period|Other reasons|0|||
13094246|NCT03629249|25836170|FG001|Overall Study|Death|0|||
13094247|NCT03629249|25836171|FG002|Overall Study|Death|0|||
13094248|NCT03629249|25836169|FG000|Overall Study|Physician Decision|1|||
13094249|NCT03629249|25836170|FG001|Overall Study|Physician Decision|0|||
13094250|NCT03629249|25836171|FG002|Overall Study|Physician Decision|0|||
13094251|NCT03629184|25836226|FG000|Overall Study|Withdrawal by Subject|2|||
13094252|NCT03629184|25836227|FG001|Overall Study|Withdrawal by Subject|1|||
13094253|NCT03629184|25836226|FG000|Overall Study|Physician Decision|1|||
13094254|NCT03629184|25836227|FG001|Overall Study|Physician Decision|0|||
13094255|NCT03629054|25836258|FG000|Period 2 (4 Days)|Not treated|0|||
13148532|NCT02574078|26040541|FG010|Pre-Treatment Period|Other reasons|2|||
13148533|NCT02574078|26040542|FG011|Pre-Treatment Period|Other reasons|0|||
13148534|NCT02574078|26040543|FG012|Pre-Treatment Period|Other reasons|0|||
13148535|NCT02574078|26040531|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
13148536|NCT02574078|26040532|FG001|Pre-Treatment Period|Poor/non-compliance|0|||
13148537|NCT02574078|26040533|FG002|Pre-Treatment Period|Poor/non-compliance|0|||
13148538|NCT02574078|26040534|FG003|Pre-Treatment Period|Poor/non-compliance|0|||
13148539|NCT02574078|26040535|FG004|Pre-Treatment Period|Poor/non-compliance|0|||
13148540|NCT02574078|26040536|FG005|Pre-Treatment Period|Poor/non-compliance|0|||
13148541|NCT02574078|26040537|FG006|Pre-Treatment Period|Poor/non-compliance|0|||
13148542|NCT02574078|26040538|FG007|Pre-Treatment Period|Poor/non-compliance|0|||
13148543|NCT02574078|26040539|FG008|Pre-Treatment Period|Poor/non-compliance|0|||
13148544|NCT02574078|26040540|FG009|Pre-Treatment Period|Poor/non-compliance|0|||
13148545|NCT02574078|26040541|FG010|Pre-Treatment Period|Poor/non-compliance|0|||
13148546|NCT02574078|26040542|FG011|Pre-Treatment Period|Poor/non-compliance|1|||
13148547|NCT02574078|26040543|FG012|Pre-Treatment Period|Poor/non-compliance|0|||
13148548|NCT02574078|26040531|FG000|Treatment Period|Disease progression|6|||
13148549|NCT02574078|26040532|FG001|Treatment Period|Disease progression|4|||
13148550|NCT02574078|26040533|FG002|Treatment Period|Disease progression|7|||
13148551|NCT02574078|26040534|FG003|Treatment Period|Disease progression|18|||
13148552|NCT02574078|26040535|FG004|Treatment Period|Disease progression|16|||
13148553|NCT02574078|26040536|FG005|Treatment Period|Disease progression|26|||
13148554|NCT02574078|26040537|FG006|Treatment Period|Disease progression|5|||
13148555|NCT02574078|26040538|FG007|Treatment Period|Disease progression|9|||
13148556|NCT02574078|26040539|FG008|Treatment Period|Disease progression|8|||
13148557|NCT02574078|26040540|FG009|Treatment Period|Disease progression|5|||
13148558|NCT02574078|26040541|FG010|Treatment Period|Disease progression|20|||
13148559|NCT02574078|26040542|FG011|Treatment Period|Disease progression|29|||
13148560|NCT02574078|26040543|FG012|Treatment Period|Disease progression|2|||
13148561|NCT02574078|26040531|FG000|Treatment Period|Study drug toxicity|1|||
13148562|NCT02574078|26040532|FG001|Treatment Period|Study drug toxicity|1|||
13148563|NCT02574078|26040533|FG002|Treatment Period|Study drug toxicity|0|||
13148564|NCT02574078|26040534|FG003|Treatment Period|Study drug toxicity|5|||
13148565|NCT02574078|26040535|FG004|Treatment Period|Study drug toxicity|3|||
13148566|NCT02574078|26040536|FG005|Treatment Period|Study drug toxicity|1|||
13148567|NCT02574078|26040537|FG006|Treatment Period|Study drug toxicity|2|||
13148568|NCT02574078|26040538|FG007|Treatment Period|Study drug toxicity|0|||
13148569|NCT02574078|26040539|FG008|Treatment Period|Study drug toxicity|2|||
13148570|NCT02574078|26040540|FG009|Treatment Period|Study drug toxicity|1|||
13148571|NCT02574078|26040541|FG010|Treatment Period|Study drug toxicity|16|||
13148572|NCT02574078|26040542|FG011|Treatment Period|Study drug toxicity|2|||
13148573|NCT02574078|26040543|FG012|Treatment Period|Study drug toxicity|4|||
13148574|NCT02574078|26040531|FG000|Treatment Period|Death|2|||
13094256|NCT03629054|25836259|FG001|Period 2 (4 Days)|Not treated|1|||
13094257|NCT03629041|25836290|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
13094258|NCT03629041|25836291|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1|||
13094259|NCT03629041|25836292|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
13094260|NCT03629041|25836293|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
13094261|NCT03629028|25836316|FG000|Overall Study|Lost to Follow-up|26|||
13094262|NCT03629028|25836317|FG001|Overall Study|Lost to Follow-up|23|||
13094263|NCT03629028|25836316|FG000|Overall Study|Pregnancy|4|||
13094264|NCT03629028|25836317|FG001|Overall Study|Pregnancy|2|||
13094265|NCT03629028|25836316|FG000|Overall Study|intolerance to examination|2|||
13094266|NCT03629028|25836317|FG001|Overall Study|intolerance to examination|0|||
13094267|NCT03628924|25836406|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2|||
13094268|NCT03628924|25836407|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
13094269|NCT03628924|25836408|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
13094270|NCT03628924|25836409|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
13094271|NCT03628924|25836410|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
13094272|NCT03628924|25836411|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
13132747|NCT02784535|25984990|FG000|Overall Study|Physician Decision|0|||
13148575|NCT02574078|26040532|FG001|Treatment Period|Death|0|||
13148576|NCT02574078|26040533|FG002|Treatment Period|Death|0|||
13148577|NCT02574078|26040534|FG003|Treatment Period|Death|0|||
13148578|NCT02574078|26040535|FG004|Treatment Period|Death|1|||
13148579|NCT02574078|26040536|FG005|Treatment Period|Death|1|||
13148580|NCT02574078|26040537|FG006|Treatment Period|Death|1|||
13148581|NCT02574078|26040538|FG007|Treatment Period|Death|1|||
13148582|NCT02574078|26040539|FG008|Treatment Period|Death|7|||
13148583|NCT02574078|26040540|FG009|Treatment Period|Death|1|||
13148584|NCT02574078|26040541|FG010|Treatment Period|Death|0|||
13148585|NCT02574078|26040542|FG011|Treatment Period|Death|2|||
13148586|NCT02574078|26040543|FG012|Treatment Period|Death|1|||
13148587|NCT02574078|26040531|FG000|Treatment Period|Adverse event unrelated to drug|0|||
13148588|NCT02574078|26040532|FG001|Treatment Period|Adverse event unrelated to drug|0|||
13148589|NCT02574078|26040533|FG002|Treatment Period|Adverse event unrelated to drug|1|||
13094273|NCT03628924|25836412|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
13094274|NCT03628924|25836406|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
13094275|NCT03628924|25836407|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
13094276|NCT03628924|25836408|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
13094277|NCT03628924|25836409|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
13094278|NCT03628924|25836410|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
13094279|NCT03628924|25836411|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
13094280|NCT03628924|25836412|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
13094281|NCT03628924|25836406|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
13094282|NCT03628924|25836407|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2|||
13094283|NCT03628924|25836408|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
13094284|NCT03628924|25836409|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
13094285|NCT03628924|25836410|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
13094286|NCT03628924|25836411|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
13094287|NCT03628924|25836412|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
13094288|NCT03628924|25836406|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
13094289|NCT03628924|25836407|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
13094290|NCT03628924|25836408|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
13094291|NCT03628924|25836409|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
13094292|NCT03628924|25836410|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
13094293|NCT03628924|25836411|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
13094294|NCT03628924|25836412|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
13094295|NCT03628924|25836406|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3|||
13094296|NCT03628924|25836407|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
13094297|NCT03628924|25836408|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1|||
13094298|NCT03628924|25836409|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
13094299|NCT03628924|25836410|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
13094300|NCT03628924|25836411|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
13094301|NCT03628924|25836412|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
13094302|NCT03628924|25836406|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
13094303|NCT03628924|25836407|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
13094304|NCT03628924|25836408|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
13094305|NCT03628924|25836409|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
13094306|NCT03628924|25836410|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
13094307|NCT03628924|25836411|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2|||
13094308|NCT03628924|25836412|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
13094309|NCT03628924|25836406|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0|||
13094310|NCT03628924|25836407|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0|||
13094311|NCT03628924|25836408|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0|||
13094312|NCT03628924|25836409|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1|||
13094313|NCT03628924|25836410|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0|||
13094314|NCT03628924|25836411|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2|||
13094315|NCT03628924|25836412|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4|||
13094316|NCT03628924|25836406|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
13094317|NCT03628924|25836407|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
13094318|NCT03628924|25836408|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
13094319|NCT03628924|25836409|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
13094320|NCT03628924|25836410|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
13094321|NCT03628924|25836411|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
13094322|NCT03628924|25836412|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
13094323|NCT03628924|25836406|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
13094324|NCT03628924|25836407|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
13094325|NCT03628924|25836408|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
13094326|NCT03628924|25836409|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5|||
13094327|NCT03628924|25836410|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1|||
13094328|NCT03628924|25836411|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4|||
13094329|NCT03628924|25836412|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2|||
13094330|NCT03628924|25836406|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
13094331|NCT03628924|25836407|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
13094332|NCT03628924|25836408|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
13094333|NCT03628924|25836409|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
13094334|NCT03628924|25836410|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1|||
13094335|NCT03628924|25836411|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5|||
13148590|NCT02574078|26040534|FG003|Treatment Period|Adverse event unrelated to drug|0|||
13094336|NCT03628924|25836412|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3|||
13094337|NCT03628898|25836420|FG000|Overall Study|Device deficiency|1|||
13094338|NCT03628781|25836439|FG000|Overall Study|Lost to Follow-up|16|||
13094339|NCT03628781|25836440|FG001|Overall Study|Lost to Follow-up|8|||
13094340|NCT03628781|25836439|FG000|Overall Study|Withdrawal by Subject|16|||
13094341|NCT03628781|25836440|FG001|Overall Study|Withdrawal by Subject|1|||
13094342|NCT03628716|25836473|FG000|Overall Study|Adverse Event|1|||
13094343|NCT03628716|25836474|FG001|Overall Study|Adverse Event|1|||
13094344|NCT03628716|25836473|FG000|Overall Study|Death|1|||
13094345|NCT03628716|25836474|FG001|Overall Study|Death|0|||
13094346|NCT03628716|25836473|FG000|Overall Study|Lack of Efficacy|15|||
13094347|NCT03628716|25836474|FG001|Overall Study|Lack of Efficacy|20|||
13094348|NCT03628716|25836473|FG000|Overall Study|Withdrawal by Subject|1|||
13094349|NCT03628716|25836474|FG001|Overall Study|Withdrawal by Subject|2|||
13094350|NCT03628716|25836473|FG000|Overall Study|Study Terminated by Sponsor|1|||
13094351|NCT03628716|25836474|FG001|Overall Study|Study Terminated by Sponsor|0|||
13094352|NCT03628599|25836491|FG000|Overall Study|Adverse Event|0|||
13094353|NCT03628599|25836492|FG001|Overall Study|Adverse Event|1|||
13094354|NCT03628508|25836499|FG000|Overall Study|Lost to Follow-up|1|||
13094355|NCT03628417|25836512|FG000|Overall Study|Death|1|||
13094356|NCT03628417|25836513|FG001|Overall Study|Death|1|||
13094357|NCT03627832|25836542|FG000|Overall Study|Withdrawal by Subject|10|||
13094358|NCT03627832|25836543|FG001|Overall Study|Withdrawal by Subject|1|||
13094359|NCT03627767|25836632|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48|||
13094360|NCT03627767|25836633|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
13094361|NCT03627767|25836634|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
13094362|NCT03627767|25836635|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
13094363|NCT03627767|25836636|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
13094364|NCT03627767|25836632|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1|||
13094365|NCT03627767|25836633|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
13094366|NCT03627767|25836634|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
13094367|NCT03627767|25836635|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
13094368|NCT03627767|25836636|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
13094369|NCT03627767|25836632|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315|||
13094370|NCT03627767|25836633|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
13094371|NCT03627767|25836634|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
13094372|NCT03627767|25836635|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
13094373|NCT03627767|25836636|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
13148591|NCT02574078|26040535|FG004|Treatment Period|Adverse event unrelated to drug|2|||
13148592|NCT02574078|26040536|FG005|Treatment Period|Adverse event unrelated to drug|3|||
13148593|NCT02574078|26040537|FG006|Treatment Period|Adverse event unrelated to drug|0|||
13148594|NCT02574078|26040538|FG007|Treatment Period|Adverse event unrelated to drug|0|||
13148595|NCT02574078|26040539|FG008|Treatment Period|Adverse event unrelated to drug|1|||
13148596|NCT02574078|26040540|FG009|Treatment Period|Adverse event unrelated to drug|2|||
13148597|NCT02574078|26040541|FG010|Treatment Period|Adverse event unrelated to drug|4|||
13148598|NCT02574078|26040542|FG011|Treatment Period|Adverse event unrelated to drug|1|||
13148599|NCT02574078|26040543|FG012|Treatment Period|Adverse event unrelated to drug|0|||
13148600|NCT02574078|26040531|FG000|Treatment Period|Administrative reason by Sponsor|0|||
13148601|NCT02574078|26040532|FG001|Treatment Period|Administrative reason by Sponsor|1|||
13148602|NCT02574078|26040533|FG002|Treatment Period|Administrative reason by Sponsor|0|||
13148603|NCT02574078|26040534|FG003|Treatment Period|Administrative reason by Sponsor|0|||
13148604|NCT02574078|26040535|FG004|Treatment Period|Administrative reason by Sponsor|0|||
13148605|NCT02574078|26040536|FG005|Treatment Period|Administrative reason by Sponsor|0|||
13148606|NCT02574078|26040537|FG006|Treatment Period|Administrative reason by Sponsor|1|||
13148607|NCT02574078|26040538|FG007|Treatment Period|Administrative reason by Sponsor|0|||
13148608|NCT02574078|26040539|FG008|Treatment Period|Administrative reason by Sponsor|0|||
13148609|NCT02574078|26040540|FG009|Treatment Period|Administrative reason by Sponsor|0|||
13148610|NCT02574078|26040541|FG010|Treatment Period|Administrative reason by Sponsor|0|||
13148611|NCT02574078|26040542|FG011|Treatment Period|Administrative reason by Sponsor|0|||
13148612|NCT02574078|26040543|FG012|Treatment Period|Administrative reason by Sponsor|3|||
13148613|NCT02574078|26040531|FG000|Treatment Period|Other reasons|1|||
13148614|NCT02574078|26040532|FG001|Treatment Period|Other reasons|0|||
13148615|NCT02574078|26040533|FG002|Treatment Period|Other reasons|1|||
13094374|NCT03627767|25836632|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13|||
13094375|NCT03627767|25836633|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
13094376|NCT03627767|25836634|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
13094377|NCT03627767|25836635|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
13094378|NCT03627767|25836636|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
13148616|NCT02574078|26040534|FG003|Treatment Period|Other reasons|3|||
13148617|NCT02574078|26040535|FG004|Treatment Period|Other reasons|3|||
13148618|NCT02574078|26040536|FG005|Treatment Period|Other reasons|1|||
13148619|NCT02574078|26040537|FG006|Treatment Period|Other reasons|2|||
13094379|NCT03627767|25836632|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11|||
13094380|NCT03627767|25836633|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
13094381|NCT03627767|25836634|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
13094382|NCT03627767|25836635|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
13094383|NCT03627767|25836636|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
13094384|NCT03627767|25836632|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40|||
13094385|NCT03627767|25836633|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
13094386|NCT03627767|25836634|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
13094387|NCT03627767|25836635|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
13094388|NCT03627767|25836636|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
13094389|NCT03627767|25836632|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1|||
13094390|NCT03627767|25836633|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
13094391|NCT03627767|25836634|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
13094392|NCT03627767|25836635|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
13094393|NCT03627767|25836636|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
13094394|NCT03627767|25836632|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2|||
13094395|NCT03627767|25836633|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
13094396|NCT03627767|25836634|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
13094397|NCT03627767|25836635|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
13094398|NCT03627767|25836636|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
13094399|NCT03627767|25836632|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4|||
13094400|NCT03627767|25836633|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
13094401|NCT03627767|25836634|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
13094402|NCT03627767|25836635|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
13094403|NCT03627767|25836636|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
13094404|NCT03627767|25836632|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2|||
13094405|NCT03627767|25836633|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
13094406|NCT03627767|25836634|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
13132748|NCT02784535|25984991|FG001|Overall Study|Physician Decision|1|||
13148620|NCT02574078|26040538|FG007|Treatment Period|Other reasons|1|||
13148621|NCT02574078|26040539|FG008|Treatment Period|Other reasons|3|||
13148622|NCT02574078|26040540|FG009|Treatment Period|Other reasons|1|||
13148623|NCT02574078|26040541|FG010|Treatment Period|Other reasons|1|||
13148624|NCT02574078|26040542|FG011|Treatment Period|Other reasons|3|||
13148625|NCT02574078|26040543|FG012|Treatment Period|Other reasons|1|||
13148626|NCT02574078|26040531|FG000|Treatment Period|Participant request to stop drug|0|||
13148627|NCT02574078|26040532|FG001|Treatment Period|Participant request to stop drug|0|||
13148628|NCT02574078|26040533|FG002|Treatment Period|Participant request to stop drug|0|||
13148629|NCT02574078|26040534|FG003|Treatment Period|Participant request to stop drug|2|||
13148630|NCT02574078|26040535|FG004|Treatment Period|Participant request to stop drug|4|||
13148631|NCT02574078|26040536|FG005|Treatment Period|Participant request to stop drug|0|||
13148632|NCT02574078|26040537|FG006|Treatment Period|Participant request to stop drug|1|||
13148633|NCT02574078|26040538|FG007|Treatment Period|Participant request to stop drug|0|||
13148634|NCT02574078|26040539|FG008|Treatment Period|Participant request to stop drug|3|||
13148635|NCT02574078|26040540|FG009|Treatment Period|Participant request to stop drug|2|||
13148636|NCT02574078|26040541|FG010|Treatment Period|Participant request to stop drug|2|||
13148637|NCT02574078|26040542|FG011|Treatment Period|Participant request to stop drug|4|||
13148638|NCT02574078|26040543|FG012|Treatment Period|Participant request to stop drug|1|||
13148639|NCT02574078|26040531|FG000|Treatment Period|Participant withdrew consent|0|||
13148640|NCT02574078|26040532|FG001|Treatment Period|Participant withdrew consent|0|||
13148641|NCT02574078|26040533|FG002|Treatment Period|Participant withdrew consent|0|||
13148642|NCT02574078|26040534|FG003|Treatment Period|Participant withdrew consent|0|||
13148643|NCT02574078|26040535|FG004|Treatment Period|Participant withdrew consent|1|||
13148644|NCT02574078|26040536|FG005|Treatment Period|Participant withdrew consent|1|||
13148645|NCT02574078|26040537|FG006|Treatment Period|Participant withdrew consent|0|||
13148646|NCT02574078|26040538|FG007|Treatment Period|Participant withdrew consent|1|||
13148647|NCT02574078|26040539|FG008|Treatment Period|Participant withdrew consent|0|||
13148648|NCT02574078|26040540|FG009|Treatment Period|Participant withdrew consent|2|||
13148649|NCT02574078|26040541|FG010|Treatment Period|Participant withdrew consent|1|||
13148650|NCT02574078|26040542|FG011|Treatment Period|Participant withdrew consent|4|||
13148651|NCT02574078|26040543|FG012|Treatment Period|Participant withdrew consent|1|||
13148652|NCT02574078|26040531|FG000|Treatment Period|Participant no longer meets criteria|0|||
13148653|NCT02574078|26040532|FG001|Treatment Period|Participant no longer meets criteria|0|||
13148654|NCT02574078|26040533|FG002|Treatment Period|Participant no longer meets criteria|0|||
13148655|NCT02574078|26040534|FG003|Treatment Period|Participant no longer meets criteria|0|||
13205090|NCT01968070|26230884|FG010|Period 1|Adverse Event|0|||
13148656|NCT02574078|26040535|FG004|Treatment Period|Participant no longer meets criteria|1|||
13148657|NCT02574078|26040536|FG005|Treatment Period|Participant no longer meets criteria|0|||
13148658|NCT02574078|26040537|FG006|Treatment Period|Participant no longer meets criteria|0|||
13148659|NCT02574078|26040538|FG007|Treatment Period|Participant no longer meets criteria|0|||
13148660|NCT02574078|26040539|FG008|Treatment Period|Participant no longer meets criteria|0|||
13148661|NCT02574078|26040540|FG009|Treatment Period|Participant no longer meets criteria|1|||
13148662|NCT02574078|26040541|FG010|Treatment Period|Participant no longer meets criteria|1|||
13148663|NCT02574078|26040542|FG011|Treatment Period|Participant no longer meets criteria|1|||
13148664|NCT02574078|26040543|FG012|Treatment Period|Participant no longer meets criteria|0|||
13148665|NCT02574078|26040531|FG000|Treatment Period|Lost to Follow-up|0|||
13148666|NCT02574078|26040532|FG001|Treatment Period|Lost to Follow-up|0|||
13148667|NCT02574078|26040533|FG002|Treatment Period|Lost to Follow-up|0|||
13148668|NCT02574078|26040534|FG003|Treatment Period|Lost to Follow-up|0|||
13148669|NCT02574078|26040535|FG004|Treatment Period|Lost to Follow-up|0|||
13148670|NCT02574078|26040536|FG005|Treatment Period|Lost to Follow-up|0|||
13148671|NCT02574078|26040537|FG006|Treatment Period|Lost to Follow-up|0|||
13148672|NCT02574078|26040538|FG007|Treatment Period|Lost to Follow-up|0|||
13148673|NCT02574078|26040539|FG008|Treatment Period|Lost to Follow-up|0|||
13148674|NCT02574078|26040540|FG009|Treatment Period|Lost to Follow-up|1|||
13148675|NCT02574078|26040541|FG010|Treatment Period|Lost to Follow-up|0|||
13148676|NCT02574078|26040542|FG011|Treatment Period|Lost to Follow-up|1|||
13148677|NCT02574078|26040543|FG012|Treatment Period|Lost to Follow-up|0|||
13148678|NCT02574078|26040531|FG000|Treatment Period|Maximum clinical benefit|0|||
13148679|NCT02574078|26040532|FG001|Treatment Period|Maximum clinical benefit|0|||
13148680|NCT02574078|26040533|FG002|Treatment Period|Maximum clinical benefit|0|||
13148681|NCT02574078|26040534|FG003|Treatment Period|Maximum clinical benefit|0|||
13094407|NCT03627767|25836635|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
13094408|NCT03627767|25836636|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
13094409|NCT03627767|25836632|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
13094410|NCT03627767|25836633|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6|||
13094411|NCT03627767|25836634|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7|||
13094412|NCT03627767|25836635|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19|||
13094413|NCT03627767|25836636|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
13094414|NCT03627767|25836632|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
13094415|NCT03627767|25836633|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
13094416|NCT03627767|25836634|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2|||
13094417|NCT03627767|25836635|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3|||
13094418|NCT03627767|25836636|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
13094419|NCT03627767|25836632|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
13094420|NCT03627767|25836633|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1|||
13094421|NCT03627767|25836634|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5|||
13094422|NCT03627767|25836635|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2|||
13094423|NCT03627767|25836636|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
13094424|NCT03627767|25836632|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
13094425|NCT03627767|25836633|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9|||
13094426|NCT03627767|25836634|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6|||
13094427|NCT03627767|25836635|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10|||
13094428|NCT03627767|25836636|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
13094429|NCT03627767|25836632|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
13094430|NCT03627767|25836633|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
13094431|NCT03627767|25836634|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1|||
13094432|NCT03627767|25836635|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
13094433|NCT03627767|25836636|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
13094434|NCT03627767|25836632|FG000|Double-blind Treatment Period (40 Weeks)|Other|0|||
13094435|NCT03627767|25836633|FG001|Double-blind Treatment Period (40 Weeks)|Other|0|||
13094436|NCT03627767|25836634|FG002|Double-blind Treatment Period (40 Weeks)|Other|1|||
13094437|NCT03627767|25836635|FG003|Double-blind Treatment Period (40 Weeks)|Other|1|||
13094438|NCT03627767|25836636|FG004|Double-blind Treatment Period (40 Weeks)|Other|0|||
13094439|NCT03627767|25836632|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
13094440|NCT03627767|25836633|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
13094441|NCT03627767|25836634|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
13094442|NCT03627767|25836635|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
13094443|NCT03627767|25836636|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9|||
13094444|NCT03627767|25836632|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
13094445|NCT03627767|25836633|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
13094446|NCT03627767|25836634|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
13094447|NCT03627767|25836635|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
13094448|NCT03627767|25836636|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1|||
13094449|NCT03627767|25836632|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
13094450|NCT03627767|25836633|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
13094451|NCT03627767|25836634|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
13094452|NCT03627767|25836635|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
13094453|NCT03627767|25836636|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9|||
13094454|NCT03627767|25836632|FG000|Open-label Rescue Period (12 Weeks)|Other|0|||
13094455|NCT03627767|25836633|FG001|Open-label Rescue Period (12 Weeks)|Other|0|||
13094456|NCT03627767|25836634|FG002|Open-label Rescue Period (12 Weeks)|Other|0|||
13094457|NCT03627767|25836635|FG003|Open-label Rescue Period (12 Weeks)|Other|0|||
13094458|NCT03627767|25836636|FG004|Open-label Rescue Period (12 Weeks)|Other|1|||
13094459|NCT03627494|25836869|FG000|Part A Washout 2 (7 Days)|Adverse Event|1|||
13094460|NCT03627494|25836870|FG001|Part A Washout 2 (7 Days)|Adverse Event|0|||
13094461|NCT03627494|25836871|FG002|Part A Washout 2 (7 Days)|Adverse Event|1|||
13094462|NCT03627494|25836872|FG003|Part A Washout 2 (7 Days)|Adverse Event|0|||
13094463|NCT03627494|25836873|FG004|Part A Washout 2 (7 Days)|Adverse Event|0|||
13094464|NCT03627494|25836874|FG005|Part A Washout 2 (7 Days)|Adverse Event|0|||
13094465|NCT03627494|25836875|FG006|Part A Washout 2 (7 Days)|Adverse Event|0|||
13094466|NCT03627494|25836876|FG007|Part A Washout 2 (7 Days)|Adverse Event|0|||
13094467|NCT03627494|25836877|FG008|Part A Washout 2 (7 Days)|Adverse Event|0|||
13094468|NCT03627494|25836878|FG009|Part A Washout 2 (7 Days)|Adverse Event|0|||
13094469|NCT03627494|25836879|FG010|Part A Washout 2 (7 Days)|Adverse Event|0|||
13094470|NCT03627494|25836880|FG011|Part A Washout 2 (7 Days)|Adverse Event|0|||
13094471|NCT03627494|25836869|FG000|Part B (Maximum of 34 Days)|Adverse Event|0|||
13094472|NCT03627494|25836870|FG001|Part B (Maximum of 34 Days)|Adverse Event|0|||
13094473|NCT03627494|25836871|FG002|Part B (Maximum of 34 Days)|Adverse Event|0|||
13094474|NCT03627494|25836872|FG003|Part B (Maximum of 34 Days)|Adverse Event|0|||
13094475|NCT03627494|25836873|FG004|Part B (Maximum of 34 Days)|Adverse Event|0|||
13094476|NCT03627494|25836874|FG005|Part B (Maximum of 34 Days)|Adverse Event|0|||
13094477|NCT03627494|25836875|FG006|Part B (Maximum of 34 Days)|Adverse Event|0|||
13094478|NCT03627494|25836876|FG007|Part B (Maximum of 34 Days)|Adverse Event|0|||
13094479|NCT03627494|25836877|FG008|Part B (Maximum of 34 Days)|Adverse Event|2|||
13148682|NCT02574078|26040535|FG004|Treatment Period|Maximum clinical benefit|0|||
13148683|NCT02574078|26040536|FG005|Treatment Period|Maximum clinical benefit|0|||
13148684|NCT02574078|26040537|FG006|Treatment Period|Maximum clinical benefit|0|||
13148685|NCT02574078|26040538|FG007|Treatment Period|Maximum clinical benefit|0|||
13148686|NCT02574078|26040539|FG008|Treatment Period|Maximum clinical benefit|0|||
13148687|NCT02574078|26040540|FG009|Treatment Period|Maximum clinical benefit|1|||
13148688|NCT02574078|26040541|FG010|Treatment Period|Maximum clinical benefit|0|||
13148689|NCT02574078|26040542|FG011|Treatment Period|Maximum clinical benefit|0|||
13148690|NCT02574078|26040543|FG012|Treatment Period|Maximum clinical benefit|0|||
13148691|NCT02573948|26040553|FG000|Longitudinal Cohort|Death|9|||
13148692|NCT02573948|26040553|FG000|Longitudinal Cohort|Lost to Follow-up|22|||
13148693|NCT02573948|26040553|FG000|Longitudinal Cohort|Incarcerated|25|||
13148694|NCT02573883|26040614|FG000|Six Month Follow Up|Lost to Follow-up|1|||
13148695|NCT02573883|26040615|FG001|Six Month Follow Up|Lost to Follow-up|0|||
13148696|NCT02573883|26040616|FG002|Six Month Follow Up|Lost to Follow-up|0|||
13148697|NCT02573883|26040617|FG003|Six Month Follow Up|Lost to Follow-up|0|||
13148698|NCT02573883|26040614|FG000|One Year Follow Up|Lost to Follow-up|2|||
13148699|NCT02573883|26040615|FG001|One Year Follow Up|Lost to Follow-up|1|||
13148700|NCT02573883|26040616|FG002|One Year Follow Up|Lost to Follow-up|0|||
13148701|NCT02573883|26040617|FG003|One Year Follow Up|Lost to Follow-up|0|||
13148702|NCT02573870|26040630|FG000|Overall Study|Adverse Event|0|||
13148703|NCT02573870|26040631|FG001|Overall Study|Adverse Event|2|||
13148704|NCT02573870|26040630|FG000|Overall Study|Lack of Efficacy|0|||
13148705|NCT02573870|26040631|FG001|Overall Study|Lack of Efficacy|1|||
13148706|NCT02573870|26040630|FG000|Overall Study|Other: Reached defined stopping criteria|0|||
13148707|NCT02573870|26040631|FG001|Overall Study|Other: Reached defined stopping criteria|1|||
13148708|NCT02573870|26040630|FG000|Overall Study|Lost to Follow-up|0|||
13148709|NCT02573870|26040631|FG001|Overall Study|Lost to Follow-up|1|||
13148710|NCT02573870|26040630|FG000|Overall Study|Other: Fail to Meet Visit|0|||
13148711|NCT02573870|26040631|FG001|Overall Study|Other: Fail to Meet Visit|2|||
13148712|NCT02573493|26040722|FG000|Overall Study|Determined to not be eligible after enrollment|0|||
13148713|NCT02573493|26040723|FG001|Overall Study|Determined to not be eligible after enrollment|0|||
13148714|NCT02573493|26040724|FG002|Overall Study|Determined to not be eligible after enrollment|0|||
13148715|NCT02573493|26040725|FG003|Overall Study|Determined to not be eligible after enrollment|1|||
13148716|NCT02573467|26040777|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0|||
13148717|NCT02573467|26040778|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0|||
13148718|NCT02573467|26040779|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1|||
13148719|NCT02573467|26040780|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0|||
13148720|NCT02573467|26040777|FG000|Double-blind Treatment Epoch|Adverse Event|1|||
13148721|NCT02573467|26040778|FG001|Double-blind Treatment Epoch|Adverse Event|0|||
13148722|NCT02573467|26040779|FG002|Double-blind Treatment Epoch|Adverse Event|1|||
13148723|NCT02573467|26040780|FG003|Double-blind Treatment Epoch|Adverse Event|0|||
13148724|NCT02573467|26040777|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2|||
13148725|NCT02573467|26040778|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
13148726|NCT02573467|26040779|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
13148727|NCT02573467|26040780|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0|||
13148728|NCT02573467|26040777|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50|||
13148729|NCT02573467|26040778|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51|||
13148730|NCT02573467|26040779|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48|||
13148731|NCT02573467|26040780|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55|||
13148732|NCT02573467|26040777|FG000|Post-treatment Follow up Epoch|Death|1|||
13148733|NCT02573467|26040778|FG001|Post-treatment Follow up Epoch|Death|1|||
13148734|NCT02573467|26040779|FG002|Post-treatment Follow up Epoch|Death|0|||
13148735|NCT02573467|26040780|FG003|Post-treatment Follow up Epoch|Death|1|||
13148736|NCT02573467|26040777|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5|||
13148737|NCT02573467|26040778|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4|||
13148738|NCT02573467|26040779|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9|||
13148739|NCT02573467|26040780|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2|||
13148740|NCT02573467|26040777|FG000|Post-treatment Follow up Epoch|Technical problems|0|||
13148741|NCT02573467|26040778|FG001|Post-treatment Follow up Epoch|Technical problems|0|||
13148742|NCT02573467|26040779|FG002|Post-treatment Follow up Epoch|Technical problems|1|||
13148743|NCT02573467|26040780|FG003|Post-treatment Follow up Epoch|Technical problems|0|||
13148744|NCT02573350|26040839|FG000|Overall Study|Lost to Follow-up|2|||
13148745|NCT02573350|26040840|FG001|Overall Study|Lost to Follow-up|1|||
13148746|NCT02573350|26040839|FG000|Overall Study|Adverse Event|3|||
13148747|NCT02573350|26040840|FG001|Overall Study|Adverse Event|4|||
13148748|NCT02573350|26040839|FG000|Overall Study|Subject met Withdrawal Criteria|1|||
13148749|NCT02573350|26040840|FG001|Overall Study|Subject met Withdrawal Criteria|1|||
13148750|NCT02573350|26040839|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3|||
13148751|NCT02573350|26040840|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1|||
13148752|NCT02573350|26040839|FG000|Overall Study|Subject withdrew consent to participate|6|||
13148753|NCT02573350|26040840|FG001|Overall Study|Subject withdrew consent to participate|1|||
13148754|NCT02573350|26040839|FG000|Overall Study|Protocol Deviation|1|||
13148755|NCT02573350|26040840|FG001|Overall Study|Protocol Deviation|1|||
13148756|NCT02573311|26040861|FG000|Disposition for Part 1|Withdrawal by Subject|7|||
13148757|NCT02573311|26040862|FG001|Disposition for Part 1|Withdrawal by Subject|3|||
13148758|NCT02573311|26040861|FG000|Disposition for Part 2|Physician Decision|25|||
13148759|NCT02573311|26040862|FG001|Disposition for Part 2|Physician Decision|7|||
13148760|NCT02573311|26040861|FG000|Disposition for Part 2|Adverse Event|36|||
13148761|NCT02573311|26040862|FG001|Disposition for Part 2|Adverse Event|5|||
13094480|NCT03627494|25836878|FG009|Part B (Maximum of 34 Days)|Adverse Event|0|||
13094481|NCT03627494|25836879|FG010|Part B (Maximum of 34 Days)|Adverse Event|0|||
13094482|NCT03627494|25836880|FG011|Part B (Maximum of 34 Days)|Adverse Event|0|||
13094483|NCT03627494|25836869|FG000|Part C Washout 1 (7 Days)|Adverse Event|0|||
13094484|NCT03627494|25836870|FG001|Part C Washout 1 (7 Days)|Adverse Event|0|||
13094485|NCT03627494|25836871|FG002|Part C Washout 1 (7 Days)|Adverse Event|0|||
13094486|NCT03627494|25836872|FG003|Part C Washout 1 (7 Days)|Adverse Event|0|||
13148762|NCT02573311|26040861|FG000|Disposition for Part 2|Lost to Follow-up|76|||
13148763|NCT02573311|26040862|FG001|Disposition for Part 2|Lost to Follow-up|7|||
13148764|NCT02573311|26040861|FG000|Disposition for Part 2|Withdrawal by Subject|60|||
13148765|NCT02573311|26040862|FG001|Disposition for Part 2|Withdrawal by Subject|3|||
13148766|NCT02573311|26040861|FG000|Disposition for Part 2|Investigator decision|0|||
13148767|NCT02573311|26040862|FG001|Disposition for Part 2|Investigator decision|1|||
13148768|NCT02573311|26040861|FG000|Disposition for Part 2|Other than specified above|13|||
13148769|NCT02573311|26040862|FG001|Disposition for Part 2|Other than specified above|3|||
13148770|NCT02573246|26040930|FG000|Overall Study|Lost to Follow-up|2|||
13148771|NCT02573246|26040931|FG001|Overall Study|Lost to Follow-up|0|||
13148772|NCT02573246|26040932|FG002|Overall Study|Lost to Follow-up|0|||
13148773|NCT02573246|26040933|FG003|Overall Study|Lost to Follow-up|0|||
13148774|NCT02573246|26040934|FG004|Overall Study|Lost to Follow-up|1|||
13148775|NCT02573246|26040930|FG000|Overall Study|Withdrawal by Subject|0|||
13148776|NCT02573246|26040931|FG001|Overall Study|Withdrawal by Subject|0|||
13148777|NCT02573246|26040932|FG002|Overall Study|Withdrawal by Subject|0|||
13148778|NCT02573246|26040933|FG003|Overall Study|Withdrawal by Subject|0|||
13148779|NCT02573246|26040934|FG004|Overall Study|Withdrawal by Subject|1|||
13148780|NCT02573246|26040930|FG000|Overall Study|Physician Decision|1|||
13148781|NCT02573246|26040931|FG001|Overall Study|Physician Decision|1|||
13148782|NCT02573246|26040932|FG002|Overall Study|Physician Decision|3|||
13148783|NCT02573246|26040933|FG003|Overall Study|Physician Decision|2|||
13148784|NCT02573246|26040934|FG004|Overall Study|Physician Decision|2|||
13094487|NCT03627494|25836873|FG004|Part C Washout 1 (7 Days)|Adverse Event|0|||
13307581|NCT01284361|26529108|FG000|Overall Study|Lost to Follow-up|2|||
13148785|NCT02573155|26041087|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0|||
13148786|NCT02573155|26041088|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1|||
13148787|NCT02573155|26041087|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0|||
13148788|NCT02573155|26041088|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1|||
13148789|NCT02573155|26041087|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0|||
13148790|NCT02573155|26041088|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3|||
13148791|NCT02573155|26041087|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1|||
13148792|NCT02573155|26041088|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0|||
13148793|NCT02573155|26041087|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0|||
13148794|NCT02573155|26041088|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2|||
13148795|NCT02573155|26041087|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0|||
13148796|NCT02573155|26041088|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1|||
13148797|NCT02573155|26041087|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0|||
13148798|NCT02573155|26041088|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1|||
13148799|NCT02573155|26041087|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0|||
13148800|NCT02573155|26041088|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1|||
13148801|NCT02573012|26041145|FG000|Overall Study|Adverse Event|5|||
13148802|NCT02573012|26041146|FG001|Overall Study|Adverse Event|5|||
13148803|NCT02573012|26041145|FG000|Overall Study|Lack of Efficacy|5|||
13148804|NCT02573012|26041146|FG001|Overall Study|Lack of Efficacy|4|||
13148805|NCT02573012|26041145|FG000|Overall Study|Non-compliance|1|||
13148806|NCT02573012|26041146|FG001|Overall Study|Non-compliance|2|||
13148807|NCT02573012|26041145|FG000|Overall Study|Withdrawal by Subject|2|||
13148808|NCT02573012|26041146|FG001|Overall Study|Withdrawal by Subject|2|||
13148809|NCT02573012|26041145|FG000|Overall Study|Study Ended per Protocol|1|||
13148810|NCT02573012|26041146|FG001|Overall Study|Study Ended per Protocol|0|||
13148811|NCT02573012|26041145|FG000|Overall Study|Physician Decision|1|||
13148812|NCT02573012|26041146|FG001|Overall Study|Physician Decision|2|||
13148813|NCT02572882|26041191|FG000|Overall Study|Withdrawal by Subject|1|||
13148814|NCT02572882|26041191|FG000|Overall Study|Participant received kidney transplant|1|||
13148815|NCT02572817|26041262|FG000|Overall Study|Death|6|||
13148816|NCT02572817|26041263|FG001|Overall Study|Death|3|||
13148817|NCT02572817|26041262|FG000|Overall Study|Lost to Follow-up|3|||
13148818|NCT02572817|26041263|FG001|Overall Study|Lost to Follow-up|3|||
13148819|NCT02572570|26041280|FG000|Overall Study|Study Terminated|27|||
13148820|NCT02572401|26041319|FG000|Overall Study|Lost to Follow-up|5|||
13148821|NCT02572401|26041320|FG001|Overall Study|Lost to Follow-up|8|||
13148822|NCT02572401|26041321|FG002|Overall Study|Lost to Follow-up|9|||
13148823|NCT02572401|26041322|FG003|Overall Study|Lost to Follow-up|9|||
13148824|NCT02572401|26041319|FG000|Overall Study|Death|0|||
13148825|NCT02572401|26041320|FG001|Overall Study|Death|0|||
13148826|NCT02572401|26041321|FG002|Overall Study|Death|0|||
13148827|NCT02572401|26041322|FG003|Overall Study|Death|1|||
13148828|NCT02572388|26041357|FG000|Overall Study|Withdrawal by Subject|1|||
13148829|NCT02572388|26041358|FG001|Overall Study|Withdrawal by Subject|1|||
13148830|NCT02572388|26041359|FG002|Overall Study|Withdrawal by Subject|2|||
13148831|NCT02572388|26041360|FG003|Overall Study|Withdrawal by Subject|2|||
13148832|NCT02572076|26041366|FG000|Overall Study|Protocol Violation|1|||
13148833|NCT02571972|26041375|FG000|Overall Study|Protocol Violation|2|||
13148834|NCT02571972|26041375|FG000|Overall Study|Withdrawal by Subject|2|||
13148835|NCT02571777|26041518|FG000|Overall Study|Subject/guardian decision|34|||
13148836|NCT02571777|26041519|FG001|Overall Study|Subject/guardian decision|26|||
13148837|NCT02571777|26041520|FG002|Overall Study|Subject/guardian decision|26|||
13148838|NCT02571777|26041521|FG003|Overall Study|Subject/guardian decision|25|||
13148839|NCT02571777|26041522|FG004|Overall Study|Subject/guardian decision|27|||
13148840|NCT02571777|26041518|FG000|Overall Study|Protocol Deviation|2|||
13148841|NCT02571777|26041519|FG001|Overall Study|Protocol Deviation|3|||
13148842|NCT02571777|26041520|FG002|Overall Study|Protocol Deviation|4|||
13094488|NCT03627494|25836874|FG005|Part C Washout 1 (7 Days)|Adverse Event|0|||
13094489|NCT03627494|25836875|FG006|Part C Washout 1 (7 Days)|Adverse Event|0|||
13094490|NCT03627494|25836876|FG007|Part C Washout 1 (7 Days)|Adverse Event|0|||
13094491|NCT03627494|25836877|FG008|Part C Washout 1 (7 Days)|Adverse Event|0|||
13094492|NCT03627494|25836878|FG009|Part C Washout 1 (7 Days)|Adverse Event|0|||
13094493|NCT03627494|25836879|FG010|Part C Washout 1 (7 Days)|Adverse Event|1|||
13094494|NCT03627494|25836880|FG011|Part C Washout 1 (7 Days)|Adverse Event|1|||
13094495|NCT03627416|25836901|FG000|Overall Study|Adverse Event|0|||
13094496|NCT03627416|25836902|FG001|Overall Study|Adverse Event|1|||
13094497|NCT03627195|25836947|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1|||
13094498|NCT03627195|25836948|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0|||
13094499|NCT03627195|25836949|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0|||
13094500|NCT03627195|25836950|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0|||
13094501|NCT03627195|25836951|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0|||
13148843|NCT02571777|26041521|FG003|Overall Study|Protocol Deviation|8|||
13148844|NCT02571777|26041522|FG004|Overall Study|Protocol Deviation|4|||
13148845|NCT02571777|26041518|FG000|Overall Study|Death|1|||
13094502|NCT03627195|25836952|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0|||
13094503|NCT03627091|25836994|FG000|Overall Study|Adverse Event|0|||
13094504|NCT03627091|25836995|FG001|Overall Study|Adverse Event|0|||
13094505|NCT03627091|25836996|FG002|Overall Study|Adverse Event|2|||
13094506|NCT03627091|25836994|FG000|Overall Study|Withdrawal by Subject|2|||
13094507|NCT03627091|25836995|FG001|Overall Study|Withdrawal by Subject|0|||
13094508|NCT03627091|25836996|FG002|Overall Study|Withdrawal by Subject|2|||
13094509|NCT03627091|25836994|FG000|Overall Study|Physician Decision|2|||
13094510|NCT03627091|25836995|FG001|Overall Study|Physician Decision|0|||
13094511|NCT03627091|25836996|FG002|Overall Study|Physician Decision|0|||
13094512|NCT03627091|25836994|FG000|Overall Study|Site terminated by sponsor|0|||
13094513|NCT03627091|25836995|FG001|Overall Study|Site terminated by sponsor|1|||
13148846|NCT02571777|26041519|FG001|Overall Study|Death|1|||
13148847|NCT02571777|26041520|FG002|Overall Study|Death|4|||
13148848|NCT02571777|26041521|FG003|Overall Study|Death|0|||
13148849|NCT02571777|26041522|FG004|Overall Study|Death|0|||
13148850|NCT02571777|26041518|FG000|Overall Study|Lost to Follow-up|1|||
13148851|NCT02571777|26041519|FG001|Overall Study|Lost to Follow-up|1|||
13148852|NCT02571777|26041520|FG002|Overall Study|Lost to Follow-up|2|||
13148853|NCT02571777|26041521|FG003|Overall Study|Lost to Follow-up|0|||
13148854|NCT02571777|26041522|FG004|Overall Study|Lost to Follow-up|1|||
13148855|NCT02571777|26041518|FG000|Overall Study|Physician Decision|1|||
13148856|NCT02571777|26041519|FG001|Overall Study|Physician Decision|7|||
13148857|NCT02571777|26041520|FG002|Overall Study|Physician Decision|5|||
13148858|NCT02571777|26041521|FG003|Overall Study|Physician Decision|2|||
13148859|NCT02571777|26041522|FG004|Overall Study|Physician Decision|4|||
13094514|NCT03627091|25836996|FG002|Overall Study|Site terminated by sponsor|0|||
13094515|NCT03627091|25836994|FG000|Overall Study|Disease relapse|7|||
13094516|NCT03627091|25836995|FG001|Overall Study|Disease relapse|5|||
13094517|NCT03627091|25836996|FG002|Overall Study|Disease relapse|1|||
13094518|NCT03627091|25836994|FG000|Overall Study|Other|1|||
13094519|NCT03627091|25836995|FG001|Overall Study|Other|0|||
13094520|NCT03627091|25836996|FG002|Overall Study|Other|0|||
13094521|NCT03627065|25837019|FG000|Overall Study|Study Terminated by sponsor|1|||
13094522|NCT03627065|25837019|FG000|Overall Study|Withdrawal by Subject|2|||
13094523|NCT03624972|25837082|FG000|Overall Study|Lost to Follow-up|2|||
13094524|NCT03624972|25837083|FG001|Overall Study|Lost to Follow-up|0|||
13094525|NCT03624972|25837084|FG002|Overall Study|Lost to Follow-up|0|||
13094526|NCT03624972|25837082|FG000|Overall Study|Withdrawal by Subject|0|||
13094527|NCT03624972|25837083|FG001|Overall Study|Withdrawal by Subject|2|||
13094528|NCT03624972|25837084|FG002|Overall Study|Withdrawal by Subject|0|||
13094529|NCT03624946|25837111|FG000|Overall Study|Lost to Follow-up|0|||
13094530|NCT03624946|25837112|FG001|Overall Study|Lost to Follow-up|1|||
13094531|NCT03624881|25837151|FG000|Overall Study|Screen Failure|14|||
13094532|NCT03624881|25837152|FG001|Overall Study|Screen Failure|0|||
13094533|NCT03624881|25837151|FG000|Overall Study|No Catheter Inserted|6|||
13094534|NCT03624881|25837152|FG001|Overall Study|No Catheter Inserted|1|||
13094535|NCT03624881|25837151|FG000|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|2|||
13094536|NCT03624881|25837152|FG001|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|0|||
13094537|NCT03624881|25837151|FG000|Overall Study|Death|2|||
13094538|NCT03624881|25837152|FG001|Overall Study|Death|0|||
13094539|NCT03624881|25837151|FG000|Overall Study|Lost to Follow-up|10|||
13094540|NCT03624881|25837152|FG001|Overall Study|Lost to Follow-up|4|||
13094541|NCT03624881|25837151|FG000|Overall Study|Withdrawal by Subject|12|||
13094542|NCT03624881|25837152|FG001|Overall Study|Withdrawal by Subject|1|||
13094543|NCT03624504|25837162|FG000|Overall Study|Unsuccessful Implant|1|||
13094544|NCT03624192|25837178|FG000|Overall Study|Lost to Follow-up|1|||
13094545|NCT03624192|25837179|FG001|Overall Study|Lost to Follow-up|1|||
13094546|NCT03622593|25837360|FG000|Overall Study|Withdrawal by Subject|11|||
13094547|NCT03622593|25837361|FG001|Overall Study|Withdrawal by Subject|9|||
13094548|NCT03622593|25837362|FG002|Overall Study|Withdrawal by Subject|13|||
13094549|NCT03622593|25837360|FG000|Overall Study|Death|12|||
13094550|NCT03622593|25837361|FG001|Overall Study|Death|9|||
13094551|NCT03622593|25837362|FG002|Overall Study|Death|10|||
13094552|NCT03622593|25837360|FG000|Overall Study|Lost to Follow-up|11|||
13094553|NCT03622593|25837361|FG001|Overall Study|Lost to Follow-up|5|||
13094554|NCT03622593|25837362|FG002|Overall Study|Lost to Follow-up|8|||
13094555|NCT03622593|25837360|FG000|Overall Study|Adverse Event|4|||
13094556|NCT03622593|25837361|FG001|Overall Study|Adverse Event|5|||
13094557|NCT03622593|25837362|FG002|Overall Study|Adverse Event|6|||
13094558|NCT03622593|25837360|FG000|Overall Study|Physician Decision|2|||
13094559|NCT03622593|25837361|FG001|Overall Study|Physician Decision|1|||
13094560|NCT03622593|25837362|FG002|Overall Study|Physician Decision|6|||
13094561|NCT03622593|25837360|FG000|Overall Study|Other|2|||
13094562|NCT03622593|25837361|FG001|Overall Study|Other|2|||
13148860|NCT02571777|26041518|FG000|Overall Study|Pregnancy|0|||
13148861|NCT02571777|26041519|FG001|Overall Study|Pregnancy|0|||
13148862|NCT02571777|26041520|FG002|Overall Study|Pregnancy|0|||
13148863|NCT02571777|26041521|FG003|Overall Study|Pregnancy|2|||
13148864|NCT02571777|26041522|FG004|Overall Study|Pregnancy|0|||
13094563|NCT03622593|25837362|FG002|Overall Study|Other|3|||
13094564|NCT03622593|25837360|FG000|Overall Study|Protocol Violation|0|||
13094565|NCT03622593|25837361|FG001|Overall Study|Protocol Violation|0|||
13094566|NCT03622593|25837362|FG002|Overall Study|Protocol Violation|1|||
13094567|NCT03622593|25837360|FG000|Overall Study|Pregnancy|0|||
13094568|NCT03622593|25837361|FG001|Overall Study|Pregnancy|0|||
13094569|NCT03622593|25837362|FG002|Overall Study|Pregnancy|1|||
13094570|NCT03622580|25837543|FG000|Overall Study|Death|16|||
13094571|NCT03622580|25837544|FG001|Overall Study|Death|21|||
13094572|NCT03622580|25837545|FG002|Overall Study|Death|13|||
13094573|NCT03622580|25837543|FG000|Overall Study|Adverse Event|6|||
13094574|NCT03622580|25837544|FG001|Overall Study|Adverse Event|6|||
13094575|NCT03622580|25837545|FG002|Overall Study|Adverse Event|5|||
13094576|NCT03622580|25837543|FG000|Overall Study|Withdrawal by Subject|12|||
13094577|NCT03622580|25837544|FG001|Overall Study|Withdrawal by Subject|7|||
13094578|NCT03622580|25837545|FG002|Overall Study|Withdrawal by Subject|19|||
13094579|NCT03622580|25837543|FG000|Overall Study|Lost to Follow-up|12|||
13094580|NCT03622580|25837544|FG001|Overall Study|Lost to Follow-up|9|||
13094581|NCT03622580|25837545|FG002|Overall Study|Lost to Follow-up|9|||
13094582|NCT03622580|25837543|FG000|Overall Study|Protocol Violation|1|||
13094583|NCT03622580|25837544|FG001|Overall Study|Protocol Violation|0|||
13094584|NCT03622580|25837545|FG002|Overall Study|Protocol Violation|1|||
13094585|NCT03622580|25837543|FG000|Overall Study|Physician Decision|3|||
13094586|NCT03622580|25837544|FG001|Overall Study|Physician Decision|0|||
13094587|NCT03622580|25837545|FG002|Overall Study|Physician Decision|1|||
13094588|NCT03622580|25837543|FG000|Overall Study|Pregnancy|0|||
13094589|NCT03622580|25837544|FG001|Overall Study|Pregnancy|1|||
13148865|NCT02571452|26041541|FG000|Overall Study Treatment|Protocol Violation|0|||
13148866|NCT02571452|26041542|FG001|Overall Study Treatment|Protocol Violation|1|||
13148867|NCT02571452|26041541|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4|||
13148868|NCT02571452|26041542|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0|||
13148869|NCT02571452|26041541|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1|||
13148870|NCT02571452|26041542|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0|||
13148871|NCT02571244|26041563|FG000|Overall Study|Lost to Follow-up|0|||
13148872|NCT02571244|26041564|FG001|Overall Study|Lost to Follow-up|1|||
13148873|NCT02571244|26041563|FG000|Overall Study|Unable to reach out post discharge|3|||
13148874|NCT02571244|26041564|FG001|Overall Study|Unable to reach out post discharge|0|||
13148875|NCT02571075|26041585|FG000|Overall Study|Lost to Follow-up|20|||
13148876|NCT02571075|26041586|FG001|Overall Study|Lost to Follow-up|24|||
13148877|NCT02571049|26041595|FG000|Screening|Did not meet entry criteria|2|||
13148878|NCT02571049|26041596|FG001|Screening|Did not meet entry criteria|2|||
13148879|NCT02571049|26041595|FG000|Randomization|No migraine attack|0|||
13148880|NCT02571049|26041596|FG001|Randomization|No migraine attack|1|||
13148881|NCT02571049|26041595|FG000|Randomization|Adverse Event|0|||
13148882|NCT02571049|26041596|FG001|Randomization|Adverse Event|1|||
13148883|NCT02570750|26041619|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
13148884|NCT02570750|26041620|FG001|Overall Study|Inclusion/exclusion criteria deviation|0|||
13148885|NCT02570750|26041619|FG000|Overall Study|Protocol deviation|4|||
13148886|NCT02570750|26041620|FG001|Overall Study|Protocol deviation|2|||
13148887|NCT02570750|26041619|FG000|Overall Study|Withdrawal by Subject|5|||
13148888|NCT02570750|26041620|FG001|Overall Study|Withdrawal by Subject|0|||
13148889|NCT02570750|26041619|FG000|Overall Study|Lost to Follow-up|2|||
13148890|NCT02570750|26041620|FG001|Overall Study|Lost to Follow-up|2|||
13148891|NCT02570750|26041619|FG000|Overall Study|Adverse Event|2|||
13148892|NCT02570750|26041620|FG001|Overall Study|Adverse Event|1|||
13148893|NCT02570711|26041633|FG000|Overall Study|Death|1|||
13148894|NCT02570711|26041634|FG001|Overall Study|Death|0|||
13148895|NCT02570711|26041633|FG000|Overall Study|Early Termination of Study by Sponsor|0|||
13148896|NCT02570711|26041634|FG001|Overall Study|Early Termination of Study by Sponsor|2|||
13148897|NCT02570165|26041679|FG000|Overall Study|Adverse Event|1|||
13148898|NCT02570165|26041680|FG001|Overall Study|Adverse Event|0|||
13148899|NCT02570165|26041681|FG002|Overall Study|Adverse Event|2|||
13148900|NCT02570165|26041682|FG003|Overall Study|Adverse Event|0|||
13148901|NCT02570165|26041683|FG004|Overall Study|Adverse Event|0|||
13148902|NCT02570165|26041684|FG005|Overall Study|Adverse Event|0|||
13148903|NCT02570165|26041685|FG006|Overall Study|Adverse Event|0|||
13148904|NCT02570165|26041679|FG000|Overall Study|Lack of Efficacy|0|||
13094590|NCT03622580|25837545|FG002|Overall Study|Pregnancy|0|||
13148905|NCT02570165|26041680|FG001|Overall Study|Lack of Efficacy|1|||
13148906|NCT02570165|26041681|FG002|Overall Study|Lack of Efficacy|0|||
13148907|NCT02570165|26041682|FG003|Overall Study|Lack of Efficacy|0|||
13148908|NCT02570165|26041683|FG004|Overall Study|Lack of Efficacy|4|||
13148909|NCT02570165|26041684|FG005|Overall Study|Lack of Efficacy|0|||
13148910|NCT02570165|26041685|FG006|Overall Study|Lack of Efficacy|0|||
13094591|NCT03622580|25837543|FG000|Overall Study|Lack of Efficacy|0|||
13094592|NCT03622580|25837544|FG001|Overall Study|Lack of Efficacy|0|||
13094593|NCT03622580|25837545|FG002|Overall Study|Lack of Efficacy|1|||
13094594|NCT03622580|25837543|FG000|Overall Study|Other|2|||
13094595|NCT03622580|25837544|FG001|Overall Study|Other|0|||
13148911|NCT02570165|26041679|FG000|Overall Study|Par. Reached Stopping Criteria|1|||
13148912|NCT02570165|26041680|FG001|Overall Study|Par. Reached Stopping Criteria|1|||
13148913|NCT02570165|26041681|FG002|Overall Study|Par. Reached Stopping Criteria|0|||
13148914|NCT02570165|26041682|FG003|Overall Study|Par. Reached Stopping Criteria|2|||
13148915|NCT02570165|26041683|FG004|Overall Study|Par. Reached Stopping Criteria|1|||
13148916|NCT02570165|26041684|FG005|Overall Study|Par. Reached Stopping Criteria|1|||
13148917|NCT02570165|26041685|FG006|Overall Study|Par. Reached Stopping Criteria|0|||
13148918|NCT02570165|26041679|FG000|Overall Study|Lost to Follow-up|0|||
13148919|NCT02570165|26041680|FG001|Overall Study|Lost to Follow-up|0|||
13148920|NCT02570165|26041681|FG002|Overall Study|Lost to Follow-up|1|||
13148921|NCT02570165|26041682|FG003|Overall Study|Lost to Follow-up|1|||
13148922|NCT02570165|26041683|FG004|Overall Study|Lost to Follow-up|0|||
13148923|NCT02570165|26041684|FG005|Overall Study|Lost to Follow-up|0|||
13148924|NCT02570165|26041685|FG006|Overall Study|Lost to Follow-up|0|||
13148925|NCT02570165|26041679|FG000|Overall Study|Physician Decision|0|||
13148926|NCT02570165|26041680|FG001|Overall Study|Physician Decision|1|||
13148927|NCT02570165|26041681|FG002|Overall Study|Physician Decision|0|||
13148928|NCT02570165|26041682|FG003|Overall Study|Physician Decision|0|||
13148929|NCT02570165|26041683|FG004|Overall Study|Physician Decision|0|||
13148930|NCT02570165|26041684|FG005|Overall Study|Physician Decision|0|||
13148931|NCT02570165|26041685|FG006|Overall Study|Physician Decision|0|||
13148932|NCT02570165|26041679|FG000|Overall Study|Withdrawal by Subject|0|||
13148933|NCT02570165|26041680|FG001|Overall Study|Withdrawal by Subject|0|||
13148934|NCT02570165|26041681|FG002|Overall Study|Withdrawal by Subject|0|||
13148935|NCT02570165|26041682|FG003|Overall Study|Withdrawal by Subject|2|||
13148936|NCT02570165|26041683|FG004|Overall Study|Withdrawal by Subject|1|||
13148937|NCT02570165|26041684|FG005|Overall Study|Withdrawal by Subject|0|||
13148938|NCT02570165|26041685|FG006|Overall Study|Withdrawal by Subject|0|||
13148939|NCT02570165|26041679|FG000|Overall Study|Par. did not Meet Continuation Criteria|0|||
13148940|NCT02570165|26041680|FG001|Overall Study|Par. did not Meet Continuation Criteria|0|||
13148941|NCT02570165|26041681|FG002|Overall Study|Par. did not Meet Continuation Criteria|0|||
13148942|NCT02570165|26041682|FG003|Overall Study|Par. did not Meet Continuation Criteria|0|||
13148943|NCT02570165|26041683|FG004|Overall Study|Par. did not Meet Continuation Criteria|0|||
13148944|NCT02570165|26041684|FG005|Overall Study|Par. did not Meet Continuation Criteria|1|||
13148945|NCT02570165|26041685|FG006|Overall Study|Par. did not Meet Continuation Criteria|0|||
13148946|NCT02570165|26041679|FG000|Overall Study|Withdrawal Request by GSK|0|||
13148947|NCT02570165|26041680|FG001|Overall Study|Withdrawal Request by GSK|0|||
13148948|NCT02570165|26041681|FG002|Overall Study|Withdrawal Request by GSK|2|||
13148949|NCT02570165|26041682|FG003|Overall Study|Withdrawal Request by GSK|0|||
13148950|NCT02570165|26041683|FG004|Overall Study|Withdrawal Request by GSK|0|||
13148951|NCT02570165|26041684|FG005|Overall Study|Withdrawal Request by GSK|0|||
13148952|NCT02570165|26041685|FG006|Overall Study|Withdrawal Request by GSK|0|||
13148953|NCT02570152|26041701|FG000|Overall Study|Protocol Violation|2|||
13148954|NCT02570152|26041701|FG000|Overall Study|Migrated/moved from study area|13|||
13148955|NCT02570126|26041732|FG000|Overall Study|Lost to Follow-up|2|||
13094596|NCT03622580|25837545|FG002|Overall Study|Other|3|||
13094597|NCT03622112|25837751|FG000|Overall Study|Withdrawal by Subject|6|||
13094598|NCT03622112|25837752|FG001|Overall Study|Withdrawal by Subject|2|||
13094599|NCT03622112|25837753|FG002|Overall Study|Withdrawal by Subject|4|||
13094600|NCT03622112|25837754|FG003|Overall Study|Withdrawal by Subject|2|||
13094601|NCT03622112|25837755|FG004|Overall Study|Withdrawal by Subject|1|||
13094602|NCT03622112|25837756|FG005|Overall Study|Withdrawal by Subject|2|||
13094603|NCT03622112|25837757|FG006|Overall Study|Withdrawal by Subject|2|||
13094604|NCT03622112|25837751|FG000|Overall Study|Death|0|||
13094605|NCT03622112|25837752|FG001|Overall Study|Death|0|||
13094606|NCT03622112|25837753|FG002|Overall Study|Death|0|||
13094607|NCT03622112|25837754|FG003|Overall Study|Death|1|||
13094608|NCT03622112|25837755|FG004|Overall Study|Death|0|||
13094609|NCT03622112|25837756|FG005|Overall Study|Death|0|||
13094610|NCT03622112|25837757|FG006|Overall Study|Death|0|||
13094611|NCT03622112|25837751|FG000|Overall Study|Lost to Follow-up|1|||
13094612|NCT03622112|25837752|FG001|Overall Study|Lost to Follow-up|1|||
13094613|NCT03622112|25837753|FG002|Overall Study|Lost to Follow-up|0|||
13094614|NCT03622112|25837754|FG003|Overall Study|Lost to Follow-up|0|||
13094615|NCT03622112|25837755|FG004|Overall Study|Lost to Follow-up|0|||
13094616|NCT03622112|25837756|FG005|Overall Study|Lost to Follow-up|0|||
13094617|NCT03622112|25837757|FG006|Overall Study|Lost to Follow-up|0|||
13094618|NCT03622112|25837751|FG000|Overall Study|Study-specific withdrawal criteria|10|||
13094619|NCT03622112|25837752|FG001|Overall Study|Study-specific withdrawal criteria|8|||
13094620|NCT03622112|25837753|FG002|Overall Study|Study-specific withdrawal criteria|7|||
13094621|NCT03622112|25837754|FG003|Overall Study|Study-specific withdrawal criteria|6|||
13094622|NCT03622112|25837755|FG004|Overall Study|Study-specific withdrawal criteria|4|||
13094623|NCT03622112|25837756|FG005|Overall Study|Study-specific withdrawal criteria|18|||
13094624|NCT03622112|25837757|FG006|Overall Study|Study-specific withdrawal criteria|4|||
13094625|NCT03622112|25837751|FG000|Overall Study|Protocol Violation|2|||
13148956|NCT02570126|26041733|FG001|Overall Study|Lost to Follow-up|0|||
13094626|NCT03622112|25837752|FG001|Overall Study|Protocol Violation|0|||
13094627|NCT03622112|25837753|FG002|Overall Study|Protocol Violation|1|||
13094628|NCT03622112|25837754|FG003|Overall Study|Protocol Violation|1|||
13094629|NCT03622112|25837755|FG004|Overall Study|Protocol Violation|0|||
13094630|NCT03622112|25837756|FG005|Overall Study|Protocol Violation|0|||
13094631|NCT03622112|25837757|FG006|Overall Study|Protocol Violation|0|||
13094632|NCT03622112|25837751|FG000|Overall Study|Adverse Event|6|||
13094633|NCT03622112|25837752|FG001|Overall Study|Adverse Event|8|||
13094634|NCT03622112|25837753|FG002|Overall Study|Adverse Event|4|||
13094635|NCT03622112|25837754|FG003|Overall Study|Adverse Event|11|||
13094636|NCT03622112|25837755|FG004|Overall Study|Adverse Event|4|||
13094637|NCT03622112|25837756|FG005|Overall Study|Adverse Event|20|||
13094638|NCT03622112|25837757|FG006|Overall Study|Adverse Event|2|||
13094639|NCT03622112|25837751|FG000|Overall Study|Reason not specified|0|||
13094640|NCT03622112|25837752|FG001|Overall Study|Reason not specified|1|||
13094641|NCT03622112|25837753|FG002|Overall Study|Reason not specified|0|||
13094642|NCT03622112|25837754|FG003|Overall Study|Reason not specified|1|||
13094643|NCT03622112|25837755|FG004|Overall Study|Reason not specified|1|||
13094644|NCT03622112|25837756|FG005|Overall Study|Reason not specified|2|||
13094645|NCT03622112|25837757|FG006|Overall Study|Reason not specified|1|||
13094646|NCT03621696|25837784|FG000|Overall Study|Not eligible|0|||
13148957|NCT02570126|26041732|FG000|Overall Study|Unable To Arrange Visit 3|1|||
13148958|NCT02570126|26041733|FG001|Overall Study|Unable To Arrange Visit 3|0|||
13148959|NCT02570126|26041732|FG000|Overall Study|Violation Of Procedures GSK|0|||
13148960|NCT02570126|26041733|FG001|Overall Study|Violation Of Procedures GSK|1|||
13148961|NCT02570126|26041732|FG000|Overall Study|Protocol Violation|0|||
13148962|NCT02570126|26041733|FG001|Overall Study|Protocol Violation|1|||
13148963|NCT02570126|26041732|FG000|Overall Study|Withdrawal by Subject|3|||
13148964|NCT02570126|26041733|FG001|Overall Study|Withdrawal by Subject|7|||
13148965|NCT02570074|26041798|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1|||
13148966|NCT02570074|26041799|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0|||
13148967|NCT02569996|26041811|FG000|Overall Study|Adverse Event|6|||
13148968|NCT02569996|26041811|FG000|Overall Study|Physician Decision|3|||
13148969|NCT02569996|26041811|FG000|Overall Study|Progression of the disease|18|||
13148970|NCT02569996|26041811|FG000|Overall Study|New anti-lymphoma treatment|1|||
13148971|NCT02569996|26041811|FG000|Overall Study|Non-compliance|9|||
13148972|NCT02569996|26041811|FG000|Overall Study|Withdrawal by Subject|5|||
13148973|NCT02569996|26041811|FG000|Overall Study|Lost to Follow-up|5|||
13148974|NCT02569996|26041811|FG000|Overall Study|Complete remission|7|||
13148975|NCT02569996|26041811|FG000|Overall Study|Unknown reason|1|||
13148976|NCT02569957|26041848|FG000|Overall Study|Withdrawal by Subject|0|||
13148977|NCT02569957|26041849|FG001|Overall Study|Withdrawal by Subject|1|||
13148978|NCT02569853|26041864|FG000|Overall Study|Adverse Event|2|||
13148979|NCT02569853|26041865|FG001|Overall Study|Adverse Event|0|||
13148980|NCT02569853|26041864|FG000|Overall Study|Withdrawal by Subject|3|||
13148981|NCT02569853|26041865|FG001|Overall Study|Withdrawal by Subject|2|||
13148982|NCT02569853|26041864|FG000|Overall Study|Lost to Follow-up|3|||
13148983|NCT02569853|26041865|FG001|Overall Study|Lost to Follow-up|3|||
13148984|NCT02569853|26041864|FG000|Overall Study|Protocol Violation|1|||
13148985|NCT02569853|26041865|FG001|Overall Study|Protocol Violation|1|||
13148986|NCT02569853|26041864|FG000|Overall Study|Did not experience migraine attack|10|||
13148987|NCT02569853|26041865|FG001|Overall Study|Did not experience migraine attack|7|||
13148988|NCT02569853|26041864|FG000|Overall Study|Physician Decision|1|||
13094647|NCT03621696|25837785|FG001|Overall Study|Not eligible|0|||
13094648|NCT03621696|25837786|FG002|Overall Study|Not eligible|0|||
13094649|NCT03621696|25837787|FG003|Overall Study|Not eligible|5|||
13094650|NCT03621696|25837784|FG000|Overall Study|Withdrawal by Subject|1|||
13094651|NCT03621696|25837785|FG001|Overall Study|Withdrawal by Subject|1|||
13094652|NCT03621696|25837786|FG002|Overall Study|Withdrawal by Subject|1|||
13094653|NCT03621696|25837787|FG003|Overall Study|Withdrawal by Subject|0|||
13148989|NCT02569853|26041865|FG001|Overall Study|Physician Decision|1|||
13148990|NCT02569801|26041891|FG000|Overall Study|Withdrawal by Subject|9|||
13148991|NCT02569801|26041892|FG001|Overall Study|Withdrawal by Subject|9|||
13148992|NCT02569801|26041891|FG000|Overall Study|Sponsor Decision|13|||
13148993|NCT02569801|26041892|FG001|Overall Study|Sponsor Decision|14|||
13148994|NCT02569801|26041891|FG000|Overall Study|Progressive Disease|2|||
13148995|NCT02569801|26041892|FG001|Overall Study|Progressive Disease|7|||
13148996|NCT02569801|26041891|FG000|Overall Study|Lost to Follow-up|0|||
13148997|NCT02569801|26041892|FG001|Overall Study|Lost to Follow-up|1|||
13148998|NCT02569801|26041891|FG000|Overall Study|Death|12|||
13148999|NCT02569801|26041892|FG001|Overall Study|Death|4|||
13094654|NCT03621696|25837784|FG000|Overall Study|Physician Decision|0|||
13094655|NCT03621696|25837785|FG001|Overall Study|Physician Decision|0|||
13094656|NCT03621696|25837786|FG002|Overall Study|Physician Decision|1|||
13094657|NCT03621696|25837787|FG003|Overall Study|Physician Decision|0|||
13149000|NCT02569710|26042231|FG000|Overall Study|Adverse Event|1|||
13149001|NCT02569710|26042232|FG001|Overall Study|Adverse Event|0|||
13149002|NCT02569710|26042233|FG002|Overall Study|Adverse Event|0|||
13149003|NCT02569710|26042234|FG003|Overall Study|Adverse Event|0|||
13149004|NCT02569710|26042235|FG004|Overall Study|Adverse Event|0|||
13149005|NCT02569710|26042236|FG005|Overall Study|Adverse Event|0|||
13149006|NCT02569710|26042237|FG006|Overall Study|Adverse Event|0|||
13149007|NCT02569710|26042238|FG007|Overall Study|Adverse Event|0|||
13149008|NCT02569710|26042239|FG008|Overall Study|Adverse Event|0|||
13149009|NCT02569710|26042240|FG009|Overall Study|Adverse Event|0|||
13149010|NCT02569710|26042231|FG000|Overall Study|Lost to Follow-up|0|||
13149011|NCT02569710|26042232|FG001|Overall Study|Lost to Follow-up|0|||
13149012|NCT02569710|26042233|FG002|Overall Study|Lost to Follow-up|0|||
13149013|NCT02569710|26042234|FG003|Overall Study|Lost to Follow-up|0|||
13149014|NCT02569710|26042235|FG004|Overall Study|Lost to Follow-up|0|||
13149015|NCT02569710|26042236|FG005|Overall Study|Lost to Follow-up|0|||
13149016|NCT02569710|26042237|FG006|Overall Study|Lost to Follow-up|1|||
13149017|NCT02569710|26042238|FG007|Overall Study|Lost to Follow-up|0|||
13149018|NCT02569710|26042239|FG008|Overall Study|Lost to Follow-up|1|||
13149019|NCT02569710|26042240|FG009|Overall Study|Lost to Follow-up|0|||
13149020|NCT02569710|26042231|FG000|Overall Study|Virologic failure|0|||
13094658|NCT03621189|25837806|FG000|Overall Study|Withdrawal by Subject|0|||
13094659|NCT03621189|25837807|FG001|Overall Study|Withdrawal by Subject|3|||
13094660|NCT03621189|25837806|FG000|Overall Study|Physician Decision|0|||
13094661|NCT03621189|25837807|FG001|Overall Study|Physician Decision|2|||
13094662|NCT03620708|25837837|FG000|Overall Study|Lost to Follow-up|1|||
13094663|NCT03620708|25837838|FG001|Overall Study|Lost to Follow-up|1|||
13094664|NCT03620708|25837839|FG002|Overall Study|Lost to Follow-up|2|||
13094665|NCT03620708|25837837|FG000|Overall Study|Withdrawal by Subject|0|||
13094666|NCT03620708|25837838|FG001|Overall Study|Withdrawal by Subject|0|||
13094667|NCT03620708|25837839|FG002|Overall Study|Withdrawal by Subject|1|||
13094668|NCT03619902|25837849|FG000|Overall Study|Termination of Study by Investigator|1|||
13094669|NCT03619902|25837849|FG000|Overall Study|Use of Excluded/Prohibited Medication|1|||
13094670|NCT03619837|25837857|FG000|Screening|received organs from HCV-negative donors|47|||
13094671|NCT03619837|25837857|FG000|Screening|died on the wait-list|2|||
13094672|NCT03619837|25837857|FG000|Screening|remained on the wait list|40|||
13094673|NCT03619837|25837857|FG000|Screening|didn't meet eligibility criteria|3|||
13094674|NCT03619837|25837857|FG000|Screening|withdrew consent|2|||
13094675|NCT03619837|25837857|FG000|Screening|never listed for HCV-viremic donor|1|||
13094676|NCT03619837|25837857|FG000|Screening|developed exclusion criteria|2|||
13094677|NCT03619837|25837857|FG000|Screening|excluded by the investigator due to non-compliance|1|||
13094678|NCT03619174|25837874|FG000|Overall Study|Lost to Follow-up|3|||
13094679|NCT03619174|25837875|FG001|Overall Study|Lost to Follow-up|0|||
13094680|NCT03619174|25837874|FG000|Overall Study|Withdrawal by Subject|4|||
13094681|NCT03619174|25837875|FG001|Overall Study|Withdrawal by Subject|3|||
13094682|NCT03619174|25837874|FG000|Overall Study|Pregnancy|1|||
13094683|NCT03619174|25837875|FG001|Overall Study|Pregnancy|1|||
13094684|NCT03619174|25837874|FG000|Overall Study|Discomfort during treatment|1|||
13094685|NCT03619174|25837875|FG001|Overall Study|Discomfort during treatment|0|||
13094686|NCT03618823|25837913|FG000|Overall Study|Lost to Follow-up|63|||
13094687|NCT03618823|25837914|FG001|Overall Study|Lost to Follow-up|61|||
13094688|NCT03618628|25837920|FG000|Overall Study|Death|1|||
13094689|NCT03618628|25837920|FG000|Overall Study|Lost to Follow-up|1|||
13094690|NCT03617861|25837959|FG000|Second Intervention (1 Day)|Adverse Event|0|||
13094691|NCT03617861|25837960|FG001|Second Intervention (1 Day)|Adverse Event|0|||
13094692|NCT03617861|25837961|FG002|Second Intervention (1 Day)|Adverse Event|1|||
13094693|NCT03617861|25837962|FG003|Second Intervention (1 Day)|Adverse Event|0|||
13094694|NCT03617770|25837983|FG000|Overall Study|Lost to Follow-up|1|||
13094695|NCT03617770|25837984|FG001|Overall Study|Lost to Follow-up|0|||
13094696|NCT03617588|25838003|FG000|Overall Study|Withdrawal by Subject|1|||
13094697|NCT03617588|25838004|FG001|Overall Study|Withdrawal by Subject|0|||
13094698|NCT03616977|25838015|FG000|Period 1|Physician Decision|0|||
13094699|NCT03616977|25838016|FG001|Period 1|Physician Decision|1|||
13094700|NCT03616977|25838015|FG000|Period 3|Adverse Event|1|||
13094701|NCT03616977|25838016|FG001|Period 3|Adverse Event|1|||
13094702|NCT03616600|25838039|FG000|Overall Study|Withdrawal by Subject|1|||
13094703|NCT03616600|25838040|FG001|Overall Study|Withdrawal by Subject|0|||
13094704|NCT03616106|25838082|FG000|Overall Study|Removed by PI|6|||
13094705|NCT03616106|25838083|FG001|Overall Study|Removed by PI|0|||
13094706|NCT03616106|25838082|FG000|Overall Study|Withdrawal by Subject|1|||
13094707|NCT03616106|25838083|FG001|Overall Study|Withdrawal by Subject|1|||
13094708|NCT03616106|25838082|FG000|Overall Study|Lost to Follow-up|7|||
13094709|NCT03616106|25838083|FG001|Overall Study|Lost to Follow-up|0|||
13094710|NCT03615924|25838130|FG000|Overall Study|Withdrawal by Subject|2|||
13149021|NCT02569710|26042232|FG001|Overall Study|Virologic failure|0|||
13149022|NCT02569710|26042233|FG002|Overall Study|Virologic failure|0|||
13149023|NCT02569710|26042234|FG003|Overall Study|Virologic failure|0|||
13094711|NCT03615924|25838131|FG001|Overall Study|Withdrawal by Subject|5|||
13094712|NCT03615924|25838130|FG000|Overall Study|Death|3|||
13094713|NCT03615924|25838131|FG001|Overall Study|Death|1|||
13149024|NCT02569710|26042235|FG004|Overall Study|Virologic failure|1|||
13149025|NCT02569710|26042236|FG005|Overall Study|Virologic failure|0|||
13094714|NCT03615924|25838130|FG000|Overall Study|Lost to Follow-up|1|||
13094715|NCT03615924|25838131|FG001|Overall Study|Lost to Follow-up|0|||
13094716|NCT03615924|25838130|FG000|Overall Study|Randomized in error|1|||
13094717|NCT03615924|25838131|FG001|Overall Study|Randomized in error|0|||
13094718|NCT03615924|25838130|FG000|Overall Study|Study termination by Sponsor|94|||
13094719|NCT03615924|25838131|FG001|Overall Study|Study termination by Sponsor|86|||
13094720|NCT03615482|25838168|FG000|Overall Study|Death|1|||
13094721|NCT03615482|25838169|FG001|Overall Study|Death|0|||
13094722|NCT03615482|25838168|FG000|Overall Study|Lost to Follow-up|7|||
13094723|NCT03615482|25838169|FG001|Overall Study|Lost to Follow-up|7|||
13094724|NCT03615482|25838168|FG000|Overall Study|Physician Decision|2|||
13094725|NCT03615482|25838169|FG001|Overall Study|Physician Decision|3|||
13094726|NCT03615482|25838168|FG000|Overall Study|Withdrawal by Subject|7|||
13094727|NCT03615482|25838169|FG001|Overall Study|Withdrawal by Subject|7|||
13094728|NCT03615404|25838176|FG000|Overall Study|Death|1|||
13094729|NCT03615404|25838176|FG000|Overall Study|vaccine did not pass quality assurance|1|||
13094730|NCT03615144|25838189|FG000|Overall Study|Participant no longer eligible for this protocol|1|||
13094731|NCT03615144|25838190|FG001|Overall Study|Participant no longer eligible for this protocol|0|||
13094732|NCT03615066|25838291|FG000|Main Study|Withdrew Consent|0|||
13094733|NCT03615066|25838292|FG001|Main Study|Withdrew Consent|1|||
13094734|NCT03615066|25838293|FG002|Main Study|Withdrew Consent|1|||
13094735|NCT03615066|25838291|FG000|Main Study|Lost to Follow-up|0|||
13094736|NCT03615066|25838292|FG001|Main Study|Lost to Follow-up|0|||
13094737|NCT03615066|25838293|FG002|Main Study|Lost to Follow-up|1|||
13094738|NCT03615066|25838291|FG000|Treatment-free Follow-up (TFFU) Phase|Adverse Event|1|||
13094739|NCT03615066|25838292|FG001|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
13094740|NCT03615066|25838293|FG002|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
13094741|NCT03615066|25838291|FG000|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|1|||
13149026|NCT02569710|26042237|FG006|Overall Study|Virologic failure|1|||
13149027|NCT02569710|26042238|FG007|Overall Study|Virologic failure|0|||
13149028|NCT02569710|26042239|FG008|Overall Study|Virologic failure|0|||
13149029|NCT02569710|26042240|FG009|Overall Study|Virologic failure|0|||
13149030|NCT02569710|26042231|FG000|Overall Study|Withdrawal by Subject|0|||
13149031|NCT02569710|26042232|FG001|Overall Study|Withdrawal by Subject|0|||
13149032|NCT02569710|26042233|FG002|Overall Study|Withdrawal by Subject|0|||
13149033|NCT02569710|26042234|FG003|Overall Study|Withdrawal by Subject|0|||
13149034|NCT02569710|26042235|FG004|Overall Study|Withdrawal by Subject|0|||
13149035|NCT02569710|26042236|FG005|Overall Study|Withdrawal by Subject|1|||
13149036|NCT02569710|26042237|FG006|Overall Study|Withdrawal by Subject|0|||
13149037|NCT02569710|26042238|FG007|Overall Study|Withdrawal by Subject|0|||
13094742|NCT03615066|25838292|FG001|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
13094743|NCT03615066|25838293|FG002|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
13094744|NCT03615066|25838291|FG000|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
13094745|NCT03615066|25838292|FG001|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|1|||
13149038|NCT02569710|26042239|FG008|Overall Study|Withdrawal by Subject|0|||
13149039|NCT02569710|26042240|FG009|Overall Study|Withdrawal by Subject|0|||
13149040|NCT02569476|26042270|FG000|Overall Study|Roll over to Long-Term Extension Study|73|||
13149041|NCT02569476|26042270|FG000|Overall Study|Death|33|||
13149042|NCT02569476|26042270|FG000|Overall Study|Withdrawal by Subject|9|||
13149043|NCT02569476|26042270|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1|||
13149044|NCT02569476|26042270|FG000|Overall Study|Palliative care|1|||
13149045|NCT02569476|26042270|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1|||
13149046|NCT02569476|26042270|FG000|Overall Study|Transitioned to Long Term Extension Study|1|||
13149047|NCT02569437|26042291|FG000|Overall Study|Lost to Follow-up|12|||
13149048|NCT02569437|26042292|FG001|Overall Study|Lost to Follow-up|14|||
13094746|NCT03615066|25838293|FG002|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
13094747|NCT03615040|25838340|FG000|Overall Study|Withdrawal by Subject|2|||
13094748|NCT03615040|25838341|FG001|Overall Study|Withdrawal by Subject|1|||
13094749|NCT03615040|25838340|FG000|Overall Study|Physician Decision|2|||
13094750|NCT03615040|25838341|FG001|Overall Study|Physician Decision|2|||
13094751|NCT03615040|25838340|FG000|Overall Study|Clinical diagnosis of lung cancer|1|||
13094752|NCT03615040|25838341|FG001|Overall Study|Clinical diagnosis of lung cancer|0|||
13094753|NCT03615040|25838340|FG000|Overall Study|Clinical diagnosis of oesophageal cancer|1|||
13094754|NCT03615040|25838341|FG001|Overall Study|Clinical diagnosis of oesophageal cancer|0|||
13094755|NCT03615040|25838340|FG000|Overall Study|Death|0|||
13149049|NCT02569398|26042325|FG000|Overall Study|Adverse Event|0|||
13149050|NCT02569398|26042326|FG001|Overall Study|Adverse Event|1|||
13149051|NCT02569398|26042327|FG002|Overall Study|Adverse Event|6|||
13094756|NCT03615040|25838341|FG001|Overall Study|Death|2|||
13094757|NCT03614975|25838358|FG000|Overall Study|Physician Decision|7|||
13094758|NCT03614975|25838359|FG001|Overall Study|Physician Decision|5|||
13094759|NCT03614975|25838358|FG000|Overall Study|Withdrawal by Subject|2|||
13094760|NCT03614975|25838359|FG001|Overall Study|Withdrawal by Subject|2|||
13094761|NCT03614975|25838358|FG000|Overall Study|Specimens not in lab batch shipment|1|||
13094762|NCT03614975|25838359|FG001|Overall Study|Specimens not in lab batch shipment|1|||
13094763|NCT03614156|25838379|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6|||
13094764|NCT03614156|25838380|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
13094765|NCT03614156|25838381|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
13094766|NCT03614156|25838382|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
13094767|NCT03614156|25838379|FG000|Open-Label Treatment Period|Adverse Event|7|||
13094768|NCT03614156|25838380|FG001|Open-Label Treatment Period|Adverse Event|0|||
13094769|NCT03614156|25838381|FG002|Open-Label Treatment Period|Adverse Event|0|||
13094770|NCT03614156|25838382|FG003|Open-Label Treatment Period|Adverse Event|0|||
13094771|NCT03614156|25838379|FG000|Open-Label Treatment Period|Lack of Efficacy|18|||
13094772|NCT03614156|25838380|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
13094773|NCT03614156|25838381|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
13094774|NCT03614156|25838382|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
13094775|NCT03614156|25838379|FG000|Open-Label Treatment Period|Withdrawal by Subject|36|||
13094776|NCT03614156|25838380|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
13094777|NCT03614156|25838381|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
13094778|NCT03614156|25838382|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
13094779|NCT03614156|25838379|FG000|Open-Label Treatment Period|Lost to Follow-up|10|||
13094780|NCT03614156|25838380|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
13094781|NCT03614156|25838381|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
13094782|NCT03614156|25838382|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
13094783|NCT03614156|25838379|FG000|Open-Label Treatment Period|Protocol Violation|2|||
13094784|NCT03614156|25838380|FG001|Open-Label Treatment Period|Protocol Violation|0|||
13094785|NCT03614156|25838381|FG002|Open-Label Treatment Period|Protocol Violation|0|||
13094786|NCT03614156|25838382|FG003|Open-Label Treatment Period|Protocol Violation|0|||
13094787|NCT03614156|25838379|FG000|Open-Label Treatment Period|Non-compliance with study drug|1|||
13094788|NCT03614156|25838380|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
13094789|NCT03614156|25838381|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
13149052|NCT02569398|26042325|FG000|Overall Study|Withdrawal by Subject|43|||
13149053|NCT02569398|26042326|FG001|Overall Study|Withdrawal by Subject|43|||
13149054|NCT02569398|26042327|FG002|Overall Study|Withdrawal by Subject|30|||
13149055|NCT02569398|26042325|FG000|Overall Study|Study terminated by sponsor|130|||
13149056|NCT02569398|26042326|FG001|Overall Study|Study terminated by sponsor|131|||
13149057|NCT02569398|26042327|FG002|Overall Study|Study terminated by sponsor|134|||
13149058|NCT02569398|26042325|FG000|Overall Study|Other|12|||
13149059|NCT02569398|26042326|FG001|Overall Study|Other|14|||
13149060|NCT02569398|26042327|FG002|Overall Study|Other|13|||
13149061|NCT02569242|26042344|FG000|Overall Study|Death|1|||
13094790|NCT03614156|25838382|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
13094791|NCT03614156|25838379|FG000|Open-Label Treatment Period|Study terminated by sponsor|74|||
13094792|NCT03614156|25838380|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
13094793|NCT03614156|25838381|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
13094794|NCT03614156|25838382|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
13094795|NCT03614156|25838379|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
13094796|NCT03614156|25838380|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2|||
13094797|NCT03614156|25838381|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
13094798|NCT03614156|25838382|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1|||
13094799|NCT03614156|25838379|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
13094800|NCT03614156|25838380|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4|||
13094801|NCT03614156|25838381|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
13094802|NCT03614156|25838382|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
13094803|NCT03614156|25838379|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
13094804|NCT03614156|25838380|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
13094805|NCT03614156|25838381|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3|||
13094806|NCT03614156|25838382|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4|||
13094807|NCT03614156|25838379|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0|||
13094808|NCT03614156|25838380|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
13094809|NCT03614156|25838381|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
13094810|NCT03614156|25838382|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
13094811|NCT03614156|25838379|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0|||
13094812|NCT03614156|25838380|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22|||
13094813|NCT03614156|25838381|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26|||
13094814|NCT03614156|25838382|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38|||
13149062|NCT02569242|26042345|FG001|Overall Study|Death|0|||
13149063|NCT02569242|26042344|FG000|Overall Study|Withdrawal by Subject|0|||
13094815|NCT03614156|25838379|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
13094816|NCT03614156|25838380|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1|||
13094817|NCT03614156|25838381|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
13149064|NCT02569242|26042345|FG001|Overall Study|Withdrawal by Subject|1|||
13094818|NCT03614156|25838382|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
13094819|NCT03614156|25838379|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2|||
13094820|NCT03614156|25838380|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0|||
13094821|NCT03614156|25838381|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0|||
13094822|NCT03614156|25838382|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0|||
13094823|NCT03614156|25838379|FG000|Safety Follow-Up Period|Withdrawal by Subject|0|||
13094824|NCT03614156|25838380|FG001|Safety Follow-Up Period|Withdrawal by Subject|0|||
13094825|NCT03614156|25838381|FG002|Safety Follow-Up Period|Withdrawal by Subject|1|||
13094826|NCT03614156|25838382|FG003|Safety Follow-Up Period|Withdrawal by Subject|0|||
13094827|NCT03614156|25838379|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
13094828|NCT03614156|25838380|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
13149065|NCT02568683|26042364|FG000|Overall Study|Death|0|||
13149066|NCT02568683|26042365|FG001|Overall Study|Death|2|||
13149067|NCT02568683|26042364|FG000|Overall Study|Withdrew Consent|1|||
13149068|NCT02568683|26042365|FG001|Overall Study|Withdrew Consent|0|||
13149069|NCT02568683|26042364|FG000|Overall Study|Study Terminated By Sponsor|5|||
13149070|NCT02568683|26042365|FG001|Overall Study|Study Terminated By Sponsor|2|||
13149071|NCT02568475|26042386|FG000|Overall Study|Lost to Follow-up|40|||
13149072|NCT02568475|26042387|FG001|Overall Study|Lost to Follow-up|39|||
13149073|NCT02568475|26042386|FG000|Overall Study|Withdrawal by Subject|2|||
13149074|NCT02568475|26042387|FG001|Overall Study|Withdrawal by Subject|0|||
13149075|NCT02568475|26042386|FG000|Overall Study|Discharged home|4|||
13149076|NCT02568475|26042387|FG001|Overall Study|Discharged home|4|||
13149077|NCT02568475|26042386|FG000|Overall Study|Short-term: Discharge location unknown|4|||
13149078|NCT02568475|26042387|FG001|Overall Study|Short-term: Discharge location unknown|0|||
13149079|NCT02568475|26042386|FG000|Overall Study|Transferred to another facility|1|||
13149080|NCT02568475|26042387|FG001|Overall Study|Transferred to another facility|0|||
13094829|NCT03614156|25838381|FG002|Safety Follow-Up Period|Lost to Follow-up|0|||
13094830|NCT03614156|25838382|FG003|Safety Follow-Up Period|Lost to Follow-up|1|||
13094831|NCT03614078|25838409|FG000|Overall Study|Withdrawal by Subject|2|||
13094832|NCT03614078|25838410|FG001|Overall Study|Withdrawal by Subject|2|||
13094833|NCT03614078|25838411|FG002|Overall Study|Withdrawal by Subject|3|||
13094834|NCT03614078|25838409|FG000|Overall Study|Participant Did Not Return for Visit|0|||
13094835|NCT03614078|25838410|FG001|Overall Study|Participant Did Not Return for Visit|1|||
13094836|NCT03614078|25838411|FG002|Overall Study|Participant Did Not Return for Visit|0|||
13094837|NCT03614078|25838409|FG000|Overall Study|High Neutrophils|0|||
13094838|NCT03614078|25838410|FG001|Overall Study|High Neutrophils|0|||
13094839|NCT03614078|25838411|FG002|Overall Study|High Neutrophils|2|||
13094840|NCT03614078|25838409|FG000|Overall Study|Patient Did Not Meet Eligibility|1|||
13094841|NCT03614078|25838410|FG001|Overall Study|Patient Did Not Meet Eligibility|0|||
13094842|NCT03614078|25838411|FG002|Overall Study|Patient Did Not Meet Eligibility|0|||
13094843|NCT03614078|25838409|FG000|Overall Study|Exacerbation of Psoriasis|0|||
13094844|NCT03614078|25838410|FG001|Overall Study|Exacerbation of Psoriasis|1|||
13094845|NCT03614078|25838411|FG002|Overall Study|Exacerbation of Psoriasis|0|||
13149081|NCT02568397|26042414|FG000|Period 2|Withdrawal by Subject|0|||
13149082|NCT02568397|26042415|FG001|Period 2|Withdrawal by Subject|1|||
13149083|NCT02568397|26042414|FG000|Period 2|Physician Decision|0|||
13149084|NCT02568397|26042415|FG001|Period 2|Physician Decision|1|||
13149085|NCT02568384|26042427|FG000|Overall Study|Mobile devices incompatible with App|2|||
13149086|NCT02568254|26042442|FG000|Period 2|Adverse Event|0|||
13149087|NCT02568254|26042443|FG001|Period 2|Adverse Event|0|||
13149088|NCT02568254|26042444|FG002|Period 2|Adverse Event|1|||
13149089|NCT02568254|26042445|FG003|Period 2|Adverse Event|0|||
13149090|NCT02568254|26042446|FG004|Period 2|Adverse Event|0|||
13149091|NCT02568254|26042447|FG005|Period 2|Adverse Event|0|||
13149092|NCT02568254|26042442|FG000|Period 3|Unstatisfactory Lens fitting|0|||
13149093|NCT02568254|26042443|FG001|Period 3|Unstatisfactory Lens fitting|0|||
13149094|NCT02568254|26042444|FG002|Period 3|Unstatisfactory Lens fitting|0|||
13149095|NCT02568254|26042445|FG003|Period 3|Unstatisfactory Lens fitting|0|||
13149096|NCT02568254|26042446|FG004|Period 3|Unstatisfactory Lens fitting|1|||
13149097|NCT02568254|26042447|FG005|Period 3|Unstatisfactory Lens fitting|0|||
13094846|NCT03614078|25838409|FG000|Overall Study|Adverse Event|0|||
13094847|NCT03614078|25838410|FG001|Overall Study|Adverse Event|2|||
13094848|NCT03614078|25838411|FG002|Overall Study|Adverse Event|0|||
13094849|NCT03614078|25838409|FG000|Overall Study|Dizziness and Rash|0|||
13094850|NCT03614078|25838410|FG001|Overall Study|Dizziness and Rash|1|||
13094851|NCT03614078|25838411|FG002|Overall Study|Dizziness and Rash|0|||
13149098|NCT02568072|26042462|FG000|Overall Study|Unavailable for appointment|23|||
13149099|NCT02568072|26042462|FG000|Overall Study|Unable to contact|3|||
13149100|NCT02568072|26042462|FG000|Overall Study|Diagnosis of Long QT Syndrome|1|||
13094852|NCT03613649|25838573|FG000|Second Treatment|Lost to Follow-up|0|||
13094853|NCT03613649|25838574|FG001|Second Treatment|Lost to Follow-up|0|||
13094854|NCT03613649|25838575|FG002|Second Treatment|Lost to Follow-up|1|||
13149101|NCT02568072|26042462|FG000|Overall Study|Withdrawal by Subject|1|||
13149102|NCT02568072|26042462|FG000|Overall Study|Sustained injury, marathon not run|24|||
13149103|NCT02568046|26042475|FG000|Overall Study|Adverse Event|0|||
13094855|NCT03613649|25838576|FG003|Second Treatment|Lost to Follow-up|0|||
13094856|NCT03613649|25838577|FG004|Second Treatment|Lost to Follow-up|0|||
13094857|NCT03613649|25838578|FG005|Second Treatment|Lost to Follow-up|0|||
13094858|NCT03613649|25838579|FG006|Second Treatment|Lost to Follow-up|0|||
13094859|NCT03613649|25838580|FG007|Second Treatment|Lost to Follow-up|0|||
13094860|NCT03613649|25838581|FG008|Second Treatment|Lost to Follow-up|0|||
13149104|NCT02568046|26042476|FG001|Overall Study|Adverse Event|1|||
13149105|NCT02568046|26042475|FG000|Overall Study|Death|2|||
13149106|NCT02568046|26042476|FG001|Overall Study|Death|0|||
13149107|NCT02568046|26042475|FG000|Overall Study|Progressive Disease|1|||
13149108|NCT02568046|26042476|FG001|Overall Study|Progressive Disease|0|||
13149109|NCT02568046|26042475|FG000|Overall Study|Withdrawal by Subject|2|||
13149110|NCT02568046|26042476|FG001|Overall Study|Withdrawal by Subject|1|||
13149111|NCT02568046|26042475|FG000|Overall Study|Other Events|0|||
13149112|NCT02568046|26042476|FG001|Overall Study|Other Events|1|||
13149113|NCT02567708|26042518|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
13149114|NCT02567708|26042519|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2|||
13149115|NCT02567708|26042518|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0|||
13149116|NCT02567708|26042519|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1|||
13149117|NCT02567708|26042518|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2|||
13149118|NCT02567708|26042519|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
13094861|NCT03613649|25838582|FG009|Second Treatment|Lost to Follow-up|0|||
13094862|NCT03613649|25838583|FG010|Second Treatment|Lost to Follow-up|0|||
13094863|NCT03613649|25838584|FG011|Second Treatment|Lost to Follow-up|0|||
13149119|NCT02567708|26042518|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
13149120|NCT02567708|26042519|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3|||
13149121|NCT02567656|26042568|FG000|Overall Study|Premature discontinuation due to PD|1|||
13149122|NCT02567656|26042569|FG001|Overall Study|Premature discontinuation due to PD|1|||
13149123|NCT02567656|26042570|FG002|Overall Study|Premature discontinuation due to PD|2|||
13149124|NCT02567656|26042571|FG003|Overall Study|Premature discontinuation due to PD|0|||
13149125|NCT02567656|26042572|FG004|Overall Study|Premature discontinuation due to PD|0|||
13149126|NCT02567656|26042573|FG005|Overall Study|Premature discontinuation due to PD|0|||
13149127|NCT02567552|26042610|FG000|Overall Study|Adverse Event|0|||
13149128|NCT02567552|26042611|FG001|Overall Study|Adverse Event|1|||
13149129|NCT02567266|26042635|FG000|Overall Study|Withdrawal by Subject|10|||
13149130|NCT02567266|26042636|FG001|Overall Study|Withdrawal by Subject|7|||
13149131|NCT02567266|26042637|FG002|Overall Study|Withdrawal by Subject|6|||
13149132|NCT02567266|26042635|FG000|Overall Study|Lost to Follow-up|13|||
13149133|NCT02567266|26042636|FG001|Overall Study|Lost to Follow-up|8|||
13149134|NCT02567266|26042637|FG002|Overall Study|Lost to Follow-up|10|||
13149135|NCT02567227|26042688|FG000|9 Weeks|Adverse Event|5|||
13149136|NCT02567227|26042689|FG001|9 Weeks|Adverse Event|5|||
13149137|NCT02567227|26042688|FG000|9 Weeks|Withdrawal by Subject|18|||
13149138|NCT02567227|26042689|FG001|9 Weeks|Withdrawal by Subject|8|||
13149139|NCT02567227|26042688|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
13149140|NCT02567227|26042689|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
13149141|NCT02567227|26042688|FG000|6 Month|Death|2|||
13149142|NCT02567227|26042689|FG001|6 Month|Death|0|||
13149143|NCT02567227|26042688|FG000|6 Month|Lost to Follow-up|43|||
13149144|NCT02567227|26042689|FG001|6 Month|Lost to Follow-up|40|||
13149145|NCT02567227|26042688|FG000|12 Months|Lost to Follow-up|31|||
13149146|NCT02567227|26042689|FG001|12 Months|Lost to Follow-up|32|||
13094864|NCT03613649|25838573|FG000|Second Treatment|Withdrawal by Subject|0|||
13094865|NCT03613649|25838574|FG001|Second Treatment|Withdrawal by Subject|0|||
13094866|NCT03613649|25838575|FG002|Second Treatment|Withdrawal by Subject|0|||
13094867|NCT03613649|25838576|FG003|Second Treatment|Withdrawal by Subject|0|||
13094868|NCT03613649|25838577|FG004|Second Treatment|Withdrawal by Subject|1|||
13094869|NCT03613649|25838578|FG005|Second Treatment|Withdrawal by Subject|0|||
13094870|NCT03613649|25838579|FG006|Second Treatment|Withdrawal by Subject|0|||
13094871|NCT03613649|25838580|FG007|Second Treatment|Withdrawal by Subject|0|||
13094872|NCT03613649|25838581|FG008|Second Treatment|Withdrawal by Subject|0|||
13094873|NCT03613649|25838582|FG009|Second Treatment|Withdrawal by Subject|0|||
13094874|NCT03613649|25838583|FG010|Second Treatment|Withdrawal by Subject|0|||
13094875|NCT03613649|25838584|FG011|Second Treatment|Withdrawal by Subject|0|||
13149147|NCT02567227|26042688|FG000|12 Months|Death|0|||
13149148|NCT02567227|26042689|FG001|12 Months|Death|2|||
13149149|NCT02567188|26042720|FG000|Overall Study|Death|10|||
13149150|NCT02567188|26042720|FG000|Overall Study|Terminated Mircera Treatment|9|||
13149151|NCT02567188|26042720|FG000|Overall Study|Lost to Follow-up|5|||
13149152|NCT02567188|26042720|FG000|Overall Study|Adverse Event|1|||
13149153|NCT02567188|26042720|FG000|Overall Study|Withdrawal by Subject|1|||
13094876|NCT03613649|25838573|FG000|Third Treatment|Lost to Follow-up|0|||
13094877|NCT03613649|25838574|FG001|Third Treatment|Lost to Follow-up|0|||
13094878|NCT03613649|25838575|FG002|Third Treatment|Lost to Follow-up|0|||
13094879|NCT03613649|25838576|FG003|Third Treatment|Lost to Follow-up|0|||
13094880|NCT03613649|25838577|FG004|Third Treatment|Lost to Follow-up|1|||
13094881|NCT03613649|25838578|FG005|Third Treatment|Lost to Follow-up|0|||
13094882|NCT03613649|25838579|FG006|Third Treatment|Lost to Follow-up|0|||
13094883|NCT03613649|25838580|FG007|Third Treatment|Lost to Follow-up|0|||
13094884|NCT03613649|25838581|FG008|Third Treatment|Lost to Follow-up|0|||
13094885|NCT03613649|25838582|FG009|Third Treatment|Lost to Follow-up|0|||
13094886|NCT03613649|25838583|FG010|Third Treatment|Lost to Follow-up|0|||
13094887|NCT03613649|25838584|FG011|Third Treatment|Lost to Follow-up|1|||
13094888|NCT03613649|25838573|FG000|Third Treatment|Protocol Violation|0|||
13094889|NCT03613649|25838574|FG001|Third Treatment|Protocol Violation|0|||
13094890|NCT03613649|25838575|FG002|Third Treatment|Protocol Violation|0|||
13094891|NCT03613649|25838576|FG003|Third Treatment|Protocol Violation|0|||
13094892|NCT03613649|25838577|FG004|Third Treatment|Protocol Violation|0|||
13094893|NCT03613649|25838578|FG005|Third Treatment|Protocol Violation|0|||
13094894|NCT03613649|25838579|FG006|Third Treatment|Protocol Violation|1|||
13094895|NCT03613649|25838580|FG007|Third Treatment|Protocol Violation|0|||
13094896|NCT03613649|25838581|FG008|Third Treatment|Protocol Violation|0|||
13094897|NCT03613649|25838582|FG009|Third Treatment|Protocol Violation|0|||
13094898|NCT03613649|25838583|FG010|Third Treatment|Protocol Violation|0|||
13094899|NCT03613649|25838584|FG011|Third Treatment|Protocol Violation|1|||
13094900|NCT03613649|25838573|FG000|Fourth Treatment|Protocol Violation|1|||
13094901|NCT03613649|25838574|FG001|Fourth Treatment|Protocol Violation|0|||
13094902|NCT03613649|25838575|FG002|Fourth Treatment|Protocol Violation|0|||
13094903|NCT03613649|25838576|FG003|Fourth Treatment|Protocol Violation|0|||
13094904|NCT03613649|25838577|FG004|Fourth Treatment|Protocol Violation|1|||
13094905|NCT03613649|25838578|FG005|Fourth Treatment|Protocol Violation|0|||
13094906|NCT03613649|25838579|FG006|Fourth Treatment|Protocol Violation|0|||
13149154|NCT02567188|26042720|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1|||
13149155|NCT02567188|26042720|FG000|Overall Study|Moved and Changed Clinic|1|||
13149156|NCT02567188|26042720|FG000|Overall Study|Started Hemodialysis|2|||
13149157|NCT02567188|26042720|FG000|Overall Study|Protocol Violation|5|||
13149158|NCT02566993|26042792|FG000|Overall Study|Randomized but not treated|5|||
13149159|NCT02566993|26042793|FG001|Overall Study|Randomized but not treated|16|||
13149160|NCT02566993|26042792|FG000|Overall Study|Progressive disease|213|||
13149161|NCT02566993|26042793|FG001|Overall Study|Progressive disease|152|||
13149162|NCT02566993|26042792|FG000|Overall Study|Withdrawal by Subject|12|||
13149163|NCT02566993|26042793|FG001|Overall Study|Withdrawal by Subject|28|||
13149164|NCT02566993|26042792|FG000|Overall Study|Death|17|||
13149165|NCT02566993|26042793|FG001|Overall Study|Death|23|||
13149166|NCT02566993|26042792|FG000|Overall Study|Physician Decision|10|||
13149167|NCT02566993|26042793|FG001|Overall Study|Physician Decision|17|||
13149168|NCT02566993|26042792|FG000|Overall Study|Study drug-related adverse event|20|||
13149169|NCT02566993|26042793|FG001|Overall Study|Study drug-related adverse event|41|||
13094907|NCT03613649|25838580|FG007|Fourth Treatment|Protocol Violation|0|||
13094908|NCT03613649|25838581|FG008|Fourth Treatment|Protocol Violation|0|||
13094909|NCT03613649|25838582|FG009|Fourth Treatment|Protocol Violation|0|||
13094910|NCT03613649|25838583|FG010|Fourth Treatment|Protocol Violation|0|||
13094911|NCT03613649|25838584|FG011|Fourth Treatment|Protocol Violation|0|||
13094912|NCT03613649|25838573|FG000|Fourth Treatment|Physician Decision|0|||
13094913|NCT03613649|25838574|FG001|Fourth Treatment|Physician Decision|0|||
13149170|NCT02566993|26042792|FG000|Overall Study|Non study drug-related adverse event|9|||
13149171|NCT02566993|26042793|FG001|Overall Study|Non study drug-related adverse event|9|||
13149172|NCT02566993|26042792|FG000|Overall Study|Symptomatic deterioration|9|||
13149173|NCT02566993|26042793|FG001|Overall Study|Symptomatic deterioration|16|||
13149174|NCT02566993|26042792|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9|||
13149175|NCT02566993|26042793|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1|||
13149176|NCT02566993|26042792|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
13149177|NCT02566993|26042793|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
13149178|NCT02566993|26042792|FG000|Overall Study|Screening failure|2|||
13149179|NCT02566993|26042793|FG001|Overall Study|Screening failure|0|||
13149180|NCT02566993|26042792|FG000|Overall Study|Lost to Follow-up|0|||
13149181|NCT02566993|26042793|FG001|Overall Study|Lost to Follow-up|1|||
13149182|NCT02566993|26042792|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0|||
13149183|NCT02566993|26042793|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1|||
13149184|NCT02566902|26042822|FG000|Overall Study|Protocol Violation|2|||
13149185|NCT02566902|26042823|FG001|Overall Study|Protocol Violation|1|||
13094914|NCT03613649|25838575|FG002|Fourth Treatment|Physician Decision|0|||
13094915|NCT03613649|25838576|FG003|Fourth Treatment|Physician Decision|0|||
13094916|NCT03613649|25838577|FG004|Fourth Treatment|Physician Decision|0|||
13094917|NCT03613649|25838578|FG005|Fourth Treatment|Physician Decision|0|||
13094918|NCT03613649|25838579|FG006|Fourth Treatment|Physician Decision|1|||
13094919|NCT03613649|25838580|FG007|Fourth Treatment|Physician Decision|0|||
13094920|NCT03613649|25838581|FG008|Fourth Treatment|Physician Decision|0|||
13094921|NCT03613649|25838582|FG009|Fourth Treatment|Physician Decision|0|||
13149186|NCT02566889|26042846|FG000|Overall Study|Withdrawal by Subject|3|||
13149187|NCT02566889|26042847|FG001|Overall Study|Withdrawal by Subject|1|||
13149188|NCT02566889|26042846|FG000|Overall Study|Adverse Event|4|||
13149189|NCT02566889|26042847|FG001|Overall Study|Adverse Event|2|||
13149190|NCT02566889|26042846|FG000|Overall Study|Other|6|||
13149191|NCT02566889|26042847|FG001|Overall Study|Other|2|||
13149192|NCT02566785|26042864|FG000|Overall Study|Lost to Follow-up|0|||
13149193|NCT02566785|26042865|FG001|Overall Study|Lost to Follow-up|2|||
13149194|NCT02566785|26042864|FG000|Overall Study|Worsening condition|1|||
13149195|NCT02566785|26042865|FG001|Overall Study|Worsening condition|1|||
13149196|NCT02566759|26043068|FG000|All Parts|Withdrawal by Subject|0|||
13149197|NCT02566759|26043069|FG001|All Parts|Withdrawal by Subject|1|||
13149198|NCT02566759|26043070|FG002|All Parts|Withdrawal by Subject|0|||
13149199|NCT02566759|26043071|FG003|All Parts|Withdrawal by Subject|0|||
13149200|NCT02566759|26043072|FG004|All Parts|Withdrawal by Subject|0|||
13149201|NCT02566759|26043073|FG005|All Parts|Withdrawal by Subject|0|||
13149202|NCT02566759|26043074|FG006|All Parts|Withdrawal by Subject|0|||
13149203|NCT02566759|26043075|FG007|All Parts|Withdrawal by Subject|0|||
13149204|NCT02566759|26043076|FG008|All Parts|Withdrawal by Subject|0|||
13149205|NCT02566759|26043077|FG009|All Parts|Withdrawal by Subject|0|||
13149206|NCT02566759|26043078|FG010|All Parts|Withdrawal by Subject|0|||
13149207|NCT02566759|26043079|FG011|All Parts|Withdrawal by Subject|0|||
13149208|NCT02566759|26043080|FG012|All Parts|Withdrawal by Subject|0|||
13149209|NCT02566759|26043081|FG013|All Parts|Withdrawal by Subject|0|||
13149210|NCT02566759|26043082|FG014|All Parts|Withdrawal by Subject|0|||
13149211|NCT02566759|26043083|FG015|All Parts|Withdrawal by Subject|0|||
13149212|NCT02566759|26043084|FG016|All Parts|Withdrawal by Subject|0|||
13149213|NCT02566759|26043068|FG000|All Parts|Adverse Event|0|||
13149214|NCT02566759|26043069|FG001|All Parts|Adverse Event|0|||
13149215|NCT02566759|26043070|FG002|All Parts|Adverse Event|0|||
13149216|NCT02566759|26043071|FG003|All Parts|Adverse Event|0|||
13149217|NCT02566759|26043072|FG004|All Parts|Adverse Event|0|||
13149218|NCT02566759|26043073|FG005|All Parts|Adverse Event|0|||
13149219|NCT02566759|26043074|FG006|All Parts|Adverse Event|0|||
13149220|NCT02566759|26043075|FG007|All Parts|Adverse Event|0|||
13149221|NCT02566759|26043076|FG008|All Parts|Adverse Event|0|||
13149222|NCT02566759|26043077|FG009|All Parts|Adverse Event|0|||
13149223|NCT02566759|26043078|FG010|All Parts|Adverse Event|0|||
13149224|NCT02566759|26043079|FG011|All Parts|Adverse Event|0|||
13149225|NCT02566759|26043080|FG012|All Parts|Adverse Event|1|||
13149226|NCT02566759|26043081|FG013|All Parts|Adverse Event|3|||
13149227|NCT02566759|26043082|FG014|All Parts|Adverse Event|0|||
13149228|NCT02566759|26043083|FG015|All Parts|Adverse Event|0|||
13149229|NCT02566759|26043084|FG016|All Parts|Adverse Event|0|||
13149230|NCT02566759|26043068|FG000|All Parts|Other|0|||
13149231|NCT02566759|26043069|FG001|All Parts|Other|0|||
13149232|NCT02566759|26043070|FG002|All Parts|Other|0|||
13149233|NCT02566759|26043071|FG003|All Parts|Other|0|||
13149234|NCT02566759|26043072|FG004|All Parts|Other|0|||
13149235|NCT02566759|26043073|FG005|All Parts|Other|0|||
13149236|NCT02566759|26043074|FG006|All Parts|Other|0|||
13149237|NCT02566759|26043075|FG007|All Parts|Other|0|||
13149238|NCT02566759|26043076|FG008|All Parts|Other|0|||
13149239|NCT02566759|26043077|FG009|All Parts|Other|0|||
13149240|NCT02566759|26043078|FG010|All Parts|Other|0|||
13149241|NCT02566759|26043079|FG011|All Parts|Other|0|||
13149242|NCT02566759|26043080|FG012|All Parts|Other|0|||
13149243|NCT02566759|26043081|FG013|All Parts|Other|2|||
13149244|NCT02566759|26043082|FG014|All Parts|Other|0|||
13149245|NCT02566759|26043083|FG015|All Parts|Other|0|||
13149246|NCT02566759|26043084|FG016|All Parts|Other|0|||
13149247|NCT02566759|26043068|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
13149248|NCT02566759|26043069|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
13149249|NCT02566759|26043070|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
13149250|NCT02566759|26043071|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
13149251|NCT02566759|26043072|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
13149252|NCT02566759|26043073|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
13149253|NCT02566759|26043074|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
13149254|NCT02566759|26043075|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
13149255|NCT02566759|26043076|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
13149256|NCT02566759|26043077|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
13149257|NCT02566759|26043078|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
13149258|NCT02566759|26043079|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
13149259|NCT02566759|26043080|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
13149260|NCT02566759|26043081|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
13149261|NCT02566759|26043082|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
13149262|NCT02566759|26043083|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
13149263|NCT02566759|26043084|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1|||
13149264|NCT02566577|26043117|FG000|Overall Study|Withdrawal by Subject|1|||
13149265|NCT02566577|26043118|FG001|Overall Study|Withdrawal by Subject|1|||
13149266|NCT02566577|26043117|FG000|Overall Study|Equipment failure|1|||
13149267|NCT02566577|26043118|FG001|Overall Study|Equipment failure|1|||
13149268|NCT02566577|26043117|FG000|Overall Study|Physical limitation|1|||
13149269|NCT02566577|26043118|FG001|Overall Study|Physical limitation|0|||
13149270|NCT02566525|26043143|FG000|Overall Study|Protocol Violation|3|||
13149271|NCT02566525|26043144|FG001|Overall Study|Protocol Violation|5|||
13149272|NCT02566109|26043156|FG000|Overall Study|Withdrawal by Subject|1|||
13149273|NCT02566031|26043178|FG000|Overall Study|Patient/guardian decision|14|||
13149274|NCT02566031|26043179|FG001|Overall Study|Patient/guardian decision|7|||
13149275|NCT02566031|26043178|FG000|Overall Study|Protocol deviation|2|||
13149276|NCT02566031|26043179|FG001|Overall Study|Protocol deviation|3|||
13149277|NCT02566031|26043178|FG000|Overall Study|Adverse Event|3|||
13149278|NCT02566031|26043179|FG001|Overall Study|Adverse Event|1|||
13149279|NCT02566031|26043178|FG000|Overall Study|Lost to Follow-up|1|||
13149280|NCT02566031|26043179|FG001|Overall Study|Lost to Follow-up|1|||
13149281|NCT02566005|26043214|FG000|Overall Study|vaginal bleeding|0|||
13149282|NCT02566005|26043215|FG001|Overall Study|vaginal bleeding|1|||
13149283|NCT02566005|26043214|FG000|Overall Study|received foley|8|||
13149284|NCT02566005|26043215|FG001|Overall Study|received foley|0|||
13149285|NCT02566005|26043214|FG000|Overall Study|did not receive foley|0|||
13149286|NCT02566005|26043215|FG001|Overall Study|did not receive foley|1|||
13149287|NCT02566005|26043214|FG000|Overall Study|labor after randomization|0|||
13149288|NCT02566005|26043215|FG001|Overall Study|labor after randomization|4|||
13149289|NCT02565810|26043226|FG000|Overall Study|Withdrawal by Subject|1|||
13149290|NCT02565784|26043236|FG000|First Treatment|Adverse Event|1|||
13149291|NCT02565784|26043236|FG000|First Treatment|Withdrawal by Subject|1|||
13149292|NCT02565784|26043236|FG000|Second Treatment|Withdrawal by Subject|2|||
13205091|NCT01968070|26230885|FG011|Period 1|Adverse Event|0|||
13205092|NCT01968070|26230886|FG012|Period 1|Adverse Event|0|||
13205093|NCT01968070|26230887|FG013|Period 1|Adverse Event|0|||
13205094|NCT01968070|26230888|FG014|Period 1|Adverse Event|0|||
13205095|NCT01968070|26230889|FG015|Period 1|Adverse Event|0|||
13205096|NCT01968070|26230890|FG016|Period 1|Adverse Event|0|||
13205097|NCT01968070|26230891|FG017|Period 1|Adverse Event|0|||
13205098|NCT01968070|26230874|FG000|Period 1|Physician Decision|0|||
13205099|NCT01968070|26230875|FG001|Period 1|Physician Decision|0|||
13205100|NCT01968070|26230876|FG002|Period 1|Physician Decision|0|||
13205101|NCT01968070|26230877|FG003|Period 1|Physician Decision|0|||
13205102|NCT01968070|26230878|FG004|Period 1|Physician Decision|0|||
13205103|NCT01968070|26230879|FG005|Period 1|Physician Decision|0|||
13205104|NCT01968070|26230880|FG006|Period 1|Physician Decision|0|||
13205105|NCT01968070|26230881|FG007|Period 1|Physician Decision|0|||
13205106|NCT01968070|26230882|FG008|Period 1|Physician Decision|0|||
13205107|NCT01968070|26230883|FG009|Period 1|Physician Decision|0|||
13205108|NCT01968070|26230884|FG010|Period 1|Physician Decision|0|||
13205109|NCT01968070|26230885|FG011|Period 1|Physician Decision|1|||
13205110|NCT01968070|26230886|FG012|Period 1|Physician Decision|0|||
13205111|NCT01968070|26230887|FG013|Period 1|Physician Decision|0|||
13205112|NCT01968070|26230888|FG014|Period 1|Physician Decision|0|||
13205113|NCT01968070|26230889|FG015|Period 1|Physician Decision|0|||
13205114|NCT01968070|26230890|FG016|Period 1|Physician Decision|0|||
13205115|NCT01968070|26230891|FG017|Period 1|Physician Decision|0|||
13205116|NCT01968070|26230874|FG000|Period 2|Withdrawal by Subject|0|||
13205117|NCT01968070|26230875|FG001|Period 2|Withdrawal by Subject|0|||
13205118|NCT01968070|26230876|FG002|Period 2|Withdrawal by Subject|0|||
13205119|NCT01968070|26230877|FG003|Period 2|Withdrawal by Subject|0|||
13205120|NCT01968070|26230878|FG004|Period 2|Withdrawal by Subject|1|||
13205121|NCT01968070|26230879|FG005|Period 2|Withdrawal by Subject|0|||
13205122|NCT01968070|26230880|FG006|Period 2|Withdrawal by Subject|0|||
13205123|NCT01968070|26230881|FG007|Period 2|Withdrawal by Subject|0|||
13205124|NCT01968070|26230882|FG008|Period 2|Withdrawal by Subject|0|||
13205125|NCT01968070|26230883|FG009|Period 2|Withdrawal by Subject|0|||
13205126|NCT01968070|26230884|FG010|Period 2|Withdrawal by Subject|0|||
13205127|NCT01968070|26230885|FG011|Period 2|Withdrawal by Subject|0|||
13205128|NCT01968070|26230886|FG012|Period 2|Withdrawal by Subject|0|||
13205129|NCT01968070|26230887|FG013|Period 2|Withdrawal by Subject|0|||
13205130|NCT01968070|26230888|FG014|Period 2|Withdrawal by Subject|0|||
13205131|NCT01968070|26230889|FG015|Period 2|Withdrawal by Subject|0|||
13205132|NCT01968070|26230890|FG016|Period 2|Withdrawal by Subject|0|||
13205133|NCT01968070|26230891|FG017|Period 2|Withdrawal by Subject|0|||
13205134|NCT01968031|26230942|FG000|Overall Study|Adverse Event|13|||
13205135|NCT01968031|26230943|FG001|Overall Study|Adverse Event|10|||
13205136|NCT01968031|26230944|FG002|Overall Study|Adverse Event|22|||
13205137|NCT01968031|26230942|FG000|Overall Study|Withdrawal by Subject|3|||
13205138|NCT01968031|26230943|FG001|Overall Study|Withdrawal by Subject|7|||
13205139|NCT01968031|26230944|FG002|Overall Study|Withdrawal by Subject|3|||
13205140|NCT01968031|26230942|FG000|Overall Study|Did not meet entry criteria|1|||
13205141|NCT01968031|26230943|FG001|Overall Study|Did not meet entry criteria|1|||
13205142|NCT01968031|26230944|FG002|Overall Study|Did not meet entry criteria|1|||
13205143|NCT01968031|26230942|FG000|Overall Study|Noncompliance|0|||
13205144|NCT01968031|26230943|FG001|Overall Study|Noncompliance|0|||
13149293|NCT02565706|26043319|FG000|Overall Study|Withdrawal by Subject|5|||
13149294|NCT02565706|26043320|FG001|Overall Study|Withdrawal by Subject|7|||
13149295|NCT02565706|26043321|FG002|Overall Study|Withdrawal by Subject|7|||
13149296|NCT02565706|26043322|FG003|Overall Study|Withdrawal by Subject|11|||
13149297|NCT02565706|26043319|FG000|Overall Study|Lost to Follow-up|72|||
13149298|NCT02565706|26043320|FG001|Overall Study|Lost to Follow-up|75|||
13149299|NCT02565706|26043321|FG002|Overall Study|Lost to Follow-up|82|||
13149300|NCT02565706|26043322|FG003|Overall Study|Lost to Follow-up|74|||
13149301|NCT02565615|26043450|FG000|Overall Study|Death|0|||
13149302|NCT02565615|26043451|FG001|Overall Study|Death|1|||
13149303|NCT02565615|26043452|FG002|Overall Study|Death|0|||
13149304|NCT02565615|26043453|FG003|Overall Study|Death|0|||
13149305|NCT02565615|26043454|FG004|Overall Study|Death|4|||
13149306|NCT02565615|26043450|FG000|Overall Study|Not willing to participate in study|2|||
13149307|NCT02565615|26043451|FG001|Overall Study|Not willing to participate in study|21|||
13149308|NCT02565615|26043452|FG002|Overall Study|Not willing to participate in study|0|||
13149309|NCT02565615|26043453|FG003|Overall Study|Not willing to participate in study|1|||
13149310|NCT02565615|26043454|FG004|Overall Study|Not willing to participate in study|169|||
13149311|NCT02565615|26043450|FG000|Overall Study|Lost to Follow-up|0|||
13149312|NCT02565615|26043451|FG001|Overall Study|Lost to Follow-up|4|||
13149313|NCT02565615|26043452|FG002|Overall Study|Lost to Follow-up|0|||
13149314|NCT02565615|26043453|FG003|Overall Study|Lost to Follow-up|1|||
13149315|NCT02565615|26043454|FG004|Overall Study|Lost to Follow-up|765|||
13149316|NCT02565615|26043450|FG000|Overall Study|Not meeting eligibility criteria|0|||
13149317|NCT02565615|26043451|FG001|Overall Study|Not meeting eligibility criteria|7|||
13149318|NCT02565615|26043452|FG002|Overall Study|Not meeting eligibility criteria|0|||
13094922|NCT03613649|25838583|FG010|Fourth Treatment|Physician Decision|0|||
13094923|NCT03613649|25838584|FG011|Fourth Treatment|Physician Decision|0|||
13094924|NCT03613454|25838607|FG000|Overall Study|Protocol Violation|1|||
13094925|NCT03613454|25838608|FG001|Overall Study|Protocol Violation|0|||
13094926|NCT03613454|25838607|FG000|Overall Study|Protocol Violation|0|||
13094927|NCT03613454|25838608|FG001|Overall Study|Protocol Violation|1|||
13094928|NCT03613129|25838644|FG000|Pre-treatment Assessment|Protocol Violation|2|||
13094929|NCT03613129|25838645|FG001|Pre-treatment Assessment|Protocol Violation|0|||
13094930|NCT03613129|25838646|FG002|Pre-treatment Assessment|Protocol Violation|0|||
13094931|NCT03613129|25838647|FG003|Pre-treatment Assessment|Protocol Violation|0|||
13094932|NCT03613129|25838648|FG004|Pre-treatment Assessment|Protocol Violation|0|||
13094933|NCT03613129|25838644|FG000|Pre-treatment Assessment|Withdrawal by Subject|1|||
13094934|NCT03613129|25838645|FG001|Pre-treatment Assessment|Withdrawal by Subject|0|||
13094935|NCT03613129|25838646|FG002|Pre-treatment Assessment|Withdrawal by Subject|0|||
13094936|NCT03613129|25838647|FG003|Pre-treatment Assessment|Withdrawal by Subject|0|||
13094937|NCT03613129|25838648|FG004|Pre-treatment Assessment|Withdrawal by Subject|0|||
13094938|NCT03611582|25838721|FG000|Overall Study|Adverse Event|26|||
13094939|NCT03611582|25838722|FG001|Overall Study|Adverse Event|6|||
13094940|NCT03611582|25838721|FG000|Overall Study|Protocol Violation|0|||
13094941|NCT03611582|25838722|FG001|Overall Study|Protocol Violation|1|||
13094942|NCT03611582|25838721|FG000|Overall Study|Pregnancy|1|||
13094943|NCT03611582|25838722|FG001|Overall Study|Pregnancy|2|||
13094944|NCT03611582|25838721|FG000|Overall Study|Lack of Efficacy|0|||
13094945|NCT03611582|25838722|FG001|Overall Study|Lack of Efficacy|1|||
13094946|NCT03611582|25838721|FG000|Overall Study|At the discretion of the investigator|1|||
13094947|NCT03611582|25838722|FG001|Overall Study|At the discretion of the investigator|0|||
13094948|NCT03611582|25838721|FG000|Overall Study|Safety concern as judged by the investigator|1|||
13094949|NCT03611582|25838722|FG001|Overall Study|Safety concern as judged by the investigator|2|||
13094950|NCT03611582|25838721|FG000|Overall Study|Withdrawal by Subject|4|||
13094951|NCT03611582|25838722|FG001|Overall Study|Withdrawal by Subject|3|||
13094952|NCT03611582|25838721|FG000|Overall Study|Lost to Follow-up|18|||
13094953|NCT03611582|25838722|FG001|Overall Study|Lost to Follow-up|7|||
13094954|NCT03611582|25838721|FG000|Overall Study|other|17|||
13094955|NCT03611582|25838722|FG001|Overall Study|other|16|||
13094956|NCT03611075|25838879|FG000|Overall Study|Physician Decision|0|||
13094957|NCT03611075|25838880|FG001|Overall Study|Physician Decision|1|||
13094958|NCT03611075|25838881|FG002|Overall Study|Physician Decision|1|||
13094959|NCT03611075|25838882|FG003|Overall Study|Physician Decision|0|||
13094960|NCT03611075|25838883|FG004|Overall Study|Physician Decision|0|||
13094961|NCT03611075|25838884|FG005|Overall Study|Physician Decision|0|||
13149319|NCT02565615|26043453|FG003|Overall Study|Not meeting eligibility criteria|0|||
13149320|NCT02565615|26043454|FG004|Overall Study|Not meeting eligibility criteria|25|||
13094962|NCT03611075|25838885|FG006|Overall Study|Physician Decision|0|||
13094963|NCT03611075|25838886|FG007|Overall Study|Physician Decision|0|||
13094964|NCT03611075|25838887|FG008|Overall Study|Physician Decision|0|||
13094965|NCT03611075|25838879|FG000|Overall Study|Lost to Follow-up|1|||
13094966|NCT03611075|25838880|FG001|Overall Study|Lost to Follow-up|0|||
13094967|NCT03611075|25838881|FG002|Overall Study|Lost to Follow-up|0|||
13149321|NCT02565615|26043450|FG000|Overall Study|Reason not defined|0|||
13149322|NCT02565615|26043451|FG001|Overall Study|Reason not defined|2|||
13149323|NCT02565615|26043452|FG002|Overall Study|Reason not defined|0|||
13094968|NCT03611075|25838882|FG003|Overall Study|Lost to Follow-up|2|||
13094969|NCT03611075|25838883|FG004|Overall Study|Lost to Follow-up|0|||
13094970|NCT03611075|25838884|FG005|Overall Study|Lost to Follow-up|0|||
13094971|NCT03611075|25838885|FG006|Overall Study|Lost to Follow-up|0|||
13094972|NCT03611075|25838886|FG007|Overall Study|Lost to Follow-up|0|||
13094973|NCT03611075|25838887|FG008|Overall Study|Lost to Follow-up|0|||
13094974|NCT03611075|25838879|FG000|Overall Study|Withdrawal by Subject|0|||
13094975|NCT03611075|25838880|FG001|Overall Study|Withdrawal by Subject|1|||
13094976|NCT03611075|25838881|FG002|Overall Study|Withdrawal by Subject|1|||
13094977|NCT03611075|25838882|FG003|Overall Study|Withdrawal by Subject|1|||
13094978|NCT03611075|25838883|FG004|Overall Study|Withdrawal by Subject|0|||
13094979|NCT03611075|25838884|FG005|Overall Study|Withdrawal by Subject|0|||
13094980|NCT03611075|25838885|FG006|Overall Study|Withdrawal by Subject|1|||
13094981|NCT03611075|25838886|FG007|Overall Study|Withdrawal by Subject|0|||
13094982|NCT03611075|25838887|FG008|Overall Study|Withdrawal by Subject|0|||
13094983|NCT03611075|25838879|FG000|Overall Study|Reason unknown|0|||
13094984|NCT03611075|25838880|FG001|Overall Study|Reason unknown|0|||
13094985|NCT03611075|25838881|FG002|Overall Study|Reason unknown|0|||
13094986|NCT03611075|25838882|FG003|Overall Study|Reason unknown|1|||
13094987|NCT03611075|25838883|FG004|Overall Study|Reason unknown|0|||
13094988|NCT03611075|25838884|FG005|Overall Study|Reason unknown|0|||
13094989|NCT03611075|25838885|FG006|Overall Study|Reason unknown|1|||
13094990|NCT03611075|25838886|FG007|Overall Study|Reason unknown|0|||
13094991|NCT03611075|25838887|FG008|Overall Study|Reason unknown|0|||
13094992|NCT03610581|25838918|FG000|Overall Study|Study terminated by sponsor|2|||
13149324|NCT02565615|26043453|FG003|Overall Study|Reason not defined|1|||
13149325|NCT02565615|26043454|FG004|Overall Study|Reason not defined|62|||
13149326|NCT02565615|26043450|FG000|Overall Study|Adverse Event|1|||
13149327|NCT02565615|26043451|FG001|Overall Study|Adverse Event|1|||
13149328|NCT02565615|26043452|FG002|Overall Study|Adverse Event|0|||
13149329|NCT02565615|26043453|FG003|Overall Study|Adverse Event|0|||
13149330|NCT02565615|26043454|FG004|Overall Study|Adverse Event|9|||
13149331|NCT02565615|26043450|FG000|Overall Study|Untreated|0|||
13149332|NCT02565615|26043451|FG001|Overall Study|Untreated|0|||
13149333|NCT02565615|26043452|FG002|Overall Study|Untreated|0|||
13149334|NCT02565615|26043453|FG003|Overall Study|Untreated|0|||
13149335|NCT02565615|26043454|FG004|Overall Study|Untreated|567|||
13149336|NCT02565576|26043486|FG000|Overall Study|abnormal lab value|2|||
13149337|NCT02565576|26043487|FG001|Overall Study|abnormal lab value|0|||
13149338|NCT02565576|26043486|FG000|Overall Study|subject / guardian decision|1|||
13149339|NCT02565576|26043487|FG001|Overall Study|subject / guardian decision|3|||
13149340|NCT02565576|26043486|FG000|Overall Study|Lost to Follow-up|1|||
13149341|NCT02565576|26043487|FG001|Overall Study|Lost to Follow-up|0|||
13149342|NCT02565576|26043486|FG000|Overall Study|Death|0|||
13149343|NCT02565576|26043487|FG001|Overall Study|Death|2|||
13149344|NCT02565576|26043486|FG000|Overall Study|Adverse Event|1|||
13149345|NCT02565576|26043487|FG001|Overall Study|Adverse Event|0|||
13149346|NCT02565511|26043574|FG000|Overall Study|Study terminated by Sponsor|35|||
13149347|NCT02565511|26043575|FG001|Overall Study|Study terminated by Sponsor|22|||
13149348|NCT02565511|26043576|FG002|Overall Study|Study terminated by Sponsor|235|||
13149349|NCT02565511|26043577|FG003|Overall Study|Study terminated by Sponsor|156|||
13149350|NCT02565511|26043574|FG000|Overall Study|Withdrawal by Subject|3|||
13149351|NCT02565511|26043575|FG001|Overall Study|Withdrawal by Subject|0|||
13149352|NCT02565511|26043576|FG002|Overall Study|Withdrawal by Subject|12|||
13149353|NCT02565511|26043577|FG003|Overall Study|Withdrawal by Subject|5|||
13149354|NCT02565511|26043574|FG000|Overall Study|Adverse Event|0|||
13149355|NCT02565511|26043575|FG001|Overall Study|Adverse Event|0|||
13149356|NCT02565511|26043576|FG002|Overall Study|Adverse Event|1|||
13149357|NCT02565511|26043577|FG003|Overall Study|Adverse Event|1|||
13149358|NCT02565511|26043574|FG000|Overall Study|Lost to Follow-up|4|||
13149359|NCT02565511|26043575|FG001|Overall Study|Lost to Follow-up|1|||
13149360|NCT02565511|26043576|FG002|Overall Study|Lost to Follow-up|0|||
13149361|NCT02565511|26043577|FG003|Overall Study|Lost to Follow-up|1|||
13149362|NCT02565511|26043574|FG000|Overall Study|Physician Decision|0|||
13149363|NCT02565511|26043575|FG001|Overall Study|Physician Decision|0|||
13149364|NCT02565511|26043576|FG002|Overall Study|Physician Decision|0|||
13149365|NCT02565511|26043577|FG003|Overall Study|Physician Decision|1|||
13149366|NCT02565511|26043574|FG000|Overall Study|Protocol deviation|0|||
13094993|NCT03610581|25838919|FG001|Overall Study|Study terminated by sponsor|0|||
13094994|NCT03610581|25838918|FG000|Overall Study|Other|0|||
13094995|NCT03610581|25838919|FG001|Overall Study|Other|1|||
13094996|NCT03610581|25838918|FG000|Overall Study|Withdrawal by Subject|1|||
13094997|NCT03610581|25838919|FG001|Overall Study|Withdrawal by Subject|0|||
13149367|NCT02565511|26043575|FG001|Overall Study|Protocol deviation|0|||
13149368|NCT02565511|26043576|FG002|Overall Study|Protocol deviation|3|||
13149369|NCT02565511|26043577|FG003|Overall Study|Protocol deviation|0|||
13149370|NCT02565381|26043625|FG000|Overall Study|Lost to Follow-up|1|||
13149371|NCT02565381|26043626|FG001|Overall Study|Lost to Follow-up|0|||
13149372|NCT02565381|26043627|FG002|Overall Study|Lost to Follow-up|1|||
13149373|NCT02565186|26043646|FG000|Overall Study|Adverse Event|113|||
13149374|NCT02565186|26043647|FG001|Overall Study|Adverse Event|148|||
13149375|NCT02565186|26043646|FG000|Overall Study|Lost to Follow-up|102|||
13149376|NCT02565186|26043647|FG001|Overall Study|Lost to Follow-up|93|||
13149377|NCT02565186|26043646|FG000|Overall Study|Non-Compliance|57|||
13149378|NCT02565186|26043647|FG001|Overall Study|Non-Compliance|55|||
13149379|NCT02565186|26043646|FG000|Overall Study|Withdrawal by Subject|229|||
13149380|NCT02565186|26043647|FG001|Overall Study|Withdrawal by Subject|214|||
13149381|NCT02565186|26043646|FG000|Overall Study|Physician Decision|18|||
13149382|NCT02565186|26043647|FG001|Overall Study|Physician Decision|16|||
13149383|NCT02565186|26043646|FG000|Overall Study|Sponsor Request|5|||
13149384|NCT02565186|26043647|FG001|Overall Study|Sponsor Request|9|||
13149385|NCT02565186|26043646|FG000|Overall Study|Missing|1|||
13149386|NCT02565186|26043647|FG001|Overall Study|Missing|0|||
13149387|NCT02565186|26043646|FG000|Overall Study|Did Not Receive Study Drug|55|||
13149388|NCT02565186|26043647|FG001|Overall Study|Did Not Receive Study Drug|86|||
13149389|NCT02565147|26043676|FG000|Overall Study|Withdrawal by Subject|5|||
13094998|NCT03610269|25838925|FG000|Overall Study|Physician Decision|10|||
13094999|NCT03610269|25838925|FG000|Overall Study|Protocol Violation|1|||
13095000|NCT03610269|25838925|FG000|Overall Study|Unable to draw blood|1|||
13095001|NCT03610269|25838925|FG000|Overall Study|Screen fail|4|||
13095002|NCT03610165|25838954|FG000|Overall Study|Device didn't work|0|||
13095003|NCT03610165|25838955|FG001|Overall Study|Device didn't work|1|||
13095004|NCT03610048|25838961|FG000|Overall Study|Study terminated by sponsor|84|||
13095005|NCT03610048|25838961|FG000|Overall Study|Adverse Event|32|||
13095006|NCT03610048|25838961|FG000|Overall Study|Withdrawal by Subject|31|||
13095007|NCT03610048|25838961|FG000|Overall Study|Lost to Follow-up|8|||
13095008|NCT03610048|25838961|FG000|Overall Study|Other|4|||
13095009|NCT03610048|25838961|FG000|Overall Study|Physician Decision|1|||
13095010|NCT03610048|25838961|FG000|Overall Study|Pregnancy|1|||
13095011|NCT03609619|25838976|FG000|Overall Study|Adverse Event|1|||
13095012|NCT03609619|25838977|FG001|Overall Study|Adverse Event|0|||
13095013|NCT03609619|25838976|FG000|Overall Study|Lack of Efficacy|1|||
13095014|NCT03609619|25838977|FG001|Overall Study|Lack of Efficacy|2|||
13095015|NCT03609619|25838976|FG000|Overall Study|Protocol Violation|5|||
13095016|NCT03609619|25838977|FG001|Overall Study|Protocol Violation|0|||
13095017|NCT03609619|25838976|FG000|Overall Study|Withdrawal by Subject|2|||
13095018|NCT03609619|25838977|FG001|Overall Study|Withdrawal by Subject|3|||
13095019|NCT03609619|25838976|FG000|Overall Study|Lost to Follow-up|1|||
13095020|NCT03609619|25838977|FG001|Overall Study|Lost to Follow-up|1|||
13095021|NCT03608774|25839000|FG000|Overall Study|Lost to Follow-up|5|||
13095022|NCT03608774|25839001|FG001|Overall Study|Lost to Follow-up|5|||
13095023|NCT03608774|25839000|FG000|Overall Study|Withdrawal by Subject|1|||
13095024|NCT03608774|25839001|FG001|Overall Study|Withdrawal by Subject|0|||
13095025|NCT03608774|25839000|FG000|Overall Study|Protocol Violation|1|||
13095026|NCT03608774|25839001|FG001|Overall Study|Protocol Violation|0|||
13095027|NCT03608774|25839000|FG000|Overall Study|Not eligible at enrollment|0|||
13095028|NCT03608774|25839001|FG001|Overall Study|Not eligible at enrollment|1|||
13095029|NCT03608774|25839000|FG000|Overall Study|Health related event|0|||
13095030|NCT03608774|25839001|FG001|Overall Study|Health related event|1|||
13095031|NCT03608254|25839008|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2|||
13095032|NCT03608254|25839008|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1|||
13095033|NCT03607695|25839015|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1|||
13095034|NCT03607695|25839015|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2|||
13095035|NCT03607682|25839029|FG000|Overall Study|Withdrawal by Subject|1|||
13095036|NCT03607682|25839029|FG000|Overall Study|Disease progression|1|||
13095037|NCT03607487|25839091|FG000|Overall Study|Withdrawal by Subject|2|||
13095038|NCT03607487|25839092|FG001|Overall Study|Withdrawal by Subject|0|||
13095039|NCT03607487|25839093|FG002|Overall Study|Withdrawal by Subject|0|||
13095040|NCT03607487|25839094|FG003|Overall Study|Withdrawal by Subject|1|||
13095041|NCT03607422|25839259|FG000|Overall Study|Adverse Event|7|||
13095042|NCT03607422|25839260|FG001|Overall Study|Adverse Event|3|||
13095043|NCT03607422|25839261|FG002|Overall Study|Adverse Event|2|||
13095044|NCT03607422|25839262|FG003|Overall Study|Adverse Event|0|||
13095045|NCT03607422|25839263|FG004|Overall Study|Adverse Event|2|||
13095046|NCT03607422|25839264|FG005|Overall Study|Adverse Event|0|||
13095047|NCT03607422|25839259|FG000|Overall Study|Withdrawal by Subject|11|||
13095048|NCT03607422|25839260|FG001|Overall Study|Withdrawal by Subject|3|||
13095049|NCT03607422|25839261|FG002|Overall Study|Withdrawal by Subject|6|||
13095050|NCT03607422|25839262|FG003|Overall Study|Withdrawal by Subject|2|||
13095051|NCT03607422|25839263|FG004|Overall Study|Withdrawal by Subject|0|||
13095052|NCT03607422|25839264|FG005|Overall Study|Withdrawal by Subject|0|||
13095053|NCT03607422|25839259|FG000|Overall Study|Lost to Follow-up|0|||
13095054|NCT03607422|25839260|FG001|Overall Study|Lost to Follow-up|0|||
13095055|NCT03607422|25839261|FG002|Overall Study|Lost to Follow-up|1|||
13095056|NCT03607422|25839262|FG003|Overall Study|Lost to Follow-up|0|||
13149390|NCT02565147|26043677|FG001|Overall Study|Withdrawal by Subject|1|||
13149391|NCT02565147|26043676|FG000|Overall Study|Lost to Follow-up|0|||
13095057|NCT03607422|25839263|FG004|Overall Study|Lost to Follow-up|0|||
13095058|NCT03607422|25839264|FG005|Overall Study|Lost to Follow-up|0|||
13095059|NCT03607422|25839259|FG000|Overall Study|Other|12|||
13095060|NCT03607422|25839260|FG001|Overall Study|Other|4|||
13095061|NCT03607422|25839261|FG002|Overall Study|Other|1|||
13095062|NCT03607422|25839262|FG003|Overall Study|Other|2|||
13095063|NCT03607422|25839263|FG004|Overall Study|Other|0|||
13095064|NCT03607422|25839264|FG005|Overall Study|Other|2|||
13095065|NCT03607422|25839259|FG000|Overall Study|Ongoing at Time of Analysis|8|||
13095066|NCT03607422|25839260|FG001|Overall Study|Ongoing at Time of Analysis|0|||
13095067|NCT03607422|25839261|FG002|Overall Study|Ongoing at Time of Analysis|2|||
13095068|NCT03607422|25839262|FG003|Overall Study|Ongoing at Time of Analysis|1|||
13095069|NCT03607422|25839263|FG004|Overall Study|Ongoing at Time of Analysis|1|||
13095070|NCT03607422|25839264|FG005|Overall Study|Ongoing at Time of Analysis|1|||
13095071|NCT03606668|25839275|FG000|Overall Study|Screen Failure|1|||
13095072|NCT03606668|25839275|FG000|Overall Study|Lost to Follow-up|1|||
13095073|NCT03606460|25839290|FG000|Overall Study|Lost to Follow-up|1|||
13095074|NCT03606460|25839291|FG001|Overall Study|Lost to Follow-up|8|||
13149392|NCT02565147|26043677|FG001|Overall Study|Lost to Follow-up|1|||
13095075|NCT03606109|25839310|FG000|Overall Study|Lost to Follow-up|2|||
13095076|NCT03606109|25839311|FG001|Overall Study|Lost to Follow-up|1|||
13095077|NCT03605862|25839342|FG000|Overall Study|Withdrawal by Subject|12|||
13095078|NCT03605862|25839343|FG001|Overall Study|Withdrawal by Subject|9|||
13095079|NCT03605862|25839342|FG000|Overall Study|Adverse Event|2|||
13095080|NCT03605862|25839343|FG001|Overall Study|Adverse Event|1|||
13095081|NCT03605862|25839342|FG000|Overall Study|Physician Decision|3|||
13095082|NCT03605862|25839343|FG001|Overall Study|Physician Decision|1|||
13095083|NCT03605862|25839342|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11|||
13095084|NCT03605862|25839343|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15|||
13132749|NCT02784431|25984998|FG000|Overall Study|Unsuccessful Implant Attempt|1|||
13132750|NCT02784431|25984998|FG000|Overall Study|Early Study Termination|19|||
13132751|NCT02784106|25985068|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3|||
13132752|NCT02784106|25985069|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5|||
13132753|NCT02784106|25985070|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
13132754|NCT02784106|25985071|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
13132755|NCT02784106|25985068|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
13132756|NCT02784106|25985069|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
13132757|NCT02784106|25985070|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
13132758|NCT02784106|25985071|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
13132759|NCT02784106|25985068|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2|||
13132760|NCT02784106|25985069|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0|||
13132761|NCT02784106|25985070|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0|||
13132762|NCT02784106|25985071|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0|||
13132763|NCT02784106|25985068|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
13132764|NCT02784106|25985069|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
13132765|NCT02784106|25985070|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
13132766|NCT02784106|25985071|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
13132767|NCT02784106|25985068|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
13132768|NCT02784106|25985069|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
13132769|NCT02784106|25985070|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2|||
13132770|NCT02784106|25985071|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1|||
13132771|NCT02784106|25985068|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
13132772|NCT02784106|25985069|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
13132773|NCT02784106|25985070|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
13132774|NCT02784106|25985071|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
13132775|NCT02783911|25985084|FG000|Overall Study|Lost to Follow-up|3|||
13132776|NCT02783911|25985085|FG001|Overall Study|Lost to Follow-up|32|||
13132777|NCT02783768|25985106|FG000|Overall Study|Lost to Follow-up|1|||
13132778|NCT02783768|25985107|FG001|Overall Study|Lost to Follow-up|0|||
13132779|NCT02783729|25985186|FG000|Overall Study|Lack of Efficacy|1|||
13132780|NCT02783729|25985187|FG001|Overall Study|Lack of Efficacy|0|||
13132781|NCT02783729|25985188|FG002|Overall Study|Lack of Efficacy|0|||
13132782|NCT02783729|25985189|FG003|Overall Study|Lack of Efficacy|0|||
13132783|NCT02783729|25985186|FG000|Overall Study|Adverse Event|2|||
13132784|NCT02783729|25985187|FG001|Overall Study|Adverse Event|6|||
13132785|NCT02783729|25985188|FG002|Overall Study|Adverse Event|2|||
13132786|NCT02783729|25985189|FG003|Overall Study|Adverse Event|3|||
13132787|NCT02783729|25985186|FG000|Overall Study|Other|1|||
13132788|NCT02783729|25985187|FG001|Overall Study|Other|6|||
13132789|NCT02783729|25985188|FG002|Overall Study|Other|2|||
13132790|NCT02783729|25985189|FG003|Overall Study|Other|3|||
13132791|NCT02783729|25985186|FG000|Overall Study|Withdrawal by Subject|2|||
13132792|NCT02783729|25985187|FG001|Overall Study|Withdrawal by Subject|3|||
13132793|NCT02783729|25985188|FG002|Overall Study|Withdrawal by Subject|1|||
13095085|NCT03605836|25839368|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2|||
13095086|NCT03605836|25839369|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
13095087|NCT03605836|25839370|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
13095088|NCT03605836|25839371|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
13095089|NCT03605836|25839368|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2|||
13095090|NCT03605836|25839369|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
13095091|NCT03605836|25839370|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
13095092|NCT03605836|25839371|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
13095093|NCT03605836|25839368|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8|||
13095094|NCT03605836|25839369|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
13095095|NCT03605836|25839370|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
13095096|NCT03605836|25839371|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
13095097|NCT03605836|25839368|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4|||
13095098|NCT03605836|25839369|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
13095099|NCT03605836|25839370|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
13095100|NCT03605836|25839371|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
13095101|NCT03605836|25839368|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4|||
13095102|NCT03605836|25839369|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
13095103|NCT03605836|25839370|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
13149393|NCT02565147|26043676|FG000|Overall Study|Death|1|||
13149394|NCT02565147|26043677|FG001|Overall Study|Death|1|||
13149395|NCT02565108|26043700|FG000|Overall Study|Adverse Event|1|||
13149396|NCT02565108|26043701|FG001|Overall Study|Adverse Event|0|||
13149397|NCT02565108|26043700|FG000|Overall Study|Withdrew Consent|1|||
13149398|NCT02565108|26043701|FG001|Overall Study|Withdrew Consent|0|||
13149399|NCT02564952|26043707|FG000|Overall Study|Adverse Event|6|||
13149400|NCT02564952|26043707|FG000|Overall Study|Lost to Follow-up|1|||
13149401|NCT02564952|26043707|FG000|Overall Study|Participant Withdrawn by Investigator|1|||
13149402|NCT02564952|26043707|FG000|Overall Study|Withdrawal by Subject|1|||
13149403|NCT02564952|26043707|FG000|Overall Study|Low Efficacy|1|||
13149404|NCT02564952|26043707|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
13149405|NCT02564887|26043730|FG000|Overall Study|Lost to Follow-up|6|||
13149406|NCT02564887|26043731|FG001|Overall Study|Lost to Follow-up|0|||
13095104|NCT03605836|25839371|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
13095105|NCT03605836|25839368|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17|||
13095106|NCT03605836|25839369|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
13095107|NCT03605836|25839370|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
13095108|NCT03605836|25839371|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
13095109|NCT03605836|25839368|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5|||
13095110|NCT03605836|25839369|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
13095111|NCT03605836|25839370|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
13095112|NCT03605836|25839371|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
13095113|NCT03605836|25839368|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7|||
13095114|NCT03605836|25839369|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
13095115|NCT03605836|25839370|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
13095116|NCT03605836|25839371|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
13095117|NCT03605836|25839368|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85|||
13095118|NCT03605836|25839369|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
13095119|NCT03605836|25839370|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
13095120|NCT03605836|25839371|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
13095121|NCT03605836|25839368|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15|||
13095122|NCT03605836|25839369|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
13095123|NCT03605836|25839370|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
13095124|NCT03605836|25839371|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
13095125|NCT03605836|25839368|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1|||
13095126|NCT03605836|25839369|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
13095127|NCT03605836|25839370|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
13095128|NCT03605836|25839371|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
13095129|NCT03605836|25839368|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0|||
13095130|NCT03605836|25839369|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2|||
13095131|NCT03605836|25839370|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
13149407|NCT02564796|26043752|FG000|Overall Study|Physician Decision|2|||
13149408|NCT02564796|26043753|FG001|Overall Study|Physician Decision|2|||
13149409|NCT02564718|26043788|FG000|Overall Study|Withdrew from treatment|0|||
13149410|NCT02564718|26043789|FG001|Overall Study|Withdrew from treatment|1|||
13149411|NCT02564471|26043824|FG000|Overall Study|Adverse Event|1|||
13149412|NCT02564471|26043825|FG001|Overall Study|Adverse Event|0|||
13149413|NCT02564471|26043826|FG002|Overall Study|Adverse Event|0|||
13149414|NCT02564471|26043827|FG003|Overall Study|Adverse Event|0|||
13149415|NCT02564471|26043824|FG000|Overall Study|Withdrawal by Subject|2|||
13149416|NCT02564471|26043825|FG001|Overall Study|Withdrawal by Subject|1|||
13149417|NCT02564471|26043826|FG002|Overall Study|Withdrawal by Subject|3|||
13149418|NCT02564471|26043827|FG003|Overall Study|Withdrawal by Subject|0|||
13149419|NCT02564471|26043824|FG000|Overall Study|Lost to Follow-up|0|||
13149420|NCT02564471|26043825|FG001|Overall Study|Lost to Follow-up|2|||
13149421|NCT02564471|26043826|FG002|Overall Study|Lost to Follow-up|0|||
13149422|NCT02564471|26043827|FG003|Overall Study|Lost to Follow-up|0|||
13149423|NCT02564211|26043835|FG000|Overall Study|Adverse Event|4|||
13149424|NCT02564198|26043869|FG000|Overall Study|Withdrawal by Subject|2|||
13149425|NCT02564198|26043870|FG001|Overall Study|Withdrawal by Subject|4|||
13149426|NCT02564198|26043871|FG002|Overall Study|Withdrawal by Subject|0|||
13149427|NCT02564198|26043869|FG000|Overall Study|Adverse Event|0|||
13149428|NCT02564198|26043870|FG001|Overall Study|Adverse Event|1|||
13149429|NCT02564198|26043871|FG002|Overall Study|Adverse Event|0|||
13149430|NCT02564120|26043925|FG000|Overall Study|Did not return release forms|160|||
13149431|NCT02564120|26043925|FG000|Overall Study|Death|58|||
13149432|NCT02564120|26043925|FG000|Overall Study|Withdrawal by Subject|204|||
13149433|NCT02564120|26043925|FG000|Overall Study|Other medical condition|24|||
13149434|NCT02564055|26044192|FG000|Overall Study|Adverse Event|1|||
13149435|NCT02564055|26044193|FG001|Overall Study|Adverse Event|0|||
13149436|NCT02564055|26044194|FG002|Overall Study|Adverse Event|4|||
13149437|NCT02564055|26044195|FG003|Overall Study|Adverse Event|1|||
13149438|NCT02564055|26044196|FG004|Overall Study|Adverse Event|4|||
13149439|NCT02564055|26044197|FG005|Overall Study|Adverse Event|1|||
13149440|NCT02564055|26044192|FG000|Overall Study|Protocol Violation|1|||
13149441|NCT02564055|26044193|FG001|Overall Study|Protocol Violation|0|||
13149442|NCT02564055|26044194|FG002|Overall Study|Protocol Violation|0|||
13149443|NCT02564055|26044195|FG003|Overall Study|Protocol Violation|0|||
13149444|NCT02564055|26044196|FG004|Overall Study|Protocol Violation|0|||
13149445|NCT02564055|26044197|FG005|Overall Study|Protocol Violation|0|||
13149446|NCT02564055|26044192|FG000|Overall Study|Reached stopping criteria|0|||
13095132|NCT03605836|25839371|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
13095133|NCT03605836|25839368|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
13095134|NCT03605836|25839369|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5|||
13095135|NCT03605836|25839370|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8|||
13095136|NCT03605836|25839371|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
13095137|NCT03605836|25839368|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
13095138|NCT03605836|25839369|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
13095139|NCT03605836|25839370|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2|||
13095140|NCT03605836|25839371|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1|||
13095141|NCT03605836|25839368|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0|||
13095142|NCT03605836|25839369|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3|||
13095143|NCT03605836|25839370|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5|||
13095144|NCT03605836|25839371|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1|||
13095145|NCT03605836|25839368|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
13095146|NCT03605836|25839369|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1|||
13095147|NCT03605836|25839370|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
13095148|NCT03605836|25839371|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4|||
13095149|NCT03605836|25839368|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
13095150|NCT03605836|25839369|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1|||
13095151|NCT03605836|25839370|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
13095152|NCT03605836|25839371|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
13095153|NCT03605836|25839368|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0|||
13095154|NCT03605836|25839369|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5|||
13095155|NCT03605836|25839370|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
13095156|NCT03605836|25839371|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
13095157|NCT03605836|25839368|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0|||
13095158|NCT03605836|25839369|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10|||
13095159|NCT03605836|25839370|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6|||
13095160|NCT03605836|25839371|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4|||
13095161|NCT03605836|25839368|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
13095162|NCT03605836|25839369|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3|||
13149447|NCT02564055|26044193|FG001|Overall Study|Reached stopping criteria|0|||
13149448|NCT02564055|26044194|FG002|Overall Study|Reached stopping criteria|0|||
13149449|NCT02564055|26044195|FG003|Overall Study|Reached stopping criteria|0|||
13149450|NCT02564055|26044196|FG004|Overall Study|Reached stopping criteria|0|||
13149451|NCT02564055|26044197|FG005|Overall Study|Reached stopping criteria|1|||
13149452|NCT02564055|26044192|FG000|Overall Study|Lost to Follow-up|0|||
13095163|NCT03605836|25839370|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1|||
13095164|NCT03605836|25839371|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
13095165|NCT03605836|25839368|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0|||
13095166|NCT03605836|25839369|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6|||
13095167|NCT03605836|25839370|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16|||
13095168|NCT03605836|25839371|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7|||
13095169|NCT03605836|25839368|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
13095170|NCT03605836|25839369|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
13095171|NCT03605836|25839370|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2|||
13095172|NCT03605836|25839371|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1|||
13095173|NCT03605745|25839380|FG000|Overall Study|Study was terminated for business reasons|47|||
13095174|NCT03605693|25839401|FG000|Overall Study|Lost to Follow-up|4|||
13095175|NCT03605693|25839402|FG001|Overall Study|Lost to Follow-up|0|||
13095176|NCT03605693|25839401|FG000|Overall Study|Physician Decision|1|||
13095177|NCT03605693|25839402|FG001|Overall Study|Physician Decision|0|||
13095178|NCT03605680|25839427|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6|||
13149453|NCT02564055|26044193|FG001|Overall Study|Lost to Follow-up|1|||
13149454|NCT02564055|26044194|FG002|Overall Study|Lost to Follow-up|4|||
13149455|NCT02564055|26044195|FG003|Overall Study|Lost to Follow-up|2|||
13149456|NCT02564055|26044196|FG004|Overall Study|Lost to Follow-up|1|||
13149457|NCT02564055|26044197|FG005|Overall Study|Lost to Follow-up|0|||
13149458|NCT02564055|26044192|FG000|Overall Study|Physician Decision|0|||
13149459|NCT02564055|26044193|FG001|Overall Study|Physician Decision|0|||
13149460|NCT02564055|26044194|FG002|Overall Study|Physician Decision|1|||
13149461|NCT02564055|26044195|FG003|Overall Study|Physician Decision|0|||
13149462|NCT02564055|26044196|FG004|Overall Study|Physician Decision|0|||
13149463|NCT02564055|26044197|FG005|Overall Study|Physician Decision|0|||
13149464|NCT02564055|26044192|FG000|Overall Study|Withdrawal by Subject|4|||
13149465|NCT02564055|26044193|FG001|Overall Study|Withdrawal by Subject|4|||
13149466|NCT02564055|26044194|FG002|Overall Study|Withdrawal by Subject|3|||
13149467|NCT02564055|26044195|FG003|Overall Study|Withdrawal by Subject|3|||
13095179|NCT03605680|25839428|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
13095180|NCT03605680|25839429|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
13095181|NCT03605680|25839430|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
13095182|NCT03605680|25839427|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1|||
13095183|NCT03605680|25839428|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
13095184|NCT03605680|25839429|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
13095185|NCT03605680|25839430|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
13095186|NCT03605680|25839427|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9|||
13095187|NCT03605680|25839428|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
13095188|NCT03605680|25839429|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
13095189|NCT03605680|25839430|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
13095190|NCT03605680|25839427|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3|||
13095191|NCT03605680|25839428|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
13095192|NCT03605680|25839429|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
13095193|NCT03605680|25839430|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
13095194|NCT03605680|25839427|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13|||
13095195|NCT03605680|25839428|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
13095196|NCT03605680|25839429|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
13095197|NCT03605680|25839430|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
13095198|NCT03605680|25839427|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12|||
13095199|NCT03605680|25839428|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
13095200|NCT03605680|25839429|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
13095201|NCT03605680|25839430|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
13095202|NCT03605680|25839427|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1|||
13095203|NCT03605680|25839428|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
13095204|NCT03605680|25839429|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
13095205|NCT03605680|25839430|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
13095206|NCT03605680|25839427|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6|||
13095207|NCT03605680|25839428|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
13095208|NCT03605680|25839429|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
13095209|NCT03605680|25839430|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
13095210|NCT03605680|25839427|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87|||
13095211|NCT03605680|25839428|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
13095212|NCT03605680|25839429|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
13149468|NCT02564055|26044196|FG004|Overall Study|Withdrawal by Subject|10|||
13149469|NCT02564055|26044197|FG005|Overall Study|Withdrawal by Subject|10|||
13149470|NCT02564042|26044428|FG000|Overall Study|Adverse Event|4|||
13149471|NCT02564042|26044429|FG001|Overall Study|Adverse Event|4|||
13095213|NCT03605680|25839430|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
13095214|NCT03605680|25839427|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0|||
13095215|NCT03605680|25839428|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5|||
13095216|NCT03605680|25839429|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7|||
13095217|NCT03605680|25839430|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8|||
13095218|NCT03605680|25839427|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0|||
13095219|NCT03605680|25839428|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
13095220|NCT03605680|25839429|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
13095221|NCT03605680|25839430|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
13095222|NCT03605680|25839427|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
13095223|NCT03605680|25839428|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
13095224|NCT03605680|25839429|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
13095225|NCT03605680|25839430|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
13095226|NCT03605680|25839427|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
13095227|NCT03605680|25839428|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
13149472|NCT02564042|26044430|FG002|Overall Study|Adverse Event|3|||
13149473|NCT02564042|26044431|FG003|Overall Study|Adverse Event|0|||
13149474|NCT02564042|26044432|FG004|Overall Study|Adverse Event|0|||
13149475|NCT02564042|26044433|FG005|Overall Study|Adverse Event|1|||
13149476|NCT02564042|26044428|FG000|Overall Study|Lost to Follow-up|1|||
13149477|NCT02564042|26044429|FG001|Overall Study|Lost to Follow-up|1|||
13149478|NCT02564042|26044430|FG002|Overall Study|Lost to Follow-up|1|||
13149479|NCT02564042|26044431|FG003|Overall Study|Lost to Follow-up|0|||
13149480|NCT02564042|26044432|FG004|Overall Study|Lost to Follow-up|1|||
13149481|NCT02564042|26044433|FG005|Overall Study|Lost to Follow-up|1|||
13149482|NCT02564042|26044428|FG000|Overall Study|Physician Decision|1|||
13149483|NCT02564042|26044429|FG001|Overall Study|Physician Decision|0|||
13149484|NCT02564042|26044430|FG002|Overall Study|Physician Decision|0|||
13149485|NCT02564042|26044431|FG003|Overall Study|Physician Decision|1|||
13149486|NCT02564042|26044432|FG004|Overall Study|Physician Decision|0|||
13149487|NCT02564042|26044433|FG005|Overall Study|Physician Decision|0|||
13149488|NCT02564042|26044428|FG000|Overall Study|Withdrawal by Subject|5|||
13149489|NCT02564042|26044429|FG001|Overall Study|Withdrawal by Subject|3|||
13149490|NCT02564042|26044430|FG002|Overall Study|Withdrawal by Subject|2|||
13149491|NCT02564042|26044431|FG003|Overall Study|Withdrawal by Subject|2|||
13149492|NCT02564042|26044432|FG004|Overall Study|Withdrawal by Subject|10|||
13149493|NCT02564042|26044433|FG005|Overall Study|Withdrawal by Subject|12|||
13149494|NCT02563925|26044440|FG000|Overall Study|Withdrawal by Subject|2|||
13149495|NCT02563899|26044494|FG000|Overall Study|Protocol Violation|1|||
13149496|NCT02563899|26044495|FG001|Overall Study|Protocol Violation|0|||
13149497|NCT02563899|26044496|FG002|Overall Study|Protocol Violation|0|||
13149498|NCT02563899|26044497|FG003|Overall Study|Protocol Violation|0|||
13149499|NCT02563899|26044494|FG000|Overall Study|Withdrawal by Subject|0|||
13149500|NCT02563899|26044495|FG001|Overall Study|Withdrawal by Subject|0|||
13149501|NCT02563899|26044496|FG002|Overall Study|Withdrawal by Subject|1|||
13149502|NCT02563899|26044497|FG003|Overall Study|Withdrawal by Subject|0|||
13149503|NCT02563561|26044527|FG000|Overall Study|Histology Other than Ta, G1-G2|3|||
13149504|NCT02563561|26044528|FG001|Overall Study|Histology Other than Ta, G1-G2|6|||
13149505|NCT02563561|26044529|FG002|Overall Study|Histology Other than Ta, G1-G2|6|||
13149506|NCT02563561|26044527|FG000|Overall Study|Withdrew of Consent|1|||
13149507|NCT02563561|26044528|FG001|Overall Study|Withdrew of Consent|1|||
13149508|NCT02563561|26044529|FG002|Overall Study|Withdrew of Consent|2|||
13149509|NCT02563561|26044527|FG000|Overall Study|Lost to Follow-up|1|||
13149510|NCT02563561|26044528|FG001|Overall Study|Lost to Follow-up|1|||
13149511|NCT02563561|26044529|FG002|Overall Study|Lost to Follow-up|0|||
13149512|NCT02563561|26044527|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4|||
13149513|NCT02563561|26044528|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2|||
13149514|NCT02563561|26044529|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1|||
13149515|NCT02563561|26044527|FG000|Overall Study|Investigator Decision|3|||
13149516|NCT02563561|26044528|FG001|Overall Study|Investigator Decision|4|||
13149517|NCT02563561|26044529|FG002|Overall Study|Investigator Decision|2|||
13149518|NCT02563561|26044527|FG000|Overall Study|Sponsor Decision|5|||
13149519|NCT02563561|26044528|FG001|Overall Study|Sponsor Decision|2|||
13149520|NCT02563561|26044529|FG002|Overall Study|Sponsor Decision|4|||
13149521|NCT02563561|26044527|FG000|Overall Study|Other|1|||
13149522|NCT02563561|26044528|FG001|Overall Study|Other|5|||
13149523|NCT02563561|26044529|FG002|Overall Study|Other|2|||
13149524|NCT02563548|26044602|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2|||
13149525|NCT02563548|26044603|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
13149526|NCT02563548|26044604|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
13149527|NCT02563548|26044605|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1|||
13149528|NCT02563548|26044606|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
13205145|NCT01968031|26230944|FG002|Overall Study|Noncompliance|2|||
13149529|NCT02563548|26044607|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
13149530|NCT02563548|26044602|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1|||
13149531|NCT02563548|26044603|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
13149532|NCT02563548|26044604|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
13149533|NCT02563548|26044605|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
13149534|NCT02563548|26044606|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
13149535|NCT02563548|26044607|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
13149536|NCT02563548|26044602|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
13149537|NCT02563548|26044603|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
13149538|NCT02563548|26044604|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3|||
13149539|NCT02563548|26044605|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
13149540|NCT02563548|26044606|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
13149541|NCT02563548|26044607|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
13149542|NCT02563548|26044602|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
13149543|NCT02563548|26044603|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
13149544|NCT02563548|26044604|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2|||
13149545|NCT02563548|26044605|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1|||
13149546|NCT02563548|26044606|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
13149547|NCT02563548|26044607|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
13149548|NCT02563548|26044602|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
13149549|NCT02563548|26044603|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
13149550|NCT02563548|26044604|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
13149551|NCT02563548|26044605|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
13149552|NCT02563548|26044606|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1|||
13149553|NCT02563548|26044607|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8|||
13149554|NCT02563548|26044602|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
13149555|NCT02563548|26044603|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
13149556|NCT02563548|26044604|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
13149557|NCT02563548|26044605|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
13149558|NCT02563548|26044606|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15|||
13149559|NCT02563548|26044607|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3|||
13149560|NCT02563548|26044602|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
13149561|NCT02563548|26044603|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
13149562|NCT02563548|26044604|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
13149563|NCT02563548|26044605|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
13149564|NCT02563548|26044606|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6|||
13149565|NCT02563548|26044607|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
13149566|NCT02563548|26044602|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
13149567|NCT02563548|26044603|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
13149568|NCT02563548|26044604|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
13149569|NCT02563548|26044605|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
13149570|NCT02563548|26044606|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2|||
13149571|NCT02563548|26044607|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1|||
13149572|NCT02563548|26044602|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
13149573|NCT02563548|26044603|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
13149574|NCT02563548|26044604|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
13149575|NCT02563548|26044605|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
13149576|NCT02563548|26044606|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
13149577|NCT02563548|26044607|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2|||
13149578|NCT02563548|26044602|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
13149579|NCT02563548|26044603|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
13149580|NCT02563548|26044604|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
13149581|NCT02563548|26044605|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
13149582|NCT02563548|26044606|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
13149583|NCT02563548|26044607|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2|||
13095228|NCT03605680|25839429|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4|||
13095229|NCT03605680|25839430|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
13095230|NCT03605680|25839427|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0|||
13095231|NCT03605680|25839428|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3|||
13095232|NCT03605680|25839429|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1|||
13095233|NCT03605680|25839430|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2|||
13095234|NCT03605680|25839427|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
13149584|NCT02563548|26044602|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
13149585|NCT02563548|26044603|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
13149586|NCT02563548|26044604|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
13149587|NCT02563548|26044605|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
13149588|NCT02563548|26044606|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
13149589|NCT02563548|26044607|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1|||
13149590|NCT02563548|26044602|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
13149591|NCT02563548|26044603|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
13149592|NCT02563548|26044604|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
13149593|NCT02563548|26044605|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
13149594|NCT02563548|26044606|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1|||
13149595|NCT02563548|26044607|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
13149596|NCT02563106|26044620|FG000|Overall Study|Withdrawal by Subject|7|||
13149597|NCT02563106|26044621|FG001|Overall Study|Withdrawal by Subject|8|||
13149598|NCT02563106|26044620|FG000|Overall Study|Adverse Event|17|||
13149599|NCT02563106|26044621|FG001|Overall Study|Adverse Event|15|||
13149600|NCT02563106|26044620|FG000|Overall Study|Protocol Violation|1|||
13149601|NCT02563106|26044621|FG001|Overall Study|Protocol Violation|0|||
13149602|NCT02563106|26044620|FG000|Overall Study|Use of non-permitted concurrent therapy|1|||
13149603|NCT02563106|26044621|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
13149604|NCT02563106|26044620|FG000|Overall Study|Lost to Follow-up|3|||
13149605|NCT02563106|26044621|FG001|Overall Study|Lost to Follow-up|2|||
13149606|NCT02563106|26044620|FG000|Overall Study|Physician Decision|3|||
13149607|NCT02563106|26044621|FG001|Overall Study|Physician Decision|1|||
13149608|NCT02563106|26044620|FG000|Overall Study|Other reason - not specified|2|||
13149609|NCT02563106|26044621|FG001|Overall Study|Other reason - not specified|1|||
13149610|NCT02563067|26044663|FG000|Overall Study|Subject/guardian decision|14|||
13149611|NCT02563067|26044664|FG001|Overall Study|Subject/guardian decision|20|||
13149612|NCT02563067|26044665|FG002|Overall Study|Subject/guardian decision|16|||
13149613|NCT02563067|26044663|FG000|Overall Study|Physician Decision|0|||
13149614|NCT02563067|26044664|FG001|Overall Study|Physician Decision|1|||
13149615|NCT02563067|26044665|FG002|Overall Study|Physician Decision|3|||
13149616|NCT02563067|26044663|FG000|Overall Study|Lost to Follow-up|1|||
13149617|NCT02563067|26044664|FG001|Overall Study|Lost to Follow-up|2|||
13149618|NCT02563067|26044665|FG002|Overall Study|Lost to Follow-up|0|||
13149619|NCT02563067|26044663|FG000|Overall Study|Technical problems|0|||
13149620|NCT02563067|26044664|FG001|Overall Study|Technical problems|1|||
13149621|NCT02563067|26044665|FG002|Overall Study|Technical problems|0|||
13149622|NCT02563067|26044663|FG000|Overall Study|Lack of Efficacy|1|||
13149623|NCT02563067|26044664|FG001|Overall Study|Lack of Efficacy|0|||
13149624|NCT02563067|26044665|FG002|Overall Study|Lack of Efficacy|0|||
13149625|NCT02563067|26044663|FG000|Overall Study|Death|0|||
13149626|NCT02563067|26044664|FG001|Overall Study|Death|1|||
13149627|NCT02563067|26044665|FG002|Overall Study|Death|1|||
13149628|NCT02563067|26044663|FG000|Overall Study|Adverse Event|2|||
13149629|NCT02563067|26044664|FG001|Overall Study|Adverse Event|1|||
13149630|NCT02563067|26044665|FG002|Overall Study|Adverse Event|0|||
13149631|NCT02563067|26044663|FG000|Overall Study|Death post Treatment/safety period|1|||
13149632|NCT02563067|26044664|FG001|Overall Study|Death post Treatment/safety period|0|||
13149633|NCT02563067|26044665|FG002|Overall Study|Death post Treatment/safety period|0|||
13149634|NCT02563028|26044674|FG000|Overall Study|Lack of equipment|1|||
13149635|NCT02563028|26044674|FG000|Overall Study|Unable to elicit VEP post induction|1|||
13149636|NCT02562716|26044701|FG000|Overall Study|Adverse Event|7|||
13149637|NCT02562716|26044702|FG001|Overall Study|Adverse Event|14|||
13149638|NCT02562716|26044701|FG000|Overall Study|Withdrawal unrelated to AE|7|||
13149639|NCT02562716|26044702|FG001|Overall Study|Withdrawal unrelated to AE|1|||
13149640|NCT02562716|26044701|FG000|Overall Study|Progression|8|||
13149641|NCT02562716|26044702|FG001|Overall Study|Progression|10|||
13149642|NCT02562716|26044701|FG000|Overall Study|Death|2|||
13149643|NCT02562716|26044702|FG001|Overall Study|Death|1|||
13149644|NCT02562716|26044701|FG000|Overall Study|Not protocol specified|4|||
13149645|NCT02562716|26044702|FG001|Overall Study|Not protocol specified|2|||
13149646|NCT02562482|26044731|FG000|Overall Study|Enrolled, but did not receive product|4|||
13149647|NCT02562482|26044732|FG001|Overall Study|Enrolled, but did not receive product|0|||
13149648|NCT02562482|26044731|FG000|Overall Study|Lost to Follow-up|9|||
13149649|NCT02562482|26044732|FG001|Overall Study|Lost to Follow-up|6|||
13149650|NCT02562482|26044731|FG000|Overall Study|Moved from area|2|||
13149651|NCT02562482|26044732|FG001|Overall Study|Moved from area|3|||
13149652|NCT02562482|26044731|FG000|Overall Study|Withdrawal by Subject|5|||
13149653|NCT02562482|26044732|FG001|Overall Study|Withdrawal by Subject|3|||
13149654|NCT02562482|26044731|FG000|Overall Study|Physician Decision|1|||
13149655|NCT02562482|26044732|FG001|Overall Study|Physician Decision|3|||
13149656|NCT02562482|26044731|FG000|Overall Study|Illness/Injury unrelated to product|0|||
13149657|NCT02562482|26044732|FG001|Overall Study|Illness/Injury unrelated to product|1|||
13149658|NCT02561962|26044789|FG000|Overall Study|Ongoing in study|1|||
13149659|NCT02561962|26044790|FG001|Overall Study|Ongoing in study|0|||
13307582|NCT01284140|26529129|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
13149660|NCT02561962|26044791|FG002|Overall Study|Ongoing in study|0|||
13149661|NCT02561962|26044792|FG003|Overall Study|Ongoing in study|1|||
13149662|NCT02561962|26044793|FG004|Overall Study|Ongoing in study|0|||
13149663|NCT02561962|26044794|FG005|Overall Study|Ongoing in study|1|||
13149664|NCT02561962|26044795|FG006|Overall Study|Ongoing in study|0|||
13149665|NCT02561962|26044796|FG007|Overall Study|Ongoing in study|4|||
13149666|NCT02561962|26044797|FG008|Overall Study|Ongoing in study|1|||
13149667|NCT02561962|26044789|FG000|Overall Study|Withdrawal by Subject|1|||
13149668|NCT02561962|26044790|FG001|Overall Study|Withdrawal by Subject|0|||
13149669|NCT02561962|26044791|FG002|Overall Study|Withdrawal by Subject|0|||
13149670|NCT02561962|26044792|FG003|Overall Study|Withdrawal by Subject|0|||
13149671|NCT02561962|26044793|FG004|Overall Study|Withdrawal by Subject|1|||
13149672|NCT02561962|26044794|FG005|Overall Study|Withdrawal by Subject|1|||
13149673|NCT02561962|26044795|FG006|Overall Study|Withdrawal by Subject|2|||
13149674|NCT02561962|26044796|FG007|Overall Study|Withdrawal by Subject|1|||
13149675|NCT02561962|26044797|FG008|Overall Study|Withdrawal by Subject|0|||
13149676|NCT02561962|26044789|FG000|Overall Study|Decision by sponsor|0|||
13149677|NCT02561962|26044790|FG001|Overall Study|Decision by sponsor|0|||
13149678|NCT02561962|26044791|FG002|Overall Study|Decision by sponsor|0|||
13149679|NCT02561962|26044792|FG003|Overall Study|Decision by sponsor|0|||
13149680|NCT02561962|26044793|FG004|Overall Study|Decision by sponsor|1|||
13149681|NCT02561962|26044794|FG005|Overall Study|Decision by sponsor|1|||
13149682|NCT02561962|26044795|FG006|Overall Study|Decision by sponsor|0|||
13149683|NCT02561962|26044796|FG007|Overall Study|Decision by sponsor|3|||
13149684|NCT02561962|26044797|FG008|Overall Study|Decision by sponsor|0|||
13149685|NCT02561962|26044789|FG000|Overall Study|Lost to Follow-up|0|||
13149686|NCT02561962|26044790|FG001|Overall Study|Lost to Follow-up|0|||
13149687|NCT02561962|26044791|FG002|Overall Study|Lost to Follow-up|0|||
13149688|NCT02561962|26044792|FG003|Overall Study|Lost to Follow-up|0|||
13149689|NCT02561962|26044793|FG004|Overall Study|Lost to Follow-up|0|||
13149690|NCT02561962|26044794|FG005|Overall Study|Lost to Follow-up|1|||
13149691|NCT02561962|26044795|FG006|Overall Study|Lost to Follow-up|0|||
13149692|NCT02561962|26044796|FG007|Overall Study|Lost to Follow-up|0|||
13149693|NCT02561962|26044797|FG008|Overall Study|Lost to Follow-up|0|||
13149694|NCT02561832|26044810|FG000|Overall Study|Withdrawal by Subject|1|||
13149695|NCT02561832|26044811|FG001|Overall Study|Withdrawal by Subject|1|||
13149696|NCT02561832|26044810|FG000|Overall Study|Adverse Event|3|||
13149697|NCT02561832|26044811|FG001|Overall Study|Adverse Event|0|||
13149698|NCT02561832|26044810|FG000|Overall Study|Disease progression|3|||
13149699|NCT02561832|26044811|FG001|Overall Study|Disease progression|3|||
13149700|NCT02561806|26044874|FG000|Induction Period|Adverse Event|0|||
13149701|NCT02561806|26044875|FG001|Induction Period|Adverse Event|2|||
13149702|NCT02561806|26044874|FG000|Induction Period|Lack of Efficacy|1|||
13149703|NCT02561806|26044875|FG001|Induction Period|Lack of Efficacy|0|||
13149704|NCT02561806|26044874|FG000|Induction Period|Withdrawal by Subject|0|||
13149705|NCT02561806|26044875|FG001|Induction Period|Withdrawal by Subject|2|||
13149706|NCT02561806|26044874|FG000|Induction Period|Site staff became unblinded|1|||
13149707|NCT02561806|26044875|FG001|Induction Period|Site staff became unblinded|0|||
13149708|NCT02561806|26044874|FG000|Induction Period|Randomized but not treated|0|||
13149709|NCT02561806|26044875|FG001|Induction Period|Randomized but not treated|1|||
13149710|NCT02561806|26044874|FG000|Maintenance Period|Adverse Event|2|||
13149711|NCT02561806|26044875|FG001|Maintenance Period|Adverse Event|1|||
13149712|NCT02561806|26044874|FG000|Maintenance Period|Lack of Efficacy|3|||
13149713|NCT02561806|26044875|FG001|Maintenance Period|Lack of Efficacy|1|||
13149714|NCT02561806|26044874|FG000|Maintenance Period|Lost to Follow-up|2|||
13149715|NCT02561806|26044875|FG001|Maintenance Period|Lost to Follow-up|2|||
13149716|NCT02561806|26044874|FG000|Maintenance Period|Protocol Violation|1|||
13149717|NCT02561806|26044875|FG001|Maintenance Period|Protocol Violation|0|||
13149718|NCT02561806|26044874|FG000|Maintenance Period|Withdrawal by Subject|5|||
13149719|NCT02561806|26044875|FG001|Maintenance Period|Withdrawal by Subject|3|||
13095235|NCT03605680|25839428|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14|||
13095236|NCT03605680|25839429|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7|||
13095237|NCT03605680|25839430|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5|||
13095238|NCT03605680|25839427|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0|||
13095239|NCT03605680|25839428|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
13095240|NCT03605680|25839429|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
13095241|NCT03605680|25839430|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7|||
13095242|NCT03605680|25839427|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
13095243|NCT03605680|25839428|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1|||
13095244|NCT03605680|25839429|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2|||
13095245|NCT03605680|25839430|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
13095246|NCT03605680|25839427|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
13095247|NCT03605680|25839428|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5|||
13095248|NCT03605680|25839429|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4|||
13095249|NCT03605680|25839430|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3|||
13149720|NCT02561806|26044874|FG000|Maintenance Period|Site staff became unblinded|0|||
13095250|NCT03605680|25839427|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0|||
13095251|NCT03605680|25839428|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1|||
13095252|NCT03605680|25839429|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2|||
13095253|NCT03605680|25839430|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3|||
13095254|NCT03605303|25839441|FG000|Period 1|Study Terminated|2|||
13095255|NCT03605303|25839442|FG001|Period 1|Study Terminated|1|||
13095256|NCT03605212|25839525|FG000|Treatment Period|Adverse Event|1|||
13095257|NCT03605212|25839526|FG001|Treatment Period|Adverse Event|0|||
13095258|NCT03605212|25839527|FG002|Treatment Period|Adverse Event|0|||
13095259|NCT03605212|25839528|FG003|Treatment Period|Adverse Event|0|||
13095260|NCT03605212|25839529|FG004|Treatment Period|Adverse Event|0|||
13095261|NCT03605212|25839525|FG000|Treatment Period|Physician Decision|0|||
13095262|NCT03605212|25839526|FG001|Treatment Period|Physician Decision|0|||
13095263|NCT03605212|25839527|FG002|Treatment Period|Physician Decision|0|||
13095264|NCT03605212|25839528|FG003|Treatment Period|Physician Decision|0|||
13149721|NCT02561806|26044875|FG001|Maintenance Period|Site staff became unblinded|1|||
13149722|NCT02561806|26044874|FG000|Post-Treatment Follow-up|Lost to Follow-up|1|||
13095265|NCT03605212|25839529|FG004|Treatment Period|Physician Decision|1|||
13095266|NCT03604523|25839548|FG000|Overall Study|Physician Decision|1|||
13095267|NCT03604523|25839549|FG001|Overall Study|Physician Decision|0|||
13095268|NCT03604497|25839559|FG000|Overall Study|Protocol Violation|52|||
13095269|NCT03604341|25839572|FG000|Overall Study|Withdrawal by Subject|1|||
13095270|NCT03604341|25839573|FG001|Overall Study|Withdrawal by Subject|1|||
13095271|NCT03604341|25839572|FG000|Overall Study|Adverse Event|1|||
13095272|NCT03604341|25839573|FG001|Overall Study|Adverse Event|0|||
13095273|NCT03604341|25839572|FG000|Overall Study|Protocol Violation|0|||
13095274|NCT03604341|25839573|FG001|Overall Study|Protocol Violation|1|||
13095275|NCT03603652|25839587|FG000|Overall Study|Death|2|||
13095276|NCT03603639|25839635|FG000|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
13095277|NCT03603639|25839636|FG001|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
13095278|NCT03603639|25839637|FG002|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
13095279|NCT03603639|25839638|FG003|Washout Period (at Least 3 Weeks)|Adverse Event|1|||
13095280|NCT03603639|25839639|FG004|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
13095281|NCT03603639|25839640|FG005|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
13095282|NCT03603639|25839635|FG000|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
13095283|NCT03603639|25839636|FG001|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
13095284|NCT03603639|25839637|FG002|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
13095285|NCT03603639|25839638|FG003|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
13095286|NCT03603639|25839639|FG004|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
13095287|NCT03603639|25839640|FG005|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
13095288|NCT03603496|25839665|FG000|Overall Study|Death|19|||
13095289|NCT03603496|25839666|FG001|Overall Study|Death|24|||
13095290|NCT03603496|25839665|FG000|Overall Study|Lost to Follow-up|141|||
13095291|NCT03603496|25839666|FG001|Overall Study|Lost to Follow-up|141|||
13095292|NCT03603496|25839665|FG000|Overall Study|Withdrawal by Subject|26|||
13095293|NCT03603496|25839666|FG001|Overall Study|Withdrawal by Subject|20|||
13095294|NCT03603028|25839673|FG000|Overall Study|Withdrawal by Subject|1|||
13095295|NCT03602482|25839699|FG000|Overall Study|Withdrawal by Subject|6|||
13095296|NCT03602482|25839700|FG001|Overall Study|Withdrawal by Subject|7|||
13095297|NCT03602482|25839701|FG002|Overall Study|Withdrawal by Subject|0|||
13095298|NCT03602482|25839702|FG003|Overall Study|Withdrawal by Subject|0|||
13095299|NCT03602339|25839731|FG000|Overall Study|Withdrawal by Subject|9|||
13095300|NCT03602339|25839731|FG000|Overall Study|Physician Decision|2|||
13095301|NCT03602339|25839731|FG000|Overall Study|Other reason|4|||
13095302|NCT03602053|25839784|FG000|Overall Study|Withdrawal by Subject|7|||
13095303|NCT03602053|25839785|FG001|Overall Study|Withdrawal by Subject|9|||
13095304|NCT03602053|25839786|FG002|Overall Study|Withdrawal by Subject|7|||
13095305|NCT03602053|25839784|FG000|Overall Study|Lost to Follow-up|5|||
13095306|NCT03602053|25839785|FG001|Overall Study|Lost to Follow-up|6|||
13095307|NCT03602053|25839786|FG002|Overall Study|Lost to Follow-up|0|||
13095308|NCT03602053|25839784|FG000|Overall Study|Protocol Violation|3|||
13095309|NCT03602053|25839785|FG001|Overall Study|Protocol Violation|0|||
13095310|NCT03602053|25839786|FG002|Overall Study|Protocol Violation|4|||
13095311|NCT03602053|25839784|FG000|Overall Study|Physician Decision|1|||
13095312|NCT03602053|25839785|FG001|Overall Study|Physician Decision|0|||
13095313|NCT03602053|25839786|FG002|Overall Study|Physician Decision|0|||
13095314|NCT03602053|25839784|FG000|Overall Study|migration|2|||
13095315|NCT03602053|25839785|FG001|Overall Study|migration|3|||
13095316|NCT03602053|25839786|FG002|Overall Study|migration|0|||
13095317|NCT03602053|25839784|FG000|Overall Study|Other|1|||
13095318|NCT03602053|25839785|FG001|Overall Study|Other|0|||
13095319|NCT03602053|25839786|FG002|Overall Study|Other|0|||
13095320|NCT03601715|25839810|FG000|Second Intervention|Lost to Follow-up|1|||
13095321|NCT03601715|25839811|FG001|Second Intervention|Lost to Follow-up|1|||
13095322|NCT03601715|25839812|FG002|Second Intervention|Lost to Follow-up|0|||
13372871|NCT00806260|26722171|FG000|Period 2|Need to take concomitant medication|1|||
13095323|NCT03601052|25839833|FG000|Overall Study|Lost to Follow-up|2|||
13095324|NCT03600909|25839851|FG000|Overall Study|Not treated|0|||
13095325|NCT03600909|25839852|FG001|Overall Study|Not treated|3|||
13149723|NCT02561806|26044875|FG001|Post-Treatment Follow-up|Lost to Follow-up|1|||
13149724|NCT02561806|26044874|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1|||
13149725|NCT02561806|26044875|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0|||
13149726|NCT02561572|26044898|FG000|Overall Study|Inadequate time before surgery|2|||
13149727|NCT02561572|26044899|FG001|Overall Study|Inadequate time before surgery|1|||
13149728|NCT02561572|26044898|FG000|Overall Study|Protocol Violation|0|||
13149729|NCT02561572|26044899|FG001|Overall Study|Protocol Violation|1|||
13149730|NCT02561455|26044926|FG000|Overall Study|Participant Transitioned to Commercial Drug|1|||
13149731|NCT02561455|26044927|FG001|Overall Study|Participant Transitioned to Commercial Drug|1|||
13149732|NCT02561455|26044928|FG002|Overall Study|Participant Transitioned to Commercial Drug|2|||
13149733|NCT02561455|26044929|FG003|Overall Study|Participant Transitioned to Commercial Drug|1|||
13149734|NCT02561455|26044926|FG000|Overall Study|Withdrawal by Subject|1|||
13149735|NCT02561455|26044927|FG001|Overall Study|Withdrawal by Subject|0|||
13149736|NCT02561455|26044928|FG002|Overall Study|Withdrawal by Subject|1|||
13095326|NCT03600909|25839853|FG002|Overall Study|Not treated|0|||
13095327|NCT03600805|25839956|FG000|Overall Study|Adverse Event|2|||
13095328|NCT03600805|25839957|FG001|Overall Study|Adverse Event|1|||
13095329|NCT03600805|25839958|FG002|Overall Study|Adverse Event|1|||
13095330|NCT03600805|25839959|FG003|Overall Study|Adverse Event|7|||
13095331|NCT03600805|25839956|FG000|Overall Study|Lack of Efficacy|2|||
13095332|NCT03600805|25839957|FG001|Overall Study|Lack of Efficacy|1|||
13095333|NCT03600805|25839958|FG002|Overall Study|Lack of Efficacy|0|||
13095334|NCT03600805|25839959|FG003|Overall Study|Lack of Efficacy|0|||
13095335|NCT03600805|25839956|FG000|Overall Study|Withdrawal by Subject|1|||
13095336|NCT03600805|25839957|FG001|Overall Study|Withdrawal by Subject|0|||
13095337|NCT03600805|25839958|FG002|Overall Study|Withdrawal by Subject|0|||
13095338|NCT03600805|25839959|FG003|Overall Study|Withdrawal by Subject|1|||
13095339|NCT03600805|25839956|FG000|Overall Study|Other unspecified|14|||
13095340|NCT03600805|25839957|FG001|Overall Study|Other unspecified|6|||
13095341|NCT03600805|25839958|FG002|Overall Study|Other unspecified|7|||
13095342|NCT03600805|25839959|FG003|Overall Study|Other unspecified|11|||
13095343|NCT03600740|25839965|FG000|Overall Study|Surgical plan was altered-subject not eligible|1|||
13095344|NCT03600428|25839986|FG000|Overall Study|Not eligible|0|||
13095345|NCT03600428|25839987|FG001|Overall Study|Not eligible|1|||
13095346|NCT03600428|25839986|FG000|Overall Study|Lost to Follow-up|5|||
13095347|NCT03600428|25839987|FG001|Overall Study|Lost to Follow-up|4|||
13095348|NCT03600376|25840002|FG000|Overall Study|Adverse Event|1|||
13149737|NCT02561455|26044929|FG003|Overall Study|Withdrawal by Subject|0|||
13149738|NCT02561455|26044926|FG000|Overall Study|Disease Progression|0|||
13149739|NCT02561455|26044927|FG001|Overall Study|Disease Progression|1|||
13149740|NCT02561455|26044928|FG002|Overall Study|Disease Progression|0|||
13149741|NCT02561455|26044929|FG003|Overall Study|Disease Progression|0|||
13149742|NCT02561299|26044952|FG000|Overall Study|Death|2|||
13149743|NCT02561299|26044953|FG001|Overall Study|Death|4|||
13149744|NCT02561299|26044952|FG000|Overall Study|Lost to Follow-up|1|||
13149745|NCT02561299|26044953|FG001|Overall Study|Lost to Follow-up|0|||
13149746|NCT02561299|26044952|FG000|Overall Study|Withdrawal by Subject|2|||
13149747|NCT02561299|26044953|FG001|Overall Study|Withdrawal by Subject|2|||
13149748|NCT02561247|26044963|FG000|Overall Study|Protocol Violation|1|||
13149749|NCT02561247|26044963|FG000|Overall Study|Withdrawal by Subject|1|||
13149750|NCT02561247|26044963|FG000|Overall Study|Two filter changes required within the first 24 hours.|4|||
13149751|NCT02561195|26045244|FG000|Vaccination 1 to 3|Adverse Event|4|||
13149752|NCT02561195|26045245|FG001|Vaccination 1 to 3|Adverse Event|5|||
13149753|NCT02561195|26045246|FG002|Vaccination 1 to 3|Adverse Event|0|||
13149754|NCT02561195|26045247|FG003|Vaccination 1 to 3|Adverse Event|3|||
13149755|NCT02561195|26045248|FG004|Vaccination 1 to 3|Adverse Event|4|||
13149756|NCT02561195|26045249|FG005|Vaccination 1 to 3|Adverse Event|0|||
13149757|NCT02561195|26045250|FG006|Vaccination 1 to 3|Adverse Event|0|||
13149758|NCT02561195|26045251|FG007|Vaccination 1 to 3|Adverse Event|0|||
13149759|NCT02561195|26045252|FG008|Vaccination 1 to 3|Adverse Event|0|||
13149760|NCT02561195|26045253|FG009|Vaccination 1 to 3|Adverse Event|0|||
13149761|NCT02561195|26045254|FG010|Vaccination 1 to 3|Adverse Event|0|||
13149762|NCT02561195|26045255|FG011|Vaccination 1 to 3|Adverse Event|0|||
13149763|NCT02561195|26045256|FG012|Vaccination 1 to 3|Adverse Event|0|||
13149764|NCT02561195|26045257|FG013|Vaccination 1 to 3|Adverse Event|0|||
13149765|NCT02561195|26045244|FG000|Vaccination 1 to 3|Lost to Follow-up|3|||
13149766|NCT02561195|26045245|FG001|Vaccination 1 to 3|Lost to Follow-up|4|||
13149767|NCT02561195|26045246|FG002|Vaccination 1 to 3|Lost to Follow-up|0|||
13149768|NCT02561195|26045247|FG003|Vaccination 1 to 3|Lost to Follow-up|2|||
13149769|NCT02561195|26045248|FG004|Vaccination 1 to 3|Lost to Follow-up|3|||
13149770|NCT02561195|26045249|FG005|Vaccination 1 to 3|Lost to Follow-up|3|||
13149771|NCT02561195|26045250|FG006|Vaccination 1 to 3|Lost to Follow-up|0|||
13149772|NCT02561195|26045251|FG007|Vaccination 1 to 3|Lost to Follow-up|0|||
13095349|NCT03600376|25840003|FG001|Overall Study|Adverse Event|1|||
13149773|NCT02561195|26045252|FG008|Vaccination 1 to 3|Lost to Follow-up|0|||
13149774|NCT02561195|26045253|FG009|Vaccination 1 to 3|Lost to Follow-up|0|||
13149775|NCT02561195|26045254|FG010|Vaccination 1 to 3|Lost to Follow-up|0|||
13149776|NCT02561195|26045255|FG011|Vaccination 1 to 3|Lost to Follow-up|0|||
13149777|NCT02561195|26045256|FG012|Vaccination 1 to 3|Lost to Follow-up|0|||
13149778|NCT02561195|26045257|FG013|Vaccination 1 to 3|Lost to Follow-up|0|||
13149779|NCT02561195|26045244|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
13149780|NCT02561195|26045245|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
13149781|NCT02561195|26045246|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
13149782|NCT02561195|26045247|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
13149783|NCT02561195|26045248|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
13149784|NCT02561195|26045249|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
13149785|NCT02561195|26045250|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
13149786|NCT02561195|26045251|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
13149787|NCT02561195|26045252|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
13149788|NCT02561195|26045253|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
13149789|NCT02561195|26045254|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
13095350|NCT03600376|25840002|FG000|Overall Study|Transferred to other facility|1|||
13095351|NCT03600376|25840003|FG001|Overall Study|Transferred to other facility|0|||
13095352|NCT03600376|25840002|FG000|Overall Study|Investigator Decision|0|||
13095353|NCT03600376|25840003|FG001|Overall Study|Investigator Decision|4|||
13095354|NCT03600376|25840002|FG000|Overall Study|Determined to be ineligible for study|0|||
13095355|NCT03600376|25840003|FG001|Overall Study|Determined to be ineligible for study|1|||
13095356|NCT03599362|25840010|FG000|Overall Study|Screen Failure|3|||
13095357|NCT03599349|25840024|FG000|Overall Study|Lost to Follow-up|1|||
13095358|NCT03599193|25840043|FG000|Overall Study|Adverse Event|0|||
13095359|NCT03599193|25840044|FG001|Overall Study|Adverse Event|2|||
13095360|NCT03599193|25840043|FG000|Overall Study|Withdrawal by Subject|1|||
13095361|NCT03599193|25840044|FG001|Overall Study|Withdrawal by Subject|0|||
13095362|NCT03599193|25840043|FG000|Overall Study|Protocol Violation|1|||
13095363|NCT03599193|25840044|FG001|Overall Study|Protocol Violation|0|||
13095364|NCT03599193|25840043|FG000|Overall Study|Lost to Follow-up|0|||
13095365|NCT03599193|25840044|FG001|Overall Study|Lost to Follow-up|1|||
13095366|NCT03599089|25840075|FG000|Overall Study|Lost to Follow-up|1|||
13095367|NCT03599089|25840076|FG001|Overall Study|Lost to Follow-up|0|||
13095368|NCT03599089|25840077|FG002|Overall Study|Lost to Follow-up|0|||
13149790|NCT02561195|26045255|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
13149791|NCT02561195|26045256|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
13149792|NCT02561195|26045257|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
13149793|NCT02561195|26045244|FG000|Vaccination 1 to 3|No longer willing to participate|2|||
13149794|NCT02561195|26045245|FG001|Vaccination 1 to 3|No longer willing to participate|4|||
13149795|NCT02561195|26045246|FG002|Vaccination 1 to 3|No longer willing to participate|0|||
13149796|NCT02561195|26045247|FG003|Vaccination 1 to 3|No longer willing to participate|4|||
13149797|NCT02561195|26045248|FG004|Vaccination 1 to 3|No longer willing to participate|1|||
13149798|NCT02561195|26045249|FG005|Vaccination 1 to 3|No longer willing to participate|3|||
13149799|NCT02561195|26045250|FG006|Vaccination 1 to 3|No longer willing to participate|0|||
13149800|NCT02561195|26045251|FG007|Vaccination 1 to 3|No longer willing to participate|0|||
13149801|NCT02561195|26045252|FG008|Vaccination 1 to 3|No longer willing to participate|0|||
13149802|NCT02561195|26045253|FG009|Vaccination 1 to 3|No longer willing to participate|0|||
13149803|NCT02561195|26045254|FG010|Vaccination 1 to 3|No longer willing to participate|0|||
13149804|NCT02561195|26045255|FG011|Vaccination 1 to 3|No longer willing to participate|0|||
13149805|NCT02561195|26045256|FG012|Vaccination 1 to 3|No longer willing to participate|0|||
13149806|NCT02561195|26045257|FG013|Vaccination 1 to 3|No longer willing to participate|0|||
13149807|NCT02561195|26045244|FG000|Vaccination 1 to 3|Other|7|||
13149808|NCT02561195|26045245|FG001|Vaccination 1 to 3|Other|3|||
13149809|NCT02561195|26045246|FG002|Vaccination 1 to 3|Other|1|||
13149810|NCT02561195|26045247|FG003|Vaccination 1 to 3|Other|7|||
13149811|NCT02561195|26045248|FG004|Vaccination 1 to 3|Other|5|||
13149812|NCT02561195|26045249|FG005|Vaccination 1 to 3|Other|1|||
13149813|NCT02561195|26045250|FG006|Vaccination 1 to 3|Other|0|||
13149814|NCT02561195|26045251|FG007|Vaccination 1 to 3|Other|0|||
13149815|NCT02561195|26045252|FG008|Vaccination 1 to 3|Other|0|||
13149816|NCT02561195|26045253|FG009|Vaccination 1 to 3|Other|0|||
13149817|NCT02561195|26045254|FG010|Vaccination 1 to 3|Other|0|||
13149818|NCT02561195|26045255|FG011|Vaccination 1 to 3|Other|0|||
13149819|NCT02561195|26045256|FG012|Vaccination 1 to 3|Other|0|||
13149820|NCT02561195|26045257|FG013|Vaccination 1 to 3|Other|0|||
13149821|NCT02561195|26045244|FG000|Vaccination 1 to 3|Protocol Violation|1|||
13149822|NCT02561195|26045245|FG001|Vaccination 1 to 3|Protocol Violation|0|||
13149823|NCT02561195|26045246|FG002|Vaccination 1 to 3|Protocol Violation|1|||
13149824|NCT02561195|26045247|FG003|Vaccination 1 to 3|Protocol Violation|2|||
13149825|NCT02561195|26045248|FG004|Vaccination 1 to 3|Protocol Violation|5|||
13149826|NCT02561195|26045249|FG005|Vaccination 1 to 3|Protocol Violation|2|||
13149827|NCT02561195|26045250|FG006|Vaccination 1 to 3|Protocol Violation|0|||
13149828|NCT02561195|26045251|FG007|Vaccination 1 to 3|Protocol Violation|0|||
13149829|NCT02561195|26045252|FG008|Vaccination 1 to 3|Protocol Violation|0|||
13095369|NCT03599089|25840078|FG003|Overall Study|Lost to Follow-up|0|||
13095370|NCT03599089|25840075|FG000|Overall Study|Withdrawal by Subject|2|||
13095371|NCT03599089|25840076|FG001|Overall Study|Withdrawal by Subject|1|||
13095372|NCT03599089|25840077|FG002|Overall Study|Withdrawal by Subject|0|||
13095373|NCT03599089|25840078|FG003|Overall Study|Withdrawal by Subject|0|||
13095374|NCT03599089|25840075|FG000|Overall Study|Lack of Efficacy|0|||
13095375|NCT03599089|25840076|FG001|Overall Study|Lack of Efficacy|0|||
13095376|NCT03599089|25840077|FG002|Overall Study|Lack of Efficacy|1|||
13095377|NCT03599089|25840078|FG003|Overall Study|Lack of Efficacy|2|||
13095378|NCT03598140|25840097|FG000|Overall Study|enrolled but didn't start|1|||
13095379|NCT03598140|25840098|FG001|Overall Study|enrolled but didn't start|0|||
13095380|NCT03598036|25840131|FG000|Overall Study|Withdrawal by Subject|1|||
13095381|NCT03598036|25840132|FG001|Overall Study|Withdrawal by Subject|0|||
13095382|NCT03597529|25840145|FG000|Overall Study|Lost to Follow-up|10|||
13095383|NCT03597529|25840146|FG001|Overall Study|Lost to Follow-up|12|||
13095384|NCT03597529|25840145|FG000|Overall Study|Physician Decision|3|||
13095385|NCT03597529|25840146|FG001|Overall Study|Physician Decision|1|||
13095386|NCT03597529|25840145|FG000|Overall Study|Withdrawal by Subject|6|||
13095387|NCT03597529|25840146|FG001|Overall Study|Withdrawal by Subject|3|||
13095388|NCT03597529|25840145|FG000|Overall Study|Non-compliant with study activities|1|||
13095389|NCT03597529|25840146|FG001|Overall Study|Non-compliant with study activities|2|||
13095390|NCT03597295|25840161|FG000|Overall Study|Death|70|||
13095391|NCT03597295|25840161|FG000|Overall Study|Lost to Follow-up|7|||
13095392|NCT03597139|25840196|FG000|Overall Study|Adverse Event|3|||
13095393|NCT03597139|25840197|FG001|Overall Study|Adverse Event|0|||
13095394|NCT03597139|25840196|FG000|Overall Study|Protocol Non-compliance|1|||
13095395|NCT03597139|25840197|FG001|Overall Study|Protocol Non-compliance|0|||
13095396|NCT03597061|25840216|FG000|Overall Study|Lost to Follow-up|1|||
13095397|NCT03597061|25840217|FG001|Overall Study|Lost to Follow-up|0|||
13095398|NCT03597061|25840216|FG000|Overall Study|Protocol Violation|0|||
13095399|NCT03597061|25840217|FG001|Overall Study|Protocol Violation|1|||
13095400|NCT03597022|25840244|FG000|Overall Study|Premature termination of the study|7|||
13095401|NCT03597022|25840245|FG001|Overall Study|Premature termination of the study|7|||
13095402|NCT03597022|25840246|FG002|Overall Study|Premature termination of the study|8|||
13095403|NCT03597022|25840244|FG000|Overall Study|Serious adverse event|1|||
13095404|NCT03597022|25840245|FG001|Overall Study|Serious adverse event|1|||
13095405|NCT03597022|25840246|FG002|Overall Study|Serious adverse event|0|||
13095406|NCT03596151|25840260|FG000|Overall Study|Withdrawal by Subject|1|||
13095407|NCT03595904|25840281|FG000|Overall Study|Protocol Violation|3|||
13095408|NCT03595904|25840282|FG001|Overall Study|Protocol Violation|1|||
13095409|NCT03595904|25840281|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4|||
13095410|NCT03595904|25840282|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3|||
13095411|NCT03595904|25840281|FG000|Overall Study|Insurance complications|1|||
13095412|NCT03595904|25840282|FG001|Overall Study|Insurance complications|0|||
13095413|NCT03595904|25840281|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2|||
13095414|NCT03595904|25840282|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1|||
13095415|NCT03595618|25840352|FG000|Overall Study|Adverse Event|16|||
13095416|NCT03595618|25840353|FG001|Overall Study|Adverse Event|17|||
13095417|NCT03595618|25840354|FG002|Overall Study|Adverse Event|20|||
13095418|NCT03595618|25840355|FG003|Overall Study|Adverse Event|8|||
13095419|NCT03595618|25840352|FG000|Overall Study|Withdrawal by Subject|12|||
13095420|NCT03595618|25840353|FG001|Overall Study|Withdrawal by Subject|14|||
13095421|NCT03595618|25840354|FG002|Overall Study|Withdrawal by Subject|14|||
13095422|NCT03595618|25840355|FG003|Overall Study|Withdrawal by Subject|10|||
13095423|NCT03595618|25840352|FG000|Overall Study|Lost to Follow-up|6|||
13095424|NCT03595618|25840353|FG001|Overall Study|Lost to Follow-up|4|||
13095425|NCT03595618|25840354|FG002|Overall Study|Lost to Follow-up|5|||
13095426|NCT03595618|25840355|FG003|Overall Study|Lost to Follow-up|6|||
13095427|NCT03595618|25840352|FG000|Overall Study|Protocol Violation|2|||
13095428|NCT03595618|25840353|FG001|Overall Study|Protocol Violation|0|||
13095429|NCT03595618|25840354|FG002|Overall Study|Protocol Violation|6|||
13095430|NCT03595618|25840355|FG003|Overall Study|Protocol Violation|2|||
13095431|NCT03595618|25840352|FG000|Overall Study|Physician Decision|0|||
13095432|NCT03595618|25840353|FG001|Overall Study|Physician Decision|0|||
13095433|NCT03595618|25840354|FG002|Overall Study|Physician Decision|1|||
13095434|NCT03595618|25840355|FG003|Overall Study|Physician Decision|2|||
13095435|NCT03595618|25840352|FG000|Overall Study|Miscellaneous|7|||
13095436|NCT03595618|25840353|FG001|Overall Study|Miscellaneous|5|||
13095437|NCT03595618|25840354|FG002|Overall Study|Miscellaneous|10|||
13095438|NCT03595618|25840355|FG003|Overall Study|Miscellaneous|6|||
13095439|NCT03595384|25840369|FG000|Overall Study|Other time commitments|8|||
13095440|NCT03595384|25840369|FG000|Overall Study|Changes to session time|7|||
13095441|NCT03595384|25840369|FG000|Overall Study|Relocation out of country|1|||
13149830|NCT02561195|26045253|FG009|Vaccination 1 to 3|Protocol Violation|0|||
13095442|NCT03595332|25840390|FG000|Overall Study|Lost to Follow-up|16|||
13095443|NCT03595332|25840391|FG001|Overall Study|Lost to Follow-up|22|||
13095444|NCT03595332|25840390|FG000|Overall Study|Unable to retrieve ID from school|0|||
13095445|NCT03595332|25840391|FG001|Overall Study|Unable to retrieve ID from school|2|||
13095446|NCT03595280|25840427|FG000|Overall Study|Lost to Follow-up|6|||
13095447|NCT03595280|25840428|FG001|Overall Study|Lost to Follow-up|9|||
13095448|NCT03595280|25840429|FG002|Overall Study|Lost to Follow-up|15|||
13095449|NCT03595176|25840495|FG000|Overall Study|Death|0|||
13095450|NCT03595176|25840496|FG001|Overall Study|Death|2|||
13095451|NCT03595176|25840495|FG000|Overall Study|Lost to Follow-up|0|||
13095452|NCT03595176|25840496|FG001|Overall Study|Lost to Follow-up|1|||
13095453|NCT03594227|25840643|FG000|Overall Study|Adverse Event|2|||
13095454|NCT03594227|25840644|FG001|Overall Study|Adverse Event|1|||
13095455|NCT03594227|25840645|FG002|Overall Study|Adverse Event|0|||
13095456|NCT03594227|25840646|FG003|Overall Study|Adverse Event|2|||
13095457|NCT03594227|25840643|FG000|Overall Study|Lost to Follow-up|1|||
13485227|NCT02880241|27032093|FG000|Overall Study|Lack of Efficacy|1|||
13485228|NCT02880241|27032094|FG001|Overall Study|Lack of Efficacy|0|||
13485229|NCT02880241|27032095|FG002|Overall Study|Lack of Efficacy|0|||
13485230|NCT02880241|27032096|FG003|Overall Study|Lack of Efficacy|0|||
13485231|NCT02880241|27032097|FG004|Overall Study|Lack of Efficacy|0|||
13485232|NCT02880241|27032098|FG005|Overall Study|Lack of Efficacy|0|||
13485233|NCT02832687|27032127|FG000|Overall Study|Adverse Event|0|||
13485234|NCT02832687|27032128|FG001|Overall Study|Adverse Event|2|||
13485235|NCT02499900|27032164|FG000|Core Study Period|Other|1|||
13095458|NCT03594227|25840644|FG001|Overall Study|Lost to Follow-up|1|||
13095459|NCT03594227|25840645|FG002|Overall Study|Lost to Follow-up|1|||
13095460|NCT03594227|25840646|FG003|Overall Study|Lost to Follow-up|0|||
13095461|NCT03594227|25840643|FG000|Overall Study|Withdrawal by Subject|1|||
13095462|NCT03594227|25840644|FG001|Overall Study|Withdrawal by Subject|1|||
13095463|NCT03594227|25840645|FG002|Overall Study|Withdrawal by Subject|1|||
13095464|NCT03594227|25840646|FG003|Overall Study|Withdrawal by Subject|1|||
13095465|NCT03594227|25840643|FG000|Overall Study|Pregnancy|0|||
13095466|NCT03594227|25840644|FG001|Overall Study|Pregnancy|1|||
13095467|NCT03594227|25840645|FG002|Overall Study|Pregnancy|0|||
13095468|NCT03594227|25840646|FG003|Overall Study|Pregnancy|0|||
13095469|NCT03594227|25840643|FG000|Overall Study|Sponsor Decision|0|||
13095470|NCT03594227|25840644|FG001|Overall Study|Sponsor Decision|0|||
13095471|NCT03594227|25840645|FG002|Overall Study|Sponsor Decision|0|||
13095472|NCT03594227|25840646|FG003|Overall Study|Sponsor Decision|1|||
13095473|NCT03594227|25840643|FG000|Overall Study|Programmatic Analysis Non-completer|1|||
13095474|NCT03594227|25840644|FG001|Overall Study|Programmatic Analysis Non-completer|0|||
13095475|NCT03594227|25840645|FG002|Overall Study|Programmatic Analysis Non-completer|1|||
13095476|NCT03594227|25840646|FG003|Overall Study|Programmatic Analysis Non-completer|1|||
13095477|NCT03594071|25840659|FG000|Overall Study|Re-operation|3|||
13095478|NCT03594071|25840659|FG000|Overall Study|Missed visit|2|||
13095479|NCT03593915|25840710|FG000|Overall Study|Adverse Event|0|||
13095480|NCT03593915|25840711|FG001|Overall Study|Adverse Event|0|||
13095481|NCT03593915|25840712|FG002|Overall Study|Adverse Event|0|||
13095482|NCT03593915|25840713|FG003|Overall Study|Adverse Event|1|||
13095483|NCT03593915|25840714|FG004|Overall Study|Adverse Event|0|||
13095484|NCT03593915|25840715|FG005|Overall Study|Adverse Event|0|||
13095485|NCT03593915|25840710|FG000|Overall Study|Physician Decision|0|||
13095486|NCT03593915|25840711|FG001|Overall Study|Physician Decision|0|||
13095487|NCT03593915|25840712|FG002|Overall Study|Physician Decision|0|||
13095488|NCT03593915|25840713|FG003|Overall Study|Physician Decision|0|||
13095489|NCT03593915|25840714|FG004|Overall Study|Physician Decision|0|||
13095490|NCT03593915|25840715|FG005|Overall Study|Physician Decision|1|||
13095491|NCT03593876|25840723|FG000|Overall Study|Withdrawal by Subject|1|||
13095492|NCT03593876|25840723|FG000|Overall Study|Discharged home before intervention completion|2|||
13095493|NCT03593681|25840748|FG000|Overall Study|Inadequate sample collected|12|||
13095494|NCT03593681|25840748|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11|||
13095495|NCT03593681|25840748|FG000|Overall Study|Protocol Violation|3|||
13095496|NCT03593681|25840748|FG000|Overall Study|Withdrawal by Subject|3|||
13095497|NCT03593681|25840748|FG000|Overall Study|Procedure not attempted|3|||
13095498|NCT03593681|25840748|FG000|Overall Study|Adverse Event|2|||
13095499|NCT03593681|25840748|FG000|Overall Study|Physician Decision|1|||
13095500|NCT03592745|25840763|FG000|Overall Study|Adverse Event|0|||
13095501|NCT03592745|25840764|FG001|Overall Study|Adverse Event|2|||
13095502|NCT03592745|25840763|FG000|Overall Study|Lost to Follow-up|2|||
13095503|NCT03592745|25840764|FG001|Overall Study|Lost to Follow-up|0|||
13095504|NCT03592745|25840763|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1|||
13095505|NCT03592745|25840764|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1|||
13095506|NCT03592277|25840787|FG000|Overall Study|Withdrawal by Subject|6|||
13095507|NCT03592277|25840788|FG001|Overall Study|Withdrawal by Subject|8|||
13149831|NCT02561195|26045254|FG010|Vaccination 1 to 3|Protocol Violation|0|||
13485236|NCT02499900|27032165|FG001|Core Study Period|Other|4|||
13485237|NCT02499900|27032164|FG000|Core Study Period|Lost to Follow-up|1|||
13485238|NCT02499900|27032165|FG001|Core Study Period|Lost to Follow-up|2|||
13095508|NCT03591874|25840805|FG000|Overall Study|Adverse Event|4|||
13095509|NCT03591874|25840806|FG001|Overall Study|Adverse Event|0|||
13149832|NCT02561195|26045255|FG011|Vaccination 1 to 3|Protocol Violation|0|||
13149833|NCT02561195|26045256|FG012|Vaccination 1 to 3|Protocol Violation|0|||
13149834|NCT02561195|26045257|FG013|Vaccination 1 to 3|Protocol Violation|0|||
13149835|NCT02561195|26045244|FG000|Vaccination 1 to 3|Death|2|||
13149836|NCT02561195|26045245|FG001|Vaccination 1 to 3|Death|1|||
13149837|NCT02561195|26045246|FG002|Vaccination 1 to 3|Death|0|||
13149838|NCT02561195|26045247|FG003|Vaccination 1 to 3|Death|2|||
13149839|NCT02561195|26045248|FG004|Vaccination 1 to 3|Death|0|||
13149840|NCT02561195|26045249|FG005|Vaccination 1 to 3|Death|0|||
13149841|NCT02561195|26045250|FG006|Vaccination 1 to 3|Death|0|||
13095510|NCT03591874|25840805|FG000|Overall Study|Withdrawal by Subject|2|||
13095511|NCT03591874|25840806|FG001|Overall Study|Withdrawal by Subject|1|||
13095512|NCT03591874|25840805|FG000|Overall Study|Investigator Withdrawal of Subject|1|||
13095513|NCT03591874|25840806|FG001|Overall Study|Investigator Withdrawal of Subject|0|||
13095514|NCT03591874|25840805|FG000|Overall Study|On Study at Time of Study Termination|12|||
13095515|NCT03591874|25840806|FG001|Overall Study|On Study at Time of Study Termination|6|||
13095516|NCT03591406|25840841|FG000|Overall Study|Adverse Event|5|||
13095517|NCT03591406|25840842|FG001|Overall Study|Adverse Event|3|||
13095518|NCT03591406|25840841|FG000|Overall Study|Protocol Violation|2|||
13095519|NCT03591406|25840842|FG001|Overall Study|Protocol Violation|1|||
13095520|NCT03591406|25840841|FG000|Overall Study|Withdrawal by Subject|0|||
13095521|NCT03591406|25840842|FG001|Overall Study|Withdrawal by Subject|5|||
13095522|NCT03591146|25840870|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
13095523|NCT03591146|25840871|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
13095524|NCT03591146|25840872|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
13095525|NCT03591146|25840873|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
13095526|NCT03591146|25840874|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1|||
13095527|NCT03591146|25840870|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
13095528|NCT03591146|25840871|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1|||
13095529|NCT03591146|25840872|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
13095530|NCT03591146|25840873|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
13095531|NCT03591146|25840874|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
13095532|NCT03591146|25840870|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
13095533|NCT03591146|25840871|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
13095534|NCT03591146|25840872|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
13095535|NCT03591146|25840873|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
13095536|NCT03591146|25840874|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1|||
13095537|NCT03591146|25840870|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
13095538|NCT03591146|25840871|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
13095539|NCT03591146|25840872|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
13095540|NCT03591146|25840873|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
13095541|NCT03591146|25840874|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
13095542|NCT03590743|25840893|FG000|Overall Study|Withdrawal by Subject|0|||
13095543|NCT03590743|25840894|FG001|Overall Study|Withdrawal by Subject|1|||
13095544|NCT03590613|25841017|FG000|Period 2, 4 Days|Physician Decision|0|||
13095545|NCT03590613|25841018|FG001|Period 2, 4 Days|Physician Decision|0|||
13095546|NCT03590613|25841019|FG002|Period 2, 4 Days|Physician Decision|0|||
13095547|NCT03590613|25841020|FG003|Period 2, 4 Days|Physician Decision|1|||
13095548|NCT03590366|25841045|FG000|Overall Study|Adverse Event|0|||
13095549|NCT03590366|25841046|FG001|Overall Study|Adverse Event|3|||
13095550|NCT03590366|25841045|FG000|Overall Study|Lost to Follow-up|3|||
13095551|NCT03590366|25841046|FG001|Overall Study|Lost to Follow-up|3|||
13095552|NCT03590366|25841045|FG000|Overall Study|Withdrawal by Subject|0|||
13095553|NCT03590366|25841046|FG001|Overall Study|Withdrawal by Subject|2|||
13095554|NCT03589885|25841086|FG000|Treatment Period 1-Randomized Set|Adverse Event|0|||
13095555|NCT03589885|25841087|FG001|Treatment Period 1-Randomized Set|Adverse Event|1|||
13095556|NCT03589885|25841088|FG002|Treatment Period 1-Randomized Set|Adverse Event|0|||
13095557|NCT03589885|25841089|FG003|Treatment Period 1-Randomized Set|Adverse Event|0|||
13095558|NCT03589885|25841090|FG004|Treatment Period 1-Randomized Set|Adverse Event|0|||
13095559|NCT03589885|25841086|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
13095560|NCT03589885|25841087|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
13095561|NCT03589885|25841088|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2|||
13095562|NCT03589885|25841089|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
13095563|NCT03589885|25841090|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
13095564|NCT03589885|25841086|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
13095565|NCT03589885|25841087|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1|||
13095566|NCT03589885|25841088|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
13095567|NCT03589885|25841089|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
13095568|NCT03589885|25841090|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
13149842|NCT02561195|26045251|FG007|Vaccination 1 to 3|Death|0|||
13149843|NCT02561195|26045252|FG008|Vaccination 1 to 3|Death|0|||
13095569|NCT03589885|25841086|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
13095570|NCT03589885|25841087|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
13095571|NCT03589885|25841088|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1|||
13095572|NCT03589885|25841089|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
13095573|NCT03589885|25841090|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
13095574|NCT03589885|25841086|FG000|Treatment Period 2-Randomized Set|Adverse Event|0|||
13095575|NCT03589885|25841087|FG001|Treatment Period 2-Randomized Set|Adverse Event|1|||
13095576|NCT03589885|25841088|FG002|Treatment Period 2-Randomized Set|Adverse Event|0|||
13095577|NCT03589885|25841089|FG003|Treatment Period 2-Randomized Set|Adverse Event|0|||
13095578|NCT03589885|25841090|FG004|Treatment Period 2-Randomized Set|Adverse Event|0|||
13095579|NCT03589885|25841086|FG000|Treatment Period 2-Randomized Set|Pregnancy|1|||
13095580|NCT03589885|25841087|FG001|Treatment Period 2-Randomized Set|Pregnancy|0|||
13095581|NCT03589885|25841088|FG002|Treatment Period 2-Randomized Set|Pregnancy|0|||
13095582|NCT03589885|25841089|FG003|Treatment Period 2-Randomized Set|Pregnancy|0|||
13095583|NCT03589885|25841090|FG004|Treatment Period 2-Randomized Set|Pregnancy|0|||
13095584|NCT03589885|25841086|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
13095585|NCT03589885|25841087|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3|||
13095586|NCT03589885|25841088|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
13095587|NCT03589885|25841089|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
13095588|NCT03589885|25841090|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
13095589|NCT03589885|25841086|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
13095590|NCT03589885|25841087|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1|||
13095591|NCT03589885|25841088|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
13095592|NCT03589885|25841089|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
13095593|NCT03589885|25841090|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
13095594|NCT03589807|25841453|FG000|Overall Study|Lost to Follow-up|0|||
13095595|NCT03589807|25841454|FG001|Overall Study|Lost to Follow-up|2|||
13095596|NCT03589807|25841455|FG002|Overall Study|Lost to Follow-up|2|||
13095597|NCT03589807|25841456|FG003|Overall Study|Lost to Follow-up|3|||
13095598|NCT03589807|25841457|FG004|Overall Study|Lost to Follow-up|1|||
13095599|NCT03589807|25841458|FG005|Overall Study|Lost to Follow-up|1|||
13095600|NCT03589807|25841453|FG000|Overall Study|Withdrawal by Subject|0|||
13095601|NCT03589807|25841454|FG001|Overall Study|Withdrawal by Subject|5|||
13095602|NCT03589807|25841455|FG002|Overall Study|Withdrawal by Subject|0|||
13095603|NCT03589807|25841456|FG003|Overall Study|Withdrawal by Subject|0|||
13095604|NCT03589807|25841457|FG004|Overall Study|Withdrawal by Subject|0|||
13095605|NCT03589807|25841458|FG005|Overall Study|Withdrawal by Subject|0|||
13095606|NCT03589807|25841453|FG000|Overall Study|Protocol Violation|0|||
13095607|NCT03589807|25841454|FG001|Overall Study|Protocol Violation|0|||
13095608|NCT03589807|25841455|FG002|Overall Study|Protocol Violation|0|||
13095609|NCT03589807|25841456|FG003|Overall Study|Protocol Violation|1|||
13095610|NCT03589807|25841457|FG004|Overall Study|Protocol Violation|0|||
13095611|NCT03589807|25841458|FG005|Overall Study|Protocol Violation|0|||
13095612|NCT03589807|25841453|FG000|Overall Study|Enrolled but treatment not administered|0|||
13095613|NCT03589807|25841454|FG001|Overall Study|Enrolled but treatment not administered|0|||
13095614|NCT03589807|25841455|FG002|Overall Study|Enrolled but treatment not administered|0|||
13095615|NCT03589807|25841456|FG003|Overall Study|Enrolled but treatment not administered|0|||
13095616|NCT03589807|25841457|FG004|Overall Study|Enrolled but treatment not administered|1|||
13095617|NCT03589807|25841458|FG005|Overall Study|Enrolled but treatment not administered|0|||
13095618|NCT03589469|25841484|FG000|Overall Study|Ongoing in study|58|||
13095619|NCT03589469|25841484|FG000|Overall Study|Withdrawal by Subject|6|||
13095620|NCT03589469|25841484|FG000|Overall Study|Physician Decision|1|||
13095621|NCT03589469|25841484|FG000|Overall Study|Death|77|||
13095622|NCT03589469|25841484|FG000|Overall Study|Lost to Follow-up|3|||
13095623|NCT03588910|25841505|FG000|Overall Study|Withdrawal by Subject|1|||
13095624|NCT03588910|25841506|FG001|Overall Study|Withdrawal by Subject|0|||
13095625|NCT03588910|25841505|FG000|Overall Study|Allergy|2|||
13095626|NCT03588910|25841506|FG001|Overall Study|Allergy|0|||
13095627|NCT03588910|25841505|FG000|Overall Study|Protocol Violation|0|||
13095628|NCT03588910|25841506|FG001|Overall Study|Protocol Violation|3|||
13095629|NCT03588910|25841505|FG000|Overall Study|Did not complete Day 1 Survey|5|||
13095630|NCT03588910|25841506|FG001|Overall Study|Did not complete Day 1 Survey|10|||
13095631|NCT03588910|25841505|FG000|Overall Study|Did not complete Day 7 Survey|5|||
13095632|NCT03588910|25841506|FG001|Overall Study|Did not complete Day 7 Survey|2|||
13095633|NCT03588741|25841513|FG000|Overall Study|Withdrawal by Subject|1|||
13095634|NCT03588572|25841536|FG000|Visitation 1|Lack of Efficacy|1|||
13095635|NCT03588572|25841537|FG001|Visitation 1|Lack of Efficacy|1|||
13095636|NCT03588572|25841536|FG000|Visitation 2|Lost to Follow-up|1|||
13095637|NCT03588572|25841537|FG001|Visitation 2|Lost to Follow-up|1|||
13095638|NCT03588572|25841536|FG000|Visitation 2|Lack of Efficacy|0|||
13095639|NCT03588572|25841537|FG001|Visitation 2|Lack of Efficacy|1|||
13095640|NCT03588572|25841536|FG000|Visitation 2|Withdrawal by Subject|1|||
13095641|NCT03588572|25841537|FG001|Visitation 2|Withdrawal by Subject|0|||
13095642|NCT03588572|25841536|FG000|Visitation 3|Lost to Follow-up|1|||
13095643|NCT03588572|25841537|FG001|Visitation 3|Lost to Follow-up|1|||
13095644|NCT03588572|25841536|FG000|Visitation 3|Physician Decision|1|||
13095645|NCT03588572|25841537|FG001|Visitation 3|Physician Decision|1|||
13095646|NCT03588572|25841536|FG000|Visitation 3|Withdrawal by Subject|1|||
13095647|NCT03588572|25841537|FG001|Visitation 3|Withdrawal by Subject|0|||
13095648|NCT03587974|25841554|FG000|Overall Study|caregiver demented, care recipient died|3|||
13095649|NCT03587974|25841555|FG001|Overall Study|caregiver demented, care recipient died|3|||
13095650|NCT03587974|25841554|FG000|Overall Study|Withdrawal by Subject|2|||
13095651|NCT03587974|25841555|FG001|Overall Study|Withdrawal by Subject|1|||
13095652|NCT03587636|25841570|FG000|Overall Study|Lost to Follow-up|2|||
13095653|NCT03587636|25841571|FG001|Overall Study|Lost to Follow-up|5|||
13095654|NCT03587584|25841584|FG000|Overall Study|SOC deviations|4|||
13095655|NCT03587584|25841585|FG001|Overall Study|SOC deviations|6|||
13095656|NCT03587584|25841584|FG000|Overall Study|Incomplete data|0|||
13095657|NCT03587584|25841585|FG001|Overall Study|Incomplete data|3|||
13095658|NCT03586830|25841620|FG000|Overall Study|Site terminated by Sponsor|1|||
13095659|NCT03586830|25841621|FG001|Overall Study|Site terminated by Sponsor|4|||
13095660|NCT03586830|25841622|FG002|Overall Study|Site terminated by Sponsor|3|||
13095661|NCT03586830|25841623|FG003|Overall Study|Site terminated by Sponsor|3|||
13095662|NCT03586830|25841620|FG000|Overall Study|Lost to Follow-up|0|||
13095663|NCT03586830|25841621|FG001|Overall Study|Lost to Follow-up|2|||
13095664|NCT03586830|25841622|FG002|Overall Study|Lost to Follow-up|2|||
13095665|NCT03586830|25841623|FG003|Overall Study|Lost to Follow-up|1|||
13095666|NCT03586830|25841620|FG000|Overall Study|Withdrawal by Subject|1|||
13095667|NCT03586830|25841621|FG001|Overall Study|Withdrawal by Subject|0|||
13095668|NCT03586830|25841622|FG002|Overall Study|Withdrawal by Subject|3|||
13095669|NCT03586830|25841623|FG003|Overall Study|Withdrawal by Subject|1|||
13095670|NCT03586726|25841642|FG000|Overall Study|Withdrawal by Subject|1|||
13095671|NCT03586648|25841653|FG000|Period 1|Withdrawal by Subject|0|||
13095672|NCT03586648|25841654|FG001|Period 1|Withdrawal by Subject|1|||
13095673|NCT03586648|25841653|FG000|Period 1|Lost to Follow-up|1|||
13095674|NCT03586648|25841654|FG001|Period 1|Lost to Follow-up|1|||
13095675|NCT03586648|25841653|FG000|Period 1|Adverse Event|1|||
13095676|NCT03586648|25841654|FG001|Period 1|Adverse Event|0|||
13095677|NCT03586648|25841653|FG000|Period 1|Study related symptoms or complaints|2|||
13095678|NCT03586648|25841654|FG001|Period 1|Study related symptoms or complaints|1|||
13095679|NCT03586648|25841653|FG000|Period 1|Physician Decision|0|||
13095680|NCT03586648|25841654|FG001|Period 1|Physician Decision|1|||
13095681|NCT03586648|25841653|FG000|Period 2|Adverse Event|1|||
13095682|NCT03586648|25841654|FG001|Period 2|Adverse Event|0|||
13095683|NCT03586544|25841667|FG000|First Intervention|Adverse Event|0|||
13095684|NCT03586544|25841668|FG001|First Intervention|Adverse Event|1|||
13095685|NCT03586544|25841667|FG000|Second Intervention|Withdrawal by Subject|0|||
13095686|NCT03586544|25841668|FG001|Second Intervention|Withdrawal by Subject|1|||
13095687|NCT03586427|25841701|FG000|Overall Study|Lost to Follow-up|0|||
13095688|NCT03586427|25841702|FG001|Overall Study|Lost to Follow-up|3|||
13095689|NCT03586427|25841703|FG002|Overall Study|Lost to Follow-up|1|||
13095690|NCT03586427|25841704|FG003|Overall Study|Lost to Follow-up|3|||
13095691|NCT03586427|25841705|FG004|Overall Study|Lost to Follow-up|3|||
13095692|NCT03586427|25841701|FG000|Overall Study|Withdrawal by Subject|0|||
13095693|NCT03586427|25841702|FG001|Overall Study|Withdrawal by Subject|1|||
13095694|NCT03586427|25841703|FG002|Overall Study|Withdrawal by Subject|2|||
13095695|NCT03586427|25841704|FG003|Overall Study|Withdrawal by Subject|1|||
13095696|NCT03586427|25841705|FG004|Overall Study|Withdrawal by Subject|1|||
13095697|NCT03586427|25841701|FG000|Overall Study|Adverse Event|0|||
13095698|NCT03586427|25841702|FG001|Overall Study|Adverse Event|0|||
13095699|NCT03586427|25841703|FG002|Overall Study|Adverse Event|1|||
13095700|NCT03586427|25841704|FG003|Overall Study|Adverse Event|0|||
13095701|NCT03586427|25841705|FG004|Overall Study|Adverse Event|0|||
13095702|NCT03586427|25841701|FG000|Overall Study|Protocol Violation|0|||
13095703|NCT03586427|25841702|FG001|Overall Study|Protocol Violation|0|||
13095704|NCT03586427|25841703|FG002|Overall Study|Protocol Violation|1|||
13095705|NCT03586427|25841704|FG003|Overall Study|Protocol Violation|0|||
13095706|NCT03586427|25841705|FG004|Overall Study|Protocol Violation|1|||
13095707|NCT03586427|25841701|FG000|Overall Study|Noncompliance with study drug|0|||
13095708|NCT03586427|25841702|FG001|Overall Study|Noncompliance with study drug|0|||
13095709|NCT03586427|25841703|FG002|Overall Study|Noncompliance with study drug|1|||
13095710|NCT03586427|25841704|FG003|Overall Study|Noncompliance with study drug|0|||
13095711|NCT03586427|25841705|FG004|Overall Study|Noncompliance with study drug|0|||
13095712|NCT03586167|25841718|FG000|Overall Study|Other|1|||
13095713|NCT03586167|25841719|FG001|Overall Study|Other|0|||
13095714|NCT03585959|25841741|FG000|Overall Study|Physician Decision|1|||
13095715|NCT03585959|25841741|FG000|Overall Study|Unsuccessful Procedure|2|||
13095716|NCT03585712|25841767|FG000|Treatment Period 1|Protocol Violation|1|||
13095717|NCT03585712|25841768|FG001|Treatment Period 1|Protocol Violation|0|||
13095718|NCT03585712|25841769|FG002|Treatment Period 1|Protocol Violation|0|||
13095719|NCT03585712|25841767|FG000|Treatment Periods 2 and 3|Protocol Violation|0|||
13095720|NCT03585712|25841768|FG001|Treatment Periods 2 and 3|Protocol Violation|1|||
13095721|NCT03585712|25841769|FG002|Treatment Periods 2 and 3|Protocol Violation|1|||
13095722|NCT03585712|25841767|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
13095723|NCT03585712|25841768|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2|||
13095724|NCT03585712|25841769|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
13095725|NCT03585712|25841767|FG000|Treatment Periods 2 and 3|Physician Decision|0|||
13095726|NCT03585712|25841768|FG001|Treatment Periods 2 and 3|Physician Decision|0|||
13095727|NCT03585712|25841769|FG002|Treatment Periods 2 and 3|Physician Decision|2|||
13095728|NCT03585504|25841786|FG000|Overall Study|Lost to Follow-up|26|||
13095729|NCT03585504|25841787|FG001|Overall Study|Lost to Follow-up|29|||
13095730|NCT03585296|25841793|FG000|Overall Study|Adverse Event|1|||
13095731|NCT03585296|25841793|FG000|Overall Study|Lost to Follow-up|2|||
13095732|NCT03585296|25841793|FG000|Overall Study|Withdrawal by Subject|2|||
13095733|NCT03585244|25841800|FG000|Overall Study|Withdrawal by Subject|15|||
13095734|NCT03584789|25841827|FG000|Overall Study|refused EHR permission|19|||
13095735|NCT03584789|25841828|FG001|Overall Study|refused EHR permission|28|||
13095736|NCT03584789|25841829|FG002|Overall Study|refused EHR permission|23|||
13095737|NCT03584789|25841827|FG000|Overall Study|patients tied to a provider who retired|0|||
13095738|NCT03584789|25841828|FG001|Overall Study|patients tied to a provider who retired|0|||
13095739|NCT03584789|25841829|FG002|Overall Study|patients tied to a provider who retired|3|||
13095740|NCT03584009|25841855|FG000|Overall Study|Death|25|||
13095741|NCT03584009|25841856|FG001|Overall Study|Death|18|||
13095742|NCT03584009|25841855|FG000|Overall Study|Lost to Follow-up|0|||
13095743|NCT03584009|25841856|FG001|Overall Study|Lost to Follow-up|1|||
13095744|NCT03584009|25841855|FG000|Overall Study|Physician Decision|1|||
13095745|NCT03584009|25841856|FG001|Overall Study|Physician Decision|1|||
13095746|NCT03584009|25841855|FG000|Overall Study|Study Terminated by Sponsor|22|||
13095747|NCT03584009|25841856|FG001|Overall Study|Study Terminated by Sponsor|30|||
13095748|NCT03584009|25841855|FG000|Overall Study|Withdrawal by Subject|3|||
13095749|NCT03584009|25841856|FG001|Overall Study|Withdrawal by Subject|2|||
13095750|NCT03583606|25841967|FG000|Overall Study|Lost to Follow-up|0|||
13095751|NCT03583606|25841968|FG001|Overall Study|Lost to Follow-up|1|||
13095752|NCT03583606|25841969|FG002|Overall Study|Lost to Follow-up|0|||
13095753|NCT03583606|25841967|FG000|Overall Study|Ineligible at baseline|1|||
13095754|NCT03583606|25841968|FG001|Overall Study|Ineligible at baseline|0|||
13095755|NCT03583606|25841969|FG002|Overall Study|Ineligible at baseline|0|||
13095756|NCT03583554|25841999|FG000|Period 2|Did not receive treatment due to loss of contact|1|||
13095757|NCT03583554|25842000|FG001|Period 2|Did not receive treatment due to loss of contact|0|||
13095758|NCT03583554|25842001|FG002|Period 2|Did not receive treatment due to loss of contact|1|||
13095759|NCT03583450|25842030|FG000|Overall Study|hardware malfunction (battery depletion)|1|||
13149844|NCT02561195|26045253|FG009|Vaccination 1 to 3|Death|0|||
13149845|NCT02561195|26045254|FG010|Vaccination 1 to 3|Death|0|||
13149846|NCT02561195|26045255|FG011|Vaccination 1 to 3|Death|0|||
13149847|NCT02561195|26045256|FG012|Vaccination 1 to 3|Death|0|||
13095760|NCT03583450|25842031|FG001|Overall Study|hardware malfunction (battery depletion)|0|||
13095761|NCT03583385|25842050|FG000|Treatment Period 1|Withdrawal by Subject|1|||
13095762|NCT03583385|25842051|FG001|Treatment Period 1|Withdrawal by Subject|1|||
13095763|NCT03583385|25842050|FG000|Treatment Period 2|Adverse Event|1|||
13095764|NCT03583385|25842051|FG001|Treatment Period 2|Adverse Event|0|||
13095765|NCT03583372|25842078|FG000|Overall Study|Withdrawal by Subject|6|||
13095766|NCT03583372|25842079|FG001|Overall Study|Withdrawal by Subject|11|||
13095767|NCT03583372|25842080|FG002|Overall Study|Withdrawal by Subject|7|||
13095768|NCT03583372|25842081|FG003|Overall Study|Withdrawal by Subject|8|||
13095769|NCT03583372|25842078|FG000|Overall Study|Lost to Follow-up|4|||
13095770|NCT03583372|25842079|FG001|Overall Study|Lost to Follow-up|6|||
13095771|NCT03583372|25842080|FG002|Overall Study|Lost to Follow-up|3|||
13095772|NCT03583372|25842081|FG003|Overall Study|Lost to Follow-up|2|||
13149848|NCT02561195|26045257|FG013|Vaccination 1 to 3|Death|0|||
13149849|NCT02561195|26045244|FG000|Vaccination 1 to 3|Withdrawal by Subject|3|||
13149850|NCT02561195|26045245|FG001|Vaccination 1 to 3|Withdrawal by Subject|4|||
13149851|NCT02561195|26045246|FG002|Vaccination 1 to 3|Withdrawal by Subject|4|||
13149852|NCT02561195|26045247|FG003|Vaccination 1 to 3|Withdrawal by Subject|2|||
13149853|NCT02561195|26045248|FG004|Vaccination 1 to 3|Withdrawal by Subject|6|||
13149854|NCT02561195|26045249|FG005|Vaccination 1 to 3|Withdrawal by Subject|0|||
13149855|NCT02561195|26045250|FG006|Vaccination 1 to 3|Withdrawal by Subject|0|||
13149856|NCT02561195|26045251|FG007|Vaccination 1 to 3|Withdrawal by Subject|0|||
13149857|NCT02561195|26045252|FG008|Vaccination 1 to 3|Withdrawal by Subject|0|||
13149858|NCT02561195|26045253|FG009|Vaccination 1 to 3|Withdrawal by Subject|0|||
13149859|NCT02561195|26045254|FG010|Vaccination 1 to 3|Withdrawal by Subject|0|||
13149860|NCT02561195|26045255|FG011|Vaccination 1 to 3|Withdrawal by Subject|0|||
13149861|NCT02561195|26045256|FG012|Vaccination 1 to 3|Withdrawal by Subject|0|||
13149862|NCT02561195|26045257|FG013|Vaccination 1 to 3|Withdrawal by Subject|0|||
13095773|NCT03583372|25842078|FG000|Overall Study|Adverse Event|1|||
13095774|NCT03583372|25842079|FG001|Overall Study|Adverse Event|3|||
13095775|NCT03583372|25842080|FG002|Overall Study|Adverse Event|4|||
13095776|NCT03583372|25842081|FG003|Overall Study|Adverse Event|4|||
13149863|NCT02561195|26045244|FG000|Vaccination 1 to 3|Randomized but not treated|1|||
13149864|NCT02561195|26045245|FG001|Vaccination 1 to 3|Randomized but not treated|0|||
13149865|NCT02561195|26045246|FG002|Vaccination 1 to 3|Randomized but not treated|0|||
13149866|NCT02561195|26045247|FG003|Vaccination 1 to 3|Randomized but not treated|0|||
13149867|NCT02561195|26045248|FG004|Vaccination 1 to 3|Randomized but not treated|0|||
13149868|NCT02561195|26045249|FG005|Vaccination 1 to 3|Randomized but not treated|0|||
13149869|NCT02561195|26045250|FG006|Vaccination 1 to 3|Randomized but not treated|0|||
13149870|NCT02561195|26045251|FG007|Vaccination 1 to 3|Randomized but not treated|0|||
13149871|NCT02561195|26045252|FG008|Vaccination 1 to 3|Randomized but not treated|0|||
13095777|NCT03583372|25842078|FG000|Overall Study|Physician Decision|0|||
13095778|NCT03583372|25842079|FG001|Overall Study|Physician Decision|1|||
13095779|NCT03583372|25842080|FG002|Overall Study|Physician Decision|1|||
13095780|NCT03583372|25842081|FG003|Overall Study|Physician Decision|1|||
13095781|NCT03583372|25842078|FG000|Overall Study|Lack of Efficacy|0|||
13095782|NCT03583372|25842079|FG001|Overall Study|Lack of Efficacy|1|||
13095783|NCT03583372|25842080|FG002|Overall Study|Lack of Efficacy|0|||
13095784|NCT03583372|25842081|FG003|Overall Study|Lack of Efficacy|1|||
13095785|NCT03583372|25842078|FG000|Overall Study|Death|1|||
13095786|NCT03583372|25842079|FG001|Overall Study|Death|0|||
13095787|NCT03583372|25842080|FG002|Overall Study|Death|0|||
13095788|NCT03583372|25842081|FG003|Overall Study|Death|0|||
13095789|NCT03583372|25842078|FG000|Overall Study|Protocol Violation|0|||
13095790|NCT03583372|25842079|FG001|Overall Study|Protocol Violation|1|||
13095791|NCT03583372|25842080|FG002|Overall Study|Protocol Violation|0|||
13095792|NCT03583372|25842081|FG003|Overall Study|Protocol Violation|0|||
13095793|NCT03583372|25842078|FG000|Overall Study|Subject Withdrawn due to Sponsor|0|||
13095794|NCT03583372|25842079|FG001|Overall Study|Subject Withdrawn due to Sponsor|0|||
13095795|NCT03583372|25842080|FG002|Overall Study|Subject Withdrawn due to Sponsor|0|||
13095796|NCT03583372|25842081|FG003|Overall Study|Subject Withdrawn due to Sponsor|1|||
13095797|NCT03583372|25842078|FG000|Overall Study|Did Not Receive Study Drug|0|||
13095798|NCT03583372|25842079|FG001|Overall Study|Did Not Receive Study Drug|1|||
13095799|NCT03583372|25842080|FG002|Overall Study|Did Not Receive Study Drug|0|||
13095800|NCT03583372|25842081|FG003|Overall Study|Did Not Receive Study Drug|0|||
13095801|NCT03583372|25842078|FG000|Overall Study|Captured as Other in the Database|1|||
13095802|NCT03583372|25842079|FG001|Overall Study|Captured as Other in the Database|2|||
13095803|NCT03583372|25842080|FG002|Overall Study|Captured as Other in the Database|4|||
13095804|NCT03583372|25842081|FG003|Overall Study|Captured as Other in the Database|1|||
13095805|NCT03583359|25842102|FG000|Overall Study|Withdrawal by Subject|15|||
13095806|NCT03583359|25842103|FG001|Overall Study|Withdrawal by Subject|6|||
13095807|NCT03583359|25842102|FG000|Overall Study|Lost to Follow-up|12|||
13095808|NCT03583359|25842103|FG001|Overall Study|Lost to Follow-up|3|||
13095809|NCT03583359|25842102|FG000|Overall Study|Adverse Event|0|||
13095810|NCT03583359|25842103|FG001|Overall Study|Adverse Event|1|||
13095811|NCT03583359|25842102|FG000|Overall Study|Protocol Violation|0|||
13095812|NCT03583359|25842103|FG001|Overall Study|Protocol Violation|1|||
13095813|NCT03583359|25842102|FG000|Overall Study|Other|2|||
13095814|NCT03583359|25842103|FG001|Overall Study|Other|1|||
13095815|NCT03582943|25842116|FG000|Allocated to Groups|Withdrawal by Subject|1|||
13149872|NCT02561195|26045253|FG009|Vaccination 1 to 3|Randomized but not treated|0|||
13149873|NCT02561195|26045254|FG010|Vaccination 1 to 3|Randomized but not treated|0|||
13149874|NCT02561195|26045255|FG011|Vaccination 1 to 3|Randomized but not treated|0|||
13149875|NCT02561195|26045256|FG012|Vaccination 1 to 3|Randomized but not treated|0|||
13149876|NCT02561195|26045257|FG013|Vaccination 1 to 3|Randomized but not treated|0|||
13149877|NCT02561195|26045244|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0|||
13149878|NCT02561195|26045245|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0|||
13149879|NCT02561195|26045246|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0|||
13149880|NCT02561195|26045247|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0|||
13149881|NCT02561195|26045248|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0|||
13149882|NCT02561195|26045249|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0|||
13149883|NCT02561195|26045250|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0|||
13149884|NCT02561195|26045251|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0|||
13149885|NCT02561195|26045252|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3|||
13149886|NCT02561195|26045253|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1|||
13149887|NCT02561195|26045254|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2|||
13149888|NCT02561195|26045255|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2|||
13149889|NCT02561195|26045256|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3|||
13149890|NCT02561195|26045257|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0|||
13149891|NCT02561195|26045244|FG000|Extension Stage (Vaccination 4)|Adverse Event|0|||
13149892|NCT02561195|26045245|FG001|Extension Stage (Vaccination 4)|Adverse Event|0|||
13149893|NCT02561195|26045246|FG002|Extension Stage (Vaccination 4)|Adverse Event|0|||
13149894|NCT02561195|26045247|FG003|Extension Stage (Vaccination 4)|Adverse Event|0|||
13149895|NCT02561195|26045248|FG004|Extension Stage (Vaccination 4)|Adverse Event|0|||
13149896|NCT02561195|26045249|FG005|Extension Stage (Vaccination 4)|Adverse Event|0|||
13095816|NCT03582943|25842117|FG001|Allocated to Groups|Withdrawal by Subject|1|||
13149897|NCT02561195|26045250|FG006|Extension Stage (Vaccination 4)|Adverse Event|0|||
13149898|NCT02561195|26045251|FG007|Extension Stage (Vaccination 4)|Adverse Event|0|||
13149899|NCT02561195|26045252|FG008|Extension Stage (Vaccination 4)|Adverse Event|0|||
13149900|NCT02561195|26045253|FG009|Extension Stage (Vaccination 4)|Adverse Event|0|||
13149901|NCT02561195|26045254|FG010|Extension Stage (Vaccination 4)|Adverse Event|0|||
13149902|NCT02561195|26045255|FG011|Extension Stage (Vaccination 4)|Adverse Event|0|||
13149903|NCT02561195|26045256|FG012|Extension Stage (Vaccination 4)|Adverse Event|0|||
13149904|NCT02561195|26045257|FG013|Extension Stage (Vaccination 4)|Adverse Event|2|||
13149905|NCT02561195|26045244|FG000|Extension Stage (Vaccination 4)|Death|0|||
13149906|NCT02561195|26045245|FG001|Extension Stage (Vaccination 4)|Death|0|||
13095817|NCT03582943|25842116|FG000|Intervention and Follow up|Withdrawal by Subject|4|||
13095818|NCT03582943|25842117|FG001|Intervention and Follow up|Withdrawal by Subject|2|||
13095819|NCT03582943|25842116|FG000|Analyzed|Protocol Violation|4|||
13095820|NCT03582943|25842117|FG001|Analyzed|Protocol Violation|1|||
13095821|NCT03582826|25842139|FG000|Overall Study|Lost to Follow-up|39|||
13095822|NCT03582826|25842140|FG001|Overall Study|Lost to Follow-up|0|||
13095823|NCT03582826|25842139|FG000|Overall Study|Withdrawal by Subject|2|||
13095824|NCT03582826|25842140|FG001|Overall Study|Withdrawal by Subject|0|||
13095825|NCT03582813|25842165|FG000|Overall Study|Lost to Follow-up|18|||
13095826|NCT03582813|25842166|FG001|Overall Study|Lost to Follow-up|21|||
13095827|NCT03582813|25842165|FG000|Overall Study|Withdrawal by Subject|1|||
13095828|NCT03582813|25842166|FG001|Overall Study|Withdrawal by Subject|0|||
13095829|NCT03582215|25842232|FG000|Overall Study|Adverse Event|1|||
13095830|NCT03582215|25842233|FG001|Overall Study|Adverse Event|0|||
13095831|NCT03582215|25842234|FG002|Overall Study|Adverse Event|0|||
13095832|NCT03582215|25842235|FG003|Overall Study|Adverse Event|0|||
13095833|NCT03582215|25842236|FG004|Overall Study|Adverse Event|0|||
13095834|NCT03582215|25842237|FG005|Overall Study|Adverse Event|0|||
13095835|NCT03582215|25842238|FG006|Overall Study|Adverse Event|2|||
13095836|NCT03582215|25842239|FG007|Overall Study|Adverse Event|2|||
13095837|NCT03581825|25842249|FG000|Period 1|Lens Discomfort|1|||
13095838|NCT03581825|25842250|FG001|Period 1|Lens Discomfort|0|||
13095839|NCT03581825|25842249|FG000|Period 2|Unsatisfactory Vision to Test|0|||
13095840|NCT03581825|25842250|FG001|Period 2|Unsatisfactory Vision to Test|1|||
13095841|NCT03581786|25842263|FG000|Overall Study|Death|17|||
13095842|NCT03581786|25842264|FG001|Overall Study|Death|12|||
13095843|NCT03581786|25842263|FG000|Overall Study|Withdrawal by Subject|2|||
13095844|NCT03581786|25842264|FG001|Overall Study|Withdrawal by Subject|4|||
13095845|NCT03581786|25842263|FG000|Overall Study|Lost to Follow-up|1|||
13095846|NCT03581786|25842264|FG001|Overall Study|Lost to Follow-up|0|||
13095847|NCT03581786|25842263|FG000|Overall Study|reason other than specified above|0|||
13095848|NCT03581786|25842264|FG001|Overall Study|reason other than specified above|1|||
13095849|NCT03581786|25842263|FG000|Overall Study|Ongoing in the study|123|||
13095850|NCT03581786|25842264|FG001|Overall Study|Ongoing in the study|129|||
13095851|NCT03580382|25842278|FG000|Overall Study|Early Termination of Study|0|||
13095852|NCT03580382|25842279|FG001|Overall Study|Early Termination of Study|3|||
13095853|NCT03579940|25842353|FG000|Period 2|Withdrawal by Subject|0|||
13095854|NCT03579940|25842354|FG001|Period 2|Withdrawal by Subject|0|||
13095855|NCT03579940|25842355|FG002|Period 2|Withdrawal by Subject|1|||
13095856|NCT03579940|25842356|FG003|Period 2|Withdrawal by Subject|0|||
13095857|NCT03579940|25842357|FG004|Period 2|Withdrawal by Subject|0|||
13095858|NCT03579940|25842358|FG005|Period 2|Withdrawal by Subject|0|||
13095859|NCT03579940|25842359|FG006|Period 2|Withdrawal by Subject|0|||
13095860|NCT03579940|25842360|FG007|Period 2|Withdrawal by Subject|0|||
13095861|NCT03579940|25842361|FG008|Period 2|Withdrawal by Subject|0|||
13095862|NCT03579940|25842362|FG009|Period 2|Withdrawal by Subject|0|||
13095863|NCT03579940|25842363|FG010|Period 2|Withdrawal by Subject|0|||
13095864|NCT03579719|25842382|FG000|Overall Study|Protocol deviation, pre-existent disease|1|||
13095865|NCT03579290|25842390|FG000|Overall Study|Lost to Follow-up|9|||
13095866|NCT03578809|25842445|FG000|Overall Study|Death|0|||
13095867|NCT03578809|25842446|FG001|Overall Study|Death|2|||
13095868|NCT03578809|25842447|FG002|Overall Study|Death|0|||
13095869|NCT03578809|25842448|FG003|Overall Study|Death|1|||
13095870|NCT03578809|25842445|FG000|Overall Study|Lost to Follow-up|0|||
13095871|NCT03578809|25842446|FG001|Overall Study|Lost to Follow-up|1|||
13095872|NCT03578809|25842447|FG002|Overall Study|Lost to Follow-up|0|||
13095873|NCT03578809|25842448|FG003|Overall Study|Lost to Follow-up|0|||
13095874|NCT03578809|25842445|FG000|Overall Study|Withdrawal by Subject|3|||
13095875|NCT03578809|25842446|FG001|Overall Study|Withdrawal by Subject|5|||
13095876|NCT03578809|25842447|FG002|Overall Study|Withdrawal by Subject|2|||
13095877|NCT03578809|25842448|FG003|Overall Study|Withdrawal by Subject|0|||
13095878|NCT03578809|25842445|FG000|Overall Study|Other|3|||
13095879|NCT03578809|25842446|FG001|Overall Study|Other|6|||
13095880|NCT03578809|25842447|FG002|Overall Study|Other|2|||
13095881|NCT03578809|25842448|FG003|Overall Study|Other|8|||
13095882|NCT03578146|25842529|FG000|Overall Study|Did Not Receive Treatment|1|||
13095883|NCT03578146|25842530|FG001|Overall Study|Did Not Receive Treatment|0|||
13095884|NCT03578146|25842531|FG002|Overall Study|Did Not Receive Treatment|0|||
13095885|NCT03578146|25842532|FG003|Overall Study|Did Not Receive Treatment|0|||
13095886|NCT03578146|25842533|FG004|Overall Study|Did Not Receive Treatment|0|||
13095887|NCT03578146|25842534|FG005|Overall Study|Did Not Receive Treatment|2|||
13095888|NCT03578146|25842529|FG000|Overall Study|Lost to Follow-up|0|||
13095889|NCT03578146|25842530|FG001|Overall Study|Lost to Follow-up|1|||
13095890|NCT03578146|25842531|FG002|Overall Study|Lost to Follow-up|1|||
13095891|NCT03578146|25842532|FG003|Overall Study|Lost to Follow-up|0|||
13095892|NCT03578146|25842533|FG004|Overall Study|Lost to Follow-up|0|||
13095893|NCT03578146|25842534|FG005|Overall Study|Lost to Follow-up|1|||
13095894|NCT03577730|25842567|FG000|Overall Study|Physician Decision|3|||
13095895|NCT03577730|25842568|FG001|Overall Study|Physician Decision|1|||
13095896|NCT03577730|25842567|FG000|Overall Study|Did not receive allocated intervention|1|||
13095897|NCT03577730|25842568|FG001|Overall Study|Did not receive allocated intervention|0|||
13095898|NCT03576768|25842599|FG000|Overall Study|Lost to Follow-up|3|||
13095899|NCT03576768|25842600|FG001|Overall Study|Lost to Follow-up|3|||
13095900|NCT03576768|25842601|FG002|Overall Study|Lost to Follow-up|0|||
13095901|NCT03576768|25842602|FG003|Overall Study|Lost to Follow-up|0|||
13095902|NCT03576066|25842641|FG000|Overall Study|Noncompliance with study drug|0|||
13095903|NCT03576066|25842642|FG001|Overall Study|Noncompliance with study drug|1|||
13132794|NCT02783729|25985189|FG003|Overall Study|Withdrawal by Subject|2|||
13132795|NCT02783729|25985186|FG000|Overall Study|Participant's choice|2|||
13132796|NCT02783729|25985187|FG001|Overall Study|Participant's choice|1|||
13132797|NCT02783729|25985188|FG002|Overall Study|Participant's choice|2|||
13132798|NCT02783729|25985189|FG003|Overall Study|Participant's choice|1|||
13132799|NCT02783729|25985186|FG000|Overall Study|Lost to Follow-up|2|||
13132800|NCT02783729|25985187|FG001|Overall Study|Lost to Follow-up|1|||
13132801|NCT02783729|25985188|FG002|Overall Study|Lost to Follow-up|1|||
13132802|NCT02783729|25985189|FG003|Overall Study|Lost to Follow-up|0|||
13132803|NCT02783599|25985204|FG000|Overall Study|Progressive disease|23|||
13132804|NCT02783599|25985204|FG000|Overall Study|Surgical Resection|10|||
13132805|NCT02783599|25985204|FG000|Overall Study|Adverse Event|4|||
13132806|NCT02783599|25985204|FG000|Overall Study|Physician Decision|2|||
13132807|NCT02783599|25985204|FG000|Overall Study|Death|1|||
13132808|NCT02783573|25985268|FG000|Placebo-Controlled Treatment Period|Adverse Event|13|||
13132809|NCT02783573|25985269|FG001|Placebo-Controlled Treatment Period|Adverse Event|17|||
13132810|NCT02783573|25985270|FG002|Placebo-Controlled Treatment Period|Adverse Event|13|||
13132811|NCT02783573|25985268|FG000|Placebo-Controlled Treatment Period|Death|4|||
13132812|NCT02783573|25985269|FG001|Placebo-Controlled Treatment Period|Death|2|||
13132813|NCT02783573|25985270|FG002|Placebo-Controlled Treatment Period|Death|3|||
13149907|NCT02561195|26045246|FG002|Extension Stage (Vaccination 4)|Death|0|||
13149908|NCT02561195|26045247|FG003|Extension Stage (Vaccination 4)|Death|0|||
13149909|NCT02561195|26045248|FG004|Extension Stage (Vaccination 4)|Death|0|||
13149910|NCT02561195|26045249|FG005|Extension Stage (Vaccination 4)|Death|0|||
13149911|NCT02561195|26045250|FG006|Extension Stage (Vaccination 4)|Death|0|||
13149912|NCT02561195|26045251|FG007|Extension Stage (Vaccination 4)|Death|0|||
13149913|NCT02561195|26045252|FG008|Extension Stage (Vaccination 4)|Death|0|||
13149914|NCT02561195|26045253|FG009|Extension Stage (Vaccination 4)|Death|1|||
13149915|NCT02561195|26045254|FG010|Extension Stage (Vaccination 4)|Death|0|||
13149916|NCT02561195|26045255|FG011|Extension Stage (Vaccination 4)|Death|0|||
13149917|NCT02561195|26045256|FG012|Extension Stage (Vaccination 4)|Death|0|||
13149918|NCT02561195|26045257|FG013|Extension Stage (Vaccination 4)|Death|0|||
13149919|NCT02561195|26045244|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
13149920|NCT02561195|26045245|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
13149921|NCT02561195|26045246|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
13149922|NCT02561195|26045247|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
13149923|NCT02561195|26045248|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
13149924|NCT02561195|26045249|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
13149925|NCT02561195|26045250|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
13149926|NCT02561195|26045251|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
13149927|NCT02561195|26045252|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
13149928|NCT02561195|26045253|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
13149929|NCT02561195|26045254|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
13149930|NCT02561195|26045255|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
13149931|NCT02561195|26045256|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
13149932|NCT02561195|26045257|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
13149933|NCT02561195|26045244|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
13149934|NCT02561195|26045245|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
13149935|NCT02561195|26045246|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
13149936|NCT02561195|26045247|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
13132814|NCT02783573|25985268|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
13132815|NCT02783573|25985269|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
13132816|NCT02783573|25985270|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
13132817|NCT02783573|25985268|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
13149937|NCT02561195|26045248|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
13149938|NCT02561195|26045249|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
13149939|NCT02561195|26045250|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
13149940|NCT02561195|26045251|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
13149941|NCT02561195|26045252|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
13149942|NCT02561195|26045253|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
13149943|NCT02561195|26045254|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
13149944|NCT02561195|26045255|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
13205146|NCT01968031|26230942|FG000|Overall Study|Failed inclusion criteria|0|||
13095904|NCT03575975|25842660|FG000|Overall Study|Lost to Follow-up|1|||
13095905|NCT03575975|25842661|FG001|Overall Study|Lost to Follow-up|0|||
13095906|NCT03575975|25842662|FG002|Overall Study|Lost to Follow-up|0|||
13095907|NCT03575871|25842734|FG000|Overall Study|Adverse Event|5|||
13095908|NCT03575871|25842735|FG001|Overall Study|Adverse Event|5|||
13095909|NCT03575871|25842736|FG002|Overall Study|Adverse Event|8|||
13095910|NCT03575871|25842734|FG000|Overall Study|Death|1|||
13095911|NCT03575871|25842735|FG001|Overall Study|Death|0|||
13095912|NCT03575871|25842736|FG002|Overall Study|Death|0|||
13095913|NCT03575871|25842734|FG000|Overall Study|Lack of Efficacy|5|||
13095914|NCT03575871|25842735|FG001|Overall Study|Lack of Efficacy|4|||
13095915|NCT03575871|25842736|FG002|Overall Study|Lack of Efficacy|7|||
13095916|NCT03575871|25842734|FG000|Overall Study|Lost to Follow-up|1|||
13095917|NCT03575871|25842735|FG001|Overall Study|Lost to Follow-up|1|||
13095918|NCT03575871|25842736|FG002|Overall Study|Lost to Follow-up|1|||
13095919|NCT03575871|25842734|FG000|Overall Study|Protocol Deviation|1|||
13095920|NCT03575871|25842735|FG001|Overall Study|Protocol Deviation|1|||
13095921|NCT03575871|25842736|FG002|Overall Study|Protocol Deviation|1|||
13095922|NCT03575871|25842734|FG000|Overall Study|Withdrawal by Subject|6|||
13095923|NCT03575871|25842735|FG001|Overall Study|Withdrawal by Subject|1|||
13095924|NCT03575871|25842736|FG002|Overall Study|Withdrawal by Subject|9|||
13095925|NCT03575871|25842734|FG000|Overall Study|Other than specified|2|||
13095926|NCT03575871|25842735|FG001|Overall Study|Other than specified|2|||
13095927|NCT03575871|25842736|FG002|Overall Study|Other than specified|0|||
13095928|NCT03575806|25842751|FG000|Overall Study|Withdrawal by Subject|0|||
13095929|NCT03575806|25842752|FG001|Overall Study|Withdrawal by Subject|2|||
13095930|NCT03575806|25842751|FG000|Overall Study|Protocol Violation|0|||
13095931|NCT03575806|25842752|FG001|Overall Study|Protocol Violation|2|||
13095932|NCT03575702|25842793|FG000|Overall Study|Withdrawal by Subject|1|||
13095933|NCT03575702|25842794|FG001|Overall Study|Withdrawal by Subject|1|||
13095934|NCT03575702|25842793|FG000|Overall Study|Lost to Follow-up|1|||
13095935|NCT03575702|25842794|FG001|Overall Study|Lost to Follow-up|2|||
13095936|NCT03575702|25842793|FG000|Overall Study|Protocol Violation|0|||
13095937|NCT03575702|25842794|FG001|Overall Study|Protocol Violation|1|||
13095938|NCT03575702|25842793|FG000|Overall Study|Patient non compliance|4|||
13095939|NCT03575702|25842794|FG001|Overall Study|Patient non compliance|0|||
13095940|NCT03575468|25842811|FG000|Overall Study|Withdrawal by Subject|3|||
13095941|NCT03575468|25842812|FG001|Overall Study|Withdrawal by Subject|0|||
13095942|NCT03575468|25842811|FG000|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|10|||
13095943|NCT03575468|25842812|FG001|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|4|||
13095944|NCT03575468|25842811|FG000|Overall Study|Lost to Follow-up|13|||
13095945|NCT03575468|25842812|FG001|Overall Study|Lost to Follow-up|17|||
13095946|NCT03575065|25842843|FG000|Overall Study|Death|31|||
13095947|NCT03575065|25842844|FG001|Overall Study|Death|12|||
13095948|NCT03575065|25842843|FG000|Overall Study|Sponsor's Decision|28|||
13095949|NCT03575065|25842844|FG001|Overall Study|Sponsor's Decision|13|||
13095950|NCT03575065|25842843|FG000|Overall Study|Withdrawal by Subject|2|||
13095951|NCT03575065|25842844|FG001|Overall Study|Withdrawal by Subject|1|||
13095952|NCT03575065|25842843|FG000|Overall Study|Lost to Follow-up|1|||
13095953|NCT03575065|25842844|FG001|Overall Study|Lost to Follow-up|0|||
13095954|NCT03574753|25842857|FG000|Overall Study|Adverse Event|3|||
13095955|NCT03574753|25842857|FG000|Overall Study|Progression/relapse|19|||
13095956|NCT03574753|25842857|FG000|Overall Study|Death|1|||
13095957|NCT03573908|25842882|FG000|Treatment Period|Adverse Event|4|||
13095958|NCT03573908|25842883|FG001|Treatment Period|Adverse Event|9|||
13095959|NCT03573908|25842884|FG002|Treatment Period|Adverse Event|0|||
13095960|NCT03573908|25842885|FG003|Treatment Period|Adverse Event|0|||
13095961|NCT03573908|25842886|FG004|Treatment Period|Adverse Event|0|||
13095962|NCT03573908|25842882|FG000|Treatment Period|Protocol Violation|1|||
13095963|NCT03573908|25842883|FG001|Treatment Period|Protocol Violation|0|||
13095964|NCT03573908|25842884|FG002|Treatment Period|Protocol Violation|0|||
13095965|NCT03573908|25842885|FG003|Treatment Period|Protocol Violation|0|||
13095966|NCT03573908|25842886|FG004|Treatment Period|Protocol Violation|0|||
13095967|NCT03573908|25842882|FG000|Treatment Period|Withdrawal by Subject|7|||
13095968|NCT03573908|25842883|FG001|Treatment Period|Withdrawal by Subject|5|||
13095969|NCT03573908|25842884|FG002|Treatment Period|Withdrawal by Subject|0|||
13095970|NCT03573908|25842885|FG003|Treatment Period|Withdrawal by Subject|0|||
13095971|NCT03573908|25842886|FG004|Treatment Period|Withdrawal by Subject|0|||
13095972|NCT03573908|25842882|FG000|Treatment Period|Lost to Follow-up|7|||
13095973|NCT03573908|25842883|FG001|Treatment Period|Lost to Follow-up|6|||
13095974|NCT03573908|25842884|FG002|Treatment Period|Lost to Follow-up|0|||
13095975|NCT03573908|25842885|FG003|Treatment Period|Lost to Follow-up|0|||
13095976|NCT03573908|25842886|FG004|Treatment Period|Lost to Follow-up|0|||
13095977|NCT03573908|25842882|FG000|Treatment Period|Pregnancy|1|||
13095978|NCT03573908|25842883|FG001|Treatment Period|Pregnancy|0|||
13095979|NCT03573908|25842884|FG002|Treatment Period|Pregnancy|0|||
13095980|NCT03573908|25842885|FG003|Treatment Period|Pregnancy|0|||
13095981|NCT03573908|25842886|FG004|Treatment Period|Pregnancy|0|||
13095982|NCT03573908|25842882|FG000|Treatment Period|Other, Not Specified|4|||
13095983|NCT03573908|25842883|FG001|Treatment Period|Other, Not Specified|6|||
13095984|NCT03573908|25842884|FG002|Treatment Period|Other, Not Specified|0|||
13095985|NCT03573908|25842885|FG003|Treatment Period|Other, Not Specified|0|||
13095986|NCT03573908|25842886|FG004|Treatment Period|Other, Not Specified|0|||
13095987|NCT03573908|25842882|FG000|Randomized Withdrawal Period|Adverse Event|0|||
13095988|NCT03573908|25842883|FG001|Randomized Withdrawal Period|Adverse Event|0|||
13095989|NCT03573908|25842884|FG002|Randomized Withdrawal Period|Adverse Event|3|||
13095990|NCT03573908|25842885|FG003|Randomized Withdrawal Period|Adverse Event|0|||
13149945|NCT02561195|26045256|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
13149946|NCT02561195|26045257|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
13149947|NCT02561195|26045244|FG000|Extension Stage (Vaccination 4)|Other|0|||
13149948|NCT02561195|26045245|FG001|Extension Stage (Vaccination 4)|Other|0|||
13149949|NCT02561195|26045246|FG002|Extension Stage (Vaccination 4)|Other|0|||
13149950|NCT02561195|26045247|FG003|Extension Stage (Vaccination 4)|Other|0|||
13149951|NCT02561195|26045248|FG004|Extension Stage (Vaccination 4)|Other|0|||
13149952|NCT02561195|26045249|FG005|Extension Stage (Vaccination 4)|Other|0|||
13149953|NCT02561195|26045250|FG006|Extension Stage (Vaccination 4)|Other|0|||
13149954|NCT02561195|26045251|FG007|Extension Stage (Vaccination 4)|Other|0|||
13149955|NCT02561195|26045252|FG008|Extension Stage (Vaccination 4)|Other|0|||
13149956|NCT02561195|26045253|FG009|Extension Stage (Vaccination 4)|Other|0|||
13149957|NCT02561195|26045254|FG010|Extension Stage (Vaccination 4)|Other|2|||
13149958|NCT02561195|26045255|FG011|Extension Stage (Vaccination 4)|Other|2|||
13149959|NCT02561195|26045256|FG012|Extension Stage (Vaccination 4)|Other|1|||
13149960|NCT02561195|26045257|FG013|Extension Stage (Vaccination 4)|Other|0|||
13149961|NCT02561195|26045244|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0|||
13149962|NCT02561195|26045245|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0|||
13149963|NCT02561195|26045246|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0|||
13149964|NCT02561195|26045247|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0|||
13149965|NCT02561195|26045248|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0|||
13149966|NCT02561195|26045249|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0|||
13149967|NCT02561195|26045250|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1|||
13149968|NCT02561195|26045251|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0|||
13149969|NCT02561195|26045252|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0|||
13149970|NCT02561195|26045253|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0|||
13149971|NCT02561195|26045254|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2|||
13149972|NCT02561195|26045255|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1|||
13149973|NCT02561195|26045256|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0|||
13149974|NCT02561195|26045257|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1|||
13149975|NCT02561156|26045467|FG000|Part 2|Adverse Event|0|||
13149976|NCT02561156|26045468|FG001|Part 2|Adverse Event|0|||
13149977|NCT02561156|26045469|FG002|Part 2|Adverse Event|0|||
13149978|NCT02561156|26045470|FG003|Part 2|Adverse Event|0|||
13149979|NCT02561156|26045471|FG004|Part 2|Adverse Event|0|||
13149980|NCT02561156|26045472|FG005|Part 2|Adverse Event|0|||
13149981|NCT02561156|26045473|FG006|Part 2|Adverse Event|0|||
13149982|NCT02561156|26045474|FG007|Part 2|Adverse Event|0|||
13149983|NCT02561156|26045475|FG008|Part 2|Adverse Event|0|||
13149984|NCT02561156|26045476|FG009|Part 2|Adverse Event|0|||
13149985|NCT02561156|26045477|FG010|Part 2|Adverse Event|0|||
13149986|NCT02561156|26045478|FG011|Part 2|Adverse Event|1|||
13149987|NCT02561156|26045479|FG012|Part 2|Adverse Event|0|||
13149988|NCT02561078|26045508|FG000|Overall Study|Adverse Event|5|||
13095991|NCT03573908|25842886|FG004|Randomized Withdrawal Period|Adverse Event|0|||
13095992|NCT03573908|25842882|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
13095993|NCT03573908|25842883|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
13149989|NCT02561078|26045509|FG001|Overall Study|Adverse Event|2|||
13149990|NCT02561078|26045508|FG000|Overall Study|Death|2|||
13149991|NCT02561078|26045509|FG001|Overall Study|Death|1|||
13149992|NCT02561078|26045508|FG000|Overall Study|Lost to Follow-up|2|||
13149993|NCT02561078|26045509|FG001|Overall Study|Lost to Follow-up|6|||
13149994|NCT02561078|26045508|FG000|Overall Study|Non-Compliance with Study Drug|6|||
13149995|NCT02561078|26045509|FG001|Overall Study|Non-Compliance with Study Drug|3|||
13149996|NCT02561078|26045508|FG000|Overall Study|Physician Decision|2|||
13149997|NCT02561078|26045509|FG001|Overall Study|Physician Decision|3|||
13149998|NCT02561078|26045508|FG000|Overall Study|Withdrawal by Subject|13|||
13149999|NCT02561078|26045509|FG001|Overall Study|Withdrawal by Subject|10|||
13150000|NCT02561000|26045533|FG000|Overall Study|Withdrawal by Subject|2|||
13150001|NCT02561000|26045534|FG001|Overall Study|Withdrawal by Subject|3|||
13150002|NCT02561000|26045535|FG002|Overall Study|Withdrawal by Subject|0|||
13150003|NCT02561000|26045533|FG000|Overall Study|Adverse Event|0|||
13150004|NCT02561000|26045534|FG001|Overall Study|Adverse Event|1|||
13150005|NCT02561000|26045535|FG002|Overall Study|Adverse Event|0|||
13095994|NCT03573908|25842884|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
13095995|NCT03573908|25842885|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
13095996|NCT03573908|25842886|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2|||
13095997|NCT03573908|25842882|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
13095998|NCT03573908|25842883|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
13095999|NCT03573908|25842884|FG002|Randomized Withdrawal Period|Lost to Follow-up|1|||
13096000|NCT03573908|25842885|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
13096001|NCT03573908|25842886|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
13096002|NCT03573908|25842882|FG000|Randomized Withdrawal Period|Other, Not Specified|0|||
13096003|NCT03573908|25842883|FG001|Randomized Withdrawal Period|Other, Not Specified|0|||
13096004|NCT03573908|25842884|FG002|Randomized Withdrawal Period|Other, Not Specified|4|||
13096005|NCT03573908|25842885|FG003|Randomized Withdrawal Period|Other, Not Specified|2|||
13096006|NCT03573908|25842886|FG004|Randomized Withdrawal Period|Other, Not Specified|0|||
13096007|NCT03573830|25842914|FG000|Overall Study|Dropped without completing treatment|0|||
13096008|NCT03573830|25842915|FG001|Overall Study|Dropped without completing treatment|7|||
13096009|NCT03573830|25842914|FG000|Overall Study|Lost to Follow-up|4|||
13096010|NCT03573830|25842915|FG001|Overall Study|Lost to Follow-up|0|||
13096011|NCT03573804|25842931|FG000|Overall Study|claustrophobia or MRI table problems|10|||
13096012|NCT03573505|25842981|FG000|Overall Study|Adverse Event|1|||
13096013|NCT03573505|25842982|FG001|Overall Study|Adverse Event|1|||
13096014|NCT03573505|25842981|FG000|Overall Study|Consent withdrawn|0|||
13096015|NCT03573505|25842982|FG001|Overall Study|Consent withdrawn|1|||
13096016|NCT03573505|25842981|FG000|Overall Study|Disease progression|0|||
13096017|NCT03573505|25842982|FG001|Overall Study|Disease progression|1|||
13096018|NCT03573505|25842981|FG000|Overall Study|Site Terminated by Sponsor|1|||
13096019|NCT03573505|25842982|FG001|Overall Study|Site Terminated by Sponsor|1|||
13096020|NCT03573505|25842981|FG000|Overall Study|Study terminated by sponsor|50|||
13096021|NCT03573505|25842982|FG001|Overall Study|Study terminated by sponsor|45|||
13096022|NCT03573505|25842981|FG000|Overall Study|Reason not specified|0|||
13096023|NCT03573505|25842982|FG001|Overall Study|Reason not specified|1|||
13096024|NCT03573505|25842981|FG000|Overall Study|Death|0|||
13096025|NCT03573505|25842982|FG001|Overall Study|Death|4|||
13096026|NCT03573336|25843024|FG000|Overall Study|Study terminated|2|||
13096027|NCT03573336|25843025|FG001|Overall Study|Study terminated|4|||
13096028|NCT03573336|25843026|FG002|Overall Study|Study terminated|2|||
13096029|NCT03573323|25843057|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
13150006|NCT02560623|26045566|FG000|Overall Study|Unable to swallow sponge|0|||
13150007|NCT02560623|26045567|FG001|Overall Study|Unable to swallow sponge|1|||
13150008|NCT02560623|26045568|FG002|Overall Study|Unable to swallow sponge|0|||
13150009|NCT02560623|26045569|FG003|Overall Study|Unable to swallow sponge|0|||
13150010|NCT02560623|26045566|FG000|Overall Study|Intervention prior to sponge administration|0|||
13150011|NCT02560623|26045567|FG001|Overall Study|Intervention prior to sponge administration|1|||
13150012|NCT02560623|26045568|FG002|Overall Study|Intervention prior to sponge administration|0|||
13150013|NCT02560623|26045569|FG003|Overall Study|Intervention prior to sponge administration|0|||
13150014|NCT02560558|26045602|FG000|Overall Study|Adverse Event|1|||
13150015|NCT02560558|26045603|FG001|Overall Study|Adverse Event|0|||
13150016|NCT02560558|26045602|FG000|Overall Study|Death|0|||
13150017|NCT02560558|26045603|FG001|Overall Study|Death|2|||
13150018|NCT02560558|26045602|FG000|Overall Study|Lost to Follow-up|0|||
13150019|NCT02560558|26045603|FG001|Overall Study|Lost to Follow-up|4|||
13150020|NCT02560558|26045602|FG000|Overall Study|Protocol Violation|3|||
13150021|NCT02560558|26045603|FG001|Overall Study|Protocol Violation|0|||
13150022|NCT02560558|26045602|FG000|Overall Study|Withdrawal by Subject|3|||
13150023|NCT02560558|26045603|FG001|Overall Study|Withdrawal by Subject|0|||
13150024|NCT02560389|26045627|FG000|Overall Study|Lost to Follow-up|1|||
13150025|NCT02560389|26045628|FG001|Overall Study|Lost to Follow-up|2|||
13150026|NCT02560389|26045629|FG002|Overall Study|Lost to Follow-up|2|||
13150027|NCT02560389|26045627|FG000|Overall Study|Tested positive for illicit substance|0|||
13150028|NCT02560389|26045628|FG001|Overall Study|Tested positive for illicit substance|1|||
13150029|NCT02560389|26045629|FG002|Overall Study|Tested positive for illicit substance|0|||
13150030|NCT02560025|26045640|FG000|Overall Study|Ineligible after consent/ registration|3|||
13150031|NCT02560012|26045646|FG000|Overall Study|Study Terminated|2|||
13150032|NCT02559895|26045749|FG000|Overall Study|Adverse Event|3|||
13150033|NCT02559895|26045750|FG001|Overall Study|Adverse Event|3|||
13150034|NCT02559895|26045751|FG002|Overall Study|Adverse Event|2|||
13150035|NCT02559895|26045752|FG003|Overall Study|Adverse Event|1|||
13150036|NCT02559895|26045749|FG000|Overall Study|Lack of Efficacy|2|||
13150037|NCT02559895|26045750|FG001|Overall Study|Lack of Efficacy|3|||
13150038|NCT02559895|26045751|FG002|Overall Study|Lack of Efficacy|2|||
13150039|NCT02559895|26045752|FG003|Overall Study|Lack of Efficacy|8|||
13150040|NCT02559895|26045749|FG000|Overall Study|Lost to Follow-up|22|||
13150041|NCT02559895|26045750|FG001|Overall Study|Lost to Follow-up|16|||
13150042|NCT02559895|26045751|FG002|Overall Study|Lost to Follow-up|12|||
13096030|NCT03573323|25843058|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
13096031|NCT03573323|25843057|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15|||
13096032|NCT03573323|25843058|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8|||
13096033|NCT03573323|25843057|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3|||
13096034|NCT03573323|25843058|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8|||
13096035|NCT03573323|25843057|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17|||
13096036|NCT03573323|25843058|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9|||
13096037|NCT03573323|25843057|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2|||
13096038|NCT03573323|25843058|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3|||
13096039|NCT03573323|25843057|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1|||
13096040|NCT03573323|25843058|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2|||
13096041|NCT03573323|25843057|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1|||
13096042|NCT03573323|25843058|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0|||
13096043|NCT03573323|25843057|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14|||
13096044|NCT03573323|25843058|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13|||
13096045|NCT03573323|25843057|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0|||
13096046|NCT03573323|25843058|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1|||
13096047|NCT03573323|25843057|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0|||
13096048|NCT03573323|25843058|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1|||
13096049|NCT03573323|25843057|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1|||
13096050|NCT03573323|25843058|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2|||
13096051|NCT03573323|25843057|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22|||
13096052|NCT03573323|25843058|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12|||
13096053|NCT03573323|25843057|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8|||
13096054|NCT03573323|25843058|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19|||
13096055|NCT03573323|25843057|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4|||
13096056|NCT03573323|25843058|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3|||
13096057|NCT03573323|25843057|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3|||
13096058|NCT03573323|25843058|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2|||
13096059|NCT03573323|25843057|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14|||
13096060|NCT03573323|25843058|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8|||
13096061|NCT03573323|25843057|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8|||
13096062|NCT03573323|25843058|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11|||
13096063|NCT03573323|25843057|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0|||
13096064|NCT03573323|25843058|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1|||
13096065|NCT03573323|25843057|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0|||
13096066|NCT03573323|25843058|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1|||
13096067|NCT03572933|25843085|FG000|Overall Study|Adverse Event|4|||
13096068|NCT03572933|25843086|FG001|Overall Study|Adverse Event|1|||
13096069|NCT03572933|25843085|FG000|Overall Study|Withdrawal by Subject|0|||
13096070|NCT03572933|25843086|FG001|Overall Study|Withdrawal by Subject|1|||
13096071|NCT03572218|25843207|FG000|Overall Study|Lost to Follow-up|3|||
13096072|NCT03572218|25843208|FG001|Overall Study|Lost to Follow-up|2|||
13096073|NCT03572218|25843207|FG000|Overall Study|No longer available for study visits|2|||
13150043|NCT02559895|26045752|FG003|Overall Study|Lost to Follow-up|17|||
13150044|NCT02559895|26045749|FG000|Overall Study|Physician Decision|1|||
13150045|NCT02559895|26045750|FG001|Overall Study|Physician Decision|1|||
13150046|NCT02559895|26045751|FG002|Overall Study|Physician Decision|3|||
13150047|NCT02559895|26045752|FG003|Overall Study|Physician Decision|0|||
13150048|NCT02559895|26045749|FG000|Overall Study|Withdrawal by Subject|16|||
13150049|NCT02559895|26045750|FG001|Overall Study|Withdrawal by Subject|9|||
13150050|NCT02559895|26045751|FG002|Overall Study|Withdrawal by Subject|20|||
13150051|NCT02559895|26045752|FG003|Overall Study|Withdrawal by Subject|9|||
13150052|NCT02559895|26045749|FG000|Overall Study|Study Burden|10|||
13150053|NCT02559895|26045750|FG001|Overall Study|Study Burden|16|||
13150054|NCT02559895|26045751|FG002|Overall Study|Study Burden|12|||
13150055|NCT02559895|26045752|FG003|Overall Study|Study Burden|22|||
13150056|NCT02559895|26045749|FG000|Overall Study|Other|1|||
13150057|NCT02559895|26045750|FG001|Overall Study|Other|5|||
13150058|NCT02559895|26045751|FG002|Overall Study|Other|3|||
13150059|NCT02559895|26045752|FG003|Overall Study|Other|3|||
13150060|NCT02559817|26045805|FG000|Treatment Period|Adverse Event|1|||
13150061|NCT02559817|26045806|FG001|Treatment Period|Adverse Event|0|||
13150062|NCT02559817|26045807|FG002|Treatment Period|Adverse Event|1|||
13150063|NCT02559817|26045808|FG003|Treatment Period|Adverse Event|0|||
13150064|NCT02559817|26045809|FG004|Treatment Period|Adverse Event|0|||
13150065|NCT02559817|26045805|FG000|Treatment Period|Lack of Efficacy|0|||
13150066|NCT02559817|26045806|FG001|Treatment Period|Lack of Efficacy|1|||
13150067|NCT02559817|26045807|FG002|Treatment Period|Lack of Efficacy|0|||
13150068|NCT02559817|26045808|FG003|Treatment Period|Lack of Efficacy|0|||
13096074|NCT03572218|25843208|FG001|Overall Study|No longer available for study visits|1|||
13096075|NCT03572218|25843207|FG000|Overall Study|No longer interested|1|||
13096076|NCT03572218|25843208|FG001|Overall Study|No longer interested|2|||
13096077|NCT03572062|25843299|FG000|Overall Study|Adverse Event|0|||
13096078|NCT03572062|25843300|FG001|Overall Study|Adverse Event|0|||
13096079|NCT03572062|25843301|FG002|Overall Study|Adverse Event|0|||
13096080|NCT03572062|25843302|FG003|Overall Study|Adverse Event|0|||
13096081|NCT03572062|25843303|FG004|Overall Study|Adverse Event|0|||
13096082|NCT03572062|25843304|FG005|Overall Study|Adverse Event|0|||
13096083|NCT03572062|25843305|FG006|Overall Study|Adverse Event|0|||
13096084|NCT03572062|25843306|FG007|Overall Study|Adverse Event|0|||
13096085|NCT03572062|25843307|FG008|Overall Study|Adverse Event|1|||
13096086|NCT03572062|25843308|FG009|Overall Study|Adverse Event|3|||
13096087|NCT03572062|25843299|FG000|Overall Study|Death|0|||
13096088|NCT03572062|25843300|FG001|Overall Study|Death|0|||
13096089|NCT03572062|25843301|FG002|Overall Study|Death|0|||
13096090|NCT03572062|25843302|FG003|Overall Study|Death|0|||
13096091|NCT03572062|25843303|FG004|Overall Study|Death|0|||
13096092|NCT03572062|25843304|FG005|Overall Study|Death|1|||
13096093|NCT03572062|25843305|FG006|Overall Study|Death|0|||
13096094|NCT03572062|25843306|FG007|Overall Study|Death|0|||
13096095|NCT03572062|25843307|FG008|Overall Study|Death|0|||
13096096|NCT03572062|25843308|FG009|Overall Study|Death|0|||
13096097|NCT03572062|25843299|FG000|Overall Study|Lost to Follow-up|0|||
13096098|NCT03572062|25843300|FG001|Overall Study|Lost to Follow-up|0|||
13096099|NCT03572062|25843301|FG002|Overall Study|Lost to Follow-up|0|||
13096100|NCT03572062|25843302|FG003|Overall Study|Lost to Follow-up|0|||
13096101|NCT03572062|25843303|FG004|Overall Study|Lost to Follow-up|0|||
13096102|NCT03572062|25843304|FG005|Overall Study|Lost to Follow-up|1|||
13096103|NCT03572062|25843305|FG006|Overall Study|Lost to Follow-up|1|||
13096104|NCT03572062|25843306|FG007|Overall Study|Lost to Follow-up|0|||
13096105|NCT03572062|25843307|FG008|Overall Study|Lost to Follow-up|0|||
13096106|NCT03572062|25843308|FG009|Overall Study|Lost to Follow-up|0|||
13096107|NCT03572062|25843299|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
13096108|NCT03572062|25843300|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
13096109|NCT03572062|25843301|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
13096110|NCT03572062|25843302|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
13096111|NCT03572062|25843303|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
13096112|NCT03572062|25843304|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
13096113|NCT03572062|25843305|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
13096114|NCT03572062|25843306|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
13096115|NCT03572062|25843307|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
13096116|NCT03572062|25843308|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
13096117|NCT03572062|25843299|FG000|Overall Study|Study Terminated By Sponsor|0|||
13096118|NCT03572062|25843300|FG001|Overall Study|Study Terminated By Sponsor|0|||
13096119|NCT03572062|25843301|FG002|Overall Study|Study Terminated By Sponsor|0|||
13096120|NCT03572062|25843302|FG003|Overall Study|Study Terminated By Sponsor|0|||
13096121|NCT03572062|25843303|FG004|Overall Study|Study Terminated By Sponsor|0|||
13096122|NCT03572062|25843304|FG005|Overall Study|Study Terminated By Sponsor|0|||
13096123|NCT03572062|25843305|FG006|Overall Study|Study Terminated By Sponsor|0|||
13096124|NCT03572062|25843306|FG007|Overall Study|Study Terminated By Sponsor|0|||
13096125|NCT03572062|25843307|FG008|Overall Study|Study Terminated By Sponsor|29|||
13096126|NCT03572062|25843308|FG009|Overall Study|Study Terminated By Sponsor|27|||
13096127|NCT03572062|25843299|FG000|Overall Study|Physician Decision|0|||
13096128|NCT03572062|25843300|FG001|Overall Study|Physician Decision|0|||
13096129|NCT03572062|25843301|FG002|Overall Study|Physician Decision|0|||
13096130|NCT03572062|25843302|FG003|Overall Study|Physician Decision|0|||
13096131|NCT03572062|25843303|FG004|Overall Study|Physician Decision|0|||
13096132|NCT03572062|25843304|FG005|Overall Study|Physician Decision|0|||
13096133|NCT03572062|25843305|FG006|Overall Study|Physician Decision|0|||
13096134|NCT03572062|25843306|FG007|Overall Study|Physician Decision|0|||
13096135|NCT03572062|25843307|FG008|Overall Study|Physician Decision|1|||
13096136|NCT03572062|25843308|FG009|Overall Study|Physician Decision|0|||
13096137|NCT03572062|25843299|FG000|Overall Study|Withdrawal by Subject|0|||
13096138|NCT03572062|25843300|FG001|Overall Study|Withdrawal by Subject|0|||
13096139|NCT03572062|25843301|FG002|Overall Study|Withdrawal by Subject|0|||
13096140|NCT03572062|25843302|FG003|Overall Study|Withdrawal by Subject|0|||
13096141|NCT03572062|25843303|FG004|Overall Study|Withdrawal by Subject|0|||
13096142|NCT03572062|25843304|FG005|Overall Study|Withdrawal by Subject|0|||
13096143|NCT03572062|25843305|FG006|Overall Study|Withdrawal by Subject|0|||
13096144|NCT03572062|25843306|FG007|Overall Study|Withdrawal by Subject|0|||
13096145|NCT03572062|25843307|FG008|Overall Study|Withdrawal by Subject|0|||
13096146|NCT03572062|25843308|FG009|Overall Study|Withdrawal by Subject|1|||
13096147|NCT03572062|25843299|FG000|Overall Study|Randomized But Not Treated|0|||
13096148|NCT03572062|25843300|FG001|Overall Study|Randomized But Not Treated|0|||
13096149|NCT03572062|25843301|FG002|Overall Study|Randomized But Not Treated|0|||
13096150|NCT03572062|25843302|FG003|Overall Study|Randomized But Not Treated|0|||
13096151|NCT03572062|25843303|FG004|Overall Study|Randomized But Not Treated|1|||
13096152|NCT03572062|25843304|FG005|Overall Study|Randomized But Not Treated|2|||
13096153|NCT03572062|25843305|FG006|Overall Study|Randomized But Not Treated|0|||
13096154|NCT03572062|25843306|FG007|Overall Study|Randomized But Not Treated|1|||
13096155|NCT03572062|25843307|FG008|Overall Study|Randomized But Not Treated|0|||
13096156|NCT03572062|25843308|FG009|Overall Study|Randomized But Not Treated|0|||
13096157|NCT03571646|25843323|FG000|Overall Study|Adverse Event|1|||
13096158|NCT03571646|25843324|FG001|Overall Study|Adverse Event|0|||
13096159|NCT03571646|25843323|FG000|Overall Study|Withdrawal by Subject|1|||
13096160|NCT03571646|25843324|FG001|Overall Study|Withdrawal by Subject|1|||
13096161|NCT03571581|25843349|FG000|Overall Study|Death|2|||
13096162|NCT03571581|25843349|FG000|Overall Study|Withdrawal by Subject|2|||
13096163|NCT03571516|25843404|FG000|Overall Study|Severe diarrhea|1|||
13096164|NCT03571516|25843405|FG001|Overall Study|Severe diarrhea|0|||
13096165|NCT03571516|25843404|FG000|Overall Study|Withdrawal by Subject|0|||
13096166|NCT03571516|25843405|FG001|Overall Study|Withdrawal by Subject|1|||
13096167|NCT03571256|25843442|FG000|Overall Study|Adverse Event|3|||
13096168|NCT03571256|25843443|FG001|Overall Study|Adverse Event|0|||
13096169|NCT03571256|25843444|FG002|Overall Study|Adverse Event|1|||
13096170|NCT03571256|25843442|FG000|Overall Study|Withdrawal by Subject|3|||
13096171|NCT03571256|25843443|FG001|Overall Study|Withdrawal by Subject|1|||
13096172|NCT03571256|25843444|FG002|Overall Study|Withdrawal by Subject|1|||
13096173|NCT03571256|25843442|FG000|Overall Study|Other than specified|0|||
13096174|NCT03571256|25843443|FG001|Overall Study|Other than specified|1|||
13096175|NCT03571256|25843444|FG002|Overall Study|Other than specified|1|||
13096176|NCT03571256|25843442|FG000|Overall Study|Protocol Violation|0|||
13096177|NCT03571256|25843443|FG001|Overall Study|Protocol Violation|1|||
13096178|NCT03571256|25843444|FG002|Overall Study|Protocol Violation|1|||
13096179|NCT03571204|25843465|FG000|Overall Study|Stopped due to COVID-19 pandemic|1|||
13096180|NCT03571204|25843466|FG001|Overall Study|Stopped due to COVID-19 pandemic|1|||
13096181|NCT03571204|25843467|FG002|Overall Study|Stopped due to COVID-19 pandemic|0|||
13096182|NCT03571204|25843465|FG000|Overall Study|Physician Decision|0|||
13096183|NCT03571204|25843466|FG001|Overall Study|Physician Decision|1|||
13096184|NCT03571204|25843467|FG002|Overall Study|Physician Decision|0|||
13096185|NCT03570697|25843492|FG000|Overall Study|Lost to Follow-up|0|||
13096186|NCT03570697|25843493|FG001|Overall Study|Lost to Follow-up|1|||
13096187|NCT03570697|25843492|FG000|Overall Study|Death|2|||
13096188|NCT03570697|25843493|FG001|Overall Study|Death|0|||
13096189|NCT03570697|25843492|FG000|Overall Study|Withdrawal by Subject|4|||
13096190|NCT03570697|25843493|FG001|Overall Study|Withdrawal by Subject|2|||
13096191|NCT03570554|25843524|FG000|Overall Study|Non-compliance with study drug|0|||
13096192|NCT03570554|25843525|FG001|Overall Study|Non-compliance with study drug|0|||
13096193|NCT03570554|25843526|FG002|Overall Study|Non-compliance with study drug|1|||
13096194|NCT03570554|25843527|FG003|Overall Study|Non-compliance with study drug|0|||
13096195|NCT03570554|25843524|FG000|Overall Study|Adverse Event|0|||
13096196|NCT03570554|25843525|FG001|Overall Study|Adverse Event|0|||
13096197|NCT03570554|25843526|FG002|Overall Study|Adverse Event|0|||
13096198|NCT03570554|25843527|FG003|Overall Study|Adverse Event|1|||
13096199|NCT03569891|25843563|FG000|Lead-in|Ineligible during lead-in|8|||
13096200|NCT03569891|25843563|FG000|Lead-in|Withdrawal by Subject|3|||
13096201|NCT03569891|25843563|FG000|Lead-in|Risks related to COVID-19|2|||
13096202|NCT03569891|25843563|FG000|AMT-061|Adverse Event|1|||
13096203|NCT03569371|25843584|FG000|Overall Study|Lack of Efficacy|1|||
13096204|NCT03569371|25843584|FG000|Overall Study|Lost to Follow-up|1|||
13096205|NCT03569371|25843584|FG000|Overall Study|Adverse Event|1|||
13096206|NCT03569202|25843621|FG000|Part 3|Physician Decision|1|||
13096207|NCT03569202|25843622|FG001|Part 3|Physician Decision|0|||
13096208|NCT03569202|25843621|FG000|Part 3|Other|1|||
13096209|NCT03569202|25843622|FG001|Part 3|Other|1|||
13096210|NCT03569098|25843682|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
13096211|NCT03569098|25843683|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2|||
13096212|NCT03569098|25843684|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
13096213|NCT03569098|25843682|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0|||
13096214|NCT03569098|25843683|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6|||
13096215|NCT03569098|25843684|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3|||
13096216|NCT03569098|25843682|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
13096217|NCT03569098|25843683|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
13096218|NCT03569098|25843684|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0|||
13096219|NCT03569098|25843682|FG000|Double-Blind Treatment Cycle 1|Technical problems|0|||
13096220|NCT03569098|25843683|FG001|Double-Blind Treatment Cycle 1|Technical problems|0|||
13096221|NCT03569098|25843684|FG002|Double-Blind Treatment Cycle 1|Technical problems|2|||
13096222|NCT03569098|25843682|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1|||
13096223|NCT03569098|25843683|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0|||
13096224|NCT03569098|25843684|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0|||
13096225|NCT03569098|25843682|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
13096226|NCT03569098|25843683|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1|||
13096227|NCT03569098|25843684|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
13096228|NCT03569098|25843682|FG000|Double-Blind Treatment Cycle 1|Other|1|||
13096229|NCT03569098|25843683|FG001|Double-Blind Treatment Cycle 1|Other|0|||
13096230|NCT03569098|25843684|FG002|Double-Blind Treatment Cycle 1|Other|1|||
13096231|NCT03569098|25843682|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
13096232|NCT03569098|25843683|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21|||
13096233|NCT03569098|25843684|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
13096234|NCT03569098|25843682|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
13096235|NCT03569098|25843683|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11|||
13096236|NCT03569098|25843684|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
13096237|NCT03569098|25843682|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
13096238|NCT03569098|25843683|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3|||
13096239|NCT03569098|25843684|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
13096240|NCT03569098|25843682|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
13096241|NCT03569098|25843683|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
13096242|NCT03569098|25843684|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4|||
13096243|NCT03569098|25843682|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0|||
13096244|NCT03569098|25843683|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
13096245|NCT03569098|25843684|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
13096246|NCT03569098|25843682|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
13096247|NCT03569098|25843683|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
13096248|NCT03569098|25843684|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1|||
13096249|NCT03568942|25843721|FG000|Overall Study|Family emergency|1|||
13096250|NCT03568942|25843721|FG000|Overall Study|Lost to Follow-up|1|||
13096251|NCT03568500|25843745|FG000|Overall Study|Lost to Follow-up|1|||
13096252|NCT03568500|25843746|FG001|Overall Study|Lost to Follow-up|1|||
13096253|NCT03568500|25843747|FG002|Overall Study|Lost to Follow-up|2|||
13096254|NCT03568500|25843745|FG000|Overall Study|Adverse Event|1|||
13096255|NCT03568500|25843746|FG001|Overall Study|Adverse Event|1|||
13096256|NCT03568500|25843747|FG002|Overall Study|Adverse Event|2|||
13096257|NCT03568500|25843745|FG000|Overall Study|Physician Decision|1|||
13096258|NCT03568500|25843746|FG001|Overall Study|Physician Decision|0|||
13096259|NCT03568500|25843747|FG002|Overall Study|Physician Decision|0|||
13096260|NCT03568500|25843745|FG000|Overall Study|Withdrawal by Subject|4|||
13096261|NCT03568500|25843746|FG001|Overall Study|Withdrawal by Subject|2|||
13096262|NCT03568500|25843747|FG002|Overall Study|Withdrawal by Subject|0|||
13096263|NCT03568500|25843745|FG000|Overall Study|Technical Problems|2|||
13096264|NCT03568500|25843746|FG001|Overall Study|Technical Problems|1|||
13096265|NCT03568500|25843747|FG002|Overall Study|Technical Problems|0|||
13096266|NCT03568500|25843745|FG000|Overall Study|Participant Noncompliance|1|||
13096267|NCT03568500|25843746|FG001|Overall Study|Participant Noncompliance|1|||
13096268|NCT03568500|25843747|FG002|Overall Study|Participant Noncompliance|0|||
13096269|NCT03568461|25843754|FG000|Overall Study|Death|7|||
13096270|NCT03568461|25843754|FG000|Overall Study|Physician Decision|5|||
13096271|NCT03568461|25843754|FG000|Overall Study|Subject decision|5|||
13096272|NCT03568461|25843754|FG000|Overall Study|Lost to Follow-up|1|||
13096273|NCT03568318|25843853|FG000|Overall Study|Adverse Event|3|||
13096274|NCT03568318|25843854|FG001|Overall Study|Adverse Event|1|||
13096275|NCT03568318|25843855|FG002|Overall Study|Adverse Event|1|||
13096276|NCT03568318|25843856|FG003|Overall Study|Adverse Event|0|||
13096277|NCT03568318|25843857|FG004|Overall Study|Adverse Event|1|||
13096278|NCT03568318|25843858|FG005|Overall Study|Adverse Event|0|||
13096279|NCT03568318|25843853|FG000|Overall Study|Withdrawal by Subject|6|||
13096280|NCT03568318|25843854|FG001|Overall Study|Withdrawal by Subject|5|||
13096281|NCT03568318|25843855|FG002|Overall Study|Withdrawal by Subject|2|||
13096282|NCT03568318|25843856|FG003|Overall Study|Withdrawal by Subject|1|||
13096283|NCT03568318|25843857|FG004|Overall Study|Withdrawal by Subject|0|||
13096284|NCT03568318|25843858|FG005|Overall Study|Withdrawal by Subject|0|||
13096285|NCT03568318|25843853|FG000|Overall Study|Lost to Follow-up|3|||
13150069|NCT02559817|26045809|FG004|Treatment Period|Lack of Efficacy|0|||
13150070|NCT02559817|26045805|FG000|Treatment Period|Lost to Follow-up|0|||
13150071|NCT02559817|26045806|FG001|Treatment Period|Lost to Follow-up|1|||
13150072|NCT02559817|26045807|FG002|Treatment Period|Lost to Follow-up|0|||
13150073|NCT02559817|26045808|FG003|Treatment Period|Lost to Follow-up|1|||
13150074|NCT02559817|26045809|FG004|Treatment Period|Lost to Follow-up|0|||
13096286|NCT03568318|25843854|FG001|Overall Study|Lost to Follow-up|2|||
13096287|NCT03568318|25843855|FG002|Overall Study|Lost to Follow-up|2|||
13096288|NCT03568318|25843856|FG003|Overall Study|Lost to Follow-up|2|||
13150075|NCT02559817|26045805|FG000|Treatment Period|Non-Compliance With Study Drug|0|||
13150076|NCT02559817|26045806|FG001|Treatment Period|Non-Compliance With Study Drug|0|||
13150077|NCT02559817|26045807|FG002|Treatment Period|Non-Compliance With Study Drug|1|||
13150078|NCT02559817|26045808|FG003|Treatment Period|Non-Compliance With Study Drug|0|||
13150079|NCT02559817|26045809|FG004|Treatment Period|Non-Compliance With Study Drug|0|||
13150080|NCT02559817|26045805|FG000|Treatment Period|Protocol Violation|0|||
13150081|NCT02559817|26045806|FG001|Treatment Period|Protocol Violation|0|||
13150082|NCT02559817|26045807|FG002|Treatment Period|Protocol Violation|0|||
13150083|NCT02559817|26045808|FG003|Treatment Period|Protocol Violation|1|||
13096289|NCT03568318|25843857|FG004|Overall Study|Lost to Follow-up|1|||
13096290|NCT03568318|25843858|FG005|Overall Study|Lost to Follow-up|0|||
13096291|NCT03568318|25843853|FG000|Overall Study|Other|3|||
13096292|NCT03568318|25843854|FG001|Overall Study|Other|1|||
13096293|NCT03568318|25843855|FG002|Overall Study|Other|3|||
13096294|NCT03568318|25843856|FG003|Overall Study|Other|0|||
13096295|NCT03568318|25843857|FG004|Overall Study|Other|0|||
13096296|NCT03568318|25843858|FG005|Overall Study|Other|0|||
13096297|NCT03568318|25843853|FG000|Overall Study|Ongoing at Time of Analysis|5|||
13096298|NCT03568318|25843854|FG001|Overall Study|Ongoing at Time of Analysis|3|||
13150084|NCT02559817|26045809|FG004|Treatment Period|Protocol Violation|0|||
13150085|NCT02559713|26045821|FG000|Overall Study|Pretreatment Event/ Adverse Event|1|||
13150086|NCT02559687|26045833|FG000|Overall Study|Death|112|||
13150087|NCT02559687|26045833|FG000|Overall Study|Sponsor Decision|5|||
13150088|NCT02559687|26045833|FG000|Overall Study|Withdrawal by Subject|4|||
13150089|NCT02559622|26045925|FG000|Overall Study|Progressive disease|0|||
13150090|NCT02559622|26045926|FG001|Overall Study|Progressive disease|1|||
13150091|NCT02559622|26045927|FG002|Overall Study|Progressive disease|0|||
13150092|NCT02559622|26045928|FG003|Overall Study|Progressive disease|0|||
13150093|NCT02559622|26045925|FG000|Overall Study|Adverse Event|0|||
13150094|NCT02559622|26045926|FG001|Overall Study|Adverse Event|2|||
13150095|NCT02559622|26045927|FG002|Overall Study|Adverse Event|2|||
13150096|NCT02559622|26045928|FG003|Overall Study|Adverse Event|2|||
13150097|NCT02559622|26045925|FG000|Overall Study|Patient/guardian decision|1|||
13150098|NCT02559622|26045926|FG001|Overall Study|Patient/guardian decision|2|||
13150099|NCT02559622|26045927|FG002|Overall Study|Patient/guardian decision|0|||
13150100|NCT02559622|26045928|FG003|Overall Study|Patient/guardian decision|1|||
13150101|NCT02559570|26045979|FG000|Overall Study|Adverse Event|0|||
13150102|NCT02559570|26045980|FG001|Overall Study|Adverse Event|2|||
13150103|NCT02559570|26045981|FG002|Overall Study|Adverse Event|0|||
13150104|NCT02559570|26045982|FG003|Overall Study|Adverse Event|1|||
13150105|NCT02559570|26045983|FG004|Overall Study|Adverse Event|0|||
13150106|NCT02559570|26045979|FG000|Overall Study|Withdrawal of Consent|0|||
13150107|NCT02559570|26045980|FG001|Overall Study|Withdrawal of Consent|0|||
13150108|NCT02559570|26045981|FG002|Overall Study|Withdrawal of Consent|1|||
13150109|NCT02559570|26045982|FG003|Overall Study|Withdrawal of Consent|2|||
13150110|NCT02559570|26045983|FG004|Overall Study|Withdrawal of Consent|1|||
13150111|NCT02559570|26045979|FG000|Overall Study|Lost to Follow-up|1|||
13150112|NCT02559570|26045980|FG001|Overall Study|Lost to Follow-up|0|||
13150113|NCT02559570|26045981|FG002|Overall Study|Lost to Follow-up|0|||
13150114|NCT02559570|26045982|FG003|Overall Study|Lost to Follow-up|0|||
13150115|NCT02559570|26045983|FG004|Overall Study|Lost to Follow-up|0|||
13150116|NCT02559570|26045979|FG000|Overall Study|Protocol Violation|1|||
13150117|NCT02559570|26045980|FG001|Overall Study|Protocol Violation|0|||
13150118|NCT02559570|26045981|FG002|Overall Study|Protocol Violation|0|||
13150119|NCT02559570|26045982|FG003|Overall Study|Protocol Violation|0|||
13150120|NCT02559570|26045983|FG004|Overall Study|Protocol Violation|1|||
13150121|NCT02559570|26045979|FG000|Overall Study|Other Miscellaneous Reasons|0|||
13150122|NCT02559570|26045980|FG001|Overall Study|Other Miscellaneous Reasons|0|||
13150123|NCT02559570|26045981|FG002|Overall Study|Other Miscellaneous Reasons|1|||
13150124|NCT02559570|26045982|FG003|Overall Study|Other Miscellaneous Reasons|0|||
13150125|NCT02559570|26045983|FG004|Overall Study|Other Miscellaneous Reasons|0|||
13150126|NCT02559505|26046030|FG000|Overall Study|Lost to Follow-up|23|||
13150127|NCT02559505|26046031|FG001|Overall Study|Lost to Follow-up|20|||
13150128|NCT02559505|26046030|FG000|Overall Study|Withdrawal by Subject|4|||
13150129|NCT02559505|26046031|FG001|Overall Study|Withdrawal by Subject|2|||
13150130|NCT02559414|26046079|FG000|Overall Study|Lost to Follow-up|0|||
13150131|NCT02559414|26046080|FG001|Overall Study|Lost to Follow-up|1|||
13150132|NCT02559414|26046081|FG002|Overall Study|Lost to Follow-up|0|||
13150133|NCT02559414|26046079|FG000|Overall Study|Withdrawal by Subject|1|||
13150134|NCT02559414|26046080|FG001|Overall Study|Withdrawal by Subject|0|||
13150135|NCT02559414|26046081|FG002|Overall Study|Withdrawal by Subject|1|||
13150136|NCT02559414|26046079|FG000|Overall Study|Other|0|||
13150137|NCT02559414|26046080|FG001|Overall Study|Other|1|||
13150138|NCT02559414|26046081|FG002|Overall Study|Other|1|||
13150139|NCT02559310|26046098|FG000|Overall Study|Death|4|||
13150140|NCT02559310|26046099|FG001|Overall Study|Death|3|||
13096299|NCT03568318|25843855|FG002|Overall Study|Ongoing at Time of Analysis|2|||
13150141|NCT02559310|26046098|FG000|Overall Study|Lost to Follow-up|5|||
13150142|NCT02559310|26046099|FG001|Overall Study|Lost to Follow-up|3|||
13150143|NCT02559310|26046098|FG000|Overall Study|Physician Decision|2|||
13150144|NCT02559310|26046099|FG001|Overall Study|Physician Decision|1|||
13150145|NCT02559310|26046098|FG000|Overall Study|Withdrawal by Subject|13|||
13150146|NCT02559310|26046099|FG001|Overall Study|Withdrawal by Subject|9|||
13150147|NCT02559310|26046098|FG000|Overall Study|Sponsor Decision|0|||
13150148|NCT02559310|26046099|FG001|Overall Study|Sponsor Decision|1|||
13096300|NCT03568318|25843856|FG003|Overall Study|Ongoing at Time of Analysis|1|||
13096301|NCT03568318|25843857|FG004|Overall Study|Ongoing at Time of Analysis|0|||
13096302|NCT03568318|25843858|FG005|Overall Study|Ongoing at Time of Analysis|0|||
13096303|NCT03568162|25843979|FG000|Overall Study|Adverse Event|0|||
13096304|NCT03568162|25843980|FG001|Overall Study|Adverse Event|1|||
13096305|NCT03568162|25843981|FG002|Overall Study|Adverse Event|2|||
13096306|NCT03568162|25843982|FG003|Overall Study|Adverse Event|0|||
13096307|NCT03568162|25843983|FG004|Overall Study|Adverse Event|0|||
13096308|NCT03568162|25843984|FG005|Overall Study|Adverse Event|1|||
13096309|NCT03568162|25843979|FG000|Overall Study|Death|0|||
13096310|NCT03568162|25843980|FG001|Overall Study|Death|0|||
13096311|NCT03568162|25843981|FG002|Overall Study|Death|0|||
13096312|NCT03568162|25843982|FG003|Overall Study|Death|0|||
13096313|NCT03568162|25843983|FG004|Overall Study|Death|1|||
13096314|NCT03568162|25843984|FG005|Overall Study|Death|0|||
13096315|NCT03568162|25843979|FG000|Overall Study|Lost to Follow-up|3|||
13096316|NCT03568162|25843980|FG001|Overall Study|Lost to Follow-up|2|||
13096317|NCT03568162|25843981|FG002|Overall Study|Lost to Follow-up|4|||
13096318|NCT03568162|25843982|FG003|Overall Study|Lost to Follow-up|2|||
13096319|NCT03568162|25843983|FG004|Overall Study|Lost to Follow-up|3|||
13096320|NCT03568162|25843984|FG005|Overall Study|Lost to Follow-up|2|||
13096321|NCT03568162|25843979|FG000|Overall Study|Physician Decision|0|||
13096322|NCT03568162|25843980|FG001|Overall Study|Physician Decision|1|||
13096323|NCT03568162|25843981|FG002|Overall Study|Physician Decision|1|||
13096324|NCT03568162|25843982|FG003|Overall Study|Physician Decision|0|||
13096325|NCT03568162|25843983|FG004|Overall Study|Physician Decision|1|||
13096326|NCT03568162|25843984|FG005|Overall Study|Physician Decision|0|||
13096327|NCT03568162|25843979|FG000|Overall Study|Pregnancy|0|||
13096328|NCT03568162|25843980|FG001|Overall Study|Pregnancy|0|||
13096329|NCT03568162|25843981|FG002|Overall Study|Pregnancy|0|||
13096330|NCT03568162|25843982|FG003|Overall Study|Pregnancy|1|||
13096331|NCT03568162|25843983|FG004|Overall Study|Pregnancy|0|||
13096332|NCT03568162|25843984|FG005|Overall Study|Pregnancy|0|||
13096333|NCT03568162|25843979|FG000|Overall Study|Protocol Violation|1|||
13096334|NCT03568162|25843980|FG001|Overall Study|Protocol Violation|0|||
13096335|NCT03568162|25843981|FG002|Overall Study|Protocol Violation|1|||
13096336|NCT03568162|25843982|FG003|Overall Study|Protocol Violation|1|||
13096337|NCT03568162|25843983|FG004|Overall Study|Protocol Violation|1|||
13096338|NCT03568162|25843984|FG005|Overall Study|Protocol Violation|1|||
13096339|NCT03568162|25843979|FG000|Overall Study|Withdrawal by Subject|15|||
13096340|NCT03568162|25843980|FG001|Overall Study|Withdrawal by Subject|15|||
13096341|NCT03568162|25843981|FG002|Overall Study|Withdrawal by Subject|26|||
13096342|NCT03568162|25843982|FG003|Overall Study|Withdrawal by Subject|22|||
13096343|NCT03568162|25843983|FG004|Overall Study|Withdrawal by Subject|6|||
13096344|NCT03568162|25843984|FG005|Overall Study|Withdrawal by Subject|9|||
13096345|NCT03568162|25843979|FG000|Overall Study|Others|3|||
13096346|NCT03568162|25843980|FG001|Overall Study|Others|4|||
13096347|NCT03568162|25843981|FG002|Overall Study|Others|1|||
13096348|NCT03568162|25843982|FG003|Overall Study|Others|4|||
13096349|NCT03568162|25843983|FG004|Overall Study|Others|2|||
13096350|NCT03568162|25843984|FG005|Overall Study|Others|1|||
13096351|NCT03567980|25843992|FG000|Overall Study|Adverse Event|1|||
13096352|NCT03567616|25844016|FG000|Overall Study|Disease progression|4|||
13096353|NCT03567616|25844016|FG000|Overall Study|Withdrawal by Subject|1|||
13096354|NCT03567616|25844016|FG000|Overall Study|Physician Decision|1|||
13096355|NCT03567616|25844016|FG000|Overall Study|Death|1|||
13096356|NCT03567616|25844016|FG000|Overall Study|Adverse Event|1|||
13096357|NCT03567382|25844040|FG000|Overall Study|Lost to Follow-up|1|||
13096358|NCT03567382|25844041|FG001|Overall Study|Lost to Follow-up|21|||
13096359|NCT03567382|25844042|FG002|Overall Study|Lost to Follow-up|1|||
13096360|NCT03567382|25844043|FG003|Overall Study|Lost to Follow-up|21|||
13096361|NCT03567382|25844040|FG000|Overall Study|Withdrawal by Subject|2|||
13150149|NCT02559310|26046098|FG000|Overall Study|Randomized but not treated|3|||
13150150|NCT02559310|26046099|FG001|Overall Study|Randomized but not treated|2|||
13096362|NCT03567382|25844041|FG001|Overall Study|Withdrawal by Subject|14|||
13096363|NCT03567382|25844042|FG002|Overall Study|Withdrawal by Subject|1|||
13096364|NCT03567382|25844043|FG003|Overall Study|Withdrawal by Subject|12|||
13096365|NCT03567291|25844069|FG000|Period I|Adverse Event|14|||
13096366|NCT03567291|25844070|FG001|Period I|Adverse Event|0|||
13096367|NCT03567291|25844071|FG002|Period I|Adverse Event|0|||
13096368|NCT03567291|25844072|FG003|Period I|Adverse Event|0|||
13096369|NCT03567291|25844069|FG000|Period I|Protocol Violation|1|||
13096370|NCT03567291|25844070|FG001|Period I|Protocol Violation|0|||
13096371|NCT03567291|25844071|FG002|Period I|Protocol Violation|0|||
13096372|NCT03567291|25844072|FG003|Period I|Protocol Violation|0|||
13150151|NCT02559206|26046164|FG000|Overall Study|Adverse Event|0|||
13096373|NCT03567291|25844069|FG000|Period I|Withdrawal by Subject|23|||
13096374|NCT03567291|25844070|FG001|Period I|Withdrawal by Subject|0|||
13096375|NCT03567291|25844071|FG002|Period I|Withdrawal by Subject|0|||
13096376|NCT03567291|25844072|FG003|Period I|Withdrawal by Subject|0|||
13096377|NCT03567291|25844069|FG000|Period I|Lost to Follow-up|2|||
13096378|NCT03567291|25844070|FG001|Period I|Lost to Follow-up|0|||
13096379|NCT03567291|25844071|FG002|Period I|Lost to Follow-up|0|||
13096380|NCT03567291|25844072|FG003|Period I|Lost to Follow-up|0|||
13096381|NCT03567291|25844069|FG000|Period I|Terminated by sponsor|44|||
13096382|NCT03567291|25844070|FG001|Period I|Terminated by sponsor|0|||
13096383|NCT03567291|25844071|FG002|Period I|Terminated by sponsor|0|||
13096384|NCT03567291|25844072|FG003|Period I|Terminated by sponsor|0|||
13096385|NCT03567291|25844069|FG000|Period I|Missing or unknown|7|||
13150152|NCT02559206|26046165|FG001|Overall Study|Adverse Event|4|||
13150153|NCT02559206|26046166|FG002|Overall Study|Adverse Event|1|||
13150154|NCT02559206|26046167|FG003|Overall Study|Adverse Event|5|||
13150155|NCT02559206|26046168|FG004|Overall Study|Adverse Event|3|||
13150156|NCT02559206|26046169|FG005|Overall Study|Adverse Event|0|||
13150157|NCT02559206|26046170|FG006|Overall Study|Adverse Event|1|||
13150158|NCT02559206|26046171|FG007|Overall Study|Adverse Event|0|||
13150159|NCT02559206|26046164|FG000|Overall Study|Protocol Violation|1|||
13150160|NCT02559206|26046165|FG001|Overall Study|Protocol Violation|0|||
13150161|NCT02559206|26046166|FG002|Overall Study|Protocol Violation|1|||
13150162|NCT02559206|26046167|FG003|Overall Study|Protocol Violation|0|||
13150163|NCT02559206|26046168|FG004|Overall Study|Protocol Violation|0|||
13150164|NCT02559206|26046169|FG005|Overall Study|Protocol Violation|2|||
13150165|NCT02559206|26046170|FG006|Overall Study|Protocol Violation|0|||
13150166|NCT02559206|26046171|FG007|Overall Study|Protocol Violation|0|||
13150167|NCT02559206|26046164|FG000|Overall Study|Withdrawal by Subject|3|||
13150168|NCT02559206|26046165|FG001|Overall Study|Withdrawal by Subject|3|||
13150169|NCT02559206|26046166|FG002|Overall Study|Withdrawal by Subject|1|||
13150170|NCT02559206|26046167|FG003|Overall Study|Withdrawal by Subject|3|||
13150171|NCT02559206|26046168|FG004|Overall Study|Withdrawal by Subject|5|||
13150172|NCT02559206|26046169|FG005|Overall Study|Withdrawal by Subject|4|||
13150173|NCT02559206|26046170|FG006|Overall Study|Withdrawal by Subject|1|||
13150174|NCT02559206|26046171|FG007|Overall Study|Withdrawal by Subject|2|||
13150175|NCT02559206|26046164|FG000|Overall Study|Lost to Follow-up|3|||
13150176|NCT02559206|26046165|FG001|Overall Study|Lost to Follow-up|5|||
13150177|NCT02559206|26046166|FG002|Overall Study|Lost to Follow-up|3|||
13150178|NCT02559206|26046167|FG003|Overall Study|Lost to Follow-up|3|||
13150179|NCT02559206|26046168|FG004|Overall Study|Lost to Follow-up|2|||
13150180|NCT02559206|26046169|FG005|Overall Study|Lost to Follow-up|5|||
13150181|NCT02559206|26046170|FG006|Overall Study|Lost to Follow-up|1|||
13150182|NCT02559206|26046171|FG007|Overall Study|Lost to Follow-up|4|||
13150183|NCT02559206|26046164|FG000|Overall Study|Lack of Efficacy|1|||
13150184|NCT02559206|26046165|FG001|Overall Study|Lack of Efficacy|0|||
13150185|NCT02559206|26046166|FG002|Overall Study|Lack of Efficacy|3|||
13150186|NCT02559206|26046167|FG003|Overall Study|Lack of Efficacy|2|||
13150187|NCT02559206|26046168|FG004|Overall Study|Lack of Efficacy|2|||
13150188|NCT02559206|26046169|FG005|Overall Study|Lack of Efficacy|3|||
13150189|NCT02559206|26046170|FG006|Overall Study|Lack of Efficacy|3|||
13150190|NCT02559206|26046171|FG007|Overall Study|Lack of Efficacy|3|||
13150191|NCT02559206|26046164|FG000|Overall Study|Other Not Specified|0|||
13150192|NCT02559206|26046165|FG001|Overall Study|Other Not Specified|0|||
13150193|NCT02559206|26046166|FG002|Overall Study|Other Not Specified|0|||
13150194|NCT02559206|26046167|FG003|Overall Study|Other Not Specified|1|||
13150195|NCT02559206|26046168|FG004|Overall Study|Other Not Specified|0|||
13150196|NCT02559206|26046169|FG005|Overall Study|Other Not Specified|0|||
13150197|NCT02559206|26046170|FG006|Overall Study|Other Not Specified|0|||
13150198|NCT02559206|26046171|FG007|Overall Study|Other Not Specified|0|||
13150199|NCT02559115|26046177|FG000|Overall Study|Withdrawal by Subject|3|||
13307583|NCT01284140|26529130|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
13096386|NCT03567291|25844070|FG001|Period I|Missing or unknown|0|||
13096387|NCT03567291|25844071|FG002|Period I|Missing or unknown|0|||
13096388|NCT03567291|25844072|FG003|Period I|Missing or unknown|0|||
13096389|NCT03567291|25844069|FG000|Period II|Adverse Event|0|||
13096390|NCT03567291|25844070|FG001|Period II|Adverse Event|1|||
13096391|NCT03567291|25844071|FG002|Period II|Adverse Event|0|||
13096392|NCT03567291|25844072|FG003|Period II|Adverse Event|0|||
13096393|NCT03567291|25844069|FG000|Period II|Missing or unknown|0|||
13096394|NCT03567291|25844070|FG001|Period II|Missing or unknown|2|||
13096395|NCT03567291|25844071|FG002|Period II|Missing or unknown|1|||
13096396|NCT03567291|25844072|FG003|Period II|Missing or unknown|0|||
13096397|NCT03567291|25844069|FG000|Period III|Adverse Event|0|||
13096398|NCT03567291|25844070|FG001|Period III|Adverse Event|0|||
13096399|NCT03567291|25844071|FG002|Period III|Adverse Event|0|||
13150200|NCT02558894|26046208|FG000|Overall Study|Death; any cause, entire study duration|28|||
13150201|NCT02558894|26046209|FG001|Overall Study|Death; any cause, entire study duration|31|||
13150202|NCT02558894|26046208|FG000|Overall Study|Withdrawal by Subject|2|||
13150203|NCT02558894|26046209|FG001|Overall Study|Withdrawal by Subject|1|||
13096400|NCT03567291|25844072|FG003|Period III|Adverse Event|4|||
13096401|NCT03567291|25844069|FG000|Period III|Withdrawal by Subject|0|||
13096402|NCT03567291|25844070|FG001|Period III|Withdrawal by Subject|0|||
13096403|NCT03567291|25844071|FG002|Period III|Withdrawal by Subject|0|||
13096404|NCT03567291|25844072|FG003|Period III|Withdrawal by Subject|4|||
13096405|NCT03567291|25844069|FG000|Period III|Lost to Follow-up|0|||
13096406|NCT03567291|25844070|FG001|Period III|Lost to Follow-up|0|||
13096407|NCT03567291|25844071|FG002|Period III|Lost to Follow-up|0|||
13096408|NCT03567291|25844072|FG003|Period III|Lost to Follow-up|1|||
13096409|NCT03567291|25844069|FG000|Period III|Terminated by sponsor|0|||
13096410|NCT03567291|25844070|FG001|Period III|Terminated by sponsor|0|||
13096411|NCT03567291|25844071|FG002|Period III|Terminated by sponsor|0|||
13096412|NCT03567291|25844072|FG003|Period III|Terminated by sponsor|68|||
13096413|NCT03567291|25844069|FG000|Period III|Missing or unknown|0|||
13096414|NCT03567291|25844070|FG001|Period III|Missing or unknown|0|||
13096415|NCT03567291|25844071|FG002|Period III|Missing or unknown|0|||
13096416|NCT03567291|25844072|FG003|Period III|Missing or unknown|8|||
13096417|NCT03566979|25844097|FG000|Overall Study|Withdrawal by Subject|2|||
13096418|NCT03566979|25844098|FG001|Overall Study|Withdrawal by Subject|0|||
13096419|NCT03566979|25844099|FG002|Overall Study|Withdrawal by Subject|1|||
13096420|NCT03566979|25844100|FG003|Overall Study|Withdrawal by Subject|1|||
13096421|NCT03566979|25844097|FG000|Overall Study|Lost to Follow-up|2|||
13096422|NCT03566979|25844098|FG001|Overall Study|Lost to Follow-up|7|||
13096423|NCT03566979|25844099|FG002|Overall Study|Lost to Follow-up|9|||
13096424|NCT03566979|25844100|FG003|Overall Study|Lost to Follow-up|5|||
13096425|NCT03566979|25844097|FG000|Overall Study|Adverse Event|1|||
13096426|NCT03566979|25844098|FG001|Overall Study|Adverse Event|0|||
13096427|NCT03566979|25844099|FG002|Overall Study|Adverse Event|0|||
13096428|NCT03566979|25844100|FG003|Overall Study|Adverse Event|0|||
13096429|NCT03566823|25844169|FG000|Overall Study|Lack of Efficacy|0|||
13096430|NCT03566823|25844170|FG001|Overall Study|Lack of Efficacy|1|||
13096431|NCT03566823|25844171|FG002|Overall Study|Lack of Efficacy|0|||
13096432|NCT03566823|25844169|FG000|Overall Study|Withdrawal by Subject|1|||
13096433|NCT03566823|25844170|FG001|Overall Study|Withdrawal by Subject|2|||
13096434|NCT03566823|25844171|FG002|Overall Study|Withdrawal by Subject|0|||
13096435|NCT03566823|25844169|FG000|Overall Study|Adverse Event|1|||
13096436|NCT03566823|25844170|FG001|Overall Study|Adverse Event|0|||
13096437|NCT03566823|25844171|FG002|Overall Study|Adverse Event|2|||
13096438|NCT03566810|25844246|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
13150204|NCT02558894|26046208|FG000|Overall Study|Closure of Part A|2|||
13150205|NCT02558894|26046209|FG001|Overall Study|Closure of Part A|1|||
13150206|NCT02558790|26046215|FG000|Overall Study|Lost to Follow-up|2|||
13150207|NCT02558790|26046215|FG000|Overall Study|Physician Decision|1|||
13150208|NCT02558790|26046215|FG000|Overall Study|Withdrawal by Subject|1|||
13150209|NCT02558790|26046215|FG000|Overall Study|Screen Fail|3|||
13150210|NCT02558400|26046236|FG000|Overall Study|Adverse Event|47|||
13150211|NCT02558400|26046237|FG001|Overall Study|Adverse Event|53|||
13150212|NCT02558400|26046238|FG002|Overall Study|Adverse Event|4|||
13150213|NCT02558400|26046236|FG000|Overall Study|Withdrawal by Subject|13|||
13150214|NCT02558400|26046237|FG001|Overall Study|Withdrawal by Subject|9|||
13150215|NCT02558400|26046238|FG002|Overall Study|Withdrawal by Subject|8|||
13150216|NCT02558400|26046236|FG000|Overall Study|Non-Compliant|0|||
13150217|NCT02558400|26046237|FG001|Overall Study|Non-Compliant|1|||
13150218|NCT02558400|26046238|FG002|Overall Study|Non-Compliant|3|||
13150219|NCT02558400|26046236|FG000|Overall Study|Lost to Follow-up|5|||
13150220|NCT02558400|26046237|FG001|Overall Study|Lost to Follow-up|5|||
13150221|NCT02558400|26046238|FG002|Overall Study|Lost to Follow-up|4|||
13150222|NCT02558400|26046236|FG000|Overall Study|Lack of Efficacy|0|||
13150223|NCT02558400|26046237|FG001|Overall Study|Lack of Efficacy|13|||
13150224|NCT02558400|26046238|FG002|Overall Study|Lack of Efficacy|1|||
13150225|NCT02558400|26046236|FG000|Overall Study|Disallowed Concurrent Medication|6|||
13150226|NCT02558400|26046237|FG001|Overall Study|Disallowed Concurrent Medication|7|||
13150227|NCT02558400|26046238|FG002|Overall Study|Disallowed Concurrent Medication|5|||
13150228|NCT02558400|26046236|FG000|Overall Study|Physician Decision|2|||
13096439|NCT03566810|25844247|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1|||
13096440|NCT03566810|25844248|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
13096441|NCT03566810|25844249|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
13096442|NCT03566680|25844260|FG000|Overall Study|Pregnancy|1|||
13096443|NCT03566680|25844260|FG000|Overall Study|Lost to Follow-up|13|||
13096444|NCT03566680|25844260|FG000|Overall Study|Withdrawal by Subject|3|||
13096445|NCT03566550|25844281|FG000|Overall Study|Withdrawal by Subject|0|||
13096446|NCT03566550|25844282|FG001|Overall Study|Withdrawal by Subject|1|||
13096447|NCT03566485|25844302|FG000|Overall Study|Disease progression|5|||
13150229|NCT02558400|26046237|FG001|Overall Study|Physician Decision|2|||
13150230|NCT02558400|26046238|FG002|Overall Study|Physician Decision|0|||
13150231|NCT02558400|26046236|FG000|Overall Study|Protocol Violation|6|||
13150232|NCT02558400|26046237|FG001|Overall Study|Protocol Violation|3|||
13150233|NCT02558400|26046238|FG002|Overall Study|Protocol Violation|8|||
13150234|NCT02558400|26046236|FG000|Overall Study|Death|0|||
13150235|NCT02558400|26046237|FG001|Overall Study|Death|1|||
13150236|NCT02558400|26046238|FG002|Overall Study|Death|0|||
13150237|NCT02558400|26046236|FG000|Overall Study|Ineligible for the study|0|||
13150238|NCT02558400|26046237|FG001|Overall Study|Ineligible for the study|2|||
13150239|NCT02558400|26046238|FG002|Overall Study|Ineligible for the study|0|||
13150240|NCT02558296|26046273|FG000|Completed the Study Through Week 24|Adverse Event|9|||
13096448|NCT03566485|25844303|FG001|Overall Study|Disease progression|4|||
13096449|NCT03566485|25844302|FG000|Overall Study|Clinical progression|0|||
13096450|NCT03566485|25844303|FG001|Overall Study|Clinical progression|1|||
13096451|NCT03566485|25844302|FG000|Overall Study|Toxicity|0|||
13096452|NCT03566485|25844303|FG001|Overall Study|Toxicity|2|||
13096453|NCT03566238|25844324|FG000|Overall Study|Adverse Event|0|||
13096454|NCT03566238|25844325|FG001|Overall Study|Adverse Event|1|||
13096455|NCT03566238|25844326|FG002|Overall Study|Adverse Event|0|||
13096456|NCT03566238|25844324|FG000|Overall Study|Lack of Efficacy|4|||
13096457|NCT03566238|25844325|FG001|Overall Study|Lack of Efficacy|2|||
13096458|NCT03566238|25844326|FG002|Overall Study|Lack of Efficacy|5|||
13096459|NCT03566238|25844324|FG000|Overall Study|Other|1|||
13096460|NCT03566238|25844325|FG001|Overall Study|Other|0|||
13096461|NCT03566238|25844326|FG002|Overall Study|Other|0|||
13096462|NCT03565900|25844391|FG000|Overall Study|Disposition Unknown|4|||
13096463|NCT03565900|25844392|FG001|Overall Study|Disposition Unknown|1|||
13096464|NCT03565900|25844391|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
13096465|NCT03565900|25844392|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
13096466|NCT03565900|25844391|FG000|Overall Study|Withdrawal by Subject|4|||
13096467|NCT03565900|25844392|FG001|Overall Study|Withdrawal by Subject|5|||
13096468|NCT03565900|25844391|FG000|Overall Study|Randomized By Mistake|0|||
13096469|NCT03565900|25844392|FG001|Overall Study|Randomized By Mistake|2|||
13096470|NCT03565900|25844391|FG000|Overall Study|Physician Decision|7|||
13096471|NCT03565900|25844392|FG001|Overall Study|Physician Decision|11|||
13096472|NCT03565900|25844391|FG000|Overall Study|Death|9|||
13096473|NCT03565900|25844392|FG001|Overall Study|Death|7|||
13096474|NCT03565887|25844407|FG000|Overall Study|Adverse Event|1|||
13096475|NCT03565887|25844408|FG001|Overall Study|Adverse Event|0|||
13096476|NCT03565887|25844407|FG000|Overall Study|Withdrawal by Subject|0|||
13096477|NCT03565887|25844408|FG001|Overall Study|Withdrawal by Subject|2|||
13096478|NCT03565315|25844458|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
13096479|NCT03565315|25844459|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
13096480|NCT03565315|25844460|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
13096481|NCT03565315|25844461|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1|||
13096482|NCT03565237|25844473|FG000|Overall Study|Non-compliance of Investigational Product|1|||
13096483|NCT03565237|25844473|FG000|Overall Study|Physician Decision|1|||
13096484|NCT03565211|25844498|FG000|Overall Study|Withdrawal by Subject|2|||
13096485|NCT03565211|25844498|FG000|Overall Study|Lost to Follow-up|1|||
13096486|NCT03565211|25844498|FG000|Overall Study|Adverse Event|44|||
13096487|NCT03565211|25844498|FG000|Overall Study|Personal issues|1|||
13096488|NCT03565068|25844798|FG000|Overall Study|Protocol Violation|0|||
13096489|NCT03565068|25844799|FG001|Overall Study|Protocol Violation|0|||
13096490|NCT03565068|25844800|FG002|Overall Study|Protocol Violation|0|||
13096491|NCT03565068|25844801|FG003|Overall Study|Protocol Violation|0|||
13096492|NCT03565068|25844802|FG004|Overall Study|Protocol Violation|1|||
13096493|NCT03565068|25844803|FG005|Overall Study|Protocol Violation|0|||
13096494|NCT03565068|25844804|FG006|Overall Study|Protocol Violation|0|||
13096495|NCT03565068|25844805|FG007|Overall Study|Protocol Violation|1|||
13096496|NCT03565068|25844806|FG008|Overall Study|Protocol Violation|0|||
13096497|NCT03565068|25844798|FG000|Overall Study|Sponsor decision|0|||
13096498|NCT03565068|25844799|FG001|Overall Study|Sponsor decision|0|||
13096499|NCT03565068|25844800|FG002|Overall Study|Sponsor decision|0|||
13096500|NCT03565068|25844801|FG003|Overall Study|Sponsor decision|0|||
13096501|NCT03565068|25844802|FG004|Overall Study|Sponsor decision|1|||
13096502|NCT03565068|25844803|FG005|Overall Study|Sponsor decision|1|||
13096503|NCT03565068|25844804|FG006|Overall Study|Sponsor decision|0|||
13096504|NCT03565068|25844805|FG007|Overall Study|Sponsor decision|0|||
13096505|NCT03565068|25844806|FG008|Overall Study|Sponsor decision|0|||
13096506|NCT03565068|25844798|FG000|Overall Study|Withdrawal by Subject|0|||
13096507|NCT03565068|25844799|FG001|Overall Study|Withdrawal by Subject|0|||
13096508|NCT03565068|25844800|FG002|Overall Study|Withdrawal by Subject|1|||
13096509|NCT03565068|25844801|FG003|Overall Study|Withdrawal by Subject|0|||
13096510|NCT03565068|25844802|FG004|Overall Study|Withdrawal by Subject|2|||
13096511|NCT03565068|25844803|FG005|Overall Study|Withdrawal by Subject|0|||
13096512|NCT03565068|25844804|FG006|Overall Study|Withdrawal by Subject|1|||
13096513|NCT03565068|25844805|FG007|Overall Study|Withdrawal by Subject|5|||
13096514|NCT03565068|25844806|FG008|Overall Study|Withdrawal by Subject|1|||
13150241|NCT02558296|26046274|FG001|Completed the Study Through Week 24|Adverse Event|3|||
13096515|NCT03565068|25844798|FG000|Overall Study|Physician Decision|0|||
13150242|NCT02558296|26046273|FG000|Completed the Study Through Week 24|Death|7|||
13307584|NCT01284140|26529129|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0|||
13096516|NCT03565068|25844799|FG001|Overall Study|Physician Decision|0|||
13485239|NCT02499900|27032164|FG000|Core Study Period|Per sponsor request|0|||
13485240|NCT02499900|27032165|FG001|Core Study Period|Per sponsor request|1|||
13485241|NCT02499900|27032164|FG000|Core Study Period|Pregnancy|1|||
13485242|NCT02499900|27032165|FG001|Core Study Period|Pregnancy|0|||
13485243|NCT02499900|27032164|FG000|Core Study Period|Protocol Violation|3|||
13485244|NCT02499900|27032165|FG001|Core Study Period|Protocol Violation|0|||
13485245|NCT02499900|27032164|FG000|Core Study Period|Withdrawal by Subject|11|||
13485246|NCT02499900|27032165|FG001|Core Study Period|Withdrawal by Subject|10|||
13485247|NCT02499900|27032164|FG000|Core Study Period|Adverse Event|18|||
13485248|NCT02499900|27032165|FG001|Core Study Period|Adverse Event|14|||
13485249|NCT02499900|27032164|FG000|Core Study Period|Death|0|||
13485250|NCT02499900|27032165|FG001|Core Study Period|Death|1|||
13485251|NCT02499900|27032164|FG000|Completed Core, Continued Into Extension|Physician Decision|1|||
13096517|NCT03565068|25844800|FG002|Overall Study|Physician Decision|0|||
13096518|NCT03565068|25844801|FG003|Overall Study|Physician Decision|0|||
13096519|NCT03565068|25844802|FG004|Overall Study|Physician Decision|0|||
13096520|NCT03565068|25844803|FG005|Overall Study|Physician Decision|0|||
13096521|NCT03565068|25844804|FG006|Overall Study|Physician Decision|0|||
13096522|NCT03565068|25844805|FG007|Overall Study|Physician Decision|1|||
13096523|NCT03565068|25844806|FG008|Overall Study|Physician Decision|0|||
13096524|NCT03565068|25844798|FG000|Overall Study|Lost to Follow-up|0|||
13096525|NCT03565068|25844799|FG001|Overall Study|Lost to Follow-up|0|||
13096526|NCT03565068|25844800|FG002|Overall Study|Lost to Follow-up|0|||
13096527|NCT03565068|25844801|FG003|Overall Study|Lost to Follow-up|0|||
13096528|NCT03565068|25844802|FG004|Overall Study|Lost to Follow-up|0|||
13096529|NCT03565068|25844803|FG005|Overall Study|Lost to Follow-up|0|||
13096530|NCT03565068|25844804|FG006|Overall Study|Lost to Follow-up|0|||
13096531|NCT03565068|25844805|FG007|Overall Study|Lost to Follow-up|1|||
13096532|NCT03565068|25844806|FG008|Overall Study|Lost to Follow-up|0|||
13096533|NCT03563716|25844821|FG000|Overall Study|Death|20|||
13096534|NCT03563716|25844822|FG001|Overall Study|Death|14|||
13096535|NCT03563716|25844821|FG000|Overall Study|Withdrawal by Subject|3|||
13096536|NCT03563716|25844822|FG001|Overall Study|Withdrawal by Subject|3|||
13096537|NCT03563716|25844821|FG000|Overall Study|Still on Study|45|||
13096538|NCT03563716|25844822|FG001|Overall Study|Still on Study|50|||
13096539|NCT03562481|25844851|FG000|First Intervention|Lost to Follow-up|1|||
13096540|NCT03562481|25844852|FG001|First Intervention|Lost to Follow-up|0|||
13096541|NCT03562117|25844948|FG000|Part 1, Up to 3 Days|Adverse Event|1|||
13096542|NCT03562117|25844949|FG001|Part 1, Up to 3 Days|Adverse Event|0|||
13096543|NCT03562117|25844950|FG002|Part 1, Up to 3 Days|Adverse Event|0|||
13096544|NCT03561883|25844969|FG000|Overall Study|Adverse Event|10|||
13096545|NCT03561883|25844970|FG001|Overall Study|Adverse Event|13|||
13096546|NCT03561883|25844969|FG000|Overall Study|Non-Compliance With Study Drug|1|||
13096547|NCT03561883|25844970|FG001|Overall Study|Non-Compliance With Study Drug|2|||
13096548|NCT03561883|25844969|FG000|Overall Study|Protocol Violation|2|||
13096549|NCT03561883|25844970|FG001|Overall Study|Protocol Violation|3|||
13096550|NCT03561883|25844969|FG000|Overall Study|Withdrawal by Subject|14|||
13096551|NCT03561883|25844970|FG001|Overall Study|Withdrawal by Subject|6|||
13096552|NCT03561883|25844969|FG000|Overall Study|Lost to Follow-up|2|||
13096553|NCT03561883|25844970|FG001|Overall Study|Lost to Follow-up|6|||
13096554|NCT03561883|25844969|FG000|Overall Study|Study Terminated by Sponsor|12|||
13096555|NCT03561883|25844970|FG001|Overall Study|Study Terminated by Sponsor|11|||
13096556|NCT03561883|25844969|FG000|Overall Study|Physician Decision|1|||
13096557|NCT03561883|25844970|FG001|Overall Study|Physician Decision|0|||
13096558|NCT03561883|25844969|FG000|Overall Study|Randomized by Mistake|1|||
13096559|NCT03561883|25844970|FG001|Overall Study|Randomized by Mistake|0|||
13096560|NCT03561883|25844969|FG000|Overall Study|Other, Not Specified|3|||
13096561|NCT03561883|25844970|FG001|Overall Study|Other, Not Specified|2|||
13096562|NCT03561090|25844989|FG000|Overall Study|Adverse Event|11|||
13096563|NCT03561090|25844990|FG001|Overall Study|Adverse Event|7|||
13096564|NCT03561090|25844989|FG000|Overall Study|Non-Compliance With Study Drug|2|||
13096565|NCT03561090|25844990|FG001|Overall Study|Non-Compliance With Study Drug|0|||
13096566|NCT03561090|25844989|FG000|Overall Study|Protocol Violation|2|||
13096567|NCT03561090|25844990|FG001|Overall Study|Protocol Violation|2|||
13096568|NCT03561090|25844989|FG000|Overall Study|Withdrawal by Subject|7|||
13096569|NCT03561090|25844990|FG001|Overall Study|Withdrawal by Subject|7|||
13096570|NCT03561090|25844989|FG000|Overall Study|Lost to Follow-up|7|||
13096571|NCT03561090|25844990|FG001|Overall Study|Lost to Follow-up|2|||
13096572|NCT03561090|25844989|FG000|Overall Study|Study Terminated by Sponsor|10|||
13096573|NCT03561090|25844990|FG001|Overall Study|Study Terminated by Sponsor|15|||
13096574|NCT03561090|25844989|FG000|Overall Study|Randomized by Mistake|1|||
13096575|NCT03561090|25844990|FG001|Overall Study|Randomized by Mistake|1|||
13096576|NCT03561090|25844989|FG000|Overall Study|Other Not Specified|0|||
13096577|NCT03561090|25844990|FG001|Overall Study|Other Not Specified|2|||
13096578|NCT03560986|25845019|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
13222664|NCT01803737|26286704|FG001|Overall Study|Lack of Time|0|||
13485252|NCT02499900|27032165|FG001|Completed Core, Continued Into Extension|Physician Decision|0|||
13096579|NCT03560986|25845020|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
13096580|NCT03560986|25845019|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
13096581|NCT03560986|25845020|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
13096582|NCT03560986|25845019|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0|||
13096583|NCT03560986|25845020|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1|||
13096584|NCT03560986|25845019|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32|||
13096585|NCT03560986|25845020|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35|||
13096586|NCT03560986|25845019|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1|||
13096587|NCT03560986|25845020|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0|||
13096588|NCT03560986|25845019|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0|||
13096589|NCT03560986|25845020|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1|||
13096590|NCT03560986|25845019|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
13096591|NCT03560986|25845020|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
13096592|NCT03560869|25845031|FG000|Overall Study|Withdrawal by Subject|3|||
13096593|NCT03560869|25845032|FG001|Overall Study|Withdrawal by Subject|4|||
13096594|NCT03560869|25845031|FG000|Overall Study|Screening failure|4|||
13096595|NCT03560869|25845032|FG001|Overall Study|Screening failure|4|||
13096596|NCT03560869|25845031|FG000|Overall Study|Withdrawal by PI|0|||
13096597|NCT03560869|25845032|FG001|Overall Study|Withdrawal by PI|1|||
13096598|NCT03560739|25845071|FG000|Overall Study|Adverse Event|0|||
13096599|NCT03560739|25845072|FG001|Overall Study|Adverse Event|1|||
13096600|NCT03560739|25845073|FG002|Overall Study|Adverse Event|0|||
13096601|NCT03560739|25845074|FG003|Overall Study|Adverse Event|0|||
13150243|NCT02558296|26046274|FG001|Completed the Study Through Week 24|Death|7|||
13150244|NCT02558296|26046273|FG000|Completed the Study Through Week 24|Lost to Follow-up|8|||
13150245|NCT02558296|26046274|FG001|Completed the Study Through Week 24|Lost to Follow-up|1|||
13150246|NCT02558296|26046273|FG000|Completed the Study Through Week 24|Physician Decision|1|||
13150247|NCT02558296|26046274|FG001|Completed the Study Through Week 24|Physician Decision|0|||
13150248|NCT02558296|26046273|FG000|Completed the Study Through Week 24|Protocol Violation|1|||
13150249|NCT02558296|26046274|FG001|Completed the Study Through Week 24|Protocol Violation|1|||
13150250|NCT02558296|26046273|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17|||
13150251|NCT02558296|26046274|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13|||
13150252|NCT02558296|26046273|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1|||
13096602|NCT03560518|25845095|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1|||
13096603|NCT03560518|25845096|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0|||
13096604|NCT03560518|25845097|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0|||
13096605|NCT03560518|25845095|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6|||
13096606|NCT03560518|25845096|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9|||
13096607|NCT03560518|25845097|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10|||
13096608|NCT03560518|25845095|FG000|Double Blind Treatment Period|Protocol Violation|1|||
13096609|NCT03560518|25845096|FG001|Double Blind Treatment Period|Protocol Violation|2|||
13096610|NCT03560518|25845097|FG002|Double Blind Treatment Period|Protocol Violation|0|||
13096611|NCT03560518|25845095|FG000|Double Blind Treatment Period|Pregnancy|0|||
13096612|NCT03560518|25845096|FG001|Double Blind Treatment Period|Pregnancy|2|||
13096613|NCT03560518|25845097|FG002|Double Blind Treatment Period|Pregnancy|0|||
13096614|NCT03560518|25845095|FG000|Double Blind Treatment Period|Lost to Follow-up|5|||
13096615|NCT03560518|25845096|FG001|Double Blind Treatment Period|Lost to Follow-up|6|||
13096616|NCT03560518|25845097|FG002|Double Blind Treatment Period|Lost to Follow-up|6|||
13096617|NCT03560518|25845095|FG000|Double Blind Treatment Period|Withdrawal by Subject|10|||
13096618|NCT03560518|25845096|FG001|Double Blind Treatment Period|Withdrawal by Subject|6|||
13096619|NCT03560518|25845097|FG002|Double Blind Treatment Period|Withdrawal by Subject|5|||
13096620|NCT03560518|25845095|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
13096621|NCT03560518|25845096|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
13096622|NCT03560518|25845097|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
13096623|NCT03560518|25845095|FG000|Double Blind Treatment Period|Adverse Event|0|||
13096624|NCT03560518|25845096|FG001|Double Blind Treatment Period|Adverse Event|3|||
13096625|NCT03560518|25845097|FG002|Double Blind Treatment Period|Adverse Event|1|||
13096626|NCT03560258|25845130|FG000|Overall Study|Lost to Follow-up|3|||
13096627|NCT03560258|25845131|FG001|Overall Study|Lost to Follow-up|0|||
13096628|NCT03560258|25845132|FG002|Overall Study|Lost to Follow-up|0|||
13096629|NCT03560258|25845130|FG000|Overall Study|Protocol Violation|0|||
13096630|NCT03560258|25845131|FG001|Overall Study|Protocol Violation|1|||
13096631|NCT03560258|25845132|FG002|Overall Study|Protocol Violation|0|||
13096632|NCT03560258|25845130|FG000|Overall Study|Withdrawal by Subject|0|||
13096633|NCT03560258|25845131|FG001|Overall Study|Withdrawal by Subject|0|||
13096634|NCT03560258|25845132|FG002|Overall Study|Withdrawal by Subject|1|||
13096635|NCT03560245|25845155|FG000|Overall Study|Withdrawal by Subject|3|||
13096636|NCT03560245|25845156|FG001|Overall Study|Withdrawal by Subject|2|||
13096637|NCT03560245|25845155|FG000|Overall Study|Adverse Event|1|||
13150253|NCT02558296|26046274|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0|||
13150254|NCT02558296|26046273|FG000|Completed the Study|Adverse Event|14|||
13096638|NCT03560245|25845156|FG001|Overall Study|Adverse Event|1|||
13096639|NCT03560245|25845155|FG000|Overall Study|Protocol Violation|1|||
13096640|NCT03560245|25845156|FG001|Overall Study|Protocol Violation|0|||
13096641|NCT03560245|25845155|FG000|Overall Study|Death|0|||
13096642|NCT03560245|25845156|FG001|Overall Study|Death|1|||
13096643|NCT03560245|25845155|FG000|Overall Study|Lost to Follow-up|0|||
13096644|NCT03560245|25845156|FG001|Overall Study|Lost to Follow-up|1|||
13096645|NCT03560245|25845155|FG000|Overall Study|Physician Decision|0|||
13096646|NCT03560245|25845156|FG001|Overall Study|Physician Decision|1|||
13096647|NCT03560245|25845155|FG000|Overall Study|Other|0|||
13096648|NCT03560245|25845156|FG001|Overall Study|Other|1|||
13096649|NCT03560206|25845171|FG000|Overall Study|Lost to Follow-up|19|||
13096650|NCT03560206|25845172|FG001|Overall Study|Lost to Follow-up|11|||
13096651|NCT03560206|25845171|FG000|Overall Study|Withdrawal by Subject|2|||
13096652|NCT03560206|25845172|FG001|Overall Study|Withdrawal by Subject|4|||
13096653|NCT03560206|25845171|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5|||
13096654|NCT03560206|25845172|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0|||
13096655|NCT03560206|25845171|FG000|Overall Study|Busy schedule|14|||
13096656|NCT03560206|25845172|FG001|Overall Study|Busy schedule|2|||
13096657|NCT03560206|25845171|FG000|Overall Study|patients' new health condition such as cancer|10|||
13096658|NCT03560206|25845172|FG001|Overall Study|patients' new health condition such as cancer|1|||
13096659|NCT03559530|25845180|FG000|Overall Study|non-location of medical records|44|||
13096660|NCT03559530|25845181|FG001|Overall Study|non-location of medical records|0|||
13096661|NCT03559530|25845180|FG000|Overall Study|culture results not considered for treat|29|||
13096662|NCT03559530|25845181|FG001|Overall Study|culture results not considered for treat|0|||
13096663|NCT03559530|25845180|FG000|Overall Study|duplicate cases|8|||
13096664|NCT03559530|25845181|FG001|Overall Study|duplicate cases|0|||
13096665|NCT03559530|25845180|FG000|Overall Study|other species of Acinetobacte|7|||
13096666|NCT03559530|25845181|FG001|Overall Study|other species of Acinetobacte|0|||
13096667|NCT03559530|25845180|FG000|Overall Study|contamination / colonization|3|||
13096668|NCT03559530|25845181|FG001|Overall Study|contamination / colonization|0|||
13096669|NCT03559517|25845250|FG000|Overall Study|Withdrawal by Subject|1|||
13096670|NCT03559517|25845251|FG001|Overall Study|Withdrawal by Subject|0|||
13096671|NCT03559517|25845252|FG002|Overall Study|Withdrawal by Subject|0|||
13096672|NCT03559257|25845303|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
13096673|NCT03559257|25845304|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
13096674|NCT03559257|25845303|FG000|Double Blind Treatment Period|Protocol Violation|1|||
13096675|NCT03559257|25845304|FG001|Double Blind Treatment Period|Protocol Violation|4|||
13096676|NCT03559257|25845303|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
13096677|NCT03559257|25845304|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
13096678|NCT03559257|25845303|FG000|Double Blind Treatment Period|Adverse Event|0|||
13096679|NCT03559257|25845304|FG001|Double Blind Treatment Period|Adverse Event|1|||
13096680|NCT03559257|25845303|FG000|Double Blind Treatment Period|Screen Failure|0|||
13096681|NCT03559257|25845304|FG001|Double Blind Treatment Period|Screen Failure|1|||
13096682|NCT03559257|25845303|FG000|Open-label Treatment Period|Adverse Event|1|||
13096683|NCT03559257|25845304|FG001|Open-label Treatment Period|Adverse Event|4|||
13096684|NCT03559257|25845303|FG000|Open-label Treatment Period|Lack of Efficacy|3|||
13096685|NCT03559257|25845304|FG001|Open-label Treatment Period|Lack of Efficacy|2|||
13096686|NCT03559257|25845303|FG000|Open-label Treatment Period|Withdrawal by Subject|3|||
13096687|NCT03559257|25845304|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
13096688|NCT03559257|25845303|FG000|Open-label Treatment Period|Protocol Violation|2|||
13096689|NCT03559257|25845304|FG001|Open-label Treatment Period|Protocol Violation|0|||
13096690|NCT03559257|25845303|FG000|Open-label Treatment Period|Lost to Follow-up|1|||
13096691|NCT03559257|25845304|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
13096692|NCT03559257|25845303|FG000|Open-label Treatment Period|Physician Decision|0|||
13096693|NCT03559257|25845304|FG001|Open-label Treatment Period|Physician Decision|1|||
13096694|NCT03559218|25845321|FG000|Overall Study|Withdrawal by Subject|1|||
13096695|NCT03559218|25845322|FG001|Overall Study|Withdrawal by Subject|0|||
13096696|NCT03559062|25845343|FG000|Overall Study|Other|0|||
13096697|NCT03559062|25845344|FG001|Overall Study|Other|1|||
13096698|NCT03559062|25845345|FG002|Overall Study|Other|0|||
13096699|NCT03558997|25845390|FG000|Overall Study|Adverse Event|0|||
13096700|NCT03558997|25845391|FG001|Overall Study|Adverse Event|2|||
13096701|NCT03558997|25845392|FG002|Overall Study|Adverse Event|5|||
13096702|NCT03558997|25845393|FG003|Overall Study|Adverse Event|1|||
13096703|NCT03558997|25845390|FG000|Overall Study|Physician Decision|0|||
13096704|NCT03558997|25845391|FG001|Overall Study|Physician Decision|0|||
13096705|NCT03558997|25845392|FG002|Overall Study|Physician Decision|1|||
13096706|NCT03558997|25845393|FG003|Overall Study|Physician Decision|0|||
13096707|NCT03558997|25845390|FG000|Overall Study|Withdrawal by Subject|1|||
13096708|NCT03558997|25845391|FG001|Overall Study|Withdrawal by Subject|0|||
13096709|NCT03558997|25845392|FG002|Overall Study|Withdrawal by Subject|1|||
13096710|NCT03558997|25845393|FG003|Overall Study|Withdrawal by Subject|1|||
13096711|NCT03558997|25845390|FG000|Overall Study|Lost to Follow-up|0|||
13096712|NCT03558997|25845391|FG001|Overall Study|Lost to Follow-up|0|||
13096713|NCT03558997|25845392|FG002|Overall Study|Lost to Follow-up|1|||
13096714|NCT03558997|25845393|FG003|Overall Study|Lost to Follow-up|0|||
13096715|NCT03558672|25845405|FG000|Overall Study|Study Early Termination|10|||
13096716|NCT03558555|25845428|FG000|Overall Study|Lost to Follow-up|2|||
13096717|NCT03558555|25845429|FG001|Overall Study|Lost to Follow-up|1|||
13096718|NCT03558516|25845454|FG000|Overall Study|Protocol Violation|2|||
13096719|NCT03558516|25845455|FG001|Overall Study|Protocol Violation|2|||
13096720|NCT03558503|25845470|FG000|Overall Study|Adverse Event|1|||
13096721|NCT03558503|25845470|FG000|Overall Study|Death|1|||
13096722|NCT03558503|25845470|FG000|Overall Study|Refused to come in for the final 12-month assessment due to COVID-19|1|||
13096723|NCT03557970|25845491|FG000|Overall Study|Study closure|1|||
13096724|NCT03557970|25845492|FG001|Overall Study|Study closure|0|||
13096725|NCT03557970|25845491|FG000|Overall Study|Physician Decision|0|||
13096726|NCT03557970|25845492|FG001|Overall Study|Physician Decision|1|||
13096727|NCT03557970|25845491|FG000|Overall Study|Death|0|||
13096728|NCT03557970|25845492|FG001|Overall Study|Death|1|||
13096729|NCT03557931|25845530|FG000|Overall Study|Adverse Event|4|||
13096730|NCT03557931|25845531|FG001|Overall Study|Adverse Event|6|||
13096731|NCT03557931|25845532|FG002|Overall Study|Adverse Event|1|||
13096732|NCT03557931|25845530|FG000|Overall Study|Lost to Follow-up|4|||
13096733|NCT03557931|25845531|FG001|Overall Study|Lost to Follow-up|4|||
13096734|NCT03557931|25845532|FG002|Overall Study|Lost to Follow-up|1|||
13096735|NCT03557931|25845530|FG000|Overall Study|Protocol Violation|1|||
13096736|NCT03557931|25845531|FG001|Overall Study|Protocol Violation|4|||
13096737|NCT03557931|25845532|FG002|Overall Study|Protocol Violation|1|||
13096738|NCT03557931|25845530|FG000|Overall Study|Withdrawal by Subject|14|||
13096739|NCT03557931|25845531|FG001|Overall Study|Withdrawal by Subject|0|||
13096740|NCT03557931|25845532|FG002|Overall Study|Withdrawal by Subject|7|||
13096741|NCT03557931|25845530|FG000|Overall Study|Miscellaneous|8|||
13096742|NCT03557931|25845531|FG001|Overall Study|Miscellaneous|5|||
13096743|NCT03557931|25845532|FG002|Overall Study|Miscellaneous|3|||
13096744|NCT03557801|25845556|FG000|Overall Study|Protocol Violation|1|||
13096745|NCT03557801|25845557|FG001|Overall Study|Protocol Violation|0|||
13096746|NCT03557801|25845558|FG002|Overall Study|Protocol Violation|0|||
13096747|NCT03557801|25845556|FG000|Overall Study|Withdrawal by Subject|1|||
13096748|NCT03557801|25845557|FG001|Overall Study|Withdrawal by Subject|0|||
13096749|NCT03557801|25845558|FG002|Overall Study|Withdrawal by Subject|3|||
13096750|NCT03557801|25845556|FG000|Overall Study|Lost to Follow-up|0|||
13096751|NCT03557801|25845557|FG001|Overall Study|Lost to Follow-up|1|||
13096752|NCT03557801|25845558|FG002|Overall Study|Lost to Follow-up|0|||
13096753|NCT03557775|25845624|FG000|Overall Study|Withdrawal by Subject|1|||
13096754|NCT03557775|25845625|FG001|Overall Study|Withdrawal by Subject|2|||
13096755|NCT03557775|25845626|FG002|Overall Study|Withdrawal by Subject|4|||
13096756|NCT03557775|25845624|FG000|Overall Study|Physician Decision|0|||
13096757|NCT03557775|25845625|FG001|Overall Study|Physician Decision|1|||
13096758|NCT03557775|25845626|FG002|Overall Study|Physician Decision|0|||
13096759|NCT03557307|25845636|FG000|To End of OCS Reduction Phase|Withdrawal by Subject|10|||
13096760|NCT03557307|25845636|FG000|To End of OCS Reduction Phase|Adverse Event|7|||
13096761|NCT03557307|25845636|FG000|To End of OCS Reduction Phase|Protocol Violation|6|||
13096762|NCT03557307|25845636|FG000|To End of OCS Reduction Phase|Lost to Follow-up|5|||
13096763|NCT03557307|25845636|FG000|To End of OCS Reduction Phase|other|3|||
13096764|NCT03557307|25845636|FG000|To End of OCS Reduction Phase|Death|2|||
13096765|NCT03557307|25845636|FG000|To End of OCS Reduction Phase|Failure to meet inclusion/exclusion criteria|2|||
13096766|NCT03557307|25845636|FG000|Maintenance Phase|Adverse Event|4|||
13096767|NCT03557307|25845636|FG000|Maintenance Phase|Death|3|||
13096768|NCT03557307|25845636|FG000|Maintenance Phase|Lost to Follow-up|2|||
13096769|NCT03557307|25845636|FG000|Maintenance Phase|Pregnancy|2|||
13096770|NCT03557307|25845636|FG000|Maintenance Phase|Protocol Violation|11|||
13096771|NCT03557307|25845636|FG000|Maintenance Phase|Withdrawal by Subject|2|||
13096772|NCT03557307|25845636|FG000|Maintenance Phase|other|3|||
13096773|NCT03557151|25845661|FG000|Randomization to 3 Months|Lost to Follow-up|2|||
13096774|NCT03557151|25845662|FG001|Randomization to 3 Months|Lost to Follow-up|2|||
13096775|NCT03557151|25845661|FG000|6 to 9 Months|moved out of state/discontinued care at Nemours|2|||
13096776|NCT03557151|25845662|FG001|6 to 9 Months|moved out of state/discontinued care at Nemours|0|||
13096777|NCT03557151|25845661|FG000|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|0|||
13096778|NCT03557151|25845662|FG001|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|2|||
13096779|NCT03557034|25845685|FG000|Overall Study|Withdrawal by Subject|1|||
13096780|NCT03557034|25845686|FG001|Overall Study|Withdrawal by Subject|0|||
13096781|NCT03555890|25845833|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
13096782|NCT03555890|25845834|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
13096783|NCT03555890|25845835|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
13096784|NCT03555890|25845836|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
13096785|NCT03555565|25845845|FG000|Overall Study|Case Report Forms Uncollected|2|||
13096786|NCT03555565|25845845|FG000|Overall Study|Protocol Deviation|13|||
13096787|NCT03555435|25845886|FG000|Overall Study|Lost to Follow-up|17|||
13096788|NCT03555435|25845887|FG001|Overall Study|Lost to Follow-up|19|||
13096789|NCT03555435|25845888|FG002|Overall Study|Lost to Follow-up|8|||
13096790|NCT03555305|25845903|FG000|Period 1|Physician Decision|0|||
13096791|NCT03555305|25845904|FG001|Period 1|Physician Decision|1|||
13096792|NCT03555305|25845903|FG000|Period 1|Adverse Event|0|||
13096793|NCT03555305|25845904|FG001|Period 1|Adverse Event|1|||
13096794|NCT03555266|25845939|FG000|Overall Study|Protocol Violation|6|||
13096795|NCT03555266|25845940|FG001|Overall Study|Protocol Violation|4|||
13096796|NCT03554772|25845963|FG000|Overall Study|Lost to Follow-up|0|||
13096797|NCT03554772|25845964|FG001|Overall Study|Lost to Follow-up|0|||
13096798|NCT03554772|25845965|FG002|Overall Study|Lost to Follow-up|0|||
13096799|NCT03554772|25845966|FG003|Overall Study|Lost to Follow-up|2|||
13096800|NCT03554629|25845996|FG000|Overall Study|Inadequate data|6|||
13096801|NCT03554486|25846015|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1|||
13096802|NCT03554486|25846016|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0|||
13096803|NCT03554486|25846017|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0|||
13096804|NCT03554486|25846015|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2|||
13096805|NCT03554486|25846016|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
13096806|NCT03554486|25846017|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
13096807|NCT03554486|25846015|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0|||
13096808|NCT03554486|25846016|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
13096809|NCT03554486|25846017|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
13096810|NCT03554018|25846034|FG000|Overall Study|Lost to Follow-up|3|||
13096811|NCT03554018|25846035|FG001|Overall Study|Lost to Follow-up|7|||
13096812|NCT03554005|25846080|FG000|Overall Study|Not in participant's best interest|0|||
13096813|NCT03554005|25846081|FG001|Overall Study|Not in participant's best interest|0|||
13150255|NCT02558296|26046274|FG001|Completed the Study|Adverse Event|5|||
13150256|NCT02558296|26046273|FG000|Completed the Study|Death|39|||
13150257|NCT02558296|26046274|FG001|Completed the Study|Death|25|||
13150258|NCT02558296|26046273|FG000|Completed the Study|Lost to Follow-up|31|||
13150259|NCT02558296|26046274|FG001|Completed the Study|Lost to Follow-up|23|||
13150260|NCT02558296|26046273|FG000|Completed the Study|Physician Decision|6|||
13150261|NCT02558296|26046274|FG001|Completed the Study|Physician Decision|0|||
13150262|NCT02558296|26046273|FG000|Completed the Study|Protocol Violation|2|||
13150263|NCT02558296|26046274|FG001|Completed the Study|Protocol Violation|1|||
13150264|NCT02558296|26046273|FG000|Completed the Study|Withdrawal by Subject|53|||
13150265|NCT02558296|26046274|FG001|Completed the Study|Withdrawal by Subject|31|||
13150266|NCT02558296|26046273|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1|||
13150267|NCT02558296|26046274|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0|||
13150268|NCT02558231|26046305|FG000|Overall Study|Death|4|||
13150269|NCT02558231|26046306|FG001|Overall Study|Death|12|||
13150270|NCT02558231|26046305|FG000|Overall Study|Lost to Follow-up|7|||
13150271|NCT02558231|26046306|FG001|Overall Study|Lost to Follow-up|4|||
13150272|NCT02558231|26046305|FG000|Overall Study|Withdrawal by Subject|7|||
13150273|NCT02558231|26046306|FG001|Overall Study|Withdrawal by Subject|4|||
13150274|NCT02558231|26046305|FG000|Overall Study|Physician Decision|7|||
13150275|NCT02558231|26046306|FG001|Overall Study|Physician Decision|5|||
13150276|NCT02558231|26046305|FG000|Overall Study|Sponsor Decision|0|||
13150277|NCT02558231|26046306|FG001|Overall Study|Sponsor Decision|1|||
13150278|NCT02557672|26046327|FG000|Overall Study|Withdrawal by Subject|4|||
13150279|NCT02557672|26046328|FG001|Overall Study|Withdrawal by Subject|2|||
13150280|NCT02557646|26046348|FG000|Overall Study|Adverse Event|40|||
13150281|NCT02557646|26046348|FG000|Overall Study|Death|1|||
13150282|NCT02557646|26046348|FG000|Overall Study|Lack of Efficacy|186|||
13150283|NCT02557646|26046348|FG000|Overall Study|Withdrawal by Subject|18|||
13150284|NCT02557646|26046348|FG000|Overall Study|Lost to Follow-up|17|||
13150285|NCT02557646|26046348|FG000|Overall Study|Other|14|||
13150286|NCT02557516|26046380|FG000|Overall Study|Adverse Event|1|||
13150287|NCT02557516|26046381|FG001|Overall Study|Adverse Event|0|||
13150288|NCT02557516|26046382|FG002|Overall Study|Adverse Event|2|||
13150289|NCT02557516|26046383|FG003|Overall Study|Adverse Event|1|||
13096814|NCT03554005|25846082|FG002|Overall Study|Not in participant's best interest|0|||
13096815|NCT03554005|25846083|FG003|Overall Study|Not in participant's best interest|0|||
13096816|NCT03554005|25846084|FG004|Overall Study|Not in participant's best interest|0|||
13096817|NCT03554005|25846085|FG005|Overall Study|Not in participant's best interest|1|||
13096818|NCT03554005|25846080|FG000|Overall Study|Disease Progression|1|||
13096819|NCT03554005|25846081|FG001|Overall Study|Disease Progression|1|||
13096820|NCT03554005|25846082|FG002|Overall Study|Disease Progression|1|||
13096821|NCT03554005|25846083|FG003|Overall Study|Disease Progression|1|||
13150290|NCT02557516|26046380|FG000|Overall Study|Disease progression|0|||
13150291|NCT02557516|26046381|FG001|Overall Study|Disease progression|2|||
13150292|NCT02557516|26046382|FG002|Overall Study|Disease progression|0|||
13150293|NCT02557516|26046383|FG003|Overall Study|Disease progression|0|||
13150294|NCT02557516|26046380|FG000|Overall Study|Physician Decision|0|||
13096822|NCT03554005|25846084|FG004|Overall Study|Disease Progression|5|||
13096823|NCT03554005|25846085|FG005|Overall Study|Disease Progression|6|||
13096824|NCT03554005|25846080|FG000|Overall Study|Adverse Event|0|||
13096825|NCT03554005|25846081|FG001|Overall Study|Adverse Event|0|||
13096826|NCT03554005|25846082|FG002|Overall Study|Adverse Event|0|||
13096827|NCT03554005|25846083|FG003|Overall Study|Adverse Event|0|||
13096828|NCT03554005|25846084|FG004|Overall Study|Adverse Event|0|||
13096829|NCT03554005|25846085|FG005|Overall Study|Adverse Event|3|||
13096830|NCT03554005|25846080|FG000|Overall Study|Physician Decision|0|||
13096831|NCT03554005|25846081|FG001|Overall Study|Physician Decision|0|||
13096832|NCT03554005|25846082|FG002|Overall Study|Physician Decision|0|||
13096833|NCT03554005|25846083|FG003|Overall Study|Physician Decision|0|||
13096834|NCT03554005|25846084|FG004|Overall Study|Physician Decision|1|||
13096835|NCT03554005|25846085|FG005|Overall Study|Physician Decision|0|||
13096836|NCT03554005|25846080|FG000|Overall Study|Other|0|||
13096837|NCT03554005|25846081|FG001|Overall Study|Other|0|||
13096838|NCT03554005|25846082|FG002|Overall Study|Other|0|||
13096839|NCT03554005|25846083|FG003|Overall Study|Other|0|||
13096840|NCT03554005|25846084|FG004|Overall Study|Other|0|||
13096841|NCT03554005|25846085|FG005|Overall Study|Other|1|||
13096842|NCT03553823|25846098|FG000|Overall Study|Physician Decision|0|||
13096843|NCT03553823|25846099|FG001|Overall Study|Physician Decision|1|||
13096844|NCT03553758|25846107|FG000|Overall Study|Lost to Follow-up|1|||
13096845|NCT03552757|25846234|FG000|Overall Study|Withdrawal by Subject|10|||
13096846|NCT03552757|25846235|FG001|Overall Study|Withdrawal by Subject|5|||
13096847|NCT03552757|25846236|FG002|Overall Study|Withdrawal by Subject|12|||
13096848|NCT03552757|25846234|FG000|Overall Study|Lost to Follow-up|2|||
13096849|NCT03552757|25846235|FG001|Overall Study|Lost to Follow-up|7|||
13096850|NCT03552757|25846236|FG002|Overall Study|Lost to Follow-up|7|||
13096851|NCT03552757|25846234|FG000|Overall Study|Death|1|||
13096852|NCT03552757|25846235|FG001|Overall Study|Death|1|||
13096853|NCT03552757|25846236|FG002|Overall Study|Death|1|||
13096854|NCT03552549|25846251|FG000|Overall Study|Disease progression|25|||
13096855|NCT03552549|25846252|FG001|Overall Study|Disease progression|17|||
13096856|NCT03552549|25846251|FG000|Overall Study|Adverse event in first 12 months|12|||
13096857|NCT03552549|25846252|FG001|Overall Study|Adverse event in first 12 months|8|||
13096858|NCT03552549|25846251|FG000|Overall Study|Withdrawal by Subject|7|||
13096859|NCT03552549|25846252|FG001|Overall Study|Withdrawal by Subject|7|||
13096860|NCT03552549|25846251|FG000|Overall Study|Unknown (no reason provided)|4|||
13096861|NCT03552549|25846252|FG001|Overall Study|Unknown (no reason provided)|2|||
13096862|NCT03552549|25846251|FG000|Overall Study|Not in participant's best interest|2|||
13096863|NCT03552549|25846252|FG001|Overall Study|Not in participant's best interest|1|||
13096864|NCT03552549|25846251|FG000|Overall Study|Did not complete study treatment|2|||
13096865|NCT03552549|25846252|FG001|Overall Study|Did not complete study treatment|3|||
13096866|NCT03552549|25846251|FG000|Overall Study|Did not meet eligibility criteria|1|||
13096867|NCT03552549|25846252|FG001|Overall Study|Did not meet eligibility criteria|0|||
13096868|NCT03552549|25846251|FG000|Overall Study|Administrative|0|||
13096869|NCT03552549|25846252|FG001|Overall Study|Administrative|14|||
13150295|NCT02557516|26046381|FG001|Overall Study|Physician Decision|2|||
13150296|NCT02557516|26046382|FG002|Overall Study|Physician Decision|0|||
13150297|NCT02557516|26046383|FG003|Overall Study|Physician Decision|0|||
13150298|NCT02557516|26046380|FG000|Overall Study|Sponsor decision|0|||
13150299|NCT02557516|26046381|FG001|Overall Study|Sponsor decision|1|||
13150300|NCT02557516|26046382|FG002|Overall Study|Sponsor decision|2|||
13150301|NCT02557516|26046383|FG003|Overall Study|Sponsor decision|8|||
13150302|NCT02557399|26046422|FG000|Overall Study|Adverse Event|6|||
13150303|NCT02557399|26046423|FG001|Overall Study|Adverse Event|5|||
13150304|NCT02557399|26046422|FG000|Overall Study|Protocol Violation|0|||
13150305|NCT02557399|26046423|FG001|Overall Study|Protocol Violation|1|||
13150306|NCT02557399|26046422|FG000|Overall Study|Protocol-defined stopping criteria|0|||
13150307|NCT02557399|26046423|FG001|Overall Study|Protocol-defined stopping criteria|1|||
13096870|NCT03552523|25846263|FG000|Overall Study|Withdrawal by Subject|1|||
13096871|NCT03552523|25846264|FG001|Overall Study|Withdrawal by Subject|1|||
13096872|NCT03552198|25846299|FG000|Overall Study|Lost to Follow-up|42|||
13096873|NCT03552198|25846300|FG001|Overall Study|Lost to Follow-up|48|||
13096874|NCT03552198|25846301|FG002|Overall Study|Lost to Follow-up|15|||
13096875|NCT03552198|25846302|FG003|Overall Study|Lost to Follow-up|19|||
13096876|NCT03552198|25846299|FG000|Overall Study|Incomplete/unmatched questionnaire|6|||
13150308|NCT02557399|26046422|FG000|Overall Study|Withdrawal by Subject|1|||
13150309|NCT02557399|26046423|FG001|Overall Study|Withdrawal by Subject|1|||
13096877|NCT03552198|25846300|FG001|Overall Study|Incomplete/unmatched questionnaire|7|||
13096878|NCT03552198|25846301|FG002|Overall Study|Incomplete/unmatched questionnaire|2|||
13096879|NCT03552198|25846302|FG003|Overall Study|Incomplete/unmatched questionnaire|2|||
13096880|NCT03552198|25846299|FG000|Overall Study|Did not receive air alerts|1|||
13096881|NCT03552198|25846300|FG001|Overall Study|Did not receive air alerts|0|||
13096882|NCT03552198|25846301|FG002|Overall Study|Did not receive air alerts|0|||
13096883|NCT03552198|25846302|FG003|Overall Study|Did not receive air alerts|1|||
13096884|NCT03552029|25846321|FG000|Overall Study|Death|3|||
13096885|NCT03552029|25846322|FG001|Overall Study|Death|0|||
13096886|NCT03552029|25846321|FG000|Overall Study|Adverse Event|1|||
13096887|NCT03552029|25846322|FG001|Overall Study|Adverse Event|0|||
13096888|NCT03552029|25846321|FG000|Overall Study|Lack of Efficacy|0|||
13096889|NCT03552029|25846322|FG001|Overall Study|Lack of Efficacy|2|||
13096890|NCT03552029|25846321|FG000|Overall Study|Physician Decision|0|||
13096891|NCT03552029|25846322|FG001|Overall Study|Physician Decision|1|||
13096892|NCT03552029|25846321|FG000|Overall Study|Study terminated by Sponsor|0|||
13096893|NCT03552029|25846322|FG001|Overall Study|Study terminated by Sponsor|1|||
13096894|NCT03552029|25846321|FG000|Overall Study|Other|0|||
13096895|NCT03552029|25846322|FG001|Overall Study|Other|2|||
13096896|NCT03551743|25846377|FG000|Overall Study|Adverse Event|1|||
13150310|NCT02557100|26046459|FG000|Single Blind Treatment Period|Lost to Follow-up|0|||
13096897|NCT03551743|25846378|FG001|Overall Study|Adverse Event|0|||
13096898|NCT03551743|25846379|FG002|Overall Study|Adverse Event|0|||
13096899|NCT03551743|25846380|FG003|Overall Study|Adverse Event|0|||
13096900|NCT03551743|25846377|FG000|Overall Study|Withdrawal by Subject|1|||
13096901|NCT03551743|25846378|FG001|Overall Study|Withdrawal by Subject|0|||
13096902|NCT03551743|25846379|FG002|Overall Study|Withdrawal by Subject|0|||
13096903|NCT03551743|25846380|FG003|Overall Study|Withdrawal by Subject|0|||
13096904|NCT03551730|25846431|FG000|Overall Study|Adverse Event|1|||
13096905|NCT03551730|25846432|FG001|Overall Study|Adverse Event|0|||
13150311|NCT02557100|26046460|FG001|Single Blind Treatment Period|Lost to Follow-up|1|||
13096906|NCT03551730|25846433|FG002|Overall Study|Adverse Event|0|||
13096907|NCT03551730|25846434|FG003|Overall Study|Adverse Event|0|||
13096908|NCT03550378|25846479|FG000|Overall Study|Death|0|||
13096909|NCT03550378|25846480|FG001|Overall Study|Death|1|||
13132818|NCT02783573|25985269|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
13132819|NCT02783573|25985270|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
13132820|NCT02783573|25985268|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0|||
13132821|NCT02783573|25985269|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1|||
13132822|NCT02783573|25985270|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0|||
13132823|NCT02783573|25985268|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0|||
13132824|NCT02783573|25985269|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1|||
13132825|NCT02783573|25985270|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2|||
13132826|NCT02783573|25985268|FG000|Placebo-Controlled Treatment Period|Physician Decision|3|||
13132827|NCT02783573|25985269|FG001|Placebo-Controlled Treatment Period|Physician Decision|1|||
13132828|NCT02783573|25985270|FG002|Placebo-Controlled Treatment Period|Physician Decision|3|||
13132829|NCT02783573|25985268|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1|||
13132830|NCT02783573|25985269|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2|||
13132831|NCT02783573|25985270|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0|||
13132832|NCT02783573|25985268|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15|||
13132833|NCT02783573|25985269|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20|||
13132834|NCT02783573|25985270|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23|||
13132835|NCT02783573|25985268|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
13132836|NCT02783573|25985269|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
13132837|NCT02783573|25985270|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9|||
13132838|NCT02783573|25985268|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494|||
13132839|NCT02783573|25985269|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512|||
13132840|NCT02783573|25985270|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492|||
13150312|NCT02557100|26046461|FG002|Single Blind Treatment Period|Lost to Follow-up|0|||
13150313|NCT02557100|26046459|FG000|Single Blind Treatment Period|Death|0|||
13150314|NCT02557100|26046460|FG001|Single Blind Treatment Period|Death|1|||
13150315|NCT02557100|26046461|FG002|Single Blind Treatment Period|Death|0|||
13150316|NCT02557100|26046459|FG000|Single Blind Treatment Period|Request to Discontinue|0|||
13150317|NCT02557100|26046460|FG001|Single Blind Treatment Period|Request to Discontinue|1|||
13150318|NCT02557100|26046461|FG002|Single Blind Treatment Period|Request to Discontinue|0|||
13150319|NCT02557100|26046459|FG000|Single Blind Treatment Period|Adverse Event|0|||
13150320|NCT02557100|26046460|FG001|Single Blind Treatment Period|Adverse Event|1|||
13150321|NCT02557100|26046461|FG002|Single Blind Treatment Period|Adverse Event|0|||
13150322|NCT02557100|26046459|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40|||
13150323|NCT02557100|26046460|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36|||
13132841|NCT02783573|25985268|FG000|Delayed-Start Period|Sponsor Decision|0|||
13132842|NCT02783573|25985269|FG001|Delayed-Start Period|Sponsor Decision|17|||
13132843|NCT02783573|25985270|FG002|Delayed-Start Period|Sponsor Decision|12|||
13132844|NCT02783170|25985318|FG000|Overall Study|Randomized but not Vaccinated|1|||
13132845|NCT02783170|25985319|FG001|Overall Study|Randomized but not Vaccinated|0|||
13132846|NCT02783066|25985335|FG000|Overall Study|Withdrawal by Subject|13|||
13132847|NCT02782923|25985343|FG000|Overall Study|Lost to Follow-up|15|||
13132848|NCT02782780|25985378|FG000|Overall Study|dropped out after randomization.|7|||
13132849|NCT02782780|25985379|FG001|Overall Study|dropped out after randomization.|5|||
13096910|NCT03550313|25846543|FG000|Overall Study|Adverse Event|0|||
13096911|NCT03550313|25846544|FG001|Overall Study|Adverse Event|1|||
13096912|NCT03550313|25846545|FG002|Overall Study|Adverse Event|0|||
13096913|NCT03550313|25846543|FG000|Overall Study|Lost to Follow-up|5|||
13096914|NCT03550313|25846544|FG001|Overall Study|Lost to Follow-up|7|||
13096915|NCT03550313|25846545|FG002|Overall Study|Lost to Follow-up|12|||
13096916|NCT03550313|25846543|FG000|Overall Study|Study terminated by sponsor|44|||
13096917|NCT03550313|25846544|FG001|Overall Study|Study terminated by sponsor|37|||
13096918|NCT03550313|25846545|FG002|Overall Study|Study terminated by sponsor|48|||
13096919|NCT03550313|25846543|FG000|Overall Study|No longer met eligibility criteria|3|||
13096920|NCT03550313|25846544|FG001|Overall Study|No longer met eligibility criteria|5|||
13096921|NCT03550313|25846545|FG002|Overall Study|No longer met eligibility criteria|6|||
13096922|NCT03550313|25846543|FG000|Overall Study|Withdrawal by parent/guardian|20|||
13096923|NCT03550313|25846544|FG001|Overall Study|Withdrawal by parent/guardian|18|||
13096924|NCT03550313|25846545|FG002|Overall Study|Withdrawal by parent/guardian|26|||
13096925|NCT03550313|25846543|FG000|Overall Study|Other|4|||
13096926|NCT03550313|25846544|FG001|Overall Study|Other|2|||
13096927|NCT03550313|25846545|FG002|Overall Study|Other|2|||
13096928|NCT03550313|25846543|FG000|Overall Study|Randomized but not vaccinated|3|||
13096929|NCT03550313|25846544|FG001|Overall Study|Randomized but not vaccinated|23|||
13096930|NCT03550313|25846545|FG002|Overall Study|Randomized but not vaccinated|2|||
13096931|NCT03550313|25846543|FG000|Overall Study|Sites terminated due to quality issues|18|||
13096932|NCT03550313|25846544|FG001|Overall Study|Sites terminated due to quality issues|17|||
13096933|NCT03550313|25846545|FG002|Overall Study|Sites terminated due to quality issues|18|||
13096934|NCT03550209|25846576|FG000|Overall Study|Lost to Follow-up|1|||
13096935|NCT03550209|25846577|FG001|Overall Study|Lost to Follow-up|0|||
13096936|NCT03550209|25846578|FG002|Overall Study|Lost to Follow-up|1|||
13096937|NCT03550209|25846579|FG003|Overall Study|Lost to Follow-up|0|||
13096938|NCT03550209|25846576|FG000|Overall Study|Withdrawal by Subject|0|||
13096939|NCT03550209|25846577|FG001|Overall Study|Withdrawal by Subject|3|||
13096940|NCT03550209|25846578|FG002|Overall Study|Withdrawal by Subject|1|||
13096941|NCT03550209|25846579|FG003|Overall Study|Withdrawal by Subject|2|||
13096942|NCT03550209|25846576|FG000|Overall Study|Excluded due to ineligibility after randomization|0|||
13096943|NCT03550209|25846577|FG001|Overall Study|Excluded due to ineligibility after randomization|0|||
13096944|NCT03550209|25846578|FG002|Overall Study|Excluded due to ineligibility after randomization|0|||
13096945|NCT03550209|25846579|FG003|Overall Study|Excluded due to ineligibility after randomization|2|||
13096946|NCT03549429|25846596|FG000|Overall Study|Protocol Violation|5|||
13096947|NCT03549429|25846597|FG001|Overall Study|Protocol Violation|3|||
13096948|NCT03549338|25846613|FG000|Overall Study|Progressive Disease|1|||
13096949|NCT03549338|25846614|FG001|Overall Study|Progressive Disease|0|||
13096950|NCT03549338|25846615|FG002|Overall Study|Progressive Disease|0|||
13096951|NCT03549338|25846613|FG000|Overall Study|Clinical Progression|0|||
13096952|NCT03549338|25846614|FG001|Overall Study|Clinical Progression|1|||
13096953|NCT03549338|25846615|FG002|Overall Study|Clinical Progression|0|||
13096954|NCT03549130|25846638|FG000|Overall Study|Adverse Event|0|||
13096955|NCT03549130|25846639|FG001|Overall Study|Adverse Event|1|||
13096956|NCT03549130|25846638|FG000|Overall Study|Lost to Follow-up|0|||
13096957|NCT03549130|25846639|FG001|Overall Study|Lost to Follow-up|1|||
13096958|NCT03549117|25846672|FG000|Overall Study|Withdrawal by Subject|1|||
13096959|NCT03549117|25846673|FG001|Overall Study|Withdrawal by Subject|0|||
13096960|NCT03549104|25846690|FG000|Overall Study|Physician Decision|2|||
13096961|NCT03549104|25846691|FG001|Overall Study|Physician Decision|0|||
13096962|NCT03549104|25846690|FG000|Overall Study|Withdrawal by Subject|5|||
13096963|NCT03549104|25846691|FG001|Overall Study|Withdrawal by Subject|2|||
13096964|NCT03549104|25846690|FG000|Overall Study|Covid shelter in place|1|||
13096965|NCT03549104|25846691|FG001|Overall Study|Covid shelter in place|2|||
13096966|NCT03548935|25846786|FG000|Overall Study|Withdrawal by Subject|26|||
13096967|NCT03548935|25846787|FG001|Overall Study|Withdrawal by Subject|17|||
13096968|NCT03548935|25846786|FG000|Overall Study|Lost to Follow-up|39|||
13096969|NCT03548935|25846787|FG001|Overall Study|Lost to Follow-up|28|||
13096970|NCT03548935|25846786|FG000|Overall Study|Death|1|||
13096971|NCT03548935|25846787|FG001|Overall Study|Death|1|||
13096972|NCT03548415|25846850|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
13096973|NCT03548415|25846851|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
13096974|NCT03548415|25846852|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
13096975|NCT03548415|25846853|FG003|Overall Study|Adverse Event or Serious Adverse Event|0|||
13096976|NCT03548415|25846854|FG004|Overall Study|Adverse Event or Serious Adverse Event|1|||
13096977|NCT03548337|25846909|FG000|Infant Series|Withdrawal by Parent/Guardian|8|||
13096978|NCT03548337|25846910|FG001|Infant Series|Withdrawal by Parent/Guardian|8|||
13096979|NCT03548337|25846909|FG000|Infant Series|No Longer Met Eligibility Criteria|1|||
13096980|NCT03548337|25846910|FG001|Infant Series|No Longer Met Eligibility Criteria|0|||
13096981|NCT03548337|25846909|FG000|Infant Series|Lost to Follow-up|2|||
13096982|NCT03548337|25846910|FG001|Infant Series|Lost to Follow-up|1|||
13096983|NCT03548337|25846909|FG000|Infant Series|Adverse Event|0|||
13096984|NCT03548337|25846910|FG001|Infant Series|Adverse Event|2|||
13096985|NCT03548337|25846909|FG000|Infant Series|Randomized but Not Vaccinated|1|||
13096986|NCT03548337|25846910|FG001|Infant Series|Randomized but Not Vaccinated|0|||
13096987|NCT03548337|25846909|FG000|Toddler Dose|Withdrawal by parent/guardian|1|||
13096988|NCT03548337|25846910|FG001|Toddler Dose|Withdrawal by parent/guardian|1|||
13096989|NCT03548051|25846939|FG000|Overall Study|Death|1|||
13096990|NCT03548051|25846940|FG001|Overall Study|Death|1|||
13096991|NCT03548051|25846939|FG000|Overall Study|Withdrawal by Subject|1|||
13096992|NCT03548051|25846940|FG001|Overall Study|Withdrawal by Subject|0|||
13096993|NCT03547687|25846950|FG000|Overall Study|Withdrawal by Subject|1|||
13096994|NCT03547687|25846950|FG000|Overall Study|Death|1|||
13096995|NCT03547635|25846968|FG000|Overall Study|Adverse Event|5|||
13096996|NCT03547635|25846969|FG001|Overall Study|Adverse Event|2|||
13096997|NCT03547635|25846970|FG002|Overall Study|Adverse Event|3|||
13096998|NCT03547635|25846968|FG000|Overall Study|Lost to Follow-up|1|||
13096999|NCT03547635|25846969|FG001|Overall Study|Lost to Follow-up|3|||
13097000|NCT03547635|25846970|FG002|Overall Study|Lost to Follow-up|4|||
13097001|NCT03547635|25846968|FG000|Overall Study|Withdrawal by Subject|1|||
13097002|NCT03547635|25846969|FG001|Overall Study|Withdrawal by Subject|0|||
13097003|NCT03547635|25846970|FG002|Overall Study|Withdrawal by Subject|0|||
13097004|NCT03547635|25846968|FG000|Overall Study|Withdrawal By PI|0|||
13097005|NCT03547635|25846969|FG001|Overall Study|Withdrawal By PI|1|||
13097006|NCT03547635|25846970|FG002|Overall Study|Withdrawal By PI|0|||
13097007|NCT03547635|25846968|FG000|Overall Study|Withdrawal by Sponsor|0|||
13097008|NCT03547635|25846969|FG001|Overall Study|Withdrawal by Sponsor|0|||
13097009|NCT03547635|25846970|FG002|Overall Study|Withdrawal by Sponsor|1|||
13097010|NCT03547635|25846968|FG000|Overall Study|Errant Randomization before Treatment|0|||
13097011|NCT03547635|25846969|FG001|Overall Study|Errant Randomization before Treatment|1|||
13097012|NCT03547635|25846970|FG002|Overall Study|Errant Randomization before Treatment|0|||
13097013|NCT03547635|25846968|FG000|Overall Study|Withdrawal by Subject|1|||
13097014|NCT03547635|25846969|FG001|Overall Study|Withdrawal by Subject|0|||
13097015|NCT03547635|25846970|FG002|Overall Study|Withdrawal by Subject|0|||
13097016|NCT03547583|25846994|FG000|Overall Study|Adverse Event|16|||
13097017|NCT03547583|25846995|FG001|Overall Study|Adverse Event|11|||
13097018|NCT03547583|25846996|FG002|Overall Study|Adverse Event|10|||
13097019|NCT03547583|25846994|FG000|Overall Study|Death|11|||
13097020|NCT03547583|25846995|FG001|Overall Study|Death|7|||
13097021|NCT03547583|25846996|FG002|Overall Study|Death|4|||
13097022|NCT03547583|25846994|FG000|Overall Study|Lost to Follow-up|1|||
13097023|NCT03547583|25846995|FG001|Overall Study|Lost to Follow-up|0|||
13097024|NCT03547583|25846996|FG002|Overall Study|Lost to Follow-up|0|||
13097025|NCT03547583|25846994|FG000|Overall Study|Non-compliance with study drug|0|||
13097026|NCT03547583|25846995|FG001|Overall Study|Non-compliance with study drug|0|||
13097027|NCT03547583|25846996|FG002|Overall Study|Non-compliance with study drug|1|||
13097028|NCT03547583|25846994|FG000|Overall Study|Physician Decision|1|||
13097029|NCT03547583|25846995|FG001|Overall Study|Physician Decision|0|||
13097030|NCT03547583|25846996|FG002|Overall Study|Physician Decision|3|||
13097031|NCT03547583|25846994|FG000|Overall Study|Protocol Violation|2|||
13097032|NCT03547583|25846995|FG001|Overall Study|Protocol Violation|1|||
13097033|NCT03547583|25846996|FG002|Overall Study|Protocol Violation|1|||
13097034|NCT03547583|25846994|FG000|Overall Study|Withdrawal by Subject|12|||
13097035|NCT03547583|25846995|FG001|Overall Study|Withdrawal by Subject|19|||
13150324|NCT02557100|26046461|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0|||
13150325|NCT02557100|26046459|FG000|Cumulative Abatacept Period|Other Reasons|0|||
13150326|NCT02557100|26046460|FG001|Cumulative Abatacept Period|Other Reasons|0|||
13150327|NCT02557100|26046461|FG002|Cumulative Abatacept Period|Other Reasons|1|||
13150328|NCT02557100|26046459|FG000|Cumulative Abatacept Period|Lost to Follow-up|0|||
13150329|NCT02557100|26046460|FG001|Cumulative Abatacept Period|Lost to Follow-up|0|||
13150330|NCT02557100|26046461|FG002|Cumulative Abatacept Period|Lost to Follow-up|2|||
13097036|NCT03547583|25846996|FG002|Overall Study|Withdrawal by Subject|10|||
13097037|NCT03547583|25846994|FG000|Overall Study|Other|2|||
13097038|NCT03547583|25846995|FG001|Overall Study|Other|2|||
13097039|NCT03547583|25846996|FG002|Overall Study|Other|3|||
13097040|NCT03547531|25847015|FG000|Overall Study|not coming in data collection : sick|2|||
13097041|NCT03547531|25847016|FG001|Overall Study|not coming in data collection : sick|2|||
13097042|NCT03547531|25847015|FG000|Overall Study|having family occasion|0|||
13097043|NCT03547531|25847016|FG001|Overall Study|having family occasion|2|||
13097044|NCT03547167|25847073|FG000|Overall Study|Withdrawal by Subject|34|||
13097045|NCT03547167|25847074|FG001|Overall Study|Withdrawal by Subject|12|||
13097046|NCT03547167|25847073|FG000|Overall Study|Screen Failure|0|||
13097047|NCT03547167|25847074|FG001|Overall Study|Screen Failure|1|||
13097048|NCT03547167|25847073|FG000|Overall Study|Lost to Follow-up|59|||
13097049|NCT03547167|25847074|FG001|Overall Study|Lost to Follow-up|15|||
13097050|NCT03547167|25847073|FG000|Overall Study|Death|4|||
13097051|NCT03547167|25847074|FG001|Overall Study|Death|2|||
13097052|NCT03547154|25847093|FG000|Overall Study|Disease Progression/Recurrence|6|||
13097053|NCT03547154|25847094|FG001|Overall Study|Disease Progression/Recurrence|14|||
13097054|NCT03547154|25847093|FG000|Overall Study|Adverse Event|26|||
13097055|NCT03547154|25847094|FG001|Overall Study|Adverse Event|31|||
13097056|NCT03547154|25847093|FG000|Overall Study|Protocol Violation|6|||
13097057|NCT03547154|25847094|FG001|Overall Study|Protocol Violation|1|||
13097058|NCT03547154|25847093|FG000|Overall Study|Physician Decision|4|||
13097059|NCT03547154|25847094|FG001|Overall Study|Physician Decision|3|||
13097060|NCT03547154|25847093|FG000|Overall Study|Insufficient Therapeutic Response|13|||
13097061|NCT03547154|25847094|FG001|Overall Study|Insufficient Therapeutic Response|10|||
13097062|NCT03547154|25847093|FG000|Overall Study|Withdrawal by Subject|10|||
13097063|NCT03547154|25847094|FG001|Overall Study|Withdrawal by Subject|6|||
13097064|NCT03547154|25847093|FG000|Overall Study|Not Selected|0|||
13097065|NCT03547154|25847094|FG001|Overall Study|Not Selected|1|||
13097066|NCT03547154|25847093|FG000|Overall Study|Continued treatment beyond 12 mo.|58|||
13097067|NCT03547154|25847094|FG001|Overall Study|Continued treatment beyond 12 mo.|50|||
13097068|NCT03546907|25847113|FG000|Overall Study|Lack of Efficacy|1|||
13097069|NCT03546907|25847114|FG001|Overall Study|Lack of Efficacy|1|||
13097070|NCT03546907|25847113|FG000|Overall Study|Withdrawal by Subject|8|||
13097071|NCT03546907|25847114|FG001|Overall Study|Withdrawal by Subject|9|||
13097072|NCT03546907|25847113|FG000|Overall Study|Adverse events (AEs)|7|||
13097073|NCT03546907|25847114|FG001|Overall Study|Adverse events (AEs)|10|||
13097074|NCT03546907|25847113|FG000|Overall Study|Other-unspecified|1|||
13097075|NCT03546907|25847114|FG001|Overall Study|Other-unspecified|1|||
13097076|NCT03546842|25847125|FG000|Overall Study|Protocol Violation|1|||
13097077|NCT03546842|25847125|FG000|Overall Study|Withdrawal by Subject|2|||
13097078|NCT03546816|25847156|FG000|Overall Study|Adverse Event|5|||
13097079|NCT03546816|25847157|FG001|Overall Study|Adverse Event|3|||
13097080|NCT03546816|25847156|FG000|Overall Study|Lack of Efficacy|2|||
13097081|NCT03546816|25847157|FG001|Overall Study|Lack of Efficacy|4|||
13097082|NCT03546816|25847156|FG000|Overall Study|Pregnancy|1|||
13097083|NCT03546816|25847157|FG001|Overall Study|Pregnancy|0|||
13097084|NCT03546816|25847156|FG000|Overall Study|Physician Decision|2|||
13150331|NCT02557100|26046459|FG000|Cumulative Abatacept Period|Request to Discontinue|0|||
13150332|NCT02557100|26046460|FG001|Cumulative Abatacept Period|Request to Discontinue|0|||
13150333|NCT02557100|26046461|FG002|Cumulative Abatacept Period|Request to Discontinue|1|||
13150334|NCT02556918|26046524|FG000|Overall Study|Protocol Violation|5|||
13150335|NCT02556918|26046525|FG001|Overall Study|Protocol Violation|6|||
13150336|NCT02556918|26046524|FG000|Overall Study|Withdrawal by Subject|4|||
13150337|NCT02556918|26046525|FG001|Overall Study|Withdrawal by Subject|4|||
13150338|NCT02556801|26046588|FG000|Overall Study|Lost to Follow-up|1|||
13150339|NCT02556801|26046589|FG001|Overall Study|Lost to Follow-up|0|||
13150340|NCT02556801|26046590|FG002|Overall Study|Lost to Follow-up|2|||
13150341|NCT02556801|26046591|FG003|Overall Study|Lost to Follow-up|0|||
13150342|NCT02556801|26046588|FG000|Overall Study|Withdrawal by Subject|1|||
13150343|NCT02556801|26046589|FG001|Overall Study|Withdrawal by Subject|1|||
13150344|NCT02556801|26046590|FG002|Overall Study|Withdrawal by Subject|1|||
13150345|NCT02556801|26046591|FG003|Overall Study|Withdrawal by Subject|0|||
13150346|NCT02556801|26046588|FG000|Overall Study|Protocol Violation|0|||
13150347|NCT02556801|26046589|FG001|Overall Study|Protocol Violation|3|||
13150348|NCT02556801|26046590|FG002|Overall Study|Protocol Violation|1|||
13150349|NCT02556801|26046591|FG003|Overall Study|Protocol Violation|1|||
13150350|NCT02556801|26046588|FG000|Overall Study|Adverse Event|0|||
13150351|NCT02556801|26046589|FG001|Overall Study|Adverse Event|2|||
13150352|NCT02556801|26046590|FG002|Overall Study|Adverse Event|0|||
13150353|NCT02556801|26046591|FG003|Overall Study|Adverse Event|3|||
13150354|NCT02556801|26046588|FG000|Overall Study|Pregnancy|0|||
13150355|NCT02556801|26046589|FG001|Overall Study|Pregnancy|1|||
13150356|NCT02556801|26046590|FG002|Overall Study|Pregnancy|0|||
13150357|NCT02556801|26046591|FG003|Overall Study|Pregnancy|0|||
13150358|NCT02556801|26046588|FG000|Overall Study|Personal reasons patient|0|||
13150359|NCT02556801|26046589|FG001|Overall Study|Personal reasons patient|0|||
13150360|NCT02556801|26046590|FG002|Overall Study|Personal reasons patient|0|||
13150361|NCT02556801|26046591|FG003|Overall Study|Personal reasons patient|1|||
13150362|NCT02556775|26046634|FG000|Overall Study|Withdrawal by Subject|1|||
13097085|NCT03546816|25847157|FG001|Overall Study|Physician Decision|0|||
13097086|NCT03546816|25847156|FG000|Overall Study|Withdrawal by Subject|8|||
13097087|NCT03546816|25847157|FG001|Overall Study|Withdrawal by Subject|10|||
13097088|NCT03546816|25847156|FG000|Overall Study|Lost to Follow-up|3|||
13097089|NCT03546816|25847157|FG001|Overall Study|Lost to Follow-up|2|||
13097090|NCT03546647|25847166|FG000|Overall Study|Adverse Event|1|||
13150363|NCT02556775|26046635|FG001|Overall Study|Withdrawal by Subject|0|||
13150364|NCT02556775|26046636|FG002|Overall Study|Withdrawal by Subject|1|||
13150365|NCT02556775|26046637|FG003|Overall Study|Withdrawal by Subject|0|||
13097091|NCT03546647|25847167|FG001|Overall Study|Adverse Event|0|||
13097092|NCT03546621|25847222|FG000|Overall Study|Withdrawal by Subject|0|||
13097093|NCT03546621|25847223|FG001|Overall Study|Withdrawal by Subject|1|||
13097094|NCT03546621|25847224|FG002|Overall Study|Withdrawal by Subject|2|||
13097095|NCT03546621|25847225|FG003|Overall Study|Withdrawal by Subject|1|||
13097096|NCT03546621|25847222|FG000|Overall Study|Lost to Follow-up|0|||
13097097|NCT03546621|25847223|FG001|Overall Study|Lost to Follow-up|1|||
13097098|NCT03546621|25847224|FG002|Overall Study|Lost to Follow-up|0|||
13097099|NCT03546621|25847225|FG003|Overall Study|Lost to Follow-up|0|||
13097100|NCT03546621|25847222|FG000|Overall Study|Adverse Event|0|||
13097101|NCT03546621|25847223|FG001|Overall Study|Adverse Event|1|||
13097102|NCT03546621|25847224|FG002|Overall Study|Adverse Event|0|||
13097103|NCT03546621|25847225|FG003|Overall Study|Adverse Event|1|||
13150366|NCT02556775|26046634|FG000|Overall Study|Lost to Follow-up|1|||
13150367|NCT02556775|26046635|FG001|Overall Study|Lost to Follow-up|0|||
13150368|NCT02556775|26046636|FG002|Overall Study|Lost to Follow-up|0|||
13150369|NCT02556775|26046637|FG003|Overall Study|Lost to Follow-up|0|||
13150370|NCT02556710|26046654|FG000|Overall Study|Surgical treatment|3|||
13150371|NCT02556710|26046655|FG001|Overall Study|Surgical treatment|0|||
13150372|NCT02556710|26046654|FG000|Overall Study|Required proscribed pain medication|2|||
13150373|NCT02556710|26046655|FG001|Overall Study|Required proscribed pain medication|1|||
13150374|NCT02556710|26046654|FG000|Overall Study|Lack of Efficacy|1|||
13150375|NCT02556710|26046655|FG001|Overall Study|Lack of Efficacy|0|||
13150376|NCT02556710|26046654|FG000|Overall Study|Worsening osteoarthritis|1|||
13150377|NCT02556710|26046655|FG001|Overall Study|Worsening osteoarthritis|0|||
13150378|NCT02556710|26046654|FG000|Overall Study|Moved out of state|1|||
13150379|NCT02556710|26046655|FG001|Overall Study|Moved out of state|0|||
13150380|NCT02556710|26046654|FG000|Overall Study|Missing reason|3|||
13150381|NCT02556710|26046655|FG001|Overall Study|Missing reason|1|||
13150382|NCT02556710|26046654|FG000|Overall Study|Pain as lack of efficacy|0|||
13150383|NCT02556710|26046655|FG001|Overall Study|Pain as lack of efficacy|4|||
13150384|NCT02556632|26046679|FG000|Overall Study|Lost to Follow-up|1|||
13150385|NCT02556632|26046680|FG001|Overall Study|Lost to Follow-up|0|||
13150386|NCT02556632|26046681|FG002|Overall Study|Lost to Follow-up|0|||
13150387|NCT02556632|26046679|FG000|Overall Study|Disliked Intervention|1|||
13150388|NCT02556632|26046680|FG001|Overall Study|Disliked Intervention|1|||
13150389|NCT02556632|26046681|FG002|Overall Study|Disliked Intervention|1|||
13150390|NCT02556632|26046679|FG000|Overall Study|No Reason|1|||
13150391|NCT02556632|26046680|FG001|Overall Study|No Reason|0|||
13150392|NCT02556632|26046681|FG002|Overall Study|No Reason|1|||
13150393|NCT02556632|26046679|FG000|Overall Study|Personal Issues|0|||
13150394|NCT02556632|26046680|FG001|Overall Study|Personal Issues|1|||
13150395|NCT02556632|26046681|FG002|Overall Study|Personal Issues|1|||
13150396|NCT02556632|26046679|FG000|Overall Study|Changed Mind|0|||
13150397|NCT02556632|26046680|FG001|Overall Study|Changed Mind|1|||
13150398|NCT02556632|26046681|FG002|Overall Study|Changed Mind|0|||
13150399|NCT02556632|26046679|FG000|Overall Study|Withdrew (Unrelated Medical)|1|||
13150400|NCT02556632|26046680|FG001|Overall Study|Withdrew (Unrelated Medical)|0|||
13150401|NCT02556632|26046681|FG002|Overall Study|Withdrew (Unrelated Medical)|0|||
13150402|NCT02556632|26046679|FG000|Overall Study|Unrelated Adverse Event|1|||
13150403|NCT02556632|26046680|FG001|Overall Study|Unrelated Adverse Event|0|||
13150404|NCT02556632|26046681|FG002|Overall Study|Unrelated Adverse Event|3|||
13150405|NCT02556632|26046679|FG000|Overall Study|Related Adverse Event|0|||
13150406|NCT02556632|26046680|FG001|Overall Study|Related Adverse Event|1|||
13150407|NCT02556632|26046681|FG002|Overall Study|Related Adverse Event|0|||
13150408|NCT02556632|26046679|FG000|Overall Study|Possibly Related Adverse Event|0|||
13150409|NCT02556632|26046680|FG001|Overall Study|Possibly Related Adverse Event|0|||
13150410|NCT02556632|26046681|FG002|Overall Study|Possibly Related Adverse Event|1|||
13150411|NCT02556632|26046679|FG000|Overall Study|Did Not Start RT|0|||
13150412|NCT02556632|26046680|FG001|Overall Study|Did Not Start RT|1|||
13150413|NCT02556632|26046681|FG002|Overall Study|Did Not Start RT|0|||
13150414|NCT02556632|26046679|FG000|Overall Study|Ineligible|0|||
13150415|NCT02556632|26046680|FG001|Overall Study|Ineligible|1|||
13150416|NCT02556632|26046681|FG002|Overall Study|Ineligible|0|||
13150417|NCT02556632|26046679|FG000|Overall Study|Disliked Study Procedures|0|||
13150418|NCT02556632|26046680|FG001|Overall Study|Disliked Study Procedures|0|||
13150419|NCT02556632|26046681|FG002|Overall Study|Disliked Study Procedures|1|||
13150420|NCT02556632|26046679|FG000|Overall Study|Treatment or Change Delay|0|||
13097104|NCT03546621|25847222|FG000|Overall Study|Progressive disease|0|||
13097105|NCT03546621|25847223|FG001|Overall Study|Progressive disease|0|||
13097106|NCT03546621|25847224|FG002|Overall Study|Progressive disease|0|||
13097107|NCT03546621|25847225|FG003|Overall Study|Progressive disease|1|||
13097108|NCT03545984|25847238|FG000|Overall Study|CSF cases not present during rotation|11|||
13097109|NCT03545984|25847239|FG001|Overall Study|CSF cases not present during rotation|9|||
13097110|NCT03545503|25847252|FG000|Overall Study|Protocol Violation|14|||
13150421|NCT02556632|26046680|FG001|Overall Study|Treatment or Change Delay|0|||
13150422|NCT02556632|26046681|FG002|Overall Study|Treatment or Change Delay|1|||
13150423|NCT02556307|26046693|FG000|Overall Study|Premature treatment interruption|11|||
13150424|NCT02556307|26046693|FG000|Overall Study|Lost to Follow-up|36|||
13150425|NCT02556307|26046693|FG000|Overall Study|Change to triple therapy|4|||
13150426|NCT02556307|26046693|FG000|Overall Study|Enrolled but not treated|2|||
13150427|NCT02556255|26046708|FG000|Overall Study|Lost to Follow-up|4|||
13150428|NCT02556203|26046735|FG000|Overall Study|Withdrawal by Subject|21|||
13150429|NCT02556203|26046736|FG001|Overall Study|Withdrawal by Subject|21|||
13150430|NCT02556203|26046735|FG000|Overall Study|Lost to Follow-up|5|||
13097111|NCT03545503|25847253|FG001|Overall Study|Protocol Violation|16|||
13097112|NCT03545113|25847302|FG000|Overall Study|Surgery Cancelled|1|||
13097113|NCT03545113|25847303|FG001|Overall Study|Surgery Cancelled|0|||
13097114|NCT03545113|25847302|FG000|Overall Study|Death|1|||
13097115|NCT03545113|25847303|FG001|Overall Study|Death|0|||
13097116|NCT03545113|25847302|FG000|Overall Study|Adverse Event|2|||
13097117|NCT03545113|25847303|FG001|Overall Study|Adverse Event|0|||
13097118|NCT03545113|25847302|FG000|Overall Study|Received different surgery|1|||
13097119|NCT03545113|25847303|FG001|Overall Study|Received different surgery|0|||
13097120|NCT03544333|25847316|FG000|Overall Study|Withdrawal by Subject|1|||
13097121|NCT03544333|25847317|FG001|Overall Study|Withdrawal by Subject|0|||
13097122|NCT03544268|25847338|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2|||
13097123|NCT03544268|25847339|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0|||
13097124|NCT03544229|25847406|FG000|Overall Study|Adverse Event|1|||
13097125|NCT03544229|25847407|FG001|Overall Study|Adverse Event|0|||
13097126|NCT03544229|25847408|FG002|Overall Study|Adverse Event|1|||
13097127|NCT03544229|25847409|FG003|Overall Study|Adverse Event|0|||
13097128|NCT03544229|25847406|FG000|Overall Study|Protocol Deviation|0|||
13097129|NCT03544229|25847407|FG001|Overall Study|Protocol Deviation|0|||
13097130|NCT03544229|25847408|FG002|Overall Study|Protocol Deviation|1|||
13097131|NCT03544229|25847409|FG003|Overall Study|Protocol Deviation|0|||
13097132|NCT03544229|25847406|FG000|Overall Study|Lost to Follow-up|3|||
13097133|NCT03544229|25847407|FG001|Overall Study|Lost to Follow-up|0|||
13097134|NCT03544229|25847408|FG002|Overall Study|Lost to Follow-up|0|||
13097135|NCT03544229|25847409|FG003|Overall Study|Lost to Follow-up|2|||
13097136|NCT03544229|25847406|FG000|Overall Study|Voluntary Withdrawal|2|||
13097137|NCT03544229|25847407|FG001|Overall Study|Voluntary Withdrawal|1|||
13097138|NCT03544229|25847408|FG002|Overall Study|Voluntary Withdrawal|3|||
13097139|NCT03544229|25847409|FG003|Overall Study|Voluntary Withdrawal|0|||
13097140|NCT03544229|25847406|FG000|Overall Study|Lack of Efficacy|0|||
13097141|NCT03544229|25847407|FG001|Overall Study|Lack of Efficacy|1|||
13097142|NCT03544229|25847408|FG002|Overall Study|Lack of Efficacy|0|||
13097143|NCT03544229|25847409|FG003|Overall Study|Lack of Efficacy|0|||
13097144|NCT03543358|25847416|FG000|Overall Study|Death|1|||
13097145|NCT03543358|25847417|FG001|Overall Study|Death|0|||
13097146|NCT03543358|25847416|FG000|Overall Study|Disease Progression|1|||
13097147|NCT03543358|25847417|FG001|Overall Study|Disease Progression|0|||
13097148|NCT03543358|25847416|FG000|Overall Study|Parent Study Closure|1|||
13097149|NCT03543358|25847417|FG001|Overall Study|Parent Study Closure|0|||
13097150|NCT03543137|25847440|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
13097151|NCT03543137|25847441|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
13097152|NCT03543137|25847440|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
13097153|NCT03543137|25847441|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
13097154|NCT03543137|25847440|FG000|Study Period 2: Up to Day 8|Adverse Event|0|||
13097155|NCT03543137|25847441|FG001|Study Period 2: Up to Day 8|Adverse Event|1|||
13097156|NCT03541317|25847468|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1|||
13097157|NCT03541317|25847469|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0|||
13097158|NCT03541317|25847470|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0|||
13097159|NCT03541317|25847471|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0|||
13097160|NCT03541317|25847472|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0|||
13097161|NCT03541317|25847473|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0|||
13097162|NCT03541252|25847482|FG000|Overall Study|Withdrawal by Subject|1|||
13097163|NCT03541200|25847497|FG000|Overall Study|Adverse Event|19|||
13097164|NCT03541200|25847497|FG000|Overall Study|Death|1|||
13097165|NCT03541200|25847497|FG000|Overall Study|Lost to Follow-up|10|||
13097166|NCT03541200|25847497|FG000|Overall Study|Physician Decision|1|||
13097167|NCT03541200|25847497|FG000|Overall Study|Protocol Violation|51|||
13097168|NCT03541200|25847497|FG000|Overall Study|Withdrawal by Subject|23|||
13097169|NCT03541200|25847497|FG000|Overall Study|other|8|||
13097170|NCT03541044|25847520|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
13097171|NCT03541044|25847521|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
13097172|NCT03541044|25847520|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
13097173|NCT03541044|25847521|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
13097174|NCT03540160|25847527|FG000|Overall Study|Protocol Violation|1|||
13097175|NCT03540160|25847527|FG000|Overall Study|Physician Decision|8|||
13097176|NCT03540160|25847527|FG000|Overall Study|Lack of Efficacy|60|||
13097177|NCT03540160|25847527|FG000|Overall Study|Pregnancy|1|||
13097178|NCT03540160|25847527|FG000|Overall Study|Adverse Event|20|||
13097179|NCT03540160|25847527|FG000|Overall Study|Withdrawal by Subject|68|||
13097180|NCT03540160|25847527|FG000|Overall Study|COVID-19|2|||
13097181|NCT03540160|25847527|FG000|Overall Study|Study Closure|10|||
13097182|NCT03540160|25847527|FG000|Overall Study|Lost to Follow-up|18|||
13097183|NCT03540160|25847527|FG000|Overall Study|Sponsor decision|191|||
13097184|NCT03540030|25847570|FG000|Overall Study|Withdrawal by Subject|2|||
13097185|NCT03540030|25847571|FG001|Overall Study|Withdrawal by Subject|1|||
13097186|NCT03540030|25847570|FG000|Overall Study|screen fail|7|||
13097187|NCT03540030|25847571|FG001|Overall Study|screen fail|1|||
13097188|NCT03540030|25847570|FG000|Overall Study|never had surgery after signing consent|9|||
13097189|NCT03540030|25847571|FG001|Overall Study|never had surgery after signing consent|1|||
13097190|NCT03539549|25847581|FG000|Overall Study|Adverse Event|12|||
13097191|NCT03539549|25847581|FG000|Overall Study|Lost to Follow-up|1|||
13097192|NCT03539549|25847581|FG000|Overall Study|Death|2|||
13097193|NCT03539549|25847581|FG000|Overall Study|Progressive Disease|1|||
13097194|NCT03539549|25847581|FG000|Overall Study|Reason not Specified|1|||
13097195|NCT03539484|25847737|FG000|Overall Study|Death|1|||
13097196|NCT03539484|25847738|FG001|Overall Study|Death|0|||
13097197|NCT03539484|25847739|FG002|Overall Study|Death|0|||
13097198|NCT03539484|25847740|FG003|Overall Study|Death|2|||
13097199|NCT03539484|25847741|FG004|Overall Study|Death|8|||
13097200|NCT03539484|25847742|FG005|Overall Study|Death|3|||
13150431|NCT02556203|26046736|FG001|Overall Study|Lost to Follow-up|5|||
13150432|NCT02556203|26046735|FG000|Overall Study|Adverse Event|1|||
13150433|NCT02556203|26046736|FG001|Overall Study|Adverse Event|0|||
13150434|NCT02556177|26046751|FG000|Overall Study|Subjects did not complete all 4 visits|283|||
13150435|NCT02556177|26046752|FG001|Overall Study|Subjects did not complete all 4 visits|61|||
13150436|NCT02556138|26046760|FG000|Overall Study|Withdrawal by Subject|1|||
13150437|NCT02555878|26046797|FG000|Overall Study|Lost to Follow-up|2|||
13150438|NCT02555878|26046798|FG001|Overall Study|Lost to Follow-up|3|||
13150439|NCT02555878|26046797|FG000|Overall Study|Withdrawal by Subject|48|||
13150440|NCT02555878|26046798|FG001|Overall Study|Withdrawal by Subject|48|||
13150441|NCT02555878|26046797|FG000|Overall Study|Adverse Event|12|||
13150442|NCT02555878|26046798|FG001|Overall Study|Adverse Event|8|||
13150443|NCT02555878|26046797|FG000|Overall Study|Death|74|||
13150444|NCT02555878|26046798|FG001|Overall Study|Death|59|||
13150445|NCT02555878|26046797|FG000|Overall Study|Protocol Violation|1|||
13150446|NCT02555878|26046798|FG001|Overall Study|Protocol Violation|2|||
13150447|NCT02555878|26046797|FG000|Overall Study|Physician Decision|12|||
13150448|NCT02555878|26046798|FG001|Overall Study|Physician Decision|13|||
13150449|NCT02555878|26046797|FG000|Overall Study|Other|17|||
13150450|NCT02555878|26046798|FG001|Overall Study|Other|17|||
13150451|NCT02555722|26046987|FG000|Week 2|Adverse Event|0|||
13150452|NCT02555722|26046988|FG001|Week 2|Adverse Event|1|||
13150453|NCT02555722|26046987|FG000|Week 2|Withdrawal by Subject|1|||
13150454|NCT02555722|26046988|FG001|Week 2|Withdrawal by Subject|0|||
13150455|NCT02555722|26046987|FG000|Month 1|Lens Discomfort|1|||
13150456|NCT02555722|26046988|FG001|Month 1|Lens Discomfort|0|||
13150457|NCT02555722|26046987|FG000|Month 2|Withdrawal by Subject|3|||
13150458|NCT02555722|26046988|FG001|Month 2|Withdrawal by Subject|0|||
13150459|NCT02555722|26046987|FG000|Month 2|Lost to Follow-up|1|||
13150460|NCT02555722|26046988|FG001|Month 2|Lost to Follow-up|0|||
13150461|NCT02555683|26047027|FG000|Overall Study|Physician Decision|1|||
13150462|NCT02555683|26047028|FG001|Overall Study|Physician Decision|0|||
13150463|NCT02555683|26047029|FG002|Overall Study|Physician Decision|2|||
13150464|NCT02555683|26047027|FG000|Overall Study|Lost to Follow-up|2|||
13150465|NCT02555683|26047028|FG001|Overall Study|Lost to Follow-up|1|||
13150466|NCT02555683|26047029|FG002|Overall Study|Lost to Follow-up|2|||
13150467|NCT02555683|26047027|FG000|Overall Study|Technical Problems|1|||
13150468|NCT02555683|26047028|FG001|Overall Study|Technical Problems|1|||
13150469|NCT02555683|26047029|FG002|Overall Study|Technical Problems|0|||
13150470|NCT02555683|26047027|FG000|Overall Study|Protocol deviation|0|||
13150471|NCT02555683|26047028|FG001|Overall Study|Protocol deviation|1|||
13150472|NCT02555683|26047029|FG002|Overall Study|Protocol deviation|0|||
13150473|NCT02555683|26047027|FG000|Overall Study|Lack of Efficacy|2|||
13150474|NCT02555683|26047028|FG001|Overall Study|Lack of Efficacy|0|||
13150475|NCT02555683|26047029|FG002|Overall Study|Lack of Efficacy|0|||
13150476|NCT02555683|26047027|FG000|Overall Study|Death|0|||
13150477|NCT02555683|26047028|FG001|Overall Study|Death|1|||
13150478|NCT02555683|26047029|FG002|Overall Study|Death|2|||
13150479|NCT02555683|26047027|FG000|Overall Study|Adverse Event|1|||
13150480|NCT02555683|26047028|FG001|Overall Study|Adverse Event|0|||
13150481|NCT02555683|26047029|FG002|Overall Study|Adverse Event|1|||
13097201|NCT03539484|25847743|FG006|Overall Study|Death|0|||
13150482|NCT02555683|26047027|FG000|Overall Study|Subject/guardian decision|12|||
13150483|NCT02555683|26047028|FG001|Overall Study|Subject/guardian decision|12|||
13150484|NCT02555683|26047029|FG002|Overall Study|Subject/guardian decision|22|||
13150485|NCT02555683|26047027|FG000|Overall Study|Death post Treatment/safety period|0|||
13150486|NCT02555683|26047028|FG001|Overall Study|Death post Treatment/safety period|1|||
13150487|NCT02555683|26047029|FG002|Overall Study|Death post Treatment/safety period|0|||
13150488|NCT02555618|26047078|FG000|Overall Study|Sponsor's Circumstances|1|||
13150489|NCT02555618|26047079|FG001|Overall Study|Sponsor's Circumstances|0|||
13150490|NCT02555371|26047100|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1|||
13150491|NCT02555371|26047101|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
13097202|NCT03539484|25847737|FG000|Overall Study|Lost to Follow-up|0|||
13097203|NCT03539484|25847738|FG001|Overall Study|Lost to Follow-up|1|||
13150492|NCT02555371|26047102|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
13150493|NCT02555371|26047103|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
13150494|NCT02555371|26047104|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
13150495|NCT02555371|26047100|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2|||
13150496|NCT02555371|26047101|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
13150497|NCT02555371|26047102|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
13150498|NCT02555371|26047103|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
13150499|NCT02555371|26047104|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
13150500|NCT02555371|26047100|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5|||
13150501|NCT02555371|26047101|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
13150502|NCT02555371|26047102|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
13150503|NCT02555371|26047103|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
13150504|NCT02555371|26047104|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
13150505|NCT02555371|26047100|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1|||
13150506|NCT02555371|26047101|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
13150507|NCT02555371|26047102|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
13150508|NCT02555371|26047103|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
13150509|NCT02555371|26047104|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
13150510|NCT02555371|26047100|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2|||
13150511|NCT02555371|26047101|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
13150512|NCT02555371|26047102|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
13150513|NCT02555371|26047103|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
13150514|NCT02555371|26047104|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
13150515|NCT02555371|26047100|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
13150516|NCT02555371|26047101|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84|||
13150517|NCT02555371|26047102|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45|||
13150518|NCT02555371|26047103|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
13150519|NCT02555371|26047104|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
13150520|NCT02555371|26047100|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
13150521|NCT02555371|26047101|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
13150522|NCT02555371|26047102|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
13150523|NCT02555371|26047103|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
13150524|NCT02555371|26047104|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
13150525|NCT02555371|26047100|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
13150526|NCT02555371|26047101|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1|||
13150527|NCT02555371|26047102|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
13150528|NCT02555371|26047103|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
13150529|NCT02555371|26047104|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
13150530|NCT02555371|26047100|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0|||
13150531|NCT02555371|26047101|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2|||
13150532|NCT02555371|26047102|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1|||
13150533|NCT02555371|26047103|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0|||
13150534|NCT02555371|26047104|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0|||
13150535|NCT02555371|26047100|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
13150536|NCT02555371|26047101|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
13150537|NCT02555371|26047102|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
13150538|NCT02555371|26047103|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1|||
13150539|NCT02555371|26047104|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
13150540|NCT02555371|26047100|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
13150541|NCT02555371|26047101|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
13150542|NCT02555371|26047102|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
13150543|NCT02555371|26047103|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2|||
13150544|NCT02555371|26047104|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
13150545|NCT02555371|26047100|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
13150546|NCT02555371|26047101|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
13150547|NCT02555371|26047102|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
13150548|NCT02555371|26047103|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
13150549|NCT02555371|26047104|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2|||
13150550|NCT02555371|26047100|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
13150551|NCT02555371|26047101|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
13150552|NCT02555371|26047102|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
13150553|NCT02555371|26047103|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
13150554|NCT02555371|26047104|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1|||
13150555|NCT02555371|26047100|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
13150556|NCT02555371|26047101|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
13150557|NCT02555371|26047102|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
13150558|NCT02555371|26047103|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1|||
13150559|NCT02555371|26047104|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
13150560|NCT02555215|26047117|FG000|Overall Study|Other|1|||
13150561|NCT02555215|26047117|FG000|Overall Study|Investigator Decision|2|||
13150562|NCT02554981|26047143|FG000|Overall Study|Adverse Event|1|||
13150563|NCT02554981|26047143|FG000|Overall Study|Administrative Reasons|1|||
13150564|NCT02554981|26047143|FG000|Overall Study|Other Miscellaneous Reasons|3|||
13150565|NCT02554929|26047166|FG000|Overall Study|Lost to Follow-up|4|||
13150566|NCT02554929|26047167|FG001|Overall Study|Lost to Follow-up|4|||
13150567|NCT02554929|26047166|FG000|Overall Study|Withdrawal by Subject|2|||
13150568|NCT02554929|26047167|FG001|Overall Study|Withdrawal by Subject|8|||
13150569|NCT02554903|26047196|FG000|Overall Study|Death|1|||
13150570|NCT02554903|26047197|FG001|Overall Study|Death|1|||
13150571|NCT02554903|26047196|FG000|Overall Study|Physician Decision|2|||
13150572|NCT02554903|26047197|FG001|Overall Study|Physician Decision|2|||
13150573|NCT02554903|26047196|FG000|Overall Study|Heart Transplant|1|||
13150574|NCT02554903|26047197|FG001|Overall Study|Heart Transplant|2|||
13150575|NCT02554890|26047228|FG000|Double-blind|Adverse Event|45|||
13150576|NCT02554890|26047229|FG001|Double-blind|Adverse Event|51|||
13150577|NCT02554890|26047228|FG000|Double-blind|Death|6|||
13150578|NCT02554890|26047229|FG001|Double-blind|Death|4|||
13150579|NCT02554890|26047228|FG000|Double-blind|Protocol Violation|1|||
13150580|NCT02554890|26047229|FG001|Double-blind|Protocol Violation|1|||
13150581|NCT02554890|26047228|FG000|Double-blind|Physician Decision|4|||
13097204|NCT03539484|25847739|FG002|Overall Study|Lost to Follow-up|0|||
13097205|NCT03539484|25847740|FG003|Overall Study|Lost to Follow-up|0|||
13097206|NCT03539484|25847741|FG004|Overall Study|Lost to Follow-up|1|||
13097207|NCT03539484|25847742|FG005|Overall Study|Lost to Follow-up|0|||
13097208|NCT03539484|25847743|FG006|Overall Study|Lost to Follow-up|0|||
13097209|NCT03539484|25847737|FG000|Overall Study|Withdrawal by Subject|0|||
13097210|NCT03539484|25847738|FG001|Overall Study|Withdrawal by Subject|0|||
13097211|NCT03539484|25847739|FG002|Overall Study|Withdrawal by Subject|0|||
13097212|NCT03539484|25847740|FG003|Overall Study|Withdrawal by Subject|0|||
13097213|NCT03539484|25847741|FG004|Overall Study|Withdrawal by Subject|2|||
13097214|NCT03539484|25847742|FG005|Overall Study|Withdrawal by Subject|0|||
13097215|NCT03539484|25847743|FG006|Overall Study|Withdrawal by Subject|1|||
13097216|NCT03539484|25847737|FG000|Overall Study|Study Terminated by Sponsor|0|||
13097217|NCT03539484|25847738|FG001|Overall Study|Study Terminated by Sponsor|0|||
13097218|NCT03539484|25847739|FG002|Overall Study|Study Terminated by Sponsor|1|||
13097219|NCT03539484|25847740|FG003|Overall Study|Study Terminated by Sponsor|1|||
13097220|NCT03539484|25847741|FG004|Overall Study|Study Terminated by Sponsor|2|||
13097221|NCT03539484|25847742|FG005|Overall Study|Study Terminated by Sponsor|2|||
13097222|NCT03539484|25847743|FG006|Overall Study|Study Terminated by Sponsor|1|||
13097223|NCT03539432|25847766|FG000|Overall Study|Lost to Follow-up|0|||
13485253|NCT02499900|27032164|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0|||
13485254|NCT02499900|27032165|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2|||
13485255|NCT02499900|27032164|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1|||
13485256|NCT02499900|27032165|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0|||
13485257|NCT02499900|27032164|FG000|Completed Core, Continued Into Extension|Personal motivation|1|||
13485258|NCT02499900|27032165|FG001|Completed Core, Continued Into Extension|Personal motivation|0|||
13485259|NCT02499900|27032164|FG000|Extension Study Period|Adverse Event|2|||
13485260|NCT02499900|27032165|FG001|Extension Study Period|Adverse Event|4|||
13485261|NCT02499900|27032164|FG000|Extension Study Period|Withdrawal by Subject|5|||
13485262|NCT02499900|27032165|FG001|Extension Study Period|Withdrawal by Subject|2|||
13485263|NCT02499900|27032164|FG000|Extension Study Period|Physician Decision|2|||
13485264|NCT02499900|27032165|FG001|Extension Study Period|Physician Decision|5|||
13485265|NCT02499900|27032164|FG000|Extension Study Period|Pregnancy|1|||
13485266|NCT02499900|27032165|FG001|Extension Study Period|Pregnancy|2|||
13485267|NCT02499900|27032164|FG000|Extension Study Period|Lost to Follow-up|2|||
13485268|NCT02499900|27032165|FG001|Extension Study Period|Lost to Follow-up|5|||
13097224|NCT03539432|25847767|FG001|Overall Study|Lost to Follow-up|1|||
13097225|NCT03538951|25847794|FG000|Overall Study|Withdrawal by Subject|1|||
13097226|NCT03538951|25847795|FG001|Overall Study|Withdrawal by Subject|2|||
13097227|NCT03538743|25847926|FG000|Overall Study|Adverse Event|0|||
13097228|NCT03538743|25847927|FG001|Overall Study|Adverse Event|0|||
13097229|NCT03538743|25847928|FG002|Overall Study|Adverse Event|1|||
13097230|NCT03538743|25847929|FG003|Overall Study|Adverse Event|1|||
13097231|NCT03538743|25847930|FG004|Overall Study|Adverse Event|0|||
13097232|NCT03538743|25847931|FG005|Overall Study|Adverse Event|0|||
13097233|NCT03538743|25847932|FG006|Overall Study|Adverse Event|0|||
13097234|NCT03538743|25847933|FG007|Overall Study|Adverse Event|0|||
13097235|NCT03538743|25847934|FG008|Overall Study|Adverse Event|0|||
13097236|NCT03538743|25847926|FG000|Overall Study|Non-Treatment-Related Reasons|0|||
13150582|NCT02554890|26047229|FG001|Double-blind|Physician Decision|3|||
13150583|NCT02554890|26047228|FG000|Double-blind|Subject/Guardian decision|21|||
13150584|NCT02554890|26047229|FG001|Double-blind|Subject/Guardian decision|16|||
13150585|NCT02554890|26047228|FG000|Double-blind|Lost to Follow-up|7|||
13150586|NCT02554890|26047229|FG001|Double-blind|Lost to Follow-up|5|||
13485269|NCT02499900|27032164|FG000|Extension Study Period|Other|0|||
13097237|NCT03538743|25847927|FG001|Overall Study|Non-Treatment-Related Reasons|0|||
13097238|NCT03538743|25847928|FG002|Overall Study|Non-Treatment-Related Reasons|0|||
13097239|NCT03538743|25847929|FG003|Overall Study|Non-Treatment-Related Reasons|0|||
13097240|NCT03538743|25847930|FG004|Overall Study|Non-Treatment-Related Reasons|0|||
13097241|NCT03538743|25847931|FG005|Overall Study|Non-Treatment-Related Reasons|0|||
13097242|NCT03538743|25847932|FG006|Overall Study|Non-Treatment-Related Reasons|0|||
13097243|NCT03538743|25847933|FG007|Overall Study|Non-Treatment-Related Reasons|0|||
13097244|NCT03538743|25847934|FG008|Overall Study|Non-Treatment-Related Reasons|3|||
13097245|NCT03538743|25847926|FG000|Overall Study|Withdrawal by Subject|0|||
13097246|NCT03538743|25847927|FG001|Overall Study|Withdrawal by Subject|0|||
13097247|NCT03538743|25847928|FG002|Overall Study|Withdrawal by Subject|0|||
13097248|NCT03538743|25847929|FG003|Overall Study|Withdrawal by Subject|1|||
13097249|NCT03538743|25847930|FG004|Overall Study|Withdrawal by Subject|0|||
13097250|NCT03538743|25847931|FG005|Overall Study|Withdrawal by Subject|0|||
13097251|NCT03538743|25847932|FG006|Overall Study|Withdrawal by Subject|0|||
13097252|NCT03538743|25847933|FG007|Overall Study|Withdrawal by Subject|0|||
13097253|NCT03538743|25847934|FG008|Overall Study|Withdrawal by Subject|0|||
13097254|NCT03538431|25847945|FG000|Overall Study|Physician Decision|0|||
13097255|NCT03538431|25847946|FG001|Overall Study|Physician Decision|1|||
13097256|NCT03538431|25847945|FG000|Overall Study|Withdrawal by Subject|1|||
13097257|NCT03538431|25847946|FG001|Overall Study|Withdrawal by Subject|0|||
13097258|NCT03538054|25847958|FG000|Baseline Phase (2 Weeks)|Physician Decision|1|||
13097259|NCT03538054|25847958|FG000|Placebo Phase (5 Weeks)|Withdrawal by Subject|2|||
13097260|NCT03538054|25847958|FG000|Dextromethorphan Phase (10 Weeks)|Withdrawal by Subject|2|||
13097261|NCT03538041|25847996|FG000|12-Week Treatment Period|Adverse Event|1|||
13097262|NCT03538041|25847997|FG001|12-Week Treatment Period|Adverse Event|1|||
13097263|NCT03538041|25847996|FG000|12-Week Treatment Period|Withdrawal by Subject|0|||
13097264|NCT03538041|25847997|FG001|12-Week Treatment Period|Withdrawal by Subject|1|||
13097265|NCT03538041|25847996|FG000|Treatment Extension Period|Adverse Event|4|||
13097266|NCT03538041|25847997|FG001|Treatment Extension Period|Adverse Event|0|||
13097267|NCT03538041|25847996|FG000|Treatment Extension Period|Physician Decision|1|||
13097268|NCT03538041|25847997|FG001|Treatment Extension Period|Physician Decision|0|||
13097269|NCT03538041|25847996|FG000|Treatment Extension Period|Lack of Efficacy|1|||
13097270|NCT03538041|25847997|FG001|Treatment Extension Period|Lack of Efficacy|3|||
13097271|NCT03538041|25847996|FG000|Treatment Extension Period|Ongoing; Still Receiving Treatment|1|||
13097272|NCT03538041|25847997|FG001|Treatment Extension Period|Ongoing; Still Receiving Treatment|7|||
13097273|NCT03537261|25848014|FG000|Overall Study|Lost to Follow-up|4|||
13097274|NCT03537261|25848015|FG001|Overall Study|Lost to Follow-up|5|||
13097275|NCT03537261|25848014|FG000|Overall Study|Withdrawal by Subject|4|||
13097276|NCT03537261|25848015|FG001|Overall Study|Withdrawal by Subject|6|||
13097277|NCT03537261|25848014|FG000|Overall Study|Did not return study questionnaires|0|||
13097278|NCT03537261|25848015|FG001|Overall Study|Did not return study questionnaires|1|||
13097279|NCT03536949|25848030|FG000|Overall Study|Adverse Event|4|||
13097280|NCT03536949|25848031|FG001|Overall Study|Adverse Event|0|||
13097281|NCT03536949|25848030|FG000|Overall Study|Lost to Follow-up|2|||
13097282|NCT03536949|25848031|FG001|Overall Study|Lost to Follow-up|1|||
13097283|NCT03536949|25848030|FG000|Overall Study|Withdrawal by Subject|6|||
13097284|NCT03536949|25848031|FG001|Overall Study|Withdrawal by Subject|0|||
13097285|NCT03536949|25848030|FG000|Overall Study|Non-compliance|2|||
13097286|NCT03536949|25848031|FG001|Overall Study|Non-compliance|1|||
13097287|NCT03536663|25848048|FG000|Endexo|Protocol Violation|1|||
13097288|NCT03535974|25848066|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
13097289|NCT03535974|25848067|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1|||
13097290|NCT03535974|25848068|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
13097291|NCT03535974|25848066|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2|||
13097292|NCT03535974|25848067|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1|||
13097293|NCT03535974|25848068|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0|||
13097294|NCT03535844|25848111|FG000|Overall Study|Withdrawal by Subject|0|||
13097295|NCT03535844|25848112|FG001|Overall Study|Withdrawal by Subject|1|||
13097296|NCT03535740|25848119|FG000|Overall Study|Ongoing at Data Cut-off Date: 30 September 2020|55|||
13097297|NCT03535740|25848119|FG000|Overall Study|Death|34|||
13097298|NCT03535740|25848119|FG000|Overall Study|Lost to Follow-up|1|||
13097299|NCT03535740|25848119|FG000|Overall Study|Withdrawal by Subject|13|||
13097300|NCT03535194|25848204|FG000|Induction Period|Adverse Event|2|||
13097301|NCT03535194|25848205|FG001|Induction Period|Adverse Event|2|||
13097302|NCT03535194|25848206|FG002|Induction Period|Adverse Event|1|||
13097303|NCT03535194|25848207|FG003|Induction Period|Adverse Event|3|||
13097304|NCT03535194|25848208|FG004|Induction Period|Adverse Event|0|||
13097305|NCT03535194|25848204|FG000|Induction Period|Death|0|||
13097306|NCT03535194|25848205|FG001|Induction Period|Death|1|||
13097307|NCT03535194|25848206|FG002|Induction Period|Death|0|||
13097308|NCT03535194|25848207|FG003|Induction Period|Death|0|||
13097309|NCT03535194|25848208|FG004|Induction Period|Death|0|||
13097310|NCT03535194|25848204|FG000|Induction Period|Lack of Efficacy|1|||
13097311|NCT03535194|25848205|FG001|Induction Period|Lack of Efficacy|3|||
13097312|NCT03535194|25848206|FG002|Induction Period|Lack of Efficacy|2|||
13097313|NCT03535194|25848207|FG003|Induction Period|Lack of Efficacy|2|||
13097314|NCT03535194|25848208|FG004|Induction Period|Lack of Efficacy|0|||
13097315|NCT03535194|25848204|FG000|Induction Period|Lost to Follow-up|3|||
13097316|NCT03535194|25848205|FG001|Induction Period|Lost to Follow-up|5|||
13097317|NCT03535194|25848206|FG002|Induction Period|Lost to Follow-up|2|||
13097318|NCT03535194|25848207|FG003|Induction Period|Lost to Follow-up|3|||
13097319|NCT03535194|25848208|FG004|Induction Period|Lost to Follow-up|0|||
13097320|NCT03535194|25848204|FG000|Induction Period|Physician Decision|1|||
13485270|NCT02499900|27032165|FG001|Extension Study Period|Other|2|||
13485271|NCT02269917|27032314|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25|||
13485272|NCT02269917|27032315|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7|||
13485273|NCT02269917|27032316|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0|||
13485274|NCT02269917|27032314|FG000|BL to EOE-Test and BL to Switch-Control|Other|19|||
13485275|NCT02269917|27032315|FG001|BL to EOE-Test and BL to Switch-Control|Other|4|||
13485276|NCT02269917|27032316|FG002|BL to EOE-Test and BL to Switch-Control|Other|0|||
13485277|NCT02269917|27032314|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32|||
13097321|NCT03535194|25848205|FG001|Induction Period|Physician Decision|1|||
13097322|NCT03535194|25848206|FG002|Induction Period|Physician Decision|0|||
13097323|NCT03535194|25848207|FG003|Induction Period|Physician Decision|0|||
13097324|NCT03535194|25848208|FG004|Induction Period|Physician Decision|0|||
13097325|NCT03535194|25848204|FG000|Induction Period|Protocol Violation|1|||
13097326|NCT03535194|25848205|FG001|Induction Period|Protocol Violation|0|||
13097327|NCT03535194|25848206|FG002|Induction Period|Protocol Violation|0|||
13097328|NCT03535194|25848207|FG003|Induction Period|Protocol Violation|1|||
13097329|NCT03535194|25848208|FG004|Induction Period|Protocol Violation|0|||
13097330|NCT03535194|25848204|FG000|Induction Period|Screen Failure|0|||
13097331|NCT03535194|25848205|FG001|Induction Period|Screen Failure|1|||
13097332|NCT03535194|25848206|FG002|Induction Period|Screen Failure|0|||
13097333|NCT03535194|25848207|FG003|Induction Period|Screen Failure|0|||
13097334|NCT03535194|25848208|FG004|Induction Period|Screen Failure|0|||
13097335|NCT03535194|25848204|FG000|Induction Period|Withdrawal by Subject|3|||
13097336|NCT03535194|25848205|FG001|Induction Period|Withdrawal by Subject|4|||
13097337|NCT03535194|25848206|FG002|Induction Period|Withdrawal by Subject|3|||
13097338|NCT03535194|25848207|FG003|Induction Period|Withdrawal by Subject|2|||
13097339|NCT03535194|25848208|FG004|Induction Period|Withdrawal by Subject|0|||
13097340|NCT03535194|25848204|FG000|Maintenance Period|Adverse Event|6|||
13097341|NCT03535194|25848205|FG001|Maintenance Period|Adverse Event|5|||
13097342|NCT03535194|25848206|FG002|Maintenance Period|Adverse Event|1|||
13097343|NCT03535194|25848207|FG003|Maintenance Period|Adverse Event|11|||
13097344|NCT03535194|25848208|FG004|Maintenance Period|Adverse Event|4|||
13097345|NCT03535194|25848204|FG000|Maintenance Period|Lack of Efficacy|3|||
13097346|NCT03535194|25848205|FG001|Maintenance Period|Lack of Efficacy|2|||
13097347|NCT03535194|25848206|FG002|Maintenance Period|Lack of Efficacy|5|||
13097348|NCT03535194|25848207|FG003|Maintenance Period|Lack of Efficacy|9|||
13097349|NCT03535194|25848208|FG004|Maintenance Period|Lack of Efficacy|0|||
13097350|NCT03535194|25848204|FG000|Maintenance Period|Lost to Follow-up|4|||
13097351|NCT03535194|25848205|FG001|Maintenance Period|Lost to Follow-up|2|||
13097352|NCT03535194|25848206|FG002|Maintenance Period|Lost to Follow-up|1|||
13097353|NCT03535194|25848207|FG003|Maintenance Period|Lost to Follow-up|5|||
13097354|NCT03535194|25848208|FG004|Maintenance Period|Lost to Follow-up|2|||
13097355|NCT03535194|25848204|FG000|Maintenance Period|Other|1|||
13097356|NCT03535194|25848205|FG001|Maintenance Period|Other|2|||
13097357|NCT03535194|25848206|FG002|Maintenance Period|Other|0|||
13097358|NCT03535194|25848207|FG003|Maintenance Period|Other|0|||
13097359|NCT03535194|25848208|FG004|Maintenance Period|Other|0|||
13097360|NCT03535194|25848204|FG000|Maintenance Period|Physician Decision|1|||
13097361|NCT03535194|25848205|FG001|Maintenance Period|Physician Decision|2|||
13097362|NCT03535194|25848206|FG002|Maintenance Period|Physician Decision|0|||
13097363|NCT03535194|25848207|FG003|Maintenance Period|Physician Decision|2|||
13097364|NCT03535194|25848208|FG004|Maintenance Period|Physician Decision|0|||
13097365|NCT03535194|25848204|FG000|Maintenance Period|Pregnancy|0|||
13097366|NCT03535194|25848205|FG001|Maintenance Period|Pregnancy|0|||
13097367|NCT03535194|25848206|FG002|Maintenance Period|Pregnancy|0|||
13097368|NCT03535194|25848207|FG003|Maintenance Period|Pregnancy|2|||
13097369|NCT03535194|25848208|FG004|Maintenance Period|Pregnancy|0|||
13097370|NCT03535194|25848204|FG000|Maintenance Period|Protocol Violation|0|||
13097371|NCT03535194|25848205|FG001|Maintenance Period|Protocol Violation|1|||
13097372|NCT03535194|25848206|FG002|Maintenance Period|Protocol Violation|0|||
13097373|NCT03535194|25848207|FG003|Maintenance Period|Protocol Violation|0|||
13097374|NCT03535194|25848208|FG004|Maintenance Period|Protocol Violation|0|||
13097375|NCT03535194|25848204|FG000|Maintenance Period|Withdrawal by Subject|7|||
13097376|NCT03535194|25848205|FG001|Maintenance Period|Withdrawal by Subject|2|||
13097377|NCT03535194|25848206|FG002|Maintenance Period|Withdrawal by Subject|1|||
13097378|NCT03535194|25848207|FG003|Maintenance Period|Withdrawal by Subject|8|||
13097379|NCT03535194|25848208|FG004|Maintenance Period|Withdrawal by Subject|0|||
13097380|NCT03535194|25848204|FG000|Post-Treatment Followup Period|Adverse Event|4|||
13097381|NCT03535194|25848205|FG001|Post-Treatment Followup Period|Adverse Event|5|||
13097382|NCT03535194|25848206|FG002|Post-Treatment Followup Period|Adverse Event|1|||
13097383|NCT03535194|25848207|FG003|Post-Treatment Followup Period|Adverse Event|8|||
13097384|NCT03535194|25848208|FG004|Post-Treatment Followup Period|Adverse Event|0|||
13097385|NCT03535194|25848204|FG000|Post-Treatment Followup Period|Lack of Efficacy|3|||
13097386|NCT03535194|25848205|FG001|Post-Treatment Followup Period|Lack of Efficacy|4|||
13097387|NCT03535194|25848206|FG002|Post-Treatment Followup Period|Lack of Efficacy|5|||
13097388|NCT03535194|25848207|FG003|Post-Treatment Followup Period|Lack of Efficacy|4|||
13097389|NCT03535194|25848208|FG004|Post-Treatment Followup Period|Lack of Efficacy|0|||
13097390|NCT03535194|25848204|FG000|Post-Treatment Followup Period|Lost to Follow-up|1|||
13097391|NCT03535194|25848205|FG001|Post-Treatment Followup Period|Lost to Follow-up|1|||
13097392|NCT03535194|25848206|FG002|Post-Treatment Followup Period|Lost to Follow-up|1|||
13097393|NCT03535194|25848207|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
13097394|NCT03535194|25848208|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
13097395|NCT03535194|25848204|FG000|Post-Treatment Followup Period|Other|1|||
13097396|NCT03535194|25848205|FG001|Post-Treatment Followup Period|Other|0|||
13097397|NCT03535194|25848206|FG002|Post-Treatment Followup Period|Other|0|||
13097398|NCT03535194|25848207|FG003|Post-Treatment Followup Period|Other|5|||
13097399|NCT03535194|25848208|FG004|Post-Treatment Followup Period|Other|0|||
13097400|NCT03535194|25848204|FG000|Post-Treatment Followup Period|Physician Decision|0|||
13097401|NCT03535194|25848205|FG001|Post-Treatment Followup Period|Physician Decision|2|||
13097402|NCT03535194|25848206|FG002|Post-Treatment Followup Period|Physician Decision|1|||
13097403|NCT03535194|25848207|FG003|Post-Treatment Followup Period|Physician Decision|1|||
13097404|NCT03535194|25848208|FG004|Post-Treatment Followup Period|Physician Decision|0|||
13097405|NCT03535194|25848204|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2|||
13097406|NCT03535194|25848205|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2|||
13097407|NCT03535194|25848206|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3|||
13097408|NCT03535194|25848207|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6|||
13097409|NCT03535194|25848208|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
13097410|NCT03533608|25848215|FG000|Overall Study|Withdrawal by Subject|3|||
13097411|NCT03533608|25848215|FG000|Overall Study|Physician Decision|2|||
13097412|NCT03533114|25848238|FG000|Overall|Adverse Event|16|||
13097413|NCT03533114|25848239|FG001|Overall|Adverse Event|11|||
13097414|NCT03533114|25848238|FG000|Overall|Consent Withdrawal by Participant|7|||
13097415|NCT03533114|25848239|FG001|Overall|Consent Withdrawal by Participant|6|||
13097416|NCT03533114|25848238|FG000|Overall|Lack of Efficacy|5|||
13097417|NCT03533114|25848239|FG001|Overall|Lack of Efficacy|3|||
13097418|NCT03533114|25848238|FG000|Overall|Lost to Follow-up|1|||
13097419|NCT03533114|25848239|FG001|Overall|Lost to Follow-up|1|||
13097420|NCT03533114|25848238|FG000|Overall|Physician Decision|0|||
13097421|NCT03533114|25848239|FG001|Overall|Physician Decision|2|||
13097422|NCT03533114|25848238|FG000|Overall|Protocol deviation|1|||
13097423|NCT03533114|25848239|FG001|Overall|Protocol deviation|1|||
13097424|NCT03533114|25848238|FG000|Overall|Failure to meet randomization criteria|1|||
13097425|NCT03533114|25848239|FG001|Overall|Failure to meet randomization criteria|2|||
13097426|NCT03533114|25848238|FG000|Overall|Non-Compliance with study drug|0|||
13097427|NCT03533114|25848239|FG001|Overall|Non-Compliance with study drug|1|||
13097428|NCT03533114|25848238|FG000|Overall|Other|0|||
13097429|NCT03533114|25848239|FG001|Overall|Other|1|||
13097430|NCT03533114|25848238|FG000|Open Label Titration and Optimization|Adverse Event|11|||
13097431|NCT03533114|25848239|FG001|Open Label Titration and Optimization|Adverse Event|8|||
13097432|NCT03533114|25848238|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2|||
13097433|NCT03533114|25848239|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1|||
13097434|NCT03533114|25848238|FG000|Open Label Titration and Optimization|Lack of Efficacy|3|||
13097435|NCT03533114|25848239|FG001|Open Label Titration and Optimization|Lack of Efficacy|1|||
13097436|NCT03533114|25848238|FG000|Open Label Titration and Optimization|Lost to Follow-up|0|||
13097437|NCT03533114|25848239|FG001|Open Label Titration and Optimization|Lost to Follow-up|1|||
13097438|NCT03533114|25848238|FG000|Open Label Titration and Optimization|Protocol Deviation|0|||
13097439|NCT03533114|25848239|FG001|Open Label Titration and Optimization|Protocol Deviation|1|||
13097440|NCT03533114|25848238|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0|||
13097441|NCT03533114|25848239|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1|||
13097442|NCT03533114|25848238|FG000|Stable Dose|Adverse Event|0|||
13097443|NCT03533114|25848239|FG001|Stable Dose|Adverse Event|2|||
13097444|NCT03533114|25848238|FG000|Stable Dose|Consent Withdrawal by Participant|1|||
13097445|NCT03533114|25848239|FG001|Stable Dose|Consent Withdrawal by Participant|0|||
13097446|NCT03533114|25848238|FG000|Stable Dose|Lack of Efficacy|1|||
13097447|NCT03533114|25848239|FG001|Stable Dose|Lack of Efficacy|0|||
13097448|NCT03533114|25848238|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1|||
13097449|NCT03533114|25848239|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1|||
13097450|NCT03533114|25848238|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1|||
13097451|NCT03533114|25848239|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0|||
13097452|NCT03533114|25848238|FG000|Open-Label Safety Extension|Adverse Event|3|||
13097453|NCT03533114|25848239|FG001|Open-Label Safety Extension|Adverse Event|0|||
13097454|NCT03533114|25848238|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2|||
13097455|NCT03533114|25848239|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3|||
13097456|NCT03533114|25848238|FG000|Open-Label Safety Extension|Lack of Efficacy|1|||
13097457|NCT03533114|25848239|FG001|Open-Label Safety Extension|Lack of Efficacy|0|||
13097458|NCT03533114|25848238|FG000|Open-Label Safety Extension|Lost to Follow-up|1|||
13097459|NCT03533114|25848239|FG001|Open-Label Safety Extension|Lost to Follow-up|0|||
13097460|NCT03533114|25848238|FG000|Open-Label Safety Extension|Protocol Deviation|1|||
13097461|NCT03533114|25848239|FG001|Open-Label Safety Extension|Protocol Deviation|0|||
13097462|NCT03532048|25848260|FG000|Overall Study|Lost to Follow-up|12|||
13097463|NCT03532048|25848261|FG001|Overall Study|Lost to Follow-up|17|||
13097464|NCT03532048|25848260|FG000|Overall Study|Withdrawal by Subject|7|||
13097465|NCT03532048|25848261|FG001|Overall Study|Withdrawal by Subject|0|||
13097466|NCT03532009|25848286|FG000|Overall Study|Other|1|||
13097467|NCT03532009|25848287|FG001|Overall Study|Other|1|||
13097468|NCT03532009|25848286|FG000|Overall Study|Death|1|||
13097469|NCT03532009|25848287|FG001|Overall Study|Death|1|||
13097470|NCT03532009|25848286|FG000|Overall Study|Withdrawal by Patient|0|||
13097471|NCT03532009|25848287|FG001|Overall Study|Withdrawal by Patient|2|||
13097472|NCT03531905|25848349|FG000|Overall Study|Withdrawal by Subject|3|||
13097473|NCT03531905|25848350|FG001|Overall Study|Withdrawal by Subject|3|||
13097474|NCT03531905|25848351|FG002|Overall Study|Withdrawal by Subject|2|||
13097475|NCT03531905|25848349|FG000|Overall Study|Lost to Follow-up|2|||
13097476|NCT03531905|25848350|FG001|Overall Study|Lost to Follow-up|2|||
13097477|NCT03531905|25848351|FG002|Overall Study|Lost to Follow-up|1|||
13097478|NCT03531905|25848349|FG000|Overall Study|Participant was out of town|1|||
13097479|NCT03531905|25848350|FG001|Overall Study|Participant was out of town|0|||
13097480|NCT03531905|25848351|FG002|Overall Study|Participant was out of town|0|||
13097481|NCT03531905|25848349|FG000|Overall Study|Could not speak with the participant|1|||
13097482|NCT03531905|25848350|FG001|Overall Study|Could not speak with the participant|0|||
13097483|NCT03531905|25848351|FG002|Overall Study|Could not speak with the participant|0|||
13097484|NCT03531840|25848385|FG000|Overall Study|Death on study|3|||
13097485|NCT03531840|25848386|FG001|Overall Study|Death on study|2|||
13097486|NCT03531840|25848387|FG002|Overall Study|Death on study|1|||
13097487|NCT03531840|25848388|FG003|Overall Study|Death on study|2|||
13097488|NCT03531840|25848385|FG000|Overall Study|Death during follow up|2|||
13097489|NCT03531840|25848386|FG001|Overall Study|Death during follow up|3|||
13097490|NCT03531840|25848387|FG002|Overall Study|Death during follow up|4|||
13097491|NCT03531840|25848388|FG003|Overall Study|Death during follow up|1|||
13150587|NCT02554890|26047228|FG000|Double-blind|Technical problems|1|||
13150588|NCT02554890|26047229|FG001|Double-blind|Technical problems|0|||
13150589|NCT02554890|26047228|FG000|Double-blind|Withdrawal by Subject|5|||
13150590|NCT02554890|26047229|FG001|Double-blind|Withdrawal by Subject|6|||
13150591|NCT02554890|26047228|FG000|Double-blind|Noncompliance with study treatment|6|||
13150592|NCT02554890|26047229|FG001|Double-blind|Noncompliance with study treatment|5|||
13150593|NCT02554890|26047228|FG000|Open-label|Adverse Event|0|||
13150594|NCT02554890|26047229|FG001|Open-label|Adverse Event|30|||
13150595|NCT02554890|26047228|FG000|Open-label|Death|0|||
13150596|NCT02554890|26047229|FG001|Open-label|Death|1|||
13150597|NCT02554890|26047228|FG000|Open-label|Physician Decision|0|||
13150598|NCT02554890|26047229|FG001|Open-label|Physician Decision|1|||
13150599|NCT02554890|26047228|FG000|Open-label|Subject/Guardian decision|0|||
13150600|NCT02554890|26047229|FG001|Open-label|Subject/Guardian decision|11|||
13150601|NCT02554890|26047228|FG000|Open-label|Lost to Follow-up|0|||
13150602|NCT02554890|26047229|FG001|Open-label|Lost to Follow-up|7|||
13150603|NCT02554890|26047228|FG000|Open-label|Technical problems|0|||
13150604|NCT02554890|26047229|FG001|Open-label|Technical problems|1|||
13150605|NCT02554890|26047228|FG000|Open-label|Withdrawal by Subject|0|||
13150606|NCT02554890|26047229|FG001|Open-label|Withdrawal by Subject|1|||
13150607|NCT02554877|26047304|FG000|Overall Study|Adverse Event|2|||
13150608|NCT02554877|26047305|FG001|Overall Study|Adverse Event|0|||
13097492|NCT03531827|25848400|FG000|Overall Study|Adverse Event|2|||
13097493|NCT03531827|25848401|FG001|Overall Study|Adverse Event|0|||
13097494|NCT03531827|25848400|FG000|Overall Study|Progressive disease|1|||
13097495|NCT03531827|25848401|FG001|Overall Study|Progressive disease|0|||
13097496|NCT03531632|25848424|FG000|Overall Study|Adverse Event|0|||
13097497|NCT03531632|25848425|FG001|Overall Study|Adverse Event|0|||
13097498|NCT03531632|25848426|FG002|Overall Study|Adverse Event|1|||
13097499|NCT03531632|25848424|FG000|Overall Study|Death|4|||
13097500|NCT03531632|25848425|FG001|Overall Study|Death|0|||
13097501|NCT03531632|25848426|FG002|Overall Study|Death|14|||
13097502|NCT03531632|25848424|FG000|Overall Study|Study Terminated|1|||
13097503|NCT03531632|25848425|FG001|Overall Study|Study Terminated|3|||
13097504|NCT03531632|25848426|FG002|Overall Study|Study Terminated|11|||
13150609|NCT02554877|26047306|FG002|Overall Study|Adverse Event|0|||
13150610|NCT02554877|26047307|FG003|Overall Study|Adverse Event|1|||
13097505|NCT03530345|25848455|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
13097506|NCT03530345|25848456|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0|||
13097507|NCT03530345|25848455|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
13097508|NCT03530345|25848456|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
13097509|NCT03530345|25848455|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17|||
13097510|NCT03530345|25848456|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21|||
13097511|NCT03530345|25848455|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5|||
13097512|NCT03530345|25848456|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7|||
13097513|NCT03529773|25848871|FG000|Overall Study|Adverse Event|0|||
13097514|NCT03529773|25848872|FG001|Overall Study|Adverse Event|0|||
13097515|NCT03529773|25848873|FG002|Overall Study|Adverse Event|0|||
13097516|NCT03529773|25848874|FG003|Overall Study|Adverse Event|0|||
13097517|NCT03529773|25848875|FG004|Overall Study|Adverse Event|0|||
13097518|NCT03529773|25848876|FG005|Overall Study|Adverse Event|0|||
13097519|NCT03529773|25848877|FG006|Overall Study|Adverse Event|0|||
13097520|NCT03529773|25848878|FG007|Overall Study|Adverse Event|0|||
13097521|NCT03529773|25848879|FG008|Overall Study|Adverse Event|0|||
13097522|NCT03529773|25848880|FG009|Overall Study|Adverse Event|0|||
13097523|NCT03529773|25848881|FG010|Overall Study|Adverse Event|0|||
13097524|NCT03529773|25848882|FG011|Overall Study|Adverse Event|0|||
13097525|NCT03529773|25848883|FG012|Overall Study|Adverse Event|0|||
13097526|NCT03529773|25848884|FG013|Overall Study|Adverse Event|0|||
13097527|NCT03529773|25848885|FG014|Overall Study|Adverse Event|0|||
13097528|NCT03529773|25848886|FG015|Overall Study|Adverse Event|0|||
13097529|NCT03529773|25848887|FG016|Overall Study|Adverse Event|0|||
13097530|NCT03529773|25848888|FG017|Overall Study|Adverse Event|0|||
13097531|NCT03529773|25848889|FG018|Overall Study|Adverse Event|0|||
13097532|NCT03529773|25848890|FG019|Overall Study|Adverse Event|0|||
13097533|NCT03529773|25848891|FG020|Overall Study|Adverse Event|0|||
13097534|NCT03529773|25848892|FG021|Overall Study|Adverse Event|0|||
13097535|NCT03529773|25848893|FG022|Overall Study|Adverse Event|0|||
13097536|NCT03529773|25848894|FG023|Overall Study|Adverse Event|0|||
13097537|NCT03529773|25848895|FG024|Overall Study|Adverse Event|0|||
13097538|NCT03529773|25848896|FG025|Overall Study|Adverse Event|0|||
13097539|NCT03529773|25848897|FG026|Overall Study|Adverse Event|0|||
13097540|NCT03529773|25848898|FG027|Overall Study|Adverse Event|0|||
13097541|NCT03529773|25848899|FG028|Overall Study|Adverse Event|0|||
13097542|NCT03529773|25848900|FG029|Overall Study|Adverse Event|0|||
13097543|NCT03529773|25848901|FG030|Overall Study|Adverse Event|1|||
13097544|NCT03529773|25848902|FG031|Overall Study|Adverse Event|0|||
13097545|NCT03529773|25848903|FG032|Overall Study|Adverse Event|0|||
13097546|NCT03529773|25848904|FG033|Overall Study|Adverse Event|0|||
13097547|NCT03529773|25848905|FG034|Overall Study|Adverse Event|0|||
13097548|NCT03529773|25848906|FG035|Overall Study|Adverse Event|1|||
13097549|NCT03529773|25848907|FG036|Overall Study|Adverse Event|0|||
13097550|NCT03529773|25848908|FG037|Overall Study|Adverse Event|0|||
13097551|NCT03529773|25848909|FG038|Overall Study|Adverse Event|1|||
13097552|NCT03529773|25848910|FG039|Overall Study|Adverse Event|1|||
13097553|NCT03529773|25848871|FG000|Overall Study|Death|0|||
13097554|NCT03529773|25848872|FG001|Overall Study|Death|0|||
13097555|NCT03529773|25848873|FG002|Overall Study|Death|0|||
13097556|NCT03529773|25848874|FG003|Overall Study|Death|0|||
13097557|NCT03529773|25848875|FG004|Overall Study|Death|0|||
13097558|NCT03529773|25848876|FG005|Overall Study|Death|0|||
13097559|NCT03529773|25848877|FG006|Overall Study|Death|0|||
13097560|NCT03529773|25848878|FG007|Overall Study|Death|0|||
13097561|NCT03529773|25848879|FG008|Overall Study|Death|0|||
13097562|NCT03529773|25848880|FG009|Overall Study|Death|0|||
13097563|NCT03529773|25848881|FG010|Overall Study|Death|0|||
13097564|NCT03529773|25848882|FG011|Overall Study|Death|0|||
13097565|NCT03529773|25848883|FG012|Overall Study|Death|1|||
13097566|NCT03529773|25848884|FG013|Overall Study|Death|0|||
13097567|NCT03529773|25848885|FG014|Overall Study|Death|0|||
13097568|NCT03529773|25848886|FG015|Overall Study|Death|0|||
13097569|NCT03529773|25848887|FG016|Overall Study|Death|0|||
13097570|NCT03529773|25848888|FG017|Overall Study|Death|0|||
13097571|NCT03529773|25848889|FG018|Overall Study|Death|0|||
13097572|NCT03529773|25848890|FG019|Overall Study|Death|1|||
13097573|NCT03529773|25848891|FG020|Overall Study|Death|0|||
13097574|NCT03529773|25848892|FG021|Overall Study|Death|0|||
13097575|NCT03529773|25848893|FG022|Overall Study|Death|1|||
13097576|NCT03529773|25848894|FG023|Overall Study|Death|0|||
13097577|NCT03529773|25848895|FG024|Overall Study|Death|0|||
13097578|NCT03529773|25848896|FG025|Overall Study|Death|0|||
13097579|NCT03529773|25848897|FG026|Overall Study|Death|0|||
13097580|NCT03529773|25848898|FG027|Overall Study|Death|0|||
13097581|NCT03529773|25848899|FG028|Overall Study|Death|0|||
13097582|NCT03529773|25848900|FG029|Overall Study|Death|0|||
13097583|NCT03529773|25848901|FG030|Overall Study|Death|0|||
13097584|NCT03529773|25848902|FG031|Overall Study|Death|0|||
13097585|NCT03529773|25848903|FG032|Overall Study|Death|0|||
13097586|NCT03529773|25848904|FG033|Overall Study|Death|1|||
13097587|NCT03529773|25848905|FG034|Overall Study|Death|1|||
13097588|NCT03529773|25848906|FG035|Overall Study|Death|0|||
13097589|NCT03529773|25848907|FG036|Overall Study|Death|1|||
13097590|NCT03529773|25848908|FG037|Overall Study|Death|0|||
13097591|NCT03529773|25848909|FG038|Overall Study|Death|0|||
13097592|NCT03529773|25848910|FG039|Overall Study|Death|0|||
13097593|NCT03529773|25848871|FG000|Overall Study|Lost to Follow-up|0|||
13097594|NCT03529773|25848872|FG001|Overall Study|Lost to Follow-up|0|||
13097595|NCT03529773|25848873|FG002|Overall Study|Lost to Follow-up|1|||
13097596|NCT03529773|25848874|FG003|Overall Study|Lost to Follow-up|0|||
13097597|NCT03529773|25848875|FG004|Overall Study|Lost to Follow-up|1|||
13097598|NCT03529773|25848876|FG005|Overall Study|Lost to Follow-up|1|||
13097599|NCT03529773|25848877|FG006|Overall Study|Lost to Follow-up|0|||
13097600|NCT03529773|25848878|FG007|Overall Study|Lost to Follow-up|0|||
13097601|NCT03529773|25848879|FG008|Overall Study|Lost to Follow-up|0|||
13097602|NCT03529773|25848880|FG009|Overall Study|Lost to Follow-up|0|||
13097603|NCT03529773|25848881|FG010|Overall Study|Lost to Follow-up|0|||
13097604|NCT03529773|25848882|FG011|Overall Study|Lost to Follow-up|0|||
13097605|NCT03529773|25848883|FG012|Overall Study|Lost to Follow-up|0|||
13097606|NCT03529773|25848884|FG013|Overall Study|Lost to Follow-up|1|||
13097607|NCT03529773|25848885|FG014|Overall Study|Lost to Follow-up|4|||
13097608|NCT03529773|25848886|FG015|Overall Study|Lost to Follow-up|1|||
13097609|NCT03529773|25848887|FG016|Overall Study|Lost to Follow-up|1|||
13097610|NCT03529773|25848888|FG017|Overall Study|Lost to Follow-up|0|||
13097611|NCT03529773|25848889|FG018|Overall Study|Lost to Follow-up|1|||
13097612|NCT03529773|25848890|FG019|Overall Study|Lost to Follow-up|1|||
13097613|NCT03529773|25848891|FG020|Overall Study|Lost to Follow-up|2|||
13097614|NCT03529773|25848892|FG021|Overall Study|Lost to Follow-up|4|||
13097615|NCT03529773|25848893|FG022|Overall Study|Lost to Follow-up|3|||
13097616|NCT03529773|25848894|FG023|Overall Study|Lost to Follow-up|4|||
13097617|NCT03529773|25848895|FG024|Overall Study|Lost to Follow-up|3|||
13097618|NCT03529773|25848896|FG025|Overall Study|Lost to Follow-up|5|||
13097619|NCT03529773|25848897|FG026|Overall Study|Lost to Follow-up|5|||
13097620|NCT03529773|25848898|FG027|Overall Study|Lost to Follow-up|0|||
13097621|NCT03529773|25848899|FG028|Overall Study|Lost to Follow-up|0|||
13097622|NCT03529773|25848900|FG029|Overall Study|Lost to Follow-up|0|||
13097623|NCT03529773|25848901|FG030|Overall Study|Lost to Follow-up|1|||
13097624|NCT03529773|25848902|FG031|Overall Study|Lost to Follow-up|0|||
13097625|NCT03529773|25848903|FG032|Overall Study|Lost to Follow-up|0|||
13097626|NCT03529773|25848904|FG033|Overall Study|Lost to Follow-up|1|||
13097627|NCT03529773|25848905|FG034|Overall Study|Lost to Follow-up|1|||
13097628|NCT03529773|25848906|FG035|Overall Study|Lost to Follow-up|0|||
13097629|NCT03529773|25848907|FG036|Overall Study|Lost to Follow-up|0|||
13097630|NCT03529773|25848908|FG037|Overall Study|Lost to Follow-up|3|||
13097631|NCT03529773|25848909|FG038|Overall Study|Lost to Follow-up|1|||
13097632|NCT03529773|25848910|FG039|Overall Study|Lost to Follow-up|1|||
13097633|NCT03529773|25848871|FG000|Overall Study|No longer meets eligibility criteria|0|||
13097634|NCT03529773|25848872|FG001|Overall Study|No longer meets eligibility criteria|0|||
13097635|NCT03529773|25848873|FG002|Overall Study|No longer meets eligibility criteria|0|||
13097636|NCT03529773|25848874|FG003|Overall Study|No longer meets eligibility criteria|0|||
13097637|NCT03529773|25848875|FG004|Overall Study|No longer meets eligibility criteria|0|||
13097638|NCT03529773|25848876|FG005|Overall Study|No longer meets eligibility criteria|0|||
13097639|NCT03529773|25848877|FG006|Overall Study|No longer meets eligibility criteria|0|||
13097640|NCT03529773|25848878|FG007|Overall Study|No longer meets eligibility criteria|0|||
13097641|NCT03529773|25848879|FG008|Overall Study|No longer meets eligibility criteria|0|||
13097642|NCT03529773|25848880|FG009|Overall Study|No longer meets eligibility criteria|0|||
13097643|NCT03529773|25848881|FG010|Overall Study|No longer meets eligibility criteria|0|||
13097644|NCT03529773|25848882|FG011|Overall Study|No longer meets eligibility criteria|0|||
13097645|NCT03529773|25848883|FG012|Overall Study|No longer meets eligibility criteria|0|||
13097646|NCT03529773|25848884|FG013|Overall Study|No longer meets eligibility criteria|0|||
13097647|NCT03529773|25848885|FG014|Overall Study|No longer meets eligibility criteria|0|||
13097648|NCT03529773|25848886|FG015|Overall Study|No longer meets eligibility criteria|0|||
13097649|NCT03529773|25848887|FG016|Overall Study|No longer meets eligibility criteria|0|||
13097650|NCT03529773|25848888|FG017|Overall Study|No longer meets eligibility criteria|0|||
13097651|NCT03529773|25848889|FG018|Overall Study|No longer meets eligibility criteria|0|||
13097652|NCT03529773|25848890|FG019|Overall Study|No longer meets eligibility criteria|0|||
13097653|NCT03529773|25848891|FG020|Overall Study|No longer meets eligibility criteria|0|||
13097654|NCT03529773|25848892|FG021|Overall Study|No longer meets eligibility criteria|0|||
13097655|NCT03529773|25848893|FG022|Overall Study|No longer meets eligibility criteria|1|||
13097656|NCT03529773|25848894|FG023|Overall Study|No longer meets eligibility criteria|0|||
13097657|NCT03529773|25848895|FG024|Overall Study|No longer meets eligibility criteria|0|||
13097658|NCT03529773|25848896|FG025|Overall Study|No longer meets eligibility criteria|0|||
13097659|NCT03529773|25848897|FG026|Overall Study|No longer meets eligibility criteria|0|||
13097660|NCT03529773|25848898|FG027|Overall Study|No longer meets eligibility criteria|0|||
13097661|NCT03529773|25848899|FG028|Overall Study|No longer meets eligibility criteria|0|||
13097662|NCT03529773|25848900|FG029|Overall Study|No longer meets eligibility criteria|0|||
13097663|NCT03529773|25848901|FG030|Overall Study|No longer meets eligibility criteria|0|||
13150611|NCT02554877|26047304|FG000|Overall Study|Lost to Follow-up|1|||
13150612|NCT02554877|26047305|FG001|Overall Study|Lost to Follow-up|1|||
13150613|NCT02554877|26047306|FG002|Overall Study|Lost to Follow-up|1|||
13150614|NCT02554877|26047307|FG003|Overall Study|Lost to Follow-up|2|||
13150615|NCT02554877|26047304|FG000|Overall Study|Did not meet entrance criteria|0|||
13150616|NCT02554877|26047305|FG001|Overall Study|Did not meet entrance criteria|0|||
13150617|NCT02554877|26047306|FG002|Overall Study|Did not meet entrance criteria|1|||
13150618|NCT02554877|26047307|FG003|Overall Study|Did not meet entrance criteria|0|||
13150619|NCT02554877|26047304|FG000|Overall Study|No longer met eligibility criteria|1|||
13150620|NCT02554877|26047305|FG001|Overall Study|No longer met eligibility criteria|0|||
13150621|NCT02554877|26047306|FG002|Overall Study|No longer met eligibility criteria|1|||
13150622|NCT02554877|26047307|FG003|Overall Study|No longer met eligibility criteria|1|||
13150623|NCT02554877|26047304|FG000|Overall Study|Protocol Violation|3|||
13150624|NCT02554877|26047305|FG001|Overall Study|Protocol Violation|1|||
13097664|NCT03529773|25848902|FG031|Overall Study|No longer meets eligibility criteria|0|||
13097665|NCT03529773|25848903|FG032|Overall Study|No longer meets eligibility criteria|0|||
13097666|NCT03529773|25848904|FG033|Overall Study|No longer meets eligibility criteria|0|||
13097667|NCT03529773|25848905|FG034|Overall Study|No longer meets eligibility criteria|0|||
13097668|NCT03529773|25848906|FG035|Overall Study|No longer meets eligibility criteria|0|||
13097669|NCT03529773|25848907|FG036|Overall Study|No longer meets eligibility criteria|0|||
13097670|NCT03529773|25848908|FG037|Overall Study|No longer meets eligibility criteria|0|||
13097671|NCT03529773|25848909|FG038|Overall Study|No longer meets eligibility criteria|1|||
13097672|NCT03529773|25848910|FG039|Overall Study|No longer meets eligibility criteria|0|||
13097673|NCT03529773|25848871|FG000|Overall Study|Other|0|||
13097674|NCT03529773|25848872|FG001|Overall Study|Other|0|||
13097675|NCT03529773|25848873|FG002|Overall Study|Other|0|||
13097676|NCT03529773|25848874|FG003|Overall Study|Other|0|||
13097677|NCT03529773|25848875|FG004|Overall Study|Other|0|||
13097678|NCT03529773|25848876|FG005|Overall Study|Other|0|||
13097679|NCT03529773|25848877|FG006|Overall Study|Other|0|||
13097680|NCT03529773|25848878|FG007|Overall Study|Other|0|||
13097681|NCT03529773|25848879|FG008|Overall Study|Other|0|||
13097682|NCT03529773|25848880|FG009|Overall Study|Other|0|||
13097683|NCT03529773|25848881|FG010|Overall Study|Other|0|||
13097684|NCT03529773|25848882|FG011|Overall Study|Other|0|||
13097685|NCT03529773|25848883|FG012|Overall Study|Other|1|||
13097686|NCT03529773|25848884|FG013|Overall Study|Other|0|||
13097687|NCT03529773|25848885|FG014|Overall Study|Other|2|||
13097688|NCT03529773|25848886|FG015|Overall Study|Other|0|||
13097689|NCT03529773|25848887|FG016|Overall Study|Other|0|||
13097690|NCT03529773|25848888|FG017|Overall Study|Other|3|||
13097691|NCT03529773|25848889|FG018|Overall Study|Other|0|||
13097692|NCT03529773|25848890|FG019|Overall Study|Other|0|||
13097693|NCT03529773|25848891|FG020|Overall Study|Other|1|||
13097694|NCT03529773|25848892|FG021|Overall Study|Other|0|||
13097695|NCT03529773|25848893|FG022|Overall Study|Other|1|||
13097696|NCT03529773|25848894|FG023|Overall Study|Other|0|||
13097697|NCT03529773|25848895|FG024|Overall Study|Other|3|||
13097698|NCT03529773|25848896|FG025|Overall Study|Other|2|||
13097699|NCT03529773|25848897|FG026|Overall Study|Other|2|||
13097700|NCT03529773|25848898|FG027|Overall Study|Other|0|||
13097701|NCT03529773|25848899|FG028|Overall Study|Other|0|||
13097702|NCT03529773|25848900|FG029|Overall Study|Other|0|||
13097703|NCT03529773|25848901|FG030|Overall Study|Other|0|||
13097704|NCT03529773|25848902|FG031|Overall Study|Other|0|||
13097705|NCT03529773|25848903|FG032|Overall Study|Other|0|||
13097706|NCT03529773|25848904|FG033|Overall Study|Other|0|||
13097707|NCT03529773|25848905|FG034|Overall Study|Other|1|||
13097708|NCT03529773|25848906|FG035|Overall Study|Other|1|||
13097709|NCT03529773|25848907|FG036|Overall Study|Other|0|||
13097710|NCT03529773|25848908|FG037|Overall Study|Other|0|||
13097711|NCT03529773|25848909|FG038|Overall Study|Other|0|||
13097712|NCT03529773|25848910|FG039|Overall Study|Other|0|||
13097713|NCT03529773|25848871|FG000|Overall Study|Physician Decision|0|||
13097714|NCT03529773|25848872|FG001|Overall Study|Physician Decision|0|||
13097715|NCT03529773|25848873|FG002|Overall Study|Physician Decision|0|||
13097716|NCT03529773|25848874|FG003|Overall Study|Physician Decision|0|||
13097717|NCT03529773|25848875|FG004|Overall Study|Physician Decision|0|||
13097718|NCT03529773|25848876|FG005|Overall Study|Physician Decision|0|||
13097719|NCT03529773|25848877|FG006|Overall Study|Physician Decision|0|||
13097720|NCT03529773|25848878|FG007|Overall Study|Physician Decision|0|||
13097721|NCT03529773|25848879|FG008|Overall Study|Physician Decision|0|||
13097722|NCT03529773|25848880|FG009|Overall Study|Physician Decision|0|||
13097723|NCT03529773|25848881|FG010|Overall Study|Physician Decision|0|||
13097724|NCT03529773|25848882|FG011|Overall Study|Physician Decision|0|||
13097725|NCT03529773|25848883|FG012|Overall Study|Physician Decision|0|||
13097726|NCT03529773|25848884|FG013|Overall Study|Physician Decision|0|||
13097727|NCT03529773|25848885|FG014|Overall Study|Physician Decision|0|||
13097728|NCT03529773|25848886|FG015|Overall Study|Physician Decision|0|||
13097729|NCT03529773|25848887|FG016|Overall Study|Physician Decision|0|||
13097730|NCT03529773|25848888|FG017|Overall Study|Physician Decision|0|||
13097731|NCT03529773|25848889|FG018|Overall Study|Physician Decision|0|||
13097732|NCT03529773|25848890|FG019|Overall Study|Physician Decision|1|||
13097733|NCT03529773|25848891|FG020|Overall Study|Physician Decision|1|||
13097734|NCT03529773|25848892|FG021|Overall Study|Physician Decision|0|||
13097735|NCT03529773|25848893|FG022|Overall Study|Physician Decision|0|||
13097736|NCT03529773|25848894|FG023|Overall Study|Physician Decision|0|||
13097737|NCT03529773|25848895|FG024|Overall Study|Physician Decision|0|||
13097738|NCT03529773|25848896|FG025|Overall Study|Physician Decision|0|||
13097739|NCT03529773|25848897|FG026|Overall Study|Physician Decision|0|||
13097740|NCT03529773|25848898|FG027|Overall Study|Physician Decision|0|||
13097741|NCT03529773|25848899|FG028|Overall Study|Physician Decision|0|||
13097742|NCT03529773|25848900|FG029|Overall Study|Physician Decision|0|||
13097743|NCT03529773|25848901|FG030|Overall Study|Physician Decision|0|||
13097744|NCT03529773|25848902|FG031|Overall Study|Physician Decision|0|||
13097745|NCT03529773|25848903|FG032|Overall Study|Physician Decision|0|||
13097746|NCT03529773|25848904|FG033|Overall Study|Physician Decision|0|||
13097747|NCT03529773|25848905|FG034|Overall Study|Physician Decision|0|||
13097748|NCT03529773|25848906|FG035|Overall Study|Physician Decision|0|||
13097749|NCT03529773|25848907|FG036|Overall Study|Physician Decision|0|||
13097750|NCT03529773|25848908|FG037|Overall Study|Physician Decision|0|||
13097751|NCT03529773|25848909|FG038|Overall Study|Physician Decision|0|||
13097752|NCT03529773|25848910|FG039|Overall Study|Physician Decision|0|||
13097753|NCT03529773|25848871|FG000|Overall Study|Protocol Violation|0|||
13097754|NCT03529773|25848872|FG001|Overall Study|Protocol Violation|0|||
13097755|NCT03529773|25848873|FG002|Overall Study|Protocol Violation|0|||
13097756|NCT03529773|25848874|FG003|Overall Study|Protocol Violation|0|||
13097757|NCT03529773|25848875|FG004|Overall Study|Protocol Violation|0|||
13097758|NCT03529773|25848876|FG005|Overall Study|Protocol Violation|0|||
13097759|NCT03529773|25848877|FG006|Overall Study|Protocol Violation|0|||
13097760|NCT03529773|25848878|FG007|Overall Study|Protocol Violation|0|||
13097761|NCT03529773|25848879|FG008|Overall Study|Protocol Violation|0|||
13097762|NCT03529773|25848880|FG009|Overall Study|Protocol Violation|0|||
13097763|NCT03529773|25848881|FG010|Overall Study|Protocol Violation|0|||
13097764|NCT03529773|25848882|FG011|Overall Study|Protocol Violation|0|||
13097765|NCT03529773|25848883|FG012|Overall Study|Protocol Violation|0|||
13097766|NCT03529773|25848884|FG013|Overall Study|Protocol Violation|0|||
13097767|NCT03529773|25848885|FG014|Overall Study|Protocol Violation|0|||
13097768|NCT03529773|25848886|FG015|Overall Study|Protocol Violation|0|||
13097769|NCT03529773|25848887|FG016|Overall Study|Protocol Violation|0|||
13097770|NCT03529773|25848888|FG017|Overall Study|Protocol Violation|0|||
13097771|NCT03529773|25848889|FG018|Overall Study|Protocol Violation|0|||
13097772|NCT03529773|25848890|FG019|Overall Study|Protocol Violation|0|||
13097773|NCT03529773|25848891|FG020|Overall Study|Protocol Violation|0|||
13097774|NCT03529773|25848892|FG021|Overall Study|Protocol Violation|0|||
13097775|NCT03529773|25848893|FG022|Overall Study|Protocol Violation|0|||
13097776|NCT03529773|25848894|FG023|Overall Study|Protocol Violation|0|||
13097777|NCT03529773|25848895|FG024|Overall Study|Protocol Violation|0|||
13097778|NCT03529773|25848896|FG025|Overall Study|Protocol Violation|0|||
13097779|NCT03529773|25848897|FG026|Overall Study|Protocol Violation|0|||
13097780|NCT03529773|25848898|FG027|Overall Study|Protocol Violation|0|||
13097781|NCT03529773|25848899|FG028|Overall Study|Protocol Violation|0|||
13150625|NCT02554877|26047306|FG002|Overall Study|Protocol Violation|1|||
13150626|NCT02554877|26047307|FG003|Overall Study|Protocol Violation|0|||
13150627|NCT02554877|26047304|FG000|Overall Study|Other|1|||
13150628|NCT02554877|26047305|FG001|Overall Study|Other|3|||
13150629|NCT02554877|26047306|FG002|Overall Study|Other|0|||
13150630|NCT02554877|26047307|FG003|Overall Study|Other|3|||
13150631|NCT02554877|26047304|FG000|Overall Study|Insufficient clinical response|4|||
13097782|NCT03529773|25848900|FG029|Overall Study|Protocol Violation|0|||
13097783|NCT03529773|25848901|FG030|Overall Study|Protocol Violation|1|||
13097784|NCT03529773|25848902|FG031|Overall Study|Protocol Violation|0|||
13097785|NCT03529773|25848903|FG032|Overall Study|Protocol Violation|0|||
13097786|NCT03529773|25848904|FG033|Overall Study|Protocol Violation|0|||
13097787|NCT03529773|25848905|FG034|Overall Study|Protocol Violation|0|||
13097788|NCT03529773|25848906|FG035|Overall Study|Protocol Violation|0|||
13097789|NCT03529773|25848907|FG036|Overall Study|Protocol Violation|0|||
13097790|NCT03529773|25848908|FG037|Overall Study|Protocol Violation|0|||
13097791|NCT03529773|25848909|FG038|Overall Study|Protocol Violation|0|||
13097792|NCT03529773|25848910|FG039|Overall Study|Protocol Violation|0|||
13097793|NCT03529773|25848871|FG000|Overall Study|Withdrawal by Subject|0|||
13150632|NCT02554877|26047305|FG001|Overall Study|Insufficient clinical response|0|||
13150633|NCT02554877|26047306|FG002|Overall Study|Insufficient clinical response|0|||
13097794|NCT03529773|25848872|FG001|Overall Study|Withdrawal by Subject|0|||
13097795|NCT03529773|25848873|FG002|Overall Study|Withdrawal by Subject|0|||
13097796|NCT03529773|25848874|FG003|Overall Study|Withdrawal by Subject|0|||
13097797|NCT03529773|25848875|FG004|Overall Study|Withdrawal by Subject|0|||
13222665|NCT01803737|26286703|FG000|Overall Study|Medical Reason|0|||
13097798|NCT03529773|25848876|FG005|Overall Study|Withdrawal by Subject|0|||
13097799|NCT03529773|25848877|FG006|Overall Study|Withdrawal by Subject|0|||
13097800|NCT03529773|25848878|FG007|Overall Study|Withdrawal by Subject|1|||
13097801|NCT03529773|25848879|FG008|Overall Study|Withdrawal by Subject|0|||
13097802|NCT03529773|25848880|FG009|Overall Study|Withdrawal by Subject|1|||
13097803|NCT03529773|25848881|FG010|Overall Study|Withdrawal by Subject|1|||
13097804|NCT03529773|25848882|FG011|Overall Study|Withdrawal by Subject|0|||
13485278|NCT02269917|27032315|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10|||
13485279|NCT02269917|27032316|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0|||
13485280|NCT02269917|27032314|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24|||
13485281|NCT02269917|27032315|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4|||
13485282|NCT02269917|27032316|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0|||
13485283|NCT02269917|27032314|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4|||
13485284|NCT02269917|27032315|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
13485285|NCT02269917|27032316|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
13485286|NCT02269917|27032314|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4|||
13485287|NCT02269917|27032315|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
13485288|NCT02269917|27032316|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
13485289|NCT02269917|27032314|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2|||
13485290|NCT02269917|27032315|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1|||
13485291|NCT02269917|27032316|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0|||
13485292|NCT02269917|27032314|FG000|BL to EOE-Test and BL to Switch-Control|Death|4|||
13097805|NCT03529773|25848883|FG012|Overall Study|Withdrawal by Subject|0|||
13097806|NCT03529773|25848884|FG013|Overall Study|Withdrawal by Subject|0|||
13097807|NCT03529773|25848885|FG014|Overall Study|Withdrawal by Subject|0|||
13097808|NCT03529773|25848886|FG015|Overall Study|Withdrawal by Subject|3|||
13097809|NCT03529773|25848887|FG016|Overall Study|Withdrawal by Subject|0|||
13097810|NCT03529773|25848888|FG017|Overall Study|Withdrawal by Subject|2|||
13097811|NCT03529773|25848889|FG018|Overall Study|Withdrawal by Subject|3|||
13097812|NCT03529773|25848890|FG019|Overall Study|Withdrawal by Subject|1|||
13097813|NCT03529773|25848891|FG020|Overall Study|Withdrawal by Subject|3|||
13097814|NCT03529773|25848892|FG021|Overall Study|Withdrawal by Subject|1|||
13097815|NCT03529773|25848893|FG022|Overall Study|Withdrawal by Subject|1|||
13097816|NCT03529773|25848894|FG023|Overall Study|Withdrawal by Subject|2|||
13097817|NCT03529773|25848895|FG024|Overall Study|Withdrawal by Subject|2|||
13097818|NCT03529773|25848896|FG025|Overall Study|Withdrawal by Subject|4|||
13097819|NCT03529773|25848897|FG026|Overall Study|Withdrawal by Subject|2|||
13097820|NCT03529773|25848898|FG027|Overall Study|Withdrawal by Subject|1|||
13097821|NCT03529773|25848899|FG028|Overall Study|Withdrawal by Subject|1|||
13097822|NCT03529773|25848900|FG029|Overall Study|Withdrawal by Subject|0|||
13097823|NCT03529773|25848901|FG030|Overall Study|Withdrawal by Subject|0|||
13097824|NCT03529773|25848902|FG031|Overall Study|Withdrawal by Subject|0|||
13097825|NCT03529773|25848903|FG032|Overall Study|Withdrawal by Subject|0|||
13097826|NCT03529773|25848904|FG033|Overall Study|Withdrawal by Subject|0|||
13097827|NCT03529773|25848905|FG034|Overall Study|Withdrawal by Subject|1|||
13097828|NCT03529773|25848906|FG035|Overall Study|Withdrawal by Subject|2|||
13097829|NCT03529773|25848907|FG036|Overall Study|Withdrawal by Subject|0|||
13097830|NCT03529773|25848908|FG037|Overall Study|Withdrawal by Subject|2|||
13097831|NCT03529773|25848909|FG038|Overall Study|Withdrawal by Subject|1|||
13097832|NCT03529773|25848910|FG039|Overall Study|Withdrawal by Subject|1|||
13097833|NCT03529773|25848871|FG000|Overall Study|Screen Failure|0|||
13097834|NCT03529773|25848872|FG001|Overall Study|Screen Failure|0|||
13097835|NCT03529773|25848873|FG002|Overall Study|Screen Failure|0|||
13097836|NCT03529773|25848874|FG003|Overall Study|Screen Failure|0|||
13097837|NCT03529773|25848875|FG004|Overall Study|Screen Failure|0|||
13097838|NCT03529773|25848876|FG005|Overall Study|Screen Failure|0|||
13097839|NCT03529773|25848877|FG006|Overall Study|Screen Failure|0|||
13097840|NCT03529773|25848878|FG007|Overall Study|Screen Failure|0|||
13097841|NCT03529773|25848879|FG008|Overall Study|Screen Failure|0|||
13097842|NCT03529773|25848880|FG009|Overall Study|Screen Failure|0|||
13097843|NCT03529773|25848881|FG010|Overall Study|Screen Failure|0|||
13097844|NCT03529773|25848882|FG011|Overall Study|Screen Failure|0|||
13097845|NCT03529773|25848883|FG012|Overall Study|Screen Failure|0|||
13097846|NCT03529773|25848884|FG013|Overall Study|Screen Failure|0|||
13097847|NCT03529773|25848885|FG014|Overall Study|Screen Failure|0|||
13097848|NCT03529773|25848886|FG015|Overall Study|Screen Failure|0|||
13097849|NCT03529773|25848887|FG016|Overall Study|Screen Failure|0|||
13097850|NCT03529773|25848888|FG017|Overall Study|Screen Failure|0|||
13097851|NCT03529773|25848889|FG018|Overall Study|Screen Failure|0|||
13097852|NCT03529773|25848890|FG019|Overall Study|Screen Failure|0|||
13097853|NCT03529773|25848891|FG020|Overall Study|Screen Failure|0|||
13097854|NCT03529773|25848892|FG021|Overall Study|Screen Failure|0|||
13097855|NCT03529773|25848893|FG022|Overall Study|Screen Failure|0|||
13097856|NCT03529773|25848894|FG023|Overall Study|Screen Failure|0|||
13097857|NCT03529773|25848895|FG024|Overall Study|Screen Failure|0|||
13097858|NCT03529773|25848896|FG025|Overall Study|Screen Failure|0|||
13097859|NCT03529773|25848897|FG026|Overall Study|Screen Failure|0|||
13097860|NCT03529773|25848898|FG027|Overall Study|Screen Failure|0|||
13097861|NCT03529773|25848899|FG028|Overall Study|Screen Failure|0|||
13097862|NCT03529773|25848900|FG029|Overall Study|Screen Failure|0|||
13097863|NCT03529773|25848901|FG030|Overall Study|Screen Failure|0|||
13097864|NCT03529773|25848902|FG031|Overall Study|Screen Failure|0|||
13097865|NCT03529773|25848903|FG032|Overall Study|Screen Failure|0|||
13097866|NCT03529773|25848904|FG033|Overall Study|Screen Failure|0|||
13097867|NCT03529773|25848905|FG034|Overall Study|Screen Failure|0|||
13097868|NCT03529773|25848906|FG035|Overall Study|Screen Failure|0|||
13097869|NCT03529773|25848907|FG036|Overall Study|Screen Failure|1|||
13097870|NCT03529773|25848908|FG037|Overall Study|Screen Failure|1|||
13097871|NCT03529773|25848909|FG038|Overall Study|Screen Failure|0|||
13097872|NCT03529773|25848910|FG039|Overall Study|Screen Failure|1|||
13097873|NCT03529773|25848871|FG000|Overall Study|Randomized but not vaccinated|0|||
13097874|NCT03529773|25848872|FG001|Overall Study|Randomized but not vaccinated|0|||
13097875|NCT03529773|25848873|FG002|Overall Study|Randomized but not vaccinated|0|||
13097876|NCT03529773|25848874|FG003|Overall Study|Randomized but not vaccinated|0|||
13097877|NCT03529773|25848875|FG004|Overall Study|Randomized but not vaccinated|0|||
13097878|NCT03529773|25848876|FG005|Overall Study|Randomized but not vaccinated|0|||
13097879|NCT03529773|25848877|FG006|Overall Study|Randomized but not vaccinated|0|||
13097880|NCT03529773|25848878|FG007|Overall Study|Randomized but not vaccinated|0|||
13097881|NCT03529773|25848879|FG008|Overall Study|Randomized but not vaccinated|0|||
13097882|NCT03529773|25848880|FG009|Overall Study|Randomized but not vaccinated|0|||
13097883|NCT03529773|25848881|FG010|Overall Study|Randomized but not vaccinated|0|||
13097884|NCT03529773|25848882|FG011|Overall Study|Randomized but not vaccinated|0|||
13097885|NCT03529773|25848883|FG012|Overall Study|Randomized but not vaccinated|0|||
13097886|NCT03529773|25848884|FG013|Overall Study|Randomized but not vaccinated|0|||
13097887|NCT03529773|25848885|FG014|Overall Study|Randomized but not vaccinated|0|||
13097888|NCT03529773|25848886|FG015|Overall Study|Randomized but not vaccinated|0|||
13097889|NCT03529773|25848887|FG016|Overall Study|Randomized but not vaccinated|0|||
13097890|NCT03529773|25848888|FG017|Overall Study|Randomized but not vaccinated|1|||
13097891|NCT03529773|25848889|FG018|Overall Study|Randomized but not vaccinated|0|||
13097892|NCT03529773|25848890|FG019|Overall Study|Randomized but not vaccinated|0|||
13097893|NCT03529773|25848891|FG020|Overall Study|Randomized but not vaccinated|0|||
13097894|NCT03529773|25848892|FG021|Overall Study|Randomized but not vaccinated|0|||
13097895|NCT03529773|25848893|FG022|Overall Study|Randomized but not vaccinated|0|||
13097896|NCT03529773|25848894|FG023|Overall Study|Randomized but not vaccinated|0|||
13097897|NCT03529773|25848895|FG024|Overall Study|Randomized but not vaccinated|0|||
13097898|NCT03529773|25848896|FG025|Overall Study|Randomized but not vaccinated|0|||
13097899|NCT03529773|25848897|FG026|Overall Study|Randomized but not vaccinated|0|||
13097900|NCT03529773|25848898|FG027|Overall Study|Randomized but not vaccinated|1|||
13097901|NCT03529773|25848899|FG028|Overall Study|Randomized but not vaccinated|0|||
13097902|NCT03529773|25848900|FG029|Overall Study|Randomized but not vaccinated|0|||
13485293|NCT02269917|27032315|FG001|BL to EOE-Test and BL to Switch-Control|Death|0|||
13485294|NCT02269917|27032316|FG002|BL to EOE-Test and BL to Switch-Control|Death|0|||
13485295|NCT02269917|27032314|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3|||
13485296|NCT02269917|27032315|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5|||
13485297|NCT02269917|27032316|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0|||
13485298|NCT02269917|27032314|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
13485299|NCT02269917|27032315|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
13485300|NCT02269917|27032316|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
13485301|NCT02269917|27032314|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
13485302|NCT02269917|27032315|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
13485303|NCT02269917|27032316|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10|||
13485304|NCT02269917|27032314|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
13485305|NCT02269917|27032315|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
13485306|NCT02269917|27032316|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11|||
13485307|NCT02269917|27032314|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
13485308|NCT02269917|27032315|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
13485309|NCT02269917|27032316|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
13485310|NCT02269917|27032314|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
13097903|NCT03529773|25848901|FG030|Overall Study|Randomized but not vaccinated|0|||
13097904|NCT03529773|25848902|FG031|Overall Study|Randomized but not vaccinated|0|||
13097905|NCT03529773|25848903|FG032|Overall Study|Randomized but not vaccinated|0|||
13097906|NCT03529773|25848904|FG033|Overall Study|Randomized but not vaccinated|0|||
13097907|NCT03529773|25848905|FG034|Overall Study|Randomized but not vaccinated|0|||
13097908|NCT03529773|25848906|FG035|Overall Study|Randomized but not vaccinated|0|||
13097909|NCT03529773|25848907|FG036|Overall Study|Randomized but not vaccinated|0|||
13485311|NCT02269917|27032315|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
13097910|NCT03529773|25848908|FG037|Overall Study|Randomized but not vaccinated|0|||
13097911|NCT03529773|25848909|FG038|Overall Study|Randomized but not vaccinated|0|||
13097912|NCT03529773|25848910|FG039|Overall Study|Randomized but not vaccinated|0|||
13097913|NCT03529409|25848949|FG000|Randomized|Lost to Follow-up|0|||
13097914|NCT03529409|25848950|FG001|Randomized|Lost to Follow-up|0|||
13097915|NCT03529409|25848951|FG002|Randomized|Lost to Follow-up|4|||
13097916|NCT03529409|25848949|FG000|Randomized|Excluded|0|||
13097917|NCT03529409|25848950|FG001|Randomized|Excluded|0|||
13097918|NCT03529409|25848951|FG002|Randomized|Excluded|1|||
13097919|NCT03529409|25848949|FG000|Post-treatment Assessment|Death|1|||
13097920|NCT03529409|25848950|FG001|Post-treatment Assessment|Death|0|||
13097921|NCT03529409|25848951|FG002|Post-treatment Assessment|Death|0|||
13097922|NCT03529409|25848949|FG000|Post-treatment Assessment|Lost to Follow-up|1|||
13097923|NCT03529409|25848950|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
13097924|NCT03529409|25848951|FG002|Post-treatment Assessment|Lost to Follow-up|0|||
13097925|NCT03529409|25848949|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2|||
13097926|NCT03529409|25848950|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4|||
13097927|NCT03529409|25848951|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0|||
13097928|NCT03529409|25848949|FG000|Follow-up Assessment|Death|1|||
13097929|NCT03529409|25848950|FG001|Follow-up Assessment|Death|0|||
13097930|NCT03529409|25848951|FG002|Follow-up Assessment|Death|0|||
13097931|NCT03529409|25848949|FG000|Follow-up Assessment|Withdrawal by Subject|0|||
13097932|NCT03529409|25848950|FG001|Follow-up Assessment|Withdrawal by Subject|1|||
13097933|NCT03529409|25848951|FG002|Follow-up Assessment|Withdrawal by Subject|0|||
13097934|NCT03529162|25848972|FG000|Overall Study|Lost to Follow-up|2|||
13097935|NCT03529162|25848973|FG001|Overall Study|Lost to Follow-up|2|||
13097936|NCT03528577|25848982|FG000|Sequence 1|Failed Spirometry|1|||
13097937|NCT03528577|25848982|FG000|Sequence 1|Restricted medication|1|||
13097938|NCT03528577|25848982|FG000|Sequence 2|Adverse Event|1|||
13097939|NCT03528577|25848982|FG000|Sequence 2|Withdrawal by Subject|1|||
13097940|NCT03528577|25848982|FG000|Sequence 2|Failed Spirometry|1|||
13097941|NCT03528577|25848982|FG000|Sequence 3|Failed Spirometry|1|||
13097942|NCT03528577|25848982|FG000|Sequence 4|Failed Spirometry|2|||
13097943|NCT03528577|25848982|FG000|Sequence 4|Adverse Event|1|||
13097944|NCT03528369|25849021|FG000|Overall Study|Withdrawal by Subject|2|||
13150634|NCT02554877|26047307|FG003|Overall Study|Insufficient clinical response|0|||
13150635|NCT02554877|26047304|FG000|Overall Study|No longer willing to participate|0|||
13150636|NCT02554877|26047305|FG001|Overall Study|No longer willing to participate|2|||
13150637|NCT02554877|26047306|FG002|Overall Study|No longer willing to participate|2|||
13150638|NCT02554877|26047307|FG003|Overall Study|No longer willing to participate|0|||
13150639|NCT02554786|26047465|FG000|Overall Study|Subject/guardian decision|29|||
13150640|NCT02554786|26047466|FG001|Overall Study|Subject/guardian decision|17|||
13150641|NCT02554786|26047467|FG002|Overall Study|Subject/guardian decision|18|||
13150642|NCT02554786|26047468|FG003|Overall Study|Subject/guardian decision|30|||
13150643|NCT02554786|26047469|FG004|Overall Study|Subject/guardian decision|20|||
13150644|NCT02554786|26047465|FG000|Overall Study|Lost to Follow-up|4|||
13150645|NCT02554786|26047466|FG001|Overall Study|Lost to Follow-up|3|||
13150646|NCT02554786|26047467|FG002|Overall Study|Lost to Follow-up|4|||
13150647|NCT02554786|26047468|FG003|Overall Study|Lost to Follow-up|2|||
13150648|NCT02554786|26047469|FG004|Overall Study|Lost to Follow-up|2|||
13150649|NCT02554786|26047465|FG000|Overall Study|Protocol deviation|1|||
13150650|NCT02554786|26047466|FG001|Overall Study|Protocol deviation|3|||
13150651|NCT02554786|26047467|FG002|Overall Study|Protocol deviation|3|||
13150652|NCT02554786|26047468|FG003|Overall Study|Protocol deviation|4|||
13150653|NCT02554786|26047469|FG004|Overall Study|Protocol deviation|2|||
13150654|NCT02554786|26047465|FG000|Overall Study|Technical problems|1|||
13150655|NCT02554786|26047466|FG001|Overall Study|Technical problems|1|||
13150656|NCT02554786|26047467|FG002|Overall Study|Technical problems|0|||
13150657|NCT02554786|26047468|FG003|Overall Study|Technical problems|2|||
13150658|NCT02554786|26047469|FG004|Overall Study|Technical problems|1|||
13150659|NCT02554786|26047465|FG000|Overall Study|Adverse Event|0|||
13150660|NCT02554786|26047466|FG001|Overall Study|Adverse Event|0|||
13150661|NCT02554786|26047467|FG002|Overall Study|Adverse Event|0|||
13150662|NCT02554786|26047468|FG003|Overall Study|Adverse Event|0|||
13150663|NCT02554786|26047469|FG004|Overall Study|Adverse Event|2|||
13150664|NCT02554786|26047465|FG000|Overall Study|Death|0|||
13150665|NCT02554786|26047466|FG001|Overall Study|Death|0|||
13150666|NCT02554786|26047467|FG002|Overall Study|Death|0|||
13150667|NCT02554786|26047468|FG003|Overall Study|Death|1|||
13150668|NCT02554786|26047469|FG004|Overall Study|Death|0|||
13150669|NCT02554786|26047465|FG000|Overall Study|Non-compliance with study treatment|0|||
13150670|NCT02554786|26047466|FG001|Overall Study|Non-compliance with study treatment|1|||
13150671|NCT02554786|26047467|FG002|Overall Study|Non-compliance with study treatment|1|||
13150672|NCT02554786|26047468|FG003|Overall Study|Non-compliance with study treatment|0|||
13150673|NCT02554786|26047469|FG004|Overall Study|Non-compliance with study treatment|1|||
13150674|NCT02554786|26047465|FG000|Overall Study|Physician Decision|0|||
13150675|NCT02554786|26047466|FG001|Overall Study|Physician Decision|1|||
13097945|NCT03528369|25849022|FG001|Overall Study|Withdrawal by Subject|0|||
13097946|NCT03528369|25849023|FG002|Overall Study|Withdrawal by Subject|0|||
13097947|NCT03528369|25849021|FG000|Overall Study|Lost to Follow-up|1|||
13097948|NCT03528369|25849022|FG001|Overall Study|Lost to Follow-up|0|||
13097949|NCT03528369|25849023|FG002|Overall Study|Lost to Follow-up|0|||
13097950|NCT03528369|25849021|FG000|Overall Study|Adverse Event|0|||
13097951|NCT03528369|25849022|FG001|Overall Study|Adverse Event|1|||
13097952|NCT03528369|25849023|FG002|Overall Study|Adverse Event|0|||
13097953|NCT03528174|25849043|FG000|Overall Study|Adverse Event|1|||
13097954|NCT03528174|25849043|FG000|Overall Study|sensors dislodged|1|||
13097955|NCT03527966|25849062|FG000|Overall Study|Lost to Follow-up|3|||
13097956|NCT03527966|25849063|FG001|Overall Study|Lost to Follow-up|0|||
13097957|NCT03527745|25849222|FG000|Overall Study|Lost to Follow-up|3|||
13097958|NCT03527745|25849223|FG001|Overall Study|Lost to Follow-up|6|||
13097959|NCT03527745|25849224|FG002|Overall Study|Lost to Follow-up|7|||
13097960|NCT03527745|25849225|FG003|Overall Study|Lost to Follow-up|9|||
13150676|NCT02554786|26047467|FG002|Overall Study|Physician Decision|4|||
13150677|NCT02554786|26047468|FG003|Overall Study|Physician Decision|1|||
13150678|NCT02554786|26047469|FG004|Overall Study|Physician Decision|1|||
13150679|NCT02554786|26047465|FG000|Overall Study|Pregnancy|0|||
13150680|NCT02554786|26047466|FG001|Overall Study|Pregnancy|0|||
13150681|NCT02554786|26047467|FG002|Overall Study|Pregnancy|0|||
13150682|NCT02554786|26047468|FG003|Overall Study|Pregnancy|1|||
13150683|NCT02554786|26047469|FG004|Overall Study|Pregnancy|1|||
13150684|NCT02554721|26047496|FG000|Overall Study|Adverse Event|1|||
13150685|NCT02554721|26047497|FG001|Overall Study|Adverse Event|0|||
13150686|NCT02554721|26047498|FG002|Overall Study|Adverse Event|0|||
13150687|NCT02554721|26047499|FG003|Overall Study|Adverse Event|0|||
13150688|NCT02554721|26047500|FG004|Overall Study|Adverse Event|1|||
13150689|NCT02554721|26047496|FG000|Overall Study|Noncompliance|0|||
13150690|NCT02554721|26047497|FG001|Overall Study|Noncompliance|0|||
13150691|NCT02554721|26047498|FG002|Overall Study|Noncompliance|0|||
13150692|NCT02554721|26047499|FG003|Overall Study|Noncompliance|0|||
13150693|NCT02554721|26047500|FG004|Overall Study|Noncompliance|1|||
13150694|NCT02554682|26047580|FG000|Overall Study|Lost to Follow-up|11|||
13150695|NCT02554682|26047581|FG001|Overall Study|Lost to Follow-up|9|||
13150696|NCT02554682|26047582|FG002|Overall Study|Lost to Follow-up|4|||
13150697|NCT02554682|26047583|FG003|Overall Study|Lost to Follow-up|3|||
13150698|NCT02554682|26047584|FG004|Overall Study|Lost to Follow-up|2|||
13150699|NCT02554682|26047585|FG005|Overall Study|Lost to Follow-up|1|||
13150700|NCT02554682|26047586|FG006|Overall Study|Lost to Follow-up|6|||
13150701|NCT02554682|26047587|FG007|Overall Study|Lost to Follow-up|6|||
13150702|NCT02554682|26047588|FG008|Overall Study|Lost to Follow-up|2|||
13150703|NCT02554682|26047589|FG009|Overall Study|Lost to Follow-up|2|||
13150704|NCT02554682|26047580|FG000|Overall Study|Withdrawal by Subject|2|||
13150705|NCT02554682|26047581|FG001|Overall Study|Withdrawal by Subject|1|||
13150706|NCT02554682|26047582|FG002|Overall Study|Withdrawal by Subject|0|||
13150707|NCT02554682|26047583|FG003|Overall Study|Withdrawal by Subject|0|||
13150708|NCT02554682|26047584|FG004|Overall Study|Withdrawal by Subject|0|||
13097961|NCT03527745|25849226|FG004|Overall Study|Lost to Follow-up|0|||
13097962|NCT03527745|25849227|FG005|Overall Study|Lost to Follow-up|2|||
13097963|NCT03527745|25849228|FG006|Overall Study|Lost to Follow-up|3|||
13097964|NCT03527745|25849229|FG007|Overall Study|Lost to Follow-up|2|||
13097965|NCT03527745|25849230|FG008|Overall Study|Lost to Follow-up|3|||
13097966|NCT03527745|25849231|FG009|Overall Study|Lost to Follow-up|2|||
13097967|NCT03527745|25849232|FG010|Overall Study|Lost to Follow-up|1|||
13097968|NCT03527745|25849233|FG011|Overall Study|Lost to Follow-up|1|||
13097969|NCT03527745|25849234|FG012|Overall Study|Lost to Follow-up|0|||
13097970|NCT03527745|25849235|FG013|Overall Study|Lost to Follow-up|0|||
13097971|NCT03527745|25849236|FG014|Overall Study|Lost to Follow-up|0|||
13097972|NCT03527745|25849237|FG015|Overall Study|Lost to Follow-up|0|||
13097973|NCT03527745|25849238|FG016|Overall Study|Lost to Follow-up|1|||
13097974|NCT03527745|25849239|FG017|Overall Study|Lost to Follow-up|0|||
13097975|NCT03527745|25849240|FG018|Overall Study|Lost to Follow-up|0|||
13097976|NCT03527745|25849241|FG019|Overall Study|Lost to Follow-up|1|||
13097977|NCT03527745|25849242|FG020|Overall Study|Lost to Follow-up|1|||
13097978|NCT03527745|25849243|FG021|Overall Study|Lost to Follow-up|5|||
13097979|NCT03527745|25849244|FG022|Overall Study|Lost to Follow-up|6|||
13097980|NCT03527745|25849245|FG023|Overall Study|Lost to Follow-up|8|||
13150709|NCT02554682|26047585|FG005|Overall Study|Withdrawal by Subject|0|||
13150710|NCT02554682|26047586|FG006|Overall Study|Withdrawal by Subject|0|||
13150711|NCT02554682|26047587|FG007|Overall Study|Withdrawal by Subject|0|||
13150712|NCT02554682|26047588|FG008|Overall Study|Withdrawal by Subject|0|||
13097981|NCT03527745|25849246|FG024|Overall Study|Lost to Follow-up|1|||
13097982|NCT03527745|25849247|FG025|Overall Study|Lost to Follow-up|3|||
13097983|NCT03527550|25849270|FG000|Overall Study|Lost to Follow-up|4|||
13097984|NCT03527550|25849271|FG001|Overall Study|Lost to Follow-up|2|||
13097985|NCT03527550|25849270|FG000|Overall Study|Withdrawal by Subject|4|||
13150713|NCT02554682|26047589|FG009|Overall Study|Withdrawal by Subject|0|||
13097986|NCT03527550|25849271|FG001|Overall Study|Withdrawal by Subject|1|||
13097987|NCT03527550|25849270|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1|||
13097988|NCT03527550|25849271|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0|||
13097989|NCT03527173|25849320|FG000|Overall Study|Lost to Follow-up|4|||
13097990|NCT03527173|25849321|FG001|Overall Study|Lost to Follow-up|2|||
13097991|NCT03527173|25849320|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1|||
13097992|NCT03527173|25849321|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0|||
13097993|NCT03527173|25849320|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
13097994|NCT03527173|25849321|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
13097995|NCT03527173|25849320|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
13097996|NCT03527173|25849321|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
13097997|NCT03527160|25849334|FG000|Overall Study|No urine collected|13|||
13097998|NCT03527160|25849334|FG000|Overall Study|No clinical serum creatinine collected|6|||
13097999|NCT03527160|25849334|FG000|Overall Study|Did not meet inclusion|2|||
13098000|NCT03526861|25849422|FG000|Initial Treatment Period|Not dosed|1|||
13098001|NCT03526861|25849423|FG001|Initial Treatment Period|Not dosed|1|||
13098002|NCT03526861|25849424|FG002|Initial Treatment Period|Not dosed|1|||
13098003|NCT03526861|25849425|FG003|Initial Treatment Period|Not dosed|0|||
13098004|NCT03526861|25849426|FG004|Initial Treatment Period|Not dosed|0|||
13098005|NCT03526861|25849427|FG005|Initial Treatment Period|Not dosed|0|||
13098006|NCT03526861|25849428|FG006|Initial Treatment Period|Not dosed|0|||
13098007|NCT03526861|25849429|FG007|Initial Treatment Period|Not dosed|0|||
13098008|NCT03526861|25849430|FG008|Initial Treatment Period|Not dosed|0|||
13098009|NCT03526861|25849422|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3|||
13098010|NCT03526861|25849423|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
13098011|NCT03526861|25849424|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5|||
13098012|NCT03526861|25849425|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
13098013|NCT03526861|25849426|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
13098014|NCT03526861|25849427|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
13098015|NCT03526861|25849428|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
13098016|NCT03526861|25849429|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
13098017|NCT03526861|25849430|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
13098018|NCT03526861|25849422|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3|||
13098019|NCT03526861|25849423|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5|||
13098020|NCT03526861|25849424|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8|||
13098021|NCT03526861|25849425|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
13098022|NCT03526861|25849426|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
13098023|NCT03526861|25849427|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
13098024|NCT03526861|25849428|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
13098025|NCT03526861|25849429|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
13098026|NCT03526861|25849430|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
13098027|NCT03526861|25849422|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
13098028|NCT03526861|25849423|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
13098029|NCT03526861|25849424|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
13098030|NCT03526861|25849425|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
13098031|NCT03526861|25849426|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
13098032|NCT03526861|25849427|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
13098033|NCT03526861|25849428|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
13098034|NCT03526861|25849429|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
13098035|NCT03526861|25849430|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
13098036|NCT03526861|25849422|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
13098037|NCT03526861|25849423|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
13098038|NCT03526861|25849424|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
13098039|NCT03526861|25849425|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6|||
13098040|NCT03526861|25849426|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
13098041|NCT03526861|25849427|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4|||
13098042|NCT03526861|25849428|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
13098043|NCT03526861|25849429|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2|||
13098044|NCT03526861|25849430|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
13098045|NCT03526861|25849422|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
13098046|NCT03526861|25849423|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
13098047|NCT03526861|25849424|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
13098048|NCT03526861|25849425|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
13098049|NCT03526861|25849426|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
13098050|NCT03526861|25849427|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
13098051|NCT03526861|25849428|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
13098052|NCT03526861|25849429|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
13098053|NCT03526861|25849430|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
13098054|NCT03526861|25849422|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
13098055|NCT03526861|25849423|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
13098056|NCT03526861|25849424|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
13098057|NCT03526861|25849425|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
13098058|NCT03526861|25849426|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
13098059|NCT03526861|25849427|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
13098060|NCT03526861|25849428|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
13098061|NCT03526861|25849429|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
13098062|NCT03526861|25849430|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19|||
13098063|NCT03526861|25849422|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
13098064|NCT03526861|25849423|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
13098065|NCT03526861|25849424|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
13098066|NCT03526861|25849425|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
13098067|NCT03526861|25849426|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
13098068|NCT03526861|25849427|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
13098069|NCT03526861|25849428|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
13098070|NCT03526861|25849429|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
13098071|NCT03526861|25849430|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1|||
13150714|NCT02554682|26047580|FG000|Overall Study|Physician Decision|2|||
13150715|NCT02554682|26047581|FG001|Overall Study|Physician Decision|2|||
13150716|NCT02554682|26047582|FG002|Overall Study|Physician Decision|0|||
13150717|NCT02554682|26047583|FG003|Overall Study|Physician Decision|0|||
13150718|NCT02554682|26047584|FG004|Overall Study|Physician Decision|0|||
13150719|NCT02554682|26047585|FG005|Overall Study|Physician Decision|0|||
13150720|NCT02554682|26047586|FG006|Overall Study|Physician Decision|0|||
13150721|NCT02554682|26047587|FG007|Overall Study|Physician Decision|0|||
13150722|NCT02554682|26047588|FG008|Overall Study|Physician Decision|0|||
13150723|NCT02554682|26047589|FG009|Overall Study|Physician Decision|0|||
13150724|NCT02554656|26047599|FG000|Overall Study|Protocol Violation|3|||
13150725|NCT02554513|26047614|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0|||
13150726|NCT02554513|26047615|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1|||
13150727|NCT02554474|26047644|FG000|Overall Study|Protocol Violation|1|||
13150728|NCT02554474|26047645|FG001|Overall Study|Protocol Violation|1|||
13150729|NCT02554474|26047644|FG000|Overall Study|Health issue not related to the study|1|||
13150730|NCT02554474|26047645|FG001|Overall Study|Health issue not related to the study|0|||
13150731|NCT02554474|26047644|FG000|Overall Study|Withdrawal by Subject|1|||
13150732|NCT02554474|26047645|FG001|Overall Study|Withdrawal by Subject|1|||
13150733|NCT02554318|26047668|FG000|Overall Study|Withdrawal by Subject|10|||
13150734|NCT02554318|26047669|FG001|Overall Study|Withdrawal by Subject|8|||
13485312|NCT02269917|27032316|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2|||
13485313|NCT02269917|27032314|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
13485314|NCT02269917|27032315|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
13485315|NCT02269917|27032316|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5|||
13485316|NCT02269917|27032314|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
13485317|NCT02269917|27032315|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
13485318|NCT02269917|27032316|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8|||
13485319|NCT02225366|27032331|FG000|Overall Study|Lack of Efficacy|1|||
13485320|NCT02225366|27032332|FG001|Overall Study|Lack of Efficacy|0|||
13485321|NCT01530997|27032354|FG000|Overall Study|Physician Decision|1|||
13485322|NCT01530997|27032354|FG000|Overall Study|Withdrawal by Subject|1|||
13485323|NCT02021773|27032425|FG000|Overall Study|Adverse Event|1|||
13098072|NCT03526861|25849422|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
13098073|NCT03526861|25849423|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
13098074|NCT03526861|25849424|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
13098075|NCT03526861|25849425|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
13098076|NCT03526861|25849426|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
13098077|NCT03526861|25849427|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
13098078|NCT03526861|25849428|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
13098079|NCT03526861|25849429|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
13098080|NCT03526861|25849430|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8|||
13098081|NCT03526458|25849455|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
13098082|NCT03526458|25849456|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
13098083|NCT03526458|25849455|FG000|Overall Study|Stone passed, surgery cancelled|2|||
13098084|NCT03526458|25849456|FG001|Overall Study|Stone passed, surgery cancelled|1|||
13098085|NCT03526458|25849455|FG000|Overall Study|Withdrawal by Subject|1|||
13098086|NCT03526458|25849456|FG001|Overall Study|Withdrawal by Subject|0|||
13098087|NCT03526458|25849455|FG000|Overall Study|Physician Decision|2|||
13098088|NCT03526458|25849456|FG001|Overall Study|Physician Decision|1|||
13098089|NCT03526458|25849455|FG000|Overall Study|Lack of equipment|1|||
13098090|NCT03526458|25849456|FG001|Overall Study|Lack of equipment|1|||
13098091|NCT03525834|25849466|FG000|Overall Study|Progressive disease|1|||
13098092|NCT03525678|25849659|FG000|Overall Study|Ongoing at the time of interim analysis|60|||
13098093|NCT03525678|25849660|FG001|Overall Study|Ongoing at the time of interim analysis|65|||
13098094|NCT03525678|25849661|FG002|Overall Study|Ongoing at the time of interim analysis|21|||
13098095|NCT03525678|25849659|FG000|Overall Study|Withdrawal by Subject|3|||
13098096|NCT03525678|25849660|FG001|Overall Study|Withdrawal by Subject|1|||
13098097|NCT03525678|25849661|FG002|Overall Study|Withdrawal by Subject|0|||
13098098|NCT03525678|25849659|FG000|Overall Study|Physician Decision|1|||
13098099|NCT03525678|25849660|FG001|Overall Study|Physician Decision|2|||
13098100|NCT03525678|25849661|FG002|Overall Study|Physician Decision|0|||
13098101|NCT03525678|25849659|FG000|Overall Study|Lost to Follow-up|1|||
13098102|NCT03525678|25849660|FG001|Overall Study|Lost to Follow-up|0|||
13098103|NCT03525678|25849661|FG002|Overall Study|Lost to Follow-up|0|||
13098104|NCT03525678|25849659|FG000|Overall Study|Death|32|||
13098105|NCT03525678|25849660|FG001|Overall Study|Death|31|||
13098106|NCT03525678|25849661|FG002|Overall Study|Death|4|||
13098107|NCT03525444|25849697|FG000|Overall Study|Adverse Event|0|||
13098108|NCT03525444|25849698|FG001|Overall Study|Adverse Event|1|||
13098109|NCT03525444|25849697|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
13098110|NCT03525444|25849698|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
13098111|NCT03525444|25849697|FG000|Overall Study|Other|0|||
13098112|NCT03525444|25849698|FG001|Overall Study|Other|1|||
13098113|NCT03525119|25849740|FG000|Overall Study|Adverse Event|0|||
13098114|NCT03525119|25849741|FG001|Overall Study|Adverse Event|1|||
13098115|NCT03525119|25849742|FG002|Overall Study|Adverse Event|0|||
13098116|NCT03525119|25849740|FG000|Overall Study|Lost to Follow-up|32|||
13098117|NCT03525119|25849741|FG001|Overall Study|Lost to Follow-up|33|||
13098118|NCT03525119|25849742|FG002|Overall Study|Lost to Follow-up|37|||
13098119|NCT03525119|25849740|FG000|Overall Study|Withdrawal by Subject|5|||
13098120|NCT03525119|25849741|FG001|Overall Study|Withdrawal by Subject|4|||
13098121|NCT03525119|25849742|FG002|Overall Study|Withdrawal by Subject|2|||
13098122|NCT03525119|25849740|FG000|Overall Study|Reason not Specified|2|||
13098123|NCT03525119|25849741|FG001|Overall Study|Reason not Specified|1|||
13098124|NCT03525119|25849742|FG002|Overall Study|Reason not Specified|2|||
13098125|NCT03525119|25849740|FG000|Overall Study|Randomized but not Vaccinated|1|||
13098126|NCT03525119|25849741|FG001|Overall Study|Randomized but not Vaccinated|0|||
13098127|NCT03525119|25849742|FG002|Overall Study|Randomized but not Vaccinated|2|||
13098128|NCT03524664|25849791|FG000|Overall Study|Withdrawal by Subject|1|||
13098129|NCT03524664|25849792|FG001|Overall Study|Withdrawal by Subject|2|||
13098130|NCT03524664|25849791|FG000|Overall Study|Lost to Follow-up|4|||
13098131|NCT03524664|25849792|FG001|Overall Study|Lost to Follow-up|13|||
13098132|NCT03524157|25849837|FG000|Overall Study|cytology not readable|0|||
13098133|NCT03524157|25849838|FG001|Overall Study|cytology not readable|0|||
13098134|NCT03524157|25849839|FG002|Overall Study|cytology not readable|1|||
13098135|NCT03523871|25849846|FG000|Overall Study|Death|1|||
13098136|NCT03523728|25849926|FG000|Stage 1 (24 Months)|Adverse Event|2|||
13098137|NCT03523728|25849927|FG001|Stage 1 (24 Months)|Adverse Event|2|||
13098138|NCT03523728|25849928|FG002|Stage 1 (24 Months)|Adverse Event|4|||
13098139|NCT03523728|25849929|FG003|Stage 1 (24 Months)|Adverse Event|0|||
13098140|NCT03523728|25849930|FG004|Stage 1 (24 Months)|Adverse Event|0|||
13098141|NCT03523728|25849926|FG000|Stage 1 (24 Months)|Progressive disease|0|||
13098142|NCT03523728|25849927|FG001|Stage 1 (24 Months)|Progressive disease|0|||
13098143|NCT03523728|25849928|FG002|Stage 1 (24 Months)|Progressive disease|1|||
13098144|NCT03523728|25849929|FG003|Stage 1 (24 Months)|Progressive disease|0|||
13098145|NCT03523728|25849930|FG004|Stage 1 (24 Months)|Progressive disease|0|||
13098146|NCT03523728|25849926|FG000|Stage 1 (24 Months)|Lack of Efficacy|2|||
13098147|NCT03523728|25849927|FG001|Stage 1 (24 Months)|Lack of Efficacy|0|||
13098148|NCT03523728|25849928|FG002|Stage 1 (24 Months)|Lack of Efficacy|0|||
13098149|NCT03523728|25849929|FG003|Stage 1 (24 Months)|Lack of Efficacy|0|||
13098150|NCT03523728|25849930|FG004|Stage 1 (24 Months)|Lack of Efficacy|0|||
13098151|NCT03523728|25849926|FG000|Stage 1 (24 Months)|Poor compliance to protocol|1|||
13098152|NCT03523728|25849927|FG001|Stage 1 (24 Months)|Poor compliance to protocol|0|||
13098153|NCT03523728|25849928|FG002|Stage 1 (24 Months)|Poor compliance to protocol|0|||
13098154|NCT03523728|25849929|FG003|Stage 1 (24 Months)|Poor compliance to protocol|0|||
13098155|NCT03523728|25849930|FG004|Stage 1 (24 Months)|Poor compliance to protocol|0|||
13098156|NCT03523728|25849926|FG000|Stage 1 (24 Months)|Withdrawal by Subject|6|||
13098157|NCT03523728|25849927|FG001|Stage 1 (24 Months)|Withdrawal by Subject|5|||
13098158|NCT03523728|25849928|FG002|Stage 1 (24 Months)|Withdrawal by Subject|7|||
13098159|NCT03523728|25849929|FG003|Stage 1 (24 Months)|Withdrawal by Subject|0|||
13098160|NCT03523728|25849930|FG004|Stage 1 (24 Months)|Withdrawal by Subject|0|||
13098161|NCT03523728|25849926|FG000|Stage 1 (24 Months)|Study terminated by sponsor|54|||
13098162|NCT03523728|25849927|FG001|Stage 1 (24 Months)|Study terminated by sponsor|59|||
13098163|NCT03523728|25849928|FG002|Stage 1 (24 Months)|Study terminated by sponsor|56|||
13098164|NCT03523728|25849929|FG003|Stage 1 (24 Months)|Study terminated by sponsor|0|||
13098165|NCT03523728|25849930|FG004|Stage 1 (24 Months)|Study terminated by sponsor|0|||
13098166|NCT03523728|25849926|FG000|Stage 1 (24 Months)|Other-Unspecified|1|||
13098167|NCT03523728|25849927|FG001|Stage 1 (24 Months)|Other-Unspecified|2|||
13098168|NCT03523728|25849928|FG002|Stage 1 (24 Months)|Other-Unspecified|0|||
13098169|NCT03523728|25849929|FG003|Stage 1 (24 Months)|Other-Unspecified|0|||
13098170|NCT03523728|25849930|FG004|Stage 1 (24 Months)|Other-Unspecified|0|||
13098171|NCT03523728|25849926|FG000|Stage 2 (24 Months)|Adverse Event|0|||
13098172|NCT03523728|25849927|FG001|Stage 2 (24 Months)|Adverse Event|0|||
13098173|NCT03523728|25849928|FG002|Stage 2 (24 Months)|Adverse Event|0|||
13098174|NCT03523728|25849929|FG003|Stage 2 (24 Months)|Adverse Event|1|||
13098175|NCT03523728|25849930|FG004|Stage 2 (24 Months)|Adverse Event|2|||
13098176|NCT03523728|25849926|FG000|Stage 2 (24 Months)|Withdrawal by Subject|0|||
13098177|NCT03523728|25849927|FG001|Stage 2 (24 Months)|Withdrawal by Subject|0|||
13098178|NCT03523728|25849928|FG002|Stage 2 (24 Months)|Withdrawal by Subject|0|||
13098179|NCT03523728|25849929|FG003|Stage 2 (24 Months)|Withdrawal by Subject|0|||
13098180|NCT03523728|25849930|FG004|Stage 2 (24 Months)|Withdrawal by Subject|4|||
13098181|NCT03523728|25849926|FG000|Stage 2 (24 Months)|Study terminated by sponsor|0|||
13098182|NCT03523728|25849927|FG001|Stage 2 (24 Months)|Study terminated by sponsor|0|||
13098183|NCT03523728|25849928|FG002|Stage 2 (24 Months)|Study terminated by sponsor|0|||
13098184|NCT03523728|25849929|FG003|Stage 2 (24 Months)|Study terminated by sponsor|119|||
13098185|NCT03523728|25849930|FG004|Stage 2 (24 Months)|Study terminated by sponsor|110|||
13098186|NCT03523728|25849926|FG000|Stage 2 (24 Months)|Other-Unspecified|0|||
13098187|NCT03523728|25849927|FG001|Stage 2 (24 Months)|Other-Unspecified|0|||
13098188|NCT03523728|25849928|FG002|Stage 2 (24 Months)|Other-Unspecified|0|||
13098189|NCT03523728|25849929|FG003|Stage 2 (24 Months)|Other-Unspecified|2|||
13098190|NCT03523728|25849930|FG004|Stage 2 (24 Months)|Other-Unspecified|3|||
13098191|NCT03523728|25849926|FG000|Stage 2 (24 Months)|Randomized and not treated|0|||
13098192|NCT03523728|25849927|FG001|Stage 2 (24 Months)|Randomized and not treated|0|||
13098193|NCT03523728|25849928|FG002|Stage 2 (24 Months)|Randomized and not treated|0|||
13098194|NCT03523728|25849929|FG003|Stage 2 (24 Months)|Randomized and not treated|1|||
13098195|NCT03523728|25849930|FG004|Stage 2 (24 Months)|Randomized and not treated|0|||
13098196|NCT03523715|25849955|FG000|Overall Study|Lost to Follow-up|11|||
13098197|NCT03523715|25849956|FG001|Overall Study|Lost to Follow-up|14|||
13098198|NCT03523715|25849955|FG000|Overall Study|Did not meet inclusion criteria|1|||
13098199|NCT03523715|25849956|FG001|Overall Study|Did not meet inclusion criteria|0|||
13098200|NCT03523715|25849955|FG000|Overall Study|Internally inconsistent reporting|0|||
13098201|NCT03523715|25849956|FG001|Overall Study|Internally inconsistent reporting|2|||
13098202|NCT03523091|25849981|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1|||
13098203|NCT03523091|25849982|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0|||
13098204|NCT03523091|25849981|FG000|Overall Study|Withdrawal by Subject|0|||
13098205|NCT03523091|25849982|FG001|Overall Study|Withdrawal by Subject|3|||
13098206|NCT03523091|25849981|FG000|Overall Study|Increase Botox dose|0|||
13098207|NCT03523091|25849982|FG001|Overall Study|Increase Botox dose|1|||
13098208|NCT03522948|25849992|FG000|Overall Study|Lost to Follow-up|1|||
13098209|NCT03522675|25850008|FG000|Overall Study|Screen fail|1|||
13098210|NCT03522675|25850008|FG000|Overall Study|Non-reactive to histamine|1|||
13098211|NCT03522506|25850069|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
13098212|NCT03522506|25850070|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
13485324|NCT02021773|27032426|FG001|Overall Study|Adverse Event|4|||
13098213|NCT03522506|25850071|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
13132850|NCT02782780|25985378|FG000|Overall Study|Protocol Violation|0|||
13098214|NCT03522506|25850072|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
13098215|NCT03522506|25850069|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
13098216|NCT03522506|25850070|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
13098217|NCT03522506|25850071|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
13098218|NCT03522506|25850072|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
13098219|NCT03521817|25850085|FG000|Overall Study|Protocol Violation|0|||
13098220|NCT03521817|25850086|FG001|Overall Study|Protocol Violation|1|||
13098221|NCT03521791|25850117|FG000|Overall Study|Protocol Violation|7|||
13098222|NCT03521791|25850118|FG001|Overall Study|Protocol Violation|17|||
13098223|NCT03521635|25850149|FG000|Overall Study|Adverse Event|1|||
13098224|NCT03521635|25850150|FG001|Overall Study|Adverse Event|1|||
13098225|NCT03521635|25850149|FG000|Overall Study|Refused to complete study visit|1|||
13098226|NCT03521635|25850150|FG001|Overall Study|Refused to complete study visit|0|||
13098227|NCT03521635|25850149|FG000|Overall Study|Refused to continue trial medication|2|||
13098228|NCT03521635|25850150|FG001|Overall Study|Refused to continue trial medication|2|||
13098229|NCT03521635|25850149|FG000|Overall Study|Lost to Follow-up|0|||
13098230|NCT03521635|25850150|FG001|Overall Study|Lost to Follow-up|1|||
13098231|NCT03521635|25850149|FG000|Overall Study|Meet exclusion criteria|0|||
13098232|NCT03521635|25850150|FG001|Overall Study|Meet exclusion criteria|1|||
13098233|NCT03521635|25850149|FG000|Overall Study|Patient not taken study medicine|0|||
13098234|NCT03521635|25850150|FG001|Overall Study|Patient not taken study medicine|1|||
13098235|NCT03521193|25850164|FG000|Overall Study|Withdrawal by Subject|8|||
13098236|NCT03521193|25850165|FG001|Overall Study|Withdrawal by Subject|0|||
13098237|NCT03521193|25850164|FG000|Overall Study|non compliant to ASA treatment|8|||
13098238|NCT03521193|25850165|FG001|Overall Study|non compliant to ASA treatment|0|||
13098239|NCT03521141|25850198|FG000|Overall Study|Death|1|||
13098240|NCT03521141|25850199|FG001|Overall Study|Death|0|||
13098241|NCT03521141|25850200|FG002|Overall Study|Death|1|||
13098242|NCT03521115|25850244|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56|||
13098243|NCT03521115|25850245|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40|||
13222666|NCT01803737|26286704|FG001|Overall Study|Medical Reason|1|||
13098244|NCT03521115|25850244|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3|||
13098245|NCT03521115|25850245|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1|||
13098246|NCT03520959|25850272|FG000|Overall Study|Study terminated by Sponsor|0|||
13098247|NCT03520959|25850273|FG001|Overall Study|Study terminated by Sponsor|1|||
13098248|NCT03520920|25850321|FG000|Overall Study|Death|13|||
13098249|NCT03520920|25850322|FG001|Overall Study|Death|1|||
13098250|NCT03520920|25850323|FG002|Overall Study|Death|0|||
13098251|NCT03520920|25850321|FG000|Overall Study|Withdrawal by Subject|2|||
13098252|NCT03520920|25850322|FG001|Overall Study|Withdrawal by Subject|1|||
13098253|NCT03520920|25850323|FG002|Overall Study|Withdrawal by Subject|0|||
13098254|NCT03520920|25850321|FG000|Overall Study|Study Terminated by the Sponsor|5|||
13098255|NCT03520920|25850322|FG001|Overall Study|Study Terminated by the Sponsor|14|||
13098256|NCT03520920|25850323|FG002|Overall Study|Study Terminated by the Sponsor|5|||
13098257|NCT03520569|25850343|FG000|Overall Study|Withdrawal by Subject|1|||
13098258|NCT03520400|25850356|FG000|Overall Study|Physician Decision|15|||
13098259|NCT03520400|25850357|FG001|Overall Study|Physician Decision|7|||
13132851|NCT02782780|25985379|FG001|Overall Study|Protocol Violation|2|||
13132852|NCT02782741|25985412|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
13132853|NCT02782741|25985413|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4|||
13132854|NCT02782741|25985412|FG000|Blinded Treatment Period: up to Week 49|Other|0|||
13132855|NCT02782741|25985413|FG001|Blinded Treatment Period: up to Week 49|Other|1|||
13132856|NCT02782741|25985412|FG000|Open-label Long-term: Week 50 to 145|Adverse Event|2|||
13132857|NCT02782741|25985413|FG001|Open-label Long-term: Week 50 to 145|Adverse Event|1|||
13132858|NCT02782741|25985412|FG000|Open-label Long-term: Week 50 to 145|Other|1|||
13132859|NCT02782741|25985413|FG001|Open-label Long-term: Week 50 to 145|Other|0|||
13132860|NCT02782741|25985412|FG000|Open-label Long-term: Week 50 to 145|Ongoing|48|||
13132861|NCT02782741|25985413|FG001|Open-label Long-term: Week 50 to 145|Ongoing|43|||
13132862|NCT02782676|25985444|FG000|Overall Study|Lost to Follow-up|0|||
13132863|NCT02782676|25985445|FG001|Overall Study|Lost to Follow-up|1|||
13132864|NCT02782377|25985460|FG000|Overall Study|Physician Decision|5|||
13132865|NCT02782325|25985494|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4|||
13132866|NCT02782325|25985495|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2|||
13132867|NCT02782325|25985496|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0|||
13132868|NCT02782325|25985494|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
13132869|NCT02782325|25985495|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
13132870|NCT02782325|25985496|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4|||
13132871|NCT02782169|25985517|FG000|Overall Study|Lost to Follow-up|1|||
13132872|NCT02782169|25985518|FG001|Overall Study|Lost to Follow-up|2|||
13132873|NCT02781844|25985665|FG000|Treatment Period 1|Adverse Event|0|||
13132874|NCT02781844|25985666|FG001|Treatment Period 1|Adverse Event|0|||
13132875|NCT02781844|25985667|FG002|Treatment Period 1|Adverse Event|0|||
13132876|NCT02781844|25985668|FG003|Treatment Period 1|Adverse Event|0|||
13132877|NCT02781844|25985669|FG004|Treatment Period 1|Adverse Event|0|||
13098260|NCT03520387|25850416|FG000|Pre-Randomization|Withdrawal by Subject|1|||
13098261|NCT03520387|25850417|FG001|Pre-Randomization|Withdrawal by Subject|0|||
13098262|NCT03520387|25850418|FG002|Pre-Randomization|Withdrawal by Subject|0|||
13098263|NCT03520387|25850419|FG003|Pre-Randomization|Withdrawal by Subject|0|||
13098264|NCT03520387|25850420|FG004|Pre-Randomization|Withdrawal by Subject|0|||
13098265|NCT03520387|25850416|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2|||
13098266|NCT03520387|25850417|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
13098267|NCT03520387|25850418|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
13098268|NCT03520387|25850419|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
13098269|NCT03520387|25850420|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
13098270|NCT03519932|25850449|FG000|First Intervention|Adverse Event|1|||
13098271|NCT03519932|25850450|FG001|First Intervention|Adverse Event|3|||
13098272|NCT03519919|25850494|FG000|Overall Study|Withdrawal by Subject|1|||
13098273|NCT03519919|25850494|FG000|Overall Study|Lack of Efficacy|1|||
13098274|NCT03519919|25850494|FG000|Overall Study|Screen Failure|1|||
13098275|NCT03519867|25850557|FG000|Overall Study|Adverse Event|1|||
13098276|NCT03519867|25850558|FG001|Overall Study|Adverse Event|1|||
13098277|NCT03519867|25850559|FG002|Overall Study|Adverse Event|0|||
13098278|NCT03519867|25850560|FG003|Overall Study|Adverse Event|0|||
13150735|NCT02554279|26047708|FG000|Overall Study|Adverse Event|2|||
13150736|NCT02554279|26047709|FG001|Overall Study|Adverse Event|5|||
13150737|NCT02554279|26047708|FG000|Overall Study|Lost to Follow-up|3|||
13150738|NCT02554279|26047709|FG001|Overall Study|Lost to Follow-up|2|||
13150739|NCT02554279|26047708|FG000|Overall Study|Withdrawal by Subject|6|||
13150740|NCT02554279|26047709|FG001|Overall Study|Withdrawal by Subject|4|||
13150741|NCT02554279|26047708|FG000|Overall Study|Protocol Violation|2|||
13150742|NCT02554279|26047709|FG001|Overall Study|Protocol Violation|1|||
13150743|NCT02554279|26047708|FG000|Overall Study|Other reason|19|||
13150744|NCT02554279|26047709|FG001|Overall Study|Other reason|6|||
13150745|NCT02554019|26047739|FG000|Overall Study|Withdrawal by Subject|1|||
13150746|NCT02554019|26047740|FG001|Overall Study|Withdrawal by Subject|0|||
13150747|NCT02554019|26047741|FG002|Overall Study|Withdrawal by Subject|2|||
13150748|NCT02554019|26047739|FG000|Overall Study|Adverse Event|1|||
13150749|NCT02554019|26047740|FG001|Overall Study|Adverse Event|0|||
13150750|NCT02554019|26047741|FG002|Overall Study|Adverse Event|0|||
13150751|NCT02553928|26047756|FG000|Overall Study|Adverse Event|2|||
13150752|NCT02553928|26047757|FG001|Overall Study|Adverse Event|1|||
13150753|NCT02553928|26047756|FG000|Overall Study|Lost to Follow-up|0|||
13150754|NCT02553928|26047757|FG001|Overall Study|Lost to Follow-up|1|||
13150755|NCT02553928|26047756|FG000|Overall Study|Administrative reason(s)|0|||
13150756|NCT02553928|26047757|FG001|Overall Study|Administrative reason(s)|1|||
13150757|NCT02553772|26047778|FG000|Overall Study|Adverse Event|2|||
13150758|NCT02553772|26047779|FG001|Overall Study|Adverse Event|3|||
13150759|NCT02553772|26047778|FG000|Overall Study|Lost to Follow-up|2|||
13150760|NCT02553772|26047779|FG001|Overall Study|Lost to Follow-up|1|||
13150761|NCT02553772|26047778|FG000|Overall Study|Withdrawal of Consent|1|||
13150762|NCT02553772|26047779|FG001|Overall Study|Withdrawal of Consent|1|||
13485325|NCT02021773|27032427|FG002|Overall Study|Adverse Event|3|||
13485326|NCT02021773|27032425|FG000|Overall Study|Lack of Efficacy|2|||
13485327|NCT02021773|27032426|FG001|Overall Study|Lack of Efficacy|2|||
13098279|NCT03519867|25850561|FG004|Overall Study|Adverse Event|0|||
13098280|NCT03519867|25850562|FG005|Overall Study|Adverse Event|0|||
13098281|NCT03519867|25850563|FG006|Overall Study|Adverse Event|0|||
13098282|NCT03519867|25850564|FG007|Overall Study|Adverse Event|0|||
13098283|NCT03519867|25850565|FG008|Overall Study|Adverse Event|0|||
13098284|NCT03519867|25850566|FG009|Overall Study|Adverse Event|0|||
13098285|NCT03519867|25850557|FG000|Overall Study|Protocol Violation|0|||
13098286|NCT03519867|25850558|FG001|Overall Study|Protocol Violation|0|||
13098287|NCT03519867|25850559|FG002|Overall Study|Protocol Violation|0|||
13098288|NCT03519867|25850560|FG003|Overall Study|Protocol Violation|0|||
13098289|NCT03519867|25850561|FG004|Overall Study|Protocol Violation|0|||
13098290|NCT03519867|25850562|FG005|Overall Study|Protocol Violation|1|||
13098291|NCT03519867|25850563|FG006|Overall Study|Protocol Violation|0|||
13098292|NCT03519867|25850564|FG007|Overall Study|Protocol Violation|0|||
13098293|NCT03519867|25850565|FG008|Overall Study|Protocol Violation|0|||
13098294|NCT03519867|25850566|FG009|Overall Study|Protocol Violation|0|||
13098295|NCT03519867|25850557|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0|||
13098296|NCT03519867|25850558|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0|||
13098297|NCT03519867|25850559|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0|||
13098298|NCT03519867|25850560|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0|||
13485328|NCT02021773|27032427|FG002|Overall Study|Lack of Efficacy|2|||
13485329|NCT02021773|27032425|FG000|Overall Study|Protocol Violation|2|||
13485330|NCT02021773|27032426|FG001|Overall Study|Protocol Violation|3|||
13150763|NCT02553772|26047778|FG000|Overall Study|Lack of Efficacy|1|||
13150764|NCT02553772|26047779|FG001|Overall Study|Lack of Efficacy|0|||
13150765|NCT02553772|26047778|FG000|Overall Study|Other Miscellaneous Reasons|0|||
13485331|NCT02021773|27032427|FG002|Overall Study|Protocol Violation|1|||
13485332|NCT02021773|27032425|FG000|Overall Study|Withdrawal by Subject|3|||
13485333|NCT02021773|27032426|FG001|Overall Study|Withdrawal by Subject|4|||
13485334|NCT02021773|27032427|FG002|Overall Study|Withdrawal by Subject|5|||
13485335|NCT02021773|27032425|FG000|Overall Study|Lost to Follow-up|1|||
13485336|NCT02021773|27032426|FG001|Overall Study|Lost to Follow-up|3|||
13485337|NCT02021773|27032427|FG002|Overall Study|Lost to Follow-up|0|||
13485338|NCT02021773|27032425|FG000|Overall Study|Reason not specified|3|||
13485339|NCT02021773|27032426|FG001|Overall Study|Reason not specified|0|||
13098299|NCT03519867|25850561|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0|||
13098300|NCT03519867|25850562|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0|||
13098301|NCT03519867|25850563|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1|||
13098302|NCT03519867|25850564|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0|||
13098303|NCT03519867|25850565|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0|||
13098304|NCT03519867|25850566|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0|||
13098305|NCT03519867|25850557|FG000|Overall Study|Admin. of other reversal agent|1|||
13098306|NCT03519867|25850558|FG001|Overall Study|Admin. of other reversal agent|1|||
13098307|NCT03519867|25850559|FG002|Overall Study|Admin. of other reversal agent|0|||
13098308|NCT03519867|25850560|FG003|Overall Study|Admin. of other reversal agent|0|||
13098309|NCT03519867|25850561|FG004|Overall Study|Admin. of other reversal agent|0|||
13098310|NCT03519867|25850562|FG005|Overall Study|Admin. of other reversal agent|1|||
13098311|NCT03519867|25850563|FG006|Overall Study|Admin. of other reversal agent|0|||
13098312|NCT03519867|25850564|FG007|Overall Study|Admin. of other reversal agent|0|||
13098313|NCT03519867|25850565|FG008|Overall Study|Admin. of other reversal agent|0|||
13098314|NCT03519867|25850566|FG009|Overall Study|Admin. of other reversal agent|0|||
13098315|NCT03519867|25850557|FG000|Overall Study|Reason not provided|1|||
13098316|NCT03519867|25850558|FG001|Overall Study|Reason not provided|1|||
13098317|NCT03519867|25850559|FG002|Overall Study|Reason not provided|1|||
13098318|NCT03519867|25850560|FG003|Overall Study|Reason not provided|1|||
13098319|NCT03519867|25850561|FG004|Overall Study|Reason not provided|0|||
13098320|NCT03519867|25850562|FG005|Overall Study|Reason not provided|1|||
13098321|NCT03519867|25850563|FG006|Overall Study|Reason not provided|0|||
13098322|NCT03519867|25850564|FG007|Overall Study|Reason not provided|1|||
13098323|NCT03519867|25850565|FG008|Overall Study|Reason not provided|1|||
13098324|NCT03519867|25850566|FG009|Overall Study|Reason not provided|0|||
13098325|NCT03519854|25850785|FG000|Overall Study|Technical Error|0|||
13098326|NCT03519854|25850786|FG001|Overall Study|Technical Error|0|||
13098327|NCT03519854|25850787|FG002|Overall Study|Technical Error|1|||
13098328|NCT03519854|25850788|FG003|Overall Study|Technical Error|0|||
13098329|NCT03519854|25850789|FG004|Overall Study|Technical Error|0|||
13098330|NCT03519854|25850790|FG005|Overall Study|Technical Error|0|||
13098331|NCT03519854|25850791|FG006|Overall Study|Technical Error|0|||
13098332|NCT03519854|25850792|FG007|Overall Study|Technical Error|0|||
13098333|NCT03519854|25850793|FG008|Overall Study|Technical Error|0|||
13098334|NCT03519854|25850794|FG009|Overall Study|Technical Error|0|||
13098335|NCT03519854|25850795|FG010|Overall Study|Technical Error|0|||
13098336|NCT03519854|25850796|FG011|Overall Study|Technical Error|0|||
13098337|NCT03519854|25850797|FG012|Overall Study|Technical Error|0|||
13098338|NCT03519854|25850798|FG013|Overall Study|Technical Error|0|||
13098339|NCT03519854|25850799|FG014|Overall Study|Technical Error|0|||
13098340|NCT03519854|25850800|FG015|Overall Study|Technical Error|0|||
13098341|NCT03519854|25850801|FG016|Overall Study|Technical Error|0|||
13098342|NCT03519854|25850802|FG017|Overall Study|Technical Error|0|||
13098343|NCT03519516|25850833|FG000|Overall Study|Adverse Event|0|||
13098344|NCT03519516|25850834|FG001|Overall Study|Adverse Event|1|||
13098345|NCT03519204|25850858|FG000|Overall Study|Lost to Follow-up|3|||
13098346|NCT03519204|25850859|FG001|Overall Study|Lost to Follow-up|8|||
13098347|NCT03519204|25850858|FG000|Overall Study|Withdrawal by Subject|9|||
13098348|NCT03519204|25850859|FG001|Overall Study|Withdrawal by Subject|7|||
13098349|NCT03519204|25850858|FG000|Overall Study|Other Miscellaneous Reasons|1|||
13098350|NCT03519204|25850859|FG001|Overall Study|Other Miscellaneous Reasons|0|||
13098351|NCT03519087|25850905|FG000|Clinic Evaluation|Physician Decision|15|||
13098352|NCT03519087|25850906|FG001|Clinic Evaluation|Physician Decision|18|||
13098353|NCT03519087|25850907|FG002|Clinic Evaluation|Physician Decision|0|||
13098354|NCT03519087|25850908|FG003|Clinic Evaluation|Physician Decision|0|||
13098355|NCT03519087|25850909|FG004|Clinic Evaluation|Physician Decision|0|||
13098356|NCT03519087|25850905|FG000|Clinic Evaluation|Protocol Violation|1|||
13098357|NCT03519087|25850906|FG001|Clinic Evaluation|Protocol Violation|0|||
13098358|NCT03519087|25850907|FG002|Clinic Evaluation|Protocol Violation|0|||
13098359|NCT03519087|25850908|FG003|Clinic Evaluation|Protocol Violation|0|||
13098360|NCT03519087|25850909|FG004|Clinic Evaluation|Protocol Violation|0|||
13098361|NCT03519087|25850905|FG000|Re-randomization for Treatment|Withdrawal by Subject|25|||
13098362|NCT03519087|25850906|FG001|Re-randomization for Treatment|Withdrawal by Subject|29|||
13098363|NCT03519087|25850907|FG002|Re-randomization for Treatment|Withdrawal by Subject|0|||
13098364|NCT03519087|25850908|FG003|Re-randomization for Treatment|Withdrawal by Subject|0|||
13098365|NCT03519087|25850909|FG004|Re-randomization for Treatment|Withdrawal by Subject|0|||
13098366|NCT03519087|25850905|FG000|Re-randomization for Treatment|Not appropriate|2|||
13098367|NCT03519087|25850906|FG001|Re-randomization for Treatment|Not appropriate|3|||
13098368|NCT03519087|25850907|FG002|Re-randomization for Treatment|Not appropriate|0|||
13098369|NCT03519087|25850908|FG003|Re-randomization for Treatment|Not appropriate|0|||
13098370|NCT03519087|25850909|FG004|Re-randomization for Treatment|Not appropriate|0|||
13098371|NCT03519087|25850905|FG000|Laboratory Testing|Lost to Follow-up|0|||
13098372|NCT03519087|25850906|FG001|Laboratory Testing|Lost to Follow-up|0|||
13098373|NCT03519087|25850907|FG002|Laboratory Testing|Lost to Follow-up|2|||
13098374|NCT03519087|25850908|FG003|Laboratory Testing|Lost to Follow-up|3|||
13098375|NCT03519087|25850909|FG004|Laboratory Testing|Lost to Follow-up|6|||
13098376|NCT03519087|25850905|FG000|Laboratory Testing|Protocol Violation|0|||
13098377|NCT03519087|25850906|FG001|Laboratory Testing|Protocol Violation|0|||
13098378|NCT03519087|25850907|FG002|Laboratory Testing|Protocol Violation|0|||
13098379|NCT03519087|25850908|FG003|Laboratory Testing|Protocol Violation|1|||
13098380|NCT03519087|25850909|FG004|Laboratory Testing|Protocol Violation|0|||
13098381|NCT03518840|25850918|FG000|Overall Study|Lost to Follow-up|6|||
13098382|NCT03518658|25850933|FG000|Overall Study|Other|51|||
13098383|NCT03518658|25850934|FG001|Overall Study|Other|0|||
13098384|NCT03518125|25851051|FG000|Overall Study|Lost to Follow-up|0|||
13098385|NCT03518125|25851052|FG001|Overall Study|Lost to Follow-up|2|||
13098386|NCT03518125|25851053|FG002|Overall Study|Lost to Follow-up|0|||
13098387|NCT03518125|25851054|FG003|Overall Study|Lost to Follow-up|0|||
13098388|NCT03518125|25851055|FG004|Overall Study|Lost to Follow-up|3|||
13098389|NCT03518125|25851056|FG005|Overall Study|Lost to Follow-up|5|||
13098390|NCT03518125|25851051|FG000|Overall Study|Physician Decision|0|||
13098391|NCT03518125|25851052|FG001|Overall Study|Physician Decision|1|||
13098392|NCT03518125|25851053|FG002|Overall Study|Physician Decision|0|||
13098393|NCT03518125|25851054|FG003|Overall Study|Physician Decision|0|||
13098394|NCT03518125|25851055|FG004|Overall Study|Physician Decision|0|||
13098395|NCT03518125|25851056|FG005|Overall Study|Physician Decision|0|||
13098396|NCT03518125|25851051|FG000|Overall Study|Withdrawal by Subject|1|||
13098397|NCT03518125|25851052|FG001|Overall Study|Withdrawal by Subject|1|||
13098398|NCT03518125|25851053|FG002|Overall Study|Withdrawal by Subject|0|||
13098399|NCT03518125|25851054|FG003|Overall Study|Withdrawal by Subject|1|||
13098400|NCT03518125|25851055|FG004|Overall Study|Withdrawal by Subject|1|||
13098401|NCT03518125|25851056|FG005|Overall Study|Withdrawal by Subject|3|||
13098402|NCT03518125|25851051|FG000|Overall Study|Missed Day 394 Visit|1|||
13098403|NCT03518125|25851052|FG001|Overall Study|Missed Day 394 Visit|0|||
13098404|NCT03518125|25851053|FG002|Overall Study|Missed Day 394 Visit|0|||
13098405|NCT03518125|25851054|FG003|Overall Study|Missed Day 394 Visit|0|||
13098406|NCT03518125|25851055|FG004|Overall Study|Missed Day 394 Visit|0|||
13098407|NCT03518125|25851056|FG005|Overall Study|Missed Day 394 Visit|0|||
13098408|NCT03518112|25851066|FG000|Overall Study|Withdrawal by Subject|1|||
13098409|NCT03518073|25851107|FG000|Overall Study|Adverse Event|2|||
13098410|NCT03518073|25851108|FG001|Overall Study|Adverse Event|4|||
13098411|NCT03518073|25851109|FG002|Overall Study|Adverse Event|2|||
13098412|NCT03518073|25851107|FG000|Overall Study|Death|2|||
13098413|NCT03518073|25851108|FG001|Overall Study|Death|1|||
13098414|NCT03518073|25851109|FG002|Overall Study|Death|3|||
13098415|NCT03518073|25851107|FG000|Overall Study|Lost to Follow-up|1|||
13098416|NCT03518073|25851108|FG001|Overall Study|Lost to Follow-up|0|||
13098417|NCT03518073|25851109|FG002|Overall Study|Lost to Follow-up|1|||
13098418|NCT03518073|25851107|FG000|Overall Study|Physician Decision|5|||
13098419|NCT03518073|25851108|FG001|Overall Study|Physician Decision|0|||
13098420|NCT03518073|25851109|FG002|Overall Study|Physician Decision|2|||
13098421|NCT03518073|25851107|FG000|Overall Study|Progressive disease|1|||
13098422|NCT03518073|25851108|FG001|Overall Study|Progressive disease|1|||
13098423|NCT03518073|25851109|FG002|Overall Study|Progressive disease|1|||
13098424|NCT03518073|25851107|FG000|Overall Study|Protocol Violation|1|||
13098425|NCT03518073|25851108|FG001|Overall Study|Protocol Violation|0|||
13098426|NCT03518073|25851109|FG002|Overall Study|Protocol Violation|0|||
13098427|NCT03518073|25851107|FG000|Overall Study|Withdrawal by Subject|30|||
13098428|NCT03518073|25851108|FG001|Overall Study|Withdrawal by Subject|34|||
13098429|NCT03518073|25851109|FG002|Overall Study|Withdrawal by Subject|29|||
13098430|NCT03518073|25851107|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
13098431|NCT03518073|25851108|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|6|||
13098432|NCT03518073|25851109|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|7|||
13098433|NCT03518073|25851107|FG000|Overall Study|Covid-19|1|||
13098434|NCT03518073|25851108|FG001|Overall Study|Covid-19|2|||
13098435|NCT03518073|25851109|FG002|Overall Study|Covid-19|1|||
13098436|NCT03518008|25851118|FG000|Period 2, Second Week of Wear|Family emergency|0|||
13098437|NCT03518008|25851119|FG001|Period 2, Second Week of Wear|Family emergency|1|||
13098438|NCT03517566|25851178|FG000|Overall Study|Adverse Event|5|||
13098439|NCT03517566|25851179|FG001|Overall Study|Adverse Event|2|||
13098440|NCT03517566|25851180|FG002|Overall Study|Adverse Event|2|||
13098441|NCT03517566|25851181|FG003|Overall Study|Adverse Event|8|||
13098442|NCT03517566|25851182|FG004|Overall Study|Adverse Event|7|||
13098443|NCT03517566|25851178|FG000|Overall Study|Lack of Efficacy|3|||
13098444|NCT03517566|25851179|FG001|Overall Study|Lack of Efficacy|2|||
13098445|NCT03517566|25851180|FG002|Overall Study|Lack of Efficacy|1|||
13098446|NCT03517566|25851181|FG003|Overall Study|Lack of Efficacy|1|||
13098447|NCT03517566|25851182|FG004|Overall Study|Lack of Efficacy|4|||
13098448|NCT03517566|25851178|FG000|Overall Study|Lost to Follow-up|3|||
13098449|NCT03517566|25851179|FG001|Overall Study|Lost to Follow-up|1|||
13098450|NCT03517566|25851180|FG002|Overall Study|Lost to Follow-up|1|||
13098451|NCT03517566|25851181|FG003|Overall Study|Lost to Follow-up|1|||
13098452|NCT03517566|25851182|FG004|Overall Study|Lost to Follow-up|0|||
13098453|NCT03517566|25851178|FG000|Overall Study|Physician Decision|1|||
13098454|NCT03517566|25851179|FG001|Overall Study|Physician Decision|1|||
13098455|NCT03517566|25851180|FG002|Overall Study|Physician Decision|0|||
13098456|NCT03517566|25851181|FG003|Overall Study|Physician Decision|1|||
13098457|NCT03517566|25851182|FG004|Overall Study|Physician Decision|0|||
13098458|NCT03517566|25851178|FG000|Overall Study|Pregnancy|0|||
13098459|NCT03517566|25851179|FG001|Overall Study|Pregnancy|1|||
13098460|NCT03517566|25851180|FG002|Overall Study|Pregnancy|0|||
13098461|NCT03517566|25851181|FG003|Overall Study|Pregnancy|0|||
13098462|NCT03517566|25851182|FG004|Overall Study|Pregnancy|0|||
13098463|NCT03517566|25851178|FG000|Overall Study|Protocol Deviation|0|||
13098464|NCT03517566|25851179|FG001|Overall Study|Protocol Deviation|1|||
13098465|NCT03517566|25851180|FG002|Overall Study|Protocol Deviation|0|||
13098466|NCT03517566|25851181|FG003|Overall Study|Protocol Deviation|1|||
13098467|NCT03517566|25851182|FG004|Overall Study|Protocol Deviation|1|||
13098468|NCT03517566|25851178|FG000|Overall Study|Study terminated by Sponsor|11|||
13098469|NCT03517566|25851179|FG001|Overall Study|Study terminated by Sponsor|5|||
13098470|NCT03517566|25851180|FG002|Overall Study|Study terminated by Sponsor|6|||
13098471|NCT03517566|25851181|FG003|Overall Study|Study terminated by Sponsor|14|||
13098472|NCT03517566|25851182|FG004|Overall Study|Study terminated by Sponsor|12|||
13098473|NCT03517566|25851178|FG000|Overall Study|Subject Decision /Guardian Decision|9|||
13098474|NCT03517566|25851179|FG001|Overall Study|Subject Decision /Guardian Decision|8|||
13098475|NCT03517566|25851180|FG002|Overall Study|Subject Decision /Guardian Decision|5|||
13098476|NCT03517566|25851181|FG003|Overall Study|Subject Decision /Guardian Decision|8|||
13098477|NCT03517566|25851182|FG004|Overall Study|Subject Decision /Guardian Decision|8|||
13098478|NCT03517436|25851188|FG000|Overall Study|Death|3|||
13098479|NCT03517436|25851188|FG000|Overall Study|Withdrawal by Subject|4|||
13098480|NCT03517436|25851188|FG000|Overall Study|Did not receive study valve.|1|||
13098481|NCT03516812|25851195|FG000|Overall Study|Adverse Event|4|||
13098482|NCT03516812|25851195|FG000|Overall Study|Lack of Efficacy|2|||
13098483|NCT03515941|25851210|FG000|Overall Study|Adverse Event|1|||
13098484|NCT03515941|25851211|FG001|Overall Study|Adverse Event|0|||
13098485|NCT03515824|25851254|FG000|Overall Study|Death|3|||
13098486|NCT03515824|25851255|FG001|Overall Study|Death|2|||
13098487|NCT03515824|25851256|FG002|Overall Study|Death|6|||
13098488|NCT03515824|25851257|FG003|Overall Study|Death|0|||
13098489|NCT03515824|25851254|FG000|Overall Study|Lost to Follow-up|0|||
13098490|NCT03515824|25851255|FG001|Overall Study|Lost to Follow-up|1|||
13098491|NCT03515824|25851256|FG002|Overall Study|Lost to Follow-up|1|||
13098492|NCT03515824|25851257|FG003|Overall Study|Lost to Follow-up|0|||
13098493|NCT03515824|25851254|FG000|Overall Study|Study terminated by sponsor|0|||
13098494|NCT03515824|25851255|FG001|Overall Study|Study terminated by sponsor|1|||
13098495|NCT03515824|25851256|FG002|Overall Study|Study terminated by sponsor|6|||
13098496|NCT03515824|25851257|FG003|Overall Study|Study terminated by sponsor|0|||
13098497|NCT03515824|25851254|FG000|Overall Study|Status not recorded|0|||
13098498|NCT03515824|25851255|FG001|Overall Study|Status not recorded|0|||
13098499|NCT03515824|25851256|FG002|Overall Study|Status not recorded|2|||
13098500|NCT03515824|25851257|FG003|Overall Study|Status not recorded|0|||
13098501|NCT03515629|25851297|FG000|Overall Study|Death|0|||
13098502|NCT03515629|25851298|FG001|Overall Study|Death|1|||
13098503|NCT03515629|25851299|FG002|Overall Study|Death|1|||
13098504|NCT03515629|25851297|FG000|Overall Study|Progressive disease|0|||
13098505|NCT03515629|25851298|FG001|Overall Study|Progressive disease|1|||
13150766|NCT02553772|26047779|FG001|Overall Study|Other Miscellaneous Reasons|1|||
13150767|NCT02553629|26047800|FG000|Overall Study|Logistic reasons|3|||
13150768|NCT02553629|26047801|FG001|Overall Study|Logistic reasons|6|||
13150769|NCT02553538|26047820|FG000|Overall Study|Could Not Reach by Telephone|133|||
13150770|NCT02553538|26047821|FG001|Overall Study|Could Not Reach by Telephone|0|||
13150771|NCT02553538|26047820|FG000|Overall Study|Died or Left Network|54|||
13150772|NCT02553538|26047821|FG001|Overall Study|Died or Left Network|56|||
13150773|NCT02553499|26047964|FG000|Overall Study|Adverse Event|0|||
13098506|NCT03515629|25851299|FG002|Overall Study|Progressive disease|0|||
13098507|NCT03514914|25851316|FG000|Overall Study|Death|3|||
13098508|NCT03514914|25851317|FG001|Overall Study|Death|3|||
13098509|NCT03514914|25851316|FG000|Overall Study|Lost to Follow-up|117|||
13098510|NCT03514914|25851317|FG001|Overall Study|Lost to Follow-up|89|||
13098511|NCT03514641|25851368|FG000|603A: 0-12 Week Study Period|Protocol Violation|3|||
13098512|NCT03514641|25851369|FG001|603A: 0-12 Week Study Period|Protocol Violation|3|||
13098513|NCT03514641|25851370|FG002|603A: 0-12 Week Study Period|Protocol Violation|0|||
13098514|NCT03514641|25851371|FG003|603A: 0-12 Week Study Period|Protocol Violation|0|||
13150774|NCT02553499|26047965|FG001|Overall Study|Adverse Event|0|||
13150775|NCT02553499|26047966|FG002|Overall Study|Adverse Event|0|||
13150776|NCT02553499|26047967|FG003|Overall Study|Adverse Event|0|||
13150777|NCT02553499|26047968|FG004|Overall Study|Adverse Event|0|||
13150778|NCT02553499|26047969|FG005|Overall Study|Adverse Event|0|||
13150779|NCT02553499|26047970|FG006|Overall Study|Adverse Event|1|||
13150780|NCT02553499|26047971|FG007|Overall Study|Adverse Event|1|||
13150781|NCT02553499|26047972|FG008|Overall Study|Adverse Event|0|||
13150782|NCT02553499|26047973|FG009|Overall Study|Adverse Event|0|||
13150783|NCT02553499|26047974|FG010|Overall Study|Adverse Event|0|||
13150784|NCT02553499|26047975|FG011|Overall Study|Adverse Event|0|||
13150785|NCT02553499|26047976|FG012|Overall Study|Adverse Event|0|||
13150786|NCT02553499|26047977|FG013|Overall Study|Adverse Event|1|||
13150787|NCT02553499|26047964|FG000|Overall Study|Death|0|||
13150788|NCT02553499|26047965|FG001|Overall Study|Death|1|||
13150789|NCT02553499|26047966|FG002|Overall Study|Death|1|||
13150790|NCT02553499|26047967|FG003|Overall Study|Death|0|||
13150791|NCT02553499|26047968|FG004|Overall Study|Death|1|||
13150792|NCT02553499|26047969|FG005|Overall Study|Death|2|||
13150793|NCT02553499|26047970|FG006|Overall Study|Death|0|||
13150794|NCT02553499|26047971|FG007|Overall Study|Death|0|||
13150795|NCT02553499|26047972|FG008|Overall Study|Death|0|||
13150796|NCT02553499|26047973|FG009|Overall Study|Death|0|||
13150797|NCT02553499|26047974|FG010|Overall Study|Death|1|||
13150798|NCT02553499|26047975|FG011|Overall Study|Death|0|||
13150799|NCT02553499|26047976|FG012|Overall Study|Death|0|||
13150800|NCT02553499|26047977|FG013|Overall Study|Death|0|||
13150801|NCT02553499|26047964|FG000|Overall Study|Lost to Follow-up|0|||
13150802|NCT02553499|26047965|FG001|Overall Study|Lost to Follow-up|0|||
13150803|NCT02553499|26047966|FG002|Overall Study|Lost to Follow-up|0|||
13150804|NCT02553499|26047967|FG003|Overall Study|Lost to Follow-up|0|||
13150805|NCT02553499|26047968|FG004|Overall Study|Lost to Follow-up|0|||
13150806|NCT02553499|26047969|FG005|Overall Study|Lost to Follow-up|0|||
13150807|NCT02553499|26047970|FG006|Overall Study|Lost to Follow-up|1|||
13150808|NCT02553499|26047971|FG007|Overall Study|Lost to Follow-up|0|||
13150809|NCT02553499|26047972|FG008|Overall Study|Lost to Follow-up|0|||
13150810|NCT02553499|26047973|FG009|Overall Study|Lost to Follow-up|0|||
13150811|NCT02553499|26047974|FG010|Overall Study|Lost to Follow-up|0|||
13150812|NCT02553499|26047975|FG011|Overall Study|Lost to Follow-up|0|||
13150813|NCT02553499|26047976|FG012|Overall Study|Lost to Follow-up|0|||
13150814|NCT02553499|26047977|FG013|Overall Study|Lost to Follow-up|0|||
13150815|NCT02553499|26047964|FG000|Overall Study|Physician Decision|0|||
13150816|NCT02553499|26047965|FG001|Overall Study|Physician Decision|1|||
13150817|NCT02553499|26047966|FG002|Overall Study|Physician Decision|1|||
13150818|NCT02553499|26047967|FG003|Overall Study|Physician Decision|0|||
13150819|NCT02553499|26047968|FG004|Overall Study|Physician Decision|1|||
13222667|NCT01803737|26286703|FG000|Overall Study|Lost to Follow-up|0|||
13098515|NCT03514641|25851368|FG000|603A: 0-12 Week Study Period|Adverse Event|5|||
13098516|NCT03514641|25851369|FG001|603A: 0-12 Week Study Period|Adverse Event|2|||
13098517|NCT03514641|25851370|FG002|603A: 0-12 Week Study Period|Adverse Event|0|||
13098518|NCT03514641|25851371|FG003|603A: 0-12 Week Study Period|Adverse Event|0|||
13098519|NCT03514641|25851368|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7|||
13098520|NCT03514641|25851369|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5|||
13098521|NCT03514641|25851370|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
13098522|NCT03514641|25851371|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
13098523|NCT03514641|25851368|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10|||
13150820|NCT02553499|26047969|FG005|Overall Study|Physician Decision|0|||
13150821|NCT02553499|26047970|FG006|Overall Study|Physician Decision|0|||
13150822|NCT02553499|26047971|FG007|Overall Study|Physician Decision|1|||
13150823|NCT02553499|26047972|FG008|Overall Study|Physician Decision|1|||
13150824|NCT02553499|26047973|FG009|Overall Study|Physician Decision|2|||
13150825|NCT02553499|26047974|FG010|Overall Study|Physician Decision|1|||
13150826|NCT02553499|26047975|FG011|Overall Study|Physician Decision|3|||
13150827|NCT02553499|26047976|FG012|Overall Study|Physician Decision|1|||
13150828|NCT02553499|26047977|FG013|Overall Study|Physician Decision|0|||
13150829|NCT02553499|26047964|FG000|Overall Study|Progressive Disease|0|||
13150830|NCT02553499|26047965|FG001|Overall Study|Progressive Disease|0|||
13150831|NCT02553499|26047966|FG002|Overall Study|Progressive Disease|0|||
13150832|NCT02553499|26047967|FG003|Overall Study|Progressive Disease|2|||
13150833|NCT02553499|26047968|FG004|Overall Study|Progressive Disease|1|||
13150834|NCT02553499|26047969|FG005|Overall Study|Progressive Disease|1|||
13150835|NCT02553499|26047970|FG006|Overall Study|Progressive Disease|1|||
13150836|NCT02553499|26047971|FG007|Overall Study|Progressive Disease|0|||
13150837|NCT02553499|26047972|FG008|Overall Study|Progressive Disease|0|||
13150838|NCT02553499|26047973|FG009|Overall Study|Progressive Disease|1|||
13150839|NCT02553499|26047974|FG010|Overall Study|Progressive Disease|0|||
13150840|NCT02553499|26047975|FG011|Overall Study|Progressive Disease|0|||
13150841|NCT02553499|26047976|FG012|Overall Study|Progressive Disease|2|||
13150842|NCT02553499|26047977|FG013|Overall Study|Progressive Disease|1|||
13150843|NCT02553499|26047964|FG000|Overall Study|Study Terminated by Sponsor|0|||
13150844|NCT02553499|26047965|FG001|Overall Study|Study Terminated by Sponsor|0|||
13150845|NCT02553499|26047966|FG002|Overall Study|Study Terminated by Sponsor|0|||
13150846|NCT02553499|26047967|FG003|Overall Study|Study Terminated by Sponsor|0|||
13150847|NCT02553499|26047968|FG004|Overall Study|Study Terminated by Sponsor|0|||
13150848|NCT02553499|26047969|FG005|Overall Study|Study Terminated by Sponsor|0|||
13150849|NCT02553499|26047970|FG006|Overall Study|Study Terminated by Sponsor|0|||
13150850|NCT02553499|26047971|FG007|Overall Study|Study Terminated by Sponsor|0|||
13150851|NCT02553499|26047972|FG008|Overall Study|Study Terminated by Sponsor|1|||
13150852|NCT02553499|26047973|FG009|Overall Study|Study Terminated by Sponsor|0|||
13150853|NCT02553499|26047974|FG010|Overall Study|Study Terminated by Sponsor|0|||
13150854|NCT02553499|26047975|FG011|Overall Study|Study Terminated by Sponsor|0|||
13150855|NCT02553499|26047976|FG012|Overall Study|Study Terminated by Sponsor|0|||
13150856|NCT02553499|26047977|FG013|Overall Study|Study Terminated by Sponsor|0|||
13150857|NCT02553499|26047964|FG000|Overall Study|Withdrawal by Subject|2|||
13150858|NCT02553499|26047965|FG001|Overall Study|Withdrawal by Subject|0|||
13150859|NCT02553499|26047966|FG002|Overall Study|Withdrawal by Subject|0|||
13150860|NCT02553499|26047967|FG003|Overall Study|Withdrawal by Subject|0|||
13150861|NCT02553499|26047968|FG004|Overall Study|Withdrawal by Subject|0|||
13150862|NCT02553499|26047969|FG005|Overall Study|Withdrawal by Subject|0|||
13150863|NCT02553499|26047970|FG006|Overall Study|Withdrawal by Subject|0|||
13150864|NCT02553499|26047971|FG007|Overall Study|Withdrawal by Subject|1|||
13150865|NCT02553499|26047972|FG008|Overall Study|Withdrawal by Subject|1|||
13150866|NCT02553499|26047973|FG009|Overall Study|Withdrawal by Subject|0|||
13150867|NCT02553499|26047974|FG010|Overall Study|Withdrawal by Subject|1|||
13150868|NCT02553499|26047975|FG011|Overall Study|Withdrawal by Subject|0|||
13150869|NCT02553499|26047976|FG012|Overall Study|Withdrawal by Subject|0|||
13150870|NCT02553499|26047977|FG013|Overall Study|Withdrawal by Subject|0|||
13205147|NCT01968031|26230943|FG001|Overall Study|Failed inclusion criteria|2|||
13205148|NCT01968031|26230944|FG002|Overall Study|Failed inclusion criteria|0|||
13205149|NCT01968031|26230942|FG000|Overall Study|Death|0|||
13205150|NCT01968031|26230943|FG001|Overall Study|Death|0|||
13205151|NCT01968031|26230944|FG002|Overall Study|Death|1|||
13205152|NCT01968031|26230942|FG000|Overall Study|Prohibited concomitant medication|1|||
13205153|NCT01968031|26230943|FG001|Overall Study|Prohibited concomitant medication|0|||
13205154|NCT01968031|26230944|FG002|Overall Study|Prohibited concomitant medication|0|||
13205155|NCT01967940|26230981|FG000|Part 2|Enrolled in Part 2 and Never Treated|0|||
13205156|NCT01967940|26230982|FG001|Part 2|Enrolled in Part 2 and Never Treated|0|||
13205157|NCT01967940|26230983|FG002|Part 2|Enrolled in Part 2 and Never Treated|0|||
13205158|NCT01967940|26230984|FG003|Part 2|Enrolled in Part 2 and Never Treated|1|||
13205159|NCT01967940|26230981|FG000|Part 2|Adverse Event|0|||
13205160|NCT01967940|26230982|FG001|Part 2|Adverse Event|0|||
13205161|NCT01967940|26230983|FG002|Part 2|Adverse Event|0|||
13205162|NCT01967940|26230984|FG003|Part 2|Adverse Event|1|||
13205163|NCT01967940|26230981|FG000|Part 2|Unknown Reason|0|||
13205164|NCT01967940|26230982|FG001|Part 2|Unknown Reason|0|||
13098524|NCT03514641|25851369|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9|||
13098525|NCT03514641|25851370|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
13098526|NCT03514641|25851371|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
13098527|NCT03514641|25851368|FG000|603A: 0-12 Week Study Period|Physician Decision|1|||
13098528|NCT03514641|25851369|FG001|603A: 0-12 Week Study Period|Physician Decision|0|||
13098529|NCT03514641|25851370|FG002|603A: 0-12 Week Study Period|Physician Decision|0|||
13098530|NCT03514641|25851371|FG003|603A: 0-12 Week Study Period|Physician Decision|0|||
13098531|NCT03514641|25851368|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1|||
13098532|NCT03514641|25851369|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
13098533|NCT03514641|25851370|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
13098534|NCT03514641|25851371|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
13098535|NCT03514641|25851368|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
13098536|NCT03514641|25851369|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1|||
13098537|NCT03514641|25851370|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
13098538|NCT03514641|25851371|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
13098539|NCT03514641|25851368|FG000|603B: 24-36 Week Study Period|Protocol Violation|0|||
13098540|NCT03514641|25851369|FG001|603B: 24-36 Week Study Period|Protocol Violation|0|||
13098541|NCT03514641|25851370|FG002|603B: 24-36 Week Study Period|Protocol Violation|0|||
13098542|NCT03514641|25851371|FG003|603B: 24-36 Week Study Period|Protocol Violation|2|||
13098543|NCT03514641|25851368|FG000|603B: 24-36 Week Study Period|Adverse Event|0|||
13205165|NCT01967940|26230983|FG002|Part 2|Unknown Reason|0|||
13205166|NCT01967940|26230984|FG003|Part 2|Unknown Reason|1|||
13205167|NCT01967888|26231059|FG000|Overall Study|Lost to Follow-up|6|||
13205168|NCT01967888|26231060|FG001|Overall Study|Lost to Follow-up|4|||
13205169|NCT01967888|26231059|FG000|Overall Study|Withdrawal by Subject|1|||
13205170|NCT01967888|26231060|FG001|Overall Study|Withdrawal by Subject|1|||
13205171|NCT01967888|26231059|FG000|Overall Study|Did Not Have Transplant|1|||
13205172|NCT01967888|26231060|FG001|Overall Study|Did Not Have Transplant|0|||
13205173|NCT01967888|26231059|FG000|Overall Study|Research visit not done, data recorded|1|||
13098544|NCT03514641|25851369|FG001|603B: 24-36 Week Study Period|Adverse Event|0|||
13098545|NCT03514641|25851370|FG002|603B: 24-36 Week Study Period|Adverse Event|3|||
13098546|NCT03514641|25851371|FG003|603B: 24-36 Week Study Period|Adverse Event|1|||
13098547|NCT03514641|25851368|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
13098548|NCT03514641|25851369|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
13098549|NCT03514641|25851370|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2|||
13098550|NCT03514641|25851371|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3|||
13098551|NCT03514641|25851368|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
13098552|NCT03514641|25851369|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
13098553|NCT03514641|25851370|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
13098554|NCT03514641|25851371|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
13098555|NCT03514641|25851368|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
13098556|NCT03514641|25851369|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
13098557|NCT03514641|25851370|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
13098558|NCT03514641|25851371|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
13098559|NCT03513588|25851413|FG000|Overall Study|Lost to Follow-up|0|||
13098560|NCT03513588|25851414|FG001|Overall Study|Lost to Follow-up|1|||
13098561|NCT03513588|25851415|FG002|Overall Study|Lost to Follow-up|1|||
13098562|NCT03513588|25851413|FG000|Overall Study|Study dosing paused by sponsor|1|||
13098563|NCT03513588|25851414|FG001|Overall Study|Study dosing paused by sponsor|1|||
13098564|NCT03513588|25851415|FG002|Overall Study|Study dosing paused by sponsor|0|||
13098565|NCT03513588|25851413|FG000|Overall Study|Death|0|||
13098566|NCT03513588|25851414|FG001|Overall Study|Death|0|||
13098567|NCT03513588|25851415|FG002|Overall Study|Death|1|||
13098568|NCT03512353|25851443|FG000|Overall Study|Sponsor Decision|3|||
13098569|NCT03512353|25851443|FG000|Overall Study|Death|1|||
13098570|NCT03512288|25851484|FG000|Overall Study|Adverse Event|1|||
13098571|NCT03512288|25851485|FG001|Overall Study|Adverse Event|0|||
13150871|NCT02553421|26047992|FG000|Overall Study|Lost to Follow-up|21|||
13150872|NCT02553421|26047993|FG001|Overall Study|Lost to Follow-up|1|||
13150873|NCT02553421|26047992|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5|||
13150874|NCT02553421|26047993|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0|||
13150875|NCT02553421|26047992|FG000|Overall Study|Improper Device Placement|3|||
13150876|NCT02553421|26047993|FG001|Overall Study|Improper Device Placement|0|||
13150877|NCT02553330|26048025|FG000|Overall Study|Study Terminated by Sponsor|2|||
13150878|NCT02553330|26048026|FG001|Overall Study|Study Terminated by Sponsor|13|||
13150879|NCT02553330|26048027|FG002|Overall Study|Study Terminated by Sponsor|12|||
13150880|NCT02553330|26048025|FG000|Overall Study|Withdrawal by Subject|3|||
13150881|NCT02553330|26048026|FG001|Overall Study|Withdrawal by Subject|19|||
13150882|NCT02553330|26048027|FG002|Overall Study|Withdrawal by Subject|21|||
13150883|NCT02553330|26048025|FG000|Overall Study|Other|0|||
13150884|NCT02553330|26048026|FG001|Overall Study|Other|1|||
13150885|NCT02553330|26048027|FG002|Overall Study|Other|0|||
13150886|NCT02553330|26048025|FG000|Overall Study|Non compliance to study treatment|0|||
13150887|NCT02553330|26048026|FG001|Overall Study|Non compliance to study treatment|1|||
13098572|NCT03512288|25851484|FG000|Overall Study|Lost to Follow-up|12|||
13098573|NCT03512288|25851485|FG001|Overall Study|Lost to Follow-up|15|||
13098574|NCT03512288|25851484|FG000|Overall Study|Physician Decision|0|||
13098575|NCT03512288|25851485|FG001|Overall Study|Physician Decision|2|||
13150888|NCT02553330|26048027|FG002|Overall Study|Non compliance to study treatment|0|||
13098576|NCT03512288|25851484|FG000|Overall Study|Protocol Violation|6|||
13098577|NCT03512288|25851485|FG001|Overall Study|Protocol Violation|4|||
13098578|NCT03512288|25851484|FG000|Overall Study|Medication error without associated adverse event|1|||
13098579|NCT03512288|25851485|FG001|Overall Study|Medication error without associated adverse event|0|||
13098580|NCT03512288|25851484|FG000|Overall Study|No longer met eligibility criteria|5|||
13098581|NCT03512288|25851485|FG001|Overall Study|No longer met eligibility criteria|2|||
13098582|NCT03512288|25851484|FG000|Overall Study|Withdrawal by parent/guardian|14|||
13098583|NCT03512288|25851485|FG001|Overall Study|Withdrawal by parent/guardian|18|||
13098584|NCT03512288|25851484|FG000|Overall Study|Other|1|||
13098585|NCT03512288|25851485|FG001|Overall Study|Other|1|||
13098586|NCT03512288|25851484|FG000|Overall Study|Randomized but not treated|1|||
13098587|NCT03512288|25851485|FG001|Overall Study|Randomized but not treated|1|||
13098588|NCT03512275|25851518|FG000|Overall Study|Withdrawal by Subject|1|||
13098589|NCT03512275|25851519|FG001|Overall Study|Withdrawal by Subject|3|||
13098590|NCT03512275|25851518|FG000|Overall Study|Physician Decision|0|||
13098591|NCT03512275|25851519|FG001|Overall Study|Physician Decision|1|||
13098592|NCT03512275|25851518|FG000|Overall Study|Lost to Follow-up|0|||
13098593|NCT03512275|25851519|FG001|Overall Study|Lost to Follow-up|3|||
13150889|NCT02553330|26048025|FG000|Overall Study|Adverse Event|0|||
13150890|NCT02553330|26048026|FG001|Overall Study|Adverse Event|1|||
13150891|NCT02553330|26048027|FG002|Overall Study|Adverse Event|0|||
13150892|NCT02553330|26048025|FG000|Overall Study|Lost to Follow-up|0|||
13098594|NCT03512275|25851518|FG000|Overall Study|Other|1|||
13098595|NCT03512275|25851519|FG001|Overall Study|Other|0|||
13098596|NCT03512028|25851532|FG000|Overall Study|Withdrawal by Subject|2|||
13150893|NCT02553330|26048026|FG001|Overall Study|Lost to Follow-up|4|||
13150894|NCT02553330|26048027|FG002|Overall Study|Lost to Follow-up|4|||
13150895|NCT02553317|26048057|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0|||
13150896|NCT02553317|26048058|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1|||
13150897|NCT02553317|26048057|FG000|Overall Treatment Period + Follow-up|Physician Decision|2|||
13150898|NCT02553317|26048058|FG001|Overall Treatment Period + Follow-up|Physician Decision|4|||
13150899|NCT02553317|26048057|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0|||
13150900|NCT02553317|26048058|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1|||
13150901|NCT02553317|26048057|FG000|Overall Treatment Period + Follow-up|Death|1|||
13150902|NCT02553317|26048058|FG001|Overall Treatment Period + Follow-up|Death|3|||
13150903|NCT02553317|26048057|FG000|Overall Treatment Period + Follow-up|Adverse Event|6|||
13150904|NCT02553317|26048058|FG001|Overall Treatment Period + Follow-up|Adverse Event|5|||
13150905|NCT02553317|26048057|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4|||
13150906|NCT02553317|26048058|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5|||
13150907|NCT02553317|26048057|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0|||
13150908|NCT02553317|26048058|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1|||
13150909|NCT02553317|26048057|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
13150910|NCT02553317|26048058|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
13150911|NCT02553317|26048057|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0|||
13150912|NCT02553317|26048058|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1|||
13150913|NCT02553317|26048057|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0|||
13150914|NCT02553317|26048058|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1|||
13150915|NCT02553265|26048112|FG000|Enrollment|Death|0|||
13150916|NCT02553265|26048113|FG001|Enrollment|Death|0|||
13150917|NCT02553265|26048114|FG002|Enrollment|Death|1|||
13150918|NCT02553265|26048112|FG000|First Intervention (28 Days)|Adverse Event|1|||
13150919|NCT02553265|26048113|FG001|First Intervention (28 Days)|Adverse Event|0|||
13150920|NCT02553265|26048114|FG002|First Intervention (28 Days)|Adverse Event|0|||
13150921|NCT02553265|26048112|FG000|First Intervention (28 Days)|Withdrawal by Subject|0|||
13150922|NCT02553265|26048113|FG001|First Intervention (28 Days)|Withdrawal by Subject|0|||
13150923|NCT02553265|26048114|FG002|First Intervention (28 Days)|Withdrawal by Subject|1|||
13150924|NCT02553265|26048112|FG000|Second Intervention (28 Days)|Adverse Event|1|||
13150925|NCT02553265|26048113|FG001|Second Intervention (28 Days)|Adverse Event|0|||
13150926|NCT02553265|26048114|FG002|Second Intervention (28 Days)|Adverse Event|0|||
13150927|NCT02553265|26048112|FG000|Third Intervention (28 Days)|Adverse Event|1|||
13150928|NCT02553265|26048113|FG001|Third Intervention (28 Days)|Adverse Event|0|||
13150929|NCT02553265|26048114|FG002|Third Intervention (28 Days)|Adverse Event|0|||
13150930|NCT02553265|26048112|FG000|Third Intervention (28 Days)|Lost to Follow-up|0|||
13150931|NCT02553265|26048113|FG001|Third Intervention (28 Days)|Lost to Follow-up|0|||
13150932|NCT02553265|26048114|FG002|Third Intervention (28 Days)|Lost to Follow-up|1|||
13150933|NCT02552966|26048123|FG000|Overall Study|Lost to Follow-up|2|||
13150934|NCT02552966|26048123|FG000|Overall Study|Withdrawal by Subject|3|||
13098597|NCT03512028|25851533|FG001|Overall Study|Withdrawal by Subject|0|||
13098598|NCT03512028|25851532|FG000|Overall Study|Protocol Violation|2|||
13098599|NCT03512028|25851533|FG001|Overall Study|Protocol Violation|0|||
13098600|NCT03511664|25851604|FG000|Overall Study|Treatment ongoing|49|||
13098601|NCT03511664|25851605|FG001|Overall Study|Treatment ongoing|5|||
13098602|NCT03511664|25851604|FG000|Overall Study|Entered long-term follow-up|140|||
13098603|NCT03511664|25851605|FG001|Overall Study|Entered long-term follow-up|50|||
13098604|NCT03511664|25851604|FG000|Overall Study|Withdrawal by Subject|29|||
13098605|NCT03511664|25851605|FG001|Overall Study|Withdrawal by Subject|53|||
13098606|NCT03511664|25851604|FG000|Overall Study|Lost to Follow-up|4|||
13098607|NCT03511664|25851605|FG001|Overall Study|Lost to Follow-up|4|||
13098608|NCT03511664|25851604|FG000|Overall Study|Physician Decision|0|||
13098609|NCT03511664|25851605|FG001|Overall Study|Physician Decision|1|||
13098610|NCT03511378|25851624|FG000|Overall Study|Withdrawal by Subject|2|||
13098611|NCT03511378|25851625|FG001|Overall Study|Withdrawal by Subject|2|||
13098612|NCT03511378|25851624|FG000|Overall Study|Patient not coming or schedule visit|1|||
13098613|NCT03511378|25851625|FG001|Overall Study|Patient not coming or schedule visit|0|||
13098614|NCT03511326|25851632|FG000|Overall Study|Withdrawal by Subject|1|||
13098615|NCT03511105|25851693|FG000|Overall Study|Adverse Event|1|||
13098616|NCT03511105|25851694|FG001|Overall Study|Adverse Event|0|||
13098617|NCT03511105|25851693|FG000|Overall Study|Withdrew consent|1|||
13098618|NCT03511105|25851694|FG001|Overall Study|Withdrew consent|0|||
13098619|NCT03511066|25851712|FG000|Overall Study|Withdrawal by Subject|1|||
13150935|NCT02552888|26048176|FG000|Overall Study|Lost to Follow-up|1|||
13150936|NCT02552888|26048177|FG001|Overall Study|Lost to Follow-up|1|||
13098620|NCT03511066|25851713|FG001|Overall Study|Withdrawal by Subject|2|||
13098621|NCT03511066|25851714|FG002|Overall Study|Withdrawal by Subject|3|||
13098622|NCT03511066|25851712|FG000|Overall Study|Lost to Follow-up|2|||
13098623|NCT03511066|25851713|FG001|Overall Study|Lost to Follow-up|3|||
13098624|NCT03511066|25851714|FG002|Overall Study|Lost to Follow-up|0|||
13098625|NCT03511053|25851722|FG000|Overall Study|Withdrawal by Subject|1|||
13098626|NCT03510910|25851743|FG000|Overall Study|Incomplete Survey|2|||
13098627|NCT03510910|25851744|FG001|Overall Study|Incomplete Survey|3|||
13098628|NCT03510715|25851769|FG000|Overall Study|Adverse Event|1|||
13098629|NCT03510715|25851770|FG001|Overall Study|Adverse Event|0|||
13098630|NCT03510663|25851805|FG000|Overall Study|Withdrawal by Subject|0|||
13098631|NCT03510663|25851806|FG001|Overall Study|Withdrawal by Subject|1|||
13098632|NCT03510663|25851807|FG002|Overall Study|Withdrawal by Subject|0|||
13098633|NCT03510663|25851808|FG003|Overall Study|Withdrawal by Subject|0|||
13098634|NCT03510663|25851809|FG004|Overall Study|Withdrawal by Subject|0|||
13098635|NCT03510663|25851810|FG005|Overall Study|Withdrawal by Subject|0|||
13098636|NCT03510663|25851811|FG006|Overall Study|Withdrawal by Subject|0|||
13098637|NCT03510663|25851812|FG007|Overall Study|Withdrawal by Subject|0|||
13098638|NCT03510455|25851837|FG000|Overall Study|Physician Decision|1|||
13098639|NCT03510273|25851848|FG000|Overall Study|Withdrawal by Subject|2|||
13098640|NCT03510273|25851848|FG000|Overall Study|Care outside study, ineligible to cont.|3|||
13098641|NCT03510273|25851848|FG000|Overall Study|Moved away from study area|4|||
13098642|NCT03510182|25851856|FG000|Overall Study|Withdrawal by Subject|2|||
13098643|NCT03509948|25851881|FG000|Overall Study|Protocol Violation|0|||
13098644|NCT03509948|25851882|FG001|Overall Study|Protocol Violation|1|||
13098645|NCT03509675|25851895|FG000|First Intervention (7 Days)|Lost to Follow-up|3|||
13098646|NCT03509675|25851896|FG001|First Intervention (7 Days)|Lost to Follow-up|3|||
13098647|NCT03509675|25851895|FG000|First Intervention (7 Days)|Lack of Efficacy|2|||
13098648|NCT03509675|25851896|FG001|First Intervention (7 Days)|Lack of Efficacy|1|||
13098649|NCT03509675|25851895|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1|||
13098650|NCT03509675|25851896|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0|||
13098651|NCT03509675|25851895|FG000|Second Intervention )7 Days)|Lost Rinse B|1|||
13098652|NCT03509675|25851896|FG001|Second Intervention )7 Days)|Lost Rinse B|0|||
13098653|NCT03509350|25851945|FG000|Overall Study|Withdrawal by Subject|0|||
13098654|NCT03509350|25851946|FG001|Overall Study|Withdrawal by Subject|2|||
13098655|NCT03509207|25851953|FG000|Overall Study|Death|2|||
13098656|NCT03508843|25851961|FG000|Overall Study|Withdrawal by Subject|1|||
13098657|NCT03508843|25851961|FG000|Overall Study|technical difficulties|2|||
13150937|NCT02552732|26048206|FG000|Overall Study|Lost to Follow-up|2|||
13150938|NCT02552732|26048206|FG000|Overall Study|Physician Decision|1|||
13150939|NCT02552732|26048206|FG000|Overall Study|Day 1 SpO2 > 96%|1|||
13150940|NCT02552732|26048206|FG000|Overall Study|Withdrawal by Subject|6|||
13150941|NCT02552355|26048261|FG000|Overall Study|Adverse Event|0|||
13150942|NCT02552355|26048262|FG001|Overall Study|Adverse Event|2|||
13150943|NCT02552355|26048263|FG002|Overall Study|Adverse Event|2|||
13150944|NCT02552355|26048264|FG003|Overall Study|Adverse Event|0|||
13150945|NCT02552355|26048261|FG000|Overall Study|Withdrawal by Subject|0|||
13150946|NCT02552355|26048262|FG001|Overall Study|Withdrawal by Subject|0|||
13150947|NCT02552355|26048263|FG002|Overall Study|Withdrawal by Subject|0|||
13150948|NCT02552355|26048264|FG003|Overall Study|Withdrawal by Subject|1|||
13150949|NCT02552316|26048314|FG000|Overall Study|Withdrawal by Subject|1|||
13098658|NCT03508830|25851980|FG000|Overall Study|Withdrawal by Subject|3|||
13098659|NCT03508830|25851981|FG001|Overall Study|Withdrawal by Subject|4|||
13098660|NCT03508830|25851980|FG000|Overall Study|Physician Decision|2|||
13098661|NCT03508830|25851981|FG001|Overall Study|Physician Decision|2|||
13098662|NCT03508609|25851993|FG000|Overall Study|Withdrawal by Subject|1|||
13098663|NCT03508050|25852030|FG000|Overall Study|Pleural adhesions|1|||
13098664|NCT03508050|25852031|FG001|Overall Study|Pleural adhesions|0|||
13098665|NCT03508050|25852030|FG000|Overall Study|Mucus plug|1|||
13098666|NCT03508050|25852031|FG001|Overall Study|Mucus plug|0|||
13098667|NCT03508050|25852030|FG000|Overall Study|Negative biopsy, surgery cancelled|3|||
13098668|NCT03508050|25852031|FG001|Overall Study|Negative biopsy, surgery cancelled|1|||
13098669|NCT03508050|25852030|FG000|Overall Study|Sustained desaturation|0|||
13098670|NCT03508050|25852031|FG001|Overall Study|Sustained desaturation|1|||
13098671|NCT03506477|25852064|FG000|Overall Study|Withdrawal by Subject|1|||
13098672|NCT03506477|25852065|FG001|Overall Study|Withdrawal by Subject|0|||
13098673|NCT03506425|25852086|FG000|Overall Study|Adverse Event|1|||
13098674|NCT03506425|25852087|FG001|Overall Study|Adverse Event|3|||
13098675|NCT03506425|25852088|FG002|Overall Study|Adverse Event|0|||
13098676|NCT03506425|25852086|FG000|Overall Study|Death|1|||
13098677|NCT03506425|25852087|FG001|Overall Study|Death|0|||
13098678|NCT03506425|25852088|FG002|Overall Study|Death|0|||
13098679|NCT03506425|25852086|FG000|Overall Study|Withdrawal by Subject|0|||
13098680|NCT03506425|25852087|FG001|Overall Study|Withdrawal by Subject|0|||
13098681|NCT03506425|25852088|FG002|Overall Study|Withdrawal by Subject|1|||
13098682|NCT03505593|25852096|FG000|Overall Study|Withdrawal by Subject|1|||
13150950|NCT02552316|26048314|FG000|Overall Study|Withdrawal due to non-compliance|1|||
13150951|NCT02552303|26048341|FG000|Allocation|Withdrawal by Subject|2|||
13150952|NCT02552303|26048342|FG001|Allocation|Withdrawal by Subject|1|||
13098683|NCT03505593|25852096|FG000|Overall Study|Died before procedure|1|||
13098684|NCT03505593|25852096|FG000|Overall Study|Anatomical abnormality|1|||
13098685|NCT03505593|25852096|FG000|Overall Study|Unable to pass through esophagus|1|||
13098686|NCT03505593|25852096|FG000|Overall Study|Obstruction by Endotracheal tube|1|||
13098687|NCT03505021|25852119|FG000|Overall Study|Protocol Violation|1|||
13098688|NCT03505021|25852120|FG001|Overall Study|Protocol Violation|0|||
13098689|NCT03505021|25852119|FG000|Overall Study|Death|9|||
13098690|NCT03505021|25852120|FG001|Overall Study|Death|8|||
13098691|NCT03505021|25852119|FG000|Overall Study|Consent withdrawn by subject|6|||
13098692|NCT03505021|25852120|FG001|Overall Study|Consent withdrawn by subject|1|||
13098693|NCT03505021|25852119|FG000|Overall Study|Lost to Follow-up|5|||
13098694|NCT03505021|25852120|FG001|Overall Study|Lost to Follow-up|3|||
13098695|NCT03505021|25852119|FG000|Overall Study|Adverse Event|26|||
13098696|NCT03505021|25852120|FG001|Overall Study|Adverse Event|9|||
13098697|NCT03505021|25852119|FG000|Overall Study|Disease progression|33|||
13098698|NCT03505021|25852120|FG001|Overall Study|Disease progression|17|||
13098699|NCT03505021|25852119|FG000|Overall Study|Other|11|||
13098700|NCT03505021|25852120|FG001|Overall Study|Other|5|||
13098701|NCT03505021|25852119|FG000|Overall Study|Personal reason|21|||
13098702|NCT03505021|25852120|FG001|Overall Study|Personal reason|12|||
13098703|NCT03504917|25852159|FG000|Blinded Treatment Period|Protocol Violation|1|||
13098704|NCT03504917|25852160|FG001|Blinded Treatment Period|Protocol Violation|0|||
13098705|NCT03504917|25852159|FG000|Blinded Treatment Period|Withdrawal by Subject|12|||
13098706|NCT03504917|25852160|FG001|Blinded Treatment Period|Withdrawal by Subject|9|||
13098707|NCT03504917|25852159|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
13150953|NCT02552303|26048343|FG002|Allocation|Withdrawal by Subject|1|||
13150954|NCT02552303|26048344|FG003|Allocation|Withdrawal by Subject|1|||
13098708|NCT03504917|25852160|FG001|Blinded Treatment Period|Lack of Efficacy|1|||
13098709|NCT03504917|25852159|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
13098710|NCT03504917|25852160|FG001|Blinded Treatment Period|Lost to Follow-up|4|||
13098711|NCT03504917|25852159|FG000|Blinded Treatment Period|Adverse Event|4|||
13098712|NCT03504917|25852160|FG001|Blinded Treatment Period|Adverse Event|4|||
13098713|NCT03504917|25852159|FG000|Blinded Treatment Period|Physician Decision|1|||
13098714|NCT03504917|25852160|FG001|Blinded Treatment Period|Physician Decision|0|||
13098715|NCT03504917|25852159|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1|||
13098716|NCT03504917|25852160|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3|||
13098717|NCT03504917|25852159|FG000|Blinded Treatment Period|Study terminated by sponsor|39|||
13098718|NCT03504917|25852160|FG001|Blinded Treatment Period|Study terminated by sponsor|34|||
13098719|NCT03504917|25852159|FG000|Blinded Treatment Period|Non-compliance with study drug|0|||
13098720|NCT03504917|25852160|FG001|Blinded Treatment Period|Non-compliance with study drug|1|||
13098721|NCT03504917|25852159|FG000|Open Label Extension Treatment Period|The participant left the study site|0|||
13098722|NCT03504917|25852160|FG001|Open Label Extension Treatment Period|The participant left the study site|1|||
13098723|NCT03504917|25852159|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8|||
13098724|NCT03504917|25852160|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2|||
13098725|NCT03504917|25852159|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1|||
13098726|NCT03504917|25852160|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4|||
13098727|NCT03504917|25852159|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3|||
13098728|NCT03504917|25852160|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1|||
13098729|NCT03504917|25852159|FG000|Open Label Extension Treatment Period|Adverse Event|7|||
13098730|NCT03504917|25852160|FG001|Open Label Extension Treatment Period|Adverse Event|0|||
13098731|NCT03504917|25852159|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0|||
13150955|NCT02552303|26048341|FG000|Allocation|ineligible|1|||
13150956|NCT02552303|26048342|FG001|Allocation|ineligible|1|||
13150957|NCT02552303|26048343|FG002|Allocation|ineligible|0|||
13150958|NCT02552303|26048344|FG003|Allocation|ineligible|0|||
13098732|NCT03504917|25852160|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1|||
13098733|NCT03504917|25852159|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81|||
13098734|NCT03504917|25852160|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88|||
13098735|NCT03504852|25852183|FG000|Overall Study|Withdrawal of informed consent|2|||
13098736|NCT03504852|25852184|FG001|Overall Study|Withdrawal of informed consent|1|||
13098737|NCT03504852|25852185|FG002|Overall Study|Withdrawal of informed consent|0|||
13098738|NCT03504852|25852183|FG000|Overall Study|Withdrawal by Subject|5|||
13098739|NCT03504852|25852184|FG001|Overall Study|Withdrawal by Subject|5|||
13098740|NCT03504852|25852185|FG002|Overall Study|Withdrawal by Subject|1|||
13098741|NCT03504852|25852183|FG000|Overall Study|Lost to Follow-up|4|||
13098742|NCT03504852|25852184|FG001|Overall Study|Lost to Follow-up|1|||
13098743|NCT03504852|25852185|FG002|Overall Study|Lost to Follow-up|0|||
13098744|NCT03504852|25852183|FG000|Overall Study|New therapy for study indication|1|||
13098745|NCT03504852|25852184|FG001|Overall Study|New therapy for study indication|0|||
13098746|NCT03504852|25852185|FG002|Overall Study|New therapy for study indication|0|||
13098747|NCT03504852|25852183|FG000|Overall Study|Lack of Efficacy|1|||
13150959|NCT02552303|26048341|FG000|Follow-Up|Lost to Follow-up|0|||
13150960|NCT02552303|26048342|FG001|Follow-Up|Lost to Follow-up|0|||
13150961|NCT02552303|26048343|FG002|Follow-Up|Lost to Follow-up|1|||
13098748|NCT03504852|25852184|FG001|Overall Study|Lack of Efficacy|2|||
13098749|NCT03504852|25852185|FG002|Overall Study|Lack of Efficacy|0|||
13098750|NCT03504852|25852183|FG000|Overall Study|Death|0|||
13098751|NCT03504852|25852184|FG001|Overall Study|Death|1|||
13098752|NCT03504852|25852185|FG002|Overall Study|Death|0|||
13098753|NCT03504852|25852183|FG000|Overall Study|Adverse Event|4|||
13098754|NCT03504852|25852184|FG001|Overall Study|Adverse Event|8|||
13098755|NCT03504852|25852185|FG002|Overall Study|Adverse Event|2|||
13098756|NCT03504189|25852196|FG000|Overall Study|Withdrawal by Subject|1|||
13098757|NCT03504189|25852196|FG000|Overall Study|Screening Failure|1|||
13098758|NCT03504189|25852196|FG000|Overall Study|Device Failure|2|||
13098759|NCT03503318|25852262|FG000|Overall Study|Death|1|||
13150962|NCT02552303|26048344|FG003|Follow-Up|Lost to Follow-up|0|||
13150963|NCT02552303|26048341|FG000|Follow-Up|ineligible|0|||
13150964|NCT02552303|26048342|FG001|Follow-Up|ineligible|2|||
13150965|NCT02552303|26048343|FG002|Follow-Up|ineligible|0|||
13150966|NCT02552303|26048344|FG003|Follow-Up|ineligible|0|||
13150967|NCT02552238|26048357|FG000|Overall Study|Withdrawal by Subject|2|||
13150968|NCT02552238|26048357|FG000|Overall Study|Adverse Event|2|||
13150969|NCT02552225|26048382|FG000|Overall Study|Withdrawal by Subject|1|||
13150970|NCT02552225|26048383|FG001|Overall Study|Withdrawal by Subject|0|||
13150971|NCT02552212|26048469|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6|||
13150972|NCT02552212|26048470|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3|||
13150973|NCT02552212|26048471|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0|||
13150974|NCT02552212|26048469|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
13150975|NCT02552212|26048470|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
13150976|NCT02552212|26048471|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0|||
13150977|NCT02552212|26048469|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
13150978|NCT02552212|26048470|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
13150979|NCT02552212|26048471|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0|||
13150980|NCT02552212|26048469|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1|||
13150981|NCT02552212|26048470|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
13150982|NCT02552212|26048471|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
13150983|NCT02552212|26048469|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3|||
13150984|NCT02552212|26048470|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7|||
13150985|NCT02552212|26048471|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0|||
13150986|NCT02552212|26048469|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
13150987|NCT02552212|26048470|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
13150988|NCT02552212|26048471|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0|||
13150989|NCT02552212|26048469|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
13150990|NCT02552212|26048470|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1|||
13150991|NCT02552212|26048471|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
13150992|NCT02552212|26048469|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
13150993|NCT02552212|26048470|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1|||
13098760|NCT03503318|25852263|FG001|Overall Study|Death|0|||
13098761|NCT03503318|25852264|FG002|Overall Study|Death|4|||
13098762|NCT03503318|25852262|FG000|Overall Study|Adverse Event|3|||
13098763|NCT03503318|25852263|FG001|Overall Study|Adverse Event|4|||
13098764|NCT03503318|25852264|FG002|Overall Study|Adverse Event|2|||
13098765|NCT03503318|25852262|FG000|Overall Study|Withdrawal by Subject|12|||
13098766|NCT03503318|25852263|FG001|Overall Study|Withdrawal by Subject|17|||
13098767|NCT03503318|25852264|FG002|Overall Study|Withdrawal by Subject|16|||
13098768|NCT03503318|25852262|FG000|Overall Study|Protocol Violation|5|||
13098769|NCT03503318|25852263|FG001|Overall Study|Protocol Violation|0|||
13098770|NCT03503318|25852264|FG002|Overall Study|Protocol Violation|3|||
13098771|NCT03503318|25852262|FG000|Overall Study|Lost to Follow-up|17|||
13098772|NCT03503318|25852263|FG001|Overall Study|Lost to Follow-up|15|||
13098773|NCT03503318|25852264|FG002|Overall Study|Lost to Follow-up|12|||
13150994|NCT02552212|26048471|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
13150995|NCT02552212|26048469|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
13150996|NCT02552212|26048470|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1|||
13150997|NCT02552212|26048471|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
13150998|NCT02552212|26048469|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1|||
13150999|NCT02552212|26048470|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
13098774|NCT03503318|25852262|FG000|Overall Study|Other than specified|1|||
13098775|NCT03503318|25852263|FG001|Overall Study|Other than specified|3|||
13098776|NCT03503318|25852264|FG002|Overall Study|Other than specified|3|||
13098777|NCT03503188|25852287|FG000|Overall Study|Non eligible in the sub study|0|||
13098778|NCT03503188|25852288|FG001|Overall Study|Non eligible in the sub study|1|||
13098779|NCT03503162|25852294|FG000|Overall Study|did not meet eligibility|1|||
13098780|NCT03502798|25852311|FG000|Overall Study|equipment failure|0|||
13098781|NCT03502798|25852312|FG001|Overall Study|equipment failure|7|||
13098782|NCT03502616|25852413|FG000|Up to Week 16|Withdrawal by Subject|1|||
13098783|NCT03502616|25852414|FG001|Up to Week 16|Withdrawal by Subject|2|||
13098784|NCT03502616|25852413|FG000|Up to Week 16|Lost to Follow-up|0|||
13098785|NCT03502616|25852414|FG001|Up to Week 16|Lost to Follow-up|1|||
13098786|NCT03502616|25852413|FG000|Up to Week 16|Randomized, but not treated|1|||
13098787|NCT03502616|25852414|FG001|Up to Week 16|Randomized, but not treated|0|||
13098788|NCT03502616|25852413|FG000|Week 16 to Week 48|Withdrawal by Subject|6|||
13098789|NCT03502616|25852414|FG001|Week 16 to Week 48|Withdrawal by Subject|6|||
13098790|NCT03502616|25852413|FG000|Week 16 to Week 48|Lost to Follow-up|1|||
13098791|NCT03502616|25852414|FG001|Week 16 to Week 48|Lost to Follow-up|0|||
13098792|NCT03502070|25852420|FG000|Overall Study|Withdrawal by Subject|1|||
13098793|NCT03502070|25852420|FG000|Overall Study|Screen Failure|1|||
13098794|NCT03501277|25852447|FG000|Intervention Period 1 (4 Days)|Other|0|||
13098795|NCT03501277|25852448|FG001|Intervention Period 1 (4 Days)|Other|0|||
13098796|NCT03501277|25852449|FG002|Intervention Period 1 (4 Days)|Other|1|||
13098797|NCT03501277|25852450|FG003|Intervention Period 1 (4 Days)|Other|0|||
13098798|NCT03501277|25852447|FG000|Intervention Period 1 (4 Days)|Adverse Event|0|||
13098799|NCT03501277|25852448|FG001|Intervention Period 1 (4 Days)|Adverse Event|0|||
13098800|NCT03501277|25852449|FG002|Intervention Period 1 (4 Days)|Adverse Event|0|||
13098801|NCT03501277|25852450|FG003|Intervention Period 1 (4 Days)|Adverse Event|1|||
13098802|NCT03501277|25852447|FG000|Intervention Period 2 (4 Days)|Adverse Event|0|||
13098803|NCT03501277|25852448|FG001|Intervention Period 2 (4 Days)|Adverse Event|0|||
13098804|NCT03501277|25852449|FG002|Intervention Period 2 (4 Days)|Adverse Event|0|||
13098805|NCT03501277|25852450|FG003|Intervention Period 2 (4 Days)|Adverse Event|1|||
13098806|NCT03501277|25852447|FG000|Intervention Period 3 (4 Days)|Adverse Event|0|||
13098807|NCT03501277|25852448|FG001|Intervention Period 3 (4 Days)|Adverse Event|0|||
13098808|NCT03501277|25852449|FG002|Intervention Period 3 (4 Days)|Adverse Event|0|||
13098809|NCT03501277|25852450|FG003|Intervention Period 3 (4 Days)|Adverse Event|1|||
13098810|NCT03500692|25852457|FG000|Overall Study|Death|76|||
13098811|NCT03500692|25852457|FG000|Overall Study|Missed visit|30|||
13098812|NCT03500692|25852457|FG000|Overall Study|Termination Reasons|3|||
13098813|NCT03500679|25852510|FG000|Overall Study|Lost to Follow-up|6|||
13098814|NCT03500679|25852511|FG001|Overall Study|Lost to Follow-up|3|||
13098815|NCT03500679|25852510|FG000|Overall Study|Withdrawal by Subject|3|||
13098816|NCT03500679|25852511|FG001|Overall Study|Withdrawal by Subject|0|||
13098817|NCT03500419|25852534|FG000|Overall Study|Withdrawal by Subject|2|||
13098818|NCT03500419|25852535|FG001|Overall Study|Withdrawal by Subject|25|||
13098819|NCT03500341|25852541|FG000|Overall Study|Withdrawn prior to Completion|2|||
13098820|NCT03500224|25852580|FG000|Overall Study|Withdrawal by Subject|2|||
13098821|NCT03500211|25852601|FG000|Overall Study|Withdrawal by Subject|1|||
13098822|NCT03500211|25852602|FG001|Overall Study|Withdrawal by Subject|1|||
13151000|NCT02552212|26048471|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
13151001|NCT02552212|26048469|FG000|SFE Period (Week 52 - 156)|Adverse Event|0|||
13151002|NCT02552212|26048470|FG001|SFE Period (Week 52 - 156)|Adverse Event|0|||
13151003|NCT02552212|26048471|FG002|SFE Period (Week 52 - 156)|Adverse Event|5|||
13151004|NCT02552212|26048469|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
13151005|NCT02552212|26048470|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
13151006|NCT02552212|26048471|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4|||
13151007|NCT02552212|26048469|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
13151008|NCT02552212|26048470|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
13151009|NCT02552212|26048471|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2|||
13098823|NCT03500198|25852623|FG000|Overall Study|Lost to Follow-up|0|||
13098824|NCT03500198|25852624|FG001|Overall Study|Lost to Follow-up|1|||
13098825|NCT03500159|25852637|FG000|Overall Study|Study Terminated|2|||
13098826|NCT03500159|25852638|FG001|Overall Study|Study Terminated|1|||
13098827|NCT03500094|25852657|FG000|Overall Study|Withdrawal by Subject|1|||
13098828|NCT03500094|25852657|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1|||
13098829|NCT03500094|25852657|FG000|Overall Study|Lost to Follow-up|1|||
13098830|NCT03499873|25852675|FG000|Overall Study|Withdrawal by Subject|4|||
13098831|NCT03499873|25852676|FG001|Overall Study|Withdrawal by Subject|6|||
13098832|NCT03499873|25852677|FG002|Overall Study|Withdrawal by Subject|1|||
13098833|NCT03499873|25852675|FG000|Overall Study|Subjects condition worsened|0|||
13098834|NCT03499873|25852676|FG001|Overall Study|Subjects condition worsened|3|||
13098835|NCT03499873|25852677|FG002|Overall Study|Subjects condition worsened|11|||
13098836|NCT03499873|25852675|FG000|Overall Study|Adverse Event|8|||
13098837|NCT03499873|25852676|FG001|Overall Study|Adverse Event|3|||
13098838|NCT03499873|25852677|FG002|Overall Study|Adverse Event|6|||
13098839|NCT03499873|25852675|FG000|Overall Study|Physician Decision|1|||
13098840|NCT03499873|25852676|FG001|Overall Study|Physician Decision|0|||
13098841|NCT03499873|25852677|FG002|Overall Study|Physician Decision|0|||
13098842|NCT03499873|25852675|FG000|Overall Study|Administrative reasons|0|||
13098843|NCT03499873|25852676|FG001|Overall Study|Administrative reasons|1|||
13098844|NCT03499873|25852677|FG002|Overall Study|Administrative reasons|0|||
13098845|NCT03499873|25852675|FG000|Overall Study|Concomitant therapy|5|||
13098846|NCT03499873|25852676|FG001|Overall Study|Concomitant therapy|4|||
13098847|NCT03499873|25852677|FG002|Overall Study|Concomitant therapy|7|||
13098848|NCT03499873|25852675|FG000|Overall Study|Miscellaneous|1|||
13098849|NCT03499873|25852676|FG001|Overall Study|Miscellaneous|2|||
13098850|NCT03499873|25852677|FG002|Overall Study|Miscellaneous|2|||
13098851|NCT03499873|25852675|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
13098852|NCT03499873|25852676|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
13098853|NCT03499873|25852677|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0|||
13098854|NCT03499353|25852742|FG000|Treatment|Adverse Event|3|||
13098855|NCT03499353|25852742|FG000|Treatment|Progressive Disease|10|||
13098856|NCT03499353|25852742|FG000|Treatment|Other|1|||
13098857|NCT03499353|25852742|FG000|Treatment|Withdrawal by Subject|2|||
13098858|NCT03499353|25852742|FG000|Long-Term Follow-up|Death|2|||
13098859|NCT03499353|25852742|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55|||
13098860|NCT03499353|25852742|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
13098861|NCT03499067|25852785|FG000|First Intervention|Physician Decision|2|||
13098862|NCT03499067|25852786|FG001|First Intervention|Physician Decision|1|||
13098863|NCT03499067|25852785|FG000|First Intervention|Withdrawal by Subject|3|||
13098864|NCT03499067|25852786|FG001|First Intervention|Withdrawal by Subject|6|||
13098865|NCT03499028|25852817|FG000|Overall Study|Lost to Follow-up|12|||
13098866|NCT03499028|25852818|FG001|Overall Study|Lost to Follow-up|9|||
13098867|NCT03499028|25852817|FG000|Overall Study|Withdrawal by Subject|5|||
13098868|NCT03499028|25852818|FG001|Overall Study|Withdrawal by Subject|8|||
13098869|NCT03499028|25852817|FG000|Overall Study|Unplanned SNF discharge|5|||
13098870|NCT03499028|25852818|FG001|Overall Study|Unplanned SNF discharge|8|||
13098871|NCT03498560|25852825|FG000|Overall Study|Found Ineligible|2|||
13098872|NCT03498560|25852825|FG000|Overall Study|Withdrawal by Subject|14|||
13098873|NCT03498560|25852825|FG000|Overall Study|Lost to Follow-up|4|||
13098874|NCT03498560|25852825|FG000|Overall Study|Death|1|||
13098875|NCT03498313|25852852|FG000|Experimental Period 1|Adverse Event|1|||
13098876|NCT03498313|25852853|FG001|Experimental Period 1|Adverse Event|0|||
13098877|NCT03498313|25852854|FG002|Experimental Period 1|Adverse Event|0|||
13098878|NCT03498313|25852855|FG003|Experimental Period 1|Adverse Event|1|||
13098879|NCT03498313|25852856|FG004|Experimental Period 1|Adverse Event|0|||
13098880|NCT03498313|25852857|FG005|Experimental Period 1|Adverse Event|0|||
13098881|NCT03498313|25852852|FG000|Experimental Period 1|Withdrawal by Subject|0|||
13098882|NCT03498313|25852853|FG001|Experimental Period 1|Withdrawal by Subject|1|||
13098883|NCT03498313|25852854|FG002|Experimental Period 1|Withdrawal by Subject|0|||
13098884|NCT03498313|25852855|FG003|Experimental Period 1|Withdrawal by Subject|0|||
13098885|NCT03498313|25852856|FG004|Experimental Period 1|Withdrawal by Subject|0|||
13098886|NCT03498313|25852857|FG005|Experimental Period 1|Withdrawal by Subject|0|||
13098887|NCT03498313|25852852|FG000|Washout Period 1|Anovulation|1|||
13098888|NCT03498313|25852853|FG001|Washout Period 1|Anovulation|0|||
13098889|NCT03498313|25852854|FG002|Washout Period 1|Anovulation|0|||
13098890|NCT03498313|25852855|FG003|Washout Period 1|Anovulation|0|||
13098891|NCT03498313|25852856|FG004|Washout Period 1|Anovulation|0|||
13098892|NCT03498313|25852857|FG005|Washout Period 1|Anovulation|0|||
13098893|NCT03498313|25852852|FG000|Washout Period 1|Withdrawal by Subject|0|||
13098894|NCT03498313|25852853|FG001|Washout Period 1|Withdrawal by Subject|3|||
13098895|NCT03498313|25852854|FG002|Washout Period 1|Withdrawal by Subject|0|||
13098896|NCT03498313|25852855|FG003|Washout Period 1|Withdrawal by Subject|1|||
13098897|NCT03498313|25852856|FG004|Washout Period 1|Withdrawal by Subject|0|||
13098898|NCT03498313|25852857|FG005|Washout Period 1|Withdrawal by Subject|1|||
13222668|NCT01803737|26286704|FG001|Overall Study|Lost to Follow-up|2|||
13222669|NCT01803711|26286727|FG000|Overall Study|Adverse Event|1|||
13222670|NCT01803711|26286728|FG001|Overall Study|Adverse Event|1|||
13222671|NCT01803646|26286745|FG000|Overall Study|Protocol Violation|1|||
13222672|NCT01803646|26286746|FG001|Overall Study|Protocol Violation|0|||
13222673|NCT01803646|26286745|FG000|Overall Study|Adverse Event|1|||
13222674|NCT01803646|26286746|FG001|Overall Study|Adverse Event|1|||
13222675|NCT01803646|26286745|FG000|Overall Study|Withdrawal by Subject|9|||
13222676|NCT01803646|26286746|FG001|Overall Study|Withdrawal by Subject|6|||
13098899|NCT03498313|25852852|FG000|Experimental Period 2|Adverse Event|0|||
13098900|NCT03498313|25852853|FG001|Experimental Period 2|Adverse Event|0|||
13098901|NCT03498313|25852854|FG002|Experimental Period 2|Adverse Event|0|||
13098902|NCT03498313|25852855|FG003|Experimental Period 2|Adverse Event|0|||
13098903|NCT03498313|25852856|FG004|Experimental Period 2|Adverse Event|1|||
13098904|NCT03498313|25852857|FG005|Experimental Period 2|Adverse Event|2|||
13098905|NCT03498313|25852852|FG000|Washout Period 2|Physician Decision|1|||
13098906|NCT03498313|25852853|FG001|Washout Period 2|Physician Decision|0|||
13098907|NCT03498313|25852854|FG002|Washout Period 2|Physician Decision|0|||
13098908|NCT03498313|25852855|FG003|Washout Period 2|Physician Decision|1|||
13098909|NCT03498313|25852856|FG004|Washout Period 2|Physician Decision|0|||
13098910|NCT03498313|25852857|FG005|Washout Period 2|Physician Decision|1|||
13098911|NCT03498313|25852852|FG000|Washout Period 2|Withdrawal by Subject|3|||
13098912|NCT03498313|25852853|FG001|Washout Period 2|Withdrawal by Subject|2|||
13098913|NCT03498313|25852854|FG002|Washout Period 2|Withdrawal by Subject|0|||
13098914|NCT03498313|25852855|FG003|Washout Period 2|Withdrawal by Subject|0|||
13222677|NCT01803646|26286745|FG000|Overall Study|Randomization error|1|||
13098915|NCT03498313|25852856|FG004|Washout Period 2|Withdrawal by Subject|2|||
13098916|NCT03498313|25852857|FG005|Washout Period 2|Withdrawal by Subject|0|||
13098917|NCT03498313|25852852|FG000|Washout Period 2|Anovulation|0|||
13098918|NCT03498313|25852853|FG001|Washout Period 2|Anovulation|0|||
13098919|NCT03498313|25852854|FG002|Washout Period 2|Anovulation|0|||
13098920|NCT03498313|25852855|FG003|Washout Period 2|Anovulation|0|||
13098921|NCT03498313|25852856|FG004|Washout Period 2|Anovulation|0|||
13098922|NCT03498313|25852857|FG005|Washout Period 2|Anovulation|1|||
13098923|NCT03498287|25852872|FG000|Overall Study|Withdrawal by Subject|3|||
13098924|NCT03498287|25852873|FG001|Overall Study|Withdrawal by Subject|0|||
13098925|NCT03498287|25852872|FG000|Overall Study|Protocol Violation|0|||
13098926|NCT03498287|25852873|FG001|Overall Study|Protocol Violation|4|||
13098927|NCT03498287|25852872|FG000|Overall Study|Adverse Event|0|||
13098928|NCT03498287|25852873|FG001|Overall Study|Adverse Event|1|||
13098929|NCT03497429|25852900|FG000|Overall Study|Progressive disease|3|||
13098930|NCT03497429|25852901|FG001|Overall Study|Progressive disease|4|||
13098931|NCT03497429|25852900|FG000|Overall Study|Adverse Event|0|||
13098932|NCT03497429|25852901|FG001|Overall Study|Adverse Event|2|||
13098933|NCT03497130|25852918|FG000|Overall Study|Lost to Follow-up|1|||
13098934|NCT03497130|25852919|FG001|Overall Study|Lost to Follow-up|1|||
13098935|NCT03497039|25852938|FG000|Overall Study|Withdrawal by Subject|1|||
13098936|NCT03497039|25852939|FG001|Overall Study|Withdrawal by Subject|0|||
13098937|NCT03497039|25852938|FG000|Overall Study|Protocol Violation|0|||
13098938|NCT03497039|25852939|FG001|Overall Study|Protocol Violation|1|||
13098939|NCT03496298|25852962|FG000|Overall Study|Adverse Event|49|||
13098940|NCT03496298|25852963|FG001|Overall Study|Adverse Event|68|||
13098941|NCT03496298|25852964|FG002|Overall Study|Adverse Event|79|||
13098942|NCT03496298|25852962|FG000|Overall Study|Study terminated by Sponsor|1050|||
13098943|NCT03496298|25852963|FG001|Overall Study|Study terminated by Sponsor|1063|||
13098944|NCT03496298|25852964|FG002|Overall Study|Study terminated by Sponsor|1071|||
13098945|NCT03496298|25852962|FG000|Overall Study|Physician decision (other than Adverse event)|12|||
13098946|NCT03496298|25852963|FG001|Overall Study|Physician decision (other than Adverse event)|17|||
13098947|NCT03496298|25852964|FG002|Overall Study|Physician decision (other than Adverse event)|10|||
13098948|NCT03496298|25852962|FG000|Overall Study|Withdrawal by Subject|176|||
13098949|NCT03496298|25852963|FG001|Overall Study|Withdrawal by Subject|154|||
13098950|NCT03496298|25852964|FG002|Overall Study|Withdrawal by Subject|151|||
13098951|NCT03496298|25852962|FG000|Overall Study|Other|29|||
13098952|NCT03496298|25852963|FG001|Overall Study|Other|20|||
13098953|NCT03496298|25852964|FG002|Overall Study|Other|23|||
13098954|NCT03496298|25852962|FG000|Overall Study|Randomized and not treated|1|||
13098955|NCT03496298|25852963|FG001|Overall Study|Randomized and not treated|1|||
13098956|NCT03496298|25852964|FG002|Overall Study|Randomized and not treated|1|||
13098957|NCT03495908|25852989|FG000|Overall Study|Withdrawal by Subject|3|||
13098958|NCT03495908|25852990|FG001|Overall Study|Withdrawal by Subject|1|||
13098959|NCT03495908|25852989|FG000|Overall Study|Lost to Follow-up|1|||
13098960|NCT03495908|25852990|FG001|Overall Study|Lost to Follow-up|4|||
13098961|NCT03495908|25852989|FG000|Overall Study|Adverse Event|0|||
13098962|NCT03495908|25852990|FG001|Overall Study|Adverse Event|2|||
13098963|NCT03495908|25852989|FG000|Overall Study|Death|1|||
13098964|NCT03495908|25852990|FG001|Overall Study|Death|0|||
13098965|NCT03495908|25852989|FG000|Overall Study|Physician Decision|5|||
13098966|NCT03495908|25852990|FG001|Overall Study|Physician Decision|4|||
13098967|NCT03495908|25852989|FG000|Overall Study|No documented reason|0|||
13098968|NCT03495908|25852990|FG001|Overall Study|No documented reason|2|||
13098969|NCT03495869|25853021|FG000|Overall Study|Lost to Follow-up|4|||
13098970|NCT03495869|25853022|FG001|Overall Study|Lost to Follow-up|17|||
13098971|NCT03495869|25853023|FG002|Overall Study|Lost to Follow-up|8|||
13098972|NCT03495869|25853024|FG003|Overall Study|Lost to Follow-up|14|||
13098973|NCT03495869|25853021|FG000|Overall Study|Withdrawal by Subject|0|||
13098974|NCT03495869|25853022|FG001|Overall Study|Withdrawal by Subject|3|||
13098975|NCT03495869|25853023|FG002|Overall Study|Withdrawal by Subject|0|||
13098976|NCT03495869|25853024|FG003|Overall Study|Withdrawal by Subject|3|||
13098977|NCT03495869|25853021|FG000|Overall Study|Dropped from study|0|||
13098978|NCT03495869|25853022|FG001|Overall Study|Dropped from study|7|||
13098979|NCT03495869|25853023|FG002|Overall Study|Dropped from study|2|||
13098980|NCT03495869|25853024|FG003|Overall Study|Dropped from study|4|||
13098981|NCT03495817|25853041|FG000|26 Week Open Label|Adverse Event|3|||
13098982|NCT03495817|25853041|FG000|26 Week Open Label|Withdrawal by Subject|4|||
13098983|NCT03495817|25853041|FG000|26 Week Open Label|Lost to Follow-up|1|||
13098984|NCT03495817|25853041|FG000|26 Week Extension|Lost to Follow-up|2|||
13098985|NCT03495453|25853058|FG000|Overall Study|Withdrawal by Subject|0|||
13098986|NCT03495453|25853059|FG001|Overall Study|Withdrawal by Subject|1|||
13098987|NCT03495154|25853070|FG000|Overall Study|Screen Failures Pre-Operatively|3|||
13098988|NCT03495154|25853070|FG000|Overall Study|Withdrawn Prior to Surgery|11|||
13098989|NCT03495154|25853070|FG000|Overall Study|Screen Failures During Surgery|6|||
13098990|NCT03495154|25853070|FG000|Overall Study|Death|2|||
13098991|NCT03495154|25853070|FG000|Overall Study|Lost to Follow-up|6|||
13098992|NCT03495154|25853070|FG000|Overall Study|Protocol Violation|1|||
13098993|NCT03495154|25853070|FG000|Overall Study|Withdrawal by Subject|1|||
13098994|NCT03495102|25853106|FG000|Overall Study|Adverse Event|5|||
13098995|NCT03495102|25853107|FG001|Overall Study|Adverse Event|7|||
13098996|NCT03495102|25853108|FG002|Overall Study|Adverse Event|10|||
13098997|NCT03495102|25853106|FG000|Overall Study|Death|3|||
13098998|NCT03495102|25853107|FG001|Overall Study|Death|4|||
13098999|NCT03495102|25853108|FG002|Overall Study|Death|4|||
13099000|NCT03495102|25853106|FG000|Overall Study|Lost to Follow-up|15|||
13099001|NCT03495102|25853107|FG001|Overall Study|Lost to Follow-up|16|||
13099002|NCT03495102|25853108|FG002|Overall Study|Lost to Follow-up|17|||
13099003|NCT03495102|25853106|FG000|Overall Study|Physician Decision|2|||
13099004|NCT03495102|25853107|FG001|Overall Study|Physician Decision|0|||
13099005|NCT03495102|25853108|FG002|Overall Study|Physician Decision|2|||
13099006|NCT03495102|25853106|FG000|Overall Study|Withdrawal by Subject|25|||
13099007|NCT03495102|25853107|FG001|Overall Study|Withdrawal by Subject|36|||
13099008|NCT03495102|25853108|FG002|Overall Study|Withdrawal by Subject|18|||
13099009|NCT03495102|25853106|FG000|Overall Study|Protocol Violation|1|||
13099010|NCT03495102|25853107|FG001|Overall Study|Protocol Violation|1|||
13099011|NCT03495102|25853108|FG002|Overall Study|Protocol Violation|0|||
13099012|NCT03495102|25853106|FG000|Overall Study|Site Closure|3|||
13099013|NCT03495102|25853107|FG001|Overall Study|Site Closure|1|||
13099014|NCT03495102|25853108|FG002|Overall Study|Site Closure|2|||
13151010|NCT02552212|26048469|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
13151011|NCT02552212|26048470|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
13151012|NCT02552212|26048471|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18|||
13151013|NCT02552212|26048469|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
13151014|NCT02552212|26048470|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
13151015|NCT02552212|26048471|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1|||
13151016|NCT02552212|26048469|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
13151017|NCT02552212|26048470|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
13151018|NCT02552212|26048471|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1|||
13099015|NCT03495102|25853106|FG000|Overall Study|Non-compliance|1|||
13099016|NCT03495102|25853107|FG001|Overall Study|Non-compliance|0|||
13099017|NCT03495102|25853108|FG002|Overall Study|Non-compliance|0|||
13099018|NCT03495102|25853106|FG000|Overall Study|Participant Duplicated at Another Site|0|||
13099019|NCT03495102|25853107|FG001|Overall Study|Participant Duplicated at Another Site|0|||
13099020|NCT03495102|25853108|FG002|Overall Study|Participant Duplicated at Another Site|1|||
13099021|NCT03495102|25853106|FG000|Overall Study|Primary Care Physician Recommendation|0|||
13099022|NCT03495102|25853107|FG001|Overall Study|Primary Care Physician Recommendation|1|||
13099023|NCT03495102|25853108|FG002|Overall Study|Primary Care Physician Recommendation|0|||
13099024|NCT03495102|25853106|FG000|Overall Study|Relocated to Another Country|0|||
13099025|NCT03495102|25853107|FG001|Overall Study|Relocated to Another Country|1|||
13099026|NCT03495102|25853108|FG002|Overall Study|Relocated to Another Country|0|||
13099027|NCT03495102|25853106|FG000|Overall Study|Participant was in Rehabilitation|1|||
13099028|NCT03495102|25853107|FG001|Overall Study|Participant was in Rehabilitation|0|||
13099029|NCT03495102|25853108|FG002|Overall Study|Participant was in Rehabilitation|0|||
13099030|NCT03494985|25853155|FG000|Overall Study|Adverse Event|3|||
13099031|NCT03494985|25853156|FG001|Overall Study|Adverse Event|2|||
13099032|NCT03494985|25853157|FG002|Overall Study|Adverse Event|3|||
13099033|NCT03494985|25853158|FG003|Overall Study|Adverse Event|0|||
13099034|NCT03494985|25853155|FG000|Overall Study|Other (Withdrawal of consent)|2|||
13099035|NCT03494985|25853156|FG001|Overall Study|Other (Withdrawal of consent)|3|||
13099036|NCT03494985|25853157|FG002|Overall Study|Other (Withdrawal of consent)|2|||
13099037|NCT03494985|25853158|FG003|Overall Study|Other (Withdrawal of consent)|5|||
13099038|NCT03494985|25853155|FG000|Overall Study|Other (Not specified)|0|||
13099039|NCT03494985|25853156|FG001|Overall Study|Other (Not specified)|1|||
13099040|NCT03494985|25853157|FG002|Overall Study|Other (Not specified)|1|||
13099041|NCT03494985|25853158|FG003|Overall Study|Other (Not specified)|0|||
13099042|NCT03494816|25853168|FG000|Overall Study|Protocol Violation|2|||
13099043|NCT03494816|25853168|FG000|Overall Study|Physician Decision|2|||
13099044|NCT03494816|25853168|FG000|Overall Study|Did not start trial treatment|1|||
13099045|NCT03494816|25853168|FG000|Overall Study|Adverse Event|1|||
13099046|NCT03494725|25853245|FG000|Overall Study|Withdrawal by Subject|0|||
13099047|NCT03494725|25853246|FG001|Overall Study|Withdrawal by Subject|2|||
13099048|NCT03494725|25853245|FG000|Overall Study|Antibiotic use|1|||
13099049|NCT03494725|25853246|FG001|Overall Study|Antibiotic use|0|||
13099050|NCT03493698|25853271|FG000|Treatment Period C|Adverse Event|1|||
13099051|NCT03493698|25853271|FG000|Treatment Period C|Withdrawal by Subject|1|||
13099052|NCT03493542|25853300|FG000|Overall Study|Ongoing|2|||
13099053|NCT03493542|25853301|FG001|Overall Study|Ongoing|3|||
13099054|NCT03493542|25853300|FG000|Overall Study|Withdrawal by parent or guardian|3|||
13099055|NCT03493542|25853301|FG001|Overall Study|Withdrawal by parent or guardian|0|||
13099056|NCT03493542|25853300|FG000|Overall Study|Withdrawal by Subject|2|||
13099057|NCT03493542|25853301|FG001|Overall Study|Withdrawal by Subject|6|||
13099058|NCT03493451|25853345|FG000|Overall Study|Death|11|||
13099059|NCT03493451|25853346|FG001|Overall Study|Death|26|||
13099060|NCT03493451|25853347|FG002|Overall Study|Death|3|||
13099061|NCT03493451|25853345|FG000|Overall Study|Lost to Follow-up|1|||
13099062|NCT03493451|25853346|FG001|Overall Study|Lost to Follow-up|4|||
13099063|NCT03493451|25853347|FG002|Overall Study|Lost to Follow-up|1|||
13099064|NCT03493451|25853345|FG000|Overall Study|Withdrawal by Subject|1|||
13099065|NCT03493451|25853346|FG001|Overall Study|Withdrawal by Subject|1|||
13099066|NCT03493451|25853347|FG002|Overall Study|Withdrawal by Subject|2|||
13099067|NCT03493451|25853345|FG000|Overall Study|Progressive Disease|1|||
13099068|NCT03493451|25853346|FG001|Overall Study|Progressive Disease|0|||
13099069|NCT03493451|25853347|FG002|Overall Study|Progressive Disease|0|||
13099070|NCT03493451|25853345|FG000|Overall Study|Transferred to long term extension study|8|||
13099071|NCT03493451|25853346|FG001|Overall Study|Transferred to long term extension study|13|||
13099072|NCT03493451|25853347|FG002|Overall Study|Transferred to long term extension study|5|||
13099073|NCT03493386|25853474|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
13099074|NCT03493386|25853475|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
13099075|NCT03493386|25853476|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
13099076|NCT03493386|25853477|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
13099077|NCT03492554|25853496|FG000|Overall Study|Protocol Violation|0|||
13099078|NCT03492554|25853497|FG001|Overall Study|Protocol Violation|14|||
13132878|NCT02781844|25985670|FG005|Treatment Period 1|Adverse Event|1|||
13132879|NCT02781844|25985671|FG006|Treatment Period 1|Adverse Event|0|||
13132880|NCT02781844|25985672|FG007|Treatment Period 1|Adverse Event|0|||
13132881|NCT02781818|25985696|FG000|Overall Study|Lost to Follow-up|4|||
13132882|NCT02781818|25985697|FG001|Overall Study|Lost to Follow-up|2|||
13132883|NCT02781818|25985698|FG002|Overall Study|Lost to Follow-up|1|||
13132884|NCT02781584|25985792|FG000|Pre-treatment Phase|Investigator's Discretion|0|||
13151019|NCT02552212|26048469|FG000|SFE Period (Week 52 - 156)|Investigator decision|0|||
13151020|NCT02552212|26048470|FG001|SFE Period (Week 52 - 156)|Investigator decision|0|||
13151021|NCT02552212|26048471|FG002|SFE Period (Week 52 - 156)|Investigator decision|1|||
13151022|NCT02552212|26048469|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
13151023|NCT02552212|26048470|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
13151024|NCT02552212|26048471|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1|||
13151025|NCT02552212|26048469|FG000|SFE Period (Week 52 - 156)|Compassionate access|0|||
13151026|NCT02552212|26048470|FG001|SFE Period (Week 52 - 156)|Compassionate access|0|||
13151027|NCT02552212|26048471|FG002|SFE Period (Week 52 - 156)|Compassionate access|2|||
13151028|NCT02552212|26048469|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
13151029|NCT02552212|26048470|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
13151030|NCT02552212|26048471|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1|||
13151031|NCT02552212|26048469|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0|||
13151032|NCT02552212|26048470|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0|||
13151033|NCT02552212|26048471|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1|||
13151034|NCT02552147|26048500|FG000|First Intervention (7 Days)|Protocol Violation|1|||
13151035|NCT02552147|26048501|FG001|First Intervention (7 Days)|Protocol Violation|0|||
13151036|NCT02552147|26048500|FG000|Second Intervention (7 Days)|Protocol Violation|2|||
13151037|NCT02552147|26048501|FG001|Second Intervention (7 Days)|Protocol Violation|0|||
13151038|NCT02552121|26048769|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2|||
13151039|NCT02552121|26048770|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
13151040|NCT02552121|26048771|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
13151041|NCT02552121|26048772|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
13151042|NCT02552121|26048773|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
13151043|NCT02552121|26048774|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
13151044|NCT02552121|26048775|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
13151045|NCT02552121|26048776|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
13151046|NCT02552121|26048769|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1|||
13132885|NCT02781584|25985793|FG001|Pre-treatment Phase|Investigator's Discretion|0|||
13132886|NCT02781584|25985794|FG002|Pre-treatment Phase|Investigator's Discretion|0|||
13132887|NCT02781584|25985795|FG003|Pre-treatment Phase|Investigator's Discretion|0|||
13132888|NCT02781584|25985796|FG004|Pre-treatment Phase|Investigator's Discretion|0|||
13132889|NCT02781584|25985797|FG005|Pre-treatment Phase|Investigator's Discretion|0|||
13132890|NCT02781584|25985798|FG006|Pre-treatment Phase|Investigator's Discretion|0|||
13132891|NCT02781584|25985799|FG007|Pre-treatment Phase|Investigator's Discretion|0|||
13132892|NCT02781584|25985800|FG008|Pre-treatment Phase|Investigator's Discretion|0|||
13132893|NCT02781584|25985801|FG009|Pre-treatment Phase|Investigator's Discretion|0|||
13132894|NCT02781584|25985802|FG010|Pre-treatment Phase|Investigator's Discretion|0|||
13132895|NCT02781584|25985803|FG011|Pre-treatment Phase|Investigator's Discretion|2|||
13132896|NCT02781584|25985804|FG012|Pre-treatment Phase|Investigator's Discretion|1|||
13132897|NCT02781584|25985792|FG000|Pre-treatment Phase|Adverse Event|0|||
13132898|NCT02781584|25985793|FG001|Pre-treatment Phase|Adverse Event|0|||
13132899|NCT02781584|25985794|FG002|Pre-treatment Phase|Adverse Event|0|||
13099079|NCT03492281|25853557|FG000|Overall Study|Withdrawal by Subject|21|||
13099080|NCT03492281|25853558|FG001|Overall Study|Withdrawal by Subject|14|||
13099081|NCT03492281|25853559|FG002|Overall Study|Withdrawal by Subject|13|||
13099082|NCT03492281|25853557|FG000|Overall Study|Lost to Follow-up|14|||
13099083|NCT03492281|25853558|FG001|Overall Study|Lost to Follow-up|15|||
13099084|NCT03492281|25853559|FG002|Overall Study|Lost to Follow-up|10|||
13099085|NCT03492281|25853557|FG000|Overall Study|Adverse Event|6|||
13099086|NCT03492281|25853558|FG001|Overall Study|Adverse Event|8|||
13099087|NCT03492281|25853559|FG002|Overall Study|Adverse Event|13|||
13099088|NCT03492281|25853557|FG000|Overall Study|Lack of Efficacy|3|||
13099089|NCT03492281|25853558|FG001|Overall Study|Lack of Efficacy|0|||
13099090|NCT03492281|25853559|FG002|Overall Study|Lack of Efficacy|1|||
13099091|NCT03492281|25853557|FG000|Overall Study|Physician Decision|1|||
13099092|NCT03492281|25853558|FG001|Overall Study|Physician Decision|0|||
13099093|NCT03492281|25853559|FG002|Overall Study|Physician Decision|3|||
13099094|NCT03492281|25853557|FG000|Overall Study|Protocol Violation|0|||
13099095|NCT03492281|25853558|FG001|Overall Study|Protocol Violation|2|||
13099096|NCT03492281|25853559|FG002|Overall Study|Protocol Violation|1|||
13099097|NCT03492281|25853557|FG000|Overall Study|Withdrawn Due to Sponsor|1|||
13099098|NCT03492281|25853558|FG001|Overall Study|Withdrawn Due to Sponsor|0|||
13099099|NCT03492281|25853559|FG002|Overall Study|Withdrawn Due to Sponsor|1|||
13099100|NCT03492281|25853557|FG000|Overall Study|Death|0|||
13099101|NCT03492281|25853558|FG001|Overall Study|Death|0|||
13099102|NCT03492281|25853559|FG002|Overall Study|Death|1|||
13099103|NCT03492281|25853557|FG000|Overall Study|Captured as Other in Database|8|||
13099104|NCT03492281|25853558|FG001|Overall Study|Captured as Other in Database|6|||
13099105|NCT03492281|25853559|FG002|Overall Study|Captured as Other in Database|3|||
13099106|NCT03491553|25853685|FG000|Main Study (Up to Week 48)|Adverse Event|0|||
13099107|NCT03491553|25853686|FG001|Main Study (Up to Week 48)|Adverse Event|0|||
13099108|NCT03491553|25853687|FG002|Main Study (Up to Week 48)|Adverse Event|0|||
13099109|NCT03491553|25853688|FG003|Main Study (Up to Week 48)|Adverse Event|1|||
13099110|NCT03491553|25853689|FG004|Main Study (Up to Week 48)|Adverse Event|0|||
13099111|NCT03491553|25853690|FG005|Main Study (Up to Week 48)|Adverse Event|0|||
13099112|NCT03491553|25853685|FG000|Main Study (Up to Week 48)|Withdrew Consent|1|||
13099113|NCT03491553|25853686|FG001|Main Study (Up to Week 48)|Withdrew Consent|1|||
13099114|NCT03491553|25853687|FG002|Main Study (Up to Week 48)|Withdrew Consent|0|||
13099115|NCT03491553|25853688|FG003|Main Study (Up to Week 48)|Withdrew Consent|0|||
13099116|NCT03491553|25853689|FG004|Main Study (Up to Week 48)|Withdrew Consent|0|||
13099117|NCT03491553|25853690|FG005|Main Study (Up to Week 48)|Withdrew Consent|0|||
13099118|NCT03491150|25853705|FG000|Overall Study|Adverse Event|1|||
13099119|NCT03491150|25853706|FG001|Overall Study|Adverse Event|0|||
13099120|NCT03491150|25853705|FG000|Overall Study|Study Terminated by Sponsor|74|||
13099121|NCT03491150|25853706|FG001|Overall Study|Study Terminated by Sponsor|70|||
13099122|NCT03491150|25853705|FG000|Overall Study|Other|0|||
13099123|NCT03491150|25853706|FG001|Overall Study|Other|1|||
13099124|NCT03491150|25853705|FG000|Overall Study|Withdrawal by Subject|1|||
13099125|NCT03491150|25853706|FG001|Overall Study|Withdrawal by Subject|2|||
13099126|NCT03490981|25853733|FG000|Overall Study|Lost to Follow-up|1|||
13099127|NCT03490981|25853734|FG001|Overall Study|Lost to Follow-up|2|||
13099128|NCT03490032|25853782|FG000|Overall Study|family issue (child custody)|1|||
13099129|NCT03490032|25853783|FG001|Overall Study|family issue (child custody)|0|||
13099130|NCT03490032|25853784|FG002|Overall Study|family issue (child custody)|0|||
13099131|NCT03489863|25853797|FG000|Overall Study|Withdrawal by Subject|0|||
13099132|NCT03489863|25853798|FG001|Overall Study|Withdrawal by Subject|1|||
13099133|NCT03489720|25853830|FG000|Overall Study|Withdrawal by Subject|2|||
13099134|NCT03489720|25853831|FG001|Overall Study|Withdrawal by Subject|0|||
13099135|NCT03489551|25853837|FG000|Overall Study|Withdrawal by Subject|2|||
13099136|NCT03489369|25853896|FG000|Overall Study|Documented Progressive Disease|3|||
13099137|NCT03489369|25853897|FG001|Overall Study|Documented Progressive Disease|2|||
13099138|NCT03489369|25853898|FG002|Overall Study|Documented Progressive Disease|3|||
13099139|NCT03489369|25853899|FG003|Overall Study|Documented Progressive Disease|6|||
13099140|NCT03489369|25853896|FG000|Overall Study|Clinical Progression (Worsening of Clini|0|||
13099141|NCT03489369|25853897|FG001|Overall Study|Clinical Progression (Worsening of Clini|1|||
13099142|NCT03489369|25853898|FG002|Overall Study|Clinical Progression (Worsening of Clini|0|||
13099143|NCT03489369|25853899|FG003|Overall Study|Clinical Progression (Worsening of Clini|0|||
13099144|NCT03489343|25854014|FG000|Overall Study|Documented progressive disease|1|||
13099145|NCT03489343|25854015|FG001|Overall Study|Documented progressive disease|0|||
13099146|NCT03489343|25854016|FG002|Overall Study|Documented progressive disease|3|||
13099147|NCT03489343|25854017|FG003|Overall Study|Documented progressive disease|1|||
13099148|NCT03489343|25854018|FG004|Overall Study|Documented progressive disease|3|||
13099149|NCT03489343|25854019|FG005|Overall Study|Documented progressive disease|5|||
13099150|NCT03489343|25854020|FG006|Overall Study|Documented progressive disease|4|||
13099151|NCT03489343|25854014|FG000|Overall Study|Adverse Event|0|||
13099152|NCT03489343|25854015|FG001|Overall Study|Adverse Event|1|||
13099153|NCT03489343|25854016|FG002|Overall Study|Adverse Event|0|||
13099154|NCT03489343|25854017|FG003|Overall Study|Adverse Event|0|||
13099155|NCT03489343|25854018|FG004|Overall Study|Adverse Event|0|||
13099156|NCT03489343|25854019|FG005|Overall Study|Adverse Event|1|||
13099157|NCT03489343|25854020|FG006|Overall Study|Adverse Event|0|||
13099158|NCT03489343|25854014|FG000|Overall Study|Withdrawal by Subject|0|||
13099159|NCT03489343|25854015|FG001|Overall Study|Withdrawal by Subject|0|||
13099160|NCT03489343|25854016|FG002|Overall Study|Withdrawal by Subject|0|||
13151047|NCT02552121|26048770|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
13151048|NCT02552121|26048771|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
13151049|NCT02552121|26048772|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
13151050|NCT02552121|26048773|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
13151051|NCT02552121|26048774|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
13151052|NCT02552121|26048775|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
13151053|NCT02552121|26048776|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
13151054|NCT02552121|26048769|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
13151055|NCT02552121|26048770|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1|||
13151056|NCT02552121|26048771|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
13151057|NCT02552121|26048772|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
13151058|NCT02552121|26048773|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
13151059|NCT02552121|26048774|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
13151060|NCT02552121|26048775|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
13151061|NCT02552121|26048776|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
13151062|NCT02552121|26048769|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
13151063|NCT02552121|26048770|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2|||
13151064|NCT02552121|26048771|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
13151065|NCT02552121|26048772|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
13151066|NCT02552121|26048773|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
13151067|NCT02552121|26048774|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
13151068|NCT02552121|26048775|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
13151069|NCT02552121|26048776|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
13151070|NCT02552121|26048769|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
13151071|NCT02552121|26048770|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2|||
13151072|NCT02552121|26048771|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
13151073|NCT02552121|26048772|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
13151074|NCT02552121|26048773|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
13151075|NCT02552121|26048774|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
13151076|NCT02552121|26048775|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
13151077|NCT02552121|26048776|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
13151078|NCT02552121|26048769|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
13222678|NCT01803646|26286746|FG001|Overall Study|Randomization error|2|||
13099161|NCT03489343|25854017|FG003|Overall Study|Withdrawal by Subject|1|||
13099162|NCT03489343|25854018|FG004|Overall Study|Withdrawal by Subject|0|||
13099163|NCT03489343|25854019|FG005|Overall Study|Withdrawal by Subject|1|||
13099164|NCT03489343|25854020|FG006|Overall Study|Withdrawal by Subject|1|||
13099165|NCT03489343|25854014|FG000|Overall Study|Clinical progression|0|||
13099166|NCT03489343|25854015|FG001|Overall Study|Clinical progression|0|||
13099167|NCT03489343|25854016|FG002|Overall Study|Clinical progression|0|||
13099168|NCT03489343|25854017|FG003|Overall Study|Clinical progression|1|||
13099169|NCT03489343|25854018|FG004|Overall Study|Clinical progression|0|||
13099170|NCT03489343|25854019|FG005|Overall Study|Clinical progression|0|||
13099171|NCT03489343|25854020|FG006|Overall Study|Clinical progression|1|||
13099172|NCT03489304|25854028|FG000|Overall Study|Lost to Follow-up|4|||
13099173|NCT03489109|25854055|FG000|Overall Study|Lost to Follow-up|1|||
13099174|NCT03489109|25854056|FG001|Overall Study|Lost to Follow-up|2|||
13099175|NCT03488927|25854077|FG000|Overall Study|Withdrawal by Subject|44|||
13099176|NCT03488927|25854078|FG001|Overall Study|Withdrawal by Subject|118|||
13099177|NCT03488927|25854079|FG002|Overall Study|Withdrawal by Subject|217|||
13099178|NCT03488563|25854124|FG000|Overall Study|Lost to Follow-up|7|||
13099179|NCT03488563|25854125|FG001|Overall Study|Lost to Follow-up|6|||
13099180|NCT03488563|25854126|FG002|Overall Study|Lost to Follow-up|7|||
13099181|NCT03488563|25854124|FG000|Overall Study|Withdrawal by Subject|8|||
13099182|NCT03488563|25854125|FG001|Overall Study|Withdrawal by Subject|7|||
13099183|NCT03488563|25854126|FG002|Overall Study|Withdrawal by Subject|7|||
13099184|NCT03488563|25854124|FG000|Overall Study|Physician Decision|0|||
13099185|NCT03488563|25854125|FG001|Overall Study|Physician Decision|0|||
13099186|NCT03488563|25854126|FG002|Overall Study|Physician Decision|1|||
13099187|NCT03488563|25854124|FG000|Overall Study|Protocol Violation|3|||
13099188|NCT03488563|25854125|FG001|Overall Study|Protocol Violation|2|||
13099189|NCT03488563|25854126|FG002|Overall Study|Protocol Violation|6|||
13099190|NCT03488563|25854124|FG000|Overall Study|Subject did not meet minimum number of migraines per month|1|||
13099191|NCT03488563|25854125|FG001|Overall Study|Subject did not meet minimum number of migraines per month|0|||
13099192|NCT03488563|25854126|FG002|Overall Study|Subject did not meet minimum number of migraines per month|0|||
13099193|NCT03488563|25854124|FG000|Overall Study|Use of prohibited medication|2|||
13099194|NCT03488563|25854125|FG001|Overall Study|Use of prohibited medication|0|||
13099195|NCT03488563|25854126|FG002|Overall Study|Use of prohibited medication|0|||
13099196|NCT03488563|25854124|FG000|Overall Study|Adverse Event|1|||
13099197|NCT03488563|25854125|FG001|Overall Study|Adverse Event|0|||
13099198|NCT03488563|25854126|FG002|Overall Study|Adverse Event|1|||
13099199|NCT03488563|25854124|FG000|Overall Study|Subject returned for ET visit|0|||
13099200|NCT03488563|25854125|FG001|Overall Study|Subject returned for ET visit|1|||
13099201|NCT03488563|25854126|FG002|Overall Study|Subject returned for ET visit|0|||
13099202|NCT03488563|25854124|FG000|Overall Study|Sponsor's decision|0|||
13099203|NCT03488563|25854125|FG001|Overall Study|Sponsor's decision|0|||
13099204|NCT03488563|25854126|FG002|Overall Study|Sponsor's decision|1|||
13099205|NCT03488251|25854193|FG000|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|1|||
13099206|NCT03488251|25854194|FG001|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
13099207|NCT03488251|25854195|FG002|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
13099208|NCT03488251|25854196|FG003|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
13099209|NCT03488251|25854193|FG000|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|1|||
13099210|NCT03488251|25854194|FG001|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
13099211|NCT03488251|25854195|FG002|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
13099212|NCT03488251|25854196|FG003|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
13099213|NCT03488251|25854193|FG000|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|4|||
13099214|NCT03488251|25854194|FG001|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
13099215|NCT03488251|25854195|FG002|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
13151079|NCT02552121|26048770|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1|||
13151080|NCT02552121|26048771|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
13151081|NCT02552121|26048772|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
13151082|NCT02552121|26048773|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
13151083|NCT02552121|26048774|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
13151084|NCT02552121|26048775|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
13151085|NCT02552121|26048776|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
13151086|NCT02552121|26048769|FG000|Part 2: Cohort Expansion|Patient Choice|0|||
13151087|NCT02552121|26048770|FG001|Part 2: Cohort Expansion|Patient Choice|0|||
13151088|NCT02552121|26048771|FG002|Part 2: Cohort Expansion|Patient Choice|1|||
13151089|NCT02552121|26048772|FG003|Part 2: Cohort Expansion|Patient Choice|0|||
13151090|NCT02552121|26048773|FG004|Part 2: Cohort Expansion|Patient Choice|0|||
13151091|NCT02552121|26048774|FG005|Part 2: Cohort Expansion|Patient Choice|0|||
13151092|NCT02552121|26048775|FG006|Part 2: Cohort Expansion|Patient Choice|1|||
13151093|NCT02552121|26048776|FG007|Part 2: Cohort Expansion|Patient Choice|0|||
13151094|NCT02552121|26048769|FG000|Part 2: Cohort Expansion|Disease Progression|0|||
13151095|NCT02552121|26048770|FG001|Part 2: Cohort Expansion|Disease Progression|0|||
13151096|NCT02552121|26048771|FG002|Part 2: Cohort Expansion|Disease Progression|3|||
13151097|NCT02552121|26048772|FG003|Part 2: Cohort Expansion|Disease Progression|2|||
13151098|NCT02552121|26048773|FG004|Part 2: Cohort Expansion|Disease Progression|1|||
13099216|NCT03488251|25854196|FG003|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
13099217|NCT03488251|25854193|FG000|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|1|||
13099218|NCT03488251|25854194|FG001|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
13099219|NCT03488251|25854195|FG002|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
13099220|NCT03488251|25854196|FG003|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
13099221|NCT03488251|25854193|FG000|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|1|||
13099222|NCT03488251|25854194|FG001|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
13099223|NCT03488251|25854195|FG002|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
13099224|NCT03488251|25854196|FG003|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
13099225|NCT03488238|25854204|FG000|Overall Study|Equipment malfunction|1|||
13099226|NCT03488238|25854204|FG000|Overall Study|Adverse Event|1|||
13151099|NCT02552121|26048774|FG005|Part 2: Cohort Expansion|Disease Progression|4|||
13151100|NCT02552121|26048775|FG006|Part 2: Cohort Expansion|Disease Progression|0|||
13151101|NCT02552121|26048776|FG007|Part 2: Cohort Expansion|Disease Progression|3|||
13151102|NCT02552121|26048769|FG000|Part 2: Cohort Expansion|Adverse Event|0|||
13151103|NCT02552121|26048770|FG001|Part 2: Cohort Expansion|Adverse Event|0|||
13151104|NCT02552121|26048771|FG002|Part 2: Cohort Expansion|Adverse Event|6|||
13151105|NCT02552121|26048772|FG003|Part 2: Cohort Expansion|Adverse Event|1|||
13151106|NCT02552121|26048773|FG004|Part 2: Cohort Expansion|Adverse Event|0|||
13151107|NCT02552121|26048774|FG005|Part 2: Cohort Expansion|Adverse Event|0|||
13151108|NCT02552121|26048775|FG006|Part 2: Cohort Expansion|Adverse Event|0|||
13151109|NCT02552121|26048776|FG007|Part 2: Cohort Expansion|Adverse Event|0|||
13151110|NCT02552121|26048769|FG000|Part 2: Cohort Expansion|Death|0|||
13151111|NCT02552121|26048770|FG001|Part 2: Cohort Expansion|Death|0|||
13151112|NCT02552121|26048771|FG002|Part 2: Cohort Expansion|Death|1|||
13151113|NCT02552121|26048772|FG003|Part 2: Cohort Expansion|Death|0|||
13151114|NCT02552121|26048773|FG004|Part 2: Cohort Expansion|Death|0|||
13151115|NCT02552121|26048774|FG005|Part 2: Cohort Expansion|Death|0|||
13151116|NCT02552121|26048775|FG006|Part 2: Cohort Expansion|Death|0|||
13151117|NCT02552121|26048776|FG007|Part 2: Cohort Expansion|Death|0|||
13151118|NCT02551991|26048839|FG000|Overall Study|Death|5|||
13151119|NCT02551991|26048840|FG001|Overall Study|Death|7|||
13151120|NCT02551991|26048841|FG002|Overall Study|Death|8|||
13151121|NCT02551991|26048842|FG003|Overall Study|Death|7|||
13151122|NCT02551991|26048843|FG004|Overall Study|Death|17|||
13151123|NCT02551991|26048839|FG000|Overall Study|Withdrawal by Subject|1|||
13151124|NCT02551991|26048840|FG001|Overall Study|Withdrawal by Subject|0|||
13151125|NCT02551991|26048841|FG002|Overall Study|Withdrawal by Subject|0|||
13151126|NCT02551991|26048842|FG003|Overall Study|Withdrawal by Subject|0|||
13151127|NCT02551991|26048843|FG004|Overall Study|Withdrawal by Subject|2|||
13151128|NCT02551991|26048839|FG000|Overall Study|Lost to Follow-up|0|||
13151129|NCT02551991|26048840|FG001|Overall Study|Lost to Follow-up|0|||
13151130|NCT02551991|26048841|FG002|Overall Study|Lost to Follow-up|1|||
13151131|NCT02551991|26048842|FG003|Overall Study|Lost to Follow-up|0|||
13151132|NCT02551991|26048843|FG004|Overall Study|Lost to Follow-up|0|||
13151133|NCT02551991|26048839|FG000|Overall Study|Sponsor Decision|1|||
13151134|NCT02551991|26048840|FG001|Overall Study|Sponsor Decision|0|||
13151135|NCT02551991|26048841|FG002|Overall Study|Sponsor Decision|1|||
13151136|NCT02551991|26048842|FG003|Overall Study|Sponsor Decision|0|||
13151137|NCT02551991|26048843|FG004|Overall Study|Sponsor Decision|5|||
13151138|NCT02551991|26048839|FG000|Overall Study|Other|0|||
13151139|NCT02551991|26048840|FG001|Overall Study|Other|0|||
13151140|NCT02551991|26048841|FG002|Overall Study|Other|0|||
13151141|NCT02551991|26048842|FG003|Overall Study|Other|0|||
13151142|NCT02551991|26048843|FG004|Overall Study|Other|1|||
13151143|NCT02551874|26048866|FG000|Overall Study|Lost to Follow-up|0|||
13151144|NCT02551874|26048867|FG001|Overall Study|Lost to Follow-up|2|||
13151145|NCT02551874|26048866|FG000|Overall Study|Pregnancy|0|||
13151146|NCT02551874|26048867|FG001|Overall Study|Pregnancy|1|||
13151147|NCT02551874|26048866|FG000|Overall Study|Reason not reported|10|||
13151148|NCT02551874|26048867|FG001|Overall Study|Reason not reported|4|||
13151149|NCT02551874|26048866|FG000|Overall Study|Did not receive randomized treatment|0|||
13151150|NCT02551874|26048867|FG001|Overall Study|Did not receive randomized treatment|7|||
13151151|NCT02551874|26048866|FG000|Overall Study|Did not enter long-term study|18|||
13151152|NCT02551874|26048867|FG001|Overall Study|Did not enter long-term study|25|||
13099227|NCT03488225|25854214|FG000|Overall Study|Off Protocol Therapy|2|||
13099228|NCT03488225|25854214|FG000|Overall Study|Stem Cell Transplant|2|||
13099229|NCT03488108|25854237|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
13099230|NCT03488108|25854238|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
13099231|NCT03488108|25854237|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
13099232|NCT03488108|25854238|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
13099233|NCT03487848|25854252|FG000|Overall Study|Lost to Follow-up|1|||
13099234|NCT03487549|25854284|FG000|Overall Study|Protocol Violation|0|||
13099235|NCT03487549|25854285|FG001|Overall Study|Protocol Violation|1|||
13099236|NCT03487549|25854284|FG000|Overall Study|Lost to Follow-up|2|||
13099237|NCT03487549|25854285|FG001|Overall Study|Lost to Follow-up|1|||
13099238|NCT03487549|25854284|FG000|Overall Study|Withdrawal by Subject|2|||
13151153|NCT02551731|26048886|FG000|Overall Study|Withdrawal by Subject|2|||
13151154|NCT02551692|26048910|FG000|Overall Study|Lost to Follow-up|0|||
13151155|NCT02551692|26048911|FG001|Overall Study|Lost to Follow-up|1|||
13151156|NCT02551692|26048912|FG002|Overall Study|Lost to Follow-up|4|||
13151157|NCT02551692|26048910|FG000|Overall Study|Withdrawal by Subject|1|||
13151158|NCT02551692|26048911|FG001|Overall Study|Withdrawal by Subject|0|||
13151159|NCT02551692|26048912|FG002|Overall Study|Withdrawal by Subject|1|||
13151160|NCT02551666|26048945|FG000|Overall Study|Withdrawal by Subject|1|||
13151161|NCT02551666|26048946|FG001|Overall Study|Withdrawal by Subject|3|||
13151162|NCT02551159|26049000|FG000|Overall Study|Death|352|||
13151163|NCT02551159|26049001|FG001|Overall Study|Death|174|||
13099239|NCT03487549|25854285|FG001|Overall Study|Withdrawal by Subject|0|||
13099240|NCT03487445|25854310|FG000|Randomization|Not treated for administrative reasons|1|||
13099241|NCT03487445|25854311|FG001|Randomization|Not treated for administrative reasons|0|||
13099242|NCT03486899|25854370|FG000|Overall Study|Lost to Follow-up|4|||
13099243|NCT03486899|25854371|FG001|Overall Study|Lost to Follow-up|1|||
13151164|NCT02551159|26049002|FG002|Overall Study|Death|161|||
13151165|NCT02551159|26049000|FG000|Overall Study|Withdrawal by Subject|8|||
13151166|NCT02551159|26049001|FG001|Overall Study|Withdrawal by Subject|5|||
13151167|NCT02551159|26049002|FG002|Overall Study|Withdrawal by Subject|16|||
13151168|NCT02551159|26049000|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53|||
13099244|NCT03486899|25854372|FG002|Overall Study|Lost to Follow-up|4|||
13099245|NCT03486899|25854373|FG003|Overall Study|Lost to Follow-up|3|||
13151169|NCT02551159|26049001|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25|||
13151170|NCT02551159|26049002|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29|||
13151171|NCT02551055|26049098|FG000|Overall Study|Death|2|||
13151172|NCT02551055|26049099|FG001|Overall Study|Death|4|||
13151173|NCT02551055|26049100|FG002|Overall Study|Death|2|||
13099246|NCT03486899|25854370|FG000|Overall Study|Death|1|||
13099247|NCT03486899|25854371|FG001|Overall Study|Death|0|||
13099248|NCT03486899|25854372|FG002|Overall Study|Death|0|||
13099249|NCT03486899|25854373|FG003|Overall Study|Death|1|||
13099250|NCT03486899|25854370|FG000|Overall Study|Adverse Event|0|||
13099251|NCT03486899|25854371|FG001|Overall Study|Adverse Event|2|||
13099252|NCT03486899|25854372|FG002|Overall Study|Adverse Event|0|||
13099253|NCT03486899|25854373|FG003|Overall Study|Adverse Event|2|||
13099254|NCT03486899|25854370|FG000|Overall Study|Withdrawal by Subject|3|||
13099255|NCT03486899|25854371|FG001|Overall Study|Withdrawal by Subject|7|||
13099256|NCT03486899|25854372|FG002|Overall Study|Withdrawal by Subject|4|||
13099257|NCT03486899|25854373|FG003|Overall Study|Withdrawal by Subject|3|||
13099258|NCT03486899|25854370|FG000|Overall Study|Other Reasons|0|||
13099259|NCT03486899|25854371|FG001|Overall Study|Other Reasons|1|||
13099260|NCT03486899|25854372|FG002|Overall Study|Other Reasons|0|||
13099261|NCT03486899|25854373|FG003|Overall Study|Other Reasons|1|||
13099262|NCT03486834|25854401|FG000|Overall Study|Withdrawal by Subject|46|||
13099263|NCT03486834|25854402|FG001|Overall Study|Withdrawal by Subject|46|||
13099264|NCT03486834|25854403|FG002|Overall Study|Withdrawal by Subject|52|||
13151174|NCT02551055|26049101|FG003|Overall Study|Death|2|||
13151175|NCT02551055|26049102|FG004|Overall Study|Death|2|||
13151176|NCT02551055|26049103|FG005|Overall Study|Death|1|||
13151177|NCT02551055|26049104|FG006|Overall Study|Death|2|||
13151178|NCT02551055|26049105|FG007|Overall Study|Death|0|||
13151179|NCT02551055|26049098|FG000|Overall Study|Study Terminated by Sponsor|1|||
13151180|NCT02551055|26049099|FG001|Overall Study|Study Terminated by Sponsor|1|||
13151181|NCT02551055|26049100|FG002|Overall Study|Study Terminated by Sponsor|0|||
13151182|NCT02551055|26049101|FG003|Overall Study|Study Terminated by Sponsor|2|||
13151183|NCT02551055|26049102|FG004|Overall Study|Study Terminated by Sponsor|2|||
13151184|NCT02551055|26049103|FG005|Overall Study|Study Terminated by Sponsor|0|||
13151185|NCT02551055|26049104|FG006|Overall Study|Study Terminated by Sponsor|0|||
13151186|NCT02551055|26049105|FG007|Overall Study|Study Terminated by Sponsor|0|||
13151187|NCT02551055|26049098|FG000|Overall Study|Withdrawal by Subject|1|||
13151188|NCT02551055|26049099|FG001|Overall Study|Withdrawal by Subject|1|||
13151189|NCT02551055|26049100|FG002|Overall Study|Withdrawal by Subject|0|||
13151190|NCT02551055|26049101|FG003|Overall Study|Withdrawal by Subject|1|||
13151191|NCT02551055|26049102|FG004|Overall Study|Withdrawal by Subject|2|||
13151192|NCT02551055|26049103|FG005|Overall Study|Withdrawal by Subject|0|||
13151193|NCT02551055|26049104|FG006|Overall Study|Withdrawal by Subject|0|||
13099265|NCT03486834|25854401|FG000|Overall Study|Adverse Event|8|||
13099266|NCT03486834|25854402|FG001|Overall Study|Adverse Event|7|||
13099267|NCT03486834|25854403|FG002|Overall Study|Adverse Event|0|||
13099268|NCT03486834|25854401|FG000|Overall Study|Lost to Follow-up|41|||
13099269|NCT03486834|25854402|FG001|Overall Study|Lost to Follow-up|24|||
13099270|NCT03486834|25854403|FG002|Overall Study|Lost to Follow-up|39|||
13099271|NCT03486834|25854401|FG000|Overall Study|Non-compliance with Study Drug|2|||
13099272|NCT03486834|25854402|FG001|Overall Study|Non-compliance with Study Drug|2|||
13099273|NCT03486834|25854403|FG002|Overall Study|Non-compliance with Study Drug|0|||
13099274|NCT03486834|25854401|FG000|Overall Study|Physician Decision|5|||
13099275|NCT03486834|25854402|FG001|Overall Study|Physician Decision|2|||
13099276|NCT03486834|25854403|FG002|Overall Study|Physician Decision|3|||
13099277|NCT03486834|25854401|FG000|Overall Study|Pregnancy|10|||
13099278|NCT03486834|25854402|FG001|Overall Study|Pregnancy|12|||
13099279|NCT03486834|25854403|FG002|Overall Study|Pregnancy|12|||
13099280|NCT03486834|25854401|FG000|Overall Study|Protocol Deviation|2|||
13099281|NCT03486834|25854402|FG001|Overall Study|Protocol Deviation|3|||
13099282|NCT03486834|25854403|FG002|Overall Study|Protocol Deviation|3|||
13099283|NCT03486834|25854401|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
13099284|NCT03486834|25854402|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
13099285|NCT03486834|25854403|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
13099286|NCT03486834|25854401|FG000|Overall Study|Randomized but not treated|4|||
13099287|NCT03486834|25854402|FG001|Overall Study|Randomized but not treated|4|||
13099288|NCT03486834|25854403|FG002|Overall Study|Randomized but not treated|1|||
13099289|NCT03486392|25854451|FG000|Overall Study|Lost to Follow-up|0|||
13099290|NCT03486392|25854452|FG001|Overall Study|Lost to Follow-up|0|||
13099291|NCT03486392|25854453|FG002|Overall Study|Lost to Follow-up|8|||
13099292|NCT03486392|25854454|FG003|Overall Study|Lost to Follow-up|5|||
13099293|NCT03486392|25854455|FG004|Overall Study|Lost to Follow-up|2|||
13099294|NCT03486392|25854451|FG000|Overall Study|Withdrawal by Subject|3|||
13099295|NCT03486392|25854452|FG001|Overall Study|Withdrawal by Subject|0|||
13099296|NCT03486392|25854453|FG002|Overall Study|Withdrawal by Subject|6|||
13099297|NCT03486392|25854454|FG003|Overall Study|Withdrawal by Subject|4|||
13099298|NCT03486392|25854455|FG004|Overall Study|Withdrawal by Subject|1|||
13099299|NCT03486392|25854451|FG000|Overall Study|Death|0|||
13099300|NCT03486392|25854452|FG001|Overall Study|Death|0|||
13151194|NCT02551055|26049105|FG007|Overall Study|Withdrawal by Subject|0|||
13151195|NCT02551055|26049098|FG000|Overall Study|Reason not specified|0|||
13151196|NCT02551055|26049099|FG001|Overall Study|Reason not specified|0|||
13151197|NCT02551055|26049100|FG002|Overall Study|Reason not specified|0|||
13099301|NCT03486392|25854453|FG002|Overall Study|Death|0|||
13099302|NCT03486392|25854454|FG003|Overall Study|Death|0|||
13099303|NCT03486392|25854455|FG004|Overall Study|Death|1|||
13099304|NCT03486314|25854472|FG000|Part A|Adverse Event|1|||
13099305|NCT03486314|25854473|FG001|Part A|Adverse Event|0|||
13099306|NCT03486314|25854474|FG002|Part A|Adverse Event|0|||
13099307|NCT03486314|25854472|FG000|Part A|Symptomatic Deterioration|2|||
13099308|NCT03486314|25854473|FG001|Part A|Symptomatic Deterioration|0|||
13099309|NCT03486314|25854474|FG002|Part A|Symptomatic Deterioration|0|||
13099310|NCT03485950|25854533|FG000|Overall Study|Adverse Event|1|||
13099311|NCT03485950|25854534|FG001|Overall Study|Adverse Event|0|||
13099312|NCT03485950|25854533|FG000|Overall Study|Death|3|||
13099313|NCT03485950|25854534|FG001|Overall Study|Death|2|||
13099314|NCT03485950|25854533|FG000|Overall Study|Withdrawal by Subject|3|||
13099315|NCT03485950|25854534|FG001|Overall Study|Withdrawal by Subject|0|||
13099316|NCT03485495|25854557|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
13099317|NCT03485495|25854558|FG001|Overall Study|Non-compliance with inclusion criteria|0|||
13099318|NCT03485222|25854581|FG000|Overall Study|Death|0|||
13099319|NCT03485222|25854582|FG001|Overall Study|Death|1|||
13099320|NCT03485222|25854581|FG000|Overall Study|Lost to Follow-up|2|||
13099321|NCT03485222|25854582|FG001|Overall Study|Lost to Follow-up|1|||
13099322|NCT03484429|25854623|FG000|Overall Study|Withdrawal by Subject|1|||
13099323|NCT03484429|25854624|FG001|Overall Study|Withdrawal by Subject|0|||
13099324|NCT03484429|25854623|FG000|Overall Study|Adverse Event|2|||
13099325|NCT03484429|25854624|FG001|Overall Study|Adverse Event|0|||
13099326|NCT03484273|25854660|FG000|Overall Study|Equipment Malfunction|1|||
13099327|NCT03484273|25854660|FG000|Overall Study|Data excluded from analysis|1|||
13099328|NCT03483961|25854736|FG000|Overall Study|Lost to Follow-up|7|||
13099329|NCT03483961|25854737|FG001|Overall Study|Lost to Follow-up|6|||
13151198|NCT02551055|26049101|FG003|Overall Study|Reason not specified|0|||
13151199|NCT02551055|26049102|FG004|Overall Study|Reason not specified|1|||
13151200|NCT02551055|26049103|FG005|Overall Study|Reason not specified|0|||
13151201|NCT02551055|26049104|FG006|Overall Study|Reason not specified|1|||
13151202|NCT02551055|26049105|FG007|Overall Study|Reason not specified|0|||
13151203|NCT02550938|26049140|FG000|Overall Study|Lost to Follow-up|8|||
13151204|NCT02550938|26049141|FG001|Overall Study|Lost to Follow-up|7|||
13151205|NCT02550938|26049142|FG002|Overall Study|Lost to Follow-up|12|||
13151206|NCT02550938|26049143|FG003|Overall Study|Lost to Follow-up|11|||
13151207|NCT02550873|26049229|FG000|Randomized Double Blind|Adverse Event|3|||
13151208|NCT02550873|26049230|FG001|Randomized Double Blind|Adverse Event|1|||
13151209|NCT02550873|26049231|FG002|Randomized Double Blind|Adverse Event|0|||
13099330|NCT03483961|25854738|FG002|Overall Study|Lost to Follow-up|6|||
13099331|NCT03483961|25854739|FG003|Overall Study|Lost to Follow-up|6|||
13099332|NCT03483961|25854740|FG004|Overall Study|Lost to Follow-up|6|||
13099333|NCT03483961|25854741|FG005|Overall Study|Lost to Follow-up|4|||
13099334|NCT03483961|25854742|FG006|Overall Study|Lost to Follow-up|4|||
13099335|NCT03483961|25854743|FG007|Overall Study|Lost to Follow-up|11|||
13099336|NCT03483961|25854744|FG008|Overall Study|Lost to Follow-up|1|||
13099337|NCT03483961|25854745|FG009|Overall Study|Lost to Follow-up|0|||
13099338|NCT03483961|25854736|FG000|Overall Study|Withdrawal by Subject|3|||
13099339|NCT03483961|25854737|FG001|Overall Study|Withdrawal by Subject|4|||
13099340|NCT03483961|25854738|FG002|Overall Study|Withdrawal by Subject|5|||
13099341|NCT03483961|25854739|FG003|Overall Study|Withdrawal by Subject|3|||
13099342|NCT03483961|25854740|FG004|Overall Study|Withdrawal by Subject|4|||
13099343|NCT03483961|25854741|FG005|Overall Study|Withdrawal by Subject|2|||
13099344|NCT03483961|25854742|FG006|Overall Study|Withdrawal by Subject|1|||
13099345|NCT03483961|25854743|FG007|Overall Study|Withdrawal by Subject|2|||
13099346|NCT03483961|25854744|FG008|Overall Study|Withdrawal by Subject|1|||
13099347|NCT03483961|25854745|FG009|Overall Study|Withdrawal by Subject|0|||
13099348|NCT03483961|25854736|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1|||
13099349|NCT03483961|25854737|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
13099350|NCT03483961|25854738|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
13099351|NCT03483961|25854739|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
13099352|NCT03483961|25854740|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
13099353|NCT03483961|25854741|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
13099354|NCT03483961|25854742|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
13099355|NCT03483961|25854743|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
13099356|NCT03483961|25854744|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
13099357|NCT03483961|25854745|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
13099358|NCT03483961|25854736|FG000|Overall Study|Adverse Event|0|||
13151210|NCT02550873|26049229|FG000|Randomized Double Blind|Disease progression|1|||
13099359|NCT03483961|25854737|FG001|Overall Study|Adverse Event|0|||
13099360|NCT03483961|25854738|FG002|Overall Study|Adverse Event|1|||
13099361|NCT03483961|25854739|FG003|Overall Study|Adverse Event|0|||
13099362|NCT03483961|25854740|FG004|Overall Study|Adverse Event|0|||
13099363|NCT03483961|25854741|FG005|Overall Study|Adverse Event|0|||
13099364|NCT03483961|25854742|FG006|Overall Study|Adverse Event|0|||
13099365|NCT03483961|25854743|FG007|Overall Study|Adverse Event|0|||
13099366|NCT03483961|25854744|FG008|Overall Study|Adverse Event|0|||
13099367|NCT03483961|25854745|FG009|Overall Study|Adverse Event|0|||
13099368|NCT03483623|25854758|FG000|Overall Study|43 complete sets achieved|1|||
13099369|NCT03482882|25854771|FG000|Overall Study|Adverse Event|3|||
13099370|NCT03482882|25854771|FG000|Overall Study|Lost to Follow-up|1|||
13099371|NCT03482882|25854771|FG000|Overall Study|Protocol Violation|2|||
13099372|NCT03482882|25854771|FG000|Overall Study|Not further specified|1|||
13099373|NCT03482635|25854810|FG000|Overall Study|Lack of Efficacy|0|||
13099374|NCT03482635|25854811|FG001|Overall Study|Lack of Efficacy|0|||
13151211|NCT02550873|26049230|FG001|Randomized Double Blind|Disease progression|1|||
13151212|NCT02550873|26049231|FG002|Randomized Double Blind|Disease progression|0|||
13151213|NCT02550873|26049229|FG000|Open Label Extension|Study ongoing|0|||
13151214|NCT02550873|26049230|FG001|Open Label Extension|Study ongoing|0|||
13151215|NCT02550873|26049231|FG002|Open Label Extension|Study ongoing|111|||
13151216|NCT02550795|26049255|FG000|Overall Study|Physician Decision|0|||
13151217|NCT02550795|26049256|FG001|Overall Study|Physician Decision|1|||
13151218|NCT02550795|26049257|FG002|Overall Study|Physician Decision|0|||
13151219|NCT02550652|26049306|FG000|Overall Study|Death|1|||
13151220|NCT02550652|26049307|FG001|Overall Study|Death|4|||
13151221|NCT02550652|26049306|FG000|Overall Study|Lack of Efficacy|1|||
13151222|NCT02550652|26049307|FG001|Overall Study|Lack of Efficacy|0|||
13151223|NCT02550652|26049306|FG000|Overall Study|Withdrawal by Subject|3|||
13151224|NCT02550652|26049307|FG001|Overall Study|Withdrawal by Subject|7|||
13151225|NCT02550652|26049306|FG000|Overall Study|Post Trial Access|1|||
13151226|NCT02550652|26049307|FG001|Overall Study|Post Trial Access|0|||
13151227|NCT02550652|26049306|FG000|Overall Study|Lost to Follow-up|1|||
13151228|NCT02550652|26049307|FG001|Overall Study|Lost to Follow-up|3|||
13151229|NCT02550652|26049306|FG000|Overall Study|Physician Decision|0|||
13151230|NCT02550652|26049307|FG001|Overall Study|Physician Decision|2|||
13151231|NCT02550652|26049306|FG000|Overall Study|Ongoing in safety/B-cell follow-up period|14|||
13151232|NCT02550652|26049307|FG001|Overall Study|Ongoing in safety/B-cell follow-up period|5|||
13151233|NCT02550288|26049420|FG000|Overall Study|Adverse Event|0|||
13151234|NCT02550288|26049421|FG001|Overall Study|Adverse Event|1|||
13099375|NCT03482635|25854812|FG002|Overall Study|Lack of Efficacy|1|||
13099376|NCT03482635|25854813|FG003|Overall Study|Lack of Efficacy|3|||
13099377|NCT03482635|25854810|FG000|Overall Study|Adverse Event|2|||
13099378|NCT03482635|25854811|FG001|Overall Study|Adverse Event|2|||
13099379|NCT03482635|25854812|FG002|Overall Study|Adverse Event|0|||
13099380|NCT03482635|25854813|FG003|Overall Study|Adverse Event|3|||
13099381|NCT03482635|25854810|FG000|Overall Study|Withdrawal by Subject|2|||
13099382|NCT03482635|25854811|FG001|Overall Study|Withdrawal by Subject|1|||
13099383|NCT03482635|25854812|FG002|Overall Study|Withdrawal by Subject|0|||
13099384|NCT03482635|25854813|FG003|Overall Study|Withdrawal by Subject|1|||
13099385|NCT03482635|25854810|FG000|Overall Study|Withdrawn by Principle Investigator|1|||
13099386|NCT03482635|25854811|FG001|Overall Study|Withdrawn by Principle Investigator|0|||
13099387|NCT03482635|25854812|FG002|Overall Study|Withdrawn by Principle Investigator|0|||
13099388|NCT03482635|25854813|FG003|Overall Study|Withdrawn by Principle Investigator|0|||
13099389|NCT03482635|25854810|FG000|Overall Study|Not treated|0|||
13099390|NCT03482635|25854811|FG001|Overall Study|Not treated|0|||
13099391|NCT03482635|25854812|FG002|Overall Study|Not treated|0|||
13099392|NCT03482635|25854813|FG003|Overall Study|Not treated|1|||
13099393|NCT03482453|25854967|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
13099394|NCT03482453|25854968|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
13099395|NCT03482453|25854969|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
13099396|NCT03482453|25854970|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
13099397|NCT03482453|25854971|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
13099398|NCT03482453|25854972|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
13099399|NCT03482453|25854973|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
13099400|NCT03482453|25854974|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
13099401|NCT03482453|25854975|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
13099402|NCT03482453|25854976|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
13099403|NCT03482453|25854977|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1|||
13099404|NCT03482453|25854978|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
13099405|NCT03482011|25855048|FG000|Induction Period (16 Weeks)|Adverse Event|1|||
13099406|NCT03482011|25855049|FG001|Induction Period (16 Weeks)|Adverse Event|3|||
13099407|NCT03482011|25855050|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
13099408|NCT03482011|25855051|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
13099409|NCT03482011|25855052|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
13151235|NCT02550288|26049422|FG002|Overall Study|Adverse Event|0|||
13099410|NCT03482011|25855053|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
13099411|NCT03482011|25855054|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
13099412|NCT03482011|25855055|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
13099413|NCT03482011|25855048|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3|||
13099414|NCT03482011|25855049|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1|||
13099415|NCT03482011|25855050|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
13099416|NCT03482011|25855051|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
13099417|NCT03482011|25855052|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
13099418|NCT03482011|25855053|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
13099419|NCT03482011|25855054|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
13099420|NCT03482011|25855055|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
13099421|NCT03482011|25855048|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0|||
13099422|NCT03482011|25855049|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1|||
13099423|NCT03482011|25855050|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0|||
13099424|NCT03482011|25855051|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0|||
13099425|NCT03482011|25855052|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0|||
13099426|NCT03482011|25855053|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0|||
13099427|NCT03482011|25855054|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0|||
13099428|NCT03482011|25855055|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0|||
13099429|NCT03482011|25855048|FG000|Induction Period (16 Weeks)|Screen Failure|0|||
13099430|NCT03482011|25855049|FG001|Induction Period (16 Weeks)|Screen Failure|1|||
13099431|NCT03482011|25855050|FG002|Induction Period (16 Weeks)|Screen Failure|0|||
13099432|NCT03482011|25855051|FG003|Induction Period (16 Weeks)|Screen Failure|0|||
13099433|NCT03482011|25855052|FG004|Induction Period (16 Weeks)|Screen Failure|0|||
13099434|NCT03482011|25855053|FG005|Induction Period (16 Weeks)|Screen Failure|0|||
13099435|NCT03482011|25855054|FG006|Induction Period (16 Weeks)|Screen Failure|0|||
13099436|NCT03482011|25855055|FG007|Induction Period (16 Weeks)|Screen Failure|0|||
13099437|NCT03482011|25855048|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
13099438|NCT03482011|25855049|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5|||
13099439|NCT03482011|25855050|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
13099440|NCT03482011|25855051|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
13099441|NCT03482011|25855052|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
13099442|NCT03482011|25855053|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
13099443|NCT03482011|25855054|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
13099444|NCT03482011|25855055|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
13099445|NCT03482011|25855048|FG000|Maintenance Period (36 Weeks)|Adverse Event|0|||
13099446|NCT03482011|25855049|FG001|Maintenance Period (36 Weeks)|Adverse Event|0|||
13099447|NCT03482011|25855050|FG002|Maintenance Period (36 Weeks)|Adverse Event|0|||
13099448|NCT03482011|25855051|FG003|Maintenance Period (36 Weeks)|Adverse Event|0|||
13099449|NCT03482011|25855052|FG004|Maintenance Period (36 Weeks)|Adverse Event|0|||
13099450|NCT03482011|25855053|FG005|Maintenance Period (36 Weeks)|Adverse Event|1|||
13099451|NCT03482011|25855054|FG006|Maintenance Period (36 Weeks)|Adverse Event|1|||
13151236|NCT02550288|26049423|FG003|Overall Study|Adverse Event|0|||
13151237|NCT02550288|26049424|FG004|Overall Study|Adverse Event|0|||
13099452|NCT03482011|25855055|FG007|Maintenance Period (36 Weeks)|Adverse Event|4|||
13099453|NCT03482011|25855048|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
13099454|NCT03482011|25855049|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
13099455|NCT03482011|25855050|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
13099456|NCT03482011|25855051|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2|||
13099457|NCT03482011|25855052|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
13099458|NCT03482011|25855053|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
13099459|NCT03482011|25855054|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
13099460|NCT03482011|25855055|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9|||
13099461|NCT03482011|25855048|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
13099462|NCT03482011|25855049|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
13099463|NCT03482011|25855050|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
13099464|NCT03482011|25855051|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
13099465|NCT03482011|25855052|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2|||
13099466|NCT03482011|25855053|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
13099467|NCT03482011|25855054|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
13099468|NCT03482011|25855055|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
13099469|NCT03482011|25855048|FG000|Maintenance Period (36 Weeks)|Physician Decision|0|||
13099470|NCT03482011|25855049|FG001|Maintenance Period (36 Weeks)|Physician Decision|0|||
13099471|NCT03482011|25855050|FG002|Maintenance Period (36 Weeks)|Physician Decision|0|||
13151238|NCT02550288|26049420|FG000|Overall Study|Physician Decision|0|||
13151239|NCT02550288|26049421|FG001|Overall Study|Physician Decision|0|||
13099472|NCT03482011|25855051|FG003|Maintenance Period (36 Weeks)|Physician Decision|1|||
13099473|NCT03482011|25855052|FG004|Maintenance Period (36 Weeks)|Physician Decision|0|||
13099474|NCT03482011|25855053|FG005|Maintenance Period (36 Weeks)|Physician Decision|1|||
13099475|NCT03482011|25855054|FG006|Maintenance Period (36 Weeks)|Physician Decision|1|||
13151240|NCT02550288|26049422|FG002|Overall Study|Physician Decision|0|||
13151241|NCT02550288|26049423|FG003|Overall Study|Physician Decision|1|||
13151242|NCT02550288|26049424|FG004|Overall Study|Physician Decision|0|||
13151243|NCT02550288|26049420|FG000|Overall Study|Protocol Violation|2|||
13151244|NCT02550288|26049421|FG001|Overall Study|Protocol Violation|2|||
13151245|NCT02550288|26049422|FG002|Overall Study|Protocol Violation|1|||
13151246|NCT02550288|26049423|FG003|Overall Study|Protocol Violation|0|||
13151247|NCT02550288|26049424|FG004|Overall Study|Protocol Violation|3|||
13151248|NCT02550288|26049420|FG000|Overall Study|Participant moved|0|||
13151249|NCT02550288|26049421|FG001|Overall Study|Participant moved|0|||
13151250|NCT02550288|26049422|FG002|Overall Study|Participant moved|0|||
13151251|NCT02550288|26049423|FG003|Overall Study|Participant moved|1|||
13151252|NCT02550288|26049424|FG004|Overall Study|Participant moved|0|||
13151253|NCT02550288|26049420|FG000|Overall Study|Withdrawal by Subject|0|||
13151254|NCT02550288|26049421|FG001|Overall Study|Withdrawal by Subject|0|||
13151255|NCT02550288|26049422|FG002|Overall Study|Withdrawal by Subject|0|||
13151256|NCT02550288|26049423|FG003|Overall Study|Withdrawal by Subject|1|||
13151257|NCT02550288|26049424|FG004|Overall Study|Withdrawal by Subject|0|||
13151258|NCT02550106|26049450|FG000|Overall Study|Adverse Event|1|||
13151259|NCT02550106|26049450|FG000|Overall Study|Lack of Efficacy|3|||
13151260|NCT02550106|26049450|FG000|Overall Study|Protocol Violation|6|||
13151261|NCT02550106|26049450|FG000|Overall Study|Withdrawal by Subject|2|||
13151262|NCT02549859|26049517|FG000|Long-term 60 Hz DBS|Study Closed|1|||
13151263|NCT02549573|26049566|FG000|Overall Study|Withdrawal by Subject|0|||
13151264|NCT02549573|26049567|FG001|Overall Study|Withdrawal by Subject|2|||
13151265|NCT02549573|26049566|FG000|Overall Study|Protocol Violation|0|||
13151266|NCT02549573|26049567|FG001|Overall Study|Protocol Violation|1|||
13151267|NCT02549352|26049588|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
13151268|NCT02549352|26049589|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
13151269|NCT02549352|26049588|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
13151270|NCT02549352|26049589|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
13151271|NCT02549352|26049588|FG000|3-day Treatment and 8-week Follow-up|Other|0|||
13151272|NCT02549352|26049589|FG001|3-day Treatment and 8-week Follow-up|Other|2|||
13151273|NCT02549352|26049588|FG000|12-month Follow-up|Withdrawal by Subject|4|||
13151274|NCT02549352|26049589|FG001|12-month Follow-up|Withdrawal by Subject|5|||
13151275|NCT02549352|26049588|FG000|12-month Follow-up|Lost to Follow-up|3|||
13151276|NCT02549352|26049589|FG001|12-month Follow-up|Lost to Follow-up|2|||
13151277|NCT02549352|26049588|FG000|12-month Follow-up|Death|0|||
13151278|NCT02549352|26049589|FG001|12-month Follow-up|Death|1|||
13151279|NCT02549352|26049588|FG000|12-month Follow-up|Protocol Violation|0|||
13099476|NCT03482011|25855055|FG007|Maintenance Period (36 Weeks)|Physician Decision|1|||
13099477|NCT03482011|25855048|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
13099478|NCT03482011|25855049|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
13099479|NCT03482011|25855050|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
13099480|NCT03482011|25855051|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
13099481|NCT03482011|25855052|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
13099482|NCT03482011|25855053|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
13099483|NCT03482011|25855054|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
13099484|NCT03482011|25855055|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
13099485|NCT03482011|25855048|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
13099486|NCT03482011|25855049|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
13099487|NCT03482011|25855050|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
13099488|NCT03482011|25855051|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2|||
13099489|NCT03482011|25855052|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
13099490|NCT03482011|25855053|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
13099491|NCT03482011|25855054|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
13099492|NCT03482011|25855055|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5|||
13099493|NCT03482011|25855048|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
13099494|NCT03482011|25855049|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
13099495|NCT03482011|25855050|FG002|Follow-up Period (12 Weeks)|Adverse Event|0|||
13099496|NCT03482011|25855051|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
13099497|NCT03482011|25855052|FG004|Follow-up Period (12 Weeks)|Adverse Event|0|||
13099498|NCT03482011|25855053|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
13099499|NCT03482011|25855054|FG006|Follow-up Period (12 Weeks)|Adverse Event|1|||
13099500|NCT03482011|25855055|FG007|Follow-up Period (12 Weeks)|Adverse Event|4|||
13099501|NCT03482011|25855048|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
13099502|NCT03482011|25855049|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
13099503|NCT03482011|25855050|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1|||
13099504|NCT03482011|25855051|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3|||
13099505|NCT03482011|25855052|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
13099506|NCT03482011|25855053|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
13151280|NCT02549352|26049589|FG001|12-month Follow-up|Protocol Violation|1|||
13151281|NCT02549352|26049588|FG000|12-month Follow-up|Other|1|||
13151282|NCT02549352|26049589|FG001|12-month Follow-up|Other|3|||
13151283|NCT02549339|26049610|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2|||
13099507|NCT03482011|25855054|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
13099508|NCT03482011|25855055|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6|||
13099509|NCT03482011|25855048|FG000|Follow-up Period (12 Weeks)|Physician Decision|0|||
13099510|NCT03482011|25855049|FG001|Follow-up Period (12 Weeks)|Physician Decision|0|||
13099511|NCT03482011|25855050|FG002|Follow-up Period (12 Weeks)|Physician Decision|0|||
13099512|NCT03482011|25855051|FG003|Follow-up Period (12 Weeks)|Physician Decision|0|||
13099513|NCT03482011|25855052|FG004|Follow-up Period (12 Weeks)|Physician Decision|0|||
13099514|NCT03482011|25855053|FG005|Follow-up Period (12 Weeks)|Physician Decision|0|||
13099515|NCT03482011|25855054|FG006|Follow-up Period (12 Weeks)|Physician Decision|0|||
13099516|NCT03482011|25855055|FG007|Follow-up Period (12 Weeks)|Physician Decision|1|||
13099517|NCT03482011|25855048|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
13099518|NCT03482011|25855049|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
13099519|NCT03482011|25855050|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
13099520|NCT03482011|25855051|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
13099521|NCT03482011|25855052|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
13099522|NCT03482011|25855053|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
13099523|NCT03482011|25855054|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
13099524|NCT03482011|25855055|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
13099525|NCT03481816|25855083|FG000|Starting Dose|Refused further vaccines after 1 dose|1|||
13099526|NCT03481816|25855084|FG001|Starting Dose|Refused further vaccines after 1 dose|0|||
13099527|NCT03481816|25855083|FG000|Dose Expansion|Off treatment due to progressive disease|0|||
13099528|NCT03481816|25855084|FG001|Dose Expansion|Off treatment due to progressive disease|5|||
13099529|NCT03481816|25855083|FG000|Dose Expansion|Withdrawal by Subject|0|||
13099530|NCT03481816|25855084|FG001|Dose Expansion|Withdrawal by Subject|2|||
13099531|NCT03481816|25855083|FG000|Dose Expansion|Physician Decision|0|||
13099532|NCT03481816|25855084|FG001|Dose Expansion|Physician Decision|5|||
13099533|NCT03481725|25855113|FG000|Overall Study|Withdrawal by Subject|1|||
13099534|NCT03481725|25855114|FG001|Overall Study|Withdrawal by Subject|0|||
13099535|NCT03481309|25855147|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1|||
13099536|NCT03481309|25855148|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
13099537|NCT03481309|25855149|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
13099538|NCT03481309|25855150|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
13099539|NCT03481309|25855151|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
13099540|NCT03481309|25855152|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
13099541|NCT03480932|25855176|FG000|Overall Study|Death|1|||
13099542|NCT03480932|25855177|FG001|Overall Study|Death|1|||
13099543|NCT03480932|25855178|FG002|Overall Study|Death|0|||
13099544|NCT03480932|25855176|FG000|Overall Study|Lost to Follow-up|0|||
13099545|NCT03480932|25855177|FG001|Overall Study|Lost to Follow-up|2|||
13099546|NCT03480932|25855178|FG002|Overall Study|Lost to Follow-up|3|||
13099547|NCT03480932|25855176|FG000|Overall Study|Incarcerated|2|||
13099548|NCT03480932|25855177|FG001|Overall Study|Incarcerated|2|||
13099549|NCT03480932|25855178|FG002|Overall Study|Incarcerated|2|||
13099550|NCT03480841|25855189|FG000|Overall Study|Lost to Follow-up|2|||
13099551|NCT03480802|25855222|FG000|Overall Study|Lost to Follow-up|5|||
13099552|NCT03480802|25855223|FG001|Overall Study|Lost to Follow-up|1|||
13099553|NCT03480802|25855222|FG000|Overall Study|Withdrawal by Subject|2|||
13099554|NCT03480802|25855223|FG001|Overall Study|Withdrawal by Subject|1|||
13099555|NCT03480802|25855222|FG000|Overall Study|Relocated|0|||
13099556|NCT03480802|25855223|FG001|Overall Study|Relocated|1|||
13099557|NCT03480763|25855292|FG000|Overall Study|Withdrawal by Subject|18|||
13099558|NCT03480763|25855293|FG001|Overall Study|Withdrawal by Subject|10|||
13099559|NCT03480763|25855292|FG000|Overall Study|Lost to Follow-up|4|||
13099560|NCT03480763|25855293|FG001|Overall Study|Lost to Follow-up|7|||
13099561|NCT03480763|25855292|FG000|Overall Study|non-study pneumococcal vaccine|1|||
13099562|NCT03480763|25855293|FG001|Overall Study|non-study pneumococcal vaccine|0|||
13099563|NCT03480763|25855292|FG000|Overall Study|oncological treatment|0|||
13099564|NCT03480763|25855293|FG001|Overall Study|oncological treatment|2|||
13099565|NCT03480763|25855292|FG000|Overall Study|pain with vaccination|1|||
13099566|NCT03480763|25855293|FG001|Overall Study|pain with vaccination|0|||
13099567|NCT03480750|25855336|FG000|Overall Study|Withdrawal by Subject|0|||
13099568|NCT03480750|25855337|FG001|Overall Study|Withdrawal by Subject|1|||
13099569|NCT03480750|25855338|FG002|Overall Study|Withdrawal by Subject|0|||
13099570|NCT03480750|25855339|FG003|Overall Study|Withdrawal by Subject|0|||
13099571|NCT03480750|25855340|FG004|Overall Study|Withdrawal by Subject|0|||
13099572|NCT03480750|25855341|FG005|Overall Study|Withdrawal by Subject|0|||
13099573|NCT03480750|25855336|FG000|Overall Study|The interruption in Trientine shippment|0|||
13099574|NCT03480750|25855337|FG001|Overall Study|The interruption in Trientine shippment|0|||
13099575|NCT03480750|25855338|FG002|Overall Study|The interruption in Trientine shippment|0|||
13099576|NCT03480750|25855339|FG003|Overall Study|The interruption in Trientine shippment|0|||
13099577|NCT03480750|25855340|FG004|Overall Study|The interruption in Trientine shippment|0|||
13099578|NCT03480750|25855341|FG005|Overall Study|The interruption in Trientine shippment|1|||
13099579|NCT03480425|25855347|FG000|Overall Study|Force transducer technical failure|1|||
13099580|NCT03480243|25855441|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1|||
13099581|NCT03480243|25855441|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1|||
13099582|NCT03480152|25855464|FG000|Phase I|Signed consent. Died before treatment.|1|||
13099583|NCT03480152|25855465|FG001|Phase I|Signed consent. Died before treatment.|0|||
13099584|NCT03480152|25855466|FG002|Phase I|Signed consent. Died before treatment.|0|||
13099585|NCT03480022|25855535|FG000|Overall Study|Pregnancy|2|||
13099586|NCT03480022|25855536|FG001|Overall Study|Pregnancy|0|||
13099587|NCT03480022|25855535|FG000|Overall Study|Adverse Event|6|||
13099588|NCT03480022|25855536|FG001|Overall Study|Adverse Event|0|||
13099589|NCT03480022|25855535|FG000|Overall Study|Lack of Efficacy|0|||
13099590|NCT03480022|25855536|FG001|Overall Study|Lack of Efficacy|2|||
13099591|NCT03480022|25855535|FG000|Overall Study|Physician Decision|0|||
13099592|NCT03480022|25855536|FG001|Overall Study|Physician Decision|1|||
13099593|NCT03480022|25855535|FG000|Overall Study|Withdrawal by Subject|2|||
13099594|NCT03480022|25855536|FG001|Overall Study|Withdrawal by Subject|0|||
13099595|NCT03480022|25855535|FG000|Overall Study|Medication concerns|1|||
13099596|NCT03480022|25855536|FG001|Overall Study|Medication concerns|0|||
13099597|NCT03480022|25855535|FG000|Overall Study|Family member COVID exposure|0|||
13099598|NCT03480022|25855536|FG001|Overall Study|Family member COVID exposure|1|||
13099599|NCT03480009|25855571|FG000|Overall Study|Lost to Follow-up|4|||
13099600|NCT03480009|25855572|FG001|Overall Study|Lost to Follow-up|5|||
13099601|NCT03480009|25855573|FG002|Overall Study|Lost to Follow-up|4|||
13099602|NCT03480009|25855574|FG003|Overall Study|Lost to Follow-up|0|||
13099603|NCT03479216|25855599|FG000|Overall Study|Withdrawal by Subject|3|||
13099604|NCT03479216|25855600|FG001|Overall Study|Withdrawal by Subject|2|||
13099605|NCT03479216|25855599|FG000|Overall Study|Physician Decision|2|||
13099606|NCT03479216|25855600|FG001|Overall Study|Physician Decision|3|||
13099607|NCT03478969|25855677|FG000|Overall Study|Withdrawal by Subject|4|||
13099608|NCT03478969|25855678|FG001|Overall Study|Withdrawal by Subject|7|||
13099609|NCT03478969|25855679|FG002|Overall Study|Withdrawal by Subject|6|||
13151284|NCT02549339|26049611|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0|||
13151285|NCT02549339|26049610|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1|||
13151286|NCT02549339|26049611|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
13151287|NCT02549339|26049610|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
13151288|NCT02549339|26049611|FG001|3-day Treatment and 8-week Follow-up|Other|0|||
13151289|NCT02549339|26049610|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
13151290|NCT02549339|26049611|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2|||
13151291|NCT02549339|26049610|FG000|12-month Follow-up|Lack of Efficacy|0|||
13151292|NCT02549339|26049611|FG001|12-month Follow-up|Lack of Efficacy|2|||
13151293|NCT02549339|26049610|FG000|12-month Follow-up|Withdrawal by Subject|8|||
13151294|NCT02549339|26049611|FG001|12-month Follow-up|Withdrawal by Subject|3|||
13151295|NCT02549339|26049610|FG000|12-month Follow-up|Lost to Follow-up|1|||
13151296|NCT02549339|26049611|FG001|12-month Follow-up|Lost to Follow-up|3|||
13151297|NCT02549339|26049610|FG000|12-month Follow-up|Other|0|||
13151298|NCT02549339|26049611|FG001|12-month Follow-up|Other|3|||
13099610|NCT03478969|25855677|FG000|Overall Study|Adverse Event|2|||
13099611|NCT03478969|25855678|FG001|Overall Study|Adverse Event|0|||
13099612|NCT03478969|25855679|FG002|Overall Study|Adverse Event|1|||
13099613|NCT03478969|25855677|FG000|Overall Study|Pregnancy|1|||
13099614|NCT03478969|25855678|FG001|Overall Study|Pregnancy|0|||
13099615|NCT03478969|25855679|FG002|Overall Study|Pregnancy|0|||
13099616|NCT03478969|25855677|FG000|Overall Study|Personal Reasons|1|||
13099617|NCT03478969|25855678|FG001|Overall Study|Personal Reasons|0|||
13099618|NCT03478969|25855679|FG002|Overall Study|Personal Reasons|1|||
13151299|NCT02549287|26049648|FG000|Overall Study|Lost to Follow-up|65|||
13151300|NCT02549287|26049649|FG001|Overall Study|Lost to Follow-up|26|||
13151301|NCT02549287|26049648|FG000|Overall Study|Withdrawal by Subject|15|||
13151302|NCT02549287|26049649|FG001|Overall Study|Withdrawal by Subject|6|||
13151303|NCT02549196|26049676|FG000|Overall Study|Protocol Violation|0|||
13151304|NCT02549196|26049677|FG001|Overall Study|Protocol Violation|0|||
13151305|NCT02549196|26049678|FG002|Overall Study|Protocol Violation|0|||
13151306|NCT02549196|26049679|FG003|Overall Study|Protocol Violation|1|||
13151307|NCT02549196|26049676|FG000|Overall Study|Withdrawal by Subject|1|||
13151308|NCT02549196|26049677|FG001|Overall Study|Withdrawal by Subject|0|||
13151309|NCT02549196|26049678|FG002|Overall Study|Withdrawal by Subject|1|||
13151310|NCT02549196|26049679|FG003|Overall Study|Withdrawal by Subject|0|||
13151311|NCT02549092|26049716|FG000|Treatment Period|Adverse Event|2|||
13151312|NCT02549092|26049717|FG001|Treatment Period|Adverse Event|2|||
13151313|NCT02549092|26049716|FG000|Treatment Period|Withdrawal by Subject|1|||
13151314|NCT02549092|26049717|FG001|Treatment Period|Withdrawal by Subject|3|||
13151315|NCT02549092|26049716|FG000|Treatment Period|Lack of Efficacy|0|||
13151316|NCT02549092|26049717|FG001|Treatment Period|Lack of Efficacy|2|||
13151317|NCT02549092|26049716|FG000|Extension/Transition Period|Still in Extension/Transition Period|4|||
13151318|NCT02549092|26049717|FG001|Extension/Transition Period|Still in Extension/Transition Period|8|||
13151319|NCT02549092|26049716|FG000|Extension/Transition Period|Premature Discontinuation for Unspecified Reason|1|||
13099619|NCT03478969|25855677|FG000|Overall Study|Covid-19|1|||
13151320|NCT02549092|26049717|FG001|Extension/Transition Period|Premature Discontinuation for Unspecified Reason|1|||
13151321|NCT02549027|26049759|FG000|Washout After Period 4|Withdrawal by Subject|0|||
13151322|NCT02549027|26049760|FG001|Washout After Period 4|Withdrawal by Subject|1|||
13151323|NCT02549027|26049761|FG002|Washout After Period 4|Withdrawal by Subject|1|||
13151324|NCT02549027|26049762|FG003|Washout After Period 4|Withdrawal by Subject|1|||
13151325|NCT02549027|26049763|FG004|Washout After Period 4|Withdrawal by Subject|0|||
13151326|NCT02549027|26049764|FG005|Washout After Period 4|Withdrawal by Subject|0|||
13151327|NCT02549027|26049759|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
13151328|NCT02549027|26049760|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
13151329|NCT02549027|26049761|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
13151330|NCT02549027|26049762|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
13151331|NCT02549027|26049763|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2|||
13151332|NCT02549027|26049764|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
13151333|NCT02548962|26049781|FG000|Overall Study|Withdrawal by Subject|1|||
13151334|NCT02548962|26049782|FG001|Overall Study|Withdrawal by Subject|0|||
13151335|NCT02548650|26049797|FG000|Triple Therapy|Adverse Event|1|||
13151336|NCT02548650|26049798|FG001|Triple Therapy|Adverse Event|0|||
13151337|NCT02548650|26049797|FG000|Triple Therapy|Withdrawal by Subject|0|||
13151338|NCT02548650|26049798|FG001|Triple Therapy|Withdrawal by Subject|4|||
13151339|NCT02548650|26049797|FG000|Double Therapy|Adverse Event|1|||
13151340|NCT02548650|26049798|FG001|Double Therapy|Adverse Event|1|||
13151341|NCT02548650|26049797|FG000|Double Therapy|Withdrawal by Subject|0|||
13151342|NCT02548650|26049798|FG001|Double Therapy|Withdrawal by Subject|1|||
13151343|NCT02548585|26050038|FG000|Overall Study|Withdrawal by Subject|0|||
13151344|NCT02548585|26050039|FG001|Overall Study|Withdrawal by Subject|0|||
13151345|NCT02548585|26050040|FG002|Overall Study|Withdrawal by Subject|0|||
13151346|NCT02548585|26050041|FG003|Overall Study|Withdrawal by Subject|0|||
13151347|NCT02548585|26050042|FG004|Overall Study|Withdrawal by Subject|0|||
13151348|NCT02548585|26050043|FG005|Overall Study|Withdrawal by Subject|1|||
13151349|NCT02548585|26050044|FG006|Overall Study|Withdrawal by Subject|0|||
13151350|NCT02548585|26050038|FG000|Overall Study|Lost to Follow-up|1|||
13151351|NCT02548585|26050039|FG001|Overall Study|Lost to Follow-up|0|||
13151352|NCT02548585|26050040|FG002|Overall Study|Lost to Follow-up|0|||
13151353|NCT02548585|26050041|FG003|Overall Study|Lost to Follow-up|0|||
13151354|NCT02548585|26050042|FG004|Overall Study|Lost to Follow-up|0|||
13151355|NCT02548585|26050043|FG005|Overall Study|Lost to Follow-up|0|||
13151356|NCT02548585|26050044|FG006|Overall Study|Lost to Follow-up|0|||
13151357|NCT02548585|26050038|FG000|Overall Study|Other|1|||
13151358|NCT02548585|26050039|FG001|Overall Study|Other|0|||
13151359|NCT02548585|26050040|FG002|Overall Study|Other|0|||
13151360|NCT02548585|26050041|FG003|Overall Study|Other|2|||
13151361|NCT02548585|26050042|FG004|Overall Study|Other|3|||
13151362|NCT02548585|26050043|FG005|Overall Study|Other|0|||
13151363|NCT02548585|26050044|FG006|Overall Study|Other|1|||
13151364|NCT02548585|26050038|FG000|Overall Study|Randomized but not treated|0|||
13151365|NCT02548585|26050039|FG001|Overall Study|Randomized but not treated|0|||
13099620|NCT03478969|25855678|FG001|Overall Study|Covid-19|4|||
13099621|NCT03478969|25855679|FG002|Overall Study|Covid-19|3|||
13099622|NCT03478969|25855677|FG000|Overall Study|Multiple Reasons|0|||
13099623|NCT03478969|25855678|FG001|Overall Study|Multiple Reasons|1|||
13099624|NCT03478969|25855679|FG002|Overall Study|Multiple Reasons|1|||
13099625|NCT03478969|25855677|FG000|Overall Study|Eligibility Criteria|0|||
13099626|NCT03478969|25855678|FG001|Overall Study|Eligibility Criteria|0|||
13099627|NCT03478969|25855679|FG002|Overall Study|Eligibility Criteria|5|||
13099628|NCT03478969|25855677|FG000|Overall Study|Lost to Follow-up|0|||
13099629|NCT03478969|25855678|FG001|Overall Study|Lost to Follow-up|0|||
13099630|NCT03478969|25855679|FG002|Overall Study|Lost to Follow-up|1|||
13099631|NCT03478891|25855738|FG000|Overall Study|Enrolled, but product never administered|0|||
13099632|NCT03478891|25855739|FG001|Overall Study|Enrolled, but product never administered|0|||
13151366|NCT02548585|26050040|FG002|Overall Study|Randomized but not treated|0|||
13151367|NCT02548585|26050041|FG003|Overall Study|Randomized but not treated|0|||
13151368|NCT02548585|26050042|FG004|Overall Study|Randomized but not treated|0|||
13151369|NCT02548585|26050043|FG005|Overall Study|Randomized but not treated|1|||
13151370|NCT02548585|26050044|FG006|Overall Study|Randomized but not treated|0|||
13151371|NCT02548455|26050050|FG000|Overall Study|Withdrawal by Subject|27|||
13151372|NCT02548455|26050050|FG000|Overall Study|Death|26|||
13151373|NCT02548455|26050050|FG000|Overall Study|Lost to Follow-up|14|||
13151374|NCT02548455|26050050|FG000|Overall Study|Visit not completed|173|||
13151375|NCT02548156|26050074|FG000|Washout Period 1|Lost to Follow-up|0|||
13151376|NCT02548156|26050075|FG001|Washout Period 1|Lost to Follow-up|0|||
13151377|NCT02548156|26050076|FG002|Washout Period 1|Lost to Follow-up|0|||
13151378|NCT02548156|26050077|FG003|Washout Period 1|Lost to Follow-up|0|||
13151379|NCT02548156|26050078|FG004|Washout Period 1|Lost to Follow-up|1|||
13151380|NCT02548156|26050079|FG005|Washout Period 1|Lost to Follow-up|0|||
13099633|NCT03478891|25855740|FG002|Overall Study|Enrolled, but product never administered|1|||
13099634|NCT03478891|25855738|FG000|Overall Study|Moved from area|0|||
13151381|NCT02548143|26050096|FG000|Overall Study|Adverse Event|1|||
13151382|NCT02548143|26050097|FG001|Overall Study|Adverse Event|0|||
13151383|NCT02548143|26050096|FG000|Overall Study|Withdrawal by Subject|0|||
13151384|NCT02548143|26050097|FG001|Overall Study|Withdrawal by Subject|1|||
13151385|NCT02548078|26050292|FG000|Overall Study|Serious adverse event/Adverse event|1|||
13151386|NCT02548078|26050293|FG001|Overall Study|Serious adverse event/Adverse event|0|||
13151387|NCT02548078|26050292|FG000|Overall Study|Moved from study area|3|||
13151388|NCT02548078|26050293|FG001|Overall Study|Moved from study area|3|||
13151389|NCT02548078|26050292|FG000|Overall Study|Lost to Follow-up|1|||
13151390|NCT02548078|26050293|FG001|Overall Study|Lost to Follow-up|3|||
13151391|NCT02547987|26050299|FG000|Overall Study|Withdrawal by Subject|1|||
13151392|NCT02547987|26050299|FG000|Overall Study|Adverse Event|2|||
13151393|NCT02547974|26050396|FG000|Overall Study|Withdrawal by Subject|1|||
13151394|NCT02547974|26050397|FG001|Overall Study|Withdrawal by Subject|0|||
13151395|NCT02547974|26050398|FG002|Overall Study|Withdrawal by Subject|0|||
13151396|NCT02547974|26050399|FG003|Overall Study|Withdrawal by Subject|0|||
13151397|NCT02547935|26050436|FG000|Overall Study|Other|0|||
13151398|NCT02547935|26050437|FG001|Overall Study|Other|1|||
13151399|NCT02547935|26050438|FG002|Overall Study|Other|0|||
13151400|NCT02547935|26050436|FG000|Overall Study|Withdrawal by Subject|2|||
13151401|NCT02547935|26050437|FG001|Overall Study|Withdrawal by Subject|3|||
13151402|NCT02547935|26050438|FG002|Overall Study|Withdrawal by Subject|4|||
13151403|NCT02547935|26050436|FG000|Overall Study|Screen Failure|2|||
13151404|NCT02547935|26050437|FG001|Overall Study|Screen Failure|0|||
13151405|NCT02547935|26050438|FG002|Overall Study|Screen Failure|0|||
13151406|NCT02547935|26050436|FG000|Overall Study|Physician Decision|0|||
13151407|NCT02547935|26050437|FG001|Overall Study|Physician Decision|1|||
13151408|NCT02547935|26050438|FG002|Overall Study|Physician Decision|0|||
13151409|NCT02547935|26050436|FG000|Overall Study|Lost to Follow-up|0|||
13151410|NCT02547935|26050437|FG001|Overall Study|Lost to Follow-up|2|||
13151411|NCT02547935|26050438|FG002|Overall Study|Lost to Follow-up|1|||
13151412|NCT02547935|26050436|FG000|Overall Study|Death|1|||
13151413|NCT02547935|26050437|FG001|Overall Study|Death|1|||
13151414|NCT02547935|26050438|FG002|Overall Study|Death|0|||
13151415|NCT02547922|26050482|FG000|Overall Study|Withdrawal by Subject|9|||
13151416|NCT02547922|26050483|FG001|Overall Study|Withdrawal by Subject|6|||
13151417|NCT02547922|26050484|FG002|Overall Study|Withdrawal by Subject|10|||
13151418|NCT02547922|26050482|FG000|Overall Study|Adverse Event|3|||
13151419|NCT02547922|26050483|FG001|Overall Study|Adverse Event|1|||
13151420|NCT02547922|26050484|FG002|Overall Study|Adverse Event|2|||
13151421|NCT02547922|26050482|FG000|Overall Study|Lost to Follow-up|1|||
13151422|NCT02547922|26050483|FG001|Overall Study|Lost to Follow-up|0|||
13151423|NCT02547922|26050484|FG002|Overall Study|Lost to Follow-up|0|||
13151424|NCT02547922|26050482|FG000|Overall Study|Lack of Efficacy|5|||
13151425|NCT02547922|26050483|FG001|Overall Study|Lack of Efficacy|7|||
13151426|NCT02547922|26050484|FG002|Overall Study|Lack of Efficacy|4|||
13151427|NCT02547922|26050482|FG000|Overall Study|Death|1|||
13099635|NCT03478891|25855739|FG001|Overall Study|Moved from area|0|||
13099636|NCT03478891|25855740|FG002|Overall Study|Moved from area|1|||
13099637|NCT03478891|25855738|FG000|Overall Study|Lost to Follow-up|1|||
13099638|NCT03478891|25855739|FG001|Overall Study|Lost to Follow-up|0|||
13099639|NCT03478891|25855740|FG002|Overall Study|Lost to Follow-up|1|||
13099640|NCT03478787|25855761|FG000|Overall Study|Adverse Event|5|||
13099641|NCT03478787|25855762|FG001|Overall Study|Adverse Event|1|||
13099642|NCT03478787|25855761|FG000|Overall Study|Protocol Violation|3|||
13099643|NCT03478787|25855762|FG001|Overall Study|Protocol Violation|0|||
13099644|NCT03478787|25855761|FG000|Overall Study|Lack of Efficacy|7|||
13099645|NCT03478787|25855762|FG001|Overall Study|Lack of Efficacy|1|||
13099646|NCT03478787|25855761|FG000|Overall Study|Lost to Follow-up|9|||
13099647|NCT03478787|25855762|FG001|Overall Study|Lost to Follow-up|5|||
13099648|NCT03478787|25855761|FG000|Overall Study|Withdrawal by Subject|2|||
13099649|NCT03478787|25855762|FG001|Overall Study|Withdrawal by Subject|6|||
13099650|NCT03478787|25855761|FG000|Overall Study|Other, Not Specified|3|||
13151428|NCT02547922|26050483|FG001|Overall Study|Death|0|||
13151429|NCT02547922|26050484|FG002|Overall Study|Death|0|||
13151430|NCT02547922|26050482|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4|||
13151431|NCT02547922|26050483|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8|||
13151432|NCT02547922|26050484|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9|||
13151433|NCT02547922|26050482|FG000|Overall Study|TECHNICAL PROBLEMS|1|||
13151434|NCT02547922|26050483|FG001|Overall Study|TECHNICAL PROBLEMS|0|||
13151435|NCT02547922|26050484|FG002|Overall Study|TECHNICAL PROBLEMS|0|||
13151436|NCT02547922|26050482|FG000|Overall Study|PROGRESSIVE DISEASE|1|||
13151437|NCT02547922|26050483|FG001|Overall Study|PROGRESSIVE DISEASE|0|||
13151438|NCT02547922|26050484|FG002|Overall Study|PROGRESSIVE DISEASE|2|||
13151439|NCT02547922|26050482|FG000|Overall Study|Physician Decision|2|||
13099651|NCT03478787|25855762|FG001|Overall Study|Other, Not Specified|0|||
13099652|NCT03478696|25855781|FG000|Overall Study|Adverse Event|1|||
13099653|NCT03478696|25855782|FG001|Overall Study|Adverse Event|5|||
13151440|NCT02547922|26050483|FG001|Overall Study|Physician Decision|1|||
13151441|NCT02547922|26050484|FG002|Overall Study|Physician Decision|2|||
13151442|NCT02547922|26050482|FG000|Overall Study|Patients did not receive IP|1|||
13151443|NCT02547922|26050483|FG001|Overall Study|Patients did not receive IP|1|||
13151444|NCT02547922|26050484|FG002|Overall Study|Patients did not receive IP|0|||
13151445|NCT02547766|26050493|FG000|Overall Study|Withdrawal by Subject|1|||
13151446|NCT02547649|26050535|FG000|Overall Study|Lost to Follow-up|3|||
13151447|NCT02547649|26050536|FG001|Overall Study|Lost to Follow-up|1|||
13151448|NCT02547649|26050537|FG002|Overall Study|Lost to Follow-up|1|||
13151449|NCT02547649|26050535|FG000|Overall Study|Not vaccinated|0|||
13151450|NCT02547649|26050536|FG001|Overall Study|Not vaccinated|0|||
13151451|NCT02547649|26050537|FG002|Overall Study|Not vaccinated|1|||
13151452|NCT02547649|26050535|FG000|Overall Study|Withdrawal by Subject|0|||
13151453|NCT02547649|26050536|FG001|Overall Study|Withdrawal by Subject|4|||
13151454|NCT02547649|26050537|FG002|Overall Study|Withdrawal by Subject|2|||
13151455|NCT02547454|26050567|FG000|Overall Study|Due to hemodialysis|53|||
13151456|NCT02547454|26050567|FG000|Overall Study|Due to transplantation|1|||
13151457|NCT02547454|26050567|FG000|Overall Study|Due to no further need to treat|4|||
13151458|NCT02547454|26050567|FG000|Overall Study|Death|38|||
13151459|NCT02547454|26050567|FG000|Overall Study|Lost to Follow-up|26|||
13151460|NCT02547454|26050567|FG000|Overall Study|Other|39|||
13151461|NCT02547454|26050567|FG000|Overall Study|No data|11|||
13151462|NCT02547441|26050591|FG000|Double-Blind Study Period|Adverse Event|4|||
13151463|NCT02547441|26050592|FG001|Double-Blind Study Period|Adverse Event|9|||
13151464|NCT02547441|26050591|FG000|Double-Blind Study Period|Lost to Follow-up|2|||
13151465|NCT02547441|26050592|FG001|Double-Blind Study Period|Lost to Follow-up|4|||
13151466|NCT02547441|26050591|FG000|Double-Blind Study Period|Physician Decision|1|||
13151467|NCT02547441|26050592|FG001|Double-Blind Study Period|Physician Decision|0|||
13151468|NCT02547441|26050591|FG000|Double-Blind Study Period|Protocol Violation|1|||
13151469|NCT02547441|26050592|FG001|Double-Blind Study Period|Protocol Violation|2|||
13151470|NCT02547441|26050591|FG000|Double-Blind Study Period|Withdrawal by Subject|15|||
13151471|NCT02547441|26050592|FG001|Double-Blind Study Period|Withdrawal by Subject|17|||
13151472|NCT02547441|26050591|FG000|Double-Blind Study Period|Sponsor Decision|1|||
13151473|NCT02547441|26050592|FG001|Double-Blind Study Period|Sponsor Decision|0|||
13151474|NCT02547441|26050591|FG000|Open-Label Study Period|Adverse Event|10|||
13151475|NCT02547441|26050592|FG001|Open-Label Study Period|Adverse Event|11|||
13151476|NCT02547441|26050591|FG000|Open-Label Study Period|Lack of Efficacy|3|||
13151477|NCT02547441|26050592|FG001|Open-Label Study Period|Lack of Efficacy|2|||
13151478|NCT02547441|26050591|FG000|Open-Label Study Period|Lost to Follow-up|7|||
13151479|NCT02547441|26050592|FG001|Open-Label Study Period|Lost to Follow-up|8|||
13151480|NCT02547441|26050591|FG000|Open-Label Study Period|Physician Decision|1|||
13151481|NCT02547441|26050592|FG001|Open-Label Study Period|Physician Decision|0|||
13151482|NCT02547441|26050591|FG000|Open-Label Study Period|Protocol Violation|2|||
13151483|NCT02547441|26050592|FG001|Open-Label Study Period|Protocol Violation|0|||
13151484|NCT02547441|26050591|FG000|Open-Label Study Period|Withdrawal by Subject|33|||
13151485|NCT02547441|26050592|FG001|Open-Label Study Period|Withdrawal by Subject|37|||
13151486|NCT02547441|26050591|FG000|Open-Label Study Period|Terminated by Sponsor|66|||
13151487|NCT02547441|26050592|FG001|Open-Label Study Period|Terminated by Sponsor|69|||
13099654|NCT03478696|25855781|FG000|Overall Study|Lost to Follow-up|1|||
13099655|NCT03478696|25855782|FG001|Overall Study|Lost to Follow-up|0|||
13099656|NCT03478696|25855781|FG000|Overall Study|Physician Decision|6|||
13099657|NCT03478696|25855782|FG001|Overall Study|Physician Decision|3|||
13099658|NCT03478696|25855781|FG000|Overall Study|Withdrawal by Subject|9|||
13099659|NCT03478696|25855782|FG001|Overall Study|Withdrawal by Subject|4|||
13099660|NCT03478683|25855801|FG000|Overall Study|Adverse Event|5|||
13099661|NCT03478683|25855802|FG001|Overall Study|Adverse Event|3|||
13099662|NCT03478683|25855801|FG000|Overall Study|Lost to Follow-up|0|||
13099663|NCT03478683|25855802|FG001|Overall Study|Lost to Follow-up|5|||
13099664|NCT03478683|25855801|FG000|Overall Study|Physician Decision|1|||
13099665|NCT03478683|25855802|FG001|Overall Study|Physician Decision|3|||
13151488|NCT02547428|26050654|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8|||
13151489|NCT02547428|26050655|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1|||
13151490|NCT02547428|26050654|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
13151491|NCT02547428|26050655|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
13151492|NCT02547428|26050654|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
13151493|NCT02547428|26050655|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
13151494|NCT02547428|26050654|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1|||
13151495|NCT02547428|26050655|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3|||
13151496|NCT02547428|26050654|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0|||
13151497|NCT02547428|26050655|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3|||
13151498|NCT02547428|26050654|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0|||
13151499|NCT02547428|26050655|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3|||
13099666|NCT03478683|25855801|FG000|Overall Study|Withdrawal by Subject|7|||
13151500|NCT02547428|26050654|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0|||
13151501|NCT02547428|26050655|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1|||
13151502|NCT02547428|26050654|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1|||
13151503|NCT02547428|26050655|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0|||
13151504|NCT02547363|26050676|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
13151505|NCT02547363|26050677|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
13151506|NCT02547363|26050676|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
13151507|NCT02547363|26050677|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8|||
13151508|NCT02547363|26050676|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
13151509|NCT02547363|26050677|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
13151510|NCT02547363|26050676|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
13151511|NCT02547363|26050677|FG001|3-day Treatment and 8-week Follow-up|Other|1|||
13151512|NCT02547363|26050676|FG000|12-month Follow-up|Withdrawal by Subject|4|||
13151513|NCT02547363|26050677|FG001|12-month Follow-up|Withdrawal by Subject|3|||
13151514|NCT02547363|26050676|FG000|12-month Follow-up|Lost to Follow-up|4|||
13151515|NCT02547363|26050677|FG001|12-month Follow-up|Lost to Follow-up|1|||
13151516|NCT02547363|26050676|FG000|12-month Follow-up|Lack of Efficacy|1|||
13151517|NCT02547363|26050677|FG001|12-month Follow-up|Lack of Efficacy|1|||
13151518|NCT02547363|26050676|FG000|12-month Follow-up|Other|1|||
13151519|NCT02547363|26050677|FG001|12-month Follow-up|Other|0|||
13151520|NCT02547233|26050698|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
13151521|NCT02547233|26050699|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
13151522|NCT02547233|26050698|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1|||
13151523|NCT02547233|26050699|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0|||
13151524|NCT02547233|26050698|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0|||
13151525|NCT02547233|26050699|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9|||
13151526|NCT02547233|26050698|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
13151527|NCT02547233|26050699|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
13151528|NCT02547233|26050698|FG000|12-month Follow-up|Withdrawal by Subject|10|||
13151529|NCT02547233|26050699|FG001|12-month Follow-up|Withdrawal by Subject|10|||
13151530|NCT02547233|26050698|FG000|12-month Follow-up|Lost to Follow-up|3|||
13151531|NCT02547233|26050699|FG001|12-month Follow-up|Lost to Follow-up|3|||
13151532|NCT02547233|26050698|FG000|12-month Follow-up|Lack of Efficacy|1|||
13151533|NCT02547233|26050699|FG001|12-month Follow-up|Lack of Efficacy|2|||
13151534|NCT02547233|26050698|FG000|12-month Follow-up|Protocol Violation|0|||
13151535|NCT02547233|26050699|FG001|12-month Follow-up|Protocol Violation|1|||
13151536|NCT02547233|26050698|FG000|12-month Follow-up|Other|0|||
13151537|NCT02547233|26050699|FG001|12-month Follow-up|Other|1|||
13151538|NCT02547220|26050740|FG000|Overall Study|Withdrawal by Subject|1|||
13151539|NCT02547220|26050741|FG001|Overall Study|Withdrawal by Subject|0|||
13151540|NCT02547220|26050740|FG000|Overall Study|Study terminated by sponsor|18|||
13099667|NCT03478683|25855802|FG001|Overall Study|Withdrawal by Subject|7|||
13099668|NCT03478657|25855822|FG000|Overall Study|Withdrawal by Subject|0|||
13099669|NCT03478657|25855823|FG001|Overall Study|Withdrawal by Subject|1|||
13099670|NCT03478644|25855842|FG000|Phase 2|Withdrawal by Subject|2|||
13099671|NCT03478644|25855843|FG001|Phase 2|Withdrawal by Subject|1|||
13151541|NCT02547220|26050741|FG001|Overall Study|Study terminated by sponsor|20|||
13151542|NCT02547129|26050760|FG000|Overall Study|Difficulty with ongoing infection|1|||
13151543|NCT02547129|26050761|FG001|Overall Study|Difficulty with ongoing infection|0|||
13151544|NCT02547038|26050774|FG000|Overall Study|Lost to Follow-up|3|||
13151545|NCT02547038|26050775|FG001|Overall Study|Lost to Follow-up|2|||
13151546|NCT02546856|26050828|FG000|4 Months Evaluation|Death|2|||
13151547|NCT02546856|26050829|FG001|4 Months Evaluation|Death|3|||
13151548|NCT02546856|26050828|FG000|4 Months Evaluation|Withdrawal by Subject|2|||
13151549|NCT02546856|26050829|FG001|4 Months Evaluation|Withdrawal by Subject|3|||
13151550|NCT02546856|26050828|FG000|4 Months Evaluation|Lost to Follow-up|3|||
13151551|NCT02546856|26050829|FG001|4 Months Evaluation|Lost to Follow-up|3|||
13151552|NCT02546856|26050828|FG000|4 Months Evaluation|Physician Decision|3|||
13151553|NCT02546856|26050829|FG001|4 Months Evaluation|Physician Decision|0|||
13151554|NCT02546856|26050828|FG000|4 Months Evaluation|Working or living abroad|5|||
13151555|NCT02546856|26050829|FG001|4 Months Evaluation|Working or living abroad|1|||
13151556|NCT02546856|26050828|FG000|4 Months Evaluation|reasons not due to titration|4|||
13099672|NCT03478644|25855842|FG000|Phase 2|Lost to Follow-up|1|||
13099673|NCT03478644|25855843|FG001|Phase 2|Lost to Follow-up|0|||
13099674|NCT03478371|25855867|FG000|Overall Study|non-compliance|1|||
13099675|NCT03478371|25855867|FG000|Overall Study|Lost to Follow-up|4|||
13099676|NCT03477903|25855880|FG000|Overall Study|Study Terminated by Sponsor|1|||
13099677|NCT03477838|25855888|FG000|Overall Study|Lost to Follow-up|14|||
13099678|NCT03476239|25855909|FG000|Overall Study|Withdrawal by Subject|10|||
13099679|NCT03476239|25855909|FG000|Overall Study|Death|80|||
13099680|NCT03476239|25855909|FG000|Overall Study|Lost to Follow-up|8|||
13099681|NCT03475875|25855920|FG000|Period 1|Lost to Follow-up|1|||
13099682|NCT03475875|25855921|FG001|Period 1|Lost to Follow-up|0|||
13151557|NCT02546856|26050829|FG001|4 Months Evaluation|reasons not due to titration|1|||
13151558|NCT02546856|26050828|FG000|4 Months Evaluation|HF Unit not active in summer|1|||
13151559|NCT02546856|26050829|FG001|4 Months Evaluation|HF Unit not active in summer|0|||
13151560|NCT02546856|26050828|FG000|6 Months Evaluation|Death|1|||
13151561|NCT02546856|26050829|FG001|6 Months Evaluation|Death|1|||
13151562|NCT02546856|26050828|FG000|6 Months Evaluation|Lost to Follow-up|1|||
13151563|NCT02546856|26050829|FG001|6 Months Evaluation|Lost to Follow-up|1|||
13151564|NCT02546856|26050828|FG000|6 Months Evaluation|Working or living abroad|6|||
13151565|NCT02546856|26050829|FG001|6 Months Evaluation|Working or living abroad|4|||
13151566|NCT02546856|26050828|FG000|6 Months Evaluation|reasons not due to titration|0|||
13151567|NCT02546856|26050829|FG001|6 Months Evaluation|reasons not due to titration|1|||
13151568|NCT02546765|26050880|FG000|Overall Study|Withdrawal by Subject|0|||
13151569|NCT02546765|26050881|FG001|Overall Study|Withdrawal by Subject|1|||
13099683|NCT03475875|25855920|FG000|Period 1|Adverse Event|2|||
13099684|NCT03475875|25855921|FG001|Period 1|Adverse Event|1|||
13099685|NCT03475875|25855920|FG000|Period 2|Adverse Event|3|||
13099686|NCT03475875|25855921|FG001|Period 2|Adverse Event|0|||
13099687|NCT03475875|25855920|FG000|Period 2|Protocol Violation|0|||
13099688|NCT03475875|25855921|FG001|Period 2|Protocol Violation|1|||
13099689|NCT03475316|25855946|FG000|6 Month Intervention|Adverse Event|2|||
13099690|NCT03475316|25855947|FG001|6 Month Intervention|Adverse Event|1|||
13099691|NCT03475316|25855946|FG000|6 Month Intervention|Withdrawal by Subject|2|||
13099692|NCT03475316|25855947|FG001|6 Month Intervention|Withdrawal by Subject|0|||
13099693|NCT03475316|25855946|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1|||
13099694|NCT03475316|25855947|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3|||
13099695|NCT03475316|25855946|FG000|9 Months|Study stopped due to COVID pandemic|3|||
13099696|NCT03475316|25855947|FG001|9 Months|Study stopped due to COVID pandemic|4|||
13099697|NCT03475056|25855988|FG000|Overall Study|Lost to Follow-up|0|||
13099698|NCT03475056|25855989|FG001|Overall Study|Lost to Follow-up|1|||
13099699|NCT03475056|25855988|FG000|Overall Study|Moved from Area|0|||
13099700|NCT03475056|25855989|FG001|Overall Study|Moved from Area|2|||
13099701|NCT03474081|25856012|FG000|Overall Study|Adverse Event|6|||
13099702|NCT03474081|25856013|FG001|Overall Study|Adverse Event|3|||
13099703|NCT03474081|25856012|FG000|Overall Study|Lost to Follow-up|2|||
13099704|NCT03474081|25856013|FG001|Overall Study|Lost to Follow-up|1|||
13099705|NCT03474081|25856012|FG000|Overall Study|Physician Decision|3|||
13099706|NCT03474081|25856013|FG001|Overall Study|Physician Decision|2|||
13099707|NCT03474081|25856012|FG000|Overall Study|Withdrawal by Subject|5|||
13099708|NCT03474081|25856013|FG001|Overall Study|Withdrawal by Subject|7|||
13099709|NCT03474081|25856012|FG000|Overall Study|Investigator site closed|1|||
13099710|NCT03474081|25856013|FG001|Overall Study|Investigator site closed|0|||
13099711|NCT03473808|25856022|FG000|Overall Study|Withdrawal by Subject|1|||
13099712|NCT03473340|25856043|FG000|Overall Study|Follow up not possible due to COVID restrictions|3|||
13099713|NCT03473340|25856044|FG001|Overall Study|Follow up not possible due to COVID restrictions|0|||
13099714|NCT03473340|25856043|FG000|Overall Study|Withdrawal by Subject|1|||
13099715|NCT03473340|25856044|FG001|Overall Study|Withdrawal by Subject|0|||
13099716|NCT03473340|25856043|FG000|Overall Study|Lost to Follow-up|1|||
13099717|NCT03473340|25856044|FG001|Overall Study|Lost to Follow-up|2|||
13099718|NCT03473301|25856068|FG000|Overall Study|Protocol Violation|4|||
13099719|NCT03473301|25856069|FG001|Overall Study|Protocol Violation|0|||
13099720|NCT03473301|25856070|FG002|Overall Study|Protocol Violation|0|||
13099721|NCT03473301|25856068|FG000|Overall Study|Withdrawal by Subject|0|||
13099722|NCT03473301|25856069|FG001|Overall Study|Withdrawal by Subject|1|||
13099723|NCT03473301|25856070|FG002|Overall Study|Withdrawal by Subject|0|||
13099724|NCT03473301|25856068|FG000|Overall Study|Missed study visit due to pandemic restrictions|7|||
13099725|NCT03473301|25856069|FG001|Overall Study|Missed study visit due to pandemic restrictions|5|||
13099726|NCT03473301|25856070|FG002|Overall Study|Missed study visit due to pandemic restrictions|6|||
13099727|NCT03473236|25856268|FG000|Overall Study|Withdrawal by Subject|0|||
13099728|NCT03473236|25856269|FG001|Overall Study|Withdrawal by Subject|0|||
13099729|NCT03473236|25856270|FG002|Overall Study|Withdrawal by Subject|0|||
13099730|NCT03473236|25856271|FG003|Overall Study|Withdrawal by Subject|0|||
13099731|NCT03473236|25856272|FG004|Overall Study|Withdrawal by Subject|0|||
13099732|NCT03473236|25856273|FG005|Overall Study|Withdrawal by Subject|1|||
13099733|NCT03473236|25856274|FG006|Overall Study|Withdrawal by Subject|0|||
13099734|NCT03473236|25856275|FG007|Overall Study|Withdrawal by Subject|0|||
13099735|NCT03473236|25856276|FG008|Overall Study|Withdrawal by Subject|1|||
13099736|NCT03473236|25856277|FG009|Overall Study|Withdrawal by Subject|0|||
13099737|NCT03473197|25856283|FG000|Overall Study|Adverse Event|4|||
13099738|NCT03473197|25856283|FG000|Overall Study|Lost to Follow-up|1|||
13099739|NCT03473197|25856283|FG000|Overall Study|Withdrawal by Subject|5|||
13099740|NCT03472885|25856293|FG000|Overall Study|Adverse Event|1|||
13099741|NCT03472547|25856299|FG000|Overall Study|Withdrawal by Subject|30|||
13099742|NCT03472534|25856305|FG000|Overall Study|Withdrawal by Subject|9|||
13099743|NCT03472534|25856305|FG000|Overall Study|Adverse Event|2|||
13099744|NCT03472521|25856322|FG000|Overall Study|Lost to Follow-up|3|||
13222679|NCT01803646|26286745|FG000|Overall Study|Lost to Follow-up|5|||
13099745|NCT03472521|25856323|FG001|Overall Study|Lost to Follow-up|2|||
13099746|NCT03472521|25856322|FG000|Overall Study|Discontinued intervention|3|||
13099747|NCT03472521|25856323|FG001|Overall Study|Discontinued intervention|1|||
13099748|NCT03472326|25856352|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
13099749|NCT03472326|25856353|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
13099750|NCT03472326|25856354|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1|||
13099751|NCT03472326|25856355|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2|||
13099752|NCT03472326|25856352|FG000|Part 2: Combination Therapy|Pregnancy|0|||
13099753|NCT03472326|25856353|FG001|Part 2: Combination Therapy|Pregnancy|0|||
13099754|NCT03472326|25856354|FG002|Part 2: Combination Therapy|Pregnancy|0|||
13099755|NCT03472326|25856355|FG003|Part 2: Combination Therapy|Pregnancy|1|||
13099756|NCT03472014|25856366|FG000|Overall Study|Lost to Follow-up|4|||
13099757|NCT03471871|25856405|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
13099758|NCT03471871|25856406|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
13099759|NCT03471871|25856407|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1|||
13099760|NCT03471871|25856408|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
13099761|NCT03471871|25856409|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
13099762|NCT03471871|25856405|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
13099763|NCT03471871|25856406|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
13099764|NCT03471871|25856407|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
13099765|NCT03471871|25856408|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
13099766|NCT03471871|25856409|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
13099767|NCT03471871|25856405|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
13099768|NCT03471871|25856406|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
13099769|NCT03471871|25856407|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
13151570|NCT02546765|26050882|FG002|Overall Study|Withdrawal by Subject|0|||
13151571|NCT02546765|26050883|FG003|Overall Study|Withdrawal by Subject|0|||
13151572|NCT02546674|26050906|FG000|Overall Study|Adverse Event|19|||
13151573|NCT02546674|26050906|FG000|Overall Study|Death|1|||
13151574|NCT02546674|26050906|FG000|Overall Study|Lost to Follow-up|1|||
13151575|NCT02546674|26050906|FG000|Overall Study|Physician Decision|13|||
13151576|NCT02546674|26050906|FG000|Overall Study|Pregnancy|1|||
13151577|NCT02546674|26050906|FG000|Overall Study|Progressive Disease|2|||
13151578|NCT02546674|26050906|FG000|Overall Study|Protocol Deviation|2|||
13151579|NCT02546674|26050906|FG000|Overall Study|Subject/Guardian Decision|6|||
13151580|NCT02546674|26050906|FG000|Overall Study|Withdrawal of Informed Consent|3|||
13099770|NCT03471871|25856408|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
13099771|NCT03471871|25856409|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1|||
13099772|NCT03471871|25856405|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
13099773|NCT03471871|25856406|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
13099774|NCT03471871|25856407|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
13099775|NCT03471871|25856408|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
13099776|NCT03471871|25856409|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1|||
13099777|NCT03471871|25856405|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
13099778|NCT03471871|25856406|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
13099779|NCT03471871|25856407|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
13099780|NCT03471871|25856408|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1|||
13099781|NCT03471871|25856409|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
13099782|NCT03471078|25856428|FG000|Overall Study|Withdrawal by Subject|9|||
13099783|NCT03471078|25856429|FG001|Overall Study|Withdrawal by Subject|1|||
13099784|NCT03471078|25856428|FG000|Overall Study|Adverse Event|4|||
13099785|NCT03471078|25856429|FG001|Overall Study|Adverse Event|1|||
13099786|NCT03471078|25856428|FG000|Overall Study|Physician Decision|3|||
13099787|NCT03471078|25856429|FG001|Overall Study|Physician Decision|2|||
13099788|NCT03471078|25856428|FG000|Overall Study|Death|2|||
13099789|NCT03471078|25856429|FG001|Overall Study|Death|0|||
13099790|NCT03471078|25856428|FG000|Overall Study|Other|3|||
13099791|NCT03471078|25856429|FG001|Overall Study|Other|2|||
13099792|NCT03470545|25856452|FG000|Overall Study|Death|0|||
13099793|NCT03470545|25856453|FG001|Overall Study|Death|1|||
13099794|NCT03470545|25856452|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1|||
13099795|NCT03470545|25856453|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0|||
13099796|NCT03470545|25856452|FG000|Overall Study|Adverse Event|2|||
13099797|NCT03470545|25856453|FG001|Overall Study|Adverse Event|0|||
13099798|NCT03470545|25856452|FG000|Overall Study|Withdrawal by Subject|1|||
13099799|NCT03470545|25856453|FG001|Overall Study|Withdrawal by Subject|1|||
13099800|NCT03470545|25856452|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0|||
13099801|NCT03470545|25856453|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1|||
13151581|NCT02546609|26050957|FG000|Overall Study|Withdrawal by Subject|0|||
13151582|NCT02546609|26050958|FG001|Overall Study|Withdrawal by Subject|1|||
13099802|NCT03470194|25856466|FG000|Overall Study|Lost to Follow-up|11|||
13099803|NCT03470194|25856467|FG001|Overall Study|Lost to Follow-up|17|||
13099804|NCT03469349|25856490|FG000|Overall Study|Withdrawal by Subject|1|||
13099805|NCT03469349|25856491|FG001|Overall Study|Withdrawal by Subject|3|||
13099806|NCT03469349|25856490|FG000|Overall Study|Progressive Disease|0|||
13099807|NCT03469349|25856491|FG001|Overall Study|Progressive Disease|1|||
13099808|NCT03469349|25856490|FG000|Overall Study|Lost to Follow-up|2|||
13099809|NCT03469349|25856491|FG001|Overall Study|Lost to Follow-up|2|||
13099810|NCT03469349|25856490|FG000|Overall Study|Adverse Event|2|||
13099811|NCT03469349|25856491|FG001|Overall Study|Adverse Event|4|||
13099812|NCT03469336|25856516|FG000|Overall Study|Adverse Event|1|||
13099813|NCT03469258|25856530|FG000|Overall Study|Upon surgery, did not meet criteria|4|||
13099814|NCT03468855|25856566|FG000|Overall Study|Adverse Event|2|||
13099815|NCT03468855|25856566|FG000|Overall Study|Lost to Follow-up|5|||
13099816|NCT03468855|25856566|FG000|Overall Study|Withdrawal by Subject|3|||
13099817|NCT03468855|25856566|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1|||
13099818|NCT03468543|25856578|FG000|Overall Study|Protocol stopping rules met|3|||
13099819|NCT03467971|25856605|FG000|Treatment Period 2|Withdrawal by Subject|0|||
13099820|NCT03467971|25856606|FG001|Treatment Period 2|Withdrawal by Subject|1|||
13099821|NCT03467945|25856671|FG000|Treatment Period 2|Withdrawal by Subject|0|||
13099822|NCT03467945|25856672|FG001|Treatment Period 2|Withdrawal by Subject|1|||
13099823|NCT03467945|25856673|FG002|Treatment Period 2|Withdrawal by Subject|0|||
13099824|NCT03467945|25856674|FG003|Treatment Period 2|Withdrawal by Subject|0|||
13099825|NCT03467945|25856671|FG000|Treatment Period 3|Withdrawal by Subject|1|||
13099826|NCT03467945|25856672|FG001|Treatment Period 3|Withdrawal by Subject|0|||
13099827|NCT03467945|25856673|FG002|Treatment Period 3|Withdrawal by Subject|2|||
13099828|NCT03467945|25856674|FG003|Treatment Period 3|Withdrawal by Subject|1|||
13099829|NCT03467763|25856684|FG000|Overall Study|Lost to Follow-up|1|||
13099830|NCT03467763|25856684|FG000|Overall Study|Protocol Violation|2|||
13099831|NCT03467425|25856701|FG000|Overall Study|Adverse Event|9|||
13099832|NCT03467425|25856702|FG001|Overall Study|Adverse Event|9|||
13099833|NCT03467425|25856701|FG000|Overall Study|Lack of Efficacy|3|||
13099834|NCT03467425|25856702|FG001|Overall Study|Lack of Efficacy|1|||
13099835|NCT03467425|25856701|FG000|Overall Study|Protocol Violation|0|||
13099836|NCT03467425|25856702|FG001|Overall Study|Protocol Violation|1|||
13099837|NCT03467425|25856701|FG000|Overall Study|Lost to Follow-up|18|||
13099838|NCT03467425|25856702|FG001|Overall Study|Lost to Follow-up|25|||
13099839|NCT03467425|25856701|FG000|Overall Study|Physician Decision|2|||
13099840|NCT03467425|25856702|FG001|Overall Study|Physician Decision|1|||
13099841|NCT03467425|25856701|FG000|Overall Study|Withdrawal by Subject|15|||
13099842|NCT03467425|25856702|FG001|Overall Study|Withdrawal by Subject|17|||
13099843|NCT03467217|25856747|FG000|Overall Study|Trial stopped early|5|||
13099844|NCT03467217|25856748|FG001|Overall Study|Trial stopped early|2|||
13099845|NCT03467217|25856747|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5|||
13099846|NCT03467217|25856748|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2|||
13099847|NCT03467217|25856747|FG000|Overall Study|Lost to Follow-up|0|||
13099848|NCT03467217|25856748|FG001|Overall Study|Lost to Follow-up|2|||
13099849|NCT03467152|25856792|FG000|Overall Study|Adverse Event|4|||
13099850|NCT03467152|25856793|FG001|Overall Study|Adverse Event|5|||
13099851|NCT03467152|25856794|FG002|Overall Study|Adverse Event|0|||
13099852|NCT03467152|25856792|FG000|Overall Study|Subject Choice|1|||
13099853|NCT03467152|25856793|FG001|Overall Study|Subject Choice|3|||
13099854|NCT03467152|25856794|FG002|Overall Study|Subject Choice|0|||
13099855|NCT03467152|25856792|FG000|Overall Study|Lost to Follow-up|1|||
13099856|NCT03467152|25856793|FG001|Overall Study|Lost to Follow-up|0|||
13099857|NCT03467152|25856794|FG002|Overall Study|Lost to Follow-up|0|||
13099858|NCT03467152|25856792|FG000|Overall Study|Withdrawal by Subject|4|||
13099859|NCT03467152|25856793|FG001|Overall Study|Withdrawal by Subject|2|||
13099860|NCT03467152|25856794|FG002|Overall Study|Withdrawal by Subject|0|||
13099861|NCT03467152|25856792|FG000|Overall Study|Others|3|||
13099862|NCT03467152|25856793|FG001|Overall Study|Others|0|||
13099863|NCT03467152|25856794|FG002|Overall Study|Others|0|||
13099864|NCT03467152|25856792|FG000|Overall Study|Not treated|3|||
13099865|NCT03467152|25856793|FG001|Overall Study|Not treated|1|||
13099866|NCT03467152|25856794|FG002|Overall Study|Not treated|6|||
13099867|NCT03466658|25856802|FG000|Overall Study|Withdrawal by Subject|3|||
13099868|NCT03466099|25856826|FG000|Overall Study|Adverse Event|1|||
13099869|NCT03466099|25856827|FG001|Overall Study|Adverse Event|1|||
13099870|NCT03466099|25856828|FG002|Overall Study|Adverse Event|1|||
13099871|NCT03466099|25856826|FG000|Overall Study|Withdrawal by Subject|2|||
13099872|NCT03466099|25856827|FG001|Overall Study|Withdrawal by Subject|3|||
13099873|NCT03466099|25856828|FG002|Overall Study|Withdrawal by Subject|1|||
13099874|NCT03466099|25856826|FG000|Overall Study|Use of rescue medication|8|||
13099875|NCT03466099|25856827|FG001|Overall Study|Use of rescue medication|9|||
13099876|NCT03466099|25856828|FG002|Overall Study|Use of rescue medication|13|||
13099877|NCT03466099|25856826|FG000|Overall Study|Rescued without meeting criteria|4|||
13099878|NCT03466099|25856827|FG001|Overall Study|Rescued without meeting criteria|1|||
13099879|NCT03466099|25856828|FG002|Overall Study|Rescued without meeting criteria|1|||
13099880|NCT03466099|25856826|FG000|Overall Study|Subject compliance|2|||
13099881|NCT03466099|25856827|FG001|Overall Study|Subject compliance|0|||
13099882|NCT03466099|25856828|FG002|Overall Study|Subject compliance|0|||
13099883|NCT03466099|25856826|FG000|Overall Study|Worsening disease|0|||
13099884|NCT03466099|25856827|FG001|Overall Study|Worsening disease|0|||
13099885|NCT03466099|25856828|FG002|Overall Study|Worsening disease|1|||
13099886|NCT03466086|25856839|FG000|Period 1|Sponsor decision due to study timeline|1|||
13099887|NCT03466086|25856840|FG001|Period 1|Sponsor decision due to study timeline|0|||
13099888|NCT03466086|25856839|FG000|Period 1|Withdrawal by Subject|1|||
13099889|NCT03466086|25856840|FG001|Period 1|Withdrawal by Subject|0|||
13099890|NCT03466073|25856889|FG000|Overall Study|Death|1|||
13099891|NCT03466073|25856890|FG001|Overall Study|Death|0|||
13099892|NCT03466073|25856891|FG002|Overall Study|Death|0|||
13099893|NCT03466073|25856892|FG003|Overall Study|Death|0|||
13099894|NCT03466073|25856893|FG004|Overall Study|Death|0|||
13099895|NCT03466073|25856894|FG005|Overall Study|Death|1|||
13099896|NCT03466060|25856921|FG000|Period 1|Test Lens Damage|0|||
13099897|NCT03466060|25856922|FG001|Period 1|Test Lens Damage|2|||
13099898|NCT03466060|25856923|FG002|Period 1|Test Lens Damage|0|||
13099899|NCT03466060|25856924|FG003|Period 1|Test Lens Damage|0|||
13099900|NCT03466060|25856925|FG004|Period 1|Test Lens Damage|0|||
13099901|NCT03466060|25856926|FG005|Period 1|Test Lens Damage|0|||
13099902|NCT03466060|25856921|FG000|Period 1|Withdrawal by Subject|0|||
13099903|NCT03466060|25856922|FG001|Period 1|Withdrawal by Subject|0|||
13099904|NCT03466060|25856923|FG002|Period 1|Withdrawal by Subject|2|||
13099905|NCT03466060|25856924|FG003|Period 1|Withdrawal by Subject|0|||
13099906|NCT03466060|25856925|FG004|Period 1|Withdrawal by Subject|0|||
13099907|NCT03466060|25856926|FG005|Period 1|Withdrawal by Subject|0|||
13099908|NCT03466060|25856921|FG000|Period 1|Lost to Follow-up|0|||
13099909|NCT03466060|25856922|FG001|Period 1|Lost to Follow-up|0|||
13099910|NCT03466060|25856923|FG002|Period 1|Lost to Follow-up|0|||
13099911|NCT03466060|25856924|FG003|Period 1|Lost to Follow-up|1|||
13099912|NCT03466060|25856925|FG004|Period 1|Lost to Follow-up|0|||
13099913|NCT03466060|25856926|FG005|Period 1|Lost to Follow-up|0|||
13099914|NCT03466060|25856921|FG000|Period 1|Grade 2 Conjunctivitis|0|||
13099915|NCT03466060|25856922|FG001|Period 1|Grade 2 Conjunctivitis|0|||
13099916|NCT03466060|25856923|FG002|Period 1|Grade 2 Conjunctivitis|1|||
13099917|NCT03466060|25856924|FG003|Period 1|Grade 2 Conjunctivitis|0|||
13099918|NCT03466060|25856925|FG004|Period 1|Grade 2 Conjunctivitis|0|||
13099919|NCT03466060|25856926|FG005|Period 1|Grade 2 Conjunctivitis|0|||
13099920|NCT03466060|25856921|FG000|Period 2|Lens Handling Difficulties|0|||
13099921|NCT03466060|25856922|FG001|Period 2|Lens Handling Difficulties|0|||
13099922|NCT03466060|25856923|FG002|Period 2|Lens Handling Difficulties|1|||
13099923|NCT03466060|25856924|FG003|Period 2|Lens Handling Difficulties|0|||
13099924|NCT03466060|25856925|FG004|Period 2|Lens Handling Difficulties|0|||
13099925|NCT03466060|25856926|FG005|Period 2|Lens Handling Difficulties|0|||
13099926|NCT03465904|25856951|FG000|Overall Study|Withdrawal by Subject|9|||
13099927|NCT03465904|25856952|FG001|Overall Study|Withdrawal by Subject|5|||
13099928|NCT03465904|25856951|FG000|Overall Study|Lost to Follow-up|10|||
13099929|NCT03465904|25856952|FG001|Overall Study|Lost to Follow-up|9|||
13099930|NCT03465904|25856951|FG000|Overall Study|Protocol Violation|8|||
13099931|NCT03465904|25856952|FG001|Overall Study|Protocol Violation|5|||
13099932|NCT03465904|25856951|FG000|Overall Study|Ineligible for mITT analysis|62|||
13099933|NCT03465904|25856952|FG001|Overall Study|Ineligible for mITT analysis|47|||
13099934|NCT03465891|25856965|FG000|Overall Study|Withdrawal by Subject|0|||
13099935|NCT03465891|25856966|FG001|Overall Study|Withdrawal by Subject|1|||
13099936|NCT03465891|25856965|FG000|Overall Study|Disease progression|1|||
13099937|NCT03465891|25856966|FG001|Overall Study|Disease progression|0|||
13099938|NCT03465878|25857013|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
13099939|NCT03465878|25857014|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1|||
13099940|NCT03465878|25857015|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
13099941|NCT03465878|25857016|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
13099942|NCT03465878|25857013|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
13099943|NCT03465878|25857014|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
13099944|NCT03465878|25857015|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
13099945|NCT03465878|25857016|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1|||
13099946|NCT03465878|25857013|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
13099947|NCT03465878|25857014|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
13099948|NCT03465878|25857015|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
13099949|NCT03465878|25857016|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1|||
13132900|NCT02781584|25985795|FG003|Pre-treatment Phase|Adverse Event|0|||
13132901|NCT02781584|25985796|FG004|Pre-treatment Phase|Adverse Event|0|||
13132902|NCT02781584|25985797|FG005|Pre-treatment Phase|Adverse Event|0|||
13132903|NCT02781584|25985798|FG006|Pre-treatment Phase|Adverse Event|0|||
13132904|NCT02781584|25985799|FG007|Pre-treatment Phase|Adverse Event|0|||
13132905|NCT02781584|25985800|FG008|Pre-treatment Phase|Adverse Event|0|||
13132906|NCT02781584|25985801|FG009|Pre-treatment Phase|Adverse Event|0|||
13151583|NCT02546609|26050959|FG002|Overall Study|Withdrawal by Subject|2|||
13151584|NCT02546609|26050957|FG000|Overall Study|Adverse Event|0|||
13151585|NCT02546609|26050958|FG001|Overall Study|Adverse Event|6|||
13151586|NCT02546609|26050959|FG002|Overall Study|Adverse Event|1|||
13151587|NCT02546609|26050957|FG000|Overall Study|Protocol Violation|0|||
13151588|NCT02546609|26050958|FG001|Overall Study|Protocol Violation|1|||
13151589|NCT02546609|26050959|FG002|Overall Study|Protocol Violation|1|||
13151590|NCT02546609|26050957|FG000|Overall Study|Lost to Follow-up|2|||
13151591|NCT02546609|26050958|FG001|Overall Study|Lost to Follow-up|3|||
13151592|NCT02546609|26050959|FG002|Overall Study|Lost to Follow-up|1|||
13099950|NCT03465709|25857026|FG000|Overall Study|Study/Site Terminated by Sponsor|14|||
13099951|NCT03465709|25857026|FG000|Overall Study|Withdrawal by Subject|3|||
13099952|NCT03465436|25857073|FG000|Period 1|Protocol Violation|0|||
13099953|NCT03465436|25857074|FG001|Period 1|Protocol Violation|0|||
13099954|NCT03465436|25857075|FG002|Period 1|Protocol Violation|1|||
13099955|NCT03465436|25857076|FG003|Period 1|Protocol Violation|0|||
13099956|NCT03465436|25857073|FG000|Period 2|Protocol Violation|0|||
13099957|NCT03465436|25857074|FG001|Period 2|Protocol Violation|1|||
13099958|NCT03465436|25857075|FG002|Period 2|Protocol Violation|0|||
13099959|NCT03465436|25857076|FG003|Period 2|Protocol Violation|0|||
13099960|NCT03465436|25857073|FG000|Period 3|Protocol Violation|1|||
13099961|NCT03465436|25857074|FG001|Period 3|Protocol Violation|1|||
13099962|NCT03465436|25857075|FG002|Period 3|Protocol Violation|0|||
13099963|NCT03465436|25857076|FG003|Period 3|Protocol Violation|0|||
13099964|NCT03465436|25857073|FG000|Period 4|Protocol Violation|0|||
13099965|NCT03465436|25857074|FG001|Period 4|Protocol Violation|0|||
13099966|NCT03465436|25857075|FG002|Period 4|Protocol Violation|1|||
13099967|NCT03465436|25857076|FG003|Period 4|Protocol Violation|0|||
13099968|NCT03464422|25857094|FG000|Overall Study|Lost to Follow-up|2|||
13099969|NCT03464422|25857094|FG000|Overall Study|Withdrawal by Subject|2|||
13099970|NCT03464383|25857129|FG000|Overall Study|Lost to Follow-up|1|||
13099971|NCT03464383|25857130|FG001|Overall Study|Lost to Follow-up|0|||
13099972|NCT03464383|25857131|FG002|Overall Study|Lost to Follow-up|0|||
13099973|NCT03464383|25857129|FG000|Overall Study|Withdrawal by Subject|0|||
13099974|NCT03464383|25857130|FG001|Overall Study|Withdrawal by Subject|1|||
13099975|NCT03464383|25857131|FG002|Overall Study|Withdrawal by Subject|0|||
13099976|NCT03464136|25857178|FG000|Overall Study|Lost to Follow-up|5|||
13099977|NCT03464136|25857179|FG001|Overall Study|Lost to Follow-up|8|||
13099978|NCT03464136|25857178|FG000|Overall Study|Withdrawal by Subject|16|||
13151593|NCT02546609|26050957|FG000|Overall Study|travel or work schedule restriction|0|||
13151594|NCT02546609|26050958|FG001|Overall Study|travel or work schedule restriction|0|||
13151595|NCT02546609|26050959|FG002|Overall Study|travel or work schedule restriction|2|||
13151596|NCT02546544|26050970|FG000|Overall Study|Disease Progression|14|||
13151597|NCT02546544|26050970|FG000|Overall Study|Adverse Event|1|||
13151598|NCT02546544|26050970|FG000|Overall Study|Withdrawal by Subject|1|||
13151599|NCT02546362|26050991|FG000|4-week Treatment Period|Lost to Follow-up|1|||
13151600|NCT02546362|26050991|FG000|4-week Treatment Period|Change in medication|2|||
13151601|NCT02546362|26050991|FG000|12-week Treatment Period|Withdrawal by Subject|6|||
13151602|NCT02546362|26050991|FG000|12-week Treatment Period|Lost to Follow-up|2|||
13151603|NCT02546362|26050991|FG000|12-week Treatment Period|Change in medication|1|||
13151604|NCT02546323|26051016|FG000|Overall Study|Withdrawal by Subject|36|||
13151605|NCT02546323|26051017|FG001|Overall Study|Withdrawal by Subject|33|||
13151606|NCT02546323|26051016|FG000|Overall Study|Eligibility Criteria not Fulfilled|0|||
13151607|NCT02546323|26051017|FG001|Overall Study|Eligibility Criteria not Fulfilled|1|||
13151608|NCT02546323|26051016|FG000|Overall Study|Adverse Event|17|||
13151609|NCT02546323|26051017|FG001|Overall Study|Adverse Event|11|||
13151610|NCT02546323|26051016|FG000|Overall Study|Patient Specific Reasons|1|||
13151611|NCT02546323|26051017|FG001|Overall Study|Patient Specific Reasons|2|||
13151612|NCT02546323|26051016|FG000|Overall Study|Lost to Follow-up|2|||
13151613|NCT02546323|26051017|FG001|Overall Study|Lost to Follow-up|3|||
13151614|NCT02546323|26051016|FG000|Overall Study|Non-compliance with Study Drug|2|||
13151615|NCT02546323|26051017|FG001|Overall Study|Non-compliance with Study Drug|2|||
13151616|NCT02546323|26051016|FG000|Overall Study|Met Withdrawal Criteria|2|||
13151617|NCT02546323|26051017|FG001|Overall Study|Met Withdrawal Criteria|14|||
13151618|NCT02546193|26051060|FG000|Overall Study|Withdrawal by Subject|2|||
13151619|NCT02546193|26051061|FG001|Overall Study|Withdrawal by Subject|0|||
13099979|NCT03464136|25857179|FG001|Overall Study|Withdrawal by Subject|13|||
13099980|NCT03464136|25857178|FG000|Overall Study|Death|1|||
13099981|NCT03464136|25857179|FG001|Overall Study|Death|0|||
13099982|NCT03464136|25857178|FG000|Overall Study|Other|8|||
13099983|NCT03464136|25857179|FG001|Overall Study|Other|4|||
13099984|NCT03463577|25857221|FG000|Overall Study|Lost to Follow-up|238|||
13099985|NCT03463577|25857222|FG001|Overall Study|Lost to Follow-up|435|||
13099986|NCT03463577|25857223|FG002|Overall Study|Lost to Follow-up|0|||
13151620|NCT02546193|26051062|FG002|Overall Study|Withdrawal by Subject|1|||
13151621|NCT02546193|26051063|FG003|Overall Study|Withdrawal by Subject|0|||
13151622|NCT02546193|26051060|FG000|Overall Study|Not eligible at time of induction|4|||
13151623|NCT02546193|26051061|FG001|Overall Study|Not eligible at time of induction|6|||
13151624|NCT02546193|26051062|FG002|Overall Study|Not eligible at time of induction|1|||
13151625|NCT02546193|26051063|FG003|Overall Study|Not eligible at time of induction|0|||
13151626|NCT02545933|26051081|FG000|Overall Study|Adverse Event|3|||
13151627|NCT02545933|26051082|FG001|Overall Study|Adverse Event|0|||
13151628|NCT02545933|26051083|FG002|Overall Study|Adverse Event|0|||
13151629|NCT02545933|26051081|FG000|Overall Study|Withdrawal by Subject|2|||
13151630|NCT02545933|26051082|FG001|Overall Study|Withdrawal by Subject|3|||
13151631|NCT02545933|26051083|FG002|Overall Study|Withdrawal by Subject|3|||
13151632|NCT02545933|26051081|FG000|Overall Study|Protocol Violation|1|||
13151633|NCT02545933|26051082|FG001|Overall Study|Protocol Violation|0|||
13151634|NCT02545933|26051083|FG002|Overall Study|Protocol Violation|1|||
13151635|NCT02545868|26051164|FG000|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|33|||
13151636|NCT02545868|26051165|FG001|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|35|||
13151637|NCT02545868|26051166|FG002|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|34|||
13151638|NCT02545543|26051197|FG000|Overall Study|Lost to Follow-up|67|||
13151639|NCT02545543|26051198|FG001|Overall Study|Lost to Follow-up|25|||
13151640|NCT02545543|26051197|FG000|Overall Study|Physician Decision|3|||
13151641|NCT02545543|26051198|FG001|Overall Study|Physician Decision|0|||
13151642|NCT02545543|26051197|FG000|Overall Study|Withdrawal by Subject|9|||
13151643|NCT02545543|26051198|FG001|Overall Study|Withdrawal by Subject|8|||
13151644|NCT02545543|26051197|FG000|Overall Study|Noncomplaince|1|||
13151645|NCT02545543|26051198|FG001|Overall Study|Noncomplaince|0|||
13151646|NCT02545543|26051197|FG000|Overall Study|Enrolment of subject at >1 study site|1|||
13151647|NCT02545543|26051198|FG001|Overall Study|Enrolment of subject at >1 study site|1|||
13151648|NCT02545504|26051219|FG000|Overall Study|Death|174|||
13151649|NCT02545504|26051220|FG001|Overall Study|Death|168|||
13151650|NCT02545504|26051219|FG000|Overall Study|Unknown reason|30|||
13151651|NCT02545504|26051220|FG001|Overall Study|Unknown reason|32|||
13151652|NCT02545504|26051219|FG000|Overall Study|Withdrew consent|9|||
13151653|NCT02545504|26051220|FG001|Overall Study|Withdrew consent|11|||
13151654|NCT02545504|26051219|FG000|Overall Study|Investigator's discretion|3|||
13099987|NCT03463577|25857224|FG003|Overall Study|Lost to Follow-up|0|||
13099988|NCT03463577|25857225|FG004|Overall Study|Lost to Follow-up|0|||
13099989|NCT03463577|25857226|FG005|Overall Study|Lost to Follow-up|0|||
13099990|NCT03463577|25857221|FG000|Overall Study|With unknown pregnancy outcome|0|||
13099991|NCT03463577|25857222|FG001|Overall Study|With unknown pregnancy outcome|5|||
13099992|NCT03463577|25857223|FG002|Overall Study|With unknown pregnancy outcome|0|||
13099993|NCT03463577|25857224|FG003|Overall Study|With unknown pregnancy outcome|0|||
13099994|NCT03463577|25857225|FG004|Overall Study|With unknown pregnancy outcome|0|||
13099995|NCT03463577|25857226|FG005|Overall Study|With unknown pregnancy outcome|0|||
13099996|NCT03463577|25857221|FG000|Overall Study|Maternal death|2|||
13099997|NCT03463577|25857222|FG001|Overall Study|Maternal death|0|||
13099998|NCT03463577|25857223|FG002|Overall Study|Maternal death|0|||
13099999|NCT03463577|25857224|FG003|Overall Study|Maternal death|0|||
13151655|NCT02545504|26051220|FG001|Overall Study|Investigator's discretion|1|||
13151656|NCT02545504|26051219|FG000|Overall Study|Lost to Follow-up|2|||
13151657|NCT02545504|26051220|FG001|Overall Study|Lost to Follow-up|2|||
13151658|NCT02545322|26051227|FG000|Overall Study|Withdrawal by Subject|3|||
13151659|NCT02545270|26051247|FG000|Overall Study|technical difficulties|0|||
13151660|NCT02545270|26051248|FG001|Overall Study|technical difficulties|1|||
13151661|NCT02545270|26051249|FG002|Overall Study|technical difficulties|0|||
13151662|NCT02545270|26051247|FG000|Overall Study|Videos being too similar to other|0|||
13151663|NCT02545270|26051248|FG001|Overall Study|Videos being too similar to other|0|||
13151664|NCT02545270|26051249|FG002|Overall Study|Videos being too similar to other|2|||
13151665|NCT02545075|26051276|FG000|Randomization|Lost to Follow-up|0|||
13151666|NCT02545075|26051277|FG001|Randomization|Lost to Follow-up|1|||
13100000|NCT03463577|25857225|FG004|Overall Study|Maternal death|0|||
13100001|NCT03463577|25857226|FG005|Overall Study|Maternal death|0|||
13100002|NCT03463577|25857221|FG000|Overall Study|Neonatal death|0|||
13151667|NCT02545075|26051276|FG000|Randomization|Withdrawal by Subject|0|||
13151668|NCT02545075|26051277|FG001|Randomization|Withdrawal by Subject|6|||
13151669|NCT02545075|26051276|FG000|Treatment|Disease progression|71|||
13151670|NCT02545075|26051277|FG001|Treatment|Disease progression|32|||
13151671|NCT02545075|26051276|FG000|Treatment|Participant dicontinued study treatment|7|||
13151672|NCT02545075|26051277|FG001|Treatment|Participant dicontinued study treatment|9|||
13151673|NCT02545075|26051276|FG000|Treatment|Withdrawal by Subject|1|||
13151674|NCT02545075|26051277|FG001|Treatment|Withdrawal by Subject|0|||
13151675|NCT02545075|26051276|FG000|Treatment|Adverse event not related to study drug|1|||
13151676|NCT02545075|26051277|FG001|Treatment|Adverse event not related to study drug|0|||
13151677|NCT02545075|26051276|FG000|Treatment|Death|1|||
13151678|NCT02545075|26051277|FG001|Treatment|Death|0|||
13151679|NCT02545075|26051276|FG000|Treatment|Participant drug toxicity|1|||
13151680|NCT02545075|26051277|FG001|Treatment|Participant drug toxicity|0|||
13151681|NCT02545075|26051276|FG000|Treatment|Completed treatment|40|||
13151682|NCT02545075|26051277|FG001|Treatment|Completed treatment|12|||
13151683|NCT02545049|26051300|FG000|Overall Study|Withdrawal by Subject|1|||
13151684|NCT02545049|26051301|FG001|Overall Study|Withdrawal by Subject|7|||
13151685|NCT02545049|26051300|FG000|Overall Study|Lost to Follow-up|4|||
13151686|NCT02545049|26051301|FG001|Overall Study|Lost to Follow-up|6|||
13151687|NCT02545049|26051300|FG000|Overall Study|GCP violations|37|||
13151688|NCT02545049|26051301|FG001|Overall Study|GCP violations|48|||
13151689|NCT02544763|26051331|FG000|Overall Study|Adverse Event|8|||
13151690|NCT02544763|26051332|FG001|Overall Study|Adverse Event|8|||
13151691|NCT02544763|26051333|FG002|Overall Study|Adverse Event|0|||
13151692|NCT02544763|26051331|FG000|Overall Study|Withdrawn by parent/guardian|1|||
13151693|NCT02544763|26051332|FG001|Overall Study|Withdrawn by parent/guardian|1|||
13151694|NCT02544763|26051333|FG002|Overall Study|Withdrawn by parent/guardian|1|||
13151695|NCT02544763|26051331|FG000|Overall Study|Met withdrawal criteria|0|||
13151696|NCT02544763|26051332|FG001|Overall Study|Met withdrawal criteria|2|||
13151697|NCT02544763|26051333|FG002|Overall Study|Met withdrawal criteria|0|||
13151698|NCT02544763|26051331|FG000|Overall Study|Physician Decision|0|||
13151699|NCT02544763|26051332|FG001|Overall Study|Physician Decision|1|||
13151700|NCT02544763|26051333|FG002|Overall Study|Physician Decision|0|||
13151701|NCT02544763|26051331|FG000|Overall Study|Difficulties taking IMP|1|||
13151702|NCT02544763|26051332|FG001|Overall Study|Difficulties taking IMP|0|||
13151703|NCT02544763|26051333|FG002|Overall Study|Difficulties taking IMP|0|||
13151704|NCT02544750|26051356|FG000|Overall Study|Physician Decision|3|||
13151705|NCT02544750|26051357|FG001|Overall Study|Physician Decision|1|||
13151706|NCT02544750|26051356|FG000|Overall Study|Other reasons|69|||
13151707|NCT02544750|26051357|FG001|Overall Study|Other reasons|39|||
13151708|NCT02544750|26051356|FG000|Overall Study|Met withdrawal criteria|2|||
13151709|NCT02544750|26051357|FG001|Overall Study|Met withdrawal criteria|2|||
13151710|NCT02544750|26051356|FG000|Overall Study|Transition To Commercial Product|1|||
13151711|NCT02544750|26051357|FG001|Overall Study|Transition To Commercial Product|0|||
13151712|NCT02544750|26051356|FG000|Overall Study|Withdrawal by Parent/Guardian|8|||
13151713|NCT02544750|26051357|FG001|Overall Study|Withdrawal by Parent/Guardian|7|||
13151714|NCT02544750|26051356|FG000|Overall Study|Adverse Event|8|||
13151715|NCT02544750|26051357|FG001|Overall Study|Adverse Event|10|||
13151716|NCT02544750|26051356|FG000|Overall Study|Withdrawal by Subject|10|||
13151717|NCT02544750|26051357|FG001|Overall Study|Withdrawal by Subject|4|||
13151718|NCT02544750|26051356|FG000|Overall Study|Lost to Follow-up|1|||
13151719|NCT02544750|26051357|FG001|Overall Study|Lost to Follow-up|0|||
13151720|NCT02544633|26051443|FG000|Treatment Period|Patient Still on Treatment/Study|0|||
13151721|NCT02544633|26051444|FG001|Treatment Period|Patient Still on Treatment/Study|1|||
13151722|NCT02544633|26051445|FG002|Treatment Period|Patient Still on Treatment/Study|1|||
13100003|NCT03463577|25857222|FG001|Overall Study|Neonatal death|0|||
13100004|NCT03463577|25857223|FG002|Overall Study|Neonatal death|0|||
13100005|NCT03463577|25857224|FG003|Overall Study|Neonatal death|15|||
13100006|NCT03463577|25857225|FG004|Overall Study|Neonatal death|17|||
13100007|NCT03463577|25857226|FG005|Overall Study|Neonatal death|0|||
13100008|NCT03463031|25857245|FG000|Overall Study|Withdrawal by Subject|4|||
13151723|NCT02544633|26051446|FG003|Treatment Period|Patient Still on Treatment/Study|0|||
13151724|NCT02544633|26051443|FG000|Treatment Period|Adverse Event|7|||
13151725|NCT02544633|26051444|FG001|Treatment Period|Adverse Event|4|||
13151726|NCT02544633|26051445|FG002|Treatment Period|Adverse Event|0|||
13151727|NCT02544633|26051446|FG003|Treatment Period|Adverse Event|5|||
13151728|NCT02544633|26051443|FG000|Treatment Period|Lack of Efficacy|17|||
13151729|NCT02544633|26051444|FG001|Treatment Period|Lack of Efficacy|11|||
13151730|NCT02544633|26051445|FG002|Treatment Period|Lack of Efficacy|5|||
13100009|NCT03463031|25857246|FG001|Overall Study|Withdrawal by Subject|2|||
13100010|NCT03463031|25857245|FG000|Overall Study|Investigator/Sponsor Decision|0|||
13100011|NCT03463031|25857246|FG001|Overall Study|Investigator/Sponsor Decision|1|||
13100012|NCT03463031|25857245|FG000|Overall Study|Lost to Follow-up|1|||
13100013|NCT03463031|25857246|FG001|Overall Study|Lost to Follow-up|1|||
13151731|NCT02544633|26051446|FG003|Treatment Period|Lack of Efficacy|5|||
13151732|NCT02544633|26051443|FG000|Treatment Period|Global Deterioration of Health|3|||
13151733|NCT02544633|26051444|FG001|Treatment Period|Global Deterioration of Health|3|||
13151734|NCT02544633|26051445|FG002|Treatment Period|Global Deterioration of Health|0|||
13151735|NCT02544633|26051446|FG003|Treatment Period|Global Deterioration of Health|1|||
13151736|NCT02544633|26051443|FG000|Treatment Period|Withdrawal by Subject|1|||
13151737|NCT02544633|26051444|FG001|Treatment Period|Withdrawal by Subject|0|||
13151738|NCT02544633|26051445|FG002|Treatment Period|Withdrawal by Subject|0|||
13151739|NCT02544633|26051446|FG003|Treatment Period|Withdrawal by Subject|0|||
13151740|NCT02544633|26051443|FG000|Treatment Period|Lost to Follow-up|0|||
13151741|NCT02544633|26051444|FG001|Treatment Period|Lost to Follow-up|1|||
13151742|NCT02544633|26051445|FG002|Treatment Period|Lost to Follow-up|0|||
13151743|NCT02544633|26051446|FG003|Treatment Period|Lost to Follow-up|0|||
13151744|NCT02544633|26051443|FG000|Treatment Period|Death|0|||
13151745|NCT02544633|26051444|FG001|Treatment Period|Death|0|||
13151746|NCT02544633|26051445|FG002|Treatment Period|Death|1|||
13151747|NCT02544633|26051446|FG003|Treatment Period|Death|0|||
13151748|NCT02544633|26051443|FG000|Treatment Period|Non-compliance|0|||
13151749|NCT02544633|26051444|FG001|Treatment Period|Non-compliance|0|||
13151750|NCT02544633|26051445|FG002|Treatment Period|Non-compliance|1|||
13151751|NCT02544633|26051446|FG003|Treatment Period|Non-compliance|0|||
13151752|NCT02544633|26051443|FG000|Treatment Period|Clinical Disease Progression|0|||
13151753|NCT02544633|26051444|FG001|Treatment Period|Clinical Disease Progression|0|||
13151754|NCT02544633|26051445|FG002|Treatment Period|Clinical Disease Progression|0|||
13151755|NCT02544633|26051446|FG003|Treatment Period|Clinical Disease Progression|1|||
13151756|NCT02544633|26051443|FG000|Survival Follow-up Period|Death|12|||
13151757|NCT02544633|26051444|FG001|Survival Follow-up Period|Death|14|||
13151758|NCT02544633|26051445|FG002|Survival Follow-up Period|Death|3|||
13151759|NCT02544633|26051446|FG003|Survival Follow-up Period|Death|9|||
13100014|NCT03463031|25857245|FG000|Overall Study|Adverse Event|4|||
13100015|NCT03463031|25857246|FG001|Overall Study|Adverse Event|1|||
13100016|NCT03463031|25857245|FG000|Overall Study|Use of prohibited medication by subject|1|||
13100017|NCT03463031|25857246|FG001|Overall Study|Use of prohibited medication by subject|0|||
13100018|NCT03462680|25857329|FG000|Overall Study|Withdrawal by Subject|3|||
13100019|NCT03462680|25857330|FG001|Overall Study|Withdrawal by Subject|5|||
13100020|NCT03462641|25857345|FG000|Visit 1|Failed to complete dopaminergic PET scan|1|||
13100021|NCT03462641|25857346|FG001|Visit 1|Failed to complete dopaminergic PET scan|0|||
13100022|NCT03462641|25857345|FG000|Visit 2|Withdrawal by Subject|0|||
13100023|NCT03462641|25857346|FG001|Visit 2|Withdrawal by Subject|1|||
13100024|NCT03462563|25857369|FG000|Overall Study|Death|1|||
13100025|NCT03462563|25857370|FG001|Overall Study|Death|1|||
13100026|NCT03462563|25857369|FG000|Overall Study|Termination of study|2|||
13100027|NCT03462563|25857370|FG001|Overall Study|Termination of study|1|||
13100028|NCT03462563|25857369|FG000|Overall Study|Adverse Event|1|||
13100029|NCT03462563|25857370|FG001|Overall Study|Adverse Event|3|||
13100030|NCT03462563|25857369|FG000|Overall Study|Unspecified reason|10|||
13100031|NCT03462563|25857370|FG001|Overall Study|Unspecified reason|12|||
13100032|NCT03462563|25857369|FG000|Overall Study|Physician Decision|1|||
13100033|NCT03462563|25857370|FG001|Overall Study|Physician Decision|0|||
13100034|NCT03462082|25857428|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0|||
13100035|NCT03462082|25857429|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0|||
13100036|NCT03462082|25857430|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0|||
13100037|NCT03462082|25857431|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0|||
13100038|NCT03462082|25857432|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0|||
13100039|NCT03462082|25857433|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0|||
13100040|NCT03462082|25857434|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1|||
13100041|NCT03462082|25857435|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2|||
13100042|NCT03462030|25857450|FG000|Overall Study|Withdrawal by Subject|1|||
13151760|NCT02544633|26051443|FG000|Survival Follow-up Period|Lost to Follow-up|0|||
13151761|NCT02544633|26051444|FG001|Survival Follow-up Period|Lost to Follow-up|1|||
13151762|NCT02544633|26051445|FG002|Survival Follow-up Period|Lost to Follow-up|1|||
13151763|NCT02544633|26051446|FG003|Survival Follow-up Period|Lost to Follow-up|0|||
13151764|NCT02544633|26051443|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
13151765|NCT02544633|26051444|FG001|Survival Follow-up Period|Withdrawal by Subject|0|||
13151766|NCT02544633|26051445|FG002|Survival Follow-up Period|Withdrawal by Subject|1|||
13151767|NCT02544633|26051446|FG003|Survival Follow-up Period|Withdrawal by Subject|0|||
13151768|NCT02544633|26051443|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12|||
13151769|NCT02544633|26051444|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4|||
13151770|NCT02544633|26051445|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2|||
13151771|NCT02544633|26051446|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3|||
13151772|NCT02544503|26051472|FG000|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|24|||
13151773|NCT02544503|26051473|FG001|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|3|||
13151774|NCT02544503|26051472|FG000|Overall Study|Lost to Follow-up|9|||
13151775|NCT02544503|26051473|FG001|Overall Study|Lost to Follow-up|0|||
13151776|NCT02544503|26051472|FG000|Overall Study|Withdrawal by Subject|1|||
13151777|NCT02544503|26051473|FG001|Overall Study|Withdrawal by Subject|0|||
13151778|NCT02544451|26051529|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1|||
13151779|NCT02544451|26051530|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6|||
13222680|NCT01803646|26286746|FG001|Overall Study|Lost to Follow-up|1|||
13100043|NCT03462030|25857451|FG001|Overall Study|Withdrawal by Subject|1|||
13100044|NCT03461289|25857458|FG000|Overall Study|Death|1|||
13100045|NCT03461146|25857468|FG000|Overall Study|Adverse Event|2|||
13100046|NCT03461146|25857468|FG000|Overall Study|Physician Decision|1|||
13100047|NCT03461003|25857491|FG000|Overall Study|Lost to Follow-up|2|||
13100048|NCT03461003|25857492|FG001|Overall Study|Lost to Follow-up|2|||
13151780|NCT02544451|26051531|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
13151781|NCT02544451|26051532|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
13151782|NCT02544451|26051529|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3|||
13151783|NCT02544451|26051530|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2|||
13151784|NCT02544451|26051531|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1|||
13151785|NCT02544451|26051532|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0|||
13151786|NCT02544451|26051529|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2|||
13100049|NCT03461003|25857491|FG000|Overall Study|Withdrawal by Subject|3|||
13100050|NCT03461003|25857492|FG001|Overall Study|Withdrawal by Subject|1|||
13100051|NCT03459443|25857506|FG000|Overall Study|Lack of Efficacy|3|||
13100052|NCT03459443|25857506|FG000|Overall Study|Adverse Event|1|||
13100053|NCT03459443|25857506|FG000|Overall Study|Sponsor's decision to close the study|18|||
13100054|NCT03459196|25857513|FG000|Overall Study|Subject didn't receive study catheter|2|||
13100055|NCT03459040|25857527|FG000|Overall Study|Death|8|||
13100056|NCT03459040|25857527|FG000|Overall Study|Withdrawal by Subject|1|||
13100057|NCT03458702|25857546|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4|||
13100058|NCT03458702|25857547|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6|||
13100059|NCT03458702|25857546|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4|||
13100060|NCT03458702|25857547|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2|||
13100061|NCT03457727|25857757|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
13100062|NCT03457727|25857758|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
13100063|NCT03457727|25857759|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
13100064|NCT03457727|25857760|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1|||
13100065|NCT03457636|25857769|FG000|Overall Study|Lost to Follow-up|2|||
13100066|NCT03457103|25857794|FG000|Overall Study|illness/hospitalization|4|||
13100067|NCT03457103|25857795|FG001|Overall Study|illness/hospitalization|2|||
13100068|NCT03457103|25857794|FG000|Overall Study|Lost to Follow-up|2|||
13100069|NCT03457103|25857795|FG001|Overall Study|Lost to Follow-up|1|||
13100070|NCT03457103|25857794|FG000|Overall Study|Withdrawal by Subject|1|||
13100071|NCT03457103|25857795|FG001|Overall Study|Withdrawal by Subject|2|||
13100072|NCT03457103|25857794|FG000|Overall Study|financial/ insurance issues|1|||
13100073|NCT03457103|25857795|FG001|Overall Study|financial/ insurance issues|1|||
13100074|NCT03456960|25857906|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
13100075|NCT03456960|25857907|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
13100076|NCT03456960|25857908|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
13100077|NCT03456960|25857909|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2|||
13100078|NCT03456960|25857910|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
13100079|NCT03456960|25857911|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
13100080|NCT03456960|25857906|FG000|Period 2 (1 Day)|Adverse Event|1|||
13100081|NCT03456960|25857907|FG001|Period 2 (1 Day)|Adverse Event|0|||
13100082|NCT03456960|25857908|FG002|Period 2 (1 Day)|Adverse Event|0|||
13100083|NCT03456960|25857909|FG003|Period 2 (1 Day)|Adverse Event|1|||
13100084|NCT03456960|25857910|FG004|Period 2 (1 Day)|Adverse Event|0|||
13100085|NCT03456960|25857911|FG005|Period 2 (1 Day)|Adverse Event|0|||
13100086|NCT03456856|25857917|FG000|Overall Study|Lost to Follow-up|2|||
13100087|NCT03456856|25857917|FG000|Overall Study|Withdrawal by Subject|1|||
13100088|NCT03455543|25857963|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2|||
13100089|NCT03455543|25857964|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5|||
13100090|NCT03455543|25857965|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0|||
13100091|NCT03455543|25857963|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7|||
13100092|NCT03455543|25857964|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2|||
13100093|NCT03455543|25857965|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0|||
13100094|NCT03455543|25857963|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2|||
13100095|NCT03455543|25857964|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
13100096|NCT03455543|25857965|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
13100097|NCT03455543|25857963|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
13100098|NCT03455543|25857964|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
13100099|NCT03455543|25857965|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3|||
13100100|NCT03455543|25857963|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
13100101|NCT03455543|25857964|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
13100102|NCT03455543|25857965|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20|||
13100103|NCT03455543|25857963|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
13100104|NCT03455543|25857964|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
13100105|NCT03455543|25857965|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7|||
13100106|NCT03455543|25857963|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
13100107|NCT03455543|25857964|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
13100108|NCT03455543|25857965|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4|||
13100109|NCT03455543|25857963|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
13100110|NCT03455543|25857964|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
13100111|NCT03455543|25857965|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2|||
13100112|NCT03455543|25857963|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
13100113|NCT03455543|25857964|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
13100114|NCT03455543|25857965|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1|||
13100115|NCT03454412|25857977|FG000|Baseline Assesment|Physician Decision|12|||
13100116|NCT03453151|25857988|FG000|Overall Study|Withdrawal by Subject|1|||
13100117|NCT03453151|25857988|FG000|Overall Study|Physician Decision|3|||
13151787|NCT02544451|26051530|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
13151788|NCT02544451|26051531|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
13151789|NCT02544451|26051532|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
13151790|NCT02544451|26051529|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4|||
13151791|NCT02544451|26051530|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
13151792|NCT02544451|26051531|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
13151793|NCT02544451|26051532|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
13151794|NCT02544451|26051529|FG000|Treatment Period 1 (96 Weeks)|Other|4|||
13151795|NCT02544451|26051530|FG001|Treatment Period 1 (96 Weeks)|Other|4|||
13151796|NCT02544451|26051531|FG002|Treatment Period 1 (96 Weeks)|Other|0|||
13151797|NCT02544451|26051532|FG003|Treatment Period 1 (96 Weeks)|Other|0|||
13151798|NCT02544451|26051529|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
13151799|NCT02544451|26051530|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
13151800|NCT02544451|26051531|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
13151801|NCT02544451|26051532|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10|||
13151802|NCT02544373|26051546|FG000|Overall Study|Lost to Follow-up|5|||
13151803|NCT02544373|26051547|FG001|Overall Study|Lost to Follow-up|3|||
13151804|NCT02544373|26051546|FG000|Overall Study|Withdrawal by Subject|8|||
13151805|NCT02544373|26051547|FG001|Overall Study|Withdrawal by Subject|2|||
13151806|NCT02544321|26051620|FG000|Overall Study|Withdrawal by Subject|1|||
13151807|NCT02544321|26051621|FG001|Overall Study|Withdrawal by Subject|2|||
13151808|NCT02544321|26051620|FG000|Overall Study|Adverse Event|1|||
13151809|NCT02544321|26051621|FG001|Overall Study|Adverse Event|1|||
13151810|NCT02544321|26051620|FG000|Overall Study|Protocol Violation|0|||
13151811|NCT02544321|26051621|FG001|Overall Study|Protocol Violation|1|||
13151812|NCT02544217|26052433|FG000|Overall Study|Withdrawal by Subject|1|||
13151813|NCT02544217|26052434|FG001|Overall Study|Withdrawal by Subject|1|||
13151814|NCT02544217|26052435|FG002|Overall Study|Withdrawal by Subject|0|||
13151815|NCT02544217|26052436|FG003|Overall Study|Withdrawal by Subject|0|||
13151816|NCT02544217|26052437|FG004|Overall Study|Withdrawal by Subject|0|||
13151817|NCT02544217|26052438|FG005|Overall Study|Withdrawal by Subject|0|||
13151818|NCT02544152|26052467|FG000|Overall Study|Adverse Event|0|||
13100118|NCT03452943|25858009|FG000|Titration Period (7 Weeks)|Adverse Event|1|||
13100119|NCT03452943|25858010|FG001|Titration Period (7 Weeks)|Adverse Event|1|||
13100120|NCT03452943|25858009|FG000|Titration Period (7 Weeks)|Protocol Violation|0|||
13100121|NCT03452943|25858010|FG001|Titration Period (7 Weeks)|Protocol Violation|1|||
13100122|NCT03452943|25858009|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3|||
13100123|NCT03452943|25858010|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2|||
13100124|NCT03452943|25858009|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1|||
13100125|NCT03452943|25858010|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0|||
13100126|NCT03452943|25858009|FG000|Maintenance Period (5 Weeks)|Adverse Event|1|||
13100127|NCT03452943|25858010|FG001|Maintenance Period (5 Weeks)|Adverse Event|0|||
13100128|NCT03452943|25858009|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2|||
13100129|NCT03452943|25858010|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0|||
13100130|NCT03452540|25858017|FG000|Overall Study|Adverse Event|1|||
13100131|NCT03452540|25858017|FG000|Overall Study|Withdrawal by Subject|1|||
13100132|NCT03452540|25858017|FG000|Overall Study|Other SAE and AE|2|||
13100133|NCT03452527|25858032|FG000|Overall Study|Withdrawal by Subject|1|||
13100134|NCT03452527|25858033|FG001|Overall Study|Withdrawal by Subject|1|||
13100135|NCT03452527|25858032|FG000|Overall Study|Study Terminated|2|||
13100136|NCT03452527|25858033|FG001|Overall Study|Study Terminated|3|||
13100137|NCT03452189|25858044|FG000|First Intervention (3 Months)|Adverse Event|1|||
13100138|NCT03452189|25858045|FG001|First Intervention (3 Months)|Adverse Event|0|||
13100139|NCT03452189|25858044|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4|||
13100140|NCT03452189|25858045|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0|||
13100141|NCT03451773|25858074|FG000|Overall Study|Death on study|1|||
13100142|NCT03451773|25858075|FG001|Overall Study|Death on study|5|||
13100143|NCT03451773|25858074|FG000|Overall Study|Death during follow-up period|0|||
13100144|NCT03451773|25858075|FG001|Overall Study|Death during follow-up period|1|||
13100145|NCT03451721|25858086|FG000|Overall Study|Death|1|||
13100146|NCT03451084|25858129|FG000|Overall Study|Withdrawal by Subject|2|||
13100147|NCT03451084|25858130|FG001|Overall Study|Withdrawal by Subject|1|||
13100148|NCT03451084|25858131|FG002|Overall Study|Withdrawal by Subject|2|||
13100149|NCT03451084|25858132|FG003|Overall Study|Withdrawal by Subject|1|||
13100150|NCT03451084|25858129|FG000|Overall Study|Disease recurrence|0|||
13100151|NCT03451084|25858130|FG001|Overall Study|Disease recurrence|2|||
13100152|NCT03451084|25858131|FG002|Overall Study|Disease recurrence|0|||
13100153|NCT03451084|25858132|FG003|Overall Study|Disease recurrence|0|||
13100154|NCT03451084|25858129|FG000|Overall Study|Lack of Efficacy|0|||
13100155|NCT03451084|25858130|FG001|Overall Study|Lack of Efficacy|3|||
13100156|NCT03451084|25858131|FG002|Overall Study|Lack of Efficacy|0|||
13100157|NCT03451084|25858132|FG003|Overall Study|Lack of Efficacy|1|||
13100158|NCT03451084|25858129|FG000|Overall Study|Death|1|||
13151819|NCT02544152|26052468|FG001|Overall Study|Adverse Event|4|||
13100159|NCT03451084|25858130|FG001|Overall Study|Death|0|||
13100160|NCT03451084|25858131|FG002|Overall Study|Death|2|||
13100161|NCT03451084|25858132|FG003|Overall Study|Death|0|||
13100162|NCT03451084|25858129|FG000|Overall Study|Physician Decision|0|||
13100163|NCT03451084|25858130|FG001|Overall Study|Physician Decision|0|||
13100164|NCT03451084|25858131|FG002|Overall Study|Physician Decision|2|||
13100165|NCT03451084|25858132|FG003|Overall Study|Physician Decision|2|||
13100166|NCT03451084|25858129|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3|||
13100167|NCT03451084|25858130|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
13100168|NCT03451084|25858131|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
13100169|NCT03451084|25858132|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2|||
13100170|NCT03451071|25858142|FG000|First Vaccine|Withdrawal by Subject|1|||
13100171|NCT03451071|25858142|FG000|Second Vaccine|Lost to Follow-up|19|||
13100172|NCT03451071|25858142|FG000|Third Vaccine|Lost to Follow-up|22|||
13100173|NCT03451071|25858142|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4|||
13100174|NCT03451006|25858175|FG000|Overall Study|Withdrawal by Subject|2|||
13100175|NCT03451006|25858176|FG001|Overall Study|Withdrawal by Subject|2|||
13100176|NCT03450070|25858182|FG000|Overall Study|Withdrawal by Subject|8|||
13100177|NCT03449979|25858205|FG000|Overall Study|Technical difficulty|0|||
13100178|NCT03449979|25858206|FG001|Overall Study|Technical difficulty|0|||
13100179|NCT03449979|25858207|FG002|Overall Study|Technical difficulty|0|||
13100180|NCT03449979|25858208|FG003|Overall Study|Technical difficulty|1|||
13100181|NCT03449758|25858243|FG000|Overall Study|Major protocol deviation|1|||
13100182|NCT03449758|25858243|FG000|Overall Study|Treatment inefficacy|5|||
13100183|NCT03449758|25858243|FG000|Overall Study|Adverse Event|9|||
13100184|NCT03449758|25858243|FG000|Overall Study|Consent withdrawal|1|||
13100185|NCT03449758|25858243|FG000|Overall Study|Other unspecified reason|3|||
13100186|NCT03449446|25858295|FG000|Overall Study|Randomized but Never Treated|0|||
13100187|NCT03449446|25858296|FG001|Overall Study|Randomized but Never Treated|0|||
13100188|NCT03449446|25858297|FG002|Overall Study|Randomized but Never Treated|1|||
13100189|NCT03449446|25858298|FG003|Overall Study|Randomized but Never Treated|1|||
13100190|NCT03449446|25858299|FG004|Overall Study|Randomized but Never Treated|1|||
13100191|NCT03449446|25858300|FG005|Overall Study|Randomized but Never Treated|0|||
13100192|NCT03449446|25858301|FG006|Overall Study|Randomized but Never Treated|0|||
13100193|NCT03449446|25858295|FG000|Overall Study|Unknown Reason|33|||
13100194|NCT03449446|25858296|FG001|Overall Study|Unknown Reason|1|||
13100195|NCT03449446|25858297|FG002|Overall Study|Unknown Reason|1|||
13100196|NCT03449446|25858298|FG003|Overall Study|Unknown Reason|1|||
13100197|NCT03449446|25858299|FG004|Overall Study|Unknown Reason|2|||
13100198|NCT03449446|25858300|FG005|Overall Study|Unknown Reason|2|||
13100199|NCT03449446|25858301|FG006|Overall Study|Unknown Reason|0|||
13100200|NCT03449446|25858295|FG000|Overall Study|Withdrew Consent|1|||
13100201|NCT03449446|25858296|FG001|Overall Study|Withdrew Consent|3|||
13100202|NCT03449446|25858297|FG002|Overall Study|Withdrew Consent|1|||
13100203|NCT03449446|25858298|FG003|Overall Study|Withdrew Consent|4|||
13100204|NCT03449446|25858299|FG004|Overall Study|Withdrew Consent|4|||
13100205|NCT03449446|25858300|FG005|Overall Study|Withdrew Consent|4|||
13100206|NCT03449446|25858301|FG006|Overall Study|Withdrew Consent|1|||
13100207|NCT03449446|25858295|FG000|Overall Study|Adverse Event|1|||
13100208|NCT03449446|25858296|FG001|Overall Study|Adverse Event|2|||
13100209|NCT03449446|25858297|FG002|Overall Study|Adverse Event|1|||
13100210|NCT03449446|25858298|FG003|Overall Study|Adverse Event|0|||
13100211|NCT03449446|25858299|FG004|Overall Study|Adverse Event|0|||
13100212|NCT03449446|25858300|FG005|Overall Study|Adverse Event|2|||
13100213|NCT03449446|25858301|FG006|Overall Study|Adverse Event|0|||
13100214|NCT03449446|25858295|FG000|Overall Study|Lost to Follow-up|0|||
13100215|NCT03449446|25858296|FG001|Overall Study|Lost to Follow-up|0|||
13100216|NCT03449446|25858297|FG002|Overall Study|Lost to Follow-up|2|||
13100217|NCT03449446|25858298|FG003|Overall Study|Lost to Follow-up|1|||
13100218|NCT03449446|25858299|FG004|Overall Study|Lost to Follow-up|3|||
13100219|NCT03449446|25858300|FG005|Overall Study|Lost to Follow-up|0|||
13100220|NCT03449446|25858301|FG006|Overall Study|Lost to Follow-up|0|||
13100221|NCT03449446|25858295|FG000|Overall Study|Investigator's Discretion|0|||
13100222|NCT03449446|25858296|FG001|Overall Study|Investigator's Discretion|1|||
13100223|NCT03449446|25858297|FG002|Overall Study|Investigator's Discretion|1|||
13100224|NCT03449446|25858298|FG003|Overall Study|Investigator's Discretion|2|||
13100225|NCT03449446|25858299|FG004|Overall Study|Investigator's Discretion|0|||
13100226|NCT03449446|25858300|FG005|Overall Study|Investigator's Discretion|0|||
13100227|NCT03449446|25858301|FG006|Overall Study|Investigator's Discretion|0|||
13100228|NCT03449446|25858295|FG000|Overall Study|Non Compliance with Study Drug|1|||
13100229|NCT03449446|25858296|FG001|Overall Study|Non Compliance with Study Drug|0|||
13100230|NCT03449446|25858297|FG002|Overall Study|Non Compliance with Study Drug|0|||
13100231|NCT03449446|25858298|FG003|Overall Study|Non Compliance with Study Drug|0|||
13100232|NCT03449446|25858299|FG004|Overall Study|Non Compliance with Study Drug|0|||
13100233|NCT03449446|25858300|FG005|Overall Study|Non Compliance with Study Drug|0|||
13100234|NCT03449446|25858301|FG006|Overall Study|Non Compliance with Study Drug|0|||
13100235|NCT03449446|25858295|FG000|Overall Study|Protocol Violation|0|||
13100236|NCT03449446|25858296|FG001|Overall Study|Protocol Violation|0|||
13100237|NCT03449446|25858297|FG002|Overall Study|Protocol Violation|0|||
13100238|NCT03449446|25858298|FG003|Overall Study|Protocol Violation|0|||
13100239|NCT03449446|25858299|FG004|Overall Study|Protocol Violation|1|||
13100240|NCT03449446|25858300|FG005|Overall Study|Protocol Violation|1|||
13100241|NCT03449446|25858301|FG006|Overall Study|Protocol Violation|0|||
13100242|NCT03449446|25858295|FG000|Overall Study|Death|0|||
13100243|NCT03449446|25858296|FG001|Overall Study|Death|0|||
13100244|NCT03449446|25858297|FG002|Overall Study|Death|0|||
13100245|NCT03449446|25858298|FG003|Overall Study|Death|0|||
13151820|NCT02544152|26052467|FG000|Overall Study|Withdrawal by Subject|0|||
13151821|NCT02544152|26052468|FG001|Overall Study|Withdrawal by Subject|3|||
13151822|NCT02544152|26052467|FG000|Overall Study|Other|1|||
13151823|NCT02544152|26052468|FG001|Overall Study|Other|0|||
13151824|NCT02544113|26052485|FG000|Overall Study|Death|3|||
13151825|NCT02544113|26052486|FG001|Overall Study|Death|4|||
13151826|NCT02544074|26052584|FG000|Overall Study|Withdrawal by Subject|0|||
13151827|NCT02544074|26052585|FG001|Overall Study|Withdrawal by Subject|1|||
13151828|NCT02544074|26052586|FG002|Overall Study|Withdrawal by Subject|0|||
13151829|NCT02544074|26052587|FG003|Overall Study|Withdrawal by Subject|0|||
13151830|NCT02544074|26052588|FG004|Overall Study|Withdrawal by Subject|0|||
13151831|NCT02544074|26052589|FG005|Overall Study|Withdrawal by Subject|0|||
13151832|NCT02544074|26052590|FG006|Overall Study|Withdrawal by Subject|0|||
13151833|NCT02544074|26052591|FG007|Overall Study|Withdrawal by Subject|0|||
13151834|NCT02544074|26052592|FG008|Overall Study|Withdrawal by Subject|0|||
13151835|NCT02544074|26052593|FG009|Overall Study|Withdrawal by Subject|0|||
13100246|NCT03449446|25858299|FG004|Overall Study|Death|1|||
13100247|NCT03449446|25858300|FG005|Overall Study|Death|0|||
13100248|NCT03449446|25858301|FG006|Overall Study|Death|0|||
13100249|NCT03449199|25858349|FG000|Overall Study|Lost to Follow-up|1|||
13100250|NCT03449199|25858350|FG001|Overall Study|Lost to Follow-up|1|||
13100251|NCT03449199|25858351|FG002|Overall Study|Lost to Follow-up|0|||
13100252|NCT03449199|25858349|FG000|Overall Study|Protocol Deviation|0|||
13100253|NCT03449199|25858350|FG001|Overall Study|Protocol Deviation|0|||
13100254|NCT03449199|25858351|FG002|Overall Study|Protocol Deviation|1|||
13100255|NCT03449199|25858349|FG000|Overall Study|Withdrawal by Subject|0|||
13100256|NCT03449199|25858350|FG001|Overall Study|Withdrawal by Subject|0|||
13100257|NCT03449199|25858351|FG002|Overall Study|Withdrawal by Subject|1|||
13100258|NCT03449147|25858396|FG000|52-week Treatment Period|Death|0|||
13100259|NCT03449147|25858397|FG001|52-week Treatment Period|Death|1|||
13100260|NCT03449147|25858398|FG002|52-week Treatment Period|Death|0|||
13100261|NCT03449147|25858396|FG000|52-week Treatment Period|Lost to Follow-up|6|||
13100262|NCT03449147|25858397|FG001|52-week Treatment Period|Lost to Follow-up|2|||
13100263|NCT03449147|25858398|FG002|52-week Treatment Period|Lost to Follow-up|5|||
13100264|NCT03449147|25858396|FG000|52-week Treatment Period|Other|0|||
13100265|NCT03449147|25858397|FG001|52-week Treatment Period|Other|1|||
13100266|NCT03449147|25858398|FG002|52-week Treatment Period|Other|2|||
13100267|NCT03449147|25858396|FG000|52-week Treatment Period|Physician Decision|1|||
13100268|NCT03449147|25858397|FG001|52-week Treatment Period|Physician Decision|0|||
13100269|NCT03449147|25858398|FG002|52-week Treatment Period|Physician Decision|3|||
13100270|NCT03449147|25858396|FG000|52-week Treatment Period|Screen Failure|1|||
13100271|NCT03449147|25858397|FG001|52-week Treatment Period|Screen Failure|2|||
13100272|NCT03449147|25858398|FG002|52-week Treatment Period|Screen Failure|0|||
13100273|NCT03449147|25858396|FG000|52-week Treatment Period|Withdrawal by Subject|46|||
13100274|NCT03449147|25858397|FG001|52-week Treatment Period|Withdrawal by Subject|68|||
13100275|NCT03449147|25858398|FG002|52-week Treatment Period|Withdrawal by Subject|74|||
13100276|NCT03449147|25858396|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1|||
13100277|NCT03449147|25858397|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
13100278|NCT03449147|25858398|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
13100279|NCT03449147|25858396|FG000|12-Week Off-Treatment Durability Period|Other|0|||
13100280|NCT03449147|25858397|FG001|12-Week Off-Treatment Durability Period|Other|1|||
13100281|NCT03449147|25858398|FG002|12-Week Off-Treatment Durability Period|Other|0|||
13100282|NCT03449134|25858443|FG000|52-Week Treatment Period|Death|2|||
13100283|NCT03449134|25858444|FG001|52-Week Treatment Period|Death|1|||
13100284|NCT03449134|25858445|FG002|52-Week Treatment Period|Death|0|||
13100285|NCT03449134|25858443|FG000|52-Week Treatment Period|Lost to Follow-up|2|||
13100286|NCT03449134|25858444|FG001|52-Week Treatment Period|Lost to Follow-up|1|||
13100287|NCT03449134|25858445|FG002|52-Week Treatment Period|Lost to Follow-up|1|||
13100288|NCT03449134|25858443|FG000|52-Week Treatment Period|Physician Decision|2|||
13100289|NCT03449134|25858444|FG001|52-Week Treatment Period|Physician Decision|3|||
13100290|NCT03449134|25858445|FG002|52-Week Treatment Period|Physician Decision|3|||
13100291|NCT03449134|25858443|FG000|52-Week Treatment Period|Screen Failure|1|||
13100292|NCT03449134|25858444|FG001|52-Week Treatment Period|Screen Failure|0|||
13100293|NCT03449134|25858445|FG002|52-Week Treatment Period|Screen Failure|1|||
13151836|NCT02544074|26052594|FG010|Overall Study|Withdrawal by Subject|0|||
13100294|NCT03449134|25858443|FG000|52-Week Treatment Period|Withdrawal by Subject|37|||
13100295|NCT03449134|25858444|FG001|52-Week Treatment Period|Withdrawal by Subject|39|||
13100296|NCT03449134|25858445|FG002|52-Week Treatment Period|Withdrawal by Subject|55|||
13100297|NCT03449134|25858443|FG000|52-Week Treatment Period|Site Closure|1|||
13100298|NCT03449134|25858444|FG001|52-Week Treatment Period|Site Closure|0|||
13100299|NCT03449134|25858445|FG002|52-Week Treatment Period|Site Closure|0|||
13100300|NCT03449030|25858649|FG000|Overall Study|Withdrawal by Subject|0|||
13100301|NCT03449030|25858650|FG001|Overall Study|Withdrawal by Subject|0|||
13100302|NCT03449030|25858651|FG002|Overall Study|Withdrawal by Subject|0|||
13100303|NCT03449030|25858652|FG003|Overall Study|Withdrawal by Subject|1|||
13100304|NCT03449030|25858653|FG004|Overall Study|Withdrawal by Subject|1|||
13100305|NCT03449030|25858654|FG005|Overall Study|Withdrawal by Subject|1|||
13100306|NCT03449030|25858655|FG006|Overall Study|Withdrawal by Subject|1|||
13100307|NCT03449030|25858656|FG007|Overall Study|Withdrawal by Subject|2|||
13100308|NCT03449030|25858657|FG008|Overall Study|Withdrawal by Subject|0|||
13100309|NCT03449030|25858658|FG009|Overall Study|Withdrawal by Subject|0|||
13100310|NCT03449030|25858649|FG000|Overall Study|Symptomatic Deterioration|0|||
13100311|NCT03449030|25858650|FG001|Overall Study|Symptomatic Deterioration|1|||
13100312|NCT03449030|25858651|FG002|Overall Study|Symptomatic Deterioration|0|||
13100313|NCT03449030|25858652|FG003|Overall Study|Symptomatic Deterioration|0|||
13100314|NCT03449030|25858653|FG004|Overall Study|Symptomatic Deterioration|0|||
13100315|NCT03449030|25858654|FG005|Overall Study|Symptomatic Deterioration|1|||
13100316|NCT03449030|25858655|FG006|Overall Study|Symptomatic Deterioration|1|||
13100317|NCT03449030|25858656|FG007|Overall Study|Symptomatic Deterioration|0|||
13100318|NCT03449030|25858657|FG008|Overall Study|Symptomatic Deterioration|2|||
13100319|NCT03449030|25858658|FG009|Overall Study|Symptomatic Deterioration|0|||
13100320|NCT03449030|25858649|FG000|Overall Study|Progressive Disease|1|||
13100321|NCT03449030|25858650|FG001|Overall Study|Progressive Disease|0|||
13100322|NCT03449030|25858651|FG002|Overall Study|Progressive Disease|1|||
13100323|NCT03449030|25858652|FG003|Overall Study|Progressive Disease|4|||
13100324|NCT03449030|25858653|FG004|Overall Study|Progressive Disease|5|||
13100325|NCT03449030|25858654|FG005|Overall Study|Progressive Disease|3|||
13100326|NCT03449030|25858655|FG006|Overall Study|Progressive Disease|0|||
13100327|NCT03449030|25858656|FG007|Overall Study|Progressive Disease|1|||
13100328|NCT03449030|25858657|FG008|Overall Study|Progressive Disease|1|||
13100329|NCT03449030|25858658|FG009|Overall Study|Progressive Disease|1|||
13100330|NCT03449030|25858649|FG000|Overall Study|Adverse Event|0|||
13100331|NCT03449030|25858650|FG001|Overall Study|Adverse Event|0|||
13100332|NCT03449030|25858651|FG002|Overall Study|Adverse Event|0|||
13100333|NCT03449030|25858652|FG003|Overall Study|Adverse Event|0|||
13100334|NCT03449030|25858653|FG004|Overall Study|Adverse Event|0|||
13100335|NCT03449030|25858654|FG005|Overall Study|Adverse Event|2|||
13100336|NCT03449030|25858655|FG006|Overall Study|Adverse Event|0|||
13100337|NCT03449030|25858656|FG007|Overall Study|Adverse Event|0|||
13100338|NCT03449030|25858657|FG008|Overall Study|Adverse Event|0|||
13100339|NCT03449030|25858658|FG009|Overall Study|Adverse Event|0|||
13100340|NCT03449030|25858649|FG000|Overall Study|Death|0|||
13100341|NCT03449030|25858650|FG001|Overall Study|Death|0|||
13100342|NCT03449030|25858651|FG002|Overall Study|Death|0|||
13100343|NCT03449030|25858652|FG003|Overall Study|Death|0|||
13100344|NCT03449030|25858653|FG004|Overall Study|Death|1|||
13100345|NCT03449030|25858654|FG005|Overall Study|Death|0|||
13100346|NCT03449030|25858655|FG006|Overall Study|Death|0|||
13100347|NCT03449030|25858656|FG007|Overall Study|Death|0|||
13100348|NCT03449030|25858657|FG008|Overall Study|Death|0|||
13100349|NCT03449030|25858658|FG009|Overall Study|Death|0|||
13100350|NCT03448536|25858689|FG000|Overall Study|Protocol Violation|2|||
13100351|NCT03448536|25858690|FG001|Overall Study|Protocol Violation|0|||
13100352|NCT03448536|25858689|FG000|Overall Study|Pregnancy|1|||
13100353|NCT03448536|25858690|FG001|Overall Study|Pregnancy|0|||
13100354|NCT03448536|25858689|FG000|Overall Study|Withdrawal by Subject|1|||
13100355|NCT03448536|25858690|FG001|Overall Study|Withdrawal by Subject|2|||
13100356|NCT03448536|25858689|FG000|Overall Study|Lost to Follow-up|3|||
13100357|NCT03448536|25858690|FG001|Overall Study|Lost to Follow-up|2|||
13100358|NCT03448536|25858689|FG000|Overall Study|Inadequate pain reporter|1|||
13100359|NCT03448536|25858690|FG001|Overall Study|Inadequate pain reporter|0|||
13100360|NCT03448536|25858689|FG000|Overall Study|Other|3|||
13100361|NCT03448536|25858690|FG001|Overall Study|Other|0|||
13100362|NCT03448536|25858689|FG000|Overall Study|Physician Decision|1|||
13100363|NCT03448536|25858690|FG001|Overall Study|Physician Decision|0|||
13100364|NCT03448419|25858721|FG000|Overall Study|Adverse Event|10|||
13100365|NCT03448419|25858722|FG001|Overall Study|Adverse Event|9|||
13100366|NCT03448419|25858721|FG000|Overall Study|Lost to Follow-up|0|||
13100367|NCT03448419|25858722|FG001|Overall Study|Lost to Follow-up|2|||
13100368|NCT03448419|25858721|FG000|Overall Study|Withdrawal by Subject|3|||
13100369|NCT03448419|25858722|FG001|Overall Study|Withdrawal by Subject|1|||
13100370|NCT03448419|25858721|FG000|Overall Study|Not treated|0|||
13100371|NCT03448419|25858722|FG001|Overall Study|Not treated|1|||
13100372|NCT03448419|25858721|FG000|Overall Study|Patient did not attend all visits|0|||
13132907|NCT02781584|25985802|FG010|Pre-treatment Phase|Adverse Event|0|||
13100373|NCT03448419|25858722|FG001|Overall Study|Patient did not attend all visits|2|||
13100374|NCT03448419|25858721|FG000|Overall Study|Withdrawn by Sponsor|0|||
13100375|NCT03448419|25858722|FG001|Overall Study|Withdrawn by Sponsor|1|||
13100376|NCT03448406|25858753|FG000|Overall Study|Noncompliance of scheduled visits|1|||
13100377|NCT03448406|25858754|FG001|Overall Study|Noncompliance of scheduled visits|2|||
13100378|NCT03448406|25858753|FG000|Overall Study|Withdrawal by Subject|1|||
13100379|NCT03448406|25858754|FG001|Overall Study|Withdrawal by Subject|2|||
13100380|NCT03448406|25858753|FG000|Overall Study|Protocol Violation|1|||
13100381|NCT03448406|25858754|FG001|Overall Study|Protocol Violation|0|||
13100382|NCT03448406|25858753|FG000|Overall Study|Adverse Event|8|||
13100383|NCT03448406|25858754|FG001|Overall Study|Adverse Event|9|||
13100384|NCT03448224|25858775|FG000|Overall Study|Provided same answer to every question|1|||
13100385|NCT03448224|25858776|FG001|Overall Study|Provided same answer to every question|0|||
13100386|NCT03447821|25858809|FG000|Overall Study|Withdrawal by Subject|1|||
13100387|NCT03447821|25858810|FG001|Overall Study|Withdrawal by Subject|1|||
13100388|NCT03447821|25858811|FG002|Overall Study|Withdrawal by Subject|0|||
13100389|NCT03447821|25858809|FG000|Overall Study|Lost to Follow-up|0|||
13100390|NCT03447821|25858810|FG001|Overall Study|Lost to Follow-up|0|||
13100391|NCT03447821|25858811|FG002|Overall Study|Lost to Follow-up|1|||
13100392|NCT03447730|25858835|FG000|Overall Study|Adverse Event|0|||
13100393|NCT03447730|25858836|FG001|Overall Study|Adverse Event|2|||
13100394|NCT03447730|25858837|FG002|Overall Study|Adverse Event|0|||
13100395|NCT03447353|25858853|FG000|Overall Study|Failure at Screening Visit|2|||
13100396|NCT03447353|25858853|FG000|Overall Study|Lost to Follow-up|4|||
13100397|NCT03447353|25858853|FG000|Overall Study|Scheduling Conflicts|3|||
13100398|NCT03447353|25858853|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1|||
13100399|NCT03447314|25859282|FG000|Part 1 (Up to 27 Months)|Death|6|||
13100400|NCT03447314|25859283|FG001|Part 1 (Up to 27 Months)|Death|5|||
13100401|NCT03447314|25859284|FG002|Part 1 (Up to 27 Months)|Death|3|||
13100402|NCT03447314|25859285|FG003|Part 1 (Up to 27 Months)|Death|3|||
13100403|NCT03447314|25859286|FG004|Part 1 (Up to 27 Months)|Death|0|||
13100404|NCT03447314|25859287|FG005|Part 1 (Up to 27 Months)|Death|4|||
13100405|NCT03447314|25859288|FG006|Part 1 (Up to 27 Months)|Death|3|||
13100406|NCT03447314|25859289|FG007|Part 1 (Up to 27 Months)|Death|0|||
13100407|NCT03447314|25859290|FG008|Part 1 (Up to 27 Months)|Death|0|||
13100408|NCT03447314|25859291|FG009|Part 1 (Up to 27 Months)|Death|0|||
13100409|NCT03447314|25859292|FG010|Part 1 (Up to 27 Months)|Death|4|||
13100410|NCT03447314|25859293|FG011|Part 1 (Up to 27 Months)|Death|2|||
13100411|NCT03447314|25859294|FG012|Part 1 (Up to 27 Months)|Death|0|||
13100412|NCT03447314|25859295|FG013|Part 1 (Up to 27 Months)|Death|0|||
13100413|NCT03447314|25859296|FG014|Part 1 (Up to 27 Months)|Death|0|||
13100414|NCT03447314|25859297|FG015|Part 1 (Up to 27 Months)|Death|0|||
13100415|NCT03447314|25859298|FG016|Part 1 (Up to 27 Months)|Death|0|||
13100416|NCT03447314|25859299|FG017|Part 1 (Up to 27 Months)|Death|0|||
13100417|NCT03447314|25859282|FG000|Part 1 (Up to 27 Months)|Ongoing in the study|2|||
13100418|NCT03447314|25859283|FG001|Part 1 (Up to 27 Months)|Ongoing in the study|1|||
13100419|NCT03447314|25859284|FG002|Part 1 (Up to 27 Months)|Ongoing in the study|3|||
13100420|NCT03447314|25859285|FG003|Part 1 (Up to 27 Months)|Ongoing in the study|1|||
13100421|NCT03447314|25859286|FG004|Part 1 (Up to 27 Months)|Ongoing in the study|2|||
13100422|NCT03447314|25859287|FG005|Part 1 (Up to 27 Months)|Ongoing in the study|1|||
13100423|NCT03447314|25859288|FG006|Part 1 (Up to 27 Months)|Ongoing in the study|2|||
13100424|NCT03447314|25859289|FG007|Part 1 (Up to 27 Months)|Ongoing in the study|0|||
13100425|NCT03447314|25859290|FG008|Part 1 (Up to 27 Months)|Ongoing in the study|0|||
13100426|NCT03447314|25859291|FG009|Part 1 (Up to 27 Months)|Ongoing in the study|0|||
13100427|NCT03447314|25859292|FG010|Part 1 (Up to 27 Months)|Ongoing in the study|3|||
13100428|NCT03447314|25859293|FG011|Part 1 (Up to 27 Months)|Ongoing in the study|4|||
13100429|NCT03447314|25859294|FG012|Part 1 (Up to 27 Months)|Ongoing in the study|0|||
13100430|NCT03447314|25859295|FG013|Part 1 (Up to 27 Months)|Ongoing in the study|0|||
13100431|NCT03447314|25859296|FG014|Part 1 (Up to 27 Months)|Ongoing in the study|0|||
13100432|NCT03447314|25859297|FG015|Part 1 (Up to 27 Months)|Ongoing in the study|0|||
13100433|NCT03447314|25859298|FG016|Part 1 (Up to 27 Months)|Ongoing in the study|0|||
13100434|NCT03447314|25859299|FG017|Part 1 (Up to 27 Months)|Ongoing in the study|0|||
13100435|NCT03447314|25859282|FG000|Part 1 (Up to 27 Months)|Withdrawal by Subject|1|||
13100436|NCT03447314|25859283|FG001|Part 1 (Up to 27 Months)|Withdrawal by Subject|0|||
13100437|NCT03447314|25859284|FG002|Part 1 (Up to 27 Months)|Withdrawal by Subject|1|||
13100438|NCT03447314|25859285|FG003|Part 1 (Up to 27 Months)|Withdrawal by Subject|0|||
13100439|NCT03447314|25859286|FG004|Part 1 (Up to 27 Months)|Withdrawal by Subject|0|||
13100440|NCT03447314|25859287|FG005|Part 1 (Up to 27 Months)|Withdrawal by Subject|1|||
13100441|NCT03447314|25859288|FG006|Part 1 (Up to 27 Months)|Withdrawal by Subject|0|||
13100442|NCT03447314|25859289|FG007|Part 1 (Up to 27 Months)|Withdrawal by Subject|0|||
13100443|NCT03447314|25859290|FG008|Part 1 (Up to 27 Months)|Withdrawal by Subject|0|||
13100444|NCT03447314|25859291|FG009|Part 1 (Up to 27 Months)|Withdrawal by Subject|0|||
13100445|NCT03447314|25859292|FG010|Part 1 (Up to 27 Months)|Withdrawal by Subject|0|||
13100446|NCT03447314|25859293|FG011|Part 1 (Up to 27 Months)|Withdrawal by Subject|0|||
13100447|NCT03447314|25859294|FG012|Part 1 (Up to 27 Months)|Withdrawal by Subject|0|||
13100448|NCT03447314|25859295|FG013|Part 1 (Up to 27 Months)|Withdrawal by Subject|0|||
13100449|NCT03447314|25859296|FG014|Part 1 (Up to 27 Months)|Withdrawal by Subject|0|||
13100450|NCT03447314|25859297|FG015|Part 1 (Up to 27 Months)|Withdrawal by Subject|0|||
13100451|NCT03447314|25859298|FG016|Part 1 (Up to 27 Months)|Withdrawal by Subject|0|||
13100452|NCT03447314|25859299|FG017|Part 1 (Up to 27 Months)|Withdrawal by Subject|0|||
13100453|NCT03447314|25859282|FG000|Part 1 (Up to 27 Months)|Disease progression|0|||
13100454|NCT03447314|25859283|FG001|Part 1 (Up to 27 Months)|Disease progression|0|||
13100455|NCT03447314|25859284|FG002|Part 1 (Up to 27 Months)|Disease progression|1|||
13100456|NCT03447314|25859285|FG003|Part 1 (Up to 27 Months)|Disease progression|0|||
13100457|NCT03447314|25859286|FG004|Part 1 (Up to 27 Months)|Disease progression|0|||
13100458|NCT03447314|25859287|FG005|Part 1 (Up to 27 Months)|Disease progression|0|||
13100459|NCT03447314|25859288|FG006|Part 1 (Up to 27 Months)|Disease progression|0|||
13100460|NCT03447314|25859289|FG007|Part 1 (Up to 27 Months)|Disease progression|0|||
13100461|NCT03447314|25859290|FG008|Part 1 (Up to 27 Months)|Disease progression|0|||
13100462|NCT03447314|25859291|FG009|Part 1 (Up to 27 Months)|Disease progression|0|||
13100463|NCT03447314|25859292|FG010|Part 1 (Up to 27 Months)|Disease progression|0|||
13100464|NCT03447314|25859293|FG011|Part 1 (Up to 27 Months)|Disease progression|0|||
13100465|NCT03447314|25859294|FG012|Part 1 (Up to 27 Months)|Disease progression|0|||
13100466|NCT03447314|25859295|FG013|Part 1 (Up to 27 Months)|Disease progression|0|||
13100467|NCT03447314|25859296|FG014|Part 1 (Up to 27 Months)|Disease progression|0|||
13100468|NCT03447314|25859297|FG015|Part 1 (Up to 27 Months)|Disease progression|0|||
13100469|NCT03447314|25859298|FG016|Part 1 (Up to 27 Months)|Disease progression|0|||
13100470|NCT03447314|25859299|FG017|Part 1 (Up to 27 Months)|Disease progression|0|||
13100471|NCT03447314|25859282|FG000|Part 1 (Up to 27 Months)|Lost to Follow-up|0|||
13100472|NCT03447314|25859283|FG001|Part 1 (Up to 27 Months)|Lost to Follow-up|0|||
13100473|NCT03447314|25859284|FG002|Part 1 (Up to 27 Months)|Lost to Follow-up|1|||
13100474|NCT03447314|25859285|FG003|Part 1 (Up to 27 Months)|Lost to Follow-up|0|||
13100475|NCT03447314|25859286|FG004|Part 1 (Up to 27 Months)|Lost to Follow-up|0|||
13100476|NCT03447314|25859287|FG005|Part 1 (Up to 27 Months)|Lost to Follow-up|0|||
13100477|NCT03447314|25859288|FG006|Part 1 (Up to 27 Months)|Lost to Follow-up|0|||
13100478|NCT03447314|25859289|FG007|Part 1 (Up to 27 Months)|Lost to Follow-up|0|||
13100479|NCT03447314|25859290|FG008|Part 1 (Up to 27 Months)|Lost to Follow-up|0|||
13100480|NCT03447314|25859291|FG009|Part 1 (Up to 27 Months)|Lost to Follow-up|0|||
13100481|NCT03447314|25859292|FG010|Part 1 (Up to 27 Months)|Lost to Follow-up|0|||
13100482|NCT03447314|25859293|FG011|Part 1 (Up to 27 Months)|Lost to Follow-up|0|||
13100483|NCT03447314|25859294|FG012|Part 1 (Up to 27 Months)|Lost to Follow-up|0|||
13100484|NCT03447314|25859295|FG013|Part 1 (Up to 27 Months)|Lost to Follow-up|0|||
13100485|NCT03447314|25859296|FG014|Part 1 (Up to 27 Months)|Lost to Follow-up|0|||
13100486|NCT03447314|25859297|FG015|Part 1 (Up to 27 Months)|Lost to Follow-up|0|||
13100487|NCT03447314|25859298|FG016|Part 1 (Up to 27 Months)|Lost to Follow-up|0|||
13100488|NCT03447314|25859299|FG017|Part 1 (Up to 27 Months)|Lost to Follow-up|0|||
13100489|NCT03447249|25859335|FG000|Overall Study|Adverse Event|1|||
13100490|NCT03447249|25859336|FG001|Overall Study|Adverse Event|0|||
13100491|NCT03447249|25859335|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
13100492|NCT03447249|25859336|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
13100493|NCT03447249|25859335|FG000|Overall Study|Other|3|||
13100494|NCT03447249|25859336|FG001|Overall Study|Other|0|||
13100495|NCT03446885|25859351|FG000|Overall Study|Lost to Follow-up|1|||
13100496|NCT03446885|25859352|FG001|Overall Study|Lost to Follow-up|0|||
13100497|NCT03446885|25859351|FG000|Overall Study|Did not complete entire visit|1|||
13100498|NCT03446885|25859352|FG001|Overall Study|Did not complete entire visit|0|||
13100499|NCT03446781|25859406|FG000|Overall Study|Lost to Follow-up|11|||
13100500|NCT03446781|25859407|FG001|Overall Study|Lost to Follow-up|5|||
13100501|NCT03446781|25859406|FG000|Overall Study|Withdrawal by Subject|9|||
13100502|NCT03446781|25859407|FG001|Overall Study|Withdrawal by Subject|7|||
13100503|NCT03446781|25859406|FG000|Overall Study|Adverse Event|8|||
13100504|NCT03446781|25859407|FG001|Overall Study|Adverse Event|2|||
13151837|NCT02544074|26052595|FG011|Overall Study|Withdrawal by Subject|0|||
13151838|NCT02544074|26052596|FG012|Overall Study|Withdrawal by Subject|0|||
13151839|NCT02544074|26052597|FG013|Overall Study|Withdrawal by Subject|0|||
13151840|NCT02544074|26052598|FG014|Overall Study|Withdrawal by Subject|0|||
13151841|NCT02544074|26052599|FG015|Overall Study|Withdrawal by Subject|0|||
13151842|NCT02544074|26052600|FG016|Overall Study|Withdrawal by Subject|0|||
13151843|NCT02544074|26052601|FG017|Overall Study|Withdrawal by Subject|0|||
13151844|NCT02544074|26052602|FG018|Overall Study|Withdrawal by Subject|0|||
13151845|NCT02544074|26052603|FG019|Overall Study|Withdrawal by Subject|0|||
13151846|NCT02544074|26052604|FG020|Overall Study|Withdrawal by Subject|0|||
13151847|NCT02544074|26052584|FG000|Overall Study|Tablet error|0|||
13151848|NCT02544074|26052585|FG001|Overall Study|Tablet error|0|||
13222681|NCT01803607|26286773|FG000|Overall Study|Adverse Event|5|||
13222682|NCT01803607|26286774|FG001|Overall Study|Adverse Event|3|||
13151849|NCT02544074|26052586|FG002|Overall Study|Tablet error|0|||
13100505|NCT03446781|25859406|FG000|Overall Study|Protocol Violation|0|||
13100506|NCT03446781|25859407|FG001|Overall Study|Protocol Violation|3|||
13100507|NCT03446573|25859486|FG000|Overall Study|Withdrawal by Subject|7|||
13100508|NCT03446573|25859487|FG001|Overall Study|Withdrawal by Subject|16|||
13100509|NCT03446573|25859486|FG000|Overall Study|Physician Decision|1|||
13100510|NCT03446573|25859487|FG001|Overall Study|Physician Decision|1|||
13100511|NCT03446573|25859486|FG000|Overall Study|Lost to Follow-up|3|||
13100512|NCT03446573|25859487|FG001|Overall Study|Lost to Follow-up|5|||
13100513|NCT03446573|25859486|FG000|Overall Study|Protocol Violation|3|||
13100514|NCT03446573|25859487|FG001|Overall Study|Protocol Violation|2|||
13100515|NCT03446573|25859486|FG000|Overall Study|Lack of Efficacy|0|||
13100516|NCT03446573|25859487|FG001|Overall Study|Lack of Efficacy|3|||
13100517|NCT03446573|25859486|FG000|Overall Study|Adverse Event|13|||
13100518|NCT03446573|25859487|FG001|Overall Study|Adverse Event|2|||
13100519|NCT03446573|25859486|FG000|Overall Study|Ongoing at the time of interim analysis|342|||
13100520|NCT03446573|25859487|FG001|Overall Study|Ongoing at the time of interim analysis|343|||
13100521|NCT03445065|25859654|FG000|Overall Study|Withdrawal by Subject|3|||
13100522|NCT03445065|25859655|FG001|Overall Study|Withdrawal by Subject|6|||
13100523|NCT03445065|25859656|FG002|Overall Study|Withdrawal by Subject|2|||
13100524|NCT03445065|25859657|FG003|Overall Study|Withdrawal by Subject|2|||
13100525|NCT03445065|25859654|FG000|Overall Study|Other|4|||
13100526|NCT03445065|25859655|FG001|Overall Study|Other|3|||
13100527|NCT03445065|25859656|FG002|Overall Study|Other|3|||
13100528|NCT03445065|25859657|FG003|Overall Study|Other|1|||
13100529|NCT03444766|25859666|FG000|Overall Study|Other Reasons|2|||
13100530|NCT03444766|25859666|FG000|Overall Study|Participant Withdrew Consent|5|||
13100531|NCT03444766|25859666|FG000|Overall Study|Lost to Follow-up|2|||
13100532|NCT03444766|25859666|FG000|Overall Study|Death|2|||
13100533|NCT03444766|25859666|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6|||
13100534|NCT03444766|25859666|FG000|Overall Study|Disease Progression|49|||
13100535|NCT03444584|25859729|FG000|Overall Study|Withdrawal by Subject|0|||
13100536|NCT03444584|25859730|FG001|Overall Study|Withdrawal by Subject|1|||
13100537|NCT03444584|25859729|FG000|Overall Study|Other|0|||
13100538|NCT03444584|25859730|FG001|Overall Study|Other|1|||
13100539|NCT03444155|25859761|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
13100540|NCT03444155|25859762|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
13100541|NCT03443713|25859801|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
13100542|NCT03443713|25859802|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
13100543|NCT03443713|25859803|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1|||
13100544|NCT03443427|25859846|FG000|Overall Study|Adverse Event|2|||
13100545|NCT03443427|25859847|FG001|Overall Study|Adverse Event|3|||
13100546|NCT03443427|25859846|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
13100547|NCT03443427|25859847|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
13100548|NCT03443427|25859846|FG000|Overall Study|Other|4|||
13100549|NCT03443427|25859847|FG001|Overall Study|Other|6|||
13100550|NCT03443414|25859900|FG000|Overall Study|Adverse Event|6|||
13100551|NCT03443414|25859901|FG001|Overall Study|Adverse Event|0|||
13100552|NCT03443414|25859902|FG002|Overall Study|Adverse Event|4|||
13100553|NCT03443414|25859903|FG003|Overall Study|Adverse Event|2|||
13100554|NCT03443414|25859904|FG004|Overall Study|Adverse Event|3|||
13100555|NCT03443414|25859900|FG000|Overall Study|Withdrawal by Subject|3|||
13100556|NCT03443414|25859901|FG001|Overall Study|Withdrawal by Subject|2|||
13100557|NCT03443414|25859902|FG002|Overall Study|Withdrawal by Subject|2|||
13100558|NCT03443414|25859903|FG003|Overall Study|Withdrawal by Subject|2|||
13100559|NCT03443414|25859904|FG004|Overall Study|Withdrawal by Subject|1|||
13100560|NCT03443414|25859900|FG000|Overall Study|Death|0|||
13100561|NCT03443414|25859901|FG001|Overall Study|Death|1|||
13100562|NCT03443414|25859902|FG002|Overall Study|Death|0|||
13100563|NCT03443414|25859903|FG003|Overall Study|Death|1|||
13100564|NCT03443414|25859904|FG004|Overall Study|Death|0|||
13100565|NCT03443414|25859900|FG000|Overall Study|Reason not specified|2|||
13100566|NCT03443414|25859901|FG001|Overall Study|Reason not specified|0|||
13100567|NCT03443414|25859902|FG002|Overall Study|Reason not specified|0|||
13100568|NCT03443414|25859903|FG003|Overall Study|Reason not specified|0|||
13100569|NCT03443414|25859904|FG004|Overall Study|Reason not specified|1|||
13100570|NCT03443024|25859971|FG000|Overall Study|Adverse Event|2|||
13100571|NCT03443024|25859972|FG001|Overall Study|Adverse Event|4|||
13100572|NCT03443024|25859973|FG002|Overall Study|Adverse Event|3|||
13100573|NCT03443024|25859974|FG003|Overall Study|Adverse Event|1|||
13100574|NCT03443024|25859971|FG000|Overall Study|Lost to Follow-up|9|||
13100575|NCT03443024|25859972|FG001|Overall Study|Lost to Follow-up|9|||
13100576|NCT03443024|25859973|FG002|Overall Study|Lost to Follow-up|7|||
13100577|NCT03443024|25859974|FG003|Overall Study|Lost to Follow-up|5|||
13100578|NCT03443024|25859971|FG000|Overall Study|Withdrawal by Subject|8|||
13100579|NCT03443024|25859972|FG001|Overall Study|Withdrawal by Subject|15|||
13100580|NCT03443024|25859973|FG002|Overall Study|Withdrawal by Subject|9|||
13100581|NCT03443024|25859974|FG003|Overall Study|Withdrawal by Subject|23|||
13100582|NCT03443024|25859971|FG000|Overall Study|Physician Decision|1|||
13100583|NCT03443024|25859972|FG001|Overall Study|Physician Decision|2|||
13100584|NCT03443024|25859973|FG002|Overall Study|Physician Decision|0|||
13100585|NCT03443024|25859974|FG003|Overall Study|Physician Decision|1|||
13100586|NCT03443024|25859971|FG000|Overall Study|Sponsor Decision|1|||
13100587|NCT03443024|25859972|FG001|Overall Study|Sponsor Decision|1|||
13100588|NCT03443024|25859973|FG002|Overall Study|Sponsor Decision|0|||
13100589|NCT03443024|25859974|FG003|Overall Study|Sponsor Decision|0|||
13100590|NCT03443024|25859971|FG000|Overall Study|Protocol Deviation|0|||
13100591|NCT03443024|25859972|FG001|Overall Study|Protocol Deviation|0|||
13100592|NCT03443024|25859973|FG002|Overall Study|Protocol Deviation|0|||
13100593|NCT03443024|25859974|FG003|Overall Study|Protocol Deviation|2|||
13100594|NCT03442985|25860015|FG000|Overall Study|Sponsor Request|55|||
13100595|NCT03442985|25860016|FG001|Overall Study|Sponsor Request|60|||
13100596|NCT03442985|25860017|FG002|Overall Study|Sponsor Request|54|||
13100597|NCT03442985|25860015|FG000|Overall Study|Lost to Follow-up|5|||
13100598|NCT03442985|25860016|FG001|Overall Study|Lost to Follow-up|2|||
13100599|NCT03442985|25860017|FG002|Overall Study|Lost to Follow-up|7|||
13100600|NCT03442985|25860015|FG000|Overall Study|Withdrawal by Subject|2|||
13100601|NCT03442985|25860016|FG001|Overall Study|Withdrawal by Subject|3|||
13100602|NCT03442985|25860017|FG002|Overall Study|Withdrawal by Subject|4|||
13100603|NCT03442985|25860015|FG000|Overall Study|Adverse Event|0|||
13100604|NCT03442985|25860016|FG001|Overall Study|Adverse Event|1|||
13100605|NCT03442985|25860017|FG002|Overall Study|Adverse Event|0|||
13100606|NCT03442829|25860038|FG000|Overall Study|Scheduling clash|3|||
13100607|NCT03442829|25860039|FG001|Overall Study|Scheduling clash|1|||
13100608|NCT03442829|25860038|FG000|Overall Study|Illness unrelated to study|1|||
13151850|NCT02544074|26052587|FG003|Overall Study|Tablet error|0|||
13100609|NCT03442829|25860039|FG001|Overall Study|Illness unrelated to study|1|||
13100610|NCT03442777|25860061|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8|||
13100611|NCT03442777|25860062|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13|||
13100612|NCT03442777|25860063|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7|||
13151851|NCT02544074|26052588|FG004|Overall Study|Tablet error|0|||
13151852|NCT02544074|26052589|FG005|Overall Study|Tablet error|1|||
13151853|NCT02544074|26052590|FG006|Overall Study|Tablet error|0|||
13151854|NCT02544074|26052591|FG007|Overall Study|Tablet error|0|||
13151855|NCT02544074|26052592|FG008|Overall Study|Tablet error|0|||
13151856|NCT02544074|26052593|FG009|Overall Study|Tablet error|1|||
13151857|NCT02544074|26052594|FG010|Overall Study|Tablet error|0|||
13151858|NCT02544074|26052595|FG011|Overall Study|Tablet error|0|||
13151859|NCT02544074|26052596|FG012|Overall Study|Tablet error|0|||
13151860|NCT02544074|26052597|FG013|Overall Study|Tablet error|0|||
13151861|NCT02544074|26052598|FG014|Overall Study|Tablet error|0|||
13151862|NCT02544074|26052599|FG015|Overall Study|Tablet error|0|||
13151863|NCT02544074|26052600|FG016|Overall Study|Tablet error|0|||
13151864|NCT02544074|26052601|FG017|Overall Study|Tablet error|0|||
13151865|NCT02544074|26052602|FG018|Overall Study|Tablet error|0|||
13151866|NCT02544074|26052603|FG019|Overall Study|Tablet error|0|||
13151867|NCT02544074|26052604|FG020|Overall Study|Tablet error|0|||
13151868|NCT02543918|26052617|FG000|Overall Study|Never treated|0|||
13151869|NCT02543918|26052618|FG001|Overall Study|Never treated|1|||
13151870|NCT02543918|26052617|FG000|Overall Study|Lost to Follow-up|1|||
13151871|NCT02543918|26052618|FG001|Overall Study|Lost to Follow-up|1|||
13151872|NCT02543918|26052617|FG000|Overall Study|Withdrawal by Subject|1|||
13151873|NCT02543918|26052618|FG001|Overall Study|Withdrawal by Subject|1|||
13151874|NCT02543918|26052617|FG000|Overall Study|Adverse Event|1|||
13151875|NCT02543918|26052618|FG001|Overall Study|Adverse Event|1|||
13151876|NCT02543892|26052689|FG000|Received Vaccination 2|Withdrawal by Subject|1|||
13151877|NCT02543892|26052690|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
13151878|NCT02543892|26052691|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
13151879|NCT02543892|26052692|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
13151880|NCT02543892|26052693|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
13100613|NCT03442764|25860085|FG000|Overall Study|Adverse Event|1|||
13100614|NCT03442764|25860086|FG001|Overall Study|Adverse Event|0|||
13100615|NCT03442764|25860087|FG002|Overall Study|Adverse Event|0|||
13151881|NCT02543892|26052694|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
13151882|NCT02543892|26052695|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
13151883|NCT02543892|26052696|FG007|Received Vaccination 2|Withdrawal by Subject|1|||
13151884|NCT02543892|26052689|FG000|Received Vaccination 2|Physician Decision|0|||
13151885|NCT02543892|26052690|FG001|Received Vaccination 2|Physician Decision|0|||
13151886|NCT02543892|26052691|FG002|Received Vaccination 2|Physician Decision|0|||
13151887|NCT02543892|26052692|FG003|Received Vaccination 2|Physician Decision|0|||
13151888|NCT02543892|26052693|FG004|Received Vaccination 2|Physician Decision|0|||
13151889|NCT02543892|26052694|FG005|Received Vaccination 2|Physician Decision|1|||
13151890|NCT02543892|26052695|FG006|Received Vaccination 2|Physician Decision|0|||
13151891|NCT02543892|26052696|FG007|Received Vaccination 2|Physician Decision|0|||
13151892|NCT02543892|26052689|FG000|Received Vaccination 2|Adverse Event|0|||
13151893|NCT02543892|26052690|FG001|Received Vaccination 2|Adverse Event|1|||
13151894|NCT02543892|26052691|FG002|Received Vaccination 2|Adverse Event|0|||
13151895|NCT02543892|26052692|FG003|Received Vaccination 2|Adverse Event|0|||
13151896|NCT02543892|26052693|FG004|Received Vaccination 2|Adverse Event|0|||
13151897|NCT02543892|26052694|FG005|Received Vaccination 2|Adverse Event|0|||
13151898|NCT02543892|26052695|FG006|Received Vaccination 2|Adverse Event|0|||
13151899|NCT02543892|26052696|FG007|Received Vaccination 2|Adverse Event|0|||
13151900|NCT02543892|26052689|FG000|Had Immunology Data|Withdrawal by Subject|0|||
13151901|NCT02543892|26052690|FG001|Had Immunology Data|Withdrawal by Subject|0|||
13100616|NCT03442595|25860111|FG000|Overall Study|Lost to Follow-up|94|||
13100617|NCT03442595|25860112|FG001|Overall Study|Lost to Follow-up|0|||
13100618|NCT03442569|25860119|FG000|Overall Study|Subject was ineligible after enrollment|1|||
13100619|NCT03442296|25860194|FG000|3 Month Follow-up|Death|3|||
13100620|NCT03442296|25860195|FG001|3 Month Follow-up|Death|1|||
13100621|NCT03442296|25860194|FG000|3 Month Follow-up|Lost to Follow-up|1|||
13100622|NCT03442296|25860195|FG001|3 Month Follow-up|Lost to Follow-up|1|||
13100623|NCT03442296|25860194|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
13100624|NCT03442296|25860195|FG001|3 Month Follow-up|Withdrawal by Subject|0|||
13100625|NCT03442296|25860194|FG000|3 Month Follow-up|Obtained Hearing Aids|0|||
13100626|NCT03442296|25860195|FG001|3 Month Follow-up|Obtained Hearing Aids|1|||
13100627|NCT03442296|25860194|FG000|12 Month Follow-up|Incomplete measurement|1|||
13100628|NCT03442296|25860195|FG001|12 Month Follow-up|Incomplete measurement|1|||
13100629|NCT03441984|25860571|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
13100630|NCT03441984|25860572|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
13100631|NCT03441984|25860573|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1|||
13100632|NCT03441984|25860574|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
13100633|NCT03441984|25860575|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
13100634|NCT03441984|25860576|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
13100635|NCT03441984|25860577|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
13100636|NCT03441984|25860578|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
13100637|NCT03441984|25860579|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
13100638|NCT03441984|25860580|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
13100639|NCT03441984|25860581|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
13151902|NCT02543892|26052691|FG002|Had Immunology Data|Withdrawal by Subject|0|||
13151903|NCT02543892|26052692|FG003|Had Immunology Data|Withdrawal by Subject|0|||
13151904|NCT02543892|26052693|FG004|Had Immunology Data|Withdrawal by Subject|0|||
13151905|NCT02543892|26052694|FG005|Had Immunology Data|Withdrawal by Subject|0|||
13151906|NCT02543892|26052695|FG006|Had Immunology Data|Withdrawal by Subject|1|||
13151907|NCT02543892|26052696|FG007|Had Immunology Data|Withdrawal by Subject|0|||
13151908|NCT02543801|26052727|FG000|Overall Study|Protocol Violation|1|||
13151909|NCT02543801|26052728|FG001|Overall Study|Protocol Violation|2|||
13151910|NCT02543801|26052729|FG002|Overall Study|Protocol Violation|0|||
13151911|NCT02543801|26052730|FG003|Overall Study|Protocol Violation|0|||
13151912|NCT02543658|26052763|FG000|Overall Study|Lack of Efficacy|0|||
13151913|NCT02543658|26052764|FG001|Overall Study|Lack of Efficacy|4|||
13151914|NCT02543528|26052789|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0|||
13151915|NCT02543528|26052790|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0|||
13151916|NCT02543528|26052791|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0|||
13151917|NCT02543528|26052792|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0|||
13151918|NCT02543528|26052793|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2|||
13151919|NCT02543528|26052789|FG000|Adaptation Period|Lens Handling Difficultes|0|||
13151920|NCT02543528|26052790|FG001|Adaptation Period|Lens Handling Difficultes|0|||
13151921|NCT02543528|26052791|FG002|Adaptation Period|Lens Handling Difficultes|0|||
13151922|NCT02543528|26052792|FG003|Adaptation Period|Lens Handling Difficultes|0|||
13151923|NCT02543528|26052793|FG004|Adaptation Period|Lens Handling Difficultes|8|||
13151924|NCT02543528|26052789|FG000|Adaptation Period|Lost to Follow-up|0|||
13151925|NCT02543528|26052790|FG001|Adaptation Period|Lost to Follow-up|0|||
13151926|NCT02543528|26052791|FG002|Adaptation Period|Lost to Follow-up|0|||
13151927|NCT02543528|26052792|FG003|Adaptation Period|Lost to Follow-up|0|||
13485340|NCT02021773|27032427|FG002|Overall Study|Reason not specified|0|||
13487985|NCT01111565|27041935|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
13151928|NCT02543528|26052793|FG004|Adaptation Period|Lost to Follow-up|14|||
13151929|NCT02543528|26052789|FG000|Adaptation Period|Adverse Event|0|||
13151930|NCT02543528|26052790|FG001|Adaptation Period|Adverse Event|0|||
13151931|NCT02543528|26052791|FG002|Adaptation Period|Adverse Event|0|||
13151932|NCT02543528|26052792|FG003|Adaptation Period|Adverse Event|0|||
13151933|NCT02543528|26052793|FG004|Adaptation Period|Adverse Event|2|||
13151934|NCT02543528|26052789|FG000|Extended Wear Period|Adverse Event|17|||
13151935|NCT02543528|26052790|FG001|Extended Wear Period|Adverse Event|11|||
13151936|NCT02543528|26052791|FG002|Extended Wear Period|Adverse Event|16|||
13151937|NCT02543528|26052792|FG003|Extended Wear Period|Adverse Event|3|||
13151938|NCT02543528|26052793|FG004|Extended Wear Period|Adverse Event|0|||
13151939|NCT02543528|26052789|FG000|Extended Wear Period|Missed too many scheduled visits|0|||
13151940|NCT02543528|26052790|FG001|Extended Wear Period|Missed too many scheduled visits|0|||
13151941|NCT02543528|26052791|FG002|Extended Wear Period|Missed too many scheduled visits|1|||
13151942|NCT02543528|26052792|FG003|Extended Wear Period|Missed too many scheduled visits|3|||
13151943|NCT02543528|26052793|FG004|Extended Wear Period|Missed too many scheduled visits|0|||
13151944|NCT02543528|26052789|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1|||
13151945|NCT02543528|26052790|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
13151946|NCT02543528|26052791|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
13151947|NCT02543528|26052792|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
13151948|NCT02543528|26052793|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
13151949|NCT02543528|26052789|FG000|Extended Wear Period|Lost to Follow-up|0|||
13151950|NCT02543528|26052790|FG001|Extended Wear Period|Lost to Follow-up|1|||
13151951|NCT02543528|26052791|FG002|Extended Wear Period|Lost to Follow-up|2|||
13151952|NCT02543528|26052792|FG003|Extended Wear Period|Lost to Follow-up|1|||
13151953|NCT02543528|26052793|FG004|Extended Wear Period|Lost to Follow-up|0|||
13151954|NCT02543528|26052789|FG000|Extended Wear Period|Withdrawal by Subject|10|||
13151955|NCT02543528|26052790|FG001|Extended Wear Period|Withdrawal by Subject|9|||
13222683|NCT01803607|26286773|FG000|Overall Study|Lack of Efficacy|0|||
13100640|NCT03441984|25860582|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
13100641|NCT03441789|25860605|FG000|Overall Study|Withdrawal by Subject|1|||
13100642|NCT03441789|25860606|FG001|Overall Study|Withdrawal by Subject|1|||
13100643|NCT03441789|25860605|FG000|Overall Study|Adverse Event|0|||
13100644|NCT03441789|25860606|FG001|Overall Study|Adverse Event|1|||
13100645|NCT03441789|25860605|FG000|Overall Study|Protocol Violation|0|||
13100646|NCT03441789|25860606|FG001|Overall Study|Protocol Violation|1|||
13100647|NCT03441789|25860605|FG000|Overall Study|Lost to Follow-up|0|||
13100648|NCT03441789|25860606|FG001|Overall Study|Lost to Follow-up|1|||
13100649|NCT03441360|25860651|FG000|Overall Study|Radiological disease progression|5|||
13100650|NCT03441360|25860652|FG001|Overall Study|Radiological disease progression|6|||
13100651|NCT03441360|25860653|FG002|Overall Study|Radiological disease progression|4|||
13100652|NCT03441360|25860651|FG000|Overall Study|Clinical disease progression|2|||
13100653|NCT03441360|25860652|FG001|Overall Study|Clinical disease progression|2|||
13100654|NCT03441360|25860653|FG002|Overall Study|Clinical disease progression|0|||
13100655|NCT03441360|25860651|FG000|Overall Study|Adverse Event|1|||
13100656|NCT03441360|25860652|FG001|Overall Study|Adverse Event|0|||
13100657|NCT03441360|25860653|FG002|Overall Study|Adverse Event|1|||
13100658|NCT03440944|25860674|FG000|Overall Study|Physician Decision|1|||
13100659|NCT03440944|25860675|FG001|Overall Study|Physician Decision|0|||
13100660|NCT03440944|25860674|FG000|Overall Study|No Acceptable Vasculature|0|||
13100661|NCT03440944|25860675|FG001|Overall Study|No Acceptable Vasculature|1|||
13100662|NCT03440918|25860710|FG000|Overall Study|Protocol Violation|0|||
13100663|NCT03440918|25860711|FG001|Overall Study|Protocol Violation|16|||
13100664|NCT03440411|25860756|FG000|Overall Study|Adverse Event|0|||
13100665|NCT03440411|25860757|FG001|Overall Study|Adverse Event|0|||
13100666|NCT03440411|25860758|FG002|Overall Study|Adverse Event|1|||
13100667|NCT03440411|25860759|FG003|Overall Study|Adverse Event|0|||
13100668|NCT03440411|25860756|FG000|Overall Study|PD|2|||
13100669|NCT03440411|25860757|FG001|Overall Study|PD|1|||
13100670|NCT03440411|25860758|FG002|Overall Study|PD|1|||
13100671|NCT03440411|25860759|FG003|Overall Study|PD|1|||
13100672|NCT03440411|25860756|FG000|Overall Study|Withdrawal by Subject|1|||
13100673|NCT03440411|25860757|FG001|Overall Study|Withdrawal by Subject|0|||
13100674|NCT03440411|25860758|FG002|Overall Study|Withdrawal by Subject|0|||
13100675|NCT03440411|25860759|FG003|Overall Study|Withdrawal by Subject|0|||
13100676|NCT03440411|25860756|FG000|Overall Study|Closed study by sponsor|0|||
13100677|NCT03440411|25860757|FG001|Overall Study|Closed study by sponsor|0|||
13100678|NCT03440411|25860758|FG002|Overall Study|Closed study by sponsor|0|||
13100679|NCT03440411|25860759|FG003|Overall Study|Closed study by sponsor|1|||
13100680|NCT03440320|25860778|FG000|Overall Study|Withdrawal by Subject|0|||
13100681|NCT03440320|25860779|FG001|Overall Study|Withdrawal by Subject|1|||
13100682|NCT03439137|25860798|FG000|Overall Study|Adverse Event|16|||
13100683|NCT03439137|25860799|FG001|Overall Study|Adverse Event|12|||
13100684|NCT03439137|25860798|FG000|Overall Study|Physician Decision|0|||
13100685|NCT03439137|25860799|FG001|Overall Study|Physician Decision|5|||
13100686|NCT03439137|25860798|FG000|Overall Study|Withdrawal by Subject|14|||
13100687|NCT03439137|25860799|FG001|Overall Study|Withdrawal by Subject|4|||
13100688|NCT03439137|25860798|FG000|Overall Study|Conducting rescue therapy|2|||
13100689|NCT03439137|25860799|FG001|Overall Study|Conducting rescue therapy|1|||
13100690|NCT03439137|25860798|FG000|Overall Study|Difficult to control Hb|10|||
13151956|NCT02543528|26052791|FG002|Extended Wear Period|Withdrawal by Subject|4|||
13151957|NCT02543528|26052792|FG003|Extended Wear Period|Withdrawal by Subject|5|||
13151958|NCT02543528|26052793|FG004|Extended Wear Period|Withdrawal by Subject|0|||
13151959|NCT02543346|26052824|FG000|Second Priming Visit|Withdrawal by Subject|0|||
13151960|NCT02543346|26052825|FG001|Second Priming Visit|Withdrawal by Subject|2|||
13151961|NCT02543346|26052826|FG002|Second Priming Visit|Withdrawal by Subject|2|||
13100691|NCT03439137|25860799|FG001|Overall Study|Difficult to control Hb|2|||
13100692|NCT03439137|25860798|FG000|Overall Study|Initiation of a renal transplant|0|||
13100693|NCT03439137|25860799|FG001|Overall Study|Initiation of a renal transplant|2|||
13100694|NCT03439072|25860834|FG000|Overall Study|Withdrawal by Subject|2|||
13100695|NCT03439072|25860835|FG001|Overall Study|Withdrawal by Subject|3|||
13100696|NCT03439072|25860834|FG000|Overall Study|Physician Decision|0|||
13100697|NCT03439072|25860835|FG001|Overall Study|Physician Decision|1|||
13100698|NCT03438539|25860880|FG000|Overall Study|Lost to Follow-up|8|||
13100699|NCT03438539|25860881|FG001|Overall Study|Lost to Follow-up|4|||
13100700|NCT03438539|25860882|FG002|Overall Study|Lost to Follow-up|10|||
13100701|NCT03438539|25860883|FG003|Overall Study|Lost to Follow-up|9|||
13100702|NCT03438539|25860884|FG004|Overall Study|Lost to Follow-up|3|||
13100703|NCT03438539|25860885|FG005|Overall Study|Lost to Follow-up|8|||
13100704|NCT03438396|25860903|FG000|Overall Study|Ongoing on study treatment|4|||
13100705|NCT03438396|25860903|FG000|Overall Study|Ongoing in survival follow-up|33|||
13100706|NCT03438396|25860903|FG000|Overall Study|Withdrawal by Subject|4|||
13100707|NCT03438396|25860903|FG000|Overall Study|Lost to Follow-up|2|||
13100708|NCT03438396|25860903|FG000|Overall Study|Death|58|||
13100709|NCT03438396|25860903|FG000|Overall Study|Not treated|1|||
13100710|NCT03438383|25860930|FG000|Overall Study|Protocol Violation|9|||
13100711|NCT03438383|25860931|FG001|Overall Study|Protocol Violation|3|||
13100712|NCT03438006|25860940|FG000|Overall Study|Adverse Event|1|||
13100713|NCT03438006|25860940|FG000|Overall Study|Lost to Follow-up|67|||
13100714|NCT03438006|25860940|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47|||
13100715|NCT03438006|25860940|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3|||
13100716|NCT03437733|25860968|FG000|Overall Study|Eligibility criteria not met|0|||
13100717|NCT03437733|25860969|FG001|Overall Study|Eligibility criteria not met|3|||
13100718|NCT03437577|25860985|FG000|Pre-Randomization|Withdrawal by Subject|0|||
13100719|NCT03437577|25860986|FG001|Pre-Randomization|Withdrawal by Subject|0|||
13100720|NCT03437577|25860987|FG002|Pre-Randomization|Withdrawal by Subject|10|||
13100721|NCT03437577|25860985|FG000|Post-Randomization|Physician Decision|0|||
13100722|NCT03437577|25860986|FG001|Post-Randomization|Physician Decision|2|||
13100723|NCT03437577|25860987|FG002|Post-Randomization|Physician Decision|0|||
13100724|NCT03437512|25861004|FG000|Randomized|Withdrawal by Subject|0|||
13100725|NCT03437512|25861005|FG001|Randomized|Withdrawal by Subject|2|||
13100726|NCT03437512|25861004|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2|||
13100727|NCT03437512|25861005|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1|||
13100728|NCT03437447|25861068|FG000|Treatment Period 1|Withdrawal by Subject|0|||
13100729|NCT03437447|25861069|FG001|Treatment Period 1|Withdrawal by Subject|0|||
13100730|NCT03437447|25861070|FG002|Treatment Period 1|Withdrawal by Subject|1|||
13100731|NCT03437265|25861083|FG000|Overall Study|Protocol Violation|6|||
13100732|NCT03436732|25861103|FG000|Overall Study|Not treated-enrolled in different study|1|||
13100733|NCT03436732|25861104|FG001|Overall Study|Not treated-enrolled in different study|0|||
13100734|NCT03436732|25861103|FG000|Overall Study|Off study after cycle 1|1|||
13100735|NCT03436732|25861104|FG001|Overall Study|Off study after cycle 1|0|||
13100736|NCT03436732|25861103|FG000|Overall Study|Adverse Event|2|||
13100737|NCT03436732|25861104|FG001|Overall Study|Adverse Event|0|||
13100738|NCT03436732|25861103|FG000|Overall Study|Death|0|||
13100739|NCT03436732|25861104|FG001|Overall Study|Death|1|||
13100740|NCT03436420|25861147|FG000|Overall Study|Lack of Efficacy|3|||
13100741|NCT03436082|25861166|FG000|Overall Study|Did not undergo procedure|1|||
13100742|NCT03436082|25861167|FG001|Overall Study|Did not undergo procedure|0|||
13100743|NCT03435692|25861218|FG000|Overall Study|Lack of Efficacy|2|||
13100744|NCT03435692|25861219|FG001|Overall Study|Lack of Efficacy|2|||
13100745|NCT03435692|25861220|FG002|Overall Study|Lack of Efficacy|0|||
13100746|NCT03435497|25861241|FG000|Overall Study|Lost to Follow-up|1|||
13100747|NCT03435497|25861242|FG001|Overall Study|Lost to Follow-up|0|||
13100748|NCT03435497|25861241|FG000|Overall Study|Death|1|||
13100749|NCT03435497|25861242|FG001|Overall Study|Death|0|||
13100750|NCT03435497|25861241|FG000|Overall Study|Withdrawal by Subject|0|||
13100751|NCT03435497|25861242|FG001|Overall Study|Withdrawal by Subject|4|||
13100752|NCT03435497|25861241|FG000|Overall Study|Wrong survey administered|0|||
13100753|NCT03435497|25861242|FG001|Overall Study|Wrong survey administered|2|||
13100754|NCT03435224|25861248|FG000|Overall Study|Unable to achieve a minimum desaturation level|4|||
13132908|NCT02781584|25985803|FG011|Pre-treatment Phase|Adverse Event|1|||
13132909|NCT02781584|25985804|FG012|Pre-treatment Phase|Adverse Event|0|||
13132910|NCT02781584|25985792|FG000|Treatment Phase|Withdrew Consent|0|||
13132911|NCT02781584|25985793|FG001|Treatment Phase|Withdrew Consent|0|||
13132912|NCT02781584|25985794|FG002|Treatment Phase|Withdrew Consent|0|||
13132913|NCT02781584|25985795|FG003|Treatment Phase|Withdrew Consent|0|||
13132914|NCT02781584|25985796|FG004|Treatment Phase|Withdrew Consent|0|||
13132915|NCT02781584|25985797|FG005|Treatment Phase|Withdrew Consent|1|||
13132916|NCT02781584|25985798|FG006|Treatment Phase|Withdrew Consent|0|||
13132917|NCT02781584|25985799|FG007|Treatment Phase|Withdrew Consent|0|||
13132918|NCT02781584|25985800|FG008|Treatment Phase|Withdrew Consent|0|||
13151962|NCT02543346|26052827|FG003|Second Priming Visit|Withdrawal by Subject|2|||
13132919|NCT02781584|25985801|FG009|Treatment Phase|Withdrew Consent|0|||
13100755|NCT03435211|25861254|FG000|Overall Study|Unable to achieve minimum desaturation level|1|||
13100756|NCT03435081|25861342|FG000|Week 0 to Week 16|Lack of Efficacy|6|||
13100757|NCT03435081|25861343|FG001|Week 0 to Week 16|Lack of Efficacy|5|||
13100758|NCT03435081|25861344|FG002|Week 0 to Week 16|Lack of Efficacy|0|||
13100759|NCT03435081|25861342|FG000|Week 0 to Week 16|Adverse Event|2|||
13100760|NCT03435081|25861343|FG001|Week 0 to Week 16|Adverse Event|2|||
13100761|NCT03435081|25861344|FG002|Week 0 to Week 16|Adverse Event|2|||
13100762|NCT03435081|25861342|FG000|Week 0 to Week 16|Withdrawal by Subject|8|||
13100763|NCT03435081|25861343|FG001|Week 0 to Week 16|Withdrawal by Subject|7|||
13100764|NCT03435081|25861344|FG002|Week 0 to Week 16|Withdrawal by Subject|10|||
13100765|NCT03435081|25861342|FG000|Week 0 to Week 16|Lost to Follow-up|3|||
13100766|NCT03435081|25861343|FG001|Week 0 to Week 16|Lost to Follow-up|1|||
13100767|NCT03435081|25861344|FG002|Week 0 to Week 16|Lost to Follow-up|4|||
13100768|NCT03435081|25861342|FG000|Week 0 to Week 16|Pregnancy|1|||
13100769|NCT03435081|25861343|FG001|Week 0 to Week 16|Pregnancy|0|||
13100770|NCT03435081|25861344|FG002|Week 0 to Week 16|Pregnancy|0|||
13100771|NCT03435081|25861342|FG000|Week 0 to Week 16|Non-compliance|1|||
13100772|NCT03435081|25861343|FG001|Week 0 to Week 16|Non-compliance|0|||
13100773|NCT03435081|25861344|FG002|Week 0 to Week 16|Non-compliance|2|||
13100774|NCT03435081|25861342|FG000|Week 0 to Week 16|Inadequate Response|0|||
13100775|NCT03435081|25861343|FG001|Week 0 to Week 16|Inadequate Response|1|||
13100776|NCT03435081|25861344|FG002|Week 0 to Week 16|Inadequate Response|0|||
13100777|NCT03435081|25861342|FG000|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
13100778|NCT03435081|25861343|FG001|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
13100779|NCT03435081|25861344|FG002|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|1|||
13100780|NCT03435081|25861342|FG000|Week 16 to Week 104|Lack of Efficacy|2|||
13100781|NCT03435081|25861343|FG001|Week 16 to Week 104|Lack of Efficacy|11|||
13100782|NCT03435081|25861344|FG002|Week 16 to Week 104|Lack of Efficacy|10|||
13100783|NCT03435081|25861342|FG000|Week 16 to Week 104|Adverse Event|1|||
13100784|NCT03435081|25861343|FG001|Week 16 to Week 104|Adverse Event|0|||
13100785|NCT03435081|25861344|FG002|Week 16 to Week 104|Adverse Event|2|||
13100786|NCT03435081|25861342|FG000|Week 16 to Week 104|Withdrawal by Subject|0|||
13100787|NCT03435081|25861343|FG001|Week 16 to Week 104|Withdrawal by Subject|1|||
13100788|NCT03435081|25861344|FG002|Week 16 to Week 104|Withdrawal by Subject|2|||
13100789|NCT03435081|25861342|FG000|Week 16 to Week 104|Lost to Follow-up|0|||
13100790|NCT03435081|25861343|FG001|Week 16 to Week 104|Lost to Follow-up|1|||
13100791|NCT03435081|25861344|FG002|Week 16 to Week 104|Lost to Follow-up|4|||
13100792|NCT03435081|25861342|FG000|Week 16 to Week 104|Non--Compliance|0|||
13100793|NCT03435081|25861343|FG001|Week 16 to Week 104|Non--Compliance|0|||
13100794|NCT03435081|25861344|FG002|Week 16 to Week 104|Non--Compliance|1|||
13100795|NCT03435055|25861357|FG000|Screening|Physician Decision|2|||
13100796|NCT03435055|25861357|FG000|Received Intervention|Did not complete nitrous administration|3|||
13100797|NCT03434977|25861398|FG000|Washout Period (at Least 6 Days)|Adverse Event|0|||
13100798|NCT03434977|25861399|FG001|Washout Period (at Least 6 Days)|Adverse Event|1|||
13100799|NCT03434834|25861407|FG000|Overall Study|unable to swallow OCT probe|16|||
13100800|NCT03434249|25861446|FG000|Overall Study|Adverse Event|1|||
13100801|NCT03434249|25861447|FG001|Overall Study|Adverse Event|0|||
13100802|NCT03434249|25861446|FG000|Overall Study|Lost to Follow-up|0|||
13100803|NCT03434249|25861447|FG001|Overall Study|Lost to Follow-up|1|||
13100804|NCT03434249|25861446|FG000|Overall Study|Non-compliance of family|2|||
13100805|NCT03434249|25861447|FG001|Overall Study|Non-compliance of family|1|||
13100806|NCT03434249|25861446|FG000|Overall Study|Difficulties in completing daily diary|2|||
13100807|NCT03434249|25861447|FG001|Overall Study|Difficulties in completing daily diary|1|||
13100808|NCT03434119|25861472|FG000|Overall Study|Randomized but not treated|1|||
13100809|NCT03434119|25861473|FG001|Overall Study|Randomized but not treated|0|||
13100810|NCT03434119|25861472|FG000|Overall Study|Adverse Event|1|||
13100811|NCT03434119|25861473|FG001|Overall Study|Adverse Event|0|||
13100812|NCT03434119|25861472|FG000|Overall Study|Poor Compliance to Protocol|0|||
13100813|NCT03434119|25861473|FG001|Overall Study|Poor Compliance to Protocol|1|||
13100814|NCT03434119|25861472|FG000|Overall Study|Study Terminated by Sponsor|91|||
13100815|NCT03434119|25861473|FG001|Overall Study|Study Terminated by Sponsor|102|||
13100816|NCT03434119|25861472|FG000|Overall Study|Withdrawal by Subject|7|||
13100817|NCT03434119|25861473|FG001|Overall Study|Withdrawal by Subject|5|||
13100818|NCT03434119|25861472|FG000|Overall Study|Other than specified|7|||
13100819|NCT03434119|25861473|FG001|Overall Study|Other than specified|5|||
13100820|NCT03433755|25861580|FG000|Overall Study|Lost to Follow-up|1|||
13100821|NCT03433755|25861581|FG001|Overall Study|Lost to Follow-up|0|||
13100822|NCT03433755|25861582|FG002|Overall Study|Lost to Follow-up|0|||
13100823|NCT03433755|25861583|FG003|Overall Study|Lost to Follow-up|0|||
13100824|NCT03433755|25861580|FG000|Overall Study|Decision by Sponsor|1|||
13100825|NCT03433755|25861581|FG001|Overall Study|Decision by Sponsor|0|||
13100826|NCT03433755|25861582|FG002|Overall Study|Decision by Sponsor|0|||
13100827|NCT03433755|25861583|FG003|Overall Study|Decision by Sponsor|0|||
13100828|NCT03433703|25861592|FG000|Overall Study|Study terminated by Sponsor|2|||
13100829|NCT03433677|25861617|FG000|Period 1|Protocol Violation|1|||
13100830|NCT03433677|25861618|FG001|Period 1|Protocol Violation|0|||
13100831|NCT03433677|25861617|FG000|Period 2|Withdrawal by Subject|1|||
13100832|NCT03433677|25861618|FG001|Period 2|Withdrawal by Subject|1|||
13100833|NCT03433482|25861681|FG000|Overall Study|Lost to Follow-up|1|||
13100834|NCT03433482|25861682|FG001|Overall Study|Lost to Follow-up|0|||
13100835|NCT03433482|25861683|FG002|Overall Study|Lost to Follow-up|1|||
13100836|NCT03433482|25861684|FG003|Overall Study|Lost to Follow-up|1|||
13100837|NCT03433482|25861681|FG000|Overall Study|Withdrawal by Subject|0|||
13100838|NCT03433482|25861682|FG001|Overall Study|Withdrawal by Subject|0|||
13100839|NCT03433482|25861683|FG002|Overall Study|Withdrawal by Subject|1|||
13100840|NCT03433482|25861684|FG003|Overall Study|Withdrawal by Subject|0|||
13100841|NCT03433482|25861681|FG000|Overall Study|Unknown reason|0|||
13100842|NCT03433482|25861682|FG001|Overall Study|Unknown reason|0|||
13100843|NCT03433482|25861683|FG002|Overall Study|Unknown reason|2|||
13100844|NCT03433482|25861684|FG003|Overall Study|Unknown reason|0|||
13100845|NCT03432858|25861771|FG000|Overall Study|Protocol Violation|2|||
13100846|NCT03432858|25861772|FG001|Overall Study|Protocol Violation|1|||
13100847|NCT03432858|25861773|FG002|Overall Study|Protocol Violation|9|||
13100848|NCT03432858|25861771|FG000|Overall Study|Withdrawal by Subject|0|||
13100849|NCT03432858|25861772|FG001|Overall Study|Withdrawal by Subject|1|||
13100850|NCT03432858|25861773|FG002|Overall Study|Withdrawal by Subject|1|||
13100851|NCT03432858|25861771|FG000|Overall Study|Procedure canceled/rescheduled|0|||
13100852|NCT03432858|25861772|FG001|Overall Study|Procedure canceled/rescheduled|9|||
13100853|NCT03432858|25861773|FG002|Overall Study|Procedure canceled/rescheduled|6|||
13100854|NCT03432858|25861771|FG000|Overall Study|Required postop mobilization with splinting|0|||
13100855|NCT03432858|25861772|FG001|Overall Study|Required postop mobilization with splinting|0|||
13100856|NCT03432858|25861773|FG002|Overall Study|Required postop mobilization with splinting|1|||
13100857|NCT03432533|25861794|FG000|Overall Study|Lost to Follow-up|1|||
13100858|NCT03432533|25861795|FG001|Overall Study|Lost to Follow-up|2|||
13151963|NCT02543346|26052824|FG000|Second Priming Visit|Adverse Event|1|||
13151964|NCT02543346|26052825|FG001|Second Priming Visit|Adverse Event|0|||
13151965|NCT02543346|26052826|FG002|Second Priming Visit|Adverse Event|0|||
13151966|NCT02543346|26052827|FG003|Second Priming Visit|Adverse Event|0|||
13151967|NCT02543294|26052834|FG000|Overall Study|Lost to Follow-up|3|||
13151968|NCT02543294|26052834|FG000|Overall Study|Physician Decision|2|||
13151969|NCT02543294|26052834|FG000|Overall Study|Withdrawal by Subject|7|||
13151970|NCT02543203|26052855|FG000|Overall Study|Unpalatable Fragrance|2|||
13151971|NCT02543203|26052856|FG001|Overall Study|Unpalatable Fragrance|2|||
13151972|NCT02543203|26052855|FG000|Overall Study|Lost to Follow-up|1|||
13151973|NCT02543203|26052856|FG001|Overall Study|Lost to Follow-up|0|||
13151974|NCT02543203|26052855|FG000|Overall Study|Increased Irritability|1|||
13151975|NCT02543203|26052856|FG001|Overall Study|Increased Irritability|0|||
13151976|NCT02543203|26052855|FG000|Overall Study|Family|1|||
13151977|NCT02543203|26052856|FG001|Overall Study|Family|2|||
13151978|NCT02543203|26052855|FG000|Overall Study|Negative Behavior|1|||
13151979|NCT02543203|26052856|FG001|Overall Study|Negative Behavior|0|||
13151980|NCT02543203|26052855|FG000|Overall Study|Withdrawal by Subject|0|||
13151981|NCT02543203|26052856|FG001|Overall Study|Withdrawal by Subject|1|||
13151982|NCT02542943|26052891|FG000|Overall Study|Lost to Follow-up|1|||
13151983|NCT02542943|26052892|FG001|Overall Study|Lost to Follow-up|0|||
13151984|NCT02542943|26052893|FG002|Overall Study|Lost to Follow-up|0|||
13151985|NCT02542943|26052891|FG000|Overall Study|Withdrawal by Subject|0|||
13151986|NCT02542943|26052892|FG001|Overall Study|Withdrawal by Subject|1|||
13151987|NCT02542943|26052893|FG002|Overall Study|Withdrawal by Subject|0|||
13151988|NCT02542865|26052944|FG000|Overall Study|Identified as screen failure|1|||
13151989|NCT02542865|26052945|FG001|Overall Study|Identified as screen failure|0|||
13151990|NCT02542865|26052944|FG000|Overall Study|Withdrawal by Subject|16|||
13151991|NCT02542865|26052945|FG001|Overall Study|Withdrawal by Subject|0|||
13151992|NCT02542631|26052974|FG000|Overall Study|Adverse Event|1|||
13151993|NCT02542631|26052975|FG001|Overall Study|Adverse Event|1|||
13151994|NCT02542631|26052974|FG000|Overall Study|Sponsor Termination|1|||
13151995|NCT02542631|26052975|FG001|Overall Study|Sponsor Termination|0|||
13151996|NCT02542631|26052974|FG000|Overall Study|Withdrawal by Subject|11|||
13151997|NCT02542631|26052975|FG001|Overall Study|Withdrawal by Subject|16|||
13151998|NCT02542631|26052974|FG000|Overall Study|Protocol Violation|1|||
13151999|NCT02542631|26052975|FG001|Overall Study|Protocol Violation|1|||
13152000|NCT02542631|26052974|FG000|Overall Study|Physician Decision|6|||
13152001|NCT02542631|26052975|FG001|Overall Study|Physician Decision|4|||
13152002|NCT02542631|26052974|FG000|Overall Study|Lost to Follow-up|6|||
13152003|NCT02542631|26052975|FG001|Overall Study|Lost to Follow-up|5|||
13485341|NCT03792750|27032503|FG000|Overall Study|Death|3|||
13152004|NCT02542631|26052974|FG000|Overall Study|Death|1|||
13152005|NCT02542631|26052975|FG001|Overall Study|Death|2|||
13152006|NCT02542631|26052974|FG000|Overall Study|Other|2|||
13152007|NCT02542631|26052975|FG001|Overall Study|Other|1|||
13152008|NCT02542631|26052974|FG000|Overall Study|Used Prohibited Medication|2|||
13152009|NCT02542631|26052975|FG001|Overall Study|Used Prohibited Medication|1|||
13152010|NCT02542605|26053026|FG000|Part B: Challenge Phase|Sponsor decision|1|||
13152011|NCT02542605|26053027|FG001|Part B: Challenge Phase|Sponsor decision|0|||
13100859|NCT03432533|25861794|FG000|Overall Study|Withdrawal by Subject|14|||
13100860|NCT03432533|25861795|FG001|Overall Study|Withdrawal by Subject|9|||
13100861|NCT03432390|25861812|FG000|Apnea Period|Protocol Violation|2|||
13100862|NCT03432390|25861813|FG001|Apnea Period|Protocol Violation|2|||
13100863|NCT03431857|25861827|FG000|Overall Study|Death|6|||
13100864|NCT03431857|25861827|FG000|Overall Study|Lost to Follow-up|41|||
13100865|NCT03431857|25861827|FG000|Overall Study|Adverse Event|6|||
13100866|NCT03431857|25861827|FG000|Overall Study|Withdrawal by Subject|1|||
13100867|NCT03431441|25861833|FG000|Overall Study|Withdrawal by Subject|2|||
13100868|NCT03431441|25861833|FG000|Overall Study|Adverse Event|2|||
13100869|NCT03431441|25861833|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1|||
13100870|NCT03431337|25861872|FG000|Overall Study|Lost to Follow-up|21|||
13100871|NCT03431337|25861873|FG001|Overall Study|Lost to Follow-up|19|||
13100872|NCT03431337|25861872|FG000|Overall Study|Withdrawal by Subject|8|||
13100873|NCT03431337|25861873|FG001|Overall Study|Withdrawal by Subject|3|||
13100874|NCT03430986|25861894|FG000|24-week Control Period|Adverse Event|1|||
13100875|NCT03430986|25861895|FG001|24-week Control Period|Adverse Event|0|||
13100876|NCT03430986|25861894|FG000|24-week Control Period|Lost to Follow-up|2|||
13100877|NCT03430986|25861895|FG001|24-week Control Period|Lost to Follow-up|2|||
13100878|NCT03430986|25861894|FG000|24-week Control Period|Withdrawal by Participant|5|||
13100879|NCT03430986|25861895|FG001|24-week Control Period|Withdrawal by Participant|0|||
13100880|NCT03430986|25861894|FG000|24-week Control Period|Protocol Deviation|0|||
13100881|NCT03430986|25861895|FG001|24-week Control Period|Protocol Deviation|2|||
13100882|NCT03430986|25861894|FG000|24-week Post-Control Period|Lost to Follow-up|1|||
13100883|NCT03430986|25861895|FG001|24-week Post-Control Period|Lost to Follow-up|1|||
13100884|NCT03430986|25861894|FG000|24-week Post-Control Period|Withdrawal by Participant|0|||
13100885|NCT03430986|25861895|FG001|24-week Post-Control Period|Withdrawal by Participant|1|||
13100886|NCT03430895|25861901|FG000|Overall Study|Not Treated|2|||
13100887|NCT03430856|25861949|FG000|Overall Study|Adverse Event|0|||
13100888|NCT03430856|25861950|FG001|Overall Study|Adverse Event|1|||
13100889|NCT03430856|25861951|FG002|Overall Study|Adverse Event|0|||
13100890|NCT03430856|25861949|FG000|Overall Study|Rescue criteria|1|||
13100891|NCT03430856|25861950|FG001|Overall Study|Rescue criteria|1|||
13100892|NCT03430856|25861951|FG002|Overall Study|Rescue criteria|0|||
13100893|NCT03430856|25861949|FG000|Overall Study|Voluntary withdrawal of consent|1|||
13100894|NCT03430856|25861950|FG001|Overall Study|Voluntary withdrawal of consent|1|||
13100895|NCT03430856|25861951|FG002|Overall Study|Voluntary withdrawal of consent|1|||
13100896|NCT03430245|25861960|FG000|Overall Study|Withdrawal by Subject|6|||
13100897|NCT03430245|25861960|FG000|Overall Study|Lost to Follow-up|1|||
13100898|NCT03430063|25861993|FG000|Overall Study|Adverse Event|0|||
13100899|NCT03430063|25861994|FG001|Overall Study|Adverse Event|1|||
13100900|NCT03430063|25861995|FG002|Overall Study|Adverse Event|0|||
13100901|NCT03430063|25861993|FG000|Overall Study|Death|3|||
13100902|NCT03430063|25861994|FG001|Overall Study|Death|2|||
13100903|NCT03430063|25861995|FG002|Overall Study|Death|3|||
13100904|NCT03430063|25861993|FG000|Overall Study|Lost to Follow-up|0|||
13100905|NCT03430063|25861994|FG001|Overall Study|Lost to Follow-up|1|||
13100906|NCT03430063|25861995|FG002|Overall Study|Lost to Follow-up|0|||
13100907|NCT03430063|25861993|FG000|Overall Study|Withdrawal by Subject|0|||
13100908|NCT03430063|25861994|FG001|Overall Study|Withdrawal by Subject|0|||
13100909|NCT03430063|25861995|FG002|Overall Study|Withdrawal by Subject|1|||
13100910|NCT03430063|25861993|FG000|Overall Study|Withdrawal of consent|3|||
13100911|NCT03430063|25861994|FG001|Overall Study|Withdrawal of consent|1|||
13100912|NCT03430063|25861995|FG002|Overall Study|Withdrawal of consent|2|||
13100913|NCT03430063|25861993|FG000|Overall Study|Progressive disease|1|||
13100914|NCT03430063|25861994|FG001|Overall Study|Progressive disease|2|||
13100915|NCT03430063|25861995|FG002|Overall Study|Progressive disease|1|||
13100916|NCT03430063|25861993|FG000|Overall Study|Other un-specified|1|||
13100917|NCT03430063|25861994|FG001|Overall Study|Other un-specified|1|||
13100918|NCT03430063|25861995|FG002|Overall Study|Other un-specified|0|||
13100919|NCT03430063|25861993|FG000|Overall Study|Randomized, but never treated|0|||
13100920|NCT03430063|25861994|FG001|Overall Study|Randomized, but never treated|0|||
13100921|NCT03430063|25861995|FG002|Overall Study|Randomized, but never treated|1|||
13100922|NCT03429556|25862054|FG000|Overall Study|Lost to Follow-up|0|||
13100923|NCT03429556|25862055|FG001|Overall Study|Lost to Follow-up|1|||
13100924|NCT03429556|25862056|FG002|Overall Study|Lost to Follow-up|0|||
13100925|NCT03429556|25862057|FG003|Overall Study|Lost to Follow-up|0|||
13100926|NCT03429049|25862076|FG000|Overall Study|Adverse Event|2|||
13100927|NCT03429049|25862077|FG001|Overall Study|Adverse Event|3|||
13100928|NCT03429049|25862076|FG000|Overall Study|Death|0|||
13100929|NCT03429049|25862077|FG001|Overall Study|Death|1|||
13100930|NCT03429049|25862076|FG000|Overall Study|Lack of Efficacy|4|||
13100931|NCT03429049|25862077|FG001|Overall Study|Lack of Efficacy|2|||
13100932|NCT03429049|25862076|FG000|Overall Study|Lost to Follow-up|9|||
13100933|NCT03429049|25862077|FG001|Overall Study|Lost to Follow-up|8|||
13100934|NCT03429049|25862076|FG000|Overall Study|Physician Decision|1|||
13100935|NCT03429049|25862077|FG001|Overall Study|Physician Decision|0|||
13100936|NCT03429049|25862076|FG000|Overall Study|Protocol Violation|3|||
13100937|NCT03429049|25862077|FG001|Overall Study|Protocol Violation|0|||
13100938|NCT03429049|25862076|FG000|Overall Study|Sponsor Decision|2|||
13100939|NCT03429049|25862077|FG001|Overall Study|Sponsor Decision|0|||
13100940|NCT03429049|25862076|FG000|Overall Study|Withdrawal by Subject|4|||
13100941|NCT03429049|25862077|FG001|Overall Study|Withdrawal by Subject|20|||
13100942|NCT03429049|25862076|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3|||
13100943|NCT03429049|25862077|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8|||
13100944|NCT03428997|25862085|FG000|Overall Study|Sponsor decision.|1|||
13100945|NCT03428997|25862085|FG000|Overall Study|Withdrawal by Subject|3|||
13100946|NCT03428997|25862085|FG000|Overall Study|Lost to Follow-up|4|||
13100947|NCT03428815|25862100|FG000|Overall Study|Lost to Follow-up|2|||
13100948|NCT03428815|25862101|FG001|Overall Study|Lost to Follow-up|2|||
13100949|NCT03428815|25862100|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5|||
13100950|NCT03428815|25862101|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2|||
13100951|NCT03428815|25862100|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3|||
13100952|NCT03428815|25862101|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1|||
13100953|NCT03428750|25862155|FG000|Overall Study|Withdrawal by Subject|11|||
13100954|NCT03428750|25862156|FG001|Overall Study|Withdrawal by Subject|10|||
13100955|NCT03428750|25862155|FG000|Overall Study|Lost to Follow-up|3|||
13100956|NCT03428750|25862156|FG001|Overall Study|Lost to Follow-up|9|||
13100957|NCT03428750|25862155|FG000|Overall Study|Adverse Event|9|||
13100958|NCT03428750|25862156|FG001|Overall Study|Adverse Event|1|||
13100959|NCT03428750|25862155|FG000|Overall Study|Protocol Violation|1|||
13100960|NCT03428750|25862156|FG001|Overall Study|Protocol Violation|0|||
13100961|NCT03428750|25862155|FG000|Overall Study|Administrative|0|||
13100962|NCT03428750|25862156|FG001|Overall Study|Administrative|1|||
13100963|NCT03428360|25862170|FG000|Overall Study|Informed consent withdrawn|5|||
13100964|NCT03428360|25862170|FG000|Overall Study|Withdrawal by Subject|4|||
13100965|NCT03428360|25862170|FG000|Overall Study|Lost to Follow-up|5|||
13100966|NCT03428360|25862170|FG000|Overall Study|Physician Decision|2|||
13100967|NCT03428360|25862170|FG000|Overall Study|Informed consent withdrawn|5|||
13100968|NCT03428360|25862170|FG000|Overall Study|Study terminated by sponsor|10|||
13100969|NCT03428360|25862170|FG000|Overall Study|Non-compliant with study|1|||
13100970|NCT03428360|25862170|FG000|Overall Study|Non-compliant with study drug|3|||
13100971|NCT03428360|25862170|FG000|Overall Study|Death|3|||
13100972|NCT03428360|25862170|FG000|Overall Study|Adverse Event|1|||
13100973|NCT03428360|25862170|FG000|Overall Study|Not on antiepileptic drug|1|||
13100974|NCT03428152|25862193|FG000|Overall Study|Physician Decision|4|||
13100975|NCT03428152|25862194|FG001|Overall Study|Physician Decision|2|||
13100976|NCT03428152|25862193|FG000|Overall Study|Protocol Violation|3|||
13100977|NCT03428152|25862194|FG001|Overall Study|Protocol Violation|5|||
13100978|NCT03428152|25862193|FG000|Overall Study|Lack of Efficacy|0|||
13100979|NCT03428152|25862194|FG001|Overall Study|Lack of Efficacy|4|||
13100980|NCT03427892|25862212|FG000|Overall Study|Lost to Follow-up|2|||
13100981|NCT03427619|25862221|FG000|Overall Study|Physician Decision|3|||
13100982|NCT03427619|25862221|FG000|Overall Study|Withdrawal by Subject|4|||
13100983|NCT03427619|25862221|FG000|Overall Study|Lost to Follow-up|5|||
13100984|NCT03427619|25862221|FG000|Overall Study|Administrative|4|||
13100985|NCT03427619|25862221|FG000|Overall Study|Other|2|||
13100986|NCT03427619|25862221|FG000|Overall Study|Unknown or Missing Completion Status|48|||
13100987|NCT03427268|25862230|FG000|Overall Study|Progressive disease|25|||
13100988|NCT03427268|25862230|FG000|Overall Study|Never treated|2|||
13100989|NCT03427268|25862230|FG000|Overall Study|Compassionate use|1|||
13100990|NCT03427268|25862230|FG000|Overall Study|Withdrawal by Subject|1|||
13100991|NCT03427268|25862230|FG000|Overall Study|Adverse Event|3|||
13100992|NCT03427073|25862305|FG000|Overall Study|Disease Progression|1|||
13100993|NCT03427073|25862306|FG001|Overall Study|Disease Progression|1|||
13100994|NCT03427073|25862307|FG002|Overall Study|Disease Progression|1|||
13100995|NCT03427073|25862308|FG003|Overall Study|Disease Progression|3|||
13100996|NCT03427073|25862309|FG004|Overall Study|Disease Progression|3|||
13100997|NCT03427073|25862310|FG005|Overall Study|Disease Progression|4|||
13100998|NCT03427073|25862311|FG006|Overall Study|Disease Progression|2|||
13100999|NCT03427073|25862312|FG007|Overall Study|Disease Progression|3|||
13101000|NCT03427073|25862305|FG000|Overall Study|Physician Decision|0|||
13101001|NCT03427073|25862306|FG001|Overall Study|Physician Decision|0|||
13101002|NCT03427073|25862307|FG002|Overall Study|Physician Decision|0|||
13101003|NCT03427073|25862308|FG003|Overall Study|Physician Decision|0|||
13101004|NCT03427073|25862309|FG004|Overall Study|Physician Decision|0|||
13101005|NCT03427073|25862310|FG005|Overall Study|Physician Decision|0|||
13101006|NCT03427073|25862311|FG006|Overall Study|Physician Decision|1|||
13101007|NCT03427073|25862312|FG007|Overall Study|Physician Decision|1|||
13101008|NCT03426995|25862717|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
13101009|NCT03426995|25862718|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
13101010|NCT03426995|25862719|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1|||
13101011|NCT03426995|25862720|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
13132920|NCT02781584|25985802|FG010|Treatment Phase|Withdrew Consent|1|||
13101012|NCT03426995|25862721|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
13101013|NCT03426995|25862722|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
13101014|NCT03426995|25862723|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
13101015|NCT03426995|25862724|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
13101016|NCT03426995|25862725|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
13101017|NCT03426995|25862726|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
13101018|NCT03426995|25862727|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
13101019|NCT03426995|25862728|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
13101020|NCT03426995|25862729|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
13101021|NCT03426995|25862730|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
13101022|NCT03426995|25862731|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
13101023|NCT03426995|25862732|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
13101024|NCT03426995|25862733|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
13101025|NCT03426995|25862734|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
13101026|NCT03426995|25862735|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
13101027|NCT03426995|25862717|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
13101028|NCT03426995|25862718|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
13101029|NCT03426995|25862719|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
13101030|NCT03426995|25862720|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
13101031|NCT03426995|25862721|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
13101032|NCT03426995|25862722|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1|||
13101033|NCT03426995|25862723|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
13101034|NCT03426995|25862724|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
13101035|NCT03426995|25862725|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
13101036|NCT03426995|25862726|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
13101037|NCT03426995|25862727|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
13101038|NCT03426995|25862728|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
13152012|NCT02542605|26053028|FG002|Part B: Challenge Phase|Sponsor decision|0|||
13152013|NCT02542605|26053026|FG000|Part B: Randomization Phase|Withdrawal by Subject|0|||
13152014|NCT02542605|26053027|FG001|Part B: Randomization Phase|Withdrawal by Subject|0|||
13152015|NCT02542605|26053028|FG002|Part B: Randomization Phase|Withdrawal by Subject|1|||
13152016|NCT02542397|26053036|FG000|Overall Study|Death|2|||
13152017|NCT02542397|26053036|FG000|Overall Study|Physician Decision|6|||
13152018|NCT02542397|26053036|FG000|Overall Study|Withdrawal by Subject|6|||
13152019|NCT02542397|26053036|FG000|Overall Study|Lost to Follow-up|2|||
13101039|NCT03426995|25862729|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
13101040|NCT03426995|25862730|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
13101041|NCT03426995|25862731|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
13101042|NCT03426995|25862732|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
13101043|NCT03426995|25862733|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
13101044|NCT03426995|25862734|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
13101045|NCT03426995|25862735|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
13101046|NCT03426995|25862717|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
13101047|NCT03426995|25862718|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
13101048|NCT03426995|25862719|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
13101049|NCT03426995|25862720|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
13101050|NCT03426995|25862721|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
13101051|NCT03426995|25862722|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
13101052|NCT03426995|25862723|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
13101053|NCT03426995|25862724|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
13101054|NCT03426995|25862725|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
13101055|NCT03426995|25862726|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
13101056|NCT03426995|25862727|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
13101057|NCT03426995|25862728|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
13101058|NCT03426995|25862729|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
13101059|NCT03426995|25862730|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
13101060|NCT03426995|25862731|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
13101061|NCT03426995|25862732|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
13101062|NCT03426995|25862733|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
13101063|NCT03426995|25862734|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
13101064|NCT03426995|25862735|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
13101065|NCT03426995|25862717|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
13101066|NCT03426995|25862718|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
13101067|NCT03426995|25862719|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
13101068|NCT03426995|25862720|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
13152020|NCT02542267|26053058|FG000|Overall Study|Withdrawal by Subject|10|||
13101069|NCT03426995|25862721|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
13101070|NCT03426995|25862722|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
13101071|NCT03426995|25862723|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
13101072|NCT03426995|25862724|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
13101073|NCT03426995|25862725|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
13101074|NCT03426995|25862726|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
13101075|NCT03426995|25862727|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1|||
13152021|NCT02542267|26053058|FG000|Overall Study|Physician Decision|6|||
13152022|NCT02542267|26053058|FG000|Overall Study|Lost to Follow-up|4|||
13152023|NCT02542267|26053058|FG000|Overall Study|Death|13|||
13152024|NCT02542267|26053058|FG000|Overall Study|Surgical Bypass of All Study Devices|13|||
13152025|NCT02542267|26053058|FG000|Overall Study|Other|9|||
13152026|NCT02542072|26053165|FG000|First Intervention (1 Month)|Adverse Event|1|||
13152027|NCT02542072|26053166|FG001|First Intervention (1 Month)|Adverse Event|1|||
13152028|NCT02542072|26053165|FG000|First Intervention (1 Month)|Lost to Follow-up|2|||
13152029|NCT02542072|26053166|FG001|First Intervention (1 Month)|Lost to Follow-up|0|||
13152030|NCT02542072|26053165|FG000|First Intervention (1 Month)|Lens discomfort|1|||
13152031|NCT02542072|26053166|FG001|First Intervention (1 Month)|Lens discomfort|2|||
13152032|NCT02542072|26053165|FG000|First Intervention (1 Month)|Protocol Violation|1|||
13152033|NCT02542072|26053166|FG001|First Intervention (1 Month)|Protocol Violation|0|||
13101076|NCT03426995|25862728|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
13101077|NCT03426995|25862729|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
13101078|NCT03426995|25862730|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
13101079|NCT03426995|25862731|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
13101080|NCT03426995|25862732|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
13101081|NCT03426995|25862733|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
13101082|NCT03426995|25862734|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
13101083|NCT03426995|25862735|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
13101084|NCT03426995|25862717|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
13101085|NCT03426995|25862718|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
13101086|NCT03426995|25862719|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
13101087|NCT03426995|25862720|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
13101088|NCT03426995|25862721|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
13101089|NCT03426995|25862722|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
13101090|NCT03426995|25862723|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
13101091|NCT03426995|25862724|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1|||
13101092|NCT03426995|25862725|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
13101093|NCT03426995|25862726|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
13101094|NCT03426995|25862727|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
13101095|NCT03426995|25862728|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
13101096|NCT03426995|25862729|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
13101097|NCT03426995|25862730|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
13101098|NCT03426995|25862731|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
13101099|NCT03426995|25862732|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
13101100|NCT03426995|25862733|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
13101101|NCT03426995|25862734|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
13101102|NCT03426995|25862735|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
13101103|NCT03426995|25862717|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
13101104|NCT03426995|25862718|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
13101105|NCT03426995|25862719|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
13101106|NCT03426995|25862720|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
13101107|NCT03426995|25862721|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
13101108|NCT03426995|25862722|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
13101109|NCT03426995|25862723|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
13101110|NCT03426995|25862724|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
13101111|NCT03426995|25862725|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
13101112|NCT03426995|25862726|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
13101113|NCT03426995|25862727|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
13101114|NCT03426995|25862728|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
13101115|NCT03426995|25862729|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
13101116|NCT03426995|25862730|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
13101117|NCT03426995|25862731|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8|||
13101118|NCT03426995|25862732|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9|||
13101119|NCT03426995|25862733|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
13101120|NCT03426995|25862734|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
13101121|NCT03426995|25862735|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
13132921|NCT02781584|25985803|FG011|Treatment Phase|Withdrew Consent|2|||
13101122|NCT03426995|25862717|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
13101123|NCT03426995|25862718|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
13101124|NCT03426995|25862719|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
13152034|NCT02542072|26053165|FG000|Second Intervention (1 Month)|Lost to Follow-up|1|||
13152035|NCT02542072|26053166|FG001|Second Intervention (1 Month)|Lost to Follow-up|0|||
13152036|NCT02542072|26053165|FG000|Second Intervention (1 Month)|Lens discomfort|1|||
13152037|NCT02542072|26053166|FG001|Second Intervention (1 Month)|Lens discomfort|0|||
13152038|NCT02541903|26053175|FG000|Overall Study|Death|1|||
13205174|NCT01967888|26231060|FG001|Overall Study|Research visit not done, data recorded|0|||
13205175|NCT01967888|26231059|FG000|Overall Study|Subject excluded after randomization|1|||
13205176|NCT01967888|26231060|FG001|Overall Study|Subject excluded after randomization|0|||
13205177|NCT01967888|26231059|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0|||
13205178|NCT01967888|26231060|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1|||
13205179|NCT01967888|26231059|FG000|Overall Study|Subject Unable To Comply With Final Day|0|||
13205180|NCT01967888|26231060|FG001|Overall Study|Subject Unable To Comply With Final Day|1|||
13206784|NCT01954121|26235527|FG000|Overall Study|Non-compliant with study procedures|1|||
13206785|NCT01954121|26235528|FG001|Overall Study|Non-compliant with study procedures|0|||
13206786|NCT01954121|26235527|FG000|Overall Study|Non-compliant patient|1|||
13101125|NCT03426995|25862720|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
13101126|NCT03426995|25862721|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
13101127|NCT03426995|25862722|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
13101128|NCT03426995|25862723|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
13101129|NCT03426995|25862724|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
13101130|NCT03426995|25862725|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
13101131|NCT03426995|25862726|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
13101132|NCT03426995|25862727|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
13101133|NCT03426995|25862728|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
13101134|NCT03426995|25862729|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
13101135|NCT03426995|25862730|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
13101136|NCT03426995|25862731|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1|||
13101137|NCT03426995|25862732|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3|||
13101138|NCT03426995|25862733|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
13101139|NCT03426995|25862734|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
13101140|NCT03426995|25862735|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
13101141|NCT03426787|25862747|FG000|Overall Study|Withdrawal by Subject|6|||
13101142|NCT03426787|25862747|FG000|Overall Study|Lost to Follow-up|7|||
13101143|NCT03426787|25862747|FG000|Overall Study|Unrelated to intervention death|1|||
13101144|NCT03426631|25862756|FG000|Overall Study|Lost to Follow-up|0|||
13101145|NCT03426631|25862757|FG001|Overall Study|Lost to Follow-up|1|||
13101146|NCT03426436|25862764|FG000|Overall Study|Incorrect lead placement|12|||
13101147|NCT03426436|25862764|FG000|Overall Study|Withdrawal by Subject|2|||
13101148|NCT03426436|25862764|FG000|Overall Study|Consent issue|1|||
13101149|NCT03426436|25862764|FG000|Overall Study|ECGs not saved|4|||
13101150|NCT03426345|25862798|FG000|Overall Study|Adverse Event|4|||
13101151|NCT03426345|25862799|FG001|Overall Study|Adverse Event|4|||
13101152|NCT03426345|25862798|FG000|Overall Study|Lack of Efficacy|1|||
13101153|NCT03426345|25862799|FG001|Overall Study|Lack of Efficacy|0|||
13101154|NCT03426345|25862798|FG000|Overall Study|Withdrawal by Subject|5|||
13101155|NCT03426345|25862799|FG001|Overall Study|Withdrawal by Subject|6|||
13101156|NCT03426345|25862798|FG000|Overall Study|Lost to Follow-up|3|||
13101157|NCT03426345|25862799|FG001|Overall Study|Lost to Follow-up|1|||
13101158|NCT03426345|25862798|FG000|Overall Study|Protocol Deviation|3|||
13101159|NCT03426345|25862799|FG001|Overall Study|Protocol Deviation|4|||
13101160|NCT03426345|25862798|FG000|Overall Study|Reason Not Specified|1|||
13101161|NCT03426345|25862799|FG001|Overall Study|Reason Not Specified|2|||
13101162|NCT03426345|25862798|FG000|Overall Study|Missing Completion Status|1|||
13101163|NCT03426345|25862799|FG001|Overall Study|Missing Completion Status|0|||
13101164|NCT03426267|25862814|FG000|Overall Study|Physician Decision|1|||
13101165|NCT03426267|25862815|FG001|Overall Study|Physician Decision|4|||
13101166|NCT03426267|25862814|FG000|Overall Study|Lost to Follow-up|1|||
13101167|NCT03426267|25862815|FG001|Overall Study|Lost to Follow-up|0|||
13101168|NCT03426267|25862814|FG000|Overall Study|Withdrawal by Subject|4|||
13101169|NCT03426267|25862815|FG001|Overall Study|Withdrawal by Subject|10|||
13101170|NCT03426267|25862814|FG000|Overall Study|Protocol Violation|1|||
13101171|NCT03426267|25862815|FG001|Overall Study|Protocol Violation|3|||
13101172|NCT03426267|25862814|FG000|Overall Study|Adverse Event|9|||
13101173|NCT03426267|25862815|FG001|Overall Study|Adverse Event|27|||
13101174|NCT03426267|25862814|FG000|Overall Study|Prohibited Treatment Intake|2|||
13101175|NCT03426267|25862815|FG001|Overall Study|Prohibited Treatment Intake|3|||
13101176|NCT03426267|25862814|FG000|Overall Study|Lack of Efficacy|0|||
13101177|NCT03426267|25862815|FG001|Overall Study|Lack of Efficacy|25|||
13101178|NCT03426267|25862814|FG000|Overall Study|other|3|||
13101179|NCT03426267|25862815|FG001|Overall Study|other|0|||
13101180|NCT03425396|25862913|FG000|Overall Study|Lost to Follow-up|2|||
13101181|NCT03425396|25862914|FG001|Overall Study|Lost to Follow-up|5|||
13101182|NCT03425396|25862915|FG002|Overall Study|Lost to Follow-up|2|||
13101183|NCT03425396|25862916|FG003|Overall Study|Lost to Follow-up|0|||
13101184|NCT03425396|25862917|FG004|Overall Study|Lost to Follow-up|0|||
13101185|NCT03425396|25862913|FG000|Overall Study|Withdrawal by Subject|0|||
13101186|NCT03425396|25862914|FG001|Overall Study|Withdrawal by Subject|1|||
13101187|NCT03425396|25862915|FG002|Overall Study|Withdrawal by Subject|0|||
13101188|NCT03425396|25862916|FG003|Overall Study|Withdrawal by Subject|1|||
13101189|NCT03425396|25862917|FG004|Overall Study|Withdrawal by Subject|0|||
13101190|NCT03425396|25862913|FG000|Overall Study|Other|0|||
13101191|NCT03425396|25862914|FG001|Overall Study|Other|1|||
13101192|NCT03425396|25862915|FG002|Overall Study|Other|1|||
13101193|NCT03425396|25862916|FG003|Overall Study|Other|0|||
13101194|NCT03425396|25862917|FG004|Overall Study|Other|1|||
13101195|NCT03425253|25862931|FG000|Overall Study|Adverse Event|2|||
13101196|NCT03425253|25862931|FG000|Overall Study|Lost to Follow-up|3|||
13101197|NCT03425253|25862931|FG000|Overall Study|Withdrew Consent|6|||
13101198|NCT03425253|25862931|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5|||
13101199|NCT03425188|25862941|FG000|Overall Study|Withdrawal by Subject|1|||
13101200|NCT03424265|25862954|FG000|Overall Study|screening failure|1|||
13101201|NCT03424265|25862955|FG001|Overall Study|screening failure|0|||
13101202|NCT03424265|25862954|FG000|Overall Study|Withdrawal by Subject|0|||
13101203|NCT03424265|25862955|FG001|Overall Study|Withdrawal by Subject|2|||
13101204|NCT03424239|25862966|FG000|Overall Study|Withdrawal by Subject|2|||
13101205|NCT03424044|25863001|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
13101206|NCT03424044|25863002|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
13101207|NCT03424044|25863003|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1|||
13101208|NCT03424044|25863004|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
13101209|NCT03424044|25863005|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
13101210|NCT03424044|25863006|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
13101211|NCT03424044|25863007|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
13101212|NCT03424044|25863008|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
13101213|NCT03424044|25863009|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
13101214|NCT03424044|25863001|FG000|First Intervention (76 Hours)|Adverse Event|0|||
13101215|NCT03424044|25863002|FG001|First Intervention (76 Hours)|Adverse Event|0|||
13101216|NCT03424044|25863003|FG002|First Intervention (76 Hours)|Adverse Event|0|||
13101217|NCT03424044|25863004|FG003|First Intervention (76 Hours)|Adverse Event|0|||
13101218|NCT03424044|25863005|FG004|First Intervention (76 Hours)|Adverse Event|1|||
13101219|NCT03424044|25863006|FG005|First Intervention (76 Hours)|Adverse Event|0|||
13101220|NCT03424044|25863007|FG006|First Intervention (76 Hours)|Adverse Event|0|||
13101221|NCT03424044|25863008|FG007|First Intervention (76 Hours)|Adverse Event|0|||
13101222|NCT03424044|25863009|FG008|First Intervention (76 Hours)|Adverse Event|0|||
13101223|NCT03424044|25863001|FG000|First Intervention (76 Hours)|device issues|0|||
13101224|NCT03424044|25863002|FG001|First Intervention (76 Hours)|device issues|0|||
13101225|NCT03424044|25863003|FG002|First Intervention (76 Hours)|device issues|0|||
13222684|NCT01803607|26286774|FG001|Overall Study|Lack of Efficacy|1|||
13101226|NCT03424044|25863004|FG003|First Intervention (76 Hours)|device issues|0|||
13101227|NCT03424044|25863005|FG004|First Intervention (76 Hours)|device issues|0|||
13101228|NCT03424044|25863006|FG005|First Intervention (76 Hours)|device issues|0|||
13101229|NCT03424044|25863007|FG006|First Intervention (76 Hours)|device issues|1|||
13101230|NCT03424044|25863008|FG007|First Intervention (76 Hours)|device issues|1|||
13101231|NCT03424044|25863009|FG008|First Intervention (76 Hours)|device issues|1|||
13101232|NCT03424044|25863001|FG000|Third Intervention (76 Hours)|Adverse Event|1|||
13101233|NCT03424044|25863002|FG001|Third Intervention (76 Hours)|Adverse Event|0|||
13101234|NCT03424044|25863003|FG002|Third Intervention (76 Hours)|Adverse Event|0|||
13101235|NCT03424044|25863004|FG003|Third Intervention (76 Hours)|Adverse Event|0|||
13101236|NCT03424044|25863005|FG004|Third Intervention (76 Hours)|Adverse Event|0|||
13101237|NCT03424044|25863006|FG005|Third Intervention (76 Hours)|Adverse Event|0|||
13101238|NCT03424044|25863007|FG006|Third Intervention (76 Hours)|Adverse Event|1|||
13101239|NCT03424044|25863008|FG007|Third Intervention (76 Hours)|Adverse Event|0|||
13101240|NCT03424044|25863009|FG008|Third Intervention (76 Hours)|Adverse Event|0|||
13101241|NCT03424044|25863001|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
13101242|NCT03424044|25863002|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
13101243|NCT03424044|25863003|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
13101244|NCT03424044|25863004|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1|||
13101245|NCT03424044|25863005|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
13101246|NCT03424044|25863006|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
13101247|NCT03424044|25863007|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
13101248|NCT03424044|25863008|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
13101249|NCT03424044|25863009|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
13101250|NCT03423238|25863081|FG000|Overall Study|Lost to Follow-up|1|||
13101251|NCT03423238|25863082|FG001|Overall Study|Lost to Follow-up|0|||
13101252|NCT03423238|25863081|FG000|Overall Study|Withdrawal by Subject|1|||
13101253|NCT03423238|25863082|FG001|Overall Study|Withdrawal by Subject|0|||
13101254|NCT03423173|25863133|FG000|Overall Study|Randomized but not vaccinated|1|||
13101255|NCT03423173|25863134|FG001|Overall Study|Randomized but not vaccinated|0|||
13101256|NCT03423173|25863135|FG002|Overall Study|Randomized but not vaccinated|2|||
13101257|NCT03423173|25863136|FG003|Overall Study|Randomized but not vaccinated|1|||
13101258|NCT03423173|25863133|FG000|Overall Study|Adverse Event|1|||
13101259|NCT03423173|25863134|FG001|Overall Study|Adverse Event|1|||
13101260|NCT03423173|25863135|FG002|Overall Study|Adverse Event|1|||
13101261|NCT03423173|25863136|FG003|Overall Study|Adverse Event|1|||
13101262|NCT03423173|25863133|FG000|Overall Study|Lost to Follow-up|10|||
13101263|NCT03423173|25863134|FG001|Overall Study|Lost to Follow-up|19|||
13101264|NCT03423173|25863135|FG002|Overall Study|Lost to Follow-up|17|||
13101265|NCT03423173|25863136|FG003|Overall Study|Lost to Follow-up|22|||
13101266|NCT03423173|25863133|FG000|Overall Study|Withdrawal of consent|4|||
13101267|NCT03423173|25863134|FG001|Overall Study|Withdrawal of consent|10|||
13101268|NCT03423173|25863135|FG002|Overall Study|Withdrawal of consent|4|||
13101269|NCT03423173|25863136|FG003|Overall Study|Withdrawal of consent|5|||
13101270|NCT03423173|25863133|FG000|Overall Study|Death|1|||
13101271|NCT03423173|25863134|FG001|Overall Study|Death|0|||
13101272|NCT03423173|25863135|FG002|Overall Study|Death|0|||
13101273|NCT03423173|25863136|FG003|Overall Study|Death|0|||
13101274|NCT03423173|25863133|FG000|Overall Study|Reason not Specified|2|||
13101275|NCT03423173|25863134|FG001|Overall Study|Reason not Specified|5|||
13101276|NCT03423173|25863135|FG002|Overall Study|Reason not Specified|3|||
13101277|NCT03423173|25863136|FG003|Overall Study|Reason not Specified|1|||
13101278|NCT03422250|25863201|FG000|Intervention|Adverse Event|0|||
13101279|NCT03422250|25863202|FG001|Intervention|Adverse Event|1|||
13101280|NCT03422250|25863203|FG002|Intervention|Adverse Event|0|||
13101281|NCT03422250|25863204|FG003|Intervention|Adverse Event|1|||
13101282|NCT03422250|25863201|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1|||
13101283|NCT03422250|25863202|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
13101284|NCT03422250|25863203|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2|||
13101285|NCT03422250|25863204|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
13101286|NCT03422250|25863201|FG000|Follow-up|Withdrawal by Subject|0|||
13101287|NCT03422250|25863202|FG001|Follow-up|Withdrawal by Subject|0|||
13101288|NCT03422250|25863203|FG002|Follow-up|Withdrawal by Subject|0|||
13101289|NCT03422250|25863204|FG003|Follow-up|Withdrawal by Subject|1|||
13101290|NCT03422250|25863201|FG000|Follow-up|Adverse Event|0|||
13101291|NCT03422250|25863202|FG001|Follow-up|Adverse Event|0|||
13101292|NCT03422250|25863203|FG002|Follow-up|Adverse Event|0|||
13101293|NCT03422250|25863204|FG003|Follow-up|Adverse Event|1|||
13101294|NCT03422172|25863249|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1|||
13101295|NCT03422172|25863249|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1|||
13101296|NCT03422172|25863249|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3|||
13101297|NCT03422159|25863276|FG000|Overall Study|Exclusion due to terminal disease|2|||
13101298|NCT03422159|25863277|FG001|Overall Study|Exclusion due to terminal disease|1|||
13101299|NCT03421730|25863361|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
13101300|NCT03421730|25863362|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2|||
13101301|NCT03421730|25863363|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
13101302|NCT03421730|25863364|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
13101303|NCT03421730|25863365|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
13101304|NCT03421730|25863366|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
13101305|NCT03421730|25863367|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
13101306|NCT03421730|25863368|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
13101307|NCT03421730|25863369|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
13101308|NCT03421730|25863370|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
13101309|NCT03421730|25863371|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
13101310|NCT03421730|25863372|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
13101311|NCT03421730|25863361|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
13101312|NCT03421730|25863362|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
13101313|NCT03421730|25863363|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
13101314|NCT03421730|25863364|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
13101315|NCT03421730|25863365|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2|||
13101316|NCT03421730|25863366|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
13101317|NCT03421730|25863367|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
13101318|NCT03421730|25863368|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
13101319|NCT03421730|25863369|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
13132922|NCT02781584|25985804|FG012|Treatment Phase|Withdrew Consent|0|||
13101320|NCT03421730|25863370|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
13101321|NCT03421730|25863371|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
13101322|NCT03421730|25863372|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
13101323|NCT03421431|25863483|FG000|Overall Study|Adverse Event|2|||
13101324|NCT03421431|25863484|FG001|Overall Study|Adverse Event|1|||
13101325|NCT03421431|25863485|FG002|Overall Study|Adverse Event|12|||
13101326|NCT03421431|25863483|FG000|Overall Study|Lost to Follow-up|1|||
13101327|NCT03421431|25863484|FG001|Overall Study|Lost to Follow-up|1|||
13101328|NCT03421431|25863485|FG002|Overall Study|Lost to Follow-up|1|||
13101329|NCT03421431|25863483|FG000|Overall Study|Withdrawal by Subject|3|||
13101330|NCT03421431|25863484|FG001|Overall Study|Withdrawal by Subject|2|||
13101331|NCT03421431|25863485|FG002|Overall Study|Withdrawal by Subject|1|||
13101332|NCT03421431|25863483|FG000|Overall Study|Protocol Violation|0|||
13101333|NCT03421431|25863484|FG001|Overall Study|Protocol Violation|1|||
13101334|NCT03421431|25863485|FG002|Overall Study|Protocol Violation|0|||
13101335|NCT03421431|25863483|FG000|Overall Study|Participant met Stopping Rules|0|||
13101336|NCT03421431|25863484|FG001|Overall Study|Participant met Stopping Rules|1|||
13101337|NCT03421431|25863485|FG002|Overall Study|Participant met Stopping Rules|0|||
13101338|NCT03421379|25863508|FG000|Period 1|Withdrawal by Subject|0|||
13101339|NCT03421379|25863509|FG001|Period 1|Withdrawal by Subject|1|||
13101340|NCT03421379|25863508|FG000|Period 1|Physician Decision|1|||
13101341|NCT03421379|25863509|FG001|Period 1|Physician Decision|1|||
13101342|NCT03421379|25863508|FG000|Period 1|Did not receive treatment|1|||
13101343|NCT03421379|25863509|FG001|Period 1|Did not receive treatment|2|||
13101344|NCT03420300|25863520|FG000|Overall Study|Death|2|||
13101345|NCT03419962|25863532|FG000|Overall Study|Change to other medication|1|||
13101346|NCT03419962|25863532|FG000|Overall Study|Refusal of continuing with trial drug|1|||
13101347|NCT03419962|25863532|FG000|Overall Study|Lost to Follow-up|3|||
13101348|NCT03419962|25863532|FG000|Overall Study|Difficulty in inhaling the doses|1|||
13101349|NCT03419962|25863532|FG000|Overall Study|Missing completion data|31|||
13101350|NCT03419741|25863557|FG000|Overall Study|Adverse Event|1|||
13101351|NCT03419741|25863558|FG001|Overall Study|Adverse Event|0|||
13101352|NCT03419741|25863557|FG000|Overall Study|Withdrawal by Subject|1|||
13101353|NCT03419741|25863558|FG001|Overall Study|Withdrawal by Subject|2|||
13101354|NCT03419598|25863567|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2|||
13101355|NCT03419403|25863622|FG000|Overall Study|Withdrawal by Subject|5|||
13101356|NCT03419403|25863623|FG001|Overall Study|Withdrawal by Subject|2|||
13101357|NCT03419403|25863624|FG002|Overall Study|Withdrawal by Subject|5|||
13101358|NCT03419403|25863625|FG003|Overall Study|Withdrawal by Subject|1|||
13101359|NCT03419403|25863622|FG000|Overall Study|Progressive disease (per protocol)|0|||
13101360|NCT03419403|25863623|FG001|Overall Study|Progressive disease (per protocol)|2|||
13101361|NCT03419403|25863624|FG002|Overall Study|Progressive disease (per protocol)|2|||
13101362|NCT03419403|25863625|FG003|Overall Study|Progressive disease (per protocol)|0|||
13101363|NCT03419403|25863622|FG000|Overall Study|Other, not specified|6|||
13101364|NCT03419403|25863623|FG001|Overall Study|Other, not specified|4|||
13101365|NCT03419403|25863624|FG002|Overall Study|Other, not specified|5|||
13101366|NCT03419403|25863625|FG003|Overall Study|Other, not specified|1|||
13101367|NCT03419403|25863622|FG000|Overall Study|Left study due to COVID-19 restrictions|1|||
13101368|NCT03419403|25863623|FG001|Overall Study|Left study due to COVID-19 restrictions|1|||
13101369|NCT03419403|25863624|FG002|Overall Study|Left study due to COVID-19 restrictions|0|||
13101370|NCT03419403|25863625|FG003|Overall Study|Left study due to COVID-19 restrictions|0|||
13101371|NCT03419364|25863676|FG000|Overall Study|Delivery due to maternal condition|2|||
13101372|NCT03419364|25863677|FG001|Overall Study|Delivery due to maternal condition|0|||
13101373|NCT03419364|25863678|FG002|Overall Study|Delivery due to maternal condition|0|||
13101374|NCT03418727|25863696|FG000|Overall Study|Adverse Event|1|||
13101375|NCT03418727|25863697|FG001|Overall Study|Adverse Event|2|||
13101376|NCT03418727|25863698|FG002|Overall Study|Adverse Event|0|||
13101377|NCT03418727|25863696|FG000|Overall Study|Withdrawal by Subject|0|||
13101378|NCT03418727|25863697|FG001|Overall Study|Withdrawal by Subject|0|||
13101379|NCT03418727|25863698|FG002|Overall Study|Withdrawal by Subject|2|||
13101380|NCT03418675|25863735|FG000|Overall Study|Lost to Follow-up|13|||
13101381|NCT03418675|25863736|FG001|Overall Study|Lost to Follow-up|10|||
13101382|NCT03418675|25863735|FG000|Overall Study|Adverse Event|2|||
13101383|NCT03418675|25863736|FG001|Overall Study|Adverse Event|0|||
13101384|NCT03418571|25863751|FG000|Overall Study|Consent withdrawn by legal guardian|1|||
13101385|NCT03418571|25863752|FG001|Overall Study|Consent withdrawn by legal guardian|0|||
13101386|NCT03418545|25863771|FG000|Overall Study|Withdrawal by Participant|2|||
13101387|NCT03418545|25863772|FG001|Overall Study|Withdrawal by Participant|4|||
13101388|NCT03418545|25863771|FG000|Overall Study|Lost to Follow-up|3|||
13101389|NCT03418545|25863772|FG001|Overall Study|Lost to Follow-up|5|||
13101390|NCT03418545|25863771|FG000|Overall Study|Reason Not Specified|0|||
13101391|NCT03418545|25863772|FG001|Overall Study|Reason Not Specified|1|||
13101392|NCT03418545|25863771|FG000|Overall Study|Missing Completion Status|0|||
13101393|NCT03418545|25863772|FG001|Overall Study|Missing Completion Status|1|||
13101394|NCT03418376|25863811|FG000|Overall Study|Musculoskeletal injury|1|||
13101395|NCT03418376|25863812|FG001|Overall Study|Musculoskeletal injury|2|||
13101396|NCT03418376|25863813|FG002|Overall Study|Musculoskeletal injury|1|||
13101397|NCT03418376|25863814|FG003|Overall Study|Musculoskeletal injury|0|||
13101398|NCT03418376|25863811|FG000|Overall Study|Personal reasons|0|||
13101399|NCT03418376|25863812|FG001|Overall Study|Personal reasons|2|||
13101400|NCT03418376|25863813|FG002|Overall Study|Personal reasons|2|||
13101401|NCT03418376|25863814|FG003|Overall Study|Personal reasons|1|||
13101402|NCT03418376|25863811|FG000|Overall Study|Exacerbation|0|||
13101403|NCT03418376|25863812|FG001|Overall Study|Exacerbation|1|||
13101404|NCT03418376|25863813|FG002|Overall Study|Exacerbation|0|||
13101405|NCT03418376|25863814|FG003|Overall Study|Exacerbation|0|||
13101406|NCT03418324|25863839|FG000|Overall Study|Death|0|||
13101407|NCT03418324|25863840|FG001|Overall Study|Death|1|||
13101408|NCT03418324|25863839|FG000|Overall Study|Physician Decision|1|||
13101409|NCT03418324|25863840|FG001|Overall Study|Physician Decision|1|||
13101410|NCT03417830|25863941|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1|||
13101411|NCT03417830|25863942|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0|||
13101412|NCT03417505|25863967|FG000|First Lens Type (30 Days)|Lost to Follow-up|1|||
13101413|NCT03417505|25863968|FG001|First Lens Type (30 Days)|Lost to Follow-up|1|||
13101414|NCT03417440|25864088|FG000|Overall Study|Lost to Follow-up|0|||
13101415|NCT03417440|25864089|FG001|Overall Study|Lost to Follow-up|1|||
13101416|NCT03417440|25864090|FG002|Overall Study|Lost to Follow-up|0|||
13101417|NCT03417440|25864091|FG003|Overall Study|Lost to Follow-up|0|||
13101418|NCT03417440|25864092|FG004|Overall Study|Lost to Follow-up|1|||
13101419|NCT03417440|25864093|FG005|Overall Study|Lost to Follow-up|0|||
13101420|NCT03417440|25864094|FG006|Overall Study|Lost to Follow-up|0|||
13101421|NCT03417440|25864095|FG007|Overall Study|Lost to Follow-up|0|||
13152039|NCT02541669|26053226|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
13152040|NCT02541669|26053227|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
13152041|NCT02541669|26053228|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
13152042|NCT02541669|26053229|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
13152043|NCT02541669|26053230|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
13152044|NCT02541604|26053372|FG000|Overall Study|Death|6|||
13152045|NCT02541604|26053373|FG001|Overall Study|Death|5|||
13152046|NCT02541604|26053374|FG002|Overall Study|Death|7|||
13152047|NCT02541604|26053375|FG003|Overall Study|Death|2|||
13152048|NCT02541604|26053376|FG004|Overall Study|Death|9|||
13152049|NCT02541604|26053377|FG005|Overall Study|Death|8|||
13152050|NCT02541604|26053378|FG006|Overall Study|Death|9|||
13152051|NCT02541604|26053379|FG007|Overall Study|Death|9|||
13152052|NCT02541604|26053380|FG008|Overall Study|Death|3|||
13152053|NCT02541604|26053381|FG009|Overall Study|Death|4|||
13152054|NCT02541604|26053382|FG010|Overall Study|Death|2|||
13152055|NCT02541604|26053383|FG011|Overall Study|Death|3|||
13152056|NCT02541604|26053372|FG000|Overall Study|Lost to Follow-up|2|||
13152057|NCT02541604|26053373|FG001|Overall Study|Lost to Follow-up|0|||
13152058|NCT02541604|26053374|FG002|Overall Study|Lost to Follow-up|1|||
13152059|NCT02541604|26053375|FG003|Overall Study|Lost to Follow-up|0|||
13152060|NCT02541604|26053376|FG004|Overall Study|Lost to Follow-up|0|||
13152061|NCT02541604|26053377|FG005|Overall Study|Lost to Follow-up|1|||
13152062|NCT02541604|26053378|FG006|Overall Study|Lost to Follow-up|1|||
13152063|NCT02541604|26053379|FG007|Overall Study|Lost to Follow-up|0|||
13152064|NCT02541604|26053380|FG008|Overall Study|Lost to Follow-up|0|||
13152065|NCT02541604|26053381|FG009|Overall Study|Lost to Follow-up|0|||
13152066|NCT02541604|26053382|FG010|Overall Study|Lost to Follow-up|0|||
13152067|NCT02541604|26053383|FG011|Overall Study|Lost to Follow-up|0|||
13152068|NCT02541604|26053372|FG000|Overall Study|Withdrawal by Subject|2|||
13152069|NCT02541604|26053373|FG001|Overall Study|Withdrawal by Subject|0|||
13152070|NCT02541604|26053374|FG002|Overall Study|Withdrawal by Subject|1|||
13152071|NCT02541604|26053375|FG003|Overall Study|Withdrawal by Subject|0|||
13152072|NCT02541604|26053376|FG004|Overall Study|Withdrawal by Subject|1|||
13152073|NCT02541604|26053377|FG005|Overall Study|Withdrawal by Subject|1|||
13152074|NCT02541604|26053378|FG006|Overall Study|Withdrawal by Subject|0|||
13152075|NCT02541604|26053379|FG007|Overall Study|Withdrawal by Subject|0|||
13152076|NCT02541604|26053380|FG008|Overall Study|Withdrawal by Subject|1|||
13152077|NCT02541604|26053381|FG009|Overall Study|Withdrawal by Subject|0|||
13152078|NCT02541604|26053382|FG010|Overall Study|Withdrawal by Subject|0|||
13152079|NCT02541604|26053383|FG011|Overall Study|Withdrawal by Subject|0|||
13152080|NCT02541604|26053372|FG000|Overall Study|Study Terminated by Sponsor|1|||
13152081|NCT02541604|26053373|FG001|Overall Study|Study Terminated by Sponsor|4|||
13152082|NCT02541604|26053374|FG002|Overall Study|Study Terminated by Sponsor|2|||
13152083|NCT02541604|26053375|FG003|Overall Study|Study Terminated by Sponsor|1|||
13101422|NCT03417440|25864088|FG000|Overall Study|Withdrawal by Subject|2|||
13101423|NCT03417440|25864089|FG001|Overall Study|Withdrawal by Subject|0|||
13101424|NCT03417440|25864090|FG002|Overall Study|Withdrawal by Subject|2|||
13152084|NCT02541604|26053376|FG004|Overall Study|Study Terminated by Sponsor|0|||
13152085|NCT02541604|26053377|FG005|Overall Study|Study Terminated by Sponsor|0|||
13152086|NCT02541604|26053378|FG006|Overall Study|Study Terminated by Sponsor|0|||
13152087|NCT02541604|26053379|FG007|Overall Study|Study Terminated by Sponsor|0|||
13152088|NCT02541604|26053380|FG008|Overall Study|Study Terminated by Sponsor|0|||
13152089|NCT02541604|26053381|FG009|Overall Study|Study Terminated by Sponsor|0|||
13152090|NCT02541604|26053382|FG010|Overall Study|Study Terminated by Sponsor|0|||
13152091|NCT02541604|26053383|FG011|Overall Study|Study Terminated by Sponsor|0|||
13152092|NCT02541604|26053372|FG000|Overall Study|Medical condition may jeopardize safety|0|||
13152093|NCT02541604|26053373|FG001|Overall Study|Medical condition may jeopardize safety|0|||
13152094|NCT02541604|26053374|FG002|Overall Study|Medical condition may jeopardize safety|0|||
13152095|NCT02541604|26053375|FG003|Overall Study|Medical condition may jeopardize safety|0|||
13152096|NCT02541604|26053376|FG004|Overall Study|Medical condition may jeopardize safety|0|||
13152097|NCT02541604|26053377|FG005|Overall Study|Medical condition may jeopardize safety|0|||
13101425|NCT03417440|25864091|FG003|Overall Study|Withdrawal by Subject|1|||
13101426|NCT03417440|25864092|FG004|Overall Study|Withdrawal by Subject|1|||
13101427|NCT03417440|25864093|FG005|Overall Study|Withdrawal by Subject|0|||
13101428|NCT03417440|25864094|FG006|Overall Study|Withdrawal by Subject|0|||
13101429|NCT03417440|25864095|FG007|Overall Study|Withdrawal by Subject|1|||
13101430|NCT03417245|25864130|FG000|Overall Study|Adverse Event|1|||
13101431|NCT03417245|25864131|FG001|Overall Study|Adverse Event|0|||
13101432|NCT03417245|25864130|FG000|Overall Study|Protocol Violation|1|||
13101433|NCT03417245|25864131|FG001|Overall Study|Protocol Violation|0|||
13101434|NCT03417245|25864130|FG000|Overall Study|Withdrawal by Subject|1|||
13101435|NCT03417245|25864131|FG001|Overall Study|Withdrawal by Subject|1|||
13101436|NCT03417219|25864148|FG000|Overall Study|Lost to Follow-up|0|||
13101437|NCT03417219|25864149|FG001|Overall Study|Lost to Follow-up|3|||
13101438|NCT03417141|25864158|FG000|Overall Study|Withdrawal by Subject|1|||
13101439|NCT03417141|25864158|FG000|Overall Study|Protocol Violation|3|||
13101440|NCT03417102|25864193|FG000|Overall Study|Adverse Event|0|||
13101441|NCT03417102|25864194|FG001|Overall Study|Adverse Event|1|||
13101442|NCT03417102|25864193|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0|||
13101443|NCT03417102|25864194|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3|||
13101444|NCT03417102|25864193|FG000|Overall Study|Other|0|||
13101445|NCT03417102|25864194|FG001|Overall Study|Other|1|||
13101446|NCT03417024|25864202|FG000|Overall Study|Study Termination prior to follow-up|11|||
13101447|NCT03417024|25864202|FG000|Overall Study|Physician Decision|2|||
13101448|NCT03416374|25864269|FG000|Between Treatment Period I and II|Other|0|||
13101449|NCT03416374|25864270|FG001|Between Treatment Period I and II|Other|9|||
13101450|NCT03416374|25864269|FG000|Treatment Period II|Lack of Efficacy|3|||
13101451|NCT03416374|25864270|FG001|Treatment Period II|Lack of Efficacy|11|||
13101452|NCT03416374|25864269|FG000|Treatment Period II|Adverse Event|1|||
13101453|NCT03416374|25864270|FG001|Treatment Period II|Adverse Event|4|||
13101454|NCT03416374|25864269|FG000|Treatment Period II|Death|0|||
13101455|NCT03416374|25864270|FG001|Treatment Period II|Death|1|||
13101456|NCT03416374|25864269|FG000|Treatment Period II|Other|0|||
13101457|NCT03416374|25864270|FG001|Treatment Period II|Other|2|||
13101458|NCT03415178|25864312|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0|||
13101459|NCT03415178|25864313|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2|||
13101460|NCT03415178|25864312|FG000|Single Arm Period (up to Week 16)|Adverse Event|0|||
13101461|NCT03415178|25864313|FG001|Single Arm Period (up to Week 16)|Adverse Event|1|||
13101462|NCT03414983|25864352|FG000|Pre-Treatment|Other reasons|1|||
13101463|NCT03414983|25864353|FG001|Pre-Treatment|Other reasons|0|||
13101464|NCT03414983|25864352|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
13101465|NCT03414983|25864353|FG001|Pre-Treatment|Participant no longer meets study criteria|3|||
13101466|NCT03414983|25864352|FG000|Pre-Treatment|Participant withdrew consent|1|||
13101467|NCT03414983|25864353|FG001|Pre-Treatment|Participant withdrew consent|3|||
13101468|NCT03414983|25864352|FG000|Treatment|Participant withdrew consent|4|||
13101469|NCT03414983|25864353|FG001|Treatment|Participant withdrew consent|3|||
13101470|NCT03414983|25864352|FG000|Treatment|Participant request to discontinue study treatment|8|||
13101471|NCT03414983|25864353|FG001|Treatment|Participant request to discontinue study treatment|10|||
13101472|NCT03414983|25864352|FG000|Treatment|Adverse Event Unrelated to Study Drug|5|||
13101473|NCT03414983|25864353|FG001|Treatment|Adverse Event Unrelated to Study Drug|2|||
13101474|NCT03414983|25864352|FG000|Treatment|Death|0|||
13101475|NCT03414983|25864353|FG001|Treatment|Death|2|||
13101476|NCT03414983|25864352|FG000|Treatment|Study Drug Toxicity|11|||
13101477|NCT03414983|25864353|FG001|Treatment|Study Drug Toxicity|4|||
13101478|NCT03414983|25864352|FG000|Treatment|Disease Progression|72|||
13101479|NCT03414983|25864353|FG001|Treatment|Disease Progression|27|||
13101480|NCT03414983|25864352|FG000|Treatment|Not reported|1|||
13101481|NCT03414983|25864353|FG001|Treatment|Not reported|0|||
13101482|NCT03414983|25864352|FG000|Treatment|Other reasons|3|||
13101483|NCT03414983|25864353|FG001|Treatment|Other reasons|2|||
13101484|NCT03414983|25864352|FG000|Treatment|Completed treatment as per protocol|8|||
13152098|NCT02541604|26053378|FG006|Overall Study|Medical condition may jeopardize safety|0|||
13152099|NCT02541604|26053379|FG007|Overall Study|Medical condition may jeopardize safety|1|||
13152100|NCT02541604|26053380|FG008|Overall Study|Medical condition may jeopardize safety|0|||
13152101|NCT02541604|26053381|FG009|Overall Study|Medical condition may jeopardize safety|0|||
13152102|NCT02541604|26053382|FG010|Overall Study|Medical condition may jeopardize safety|0|||
13152103|NCT02541604|26053383|FG011|Overall Study|Medical condition may jeopardize safety|0|||
13152104|NCT02540993|26053406|FG000|Overall Study|Lost to Follow-up|5|||
13101485|NCT03414983|25864353|FG001|Treatment|Completed treatment as per protocol|0|||
13101486|NCT03414983|25864352|FG000|Treatment|Poor/non-compliance|2|||
13101487|NCT03414983|25864353|FG001|Treatment|Poor/non-compliance|0|||
13101488|NCT03414983|25864352|FG000|Treatment|Maximum clinical benefit|5|||
13101489|NCT03414983|25864353|FG001|Treatment|Maximum clinical benefit|9|||
13101490|NCT03414983|25864352|FG000|Treatment|Lost to Follow-up|0|||
13101491|NCT03414983|25864353|FG001|Treatment|Lost to Follow-up|1|||
13101492|NCT03414359|25864368|FG000|Overall Study|Lack of Efficacy|1|||
13101493|NCT03414359|25864369|FG001|Overall Study|Lack of Efficacy|1|||
13101494|NCT03414359|25864368|FG000|Overall Study|Protocol Violation|0|||
13101495|NCT03414359|25864369|FG001|Overall Study|Protocol Violation|1|||
13101496|NCT03414047|25864413|FG000|Overall Study|Adverse Event|0|||
13101497|NCT03414047|25864414|FG001|Overall Study|Adverse Event|0|||
13101498|NCT03414047|25864415|FG002|Overall Study|Adverse Event|1|||
13101499|NCT03414047|25864416|FG003|Overall Study|Adverse Event|1|||
13101500|NCT03414047|25864413|FG000|Overall Study|Physician Decision|1|||
13101501|NCT03414047|25864414|FG001|Overall Study|Physician Decision|0|||
13101502|NCT03414047|25864415|FG002|Overall Study|Physician Decision|0|||
13101503|NCT03414047|25864416|FG003|Overall Study|Physician Decision|1|||
13101504|NCT03414047|25864413|FG000|Overall Study|Withdrawal by Subject|1|||
13101505|NCT03414047|25864414|FG001|Overall Study|Withdrawal by Subject|0|||
13101506|NCT03414047|25864415|FG002|Overall Study|Withdrawal by Subject|2|||
13101507|NCT03414047|25864416|FG003|Overall Study|Withdrawal by Subject|0|||
13101508|NCT03412929|25864427|FG000|Overall Study|Protocol Violation|3|||
13101509|NCT03412747|25864483|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
13101510|NCT03412747|25864484|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
13101511|NCT03412747|25864485|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3|||
13101512|NCT03412747|25864483|FG000|Initial Treatment Period: Wk0-Wk16|Death|0|||
13101513|NCT03412747|25864484|FG001|Initial Treatment Period: Wk0-Wk16|Death|0|||
13101514|NCT03412747|25864485|FG002|Initial Treatment Period: Wk0-Wk16|Death|1|||
13101515|NCT03412747|25864483|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
13101516|NCT03412747|25864484|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
13101517|NCT03412747|25864485|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1|||
13101518|NCT03412747|25864483|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
13101519|NCT03412747|25864484|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
13101520|NCT03412747|25864485|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2|||
13101521|NCT03412747|25864483|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0|||
13101522|NCT03412747|25864484|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2|||
13101523|NCT03412747|25864485|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1|||
13101524|NCT03412747|25864483|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4|||
13101525|NCT03412747|25864484|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
13101526|NCT03412747|25864485|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
13101527|NCT03412747|25864483|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1|||
13101528|NCT03412747|25864484|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
13101529|NCT03412747|25864485|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
13101530|NCT03412747|25864483|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3|||
13101531|NCT03412747|25864484|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1|||
13101532|NCT03412747|25864485|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0|||
13101533|NCT03412747|25864483|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1|||
13101534|NCT03412747|25864484|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
13101535|NCT03412747|25864485|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
13101536|NCT03412747|25864483|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
13101537|NCT03412747|25864484|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
13101538|NCT03412747|25864485|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1|||
13101539|NCT03412747|25864483|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1|||
13132923|NCT02781584|25985792|FG000|Treatment Phase|Adverse Event|0|||
13152105|NCT02540993|26053407|FG001|Overall Study|Lost to Follow-up|3|||
13152106|NCT02540993|26053406|FG000|Overall Study|Withdrawal by Subject|4|||
13152107|NCT02540993|26053407|FG001|Overall Study|Withdrawal by Subject|6|||
13152108|NCT02540993|26053406|FG000|Overall Study|GCP violations|33|||
13152109|NCT02540993|26053407|FG001|Overall Study|GCP violations|27|||
13152110|NCT02540954|26053434|FG000|Overall Study|Physician Decision|3|||
13152111|NCT02540954|26053435|FG001|Overall Study|Physician Decision|1|||
13152112|NCT02540954|26053434|FG000|Overall Study|Withdrawal by Subject|6|||
13152113|NCT02540954|26053435|FG001|Overall Study|Withdrawal by Subject|5|||
13152114|NCT02540954|26053434|FG000|Overall Study|Lost to Follow-up|1|||
13152115|NCT02540954|26053435|FG001|Overall Study|Lost to Follow-up|1|||
13152116|NCT02540954|26053434|FG000|Overall Study|Adverse Event|4|||
13152117|NCT02540954|26053435|FG001|Overall Study|Adverse Event|2|||
13152118|NCT02540954|26053434|FG000|Overall Study|Death|0|||
13152119|NCT02540954|26053435|FG001|Overall Study|Death|3|||
13152120|NCT02540954|26053434|FG000|Overall Study|Treatment failure|1|||
13152121|NCT02540954|26053435|FG001|Overall Study|Treatment failure|0|||
13152122|NCT02540954|26053434|FG000|Overall Study|Other reason|4|||
13152123|NCT02540954|26053435|FG001|Overall Study|Other reason|2|||
13152124|NCT02540850|26053471|FG000|Overall Study|Lost to Follow-up|69|||
13152125|NCT02540850|26053472|FG001|Overall Study|Lost to Follow-up|66|||
13152126|NCT02540850|26053473|FG002|Overall Study|Lost to Follow-up|34|||
13152127|NCT02540668|26053493|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0|||
13152128|NCT02540668|26053494|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1|||
13152129|NCT02540538|26053518|FG000|Overall Study|Pregnancy|0|||
13152130|NCT02540538|26053519|FG001|Overall Study|Pregnancy|1|||
13101540|NCT03412747|25864484|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
13101541|NCT03412747|25864485|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
13101542|NCT03412747|25864483|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3|||
13101543|NCT03412747|25864484|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4|||
13101544|NCT03412747|25864485|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6|||
13101545|NCT03412747|25864483|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0|||
13101546|NCT03412747|25864484|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
13101547|NCT03412747|25864485|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
13101548|NCT03412747|25864483|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0|||
13101549|NCT03412747|25864484|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2|||
13152131|NCT02540538|26053520|FG002|Overall Study|Pregnancy|0|||
13152132|NCT02540356|26053558|FG000|Overall Study|Terminated due to disease progression|1|||
13152133|NCT02540356|26053559|FG001|Overall Study|Terminated due to disease progression|0|||
13152134|NCT02540291|26053604|FG000|Overall Study|Death|7|||
13152135|NCT02540291|26053605|FG001|Overall Study|Death|7|||
13152136|NCT02540291|26053606|FG002|Overall Study|Death|5|||
13152137|NCT02540291|26053607|FG003|Overall Study|Death|7|||
13152138|NCT02540291|26053604|FG000|Overall Study|Lost to Follow-up|0|||
13152139|NCT02540291|26053605|FG001|Overall Study|Lost to Follow-up|0|||
13152140|NCT02540291|26053606|FG002|Overall Study|Lost to Follow-up|1|||
13152141|NCT02540291|26053607|FG003|Overall Study|Lost to Follow-up|0|||
13152142|NCT02540291|26053604|FG000|Overall Study|Withdrawal Of Consent|0|||
13152143|NCT02540291|26053605|FG001|Overall Study|Withdrawal Of Consent|1|||
13152144|NCT02540291|26053606|FG002|Overall Study|Withdrawal Of Consent|0|||
13152145|NCT02540291|26053607|FG003|Overall Study|Withdrawal Of Consent|0|||
13152146|NCT02540291|26053604|FG000|Overall Study|Study Terminated By Sponsor|1|||
13152147|NCT02540291|26053605|FG001|Overall Study|Study Terminated By Sponsor|0|||
13152148|NCT02540291|26053606|FG002|Overall Study|Study Terminated By Sponsor|0|||
13152149|NCT02540291|26053607|FG003|Overall Study|Study Terminated By Sponsor|0|||
13152150|NCT02540291|26053604|FG000|Overall Study|Other|0|||
13152151|NCT02540291|26053605|FG001|Overall Study|Other|0|||
13152152|NCT02540291|26053606|FG002|Overall Study|Other|1|||
13152153|NCT02540291|26053607|FG003|Overall Study|Other|0|||
13152154|NCT02540265|26053637|FG000|Overall Study|Lost to Follow-up|0|||
13152155|NCT02540265|26053638|FG001|Overall Study|Lost to Follow-up|0|||
13152156|NCT02540265|26053639|FG002|Overall Study|Lost to Follow-up|1|||
13152157|NCT02540213|26053662|FG000|Overall Study|Death/adverse event|18|||
13152158|NCT02540213|26053662|FG000|Overall Study|Administrative reasons|3|||
13152159|NCT02540213|26053662|FG000|Overall Study|Kidney transplant|3|||
13152160|NCT02540213|26053662|FG000|Overall Study|Lack of Efficacy|6|||
13152161|NCT02540213|26053662|FG000|Overall Study|Consent withdrawn|7|||
13152162|NCT02540213|26053662|FG000|Overall Study|Enrolled but not treated|2|||
13152163|NCT02540083|26053674|FG000|Overall Study|Withdrawal by Subject|16|||
13152164|NCT02539797|26053689|FG000|Overall Study|Lost to Follow-up|0|||
13152165|NCT02539797|26053690|FG001|Overall Study|Lost to Follow-up|1|||
13152166|NCT02539797|26053691|FG002|Overall Study|Lost to Follow-up|0|||
13152167|NCT02539368|26053827|FG000|Overall Study|Death|4|||
13152168|NCT02539368|26053828|FG001|Overall Study|Death|2|||
13152169|NCT02539368|26053829|FG002|Overall Study|Death|1|||
13152170|NCT02539368|26053830|FG003|Overall Study|Death|0|||
13152171|NCT02539368|26053831|FG004|Overall Study|Death|0|||
13152172|NCT02539368|26053827|FG000|Overall Study|Withdrawal by Subject|44|||
13152173|NCT02539368|26053828|FG001|Overall Study|Withdrawal by Subject|35|||
13152174|NCT02539368|26053829|FG002|Overall Study|Withdrawal by Subject|9|||
13152175|NCT02539368|26053830|FG003|Overall Study|Withdrawal by Subject|1|||
13152176|NCT02539368|26053831|FG004|Overall Study|Withdrawal by Subject|3|||
13152177|NCT02539368|26053827|FG000|Overall Study|Physician Decision|49|||
13152178|NCT02539368|26053828|FG001|Overall Study|Physician Decision|15|||
13152179|NCT02539368|26053829|FG002|Overall Study|Physician Decision|7|||
13152180|NCT02539368|26053830|FG003|Overall Study|Physician Decision|0|||
13152181|NCT02539368|26053831|FG004|Overall Study|Physician Decision|2|||
13152182|NCT02539368|26053827|FG000|Overall Study|Lost to Follow-up|96|||
13152183|NCT02539368|26053828|FG001|Overall Study|Lost to Follow-up|21|||
13152184|NCT02539368|26053829|FG002|Overall Study|Lost to Follow-up|16|||
13152185|NCT02539368|26053830|FG003|Overall Study|Lost to Follow-up|4|||
13152186|NCT02539368|26053831|FG004|Overall Study|Lost to Follow-up|3|||
13152187|NCT02539368|26053827|FG000|Overall Study|Adverse Event|44|||
13152188|NCT02539368|26053828|FG001|Overall Study|Adverse Event|5|||
13152189|NCT02539368|26053829|FG002|Overall Study|Adverse Event|9|||
13152190|NCT02539368|26053830|FG003|Overall Study|Adverse Event|0|||
13152191|NCT02539368|26053831|FG004|Overall Study|Adverse Event|3|||
13152192|NCT02539368|26053827|FG000|Overall Study|Participant Non-compliant|13|||
13152193|NCT02539368|26053828|FG001|Overall Study|Participant Non-compliant|2|||
13152194|NCT02539368|26053829|FG002|Overall Study|Participant Non-compliant|1|||
13152195|NCT02539368|26053830|FG003|Overall Study|Participant Non-compliant|1|||
13152196|NCT02539368|26053831|FG004|Overall Study|Participant Non-compliant|0|||
13152197|NCT02539368|26053827|FG000|Overall Study|Other|145|||
13101550|NCT03412747|25864485|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5|||
13101551|NCT03412747|25864483|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3|||
13101552|NCT03412747|25864484|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1|||
13101553|NCT03412747|25864485|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4|||
13101554|NCT03412747|25864483|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
13101555|NCT03412747|25864484|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1|||
13101556|NCT03412747|25864485|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
13101557|NCT03412734|25864498|FG000|Overall Study|Incorrect labeling of samples|2|||
13101558|NCT03412734|25864499|FG001|Overall Study|Incorrect labeling of samples|0|||
13101559|NCT03412734|25864498|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1|||
13101560|NCT03412734|25864499|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0|||
13101561|NCT03412604|25864509|FG000|Overall Study|Withdrawal by Subject|1|||
13101562|NCT03412084|25864524|FG000|Overall Study|Withdrawal by Subject|2|||
13101563|NCT03412084|25864525|FG001|Overall Study|Withdrawal by Subject|0|||
13101564|NCT03412084|25864524|FG000|Overall Study|Participant moved|1|||
13101565|NCT03412084|25864525|FG001|Overall Study|Participant moved|0|||
13101566|NCT03412084|25864524|FG000|Overall Study|Lost to Follow-up|1|||
13101567|NCT03412084|25864525|FG001|Overall Study|Lost to Follow-up|1|||
13101568|NCT03412019|25864542|FG000|Overall Study|Withdrawal by Subject|1|||
13101569|NCT03412019|25864543|FG001|Overall Study|Withdrawal by Subject|1|||
13101570|NCT03411902|25864568|FG000|Overall Study|Lost to Follow-up|3|||
13101571|NCT03411902|25864569|FG001|Overall Study|Lost to Follow-up|0|||
13101572|NCT03411863|25864584|FG000|Overall Study|Withdrawal by Subject|3|||
13101573|NCT03411863|25864585|FG001|Overall Study|Withdrawal by Subject|1|||
13101574|NCT03411863|25864584|FG000|Overall Study|Physician Decision|0|||
13101575|NCT03411863|25864585|FG001|Overall Study|Physician Decision|1|||
13101576|NCT03410992|25864669|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0|||
13101577|NCT03410992|25864670|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5|||
13101578|NCT03410992|25864671|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0|||
13101579|NCT03410992|25864672|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0|||
13101580|NCT03410992|25864673|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0|||
13101581|NCT03410992|25864674|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0|||
13101582|NCT03410992|25864675|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0|||
13101583|NCT03410992|25864676|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0|||
13101584|NCT03410992|25864677|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0|||
13101585|NCT03410992|25864678|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0|||
13101586|NCT03410992|25864679|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0|||
13101587|NCT03410992|25864669|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2|||
13101588|NCT03410992|25864670|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1|||
13101589|NCT03410992|25864671|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
13101590|NCT03410992|25864672|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
13101591|NCT03410992|25864673|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
13101592|NCT03410992|25864674|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
13101593|NCT03410992|25864675|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
13101594|NCT03410992|25864676|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
13101595|NCT03410992|25864677|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
13101596|NCT03410992|25864678|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
13101597|NCT03410992|25864679|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
13101598|NCT03410992|25864669|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1|||
13101599|NCT03410992|25864670|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3|||
13101600|NCT03410992|25864671|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
13101601|NCT03410992|25864672|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
13101602|NCT03410992|25864673|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
13101603|NCT03410992|25864674|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
13101604|NCT03410992|25864675|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
13101605|NCT03410992|25864676|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
13152198|NCT02539368|26053828|FG001|Overall Study|Other|18|||
13101606|NCT03410992|25864677|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
13101607|NCT03410992|25864678|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
13101608|NCT03410992|25864679|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
13101609|NCT03410992|25864669|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1|||
13101610|NCT03410992|25864670|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
13101611|NCT03410992|25864671|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
13101612|NCT03410992|25864672|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
13101613|NCT03410992|25864673|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
13101614|NCT03410992|25864674|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
13101615|NCT03410992|25864675|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
13101616|NCT03410992|25864676|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
13101617|NCT03410992|25864677|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
13101618|NCT03410992|25864678|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
13101619|NCT03410992|25864679|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
13101620|NCT03410992|25864669|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81|||
13101621|NCT03410992|25864670|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23|||
13101622|NCT03410992|25864671|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
13101623|NCT03410992|25864672|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
13101624|NCT03410992|25864673|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
13101625|NCT03410992|25864674|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
13101626|NCT03410992|25864675|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
13101627|NCT03410992|25864676|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
13101628|NCT03410992|25864677|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
13101629|NCT03410992|25864678|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
13101630|NCT03410992|25864679|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
13101631|NCT03410992|25864669|FG000|Week 16 Assessment|Incorrect escapers|0|||
13101632|NCT03410992|25864670|FG001|Week 16 Assessment|Incorrect escapers|6|||
13101633|NCT03410992|25864671|FG002|Week 16 Assessment|Incorrect escapers|0|||
13101634|NCT03410992|25864672|FG003|Week 16 Assessment|Incorrect escapers|0|||
13101635|NCT03410992|25864673|FG004|Week 16 Assessment|Incorrect escapers|0|||
13101636|NCT03410992|25864674|FG005|Week 16 Assessment|Incorrect escapers|0|||
13101637|NCT03410992|25864675|FG006|Week 16 Assessment|Incorrect escapers|0|||
13101638|NCT03410992|25864676|FG007|Week 16 Assessment|Incorrect escapers|0|||
13101639|NCT03410992|25864677|FG008|Week 16 Assessment|Incorrect escapers|0|||
13101640|NCT03410992|25864678|FG009|Week 16 Assessment|Incorrect escapers|0|||
13101641|NCT03410992|25864679|FG010|Week 16 Assessment|Incorrect escapers|0|||
13101642|NCT03410992|25864669|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
13101643|NCT03410992|25864670|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
13101644|NCT03410992|25864671|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
13101645|NCT03410992|25864672|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3|||
13101646|NCT03410992|25864673|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2|||
13101647|NCT03410992|25864674|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
13101648|NCT03410992|25864675|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
13101649|NCT03410992|25864676|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
13101650|NCT03410992|25864677|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
13101651|NCT03410992|25864678|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
13101652|NCT03410992|25864679|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
13101653|NCT03410992|25864669|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
13101654|NCT03410992|25864670|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
13101655|NCT03410992|25864671|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
13101656|NCT03410992|25864672|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
13152199|NCT02539368|26053829|FG002|Overall Study|Other|24|||
13152200|NCT02539368|26053830|FG003|Overall Study|Other|1|||
13152201|NCT02539368|26053831|FG004|Overall Study|Other|3|||
13152202|NCT02539368|26053827|FG000|Overall Study|Missing|10|||
13152203|NCT02539368|26053828|FG001|Overall Study|Missing|3|||
13152204|NCT02539368|26053829|FG002|Overall Study|Missing|0|||
13152205|NCT02539368|26053830|FG003|Overall Study|Missing|0|||
13152206|NCT02539368|26053831|FG004|Overall Study|Missing|0|||
13152207|NCT02539134|26053902|FG000|Overall Study|Lost to Follow-up|1|||
13152208|NCT02539134|26053903|FG001|Overall Study|Lost to Follow-up|0|||
13152209|NCT02539134|26053904|FG002|Overall Study|Lost to Follow-up|0|||
13152210|NCT02539134|26053905|FG003|Overall Study|Lost to Follow-up|0|||
13152211|NCT02539134|26053906|FG004|Overall Study|Lost to Follow-up|0|||
13152212|NCT02539134|26053907|FG005|Overall Study|Lost to Follow-up|0|||
13152213|NCT02538965|26053928|FG000|Treatment Period|Other = Death due to disease progression|1|||
13152214|NCT02538965|26053928|FG000|Treatment Period|Adverse Event|2|||
13152215|NCT02538965|26053928|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
13152216|NCT02538965|26053928|FG000|Treatment Period|Treatment Failure|9|||
13101657|NCT03410992|25864673|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1|||
13152217|NCT02538965|26053928|FG000|Treatment Period|Disease Progression|1|||
13152218|NCT02538965|26053928|FG000|Treatment Period|Physician Decision|2|||
13152219|NCT02538965|26053928|FG000|Follow-Up Period|Other = Death due to disease progression|13|||
13152220|NCT02538965|26053928|FG000|Follow-Up Period|Withdrawal by Parent|4|||
13152221|NCT02538900|26053946|FG000|Overall Study|Death|2|||
13152222|NCT02538900|26053947|FG001|Overall Study|Death|2|||
13152223|NCT02538900|26053948|FG002|Overall Study|Death|2|||
13152224|NCT02538900|26053946|FG000|Overall Study|Withdrawal by Subject|18|||
13152225|NCT02538900|26053947|FG001|Overall Study|Withdrawal by Subject|16|||
13152226|NCT02538900|26053948|FG002|Overall Study|Withdrawal by Subject|15|||
13222685|NCT01803607|26286773|FG000|Overall Study|Protocol Violation|3|||
13101658|NCT03410992|25864674|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
13101659|NCT03410992|25864675|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
13101660|NCT03410992|25864676|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
13101661|NCT03410992|25864677|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
13101662|NCT03410992|25864678|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
13101663|NCT03410992|25864679|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
13101664|NCT03410992|25864669|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
13101665|NCT03410992|25864670|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
13101666|NCT03410992|25864671|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
13101667|NCT03410992|25864672|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
13101668|NCT03410992|25864673|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
13101669|NCT03410992|25864674|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3|||
13101670|NCT03410992|25864675|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
13101671|NCT03410992|25864676|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
13101672|NCT03410992|25864677|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
13101673|NCT03410992|25864678|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
13101674|NCT03410992|25864679|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
13101675|NCT03410992|25864669|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
13101676|NCT03410992|25864670|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
13101677|NCT03410992|25864671|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
13101678|NCT03410992|25864672|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67|||
13101679|NCT03410992|25864673|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4|||
13101680|NCT03410992|25864674|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7|||
13101681|NCT03410992|25864675|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
13101682|NCT03410992|25864676|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
13101683|NCT03410992|25864677|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
13101684|NCT03410992|25864678|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
13101685|NCT03410992|25864679|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
13101686|NCT03410992|25864669|FG000|Escape Treatment: 12 Weeks|Adverse Event|0|||
13101687|NCT03410992|25864670|FG001|Escape Treatment: 12 Weeks|Adverse Event|0|||
13101688|NCT03410992|25864671|FG002|Escape Treatment: 12 Weeks|Adverse Event|0|||
13101689|NCT03410992|25864672|FG003|Escape Treatment: 12 Weeks|Adverse Event|0|||
13101690|NCT03410992|25864673|FG004|Escape Treatment: 12 Weeks|Adverse Event|0|||
13101691|NCT03410992|25864674|FG005|Escape Treatment: 12 Weeks|Adverse Event|0|||
13101692|NCT03410992|25864675|FG006|Escape Treatment: 12 Weeks|Adverse Event|0|||
13101693|NCT03410992|25864676|FG007|Escape Treatment: 12 Weeks|Adverse Event|1|||
13101694|NCT03410992|25864677|FG008|Escape Treatment: 12 Weeks|Adverse Event|0|||
13101695|NCT03410992|25864678|FG009|Escape Treatment: 12 Weeks|Adverse Event|0|||
13101696|NCT03410992|25864679|FG010|Escape Treatment: 12 Weeks|Adverse Event|0|||
13101697|NCT03410992|25864669|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
13101698|NCT03410992|25864670|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
13101699|NCT03410992|25864671|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
13101700|NCT03410992|25864672|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
13101701|NCT03410992|25864673|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
13101702|NCT03410992|25864674|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
13101703|NCT03410992|25864675|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
13101704|NCT03410992|25864676|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
13101705|NCT03410992|25864677|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1|||
13101706|NCT03410992|25864678|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
13101707|NCT03410992|25864679|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
13101708|NCT03410693|25864708|FG000|Overall Study|Disc trt: Withdrawal by participant|6|||
13101709|NCT03410693|25864709|FG001|Overall Study|Disc trt: Withdrawal by participant|4|||
13101710|NCT03410693|25864708|FG000|Overall Study|Disc trt: Lost to follow up|0|||
13101711|NCT03410693|25864709|FG001|Overall Study|Disc trt: Lost to follow up|1|||
13101712|NCT03410693|25864708|FG000|Overall Study|Disc trt: radiological progression|58|||
13101713|NCT03410693|25864709|FG001|Overall Study|Disc trt: radiological progression|50|||
13101714|NCT03410693|25864708|FG000|Overall Study|Disc trt: Other|1|||
13101715|NCT03410693|25864709|FG001|Overall Study|Disc trt: Other|0|||
13101716|NCT03410693|25864708|FG000|Overall Study|Study drug never administered|1|||
13101717|NCT03410693|25864709|FG001|Overall Study|Study drug never administered|6|||
13101718|NCT03410693|25864708|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6|||
13101719|NCT03410693|25864709|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4|||
13101720|NCT03410693|25864708|FG000|Overall Study|Disc trt: Adverse Event (AE)|13|||
13101721|NCT03410693|25864709|FG001|Overall Study|Disc trt: Adverse Event (AE)|9|||
13101722|NCT03410693|25864708|FG000|Overall Study|Disc trt: Physician decision|0|||
13101723|NCT03410693|25864709|FG001|Overall Study|Disc trt: Physician decision|5|||
13101724|NCT03410693|25864708|FG000|Overall Study|Disc trt: clinical progression|1|||
13101725|NCT03410693|25864709|FG001|Overall Study|Disc trt: clinical progression|5|||
13101726|NCT03410693|25864708|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1|||
13101727|NCT03410693|25864709|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4|||
13101728|NCT03410108|25864735|FG000|Overall Study|Ongoing|41|||
13101729|NCT03410108|25864735|FG000|Overall Study|Adverse Event|4|||
13101730|NCT03410108|25864735|FG000|Overall Study|Progressive Disease|58|||
13101731|NCT03410108|25864735|FG000|Overall Study|Withdrawal by Subject|1|||
13101732|NCT03410056|25864815|FG000|Overall Study|Decision by Sponsor|0|||
13101733|NCT03410056|25864816|FG001|Overall Study|Decision by Sponsor|0|||
13101734|NCT03410056|25864817|FG002|Overall Study|Decision by Sponsor|3|||
13101735|NCT03410056|25864818|FG003|Overall Study|Decision by Sponsor|0|||
13101736|NCT03410056|25864819|FG004|Overall Study|Decision by Sponsor|0|||
13101737|NCT03410056|25864820|FG005|Overall Study|Decision by Sponsor|0|||
13101738|NCT03410056|25864821|FG006|Overall Study|Decision by Sponsor|0|||
13101739|NCT03410056|25864815|FG000|Overall Study|Withdrawal by Subject|0|||
13101740|NCT03410056|25864816|FG001|Overall Study|Withdrawal by Subject|2|||
13101741|NCT03410056|25864817|FG002|Overall Study|Withdrawal by Subject|5|||
13101742|NCT03410056|25864818|FG003|Overall Study|Withdrawal by Subject|5|||
13101743|NCT03410056|25864819|FG004|Overall Study|Withdrawal by Subject|0|||
13101744|NCT03410056|25864820|FG005|Overall Study|Withdrawal by Subject|0|||
13101745|NCT03410056|25864821|FG006|Overall Study|Withdrawal by Subject|0|||
13101746|NCT03409731|25864893|FG000|Overall Study|Withdrawal by Subject|1|||
13101747|NCT03409731|25864893|FG000|Overall Study|Death|2|||
13101748|NCT03409666|25864922|FG000|Overall Study|Physician Decision|0|||
13101749|NCT03409666|25864923|FG001|Overall Study|Physician Decision|1|||
13101750|NCT03409666|25864922|FG000|Overall Study|Protocol Violation|0|||
13101751|NCT03409666|25864923|FG001|Overall Study|Protocol Violation|3|||
13101752|NCT03409276|25865035|FG000|Overall Study|Withdrawal by Subject|0|||
13101753|NCT03409276|25865036|FG001|Overall Study|Withdrawal by Subject|0|||
13101754|NCT03409276|25865037|FG002|Overall Study|Withdrawal by Subject|0|||
13101755|NCT03409276|25865038|FG003|Overall Study|Withdrawal by Subject|0|||
13101756|NCT03409276|25865039|FG004|Overall Study|Withdrawal by Subject|1|||
13101757|NCT03409276|25865035|FG000|Overall Study|Lost to Follow-up|0|||
13101758|NCT03409276|25865036|FG001|Overall Study|Lost to Follow-up|0|||
13101759|NCT03409276|25865037|FG002|Overall Study|Lost to Follow-up|0|||
13101760|NCT03409276|25865038|FG003|Overall Study|Lost to Follow-up|2|||
13101761|NCT03409276|25865039|FG004|Overall Study|Lost to Follow-up|2|||
13101762|NCT03409107|25865094|FG000|Overall Study|Withdrawal by Subject|4|||
13101763|NCT03409107|25865095|FG001|Overall Study|Withdrawal by Subject|2|||
13101764|NCT03409107|25865094|FG000|Overall Study|Physician Decision|1|||
13101765|NCT03409107|25865095|FG001|Overall Study|Physician Decision|0|||
13101766|NCT03409107|25865094|FG000|Overall Study|Lost to Follow-up|7|||
13101767|NCT03409107|25865095|FG001|Overall Study|Lost to Follow-up|2|||
13101768|NCT03409107|25865094|FG000|Overall Study|Adverse Event|5|||
13101769|NCT03409107|25865095|FG001|Overall Study|Adverse Event|3|||
13101770|NCT03408873|25865115|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3|||
13101771|NCT03408873|25865115|FG000|Visit 2 Assessment|Lost to Follow-up|1|||
13101772|NCT03408873|25865115|FG000|Visit 3 Assessment|Withdrawal by Subject|1|||
13101773|NCT03408873|25865115|FG000|Visit 4 Assessment|Lost to Follow-up|2|||
13101774|NCT03408873|25865115|FG000|Visit 5 Assessment|Lost to Follow-up|1|||
13101775|NCT03408873|25865115|FG000|Visit 6 Assessment|Withdrawal by Subject|1|||
13101776|NCT03408639|25865150|FG000|Overall Study|Death|5|||
13101777|NCT03408639|25865151|FG001|Overall Study|Death|5|||
13101778|NCT03408639|25865150|FG000|Overall Study|Lost to Follow-up|1|||
13101779|NCT03408639|25865151|FG001|Overall Study|Lost to Follow-up|4|||
13101780|NCT03408639|25865150|FG000|Overall Study|Withdrawal by Subject|2|||
13101781|NCT03408639|25865151|FG001|Overall Study|Withdrawal by Subject|7|||
13101782|NCT03408639|25865150|FG000|Overall Study|Physician Decision|3|||
13101783|NCT03408639|25865151|FG001|Overall Study|Physician Decision|6|||
13132924|NCT02781584|25985793|FG001|Treatment Phase|Adverse Event|0|||
13132925|NCT02781584|25985794|FG002|Treatment Phase|Adverse Event|0|||
13132926|NCT02781584|25985795|FG003|Treatment Phase|Adverse Event|0|||
13132927|NCT02781584|25985796|FG004|Treatment Phase|Adverse Event|0|||
13132928|NCT02781584|25985797|FG005|Treatment Phase|Adverse Event|0|||
13132929|NCT02781584|25985798|FG006|Treatment Phase|Adverse Event|0|||
13132930|NCT02781584|25985799|FG007|Treatment Phase|Adverse Event|1|||
13101784|NCT03408483|25865184|FG000|Overall Study|Physician Decision|3|||
13101785|NCT03408483|25865185|FG001|Overall Study|Physician Decision|3|||
13101786|NCT03408483|25865184|FG000|Overall Study|Lost to Follow-up|3|||
13101787|NCT03408483|25865185|FG001|Overall Study|Lost to Follow-up|0|||
13101788|NCT03407729|25865202|FG000|Overall Study|Lost to Follow-up|2|||
13101789|NCT03407729|25865203|FG001|Overall Study|Lost to Follow-up|0|||
13101790|NCT03407729|25865202|FG000|Overall Study|Unable to schedule|0|||
13101791|NCT03407729|25865203|FG001|Overall Study|Unable to schedule|3|||
13101792|NCT03407482|25865214|FG000|Overall Study|Adverse Event|12|||
13101793|NCT03407482|25865214|FG000|Overall Study|Disease Relapse|1|||
13101794|NCT03407482|25865214|FG000|Overall Study|Lost to Follow-up|1|||
13101795|NCT03407482|25865214|FG000|Overall Study|Non-Compliance With Study Drug|1|||
13101796|NCT03407482|25865214|FG000|Overall Study|Pregnancy|2|||
13101797|NCT03407482|25865214|FG000|Overall Study|Protocol Violation|1|||
13101798|NCT03407482|25865214|FG000|Overall Study|Study Terminated By Sponsor|106|||
13101799|NCT03407482|25865214|FG000|Overall Study|Withdrawal by Subject|6|||
13101800|NCT03407482|25865214|FG000|Overall Study|Data Entry Error|1|||
13101801|NCT03407430|25865253|FG000|Washout|Protocol Violation|1|||
13101802|NCT03407430|25865254|FG001|Washout|Protocol Violation|0|||
13101803|NCT03407170|25865269|FG000|Overall Study|Adverse Event|1|||
13101804|NCT03407118|25865280|FG000|Period 2|Withdrawal by Subject|1|||
13101805|NCT03407118|25865281|FG001|Period 2|Withdrawal by Subject|0|||
13101806|NCT03406962|25865290|FG000|Overall Study|Death|2|||
13101807|NCT03406962|25865290|FG000|Overall Study|Adverse Event|1|||
13101808|NCT03406858|25865296|FG000|Overall Study|Failure to receive treatment drug.|1|||
13101809|NCT03406858|25865296|FG000|Overall Study|ineligible|1|||
13101810|NCT03406702|25865393|FG000|Overall Study|Missed Day 27 Dosing|1|||
13101811|NCT03406260|25865424|FG000|Period 1|Adverse Event|0|||
13101812|NCT03406260|25865425|FG001|Period 1|Adverse Event|0|||
13101813|NCT03406260|25865426|FG002|Period 1|Adverse Event|0|||
13101814|NCT03406260|25865427|FG003|Period 1|Adverse Event|0|||
13101815|NCT03406260|25865428|FG004|Period 1|Adverse Event|1|||
13101816|NCT03406260|25865429|FG005|Period 1|Adverse Event|0|||
13101817|NCT03406156|25865458|FG000|Overall Study|Death|6|||
13101818|NCT03406156|25865459|FG001|Overall Study|Death|2|||
13101819|NCT03406156|25865458|FG000|Overall Study|Withdrawal by Subject|0|||
13101820|NCT03406156|25865459|FG001|Overall Study|Withdrawal by Subject|2|||
13101821|NCT03406156|25865458|FG000|Overall Study|COVID-19 infection|1|||
13101822|NCT03406156|25865459|FG001|Overall Study|COVID-19 infection|0|||
13101823|NCT03406156|25865458|FG000|Overall Study|Non-compliance with study procedures|0|||
13101824|NCT03406156|25865459|FG001|Overall Study|Non-compliance with study procedures|1|||
13101825|NCT03406156|25865458|FG000|Overall Study|Other, not specified|0|||
13101826|NCT03406156|25865459|FG001|Overall Study|Other, not specified|1|||
13101827|NCT03405935|25865488|FG000|Overall Study|Adverse Event|3|||
13101828|NCT03405935|25865488|FG000|Overall Study|Death|2|||
13101829|NCT03405935|25865488|FG000|Overall Study|Withdrawal by Subject|1|||
13101830|NCT03405935|25865488|FG000|Overall Study|Lost to Follow-up|2|||
13101831|NCT03405818|25865531|FG000|Overall Study|Withdrawal by Subject|4|||
13101832|NCT03405818|25865531|FG000|Overall Study|Lost to Follow-up|4|||
13101833|NCT03404843|25865564|FG000|Overall Study|Study difficulties unrelated to Tx|4|||
13101834|NCT03404843|25865565|FG001|Overall Study|Study difficulties unrelated to Tx|1|||
13101835|NCT03404674|25865676|FG000|Overall Study|Inability to Attend Future Visits|0|||
13101836|NCT03404674|25865677|FG001|Overall Study|Inability to Attend Future Visits|1|||
13101837|NCT03404674|25865678|FG002|Overall Study|Inability to Attend Future Visits|1|||
13101838|NCT03404674|25865679|FG003|Overall Study|Inability to Attend Future Visits|0|||
13101839|NCT03404674|25865680|FG004|Overall Study|Inability to Attend Future Visits|0|||
13101840|NCT03404674|25865681|FG005|Overall Study|Inability to Attend Future Visits|0|||
13101841|NCT03404674|25865676|FG000|Overall Study|Behavioral Problems|0|||
13101842|NCT03404674|25865677|FG001|Overall Study|Behavioral Problems|0|||
13101843|NCT03404674|25865678|FG002|Overall Study|Behavioral Problems|1|||
13101844|NCT03404674|25865679|FG003|Overall Study|Behavioral Problems|0|||
13101845|NCT03404674|25865680|FG004|Overall Study|Behavioral Problems|0|||
13101846|NCT03404674|25865681|FG005|Overall Study|Behavioral Problems|0|||
13101847|NCT03404674|25865676|FG000|Overall Study|Started a Medication that Precluded Eligibility|0|||
13101848|NCT03404674|25865677|FG001|Overall Study|Started a Medication that Precluded Eligibility|0|||
13101849|NCT03404674|25865678|FG002|Overall Study|Started a Medication that Precluded Eligibility|0|||
13101850|NCT03404674|25865679|FG003|Overall Study|Started a Medication that Precluded Eligibility|1|||
13101851|NCT03404674|25865680|FG004|Overall Study|Started a Medication that Precluded Eligibility|0|||
13101852|NCT03404674|25865681|FG005|Overall Study|Started a Medication that Precluded Eligibility|1|||
13101853|NCT03404518|25865698|FG000|Overall Study|Lost to Follow-up|28|||
13101854|NCT03404518|25865699|FG001|Overall Study|Lost to Follow-up|30|||
13101855|NCT03404518|25865698|FG000|Overall Study|Protocol Violation|13|||
13101856|NCT03404518|25865699|FG001|Overall Study|Protocol Violation|6|||
13101857|NCT03404206|25865723|FG000|Overall Study|Withdrawal by Subject|1|||
13101858|NCT03404206|25865724|FG001|Overall Study|Withdrawal by Subject|1|||
13101859|NCT03404206|25865725|FG002|Overall Study|Withdrawal by Subject|0|||
13101860|NCT03404206|25865723|FG000|Overall Study|Lost to Follow-up|3|||
13101861|NCT03404206|25865724|FG001|Overall Study|Lost to Follow-up|1|||
13101862|NCT03404206|25865725|FG002|Overall Study|Lost to Follow-up|0|||
13101863|NCT03403751|25865768|FG000|Overall Study|Death|5|||
13101864|NCT03403751|25865769|FG001|Overall Study|Death|6|||
13101865|NCT03403751|25865768|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2|||
13101866|NCT03403751|25865769|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2|||
13101867|NCT03403634|25865779|FG000|Overall Study|Disease progression|3|||
13101868|NCT03403634|25865779|FG000|Overall Study|Did not meet eligibility criteria|4|||
13101869|NCT03403426|25865794|FG000|Overall Study|Death|1|||
13101870|NCT03403426|25865794|FG000|Overall Study|Lost to Follow-up|2|||
13101871|NCT03403413|25865811|FG000|Overall Study|Lack of Efficacy|2|||
13101872|NCT03403400|25865853|FG000|Overall Study|Lost to Follow-up|1|||
13101873|NCT03403400|25865854|FG001|Overall Study|Lost to Follow-up|0|||
13101874|NCT03403400|25865855|FG002|Overall Study|Lost to Follow-up|1|||
13101875|NCT03403400|25865853|FG000|Overall Study|Hospitalization|1|||
13101876|NCT03403400|25865854|FG001|Overall Study|Hospitalization|0|||
13101877|NCT03403400|25865855|FG002|Overall Study|Hospitalization|0|||
13101878|NCT03403400|25865853|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
13101879|NCT03403400|25865854|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
13101880|NCT03403400|25865855|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1|||
13101881|NCT03403374|25865864|FG000|Overall Study|Lost to Follow-up|1|||
13101882|NCT03403192|25865899|FG000|Overall Study|Lost to Follow-up|1|||
13101883|NCT03403192|25865900|FG001|Overall Study|Lost to Follow-up|2|||
13101884|NCT03403192|25865901|FG002|Overall Study|Lost to Follow-up|0|||
13101885|NCT03403192|25865902|FG003|Overall Study|Lost to Follow-up|0|||
13101886|NCT03403192|25865899|FG000|Overall Study|Unable to respond|0|||
13101887|NCT03403192|25865900|FG001|Overall Study|Unable to respond|1|||
13101888|NCT03403192|25865901|FG002|Overall Study|Unable to respond|0|||
13101889|NCT03403192|25865902|FG003|Overall Study|Unable to respond|0|||
13101890|NCT03403192|25865899|FG000|Overall Study|Incomplete|3|||
13101891|NCT03403192|25865900|FG001|Overall Study|Incomplete|1|||
13101892|NCT03403192|25865901|FG002|Overall Study|Incomplete|3|||
13101893|NCT03403192|25865902|FG003|Overall Study|Incomplete|6|||
13101894|NCT03403036|25865910|FG000|Overall Study|Lack of Efficacy|5|||
13101895|NCT03402893|25865921|FG000|Overall Study|Withdrawal by Subject|1|||
13101896|NCT03402750|25865942|FG000|Overall Study|Lost to Follow-up|2|||
13101897|NCT03402750|25865943|FG001|Overall Study|Lost to Follow-up|1|||
13101898|NCT03402386|25865953|FG000|Overall Study|Adverse Event|3|||
13101899|NCT03402386|25865953|FG000|Overall Study|Physician Decision|1|||
13101900|NCT03402386|25865953|FG000|Overall Study|Difficult to control Hb|2|||
13101901|NCT03402126|25865959|FG000|Overall Study|Lost to Follow-up|6|||
13101902|NCT03402126|25865959|FG000|Overall Study|Protocol Violation|10|||
13101903|NCT03402126|25865959|FG000|Overall Study|Sponsor request/Study termination|29|||
13101904|NCT03402126|25865959|FG000|Overall Study|Study product no longer in use|1|||
13101905|NCT03402126|25865959|FG000|Overall Study|Technical problems|1|||
13101906|NCT03402126|25865959|FG000|Overall Study|Withdrawal by Subject|6|||
13101907|NCT03402126|25865959|FG000|Overall Study|Physician Decision|2|||
13101908|NCT03402126|25865959|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3|||
13101909|NCT03402126|25865959|FG000|Overall Study|Death|4|||
13101910|NCT03401749|25865980|FG000|Overall Study|Lost to Follow-up|20|||
13101911|NCT03401749|25865981|FG001|Overall Study|Lost to Follow-up|16|||
13101912|NCT03401749|25865982|FG002|Overall Study|Lost to Follow-up|26|||
13101913|NCT03401450|25865999|FG000|Overall Study|Lost to Follow-up|4|||
13101914|NCT03401450|25866000|FG001|Overall Study|Lost to Follow-up|6|||
13101915|NCT03401450|25865999|FG000|Overall Study|Anesthesia plan changed|2|||
13101916|NCT03401450|25866000|FG001|Overall Study|Anesthesia plan changed|2|||
13101917|NCT03401450|25865999|FG000|Overall Study|Did not complete medication diary|4|||
13101918|NCT03401450|25866000|FG001|Overall Study|Did not complete medication diary|2|||
13101919|NCT03401450|25865999|FG000|Overall Study|post surgery medication change|2|||
13101920|NCT03401450|25866000|FG001|Overall Study|post surgery medication change|1|||
13101921|NCT03401450|25865999|FG000|Overall Study|Cancelled surgery|0|||
13101922|NCT03401450|25866000|FG001|Overall Study|Cancelled surgery|2|||
13101923|NCT03401229|25866081|FG000|Overall Study|Lost to Follow-up|2|||
13101924|NCT03401229|25866082|FG001|Overall Study|Lost to Follow-up|1|||
13101925|NCT03401229|25866081|FG000|Overall Study|Other|1|||
13101926|NCT03401229|25866082|FG001|Overall Study|Other|3|||
13101927|NCT03401229|25866081|FG000|Overall Study|Adverse Event|8|||
13101928|NCT03401229|25866082|FG001|Overall Study|Adverse Event|6|||
13101929|NCT03401229|25866081|FG000|Overall Study|Withdrawal by Subject|29|||
13101930|NCT03401229|25866082|FG001|Overall Study|Withdrawal by Subject|26|||
13101931|NCT03401229|25866081|FG000|Overall Study|COVID-19|0|||
13101932|NCT03401229|25866082|FG001|Overall Study|COVID-19|1|||
13101933|NCT03401112|25866141|FG000|Overall Study|Adverse Event|1|||
13101934|NCT03401112|25866142|FG001|Overall Study|Adverse Event|2|||
13101935|NCT03401112|25866143|FG002|Overall Study|Adverse Event|3|||
13101936|NCT03401112|25866144|FG003|Overall Study|Adverse Event|2|||
13101937|NCT03401112|25866145|FG004|Overall Study|Adverse Event|0|||
13101938|NCT03401112|25866141|FG000|Overall Study|Lost to Follow-up|1|||
13101939|NCT03401112|25866142|FG001|Overall Study|Lost to Follow-up|0|||
13101940|NCT03401112|25866143|FG002|Overall Study|Lost to Follow-up|0|||
13101941|NCT03401112|25866144|FG003|Overall Study|Lost to Follow-up|0|||
13101942|NCT03401112|25866145|FG004|Overall Study|Lost to Follow-up|0|||
13101943|NCT03401112|25866141|FG000|Overall Study|Noncompliance|1|||
13101944|NCT03401112|25866142|FG001|Overall Study|Noncompliance|2|||
13101945|NCT03401112|25866143|FG002|Overall Study|Noncompliance|3|||
13101946|NCT03401112|25866144|FG003|Overall Study|Noncompliance|0|||
13101947|NCT03401112|25866145|FG004|Overall Study|Noncompliance|0|||
13101948|NCT03401112|25866141|FG000|Overall Study|Did not Meet Inclusion Criteria|1|||
13101949|NCT03401112|25866142|FG001|Overall Study|Did not Meet Inclusion Criteria|0|||
13101950|NCT03401112|25866143|FG002|Overall Study|Did not Meet Inclusion Criteria|0|||
13101951|NCT03401112|25866144|FG003|Overall Study|Did not Meet Inclusion Criteria|0|||
13101952|NCT03401112|25866145|FG004|Overall Study|Did not Meet Inclusion Criteria|0|||
13101953|NCT03401112|25866141|FG000|Overall Study|Withdrawal by Subject|0|||
13101954|NCT03401112|25866142|FG001|Overall Study|Withdrawal by Subject|3|||
13101955|NCT03401112|25866143|FG002|Overall Study|Withdrawal by Subject|2|||
13101956|NCT03401112|25866144|FG003|Overall Study|Withdrawal by Subject|1|||
13101957|NCT03401112|25866145|FG004|Overall Study|Withdrawal by Subject|0|||
13101958|NCT03401112|25866141|FG000|Overall Study|Physician Decision|0|||
13101959|NCT03401112|25866142|FG001|Overall Study|Physician Decision|0|||
13101960|NCT03401112|25866143|FG002|Overall Study|Physician Decision|0|||
13101961|NCT03401112|25866144|FG003|Overall Study|Physician Decision|2|||
13101962|NCT03401112|25866145|FG004|Overall Study|Physician Decision|0|||
13101963|NCT03401112|25866141|FG000|Overall Study|Study was Terminated by Sponsor|0|||
13101964|NCT03401112|25866142|FG001|Overall Study|Study was Terminated by Sponsor|0|||
13101965|NCT03401112|25866143|FG002|Overall Study|Study was Terminated by Sponsor|0|||
13101966|NCT03401112|25866144|FG003|Overall Study|Study was Terminated by Sponsor|1|||
13101967|NCT03401112|25866145|FG004|Overall Study|Study was Terminated by Sponsor|0|||
13101968|NCT03401112|25866141|FG000|Overall Study|Day 1 Assessment not Done|1|||
13101969|NCT03401112|25866142|FG001|Overall Study|Day 1 Assessment not Done|0|||
13101970|NCT03401112|25866143|FG002|Overall Study|Day 1 Assessment not Done|0|||
13101971|NCT03401112|25866144|FG003|Overall Study|Day 1 Assessment not Done|0|||
13101972|NCT03401112|25866145|FG004|Overall Study|Day 1 Assessment not Done|0|||
13101973|NCT03401112|25866141|FG000|Overall Study|Not Dosed|0|||
13101974|NCT03401112|25866142|FG001|Overall Study|Not Dosed|0|||
13101975|NCT03401112|25866143|FG002|Overall Study|Not Dosed|1|||
13101976|NCT03401112|25866144|FG003|Overall Study|Not Dosed|0|||
13101977|NCT03401112|25866145|FG004|Overall Study|Not Dosed|0|||
13101978|NCT03401112|25866141|FG000|Overall Study|Missed Clinical Visit|0|||
13101979|NCT03401112|25866142|FG001|Overall Study|Missed Clinical Visit|0|||
13101980|NCT03401112|25866143|FG002|Overall Study|Missed Clinical Visit|1|||
13101981|NCT03401112|25866144|FG003|Overall Study|Missed Clinical Visit|0|||
13101982|NCT03401112|25866145|FG004|Overall Study|Missed Clinical Visit|0|||
13101983|NCT03401112|25866141|FG000|Overall Study|Missed Doses|0|||
13101984|NCT03401112|25866142|FG001|Overall Study|Missed Doses|0|||
13101985|NCT03401112|25866143|FG002|Overall Study|Missed Doses|1|||
13101986|NCT03401112|25866144|FG003|Overall Study|Missed Doses|0|||
13101987|NCT03401112|25866145|FG004|Overall Study|Missed Doses|0|||
13101988|NCT03400852|25866173|FG000|Blinded Treatment Period|Physician Decision|0|||
13101989|NCT03400852|25866174|FG001|Blinded Treatment Period|Physician Decision|1|||
13101990|NCT03400852|25866175|FG002|Blinded Treatment Period|Physician Decision|0|||
13101991|NCT03400852|25866173|FG000|Blinded Treatment Period|Adverse Event|1|||
13101992|NCT03400852|25866174|FG001|Blinded Treatment Period|Adverse Event|1|||
13101993|NCT03400852|25866175|FG002|Blinded Treatment Period|Adverse Event|0|||
13101994|NCT03400852|25866173|FG000|Blinded Treatment Period|Study terminated by sponsor|8|||
13101995|NCT03400852|25866174|FG001|Blinded Treatment Period|Study terminated by sponsor|4|||
13101996|NCT03400852|25866175|FG002|Blinded Treatment Period|Study terminated by sponsor|0|||
13101997|NCT03400852|25866173|FG000|Open Label Period|Physician Decision|0|||
13101998|NCT03400852|25866174|FG001|Open Label Period|Physician Decision|0|||
13101999|NCT03400852|25866175|FG002|Open Label Period|Physician Decision|1|||
13102000|NCT03400852|25866173|FG000|Open Label Period|Study terminated by sponsor|0|||
13102001|NCT03400852|25866174|FG001|Open Label Period|Study terminated by sponsor|0|||
13102002|NCT03400852|25866175|FG002|Open Label Period|Study terminated by sponsor|21|||
13152227|NCT02538614|26053966|FG000|Overall Study|Progressive Disease|2|||
13152228|NCT02538471|26053976|FG000|Overall Study|Progression of disease|2|||
13152229|NCT02538341|26053999|FG000|Overall Study|Lost to Follow-up|51|||
13152230|NCT02538341|26054000|FG001|Overall Study|Lost to Follow-up|46|||
13152231|NCT02538341|26053999|FG000|Overall Study|Withdrawal by Subject|3|||
13152232|NCT02538341|26054000|FG001|Overall Study|Withdrawal by Subject|1|||
13152233|NCT02538341|26053999|FG000|Overall Study|Death|2|||
13222686|NCT01803607|26286774|FG001|Overall Study|Protocol Violation|2|||
13102003|NCT03400787|25866188|FG000|Overall Study|Lost to Follow-up|1|||
13102004|NCT03400787|25866189|FG001|Overall Study|Lost to Follow-up|0|||
13102005|NCT03400787|25866188|FG000|Overall Study|Death|1|||
13102006|NCT03400787|25866189|FG001|Overall Study|Death|0|||
13102007|NCT03400787|25866188|FG000|Overall Study|Protocol Violation|0|||
13152234|NCT02538341|26054000|FG001|Overall Study|Death|0|||
13152235|NCT02538107|26054022|FG000|Overall Study|Did not receive any Mircera dose|11|||
13152236|NCT02538107|26054022|FG000|Overall Study|Missing|5|||
13152237|NCT02538107|26054022|FG000|Overall Study|Necessity of dialysis|20|||
13152238|NCT02538107|26054022|FG000|Overall Study|Administration of other ESA|11|||
13152239|NCT02538107|26054022|FG000|Overall Study|No further treatment necessary|18|||
13152240|NCT02538107|26054022|FG000|Overall Study|Withdrawal by Subject|17|||
13152241|NCT02538107|26054022|FG000|Overall Study|Death|4|||
13102008|NCT03400787|25866189|FG001|Overall Study|Protocol Violation|2|||
13102009|NCT03400787|25866188|FG000|Overall Study|Unblinded before 3-month follow-upa-|0|||
13102010|NCT03400787|25866189|FG001|Overall Study|Unblinded before 3-month follow-upa-|6|||
13102011|NCT03400033|25866240|FG000|Overall Study|Withdrawal by Subject|1|||
13102012|NCT03400033|25866241|FG001|Overall Study|Withdrawal by Subject|2|||
13102013|NCT03399786|25866290|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
13102014|NCT03399786|25866291|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
13102015|NCT03399786|25866292|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
13102016|NCT03399786|25866293|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
13102017|NCT03399786|25866290|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
13102018|NCT03399786|25866291|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
13102019|NCT03399786|25866292|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1|||
13102020|NCT03399786|25866293|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
13102021|NCT03399786|25866290|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0|||
13102022|NCT03399786|25866291|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0|||
13102023|NCT03399786|25866292|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0|||
13102024|NCT03399786|25866293|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1|||
13102025|NCT03398356|25866326|FG000|Before Treatment|Lost to Follow-up|1|||
13102026|NCT03398356|25866327|FG001|Before Treatment|Lost to Follow-up|2|||
13102027|NCT03398356|25866328|FG002|Before Treatment|Lost to Follow-up|0|||
13102028|NCT03398356|25866326|FG000|Before Treatment|drug intolerance|2|||
13102029|NCT03398356|25866327|FG001|Before Treatment|drug intolerance|1|||
13102030|NCT03398356|25866328|FG002|Before Treatment|drug intolerance|0|||
13102031|NCT03398356|25866326|FG000|Before Treatment|Withdrawal by Subject|0|||
13102032|NCT03398356|25866327|FG001|Before Treatment|Withdrawal by Subject|5|||
13152242|NCT02538107|26054022|FG000|Overall Study|Administrative reason|5|||
13152243|NCT02538107|26054022|FG000|Overall Study|Adverse Event|4|||
13152244|NCT02538107|26054022|FG000|Overall Study|Surgery|1|||
13152245|NCT02538107|26054022|FG000|Overall Study|Other|7|||
13152246|NCT02538107|26054022|FG000|Overall Study|Not recorded|7|||
13152247|NCT02538094|26054033|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0|||
13152248|NCT02538094|26054034|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1|||
13152249|NCT02538094|26054033|FG000|Washout (4 Weeks)|Withdrawal by Subject|0|||
13152250|NCT02538094|26054034|FG001|Washout (4 Weeks)|Withdrawal by Subject|1|||
13152251|NCT02538029|26054066|FG000|Overall Study|unable to complete cognitive assessments|1|||
13152252|NCT02538029|26054067|FG001|Overall Study|unable to complete cognitive assessments|0|||
13152253|NCT02538029|26054068|FG002|Overall Study|unable to complete cognitive assessments|1|||
13152254|NCT02537678|26054133|FG000|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|4|||
13152255|NCT02537678|26054134|FG001|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|3|||
13152256|NCT02537678|26054133|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
13152257|NCT02537678|26054134|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
13152258|NCT02537678|26054133|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|6|||
13152259|NCT02537678|26054134|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|5|||
13152260|NCT02537678|26054133|FG000|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|2|||
13152261|NCT02537678|26054134|FG001|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|3|||
13152262|NCT02537678|26054133|FG000|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|14|||
13152263|NCT02537678|26054134|FG001|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|6|||
13152264|NCT02537678|26054133|FG000|Post-treatment to 6 Month Assessment|Lost to Follow-up|8|||
13152265|NCT02537678|26054134|FG001|Post-treatment to 6 Month Assessment|Lost to Follow-up|7|||
13152266|NCT02537678|26054133|FG000|6 Month to 12 Month Assessment|Lost to Follow-up|0|||
13152267|NCT02537678|26054134|FG001|6 Month to 12 Month Assessment|Lost to Follow-up|1|||
13152268|NCT02537574|26054170|FG000|Overall Study|Adverse Event|1|||
13152269|NCT02537574|26054171|FG001|Overall Study|Adverse Event|3|||
13152270|NCT02537574|26054172|FG002|Overall Study|Adverse Event|2|||
13152271|NCT02537574|26054170|FG000|Overall Study|Lost to Follow-up|40|||
13152272|NCT02537574|26054171|FG001|Overall Study|Lost to Follow-up|51|||
13152273|NCT02537574|26054172|FG002|Overall Study|Lost to Follow-up|55|||
13152274|NCT02537574|26054170|FG000|Overall Study|Noncompliance with study drug|0|||
13152275|NCT02537574|26054171|FG001|Overall Study|Noncompliance with study drug|1|||
13152276|NCT02537574|26054172|FG002|Overall Study|Noncompliance with study drug|1|||
13152277|NCT02537574|26054170|FG000|Overall Study|Physician Decision|2|||
13152278|NCT02537574|26054171|FG001|Overall Study|Physician Decision|0|||
13152279|NCT02537574|26054172|FG002|Overall Study|Physician Decision|0|||
13152280|NCT02537574|26054170|FG000|Overall Study|Protocol Violation|4|||
13152281|NCT02537574|26054171|FG001|Overall Study|Protocol Violation|2|||
13152282|NCT02537574|26054172|FG002|Overall Study|Protocol Violation|3|||
13152283|NCT02537574|26054170|FG000|Overall Study|Withdrawal by Subject|37|||
13152284|NCT02537574|26054171|FG001|Overall Study|Withdrawal by Subject|27|||
13152285|NCT02537574|26054172|FG002|Overall Study|Withdrawal by Subject|29|||
13102033|NCT03398356|25866328|FG002|Before Treatment|Withdrawal by Subject|0|||
13102034|NCT03398356|25866326|FG000|Before Treatment|Physician Decision|0|||
13152286|NCT02537574|26054170|FG000|Overall Study|Lack of Efficacy|14|||
13152287|NCT02537574|26054171|FG001|Overall Study|Lack of Efficacy|16|||
13152288|NCT02537574|26054172|FG002|Overall Study|Lack of Efficacy|15|||
13152289|NCT02537574|26054170|FG000|Overall Study|Duplicate Patient|1|||
13152290|NCT02537574|26054171|FG001|Overall Study|Duplicate Patient|0|||
13152291|NCT02537574|26054172|FG002|Overall Study|Duplicate Patient|0|||
13152292|NCT02537574|26054170|FG000|Overall Study|Patient not Stable|0|||
13152293|NCT02537574|26054171|FG001|Overall Study|Patient not Stable|1|||
13152294|NCT02537574|26054172|FG002|Overall Study|Patient not Stable|0|||
13152295|NCT02537574|26054170|FG000|Overall Study|Incarceration|0|||
13152296|NCT02537574|26054171|FG001|Overall Study|Incarceration|1|||
13152297|NCT02537574|26054172|FG002|Overall Study|Incarceration|0|||
13152298|NCT02537574|26054170|FG000|Overall Study|Failed Naloxone Challenge|0|||
13152299|NCT02537574|26054171|FG001|Overall Study|Failed Naloxone Challenge|1|||
13152300|NCT02537574|26054172|FG002|Overall Study|Failed Naloxone Challenge|0|||
13152301|NCT02537574|26054170|FG000|Overall Study|Transportation Issues|0|||
13152302|NCT02537574|26054171|FG001|Overall Study|Transportation Issues|0|||
13102035|NCT03398356|25866327|FG001|Before Treatment|Physician Decision|0|||
13102036|NCT03398356|25866328|FG002|Before Treatment|Physician Decision|11|||
13102037|NCT03398356|25866326|FG000|After 6 Weeks of Treatment|Physician Decision|0|||
13102038|NCT03398356|25866327|FG001|After 6 Weeks of Treatment|Physician Decision|2|||
13102039|NCT03398356|25866328|FG002|After 6 Weeks of Treatment|Physician Decision|0|||
13102040|NCT03397771|25866343|FG000|Overall Study|2 erroneously randomized, never treated|3|||
13102041|NCT03397771|25866344|FG001|Overall Study|2 erroneously randomized, never treated|1|||
13102042|NCT03397771|25866343|FG000|Overall Study|Withdrawal by Subject|1|||
13102043|NCT03397771|25866344|FG001|Overall Study|Withdrawal by Subject|3|||
13102044|NCT03397771|25866343|FG000|Overall Study|Protocol Violation|2|||
13102045|NCT03397771|25866344|FG001|Overall Study|Protocol Violation|2|||
13102046|NCT03397771|25866343|FG000|Overall Study|Adverse Event|2|||
13102047|NCT03397771|25866344|FG001|Overall Study|Adverse Event|1|||
13102048|NCT03396913|25866361|FG000|Overall Study|Lost to Follow-up|0|||
13102049|NCT03396913|25866362|FG001|Overall Study|Lost to Follow-up|6|||
13102050|NCT03396835|25866368|FG000|Overall Study|Withdrawn prior to completion|1|||
13102051|NCT03396835|25866368|FG000|Overall Study|Did not meet criteria for data analysis|1|||
13102052|NCT03395639|25866393|FG000|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
13102053|NCT03395639|25866394|FG001|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
13102054|NCT03395639|25866395|FG002|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|0|||
13102055|NCT03395639|25866393|FG000|Main Treatment Period (0 to 4 Months)|Adverse Event|1|||
13102056|NCT03395639|25866394|FG001|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
13102057|NCT03395639|25866395|FG002|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
13102058|NCT03395639|25866393|FG000|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
13102059|NCT03395639|25866394|FG001|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|1|||
13102060|NCT03395639|25866395|FG002|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
13102061|NCT03395639|25866393|FG000|Extension Period (4-13 Months)|Adverse Event|0|||
13102062|NCT03395639|25866394|FG001|Extension Period (4-13 Months)|Adverse Event|0|||
13102063|NCT03395639|25866395|FG002|Extension Period (4-13 Months)|Adverse Event|2|||
13102064|NCT03395639|25866393|FG000|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
13102065|NCT03395639|25866394|FG001|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
13102066|NCT03395639|25866395|FG002|Extension Period (4-13 Months)|Subject discontinued at PI discretion|1|||
13102067|NCT03395405|25866420|FG000|Overall Study|Death|0|||
13102068|NCT03395405|25866421|FG001|Overall Study|Death|2|||
13102069|NCT03395405|25866420|FG000|Overall Study|Lost to Follow-up|0|||
13102070|NCT03395405|25866421|FG001|Overall Study|Lost to Follow-up|1|||
13102071|NCT03395405|25866420|FG000|Overall Study|Protocol Violation|0|||
13102072|NCT03395405|25866421|FG001|Overall Study|Protocol Violation|1|||
13102073|NCT03395405|25866420|FG000|Overall Study|Withdrawal by Subject|3|||
13102074|NCT03395405|25866421|FG001|Overall Study|Withdrawal by Subject|1|||
13152303|NCT02537574|26054172|FG002|Overall Study|Transportation Issues|1|||
13152304|NCT02537574|26054170|FG000|Overall Study|Subject did not want last Vivitrol Injec|0|||
13152305|NCT02537574|26054171|FG001|Overall Study|Subject did not want last Vivitrol Injec|0|||
13485342|NCT03739138|27032561|FG000|Overall Study|Death|0|||
13102075|NCT03395405|25866420|FG000|Overall Study|COVID-19 Pandemic|1|||
13102076|NCT03395405|25866421|FG001|Overall Study|COVID-19 Pandemic|0|||
13102077|NCT03395353|25866433|FG000|Overall Study|Adverse Event|20|||
13102078|NCT03395353|25866433|FG000|Overall Study|Protocol Violation|1|||
13102079|NCT03395353|25866433|FG000|Overall Study|Lack of Efficacy|3|||
13102080|NCT03395353|25866433|FG000|Overall Study|Withdrawal by Subject|24|||
13102081|NCT03395353|25866433|FG000|Overall Study|Discontinued visit|1|||
13102082|NCT03395353|25866433|FG000|Overall Study|Refrain from visit due to COVID-19|1|||
13102083|NCT03395353|25866433|FG000|Overall Study|Physician Decision|4|||
13102084|NCT03395353|25866433|FG000|Overall Study|Early termination of overall study|33|||
13102085|NCT03394924|25866508|FG000|Overall Study|Adverse Event|0|||
13152306|NCT02537574|26054172|FG002|Overall Study|Subject did not want last Vivitrol Injec|1|||
13152307|NCT02537574|26054170|FG000|Overall Study|Noncompliance with Protocol|0|||
13152308|NCT02537574|26054171|FG001|Overall Study|Noncompliance with Protocol|0|||
13152309|NCT02537574|26054172|FG002|Overall Study|Noncompliance with Protocol|1|||
13152310|NCT02537522|26054185|FG000|Phase I - Contralateral|Subject no longer eligible|15|||
13152311|NCT02537522|26054186|FG001|Phase I - Contralateral|Subject no longer eligible|7|||
13152312|NCT02537522|26054187|FG002|Phase I - Contralateral|Subject no longer eligible|0|||
13152313|NCT02537522|26054188|FG003|Phase I - Contralateral|Subject no longer eligible|0|||
13152314|NCT02537522|26054185|FG000|Phase I - Contralateral|Withdrawal by Subject|0|||
13152315|NCT02537522|26054186|FG001|Phase I - Contralateral|Withdrawal by Subject|1|||
13152316|NCT02537522|26054187|FG002|Phase I - Contralateral|Withdrawal by Subject|0|||
13152317|NCT02537522|26054188|FG003|Phase I - Contralateral|Withdrawal by Subject|0|||
13152318|NCT02537522|26054185|FG000|Phase I - Contralateral|incorrect randomization|0|||
13152319|NCT02537522|26054186|FG001|Phase I - Contralateral|incorrect randomization|1|||
13152320|NCT02537522|26054187|FG002|Phase I - Contralateral|incorrect randomization|0|||
13152321|NCT02537522|26054188|FG003|Phase I - Contralateral|incorrect randomization|0|||
13152322|NCT02537522|26054185|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0|||
13152323|NCT02537522|26054186|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1|||
13152324|NCT02537522|26054187|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0|||
13152325|NCT02537522|26054188|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0|||
13152326|NCT02537522|26054185|FG000|Phase II - Period 1 Bilateral|Adverse Event|0|||
13152327|NCT02537522|26054186|FG001|Phase II - Period 1 Bilateral|Adverse Event|0|||
13152328|NCT02537522|26054187|FG002|Phase II - Period 1 Bilateral|Adverse Event|0|||
13152329|NCT02537522|26054188|FG003|Phase II - Period 1 Bilateral|Adverse Event|1|||
13152330|NCT02537431|26054219|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
13152331|NCT02537015|26054225|FG000|Overall Study|Adverse Event|3|||
13152332|NCT02537015|26054225|FG000|Overall Study|Withdrawal by Subject|2|||
13152333|NCT02537015|26054225|FG000|Overall Study|Other Miscellaneous Reasons|1|||
13152334|NCT02536976|26054242|FG000|Overall Study|Physician Decision|0|||
13152335|NCT02536976|26054243|FG001|Overall Study|Physician Decision|1|||
13152336|NCT02536963|26054249|FG000|Overall Study|Withdrawal by Subject|18|||
13152337|NCT02536846|26054287|FG000|Overall Study|Withdrawal by Subject|1|||
13152338|NCT02536833|26054359|FG000|Overall Study|Discontinued Before Treatment|0|||
13152339|NCT02536833|26054360|FG001|Overall Study|Discontinued Before Treatment|0|||
13152340|NCT02536833|26054361|FG002|Overall Study|Discontinued Before Treatment|1|||
13152341|NCT02536833|26054362|FG003|Overall Study|Discontinued Before Treatment|2|||
13152342|NCT02536833|26054359|FG000|Overall Study|Adverse Event|1|||
13152343|NCT02536833|26054360|FG001|Overall Study|Adverse Event|3|||
13152344|NCT02536833|26054361|FG002|Overall Study|Adverse Event|4|||
13152345|NCT02536833|26054362|FG003|Overall Study|Adverse Event|1|||
13152346|NCT02536833|26054359|FG000|Overall Study|Lost to Follow-up|2|||
13152347|NCT02536833|26054360|FG001|Overall Study|Lost to Follow-up|1|||
13152348|NCT02536833|26054361|FG002|Overall Study|Lost to Follow-up|2|||
13152349|NCT02536833|26054362|FG003|Overall Study|Lost to Follow-up|2|||
13152350|NCT02536833|26054359|FG000|Overall Study|Physician Decision|0|||
13152351|NCT02536833|26054360|FG001|Overall Study|Physician Decision|0|||
13152352|NCT02536833|26054361|FG002|Overall Study|Physician Decision|0|||
13152353|NCT02536833|26054362|FG003|Overall Study|Physician Decision|1|||
13152354|NCT02536833|26054359|FG000|Overall Study|Site Terminated by Sponsor|2|||
13152355|NCT02536833|26054360|FG001|Overall Study|Site Terminated by Sponsor|2|||
13152356|NCT02536833|26054361|FG002|Overall Study|Site Terminated by Sponsor|2|||
13152357|NCT02536833|26054362|FG003|Overall Study|Site Terminated by Sponsor|2|||
13152358|NCT02536833|26054359|FG000|Overall Study|Subject Non-Compliance|0|||
13152359|NCT02536833|26054360|FG001|Overall Study|Subject Non-Compliance|1|||
13152360|NCT02536833|26054361|FG002|Overall Study|Subject Non-Compliance|1|||
13152361|NCT02536833|26054362|FG003|Overall Study|Subject Non-Compliance|0|||
13152362|NCT02536833|26054359|FG000|Overall Study|Withdrawal by Subject|4|||
13152363|NCT02536833|26054360|FG001|Overall Study|Withdrawal by Subject|3|||
13152364|NCT02536833|26054361|FG002|Overall Study|Withdrawal by Subject|5|||
13152365|NCT02536833|26054362|FG003|Overall Study|Withdrawal by Subject|11|||
13152366|NCT02536781|26054377|FG000|Overall Study|Lost to Follow-up|2|||
13152367|NCT02536781|26054378|FG001|Overall Study|Lost to Follow-up|0|||
13152368|NCT02536664|26054403|FG000|Overall Study|Inadequate completion of documentation|2|||
13152369|NCT02536664|26054404|FG001|Overall Study|Inadequate completion of documentation|4|||
13152370|NCT02536664|26054403|FG000|Overall Study|Progression|13|||
13102086|NCT03394924|25866509|FG001|Overall Study|Adverse Event|5|||
13102087|NCT03394924|25866510|FG002|Overall Study|Adverse Event|0|||
13102088|NCT03394924|25866508|FG000|Overall Study|Withdrawal by Subject|2|||
13102089|NCT03394924|25866509|FG001|Overall Study|Withdrawal by Subject|0|||
13102090|NCT03394924|25866510|FG002|Overall Study|Withdrawal by Subject|0|||
13102091|NCT03394924|25866508|FG000|Overall Study|Lost to Follow-up|0|||
13102092|NCT03394924|25866509|FG001|Overall Study|Lost to Follow-up|1|||
13102093|NCT03394924|25866510|FG002|Overall Study|Lost to Follow-up|0|||
13102094|NCT03394924|25866508|FG000|Overall Study|Did not meet all inclusion criteria|1|||
13102095|NCT03394924|25866509|FG001|Overall Study|Did not meet all inclusion criteria|0|||
13102096|NCT03394924|25866510|FG002|Overall Study|Did not meet all inclusion criteria|0|||
13102097|NCT03394885|25866524|FG000|Overall Study|Adverse Event|4|||
13102098|NCT03394885|25866524|FG000|Overall Study|Lack of Efficacy|1|||
13102099|NCT03394885|25866524|FG000|Overall Study|Physician Decision|1|||
13102100|NCT03394885|25866524|FG000|Overall Study|Withdrawal by Subject|8|||
13102101|NCT03394885|25866524|FG000|Overall Study|Alternative Therapy|1|||
13102102|NCT03394508|25866555|FG000|Overall Study|Protocol Violation|0|||
13102103|NCT03394508|25866556|FG001|Overall Study|Protocol Violation|3|||
13102104|NCT03394508|25866555|FG000|Overall Study|Lost to Follow-up|1|||
13102105|NCT03394508|25866556|FG001|Overall Study|Lost to Follow-up|0|||
13102106|NCT03394391|25866579|FG000|Overall Study|Lost to Follow-up|1|||
13102107|NCT03394391|25866580|FG001|Overall Study|Lost to Follow-up|2|||
13102108|NCT03394027|25866622|FG000|Overall Study|Ineligible|3|||
13102109|NCT03394027|25866623|FG001|Overall Study|Ineligible|1|||
13102110|NCT03394027|25866624|FG002|Overall Study|Ineligible|3|||
13102111|NCT03394027|25866622|FG000|Overall Study|Participant declined to participate before treatment started|0|||
13102112|NCT03394027|25866623|FG001|Overall Study|Participant declined to participate before treatment started|0|||
13102113|NCT03394027|25866624|FG002|Overall Study|Participant declined to participate before treatment started|1|||
13102114|NCT03393806|25866674|FG000|Overall Study|Physician Decision|1|||
13102115|NCT03393806|25866675|FG001|Overall Study|Physician Decision|0|||
13152371|NCT02536664|26054404|FG001|Overall Study|Progression|18|||
13152372|NCT02536664|26054403|FG000|Overall Study|Death due to lymphoma|2|||
13152373|NCT02536664|26054404|FG001|Overall Study|Death due to lymphoma|1|||
13152374|NCT02536664|26054403|FG000|Overall Study|Death due to other reason|3|||
13152375|NCT02536664|26054404|FG001|Overall Study|Death due to other reason|2|||
13152376|NCT02536664|26054403|FG000|Overall Study|Intolerability|8|||
13152377|NCT02536664|26054404|FG001|Overall Study|Intolerability|6|||
13152378|NCT02536664|26054403|FG000|Overall Study|Withdrawal by Subject|8|||
13152379|NCT02536664|26054404|FG001|Overall Study|Withdrawal by Subject|5|||
13152380|NCT02536664|26054403|FG000|Overall Study|Other|18|||
13152381|NCT02536664|26054404|FG001|Overall Study|Other|24|||
13152382|NCT02536664|26054403|FG000|Overall Study|Missing|53|||
13152383|NCT02536664|26054404|FG001|Overall Study|Missing|20|||
13152384|NCT02536508|26054425|FG000|Overall Study|Withdrawal by Subject|18|||
13152385|NCT02536508|26054426|FG001|Overall Study|Withdrawal by Subject|13|||
13152386|NCT02536508|26054427|FG002|Overall Study|Withdrawal by Subject|7|||
13152387|NCT02536508|26054425|FG000|Overall Study|Adverse Event|14|||
13152388|NCT02536508|26054426|FG001|Overall Study|Adverse Event|13|||
13152389|NCT02536508|26054427|FG002|Overall Study|Adverse Event|6|||
13152390|NCT02536508|26054425|FG000|Overall Study|Lost to Follow-up|12|||
13152391|NCT02536508|26054426|FG001|Overall Study|Lost to Follow-up|4|||
13152392|NCT02536508|26054427|FG002|Overall Study|Lost to Follow-up|0|||
13152393|NCT02536508|26054425|FG000|Overall Study|Lack of Efficacy|3|||
13152394|NCT02536508|26054426|FG001|Overall Study|Lack of Efficacy|5|||
13152395|NCT02536508|26054427|FG002|Overall Study|Lack of Efficacy|4|||
13152396|NCT02536508|26054425|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
13152397|NCT02536508|26054426|FG001|Overall Study|Protocol Discontinuation Criteria|2|||
13152398|NCT02536508|26054427|FG002|Overall Study|Protocol Discontinuation Criteria|2|||
13152399|NCT02536508|26054425|FG000|Overall Study|Physician Decision|0|||
13152400|NCT02536508|26054426|FG001|Overall Study|Physician Decision|4|||
13152401|NCT02536508|26054427|FG002|Overall Study|Physician Decision|2|||
13152402|NCT02536508|26054425|FG000|Overall Study|Major Protocol Deviation|2|||
13152403|NCT02536508|26054426|FG001|Overall Study|Major Protocol Deviation|2|||
13152404|NCT02536508|26054427|FG002|Overall Study|Major Protocol Deviation|2|||
13152405|NCT02536508|26054425|FG000|Overall Study|Administrative Reasons|0|||
13152406|NCT02536508|26054426|FG001|Overall Study|Administrative Reasons|1|||
13152407|NCT02536508|26054427|FG002|Overall Study|Administrative Reasons|0|||
13152408|NCT02536404|26054448|FG000|Overall Study|Adverse Event|5|||
13152409|NCT02536404|26054449|FG001|Overall Study|Adverse Event|0|||
13152410|NCT02536404|26054448|FG000|Overall Study|Withdrawal by Subject|4|||
13152411|NCT02536404|26054449|FG001|Overall Study|Withdrawal by Subject|1|||
13152412|NCT02536404|26054448|FG000|Overall Study|Physician Decision|10|||
13102116|NCT03393000|25866681|FG000|Overall Study|Death|11|||
13102117|NCT03393000|25866681|FG000|Overall Study|Withdrawal by Subject|2|||
13102118|NCT03393000|25866681|FG000|Overall Study|Physician Decision|1|||
13102119|NCT03392194|25866694|FG000|Overall Study|Withdrawal by Subject|1|||
13102120|NCT03392194|25866695|FG001|Overall Study|Withdrawal by Subject|2|||
13152413|NCT02536404|26054449|FG001|Overall Study|Physician Decision|0|||
13152414|NCT02536404|26054448|FG000|Overall Study|Sponsor decision|1|||
13152415|NCT02536404|26054449|FG001|Overall Study|Sponsor decision|0|||
13152416|NCT02536378|26054470|FG000|Overall Study|Physician Decision|0|||
13152417|NCT02536378|26054471|FG001|Overall Study|Physician Decision|2|||
13152418|NCT02536378|26054470|FG000|Overall Study|Withdrawal by Subject|0|||
13102121|NCT03392194|25866694|FG000|Overall Study|Conflicts with personal schedule|1|||
13102122|NCT03392194|25866695|FG001|Overall Study|Conflicts with personal schedule|0|||
13102123|NCT03392168|25866726|FG000|Period 2: Cohort 2|Lost to Follow-up|0|||
13102124|NCT03392168|25866727|FG001|Period 2: Cohort 2|Lost to Follow-up|1|||
13102125|NCT03392168|25866728|FG002|Period 2: Cohort 2|Lost to Follow-up|1|||
13102126|NCT03392168|25866729|FG003|Period 2: Cohort 2|Lost to Follow-up|1|||
13102127|NCT03392168|25866726|FG000|Period 2: Cohort 2|Other|0|||
13102128|NCT03392168|25866727|FG001|Period 2: Cohort 2|Other|1|||
13102129|NCT03392168|25866728|FG002|Period 2: Cohort 2|Other|0|||
13102130|NCT03392168|25866729|FG003|Period 2: Cohort 2|Other|0|||
13102131|NCT03391960|25866747|FG000|Overall Study|Protocol Violation|0|||
13102132|NCT03391960|25866748|FG001|Overall Study|Protocol Violation||||
13102133|NCT03391765|25866799|FG000|Overall Study|Adverse Event|2|||
13102134|NCT03391765|25866800|FG001|Overall Study|Adverse Event|0|||
13102135|NCT03391765|25866801|FG002|Overall Study|Adverse Event|0|||
13102136|NCT03391765|25866802|FG003|Overall Study|Adverse Event|2|||
13102137|NCT03391765|25866799|FG000|Overall Study|Withdrew consent|5|||
13102138|NCT03391765|25866800|FG001|Overall Study|Withdrew consent|7|||
13102139|NCT03391765|25866801|FG002|Overall Study|Withdrew consent|2|||
13102140|NCT03391765|25866802|FG003|Overall Study|Withdrew consent|5|||
13102141|NCT03391765|25866799|FG000|Overall Study|Other, not specified|44|||
13102142|NCT03391765|25866800|FG001|Overall Study|Other, not specified|38|||
13102143|NCT03391765|25866801|FG002|Overall Study|Other, not specified|21|||
13102144|NCT03391765|25866802|FG003|Overall Study|Other, not specified|16|||
13102145|NCT03391232|25866825|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0|||
13102146|NCT03391232|25866826|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1|||
13102147|NCT03391232|25866825|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0|||
13102148|NCT03391232|25866826|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2|||
13102149|NCT03390426|25866845|FG000|Overall Study|Protocol Violation|0|||
13102150|NCT03390426|25866846|FG001|Overall Study|Protocol Violation|1|||
13102151|NCT03390166|25866865|FG000|Overall Study|Death|0|||
13102152|NCT03390166|25866866|FG001|Overall Study|Death|1|||
13102153|NCT03390166|25866865|FG000|Overall Study|Lost to Follow-up|6|||
13102154|NCT03390166|25866866|FG001|Overall Study|Lost to Follow-up|4|||
13102155|NCT03390166|25866865|FG000|Overall Study|Physician Decision|2|||
13102156|NCT03390166|25866866|FG001|Overall Study|Physician Decision|1|||
13102157|NCT03390166|25866865|FG000|Overall Study|Move from study area|3|||
13102158|NCT03390166|25866866|FG001|Overall Study|Move from study area|2|||
13102159|NCT03390166|25866865|FG000|Overall Study|To militarycamp for conscript|1|||
13102160|NCT03390166|25866866|FG001|Overall Study|To militarycamp for conscript|0|||
13102161|NCT03390166|25866865|FG000|Overall Study|To drug therapy course|0|||
13102162|NCT03390166|25866866|FG001|Overall Study|To drug therapy course|1|||
13102163|NCT03390166|25866865|FG000|Overall Study|Move to work oversea|0|||
13102164|NCT03390166|25866866|FG001|Overall Study|Move to work oversea|1|||
13102165|NCT03389893|25866899|FG000|Randomized Double Blind Period|Withdrawal by Subject|1|||
13102166|NCT03389893|25866900|FG001|Randomized Double Blind Period|Withdrawal by Subject|0|||
13102167|NCT03389893|25866901|FG002|Randomized Double Blind Period|Withdrawal by Subject|0|||
13102168|NCT03389893|25866902|FG003|Randomized Double Blind Period|Withdrawal by Subject|0|||
13102169|NCT03389893|25866899|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
13102170|NCT03389893|25866900|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
13102171|NCT03389893|25866901|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2|||
13102172|NCT03389893|25866902|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1|||
13102173|NCT03389893|25866899|FG000|Open Label Extension and Follow-Up|Physician Decision|0|||
13102174|NCT03389893|25866900|FG001|Open Label Extension and Follow-Up|Physician Decision|0|||
13102175|NCT03389893|25866901|FG002|Open Label Extension and Follow-Up|Physician Decision|1|||
13102176|NCT03389893|25866902|FG003|Open Label Extension and Follow-Up|Physician Decision|0|||
13102177|NCT03389893|25866899|FG000|Open Label Extension and Follow-Up|Participant Moved|0|||
13102178|NCT03389893|25866900|FG001|Open Label Extension and Follow-Up|Participant Moved|0|||
13102179|NCT03389893|25866901|FG002|Open Label Extension and Follow-Up|Participant Moved|1|||
13102180|NCT03389893|25866902|FG003|Open Label Extension and Follow-Up|Participant Moved|0|||
13102181|NCT03389555|25866933|FG000|Overall Study|Protocol Violation|1|||
13102182|NCT03389555|25866934|FG001|Overall Study|Protocol Violation|3|||
13102183|NCT03389555|25866933|FG000|Overall Study|Death|1|||
13102184|NCT03389555|25866934|FG001|Overall Study|Death|0|||
13102185|NCT03389308|25866940|FG000|Overall Study|Withdrawal by Subject|5|||
13102186|NCT03389308|25866940|FG000|Overall Study|Lost to Follow-up|3|||
13102187|NCT03389308|25866940|FG000|Overall Study|Adverse Event|2|||
13152419|NCT02536378|26054471|FG001|Overall Study|Withdrawal by Subject|1|||
13102188|NCT03389308|25866940|FG000|Overall Study|Sponsor Request|2|||
13102189|NCT03388164|25866955|FG000|Overall Study|Withdrawal by Subject|3|||
13152420|NCT02536378|26054470|FG000|Overall Study|Death|1|||
13102190|NCT03388164|25866956|FG001|Overall Study|Withdrawal by Subject|1|||
13102191|NCT03388138|25866975|FG000|Overall Study|Protocol Violation|1|||
13102192|NCT03388138|25866976|FG001|Overall Study|Protocol Violation|0|||
13102193|NCT03387735|25867007|FG000|Overall Study|Lost to Follow-up|4|||
13102194|NCT03387735|25867008|FG001|Overall Study|Lost to Follow-up|8|||
13102195|NCT03387735|25867007|FG000|Overall Study|Death|4|||
13102196|NCT03387735|25867008|FG001|Overall Study|Death|8|||
13102197|NCT03387683|25867023|FG000|Overall Study|In receipt of disallowed medication|1|||
13102198|NCT03387683|25867024|FG001|Overall Study|In receipt of disallowed medication|0|||
13102199|NCT03387683|25867023|FG000|Overall Study|Did not receive treatment|1|||
13102200|NCT03387683|25867024|FG001|Overall Study|Did not receive treatment|0|||
13102201|NCT03387462|25867033|FG000|Overall Study|Lost to Follow-up|1|||
13152421|NCT02536378|26054471|FG001|Overall Study|Death|2|||
13152422|NCT02536378|26054470|FG000|Overall Study|Patient refused further follow up|6|||
13152423|NCT02536378|26054471|FG001|Overall Study|Patient refused further follow up|2|||
13152424|NCT02536313|26054494|FG000|Overall Study|Lack of Efficacy|0|||
13152425|NCT02536313|26054495|FG001|Overall Study|Lack of Efficacy|1|||
13152426|NCT02535741|26054505|FG000|Overall Study|Adverse Event|3|||
13152427|NCT02535741|26054505|FG000|Overall Study|Withdrawal by Subject|9|||
13152428|NCT02535741|26054505|FG000|Overall Study|Lost to Follow-up|10|||
13152429|NCT02535741|26054505|FG000|Overall Study|Exclusion criteria: Bilateral implant|4|||
13152430|NCT02535741|26054505|FG000|Overall Study|Missing data|6|||
13152431|NCT02535715|26054529|FG000|Overall Study|Withdrawal by Subject|0|||
13152432|NCT02535715|26054530|FG001|Overall Study|Withdrawal by Subject|0|||
13152433|NCT02535715|26054531|FG002|Overall Study|Withdrawal by Subject|1|||
13152434|NCT02535416|26054611|FG000|Overall Study|Family bereavement overseas|1|||
13152435|NCT02535416|26054612|FG001|Overall Study|Family bereavement overseas|0|||
13152436|NCT02535416|26054613|FG002|Overall Study|Family bereavement overseas|0|||
13152437|NCT02535416|26054614|FG003|Overall Study|Family bereavement overseas|0|||
13152438|NCT02535416|26054615|FG004|Overall Study|Family bereavement overseas|0|||
13152439|NCT02535416|26054616|FG005|Overall Study|Family bereavement overseas|0|||
13152440|NCT02535416|26054617|FG006|Overall Study|Family bereavement overseas|0|||
13152441|NCT02535416|26054618|FG007|Overall Study|Family bereavement overseas|0|||
13152442|NCT02535416|26054619|FG008|Overall Study|Family bereavement overseas|0|||
13152443|NCT02535364|26054646|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22|||
13152444|NCT02535364|26054646|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2|||
13152445|NCT02535364|26054646|FG000|Part A Screening Through Leukapheresis|Disease progression|1|||
13152446|NCT02535364|26054646|FG000|Part B Screening|Study placed on clinical hold by FDA|7|||
13152447|NCT02535364|26054646|FG000|Part B Screening|Unable to manufacture JCAR015|3|||
13152448|NCT02535364|26054646|FG000|Part B Screening|Death|2|||
13152449|NCT02535364|26054646|FG000|Part B Screening|Physician Decision|1|||
13152450|NCT02535364|26054646|FG000|Part B Screening|Withdrawal by Subject|1|||
13152451|NCT02535364|26054646|FG000|Part B Screening|Adverse Event|1|||
13152452|NCT02535364|26054646|FG000|Part B Screening|Change in diagnosis, no longer eligible|2|||
13152453|NCT02535364|26054646|FG000|Study Treatment|Death|1|||
13152454|NCT02535364|26054646|FG000|Study Treatment|Study placed on clinical hold by FDA|1|||
13152455|NCT02535364|26054646|FG000|12-Month Follow-up Period|Disease progression|22|||
13152456|NCT02535364|26054646|FG000|12-Month Follow-up Period|Death|5|||
13152457|NCT02535364|26054646|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5|||
13152458|NCT02535364|26054646|FG000|12-Month Follow-up Period|Subject received alternative therapy|2|||
13152459|NCT02535364|26054646|FG000|12-Month Follow-up Period|Subject transferred to hospice|1|||
13152460|NCT02535065|26054653|FG000|Overall Study|Death|13|||
13152461|NCT02535065|26054653|FG000|Overall Study|Lost to Follow-up|1|||
13152462|NCT02535065|26054653|FG000|Overall Study|Withdrawal by Subject|6|||
13152463|NCT02535000|26054668|FG000|Overall Study|Cancellation of surgery.|1|||
13152464|NCT02535000|26054669|FG001|Overall Study|Cancellation of surgery.|2|||
13152465|NCT02534935|26054848|FG000|Stage 1: 24 Months|Withdrawal by Subject|0|||
13152466|NCT02534935|26054849|FG001|Stage 1: 24 Months|Withdrawal by Subject|3|||
13152467|NCT02534935|26054850|FG002|Stage 1: 24 Months|Withdrawal by Subject|3|||
13152468|NCT02534935|26054848|FG000|Stage 1: 24 Months|No longer willing to participate in study|0|||
13152469|NCT02534935|26054849|FG001|Stage 1: 24 Months|No longer willing to participate in study|1|||
13152470|NCT02534935|26054850|FG002|Stage 1: 24 Months|No longer willing to participate in study|1|||
13152471|NCT02534935|26054848|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
13152472|NCT02534935|26054849|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3|||
13152473|NCT02534935|26054850|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
13152474|NCT02534935|26054848|FG000|Stage 1: 24 Months|Lost to Follow-up|0|||
13152475|NCT02534935|26054849|FG001|Stage 1: 24 Months|Lost to Follow-up|1|||
13152476|NCT02534935|26054850|FG002|Stage 1: 24 Months|Lost to Follow-up|1|||
13152477|NCT02534935|26054848|FG000|Stage 1: 24 Months|Adverse Event|0|||
13152478|NCT02534935|26054849|FG001|Stage 1: 24 Months|Adverse Event|2|||
13152479|NCT02534935|26054850|FG002|Stage 1: 24 Months|Adverse Event|0|||
13152480|NCT02534935|26054848|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
13152481|NCT02534935|26054849|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4|||
13152482|NCT02534935|26054850|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
13152483|NCT02534935|26054848|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
13152484|NCT02534935|26054849|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1|||
13152485|NCT02534935|26054850|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
13152486|NCT02534896|26054877|FG000|Overall Study|Adverse Event|2|||
13152487|NCT02534896|26054878|FG001|Overall Study|Adverse Event|1|||
13102202|NCT03387059|25867052|FG000|Overall Study|Study termination|5|||
13102203|NCT03387059|25867053|FG001|Overall Study|Study termination|4|||
13102204|NCT03387046|25867084|FG000|Overall Study|Adverse Event|1|||
13102205|NCT03387046|25867085|FG001|Overall Study|Adverse Event|1|||
13102206|NCT03387020|25867122|FG000|Overall Study|Adverse Event|0|||
13102207|NCT03387020|25867123|FG001|Overall Study|Adverse Event|2|||
13102208|NCT03387020|25867124|FG002|Overall Study|Adverse Event|0|||
13102209|NCT03387020|25867122|FG000|Overall Study|Withdrawal by Subject|2|||
13102210|NCT03387020|25867123|FG001|Overall Study|Withdrawal by Subject|0|||
13102211|NCT03387020|25867124|FG002|Overall Study|Withdrawal by Subject|0|||
13102212|NCT03386994|25867190|FG000|Overall Study|Lung transplant|1|||
13102213|NCT03386994|25867190|FG000|Overall Study|Adverse Event|14|||
13102214|NCT03386994|25867190|FG000|Overall Study|Lost to Follow-up|4|||
13102215|NCT03386994|25867190|FG000|Overall Study|Withdrawal by Subject|3|||
13102216|NCT03386994|25867190|FG000|Overall Study|Death|16|||
13102217|NCT03386773|25867211|FG000|Overall Study|Lost to Follow-up|24|||
13102218|NCT03386773|25867212|FG001|Overall Study|Lost to Follow-up|33|||
13102219|NCT03386773|25867211|FG000|Overall Study|Withdrawal by Subject|3|||
13102220|NCT03386773|25867212|FG001|Overall Study|Withdrawal by Subject|2|||
13102221|NCT03386474|25867239|FG000|Overall Study|Death|1|||
13102222|NCT03386474|25867240|FG001|Overall Study|Death|0|||
13102223|NCT03386474|25867239|FG000|Overall Study|Adverse Event|0|||
13102224|NCT03386474|25867240|FG001|Overall Study|Adverse Event|1|||
13102225|NCT03386448|25867253|FG000|Overall Study|Adverse Event|0|||
13102226|NCT03386448|25867254|FG001|Overall Study|Adverse Event|2|||
13102227|NCT03386435|25867273|FG000|Overall Study|Protocol Violation|5|||
13102228|NCT03386435|25867274|FG001|Overall Study|Protocol Violation|7|||
13102229|NCT03386344|25867316|FG000|Overall Study|Adverse Event|6|||
13102230|NCT03386344|25867317|FG001|Overall Study|Adverse Event|3|||
13102231|NCT03386344|25867318|FG002|Overall Study|Adverse Event|1|||
13102232|NCT03386344|25867316|FG000|Overall Study|Poor Compliance to Protocol|0|||
13102233|NCT03386344|25867317|FG001|Overall Study|Poor Compliance to Protocol|1|||
13102234|NCT03386344|25867318|FG002|Overall Study|Poor Compliance to Protocol|0|||
13102235|NCT03386344|25867316|FG000|Overall Study|Study Terminated by Sponsor|101|||
13102236|NCT03386344|25867317|FG001|Overall Study|Study Terminated by Sponsor|102|||
13102237|NCT03386344|25867318|FG002|Overall Study|Study Terminated by Sponsor|106|||
13102238|NCT03386344|25867316|FG000|Overall Study|Lost to Follow-up|3|||
13102239|NCT03386344|25867317|FG001|Overall Study|Lost to Follow-up|2|||
13102240|NCT03386344|25867318|FG002|Overall Study|Lost to Follow-up|1|||
13102241|NCT03386344|25867316|FG000|Overall Study|At the Participant's own Request|7|||
13102242|NCT03386344|25867317|FG001|Overall Study|At the Participant's own Request|7|||
13102243|NCT03386344|25867318|FG002|Overall Study|At the Participant's own Request|8|||
13102244|NCT03386344|25867316|FG000|Overall Study|Reason not Specified|0|||
13102245|NCT03386344|25867317|FG001|Overall Study|Reason not Specified|1|||
13102246|NCT03386344|25867318|FG002|Overall Study|Reason not Specified|0|||
13102247|NCT03386032|25867339|FG000|Overall Study|Lack of Efficacy|6|||
13102248|NCT03386032|25867340|FG001|Overall Study|Lack of Efficacy|2|||
13102249|NCT03386032|25867341|FG002|Overall Study|Lack of Efficacy|0|||
13102250|NCT03386032|25867339|FG000|Overall Study|Adverse Event|2|||
13102251|NCT03386032|25867340|FG001|Overall Study|Adverse Event|2|||
13102252|NCT03386032|25867341|FG002|Overall Study|Adverse Event|0|||
13102253|NCT03386032|25867339|FG000|Overall Study|Withdrawal by Subject|1|||
13102254|NCT03386032|25867340|FG001|Overall Study|Withdrawal by Subject|0|||
13152488|NCT02534896|26054879|FG002|Overall Study|Adverse Event|1|||
13152489|NCT02534896|26054877|FG000|Overall Study|Insufficient therapeutic response|2|||
13152490|NCT02534896|26054878|FG001|Overall Study|Insufficient therapeutic response|0|||
13152491|NCT02534896|26054879|FG002|Overall Study|Insufficient therapeutic response|0|||
13152492|NCT02534883|26054902|FG000|Overall Study|Early Termination|8|||
13152493|NCT02534883|26054903|FG001|Overall Study|Early Termination|3|||
13152494|NCT02534493|26054914|FG000|Overall Study|Lost to Follow-up|1|||
13152495|NCT02534493|26054914|FG000|Overall Study|Withdrawal by Subject|1|||
13152496|NCT02534350|26054933|FG000|Overall Study|Randomized But Not Treated|1|||
13152497|NCT02534350|26054934|FG001|Overall Study|Randomized But Not Treated|0|||
13152498|NCT02534350|26054933|FG000|Overall Study|Protocol Violation|1|||
13152499|NCT02534350|26054934|FG001|Overall Study|Protocol Violation|0|||
13152500|NCT02534350|26054933|FG000|Overall Study|Withdrew Consent|2|||
13152501|NCT02534350|26054934|FG001|Overall Study|Withdrew Consent|0|||
13102255|NCT03386032|25867341|FG002|Overall Study|Withdrawal by Subject|0|||
13102256|NCT03386032|25867339|FG000|Overall Study|Lost to Follow-up|9|||
13102257|NCT03386032|25867340|FG001|Overall Study|Lost to Follow-up|3|||
13102258|NCT03386032|25867341|FG002|Overall Study|Lost to Follow-up|0|||
13152502|NCT02534324|26054951|FG000|Overall Study|Protocol Violation|4|||
13152503|NCT02534324|26054952|FG001|Overall Study|Protocol Violation|1|||
13102259|NCT03385564|25867404|FG000|Overall Study|Adverse Event|0|||
13102260|NCT03385564|25867405|FG001|Overall Study|Adverse Event|0|||
13102261|NCT03385564|25867406|FG002|Overall Study|Adverse Event|3|||
13102262|NCT03385564|25867407|FG003|Overall Study|Adverse Event|3|||
13102263|NCT03385564|25867404|FG000|Overall Study|Other than listed|0|||
13102264|NCT03385564|25867405|FG001|Overall Study|Other than listed|0|||
13102265|NCT03385564|25867406|FG002|Overall Study|Other than listed|0|||
13102266|NCT03385564|25867407|FG003|Overall Study|Other than listed|5|||
13102267|NCT03385564|25867404|FG000|Overall Study|Withdrawal by Subject|0|||
13102268|NCT03385564|25867405|FG001|Overall Study|Withdrawal by Subject|1|||
13102269|NCT03385564|25867406|FG002|Overall Study|Withdrawal by Subject|1|||
13102270|NCT03385564|25867407|FG003|Overall Study|Withdrawal by Subject|0|||
13102271|NCT03385564|25867404|FG000|Overall Study|Lack of Efficacy|0|||
13102272|NCT03385564|25867405|FG001|Overall Study|Lack of Efficacy|0|||
13102273|NCT03385564|25867406|FG002|Overall Study|Lack of Efficacy|0|||
13102274|NCT03385564|25867407|FG003|Overall Study|Lack of Efficacy|1|||
13102275|NCT03385564|25867404|FG000|Overall Study|Death|0|||
13102276|NCT03385564|25867405|FG001|Overall Study|Death|0|||
13102277|NCT03385564|25867406|FG002|Overall Study|Death|1|||
13102278|NCT03385564|25867407|FG003|Overall Study|Death|0|||
13102279|NCT03384966|25867452|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1|||
13102280|NCT03384966|25867453|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
13102281|NCT03384966|25867454|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
13102282|NCT03384966|25867452|FG000|Follow-up Period|Adverse Event|1|||
13102283|NCT03384966|25867453|FG001|Follow-up Period|Adverse Event|0|||
13102284|NCT03384966|25867454|FG002|Follow-up Period|Adverse Event|0|||
13102285|NCT03384940|25867515|FG000|Overall Study|Progressive disease|36|||
13102286|NCT03384940|25867516|FG001|Overall Study|Progressive disease|11|||
13102287|NCT03384940|25867517|FG002|Overall Study|Progressive disease|13|||
13102288|NCT03384940|25867515|FG000|Overall Study|Clinical progression|4|||
13102289|NCT03384940|25867516|FG001|Overall Study|Clinical progression|0|||
13102290|NCT03384940|25867517|FG002|Overall Study|Clinical progression|3|||
13102291|NCT03384940|25867515|FG000|Overall Study|Adverse Event|7|||
13102292|NCT03384940|25867516|FG001|Overall Study|Adverse Event|1|||
13102293|NCT03384940|25867517|FG002|Overall Study|Adverse Event|1|||
13102294|NCT03384940|25867515|FG000|Overall Study|Withdrawal by Subject|3|||
13102295|NCT03384940|25867516|FG001|Overall Study|Withdrawal by Subject|1|||
13102296|NCT03384940|25867517|FG002|Overall Study|Withdrawal by Subject|0|||
13102297|NCT03384940|25867515|FG000|Overall Study|Physician Decision|1|||
13102298|NCT03384940|25867516|FG001|Overall Study|Physician Decision|1|||
13102299|NCT03384940|25867517|FG002|Overall Study|Physician Decision|0|||
13102300|NCT03384940|25867515|FG000|Overall Study|Death|2|||
13102301|NCT03384940|25867516|FG001|Overall Study|Death|1|||
13102302|NCT03384940|25867517|FG002|Overall Study|Death|0|||
13102303|NCT03384940|25867515|FG000|Overall Study|Other|0|||
13102304|NCT03384940|25867516|FG001|Overall Study|Other|0|||
13102305|NCT03384940|25867517|FG002|Overall Study|Other|1|||
13102306|NCT03384745|25867571|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
13102307|NCT03384745|25867572|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
13102308|NCT03384745|25867573|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1|||
13102309|NCT03384745|25867574|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2|||
13102310|NCT03384745|25867575|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
13102311|NCT03384745|25867576|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
13102312|NCT03384745|25867571|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
13102313|NCT03384745|25867572|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
13102314|NCT03384745|25867573|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
13102315|NCT03384745|25867574|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
13102316|NCT03384745|25867575|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3|||
13102317|NCT03384745|25867576|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1|||
13102318|NCT03384745|25867571|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
13102319|NCT03384745|25867572|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
13102320|NCT03384745|25867573|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
13102321|NCT03384745|25867574|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
13102322|NCT03384745|25867575|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
13102323|NCT03384745|25867576|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
13102324|NCT03384745|25867571|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
13102325|NCT03384745|25867572|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
13102326|NCT03384745|25867573|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1|||
13102327|NCT03384745|25867574|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
13102328|NCT03384745|25867575|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
13152504|NCT02534324|26054951|FG000|Overall Study|Lost to Follow-up|20|||
13102329|NCT03384745|25867576|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
13102330|NCT03384745|25867571|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
13102331|NCT03384745|25867572|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
13102332|NCT03384745|25867573|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
13102333|NCT03384745|25867574|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
13102334|NCT03384745|25867575|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
13102335|NCT03384745|25867576|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
13102336|NCT03384745|25867571|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
13102337|NCT03384745|25867572|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
13102338|NCT03384745|25867573|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
13102339|NCT03384745|25867574|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
13102340|NCT03384745|25867575|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1|||
13102341|NCT03384745|25867576|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
13102342|NCT03384745|25867571|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
13102343|NCT03384745|25867572|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
13102344|NCT03384745|25867573|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
13102345|NCT03384745|25867574|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
13102346|NCT03384745|25867575|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
13102347|NCT03384745|25867576|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
13102348|NCT03384745|25867571|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
13102349|NCT03384745|25867572|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
13102350|NCT03384745|25867573|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3|||
13102351|NCT03384745|25867574|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
13102352|NCT03384745|25867575|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
13102353|NCT03384745|25867576|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
13102354|NCT03384745|25867571|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
13102355|NCT03384745|25867572|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
13102356|NCT03384745|25867573|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
13102357|NCT03384745|25867574|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
13102358|NCT03384745|25867575|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
13102359|NCT03384745|25867576|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
13102360|NCT03384745|25867571|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
13102361|NCT03384745|25867572|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
13102362|NCT03384745|25867573|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
13102363|NCT03384745|25867574|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2|||
13102364|NCT03384745|25867575|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
13102365|NCT03384745|25867576|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
13102366|NCT03384745|25867571|FG000|Response Assess/Dose Hold (W24-W48)|Death|0|||
13102367|NCT03384745|25867572|FG001|Response Assess/Dose Hold (W24-W48)|Death|1|||
13102368|NCT03384745|25867573|FG002|Response Assess/Dose Hold (W24-W48)|Death|0|||
13102369|NCT03384745|25867574|FG003|Response Assess/Dose Hold (W24-W48)|Death|0|||
13102370|NCT03384745|25867575|FG004|Response Assess/Dose Hold (W24-W48)|Death|0|||
13102371|NCT03384745|25867576|FG005|Response Assess/Dose Hold (W24-W48)|Death|0|||
13102372|NCT03384693|25867588|FG000|Overall Study|Adverse Event|3|||
13102373|NCT03384316|25867618|FG000|Overall Study|Screen failure|0|||
13102374|NCT03384316|25867619|FG001|Overall Study|Screen failure|1|||
13102375|NCT03383887|25867630|FG000|Overall Study|Lost to Follow-up|0|||
13102376|NCT03383887|25867631|FG001|Overall Study|Lost to Follow-up|1|||
13102377|NCT03383783|25867697|FG000|Overall Study|Withdrawal by Subject|2|||
13102378|NCT03383692|25867722|FG000|Overall Study|Progressive disease as per RECIST|3|||
13102379|NCT03383692|25867723|FG001|Overall Study|Progressive disease as per RECIST|3|||
13102380|NCT03383692|25867722|FG000|Overall Study|Clinical progression|0|||
13102381|NCT03383692|25867723|FG001|Overall Study|Clinical progression|1|||
13102382|NCT03383692|25867722|FG000|Overall Study|Adverse Event|3|||
13102383|NCT03383692|25867723|FG001|Overall Study|Adverse Event|0|||
13102384|NCT03383614|25867900|FG000|Overall Study|Withdrawal by Subject|0|||
13102385|NCT03383614|25867901|FG001|Overall Study|Withdrawal by Subject|1|||
13102386|NCT03383614|25867902|FG002|Overall Study|Withdrawal by Subject|0|||
13102387|NCT03383614|25867903|FG003|Overall Study|Withdrawal by Subject|0|||
13102388|NCT03383146|25867929|FG000|Overall Study|Screen Failure|1|||
13102389|NCT03383146|25867930|FG001|Overall Study|Screen Failure|0|||
13102390|NCT03383146|25867929|FG000|Overall Study|Adverse Event|6|||
13102391|NCT03383146|25867930|FG001|Overall Study|Adverse Event|18|||
13152505|NCT02534324|26054952|FG001|Overall Study|Lost to Follow-up|7|||
13152506|NCT02534324|26054951|FG000|Overall Study|Adverse Event|1|||
13152507|NCT02534324|26054952|FG001|Overall Study|Adverse Event|0|||
13152508|NCT02533999|26054977|FG000|Overall Study|Lost to Follow-up|3|||
13152509|NCT02533999|26054978|FG001|Overall Study|Lost to Follow-up|5|||
13152510|NCT02533999|26054977|FG000|Overall Study|Protocol Violation|3|||
13102392|NCT03383146|25867929|FG000|Overall Study|Lack of Efficacy|0|||
13152511|NCT02533999|26054978|FG001|Overall Study|Protocol Violation|0|||
13152512|NCT02533999|26054977|FG000|Overall Study|Adverse Event|0|||
13152513|NCT02533999|26054978|FG001|Overall Study|Adverse Event|1|||
13152514|NCT02533999|26054977|FG000|Overall Study|Randomized but intervention not received|0|||
13102393|NCT03383146|25867930|FG001|Overall Study|Lack of Efficacy|3|||
13102394|NCT03383146|25867929|FG000|Overall Study|Withdrawal by Subject|20|||
13102395|NCT03383146|25867930|FG001|Overall Study|Withdrawal by Subject|36|||
13102396|NCT03383146|25867929|FG000|Overall Study|Lost to Follow-up|5|||
13102397|NCT03383146|25867930|FG001|Overall Study|Lost to Follow-up|15|||
13102398|NCT03383146|25867929|FG000|Overall Study|Death|0|||
13102399|NCT03383146|25867930|FG001|Overall Study|Death|2|||
13102400|NCT03383146|25867929|FG000|Overall Study|Physician Decision|0|||
13102401|NCT03383146|25867930|FG001|Overall Study|Physician Decision|1|||
13102402|NCT03383146|25867929|FG000|Overall Study|Protocol Deviation|1|||
13102403|NCT03383146|25867930|FG001|Overall Study|Protocol Deviation|8|||
13102404|NCT03383146|25867929|FG000|Overall Study|Study Terminated by the Sponsor|48|||
13102405|NCT03383146|25867930|FG001|Overall Study|Study Terminated by the Sponsor|95|||
13102406|NCT03383146|25867929|FG000|Overall Study|Reason not Specified|4|||
13102407|NCT03383146|25867930|FG001|Overall Study|Reason not Specified|6|||
13102408|NCT03382912|25867951|FG000|Overall Study|Physician Decision|0|||
13102409|NCT03382912|25867952|FG001|Overall Study|Physician Decision|1|||
13102410|NCT03382912|25867951|FG000|Overall Study|Sponsor Decision|6|||
13102411|NCT03382912|25867952|FG001|Overall Study|Sponsor Decision|6|||
13102412|NCT03382912|25867951|FG000|Overall Study|Withdrawal by Subject|0|||
13102413|NCT03382912|25867952|FG001|Overall Study|Withdrawal by Subject|5|||
13102414|NCT03382899|25867973|FG000|Overall Study|Ineligibility Determined|0|||
13102415|NCT03382899|25867974|FG001|Overall Study|Ineligibility Determined|1|||
13102416|NCT03382899|25867973|FG000|Overall Study|Lost to Follow-up|0|||
13102417|NCT03382899|25867974|FG001|Overall Study|Lost to Follow-up|1|||
13102418|NCT03382899|25867973|FG000|Overall Study|Sponsor's decision|31|||
13102419|NCT03382899|25867974|FG001|Overall Study|Sponsor's decision|28|||
13102420|NCT03382899|25867973|FG000|Overall Study|Withdrawal by Subject|0|||
13102421|NCT03382899|25867974|FG001|Overall Study|Withdrawal by Subject|5|||
13102422|NCT03382418|25868073|FG000|Overall Study|Withdrawal by Subject|1|||
13102423|NCT03382418|25868074|FG001|Overall Study|Withdrawal by Subject|0|||
13102424|NCT03382418|25868075|FG002|Overall Study|Withdrawal by Subject|0|||
13102425|NCT03382418|25868073|FG000|Overall Study|Lost to Follow-up|2|||
13102426|NCT03382418|25868074|FG001|Overall Study|Lost to Follow-up|3|||
13102427|NCT03382418|25868075|FG002|Overall Study|Lost to Follow-up|0|||
13102428|NCT03382262|25868102|FG000|Overall Study|Physician Decision|0|||
13152515|NCT02533999|26054978|FG001|Overall Study|Randomized but intervention not received|1|||
13152516|NCT02533674|26055029|FG000|Dose Level I|Progressive disease|1|||
13152517|NCT02533674|26055030|FG001|Dose Level I|Progressive disease|0|||
13152518|NCT02533674|26055031|FG002|Dose Level I|Progressive disease|0|||
13152519|NCT02533674|26055032|FG003|Dose Level I|Progressive disease|0|||
13152520|NCT02533674|26055033|FG004|Dose Level I|Progressive disease|0|||
13152521|NCT02533674|26055034|FG005|Dose Level I|Progressive disease|0|||
13152522|NCT02533674|26055035|FG006|Dose Level I|Progressive disease|0|||
13152523|NCT02533674|26055036|FG007|Dose Level I|Progressive disease|0|||
13152524|NCT02533674|26055029|FG000|Dose Level I|Withdrawal by Subject|1|||
13152525|NCT02533674|26055030|FG001|Dose Level I|Withdrawal by Subject|0|||
13152526|NCT02533674|26055031|FG002|Dose Level I|Withdrawal by Subject|0|||
13152527|NCT02533674|26055032|FG003|Dose Level I|Withdrawal by Subject|0|||
13152528|NCT02533674|26055033|FG004|Dose Level I|Withdrawal by Subject|0|||
13152529|NCT02533674|26055034|FG005|Dose Level I|Withdrawal by Subject|0|||
13152530|NCT02533674|26055035|FG006|Dose Level I|Withdrawal by Subject|0|||
13152531|NCT02533674|26055036|FG007|Dose Level I|Withdrawal by Subject|0|||
13152532|NCT02533674|26055029|FG000|Dose Level I|Physician Decision|1|||
13152533|NCT02533674|26055030|FG001|Dose Level I|Physician Decision|0|||
13152534|NCT02533674|26055031|FG002|Dose Level I|Physician Decision|0|||
13152535|NCT02533674|26055032|FG003|Dose Level I|Physician Decision|0|||
13152536|NCT02533674|26055033|FG004|Dose Level I|Physician Decision|0|||
13152537|NCT02533674|26055034|FG005|Dose Level I|Physician Decision|0|||
13152538|NCT02533674|26055035|FG006|Dose Level I|Physician Decision|0|||
13152539|NCT02533674|26055036|FG007|Dose Level I|Physician Decision|0|||
13152540|NCT02533674|26055029|FG000|Dose Level I|Death|1|||
13152541|NCT02533674|26055030|FG001|Dose Level I|Death|0|||
13152542|NCT02533674|26055031|FG002|Dose Level I|Death|0|||
13152543|NCT02533674|26055032|FG003|Dose Level I|Death|0|||
13152544|NCT02533674|26055033|FG004|Dose Level I|Death|0|||
13152545|NCT02533674|26055034|FG005|Dose Level I|Death|0|||
13102429|NCT03382262|25868103|FG001|Overall Study|Physician Decision|0|||
13102430|NCT03382262|25868104|FG002|Overall Study|Physician Decision|1|||
13102431|NCT03382262|25868105|FG003|Overall Study|Physician Decision|0|||
13152546|NCT02533674|26055035|FG006|Dose Level I|Death|0|||
13152547|NCT02533674|26055036|FG007|Dose Level I|Death|0|||
13152548|NCT02533674|26055029|FG000|Dose Level I|Never Treated|1|||
13152549|NCT02533674|26055030|FG001|Dose Level I|Never Treated|0|||
13152550|NCT02533674|26055031|FG002|Dose Level I|Never Treated|0|||
13152551|NCT02533674|26055032|FG003|Dose Level I|Never Treated|0|||
13152552|NCT02533674|26055033|FG004|Dose Level I|Never Treated|0|||
13152553|NCT02533674|26055034|FG005|Dose Level I|Never Treated|0|||
13152554|NCT02533674|26055035|FG006|Dose Level I|Never Treated|0|||
13102432|NCT03382262|25868102|FG000|Overall Study|Withdrawal by Subject|0|||
13102433|NCT03382262|25868103|FG001|Overall Study|Withdrawal by Subject|0|||
13152555|NCT02533674|26055036|FG007|Dose Level I|Never Treated|0|||
13152556|NCT02533674|26055029|FG000|Dose Level II|Progressive disease|0|||
13152557|NCT02533674|26055030|FG001|Dose Level II|Progressive disease|3|||
13152558|NCT02533674|26055031|FG002|Dose Level II|Progressive disease|0|||
13152559|NCT02533674|26055032|FG003|Dose Level II|Progressive disease|0|||
13152560|NCT02533674|26055033|FG004|Dose Level II|Progressive disease|0|||
13152561|NCT02533674|26055034|FG005|Dose Level II|Progressive disease|0|||
13152562|NCT02533674|26055035|FG006|Dose Level II|Progressive disease|0|||
13152563|NCT02533674|26055036|FG007|Dose Level II|Progressive disease|0|||
13152564|NCT02533674|26055029|FG000|Dose Level II|Withdrawal by Subject|0|||
13152565|NCT02533674|26055030|FG001|Dose Level II|Withdrawal by Subject|1|||
13152566|NCT02533674|26055031|FG002|Dose Level II|Withdrawal by Subject|0|||
13152567|NCT02533674|26055032|FG003|Dose Level II|Withdrawal by Subject|0|||
13152568|NCT02533674|26055033|FG004|Dose Level II|Withdrawal by Subject|0|||
13152569|NCT02533674|26055034|FG005|Dose Level II|Withdrawal by Subject|0|||
13152570|NCT02533674|26055035|FG006|Dose Level II|Withdrawal by Subject|0|||
13152571|NCT02533674|26055036|FG007|Dose Level II|Withdrawal by Subject|0|||
13152572|NCT02533674|26055029|FG000|Dose Level II|Treatment-related AE|0|||
13152573|NCT02533674|26055030|FG001|Dose Level II|Treatment-related AE|1|||
13152574|NCT02533674|26055031|FG002|Dose Level II|Treatment-related AE|0|||
13152575|NCT02533674|26055032|FG003|Dose Level II|Treatment-related AE|0|||
13152576|NCT02533674|26055033|FG004|Dose Level II|Treatment-related AE|0|||
13152577|NCT02533674|26055034|FG005|Dose Level II|Treatment-related AE|0|||
13152578|NCT02533674|26055035|FG006|Dose Level II|Treatment-related AE|0|||
13152579|NCT02533674|26055036|FG007|Dose Level II|Treatment-related AE|0|||
13152580|NCT02533674|26055029|FG000|Dose Level II|Physician Decision|0|||
13152581|NCT02533674|26055030|FG001|Dose Level II|Physician Decision|1|||
13152582|NCT02533674|26055031|FG002|Dose Level II|Physician Decision|0|||
13152583|NCT02533674|26055032|FG003|Dose Level II|Physician Decision|0|||
13152584|NCT02533674|26055033|FG004|Dose Level II|Physician Decision|0|||
13152585|NCT02533674|26055034|FG005|Dose Level II|Physician Decision|0|||
13152586|NCT02533674|26055035|FG006|Dose Level II|Physician Decision|0|||
13152587|NCT02533674|26055036|FG007|Dose Level II|Physician Decision|0|||
13152588|NCT02533674|26055029|FG000|Dose Level II|Non-treatment-related AE|0|||
13152589|NCT02533674|26055030|FG001|Dose Level II|Non-treatment-related AE|1|||
13152590|NCT02533674|26055031|FG002|Dose Level II|Non-treatment-related AE|0|||
13152591|NCT02533674|26055032|FG003|Dose Level II|Non-treatment-related AE|0|||
13152592|NCT02533674|26055033|FG004|Dose Level II|Non-treatment-related AE|0|||
13152593|NCT02533674|26055034|FG005|Dose Level II|Non-treatment-related AE|0|||
13152594|NCT02533674|26055035|FG006|Dose Level II|Non-treatment-related AE|0|||
13152595|NCT02533674|26055036|FG007|Dose Level II|Non-treatment-related AE|0|||
13152596|NCT02533674|26055029|FG000|Dose Level III|Progressive disease|0|||
13152597|NCT02533674|26055030|FG001|Dose Level III|Progressive disease|0|||
13152598|NCT02533674|26055031|FG002|Dose Level III|Progressive disease|2|||
13152599|NCT02533674|26055032|FG003|Dose Level III|Progressive disease|0|||
13152600|NCT02533674|26055033|FG004|Dose Level III|Progressive disease|0|||
13152601|NCT02533674|26055034|FG005|Dose Level III|Progressive disease|0|||
13152602|NCT02533674|26055035|FG006|Dose Level III|Progressive disease|0|||
13152603|NCT02533674|26055036|FG007|Dose Level III|Progressive disease|0|||
13152604|NCT02533674|26055029|FG000|Dose Level III|Withdrawal by Subject|0|||
13152605|NCT02533674|26055030|FG001|Dose Level III|Withdrawal by Subject|0|||
13152606|NCT02533674|26055031|FG002|Dose Level III|Withdrawal by Subject|1|||
13152607|NCT02533674|26055032|FG003|Dose Level III|Withdrawal by Subject|0|||
13152608|NCT02533674|26055033|FG004|Dose Level III|Withdrawal by Subject|0|||
13152609|NCT02533674|26055034|FG005|Dose Level III|Withdrawal by Subject|0|||
13152610|NCT02533674|26055035|FG006|Dose Level III|Withdrawal by Subject|0|||
13102434|NCT03382262|25868104|FG002|Overall Study|Withdrawal by Subject|0|||
13102435|NCT03382262|25868105|FG003|Overall Study|Withdrawal by Subject|1|||
13102436|NCT03382041|25868162|FG000|Overall Study|Consent Form Lost|2|||
13102437|NCT03382041|25868163|FG001|Overall Study|Consent Form Lost|1|||
13102438|NCT03382041|25868162|FG000|Overall Study|Withdrawal by Subject|1|||
13102439|NCT03382041|25868163|FG001|Overall Study|Withdrawal by Subject|4|||
13152611|NCT02533674|26055036|FG007|Dose Level III|Withdrawal by Subject|0|||
13152612|NCT02533674|26055029|FG000|Dose Level III|Treatment-related AE|0|||
13152613|NCT02533674|26055030|FG001|Dose Level III|Treatment-related AE|0|||
13152614|NCT02533674|26055031|FG002|Dose Level III|Treatment-related AE|1|||
13152615|NCT02533674|26055032|FG003|Dose Level III|Treatment-related AE|0|||
13152616|NCT02533674|26055033|FG004|Dose Level III|Treatment-related AE|0|||
13152617|NCT02533674|26055034|FG005|Dose Level III|Treatment-related AE|0|||
13152618|NCT02533674|26055035|FG006|Dose Level III|Treatment-related AE|0|||
13152619|NCT02533674|26055036|FG007|Dose Level III|Treatment-related AE|0|||
13152620|NCT02533674|26055029|FG000|Dose Level IV|Progressive disease|0|||
13152621|NCT02533674|26055030|FG001|Dose Level IV|Progressive disease|0|||
13152622|NCT02533674|26055031|FG002|Dose Level IV|Progressive disease|0|||
13102440|NCT03382041|25868162|FG000|Overall Study|Lost to Follow-up|1|||
13102441|NCT03382041|25868163|FG001|Overall Study|Lost to Follow-up|4|||
13102442|NCT03381339|25868176|FG000|Overall Study|Protocol Violation|4|||
13102443|NCT03381339|25868177|FG001|Overall Study|Protocol Violation|3|||
13102444|NCT03381339|25868176|FG000|Overall Study|Lost to Follow-up|0|||
13102445|NCT03381339|25868177|FG001|Overall Study|Lost to Follow-up|1|||
13102446|NCT03381274|25868276|FG000|Overall Study|Death|2|||
13152623|NCT02533674|26055032|FG003|Dose Level IV|Progressive disease|3|||
13152624|NCT02533674|26055033|FG004|Dose Level IV|Progressive disease|0|||
13152625|NCT02533674|26055034|FG005|Dose Level IV|Progressive disease|0|||
13152626|NCT02533674|26055035|FG006|Dose Level IV|Progressive disease|0|||
13152627|NCT02533674|26055036|FG007|Dose Level IV|Progressive disease|0|||
13152628|NCT02533674|26055029|FG000|Dose Level IV|Withdrawal by Subject|0|||
13152629|NCT02533674|26055030|FG001|Dose Level IV|Withdrawal by Subject|0|||
13152630|NCT02533674|26055031|FG002|Dose Level IV|Withdrawal by Subject|0|||
13152631|NCT02533674|26055032|FG003|Dose Level IV|Withdrawal by Subject|1|||
13152632|NCT02533674|26055033|FG004|Dose Level IV|Withdrawal by Subject|0|||
13152633|NCT02533674|26055034|FG005|Dose Level IV|Withdrawal by Subject|0|||
13102447|NCT03381274|25868277|FG001|Overall Study|Death|9|||
13102448|NCT03381274|25868278|FG002|Overall Study|Death|3|||
13102449|NCT03381274|25868279|FG003|Overall Study|Death|2|||
13102450|NCT03381274|25868280|FG004|Overall Study|Death|3|||
13102451|NCT03381274|25868276|FG000|Overall Study|Lost to Follow-up|0|||
13102452|NCT03381274|25868277|FG001|Overall Study|Lost to Follow-up|0|||
13102453|NCT03381274|25868278|FG002|Overall Study|Lost to Follow-up|0|||
13102454|NCT03381274|25868279|FG003|Overall Study|Lost to Follow-up|1|||
13102455|NCT03381274|25868280|FG004|Overall Study|Lost to Follow-up|0|||
13102456|NCT03381274|25868276|FG000|Overall Study|Withdrawal by Subject|2|||
13102457|NCT03381274|25868277|FG001|Overall Study|Withdrawal by Subject|1|||
13102458|NCT03381274|25868278|FG002|Overall Study|Withdrawal by Subject|3|||
13102459|NCT03381274|25868279|FG003|Overall Study|Withdrawal by Subject|1|||
13102460|NCT03381274|25868280|FG004|Overall Study|Withdrawal by Subject|0|||
13102461|NCT03381274|25868276|FG000|Overall Study|Other|1|||
13102462|NCT03381274|25868277|FG001|Overall Study|Other|11|||
13102463|NCT03381274|25868278|FG002|Overall Study|Other|0|||
13102464|NCT03381274|25868279|FG003|Overall Study|Other|2|||
13102465|NCT03381274|25868280|FG004|Overall Study|Other|2|||
13102466|NCT03381248|25868301|FG000|Overall Study|Withdrawal by Subject|5|||
13102467|NCT03381248|25868302|FG001|Overall Study|Withdrawal by Subject|3|||
13102468|NCT03381248|25868301|FG000|Overall Study|Lost to Follow-up|3|||
13102469|NCT03381248|25868302|FG001|Overall Study|Lost to Follow-up|2|||
13102470|NCT03381248|25868301|FG000|Overall Study|Lack of Efficacy|1|||
13102471|NCT03381248|25868302|FG001|Overall Study|Lack of Efficacy|0|||
13102472|NCT03381248|25868301|FG000|Overall Study|Adverse Event|2|||
13102473|NCT03381248|25868302|FG001|Overall Study|Adverse Event|0|||
13102474|NCT03381248|25868301|FG000|Overall Study|Protocol Violation|2|||
13102475|NCT03381248|25868302|FG001|Overall Study|Protocol Violation|1|||
13102476|NCT03381196|25868330|FG000|Overall Study|Withdrawal by Subject|7|||
13102477|NCT03381196|25868331|FG001|Overall Study|Withdrawal by Subject|7|||
13102478|NCT03381196|25868330|FG000|Overall Study|Other|0|||
13102479|NCT03381196|25868331|FG001|Overall Study|Other|1|||
13102480|NCT03381196|25868330|FG000|Overall Study|Lost to Follow-up|5|||
13102481|NCT03381196|25868331|FG001|Overall Study|Lost to Follow-up|4|||
13102482|NCT03381196|25868330|FG000|Overall Study|Death|0|||
13102483|NCT03381196|25868331|FG001|Overall Study|Death|1|||
13102484|NCT03381196|25868330|FG000|Overall Study|Adverse Event|1|||
13102485|NCT03381196|25868331|FG001|Overall Study|Adverse Event|0|||
13102486|NCT03381196|25868330|FG000|Overall Study|Randomized, not treated|3|||
13102487|NCT03381196|25868331|FG001|Overall Study|Randomized, not treated|6|||
13102488|NCT03380429|25868400|FG000|Overall Study|Physician Decision|0|||
13102489|NCT03380429|25868401|FG001|Overall Study|Physician Decision|1|||
13102490|NCT03380429|25868402|FG002|Overall Study|Physician Decision|0|||
13102491|NCT03380429|25868403|FG003|Overall Study|Physician Decision|1|||
13102492|NCT03380429|25868404|FG004|Overall Study|Physician Decision|1|||
13102493|NCT03380429|25868400|FG000|Overall Study|Withdrawal by Subject|3|||
13102494|NCT03380429|25868401|FG001|Overall Study|Withdrawal by Subject|3|||
13102495|NCT03380429|25868402|FG002|Overall Study|Withdrawal by Subject|5|||
13102496|NCT03380429|25868403|FG003|Overall Study|Withdrawal by Subject|2|||
13102497|NCT03380429|25868404|FG004|Overall Study|Withdrawal by Subject|1|||
13102498|NCT03380429|25868400|FG000|Overall Study|Lost to Follow-up|0|||
13102499|NCT03380429|25868401|FG001|Overall Study|Lost to Follow-up|2|||
13102500|NCT03380429|25868402|FG002|Overall Study|Lost to Follow-up|4|||
13102501|NCT03380429|25868403|FG003|Overall Study|Lost to Follow-up|3|||
13152634|NCT02533674|26055035|FG006|Dose Level IV|Withdrawal by Subject|0|||
13152635|NCT02533674|26055036|FG007|Dose Level IV|Withdrawal by Subject|0|||
13102502|NCT03380429|25868404|FG004|Overall Study|Lost to Follow-up|1|||
13102503|NCT03380429|25868400|FG000|Overall Study|Protocol Violation|1|||
13102504|NCT03380429|25868401|FG001|Overall Study|Protocol Violation|0|||
13102505|NCT03380429|25868402|FG002|Overall Study|Protocol Violation|1|||
13102506|NCT03380429|25868403|FG003|Overall Study|Protocol Violation|0|||
13102507|NCT03380429|25868404|FG004|Overall Study|Protocol Violation|1|||
13152636|NCT02533674|26055029|FG000|Dose Level IV|Physician Decision|0|||
13152637|NCT02533674|26055030|FG001|Dose Level IV|Physician Decision|0|||
13152638|NCT02533674|26055031|FG002|Dose Level IV|Physician Decision|0|||
13152639|NCT02533674|26055032|FG003|Dose Level IV|Physician Decision|1|||
13152640|NCT02533674|26055033|FG004|Dose Level IV|Physician Decision|0|||
13152641|NCT02533674|26055034|FG005|Dose Level IV|Physician Decision|0|||
13152642|NCT02533674|26055035|FG006|Dose Level IV|Physician Decision|0|||
13152643|NCT02533674|26055036|FG007|Dose Level IV|Physician Decision|0|||
13152644|NCT02533674|26055029|FG000|Dose Level V|Progressive disease|0|||
13152645|NCT02533674|26055030|FG001|Dose Level V|Progressive disease|0|||
13152646|NCT02533674|26055031|FG002|Dose Level V|Progressive disease|0|||
13152647|NCT02533674|26055032|FG003|Dose Level V|Progressive disease|0|||
13152648|NCT02533674|26055033|FG004|Dose Level V|Progressive disease|3|||
13152649|NCT02533674|26055034|FG005|Dose Level V|Progressive disease|0|||
13152650|NCT02533674|26055035|FG006|Dose Level V|Progressive disease|0|||
13152651|NCT02533674|26055036|FG007|Dose Level V|Progressive disease|0|||
13152652|NCT02533674|26055029|FG000|Dose Level V|Withdrawal by Subject|0|||
13152653|NCT02533674|26055030|FG001|Dose Level V|Withdrawal by Subject|0|||
13152654|NCT02533674|26055031|FG002|Dose Level V|Withdrawal by Subject|0|||
13152655|NCT02533674|26055032|FG003|Dose Level V|Withdrawal by Subject|0|||
13152656|NCT02533674|26055033|FG004|Dose Level V|Withdrawal by Subject|1|||
13152657|NCT02533674|26055034|FG005|Dose Level V|Withdrawal by Subject|0|||
13152658|NCT02533674|26055035|FG006|Dose Level V|Withdrawal by Subject|0|||
13152659|NCT02533674|26055036|FG007|Dose Level V|Withdrawal by Subject|0|||
13152660|NCT02533674|26055029|FG000|Dose Level V|Physician Decision|0|||
13152661|NCT02533674|26055030|FG001|Dose Level V|Physician Decision|0|||
13152662|NCT02533674|26055031|FG002|Dose Level V|Physician Decision|0|||
13152663|NCT02533674|26055032|FG003|Dose Level V|Physician Decision|0|||
13152664|NCT02533674|26055033|FG004|Dose Level V|Physician Decision|1|||
13152665|NCT02533674|26055034|FG005|Dose Level V|Physician Decision|0|||
13152666|NCT02533674|26055035|FG006|Dose Level V|Physician Decision|0|||
13152667|NCT02533674|26055036|FG007|Dose Level V|Physician Decision|0|||
13152668|NCT02533674|26055029|FG000|Dose Level VI|Progressive disease|0|||
13152669|NCT02533674|26055030|FG001|Dose Level VI|Progressive disease|0|||
13152670|NCT02533674|26055031|FG002|Dose Level VI|Progressive disease|0|||
13152671|NCT02533674|26055032|FG003|Dose Level VI|Progressive disease|0|||
13152672|NCT02533674|26055033|FG004|Dose Level VI|Progressive disease|0|||
13152673|NCT02533674|26055034|FG005|Dose Level VI|Progressive disease|7|||
13152674|NCT02533674|26055035|FG006|Dose Level VI|Progressive disease|0|||
13152675|NCT02533674|26055036|FG007|Dose Level VI|Progressive disease|0|||
13152676|NCT02533674|26055029|FG000|Dose Level VI|Withdrawal by Subject|0|||
13152677|NCT02533674|26055030|FG001|Dose Level VI|Withdrawal by Subject|0|||
13152678|NCT02533674|26055031|FG002|Dose Level VI|Withdrawal by Subject|0|||
13152679|NCT02533674|26055032|FG003|Dose Level VI|Withdrawal by Subject|0|||
13152680|NCT02533674|26055033|FG004|Dose Level VI|Withdrawal by Subject|0|||
13152681|NCT02533674|26055034|FG005|Dose Level VI|Withdrawal by Subject|1|||
13152682|NCT02533674|26055035|FG006|Dose Level VI|Withdrawal by Subject|0|||
13152683|NCT02533674|26055036|FG007|Dose Level VI|Withdrawal by Subject|0|||
13152684|NCT02533674|26055029|FG000|Dose Level VI|Treatment-related AE|0|||
13152685|NCT02533674|26055030|FG001|Dose Level VI|Treatment-related AE|0|||
13152686|NCT02533674|26055031|FG002|Dose Level VI|Treatment-related AE|0|||
13152687|NCT02533674|26055032|FG003|Dose Level VI|Treatment-related AE|0|||
13152688|NCT02533674|26055033|FG004|Dose Level VI|Treatment-related AE|0|||
13152689|NCT02533674|26055034|FG005|Dose Level VI|Treatment-related AE|1|||
13152690|NCT02533674|26055035|FG006|Dose Level VI|Treatment-related AE|0|||
13152691|NCT02533674|26055036|FG007|Dose Level VI|Treatment-related AE|0|||
13152692|NCT02533674|26055029|FG000|Dose Level VII|Progressive disease|0|||
13102508|NCT03380429|25868400|FG000|Overall Study|Lack of Efficacy|0|||
13102509|NCT03380429|25868401|FG001|Overall Study|Lack of Efficacy|0|||
13102510|NCT03380429|25868402|FG002|Overall Study|Lack of Efficacy|0|||
13102511|NCT03380429|25868403|FG003|Overall Study|Lack of Efficacy|2|||
13102512|NCT03380429|25868404|FG004|Overall Study|Lack of Efficacy|1|||
13102513|NCT03380429|25868400|FG000|Overall Study|Adverse Event|1|||
13102514|NCT03380429|25868401|FG001|Overall Study|Adverse Event|1|||
13102515|NCT03380429|25868402|FG002|Overall Study|Adverse Event|1|||
13152693|NCT02533674|26055030|FG001|Dose Level VII|Progressive disease|0|||
13152694|NCT02533674|26055031|FG002|Dose Level VII|Progressive disease|0|||
13152695|NCT02533674|26055032|FG003|Dose Level VII|Progressive disease|0|||
13152696|NCT02533674|26055033|FG004|Dose Level VII|Progressive disease|0|||
13152697|NCT02533674|26055034|FG005|Dose Level VII|Progressive disease|0|||
13152698|NCT02533674|26055035|FG006|Dose Level VII|Progressive disease|10|||
13152699|NCT02533674|26055036|FG007|Dose Level VII|Progressive disease|0|||
13152700|NCT02533674|26055029|FG000|Dose Level VII|Withdrawal by Subject|0|||
13102516|NCT03380429|25868403|FG003|Overall Study|Adverse Event|2|||
13102517|NCT03380429|25868404|FG004|Overall Study|Adverse Event|0|||
13152701|NCT02533674|26055030|FG001|Dose Level VII|Withdrawal by Subject|0|||
13152702|NCT02533674|26055031|FG002|Dose Level VII|Withdrawal by Subject|0|||
13102518|NCT03380390|25868412|FG000|Overall Study|Adverse Event|3|||
13102519|NCT03380091|25868431|FG000|Overall Study|Withdrawal by Subject|2|||
13102520|NCT03380091|25868432|FG001|Overall Study|Withdrawal by Subject|1|||
13132931|NCT02781584|25985800|FG008|Treatment Phase|Adverse Event|0|||
13132932|NCT02781584|25985801|FG009|Treatment Phase|Adverse Event|0|||
13132933|NCT02781584|25985802|FG010|Treatment Phase|Adverse Event|0|||
13132934|NCT02781584|25985803|FG011|Treatment Phase|Adverse Event|0|||
13132935|NCT02781584|25985804|FG012|Treatment Phase|Adverse Event|0|||
13132936|NCT02781558|25985847|FG000|Overall Study|Lost to Follow-up|2|||
13132937|NCT02781558|25985848|FG001|Overall Study|Lost to Follow-up|2|||
13132938|NCT02781558|25985847|FG000|Overall Study|Adverse Event|1|||
13132939|NCT02781558|25985848|FG001|Overall Study|Adverse Event|0|||
13132940|NCT02781506|25985864|FG000|Overall Study|Adverse Event|5|||
13132941|NCT02781324|25985897|FG000|Overall Study|Withdrawal by Subject|1|||
13132942|NCT02781324|25985898|FG001|Overall Study|Withdrawal by Subject|0|||
13132943|NCT02781324|25985897|FG000|Overall Study|Physician Decision|1|||
13132944|NCT02781324|25985898|FG001|Overall Study|Physician Decision|2|||
13132945|NCT02781311|25985917|FG000|Overall Study|Adverse Event|2|||
13132946|NCT02781311|25985918|FG001|Overall Study|Adverse Event|6|||
13132947|NCT02781311|25985919|FG002|Overall Study|Adverse Event|1|||
13132948|NCT02781311|25985917|FG000|Overall Study|Withdrawal of Consent|11|||
13132949|NCT02781311|25985918|FG001|Overall Study|Withdrawal of Consent|12|||
13132950|NCT02781311|25985919|FG002|Overall Study|Withdrawal of Consent|2|||
13132951|NCT02781311|25985917|FG000|Overall Study|Lost to Follow-up|11|||
13152703|NCT02533674|26055032|FG003|Dose Level VII|Withdrawal by Subject|0|||
13152704|NCT02533674|26055033|FG004|Dose Level VII|Withdrawal by Subject|0|||
13152705|NCT02533674|26055034|FG005|Dose Level VII|Withdrawal by Subject|0|||
13152706|NCT02533674|26055035|FG006|Dose Level VII|Withdrawal by Subject|3|||
13152707|NCT02533674|26055036|FG007|Dose Level VII|Withdrawal by Subject|0|||
13152708|NCT02533674|26055029|FG000|Dose Level VII|Treatment-related AE|0|||
13152709|NCT02533674|26055030|FG001|Dose Level VII|Treatment-related AE|0|||
13152710|NCT02533674|26055031|FG002|Dose Level VII|Treatment-related AE|0|||
13152711|NCT02533674|26055032|FG003|Dose Level VII|Treatment-related AE|0|||
13152712|NCT02533674|26055033|FG004|Dose Level VII|Treatment-related AE|0|||
13152713|NCT02533674|26055034|FG005|Dose Level VII|Treatment-related AE|0|||
13152714|NCT02533674|26055035|FG006|Dose Level VII|Treatment-related AE|1|||
13152715|NCT02533674|26055036|FG007|Dose Level VII|Treatment-related AE|0|||
13152716|NCT02533674|26055029|FG000|Dose Level VII|Death|0|||
13152717|NCT02533674|26055030|FG001|Dose Level VII|Death|0|||
13152718|NCT02533674|26055031|FG002|Dose Level VII|Death|0|||
13152719|NCT02533674|26055032|FG003|Dose Level VII|Death|0|||
13152720|NCT02533674|26055033|FG004|Dose Level VII|Death|0|||
13152721|NCT02533674|26055034|FG005|Dose Level VII|Death|0|||
13152722|NCT02533674|26055035|FG006|Dose Level VII|Death|2|||
13152723|NCT02533674|26055036|FG007|Dose Level VII|Death|0|||
13152724|NCT02533674|26055029|FG000|Dose Level VIII|Progressive disease|0|||
13152725|NCT02533674|26055030|FG001|Dose Level VIII|Progressive disease|0|||
13152726|NCT02533674|26055031|FG002|Dose Level VIII|Progressive disease|0|||
13152727|NCT02533674|26055032|FG003|Dose Level VIII|Progressive disease|0|||
13152728|NCT02533674|26055033|FG004|Dose Level VIII|Progressive disease|0|||
13152729|NCT02533674|26055034|FG005|Dose Level VIII|Progressive disease|0|||
13152730|NCT02533674|26055035|FG006|Dose Level VIII|Progressive disease|0|||
13152731|NCT02533674|26055036|FG007|Dose Level VIII|Progressive disease|3|||
13152732|NCT02533674|26055029|FG000|Dose Level VIII|Withdrawal by Subject|0|||
13152733|NCT02533674|26055030|FG001|Dose Level VIII|Withdrawal by Subject|0|||
13152734|NCT02533674|26055031|FG002|Dose Level VIII|Withdrawal by Subject|0|||
13152735|NCT02533674|26055032|FG003|Dose Level VIII|Withdrawal by Subject|0|||
13152736|NCT02533674|26055033|FG004|Dose Level VIII|Withdrawal by Subject|0|||
13152737|NCT02533674|26055034|FG005|Dose Level VIII|Withdrawal by Subject|0|||
13152738|NCT02533674|26055035|FG006|Dose Level VIII|Withdrawal by Subject|0|||
13152739|NCT02533674|26055036|FG007|Dose Level VIII|Withdrawal by Subject|1|||
13152740|NCT02533674|26055029|FG000|Dose Level VIII|Treatment-related AE|0|||
13152741|NCT02533674|26055030|FG001|Dose Level VIII|Treatment-related AE|0|||
13152742|NCT02533674|26055031|FG002|Dose Level VIII|Treatment-related AE|0|||
13152743|NCT02533674|26055032|FG003|Dose Level VIII|Treatment-related AE|0|||
13132952|NCT02781311|25985918|FG001|Overall Study|Lost to Follow-up|8|||
13132953|NCT02781311|25985919|FG002|Overall Study|Lost to Follow-up|1|||
13132954|NCT02781311|25985917|FG000|Overall Study|Non-Compliance with Study Drug|2|||
13132955|NCT02781311|25985918|FG001|Overall Study|Non-Compliance with Study Drug|0|||
13132956|NCT02781311|25985919|FG002|Overall Study|Non-Compliance with Study Drug|0|||
13152744|NCT02533674|26055033|FG004|Dose Level VIII|Treatment-related AE|0|||
13152745|NCT02533674|26055034|FG005|Dose Level VIII|Treatment-related AE|0|||
13152746|NCT02533674|26055035|FG006|Dose Level VIII|Treatment-related AE|0|||
13152747|NCT02533674|26055036|FG007|Dose Level VIII|Treatment-related AE|1|||
13152748|NCT02533674|26055029|FG000|Dose Level VIII|Never treated|0|||
13152749|NCT02533674|26055030|FG001|Dose Level VIII|Never treated|0|||
13152750|NCT02533674|26055031|FG002|Dose Level VIII|Never treated|0|||
13152751|NCT02533674|26055032|FG003|Dose Level VIII|Never treated|0|||
13102521|NCT03379753|25868445|FG000|Overall Study|Withdrawal by Subject|2|||
13102522|NCT03379753|25868446|FG001|Overall Study|Withdrawal by Subject|1|||
13102523|NCT03379753|25868445|FG000|Overall Study|not having correct procedure|1|||
13102524|NCT03379753|25868446|FG001|Overall Study|not having correct procedure|2|||
13102525|NCT03379753|25868445|FG000|Overall Study|No primary outcome|12|||
13102526|NCT03379753|25868446|FG001|Overall Study|No primary outcome|22|||
13102527|NCT03379675|25868578|FG000|Overall Study|Lost to Follow-up|0|||
13102528|NCT03379675|25868579|FG001|Overall Study|Lost to Follow-up|1|||
13102529|NCT03379675|25868580|FG002|Overall Study|Lost to Follow-up|0|||
13102530|NCT03379675|25868578|FG000|Overall Study|Adverse Event|2|||
13102531|NCT03379675|25868579|FG001|Overall Study|Adverse Event|0|||
13102532|NCT03379675|25868580|FG002|Overall Study|Adverse Event|0|||
13102533|NCT03379675|25868578|FG000|Overall Study|Withdrawal by Subject|2|||
13102534|NCT03379675|25868579|FG001|Overall Study|Withdrawal by Subject|1|||
13102535|NCT03379675|25868580|FG002|Overall Study|Withdrawal by Subject|2|||
13102536|NCT03379376|25868590|FG000|Overall Study|Lost to Follow-up|2|||
13102537|NCT03379376|25868590|FG000|Overall Study|Did not wish to complete follow up|1|||
13102538|NCT03379376|25868590|FG000|Overall Study|Overwhelmed, didn't want to continue|1|||
13102539|NCT03379376|25868590|FG000|Overall Study|Death|1|||
13102540|NCT03379259|25868687|FG000|Overall Study|Commenced new anti-cancer therapy|1|||
13102541|NCT03379259|25868688|FG001|Overall Study|Commenced new anti-cancer therapy|0|||
13102542|NCT03379259|25868689|FG002|Overall Study|Commenced new anti-cancer therapy|0|||
13102543|NCT03379259|25868690|FG003|Overall Study|Commenced new anti-cancer therapy|0|||
13152752|NCT02533674|26055033|FG004|Dose Level VIII|Never treated|0|||
13152753|NCT02533674|26055034|FG005|Dose Level VIII|Never treated|0|||
13152754|NCT02533674|26055035|FG006|Dose Level VIII|Never treated|0|||
13152755|NCT02533674|26055036|FG007|Dose Level VIII|Never treated|1|||
13152756|NCT02533570|26055057|FG000|Overall Study|Adverse Event|0|||
13152757|NCT02533570|26055058|FG001|Overall Study|Adverse Event|1|||
13152758|NCT02533570|26055059|FG002|Overall Study|Adverse Event|1|||
13152759|NCT02533531|26055066|FG000|Overall Study|Device did not turn on|1|||
13152760|NCT02533453|26055077|FG000|Overall Study|Adverse Event|6|||
13152761|NCT02533453|26055077|FG000|Overall Study|Protocol Violation|1|||
13152762|NCT02533453|26055077|FG000|Overall Study|Withdrawal by Subject|2|||
13152763|NCT02533401|26055087|FG000|Overall Study|Adverse Event/Intercurrent Disease|3|||
13152764|NCT02533401|26055087|FG000|Overall Study|Death|5|||
13152765|NCT02533401|26055087|FG000|Overall Study|Insufficient Response/Progressed Disease|1|||
13152766|NCT02533401|26055087|FG000|Overall Study|Lost to Follow-up|1|||
13152767|NCT02533401|26055087|FG000|Overall Study|Violation of Selection Criteria|1|||
13152768|NCT02533375|26055121|FG000|Overall Study|Lack of Efficacy|3|||
13152769|NCT02533375|26055121|FG000|Overall Study|Adverse Event|2|||
13152770|NCT02533258|26055135|FG000|Overall Study|Adverse Event|1|||
13152771|NCT02533258|26055135|FG000|Overall Study|Death|2|||
13152772|NCT02533258|26055135|FG000|Overall Study|Other|1|||
13152773|NCT02533258|26055135|FG000|Overall Study|Economic factor|1|||
13152774|NCT02533258|26055135|FG000|Overall Study|Progression of pleural effusion|1|||
13152775|NCT02533258|26055135|FG000|Overall Study|Lack of Efficacy|2|||
13152776|NCT02533180|26055147|FG000|Overall Study|Death|0|||
13152777|NCT02533180|26055148|FG001|Overall Study|Death|1|||
13152778|NCT02533180|26055147|FG000|Overall Study|Lost to Follow-up|0|||
13152779|NCT02533180|26055148|FG001|Overall Study|Lost to Follow-up|1|||
13152780|NCT02533180|26055147|FG000|Overall Study|Physician Decision|0|||
13152781|NCT02533180|26055148|FG001|Overall Study|Physician Decision|1|||
13152782|NCT02533180|26055147|FG000|Overall Study|Withdrawal by Subject|2|||
13152783|NCT02533180|26055148|FG001|Overall Study|Withdrawal by Subject|4|||
13152784|NCT02533180|26055147|FG000|Overall Study|Screen Failure|37|||
13152785|NCT02533180|26055148|FG001|Overall Study|Screen Failure|0|||
13152786|NCT02533180|26055147|FG000|Overall Study|Protocol Deviation|0|||
13152787|NCT02533180|26055148|FG001|Overall Study|Protocol Deviation|1|||
13152788|NCT02533180|26055147|FG000|Overall Study|On Study|0|||
13152789|NCT02533180|26055148|FG001|Overall Study|On Study|39|||
13152790|NCT02532972|26055156|FG000|Overall Study|Withdrawal by Subject|1|||
13152791|NCT02532855|26055187|FG000|Overall Study|Lost to Follow-up|4|||
13152792|NCT02532855|26055188|FG001|Overall Study|Lost to Follow-up|3|||
13152793|NCT02532855|26055187|FG000|Overall Study|Withdrawal by Subject|4|||
13152794|NCT02532855|26055188|FG001|Overall Study|Withdrawal by Subject|8|||
13102544|NCT03379259|25868691|FG004|Overall Study|Commenced new anti-cancer therapy|0|||
13102545|NCT03379259|25868692|FG005|Overall Study|Commenced new anti-cancer therapy|0|||
13152795|NCT02532764|26055367|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
13152796|NCT02532764|26055368|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
13222687|NCT01803607|26286773|FG000|Overall Study|Study terminated by sponsor|54|||
13152797|NCT02532764|26055369|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
13152798|NCT02532764|26055370|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
13152799|NCT02532764|26055371|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
13152800|NCT02532764|26055372|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
13152801|NCT02532764|26055373|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
13102546|NCT03379259|25868687|FG000|Overall Study|Death|0|||
13102547|NCT03379259|25868688|FG001|Overall Study|Death|1|||
13102548|NCT03379259|25868689|FG002|Overall Study|Death|2|||
13102549|NCT03379259|25868690|FG003|Overall Study|Death|1|||
13102550|NCT03379259|25868691|FG004|Overall Study|Death|4|||
13102551|NCT03379259|25868692|FG005|Overall Study|Death|2|||
13102552|NCT03379259|25868687|FG000|Overall Study|Withdrawal by Subject|0|||
13102553|NCT03379259|25868688|FG001|Overall Study|Withdrawal by Subject|0|||
13102554|NCT03379259|25868689|FG002|Overall Study|Withdrawal by Subject|1|||
13102555|NCT03379259|25868690|FG003|Overall Study|Withdrawal by Subject|0|||
13102556|NCT03379259|25868691|FG004|Overall Study|Withdrawal by Subject|2|||
13102557|NCT03379259|25868692|FG005|Overall Study|Withdrawal by Subject|0|||
13102558|NCT03379259|25868687|FG000|Overall Study|Study terminated by sponsor|0|||
13102559|NCT03379259|25868688|FG001|Overall Study|Study terminated by sponsor|0|||
13102560|NCT03379259|25868689|FG002|Overall Study|Study terminated by sponsor|0|||
13102561|NCT03379259|25868690|FG003|Overall Study|Study terminated by sponsor|1|||
13102562|NCT03379259|25868691|FG004|Overall Study|Study terminated by sponsor|1|||
13102563|NCT03379259|25868692|FG005|Overall Study|Study terminated by sponsor|4|||
13102564|NCT03379259|25868687|FG000|Overall Study|Disease progression|0|||
13102565|NCT03379259|25868688|FG001|Overall Study|Disease progression|0|||
13102566|NCT03379259|25868689|FG002|Overall Study|Disease progression|0|||
13102567|NCT03379259|25868690|FG003|Overall Study|Disease progression|1|||
13102568|NCT03379259|25868691|FG004|Overall Study|Disease progression|0|||
13102569|NCT03379259|25868692|FG005|Overall Study|Disease progression|1|||
13102570|NCT03379259|25868687|FG000|Overall Study|Lost to Follow-up|0|||
13102571|NCT03379259|25868688|FG001|Overall Study|Lost to Follow-up|0|||
13102572|NCT03379259|25868689|FG002|Overall Study|Lost to Follow-up|0|||
13102573|NCT03379259|25868690|FG003|Overall Study|Lost to Follow-up|0|||
13102574|NCT03379259|25868691|FG004|Overall Study|Lost to Follow-up|1|||
13102575|NCT03379259|25868692|FG005|Overall Study|Lost to Follow-up|0|||
13102576|NCT03379259|25868687|FG000|Overall Study|Deteriorating condition|0|||
13152802|NCT02532764|26055374|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
13152803|NCT02532764|26055375|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
13152804|NCT02532764|26055376|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
13152805|NCT02532647|26055400|FG000|Overall Study|Did not receive trial medication|1|||
13152806|NCT02532647|26055401|FG001|Overall Study|Did not receive trial medication|0|||
13152807|NCT02532647|26055402|FG002|Overall Study|Did not receive trial medication|1|||
13152808|NCT02532543|26055449|FG000|Overall Study|Lost to Follow-up|0|||
13152809|NCT02532543|26055450|FG001|Overall Study|Lost to Follow-up|0|||
13152810|NCT02532543|26055451|FG002|Overall Study|Lost to Follow-up|1|||
13152811|NCT02532543|26055452|FG003|Overall Study|Lost to Follow-up|0|||
13152812|NCT02532517|26055472|FG000|Overall Study|Did not complete 24-Month visit|4|||
13152813|NCT02532517|26055472|FG000|Overall Study|Failed Angiographic eligibility|1|||
13152814|NCT02532517|26055472|FG000|Overall Study|Lost to Follow-up|4|||
13152815|NCT02532517|26055472|FG000|Overall Study|Withdrawal by Subject|4|||
13152816|NCT02532517|26055472|FG000|Overall Study|Death|4|||
13152817|NCT02532465|26055489|FG000|Overall Study|Protocol Violation|1|||
13152818|NCT02532465|26055490|FG001|Overall Study|Protocol Violation|0|||
13152819|NCT02532465|26055489|FG000|Overall Study|Lack of Efficacy|0|||
13152820|NCT02532465|26055490|FG001|Overall Study|Lack of Efficacy|1|||
13152821|NCT02532374|26055516|FG000|Overall Study|Withdrawal by Subject|1|||
13152822|NCT02532374|26055516|FG000|Overall Study|Physician Decision|1|||
13152823|NCT02532283|26055565|FG000|Overall Study|Adverse Event|0|||
13152824|NCT02532283|26055566|FG001|Overall Study|Adverse Event|1|||
13152825|NCT02532283|26055565|FG000|Overall Study|Death|1|||
13152826|NCT02532283|26055566|FG001|Overall Study|Death|0|||
13152827|NCT02532283|26055565|FG000|Overall Study|Lost to Follow-up|0|||
13152828|NCT02532283|26055566|FG001|Overall Study|Lost to Follow-up|1|||
13152829|NCT02532283|26055565|FG000|Overall Study|Withdrawal by Subject|8|||
13152830|NCT02532283|26055566|FG001|Overall Study|Withdrawal by Subject|3|||
13152831|NCT02532179|26055577|FG000|Overall Study|Lost to Follow-up|1|||
13152832|NCT02532179|26055577|FG000|Overall Study|Pregnancy|1|||
13152833|NCT02532179|26055577|FG000|Overall Study|Subject received depot steroid injection|1|||
13152834|NCT02531802|26056071|FG000|Received Vaccination 2|Medication interfering with study taken|0|||
13152835|NCT02531802|26056072|FG001|Received Vaccination 2|Medication interfering with study taken|0|||
13152836|NCT02531802|26056073|FG002|Received Vaccination 2|Medication interfering with study taken|1|||
13152837|NCT02531802|26056074|FG003|Received Vaccination 2|Medication interfering with study taken|0|||
13102577|NCT03379259|25868688|FG001|Overall Study|Deteriorating condition|0|||
13102578|NCT03379259|25868689|FG002|Overall Study|Deteriorating condition|0|||
13102579|NCT03379259|25868690|FG003|Overall Study|Deteriorating condition|0|||
13102580|NCT03379259|25868691|FG004|Overall Study|Deteriorating condition|1|||
13152838|NCT02531802|26056075|FG004|Received Vaccination 2|Medication interfering with study taken|0|||
13152839|NCT02531802|26056076|FG005|Received Vaccination 2|Medication interfering with study taken|0|||
13152840|NCT02531802|26056077|FG006|Received Vaccination 2|Medication interfering with study taken|0|||
13152841|NCT02531802|26056078|FG007|Received Vaccination 2|Medication interfering with study taken|0|||
13485343|NCT03739138|27032562|FG001|Overall Study|Death|7|||
13102581|NCT03379259|25868692|FG005|Overall Study|Deteriorating condition|0|||
13102582|NCT03379233|25868711|FG000|Overall Study|Technical issues with Concept 2 inhalers|1|||
13102583|NCT03379233|25868712|FG001|Overall Study|Technical issues with Concept 2 inhalers|6|||
13102584|NCT03378635|25868758|FG000|Overall Study|Adverse Event|1|||
13102585|NCT03378635|25868759|FG001|Overall Study|Adverse Event|0|||
13102586|NCT03378635|25868760|FG002|Overall Study|Adverse Event|0|||
13102587|NCT03378635|25868758|FG000|Overall Study|Withdrawal by Subject|1|||
13102588|NCT03378635|25868759|FG001|Overall Study|Withdrawal by Subject|0|||
13102589|NCT03378635|25868760|FG002|Overall Study|Withdrawal by Subject|0|||
13102590|NCT03377634|25868789|FG000|Study Period|Adverse Event|1|||
13102591|NCT03377634|25868790|FG001|Study Period|Adverse Event|0|||
13102592|NCT03377634|25868789|FG000|Study Period|Withdrawal by Subject|1|||
13102593|NCT03377634|25868790|FG001|Study Period|Withdrawal by Subject|0|||
13102594|NCT03377556|25868804|FG000|Overall Study|Adverse Event|5|||
13102595|NCT03377556|25868804|FG000|Overall Study|Refusal unrelated to adverse events|1|||
13102596|NCT03377556|25868804|FG000|Overall Study|Progression/relapse|38|||
13102597|NCT03377556|25868804|FG000|Overall Study|Death|3|||
13152842|NCT02531802|26056079|FG008|Received Vaccination 2|Medication interfering with study taken|0|||
13152843|NCT02531802|26056080|FG009|Received Vaccination 2|Medication interfering with study taken|1|||
13152844|NCT02531802|26056081|FG010|Received Vaccination 2|Medication interfering with study taken|1|||
13152845|NCT02531802|26056082|FG011|Received Vaccination 2|Medication interfering with study taken|0|||
13152846|NCT02531802|26056083|FG012|Received Vaccination 2|Medication interfering with study taken|1|||
13152847|NCT02531802|26056084|FG013|Received Vaccination 2|Medication interfering with study taken|0|||
13152848|NCT02531802|26056085|FG014|Received Vaccination 2|Medication interfering with study taken|0|||
13152849|NCT02531802|26056086|FG015|Received Vaccination 2|Medication interfering with study taken|0|||
13152850|NCT02531802|26056087|FG016|Received Vaccination 2|Medication interfering with study taken|0|||
13152851|NCT02531802|26056088|FG017|Received Vaccination 2|Medication interfering with study taken|0|||
13152852|NCT02531802|26056089|FG018|Received Vaccination 2|Medication interfering with study taken|1|||
13152853|NCT02531802|26056090|FG019|Received Vaccination 2|Medication interfering with study taken|0|||
13152854|NCT02531802|26056091|FG020|Received Vaccination 2|Medication interfering with study taken|0|||
13152855|NCT02531802|26056071|FG000|Received Vaccination 2|Physician Decision|0|||
13152856|NCT02531802|26056072|FG001|Received Vaccination 2|Physician Decision|0|||
13152857|NCT02531802|26056073|FG002|Received Vaccination 2|Physician Decision|0|||
13152858|NCT02531802|26056074|FG003|Received Vaccination 2|Physician Decision|0|||
13152859|NCT02531802|26056075|FG004|Received Vaccination 2|Physician Decision|0|||
13152860|NCT02531802|26056076|FG005|Received Vaccination 2|Physician Decision|1|||
13152861|NCT02531802|26056077|FG006|Received Vaccination 2|Physician Decision|0|||
13152862|NCT02531802|26056078|FG007|Received Vaccination 2|Physician Decision|0|||
13152863|NCT02531802|26056079|FG008|Received Vaccination 2|Physician Decision|0|||
13152864|NCT02531802|26056080|FG009|Received Vaccination 2|Physician Decision|2|||
13152865|NCT02531802|26056081|FG010|Received Vaccination 2|Physician Decision|0|||
13152866|NCT02531802|26056082|FG011|Received Vaccination 2|Physician Decision|0|||
13152867|NCT02531802|26056083|FG012|Received Vaccination 2|Physician Decision|0|||
13152868|NCT02531802|26056084|FG013|Received Vaccination 2|Physician Decision|1|||
13152869|NCT02531802|26056085|FG014|Received Vaccination 2|Physician Decision|0|||
13152870|NCT02531802|26056086|FG015|Received Vaccination 2|Physician Decision|0|||
13152871|NCT02531802|26056087|FG016|Received Vaccination 2|Physician Decision|0|||
13152872|NCT02531802|26056088|FG017|Received Vaccination 2|Physician Decision|1|||
13152873|NCT02531802|26056089|FG018|Received Vaccination 2|Physician Decision|0|||
13152874|NCT02531802|26056090|FG019|Received Vaccination 2|Physician Decision|0|||
13152875|NCT02531802|26056091|FG020|Received Vaccination 2|Physician Decision|0|||
13152876|NCT02531802|26056071|FG000|Received Vaccination 2|Adverse Event|0|||
13152877|NCT02531802|26056072|FG001|Received Vaccination 2|Adverse Event|0|||
13152878|NCT02531802|26056073|FG002|Received Vaccination 2|Adverse Event|0|||
13152879|NCT02531802|26056074|FG003|Received Vaccination 2|Adverse Event|0|||
13152880|NCT02531802|26056075|FG004|Received Vaccination 2|Adverse Event|0|||
13152881|NCT02531802|26056076|FG005|Received Vaccination 2|Adverse Event|2|||
13152882|NCT02531802|26056077|FG006|Received Vaccination 2|Adverse Event|0|||
13152883|NCT02531802|26056078|FG007|Received Vaccination 2|Adverse Event|0|||
13152884|NCT02531802|26056079|FG008|Received Vaccination 2|Adverse Event|0|||
13152885|NCT02531802|26056080|FG009|Received Vaccination 2|Adverse Event|0|||
13152886|NCT02531802|26056081|FG010|Received Vaccination 2|Adverse Event|0|||
13152887|NCT02531802|26056082|FG011|Received Vaccination 2|Adverse Event|0|||
13152888|NCT02531802|26056083|FG012|Received Vaccination 2|Adverse Event|0|||
13102598|NCT03376516|25868836|FG000|Overall Study|Not treated|1|||
13102599|NCT03376516|25868836|FG000|Overall Study|Consent withdrawn|1|||
13152889|NCT02531802|26056084|FG013|Received Vaccination 2|Adverse Event|0|||
13152890|NCT02531802|26056085|FG014|Received Vaccination 2|Adverse Event|0|||
13152891|NCT02531802|26056086|FG015|Received Vaccination 2|Adverse Event|0|||
13152892|NCT02531802|26056087|FG016|Received Vaccination 2|Adverse Event|0|||
13152893|NCT02531802|26056088|FG017|Received Vaccination 2|Adverse Event|2|||
13152894|NCT02531802|26056089|FG018|Received Vaccination 2|Adverse Event|1|||
13152895|NCT02531802|26056090|FG019|Received Vaccination 2|Adverse Event|0|||
13152896|NCT02531802|26056091|FG020|Received Vaccination 2|Adverse Event|1|||
13102600|NCT03376321|25868866|FG000|Overall Study|Other|5|||
13102601|NCT03376321|25868867|FG001|Overall Study|Other|1|||
13102602|NCT03376321|25868866|FG000|Overall Study|Withdrawal by Subject|8|||
13102603|NCT03376321|25868867|FG001|Overall Study|Withdrawal by Subject|14|||
13102604|NCT03376321|25868866|FG000|Overall Study|Lost to Follow-up|1|||
13102605|NCT03376321|25868867|FG001|Overall Study|Lost to Follow-up|7|||
13102606|NCT03376321|25868866|FG000|Overall Study|Death|4|||
13102607|NCT03376321|25868867|FG001|Overall Study|Death|0|||
13102608|NCT03376321|25868866|FG000|Overall Study|Randomized, not treated|5|||
13102609|NCT03376321|25868867|FG001|Overall Study|Randomized, not treated|3|||
13102610|NCT03374995|25868886|FG000|Overall Study|Withdrawal by Subject|0|||
13102611|NCT03374995|25868887|FG001|Overall Study|Withdrawal by Subject|1|||
13102612|NCT03374488|25868905|FG000|Overall Study|Death|13|||
13102613|NCT03374488|25868906|FG001|Overall Study|Death|13|||
13102614|NCT03374488|25868905|FG000|Overall Study|Withdrawal by Subject|3|||
13102615|NCT03374488|25868906|FG001|Overall Study|Withdrawal by Subject|1|||
13102616|NCT03374488|25868905|FG000|Overall Study|Physician Decision|3|||
13102617|NCT03374488|25868906|FG001|Overall Study|Physician Decision|0|||
13102618|NCT03374358|25868933|FG000|Overall Study|Withdrawal by Subject|0|||
13102619|NCT03374358|25868934|FG001|Overall Study|Withdrawal by Subject|2|||
13102620|NCT03374189|25868959|FG000|Overall Study|Lost to Follow-up|1|||
13102621|NCT03374189|25868960|FG001|Overall Study|Lost to Follow-up|0|||
13102622|NCT03373760|25868979|FG000|Overall Study|Adverse Event|8|||
13102623|NCT03373760|25868979|FG000|Overall Study|Disease Progression|46|||
13102624|NCT03373760|25868979|FG000|Overall Study|Death|4|||
13102625|NCT03372603|25869024|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1|||
13102626|NCT03372603|25869025|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0|||
13102627|NCT03372603|25869024|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1|||
13102628|NCT03372603|25869025|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0|||
13102629|NCT03372551|25869045|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
13102630|NCT03372551|25869046|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
13102631|NCT03372369|25869065|FG000|Qualification Period|Withdrawal by Subject|16|||
13102632|NCT03372369|25869066|FG001|Qualification Period|Withdrawal by Subject|13|||
13102633|NCT03372369|25869065|FG000|Qualification Period|Inconsistent Eligibility Results|10|||
13102634|NCT03372369|25869066|FG001|Qualification Period|Inconsistent Eligibility Results|9|||
13102635|NCT03372369|25869065|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
13152897|NCT02531802|26056071|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
13152898|NCT02531802|26056072|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
13152899|NCT02531802|26056073|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
13152900|NCT02531802|26056074|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
13152901|NCT02531802|26056075|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
13152902|NCT02531802|26056076|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
13152903|NCT02531802|26056077|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
13152904|NCT02531802|26056078|FG007|Received Vaccination 2|Withdrawal by Subject|0|||
13152905|NCT02531802|26056079|FG008|Received Vaccination 2|Withdrawal by Subject|0|||
13152906|NCT02531802|26056080|FG009|Received Vaccination 2|Withdrawal by Subject|0|||
13152907|NCT02531802|26056081|FG010|Received Vaccination 2|Withdrawal by Subject|1|||
13152908|NCT02531802|26056082|FG011|Received Vaccination 2|Withdrawal by Subject|0|||
13152909|NCT02531802|26056083|FG012|Received Vaccination 2|Withdrawal by Subject|1|||
13152910|NCT02531802|26056084|FG013|Received Vaccination 2|Withdrawal by Subject|1|||
13152911|NCT02531802|26056085|FG014|Received Vaccination 2|Withdrawal by Subject|1|||
13152912|NCT02531802|26056086|FG015|Received Vaccination 2|Withdrawal by Subject|0|||
13152913|NCT02531802|26056087|FG016|Received Vaccination 2|Withdrawal by Subject|0|||
13152914|NCT02531802|26056088|FG017|Received Vaccination 2|Withdrawal by Subject|1|||
13152915|NCT02531802|26056089|FG018|Received Vaccination 2|Withdrawal by Subject|1|||
13152916|NCT02531802|26056090|FG019|Received Vaccination 2|Withdrawal by Subject|1|||
13152917|NCT02531802|26056091|FG020|Received Vaccination 2|Withdrawal by Subject|0|||
13152918|NCT02531698|26056342|FG000|Overall Study|Adverse Event|2|||
13102636|NCT03372369|25869066|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
13102637|NCT03372096|25869079|FG000|Overall Study|Study Closed|8|||
13102638|NCT03372083|25869113|FG000|Overall Study|Adverse Event|3|||
13102639|NCT03372083|25869113|FG000|Overall Study|Physician Decision|1|||
13102640|NCT03372083|25869113|FG000|Overall Study|Withdrawal by Subject|1|||
13102641|NCT03371459|25869124|FG000|Washout|Lost to Follow-up|0|||
13102642|NCT03371459|25869125|FG001|Washout|Lost to Follow-up|1|||
13102643|NCT03371381|25869139|FG000|Overall Study|Death|5|||
13102644|NCT03371381|25869139|FG000|Overall Study|Study terminated by sponsor|3|||
13102645|NCT03371381|25869139|FG000|Overall Study|Other|4|||
13102646|NCT03371355|25869266|FG000|Overall Study|Investigator judgment|0|||
13102647|NCT03371355|25869267|FG001|Overall Study|Investigator judgment|0|||
13102648|NCT03371355|25869268|FG002|Overall Study|Investigator judgment|1|||
13102649|NCT03371355|25869269|FG003|Overall Study|Investigator judgment|1|||
13102650|NCT03371355|25869266|FG000|Overall Study|Voluntary withdrawal|1|||
13102651|NCT03371355|25869267|FG001|Overall Study|Voluntary withdrawal|0|||
13102652|NCT03371355|25869268|FG002|Overall Study|Voluntary withdrawal|1|||
13102653|NCT03371355|25869269|FG003|Overall Study|Voluntary withdrawal|2|||
13102654|NCT03371355|25869266|FG000|Overall Study|Adverse Event|0|||
13102655|NCT03371355|25869267|FG001|Overall Study|Adverse Event|1|||
13102656|NCT03371355|25869268|FG002|Overall Study|Adverse Event|2|||
13102657|NCT03371355|25869269|FG003|Overall Study|Adverse Event|3|||
13102658|NCT03371355|25869266|FG000|Overall Study|Reason not Specified|0|||
13102659|NCT03371355|25869267|FG001|Overall Study|Reason not Specified|1|||
13102660|NCT03371355|25869268|FG002|Overall Study|Reason not Specified|0|||
13102661|NCT03371355|25869269|FG003|Overall Study|Reason not Specified|1|||
13102662|NCT03371251|25869386|FG000|Overall Study|Withdrawal by Subject|1|||
13102663|NCT03371251|25869387|FG001|Overall Study|Withdrawal by Subject|0|||
13102664|NCT03371251|25869388|FG002|Overall Study|Withdrawal by Subject|1|||
13102665|NCT03371251|25869389|FG003|Overall Study|Withdrawal by Subject|0|||
13102666|NCT03371251|25869390|FG004|Overall Study|Withdrawal by Subject|2|||
13102667|NCT03371251|25869391|FG005|Overall Study|Withdrawal by Subject|2|||
13102668|NCT03371251|25869386|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1|||
13102669|NCT03371251|25869387|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
13102670|NCT03371251|25869388|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
13102671|NCT03371251|25869389|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
13102672|NCT03371251|25869390|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2|||
13102673|NCT03371251|25869391|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3|||
13152919|NCT02531698|26056343|FG001|Overall Study|Adverse Event|1|||
13152920|NCT02531698|26056342|FG000|Overall Study|Withdrawal by Subject|6|||
13152921|NCT02531698|26056343|FG001|Overall Study|Withdrawal by Subject|1|||
13152922|NCT02531698|26056342|FG000|Overall Study|Protocol Violation|2|||
13152923|NCT02531698|26056343|FG001|Overall Study|Protocol Violation|0|||
13152924|NCT02531698|26056342|FG000|Overall Study|Lost to Follow-up|1|||
13152925|NCT02531698|26056343|FG001|Overall Study|Lost to Follow-up|0|||
13152926|NCT02531646|26056367|FG000|Overall Study|equip. image processing issue|5|||
13152927|NCT02531646|26056368|FG001|Overall Study|equip. image processing issue|1|||
13152928|NCT02531646|26056369|FG002|Overall Study|equip. image processing issue|0|||
13152929|NCT02531633|26056867|FG000|Part A (52 Weeks)|Sponsor request|24|||
13152930|NCT02531633|26056868|FG001|Part A (52 Weeks)|Sponsor request|24|||
13152931|NCT02531633|26056869|FG002|Part A (52 Weeks)|Sponsor request|18|||
13152932|NCT02531633|26056870|FG003|Part A (52 Weeks)|Sponsor request|18|||
13152933|NCT02531633|26056871|FG004|Part A (52 Weeks)|Sponsor request|19|||
13152934|NCT02531633|26056872|FG005|Part A (52 Weeks)|Sponsor request|0|||
13152935|NCT02531633|26056873|FG006|Part A (52 Weeks)|Sponsor request|0|||
13152936|NCT02531633|26056874|FG007|Part A (52 Weeks)|Sponsor request|0|||
13152937|NCT02531633|26056875|FG008|Part A (52 Weeks)|Sponsor request|0|||
13152938|NCT02531633|26056876|FG009|Part A (52 Weeks)|Sponsor request|0|||
13152939|NCT02531633|26056867|FG000|Part A (52 Weeks)|Protocol Violation|1|||
13152940|NCT02531633|26056868|FG001|Part A (52 Weeks)|Protocol Violation|0|||
13152941|NCT02531633|26056869|FG002|Part A (52 Weeks)|Protocol Violation|0|||
13152942|NCT02531633|26056870|FG003|Part A (52 Weeks)|Protocol Violation|0|||
13152943|NCT02531633|26056871|FG004|Part A (52 Weeks)|Protocol Violation|0|||
13152944|NCT02531633|26056872|FG005|Part A (52 Weeks)|Protocol Violation|0|||
13152945|NCT02531633|26056873|FG006|Part A (52 Weeks)|Protocol Violation|0|||
13152946|NCT02531633|26056874|FG007|Part A (52 Weeks)|Protocol Violation|0|||
13152947|NCT02531633|26056875|FG008|Part A (52 Weeks)|Protocol Violation|0|||
13152948|NCT02531633|26056876|FG009|Part A (52 Weeks)|Protocol Violation|0|||
13152949|NCT02531633|26056867|FG000|Part A (52 Weeks)|Lost to Follow-up|0|||
13152950|NCT02531633|26056868|FG001|Part A (52 Weeks)|Lost to Follow-up|0|||
13152951|NCT02531633|26056869|FG002|Part A (52 Weeks)|Lost to Follow-up|0|||
13152952|NCT02531633|26056870|FG003|Part A (52 Weeks)|Lost to Follow-up|0|||
13152953|NCT02531633|26056871|FG004|Part A (52 Weeks)|Lost to Follow-up|1|||
13152954|NCT02531633|26056872|FG005|Part A (52 Weeks)|Lost to Follow-up|0|||
13152955|NCT02531633|26056873|FG006|Part A (52 Weeks)|Lost to Follow-up|0|||
13152956|NCT02531633|26056874|FG007|Part A (52 Weeks)|Lost to Follow-up|0|||
13152957|NCT02531633|26056875|FG008|Part A (52 Weeks)|Lost to Follow-up|0|||
13152958|NCT02531633|26056876|FG009|Part A (52 Weeks)|Lost to Follow-up|0|||
13152959|NCT02531633|26056867|FG000|Part A (52 Weeks)|Physician Decision|1|||
13152960|NCT02531633|26056868|FG001|Part A (52 Weeks)|Physician Decision|4|||
13152961|NCT02531633|26056869|FG002|Part A (52 Weeks)|Physician Decision|3|||
13152962|NCT02531633|26056870|FG003|Part A (52 Weeks)|Physician Decision|1|||
13152963|NCT02531633|26056871|FG004|Part A (52 Weeks)|Physician Decision|0|||
13152964|NCT02531633|26056872|FG005|Part A (52 Weeks)|Physician Decision|0|||
13152965|NCT02531633|26056873|FG006|Part A (52 Weeks)|Physician Decision|0|||
13152966|NCT02531633|26056874|FG007|Part A (52 Weeks)|Physician Decision|0|||
13152967|NCT02531633|26056875|FG008|Part A (52 Weeks)|Physician Decision|0|||
13152968|NCT02531633|26056876|FG009|Part A (52 Weeks)|Physician Decision|0|||
13152969|NCT02531633|26056867|FG000|Part A (52 Weeks)|Withdrawal by Subject|6|||
13152970|NCT02531633|26056868|FG001|Part A (52 Weeks)|Withdrawal by Subject|6|||
13152971|NCT02531633|26056869|FG002|Part A (52 Weeks)|Withdrawal by Subject|1|||
13152972|NCT02531633|26056870|FG003|Part A (52 Weeks)|Withdrawal by Subject|3|||
13152973|NCT02531633|26056871|FG004|Part A (52 Weeks)|Withdrawal by Subject|3|||
13152974|NCT02531633|26056872|FG005|Part A (52 Weeks)|Withdrawal by Subject|0|||
13152975|NCT02531633|26056873|FG006|Part A (52 Weeks)|Withdrawal by Subject|0|||
13152976|NCT02531633|26056874|FG007|Part A (52 Weeks)|Withdrawal by Subject|0|||
13152977|NCT02531633|26056875|FG008|Part A (52 Weeks)|Withdrawal by Subject|0|||
13152978|NCT02531633|26056876|FG009|Part A (52 Weeks)|Withdrawal by Subject|0|||
13152979|NCT02531633|26056867|FG000|Part A (52 Weeks)|Other|2|||
13152980|NCT02531633|26056868|FG001|Part A (52 Weeks)|Other|0|||
13152981|NCT02531633|26056869|FG002|Part A (52 Weeks)|Other|0|||
13152982|NCT02531633|26056870|FG003|Part A (52 Weeks)|Other|0|||
13152983|NCT02531633|26056871|FG004|Part A (52 Weeks)|Other|0|||
13152984|NCT02531633|26056872|FG005|Part A (52 Weeks)|Other|0|||
13152985|NCT02531633|26056873|FG006|Part A (52 Weeks)|Other|0|||
13152986|NCT02531633|26056874|FG007|Part A (52 Weeks)|Other|0|||
13152987|NCT02531633|26056875|FG008|Part A (52 Weeks)|Other|0|||
13152988|NCT02531633|26056876|FG009|Part A (52 Weeks)|Other|0|||
13152989|NCT02531633|26056867|FG000|Part B (104 Weeks)|Sponsor request|0|||
13152990|NCT02531633|26056868|FG001|Part B (104 Weeks)|Sponsor request|0|||
13152991|NCT02531633|26056869|FG002|Part B (104 Weeks)|Sponsor request|0|||
13102674|NCT03371251|25869386|FG000|Overall Study|Adverse Event|0|||
13102675|NCT03371251|25869387|FG001|Overall Study|Adverse Event|0|||
13102676|NCT03371251|25869388|FG002|Overall Study|Adverse Event|0|||
13102677|NCT03371251|25869389|FG003|Overall Study|Adverse Event|0|||
13102678|NCT03371251|25869390|FG004|Overall Study|Adverse Event|1|||
13102679|NCT03371251|25869391|FG005|Overall Study|Adverse Event|0|||
13102680|NCT03371251|25869386|FG000|Overall Study|Decision by Sponsor|0|||
13102681|NCT03371251|25869387|FG001|Overall Study|Decision by Sponsor|0|||
13102682|NCT03371251|25869388|FG002|Overall Study|Decision by Sponsor|0|||
13102683|NCT03371251|25869389|FG003|Overall Study|Decision by Sponsor|0|||
13102684|NCT03371251|25869390|FG004|Overall Study|Decision by Sponsor|2|||
13102685|NCT03371251|25869391|FG005|Overall Study|Decision by Sponsor|0|||
13102686|NCT03370770|25869398|FG000|Overall Study|Patient was followed in another hospital center|1|||
13102687|NCT03370770|25869398|FG000|Overall Study|Progressive Disease|98|||
13102688|NCT03370770|25869398|FG000|Overall Study|Adverse Event|2|||
13102689|NCT03370770|25869398|FG000|Overall Study|Death|5|||
13102690|NCT03370510|25869435|FG000|Overall Study|COVID-19|2|||
13102691|NCT03370510|25869436|FG001|Overall Study|COVID-19|0|||
13102692|NCT03370471|25869455|FG000|Overall Study|Withdrawal by Subject|6|||
13102693|NCT03370471|25869456|FG001|Overall Study|Withdrawal by Subject|1|||
13102694|NCT03370471|25869455|FG000|Overall Study|Unable to access veins for blood draw|0|||
13102695|NCT03370471|25869456|FG001|Overall Study|Unable to access veins for blood draw|1|||
13102696|NCT03370471|25869455|FG000|Overall Study|Screen fail|1|||
13102697|NCT03370471|25869456|FG001|Overall Study|Screen fail|0|||
13102698|NCT03370419|25869462|FG000|Overall Study|Lost to Follow-up|16|||
13102699|NCT03370341|25869477|FG000|Overall Study|Lost to Follow-up|0|||
13102700|NCT03370341|25869478|FG001|Overall Study|Lost to Follow-up|1|||
13102701|NCT03370302|25869594|FG000|Dose Escalation Phase|Other|0|||
13102702|NCT03370302|25869595|FG001|Dose Escalation Phase|Other|1|||
13102703|NCT03370302|25869596|FG002|Dose Escalation Phase|Other|1|||
13102704|NCT03370302|25869597|FG003|Dose Escalation Phase|Other|0|||
13102705|NCT03370302|25869598|FG004|Dose Escalation Phase|Other|0|||
13102706|NCT03370302|25869599|FG005|Dose Escalation Phase|Other|0|||
13102707|NCT03370302|25869594|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
13102708|NCT03370302|25869595|FG001|Dose Escalation Phase|Withdrawal by Subject|1|||
13102709|NCT03370302|25869596|FG002|Dose Escalation Phase|Withdrawal by Subject|2|||
13102710|NCT03370302|25869597|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
13102711|NCT03370302|25869598|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
13102712|NCT03370302|25869599|FG005|Dose Escalation Phase|Withdrawal by Subject|2|||
13102713|NCT03370302|25869594|FG000|Dose Escalation Phase|Adverse Event|1|||
13102714|NCT03370302|25869595|FG001|Dose Escalation Phase|Adverse Event|0|||
13102715|NCT03370302|25869596|FG002|Dose Escalation Phase|Adverse Event|2|||
13102716|NCT03370302|25869597|FG003|Dose Escalation Phase|Adverse Event|0|||
13102717|NCT03370302|25869598|FG004|Dose Escalation Phase|Adverse Event|0|||
13102718|NCT03370302|25869599|FG005|Dose Escalation Phase|Adverse Event|0|||
13102719|NCT03370302|25869594|FG000|Dose Escalation Phase|Progressive Disease|2|||
13152992|NCT02531633|26056870|FG003|Part B (104 Weeks)|Sponsor request|0|||
13102720|NCT03370302|25869595|FG001|Dose Escalation Phase|Progressive Disease|4|||
13102721|NCT03370302|25869596|FG002|Dose Escalation Phase|Progressive Disease|2|||
13102722|NCT03370302|25869597|FG003|Dose Escalation Phase|Progressive Disease|0|||
13102723|NCT03370302|25869598|FG004|Dose Escalation Phase|Progressive Disease|3|||
13102724|NCT03370302|25869599|FG005|Dose Escalation Phase|Progressive Disease|1|||
13102725|NCT03370302|25869594|FG000|Dose Expansion Phase|Progressive Disease|0|||
13102726|NCT03370302|25869595|FG001|Dose Expansion Phase|Progressive Disease|0|||
13152993|NCT02531633|26056871|FG004|Part B (104 Weeks)|Sponsor request|0|||
13152994|NCT02531633|26056872|FG005|Part B (104 Weeks)|Sponsor request|8|||
13102727|NCT03370302|25869596|FG002|Dose Expansion Phase|Progressive Disease|0|||
13102728|NCT03370302|25869597|FG003|Dose Expansion Phase|Progressive Disease|6|||
13102729|NCT03370302|25869598|FG004|Dose Expansion Phase|Progressive Disease|0|||
13102730|NCT03370302|25869599|FG005|Dose Expansion Phase|Progressive Disease|0|||
13102731|NCT03370289|25869618|FG000|Overall Study|Screen Failure|1|||
13102732|NCT03370289|25869618|FG000|Overall Study|Sample Size Sufficient|4|||
13102733|NCT03370133|25869693|FG000|Initial Treatment Period (WK 16)|Adverse Event|5|||
13102734|NCT03370133|25869694|FG001|Initial Treatment Period (WK 16)|Adverse Event|5|||
13102735|NCT03370133|25869695|FG002|Initial Treatment Period (WK 16)|Adverse Event|2|||
13102736|NCT03370133|25869696|FG003|Initial Treatment Period (WK 16)|Adverse Event|0|||
13102737|NCT03370133|25869697|FG004|Initial Treatment Period (WK 16)|Adverse Event|0|||
13102738|NCT03370133|25869698|FG005|Initial Treatment Period (WK 16)|Adverse Event|0|||
13102739|NCT03370133|25869693|FG000|Initial Treatment Period (WK 16)|Death|1|||
13102740|NCT03370133|25869694|FG001|Initial Treatment Period (WK 16)|Death|1|||
13102741|NCT03370133|25869695|FG002|Initial Treatment Period (WK 16)|Death|1|||
13102742|NCT03370133|25869696|FG003|Initial Treatment Period (WK 16)|Death|0|||
13102743|NCT03370133|25869697|FG004|Initial Treatment Period (WK 16)|Death|0|||
13102744|NCT03370133|25869698|FG005|Initial Treatment Period (WK 16)|Death|0|||
13102745|NCT03370133|25869693|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2|||
13102746|NCT03370133|25869694|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1|||
13102747|NCT03370133|25869695|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
13102748|NCT03370133|25869696|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
13102749|NCT03370133|25869697|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
13102750|NCT03370133|25869698|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
13102751|NCT03370133|25869693|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0|||
13102752|NCT03370133|25869694|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0|||
13102753|NCT03370133|25869695|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2|||
13102754|NCT03370133|25869696|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0|||
13102755|NCT03370133|25869697|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0|||
13102756|NCT03370133|25869698|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0|||
13102757|NCT03370133|25869693|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
13102758|NCT03370133|25869694|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3|||
13102759|NCT03370133|25869695|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
13102760|NCT03370133|25869696|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
13102761|NCT03370133|25869697|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
13102762|NCT03370133|25869698|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
13102763|NCT03370133|25869693|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
13102764|NCT03370133|25869694|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2|||
13102765|NCT03370133|25869695|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
13102766|NCT03370133|25869696|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
13102767|NCT03370133|25869697|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
13102768|NCT03370133|25869698|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
13102769|NCT03370133|25869693|FG000|Initial Treatment Period (WK 16)|Non-compliance|0|||
13102770|NCT03370133|25869694|FG001|Initial Treatment Period (WK 16)|Non-compliance|1|||
13102771|NCT03370133|25869695|FG002|Initial Treatment Period (WK 16)|Non-compliance|0|||
13102772|NCT03370133|25869696|FG003|Initial Treatment Period (WK 16)|Non-compliance|0|||
13102773|NCT03370133|25869697|FG004|Initial Treatment Period (WK 16)|Non-compliance|0|||
13102774|NCT03370133|25869698|FG005|Initial Treatment Period (WK 16)|Non-compliance|0|||
13102775|NCT03370133|25869693|FG000|Initial Treatment Period (WK 16)|Site closed|0|||
13102776|NCT03370133|25869694|FG001|Initial Treatment Period (WK 16)|Site closed|2|||
13102777|NCT03370133|25869695|FG002|Initial Treatment Period (WK 16)|Site closed|0|||
13102778|NCT03370133|25869696|FG003|Initial Treatment Period (WK 16)|Site closed|0|||
13102779|NCT03370133|25869697|FG004|Initial Treatment Period (WK 16)|Site closed|0|||
13102780|NCT03370133|25869698|FG005|Initial Treatment Period (WK 16)|Site closed|0|||
13102781|NCT03370133|25869693|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
13102782|NCT03370133|25869694|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
13102783|NCT03370133|25869695|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
13102784|NCT03370133|25869696|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3|||
13102785|NCT03370133|25869697|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12|||
13102786|NCT03370133|25869698|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4|||
13102787|NCT03370133|25869693|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
13152995|NCT02531633|26056873|FG006|Part B (104 Weeks)|Sponsor request|5|||
13102788|NCT03370133|25869694|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
13102789|NCT03370133|25869695|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
13102790|NCT03370133|25869696|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
13102791|NCT03370133|25869697|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1|||
13102792|NCT03370133|25869698|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4|||
13102793|NCT03370133|25869693|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
13152996|NCT02531633|26056874|FG007|Part B (104 Weeks)|Sponsor request|3|||
13102794|NCT03370133|25869694|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
13152997|NCT02531633|26056875|FG008|Part B (104 Weeks)|Sponsor request|5|||
13152998|NCT02531633|26056876|FG009|Part B (104 Weeks)|Sponsor request|4|||
13152999|NCT02531633|26056867|FG000|Part B (104 Weeks)|Lost to Follow-up|0|||
13153000|NCT02531633|26056868|FG001|Part B (104 Weeks)|Lost to Follow-up|0|||
13153001|NCT02531633|26056869|FG002|Part B (104 Weeks)|Lost to Follow-up|0|||
13153002|NCT02531633|26056870|FG003|Part B (104 Weeks)|Lost to Follow-up|0|||
13102795|NCT03370133|25869695|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
13102796|NCT03370133|25869696|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
13102797|NCT03370133|25869697|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
13102798|NCT03370133|25869698|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
13102799|NCT03370133|25869693|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
13102800|NCT03370133|25869694|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
13102801|NCT03370133|25869695|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
13102802|NCT03370133|25869696|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
13102803|NCT03370133|25869697|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4|||
13102804|NCT03370133|25869698|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3|||
13102805|NCT03370133|25869693|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
13102806|NCT03370133|25869694|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
13102807|NCT03370133|25869695|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
13102808|NCT03370133|25869696|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1|||
13102809|NCT03370133|25869697|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
13102810|NCT03370133|25869698|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
13102811|NCT03370133|25869693|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
13102812|NCT03370133|25869694|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
13102813|NCT03370133|25869695|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
13102814|NCT03370133|25869696|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
13102815|NCT03370133|25869697|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1|||
13102816|NCT03370133|25869698|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
13102817|NCT03370133|25869693|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
13102818|NCT03370133|25869694|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
13102819|NCT03370133|25869695|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
13102820|NCT03370133|25869696|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
13102821|NCT03370133|25869697|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
13102822|NCT03370133|25869698|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1|||
13102823|NCT03369951|25869725|FG000|Overall Study|Withdrawal by Subject|3|||
13102824|NCT03369951|25869725|FG000|Overall Study|Death|1|||
13102825|NCT03369951|25869725|FG000|Overall Study|Lost to Follow-up|1|||
13102826|NCT03369951|25869725|FG000|Overall Study|Protocol Violation|1|||
13102827|NCT03369704|25869765|FG000|Treatment Epoch|technical problems|1|||
13102828|NCT03369704|25869766|FG001|Treatment Epoch|technical problems|0|||
13102829|NCT03369704|25869765|FG000|Treatment Epoch|Protocol Violation|1|||
13102830|NCT03369704|25869766|FG001|Treatment Epoch|Protocol Violation|0|||
13102831|NCT03369704|25869765|FG000|Treatment Epoch|Lost to Follow-up|0|||
13102832|NCT03369704|25869766|FG001|Treatment Epoch|Lost to Follow-up|1|||
13102833|NCT03369704|25869765|FG000|Treatment Epoch|Lack of Efficacy|0|||
13102834|NCT03369704|25869766|FG001|Treatment Epoch|Lack of Efficacy|2|||
13102835|NCT03369704|25869765|FG000|Treatment Epoch|Adverse Event|2|||
13102836|NCT03369704|25869766|FG001|Treatment Epoch|Adverse Event|0|||
13102837|NCT03369704|25869765|FG000|Follow-up Epoch|Lost to Follow-up|1|||
13102838|NCT03369704|25869766|FG001|Follow-up Epoch|Lost to Follow-up|0|||
13102839|NCT03369418|25869781|FG000|Overall Study|Withdrawal by Subject|3|||
13102840|NCT03369418|25869782|FG001|Overall Study|Withdrawal by Subject|3|||
13102841|NCT03368859|25869813|FG000|Overall Study|Withdrew Consent|5|||
13102842|NCT03368859|25869814|FG001|Overall Study|Withdrew Consent|4|||
13102843|NCT03368859|25869813|FG000|Overall Study|Death|12|||
13102844|NCT03368859|25869814|FG001|Overall Study|Death|6|||
13102845|NCT03368859|25869813|FG000|Overall Study|Study terminated by Sponsor|18|||
13102846|NCT03368859|25869814|FG001|Overall Study|Study terminated by Sponsor|23|||
13102847|NCT03368859|25869813|FG000|Overall Study|Other|1|||
13102848|NCT03368859|25869814|FG001|Overall Study|Other|1|||
13102849|NCT03368807|25869830|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3|||
13102850|NCT03368807|25869830|FG000|Period 1 (Blinded CGM)|Protocol Violation|1|||
13153003|NCT02531633|26056871|FG004|Part B (104 Weeks)|Lost to Follow-up|0|||
13102851|NCT03368807|25869830|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1|||
13153004|NCT02531633|26056872|FG005|Part B (104 Weeks)|Lost to Follow-up|0|||
13153005|NCT02531633|26056873|FG006|Part B (104 Weeks)|Lost to Follow-up|0|||
13153006|NCT02531633|26056874|FG007|Part B (104 Weeks)|Lost to Follow-up|1|||
13153007|NCT02531633|26056875|FG008|Part B (104 Weeks)|Lost to Follow-up|0|||
13153008|NCT02531633|26056876|FG009|Part B (104 Weeks)|Lost to Follow-up|0|||
13153009|NCT02531594|26056907|FG000|Overall Study|Withdrawal by Subject|7|||
13153010|NCT02531594|26056908|FG001|Overall Study|Withdrawal by Subject|8|||
13153011|NCT02531438|26056925|FG000|Overall Study|Adverse Event|7|||
13153012|NCT02531438|26056926|FG001|Overall Study|Adverse Event|9|||
13153013|NCT02531438|26056925|FG000|Overall Study|Lost to Follow-up|0|||
13153014|NCT02531438|26056926|FG001|Overall Study|Lost to Follow-up|3|||
13153015|NCT02531438|26056925|FG000|Overall Study|Withdrawal by Subject|7|||
13153016|NCT02531438|26056926|FG001|Overall Study|Withdrawal by Subject|8|||
13153017|NCT02531438|26056925|FG000|Overall Study|Physician Decision|0|||
13153018|NCT02531438|26056926|FG001|Overall Study|Physician Decision|1|||
13153019|NCT02531438|26056925|FG000|Overall Study|Death|6|||
13153020|NCT02531438|26056926|FG001|Overall Study|Death|3|||
13153021|NCT02531438|26056925|FG000|Overall Study|Randomized, but Not Treated|4|||
13153022|NCT02531438|26056926|FG001|Overall Study|Randomized, but Not Treated|0|||
13153023|NCT02531438|26056925|FG000|Overall Study|Missed EOT/PTE Visit|5|||
13153024|NCT02531438|26056926|FG001|Overall Study|Missed EOT/PTE Visit|2|||
13153025|NCT02531438|26056925|FG000|Overall Study|Randomized with Exclusion Criteria|1|||
13153026|NCT02531438|26056926|FG001|Overall Study|Randomized with Exclusion Criteria|0|||
13153027|NCT02531373|26057011|FG000|Overall Study|Lack of Efficacy|0|||
13153028|NCT02531373|26057012|FG001|Overall Study|Lack of Efficacy|0|||
13153029|NCT02531373|26057013|FG002|Overall Study|Lack of Efficacy|0|||
13153030|NCT02531373|26057014|FG003|Overall Study|Lack of Efficacy|0|||
13153031|NCT02531373|26057015|FG004|Overall Study|Lack of Efficacy|3|||
13153032|NCT02531373|26057016|FG005|Overall Study|Lack of Efficacy|2|||
13153033|NCT02531373|26057017|FG006|Overall Study|Lack of Efficacy|4|||
13153034|NCT02531373|26057018|FG007|Overall Study|Lack of Efficacy|8|||
13153035|NCT02531373|26057019|FG008|Overall Study|Lack of Efficacy|5|||
13153036|NCT02531373|26057011|FG000|Overall Study|Lost to Follow-up|0|||
13153037|NCT02531373|26057012|FG001|Overall Study|Lost to Follow-up|0|||
13153038|NCT02531373|26057013|FG002|Overall Study|Lost to Follow-up|0|||
13153039|NCT02531373|26057014|FG003|Overall Study|Lost to Follow-up|0|||
13153040|NCT02531373|26057015|FG004|Overall Study|Lost to Follow-up|0|||
13153041|NCT02531373|26057016|FG005|Overall Study|Lost to Follow-up|2|||
13153042|NCT02531373|26057017|FG006|Overall Study|Lost to Follow-up|2|||
13153043|NCT02531373|26057018|FG007|Overall Study|Lost to Follow-up|0|||
13153044|NCT02531373|26057019|FG008|Overall Study|Lost to Follow-up|0|||
13153045|NCT02531373|26057011|FG000|Overall Study|Physician Decision|0|||
13153046|NCT02531373|26057012|FG001|Overall Study|Physician Decision|0|||
13153047|NCT02531373|26057013|FG002|Overall Study|Physician Decision|0|||
13153048|NCT02531373|26057014|FG003|Overall Study|Physician Decision|0|||
13153049|NCT02531373|26057015|FG004|Overall Study|Physician Decision|2|||
13153050|NCT02531373|26057016|FG005|Overall Study|Physician Decision|1|||
13153051|NCT02531373|26057017|FG006|Overall Study|Physician Decision|0|||
13153052|NCT02531373|26057018|FG007|Overall Study|Physician Decision|0|||
13153053|NCT02531373|26057019|FG008|Overall Study|Physician Decision|0|||
13153054|NCT02531373|26057011|FG000|Overall Study|Protocol Violation|0|||
13153055|NCT02531373|26057012|FG001|Overall Study|Protocol Violation|0|||
13153056|NCT02531373|26057013|FG002|Overall Study|Protocol Violation|0|||
13153057|NCT02531373|26057014|FG003|Overall Study|Protocol Violation|0|||
13153058|NCT02531373|26057015|FG004|Overall Study|Protocol Violation|0|||
13153059|NCT02531373|26057016|FG005|Overall Study|Protocol Violation|1|||
13153060|NCT02531373|26057017|FG006|Overall Study|Protocol Violation|1|||
13153061|NCT02531373|26057018|FG007|Overall Study|Protocol Violation|0|||
13153062|NCT02531373|26057019|FG008|Overall Study|Protocol Violation|1|||
13153063|NCT02531373|26057011|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
13153064|NCT02531373|26057012|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
13153065|NCT02531373|26057013|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
13153066|NCT02531373|26057014|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
13153067|NCT02531373|26057015|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
13153068|NCT02531373|26057016|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
13153069|NCT02531373|26057017|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
13153070|NCT02531373|26057018|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
13153071|NCT02531373|26057019|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
13102852|NCT03368807|25869830|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1|||
13102853|NCT03368664|25869841|FG000|Phase1: Prior DMT:Month -4 to Month 0|Physician Decision|1|||
13102854|NCT03368664|25869841|FG000|Phase1: Prior DMT:Month -4 to Month 0|Participant was withdrawn from study|1|||
13102855|NCT03368664|25869841|FG000|Phase1: Prior DMT:Month -4 to Month 0|Principal Investigator and Parents Decision|1|||
13102856|NCT03368664|25869841|FG000|Phase1: Prior DMT:Month -4 to Month 0|Still on Prior DMT Phase or missing Completion|1|||
13102857|NCT03368170|25869860|FG000|Overall Study|Adverse Event|2|||
13102858|NCT03368170|25869861|FG001|Overall Study|Adverse Event|1|||
13102859|NCT03367793|25869921|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
13102860|NCT03367793|25869922|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
13102861|NCT03367793|25869923|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1|||
13102862|NCT03367793|25869924|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
13153072|NCT02531373|26057011|FG000|Overall Study|Withdrawal by Subject|0|||
13153073|NCT02531373|26057012|FG001|Overall Study|Withdrawal by Subject|0|||
13153074|NCT02531373|26057013|FG002|Overall Study|Withdrawal by Subject|0|||
13153075|NCT02531373|26057014|FG003|Overall Study|Withdrawal by Subject|0|||
13153076|NCT02531373|26057015|FG004|Overall Study|Withdrawal by Subject|3|||
13153077|NCT02531373|26057016|FG005|Overall Study|Withdrawal by Subject|0|||
13153078|NCT02531373|26057017|FG006|Overall Study|Withdrawal by Subject|0|||
13153079|NCT02531373|26057018|FG007|Overall Study|Withdrawal by Subject|0|||
13153080|NCT02531373|26057019|FG008|Overall Study|Withdrawal by Subject|0|||
13153081|NCT02531113|26057055|FG000|Induction Period: Week 0 to 12|Adverse Event|4|||
13153082|NCT02531113|26057055|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4|||
13153083|NCT02531113|26057055|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3|||
13153084|NCT02531113|26057055|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2|||
13153085|NCT02531113|26057055|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5|||
13153086|NCT02531113|26057055|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19|||
13153087|NCT02531113|26057055|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11|||
13153088|NCT02531113|26057055|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1|||
13153089|NCT02531035|26057076|FG000|Overall Study|Death|0|||
13153090|NCT02531035|26057077|FG001|Overall Study|Death|1|||
13153091|NCT02531035|26057076|FG000|Overall Study|Protocol Violation|1|||
13153092|NCT02531035|26057077|FG001|Overall Study|Protocol Violation|1|||
13153093|NCT02531035|26057076|FG000|Overall Study|Noncompliance with study drug|8|||
13153094|NCT02531035|26057077|FG001|Overall Study|Noncompliance with study drug|3|||
13153095|NCT02531035|26057076|FG000|Overall Study|Physician Decision|1|||
13153096|NCT02531035|26057077|FG001|Overall Study|Physician Decision|0|||
13153097|NCT02531035|26057076|FG000|Overall Study|Adverse Event|16|||
13153098|NCT02531035|26057077|FG001|Overall Study|Adverse Event|45|||
13153099|NCT02531035|26057076|FG000|Overall Study|Other|3|||
13153100|NCT02531035|26057077|FG001|Overall Study|Other|2|||
13153101|NCT02531035|26057076|FG000|Overall Study|Withdrawal by Subject|42|||
13153102|NCT02531035|26057077|FG001|Overall Study|Withdrawal by Subject|32|||
13153103|NCT02531035|26057076|FG000|Overall Study|Lost to Follow-up|8|||
13153104|NCT02531035|26057077|FG001|Overall Study|Lost to Follow-up|10|||
13153105|NCT02531035|26057076|FG000|Overall Study|Randomized, not treated|2|||
13153106|NCT02531035|26057077|FG001|Overall Study|Randomized, not treated|1|||
13153107|NCT02530970|26057084|FG000|Overall Study|Adverse Event|8|||
13153108|NCT02530970|26057084|FG000|Overall Study|Lost to Follow-up|88|||
13153109|NCT02530970|26057084|FG000|Overall Study|Physician Decision|5|||
13153110|NCT02530970|26057084|FG000|Overall Study|Withdrawal by Subject|14|||
13153111|NCT02530970|26057084|FG000|Overall Study|Death|6|||
13153112|NCT02530970|26057084|FG000|Overall Study|Hospitalization|1|||
13153113|NCT02530970|26057084|FG000|Overall Study|Insurance|2|||
13153114|NCT02530970|26057084|FG000|Overall Study|Explant|2|||
13153115|NCT02530970|26057084|FG000|Overall Study|Change in Provider|5|||
13102863|NCT03367793|25869925|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
13102864|NCT03367793|25869926|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
13102865|NCT03366428|25869941|FG000|Overall Study|Progressive disease per RECIST v1.1|33|||
13102866|NCT03366428|25869941|FG000|Overall Study|Adverse Event|12|||
13102867|NCT03366428|25869941|FG000|Overall Study|Clinical progression|2|||
13102868|NCT03366428|25869941|FG000|Overall Study|Withdrawal by Subject|4|||
13102869|NCT03366194|25869948|FG000|Overall Study|Lost to Follow-up|2|||
13102870|NCT03365934|25870223|FG000|Overall Study|Adverse Event|1|||
13102871|NCT03365934|25870223|FG000|Overall Study|Withdrawal by Subject|1|||
13102872|NCT03365791|25870238|FG000|Overall Study|Adverse Event|5|||
13102873|NCT03365791|25870238|FG000|Overall Study|Death|1|||
13102874|NCT03365791|25870238|FG000|Overall Study|Lost to Follow-up|1|||
13102875|NCT03365791|25870238|FG000|Overall Study|Physician Decision|9|||
13102876|NCT03365791|25870238|FG000|Overall Study|Progressive disease|51|||
13102877|NCT03365791|25870238|FG000|Overall Study|Subject/guardian decision|5|||
13102878|NCT03365011|25870255|FG000|Overall Study|Withdrawal by Subject|1|||
13102879|NCT03365011|25870256|FG001|Overall Study|Withdrawal by Subject|2|||
13102880|NCT03364686|25870266|FG000|Overall Study|Physician Decision|2|||
13102881|NCT03364608|25870290|FG000|Overall Study|Withdrawal by Subject|4|||
13102882|NCT03364608|25870290|FG000|Overall Study|Protocol Violation|2|||
13102883|NCT03364608|25870290|FG000|Overall Study|Lost to Follow-up|2|||
13102884|NCT03364335|25870378|FG000|Overall Study|Adverse Event|3|||
13102885|NCT03364335|25870379|FG001|Overall Study|Adverse Event|4|||
13102886|NCT03364335|25870380|FG002|Overall Study|Adverse Event|1|||
13102887|NCT03364335|25870381|FG003|Overall Study|Adverse Event|2|||
13102888|NCT03364335|25870382|FG004|Overall Study|Adverse Event|0|||
13102889|NCT03364335|25870378|FG000|Overall Study|Lost to Follow-up|7|||
13102890|NCT03364335|25870379|FG001|Overall Study|Lost to Follow-up|7|||
13102891|NCT03364335|25870380|FG002|Overall Study|Lost to Follow-up|10|||
13102892|NCT03364335|25870381|FG003|Overall Study|Lost to Follow-up|11|||
13102893|NCT03364335|25870382|FG004|Overall Study|Lost to Follow-up|11|||
13102894|NCT03364309|25870477|FG000|Induction Period|Adverse Event|4|||
13102895|NCT03364309|25870478|FG001|Induction Period|Adverse Event|0|||
13102896|NCT03364309|25870479|FG002|Induction Period|Adverse Event|1|||
13153116|NCT02530970|26057084|FG000|Overall Study|Relocation|3|||
13153117|NCT02530905|26057179|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
13153118|NCT02530905|26057180|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
13153119|NCT02530905|26057181|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1|||
13153120|NCT02530671|26057204|FG000|Overall Study|Lost to Follow-up|2|||
13153121|NCT02530671|26057205|FG001|Overall Study|Lost to Follow-up|0|||
13153122|NCT02530671|26057204|FG000|Overall Study|Withdrawal by Subject|1|||
13153123|NCT02530671|26057205|FG001|Overall Study|Withdrawal by Subject|0|||
13153124|NCT02530619|26057211|FG000|Registered for Study|Withdrawal by Subject|2|||
13153125|NCT02530619|26057211|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2|||
13153126|NCT02530619|26057211|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2|||
13153127|NCT02530619|26057211|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4|||
13153128|NCT02530619|26057211|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2|||
13153129|NCT02530619|26057211|FG000|Follow-up Period (6 Months)|Death|4|||
13153130|NCT02530619|26057211|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2|||
13153131|NCT02530619|26057211|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5|||
13153132|NCT02530385|26057232|FG000|Overall Study|Withdrawal by Subject|0|||
13153133|NCT02530385|26057233|FG001|Overall Study|Withdrawal by Subject|1|||
13153134|NCT02530242|26057246|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0|||
13153135|NCT02530242|26057247|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1|||
13153136|NCT02530125|26057261|FG000|Completed Treatment|Early termination of study|1|||
13153137|NCT02530125|26057261|FG000|Followed for Survival for 2 Years|Early termination of study|3|||
13153138|NCT02529995|26057302|FG000|Part A|Ongoing Study at Data Cut-off|14|||
13153139|NCT02529995|26057303|FG001|Part A|Ongoing Study at Data Cut-off|16|||
13153140|NCT02529995|26057302|FG000|Part A|Discontinued Study|1|||
13153141|NCT02529995|26057303|FG001|Part A|Discontinued Study|0|||
13153142|NCT02529995|26057302|FG000|Part B|Ongoing Study at Data Cut-off|0|||
13153143|NCT02529995|26057303|FG001|Part B|Ongoing Study at Data Cut-off|7|||
13153144|NCT02529995|26057302|FG000|Part B|Discontinued Study|6|||
13153145|NCT02529995|26057303|FG001|Part B|Discontinued Study|5|||
13153146|NCT02529553|26057370|FG000|Overall Study|Progressive Disease|1|||
13153147|NCT02529553|26057371|FG001|Overall Study|Progressive Disease|0|||
13153148|NCT02529553|26057372|FG002|Overall Study|Progressive Disease|1|||
13102897|NCT03364309|25870480|FG003|Induction Period|Adverse Event|0|||
13102898|NCT03364309|25870481|FG004|Induction Period|Adverse Event|0|||
13102899|NCT03364309|25870482|FG005|Induction Period|Adverse Event|0|||
13102900|NCT03364309|25870483|FG006|Induction Period|Adverse Event|0|||
13102901|NCT03364309|25870484|FG007|Induction Period|Adverse Event|0|||
13102902|NCT03364309|25870485|FG008|Induction Period|Adverse Event|0|||
13102903|NCT03364309|25870486|FG009|Induction Period|Adverse Event|0|||
13102904|NCT03364309|25870487|FG010|Induction Period|Adverse Event|0|||
13102905|NCT03364309|25870488|FG011|Induction Period|Adverse Event|0|||
13102906|NCT03364309|25870489|FG012|Induction Period|Adverse Event|0|||
13102907|NCT03364309|25870490|FG013|Induction Period|Adverse Event|0|||
13102908|NCT03364309|25870491|FG014|Induction Period|Adverse Event|0|||
13102909|NCT03364309|25870492|FG015|Induction Period|Adverse Event|0|||
13102910|NCT03364309|25870493|FG016|Induction Period|Adverse Event|0|||
13102911|NCT03364309|25870494|FG017|Induction Period|Adverse Event|0|||
13102912|NCT03364309|25870495|FG018|Induction Period|Adverse Event|0|||
13102913|NCT03364309|25870477|FG000|Induction Period|Withdrawal by Subject|1|||
13102914|NCT03364309|25870478|FG001|Induction Period|Withdrawal by Subject|3|||
13102915|NCT03364309|25870479|FG002|Induction Period|Withdrawal by Subject|0|||
13102916|NCT03364309|25870480|FG003|Induction Period|Withdrawal by Subject|0|||
13102917|NCT03364309|25870481|FG004|Induction Period|Withdrawal by Subject|0|||
13102918|NCT03364309|25870482|FG005|Induction Period|Withdrawal by Subject|0|||
13102919|NCT03364309|25870483|FG006|Induction Period|Withdrawal by Subject|0|||
13102920|NCT03364309|25870484|FG007|Induction Period|Withdrawal by Subject|0|||
13102921|NCT03364309|25870485|FG008|Induction Period|Withdrawal by Subject|0|||
13102922|NCT03364309|25870486|FG009|Induction Period|Withdrawal by Subject|0|||
13102923|NCT03364309|25870487|FG010|Induction Period|Withdrawal by Subject|0|||
13102924|NCT03364309|25870488|FG011|Induction Period|Withdrawal by Subject|0|||
13102925|NCT03364309|25870489|FG012|Induction Period|Withdrawal by Subject|0|||
13102926|NCT03364309|25870490|FG013|Induction Period|Withdrawal by Subject|0|||
13132957|NCT02780856|25985929|FG000|Overall Study|Lost to Follow-up|1|||
13132958|NCT02780713|25986012|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
13132959|NCT02780713|25986013|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
13132960|NCT02780713|25986014|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2|||
13132961|NCT02780713|25986015|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
13132962|NCT02780713|25986016|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
13132963|NCT02780700|25986026|FG000|Overall Study|Progressive disease|1|||
13132964|NCT02780687|25986044|FG000|Overall Study|Adverse Event|1|||
13132965|NCT02780687|25986045|FG001|Overall Study|Adverse Event|1|||
13132966|NCT02780687|25986044|FG000|Overall Study|Withdrawal by Subject|2|||
13132967|NCT02780687|25986045|FG001|Overall Study|Withdrawal by Subject|1|||
13132968|NCT02780687|25986044|FG000|Overall Study|Switched to commercial program (in CTP)|2|||
13132969|NCT02780687|25986045|FG001|Overall Study|Switched to commercial program (in CTP)|0|||
13102927|NCT03364309|25870491|FG014|Induction Period|Withdrawal by Subject|0|||
13102928|NCT03364309|25870492|FG015|Induction Period|Withdrawal by Subject|0|||
13102929|NCT03364309|25870493|FG016|Induction Period|Withdrawal by Subject|0|||
13153149|NCT02529553|26057373|FG003|Overall Study|Progressive Disease|3|||
13153150|NCT02529553|26057374|FG004|Overall Study|Progressive Disease|2|||
13153151|NCT02529553|26057375|FG005|Overall Study|Progressive Disease|3|||
13153152|NCT02529553|26057376|FG006|Overall Study|Progressive Disease|3|||
13153153|NCT02529553|26057377|FG007|Overall Study|Progressive Disease|5|||
13153154|NCT02529553|26057378|FG008|Overall Study|Progressive Disease|3|||
13153155|NCT02529553|26057370|FG000|Overall Study|Physician Decision|0|||
13153156|NCT02529553|26057371|FG001|Overall Study|Physician Decision|1|||
13153157|NCT02529553|26057372|FG002|Overall Study|Physician Decision|0|||
13153158|NCT02529553|26057373|FG003|Overall Study|Physician Decision|0|||
13153159|NCT02529553|26057374|FG004|Overall Study|Physician Decision|1|||
13153160|NCT02529553|26057375|FG005|Overall Study|Physician Decision|0|||
13153161|NCT02529553|26057376|FG006|Overall Study|Physician Decision|0|||
13153162|NCT02529553|26057377|FG007|Overall Study|Physician Decision|0|||
13153163|NCT02529553|26057378|FG008|Overall Study|Physician Decision|0|||
13153164|NCT02529553|26057370|FG000|Overall Study|Withdrawal by Subject|0|||
13153165|NCT02529553|26057371|FG001|Overall Study|Withdrawal by Subject|0|||
13153166|NCT02529553|26057372|FG002|Overall Study|Withdrawal by Subject|0|||
13153167|NCT02529553|26057373|FG003|Overall Study|Withdrawal by Subject|0|||
13153168|NCT02529553|26057374|FG004|Overall Study|Withdrawal by Subject|0|||
13153169|NCT02529553|26057375|FG005|Overall Study|Withdrawal by Subject|1|||
13153170|NCT02529553|26057376|FG006|Overall Study|Withdrawal by Subject|0|||
13153171|NCT02529553|26057377|FG007|Overall Study|Withdrawal by Subject|1|||
13153172|NCT02529553|26057378|FG008|Overall Study|Withdrawal by Subject|0|||
13153173|NCT02529488|26057388|FG000|Overall Study|Adverse Event|1|||
13153174|NCT02529488|26057388|FG000|Overall Study|Death|3|||
13153175|NCT02529137|26057395|FG000|Overall Study|Discontinuation for different reasons|8|||
13153176|NCT02528942|26057402|FG000|Overall Study|Did not meet imaging criteria|9|||
13153177|NCT02528942|26057402|FG000|Overall Study|Lost to Follow-up|25|||
13102930|NCT03364309|25870494|FG017|Induction Period|Withdrawal by Subject|0|||
13102931|NCT03364309|25870495|FG018|Induction Period|Withdrawal by Subject|0|||
13102932|NCT03364309|25870477|FG000|Induction Period|Lost to Follow-up|1|||
13102933|NCT03364309|25870478|FG001|Induction Period|Lost to Follow-up|0|||
13102934|NCT03364309|25870479|FG002|Induction Period|Lost to Follow-up|0|||
13102935|NCT03364309|25870480|FG003|Induction Period|Lost to Follow-up|0|||
13132970|NCT02780687|25986044|FG000|Overall Study|progressive disease|29|||
13132971|NCT02780687|25986045|FG001|Overall Study|progressive disease|6|||
13132972|NCT02780388|25986118|FG000|Overall Study|Lost to Follow-up|0|||
13132973|NCT02780388|25986119|FG001|Overall Study|Lost to Follow-up|1|||
13132974|NCT02780388|25986120|FG002|Overall Study|Lost to Follow-up|0|||
13132975|NCT02780388|25986121|FG003|Overall Study|Lost to Follow-up|0|||
13132976|NCT02780388|25986122|FG004|Overall Study|Lost to Follow-up|0|||
13132977|NCT02780388|25986118|FG000|Overall Study|Withdrawal by Subject|1|||
13132978|NCT02780388|25986119|FG001|Overall Study|Withdrawal by Subject|1|||
13132979|NCT02780388|25986120|FG002|Overall Study|Withdrawal by Subject|0|||
13132980|NCT02780388|25986121|FG003|Overall Study|Withdrawal by Subject|0|||
13132981|NCT02780388|25986122|FG004|Overall Study|Withdrawal by Subject|0|||
13132982|NCT02780167|25986270|FG000|Overall Study|Adverse Event|9|||
13132983|NCT02780167|25986271|FG001|Overall Study|Adverse Event|8|||
13132984|NCT02780167|25986272|FG002|Overall Study|Adverse Event|8|||
13132985|NCT02780167|25986273|FG003|Overall Study|Adverse Event|12|||
13132986|NCT02780167|25986274|FG004|Overall Study|Adverse Event|8|||
13132987|NCT02780167|25986270|FG000|Overall Study|Lack of Efficacy|6|||
13132988|NCT02780167|25986271|FG001|Overall Study|Lack of Efficacy|5|||
13132989|NCT02780167|25986272|FG002|Overall Study|Lack of Efficacy|6|||
13132990|NCT02780167|25986273|FG003|Overall Study|Lack of Efficacy|1|||
13132991|NCT02780167|25986274|FG004|Overall Study|Lack of Efficacy|0|||
13132992|NCT02780167|25986270|FG000|Overall Study|Lost to Follow-up|2|||
13132993|NCT02780167|25986271|FG001|Overall Study|Lost to Follow-up|0|||
13132994|NCT02780167|25986272|FG002|Overall Study|Lost to Follow-up|1|||
13132995|NCT02780167|25986273|FG003|Overall Study|Lost to Follow-up|0|||
13132996|NCT02780167|25986274|FG004|Overall Study|Lost to Follow-up|0|||
13132997|NCT02780167|25986270|FG000|Overall Study|Does not meet entrance criteria|0|||
13132998|NCT02780167|25986271|FG001|Overall Study|Does not meet entrance criteria|0|||
13132999|NCT02780167|25986272|FG002|Overall Study|Does not meet entrance criteria|1|||
13133000|NCT02780167|25986273|FG003|Overall Study|Does not meet entrance criteria|0|||
13133001|NCT02780167|25986274|FG004|Overall Study|Does not meet entrance criteria|0|||
13133002|NCT02780167|25986270|FG000|Overall Study|No longer meets eligibility criteria|0|||
13133003|NCT02780167|25986271|FG001|Overall Study|No longer meets eligibility criteria|0|||
13133004|NCT02780167|25986272|FG002|Overall Study|No longer meets eligibility criteria|0|||
13133005|NCT02780167|25986273|FG003|Overall Study|No longer meets eligibility criteria|1|||
13133006|NCT02780167|25986274|FG004|Overall Study|No longer meets eligibility criteria|1|||
13102936|NCT03364309|25870481|FG004|Induction Period|Lost to Follow-up|0|||
13102937|NCT03364309|25870482|FG005|Induction Period|Lost to Follow-up|0|||
13102938|NCT03364309|25870483|FG006|Induction Period|Lost to Follow-up|0|||
13102939|NCT03364309|25870484|FG007|Induction Period|Lost to Follow-up|0|||
13102940|NCT03364309|25870485|FG008|Induction Period|Lost to Follow-up|0|||
13102941|NCT03364309|25870486|FG009|Induction Period|Lost to Follow-up|0|||
13102942|NCT03364309|25870487|FG010|Induction Period|Lost to Follow-up|0|||
13102943|NCT03364309|25870488|FG011|Induction Period|Lost to Follow-up|0|||
13102944|NCT03364309|25870489|FG012|Induction Period|Lost to Follow-up|0|||
13102945|NCT03364309|25870490|FG013|Induction Period|Lost to Follow-up|0|||
13102946|NCT03364309|25870491|FG014|Induction Period|Lost to Follow-up|0|||
13102947|NCT03364309|25870492|FG015|Induction Period|Lost to Follow-up|0|||
13102948|NCT03364309|25870493|FG016|Induction Period|Lost to Follow-up|0|||
13102949|NCT03364309|25870494|FG017|Induction Period|Lost to Follow-up|0|||
13102950|NCT03364309|25870495|FG018|Induction Period|Lost to Follow-up|0|||
13102951|NCT03364309|25870477|FG000|Induction Period|Physician Decision|0|||
13102952|NCT03364309|25870478|FG001|Induction Period|Physician Decision|1|||
13102953|NCT03364309|25870479|FG002|Induction Period|Physician Decision|0|||
13102954|NCT03364309|25870480|FG003|Induction Period|Physician Decision|0|||
13102955|NCT03364309|25870481|FG004|Induction Period|Physician Decision|0|||
13102956|NCT03364309|25870482|FG005|Induction Period|Physician Decision|0|||
13102957|NCT03364309|25870483|FG006|Induction Period|Physician Decision|0|||
13102958|NCT03364309|25870484|FG007|Induction Period|Physician Decision|0|||
13102959|NCT03364309|25870485|FG008|Induction Period|Physician Decision|0|||
13102960|NCT03364309|25870486|FG009|Induction Period|Physician Decision|0|||
13102961|NCT03364309|25870487|FG010|Induction Period|Physician Decision|0|||
13102962|NCT03364309|25870488|FG011|Induction Period|Physician Decision|0|||
13102963|NCT03364309|25870489|FG012|Induction Period|Physician Decision|0|||
13102964|NCT03364309|25870490|FG013|Induction Period|Physician Decision|0|||
13102965|NCT03364309|25870491|FG014|Induction Period|Physician Decision|0|||
13102966|NCT03364309|25870492|FG015|Induction Period|Physician Decision|0|||
13102967|NCT03364309|25870493|FG016|Induction Period|Physician Decision|0|||
13102968|NCT03364309|25870494|FG017|Induction Period|Physician Decision|0|||
13102969|NCT03364309|25870495|FG018|Induction Period|Physician Decision|0|||
13102970|NCT03364309|25870477|FG000|Maintenance Period|Withdrawal by Subject|0|||
13102971|NCT03364309|25870478|FG001|Maintenance Period|Withdrawal by Subject|0|||
13102972|NCT03364309|25870479|FG002|Maintenance Period|Withdrawal by Subject|0|||
13102973|NCT03364309|25870480|FG003|Maintenance Period|Withdrawal by Subject|1|||
13102974|NCT03364309|25870481|FG004|Maintenance Period|Withdrawal by Subject|3|||
13102975|NCT03364309|25870482|FG005|Maintenance Period|Withdrawal by Subject|1|||
13102976|NCT03364309|25870483|FG006|Maintenance Period|Withdrawal by Subject|3|||
13102977|NCT03364309|25870484|FG007|Maintenance Period|Withdrawal by Subject|0|||
13102978|NCT03364309|25870485|FG008|Maintenance Period|Withdrawal by Subject|1|||
13102979|NCT03364309|25870486|FG009|Maintenance Period|Withdrawal by Subject|1|||
13102980|NCT03364309|25870487|FG010|Maintenance Period|Withdrawal by Subject|2|||
13102981|NCT03364309|25870488|FG011|Maintenance Period|Withdrawal by Subject|0|||
13102982|NCT03364309|25870489|FG012|Maintenance Period|Withdrawal by Subject|0|||
13102983|NCT03364309|25870490|FG013|Maintenance Period|Withdrawal by Subject|0|||
13153178|NCT02528357|26057840|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
13153179|NCT02528357|26057841|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1|||
13153180|NCT02528357|26057842|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
13153181|NCT02528357|26057843|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
13153182|NCT02528357|26057844|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
13153183|NCT02528357|26057845|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
13153184|NCT02528357|26057846|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
13153185|NCT02528357|26057847|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
13153186|NCT02528357|26057848|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
13153187|NCT02528357|26057849|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
13153188|NCT02528357|26057850|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
13153189|NCT02528357|26057851|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
13153190|NCT02528357|26057852|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
13485344|NCT03739138|27032563|FG002|Overall Study|Death|4|||
13102984|NCT03364309|25870491|FG014|Maintenance Period|Withdrawal by Subject|0|||
13102985|NCT03364309|25870492|FG015|Maintenance Period|Withdrawal by Subject|0|||
13102986|NCT03364309|25870493|FG016|Maintenance Period|Withdrawal by Subject|0|||
13102987|NCT03364309|25870494|FG017|Maintenance Period|Withdrawal by Subject|0|||
13102988|NCT03364309|25870495|FG018|Maintenance Period|Withdrawal by Subject|0|||
13102989|NCT03364309|25870477|FG000|Maintenance Period|Adverse Event|0|||
13102990|NCT03364309|25870478|FG001|Maintenance Period|Adverse Event|0|||
13102991|NCT03364309|25870479|FG002|Maintenance Period|Adverse Event|0|||
13102992|NCT03364309|25870480|FG003|Maintenance Period|Adverse Event|0|||
13102993|NCT03364309|25870481|FG004|Maintenance Period|Adverse Event|2|||
13102994|NCT03364309|25870482|FG005|Maintenance Period|Adverse Event|0|||
13102995|NCT03364309|25870483|FG006|Maintenance Period|Adverse Event|3|||
13102996|NCT03364309|25870484|FG007|Maintenance Period|Adverse Event|0|||
13102997|NCT03364309|25870485|FG008|Maintenance Period|Adverse Event|1|||
13102998|NCT03364309|25870486|FG009|Maintenance Period|Adverse Event|0|||
13102999|NCT03364309|25870487|FG010|Maintenance Period|Adverse Event|2|||
13103000|NCT03364309|25870488|FG011|Maintenance Period|Adverse Event|0|||
13103001|NCT03364309|25870489|FG012|Maintenance Period|Adverse Event|0|||
13103002|NCT03364309|25870490|FG013|Maintenance Period|Adverse Event|0|||
13103003|NCT03364309|25870491|FG014|Maintenance Period|Adverse Event|0|||
13103004|NCT03364309|25870492|FG015|Maintenance Period|Adverse Event|0|||
13103005|NCT03364309|25870493|FG016|Maintenance Period|Adverse Event|0|||
13103006|NCT03364309|25870494|FG017|Maintenance Period|Adverse Event|0|||
13103007|NCT03364309|25870495|FG018|Maintenance Period|Adverse Event|0|||
13103008|NCT03364309|25870477|FG000|Maintenance Period|Relapsed|0|||
13103009|NCT03364309|25870478|FG001|Maintenance Period|Relapsed|0|||
13103010|NCT03364309|25870479|FG002|Maintenance Period|Relapsed|0|||
13103011|NCT03364309|25870480|FG003|Maintenance Period|Relapsed|43|||
13103012|NCT03364309|25870481|FG004|Maintenance Period|Relapsed|7|||
13103013|NCT03364309|25870482|FG005|Maintenance Period|Relapsed|45|||
13103014|NCT03364309|25870483|FG006|Maintenance Period|Relapsed|10|||
13103015|NCT03364309|25870484|FG007|Maintenance Period|Relapsed|2|||
13103016|NCT03364309|25870485|FG008|Maintenance Period|Relapsed|0|||
13103017|NCT03364309|25870486|FG009|Maintenance Period|Relapsed|0|||
13103018|NCT03364309|25870487|FG010|Maintenance Period|Relapsed|0|||
13103019|NCT03364309|25870488|FG011|Maintenance Period|Relapsed|0|||
13103020|NCT03364309|25870489|FG012|Maintenance Period|Relapsed|0|||
13103021|NCT03364309|25870490|FG013|Maintenance Period|Relapsed|0|||
13103022|NCT03364309|25870491|FG014|Maintenance Period|Relapsed|0|||
13103023|NCT03364309|25870492|FG015|Maintenance Period|Relapsed|0|||
13103024|NCT03364309|25870493|FG016|Maintenance Period|Relapsed|0|||
13103025|NCT03364309|25870494|FG017|Maintenance Period|Relapsed|0|||
13103026|NCT03364309|25870495|FG018|Maintenance Period|Relapsed|0|||
13103027|NCT03364309|25870477|FG000|Maintenance Period|Lack of Efficacy|0|||
13103028|NCT03364309|25870478|FG001|Maintenance Period|Lack of Efficacy|0|||
13103029|NCT03364309|25870479|FG002|Maintenance Period|Lack of Efficacy|0|||
13103030|NCT03364309|25870480|FG003|Maintenance Period|Lack of Efficacy|0|||
13103031|NCT03364309|25870481|FG004|Maintenance Period|Lack of Efficacy|0|||
13103032|NCT03364309|25870482|FG005|Maintenance Period|Lack of Efficacy|0|||
13103033|NCT03364309|25870483|FG006|Maintenance Period|Lack of Efficacy|0|||
13103034|NCT03364309|25870484|FG007|Maintenance Period|Lack of Efficacy|0|||
13103035|NCT03364309|25870485|FG008|Maintenance Period|Lack of Efficacy|1|||
13103036|NCT03364309|25870486|FG009|Maintenance Period|Lack of Efficacy|3|||
13103037|NCT03364309|25870487|FG010|Maintenance Period|Lack of Efficacy|2|||
13103038|NCT03364309|25870488|FG011|Maintenance Period|Lack of Efficacy|0|||
13103039|NCT03364309|25870489|FG012|Maintenance Period|Lack of Efficacy|0|||
13103040|NCT03364309|25870490|FG013|Maintenance Period|Lack of Efficacy|0|||
13103041|NCT03364309|25870491|FG014|Maintenance Period|Lack of Efficacy|0|||
13103042|NCT03364309|25870492|FG015|Maintenance Period|Lack of Efficacy|0|||
13103043|NCT03364309|25870493|FG016|Maintenance Period|Lack of Efficacy|0|||
13103044|NCT03364309|25870494|FG017|Maintenance Period|Lack of Efficacy|0|||
13103045|NCT03364309|25870495|FG018|Maintenance Period|Lack of Efficacy|0|||
13103046|NCT03364309|25870477|FG000|Maintenance Period|Death|0|||
13103047|NCT03364309|25870478|FG001|Maintenance Period|Death|0|||
13103048|NCT03364309|25870479|FG002|Maintenance Period|Death|0|||
13103049|NCT03364309|25870480|FG003|Maintenance Period|Death|0|||
13103050|NCT03364309|25870481|FG004|Maintenance Period|Death|0|||
13103051|NCT03364309|25870482|FG005|Maintenance Period|Death|0|||
13103052|NCT03364309|25870483|FG006|Maintenance Period|Death|0|||
13103053|NCT03364309|25870484|FG007|Maintenance Period|Death|0|||
13103054|NCT03364309|25870485|FG008|Maintenance Period|Death|1|||
13153191|NCT02528357|26057853|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
13153192|NCT02528357|26057854|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
13153193|NCT02528357|26057855|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
13153194|NCT02528357|26057856|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
13153195|NCT02528357|26057857|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
13153196|NCT02528357|26057858|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
13103055|NCT03364309|25870486|FG009|Maintenance Period|Death|0|||
13103056|NCT03364309|25870487|FG010|Maintenance Period|Death|0|||
13103057|NCT03364309|25870488|FG011|Maintenance Period|Death|0|||
13103058|NCT03364309|25870489|FG012|Maintenance Period|Death|0|||
13103059|NCT03364309|25870490|FG013|Maintenance Period|Death|0|||
13103060|NCT03364309|25870491|FG014|Maintenance Period|Death|0|||
13103061|NCT03364309|25870492|FG015|Maintenance Period|Death|0|||
13103062|NCT03364309|25870493|FG016|Maintenance Period|Death|0|||
13103063|NCT03364309|25870494|FG017|Maintenance Period|Death|0|||
13103064|NCT03364309|25870495|FG018|Maintenance Period|Death|0|||
13103065|NCT03364309|25870477|FG000|Maintenance Period|Lost to Follow-up|0|||
13103066|NCT03364309|25870478|FG001|Maintenance Period|Lost to Follow-up|0|||
13103067|NCT03364309|25870479|FG002|Maintenance Period|Lost to Follow-up|0|||
13153197|NCT02528357|26057840|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
13153198|NCT02528357|26057841|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
13153199|NCT02528357|26057842|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
13153200|NCT02528357|26057843|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
13153201|NCT02528357|26057844|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
13153202|NCT02528357|26057845|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2|||
13153203|NCT02528357|26057846|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
13153204|NCT02528357|26057847|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
13153205|NCT02528357|26057848|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
13153206|NCT02528357|26057849|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
13153207|NCT02528357|26057850|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
13153208|NCT02528357|26057851|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
13153209|NCT02528357|26057852|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
13153210|NCT02528357|26057853|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
13153211|NCT02528357|26057854|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
13153212|NCT02528357|26057855|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
13103068|NCT03364309|25870480|FG003|Maintenance Period|Lost to Follow-up|0|||
13103069|NCT03364309|25870481|FG004|Maintenance Period|Lost to Follow-up|0|||
13103070|NCT03364309|25870482|FG005|Maintenance Period|Lost to Follow-up|0|||
13103071|NCT03364309|25870483|FG006|Maintenance Period|Lost to Follow-up|0|||
13103072|NCT03364309|25870484|FG007|Maintenance Period|Lost to Follow-up|0|||
13103073|NCT03364309|25870485|FG008|Maintenance Period|Lost to Follow-up|1|||
13103074|NCT03364309|25870486|FG009|Maintenance Period|Lost to Follow-up|0|||
13103075|NCT03364309|25870487|FG010|Maintenance Period|Lost to Follow-up|0|||
13103076|NCT03364309|25870488|FG011|Maintenance Period|Lost to Follow-up|0|||
13103077|NCT03364309|25870489|FG012|Maintenance Period|Lost to Follow-up|0|||
13103078|NCT03364309|25870490|FG013|Maintenance Period|Lost to Follow-up|0|||
13103079|NCT03364309|25870491|FG014|Maintenance Period|Lost to Follow-up|0|||
13103080|NCT03364309|25870492|FG015|Maintenance Period|Lost to Follow-up|0|||
13103081|NCT03364309|25870493|FG016|Maintenance Period|Lost to Follow-up|0|||
13103082|NCT03364309|25870494|FG017|Maintenance Period|Lost to Follow-up|0|||
13103083|NCT03364309|25870495|FG018|Maintenance Period|Lost to Follow-up|0|||
13103084|NCT03364309|25870477|FG000|Maintenance Period|Miscellaneous|0|||
13103085|NCT03364309|25870478|FG001|Maintenance Period|Miscellaneous|0|||
13103086|NCT03364309|25870479|FG002|Maintenance Period|Miscellaneous|0|||
13103087|NCT03364309|25870480|FG003|Maintenance Period|Miscellaneous|0|||
13103088|NCT03364309|25870481|FG004|Maintenance Period|Miscellaneous|0|||
13103089|NCT03364309|25870482|FG005|Maintenance Period|Miscellaneous|0|||
13103090|NCT03364309|25870483|FG006|Maintenance Period|Miscellaneous|0|||
13103091|NCT03364309|25870484|FG007|Maintenance Period|Miscellaneous|0|||
13103092|NCT03364309|25870485|FG008|Maintenance Period|Miscellaneous|1|||
13103093|NCT03364309|25870486|FG009|Maintenance Period|Miscellaneous|0|||
13103094|NCT03364309|25870487|FG010|Maintenance Period|Miscellaneous|0|||
13103095|NCT03364309|25870488|FG011|Maintenance Period|Miscellaneous|0|||
13103096|NCT03364309|25870489|FG012|Maintenance Period|Miscellaneous|0|||
13103097|NCT03364309|25870490|FG013|Maintenance Period|Miscellaneous|0|||
13103098|NCT03364309|25870491|FG014|Maintenance Period|Miscellaneous|0|||
13103099|NCT03364309|25870492|FG015|Maintenance Period|Miscellaneous|0|||
13103100|NCT03364309|25870493|FG016|Maintenance Period|Miscellaneous|0|||
13103101|NCT03364309|25870494|FG017|Maintenance Period|Miscellaneous|0|||
13103102|NCT03364309|25870495|FG018|Maintenance Period|Miscellaneous|0|||
13103103|NCT03364309|25870477|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
13103104|NCT03364309|25870478|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
13103105|NCT03364309|25870479|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
13103106|NCT03364309|25870480|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
13103107|NCT03364309|25870481|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
13103108|NCT03364309|25870482|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
13103109|NCT03364309|25870483|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
13103110|NCT03364309|25870484|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
13103111|NCT03364309|25870485|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
13103112|NCT03364309|25870486|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
13103113|NCT03364309|25870487|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
13103114|NCT03364309|25870488|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
13103115|NCT03364309|25870489|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
13103116|NCT03364309|25870490|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
13103117|NCT03364309|25870491|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
13103118|NCT03364309|25870492|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
13103119|NCT03364309|25870493|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
13103120|NCT03364309|25870494|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
13103121|NCT03364309|25870495|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
13153213|NCT02528357|26057856|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
13153214|NCT02528357|26057857|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
13153215|NCT02528357|26057858|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
13153216|NCT02528357|26057840|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
13153217|NCT02528357|26057841|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
13153218|NCT02528357|26057842|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
13153219|NCT02528357|26057843|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
13153220|NCT02528357|26057844|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3|||
13153221|NCT02528357|26057845|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
13153222|NCT02528357|26057846|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
13153223|NCT02528357|26057847|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1|||
13153224|NCT02528357|26057848|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
13153225|NCT02528357|26057849|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
13153226|NCT02528357|26057850|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
13153227|NCT02528357|26057851|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
13153228|NCT02528357|26057852|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
13153229|NCT02528357|26057853|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
13153230|NCT02528357|26057854|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
13153231|NCT02528357|26057855|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
13153232|NCT02528357|26057856|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
13153233|NCT02528357|26057857|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
13153234|NCT02528357|26057858|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
13153235|NCT02528357|26057840|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
13153236|NCT02528357|26057841|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
13153237|NCT02528357|26057842|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
13153238|NCT02528357|26057843|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
13153239|NCT02528357|26057844|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
13153240|NCT02528357|26057845|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
13153241|NCT02528357|26057846|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
13153242|NCT02528357|26057847|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
13153243|NCT02528357|26057848|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
13153244|NCT02528357|26057849|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
13153245|NCT02528357|26057850|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
13153246|NCT02528357|26057851|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
13153247|NCT02528357|26057852|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
13153248|NCT02528357|26057853|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
13153249|NCT02528357|26057854|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
13153250|NCT02528357|26057855|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
13153251|NCT02528357|26057856|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
13153252|NCT02528357|26057857|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
13153253|NCT02528357|26057858|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
13153254|NCT02528357|26057840|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
13153255|NCT02528357|26057841|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
13153256|NCT02528357|26057842|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
13153257|NCT02528357|26057843|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
13153258|NCT02528357|26057844|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
13103122|NCT03364309|25870477|FG000|Re-treatment (Maintenance) Period|Adverse Event|0|||
13103123|NCT03364309|25870478|FG001|Re-treatment (Maintenance) Period|Adverse Event|0|||
13103124|NCT03364309|25870479|FG002|Re-treatment (Maintenance) Period|Adverse Event|0|||
13103125|NCT03364309|25870480|FG003|Re-treatment (Maintenance) Period|Adverse Event|0|||
13103126|NCT03364309|25870481|FG004|Re-treatment (Maintenance) Period|Adverse Event|0|||
13103127|NCT03364309|25870482|FG005|Re-treatment (Maintenance) Period|Adverse Event|0|||
13103128|NCT03364309|25870483|FG006|Re-treatment (Maintenance) Period|Adverse Event|0|||
13103129|NCT03364309|25870484|FG007|Re-treatment (Maintenance) Period|Adverse Event|0|||
13103130|NCT03364309|25870485|FG008|Re-treatment (Maintenance) Period|Adverse Event|0|||
13103131|NCT03364309|25870486|FG009|Re-treatment (Maintenance) Period|Adverse Event|0|||
13103132|NCT03364309|25870487|FG010|Re-treatment (Maintenance) Period|Adverse Event|0|||
13103133|NCT03364309|25870488|FG011|Re-treatment (Maintenance) Period|Adverse Event|0|||
13103134|NCT03364309|25870489|FG012|Re-treatment (Maintenance) Period|Adverse Event|0|||
13103135|NCT03364309|25870490|FG013|Re-treatment (Maintenance) Period|Adverse Event|0|||
13103136|NCT03364309|25870491|FG014|Re-treatment (Maintenance) Period|Adverse Event|1|||
13103137|NCT03364309|25870492|FG015|Re-treatment (Maintenance) Period|Adverse Event|0|||
13103138|NCT03364309|25870493|FG016|Re-treatment (Maintenance) Period|Adverse Event|0|||
13222688|NCT01803607|26286774|FG001|Overall Study|Study terminated by sponsor|56|||
13103139|NCT03364309|25870494|FG017|Re-treatment (Maintenance) Period|Adverse Event|0|||
13103140|NCT03364309|25870495|FG018|Re-treatment (Maintenance) Period|Adverse Event|0|||
13103141|NCT03364309|25870477|FG000|Re-treatment (Maintenance) Period|Relapse|0|||
13103142|NCT03364309|25870478|FG001|Re-treatment (Maintenance) Period|Relapse|0|||
13103143|NCT03364309|25870479|FG002|Re-treatment (Maintenance) Period|Relapse|0|||
13103144|NCT03364309|25870480|FG003|Re-treatment (Maintenance) Period|Relapse|0|||
13103145|NCT03364309|25870481|FG004|Re-treatment (Maintenance) Period|Relapse|0|||
13103146|NCT03364309|25870482|FG005|Re-treatment (Maintenance) Period|Relapse|0|||
13103147|NCT03364309|25870483|FG006|Re-treatment (Maintenance) Period|Relapse|0|||
13103148|NCT03364309|25870484|FG007|Re-treatment (Maintenance) Period|Relapse|0|||
13103149|NCT03364309|25870485|FG008|Re-treatment (Maintenance) Period|Relapse|0|||
13103150|NCT03364309|25870486|FG009|Re-treatment (Maintenance) Period|Relapse|0|||
13103151|NCT03364309|25870487|FG010|Re-treatment (Maintenance) Period|Relapse|0|||
13103152|NCT03364309|25870488|FG011|Re-treatment (Maintenance) Period|Relapse|0|||
13103153|NCT03364309|25870489|FG012|Re-treatment (Maintenance) Period|Relapse|1|||
13103154|NCT03364309|25870490|FG013|Re-treatment (Maintenance) Period|Relapse|0|||
13103155|NCT03364309|25870491|FG014|Re-treatment (Maintenance) Period|Relapse|0|||
13103156|NCT03364309|25870492|FG015|Re-treatment (Maintenance) Period|Relapse|1|||
13103157|NCT03364309|25870493|FG016|Re-treatment (Maintenance) Period|Relapse|0|||
13103158|NCT03364309|25870494|FG017|Re-treatment (Maintenance) Period|Relapse|0|||
13103159|NCT03364309|25870495|FG018|Re-treatment (Maintenance) Period|Relapse|0|||
13103160|NCT03364309|25870477|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0|||
13103161|NCT03364309|25870478|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0|||
13103162|NCT03364309|25870479|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0|||
13103163|NCT03364309|25870480|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0|||
13103164|NCT03364309|25870481|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
13103165|NCT03364309|25870482|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0|||
13103166|NCT03364309|25870483|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0|||
13103167|NCT03364309|25870484|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0|||
13103168|NCT03364309|25870485|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0|||
13103169|NCT03364309|25870486|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0|||
13103170|NCT03364309|25870487|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0|||
13103171|NCT03364309|25870488|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0|||
13103172|NCT03364309|25870489|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0|||
13103173|NCT03364309|25870490|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0|||
13103174|NCT03364309|25870491|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0|||
13103175|NCT03364309|25870492|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0|||
13103176|NCT03364309|25870493|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3|||
13103177|NCT03364309|25870494|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19|||
13103178|NCT03364309|25870495|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1|||
13103179|NCT03364309|25870477|FG000|Post-Treatment Followup Period|Adverse Event|0|||
13103180|NCT03364309|25870478|FG001|Post-Treatment Followup Period|Adverse Event|0|||
13103181|NCT03364309|25870479|FG002|Post-Treatment Followup Period|Adverse Event|0|||
13103182|NCT03364309|25870480|FG003|Post-Treatment Followup Period|Adverse Event|0|||
13103183|NCT03364309|25870481|FG004|Post-Treatment Followup Period|Adverse Event|0|||
13103184|NCT03364309|25870482|FG005|Post-Treatment Followup Period|Adverse Event|0|||
13103185|NCT03364309|25870483|FG006|Post-Treatment Followup Period|Adverse Event|0|||
13103186|NCT03364309|25870484|FG007|Post-Treatment Followup Period|Adverse Event|0|||
13103187|NCT03364309|25870485|FG008|Post-Treatment Followup Period|Adverse Event|0|||
13103188|NCT03364309|25870486|FG009|Post-Treatment Followup Period|Adverse Event|0|||
13103189|NCT03364309|25870487|FG010|Post-Treatment Followup Period|Adverse Event|0|||
13103190|NCT03364309|25870488|FG011|Post-Treatment Followup Period|Adverse Event|0|||
13103191|NCT03364309|25870489|FG012|Post-Treatment Followup Period|Adverse Event|0|||
13103192|NCT03364309|25870490|FG013|Post-Treatment Followup Period|Adverse Event|0|||
13103193|NCT03364309|25870491|FG014|Post-Treatment Followup Period|Adverse Event|0|||
13103194|NCT03364309|25870492|FG015|Post-Treatment Followup Period|Adverse Event|0|||
13103195|NCT03364309|25870493|FG016|Post-Treatment Followup Period|Adverse Event|2|||
13103196|NCT03364309|25870494|FG017|Post-Treatment Followup Period|Adverse Event|6|||
13103197|NCT03364309|25870495|FG018|Post-Treatment Followup Period|Adverse Event|1|||
13103198|NCT03364309|25870477|FG000|Post-Treatment Followup Period|Lost to Follow-up|0|||
13103199|NCT03364309|25870478|FG001|Post-Treatment Followup Period|Lost to Follow-up|0|||
13103200|NCT03364309|25870479|FG002|Post-Treatment Followup Period|Lost to Follow-up|0|||
13103201|NCT03364309|25870480|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
13103202|NCT03364309|25870481|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
13103203|NCT03364309|25870482|FG005|Post-Treatment Followup Period|Lost to Follow-up|0|||
13153259|NCT02528357|26057845|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
13153260|NCT02528357|26057846|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
13153261|NCT02528357|26057847|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
13153262|NCT02528357|26057848|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
13153263|NCT02528357|26057849|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
13153264|NCT02528357|26057850|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
13153265|NCT02528357|26057851|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
13153266|NCT02528357|26057852|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
13153267|NCT02528357|26057853|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1|||
13153268|NCT02528357|26057854|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5|||
13153269|NCT02528357|26057855|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
13153270|NCT02528357|26057856|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
13153271|NCT02528357|26057857|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
13153272|NCT02528357|26057858|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
13153273|NCT02528357|26057840|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
13485345|NCT03739138|27032564|FG003|Overall Study|Death|13|||
13103204|NCT03364309|25870483|FG006|Post-Treatment Followup Period|Lost to Follow-up|0|||
13103205|NCT03364309|25870484|FG007|Post-Treatment Followup Period|Lost to Follow-up|0|||
13103206|NCT03364309|25870485|FG008|Post-Treatment Followup Period|Lost to Follow-up|0|||
13103207|NCT03364309|25870486|FG009|Post-Treatment Followup Period|Lost to Follow-up|0|||
13103208|NCT03364309|25870487|FG010|Post-Treatment Followup Period|Lost to Follow-up|0|||
13103209|NCT03364309|25870488|FG011|Post-Treatment Followup Period|Lost to Follow-up|0|||
13103210|NCT03364309|25870489|FG012|Post-Treatment Followup Period|Lost to Follow-up|0|||
13103211|NCT03364309|25870490|FG013|Post-Treatment Followup Period|Lost to Follow-up|0|||
13103212|NCT03364309|25870491|FG014|Post-Treatment Followup Period|Lost to Follow-up|0|||
13103213|NCT03364309|25870492|FG015|Post-Treatment Followup Period|Lost to Follow-up|0|||
13103214|NCT03364309|25870493|FG016|Post-Treatment Followup Period|Lost to Follow-up|0|||
13103215|NCT03364309|25870494|FG017|Post-Treatment Followup Period|Lost to Follow-up|2|||
13103216|NCT03364309|25870495|FG018|Post-Treatment Followup Period|Lost to Follow-up|0|||
13103217|NCT03364309|25870477|FG000|Post-Treatment Followup Period|Miscellaneous|0|||
13103218|NCT03364309|25870478|FG001|Post-Treatment Followup Period|Miscellaneous|0|||
13103219|NCT03364309|25870479|FG002|Post-Treatment Followup Period|Miscellaneous|0|||
13103220|NCT03364309|25870480|FG003|Post-Treatment Followup Period|Miscellaneous|0|||
13103221|NCT03364309|25870481|FG004|Post-Treatment Followup Period|Miscellaneous|0|||
13103222|NCT03364309|25870482|FG005|Post-Treatment Followup Period|Miscellaneous|0|||
13103223|NCT03364309|25870483|FG006|Post-Treatment Followup Period|Miscellaneous|0|||
13103224|NCT03364309|25870484|FG007|Post-Treatment Followup Period|Miscellaneous|0|||
13103225|NCT03364309|25870485|FG008|Post-Treatment Followup Period|Miscellaneous|0|||
13103226|NCT03364309|25870486|FG009|Post-Treatment Followup Period|Miscellaneous|0|||
13103227|NCT03364309|25870487|FG010|Post-Treatment Followup Period|Miscellaneous|0|||
13103228|NCT03364309|25870488|FG011|Post-Treatment Followup Period|Miscellaneous|0|||
13103229|NCT03364309|25870489|FG012|Post-Treatment Followup Period|Miscellaneous|0|||
13103230|NCT03364309|25870490|FG013|Post-Treatment Followup Period|Miscellaneous|0|||
13103231|NCT03364309|25870491|FG014|Post-Treatment Followup Period|Miscellaneous|0|||
13103232|NCT03364309|25870492|FG015|Post-Treatment Followup Period|Miscellaneous|0|||
13103233|NCT03364309|25870493|FG016|Post-Treatment Followup Period|Miscellaneous|0|||
13103234|NCT03364309|25870494|FG017|Post-Treatment Followup Period|Miscellaneous|4|||
13103235|NCT03364309|25870495|FG018|Post-Treatment Followup Period|Miscellaneous|0|||
13103236|NCT03364192|25870504|FG000|Overall Study|Ineligible|10|||
13103237|NCT03364192|25870504|FG000|Overall Study|Withdrawal by Subject|5|||
13103238|NCT03364192|25870504|FG000|Overall Study|Lost to Follow-up|1|||
13103239|NCT03364049|25870563|FG000|Overall Study|Death|6|||
13103240|NCT03364049|25870564|FG001|Overall Study|Death|4|||
13103241|NCT03364049|25870565|FG002|Overall Study|Death|5|||
13103242|NCT03364049|25870566|FG003|Overall Study|Death|14|||
13103243|NCT03364049|25870563|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
13103244|NCT03364049|25870564|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1|||
13103245|NCT03364049|25870565|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
13103246|NCT03364049|25870566|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
13103247|NCT03364049|25870563|FG000|Overall Study|Withdrawal by Subject|0|||
13103248|NCT03364049|25870564|FG001|Overall Study|Withdrawal by Subject|1|||
13103249|NCT03364049|25870565|FG002|Overall Study|Withdrawal by Subject|1|||
13103250|NCT03364049|25870566|FG003|Overall Study|Withdrawal by Subject|1|||
13103251|NCT03364036|25870574|FG000|Overall Study|Adverse Event|1|||
13103252|NCT03364036|25870574|FG000|Overall Study|Lost to Follow-up|1|||
13103253|NCT03364036|25870574|FG000|Overall Study|Withdrew Consent|1|||
13103254|NCT03364036|25870574|FG000|Overall Study|Protocol Non-Compliance|1|||
13103255|NCT03364036|25870574|FG000|Overall Study|Other|2|||
13103256|NCT03364023|25870583|FG000|Overall Study|Lost to Follow-up|3|||
13103257|NCT03364023|25870583|FG000|Overall Study|Death|14|||
13103258|NCT03363906|25870594|FG000|Period 1 (Reference or Test)|Adverse Event|1|||
13103259|NCT03363906|25870595|FG001|Period 1 (Reference or Test)|Adverse Event|2|||
13103260|NCT03363906|25870594|FG000|Period 2 (Test or Reference)|Adverse Event|2|||
13103261|NCT03363906|25870595|FG001|Period 2 (Test or Reference)|Adverse Event|0|||
13103262|NCT03363906|25870594|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
13103263|NCT03363906|25870595|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
13103264|NCT03363906|25870594|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1|||
13103265|NCT03363906|25870595|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0|||
13103266|NCT03363776|25870697|FG000|Overall Study|Progressive disease|2|||
13103267|NCT03363776|25870698|FG001|Overall Study|Progressive disease|3|||
13103268|NCT03363776|25870699|FG002|Overall Study|Progressive disease|1|||
13103269|NCT03363776|25870697|FG000|Overall Study|Study drug toxicity|0|||
13103270|NCT03363776|25870698|FG001|Overall Study|Study drug toxicity|0|||
13103271|NCT03363776|25870699|FG002|Overall Study|Study drug toxicity|1|||
13103272|NCT03363776|25870697|FG000|Overall Study|Death|1|||
13103273|NCT03363776|25870698|FG001|Overall Study|Death|0|||
13103274|NCT03363776|25870699|FG002|Overall Study|Death|0|||
13103275|NCT03363321|25870753|FG000|Overall Study|Withdrawal by Subject|0|||
13103276|NCT03363321|25870754|FG001|Overall Study|Withdrawal by Subject|1|||
13103277|NCT03363321|25870755|FG002|Overall Study|Withdrawal by Subject|0|||
13153274|NCT02528357|26057841|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
13153275|NCT02528357|26057842|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
13153276|NCT02528357|26057843|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
13153277|NCT02528357|26057844|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
13153278|NCT02528357|26057845|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
13153279|NCT02528357|26057846|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
13153280|NCT02528357|26057847|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
13153281|NCT02528357|26057848|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
13153282|NCT02528357|26057849|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
13153283|NCT02528357|26057850|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
13153284|NCT02528357|26057851|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
13153285|NCT02528357|26057852|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
13153286|NCT02528357|26057853|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1|||
13153287|NCT02528357|26057854|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
13153288|NCT02528357|26057855|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
13153289|NCT02528357|26057856|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
13153290|NCT02528357|26057857|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
13153291|NCT02528357|26057858|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
13153292|NCT02528357|26057840|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
13153293|NCT02528357|26057841|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
13153294|NCT02528357|26057842|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
13153295|NCT02528357|26057843|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
13153296|NCT02528357|26057844|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
13153297|NCT02528357|26057845|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
13153298|NCT02528357|26057846|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
13153299|NCT02528357|26057847|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
13153300|NCT02528357|26057848|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
13153301|NCT02528357|26057849|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
13153302|NCT02528357|26057850|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
13153303|NCT02528357|26057851|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
13153304|NCT02528357|26057852|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
13103278|NCT03363321|25870756|FG003|Overall Study|Withdrawal by Subject|1|||
13103279|NCT03363321|25870757|FG004|Overall Study|Withdrawal by Subject|0|||
13103280|NCT03362190|25870796|FG000|Overall Study|Adverse Event|0|||
13103281|NCT03362190|25870797|FG001|Overall Study|Adverse Event|0|||
13103282|NCT03362190|25870798|FG002|Overall Study|Adverse Event|0|||
13103283|NCT03362190|25870799|FG003|Overall Study|Adverse Event|1|||
13103284|NCT03362190|25870796|FG000|Overall Study|Withdrawal by Subject|0|||
13103285|NCT03362190|25870797|FG001|Overall Study|Withdrawal by Subject|0|||
13103286|NCT03362190|25870798|FG002|Overall Study|Withdrawal by Subject|0|||
13103287|NCT03362190|25870799|FG003|Overall Study|Withdrawal by Subject|1|||
13103288|NCT03361956|25870968|FG000|Overall Study|Adverse Event|1|||
13103289|NCT03361956|25870969|FG001|Overall Study|Adverse Event|0|||
13103290|NCT03361956|25870970|FG002|Overall Study|Adverse Event|1|||
13103291|NCT03361956|25870971|FG003|Overall Study|Adverse Event|1|||
13103292|NCT03361956|25870972|FG004|Overall Study|Adverse Event|0|||
13103293|NCT03361956|25870968|FG000|Overall Study|Other|0|||
13103294|NCT03361956|25870969|FG001|Overall Study|Other|0|||
13103295|NCT03361956|25870970|FG002|Overall Study|Other|0|||
13103296|NCT03361956|25870971|FG003|Overall Study|Other|1|||
13103297|NCT03361956|25870972|FG004|Overall Study|Other|0|||
13103298|NCT03361956|25870968|FG000|Overall Study|Withdrawal by Subject|2|||
13103299|NCT03361956|25870969|FG001|Overall Study|Withdrawal by Subject|2|||
13103300|NCT03361956|25870970|FG002|Overall Study|Withdrawal by Subject|2|||
13103301|NCT03361956|25870971|FG003|Overall Study|Withdrawal by Subject|0|||
13103302|NCT03361956|25870972|FG004|Overall Study|Withdrawal by Subject|3|||
13103303|NCT03361956|25870968|FG000|Overall Study|Disease Relapse|0|||
13103304|NCT03361956|25870969|FG001|Overall Study|Disease Relapse|0|||
13103305|NCT03361956|25870970|FG002|Overall Study|Disease Relapse|1|||
13103306|NCT03361956|25870971|FG003|Overall Study|Disease Relapse|0|||
13103307|NCT03361956|25870972|FG004|Overall Study|Disease Relapse|0|||
13103308|NCT03361956|25870968|FG000|Overall Study|Physician Decision|0|||
13103309|NCT03361956|25870969|FG001|Overall Study|Physician Decision|2|||
13103310|NCT03361956|25870970|FG002|Overall Study|Physician Decision|0|||
13103311|NCT03361956|25870971|FG003|Overall Study|Physician Decision|1|||
13103312|NCT03361956|25870972|FG004|Overall Study|Physician Decision|0|||
13103313|NCT03361956|25870968|FG000|Overall Study|Lost to Follow-up|0|||
13103314|NCT03361956|25870969|FG001|Overall Study|Lost to Follow-up|0|||
13103315|NCT03361956|25870970|FG002|Overall Study|Lost to Follow-up|1|||
13103316|NCT03361956|25870971|FG003|Overall Study|Lost to Follow-up|1|||
13103317|NCT03361956|25870972|FG004|Overall Study|Lost to Follow-up|2|||
13103318|NCT03361605|25870979|FG000|Overall Study|Analyzable data not available|3|||
13103319|NCT03361423|25871006|FG000|Overall Study|Withdrawal by Subject|4|||
13103320|NCT03361423|25871007|FG001|Overall Study|Withdrawal by Subject|3|||
13103321|NCT03361423|25871006|FG000|Overall Study|Did not treat|19|||
13103322|NCT03361423|25871007|FG001|Overall Study|Did not treat|18|||
13103323|NCT03361423|25871006|FG000|Overall Study|Started >60 minutes from migraine onset|0|||
13103324|NCT03361423|25871007|FG001|Overall Study|Started >60 minutes from migraine onset|1|||
13103325|NCT03361423|25871006|FG000|Overall Study|Missing data|4|||
13103326|NCT03361423|25871007|FG001|Overall Study|Missing data|1|||
13103327|NCT03361293|25871034|FG000|Overall Study|Lost to Follow-up|0|||
13103328|NCT03361293|25871035|FG001|Overall Study|Lost to Follow-up|2|||
13103329|NCT03361293|25871034|FG000|Overall Study|Withdrawal by Subject|1|||
13103330|NCT03361293|25871035|FG001|Overall Study|Withdrawal by Subject|3|||
13103331|NCT03361228|25871062|FG000|Overall Study|Other|1|||
13103332|NCT03361228|25871063|FG001|Overall Study|Other|1|||
13103333|NCT03361228|25871062|FG000|Overall Study|Death|3|||
13103334|NCT03361228|25871063|FG001|Overall Study|Death|0|||
13103335|NCT03361176|25871080|FG000|Overall Study|Lost to Follow-up|1|||
13103336|NCT03361176|25871081|FG001|Overall Study|Lost to Follow-up|2|||
13103337|NCT03361176|25871080|FG000|Overall Study|Adverse Event|0|||
13103338|NCT03361176|25871081|FG001|Overall Study|Adverse Event|2|||
13103339|NCT03361176|25871080|FG000|Overall Study|Withdrawal by Subject|0|||
13153305|NCT02528357|26057853|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
13153306|NCT02528357|26057854|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
13153307|NCT02528357|26057855|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
13153308|NCT02528357|26057856|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
13153309|NCT02528357|26057857|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
13153310|NCT02528357|26057858|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
13153311|NCT02528357|26057840|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
13153312|NCT02528357|26057841|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
13153313|NCT02528357|26057842|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
13103340|NCT03361176|25871081|FG001|Overall Study|Withdrawal by Subject|1|||
13153314|NCT02528357|26057843|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
13153315|NCT02528357|26057844|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
13153316|NCT02528357|26057845|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
13153317|NCT02528357|26057846|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
13153318|NCT02528357|26057847|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
13153319|NCT02528357|26057848|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
13153320|NCT02528357|26057849|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
13153321|NCT02528357|26057850|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
13205181|NCT01967732|26231081|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
13103341|NCT03361137|25871136|FG000|Overall Study|Reason not specified|1|||
13103342|NCT03361137|25871137|FG001|Overall Study|Reason not specified|0|||
13103343|NCT03361137|25871138|FG002|Overall Study|Reason not specified|0|||
13103344|NCT03361137|25871139|FG003|Overall Study|Reason not specified|0|||
13103345|NCT03361137|25871140|FG004|Overall Study|Reason not specified|0|||
13153322|NCT02528357|26057851|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
13153323|NCT02528357|26057852|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
13153324|NCT02528357|26057853|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
13153325|NCT02528357|26057854|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
13153326|NCT02528357|26057855|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
13153327|NCT02528357|26057856|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
13153328|NCT02528357|26057857|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
13153329|NCT02528357|26057858|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
13153330|NCT02528357|26057840|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
13153331|NCT02528357|26057841|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
13153332|NCT02528357|26057842|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
13153333|NCT02528357|26057843|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
13153334|NCT02528357|26057844|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
13153335|NCT02528357|26057845|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
13153336|NCT02528357|26057846|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
13153337|NCT02528357|26057847|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
13153338|NCT02528357|26057848|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
13153339|NCT02528357|26057849|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
13153340|NCT02528357|26057850|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
13153341|NCT02528357|26057851|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
13153342|NCT02528357|26057852|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
13153343|NCT02528357|26057853|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
13153344|NCT02528357|26057854|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
13153345|NCT02528357|26057855|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
13153346|NCT02528357|26057856|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2|||
13153347|NCT02528357|26057857|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
13153348|NCT02528357|26057858|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
13153349|NCT02528357|26057840|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
13153350|NCT02528357|26057841|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
13153351|NCT02528357|26057842|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
13153352|NCT02528357|26057843|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
13222689|NCT01803607|26286773|FG000|Overall Study|Withdrawal by Subject|6|||
13103346|NCT03360747|25871155|FG000|Overall Study|Voluntary Withdrawal|1|||
13103347|NCT03360344|25871185|FG000|Overall Study|Withdrawal by Subject|0|||
13103348|NCT03360344|25871186|FG001|Overall Study|Withdrawal by Subject|1|||
13103349|NCT03360344|25871187|FG002|Overall Study|Withdrawal by Subject|1|||
13103350|NCT03360071|25871206|FG000|Overall Study|Lost to Follow-up|1|||
13103351|NCT03360071|25871207|FG001|Overall Study|Lost to Follow-up|0|||
13103352|NCT03359850|25871284|FG000|PK Phase (Up to Day 8)|Physician Decision|0|||
13103353|NCT03359850|25871285|FG001|PK Phase (Up to Day 8)|Physician Decision|1|||
13103354|NCT03359850|25871284|FG000|PK Phase (Up to Day 8)|Adverse Event|1|||
13103355|NCT03359850|25871285|FG001|PK Phase (Up to Day 8)|Adverse Event|0|||
13103356|NCT03359850|25871284|FG000|Extension Phase (Up to 28 Months)|Death|2|||
13103357|NCT03359850|25871285|FG001|Extension Phase (Up to 28 Months)|Death|4|||
13103358|NCT03359850|25871284|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1|||
13103359|NCT03359850|25871285|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2|||
13103360|NCT03359850|25871284|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5|||
13103361|NCT03359850|25871285|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0|||
13103362|NCT03359811|25871310|FG000|Overall Study|Protocol Violation|2|||
13103363|NCT03359811|25871311|FG001|Overall Study|Protocol Violation|0|||
13103364|NCT03359590|25871320|FG000|First Intervention|Withdrawal by Subject|1|||
13103365|NCT03359590|25871321|FG001|First Intervention|Withdrawal by Subject|1|||
13103366|NCT03359590|25871320|FG000|First Intervention|Protocol Violation|0|||
13103367|NCT03359590|25871321|FG001|First Intervention|Protocol Violation|1|||
13103368|NCT03359473|25871544|FG000|Overall Study|Adverse Event|0|||
13103369|NCT03359473|25871545|FG001|Overall Study|Adverse Event|2|||
13103370|NCT03359473|25871546|FG002|Overall Study|Adverse Event|5|||
13103371|NCT03359473|25871547|FG003|Overall Study|Adverse Event|3|||
13103372|NCT03359473|25871544|FG000|Overall Study|Lost to Follow-up|0|||
13103373|NCT03359473|25871545|FG001|Overall Study|Lost to Follow-up|1|||
13103374|NCT03359473|25871546|FG002|Overall Study|Lost to Follow-up|0|||
13103375|NCT03359473|25871547|FG003|Overall Study|Lost to Follow-up|0|||
13103376|NCT03359473|25871544|FG000|Overall Study|Physician Decision|0|||
13103377|NCT03359473|25871545|FG001|Overall Study|Physician Decision|1|||
13103378|NCT03359473|25871546|FG002|Overall Study|Physician Decision|0|||
13103379|NCT03359473|25871547|FG003|Overall Study|Physician Decision|1|||
13103380|NCT03359473|25871544|FG000|Overall Study|Withdrawal by Subject|1|||
13103381|NCT03359473|25871545|FG001|Overall Study|Withdrawal by Subject|2|||
13103382|NCT03359473|25871546|FG002|Overall Study|Withdrawal by Subject|1|||
13103383|NCT03359473|25871547|FG003|Overall Study|Withdrawal by Subject|0|||
13103384|NCT03359473|25871544|FG000|Overall Study|Protocol-defined stopping criteria|1|||
13103385|NCT03359473|25871545|FG001|Overall Study|Protocol-defined stopping criteria|0|||
13103386|NCT03359473|25871546|FG002|Overall Study|Protocol-defined stopping criteria|0|||
13103387|NCT03359473|25871547|FG003|Overall Study|Protocol-defined stopping criteria|1|||
13103388|NCT03359395|25871582|FG000|First Intervention A / B|Withdrawal by Subject|1|||
13103389|NCT03359395|25871583|FG001|First Intervention A / B|Withdrawal by Subject|0|||
13103390|NCT03359395|25871582|FG000|First Intervention A / B|Lost to Follow-up|2|||
13103391|NCT03359395|25871583|FG001|First Intervention A / B|Lost to Follow-up|3|||
13103392|NCT03359395|25871582|FG000|Second Intervention B/A|Exclusion criteria|0|||
13103393|NCT03359395|25871583|FG001|Second Intervention B/A|Exclusion criteria|1|||
13103394|NCT03359395|25871582|FG000|Second Intervention B/A|Lost to Follow-up|3|||
13103395|NCT03359395|25871583|FG001|Second Intervention B/A|Lost to Follow-up|2|||
13103396|NCT03359174|25871595|FG000|Overall Study|Adverse Event|1|||
13103397|NCT03358472|25871619|FG000|Overall Study|Death|6|||
13103398|NCT03358472|25871620|FG001|Overall Study|Death|3|||
13103399|NCT03358472|25871621|FG002|Overall Study|Death|10|||
13103400|NCT03358472|25871619|FG000|Overall Study|Physician Decision|0|||
13103401|NCT03358472|25871620|FG001|Overall Study|Physician Decision|1|||
13103402|NCT03358472|25871621|FG002|Overall Study|Physician Decision|0|||
13103403|NCT03358472|25871619|FG000|Overall Study|Withdrawal by Subject|0|||
13103404|NCT03358472|25871620|FG001|Overall Study|Withdrawal by Subject|0|||
13103405|NCT03358472|25871621|FG002|Overall Study|Withdrawal by Subject|1|||
13103406|NCT03358472|25871619|FG000|Overall Study|On-going at clinical cut off date|9|||
13103407|NCT03358472|25871620|FG001|Overall Study|On-going at clinical cut off date|6|||
13103408|NCT03358472|25871621|FG002|Overall Study|On-going at clinical cut off date|5|||
13103409|NCT03358407|25871914|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
13103410|NCT03358407|25871915|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
13103411|NCT03358407|25871916|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1|||
13103412|NCT03358407|25871917|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
13103413|NCT03358407|25871918|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
13103414|NCT03358407|25871919|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
13103415|NCT03358407|25871920|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
13103416|NCT03358407|25871921|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
13103417|NCT03358407|25871922|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
13103418|NCT03358407|25871923|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
13103419|NCT03358407|25871914|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
13103420|NCT03358407|25871915|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
13103421|NCT03358407|25871916|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
13103422|NCT03358407|25871917|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
13103423|NCT03358407|25871918|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1|||
13103424|NCT03358407|25871919|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
13103425|NCT03358407|25871920|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
13103426|NCT03358407|25871921|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
13103427|NCT03358407|25871922|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
13103428|NCT03358407|25871923|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
13103429|NCT03358407|25871914|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
13103430|NCT03358407|25871915|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
13153353|NCT02528357|26057844|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
13153354|NCT02528357|26057845|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
13153355|NCT02528357|26057846|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
13153356|NCT02528357|26057847|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
13103431|NCT03358407|25871916|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
13103432|NCT03358407|25871917|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
13103433|NCT03358407|25871918|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
13103434|NCT03358407|25871919|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1|||
13103435|NCT03358407|25871920|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
13153357|NCT02528357|26057848|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
13153358|NCT02528357|26057849|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
13153359|NCT02528357|26057850|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
13153360|NCT02528357|26057851|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
13153361|NCT02528357|26057852|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
13153362|NCT02528357|26057853|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
13153363|NCT02528357|26057854|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
13153364|NCT02528357|26057855|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
13153365|NCT02528357|26057856|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
13153366|NCT02528357|26057857|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
13153367|NCT02528357|26057858|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
13153368|NCT02528331|26057867|FG000|Overall Study|Withdrawal by Subject|2|||
13153369|NCT02528305|26057911|FG000|Overall Study|Withdrawal by Subject|1|||
13153370|NCT02528305|26057911|FG000|Overall Study|Adverse Event|1|||
13153371|NCT02528305|26057911|FG000|Overall Study|Physician Decision|1|||
13153372|NCT02528253|26058218|FG000|Overall Study|Adverse Event|3|||
13153373|NCT02528253|26058219|FG001|Overall Study|Adverse Event|4|||
13153374|NCT02528253|26058220|FG002|Overall Study|Adverse Event|4|||
13153375|NCT02528253|26058221|FG003|Overall Study|Adverse Event|8|||
13153376|NCT02528253|26058222|FG004|Overall Study|Adverse Event|18|||
13153377|NCT02528253|26058218|FG000|Overall Study|Death|2|||
13153378|NCT02528253|26058219|FG001|Overall Study|Death|2|||
13153379|NCT02528253|26058220|FG002|Overall Study|Death|1|||
13153380|NCT02528253|26058221|FG003|Overall Study|Death|0|||
13153381|NCT02528253|26058222|FG004|Overall Study|Death|1|||
13153382|NCT02528253|26058218|FG000|Overall Study|Insufficient clinical response|7|||
13153383|NCT02528253|26058219|FG001|Overall Study|Insufficient clinical response|10|||
13153384|NCT02528253|26058220|FG002|Overall Study|Insufficient clinical response|13|||
13153385|NCT02528253|26058221|FG003|Overall Study|Insufficient clinical response|12|||
13153386|NCT02528253|26058222|FG004|Overall Study|Insufficient clinical response|16|||
13153387|NCT02528253|26058218|FG000|Overall Study|Lost to Follow-up|16|||
13153388|NCT02528253|26058219|FG001|Overall Study|Lost to Follow-up|9|||
13153389|NCT02528253|26058220|FG002|Overall Study|Lost to Follow-up|31|||
13153390|NCT02528253|26058221|FG003|Overall Study|Lost to Follow-up|16|||
13153391|NCT02528253|26058222|FG004|Overall Study|Lost to Follow-up|34|||
13153392|NCT02528253|26058218|FG000|Overall Study|Other|21|||
13153393|NCT02528253|26058219|FG001|Overall Study|Other|22|||
13153394|NCT02528253|26058220|FG002|Overall Study|Other|58|||
13153395|NCT02528253|26058221|FG003|Overall Study|Other|52|||
13153396|NCT02528253|26058222|FG004|Overall Study|Other|76|||
13153397|NCT02528253|26058218|FG000|Overall Study|Withdrawal by Subject|25|||
13153398|NCT02528253|26058219|FG001|Overall Study|Withdrawal by Subject|20|||
13153399|NCT02528253|26058220|FG002|Overall Study|Withdrawal by Subject|29|||
13103436|NCT03358407|25871921|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2|||
13103437|NCT03358407|25871922|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
13103438|NCT03358407|25871923|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
13103439|NCT03358407|25871914|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
13103440|NCT03358407|25871915|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
13103441|NCT03358407|25871916|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
13103442|NCT03358407|25871917|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
13103443|NCT03358407|25871918|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
13103444|NCT03358407|25871919|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
13103445|NCT03358407|25871920|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
13103446|NCT03358407|25871921|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
13103447|NCT03358407|25871922|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
13103448|NCT03358407|25871923|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
13103449|NCT03358407|25871914|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
13103450|NCT03358407|25871915|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
13103451|NCT03358407|25871916|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
13133007|NCT02780167|25986270|FG000|Overall Study|Protocol Violation|5|||
13133008|NCT02780167|25986271|FG001|Overall Study|Protocol Violation|5|||
13133009|NCT02780167|25986272|FG002|Overall Study|Protocol Violation|1|||
13133010|NCT02780167|25986273|FG003|Overall Study|Protocol Violation|1|||
13133011|NCT02780167|25986274|FG004|Overall Study|Protocol Violation|2|||
13133012|NCT02780167|25986270|FG000|Overall Study|Withdrawal by Subject|6|||
13133013|NCT02780167|25986271|FG001|Overall Study|Withdrawal by Subject|4|||
13133014|NCT02780167|25986272|FG002|Overall Study|Withdrawal by Subject|4|||
13133015|NCT02780167|25986273|FG003|Overall Study|Withdrawal by Subject|3|||
13133016|NCT02780167|25986274|FG004|Overall Study|Withdrawal by Subject|4|||
13133017|NCT02780167|25986270|FG000|Overall Study|Other|0|||
13133018|NCT02780167|25986271|FG001|Overall Study|Other|0|||
13133019|NCT02780167|25986272|FG002|Overall Study|Other|3|||
13133020|NCT02780167|25986273|FG003|Overall Study|Other|1|||
13133021|NCT02780167|25986274|FG004|Overall Study|Other|2|||
13133022|NCT02780115|25986307|FG000|Overall Study|Withdrawal by Subject|0|||
13133023|NCT02780115|25986308|FG001|Overall Study|Withdrawal by Subject|1|||
13153400|NCT02528253|26058221|FG003|Overall Study|Withdrawal by Subject|48|||
13153401|NCT02528253|26058222|FG004|Overall Study|Withdrawal by Subject|73|||
13153402|NCT02528253|26058218|FG000|Overall Study|Protocol Violation|1|||
13153403|NCT02528253|26058219|FG001|Overall Study|Protocol Violation|2|||
13153404|NCT02528253|26058220|FG002|Overall Study|Protocol Violation|4|||
13103452|NCT03358407|25871917|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
13103453|NCT03358407|25871918|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
13103454|NCT03358407|25871919|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
13103455|NCT03358407|25871920|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
13103456|NCT03358407|25871921|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
13103457|NCT03358407|25871922|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
13103458|NCT03358407|25871923|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
13103459|NCT03358407|25871914|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
13103460|NCT03358407|25871915|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
13103461|NCT03358407|25871916|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
13103462|NCT03358407|25871917|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
13103463|NCT03358407|25871918|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
13103464|NCT03358407|25871919|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
13103465|NCT03358407|25871920|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
13103466|NCT03358407|25871921|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6|||
13103467|NCT03358407|25871922|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
13103468|NCT03358407|25871923|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
13103469|NCT03358329|25871931|FG000|Overall Study|Lost to Follow-up|2|||
13103470|NCT03358329|25871931|FG000|Overall Study|Withdrawal by Subject|2|||
13103471|NCT03358290|25872023|FG000|Overall Study|Study discontinued by Sponsor|0|||
13153405|NCT02528253|26058221|FG003|Overall Study|Protocol Violation|0|||
13153406|NCT02528253|26058222|FG004|Overall Study|Protocol Violation|4|||
13153407|NCT02528253|26058218|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
13153408|NCT02528253|26058219|FG001|Overall Study|Withdrawn Due to Pregnancy|1|||
13153409|NCT02528253|26058220|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
13153410|NCT02528253|26058221|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
13153411|NCT02528253|26058222|FG004|Overall Study|Withdrawn Due to Pregnancy|1|||
13153412|NCT02528214|26058261|FG000|Overall Study|Protocol Violation|0|||
13153413|NCT02528214|26058262|FG001|Overall Study|Protocol Violation|1|||
13153414|NCT02528214|26058261|FG000|Overall Study|Adverse Event|0|||
13153415|NCT02528214|26058262|FG001|Overall Study|Adverse Event|1|||
13153416|NCT02528214|26058261|FG000|Overall Study|Other than specified above|0|||
13153417|NCT02528214|26058262|FG001|Overall Study|Other than specified above|1|||
13153418|NCT02528188|26058522|FG000|Overall Study|Adverse Event|23|||
13153419|NCT02528188|26058523|FG001|Overall Study|Adverse Event|22|||
13153420|NCT02528188|26058524|FG002|Overall Study|Adverse Event|8|||
13153421|NCT02528188|26058522|FG000|Overall Study|Protocol Violation|4|||
13153422|NCT02528188|26058523|FG001|Overall Study|Protocol Violation|6|||
13153423|NCT02528188|26058524|FG002|Overall Study|Protocol Violation|4|||
13153424|NCT02528188|26058522|FG000|Overall Study|Lack of Efficacy|19|||
13153425|NCT02528188|26058523|FG001|Overall Study|Lack of Efficacy|21|||
13153426|NCT02528188|26058524|FG002|Overall Study|Lack of Efficacy|22|||
13153427|NCT02528188|26058522|FG000|Overall Study|Withdrawal by Subject|97|||
13153428|NCT02528188|26058523|FG001|Overall Study|Withdrawal by Subject|104|||
13153429|NCT02528188|26058524|FG002|Overall Study|Withdrawal by Subject|100|||
13153430|NCT02528188|26058522|FG000|Overall Study|Lost to Follow-up|25|||
13153431|NCT02528188|26058523|FG001|Overall Study|Lost to Follow-up|21|||
13153432|NCT02528188|26058524|FG002|Overall Study|Lost to Follow-up|31|||
13153433|NCT02528188|26058522|FG000|Overall Study|Death|4|||
13153434|NCT02528188|26058523|FG001|Overall Study|Death|4|||
13153435|NCT02528188|26058524|FG002|Overall Study|Death|0|||
13153436|NCT02528188|26058522|FG000|Overall Study|Other|89|||
13153437|NCT02528188|26058523|FG001|Overall Study|Other|91|||
13153438|NCT02528188|26058524|FG002|Overall Study|Other|74|||
13153439|NCT02528188|26058522|FG000|Overall Study|Randomized but not treated|6|||
13153440|NCT02528188|26058523|FG001|Overall Study|Randomized but not treated|7|||
13153441|NCT02528188|26058524|FG002|Overall Study|Randomized but not treated|12|||
13153442|NCT02527421|26058539|FG000|Overall Study|Withdrawal by Subject|1|||
13153443|NCT02527421|26058540|FG001|Overall Study|Withdrawal by Subject|0|||
13153444|NCT02527343|26058591|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1|||
13153445|NCT02527343|26058592|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
13153446|NCT02527343|26058593|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
13153447|NCT02527343|26058594|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
13153448|NCT02527343|26058595|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
13153449|NCT02527343|26058596|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
13153450|NCT02527343|26058591|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1|||
13153451|NCT02527343|26058592|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
13153452|NCT02527343|26058593|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
13153453|NCT02527343|26058594|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
13103472|NCT03358290|25872024|FG001|Overall Study|Study discontinued by Sponsor|1|||
13103473|NCT03358290|25872025|FG002|Overall Study|Study discontinued by Sponsor|1|||
13103474|NCT03358290|25872026|FG003|Overall Study|Study discontinued by Sponsor|0|||
13103475|NCT03358290|25872027|FG004|Overall Study|Study discontinued by Sponsor|0|||
13103476|NCT03358290|25872023|FG000|Overall Study|Adverse Event|0|||
13103477|NCT03358290|25872024|FG001|Overall Study|Adverse Event|0|||
13103478|NCT03358290|25872025|FG002|Overall Study|Adverse Event|1|||
13103479|NCT03358290|25872026|FG003|Overall Study|Adverse Event|2|||
13103480|NCT03358290|25872027|FG004|Overall Study|Adverse Event|0|||
13103481|NCT03358290|25872023|FG000|Overall Study|Withdrawal by Subject|0|||
13103482|NCT03358290|25872024|FG001|Overall Study|Withdrawal by Subject|0|||
13103483|NCT03358290|25872025|FG002|Overall Study|Withdrawal by Subject|0|||
13103484|NCT03358290|25872026|FG003|Overall Study|Withdrawal by Subject|0|||
13103485|NCT03358290|25872027|FG004|Overall Study|Withdrawal by Subject|1|||
13103486|NCT03358238|25872049|FG000|Overall Study|Withdrawal by Subject|0|||
13103487|NCT03358238|25872050|FG001|Overall Study|Withdrawal by Subject|1|||
13103488|NCT03358147|25872103|FG000|Overall Study|Withdrawal by Subject|13|||
13103489|NCT03358147|25872104|FG001|Overall Study|Withdrawal by Subject|19|||
13103490|NCT03358147|25872105|FG002|Overall Study|Withdrawal by Subject|16|||
13103491|NCT03358147|25872106|FG003|Overall Study|Withdrawal by Subject|10|||
13153454|NCT02527343|26058595|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
13153455|NCT02527343|26058596|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
13153456|NCT02527343|26058591|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
13153457|NCT02527343|26058592|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4|||
13153458|NCT02527343|26058593|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
13153459|NCT02527343|26058594|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
13153460|NCT02527343|26058595|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
13153461|NCT02527343|26058596|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
13153462|NCT02527343|26058591|FG000|RT Period: Weeks 1 to 52|Other|4|||
13153463|NCT02527343|26058592|FG001|RT Period: Weeks 1 to 52|Other|3|||
13153464|NCT02527343|26058593|FG002|RT Period: Weeks 1 to 52|Other|0|||
13153465|NCT02527343|26058594|FG003|RT Period: Weeks 1 to 52|Other|0|||
13153466|NCT02527343|26058595|FG004|RT Period: Weeks 1 to 52|Other|0|||
13153467|NCT02527343|26058596|FG005|RT Period: Weeks 1 to 52|Other|0|||
13153468|NCT02527343|26058591|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
13153469|NCT02527343|26058592|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
13153470|NCT02527343|26058593|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1|||
13153471|NCT02527343|26058594|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
13153472|NCT02527343|26058595|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
13153473|NCT02527343|26058596|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
13153474|NCT02527343|26058591|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
13153475|NCT02527343|26058592|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
13153476|NCT02527343|26058593|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
13153477|NCT02527343|26058594|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2|||
13153478|NCT02527343|26058595|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
13153479|NCT02527343|26058596|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
13153480|NCT02527343|26058591|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
13153481|NCT02527343|26058592|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
13153482|NCT02527343|26058593|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
13153483|NCT02527343|26058594|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
13153484|NCT02527343|26058595|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1|||
13153485|NCT02527343|26058596|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
13153486|NCT02527343|26058591|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
13153487|NCT02527343|26058592|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
13153488|NCT02527343|26058593|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
13153489|NCT02527343|26058594|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
13153490|NCT02527343|26058595|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3|||
13153491|NCT02527343|26058596|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1|||
13153492|NCT02527343|26058591|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
13153493|NCT02527343|26058592|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
13153494|NCT02527343|26058593|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
13153495|NCT02527343|26058594|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
13153496|NCT02527343|26058595|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2|||
13153497|NCT02527343|26058596|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1|||
13153498|NCT02527343|26058591|FG000|OLE Period-Year 1: Week 53 to 104|Other|0|||
13153499|NCT02527343|26058592|FG001|OLE Period-Year 1: Week 53 to 104|Other|0|||
13222690|NCT01803607|26286774|FG001|Overall Study|Withdrawal by Subject|5|||
13103492|NCT03358147|25872107|FG004|Overall Study|Withdrawal by Subject|5|||
13153500|NCT02527343|26058593|FG002|OLE Period-Year 1: Week 53 to 104|Other|0|||
13153501|NCT02527343|26058594|FG003|OLE Period-Year 1: Week 53 to 104|Other|0|||
13153502|NCT02527343|26058595|FG004|OLE Period-Year 1: Week 53 to 104|Other|5|||
13153503|NCT02527343|26058596|FG005|OLE Period-Year 1: Week 53 to 104|Other|7|||
13153504|NCT02527343|26058591|FG000|OLE Period-Year 2: Week 105 to 156|Other|0|||
13153505|NCT02527343|26058592|FG001|OLE Period-Year 2: Week 105 to 156|Other|0|||
13153506|NCT02527343|26058593|FG002|OLE Period-Year 2: Week 105 to 156|Other|0|||
13153507|NCT02527343|26058594|FG003|OLE Period-Year 2: Week 105 to 156|Other|0|||
13153508|NCT02527343|26058595|FG004|OLE Period-Year 2: Week 105 to 156|Other|1|||
13153509|NCT02527343|26058596|FG005|OLE Period-Year 2: Week 105 to 156|Other|2|||
13153510|NCT02527343|26058591|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
13153511|NCT02527343|26058592|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
13153512|NCT02527343|26058593|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
13153513|NCT02527343|26058594|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
13153514|NCT02527343|26058595|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1|||
13153515|NCT02527343|26058596|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
13153516|NCT02527343|26058591|FG000|PT Follow-up: Weeks 104 to 169|Other|0|||
13153517|NCT02527343|26058592|FG001|PT Follow-up: Weeks 104 to 169|Other|0|||
13153518|NCT02527343|26058593|FG002|PT Follow-up: Weeks 104 to 169|Other|0|||
13153519|NCT02527343|26058594|FG003|PT Follow-up: Weeks 104 to 169|Other|0|||
13153520|NCT02527343|26058595|FG004|PT Follow-up: Weeks 104 to 169|Other|0|||
13153521|NCT02527343|26058596|FG005|PT Follow-up: Weeks 104 to 169|Other|1|||
13153522|NCT02527200|26059224|FG000|Overall Study|Withdrawal by Subject|3|||
13153523|NCT02527200|26059225|FG001|Overall Study|Withdrawal by Subject|2|||
13153524|NCT02527200|26059226|FG002|Overall Study|Withdrawal by Subject|1|||
13153525|NCT02527200|26059227|FG003|Overall Study|Withdrawal by Subject|0|||
13153526|NCT02527200|26059224|FG000|Overall Study|Unclassified|0|||
13153527|NCT02527200|26059225|FG001|Overall Study|Unclassified|1|||
13153528|NCT02527200|26059226|FG002|Overall Study|Unclassified|0|||
13153529|NCT02527200|26059227|FG003|Overall Study|Unclassified|0|||
13153530|NCT02527200|26059224|FG000|Overall Study|Lost to Follow-up|0|||
13153531|NCT02527200|26059225|FG001|Overall Study|Lost to Follow-up|0|||
13153532|NCT02527200|26059226|FG002|Overall Study|Lost to Follow-up|1|||
13153533|NCT02527200|26059227|FG003|Overall Study|Lost to Follow-up|0|||
13153534|NCT02527161|26059246|FG000|Overall Study|Failed MRI|52|||
13153535|NCT02527161|26059246|FG000|Overall Study|Withdrawal by Subject|19|||
13153536|NCT02527161|26059246|FG000|Overall Study|Delay in or unfit for surgery|16|||
13153537|NCT02527161|26059246|FG000|Overall Study|MRI contraindication|6|||
13153538|NCT02527161|26059246|FG000|Overall Study|Consent violation|4|||
13153539|NCT02527161|26059246|FG000|Overall Study|Only Recruited to Part A|27|||
13153540|NCT02527161|26059246|FG000|Overall Study|Physician Decision|1|||
13153541|NCT02527161|26059246|FG000|Overall Study|Adverse Event|1|||
13153542|NCT02527161|26059246|FG000|Overall Study|Lost to Follow-up|6|||
13205182|NCT01967732|26231082|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1|||
13205183|NCT01967732|26231083|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
13205184|NCT01967732|26231084|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
13205185|NCT01967732|26231081|FG000|First Intervention (Day 1)|Poor venous access|0|||
13205186|NCT01967732|26231082|FG001|First Intervention (Day 1)|Poor venous access|1|||
13205187|NCT01967732|26231083|FG002|First Intervention (Day 1)|Poor venous access|0|||
13205188|NCT01967732|26231084|FG003|First Intervention (Day 1)|Poor venous access|0|||
13205189|NCT01967719|26231106|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
13205190|NCT01967719|26231107|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
13205191|NCT01967719|26231108|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
13205192|NCT01967719|26231109|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
13205193|NCT01967719|26231106|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0|||
13103493|NCT03358147|25872103|FG000|Overall Study|Adverse Event|3|||
13103494|NCT03358147|25872104|FG001|Overall Study|Adverse Event|9|||
13103495|NCT03358147|25872105|FG002|Overall Study|Adverse Event|7|||
13103496|NCT03358147|25872106|FG003|Overall Study|Adverse Event|5|||
13103497|NCT03358147|25872107|FG004|Overall Study|Adverse Event|2|||
13103498|NCT03358147|25872103|FG000|Overall Study|Lost to Follow-up|4|||
13103499|NCT03358147|25872104|FG001|Overall Study|Lost to Follow-up|3|||
13103500|NCT03358147|25872105|FG002|Overall Study|Lost to Follow-up|7|||
13103501|NCT03358147|25872106|FG003|Overall Study|Lost to Follow-up|6|||
13103502|NCT03358147|25872107|FG004|Overall Study|Lost to Follow-up|4|||
13103503|NCT03358147|25872103|FG000|Overall Study|Major Protocol Deviation|11|||
13103504|NCT03358147|25872104|FG001|Overall Study|Major Protocol Deviation|3|||
13103505|NCT03358147|25872105|FG002|Overall Study|Major Protocol Deviation|2|||
13103506|NCT03358147|25872106|FG003|Overall Study|Major Protocol Deviation|3|||
13103507|NCT03358147|25872107|FG004|Overall Study|Major Protocol Deviation|1|||
13103508|NCT03358147|25872103|FG000|Overall Study|Protocol specified criteria|2|||
13103509|NCT03358147|25872104|FG001|Overall Study|Protocol specified criteria|3|||
13205194|NCT01967719|26231107|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1|||
13103510|NCT03358147|25872105|FG002|Overall Study|Protocol specified criteria|0|||
13103511|NCT03358147|25872106|FG003|Overall Study|Protocol specified criteria|3|||
13103512|NCT03358147|25872107|FG004|Overall Study|Protocol specified criteria|1|||
13103513|NCT03358147|25872103|FG000|Overall Study|Physician Decision|1|||
13103514|NCT03358147|25872104|FG001|Overall Study|Physician Decision|0|||
13103515|NCT03358147|25872105|FG002|Overall Study|Physician Decision|1|||
13103516|NCT03358147|25872106|FG003|Overall Study|Physician Decision|6|||
13103517|NCT03358147|25872107|FG004|Overall Study|Physician Decision|1|||
13103518|NCT03358147|25872103|FG000|Overall Study|Administrative reasons|0|||
13153543|NCT02527148|26059281|FG000|Overall Study|Did not receive study intervention|1|||
13153544|NCT02527148|26059282|FG001|Overall Study|Did not receive study intervention|0|||
13153545|NCT02526693|26059299|FG000|Overall Study|Physician Decision|3|||
13153546|NCT02526693|26059300|FG001|Overall Study|Physician Decision|1|||
13153547|NCT02526550|26059308|FG000|Overall Study|Lost to Follow-up|1|||
13153548|NCT02526524|26059341|FG000|Overall Study|Withdrawal by Subject|3|||
13153549|NCT02526524|26059342|FG001|Overall Study|Withdrawal by Subject|3|||
13153550|NCT02526524|26059343|FG002|Overall Study|Withdrawal by Subject|6|||
13153551|NCT02526524|26059344|FG003|Overall Study|Withdrawal by Subject|1|||
13153552|NCT02526524|26059345|FG004|Overall Study|Withdrawal by Subject|9|||
13103519|NCT03358147|25872104|FG001|Overall Study|Administrative reasons|1|||
13103520|NCT03358147|25872105|FG002|Overall Study|Administrative reasons|0|||
13103521|NCT03358147|25872106|FG003|Overall Study|Administrative reasons|3|||
13103522|NCT03358147|25872107|FG004|Overall Study|Administrative reasons|0|||
13103523|NCT03358147|25872103|FG000|Overall Study|Lack of Efficacy|0|||
13103524|NCT03358147|25872104|FG001|Overall Study|Lack of Efficacy|1|||
13103525|NCT03358147|25872105|FG002|Overall Study|Lack of Efficacy|1|||
13103526|NCT03358147|25872106|FG003|Overall Study|Lack of Efficacy|0|||
13153553|NCT02526524|26059346|FG005|Overall Study|Withdrawal by Subject|5|||
13153554|NCT02526524|26059341|FG000|Overall Study|Adverse Event|3|||
13153555|NCT02526524|26059342|FG001|Overall Study|Adverse Event|2|||
13153556|NCT02526524|26059343|FG002|Overall Study|Adverse Event|4|||
13153557|NCT02526524|26059344|FG003|Overall Study|Adverse Event|2|||
13153558|NCT02526524|26059345|FG004|Overall Study|Adverse Event|6|||
13153559|NCT02526524|26059346|FG005|Overall Study|Adverse Event|8|||
13153560|NCT02526524|26059341|FG000|Overall Study|Lost to Follow-up|2|||
13153561|NCT02526524|26059342|FG001|Overall Study|Lost to Follow-up|3|||
13153562|NCT02526524|26059343|FG002|Overall Study|Lost to Follow-up|8|||
13153563|NCT02526524|26059344|FG003|Overall Study|Lost to Follow-up|1|||
13153564|NCT02526524|26059345|FG004|Overall Study|Lost to Follow-up|2|||
13153565|NCT02526524|26059346|FG005|Overall Study|Lost to Follow-up|5|||
13153566|NCT02526524|26059341|FG000|Overall Study|Protocol Violation|3|||
13153567|NCT02526524|26059342|FG001|Overall Study|Protocol Violation|1|||
13153568|NCT02526524|26059343|FG002|Overall Study|Protocol Violation|5|||
13153569|NCT02526524|26059344|FG003|Overall Study|Protocol Violation|3|||
13153570|NCT02526524|26059345|FG004|Overall Study|Protocol Violation|4|||
13153571|NCT02526524|26059346|FG005|Overall Study|Protocol Violation|3|||
13153572|NCT02526524|26059341|FG000|Overall Study|Loss of Glucose Control|0|||
13153573|NCT02526524|26059342|FG001|Overall Study|Loss of Glucose Control|0|||
13153574|NCT02526524|26059343|FG002|Overall Study|Loss of Glucose Control|3|||
13153575|NCT02526524|26059344|FG003|Overall Study|Loss of Glucose Control|0|||
13153576|NCT02526524|26059345|FG004|Overall Study|Loss of Glucose Control|2|||
13153577|NCT02526524|26059346|FG005|Overall Study|Loss of Glucose Control|0|||
13153578|NCT02526524|26059341|FG000|Overall Study|Physician Decision|0|||
13153579|NCT02526524|26059342|FG001|Overall Study|Physician Decision|0|||
13103527|NCT03358147|25872107|FG004|Overall Study|Lack of Efficacy|0|||
13103528|NCT03357731|25872140|FG000|Overall Study|Withdrew consent due to personal reasons|0|||
13103529|NCT03357731|25872141|FG001|Overall Study|Withdrew consent due to personal reasons|0|||
13103530|NCT03357731|25872142|FG002|Overall Study|Withdrew consent due to personal reasons|0|||
13103531|NCT03357731|25872143|FG003|Overall Study|Withdrew consent due to personal reasons|0|||
13103532|NCT03357731|25872144|FG004|Overall Study|Withdrew consent due to personal reasons|1|||
13103533|NCT03357731|25872145|FG005|Overall Study|Withdrew consent due to personal reasons|0|||
13103534|NCT03357731|25872140|FG000|Overall Study|Acute bradycardia and hypotension|0|||
13103535|NCT03357731|25872141|FG001|Overall Study|Acute bradycardia and hypotension|0|||
13103536|NCT03357731|25872142|FG002|Overall Study|Acute bradycardia and hypotension|0|||
13103537|NCT03357731|25872143|FG003|Overall Study|Acute bradycardia and hypotension|1|||
13103538|NCT03357731|25872144|FG004|Overall Study|Acute bradycardia and hypotension|0|||
13103539|NCT03357731|25872145|FG005|Overall Study|Acute bradycardia and hypotension|0|||
13103540|NCT03357731|25872140|FG000|Overall Study|Adverse Event|0|||
13103541|NCT03357731|25872141|FG001|Overall Study|Adverse Event|0|||
13153580|NCT02526524|26059343|FG002|Overall Study|Physician Decision|0|||
13153581|NCT02526524|26059344|FG003|Overall Study|Physician Decision|0|||
13153582|NCT02526524|26059345|FG004|Overall Study|Physician Decision|1|||
13153583|NCT02526524|26059346|FG005|Overall Study|Physician Decision|0|||
13153584|NCT02526524|26059341|FG000|Overall Study|Sponsor Decision|1|||
13153585|NCT02526524|26059342|FG001|Overall Study|Sponsor Decision|0|||
13103542|NCT03357731|25872142|FG002|Overall Study|Adverse Event|0|||
13103543|NCT03357731|25872143|FG003|Overall Study|Adverse Event|0|||
13153586|NCT02526524|26059343|FG002|Overall Study|Sponsor Decision|0|||
13103544|NCT03357731|25872144|FG004|Overall Study|Adverse Event|0|||
13103545|NCT03357731|25872145|FG005|Overall Study|Adverse Event|1|||
13103546|NCT03357731|25872140|FG000|Overall Study|Hypotension|0|||
13153587|NCT02526524|26059344|FG003|Overall Study|Sponsor Decision|0|||
13153588|NCT02526524|26059345|FG004|Overall Study|Sponsor Decision|0|||
13153589|NCT02526524|26059346|FG005|Overall Study|Sponsor Decision|0|||
13153590|NCT02526290|26059355|FG000|Overall Study|Adverse Event|3|||
13153591|NCT02526290|26059355|FG000|Overall Study|Withdrawal by Subject|4|||
13153592|NCT02526290|26059355|FG000|Overall Study|Physician Decision|1|||
13153593|NCT02526212|26059376|FG000|Overall Study|Incarceration|1|||
13153594|NCT02526212|26059377|FG001|Overall Study|Incarceration|0|||
13153595|NCT02526212|26059376|FG000|Overall Study|Lost to Follow-up|1|||
13153596|NCT02526212|26059377|FG001|Overall Study|Lost to Follow-up|0|||
13153597|NCT02526212|26059376|FG000|Overall Study|Death|0|||
13153598|NCT02526212|26059377|FG001|Overall Study|Death|1|||
13153599|NCT02526160|26059456|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0|||
13153600|NCT02526160|26059457|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1|||
13153601|NCT02526160|26059456|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0|||
13153602|NCT02526160|26059457|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1|||
13153603|NCT02526160|26059456|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3|||
13153604|NCT02526160|26059457|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3|||
13153605|NCT02526160|26059456|FG000|Open-Label Treatment Extension Period I|Death|0|||
13153606|NCT02526160|26059457|FG001|Open-Label Treatment Extension Period I|Death|1|||
13153607|NCT02526160|26059456|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3|||
13153608|NCT02526160|26059457|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1|||
13153609|NCT02526160|26059456|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0|||
13103547|NCT03357731|25872141|FG001|Overall Study|Hypotension|0|||
13103548|NCT03357731|25872142|FG002|Overall Study|Hypotension|1|||
13103549|NCT03357731|25872143|FG003|Overall Study|Hypotension|1|||
13103550|NCT03357731|25872144|FG004|Overall Study|Hypotension|0|||
13103551|NCT03357731|25872145|FG005|Overall Study|Hypotension|0|||
13103552|NCT03357731|25872140|FG000|Overall Study|Lost to Follow-up|0|||
13103553|NCT03357731|25872141|FG001|Overall Study|Lost to Follow-up|0|||
13103554|NCT03357731|25872142|FG002|Overall Study|Lost to Follow-up|0|||
13103555|NCT03357731|25872143|FG003|Overall Study|Lost to Follow-up|1|||
13103556|NCT03357731|25872144|FG004|Overall Study|Lost to Follow-up|0|||
13103557|NCT03357731|25872145|FG005|Overall Study|Lost to Follow-up|0|||
13103558|NCT03357471|25872176|FG000|Overall Study|Adverse Event|1|||
13103559|NCT03357471|25872177|FG001|Overall Study|Adverse Event|0|||
13103560|NCT03357471|25872176|FG000|Overall Study|Lost to Follow-up|1|||
13103561|NCT03357471|25872177|FG001|Overall Study|Lost to Follow-up|0|||
13103562|NCT03357341|25872224|FG000|Overall Study|Withdrawal by Subject|3|||
13103563|NCT03357341|25872225|FG001|Overall Study|Withdrawal by Subject|6|||
13103564|NCT03357341|25872224|FG000|Overall Study|Lost to Follow-up|4|||
13103565|NCT03357341|25872225|FG001|Overall Study|Lost to Follow-up|5|||
13103566|NCT03357341|25872224|FG000|Overall Study|Death|0|||
13103567|NCT03357341|25872225|FG001|Overall Study|Death|1|||
13103568|NCT03356977|25872239|FG000|Overall Study|Lost to Follow-up|3|||
13103569|NCT03356977|25872239|FG000|Overall Study|Withdrawal by parent/guardian|2|||
13103570|NCT03356145|25872264|FG000|Overall Study|Withdrawal by Subject|2|||
13103571|NCT03356145|25872265|FG001|Overall Study|Withdrawal by Subject|1|||
13103572|NCT03356145|25872264|FG000|Overall Study|Did not meet inclusion criteria|1|||
13153610|NCT02526160|26059457|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1|||
13153611|NCT02526160|26059456|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0|||
13153612|NCT02526160|26059457|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1|||
13153613|NCT02526160|26059456|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1|||
13153614|NCT02526160|26059457|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0|||
13153615|NCT02525874|26059472|FG000|Overall Study|Other|1|||
13153616|NCT02525874|26059472|FG000|Overall Study|Investigator Decision|1|||
13153617|NCT02525874|26059472|FG000|Overall Study|Consent withdrawn|22|||
13153618|NCT02525874|26059472|FG000|Overall Study|Non-compliance with study drug|3|||
13153619|NCT02525874|26059472|FG000|Overall Study|Adverse Event|17|||
13153620|NCT02525874|26059472|FG000|Overall Study|Lost to Follow-up|7|||
13153621|NCT02525874|26059472|FG000|Overall Study|Disease progression, defined by protocol|2|||
13153622|NCT02525874|26059472|FG000|Overall Study|Disease relapse|4|||
13153623|NCT02525874|26059472|FG000|Overall Study|Alternative Treatment for MS|2|||
13153624|NCT02525874|26059472|FG000|Overall Study|New lesions in Brain|1|||
13153625|NCT02525861|26059501|FG000|Overall Study|Adverse Event|1|||
13153626|NCT02525861|26059502|FG001|Overall Study|Adverse Event|0|||
13153627|NCT02525861|26059501|FG000|Overall Study|Withdrawal by Subject|0|||
13153628|NCT02525861|26059502|FG001|Overall Study|Withdrawal by Subject|1|||
13103573|NCT03356145|25872265|FG001|Overall Study|Did not meet inclusion criteria|0|||
13153629|NCT02525861|26059501|FG000|Overall Study|Physician Decision|0|||
13153630|NCT02525861|26059502|FG001|Overall Study|Physician Decision|1|||
13153631|NCT02525744|26059521|FG000|Period 1|Physician Decision|0|||
13153632|NCT02525744|26059522|FG001|Period 1|Physician Decision|0|||
13153633|NCT02525744|26059523|FG002|Period 1|Physician Decision|1|||
13153634|NCT02525744|26059524|FG003|Period 1|Physician Decision|0|||
13153635|NCT02525744|26059521|FG000|Period 3|Adverse Event|0|||
13153636|NCT02525744|26059522|FG001|Period 3|Adverse Event|1|||
13153637|NCT02525744|26059523|FG002|Period 3|Adverse Event|0|||
13153638|NCT02525744|26059524|FG003|Period 3|Adverse Event|0|||
13153639|NCT02525744|26059521|FG000|Period 4|Withdrawal by Subject|1|||
13153640|NCT02525744|26059522|FG001|Period 4|Withdrawal by Subject|0|||
13153641|NCT02525744|26059523|FG002|Period 4|Withdrawal by Subject|0|||
13153642|NCT02525744|26059524|FG003|Period 4|Withdrawal by Subject|0|||
13153643|NCT02525744|26059521|FG000|Period 5|Physician Decision|1|||
13153644|NCT02525744|26059522|FG001|Period 5|Physician Decision|0|||
13153645|NCT02525744|26059523|FG002|Period 5|Physician Decision|0|||
13153646|NCT02525744|26059524|FG003|Period 5|Physician Decision|0|||
13153647|NCT02525627|26059541|FG000|Overall Study|Revision|1|||
13153648|NCT02525627|26059542|FG001|Overall Study|Revision|1|||
13153649|NCT02525627|26059541|FG000|Overall Study|Withdrawal by Subject|1|||
13153650|NCT02525627|26059542|FG001|Overall Study|Withdrawal by Subject|2|||
13153651|NCT02525627|26059541|FG000|Overall Study|Death|1|||
13153652|NCT02525627|26059542|FG001|Overall Study|Death|0|||
13153653|NCT02525627|26059541|FG000|Overall Study|Site terminated|11|||
13153654|NCT02525627|26059542|FG001|Overall Study|Site terminated|10|||
13103574|NCT03355742|25872306|FG000|Overall Study|Lost to Follow-up|4|||
13103575|NCT03355742|25872306|FG000|Overall Study|Withdrawal by Subject|29|||
13103576|NCT03355742|25872306|FG000|Overall Study|Physician Decision|6|||
13103577|NCT03355742|25872306|FG000|Overall Study|Death|55|||
13103578|NCT03355742|25872306|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5|||
13103579|NCT03355326|25872331|FG000|Overall Study|Protocol Violation|3|||
13103580|NCT03355326|25872332|FG001|Overall Study|Protocol Violation|3|||
13103581|NCT03354663|25872358|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4|||
13103582|NCT03354663|25872358|FG000|Enrollment to Catheter Insertion|Adverse Event|1|||
13103583|NCT03354663|25872358|FG000|Completed 30-day Visit|Withdrawal by Subject|1|||
13103584|NCT03354663|25872358|FG000|Completed 30-day Visit|Missed Visit|1|||
13103585|NCT03354637|25872425|FG000|Double-blind Period|Protocol Violation|2|||
13103586|NCT03354637|25872426|FG001|Double-blind Period|Protocol Violation|0|||
13103587|NCT03354637|25872427|FG002|Double-blind Period|Protocol Violation|0|||
13103588|NCT03354637|25872425|FG000|Double-blind Period|Adverse Event|1|||
13103589|NCT03354637|25872426|FG001|Double-blind Period|Adverse Event|2|||
13103590|NCT03354637|25872427|FG002|Double-blind Period|Adverse Event|0|||
13103591|NCT03354637|25872425|FG000|Double-blind Period|Lost to Follow-up|3|||
13103592|NCT03354637|25872426|FG001|Double-blind Period|Lost to Follow-up|4|||
13103593|NCT03354637|25872427|FG002|Double-blind Period|Lost to Follow-up|3|||
13103594|NCT03354637|25872425|FG000|Double-blind Period|Withdrawal by Subject|10|||
13153655|NCT02525588|26059565|FG000|Overall Study|Death|3|||
13153656|NCT02525588|26059566|FG001|Overall Study|Death|1|||
13103595|NCT03354637|25872426|FG001|Double-blind Period|Withdrawal by Subject|6|||
13103596|NCT03354637|25872427|FG002|Double-blind Period|Withdrawal by Subject|4|||
13103597|NCT03354637|25872425|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1|||
13153657|NCT02525588|26059565|FG000|Overall Study|Lost to Follow-up|2|||
13153658|NCT02525588|26059566|FG001|Overall Study|Lost to Follow-up|0|||
13153659|NCT02525588|26059565|FG000|Overall Study|Withdrawal by Subject|1|||
13153660|NCT02525588|26059566|FG001|Overall Study|Withdrawal by Subject|1|||
13153661|NCT02525588|26059565|FG000|Overall Study|Adverse Event|0|||
13153662|NCT02525588|26059566|FG001|Overall Study|Adverse Event|1|||
13153663|NCT02525471|26059578|FG000|Overall Study|Screen Failure|6|||
13153664|NCT02525471|26059578|FG000|Overall Study|Withdrawal by Subject|4|||
13153665|NCT02525471|26059578|FG000|Overall Study|Death|1|||
13153666|NCT02525133|26059601|FG000|Overall Study|Adverse Event|0|||
13153667|NCT02525133|26059602|FG001|Overall Study|Adverse Event|1|||
13153668|NCT02525133|26059601|FG000|Overall Study|Death|0|||
13153669|NCT02525133|26059602|FG001|Overall Study|Death|1|||
13153670|NCT02525133|26059601|FG000|Overall Study|did not meet randomization criteria|1|||
13153671|NCT02525133|26059602|FG001|Overall Study|did not meet randomization criteria|0|||
13153672|NCT02525133|26059601|FG000|Overall Study|Lost to Follow-up|5|||
13153673|NCT02525133|26059602|FG001|Overall Study|Lost to Follow-up|1|||
13153674|NCT02525133|26059601|FG000|Overall Study|randomized not enrolled|3|||
13153675|NCT02525133|26059602|FG001|Overall Study|randomized not enrolled|0|||
13153676|NCT02525133|26059601|FG000|Overall Study|Withdrawal by Subject|1|||
13153677|NCT02525133|26059602|FG001|Overall Study|Withdrawal by Subject|0|||
13153678|NCT02525094|26059636|FG000|Overall Study|Lost to Follow-up|2|||
13153679|NCT02525094|26059637|FG001|Overall Study|Lost to Follow-up|1|||
13153680|NCT02525094|26059636|FG000|Overall Study|Withdrawal by Subject|5|||
13222691|NCT01803464|26286805|FG000|Overall Study|Incomplete data|0|||
13153681|NCT02525094|26059637|FG001|Overall Study|Withdrawal by Subject|6|||
13153682|NCT02525094|26059636|FG000|Overall Study|Not Treated|1|||
13153683|NCT02525094|26059637|FG001|Overall Study|Not Treated|1|||
13153684|NCT02524847|26059651|FG000|Overall Study|Adverse Event|4|||
13153685|NCT02524847|26059651|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
13222692|NCT01803464|26286806|FG001|Overall Study|Incomplete data|0|||
13153686|NCT02524847|26059651|FG000|Overall Study|Condition no Longer Requires Treatment|4|||
13153687|NCT02524847|26059651|FG000|Overall Study|Death|1|||
13153688|NCT02524847|26059651|FG000|Overall Study|Reason not Specified|1|||
13153689|NCT02524730|26059662|FG000|Overall Study|Lost to Follow-up|5|||
13153690|NCT02524730|26059662|FG000|Overall Study|Withdrawal by Subject|18|||
13153691|NCT02524730|26059662|FG000|Overall Study|Death|10|||
13153692|NCT02524730|26059662|FG000|Overall Study|Adverse Event|8|||
13153693|NCT02524730|26059662|FG000|Overall Study|Protocol Violation|1|||
13153694|NCT02524730|26059662|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4|||
13153695|NCT02524665|26059679|FG000|Overall Study|Lost to Follow-up|1|||
13153696|NCT02524379|26059688|FG000|Overall Study|Death|1|||
13153697|NCT02524275|26059696|FG000|Overall Study|not evaluable, completed less than 2 courses of chemotherapy.|5|||
13153698|NCT02524158|26059742|FG000|12-weeks Assessment|Withdrawal by Subject|1|||
13153699|NCT02524158|26059743|FG001|12-weeks Assessment|Withdrawal by Subject|1|||
13153700|NCT02524158|26059742|FG000|12-weeks Assessment|Lost to Follow-up|18|||
13153701|NCT02524158|26059743|FG001|12-weeks Assessment|Lost to Follow-up|12|||
13153702|NCT02524158|26059742|FG000|6-month Assessment|Withdrawal by Subject|1|||
13153703|NCT02524158|26059743|FG001|6-month Assessment|Withdrawal by Subject|1|||
13103598|NCT03354637|25872426|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1|||
13153704|NCT02524158|26059742|FG000|6-month Assessment|Lost to Follow-up|21|||
13153705|NCT02524158|26059743|FG001|6-month Assessment|Lost to Follow-up|20|||
13153706|NCT02524145|26059763|FG000|Overall Study|Withdrawal by Subject|2|||
13153707|NCT02524145|26059764|FG001|Overall Study|Withdrawal by Subject|2|||
13153708|NCT02524145|26059765|FG002|Overall Study|Withdrawal by Subject|3|||
13153709|NCT02523599|26059788|FG000|Overall Study|Adverse Event|1|||
13153710|NCT02523599|26059789|FG001|Overall Study|Adverse Event|0|||
13153711|NCT02523599|26059788|FG000|Overall Study|Physician Decision|1|||
13153712|NCT02523599|26059789|FG001|Overall Study|Physician Decision|0|||
13153713|NCT02523599|26059788|FG000|Overall Study|Lost to Follow-up|4|||
13153714|NCT02523599|26059789|FG001|Overall Study|Lost to Follow-up|1|||
13153715|NCT02523599|26059788|FG000|Overall Study|Did not return for Day 30 visit|2|||
13153716|NCT02523599|26059789|FG001|Overall Study|Did not return for Day 30 visit|0|||
13153717|NCT02522884|26059796|FG000|Overall Study|Withdrawal by Subject|6|||
13153718|NCT02522884|26059796|FG000|Overall Study|Death|3|||
13153719|NCT02522884|26059796|FG000|Overall Study|Missed 12-month Follow-up|9|||
13153720|NCT02522780|26059831|FG000|Overall Study|Consent withdrawn by subject|5|||
13153721|NCT02522780|26059832|FG001|Overall Study|Consent withdrawn by subject|7|||
13153722|NCT02522780|26059831|FG000|Overall Study|Protocol deviation|1|||
13153723|NCT02522780|26059832|FG001|Overall Study|Protocol deviation|3|||
13153724|NCT02522780|26059831|FG000|Overall Study|Subject refused endoscopic procedure|0|||
13153725|NCT02522780|26059832|FG001|Overall Study|Subject refused endoscopic procedure|1|||
13153726|NCT02522780|26059831|FG000|Overall Study|Adverse event, non-fatal|11|||
13153727|NCT02522780|26059832|FG001|Overall Study|Adverse event, non-fatal|16|||
13153728|NCT02522767|26059879|FG000|Double-blind|Withdrawal by Subject|8|||
13153729|NCT02522767|26059880|FG001|Double-blind|Withdrawal by Subject|11|||
13153730|NCT02522767|26059879|FG000|Double-blind|Lost to Follow-up|1|||
13153731|NCT02522767|26059880|FG001|Double-blind|Lost to Follow-up|0|||
13153732|NCT02522767|26059879|FG000|Double-blind|Adverse Event|1|||
13153733|NCT02522767|26059880|FG001|Double-blind|Adverse Event|10|||
13103599|NCT03354637|25872427|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0|||
13103600|NCT03354637|25872425|FG000|Open Label Extension|Adverse Event|0|||
13103601|NCT03354637|25872426|FG001|Open Label Extension|Adverse Event|0|||
13103602|NCT03354637|25872427|FG002|Open Label Extension|Adverse Event|1|||
13103603|NCT03354637|25872425|FG000|Open Label Extension|Lost to Follow-up|0|||
13103604|NCT03354637|25872426|FG001|Open Label Extension|Lost to Follow-up|0|||
13103605|NCT03354637|25872427|FG002|Open Label Extension|Lost to Follow-up|2|||
13153734|NCT02522767|26059879|FG000|Double-blind|Protocol Violation|0|||
13153735|NCT02522767|26059880|FG001|Double-blind|Protocol Violation|1|||
13153736|NCT02522767|26059879|FG000|Double-blind|Lack of Efficacy|0|||
13153737|NCT02522767|26059880|FG001|Double-blind|Lack of Efficacy|2|||
13153738|NCT02522767|26059879|FG000|Double-blind|Protocol Deviation|1|||
13153739|NCT02522767|26059880|FG001|Double-blind|Protocol Deviation|0|||
13153740|NCT02522767|26059879|FG000|Open-label|Withdrawal by Subject|2|||
13153741|NCT02522767|26059880|FG001|Open-label|Withdrawal by Subject|3|||
13153742|NCT02522767|26059879|FG000|Open-label|Lost to Follow-up|0|||
13103606|NCT03354637|25872425|FG000|Open Label Extension|Withdrawal by Subject|0|||
13103607|NCT03354637|25872426|FG001|Open Label Extension|Withdrawal by Subject|0|||
13103608|NCT03354637|25872427|FG002|Open Label Extension|Withdrawal by Subject|5|||
13103609|NCT03354637|25872425|FG000|Open Label Extension|Study Terminated by Sponsor|0|||
13103610|NCT03354637|25872426|FG001|Open Label Extension|Study Terminated by Sponsor|0|||
13103611|NCT03354637|25872427|FG002|Open Label Extension|Study Terminated by Sponsor|17|||
13103612|NCT03354637|25872425|FG000|Open Label Extension|Subject Noncompliance|0|||
13153743|NCT02522767|26059880|FG001|Open-label|Lost to Follow-up|1|||
13153744|NCT02522767|26059879|FG000|Open-label|Adverse Event|2|||
13153745|NCT02522767|26059880|FG001|Open-label|Adverse Event|1|||
13153746|NCT02522767|26059879|FG000|Open-label|Lack of Efficacy|1|||
13103613|NCT03354637|25872426|FG001|Open Label Extension|Subject Noncompliance|0|||
13103614|NCT03354637|25872427|FG002|Open Label Extension|Subject Noncompliance|1|||
13103615|NCT03354637|25872425|FG000|Open Label Extension|Lack of Efficacy|0|||
13103616|NCT03354637|25872426|FG001|Open Label Extension|Lack of Efficacy|0|||
13103617|NCT03354637|25872427|FG002|Open Label Extension|Lack of Efficacy|1|||
13103618|NCT03354637|25872425|FG000|Open Label Extension|Physician Decision|0|||
13103619|NCT03354637|25872426|FG001|Open Label Extension|Physician Decision|0|||
13103620|NCT03354637|25872427|FG002|Open Label Extension|Physician Decision|1|||
13103621|NCT03354429|25872452|FG000|Overall Study|Withdrawal by Subject|8|||
13103622|NCT03354429|25872453|FG001|Overall Study|Withdrawal by Subject|7|||
13103623|NCT03354429|25872452|FG000|Overall Study|Lost to Follow-up|1|||
13103624|NCT03354429|25872453|FG001|Overall Study|Lost to Follow-up|0|||
13103625|NCT03353792|25872474|FG000|Overall Study|Lost to Follow-up|1|||
13103626|NCT03353792|25872475|FG001|Overall Study|Lost to Follow-up|0|||
13103627|NCT03353792|25872474|FG000|Overall Study|Participant Unable to Manage Device|1|||
13103628|NCT03353792|25872475|FG001|Overall Study|Participant Unable to Manage Device|0|||
13103629|NCT03353740|25872502|FG000|Overall Study|Images for these participants not viable|52|||
13103630|NCT03353220|25872523|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4|||
13103631|NCT03353220|25872524|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7|||
13103632|NCT03352713|25872532|FG000|Overall Study|Lost to Follow-up|8|||
13103633|NCT03352713|25872532|FG000|Overall Study|Withdrawn by investigator|5|||
13103634|NCT03352713|25872532|FG000|Overall Study|Completed 0 EMAs|8|||
13103635|NCT03352713|25872532|FG000|Overall Study|Device incompatible/stolen|5|||
13103636|NCT03352453|25872551|FG000|Overall Study|Miscellaneous Reasons|1|||
13103637|NCT03352453|25872552|FG001|Overall Study|Miscellaneous Reasons|2|||
13103638|NCT03352453|25872551|FG000|Overall Study|Lack of Efficacy|1|||
13103639|NCT03352453|25872552|FG001|Overall Study|Lack of Efficacy|0|||
13103640|NCT03352453|25872551|FG000|Overall Study|Withdrawal by Subject|8|||
13103641|NCT03352453|25872552|FG001|Overall Study|Withdrawal by Subject|14|||
13103642|NCT03352453|25872551|FG000|Overall Study|Study Terminated by Sponsor|2|||
13103643|NCT03352453|25872552|FG001|Overall Study|Study Terminated by Sponsor|1|||
13103644|NCT03352453|25872551|FG000|Overall Study|Protocol Deviation|1|||
13103645|NCT03352453|25872552|FG001|Overall Study|Protocol Deviation|0|||
13103646|NCT03352453|25872551|FG000|Overall Study|Lost to Follow-up|7|||
13153747|NCT02522767|26059880|FG001|Open-label|Lack of Efficacy|1|||
13153748|NCT02522767|26059879|FG000|Open-label|Protocol Violation|0|||
13153749|NCT02522767|26059880|FG001|Open-label|Protocol Violation|1|||
13153750|NCT02522728|26059901|FG000|Overall Study|Withdrawal by Subject|6|||
13153751|NCT02522728|26059902|FG001|Overall Study|Withdrawal by Subject|6|||
13153752|NCT02522728|26059901|FG000|Overall Study|Death|4|||
13153753|NCT02522728|26059902|FG001|Overall Study|Death|3|||
13153754|NCT02522728|26059901|FG000|Overall Study|Adverse Event|2|||
13153755|NCT02522728|26059902|FG001|Overall Study|Adverse Event|1|||
13153756|NCT02522728|26059901|FG000|Overall Study|Did not receive randomized study device|0|||
13153757|NCT02522728|26059902|FG001|Overall Study|Did not receive randomized study device|1|||
13153758|NCT02522624|26059925|FG000|Overall Study|Technical failure|1|||
13153759|NCT02522624|26059926|FG001|Overall Study|Technical failure|0|||
13153760|NCT02522494|26059965|FG000|Overall Study|Lost to Follow-up|6|||
13153761|NCT02522494|26059966|FG001|Overall Study|Lost to Follow-up|2|||
13153762|NCT02522494|26059965|FG000|Overall Study|Withdrawal by Subject|1|||
13153763|NCT02522494|26059966|FG001|Overall Study|Withdrawal by Subject|0|||
13153764|NCT02522494|26059965|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6|||
13153765|NCT02522494|26059966|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2|||
13103647|NCT03352453|25872552|FG001|Overall Study|Lost to Follow-up|6|||
13103648|NCT03352453|25872551|FG000|Overall Study|Adverse Event|2|||
13103649|NCT03352453|25872552|FG001|Overall Study|Adverse Event|9|||
13103650|NCT03352414|25872575|FG000|Overall Study|Ineligible by operative criteria|12|||
13103651|NCT03352414|25872576|FG001|Overall Study|Ineligible by operative criteria|10|||
13103652|NCT03351738|25872666|FG000|Overall Study|Withdrawal by Subject|0|||
13103653|NCT03351738|25872667|FG001|Overall Study|Withdrawal by Subject|1|||
13103654|NCT03351738|25872668|FG002|Overall Study|Withdrawal by Subject|0|||
13103655|NCT03351738|25872669|FG003|Overall Study|Withdrawal by Subject|1|||
13153766|NCT02522494|26059965|FG000|Overall Study|Participant did not watch the video|1|||
13153767|NCT02522494|26059966|FG001|Overall Study|Participant did not watch the video|0|||
13153768|NCT02522494|26059965|FG000|Overall Study|Death|0|||
13153769|NCT02522494|26059966|FG001|Overall Study|Death|1|||
13153770|NCT02522481|26059979|FG000|Overall Study|discontinued|1|||
13153771|NCT02522481|26059979|FG000|Overall Study|Not dosed|2|||
13153772|NCT02522403|26059996|FG000|Overall Study|Lost to Follow-up|2|||
13153773|NCT02522403|26059997|FG001|Overall Study|Lost to Follow-up|2|||
13153774|NCT02522403|26059996|FG000|Overall Study|Withdrawal by Subject|2|||
13153775|NCT02522403|26059997|FG001|Overall Study|Withdrawal by Subject|4|||
13153776|NCT02522377|26060020|FG000|Overall Study|Withdrawal by Subject|1|||
13153777|NCT02522377|26060021|FG001|Overall Study|Withdrawal by Subject|0|||
13153778|NCT02522377|26060020|FG000|Overall Study|Remission Achieved|3|||
13103656|NCT03351738|25872670|FG004|Overall Study|Withdrawal by Subject|0|||
13103657|NCT03351738|25872671|FG005|Overall Study|Withdrawal by Subject|0|||
13133024|NCT02780115|25986309|FG002|Overall Study|Withdrawal by Subject|1|||
13133025|NCT02780115|25986310|FG003|Overall Study|Withdrawal by Subject|0|||
13133026|NCT02780115|25986311|FG004|Overall Study|Withdrawal by Subject|0|||
13133027|NCT02780115|25986307|FG000|Overall Study|Adverse Event|0|||
13133028|NCT02780115|25986308|FG001|Overall Study|Adverse Event|0|||
13133029|NCT02780115|25986309|FG002|Overall Study|Adverse Event|0|||
13133030|NCT02780115|25986310|FG003|Overall Study|Adverse Event|1|||
13133031|NCT02780115|25986311|FG004|Overall Study|Adverse Event|1|||
13153779|NCT02522377|26060021|FG001|Overall Study|Remission Achieved|0|||
13153780|NCT02522325|26060030|FG000|Overall Study|Adverse Event|0|||
13153781|NCT02522325|26060031|FG001|Overall Study|Adverse Event|1|||
13153782|NCT02522299|26060117|FG000|Overall Study|Adverse Event|2|||
13153783|NCT02522299|26060118|FG001|Overall Study|Adverse Event|0|||
13153784|NCT02522299|26060117|FG000|Overall Study|Physician Decision|0|||
13153785|NCT02522299|26060118|FG001|Overall Study|Physician Decision|1|||
13153786|NCT02522299|26060117|FG000|Overall Study|Withdrawal by Subject|2|||
13153787|NCT02522299|26060118|FG001|Overall Study|Withdrawal by Subject|0|||
13153788|NCT02522286|26060157|FG000|Overall Study|Withdrawal by Subject|3|||
13153789|NCT02522286|26060158|FG001|Overall Study|Withdrawal by Subject|0|||
13153790|NCT02522286|26060159|FG002|Overall Study|Withdrawal by Subject|0|||
13153791|NCT02522286|26060160|FG003|Overall Study|Withdrawal by Subject|3|||
13153792|NCT02521948|26060171|FG000|Overall Study|Adverse Event|2|||
13153793|NCT02521948|26060171|FG000|Overall Study|Death|4|||
13153794|NCT02521948|26060171|FG000|Overall Study|Lost to Follow-up|1|||
13153795|NCT02521948|26060171|FG000|Overall Study|Did not attend one or both follow-ups|6|||
13153796|NCT02521870|26060262|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
13153797|NCT02521870|26060263|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1|||
13153798|NCT02521870|26060264|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
13153799|NCT02521870|26060265|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
13153800|NCT02521870|26060266|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
13153801|NCT02521870|26060267|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
13153802|NCT02521870|26060268|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
13153803|NCT02521870|26060269|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
13153804|NCT02521870|26060270|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
13153805|NCT02521870|26060271|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
13153806|NCT02521870|26060272|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
13153807|NCT02521870|26060273|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
13153808|NCT02521870|26060262|FG000|Phase 1: Dose Escalation|Adverse Event|2|||
13153809|NCT02521870|26060263|FG001|Phase 1: Dose Escalation|Adverse Event|1|||
13153810|NCT02521870|26060264|FG002|Phase 1: Dose Escalation|Adverse Event|0|||
13153811|NCT02521870|26060265|FG003|Phase 1: Dose Escalation|Adverse Event|0|||
13153812|NCT02521870|26060266|FG004|Phase 1: Dose Escalation|Adverse Event|0|||
13153813|NCT02521870|26060267|FG005|Phase 1: Dose Escalation|Adverse Event|0|||
13153814|NCT02521870|26060268|FG006|Phase 1: Dose Escalation|Adverse Event|0|||
13133032|NCT02779855|25986330|FG000|Overall Study|Withdrawal by patient prior to treatment|1|||
13133033|NCT02779855|25986331|FG001|Overall Study|Withdrawal by patient prior to treatment|0|||
13133034|NCT02779855|25986332|FG002|Overall Study|Withdrawal by patient prior to treatment|0|||
13133035|NCT02779075|25986343|FG000|Overall Study|Withdrawal by Subject|1|||
13133036|NCT02779075|25986344|FG001|Overall Study|Withdrawal by Subject|3|||
13133037|NCT02779075|25986343|FG000|Overall Study|IV lost during 2nd study|1|||
13133038|NCT02779075|25986344|FG001|Overall Study|IV lost during 2nd study|0|||
13133039|NCT02778867|25986371|FG000|Phase 1|Withdrawal by Subject|2|||
13133040|NCT02778867|25986372|FG001|Phase 1|Withdrawal by Subject|3|||
13133041|NCT02778867|25986373|FG002|Phase 1|Withdrawal by Subject|0|||
13133042|NCT02778867|25986374|FG003|Phase 1|Withdrawal by Subject|0|||
13133043|NCT02778867|25986371|FG000|Phase 2|Withdrawal by Subject|0|||
13133044|NCT02778867|25986372|FG001|Phase 2|Withdrawal by Subject|0|||
13133045|NCT02778867|25986373|FG002|Phase 2|Withdrawal by Subject|1|||
13133046|NCT02778867|25986374|FG003|Phase 2|Withdrawal by Subject|0|||
13133047|NCT02778867|25986371|FG000|Phase 2|Physician Decision|0|||
13133048|NCT02778867|25986372|FG001|Phase 2|Physician Decision|0|||
13133049|NCT02778867|25986373|FG002|Phase 2|Physician Decision|0|||
13153815|NCT02521870|26060269|FG007|Phase 1: Dose Escalation|Adverse Event|0|||
13153816|NCT02521870|26060270|FG008|Phase 1: Dose Escalation|Adverse Event|0|||
13153817|NCT02521870|26060271|FG009|Phase 1: Dose Escalation|Adverse Event|0|||
13153818|NCT02521870|26060272|FG010|Phase 1: Dose Escalation|Adverse Event|0|||
13153819|NCT02521870|26060273|FG011|Phase 1: Dose Escalation|Adverse Event|0|||
13153820|NCT02521870|26060262|FG000|Phase 1: Dose Escalation|Progressive Disease|3|||
13133050|NCT02778867|25986374|FG003|Phase 2|Physician Decision|1|||
13133051|NCT02778867|25986371|FG000|Phase 2|Adverse Event|0|||
13133052|NCT02778867|25986372|FG001|Phase 2|Adverse Event|0|||
13133053|NCT02778867|25986373|FG002|Phase 2|Adverse Event|0|||
13133054|NCT02778867|25986374|FG003|Phase 2|Adverse Event|1|||
13133055|NCT02778555|25986392|FG000|Overall Study|Withdrawal by Subject|55|||
13103658|NCT03351608|25872740|FG000|Overall Study|Lost to Follow-up|0|||
13103659|NCT03351608|25872741|FG001|Overall Study|Lost to Follow-up|1|||
13103660|NCT03351608|25872742|FG002|Overall Study|Lost to Follow-up|1|||
13103661|NCT03351608|25872743|FG003|Overall Study|Lost to Follow-up|1|||
13103662|NCT03351608|25872744|FG004|Overall Study|Lost to Follow-up|1|||
13103663|NCT03351608|25872740|FG000|Overall Study|Physician Decision|1|||
13103664|NCT03351608|25872741|FG001|Overall Study|Physician Decision|0|||
13103665|NCT03351608|25872742|FG002|Overall Study|Physician Decision|0|||
13103666|NCT03351608|25872743|FG003|Overall Study|Physician Decision|2|||
13103667|NCT03351608|25872744|FG004|Overall Study|Physician Decision|1|||
13103668|NCT03351608|25872740|FG000|Overall Study|Randomized by mistake, no treatment given|0|||
13103669|NCT03351608|25872741|FG001|Overall Study|Randomized by mistake, no treatment given|0|||
13103670|NCT03351608|25872742|FG002|Overall Study|Randomized by mistake, no treatment given|0|||
13103671|NCT03351608|25872743|FG003|Overall Study|Randomized by mistake, no treatment given|1|||
13103672|NCT03351608|25872744|FG004|Overall Study|Randomized by mistake, no treatment given|0|||
13103673|NCT03351608|25872740|FG000|Overall Study|Withdrawal by parent/guardian|0|||
13103674|NCT03351608|25872741|FG001|Overall Study|Withdrawal by parent/guardian|0|||
13103675|NCT03351608|25872742|FG002|Overall Study|Withdrawal by parent/guardian|1|||
13103676|NCT03351608|25872743|FG003|Overall Study|Withdrawal by parent/guardian|1|||
13103677|NCT03351608|25872744|FG004|Overall Study|Withdrawal by parent/guardian|0|||
13103678|NCT03351608|25872740|FG000|Overall Study|Other|0|||
13103679|NCT03351608|25872741|FG001|Overall Study|Other|1|||
13103680|NCT03351608|25872742|FG002|Overall Study|Other|1|||
13103681|NCT03351608|25872743|FG003|Overall Study|Other|3|||
13103682|NCT03351608|25872744|FG004|Overall Study|Other|0|||
13103683|NCT03351478|25872783|FG000|Overall Study|At the subject's own request|11|||
13103684|NCT03351478|25872784|FG001|Overall Study|At the subject's own request|12|||
13103685|NCT03351478|25872785|FG002|Overall Study|At the subject's own request|5|||
13103686|NCT03351478|25872783|FG000|Overall Study|Adverse Event|1|||
13103687|NCT03351478|25872784|FG001|Overall Study|Adverse Event|2|||
13103688|NCT03351478|25872785|FG002|Overall Study|Adverse Event|1|||
13103689|NCT03351478|25872783|FG000|Overall Study|Poor compliance to protocol|1|||
13103690|NCT03351478|25872784|FG001|Overall Study|Poor compliance to protocol|0|||
13103691|NCT03351478|25872785|FG002|Overall Study|Poor compliance to protocol|0|||
13103692|NCT03351478|25872783|FG000|Overall Study|Reason not Specified|1|||
13103693|NCT03351478|25872784|FG001|Overall Study|Reason not Specified|3|||
13103694|NCT03351478|25872785|FG002|Overall Study|Reason not Specified|0|||
13103695|NCT03351478|25872783|FG000|Overall Study|Lost to Follow-up|0|||
13103696|NCT03351478|25872784|FG001|Overall Study|Lost to Follow-up|0|||
13103697|NCT03351478|25872785|FG002|Overall Study|Lost to Follow-up|1|||
13103698|NCT03351335|25872815|FG000|Overall Study|Failure to maintain inclusion/exclusion|0|||
13103699|NCT03351335|25872816|FG001|Overall Study|Failure to maintain inclusion/exclusion|0|||
13103700|NCT03351335|25872817|FG002|Overall Study|Failure to maintain inclusion/exclusion|4|||
13103701|NCT03351244|25872861|FG000|Overall Study|Adverse Event|7|||
13103702|NCT03351244|25872862|FG001|Overall Study|Adverse Event|11|||
13103703|NCT03351244|25872863|FG002|Overall Study|Adverse Event|12|||
13103704|NCT03351244|25872861|FG000|Overall Study|Investigator's decision|0|||
13103705|NCT03351244|25872862|FG001|Overall Study|Investigator's decision|0|||
13103706|NCT03351244|25872863|FG002|Overall Study|Investigator's decision|2|||
13103707|NCT03351244|25872861|FG000|Overall Study|System error|0|||
13103708|NCT03351244|25872862|FG001|Overall Study|System error|0|||
13103709|NCT03351244|25872863|FG002|Overall Study|System error|2|||
13103710|NCT03351244|25872861|FG000|Overall Study|COVID-19 restrictions|3|||
13103711|NCT03351244|25872862|FG001|Overall Study|COVID-19 restrictions|0|||
13103712|NCT03351244|25872863|FG002|Overall Study|COVID-19 restrictions|1|||
13103713|NCT03351244|25872861|FG000|Overall Study|Non-compliance|2|||
13103714|NCT03351244|25872862|FG001|Overall Study|Non-compliance|5|||
13103715|NCT03351244|25872863|FG002|Overall Study|Non-compliance|0|||
13103716|NCT03351244|25872861|FG000|Overall Study|Withdrawal by Subject|11|||
13153821|NCT02521870|26060263|FG001|Phase 1: Dose Escalation|Progressive Disease|2|||
13153822|NCT02521870|26060264|FG002|Phase 1: Dose Escalation|Progressive Disease|4|||
13153823|NCT02521870|26060265|FG003|Phase 1: Dose Escalation|Progressive Disease|6|||
13153824|NCT02521870|26060266|FG004|Phase 1: Dose Escalation|Progressive Disease|0|||
13153825|NCT02521870|26060267|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
13153826|NCT02521870|26060268|FG006|Phase 1: Dose Escalation|Progressive Disease|0|||
13153827|NCT02521870|26060269|FG007|Phase 1: Dose Escalation|Progressive Disease|0|||
13153828|NCT02521870|26060270|FG008|Phase 1: Dose Escalation|Progressive Disease|0|||
13153829|NCT02521870|26060271|FG009|Phase 1: Dose Escalation|Progressive Disease|0|||
13103717|NCT03351244|25872862|FG001|Overall Study|Withdrawal by Subject|16|||
13153830|NCT02521870|26060272|FG010|Phase 1: Dose Escalation|Progressive Disease|0|||
13153831|NCT02521870|26060273|FG011|Phase 1: Dose Escalation|Progressive Disease|0|||
13153832|NCT02521870|26060262|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
13153833|NCT02521870|26060263|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
13153834|NCT02521870|26060264|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
13103718|NCT03351244|25872863|FG002|Overall Study|Withdrawal by Subject|13|||
13153835|NCT02521870|26060265|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
13153836|NCT02521870|26060266|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5|||
13153837|NCT02521870|26060267|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
13153838|NCT02521870|26060268|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
13153839|NCT02521870|26060269|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
13153840|NCT02521870|26060270|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
13153841|NCT02521870|26060271|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
13153842|NCT02521870|26060272|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2|||
13153843|NCT02521870|26060273|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
13153844|NCT02521870|26060262|FG000|Phase 2: Dose Expansion|Adverse Event|0|||
13153845|NCT02521870|26060263|FG001|Phase 2: Dose Expansion|Adverse Event|0|||
13153846|NCT02521870|26060264|FG002|Phase 2: Dose Expansion|Adverse Event|0|||
13153847|NCT02521870|26060265|FG003|Phase 2: Dose Expansion|Adverse Event|0|||
13153848|NCT02521870|26060266|FG004|Phase 2: Dose Expansion|Adverse Event|11|||
13153849|NCT02521870|26060267|FG005|Phase 2: Dose Expansion|Adverse Event|2|||
13153850|NCT02521870|26060268|FG006|Phase 2: Dose Expansion|Adverse Event|0|||
13153851|NCT02521870|26060269|FG007|Phase 2: Dose Expansion|Adverse Event|1|||
13153852|NCT02521870|26060270|FG008|Phase 2: Dose Expansion|Adverse Event|5|||
13153853|NCT02521870|26060271|FG009|Phase 2: Dose Expansion|Adverse Event|0|||
13153854|NCT02521870|26060272|FG010|Phase 2: Dose Expansion|Adverse Event|1|||
13153855|NCT02521870|26060273|FG011|Phase 2: Dose Expansion|Adverse Event|0|||
13153856|NCT02521870|26060262|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
13153857|NCT02521870|26060263|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
13153858|NCT02521870|26060264|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
13153859|NCT02521870|26060265|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
13153860|NCT02521870|26060266|FG004|Phase 2: Dose Expansion|Progressive Disease|22|||
13153861|NCT02521870|26060267|FG005|Phase 2: Dose Expansion|Progressive Disease|18|||
13153862|NCT02521870|26060268|FG006|Phase 2: Dose Expansion|Progressive Disease|17|||
13153863|NCT02521870|26060269|FG007|Phase 2: Dose Expansion|Progressive Disease|7|||
13153864|NCT02521870|26060270|FG008|Phase 2: Dose Expansion|Progressive Disease|5|||
13103719|NCT03351244|25872861|FG000|Overall Study|Lost to Follow-up|2|||
13103720|NCT03351244|25872862|FG001|Overall Study|Lost to Follow-up|6|||
13103721|NCT03351244|25872863|FG002|Overall Study|Lost to Follow-up|4|||
13103722|NCT03351244|25872861|FG000|Overall Study|Protocol Violation|2|||
13103723|NCT03351244|25872862|FG001|Overall Study|Protocol Violation|2|||
13103724|NCT03351244|25872863|FG002|Overall Study|Protocol Violation|0|||
13103725|NCT03351231|25872887|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1|||
13103726|NCT03351231|25872887|FG000|Combination Therapy Period|Disease progression|2|||
13103727|NCT03351231|25872887|FG000|Combination Therapy Period|Study drug toxicity|1|||
13103728|NCT03351231|25872887|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1|||
13103729|NCT03351231|25872887|FG000|Safety Follow-Up Period|Participant withdrew consent|1|||
13103730|NCT03351231|25872887|FG000|Safety Follow-Up Period|Other reason|2|||
13103731|NCT03351114|25872897|FG000|Overall Study|Withdrawal by Subject|1|||
13103732|NCT03350750|25872928|FG000|Overall Study|Death|1|||
13103733|NCT03350750|25872929|FG001|Overall Study|Death|1|||
13103734|NCT03350672|25872947|FG000|Overall Study|Withdrawal by Subject|7|||
13103735|NCT03350672|25872948|FG001|Overall Study|Withdrawal by Subject|0|||
13103736|NCT03350672|25872949|FG002|Overall Study|Withdrawal by Subject|0|||
13103737|NCT03350256|25872971|FG000|Overall Study|Inclusion/exclusion violation|4|||
13103738|NCT03350256|25872971|FG000|Overall Study|Recommended for other therapies|2|||
13103739|NCT03350256|25872971|FG000|Overall Study|Protocol Violation|3|||
13153865|NCT02521870|26060271|FG009|Phase 2: Dose Expansion|Progressive Disease|17|||
13153866|NCT02521870|26060272|FG010|Phase 2: Dose Expansion|Progressive Disease|17|||
13153867|NCT02521870|26060273|FG011|Phase 2: Dose Expansion|Progressive Disease|21|||
13153868|NCT02521870|26060262|FG000|Phase 2: Dose Expansion|Death|0|||
13153869|NCT02521870|26060263|FG001|Phase 2: Dose Expansion|Death|0|||
13153870|NCT02521870|26060264|FG002|Phase 2: Dose Expansion|Death|0|||
13103740|NCT03350256|25872971|FG000|Overall Study|Non compliance|2|||
13103741|NCT03350256|25872971|FG000|Overall Study|Denial by insurance|1|||
13103742|NCT03350256|25872971|FG000|Overall Study|Adverse Event|2|||
13103743|NCT03350256|25872971|FG000|Overall Study|Trial failure|12|||
13103744|NCT03350256|25872971|FG000|Overall Study|Did not proceed to permanent implant|3|||
13103745|NCT03350256|25872971|FG000|Overall Study|Withdrawal by Subject|3|||
13103746|NCT03350256|25872971|FG000|Overall Study|Subject moving out of state|1|||
13153871|NCT02521870|26060265|FG003|Phase 2: Dose Expansion|Death|0|||
13153872|NCT02521870|26060266|FG004|Phase 2: Dose Expansion|Death|1|||
13153873|NCT02521870|26060267|FG005|Phase 2: Dose Expansion|Death|1|||
13153874|NCT02521870|26060268|FG006|Phase 2: Dose Expansion|Death|3|||
13153875|NCT02521870|26060269|FG007|Phase 2: Dose Expansion|Death|1|||
13103747|NCT03350256|25872971|FG000|Overall Study|Lost to Follow-up|1|||
13153876|NCT02521870|26060270|FG008|Phase 2: Dose Expansion|Death|1|||
13153877|NCT02521870|26060271|FG009|Phase 2: Dose Expansion|Death|5|||
13153878|NCT02521870|26060272|FG010|Phase 2: Dose Expansion|Death|2|||
13153879|NCT02521870|26060273|FG011|Phase 2: Dose Expansion|Death|2|||
13153880|NCT02521870|26060262|FG000|Phase 2: Dose Expansion|Other|0|||
13153881|NCT02521870|26060263|FG001|Phase 2: Dose Expansion|Other|0|||
13153882|NCT02521870|26060264|FG002|Phase 2: Dose Expansion|Other|0|||
13153883|NCT02521870|26060265|FG003|Phase 2: Dose Expansion|Other|0|||
13153884|NCT02521870|26060266|FG004|Phase 2: Dose Expansion|Other|10|||
13103748|NCT03350256|25872971|FG000|Overall Study|Lack of Efficacy|2|||
13103749|NCT03349710|25873030|FG000|Treatment Period|Death|0|||
13103750|NCT03349710|25873031|FG001|Treatment Period|Death|0|||
13103751|NCT03349710|25873032|FG002|Treatment Period|Death|1|||
13103752|NCT03349710|25873033|FG003|Treatment Period|Death|0|||
13103753|NCT03349710|25873030|FG000|Treatment Period|Disease Progression|0|||
13103754|NCT03349710|25873031|FG001|Treatment Period|Disease Progression|2|||
13103755|NCT03349710|25873032|FG002|Treatment Period|Disease Progression|0|||
13103756|NCT03349710|25873033|FG003|Treatment Period|Disease Progression|1|||
13103757|NCT03349710|25873030|FG000|Treatment Period|Study Drug Toxicity|1|||
13103758|NCT03349710|25873031|FG001|Treatment Period|Study Drug Toxicity|0|||
13103759|NCT03349710|25873032|FG002|Treatment Period|Study Drug Toxicity|1|||
13103760|NCT03349710|25873033|FG003|Treatment Period|Study Drug Toxicity|1|||
13103761|NCT03349710|25873030|FG000|Treatment Period|Adverse event unrelated to Study Drug|2|||
13103762|NCT03349710|25873031|FG001|Treatment Period|Adverse event unrelated to Study Drug|1|||
13103763|NCT03349710|25873032|FG002|Treatment Period|Adverse event unrelated to Study Drug|1|||
13103764|NCT03349710|25873033|FG003|Treatment Period|Adverse event unrelated to Study Drug|1|||
13103765|NCT03349710|25873030|FG000|Treatment Period|admin reason by sponsor|0|||
13103766|NCT03349710|25873031|FG001|Treatment Period|admin reason by sponsor|7|||
13103767|NCT03349710|25873032|FG002|Treatment Period|admin reason by sponsor|0|||
13103768|NCT03349710|25873033|FG003|Treatment Period|admin reason by sponsor|19|||
13103769|NCT03349710|25873030|FG000|Treatment Period|Other Reason|2|||
13103770|NCT03349710|25873031|FG001|Treatment Period|Other Reason|0|||
13103771|NCT03349710|25873032|FG002|Treatment Period|Other Reason|2|||
13103772|NCT03349710|25873033|FG003|Treatment Period|Other Reason|1|||
13103773|NCT03349710|25873030|FG000|Treatment Period|completed|6|||
13103774|NCT03349710|25873031|FG001|Treatment Period|completed|0|||
13103775|NCT03349710|25873032|FG002|Treatment Period|completed|18|||
13103776|NCT03349710|25873033|FG003|Treatment Period|completed|1|||
13103777|NCT03349710|25873030|FG000|Treatment Period|participant request to discontinue|0|||
13103778|NCT03349710|25873031|FG001|Treatment Period|participant request to discontinue|0|||
13103779|NCT03349710|25873032|FG002|Treatment Period|participant request to discontinue|4|||
13103780|NCT03349710|25873033|FG003|Treatment Period|participant request to discontinue|0|||
13153885|NCT02521870|26060267|FG005|Phase 2: Dose Expansion|Other|3|||
13153886|NCT02521870|26060268|FG006|Phase 2: Dose Expansion|Other|2|||
13153887|NCT02521870|26060269|FG007|Phase 2: Dose Expansion|Other|0|||
13103781|NCT03349710|25873030|FG000|Treatment Period|participant withdrew consent|1|||
13103782|NCT03349710|25873031|FG001|Treatment Period|participant withdrew consent|0|||
13103783|NCT03349710|25873032|FG002|Treatment Period|participant withdrew consent|0|||
13103784|NCT03349710|25873033|FG003|Treatment Period|participant withdrew consent|0|||
13103785|NCT03349645|25873039|FG000|Overall Study|Sponsor Terminated Study|75|||
13103786|NCT03349645|25873039|FG000|Overall Study|Withdrawal by Subject|4|||
13103787|NCT03349645|25873039|FG000|Overall Study|Protocol Violation|1|||
13103788|NCT03349645|25873039|FG000|Overall Study|Other|2|||
13103789|NCT03349515|25873052|FG000|Overall Study|Lack of Efficacy|2|||
13103790|NCT03349515|25873053|FG001|Overall Study|Lack of Efficacy|0|||
13103791|NCT03349515|25873052|FG000|Overall Study|Physician Decision|3|||
13103792|NCT03349515|25873053|FG001|Overall Study|Physician Decision|1|||
13103793|NCT03349437|25873064|FG000|Screening|Screen Fail|4|||
13103794|NCT03349437|25873065|FG001|Screening|Screen Fail|0|||
13103795|NCT03349437|25873066|FG002|Screening|Screen Fail|0|||
13103796|NCT03349437|25873064|FG000|Screening|Withdrawn|1|||
13103797|NCT03349437|25873065|FG001|Screening|Withdrawn|0|||
13103798|NCT03349437|25873066|FG002|Screening|Withdrawn|0|||
13103799|NCT03349333|25873089|FG000|Overall Study|Progression of Disease|36|||
13103800|NCT03349333|25873089|FG000|Overall Study|Adverse Event|11|||
13103801|NCT03349333|25873089|FG000|Overall Study|Other|6|||
13103802|NCT03349333|25873089|FG000|Overall Study|Withdrawal by Subject|5|||
13103803|NCT03349333|25873089|FG000|Overall Study|Conditions interfere with participation|2|||
13103804|NCT03349333|25873089|FG000|Overall Study|Physician Decision|2|||
13103805|NCT03349333|25873089|FG000|Overall Study|3-week lapse between pralatrexate doses|1|||
13103806|NCT03349333|25873089|FG000|Overall Study|Patients in treatment less than 24 month|8|||
13103807|NCT03349099|25873106|FG000|Overall Study|Physician Decision|3|||
13103808|NCT03349099|25873107|FG001|Overall Study|Physician Decision|4|||
13103809|NCT03349099|25873106|FG000|Overall Study|Stone migrated from the kidney|1|||
13103810|NCT03349099|25873107|FG001|Overall Study|Stone migrated from the kidney|0|||
13103811|NCT03349060|25873256|FG000|Overall Study|Adverse Event|9|||
13103812|NCT03349060|25873257|FG001|Overall Study|Adverse Event|9|||
13103813|NCT03349060|25873258|FG002|Overall Study|Adverse Event|7|||
13103814|NCT03349060|25873256|FG000|Overall Study|Lack of Efficacy|1|||
13103815|NCT03349060|25873257|FG001|Overall Study|Lack of Efficacy|0|||
13153888|NCT02521870|26060270|FG008|Phase 2: Dose Expansion|Other|10|||
13153889|NCT02521870|26060271|FG009|Phase 2: Dose Expansion|Other|5|||
13103816|NCT03349060|25873258|FG002|Overall Study|Lack of Efficacy|2|||
13103817|NCT03349060|25873256|FG000|Overall Study|Lost to Follow-up|2|||
13103818|NCT03349060|25873257|FG001|Overall Study|Lost to Follow-up|1|||
13103819|NCT03349060|25873258|FG002|Overall Study|Lost to Follow-up|1|||
13103820|NCT03349060|25873256|FG000|Overall Study|Protocol Violation|2|||
13103821|NCT03349060|25873257|FG001|Overall Study|Protocol Violation|2|||
13103822|NCT03349060|25873258|FG002|Overall Study|Protocol Violation|1|||
13103823|NCT03349060|25873256|FG000|Overall Study|Withdrawal by Subject|5|||
13153890|NCT02521870|26060272|FG010|Phase 2: Dose Expansion|Other|1|||
13153891|NCT02521870|26060273|FG011|Phase 2: Dose Expansion|Other|7|||
13153892|NCT02521870|26060262|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
13153893|NCT02521870|26060263|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
13153894|NCT02521870|26060264|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
13103824|NCT03349060|25873257|FG001|Overall Study|Withdrawal by Subject|3|||
13103825|NCT03349060|25873258|FG002|Overall Study|Withdrawal by Subject|4|||
13103826|NCT03349060|25873256|FG000|Overall Study|Medication error,no linked adverse event|0|||
13103827|NCT03349060|25873257|FG001|Overall Study|Medication error,no linked adverse event|0|||
13153895|NCT02521870|26060265|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
13153896|NCT02521870|26060266|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1|||
13153897|NCT02521870|26060267|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0|||
13153898|NCT02521870|26060268|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0|||
13153899|NCT02521870|26060269|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0|||
13153900|NCT02521870|26060270|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0|||
13153901|NCT02521870|26060271|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0|||
13153902|NCT02521870|26060272|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0|||
13153903|NCT02521870|26060273|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0|||
13153904|NCT02521870|26060262|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
13153905|NCT02521870|26060263|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
13153906|NCT02521870|26060264|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
13153907|NCT02521870|26060265|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
13153908|NCT02521870|26060266|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2|||
13153909|NCT02521870|26060267|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
13153910|NCT02521870|26060268|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
13153911|NCT02521870|26060269|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
13153912|NCT02521870|26060270|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
13153913|NCT02521870|26060271|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
13153914|NCT02521870|26060272|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
13153915|NCT02521870|26060273|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
13153916|NCT02521792|26060288|FG000|Overall Study|Study Terminated|6|||
13153917|NCT02521376|26060331|FG000|Overall Study|Enrolled, But Not Treated|1|||
13153918|NCT02521376|26060332|FG001|Overall Study|Enrolled, But Not Treated|0|||
13153919|NCT02521376|26060333|FG002|Overall Study|Enrolled, But Not Treated|0|||
13153920|NCT02521376|26060334|FG003|Overall Study|Enrolled, But Not Treated|0|||
13153921|NCT02520726|26060349|FG000|Overall Study|Lost to Follow-up|3|||
13153922|NCT02520726|26060350|FG001|Overall Study|Lost to Follow-up|2|||
13153923|NCT02520661|26060385|FG000|Overall Study|Lost to Follow-up|7|||
13153924|NCT02520661|26060386|FG001|Overall Study|Lost to Follow-up|3|||
13103828|NCT03349060|25873258|FG002|Overall Study|Medication error,no linked adverse event|1|||
13103829|NCT03349060|25873256|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
13103830|NCT03349060|25873257|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
13103831|NCT03349060|25873258|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
13103832|NCT03349060|25873256|FG000|Overall Study|Other|2|||
13103833|NCT03349060|25873257|FG001|Overall Study|Other|1|||
13153925|NCT02520661|26060385|FG000|Overall Study|Admitted from ED|49|||
13153926|NCT02520661|26060386|FG001|Overall Study|Admitted from ED|48|||
13153927|NCT02520661|26060385|FG000|Overall Study|ED greater than 24 hours|29|||
13153928|NCT02520661|26060386|FG001|Overall Study|ED greater than 24 hours|38|||
13153929|NCT02520661|26060385|FG000|Overall Study|other ineligibility|14|||
13153930|NCT02520661|26060386|FG001|Overall Study|other ineligibility|22|||
13153931|NCT02520661|26060385|FG000|Overall Study|Withdrawal by Subject|7|||
13153932|NCT02520661|26060386|FG001|Overall Study|Withdrawal by Subject|16|||
13153933|NCT02520531|26060407|FG000|Overall Study|Revision of study device components|2|||
13153934|NCT02520531|26060408|FG001|Overall Study|Revision of study device components|2|||
13153935|NCT02520531|26060407|FG000|Overall Study|Death|1|||
13153936|NCT02520531|26060408|FG001|Overall Study|Death|2|||
13153937|NCT02520531|26060407|FG000|Overall Study|Lost to Follow-up|1|||
13153938|NCT02520531|26060408|FG001|Overall Study|Lost to Follow-up|1|||
13103834|NCT03349060|25873258|FG002|Overall Study|Other|0|||
13153939|NCT02520531|26060407|FG000|Overall Study|Meet exclusion criterion|0|||
13153940|NCT02520531|26060408|FG001|Overall Study|Meet exclusion criterion|1|||
13103835|NCT03349034|25873283|FG000|Overall Study|catheters dislodged during transport|2|||
13103836|NCT03349034|25873284|FG001|Overall Study|catheters dislodged during transport|0|||
13103837|NCT03349034|25873283|FG000|Overall Study|intubated for >48 hrs following surgery|1|||
13103838|NCT03349034|25873284|FG001|Overall Study|intubated for >48 hrs following surgery|1|||
13153941|NCT02520531|26060407|FG000|Overall Study|Withdrawal by Subject|1|||
13153942|NCT02520531|26060408|FG001|Overall Study|Withdrawal by Subject|0|||
13153943|NCT02520531|26060407|FG000|Overall Study|Not study device|1|||
13153944|NCT02520531|26060408|FG001|Overall Study|Not study device|0|||
13153945|NCT02520388|26060423|FG000|Overall Study|Physician Decision|1|||
13153946|NCT02520388|26060424|FG001|Overall Study|Physician Decision|0|||
13153947|NCT02520388|26060423|FG000|Overall Study|Subject or parent/guardian request|0|||
13103839|NCT03349034|25873283|FG000|Overall Study|soft tissue flap used|1|||
13103840|NCT03349034|25873284|FG001|Overall Study|soft tissue flap used|0|||
13103841|NCT03349034|25873283|FG000|Overall Study|Other|0|||
13222693|NCT01803464|26286807|FG002|Overall Study|Incomplete data|4|||
13222694|NCT01803464|26286808|FG003|Overall Study|Incomplete data|0|||
13222695|NCT01803464|26286805|FG000|Overall Study|Withdrawal by Subject|1|||
13222696|NCT01803464|26286806|FG001|Overall Study|Withdrawal by Subject|0|||
13222697|NCT01803464|26286807|FG002|Overall Study|Withdrawal by Subject|0|||
13222698|NCT01803464|26286808|FG003|Overall Study|Withdrawal by Subject|0|||
13103842|NCT03349034|25873284|FG001|Overall Study|Other|1|||
13103843|NCT03348930|25873301|FG000|Washout (1 Week)|Lost to Follow-up|1|||
13222699|NCT01803282|26286883|FG000|Overall Study|Progressive Disease|4|||
13222700|NCT01803282|26286884|FG001|Overall Study|Progressive Disease|3|||
13222701|NCT01803282|26286885|FG002|Overall Study|Progressive Disease|6|||
13222702|NCT01803282|26286886|FG003|Overall Study|Progressive Disease|22|||
13222703|NCT01803282|26286887|FG004|Overall Study|Progressive Disease|5|||
13222704|NCT01803282|26286888|FG005|Overall Study|Progressive Disease|8|||
13222705|NCT01803282|26286889|FG006|Overall Study|Progressive Disease|23|||
13222706|NCT01803282|26286890|FG007|Overall Study|Progressive Disease|24|||
13222707|NCT01803282|26286891|FG008|Overall Study|Progressive Disease|3|||
13222708|NCT01803282|26286892|FG009|Overall Study|Progressive Disease|29|||
13222709|NCT01803282|26286893|FG010|Overall Study|Progressive Disease|6|||
13103844|NCT03348930|25873302|FG001|Washout (1 Week)|Lost to Follow-up|1|||
13222710|NCT01803282|26286894|FG011|Overall Study|Progressive Disease|11|||
13222711|NCT01803282|26286883|FG000|Overall Study|Death|0|||
13222712|NCT01803282|26286884|FG001|Overall Study|Death|0|||
13222713|NCT01803282|26286885|FG002|Overall Study|Death|0|||
13222714|NCT01803282|26286886|FG003|Overall Study|Death|0|||
13222715|NCT01803282|26286887|FG004|Overall Study|Death|2|||
13222716|NCT01803282|26286888|FG005|Overall Study|Death|1|||
13222717|NCT01803282|26286889|FG006|Overall Study|Death|1|||
13222718|NCT01803282|26286890|FG007|Overall Study|Death|5|||
13222719|NCT01803282|26286891|FG008|Overall Study|Death|1|||
13222720|NCT01803282|26286892|FG009|Overall Study|Death|1|||
13222721|NCT01803282|26286893|FG010|Overall Study|Death|0|||
13222722|NCT01803282|26286894|FG011|Overall Study|Death|0|||
13103845|NCT03348904|25873329|FG000|Overall Study|Administrative reason by the sponsor|0|||
13103846|NCT03348904|25873330|FG001|Overall Study|Administrative reason by the sponsor|1|||
13103847|NCT03348904|25873331|FG002|Overall Study|Administrative reason by the sponsor|0|||
13103848|NCT03348163|25873498|FG000|Overall Study|Withdrawal by Subject|2|||
13103849|NCT03348163|25873499|FG001|Overall Study|Withdrawal by Subject|0|||
13103850|NCT03347695|25873526|FG000|Overall Study|Death|0|||
13103851|NCT03347695|25873527|FG001|Overall Study|Death|4|||
13103852|NCT03347695|25873526|FG000|Overall Study|Lost to Follow-up|0|||
13103853|NCT03347695|25873527|FG001|Overall Study|Lost to Follow-up|1|||
13103854|NCT03347396|25873561|FG000|Part A (26 Weeks)|Adverse Event|1|||
13103855|NCT03347396|25873562|FG001|Part A (26 Weeks)|Adverse Event|0|||
13103856|NCT03347396|25873561|FG000|Part A (26 Weeks)|Death|0|||
13103857|NCT03347396|25873562|FG001|Part A (26 Weeks)|Death|1|||
13153948|NCT02520388|26060424|FG001|Overall Study|Subject or parent/guardian request|6|||
13153949|NCT02520388|26060423|FG000|Overall Study|Adverse Event|1|||
13153950|NCT02520388|26060424|FG001|Overall Study|Adverse Event|4|||
13153951|NCT02520388|26060423|FG000|Overall Study|Lost to Follow-up|3|||
13153952|NCT02520388|26060424|FG001|Overall Study|Lost to Follow-up|2|||
13153953|NCT02520388|26060423|FG000|Overall Study|Other (reason not defined)|4|||
13153954|NCT02520388|26060424|FG001|Overall Study|Other (reason not defined)|4|||
13153955|NCT02520310|26060616|FG000|At 6 Months Clinical Follow-up|Death|1|||
13153956|NCT02520310|26060616|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1|||
13153957|NCT02520310|26060616|FG000|AT 3 Year Clinical Follow-up|Death|2|||
13153958|NCT02520310|26060616|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2|||
13153959|NCT02520310|26060616|FG000|AT 4 Year Clinical Follow-up|Death|1|||
13153960|NCT02520310|26060616|FG000|AT 4 Year Clinical Follow-up|missed visit|1|||
13222723|NCT01803282|26286883|FG000|Overall Study|Withdrew Consent|0|||
13222724|NCT01803282|26286884|FG001|Overall Study|Withdrew Consent|0|||
13222725|NCT01803282|26286885|FG002|Overall Study|Withdrew Consent|0|||
13222726|NCT01803282|26286886|FG003|Overall Study|Withdrew Consent|6|||
13103858|NCT03347396|25873561|FG000|Part B (149 Weeks)|Adverse Event|1|||
13103859|NCT03347396|25873562|FG001|Part B (149 Weeks)|Adverse Event|1|||
13153961|NCT02520284|26060658|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1|||
13222727|NCT01803282|26286887|FG004|Overall Study|Withdrew Consent|1|||
13222728|NCT01803282|26286888|FG005|Overall Study|Withdrew Consent|0|||
13222729|NCT01803282|26286889|FG006|Overall Study|Withdrew Consent|8|||
13153962|NCT02520284|26060659|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3|||
13153963|NCT02520284|26060660|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0|||
13153964|NCT02520284|26060658|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
13153965|NCT02520284|26060659|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
13153966|NCT02520284|26060660|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
13153967|NCT02520284|26060658|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
13153968|NCT02520284|26060659|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
13153969|NCT02520284|26060660|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1|||
13153970|NCT02520284|26060658|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17|||
13153971|NCT02520284|26060659|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11|||
13153972|NCT02520284|26060660|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15|||
13153973|NCT02520284|26060658|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
13153974|NCT02520284|26060659|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
13153975|NCT02520284|26060660|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3|||
13153976|NCT02520284|26060658|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
13153977|NCT02520284|26060659|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
13153978|NCT02520284|26060660|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0|||
13153979|NCT02520284|26060658|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
13153980|NCT02520284|26060659|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2|||
13153981|NCT02520284|26060660|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
13153982|NCT02520284|26060658|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25|||
13153983|NCT02520284|26060659|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29|||
13153984|NCT02520284|26060660|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28|||
13153985|NCT02520284|26060658|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3|||
13153986|NCT02520284|26060659|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4|||
13153987|NCT02520284|26060660|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2|||
13153988|NCT02520284|26060658|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2|||
13153989|NCT02520284|26060659|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1|||
13153990|NCT02520284|26060660|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3|||
13153991|NCT02520284|26060658|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2|||
13153992|NCT02520284|26060659|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
13153993|NCT02520284|26060660|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
13153994|NCT02520089|26060675|FG000|Overall Study|Lost to Follow-up|3|||
13153995|NCT02520089|26060676|FG001|Overall Study|Lost to Follow-up|4|||
13153996|NCT02520011|26060699|FG000|Overall Study|Adverse Event|0|||
13153997|NCT02520011|26060700|FG001|Overall Study|Adverse Event|1|||
13153998|NCT02520011|26060701|FG002|Overall Study|Adverse Event|2|||
13153999|NCT02520011|26060699|FG000|Overall Study|Death|0|||
13154000|NCT02520011|26060700|FG001|Overall Study|Death|8|||
13154001|NCT02520011|26060701|FG002|Overall Study|Death|1|||
13154002|NCT02520011|26060699|FG000|Overall Study|Lack of Efficacy|4|||
13154003|NCT02520011|26060700|FG001|Overall Study|Lack of Efficacy|26|||
13154004|NCT02520011|26060701|FG002|Overall Study|Lack of Efficacy|4|||
13154005|NCT02520011|26060699|FG000|Overall Study|Physician Decision|0|||
13154006|NCT02520011|26060700|FG001|Overall Study|Physician Decision|2|||
13154007|NCT02520011|26060701|FG002|Overall Study|Physician Decision|0|||
13154008|NCT02520011|26060699|FG000|Overall Study|Withdrawal by Subject|1|||
13154009|NCT02520011|26060700|FG001|Overall Study|Withdrawal by Subject|3|||
13154010|NCT02520011|26060701|FG002|Overall Study|Withdrawal by Subject|0|||
13103860|NCT03347396|25873561|FG000|Part B (149 Weeks)|Death|1|||
13154011|NCT02520011|26060699|FG000|Overall Study|Protocol Deviation|0|||
13154012|NCT02520011|26060700|FG001|Overall Study|Protocol Deviation|1|||
13154013|NCT02520011|26060701|FG002|Overall Study|Protocol Deviation|0|||
13154014|NCT02520011|26060699|FG000|Overall Study|Patient went to hospice|0|||
13154015|NCT02520011|26060700|FG001|Overall Study|Patient went to hospice|1|||
13154016|NCT02520011|26060701|FG002|Overall Study|Patient went to hospice|0|||
13154017|NCT02520011|26060699|FG000|Overall Study|Progressive disease following response|0|||
13154018|NCT02520011|26060700|FG001|Overall Study|Progressive disease following response|4|||
13103861|NCT03347396|25873562|FG001|Part B (149 Weeks)|Death|0|||
13103862|NCT03347279|25873635|FG000|Overall Study|Withdrawal by Subject|8|||
13103863|NCT03347279|25873636|FG001|Overall Study|Withdrawal by Subject|15|||
13103864|NCT03347279|25873635|FG000|Overall Study|Death|0|||
13103865|NCT03347279|25873636|FG001|Overall Study|Death|2|||
13103866|NCT03347279|25873635|FG000|Overall Study|Lost to Follow-up|5|||
13103867|NCT03347279|25873636|FG001|Overall Study|Lost to Follow-up|2|||
13103868|NCT03347279|25873635|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
13103869|NCT03347279|25873636|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
13154019|NCT02520011|26060701|FG002|Overall Study|Progressive disease following response|2|||
13154020|NCT02519855|26060724|FG000|Overall Study|Adverse Event|0|||
13154021|NCT02519855|26060725|FG001|Overall Study|Adverse Event|1|||
13103870|NCT03346759|25873652|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2|||
13103871|NCT03346759|25873653|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3|||
13103872|NCT03346759|25873652|FG000|First Menstrual Cycle|Withdrawal by Subject|1|||
13103873|NCT03346759|25873653|FG001|First Menstrual Cycle|Withdrawal by Subject|0|||
13154022|NCT02519855|26060724|FG000|Overall Study|Lost to Follow-up|3|||
13103874|NCT03346759|25873652|FG000|Second Menstrual Cycle|Lost to Follow-up|1|||
13103875|NCT03346759|25873653|FG001|Second Menstrual Cycle|Lost to Follow-up|0|||
13103876|NCT03346434|25873782|FG000|Overall Study|Randomized in Error|0|||
13103877|NCT03346434|25873783|FG001|Overall Study|Randomized in Error|0|||
13103878|NCT03346434|25873784|FG002|Overall Study|Randomized in Error|0|||
13103879|NCT03346434|25873785|FG003|Overall Study|Randomized in Error|0|||
13103880|NCT03346434|25873786|FG004|Overall Study|Randomized in Error|1|||
13103881|NCT03346434|25873787|FG005|Overall Study|Randomized in Error|0|||
13154023|NCT02519855|26060725|FG001|Overall Study|Lost to Follow-up|3|||
13154024|NCT02519842|26060752|FG000|Base Study: Cycle 1|Screening Failure|1|||
13154025|NCT02519842|26060753|FG001|Base Study: Cycle 1|Screening Failure|1|||
13154026|NCT02519842|26060754|FG002|Base Study: Cycle 1|Screening Failure|0|||
13154027|NCT02519842|26060752|FG000|Base Study: Cycle 1|Adverse Event|1|||
13154028|NCT02519842|26060753|FG001|Base Study: Cycle 1|Adverse Event|0|||
13154029|NCT02519842|26060754|FG002|Base Study: Cycle 1|Adverse Event|0|||
13154030|NCT02519842|26060752|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
13154031|NCT02519842|26060753|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1|||
13154032|NCT02519842|26060754|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
13154033|NCT02519842|26060752|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
13154034|NCT02519842|26060753|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1|||
13154035|NCT02519842|26060754|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
13154036|NCT02519842|26060752|FG000|Optional Extension: Cycles 2-6|Physician Decision|0|||
13154037|NCT02519842|26060753|FG001|Optional Extension: Cycles 2-6|Physician Decision|0|||
13154038|NCT02519842|26060754|FG002|Optional Extension: Cycles 2-6|Physician Decision|5|||
13154039|NCT02519842|26060752|FG000|Optional Extension: Cycles 2-6|Adverse Event|0|||
13154040|NCT02519842|26060753|FG001|Optional Extension: Cycles 2-6|Adverse Event|0|||
13154041|NCT02519842|26060754|FG002|Optional Extension: Cycles 2-6|Adverse Event|1|||
13154042|NCT02519842|26060752|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
13154043|NCT02519842|26060753|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
13154044|NCT02519842|26060754|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3|||
13154045|NCT02519842|26060752|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
13154046|NCT02519842|26060753|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
13154047|NCT02519842|26060754|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1|||
13154048|NCT02519842|26060752|FG000|Optional Extension: Cycles 2-6|Death|0|||
13154049|NCT02519842|26060753|FG001|Optional Extension: Cycles 2-6|Death|0|||
13154050|NCT02519842|26060754|FG002|Optional Extension: Cycles 2-6|Death|1|||
13154051|NCT02519842|26060752|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
13154052|NCT02519842|26060753|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
13154053|NCT02519842|26060754|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2|||
13154054|NCT02519842|26060752|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
13154055|NCT02519842|26060753|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
13154056|NCT02519842|26060754|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13|||
13154057|NCT02519842|26060752|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
13154058|NCT02519842|26060753|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
13154059|NCT02519842|26060754|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1|||
13154060|NCT02519842|26060752|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
13154061|NCT02519842|26060753|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
13154062|NCT02519842|26060754|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2|||
13154063|NCT02519777|26060820|FG000|Overall Study|Death|1|||
13154064|NCT02519777|26060821|FG001|Overall Study|Death|0|||
13154065|NCT02519777|26060822|FG002|Overall Study|Death|0|||
13154066|NCT02519777|26060820|FG000|Overall Study|Lost to Follow-up|0|||
13154067|NCT02519777|26060821|FG001|Overall Study|Lost to Follow-up|4|||
13154068|NCT02519777|26060822|FG002|Overall Study|Lost to Follow-up|2|||
13154069|NCT02519777|26060820|FG000|Overall Study|Withdrawal by Subject|3|||
13154070|NCT02519777|26060821|FG001|Overall Study|Withdrawal by Subject|1|||
13154071|NCT02519777|26060822|FG002|Overall Study|Withdrawal by Subject|0|||
13154072|NCT02519777|26060820|FG000|Overall Study|Severe Debilitation|1|||
13154073|NCT02519777|26060821|FG001|Overall Study|Severe Debilitation|1|||
13154074|NCT02519777|26060822|FG002|Overall Study|Severe Debilitation|1|||
13154075|NCT02519777|26060820|FG000|Overall Study|Not able to get to clinic|1|||
13154076|NCT02519777|26060821|FG001|Overall Study|Not able to get to clinic|2|||
13154077|NCT02519777|26060822|FG002|Overall Study|Not able to get to clinic|1|||
13154078|NCT02519712|26060828|FG000|Overall Study|Disease Relapse|1|||
13154079|NCT02519712|26060828|FG000|Overall Study|Disease Progression|1|||
13154080|NCT02519712|26060828|FG000|Overall Study|Accruals are donors|2|||
13154081|NCT02519595|26060861|FG000|Overall Study|Protocol Violation|8|||
13154082|NCT02519595|26060862|FG001|Overall Study|Protocol Violation|22|||
13154083|NCT02519595|26060863|FG002|Overall Study|Protocol Violation|16|||
13154084|NCT02519504|26060930|FG000|Overall Study|Protocol Violation|6|||
13154085|NCT02519504|26060931|FG001|Overall Study|Protocol Violation|5|||
13154086|NCT02519504|26060930|FG000|Overall Study|Ineligible for direct testing|12|||
13154087|NCT02519504|26060931|FG001|Overall Study|Ineligible for direct testing|12|||
13154088|NCT02519504|26060930|FG000|Overall Study|Did not participate in direct testing|95|||
13154089|NCT02519504|26060931|FG001|Overall Study|Did not participate in direct testing|86|||
13154090|NCT02519231|26060946|FG000|Overall Study|Lost to Follow-up|2|||
13154091|NCT02519231|26060947|FG001|Overall Study|Lost to Follow-up|5|||
13154092|NCT02519231|26060946|FG000|Overall Study|Withdrawal by Subject|0|||
13154093|NCT02519231|26060947|FG001|Overall Study|Withdrawal by Subject|1|||
13154094|NCT02518971|26060971|FG000|Overall Study|Lost to Follow-up|0|||
13154095|NCT02518971|26060972|FG001|Overall Study|Lost to Follow-up|1|||
13154096|NCT02518971|26060971|FG000|Overall Study|Physician Decision|6|||
13154097|NCT02518971|26060972|FG001|Overall Study|Physician Decision|6|||
13154098|NCT02518971|26060971|FG000|Overall Study|Protocol Violation|6|||
13154099|NCT02518971|26060972|FG001|Overall Study|Protocol Violation|4|||
13154100|NCT02518971|26060971|FG000|Overall Study|Withdrawal by Subject|4|||
13154101|NCT02518971|26060972|FG001|Overall Study|Withdrawal by Subject|5|||
13154102|NCT02518971|26060971|FG000|Overall Study|Side effects|1|||
13154103|NCT02518971|26060972|FG001|Overall Study|Side effects|0|||
13154104|NCT02518971|26060971|FG000|Overall Study|medication lost in mail|0|||
13103882|NCT03346434|25873782|FG000|Overall Study|Withdrawal by Subject|0|||
13103883|NCT03346434|25873783|FG001|Overall Study|Withdrawal by Subject|0|||
13103884|NCT03346434|25873784|FG002|Overall Study|Withdrawal by Subject|1|||
13103885|NCT03346434|25873785|FG003|Overall Study|Withdrawal by Subject|0|||
13103886|NCT03346434|25873786|FG004|Overall Study|Withdrawal by Subject|1|||
13103887|NCT03346434|25873787|FG005|Overall Study|Withdrawal by Subject|0|||
13103888|NCT03346434|25873782|FG000|Overall Study|Lost to Follow-up|0|||
13103889|NCT03346434|25873783|FG001|Overall Study|Lost to Follow-up|0|||
13103890|NCT03346434|25873784|FG002|Overall Study|Lost to Follow-up|0|||
13103891|NCT03346434|25873785|FG003|Overall Study|Lost to Follow-up|0|||
13103892|NCT03346434|25873786|FG004|Overall Study|Lost to Follow-up|1|||
13103893|NCT03346434|25873787|FG005|Overall Study|Lost to Follow-up|1|||
13103894|NCT03346434|25873782|FG000|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
13103895|NCT03346434|25873783|FG001|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
13103896|NCT03346434|25873784|FG002|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
13103897|NCT03346434|25873785|FG003|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
13103898|NCT03346434|25873786|FG004|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|75|||
13103899|NCT03346434|25873787|FG005|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|81|||
13103900|NCT03346070|25873887|FG000|Overall Study|Death|0|||
13103901|NCT03346070|25873888|FG001|Overall Study|Death|0|||
13103902|NCT03346070|25873889|FG002|Overall Study|Death|0|||
13103903|NCT03346070|25873890|FG003|Overall Study|Death|0|||
13103904|NCT03346070|25873891|FG004|Overall Study|Death|1|||
13103905|NCT03346070|25873887|FG000|Overall Study|Lost to Follow-up|0|||
13103906|NCT03346070|25873888|FG001|Overall Study|Lost to Follow-up|1|||
13103907|NCT03346070|25873889|FG002|Overall Study|Lost to Follow-up|2|||
13103908|NCT03346070|25873890|FG003|Overall Study|Lost to Follow-up|0|||
13154105|NCT02518971|26060972|FG001|Overall Study|medication lost in mail|1|||
13154106|NCT02518971|26060971|FG000|Overall Study|eligibility criteria no longer met|6|||
13154107|NCT02518971|26060972|FG001|Overall Study|eligibility criteria no longer met|3|||
13154108|NCT02518919|26061002|FG000|Overall Study|Protocol Violation|1|||
13154109|NCT02518919|26061003|FG001|Overall Study|Protocol Violation|1|||
13154110|NCT02518919|26061004|FG002|Overall Study|Protocol Violation|2|||
13154111|NCT02518685|26061018|FG000|Overall Study|Adverse Event|29|||
13154112|NCT02518685|26061019|FG001|Overall Study|Adverse Event|1|||
13154113|NCT02518685|26061018|FG000|Overall Study|Withdrawal by Subject|10|||
13154114|NCT02518685|26061019|FG001|Overall Study|Withdrawal by Subject|3|||
13154115|NCT02518685|26061018|FG000|Overall Study|relocation, study fatigue|7|||
13103909|NCT03346070|25873891|FG004|Overall Study|Lost to Follow-up|0|||
13154116|NCT02518685|26061019|FG001|Overall Study|relocation, study fatigue|2|||
13154117|NCT02518685|26061018|FG000|Overall Study|Pregnancy|1|||
13103910|NCT03346070|25873887|FG000|Overall Study|Physician Decision|0|||
13154118|NCT02518685|26061019|FG001|Overall Study|Pregnancy|0|||
13154119|NCT02518685|26061018|FG000|Overall Study|Physician Decision|1|||
13154120|NCT02518685|26061019|FG001|Overall Study|Physician Decision|0|||
13154121|NCT02518685|26061018|FG000|Overall Study|Lost to Follow-up|1|||
13154122|NCT02518685|26061019|FG001|Overall Study|Lost to Follow-up|4|||
13154123|NCT02518620|26061049|FG000|Overall Study|Adverse Event|23|||
13154124|NCT02518620|26061050|FG001|Overall Study|Adverse Event|11|||
13154125|NCT02518620|26061049|FG000|Overall Study|Lack of Efficacy|2|||
13154126|NCT02518620|26061050|FG001|Overall Study|Lack of Efficacy|0|||
13154127|NCT02518620|26061049|FG000|Overall Study|Non-Compliance with Study Drug|1|||
13154128|NCT02518620|26061050|FG001|Overall Study|Non-Compliance with Study Drug|0|||
13154129|NCT02518620|26061049|FG000|Overall Study|Physician Decision|1|||
13154130|NCT02518620|26061050|FG001|Overall Study|Physician Decision|1|||
13154131|NCT02518620|26061049|FG000|Overall Study|Sponsor's Decision|0|||
13154132|NCT02518620|26061050|FG001|Overall Study|Sponsor's Decision|3|||
13154133|NCT02518620|26061049|FG000|Overall Study|Lost to Follow-up|1|||
13154134|NCT02518620|26061050|FG001|Overall Study|Lost to Follow-up|1|||
13154135|NCT02518620|26061049|FG000|Overall Study|Withdrawal by Subject|17|||
13154136|NCT02518620|26061050|FG001|Overall Study|Withdrawal by Subject|9|||
13154137|NCT02518620|26061049|FG000|Overall Study|Death|1|||
13154138|NCT02518620|26061050|FG001|Overall Study|Death|0|||
13154139|NCT02518620|26061049|FG000|Overall Study|Pregnancy Wish|3|||
13154140|NCT02518620|26061050|FG001|Overall Study|Pregnancy Wish|0|||
13154141|NCT02518620|26061049|FG000|Overall Study|Pregnancy|1|||
13154142|NCT02518620|26061050|FG001|Overall Study|Pregnancy|0|||
13154143|NCT02518620|26061049|FG000|Overall Study|Relocation|2|||
13154144|NCT02518620|26061050|FG001|Overall Study|Relocation|1|||
13154145|NCT02518490|26061071|FG000|Overall Study|Withdrawal by Subject|1|||
13154146|NCT02518490|26061072|FG001|Overall Study|Withdrawal by Subject|1|||
13154147|NCT02518464|26061078|FG000|Overall Study|Adverse Event|2|||
13154148|NCT02518113|26061132|FG000|Overall Study|Adverse Event|1|||
13154149|NCT02518113|26061133|FG001|Overall Study|Adverse Event|0|||
13154150|NCT02518113|26061134|FG002|Overall Study|Adverse Event|1|||
13154151|NCT02518113|26061135|FG003|Overall Study|Adverse Event|0|||
13154152|NCT02518113|26061132|FG000|Overall Study|Death|1|||
13154153|NCT02518113|26061133|FG001|Overall Study|Death|2|||
13154154|NCT02518113|26061134|FG002|Overall Study|Death|0|||
13154155|NCT02518113|26061135|FG003|Overall Study|Death|0|||
13154156|NCT02518113|26061132|FG000|Overall Study|Physician Decision|0|||
13154157|NCT02518113|26061133|FG001|Overall Study|Physician Decision|1|||
13154158|NCT02518113|26061134|FG002|Overall Study|Physician Decision|0|||
13154159|NCT02518113|26061135|FG003|Overall Study|Physician Decision|0|||
13154160|NCT02518113|26061132|FG000|Overall Study|Progressive Disease|1|||
13154161|NCT02518113|26061133|FG001|Overall Study|Progressive Disease|2|||
13154162|NCT02518113|26061134|FG002|Overall Study|Progressive Disease|3|||
13154163|NCT02518113|26061135|FG003|Overall Study|Progressive Disease|0|||
13154164|NCT02518048|26061148|FG000|Overall Study|Withdrawal by Subject|1|||
13154165|NCT02517905|26061171|FG000|Overall Study|Lost to Follow-up|4|||
13154166|NCT02517905|26061172|FG001|Overall Study|Lost to Follow-up|0|||
13154167|NCT02517905|26061171|FG000|Overall Study|Withdrawal by Subject|4|||
13154168|NCT02517905|26061172|FG001|Overall Study|Withdrawal by Subject|0|||
13154169|NCT02517905|26061171|FG000|Overall Study|Screen failure|2|||
13103911|NCT03346070|25873888|FG001|Overall Study|Physician Decision|0|||
13103912|NCT03346070|25873889|FG002|Overall Study|Physician Decision|0|||
13103913|NCT03346070|25873890|FG003|Overall Study|Physician Decision|1|||
13103914|NCT03346070|25873891|FG004|Overall Study|Physician Decision|1|||
13103915|NCT03346070|25873887|FG000|Overall Study|Withdrawal by Subject|1|||
13103916|NCT03346070|25873888|FG001|Overall Study|Withdrawal by Subject|0|||
13103917|NCT03346070|25873889|FG002|Overall Study|Withdrawal by Subject|0|||
13103918|NCT03346070|25873890|FG003|Overall Study|Withdrawal by Subject|1|||
13154170|NCT02517905|26061172|FG001|Overall Study|Screen failure|2|||
13154171|NCT02517866|26061218|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
13154172|NCT02517866|26061219|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
13154173|NCT02517866|26061220|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
13154174|NCT02517866|26061218|FG000|Overall Study|Significant Protocol Deviation|4|||
13154175|NCT02517866|26061219|FG001|Overall Study|Significant Protocol Deviation|1|||
13154176|NCT02517866|26061220|FG002|Overall Study|Significant Protocol Deviation|0|||
13154177|NCT02517866|26061218|FG000|Overall Study|Lost to Follow-up|1|||
13154178|NCT02517866|26061219|FG001|Overall Study|Lost to Follow-up|0|||
13154179|NCT02517866|26061220|FG002|Overall Study|Lost to Follow-up|0|||
13154180|NCT02517866|26061218|FG000|Overall Study|Voluntary Withdrawal|2|||
13154181|NCT02517866|26061219|FG001|Overall Study|Voluntary Withdrawal|2|||
13154182|NCT02517866|26061220|FG002|Overall Study|Voluntary Withdrawal|0|||
13154183|NCT02517866|26061218|FG000|Overall Study|Investigator Decision|2|||
13154184|NCT02517866|26061219|FG001|Overall Study|Investigator Decision|1|||
13154185|NCT02517866|26061220|FG002|Overall Study|Investigator Decision|0|||
13154186|NCT02517866|26061218|FG000|Overall Study|Reason not specified|2|||
13154187|NCT02517866|26061219|FG001|Overall Study|Reason not specified|0|||
13154188|NCT02517866|26061220|FG002|Overall Study|Reason not specified|0|||
13154189|NCT02517541|26061228|FG000|Baseline Period (Own Product)|Protocol Violation|1|||
13154190|NCT02517541|26061228|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3|||
13154191|NCT02517541|26061228|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2|||
13154192|NCT02517541|26061228|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1|||
13154193|NCT02517541|26061228|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4|||
13154194|NCT02517541|26061228|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2|||
13154195|NCT02517528|26061238|FG000|Overall Study|Withdrawal by Subject|1|||
13154196|NCT02517515|26061260|FG000|Overall Study|Adverse Event|0|||
13154197|NCT02517515|26061261|FG001|Overall Study|Adverse Event|1|||
13103919|NCT03346070|25873891|FG004|Overall Study|Withdrawal by Subject|0|||
13154198|NCT02517515|26061260|FG000|Overall Study|Withdrew Consent|0|||
13154199|NCT02517515|26061261|FG001|Overall Study|Withdrew Consent|1|||
13154200|NCT02517515|26061260|FG000|Overall Study|Lost to Follow-up|1|||
13154201|NCT02517515|26061261|FG001|Overall Study|Lost to Follow-up|0|||
13154202|NCT02517515|26061260|FG000|Overall Study|Other|1|||
13154203|NCT02517515|26061261|FG001|Overall Study|Other|0|||
13154204|NCT02517463|26061278|FG000|Overall Study|Lost to Follow-up|5|||
13154205|NCT02517463|26061279|FG001|Overall Study|Lost to Follow-up|2|||
13154206|NCT02517268|26061300|FG000|Overall Study|Withdrawal by Subject|1|||
13154207|NCT02517268|26061301|FG001|Overall Study|Withdrawal by Subject|0|||
13154208|NCT02516982|26061336|FG000|Overall Study|Called in to antenatal appointment|32|||
13154209|NCT02516982|26061337|FG001|Overall Study|Called in to antenatal appointment|35|||
13154210|NCT02516982|26061338|FG002|Overall Study|Called in to antenatal appointment|0|||
13154211|NCT02516982|26061339|FG003|Overall Study|Called in to antenatal appointment|0|||
13154212|NCT02516982|26061336|FG000|Overall Study|Withdrawal by Subject|0|||
13154213|NCT02516982|26061337|FG001|Overall Study|Withdrawal by Subject|0|||
13154214|NCT02516982|26061338|FG002|Overall Study|Withdrawal by Subject|1|||
13154215|NCT02516982|26061339|FG003|Overall Study|Withdrawal by Subject|2|||
13154216|NCT02516982|26061336|FG000|Overall Study|Protocol Violation|0|||
13154217|NCT02516982|26061337|FG001|Overall Study|Protocol Violation|0|||
13154218|NCT02516982|26061338|FG002|Overall Study|Protocol Violation|1|||
13154219|NCT02516982|26061339|FG003|Overall Study|Protocol Violation|1|||
13154220|NCT02516982|26061336|FG000|Overall Study|Did not install the app|0|||
13154221|NCT02516982|26061337|FG001|Overall Study|Did not install the app|0|||
13154222|NCT02516982|26061338|FG002|Overall Study|Did not install the app|46|||
13154223|NCT02516982|26061339|FG003|Overall Study|Did not install the app|47|||
13154224|NCT02516605|26061424|FG000|Overall Study|Protocol Violation|0|||
13154225|NCT02516605|26061425|FG001|Overall Study|Protocol Violation|0|||
13154226|NCT02516605|26061426|FG002|Overall Study|Protocol Violation|0|||
13154227|NCT02516605|26061427|FG003|Overall Study|Protocol Violation|0|||
13154228|NCT02516605|26061428|FG004|Overall Study|Protocol Violation|1|||
13154229|NCT02516605|26061424|FG000|Overall Study|Withdrawal by Subject|0|||
13154230|NCT02516605|26061425|FG001|Overall Study|Withdrawal by Subject|0|||
13154231|NCT02516605|26061426|FG002|Overall Study|Withdrawal by Subject|0|||
13103920|NCT03346070|25873887|FG000|Overall Study|Study medication not received as planned|2|||
13103921|NCT03346070|25873888|FG001|Overall Study|Study medication not received as planned|3|||
13103922|NCT03346070|25873889|FG002|Overall Study|Study medication not received as planned|2|||
13103923|NCT03346070|25873890|FG003|Overall Study|Study medication not received as planned|3|||
13103924|NCT03346070|25873891|FG004|Overall Study|Study medication not received as planned|2|||
13103925|NCT03346070|25873887|FG000|Overall Study|Screen Failure|0|||
13103926|NCT03346070|25873888|FG001|Overall Study|Screen Failure|0|||
13103927|NCT03346070|25873889|FG002|Overall Study|Screen Failure|0|||
13103928|NCT03346070|25873890|FG003|Overall Study|Screen Failure|1|||
13103929|NCT03346070|25873891|FG004|Overall Study|Screen Failure|1|||
13103930|NCT03346057|25873934|FG000|Overall Study|Death|1|||
13103931|NCT03346057|25873935|FG001|Overall Study|Death|2|||
13103932|NCT03346057|25873936|FG002|Overall Study|Death|0|||
13103933|NCT03346057|25873937|FG003|Overall Study|Death|0|||
13103934|NCT03346057|25873934|FG000|Overall Study|Lost to Follow-up|0|||
13103935|NCT03346057|25873935|FG001|Overall Study|Lost to Follow-up|2|||
13103936|NCT03346057|25873936|FG002|Overall Study|Lost to Follow-up|1|||
13103937|NCT03346057|25873937|FG003|Overall Study|Lost to Follow-up|0|||
13103938|NCT03346057|25873934|FG000|Overall Study|Ineligible For Study - Not Treated|0|||
13103939|NCT03346057|25873935|FG001|Overall Study|Ineligible For Study - Not Treated|1|||
13103940|NCT03346057|25873936|FG002|Overall Study|Ineligible For Study - Not Treated|0|||
13103941|NCT03346057|25873937|FG003|Overall Study|Ineligible For Study - Not Treated|0|||
13103942|NCT03346057|25873934|FG000|Overall Study|Renal Insufficiency - Not Treated|1|||
13103943|NCT03346057|25873935|FG001|Overall Study|Renal Insufficiency - Not Treated|0|||
13103944|NCT03346057|25873936|FG002|Overall Study|Renal Insufficiency - Not Treated|0|||
13103945|NCT03346057|25873937|FG003|Overall Study|Renal Insufficiency - Not Treated|0|||
13103946|NCT03346057|25873934|FG000|Overall Study|Physician Decision|3|||
13103947|NCT03346057|25873935|FG001|Overall Study|Physician Decision|2|||
13103948|NCT03346057|25873936|FG002|Overall Study|Physician Decision|0|||
13103949|NCT03346057|25873937|FG003|Overall Study|Physician Decision|2|||
13103950|NCT03346057|25873934|FG000|Overall Study|Randomization Mistake - Not Treated|1|||
13103951|NCT03346057|25873935|FG001|Overall Study|Randomization Mistake - Not Treated|1|||
13103952|NCT03346057|25873936|FG002|Overall Study|Randomization Mistake - Not Treated|0|||
13103953|NCT03346057|25873937|FG003|Overall Study|Randomization Mistake - Not Treated|0|||
13103954|NCT03346057|25873934|FG000|Overall Study|Withdrawal by Subject|1|||
13154232|NCT02516605|26061427|FG003|Overall Study|Withdrawal by Subject|1|||
13103955|NCT03346057|25873935|FG001|Overall Study|Withdrawal by Subject|0|||
13103956|NCT03346057|25873936|FG002|Overall Study|Withdrawal by Subject|0|||
13154233|NCT02516605|26061428|FG004|Overall Study|Withdrawal by Subject|0|||
13154234|NCT02516592|26061449|FG000|Overall Study|Patient withdrew consent|5|||
13154235|NCT02516592|26061450|FG001|Overall Study|Patient withdrew consent|2|||
13154236|NCT02516592|26061449|FG000|Overall Study|Protocol deviation|4|||
13154237|NCT02516592|26061450|FG001|Overall Study|Protocol deviation|4|||
13154238|NCT02516592|26061449|FG000|Overall Study|Lost to Follow-up|2|||
13154239|NCT02516592|26061450|FG001|Overall Study|Lost to Follow-up|3|||
13154240|NCT02516592|26061449|FG000|Overall Study|Patient/guardian decision|2|||
13154241|NCT02516592|26061450|FG001|Overall Study|Patient/guardian decision|1|||
13154242|NCT02516592|26061449|FG000|Overall Study|Adverse Event|1|||
13154243|NCT02516592|26061450|FG001|Overall Study|Adverse Event|2|||
13154244|NCT02516592|26061449|FG000|Overall Study|Abnormal test procedure result|1|||
13154245|NCT02516592|26061450|FG001|Overall Study|Abnormal test procedure result|0|||
13154246|NCT02516592|26061449|FG000|Overall Study|Death|1|||
13154247|NCT02516592|26061450|FG001|Overall Study|Death|1|||
13154248|NCT02516410|26061484|FG000|Overall Study|Adverse Event|0|||
13154249|NCT02516410|26061485|FG001|Overall Study|Adverse Event|1|||
13154250|NCT02516410|26061484|FG000|Overall Study|Withdrawal by Subject|0|||
13154251|NCT02516410|26061485|FG001|Overall Study|Withdrawal by Subject|1|||
13154252|NCT02516332|26061521|FG000|Overall Study|Withdrawal by Subject|2|||
13154253|NCT02516332|26061522|FG001|Overall Study|Withdrawal by Subject|1|||
13154254|NCT02516332|26061523|FG002|Overall Study|Withdrawal by Subject|2|||
13154255|NCT02516306|26061536|FG000|Period 2: Day 8 - 91|Protocol Violation|1|||
13154256|NCT02516306|26061537|FG001|Period 2: Day 8 - 91|Protocol Violation|2|||
13154257|NCT02516241|26061662|FG000|Overall Study|Death|255|||
13154258|NCT02516241|26061663|FG001|Overall Study|Death|262|||
13154259|NCT02516241|26061664|FG002|Overall Study|Death|270|||
13103957|NCT03346057|25873937|FG003|Overall Study|Withdrawal by Subject|0|||
13103958|NCT03345979|25873962|FG000|Overall Study|Withdrawal by Subject|20|||
13103959|NCT03345979|25873963|FG001|Overall Study|Withdrawal by Subject|31|||
13103960|NCT03345979|25873962|FG000|Overall Study|Adverse Event|10|||
13103961|NCT03345979|25873963|FG001|Overall Study|Adverse Event|11|||
13103962|NCT03345979|25873962|FG000|Overall Study|Lost to Follow-up|8|||
13103963|NCT03345979|25873963|FG001|Overall Study|Lost to Follow-up|9|||
13103964|NCT03345979|25873962|FG000|Overall Study|Lack of Efficacy|4|||
13103965|NCT03345979|25873963|FG001|Overall Study|Lack of Efficacy|2|||
13103966|NCT03345979|25873962|FG000|Overall Study|Protocol Violation|1|||
13103967|NCT03345979|25873963|FG001|Overall Study|Protocol Violation|3|||
13103968|NCT03345979|25873962|FG000|Overall Study|Physician Decision|0|||
13103969|NCT03345979|25873963|FG001|Overall Study|Physician Decision|2|||
13103970|NCT03345914|25874044|FG000|Overall Study|Transition to another study at week 16|80|||
13103971|NCT03345914|25874045|FG001|Overall Study|Transition to another study at week 16|86|||
13103972|NCT03345914|25874046|FG002|Overall Study|Transition to another study at week 16|78|||
13103973|NCT03345914|25874044|FG000|Overall Study|Transition to OLE during follow-up|37|||
13103974|NCT03345914|25874045|FG001|Overall Study|Transition to OLE during follow-up|33|||
13103975|NCT03345914|25874046|FG002|Overall Study|Transition to OLE during follow-up|39|||
13103976|NCT03345914|25874044|FG000|Overall Study|Physician Decision|0|||
13103977|NCT03345914|25874045|FG001|Overall Study|Physician Decision|1|||
13103978|NCT03345914|25874046|FG002|Overall Study|Physician Decision|1|||
13103979|NCT03345914|25874044|FG000|Overall Study|Withdrawal by Subject|5|||
13103980|NCT03345914|25874045|FG001|Overall Study|Withdrawal by Subject|1|||
13103981|NCT03345914|25874046|FG002|Overall Study|Withdrawal by Subject|2|||
13103982|NCT03345914|25874044|FG000|Overall Study|Other|1|||
13103983|NCT03345914|25874045|FG001|Overall Study|Other|1|||
13154260|NCT02516241|26061662|FG000|Overall Study|Lost to Follow-up|1|||
13154261|NCT02516241|26061663|FG001|Overall Study|Lost to Follow-up|1|||
13154262|NCT02516241|26061664|FG002|Overall Study|Lost to Follow-up|3|||
13154263|NCT02516241|26061662|FG000|Overall Study|Withdrawal by Subject|2|||
13154264|NCT02516241|26061663|FG001|Overall Study|Withdrawal by Subject|7|||
13154265|NCT02516241|26061664|FG002|Overall Study|Withdrawal by Subject|12|||
13154266|NCT02516241|26061662|FG000|Overall Study|participants ongoing at data cut-off|84|||
13154267|NCT02516241|26061663|FG001|Overall Study|participants ongoing at data cut-off|76|||
13154268|NCT02516241|26061664|FG002|Overall Study|participants ongoing at data cut-off|59|||
13154269|NCT02516228|26061674|FG000|Overall Study|Lost to Follow-up|1|||
13154270|NCT02516228|26061674|FG000|Overall Study|Withdrawal by Subject|1|||
13154271|NCT02516228|26061674|FG000|Overall Study|Physician Decision|1|||
13154272|NCT02516202|26061710|FG000|Overall Study|Withdrawal by Subject|1|||
13154273|NCT02516202|26061711|FG001|Overall Study|Withdrawal by Subject|0|||
13154274|NCT02516202|26061712|FG002|Overall Study|Withdrawal by Subject|1|||
13154275|NCT02516202|26061710|FG000|Overall Study|Lost to Follow-up|1|||
13154276|NCT02516202|26061711|FG001|Overall Study|Lost to Follow-up|1|||
13154277|NCT02516202|26061712|FG002|Overall Study|Lost to Follow-up|1|||
13154278|NCT02516202|26061710|FG000|Overall Study|Stopped Follow-up|0|||
13154279|NCT02516202|26061711|FG001|Overall Study|Stopped Follow-up|0|||
13154280|NCT02516202|26061712|FG002|Overall Study|Stopped Follow-up|1|||
13154281|NCT02516163|26061718|FG000|Overall Study|Withdrawal by Subject|1|||
13154282|NCT02516163|26061718|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11|||
13154283|NCT02516163|26061718|FG000|Overall Study|Unfit/delay in surgery|3|||
13154284|NCT02516163|26061718|FG000|Overall Study|Use of incorrect measurement technique|5|||
13103984|NCT03345914|25874046|FG002|Overall Study|Other|1|||
13154285|NCT02516163|26061718|FG000|Overall Study|Data not recorded|2|||
13154286|NCT02516163|26061718|FG000|Overall Study|MRI contraindication exclusion|6|||
13154287|NCT02516098|26061737|FG000|Period 1|Protocol Violation|1|||
13154288|NCT02516098|26061738|FG001|Period 1|Protocol Violation|0|||
13154289|NCT02516098|26061737|FG000|Washout After Period 1|Adverse Event|0|||
13154290|NCT02516098|26061738|FG001|Washout After Period 1|Adverse Event|1|||
13154291|NCT02516098|26061737|FG000|Period 2|Withdrawal by Subject|0|||
13154292|NCT02516098|26061738|FG001|Period 2|Withdrawal by Subject|1|||
13154293|NCT02515994|26061757|FG000|Overall Study|Protocol Violation|3|||
13154294|NCT02515994|26061758|FG001|Overall Study|Protocol Violation|5|||
13154295|NCT02515994|26061757|FG000|Overall Study|No Longer Meets Eligibility Criteria|2|||
13154296|NCT02515994|26061758|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
13154297|NCT02515994|26061757|FG000|Overall Study|Adverse Event|3|||
13154298|NCT02515994|26061758|FG001|Overall Study|Adverse Event|1|||
13154299|NCT02515994|26061757|FG000|Overall Study|Withdrawal by Subject|2|||
13154300|NCT02515994|26061758|FG001|Overall Study|Withdrawal by Subject|0|||
13154301|NCT02515942|26061815|FG000|Overall Study|Adverse Event|5|||
13154302|NCT02515942|26061816|FG001|Overall Study|Adverse Event|0|||
13154303|NCT02515942|26061817|FG002|Overall Study|Adverse Event|0|||
13154304|NCT02515942|26061815|FG000|Overall Study|Death|0|||
13154305|NCT02515942|26061816|FG001|Overall Study|Death|0|||
13154306|NCT02515942|26061817|FG002|Overall Study|Death|1|||
13154307|NCT02515942|26061815|FG000|Overall Study|Lack of Efficacy|0|||
13154308|NCT02515942|26061816|FG001|Overall Study|Lack of Efficacy|0|||
13154309|NCT02515942|26061817|FG002|Overall Study|Lack of Efficacy|1|||
13154310|NCT02515942|26061815|FG000|Overall Study|Lost to Follow-up|2|||
13154311|NCT02515942|26061816|FG001|Overall Study|Lost to Follow-up|0|||
13154312|NCT02515942|26061817|FG002|Overall Study|Lost to Follow-up|0|||
13154313|NCT02515942|26061815|FG000|Overall Study|Withdrawal by Subject|0|||
13154314|NCT02515942|26061816|FG001|Overall Study|Withdrawal by Subject|3|||
13103985|NCT03345914|25874044|FG000|Overall Study|Ongoing|0|||
13103986|NCT03345914|25874045|FG001|Overall Study|Ongoing|0|||
13103987|NCT03345914|25874046|FG002|Overall Study|Ongoing|1|||
13103988|NCT03345901|25874053|FG000|Overall Study|The study was terminated|18|||
13103989|NCT03345836|25874104|FG000|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|5|||
13103990|NCT03345836|25874105|FG001|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|17|||
13103991|NCT03345836|25874106|FG002|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|2|||
13103992|NCT03345836|25874107|FG003|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
13103993|NCT03345836|25874108|FG004|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
13103994|NCT03345836|25874109|FG005|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
13103995|NCT03345836|25874104|FG000|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
13103996|NCT03345836|25874105|FG001|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
13103997|NCT03345836|25874106|FG002|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|3|||
13103998|NCT03345836|25874107|FG003|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
13103999|NCT03345836|25874108|FG004|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
13154315|NCT02515942|26061817|FG002|Overall Study|Withdrawal by Subject|2|||
13154316|NCT02515669|26061906|FG000|228 Week Open-Label Phase|Other|0|||
13154317|NCT02515669|26061907|FG001|228 Week Open-Label Phase|Other|0|||
13154318|NCT02515669|26061908|FG002|228 Week Open-Label Phase|Other|1|||
13154319|NCT02515669|26061909|FG003|228 Week Open-Label Phase|Other|4|||
13154320|NCT02515669|26061906|FG000|228 Week Open-Label Phase|Lack of Efficacy|0|||
13154321|NCT02515669|26061907|FG001|228 Week Open-Label Phase|Lack of Efficacy|0|||
13154322|NCT02515669|26061908|FG002|228 Week Open-Label Phase|Lack of Efficacy|1|||
13154323|NCT02515669|26061909|FG003|228 Week Open-Label Phase|Lack of Efficacy|0|||
13154324|NCT02515669|26061906|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
13154325|NCT02515669|26061907|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
13154326|NCT02515669|26061908|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2|||
13154327|NCT02515669|26061909|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3|||
13154328|NCT02515669|26061906|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0|||
13154329|NCT02515669|26061907|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7|||
13154330|NCT02515669|26061908|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2|||
13154331|NCT02515669|26061909|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17|||
13154332|NCT02515669|26061906|FG000|228 Week Open-Label Phase|Missing|0|||
13154333|NCT02515669|26061907|FG001|228 Week Open-Label Phase|Missing|2|||
13154334|NCT02515669|26061908|FG002|228 Week Open-Label Phase|Missing|2|||
13154335|NCT02515669|26061909|FG003|228 Week Open-Label Phase|Missing|2|||
13154336|NCT02515630|26061985|FG000|Overall Study|Withdrawal by Subject|5|||
13154337|NCT02515630|26061985|FG000|Overall Study|Adverse Event|4|||
13154338|NCT02515630|26061985|FG000|Overall Study|Physician Decision|4|||
13154339|NCT02515630|26061985|FG000|Overall Study|Death|2|||
13154340|NCT02515630|26061985|FG000|Overall Study|Disease Progression|1|||
13154341|NCT02515331|26062016|FG000|Overall Study|Withdrawal by Subject|0|||
13154342|NCT02515331|26062017|FG001|Overall Study|Withdrawal by Subject|0|||
13154343|NCT02515331|26062018|FG002|Overall Study|Withdrawal by Subject|1|||
13154344|NCT02515331|26062016|FG000|Overall Study|Protocol deviation|0|||
13154345|NCT02515331|26062017|FG001|Overall Study|Protocol deviation|0|||
13154346|NCT02515331|26062018|FG002|Overall Study|Protocol deviation|3|||
13154347|NCT02515331|26062016|FG000|Overall Study|Adverse Event|2|||
13154348|NCT02515331|26062017|FG001|Overall Study|Adverse Event|0|||
13154349|NCT02515331|26062018|FG002|Overall Study|Adverse Event|0|||
13154350|NCT02515279|26062026|FG000|Overall Study|Adverse Event|7|||
13154351|NCT02515279|26062026|FG000|Overall Study|Lack of Efficacy|31|||
13154352|NCT02515279|26062026|FG000|Overall Study|Lost to Follow-up|9|||
13154353|NCT02515279|26062026|FG000|Overall Study|Withdrawal by Subject|18|||
13154354|NCT02515279|26062026|FG000|Overall Study|End-of-treatment visit not attended|17|||
13154355|NCT02515279|26062026|FG000|Overall Study|Other|22|||
13154356|NCT02515097|26062041|FG000|Overall Study|Lost to Follow-up|4|||
13154357|NCT02515097|26062042|FG001|Overall Study|Lost to Follow-up|2|||
13154358|NCT02515097|26062041|FG000|Overall Study|Withdrawal by Subject|1|||
13154359|NCT02515097|26062042|FG001|Overall Study|Withdrawal by Subject|3|||
13154360|NCT02515097|26062041|FG000|Overall Study|Adverse Event|2|||
13154361|NCT02515097|26062042|FG001|Overall Study|Adverse Event|1|||
13154362|NCT02515045|26062064|FG000|Overall Study|Adverse Event|0|||
13154363|NCT02515045|26062065|FG001|Overall Study|Adverse Event|3|||
13154364|NCT02515045|26062066|FG002|Overall Study|Adverse Event|3|||
13154365|NCT02515045|26062064|FG000|Overall Study|Lost to Follow-up|0|||
13154366|NCT02515045|26062065|FG001|Overall Study|Lost to Follow-up|1|||
13154367|NCT02515045|26062066|FG002|Overall Study|Lost to Follow-up|1|||
13154368|NCT02514824|26062084|FG000|Overall Study|Withdrawal by Subject|1|||
13154369|NCT02514824|26062085|FG001|Overall Study|Withdrawal by Subject|0|||
13104000|NCT03345836|25874109|FG005|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
13104001|NCT03345836|25874104|FG000|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
13104002|NCT03345836|25874105|FG001|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|1|||
13104003|NCT03345836|25874106|FG002|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
13104004|NCT03345836|25874107|FG003|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
13104005|NCT03345836|25874108|FG004|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
13104006|NCT03345836|25874109|FG005|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
13104007|NCT03345836|25874104|FG000|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|8|||
13104008|NCT03345836|25874105|FG001|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|4|||
13104009|NCT03345836|25874106|FG002|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
13104010|NCT03345836|25874107|FG003|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
13104011|NCT03345836|25874108|FG004|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
13104012|NCT03345836|25874109|FG005|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
13104013|NCT03345836|25874104|FG000|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
13104014|NCT03345836|25874105|FG001|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|3|||
13104015|NCT03345836|25874106|FG002|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
13154370|NCT02514824|26062086|FG002|Overall Study|Withdrawal by Subject|0|||
13154371|NCT02514824|26062087|FG003|Overall Study|Withdrawal by Subject|0|||
13154372|NCT02514824|26062084|FG000|Overall Study|Dose-Limiting Toxicity|0|||
13154373|NCT02514824|26062085|FG001|Overall Study|Dose-Limiting Toxicity|1|||
13154374|NCT02514824|26062086|FG002|Overall Study|Dose-Limiting Toxicity|0|||
13154375|NCT02514824|26062087|FG003|Overall Study|Dose-Limiting Toxicity|0|||
13154376|NCT02514772|26062106|FG000|Overall Study|Adverse Event|1|||
13154377|NCT02514772|26062107|FG001|Overall Study|Adverse Event|0|||
13154378|NCT02514772|26062106|FG000|Overall Study|Death|0|||
13154379|NCT02514772|26062107|FG001|Overall Study|Death|1|||
13154380|NCT02514772|26062106|FG000|Overall Study|Withdrawal by Subject|2|||
13154381|NCT02514772|26062107|FG001|Overall Study|Withdrawal by Subject|1|||
13154382|NCT02514746|26062149|FG000|Overall Study|Chronically Ill|1|||
13154383|NCT02514746|26062150|FG001|Overall Study|Chronically Ill|2|||
13154384|NCT02514746|26062149|FG000|Overall Study|Physician Decision|4|||
13154385|NCT02514746|26062150|FG001|Overall Study|Physician Decision|2|||
13154386|NCT02514746|26062149|FG000|Overall Study|Withdrawal by Subject|12|||
13154387|NCT02514746|26062150|FG001|Overall Study|Withdrawal by Subject|10|||
13154388|NCT02514746|26062149|FG000|Overall Study|Other|5|||
13154389|NCT02514746|26062150|FG001|Overall Study|Other|1|||
13154390|NCT02514577|26062165|FG000|Overall Study|Lost to Follow-up|6|||
13154391|NCT02514577|26062166|FG001|Overall Study|Lost to Follow-up|6|||
13154392|NCT02514577|26062165|FG000|Overall Study|Protocol Violation|1|||
13154393|NCT02514577|26062166|FG001|Overall Study|Protocol Violation|0|||
13154394|NCT02514577|26062165|FG000|Overall Study|Withdrawal by Subject|6|||
13154395|NCT02514577|26062166|FG001|Overall Study|Withdrawal by Subject|6|||
13154396|NCT02514577|26062165|FG000|Overall Study|Adverse Event|1|||
13154397|NCT02514577|26062166|FG001|Overall Study|Adverse Event|1|||
13154398|NCT02514551|26062188|FG000|Overall Study|Lost to Follow-up|0|||
13154399|NCT02514551|26062189|FG001|Overall Study|Lost to Follow-up|1|||
13154400|NCT02514551|26062188|FG000|Overall Study|Participant Never Treated|0|||
13154401|NCT02514551|26062189|FG001|Overall Study|Participant Never Treated|2|||
13154402|NCT02514473|26062237|FG000|Overall Study|Adverse Event|0|||
13154403|NCT02514473|26062238|FG001|Overall Study|Adverse Event|2|||
13154404|NCT02514473|26062237|FG000|Overall Study|Withdrawal by Subject|2|||
13154405|NCT02514473|26062238|FG001|Overall Study|Withdrawal by Subject|1|||
13154406|NCT02514473|26062237|FG000|Overall Study|Lost to Follow-up|0|||
13154407|NCT02514473|26062238|FG001|Overall Study|Lost to Follow-up|1|||
13154408|NCT02514473|26062237|FG000|Overall Study|Other|1|||
13154409|NCT02514473|26062238|FG001|Overall Study|Other|1|||
13154410|NCT02514174|26062249|FG000|Overall Study|Patient refused to continue medication|1|||
13154411|NCT02514174|26062249|FG000|Overall Study|Adverse Event|2|||
13154412|NCT02514174|26062249|FG000|Overall Study|Study closed by sponsor|9|||
13154413|NCT02514174|26062249|FG000|Overall Study|Progressive disease|11|||
13154414|NCT02514174|26062249|FG000|Overall Study|Treatment change|1|||
13154415|NCT02514174|26062249|FG000|Overall Study|Treated off study with Afatinib.|1|||
13154416|NCT02514122|26062264|FG000|Overall Study|Withdrawal by Subject|2|||
13154417|NCT02514122|26062265|FG001|Overall Study|Withdrawal by Subject|0|||
13154418|NCT02513823|26062272|FG000|Overall Study|Lost to Follow-up|4|||
13154419|NCT02513823|26062272|FG000|Overall Study|Physician Decision|1|||
13154420|NCT02513771|26062315|FG000|Overall Study|Lost to Follow-up|1|||
13154421|NCT02513771|26062316|FG001|Overall Study|Lost to Follow-up|1|||
13154422|NCT02513771|26062315|FG000|Overall Study|Not being able to get to clinic|1|||
13154423|NCT02513771|26062316|FG001|Overall Study|Not being able to get to clinic|0|||
13154424|NCT02513745|26062333|FG000|Overall Study|Criteria at time of surgery not met.|3|||
13154425|NCT02513745|26062334|FG001|Overall Study|Criteria at time of surgery not met.|3|||
13154426|NCT02513732|26062466|FG000|Overall Study|Lost to Follow-up|11|||
13154427|NCT02513732|26062466|FG000|Overall Study|Death|9|||
13154428|NCT02513732|26062466|FG000|Overall Study|Changing hospital|2|||
13205195|NCT01967719|26231108|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0|||
13205196|NCT01967719|26231109|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0|||
13205197|NCT01967706|26231131|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
13205198|NCT01967706|26231132|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
13205199|NCT01967706|26231133|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
13205200|NCT01967706|26231134|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
13205201|NCT01967628|26231147|FG000|Overall Study|Withdrawal by Subject|2|||
13205202|NCT01967628|26231148|FG001|Overall Study|Withdrawal by Subject|0|||
13205203|NCT01967628|26231147|FG000|Overall Study|Unable to complete bronchoscopy|4|||
13205204|NCT01967628|26231148|FG001|Overall Study|Unable to complete bronchoscopy|6|||
13205205|NCT01967628|26231147|FG000|Overall Study|Lost to Follow-up|1|||
13205206|NCT01967628|26231148|FG001|Overall Study|Lost to Follow-up|0|||
13205207|NCT01967628|26231147|FG000|Overall Study|Low protein concentration in sample|20|||
13205208|NCT01967628|26231148|FG001|Overall Study|Low protein concentration in sample|25|||
13205209|NCT01967576|26231159|FG000|Overall Study|Withdrawal by Subject|3|||
13205210|NCT01967576|26231159|FG000|Overall Study|Progressed/Removed from treatment|1|||
13205211|NCT01967576|26231159|FG000|Overall Study|Study closing at site|1|||
13205212|NCT01967576|26231159|FG000|Overall Study|Adverse Event|1|||
13205213|NCT01967576|26231159|FG000|Overall Study|Refused further treatment|1|||
13205214|NCT01967550|26231172|FG000|Overall Study|Withdrawal by Subject|1|||
13205215|NCT01967550|26231173|FG001|Overall Study|Withdrawal by Subject|0|||
13205216|NCT01967550|26231172|FG000|Overall Study|Adverse Event|2|||
13205217|NCT01967550|26231173|FG001|Overall Study|Adverse Event|0|||
13205218|NCT01967550|26231172|FG000|Overall Study|Protocol Violation|2|||
13205219|NCT01967550|26231173|FG001|Overall Study|Protocol Violation|1|||
13205220|NCT01967550|26231172|FG000|Overall Study|Non Compliance|0|||
13205221|NCT01967550|26231173|FG001|Overall Study|Non Compliance|1|||
13205222|NCT01967537|26231184|FG000|Overall Study|Withdrawal by Subject|52|||
13205223|NCT01967537|26231184|FG000|Overall Study|Refuse treatment|2|||
13205224|NCT01967537|26231184|FG000|Overall Study|Lost to Follow-up|6|||
13205225|NCT01967277|26231199|FG000|Overall Study|Lost to Follow-up|1|||
13205226|NCT01967277|26231200|FG001|Overall Study|Lost to Follow-up|2|||
13205227|NCT01967277|26231199|FG000|Overall Study|Unrelated illness|0|||
13205228|NCT01967277|26231200|FG001|Overall Study|Unrelated illness|1|||
13205229|NCT01967225|26231235|FG000|Overall Study|Adverse Event|3|||
13205230|NCT01967225|26231236|FG001|Overall Study|Adverse Event|1|||
13205231|NCT01967225|26231235|FG000|Overall Study|Withdrawal by Subject|2|||
13205232|NCT01967225|26231236|FG001|Overall Study|Withdrawal by Subject|1|||
13205233|NCT01967225|26231235|FG000|Overall Study|Lack of Efficacy|1|||
13205234|NCT01967225|26231236|FG001|Overall Study|Lack of Efficacy|1|||
13205235|NCT01967225|26231235|FG000|Overall Study|Switching to other therapy|2|||
13205236|NCT01967225|26231236|FG001|Overall Study|Switching to other therapy|0|||
13205237|NCT01967225|26231235|FG000|Overall Study|Protocol driven decision point|1|||
13205238|NCT01967225|26231236|FG001|Overall Study|Protocol driven decision point|0|||
13205239|NCT01967225|26231235|FG000|Overall Study|Logistical difficulties|1|||
13205240|NCT01967225|26231236|FG001|Overall Study|Logistical difficulties|0|||
13205241|NCT01967225|26231235|FG000|Overall Study|Protocol Violation|2|||
13205242|NCT01967225|26231236|FG001|Overall Study|Protocol Violation|0|||
13205243|NCT01967173|26231273|FG000|Overall Study|Lost to Follow-up|5|||
13205244|NCT01967173|26231274|FG001|Overall Study|Lost to Follow-up|3|||
13205245|NCT01967173|26231275|FG002|Overall Study|Lost to Follow-up|2|||
13205246|NCT01967173|26231276|FG003|Overall Study|Lost to Follow-up|4|||
13154429|NCT02513667|26062479|FG000|Overall Study|Withdrawal by Subject|0|||
13154430|NCT02513667|26062480|FG001|Overall Study|Withdrawal by Subject|1|||
13154431|NCT02513550|26062571|FG000|Double Blind Treatment Period|Withdrawal by Subject|11|||
13154432|NCT02513550|26062572|FG001|Double Blind Treatment Period|Withdrawal by Subject|11|||
13154433|NCT02513550|26062573|FG002|Double Blind Treatment Period|Withdrawal by Subject|25|||
13154434|NCT02513550|26062574|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
13154435|NCT02513550|26062575|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
13154436|NCT02513550|26062576|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
13154437|NCT02513550|26062571|FG000|Double Blind Treatment Period|Adverse Event|5|||
13154438|NCT02513550|26062572|FG001|Double Blind Treatment Period|Adverse Event|13|||
13154439|NCT02513550|26062573|FG002|Double Blind Treatment Period|Adverse Event|17|||
13154440|NCT02513550|26062574|FG003|Double Blind Treatment Period|Adverse Event|0|||
13154441|NCT02513550|26062575|FG004|Double Blind Treatment Period|Adverse Event|1|||
13154442|NCT02513550|26062576|FG005|Double Blind Treatment Period|Adverse Event|0|||
13154443|NCT02513550|26062571|FG000|Double Blind Treatment Period|Lost to Follow-up|9|||
13154444|NCT02513550|26062572|FG001|Double Blind Treatment Period|Lost to Follow-up|7|||
13154445|NCT02513550|26062573|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
13154446|NCT02513550|26062574|FG003|Double Blind Treatment Period|Lost to Follow-up|0|||
13154447|NCT02513550|26062575|FG004|Double Blind Treatment Period|Lost to Follow-up|0|||
13154448|NCT02513550|26062576|FG005|Double Blind Treatment Period|Lost to Follow-up|1|||
13154449|NCT02513550|26062571|FG000|Double Blind Treatment Period|Lack of Efficacy|4|||
13154450|NCT02513550|26062572|FG001|Double Blind Treatment Period|Lack of Efficacy|5|||
13154451|NCT02513550|26062573|FG002|Double Blind Treatment Period|Lack of Efficacy|6|||
13154452|NCT02513550|26062574|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
13154453|NCT02513550|26062575|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
13154454|NCT02513550|26062576|FG005|Double Blind Treatment Period|Lack of Efficacy|0|||
13154455|NCT02513550|26062571|FG000|Double Blind Treatment Period|Protocol Violation|1|||
13154456|NCT02513550|26062572|FG001|Double Blind Treatment Period|Protocol Violation|1|||
13154457|NCT02513550|26062573|FG002|Double Blind Treatment Period|Protocol Violation|4|||
13154458|NCT02513550|26062574|FG003|Double Blind Treatment Period|Protocol Violation|0|||
13154459|NCT02513550|26062575|FG004|Double Blind Treatment Period|Protocol Violation|0|||
13154460|NCT02513550|26062576|FG005|Double Blind Treatment Period|Protocol Violation|0|||
13154461|NCT02513550|26062571|FG000|Double Blind Treatment Period|Physician Decision|2|||
13154462|NCT02513550|26062572|FG001|Double Blind Treatment Period|Physician Decision|0|||
13154463|NCT02513550|26062573|FG002|Double Blind Treatment Period|Physician Decision|4|||
13154464|NCT02513550|26062574|FG003|Double Blind Treatment Period|Physician Decision|0|||
13154465|NCT02513550|26062575|FG004|Double Blind Treatment Period|Physician Decision|0|||
13154466|NCT02513550|26062576|FG005|Double Blind Treatment Period|Physician Decision|0|||
13154467|NCT02513550|26062571|FG000|Double Blind Treatment Period|Site terminated by sponsor|1|||
13154468|NCT02513550|26062572|FG001|Double Blind Treatment Period|Site terminated by sponsor|1|||
13154469|NCT02513550|26062573|FG002|Double Blind Treatment Period|Site terminated by sponsor|3|||
13154470|NCT02513550|26062574|FG003|Double Blind Treatment Period|Site terminated by sponsor|0|||
13154471|NCT02513550|26062575|FG004|Double Blind Treatment Period|Site terminated by sponsor|0|||
13154472|NCT02513550|26062576|FG005|Double Blind Treatment Period|Site terminated by sponsor|0|||
13154473|NCT02513550|26062571|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
13154474|NCT02513550|26062572|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
13154475|NCT02513550|26062573|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1|||
13154476|NCT02513550|26062574|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
13154477|NCT02513550|26062575|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
13154478|NCT02513550|26062576|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
13154479|NCT02513550|26062571|FG000|Double Blind Treatment Period|Due to personal business|2|||
13154480|NCT02513550|26062572|FG001|Double Blind Treatment Period|Due to personal business|0|||
13154481|NCT02513550|26062573|FG002|Double Blind Treatment Period|Due to personal business|1|||
13154482|NCT02513550|26062574|FG003|Double Blind Treatment Period|Due to personal business|0|||
13154483|NCT02513550|26062575|FG004|Double Blind Treatment Period|Due to personal business|0|||
13154484|NCT02513550|26062576|FG005|Double Blind Treatment Period|Due to personal business|0|||
13154485|NCT02513550|26062571|FG000|Double Blind Treatment Period|Death|1|||
13154486|NCT02513550|26062572|FG001|Double Blind Treatment Period|Death|0|||
13154487|NCT02513550|26062573|FG002|Double Blind Treatment Period|Death|2|||
13154488|NCT02513550|26062574|FG003|Double Blind Treatment Period|Death|0|||
13154489|NCT02513550|26062575|FG004|Double Blind Treatment Period|Death|0|||
13154490|NCT02513550|26062576|FG005|Double Blind Treatment Period|Death|0|||
13154491|NCT02513550|26062571|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12|||
13154492|NCT02513550|26062572|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20|||
13154493|NCT02513550|26062573|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26|||
13154494|NCT02513550|26062574|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
13154495|NCT02513550|26062575|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
13154496|NCT02513550|26062576|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
13154497|NCT02513550|26062571|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12|||
13154498|NCT02513550|26062572|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16|||
13154499|NCT02513550|26062573|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20|||
13154500|NCT02513550|26062574|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
13154501|NCT02513550|26062575|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
13154502|NCT02513550|26062576|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
13154503|NCT02513550|26062571|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4|||
13154504|NCT02513550|26062572|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2|||
13154505|NCT02513550|26062573|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7|||
13154506|NCT02513550|26062574|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
13154507|NCT02513550|26062575|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
13154508|NCT02513550|26062576|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
13154509|NCT02513550|26062571|FG000|Post-Treatment Follow-up Period|Adverse Event|1|||
13154510|NCT02513550|26062572|FG001|Post-Treatment Follow-up Period|Adverse Event|1|||
13154511|NCT02513550|26062573|FG002|Post-Treatment Follow-up Period|Adverse Event|4|||
13154512|NCT02513550|26062574|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
13154513|NCT02513550|26062575|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
13154514|NCT02513550|26062576|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
13154515|NCT02513550|26062571|FG000|Post-Treatment Follow-up Period|Physician Decision|2|||
13154516|NCT02513550|26062572|FG001|Post-Treatment Follow-up Period|Physician Decision|0|||
13154517|NCT02513550|26062573|FG002|Post-Treatment Follow-up Period|Physician Decision|0|||
13154518|NCT02513550|26062574|FG003|Post-Treatment Follow-up Period|Physician Decision|0|||
13154519|NCT02513550|26062575|FG004|Post-Treatment Follow-up Period|Physician Decision|0|||
13154520|NCT02513550|26062576|FG005|Post-Treatment Follow-up Period|Physician Decision|0|||
13154521|NCT02513550|26062571|FG000|Post-Treatment Follow-up Period|Death|0|||
13154522|NCT02513550|26062572|FG001|Post-Treatment Follow-up Period|Death|0|||
13154523|NCT02513550|26062573|FG002|Post-Treatment Follow-up Period|Death|1|||
13154524|NCT02513550|26062574|FG003|Post-Treatment Follow-up Period|Death|0|||
13154525|NCT02513550|26062575|FG004|Post-Treatment Follow-up Period|Death|0|||
13154526|NCT02513550|26062576|FG005|Post-Treatment Follow-up Period|Death|0|||
13154527|NCT02513550|26062571|FG000|Post-Treatment Follow-up Period|Subject move out of town|0|||
13154528|NCT02513550|26062572|FG001|Post-Treatment Follow-up Period|Subject move out of town|0|||
13154529|NCT02513550|26062573|FG002|Post-Treatment Follow-up Period|Subject move out of town|1|||
13154530|NCT02513550|26062574|FG003|Post-Treatment Follow-up Period|Subject move out of town|0|||
13154531|NCT02513550|26062575|FG004|Post-Treatment Follow-up Period|Subject move out of town|0|||
13154532|NCT02513550|26062576|FG005|Post-Treatment Follow-up Period|Subject move out of town|0|||
13154533|NCT02513550|26062571|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
13154534|NCT02513550|26062572|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
13154535|NCT02513550|26062573|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3|||
13154536|NCT02513550|26062574|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
13154537|NCT02513550|26062575|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
13154538|NCT02513550|26062576|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
13154539|NCT02513550|26062571|FG000|Post-Treatment Follow-up Period|Labor Reasons|0|||
13154540|NCT02513550|26062572|FG001|Post-Treatment Follow-up Period|Labor Reasons|0|||
13154541|NCT02513550|26062573|FG002|Post-Treatment Follow-up Period|Labor Reasons|1|||
13154542|NCT02513550|26062574|FG003|Post-Treatment Follow-up Period|Labor Reasons|0|||
13154543|NCT02513550|26062575|FG004|Post-Treatment Follow-up Period|Labor Reasons|0|||
13154544|NCT02513550|26062576|FG005|Post-Treatment Follow-up Period|Labor Reasons|0|||
13154545|NCT02513485|26062615|FG000|Overall Study|Adverse Event|1|||
13154546|NCT02513485|26062616|FG001|Overall Study|Adverse Event|0|||
13104016|NCT03345836|25874107|FG003|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
13104017|NCT03345836|25874108|FG004|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
13104018|NCT03345836|25874109|FG005|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
13104019|NCT03345836|25874104|FG000|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
13104020|NCT03345836|25874105|FG001|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
13104021|NCT03345836|25874106|FG002|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
13104022|NCT03345836|25874107|FG003|Period 2: 12-Week Extended Treatment|Adverse Event|8|||
13104023|NCT03345836|25874108|FG004|Period 2: 12-Week Extended Treatment|Adverse Event|5|||
13104024|NCT03345836|25874109|FG005|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
13104025|NCT03345836|25874104|FG000|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
13104026|NCT03345836|25874105|FG001|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
13104027|NCT03345836|25874106|FG002|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
13104028|NCT03345836|25874107|FG003|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
13104029|NCT03345836|25874108|FG004|Period 2: 12-Week Extended Treatment|Withdrew Consent|5|||
13104030|NCT03345836|25874109|FG005|Period 2: 12-Week Extended Treatment|Withdrew Consent|1|||
13104031|NCT03345836|25874104|FG000|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
13104032|NCT03345836|25874105|FG001|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
13104033|NCT03345836|25874106|FG002|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
13104034|NCT03345836|25874107|FG003|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
13104035|NCT03345836|25874108|FG004|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
13104036|NCT03345836|25874109|FG005|Period 2: 12-Week Extended Treatment|Lost to Follow-up|1|||
13104037|NCT03345836|25874104|FG000|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
13104038|NCT03345836|25874105|FG001|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
13104039|NCT03345836|25874106|FG002|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
13104040|NCT03345836|25874107|FG003|Period 2: 12-Week Extended Treatment|Lack of Efficacy|2|||
13104041|NCT03345836|25874108|FG004|Period 2: 12-Week Extended Treatment|Lack of Efficacy|6|||
13104042|NCT03345836|25874109|FG005|Period 2: 12-Week Extended Treatment|Lack of Efficacy|3|||
13104043|NCT03345836|25874104|FG000|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
13104044|NCT03345836|25874105|FG001|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
13104045|NCT03345836|25874106|FG002|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
13104046|NCT03345836|25874107|FG003|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
13104047|NCT03345836|25874108|FG004|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|1|||
13104048|NCT03345836|25874109|FG005|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
13104049|NCT03345836|25874104|FG000|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
13104050|NCT03345836|25874105|FG001|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
13104051|NCT03345836|25874106|FG002|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
13104052|NCT03345836|25874107|FG003|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
13104053|NCT03345836|25874108|FG004|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
13104054|NCT03345836|25874109|FG005|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
13104055|NCT03345472|25874118|FG000|Implant to 3 Months|Withdrawal by Subject|2|||
13104056|NCT03345472|25874118|FG000|Implant to 3 Months|Physician Decision|1|||
13104057|NCT03345472|25874118|FG000|Implant to 3 Months|Adverse Event|1|||
13104058|NCT03345472|25874118|FG000|3 Months to 12 Months|Physician Decision|3|||
13104059|NCT03345472|25874118|FG000|3 Months to 12 Months|Lost to Follow-up|2|||
13104060|NCT03345472|25874118|FG000|3 Months to 12 Months|Withdrawal by Subject|1|||
13104061|NCT03345472|25874118|FG000|3 Months to 12 Months|Adverse Event|1|||
13104062|NCT03345472|25874118|FG000|3 Months to 12 Months|Death|1|||
13104063|NCT03345407|25874325|FG000|Overall Study|Withdrawal by Subject|11|||
13104064|NCT03345407|25874326|FG001|Overall Study|Withdrawal by Subject|1|||
13104065|NCT03345407|25874327|FG002|Overall Study|Withdrawal by Subject|5|||
13104066|NCT03345407|25874328|FG003|Overall Study|Withdrawal by Subject|6|||
13104067|NCT03345407|25874329|FG004|Overall Study|Withdrawal by Subject|3|||
13104068|NCT03345407|25874330|FG005|Overall Study|Withdrawal by Subject|6|||
13104069|NCT03345407|25874331|FG006|Overall Study|Withdrawal by Subject|16|||
13154547|NCT02513472|26062658|FG000|Overall Study|Radiological Disease Progression|45|||
13154548|NCT02513472|26062659|FG001|Overall Study|Radiological Disease Progression|57|||
13154549|NCT02513472|26062658|FG000|Overall Study|Clinical Disease Progression|5|||
13154550|NCT02513472|26062659|FG001|Overall Study|Clinical Disease Progression|13|||
13154551|NCT02513472|26062658|FG000|Overall Study|Adverse Event|8|||
13154552|NCT02513472|26062659|FG001|Overall Study|Adverse Event|11|||
13154553|NCT02513472|26062658|FG000|Overall Study|Withdrawal by Subject|0|||
13154554|NCT02513472|26062659|FG001|Overall Study|Withdrawal by Subject|4|||
13154555|NCT02513472|26062658|FG000|Overall Study|Subject Choice|2|||
13154556|NCT02513472|26062659|FG001|Overall Study|Subject Choice|7|||
13154557|NCT02513472|26062658|FG000|Overall Study|Treatment Completed as per Protocol|3|||
13154558|NCT02513472|26062659|FG001|Overall Study|Treatment Completed as per Protocol|3|||
13154559|NCT02513472|26062658|FG000|Overall Study|Other|3|||
13154560|NCT02513472|26062659|FG001|Overall Study|Other|6|||
13154561|NCT02513459|26062700|FG000|Overall Study|Adverse Event|7|||
13154562|NCT02513459|26062700|FG000|Overall Study|Withdrew consent|5|||
13154563|NCT02513459|26062700|FG000|Overall Study|Loss of efficacy|2|||
13154564|NCT02513459|26062700|FG000|Overall Study|Pregnancy|2|||
13154565|NCT02513459|26062700|FG000|Overall Study|Subject decision|2|||
13154566|NCT02513459|26062700|FG000|Overall Study|Lack of response|1|||
13154567|NCT02513459|26062700|FG000|Overall Study|Reproductive plans|1|||
13154568|NCT02513459|26062700|FG000|Overall Study|Surgery planned-- not done|1|||
13154569|NCT02513394|26062721|FG000|Overall Study|Withdrawal by Subject|11|||
13154570|NCT02513394|26062722|FG001|Overall Study|Withdrawal by Subject|23|||
13154571|NCT02513394|26062721|FG000|Overall Study|Ineligible|1|||
13154572|NCT02513394|26062722|FG001|Overall Study|Ineligible|0|||
13154573|NCT02513160|26062770|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33|||
13154574|NCT02513160|26062771|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
13154575|NCT02513160|26062772|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
13154576|NCT02513160|26062773|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
13154577|NCT02513160|26062770|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214|||
13205247|NCT01967173|26231277|FG004|Overall Study|Lost to Follow-up|8|||
13154578|NCT02513160|26062771|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
13154579|NCT02513160|26062772|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
13154580|NCT02513160|26062773|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
13154581|NCT02513160|26062770|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6|||
13154582|NCT02513160|26062771|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
13154583|NCT02513160|26062772|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
13154584|NCT02513160|26062773|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
13154585|NCT02513160|26062770|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4|||
13154586|NCT02513160|26062771|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
13154587|NCT02513160|26062772|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
13154588|NCT02513160|26062773|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
13154589|NCT02513160|26062770|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20|||
13154590|NCT02513160|26062771|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
13154591|NCT02513160|26062772|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
13154592|NCT02513160|26062773|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
13154593|NCT02513160|26062770|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1|||
13154594|NCT02513160|26062771|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
13154595|NCT02513160|26062772|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
13154596|NCT02513160|26062773|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
13154597|NCT02513160|26062770|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10|||
13154598|NCT02513160|26062771|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
13154599|NCT02513160|26062772|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
13154600|NCT02513160|26062773|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
13154601|NCT02513160|26062770|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
13154602|NCT02513160|26062771|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
13154603|NCT02513160|26062772|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0|||
13154604|NCT02513160|26062773|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1|||
13154605|NCT02513160|26062770|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1|||
13154606|NCT02513160|26062771|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
13154607|NCT02513160|26062772|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
13154608|NCT02513160|26062773|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
13154609|NCT02513160|26062770|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2|||
13154610|NCT02513160|26062771|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
13154611|NCT02513160|26062772|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
13154612|NCT02513160|26062773|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
13154613|NCT02513160|26062770|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1|||
13154614|NCT02513160|26062771|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
13154615|NCT02513160|26062772|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
13154616|NCT02513160|26062773|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
13154617|NCT02513160|26062770|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
13154618|NCT02513160|26062771|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1|||
13154619|NCT02513160|26062772|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
13154620|NCT02513160|26062773|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
13154621|NCT02512965|26062792|FG000|Overall Study|Withdrawal by Subject|0|||
13154622|NCT02512965|26062793|FG001|Overall Study|Withdrawal by Subject|4|||
13154623|NCT02512861|26062818|FG000|Overall Study|Protocol Violation|3|||
13154624|NCT02512861|26062819|FG001|Overall Study|Protocol Violation|7|||
13154625|NCT02512861|26062818|FG000|Overall Study|Physician Decision|3|||
13154626|NCT02512861|26062819|FG001|Overall Study|Physician Decision|1|||
13154627|NCT02512861|26062818|FG000|Overall Study|Withdrawal by Subject|0|||
13154628|NCT02512861|26062819|FG001|Overall Study|Withdrawal by Subject|1|||
13154629|NCT02512302|26062902|FG000|Period 1|Adverse Event|0|||
13154630|NCT02512302|26062903|FG001|Period 1|Adverse Event|1|||
13154631|NCT02512302|26062904|FG002|Period 1|Adverse Event|0|||
13154632|NCT02512302|26062905|FG003|Period 1|Adverse Event|0|||
13154633|NCT02512302|26062906|FG004|Period 1|Adverse Event|0|||
13154634|NCT02512302|26062907|FG005|Period 1|Adverse Event|0|||
13154635|NCT02512302|26062908|FG006|Period 1|Adverse Event|0|||
13154636|NCT02512302|26062909|FG007|Period 1|Adverse Event|0|||
13154637|NCT02512302|26062910|FG008|Period 1|Adverse Event|0|||
13154638|NCT02512302|26062911|FG009|Period 1|Adverse Event|0|||
13154639|NCT02512302|26062902|FG000|Period 2|Adverse Event|0|||
13154640|NCT02512302|26062903|FG001|Period 2|Adverse Event|0|||
13154641|NCT02512302|26062904|FG002|Period 2|Adverse Event|0|||
13154642|NCT02512302|26062905|FG003|Period 2|Adverse Event|0|||
13154643|NCT02512302|26062906|FG004|Period 2|Adverse Event|0|||
13154644|NCT02512302|26062907|FG005|Period 2|Adverse Event|0|||
13154645|NCT02512302|26062908|FG006|Period 2|Adverse Event|0|||
13154646|NCT02512302|26062909|FG007|Period 2|Adverse Event|0|||
13154647|NCT02512302|26062910|FG008|Period 2|Adverse Event|0|||
13154648|NCT02512302|26062911|FG009|Period 2|Adverse Event|1|||
13154649|NCT02512302|26062902|FG000|Period 3|Lost to Follow-up|0|||
13154650|NCT02512302|26062903|FG001|Period 3|Lost to Follow-up|0|||
13154651|NCT02512302|26062904|FG002|Period 3|Lost to Follow-up|1|||
13154652|NCT02512302|26062905|FG003|Period 3|Lost to Follow-up|0|||
13154653|NCT02512302|26062906|FG004|Period 3|Lost to Follow-up|0|||
13154654|NCT02512302|26062907|FG005|Period 3|Lost to Follow-up|0|||
13154655|NCT02512302|26062908|FG006|Period 3|Lost to Follow-up|0|||
13154656|NCT02512302|26062909|FG007|Period 3|Lost to Follow-up|0|||
13154657|NCT02512302|26062910|FG008|Period 3|Lost to Follow-up|0|||
13154658|NCT02512302|26062911|FG009|Period 3|Lost to Follow-up|0|||
13154659|NCT02512302|26062902|FG000|Period 4|Adverse Event|0|||
13154660|NCT02512302|26062903|FG001|Period 4|Adverse Event|0|||
13154661|NCT02512302|26062904|FG002|Period 4|Adverse Event|0|||
13154662|NCT02512302|26062905|FG003|Period 4|Adverse Event|0|||
13154663|NCT02512302|26062906|FG004|Period 4|Adverse Event|0|||
13154664|NCT02512302|26062907|FG005|Period 4|Adverse Event|0|||
13154665|NCT02512302|26062908|FG006|Period 4|Adverse Event|1|||
13154666|NCT02512302|26062909|FG007|Period 4|Adverse Event|0|||
13154667|NCT02512302|26062910|FG008|Period 4|Adverse Event|0|||
13154668|NCT02512302|26062911|FG009|Period 4|Adverse Event|0|||
13154669|NCT02512068|26062942|FG000|Overall Study|Pretreatment Event/Adverse Event|8|||
13154670|NCT02512068|26062943|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
13154671|NCT02512068|26062942|FG000|Overall Study|Major Protocol Deviation|1|||
13154672|NCT02512068|26062943|FG001|Overall Study|Major Protocol Deviation|0|||
13154673|NCT02512068|26062942|FG000|Overall Study|Voluntary Withdrawal|0|||
13154674|NCT02512068|26062943|FG001|Overall Study|Voluntary Withdrawal|1|||
13154675|NCT02512068|26062942|FG000|Overall Study|Lack of Efficacy|0|||
13154676|NCT02512068|26062943|FG001|Overall Study|Lack of Efficacy|1|||
13154677|NCT02512068|26062942|FG000|Overall Study|Reason Not Specified|3|||
13154678|NCT02512068|26062943|FG001|Overall Study|Reason Not Specified|5|||
13154679|NCT02512042|26062956|FG000|Overall Study|Adverse Event|0|||
13154680|NCT02512042|26062957|FG001|Overall Study|Adverse Event|4|||
13154681|NCT02512042|26062956|FG000|Overall Study|Withdrawal by Subject|6|||
13154682|NCT02512042|26062957|FG001|Overall Study|Withdrawal by Subject|6|||
13154683|NCT02512042|26062956|FG000|Overall Study|Non-compliance with study drug|1|||
13154684|NCT02512042|26062957|FG001|Overall Study|Non-compliance with study drug|2|||
13154685|NCT02512042|26062956|FG000|Overall Study|Lost to Follow-up|5|||
13154686|NCT02512042|26062957|FG001|Overall Study|Lost to Follow-up|2|||
13154687|NCT02512042|26062956|FG000|Overall Study|Other|11|||
13154688|NCT02512042|26062957|FG001|Overall Study|Other|11|||
13154689|NCT02511782|26062977|FG000|Overall Study|Withdrawal by Subject|1|||
13154690|NCT02511782|26062978|FG001|Overall Study|Withdrawal by Subject|0|||
13154691|NCT02511782|26062979|FG002|Overall Study|Withdrawal by Subject|0|||
13154692|NCT02511678|26062994|FG000|Overall Study|Withdrawal by Subject|2|||
13154693|NCT02511678|26062994|FG000|Overall Study|Lost to Follow-up|4|||
13154694|NCT02511678|26062994|FG000|Overall Study|Death|19|||
13154695|NCT02511678|26062994|FG000|Overall Study|Adverse Event|1|||
13222730|NCT01803282|26286890|FG007|Overall Study|Withdrew Consent|3|||
13222731|NCT01803282|26286891|FG008|Overall Study|Withdrew Consent|1|||
13222732|NCT01803282|26286892|FG009|Overall Study|Withdrew Consent|5|||
13222733|NCT01803282|26286893|FG010|Overall Study|Withdrew Consent|0|||
13222734|NCT01803282|26286894|FG011|Overall Study|Withdrew Consent|1|||
13222735|NCT01803282|26286883|FG000|Overall Study|Investigator's Discretion|0|||
13222736|NCT01803282|26286884|FG001|Overall Study|Investigator's Discretion|0|||
13222737|NCT01803282|26286885|FG002|Overall Study|Investigator's Discretion|0|||
13222738|NCT01803282|26286886|FG003|Overall Study|Investigator's Discretion|7|||
13222739|NCT01803282|26286887|FG004|Overall Study|Investigator's Discretion|2|||
13222740|NCT01803282|26286888|FG005|Overall Study|Investigator's Discretion|1|||
13222741|NCT01803282|26286889|FG006|Overall Study|Investigator's Discretion|7|||
13222742|NCT01803282|26286890|FG007|Overall Study|Investigator's Discretion|10|||
13222743|NCT01803282|26286891|FG008|Overall Study|Investigator's Discretion|6|||
13222744|NCT01803282|26286892|FG009|Overall Study|Investigator's Discretion|7|||
13222745|NCT01803282|26286893|FG010|Overall Study|Investigator's Discretion|1|||
13222746|NCT01803282|26286894|FG011|Overall Study|Investigator's Discretion|0|||
13222747|NCT01803282|26286883|FG000|Overall Study|Adverse Event|0|||
13222748|NCT01803282|26286884|FG001|Overall Study|Adverse Event|0|||
13222749|NCT01803282|26286885|FG002|Overall Study|Adverse Event|0|||
13222750|NCT01803282|26286886|FG003|Overall Study|Adverse Event|0|||
13222751|NCT01803282|26286887|FG004|Overall Study|Adverse Event|0|||
13222752|NCT01803282|26286888|FG005|Overall Study|Adverse Event|0|||
13104070|NCT03345407|25874325|FG000|Overall Study|Physician Decision|3|||
13104071|NCT03345407|25874326|FG001|Overall Study|Physician Decision|1|||
13104072|NCT03345407|25874327|FG002|Overall Study|Physician Decision|0|||
13104073|NCT03345407|25874328|FG003|Overall Study|Physician Decision|0|||
13104074|NCT03345407|25874329|FG004|Overall Study|Physician Decision|1|||
13104075|NCT03345407|25874330|FG005|Overall Study|Physician Decision|2|||
13104076|NCT03345407|25874331|FG006|Overall Study|Physician Decision|3|||
13104077|NCT03345407|25874325|FG000|Overall Study|Lost to Follow-up|2|||
13104078|NCT03345407|25874326|FG001|Overall Study|Lost to Follow-up|0|||
13154696|NCT02511678|26062994|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5|||
13154697|NCT02511678|26062994|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1|||
13154698|NCT02511678|26062994|FG000|Overall Study|Required Radiofrequency Ablation|1|||
13154699|NCT02511678|26062994|FG000|Overall Study|Biopsy was Negative|1|||
13154700|NCT02511678|26062994|FG000|Overall Study|Protocol Violation|1|||
13154701|NCT02511678|26062994|FG000|Overall Study|Received Radiation Treatment|1|||
13154702|NCT02511431|26063034|FG000|Treatment|Lost to Follow-up|0|||
13154703|NCT02511431|26063035|FG001|Treatment|Lost to Follow-up|0|||
13154704|NCT02511431|26063036|FG002|Treatment|Lost to Follow-up|1|||
13154705|NCT02511431|26063037|FG003|Treatment|Lost to Follow-up|0|||
13154706|NCT02511431|26063038|FG004|Treatment|Lost to Follow-up|0|||
13154707|NCT02511431|26063039|FG005|Treatment|Lost to Follow-up|1|||
13154708|NCT02511184|26063096|FG000|Overall Study|Death|1|||
13154709|NCT02511184|26063097|FG001|Overall Study|Death|0|||
13154710|NCT02511184|26063096|FG000|Overall Study|Lost to Follow-up|0|||
13154711|NCT02511184|26063097|FG001|Overall Study|Lost to Follow-up|1|||
13154712|NCT02511184|26063096|FG000|Overall Study|Study terminated by sponsor|1|||
13154713|NCT02511184|26063097|FG001|Overall Study|Study terminated by sponsor|5|||
13154714|NCT02511184|26063096|FG000|Overall Study|Withdrawal by Subject|0|||
13154715|NCT02511184|26063097|FG001|Overall Study|Withdrawal by Subject|1|||
13154716|NCT02510820|26063138|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
13154717|NCT02510820|26063139|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
13154718|NCT02510820|26063138|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
13154719|NCT02510820|26063139|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
13154720|NCT02510794|26063210|FG000|Overall Study|Adverse Event|0|||
13154721|NCT02510794|26063211|FG001|Overall Study|Adverse Event|1|||
13154722|NCT02510794|26063212|FG002|Overall Study|Adverse Event|0|||
13154723|NCT02510794|26063213|FG003|Overall Study|Adverse Event|0|||
13154724|NCT02510794|26063210|FG000|Overall Study|Death|1|||
13154725|NCT02510794|26063211|FG001|Overall Study|Death|2|||
13154726|NCT02510794|26063212|FG002|Overall Study|Death|1|||
13154727|NCT02510794|26063213|FG003|Overall Study|Death|1|||
13154728|NCT02510794|26063210|FG000|Overall Study|Lack of Efficacy|3|||
13154729|NCT02510794|26063211|FG001|Overall Study|Lack of Efficacy|1|||
13154730|NCT02510794|26063212|FG002|Overall Study|Lack of Efficacy|1|||
13154731|NCT02510794|26063213|FG003|Overall Study|Lack of Efficacy|0|||
13154732|NCT02510794|26063210|FG000|Overall Study|Participant moved out of the area|0|||
13154733|NCT02510794|26063211|FG001|Overall Study|Participant moved out of the area|0|||
13154734|NCT02510794|26063212|FG002|Overall Study|Participant moved out of the area|0|||
13154735|NCT02510794|26063213|FG003|Overall Study|Participant moved out of the area|1|||
13154736|NCT02510794|26063210|FG000|Overall Study|Physician Decision|3|||
13154737|NCT02510794|26063211|FG001|Overall Study|Physician Decision|0|||
13154738|NCT02510794|26063212|FG002|Overall Study|Physician Decision|0|||
13154739|NCT02510794|26063213|FG003|Overall Study|Physician Decision|0|||
13154740|NCT02510794|26063210|FG000|Overall Study|Protocol Violation|0|||
13154741|NCT02510794|26063211|FG001|Overall Study|Protocol Violation|0|||
13154742|NCT02510794|26063212|FG002|Overall Study|Protocol Violation|1|||
13154743|NCT02510794|26063213|FG003|Overall Study|Protocol Violation|0|||
13154744|NCT02510794|26063210|FG000|Overall Study|Withdrawal by Subject|1|||
13154745|NCT02510794|26063211|FG001|Overall Study|Withdrawal by Subject|2|||
13154746|NCT02510794|26063212|FG002|Overall Study|Withdrawal by Subject|4|||
13154747|NCT02510794|26063213|FG003|Overall Study|Withdrawal by Subject|3|||
13154748|NCT02510664|26063252|FG000|Overall Study|Transferred Care|9|||
13154749|NCT02510664|26063253|FG001|Overall Study|Transferred Care|9|||
13154750|NCT02510664|26063254|FG002|Overall Study|Transferred Care|0|||
13154751|NCT02510664|26063252|FG000|Overall Study|Provider Retired/No Time to Reschedule|10|||
13154752|NCT02510664|26063253|FG001|Overall Study|Provider Retired/No Time to Reschedule|10|||
13154753|NCT02510664|26063254|FG002|Overall Study|Provider Retired/No Time to Reschedule|0|||
13154754|NCT02510664|26063252|FG000|Overall Study|Time Constraints|1|||
13154755|NCT02510664|26063253|FG001|Overall Study|Time Constraints|1|||
13154756|NCT02510664|26063254|FG002|Overall Study|Time Constraints|0|||
13154757|NCT02510040|26063280|FG000|Overall Study|Deemed no longer eligible|18|||
13154758|NCT02510040|26063281|FG001|Overall Study|Deemed no longer eligible|3|||
13154759|NCT02510040|26063282|FG002|Overall Study|Deemed no longer eligible|1|||
13154760|NCT02510014|26063309|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
13154761|NCT02510014|26063310|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
13154762|NCT02510014|26063309|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1|||
13154763|NCT02510014|26063310|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0|||
13154764|NCT02510014|26063309|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44|||
13154765|NCT02510014|26063310|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3|||
13154766|NCT02510014|26063309|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0|||
13154767|NCT02510014|26063310|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1|||
13154768|NCT02510014|26063309|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22|||
13154769|NCT02510014|26063310|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3|||
13154770|NCT02510014|26063309|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7|||
13154771|NCT02510014|26063310|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1|||
13154772|NCT02510014|26063309|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2|||
13154773|NCT02510014|26063310|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0|||
13154774|NCT02510014|26063309|FG000|Run-In Period (Days -14 to Day -1)|Other|19|||
13154775|NCT02510014|26063310|FG001|Run-In Period (Days -14 to Day -1)|Other|1|||
13154776|NCT02510014|26063309|FG000|Treatment Period|Adverse Event|11|||
13154777|NCT02510014|26063310|FG001|Treatment Period|Adverse Event|4|||
13154778|NCT02510014|26063309|FG000|Treatment Period|Withdrawal symptoms|3|||
13154779|NCT02510014|26063310|FG001|Treatment Period|Withdrawal symptoms|0|||
13154780|NCT02510014|26063309|FG000|Treatment Period|Lost to Follow-up|80|||
13154781|NCT02510014|26063310|FG001|Treatment Period|Lost to Follow-up|19|||
13154782|NCT02510014|26063309|FG000|Treatment Period|Physician Decision|5|||
13154783|NCT02510014|26063310|FG001|Treatment Period|Physician Decision|0|||
13154784|NCT02510014|26063309|FG000|Treatment Period|Withdrawal by Subject|67|||
13154785|NCT02510014|26063310|FG001|Treatment Period|Withdrawal by Subject|24|||
13154786|NCT02510014|26063309|FG000|Treatment Period|Withdrawn by the investigator|7|||
13154787|NCT02510014|26063310|FG001|Treatment Period|Withdrawn by the investigator|1|||
13154788|NCT02510014|26063309|FG000|Treatment Period|Protocol Violation|4|||
13154789|NCT02510014|26063310|FG001|Treatment Period|Protocol Violation|4|||
13154790|NCT02510014|26063309|FG000|Treatment Period|Incarceration, pregnancy, misc|29|||
13154791|NCT02510014|26063310|FG001|Treatment Period|Incarceration, pregnancy, misc|5|||
13154792|NCT02510001|26063410|FG000|Overall Study|Early disease progression|0|||
13154793|NCT02510001|26063411|FG001|Overall Study|Early disease progression|0|||
13154794|NCT02510001|26063412|FG002|Overall Study|Early disease progression|0|||
13154795|NCT02510001|26063413|FG003|Overall Study|Early disease progression|1|||
13154796|NCT02510001|26063414|FG004|Overall Study|Early disease progression|1|||
13154797|NCT02510001|26063415|FG005|Overall Study|Early disease progression|1|||
13154798|NCT02510001|26063416|FG006|Overall Study|Early disease progression|0|||
13154799|NCT02510001|26063417|FG007|Overall Study|Early disease progression|0|||
13154800|NCT02510001|26063410|FG000|Overall Study|Adverse Event|0|||
13154801|NCT02510001|26063411|FG001|Overall Study|Adverse Event|0|||
13154802|NCT02510001|26063412|FG002|Overall Study|Adverse Event|0|||
13154803|NCT02510001|26063413|FG003|Overall Study|Adverse Event|1|||
13154804|NCT02510001|26063414|FG004|Overall Study|Adverse Event|2|||
13154805|NCT02510001|26063415|FG005|Overall Study|Adverse Event|1|||
13154806|NCT02510001|26063416|FG006|Overall Study|Adverse Event|2|||
13154807|NCT02510001|26063417|FG007|Overall Study|Adverse Event|5|||
13154808|NCT02510001|26063410|FG000|Overall Study|Physician Decision|0|||
13154809|NCT02510001|26063411|FG001|Overall Study|Physician Decision|0|||
13154810|NCT02510001|26063412|FG002|Overall Study|Physician Decision|0|||
13154811|NCT02510001|26063413|FG003|Overall Study|Physician Decision|0|||
13154812|NCT02510001|26063414|FG004|Overall Study|Physician Decision|1|||
13154813|NCT02510001|26063415|FG005|Overall Study|Physician Decision|0|||
13154814|NCT02510001|26063416|FG006|Overall Study|Physician Decision|0|||
13154815|NCT02510001|26063417|FG007|Overall Study|Physician Decision|0|||
13154816|NCT02510001|26063410|FG000|Overall Study|Withdrawal by Subject|0|||
13154817|NCT02510001|26063411|FG001|Overall Study|Withdrawal by Subject|0|||
13154818|NCT02510001|26063412|FG002|Overall Study|Withdrawal by Subject|0|||
13154819|NCT02510001|26063413|FG003|Overall Study|Withdrawal by Subject|0|||
13154820|NCT02510001|26063414|FG004|Overall Study|Withdrawal by Subject|0|||
13154821|NCT02510001|26063415|FG005|Overall Study|Withdrawal by Subject|0|||
13154822|NCT02510001|26063416|FG006|Overall Study|Withdrawal by Subject|0|||
13154823|NCT02510001|26063417|FG007|Overall Study|Withdrawal by Subject|2|||
13154824|NCT02509312|26063452|FG000|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|5|||
13154825|NCT02509312|26063453|FG001|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|3|||
13154826|NCT02509312|26063452|FG000|Overall Study|Obstetrician refusal|0|||
13154827|NCT02509312|26063453|FG001|Overall Study|Obstetrician refusal|1|||
13154828|NCT02509312|26063452|FG000|Overall Study|Patient elected for TOLAC|1|||
13154829|NCT02509312|26063453|FG001|Overall Study|Patient elected for TOLAC|0|||
13154830|NCT02509312|26063452|FG000|Overall Study|Cesarean deemed stat|1|||
13154831|NCT02509312|26063453|FG001|Overall Study|Cesarean deemed stat|0|||
13154832|NCT02509312|26063452|FG000|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|0|||
13154833|NCT02509312|26063453|FG001|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|1|||
13154834|NCT02509156|26063520|FG000|Randomized Phase|Death|1|||
13154835|NCT02509156|26063521|FG001|Randomized Phase|Death|0|||
13154836|NCT02509156|26063520|FG000|Randomized Phase|Withdrawal by Subject|1|||
13154837|NCT02509156|26063521|FG001|Randomized Phase|Withdrawal by Subject|1|||
13154838|NCT02509117|26063761|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
13154839|NCT02509117|26063762|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1|||
13154840|NCT02509117|26063763|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
13154841|NCT02509117|26063764|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
13154842|NCT02509117|26063765|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
13154843|NCT02509117|26063766|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
13154844|NCT02509117|26063767|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
13154845|NCT02509117|26063768|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
13154846|NCT02509117|26063769|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
13154847|NCT02509117|26063770|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
13154848|NCT02509117|26063761|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
13154849|NCT02509117|26063762|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
13154850|NCT02509117|26063763|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
13154851|NCT02509117|26063764|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
13154852|NCT02509117|26063765|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
13154853|NCT02509117|26063766|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
13154854|NCT02509117|26063767|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
13154855|NCT02509117|26063768|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
13154856|NCT02509117|26063769|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
13154857|NCT02509117|26063770|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1|||
13154858|NCT02509117|26063761|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
13154859|NCT02509117|26063762|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
13154860|NCT02509117|26063763|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
13154861|NCT02509117|26063764|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
13154862|NCT02509117|26063765|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
13154863|NCT02509117|26063766|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
13154864|NCT02509117|26063767|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
13154865|NCT02509117|26063768|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
13154866|NCT02509117|26063769|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
13154867|NCT02509117|26063770|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1|||
13154868|NCT02509078|26063813|FG000|Overall Study|Protocol Violation|1|||
13154869|NCT02509078|26063814|FG001|Overall Study|Protocol Violation|1|||
13154870|NCT02509026|26064013|FG000|Induction Period (24 Weeks)|Adverse Event|5|||
13154871|NCT02509026|26064013|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5|||
13154872|NCT02509026|26064013|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6|||
13154873|NCT02509026|26064013|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1|||
13154874|NCT02509026|26064013|FG000|Induction Period (24 Weeks)|Other|2|||
13154875|NCT02509026|26064013|FG000|Induction Period (24 Weeks)|Protocol Violation|1|||
13154876|NCT02509026|26064013|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1|||
13154877|NCT02509026|26064013|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1|||
13154878|NCT02509026|26064013|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2|||
13154879|NCT02509026|26064013|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5|||
13154880|NCT02509026|26064013|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1|||
13154881|NCT02509026|26064013|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2|||
13154882|NCT02509026|26064013|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1|||
13154883|NCT02508935|26064027|FG000|Overall Study|Withdrawal by Subject|1|||
13154884|NCT02508935|26064027|FG000|Overall Study|Withdrawal by Caregiver|8|||
13154885|NCT02508935|26064027|FG000|Overall Study|Pain Score <4|1|||
13154886|NCT02508935|26064027|FG000|Overall Study|Emesis|3|||
13154887|NCT02508935|26064027|FG000|Overall Study|Adverse Event|3|||
13154888|NCT02508935|26064027|FG000|Overall Study|Protocol Violation|1|||
13154889|NCT02508935|26064027|FG000|Overall Study|Physician Decision|1|||
13154890|NCT02508935|26064027|FG000|Overall Study|Trial terminated by sponsor|5|||
13154891|NCT02508701|26064062|FG000|Overall Study|Lost to Follow-up|9|||
13154892|NCT02508701|26064063|FG001|Overall Study|Lost to Follow-up|5|||
13154893|NCT02508701|26064064|FG002|Overall Study|Lost to Follow-up|5|||
13154894|NCT02508701|26064065|FG003|Overall Study|Lost to Follow-up|3|||
13154895|NCT02508649|26064167|FG000|Overall Study|Withdrawal by Subject|4|||
13154896|NCT02508649|26064168|FG001|Overall Study|Withdrawal by Subject|6|||
13154897|NCT02508649|26064169|FG002|Overall Study|Withdrawal by Subject|5|||
13154898|NCT02508649|26064170|FG003|Overall Study|Withdrawal by Subject|6|||
13154899|NCT02508649|26064167|FG000|Overall Study|Investigator withdrew the subject|1|||
13154900|NCT02508649|26064168|FG001|Overall Study|Investigator withdrew the subject|2|||
13154901|NCT02508649|26064169|FG002|Overall Study|Investigator withdrew the subject|1|||
13154902|NCT02508649|26064170|FG003|Overall Study|Investigator withdrew the subject|0|||
13154903|NCT02508649|26064167|FG000|Overall Study|Post randomization screening failure|12|||
13154904|NCT02508649|26064168|FG001|Overall Study|Post randomization screening failure|4|||
13154905|NCT02508649|26064169|FG002|Overall Study|Post randomization screening failure|9|||
13154906|NCT02508649|26064170|FG003|Overall Study|Post randomization screening failure|3|||
13154907|NCT02508649|26064167|FG000|Overall Study|Lost to Follow-up|1|||
13154908|NCT02508649|26064168|FG001|Overall Study|Lost to Follow-up|1|||
13154909|NCT02508649|26064169|FG002|Overall Study|Lost to Follow-up|0|||
13154910|NCT02508649|26064170|FG003|Overall Study|Lost to Follow-up|1|||
13154911|NCT02508532|26064264|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
13154912|NCT02508532|26064265|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
13154913|NCT02508532|26064266|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
13154914|NCT02508532|26064267|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
13154915|NCT02508532|26064268|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
13154916|NCT02508532|26064269|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
13154917|NCT02508532|26064270|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1|||
13154918|NCT02508532|26064271|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
13154919|NCT02508532|26064272|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
13154920|NCT02508532|26064264|FG000|Part 1 - Dose Determining Period|Not Evaluable|0|||
13154921|NCT02508532|26064265|FG001|Part 1 - Dose Determining Period|Not Evaluable|0|||
13154922|NCT02508532|26064266|FG002|Part 1 - Dose Determining Period|Not Evaluable|0|||
13154923|NCT02508532|26064267|FG003|Part 1 - Dose Determining Period|Not Evaluable|0|||
13154924|NCT02508532|26064268|FG004|Part 1 - Dose Determining Period|Not Evaluable|0|||
13154925|NCT02508532|26064269|FG005|Part 1 - Dose Determining Period|Not Evaluable|0|||
13154926|NCT02508532|26064270|FG006|Part 1 - Dose Determining Period|Not Evaluable|0|||
13154927|NCT02508532|26064271|FG007|Part 1 - Dose Determining Period|Not Evaluable|1|||
13154928|NCT02508532|26064272|FG008|Part 1 - Dose Determining Period|Not Evaluable|0|||
13154929|NCT02508532|26064264|FG000|Part 2 - Treatment|Disease Progression|0|||
13154930|NCT02508532|26064265|FG001|Part 2 - Treatment|Disease Progression|0|||
13154931|NCT02508532|26064266|FG002|Part 2 - Treatment|Disease Progression|0|||
13154932|NCT02508532|26064267|FG003|Part 2 - Treatment|Disease Progression|0|||
13154933|NCT02508532|26064268|FG004|Part 2 - Treatment|Disease Progression|0|||
13154934|NCT02508532|26064269|FG005|Part 2 - Treatment|Disease Progression|0|||
13154935|NCT02508532|26064270|FG006|Part 2 - Treatment|Disease Progression|0|||
13154936|NCT02508532|26064271|FG007|Part 2 - Treatment|Disease Progression|0|||
13154937|NCT02508532|26064272|FG008|Part 2 - Treatment|Disease Progression|118|||
13154938|NCT02508532|26064264|FG000|Part 2 - Treatment|Adverse Event|0|||
13154939|NCT02508532|26064265|FG001|Part 2 - Treatment|Adverse Event|0|||
13154940|NCT02508532|26064266|FG002|Part 2 - Treatment|Adverse Event|0|||
13154941|NCT02508532|26064267|FG003|Part 2 - Treatment|Adverse Event|0|||
13154942|NCT02508532|26064268|FG004|Part 2 - Treatment|Adverse Event|0|||
13154943|NCT02508532|26064269|FG005|Part 2 - Treatment|Adverse Event|0|||
13154944|NCT02508532|26064270|FG006|Part 2 - Treatment|Adverse Event|0|||
13154945|NCT02508532|26064271|FG007|Part 2 - Treatment|Adverse Event|0|||
13154946|NCT02508532|26064272|FG008|Part 2 - Treatment|Adverse Event|49|||
13154947|NCT02508532|26064264|FG000|Part 2 - Treatment|Physician Decision|0|||
13154948|NCT02508532|26064265|FG001|Part 2 - Treatment|Physician Decision|0|||
13154949|NCT02508532|26064266|FG002|Part 2 - Treatment|Physician Decision|0|||
13154950|NCT02508532|26064267|FG003|Part 2 - Treatment|Physician Decision|0|||
13154951|NCT02508532|26064268|FG004|Part 2 - Treatment|Physician Decision|0|||
13154952|NCT02508532|26064269|FG005|Part 2 - Treatment|Physician Decision|0|||
13154953|NCT02508532|26064270|FG006|Part 2 - Treatment|Physician Decision|0|||
13154954|NCT02508532|26064271|FG007|Part 2 - Treatment|Physician Decision|0|||
13154955|NCT02508532|26064272|FG008|Part 2 - Treatment|Physician Decision|12|||
13154956|NCT02508532|26064264|FG000|Part 2 - Treatment|Administrative|0|||
13154957|NCT02508532|26064265|FG001|Part 2 - Treatment|Administrative|0|||
13154958|NCT02508532|26064266|FG002|Part 2 - Treatment|Administrative|0|||
13154959|NCT02508532|26064267|FG003|Part 2 - Treatment|Administrative|0|||
13154960|NCT02508532|26064268|FG004|Part 2 - Treatment|Administrative|0|||
13154961|NCT02508532|26064269|FG005|Part 2 - Treatment|Administrative|0|||
13154962|NCT02508532|26064270|FG006|Part 2 - Treatment|Administrative|0|||
13154963|NCT02508532|26064271|FG007|Part 2 - Treatment|Administrative|0|||
13154964|NCT02508532|26064272|FG008|Part 2 - Treatment|Administrative|3|||
13154965|NCT02508532|26064264|FG000|Part 2 - Treatment|Sponsor Decision|0|||
13154966|NCT02508532|26064265|FG001|Part 2 - Treatment|Sponsor Decision|0|||
13154967|NCT02508532|26064266|FG002|Part 2 - Treatment|Sponsor Decision|0|||
13154968|NCT02508532|26064267|FG003|Part 2 - Treatment|Sponsor Decision|0|||
13154969|NCT02508532|26064268|FG004|Part 2 - Treatment|Sponsor Decision|0|||
13154970|NCT02508532|26064269|FG005|Part 2 - Treatment|Sponsor Decision|0|||
13154971|NCT02508532|26064270|FG006|Part 2 - Treatment|Sponsor Decision|0|||
13154972|NCT02508532|26064271|FG007|Part 2 - Treatment|Sponsor Decision|0|||
13154973|NCT02508532|26064272|FG008|Part 2 - Treatment|Sponsor Decision|28|||
13154974|NCT02508532|26064264|FG000|Part 2 - Treatment|Death|0|||
13154975|NCT02508532|26064265|FG001|Part 2 - Treatment|Death|0|||
13154976|NCT02508532|26064266|FG002|Part 2 - Treatment|Death|0|||
13154977|NCT02508532|26064267|FG003|Part 2 - Treatment|Death|0|||
13154978|NCT02508532|26064268|FG004|Part 2 - Treatment|Death|0|||
13154979|NCT02508532|26064269|FG005|Part 2 - Treatment|Death|0|||
13154980|NCT02508532|26064270|FG006|Part 2 - Treatment|Death|0|||
13154981|NCT02508532|26064271|FG007|Part 2 - Treatment|Death|0|||
13154982|NCT02508532|26064272|FG008|Part 2 - Treatment|Death|1|||
13154983|NCT02508532|26064264|FG000|Part 2 - Treatment|Withdrawal by Subject|0|||
13154984|NCT02508532|26064265|FG001|Part 2 - Treatment|Withdrawal by Subject|0|||
13154985|NCT02508532|26064266|FG002|Part 2 - Treatment|Withdrawal by Subject|0|||
13154986|NCT02508532|26064267|FG003|Part 2 - Treatment|Withdrawal by Subject|0|||
13154987|NCT02508532|26064268|FG004|Part 2 - Treatment|Withdrawal by Subject|0|||
13154988|NCT02508532|26064269|FG005|Part 2 - Treatment|Withdrawal by Subject|0|||
13154989|NCT02508532|26064270|FG006|Part 2 - Treatment|Withdrawal by Subject|0|||
13154990|NCT02508532|26064271|FG007|Part 2 - Treatment|Withdrawal by Subject|0|||
13154991|NCT02508532|26064272|FG008|Part 2 - Treatment|Withdrawal by Subject|6|||
13154992|NCT02508532|26064264|FG000|Part 1 and Part 2 End of Study|Disease Progression|2|||
13154993|NCT02508532|26064265|FG001|Part 1 and Part 2 End of Study|Disease Progression|0|||
13154994|NCT02508532|26064266|FG002|Part 1 and Part 2 End of Study|Disease Progression|0|||
13154995|NCT02508532|26064267|FG003|Part 1 and Part 2 End of Study|Disease Progression|0|||
13154996|NCT02508532|26064268|FG004|Part 1 and Part 2 End of Study|Disease Progression|0|||
13154997|NCT02508532|26064269|FG005|Part 1 and Part 2 End of Study|Disease Progression|0|||
13154998|NCT02508532|26064270|FG006|Part 1 and Part 2 End of Study|Disease Progression|0|||
13154999|NCT02508532|26064271|FG007|Part 1 and Part 2 End of Study|Disease Progression|1|||
13155000|NCT02508532|26064272|FG008|Part 1 and Part 2 End of Study|Disease Progression|6|||
13155001|NCT02508532|26064264|FG000|Part 1 and Part 2 End of Study|Adverse Event|1|||
13155002|NCT02508532|26064265|FG001|Part 1 and Part 2 End of Study|Adverse Event|0|||
13155003|NCT02508532|26064266|FG002|Part 1 and Part 2 End of Study|Adverse Event|1|||
13155004|NCT02508532|26064267|FG003|Part 1 and Part 2 End of Study|Adverse Event|0|||
13155005|NCT02508532|26064268|FG004|Part 1 and Part 2 End of Study|Adverse Event|0|||
13155006|NCT02508532|26064269|FG005|Part 1 and Part 2 End of Study|Adverse Event|0|||
13155007|NCT02508532|26064270|FG006|Part 1 and Part 2 End of Study|Adverse Event|0|||
13155008|NCT02508532|26064271|FG007|Part 1 and Part 2 End of Study|Adverse Event|0|||
13155009|NCT02508532|26064272|FG008|Part 1 and Part 2 End of Study|Adverse Event|2|||
13155010|NCT02508532|26064264|FG000|Part 1 and Part 2 End of Study|Death|0|||
13155011|NCT02508532|26064265|FG001|Part 1 and Part 2 End of Study|Death|4|||
13155012|NCT02508532|26064266|FG002|Part 1 and Part 2 End of Study|Death|2|||
13155013|NCT02508532|26064267|FG003|Part 1 and Part 2 End of Study|Death|4|||
13155014|NCT02508532|26064268|FG004|Part 1 and Part 2 End of Study|Death|3|||
13155015|NCT02508532|26064269|FG005|Part 1 and Part 2 End of Study|Death|0|||
13155016|NCT02508532|26064270|FG006|Part 1 and Part 2 End of Study|Death|0|||
13155017|NCT02508532|26064271|FG007|Part 1 and Part 2 End of Study|Death|1|||
13155018|NCT02508532|26064272|FG008|Part 1 and Part 2 End of Study|Death|111|||
13155019|NCT02508532|26064264|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
13155020|NCT02508532|26064265|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
13155021|NCT02508532|26064266|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
13155022|NCT02508532|26064267|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
13155023|NCT02508532|26064268|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
13155024|NCT02508532|26064269|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
13155025|NCT02508532|26064270|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
13155026|NCT02508532|26064271|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
13155027|NCT02508532|26064272|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6|||
13155028|NCT02508532|26064264|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
13155029|NCT02508532|26064265|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
13155030|NCT02508532|26064266|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
13155031|NCT02508532|26064267|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
13155032|NCT02508532|26064268|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
13155033|NCT02508532|26064269|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
13155034|NCT02508532|26064270|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
13155035|NCT02508532|26064271|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
13155036|NCT02508532|26064272|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15|||
13155037|NCT02508532|26064264|FG000|Part 1 and Part 2 End of Study|Physician Decision|0|||
13155038|NCT02508532|26064265|FG001|Part 1 and Part 2 End of Study|Physician Decision|0|||
13155039|NCT02508532|26064266|FG002|Part 1 and Part 2 End of Study|Physician Decision|1|||
13155040|NCT02508532|26064267|FG003|Part 1 and Part 2 End of Study|Physician Decision|0|||
13155041|NCT02508532|26064268|FG004|Part 1 and Part 2 End of Study|Physician Decision|1|||
13155042|NCT02508532|26064269|FG005|Part 1 and Part 2 End of Study|Physician Decision|0|||
13155043|NCT02508532|26064270|FG006|Part 1 and Part 2 End of Study|Physician Decision|0|||
13155044|NCT02508532|26064271|FG007|Part 1 and Part 2 End of Study|Physician Decision|0|||
13155045|NCT02508532|26064272|FG008|Part 1 and Part 2 End of Study|Physician Decision|8|||
13155046|NCT02508532|26064264|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
13155047|NCT02508532|26064265|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
13155048|NCT02508532|26064266|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
13155049|NCT02508532|26064267|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
13155050|NCT02508532|26064268|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
13155051|NCT02508532|26064269|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
13155052|NCT02508532|26064270|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
13155053|NCT02508532|26064271|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
13155054|NCT02508532|26064272|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1|||
13205248|NCT01967173|26231278|FG005|Overall Study|Lost to Follow-up|12|||
13155055|NCT02508532|26064264|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
13155056|NCT02508532|26064265|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
13155057|NCT02508532|26064266|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
13155058|NCT02508532|26064267|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
13155059|NCT02508532|26064268|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
13155060|NCT02508532|26064269|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
13155061|NCT02508532|26064270|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
13155062|NCT02508532|26064271|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
13155063|NCT02508532|26064272|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|68|||
13155064|NCT02508428|26064293|FG000|Overall Study|Death|32|||
13155065|NCT02508428|26064294|FG001|Overall Study|Death|33|||
13155066|NCT02508428|26064293|FG000|Overall Study|Liner revised|3|||
13155067|NCT02508428|26064294|FG001|Overall Study|Liner revised|19|||
13155068|NCT02508428|26064293|FG000|Overall Study|Incomplete follow-up|17|||
13155069|NCT02508428|26064294|FG001|Overall Study|Incomplete follow-up|15|||
13155070|NCT02508194|26064339|FG000|Overall Study|Death|5|||
13155071|NCT02508194|26064340|FG001|Overall Study|Death|3|||
13155072|NCT02508194|26064339|FG000|Overall Study|Lost to Follow-up|25|||
13155073|NCT02508194|26064340|FG001|Overall Study|Lost to Follow-up|18|||
13155074|NCT02508194|26064339|FG000|Overall Study|Withdrawal by Subject|20|||
13155075|NCT02508194|26064340|FG001|Overall Study|Withdrawal by Subject|18|||
13155076|NCT02508194|26064339|FG000|Overall Study|Error in Randomization|1|||
13155077|NCT02508194|26064340|FG001|Overall Study|Error in Randomization|3|||
13155078|NCT02508194|26064339|FG000|Overall Study|Principal Investigator Decision|1|||
13155079|NCT02508194|26064340|FG001|Overall Study|Principal Investigator Decision|2|||
13155080|NCT02508116|26064359|FG000|Overall Study|Lost to Follow-up|2|||
13155081|NCT02508116|26064360|FG001|Overall Study|Lost to Follow-up|3|||
13155082|NCT02508116|26064359|FG000|Overall Study|Withdrawal by Subject|3|||
13155083|NCT02508116|26064360|FG001|Overall Study|Withdrawal by Subject|2|||
13155084|NCT02508116|26064359|FG000|Overall Study|Protocol Violation|1|||
13155085|NCT02508116|26064360|FG001|Overall Study|Protocol Violation|2|||
13155086|NCT02508116|26064359|FG000|Overall Study|Physician Decision|2|||
13155087|NCT02508116|26064360|FG001|Overall Study|Physician Decision|0|||
13155088|NCT02507752|26064380|FG000|Overall Study|Adverse Event|1|||
13155089|NCT02507752|26064380|FG000|Overall Study|Protocol Violation|6|||
13155090|NCT02507752|26064380|FG000|Overall Study|Lost to Follow-up|7|||
13155091|NCT02507752|26064380|FG000|Overall Study|Infusion reaction at first infusion|1|||
13155092|NCT02507752|26064380|FG000|Overall Study|Participant didn't perform visit Week 12|1|||
13155093|NCT02507752|26064380|FG000|Overall Study|Participant didn't perform visit Week 24|1|||
13155094|NCT02507375|26064404|FG000|Overall Study|Progressive Disease|4|||
13155095|NCT02507375|26064405|FG001|Overall Study|Progressive Disease|5|||
13155096|NCT02507375|26064404|FG000|Overall Study|Death|0|||
13155097|NCT02507375|26064405|FG001|Overall Study|Death|1|||
13155098|NCT02507375|26064404|FG000|Overall Study|Refused treatment|0|||
13155099|NCT02507375|26064405|FG001|Overall Study|Refused treatment|1|||
13155100|NCT02507375|26064404|FG000|Overall Study|Adverse Event|0|||
13155101|NCT02507375|26064405|FG001|Overall Study|Adverse Event|1|||
13155102|NCT02507349|26064436|FG000|Overall Study|Death|12|||
13155103|NCT02507349|26064437|FG001|Overall Study|Death|16|||
13155104|NCT02507349|26064436|FG000|Overall Study|Withdrawal by Subject|1|||
13155105|NCT02507349|26064437|FG001|Overall Study|Withdrawal by Subject|1|||
13155106|NCT02507349|26064436|FG000|Overall Study|Lost to Follow-up|174|||
13155107|NCT02507349|26064437|FG001|Overall Study|Lost to Follow-up|144|||
13155108|NCT02507297|26064458|FG000|Overall Study|Withdrawal by Subject|1|||
13155109|NCT02507297|26064459|FG001|Overall Study|Withdrawal by Subject|0|||
13155110|NCT02507297|26064458|FG000|Overall Study|Lost to Follow-up|0|||
13155111|NCT02507297|26064459|FG001|Overall Study|Lost to Follow-up|1|||
13155112|NCT02507219|26064474|FG000|Overall Study|Physician Decision|1|||
13155113|NCT02507219|26064475|FG001|Overall Study|Physician Decision|0|||
13155114|NCT02507219|26064476|FG002|Overall Study|Physician Decision|0|||
13155115|NCT02507219|26064477|FG003|Overall Study|Physician Decision|0|||
13155116|NCT02507219|26064478|FG004|Overall Study|Physician Decision|0|||
13155117|NCT02507219|26064479|FG005|Overall Study|Physician Decision|0|||
13155118|NCT02507219|26064474|FG000|Overall Study|Withdrawal by Subject|0|||
13155119|NCT02507219|26064475|FG001|Overall Study|Withdrawal by Subject|0|||
13155120|NCT02507219|26064476|FG002|Overall Study|Withdrawal by Subject|0|||
13155121|NCT02507219|26064477|FG003|Overall Study|Withdrawal by Subject|0|||
13155122|NCT02507219|26064478|FG004|Overall Study|Withdrawal by Subject|1|||
13155123|NCT02507219|26064479|FG005|Overall Study|Withdrawal by Subject|0|||
13155124|NCT02506881|26064526|FG000|First Intervention (Day 1)|Protocol Violation|0|||
13155125|NCT02506881|26064527|FG001|First Intervention (Day 1)|Protocol Violation|0|||
13155126|NCT02506881|26064528|FG002|First Intervention (Day 1)|Protocol Violation|1|||
13155127|NCT02506881|26064529|FG003|First Intervention (Day 1)|Protocol Violation|0|||
13155128|NCT02506881|26064526|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
13155129|NCT02506881|26064527|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
13155130|NCT02506881|26064528|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
13155131|NCT02506881|26064529|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
13155132|NCT02506881|26064526|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0|||
13155133|NCT02506881|26064527|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0|||
13155134|NCT02506881|26064528|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12|||
13155135|NCT02506881|26064529|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12|||
13155136|NCT02506816|26064538|FG000|Overall Study|Adverse Event|3|||
13155137|NCT02506257|26064581|FG000|Overall Study|Adverse Event|0|||
13155138|NCT02506257|26064582|FG001|Overall Study|Adverse Event|2|||
13155139|NCT02506257|26064583|FG002|Overall Study|Adverse Event|3|||
13155140|NCT02506257|26064584|FG003|Overall Study|Adverse Event|0|||
13155141|NCT02506257|26064581|FG000|Overall Study|Protocol Violation|0|||
13155142|NCT02506257|26064582|FG001|Overall Study|Protocol Violation|0|||
13155143|NCT02506257|26064583|FG002|Overall Study|Protocol Violation|1|||
13155144|NCT02506257|26064584|FG003|Overall Study|Protocol Violation|0|||
13155145|NCT02506101|26064605|FG000|Overall Study|Transportation issues|1|||
13155146|NCT02506101|26064606|FG001|Overall Study|Transportation issues|0|||
13155147|NCT02506101|26064605|FG000|Overall Study|No enrollment and staff unavailability|1|||
13155148|NCT02506101|26064606|FG001|Overall Study|No enrollment and staff unavailability|0|||
13155149|NCT02506036|26064619|FG000|First Intervention (4-6 Weeks)|Death|1|||
13155150|NCT02506036|26064620|FG001|First Intervention (4-6 Weeks)|Death|0|||
13155151|NCT02506036|26064619|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0|||
13155152|NCT02506036|26064620|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1|||
13155153|NCT02506036|26064619|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0|||
13155154|NCT02506036|26064620|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1|||
13155155|NCT02505945|26064635|FG000|Overall Study|Withdrawal by Subject|13|||
13155156|NCT02505945|26064636|FG001|Overall Study|Withdrawal by Subject|2|||
13155157|NCT02505945|26064635|FG000|Overall Study|Adverse Event|1|||
13155158|NCT02505945|26064636|FG001|Overall Study|Adverse Event|0|||
13155159|NCT02505945|26064635|FG000|Overall Study|Physician Decision|2|||
13155160|NCT02505945|26064636|FG001|Overall Study|Physician Decision|1|||
13155161|NCT02505945|26064635|FG000|Overall Study|Lost to Follow-up|6|||
13155162|NCT02505945|26064636|FG001|Overall Study|Lost to Follow-up|1|||
13155163|NCT02505867|26064649|FG000|Overall Study|Lack of Efficacy|6|||
13155164|NCT02505867|26064650|FG001|Overall Study|Lack of Efficacy|6|||
13155165|NCT02505542|26064761|FG000|Part A: Open-Label Period|Adverse Event|31|||
13155166|NCT02505542|26064762|FG001|Part A: Open-Label Period|Adverse Event|0|||
13155167|NCT02505542|26064763|FG002|Part A: Open-Label Period|Adverse Event|0|||
13155168|NCT02505542|26064764|FG003|Part A: Open-Label Period|Adverse Event|0|||
13155169|NCT02505542|26064761|FG000|Part A: Open-Label Period|Lack of Efficacy|5|||
13155170|NCT02505542|26064762|FG001|Part A: Open-Label Period|Lack of Efficacy|0|||
13155171|NCT02505542|26064763|FG002|Part A: Open-Label Period|Lack of Efficacy|0|||
13155172|NCT02505542|26064764|FG003|Part A: Open-Label Period|Lack of Efficacy|0|||
13155173|NCT02505542|26064761|FG000|Part A: Open-Label Period|Protocol Violation|1|||
13155174|NCT02505542|26064762|FG001|Part A: Open-Label Period|Protocol Violation|0|||
13155175|NCT02505542|26064763|FG002|Part A: Open-Label Period|Protocol Violation|0|||
13155176|NCT02505542|26064764|FG003|Part A: Open-Label Period|Protocol Violation|0|||
13155177|NCT02505542|26064761|FG000|Part A: Open-Label Period|Lost to Follow-up|5|||
13155178|NCT02505542|26064762|FG001|Part A: Open-Label Period|Lost to Follow-up|0|||
13155179|NCT02505542|26064763|FG002|Part A: Open-Label Period|Lost to Follow-up|0|||
13155180|NCT02505542|26064764|FG003|Part A: Open-Label Period|Lost to Follow-up|0|||
13155181|NCT02505542|26064761|FG000|Part A: Open-Label Period|Withdrawal by Subject|27|||
13155182|NCT02505542|26064762|FG001|Part A: Open-Label Period|Withdrawal by Subject|0|||
13155183|NCT02505542|26064763|FG002|Part A: Open-Label Period|Withdrawal by Subject|0|||
13155184|NCT02505542|26064764|FG003|Part A: Open-Label Period|Withdrawal by Subject|0|||
13155185|NCT02505542|26064761|FG000|Part A: Open-Label Period|New medical history available|1|||
13155186|NCT02505542|26064762|FG001|Part A: Open-Label Period|New medical history available|0|||
13155187|NCT02505542|26064763|FG002|Part A: Open-Label Period|New medical history available|0|||
13155188|NCT02505542|26064764|FG003|Part A: Open-Label Period|New medical history available|0|||
13155189|NCT02505542|26064761|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1|||
13155190|NCT02505542|26064762|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
13155191|NCT02505542|26064763|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
13155192|NCT02505542|26064764|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
13155193|NCT02505542|26064761|FG000|Part A: Open-Label Period|Pregnancy|2|||
13155194|NCT02505542|26064762|FG001|Part A: Open-Label Period|Pregnancy|0|||
13155195|NCT02505542|26064763|FG002|Part A: Open-Label Period|Pregnancy|0|||
13155196|NCT02505542|26064764|FG003|Part A: Open-Label Period|Pregnancy|0|||
13155197|NCT02505542|26064761|FG000|Part A: Open-Label Period|Sponsor directive|1|||
13155198|NCT02505542|26064762|FG001|Part A: Open-Label Period|Sponsor directive|0|||
13155199|NCT02505542|26064763|FG002|Part A: Open-Label Period|Sponsor directive|0|||
13155200|NCT02505542|26064764|FG003|Part A: Open-Label Period|Sponsor directive|0|||
13155201|NCT02505542|26064761|FG000|Part A: Open-Label Period|Medical monitor decision|1|||
13155202|NCT02505542|26064762|FG001|Part A: Open-Label Period|Medical monitor decision|0|||
13155203|NCT02505542|26064763|FG002|Part A: Open-Label Period|Medical monitor decision|0|||
13155204|NCT02505542|26064764|FG003|Part A: Open-Label Period|Medical monitor decision|0|||
13155205|NCT02505542|26064761|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1|||
13155206|NCT02505542|26064762|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0|||
13155207|NCT02505542|26064763|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0|||
13155208|NCT02505542|26064764|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0|||
13155209|NCT02505542|26064761|FG000|Part A: Open-Label Period|Non-compliance|1|||
13155210|NCT02505542|26064762|FG001|Part A: Open-Label Period|Non-compliance|0|||
13155211|NCT02505542|26064763|FG002|Part A: Open-Label Period|Non-compliance|0|||
13155212|NCT02505542|26064764|FG003|Part A: Open-Label Period|Non-compliance|0|||
13155213|NCT02505542|26064761|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2|||
13155214|NCT02505542|26064762|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
13155215|NCT02505542|26064763|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
13155216|NCT02505542|26064764|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
13155217|NCT02505542|26064761|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3|||
13155218|NCT02505542|26064762|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
13155219|NCT02505542|26064763|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
13155220|NCT02505542|26064764|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
13155221|NCT02505542|26064761|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341|||
13155222|NCT02505542|26064762|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
13155223|NCT02505542|26064763|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
13155224|NCT02505542|26064764|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
13155225|NCT02505542|26064761|FG000|Part B: Double-Blind Period|Adverse Event|0|||
13155226|NCT02505542|26064762|FG001|Part B: Double-Blind Period|Adverse Event|0|||
13155227|NCT02505542|26064763|FG002|Part B: Double-Blind Period|Adverse Event|1|||
13155228|NCT02505542|26064764|FG003|Part B: Double-Blind Period|Adverse Event|3|||
13155229|NCT02505542|26064761|FG000|Part B: Double-Blind Period|Lost to Follow-up|0|||
13155230|NCT02505542|26064762|FG001|Part B: Double-Blind Period|Lost to Follow-up|0|||
13155231|NCT02505542|26064763|FG002|Part B: Double-Blind Period|Lost to Follow-up|0|||
13155232|NCT02505542|26064764|FG003|Part B: Double-Blind Period|Lost to Follow-up|1|||
13155233|NCT02505542|26064761|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0|||
13155234|NCT02505542|26064762|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8|||
13155235|NCT02505542|26064763|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7|||
13155236|NCT02505542|26064764|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2|||
13155237|NCT02505542|26064761|FG000|Part B: Double-Blind Period|Planning pregnancy|0|||
13155238|NCT02505542|26064762|FG001|Part B: Double-Blind Period|Planning pregnancy|1|||
13155239|NCT02505542|26064763|FG002|Part B: Double-Blind Period|Planning pregnancy|0|||
13155240|NCT02505542|26064764|FG003|Part B: Double-Blind Period|Planning pregnancy|0|||
13155241|NCT02505542|26064761|FG000|Part B: Double-Blind Period|Week 94 missed|0|||
13155242|NCT02505542|26064762|FG001|Part B: Double-Blind Period|Week 94 missed|0|||
13155243|NCT02505542|26064763|FG002|Part B: Double-Blind Period|Week 94 missed|1|||
13155244|NCT02505542|26064764|FG003|Part B: Double-Blind Period|Week 94 missed|0|||
13155245|NCT02505542|26064761|FG000|Part B: Double-Blind Period|Patient was moved from the country|0|||
13155246|NCT02505542|26064762|FG001|Part B: Double-Blind Period|Patient was moved from the country|0|||
13155247|NCT02505542|26064763|FG002|Part B: Double-Blind Period|Patient was moved from the country|0|||
13155248|NCT02505542|26064764|FG003|Part B: Double-Blind Period|Patient was moved from the country|1|||
13155249|NCT02505542|26064761|FG000|Part B: Double-Blind Period|Lack of Efficacy|0|||
13155250|NCT02505542|26064762|FG001|Part B: Double-Blind Period|Lack of Efficacy|1|||
13155251|NCT02505542|26064763|FG002|Part B: Double-Blind Period|Lack of Efficacy|0|||
13155252|NCT02505542|26064764|FG003|Part B: Double-Blind Period|Lack of Efficacy|0|||
13155253|NCT02505542|26064761|FG000|Part B: Double-Blind Period|Miscalculation|0|||
13155254|NCT02505542|26064762|FG001|Part B: Double-Blind Period|Miscalculation|1|||
13155255|NCT02505542|26064763|FG002|Part B: Double-Blind Period|Miscalculation|0|||
13155256|NCT02505542|26064764|FG003|Part B: Double-Blind Period|Miscalculation|0|||
13155257|NCT02505542|26064761|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0|||
13155258|NCT02505542|26064762|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1|||
13155259|NCT02505542|26064763|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0|||
13155260|NCT02505542|26064764|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0|||
13155261|NCT02505334|26064896|FG000|Main Treatment Period|Adverse Event|3|||
13155262|NCT02505334|26064897|FG001|Main Treatment Period|Adverse Event|3|||
13155263|NCT02505334|26064896|FG000|Main Treatment Period|Lack of Efficacy|7|||
13155264|NCT02505334|26064897|FG001|Main Treatment Period|Lack of Efficacy|17|||
13155265|NCT02505334|26064896|FG000|Main Treatment Period|Protocol Violation|0|||
13155266|NCT02505334|26064897|FG001|Main Treatment Period|Protocol Violation|1|||
13155267|NCT02505334|26064896|FG000|Main Treatment Period|Withdrawal by Subject|1|||
13155268|NCT02505334|26064897|FG001|Main Treatment Period|Withdrawal by Subject|8|||
13155269|NCT02505334|26064896|FG000|Main Treatment Period|Unclassified|4|||
13155270|NCT02505334|26064897|FG001|Main Treatment Period|Unclassified|10|||
13155271|NCT02505334|26064896|FG000|Extension Treatment Period|Adverse Event|5|||
13155272|NCT02505334|26064897|FG001|Extension Treatment Period|Adverse Event|0|||
13155273|NCT02505334|26064896|FG000|Extension Treatment Period|Lack of Efficacy|4|||
13155274|NCT02505334|26064897|FG001|Extension Treatment Period|Lack of Efficacy|0|||
13155275|NCT02505334|26064896|FG000|Extension Treatment Period|Withdrawal by Subject|6|||
13155276|NCT02505334|26064897|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
13155277|NCT02505334|26064896|FG000|Extension Treatment Period|Unclassified|3|||
13155278|NCT02505334|26064897|FG001|Extension Treatment Period|Unclassified|0|||
13155279|NCT02505217|26064912|FG000|Overall Study|Withdrawal by Subject|1|||
13155280|NCT02505217|26064913|FG001|Overall Study|Withdrawal by Subject|2|||
13155281|NCT02504892|26064922|FG000|Overall Study|Adverse event-pneumonitis|2|||
13155282|NCT02504827|26064929|FG000|Overall Study|Could not produce sputum|1|||
13155283|NCT02504671|26065088|FG000|Overall Study|Withdrawal by Subject|1|||
13155284|NCT02504671|26065089|FG001|Overall Study|Withdrawal by Subject|5|||
13155285|NCT02504671|26065090|FG002|Overall Study|Withdrawal by Subject|4|||
13155286|NCT02504671|26065091|FG003|Overall Study|Withdrawal by Subject|4|||
13155287|NCT02504671|26065092|FG004|Overall Study|Withdrawal by Subject|5|||
13155288|NCT02504671|26065093|FG005|Overall Study|Withdrawal by Subject|3|||
13155289|NCT02504671|26065088|FG000|Overall Study|Lack of Efficacy|1|||
13155290|NCT02504671|26065089|FG001|Overall Study|Lack of Efficacy|3|||
13155291|NCT02504671|26065090|FG002|Overall Study|Lack of Efficacy|1|||
13155292|NCT02504671|26065091|FG003|Overall Study|Lack of Efficacy|0|||
13155293|NCT02504671|26065092|FG004|Overall Study|Lack of Efficacy|4|||
13155294|NCT02504671|26065093|FG005|Overall Study|Lack of Efficacy|4|||
13155295|NCT02504671|26065088|FG000|Overall Study|Adverse Event|1|||
13155296|NCT02504671|26065089|FG001|Overall Study|Adverse Event|1|||
13155297|NCT02504671|26065090|FG002|Overall Study|Adverse Event|0|||
13155298|NCT02504671|26065091|FG003|Overall Study|Adverse Event|1|||
13155299|NCT02504671|26065092|FG004|Overall Study|Adverse Event|0|||
13155300|NCT02504671|26065093|FG005|Overall Study|Adverse Event|2|||
13155301|NCT02504671|26065088|FG000|Overall Study|Protocol Violation|2|||
13155302|NCT02504671|26065089|FG001|Overall Study|Protocol Violation|1|||
13155303|NCT02504671|26065090|FG002|Overall Study|Protocol Violation|0|||
13155304|NCT02504671|26065091|FG003|Overall Study|Protocol Violation|0|||
13155305|NCT02504671|26065092|FG004|Overall Study|Protocol Violation|0|||
13155306|NCT02504671|26065093|FG005|Overall Study|Protocol Violation|1|||
13155307|NCT02504671|26065088|FG000|Overall Study|Lost to Follow-up|0|||
13155308|NCT02504671|26065089|FG001|Overall Study|Lost to Follow-up|0|||
13155309|NCT02504671|26065090|FG002|Overall Study|Lost to Follow-up|2|||
13155310|NCT02504671|26065091|FG003|Overall Study|Lost to Follow-up|0|||
13155311|NCT02504671|26065092|FG004|Overall Study|Lost to Follow-up|0|||
13155312|NCT02504671|26065093|FG005|Overall Study|Lost to Follow-up|1|||
13155313|NCT02504671|26065088|FG000|Overall Study|Protocol defined stopping criteria|7|||
13155314|NCT02504671|26065089|FG001|Overall Study|Protocol defined stopping criteria|4|||
13155315|NCT02504671|26065090|FG002|Overall Study|Protocol defined stopping criteria|3|||
13155316|NCT02504671|26065091|FG003|Overall Study|Protocol defined stopping criteria|5|||
13155317|NCT02504671|26065092|FG004|Overall Study|Protocol defined stopping criteria|3|||
13155318|NCT02504671|26065093|FG005|Overall Study|Protocol defined stopping criteria|3|||
13155319|NCT02504541|26065099|FG000|Overall Study|Adverse Event|4|||
13155320|NCT02504541|26065099|FG000|Overall Study|Withdrawal by Subject|4|||
13155321|NCT02504541|26065099|FG000|Overall Study|Lost to Follow-up|1|||
13155322|NCT02504541|26065099|FG000|Overall Study|Met Stopping Criteria|1|||
13155323|NCT02504541|26065099|FG000|Overall Study|Protocol Violation|2|||
13155324|NCT02504541|26065099|FG000|Overall Study|Termination by Sponsor|1|||
13155325|NCT02504541|26065099|FG000|Overall Study|Other|2|||
13155326|NCT02504541|26065099|FG000|Overall Study|Multiple|5|||
13155327|NCT02504502|26065112|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4|||
13155328|NCT02504502|26065113|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7|||
13155329|NCT02504502|26065112|FG000|Crossover to Enhanced Report|Lost to Follow-up|5|||
13155330|NCT02504502|26065113|FG001|Crossover to Enhanced Report|Lost to Follow-up|0|||
13155331|NCT02504424|26065120|FG000|Overall Study|Withdrawal by Subject|2|||
13155332|NCT02504320|26065151|FG000|Treatment Period 1|Positive Drug Screen|0|||
13155333|NCT02504320|26065152|FG001|Treatment Period 1|Positive Drug Screen|0|||
13155334|NCT02504320|26065153|FG002|Treatment Period 1|Positive Drug Screen|1|||
13155335|NCT02504320|26065154|FG003|Treatment Period 1|Positive Drug Screen|0|||
13155336|NCT02504320|26065151|FG000|Treatment Period 2|Positive Drug Screen|0|||
13155337|NCT02504320|26065152|FG001|Treatment Period 2|Positive Drug Screen|1|||
13155338|NCT02504320|26065153|FG002|Treatment Period 2|Positive Drug Screen|0|||
13155339|NCT02504320|26065154|FG003|Treatment Period 2|Positive Drug Screen|0|||
13155340|NCT02504320|26065151|FG000|Treatment Period 3|Positive Drug Screen|0|||
13155341|NCT02504320|26065152|FG001|Treatment Period 3|Positive Drug Screen|0|||
13155342|NCT02504320|26065153|FG002|Treatment Period 3|Positive Drug Screen|0|||
13155343|NCT02504320|26065154|FG003|Treatment Period 3|Positive Drug Screen|1|||
13155344|NCT02504320|26065151|FG000|Treatment Period 3|Adverse Event|0|||
13155345|NCT02504320|26065152|FG001|Treatment Period 3|Adverse Event|0|||
13155346|NCT02504320|26065153|FG002|Treatment Period 3|Adverse Event|1|||
13155347|NCT02504320|26065154|FG003|Treatment Period 3|Adverse Event|0|||
13155348|NCT02504294|26065169|FG000|Overall Study|Adverse Event|15|||
13155349|NCT02504294|26065170|FG001|Overall Study|Adverse Event|12|||
13155350|NCT02504294|26065169|FG000|Overall Study|Withdrawal by Subject|7|||
13155351|NCT02504294|26065170|FG001|Overall Study|Withdrawal by Subject|1|||
13155352|NCT02504294|26065169|FG000|Overall Study|Protocol Violation|27|||
13155353|NCT02504294|26065170|FG001|Overall Study|Protocol Violation|26|||
13155354|NCT02504294|26065169|FG000|Overall Study|Physician Decision|1|||
13155355|NCT02504294|26065170|FG001|Overall Study|Physician Decision|2|||
13155356|NCT02504294|26065169|FG000|Overall Study|Lost to Follow-up|6|||
13155357|NCT02504294|26065170|FG001|Overall Study|Lost to Follow-up|7|||
13155358|NCT02504268|26065242|FG000|Overall Study|Adverse Event|18|||
13155359|NCT02504268|26065243|FG001|Overall Study|Adverse Event|8|||
13155360|NCT02504268|26065244|FG002|Overall Study|Adverse Event|14|||
13155361|NCT02504268|26065245|FG003|Overall Study|Adverse Event|0|||
13155362|NCT02504268|26065246|FG004|Overall Study|Adverse Event|0|||
13155363|NCT02504268|26065247|FG005|Overall Study|Adverse Event|0|||
13155364|NCT02504268|26065248|FG006|Overall Study|Adverse Event|0|||
13155365|NCT02504268|26065249|FG007|Overall Study|Adverse Event|0|||
13155366|NCT02504268|26065250|FG008|Overall Study|Adverse Event|0|||
13155367|NCT02504268|26065242|FG000|Overall Study|Withdrawal of Consent|11|||
13155368|NCT02504268|26065243|FG001|Overall Study|Withdrawal of Consent|10|||
13155369|NCT02504268|26065244|FG002|Overall Study|Withdrawal of Consent|3|||
13155370|NCT02504268|26065245|FG003|Overall Study|Withdrawal of Consent|0|||
13155371|NCT02504268|26065246|FG004|Overall Study|Withdrawal of Consent|0|||
13155372|NCT02504268|26065247|FG005|Overall Study|Withdrawal of Consent|0|||
13155373|NCT02504268|26065248|FG006|Overall Study|Withdrawal of Consent|0|||
13155374|NCT02504268|26065249|FG007|Overall Study|Withdrawal of Consent|0|||
13155375|NCT02504268|26065250|FG008|Overall Study|Withdrawal of Consent|0|||
13155376|NCT02504268|26065242|FG000|Overall Study|Pregnancy|2|||
13155377|NCT02504268|26065243|FG001|Overall Study|Pregnancy|0|||
13155378|NCT02504268|26065244|FG002|Overall Study|Pregnancy|0|||
13155379|NCT02504268|26065245|FG003|Overall Study|Pregnancy|0|||
13155380|NCT02504268|26065246|FG004|Overall Study|Pregnancy|0|||
13155381|NCT02504268|26065247|FG005|Overall Study|Pregnancy|0|||
13155382|NCT02504268|26065248|FG006|Overall Study|Pregnancy|0|||
13155383|NCT02504268|26065249|FG007|Overall Study|Pregnancy|0|||
13155384|NCT02504268|26065250|FG008|Overall Study|Pregnancy|0|||
13155385|NCT02504268|26065242|FG000|Overall Study|Lost to Follow-up|3|||
13155386|NCT02504268|26065243|FG001|Overall Study|Lost to Follow-up|6|||
13155387|NCT02504268|26065244|FG002|Overall Study|Lost to Follow-up|4|||
13155388|NCT02504268|26065245|FG003|Overall Study|Lost to Follow-up|0|||
13155389|NCT02504268|26065246|FG004|Overall Study|Lost to Follow-up|0|||
13155390|NCT02504268|26065247|FG005|Overall Study|Lost to Follow-up|0|||
13155391|NCT02504268|26065248|FG006|Overall Study|Lost to Follow-up|0|||
13155392|NCT02504268|26065249|FG007|Overall Study|Lost to Follow-up|0|||
13155393|NCT02504268|26065250|FG008|Overall Study|Lost to Follow-up|0|||
13155394|NCT02504268|26065242|FG000|Overall Study|Death|1|||
13155395|NCT02504268|26065243|FG001|Overall Study|Death|1|||
13155396|NCT02504268|26065244|FG002|Overall Study|Death|0|||
13155397|NCT02504268|26065245|FG003|Overall Study|Death|0|||
13155398|NCT02504268|26065246|FG004|Overall Study|Death|0|||
13155399|NCT02504268|26065247|FG005|Overall Study|Death|0|||
13155400|NCT02504268|26065248|FG006|Overall Study|Death|0|||
13155401|NCT02504268|26065249|FG007|Overall Study|Death|0|||
13155402|NCT02504268|26065250|FG008|Overall Study|Death|0|||
13155403|NCT02504268|26065242|FG000|Overall Study|Subject Request to Discontinue|11|||
13155404|NCT02504268|26065243|FG001|Overall Study|Subject Request to Discontinue|3|||
13155405|NCT02504268|26065244|FG002|Overall Study|Subject Request to Discontinue|6|||
13155406|NCT02504268|26065245|FG003|Overall Study|Subject Request to Discontinue|0|||
13155407|NCT02504268|26065246|FG004|Overall Study|Subject Request to Discontinue|0|||
13155408|NCT02504268|26065247|FG005|Overall Study|Subject Request to Discontinue|0|||
13155409|NCT02504268|26065248|FG006|Overall Study|Subject Request to Discontinue|0|||
13155410|NCT02504268|26065249|FG007|Overall Study|Subject Request to Discontinue|0|||
13155411|NCT02504268|26065250|FG008|Overall Study|Subject Request to Discontinue|0|||
13155412|NCT02504268|26065242|FG000|Overall Study|No Longer Meets Study Criteria|2|||
13155413|NCT02504268|26065243|FG001|Overall Study|No Longer Meets Study Criteria|3|||
13155414|NCT02504268|26065244|FG002|Overall Study|No Longer Meets Study Criteria|0|||
13155415|NCT02504268|26065245|FG003|Overall Study|No Longer Meets Study Criteria|0|||
13155416|NCT02504268|26065246|FG004|Overall Study|No Longer Meets Study Criteria|0|||
13155417|NCT02504268|26065247|FG005|Overall Study|No Longer Meets Study Criteria|0|||
13155418|NCT02504268|26065248|FG006|Overall Study|No Longer Meets Study Criteria|0|||
13155419|NCT02504268|26065249|FG007|Overall Study|No Longer Meets Study Criteria|0|||
13155420|NCT02504268|26065250|FG008|Overall Study|No Longer Meets Study Criteria|0|||
13155421|NCT02504268|26065242|FG000|Overall Study|Lack of Efficacy|11|||
13155422|NCT02504268|26065243|FG001|Overall Study|Lack of Efficacy|35|||
13155423|NCT02504268|26065244|FG002|Overall Study|Lack of Efficacy|9|||
13155424|NCT02504268|26065245|FG003|Overall Study|Lack of Efficacy|0|||
13155425|NCT02504268|26065246|FG004|Overall Study|Lack of Efficacy|0|||
13155426|NCT02504268|26065247|FG005|Overall Study|Lack of Efficacy|0|||
13155427|NCT02504268|26065248|FG006|Overall Study|Lack of Efficacy|0|||
13155428|NCT02504268|26065249|FG007|Overall Study|Lack of Efficacy|0|||
13155429|NCT02504268|26065250|FG008|Overall Study|Lack of Efficacy|0|||
13155430|NCT02504268|26065242|FG000|Overall Study|Poor/Non-Compliance|3|||
13155431|NCT02504268|26065243|FG001|Overall Study|Poor/Non-Compliance|2|||
13155432|NCT02504268|26065244|FG002|Overall Study|Poor/Non-Compliance|3|||
13155433|NCT02504268|26065245|FG003|Overall Study|Poor/Non-Compliance|0|||
13155434|NCT02504268|26065246|FG004|Overall Study|Poor/Non-Compliance|0|||
13155435|NCT02504268|26065247|FG005|Overall Study|Poor/Non-Compliance|0|||
13155436|NCT02504268|26065248|FG006|Overall Study|Poor/Non-Compliance|0|||
13155437|NCT02504268|26065249|FG007|Overall Study|Poor/Non-Compliance|0|||
13155438|NCT02504268|26065250|FG008|Overall Study|Poor/Non-Compliance|0|||
13155439|NCT02504268|26065242|FG000|Overall Study|Not Disclosed|1|||
13155440|NCT02504268|26065243|FG001|Overall Study|Not Disclosed|0|||
13155441|NCT02504268|26065244|FG002|Overall Study|Not Disclosed|2|||
13155442|NCT02504268|26065245|FG003|Overall Study|Not Disclosed|0|||
13155443|NCT02504268|26065246|FG004|Overall Study|Not Disclosed|0|||
13155444|NCT02504268|26065247|FG005|Overall Study|Not Disclosed|0|||
13155445|NCT02504268|26065248|FG006|Overall Study|Not Disclosed|0|||
13155446|NCT02504268|26065249|FG007|Overall Study|Not Disclosed|0|||
13155447|NCT02504268|26065250|FG008|Overall Study|Not Disclosed|0|||
13155448|NCT02504216|26065283|FG000|Overall Study|Lost to Follow-up|3|||
13155449|NCT02504216|26065284|FG001|Overall Study|Lost to Follow-up|3|||
13155450|NCT02504216|26065283|FG000|Overall Study|Withdrawal by Subject|8|||
13155451|NCT02504216|26065284|FG001|Overall Study|Withdrawal by Subject|12|||
13155452|NCT02504151|26065303|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
13155453|NCT02504151|26065304|FG001|First Intervention (4 Weeks)|Physician Decision|1|||
13155454|NCT02504151|26065303|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
13155455|NCT02504151|26065304|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
13155456|NCT02504151|26065303|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
13155457|NCT02504151|26065304|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
13155458|NCT02504151|26065303|FG000|Second Intervention (4 Weeks)|Physician Decision|2|||
13155459|NCT02504151|26065304|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
13155460|NCT02503865|26065334|FG000|Overall Study|Moved out of area|1|||
13155461|NCT02503865|26065335|FG001|Overall Study|Moved out of area|8|||
13155462|NCT02503865|26065336|FG002|Overall Study|Moved out of area|0|||
13155463|NCT02503865|26065334|FG000|Overall Study|Refused treatment|4|||
13155464|NCT02503865|26065335|FG001|Overall Study|Refused treatment|39|||
13155465|NCT02503865|26065336|FG002|Overall Study|Refused treatment|2|||
13155466|NCT02503787|26065345|FG000|Enrollment|Withdrawal by Subject|6|||
13155467|NCT02503787|26065345|FG000|Enrollment|Inclusion/exclusion criteria not met|4|||
13155468|NCT02503787|26065345|FG000|Enrollment|Physician Decision|2|||
13155469|NCT02503787|26065345|FG000|Enrollment|Insurance issue|2|||
13155470|NCT02503787|26065345|FG000|Enrollment|Lost to Follow-up|1|||
13155471|NCT02503787|26065345|FG000|Enrollment|Study closure|1|||
13155472|NCT02503787|26065345|FG000|Enrollment|Adverse Event|1|||
13155473|NCT02503787|26065345|FG000|Enrollment|Protocol Violation|1|||
13155474|NCT02503787|26065345|FG000|Enrollment|Inability to implant system|1|||
13155475|NCT02503787|26065345|FG000|Enrollment|Unable to be programmed|1|||
13155476|NCT02503787|26065345|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6|||
13155477|NCT02503787|26065345|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1|||
13155478|NCT02503787|26065345|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3|||
13155479|NCT02503787|26065345|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2|||
13155480|NCT02503787|26065345|FG000|Implant to 3 Month Endpoint|Adverse Event|2|||
13155481|NCT02503787|26065345|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1|||
13155482|NCT02503540|26065367|FG000|Overall Study|Death|2|||
13205249|NCT01967173|26231279|FG006|Overall Study|Lost to Follow-up|6|||
13104079|NCT03345407|25874327|FG002|Overall Study|Lost to Follow-up|1|||
13104080|NCT03345407|25874328|FG003|Overall Study|Lost to Follow-up|0|||
13104081|NCT03345407|25874329|FG004|Overall Study|Lost to Follow-up|1|||
13104082|NCT03345407|25874330|FG005|Overall Study|Lost to Follow-up|2|||
13104083|NCT03345407|25874331|FG006|Overall Study|Lost to Follow-up|3|||
13104084|NCT03345407|25874325|FG000|Overall Study|Protocol-defined stopping criteria|9|||
13104085|NCT03345407|25874326|FG001|Overall Study|Protocol-defined stopping criteria|0|||
13104086|NCT03345407|25874327|FG002|Overall Study|Protocol-defined stopping criteria|0|||
13104087|NCT03345407|25874328|FG003|Overall Study|Protocol-defined stopping criteria|0|||
13104088|NCT03345407|25874329|FG004|Overall Study|Protocol-defined stopping criteria|2|||
13104089|NCT03345407|25874330|FG005|Overall Study|Protocol-defined stopping criteria|1|||
13104090|NCT03345407|25874331|FG006|Overall Study|Protocol-defined stopping criteria|1|||
13104091|NCT03345407|25874325|FG000|Overall Study|Protocol Violation|2|||
13104092|NCT03345407|25874326|FG001|Overall Study|Protocol Violation|0|||
13104093|NCT03345407|25874327|FG002|Overall Study|Protocol Violation|0|||
13104094|NCT03345407|25874328|FG003|Overall Study|Protocol Violation|0|||
13104095|NCT03345407|25874329|FG004|Overall Study|Protocol Violation|1|||
13104096|NCT03345407|25874330|FG005|Overall Study|Protocol Violation|0|||
13155483|NCT02503540|26065367|FG000|Overall Study|Withdrawal by Subject|1|||
13155484|NCT02503501|26065384|FG000|Overall Study|Physician Decision|1|||
13155485|NCT02503501|26065385|FG001|Overall Study|Physician Decision|0|||
13155486|NCT02503501|26065384|FG000|Overall Study|Protocol Violation|0|||
13155487|NCT02503501|26065385|FG001|Overall Study|Protocol Violation|1|||
13155488|NCT02503501|26065384|FG000|Overall Study|Withdrawal by Subject|0|||
13155489|NCT02503501|26065385|FG001|Overall Study|Withdrawal by Subject|2|||
13155490|NCT02503332|26065431|FG000|Overall Study|Adverse Event|17|||
13155491|NCT02503332|26065432|FG001|Overall Study|Adverse Event|5|||
13155492|NCT02503332|26065433|FG002|Overall Study|Adverse Event|3|||
13155493|NCT02503332|26065434|FG003|Overall Study|Adverse Event|1|||
13155494|NCT02503332|26065431|FG000|Overall Study|Investigator's Decision|5|||
13155495|NCT02503332|26065432|FG001|Overall Study|Investigator's Decision|1|||
13155496|NCT02503332|26065433|FG002|Overall Study|Investigator's Decision|0|||
13155497|NCT02503332|26065434|FG003|Overall Study|Investigator's Decision|0|||
13155498|NCT02503332|26065431|FG000|Overall Study|Sponsor's Decision|1|||
13155499|NCT02503332|26065432|FG001|Overall Study|Sponsor's Decision|0|||
13155500|NCT02503332|26065433|FG002|Overall Study|Sponsor's Decision|0|||
13155501|NCT02503332|26065434|FG003|Overall Study|Sponsor's Decision|1|||
13155502|NCT02503332|26065431|FG000|Overall Study|Subject Request|6|||
13155503|NCT02503332|26065432|FG001|Overall Study|Subject Request|5|||
13155504|NCT02503332|26065433|FG002|Overall Study|Subject Request|2|||
13155505|NCT02503332|26065434|FG003|Overall Study|Subject Request|1|||
13155506|NCT02503332|26065431|FG000|Overall Study|Death|0|||
13155507|NCT02503332|26065432|FG001|Overall Study|Death|2|||
13155508|NCT02503332|26065433|FG002|Overall Study|Death|2|||
13155509|NCT02503332|26065434|FG003|Overall Study|Death|0|||
13155510|NCT02503332|26065431|FG000|Overall Study|Other|5|||
13155511|NCT02503332|26065432|FG001|Overall Study|Other|6|||
13155512|NCT02503332|26065433|FG002|Overall Study|Other|1|||
13155513|NCT02503332|26065434|FG003|Overall Study|Other|1|||
13155514|NCT02503215|26065442|FG000|Overall Study|Unable to wear compression stockings|1|||
13155515|NCT02503215|26065442|FG000|Overall Study|Unable to use positive airway pressure|2|||
13155516|NCT02503202|26065500|FG000|Base Study: Up to Month 6|Death|1|||
13155517|NCT02503202|26065501|FG001|Base Study: Up to Month 6|Death|1|||
13155518|NCT02503202|26065502|FG002|Base Study: Up to Month 6|Death|0|||
13155519|NCT02503202|26065503|FG003|Base Study: Up to Month 6|Death|0|||
13155520|NCT02503202|26065504|FG004|Base Study: Up to Month 6|Death|0|||
13155521|NCT02503202|26065500|FG000|Base Study: Up to Month 6|Lost to Follow-up|11|||
13155522|NCT02503202|26065501|FG001|Base Study: Up to Month 6|Lost to Follow-up|8|||
13155523|NCT02503202|26065502|FG002|Base Study: Up to Month 6|Lost to Follow-up|10|||
13155524|NCT02503202|26065503|FG003|Base Study: Up to Month 6|Lost to Follow-up|5|||
13155525|NCT02503202|26065504|FG004|Base Study: Up to Month 6|Lost to Follow-up|1|||
13155526|NCT02503202|26065500|FG000|Base Study: Up to Month 6|Physician Decision|0|||
13155527|NCT02503202|26065501|FG001|Base Study: Up to Month 6|Physician Decision|0|||
13155528|NCT02503202|26065502|FG002|Base Study: Up to Month 6|Physician Decision|0|||
13155529|NCT02503202|26065503|FG003|Base Study: Up to Month 6|Physician Decision|0|||
13155530|NCT02503202|26065504|FG004|Base Study: Up to Month 6|Physician Decision|1|||
13155531|NCT02503202|26065500|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6|||
13155532|NCT02503202|26065501|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3|||
13155533|NCT02503202|26065502|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4|||
13155534|NCT02503202|26065503|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4|||
13155535|NCT02503202|26065504|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1|||
13155536|NCT02503202|26065500|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0|||
13155537|NCT02503202|26065501|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0|||
13155538|NCT02503202|26065502|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1|||
13155539|NCT02503202|26065503|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2|||
13104097|NCT03345407|25874331|FG006|Overall Study|Protocol Violation|3|||
13104098|NCT03345407|25874325|FG000|Overall Study|Lack of Efficacy|1|||
13104099|NCT03345407|25874326|FG001|Overall Study|Lack of Efficacy|1|||
13104100|NCT03345407|25874327|FG002|Overall Study|Lack of Efficacy|1|||
13104101|NCT03345407|25874328|FG003|Overall Study|Lack of Efficacy|1|||
13104102|NCT03345407|25874329|FG004|Overall Study|Lack of Efficacy|1|||
13104103|NCT03345407|25874330|FG005|Overall Study|Lack of Efficacy|0|||
13104104|NCT03345407|25874331|FG006|Overall Study|Lack of Efficacy|3|||
13104105|NCT03345407|25874325|FG000|Overall Study|Adverse Event|4|||
13155540|NCT02503202|26065504|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0|||
13155541|NCT02503202|26065500|FG000|Extension: Month 6 to 24|Protocol Violation|0|||
13155542|NCT02503202|26065501|FG001|Extension: Month 6 to 24|Protocol Violation|0|||
13155543|NCT02503202|26065502|FG002|Extension: Month 6 to 24|Protocol Violation|0|||
13155544|NCT02503202|26065503|FG003|Extension: Month 6 to 24|Protocol Violation|1|||
13155545|NCT02503202|26065504|FG004|Extension: Month 6 to 24|Protocol Violation|0|||
13155546|NCT02503202|26065500|FG000|Extension: Month 6 to 24|Death|1|||
13155547|NCT02503202|26065501|FG001|Extension: Month 6 to 24|Death|0|||
13155548|NCT02503202|26065502|FG002|Extension: Month 6 to 24|Death|0|||
13104106|NCT03345407|25874326|FG001|Overall Study|Adverse Event|0|||
13104107|NCT03345407|25874327|FG002|Overall Study|Adverse Event|5|||
13104108|NCT03345407|25874328|FG003|Overall Study|Adverse Event|4|||
13104109|NCT03345407|25874329|FG004|Overall Study|Adverse Event|6|||
13104110|NCT03345407|25874330|FG005|Overall Study|Adverse Event|5|||
13104111|NCT03345407|25874331|FG006|Overall Study|Adverse Event|16|||
13104112|NCT03344640|25874365|FG000|Overall Study|Adverse Event|1|||
13104113|NCT03344640|25874366|FG001|Overall Study|Adverse Event|0|||
13104114|NCT03344640|25874365|FG000|Overall Study|Physician Decision|1|||
13104115|NCT03344640|25874366|FG001|Overall Study|Physician Decision|1|||
13104116|NCT03344640|25874365|FG000|Overall Study|Withdrawal by Subject|1|||
13104117|NCT03344640|25874366|FG001|Overall Study|Withdrawal by Subject|2|||
13104118|NCT03344640|25874365|FG000|Follow-up Epoch|Withdrawal by Subject|0|||
13104119|NCT03344640|25874366|FG001|Follow-up Epoch|Withdrawal by Subject|2|||
13104120|NCT03344562|25874383|FG000|Overall Study|Withdrawal by Subject|2|||
13104121|NCT03344562|25874384|FG001|Overall Study|Withdrawal by Subject|0|||
13104122|NCT03344172|25874407|FG000|Overall Study|Received <1 dose of treatment|1|||
13104123|NCT03344172|25874408|FG001|Overall Study|Received <1 dose of treatment|0|||
13104124|NCT03343639|25874427|FG000|Overall Study|Withdrawal by Subject|10|||
13104125|NCT03343639|25874428|FG001|Overall Study|Withdrawal by Subject|6|||
13104126|NCT03343639|25874427|FG000|Overall Study|Lost to Follow-up|4|||
13104127|NCT03343639|25874428|FG001|Overall Study|Lost to Follow-up|5|||
13104128|NCT03343639|25874427|FG000|Overall Study|Protocol Violation|0|||
13104129|NCT03343639|25874428|FG001|Overall Study|Protocol Violation|1|||
13104130|NCT03343626|25874575|FG000|Overall Study|Lost to Follow-up|4|||
13104131|NCT03343626|25874576|FG001|Overall Study|Lost to Follow-up|3|||
13104132|NCT03343626|25874577|FG002|Overall Study|Lost to Follow-up|2|||
13104133|NCT03343626|25874578|FG003|Overall Study|Lost to Follow-up|5|||
13104134|NCT03343626|25874579|FG004|Overall Study|Lost to Follow-up|4|||
13104135|NCT03343626|25874580|FG005|Overall Study|Lost to Follow-up|4|||
13104136|NCT03343626|25874581|FG006|Overall Study|Lost to Follow-up|4|||
13104137|NCT03343626|25874582|FG007|Overall Study|Lost to Follow-up|7|||
13104138|NCT03343626|25874575|FG000|Overall Study|Withdrawal of Consent|2|||
13104139|NCT03343626|25874576|FG001|Overall Study|Withdrawal of Consent|1|||
13104140|NCT03343626|25874577|FG002|Overall Study|Withdrawal of Consent|0|||
13104141|NCT03343626|25874578|FG003|Overall Study|Withdrawal of Consent|3|||
13104142|NCT03343626|25874579|FG004|Overall Study|Withdrawal of Consent|3|||
13104143|NCT03343626|25874580|FG005|Overall Study|Withdrawal of Consent|1|||
13104144|NCT03343626|25874581|FG006|Overall Study|Withdrawal of Consent|1|||
13104145|NCT03343626|25874582|FG007|Overall Study|Withdrawal of Consent|2|||
13104146|NCT03343626|25874575|FG000|Overall Study|Reason not Specified|0|||
13104147|NCT03343626|25874576|FG001|Overall Study|Reason not Specified|1|||
13104148|NCT03343626|25874577|FG002|Overall Study|Reason not Specified|0|||
13104149|NCT03343626|25874578|FG003|Overall Study|Reason not Specified|0|||
13104150|NCT03343626|25874579|FG004|Overall Study|Reason not Specified|0|||
13104151|NCT03343626|25874580|FG005|Overall Study|Reason not Specified|0|||
13104152|NCT03343626|25874581|FG006|Overall Study|Reason not Specified|0|||
13104153|NCT03343626|25874582|FG007|Overall Study|Reason not Specified|1|||
13104154|NCT03343626|25874575|FG000|Overall Study|Data Entry Error|0|||
13104155|NCT03343626|25874576|FG001|Overall Study|Data Entry Error|0|||
13104156|NCT03343626|25874577|FG002|Overall Study|Data Entry Error|0|||
13104157|NCT03343626|25874578|FG003|Overall Study|Data Entry Error|0|||
13104158|NCT03343626|25874579|FG004|Overall Study|Data Entry Error|0|||
13104159|NCT03343626|25874580|FG005|Overall Study|Data Entry Error|0|||
13104160|NCT03343626|25874581|FG006|Overall Study|Data Entry Error|0|||
13104161|NCT03343626|25874582|FG007|Overall Study|Data Entry Error|1|||
13104162|NCT03343067|25874717|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0|||
13104163|NCT03343067|25874718|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3|||
13104164|NCT03343067|25874719|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1|||
13104165|NCT03343054|25874801|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2|||
13104166|NCT03343054|25874802|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6|||
13104167|NCT03343054|25874803|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0|||
13104168|NCT03343054|25874801|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1|||
13104169|NCT03343054|25874802|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
13104170|NCT03343054|25874803|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
13104171|NCT03343054|25874801|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
13104172|NCT03343054|25874802|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
13104173|NCT03343054|25874803|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11|||
13104174|NCT03343054|25874801|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
13104175|NCT03343054|25874802|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
13104176|NCT03343054|25874803|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8|||
13104177|NCT03342963|25874830|FG000|Overall Study|Adverse Event|1|||
13104178|NCT03342963|25874831|FG001|Overall Study|Adverse Event|2|||
13104179|NCT03342963|25874832|FG002|Overall Study|Adverse Event|0|||
13104180|NCT03342963|25874833|FG003|Overall Study|Adverse Event|0|||
13155549|NCT02503202|26065503|FG003|Extension: Month 6 to 24|Death|0|||
13155550|NCT02503202|26065504|FG004|Extension: Month 6 to 24|Death|0|||
13155551|NCT02503202|26065500|FG000|Extension: Month 6 to 24|Lost to Follow-up|4|||
13155552|NCT02503202|26065501|FG001|Extension: Month 6 to 24|Lost to Follow-up|8|||
13155553|NCT02503202|26065502|FG002|Extension: Month 6 to 24|Lost to Follow-up|6|||
13155554|NCT02503202|26065503|FG003|Extension: Month 6 to 24|Lost to Follow-up|10|||
13155555|NCT02503202|26065504|FG004|Extension: Month 6 to 24|Lost to Follow-up|1|||
13155556|NCT02503202|26065500|FG000|Extension: Month 6 to 24|Physician Decision|1|||
13155557|NCT02503202|26065501|FG001|Extension: Month 6 to 24|Physician Decision|0|||
13155558|NCT02503202|26065502|FG002|Extension: Month 6 to 24|Physician Decision|1|||
13155559|NCT02503202|26065503|FG003|Extension: Month 6 to 24|Physician Decision|3|||
13155560|NCT02503202|26065504|FG004|Extension: Month 6 to 24|Physician Decision|0|||
13155561|NCT02503202|26065500|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5|||
13155562|NCT02503202|26065501|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8|||
13155563|NCT02503202|26065502|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2|||
13155564|NCT02503202|26065503|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4|||
13155565|NCT02503202|26065504|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0|||
13155566|NCT02503085|26065548|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
13155567|NCT02503085|26065549|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
13155568|NCT02503085|26065550|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
13155569|NCT02503085|26065551|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
13155570|NCT02502864|26065562|FG000|Overall Study|Withdrawal by Subject|1|||
13155571|NCT02502734|26065573|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
13155572|NCT02502734|26065574|FG001|Double-blind Treatment Period 1|Adverse Event|0|||
13155573|NCT02502734|26065573|FG000|Washout Period|Adverse Event|1|||
13155574|NCT02502734|26065574|FG001|Washout Period|Adverse Event|0|||
13155575|NCT02502526|26065597|FG000|Overall Study|Lost to Follow-up|2|||
13104181|NCT03342963|25874830|FG000|Overall Study|Withdrawal by Subject|1|||
13104182|NCT03342963|25874831|FG001|Overall Study|Withdrawal by Subject|0|||
13104183|NCT03342963|25874832|FG002|Overall Study|Withdrawal by Subject|0|||
13104184|NCT03342963|25874833|FG003|Overall Study|Withdrawal by Subject|0|||
13104185|NCT03342898|25874884|FG000|Overall Study|Adverse Event|3|||
13104186|NCT03342898|25874885|FG001|Overall Study|Adverse Event|1|||
13104187|NCT03342898|25874886|FG002|Overall Study|Adverse Event|0|||
13104188|NCT03342898|25874884|FG000|Overall Study|Lost to Follow-up|44|||
13104189|NCT03342898|25874885|FG001|Overall Study|Lost to Follow-up|40|||
13104190|NCT03342898|25874886|FG002|Overall Study|Lost to Follow-up|42|||
13104191|NCT03342898|25874884|FG000|Overall Study|Withdrawal of Consent|5|||
13104192|NCT03342898|25874885|FG001|Overall Study|Withdrawal of Consent|9|||
13104193|NCT03342898|25874886|FG002|Overall Study|Withdrawal of Consent|11|||
13104194|NCT03342898|25874884|FG000|Overall Study|Death|0|||
13104195|NCT03342898|25874885|FG001|Overall Study|Death|1|||
13104196|NCT03342898|25874886|FG002|Overall Study|Death|1|||
13104197|NCT03342898|25874884|FG000|Overall Study|Reason not Specified|2|||
13104198|NCT03342898|25874885|FG001|Overall Study|Reason not Specified|2|||
13104199|NCT03342898|25874886|FG002|Overall Study|Reason not Specified|0|||
13104200|NCT03342690|25874897|FG000|Overall Study|Missing Information|9|||
13104201|NCT03342690|25874897|FG000|Overall Study|Protocol Violation|16|||
13104202|NCT03342638|25874910|FG000|Overall Study|Withdrawal by Subject|1|||
13104203|NCT03342638|25874911|FG001|Overall Study|Withdrawal by Subject|0|||
13104204|NCT03342638|25874910|FG000|Overall Study|Physician Decision|0|||
13104205|NCT03342638|25874911|FG001|Overall Study|Physician Decision|1|||
13104206|NCT03342560|25874921|FG000|Overall Study|Lost to Follow-up|2|||
13104207|NCT03342469|25874946|FG000|Overall Study|Withdrawal by Subject|0|||
13104208|NCT03342469|25874947|FG001|Overall Study|Withdrawal by Subject|1|||
13104209|NCT03342469|25874948|FG002|Overall Study|Withdrawal by Subject|0|||
13104210|NCT03342469|25874949|FG003|Overall Study|Withdrawal by Subject|0|||
13104211|NCT03342001|25874955|FG000|Overall Study|Adverse Event|1|||
13104212|NCT03342001|25874955|FG000|Overall Study|Lost to Follow-up|1|||
13155576|NCT02502526|26065598|FG001|Overall Study|Lost to Follow-up|2|||
13155577|NCT02502526|26065599|FG002|Overall Study|Lost to Follow-up|3|||
13155578|NCT02502526|26065597|FG000|Overall Study|Withdrawal by Subject|0|||
13155579|NCT02502526|26065598|FG001|Overall Study|Withdrawal by Subject|1|||
13155580|NCT02502526|26065599|FG002|Overall Study|Withdrawal by Subject|1|||
13155581|NCT02502526|26065597|FG000|Overall Study|Disqualified due to cataract grading|0|||
13155582|NCT02502526|26065598|FG001|Overall Study|Disqualified due to cataract grading|0|||
13155583|NCT02502526|26065599|FG002|Overall Study|Disqualified due to cataract grading|1|||
13155584|NCT02502526|26065597|FG000|Overall Study|Enrollment suspension|4|||
13155585|NCT02502526|26065598|FG001|Overall Study|Enrollment suspension|1|||
13155586|NCT02502526|26065599|FG002|Overall Study|Enrollment suspension|1|||
13155587|NCT02502149|26065724|FG000|Intermediate|Discontinued prematurely|1|||
13155588|NCT02502149|26065725|FG001|Intermediate|Discontinued prematurely|0|||
13104213|NCT03341923|25874966|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0|||
13155589|NCT02502149|26065726|FG002|Intermediate|Discontinued prematurely|0|||
13155590|NCT02502149|26065727|FG003|Intermediate|Discontinued prematurely|0|||
13155591|NCT02502149|26065728|FG004|Intermediate|Discontinued prematurely|0|||
13155592|NCT02502097|26065818|FG000|Period 1|Adverse Event|0|||
13155593|NCT02502097|26065819|FG001|Period 1|Adverse Event|0|||
13155594|NCT02502097|26065820|FG002|Period 1|Adverse Event|1|||
13155595|NCT02502097|26065821|FG003|Period 1|Adverse Event|0|||
13155596|NCT02502097|26065818|FG000|Wash Out Period|Adverse Event|0|||
13155597|NCT02502097|26065819|FG001|Wash Out Period|Adverse Event|1|||
13155598|NCT02502097|26065820|FG002|Wash Out Period|Adverse Event|1|||
13155599|NCT02502097|26065821|FG003|Wash Out Period|Adverse Event|1|||
13155600|NCT02502097|26065818|FG000|Period 2|Adverse Event|0|||
13155601|NCT02502097|26065819|FG001|Period 2|Adverse Event|0|||
13155602|NCT02502097|26065820|FG002|Period 2|Adverse Event|1|||
13155603|NCT02502097|26065821|FG003|Period 2|Adverse Event|0|||
13155604|NCT02501928|26066052|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
13155605|NCT02501928|26066053|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
13155606|NCT02501928|26066054|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
13155607|NCT02501928|26066055|FG003|Overall Study|Withdrawal By Parent/Guardian|0|||
13104214|NCT03341923|25874967|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1|||
13155608|NCT02501928|26066056|FG004|Overall Study|Withdrawal By Parent/Guardian|1|||
13155609|NCT02501928|26066057|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
13155610|NCT02501902|26066343|FG000|Overall Study|Subject Refused Further Follow-up|0|||
13155611|NCT02501902|26066344|FG001|Overall Study|Subject Refused Further Follow-up|0|||
13155612|NCT02501902|26066345|FG002|Overall Study|Subject Refused Further Follow-up|0|||
13155613|NCT02501902|26066346|FG003|Overall Study|Subject Refused Further Follow-up|0|||
13155614|NCT02501902|26066347|FG004|Overall Study|Subject Refused Further Follow-up|0|||
13155615|NCT02501902|26066348|FG005|Overall Study|Subject Refused Further Follow-up|0|||
13104215|NCT03341637|25874996|FG000|Overall Study|Lost to Follow-up|1|||
13104216|NCT03341637|25874997|FG001|Overall Study|Lost to Follow-up|0|||
13104217|NCT03341637|25874996|FG000|Overall Study|Withdrawal by Subject|3|||
13104218|NCT03341637|25874997|FG001|Overall Study|Withdrawal by Subject|3|||
13104219|NCT03341637|25874996|FG000|Overall Study|Reason not Specified|1|||
13104220|NCT03341637|25874997|FG001|Overall Study|Reason not Specified|1|||
13104221|NCT03341533|25875016|FG000|Overall Study|Withdrawal by Subject|1|||
13104222|NCT03341533|25875017|FG001|Overall Study|Withdrawal by Subject|1|||
13104223|NCT03341533|25875016|FG000|Overall Study|Not eligible after randomization|2|||
13104224|NCT03341533|25875017|FG001|Overall Study|Not eligible after randomization|1|||
13104225|NCT03341507|25875026|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34|||
13104226|NCT03341312|25875043|FG000|Period 1|Withdrawal by Subject|0|||
13104227|NCT03341312|25875044|FG001|Period 1|Withdrawal by Subject|1|||
13104228|NCT03341312|25875045|FG002|Period 1|Withdrawal by Subject|0|||
13104229|NCT03341312|25875046|FG003|Period 1|Withdrawal by Subject|0|||
13104230|NCT03341299|25875063|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
13104231|NCT03341299|25875064|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
13104232|NCT03341299|25875065|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1|||
13104233|NCT03341299|25875066|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
13104234|NCT03341273|25875115|FG000|Overall Study|Lost to Follow-up|7|||
13104235|NCT03341273|25875116|FG001|Overall Study|Lost to Follow-up|7|||
13104236|NCT03341273|25875115|FG000|Overall Study|Withdrawal by Subject|4|||
13104237|NCT03341273|25875116|FG001|Overall Study|Withdrawal by Subject|2|||
13104238|NCT03341273|25875115|FG000|Overall Study|Physician Decision|1|||
13104239|NCT03341273|25875116|FG001|Overall Study|Physician Decision|0|||
13104240|NCT03341273|25875115|FG000|Overall Study|Protocol Violation|0|||
13104241|NCT03341273|25875116|FG001|Overall Study|Protocol Violation|1|||
13104242|NCT03341273|25875115|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
13104243|NCT03341273|25875116|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
13104244|NCT03341273|25875115|FG000|Overall Study|Became ineligible after enrollment|1|||
13104245|NCT03341273|25875116|FG001|Overall Study|Became ineligible after enrollment|0|||
13104246|NCT03341273|25875115|FG000|Overall Study|Not Eligible at Enrollment|0|||
13104247|NCT03341273|25875116|FG001|Overall Study|Not Eligible at Enrollment|1|||
13104248|NCT03341273|25875115|FG000|Overall Study|Participant incarcerated|1|||
13104249|NCT03341273|25875116|FG001|Overall Study|Participant incarcerated|0|||
13155616|NCT02501902|26066349|FG006|Overall Study|Subject Refused Further Follow-up|0|||
13155617|NCT02501902|26066350|FG007|Overall Study|Subject Refused Further Follow-up|1|||
13104250|NCT03340961|25875147|FG000|Overall Study|Adverse Event|1|||
13104251|NCT03340961|25875148|FG001|Overall Study|Adverse Event|3|||
13104252|NCT03340961|25875149|FG002|Overall Study|Adverse Event|2|||
13104253|NCT03340961|25875150|FG003|Overall Study|Adverse Event|4|||
13104254|NCT03340961|25875147|FG000|Overall Study|Lost to Follow-up|0|||
13104255|NCT03340961|25875148|FG001|Overall Study|Lost to Follow-up|1|||
13104256|NCT03340961|25875149|FG002|Overall Study|Lost to Follow-up|0|||
13104257|NCT03340961|25875150|FG003|Overall Study|Lost to Follow-up|1|||
13104258|NCT03340961|25875147|FG000|Overall Study|Withdrawal by Subject|3|||
13104259|NCT03340961|25875148|FG001|Overall Study|Withdrawal by Subject|2|||
13155618|NCT02501902|26066343|FG000|Overall Study|Study Terminated by Sponsor|0|||
13155619|NCT02501902|26066344|FG001|Overall Study|Study Terminated by Sponsor|3|||
13155620|NCT02501902|26066345|FG002|Overall Study|Study Terminated by Sponsor|0|||
13104260|NCT03340961|25875149|FG002|Overall Study|Withdrawal by Subject|4|||
13104261|NCT03340961|25875150|FG003|Overall Study|Withdrawal by Subject|7|||
13104262|NCT03340961|25875147|FG000|Overall Study|Use of prohibited treatment|0|||
13104263|NCT03340961|25875148|FG001|Overall Study|Use of prohibited treatment|3|||
13104264|NCT03340961|25875149|FG002|Overall Study|Use of prohibited treatment|2|||
13104265|NCT03340961|25875150|FG003|Overall Study|Use of prohibited treatment|4|||
13104266|NCT03340961|25875147|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
13104267|NCT03340961|25875148|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
13104268|NCT03340961|25875149|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
13104269|NCT03340961|25875150|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
13104270|NCT03340961|25875147|FG000|Overall Study|Subject developed an exclusion criterion|0|||
13104271|NCT03340961|25875148|FG001|Overall Study|Subject developed an exclusion criterion|1|||
13104272|NCT03340961|25875149|FG002|Overall Study|Subject developed an exclusion criterion|0|||
13104273|NCT03340961|25875150|FG003|Overall Study|Subject developed an exclusion criterion|0|||
13104274|NCT03340961|25875147|FG000|Overall Study|Protocol Violation|1|||
13104275|NCT03340961|25875148|FG001|Overall Study|Protocol Violation|0|||
13104276|NCT03340961|25875149|FG002|Overall Study|Protocol Violation|1|||
13104277|NCT03340961|25875150|FG003|Overall Study|Protocol Violation|0|||
13104278|NCT03340961|25875147|FG000|Overall Study|Adverse Event|1|||
13104279|NCT03340961|25875148|FG001|Overall Study|Adverse Event|1|||
13104280|NCT03340961|25875149|FG002|Overall Study|Adverse Event|0|||
13104281|NCT03340961|25875150|FG003|Overall Study|Adverse Event|0|||
13155621|NCT02501902|26066346|FG003|Overall Study|Study Terminated by Sponsor|1|||
13155622|NCT02501902|26066347|FG004|Overall Study|Study Terminated by Sponsor|1|||
13155623|NCT02501902|26066348|FG005|Overall Study|Study Terminated by Sponsor|0|||
13155624|NCT02501902|26066349|FG006|Overall Study|Study Terminated by Sponsor|2|||
13155625|NCT02501902|26066350|FG007|Overall Study|Study Terminated by Sponsor|4|||
13155626|NCT02501902|26066343|FG000|Overall Study|Death|3|||
13155627|NCT02501902|26066344|FG001|Overall Study|Death|4|||
13104282|NCT03340961|25875147|FG000|Overall Study|Lack of Efficacy|0|||
13104283|NCT03340961|25875148|FG001|Overall Study|Lack of Efficacy|0|||
13104284|NCT03340961|25875149|FG002|Overall Study|Lack of Efficacy|0|||
13104285|NCT03340961|25875150|FG003|Overall Study|Lack of Efficacy|1|||
13104286|NCT03340025|25875163|FG000|Overall Study|Lost to Follow-up|2|||
13104287|NCT03340025|25875164|FG001|Overall Study|Lost to Follow-up|2|||
13104288|NCT03339999|25875218|FG000|Overall Study|Adverse Event|1|||
13104289|NCT03339999|25875219|FG001|Overall Study|Adverse Event|2|||
13104290|NCT03339999|25875220|FG002|Overall Study|Adverse Event|2|||
13104291|NCT03339999|25875221|FG003|Overall Study|Adverse Event|1|||
13104292|NCT03339999|25875218|FG000|Overall Study|Lack of Efficacy|0|||
13104293|NCT03339999|25875219|FG001|Overall Study|Lack of Efficacy|1|||
13104294|NCT03339999|25875220|FG002|Overall Study|Lack of Efficacy|0|||
13104295|NCT03339999|25875221|FG003|Overall Study|Lack of Efficacy|0|||
13104296|NCT03339999|25875218|FG000|Overall Study|Lost to Follow-up|0|||
13104297|NCT03339999|25875219|FG001|Overall Study|Lost to Follow-up|0|||
13104298|NCT03339999|25875220|FG002|Overall Study|Lost to Follow-up|0|||
13104299|NCT03339999|25875221|FG003|Overall Study|Lost to Follow-up|1|||
13104300|NCT03339999|25875218|FG000|Overall Study|Study Terminated by Sponsor|6|||
13104301|NCT03339999|25875219|FG001|Overall Study|Study Terminated by Sponsor|3|||
13104302|NCT03339999|25875220|FG002|Overall Study|Study Terminated by Sponsor|4|||
13104303|NCT03339999|25875221|FG003|Overall Study|Study Terminated by Sponsor|3|||
13104304|NCT03339726|25875287|FG000|Overall Study|Withdrawal by Subject|1|||
13104305|NCT03339726|25875288|FG001|Overall Study|Withdrawal by Subject|0|||
13104306|NCT03339726|25875289|FG002|Overall Study|Withdrawal by Subject|0|||
13104307|NCT03339726|25875287|FG000|Overall Study|Lost to Follow-up|0|||
13104308|NCT03339726|25875288|FG001|Overall Study|Lost to Follow-up|1|||
13104309|NCT03339726|25875289|FG002|Overall Study|Lost to Follow-up|0|||
13104310|NCT03339713|25875322|FG000|Overall Study|Lost to Follow-up|2|||
13104311|NCT03339713|25875323|FG001|Overall Study|Lost to Follow-up|1|||
13104312|NCT03339713|25875322|FG000|Overall Study|Protocol Violation|1|||
13104313|NCT03339713|25875323|FG001|Overall Study|Protocol Violation|0|||
13104314|NCT03339713|25875322|FG000|Overall Study|Withdrawal by Subject|1|||
13104315|NCT03339713|25875323|FG001|Overall Study|Withdrawal by Subject|1|||
13104316|NCT03339583|25875368|FG000|First Intervention (14 Days)|Adverse Event|1|||
13104317|NCT03339583|25875369|FG001|First Intervention (14 Days)|Adverse Event|0|||
13104318|NCT03339583|25875368|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0|||
13104319|NCT03339583|25875369|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1|||
13104320|NCT03339583|25875368|FG000|Second Intervention (14 Days)|Adverse Event|0|||
13104321|NCT03339583|25875369|FG001|Second Intervention (14 Days)|Adverse Event|1|||
13104322|NCT03339583|25875368|FG000|Follow-up (14 Days)|Physician Decision|6|||
13104323|NCT03339583|25875369|FG001|Follow-up (14 Days)|Physician Decision|3|||
13104324|NCT03339453|25875388|FG000|First Visit of Glucagon Treatment|Adverse Event|0|||
13104325|NCT03339453|25875389|FG001|First Visit of Glucagon Treatment|Adverse Event|1|||
13104326|NCT03339401|25875402|FG000|Overall Study|Death|2|||
13104327|NCT03339401|25875403|FG001|Overall Study|Death|1|||
13155628|NCT02501902|26066345|FG002|Overall Study|Death|4|||
13104328|NCT03339401|25875402|FG000|Overall Study|Withdrawal by Subject|2|||
13104329|NCT03339401|25875403|FG001|Overall Study|Withdrawal by Subject|0|||
13104330|NCT03339401|25875402|FG000|Overall Study|Study terminated|4|||
13104331|NCT03339401|25875403|FG001|Overall Study|Study terminated|3|||
13104332|NCT03339401|25875402|FG000|Overall Study|Investigator Decision|1|||
13104333|NCT03339401|25875403|FG001|Overall Study|Investigator Decision|0|||
13104334|NCT03339297|25875466|FG000|Overall Study|Relapse of Hematologic Disease|1|||
13104335|NCT03339297|25875467|FG001|Overall Study|Relapse of Hematologic Disease|0|||
13104336|NCT03339297|25875466|FG000|Overall Study|Death|10|||
13104337|NCT03339297|25875467|FG001|Overall Study|Death|7|||
13104338|NCT03339297|25875466|FG000|Overall Study|Hepatic Candidosis|1|||
13104339|NCT03339297|25875467|FG001|Overall Study|Hepatic Candidosis|0|||
13104340|NCT03339297|25875466|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
13104341|NCT03339297|25875467|FG001|Overall Study|Adverse Event, Serious Fatal|2|||
13104342|NCT03339297|25875466|FG000|Overall Study|Consent Withdrawn by Participant|3|||
13104343|NCT03339297|25875467|FG001|Overall Study|Consent Withdrawn by Participant|3|||
13104344|NCT03339297|25875466|FG000|Overall Study|Disease Relapse|2|||
13104345|NCT03339297|25875467|FG001|Overall Study|Disease Relapse|0|||
13104346|NCT03339297|25875466|FG000|Overall Study|Physician Decision|1|||
13104347|NCT03339297|25875467|FG001|Overall Study|Physician Decision|1|||
13104348|NCT03339297|25875466|FG000|Overall Study|Relapse of Disease New Transplant Performed|1|||
13104349|NCT03339297|25875467|FG001|Overall Study|Relapse of Disease New Transplant Performed|0|||
13104350|NCT03339297|25875466|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1|||
13104351|NCT03339297|25875467|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0|||
13104352|NCT03339297|25875466|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1|||
13104353|NCT03339297|25875467|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0|||
13104354|NCT03339297|25875466|FG000|Overall Study|Adverse Event, Non-fatal|1|||
13104355|NCT03339297|25875467|FG001|Overall Study|Adverse Event, Non-fatal|0|||
13104356|NCT03339297|25875466|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0|||
13104357|NCT03339297|25875467|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1|||
13104358|NCT03339297|25875466|FG000|Overall Study|Patient Was Not Eligible|1|||
13104359|NCT03339297|25875467|FG001|Overall Study|Patient Was Not Eligible|0|||
13155629|NCT02501902|26066346|FG003|Overall Study|Death|10|||
13155630|NCT02501902|26066347|FG004|Overall Study|Death|10|||
13155631|NCT02501902|26066348|FG005|Overall Study|Death|11|||
13155632|NCT02501902|26066349|FG006|Overall Study|Death|7|||
13155633|NCT02501902|26066350|FG007|Overall Study|Death|15|||
13155634|NCT02501811|26066505|FG000|Overall Study|Death|1|||
13155635|NCT02501811|26066506|FG001|Overall Study|Death|3|||
13155636|NCT02501811|26066507|FG002|Overall Study|Death|2|||
13155637|NCT02501811|26066508|FG003|Overall Study|Death|3|||
13155638|NCT02501811|26066505|FG000|Overall Study|Withdrawal by Subject|3|||
13155639|NCT02501811|26066506|FG001|Overall Study|Withdrawal by Subject|3|||
13155640|NCT02501811|26066507|FG002|Overall Study|Withdrawal by Subject|2|||
13155641|NCT02501811|26066508|FG003|Overall Study|Withdrawal by Subject|3|||
13155642|NCT02501811|26066505|FG000|Overall Study|Lost to Follow-up|0|||
13155643|NCT02501811|26066506|FG001|Overall Study|Lost to Follow-up|0|||
13155644|NCT02501811|26066507|FG002|Overall Study|Lost to Follow-up|2|||
13155645|NCT02501811|26066508|FG003|Overall Study|Lost to Follow-up|1|||
13155646|NCT02501642|26066521|FG000|Overall Study|Lost to Follow-up|7|||
13155647|NCT02501642|26066522|FG001|Overall Study|Lost to Follow-up|11|||
13155648|NCT02501629|26066551|FG000|Overall Study|Death|0|||
13155649|NCT02501629|26066552|FG001|Overall Study|Death|1|||
13155650|NCT02501629|26066551|FG000|Overall Study|Withdrawn from study by sponsor|1|||
13155651|NCT02501629|26066552|FG001|Overall Study|Withdrawn from study by sponsor|0|||
13155652|NCT02501629|26066551|FG000|Overall Study|Early termination by sponsor|1|||
13155653|NCT02501629|26066552|FG001|Overall Study|Early termination by sponsor|0|||
13155654|NCT02501629|26066551|FG000|Overall Study|Withdrawal by Subject|3|||
13155655|NCT02501629|26066552|FG001|Overall Study|Withdrawal by Subject|5|||
13155656|NCT02501629|26066551|FG000|Overall Study|Subject did not return to site|0|||
13155657|NCT02501629|26066552|FG001|Overall Study|Subject did not return to site|1|||
13155658|NCT02501473|26066668|FG000|Overall Study|Study Terminated|2|||
13155659|NCT02501473|26066669|FG001|Overall Study|Study Terminated|3|||
13155660|NCT02501473|26066670|FG002|Overall Study|Study Terminated|7|||
13155661|NCT02501473|26066671|FG003|Overall Study|Study Terminated|9|||
13155662|NCT02501473|26066672|FG004|Overall Study|Study Terminated|2|||
13155663|NCT02501473|26066673|FG005|Overall Study|Study Terminated|10|||
13155664|NCT02501473|26066674|FG006|Overall Study|Study Terminated|1|||
13155665|NCT02501473|26066675|FG007|Overall Study|Study Terminated|0|||
13155666|NCT02501473|26066668|FG000|Overall Study|Withdrawal by Subject|0|||
13104360|NCT03339245|25875480|FG000|Overall Study|Adverse Event|1|||
13155667|NCT02501473|26066669|FG001|Overall Study|Withdrawal by Subject|0|||
13155668|NCT02501473|26066670|FG002|Overall Study|Withdrawal by Subject|3|||
13155669|NCT02501473|26066671|FG003|Overall Study|Withdrawal by Subject|3|||
13155670|NCT02501473|26066672|FG004|Overall Study|Withdrawal by Subject|2|||
13155671|NCT02501473|26066673|FG005|Overall Study|Withdrawal by Subject|2|||
13155672|NCT02501473|26066674|FG006|Overall Study|Withdrawal by Subject|0|||
13155673|NCT02501473|26066675|FG007|Overall Study|Withdrawal by Subject|0|||
13155674|NCT02501473|26066668|FG000|Overall Study|Death|0|||
13155675|NCT02501473|26066669|FG001|Overall Study|Death|0|||
13155676|NCT02501473|26066670|FG002|Overall Study|Death|1|||
13155677|NCT02501473|26066671|FG003|Overall Study|Death|1|||
13155678|NCT02501473|26066672|FG004|Overall Study|Death|0|||
13155679|NCT02501473|26066673|FG005|Overall Study|Death|1|||
13155680|NCT02501473|26066674|FG006|Overall Study|Death|0|||
13155681|NCT02501473|26066675|FG007|Overall Study|Death|0|||
13155682|NCT02501473|26066668|FG000|Overall Study|Lost to Follow-up|1|||
13155683|NCT02501473|26066669|FG001|Overall Study|Lost to Follow-up|0|||
13155684|NCT02501473|26066670|FG002|Overall Study|Lost to Follow-up|1|||
13155685|NCT02501473|26066671|FG003|Overall Study|Lost to Follow-up|0|||
13155686|NCT02501473|26066672|FG004|Overall Study|Lost to Follow-up|0|||
13155687|NCT02501473|26066673|FG005|Overall Study|Lost to Follow-up|1|||
13155688|NCT02501473|26066674|FG006|Overall Study|Lost to Follow-up|0|||
13155689|NCT02501473|26066675|FG007|Overall Study|Lost to Follow-up|0|||
13155690|NCT02501473|26066668|FG000|Overall Study|Reason not specified|0|||
13155691|NCT02501473|26066669|FG001|Overall Study|Reason not specified|0|||
13155692|NCT02501473|26066670|FG002|Overall Study|Reason not specified|1|||
13155693|NCT02501473|26066671|FG003|Overall Study|Reason not specified|1|||
13155694|NCT02501473|26066672|FG004|Overall Study|Reason not specified|0|||
13155695|NCT02501473|26066673|FG005|Overall Study|Reason not specified|0|||
13155696|NCT02501473|26066674|FG006|Overall Study|Reason not specified|0|||
13155697|NCT02501473|26066675|FG007|Overall Study|Reason not specified|0|||
13155698|NCT02501161|26066794|FG000|Overall Study|Adverse Event|2|||
13155699|NCT02501161|26066795|FG001|Overall Study|Adverse Event|6|||
13155700|NCT02501161|26066794|FG000|Overall Study|Lost to Follow-up|7|||
13155701|NCT02501161|26066795|FG001|Overall Study|Lost to Follow-up|4|||
13155702|NCT02501161|26066794|FG000|Overall Study|Withdrawal by Subject|10|||
13155703|NCT02501161|26066795|FG001|Overall Study|Withdrawal by Subject|15|||
13155704|NCT02501161|26066794|FG000|Overall Study|Other|3|||
13155705|NCT02501161|26066795|FG001|Overall Study|Other|0|||
13155706|NCT02500979|26066836|FG000|Period 1|Hyperglycemia|1|||
13155707|NCT02500979|26066837|FG001|Period 1|Hyperglycemia|0|||
13155708|NCT02500979|26066836|FG000|Period 1|Severe non-compliance to protocol|0|||
13155709|NCT02500979|26066837|FG001|Period 1|Severe non-compliance to protocol|1|||
13155710|NCT02500979|26066836|FG000|Period 1|Adverse Event|1|||
13155711|NCT02500979|26066837|FG001|Period 1|Adverse Event|0|||
13155712|NCT02500979|26066836|FG000|Period 1|Subject decision|2|||
13155713|NCT02500979|26066837|FG001|Period 1|Subject decision|0|||
13155714|NCT02500979|26066836|FG000|Period 2|Change in risk|1|||
13155715|NCT02500979|26066837|FG001|Period 2|Change in risk|0|||
13155716|NCT02500901|26066845|FG000|Overall Study|Disease ProgressionDD|2|||
13155717|NCT02500797|26066928|FG000|Overall Study|Cancel (rapid disease progression)|0|||
13155718|NCT02500797|26066929|FG001|Overall Study|Cancel (rapid disease progression)|0|||
13155719|NCT02500797|26066930|FG002|Overall Study|Cancel (rapid disease progression)|0|||
13155720|NCT02500797|26066931|FG003|Overall Study|Cancel (rapid disease progression)|0|||
13155721|NCT02500797|26066932|FG004|Overall Study|Cancel (rapid disease progression)|1|||
13155722|NCT02500797|26066933|FG005|Overall Study|Cancel (rapid disease progression)|1|||
13155723|NCT02500797|26066934|FG006|Overall Study|Cancel (rapid disease progression)|0|||
13155724|NCT02500797|26066935|FG007|Overall Study|Cancel (rapid disease progression)|0|||
13155725|NCT02500797|26066928|FG000|Overall Study|Withdrawal by Subject|1|||
13155726|NCT02500797|26066929|FG001|Overall Study|Withdrawal by Subject|0|||
13155727|NCT02500797|26066930|FG002|Overall Study|Withdrawal by Subject|0|||
13155728|NCT02500797|26066931|FG003|Overall Study|Withdrawal by Subject|0|||
13155729|NCT02500797|26066932|FG004|Overall Study|Withdrawal by Subject|0|||
13155730|NCT02500797|26066933|FG005|Overall Study|Withdrawal by Subject|0|||
13155731|NCT02500797|26066934|FG006|Overall Study|Withdrawal by Subject|0|||
13155732|NCT02500797|26066935|FG007|Overall Study|Withdrawal by Subject|0|||
13155733|NCT02500758|26066950|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0|||
13155734|NCT02500758|26066951|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1|||
13155735|NCT02500758|26066950|FG000|Washout (1 Week)|Lost to Follow-up|2|||
13155736|NCT02500758|26066951|FG001|Washout (1 Week)|Lost to Follow-up|2|||
13155737|NCT02500758|26066950|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2|||
13155738|NCT02500758|26066951|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0|||
13155739|NCT02500758|26066950|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0|||
13155740|NCT02500758|26066951|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1|||
13155741|NCT02500758|26066950|FG000|Second Intervention (2 Minutes)|Protocol Violation|1|||
13155742|NCT02500758|26066951|FG001|Second Intervention (2 Minutes)|Protocol Violation|1|||
13155743|NCT02500732|26066972|FG000|Overall Study|Physician Decision|0|||
13155744|NCT02500732|26066973|FG001|Overall Study|Physician Decision|1|||
13155745|NCT02500719|26066986|FG000|Overall Study|Lost to Follow-up|2|||
13155746|NCT02500719|26066987|FG001|Overall Study|Lost to Follow-up|3|||
13155747|NCT02500719|26066986|FG000|Overall Study|Trauma history|1|||
13155748|NCT02500719|26066987|FG001|Overall Study|Trauma history|0|||
13155749|NCT02500719|26066986|FG000|Overall Study|MRI data found to be unusable during analysis|0|||
13155750|NCT02500719|26066987|FG001|Overall Study|MRI data found to be unusable during analysis|1|||
13155751|NCT02500719|26066986|FG000|Overall Study|Did not meet criteria for PTSD|0|||
13155752|NCT02500719|26066987|FG001|Overall Study|Did not meet criteria for PTSD|1|||
13155753|NCT02500719|26066986|FG000|Overall Study|Claustrophobia|0|||
13155754|NCT02500719|26066987|FG001|Overall Study|Claustrophobia|1|||
13155755|NCT02500719|26066986|FG000|Overall Study|History of head trauma|0|||
13155756|NCT02500719|26066987|FG001|Overall Study|History of head trauma|1|||
13155757|NCT02500706|26067149|FG000|Overall Study|Adverse Event|0|||
13155758|NCT02500706|26067150|FG001|Overall Study|Adverse Event|0|||
13155759|NCT02500706|26067151|FG002|Overall Study|Adverse Event|1|||
13155760|NCT02500706|26067149|FG000|Overall Study|Lost to Follow-up|0|||
13155761|NCT02500706|26067150|FG001|Overall Study|Lost to Follow-up|1|||
13155762|NCT02500706|26067151|FG002|Overall Study|Lost to Follow-up|1|||
13155763|NCT02500706|26067149|FG000|Overall Study|Withdrawal by Subject|4|||
13155764|NCT02500706|26067150|FG001|Overall Study|Withdrawal by Subject|6|||
13155765|NCT02500706|26067151|FG002|Overall Study|Withdrawal by Subject|4|||
13155766|NCT02500706|26067149|FG000|Overall Study|Unclassified|0|||
13155767|NCT02500706|26067150|FG001|Overall Study|Unclassified|0|||
13155768|NCT02500706|26067151|FG002|Overall Study|Unclassified|1|||
13155769|NCT02500641|26067164|FG000|Overall Study|Adverse Event|0|||
13155770|NCT02500641|26067165|FG001|Overall Study|Adverse Event|2|||
13155771|NCT02500641|26067164|FG000|Overall Study|Withdrawal by Subject|4|||
13155772|NCT02500641|26067165|FG001|Overall Study|Withdrawal by Subject|5|||
13155773|NCT02500641|26067164|FG000|Overall Study|Unable to follow study procedures|3|||
13155774|NCT02500641|26067165|FG001|Overall Study|Unable to follow study procedures|2|||
13155775|NCT02500641|26067164|FG000|Overall Study|Protocol Violation|1|||
13155776|NCT02500641|26067165|FG001|Overall Study|Protocol Violation|2|||
13155777|NCT02500641|26067164|FG000|Overall Study|Lost to Follow-up|1|||
13155778|NCT02500641|26067165|FG001|Overall Study|Lost to Follow-up|0|||
13155779|NCT02500641|26067164|FG000|Overall Study|Sponsor decision|1|||
13155780|NCT02500641|26067165|FG001|Overall Study|Sponsor decision|0|||
13155781|NCT02500641|26067164|FG000|Overall Study|Non compliance to study drug|0|||
13155782|NCT02500641|26067165|FG001|Overall Study|Non compliance to study drug|1|||
13155783|NCT02500550|26067179|FG000|Overall Study|Death|7|||
13155784|NCT02500537|26067204|FG000|Overall Study|Death|2|||
13155785|NCT02500537|26067205|FG001|Overall Study|Death|0|||
13155786|NCT02500537|26067204|FG000|Overall Study|Lost to Follow-up|0|||
13155787|NCT02500537|26067205|FG001|Overall Study|Lost to Follow-up|1|||
13155788|NCT02500537|26067204|FG000|Overall Study|Withdrawal by Subject|1|||
13104361|NCT03339245|25875481|FG001|Overall Study|Adverse Event|1|||
13104362|NCT03339245|25875480|FG000|Overall Study|Withdrawal by Subject|1|||
13104363|NCT03339245|25875481|FG001|Overall Study|Withdrawal by Subject|0|||
13155789|NCT02500537|26067205|FG001|Overall Study|Withdrawal by Subject|0|||
13155790|NCT02500121|26067228|FG000|Overall Study|Lost to Follow-up|0|||
13104364|NCT03339219|25875497|FG000|Overall Study|Death|12|||
13104365|NCT03339219|25875497|FG000|Overall Study|Site Terminated by Sponsor|22|||
13104366|NCT03339219|25875497|FG000|Overall Study|Withdrawal by Subject|1|||
13104367|NCT03338998|25875512|FG000|Treatment Period|Withdrawal by Subject|1|||
13104368|NCT03338998|25875513|FG001|Treatment Period|Withdrawal by Subject|1|||
13104369|NCT03338998|25875512|FG000|Treatment Period|Adverse Event|0|||
13104370|NCT03338998|25875513|FG001|Treatment Period|Adverse Event|2|||
13104371|NCT03338998|25875512|FG000|Treatment Period|Protocol deviation|1|||
13104372|NCT03338998|25875513|FG001|Treatment Period|Protocol deviation|0|||
13104373|NCT03338998|25875512|FG000|Treatment Period|Physician Decision|2|||
13104374|NCT03338998|25875513|FG001|Treatment Period|Physician Decision|0|||
13104375|NCT03338998|25875512|FG000|Treatment Period|Subject failed swallow test|4|||
13104376|NCT03338998|25875513|FG001|Treatment Period|Subject failed swallow test|0|||
13104377|NCT03338998|25875512|FG000|Safety Follow-Up Period|Adverse Event|0|||
13104378|NCT03338998|25875513|FG001|Safety Follow-Up Period|Adverse Event|1|||
13104379|NCT03338998|25875512|FG000|Safety Follow-Up Period|Protocol deviation|1|||
13104380|NCT03338998|25875513|FG001|Safety Follow-Up Period|Protocol deviation|0|||
13104381|NCT03338998|25875512|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
13104382|NCT03338998|25875513|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
13104383|NCT03338972|25875544|FG000|Overall Study|Death|1|||
13104384|NCT03338972|25875545|FG001|Overall Study|Death|1|||
13104385|NCT03338972|25875546|FG002|Overall Study|Death|0|||
13104386|NCT03338972|25875547|FG003|Overall Study|Death|0|||
13104387|NCT03338972|25875544|FG000|Overall Study|Withdrawal by Subject|1|||
13104388|NCT03338972|25875545|FG001|Overall Study|Withdrawal by Subject|0|||
13104389|NCT03338972|25875546|FG002|Overall Study|Withdrawal by Subject|0|||
13104390|NCT03338972|25875547|FG003|Overall Study|Withdrawal by Subject|0|||
13104391|NCT03338894|25875554|FG000|Overall Study|not able able to attend 9 or more classes|10|||
13104392|NCT03338855|25875581|FG000|Overall Study|Withdrawn as birth control pill stopped|1|||
13104393|NCT03338855|25875582|FG001|Overall Study|Withdrawn as birth control pill stopped|0|||
13155791|NCT02500121|26067229|FG001|Overall Study|Lost to Follow-up|1|||
13155792|NCT02500121|26067228|FG000|Overall Study|Withdrawal by Subject|1|||
13104394|NCT03338816|25875622|FG000|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
13104395|NCT03338816|25875623|FG001|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
13104396|NCT03338816|25875624|FG002|6-Month DB + Open-Label Extension Period|Adverse Event|2|||
13104397|NCT03338816|25875625|FG003|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
13104398|NCT03338816|25875622|FG000|6-Month DB + Open-Label Extension Period|Death|0|||
13104399|NCT03338816|25875623|FG001|6-Month DB + Open-Label Extension Period|Death|0|||
13104400|NCT03338816|25875624|FG002|6-Month DB + Open-Label Extension Period|Death|0|||
13104401|NCT03338816|25875625|FG003|6-Month DB + Open-Label Extension Period|Death|1|||
13104402|NCT03338816|25875622|FG000|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
13104403|NCT03338816|25875623|FG001|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
13104404|NCT03338816|25875624|FG002|6-Month DB + Open-Label Extension Period|Lost to Follow-up|1|||
13104405|NCT03338816|25875625|FG003|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
13104406|NCT03338816|25875622|FG000|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
13104407|NCT03338816|25875623|FG001|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
13104408|NCT03338816|25875624|FG002|6-Month DB + Open-Label Extension Period|Physician Decision|1|||
13104409|NCT03338816|25875625|FG003|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
13155793|NCT02500121|26067229|FG001|Overall Study|Withdrawal by Subject|1|||
13155794|NCT02500121|26067228|FG000|Overall Study|Death|26|||
13155795|NCT02500121|26067229|FG001|Overall Study|Death|24|||
13155796|NCT02500056|26067246|FG000|Overall Study|Lost to Follow-up|3|||
13155797|NCT02500056|26067247|FG001|Overall Study|Lost to Follow-up|7|||
13155798|NCT02500056|26067246|FG000|Overall Study|Recurrence|1|||
13155799|NCT02500056|26067247|FG001|Overall Study|Recurrence|0|||
13155800|NCT02500056|26067246|FG000|Overall Study|Death|3|||
13155801|NCT02500056|26067247|FG001|Overall Study|Death|1|||
13155802|NCT02500043|26067274|FG000|Overall Study|Randomized, but not Treated|2|||
13155803|NCT02500043|26067275|FG001|Overall Study|Randomized, but not Treated|2|||
13155804|NCT02500043|26067274|FG000|Overall Study|Ongoing at Date of Cut-Off|19|||
13155805|NCT02500043|26067275|FG001|Overall Study|Ongoing at Date of Cut-Off|3|||
13155806|NCT02500043|26067274|FG000|Overall Study|Adverse Event|33|||
13155807|NCT02500043|26067275|FG001|Overall Study|Adverse Event|11|||
13155808|NCT02500043|26067274|FG000|Overall Study|Clinical Progression|54|||
13155809|NCT02500043|26067275|FG001|Overall Study|Clinical Progression|35|||
13155810|NCT02500043|26067274|FG000|Overall Study|Radiological Progression|192|||
13155811|NCT02500043|26067275|FG001|Overall Study|Radiological Progression|110|||
13155812|NCT02500043|26067274|FG000|Overall Study|Physician's Decision|11|||
13155813|NCT02500043|26067275|FG001|Overall Study|Physician's Decision|3|||
13155814|NCT02500043|26067274|FG000|Overall Study|Withdrawal by Subject|14|||
13155815|NCT02500043|26067275|FG001|Overall Study|Withdrawal by Subject|4|||
13155816|NCT02500043|26067274|FG000|Overall Study|Death|11|||
13155817|NCT02500043|26067275|FG001|Overall Study|Death|2|||
13155818|NCT02500043|26067274|FG000|Overall Study|Protocol Deviation|1|||
13155819|NCT02500043|26067275|FG001|Overall Study|Protocol Deviation|0|||
13155820|NCT02499952|26067284|FG000|Overall Study|Lost to Follow-up|1|||
13155821|NCT02499952|26067284|FG000|Overall Study|Death|9|||
13155822|NCT02499783|26067339|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2|||
13155823|NCT02499783|26067340|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4|||
13155824|NCT02499783|26067341|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0|||
13155825|NCT02499783|26067339|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1|||
13155826|NCT02499783|26067340|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
13155827|NCT02499783|26067341|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
13155828|NCT02499783|26067339|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
13155829|NCT02499783|26067340|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
13155830|NCT02499783|26067341|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0|||
13155831|NCT02499783|26067339|FG000|DB Period: Weeks 0-8|Adverse Event|8|||
13155832|NCT02499783|26067340|FG001|DB Period: Weeks 0-8|Adverse Event|6|||
13155833|NCT02499783|26067341|FG002|DB Period: Weeks 0-8|Adverse Event|0|||
13155834|NCT02499783|26067339|FG000|DB Period: Weeks 0-8|Withdrew Consent|1|||
13155835|NCT02499783|26067340|FG001|DB Period: Weeks 0-8|Withdrew Consent|0|||
13155836|NCT02499783|26067341|FG002|DB Period: Weeks 0-8|Withdrew Consent|0|||
13155837|NCT02499783|26067339|FG000|DB Period: Weeks 0-8|Other|1|||
13155838|NCT02499783|26067340|FG001|DB Period: Weeks 0-8|Other|1|||
13155839|NCT02499783|26067341|FG002|DB Period: Weeks 0-8|Other|0|||
13155840|NCT02499783|26067339|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
13155841|NCT02499783|26067340|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
13155842|NCT02499783|26067341|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16|||
13155843|NCT02499783|26067339|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
13155844|NCT02499783|26067340|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
13222753|NCT01803282|26286889|FG006|Overall Study|Adverse Event|1|||
13155845|NCT02499783|26067341|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2|||
13155846|NCT02499783|26067339|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
13155847|NCT02499783|26067340|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
13155848|NCT02499783|26067341|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9|||
13155849|NCT02499783|26067339|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
13155850|NCT02499783|26067340|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
13155851|NCT02499783|26067341|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2|||
13155852|NCT02499770|26067457|FG000|Overall Study|Death|17|||
13155853|NCT02499770|26067458|FG001|Overall Study|Death|56|||
13155854|NCT02499770|26067457|FG000|Overall Study|Study completion|1|||
13155855|NCT02499770|26067458|FG001|Overall Study|Study completion|10|||
13155856|NCT02499770|26067457|FG000|Overall Study|Withdrawal by Subject|0|||
13155857|NCT02499770|26067458|FG001|Overall Study|Withdrawal by Subject|7|||
13104410|NCT03338816|25875622|FG000|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
13104411|NCT03338816|25875623|FG001|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
13104412|NCT03338816|25875624|FG002|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
13104413|NCT03338816|25875625|FG003|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
13104414|NCT03338816|25875622|FG000|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
13104415|NCT03338816|25875623|FG001|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
13104416|NCT03338816|25875624|FG002|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
13104417|NCT03338816|25875625|FG003|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
13104418|NCT03338816|25875622|FG000|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
13104419|NCT03338816|25875623|FG001|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
13155858|NCT02499770|26067457|FG000|Overall Study|Lost to Follow-up|0|||
13155859|NCT02499770|26067458|FG001|Overall Study|Lost to Follow-up|2|||
13155860|NCT02499770|26067457|FG000|Overall Study|Subject declined further treatment|1|||
13155861|NCT02499770|26067458|FG001|Overall Study|Subject declined further treatment|0|||
13155862|NCT02499770|26067457|FG000|Overall Study|Withdrawn by PI for compassionate reason|0|||
13155863|NCT02499770|26067458|FG001|Overall Study|Withdrawn by PI for compassionate reason|1|||
13155864|NCT02499770|26067457|FG000|Overall Study|Randomized but not enrolled|0|||
13155865|NCT02499770|26067458|FG001|Overall Study|Randomized but not enrolled|1|||
13155866|NCT02499575|26067475|FG000|Overall Study|Protocol Violation|0|||
13155867|NCT02499575|26067476|FG001|Overall Study|Protocol Violation|1|||
13155868|NCT02499406|26067494|FG000|Overall Study|missed 3 treatment sessions|4|||
13205250|NCT01967173|26231280|FG007|Overall Study|Lost to Follow-up|8|||
13205251|NCT01967173|26231273|FG000|Overall Study|Physician Decision|2|||
13205252|NCT01967173|26231274|FG001|Overall Study|Physician Decision|0|||
13205253|NCT01967173|26231275|FG002|Overall Study|Physician Decision|2|||
13205254|NCT01967173|26231276|FG003|Overall Study|Physician Decision|1|||
13205255|NCT01967173|26231277|FG004|Overall Study|Physician Decision|1|||
13205256|NCT01967173|26231278|FG005|Overall Study|Physician Decision|1|||
13205257|NCT01967173|26231279|FG006|Overall Study|Physician Decision|1|||
13205258|NCT01967173|26231280|FG007|Overall Study|Physician Decision|0|||
13205259|NCT01967173|26231273|FG000|Overall Study|Lack of Efficacy|2|||
13205260|NCT01967173|26231274|FG001|Overall Study|Lack of Efficacy|0|||
13205261|NCT01967173|26231275|FG002|Overall Study|Lack of Efficacy|2|||
13205262|NCT01967173|26231276|FG003|Overall Study|Lack of Efficacy|2|||
13205263|NCT01967173|26231277|FG004|Overall Study|Lack of Efficacy|0|||
13205264|NCT01967173|26231278|FG005|Overall Study|Lack of Efficacy|1|||
13205265|NCT01967173|26231279|FG006|Overall Study|Lack of Efficacy|0|||
13205266|NCT01967173|26231280|FG007|Overall Study|Lack of Efficacy|2|||
13205267|NCT01967173|26231273|FG000|Overall Study|Pregnancy|0|||
13205268|NCT01967173|26231274|FG001|Overall Study|Pregnancy|0|||
13205269|NCT01967173|26231275|FG002|Overall Study|Pregnancy|0|||
13205270|NCT01967173|26231276|FG003|Overall Study|Pregnancy|0|||
13205271|NCT01967173|26231277|FG004|Overall Study|Pregnancy|0|||
13205272|NCT01967173|26231278|FG005|Overall Study|Pregnancy|0|||
13205273|NCT01967173|26231279|FG006|Overall Study|Pregnancy|1|||
13205274|NCT01967173|26231280|FG007|Overall Study|Pregnancy|1|||
13205275|NCT01967173|26231273|FG000|Overall Study|Adverse Event|0|||
13205276|NCT01967173|26231274|FG001|Overall Study|Adverse Event|0|||
13205277|NCT01967173|26231275|FG002|Overall Study|Adverse Event|0|||
13205278|NCT01967173|26231276|FG003|Overall Study|Adverse Event|0|||
13205279|NCT01967173|26231277|FG004|Overall Study|Adverse Event|0|||
13205280|NCT01967173|26231278|FG005|Overall Study|Adverse Event|0|||
13205281|NCT01967173|26231279|FG006|Overall Study|Adverse Event|0|||
13205282|NCT01967173|26231280|FG007|Overall Study|Adverse Event|1|||
13205283|NCT01967173|26231273|FG000|Overall Study|Withdrawal by Subject|15|||
13205284|NCT01967173|26231274|FG001|Overall Study|Withdrawal by Subject|14|||
13205285|NCT01967173|26231275|FG002|Overall Study|Withdrawal by Subject|10|||
13205286|NCT01967173|26231276|FG003|Overall Study|Withdrawal by Subject|7|||
13205287|NCT01967173|26231277|FG004|Overall Study|Withdrawal by Subject|8|||
13205288|NCT01967173|26231278|FG005|Overall Study|Withdrawal by Subject|9|||
13205289|NCT01967173|26231279|FG006|Overall Study|Withdrawal by Subject|10|||
13205290|NCT01967173|26231280|FG007|Overall Study|Withdrawal by Subject|12|||
13205291|NCT01967147|26231302|FG000|Overall Study|Adverse Event|5|||
13205292|NCT01967147|26231303|FG001|Overall Study|Adverse Event|2|||
13205293|NCT01967147|26231302|FG000|Overall Study|Lack of Efficacy|1|||
13205294|NCT01967147|26231303|FG001|Overall Study|Lack of Efficacy|4|||
13205295|NCT01967147|26231302|FG000|Overall Study|Lost to Follow-up|1|||
13104420|NCT03338816|25875624|FG002|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
13104421|NCT03338816|25875625|FG003|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|1|||
13104422|NCT03338673|25875640|FG000|Overall Study|Lost to Follow-up|1|||
13104423|NCT03338673|25875641|FG001|Overall Study|Lost to Follow-up|1|||
13104424|NCT03338569|25875676|FG000|Overall Study|Physician Decision|8|||
13104425|NCT03338569|25875677|FG001|Overall Study|Physician Decision|3|||
13104426|NCT03338569|25875676|FG000|Overall Study|Withdrawal by Subject|0|||
13104427|NCT03338569|25875677|FG001|Overall Study|Withdrawal by Subject|1|||
13104428|NCT03338569|25875676|FG000|Overall Study|Lost to Follow-up|0|||
13104429|NCT03338569|25875677|FG001|Overall Study|Lost to Follow-up|1|||
13104430|NCT03338400|25875698|FG000|Overall Study|Lost to Follow-up|1|||
13104431|NCT03338400|25875699|FG001|Overall Study|Lost to Follow-up|2|||
13104432|NCT03338296|25875758|FG000|Overall Study|Adverse Event|0|||
13104433|NCT03338296|25875759|FG001|Overall Study|Adverse Event|1|||
13155869|NCT02499263|26067529|FG000|Overall Study|Lost to Follow-up|9|||
13155870|NCT02499263|26067529|FG000|Overall Study|Participant's withdrawal of consent|4|||
13155871|NCT02499263|26067529|FG000|Overall Study|Lack of Efficacy|22|||
13155872|NCT02499263|26067529|FG000|Overall Study|investigator's judgment|12|||
13155873|NCT02499263|26067529|FG000|Overall Study|Adverse Events/Serious Adverse Events|11|||
13155874|NCT02499263|26067529|FG000|Overall Study|Participant's decision|3|||
13155875|NCT02499263|26067529|FG000|Overall Study|Pregnancy|1|||
13155876|NCT02499172|26067552|FG000|Overall Study|Financial reason|0|||
13104434|NCT03338296|25875758|FG000|Overall Study|Withdrawal by Subject|14|||
13104435|NCT03338296|25875759|FG001|Overall Study|Withdrawal by Subject|13|||
13104436|NCT03338296|25875758|FG000|Overall Study|Lost to Follow-up|10|||
13104437|NCT03338296|25875759|FG001|Overall Study|Lost to Follow-up|10|||
13104438|NCT03338296|25875758|FG000|Overall Study|Study Terminated by Sponsor|77|||
13104439|NCT03338296|25875759|FG001|Overall Study|Study Terminated by Sponsor|76|||
13155877|NCT02499172|26067553|FG001|Overall Study|Financial reason|0|||
13155878|NCT02499172|26067554|FG002|Overall Study|Financial reason|523|||
13155879|NCT02499172|26067555|FG003|Overall Study|Financial reason|436|||
13155880|NCT02499172|26067552|FG000|Overall Study|Lost to Follow-up|65|||
13155881|NCT02499172|26067553|FG001|Overall Study|Lost to Follow-up|64|||
13155882|NCT02499172|26067554|FG002|Overall Study|Lost to Follow-up|0|||
13155883|NCT02499172|26067555|FG003|Overall Study|Lost to Follow-up|0|||
13155884|NCT02499159|26067586|FG000|Randomization|Protocol Violation|1|||
13155885|NCT02499159|26067587|FG001|Randomization|Protocol Violation|1|||
13155886|NCT02499159|26067586|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
13155887|NCT02499159|26067587|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
13155888|NCT02499159|26067586|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3|||
13155889|NCT02499159|26067587|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1|||
13155890|NCT02499159|26067586|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2|||
13155891|NCT02499159|26067587|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0|||
13155892|NCT02499159|26067586|FG000|30-Day Follow-Up Phone Call|Other|1|||
13155893|NCT02499159|26067587|FG001|30-Day Follow-Up Phone Call|Other|0|||
13155894|NCT02499146|26067627|FG000|Overall Study|Lost to Follow-up|1|||
13155895|NCT02499146|26067627|FG000|Overall Study|Withdrawal by Subject|1|||
13155896|NCT02499146|26067627|FG000|Overall Study|Other|2|||
13155897|NCT02499146|26067627|FG000|Overall Study|Ongoing at date of cut-off|9|||
13155898|NCT02499146|26067627|FG000|Overall Study|Began other treatment/therapy|13|||
13155899|NCT02499029|26067646|FG000|Overall Study|Lost to Follow-up|2|||
13155900|NCT02499029|26067647|FG001|Overall Study|Lost to Follow-up|2|||
13155901|NCT02499029|26067646|FG000|Overall Study|Physician Decision|2|||
13155902|NCT02499029|26067647|FG001|Overall Study|Physician Decision|1|||
13155903|NCT02499029|26067646|FG000|Overall Study|Death|1|||
13155904|NCT02499029|26067647|FG001|Overall Study|Death|0|||
13155905|NCT02498821|26067681|FG000|Overall Study|Screen failure|3|||
13155906|NCT02498821|26067682|FG001|Overall Study|Screen failure|5|||
13155907|NCT02498678|26067703|FG000|Overall Study|interference from the surgical team|0|||
13155908|NCT02498678|26067704|FG001|Overall Study|interference from the surgical team|2|||
13155909|NCT02498652|26067810|FG000|Overall Study|Protocol Violation|0|||
13155910|NCT02498652|26067811|FG001|Overall Study|Protocol Violation|1|||
13155911|NCT02498444|26067832|FG000|Overall Study|Withdrawal by Subject|3|||
13155912|NCT02498444|26067833|FG001|Overall Study|Withdrawal by Subject|0|||
13155913|NCT02498444|26067832|FG000|Overall Study|Physician Decision|1|||
13155914|NCT02498444|26067833|FG001|Overall Study|Physician Decision|0|||
13155915|NCT02498418|26067859|FG000|Overall Study|Lack of Efficacy|0|||
13222754|NCT01803282|26286890|FG007|Overall Study|Adverse Event|2|||
13104440|NCT03338296|25875758|FG000|Overall Study|Other|2|||
13104441|NCT03338296|25875759|FG001|Overall Study|Other|7|||
13104442|NCT03338296|25875758|FG000|Overall Study|Missing|0|||
13155916|NCT02498418|26067860|FG001|Overall Study|Lack of Efficacy|0|||
13155917|NCT02498418|26067861|FG002|Overall Study|Lack of Efficacy|1|||
13155918|NCT02498418|26067859|FG000|Overall Study|Withdrawal by Subject|2|||
13155919|NCT02498418|26067860|FG001|Overall Study|Withdrawal by Subject|0|||
13155920|NCT02498418|26067861|FG002|Overall Study|Withdrawal by Subject|3|||
13155921|NCT02498418|26067859|FG000|Overall Study|Lost to Follow-up|0|||
13222755|NCT01803282|26286891|FG008|Overall Study|Adverse Event|0|||
13155922|NCT02498418|26067860|FG001|Overall Study|Lost to Follow-up|1|||
13155923|NCT02498418|26067861|FG002|Overall Study|Lost to Follow-up|1|||
13155924|NCT02498418|26067859|FG000|Overall Study|Participant taken prohibited medication|0|||
13155925|NCT02498418|26067860|FG001|Overall Study|Participant taken prohibited medication|1|||
13155926|NCT02498418|26067861|FG002|Overall Study|Participant taken prohibited medication|1|||
13155927|NCT02498392|26067920|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7|||
13155928|NCT02498392|26067921|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0|||
13155929|NCT02498392|26067920|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3|||
13155930|NCT02498392|26067921|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0|||
13155931|NCT02498392|26067920|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0|||
13155932|NCT02498392|26067921|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2|||
13155933|NCT02498392|26067920|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0|||
13155934|NCT02498392|26067921|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2|||
13155935|NCT02498392|26067920|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2|||
13104443|NCT03338296|25875759|FG001|Overall Study|Missing|1|||
13155936|NCT02498392|26067921|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3|||
13155937|NCT02498392|26067920|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1|||
13155938|NCT02498392|26067921|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3|||
13155939|NCT02498236|26067975|FG000|Overall Study|Did not show for testing|1|||
13104444|NCT03338062|25875789|FG000|Overall Study|Alternative Therapy|1|||
13104445|NCT03338062|25875790|FG001|Overall Study|Alternative Therapy|0|||
13104446|NCT03338023|25875827|FG000|Overall Study|Withdrawal by Subject|3|||
13104447|NCT03338023|25875828|FG001|Overall Study|Withdrawal by Subject|4|||
13104448|NCT03338023|25875827|FG000|Overall Study|Protocol Violation|3|||
13104449|NCT03338023|25875828|FG001|Overall Study|Protocol Violation|3|||
13104450|NCT03338023|25875827|FG000|Overall Study|Lost to Follow-up|2|||
13104451|NCT03338023|25875828|FG001|Overall Study|Lost to Follow-up|1|||
13104452|NCT03338023|25875827|FG000|Overall Study|Physician Decision|1|||
13104453|NCT03338023|25875828|FG001|Overall Study|Physician Decision|2|||
13104454|NCT03338010|25875863|FG000|Overall Study|Withdrawal by Subject|14|||
13104455|NCT03338010|25875864|FG001|Overall Study|Withdrawal by Subject|8|||
13104456|NCT03338010|25875863|FG000|Overall Study|Lost to Follow-up|4|||
13104457|NCT03338010|25875864|FG001|Overall Study|Lost to Follow-up|2|||
13104458|NCT03338010|25875863|FG000|Overall Study|Adverse Event|3|||
13104459|NCT03338010|25875864|FG001|Overall Study|Adverse Event|2|||
13104460|NCT03338010|25875863|FG000|Overall Study|Physician Decision|2|||
13104461|NCT03338010|25875864|FG001|Overall Study|Physician Decision|2|||
13104462|NCT03338010|25875863|FG000|Overall Study|Non-Compliance with Study Drug|0|||
13104463|NCT03338010|25875864|FG001|Overall Study|Non-Compliance with Study Drug|3|||
13104464|NCT03338010|25875863|FG000|Overall Study|Protocol Violation|0|||
13104465|NCT03338010|25875864|FG001|Overall Study|Protocol Violation|1|||
13104466|NCT03337542|25875880|FG000|Overall Study|Withdrew Consent|17|||
13104467|NCT03337542|25875880|FG000|Overall Study|Allergic Adverse Event|1|||
13104468|NCT03337542|25875880|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1|||
13104469|NCT03337542|25875880|FG000|Overall Study|Lost to Follow-up|1|||
13104470|NCT03337542|25875880|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1|||
13104471|NCT03337490|25875901|FG000|Overall Study|Withdrawal by Subject|1|||
13104472|NCT03337490|25875902|FG001|Overall Study|Withdrawal by Subject|0|||
13104473|NCT03337490|25875903|FG002|Overall Study|Withdrawal by Subject|0|||
13104474|NCT03337490|25875901|FG000|Overall Study|Lack of Efficacy|10|||
13104475|NCT03337490|25875902|FG001|Overall Study|Lack of Efficacy|12|||
13104476|NCT03337490|25875903|FG002|Overall Study|Lack of Efficacy|35|||
13104477|NCT03337490|25875901|FG000|Overall Study|Physician Decision|0|||
13104478|NCT03337490|25875902|FG001|Overall Study|Physician Decision|1|||
13104479|NCT03337490|25875903|FG002|Overall Study|Physician Decision|0|||
13104480|NCT03337490|25875901|FG000|Overall Study|Lost to Follow-up|0|||
13104481|NCT03337490|25875902|FG001|Overall Study|Lost to Follow-up|1|||
13104482|NCT03337490|25875903|FG002|Overall Study|Lost to Follow-up|0|||
13104483|NCT03337477|25875930|FG000|Overall Study|not categorized into the listed ones|11|||
13104484|NCT03337477|25875931|FG001|Overall Study|not categorized into the listed ones|9|||
13104485|NCT03337477|25875930|FG000|Overall Study|Withdrawal by Subject|0|||
13104486|NCT03337477|25875931|FG001|Overall Study|Withdrawal by Subject|1|||
13104487|NCT03337477|25875930|FG000|Overall Study|Death|0|||
13104488|NCT03337477|25875931|FG001|Overall Study|Death|1|||
13104489|NCT03337477|25875930|FG000|Overall Study|Lost to Follow-up|0|||
13104490|NCT03337477|25875931|FG001|Overall Study|Lost to Follow-up|2|||
13104491|NCT03337308|25875978|FG000|Overall Study|Adverse Event|2|||
13104492|NCT03337308|25875979|FG001|Overall Study|Adverse Event|3|||
13104493|NCT03337308|25875980|FG002|Overall Study|Adverse Event|3|||
13104494|NCT03337308|25875981|FG003|Overall Study|Adverse Event|1|||
13155940|NCT02498236|26067976|FG001|Overall Study|Did not show for testing|0|||
13104495|NCT03337308|25875978|FG000|Overall Study|Lost to Follow-up|1|||
13104496|NCT03337308|25875979|FG001|Overall Study|Lost to Follow-up|2|||
13104497|NCT03337308|25875980|FG002|Overall Study|Lost to Follow-up|0|||
13104498|NCT03337308|25875981|FG003|Overall Study|Lost to Follow-up|0|||
13155941|NCT02498236|26067977|FG002|Overall Study|Did not show for testing|0|||
13155942|NCT02498236|26067978|FG003|Overall Study|Did not show for testing|0|||
13155943|NCT02498236|26067979|FG004|Overall Study|Did not show for testing|0|||
13155944|NCT02498236|26067980|FG005|Overall Study|Did not show for testing|0|||
13155945|NCT02498236|26067981|FG006|Overall Study|Did not show for testing|0|||
13155946|NCT02498236|26067982|FG007|Overall Study|Did not show for testing|1|||
13155947|NCT02498236|26067975|FG000|Overall Study|Equipment failure|0|||
13155948|NCT02498236|26067976|FG001|Overall Study|Equipment failure|0|||
13155949|NCT02498236|26067977|FG002|Overall Study|Equipment failure|0|||
13155950|NCT02498236|26067978|FG003|Overall Study|Equipment failure|0|||
13155951|NCT02498236|26067979|FG004|Overall Study|Equipment failure|0|||
13155952|NCT02498236|26067980|FG005|Overall Study|Equipment failure|0|||
13155953|NCT02498236|26067981|FG006|Overall Study|Equipment failure|1|||
13155954|NCT02498236|26067982|FG007|Overall Study|Equipment failure|0|||
13155955|NCT02498236|26067975|FG000|Overall Study|Withdrawal by Subject|0|||
13155956|NCT02498236|26067976|FG001|Overall Study|Withdrawal by Subject|0|||
13155957|NCT02498236|26067977|FG002|Overall Study|Withdrawal by Subject|0|||
13155958|NCT02498236|26067978|FG003|Overall Study|Withdrawal by Subject|0|||
13155959|NCT02498236|26067979|FG004|Overall Study|Withdrawal by Subject|1|||
13155960|NCT02498236|26067980|FG005|Overall Study|Withdrawal by Subject|0|||
13155961|NCT02498236|26067981|FG006|Overall Study|Withdrawal by Subject|0|||
13155962|NCT02498236|26067982|FG007|Overall Study|Withdrawal by Subject|0|||
13155963|NCT02498067|26068003|FG000|Overall Study|Lost to Follow-up|22|||
13155964|NCT02498067|26068003|FG000|Overall Study|Did not meet inclusion criteria|11|||
13155965|NCT02497976|26068026|FG000|Overall Study|Withdrawal by Subject|2|||
13155966|NCT02497976|26068027|FG001|Overall Study|Withdrawal by Subject|0|||
13155967|NCT02497976|26068026|FG000|Overall Study|Moved out of area|0|||
13155968|NCT02497976|26068027|FG001|Overall Study|Moved out of area|1|||
13155969|NCT02497781|26068095|FG000|Overall Study|Withdrawal by Subject|2|||
13155970|NCT02497781|26068096|FG001|Overall Study|Withdrawal by Subject|0|||
13155971|NCT02497781|26068095|FG000|Overall Study|Lack of Efficacy|0|||
13155972|NCT02497781|26068096|FG001|Overall Study|Lack of Efficacy|1|||
13155973|NCT02497781|26068095|FG000|Overall Study|Randomised but not treated|1|||
13155974|NCT02497781|26068096|FG001|Overall Study|Randomised but not treated|1|||
13155975|NCT02497781|26068095|FG000|Overall Study|Lost to Follow-up|1|||
13155976|NCT02497781|26068096|FG001|Overall Study|Lost to Follow-up|1|||
13155977|NCT02497755|26068116|FG000|Overall Study|Protocol Violation|1|||
13155978|NCT02497755|26068117|FG001|Overall Study|Protocol Violation|0|||
13155979|NCT02497469|26068134|FG000|Overall Study|Randomized but not Treated|0|||
13155980|NCT02497469|26068135|FG001|Overall Study|Randomized but not Treated|2|||
13155981|NCT02497469|26068134|FG000|Overall Study|Pretreatment Event/Adverse Event|18|||
13155982|NCT02497469|26068135|FG001|Overall Study|Pretreatment Event/Adverse Event|16|||
13155983|NCT02497469|26068134|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
13155984|NCT02497469|26068135|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
13155985|NCT02497469|26068134|FG000|Overall Study|Significant Protocol Deviation|4|||
13155986|NCT02497469|26068135|FG001|Overall Study|Significant Protocol Deviation|5|||
13155987|NCT02497469|26068134|FG000|Overall Study|Lost to Follow-up|14|||
13155988|NCT02497469|26068135|FG001|Overall Study|Lost to Follow-up|4|||
13155989|NCT02497469|26068134|FG000|Overall Study|Voluntary Withdrawal|39|||
13155990|NCT02497469|26068135|FG001|Overall Study|Voluntary Withdrawal|41|||
13155991|NCT02497469|26068134|FG000|Overall Study|Pregnancy|1|||
13155992|NCT02497469|26068135|FG001|Overall Study|Pregnancy|1|||
13155993|NCT02497469|26068134|FG000|Overall Study|Lack of Efficacy|86|||
13155994|NCT02497469|26068135|FG001|Overall Study|Lack of Efficacy|40|||
13155995|NCT02497469|26068134|FG000|Overall Study|Reason not Specified|6|||
13155996|NCT02497469|26068135|FG001|Overall Study|Reason not Specified|6|||
13155997|NCT02497404|26068149|FG000|Overall Study|Adverse Event|1|||
13155998|NCT02497391|26068167|FG000|Period 2 (14 Days)|Withdrawal by Subject|1|||
13155999|NCT02497391|26068168|FG001|Period 2 (14 Days)|Withdrawal by Subject|0|||
13156000|NCT02497391|26068169|FG002|Period 2 (14 Days)|Withdrawal by Subject|1|||
13156001|NCT02497391|26068170|FG003|Period 2 (14 Days)|Withdrawal by Subject|0|||
13156002|NCT02497391|26068171|FG004|Period 2 (14 Days)|Withdrawal by Subject|0|||
13156003|NCT02497391|26068172|FG005|Period 2 (14 Days)|Withdrawal by Subject|0|||
13156004|NCT02497391|26068167|FG000|Period 2 (14 Days)|Sponsor Decision|3|||
13156005|NCT02497391|26068168|FG001|Period 2 (14 Days)|Sponsor Decision|1|||
13156006|NCT02497391|26068169|FG002|Period 2 (14 Days)|Sponsor Decision|2|||
13156007|NCT02497391|26068170|FG003|Period 2 (14 Days)|Sponsor Decision|3|||
13156008|NCT02497391|26068171|FG004|Period 2 (14 Days)|Sponsor Decision|2|||
13156009|NCT02497391|26068172|FG005|Period 2 (14 Days)|Sponsor Decision|3|||
13156010|NCT02497391|26068167|FG000|Period 3 (14 Days)|Adverse Event|0|||
13156011|NCT02497391|26068168|FG001|Period 3 (14 Days)|Adverse Event|1|||
13156012|NCT02497391|26068169|FG002|Period 3 (14 Days)|Adverse Event|0|||
13156013|NCT02497391|26068170|FG003|Period 3 (14 Days)|Adverse Event|0|||
13156014|NCT02497391|26068171|FG004|Period 3 (14 Days)|Adverse Event|0|||
13156015|NCT02497391|26068172|FG005|Period 3 (14 Days)|Adverse Event|0|||
13156016|NCT02497391|26068167|FG000|Period 3 (14 Days)|Sponsor Decision|0|||
13156017|NCT02497391|26068168|FG001|Period 3 (14 Days)|Sponsor Decision|0|||
13156018|NCT02497391|26068169|FG002|Period 3 (14 Days)|Sponsor Decision|0|||
13156019|NCT02497391|26068170|FG003|Period 3 (14 Days)|Sponsor Decision|0|||
13156020|NCT02497391|26068171|FG004|Period 3 (14 Days)|Sponsor Decision|1|||
13156021|NCT02497391|26068172|FG005|Period 3 (14 Days)|Sponsor Decision|0|||
13156022|NCT02497391|26068167|FG000|Period 3 (14 Days)|Withdrawal by Subject|0|||
13156023|NCT02497391|26068168|FG001|Period 3 (14 Days)|Withdrawal by Subject|0|||
13156024|NCT02497391|26068169|FG002|Period 3 (14 Days)|Withdrawal by Subject|1|||
13156025|NCT02497391|26068170|FG003|Period 3 (14 Days)|Withdrawal by Subject|0|||
13156026|NCT02497391|26068171|FG004|Period 3 (14 Days)|Withdrawal by Subject|0|||
13156027|NCT02497391|26068172|FG005|Period 3 (14 Days)|Withdrawal by Subject|0|||
13156028|NCT02497287|26068213|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84|||
13156029|NCT02497287|26068213|FG000|Induction Phase (4 Weeks)|Adverse Event|52|||
13156030|NCT02497287|26068213|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22|||
13156031|NCT02497287|26068213|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21|||
13156032|NCT02497287|26068213|FG000|Induction Phase (4 Weeks)|Other|13|||
13156033|NCT02497287|26068213|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5|||
13156034|NCT02497287|26068213|FG000|Induction Phase (4 Weeks)|Protocol Violation|1|||
13156035|NCT02497287|26068213|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1|||
13156036|NCT02497287|26068213|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331|||
13156037|NCT02497287|26068213|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30|||
13156038|NCT02497287|26068213|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25|||
13156039|NCT02497287|26068213|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25|||
13156040|NCT02497287|26068213|FG000|Optimization/Maintenance (48 Weeks)|Other|21|||
13156041|NCT02497287|26068213|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10|||
13156042|NCT02497287|26068213|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3|||
13156043|NCT02497287|26068213|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3|||
13156044|NCT02497287|26068213|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2|||
13156045|NCT02497287|26068213|FG000|Optimization/Maintenance (48 Weeks)|Death|2|||
13156046|NCT02497287|26068213|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1|||
13156047|NCT02497287|26068213|FG000|Follow-up Phase (4 Week)|PI Decision|12|||
13156048|NCT02497287|26068213|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10|||
13156049|NCT02497287|26068213|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5|||
13156050|NCT02497287|26068213|FG000|Follow-up Phase (4 Week)|Adverse Event|3|||
13156051|NCT02497287|26068213|FG000|Follow-up Phase (4 Week)|Other|1|||
13156052|NCT02497001|26068283|FG000|Overall Study|Lost to Follow-up|10|||
13156053|NCT02497001|26068284|FG001|Overall Study|Lost to Follow-up|2|||
13156054|NCT02497001|26068285|FG002|Overall Study|Lost to Follow-up|0|||
13156055|NCT02497001|26068286|FG003|Overall Study|Lost to Follow-up|2|||
13156056|NCT02497001|26068283|FG000|Overall Study|Adverse Event|28|||
13156057|NCT02497001|26068284|FG001|Overall Study|Adverse Event|30|||
13156058|NCT02497001|26068285|FG002|Overall Study|Adverse Event|11|||
13156059|NCT02497001|26068286|FG003|Overall Study|Adverse Event|11|||
13156060|NCT02497001|26068283|FG000|Overall Study|Withdrawal by Subject|14|||
13156061|NCT02497001|26068284|FG001|Overall Study|Withdrawal by Subject|37|||
13156062|NCT02497001|26068285|FG002|Overall Study|Withdrawal by Subject|19|||
13156063|NCT02497001|26068286|FG003|Overall Study|Withdrawal by Subject|15|||
13156064|NCT02497001|26068283|FG000|Overall Study|Physician Decision|5|||
13156065|NCT02497001|26068284|FG001|Overall Study|Physician Decision|11|||
13156066|NCT02497001|26068285|FG002|Overall Study|Physician Decision|5|||
13156067|NCT02497001|26068286|FG003|Overall Study|Physician Decision|1|||
13156068|NCT02497001|26068283|FG000|Overall Study|subjects that were not treated|1|||
13156069|NCT02497001|26068284|FG001|Overall Study|subjects that were not treated|2|||
13156070|NCT02497001|26068285|FG002|Overall Study|subjects that were not treated|2|||
13156071|NCT02497001|26068286|FG003|Overall Study|subjects that were not treated|1|||
13156072|NCT02497001|26068283|FG000|Overall Study|Major Protocol Deviation|3|||
13156073|NCT02497001|26068284|FG001|Overall Study|Major Protocol Deviation|4|||
13156074|NCT02497001|26068285|FG002|Overall Study|Major Protocol Deviation|4|||
13156075|NCT02497001|26068286|FG003|Overall Study|Major Protocol Deviation|4|||
13156076|NCT02497001|26068283|FG000|Overall Study|Lack of Efficacy|10|||
13156077|NCT02497001|26068284|FG001|Overall Study|Lack of Efficacy|16|||
13156078|NCT02497001|26068285|FG002|Overall Study|Lack of Efficacy|6|||
13156079|NCT02497001|26068286|FG003|Overall Study|Lack of Efficacy|6|||
13156080|NCT02497001|26068283|FG000|Overall Study|Protocol Violation|3|||
13156081|NCT02497001|26068284|FG001|Overall Study|Protocol Violation|1|||
13156082|NCT02497001|26068285|FG002|Overall Study|Protocol Violation|3|||
13156083|NCT02497001|26068286|FG003|Overall Study|Protocol Violation|1|||
13156084|NCT02496884|26068321|FG000|Overall Study|Counted twice as enrolled|2|||
13156085|NCT02496884|26068322|FG001|Overall Study|Counted twice as enrolled|0|||
13156086|NCT02496884|26068323|FG002|Overall Study|Counted twice as enrolled|0|||
13156087|NCT02496884|26068324|FG003|Overall Study|Counted twice as enrolled|0|||
13156088|NCT02496884|26068321|FG000|Overall Study|Withdrawal by Subject|0|||
13156089|NCT02496884|26068322|FG001|Overall Study|Withdrawal by Subject|3|||
13156090|NCT02496884|26068323|FG002|Overall Study|Withdrawal by Subject|0|||
13156091|NCT02496884|26068324|FG003|Overall Study|Withdrawal by Subject|0|||
13156092|NCT02496767|26068379|FG000|Open-label Lead-in Phase|Adverse Event|176|||
13156093|NCT02496767|26068380|FG001|Open-label Lead-in Phase|Adverse Event|0|||
13156094|NCT02496767|26068381|FG002|Open-label Lead-in Phase|Adverse Event|0|||
13156095|NCT02496767|26068382|FG003|Open-label Lead-in Phase|Adverse Event|0|||
13156096|NCT02496767|26068383|FG004|Open-label Lead-in Phase|Adverse Event|0|||
13156097|NCT02496767|26068384|FG005|Open-label Lead-in Phase|Adverse Event|0|||
13156098|NCT02496767|26068385|FG006|Open-label Lead-in Phase|Adverse Event|0|||
13156099|NCT02496767|26068386|FG007|Open-label Lead-in Phase|Adverse Event|0|||
13156100|NCT02496767|26068379|FG000|Open-label Lead-in Phase|Protocol Violation|2|||
13156101|NCT02496767|26068380|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
13156102|NCT02496767|26068381|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
13156103|NCT02496767|26068382|FG003|Open-label Lead-in Phase|Protocol Violation|0|||
13156104|NCT02496767|26068383|FG004|Open-label Lead-in Phase|Protocol Violation|0|||
13156105|NCT02496767|26068384|FG005|Open-label Lead-in Phase|Protocol Violation|0|||
13156106|NCT02496767|26068385|FG006|Open-label Lead-in Phase|Protocol Violation|0|||
13156107|NCT02496767|26068386|FG007|Open-label Lead-in Phase|Protocol Violation|0|||
13156108|NCT02496767|26068379|FG000|Open-label Lead-in Phase|Lost to Follow-up|1|||
13156109|NCT02496767|26068380|FG001|Open-label Lead-in Phase|Lost to Follow-up|0|||
13156110|NCT02496767|26068381|FG002|Open-label Lead-in Phase|Lost to Follow-up|0|||
13156111|NCT02496767|26068382|FG003|Open-label Lead-in Phase|Lost to Follow-up|0|||
13156112|NCT02496767|26068383|FG004|Open-label Lead-in Phase|Lost to Follow-up|0|||
13156113|NCT02496767|26068384|FG005|Open-label Lead-in Phase|Lost to Follow-up|0|||
13156114|NCT02496767|26068385|FG006|Open-label Lead-in Phase|Lost to Follow-up|0|||
13104499|NCT03337308|25875978|FG000|Overall Study|Withdrawal by Subject|2|||
13104500|NCT03337308|25875979|FG001|Overall Study|Withdrawal by Subject|1|||
13104501|NCT03337308|25875980|FG002|Overall Study|Withdrawal by Subject|2|||
13104502|NCT03337308|25875981|FG003|Overall Study|Withdrawal by Subject|1|||
13156115|NCT02496767|26068386|FG007|Open-label Lead-in Phase|Lost to Follow-up|0|||
13156116|NCT02496767|26068379|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
13156117|NCT02496767|26068380|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13|||
13156118|NCT02496767|26068381|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23|||
13222756|NCT01803282|26286892|FG009|Overall Study|Adverse Event|1|||
13104503|NCT03337308|25875978|FG000|Overall Study|Protocol Violation|0|||
13104504|NCT03337308|25875979|FG001|Overall Study|Protocol Violation|1|||
13104505|NCT03337308|25875980|FG002|Overall Study|Protocol Violation|0|||
13104506|NCT03337308|25875981|FG003|Overall Study|Protocol Violation|0|||
13104507|NCT03337152|25876006|FG000|Overall Study|Physician Decision|1|||
13104508|NCT03337152|25876007|FG001|Overall Study|Physician Decision|0|||
13104509|NCT03337152|25876006|FG000|Overall Study|Lost to Follow-up|1|||
13104510|NCT03337152|25876007|FG001|Overall Study|Lost to Follow-up|3|||
13104511|NCT03337152|25876006|FG000|Overall Study|Adverse Event|3|||
13104512|NCT03337152|25876007|FG001|Overall Study|Adverse Event|1|||
13104513|NCT03337152|25876006|FG000|Overall Study|Stopped drug dosing due to study halt|6|||
13104514|NCT03337152|25876007|FG001|Overall Study|Stopped drug dosing due to study halt|7|||
13104515|NCT03337139|25876032|FG000|Phase I|Withdrawal by Subject|10|||
13104516|NCT03337139|25876033|FG001|Phase I|Withdrawal by Subject|0|||
13104517|NCT03337113|25876080|FG000|Overall Study|Adverse Event|1|||
13104518|NCT03337113|25876081|FG001|Overall Study|Adverse Event|1|||
13104519|NCT03337113|25876082|FG002|Overall Study|Adverse Event|0|||
13104520|NCT03337113|25876083|FG003|Overall Study|Adverse Event|1|||
13104521|NCT03337113|25876080|FG000|Overall Study|Physician Decision|0|||
13104522|NCT03337113|25876081|FG001|Overall Study|Physician Decision|2|||
13104523|NCT03337113|25876082|FG002|Overall Study|Physician Decision|0|||
13104524|NCT03337113|25876083|FG003|Overall Study|Physician Decision|1|||
13104525|NCT03337113|25876080|FG000|Overall Study|Withdrawal by Subject|0|||
13104526|NCT03337113|25876081|FG001|Overall Study|Withdrawal by Subject|0|||
13104527|NCT03337113|25876082|FG002|Overall Study|Withdrawal by Subject|1|||
13104528|NCT03337113|25876083|FG003|Overall Study|Withdrawal by Subject|0|||
13104529|NCT03336619|25876116|FG000|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|192|||
13104530|NCT03336619|25876117|FG001|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|204|||
13104531|NCT03336619|25876116|FG000|Overall Study|Withdrawal by Subject|17|||
13104532|NCT03336619|25876117|FG001|Overall Study|Withdrawal by Subject|16|||
13104533|NCT03336619|25876116|FG000|Overall Study|Adverse Event|2|||
13104534|NCT03336619|25876117|FG001|Overall Study|Adverse Event|5|||
13104535|NCT03336619|25876116|FG000|Overall Study|Physician Decision|3|||
13104536|NCT03336619|25876117|FG001|Overall Study|Physician Decision|0|||
13104537|NCT03336528|25876162|FG000|Overall Study|Protocol Violation|1|||
13104538|NCT03336528|25876163|FG001|Overall Study|Protocol Violation|1|||
13104539|NCT03336528|25876162|FG000|Overall Study|Discharged within 48 hours of study medication|8|||
13104540|NCT03336528|25876163|FG001|Overall Study|Discharged within 48 hours of study medication|6|||
13104541|NCT03336528|25876162|FG000|Overall Study|Did not receive study medication|1|||
13104542|NCT03336528|25876163|FG001|Overall Study|Did not receive study medication|2|||
13104543|NCT03336502|25876197|FG000|Overall Study|Physician Decision|0|||
13222757|NCT01803282|26286893|FG010|Overall Study|Adverse Event|0|||
13156119|NCT02496767|26068382|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
13156120|NCT02496767|26068383|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
13156121|NCT02496767|26068384|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
13156122|NCT02496767|26068385|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
13156123|NCT02496767|26068386|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
13156124|NCT02496767|26068379|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
13156125|NCT02496767|26068380|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13|||
13156126|NCT02496767|26068381|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9|||
13156127|NCT02496767|26068382|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8|||
13156128|NCT02496767|26068383|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14|||
13156129|NCT02496767|26068384|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
13156130|NCT02496767|26068385|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
13156131|NCT02496767|26068386|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
13156132|NCT02496767|26068379|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
13156133|NCT02496767|26068380|FG001|Double-blind, Placebo-controlled Phase|Death|10|||
13156134|NCT02496767|26068381|FG002|Double-blind, Placebo-controlled Phase|Death|6|||
13156135|NCT02496767|26068382|FG003|Double-blind, Placebo-controlled Phase|Death|2|||
13156136|NCT02496767|26068383|FG004|Double-blind, Placebo-controlled Phase|Death|4|||
13156137|NCT02496767|26068384|FG005|Double-blind, Placebo-controlled Phase|Death|0|||
13156138|NCT02496767|26068385|FG006|Double-blind, Placebo-controlled Phase|Death|0|||
13156139|NCT02496767|26068386|FG007|Double-blind, Placebo-controlled Phase|Death|0|||
13156140|NCT02496767|26068379|FG000|Double-blind, Placebo-controlled Phase|Various|0|||
13156141|NCT02496767|26068380|FG001|Double-blind, Placebo-controlled Phase|Various|9|||
13156142|NCT02496767|26068381|FG002|Double-blind, Placebo-controlled Phase|Various|4|||
13156143|NCT02496767|26068382|FG003|Double-blind, Placebo-controlled Phase|Various|5|||
13156144|NCT02496767|26068383|FG004|Double-blind, Placebo-controlled Phase|Various|2|||
13156145|NCT02496767|26068384|FG005|Double-blind, Placebo-controlled Phase|Various|0|||
13156146|NCT02496767|26068385|FG006|Double-blind, Placebo-controlled Phase|Various|0|||
13156147|NCT02496767|26068386|FG007|Double-blind, Placebo-controlled Phase|Various|0|||
13156148|NCT02496767|26068379|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
13156149|NCT02496767|26068380|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4|||
13156150|NCT02496767|26068381|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3|||
13156151|NCT02496767|26068382|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1|||
13156152|NCT02496767|26068383|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2|||
13156153|NCT02496767|26068384|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
13156154|NCT02496767|26068385|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
13156155|NCT02496767|26068386|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
13156156|NCT02496767|26068379|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
13156157|NCT02496767|26068380|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4|||
13156158|NCT02496767|26068381|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1|||
13156159|NCT02496767|26068382|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
13156160|NCT02496767|26068383|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
13156161|NCT02496767|26068384|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
13156162|NCT02496767|26068385|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
13156163|NCT02496767|26068386|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
13156164|NCT02496767|26068379|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
13156165|NCT02496767|26068380|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
13156166|NCT02496767|26068381|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
13156167|NCT02496767|26068382|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
13156168|NCT02496767|26068383|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1|||
13156169|NCT02496767|26068384|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
13156170|NCT02496767|26068385|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
13156171|NCT02496767|26068386|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
13156172|NCT02496767|26068379|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
13156173|NCT02496767|26068380|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1|||
13156174|NCT02496767|26068381|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
13156175|NCT02496767|26068382|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
13156176|NCT02496767|26068383|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
13156177|NCT02496767|26068384|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
13156178|NCT02496767|26068385|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
13156179|NCT02496767|26068386|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
13156180|NCT02496767|26068379|FG000|Double-blind, Withdrawal Phase|Progressive disease|0|||
13156181|NCT02496767|26068380|FG001|Double-blind, Withdrawal Phase|Progressive disease|0|||
13156182|NCT02496767|26068381|FG002|Double-blind, Withdrawal Phase|Progressive disease|0|||
13222758|NCT01803282|26286894|FG011|Overall Study|Adverse Event|3|||
13222759|NCT01803282|26286883|FG000|Overall Study|Non-Compliance with Study Drug|0|||
13156183|NCT02496767|26068382|FG003|Double-blind, Withdrawal Phase|Progressive disease|0|||
13156184|NCT02496767|26068383|FG004|Double-blind, Withdrawal Phase|Progressive disease|0|||
13156185|NCT02496767|26068384|FG005|Double-blind, Withdrawal Phase|Progressive disease|4|||
13156186|NCT02496767|26068385|FG006|Double-blind, Withdrawal Phase|Progressive disease|0|||
13156187|NCT02496767|26068386|FG007|Double-blind, Withdrawal Phase|Progressive disease|1|||
13156188|NCT02496767|26068379|FG000|Double-blind, Withdrawal Phase|Adverse Event|0|||
13156189|NCT02496767|26068380|FG001|Double-blind, Withdrawal Phase|Adverse Event|0|||
13156190|NCT02496767|26068381|FG002|Double-blind, Withdrawal Phase|Adverse Event|0|||
13156191|NCT02496767|26068382|FG003|Double-blind, Withdrawal Phase|Adverse Event|0|||
13156192|NCT02496767|26068383|FG004|Double-blind, Withdrawal Phase|Adverse Event|0|||
13156193|NCT02496767|26068384|FG005|Double-blind, Withdrawal Phase|Adverse Event|1|||
13156194|NCT02496767|26068385|FG006|Double-blind, Withdrawal Phase|Adverse Event|2|||
13156195|NCT02496767|26068386|FG007|Double-blind, Withdrawal Phase|Adverse Event|1|||
13156196|NCT02496767|26068379|FG000|Double-blind, Withdrawal Phase|Death|0|||
13156197|NCT02496767|26068380|FG001|Double-blind, Withdrawal Phase|Death|0|||
13156198|NCT02496767|26068381|FG002|Double-blind, Withdrawal Phase|Death|0|||
13156199|NCT02496767|26068382|FG003|Double-blind, Withdrawal Phase|Death|0|||
13156200|NCT02496767|26068383|FG004|Double-blind, Withdrawal Phase|Death|0|||
13156201|NCT02496767|26068384|FG005|Double-blind, Withdrawal Phase|Death|0|||
13156202|NCT02496767|26068385|FG006|Double-blind, Withdrawal Phase|Death|1|||
13156203|NCT02496767|26068386|FG007|Double-blind, Withdrawal Phase|Death|2|||
13156204|NCT02496767|26068379|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
13156205|NCT02496767|26068380|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
13156206|NCT02496767|26068381|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
13156207|NCT02496767|26068382|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
13156208|NCT02496767|26068383|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
13156209|NCT02496767|26068384|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
13156210|NCT02496767|26068385|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
13156211|NCT02496767|26068386|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
13156212|NCT02496702|26068413|FG000|Overall Study|Lost to Follow-up|8|||
13156213|NCT02496702|26068414|FG001|Overall Study|Lost to Follow-up|6|||
13156214|NCT02496702|26068413|FG000|Overall Study|Only partially tested|0|||
13156215|NCT02496702|26068414|FG001|Overall Study|Only partially tested|2|||
13156216|NCT02496676|26068443|FG000|Phase 1 - Period 1|Adverse Event|0|||
13156217|NCT02496676|26068444|FG001|Phase 1 - Period 1|Adverse Event|1|||
13156218|NCT02496676|26068443|FG000|Phase 2 - IV MgSO4|Adverse Event|0|||
13156219|NCT02496676|26068444|FG001|Phase 2 - IV MgSO4|Adverse Event|1|||
13156220|NCT02496533|26068463|FG000|Overall Study|Lack of data on outcome|3|||
13156221|NCT02496533|26068464|FG001|Overall Study|Lack of data on outcome|0|||
13156222|NCT02496533|26068463|FG000|Overall Study|Patient did not complete all measures|0|||
13156223|NCT02496533|26068464|FG001|Overall Study|Patient did not complete all measures|4|||
13156224|NCT02496533|26068463|FG000|Overall Study|Late for radiologic testing|0|||
13156225|NCT02496533|26068464|FG001|Overall Study|Late for radiologic testing|2|||
13156226|NCT02496221|26068501|FG000|Treatment Period 2 - 4 Days|Adverse Event|0|||
13156227|NCT02496221|26068502|FG001|Treatment Period 2 - 4 Days|Adverse Event|1|||
13156228|NCT02496221|26068501|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1|||
13156229|NCT02496221|26068502|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0|||
13156230|NCT02496221|26068501|FG000|Treatment Period 2 - 4 Days|Physician Decision|1|||
13156231|NCT02496221|26068502|FG001|Treatment Period 2 - 4 Days|Physician Decision|0|||
13156232|NCT02496091|26068513|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
13156233|NCT02496039|26068527|FG000|Overall Study|Adverse Event|3|||
13156234|NCT02496039|26068527|FG000|Overall Study|Protocol Violation|1|||
13156235|NCT02496000|26068558|FG000|Overall Study|Withdrawal by Subject|1|||
13156236|NCT02496000|26068559|FG001|Overall Study|Withdrawal by Subject|2|||
13156237|NCT02496000|26068560|FG002|Overall Study|Withdrawal by Subject|0|||
13156238|NCT02496000|26068558|FG000|Overall Study|Lost to Follow-up|1|||
13156239|NCT02496000|26068559|FG001|Overall Study|Lost to Follow-up|0|||
13156240|NCT02496000|26068560|FG002|Overall Study|Lost to Follow-up|1|||
13156241|NCT02496000|26068558|FG000|Overall Study|Protocol Violation|0|||
13156242|NCT02496000|26068559|FG001|Overall Study|Protocol Violation|0|||
13156243|NCT02496000|26068560|FG002|Overall Study|Protocol Violation|1|||
13156244|NCT02496000|26068558|FG000|Overall Study|Non-compliance or lack of cooperation|0|||
13156245|NCT02496000|26068559|FG001|Overall Study|Non-compliance or lack of cooperation|2|||
13156246|NCT02496000|26068560|FG002|Overall Study|Non-compliance or lack of cooperation|0|||
13156247|NCT02496000|26068558|FG000|Overall Study|undetermined|0|||
13156248|NCT02496000|26068559|FG001|Overall Study|undetermined|1|||
13156249|NCT02496000|26068560|FG002|Overall Study|undetermined|0|||
13156250|NCT02495948|26068570|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
13156251|NCT02495948|26068571|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
13156252|NCT02495948|26068570|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
13156253|NCT02495948|26068571|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
13156254|NCT02495883|26068583|FG000|Overall Study|Excessive head motion|1|||
13156255|NCT02495883|26068584|FG001|Overall Study|Excessive head motion|0|||
13156256|NCT02495857|26068608|FG000|Overall Study|Adverse Event|5|||
13156257|NCT02495857|26068609|FG001|Overall Study|Adverse Event|0|||
13156258|NCT02495857|26068610|FG002|Overall Study|Adverse Event|1|||
13156259|NCT02495857|26068608|FG000|Overall Study|Withdrawal by Subject|9|||
13156260|NCT02495857|26068609|FG001|Overall Study|Withdrawal by Subject|6|||
13156261|NCT02495857|26068610|FG002|Overall Study|Withdrawal by Subject|10|||
13156262|NCT02495857|26068608|FG000|Overall Study|Physician Decision|0|||
13156263|NCT02495857|26068609|FG001|Overall Study|Physician Decision|1|||
13156264|NCT02495857|26068610|FG002|Overall Study|Physician Decision|0|||
13156265|NCT02495857|26068608|FG000|Overall Study|Protocol Violation|1|||
13156266|NCT02495857|26068609|FG001|Overall Study|Protocol Violation|1|||
13156267|NCT02495857|26068610|FG002|Overall Study|Protocol Violation|2|||
13156268|NCT02495857|26068608|FG000|Overall Study|Lost to Follow-up|4|||
13156269|NCT02495857|26068609|FG001|Overall Study|Lost to Follow-up|5|||
13156270|NCT02495857|26068610|FG002|Overall Study|Lost to Follow-up|3|||
13156271|NCT02495857|26068608|FG000|Overall Study|Other|3|||
13156272|NCT02495857|26068609|FG001|Overall Study|Other|3|||
13156273|NCT02495857|26068610|FG002|Overall Study|Other|2|||
13156274|NCT02495844|26068647|FG000|Overall Study|Lack of Efficacy|1|||
13156275|NCT02495844|26068648|FG001|Overall Study|Lack of Efficacy|2|||
13156276|NCT02495844|26068647|FG000|Overall Study|AE, non-fatal|0|||
13156277|NCT02495844|26068648|FG001|Overall Study|AE, non-fatal|1|||
13156278|NCT02495844|26068647|FG000|Overall Study|Hepatitis Positivity|0|||
13156279|NCT02495844|26068648|FG001|Overall Study|Hepatitis Positivity|1|||
13156280|NCT02495389|26068658|FG000|Overall Study|Withdrawal by Subject|40|||
13156281|NCT02495233|26068691|FG000|Overall Study|Miscellaneous|0|||
13156282|NCT02495233|26068692|FG001|Overall Study|Miscellaneous|1|||
13156283|NCT02495168|26068719|FG000|Overall Study|Other than Specified|18|||
13156284|NCT02495168|26068720|FG001|Overall Study|Other than Specified|22|||
13156285|NCT02495168|26068721|FG002|Overall Study|Other than Specified|5|||
13156286|NCT02495168|26068719|FG000|Overall Study|Did not Complete Final Visit On Time|4|||
13156287|NCT02495168|26068720|FG001|Overall Study|Did not Complete Final Visit On Time|3|||
13156288|NCT02495168|26068721|FG002|Overall Study|Did not Complete Final Visit On Time|2|||
13156289|NCT02495168|26068719|FG000|Overall Study|Physician Decision|1|||
13156290|NCT02495168|26068720|FG001|Overall Study|Physician Decision|1|||
13156291|NCT02495168|26068721|FG002|Overall Study|Physician Decision|0|||
13156292|NCT02495168|26068719|FG000|Overall Study|Lost to Follow-up|10|||
13156293|NCT02495168|26068720|FG001|Overall Study|Lost to Follow-up|6|||
13156294|NCT02495168|26068721|FG002|Overall Study|Lost to Follow-up|1|||
13156295|NCT02495168|26068719|FG000|Overall Study|Withdrawal by Subject|1|||
13156296|NCT02495168|26068720|FG001|Overall Study|Withdrawal by Subject|4|||
13156297|NCT02495168|26068721|FG002|Overall Study|Withdrawal by Subject|2|||
13156298|NCT02495168|26068719|FG000|Overall Study|Protocol Violation|0|||
13156299|NCT02495168|26068720|FG001|Overall Study|Protocol Violation|10|||
13156300|NCT02495168|26068721|FG002|Overall Study|Protocol Violation|1|||
13156301|NCT02495168|26068719|FG000|Overall Study|Adverse Event|4|||
13156302|NCT02495168|26068720|FG001|Overall Study|Adverse Event|8|||
13156303|NCT02495168|26068721|FG002|Overall Study|Adverse Event|3|||
13156304|NCT02495168|26068719|FG000|Overall Study|Lack of Efficacy|0|||
13156305|NCT02495168|26068720|FG001|Overall Study|Lack of Efficacy|0|||
13156306|NCT02495168|26068721|FG002|Overall Study|Lack of Efficacy|3|||
13156307|NCT02495077|26068826|FG000|Overall Study|Adverse Event|0|||
13156308|NCT02495077|26068827|FG001|Overall Study|Adverse Event|1|||
13156309|NCT02495077|26068828|FG002|Overall Study|Adverse Event|1|||
13156310|NCT02495077|26068829|FG003|Overall Study|Adverse Event|0|||
13156311|NCT02495077|26068826|FG000|Overall Study|Death|3|||
13156312|NCT02495077|26068827|FG001|Overall Study|Death|5|||
13156313|NCT02495077|26068828|FG002|Overall Study|Death|0|||
13156314|NCT02495077|26068829|FG003|Overall Study|Death|0|||
13156315|NCT02495077|26068826|FG000|Overall Study|Lost to Follow-up|6|||
13156316|NCT02495077|26068827|FG001|Overall Study|Lost to Follow-up|4|||
13156317|NCT02495077|26068828|FG002|Overall Study|Lost to Follow-up|0|||
13156318|NCT02495077|26068829|FG003|Overall Study|Lost to Follow-up|0|||
13156319|NCT02495077|26068826|FG000|Overall Study|Physician Decision|2|||
13156320|NCT02495077|26068827|FG001|Overall Study|Physician Decision|1|||
13156321|NCT02495077|26068828|FG002|Overall Study|Physician Decision|4|||
13156322|NCT02495077|26068829|FG003|Overall Study|Physician Decision|0|||
13156323|NCT02495077|26068826|FG000|Overall Study|Protocol Violation|0|||
13156324|NCT02495077|26068827|FG001|Overall Study|Protocol Violation|1|||
13156325|NCT02495077|26068828|FG002|Overall Study|Protocol Violation|0|||
13156326|NCT02495077|26068829|FG003|Overall Study|Protocol Violation|0|||
13156327|NCT02495077|26068826|FG000|Overall Study|Screen Failure|0|||
13156328|NCT02495077|26068827|FG001|Overall Study|Screen Failure|0|||
13156329|NCT02495077|26068828|FG002|Overall Study|Screen Failure|0|||
13156330|NCT02495077|26068829|FG003|Overall Study|Screen Failure|48|||
13156331|NCT02495077|26068826|FG000|Overall Study|Withdrawal by Subject|7|||
13156332|NCT02495077|26068827|FG001|Overall Study|Withdrawal by Subject|7|||
13156333|NCT02495077|26068828|FG002|Overall Study|Withdrawal by Subject|7|||
13156334|NCT02495077|26068829|FG003|Overall Study|Withdrawal by Subject|0|||
13156335|NCT02495077|26068826|FG000|Overall Study|Covid-19 research restrictions|1|||
13156336|NCT02495077|26068827|FG001|Overall Study|Covid-19 research restrictions|0|||
13156337|NCT02495077|26068828|FG002|Overall Study|Covid-19 research restrictions|0|||
13156338|NCT02495077|26068829|FG003|Overall Study|Covid-19 research restrictions|0|||
13156339|NCT02495077|26068826|FG000|Overall Study|Visit 14 scheduling difficulties|1|||
13156340|NCT02495077|26068827|FG001|Overall Study|Visit 14 scheduling difficulties|0|||
13156341|NCT02495077|26068828|FG002|Overall Study|Visit 14 scheduling difficulties|0|||
13156342|NCT02495077|26068829|FG003|Overall Study|Visit 14 scheduling difficulties|0|||
13156343|NCT02495077|26068826|FG000|Overall Study|Incarcerated|0|||
13156344|NCT02495077|26068827|FG001|Overall Study|Incarcerated|1|||
13156345|NCT02495077|26068828|FG002|Overall Study|Incarcerated|0|||
13156346|NCT02495077|26068829|FG003|Overall Study|Incarcerated|0|||
13156347|NCT02495077|26068826|FG000|Overall Study|Transplant nephrectomy, patient decision|0|||
13156348|NCT02495077|26068827|FG001|Overall Study|Transplant nephrectomy, patient decision|1|||
13156349|NCT02495077|26068828|FG002|Overall Study|Transplant nephrectomy, patient decision|0|||
13156350|NCT02495077|26068829|FG003|Overall Study|Transplant nephrectomy, patient decision|0|||
13156351|NCT02495077|26068826|FG000|Overall Study|Timing of transplant and randomization|0|||
13156352|NCT02495077|26068827|FG001|Overall Study|Timing of transplant and randomization|0|||
13156353|NCT02495077|26068828|FG002|Overall Study|Timing of transplant and randomization|5|||
13156354|NCT02495077|26068829|FG003|Overall Study|Timing of transplant and randomization|0|||
13156355|NCT02495025|26068848|FG000|Overall Study|Lost to Follow-up|21|||
13156356|NCT02495025|26068849|FG001|Overall Study|Lost to Follow-up|14|||
13156357|NCT02495025|26068848|FG000|Overall Study|Withdrawal by Subject|5|||
13156358|NCT02495025|26068849|FG001|Overall Study|Withdrawal by Subject|0|||
13156359|NCT02494921|26068891|FG000|Phase 1b, Dose Level I|Adverse Event|2|||
13156360|NCT02494921|26068892|FG001|Phase 1b, Dose Level I|Adverse Event|0|||
13156361|NCT02494921|26068893|FG002|Phase 1b, Dose Level I|Adverse Event|0|||
13156362|NCT02494921|26068894|FG003|Phase 1b, Dose Level I|Adverse Event|0|||
13156363|NCT02494921|26068895|FG004|Phase 1b, Dose Level I|Adverse Event|0|||
13156364|NCT02494921|26068891|FG000|Phase 1b, Dose Level IA|Adverse Event|0|||
13156365|NCT02494921|26068892|FG001|Phase 1b, Dose Level IA|Adverse Event|1|||
13156366|NCT02494921|26068893|FG002|Phase 1b, Dose Level IA|Adverse Event|0|||
13156367|NCT02494921|26068894|FG003|Phase 1b, Dose Level IA|Adverse Event|0|||
13156368|NCT02494921|26068895|FG004|Phase 1b, Dose Level IA|Adverse Event|0|||
13156369|NCT02494921|26068891|FG000|Phase 1b, Dose Level IIC|Physician Decision|0|||
13156370|NCT02494921|26068892|FG001|Phase 1b, Dose Level IIC|Physician Decision|0|||
13156371|NCT02494921|26068893|FG002|Phase 1b, Dose Level IIC|Physician Decision|1|||
13156372|NCT02494921|26068894|FG003|Phase 1b, Dose Level IIC|Physician Decision|0|||
13156373|NCT02494921|26068895|FG004|Phase 1b, Dose Level IIC|Physician Decision|0|||
13156374|NCT02494778|26068903|FG000|Overall Study|Death|3|||
13156375|NCT02494778|26068903|FG000|Overall Study|Other|173|||
13156376|NCT02494778|26068903|FG000|Overall Study|Lack of Efficacy|4|||
13156377|NCT02494778|26068903|FG000|Overall Study|Adverse Event|18|||
13156378|NCT02494778|26068903|FG000|Overall Study|Withdrawal by Subject|20|||
13156379|NCT02494778|26068903|FG000|Overall Study|Lost to Follow-up|2|||
13156380|NCT02494778|26068903|FG000|Overall Study|Noncompliant with study drug admin.|1|||
13156381|NCT02494596|26068932|FG000|Overall Study|Insufficient Therapeutic Response|3|||
13156382|NCT02494596|26068933|FG001|Overall Study|Insufficient Therapeutic Response|3|||
13156383|NCT02494596|26068934|FG002|Overall Study|Insufficient Therapeutic Response|1|||
13156384|NCT02494596|26068932|FG000|Overall Study|Adverse Event|0|||
13156385|NCT02494596|26068933|FG001|Overall Study|Adverse Event|1|||
13156386|NCT02494596|26068934|FG002|Overall Study|Adverse Event|0|||
13156387|NCT02494596|26068932|FG000|Overall Study|Refused Treatment|0|||
13156388|NCT02494596|26068933|FG001|Overall Study|Refused Treatment|1|||
13156389|NCT02494596|26068934|FG002|Overall Study|Refused Treatment|0|||
13156390|NCT02494583|26068997|FG000|Overall Study|Death|195|||
13156391|NCT02494583|26068998|FG001|Overall Study|Death|189|||
13156392|NCT02494583|26068999|FG002|Overall Study|Death|201|||
13156393|NCT02494583|26068997|FG000|Overall Study|Lost to Follow-up|1|||
13156394|NCT02494583|26068998|FG001|Overall Study|Lost to Follow-up|0|||
13156395|NCT02494583|26068999|FG002|Overall Study|Lost to Follow-up|0|||
13156396|NCT02494583|26068997|FG000|Overall Study|Protocol Violation|1|||
13156397|NCT02494583|26068998|FG001|Overall Study|Protocol Violation|2|||
13156398|NCT02494583|26068999|FG002|Overall Study|Protocol Violation|0|||
13156399|NCT02494583|26068997|FG000|Overall Study|Withdrawal by Subject|3|||
13156400|NCT02494583|26068998|FG001|Overall Study|Withdrawal by Subject|15|||
13156401|NCT02494583|26068999|FG002|Overall Study|Withdrawal by Subject|15|||
13156402|NCT02494583|26068997|FG000|Overall Study|Ongoing in Study|56|||
13156403|NCT02494583|26068998|FG001|Overall Study|Ongoing in Study|51|||
13156404|NCT02494583|26068999|FG002|Overall Study|Ongoing in Study|34|||
13156405|NCT02494401|26069044|FG000|Overall Study|Lost to Follow-up|22|||
13156406|NCT02494401|26069045|FG001|Overall Study|Lost to Follow-up|25|||
13156407|NCT02494401|26069044|FG000|Overall Study|Withdrawal by Subject|3|||
13156408|NCT02494401|26069045|FG001|Overall Study|Withdrawal by Subject|2|||
13156409|NCT02494206|26069051|FG000|Overall Study|Adverse Event|1|||
13156410|NCT02494206|26069051|FG000|Overall Study|Disease Progression|1|||
13156411|NCT02493946|26069094|FG000|DB Period|Withdrawal by Subject|8|||
13156412|NCT02493946|26069095|FG001|DB Period|Withdrawal by Subject|5|||
13156413|NCT02493946|26069096|FG002|DB Period|Withdrawal by Subject|0|||
13156414|NCT02493946|26069094|FG000|Open Label Period|Withdrawal by Subject|0|||
13156415|NCT02493946|26069095|FG001|Open Label Period|Withdrawal by Subject|0|||
13156416|NCT02493946|26069096|FG002|Open Label Period|Withdrawal by Subject|74|||
13156417|NCT02493946|26069094|FG000|Open Label Period|Adverse Event|0|||
13156418|NCT02493946|26069095|FG001|Open Label Period|Adverse Event|0|||
13156419|NCT02493946|26069096|FG002|Open Label Period|Adverse Event|4|||
13156420|NCT02493946|26069094|FG000|Open Label Period|Lost to Follow-up|0|||
13156421|NCT02493946|26069095|FG001|Open Label Period|Lost to Follow-up|0|||
13156422|NCT02493946|26069096|FG002|Open Label Period|Lost to Follow-up|1|||
13156423|NCT02493946|26069094|FG000|Open Label Period|Investigator decision, non-compliance|0|||
13156424|NCT02493946|26069095|FG001|Open Label Period|Investigator decision, non-compliance|0|||
13156425|NCT02493946|26069096|FG002|Open Label Period|Investigator decision, non-compliance|2|||
13156426|NCT02493946|26069094|FG000|Open Label Period|Investigator decision, non-availability|0|||
13156427|NCT02493946|26069095|FG001|Open Label Period|Investigator decision, non-availability|0|||
13156428|NCT02493946|26069096|FG002|Open Label Period|Investigator decision, non-availability|1|||
13156429|NCT02493946|26069094|FG000|Open Label Period|Pregnancy|0|||
13156430|NCT02493946|26069095|FG001|Open Label Period|Pregnancy|0|||
13156431|NCT02493946|26069096|FG002|Open Label Period|Pregnancy|3|||
13156432|NCT02493946|26069094|FG000|Open Label Period|Site error|0|||
13156433|NCT02493946|26069095|FG001|Open Label Period|Site error|0|||
13156434|NCT02493946|26069096|FG002|Open Label Period|Site error|1|||
13156435|NCT02493868|26069145|FG000|Induction Phase: DE Participants|Adverse Event|22|||
13156436|NCT02493868|26069146|FG001|Induction Phase: DE Participants|Adverse Event|0|||
13156437|NCT02493868|26069145|FG000|Induction Phase: DE Participants|Lost to Follow-up|1|||
13156438|NCT02493868|26069146|FG001|Induction Phase: DE Participants|Lost to Follow-up|0|||
13156439|NCT02493868|26069145|FG000|Induction Phase: DE Participants|Lack of Efficacy|2|||
13156440|NCT02493868|26069146|FG001|Induction Phase: DE Participants|Lack of Efficacy|0|||
13156441|NCT02493868|26069145|FG000|Induction Phase: DE Participants|Protocol Violation|2|||
13156442|NCT02493868|26069146|FG001|Induction Phase: DE Participants|Protocol Violation|0|||
13156443|NCT02493868|26069145|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15|||
13156444|NCT02493868|26069146|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0|||
13156445|NCT02493868|26069145|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114|||
13156446|NCT02493868|26069146|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0|||
13156447|NCT02493868|26069145|FG000|Induction Phase: DE Participants|Other|8|||
13156448|NCT02493868|26069146|FG001|Induction Phase: DE Participants|Other|0|||
13156449|NCT02493868|26069145|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5|||
13156450|NCT02493868|26069146|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0|||
13156451|NCT02493868|26069145|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2|||
13156452|NCT02493868|26069146|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1|||
13156453|NCT02493868|26069145|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8|||
13156454|NCT02493868|26069146|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0|||
13156455|NCT02493868|26069145|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4|||
13156456|NCT02493868|26069146|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1|||
13156457|NCT02493868|26069145|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8|||
13156458|NCT02493868|26069146|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3|||
13156459|NCT02493868|26069145|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14|||
13156460|NCT02493868|26069146|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5|||
13156461|NCT02493868|26069145|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107|||
13156462|NCT02493868|26069146|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20|||
13156463|NCT02493868|26069145|FG000|Optimization Phase: DE+TE Participants|Other|10|||
13104544|NCT03336502|25876198|FG001|Overall Study|Physician Decision|1|||
13104545|NCT03336502|25876197|FG000|Overall Study|Prohibited Drugs|1|||
13104546|NCT03336502|25876198|FG001|Overall Study|Prohibited Drugs|1|||
13104547|NCT03336502|25876197|FG000|Overall Study|Death|1|||
13104548|NCT03336502|25876198|FG001|Overall Study|Death|2|||
13104549|NCT03336502|25876197|FG000|Overall Study|Adverse Event|2|||
13104550|NCT03336502|25876198|FG001|Overall Study|Adverse Event|5|||
13104551|NCT03335566|25876217|FG000|Overall Study|Adverse Event|0|||
13104552|NCT03335566|25876218|FG001|Overall Study|Adverse Event|1|||
13104553|NCT03335566|25876217|FG000|Overall Study|Lost to Follow-up|1|||
13104554|NCT03335566|25876218|FG001|Overall Study|Lost to Follow-up|0|||
13104555|NCT03335566|25876217|FG000|Overall Study|Technical Problems|1|||
13104556|NCT03335566|25876218|FG001|Overall Study|Technical Problems|0|||
13104557|NCT03335566|25876217|FG000|Overall Study|Protocol Violation|1|||
13104558|NCT03335566|25876218|FG001|Overall Study|Protocol Violation|0|||
13156464|NCT02493868|26069146|FG001|Optimization Phase: DE+TE Participants|Other|2|||
13156465|NCT02493868|26069145|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1|||
13104559|NCT03335566|25876217|FG000|Overall Study|Other than specified above|1|||
13104560|NCT03335566|25876218|FG001|Overall Study|Other than specified above|2|||
13104561|NCT03335163|25876224|FG000|Overall Study|Not eligible due to laboratory criteria|3|||
13104562|NCT03335163|25876224|FG000|Overall Study|Withdrawal by Subject|18|||
13104563|NCT03335150|25876253|FG000|Overall Study|Withdrawal by Subject|10|||
13104564|NCT03335150|25876254|FG001|Overall Study|Withdrawal by Subject|4|||
13104565|NCT03335150|25876253|FG000|Overall Study|Adverse Event|0|||
13104566|NCT03335150|25876254|FG001|Overall Study|Adverse Event|1|||
13104567|NCT03334903|25876279|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1|||
13104568|NCT03334903|25876280|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0|||
13104569|NCT03334903|25876279|FG000|Overall Study|Protocol Violation|1|||
13104570|NCT03334903|25876280|FG001|Overall Study|Protocol Violation|3|||
13104571|NCT03334903|25876279|FG000|Overall Study|Surgery postponed|1|||
13104572|NCT03334903|25876280|FG001|Overall Study|Surgery postponed|0|||
13104573|NCT03334903|25876279|FG000|Overall Study|Adverse Event|1|||
13104574|NCT03334903|25876280|FG001|Overall Study|Adverse Event|1|||
13104575|NCT03334903|25876279|FG000|Overall Study|Withdrawal by Subject|0|||
13104576|NCT03334903|25876280|FG001|Overall Study|Withdrawal by Subject|1|||
13104577|NCT03334747|25876396|FG000|Treatment Phase|Technical problems|0|||
13104578|NCT03334747|25876397|FG001|Treatment Phase|Technical problems|0|||
13104579|NCT03334747|25876398|FG002|Treatment Phase|Technical problems|0|||
13104580|NCT03334747|25876399|FG003|Treatment Phase|Technical problems|0|||
13104581|NCT03334747|25876400|FG004|Treatment Phase|Technical problems|1|||
13104582|NCT03334747|25876401|FG005|Treatment Phase|Technical problems|0|||
13104583|NCT03334747|25876402|FG006|Treatment Phase|Technical problems|0|||
13104584|NCT03334747|25876403|FG007|Treatment Phase|Technical problems|0|||
13104585|NCT03334747|25876404|FG008|Treatment Phase|Technical problems|0|||
13104586|NCT03334747|25876396|FG000|Treatment Phase|Subject/guardian decision|1|||
13104587|NCT03334747|25876397|FG001|Treatment Phase|Subject/guardian decision|0|||
13104588|NCT03334747|25876398|FG002|Treatment Phase|Subject/guardian decision|0|||
13104589|NCT03334747|25876399|FG003|Treatment Phase|Subject/guardian decision|0|||
13104590|NCT03334747|25876400|FG004|Treatment Phase|Subject/guardian decision|0|||
13104591|NCT03334747|25876401|FG005|Treatment Phase|Subject/guardian decision|1|||
13104592|NCT03334747|25876402|FG006|Treatment Phase|Subject/guardian decision|0|||
13104593|NCT03334747|25876403|FG007|Treatment Phase|Subject/guardian decision|0|||
13104594|NCT03334747|25876404|FG008|Treatment Phase|Subject/guardian decision|0|||
13104595|NCT03334747|25876396|FG000|Follow-Up Phase|Subject/guardian decision|0|||
13104596|NCT03334747|25876397|FG001|Follow-Up Phase|Subject/guardian decision|0|||
13104597|NCT03334747|25876398|FG002|Follow-Up Phase|Subject/guardian decision|0|||
13104598|NCT03334747|25876399|FG003|Follow-Up Phase|Subject/guardian decision|0|||
13104599|NCT03334747|25876400|FG004|Follow-Up Phase|Subject/guardian decision|0|||
13104600|NCT03334747|25876401|FG005|Follow-Up Phase|Subject/guardian decision|0|||
13104601|NCT03334747|25876402|FG006|Follow-Up Phase|Subject/guardian decision|1|||
13104602|NCT03334747|25876403|FG007|Follow-Up Phase|Subject/guardian decision|0|||
13104603|NCT03334747|25876404|FG008|Follow-Up Phase|Subject/guardian decision|1|||
13104604|NCT03334721|25876417|FG000|Overall Study|Withdrawal by Subject|1|||
13104605|NCT03334721|25876418|FG001|Overall Study|Withdrawal by Subject|0|||
13104606|NCT03334721|25876417|FG000|Overall Study|No longer met inclusion/exclusion criter|1|||
13104607|NCT03334721|25876418|FG001|Overall Study|No longer met inclusion/exclusion criter|0|||
13104608|NCT03334695|25876459|FG000|Overall Study|Lost to Follow-up|3|||
13104609|NCT03334695|25876460|FG001|Overall Study|Lost to Follow-up|3|||
13104610|NCT03334695|25876459|FG000|Overall Study|Physician Decision|1|||
13104611|NCT03334695|25876460|FG001|Overall Study|Physician Decision|2|||
13104612|NCT03334695|25876459|FG000|Overall Study|Protocol Violation|0|||
13156466|NCT02493868|26069146|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4|||
13156467|NCT02493868|26069145|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1|||
13156468|NCT02493868|26069146|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0|||
13156469|NCT02493868|26069145|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
13156470|NCT02493868|26069146|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
13104613|NCT03334695|25876460|FG001|Overall Study|Protocol Violation|1|||
13104614|NCT03334630|25876509|FG000|Overall Study|Withdrawal by Subject|7|||
13104615|NCT03334630|25876510|FG001|Overall Study|Withdrawal by Subject|7|||
13104616|NCT03334630|25876509|FG000|Overall Study|Lost to Follow-up|3|||
13104617|NCT03334630|25876510|FG001|Overall Study|Lost to Follow-up|1|||
13104618|NCT03334630|25876509|FG000|Overall Study|Adverse Event|0|||
13104619|NCT03334630|25876510|FG001|Overall Study|Adverse Event|1|||
13104620|NCT03334630|25876509|FG000|Overall Study|Physician Decision|1|||
13104621|NCT03334630|25876510|FG001|Overall Study|Physician Decision|1|||
13104622|NCT03334630|25876509|FG000|Overall Study|Enrollment closed|2|||
13104623|NCT03334630|25876510|FG001|Overall Study|Enrollment closed|1|||
13104624|NCT03334630|25876509|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0|||
13104625|NCT03334630|25876510|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1|||
13104626|NCT03334630|25876509|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
13104627|NCT03334630|25876510|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
13104628|NCT03334448|25876523|FG000|Washout|Personal Reason|0|||
13104629|NCT03334448|25876524|FG001|Washout|Personal Reason|1|||
13104630|NCT03334448|25876525|FG002|Washout|Personal Reason|0|||
13104631|NCT03334448|25876526|FG003|Washout|Personal Reason|0|||
13104632|NCT03334448|25876523|FG000|Washout|Protocol Violation|0|||
13104633|NCT03334448|25876524|FG001|Washout|Protocol Violation|0|||
13104634|NCT03334448|25876525|FG002|Washout|Protocol Violation|0|||
13156471|NCT02493868|26069145|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5|||
13156472|NCT02493868|26069146|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7|||
13156473|NCT02493868|26069145|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1|||
13156474|NCT02493868|26069146|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0|||
13156475|NCT02493868|26069145|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0|||
13156476|NCT02493868|26069146|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1|||
13156477|NCT02493868|26069145|FG000|Maintenance Phase: DE+TE Participants|Other|4|||
13156478|NCT02493868|26069146|FG001|Maintenance Phase: DE+TE Participants|Other|9|||
13156479|NCT02493868|26069145|FG000|Follow-up Phase|Lost to Follow-up|1|||
13156480|NCT02493868|26069146|FG001|Follow-up Phase|Lost to Follow-up|0|||
13156481|NCT02493868|26069145|FG000|Follow-up Phase|Withdrawal by Subject|3|||
13156482|NCT02493868|26069146|FG001|Follow-up Phase|Withdrawal by Subject|0|||
13156483|NCT02493868|26069145|FG000|Follow-up Phase|Investigator Decision|5|||
13156484|NCT02493868|26069146|FG001|Follow-up Phase|Investigator Decision|1|||
13156485|NCT02493868|26069145|FG000|Follow-up Phase|Other|2|||
13156486|NCT02493868|26069146|FG001|Follow-up Phase|Other|1|||
13156487|NCT02493855|26069164|FG000|Overall Study|Non-compliance|1|||
13156488|NCT02493855|26069165|FG001|Overall Study|Non-compliance|0|||
13156489|NCT02493855|26069166|FG002|Overall Study|Non-compliance|0|||
13156490|NCT02493855|26069164|FG000|Overall Study|Adverse Event|0|||
13156491|NCT02493855|26069165|FG001|Overall Study|Adverse Event|1|||
13156492|NCT02493855|26069166|FG002|Overall Study|Adverse Event|0|||
13156493|NCT02493855|26069164|FG000|Overall Study|Withdrawal by Subject|1|||
13156494|NCT02493855|26069165|FG001|Overall Study|Withdrawal by Subject|0|||
13156495|NCT02493855|26069166|FG002|Overall Study|Withdrawal by Subject|0|||
13156496|NCT02493777|26069181|FG000|Overall Study|Lost to Follow-up|0|||
13156497|NCT02493777|26069182|FG001|Overall Study|Lost to Follow-up|1|||
13156498|NCT02493764|26069237|FG000|Overall Study|Adverse Event|2|||
13156499|NCT02493764|26069238|FG001|Overall Study|Adverse Event|2|||
13156500|NCT02493764|26069237|FG000|Overall Study|Death|44|||
13156501|NCT02493764|26069238|FG001|Overall Study|Death|58|||
13156502|NCT02493764|26069237|FG000|Overall Study|Lost to Follow-up|2|||
13156503|NCT02493764|26069238|FG001|Overall Study|Lost to Follow-up|1|||
13156504|NCT02493764|26069237|FG000|Overall Study|Protocol Violation|6|||
13156505|NCT02493764|26069238|FG001|Overall Study|Protocol Violation|7|||
13156506|NCT02493764|26069237|FG000|Overall Study|Physician Decision|1|||
13156507|NCT02493764|26069238|FG001|Overall Study|Physician Decision|1|||
13104635|NCT03334448|25876526|FG003|Washout|Protocol Violation|1|||
13104636|NCT03334422|25876638|FG000|Overall Study|Adverse Event|1|||
13104637|NCT03334422|25876639|FG001|Overall Study|Adverse Event|3|||
13104638|NCT03334422|25876640|FG002|Overall Study|Adverse Event|2|||
13156508|NCT02493764|26069237|FG000|Overall Study|Participant moved|17|||
13156509|NCT02493764|26069238|FG001|Overall Study|Participant moved|5|||
13156510|NCT02493764|26069237|FG000|Overall Study|Withdrawal parent/guardian|0|||
13156511|NCT02493764|26069238|FG001|Overall Study|Withdrawal parent/guardian|1|||
13156512|NCT02493764|26069237|FG000|Overall Study|Withdrawal by Subject|11|||
13156513|NCT02493764|26069238|FG001|Overall Study|Withdrawal by Subject|7|||
13156514|NCT02493751|26069286|FG000|Overall Study|Withdrawal by Subject|2|||
13156515|NCT02493751|26069287|FG001|Overall Study|Withdrawal by Subject|8|||
13156516|NCT02493751|26069286|FG000|Overall Study|Death|6|||
13156517|NCT02493751|26069287|FG001|Overall Study|Death|13|||
13156518|NCT02493751|26069286|FG000|Overall Study|Lost to Follow-up|2|||
13156519|NCT02493751|26069287|FG001|Overall Study|Lost to Follow-up|3|||
13156520|NCT02493751|26069286|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6|||
13156521|NCT02493751|26069287|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15|||
13156522|NCT02493712|26069308|FG000|Overall Study|Withdrawal by Subject|1|||
13156523|NCT02493712|26069309|FG001|Overall Study|Withdrawal by Subject|0|||
13156524|NCT02493712|26069310|FG002|Overall Study|Withdrawal by Subject|2|||
13156525|NCT02493712|26069308|FG000|Overall Study|Protocol Violation|0|||
13156526|NCT02493712|26069309|FG001|Overall Study|Protocol Violation|0|||
13104639|NCT03334422|25876641|FG003|Overall Study|Adverse Event|2|||
13156527|NCT02493712|26069310|FG002|Overall Study|Protocol Violation|1|||
13156528|NCT02493712|26069308|FG000|Overall Study|Lost to Follow-up|1|||
13156529|NCT02493712|26069309|FG001|Overall Study|Lost to Follow-up|0|||
13156530|NCT02493712|26069310|FG002|Overall Study|Lost to Follow-up|0|||
13156531|NCT02493712|26069308|FG000|Overall Study|Physician Decision|0|||
13156532|NCT02493712|26069309|FG001|Overall Study|Physician Decision|1|||
13156533|NCT02493712|26069310|FG002|Overall Study|Physician Decision|0|||
13156534|NCT02493712|26069308|FG000|Overall Study|Lack of Efficacy|0|||
13156535|NCT02493712|26069309|FG001|Overall Study|Lack of Efficacy|5|||
13156536|NCT02493712|26069310|FG002|Overall Study|Lack of Efficacy|3|||
13156537|NCT02493517|26069339|FG000|Overall Study|Protocol Violation|1|||
13156538|NCT02493517|26069340|FG001|Overall Study|Protocol Violation|2|||
13156539|NCT02493517|26069339|FG000|Overall Study|Withdrawal by Subject|1|||
13156540|NCT02493517|26069340|FG001|Overall Study|Withdrawal by Subject|2|||
13156541|NCT02493517|26069339|FG000|Overall Study|Adverse Event|0|||
13156542|NCT02493517|26069340|FG001|Overall Study|Adverse Event|2|||
13156543|NCT02493517|26069339|FG000|Overall Study|Missed study visit|0|||
13156544|NCT02493517|26069340|FG001|Overall Study|Missed study visit|1|||
13156545|NCT02493361|26069352|FG000|Overall Study|Withdrawal by Subject|3|||
13156546|NCT02493127|26069371|FG000|Overall Study|Lost to Follow-up|1|||
13156547|NCT02493127|26069372|FG001|Overall Study|Lost to Follow-up|1|||
13156548|NCT02493062|26069382|FG000|Overall Study|Physician Decision|12|||
13156549|NCT02492997|26069397|FG000|Overall Study|Withdrawal by Subject|1|||
13156550|NCT02492997|26069398|FG001|Overall Study|Withdrawal by Subject|0|||
13156551|NCT02492997|26069397|FG000|Overall Study|Gained Weight|1|||
13156552|NCT02492997|26069398|FG001|Overall Study|Gained Weight|0|||
13156553|NCT02492997|26069397|FG000|Overall Study|Lost to Follow-up|0|||
13156554|NCT02492997|26069398|FG001|Overall Study|Lost to Follow-up|1|||
13156555|NCT02492984|26069425|FG000|Overall Study|Adverse Event|1|||
13156556|NCT02492984|26069426|FG001|Overall Study|Adverse Event|0|||
13156557|NCT02492984|26069425|FG000|Overall Study|Protocol Violation|1|||
13156558|NCT02492984|26069426|FG001|Overall Study|Protocol Violation|0|||
13156559|NCT02492984|26069425|FG000|Overall Study|Withdrawal by Subject|1|||
13156560|NCT02492984|26069426|FG001|Overall Study|Withdrawal by Subject|0|||
13156561|NCT02492958|26069525|FG000|Overall Study|Withdrawal by Subject|0|||
13156562|NCT02492958|26069526|FG001|Overall Study|Withdrawal by Subject|0|||
13156563|NCT02492958|26069527|FG002|Overall Study|Withdrawal by Subject|1|||
13156564|NCT02492958|26069528|FG003|Overall Study|Withdrawal by Subject|0|||
13156565|NCT02492958|26069525|FG000|Overall Study|Adverse Event|1|||
13156566|NCT02492958|26069526|FG001|Overall Study|Adverse Event|0|||
13156567|NCT02492958|26069527|FG002|Overall Study|Adverse Event|1|||
13156568|NCT02492958|26069528|FG003|Overall Study|Adverse Event|0|||
13156569|NCT02492880|26069534|FG000|Overall Study|Lost to Follow-up|1|||
13156570|NCT02492880|26069534|FG000|Overall Study|Protocol Violation|1|||
13156571|NCT02492841|26069555|FG000|Overall Study|Lost to Follow-up|34|||
13156572|NCT02492841|26069556|FG001|Overall Study|Lost to Follow-up|31|||
13156573|NCT02492841|26069557|FG002|Overall Study|Lost to Follow-up|35|||
13156574|NCT02492763|26069624|FG000|Overall Study|Withdrawal by Subject|0|||
13156575|NCT02492763|26069625|FG001|Overall Study|Withdrawal by Subject|2|||
13156576|NCT02492763|26069626|FG002|Overall Study|Withdrawal by Subject|1|||
13156577|NCT02492763|26069627|FG003|Overall Study|Withdrawal by Subject|0|||
13156578|NCT02492763|26069624|FG000|Overall Study|Adverse Event|3|||
13156579|NCT02492763|26069625|FG001|Overall Study|Adverse Event|1|||
13156580|NCT02492763|26069626|FG002|Overall Study|Adverse Event|1|||
13156581|NCT02492763|26069627|FG003|Overall Study|Adverse Event|2|||
13156582|NCT02492763|26069624|FG000|Overall Study|Death|0|||
13156583|NCT02492763|26069625|FG001|Overall Study|Death|0|||
13156584|NCT02492763|26069626|FG002|Overall Study|Death|1|||
13222760|NCT01803282|26286884|FG001|Overall Study|Non-Compliance with Study Drug|0|||
13222761|NCT01803282|26286885|FG002|Overall Study|Non-Compliance with Study Drug|0|||
13222762|NCT01803282|26286886|FG003|Overall Study|Non-Compliance with Study Drug|1|||
13222763|NCT01803282|26286887|FG004|Overall Study|Non-Compliance with Study Drug|0|||
13222764|NCT01803282|26286888|FG005|Overall Study|Non-Compliance with Study Drug|0|||
13222765|NCT01803282|26286889|FG006|Overall Study|Non-Compliance with Study Drug|0|||
13222766|NCT01803282|26286890|FG007|Overall Study|Non-Compliance with Study Drug|0|||
13485346|NCT03739138|27032565|FG004|Overall Study|Death|0|||
13485347|NCT03739138|27032561|FG000|Overall Study|Lost to Follow-up|0|||
13485348|NCT03739138|27032562|FG001|Overall Study|Lost to Follow-up|0|||
13485349|NCT03739138|27032563|FG002|Overall Study|Lost to Follow-up|1|||
13485350|NCT03739138|27032564|FG003|Overall Study|Lost to Follow-up|0|||
13485351|NCT03739138|27032565|FG004|Overall Study|Lost to Follow-up|0|||
13104640|NCT03334422|25876638|FG000|Overall Study|Lack of Efficacy|10|||
13104641|NCT03334422|25876639|FG001|Overall Study|Lack of Efficacy|2|||
13104642|NCT03334422|25876640|FG002|Overall Study|Lack of Efficacy|7|||
13104643|NCT03334422|25876641|FG003|Overall Study|Lack of Efficacy|3|||
13104644|NCT03334422|25876638|FG000|Overall Study|Withdrawal by Subject|8|||
13104645|NCT03334422|25876639|FG001|Overall Study|Withdrawal by Subject|3|||
13104646|NCT03334422|25876640|FG002|Overall Study|Withdrawal by Subject|1|||
13104647|NCT03334422|25876641|FG003|Overall Study|Withdrawal by Subject|0|||
13485352|NCT03739138|27032561|FG000|Overall Study|Study Terminated By Sponsor|0|||
13485353|NCT03739138|27032562|FG001|Overall Study|Study Terminated By Sponsor|0|||
13104648|NCT03334422|25876638|FG000|Overall Study|Lost to Follow-up|0|||
13104649|NCT03334422|25876639|FG001|Overall Study|Lost to Follow-up|0|||
13104650|NCT03334422|25876640|FG002|Overall Study|Lost to Follow-up|0|||
13156585|NCT02492763|26069627|FG003|Overall Study|Death|0|||
13156586|NCT02492763|26069624|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
13156587|NCT02492763|26069625|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1|||
13205296|NCT01967147|26231303|FG001|Overall Study|Lost to Follow-up|2|||
13485354|NCT03739138|27032563|FG002|Overall Study|Study Terminated By Sponsor|0|||
13485355|NCT03739138|27032564|FG003|Overall Study|Study Terminated By Sponsor|4|||
13485356|NCT03739138|27032565|FG004|Overall Study|Study Terminated By Sponsor|0|||
13485357|NCT03739138|27032561|FG000|Overall Study|Withdrawal by Subject|0|||
13485358|NCT03739138|27032562|FG001|Overall Study|Withdrawal by Subject|0|||
13485359|NCT03739138|27032563|FG002|Overall Study|Withdrawal by Subject|0|||
13485360|NCT03739138|27032564|FG003|Overall Study|Withdrawal by Subject|1|||
13485361|NCT03739138|27032565|FG004|Overall Study|Withdrawal by Subject|0|||
13485362|NCT03468309|27032574|FG000|Overall Study|Lost to Follow-up|4|||
13485363|NCT03468309|27032574|FG000|Overall Study|Withdrawal by Subject|2|||
13485364|NCT03347123|27032611|FG000|Overall Study|Death|1|||
13485365|NCT03347123|27032612|FG001|Overall Study|Death|2|||
13485366|NCT03347123|27032613|FG002|Overall Study|Death|0|||
13485367|NCT03347123|27032614|FG003|Overall Study|Death|0|||
13485368|NCT03347123|27032615|FG004|Overall Study|Death|0|||
13485369|NCT03347123|27032616|FG005|Overall Study|Death|0|||
13485370|NCT03347123|27032617|FG006|Overall Study|Death|0|||
13485371|NCT03347123|27032611|FG000|Overall Study|Withdrawal by Subject|1|||
13104651|NCT03334422|25876641|FG003|Overall Study|Lost to Follow-up|1|||
13104652|NCT03334422|25876638|FG000|Overall Study|Inability to obtain laboratory samples|0|||
13104653|NCT03334422|25876639|FG001|Overall Study|Inability to obtain laboratory samples|1|||
13104654|NCT03334422|25876640|FG002|Overall Study|Inability to obtain laboratory samples|0|||
13104655|NCT03334422|25876641|FG003|Overall Study|Inability to obtain laboratory samples|0|||
13104656|NCT03334422|25876638|FG000|Overall Study|Pregnancy|0|||
13104657|NCT03334422|25876639|FG001|Overall Study|Pregnancy|1|||
13104658|NCT03334422|25876640|FG002|Overall Study|Pregnancy|0|||
13104659|NCT03334422|25876641|FG003|Overall Study|Pregnancy|0|||
13104660|NCT03334409|25876664|FG000|Overall Study|Did not meet inclusion criteria|1|||
13104661|NCT03334409|25876665|FG001|Overall Study|Did not meet inclusion criteria|0|||
13104662|NCT03334396|25876793|FG000|Overall Study|Adverse Event|1|||
13104663|NCT03334396|25876794|FG001|Overall Study|Adverse Event|0|||
13104664|NCT03334396|25876795|FG002|Overall Study|Adverse Event|1|||
13104665|NCT03334396|25876796|FG003|Overall Study|Adverse Event|0|||
13104666|NCT03334396|25876797|FG004|Overall Study|Adverse Event|0|||
13104667|NCT03334396|25876798|FG005|Overall Study|Adverse Event|0|||
13104668|NCT03334396|25876799|FG006|Overall Study|Adverse Event|0|||
13104669|NCT03334396|25876800|FG007|Overall Study|Adverse Event|0|||
13104670|NCT03334396|25876793|FG000|Overall Study|Lack of Efficacy|10|||
13104671|NCT03334396|25876794|FG001|Overall Study|Lack of Efficacy|4|||
13104672|NCT03334396|25876795|FG002|Overall Study|Lack of Efficacy|1|||
13104673|NCT03334396|25876796|FG003|Overall Study|Lack of Efficacy|3|||
13104674|NCT03334396|25876797|FG004|Overall Study|Lack of Efficacy|1|||
13104675|NCT03334396|25876798|FG005|Overall Study|Lack of Efficacy|0|||
13104676|NCT03334396|25876799|FG006|Overall Study|Lack of Efficacy|0|||
13104677|NCT03334396|25876800|FG007|Overall Study|Lack of Efficacy|1|||
13104678|NCT03334396|25876793|FG000|Overall Study|Lost to Follow-up|0|||
13104679|NCT03334396|25876794|FG001|Overall Study|Lost to Follow-up|0|||
13104680|NCT03334396|25876795|FG002|Overall Study|Lost to Follow-up|1|||
13104681|NCT03334396|25876796|FG003|Overall Study|Lost to Follow-up|0|||
13104682|NCT03334396|25876797|FG004|Overall Study|Lost to Follow-up|0|||
13485372|NCT03347123|27032612|FG001|Overall Study|Withdrawal by Subject|0|||
13485373|NCT03347123|27032613|FG002|Overall Study|Withdrawal by Subject|0|||
13485374|NCT03347123|27032614|FG003|Overall Study|Withdrawal by Subject|0|||
13104683|NCT03334396|25876798|FG005|Overall Study|Lost to Follow-up|0|||
13104684|NCT03334396|25876799|FG006|Overall Study|Lost to Follow-up|1|||
13104685|NCT03334396|25876800|FG007|Overall Study|Lost to Follow-up|0|||
13104686|NCT03334396|25876793|FG000|Overall Study|Physician Decision|1|||
13104687|NCT03334396|25876794|FG001|Overall Study|Physician Decision|0|||
13104688|NCT03334396|25876795|FG002|Overall Study|Physician Decision|0|||
13104689|NCT03334396|25876796|FG003|Overall Study|Physician Decision|0|||
13104690|NCT03334396|25876797|FG004|Overall Study|Physician Decision|0|||
13104691|NCT03334396|25876798|FG005|Overall Study|Physician Decision|0|||
13104692|NCT03334396|25876799|FG006|Overall Study|Physician Decision|0|||
13104693|NCT03334396|25876800|FG007|Overall Study|Physician Decision|0|||
13156588|NCT02492763|26069626|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
13156589|NCT02492763|26069627|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
13156590|NCT02492763|26069624|FG000|Overall Study|Lost to Follow-up|0|||
13156591|NCT02492763|26069625|FG001|Overall Study|Lost to Follow-up|0|||
13485375|NCT03347123|27032615|FG004|Overall Study|Withdrawal by Subject|0|||
13485376|NCT03347123|27032616|FG005|Overall Study|Withdrawal by Subject|0|||
13104694|NCT03334396|25876793|FG000|Overall Study|Withdrawal by Subject|10|||
13104695|NCT03334396|25876794|FG001|Overall Study|Withdrawal by Subject|5|||
13104696|NCT03334396|25876795|FG002|Overall Study|Withdrawal by Subject|7|||
13104697|NCT03334396|25876796|FG003|Overall Study|Withdrawal by Subject|2|||
13104698|NCT03334396|25876797|FG004|Overall Study|Withdrawal by Subject|2|||
13104699|NCT03334396|25876798|FG005|Overall Study|Withdrawal by Subject|1|||
13104700|NCT03334396|25876799|FG006|Overall Study|Withdrawal by Subject|2|||
13104701|NCT03334396|25876800|FG007|Overall Study|Withdrawal by Subject|0|||
13485377|NCT03347123|27032617|FG006|Overall Study|Withdrawal by Subject|0|||
13104702|NCT03334396|25876793|FG000|Overall Study|Pregnancy|0|||
13104703|NCT03334396|25876794|FG001|Overall Study|Pregnancy|1|||
13104704|NCT03334396|25876795|FG002|Overall Study|Pregnancy|0|||
13104705|NCT03334396|25876796|FG003|Overall Study|Pregnancy|0|||
13104706|NCT03334396|25876797|FG004|Overall Study|Pregnancy|0|||
13104707|NCT03334396|25876798|FG005|Overall Study|Pregnancy|0|||
13104708|NCT03334396|25876799|FG006|Overall Study|Pregnancy|0|||
13104709|NCT03334396|25876800|FG007|Overall Study|Pregnancy|0|||
13104710|NCT03334396|25876793|FG000|Overall Study|Ineligible|0|||
13104711|NCT03334396|25876794|FG001|Overall Study|Ineligible|1|||
13104712|NCT03334396|25876795|FG002|Overall Study|Ineligible|0|||
13104713|NCT03334396|25876796|FG003|Overall Study|Ineligible|0|||
13104714|NCT03334396|25876797|FG004|Overall Study|Ineligible|0|||
13104715|NCT03334396|25876798|FG005|Overall Study|Ineligible|0|||
13104716|NCT03334396|25876799|FG006|Overall Study|Ineligible|0|||
13104717|NCT03334396|25876800|FG007|Overall Study|Ineligible|0|||
13104718|NCT03334396|25876793|FG000|Overall Study|Started New Job|1|||
13104719|NCT03334396|25876794|FG001|Overall Study|Started New Job|0|||
13104720|NCT03334396|25876795|FG002|Overall Study|Started New Job|0|||
13104721|NCT03334396|25876796|FG003|Overall Study|Started New Job|0|||
13104722|NCT03334396|25876797|FG004|Overall Study|Started New Job|0|||
13104723|NCT03334396|25876798|FG005|Overall Study|Started New Job|0|||
13104724|NCT03334396|25876799|FG006|Overall Study|Started New Job|0|||
13104725|NCT03334396|25876800|FG007|Overall Study|Started New Job|0|||
13104726|NCT03334214|25876831|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
13104727|NCT03334214|25876832|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
13104728|NCT03334214|25876831|FG000|Overall Study|Withdrawal by Subject|0|||
13104729|NCT03334214|25876832|FG001|Overall Study|Withdrawal by Subject|1|||
13104730|NCT03334214|25876831|FG000|Overall Study|Other|1|||
13104731|NCT03334214|25876832|FG001|Overall Study|Other|0|||
13133056|NCT02778555|25986393|FG001|Overall Study|Withdrawal by Subject|32|||
13133057|NCT02778555|25986394|FG002|Overall Study|Withdrawal by Subject|107|||
13133058|NCT02778399|25986513|FG000|Up to Week 12 Treatment Period|Adverse Event|1|||
13133059|NCT02778399|25986514|FG001|Up to Week 12 Treatment Period|Adverse Event|2|||
13133060|NCT02778399|25986515|FG002|Up to Week 12 Treatment Period|Adverse Event|3|||
13133061|NCT02778399|25986516|FG003|Up to Week 12 Treatment Period|Adverse Event|2|||
13133062|NCT02778399|25986517|FG004|Up to Week 12 Treatment Period|Adverse Event|3|||
13133063|NCT02778399|25986518|FG005|Up to Week 12 Treatment Period|Adverse Event|3|||
13133064|NCT02778399|25986513|FG000|Up to Week 12 Treatment Period|Withdrawal by Subject|5|||
13133065|NCT02778399|25986514|FG001|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
13133066|NCT02778399|25986515|FG002|Up to Week 12 Treatment Period|Withdrawal by Subject|1|||
13133067|NCT02778399|25986516|FG003|Up to Week 12 Treatment Period|Withdrawal by Subject|4|||
13156592|NCT02492763|26069626|FG002|Overall Study|Lost to Follow-up|1|||
13156593|NCT02492763|26069627|FG003|Overall Study|Lost to Follow-up|0|||
13156594|NCT02492763|26069624|FG000|Overall Study|Non-Compliance With Study Drug|0|||
13156595|NCT02492763|26069625|FG001|Overall Study|Non-Compliance With Study Drug|1|||
13156596|NCT02492763|26069626|FG002|Overall Study|Non-Compliance With Study Drug|0|||
13156597|NCT02492763|26069627|FG003|Overall Study|Non-Compliance With Study Drug|0|||
13156598|NCT02492763|26069624|FG000|Overall Study|Screen Failure|0|||
13156599|NCT02492763|26069625|FG001|Overall Study|Screen Failure|0|||
13156600|NCT02492763|26069626|FG002|Overall Study|Screen Failure|0|||
13156601|NCT02492763|26069627|FG003|Overall Study|Screen Failure|1|||
13156602|NCT02492763|26069624|FG000|Overall Study|Study Terminated by Sponsor|13|||
13156603|NCT02492763|26069625|FG001|Overall Study|Study Terminated by Sponsor|10|||
13156604|NCT02492763|26069626|FG002|Overall Study|Study Terminated by Sponsor|6|||
13156605|NCT02492763|26069627|FG003|Overall Study|Study Terminated by Sponsor|10|||
13156606|NCT02492165|26069662|FG000|Overall Study|Withdrawal by Subject|0|||
13156607|NCT02492165|26069663|FG001|Overall Study|Withdrawal by Subject|1|||
13156608|NCT02492165|26069664|FG002|Overall Study|Withdrawal by Subject|0|||
13156609|NCT02492165|26069665|FG003|Overall Study|Withdrawal by Subject|0|||
13156610|NCT02492100|26069674|FG000|Overall Study|Death|1|||
13156611|NCT02491892|26069725|FG000|Overall Study|Adverse Event|1|||
13156612|NCT02491892|26069726|FG001|Overall Study|Adverse Event|1|||
13156613|NCT02491892|26069725|FG000|Overall Study|Death|1|||
13156614|NCT02491892|26069726|FG001|Overall Study|Death|1|||
13156615|NCT02491892|26069725|FG000|Overall Study|Lack of Efficacy|37|||
13156616|NCT02491892|26069726|FG001|Overall Study|Lack of Efficacy|36|||
13156617|NCT02491892|26069725|FG000|Overall Study|Refused Treatment|1|||
13156618|NCT02491892|26069726|FG001|Overall Study|Refused Treatment|0|||
13156619|NCT02491892|26069725|FG000|Overall Study|Lost to Follow-up|1|||
13156620|NCT02491892|26069726|FG001|Overall Study|Lost to Follow-up|0|||
13156621|NCT02491684|26069767|FG000|Treatment Phase|Adverse Event|2|||
13156622|NCT02491684|26069768|FG001|Treatment Phase|Adverse Event|2|||
13133068|NCT02778399|25986517|FG004|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
13133069|NCT02778399|25986518|FG005|Up to Week 12 Treatment Period|Withdrawal by Subject|3|||
13133070|NCT02778399|25986513|FG000|Up to Week 12 Treatment Period|Protocol Violation|0|||
13133071|NCT02778399|25986514|FG001|Up to Week 12 Treatment Period|Protocol Violation|0|||
13156623|NCT02491684|26069767|FG000|Treatment Phase|Incorrect randomisation|1|||
13156624|NCT02491684|26069768|FG001|Treatment Phase|Incorrect randomisation|0|||
13156625|NCT02491684|26069767|FG000|Treatment Phase|Investigator and Sponsor decision|0|||
13156626|NCT02491684|26069768|FG001|Treatment Phase|Investigator and Sponsor decision|1|||
13156627|NCT02491671|26069787|FG000|Overall Study|Adverse Event|6|||
13156628|NCT02491671|26069788|FG001|Overall Study|Adverse Event|8|||
13156629|NCT02491671|26069787|FG000|Overall Study|Death|0|||
13156630|NCT02491671|26069788|FG001|Overall Study|Death|2|||
13156631|NCT02491671|26069787|FG000|Overall Study|Use of sealants other than Hemopatch|5|||
13156632|NCT02491671|26069788|FG001|Overall Study|Use of sealants other than Hemopatch|3|||
13156633|NCT02491463|26069887|FG000|Overall Study|Withdrawal by Subject|1|||
13156634|NCT02491463|26069888|FG001|Overall Study|Withdrawal by Subject|2|||
13156635|NCT02491463|26069889|FG002|Overall Study|Withdrawal by Subject|0|||
13156636|NCT02491463|26069890|FG003|Overall Study|Withdrawal by Subject|0|||
13156637|NCT02491463|26069887|FG000|Overall Study|Migrated/moved from study area|1|||
13156638|NCT02491463|26069888|FG001|Overall Study|Migrated/moved from study area|5|||
13156639|NCT02491463|26069889|FG002|Overall Study|Migrated/moved from study area|1|||
13156640|NCT02491463|26069890|FG003|Overall Study|Migrated/moved from study area|1|||
13156641|NCT02491463|26069887|FG000|Overall Study|Lost to Follow-up|0|||
13156642|NCT02491463|26069888|FG001|Overall Study|Lost to Follow-up|3|||
13156643|NCT02491463|26069889|FG002|Overall Study|Lost to Follow-up|3|||
13156644|NCT02491463|26069890|FG003|Overall Study|Lost to Follow-up|0|||
13156645|NCT02491411|26069902|FG000|Overall Study|Physician Decision|4|||
13156646|NCT02491073|26069935|FG000|Overall Study|screen failure|1|||
13156647|NCT02491073|26069936|FG001|Overall Study|screen failure|0|||
13156648|NCT02490878|26069963|FG000|Overall Study|deemed ineligible|0|||
13156649|NCT02490878|26069964|FG001|Overall Study|deemed ineligible|1|||
13156650|NCT02490878|26069963|FG000|Overall Study|progression prior to treatment|0|||
13156651|NCT02490878|26069964|FG001|Overall Study|progression prior to treatment|1|||
13156652|NCT02490878|26069963|FG000|Overall Study|only submitted baseline QOL|0|||
13156653|NCT02490878|26069964|FG001|Overall Study|only submitted baseline QOL|1|||
13156654|NCT02490475|26070053|FG000|Period 1: First 6 Cycles|Adverse Event|2|||
13156655|NCT02490475|26070054|FG001|Period 1: First 6 Cycles|Adverse Event|1|||
13156656|NCT02490475|26070055|FG002|Period 1: First 6 Cycles|Adverse Event|0|||
13156657|NCT02490475|26070056|FG003|Period 1: First 6 Cycles|Adverse Event|1|||
13156658|NCT02490475|26070053|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
13156659|NCT02490475|26070054|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0|||
13156660|NCT02490475|26070055|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
13156661|NCT02490475|26070056|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
13156662|NCT02490475|26070053|FG000|Period 1: First 6 Cycles|Refused Treatment|1|||
13156663|NCT02490475|26070054|FG001|Period 1: First 6 Cycles|Refused Treatment|0|||
13156664|NCT02490475|26070055|FG002|Period 1: First 6 Cycles|Refused Treatment|0|||
13156665|NCT02490475|26070056|FG003|Period 1: First 6 Cycles|Refused Treatment|0|||
13156666|NCT02490475|26070053|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
13156667|NCT02490475|26070054|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
13156668|NCT02490475|26070055|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4|||
13156669|NCT02490475|26070056|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2|||
13156670|NCT02490475|26070053|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1|||
13156671|NCT02490475|26070054|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
13156672|NCT02490475|26070055|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2|||
13156673|NCT02490475|26070056|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
13156674|NCT02490475|26070053|FG000|Period 2: Extension Phase|Refused Treatment|0|||
13156675|NCT02490475|26070054|FG001|Period 2: Extension Phase|Refused Treatment|0|||
13156676|NCT02490475|26070055|FG002|Period 2: Extension Phase|Refused Treatment|0|||
13156677|NCT02490475|26070056|FG003|Period 2: Extension Phase|Refused Treatment|1|||
13156678|NCT02490475|26070053|FG000|Period 2: Extension Phase|Adverse Event|0|||
13156679|NCT02490475|26070054|FG001|Period 2: Extension Phase|Adverse Event|0|||
13156680|NCT02490475|26070055|FG002|Period 2: Extension Phase|Adverse Event|1|||
13156681|NCT02490475|26070056|FG003|Period 2: Extension Phase|Adverse Event|0|||
13156682|NCT02490371|26070079|FG000|Overall Study|Lost to Follow-up|1|||
13156683|NCT02490371|26070080|FG001|Overall Study|Lost to Follow-up|1|||
13156684|NCT02489981|26070087|FG000|Overall Study|Adverse Event|21|||
13156685|NCT02489981|26070087|FG000|Overall Study|Insufficient effectiveness|16|||
13156686|NCT02489981|26070087|FG000|Overall Study|Improved|31|||
13156687|NCT02489981|26070087|FG000|Overall Study|Lost to Follow-up|31|||
13156688|NCT02489981|26070087|FG000|Overall Study|Other than listed|28|||
13156689|NCT02489968|26070110|FG000|Open-label Treatment Period|Adverse Event|14|||
13156690|NCT02489968|26070111|FG001|Open-label Treatment Period|Adverse Event|7|||
13156691|NCT02489968|26070112|FG002|Open-label Treatment Period|Adverse Event|0|||
13156692|NCT02489968|26070113|FG003|Open-label Treatment Period|Adverse Event|0|||
13156693|NCT02489968|26070114|FG004|Open-label Treatment Period|Adverse Event|0|||
13156694|NCT02489968|26070115|FG005|Open-label Treatment Period|Adverse Event|0|||
13156695|NCT02489968|26070110|FG000|Open-label Treatment Period|Protocol Violation|2|||
13156696|NCT02489968|26070111|FG001|Open-label Treatment Period|Protocol Violation|2|||
13156697|NCT02489968|26070112|FG002|Open-label Treatment Period|Protocol Violation|0|||
13156698|NCT02489968|26070113|FG003|Open-label Treatment Period|Protocol Violation|0|||
13156699|NCT02489968|26070114|FG004|Open-label Treatment Period|Protocol Violation|0|||
13156700|NCT02489968|26070115|FG005|Open-label Treatment Period|Protocol Violation|0|||
13156701|NCT02489968|26070110|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
13156702|NCT02489968|26070111|FG001|Open-label Treatment Period|Lost to Follow-up|3|||
13156703|NCT02489968|26070112|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
13156704|NCT02489968|26070113|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
13156705|NCT02489968|26070114|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
13156706|NCT02489968|26070115|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
13156707|NCT02489968|26070110|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
13156708|NCT02489968|26070111|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
13156709|NCT02489968|26070112|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
13156710|NCT02489968|26070113|FG003|Open-label Treatment Period|Withdrawal by Subject|0|||
13156711|NCT02489968|26070114|FG004|Open-label Treatment Period|Withdrawal by Subject|0|||
13156712|NCT02489968|26070115|FG005|Open-label Treatment Period|Withdrawal by Subject|0|||
13156713|NCT02489968|26070110|FG000|Open-label Treatment Period|Other than specified above|204|||
13156714|NCT02489968|26070111|FG001|Open-label Treatment Period|Other than specified above|189|||
13156715|NCT02489968|26070112|FG002|Open-label Treatment Period|Other than specified above|0|||
13156716|NCT02489968|26070113|FG003|Open-label Treatment Period|Other than specified above|0|||
13156717|NCT02489968|26070114|FG004|Open-label Treatment Period|Other than specified above|0|||
13156718|NCT02489968|26070115|FG005|Open-label Treatment Period|Other than specified above|0|||
13156719|NCT02489968|26070110|FG000|Double-blind Treatment Period|Adverse Event|0|||
13156720|NCT02489968|26070111|FG001|Double-blind Treatment Period|Adverse Event|0|||
13156721|NCT02489968|26070112|FG002|Double-blind Treatment Period|Adverse Event|2|||
13156722|NCT02489968|26070113|FG003|Double-blind Treatment Period|Adverse Event|6|||
13156723|NCT02489968|26070114|FG004|Double-blind Treatment Period|Adverse Event|4|||
13156724|NCT02489968|26070115|FG005|Double-blind Treatment Period|Adverse Event|5|||
13156725|NCT02489968|26070110|FG000|Double-blind Treatment Period|Protocol Violation|0|||
13156726|NCT02489968|26070111|FG001|Double-blind Treatment Period|Protocol Violation|0|||
13156727|NCT02489968|26070112|FG002|Double-blind Treatment Period|Protocol Violation|0|||
13156728|NCT02489968|26070113|FG003|Double-blind Treatment Period|Protocol Violation|0|||
13156729|NCT02489968|26070114|FG004|Double-blind Treatment Period|Protocol Violation|1|||
13156730|NCT02489968|26070115|FG005|Double-blind Treatment Period|Protocol Violation|1|||
13156731|NCT02489968|26070110|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
13222767|NCT01803282|26286891|FG008|Overall Study|Non-Compliance with Study Drug|0|||
13156732|NCT02489968|26070111|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
13156733|NCT02489968|26070112|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
13156734|NCT02489968|26070113|FG003|Double-blind Treatment Period|Withdrawal by Subject|2|||
13156735|NCT02489968|26070114|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
13156736|NCT02489968|26070115|FG005|Double-blind Treatment Period|Withdrawal by Subject|2|||
13156737|NCT02489968|26070110|FG000|Double-blind Treatment Period|Other than specified above|0|||
13156738|NCT02489968|26070111|FG001|Double-blind Treatment Period|Other than specified above|0|||
13156739|NCT02489968|26070112|FG002|Double-blind Treatment Period|Other than specified above|0|||
13156740|NCT02489968|26070113|FG003|Double-blind Treatment Period|Other than specified above|0|||
13156741|NCT02489968|26070114|FG004|Double-blind Treatment Period|Other than specified above|1|||
13156742|NCT02489968|26070115|FG005|Double-blind Treatment Period|Other than specified above|0|||
13156743|NCT02489799|26070146|FG000|Overall Study|Lost to Follow-up|4|||
13156744|NCT02489799|26070147|FG001|Overall Study|Lost to Follow-up|1|||
13156745|NCT02489799|26070146|FG000|Overall Study|Failure to Maintain Eligibility|4|||
13156746|NCT02489799|26070147|FG001|Overall Study|Failure to Maintain Eligibility|6|||
13156747|NCT02489799|26070146|FG000|Overall Study|Withdrawal by Subject|1|||
13156748|NCT02489799|26070147|FG001|Overall Study|Withdrawal by Subject|1|||
13156749|NCT02489799|26070146|FG000|Overall Study|Death|0|||
13156750|NCT02489799|26070147|FG001|Overall Study|Death|1|||
13156751|NCT02489773|26070162|FG000|Overall Study|Lost to Follow-up|4|||
13156752|NCT02489773|26070163|FG001|Overall Study|Lost to Follow-up|1|||
13156753|NCT02489773|26070162|FG000|Overall Study|Physician Decision|1|||
13156754|NCT02489773|26070163|FG001|Overall Study|Physician Decision|0|||
13156755|NCT02489773|26070162|FG000|Overall Study|Withdrawal by Subject|1|||
13156756|NCT02489773|26070163|FG001|Overall Study|Withdrawal by Subject|0|||
13156757|NCT02489773|26070162|FG000|Overall Study|Leave the country or the state|1|||
13156758|NCT02489773|26070163|FG001|Overall Study|Leave the country or the state|1|||
13156759|NCT02489630|26070180|FG000|Overall Study|Oversedation|1|||
13156760|NCT02489630|26070181|FG001|Overall Study|Oversedation|1|||
13156761|NCT02489630|26070180|FG000|Overall Study|Time to med. admin. > protocol limit|1|||
13156762|NCT02489630|26070181|FG001|Overall Study|Time to med. admin. > protocol limit|1|||
13156763|NCT02489500|26070200|FG000|Overall Study|Death|1|||
13156764|NCT02489500|26070201|FG001|Overall Study|Death|1|||
13156765|NCT02489448|26070214|FG000|Overall Study|Death|3|||
13156766|NCT02489448|26070214|FG000|Overall Study|Withdrawal by Subject|2|||
13156767|NCT02489344|26070257|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1|||
13156768|NCT02489344|26070257|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1|||
13156769|NCT02489344|26070257|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1|||
13156770|NCT02489344|26070257|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2|||
13156771|NCT02489279|26070276|FG000|Overall Study|Lost to Follow-up|12|||
13156772|NCT02489279|26070277|FG001|Overall Study|Lost to Follow-up|10|||
13156773|NCT02489045|26070285|FG000|Overall Study|unable to collect usable data|53|||
13156774|NCT02489045|26070285|FG000|Follow-up|Lost to Follow-up|10|||
13156775|NCT02488980|26070312|FG000|Overall Study|Protocol Violation|2|||
13156776|NCT02488980|26070313|FG001|Overall Study|Protocol Violation|2|||
13156777|NCT02488980|26070314|FG002|Overall Study|Protocol Violation|2|||
13156778|NCT02488915|26070332|FG000|Overall Study|Death|21|||
13156779|NCT02488915|26070332|FG000|Overall Study|Lost to Follow-up|4|||
13156780|NCT02488915|26070332|FG000|Overall Study|Withdrawal by Subject|1|||
13156781|NCT02488824|26070353|FG000|Overall Study|Adverse Event|1|||
13156782|NCT02488824|26070354|FG001|Overall Study|Adverse Event|1|||
13156783|NCT02488681|26070360|FG000|Overall Study|Implant unsuccessful|7|||
13156784|NCT02488551|26070391|FG000|Overall Study|Lost to Follow-up|4|||
13156785|NCT02488551|26070392|FG001|Overall Study|Lost to Follow-up|7|||
13156786|NCT02488551|26070393|FG002|Overall Study|Lost to Follow-up|0|||
13156787|NCT02488551|26070394|FG003|Overall Study|Lost to Follow-up|0|||
13156788|NCT02488551|26070391|FG000|Overall Study|Military Deployment|1|||
13156789|NCT02488551|26070392|FG001|Overall Study|Military Deployment|1|||
13156790|NCT02488551|26070393|FG002|Overall Study|Military Deployment|0|||
13156791|NCT02488551|26070394|FG003|Overall Study|Military Deployment|0|||
13156792|NCT02488330|26070400|FG000|Overall Study|Adverse Event|1|||
13156793|NCT02488330|26070400|FG000|Overall Study|Physician Decision|2|||
13156794|NCT02488330|26070400|FG000|Overall Study|Death|2|||
13156795|NCT02488330|26070400|FG000|Overall Study|Disease Progression|3|||
13156796|NCT02488330|26070400|FG000|Overall Study|Study Termination by Sponsor|4|||
13156797|NCT02488239|26070407|FG000|Overall Study|Death|3|||
13156798|NCT02488239|26070407|FG000|Overall Study|Withdrawal by Subject|3|||
13156799|NCT02488239|26070407|FG000|Overall Study|Physician Decision|2|||
13156800|NCT02488239|26070407|FG000|Overall Study|Consent ineligible|1|||
13156801|NCT02488239|26070407|FG000|Overall Study|Did not undergo implant procedure|1|||
13156802|NCT02488109|26070424|FG000|Treatment in Hospital|Withdrawal by Subject|0|||
13156803|NCT02488109|26070425|FG001|Treatment in Hospital|Withdrawal by Subject|5|||
13156804|NCT02488109|26070424|FG000|12-month Follow-Up|Lost to Follow-up|4|||
13156805|NCT02488109|26070425|FG001|12-month Follow-Up|Lost to Follow-up|7|||
13156806|NCT02488005|26070437|FG000|Overall Study|Lost to Follow-up|2|||
13156807|NCT02487810|26070474|FG000|Overall Study|Withdrawal by Subject|1|||
13156808|NCT02487810|26070475|FG001|Overall Study|Withdrawal by Subject|0|||
13156809|NCT02487771|26070632|FG000|Overall Study|Lost to Follow-up|2|||
13156810|NCT02487771|26070633|FG001|Overall Study|Lost to Follow-up|3|||
13156811|NCT02487771|26070632|FG000|Overall Study|Moved out of area|5|||
13156812|NCT02487771|26070633|FG001|Overall Study|Moved out of area|6|||
13156813|NCT02487771|26070632|FG000|Overall Study|Withdrawal by Subject|3|||
13156814|NCT02487771|26070633|FG001|Overall Study|Withdrawal by Subject|5|||
13156815|NCT02487498|26070659|FG000|Period: Period 1|Adverse Event|2|||
13156816|NCT02487498|26070660|FG001|Period: Period 1|Adverse Event|4|||
13156817|NCT02487498|26070659|FG000|Period: Period 1|Subject/guardian decision|2|||
13156818|NCT02487498|26070660|FG001|Period: Period 1|Subject/guardian decision|4|||
13156819|NCT02487498|26070659|FG000|Period: Period 1|Lost to Follow-up|0|||
13156820|NCT02487498|26070660|FG001|Period: Period 1|Lost to Follow-up|2|||
13156821|NCT02487498|26070659|FG000|Period: Period 1|Lack of Efficacy|1|||
13156822|NCT02487498|26070660|FG001|Period: Period 1|Lack of Efficacy|0|||
13156823|NCT02487498|26070659|FG000|Period: Period 1|Physician Decision|0|||
13156824|NCT02487498|26070660|FG001|Period: Period 1|Physician Decision|1|||
13156825|NCT02487498|26070659|FG000|Period: Period 1|Protocol deviation|1|||
13156826|NCT02487498|26070660|FG001|Period: Period 1|Protocol deviation|0|||
13156827|NCT02487498|26070659|FG000|Period: Washout|Subject/guardian decision|0|||
13156828|NCT02487498|26070660|FG001|Period: Washout|Subject/guardian decision|5|||
13156829|NCT02487498|26070659|FG000|Period: Washout|Lack of Efficacy|1|||
13156830|NCT02487498|26070660|FG001|Period: Washout|Lack of Efficacy|1|||
13156831|NCT02487498|26070659|FG000|Period: Washout|Physician Decision|1|||
13156832|NCT02487498|26070660|FG001|Period: Washout|Physician Decision|0|||
13156833|NCT02487498|26070659|FG000|Period: Washout|Non-compliance with study treatment|0|||
13156834|NCT02487498|26070660|FG001|Period: Washout|Non-compliance with study treatment|1|||
13156835|NCT02487498|26070659|FG000|Period: Period 2|Adverse Event|2|||
13156836|NCT02487498|26070660|FG001|Period: Period 2|Adverse Event|2|||
13156837|NCT02487498|26070659|FG000|Period: Period 2|Subject/guardian decision|2|||
13156838|NCT02487498|26070660|FG001|Period: Period 2|Subject/guardian decision|1|||
13156839|NCT02487498|26070659|FG000|Period: Period 2|Lost to Follow-up|1|||
13156840|NCT02487498|26070660|FG001|Period: Period 2|Lost to Follow-up|1|||
13156841|NCT02487498|26070659|FG000|Period: Period 2|Death|0|||
13156842|NCT02487498|26070660|FG001|Period: Period 2|Death|1|||
13156843|NCT02487498|26070659|FG000|Period: Period 2|Physician Decision|1|||
13156844|NCT02487498|26070660|FG001|Period: Period 2|Physician Decision|0|||
13156845|NCT02487472|26070678|FG000|Overall Study|Did not complete telephonic interviews|9|||
13156846|NCT02487472|26070678|FG000|Overall Study|Other|2|||
13156847|NCT02487446|26070704|FG000|Period 1|Physician Decision|0|||
13156848|NCT02487446|26070705|FG001|Period 1|Physician Decision|1|||
13156849|NCT02487446|26070704|FG000|Period 1|Lack of Efficacy|1|||
13156850|NCT02487446|26070705|FG001|Period 1|Lack of Efficacy|0|||
13156851|NCT02487446|26070704|FG000|Period 1|Protocol deviation|3|||
13156852|NCT02487446|26070705|FG001|Period 1|Protocol deviation|2|||
13156853|NCT02487446|26070704|FG000|Period 1|Lost to Follow-up|2|||
13156854|NCT02487446|26070705|FG001|Period 1|Lost to Follow-up|0|||
13156855|NCT02487446|26070704|FG000|Period 1|Withdrawal by Subject|2|||
13156856|NCT02487446|26070705|FG001|Period 1|Withdrawal by Subject|0|||
13156857|NCT02487446|26070704|FG000|Period 1|Adverse Event|5|||
13156858|NCT02487446|26070705|FG001|Period 1|Adverse Event|5|||
13156859|NCT02487446|26070704|FG000|Washout|Lost to Follow-up|0|||
13156860|NCT02487446|26070705|FG001|Washout|Lost to Follow-up|2|||
13156861|NCT02487446|26070704|FG000|Washout|Withdrawal by Subject|1|||
13156862|NCT02487446|26070705|FG001|Washout|Withdrawal by Subject|4|||
13156863|NCT02487446|26070704|FG000|Washout|Adverse Event|2|||
13156864|NCT02487446|26070705|FG001|Washout|Adverse Event|2|||
13156865|NCT02487446|26070704|FG000|Period 2|Protocol deviation|0|||
13156866|NCT02487446|26070705|FG001|Period 2|Protocol deviation|1|||
13156867|NCT02487446|26070704|FG000|Period 2|Lost to Follow-up|1|||
13156868|NCT02487446|26070705|FG001|Period 2|Lost to Follow-up|1|||
13156869|NCT02487446|26070704|FG000|Period 2|Withdrawal by Subject|1|||
13156870|NCT02487446|26070705|FG001|Period 2|Withdrawal by Subject|1|||
13156871|NCT02487446|26070704|FG000|Period 2|Adverse Event|6|||
13156872|NCT02487446|26070705|FG001|Period 2|Adverse Event|2|||
13156873|NCT02487199|26070724|FG000|Overall Study|Withdrew Consent|0|||
13156874|NCT02487199|26070725|FG001|Overall Study|Withdrew Consent|1|||
13156875|NCT02487108|26070788|FG000|Overall Study|Adverse Event|1|||
13156876|NCT02487108|26070789|FG001|Overall Study|Adverse Event|6|||
13156877|NCT02487108|26070790|FG002|Overall Study|Adverse Event|12|||
13156878|NCT02487108|26070791|FG003|Overall Study|Adverse Event|6|||
13156879|NCT02487108|26070788|FG000|Overall Study|Withdrawal by Subject|8|||
13156880|NCT02487108|26070789|FG001|Overall Study|Withdrawal by Subject|5|||
13156881|NCT02487108|26070790|FG002|Overall Study|Withdrawal by Subject|5|||
13156882|NCT02487108|26070791|FG003|Overall Study|Withdrawal by Subject|0|||
13156883|NCT02487108|26070788|FG000|Overall Study|Non-compliance to study medication|3|||
13156884|NCT02487108|26070789|FG001|Overall Study|Non-compliance to study medication|2|||
13156885|NCT02487108|26070790|FG002|Overall Study|Non-compliance to study medication|5|||
13156886|NCT02487108|26070791|FG003|Overall Study|Non-compliance to study medication|4|||
13156887|NCT02487108|26070788|FG000|Overall Study|Protocol Violation|1|||
13156888|NCT02487108|26070789|FG001|Overall Study|Protocol Violation|1|||
13156889|NCT02487108|26070790|FG002|Overall Study|Protocol Violation|2|||
13156890|NCT02487108|26070791|FG003|Overall Study|Protocol Violation|0|||
13156891|NCT02487108|26070788|FG000|Overall Study|Non-compliance to study procedures|0|||
13156892|NCT02487108|26070789|FG001|Overall Study|Non-compliance to study procedures|0|||
13156893|NCT02487108|26070790|FG002|Overall Study|Non-compliance to study procedures|0|||
13156894|NCT02487108|26070791|FG003|Overall Study|Non-compliance to study procedures|1|||
13156895|NCT02487108|26070788|FG000|Overall Study|Other than specified|3|||
13156896|NCT02487108|26070789|FG001|Overall Study|Other than specified|2|||
13156897|NCT02487108|26070790|FG002|Overall Study|Other than specified|2|||
13156898|NCT02487108|26070791|FG003|Overall Study|Other than specified|0|||
13156899|NCT02487095|26070853|FG000|Dose Expansion|Unable to scan/restage participant|0|||
13156900|NCT02487095|26070854|FG001|Dose Expansion|Unable to scan/restage participant|0|||
13156901|NCT02487095|26070855|FG002|Dose Expansion|Unable to scan/restage participant|0|||
13156902|NCT02487095|26070856|FG003|Dose Expansion|Unable to scan/restage participant|0|||
13156903|NCT02487095|26070857|FG004|Dose Expansion|Unable to scan/restage participant|1|||
13205297|NCT01967147|26231302|FG000|Overall Study|Withdrawal by Subject|2|||
13205298|NCT01967147|26231303|FG001|Overall Study|Withdrawal by Subject|4|||
13205299|NCT01967147|26231302|FG000|Overall Study|Non-compliance with Study Drug|0|||
13205300|NCT01967147|26231303|FG001|Overall Study|Non-compliance with Study Drug|3|||
13205301|NCT01967147|26231302|FG000|Overall Study|Other|4|||
13205302|NCT01967147|26231303|FG001|Overall Study|Other|5|||
13205303|NCT01967134|26231333|FG000|Overall Study|Lost to Follow-up|0|||
13205304|NCT01967134|26231334|FG001|Overall Study|Lost to Follow-up|1|||
13205305|NCT01967134|26231335|FG002|Overall Study|Lost to Follow-up|0|||
13205306|NCT01967069|26231348|FG000|Overall Study|Adverse Event|2|||
13205307|NCT01967069|26231349|FG001|Overall Study|Adverse Event|2|||
13205308|NCT01967069|26231348|FG000|Overall Study|Lost to Follow-up|5|||
13205309|NCT01967069|26231349|FG001|Overall Study|Lost to Follow-up|2|||
13205310|NCT01967069|26231348|FG000|Overall Study|Withdrawal by Subject|1|||
13205311|NCT01967069|26231349|FG001|Overall Study|Withdrawal by Subject|3|||
13205312|NCT01967069|26231348|FG000|Overall Study|Lack of Efficacy|0|||
13205313|NCT01967069|26231349|FG001|Overall Study|Lack of Efficacy|1|||
13156904|NCT02487030|26070910|FG000|Overall Study|Lack of Efficacy|2|||
13156905|NCT02487030|26070911|FG001|Overall Study|Lack of Efficacy|4|||
13156906|NCT02487030|26070912|FG002|Overall Study|Lack of Efficacy|1|||
13156907|NCT02487030|26070913|FG003|Overall Study|Lack of Efficacy|0|||
13156908|NCT02487030|26070914|FG004|Overall Study|Lack of Efficacy|1|||
13156909|NCT02487030|26070915|FG005|Overall Study|Lack of Efficacy|0|||
13156910|NCT02487030|26070916|FG006|Overall Study|Lack of Efficacy|0|||
13156911|NCT02487030|26070910|FG000|Overall Study|Lost to Follow-up|0|||
13156912|NCT02487030|26070911|FG001|Overall Study|Lost to Follow-up|0|||
13156913|NCT02487030|26070912|FG002|Overall Study|Lost to Follow-up|1|||
13156914|NCT02487030|26070913|FG003|Overall Study|Lost to Follow-up|1|||
13156915|NCT02487030|26070914|FG004|Overall Study|Lost to Follow-up|0|||
13156916|NCT02487030|26070915|FG005|Overall Study|Lost to Follow-up|1|||
13156917|NCT02487030|26070916|FG006|Overall Study|Lost to Follow-up|0|||
13156918|NCT02487030|26070910|FG000|Overall Study|Adverse Event|0|||
13156919|NCT02487030|26070911|FG001|Overall Study|Adverse Event|0|||
13156920|NCT02487030|26070912|FG002|Overall Study|Adverse Event|0|||
13156921|NCT02487030|26070913|FG003|Overall Study|Adverse Event|1|||
13156922|NCT02487030|26070914|FG004|Overall Study|Adverse Event|0|||
13156923|NCT02487030|26070915|FG005|Overall Study|Adverse Event|0|||
13156924|NCT02487030|26070916|FG006|Overall Study|Adverse Event|0|||
13156925|NCT02487030|26070910|FG000|Overall Study|Death|0|||
13156926|NCT02487030|26070911|FG001|Overall Study|Death|0|||
13104732|NCT05045625|25876842|FG000|Overall Study|Lost to Follow-up|3|||
13104733|NCT05009251|25876890|FG000|Overall Study|Protocol Violation|100|||
13104734|NCT05009251|25876891|FG001|Overall Study|Protocol Violation|105|||
13104735|NCT05009251|25876892|FG002|Overall Study|Protocol Violation|119|||
13104736|NCT05009251|25876893|FG003|Overall Study|Protocol Violation|120|||
13104737|NCT05009251|25876894|FG004|Overall Study|Protocol Violation|119|||
13104738|NCT05009251|25876890|FG000|Overall Study|Death|25|||
13104739|NCT05009251|25876891|FG001|Overall Study|Death|22|||
13104740|NCT05009251|25876892|FG002|Overall Study|Death|24|||
13104741|NCT05009251|25876893|FG003|Overall Study|Death|19|||
13104742|NCT05009251|25876894|FG004|Overall Study|Death|15|||
13104745|NCT04252287|25876929|FG000|Overall Study|Death|5|||
13104746|NCT04252287|25876930|FG001|Overall Study|Death|3|||
13104747|NCT04252287|25876929|FG000|Overall Study|Lost to Follow-up|4|||
13104748|NCT04252287|25876930|FG001|Overall Study|Lost to Follow-up|6|||
13104749|NCT04252287|25876929|FG000|Overall Study|Withdrawal by Subject|19|||
13104750|NCT04252287|25876930|FG001|Overall Study|Withdrawal by Subject|16|||
13104751|NCT04252287|25876929|FG000|Overall Study|Protocol Violation|3|||
13156927|NCT02487030|26070912|FG002|Overall Study|Death|0|||
13156928|NCT02487030|26070913|FG003|Overall Study|Death|0|||
13156929|NCT02487030|26070914|FG004|Overall Study|Death|1|||
13156930|NCT02487030|26070915|FG005|Overall Study|Death|0|||
13156931|NCT02487030|26070916|FG006|Overall Study|Death|0|||
13156932|NCT02486952|26070923|FG000|Overall Study|Not Started Induction Therapy|3|||
13156933|NCT02486952|26070923|FG000|Overall Study|Adverse Event|1|||
13156934|NCT02486952|26070923|FG000|Overall Study|Death|15|||
13156935|NCT02486952|26070923|FG000|Overall Study|Lack of Efficacy|3|||
13156936|NCT02486952|26070923|FG000|Overall Study|Lost to Follow-up|26|||
13156937|NCT02486952|26070923|FG000|Overall Study|Other|2|||
13156938|NCT02486796|26070942|FG000|Overall Study|Withdrawal by Subject|1|||
13156939|NCT02486796|26070943|FG001|Overall Study|Withdrawal by Subject|1|||
13156940|NCT02486796|26070942|FG000|Overall Study|Physician Decision|1|||
13156941|NCT02486796|26070943|FG001|Overall Study|Physician Decision|0|||
13156942|NCT02486757|26070949|FG000|Overall Study|Lost to Follow-up|1|||
13156943|NCT02486692|26070966|FG000|Overall Study|did not login for randomization|4|||
13156944|NCT02486692|26070967|FG001|Overall Study|did not login for randomization|7|||
13156945|NCT02486653|26070996|FG000|Overall Study|Withdrawal by Subject|1|||
13156946|NCT02486653|26070997|FG001|Overall Study|Withdrawal by Subject|3|||
13156947|NCT02486653|26070996|FG000|Overall Study|Protocol Violation|1|||
13156948|NCT02486653|26070997|FG001|Overall Study|Protocol Violation|0|||
13156949|NCT02486653|26070996|FG000|Overall Study|surgery cancelled|4|||
13156950|NCT02486653|26070997|FG001|Overall Study|surgery cancelled|1|||
13156951|NCT02486627|26071021|FG000|Overall Study|Death|1|||
13156952|NCT02486627|26071022|FG001|Overall Study|Death|0|||
13156953|NCT02486627|26071021|FG000|Overall Study|Other Unspecified|0|||
13156954|NCT02486627|26071022|FG001|Overall Study|Other Unspecified|2|||
13104752|NCT04252287|25876930|FG001|Overall Study|Protocol Violation|4|||
13104753|NCT03523000|25877028|FG000|Overall Study|Withdrawal by Subject|3|||
13104754|NCT03523000|25877029|FG001|Overall Study|Withdrawal by Subject|0|||
13104755|NCT03523000|25877028|FG000|Overall Study|Unsuccessful trial|2|||
13104756|NCT03523000|25877029|FG001|Overall Study|Unsuccessful trial|0|||
13156955|NCT02486627|26071021|FG000|Overall Study|Consent Withdrawn by Participant|4|||
13156956|NCT02486627|26071022|FG001|Overall Study|Consent Withdrawn by Participant|3|||
13156957|NCT02486627|26071021|FG000|Overall Study|Significant Participant Noncompliance|1|||
13156958|NCT02486627|26071022|FG001|Overall Study|Significant Participant Noncompliance|1|||
13156959|NCT02486627|26071021|FG000|Overall Study|Lost to Follow-up|1|||
13156960|NCT02486627|26071022|FG001|Overall Study|Lost to Follow-up|3|||
13156961|NCT02486588|26071097|FG000|Overall Study|Randomized in error- ineligible|738|||
13156962|NCT02486588|26071098|FG001|Overall Study|Randomized in error- ineligible|750|||
13156963|NCT02486588|26071099|FG002|Overall Study|Randomized in error- ineligible|755|||
13156964|NCT02486588|26071100|FG003|Overall Study|Randomized in error- ineligible|738|||
13156965|NCT02486588|26071101|FG004|Overall Study|Randomized in error- ineligible|746|||
13156966|NCT02486588|26071102|FG005|Overall Study|Randomized in error- ineligible|746|||
13156967|NCT02486406|26071180|FG000|Overall Study|Withdrew consent|1|||
13156968|NCT02486406|26071181|FG001|Overall Study|Withdrew consent|0|||
13156969|NCT02486406|26071182|FG002|Overall Study|Withdrew consent|0|||
13156970|NCT02486406|26071183|FG003|Overall Study|Withdrew consent|1|||
13156971|NCT02486406|26071180|FG000|Overall Study|Lost to Follow-up|1|||
13156972|NCT02486406|26071181|FG001|Overall Study|Lost to Follow-up|3|||
13156973|NCT02486406|26071182|FG002|Overall Study|Lost to Follow-up|1|||
13156974|NCT02486406|26071183|FG003|Overall Study|Lost to Follow-up|3|||
13156975|NCT02486406|26071180|FG000|Overall Study|Other, not specified|0|||
13156976|NCT02486406|26071181|FG001|Overall Study|Other, not specified|0|||
13485378|NCT03347123|27032611|FG000|Overall Study|Reason not Specified|3|||
13485379|NCT03347123|27032612|FG001|Overall Study|Reason not Specified|4|||
13485380|NCT03347123|27032613|FG002|Overall Study|Reason not Specified|0|||
13485381|NCT03347123|27032614|FG003|Overall Study|Reason not Specified|0|||
13104743|NCT04969861|25876907|FG000|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|1|||
13104744|NCT04969861|25876908|FG001|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|0|||
13104757|NCT03284710|25877205|FG000|Overall Study|Withdrawal by Subject|1|||
13104758|NCT03284710|25877206|FG001|Overall Study|Withdrawal by Subject|0|||
13104759|NCT03284710|25877207|FG002|Overall Study|Withdrawal by Subject|1|||
13104760|NCT03284710|25877208|FG003|Overall Study|Withdrawal by Subject|6|||
13104761|NCT03284710|25877205|FG000|Overall Study|Lost to Follow-up|3|||
13104762|NCT03284710|25877206|FG001|Overall Study|Lost to Follow-up|3|||
13104763|NCT03284710|25877207|FG002|Overall Study|Lost to Follow-up|1|||
13104764|NCT03284710|25877208|FG003|Overall Study|Lost to Follow-up|0|||
13104765|NCT03284710|25877205|FG000|Overall Study|Physician Decision|1|||
13104766|NCT03284710|25877206|FG001|Overall Study|Physician Decision|0|||
13104767|NCT03284710|25877207|FG002|Overall Study|Physician Decision|0|||
13104768|NCT03284710|25877208|FG003|Overall Study|Physician Decision|0|||
13104769|NCT03284710|25877205|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
13104770|NCT03284710|25877206|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
13104771|NCT03284710|25877207|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
13104772|NCT03284710|25877208|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
13104773|NCT03284710|25877205|FG000|Overall Study|HIV Infection|0|||
13104774|NCT03284710|25877206|FG001|Overall Study|HIV Infection|2|||
13156977|NCT02486406|26071182|FG002|Overall Study|Other, not specified|1|||
13156978|NCT02486406|26071183|FG003|Overall Study|Other, not specified|0|||
13156979|NCT02486302|26071240|FG000|Overall Study|Discontinued prematurely|410|||
13156980|NCT02486302|26071240|FG000|Overall Study|Documentation not completed|255|||
13485382|NCT03347123|27032615|FG004|Overall Study|Reason not Specified|0|||
13485383|NCT03347123|27032616|FG005|Overall Study|Reason not Specified|0|||
13485384|NCT03347123|27032617|FG006|Overall Study|Reason not Specified|0|||
13485385|NCT03318523|27032707|FG000|PC Period: Up to Year 1|Adverse Event|1|||
13485386|NCT03318523|27032708|FG001|PC Period: Up to Year 1|Adverse Event|0|||
13485387|NCT03318523|27032709|FG002|PC Period: Up to Year 1|Adverse Event|2|||
13485388|NCT03318523|27032710|FG003|PC Period: Up to Year 1|Adverse Event|0|||
13485389|NCT03318523|27032711|FG004|PC Period: Up to Year 1|Adverse Event|0|||
13485390|NCT03318523|27032712|FG005|PC Period: Up to Year 1|Adverse Event|0|||
13485391|NCT03318523|27032713|FG006|PC Period: Up to Year 1|Adverse Event|0|||
13485392|NCT03318523|27032714|FG007|PC Period: Up to Year 1|Adverse Event|0|||
13485393|NCT03318523|27032715|FG008|PC Period: Up to Year 1|Adverse Event|0|||
13485394|NCT03318523|27032716|FG009|PC Period: Up to Year 1|Adverse Event|0|||
13485395|NCT03318523|27032707|FG000|PC Period: Up to Year 1|Consent Withdrawn|3|||
13485396|NCT03318523|27032708|FG001|PC Period: Up to Year 1|Consent Withdrawn|2|||
13485397|NCT03318523|27032709|FG002|PC Period: Up to Year 1|Consent Withdrawn|0|||
13485398|NCT03318523|27032710|FG003|PC Period: Up to Year 1|Consent Withdrawn|4|||
13485399|NCT03318523|27032711|FG004|PC Period: Up to Year 1|Consent Withdrawn|0|||
13485400|NCT03318523|27032712|FG005|PC Period: Up to Year 1|Consent Withdrawn|0|||
13104775|NCT03284710|25877207|FG002|Overall Study|HIV Infection|2|||
13156981|NCT02486302|26071240|FG000|Overall Study|Excluded due to legal reasons|8|||
13156982|NCT02486302|26071240|FG000|Overall Study|Not treated|3|||
13156983|NCT02485925|26071250|FG000|Overall Study|Withdrawal by Subject|3|||
13156984|NCT02485925|26071250|FG000|Overall Study|Death|1|||
13156985|NCT02485925|26071250|FG000|Overall Study|Lost to Follow-up|11|||
13156986|NCT02485899|26071269|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
13156987|NCT02485899|26071270|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
13156988|NCT02485899|26071269|FG000|Overall Study|Withdrawal by Subject|1|||
13485401|NCT03318523|27032713|FG006|PC Period: Up to Year 1|Consent Withdrawn|0|||
13485402|NCT03318523|27032714|FG007|PC Period: Up to Year 1|Consent Withdrawn|0|||
13485403|NCT03318523|27032715|FG008|PC Period: Up to Year 1|Consent Withdrawn|0|||
13104776|NCT03284710|25877208|FG003|Overall Study|HIV Infection|1|||
13156989|NCT02485899|26071270|FG001|Overall Study|Withdrawal by Subject|0|||
13156990|NCT02485899|26071269|FG000|Overall Study|Withdrawal by Parent/ Guardian|4|||
13156991|NCT02485899|26071270|FG001|Overall Study|Withdrawal by Parent/ Guardian|0|||
13156992|NCT02485717|26071293|FG000|Overall Study|Lost to Follow-up|6|||
13156993|NCT02485717|26071294|FG001|Overall Study|Lost to Follow-up|0|||
13156994|NCT02485717|26071295|FG002|Overall Study|Lost to Follow-up|0|||
13156995|NCT02485717|26071293|FG000|Overall Study|Withdrawal by Subject|0|||
13156996|NCT02485717|26071294|FG001|Overall Study|Withdrawal by Subject|0|||
13156997|NCT02485717|26071295|FG002|Overall Study|Withdrawal by Subject|1|||
13156998|NCT02485717|26071293|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
13156999|NCT02485717|26071294|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1|||
13157000|NCT02485717|26071295|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
13157001|NCT02485717|26071293|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
13157002|NCT02485717|26071294|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1|||
13157003|NCT02485717|26071295|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
13157004|NCT02485704|26071308|FG000|Overall Study|Lost to Follow-up|4|||
13157005|NCT02485704|26071309|FG001|Overall Study|Lost to Follow-up|5|||
13157006|NCT02485704|26071308|FG000|Overall Study|Withdrawal by Subject|0|||
13157007|NCT02485704|26071309|FG001|Overall Study|Withdrawal by Subject|3|||
13157008|NCT02485704|26071308|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1|||
13157009|NCT02485704|26071309|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0|||
13157010|NCT02485691|26071348|FG000|Overall Study|Adverse Event|25|||
13157011|NCT02485691|26071349|FG001|Overall Study|Adverse Event|11|||
13157012|NCT02485691|26071348|FG000|Overall Study|Poor compliance to protocol|0|||
13157013|NCT02485691|26071349|FG001|Overall Study|Poor compliance to protocol|1|||
13157014|NCT02485691|26071348|FG000|Overall Study|Disease progression|57|||
13157015|NCT02485691|26071349|FG001|Overall Study|Disease progression|92|||
13157016|NCT02485691|26071348|FG000|Overall Study|Investigator's decision|23|||
13157017|NCT02485691|26071349|FG001|Overall Study|Investigator's decision|5|||
13157018|NCT02485691|26071348|FG000|Overall Study|Participant's request|13|||
13104777|NCT03179761|25877229|FG000|Overall Study|Death|2|||
13104778|NCT03179761|25877230|FG001|Overall Study|Death|5|||
13104779|NCT03179761|25877229|FG000|Overall Study|Lost to Follow-up|2|||
13104780|NCT03179761|25877230|FG001|Overall Study|Lost to Follow-up|2|||
13485404|NCT03318523|27032716|FG009|PC Period: Up to Year 1|Consent Withdrawn|0|||
13485405|NCT03318523|27032707|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
13104781|NCT03179761|25877229|FG000|Overall Study|Protocol Violation|1|||
13104782|NCT03179761|25877230|FG001|Overall Study|Protocol Violation|0|||
13104783|NCT03179761|25877229|FG000|Overall Study|Withdrawal by Subject|1|||
13104784|NCT03179761|25877230|FG001|Overall Study|Withdrawal by Subject|4|||
13104785|NCT03179761|25877229|FG000|Overall Study|Investigator Request|0|||
13104786|NCT03179761|25877230|FG001|Overall Study|Investigator Request|2|||
13104787|NCT03143153|25877260|FG000|Pre-Treatment|Participant request to discontinue study treatment|0|||
13157019|NCT02485691|26071349|FG001|Overall Study|Participant's request|6|||
13157020|NCT02485691|26071348|FG000|Overall Study|Other reason|8|||
13157021|NCT02485691|26071349|FG001|Overall Study|Other reason|9|||
13157022|NCT02485691|26071348|FG000|Overall Study|Randomized and not treated|3|||
13157023|NCT02485691|26071349|FG001|Overall Study|Randomized and not treated|2|||
13157024|NCT02485483|26071371|FG000|Overall Study|Depression at baseline|15|||
13157025|NCT02485483|26071372|FG001|Overall Study|Depression at baseline|0|||
13157026|NCT02485483|26071371|FG000|Overall Study|Discontinued after baseline|39|||
13157027|NCT02485483|26071372|FG001|Overall Study|Discontinued after baseline|0|||
13157028|NCT02485353|26071379|FG000|Overall Study|Death|1|||
13157029|NCT02485353|26071379|FG000|Overall Study|Disease Progression|1|||
13157030|NCT02485301|26071436|FG000|Overall Study|Serious Adverse Events|2|||
13157031|NCT02485301|26071437|FG001|Overall Study|Serious Adverse Events|1|||
13157032|NCT02485301|26071436|FG000|Overall Study|Protocol Violation|0|||
13157033|NCT02485301|26071437|FG001|Overall Study|Protocol Violation|1|||
13157034|NCT02485301|26071436|FG000|Overall Study|Withdrawal by Subject|6|||
13104788|NCT03143153|25877261|FG001|Pre-Treatment|Participant request to discontinue study treatment|0|||
13104789|NCT03143153|25877262|FG002|Pre-Treatment|Participant request to discontinue study treatment|2|||
13104790|NCT03143153|25877260|FG000|Pre-Treatment|Participant withdrew consent|0|||
13104791|NCT03143153|25877261|FG001|Pre-Treatment|Participant withdrew consent|1|||
13157035|NCT02485301|26071437|FG001|Overall Study|Withdrawal by Subject|7|||
13157036|NCT02485301|26071436|FG000|Overall Study|Migrated/moved from study area|10|||
13157037|NCT02485301|26071437|FG001|Overall Study|Migrated/moved from study area|19|||
13157038|NCT02485301|26071436|FG000|Overall Study|Lost to Follow-up|17|||
13157039|NCT02485301|26071437|FG001|Overall Study|Lost to Follow-up|17|||
13157040|NCT02485301|26071436|FG000|Overall Study|Other|3|||
13104792|NCT03143153|25877262|FG002|Pre-Treatment|Participant withdrew consent|12|||
13104793|NCT03143153|25877260|FG000|Pre-Treatment|Participant no longer meets study criteria|0|||
13157041|NCT02485301|26071437|FG001|Overall Study|Other|4|||
13157042|NCT02485158|26071526|FG000|Overall Study|Withdrawal by Subject|3|||
13157043|NCT02485158|26071526|FG000|Overall Study|expected drug side effect|1|||
13157044|NCT02484911|26071561|FG000|Overall Study|Withdrawal by Subject|2|||
13157045|NCT02484911|26071562|FG001|Overall Study|Withdrawal by Subject|1|||
13157046|NCT02484911|26071561|FG000|Overall Study|Protocol Violation|2|||
13157047|NCT02484911|26071562|FG001|Overall Study|Protocol Violation|1|||
13157048|NCT02484729|26071789|FG000|Overall Study|Failure of IntelliCap Error|0|||
13157049|NCT02484729|26071790|FG001|Overall Study|Failure of IntelliCap Error|0|||
13157050|NCT02484729|26071791|FG002|Overall Study|Failure of IntelliCap Error|0|||
13157051|NCT02484729|26071792|FG003|Overall Study|Failure of IntelliCap Error|0|||
13157052|NCT02484729|26071793|FG004|Overall Study|Failure of IntelliCap Error|0|||
13157053|NCT02484729|26071794|FG005|Overall Study|Failure of IntelliCap Error|0|||
13157054|NCT02484729|26071795|FG006|Overall Study|Failure of IntelliCap Error|0|||
13157055|NCT02484729|26071796|FG007|Overall Study|Failure of IntelliCap Error|0|||
13157056|NCT02484729|26071797|FG008|Overall Study|Failure of IntelliCap Error|0|||
13157057|NCT02484729|26071798|FG009|Overall Study|Failure of IntelliCap Error|1|||
13157058|NCT02484690|26071956|FG000|Overall Study|Adverse Event|1|||
13157059|NCT02484690|26071957|FG001|Overall Study|Adverse Event|3|||
13157060|NCT02484690|26071958|FG002|Overall Study|Adverse Event|0|||
13157061|NCT02484690|26071959|FG003|Overall Study|Adverse Event|0|||
13157062|NCT02484690|26071960|FG004|Overall Study|Adverse Event|5|||
13157063|NCT02484690|26071956|FG000|Overall Study|Death|0|||
13157064|NCT02484690|26071957|FG001|Overall Study|Death|0|||
13157065|NCT02484690|26071958|FG002|Overall Study|Death|0|||
13157066|NCT02484690|26071959|FG003|Overall Study|Death|0|||
13157067|NCT02484690|26071960|FG004|Overall Study|Death|1|||
13157068|NCT02484690|26071956|FG000|Overall Study|Withdrawal by Subject|1|||
13157069|NCT02484690|26071957|FG001|Overall Study|Withdrawal by Subject|3|||
13157070|NCT02484690|26071958|FG002|Overall Study|Withdrawal by Subject|1|||
13157071|NCT02484690|26071959|FG003|Overall Study|Withdrawal by Subject|2|||
13157072|NCT02484690|26071960|FG004|Overall Study|Withdrawal by Subject|0|||
13157073|NCT02484690|26071956|FG000|Overall Study|Physician Decision|2|||
13157074|NCT02484690|26071957|FG001|Overall Study|Physician Decision|0|||
13157075|NCT02484690|26071958|FG002|Overall Study|Physician Decision|1|||
13157076|NCT02484690|26071959|FG003|Overall Study|Physician Decision|0|||
13157077|NCT02484690|26071960|FG004|Overall Study|Physician Decision|0|||
13157078|NCT02484690|26071956|FG000|Overall Study|Lost to Follow-up|0|||
13157079|NCT02484690|26071957|FG001|Overall Study|Lost to Follow-up|0|||
13157080|NCT02484690|26071958|FG002|Overall Study|Lost to Follow-up|1|||
13157081|NCT02484690|26071959|FG003|Overall Study|Lost to Follow-up|0|||
13157082|NCT02484690|26071960|FG004|Overall Study|Lost to Follow-up|0|||
13157083|NCT02484547|26071995|FG000|Placebo-Controlled Period|Adverse Event|10|||
13157084|NCT02484547|26071996|FG001|Placebo-Controlled Period|Adverse Event|13|||
13157085|NCT02484547|26071997|FG002|Placebo-Controlled Period|Adverse Event|20|||
13157086|NCT02484547|26071998|FG003|Placebo-Controlled Period|Adverse Event|0|||
13157087|NCT02484547|26071999|FG004|Placebo-Controlled Period|Adverse Event|0|||
13157088|NCT02484547|26072000|FG005|Placebo-Controlled Period|Adverse Event|0|||
13157089|NCT02484547|26072001|FG006|Placebo-Controlled Period|Adverse Event|0|||
13157090|NCT02484547|26071995|FG000|Placebo-Controlled Period|Change of Treatment|0|||
13157091|NCT02484547|26071996|FG001|Placebo-Controlled Period|Change of Treatment|0|||
13157092|NCT02484547|26071997|FG002|Placebo-Controlled Period|Change of Treatment|1|||
13157093|NCT02484547|26071998|FG003|Placebo-Controlled Period|Change of Treatment|0|||
13157094|NCT02484547|26071999|FG004|Placebo-Controlled Period|Change of Treatment|0|||
13157095|NCT02484547|26072000|FG005|Placebo-Controlled Period|Change of Treatment|0|||
13157096|NCT02484547|26072001|FG006|Placebo-Controlled Period|Change of Treatment|0|||
13157097|NCT02484547|26071995|FG000|Placebo-Controlled Period|Consent Withdrawn|15|||
13157098|NCT02484547|26071996|FG001|Placebo-Controlled Period|Consent Withdrawn|32|||
13157099|NCT02484547|26071997|FG002|Placebo-Controlled Period|Consent Withdrawn|26|||
13157100|NCT02484547|26071998|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
13157101|NCT02484547|26071999|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
13157102|NCT02484547|26072000|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
13157103|NCT02484547|26072001|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
13157104|NCT02484547|26071995|FG000|Placebo-Controlled Period|Death|5|||
13157105|NCT02484547|26071996|FG001|Placebo-Controlled Period|Death|0|||
13157106|NCT02484547|26071997|FG002|Placebo-Controlled Period|Death|6|||
13157107|NCT02484547|26071998|FG003|Placebo-Controlled Period|Death|0|||
13157108|NCT02484547|26071999|FG004|Placebo-Controlled Period|Death|0|||
13157109|NCT02484547|26072000|FG005|Placebo-Controlled Period|Death|0|||
13157110|NCT02484547|26072001|FG006|Placebo-Controlled Period|Death|0|||
13157111|NCT02484547|26071995|FG000|Placebo-Controlled Period|Disease Progression|2|||
13157112|NCT02484547|26071996|FG001|Placebo-Controlled Period|Disease Progression|0|||
13157113|NCT02484547|26071997|FG002|Placebo-Controlled Period|Disease Progression|1|||
13157114|NCT02484547|26071998|FG003|Placebo-Controlled Period|Disease Progression|0|||
13157115|NCT02484547|26071999|FG004|Placebo-Controlled Period|Disease Progression|0|||
13157116|NCT02484547|26072000|FG005|Placebo-Controlled Period|Disease Progression|0|||
13157117|NCT02484547|26072001|FG006|Placebo-Controlled Period|Disease Progression|0|||
13157118|NCT02484547|26071995|FG000|Placebo-Controlled Period|Investigator Decision|2|||
13157119|NCT02484547|26071996|FG001|Placebo-Controlled Period|Investigator Decision|2|||
13157120|NCT02484547|26071997|FG002|Placebo-Controlled Period|Investigator Decision|5|||
13157121|NCT02484547|26071998|FG003|Placebo-Controlled Period|Investigator Decision|0|||
13157122|NCT02484547|26071999|FG004|Placebo-Controlled Period|Investigator Decision|0|||
13157123|NCT02484547|26072000|FG005|Placebo-Controlled Period|Investigator Decision|0|||
13157124|NCT02484547|26072001|FG006|Placebo-Controlled Period|Investigator Decision|0|||
13157125|NCT02484547|26071995|FG000|Placebo-Controlled Period|Lost to Follow-up|3|||
13157126|NCT02484547|26071996|FG001|Placebo-Controlled Period|Lost to Follow-up|1|||
13157127|NCT02484547|26071997|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
13157128|NCT02484547|26071998|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
13157129|NCT02484547|26071999|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
13157130|NCT02484547|26072000|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
13157131|NCT02484547|26072001|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
13157132|NCT02484547|26071995|FG000|Placebo-Controlled Period|Relocation|1|||
13157133|NCT02484547|26071996|FG001|Placebo-Controlled Period|Relocation|1|||
13157134|NCT02484547|26071997|FG002|Placebo-Controlled Period|Relocation|1|||
13157135|NCT02484547|26071998|FG003|Placebo-Controlled Period|Relocation|0|||
13157136|NCT02484547|26071999|FG004|Placebo-Controlled Period|Relocation|0|||
13157137|NCT02484547|26072000|FG005|Placebo-Controlled Period|Relocation|0|||
13157138|NCT02484547|26072001|FG006|Placebo-Controlled Period|Relocation|0|||
13157139|NCT02484547|26071995|FG000|Placebo-Controlled Period|Study Visit Burden|2|||
13157140|NCT02484547|26071996|FG001|Placebo-Controlled Period|Study Visit Burden|8|||
13157141|NCT02484547|26071997|FG002|Placebo-Controlled Period|Study Visit Burden|5|||
13157142|NCT02484547|26071998|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
13157143|NCT02484547|26071999|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
13157144|NCT02484547|26072000|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
13157145|NCT02484547|26072001|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
13157146|NCT02484547|26071995|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4|||
13157147|NCT02484547|26071996|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
13157148|NCT02484547|26071997|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
13157149|NCT02484547|26071998|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
13157150|NCT02484547|26071999|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
13157151|NCT02484547|26072000|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
13157152|NCT02484547|26072001|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
13222768|NCT01803282|26286892|FG009|Overall Study|Non-Compliance with Study Drug|0|||
13157153|NCT02484547|26071995|FG000|Placebo-Controlled Period|Reason not Specified|216|||
13157154|NCT02484547|26071996|FG001|Placebo-Controlled Period|Reason not Specified|194|||
13157155|NCT02484547|26071997|FG002|Placebo-Controlled Period|Reason not Specified|183|||
13157156|NCT02484547|26071998|FG003|Placebo-Controlled Period|Reason not Specified|0|||
13157157|NCT02484547|26071999|FG004|Placebo-Controlled Period|Reason not Specified|0|||
13157158|NCT02484547|26072000|FG005|Placebo-Controlled Period|Reason not Specified|0|||
13157159|NCT02484547|26072001|FG006|Placebo-Controlled Period|Reason not Specified|0|||
13157160|NCT02484547|26071995|FG000|Long-Term Extension Period|Adverse Event|0|||
13157161|NCT02484547|26071996|FG001|Long-Term Extension Period|Adverse Event|0|||
13157162|NCT02484547|26071997|FG002|Long-Term Extension Period|Adverse Event|0|||
13157163|NCT02484547|26071998|FG003|Long-Term Extension Period|Adverse Event|0|||
13157164|NCT02484547|26071999|FG004|Long-Term Extension Period|Adverse Event|1|||
13157165|NCT02484547|26072000|FG005|Long-Term Extension Period|Adverse Event|3|||
13157166|NCT02484547|26072001|FG006|Long-Term Extension Period|Adverse Event|2|||
13157167|NCT02484547|26071995|FG000|Long-Term Extension Period|Death|0|||
13157168|NCT02484547|26071996|FG001|Long-Term Extension Period|Death|0|||
13157169|NCT02484547|26071997|FG002|Long-Term Extension Period|Death|0|||
13157170|NCT02484547|26071998|FG003|Long-Term Extension Period|Death|0|||
13157171|NCT02484547|26071999|FG004|Long-Term Extension Period|Death|0|||
13157172|NCT02484547|26072000|FG005|Long-Term Extension Period|Death|3|||
13157173|NCT02484547|26072001|FG006|Long-Term Extension Period|Death|0|||
13157174|NCT02484547|26071995|FG000|Long-Term Extension Period|Disease Progression|0|||
13157175|NCT02484547|26071996|FG001|Long-Term Extension Period|Disease Progression|0|||
13157176|NCT02484547|26071997|FG002|Long-Term Extension Period|Disease Progression|0|||
13157177|NCT02484547|26071998|FG003|Long-Term Extension Period|Disease Progression|0|||
13157178|NCT02484547|26071999|FG004|Long-Term Extension Period|Disease Progression|2|||
13157179|NCT02484547|26072000|FG005|Long-Term Extension Period|Disease Progression|4|||
13157180|NCT02484547|26072001|FG006|Long-Term Extension Period|Disease Progression|0|||
13157181|NCT02484547|26071995|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
13157182|NCT02484547|26071996|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
13157183|NCT02484547|26071997|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
13157184|NCT02484547|26071998|FG003|Long-Term Extension Period|Lost to Follow-up|1|||
13157185|NCT02484547|26071999|FG004|Long-Term Extension Period|Lost to Follow-up|1|||
13157186|NCT02484547|26072000|FG005|Long-Term Extension Period|Lost to Follow-up|2|||
13157187|NCT02484547|26072001|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
13157188|NCT02484547|26071995|FG000|Long-Term Extension Period|Loss of Capacity|0|||
13157189|NCT02484547|26071996|FG001|Long-Term Extension Period|Loss of Capacity|0|||
13157190|NCT02484547|26071997|FG002|Long-Term Extension Period|Loss of Capacity|0|||
13157191|NCT02484547|26071998|FG003|Long-Term Extension Period|Loss of Capacity|0|||
13157192|NCT02484547|26071999|FG004|Long-Term Extension Period|Loss of Capacity|1|||
13157193|NCT02484547|26072000|FG005|Long-Term Extension Period|Loss of Capacity|0|||
13157194|NCT02484547|26072001|FG006|Long-Term Extension Period|Loss of Capacity|0|||
13157195|NCT02484547|26071995|FG000|Long-Term Extension Period|Change of Treatment|0|||
13157196|NCT02484547|26071996|FG001|Long-Term Extension Period|Change of Treatment|0|||
13157197|NCT02484547|26071997|FG002|Long-Term Extension Period|Change of Treatment|0|||
13157198|NCT02484547|26071998|FG003|Long-Term Extension Period|Change of Treatment|0|||
13157199|NCT02484547|26071999|FG004|Long-Term Extension Period|Change of Treatment|0|||
13157200|NCT02484547|26072000|FG005|Long-Term Extension Period|Change of Treatment|0|||
13157201|NCT02484547|26072001|FG006|Long-Term Extension Period|Change of Treatment|1|||
13157202|NCT02484547|26071995|FG000|Long-Term Extension Period|Consent Withdrawn|0|||
13157203|NCT02484547|26071996|FG001|Long-Term Extension Period|Consent Withdrawn|0|||
13157204|NCT02484547|26071997|FG002|Long-Term Extension Period|Consent Withdrawn|0|||
13157205|NCT02484547|26071998|FG003|Long-Term Extension Period|Consent Withdrawn|6|||
13157206|NCT02484547|26071999|FG004|Long-Term Extension Period|Consent Withdrawn|7|||
13157207|NCT02484547|26072000|FG005|Long-Term Extension Period|Consent Withdrawn|13|||
13157208|NCT02484547|26072001|FG006|Long-Term Extension Period|Consent Withdrawn|17|||
13157209|NCT02484547|26071995|FG000|Long-Term Extension Period|Investigator Decision|0|||
13157210|NCT02484547|26071996|FG001|Long-Term Extension Period|Investigator Decision|0|||
13157211|NCT02484547|26071997|FG002|Long-Term Extension Period|Investigator Decision|0|||
13157212|NCT02484547|26071998|FG003|Long-Term Extension Period|Investigator Decision|2|||
13157213|NCT02484547|26071999|FG004|Long-Term Extension Period|Investigator Decision|1|||
13157214|NCT02484547|26072000|FG005|Long-Term Extension Period|Investigator Decision|0|||
13157215|NCT02484547|26072001|FG006|Long-Term Extension Period|Investigator Decision|1|||
13157216|NCT02484547|26071995|FG000|Long-Term Extension Period|Relocation|0|||
13157217|NCT02484547|26071996|FG001|Long-Term Extension Period|Relocation|0|||
13157218|NCT02484547|26071997|FG002|Long-Term Extension Period|Relocation|0|||
13157219|NCT02484547|26071998|FG003|Long-Term Extension Period|Relocation|1|||
13157220|NCT02484547|26071999|FG004|Long-Term Extension Period|Relocation|1|||
13157221|NCT02484547|26072000|FG005|Long-Term Extension Period|Relocation|0|||
13157222|NCT02484547|26072001|FG006|Long-Term Extension Period|Relocation|0|||
13157223|NCT02484547|26071995|FG000|Long-Term Extension Period|Study Visit Burden|0|||
13157224|NCT02484547|26071996|FG001|Long-Term Extension Period|Study Visit Burden|0|||
13157225|NCT02484547|26071997|FG002|Long-Term Extension Period|Study Visit Burden|0|||
13157226|NCT02484547|26071998|FG003|Long-Term Extension Period|Study Visit Burden|2|||
13157227|NCT02484547|26071999|FG004|Long-Term Extension Period|Study Visit Burden|0|||
13157228|NCT02484547|26072000|FG005|Long-Term Extension Period|Study Visit Burden|0|||
13157229|NCT02484547|26072001|FG006|Long-Term Extension Period|Study Visit Burden|3|||
13157230|NCT02484547|26071995|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
13157231|NCT02484547|26071996|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
13157232|NCT02484547|26071997|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
13157233|NCT02484547|26071998|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
13157234|NCT02484547|26071999|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1|||
13157235|NCT02484547|26072000|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3|||
13157236|NCT02484547|26072001|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2|||
13157237|NCT02484547|26071995|FG000|Long-Term Extension Period|Reason not Specified|0|||
13157238|NCT02484547|26071996|FG001|Long-Term Extension Period|Reason not Specified|0|||
13157239|NCT02484547|26071997|FG002|Long-Term Extension Period|Reason not Specified|0|||
13157240|NCT02484547|26071998|FG003|Long-Term Extension Period|Reason not Specified|119|||
13157241|NCT02484547|26071999|FG004|Long-Term Extension Period|Reason not Specified|117|||
13157242|NCT02484547|26072000|FG005|Long-Term Extension Period|Reason not Specified|223|||
13157243|NCT02484547|26072001|FG006|Long-Term Extension Period|Reason not Specified|231|||
13157244|NCT02483975|26072022|FG000|Overall Study|Adverse Event|0|||
13157245|NCT02483975|26072023|FG001|Overall Study|Adverse Event|1|||
13157246|NCT02483975|26072022|FG000|Overall Study|Lost to Follow-up|0|||
13157247|NCT02483975|26072023|FG001|Overall Study|Lost to Follow-up|1|||
13157248|NCT02483975|26072022|FG000|Overall Study|Physician Decision|2|||
13157249|NCT02483975|26072023|FG001|Overall Study|Physician Decision|0|||
13157250|NCT02483611|26072128|FG000|Overall Study|Protocol Violation|0|||
13157251|NCT02483611|26072129|FG001|Overall Study|Protocol Violation|0|||
13157252|NCT02483611|26072130|FG002|Overall Study|Protocol Violation|1|||
13157253|NCT02483585|26072157|FG000|Double-blind Treatment Phase|Decision by Sponsor|1|||
13157254|NCT02483585|26072158|FG001|Double-blind Treatment Phase|Decision by Sponsor|1|||
13157255|NCT02483585|26072157|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12|||
13157256|NCT02483585|26072158|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
13157257|NCT02483585|26072157|FG000|Double-blind Treatment Phase|Lost to Follow-up|3|||
13157258|NCT02483585|26072158|FG001|Double-blind Treatment Phase|Lost to Follow-up|2|||
13157259|NCT02483585|26072157|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6|||
13157260|NCT02483585|26072158|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5|||
13104794|NCT03143153|25877261|FG001|Pre-Treatment|Participant no longer meets study criteria|4|||
13104795|NCT03143153|25877262|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
13104796|NCT03143153|25877260|FG000|Pre-Treatment|Other Reasons|1|||
13104797|NCT03143153|25877261|FG001|Pre-Treatment|Other Reasons|2|||
13104798|NCT03143153|25877262|FG002|Pre-Treatment|Other Reasons|1|||
13104799|NCT03143153|25877260|FG000|Pre-Treatment|Disease Progression|1|||
13104800|NCT03143153|25877261|FG001|Pre-Treatment|Disease Progression|1|||
13104801|NCT03143153|25877262|FG002|Pre-Treatment|Disease Progression|2|||
13104802|NCT03143153|25877260|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
13104803|NCT03143153|25877261|FG001|Pre-Treatment|Adverse event unrelated to study drug|3|||
13104804|NCT03143153|25877262|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
13104805|NCT03143153|25877260|FG000|Treatment|Disease progression|174|||
13104806|NCT03143153|25877261|FG001|Treatment|Disease progression|184|||
13104807|NCT03143153|25877262|FG002|Treatment|Disease progression|193|||
13104808|NCT03143153|25877260|FG000|Treatment|Study drug toxicity|59|||
13104809|NCT03143153|25877261|FG001|Treatment|Study drug toxicity|33|||
13104810|NCT03143153|25877262|FG002|Treatment|Study drug toxicity|40|||
13104811|NCT03143153|25877260|FG000|Treatment|Death|5|||
13104812|NCT03143153|25877261|FG001|Treatment|Death|3|||
13104813|NCT03143153|25877262|FG002|Treatment|Death|4|||
13104814|NCT03143153|25877260|FG000|Treatment|Adverse event unrelated to study drug|19|||
13104815|NCT03143153|25877261|FG001|Treatment|Adverse event unrelated to study drug|28|||
13104816|NCT03143153|25877262|FG002|Treatment|Adverse event unrelated to study drug|12|||
13104817|NCT03143153|25877260|FG000|Treatment|Participant request to discontinue study treatment|13|||
13104818|NCT03143153|25877261|FG001|Treatment|Participant request to discontinue study treatment|15|||
13104819|NCT03143153|25877262|FG002|Treatment|Participant request to discontinue study treatment|20|||
13104820|NCT03143153|25877260|FG000|Treatment|Participant withdrew consent|3|||
13104821|NCT03143153|25877261|FG001|Treatment|Participant withdrew consent|4|||
13104822|NCT03143153|25877262|FG002|Treatment|Participant withdrew consent|12|||
13104823|NCT03143153|25877260|FG000|Treatment|Pregnancy|1|||
13104824|NCT03143153|25877261|FG001|Treatment|Pregnancy|0|||
13104825|NCT03143153|25877262|FG002|Treatment|Pregnancy|0|||
13104826|NCT03143153|25877260|FG000|Treatment|Maximum clinical benefit|1|||
13104827|NCT03143153|25877261|FG001|Treatment|Maximum clinical benefit|3|||
13104828|NCT03143153|25877262|FG002|Treatment|Maximum clinical benefit|4|||
13104829|NCT03143153|25877260|FG000|Treatment|Completed treatment as per Protocol|13|||
13104830|NCT03143153|25877261|FG001|Treatment|Completed treatment as per Protocol|8|||
13104831|NCT03143153|25877262|FG002|Treatment|Completed treatment as per Protocol|0|||
13104832|NCT03143153|25877260|FG000|Treatment|Other reasons|12|||
13104833|NCT03143153|25877261|FG001|Treatment|Other reasons|7|||
13104834|NCT03143153|25877262|FG002|Treatment|Other reasons|15|||
13104835|NCT03143153|25877260|FG000|Treatment|Not reported|1|||
13104836|NCT03143153|25877261|FG001|Treatment|Not reported|0|||
13104837|NCT03143153|25877262|FG002|Treatment|Not reported|0|||
13104838|NCT02998528|25877285|FG000|Randomization Period|Adverse event unrelated to study drug|0|||
13104839|NCT02998528|25877286|FG001|Randomization Period|Adverse event unrelated to study drug|0|||
13104840|NCT02998528|25877287|FG002|Randomization Period|Adverse event unrelated to study drug|1|||
13104841|NCT02998528|25877285|FG000|Randomization Period|Participant withdrew consent|0|||
13104842|NCT02998528|25877286|FG001|Randomization Period|Participant withdrew consent|3|||
13104843|NCT02998528|25877287|FG002|Randomization Period|Participant withdrew consent|0|||
13104844|NCT02998528|25877285|FG000|Randomization Period|Participant no longer meets study criteria|1|||
13104845|NCT02998528|25877286|FG001|Randomization Period|Participant no longer meets study criteria|3|||
13104846|NCT02998528|25877287|FG002|Randomization Period|Participant no longer meets study criteria|2|||
13104847|NCT02998528|25877285|FG000|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
13104848|NCT02998528|25877286|FG001|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|7|||
13104849|NCT02998528|25877287|FG002|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
13104850|NCT02998528|25877285|FG000|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
13104851|NCT02998528|25877286|FG001|Neoadjuvant Treatment Period|Participant withdrew consent|4|||
13104852|NCT02998528|25877287|FG002|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
13104853|NCT02998528|25877285|FG000|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
13104854|NCT02998528|25877286|FG001|Neoadjuvant Treatment Period|Participant no longer meets study criteria|1|||
13104855|NCT02998528|25877287|FG002|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
13104856|NCT02998528|25877285|FG000|Neoadjuvant Treatment Period|Disease progression|3|||
13104857|NCT02998528|25877286|FG001|Neoadjuvant Treatment Period|Disease progression|2|||
13104858|NCT02998528|25877287|FG002|Neoadjuvant Treatment Period|Disease progression|1|||
13104859|NCT02998528|25877285|FG000|Neoadjuvant Treatment Period|Study drug toxicity|6|||
13104860|NCT02998528|25877286|FG001|Neoadjuvant Treatment Period|Study drug toxicity|14|||
13104861|NCT02998528|25877287|FG002|Neoadjuvant Treatment Period|Study drug toxicity|10|||
13104862|NCT02998528|25877285|FG000|Neoadjuvant Treatment Period|Death|1|||
13104863|NCT02998528|25877286|FG001|Neoadjuvant Treatment Period|Death|0|||
13104864|NCT02998528|25877287|FG002|Neoadjuvant Treatment Period|Death|0|||
13157261|NCT02483585|26072157|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
13157262|NCT02483585|26072158|FG001|Open-label Treatment Phase|Decision by Sponsor|1|||
13157263|NCT02483585|26072157|FG000|Open-label Treatment Phase|Withdrawal by Subject|18|||
13157264|NCT02483585|26072158|FG001|Open-label Treatment Phase|Withdrawal by Subject|14|||
13157265|NCT02483585|26072157|FG000|Open-label Treatment Phase|Lost to Follow-up|3|||
13157266|NCT02483585|26072158|FG001|Open-label Treatment Phase|Lost to Follow-up|5|||
13157267|NCT02483572|26072177|FG000|Overall Study|Withdrawal by Subject|1|||
13157268|NCT02483572|26072178|FG001|Overall Study|Withdrawal by Subject|0|||
13157269|NCT02483572|26072177|FG000|Overall Study|Lost to Follow-up|1|||
13157270|NCT02483572|26072178|FG001|Overall Study|Lost to Follow-up|0|||
13157271|NCT02483572|26072177|FG000|Overall Study|Physician Decision|0|||
13157272|NCT02483572|26072178|FG001|Overall Study|Physician Decision|1|||
13157273|NCT02483533|26072193|FG000|Overall Study|Lack of Efficacy|50|||
13157274|NCT02483533|26072194|FG001|Overall Study|Lack of Efficacy|50|||
13157275|NCT02483520|26072239|FG000|Overall Study|Lost to Follow-up|3|||
13157276|NCT02483520|26072240|FG001|Overall Study|Lost to Follow-up|4|||
13157277|NCT02483520|26072239|FG000|Overall Study|Withdrawal by Subject|4|||
13157278|NCT02483520|26072240|FG001|Overall Study|Withdrawal by Subject|14|||
13157279|NCT02483520|26072239|FG000|Overall Study|Hospitalized|2|||
13157280|NCT02483520|26072240|FG001|Overall Study|Hospitalized|3|||
13157281|NCT02483520|26072239|FG000|Overall Study|Moved to LTC|2|||
13157282|NCT02483520|26072240|FG001|Overall Study|Moved to LTC|3|||
13157283|NCT02483416|26072302|FG000|Overall Study|Other reason|0|||
13157284|NCT02483416|26072303|FG001|Overall Study|Other reason|1|||
13157285|NCT02483416|26072302|FG000|Overall Study|Treatment stop|3|||
13157286|NCT02483416|26072303|FG001|Overall Study|Treatment stop|0|||
13157287|NCT02483078|26072335|FG000|Part 1 One-week Randomized|Lost to Follow-up|0|||
13157288|NCT02483078|26072336|FG001|Part 1 One-week Randomized|Lost to Follow-up|1|||
13157289|NCT02483078|26072335|FG000|Part 2 Open Label Treatment Period|Non-medical|0|||
13157290|NCT02483078|26072336|FG001|Part 2 Open Label Treatment Period|Non-medical|1|||
13157291|NCT02483078|26072335|FG000|Part 2 Open Label Treatment Period|Withdrawal by Subject|0|||
13157292|NCT02483078|26072336|FG001|Part 2 Open Label Treatment Period|Withdrawal by Subject|1|||
13157293|NCT02483078|26072335|FG000|Part 2 Open Label Treatment Period|Subject non compliant|0|||
13157294|NCT02483078|26072336|FG001|Part 2 Open Label Treatment Period|Subject non compliant|1|||
13157295|NCT02483078|26072335|FG000|Part 2 Open Label Treatment Period|Lost to Follow-up|0|||
13157296|NCT02483078|26072336|FG001|Part 2 Open Label Treatment Period|Lost to Follow-up|1|||
13157297|NCT02483078|26072335|FG000|Part 2 Open Label Treatment Period|Adverse Event|0|||
13157298|NCT02483078|26072336|FG001|Part 2 Open Label Treatment Period|Adverse Event|1|||
13157299|NCT02482935|26072349|FG000|Period 1|Withdrawal by Subject|1|||
13157300|NCT02482935|26072350|FG001|Period 1|Withdrawal by Subject|0|||
13157301|NCT02482805|26072374|FG000|Overall Study|Lost to Follow-up|4|||
13157302|NCT02482805|26072375|FG001|Overall Study|Lost to Follow-up|4|||
13157303|NCT02482805|26072376|FG002|Overall Study|Lost to Follow-up|0|||
13157304|NCT02482571|26072385|FG000|Overall Study|Adverse Event|1|||
13157305|NCT02482571|26072385|FG000|Overall Study|Scanner or Respiract failure|3|||
13157306|NCT02482571|26072385|FG000|Overall Study|Withdrawal by Subject|4|||
13157307|NCT02482428|26072421|FG000|Overall Study|Lost to Follow-up|4|||
13157308|NCT02482428|26072422|FG001|Overall Study|Lost to Follow-up|9|||
13157309|NCT02482428|26072423|FG002|Overall Study|Lost to Follow-up|1|||
13157310|NCT02482428|26072424|FG003|Overall Study|Lost to Follow-up|2|||
13157311|NCT02482428|26072425|FG004|Overall Study|Lost to Follow-up|4|||
13157312|NCT02482428|26072421|FG000|Overall Study|Physician Decision|0|||
13157313|NCT02482428|26072422|FG001|Overall Study|Physician Decision|0|||
13157314|NCT02482428|26072423|FG002|Overall Study|Physician Decision|0|||
13157315|NCT02482428|26072424|FG003|Overall Study|Physician Decision|0|||
13157316|NCT02482428|26072425|FG004|Overall Study|Physician Decision|1|||
13157317|NCT02482428|26072421|FG000|Overall Study|protocol deviation|1|||
13157318|NCT02482428|26072422|FG001|Overall Study|protocol deviation|1|||
13157319|NCT02482428|26072423|FG002|Overall Study|protocol deviation|0|||
13157320|NCT02482428|26072424|FG003|Overall Study|protocol deviation|0|||
13157321|NCT02482428|26072425|FG004|Overall Study|protocol deviation|0|||
13157322|NCT02482428|26072421|FG000|Overall Study|subject/guardian decision|4|||
13157323|NCT02482428|26072422|FG001|Overall Study|subject/guardian decision|2|||
13157324|NCT02482428|26072423|FG002|Overall Study|subject/guardian decision|0|||
13157325|NCT02482428|26072424|FG003|Overall Study|subject/guardian decision|0|||
13157326|NCT02482428|26072425|FG004|Overall Study|subject/guardian decision|2|||
13157327|NCT02482298|26072455|FG000|Overall Study|Withdrawal by Subject|2|||
13157328|NCT02482298|26072456|FG001|Overall Study|Withdrawal by Subject|1|||
13157329|NCT02482298|26072457|FG002|Overall Study|Withdrawal by Subject|2|||
13157330|NCT02482298|26072455|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0|||
13157331|NCT02482298|26072456|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1|||
13157332|NCT02482298|26072457|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0|||
13157333|NCT02482298|26072455|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
13157334|NCT02482298|26072456|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
13157335|NCT02482298|26072457|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1|||
13157336|NCT02482298|26072455|FG000|Overall Study|Lost to Follow-up|0|||
13157337|NCT02482298|26072456|FG001|Overall Study|Lost to Follow-up|1|||
13157338|NCT02482298|26072457|FG002|Overall Study|Lost to Follow-up|0|||
13157339|NCT02482129|26072491|FG000|Overall Study|Adverse Event-prior to treatment|0|||
13157340|NCT02482129|26072492|FG001|Overall Study|Adverse Event-prior to treatment|1|||
13157341|NCT02482129|26072491|FG000|Overall Study|Withdrawal by subject-prior to treatment|0|||
13157342|NCT02482129|26072492|FG001|Overall Study|Withdrawal by subject-prior to treatment|1|||
13157343|NCT02482129|26072491|FG000|Overall Study|Unable to draw blood-prior to treatment|1|||
13157344|NCT02482129|26072492|FG001|Overall Study|Unable to draw blood-prior to treatment|0|||
13157345|NCT02482129|26072491|FG000|Overall Study|Criteria not met-prior to treatment|1|||
13157346|NCT02482129|26072492|FG001|Overall Study|Criteria not met-prior to treatment|0|||
13157347|NCT02482129|26072491|FG000|Overall Study|Adverse Event|1|||
13157348|NCT02482129|26072492|FG001|Overall Study|Adverse Event|0|||
13157349|NCT02482129|26072491|FG000|Overall Study|Withdrawal by Subject|2|||
13157350|NCT02482129|26072492|FG001|Overall Study|Withdrawal by Subject|0|||
13157351|NCT02482129|26072491|FG000|Overall Study|Criteria not met|1|||
13157352|NCT02482129|26072492|FG001|Overall Study|Criteria not met|0|||
13157353|NCT02481947|26072505|FG000|Overall Study|Withdrawal by Subject|24|||
13157354|NCT02481947|26072506|FG001|Overall Study|Withdrawal by Subject|10|||
13157355|NCT02481947|26072505|FG000|Overall Study|Lost to Follow-up|11|||
13157356|NCT02481947|26072506|FG001|Overall Study|Lost to Follow-up|5|||
13157357|NCT02481947|26072505|FG000|Overall Study|Adverse Event|6|||
13157358|NCT02481947|26072506|FG001|Overall Study|Adverse Event|11|||
13157359|NCT02481947|26072505|FG000|Overall Study|Physician Decision|4|||
13157360|NCT02481947|26072506|FG001|Overall Study|Physician Decision|5|||
13157361|NCT02481947|26072505|FG000|Overall Study|Protocol Violation|1|||
13157362|NCT02481947|26072506|FG001|Overall Study|Protocol Violation|5|||
13157363|NCT02481934|26072513|FG000|Overall Study|Death|2|||
13157364|NCT02481869|26072538|FG000|Overall Study|Lost to Follow-up|3|||
13157365|NCT02481869|26072539|FG001|Overall Study|Lost to Follow-up|4|||
13157366|NCT02481869|26072538|FG000|Overall Study|Withdrawal by Subject|2|||
13157367|NCT02481869|26072539|FG001|Overall Study|Withdrawal by Subject|0|||
13157368|NCT02481830|26072556|FG000|Overall Study|No longer meets Study Criteria|1|||
13157369|NCT02481830|26072557|FG001|Overall Study|No longer meets Study Criteria|4|||
13157370|NCT02481830|26072556|FG000|Overall Study|Withdrawal by Subject|0|||
13157371|NCT02481830|26072557|FG001|Overall Study|Withdrawal by Subject|14|||
13157372|NCT02481830|26072556|FG000|Overall Study|Disease Progression|1|||
13157373|NCT02481830|26072557|FG001|Overall Study|Disease Progression|1|||
13157374|NCT02481830|26072556|FG000|Overall Study|Participant not eligible for trial|0|||
13157375|NCT02481830|26072557|FG001|Overall Study|Participant not eligible for trial|1|||
13157376|NCT02481310|26072572|FG000|Follow up|Still in follow up|0|||
13157377|NCT02481310|26072573|FG001|Follow up|Still in follow up|3|||
13157378|NCT02481310|26072574|FG002|Follow up|Still in follow up|0|||
13157379|NCT02481050|26072585|FG000|Overall Study|Adverse Event|1|||
13157380|NCT02481050|26072585|FG000|Overall Study|Disease Progression|47|||
13157381|NCT02481050|26072585|FG000|Overall Study|Withdrawal by Subject|7|||
13157382|NCT02481050|26072585|FG000|Overall Study|Other|3|||
13205314|NCT01966445|26231476|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
13205315|NCT01966445|26231477|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
13205316|NCT01966445|26231478|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
13205317|NCT01966445|26231479|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2|||
13205318|NCT01966445|26231480|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
13205319|NCT01966445|26231481|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1|||
13205320|NCT01966445|26231482|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
13205321|NCT01966445|26231476|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
13205322|NCT01966445|26231477|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
13205323|NCT01966445|26231478|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
13205324|NCT01966445|26231479|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
13205325|NCT01966445|26231480|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
13205326|NCT01966445|26231481|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
13205327|NCT01966445|26231482|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
13205328|NCT01966445|26231476|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
13205329|NCT01966445|26231477|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
13205330|NCT01966445|26231478|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
13205331|NCT01966445|26231479|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
13205332|NCT01966445|26231480|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2|||
13205333|NCT01966445|26231481|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
13205334|NCT01966445|26231482|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
13205335|NCT01966445|26231476|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
13205336|NCT01966445|26231477|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
13205337|NCT01966445|26231478|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
13205338|NCT01966445|26231479|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
13157383|NCT02480764|26072621|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
13157384|NCT02480764|26072622|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
13157385|NCT02480764|26072623|FG002|Overall Study|Pretreatment Event/Adverse Event|3|||
13157386|NCT02480764|26072621|FG000|Overall Study|Major Protocol Deviation|1|||
13157387|NCT02480764|26072622|FG001|Overall Study|Major Protocol Deviation|4|||
13157388|NCT02480764|26072623|FG002|Overall Study|Major Protocol Deviation|3|||
13157389|NCT02480764|26072621|FG000|Overall Study|Lost to Follow-up|0|||
13157390|NCT02480764|26072622|FG001|Overall Study|Lost to Follow-up|1|||
13157391|NCT02480764|26072623|FG002|Overall Study|Lost to Follow-up|2|||
13157392|NCT02480764|26072621|FG000|Overall Study|Voluntary Withdrawal|6|||
13157393|NCT02480764|26072622|FG001|Overall Study|Voluntary Withdrawal|5|||
13157394|NCT02480764|26072623|FG002|Overall Study|Voluntary Withdrawal|10|||
13157395|NCT02480764|26072621|FG000|Overall Study|Lack of Efficacy|0|||
13157396|NCT02480764|26072622|FG001|Overall Study|Lack of Efficacy|3|||
13157397|NCT02480764|26072623|FG002|Overall Study|Lack of Efficacy|3|||
13157398|NCT02480764|26072621|FG000|Overall Study|Reason not Specified|0|||
13157399|NCT02480764|26072622|FG001|Overall Study|Reason not Specified|1|||
13157400|NCT02480764|26072623|FG002|Overall Study|Reason not Specified|0|||
13157401|NCT02480712|26072642|FG000|Overall Study|Enrolled but Never Treated|1|||
13157402|NCT02480712|26072642|FG000|Overall Study|Lost to Follow-up|5|||
13157403|NCT02480712|26072642|FG000|Overall Study|Withdrew Consent|3|||
13157404|NCT02480712|26072642|FG000|Overall Study|Death|1|||
13157405|NCT02480712|26072642|FG000|Overall Study|Lack of Efficacy|1|||
13157406|NCT02480621|26072655|FG000|Randomization|Withdrawal by Subject|1|||
13157407|NCT02480621|26072656|FG001|Randomization|Withdrawal by Subject|0|||
13157408|NCT02480621|26072655|FG000|Randomization|Surgeon did not give intervention|0|||
13157409|NCT02480621|26072656|FG001|Randomization|Surgeon did not give intervention|1|||
13157410|NCT02480621|26072655|FG000|Follow Up|Lost to Follow-up|4|||
13157411|NCT02480621|26072656|FG001|Follow Up|Lost to Follow-up|2|||
13157412|NCT02480153|26072839|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
13157413|NCT02480153|26072840|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1|||
13157414|NCT02480153|26072841|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
13157415|NCT02480153|26072839|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
13157416|NCT02480153|26072840|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1|||
13157417|NCT02480153|26072841|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
13157418|NCT02480153|26072839|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1|||
13157419|NCT02480153|26072840|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2|||
13157420|NCT02480153|26072841|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0|||
13157421|NCT02480153|26072839|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3|||
13157422|NCT02480153|26072840|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8|||
13157423|NCT02480153|26072841|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0|||
13157424|NCT02480153|26072839|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
13157425|NCT02480153|26072840|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1|||
13157426|NCT02480153|26072841|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
13157427|NCT02480153|26072839|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
13157428|NCT02480153|26072840|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1|||
13157429|NCT02480153|26072841|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
13157430|NCT02480153|26072839|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
13157431|NCT02480153|26072840|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2|||
13157432|NCT02480153|26072841|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
13157433|NCT02480153|26072839|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4|||
13157434|NCT02480153|26072840|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1|||
13157435|NCT02480153|26072841|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3|||
13157436|NCT02480153|26072839|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
13157437|NCT02480153|26072840|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1|||
13157438|NCT02480153|26072841|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
13157439|NCT02480153|26072839|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8|||
13157440|NCT02480153|26072840|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3|||
13157441|NCT02480153|26072841|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1|||
13157442|NCT02480153|26072839|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6|||
13157443|NCT02480153|26072840|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7|||
13157444|NCT02480153|26072841|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3|||
13157445|NCT02480153|26072839|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2|||
13157446|NCT02480153|26072840|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
13157447|NCT02480153|26072841|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
13157448|NCT02480153|26072839|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
13157449|NCT02480153|26072840|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1|||
13157450|NCT02480153|26072841|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
13157451|NCT02480153|26072839|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3|||
13157452|NCT02480153|26072840|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2|||
13157453|NCT02480153|26072841|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1|||
13157454|NCT02480153|26072839|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4|||
13157455|NCT02480153|26072840|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0|||
13157456|NCT02480153|26072841|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1|||
13157457|NCT02480153|26072839|FG000|Period 3: Week 52 Dosing to Week 78|Other|0|||
13157458|NCT02480153|26072840|FG001|Period 3: Week 52 Dosing to Week 78|Other|0|||
13157459|NCT02480153|26072841|FG002|Period 3: Week 52 Dosing to Week 78|Other|1|||
13157460|NCT02480153|26072839|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
13157461|NCT02480153|26072840|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
13157462|NCT02480153|26072841|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1|||
13157463|NCT02480153|26072839|FG000|Period 3: Week 52 Dosing to Week 78|Death|0|||
13157464|NCT02480153|26072840|FG001|Period 3: Week 52 Dosing to Week 78|Death|1|||
13157465|NCT02480153|26072841|FG002|Period 3: Week 52 Dosing to Week 78|Death|0|||
13157466|NCT02480114|26072858|FG000|Overall Study|Not completing surveys|3|||
13157467|NCT02480114|26072859|FG001|Overall Study|Not completing surveys|2|||
13157468|NCT02480114|26072858|FG000|Overall Study|Withdrawal by Subject|2|||
13157469|NCT02480114|26072859|FG001|Overall Study|Withdrawal by Subject|4|||
13157470|NCT02480114|26072858|FG000|Overall Study|Disease progression|3|||
13157471|NCT02480114|26072859|FG001|Overall Study|Disease progression|0|||
13157472|NCT02480114|26072858|FG000|Overall Study|Improper completion of survey|1|||
13157473|NCT02480114|26072859|FG001|Overall Study|Improper completion of survey|1|||
13157474|NCT02480114|26072858|FG000|Overall Study|Not eligible|0|||
13157475|NCT02480114|26072859|FG001|Overall Study|Not eligible|1|||
13157476|NCT02480010|26072910|FG000|Overall Study|Adverse Event|3|||
13157477|NCT02480010|26072911|FG001|Overall Study|Adverse Event|1|||
13157478|NCT02480010|26072910|FG000|Overall Study|Death|1|||
13157479|NCT02480010|26072911|FG001|Overall Study|Death|0|||
13157480|NCT02480010|26072910|FG000|Overall Study|Insufficient therapeutic response|31|||
13157481|NCT02480010|26072911|FG001|Overall Study|Insufficient therapeutic response|29|||
13157482|NCT02480010|26072910|FG000|Overall Study|Refused Treatment|0|||
13157483|NCT02480010|26072911|FG001|Overall Study|Refused Treatment|3|||
13157484|NCT02479880|26072924|FG000|Overall Study|Study Terminated by Sponsor|13|||
13157485|NCT02479880|26072925|FG001|Overall Study|Study Terminated by Sponsor|12|||
13157486|NCT02479880|26072924|FG000|Overall Study|Pregnancy|0|||
13157487|NCT02479880|26072925|FG001|Overall Study|Pregnancy|1|||
13157488|NCT02479802|26072936|FG000|Overall Study|Lost to Follow-up|1|||
13157489|NCT02479802|26072936|FG000|Overall Study|Adverse Event|1|||
13157490|NCT02479412|26073035|FG000|Overall Study|Adverse Event|0|||
13157491|NCT02479412|26073036|FG001|Overall Study|Adverse Event|0|||
13157492|NCT02479412|26073037|FG002|Overall Study|Adverse Event|1|||
13157493|NCT02479412|26073038|FG003|Overall Study|Adverse Event|0|||
13157494|NCT02479412|26073039|FG004|Overall Study|Adverse Event|0|||
13157495|NCT02479412|26073040|FG005|Overall Study|Adverse Event|0|||
13157496|NCT02479412|26073041|FG006|Overall Study|Adverse Event|0|||
13157497|NCT02479412|26073042|FG007|Overall Study|Adverse Event|0|||
13157498|NCT02479412|26073043|FG008|Overall Study|Adverse Event|0|||
13157499|NCT02479412|26073035|FG000|Overall Study|Study-specific withdrawal criteria|0|||
13157500|NCT02479412|26073036|FG001|Overall Study|Study-specific withdrawal criteria|0|||
13157501|NCT02479412|26073037|FG002|Overall Study|Study-specific withdrawal criteria|1|||
13157502|NCT02479412|26073038|FG003|Overall Study|Study-specific withdrawal criteria|1|||
13157503|NCT02479412|26073039|FG004|Overall Study|Study-specific withdrawal criteria|0|||
13157504|NCT02479412|26073040|FG005|Overall Study|Study-specific withdrawal criteria|0|||
13157505|NCT02479412|26073041|FG006|Overall Study|Study-specific withdrawal criteria|0|||
13157506|NCT02479412|26073042|FG007|Overall Study|Study-specific withdrawal criteria|1|||
13157507|NCT02479412|26073043|FG008|Overall Study|Study-specific withdrawal criteria|1|||
13157508|NCT02479412|26073035|FG000|Overall Study|Randomization to wrong PK sampling group|0|||
13157509|NCT02479412|26073036|FG001|Overall Study|Randomization to wrong PK sampling group|0|||
13157510|NCT02479412|26073037|FG002|Overall Study|Randomization to wrong PK sampling group|0|||
13157511|NCT02479412|26073038|FG003|Overall Study|Randomization to wrong PK sampling group|0|||
13157512|NCT02479412|26073039|FG004|Overall Study|Randomization to wrong PK sampling group|1|||
13157513|NCT02479412|26073040|FG005|Overall Study|Randomization to wrong PK sampling group|0|||
13157514|NCT02479412|26073041|FG006|Overall Study|Randomization to wrong PK sampling group|0|||
13157515|NCT02479412|26073042|FG007|Overall Study|Randomization to wrong PK sampling group|0|||
13157516|NCT02479412|26073043|FG008|Overall Study|Randomization to wrong PK sampling group|0|||
13157517|NCT02479139|26073088|FG000|Overall Study|Lost to Follow-up|2|||
13157518|NCT02479139|26073089|FG001|Overall Study|Lost to Follow-up|4|||
13157519|NCT02479139|26073090|FG002|Overall Study|Lost to Follow-up|4|||
13157520|NCT02479139|26073091|FG003|Overall Study|Lost to Follow-up|2|||
13157521|NCT02479139|26073092|FG004|Overall Study|Lost to Follow-up|3|||
13157522|NCT02479139|26073093|FG005|Overall Study|Lost to Follow-up|5|||
13157523|NCT02479139|26073088|FG000|Overall Study|Withdrew Consent|5|||
13157524|NCT02479139|26073089|FG001|Overall Study|Withdrew Consent|6|||
13157525|NCT02479139|26073090|FG002|Overall Study|Withdrew Consent|1|||
13157526|NCT02479139|26073091|FG003|Overall Study|Withdrew Consent|4|||
13157527|NCT02479139|26073092|FG004|Overall Study|Withdrew Consent|1|||
13157528|NCT02479139|26073093|FG005|Overall Study|Withdrew Consent|1|||
13157529|NCT02479139|26073088|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0|||
13157530|NCT02479139|26073089|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0|||
13157531|NCT02479139|26073090|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1|||
13157532|NCT02479139|26073091|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0|||
13157533|NCT02479139|26073092|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0|||
13157534|NCT02479139|26073093|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0|||
13157535|NCT02479139|26073088|FG000|Overall Study|Other Miscellaneous Reasons|1|||
13157536|NCT02479139|26073089|FG001|Overall Study|Other Miscellaneous Reasons|0|||
13157537|NCT02479139|26073090|FG002|Overall Study|Other Miscellaneous Reasons|1|||
13157538|NCT02479139|26073091|FG003|Overall Study|Other Miscellaneous Reasons|1|||
13157539|NCT02479139|26073092|FG004|Overall Study|Other Miscellaneous Reasons|1|||
13157540|NCT02479139|26073093|FG005|Overall Study|Other Miscellaneous Reasons|0|||
13157541|NCT02478632|26073124|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4|||
13157542|NCT02478632|26073125|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5|||
13157543|NCT02478632|26073124|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2|||
13157544|NCT02478632|26073125|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3|||
13157545|NCT02478632|26073124|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5|||
13157546|NCT02478632|26073125|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1|||
13157547|NCT02478463|26073242|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1|||
13157548|NCT02478463|26073242|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1|||
13157549|NCT02478463|26073242|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1|||
13157550|NCT02478398|26073267|FG000|Overall Study|Adverse Event|20|||
13157551|NCT02478398|26073268|FG001|Overall Study|Adverse Event|5|||
13157552|NCT02478398|26073267|FG000|Overall Study|Lost to Follow-up|5|||
13157553|NCT02478398|26073268|FG001|Overall Study|Lost to Follow-up|4|||
13157554|NCT02478398|26073267|FG000|Overall Study|Non-Compliance With Study Drug|5|||
13157555|NCT02478398|26073268|FG001|Overall Study|Non-Compliance With Study Drug|1|||
13157556|NCT02478398|26073267|FG000|Overall Study|Protocol Violation|3|||
13157557|NCT02478398|26073268|FG001|Overall Study|Protocol Violation|1|||
13157558|NCT02478398|26073267|FG000|Overall Study|Withdrawal By Parent/Guardian|9|||
13157559|NCT02478398|26073268|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
13157560|NCT02478398|26073267|FG000|Overall Study|Withdrawal By Participant|10|||
13157561|NCT02478398|26073268|FG001|Overall Study|Withdrawal By Participant|4|||
13157562|NCT02478372|26073297|FG000|Overall Study|Protocol Violation|12|||
13157563|NCT02478372|26073298|FG001|Overall Study|Protocol Violation|8|||
13157564|NCT02478372|26073297|FG000|Overall Study|Lost to Follow-up|1|||
13157565|NCT02478372|26073298|FG001|Overall Study|Lost to Follow-up|4|||
13157566|NCT02478372|26073297|FG000|Overall Study|Death|0|||
13157567|NCT02478372|26073298|FG001|Overall Study|Death|2|||
13157568|NCT02478359|26073377|FG000|Overall Study|Disenrolled from health plan|106|||
13157569|NCT02478359|26073378|FG001|Overall Study|Disenrolled from health plan|65|||
13157570|NCT02478164|26073387|FG000|Overall Study|Lack of Efficacy|13|||
13157571|NCT02478164|26073387|FG000|Overall Study|Adverse Event|1|||
13157572|NCT02478164|26073387|FG000|Overall Study|Withdrawal by Subject|1|||
13157573|NCT02477839|26073422|FG000|Overall Study|Adverse Event|0|||
13157574|NCT02477839|26073423|FG001|Overall Study|Adverse Event|1|||
13157575|NCT02477839|26073422|FG000|Overall Study|Protocol Violation|0|||
13157576|NCT02477839|26073423|FG001|Overall Study|Protocol Violation|2|||
13157577|NCT02477839|26073422|FG000|Overall Study|Withdrawal by Subject|3|||
13157578|NCT02477839|26073423|FG001|Overall Study|Withdrawal by Subject|3|||
13157579|NCT02477839|26073422|FG000|Overall Study|Participant had PGS during V6|0|||
13157580|NCT02477839|26073423|FG001|Overall Study|Participant had PGS during V6|1|||
13157581|NCT02477839|26073422|FG000|Overall Study|Parents decided to stop medication|0|||
13157582|NCT02477839|26073423|FG001|Overall Study|Parents decided to stop medication|1|||
13157583|NCT02477839|26073422|FG000|Overall Study|Lack of tolerability|0|||
13157584|NCT02477839|26073423|FG001|Overall Study|Lack of tolerability|1|||
13157585|NCT02477839|26073422|FG000|Overall Study|Exclusion criterion|0|||
13157586|NCT02477839|26073423|FG001|Overall Study|Exclusion criterion|1|||
13157587|NCT02477800|26073458|FG000|Placebo-Controlled Period|Adverse Event|16|||
13157588|NCT02477800|26073459|FG001|Placebo-Controlled Period|Adverse Event|25|||
13157589|NCT02477800|26073460|FG002|Placebo-Controlled Period|Adverse Event|28|||
13157590|NCT02477800|26073461|FG003|Placebo-Controlled Period|Adverse Event|0|||
13157591|NCT02477800|26073462|FG004|Placebo-Controlled Period|Adverse Event|0|||
13157592|NCT02477800|26073463|FG005|Placebo-Controlled Period|Adverse Event|0|||
13157593|NCT02477800|26073464|FG006|Placebo-Controlled Period|Adverse Event|0|||
13157594|NCT02477800|26073458|FG000|Placebo-Controlled Period|Change of Treatment|1|||
13157595|NCT02477800|26073459|FG001|Placebo-Controlled Period|Change of Treatment|2|||
13157596|NCT02477800|26073460|FG002|Placebo-Controlled Period|Change of Treatment|1|||
13157597|NCT02477800|26073461|FG003|Placebo-Controlled Period|Change of Treatment|0|||
13157598|NCT02477800|26073462|FG004|Placebo-Controlled Period|Change of Treatment|0|||
13157599|NCT02477800|26073463|FG005|Placebo-Controlled Period|Change of Treatment|0|||
13157600|NCT02477800|26073464|FG006|Placebo-Controlled Period|Change of Treatment|0|||
13157601|NCT02477800|26073458|FG000|Placebo-Controlled Period|Consent Withdrawn|26|||
13157602|NCT02477800|26073459|FG001|Placebo-Controlled Period|Consent Withdrawn|16|||
13157603|NCT02477800|26073460|FG002|Placebo-Controlled Period|Consent Withdrawn|27|||
13157604|NCT02477800|26073461|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
13157605|NCT02477800|26073462|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
13157606|NCT02477800|26073463|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
13157607|NCT02477800|26073464|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
13157608|NCT02477800|26073458|FG000|Placebo-Controlled Period|Death|0|||
13157609|NCT02477800|26073459|FG001|Placebo-Controlled Period|Death|3|||
13157610|NCT02477800|26073460|FG002|Placebo-Controlled Period|Death|2|||
13157611|NCT02477800|26073461|FG003|Placebo-Controlled Period|Death|0|||
13157612|NCT02477800|26073462|FG004|Placebo-Controlled Period|Death|0|||
13157613|NCT02477800|26073463|FG005|Placebo-Controlled Period|Death|0|||
13157614|NCT02477800|26073464|FG006|Placebo-Controlled Period|Death|0|||
13157615|NCT02477800|26073458|FG000|Placebo-Controlled Period|Disease Progression|1|||
13157616|NCT02477800|26073459|FG001|Placebo-Controlled Period|Disease Progression|0|||
13157617|NCT02477800|26073460|FG002|Placebo-Controlled Period|Disease Progression|1|||
13157618|NCT02477800|26073461|FG003|Placebo-Controlled Period|Disease Progression|0|||
13157619|NCT02477800|26073462|FG004|Placebo-Controlled Period|Disease Progression|0|||
13157620|NCT02477800|26073463|FG005|Placebo-Controlled Period|Disease Progression|0|||
13157621|NCT02477800|26073464|FG006|Placebo-Controlled Period|Disease Progression|0|||
13157622|NCT02477800|26073458|FG000|Placebo-Controlled Period|Investigator Decision|3|||
13157623|NCT02477800|26073459|FG001|Placebo-Controlled Period|Investigator Decision|2|||
13157624|NCT02477800|26073460|FG002|Placebo-Controlled Period|Investigator Decision|1|||
13157625|NCT02477800|26073461|FG003|Placebo-Controlled Period|Investigator Decision|0|||
13157626|NCT02477800|26073462|FG004|Placebo-Controlled Period|Investigator Decision|0|||
13157627|NCT02477800|26073463|FG005|Placebo-Controlled Period|Investigator Decision|0|||
13157628|NCT02477800|26073464|FG006|Placebo-Controlled Period|Investigator Decision|0|||
13157629|NCT02477800|26073458|FG000|Placebo-Controlled Period|Lost to Follow-up|1|||
13157630|NCT02477800|26073459|FG001|Placebo-Controlled Period|Lost to Follow-up|3|||
13157631|NCT02477800|26073460|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
13157632|NCT02477800|26073461|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
13157633|NCT02477800|26073462|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
13157634|NCT02477800|26073463|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
13157635|NCT02477800|26073464|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
13157636|NCT02477800|26073458|FG000|Placebo-Controlled Period|Relocation|2|||
13104865|NCT02998528|25877285|FG000|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
13157637|NCT02477800|26073459|FG001|Placebo-Controlled Period|Relocation|0|||
13157638|NCT02477800|26073460|FG002|Placebo-Controlled Period|Relocation|0|||
13157639|NCT02477800|26073461|FG003|Placebo-Controlled Period|Relocation|0|||
13157640|NCT02477800|26073462|FG004|Placebo-Controlled Period|Relocation|0|||
13157641|NCT02477800|26073463|FG005|Placebo-Controlled Period|Relocation|0|||
13157642|NCT02477800|26073464|FG006|Placebo-Controlled Period|Relocation|0|||
13157643|NCT02477800|26073458|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1|||
13157644|NCT02477800|26073459|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1|||
13157645|NCT02477800|26073460|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1|||
13157646|NCT02477800|26073461|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0|||
13157647|NCT02477800|26073462|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0|||
13157648|NCT02477800|26073463|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0|||
13157649|NCT02477800|26073464|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0|||
13157650|NCT02477800|26073458|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2|||
13157651|NCT02477800|26073459|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1|||
13157652|NCT02477800|26073460|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
13104866|NCT02998528|25877286|FG001|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|3|||
13104867|NCT02998528|25877287|FG002|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
13104868|NCT02998528|25877285|FG000|Systemic Adjuvant Treatment Period|Disease progression|1|||
13104869|NCT02998528|25877286|FG001|Systemic Adjuvant Treatment Period|Disease progression|0|||
13104870|NCT02998528|25877287|FG002|Systemic Adjuvant Treatment Period|Disease progression|0|||
13104871|NCT02998528|25877285|FG000|Systemic Adjuvant Treatment Period|Study drug toxicity|4|||
13104872|NCT02998528|25877286|FG001|Systemic Adjuvant Treatment Period|Study drug toxicity|5|||
13157653|NCT02477800|26073461|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
13157654|NCT02477800|26073462|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
13157655|NCT02477800|26073463|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
13157656|NCT02477800|26073464|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
13157657|NCT02477800|26073458|FG000|Placebo-Controlled Period|Study Visit Burden|5|||
13157658|NCT02477800|26073459|FG001|Placebo-Controlled Period|Study Visit Burden|3|||
13157659|NCT02477800|26073460|FG002|Placebo-Controlled Period|Study Visit Burden|11|||
13157660|NCT02477800|26073461|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
13157661|NCT02477800|26073462|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
13157662|NCT02477800|26073463|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
13157663|NCT02477800|26073464|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
13157664|NCT02477800|26073458|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
13157665|NCT02477800|26073459|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5|||
13157666|NCT02477800|26073460|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3|||
13157667|NCT02477800|26073461|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
13157668|NCT02477800|26073462|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
13157669|NCT02477800|26073463|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
13157670|NCT02477800|26073464|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
13157671|NCT02477800|26073458|FG000|Placebo-Controlled Period|Reason not Specified|161|||
13157672|NCT02477800|26073459|FG001|Placebo-Controlled Period|Reason not Specified|161|||
13157673|NCT02477800|26073460|FG002|Placebo-Controlled Period|Reason not Specified|189|||
13157674|NCT02477800|26073461|FG003|Placebo-Controlled Period|Reason not Specified|0|||
13157675|NCT02477800|26073462|FG004|Placebo-Controlled Period|Reason not Specified|0|||
13157676|NCT02477800|26073463|FG005|Placebo-Controlled Period|Reason not Specified|0|||
13157677|NCT02477800|26073464|FG006|Placebo-Controlled Period|Reason not Specified|0|||
13157678|NCT02477800|26073458|FG000|Long Term Extension Period|Adverse Event|0|||
13157679|NCT02477800|26073459|FG001|Long Term Extension Period|Adverse Event|0|||
13485406|NCT03318523|27032708|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
13485407|NCT03318523|27032709|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
13485408|NCT03318523|27032710|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
13485409|NCT03318523|27032711|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
13485410|NCT03318523|27032712|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
13485411|NCT03318523|27032713|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
13485412|NCT03318523|27032714|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
13485413|NCT03318523|27032715|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
13485414|NCT03318523|27032716|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2|||
13485415|NCT03318523|27032707|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
13485416|NCT03318523|27032708|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
13485417|NCT03318523|27032709|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
13485418|NCT03318523|27032710|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
13157680|NCT02477800|26073460|FG002|Long Term Extension Period|Adverse Event|0|||
13157681|NCT02477800|26073461|FG003|Long Term Extension Period|Adverse Event|6|||
13157682|NCT02477800|26073462|FG004|Long Term Extension Period|Adverse Event|2|||
13157683|NCT02477800|26073463|FG005|Long Term Extension Period|Adverse Event|4|||
13157684|NCT02477800|26073464|FG006|Long Term Extension Period|Adverse Event|3|||
13157685|NCT02477800|26073458|FG000|Long Term Extension Period|Death|0|||
13157686|NCT02477800|26073459|FG001|Long Term Extension Period|Death|0|||
13157687|NCT02477800|26073460|FG002|Long Term Extension Period|Death|0|||
13157688|NCT02477800|26073461|FG003|Long Term Extension Period|Death|1|||
13157689|NCT02477800|26073462|FG004|Long Term Extension Period|Death|1|||
13157690|NCT02477800|26073463|FG005|Long Term Extension Period|Death|1|||
13157691|NCT02477800|26073464|FG006|Long Term Extension Period|Death|2|||
13157692|NCT02477800|26073458|FG000|Long Term Extension Period|Consent Withdrawn|0|||
13157693|NCT02477800|26073459|FG001|Long Term Extension Period|Consent Withdrawn|0|||
13157694|NCT02477800|26073460|FG002|Long Term Extension Period|Consent Withdrawn|0|||
13157695|NCT02477800|26073461|FG003|Long Term Extension Period|Consent Withdrawn|10|||
13157696|NCT02477800|26073462|FG004|Long Term Extension Period|Consent Withdrawn|4|||
13157697|NCT02477800|26073463|FG005|Long Term Extension Period|Consent Withdrawn|13|||
13157698|NCT02477800|26073464|FG006|Long Term Extension Period|Consent Withdrawn|16|||
13157699|NCT02477800|26073458|FG000|Long Term Extension Period|Disease Progression|0|||
13157700|NCT02477800|26073459|FG001|Long Term Extension Period|Disease Progression|0|||
13157701|NCT02477800|26073460|FG002|Long Term Extension Period|Disease Progression|0|||
13157702|NCT02477800|26073461|FG003|Long Term Extension Period|Disease Progression|3|||
13157703|NCT02477800|26073462|FG004|Long Term Extension Period|Disease Progression|1|||
13157704|NCT02477800|26073463|FG005|Long Term Extension Period|Disease Progression|1|||
13157705|NCT02477800|26073464|FG006|Long Term Extension Period|Disease Progression|0|||
13157706|NCT02477800|26073458|FG000|Long Term Extension Period|Investigator Decision|0|||
13157707|NCT02477800|26073459|FG001|Long Term Extension Period|Investigator Decision|0|||
13157708|NCT02477800|26073460|FG002|Long Term Extension Period|Investigator Decision|0|||
13157709|NCT02477800|26073461|FG003|Long Term Extension Period|Investigator Decision|0|||
13157710|NCT02477800|26073462|FG004|Long Term Extension Period|Investigator Decision|0|||
13157711|NCT02477800|26073463|FG005|Long Term Extension Period|Investigator Decision|0|||
13157712|NCT02477800|26073464|FG006|Long Term Extension Period|Investigator Decision|2|||
13157713|NCT02477800|26073458|FG000|Long Term Extension Period|Lost to Follow-up|0|||
13157714|NCT02477800|26073459|FG001|Long Term Extension Period|Lost to Follow-up|0|||
13157715|NCT02477800|26073460|FG002|Long Term Extension Period|Lost to Follow-up|0|||
13157716|NCT02477800|26073461|FG003|Long Term Extension Period|Lost to Follow-up|0|||
13157717|NCT02477800|26073462|FG004|Long Term Extension Period|Lost to Follow-up|1|||
13157718|NCT02477800|26073463|FG005|Long Term Extension Period|Lost to Follow-up|3|||
13157719|NCT02477800|26073464|FG006|Long Term Extension Period|Lost to Follow-up|0|||
13157720|NCT02477800|26073458|FG000|Long Term Extension Period|Site Terminated By Sponsor|0|||
13157721|NCT02477800|26073459|FG001|Long Term Extension Period|Site Terminated By Sponsor|0|||
13157722|NCT02477800|26073460|FG002|Long Term Extension Period|Site Terminated By Sponsor|0|||
13157723|NCT02477800|26073461|FG003|Long Term Extension Period|Site Terminated By Sponsor|0|||
13157724|NCT02477800|26073462|FG004|Long Term Extension Period|Site Terminated By Sponsor|0|||
13157725|NCT02477800|26073463|FG005|Long Term Extension Period|Site Terminated By Sponsor|2|||
13157726|NCT02477800|26073464|FG006|Long Term Extension Period|Site Terminated By Sponsor|1|||
13157727|NCT02477800|26073458|FG000|Long Term Extension Period|Study Visit Burden|0|||
13157728|NCT02477800|26073459|FG001|Long Term Extension Period|Study Visit Burden|0|||
13157729|NCT02477800|26073460|FG002|Long Term Extension Period|Study Visit Burden|0|||
13157730|NCT02477800|26073461|FG003|Long Term Extension Period|Study Visit Burden|3|||
13157731|NCT02477800|26073462|FG004|Long Term Extension Period|Study Visit Burden|0|||
13157732|NCT02477800|26073463|FG005|Long Term Extension Period|Study Visit Burden|2|||
13157733|NCT02477800|26073464|FG006|Long Term Extension Period|Study Visit Burden|2|||
13157734|NCT02477800|26073458|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
13157735|NCT02477800|26073459|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
13157736|NCT02477800|26073460|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
13157737|NCT02477800|26073461|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
13157738|NCT02477800|26073462|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
13157739|NCT02477800|26073463|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
13157740|NCT02477800|26073464|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
13157741|NCT02477800|26073458|FG000|Long Term Extension Period|Reason not Specified|0|||
13157742|NCT02477800|26073459|FG001|Long Term Extension Period|Reason not Specified|0|||
13157743|NCT02477800|26073460|FG002|Long Term Extension Period|Reason not Specified|0|||
13157744|NCT02477800|26073461|FG003|Long Term Extension Period|Reason not Specified|126|||
13157745|NCT02477800|26073462|FG004|Long Term Extension Period|Reason not Specified|140|||
13157746|NCT02477800|26073463|FG005|Long Term Extension Period|Reason not Specified|270|||
13157747|NCT02477800|26073464|FG006|Long Term Extension Period|Reason not Specified|224|||
13157748|NCT02477670|26073690|FG000|Stage 1|Adverse Event|2|||
13157749|NCT02477670|26073691|FG001|Stage 1|Adverse Event|7|||
13157750|NCT02477670|26073692|FG002|Stage 1|Adverse Event|0|||
13157751|NCT02477670|26073693|FG003|Stage 1|Adverse Event|0|||
13157752|NCT02477670|26073694|FG004|Stage 1|Adverse Event|0|||
13157753|NCT02477670|26073695|FG005|Stage 1|Adverse Event|0|||
13157754|NCT02477670|26073696|FG006|Stage 1|Adverse Event|0|||
13157755|NCT02477670|26073690|FG000|Stage 1|Lost to Follow-up|0|||
13157756|NCT02477670|26073691|FG001|Stage 1|Lost to Follow-up|2|||
13157757|NCT02477670|26073692|FG002|Stage 1|Lost to Follow-up|0|||
13157758|NCT02477670|26073693|FG003|Stage 1|Lost to Follow-up|0|||
13157759|NCT02477670|26073694|FG004|Stage 1|Lost to Follow-up|0|||
13157760|NCT02477670|26073695|FG005|Stage 1|Lost to Follow-up|0|||
13157761|NCT02477670|26073696|FG006|Stage 1|Lost to Follow-up|0|||
13157762|NCT02477670|26073690|FG000|Stage 1|Withdrawal by Subject|1|||
13157763|NCT02477670|26073691|FG001|Stage 1|Withdrawal by Subject|2|||
13157764|NCT02477670|26073692|FG002|Stage 1|Withdrawal by Subject|0|||
13157765|NCT02477670|26073693|FG003|Stage 1|Withdrawal by Subject|0|||
13157766|NCT02477670|26073694|FG004|Stage 1|Withdrawal by Subject|0|||
13157767|NCT02477670|26073695|FG005|Stage 1|Withdrawal by Subject|0|||
13157768|NCT02477670|26073696|FG006|Stage 1|Withdrawal by Subject|0|||
13157769|NCT02477670|26073690|FG000|Stage 1|Non-compliance with Study Drug|1|||
13157770|NCT02477670|26073691|FG001|Stage 1|Non-compliance with Study Drug|2|||
13157771|NCT02477670|26073692|FG002|Stage 1|Non-compliance with Study Drug|0|||
13157772|NCT02477670|26073693|FG003|Stage 1|Non-compliance with Study Drug|0|||
13157773|NCT02477670|26073694|FG004|Stage 1|Non-compliance with Study Drug|0|||
13157774|NCT02477670|26073695|FG005|Stage 1|Non-compliance with Study Drug|0|||
13157775|NCT02477670|26073696|FG006|Stage 1|Non-compliance with Study Drug|0|||
13157776|NCT02477670|26073690|FG000|Stage 2|Adverse Event|0|||
13157777|NCT02477670|26073691|FG001|Stage 2|Adverse Event|0|||
13157778|NCT02477670|26073692|FG002|Stage 2|Adverse Event|1|||
13157779|NCT02477670|26073693|FG003|Stage 2|Adverse Event|0|||
13157780|NCT02477670|26073694|FG004|Stage 2|Adverse Event|0|||
13157781|NCT02477670|26073695|FG005|Stage 2|Adverse Event|0|||
13157782|NCT02477670|26073696|FG006|Stage 2|Adverse Event|0|||
13157783|NCT02477670|26073690|FG000|Stage 2|Antipsychotic Medication Changed|0|||
13157784|NCT02477670|26073691|FG001|Stage 2|Antipsychotic Medication Changed|0|||
13157785|NCT02477670|26073692|FG002|Stage 2|Antipsychotic Medication Changed|1|||
13157786|NCT02477670|26073693|FG003|Stage 2|Antipsychotic Medication Changed|0|||
13157787|NCT02477670|26073694|FG004|Stage 2|Antipsychotic Medication Changed|0|||
13157788|NCT02477670|26073695|FG005|Stage 2|Antipsychotic Medication Changed|0|||
13157789|NCT02477670|26073696|FG006|Stage 2|Antipsychotic Medication Changed|0|||
13157790|NCT02477670|26073690|FG000|Stage 2|Withdrawal by Subject|0|||
13157791|NCT02477670|26073691|FG001|Stage 2|Withdrawal by Subject|0|||
13157792|NCT02477670|26073692|FG002|Stage 2|Withdrawal by Subject|0|||
13157793|NCT02477670|26073693|FG003|Stage 2|Withdrawal by Subject|1|||
13157794|NCT02477670|26073694|FG004|Stage 2|Withdrawal by Subject|0|||
13157795|NCT02477670|26073695|FG005|Stage 2|Withdrawal by Subject|0|||
13157796|NCT02477670|26073696|FG006|Stage 2|Withdrawal by Subject|0|||
13157797|NCT02477605|26073717|FG000|Overall Study|Discontinued prior to treatment|1|||
13157798|NCT02477605|26073718|FG001|Overall Study|Discontinued prior to treatment|0|||
13157799|NCT02477605|26073717|FG000|Overall Study|Lost to Follow-up|0|||
13157800|NCT02477605|26073718|FG001|Overall Study|Lost to Follow-up|2|||
13157801|NCT02477605|26073717|FG000|Overall Study|Withdrawal by Subject|0|||
13157802|NCT02477605|26073718|FG001|Overall Study|Withdrawal by Subject|1|||
13157803|NCT02477605|26073717|FG000|Overall Study|Administered gas during surgery|0|||
13157804|NCT02477605|26073718|FG001|Overall Study|Administered gas during surgery|1|||
13157805|NCT02477553|26073745|FG000|Overall Study|Screening up-to-date|12|||
13157806|NCT02477553|26073746|FG001|Overall Study|Screening up-to-date|13|||
13157807|NCT02477553|26073745|FG000|Overall Study|No MD visit|1|||
13157808|NCT02477553|26073746|FG001|Overall Study|No MD visit|1|||
13157809|NCT02477553|26073745|FG000|Overall Study|Workup consistent w/CRC|1|||
13157810|NCT02477553|26073746|FG001|Overall Study|Workup consistent w/CRC|1|||
13157811|NCT02477553|26073745|FG000|Overall Study|Technical issues with intervention|2|||
13157812|NCT02477553|26073746|FG001|Overall Study|Technical issues with intervention|0|||
13157813|NCT02477553|26073745|FG000|Overall Study|Elevated risk for CRC|2|||
13157814|NCT02477553|26073746|FG001|Overall Study|Elevated risk for CRC|2|||
13157815|NCT02477553|26073745|FG000|Overall Study|MD advised against screening|1|||
13157816|NCT02477553|26073746|FG001|Overall Study|MD advised against screening|3|||
13157817|NCT02477553|26073745|FG000|Overall Study|patient deceased|1|||
13157818|NCT02477553|26073746|FG001|Overall Study|patient deceased|0|||
13157819|NCT02477527|26073756|FG000|Overall Study|Lost to Follow-up|2|||
13157820|NCT02477527|26073756|FG000|Overall Study|Withdrawal by Subject|1|||
13157821|NCT02477527|26073756|FG000|Overall Study|Screen Failure|3|||
13157822|NCT02477332|26073849|FG000|Overall Study|Adverse Event|0|||
13157823|NCT02477332|26073850|FG001|Overall Study|Adverse Event|1|||
13157824|NCT02477332|26073851|FG002|Overall Study|Adverse Event|1|||
13157825|NCT02477332|26073852|FG003|Overall Study|Adverse Event|2|||
13157826|NCT02477332|26073853|FG004|Overall Study|Adverse Event|1|||
13157827|NCT02477332|26073854|FG005|Overall Study|Adverse Event|2|||
13157828|NCT02477332|26073849|FG000|Overall Study|Lack of Efficacy|1|||
13485419|NCT03318523|27032711|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
13485420|NCT03318523|27032712|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
13485421|NCT03318523|27032713|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
13485422|NCT03318523|27032714|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
13485423|NCT03318523|27032715|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3|||
13485424|NCT03318523|27032716|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2|||
13485425|NCT03318523|27032707|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
13485426|NCT03318523|27032708|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
13485427|NCT03318523|27032709|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
13485428|NCT03318523|27032710|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
13485429|NCT03318523|27032711|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
13485430|NCT03318523|27032712|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1|||
13485431|NCT03318523|27032713|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
13485432|NCT03318523|27032714|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
13485433|NCT03318523|27032715|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
13485434|NCT03318523|27032716|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
13485435|NCT03318523|27032707|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
13485436|NCT03318523|27032708|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
13485437|NCT03318523|27032709|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
13485438|NCT03318523|27032710|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
13485439|NCT03318523|27032711|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
13485440|NCT03318523|27032712|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
13485441|NCT03318523|27032713|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
13485442|NCT03318523|27032714|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
13485443|NCT03318523|27032715|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
13485444|NCT03318523|27032716|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1|||
13485445|NCT03318523|27032707|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
13485446|NCT03318523|27032708|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
13157829|NCT02477332|26073850|FG001|Overall Study|Lack of Efficacy|2|||
13157830|NCT02477332|26073851|FG002|Overall Study|Lack of Efficacy|1|||
13157831|NCT02477332|26073852|FG003|Overall Study|Lack of Efficacy|2|||
13157832|NCT02477332|26073853|FG004|Overall Study|Lack of Efficacy|1|||
13157833|NCT02477332|26073854|FG005|Overall Study|Lack of Efficacy|1|||
13157834|NCT02477332|26073849|FG000|Overall Study|Non-compliance with study treatment|0|||
13157835|NCT02477332|26073850|FG001|Overall Study|Non-compliance with study treatment|1|||
13157836|NCT02477332|26073851|FG002|Overall Study|Non-compliance with study treatment|2|||
13157837|NCT02477332|26073852|FG003|Overall Study|Non-compliance with study treatment|0|||
13157838|NCT02477332|26073853|FG004|Overall Study|Non-compliance with study treatment|0|||
13157839|NCT02477332|26073854|FG005|Overall Study|Non-compliance with study treatment|0|||
13157840|NCT02477332|26073849|FG000|Overall Study|Pregnancy|0|||
13157841|NCT02477332|26073850|FG001|Overall Study|Pregnancy|0|||
13157842|NCT02477332|26073851|FG002|Overall Study|Pregnancy|0|||
13157843|NCT02477332|26073852|FG003|Overall Study|Pregnancy|1|||
13157844|NCT02477332|26073853|FG004|Overall Study|Pregnancy|0|||
13157845|NCT02477332|26073854|FG005|Overall Study|Pregnancy|0|||
13157846|NCT02477332|26073849|FG000|Overall Study|Protocol Violation|2|||
13157847|NCT02477332|26073850|FG001|Overall Study|Protocol Violation|0|||
13157848|NCT02477332|26073851|FG002|Overall Study|Protocol Violation|3|||
13157849|NCT02477332|26073852|FG003|Overall Study|Protocol Violation|3|||
13157850|NCT02477332|26073853|FG004|Overall Study|Protocol Violation|1|||
13157851|NCT02477332|26073854|FG005|Overall Study|Protocol Violation|1|||
13157852|NCT02477332|26073849|FG000|Overall Study|Technical problems|0|||
13157853|NCT02477332|26073850|FG001|Overall Study|Technical problems|0|||
13157854|NCT02477332|26073851|FG002|Overall Study|Technical problems|1|||
13157855|NCT02477332|26073852|FG003|Overall Study|Technical problems|0|||
13157856|NCT02477332|26073853|FG004|Overall Study|Technical problems|0|||
13157857|NCT02477332|26073854|FG005|Overall Study|Technical problems|0|||
13157858|NCT02477332|26073849|FG000|Overall Study|Lost to Follow-up|0|||
13157859|NCT02477332|26073850|FG001|Overall Study|Lost to Follow-up|0|||
13157860|NCT02477332|26073851|FG002|Overall Study|Lost to Follow-up|2|||
13157861|NCT02477332|26073852|FG003|Overall Study|Lost to Follow-up|0|||
13157862|NCT02477332|26073853|FG004|Overall Study|Lost to Follow-up|0|||
13157863|NCT02477332|26073854|FG005|Overall Study|Lost to Follow-up|0|||
13485447|NCT03318523|27032709|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
13157864|NCT02477332|26073849|FG000|Overall Study|Physician Decision|0|||
13157865|NCT02477332|26073850|FG001|Overall Study|Physician Decision|0|||
13157866|NCT02477332|26073851|FG002|Overall Study|Physician Decision|1|||
13157867|NCT02477332|26073852|FG003|Overall Study|Physician Decision|3|||
13485448|NCT03318523|27032710|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
13485449|NCT03318523|27032711|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17|||
13157868|NCT02477332|26073853|FG004|Overall Study|Physician Decision|0|||
13157869|NCT02477332|26073854|FG005|Overall Study|Physician Decision|1|||
13157870|NCT02477332|26073849|FG000|Overall Study|Withdrawal by Subject|0|||
13157871|NCT02477332|26073850|FG001|Overall Study|Withdrawal by Subject|3|||
13157872|NCT02477332|26073851|FG002|Overall Study|Withdrawal by Subject|1|||
13157873|NCT02477332|26073852|FG003|Overall Study|Withdrawal by Subject|2|||
13157874|NCT02477332|26073853|FG004|Overall Study|Withdrawal by Subject|1|||
13157875|NCT02477332|26073854|FG005|Overall Study|Withdrawal by Subject|0|||
13157876|NCT02477215|26073880|FG000|Dose Escalation Phase|Physician Decision|1|||
13157877|NCT02477215|26073881|FG001|Dose Escalation Phase|Physician Decision|2|||
13157878|NCT02477215|26073882|FG002|Dose Escalation Phase|Physician Decision|0|||
13157879|NCT02477215|26073880|FG000|Fixed Dose Phase|Physician Decision|0|||
13157880|NCT02477215|26073881|FG001|Fixed Dose Phase|Physician Decision|7|||
13157881|NCT02477215|26073882|FG002|Fixed Dose Phase|Physician Decision|0|||
13157882|NCT02477111|26073896|FG000|Overall Study|Death|5|||
13157883|NCT02477111|26073896|FG000|Overall Study|Withdrawal by Subject|2|||
13157884|NCT02477111|26073896|FG000|Overall Study|missed visit|4|||
13157885|NCT02477020|26073931|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
13157886|NCT02477020|26073932|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
13157887|NCT02477020|26073931|FG000|Overall Study|Voluntary Withdrawal|7|||
13157888|NCT02477020|26073932|FG001|Overall Study|Voluntary Withdrawal|16|||
13157889|NCT02477020|26073931|FG000|Overall Study|Reason not Specified|3|||
13157890|NCT02477020|26073932|FG001|Overall Study|Reason not Specified|1|||
13157891|NCT02477020|26073931|FG000|Overall Study|Lack of Efficacy|14|||
13157892|NCT02477020|26073932|FG001|Overall Study|Lack of Efficacy|5|||
13157893|NCT02476994|26073965|FG000|Overall Study|Based on feedback from FDA|1|||
13157894|NCT02476994|26073966|FG001|Overall Study|Based on feedback from FDA|0|||
13157895|NCT02476968|26074009|FG000|Overall Study|Other|0|||
13485450|NCT03318523|27032712|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36|||
13485451|NCT03318523|27032713|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39|||
13485452|NCT03318523|27032714|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48|||
13485453|NCT03318523|27032715|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94|||
13485454|NCT03318523|27032716|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91|||
13485455|NCT03318523|27032707|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
13485456|NCT03318523|27032708|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
13157896|NCT02476968|26074010|FG001|Overall Study|Other|2|||
13157897|NCT02476968|26074011|FG002|Overall Study|Other|0|||
13157898|NCT02476968|26074009|FG000|Overall Study|Lost to Follow-up|10|||
13157899|NCT02476968|26074010|FG001|Overall Study|Lost to Follow-up|0|||
13157900|NCT02476968|26074011|FG002|Overall Study|Lost to Follow-up|1|||
13157901|NCT02476968|26074009|FG000|Overall Study|Death|48|||
13485457|NCT03318523|27032709|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
13485458|NCT03318523|27032710|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
13485459|NCT03318523|27032711|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1|||
13485460|NCT03318523|27032712|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
13485461|NCT03318523|27032713|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
13485462|NCT03318523|27032714|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2|||
13485463|NCT03318523|27032715|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3|||
13104873|NCT02998528|25877287|FG002|Systemic Adjuvant Treatment Period|Study drug toxicity|1|||
13104874|NCT02998528|25877285|FG000|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
13104875|NCT02998528|25877286|FG001|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|0|||
13104876|NCT02998528|25877287|FG002|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
13104877|NCT02998528|25877285|FG000|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|3|||
13104878|NCT02998528|25877286|FG001|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
13104879|NCT02998528|25877287|FG002|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
13157902|NCT02476968|26074010|FG001|Overall Study|Death|8|||
13157903|NCT02476968|26074011|FG002|Overall Study|Death|1|||
13157904|NCT02476968|26074009|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
13157905|NCT02476968|26074010|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
13157906|NCT02476968|26074011|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
13157907|NCT02476968|26074009|FG000|Overall Study|Patient decision|37|||
13157908|NCT02476968|26074010|FG001|Overall Study|Patient decision|8|||
13157909|NCT02476968|26074011|FG002|Overall Study|Patient decision|0|||
13157910|NCT02476916|26074060|FG000|Core Period|Adverse Event|2|||
13157911|NCT02476916|26074061|FG001|Core Period|Adverse Event|2|||
13157912|NCT02476916|26074060|FG000|Core Period|Investigator decision|1|||
13157913|NCT02476916|26074061|FG001|Core Period|Investigator decision|1|||
13157914|NCT02476916|26074060|FG000|Core Period|Withdrawal by Subject|3|||
13157915|NCT02476916|26074061|FG001|Core Period|Withdrawal by Subject|0|||
13157916|NCT02476916|26074060|FG000|Extension Period|Prematurely Discontinued Treatment|6|||
13157917|NCT02476916|26074061|FG001|Extension Period|Prematurely Discontinued Treatment|1|||
13157918|NCT02476916|26074060|FG000|Extension Period|On Treatment|12|||
13157919|NCT02476916|26074061|FG001|Extension Period|On Treatment|17|||
13157920|NCT02476617|26074067|FG000|Overall Study|Adverse Event|1|||
13157921|NCT02476617|26074067|FG000|Overall Study|Lost to Follow-up|1|||
13157922|NCT02476578|26074086|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35|||
13157923|NCT02476578|26074087|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43|||
13157924|NCT02476578|26074086|FG000|Overall Study|Lost to Follow-up|6|||
13157925|NCT02476578|26074087|FG001|Overall Study|Lost to Follow-up|13|||
13157926|NCT02476422|26074124|FG000|Overall Study|Subject/guardian decision|0|||
13157927|NCT02476422|26074125|FG001|Overall Study|Subject/guardian decision|1|||
13157928|NCT02476175|26074135|FG000|Overall Study|Adverse Event|2|||
13157929|NCT02476006|26074151|FG000|Overall Study|Death|4|||
13157930|NCT02476006|26074151|FG000|Overall Study|Lack of treatment efficacy|2|||
13157931|NCT02476006|26074151|FG000|Overall Study|Pregnancy|1|||
13157932|NCT02476006|26074151|FG000|Overall Study|Participant did not wish to continue|39|||
13157933|NCT02476006|26074151|FG000|Overall Study|Adverse Event|41|||
13157934|NCT02476006|26074151|FG000|Overall Study|Poor compliance to study protocol|3|||
13157935|NCT02476006|26074151|FG000|Overall Study|Sponsor decision|6|||
13157936|NCT02476006|26074151|FG000|Overall Study|Lost to Follow-up|5|||
13157937|NCT02476006|26074151|FG000|Overall Study|Physician Decision|5|||
13157938|NCT02476006|26074151|FG000|Overall Study|Study ended treatment not available|4|||
13157939|NCT02476006|26074151|FG000|Overall Study|Switched to commercial drug|4|||
13157940|NCT02476006|26074151|FG000|Overall Study|Excluded from study|1|||
13157941|NCT02476006|26074151|FG000|Overall Study|Protocol Violation|1|||
13157942|NCT02476006|26074151|FG000|Overall Study|Enrolled but not treated|4|||
13485464|NCT03318523|27032716|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
13487986|NCT01111565|27041931|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1|||
13487987|NCT01111565|27041932|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
13487988|NCT01111565|27041933|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
13487989|NCT01111565|27041934|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
13487990|NCT01111565|27041935|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
13487991|NCT01111565|27041931|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1|||
13487992|NCT01111565|27041932|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
13487993|NCT01111565|27041933|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
13487994|NCT01111565|27041934|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
13487995|NCT01111565|27041935|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
13487996|NCT01111565|27041931|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1|||
13487997|NCT01111565|27041932|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
13487998|NCT01111565|27041933|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
13487999|NCT01111565|27041934|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
13488000|NCT01111565|27041935|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
13157943|NCT02475980|26074162|FG000|Overall Study|Lost to Follow-up|4|||
13157944|NCT02475980|26074162|FG000|Overall Study|Withdrawal by Subject|1|||
13157945|NCT02475954|26074177|FG000|Overall Study|Withdrawal by Subject|2|||
13157946|NCT02475954|26074178|FG001|Overall Study|Withdrawal by Subject|2|||
13157947|NCT02475954|26074177|FG000|Overall Study|Lost to Follow-up|11|||
13157948|NCT02475954|26074178|FG001|Overall Study|Lost to Follow-up|9|||
13157949|NCT02475954|26074177|FG000|Overall Study|Death|1|||
13157950|NCT02475954|26074178|FG001|Overall Study|Death|1|||
13157951|NCT02475850|26074205|FG000|Overall Study|Death|155|||
13157952|NCT02475850|26074206|FG001|Overall Study|Death|141|||
13157953|NCT02475850|26074205|FG000|Overall Study|Lost to Follow-up|217|||
13157954|NCT02475850|26074206|FG001|Overall Study|Lost to Follow-up|188|||
13157955|NCT02475850|26074205|FG000|Overall Study|Withdrawal by Subject|221|||
13157956|NCT02475850|26074206|FG001|Overall Study|Withdrawal by Subject|155|||
13157957|NCT02475733|26074268|FG000|Overall Study|Withdrawal by Subject|1|||
13157958|NCT02475733|26074269|FG001|Overall Study|Withdrawal by Subject|0|||
13157959|NCT02475733|26074268|FG000|Overall Study|Physician Decision|1|||
13157960|NCT02475733|26074269|FG001|Overall Study|Physician Decision|0|||
13157961|NCT02475655|26074428|FG000|Overall Study|Lost to Follow-up|0|||
13157962|NCT02475655|26074429|FG001|Overall Study|Lost to Follow-up|1|||
13157963|NCT02475629|26074452|FG000|Overall Study|Adverse Event|1|||
13157964|NCT02475629|26074452|FG000|Overall Study|Death|4|||
13157965|NCT02475629|26074452|FG000|Overall Study|Physician Decision|1|||
13157966|NCT02475629|26074452|FG000|Overall Study|Withdrawal by Subject|1|||
13157967|NCT02475629|26074452|FG000|Overall Study|Lost to Follow-up|1|||
13157968|NCT02475629|26074452|FG000|Overall Study|Subject non-compliance|1|||
13157969|NCT02475564|26074469|FG000|Overall Study|Withdrawal by Subject|1|||
13157970|NCT02475564|26074470|FG001|Overall Study|Withdrawal by Subject|0|||
13157971|NCT02475564|26074469|FG000|Overall Study|Lost to Follow-up|2|||
13157972|NCT02475564|26074470|FG001|Overall Study|Lost to Follow-up|1|||
13157973|NCT02475564|26074469|FG000|Overall Study|Intense Menstrual bleeding|1|||
13157974|NCT02475564|26074470|FG001|Overall Study|Intense Menstrual bleeding|0|||
13157975|NCT02475395|26074487|FG000|Overall Study|Protocol Violation|30|||
13157976|NCT02475395|26074488|FG001|Overall Study|Protocol Violation|3|||
13157977|NCT02475369|26074502|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7|||
13157978|NCT02475369|26074503|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2|||
13157979|NCT02475278|26074516|FG000|Overall Study|Lost to Follow-up|1|||
13157980|NCT02475278|26074516|FG000|Overall Study|Reason Not Specified|1|||
13157981|NCT02475265|26074522|FG000|Overall Study|Physician Decision|1|||
13157982|NCT02475265|26074522|FG000|Overall Study|Withdrawal by Subject|2|||
13157983|NCT02474589|26074535|FG000|Overall Study|Adverse Event|6|||
13157984|NCT02474589|26074536|FG001|Overall Study|Adverse Event|2|||
13157985|NCT02474589|26074535|FG000|Overall Study|Lost to Follow-up|6|||
13157986|NCT02474589|26074536|FG001|Overall Study|Lost to Follow-up|1|||
13157987|NCT02474589|26074535|FG000|Overall Study|Protocol Violation|4|||
13157988|NCT02474589|26074536|FG001|Overall Study|Protocol Violation|1|||
13157989|NCT02474589|26074535|FG000|Overall Study|Withdrawal by Subject|4|||
13157990|NCT02474589|26074536|FG001|Overall Study|Withdrawal by Subject|0|||
13157991|NCT02474589|26074535|FG000|Overall Study|Inability to complete study procedures|5|||
13157992|NCT02474589|26074536|FG001|Overall Study|Inability to complete study procedures|1|||
13157993|NCT02474355|26074546|FG000|Overall Study|Other|43|||
13157994|NCT02474355|26074546|FG000|Overall Study|Eligibility Criteria not Fulfilled|2|||
13157995|NCT02474355|26074546|FG000|Overall Study|Lost to Follow-up|98|||
13157996|NCT02474355|26074546|FG000|Overall Study|Withdrawal by Subject|124|||
13157997|NCT02474355|26074546|FG000|Overall Study|Death|1361|||
13157998|NCT02474199|26074568|FG000|Overall Study|Lost to Follow-up|1|||
13157999|NCT02474199|26074569|FG001|Overall Study|Lost to Follow-up|0|||
13158000|NCT02474199|26074570|FG002|Overall Study|Lost to Follow-up|0|||
13158001|NCT02474199|26074571|FG003|Overall Study|Lost to Follow-up|0|||
13158002|NCT02474199|26074568|FG000|Overall Study|Withdrawal by Subject|1|||
13158003|NCT02474199|26074569|FG001|Overall Study|Withdrawal by Subject|2|||
13158004|NCT02474199|26074570|FG002|Overall Study|Withdrawal by Subject|0|||
13158005|NCT02474199|26074571|FG003|Overall Study|Withdrawal by Subject|1|||
13158006|NCT02474199|26074568|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
13104880|NCT02998528|25877285|FG000|Systemic Adjuvant Treatment Period|Other reasons|0|||
13104881|NCT02998528|25877286|FG001|Systemic Adjuvant Treatment Period|Other reasons|0|||
13104882|NCT02998528|25877287|FG002|Systemic Adjuvant Treatment Period|Other reasons|1|||
13104883|NCT02962960|25877368|FG000|Overall Study|Withdrawal by Subject|1|||
13104884|NCT02962960|25877369|FG001|Overall Study|Withdrawal by Subject|1|||
13104885|NCT02962960|25877370|FG002|Overall Study|Withdrawal by Subject|0|||
13104886|NCT02962960|25877368|FG000|Overall Study|Adverse Event|1|||
13104887|NCT02962960|25877369|FG001|Overall Study|Adverse Event|1|||
13158007|NCT02474199|26074569|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1|||
13158008|NCT02474199|26074570|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
13158009|NCT02474199|26074571|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
13158010|NCT02474199|26074568|FG000|Overall Study|Did not meet eligibility criteria|0|||
13158011|NCT02474199|26074569|FG001|Overall Study|Did not meet eligibility criteria|0|||
13158012|NCT02474199|26074570|FG002|Overall Study|Did not meet eligibility criteria|2|||
13158013|NCT02474199|26074571|FG003|Overall Study|Did not meet eligibility criteria|2|||
13158014|NCT02474082|26074612|FG000|Overall Study|Adverse Event|2|||
13158015|NCT02474082|26074613|FG001|Overall Study|Adverse Event|32|||
13158016|NCT02474082|26074612|FG000|Overall Study|Withdrawal of informed consent|1|||
13158017|NCT02474082|26074613|FG001|Overall Study|Withdrawal of informed consent|11|||
13158018|NCT02474082|26074612|FG000|Overall Study|Lost to Follow-up|2|||
13158019|NCT02474082|26074613|FG001|Overall Study|Lost to Follow-up|2|||
13158020|NCT02474082|26074612|FG000|Overall Study|Dose tapering not achieved|0|||
13158021|NCT02474082|26074613|FG001|Overall Study|Dose tapering not achieved|4|||
13158022|NCT02474082|26074612|FG000|Overall Study|Participant/guardian decision|1|||
13158023|NCT02474082|26074613|FG001|Overall Study|Participant/guardian decision|2|||
13158024|NCT02474082|26074612|FG000|Overall Study|Non-compliance with study treatment|0|||
13158025|NCT02474082|26074613|FG001|Overall Study|Non-compliance with study treatment|2|||
13158026|NCT02474082|26074612|FG000|Overall Study|Protocol deviation|0|||
13158027|NCT02474082|26074613|FG001|Overall Study|Protocol deviation|1|||
13158028|NCT02474069|26074642|FG000|Selection Phase (SP)|Adverse Event|8|||
13158029|NCT02474069|26074643|FG001|Selection Phase (SP)|Adverse Event|0|||
13158030|NCT02474069|26074644|FG002|Selection Phase (SP)|Adverse Event|0|||
13104888|NCT02962960|25877370|FG002|Overall Study|Adverse Event|0|||
13104889|NCT02962960|25877368|FG000|Overall Study|Protocol Violation|1|||
13104890|NCT02962960|25877369|FG001|Overall Study|Protocol Violation|0|||
13104891|NCT02962960|25877370|FG002|Overall Study|Protocol Violation|0|||
13104892|NCT02913612|25877414|FG000|Overall Study|Lost to Follow-up|6|||
13104893|NCT02913612|25877415|FG001|Overall Study|Lost to Follow-up|5|||
13104894|NCT02913612|25877416|FG002|Overall Study|Lost to Follow-up|2|||
13104895|NCT02913612|25877417|FG003|Overall Study|Lost to Follow-up|0|||
13158031|NCT02474069|26074642|FG000|Selection Phase (SP)|Lack of Efficacy|1|||
13158032|NCT02474069|26074643|FG001|Selection Phase (SP)|Lack of Efficacy|0|||
13158033|NCT02474069|26074644|FG002|Selection Phase (SP)|Lack of Efficacy|0|||
13104896|NCT02913612|25877414|FG000|Overall Study|Physician Decision|1|||
13104897|NCT02913612|25877415|FG001|Overall Study|Physician Decision|4|||
13104898|NCT02913612|25877416|FG002|Overall Study|Physician Decision|1|||
13104899|NCT02913612|25877417|FG003|Overall Study|Physician Decision|0|||
13104900|NCT02913612|25877414|FG000|Overall Study|Withdrawal by Subject|2|||
13104901|NCT02913612|25877415|FG001|Overall Study|Withdrawal by Subject|4|||
13104902|NCT02913612|25877416|FG002|Overall Study|Withdrawal by Subject|0|||
13104903|NCT02913612|25877417|FG003|Overall Study|Withdrawal by Subject|0|||
13104904|NCT02913612|25877414|FG000|Overall Study|Hemangioma resolved|1|||
13104905|NCT02913612|25877415|FG001|Overall Study|Hemangioma resolved|0|||
13104906|NCT02913612|25877416|FG002|Overall Study|Hemangioma resolved|0|||
13104907|NCT02913612|25877417|FG003|Overall Study|Hemangioma resolved|0|||
13104908|NCT02913612|25877414|FG000|Overall Study|Local IRB decision|1|||
13104909|NCT02913612|25877415|FG001|Overall Study|Local IRB decision|0|||
13104910|NCT02913612|25877416|FG002|Overall Study|Local IRB decision|0|||
13104911|NCT02913612|25877417|FG003|Overall Study|Local IRB decision|0|||
13104912|NCT02913612|25877414|FG000|Overall Study|Study drug non-compliance|1|||
13104913|NCT02913612|25877415|FG001|Overall Study|Study drug non-compliance|1|||
13104914|NCT02913612|25877416|FG002|Overall Study|Study drug non-compliance|0|||
13104915|NCT02913612|25877417|FG003|Overall Study|Study drug non-compliance|0|||
13104916|NCT02913612|25877414|FG000|Overall Study|Insurance issues|0|||
13104917|NCT02913612|25877415|FG001|Overall Study|Insurance issues|1|||
13104918|NCT02913612|25877416|FG002|Overall Study|Insurance issues|0|||
13104919|NCT02913612|25877417|FG003|Overall Study|Insurance issues|0|||
13104920|NCT02913612|25877414|FG000|Overall Study|Needed to treat second hemangioma|0|||
13104921|NCT02913612|25877415|FG001|Overall Study|Needed to treat second hemangioma|1|||
13104922|NCT02913612|25877416|FG002|Overall Study|Needed to treat second hemangioma|0|||
13104923|NCT02913612|25877417|FG003|Overall Study|Needed to treat second hemangioma|0|||
13104924|NCT02913612|25877414|FG000|Overall Study|Study completion criteria not met|0|||
13104925|NCT02913612|25877415|FG001|Overall Study|Study completion criteria not met|1|||
13104926|NCT02913612|25877416|FG002|Overall Study|Study completion criteria not met|0|||
13104927|NCT02913612|25877417|FG003|Overall Study|Study completion criteria not met|0|||
13104928|NCT02913612|25877414|FG000|Overall Study|Ineligible|0|||
13104929|NCT02913612|25877415|FG001|Overall Study|Ineligible|1|||
13104930|NCT02913612|25877416|FG002|Overall Study|Ineligible|0|||
13104931|NCT02913612|25877417|FG003|Overall Study|Ineligible|0|||
13104932|NCT02844777|25877447|FG000|Overall Study|Withdrawal by Subject|2|||
13104933|NCT02844777|25877448|FG001|Overall Study|Withdrawal by Subject|0|||
13104934|NCT02844777|25877449|FG002|Overall Study|Withdrawal by Subject|0|||
13104935|NCT02650895|25877502|FG000|Overall Study|Withdrawal by Subject|0|||
13104936|NCT02650895|25877503|FG001|Overall Study|Withdrawal by Subject|1|||
13104937|NCT02650895|25877504|FG002|Overall Study|Withdrawal by Subject|0|||
13104938|NCT02650895|25877505|FG003|Overall Study|Withdrawal by Subject|0|||
13104939|NCT02650895|25877506|FG004|Overall Study|Withdrawal by Subject|0|||
13104940|NCT02650895|25877507|FG005|Overall Study|Withdrawal by Subject|0|||
13158034|NCT02474069|26074642|FG000|Selection Phase (SP)|Lost to Follow-up|4|||
13158035|NCT02474069|26074643|FG001|Selection Phase (SP)|Lost to Follow-up|0|||
13158036|NCT02474069|26074644|FG002|Selection Phase (SP)|Lost to Follow-up|0|||
13158037|NCT02474069|26074642|FG000|Selection Phase (SP)|Physician Decision|1|||
13158038|NCT02474069|26074643|FG001|Selection Phase (SP)|Physician Decision|0|||
13158039|NCT02474069|26074644|FG002|Selection Phase (SP)|Physician Decision|0|||
13158040|NCT02474069|26074642|FG000|Selection Phase (SP)|Protocol Violation|1|||
13158041|NCT02474069|26074643|FG001|Selection Phase (SP)|Protocol Violation|0|||
13158042|NCT02474069|26074644|FG002|Selection Phase (SP)|Protocol Violation|0|||
13158043|NCT02474069|26074642|FG000|Selection Phase (SP)|No longer requires treatment|1|||
13158044|NCT02474069|26074643|FG001|Selection Phase (SP)|No longer requires treatment|0|||
13158045|NCT02474069|26074644|FG002|Selection Phase (SP)|No longer requires treatment|0|||
13158046|NCT02474069|26074642|FG000|Selection Phase (SP)|Technical Problem|1|||
13158047|NCT02474069|26074643|FG001|Selection Phase (SP)|Technical Problem|0|||
13158048|NCT02474069|26074644|FG002|Selection Phase (SP)|Technical Problem|0|||
13158049|NCT02474069|26074642|FG000|Selection Phase (SP)|Withdrawal by Subject|3|||
13158050|NCT02474069|26074643|FG001|Selection Phase (SP)|Withdrawal by Subject|0|||
13158051|NCT02474069|26074644|FG002|Selection Phase (SP)|Withdrawal by Subject|0|||
13158052|NCT02474069|26074642|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3|||
13158053|NCT02474069|26074643|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
13158054|NCT02474069|26074644|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
13158055|NCT02474069|26074642|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0|||
13158056|NCT02474069|26074643|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3|||
13158057|NCT02474069|26074644|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2|||
13158058|NCT02474069|26074642|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0|||
13158059|NCT02474069|26074643|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4|||
13158060|NCT02474069|26074644|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1|||
13158061|NCT02474069|26074642|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
13158062|NCT02474069|26074643|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
13158063|NCT02474069|26074644|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1|||
13158064|NCT02474069|26074642|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0|||
13158065|NCT02474069|26074643|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
13158066|NCT02474069|26074644|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
13158067|NCT02473965|26074661|FG000|Overall Study|Adverse Event|6|||
13158068|NCT02473965|26074662|FG001|Overall Study|Adverse Event|4|||
13158069|NCT02473965|26074661|FG000|Overall Study|MG worsening|4|||
13158070|NCT02473965|26074662|FG001|Overall Study|MG worsening|1|||
13158071|NCT02473965|26074661|FG000|Overall Study|Withdrawal by Subject|2|||
13158072|NCT02473965|26074662|FG001|Overall Study|Withdrawal by Subject|3|||
13158073|NCT02473965|26074661|FG000|Overall Study|Physician Decision|0|||
13158074|NCT02473965|26074662|FG001|Overall Study|Physician Decision|2|||
13158075|NCT02473952|26074675|FG000|Overall Study|Adverse Event|2|||
13158076|NCT02473952|26074676|FG001|Overall Study|Adverse Event|2|||
13158077|NCT02473952|26074675|FG000|Overall Study|Withdrawal by Subject|0|||
13158078|NCT02473952|26074676|FG001|Overall Study|Withdrawal by Subject|6|||
13158079|NCT02473913|26074701|FG000|Overall Study|Lost to Follow-up|3|||
13158080|NCT02473913|26074702|FG001|Overall Study|Lost to Follow-up|3|||
13158081|NCT02473640|26074713|FG000|Treatment Period 1|Adverse Event|1|||
13158082|NCT02473614|26074724|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1|||
13158083|NCT02473614|26074725|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0|||
13205339|NCT01966445|26231480|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
13205340|NCT01966445|26231481|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
13205341|NCT01966445|26231482|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3|||
13205342|NCT01966445|26231476|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
13205343|NCT01966445|26231477|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
13205344|NCT01966445|26231478|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
13205345|NCT01966445|26231479|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
13205346|NCT01966445|26231480|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
13205347|NCT01966445|26231481|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
13205348|NCT01966445|26231482|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2|||
13205349|NCT01966432|26231512|FG000|Overall Study|Lost to Follow-up|3|||
13205350|NCT01966432|26231513|FG001|Overall Study|Lost to Follow-up|2|||
13205351|NCT01966432|26231514|FG002|Overall Study|Lost to Follow-up|5|||
13205352|NCT01966432|26231512|FG000|Overall Study|Withdrawal by Subject|1|||
13205353|NCT01966432|26231513|FG001|Overall Study|Withdrawal by Subject|3|||
13205354|NCT01966432|26231514|FG002|Overall Study|Withdrawal by Subject|0|||
13205355|NCT01966432|26231512|FG000|Overall Study|Subject Incarcerated|0|||
13205356|NCT01966432|26231513|FG001|Overall Study|Subject Incarcerated|0|||
13205357|NCT01966432|26231514|FG002|Overall Study|Subject Incarcerated|1|||
13205358|NCT01966432|26231512|FG000|Overall Study|SBIRT program ended|1|||
13222769|NCT01803282|26286893|FG010|Overall Study|Non-Compliance with Study Drug|0|||
13205359|NCT01966432|26231513|FG001|Overall Study|SBIRT program ended|8|||
13205360|NCT01966432|26231514|FG002|Overall Study|SBIRT program ended|20|||
13205361|NCT01966120|26231543|FG000|Overall Study|Withdrawal by Subject|0|||
13158084|NCT02473523|26074746|FG000|Overall Study|Death|1|||
13158085|NCT02473523|26074746|FG000|Overall Study|Lost to Follow-up|1|||
13158086|NCT02473510|26074767|FG000|Overall Study|Lost to Follow-up|1|||
13158087|NCT02473510|26074768|FG001|Overall Study|Lost to Follow-up|2|||
13158088|NCT02473471|26074801|FG000|Overall Study|poor oral hygiene|2|||
13158089|NCT02473471|26074801|FG000|Overall Study|Lost to Follow-up|1|||
13158090|NCT02473445|26074809|FG000|Overall Study|Withdrawal by Subject|2|||
13158091|NCT02473445|26074809|FG000|Overall Study|Sponsor Decision|20|||
13158092|NCT02473393|26074861|FG000|Overall Study|Adverse Event|0|||
13158093|NCT02473393|26074862|FG001|Overall Study|Adverse Event|0|||
13158094|NCT02473393|26074863|FG002|Overall Study|Adverse Event|1|||
13158095|NCT02473393|26074864|FG003|Overall Study|Adverse Event|0|||
13158096|NCT02473393|26074861|FG000|Overall Study|Withdrawal by Subject|0|||
13158097|NCT02473393|26074862|FG001|Overall Study|Withdrawal by Subject|0|||
13158098|NCT02473393|26074863|FG002|Overall Study|Withdrawal by Subject|1|||
13158099|NCT02473393|26074864|FG003|Overall Study|Withdrawal by Subject|1|||
13158100|NCT02473367|26074884|FG000|Wait 1|Withdrawal by Subject|1|||
13158101|NCT02473367|26074884|FG000|Period 4|Lost to Follow-up|1|||
13158102|NCT02473289|26074913|FG000|Overall Study|Adverse Event|2|||
13158103|NCT02473289|26074914|FG001|Overall Study|Adverse Event|3|||
13158104|NCT02473289|26074913|FG000|Overall Study|Lost to Follow-up|1|||
13158105|NCT02473289|26074914|FG001|Overall Study|Lost to Follow-up|1|||
13104941|NCT02612337|25877530|FG000|Overall Study|Lack of Efficacy|1|||
13104942|NCT02612337|25877531|FG001|Overall Study|Lack of Efficacy|0|||
13104943|NCT02612337|25877530|FG000|Overall Study|Withdrawal by Subject|2|||
13104944|NCT02612337|25877531|FG001|Overall Study|Withdrawal by Subject|2|||
13104945|NCT02612337|25877530|FG000|Overall Study|Did not receive study drug|0|||
13104946|NCT02612337|25877531|FG001|Overall Study|Did not receive study drug|1|||
13104947|NCT02469064|25877546|FG000|Overall Study|Request not to receive intervention.|1|||
13104948|NCT02469064|25877547|FG001|Overall Study|Request not to receive intervention.|3|||
13104949|NCT02446912|25877628|FG000|Overall Study|Adverse Event|3|||
13104950|NCT02446912|25877629|FG001|Overall Study|Adverse Event|13|||
13104951|NCT02446912|25877630|FG002|Overall Study|Adverse Event|5|||
13104952|NCT02446912|25877628|FG000|Overall Study|Condition under investigation worsened|0|||
13104953|NCT02446912|25877629|FG001|Overall Study|Condition under investigation worsened|1|||
13104954|NCT02446912|25877630|FG002|Overall Study|Condition under investigation worsened|1|||
13104955|NCT02446912|25877628|FG000|Overall Study|Study-specific withdrawal criteria|1|||
13104956|NCT02446912|25877629|FG001|Overall Study|Study-specific withdrawal criteria|0|||
13104957|NCT02446912|25877630|FG002|Overall Study|Study-specific withdrawal criteria|0|||
13104958|NCT02446912|25877628|FG000|Overall Study|Lack of Efficacy|1|||
13104959|NCT02446912|25877629|FG001|Overall Study|Lack of Efficacy|4|||
13104960|NCT02446912|25877630|FG002|Overall Study|Lack of Efficacy|7|||
13104961|NCT02446912|25877628|FG000|Overall Study|Lost to Follow-up|0|||
13104962|NCT02446912|25877629|FG001|Overall Study|Lost to Follow-up|0|||
13104963|NCT02446912|25877630|FG002|Overall Study|Lost to Follow-up|2|||
13104964|NCT02446912|25877628|FG000|Overall Study|Severe non-compliance to protocol|1|||
13104965|NCT02446912|25877629|FG001|Overall Study|Severe non-compliance to protocol|0|||
13104966|NCT02446912|25877630|FG002|Overall Study|Severe non-compliance to protocol|1|||
13104967|NCT02446912|25877628|FG000|Overall Study|Withdrawal by Subject|10|||
13104968|NCT02446912|25877629|FG001|Overall Study|Withdrawal by Subject|15|||
13104969|NCT02446912|25877630|FG002|Overall Study|Withdrawal by Subject|15|||
13104970|NCT02446912|25877628|FG000|Overall Study|Miscellaneous|2|||
13104971|NCT02446912|25877629|FG001|Overall Study|Miscellaneous|2|||
13104972|NCT02446912|25877630|FG002|Overall Study|Miscellaneous|4|||
13104973|NCT02388906|25877657|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
13104974|NCT02388906|25877658|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
13104975|NCT02388906|25877657|FG000|Treatment Period|Disease progression|121|||
13104976|NCT02388906|25877658|FG001|Treatment Period|Disease progression|101|||
13104977|NCT02388906|25877657|FG000|Treatment Period|Study drug toxicity|41|||
13104978|NCT02388906|25877658|FG001|Treatment Period|Study drug toxicity|208|||
13104979|NCT02388906|25877657|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
13104980|NCT02388906|25877658|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
13104981|NCT02388906|25877657|FG000|Treatment Period|Participant request to stop treatment|5|||
13104982|NCT02388906|25877658|FG001|Treatment Period|Participant request to stop treatment|9|||
13104983|NCT02388906|25877657|FG000|Treatment Period|Participant withdrew consent|2|||
13104984|NCT02388906|25877658|FG001|Treatment Period|Participant withdrew consent|3|||
13104985|NCT02388906|25877657|FG000|Treatment Period|Poor/non-compliance|0|||
13104986|NCT02388906|25877658|FG001|Treatment Period|Poor/non-compliance|1|||
13104987|NCT02388906|25877657|FG000|Treatment Period|Participant no longer meets study criteria|0|||
13104988|NCT02388906|25877658|FG001|Treatment Period|Participant no longer meets study criteria|1|||
13104989|NCT02388906|25877657|FG000|Treatment Period|Other reasons|3|||
13158106|NCT02473289|26074913|FG000|Overall Study|Protocol Violation|0|||
13158107|NCT02473289|26074914|FG001|Overall Study|Protocol Violation|1|||
13158108|NCT02473289|26074913|FG000|Overall Study|Withdrawal of consent|6|||
13158109|NCT02473289|26074914|FG001|Overall Study|Withdrawal of consent|7|||
13104990|NCT02388906|25877658|FG001|Treatment Period|Other reasons|3|||
13133072|NCT02778399|25986515|FG002|Up to Week 12 Treatment Period|Protocol Violation|0|||
13133073|NCT02778399|25986516|FG003|Up to Week 12 Treatment Period|Protocol Violation|0|||
13133074|NCT02778399|25986517|FG004|Up to Week 12 Treatment Period|Protocol Violation|1|||
13133075|NCT02778399|25986518|FG005|Up to Week 12 Treatment Period|Protocol Violation|0|||
13133076|NCT02778399|25986513|FG000|Up to Week 12 Treatment Period|Lost to Follow-up|3|||
13133077|NCT02778399|25986514|FG001|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
13133078|NCT02778399|25986515|FG002|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
13133079|NCT02778399|25986516|FG003|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
13133080|NCT02778399|25986517|FG004|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
13133081|NCT02778399|25986518|FG005|Up to Week 12 Treatment Period|Lost to Follow-up|2|||
13133082|NCT02778399|25986513|FG000|Up to Week 12 Treatment Period|other - reason not stated|0|||
13133083|NCT02778399|25986514|FG001|Up to Week 12 Treatment Period|other - reason not stated|0|||
13133084|NCT02778399|25986515|FG002|Up to Week 12 Treatment Period|other - reason not stated|0|||
13133085|NCT02778399|25986516|FG003|Up to Week 12 Treatment Period|other - reason not stated|1|||
13133086|NCT02778399|25986517|FG004|Up to Week 12 Treatment Period|other - reason not stated|2|||
13133087|NCT02778399|25986518|FG005|Up to Week 12 Treatment Period|other - reason not stated|0|||
13133088|NCT02778399|25986513|FG000|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
13133089|NCT02778399|25986514|FG001|Week 12 to Week 24 Treatment Period|Adverse Event|0|||
13158110|NCT02473289|26074913|FG000|Overall Study|Treatment Unblinded + Adverse event|0|||
13158111|NCT02473289|26074914|FG001|Overall Study|Treatment Unblinded + Adverse event|1|||
13158112|NCT02473289|26074913|FG000|Overall Study|Other|2|||
13158113|NCT02473289|26074914|FG001|Overall Study|Other|0|||
13158114|NCT02473250|26074923|FG000|Overall Study|Lost to Follow-up|10|||
13158115|NCT02473250|26074923|FG000|Overall Study|Physician Decision|5|||
13158116|NCT02473250|26074923|FG000|Overall Study|Did not tolerate medication washout|3|||
13158117|NCT02473250|26074923|FG000|Overall Study|Antidepressant effect of divalproex|2|||
13158118|NCT02472977|26074956|FG000|Overall Study|Disease progression|4|||
13158119|NCT02472977|26074957|FG001|Overall Study|Disease progression|25|||
13158120|NCT02472977|26074958|FG002|Overall Study|Disease progression|6|||
13158121|NCT02472977|26074956|FG000|Overall Study|Withdrawal by Subject|0|||
13158122|NCT02472977|26074957|FG001|Overall Study|Withdrawal by Subject|1|||
13158123|NCT02472977|26074958|FG002|Overall Study|Withdrawal by Subject|0|||
13158124|NCT02472977|26074956|FG000|Overall Study|Study drug toxicity|2|||
13158125|NCT02472977|26074957|FG001|Overall Study|Study drug toxicity|0|||
13158126|NCT02472977|26074958|FG002|Overall Study|Study drug toxicity|2|||
13158127|NCT02472977|26074956|FG000|Overall Study|Subject request to discontinue treatment|0|||
13158128|NCT02472977|26074957|FG001|Overall Study|Subject request to discontinue treatment|1|||
13158129|NCT02472977|26074958|FG002|Overall Study|Subject request to discontinue treatment|0|||
13158130|NCT02472886|26074994|FG000|Overall Study|Lack of Efficacy|0|||
13158131|NCT02472886|26074995|FG001|Overall Study|Lack of Efficacy|2|||
13158132|NCT02472886|26074996|FG002|Overall Study|Lack of Efficacy|1|||
13158133|NCT02472847|26075009|FG000|Overall Study|Withdrawal by Subject|1|||
13158134|NCT02472847|26075010|FG001|Overall Study|Withdrawal by Subject|5|||
13158135|NCT02472795|26075058|FG000|Overall Study|Adverse Event|0|||
13158136|NCT02472795|26075059|FG001|Overall Study|Adverse Event|1|||
13158137|NCT02472795|26075060|FG002|Overall Study|Adverse Event|0|||
13158138|NCT02472795|26075061|FG003|Overall Study|Adverse Event|0|||
13158139|NCT02472795|26075062|FG004|Overall Study|Adverse Event|2|||
13158140|NCT02472795|26075058|FG000|Overall Study|Withdrawal by Subject|0|||
13158141|NCT02472795|26075059|FG001|Overall Study|Withdrawal by Subject|0|||
13158142|NCT02472795|26075060|FG002|Overall Study|Withdrawal by Subject|0|||
13158143|NCT02472795|26075061|FG003|Overall Study|Withdrawal by Subject|0|||
13158144|NCT02472795|26075062|FG004|Overall Study|Withdrawal by Subject|1|||
13158145|NCT02472756|26075070|FG000|Induction (Approximately 6 Months)|Adverse Event|1|||
13158146|NCT02472756|26075070|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1|||
13158147|NCT02472756|26075070|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7|||
13158148|NCT02472756|26075070|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2|||
13158149|NCT02472756|26075070|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1|||
13158150|NCT02472652|26075077|FG000|Overall Study|Lost to Follow-up|1|||
13158151|NCT02472639|26075098|FG000|Overall Study|Physician Decision|4|||
13158152|NCT02472639|26075099|FG001|Overall Study|Physician Decision|3|||
13158153|NCT02472405|26075107|FG000|Overall Study|Lost to Follow-up|9|||
13158154|NCT02472405|26075107|FG000|Overall Study|Adverse Event|1|||
13158155|NCT02472366|26075128|FG000|Overall Study|Lost to Follow-up|1|||
13158156|NCT02472366|26075129|FG001|Overall Study|Lost to Follow-up|0|||
13158157|NCT02472353|26075142|FG000|Overall Study|Lost to Follow-up|1|||
13158158|NCT02472353|26075143|FG001|Overall Study|Lost to Follow-up|1|||
13158159|NCT02472353|26075142|FG000|Overall Study|Withdrawal by Subject|2|||
13158160|NCT02472353|26075143|FG001|Overall Study|Withdrawal by Subject|1|||
13158161|NCT02472353|26075142|FG000|Overall Study|Study Termination|1|||
13158162|NCT02472353|26075143|FG001|Overall Study|Study Termination|4|||
13158163|NCT02472145|26075172|FG000|Overall Study|Death|10|||
13158164|NCT02472145|26075173|FG001|Overall Study|Death|101|||
13158165|NCT02472145|26075174|FG002|Overall Study|Death|99|||
13158166|NCT02472145|26075172|FG000|Overall Study|Lost to Follow-up|0|||
13158167|NCT02472145|26075173|FG001|Overall Study|Lost to Follow-up|1|||
13158168|NCT02472145|26075174|FG002|Overall Study|Lost to Follow-up|0|||
13158169|NCT02472145|26075172|FG000|Overall Study|Withdrawal by Subject|0|||
13158170|NCT02472145|26075173|FG001|Overall Study|Withdrawal by Subject|9|||
13158171|NCT02472145|26075174|FG002|Overall Study|Withdrawal by Subject|13|||
13158172|NCT02472145|26075172|FG000|Overall Study|Sponsor decision|0|||
13158173|NCT02472145|26075173|FG001|Overall Study|Sponsor decision|3|||
13158174|NCT02472145|26075174|FG002|Overall Study|Sponsor decision|2|||
13158175|NCT02472145|26075172|FG000|Overall Study|Other|0|||
13158176|NCT02472145|26075173|FG001|Overall Study|Other|45|||
13158177|NCT02472145|26075174|FG002|Overall Study|Other|43|||
13158178|NCT02471755|26075197|FG000|Overall Study|Withdrawal by Subject|1|||
13158179|NCT02471755|26075198|FG001|Overall Study|Withdrawal by Subject|0|||
13158180|NCT02471755|26075197|FG000|Overall Study|Lost to Follow-up|0|||
13158181|NCT02471755|26075198|FG001|Overall Study|Lost to Follow-up|1|||
13158182|NCT02471716|26075263|FG000|Overall Study|Withdrawal by Subject|0|||
13158183|NCT02471716|26075264|FG001|Overall Study|Withdrawal by Subject|1|||
13158184|NCT02471716|26075265|FG002|Overall Study|Withdrawal by Subject|0|||
13158185|NCT02471716|26075266|FG003|Overall Study|Withdrawal by Subject|2|||
13158186|NCT02471716|26075267|FG004|Overall Study|Withdrawal by Subject|5|||
13158187|NCT02471716|26075263|FG000|Overall Study|Study Terminiated by sponsor|0|||
13158188|NCT02471716|26075264|FG001|Overall Study|Study Terminiated by sponsor|0|||
13158189|NCT02471716|26075265|FG002|Overall Study|Study Terminiated by sponsor|0|||
13158190|NCT02471716|26075266|FG003|Overall Study|Study Terminiated by sponsor|1|||
13158191|NCT02471716|26075267|FG004|Overall Study|Study Terminiated by sponsor|0|||
13158192|NCT02471716|26075263|FG000|Overall Study|Lost to Follow-up|0|||
13158193|NCT02471716|26075264|FG001|Overall Study|Lost to Follow-up|0|||
13158194|NCT02471716|26075265|FG002|Overall Study|Lost to Follow-up|0|||
13158195|NCT02471716|26075266|FG003|Overall Study|Lost to Follow-up|3|||
13158196|NCT02471716|26075267|FG004|Overall Study|Lost to Follow-up|2|||
13158197|NCT02471716|26075263|FG000|Overall Study|Death|0|||
13158198|NCT02471716|26075264|FG001|Overall Study|Death|0|||
13158199|NCT02471716|26075265|FG002|Overall Study|Death|0|||
13158200|NCT02471716|26075266|FG003|Overall Study|Death|1|||
13158201|NCT02471716|26075267|FG004|Overall Study|Death|0|||
13158202|NCT02471716|26075263|FG000|Overall Study|Other|0|||
13158203|NCT02471716|26075264|FG001|Overall Study|Other|0|||
13158204|NCT02471716|26075265|FG002|Overall Study|Other|0|||
13158205|NCT02471716|26075266|FG003|Overall Study|Other|8|||
13158206|NCT02471716|26075267|FG004|Overall Study|Other|9|||
13158207|NCT02471612|26075286|FG000|Overall Study|Lost to Follow-up|2|||
13158208|NCT02471586|26075403|FG000|Overall Study|Lost to Follow-up|3|||
13158209|NCT02471586|26075404|FG001|Overall Study|Lost to Follow-up|8|||
13158210|NCT02471586|26075405|FG002|Overall Study|Lost to Follow-up|4|||
13158211|NCT02471586|26075403|FG000|Overall Study|Death|2|||
13158212|NCT02471586|26075404|FG001|Overall Study|Death|2|||
13158213|NCT02471586|26075405|FG002|Overall Study|Death|0|||
13158214|NCT02471404|26075438|FG000|Overall Study|Adverse Event|7|||
13158215|NCT02471404|26075439|FG001|Overall Study|Adverse Event|1|||
13158216|NCT02471404|26075440|FG002|Overall Study|Adverse Event|2|||
13158217|NCT02471404|26075438|FG000|Overall Study|Developed Study Withdrawal Criteria|4|||
13158218|NCT02471404|26075439|FG001|Overall Study|Developed Study Withdrawal Criteria|1|||
13158219|NCT02471404|26075440|FG002|Overall Study|Developed Study Withdrawal Criteria|2|||
13158220|NCT02471404|26075438|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
13158221|NCT02471404|26075439|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
13158222|NCT02471404|26075440|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
13158223|NCT02471404|26075438|FG000|Overall Study|Lost to Follow-up|1|||
13158224|NCT02471404|26075439|FG001|Overall Study|Lost to Follow-up|1|||
13158225|NCT02471404|26075440|FG002|Overall Study|Lost to Follow-up|3|||
13158226|NCT02471404|26075438|FG000|Overall Study|Protocol Violation|1|||
13158227|NCT02471404|26075439|FG001|Overall Study|Protocol Violation|0|||
13158228|NCT02471404|26075440|FG002|Overall Study|Protocol Violation|0|||
13158229|NCT02471404|26075438|FG000|Overall Study|Withdrawal by Subject|8|||
13158230|NCT02471404|26075439|FG001|Overall Study|Withdrawal by Subject|4|||
13158231|NCT02471404|26075440|FG002|Overall Study|Withdrawal by Subject|5|||
13158232|NCT02471404|26075438|FG000|Overall Study|Other reasons not specified|10|||
13158233|NCT02471404|26075439|FG001|Overall Study|Other reasons not specified|7|||
13158234|NCT02471404|26075440|FG002|Overall Study|Other reasons not specified|12|||
13158235|NCT02471183|26075457|FG000|Main Treatment Period|Adverse Event|1|||
13158236|NCT02471183|26075457|FG000|Main Treatment Period|Withdrawal by Subject|1|||
13158237|NCT02471183|26075457|FG000|Extended Treatment Period|Lack of Efficacy|1|||
13158238|NCT02471014|26075470|FG000|Overall Study|Lost to Follow-up|2|||
13158239|NCT02471014|26075471|FG001|Overall Study|Lost to Follow-up|2|||
13158240|NCT02470806|26075492|FG000|Overall Study|Lost to Follow-up|1|||
13158241|NCT02470806|26075493|FG001|Overall Study|Lost to Follow-up|1|||
13158242|NCT02470806|26075492|FG000|Overall Study|Adverse Event|5|||
13158243|NCT02470806|26075493|FG001|Overall Study|Adverse Event|2|||
13158244|NCT02470806|26075492|FG000|Overall Study|Protocol Violation|4|||
13158245|NCT02470806|26075493|FG001|Overall Study|Protocol Violation|11|||
13158246|NCT02470806|26075492|FG000|Overall Study|Physician Decision|0|||
13158247|NCT02470806|26075493|FG001|Overall Study|Physician Decision|3|||
13158248|NCT02470806|26075492|FG000|Overall Study|Withdrawal by Subject|3|||
13158249|NCT02470806|26075493|FG001|Overall Study|Withdrawal by Subject|10|||
13158250|NCT02470806|26075492|FG000|Overall Study|Lack of Efficacy|5|||
13158251|NCT02470806|26075493|FG001|Overall Study|Lack of Efficacy|15|||
13158252|NCT02470429|26075513|FG000|Overall Study|Adverse Event|1|||
13158253|NCT02470429|26075514|FG001|Overall Study|Adverse Event|0|||
13158254|NCT02470429|26075513|FG000|Overall Study|Withdrawal by Subject|1|||
13158255|NCT02470429|26075514|FG001|Overall Study|Withdrawal by Subject|0|||
13158256|NCT02470403|26075568|FG000|Overall Study|Adverse Event|1|||
13158257|NCT02470403|26075569|FG001|Overall Study|Adverse Event|0|||
13158258|NCT02470403|26075570|FG002|Overall Study|Adverse Event|0|||
13158259|NCT02470403|26075571|FG003|Overall Study|Adverse Event|0|||
13158260|NCT02470403|26075572|FG004|Overall Study|Adverse Event|0|||
13158261|NCT02470403|26075568|FG000|Overall Study|Lost to Follow-up|0|||
13158262|NCT02470403|26075569|FG001|Overall Study|Lost to Follow-up|1|||
13158263|NCT02470403|26075570|FG002|Overall Study|Lost to Follow-up|0|||
13158264|NCT02470403|26075571|FG003|Overall Study|Lost to Follow-up|0|||
13104991|NCT02227199|25877683|FG000|Overall Study|Physician Decision|0|||
13104992|NCT02227199|25877684|FG001|Overall Study|Physician Decision|0|||
13104993|NCT02227199|25877685|FG002|Overall Study|Physician Decision|1|||
13104994|NCT02227199|25877683|FG000|Overall Study|Adverse Event|0|||
13104995|NCT02227199|25877684|FG001|Overall Study|Adverse Event|0|||
13104996|NCT02227199|25877685|FG002|Overall Study|Adverse Event|3|||
13104997|NCT01964547|25877716|FG000|Overall Study|Adverse Event|8|||
13104998|NCT01964547|25877717|FG001|Overall Study|Adverse Event|2|||
13104999|NCT01964547|25877716|FG000|Overall Study|Withdrawal by Subject|4|||
13105000|NCT01964547|25877717|FG001|Overall Study|Withdrawal by Subject|7|||
13105001|NCT01964547|25877716|FG000|Overall Study|Lost to Follow-up|0|||
13105002|NCT01964547|25877717|FG001|Overall Study|Lost to Follow-up|1|||
13105003|NCT01964547|25877716|FG000|Overall Study|Withdrawal by Investigator|0|||
13105004|NCT01964547|25877717|FG001|Overall Study|Withdrawal by Investigator|1|||
13105005|NCT01952730|25877726|FG000|Overall Study|FDA shut down core lab used by study|1|||
13105006|NCT01610700|25877797|FG000|Overall Study|Adverse Event|3|||
13105007|NCT01610700|25877798|FG001|Overall Study|Adverse Event|1|||
13105008|NCT01610700|25877797|FG000|Overall Study|Withdrawal by Subject|0|||
13105009|NCT01610700|25877798|FG001|Overall Study|Withdrawal by Subject|1|||
13105010|NCT01610700|25877797|FG000|Overall Study|subject took one dose of street cannabis|0|||
13105011|NCT01610700|25877798|FG001|Overall Study|subject took one dose of street cannabis|1|||
13105012|NCT01106391|25877813|FG000|Overall Study|Death|12|||
13105013|NCT01106391|25877813|FG000|Overall Study|Withdrawal by Subject|7|||
13105014|NCT01005745|25877820|FG000|Overall Study|No TIL growth|1|||
13105015|NCT01005745|25877820|FG000|Overall Study|Disease progressed during TIL growth|3|||
13105016|NCT01005745|25877820|FG000|Overall Study|Death prior to treatment|1|||
13105017|NCT01005745|25877820|FG000|Overall Study|Inappropriate antidiuretic hormone|1|||
13105018|NCT00736840|25877827|FG000|Overall Study|Lost to Follow-up|13|||
13105019|NCT03334188|25877861|FG000|Overall Study|Withdrawal by Subject|0|||
13105020|NCT03334188|25877862|FG001|Overall Study|Withdrawal by Subject|1|||
13105021|NCT03334188|25877861|FG000|Overall Study|Death|1|||
13105022|NCT03334188|25877862|FG001|Overall Study|Death|0|||
13105023|NCT03334188|25877861|FG000|Overall Study|Never had qualifying clinic visit|7|||
13105024|NCT03334188|25877862|FG001|Overall Study|Never had qualifying clinic visit|7|||
13105025|NCT03334175|25877889|FG000|Overall Study|Lost to Follow-up|0|||
13105026|NCT03334175|25877890|FG001|Overall Study|Lost to Follow-up|1|||
13105027|NCT03333941|25877896|FG000|Overall Study|Lost to Follow-up|10|||
13105028|NCT03333941|25877896|FG000|Overall Study|Death|2|||
13105029|NCT03333941|25877896|FG000|Overall Study|Adverse Event|1|||
13105030|NCT03333928|25877966|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0|||
13105031|NCT03333928|25877967|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0|||
13105032|NCT03333928|25877968|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1|||
13105033|NCT03333928|25877966|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0|||
13105034|NCT03333928|25877967|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
13105035|NCT03333928|25877968|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
13105036|NCT03333928|25877966|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
13105037|NCT03333928|25877967|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0|||
13105038|NCT03333928|25877968|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
13105039|NCT03333928|25877966|FG000|Initial Dosing Period (Period 1)|Adverse Event|0|||
13105040|NCT03333928|25877967|FG001|Initial Dosing Period (Period 1)|Adverse Event|3|||
13105041|NCT03333928|25877968|FG002|Initial Dosing Period (Period 1)|Adverse Event|1|||
13158265|NCT02470403|26075572|FG004|Overall Study|Lost to Follow-up|0|||
13158266|NCT02470403|26075568|FG000|Overall Study|Subject/guardian decision|1|||
13158267|NCT02470403|26075569|FG001|Overall Study|Subject/guardian decision|0|||
13105042|NCT03333928|25877966|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2|||
13105043|NCT03333928|25877967|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1|||
13105044|NCT03333928|25877968|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0|||
13105045|NCT03333928|25877966|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1|||
13105046|NCT03333928|25877967|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
13105047|NCT03333928|25877968|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
13105048|NCT03333928|25877966|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1|||
13105049|NCT03333928|25877967|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0|||
13105050|NCT03333928|25877968|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0|||
13105051|NCT03333928|25877966|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
13105052|NCT03333928|25877967|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0|||
13105053|NCT03333928|25877968|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
13105054|NCT03333876|25877995|FG000|Screening Period|Screen Failure|4|||
13105055|NCT03333876|25877995|FG000|Nasal Dilator|Bed Partner Lost to follow up|6|||
13105056|NCT03333876|25877995|FG000|Mandibular Advancement|Adverse Event|2|||
13105057|NCT03333876|25877995|FG000|Mandibular Advancement|Product Damage|2|||
13105058|NCT03333837|25878143|FG000|Overall Study|Adverse Event|2|||
13105059|NCT03333837|25878144|FG001|Overall Study|Adverse Event|1|||
13105060|NCT03333837|25878145|FG002|Overall Study|Adverse Event|1|||
13158268|NCT02470403|26075570|FG002|Overall Study|Subject/guardian decision|0|||
13158269|NCT02470403|26075571|FG003|Overall Study|Subject/guardian decision|4|||
13158270|NCT02470403|26075572|FG004|Overall Study|Subject/guardian decision|0|||
13158271|NCT02469961|26075591|FG000|Overall Study|Physician Decision|4|||
13158272|NCT02469961|26075592|FG001|Overall Study|Physician Decision|1|||
13158273|NCT02469896|26075623|FG000|Overall Study|Withdrawal by Subject|2|||
13158274|NCT02469896|26075624|FG001|Overall Study|Withdrawal by Subject|0|||
13158275|NCT02469857|26075675|FG000|Overall Study|Death|24|||
13158276|NCT02469857|26075676|FG001|Overall Study|Death|29|||
13158277|NCT02469857|26075675|FG000|Overall Study|Discontinuation|1|||
13158278|NCT02469857|26075676|FG001|Overall Study|Discontinuation|3|||
13158279|NCT02469623|26075683|FG000|Overall Study|Not consented for long-term follow-up|4|||
13158280|NCT02469623|26075683|FG000|Overall Study|Lost to Follow-up|4|||
13158281|NCT02469623|26075683|FG000|Overall Study|Withdrawal by Subject|2|||
13158282|NCT02469623|26075683|FG000|Overall Study|Death|3|||
13158283|NCT02469610|26075698|FG000|Overall Study|Death|1|||
13158284|NCT02469610|26075699|FG001|Overall Study|Death|0|||
13158285|NCT02469610|26075698|FG000|Overall Study|Lost to Follow-up|1|||
13158286|NCT02469610|26075699|FG001|Overall Study|Lost to Follow-up|0|||
13158287|NCT02469610|26075698|FG000|Overall Study|exclusion criteria|2|||
13158288|NCT02469610|26075699|FG001|Overall Study|exclusion criteria|1|||
13158289|NCT02469415|26075705|FG000|Overall Study|Withdrawal by Subject|1|||
13158290|NCT02469415|26075705|FG000|Overall Study|Investigational agent placed on hold|2|||
13158291|NCT02469298|26075856|FG000|Overall Study|Protocol Violation|0|||
13158292|NCT02469298|26075857|FG001|Overall Study|Protocol Violation|1|||
13158293|NCT02469298|26075858|FG002|Overall Study|Protocol Violation|1|||
13158294|NCT02469298|26075859|FG003|Overall Study|Protocol Violation|0|||
13158295|NCT02469298|26075856|FG000|Overall Study|Lost to Follow-up|1|||
13158296|NCT02469298|26075857|FG001|Overall Study|Lost to Follow-up|0|||
13158297|NCT02469298|26075858|FG002|Overall Study|Lost to Follow-up|1|||
13158298|NCT02469298|26075859|FG003|Overall Study|Lost to Follow-up|0|||
13158299|NCT02469298|26075856|FG000|Overall Study|Physician Decision|0|||
13158300|NCT02469298|26075857|FG001|Overall Study|Physician Decision|0|||
13158301|NCT02469298|26075858|FG002|Overall Study|Physician Decision|0|||
13158302|NCT02469298|26075859|FG003|Overall Study|Physician Decision|1|||
13158303|NCT02469298|26075856|FG000|Overall Study|Withdrawal by Subject|0|||
13158304|NCT02469298|26075857|FG001|Overall Study|Withdrawal by Subject|0|||
13158305|NCT02469298|26075858|FG002|Overall Study|Withdrawal by Subject|0|||
13158306|NCT02469298|26075859|FG003|Overall Study|Withdrawal by Subject|1|||
13158307|NCT02469246|26075896|FG000|Double-Blind Phase|Randomized and Never Treated|5|||
13158308|NCT02469246|26075897|FG001|Double-Blind Phase|Randomized and Never Treated|6|||
13158309|NCT02469246|26075896|FG000|Double-Blind Phase|Adverse Event|12|||
13158310|NCT02469246|26075897|FG001|Double-Blind Phase|Adverse Event|9|||
13158311|NCT02469246|26075896|FG000|Double-Blind Phase|Death|2|||
13158312|NCT02469246|26075897|FG001|Double-Blind Phase|Death|0|||
13158313|NCT02469246|26075896|FG000|Double-Blind Phase|Lack of Efficacy|2|||
13158314|NCT02469246|26075897|FG001|Double-Blind Phase|Lack of Efficacy|1|||
13158315|NCT02469246|26075896|FG000|Double-Blind Phase|Investigator's Discretion|8|||
13158316|NCT02469246|26075897|FG001|Double-Blind Phase|Investigator's Discretion|8|||
13158317|NCT02469246|26075896|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
13158318|NCT02469246|26075897|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
13158319|NCT02469246|26075896|FG000|Double-Blind Phase|Protocol Violation|1|||
13158320|NCT02469246|26075897|FG001|Double-Blind Phase|Protocol Violation|1|||
13158321|NCT02469246|26075896|FG000|Double-Blind Phase|Withdrew Consent|25|||
13158322|NCT02469246|26075897|FG001|Double-Blind Phase|Withdrew Consent|25|||
13158323|NCT02469246|26075896|FG000|Double-Blind Phase|Lost to Follow-up|9|||
13158324|NCT02469246|26075897|FG001|Double-Blind Phase|Lost to Follow-up|5|||
13158325|NCT02469168|26075912|FG000|Overall Study|Trial closed|1|||
13158326|NCT02469168|26075913|FG001|Overall Study|Trial closed|0|||
13158327|NCT02469090|26075946|FG000|Period 1: Dose Titration Phase|Adverse Event|12|||
13158328|NCT02469090|26075947|FG001|Period 1: Dose Titration Phase|Adverse Event|0|||
13158329|NCT02469090|26075948|FG002|Period 1: Dose Titration Phase|Adverse Event|0|||
13158330|NCT02469090|26075946|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8|||
13158331|NCT02469090|26075947|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
13158332|NCT02469090|26075948|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
13158333|NCT02469090|26075946|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1|||
13158334|NCT02469090|26075947|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
13158335|NCT02469090|26075948|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
13158336|NCT02469090|26075946|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11|||
13158337|NCT02469090|26075947|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
13158338|NCT02469090|26075948|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
13158339|NCT02469090|26075946|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0|||
13158340|NCT02469090|26075947|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5|||
13158341|NCT02469090|26075948|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15|||
13158342|NCT02469090|26075946|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0|||
13158343|NCT02469090|26075947|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3|||
13158344|NCT02469090|26075948|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4|||
13158345|NCT02469090|26075946|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
13158346|NCT02469090|26075947|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1|||
13158347|NCT02469090|26075948|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
13158348|NCT02469090|26075946|FG000|Period 2: Maintenance Treatment Phase|Death|0|||
13158349|NCT02469090|26075947|FG001|Period 2: Maintenance Treatment Phase|Death|0|||
13158350|NCT02469090|26075948|FG002|Period 2: Maintenance Treatment Phase|Death|1|||
13158351|NCT02469077|26075985|FG000|Post Randomization/Intervention Period|Scheduling issues|3|||
13158352|NCT02469077|26075986|FG001|Post Randomization/Intervention Period|Scheduling issues|2|||
13158353|NCT02469077|26075985|FG000|Post Randomization/Intervention Period|Relocated|1|||
13158354|NCT02469077|26075986|FG001|Post Randomization/Intervention Period|Relocated|1|||
13158355|NCT02469077|26075985|FG000|Post Randomization/Intervention Period|Conflicting health issues|0|||
13158356|NCT02469077|26075986|FG001|Post Randomization/Intervention Period|Conflicting health issues|1|||
13158357|NCT02469077|26075985|FG000|Post Intervention /Followup|Withdrawal by Subject|2|||
13158358|NCT02469077|26075986|FG001|Post Intervention /Followup|Withdrawal by Subject|1|||
13158359|NCT02469038|26076011|FG000|Overall Study|Physician Decision|4|||
13158360|NCT02469038|26076012|FG001|Overall Study|Physician Decision|5|||
13158361|NCT02468934|26076033|FG000|Overall Study|Withdrawal by Subject|4|||
13158362|NCT02468934|26076033|FG000|Overall Study|Screen Failure|3|||
13158363|NCT02468778|26076051|FG000|Overall Study|Death|2|||
13158364|NCT02468778|26076052|FG001|Overall Study|Death|1|||
13158365|NCT02468778|26076053|FG002|Overall Study|Death|0|||
13158366|NCT02468778|26076051|FG000|Overall Study|Lost to Follow-up|1|||
13158367|NCT02468778|26076052|FG001|Overall Study|Lost to Follow-up|2|||
13158368|NCT02468778|26076053|FG002|Overall Study|Lost to Follow-up|2|||
13158369|NCT02468778|26076051|FG000|Overall Study|Withdrawal by Subject|0|||
13158370|NCT02468778|26076052|FG001|Overall Study|Withdrawal by Subject|1|||
13158371|NCT02468778|26076053|FG002|Overall Study|Withdrawal by Subject|1|||
13158372|NCT02468674|26076137|FG000|Overall Study|Adverse Event|0|||
13158373|NCT02468674|26076138|FG001|Overall Study|Adverse Event|0|||
13158374|NCT02468674|26076139|FG002|Overall Study|Adverse Event|0|||
13158375|NCT02468674|26076140|FG003|Overall Study|Adverse Event|1|||
13158376|NCT02468674|26076141|FG004|Overall Study|Adverse Event|0|||
13158377|NCT02468674|26076142|FG005|Overall Study|Adverse Event|1|||
13158378|NCT02468674|26076143|FG006|Overall Study|Adverse Event|0|||
13158379|NCT02468674|26076144|FG007|Overall Study|Adverse Event|0|||
13158380|NCT02468674|26076145|FG008|Overall Study|Adverse Event|0|||
13158381|NCT02468674|26076137|FG000|Overall Study|Lost to Follow-up|1|||
13158382|NCT02468674|26076138|FG001|Overall Study|Lost to Follow-up|0|||
13158383|NCT02468674|26076139|FG002|Overall Study|Lost to Follow-up|0|||
13158384|NCT02468674|26076140|FG003|Overall Study|Lost to Follow-up|0|||
13158385|NCT02468674|26076141|FG004|Overall Study|Lost to Follow-up|0|||
13158386|NCT02468674|26076142|FG005|Overall Study|Lost to Follow-up|0|||
13158387|NCT02468674|26076143|FG006|Overall Study|Lost to Follow-up|0|||
13158388|NCT02468674|26076144|FG007|Overall Study|Lost to Follow-up|1|||
13158389|NCT02468674|26076145|FG008|Overall Study|Lost to Follow-up|1|||
13158390|NCT02468674|26076137|FG000|Overall Study|Physician Decision|0|||
13158391|NCT02468674|26076138|FG001|Overall Study|Physician Decision|0|||
13158392|NCT02468674|26076139|FG002|Overall Study|Physician Decision|0|||
13158393|NCT02468674|26076140|FG003|Overall Study|Physician Decision|0|||
13158394|NCT02468674|26076141|FG004|Overall Study|Physician Decision|0|||
13158395|NCT02468674|26076142|FG005|Overall Study|Physician Decision|0|||
13158396|NCT02468674|26076143|FG006|Overall Study|Physician Decision|1|||
13158397|NCT02468674|26076144|FG007|Overall Study|Physician Decision|0|||
13158398|NCT02468674|26076145|FG008|Overall Study|Physician Decision|0|||
13158399|NCT02468674|26076137|FG000|Overall Study|Patient/Guardian Decision|0|||
13158400|NCT02468674|26076138|FG001|Overall Study|Patient/Guardian Decision|0|||
13158401|NCT02468674|26076139|FG002|Overall Study|Patient/Guardian Decision|0|||
13158402|NCT02468674|26076140|FG003|Overall Study|Patient/Guardian Decision|0|||
13158403|NCT02468674|26076141|FG004|Overall Study|Patient/Guardian Decision|1|||
13158404|NCT02468674|26076142|FG005|Overall Study|Patient/Guardian Decision|0|||
13158405|NCT02468674|26076143|FG006|Overall Study|Patient/Guardian Decision|0|||
13158406|NCT02468674|26076144|FG007|Overall Study|Patient/Guardian Decision|2|||
13158407|NCT02468674|26076145|FG008|Overall Study|Patient/Guardian Decision|1|||
13158408|NCT02468674|26076137|FG000|Overall Study|Protocol Deviation|0|||
13158409|NCT02468674|26076138|FG001|Overall Study|Protocol Deviation|0|||
13158410|NCT02468674|26076139|FG002|Overall Study|Protocol Deviation|0|||
13158411|NCT02468674|26076140|FG003|Overall Study|Protocol Deviation|0|||
13158412|NCT02468674|26076141|FG004|Overall Study|Protocol Deviation|0|||
13158413|NCT02468674|26076142|FG005|Overall Study|Protocol Deviation|0|||
13158414|NCT02468674|26076143|FG006|Overall Study|Protocol Deviation|0|||
13158415|NCT02468674|26076144|FG007|Overall Study|Protocol Deviation|1|||
13158416|NCT02468674|26076145|FG008|Overall Study|Protocol Deviation|1|||
13158417|NCT02468648|26076154|FG000|Overall Study|Death|1|||
13158418|NCT02468557|26076177|FG000|Overall Study|Adverse Event|1|||
13158419|NCT02468557|26076177|FG000|Overall Study|Death|1|||
13158420|NCT02468557|26076177|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10|||
13158421|NCT02468557|26076177|FG000|Overall Study|All Enrolled but Never Dosed|4|||
13158422|NCT02468414|26076190|FG000|Overall Study|Early Study Termination by Sponsor|1|||
13158423|NCT02468414|26076191|FG001|Overall Study|Early Study Termination by Sponsor|0|||
13158424|NCT02468414|26076190|FG000|Overall Study|Poor in-vitro secreting TARGTs|1|||
13158425|NCT02468414|26076191|FG001|Overall Study|Poor in-vitro secreting TARGTs|0|||
13158426|NCT02468414|26076190|FG000|Overall Study|Screen Failure|1|||
13158427|NCT02468414|26076191|FG001|Overall Study|Screen Failure|0|||
13158428|NCT02468193|26076285|FG000|Overall Study|Adverse Event|4|||
13158429|NCT02468193|26076285|FG000|Overall Study|Subject/ Guardian decision|2|||
13158430|NCT02467192|26076295|FG000|Overall Study|Death|1|||
13158431|NCT02467192|26076295|FG000|Overall Study|revealed to have pneumonia before|2|||
13158432|NCT02466659|26076310|FG000|Overall Study|Lost to Follow-up|5|||
13158433|NCT02466659|26076311|FG001|Overall Study|Lost to Follow-up|2|||
13158434|NCT02466555|26076320|FG000|Overall Study|Lost to Follow-up|2|||
13158435|NCT02466516|26076353|FG000|Overall Study|Adverse Event|1|||
13158436|NCT02466516|26076354|FG001|Overall Study|Adverse Event|1|||
13158437|NCT02466516|26076355|FG002|Overall Study|Adverse Event|0|||
13158438|NCT02466516|26076356|FG003|Overall Study|Adverse Event|0|||
13158439|NCT02466516|26076357|FG004|Overall Study|Adverse Event|0|||
13158440|NCT02466516|26076353|FG000|Overall Study|Withdrew Consent|1|||
13158441|NCT02466516|26076354|FG001|Overall Study|Withdrew Consent|0|||
13158442|NCT02466516|26076355|FG002|Overall Study|Withdrew Consent|0|||
13158443|NCT02466516|26076356|FG003|Overall Study|Withdrew Consent|0|||
13158444|NCT02466516|26076357|FG004|Overall Study|Withdrew Consent|0|||
13158445|NCT02466516|26076353|FG000|Overall Study|Lost to Follow-up|2|||
13158446|NCT02466516|26076354|FG001|Overall Study|Lost to Follow-up|0|||
13158447|NCT02466516|26076355|FG002|Overall Study|Lost to Follow-up|1|||
13158448|NCT02466516|26076356|FG003|Overall Study|Lost to Follow-up|0|||
13158449|NCT02466516|26076357|FG004|Overall Study|Lost to Follow-up|0|||
13158450|NCT02466425|26076372|FG000|Overall Study|Adverse Event|3|||
13158451|NCT02466425|26076373|FG001|Overall Study|Adverse Event|11|||
13158452|NCT02466425|26076372|FG000|Overall Study|Lack of Efficacy|4|||
13158453|NCT02466425|26076373|FG001|Overall Study|Lack of Efficacy|1|||
13158454|NCT02466425|26076372|FG000|Overall Study|Lost to Follow-up|3|||
13158455|NCT02466425|26076373|FG001|Overall Study|Lost to Follow-up|0|||
13158456|NCT02466425|26076372|FG000|Overall Study|Protocol Violation|1|||
13158457|NCT02466425|26076373|FG001|Overall Study|Protocol Violation|0|||
13158458|NCT02466425|26076372|FG000|Overall Study|Withdrawal by Subject|0|||
13158459|NCT02466425|26076373|FG001|Overall Study|Withdrawal by Subject|1|||
13158460|NCT02466425|26076372|FG000|Overall Study|Other|1|||
13158461|NCT02466425|26076373|FG001|Overall Study|Other|3|||
13158462|NCT02466425|26076372|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
13158463|NCT02466425|26076373|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
13158464|NCT02466399|26076386|FG000|Overall Study|Adverse Event|1|||
13158465|NCT02466399|26076387|FG001|Overall Study|Adverse Event|0|||
13158466|NCT02466399|26076386|FG000|Overall Study|Early exit due to family emergency|1|||
13158467|NCT02466399|26076387|FG001|Overall Study|Early exit due to family emergency|0|||
13158468|NCT02466386|26076401|FG000|Overall Study|Adverse Event|5|||
13158469|NCT02466386|26076401|FG000|Overall Study|Protocol Violation|2|||
13158470|NCT02466386|26076401|FG000|Overall Study|Withdrawal by Subject|14|||
13158471|NCT02466386|26076401|FG000|Overall Study|Lost to Follow-up|5|||
13158472|NCT02466386|26076401|FG000|Overall Study|Lack of Efficacy|8|||
13158473|NCT02466386|26076401|FG000|Overall Study|Other|10|||
13158474|NCT02465931|26076414|FG000|Overall Study|Lost to Follow-up|9|||
13158475|NCT02465931|26076415|FG001|Overall Study|Lost to Follow-up|11|||
13158476|NCT02465931|26076414|FG000|Overall Study|Protocol Violation|1|||
13158477|NCT02465931|26076415|FG001|Overall Study|Protocol Violation|0|||
13158478|NCT02465931|26076414|FG000|Overall Study|Withdrawal by Subject|1|||
13158479|NCT02465931|26076415|FG001|Overall Study|Withdrawal by Subject|0|||
13158480|NCT02465866|26076490|FG000|Period 3|Withdrawal by Subject|0|||
13158481|NCT02465866|26076491|FG001|Period 3|Withdrawal by Subject|1|||
13158482|NCT02465866|26076492|FG002|Period 3|Withdrawal by Subject|0|||
13158483|NCT02465866|26076493|FG003|Period 3|Withdrawal by Subject|0|||
13158484|NCT02465567|26076536|FG000|Overall Study|Adverse Event|118|||
13158485|NCT02465567|26076537|FG001|Overall Study|Adverse Event|113|||
13158486|NCT02465567|26076538|FG002|Overall Study|Adverse Event|147|||
13158487|NCT02465567|26076539|FG003|Overall Study|Adverse Event|138|||
13158488|NCT02465567|26076536|FG000|Overall Study|Lack of Efficacy|103|||
13158489|NCT02465567|26076537|FG001|Overall Study|Lack of Efficacy|102|||
13158490|NCT02465567|26076538|FG002|Overall Study|Lack of Efficacy|171|||
13158491|NCT02465567|26076539|FG003|Overall Study|Lack of Efficacy|135|||
13158492|NCT02465567|26076536|FG000|Overall Study|Withdrawal by Subject|104|||
13158493|NCT02465567|26076537|FG001|Overall Study|Withdrawal by Subject|94|||
13158494|NCT02465567|26076538|FG002|Overall Study|Withdrawal by Subject|123|||
13158495|NCT02465567|26076539|FG003|Overall Study|Withdrawal by Subject|130|||
13158496|NCT02465567|26076536|FG000|Overall Study|Physician Decision|23|||
13158497|NCT02465567|26076537|FG001|Overall Study|Physician Decision|33|||
13158498|NCT02465567|26076538|FG002|Overall Study|Physician Decision|38|||
13158499|NCT02465567|26076539|FG003|Overall Study|Physician Decision|28|||
13158500|NCT02465567|26076536|FG000|Overall Study|Major Protocol Deviation|24|||
13158501|NCT02465567|26076537|FG001|Overall Study|Major Protocol Deviation|26|||
13158502|NCT02465567|26076538|FG002|Overall Study|Major Protocol Deviation|22|||
13158503|NCT02465567|26076539|FG003|Overall Study|Major Protocol Deviation|25|||
13158504|NCT02465567|26076536|FG000|Overall Study|Lost to Follow-up|25|||
13158505|NCT02465567|26076537|FG001|Overall Study|Lost to Follow-up|21|||
13158506|NCT02465567|26076538|FG002|Overall Study|Lost to Follow-up|19|||
13158507|NCT02465567|26076539|FG003|Overall Study|Lost to Follow-up|15|||
13158508|NCT02465567|26076536|FG000|Overall Study|Protocol Specified Criteria|20|||
13158509|NCT02465567|26076537|FG001|Overall Study|Protocol Specified Criteria|10|||
13158510|NCT02465567|26076538|FG002|Overall Study|Protocol Specified Criteria|9|||
13158511|NCT02465567|26076539|FG003|Overall Study|Protocol Specified Criteria|12|||
13158512|NCT02465567|26076536|FG000|Overall Study|Administrative Reasons|12|||
13158513|NCT02465567|26076537|FG001|Overall Study|Administrative Reasons|9|||
13158514|NCT02465567|26076538|FG002|Overall Study|Administrative Reasons|11|||
13158515|NCT02465567|26076539|FG003|Overall Study|Administrative Reasons|5|||
13158516|NCT02465567|26076536|FG000|Overall Study|Randomized but not treated|1|||
13158517|NCT02465567|26076537|FG001|Overall Study|Randomized but not treated|5|||
13158518|NCT02465567|26076538|FG002|Overall Study|Randomized but not treated|4|||
13158519|NCT02465567|26076539|FG003|Overall Study|Randomized but not treated|5|||
13158520|NCT02465567|26076536|FG000|Overall Study|enrolled in >1 studies|18|||
13158521|NCT02465567|26076537|FG001|Overall Study|enrolled in >1 studies|11|||
13158522|NCT02465567|26076538|FG002|Overall Study|enrolled in >1 studies|19|||
13158523|NCT02465567|26076539|FG003|Overall Study|enrolled in >1 studies|15|||
13158524|NCT02465567|26076536|FG000|Overall Study|missing PI Signature|1|||
13158525|NCT02465567|26076537|FG001|Overall Study|missing PI Signature|0|||
13158526|NCT02465567|26076538|FG002|Overall Study|missing PI Signature|0|||
13158527|NCT02465567|26076539|FG003|Overall Study|missing PI Signature|0|||
13158528|NCT02465528|26076583|FG000|Overall Study|Progressive disease|0|||
13158529|NCT02465528|26076584|FG001|Overall Study|Progressive disease|2|||
13158530|NCT02465528|26076585|FG002|Overall Study|Progressive disease|9|||
13158531|NCT02465528|26076586|FG003|Overall Study|Progressive disease|4|||
13158532|NCT02465528|26076583|FG000|Overall Study|Study terminated by sponsor|1|||
13158533|NCT02465528|26076584|FG001|Overall Study|Study terminated by sponsor|2|||
13158534|NCT02465528|26076585|FG002|Overall Study|Study terminated by sponsor|0|||
13158535|NCT02465528|26076586|FG003|Overall Study|Study terminated by sponsor|0|||
13158536|NCT02465528|26076583|FG000|Overall Study|Withdrawal by Subject|0|||
13158537|NCT02465528|26076584|FG001|Overall Study|Withdrawal by Subject|0|||
13158538|NCT02465528|26076585|FG002|Overall Study|Withdrawal by Subject|2|||
13158539|NCT02465528|26076586|FG003|Overall Study|Withdrawal by Subject|0|||
13158540|NCT02465528|26076583|FG000|Overall Study|Adverse Event|0|||
13158541|NCT02465528|26076584|FG001|Overall Study|Adverse Event|0|||
13158542|NCT02465528|26076585|FG002|Overall Study|Adverse Event|0|||
13158543|NCT02465528|26076586|FG003|Overall Study|Adverse Event|1|||
13158544|NCT02465528|26076583|FG000|Overall Study|Physician Decision|0|||
13158545|NCT02465528|26076584|FG001|Overall Study|Physician Decision|0|||
13158546|NCT02465528|26076585|FG002|Overall Study|Physician Decision|1|||
13158547|NCT02465528|26076586|FG003|Overall Study|Physician Decision|0|||
13158548|NCT02465515|26076639|FG000|Overall Study|Investigator site closed|4|||
13158549|NCT02465515|26076640|FG001|Overall Study|Investigator site closed|5|||
13158550|NCT02465515|26076639|FG000|Overall Study|Withdrawal by Subject|74|||
13158551|NCT02465515|26076640|FG001|Overall Study|Withdrawal by Subject|43|||
13158552|NCT02465515|26076639|FG000|Overall Study|Physician Decision|8|||
13158553|NCT02465515|26076640|FG001|Overall Study|Physician Decision|12|||
13158554|NCT02465515|26076639|FG000|Overall Study|Lost to Follow-up|68|||
13158555|NCT02465515|26076640|FG001|Overall Study|Lost to Follow-up|51|||
13158556|NCT02465489|26076669|FG000|Overall Study|Adverse Event|5|||
13158557|NCT02465463|26076692|FG000|Overall Study|Lost to Follow-up|2|||
13158558|NCT02465463|26076693|FG001|Overall Study|Lost to Follow-up|1|||
13158559|NCT02465463|26076692|FG000|Overall Study|Death|1|||
13158560|NCT02465463|26076693|FG001|Overall Study|Death|0|||
13158561|NCT02465463|26076692|FG000|Overall Study|Protocol Violation|1|||
13158562|NCT02465463|26076693|FG001|Overall Study|Protocol Violation|0|||
13158563|NCT02465437|26076724|FG000|Overall Study|Physician Decision|0|||
13158564|NCT02465437|26076725|FG001|Overall Study|Physician Decision|0|||
13158565|NCT02465437|26076726|FG002|Overall Study|Physician Decision|1|||
13158566|NCT02465437|26076727|FG003|Overall Study|Physician Decision|0|||
13158567|NCT02465437|26076724|FG000|Overall Study|Withdrawal by Subject|1|||
13158568|NCT02465437|26076725|FG001|Overall Study|Withdrawal by Subject|0|||
13158569|NCT02465437|26076726|FG002|Overall Study|Withdrawal by Subject|0|||
13158570|NCT02465437|26076727|FG003|Overall Study|Withdrawal by Subject|1|||
13158571|NCT02465437|26076724|FG000|Overall Study|Adverse Event|0|||
13158572|NCT02465437|26076725|FG001|Overall Study|Adverse Event|1|||
13158573|NCT02465437|26076726|FG002|Overall Study|Adverse Event|0|||
13158574|NCT02465437|26076727|FG003|Overall Study|Adverse Event|0|||
13158575|NCT02465203|26076748|FG000|Overall Study|Protocol Violation|1|||
13158576|NCT02465203|26076749|FG001|Overall Study|Protocol Violation|1|||
13158577|NCT02465203|26076750|FG002|Overall Study|Protocol Violation|1|||
13158578|NCT02465203|26076748|FG000|Overall Study|Study terminated by sponsor|50|||
13158579|NCT02465203|26076749|FG001|Overall Study|Study terminated by sponsor|34|||
13158580|NCT02465203|26076750|FG002|Overall Study|Study terminated by sponsor|11|||
13158581|NCT02465203|26076748|FG000|Overall Study|New therapy for study indication|4|||
13158582|NCT02465203|26076749|FG001|Overall Study|New therapy for study indication|0|||
13158583|NCT02465203|26076750|FG002|Overall Study|New therapy for study indication|0|||
13158584|NCT02465203|26076748|FG000|Overall Study|Patient/guardian decision|1|||
13158585|NCT02465203|26076749|FG001|Overall Study|Patient/guardian decision|1|||
13158586|NCT02465203|26076750|FG002|Overall Study|Patient/guardian decision|1|||
13158587|NCT02465034|26076789|FG000|Overall Study|Withdrawal by Subject|1|||
13158588|NCT02465034|26076790|FG001|Overall Study|Withdrawal by Subject|1|||
13158589|NCT02465034|26076789|FG000|Overall Study|Screen fail|2|||
13158590|NCT02465034|26076790|FG001|Overall Study|Screen fail|0|||
13158591|NCT02465034|26076789|FG000|Overall Study|Could not be scheduled for study visit|0|||
13158592|NCT02465034|26076790|FG001|Overall Study|Could not be scheduled for study visit|5|||
13158593|NCT02464410|26076821|FG000|Overall Study|Death|3|||
13158594|NCT02464410|26076822|FG001|Overall Study|Death|4|||
13158595|NCT02464410|26076821|FG000|Overall Study|Lost to Follow-up|7|||
13158596|NCT02464410|26076822|FG001|Overall Study|Lost to Follow-up|9|||
13158597|NCT02464410|26076821|FG000|Overall Study|Withdrawal by Subject|12|||
13158598|NCT02464410|26076822|FG001|Overall Study|Withdrawal by Subject|3|||
13158599|NCT02464059|26076830|FG000|Overall Study|Lost to Follow-up|6|||
13158600|NCT02463409|26076838|FG000|Overall Study|Withdrawal by Subject|1|||
13158601|NCT02463409|26076838|FG000|Overall Study|Screen failure|1|||
13158602|NCT02463357|26076886|FG000|Overall Study|Withdrawal by Subject|1|||
13158603|NCT02463357|26076887|FG001|Overall Study|Withdrawal by Subject|0|||
13158604|NCT02463357|26076888|FG002|Overall Study|Withdrawal by Subject|0|||
13158605|NCT02463357|26076889|FG003|Overall Study|Withdrawal by Subject|0|||
13158606|NCT02463357|26076890|FG004|Overall Study|Withdrawal by Subject|0|||
13158607|NCT02463357|26076886|FG000|Overall Study|Withdrawal by Subject|0|||
13158608|NCT02463357|26076887|FG001|Overall Study|Withdrawal by Subject|0|||
13158609|NCT02463357|26076888|FG002|Overall Study|Withdrawal by Subject|0|||
13158610|NCT02463357|26076889|FG003|Overall Study|Withdrawal by Subject|0|||
13158611|NCT02463357|26076890|FG004|Overall Study|Withdrawal by Subject|1|||
13158612|NCT02463331|26076905|FG000|Overall Study|Adverse Event|4|||
13158613|NCT02463331|26076906|FG001|Overall Study|Adverse Event|2|||
13158614|NCT02463331|26076905|FG000|Overall Study|Lost to Follow-up|1|||
13158615|NCT02463331|26076906|FG001|Overall Study|Lost to Follow-up|1|||
13158616|NCT02463331|26076905|FG000|Overall Study|Pregnancy|2|||
13158617|NCT02463331|26076906|FG001|Overall Study|Pregnancy|3|||
13158618|NCT02463331|26076905|FG000|Overall Study|Lack of Efficacy|6|||
13158619|NCT02463331|26076906|FG001|Overall Study|Lack of Efficacy|0|||
13158620|NCT02463331|26076905|FG000|Overall Study|Physician Decision|3|||
13222770|NCT01803282|26286894|FG011|Overall Study|Non-Compliance with Study Drug|0|||
13158621|NCT02463331|26076906|FG001|Overall Study|Physician Decision|0|||
13158622|NCT02463097|26076914|FG000|Overall Study|Withdrawal by Subject|1|||
13158623|NCT02463071|26076950|FG000|Overall Study|Adverse Event|3|||
13158624|NCT02463071|26076951|FG001|Overall Study|Adverse Event|5|||
13158625|NCT02463071|26076952|FG002|Overall Study|Adverse Event|1|||
13158626|NCT02463071|26076950|FG000|Overall Study|Death|1|||
13158627|NCT02463071|26076951|FG001|Overall Study|Death|0|||
13158628|NCT02463071|26076952|FG002|Overall Study|Death|0|||
13158629|NCT02463071|26076950|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
13158630|NCT02463071|26076951|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
13158631|NCT02463071|26076952|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
13158632|NCT02463071|26076950|FG000|Overall Study|Reason not specified|7|||
13158633|NCT02463071|26076951|FG001|Overall Study|Reason not specified|9|||
13158634|NCT02463071|26076952|FG002|Overall Study|Reason not specified|4|||
13158635|NCT02463071|26076950|FG000|Overall Study|Protocol Violation|0|||
13158636|NCT02463071|26076951|FG001|Overall Study|Protocol Violation|2|||
13158637|NCT02463071|26076952|FG002|Overall Study|Protocol Violation|0|||
13158638|NCT02463071|26076950|FG000|Overall Study|Lost to Follow-up|0|||
13158639|NCT02463071|26076951|FG001|Overall Study|Lost to Follow-up|0|||
13158640|NCT02463071|26076952|FG002|Overall Study|Lost to Follow-up|1|||
13158641|NCT02463032|26076977|FG000|Overall Study|Lack of Efficacy|61|||
13158642|NCT02463032|26076978|FG001|Overall Study|Lack of Efficacy|50|||
13158643|NCT02463032|26076977|FG000|Overall Study|Death|8|||
13158644|NCT02463032|26076978|FG001|Overall Study|Death|8|||
13158645|NCT02463032|26076977|FG000|Overall Study|Adverse Event|2|||
13158646|NCT02463032|26076978|FG001|Overall Study|Adverse Event|6|||
13158647|NCT02462928|26077008|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
13158648|NCT02462928|26077009|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
13158649|NCT02462928|26077010|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2|||
13158650|NCT02462928|26077008|FG000|Overall Study|Adverse Event|47|||
13158651|NCT02462928|26077009|FG001|Overall Study|Adverse Event|51|||
13158652|NCT02462928|26077010|FG002|Overall Study|Adverse Event|25|||
13158653|NCT02462928|26077008|FG000|Overall Study|Lack of Efficacy|3|||
13158654|NCT02462928|26077009|FG001|Overall Study|Lack of Efficacy|8|||
13158655|NCT02462928|26077010|FG002|Overall Study|Lack of Efficacy|3|||
13158656|NCT02462928|26077008|FG000|Overall Study|Lost to Follow-up|4|||
13158657|NCT02462928|26077009|FG001|Overall Study|Lost to Follow-up|4|||
13158658|NCT02462928|26077010|FG002|Overall Study|Lost to Follow-up|1|||
13158659|NCT02462928|26077008|FG000|Overall Study|Withdrawal by Patient|31|||
13158660|NCT02462928|26077009|FG001|Overall Study|Withdrawal by Patient|21|||
13158661|NCT02462928|26077010|FG002|Overall Study|Withdrawal by Patient|21|||
13158662|NCT02462928|26077008|FG000|Overall Study|Protocol Violation|0|||
13158663|NCT02462928|26077009|FG001|Overall Study|Protocol Violation|1|||
13158664|NCT02462928|26077010|FG002|Overall Study|Protocol Violation|0|||
13158665|NCT02462928|26077008|FG000|Overall Study|Reason not Specified|4|||
13158666|NCT02462928|26077009|FG001|Overall Study|Reason not Specified|6|||
13158667|NCT02462928|26077010|FG002|Overall Study|Reason not Specified|5|||
13158668|NCT02462876|26077026|FG000|Overall Study|Death|3|||
13158669|NCT02462876|26077026|FG000|Overall Study|Lost to Follow-up|7|||
13158670|NCT02462876|26077026|FG000|Overall Study|Surgical Bypass|9|||
13158671|NCT02462876|26077026|FG000|Overall Study|Amputation Above the Metatarsals|1|||
13158672|NCT02462876|26077026|FG000|Overall Study|36 months follow-up visit missed|1|||
13158673|NCT02462876|26077026|FG000|Overall Study|Patient did not come back since 4 months follow-up|1|||
13158674|NCT02462876|26077026|FG000|Overall Study|Patient did not come back to the vascular department|1|||
13158675|NCT02462876|26077026|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1|||
13158676|NCT02462876|26077026|FG000|Overall Study|Patient refused to come back|1|||
13158677|NCT02462876|26077026|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1|||
13158678|NCT02462876|26077026|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1|||
13158679|NCT02462759|26077082|FG000|Part 1: Double Blind|Death|1|||
13158680|NCT02462759|26077083|FG001|Part 1: Double Blind|Death|0|||
13158681|NCT02462759|26077084|FG002|Part 1: Double Blind|Death|0|||
13158682|NCT02462720|26077097|FG000|Part 2|Withdrawal by Subject|1|||
13158683|NCT02462720|26077098|FG001|Part 2|Withdrawal by Subject|0|||
13158684|NCT02462720|26077097|FG000|Part 2|Protocol Violation|0|||
13158685|NCT02462720|26077098|FG001|Part 2|Protocol Violation|1|||
13158686|NCT02462603|26077116|FG000|Overall Study|Investigator Decision|1|||
13158687|NCT02462603|26077116|FG000|Overall Study|Non-Compliance|1|||
13158688|NCT02462603|26077116|FG000|Overall Study|Withdrawal by Subject|2|||
13158689|NCT02462486|26077146|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
13158690|NCT02462486|26077147|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
13158691|NCT02462486|26077148|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3|||
13158692|NCT02462486|26077146|FG000|Overall Study|Adverse Event|53|||
13158693|NCT02462486|26077147|FG001|Overall Study|Adverse Event|48|||
13158694|NCT02462486|26077148|FG002|Overall Study|Adverse Event|21|||
13158695|NCT02462486|26077146|FG000|Overall Study|Lack of Efficacy|6|||
13158696|NCT02462486|26077147|FG001|Overall Study|Lack of Efficacy|12|||
13158697|NCT02462486|26077148|FG002|Overall Study|Lack of Efficacy|3|||
13158698|NCT02462486|26077146|FG000|Overall Study|Lost to Follow-up|3|||
13158699|NCT02462486|26077147|FG001|Overall Study|Lost to Follow-up|4|||
13158700|NCT02462486|26077148|FG002|Overall Study|Lost to Follow-up|2|||
13158701|NCT02462486|26077146|FG000|Overall Study|Withdrawal by Subject|25|||
13158702|NCT02462486|26077147|FG001|Overall Study|Withdrawal by Subject|22|||
13158703|NCT02462486|26077148|FG002|Overall Study|Withdrawal by Subject|19|||
13158704|NCT02462486|26077146|FG000|Overall Study|Protocol Violation|3|||
13158705|NCT02462486|26077147|FG001|Overall Study|Protocol Violation|1|||
13158706|NCT02462486|26077148|FG002|Overall Study|Protocol Violation|1|||
13158707|NCT02462486|26077146|FG000|Overall Study|Reason not Specified|3|||
13158708|NCT02462486|26077147|FG001|Overall Study|Reason not Specified|4|||
13158709|NCT02462486|26077148|FG002|Overall Study|Reason not Specified|3|||
13158710|NCT02462473|26077161|FG000|Overall Study|Death|1|||
13158711|NCT02462473|26077161|FG000|Overall Study|Other|3|||
13158712|NCT02462083|26077167|FG000|Overall Study|Sponsor request|39|||
13158713|NCT02462083|26077167|FG000|Overall Study|Withdrawal by Subject|87|||
13158714|NCT02462083|26077167|FG000|Overall Study|Lost to Follow-up|41|||
13158715|NCT02462083|26077167|FG000|Overall Study|Lack of Efficacy|151|||
13158716|NCT02462083|26077167|FG000|Overall Study|Pregnancy|1|||
13158717|NCT02462083|26077167|FG000|Overall Study|Protocol Violation|6|||
13158718|NCT02462083|26077167|FG000|Overall Study|Adverse Event|33|||
13158719|NCT02462083|26077167|FG000|Overall Study|Worsening condition|16|||
13158720|NCT02462083|26077167|FG000|Overall Study|Other than specified|45|||
13158721|NCT02462057|26077195|FG000|Overall Study|Left Vitality|32|||
13158722|NCT02462057|26077196|FG001|Overall Study|Left Vitality|27|||
13158723|NCT02462057|26077197|FG002|Overall Study|Left Vitality|23|||
13158724|NCT02462057|26077198|FG003|Overall Study|Left Vitality|35|||
13158725|NCT02462057|26077199|FG004|Overall Study|Left Vitality|33|||
13158726|NCT02462057|26077195|FG000|Overall Study|Joined HealthyFood Before Intervention|22|||
13158727|NCT02462057|26077196|FG001|Overall Study|Joined HealthyFood Before Intervention|13|||
13158728|NCT02462057|26077197|FG002|Overall Study|Joined HealthyFood Before Intervention|23|||
13158729|NCT02462057|26077198|FG003|Overall Study|Joined HealthyFood Before Intervention|16|||
13158730|NCT02462057|26077199|FG004|Overall Study|Joined HealthyFood Before Intervention|17|||
13158731|NCT02461758|26077236|FG000|Overall Study|Lost to Follow-up|0|||
13158732|NCT02461758|26077237|FG001|Overall Study|Lost to Follow-up|1|||
13158733|NCT02461758|26077238|FG002|Overall Study|Lost to Follow-up|1|||
13158734|NCT02461758|26077239|FG003|Overall Study|Lost to Follow-up|0|||
13158735|NCT02461745|26077254|FG000|Overall Study|Lack of Efficacy|9|||
13158736|NCT02461745|26077255|FG001|Overall Study|Lack of Efficacy|1|||
13158737|NCT02461745|26077254|FG000|Overall Study|Lost to Follow-up|2|||
13158738|NCT02461745|26077255|FG001|Overall Study|Lost to Follow-up|2|||
13158739|NCT02461745|26077254|FG000|Overall Study|Withdrawal by Subject|3|||
13158740|NCT02461745|26077255|FG001|Overall Study|Withdrawal by Subject|1|||
13158741|NCT02461628|26077276|FG000|Overall Study|Refused to complete survey|4|||
13158742|NCT02461628|26077277|FG001|Overall Study|Refused to complete survey|7|||
13158743|NCT02461589|26077360|FG000|Overall Study|Withdrawal by Subject|5|||
13158744|NCT02461589|26077361|FG001|Overall Study|Withdrawal by Subject|1|||
13158745|NCT02461589|26077362|FG002|Overall Study|Withdrawal by Subject|3|||
13158746|NCT02461589|26077363|FG003|Overall Study|Withdrawal by Subject|2|||
13158747|NCT02461589|26077364|FG004|Overall Study|Withdrawal by Subject|1|||
13158748|NCT02461589|26077365|FG005|Overall Study|Withdrawal by Subject|2|||
13158749|NCT02461589|26077366|FG006|Overall Study|Withdrawal by Subject|1|||
13158750|NCT02461589|26077367|FG007|Overall Study|Withdrawal by Subject|3|||
13158751|NCT02461589|26077368|FG008|Overall Study|Withdrawal by Subject|3|||
13158752|NCT02461589|26077369|FG009|Overall Study|Withdrawal by Subject|1|||
13158753|NCT02461589|26077360|FG000|Overall Study|Lost to Follow-up|0|||
13158754|NCT02461589|26077361|FG001|Overall Study|Lost to Follow-up|0|||
13158755|NCT02461589|26077362|FG002|Overall Study|Lost to Follow-up|2|||
13158756|NCT02461589|26077363|FG003|Overall Study|Lost to Follow-up|3|||
13158757|NCT02461589|26077364|FG004|Overall Study|Lost to Follow-up|1|||
13158758|NCT02461589|26077365|FG005|Overall Study|Lost to Follow-up|1|||
13158759|NCT02461589|26077366|FG006|Overall Study|Lost to Follow-up|3|||
13158760|NCT02461589|26077367|FG007|Overall Study|Lost to Follow-up|1|||
13158761|NCT02461589|26077368|FG008|Overall Study|Lost to Follow-up|3|||
13158762|NCT02461589|26077369|FG009|Overall Study|Lost to Follow-up|1|||
13158763|NCT02461589|26077360|FG000|Overall Study|Death|0|||
13158764|NCT02461589|26077361|FG001|Overall Study|Death|0|||
13158765|NCT02461589|26077362|FG002|Overall Study|Death|0|||
13158766|NCT02461589|26077363|FG003|Overall Study|Death|0|||
13158767|NCT02461589|26077364|FG004|Overall Study|Death|0|||
13158768|NCT02461589|26077365|FG005|Overall Study|Death|0|||
13158769|NCT02461589|26077366|FG006|Overall Study|Death|0|||
13158770|NCT02461589|26077367|FG007|Overall Study|Death|1|||
13158771|NCT02461589|26077368|FG008|Overall Study|Death|0|||
13158772|NCT02461589|26077369|FG009|Overall Study|Death|0|||
13158773|NCT02461589|26077360|FG000|Overall Study|Unclassified|0|||
13158774|NCT02461589|26077361|FG001|Overall Study|Unclassified|0|||
13158775|NCT02461589|26077362|FG002|Overall Study|Unclassified|0|||
13158776|NCT02461589|26077363|FG003|Overall Study|Unclassified|0|||
13158777|NCT02461589|26077364|FG004|Overall Study|Unclassified|0|||
13158778|NCT02461589|26077365|FG005|Overall Study|Unclassified|0|||
13158779|NCT02461589|26077366|FG006|Overall Study|Unclassified|1|||
13158780|NCT02461589|26077367|FG007|Overall Study|Unclassified|0|||
13158781|NCT02461589|26077368|FG008|Overall Study|Unclassified|0|||
13158782|NCT02461589|26077369|FG009|Overall Study|Unclassified|2|||
13158783|NCT02461589|26077360|FG000|Overall Study|Missing follow-up information|1|||
13158784|NCT02461589|26077361|FG001|Overall Study|Missing follow-up information|1|||
13158785|NCT02461589|26077362|FG002|Overall Study|Missing follow-up information|0|||
13158786|NCT02461589|26077363|FG003|Overall Study|Missing follow-up information|0|||
13158787|NCT02461589|26077364|FG004|Overall Study|Missing follow-up information|0|||
13158788|NCT02461589|26077365|FG005|Overall Study|Missing follow-up information|0|||
13158789|NCT02461589|26077366|FG006|Overall Study|Missing follow-up information|1|||
13158790|NCT02461589|26077367|FG007|Overall Study|Missing follow-up information|0|||
13158791|NCT02461589|26077368|FG008|Overall Study|Missing follow-up information|0|||
13158792|NCT02461589|26077369|FG009|Overall Study|Missing follow-up information|0|||
13158793|NCT02461589|26077360|FG000|Overall Study|Withdrawal from trial before exposure|0|||
13158794|NCT02461589|26077361|FG001|Overall Study|Withdrawal from trial before exposure|0|||
13158795|NCT02461589|26077362|FG002|Overall Study|Withdrawal from trial before exposure|0|||
13158796|NCT02461589|26077363|FG003|Overall Study|Withdrawal from trial before exposure|0|||
13158797|NCT02461589|26077364|FG004|Overall Study|Withdrawal from trial before exposure|0|||
13158798|NCT02461589|26077365|FG005|Overall Study|Withdrawal from trial before exposure|0|||
13158799|NCT02461589|26077366|FG006|Overall Study|Withdrawal from trial before exposure|0|||
13158800|NCT02461589|26077367|FG007|Overall Study|Withdrawal from trial before exposure|0|||
13158801|NCT02461589|26077368|FG008|Overall Study|Withdrawal from trial before exposure|0|||
13158802|NCT02461589|26077369|FG009|Overall Study|Withdrawal from trial before exposure|1|||
13158803|NCT02461290|26077378|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7|||
13158804|NCT02461290|26077378|FG000|Overall Study|Lost to Follow-up|3|||
13158805|NCT02461160|26077629|FG000|Overall Study|Lost to Follow-up|0|||
13158806|NCT02461160|26077630|FG001|Overall Study|Lost to Follow-up|0|||
13158807|NCT02461160|26077631|FG002|Overall Study|Lost to Follow-up|0|||
13158808|NCT02461160|26077632|FG003|Overall Study|Lost to Follow-up|0|||
13158809|NCT02461160|26077633|FG004|Overall Study|Lost to Follow-up|0|||
13158810|NCT02461160|26077634|FG005|Overall Study|Lost to Follow-up|0|||
13158811|NCT02461160|26077635|FG006|Overall Study|Lost to Follow-up|0|||
13158812|NCT02461160|26077636|FG007|Overall Study|Lost to Follow-up|1|||
13158813|NCT02461160|26077637|FG008|Overall Study|Lost to Follow-up|0|||
13158814|NCT02461160|26077638|FG009|Overall Study|Lost to Follow-up|0|||
13158815|NCT02461160|26077639|FG010|Overall Study|Lost to Follow-up|0|||
13158816|NCT02461160|26077640|FG011|Overall Study|Lost to Follow-up|0|||
13158817|NCT02461160|26077641|FG012|Overall Study|Lost to Follow-up|0|||
13158818|NCT02461134|26077649|FG000|Overall Study|Adverse Event|1|||
13158819|NCT02460991|26077670|FG000|Overall Study|Withdrawal by Subject|0|||
13158820|NCT02460991|26077671|FG001|Overall Study|Withdrawal by Subject|2|||
13158821|NCT02460978|26077707|FG000|Overall Study|Adverse Event|17|||
13158822|NCT02460978|26077708|FG001|Overall Study|Adverse Event|11|||
13158823|NCT02460978|26077709|FG002|Overall Study|Adverse Event|11|||
13158824|NCT02460978|26077707|FG000|Overall Study|Withdrawal by Subject|5|||
13158825|NCT02460978|26077708|FG001|Overall Study|Withdrawal by Subject|5|||
13158826|NCT02460978|26077709|FG002|Overall Study|Withdrawal by Subject|14|||
13158827|NCT02460978|26077707|FG000|Overall Study|Lost to Follow-up|2|||
13158828|NCT02460978|26077708|FG001|Overall Study|Lost to Follow-up|3|||
13158829|NCT02460978|26077709|FG002|Overall Study|Lost to Follow-up|1|||
13158830|NCT02460978|26077707|FG000|Overall Study|Protocol Violation|1|||
13158831|NCT02460978|26077708|FG001|Overall Study|Protocol Violation|1|||
13158832|NCT02460978|26077709|FG002|Overall Study|Protocol Violation|1|||
13158833|NCT02460978|26077707|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2|||
13158834|NCT02460978|26077708|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5|||
13158835|NCT02460978|26077709|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4|||
13158836|NCT02460978|26077707|FG000|Overall Study|Pregnancy|0|||
13158837|NCT02460978|26077708|FG001|Overall Study|Pregnancy|0|||
13158838|NCT02460978|26077709|FG002|Overall Study|Pregnancy|2|||
13158839|NCT02460822|26077720|FG000|Overall Study|Withdrawal by Subject|1|||
13158840|NCT02460679|26077745|FG000|Overall Study|Investigator Decision|1|||
13158841|NCT02460679|26077745|FG000|Overall Study|Withdrawal by Subject|4|||
13158842|NCT02460575|26077760|FG000|Overall Study|Lost to Follow-up|1|||
13158843|NCT02460575|26077761|FG001|Overall Study|Lost to Follow-up|0|||
13158844|NCT02460562|26077776|FG000|Overall Study|Lost to Follow-up|15|||
13158845|NCT02460562|26077777|FG001|Overall Study|Lost to Follow-up|16|||
13158846|NCT02460380|26077804|FG000|Overall Study|Withdrawal by Subject|10|||
13158847|NCT02460380|26077805|FG001|Overall Study|Withdrawal by Subject|5|||
13158848|NCT02460263|26077818|FG000|Transition Period|Withdrawal by Subject|1|||
13158849|NCT02460263|26077818|FG000|Transition Period|Death|1|||
13158850|NCT02460198|26077845|FG000|Overall Study|Adverse Event|1|||
13158851|NCT02460198|26077846|FG001|Overall Study|Adverse Event|3|||
13158852|NCT02460198|26077845|FG000|Overall Study|Death|36|||
13158853|NCT02460198|26077846|FG001|Overall Study|Death|28|||
13158854|NCT02460198|26077845|FG000|Overall Study|Lost to Follow-up|1|||
13158855|NCT02460198|26077846|FG001|Overall Study|Lost to Follow-up|1|||
13158856|NCT02460198|26077845|FG000|Overall Study|Transferred to Extension Study|15|||
13158857|NCT02460198|26077846|FG001|Overall Study|Transferred to Extension Study|15|||
13158858|NCT02460198|26077845|FG000|Overall Study|Withdrawal by Subject|2|||
13158859|NCT02460198|26077846|FG001|Overall Study|Withdrawal by Subject|4|||
13158860|NCT02460198|26077845|FG000|Overall Study|Site Terminated By Sponsor|0|||
13158861|NCT02460198|26077846|FG001|Overall Study|Site Terminated By Sponsor|1|||
13158862|NCT02460198|26077845|FG000|Overall Study|Did Not Continue on Extension Study|6|||
13158863|NCT02460198|26077846|FG001|Overall Study|Did Not Continue on Extension Study|11|||
13158864|NCT02460159|26077881|FG000|Overall Study|Adverse Event|4|||
13158865|NCT02460159|26077882|FG001|Overall Study|Adverse Event|1|||
13158866|NCT02460159|26077881|FG000|Overall Study|Withdrawal by Subject|2|||
13158867|NCT02460159|26077882|FG001|Overall Study|Withdrawal by Subject|0|||
13158868|NCT02459964|26077901|FG000|Overall Study|Withdrawal by Subject|0|||
13158869|NCT02459964|26077902|FG001|Overall Study|Withdrawal by Subject|0|||
13158870|NCT02459964|26077903|FG002|Overall Study|Withdrawal by Subject|1|||
13158871|NCT02459964|26077901|FG000|Overall Study|Abnormal EKG changes|0|||
13158872|NCT02459964|26077902|FG001|Overall Study|Abnormal EKG changes|0|||
13158873|NCT02459964|26077903|FG002|Overall Study|Abnormal EKG changes|1|||
13205362|NCT01966120|26231544|FG001|Overall Study|Withdrawal by Subject|5|||
13205363|NCT01966120|26231543|FG000|Overall Study|Lost to Follow-up|1|||
13205364|NCT01966120|26231544|FG001|Overall Study|Lost to Follow-up|1|||
13205365|NCT01966107|26231563|FG000|Overall Study|excluded from FAS|21|||
13205366|NCT01966107|26231564|FG001|Overall Study|excluded from FAS|20|||
13205367|NCT01966107|26231563|FG000|Overall Study|discontinued treatment|345|||
13205368|NCT01966107|26231564|FG001|Overall Study|discontinued treatment|372|||
13205369|NCT01966107|26231563|FG000|Overall Study|due to study closure|164|||
13205370|NCT01966107|26231564|FG001|Overall Study|due to study closure|186|||
13205371|NCT01966107|26231563|FG000|Overall Study|withdrew from the study|272|||
13205372|NCT01966107|26231564|FG001|Overall Study|withdrew from the study|303|||
13205373|NCT01966068|26231575|FG000|Overall Study|Withdrawal by Subject|57|||
13205374|NCT01966068|26231575|FG000|Overall Study|Lost to Follow-up|81|||
13222771|NCT01803282|26286883|FG000|Overall Study|Unknown Reason|0|||
13222772|NCT01803282|26286884|FG001|Overall Study|Unknown Reason|0|||
13222773|NCT01803282|26286885|FG002|Overall Study|Unknown Reason|0|||
13222774|NCT01803282|26286886|FG003|Overall Study|Unknown Reason|0|||
13222775|NCT01803282|26286887|FG004|Overall Study|Unknown Reason|0|||
13222776|NCT01803282|26286888|FG005|Overall Study|Unknown Reason|0|||
13222777|NCT01803282|26286889|FG006|Overall Study|Unknown Reason|0|||
13222778|NCT01803282|26286890|FG007|Overall Study|Unknown Reason|1|||
13222779|NCT01803282|26286891|FG008|Overall Study|Unknown Reason|0|||
13222780|NCT01803282|26286892|FG009|Overall Study|Unknown Reason|0|||
13222781|NCT01803282|26286893|FG010|Overall Study|Unknown Reason|0|||
13222782|NCT01803282|26286894|FG011|Overall Study|Unknown Reason|0|||
13222783|NCT01803282|26286883|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
13222784|NCT01803282|26286884|FG001|Overall Study|Specified Criteria for Withdrawal|0|||
13222785|NCT01803282|26286885|FG002|Overall Study|Specified Criteria for Withdrawal|0|||
13222786|NCT01803282|26286886|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
13222787|NCT01803282|26286887|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
13222788|NCT01803282|26286888|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
13222789|NCT01803282|26286889|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
13222790|NCT01803282|26286890|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
13222791|NCT01803282|26286891|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
13222792|NCT01803282|26286892|FG009|Overall Study|Specified Criteria for Withdrawal|1|||
13222793|NCT01803282|26286893|FG010|Overall Study|Specified Criteria for Withdrawal|1|||
13222794|NCT01803282|26286894|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
13222795|NCT01803282|26286883|FG000|Overall Study|Enrolled but Never Treated|0|||
13222796|NCT01803282|26286884|FG001|Overall Study|Enrolled but Never Treated|0|||
13222797|NCT01803282|26286885|FG002|Overall Study|Enrolled but Never Treated|0|||
13222798|NCT01803282|26286886|FG003|Overall Study|Enrolled but Never Treated|0|||
13222799|NCT01803282|26286887|FG004|Overall Study|Enrolled but Never Treated|1|||
13222800|NCT01803282|26286888|FG005|Overall Study|Enrolled but Never Treated|0|||
13222801|NCT01803282|26286889|FG006|Overall Study|Enrolled but Never Treated|1|||
13222802|NCT01803282|26286890|FG007|Overall Study|Enrolled but Never Treated|1|||
13205375|NCT01966042|26231584|FG000|Overall Study|Death|2|||
13205376|NCT01966003|26231607|FG000|Overall Study|Death|43|||
13205377|NCT01966003|26231608|FG001|Overall Study|Death|36|||
13205378|NCT01966003|26231607|FG000|Overall Study|Protocol Violation|6|||
13205379|NCT01966003|26231608|FG001|Overall Study|Protocol Violation|4|||
13205380|NCT01966003|26231607|FG000|Overall Study|Lost to Follow-up|4|||
13205381|NCT01966003|26231608|FG001|Overall Study|Lost to Follow-up|3|||
13205382|NCT01966003|26231607|FG000|Overall Study|Physician Decision|12|||
13205383|NCT01966003|26231608|FG001|Overall Study|Physician Decision|13|||
13205384|NCT01966003|26231607|FG000|Overall Study|Withdrawal by Subject|29|||
13205385|NCT01966003|26231608|FG001|Overall Study|Withdrawal by Subject|19|||
13205386|NCT01966003|26231607|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131|||
13205387|NCT01966003|26231608|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127|||
13205388|NCT01966003|26231607|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44|||
13222803|NCT01803282|26286891|FG008|Overall Study|Enrolled but Never Treated|0|||
13222804|NCT01803282|26286892|FG009|Overall Study|Enrolled but Never Treated|1|||
13222805|NCT01803282|26286893|FG010|Overall Study|Enrolled but Never Treated|0|||
13222806|NCT01803282|26286894|FG011|Overall Study|Enrolled but Never Treated|0|||
13222807|NCT01803269|26286924|FG000|Overall Study|Withdrawal by Subject|3|||
13222808|NCT01803269|26286925|FG001|Overall Study|Withdrawal by Subject|0|||
13158874|NCT02459951|26077912|FG000|Overall Study|Unable to meet holding requirement|1|||
13158875|NCT02459899|26077955|FG000|Overall Study|Adverse Event|1|||
13158876|NCT02459899|26077956|FG001|Overall Study|Adverse Event|1|||
13158877|NCT02459899|26077957|FG002|Overall Study|Adverse Event|0|||
13158878|NCT02459899|26077958|FG003|Overall Study|Adverse Event|0|||
13158879|NCT02459899|26077955|FG000|Overall Study|Lost to Follow-up|1|||
13158880|NCT02459899|26077956|FG001|Overall Study|Lost to Follow-up|2|||
13158881|NCT02459899|26077957|FG002|Overall Study|Lost to Follow-up|0|||
13158882|NCT02459899|26077958|FG003|Overall Study|Lost to Follow-up|1|||
13158883|NCT02459899|26077955|FG000|Overall Study|Non-compliance with the treatment|0|||
13158884|NCT02459899|26077956|FG001|Overall Study|Non-compliance with the treatment|0|||
13158885|NCT02459899|26077957|FG002|Overall Study|Non-compliance with the treatment|0|||
13158886|NCT02459899|26077958|FG003|Overall Study|Non-compliance with the treatment|1|||
13158887|NCT02459899|26077955|FG000|Overall Study|Withdrawal by Subject|1|||
13158888|NCT02459899|26077956|FG001|Overall Study|Withdrawal by Subject|3|||
13158889|NCT02459899|26077957|FG002|Overall Study|Withdrawal by Subject|0|||
13158890|NCT02459899|26077958|FG003|Overall Study|Withdrawal by Subject|0|||
13158891|NCT02459665|26078000|FG000|Overall Study|Withdrawal by Subject|0|||
13158892|NCT02459665|26078001|FG001|Overall Study|Withdrawal by Subject|1|||
13158893|NCT02459665|26078002|FG002|Overall Study|Withdrawal by Subject|1|||
13158894|NCT02459665|26078003|FG003|Overall Study|Withdrawal by Subject|2|||
13158895|NCT02459587|26078020|FG000|3-Month Follow-up Assessment|Death|0|||
13158896|NCT02459587|26078021|FG001|3-Month Follow-up Assessment|Death|2|||
13158897|NCT02459587|26078020|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
13158898|NCT02459587|26078021|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
13158899|NCT02459587|26078020|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27|||
13158900|NCT02459587|26078021|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22|||
13158901|NCT02459587|26078020|FG000|3-Month Follow-up Assessment|Researcher withdrew|2|||
13158902|NCT02459587|26078021|FG001|3-Month Follow-up Assessment|Researcher withdrew|4|||
13158903|NCT02459587|26078020|FG000|6-month Follow-up Assessment|Death|2|||
13158904|NCT02459587|26078021|FG001|6-month Follow-up Assessment|Death|1|||
13158905|NCT02459587|26078020|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1|||
13158906|NCT02459587|26078021|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2|||
13158907|NCT02459587|26078020|FG000|6-month Follow-up Assessment|Lost to Follow-up|21|||
13158908|NCT02459587|26078021|FG001|6-month Follow-up Assessment|Lost to Follow-up|22|||
13158909|NCT02459587|26078020|FG000|12-month Follow-up Assessment|Death|2|||
13158910|NCT02459587|26078021|FG001|12-month Follow-up Assessment|Death|0|||
13158911|NCT02459587|26078020|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2|||
13158912|NCT02459587|26078021|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4|||
13158913|NCT02459587|26078020|FG000|12-month Follow-up Assessment|Lost to Follow-up|18|||
13158914|NCT02459587|26078021|FG001|12-month Follow-up Assessment|Lost to Follow-up|22|||
13158915|NCT02459587|26078020|FG000|12-month Follow-up Assessment|Researcher withdrew|0|||
13158916|NCT02459587|26078021|FG001|12-month Follow-up Assessment|Researcher withdrew|1|||
13158917|NCT02459418|26078048|FG000|Overall Study|Exclusion Criteria|4|||
13158918|NCT02459418|26078049|FG001|Overall Study|Exclusion Criteria|0|||
13158919|NCT02459418|26078048|FG000|Overall Study|Protocol Violation|0|||
13158920|NCT02459418|26078049|FG001|Overall Study|Protocol Violation|2|||
13158921|NCT02459418|26078048|FG000|Overall Study|Physician Decision|0|||
13158922|NCT02459418|26078049|FG001|Overall Study|Physician Decision|2|||
13158923|NCT02459418|26078048|FG000|Overall Study|Endometrial thickness of >5 mm|1|||
13158924|NCT02459418|26078049|FG001|Overall Study|Endometrial thickness of >5 mm|0|||
13158925|NCT02459418|26078048|FG000|Overall Study|Adverse Event|0|||
13158926|NCT02459418|26078049|FG001|Overall Study|Adverse Event|1|||
13158927|NCT02459418|26078048|FG000|Overall Study|Withdrawal by Subject|1|||
13158928|NCT02459418|26078049|FG001|Overall Study|Withdrawal by Subject|1|||
13158929|NCT02459418|26078048|FG000|Overall Study|Elevated Creatine Kinase|1|||
13158930|NCT02459418|26078049|FG001|Overall Study|Elevated Creatine Kinase|0|||
13158931|NCT02459418|26078048|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1|||
13158932|NCT02459418|26078049|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0|||
13158933|NCT02459262|26078126|FG000|Overall Study|Withdrawal by Subject|0|||
13158934|NCT02459262|26078127|FG001|Overall Study|Withdrawal by Subject|0|||
13158935|NCT02459262|26078128|FG002|Overall Study|Withdrawal by Subject|0|||
13158936|NCT02459262|26078129|FG003|Overall Study|Withdrawal by Subject|0|||
13158937|NCT02459262|26078130|FG004|Overall Study|Withdrawal by Subject|0|||
13158938|NCT02459262|26078131|FG005|Overall Study|Withdrawal by Subject|0|||
13158939|NCT02459262|26078132|FG006|Overall Study|Withdrawal by Subject|0|||
13158940|NCT02459262|26078133|FG007|Overall Study|Withdrawal by Subject|0|||
13158941|NCT02459262|26078134|FG008|Overall Study|Withdrawal by Subject|0|||
13158942|NCT02459262|26078135|FG009|Overall Study|Withdrawal by Subject|1|||
13158943|NCT02459262|26078136|FG010|Overall Study|Withdrawal by Subject|0|||
13158944|NCT02459093|26078151|FG000|Overall Study|Protocol Violation|6|||
13158945|NCT02459093|26078152|FG001|Overall Study|Protocol Violation|11|||
13158946|NCT02459093|26078151|FG000|Overall Study|Lost to Follow-up|6|||
13158947|NCT02459093|26078152|FG001|Overall Study|Lost to Follow-up|7|||
13158948|NCT02458638|26078174|FG000|Overall Study|Death|309|||
13158949|NCT02458638|26078174|FG000|Overall Study|End of Cohort/End of Study|67|||
13158950|NCT02458638|26078174|FG000|Overall Study|Lost to Follow-up|31|||
13158951|NCT02458638|26078174|FG000|Overall Study|Other Reasons|4|||
13158952|NCT02458638|26078174|FG000|Overall Study|Physician Decision|1|||
13158953|NCT02458638|26078174|FG000|Overall Study|Withdrawal by Subject|47|||
13158954|NCT02458469|26078192|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
13158955|NCT02458469|26078193|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
13158956|NCT02458469|26078194|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1|||
13158957|NCT02458469|26078195|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0|||
13158958|NCT02458469|26078196|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0|||
13158959|NCT02458469|26078197|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0|||
13158960|NCT02458469|26078192|FG000|First Intervention (2 Weeks)|Physician Decision|1|||
13158961|NCT02458469|26078193|FG001|First Intervention (2 Weeks)|Physician Decision|0|||
13158962|NCT02458469|26078194|FG002|First Intervention (2 Weeks)|Physician Decision|0|||
13158963|NCT02458469|26078195|FG003|First Intervention (2 Weeks)|Physician Decision|0|||
13158964|NCT02458469|26078196|FG004|First Intervention (2 Weeks)|Physician Decision|0|||
13158965|NCT02458469|26078197|FG005|First Intervention (2 Weeks)|Physician Decision|0|||
13158966|NCT02458469|26078192|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
13158967|NCT02458469|26078193|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
13158968|NCT02458469|26078194|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
13158969|NCT02458469|26078195|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
13158970|NCT02458469|26078196|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
13158971|NCT02458469|26078197|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
13158972|NCT02458287|26078255|FG000|Overall Study|Adverse Event|0|||
13158973|NCT02458287|26078256|FG001|Overall Study|Adverse Event|0|||
13158974|NCT02458287|26078257|FG002|Overall Study|Adverse Event|0|||
13158975|NCT02458287|26078258|FG003|Overall Study|Adverse Event|1|||
13158976|NCT02458287|26078255|FG000|Overall Study|Lost to Follow-up|0|||
13158977|NCT02458287|26078256|FG001|Overall Study|Lost to Follow-up|1|||
13158978|NCT02458287|26078257|FG002|Overall Study|Lost to Follow-up|1|||
13158979|NCT02458287|26078258|FG003|Overall Study|Lost to Follow-up|0|||
13158980|NCT02458287|26078255|FG000|Overall Study|Protocol Violation|0|||
13158981|NCT02458287|26078256|FG001|Overall Study|Protocol Violation|1|||
13158982|NCT02458287|26078257|FG002|Overall Study|Protocol Violation|0|||
13158983|NCT02458287|26078258|FG003|Overall Study|Protocol Violation|0|||
13158984|NCT02458287|26078255|FG000|Overall Study|Withdrawal by Subject|0|||
13158985|NCT02458287|26078256|FG001|Overall Study|Withdrawal by Subject|2|||
13158986|NCT02458287|26078257|FG002|Overall Study|Withdrawal by Subject|2|||
13158987|NCT02458287|26078258|FG003|Overall Study|Withdrawal by Subject|1|||
13158988|NCT02458287|26078255|FG000|Overall Study|Relocated Out of State|0|||
13158989|NCT02458287|26078256|FG001|Overall Study|Relocated Out of State|0|||
13158990|NCT02458287|26078257|FG002|Overall Study|Relocated Out of State|0|||
13158991|NCT02458287|26078258|FG003|Overall Study|Relocated Out of State|1|||
13158992|NCT02458092|26078277|FG000|Overall Study|Withdrawal by Subject|1|||
13158993|NCT02458092|26078278|FG001|Overall Study|Withdrawal by Subject|0|||
13158994|NCT02457910|26078314|FG000|Overall Study|Withdrawal by Subject|0|||
13158995|NCT02457910|26078315|FG001|Overall Study|Withdrawal by Subject|0|||
13158996|NCT02457910|26078316|FG002|Overall Study|Withdrawal by Subject|0|||
13158997|NCT02457910|26078317|FG003|Overall Study|Withdrawal by Subject|0|||
13158998|NCT02457910|26078318|FG004|Overall Study|Withdrawal by Subject|0|||
13158999|NCT02457910|26078319|FG005|Overall Study|Withdrawal by Subject|1|||
13159000|NCT02457910|26078314|FG000|Overall Study|Adverse Event|0|||
13159001|NCT02457910|26078315|FG001|Overall Study|Adverse Event|2|||
13159002|NCT02457910|26078316|FG002|Overall Study|Adverse Event|1|||
13159003|NCT02457910|26078317|FG003|Overall Study|Adverse Event|1|||
13159004|NCT02457910|26078318|FG004|Overall Study|Adverse Event|1|||
13159005|NCT02457910|26078319|FG005|Overall Study|Adverse Event|3|||
13159006|NCT02457910|26078314|FG000|Overall Study|Disease progression|3|||
13159007|NCT02457910|26078315|FG001|Overall Study|Disease progression|3|||
13105061|NCT03333837|25878146|FG003|Overall Study|Adverse Event|1|||
13105062|NCT03333837|25878147|FG004|Overall Study|Adverse Event|0|||
13105063|NCT03333837|25878143|FG000|Overall Study|Caregiver withdrew|0|||
13105064|NCT03333837|25878144|FG001|Overall Study|Caregiver withdrew|2|||
13105065|NCT03333837|25878145|FG002|Overall Study|Caregiver withdrew|1|||
13105066|NCT03333837|25878146|FG003|Overall Study|Caregiver withdrew|0|||
13105067|NCT03333837|25878147|FG004|Overall Study|Caregiver withdrew|0|||
13105068|NCT03333837|25878143|FG000|Overall Study|Withdrawal by Subject|0|||
13105069|NCT03333837|25878144|FG001|Overall Study|Withdrawal by Subject|0|||
13105070|NCT03333837|25878145|FG002|Overall Study|Withdrawal by Subject|1|||
13105071|NCT03333837|25878146|FG003|Overall Study|Withdrawal by Subject|1|||
13159008|NCT02457910|26078316|FG002|Overall Study|Disease progression|1|||
13159009|NCT02457910|26078317|FG003|Overall Study|Disease progression|1|||
13159010|NCT02457910|26078318|FG004|Overall Study|Disease progression|4|||
13159011|NCT02457910|26078319|FG005|Overall Study|Disease progression|6|||
13159012|NCT02457910|26078314|FG000|Overall Study|Other complicating illness|0|||
13159013|NCT02457910|26078315|FG001|Overall Study|Other complicating illness|0|||
13159014|NCT02457910|26078316|FG002|Overall Study|Other complicating illness|0|||
13105072|NCT03333837|25878147|FG004|Overall Study|Withdrawal by Subject|3|||
13105073|NCT03333837|25878143|FG000|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
13105074|NCT03333837|25878144|FG001|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
13105075|NCT03333837|25878145|FG002|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|2|||
13159015|NCT02457910|26078317|FG003|Overall Study|Other complicating illness|0|||
13159016|NCT02457910|26078318|FG004|Overall Study|Other complicating illness|0|||
13105076|NCT03333837|25878146|FG003|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
13105077|NCT03333837|25878147|FG004|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
13105078|NCT03333109|25878174|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
13105079|NCT03333109|25878175|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
13105080|NCT03333109|25878176|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
13105081|NCT03333109|25878174|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
13105082|NCT03333109|25878175|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
13105083|NCT03333109|25878176|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
13105084|NCT03333109|25878174|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4|||
13105085|NCT03333109|25878175|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
13105086|NCT03333109|25878176|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1|||
13105087|NCT03333109|25878174|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1|||
13105088|NCT03333109|25878175|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
13105089|NCT03333109|25878176|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
13105090|NCT03333109|25878174|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9|||
13105091|NCT03333109|25878175|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
13159017|NCT02457910|26078319|FG005|Overall Study|Other complicating illness|1|||
13159018|NCT02457910|26078314|FG000|Overall Study|Death|0|||
13159019|NCT02457910|26078315|FG001|Overall Study|Death|0|||
13159020|NCT02457910|26078316|FG002|Overall Study|Death|1|||
13159021|NCT02457910|26078317|FG003|Overall Study|Death|0|||
13105092|NCT03333109|25878176|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5|||
13105093|NCT03333109|25878174|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
13105094|NCT03333109|25878175|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0|||
13105095|NCT03333109|25878176|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
13105096|NCT03333109|25878174|FG000|Safety Follow-up Period|Lost to Follow-up|6|||
13105097|NCT03333109|25878175|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
13105098|NCT03333109|25878176|FG002|Safety Follow-up Period|Lost to Follow-up|1|||
13105099|NCT03333109|25878174|FG000|Safety Follow-up Period|Withdrawal by Subject|7|||
13105100|NCT03333109|25878175|FG001|Safety Follow-up Period|Withdrawal by Subject|2|||
13105101|NCT03333109|25878176|FG002|Safety Follow-up Period|Withdrawal by Subject|12|||
13105102|NCT03332784|25878493|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
13105103|NCT03332784|25878494|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
13105104|NCT03332784|25878495|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
13105105|NCT03332784|25878496|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
13105106|NCT03332784|25878497|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
13105107|NCT03332784|25878498|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
13105108|NCT03332784|25878499|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
13105109|NCT03332784|25878500|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
13105110|NCT03332784|25878501|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
13105111|NCT03332784|25878502|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
13105112|NCT03332784|25878503|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
13105113|NCT03332784|25878504|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
13105114|NCT03332784|25878505|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
13105115|NCT03332784|25878506|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
13105116|NCT03332784|25878507|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
13105117|NCT03332784|25878508|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
13105118|NCT03332784|25878509|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
13105119|NCT03332784|25878510|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
13105120|NCT03332784|25878511|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
13105121|NCT03332784|25878512|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
13105122|NCT03332771|25878563|FG000|Overall Study|Adverse Event|6|||
13105123|NCT03332771|25878564|FG001|Overall Study|Adverse Event|4|||
13105124|NCT03332771|25878565|FG002|Overall Study|Adverse Event|1|||
13105125|NCT03332771|25878566|FG003|Overall Study|Adverse Event|3|||
13105126|NCT03332771|25878563|FG000|Overall Study|Poor Compliance to Protocol|0|||
13105127|NCT03332771|25878564|FG001|Overall Study|Poor Compliance to Protocol|1|||
13105128|NCT03332771|25878565|FG002|Overall Study|Poor Compliance to Protocol|0|||
13105129|NCT03332771|25878566|FG003|Overall Study|Poor Compliance to Protocol|1|||
13105130|NCT03332771|25878563|FG000|Overall Study|Lost to Follow-up|2|||
13159022|NCT02457910|26078318|FG004|Overall Study|Death|0|||
13159023|NCT02457910|26078319|FG005|Overall Study|Death|0|||
13105131|NCT03332771|25878564|FG001|Overall Study|Lost to Follow-up|2|||
13105132|NCT03332771|25878565|FG002|Overall Study|Lost to Follow-up|1|||
13105133|NCT03332771|25878566|FG003|Overall Study|Lost to Follow-up|2|||
13105134|NCT03332771|25878563|FG000|Overall Study|At the Participant's own request|20|||
13105135|NCT03332771|25878564|FG001|Overall Study|At the Participant's own request|26|||
13105136|NCT03332771|25878565|FG002|Overall Study|At the Participant's own request|14|||
13105137|NCT03332771|25878566|FG003|Overall Study|At the Participant's own request|23|||
13159024|NCT02457819|26078327|FG000|Overall Study|reason not given|8|||
13159025|NCT02457819|26078327|FG000|Overall Study|Withdrawal by Subject|24|||
13159026|NCT02457819|26078327|FG000|Overall Study|Protocol Violation|1|||
13159027|NCT02457819|26078327|FG000|Overall Study|non compliance with study drug|4|||
13159028|NCT02457819|26078327|FG000|Overall Study|Lost to Follow-up|10|||
13159029|NCT02457819|26078327|FG000|Overall Study|Lack of Efficacy|19|||
13159030|NCT02457819|26078327|FG000|Overall Study|Adverse Event|33|||
13105138|NCT03332771|25878563|FG000|Overall Study|Reason Not Specified|6|||
13105139|NCT03332771|25878564|FG001|Overall Study|Reason Not Specified|18|||
13105140|NCT03332771|25878565|FG002|Overall Study|Reason Not Specified|16|||
13159031|NCT02457793|26078486|FG000|Overall Study|Reason not specified|0|||
13159032|NCT02457793|26078487|FG001|Overall Study|Reason not specified|0|||
13159033|NCT02457793|26078488|FG002|Overall Study|Reason not specified|0|||
13159034|NCT02457793|26078489|FG003|Overall Study|Reason not specified|1|||
13159035|NCT02457793|26078490|FG004|Overall Study|Reason not specified|1|||
13159036|NCT02457793|26078491|FG005|Overall Study|Reason not specified|1|||
13159037|NCT02457793|26078486|FG000|Overall Study|Withdrawal by Subject|0|||
13159038|NCT02457793|26078487|FG001|Overall Study|Withdrawal by Subject|4|||
13159039|NCT02457793|26078488|FG002|Overall Study|Withdrawal by Subject|2|||
13159040|NCT02457793|26078489|FG003|Overall Study|Withdrawal by Subject|2|||
13159041|NCT02457793|26078490|FG004|Overall Study|Withdrawal by Subject|2|||
13159042|NCT02457793|26078491|FG005|Overall Study|Withdrawal by Subject|2|||
13159043|NCT02457793|26078486|FG000|Overall Study|Adverse Event|0|||
13159044|NCT02457793|26078487|FG001|Overall Study|Adverse Event|0|||
13159045|NCT02457793|26078488|FG002|Overall Study|Adverse Event|0|||
13159046|NCT02457793|26078489|FG003|Overall Study|Adverse Event|1|||
13159047|NCT02457793|26078490|FG004|Overall Study|Adverse Event|0|||
13159048|NCT02457793|26078491|FG005|Overall Study|Adverse Event|0|||
13159049|NCT02457793|26078486|FG000|Overall Study|Physician Decision|1|||
13105141|NCT03332771|25878566|FG003|Overall Study|Reason Not Specified|19|||
13105142|NCT03332628|25878575|FG000|Overall Study|Physician Decision|2|||
13105143|NCT03332589|25878608|FG000|Overall Study|Lack of Efficacy|2|||
13105144|NCT03332589|25878609|FG001|Overall Study|Lack of Efficacy|0|||
13105145|NCT03332589|25878610|FG002|Overall Study|Lack of Efficacy|0|||
13105146|NCT03332589|25878608|FG000|Overall Study|Adverse Event|1|||
13105147|NCT03332589|25878609|FG001|Overall Study|Adverse Event|0|||
13105148|NCT03332589|25878610|FG002|Overall Study|Adverse Event|0|||
13105149|NCT03332589|25878608|FG000|Overall Study|Death|1|||
13105150|NCT03332589|25878609|FG001|Overall Study|Death|0|||
13105151|NCT03332589|25878610|FG002|Overall Study|Death|0|||
13159050|NCT02457793|26078487|FG001|Overall Study|Physician Decision|0|||
13159051|NCT02457793|26078488|FG002|Overall Study|Physician Decision|1|||
13159052|NCT02457793|26078489|FG003|Overall Study|Physician Decision|1|||
13159053|NCT02457793|26078490|FG004|Overall Study|Physician Decision|1|||
13159054|NCT02457793|26078491|FG005|Overall Study|Physician Decision|3|||
13159055|NCT02457637|26078501|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71|||
13159056|NCT02457611|26078515|FG000|Overall Study|Lost to Follow-up|3|||
13159057|NCT02457546|26078530|FG000|Overall Study|Other reasons|4|||
13159058|NCT02457546|26078531|FG001|Overall Study|Other reasons|1|||
13159059|NCT02457546|26078530|FG000|Overall Study|Refused to complete study/procedures|1|||
13159060|NCT02457546|26078531|FG001|Overall Study|Refused to complete study/procedures|1|||
13159061|NCT02457546|26078530|FG000|Overall Study|Lost to Follow-up|4|||
13159062|NCT02457546|26078531|FG001|Overall Study|Lost to Follow-up|1|||
13159063|NCT02457546|26078530|FG000|Overall Study|Adverse Event|0|||
13159064|NCT02457546|26078531|FG001|Overall Study|Adverse Event|1|||
13159065|NCT02457520|26078574|FG000|Active Treatment Phase|Adverse Event|10|||
13159066|NCT02457520|26078574|FG000|Active Treatment Phase|Lost to Follow-up|8|||
13159067|NCT02457520|26078574|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3|||
13159068|NCT02457520|26078574|FG000|Active Treatment Phase|other|4|||
13159069|NCT02457520|26078574|FG000|Active Treatment Phase|Physician Decision|1|||
13159070|NCT02457520|26078574|FG000|Active Treatment Phase|Protocol Violation|1|||
13159071|NCT02457520|26078574|FG000|Active Treatment Phase|Withdrawal by Subject|7|||
13159072|NCT02457520|26078574|FG000|Post-treatment Period|Other: Retreatment Required|7|||
13159073|NCT02457520|26078574|FG000|Post-treatment Period|Lost to Follow-up|23|||
13159074|NCT02457520|26078574|FG000|Post-treatment Period|Other|3|||
13222809|NCT01803269|26286926|FG002|Overall Study|Withdrawal by Subject|0|||
13159075|NCT02457520|26078574|FG000|Post-treatment Period|Physician Decision|1|||
13159076|NCT02457520|26078574|FG000|Post-treatment Period|Withdrawal by Subject|14|||
13159077|NCT02457325|26078607|FG000|First Intervention (1 Day)|Lost to Follow-up|2|||
13159078|NCT02457325|26078608|FG001|First Intervention (1 Day)|Lost to Follow-up|2|||
13159079|NCT02457247|26078641|FG000|Period 1|Pretreatment Event/Adverse Event|0|||
13159080|NCT02457247|26078642|FG001|Period 1|Pretreatment Event/Adverse Event|1|||
13159081|NCT02457247|26078643|FG002|Period 1|Pretreatment Event/Adverse Event|0|||
13159082|NCT02457247|26078644|FG003|Period 1|Pretreatment Event/Adverse Event|0|||
13159083|NCT02457247|26078641|FG000|Period 1|Significant Protocol Deviation|1|||
13159084|NCT02457247|26078642|FG001|Period 1|Significant Protocol Deviation|1|||
13159085|NCT02457247|26078643|FG002|Period 1|Significant Protocol Deviation|0|||
13159086|NCT02457247|26078644|FG003|Period 1|Significant Protocol Deviation|0|||
13159087|NCT02457247|26078641|FG000|Period 1|Voluntary Withdrawal|1|||
13159088|NCT02457247|26078642|FG001|Period 1|Voluntary Withdrawal|0|||
13159089|NCT02457247|26078643|FG002|Period 1|Voluntary Withdrawal|0|||
13159090|NCT02457247|26078644|FG003|Period 1|Voluntary Withdrawal|0|||
13105152|NCT03332212|25878631|FG000|Overall Study|Not treated|0|||
13159091|NCT02457247|26078641|FG000|Period 2|Pretreatment Event/Adverse Event|0|||
13105153|NCT03332212|25878632|FG001|Overall Study|Not treated|1|||
13105154|NCT03332212|25878633|FG002|Overall Study|Not treated|0|||
13159092|NCT02457247|26078642|FG001|Period 2|Pretreatment Event/Adverse Event|1|||
13159093|NCT02457247|26078643|FG002|Period 2|Pretreatment Event/Adverse Event|0|||
13159094|NCT02457247|26078644|FG003|Period 2|Pretreatment Event/Adverse Event|0|||
13159095|NCT02457247|26078641|FG000|Period 2|Significant Protocol Deviation|1|||
13159096|NCT02457247|26078642|FG001|Period 2|Significant Protocol Deviation|0|||
13159097|NCT02457247|26078643|FG002|Period 2|Significant Protocol Deviation|0|||
13159098|NCT02457247|26078644|FG003|Period 2|Significant Protocol Deviation|0|||
13159099|NCT02457247|26078641|FG000|Period 2|Lost to Follow-up|0|||
13159100|NCT02457247|26078642|FG001|Period 2|Lost to Follow-up|1|||
13159101|NCT02457247|26078643|FG002|Period 2|Lost to Follow-up|0|||
13159102|NCT02457247|26078644|FG003|Period 2|Lost to Follow-up|0|||
13159103|NCT02457247|26078641|FG000|Period 2|Voluntary Withdrawal|1|||
13159104|NCT02457247|26078642|FG001|Period 2|Voluntary Withdrawal|1|||
13159105|NCT02457247|26078643|FG002|Period 2|Voluntary Withdrawal|0|||
13159106|NCT02457247|26078644|FG003|Period 2|Voluntary Withdrawal|0|||
13159107|NCT02457195|26078650|FG000|Overall Study|Adverse Event|3|||
13159108|NCT02457195|26078650|FG000|Overall Study|Protocol Violation|2|||
13159109|NCT02457195|26078650|FG000|Overall Study|Withdrawal by Subject|4|||
13159110|NCT02457182|26078673|FG000|Overall Study|Lost to Follow-up|1|||
13159111|NCT02457182|26078674|FG001|Overall Study|Lost to Follow-up|0|||
13159112|NCT02457065|26078689|FG000|Overall Study|Lost to Follow-up|9|||
13159113|NCT02457065|26078690|FG001|Overall Study|Lost to Follow-up|11|||
13159114|NCT02456909|26078707|FG000|Overall Study|Did not receive allocated intervention|24|||
13159115|NCT02456909|26078708|FG001|Overall Study|Did not receive allocated intervention|26|||
13159116|NCT02456909|26078707|FG000|Overall Study|Did not complete the primary outcome|0|||
13159117|NCT02456909|26078708|FG001|Overall Study|Did not complete the primary outcome|1|||
13159118|NCT02456740|26078746|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
13159119|NCT02456740|26078747|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
13159120|NCT02456740|26078748|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
13159121|NCT02456740|26078749|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
13159122|NCT02456740|26078750|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
13159123|NCT02456740|26078751|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
13159124|NCT02456740|26078752|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
13159125|NCT02456740|26078753|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
13159126|NCT02456740|26078754|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
13159127|NCT02456740|26078746|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27|||
13159128|NCT02456740|26078747|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28|||
13159129|NCT02456740|26078748|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21|||
13159130|NCT02456740|26078749|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
13159131|NCT02456740|26078750|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
13159132|NCT02456740|26078751|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
13159133|NCT02456740|26078752|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
13159134|NCT02456740|26078753|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
13159135|NCT02456740|26078754|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
13222810|NCT01802879|26286933|FG000|Overall Study|Administrative problems|2|||
13105155|NCT03332212|25878634|FG003|Overall Study|Not treated|0|||
13105156|NCT03332212|25878631|FG000|Overall Study|Adverse Event|0|||
13105157|NCT03332212|25878632|FG001|Overall Study|Adverse Event|0|||
13105158|NCT03332212|25878633|FG002|Overall Study|Adverse Event|0|||
13105159|NCT03332212|25878634|FG003|Overall Study|Adverse Event|1|||
13105160|NCT03332212|25878631|FG000|Overall Study|worsening of disease under study|1|||
13105161|NCT03332212|25878632|FG001|Overall Study|worsening of disease under study|1|||
13105162|NCT03332212|25878633|FG002|Overall Study|worsening of disease under study|0|||
13105163|NCT03332212|25878634|FG003|Overall Study|worsening of disease under study|0|||
13159136|NCT02456740|26078746|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9|||
13159137|NCT02456740|26078747|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4|||
13159138|NCT02456740|26078748|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5|||
13159139|NCT02456740|26078749|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
13159140|NCT02456740|26078750|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
13159141|NCT02456740|26078751|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
13159142|NCT02456740|26078752|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
13159143|NCT02456740|26078753|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
13159144|NCT02456740|26078754|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
13159145|NCT02456740|26078746|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
13159146|NCT02456740|26078747|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
13159147|NCT02456740|26078748|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
13159148|NCT02456740|26078749|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1|||
13159149|NCT02456740|26078750|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4|||
13159150|NCT02456740|26078751|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
13159151|NCT02456740|26078752|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
13159152|NCT02456740|26078753|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
13159153|NCT02456740|26078754|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5|||
13159154|NCT02456740|26078746|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
13159155|NCT02456740|26078747|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
13159156|NCT02456740|26078748|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
13159157|NCT02456740|26078749|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10|||
13159158|NCT02456740|26078750|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11|||
13159159|NCT02456740|26078751|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
13159160|NCT02456740|26078752|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
13159161|NCT02456740|26078753|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
13159162|NCT02456740|26078754|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
13159163|NCT02456740|26078746|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
13159164|NCT02456740|26078747|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
13159165|NCT02456740|26078748|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
13159166|NCT02456740|26078749|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
13159167|NCT02456740|26078750|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
13159168|NCT02456740|26078751|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
13159169|NCT02456740|26078752|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
13159170|NCT02456740|26078753|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1|||
13159171|NCT02456740|26078754|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
13105164|NCT03332160|25878671|FG000|Overall Study|Withdrawal by Subject|1|||
13105165|NCT03332160|25878672|FG001|Overall Study|Withdrawal by Subject|1|||
13105166|NCT03332160|25878671|FG000|Overall Study|Adverse Event|0|||
13105167|NCT03332160|25878672|FG001|Overall Study|Adverse Event|1|||
13105168|NCT03332160|25878671|FG000|Overall Study|Developed Exclusion Criteria|0|||
13105169|NCT03332160|25878672|FG001|Overall Study|Developed Exclusion Criteria|1|||
13105170|NCT03332160|25878671|FG000|Overall Study|Non-adherence to treatment|0|||
13105171|NCT03332160|25878672|FG001|Overall Study|Non-adherence to treatment|2|||
13105172|NCT03332095|25878727|FG000|Overall Study|Lost to Follow-up|1|||
13105173|NCT03332095|25878728|FG001|Overall Study|Lost to Follow-up|0|||
13105174|NCT03332095|25878727|FG000|Overall Study|Pregnancy|0|||
13105175|NCT03332095|25878728|FG001|Overall Study|Pregnancy|1|||
13105176|NCT03331666|25878743|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
13105177|NCT03331666|25878744|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
13105178|NCT03331315|25878771|FG000|Overall Study|Physician Decision|18|||
13105179|NCT03331315|25878772|FG001|Overall Study|Physician Decision|14|||
13105180|NCT03331042|25878831|FG000|Overall Study|Protocol Violation|1|||
13105181|NCT03331042|25878832|FG001|Overall Study|Protocol Violation|0|||
13485465|NCT02906020|27032867|FG000|Part 1: Dose Escalation Period|Adverse Event|0|||
13485466|NCT02906020|27032868|FG001|Part 1: Dose Escalation Period|Adverse Event|1|||
13485467|NCT02906020|27032869|FG002|Part 1: Dose Escalation Period|Adverse Event|0|||
13485468|NCT02906020|27032870|FG003|Part 1: Dose Escalation Period|Adverse Event|1|||
13485469|NCT02906020|27032871|FG004|Part 1: Dose Escalation Period|Adverse Event|0|||
13485470|NCT02906020|27032872|FG005|Part 1: Dose Escalation Period|Adverse Event|0|||
13485471|NCT02906020|27032873|FG006|Part 1: Dose Escalation Period|Adverse Event|0|||
13485472|NCT02906020|27032874|FG007|Part 1: Dose Escalation Period|Adverse Event|0|||
13485473|NCT02906020|27032875|FG008|Part 1: Dose Escalation Period|Adverse Event|0|||
13485474|NCT02906020|27032876|FG009|Part 1: Dose Escalation Period|Adverse Event|0|||
13485475|NCT02906020|27032877|FG010|Part 1: Dose Escalation Period|Adverse Event|0|||
13105182|NCT03331042|25878833|FG002|Overall Study|Protocol Violation|0|||
13105183|NCT03331042|25878834|FG003|Overall Study|Protocol Violation|0|||
13105184|NCT03331042|25878831|FG000|Overall Study|Physician Decision|0|||
13105185|NCT03331042|25878832|FG001|Overall Study|Physician Decision|0|||
13159172|NCT02456740|26078746|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
13159173|NCT02456740|26078747|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
13159174|NCT02456740|26078748|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
13159175|NCT02456740|26078749|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
13159176|NCT02456740|26078750|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2|||
13159177|NCT02456740|26078751|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
13159178|NCT02456740|26078752|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
13159179|NCT02456740|26078753|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
13159180|NCT02456740|26078754|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
13105186|NCT03331042|25878833|FG002|Overall Study|Physician Decision|1|||
13105187|NCT03331042|25878834|FG003|Overall Study|Physician Decision|0|||
13105188|NCT03331042|25878831|FG000|Overall Study|Lost to Follow-up|0|||
13105189|NCT03331042|25878832|FG001|Overall Study|Lost to Follow-up|0|||
13105190|NCT03331042|25878833|FG002|Overall Study|Lost to Follow-up|0|||
13159181|NCT02456727|26078841|FG000|Overall Study|Lost to Follow-up|63|||
13159182|NCT02456727|26078842|FG001|Overall Study|Lost to Follow-up|65|||
13159183|NCT02456727|26078841|FG000|Overall Study|Death|2|||
13159184|NCT02456727|26078842|FG001|Overall Study|Death|1|||
13159185|NCT02456727|26078841|FG000|Overall Study|Withdrawal by Subject|1|||
13159186|NCT02456727|26078842|FG001|Overall Study|Withdrawal by Subject|10|||
13159187|NCT02456727|26078841|FG000|Overall Study|Never Initiated Treatment|43|||
13159188|NCT02456727|26078842|FG001|Overall Study|Never Initiated Treatment|30|||
13159189|NCT02456662|26078855|FG000|Overall Study|Lost to Follow-up|2|||
13159190|NCT02456662|26078856|FG001|Overall Study|Lost to Follow-up|1|||
13159191|NCT02456636|26078916|FG000|Overall Study|Death|0|||
13159192|NCT02456636|26078917|FG001|Overall Study|Death|3|||
13159193|NCT02456636|26078918|FG002|Overall Study|Death|0|||
13159194|NCT02456636|26078916|FG000|Overall Study|Pregnancy|1|||
13159195|NCT02456636|26078917|FG001|Overall Study|Pregnancy|3|||
13159196|NCT02456636|26078918|FG002|Overall Study|Pregnancy|5|||
13159197|NCT02456636|26078916|FG000|Overall Study|Physician Decision|4|||
13159198|NCT02456636|26078917|FG001|Overall Study|Physician Decision|5|||
13159199|NCT02456636|26078918|FG002|Overall Study|Physician Decision|4|||
13159200|NCT02456636|26078916|FG000|Overall Study|Withdrawal by Subject|13|||
13159201|NCT02456636|26078917|FG001|Overall Study|Withdrawal by Subject|14|||
13159202|NCT02456636|26078918|FG002|Overall Study|Withdrawal by Subject|16|||
13159203|NCT02456636|26078916|FG000|Overall Study|Lost to Follow-up|50|||
13159204|NCT02456636|26078917|FG001|Overall Study|Lost to Follow-up|44|||
13159205|NCT02456636|26078918|FG002|Overall Study|Lost to Follow-up|50|||
13159206|NCT02456103|26078929|FG000|Overall Study|Study Closure|207|||
13159207|NCT02456103|26078929|FG000|Overall Study|Physician Decision|1|||
13159208|NCT02456103|26078929|FG000|Overall Study|Required prohibited medications|5|||
13159209|NCT02456103|26078929|FG000|Overall Study|Protocol Violation|1|||
13105191|NCT03331042|25878834|FG003|Overall Study|Lost to Follow-up|1|||
13105192|NCT03330847|25878881|FG000|Overall Study|Patients ongoing study|62|||
13159210|NCT02456103|26078929|FG000|Overall Study|Adverse Event|5|||
13159211|NCT02456103|26078929|FG000|Overall Study|Abnormal Laboratory Value|2|||
13159212|NCT02456103|26078929|FG000|Overall Study|Lost to Follow-up|1|||
13159213|NCT02456103|26078929|FG000|Overall Study|Withdrawal by Subject|24|||
13159214|NCT02455557|26078937|FG000|Overall Study|Withdrawal by Subject|2|||
13159215|NCT02455518|26078964|FG000|Overall Study|Protocol Violation|0|||
13159216|NCT02455518|26078965|FG001|Overall Study|Protocol Violation|1|||
13159217|NCT02455518|26078966|FG002|Overall Study|Protocol Violation|1|||
13159218|NCT02455518|26078967|FG003|Overall Study|Protocol Violation|3|||
13159219|NCT02455388|26078984|FG000|Overall Study|Protocol Violation|1|||
13159220|NCT02455388|26078985|FG001|Overall Study|Protocol Violation|0|||
13159221|NCT02455388|26078986|FG002|Overall Study|Protocol Violation|4|||
13159222|NCT02455388|26078984|FG000|Overall Study|Withdrawal by Subject|0|||
13159223|NCT02455388|26078985|FG001|Overall Study|Withdrawal by Subject|0|||
13159224|NCT02455388|26078986|FG002|Overall Study|Withdrawal by Subject|7|||
13159225|NCT02455336|26079003|FG000|Overall Study|Withdrawal by Subject|0|||
13159226|NCT02455336|26079004|FG001|Overall Study|Withdrawal by Subject|2|||
13159227|NCT02455336|26079003|FG000|Overall Study|Adverse Event|3|||
13159228|NCT02455336|26079004|FG001|Overall Study|Adverse Event|0|||
13159229|NCT02455336|26079003|FG000|Overall Study|Non-responder to treatment|2|||
13159230|NCT02455336|26079004|FG001|Overall Study|Non-responder to treatment|0|||
13159231|NCT02455076|26079102|FG000|Inpatient|Withdrawal by Subject|1|||
13159232|NCT02455076|26079103|FG001|Inpatient|Withdrawal by Subject|0|||
13159233|NCT02455076|26079104|FG002|Inpatient|Withdrawal by Subject|0|||
13159234|NCT02455076|26079105|FG003|Inpatient|Withdrawal by Subject|0|||
13105193|NCT03330847|25878882|FG001|Overall Study|Patients ongoing study|65|||
13105194|NCT03330847|25878883|FG002|Overall Study|Patients ongoing study|15|||
13105195|NCT03330288|25878910|FG000|Overall Study|Other reason|1|||
13105196|NCT03330288|25878911|FG001|Overall Study|Other reason|1|||
13159235|NCT02455076|26079106|FG004|Inpatient|Withdrawal by Subject|0|||
13159236|NCT02455076|26079102|FG000|Inpatient|Discharged <24 h after admission|0|||
13159237|NCT02455076|26079103|FG001|Inpatient|Discharged <24 h after admission|1|||
13159238|NCT02455076|26079104|FG002|Inpatient|Discharged <24 h after admission|0|||
13159239|NCT02455076|26079105|FG003|Inpatient|Discharged <24 h after admission|0|||
13105197|NCT03330288|25878910|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1|||
13105198|NCT03330288|25878911|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0|||
13105199|NCT03330288|25878910|FG000|Overall Study|Adverse Event|1|||
13105200|NCT03330288|25878911|FG001|Overall Study|Adverse Event|0|||
13105201|NCT03330288|25878910|FG000|Overall Study|Withdrawal by Subject|1|||
13105202|NCT03330288|25878911|FG001|Overall Study|Withdrawal by Subject|0|||
13105203|NCT03330288|25878910|FG000|Overall Study|Lost to Follow-up|26|||
13105204|NCT03330288|25878911|FG001|Overall Study|Lost to Follow-up|7|||
13105205|NCT03330236|25878942|FG000|Overall Study|Death|2|||
13105206|NCT03330236|25878943|FG001|Overall Study|Death|1|||
13105207|NCT03330236|25878942|FG000|Overall Study|Withdrawal by Subject|2|||
13105208|NCT03330236|25878943|FG001|Overall Study|Withdrawal by Subject|4|||
13105209|NCT03330236|25878942|FG000|Overall Study|Lost to Follow-up|0|||
13105210|NCT03330236|25878943|FG001|Overall Study|Lost to Follow-up|2|||
13159240|NCT02455076|26079106|FG004|Inpatient|Discharged <24 h after admission|0|||
13159241|NCT02455076|26079102|FG000|Inpatient|Adverse Event|3|||
13159242|NCT02455076|26079103|FG001|Inpatient|Adverse Event|0|||
13159243|NCT02455076|26079104|FG002|Inpatient|Adverse Event|0|||
13159244|NCT02455076|26079105|FG003|Inpatient|Adverse Event|0|||
13159245|NCT02455076|26079106|FG004|Inpatient|Adverse Event|0|||
13159246|NCT02455076|26079102|FG000|Outpatient|Adverse Event|0|||
13159247|NCT02455076|26079103|FG001|Outpatient|Adverse Event|0|||
13159248|NCT02455076|26079104|FG002|Outpatient|Adverse Event|0|||
13159249|NCT02455076|26079105|FG003|Outpatient|Adverse Event|5|||
13159250|NCT02455076|26079106|FG004|Outpatient|Adverse Event|0|||
13159251|NCT02455076|26079102|FG000|Outpatient|Lost to Follow-up|0|||
13159252|NCT02455076|26079103|FG001|Outpatient|Lost to Follow-up|0|||
13159253|NCT02455076|26079104|FG002|Outpatient|Lost to Follow-up|0|||
13159254|NCT02455076|26079105|FG003|Outpatient|Lost to Follow-up|1|||
13159255|NCT02455076|26079106|FG004|Outpatient|Lost to Follow-up|12|||
13159256|NCT02455050|26079183|FG000|Treatment Period 1|Lost to Follow-up|1|||
13159257|NCT02455050|26079184|FG001|Treatment Period 1|Lost to Follow-up|1|||
13159258|NCT02455050|26079185|FG002|Treatment Period 1|Lost to Follow-up|1|||
13159259|NCT02455050|26079186|FG003|Treatment Period 1|Lost to Follow-up|2|||
13159260|NCT02455050|26079183|FG000|Treatment Period 2|Lost to Follow-up|1|||
13159261|NCT02455050|26079184|FG001|Treatment Period 2|Lost to Follow-up|0|||
13159262|NCT02455050|26079185|FG002|Treatment Period 2|Lost to Follow-up|2|||
13159263|NCT02455050|26079186|FG003|Treatment Period 2|Lost to Follow-up|1|||
13159264|NCT02454972|26079316|FG000|Overall Study|Progressive disease|17|||
13159265|NCT02454972|26079317|FG001|Overall Study|Progressive disease|16|||
13159266|NCT02454972|26079318|FG002|Overall Study|Progressive disease|59|||
13159267|NCT02454972|26079319|FG003|Overall Study|Progressive disease|23|||
13159268|NCT02454972|26079320|FG004|Overall Study|Progressive disease|16|||
13159269|NCT02454972|26079321|FG005|Overall Study|Progressive disease|12|||
13159270|NCT02454972|26079322|FG006|Overall Study|Progressive disease|19|||
13159271|NCT02454972|26079323|FG007|Overall Study|Progressive disease|27|||
13159272|NCT02454972|26079324|FG008|Overall Study|Progressive disease|84|||
13159273|NCT02454972|26079316|FG000|Overall Study|Death|0|||
13159274|NCT02454972|26079317|FG001|Overall Study|Death|0|||
13105211|NCT03330236|25878942|FG000|Overall Study|Physician Decision|2|||
13105212|NCT03330236|25878943|FG001|Overall Study|Physician Decision|0|||
13105213|NCT03330236|25878942|FG000|Overall Study|Protocol Violation|4|||
13105214|NCT03330236|25878943|FG001|Overall Study|Protocol Violation|3|||
13159275|NCT02454972|26079318|FG002|Overall Study|Death|5|||
13159276|NCT02454972|26079319|FG003|Overall Study|Death|1|||
13159277|NCT02454972|26079320|FG004|Overall Study|Death|0|||
13159278|NCT02454972|26079321|FG005|Overall Study|Death|0|||
13159279|NCT02454972|26079322|FG006|Overall Study|Death|0|||
13159280|NCT02454972|26079323|FG007|Overall Study|Death|0|||
13159281|NCT02454972|26079324|FG008|Overall Study|Death|2|||
13159282|NCT02454972|26079316|FG000|Overall Study|Physician Decision|0|||
13159283|NCT02454972|26079317|FG001|Overall Study|Physician Decision|1|||
13159284|NCT02454972|26079318|FG002|Overall Study|Physician Decision|2|||
13159285|NCT02454972|26079319|FG003|Overall Study|Physician Decision|1|||
13159286|NCT02454972|26079320|FG004|Overall Study|Physician Decision|2|||
13159287|NCT02454972|26079321|FG005|Overall Study|Physician Decision|0|||
13159288|NCT02454972|26079322|FG006|Overall Study|Physician Decision|0|||
13159289|NCT02454972|26079323|FG007|Overall Study|Physician Decision|1|||
13159290|NCT02454972|26079324|FG008|Overall Study|Physician Decision|4|||
13159291|NCT02454972|26079316|FG000|Overall Study|Non treatment-related adverse event|2|||
13159292|NCT02454972|26079317|FG001|Overall Study|Non treatment-related adverse event|0|||
13159293|NCT02454972|26079318|FG002|Overall Study|Non treatment-related adverse event|1|||
13159294|NCT02454972|26079319|FG003|Overall Study|Non treatment-related adverse event|0|||
13159295|NCT02454972|26079320|FG004|Overall Study|Non treatment-related adverse event|0|||
13159296|NCT02454972|26079321|FG005|Overall Study|Non treatment-related adverse event|1|||
13159297|NCT02454972|26079322|FG006|Overall Study|Non treatment-related adverse event|0|||
13159298|NCT02454972|26079323|FG007|Overall Study|Non treatment-related adverse event|1|||
13159299|NCT02454972|26079324|FG008|Overall Study|Non treatment-related adverse event|0|||
13159300|NCT02454972|26079316|FG000|Overall Study|Treatment-related adverse events|0|||
13105215|NCT03330236|25878942|FG000|Overall Study|SedLine malfunction/blinding|19|||
13105216|NCT03330236|25878943|FG001|Overall Study|SedLine malfunction/blinding|14|||
13105217|NCT03330236|25878942|FG000|Overall Study|Volatile anesthetics used|11|||
13105218|NCT03330236|25878943|FG001|Overall Study|Volatile anesthetics used|8|||
13105219|NCT03330236|25878942|FG000|Overall Study|Surgery aborted/converted to open|60|||
13105220|NCT03330236|25878943|FG001|Overall Study|Surgery aborted/converted to open|52|||
13105221|NCT03330119|25878956|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166|||
13105222|NCT03330119|25878957|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282|||
13105223|NCT03330002|25878965|FG000|Overall Study|Lost to Follow-up|15|||
13105224|NCT03330002|25878965|FG000|Overall Study|Death|7|||
13105225|NCT03329989|25878979|FG000|Overall Study|Withdrawal by Subject|9|||
13105226|NCT03329989|25878979|FG000|Overall Study|Lost to Follow-up|8|||
13105227|NCT03329989|25878979|FG000|Overall Study|Adverse Event|5|||
13105228|NCT03329989|25878979|FG000|Overall Study|Protocol Violation|1|||
13105229|NCT03329885|25879165|FG000|Overall Study|Sponsor discontinued the study early|0|||
13105230|NCT03329885|25879166|FG001|Overall Study|Sponsor discontinued the study early|0|||
13105231|NCT03329885|25879167|FG002|Overall Study|Sponsor discontinued the study early|0|||
13105232|NCT03329885|25879168|FG003|Overall Study|Sponsor discontinued the study early|0|||
13105233|NCT03329885|25879169|FG004|Overall Study|Sponsor discontinued the study early|0|||
13105234|NCT03329885|25879170|FG005|Overall Study|Sponsor discontinued the study early|0|||
13105235|NCT03329885|25879171|FG006|Overall Study|Sponsor discontinued the study early|1|||
13105236|NCT03329885|25879172|FG007|Overall Study|Sponsor discontinued the study early|1|||
13105237|NCT03329885|25879173|FG008|Overall Study|Sponsor discontinued the study early|0|||
13105238|NCT03329846|25879186|FG000|Overall Study|Disease progression|4|||
13105239|NCT03329846|25879187|FG001|Overall Study|Disease progression|6|||
13105240|NCT03329846|25879186|FG000|Overall Study|Study drug toxicity|1|||
13105241|NCT03329846|25879187|FG001|Overall Study|Study drug toxicity|0|||
13105242|NCT03329846|25879186|FG000|Overall Study|Participant request to discontinue treatment|0|||
13105243|NCT03329846|25879187|FG001|Overall Study|Participant request to discontinue treatment|1|||
13105244|NCT03329846|25879186|FG000|Overall Study|Participant withdrew consent|1|||
13105245|NCT03329846|25879187|FG001|Overall Study|Participant withdrew consent|0|||
13105246|NCT03329846|25879186|FG000|Overall Study|Other reasons|2|||
13105247|NCT03329846|25879187|FG001|Overall Study|Other reasons|2|||
13105248|NCT03329690|25879287|FG000|Overall Study|Progressive disease per RECIST|85|||
13105249|NCT03329690|25879288|FG001|Overall Study|Progressive disease per RECIST|44|||
13105250|NCT03329690|25879289|FG002|Overall Study|Progressive disease per RECIST|6|||
13105251|NCT03329690|25879290|FG003|Overall Study|Progressive disease per RECIST|16|||
13105252|NCT03329690|25879291|FG004|Overall Study|Progressive disease per RECIST|20|||
13105253|NCT03329690|25879287|FG000|Overall Study|Clinical progression|7|||
13105254|NCT03329690|25879288|FG001|Overall Study|Clinical progression|4|||
13105255|NCT03329690|25879289|FG002|Overall Study|Clinical progression|1|||
13105256|NCT03329690|25879290|FG003|Overall Study|Clinical progression|1|||
13105257|NCT03329690|25879291|FG004|Overall Study|Clinical progression|1|||
13105258|NCT03329690|25879287|FG000|Overall Study|Adverse Event|22|||
13105259|NCT03329690|25879288|FG001|Overall Study|Adverse Event|4|||
13105260|NCT03329690|25879289|FG002|Overall Study|Adverse Event|0|||
13105261|NCT03329690|25879290|FG003|Overall Study|Adverse Event|1|||
13105262|NCT03329690|25879291|FG004|Overall Study|Adverse Event|2|||
13105263|NCT03329690|25879287|FG000|Overall Study|Death|2|||
13105264|NCT03329690|25879288|FG001|Overall Study|Death|0|||
13105265|NCT03329690|25879289|FG002|Overall Study|Death|0|||
13105266|NCT03329690|25879290|FG003|Overall Study|Death|1|||
13105267|NCT03329690|25879291|FG004|Overall Study|Death|0|||
13105268|NCT03329690|25879287|FG000|Overall Study|Withdrawal by Subject|2|||
13105269|NCT03329690|25879288|FG001|Overall Study|Withdrawal by Subject|3|||
13105270|NCT03329690|25879289|FG002|Overall Study|Withdrawal by Subject|0|||
13105271|NCT03329690|25879290|FG003|Overall Study|Withdrawal by Subject|1|||
13105272|NCT03329690|25879291|FG004|Overall Study|Withdrawal by Subject|0|||
13105273|NCT03329690|25879287|FG000|Overall Study|Physician Decision|1|||
13105274|NCT03329690|25879288|FG001|Overall Study|Physician Decision|0|||
13105275|NCT03329690|25879289|FG002|Overall Study|Physician Decision|0|||
13105276|NCT03329690|25879290|FG003|Overall Study|Physician Decision|0|||
13105277|NCT03329690|25879291|FG004|Overall Study|Physician Decision|1|||
13105278|NCT03329690|25879287|FG000|Overall Study|Miscellaneous|6|||
13105279|NCT03329690|25879288|FG001|Overall Study|Miscellaneous|0|||
13105280|NCT03329690|25879289|FG002|Overall Study|Miscellaneous|0|||
13105281|NCT03329690|25879290|FG003|Overall Study|Miscellaneous|0|||
13105282|NCT03329690|25879291|FG004|Overall Study|Miscellaneous|0|||
13105283|NCT03329690|25879287|FG000|Overall Study|Did not receive treatment|1|||
13105284|NCT03329690|25879288|FG001|Overall Study|Did not receive treatment|0|||
13105285|NCT03329690|25879289|FG002|Overall Study|Did not receive treatment|0|||
13105286|NCT03329690|25879290|FG003|Overall Study|Did not receive treatment|1|||
13105287|NCT03329690|25879291|FG004|Overall Study|Did not receive treatment|0|||
13159301|NCT02454972|26079317|FG001|Overall Study|Treatment-related adverse events|1|||
13159302|NCT02454972|26079318|FG002|Overall Study|Treatment-related adverse events|1|||
13159303|NCT02454972|26079319|FG003|Overall Study|Treatment-related adverse events|0|||
13159304|NCT02454972|26079320|FG004|Overall Study|Treatment-related adverse events|2|||
13159305|NCT02454972|26079321|FG005|Overall Study|Treatment-related adverse events|0|||
13159306|NCT02454972|26079322|FG006|Overall Study|Treatment-related adverse events|0|||
13159307|NCT02454972|26079323|FG007|Overall Study|Treatment-related adverse events|2|||
13159308|NCT02454972|26079324|FG008|Overall Study|Treatment-related adverse events|2|||
13159309|NCT02454972|26079316|FG000|Overall Study|Patient moves to compassionate use|0|||
13159310|NCT02454972|26079317|FG001|Overall Study|Patient moves to compassionate use|0|||
13159311|NCT02454972|26079318|FG002|Overall Study|Patient moves to compassionate use|0|||
13159312|NCT02454972|26079319|FG003|Overall Study|Patient moves to compassionate use|0|||
13159313|NCT02454972|26079320|FG004|Overall Study|Patient moves to compassionate use|0|||
13159314|NCT02454972|26079321|FG005|Overall Study|Patient moves to compassionate use|0|||
13159315|NCT02454972|26079322|FG006|Overall Study|Patient moves to compassionate use|2|||
13159316|NCT02454972|26079323|FG007|Overall Study|Patient moves to compassionate use|0|||
13159317|NCT02454972|26079324|FG008|Overall Study|Patient moves to compassionate use|11|||
13159318|NCT02454972|26079316|FG000|Overall Study|Withdrawal by Subject|0|||
13159319|NCT02454972|26079317|FG001|Overall Study|Withdrawal by Subject|1|||
13159320|NCT02454972|26079318|FG002|Overall Study|Withdrawal by Subject|5|||
13159321|NCT02454972|26079319|FG003|Overall Study|Withdrawal by Subject|2|||
13159322|NCT02454972|26079320|FG004|Overall Study|Withdrawal by Subject|3|||
13159323|NCT02454972|26079321|FG005|Overall Study|Withdrawal by Subject|2|||
13159324|NCT02454972|26079322|FG006|Overall Study|Withdrawal by Subject|0|||
13159325|NCT02454972|26079323|FG007|Overall Study|Withdrawal by Subject|1|||
13159326|NCT02454972|26079324|FG008|Overall Study|Withdrawal by Subject|2|||
13159327|NCT02454972|26079316|FG000|Overall Study|Multiple delay/holds on treatment|0|||
13159328|NCT02454972|26079317|FG001|Overall Study|Multiple delay/holds on treatment|0|||
13159329|NCT02454972|26079318|FG002|Overall Study|Multiple delay/holds on treatment|0|||
13159330|NCT02454972|26079319|FG003|Overall Study|Multiple delay/holds on treatment|1|||
13159331|NCT02454972|26079320|FG004|Overall Study|Multiple delay/holds on treatment|0|||
13159332|NCT02454972|26079321|FG005|Overall Study|Multiple delay/holds on treatment|0|||
13159333|NCT02454972|26079322|FG006|Overall Study|Multiple delay/holds on treatment|0|||
13159334|NCT02454972|26079323|FG007|Overall Study|Multiple delay/holds on treatment|0|||
13159335|NCT02454972|26079324|FG008|Overall Study|Multiple delay/holds on treatment|0|||
13159336|NCT02454972|26079316|FG000|Overall Study|Never treated|0|||
13159337|NCT02454972|26079317|FG001|Overall Study|Never treated|0|||
13159338|NCT02454972|26079318|FG002|Overall Study|Never treated|3|||
13159339|NCT02454972|26079319|FG003|Overall Study|Never treated|1|||
13159340|NCT02454972|26079320|FG004|Overall Study|Never treated|1|||
13159341|NCT02454972|26079321|FG005|Overall Study|Never treated|0|||
13159342|NCT02454972|26079322|FG006|Overall Study|Never treated|0|||
13159343|NCT02454972|26079323|FG007|Overall Study|Never treated|0|||
13159344|NCT02454972|26079324|FG008|Overall Study|Never treated|5|||
13159345|NCT02454959|26079344|FG000|Overall Study|Protocol-Specified Criteria|3|||
13159346|NCT02454959|26079344|FG000|Overall Study|Physician Decision|1|||
13159347|NCT02454959|26079344|FG000|Overall Study|Withdrawal by Subject|3|||
13159348|NCT02454959|26079344|FG000|Overall Study|Adverse Event|2|||
13105288|NCT03329573|25879370|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
13105289|NCT03329573|25879371|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1|||
13105290|NCT03329573|25879372|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
13105291|NCT03329573|25879373|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
13105292|NCT03329573|25879370|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
13105293|NCT03329573|25879371|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2|||
13105294|NCT03329573|25879372|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
13105295|NCT03329573|25879373|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
13105296|NCT03329573|25879370|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1|||
13105297|NCT03329573|25879371|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
13105298|NCT03329573|25879372|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
13105299|NCT03329573|25879373|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
13105300|NCT03329573|25879370|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
13105301|NCT03329573|25879371|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1|||
13105302|NCT03329573|25879372|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
13105303|NCT03329573|25879373|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
13105304|NCT03329404|25879386|FG000|Overall Study|The study was suspended.|1|||
13105305|NCT03329404|25879387|FG001|Overall Study|The study was suspended.|4|||
13105306|NCT03329196|25879410|FG000|Overall Study|Adverse Event|10|||
13105307|NCT03329196|25879411|FG001|Overall Study|Adverse Event|5|||
13105308|NCT03329196|25879410|FG000|Overall Study|Physician Decision|2|||
13105309|NCT03329196|25879411|FG001|Overall Study|Physician Decision|2|||
13159349|NCT02454608|26079375|FG000|Double-Blind Period|Lack of Efficacy|0|||
13159350|NCT02454608|26079376|FG001|Double-Blind Period|Lack of Efficacy|2|||
13159351|NCT02454608|26079377|FG002|Double-Blind Period|Lack of Efficacy|0|||
13105310|NCT03329196|25879410|FG000|Overall Study|Withdrawal by Subject|11|||
13105311|NCT03329196|25879411|FG001|Overall Study|Withdrawal by Subject|3|||
13105312|NCT03329196|25879410|FG000|Overall Study|Hepatic function abnormalities|0|||
13105313|NCT03329196|25879411|FG001|Overall Study|Hepatic function abnormalities|1|||
13105314|NCT03329196|25879410|FG000|Overall Study|Conducting rescue therapy before Week 24|2|||
13105315|NCT03329196|25879411|FG001|Overall Study|Conducting rescue therapy before Week 24|1|||
13105316|NCT03329196|25879410|FG000|Overall Study|Difficult to control Hb|2|||
13105317|NCT03329196|25879411|FG001|Overall Study|Difficult to control Hb|3|||
13105318|NCT03329196|25879410|FG000|Overall Study|Dialysis or renal transplant|13|||
13105319|NCT03329196|25879411|FG001|Overall Study|Dialysis or renal transplant|15|||
13105320|NCT03328897|25879450|FG000|Randomized-treatment Epoch|Adverse Event|4|||
13159352|NCT02454608|26079375|FG000|Open Label Period|Lost to Follow-up|0|||
13159353|NCT02454608|26079376|FG001|Open Label Period|Lost to Follow-up|0|||
13159354|NCT02454608|26079377|FG002|Open Label Period|Lost to Follow-up|11|||
13159355|NCT02454608|26079375|FG000|Open Label Period|Withdrawal by Subject|0|||
13159356|NCT02454608|26079376|FG001|Open Label Period|Withdrawal by Subject|0|||
13159357|NCT02454608|26079377|FG002|Open Label Period|Withdrawal by Subject|8|||
13159358|NCT02454530|26079421|FG000|Overall Study|Other|8|||
13159359|NCT02454530|26079422|FG001|Overall Study|Other|13|||
13159360|NCT02454530|26079421|FG000|Overall Study|Missing information|56|||
13159361|NCT02454530|26079422|FG001|Overall Study|Missing information|69|||
13159362|NCT02454530|26079421|FG000|Overall Study|Death|2|||
13159363|NCT02454530|26079422|FG001|Overall Study|Death|41|||
13159364|NCT02454530|26079421|FG000|Overall Study|Lost to Follow-up|4|||
13159365|NCT02454530|26079422|FG001|Overall Study|Lost to Follow-up|4|||
13159366|NCT02454478|26079438|FG000|Overall Study|Incomplete DLT Evaluation|1|||
13159367|NCT02454101|26079467|FG000|Overall Study|Adverse Event|2|||
13159368|NCT02454101|26079468|FG001|Overall Study|Adverse Event|3|||
13159369|NCT02454101|26079467|FG000|Overall Study|Lost to Follow-up|3|||
13159370|NCT02454101|26079468|FG001|Overall Study|Lost to Follow-up|4|||
13159371|NCT02453841|26079477|FG000|Overall Study|Protocol Violation|1|||
13159372|NCT02453841|26079477|FG000|Overall Study|Unable to obtain blood samples|2|||
13159373|NCT02453711|26079847|FG000|Overall Study|Withdrawal by Subject|5|||
13159374|NCT02453711|26079848|FG001|Overall Study|Withdrawal by Subject|4|||
13159375|NCT02453711|26079849|FG002|Overall Study|Withdrawal by Subject|6|||
13159376|NCT02453711|26079850|FG003|Overall Study|Withdrawal by Subject|4|||
13159377|NCT02453711|26079851|FG004|Overall Study|Withdrawal by Subject|1|||
13159378|NCT02453711|26079852|FG005|Overall Study|Withdrawal by Subject|1|||
13159379|NCT02453711|26079853|FG006|Overall Study|Withdrawal by Subject|0|||
13159380|NCT02453711|26079854|FG007|Overall Study|Withdrawal by Subject|1|||
13159381|NCT02453711|26079855|FG008|Overall Study|Withdrawal by Subject|7|||
13159382|NCT02453711|26079847|FG000|Overall Study|Lost to Follow-up|5|||
13159383|NCT02453711|26079848|FG001|Overall Study|Lost to Follow-up|3|||
13159384|NCT02453711|26079849|FG002|Overall Study|Lost to Follow-up|2|||
13159385|NCT02453711|26079850|FG003|Overall Study|Lost to Follow-up|3|||
13159386|NCT02453711|26079851|FG004|Overall Study|Lost to Follow-up|1|||
13159387|NCT02453711|26079852|FG005|Overall Study|Lost to Follow-up|5|||
13159388|NCT02453711|26079853|FG006|Overall Study|Lost to Follow-up|2|||
13159389|NCT02453711|26079854|FG007|Overall Study|Lost to Follow-up|6|||
13159390|NCT02453711|26079855|FG008|Overall Study|Lost to Follow-up|6|||
13159391|NCT02453711|26079847|FG000|Overall Study|Death|0|||
13159392|NCT02453711|26079848|FG001|Overall Study|Death|0|||
13159393|NCT02453711|26079849|FG002|Overall Study|Death|0|||
13159394|NCT02453711|26079850|FG003|Overall Study|Death|0|||
13159395|NCT02453711|26079851|FG004|Overall Study|Death|0|||
13159396|NCT02453711|26079852|FG005|Overall Study|Death|0|||
13159397|NCT02453711|26079853|FG006|Overall Study|Death|1|||
13159398|NCT02453711|26079854|FG007|Overall Study|Death|0|||
13159399|NCT02453711|26079855|FG008|Overall Study|Death|0|||
13159400|NCT02453711|26079847|FG000|Overall Study|Unclassified|1|||
13159401|NCT02453711|26079848|FG001|Overall Study|Unclassified|0|||
13159402|NCT02453711|26079849|FG002|Overall Study|Unclassified|1|||
13159403|NCT02453711|26079850|FG003|Overall Study|Unclassified|0|||
13159404|NCT02453711|26079851|FG004|Overall Study|Unclassified|0|||
13159405|NCT02453711|26079852|FG005|Overall Study|Unclassified|0|||
13159406|NCT02453711|26079853|FG006|Overall Study|Unclassified|0|||
13159407|NCT02453711|26079854|FG007|Overall Study|Unclassified|0|||
13159408|NCT02453711|26079855|FG008|Overall Study|Unclassified|0|||
13159409|NCT02453685|26079874|FG000|Overall Study|Adverse Event|0|||
13159410|NCT02453685|26079875|FG001|Overall Study|Adverse Event|1|||
13159411|NCT02453685|26079874|FG000|Overall Study|Protocol Violation|7|||
13159412|NCT02453685|26079875|FG001|Overall Study|Protocol Violation|4|||
13159413|NCT02453685|26079874|FG000|Overall Study|Lost to Follow-up|0|||
13159414|NCT02453685|26079875|FG001|Overall Study|Lost to Follow-up|1|||
13222811|NCT01802879|26286933|FG000|Overall Study|Disease progression|6|||
13159415|NCT02453685|26079874|FG000|Overall Study|Withdrawal by Subject|8|||
13159416|NCT02453685|26079875|FG001|Overall Study|Withdrawal by Subject|4|||
13105321|NCT03328897|25879451|FG001|Randomized-treatment Epoch|Adverse Event|1|||
13159417|NCT02453685|26079874|FG000|Overall Study|Unclassified|4|||
13105322|NCT03328897|25879452|FG002|Randomized-treatment Epoch|Adverse Event|1|||
13159418|NCT02453685|26079875|FG001|Overall Study|Unclassified|2|||
13159419|NCT02453555|26079899|FG000|24-week Double-blind Treatment Period|Adverse Event|2|||
13159420|NCT02453555|26079900|FG001|24-week Double-blind Treatment Period|Adverse Event|0|||
13159421|NCT02453555|26079901|FG002|24-week Double-blind Treatment Period|Adverse Event|0|||
13105323|NCT03328897|25879450|FG000|Randomized-treatment Epoch|Lost to Follow-up|0|||
13105324|NCT03328897|25879451|FG001|Randomized-treatment Epoch|Lost to Follow-up|1|||
13105325|NCT03328897|25879452|FG002|Randomized-treatment Epoch|Lost to Follow-up|0|||
13105326|NCT03328897|25879450|FG000|Randomized-treatment Epoch|Pregnancy|3|||
13105327|NCT03328897|25879451|FG001|Randomized-treatment Epoch|Pregnancy|0|||
13105328|NCT03328897|25879452|FG002|Randomized-treatment Epoch|Pregnancy|0|||
13159422|NCT02453555|26079902|FG003|24-week Double-blind Treatment Period|Adverse Event|0|||
13159423|NCT02453555|26079903|FG004|24-week Double-blind Treatment Period|Adverse Event|0|||
13159424|NCT02453555|26079904|FG005|24-week Double-blind Treatment Period|Adverse Event|0|||
13159425|NCT02453555|26079899|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1|||
13159426|NCT02453555|26079900|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
13159427|NCT02453555|26079901|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
13159428|NCT02453555|26079902|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
13159429|NCT02453555|26079903|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
13159430|NCT02453555|26079904|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
13159431|NCT02453555|26079899|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2|||
13159432|NCT02453555|26079900|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4|||
13159433|NCT02453555|26079901|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
13159434|NCT02453555|26079902|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
13159435|NCT02453555|26079903|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
13159436|NCT02453555|26079904|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
13159437|NCT02453555|26079899|FG000|24-week Double-blind Treatment Period|Other than specified above|0|||
13159438|NCT02453555|26079900|FG001|24-week Double-blind Treatment Period|Other than specified above|3|||
13159439|NCT02453555|26079901|FG002|24-week Double-blind Treatment Period|Other than specified above|0|||
13159440|NCT02453555|26079902|FG003|24-week Double-blind Treatment Period|Other than specified above|0|||
13159441|NCT02453555|26079903|FG004|24-week Double-blind Treatment Period|Other than specified above|0|||
13159442|NCT02453555|26079904|FG005|24-week Double-blind Treatment Period|Other than specified above|0|||
13159443|NCT02453555|26079899|FG000|Extension Period|Adverse Event|0|||
13159444|NCT02453555|26079900|FG001|Extension Period|Adverse Event|0|||
13159445|NCT02453555|26079901|FG002|Extension Period|Adverse Event|1|||
13159446|NCT02453555|26079902|FG003|Extension Period|Adverse Event|2|||
13159447|NCT02453555|26079903|FG004|Extension Period|Adverse Event|1|||
13159448|NCT02453555|26079904|FG005|Extension Period|Adverse Event|1|||
13159449|NCT02453555|26079899|FG000|Extension Period|Protocol Violation|0|||
13159450|NCT02453555|26079900|FG001|Extension Period|Protocol Violation|0|||
13159451|NCT02453555|26079901|FG002|Extension Period|Protocol Violation|1|||
13159452|NCT02453555|26079902|FG003|Extension Period|Protocol Violation|0|||
13159453|NCT02453555|26079903|FG004|Extension Period|Protocol Violation|0|||
13159454|NCT02453555|26079904|FG005|Extension Period|Protocol Violation|0|||
13159455|NCT02453555|26079899|FG000|Extension Period|Withdrawal by Subject|0|||
13159456|NCT02453555|26079900|FG001|Extension Period|Withdrawal by Subject|0|||
13159457|NCT02453555|26079901|FG002|Extension Period|Withdrawal by Subject|1|||
13159458|NCT02453555|26079902|FG003|Extension Period|Withdrawal by Subject|0|||
13159459|NCT02453555|26079903|FG004|Extension Period|Withdrawal by Subject|0|||
13159460|NCT02453555|26079904|FG005|Extension Period|Withdrawal by Subject|0|||
13159461|NCT02453386|26079937|FG000|Overall Study|Adverse Event|22|||
13159462|NCT02453386|26079938|FG001|Overall Study|Adverse Event|30|||
13159463|NCT02453386|26079939|FG002|Overall Study|Adverse Event|15|||
13159464|NCT02453386|26079937|FG000|Overall Study|Protocol Violation|1|||
13159465|NCT02453386|26079938|FG001|Overall Study|Protocol Violation|0|||
13159466|NCT02453386|26079939|FG002|Overall Study|Protocol Violation|1|||
13159467|NCT02453386|26079937|FG000|Overall Study|Withdrawal by Subject|10|||
13159468|NCT02453386|26079938|FG001|Overall Study|Withdrawal by Subject|9|||
13159469|NCT02453386|26079939|FG002|Overall Study|Withdrawal by Subject|9|||
13159470|NCT02453386|26079937|FG000|Overall Study|Sponsor Terminated Study|14|||
13105329|NCT03328897|25879450|FG000|Randomized-treatment Epoch|Patient/guardian decision|8|||
13105330|NCT03328897|25879451|FG001|Randomized-treatment Epoch|Patient/guardian decision|3|||
13105331|NCT03328897|25879452|FG002|Randomized-treatment Epoch|Patient/guardian decision|1|||
13105332|NCT03328897|25879450|FG000|Randomized-treatment Epoch|Lack of Efficacy|1|||
13105333|NCT03328897|25879451|FG001|Randomized-treatment Epoch|Lack of Efficacy|0|||
13105334|NCT03328897|25879452|FG002|Randomized-treatment Epoch|Lack of Efficacy|0|||
13105335|NCT03328897|25879450|FG000|Follow-up Epoch|Adverse Event|4|||
13105336|NCT03328897|25879451|FG001|Follow-up Epoch|Adverse Event|0|||
13105337|NCT03328897|25879452|FG002|Follow-up Epoch|Adverse Event|1|||
13105338|NCT03328897|25879450|FG000|Follow-up Epoch|Lack of Efficacy|1|||
13105339|NCT03328897|25879451|FG001|Follow-up Epoch|Lack of Efficacy|1|||
13159471|NCT02453386|26079938|FG001|Overall Study|Sponsor Terminated Study|8|||
13159472|NCT02453386|26079939|FG002|Overall Study|Sponsor Terminated Study|11|||
13159473|NCT02453386|26079937|FG000|Overall Study|Subject Terminated by Sponsor|1|||
13159474|NCT02453386|26079938|FG001|Overall Study|Subject Terminated by Sponsor|1|||
13159475|NCT02453386|26079939|FG002|Overall Study|Subject Terminated by Sponsor|1|||
13159476|NCT02453386|26079937|FG000|Overall Study|Sponsor Terminated by Investigator|0|||
13159477|NCT02453386|26079938|FG001|Overall Study|Sponsor Terminated by Investigator|1|||
13159478|NCT02453386|26079939|FG002|Overall Study|Sponsor Terminated by Investigator|2|||
13159479|NCT02453386|26079937|FG000|Overall Study|Lost to Follow-up|0|||
13159480|NCT02453386|26079938|FG001|Overall Study|Lost to Follow-up|0|||
13159481|NCT02453386|26079939|FG002|Overall Study|Lost to Follow-up|1|||
13159482|NCT02453386|26079937|FG000|Overall Study|Other|1|||
13159483|NCT02453386|26079938|FG001|Overall Study|Other|0|||
13159484|NCT02453386|26079939|FG002|Overall Study|Other|1|||
13159485|NCT02453334|26079988|FG000|Overall Study|Death|15|||
13159486|NCT02453334|26079989|FG001|Overall Study|Death|13|||
13159487|NCT02453334|26079988|FG000|Overall Study|Adverse Event|2|||
13159488|NCT02453334|26079989|FG001|Overall Study|Adverse Event|1|||
13159489|NCT02453334|26079988|FG000|Overall Study|Lost to Follow-up|5|||
13159490|NCT02453334|26079989|FG001|Overall Study|Lost to Follow-up|9|||
13159491|NCT02453334|26079988|FG000|Overall Study|Physician Decision|1|||
13159492|NCT02453334|26079989|FG001|Overall Study|Physician Decision|0|||
13159493|NCT02453334|26079988|FG000|Overall Study|Withdrawal by Subject|17|||
13105340|NCT03328897|25879452|FG002|Follow-up Epoch|Lack of Efficacy|1|||
13105341|NCT03328897|25879450|FG000|Follow-up Epoch|Lost to Follow-up|0|||
13105342|NCT03328897|25879451|FG001|Follow-up Epoch|Lost to Follow-up|1|||
13159494|NCT02453334|26079989|FG001|Overall Study|Withdrawal by Subject|13|||
13159495|NCT02453334|26079988|FG000|Overall Study|Other reason|1|||
13159496|NCT02453334|26079989|FG001|Overall Study|Other reason|4|||
13159497|NCT02453321|26080016|FG000|Overall Study|Weakness|1|||
13159498|NCT02453321|26080017|FG001|Overall Study|Weakness|1|||
13159499|NCT02453321|26080018|FG002|Overall Study|Weakness|2|||
13159500|NCT02453321|26080016|FG000|Overall Study|Deep Venous Thrombosis|0|||
13159501|NCT02453321|26080017|FG001|Overall Study|Deep Venous Thrombosis|1|||
13159502|NCT02453321|26080018|FG002|Overall Study|Deep Venous Thrombosis|0|||
13159503|NCT02453256|26080145|FG000|Double Blind Period|Death|1|||
13159504|NCT02453256|26080146|FG001|Double Blind Period|Death|1|||
13159505|NCT02453256|26080145|FG000|Double Blind Period|Adverse Event|3|||
13159506|NCT02453256|26080146|FG001|Double Blind Period|Adverse Event|2|||
13159507|NCT02453256|26080145|FG000|Double Blind Period|Withdrawal by Subject|9|||
13159508|NCT02453256|26080146|FG001|Double Blind Period|Withdrawal by Subject|5|||
13159509|NCT02453256|26080145|FG000|Double Blind Period|Other|0|||
13159510|NCT02453256|26080146|FG001|Double Blind Period|Other|1|||
13159511|NCT02453256|26080145|FG000|Open Label Period|Adverse Event|1|||
13159512|NCT02453256|26080146|FG001|Open Label Period|Adverse Event|3|||
13159513|NCT02453256|26080145|FG000|Open Label Period|Death|0|||
13159514|NCT02453256|26080146|FG001|Open Label Period|Death|1|||
13159515|NCT02453256|26080145|FG000|Open Label Period|Lost to Follow-up|1|||
13159516|NCT02453256|26080146|FG001|Open Label Period|Lost to Follow-up|0|||
13159517|NCT02453256|26080145|FG000|Open Label Period|Other|0|||
13105343|NCT03328897|25879452|FG002|Follow-up Epoch|Lost to Follow-up|0|||
13105344|NCT03328897|25879450|FG000|Follow-up Epoch|Pregnancy|1|||
13105345|NCT03328897|25879451|FG001|Follow-up Epoch|Pregnancy|0|||
13105346|NCT03328897|25879452|FG002|Follow-up Epoch|Pregnancy|0|||
13105347|NCT03328897|25879450|FG000|Follow-up Epoch|Patient/guardian decision|2|||
13105348|NCT03328897|25879451|FG001|Follow-up Epoch|Patient/guardian decision|1|||
13105349|NCT03328897|25879452|FG002|Follow-up Epoch|Patient/guardian decision|0|||
13105350|NCT03328832|25879469|FG000|Overall Study|Lost to Follow-up|0|||
13105351|NCT03328832|25879470|FG001|Overall Study|Lost to Follow-up|1|||
13105352|NCT03328325|25879481|FG000|Overall Study|Lost to Follow-up|4|||
13105353|NCT03328325|25879481|FG000|Overall Study|Physician Decision|1|||
13105354|NCT03328325|25879481|FG000|Overall Study|Withdrawal by Subject|3|||
13105355|NCT03328325|25879481|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3|||
13105356|NCT03328182|25879488|FG000|Overall Study|Withdrawal by Subject|1|||
13105357|NCT03328182|25879488|FG000|Overall Study|Protocol Violation|2|||
13105358|NCT03328182|25879488|FG000|Overall Study|No Product Evaluated|1|||
13105359|NCT03327402|25879523|FG000|Overall Study|Withdrawal by Subject|1|||
13105360|NCT03327402|25879523|FG000|Overall Study|Other (Visit Out-Of-Window)|1|||
13105361|NCT03327220|25879542|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1|||
13105362|NCT03327220|25879543|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2|||
13105363|NCT03327220|25879542|FG000|Overall Study|Investigator Decision|2|||
13105364|NCT03327220|25879543|FG001|Overall Study|Investigator Decision|0|||
13105365|NCT03327220|25879542|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0|||
13105366|NCT03327220|25879543|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1|||
13159518|NCT02453256|26080146|FG001|Open Label Period|Other|2|||
13105367|NCT03327220|25879542|FG000|Overall Study|Fungal infection|1|||
13105368|NCT03327220|25879543|FG001|Overall Study|Fungal infection|0|||
13105369|NCT03327220|25879542|FG000|Overall Study|Discharged to Rehabilitation|0|||
13159519|NCT02453256|26080145|FG000|Open Label Period|Withdrawal by Subject|5|||
13159520|NCT02453256|26080146|FG001|Open Label Period|Withdrawal by Subject|1|||
13159521|NCT02453191|26080156|FG000|Overall Study|Withdrawal by Subject|1|||
13159522|NCT02453048|26080194|FG000|Overall Study|Only part of initial 6 mo. study|0|||
13159523|NCT02453048|26080195|FG001|Overall Study|Only part of initial 6 mo. study|0|||
13159524|NCT02453048|26080196|FG002|Overall Study|Only part of initial 6 mo. study|0|||
13105370|NCT03327220|25879543|FG001|Overall Study|Discharged to Rehabilitation|1|||
13105371|NCT03327220|25879542|FG000|Overall Study|Missing|1|||
13105372|NCT03327220|25879543|FG001|Overall Study|Missing|0|||
13105373|NCT03326869|25879558|FG000|Overall Study|Study data has been lost to natural disa|1|||
13159525|NCT02453048|26080197|FG003|Overall Study|Only part of initial 6 mo. study|0|||
13159526|NCT02453048|26080198|FG004|Overall Study|Only part of initial 6 mo. study|6|||
13159527|NCT02453048|26080194|FG000|Overall Study|Lost to Follow-up|0|||
13159528|NCT02453048|26080195|FG001|Overall Study|Lost to Follow-up|1|||
13159529|NCT02453048|26080196|FG002|Overall Study|Lost to Follow-up|2|||
13159530|NCT02453048|26080197|FG003|Overall Study|Lost to Follow-up|0|||
13159531|NCT02453048|26080198|FG004|Overall Study|Lost to Follow-up|0|||
13159532|NCT02452892|26080240|FG000|Week 1 Initial Randommization|Adverse Event|1|||
13159533|NCT02452892|26080241|FG001|Week 1 Initial Randommization|Adverse Event|0|||
13159534|NCT02452892|26080242|FG002|Week 1 Initial Randommization|Adverse Event|0|||
13159535|NCT02452892|26080243|FG003|Week 1 Initial Randommization|Adverse Event|0|||
13159536|NCT02452892|26080240|FG000|Week 1 Initial Randommization|Lost to Follow-up|0|||
13159537|NCT02452892|26080241|FG001|Week 1 Initial Randommization|Lost to Follow-up|0|||
13159538|NCT02452892|26080242|FG002|Week 1 Initial Randommization|Lost to Follow-up|1|||
13159539|NCT02452892|26080243|FG003|Week 1 Initial Randommization|Lost to Follow-up|0|||
13159540|NCT02452892|26080240|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
13159541|NCT02452892|26080241|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
13159542|NCT02452892|26080242|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
13159543|NCT02452892|26080243|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2|||
13159544|NCT02452892|26080240|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2|||
13159545|NCT02452892|26080241|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
13159546|NCT02452892|26080242|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
13159547|NCT02452892|26080243|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
13159548|NCT02452892|26080240|FG000|Follow-up|Withdrawal by Subject|0|||
13159549|NCT02452892|26080241|FG001|Follow-up|Withdrawal by Subject|0|||
13159550|NCT02452892|26080242|FG002|Follow-up|Withdrawal by Subject|0|||
13159551|NCT02452892|26080243|FG003|Follow-up|Withdrawal by Subject|1|||
13159552|NCT02452892|26080240|FG000|Follow-up|Subject left town on Day 42|1|||
13159553|NCT02452892|26080241|FG001|Follow-up|Subject left town on Day 42|0|||
13159554|NCT02452892|26080242|FG002|Follow-up|Subject left town on Day 42|0|||
13159555|NCT02452892|26080243|FG003|Follow-up|Subject left town on Day 42|0|||
13159556|NCT02452762|26080265|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4|||
13159557|NCT02452762|26080266|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3|||
13159558|NCT02452762|26080265|FG000|Overall Study|Withdrawal by Subject|1|||
13159559|NCT02452762|26080266|FG001|Overall Study|Withdrawal by Subject|0|||
13159560|NCT02452476|26080293|FG000|Overall Study|Death|4|||
13159561|NCT02452476|26080294|FG001|Overall Study|Death|7|||
13159562|NCT02452476|26080293|FG000|Overall Study|Lost to Follow-up|1|||
13159563|NCT02452476|26080294|FG001|Overall Study|Lost to Follow-up|1|||
13159564|NCT02452476|26080293|FG000|Overall Study|Physician Decision|1|||
13159565|NCT02452476|26080294|FG001|Overall Study|Physician Decision|1|||
13159566|NCT02452476|26080293|FG000|Overall Study|Not treated|5|||
13159567|NCT02452476|26080294|FG001|Overall Study|Not treated|1|||
13159568|NCT02452463|26080336|FG000|Overall Study|Death|1|||
13159569|NCT02452463|26080337|FG001|Overall Study|Death|0|||
13159570|NCT02452463|26080338|FG002|Overall Study|Death|0|||
13159571|NCT02452463|26080336|FG000|Overall Study|Study Suspended|1|||
13159572|NCT02452463|26080337|FG001|Overall Study|Study Suspended|0|||
13159573|NCT02452463|26080338|FG002|Overall Study|Study Suspended|0|||
13159574|NCT02452463|26080336|FG000|Overall Study|Recommended by DSMB|0|||
13159575|NCT02452463|26080337|FG001|Overall Study|Recommended by DSMB|1|||
13159576|NCT02452463|26080338|FG002|Overall Study|Recommended by DSMB|0|||
13105374|NCT03326869|25879559|FG001|Overall Study|Study data has been lost to natural disa|1|||
13105375|NCT03326856|25879597|FG000|Overall Study|Lost to Follow-up|1|||
13105376|NCT03326856|25879598|FG001|Overall Study|Lost to Follow-up|1|||
13105377|NCT03326856|25879599|FG002|Overall Study|Lost to Follow-up|0|||
13105378|NCT03326856|25879600|FG003|Overall Study|Lost to Follow-up|0|||
13105379|NCT03326856|25879601|FG004|Overall Study|Lost to Follow-up|0|||
13105380|NCT03326518|25879646|FG000|Overall Study|Protocol Violation|1|||
13105381|NCT03326518|25879647|FG001|Overall Study|Protocol Violation|0|||
13105382|NCT03326518|25879648|FG002|Overall Study|Protocol Violation|0|||
13105383|NCT03326518|25879646|FG000|Overall Study|Withdrawal by Subject|1|||
13105384|NCT03326518|25879647|FG001|Overall Study|Withdrawal by Subject|0|||
13159577|NCT02452463|26080336|FG000|Overall Study|Withdrawal by Subject|0|||
13159578|NCT02452463|26080337|FG001|Overall Study|Withdrawal by Subject|1|||
13159579|NCT02452463|26080338|FG002|Overall Study|Withdrawal by Subject|0|||
13105385|NCT03326518|25879648|FG002|Overall Study|Withdrawal by Subject|0|||
13105386|NCT03326518|25879646|FG000|Overall Study|Lost to Follow-up|1|||
13105387|NCT03326518|25879647|FG001|Overall Study|Lost to Follow-up|0|||
13105388|NCT03326518|25879648|FG002|Overall Study|Lost to Follow-up|1|||
13105389|NCT03326323|25879655|FG000|Overall Study|Unable to receive ANH protocol|3|||
13105390|NCT03325894|25879728|FG000|Overall Study|Adverse Event|2|||
13105391|NCT03325894|25879729|FG001|Overall Study|Adverse Event|3|||
13105392|NCT03325894|25879728|FG000|Overall Study|Protocol Violation|1|||
13105393|NCT03325894|25879729|FG001|Overall Study|Protocol Violation|2|||
13159580|NCT02452424|26080407|FG000|Overall Study|Death|2|||
13159581|NCT02452424|26080408|FG001|Overall Study|Death|2|||
13159582|NCT02452424|26080409|FG002|Overall Study|Death|2|||
13159583|NCT02452424|26080410|FG003|Overall Study|Death|6|||
13159584|NCT02452424|26080411|FG004|Overall Study|Death|2|||
13159585|NCT02452424|26080412|FG005|Overall Study|Death|0|||
13105394|NCT03325894|25879728|FG000|Overall Study|Withdrawal by Subject|10|||
13105395|NCT03325894|25879729|FG001|Overall Study|Withdrawal by Subject|6|||
13105396|NCT03325894|25879728|FG000|Overall Study|Lost to Follow-up|4|||
13105397|NCT03325894|25879729|FG001|Overall Study|Lost to Follow-up|9|||
13105398|NCT03325894|25879728|FG000|Overall Study|Lack of Efficacy|8|||
13105399|NCT03325894|25879729|FG001|Overall Study|Lack of Efficacy|14|||
13105400|NCT03325894|25879728|FG000|Overall Study|Study Terminated by Sponsor|38|||
13105401|NCT03325894|25879729|FG001|Overall Study|Study Terminated by Sponsor|43|||
13105402|NCT03325894|25879728|FG000|Overall Study|Other (Not received Treatment)|1|||
13159586|NCT02452424|26080413|FG006|Overall Study|Death|5|||
13159587|NCT02452424|26080414|FG007|Overall Study|Death|1|||
13159588|NCT02452424|26080415|FG008|Overall Study|Death|3|||
13159589|NCT02452424|26080416|FG009|Overall Study|Death|1|||
13159590|NCT02452424|26080417|FG010|Overall Study|Death|0|||
13159591|NCT02452424|26080407|FG000|Overall Study|Lost to Follow-up|0|||
13159592|NCT02452424|26080408|FG001|Overall Study|Lost to Follow-up|1|||
13159593|NCT02452424|26080409|FG002|Overall Study|Lost to Follow-up|1|||
13159594|NCT02452424|26080410|FG003|Overall Study|Lost to Follow-up|0|||
13159595|NCT02452424|26080411|FG004|Overall Study|Lost to Follow-up|0|||
13159596|NCT02452424|26080412|FG005|Overall Study|Lost to Follow-up|0|||
13159597|NCT02452424|26080413|FG006|Overall Study|Lost to Follow-up|0|||
13159598|NCT02452424|26080414|FG007|Overall Study|Lost to Follow-up|0|||
13159599|NCT02452424|26080415|FG008|Overall Study|Lost to Follow-up|0|||
13159600|NCT02452424|26080416|FG009|Overall Study|Lost to Follow-up|0|||
13159601|NCT02452424|26080417|FG010|Overall Study|Lost to Follow-up|0|||
13159602|NCT02452424|26080407|FG000|Overall Study|Withdrawal by Subject|0|||
13159603|NCT02452424|26080408|FG001|Overall Study|Withdrawal by Subject|0|||
13159604|NCT02452424|26080409|FG002|Overall Study|Withdrawal by Subject|3|||
13159605|NCT02452424|26080410|FG003|Overall Study|Withdrawal by Subject|2|||
13159606|NCT02452424|26080411|FG004|Overall Study|Withdrawal by Subject|0|||
13159607|NCT02452424|26080412|FG005|Overall Study|Withdrawal by Subject|0|||
13159608|NCT02452424|26080413|FG006|Overall Study|Withdrawal by Subject|1|||
13159609|NCT02452424|26080414|FG007|Overall Study|Withdrawal by Subject|0|||
13159610|NCT02452424|26080415|FG008|Overall Study|Withdrawal by Subject|1|||
13159611|NCT02452424|26080416|FG009|Overall Study|Withdrawal by Subject|1|||
13159612|NCT02452424|26080417|FG010|Overall Study|Withdrawal by Subject|0|||
13159613|NCT02452424|26080407|FG000|Overall Study|Other|0|||
13159614|NCT02452424|26080408|FG001|Overall Study|Other|0|||
13159615|NCT02452424|26080409|FG002|Overall Study|Other|1|||
13159616|NCT02452424|26080410|FG003|Overall Study|Other|0|||
13159617|NCT02452424|26080411|FG004|Overall Study|Other|0|||
13159618|NCT02452424|26080412|FG005|Overall Study|Other|1|||
13159619|NCT02452424|26080413|FG006|Overall Study|Other|4|||
13159620|NCT02452424|26080414|FG007|Overall Study|Other|3|||
13159621|NCT02452424|26080415|FG008|Overall Study|Other|0|||
13159622|NCT02452424|26080416|FG009|Overall Study|Other|0|||
13159623|NCT02452424|26080417|FG010|Overall Study|Other|1|||
13159624|NCT02452424|26080407|FG000|Overall Study|Progressive disease (per RECIST)|0|||
13159625|NCT02452424|26080408|FG001|Overall Study|Progressive disease (per RECIST)|0|||
13159626|NCT02452424|26080409|FG002|Overall Study|Progressive disease (per RECIST)|0|||
13159627|NCT02452424|26080410|FG003|Overall Study|Progressive disease (per RECIST)|0|||
13159628|NCT02452424|26080411|FG004|Overall Study|Progressive disease (per RECIST)|0|||
13159629|NCT02452424|26080412|FG005|Overall Study|Progressive disease (per RECIST)|0|||
13159630|NCT02452424|26080413|FG006|Overall Study|Progressive disease (per RECIST)|0|||
13159631|NCT02452424|26080414|FG007|Overall Study|Progressive disease (per RECIST)|0|||
13105403|NCT03325894|25879729|FG001|Overall Study|Other (Not received Treatment)|0|||
13105404|NCT03325881|25879762|FG000|Overall Study|Protocol Violation|0|||
13159632|NCT02452424|26080415|FG008|Overall Study|Progressive disease (per RECIST)|2|||
13159633|NCT02452424|26080416|FG009|Overall Study|Progressive disease (per RECIST)|0|||
13159634|NCT02452424|26080417|FG010|Overall Study|Progressive disease (per RECIST)|0|||
13159635|NCT02452424|26080407|FG000|Overall Study|Adverse Event|0|||
13159636|NCT02452424|26080408|FG001|Overall Study|Adverse Event|0|||
13159637|NCT02452424|26080409|FG002|Overall Study|Adverse Event|0|||
13159638|NCT02452424|26080410|FG003|Overall Study|Adverse Event|0|||
13159639|NCT02452424|26080411|FG004|Overall Study|Adverse Event|0|||
13159640|NCT02452424|26080412|FG005|Overall Study|Adverse Event|0|||
13159641|NCT02452424|26080413|FG006|Overall Study|Adverse Event|0|||
13159642|NCT02452424|26080414|FG007|Overall Study|Adverse Event|0|||
13159643|NCT02452424|26080415|FG008|Overall Study|Adverse Event|0|||
13159644|NCT02452424|26080416|FG009|Overall Study|Adverse Event|0|||
13159645|NCT02452424|26080417|FG010|Overall Study|Adverse Event|1|||
13159646|NCT02452398|26080423|FG000|Overall Study|Adverse Event|1|||
13159647|NCT02452398|26080423|FG000|Overall Study|Lost to Follow-up|28|||
13159648|NCT02452398|26080423|FG000|Overall Study|Physician Decision|2|||
13159649|NCT02452398|26080423|FG000|Overall Study|Withdrawal by Subject|6|||
13159650|NCT02452398|26080423|FG000|Overall Study|Moved away|4|||
13159651|NCT02452359|26080429|FG000|Overall Study|Adverse Event|1|||
13159652|NCT02452359|26080429|FG000|Overall Study|Lost to Follow-up|15|||
13159653|NCT02452359|26080429|FG000|Overall Study|Pregnancy|1|||
13159654|NCT02452359|26080429|FG000|Overall Study|Withdrawal by Subject|4|||
13159655|NCT02452320|26080446|FG000|Overall Study|Adverse Event|0|||
13159656|NCT02452320|26080447|FG001|Overall Study|Adverse Event|1|||
13159657|NCT02452190|26080478|FG000|Overall Study|Withdrawal by Sponsor|1|||
13159658|NCT02452190|26080479|FG001|Overall Study|Withdrawal by Sponsor|3|||
13159659|NCT02452190|26080478|FG000|Overall Study|Pregnancy|1|||
13159660|NCT02452190|26080479|FG001|Overall Study|Pregnancy|0|||
13159661|NCT02452190|26080478|FG000|Overall Study|Investigator's Decision|2|||
13159662|NCT02452190|26080479|FG001|Overall Study|Investigator's Decision|0|||
13159663|NCT02452190|26080478|FG000|Overall Study|Lack of Efficacy|3|||
13159664|NCT02452190|26080479|FG001|Overall Study|Lack of Efficacy|1|||
13159665|NCT02452190|26080478|FG000|Overall Study|Lost to Follow-up|4|||
13159666|NCT02452190|26080479|FG001|Overall Study|Lost to Follow-up|3|||
13159667|NCT02452190|26080478|FG000|Overall Study|Adverse Event|2|||
13159668|NCT02452190|26080479|FG001|Overall Study|Adverse Event|5|||
13159669|NCT02452190|26080478|FG000|Overall Study|Withdrawal by Subject|20|||
13159670|NCT02452190|26080479|FG001|Overall Study|Withdrawal by Subject|11|||
13159671|NCT02452190|26080478|FG000|Overall Study|Noncompliance with study drug|1|||
13159672|NCT02452190|26080479|FG001|Overall Study|Noncompliance with study drug|0|||
13159673|NCT02452190|26080478|FG000|Overall Study|Participant traveled abroad|1|||
13159674|NCT02452190|26080479|FG001|Overall Study|Participant traveled abroad|0|||
13159675|NCT02452190|26080478|FG000|Overall Study|Death|0|||
13159676|NCT02452190|26080479|FG001|Overall Study|Death|1|||
13159677|NCT02452047|26080548|FG000|Overall Study|Adverse Event|0|||
13159678|NCT02452047|26080549|FG001|Overall Study|Adverse Event|1|||
13159679|NCT02452047|26080550|FG002|Overall Study|Adverse Event|1|||
13159680|NCT02452047|26080548|FG000|Overall Study|Death|1|||
13159681|NCT02452047|26080549|FG001|Overall Study|Death|3|||
13159682|NCT02452047|26080550|FG002|Overall Study|Death|1|||
13159683|NCT02452047|26080548|FG000|Overall Study|Physician Decision|1|||
13159684|NCT02452047|26080549|FG001|Overall Study|Physician Decision|0|||
13159685|NCT02452047|26080550|FG002|Overall Study|Physician Decision|0|||
13159686|NCT02452047|26080548|FG000|Overall Study|Lost to Follow-up|1|||
13159687|NCT02452047|26080549|FG001|Overall Study|Lost to Follow-up|1|||
13159688|NCT02452047|26080550|FG002|Overall Study|Lost to Follow-up|0|||
13159689|NCT02452047|26080548|FG000|Overall Study|Withdrawal by Subject|1|||
13159690|NCT02452047|26080549|FG001|Overall Study|Withdrawal by Subject|0|||
13159691|NCT02452047|26080550|FG002|Overall Study|Withdrawal by Subject|0|||
13159692|NCT02452034|26080631|FG000|Overall Study|Adverse Event|0|||
13159693|NCT02452034|26080632|FG001|Overall Study|Adverse Event|0|||
13159694|NCT02452034|26080633|FG002|Overall Study|Adverse Event|0|||
13159695|NCT02452034|26080634|FG003|Overall Study|Adverse Event|0|||
13159696|NCT02452034|26080635|FG004|Overall Study|Adverse Event|0|||
13159697|NCT02452034|26080636|FG005|Overall Study|Adverse Event|1|||
13159698|NCT02452034|26080631|FG000|Overall Study|Death|0|||
13159699|NCT02452034|26080632|FG001|Overall Study|Death|0|||
13159700|NCT02452034|26080633|FG002|Overall Study|Death|0|||
13159701|NCT02452034|26080634|FG003|Overall Study|Death|0|||
13159702|NCT02452034|26080635|FG004|Overall Study|Death|1|||
13159703|NCT02452034|26080636|FG005|Overall Study|Death|1|||
13159704|NCT02452034|26080631|FG000|Overall Study|Physician Decision|0|||
13159705|NCT02452034|26080632|FG001|Overall Study|Physician Decision|1|||
13159706|NCT02452034|26080633|FG002|Overall Study|Physician Decision|1|||
13159707|NCT02452034|26080634|FG003|Overall Study|Physician Decision|0|||
13159708|NCT02452034|26080635|FG004|Overall Study|Physician Decision|0|||
13159709|NCT02452034|26080636|FG005|Overall Study|Physician Decision|0|||
13159710|NCT02452034|26080631|FG000|Overall Study|Protocol Violation|0|||
13159711|NCT02452034|26080632|FG001|Overall Study|Protocol Violation|0|||
13159712|NCT02452034|26080633|FG002|Overall Study|Protocol Violation|0|||
13159713|NCT02452034|26080634|FG003|Overall Study|Protocol Violation|0|||
13159714|NCT02452034|26080635|FG004|Overall Study|Protocol Violation|0|||
13159715|NCT02452034|26080636|FG005|Overall Study|Protocol Violation|1|||
13159716|NCT02452034|26080631|FG000|Overall Study|Screen Failure|1|||
13159717|NCT02452034|26080632|FG001|Overall Study|Screen Failure|0|||
13159718|NCT02452034|26080633|FG002|Overall Study|Screen Failure|0|||
13159719|NCT02452034|26080634|FG003|Overall Study|Screen Failure|1|||
13159720|NCT02452034|26080635|FG004|Overall Study|Screen Failure|0|||
13159721|NCT02452034|26080636|FG005|Overall Study|Screen Failure|0|||
13159722|NCT02452034|26080631|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
13159723|NCT02452034|26080632|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
13159724|NCT02452034|26080633|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
13159725|NCT02452034|26080634|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
13159726|NCT02452034|26080635|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
13159727|NCT02452034|26080636|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
13159728|NCT02451943|26080669|FG000|Overall Study|On Treatment|4|||
13159729|NCT02451943|26080670|FG001|Overall Study|On Treatment|4|||
13159730|NCT02451943|26080669|FG000|Overall Study|Withdrawal by Subject|13|||
13159731|NCT02451943|26080670|FG001|Overall Study|Withdrawal by Subject|16|||
13159732|NCT02451943|26080669|FG000|Overall Study|Lost to Follow-up|3|||
13159733|NCT02451943|26080670|FG001|Overall Study|Lost to Follow-up|4|||
13159734|NCT02451930|26080700|FG000|Overall Study|Death|0|||
13159735|NCT02451930|26080701|FG001|Overall Study|Death|15|||
13159736|NCT02451930|26080700|FG000|Overall Study|Lost to Follow-up|0|||
13159737|NCT02451930|26080701|FG001|Overall Study|Lost to Follow-up|3|||
13159738|NCT02451930|26080700|FG000|Overall Study|Sponsor Decision|2|||
13159739|NCT02451930|26080701|FG001|Overall Study|Sponsor Decision|10|||
13159740|NCT02451930|26080700|FG000|Overall Study|Withdrawal by Subject|0|||
13159741|NCT02451930|26080701|FG001|Overall Study|Withdrawal by Subject|1|||
13159742|NCT02451930|26080700|FG000|Overall Study|Other|0|||
13159743|NCT02451930|26080701|FG001|Overall Study|Other|1|||
13159744|NCT02451917|26080726|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2|||
13159745|NCT02451917|26080727|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0|||
13159746|NCT02451917|26080726|FG000|First Intervention (24 Weeks)|Death|0|||
13159747|NCT02451917|26080727|FG001|First Intervention (24 Weeks)|Death|1|||
13159748|NCT02451917|26080726|FG000|First Intervention (24 Weeks)|Adverse Event|0|||
13159749|NCT02451917|26080727|FG001|First Intervention (24 Weeks)|Adverse Event|2|||
13159750|NCT02451696|26080748|FG000|Overall Study|Surgery postponed|1|||
13159751|NCT02451696|26080749|FG001|Overall Study|Surgery postponed|0|||
13159752|NCT02451670|26080762|FG000|Overall Study|Did not have qualifying follow-up visit.|714|||
13159753|NCT02451670|26080763|FG001|Overall Study|Did not have qualifying follow-up visit.|696|||
13159754|NCT02451358|26080798|FG000|Overall Study|Withdrawal by Subject|1|||
13159755|NCT02451358|26080799|FG001|Overall Study|Withdrawal by Subject|1|||
13159756|NCT02451358|26080800|FG002|Overall Study|Withdrawal by Subject|0|||
13159757|NCT02451358|26080801|FG003|Overall Study|Withdrawal by Subject|0|||
13159758|NCT02451358|26080798|FG000|Overall Study|Protocol Violation|0|||
13159759|NCT02451358|26080799|FG001|Overall Study|Protocol Violation|1|||
13159760|NCT02451358|26080800|FG002|Overall Study|Protocol Violation|1|||
13159761|NCT02451358|26080801|FG003|Overall Study|Protocol Violation|0|||
13159762|NCT02451137|26080838|FG000|Overall Study|Randomized but not treated|19|||
13159763|NCT02451137|26080839|FG001|Overall Study|Randomized but not treated|27|||
13159764|NCT02451137|26080838|FG000|Overall Study|Adverse Event|43|||
13159765|NCT02451137|26080839|FG001|Overall Study|Adverse Event|42|||
13159766|NCT02451137|26080838|FG000|Overall Study|Lack of Efficacy|4|||
13159767|NCT02451137|26080839|FG001|Overall Study|Lack of Efficacy|9|||
13159768|NCT02451137|26080838|FG000|Overall Study|Participant decision:discontinue insulin|41|||
13159769|NCT02451137|26080839|FG001|Overall Study|Participant decision:discontinue insulin|43|||
13159770|NCT02451137|26080838|FG000|Overall Study|Hypoglycemia|2|||
13159771|NCT02451137|26080839|FG001|Overall Study|Hypoglycemia|1|||
13159772|NCT02451137|26080838|FG000|Overall Study|Investigator's decision|23|||
13159773|NCT02451137|26080839|FG001|Overall Study|Investigator's decision|19|||
13159774|NCT02451137|26080838|FG000|Overall Study|Lost to Follow-up|53|||
13159775|NCT02451137|26080839|FG001|Overall Study|Lost to Follow-up|61|||
13159776|NCT02451137|26080838|FG000|Overall Study|Physician Decision|6|||
13159777|NCT02451137|26080839|FG001|Overall Study|Physician Decision|5|||
13159778|NCT02451137|26080838|FG000|Overall Study|Sponsor decision|13|||
13159779|NCT02451137|26080839|FG001|Overall Study|Sponsor decision|25|||
13159780|NCT02451137|26080838|FG000|Overall Study|Withdrawal by Subject|40|||
13159781|NCT02451137|26080839|FG001|Overall Study|Withdrawal by Subject|63|||
13159782|NCT02451137|26080838|FG000|Overall Study|Other than specified above|2|||
13159783|NCT02451137|26080839|FG001|Overall Study|Other than specified above|3|||
13159784|NCT02451124|26080852|FG000|Overall Study|Withdrawal by Subject|1|||
13159785|NCT02451007|26080861|FG000|Overall Study|Withdrawal by Subject|4|||
13159786|NCT02451007|26080861|FG000|Overall Study|Adverse Event|1|||
13159787|NCT02451007|26080861|FG000|Overall Study|Disease Progression|2|||
13159788|NCT02450903|26080874|FG000|Overall Study|Adverse Event|3|||
13159789|NCT02450903|26080874|FG000|Overall Study|Progressive disease|15|||
13159790|NCT02450903|26080874|FG000|Overall Study|Switched to commercial drug|1|||
13159791|NCT02450903|26080874|FG000|Overall Study|Subject/guardian decision|1|||
13159792|NCT02450578|26080930|FG000|Overall Study|ECG abnormality so not treated|1|||
13159793|NCT02450578|26080931|FG001|Overall Study|ECG abnormality so not treated|0|||
13159794|NCT02450578|26080932|FG002|Overall Study|ECG abnormality so not treated|0|||
13159795|NCT02450578|26080933|FG003|Overall Study|ECG abnormality so not treated|0|||
13222812|NCT01802775|26286956|FG000|Overall Study|Death|0|||
13159796|NCT02450552|26080984|FG000|Overall Study|Withdrawal by Subject|4|||
13159797|NCT02450552|26080985|FG001|Overall Study|Withdrawal by Subject|0|||
13159798|NCT02450552|26080986|FG002|Overall Study|Withdrawal by Subject|4|||
13159799|NCT02450552|26080984|FG000|Overall Study|Physician Decision|1|||
13159800|NCT02450552|26080985|FG001|Overall Study|Physician Decision|0|||
13159801|NCT02450552|26080986|FG002|Overall Study|Physician Decision|1|||
13159802|NCT02450539|26081015|FG000|Overall Study|Withdrawal by Subject|12|||
13159803|NCT02450539|26081016|FG001|Overall Study|Withdrawal by Subject|6|||
13159804|NCT02450539|26081015|FG000|Overall Study|Lost to Follow-up|4|||
13159805|NCT02450539|26081016|FG001|Overall Study|Lost to Follow-up|1|||
13159806|NCT02450526|26081115|FG000|DB Period (Cycle 1)|Adverse Event|0|||
13159807|NCT02450526|26081116|FG001|DB Period (Cycle 1)|Adverse Event|0|||
13159808|NCT02450526|26081117|FG002|DB Period (Cycle 1)|Adverse Event|2|||
13159809|NCT02450526|26081118|FG003|DB Period (Cycle 1)|Adverse Event|0|||
13159810|NCT02450526|26081119|FG004|DB Period (Cycle 1)|Adverse Event|0|||
13159811|NCT02450526|26081115|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28|||
13159812|NCT02450526|26081116|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3|||
13159813|NCT02450526|26081117|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8|||
13159814|NCT02450526|26081118|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1|||
13159815|NCT02450526|26081119|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0|||
13159816|NCT02450526|26081115|FG000|DB Period (Cycle 1)|Lost to Follow-up|1|||
13159817|NCT02450526|26081116|FG001|DB Period (Cycle 1)|Lost to Follow-up|0|||
13159818|NCT02450526|26081117|FG002|DB Period (Cycle 1)|Lost to Follow-up|0|||
13159819|NCT02450526|26081118|FG003|DB Period (Cycle 1)|Lost to Follow-up|0|||
13159820|NCT02450526|26081119|FG004|DB Period (Cycle 1)|Lost to Follow-up|0|||
13159821|NCT02450526|26081115|FG000|DB Period (Cycle 1)|Protocol Violation|2|||
13159822|NCT02450526|26081116|FG001|DB Period (Cycle 1)|Protocol Violation|0|||
13159823|NCT02450526|26081117|FG002|DB Period (Cycle 1)|Protocol Violation|0|||
13159824|NCT02450526|26081118|FG003|DB Period (Cycle 1)|Protocol Violation|1|||
13159825|NCT02450526|26081119|FG004|DB Period (Cycle 1)|Protocol Violation|0|||
13159826|NCT02450526|26081115|FG000|OL Period (Cycles 2-5)|Adverse Event|0|||
13159827|NCT02450526|26081116|FG001|OL Period (Cycles 2-5)|Adverse Event|0|||
13159828|NCT02450526|26081117|FG002|OL Period (Cycles 2-5)|Adverse Event|0|||
13159829|NCT02450526|26081118|FG003|OL Period (Cycles 2-5)|Adverse Event|0|||
13159830|NCT02450526|26081119|FG004|OL Period (Cycles 2-5)|Adverse Event|2|||
13159831|NCT02450526|26081115|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
13159832|NCT02450526|26081116|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
13159833|NCT02450526|26081117|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
13159834|NCT02450526|26081118|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
13159835|NCT02450526|26081119|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31|||
13159836|NCT02450526|26081115|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
13159837|NCT02450526|26081116|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
13159838|NCT02450526|26081117|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
13159839|NCT02450526|26081118|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
13159840|NCT02450526|26081119|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1|||
13159841|NCT02450526|26081115|FG000|OL Period (Cycles 2-5)|Protocol Violation|0|||
13159842|NCT02450526|26081116|FG001|OL Period (Cycles 2-5)|Protocol Violation|0|||
13159843|NCT02450526|26081117|FG002|OL Period (Cycles 2-5)|Protocol Violation|0|||
13159844|NCT02450526|26081118|FG003|OL Period (Cycles 2-5)|Protocol Violation|0|||
13159845|NCT02450526|26081119|FG004|OL Period (Cycles 2-5)|Protocol Violation|7|||
13159846|NCT02450487|26081126|FG000|Overall Study|Lost to Follow-up|3|||
13159847|NCT02450331|26081154|FG000|Overall Study|Death|120|||
13159848|NCT02450331|26081155|FG001|Overall Study|Death|114|||
13159849|NCT02450331|26081154|FG000|Overall Study|Lost to Follow-up|9|||
13159850|NCT02450331|26081155|FG001|Overall Study|Lost to Follow-up|7|||
13159851|NCT02450331|26081154|FG000|Overall Study|Withdrawal by Subject|50|||
13159852|NCT02450331|26081155|FG001|Overall Study|Withdrawal by Subject|39|||
13159853|NCT02450331|26081154|FG000|Overall Study|On-Study Status: In Disease recurrence follow-up|179|||
13159854|NCT02450331|26081155|FG001|Overall Study|On-Study Status: In Disease recurrence follow-up|208|||
13159855|NCT02450331|26081154|FG000|Overall Study|On-Study Status: In Survival follow-up|45|||
13159856|NCT02450331|26081155|FG001|Overall Study|On-Study Status: In Survival follow-up|38|||
13159857|NCT02449915|26081168|FG000|Overall Study|Exclusion criteria - drug use|1|||
13159858|NCT02449915|26081169|FG001|Overall Study|Exclusion criteria - drug use|0|||
13159859|NCT02449915|26081168|FG000|Overall Study|Withdrawal by Subject|0|||
13159860|NCT02449915|26081169|FG001|Overall Study|Withdrawal by Subject|2|||
13159861|NCT02449915|26081168|FG000|Overall Study|Intraoperative surgical findings|1|||
13159862|NCT02449915|26081169|FG001|Overall Study|Intraoperative surgical findings|1|||
13159863|NCT02449915|26081168|FG000|Overall Study|Abnormal preop lab|0|||
13159864|NCT02449915|26081169|FG001|Overall Study|Abnormal preop lab|1|||
13159865|NCT02449902|26081200|FG000|Overall Study|Adverse Event|0|||
13159866|NCT02449902|26081201|FG001|Overall Study|Adverse Event|1|||
13159867|NCT02449902|26081200|FG000|Overall Study|Withdrawal by Subject|0|||
13159868|NCT02449902|26081201|FG001|Overall Study|Withdrawal by Subject|1|||
13159869|NCT02449889|26081237|FG000|Overall Study|Adverse Event|1|||
13159870|NCT02449889|26081238|FG001|Overall Study|Adverse Event|2|||
13159871|NCT02449889|26081239|FG002|Overall Study|Adverse Event|0|||
13159872|NCT02449889|26081237|FG000|Overall Study|Protocol Violation|0|||
13159873|NCT02449889|26081238|FG001|Overall Study|Protocol Violation|4|||
13159874|NCT02449889|26081239|FG002|Overall Study|Protocol Violation|1|||
13159875|NCT02449044|26081260|FG000|Overall Study|Lost to Follow-up|2|||
13159876|NCT02449044|26081260|FG000|Overall Study|Withdrawal by Subject|13|||
13159877|NCT02449044|26081260|FG000|Overall Study|Adverse Event|30|||
13159878|NCT02449044|26081260|FG000|Overall Study|Met Withdrawal Criteria|7|||
13159879|NCT02449044|26081260|FG000|Overall Study|Physician Decision|9|||
13159880|NCT02449044|26081260|FG000|Overall Study|Sponsor Discontinued Trial|3|||
13159881|NCT02449018|26081294|FG000|Overall Study|Abnormal laboratory value|0|||
13159882|NCT02449018|26081295|FG001|Overall Study|Abnormal laboratory value|1|||
13159883|NCT02449018|26081294|FG000|Overall Study|Administrative problems|1|||
13159884|NCT02449018|26081295|FG001|Overall Study|Administrative problems|0|||
13159885|NCT02449018|26081294|FG000|Overall Study|Adverse Event|5|||
13159886|NCT02449018|26081295|FG001|Overall Study|Adverse Event|1|||
13159887|NCT02449018|26081294|FG000|Overall Study|Protocol deviation|4|||
13159888|NCT02449018|26081295|FG001|Overall Study|Protocol deviation|0|||
13159889|NCT02449018|26081294|FG000|Overall Study|Patient decision|2|||
13159890|NCT02449018|26081295|FG001|Overall Study|Patient decision|0|||
13159891|NCT02448875|26081328|FG000|Overall Study|Adverse Event|2|||
13159892|NCT02448875|26081329|FG001|Overall Study|Adverse Event|1|||
13159893|NCT02448875|26081330|FG002|Overall Study|Adverse Event|0|||
13159894|NCT02448875|26081328|FG000|Overall Study|Lost to Follow-up|1|||
13159895|NCT02448875|26081329|FG001|Overall Study|Lost to Follow-up|0|||
13159896|NCT02448875|26081330|FG002|Overall Study|Lost to Follow-up|0|||
13159897|NCT02448875|26081328|FG000|Overall Study|Investigator Decision|3|||
13159898|NCT02448875|26081329|FG001|Overall Study|Investigator Decision|0|||
13159899|NCT02448875|26081330|FG002|Overall Study|Investigator Decision|1|||
13159900|NCT02448875|26081328|FG000|Overall Study|Withdrawal by Subject|1|||
13159901|NCT02448875|26081329|FG001|Overall Study|Withdrawal by Subject|0|||
13159902|NCT02448875|26081330|FG002|Overall Study|Withdrawal by Subject|0|||
13159903|NCT02448810|26081421|FG000|Overall Study|Adverse Event|0|||
13159904|NCT02448810|26081422|FG001|Overall Study|Adverse Event|0|||
13159905|NCT02448810|26081423|FG002|Overall Study|Adverse Event|1|||
13159906|NCT02448810|26081424|FG003|Overall Study|Adverse Event|0|||
13159907|NCT02448810|26081425|FG004|Overall Study|Adverse Event|0|||
13159908|NCT02448810|26081426|FG005|Overall Study|Adverse Event|0|||
13159909|NCT02448810|26081427|FG006|Overall Study|Adverse Event|0|||
13159910|NCT02448810|26081428|FG007|Overall Study|Adverse Event|0|||
13159911|NCT02448810|26081421|FG000|Overall Study|Withdrawal by Subject|0|||
13159912|NCT02448810|26081422|FG001|Overall Study|Withdrawal by Subject|0|||
13159913|NCT02448810|26081423|FG002|Overall Study|Withdrawal by Subject|1|||
13159914|NCT02448810|26081424|FG003|Overall Study|Withdrawal by Subject|0|||
13159915|NCT02448810|26081425|FG004|Overall Study|Withdrawal by Subject|3|||
13159916|NCT02448810|26081426|FG005|Overall Study|Withdrawal by Subject|5|||
13159917|NCT02448810|26081427|FG006|Overall Study|Withdrawal by Subject|0|||
13159918|NCT02448810|26081428|FG007|Overall Study|Withdrawal by Subject|2|||
13159919|NCT02448810|26081421|FG000|Overall Study|Other (study terminated by sponsor)|0|||
13159920|NCT02448810|26081422|FG001|Overall Study|Other (study terminated by sponsor)|0|||
13159921|NCT02448810|26081423|FG002|Overall Study|Other (study terminated by sponsor)|0|||
13159922|NCT02448810|26081424|FG003|Overall Study|Other (study terminated by sponsor)|0|||
13159923|NCT02448810|26081425|FG004|Overall Study|Other (study terminated by sponsor)|4|||
13159924|NCT02448810|26081426|FG005|Overall Study|Other (study terminated by sponsor)|2|||
13159925|NCT02448810|26081427|FG006|Overall Study|Other (study terminated by sponsor)|2|||
13159926|NCT02448810|26081428|FG007|Overall Study|Other (study terminated by sponsor)|1|||
13159927|NCT02448810|26081421|FG000|Overall Study|Death|1|||
13159928|NCT02448810|26081422|FG001|Overall Study|Death|0|||
13159929|NCT02448810|26081423|FG002|Overall Study|Death|1|||
13159930|NCT02448810|26081424|FG003|Overall Study|Death|0|||
13159931|NCT02448810|26081425|FG004|Overall Study|Death|1|||
13159932|NCT02448810|26081426|FG005|Overall Study|Death|0|||
13159933|NCT02448810|26081427|FG006|Overall Study|Death|0|||
13159934|NCT02448810|26081428|FG007|Overall Study|Death|0|||
13159935|NCT02448810|26081421|FG000|Overall Study|Other (Progressive disease)|2|||
13159936|NCT02448810|26081422|FG001|Overall Study|Other (Progressive disease)|2|||
13159937|NCT02448810|26081423|FG002|Overall Study|Other (Progressive disease)|0|||
13159938|NCT02448810|26081424|FG003|Overall Study|Other (Progressive disease)|3|||
13159939|NCT02448810|26081425|FG004|Overall Study|Other (Progressive disease)|23|||
13159940|NCT02448810|26081426|FG005|Overall Study|Other (Progressive disease)|9|||
13159941|NCT02448810|26081427|FG006|Overall Study|Other (Progressive disease)|14|||
13159942|NCT02448810|26081428|FG007|Overall Study|Other (Progressive disease)|5|||
13159943|NCT02448810|26081421|FG000|Overall Study|Lost to Follow-up|0|||
13159944|NCT02448810|26081422|FG001|Overall Study|Lost to Follow-up|1|||
13159945|NCT02448810|26081423|FG002|Overall Study|Lost to Follow-up|0|||
13159946|NCT02448810|26081424|FG003|Overall Study|Lost to Follow-up|0|||
13159947|NCT02448810|26081425|FG004|Overall Study|Lost to Follow-up|0|||
13159948|NCT02448810|26081426|FG005|Overall Study|Lost to Follow-up|0|||
13159949|NCT02448810|26081427|FG006|Overall Study|Lost to Follow-up|0|||
13159950|NCT02448810|26081428|FG007|Overall Study|Lost to Follow-up|0|||
13159951|NCT02448810|26081421|FG000|Overall Study|Other (unspecified)|0|||
13159952|NCT02448810|26081422|FG001|Overall Study|Other (unspecified)|0|||
13159953|NCT02448810|26081423|FG002|Overall Study|Other (unspecified)|0|||
13159954|NCT02448810|26081424|FG003|Overall Study|Other (unspecified)|0|||
13159955|NCT02448810|26081425|FG004|Overall Study|Other (unspecified)|0|||
13159956|NCT02448810|26081426|FG005|Overall Study|Other (unspecified)|0|||
13159957|NCT02448810|26081427|FG006|Overall Study|Other (unspecified)|2|||
13159958|NCT02448810|26081428|FG007|Overall Study|Other (unspecified)|0|||
13159959|NCT02448771|26081443|FG000|Overall Study|Disease Progression|30|||
13159960|NCT02448771|26081443|FG000|Overall Study|Unacceptable Toxicity|1|||
13159961|NCT02448771|26081443|FG000|Overall Study|Physician Decision|3|||
13159962|NCT02448771|26081443|FG000|Overall Study|Started new therapy|2|||
13159963|NCT02448719|26081701|FG000|Overall Study|Withdrawal by Subject|0|||
13159964|NCT02448719|26081702|FG001|Overall Study|Withdrawal by Subject|0|||
13159965|NCT02448719|26081703|FG002|Overall Study|Withdrawal by Subject|0|||
13159966|NCT02448719|26081704|FG003|Overall Study|Withdrawal by Subject|0|||
13159967|NCT02448719|26081705|FG004|Overall Study|Withdrawal by Subject|1|||
13159968|NCT02448719|26081706|FG005|Overall Study|Withdrawal by Subject|0|||
13159969|NCT02448719|26081707|FG006|Overall Study|Withdrawal by Subject|0|||
13159970|NCT02448719|26081708|FG007|Overall Study|Withdrawal by Subject|0|||
13159971|NCT02448719|26081709|FG008|Overall Study|Withdrawal by Subject|0|||
13159972|NCT02448719|26081710|FG009|Overall Study|Withdrawal by Subject|0|||
13159973|NCT02448719|26081711|FG010|Overall Study|Withdrawal by Subject|0|||
13159974|NCT02448706|26081726|FG000|Overall Study|Withdrawal by Subject|4|||
13159975|NCT02448706|26081727|FG001|Overall Study|Withdrawal by Subject|3|||
13159976|NCT02448706|26081726|FG000|Overall Study|Protocol Violation|1|||
13159977|NCT02448706|26081727|FG001|Overall Study|Protocol Violation|1|||
13159978|NCT02448680|26081752|FG000|Overall Study|Physician Decision|1|||
13159979|NCT02448680|26081753|FG001|Overall Study|Physician Decision|1|||
13159980|NCT02448680|26081752|FG000|Overall Study|Withdrawal by Subject|0|||
13159981|NCT02448680|26081753|FG001|Overall Study|Withdrawal by Subject|2|||
13159982|NCT02448563|26081783|FG000|Overall Study|Lost to Follow-up|16|||
13105405|NCT03325881|25879763|FG001|Overall Study|Protocol Violation|1|||
13105406|NCT03325881|25879762|FG000|Overall Study|Withdrawal by Subject|0|||
13105407|NCT03325881|25879763|FG001|Overall Study|Withdrawal by Subject|2|||
13105408|NCT03325881|25879762|FG000|Overall Study|Lack of Efficacy|2|||
13105409|NCT03325881|25879763|FG001|Overall Study|Lack of Efficacy|0|||
13105410|NCT03325881|25879762|FG000|Overall Study|Not treated|1|||
13105411|NCT03325881|25879763|FG001|Overall Study|Not treated|0|||
13159983|NCT02448563|26081784|FG001|Overall Study|Lost to Follow-up|10|||
13159984|NCT02448563|26081783|FG000|Overall Study|Withdrawal by Subject|0|||
13159985|NCT02448563|26081784|FG001|Overall Study|Withdrawal by Subject|1|||
13159986|NCT02448537|26081808|FG000|Overall Study|Withdrawal by Subject|1|||
13159987|NCT02448537|26081809|FG001|Overall Study|Withdrawal by Subject|1|||
13159988|NCT02448537|26081810|FG002|Overall Study|Withdrawal by Subject|1|||
13159989|NCT02448446|26081839|FG000|Overall Study|Withdrawal by Subject|1|||
13159990|NCT02448446|26081840|FG001|Overall Study|Withdrawal by Subject|0|||
13159991|NCT02448381|26081863|FG000|Overall Study|Adverse Event|2|||
13159992|NCT02448381|26081864|FG001|Overall Study|Adverse Event|0|||
13159993|NCT02448381|26081863|FG000|Overall Study|Lost to Follow-up|16|||
13159994|NCT02448381|26081864|FG001|Overall Study|Lost to Follow-up|9|||
13159995|NCT02448381|26081863|FG000|Overall Study|Physician Decision|1|||
13159996|NCT02448381|26081864|FG001|Overall Study|Physician Decision|1|||
13159997|NCT02448381|26081863|FG000|Overall Study|Pregnancy|1|||
13159998|NCT02448381|26081864|FG001|Overall Study|Pregnancy|0|||
13159999|NCT02448381|26081863|FG000|Overall Study|Withdrawal by Subject|13|||
13160000|NCT02448381|26081864|FG001|Overall Study|Withdrawal by Subject|9|||
13160001|NCT02448381|26081863|FG000|Overall Study|Noncompliance with Study Procedures|2|||
13160002|NCT02448381|26081864|FG001|Overall Study|Noncompliance with Study Procedures|0|||
13160003|NCT02448225|26081874|FG000|Overall Study|Withdrawal by Subject|1|||
13160004|NCT02448225|26081874|FG000|Overall Study|Did not get FSPG scan|18|||
13160005|NCT02448225|26081874|FG000|Overall Study|Treated between the FDG and FSPG scan|1|||
13160006|NCT02448043|26081899|FG000|Overall Study|Withdrawal by Subject|2|||
13160007|NCT02448043|26081900|FG001|Overall Study|Withdrawal by Subject|2|||
13160008|NCT02448043|26081899|FG000|Overall Study|Protocol Violation|1|||
13160009|NCT02448043|26081900|FG001|Overall Study|Protocol Violation|2|||
13160010|NCT02447991|26081945|FG000|Overall Study|Withdrawn by subject - no data|0|||
13160011|NCT02447991|26081946|FG001|Overall Study|Withdrawn by subject - no data|2|||
13160012|NCT02447991|26081945|FG000|Overall Study|Withdrawn by Subject - with data|4|||
13160013|NCT02447991|26081946|FG001|Overall Study|Withdrawn by Subject - with data|4|||
13160014|NCT02447991|26081945|FG000|Overall Study|Lost to Follow-up - no data|3|||
13160015|NCT02447991|26081946|FG001|Overall Study|Lost to Follow-up - no data|6|||
13160016|NCT02447991|26081945|FG000|Overall Study|Lost to follow-up - with data|0|||
13222813|NCT01802775|26286957|FG001|Overall Study|Death|3|||
13222814|NCT01802775|26286956|FG000|Overall Study|Reason not provided|0|||
13105412|NCT03325712|25879840|FG000|Overall Study|Protocol Violation|0|||
13105413|NCT03325712|25879841|FG001|Overall Study|Protocol Violation|0|||
13160017|NCT02447991|26081946|FG001|Overall Study|Lost to follow-up - with data|3|||
13160018|NCT02447991|26081945|FG000|Overall Study|End of study - no treatment results|3|||
13160019|NCT02447991|26081946|FG001|Overall Study|End of study - no treatment results|6|||
13160020|NCT02447991|26081945|FG000|Overall Study|End of study - partial treatment results|0|||
13160021|NCT02447991|26081946|FG001|Overall Study|End of study - partial treatment results|9|||
13105414|NCT03325712|25879842|FG002|Overall Study|Protocol Violation|0|||
13160022|NCT02447952|26082000|FG000|Overall Study|Adverse Event|2|||
13160023|NCT02447952|26082000|FG000|Overall Study|Physician Decision|1|||
13160024|NCT02447952|26082000|FG000|Overall Study|Withdrawal by Subject|4|||
13160025|NCT02447887|26082015|FG000|Overall Study|Study was terminated|3|||
13160026|NCT02447848|26082023|FG000|Overall Study|Patient discharged|3|||
13160027|NCT02447848|26082023|FG000|Overall Study|Lack of Efficacy|4|||
13160028|NCT02447848|26082023|FG000|Overall Study|Withdrawal by Subject|4|||
13160029|NCT02447744|26082040|FG000|Overall Study|Withdrawal by Subject|3|||
13160030|NCT02447744|26082041|FG001|Overall Study|Withdrawal by Subject|1|||
13160031|NCT02447744|26082040|FG000|Overall Study|Data not collected b/c logistic reasons|3|||
13160032|NCT02447744|26082041|FG001|Overall Study|Data not collected b/c logistic reasons|0|||
13205389|NCT01966003|26231608|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67|||
13205390|NCT01966003|26231607|FG000|Overall Study|Other|1|||
13205391|NCT01966003|26231608|FG001|Overall Study|Other|1|||
13205392|NCT01965938|26231635|FG000|Overall Study|Withdrawal by Subject|1|||
13205393|NCT01965938|26231636|FG001|Overall Study|Withdrawal by Subject|0|||
13205394|NCT01965860|26231657|FG000|Overall Study|Pregnancy|1|||
13205395|NCT01965860|26231658|FG001|Overall Study|Pregnancy|0|||
13205396|NCT01965860|26231659|FG002|Overall Study|Pregnancy|1|||
13205397|NCT01965860|26231657|FG000|Overall Study|Logistics|1|||
13205398|NCT01965860|26231658|FG001|Overall Study|Logistics|0|||
13205399|NCT01965860|26231659|FG002|Overall Study|Logistics|0|||
13205400|NCT01965834|26231667|FG000|Overall Study|Lack of Efficacy|4|||
13205401|NCT01965704|26231694|FG000|Overall Study|Withdrawal by Subject|2|||
13205402|NCT01965704|26231695|FG001|Overall Study|Withdrawal by Subject|2|||
13205403|NCT01965704|26231696|FG002|Overall Study|Withdrawal by Subject|1|||
13205404|NCT01965704|26231697|FG003|Overall Study|Withdrawal by Subject|1|||
13205405|NCT01965704|26231694|FG000|Overall Study|Delivered at home|1|||
13205406|NCT01965704|26231695|FG001|Overall Study|Delivered at home|1|||
13205407|NCT01965704|26231696|FG002|Overall Study|Delivered at home|0|||
13205408|NCT01965704|26231697|FG003|Overall Study|Delivered at home|0|||
13205409|NCT01965704|26231694|FG000|Overall Study|Experienced complications|0|||
13205410|NCT01965704|26231695|FG001|Overall Study|Experienced complications|0|||
13205411|NCT01965704|26231696|FG002|Overall Study|Experienced complications|2|||
13205412|NCT01965704|26231697|FG003|Overall Study|Experienced complications|2|||
13205413|NCT01965704|26231694|FG000|Overall Study|Adverse Event|0|||
13205414|NCT01965704|26231695|FG001|Overall Study|Adverse Event|0|||
13205415|NCT01965704|26231696|FG002|Overall Study|Adverse Event|1|||
13205416|NCT01965704|26231697|FG003|Overall Study|Adverse Event|1|||
13205417|NCT01965704|26231694|FG000|Overall Study|Did not meet inclusion criteria|0|||
13105415|NCT03325712|25879843|FG003|Overall Study|Protocol Violation|0|||
13105416|NCT03325712|25879844|FG004|Overall Study|Protocol Violation|1|||
13105417|NCT03325712|25879845|FG005|Overall Study|Protocol Violation|0|||
13105418|NCT03325712|25879846|FG006|Overall Study|Protocol Violation|0|||
13105419|NCT03325712|25879847|FG007|Overall Study|Protocol Violation|0|||
13105420|NCT03325712|25879840|FG000|Overall Study|Adverse Event|0|||
13105421|NCT03325712|25879841|FG001|Overall Study|Adverse Event|0|||
13105422|NCT03325712|25879842|FG002|Overall Study|Adverse Event|0|||
13105423|NCT03325712|25879843|FG003|Overall Study|Adverse Event|0|||
13105424|NCT03325712|25879844|FG004|Overall Study|Adverse Event|1|||
13105425|NCT03325712|25879845|FG005|Overall Study|Adverse Event|0|||
13105426|NCT03325712|25879846|FG006|Overall Study|Adverse Event|0|||
13105427|NCT03325712|25879847|FG007|Overall Study|Adverse Event|0|||
13205418|NCT01965704|26231695|FG001|Overall Study|Did not meet inclusion criteria|0|||
13205419|NCT01965704|26231696|FG002|Overall Study|Did not meet inclusion criteria|1|||
13205420|NCT01965704|26231697|FG003|Overall Study|Did not meet inclusion criteria|1|||
13205421|NCT01965652|26231734|FG000|Overall Study|Adverse Event|40|||
13205422|NCT01965652|26231735|FG001|Overall Study|Adverse Event|37|||
13105428|NCT03325673|25879866|FG000|Overall Study|Adverse Event|4|||
13105429|NCT03325673|25879867|FG001|Overall Study|Adverse Event|0|||
13205423|NCT01965652|26231734|FG000|Overall Study|Withdrawal by Subject|62|||
13205424|NCT01965652|26231735|FG001|Overall Study|Withdrawal by Subject|69|||
13205425|NCT01965652|26231734|FG000|Overall Study|Lost to Follow-up|53|||
13205426|NCT01965652|26231735|FG001|Overall Study|Lost to Follow-up|40|||
13205427|NCT01965652|26231734|FG000|Overall Study|Protocol Violation|34|||
13205428|NCT01965652|26231735|FG001|Overall Study|Protocol Violation|38|||
13205429|NCT01965652|26231734|FG000|Overall Study|Death|3|||
13205430|NCT01965652|26231735|FG001|Overall Study|Death|4|||
13105430|NCT03325556|25879880|FG000|Open-label Period|Lack of Response in OL period|70|||
13105431|NCT03325556|25879881|FG001|Open-label Period|Lack of Response in OL period|0|||
13105432|NCT03325556|25879882|FG002|Open-label Period|Lack of Response in OL period|0|||
13105433|NCT03325556|25879880|FG000|Open-label Period|Adverse Event|27|||
13105434|NCT03325556|25879881|FG001|Open-label Period|Adverse Event|0|||
13160033|NCT02447718|26082066|FG000|Overall Study|Lost to Follow-up|8|||
13160034|NCT02447718|26082067|FG001|Overall Study|Lost to Follow-up|0|||
13160035|NCT02447718|26082066|FG000|Overall Study|Withdrawal by Subject|3|||
13222815|NCT01802775|26286957|FG001|Overall Study|Reason not provided|1|||
13105435|NCT03325556|25879882|FG002|Open-label Period|Adverse Event|0|||
13160036|NCT02447718|26082067|FG001|Overall Study|Withdrawal by Subject|0|||
13160037|NCT02447718|26082066|FG000|Overall Study|Screen Failure|1|||
13160038|NCT02447718|26082067|FG001|Overall Study|Screen Failure|0|||
13160039|NCT02447497|26082098|FG000|Overall Study|Did not meet treatment day baseline.|6|||
13160040|NCT02447497|26082099|FG001|Overall Study|Did not meet treatment day baseline.|5|||
13160041|NCT02447497|26082100|FG002|Overall Study|Did not meet treatment day baseline.|2|||
13160042|NCT02447497|26082101|FG003|Overall Study|Did not meet treatment day baseline.|2|||
13160043|NCT02447497|26082098|FG000|Overall Study|Dressing was compromised|0|||
13160044|NCT02447497|26082099|FG001|Overall Study|Dressing was compromised|1|||
13160045|NCT02447497|26082100|FG002|Overall Study|Dressing was compromised|0|||
13160046|NCT02447497|26082101|FG003|Overall Study|Dressing was compromised|0|||
13160047|NCT02447458|26082216|FG000|Overall Study|Other|0|||
13160048|NCT02447458|26082217|FG001|Overall Study|Other|0|||
13160049|NCT02447458|26082218|FG002|Overall Study|Other|1|||
13160050|NCT02447458|26082219|FG003|Overall Study|Other|0|||
13160051|NCT02447458|26082220|FG004|Overall Study|Other|0|||
13160052|NCT02447458|26082221|FG005|Overall Study|Other|0|||
13160053|NCT02447432|26082260|FG000|Epoch 001|Adverse Event|1|||
13160054|NCT02447432|26082261|FG001|Epoch 001|Adverse Event|1|||
13160055|NCT02447432|26082260|FG000|Epoch 001|Withdrawal by Subject|0|||
13160056|NCT02447432|26082261|FG001|Epoch 001|Withdrawal by Subject|4|||
13160057|NCT02447432|26082260|FG000|Epoch 001|Migrated/moved from study area|3|||
13160058|NCT02447432|26082261|FG001|Epoch 001|Migrated/moved from study area|5|||
13160059|NCT02447432|26082260|FG000|Epoch 001|Lost to Follow-up|1|||
13160060|NCT02447432|26082261|FG001|Epoch 001|Lost to Follow-up|3|||
13160061|NCT02447328|26082267|FG000|Overall Study|Withdrawal by Subject|1|||
13105436|NCT03325556|25879880|FG000|Open-label Period|Death|1|||
13105437|NCT03325556|25879881|FG001|Open-label Period|Death|0|||
13105438|NCT03325556|25879882|FG002|Open-label Period|Death|0|||
13105439|NCT03325556|25879880|FG000|Open-label Period|Lost to Follow-up|1|||
13105440|NCT03325556|25879881|FG001|Open-label Period|Lost to Follow-up|0|||
13105441|NCT03325556|25879882|FG002|Open-label Period|Lost to Follow-up|0|||
13105442|NCT03325556|25879880|FG000|Open-label Period|Non-compliance with study drug|5|||
13160062|NCT02447302|26082303|FG000|Overall Study|Physician Decision|1|||
13160063|NCT02447302|26082304|FG001|Overall Study|Physician Decision|0|||
13160064|NCT02447302|26082305|FG002|Overall Study|Physician Decision|0|||
13160065|NCT02447302|26082303|FG000|Overall Study|Adverse Event|4|||
13160066|NCT02447302|26082304|FG001|Overall Study|Adverse Event|3|||
13160067|NCT02447302|26082305|FG002|Overall Study|Adverse Event|0|||
13160068|NCT02447302|26082303|FG000|Overall Study|Withdrawal by Subject|0|||
13160069|NCT02447302|26082304|FG001|Overall Study|Withdrawal by Subject|1|||
13160070|NCT02447302|26082305|FG002|Overall Study|Withdrawal by Subject|5|||
13160071|NCT02447302|26082303|FG000|Overall Study|Sponsor Decision|0|||
13105443|NCT03325556|25879881|FG001|Open-label Period|Non-compliance with study drug|0|||
13105444|NCT03325556|25879882|FG002|Open-label Period|Non-compliance with study drug|0|||
13105445|NCT03325556|25879880|FG000|Open-label Period|Use of prohibited medication|1|||
13105446|NCT03325556|25879881|FG001|Open-label Period|Use of prohibited medication|0|||
13105447|NCT03325556|25879882|FG002|Open-label Period|Use of prohibited medication|0|||
13160072|NCT02447302|26082304|FG001|Overall Study|Sponsor Decision|0|||
13105448|NCT03325556|25879880|FG000|Open-label Period|Protocol Violation|4|||
13105449|NCT03325556|25879881|FG001|Open-label Period|Protocol Violation|0|||
13105450|NCT03325556|25879882|FG002|Open-label Period|Protocol Violation|0|||
13105451|NCT03325556|25879880|FG000|Open-label Period|Withdrawal by Subject|17|||
13105452|NCT03325556|25879881|FG001|Open-label Period|Withdrawal by Subject|0|||
13105453|NCT03325556|25879882|FG002|Open-label Period|Withdrawal by Subject|0|||
13105454|NCT03325556|25879880|FG000|Open-label Period|Not otherwise specified|8|||
13105455|NCT03325556|25879881|FG001|Open-label Period|Not otherwise specified|0|||
13105456|NCT03325556|25879882|FG002|Open-label Period|Not otherwise specified|0|||
13105457|NCT03325556|25879880|FG000|Open-label Period|Administrative discont. at study termination|41|||
13160073|NCT02447302|26082305|FG002|Overall Study|Sponsor Decision|1|||
13160074|NCT02447250|26082318|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1|||
13160075|NCT02447250|26082318|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1|||
13160076|NCT02447250|26082318|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4|||
13160077|NCT02447172|26082345|FG000|Overall Study|Adverse Event|11|||
13160078|NCT02447172|26082346|FG001|Overall Study|Adverse Event|8|||
13160079|NCT02447172|26082347|FG002|Overall Study|Adverse Event|7|||
13160080|NCT02447172|26082345|FG000|Overall Study|Death|3|||
13160081|NCT02447172|26082346|FG001|Overall Study|Death|1|||
13160082|NCT02447172|26082347|FG002|Overall Study|Death|0|||
13160083|NCT02447172|26082345|FG000|Overall Study|Protocol Violation|2|||
13105458|NCT03325556|25879881|FG001|Open-label Period|Administrative discont. at study termination|0|||
13160084|NCT02447172|26082346|FG001|Overall Study|Protocol Violation|1|||
13105459|NCT03325556|25879882|FG002|Open-label Period|Administrative discont. at study termination|0|||
13105460|NCT03325556|25879880|FG000|Double-blind Period|Relapse|0|||
13105461|NCT03325556|25879881|FG001|Double-blind Period|Relapse|15|||
13105462|NCT03325556|25879882|FG002|Double-blind Period|Relapse|34|||
13105463|NCT03325556|25879880|FG000|Double-blind Period|Adverse Event|0|||
13105464|NCT03325556|25879881|FG001|Double-blind Period|Adverse Event|3|||
13105465|NCT03325556|25879882|FG002|Double-blind Period|Adverse Event|1|||
13105466|NCT03325556|25879880|FG000|Double-blind Period|Noncompliance with study drug|0|||
13105467|NCT03325556|25879881|FG001|Double-blind Period|Noncompliance with study drug|0|||
13105468|NCT03325556|25879882|FG002|Double-blind Period|Noncompliance with study drug|1|||
13105469|NCT03325556|25879880|FG000|Double-blind Period|Use of prohibited medication|0|||
13105470|NCT03325556|25879881|FG001|Double-blind Period|Use of prohibited medication|1|||
13160085|NCT02447172|26082347|FG002|Overall Study|Protocol Violation|2|||
13160086|NCT02447172|26082345|FG000|Overall Study|Lost to Follow-up|7|||
13160087|NCT02447172|26082346|FG001|Overall Study|Lost to Follow-up|4|||
13160088|NCT02447172|26082347|FG002|Overall Study|Lost to Follow-up|4|||
13160089|NCT02447172|26082345|FG000|Overall Study|Withdrawal by Subject|5|||
13160090|NCT02447172|26082346|FG001|Overall Study|Withdrawal by Subject|1|||
13160091|NCT02447172|26082347|FG002|Overall Study|Withdrawal by Subject|3|||
13160092|NCT02447172|26082345|FG000|Overall Study|protocol specific treatment unrelated|3|||
13160093|NCT02447172|26082346|FG001|Overall Study|protocol specific treatment unrelated|0|||
13160094|NCT02447172|26082347|FG002|Overall Study|protocol specific treatment unrelated|2|||
13160095|NCT02447081|26082363|FG000|Overall Study|Death|161|||
13160096|NCT02447081|26082363|FG000|Overall Study|Lost to Follow-up|36|||
13160097|NCT02447081|26082363|FG000|Overall Study|Visit not completed|17|||
13160098|NCT02447081|26082363|FG000|Overall Study|unsuccessful implant procedure|10|||
13160099|NCT02447029|26082388|FG000|Overall Study|Withdrawal by Subject|3|||
13160100|NCT02447029|26082389|FG001|Overall Study|Withdrawal by Subject|2|||
13160101|NCT02447003|26082430|FG000|Overall Study|Other|0|||
13160102|NCT02447003|26082431|FG001|Overall Study|Other|4|||
13160103|NCT02447003|26082430|FG000|Overall Study|Site discontinued|0|||
13160104|NCT02447003|26082431|FG001|Overall Study|Site discontinued|2|||
13160105|NCT02447003|26082430|FG000|Overall Study|Physician Decision|0|||
13160106|NCT02447003|26082431|FG001|Overall Study|Physician Decision|1|||
13160107|NCT02447003|26082430|FG000|Overall Study|Withdrawal by Subject|4|||
13160108|NCT02447003|26082431|FG001|Overall Study|Withdrawal by Subject|3|||
13160109|NCT02447003|26082430|FG000|Overall Study|Sponsor Decision|6|||
13160110|NCT02447003|26082431|FG001|Overall Study|Sponsor Decision|11|||
13160111|NCT02447003|26082430|FG000|Overall Study|Progressive Disease|1|||
13160112|NCT02447003|26082431|FG001|Overall Study|Progressive Disease|0|||
13160113|NCT02447003|26082430|FG000|Overall Study|Lost to Follow-up|5|||
13160114|NCT02447003|26082431|FG001|Overall Study|Lost to Follow-up|0|||
13160115|NCT02447003|26082430|FG000|Overall Study|Death|154|||
13160116|NCT02447003|26082431|FG001|Overall Study|Death|63|||
13160117|NCT02446990|26082470|FG000|Overall Study|Death|485|||
13160118|NCT02446990|26082471|FG001|Overall Study|Death|458|||
13160119|NCT02446990|26082470|FG000|Overall Study|Lost to Follow-up|3|||
13160120|NCT02446990|26082471|FG001|Overall Study|Lost to Follow-up|1|||
13160121|NCT02446990|26082470|FG000|Overall Study|Physician Decision|1|||
13160122|NCT02446990|26082471|FG001|Overall Study|Physician Decision|0|||
13160123|NCT02446990|26082470|FG000|Overall Study|Withdrawal by Subject|231|||
13160124|NCT02446990|26082471|FG001|Overall Study|Withdrawal by Subject|199|||
13160125|NCT02446886|26082494|FG000|Overall Study|Adverse Event|1|||
13160126|NCT02446886|26082495|FG001|Overall Study|Adverse Event|3|||
13160127|NCT02446886|26082494|FG000|Overall Study|Withdrawal by Subject|1|||
13160128|NCT02446886|26082495|FG001|Overall Study|Withdrawal by Subject|1|||
13160129|NCT02446769|26082520|FG000|Screening Period|Screen Failure|11|||
13160130|NCT02446769|26082521|FG001|Screening Period|Screen Failure|0|||
13160131|NCT02446769|26082522|FG002|Screening Period|Screen Failure|0|||
13160132|NCT02446769|26082520|FG000|Study Period|Randomized in Error|0|||
13160133|NCT02446769|26082521|FG001|Study Period|Randomized in Error|2|||
13160134|NCT02446769|26082522|FG002|Study Period|Randomized in Error|0|||
13485476|NCT02906020|27032878|FG011|Part 1: Dose Escalation Period|Adverse Event|0|||
13485477|NCT02906020|27032879|FG012|Part 1: Dose Escalation Period|Adverse Event|0|||
13160135|NCT02446743|26082679|FG000|Overall Study|Withdrawal by Subject|1|||
13160136|NCT02446743|26082680|FG001|Overall Study|Withdrawal by Subject|1|||
13160137|NCT02446743|26082679|FG000|Overall Study|Lost to Follow-up|1|||
13160138|NCT02446743|26082680|FG001|Overall Study|Lost to Follow-up|0|||
13160139|NCT02446743|26082679|FG000|Overall Study|Adverse Event|1|||
13160140|NCT02446743|26082680|FG001|Overall Study|Adverse Event|1|||
13160141|NCT02446743|26082679|FG000|Overall Study|Other|2|||
13160142|NCT02446743|26082680|FG001|Overall Study|Other|3|||
13160143|NCT02446717|26082723|FG000|Overall Study|Adverse Event|0|||
13160144|NCT02446717|26082724|FG001|Overall Study|Adverse Event|0|||
13160145|NCT02446717|26082725|FG002|Overall Study|Adverse Event|1|||
13160146|NCT02446717|26082726|FG003|Overall Study|Adverse Event|0|||
13160147|NCT02446717|26082727|FG004|Overall Study|Adverse Event|0|||
13160148|NCT02446717|26082723|FG000|Overall Study|Lost to Follow-up|0|||
13160149|NCT02446717|26082724|FG001|Overall Study|Lost to Follow-up|1|||
13160150|NCT02446717|26082725|FG002|Overall Study|Lost to Follow-up|1|||
13160151|NCT02446717|26082726|FG003|Overall Study|Lost to Follow-up|0|||
13160152|NCT02446717|26082727|FG004|Overall Study|Lost to Follow-up|1|||
13105471|NCT03325556|25879882|FG002|Double-blind Period|Use of prohibited medication|0|||
13160153|NCT02446717|26082723|FG000|Overall Study|Withdrew consent|0|||
13160154|NCT02446717|26082724|FG001|Overall Study|Withdrew consent|0|||
13160155|NCT02446717|26082725|FG002|Overall Study|Withdrew consent|0|||
13160156|NCT02446717|26082726|FG003|Overall Study|Withdrew consent|1|||
13160157|NCT02446717|26082727|FG004|Overall Study|Withdrew consent|0|||
13160158|NCT02446691|26082747|FG000|Overall Study|Withdrawal by Subject|2|||
13160159|NCT02446691|26082747|FG000|Overall Study|Lost to Follow-up|8|||
13160160|NCT02446691|26082747|FG000|Overall Study|Protocol Violation|1|||
13160161|NCT02446418|26082764|FG000|Overall Study|Adverse Event|4|||
13160162|NCT02446418|26082765|FG001|Overall Study|Adverse Event|8|||
13160163|NCT02446418|26082764|FG000|Overall Study|Physician Decision|5|||
13160164|NCT02446418|26082765|FG001|Overall Study|Physician Decision|1|||
13160165|NCT02446418|26082764|FG000|Overall Study|Withdrawal by Subject|3|||
13160166|NCT02446418|26082765|FG001|Overall Study|Withdrawal by Subject|3|||
13160167|NCT02446418|26082764|FG000|Overall Study|Lost to Follow-up|2|||
13160168|NCT02446418|26082765|FG001|Overall Study|Lost to Follow-up|2|||
13160169|NCT02446418|26082764|FG000|Overall Study|Protocol Violation|1|||
13160170|NCT02446418|26082765|FG001|Overall Study|Protocol Violation|2|||
13160171|NCT02446418|26082764|FG000|Overall Study|Lack of Efficacy|2|||
13160172|NCT02446418|26082765|FG001|Overall Study|Lack of Efficacy|0|||
13160173|NCT02446418|26082764|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
13160174|NCT02446418|26082765|FG001|Overall Study|Protocol defined stopping criteria reach|0|||
13160175|NCT02446171|26082847|FG000|Overall Study|Withdrawal by Subject|0|||
13160176|NCT02446171|26082848|FG001|Overall Study|Withdrawal by Subject|0|||
13160177|NCT02446171|26082849|FG002|Overall Study|Withdrawal by Subject|2|||
13160178|NCT02446171|26082850|FG003|Overall Study|Withdrawal by Subject|0|||
13160179|NCT02446015|26082868|FG000|Overall Study|Adverse Event|0|||
13160180|NCT02446015|26082869|FG001|Overall Study|Adverse Event|1|||
13160181|NCT02446015|26082868|FG000|Overall Study|Withdrawal by Subject|1|||
13160182|NCT02446015|26082869|FG001|Overall Study|Withdrawal by Subject|0|||
13160183|NCT02445963|26082904|FG000|Overall Study|Lost to Follow-up|1|||
13160184|NCT02445963|26082905|FG001|Overall Study|Lost to Follow-up|0|||
13160185|NCT02445963|26082906|FG002|Overall Study|Lost to Follow-up|0|||
13160186|NCT02445963|26082907|FG003|Overall Study|Lost to Follow-up|0|||
13160187|NCT02445963|26082904|FG000|Overall Study|Change in employment|1|||
13160188|NCT02445963|26082905|FG001|Overall Study|Change in employment|0|||
13160189|NCT02445963|26082906|FG002|Overall Study|Change in employment|0|||
13160190|NCT02445963|26082907|FG003|Overall Study|Change in employment|0|||
13160191|NCT02445963|26082904|FG000|Overall Study|Symptoms post-vaccination|0|||
13160192|NCT02445963|26082905|FG001|Overall Study|Symptoms post-vaccination|0|||
13160193|NCT02445963|26082906|FG002|Overall Study|Symptoms post-vaccination|1|||
13160194|NCT02445963|26082907|FG003|Overall Study|Symptoms post-vaccination|0|||
13160195|NCT02445794|26082950|FG000|Overall Study|Adverse Event|0|||
13160196|NCT02445794|26082951|FG001|Overall Study|Adverse Event|0|||
13160197|NCT02445794|26082952|FG002|Overall Study|Adverse Event|2|||
13160198|NCT02445794|26082953|FG003|Overall Study|Adverse Event|0|||
13160199|NCT02445755|26082962|FG000|Overall Study|Withdrawal by Subject|2|||
13160200|NCT02445755|26082962|FG000|Overall Study|Protocol Violation|6|||
13160201|NCT02445755|26082962|FG000|Overall Study|Screen Failure|5|||
13160202|NCT02445586|26083002|FG000|Overall Study|Death|14|||
13160203|NCT02445586|26083002|FG000|Overall Study|Withdrawal by Subject|13|||
13160204|NCT02445586|26083002|FG000|Overall Study|Disease Progression|10|||
13222816|NCT01802775|26286956|FG000|Overall Study|Physician Decision|1|||
13105472|NCT03325556|25879880|FG000|Double-blind Period|Physician Decision|0|||
13105473|NCT03325556|25879881|FG001|Double-blind Period|Physician Decision|0|||
13105474|NCT03325556|25879882|FG002|Double-blind Period|Physician Decision|1|||
13105475|NCT03325556|25879880|FG000|Double-blind Period|Withdrawal by Subject|0|||
13105476|NCT03325556|25879881|FG001|Double-blind Period|Withdrawal by Subject|6|||
13105477|NCT03325556|25879882|FG002|Double-blind Period|Withdrawal by Subject|4|||
13105478|NCT03325556|25879880|FG000|Double-blind Period|Not otherwise specified|0|||
13105479|NCT03325556|25879881|FG001|Double-blind Period|Not otherwise specified|1|||
13105480|NCT03325556|25879882|FG002|Double-blind Period|Not otherwise specified|5|||
13105481|NCT03325556|25879880|FG000|Double-blind Period|Administrative discont. at study termination|0|||
13105482|NCT03325556|25879881|FG001|Double-blind Period|Administrative discont. at study termination|35|||
13105483|NCT03325556|25879882|FG002|Double-blind Period|Administrative discont. at study termination|31|||
13105484|NCT03325166|25879894|FG000|Overall Study|Adverse Event|1|||
13105485|NCT03325010|25879913|FG000|Overall Study|Adverse Event|3|||
13105486|NCT03325010|25879914|FG001|Overall Study|Adverse Event|8|||
13160205|NCT02445586|26083002|FG000|Overall Study|Protocol Violation|1|||
13160206|NCT02445586|26083002|FG000|Overall Study|Medical Condition|1|||
13160207|NCT02445573|26083023|FG000|Overall Study|Withdrawal by Subject|1|||
13160208|NCT02445573|26083024|FG001|Overall Study|Withdrawal by Subject|1|||
13160209|NCT02445573|26083023|FG000|Overall Study|Lost to Follow-up|0|||
13160210|NCT02445573|26083024|FG001|Overall Study|Lost to Follow-up|1|||
13160211|NCT02445339|26083065|FG000|Overall Study|Physician Decision|1|||
13160212|NCT02445339|26083066|FG001|Overall Study|Physician Decision|0|||
13160213|NCT02445339|26083065|FG000|Overall Study|Lost to Follow-up|11|||
13160214|NCT02445339|26083066|FG001|Overall Study|Lost to Follow-up|15|||
13160215|NCT02444793|26083204|FG000|Overall Study|Lost to Follow-up|2|||
13160216|NCT02444793|26083205|FG001|Overall Study|Lost to Follow-up|2|||
13160217|NCT02444793|26083206|FG002|Overall Study|Lost to Follow-up|0|||
13160218|NCT02444793|26083207|FG003|Overall Study|Lost to Follow-up|0|||
13160219|NCT02444793|26083204|FG000|Overall Study|Death|0|||
13160220|NCT02444793|26083205|FG001|Overall Study|Death|3|||
13160221|NCT02444793|26083206|FG002|Overall Study|Death|0|||
13160222|NCT02444793|26083207|FG003|Overall Study|Death|0|||
13160223|NCT02444793|26083204|FG000|Overall Study|Other|0|||
13160224|NCT02444793|26083205|FG001|Overall Study|Other|0|||
13160225|NCT02444793|26083206|FG002|Overall Study|Other|2|||
13160226|NCT02444793|26083207|FG003|Overall Study|Other|0|||
13160227|NCT02444793|26083204|FG000|Overall Study|Objective progression or relapse|9|||
13160228|NCT02444793|26083205|FG001|Overall Study|Objective progression or relapse|1|||
13160229|NCT02444793|26083206|FG002|Overall Study|Objective progression or relapse|2|||
13160230|NCT02444793|26083207|FG003|Overall Study|Objective progression or relapse|3|||
13160231|NCT02444533|26083228|FG000|Overall Study|Not able to complete forms|0|||
13160232|NCT02444533|26083229|FG001|Overall Study|Not able to complete forms|2|||
13160233|NCT02444533|26083228|FG000|Overall Study|Only gave post-procedure complications|2|||
13160234|NCT02444533|26083229|FG001|Overall Study|Only gave post-procedure complications|2|||
13160235|NCT02444182|26083244|FG000|Overall Study|non-compliance|2|||
13160236|NCT02444182|26083245|FG001|Overall Study|non-compliance|1|||
13160237|NCT02444182|26083244|FG000|Overall Study|Lost to Follow-up|0|||
13160238|NCT02444182|26083245|FG001|Overall Study|Lost to Follow-up|4|||
13160239|NCT02443883|26083276|FG000|Overall Study|Adverse Event|0|||
13160240|NCT02443883|26083277|FG001|Overall Study|Adverse Event|1|||
13160241|NCT02443883|26083278|FG002|Overall Study|Adverse Event|0|||
13160242|NCT02443883|26083279|FG003|Overall Study|Adverse Event|0|||
13160243|NCT02443883|26083276|FG000|Overall Study|Lost to Follow-up|3|||
13160244|NCT02443883|26083277|FG001|Overall Study|Lost to Follow-up|2|||
13160245|NCT02443883|26083278|FG002|Overall Study|Lost to Follow-up|1|||
13160246|NCT02443883|26083279|FG003|Overall Study|Lost to Follow-up|0|||
13160247|NCT02443883|26083276|FG000|Overall Study|Physician Decision|1|||
13160248|NCT02443883|26083277|FG001|Overall Study|Physician Decision|1|||
13160249|NCT02443883|26083278|FG002|Overall Study|Physician Decision|0|||
13160250|NCT02443883|26083279|FG003|Overall Study|Physician Decision|3|||
13160251|NCT02443883|26083276|FG000|Overall Study|Withdrawal by Subject|1|||
13160252|NCT02443883|26083277|FG001|Overall Study|Withdrawal by Subject|0|||
13160253|NCT02443883|26083278|FG002|Overall Study|Withdrawal by Subject|0|||
13160254|NCT02443883|26083279|FG003|Overall Study|Withdrawal by Subject|2|||
13160255|NCT02443883|26083276|FG000|Overall Study|Randomized, but never treated|1|||
13160256|NCT02443883|26083277|FG001|Overall Study|Randomized, but never treated|0|||
13105487|NCT03325010|25879913|FG000|Overall Study|Protocol Violation|1|||
13105488|NCT03325010|25879914|FG001|Overall Study|Protocol Violation|8|||
13105489|NCT03325010|25879913|FG000|Overall Study|Withdrawal by Subject|1|||
13105490|NCT03325010|25879914|FG001|Overall Study|Withdrawal by Subject|3|||
13105491|NCT03325010|25879913|FG000|Overall Study|Lost to Follow-up|1|||
13105492|NCT03325010|25879914|FG001|Overall Study|Lost to Follow-up|0|||
13105493|NCT03325010|25879913|FG000|Overall Study|Physician Decision|1|||
13160257|NCT02443883|26083278|FG002|Overall Study|Randomized, but never treated|0|||
13160258|NCT02443883|26083279|FG003|Overall Study|Randomized, but never treated|0|||
13160259|NCT02443805|26083296|FG000|Overall Study|Adverse Event|100|||
13160260|NCT02443805|26083297|FG001|Overall Study|Adverse Event|18|||
13160261|NCT02443805|26083296|FG000|Overall Study|Withdrawal by Subject|73|||
13160262|NCT02443805|26083297|FG001|Overall Study|Withdrawal by Subject|74|||
13160263|NCT02443805|26083296|FG000|Overall Study|Lost to Follow-up|19|||
13160264|NCT02443805|26083297|FG001|Overall Study|Lost to Follow-up|14|||
13160265|NCT02443805|26083296|FG000|Overall Study|Pregnancy|6|||
13160266|NCT02443805|26083297|FG001|Overall Study|Pregnancy|5|||
13160267|NCT02443805|26083296|FG000|Overall Study|Protocol Violation|2|||
13160268|NCT02443805|26083297|FG001|Overall Study|Protocol Violation|4|||
13105494|NCT03325010|25879914|FG001|Overall Study|Physician Decision|1|||
13105495|NCT03325010|25879913|FG000|Overall Study|Lack of Efficacy|2|||
13105496|NCT03325010|25879914|FG001|Overall Study|Lack of Efficacy|0|||
13105497|NCT03324581|25879932|FG000|Overall Study|Adverse Event|18|||
13105498|NCT03324581|25879933|FG001|Overall Study|Adverse Event|11|||
13105499|NCT03324581|25879934|FG002|Overall Study|Adverse Event|7|||
13105500|NCT03324581|25879932|FG000|Overall Study|Lack of Efficacy|0|||
13105501|NCT03324581|25879933|FG001|Overall Study|Lack of Efficacy|1|||
13105502|NCT03324581|25879934|FG002|Overall Study|Lack of Efficacy|0|||
13105503|NCT03324581|25879932|FG000|Overall Study|Lost to Follow-up|5|||
13105504|NCT03324581|25879933|FG001|Overall Study|Lost to Follow-up|3|||
13105505|NCT03324581|25879934|FG002|Overall Study|Lost to Follow-up|6|||
13160269|NCT02443805|26083296|FG000|Overall Study|Lack of Efficacy|1|||
13160270|NCT02443805|26083297|FG001|Overall Study|Lack of Efficacy|1|||
13160271|NCT02443805|26083296|FG000|Overall Study|Non-compliance with study drug|6|||
13160272|NCT02443805|26083297|FG001|Overall Study|Non-compliance with study drug|4|||
13160273|NCT02443805|26083296|FG000|Overall Study|Withdrawal by parent/guardian|3|||
13160274|NCT02443805|26083297|FG001|Overall Study|Withdrawal by parent/guardian|5|||
13160275|NCT02443805|26083296|FG000|Overall Study|Any other reason not above-mentioned|3|||
13160276|NCT02443805|26083297|FG001|Overall Study|Any other reason not above-mentioned|2|||
13160277|NCT02443740|26083496|FG000|Intervention Period 1 (3 Days)|Adverse Event|0|||
13160278|NCT02443740|26083497|FG001|Intervention Period 1 (3 Days)|Adverse Event|0|||
13160279|NCT02443740|26083498|FG002|Intervention Period 1 (3 Days)|Adverse Event|0|||
13160280|NCT02443740|26083499|FG003|Intervention Period 1 (3 Days)|Adverse Event|0|||
13160281|NCT02443740|26083500|FG004|Intervention Period 1 (3 Days)|Adverse Event|0|||
13160282|NCT02443740|26083501|FG005|Intervention Period 1 (3 Days)|Adverse Event|1|||
13160283|NCT02443740|26083502|FG006|Intervention Period 1 (3 Days)|Adverse Event|0|||
13160284|NCT02443740|26083503|FG007|Intervention Period 1 (3 Days)|Adverse Event|0|||
13160285|NCT02443740|26083504|FG008|Intervention Period 1 (3 Days)|Adverse Event|0|||
13160286|NCT02443740|26083505|FG009|Intervention Period 1 (3 Days)|Adverse Event|0|||
13160287|NCT02443740|26083506|FG010|Intervention Period 1 (3 Days)|Adverse Event|0|||
13160288|NCT02443740|26083496|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1|||
13160289|NCT02443740|26083497|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0|||
13160290|NCT02443740|26083498|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0|||
13160291|NCT02443740|26083499|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0|||
13160292|NCT02443740|26083500|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0|||
13160293|NCT02443740|26083501|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0|||
13160294|NCT02443740|26083502|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1|||
13160295|NCT02443740|26083503|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0|||
13160296|NCT02443740|26083504|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0|||
13160297|NCT02443740|26083505|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0|||
13160298|NCT02443740|26083506|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0|||
13160299|NCT02443740|26083496|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
13160300|NCT02443740|26083497|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
13160301|NCT02443740|26083498|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
13160302|NCT02443740|26083499|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
13160303|NCT02443740|26083500|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
13160304|NCT02443740|26083501|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1|||
13160305|NCT02443740|26083502|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
13160306|NCT02443740|26083503|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
13160307|NCT02443740|26083504|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
13160308|NCT02443740|26083505|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
13160309|NCT02443740|26083506|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
13160310|NCT02443688|26083578|FG000|Overall Study|Adverse Event|2|||
13160311|NCT02443688|26083579|FG001|Overall Study|Adverse Event|3|||
13160312|NCT02443688|26083580|FG002|Overall Study|Adverse Event|2|||
13160313|NCT02443688|26083578|FG000|Overall Study|Lost to Follow-up|1|||
13160314|NCT02443688|26083579|FG001|Overall Study|Lost to Follow-up|0|||
13160315|NCT02443688|26083580|FG002|Overall Study|Lost to Follow-up|0|||
13160316|NCT02443688|26083578|FG000|Overall Study|Physician Decision|3|||
13160317|NCT02443688|26083579|FG001|Overall Study|Physician Decision|0|||
13160318|NCT02443688|26083580|FG002|Overall Study|Physician Decision|1|||
13160319|NCT02443688|26083578|FG000|Overall Study|Pregnancy|0|||
13160320|NCT02443688|26083579|FG001|Overall Study|Pregnancy|0|||
13160321|NCT02443688|26083580|FG002|Overall Study|Pregnancy|1|||
13160322|NCT02443688|26083578|FG000|Overall Study|Withdrawal by Subject|3|||
13160323|NCT02443688|26083579|FG001|Overall Study|Withdrawal by Subject|3|||
13160324|NCT02443688|26083580|FG002|Overall Study|Withdrawal by Subject|4|||
13160325|NCT02443688|26083578|FG000|Overall Study|Non-compliance with study drug|1|||
13160326|NCT02443688|26083579|FG001|Overall Study|Non-compliance with study drug|2|||
13160327|NCT02443688|26083580|FG002|Overall Study|Non-compliance with study drug|4|||
13160328|NCT02443688|26083578|FG000|Overall Study|Sponsor Request|2|||
13160329|NCT02443688|26083579|FG001|Overall Study|Sponsor Request|1|||
13160330|NCT02443688|26083580|FG002|Overall Study|Sponsor Request|0|||
13160331|NCT02443402|26083647|FG000|Overall Study|Withdrawal by Subject|3|||
13160332|NCT02443402|26083648|FG001|Overall Study|Withdrawal by Subject|1|||
13160333|NCT02443402|26083647|FG000|Overall Study|Screen Failure|1|||
13160334|NCT02443402|26083648|FG001|Overall Study|Screen Failure|2|||
13160335|NCT02443337|26083671|FG000|Overall Study|Adverse Event|0|||
13160336|NCT02443337|26083672|FG001|Overall Study|Adverse Event|1|||
13160337|NCT02443337|26083671|FG000|Overall Study|Clinical Progressive Disease|3|||
13160338|NCT02443337|26083672|FG001|Overall Study|Clinical Progressive Disease|0|||
13160339|NCT02443337|26083671|FG000|Overall Study|Withdrawal by Subject|2|||
13160340|NCT02443337|26083672|FG001|Overall Study|Withdrawal by Subject|1|||
13160341|NCT02443298|26083699|FG000|Overall Study|Adverse Event|3|||
13160342|NCT02443298|26083700|FG001|Overall Study|Adverse Event|3|||
13160343|NCT02443298|26083699|FG000|Overall Study|Withdrawal by Subject|1|||
13160344|NCT02443298|26083700|FG001|Overall Study|Withdrawal by Subject|2|||
13160345|NCT02443155|26084157|FG000|Overall Study|Adverse Event|3|||
13160346|NCT02443155|26084158|FG001|Overall Study|Adverse Event|4|||
13160347|NCT02443155|26084159|FG002|Overall Study|Adverse Event|1|||
13160348|NCT02443155|26084160|FG003|Overall Study|Adverse Event|2|||
13160349|NCT02443155|26084157|FG000|Overall Study|Unclassified|0|||
13160350|NCT02443155|26084158|FG001|Overall Study|Unclassified|0|||
13160351|NCT02443155|26084159|FG002|Overall Study|Unclassified|2|||
13160352|NCT02443155|26084160|FG003|Overall Study|Unclassified|1|||
13160353|NCT02443155|26084157|FG000|Overall Study|Withdrawal by Subject|4|||
13160354|NCT02443155|26084158|FG001|Overall Study|Withdrawal by Subject|7|||
13160355|NCT02443155|26084159|FG002|Overall Study|Withdrawal by Subject|3|||
13160356|NCT02443155|26084160|FG003|Overall Study|Withdrawal by Subject|9|||
13160357|NCT02443155|26084157|FG000|Overall Study|Pregnancy|3|||
13160358|NCT02443155|26084158|FG001|Overall Study|Pregnancy|1|||
13160359|NCT02443155|26084159|FG002|Overall Study|Pregnancy|1|||
13160360|NCT02443155|26084160|FG003|Overall Study|Pregnancy|2|||
13105506|NCT03324581|25879932|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
13105507|NCT03324581|25879933|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
13105508|NCT03324581|25879934|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0|||
13105509|NCT03324581|25879932|FG000|Overall Study|Physician Decision|0|||
13105510|NCT03324581|25879933|FG001|Overall Study|Physician Decision|1|||
13105511|NCT03324581|25879934|FG002|Overall Study|Physician Decision|2|||
13105512|NCT03324581|25879932|FG000|Overall Study|Protocol Deviation|8|||
13105513|NCT03324581|25879933|FG001|Overall Study|Protocol Deviation|9|||
13105514|NCT03324581|25879934|FG002|Overall Study|Protocol Deviation|4|||
13105515|NCT03324581|25879932|FG000|Overall Study|Withdrawal by Subject|6|||
13105516|NCT03324581|25879933|FG001|Overall Study|Withdrawal by Subject|8|||
13105517|NCT03324581|25879934|FG002|Overall Study|Withdrawal by Subject|6|||
13105518|NCT03324581|25879932|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
13105519|NCT03324581|25879933|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1|||
13160361|NCT02443155|26084157|FG000|Overall Study|Lost to Follow-up|1|||
13160362|NCT02443155|26084158|FG001|Overall Study|Lost to Follow-up|2|||
13160363|NCT02443155|26084159|FG002|Overall Study|Lost to Follow-up|0|||
13160364|NCT02443155|26084160|FG003|Overall Study|Lost to Follow-up|1|||
13160365|NCT02443155|26084157|FG000|Overall Study|Protocol Violation|1|||
13160366|NCT02443155|26084158|FG001|Overall Study|Protocol Violation|0|||
13160367|NCT02443155|26084159|FG002|Overall Study|Protocol Violation|1|||
13160368|NCT02443155|26084160|FG003|Overall Study|Protocol Violation|1|||
13160369|NCT02443155|26084157|FG000|Overall Study|Death|0|||
13160370|NCT02443155|26084158|FG001|Overall Study|Death|0|||
13160371|NCT02443155|26084159|FG002|Overall Study|Death|1|||
13160372|NCT02443155|26084160|FG003|Overall Study|Death|0|||
13160373|NCT02443103|26084167|FG000|Overall Study|Adverse Event|2|||
13160374|NCT02443103|26084167|FG000|Overall Study|Noncompliance|1|||
13160375|NCT02442830|26084182|FG000|Overall Study|Technical Failure|0|||
13160376|NCT02442830|26084183|FG001|Overall Study|Technical Failure|1|||
13160377|NCT02442804|26084218|FG000|Overall Study|Withdrawal by Subject|0|||
13160378|NCT02442804|26084219|FG001|Overall Study|Withdrawal by Subject|1|||
13160379|NCT02442804|26084218|FG000|Overall Study|Adverse Event|1|||
13160380|NCT02442804|26084219|FG001|Overall Study|Adverse Event|0|||
13160381|NCT02442778|26084288|FG000|Overall Study|Adverse Event|2|||
13160382|NCT02442778|26084289|FG001|Overall Study|Adverse Event|6|||
13160383|NCT02442778|26084290|FG002|Overall Study|Adverse Event|6|||
13160384|NCT02442778|26084288|FG000|Overall Study|Death|0|||
13160385|NCT02442778|26084289|FG001|Overall Study|Death|2|||
13160386|NCT02442778|26084290|FG002|Overall Study|Death|0|||
13160387|NCT02442778|26084288|FG000|Overall Study|Lack of Efficacy|1|||
13160388|NCT02442778|26084289|FG001|Overall Study|Lack of Efficacy|0|||
13160389|NCT02442778|26084290|FG002|Overall Study|Lack of Efficacy|0|||
13160390|NCT02442778|26084288|FG000|Overall Study|Lost to Follow-up|1|||
13160391|NCT02442778|26084289|FG001|Overall Study|Lost to Follow-up|1|||
13160392|NCT02442778|26084290|FG002|Overall Study|Lost to Follow-up|1|||
13160393|NCT02442778|26084288|FG000|Overall Study|Non-compliance with study drug|2|||
13160394|NCT02442778|26084289|FG001|Overall Study|Non-compliance with study drug|0|||
13160395|NCT02442778|26084290|FG002|Overall Study|Non-compliance with study drug|1|||
13160396|NCT02442778|26084288|FG000|Overall Study|Physician Decision|1|||
13160397|NCT02442778|26084289|FG001|Overall Study|Physician Decision|1|||
13160398|NCT02442778|26084290|FG002|Overall Study|Physician Decision|1|||
13160399|NCT02442778|26084288|FG000|Overall Study|Protocol Deviation|3|||
13160400|NCT02442778|26084289|FG001|Overall Study|Protocol Deviation|0|||
13160401|NCT02442778|26084290|FG002|Overall Study|Protocol Deviation|1|||
13160402|NCT02442778|26084288|FG000|Overall Study|Study participant withdrawal by parent or guardian|3|||
13160403|NCT02442778|26084289|FG001|Overall Study|Study participant withdrawal by parent or guardian|12|||
13160404|NCT02442778|26084290|FG002|Overall Study|Study participant withdrawal by parent or guardian|2|||
13160405|NCT02442778|26084288|FG000|Overall Study|Withdrawal by Subject|4|||
13160406|NCT02442778|26084289|FG001|Overall Study|Withdrawal by Subject|4|||
13160407|NCT02442778|26084290|FG002|Overall Study|Withdrawal by Subject|3|||
13160408|NCT02442778|26084288|FG000|Overall Study|Reason not specified|1|||
13160409|NCT02442778|26084289|FG001|Overall Study|Reason not specified|4|||
13160410|NCT02442778|26084290|FG002|Overall Study|Reason not specified|0|||
13160411|NCT02442622|26084307|FG000|Overall Study|Withdrawal by Subject|3|||
13160412|NCT02442622|26084308|FG001|Overall Study|Withdrawal by Subject|1|||
13160413|NCT02442349|26084315|FG000|Overall Study|Death|14|||
13160414|NCT02442349|26084315|FG000|Overall Study|Withdrawal by Subject|8|||
13160415|NCT02442349|26084315|FG000|Overall Study|On-going Study at Data Cut-off|149|||
13160416|NCT02442336|26084321|FG000|Overall Study|6 patients assisted with the intervention development only.|6|||
13160417|NCT02442336|26084321|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19|||
13160418|NCT02442336|26084321|FG000|Overall Study|Lost to Follow-up|11|||
13105520|NCT03324581|25879934|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
13105521|NCT03323736|25879955|FG000|Overall Study|Screen Failure|14|||
13105522|NCT03323736|25879956|FG001|Overall Study|Screen Failure|9|||
13105523|NCT03323736|25879957|FG002|Overall Study|Screen Failure|1|||
13105524|NCT03323736|25879955|FG000|Overall Study|Withdrawal Before Treatment|3|||
13160419|NCT02442310|26084345|FG000|Overall Study|Adverse Event|2|||
13160420|NCT02442310|26084345|FG000|Overall Study|Withdrawal by Subject|1|||
13160421|NCT02442284|26084354|FG000|Overall Study|Adverse Event|1|||
13160422|NCT02442284|26084354|FG000|Overall Study|Withdrew Consent|2|||
13160423|NCT02442284|26084354|FG000|Overall Study|Lost to Follow-up|3|||
13160424|NCT02442284|26084354|FG000|Overall Study|Other|1|||
13160425|NCT02442271|26084380|FG000|Overall Study|Adverse Event|1|||
13160426|NCT02442271|26084380|FG000|Overall Study|Withdrew Consent|1|||
13160427|NCT02442271|26084380|FG000|Overall Study|Lost to Follow-up|1|||
13160428|NCT02442271|26084380|FG000|Overall Study|Other|1|||
13160429|NCT02442206|26084416|FG000|Period 1|Adverse Event|1|||
13160430|NCT02442206|26084417|FG001|Period 1|Adverse Event|1|||
13160431|NCT02442206|26084416|FG000|Period 1|withdrew consent|0|||
13160432|NCT02442206|26084417|FG001|Period 1|withdrew consent|1|||
13160433|NCT02442206|26084416|FG000|Period 1|COPD exacerbation|0|||
13160434|NCT02442206|26084417|FG001|Period 1|COPD exacerbation|1|||
13160435|NCT02442206|26084416|FG000|Period 2|Adverse Event|1|||
13160436|NCT02442206|26084417|FG001|Period 2|Adverse Event|0|||
13160437|NCT02441946|26084448|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
13160438|NCT02441946|26084449|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
13160439|NCT02441946|26084450|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0|||
13160440|NCT02441946|26084448|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1|||
13160441|NCT02441946|26084449|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
13160442|NCT02441946|26084450|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
13160443|NCT02441946|26084448|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
13160444|NCT02441946|26084449|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3|||
13160445|NCT02441946|26084450|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
13160446|NCT02441946|26084448|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
13160447|NCT02441946|26084449|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1|||
13160448|NCT02441946|26084450|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
13160449|NCT02441946|26084448|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15|||
13105525|NCT03323736|25879956|FG001|Overall Study|Withdrawal Before Treatment|1|||
13105526|NCT03323736|25879957|FG002|Overall Study|Withdrawal Before Treatment|1|||
13105527|NCT03323736|25879955|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2|||
13105528|NCT03323736|25879956|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2|||
13105529|NCT03323736|25879957|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0|||
13105530|NCT03323164|25879988|FG000|Overall Study|Poor quality imaging/scans|2|||
13105531|NCT03323164|25879989|FG001|Overall Study|Poor quality imaging/scans|2|||
13105532|NCT03323086|25880012|FG000|Overall Study|Lost to Follow-up|3|||
13105533|NCT03323086|25880013|FG001|Overall Study|Lost to Follow-up|2|||
13105534|NCT03323034|25880072|FG000|Overall Study|Lack of Efficacy|5|||
13105535|NCT03323034|25880073|FG001|Overall Study|Lack of Efficacy|5|||
13105536|NCT03323034|25880074|FG002|Overall Study|Lack of Efficacy|6|||
13105537|NCT03323034|25880075|FG003|Overall Study|Lack of Efficacy|5|||
13105538|NCT03323034|25880076|FG004|Overall Study|Lack of Efficacy|5|||
13105539|NCT03323034|25880072|FG000|Overall Study|Physician Decision|0|||
13105540|NCT03323034|25880073|FG001|Overall Study|Physician Decision|0|||
13105541|NCT03323034|25880074|FG002|Overall Study|Physician Decision|0|||
13105542|NCT03323034|25880075|FG003|Overall Study|Physician Decision|0|||
13105543|NCT03323034|25880076|FG004|Overall Study|Physician Decision|1|||
13105544|NCT03323034|25880072|FG000|Overall Study|Withdrawal by Subject|1|||
13105545|NCT03323034|25880073|FG001|Overall Study|Withdrawal by Subject|1|||
13105546|NCT03323034|25880074|FG002|Overall Study|Withdrawal by Subject|0|||
13160450|NCT02441946|26084449|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
13160451|NCT02441946|26084450|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
13105547|NCT03323034|25880075|FG003|Overall Study|Withdrawal by Subject|1|||
13160452|NCT02441946|26084448|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1|||
13105548|NCT03323034|25880076|FG004|Overall Study|Withdrawal by Subject|0|||
13105549|NCT03322514|25880093|FG000|Overall Study|Withdrawal by Subject|1|||
13160453|NCT02441946|26084449|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
13160454|NCT02441946|26084450|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
13160455|NCT02441946|26084448|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1|||
13160456|NCT02441946|26084449|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
13160457|NCT02441946|26084450|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
13160458|NCT02441946|26084448|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1|||
13160459|NCT02441946|26084449|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
13160460|NCT02441946|26084450|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
13160461|NCT02441946|26084448|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9|||
13160462|NCT02441946|26084449|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
13160463|NCT02441946|26084450|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
13160464|NCT02441946|26084448|FG000|Extension Period (8 Weeks)|Adverse Event|1|||
13160465|NCT02441946|26084449|FG001|Extension Period (8 Weeks)|Adverse Event|0|||
13160466|NCT02441946|26084450|FG002|Extension Period (8 Weeks)|Adverse Event|0|||
13160467|NCT02441946|26084448|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1|||
13160468|NCT02441946|26084449|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
13160469|NCT02441946|26084450|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
13160470|NCT02441517|26084462|FG000|Overall Study|Lost to Follow-up|1|||
13160471|NCT02441517|26084462|FG000|Overall Study|Withdrawal by Subject|2|||
13160472|NCT02441517|26084462|FG000|Overall Study|Study Terminated by Sponsor|1|||
13160473|NCT02441309|26084501|FG000|Overall Study|Disease progression|2|||
13160474|NCT02441309|26084502|FG001|Overall Study|Disease progression|1|||
13160475|NCT02441309|26084503|FG002|Overall Study|Disease progression|2|||
13160476|NCT02441309|26084501|FG000|Overall Study|Adverse Event|0|||
13160477|NCT02441309|26084502|FG001|Overall Study|Adverse Event|1|||
13160478|NCT02441309|26084503|FG002|Overall Study|Adverse Event|0|||
13160479|NCT02441309|26084501|FG000|Overall Study|Withdrawal by Subject|1|||
13160480|NCT02441309|26084502|FG001|Overall Study|Withdrawal by Subject|0|||
13160481|NCT02441309|26084503|FG002|Overall Study|Withdrawal by Subject|1|||
13160482|NCT02441283|26084516|FG000|Overall Study|Withdrew consent|15|||
13160483|NCT02441283|26084516|FG000|Overall Study|Lost to Follow-up|42|||
13160484|NCT02441283|26084516|FG000|Overall Study|Death|1|||
13160485|NCT02441283|26084516|FG000|Overall Study|Other, not specified|32|||
13160486|NCT02441218|26084547|FG000|Overall Study|Death|503|||
13160487|NCT02441218|26084548|FG001|Overall Study|Death|553|||
13160488|NCT02441218|26084547|FG000|Overall Study|Withdrawal by Subject|73|||
13160489|NCT02441218|26084548|FG001|Overall Study|Withdrawal by Subject|58|||
13160490|NCT02441218|26084547|FG000|Overall Study|Lost to Follow-up|2|||
13160491|NCT02441218|26084548|FG001|Overall Study|Lost to Follow-up|1|||
13160492|NCT02441179|26084573|FG000|Overall Study|Withdrawal by Subject|1|||
13160493|NCT02441179|26084574|FG001|Overall Study|Withdrawal by Subject|1|||
13160494|NCT02441114|26084582|FG000|Washout2|Withdrawal by Subject|4|||
13160495|NCT02441036|26084625|FG000|Overall Study|No tissue resected|0|||
13160496|NCT02441036|26084626|FG001|Overall Study|No tissue resected|1|||
13160497|NCT02441036|26084627|FG002|Overall Study|No tissue resected|0|||
13160498|NCT02441036|26084628|FG003|Overall Study|No tissue resected|1|||
13105550|NCT03322514|25880094|FG001|Overall Study|Withdrawal by Subject|1|||
13105551|NCT03322462|25880105|FG000|Overall Study|Technical difficulties|2|||
13105552|NCT03322462|25880105|FG000|Overall Study|Other|1|||
13105553|NCT03322423|25880118|FG000|Period 1|Subject no longer eligible|0|||
13105554|NCT03322423|25880119|FG001|Period 1|Subject no longer eligible|1|||
13105555|NCT03322423|25880118|FG000|Period 1|Withdrawal by Subject|0|||
13105556|NCT03322423|25880119|FG001|Period 1|Withdrawal by Subject|1|||
13105557|NCT03322423|25880118|FG000|Period 1|Incorrect Lens Dispensed|1|||
13105558|NCT03322423|25880119|FG001|Period 1|Incorrect Lens Dispensed|0|||
13105559|NCT03322423|25880118|FG000|Period 1|Unsatisfactory Lens Fitting|1|||
13105560|NCT03322423|25880119|FG001|Period 1|Unsatisfactory Lens Fitting|0|||
13105561|NCT03322423|25880118|FG000|Period 2|Dispensed incorrect lens in left eye|0|||
13105562|NCT03322423|25880119|FG001|Period 2|Dispensed incorrect lens in left eye|1|||
13105563|NCT03322423|25880118|FG000|Period 2|Protocol Violation|1|||
13105564|NCT03322423|25880119|FG001|Period 2|Protocol Violation|0|||
13105565|NCT03322423|25880118|FG000|Period 2|Subject not eligible for Pytergiumectomy|0|||
13105566|NCT03322423|25880119|FG001|Period 2|Subject not eligible for Pytergiumectomy|1|||
13105567|NCT03321721|25880146|FG000|Overall Study|Lost to Follow-up|4|||
13160499|NCT02441036|26084629|FG004|Overall Study|No tissue resected|0|||
13160500|NCT02440854|26084664|FG000|Overall Study|Relocation of patient|1|||
13160501|NCT02440854|26084664|FG000|Overall Study|Death|6|||
13160502|NCT02440854|26084664|FG000|Overall Study|Lost to Follow-up|10|||
13160503|NCT02440854|26084664|FG000|Overall Study|Afatinib discontinuation|46|||
13160504|NCT02440854|26084664|FG000|Overall Study|stopped study at earlier timepoint|14|||
13160505|NCT02440854|26084664|FG000|Overall Study|Study medication not received|1|||
13160506|NCT02440854|26084664|FG000|Overall Study|Violation of inclusion criteria|2|||
13160507|NCT02440789|26084715|FG000|Overall Study|Withdrawal by Subject|3|||
13105568|NCT03321721|25880147|FG001|Overall Study|Lost to Follow-up|8|||
13105569|NCT03321721|25880148|FG002|Overall Study|Lost to Follow-up|11|||
13105570|NCT03321526|25880239|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
13105571|NCT03321526|25880240|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
13105572|NCT03321526|25880239|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|9|||
13105573|NCT03321526|25880240|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|3|||
13105574|NCT03321526|25880239|FG000|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|1|||
13105575|NCT03321526|25880240|FG001|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|3|||
13105576|NCT03321526|25880239|FG000|Double-blind Treatment Phase (24 Weeks)|Adverse Event|7|||
13105577|NCT03321526|25880240|FG001|Double-blind Treatment Phase (24 Weeks)|Adverse Event|8|||
13105578|NCT03321526|25880239|FG000|Double-blind Treatment Phase (24 Weeks)|Death|1|||
13105579|NCT03321526|25880240|FG001|Double-blind Treatment Phase (24 Weeks)|Death|0|||
13105580|NCT03321526|25880239|FG000|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|3|||
13105581|NCT03321526|25880240|FG001|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|6|||
13105582|NCT03321526|25880239|FG000|Double-blind Treatment Phase (24 Weeks)|Other|1|||
13105583|NCT03321526|25880240|FG001|Double-blind Treatment Phase (24 Weeks)|Other|4|||
13105584|NCT03321526|25880239|FG000|Follow-up Phase (2 Weeks)|Other|24|||
13105585|NCT03321526|25880240|FG001|Follow-up Phase (2 Weeks)|Other|24|||
13105586|NCT03321396|25880248|FG000|Overall Study|Physician Decision|1|||
13105587|NCT03321006|25880265|FG000|Overall Study|Death|1|||
13160508|NCT02440789|26084715|FG000|Overall Study|Not willing to adhere to reqs|1|||
13160509|NCT02440594|26084772|FG000|Overall Study|Lost to Follow-up|34|||
13160510|NCT02440594|26084773|FG001|Overall Study|Lost to Follow-up|33|||
13160511|NCT02440594|26084774|FG002|Overall Study|Lost to Follow-up|54|||
13160512|NCT02440594|26084775|FG003|Overall Study|Lost to Follow-up|47|||
13160513|NCT02440594|26084776|FG004|Overall Study|Lost to Follow-up|5|||
13160514|NCT02440594|26084777|FG005|Overall Study|Lost to Follow-up|4|||
13160515|NCT02440594|26084778|FG006|Overall Study|Lost to Follow-up|28|||
13160516|NCT02440594|26084779|FG007|Overall Study|Lost to Follow-up|48|||
13160517|NCT02440594|26084772|FG000|Overall Study|Cognitive Impairment/Communication Issue|14|||
13160518|NCT02440594|26084773|FG001|Overall Study|Cognitive Impairment/Communication Issue|6|||
13160519|NCT02440594|26084774|FG002|Overall Study|Cognitive Impairment/Communication Issue|4|||
13160520|NCT02440594|26084775|FG003|Overall Study|Cognitive Impairment/Communication Issue|4|||
13160521|NCT02440594|26084776|FG004|Overall Study|Cognitive Impairment/Communication Issue|2|||
13160522|NCT02440594|26084777|FG005|Overall Study|Cognitive Impairment/Communication Issue|1|||
13160523|NCT02440594|26084778|FG006|Overall Study|Cognitive Impairment/Communication Issue|0|||
13160524|NCT02440594|26084779|FG007|Overall Study|Cognitive Impairment/Communication Issue|0|||
13160525|NCT02440594|26084772|FG000|Overall Study|Withdrawal by Subject|81|||
13160526|NCT02440594|26084773|FG001|Overall Study|Withdrawal by Subject|67|||
13160527|NCT02440594|26084774|FG002|Overall Study|Withdrawal by Subject|59|||
13160528|NCT02440594|26084775|FG003|Overall Study|Withdrawal by Subject|38|||
13160529|NCT02440594|26084776|FG004|Overall Study|Withdrawal by Subject|2|||
13160530|NCT02440594|26084777|FG005|Overall Study|Withdrawal by Subject|2|||
13160531|NCT02440594|26084778|FG006|Overall Study|Withdrawal by Subject|7|||
13160532|NCT02440594|26084779|FG007|Overall Study|Withdrawal by Subject|7|||
13160533|NCT02440594|26084772|FG000|Overall Study|Administratively w/drawn|3|||
13160534|NCT02440594|26084773|FG001|Overall Study|Administratively w/drawn|2|||
13160535|NCT02440594|26084774|FG002|Overall Study|Administratively w/drawn|0|||
13160536|NCT02440594|26084775|FG003|Overall Study|Administratively w/drawn|0|||
13160537|NCT02440594|26084776|FG004|Overall Study|Administratively w/drawn|0|||
13160538|NCT02440594|26084777|FG005|Overall Study|Administratively w/drawn|0|||
13160539|NCT02440594|26084778|FG006|Overall Study|Administratively w/drawn|2|||
13160540|NCT02440594|26084779|FG007|Overall Study|Administratively w/drawn|1|||
13160541|NCT02440568|26084822|FG000|Overall Study|Death|1|||
13160542|NCT02440568|26084823|FG001|Overall Study|Death|3|||
13160543|NCT02440568|26084824|FG002|Overall Study|Death|4|||
13160544|NCT02440568|26084825|FG003|Overall Study|Death|2|||
13160545|NCT02440568|26084822|FG000|Overall Study|Lack of Efficacy|2|||
13160546|NCT02440568|26084823|FG001|Overall Study|Lack of Efficacy|0|||
13160547|NCT02440568|26084824|FG002|Overall Study|Lack of Efficacy|1|||
13160548|NCT02440568|26084825|FG003|Overall Study|Lack of Efficacy|0|||
13160549|NCT02440568|26084822|FG000|Overall Study|Lost to Follow-up|1|||
13160550|NCT02440568|26084823|FG001|Overall Study|Lost to Follow-up|0|||
13160551|NCT02440568|26084824|FG002|Overall Study|Lost to Follow-up|0|||
13160552|NCT02440568|26084825|FG003|Overall Study|Lost to Follow-up|0|||
13105588|NCT03321006|25880266|FG001|Overall Study|Death|0|||
13160553|NCT02439970|26084838|FG000|Overall Study|Study Terminated|2|||
13160554|NCT02439970|26084839|FG001|Overall Study|Study Terminated|3|||
13160555|NCT02439957|26084852|FG000|Overall Study|Study Terminated|3|||
13160556|NCT02439957|26084853|FG001|Overall Study|Study Terminated|3|||
13160557|NCT02439320|26084906|FG000|Overall Study|Adverse Event|0|||
13160558|NCT02439320|26084907|FG001|Overall Study|Adverse Event|2|||
13160559|NCT02439320|26084908|FG002|Overall Study|Adverse Event|0|||
13160560|NCT02439320|26084906|FG000|Overall Study|Lost to Follow-up|37|||
13160561|NCT02439320|26084907|FG001|Overall Study|Lost to Follow-up|34|||
13160562|NCT02439320|26084908|FG002|Overall Study|Lost to Follow-up|42|||
13105589|NCT03321006|25880265|FG000|Overall Study|Lack of Efficacy|1|||
13105590|NCT03321006|25880266|FG001|Overall Study|Lack of Efficacy|0|||
13105591|NCT03320941|25880383|FG000|Overall Study|subject/guardian decision|0|||
13105592|NCT03320941|25880384|FG001|Overall Study|subject/guardian decision|0|||
13105593|NCT03320941|25880385|FG002|Overall Study|subject/guardian decision|0|||
13105594|NCT03320941|25880386|FG003|Overall Study|subject/guardian decision|1|||
13105595|NCT03320941|25880387|FG004|Overall Study|subject/guardian decision|0|||
13105596|NCT03320850|25880455|FG000|Overall Study|Lost to Follow-up|0|||
13160563|NCT02439320|26084906|FG000|Overall Study|Death|0|||
13160564|NCT02439320|26084907|FG001|Overall Study|Death|1|||
13160565|NCT02439320|26084908|FG002|Overall Study|Death|0|||
13160566|NCT02439320|26084906|FG000|Overall Study|Noncompliance with Protocol|10|||
13160567|NCT02439320|26084907|FG001|Overall Study|Noncompliance with Protocol|11|||
13160568|NCT02439320|26084908|FG002|Overall Study|Noncompliance with Protocol|7|||
13160569|NCT02439320|26084906|FG000|Overall Study|Pregnancy|0|||
13160570|NCT02439320|26084907|FG001|Overall Study|Pregnancy|1|||
13160571|NCT02439320|26084908|FG002|Overall Study|Pregnancy|1|||
13160572|NCT02439320|26084906|FG000|Overall Study|Withdrawal by Subject|12|||
13160573|NCT02439320|26084907|FG001|Overall Study|Withdrawal by Subject|16|||
13160574|NCT02439320|26084908|FG002|Overall Study|Withdrawal by Subject|14|||
13160575|NCT02439320|26084906|FG000|Overall Study|Physician Decision|2|||
13160576|NCT02439320|26084907|FG001|Overall Study|Physician Decision|1|||
13160577|NCT02439320|26084908|FG002|Overall Study|Physician Decision|0|||
13160578|NCT02439320|26084906|FG000|Overall Study|Sponsor Request|0|||
13160579|NCT02439320|26084907|FG001|Overall Study|Sponsor Request|2|||
13160580|NCT02439320|26084908|FG002|Overall Study|Sponsor Request|1|||
13160581|NCT02439320|26084906|FG000|Overall Study|Randomization Failure|35|||
13160582|NCT02439320|26084907|FG001|Overall Study|Randomization Failure|46|||
13160583|NCT02439320|26084908|FG002|Overall Study|Randomization Failure|34|||
13160584|NCT02439216|26084960|FG000|PartA(7 Day Open-Label Treatment Period)|Screen failure|1|||
13160585|NCT02439216|26084961|FG001|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
13160586|NCT02439216|26084962|FG002|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
13160587|NCT02439216|26084963|FG003|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
13160588|NCT02439216|26084964|FG004|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
13160589|NCT02439216|26084965|FG005|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
13160590|NCT02439216|26084966|FG006|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
13160591|NCT02439216|26084967|FG007|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
13160592|NCT02439216|26084968|FG008|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
13160593|NCT02439216|26084960|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
13160594|NCT02439216|26084961|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
13160595|NCT02439216|26084962|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
13160596|NCT02439216|26084963|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
13160597|NCT02439216|26084964|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
13160598|NCT02439216|26084965|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
13160599|NCT02439216|26084966|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
13160600|NCT02439216|26084967|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|1|||
13160601|NCT02439216|26084968|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
13160602|NCT02439216|26084960|FG000|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
13160603|NCT02439216|26084961|FG001|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
13160604|NCT02439216|26084962|FG002|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
13160605|NCT02439216|26084963|FG003|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
13160606|NCT02439216|26084964|FG004|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
13160607|NCT02439216|26084965|FG005|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
13160608|NCT02439216|26084966|FG006|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
13160609|NCT02439216|26084967|FG007|Part C (138-week, Open-label Treatment)|Lost to Follow-up|1|||
13160610|NCT02439216|26084968|FG008|Part C (138-week, Open-label Treatment)|Lost to Follow-up|2|||
13160611|NCT02439216|26084960|FG000|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
13160612|NCT02439216|26084961|FG001|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
13160613|NCT02439216|26084962|FG002|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
13160614|NCT02439216|26084963|FG003|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
13160615|NCT02439216|26084964|FG004|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
13160616|NCT02439216|26084965|FG005|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
13160617|NCT02439216|26084966|FG006|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
13160618|NCT02439216|26084967|FG007|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
13160619|NCT02439216|26084968|FG008|Part C (138-week, Open-label Treatment)|Progressive disease|3|||
13160620|NCT02439216|26084960|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
13105597|NCT03320850|25880456|FG001|Overall Study|Lost to Follow-up|0|||
13105598|NCT03320850|25880457|FG002|Overall Study|Lost to Follow-up|0|||
13160621|NCT02439216|26084961|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
13222817|NCT01802775|26286957|FG001|Overall Study|Physician Decision|0|||
13160622|NCT02439216|26084962|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
13160623|NCT02439216|26084963|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
13160624|NCT02439216|26084964|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
13160625|NCT02439216|26084965|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
13160626|NCT02439216|26084966|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
13160627|NCT02439216|26084967|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|5|||
13160628|NCT02439216|26084968|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|6|||
13160629|NCT02439138|26084981|FG000|Overall Study|Adverse Event|1|||
13160630|NCT02439138|26084981|FG000|Overall Study|PI decision to terminate the study|2|||
13160631|NCT02438826|26085024|FG000|Double-Blind Treatment Phase|Adverse Event|1|||
13160632|NCT02438826|26085025|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
13160633|NCT02438826|26085026|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
13105599|NCT03320850|25880458|FG003|Overall Study|Lost to Follow-up|0|||
13105600|NCT03320850|25880459|FG004|Overall Study|Lost to Follow-up|1|||
13105601|NCT03320850|25880460|FG005|Overall Study|Lost to Follow-up|2|||
13160634|NCT02438826|26085027|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
13160635|NCT02438826|26085024|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1|||
13160636|NCT02438826|26085025|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
13160637|NCT02438826|26085026|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
13160638|NCT02438826|26085027|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
13160639|NCT02438826|26085024|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
13160640|NCT02438826|26085025|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
13160641|NCT02438826|26085026|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
13160642|NCT02438826|26085027|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
13160643|NCT02438826|26085024|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
13160644|NCT02438826|26085025|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
13160645|NCT02438826|26085026|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
13160646|NCT02438826|26085027|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
13160647|NCT02438826|26085024|FG000|Double-Blind Treatment Phase|Screen Failure|2|||
13160648|NCT02438826|26085025|FG001|Double-Blind Treatment Phase|Screen Failure|0|||
13160649|NCT02438826|26085026|FG002|Double-Blind Treatment Phase|Screen Failure|0|||
13160650|NCT02438826|26085027|FG003|Double-Blind Treatment Phase|Screen Failure|0|||
13160651|NCT02438826|26085024|FG000|Open-Label Treatment Phase|Adverse Event|11|||
13160652|NCT02438826|26085025|FG001|Open-Label Treatment Phase|Adverse Event|6|||
13160653|NCT02438826|26085026|FG002|Open-Label Treatment Phase|Adverse Event|0|||
13160654|NCT02438826|26085027|FG003|Open-Label Treatment Phase|Adverse Event|0|||
13160655|NCT02438826|26085024|FG000|Open-Label Treatment Phase|Lack of Efficacy|27|||
13160656|NCT02438826|26085025|FG001|Open-Label Treatment Phase|Lack of Efficacy|18|||
13160657|NCT02438826|26085026|FG002|Open-Label Treatment Phase|Lack of Efficacy|0|||
13160658|NCT02438826|26085027|FG003|Open-Label Treatment Phase|Lack of Efficacy|0|||
13160659|NCT02438826|26085024|FG000|Open-Label Treatment Phase|Lost to Follow-up|0|||
13160660|NCT02438826|26085025|FG001|Open-Label Treatment Phase|Lost to Follow-up|2|||
13160661|NCT02438826|26085026|FG002|Open-Label Treatment Phase|Lost to Follow-up|0|||
13160662|NCT02438826|26085027|FG003|Open-Label Treatment Phase|Lost to Follow-up|0|||
13160663|NCT02438826|26085024|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6|||
13160664|NCT02438826|26085025|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
13160665|NCT02438826|26085026|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0|||
13160666|NCT02438826|26085027|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0|||
13105602|NCT03320850|25880461|FG006|Overall Study|Lost to Follow-up|2|||
13160667|NCT02438826|26085024|FG000|Post-Treatment Phase|Adverse Event|3|||
13160668|NCT02438826|26085025|FG001|Post-Treatment Phase|Adverse Event|0|||
13105603|NCT03320850|25880462|FG007|Overall Study|Lost to Follow-up|0|||
13160669|NCT02438826|26085026|FG002|Post-Treatment Phase|Adverse Event|0|||
13105604|NCT03320850|25880463|FG008|Overall Study|Lost to Follow-up|6|||
13160670|NCT02438826|26085027|FG003|Post-Treatment Phase|Adverse Event|0|||
13160671|NCT02438826|26085024|FG000|Post-Treatment Phase|Lack of Efficacy|4|||
13160672|NCT02438826|26085025|FG001|Post-Treatment Phase|Lack of Efficacy|0|||
13160673|NCT02438826|26085026|FG002|Post-Treatment Phase|Lack of Efficacy|0|||
13160674|NCT02438826|26085027|FG003|Post-Treatment Phase|Lack of Efficacy|0|||
13160675|NCT02438826|26085024|FG000|Post-Treatment Phase|Physician Decision|1|||
13160676|NCT02438826|26085025|FG001|Post-Treatment Phase|Physician Decision|0|||
13160677|NCT02438826|26085026|FG002|Post-Treatment Phase|Physician Decision|0|||
13105605|NCT03320850|25880464|FG009|Overall Study|Lost to Follow-up|4|||
13105606|NCT03320850|25880455|FG000|Overall Study|Withdrawal by Subject|0|||
13105607|NCT03320850|25880456|FG001|Overall Study|Withdrawal by Subject|0|||
13105608|NCT03320850|25880457|FG002|Overall Study|Withdrawal by Subject|0|||
13160678|NCT02438826|26085027|FG003|Post-Treatment Phase|Physician Decision|0|||
13105609|NCT03320850|25880458|FG003|Overall Study|Withdrawal by Subject|0|||
13160679|NCT02438826|26085024|FG000|Post-Treatment Phase|Withdrawal by Subject|1|||
13160680|NCT02438826|26085025|FG001|Post-Treatment Phase|Withdrawal by Subject|1|||
13160681|NCT02438826|26085026|FG002|Post-Treatment Phase|Withdrawal by Subject|0|||
13160682|NCT02438826|26085027|FG003|Post-Treatment Phase|Withdrawal by Subject|0|||
13160683|NCT02438813|26085078|FG000|Overall Study|Patient Decision|59|||
13160684|NCT02438813|26085078|FG000|Overall Study|Patient Lost to Follow-Up|137|||
13160685|NCT02438813|26085078|FG000|Overall Study|Study Ended by Sponsor|80|||
13160686|NCT02438813|26085078|FG000|Overall Study|Patients Not Treated/No EOT Visit|249|||
13160687|NCT02438787|26085131|FG000|Overall Study|Adverse Event|1|||
13160688|NCT02438787|26085132|FG001|Overall Study|Adverse Event|0|||
13160689|NCT02438787|26085133|FG002|Overall Study|Adverse Event|2|||
13160690|NCT02438787|26085131|FG000|Overall Study|Lack of Efficacy|1|||
13160691|NCT02438787|26085132|FG001|Overall Study|Lack of Efficacy|2|||
13160692|NCT02438787|26085133|FG002|Overall Study|Lack of Efficacy|0|||
13105610|NCT03320850|25880459|FG004|Overall Study|Withdrawal by Subject|1|||
13105611|NCT03320850|25880460|FG005|Overall Study|Withdrawal by Subject|2|||
13105612|NCT03320850|25880461|FG006|Overall Study|Withdrawal by Subject|4|||
13105613|NCT03320850|25880462|FG007|Overall Study|Withdrawal by Subject|5|||
13105614|NCT03320850|25880463|FG008|Overall Study|Withdrawal by Subject|2|||
13105615|NCT03320850|25880464|FG009|Overall Study|Withdrawal by Subject|1|||
13105616|NCT03320850|25880455|FG000|Overall Study|Lack of Efficacy|0|||
13105617|NCT03320850|25880456|FG001|Overall Study|Lack of Efficacy|0|||
13105618|NCT03320850|25880457|FG002|Overall Study|Lack of Efficacy|0|||
13105619|NCT03320850|25880458|FG003|Overall Study|Lack of Efficacy|1|||
13105620|NCT03320850|25880459|FG004|Overall Study|Lack of Efficacy|0|||
13105621|NCT03320850|25880460|FG005|Overall Study|Lack of Efficacy|1|||
13105622|NCT03320850|25880461|FG006|Overall Study|Lack of Efficacy|0|||
13105623|NCT03320850|25880462|FG007|Overall Study|Lack of Efficacy|2|||
13105624|NCT03320850|25880463|FG008|Overall Study|Lack of Efficacy|0|||
13105625|NCT03320850|25880464|FG009|Overall Study|Lack of Efficacy|3|||
13105626|NCT03320850|25880455|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
13105627|NCT03320850|25880456|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
13105628|NCT03320850|25880457|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
13105629|NCT03320850|25880458|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
13105630|NCT03320850|25880459|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
13105631|NCT03320850|25880460|FG005|Overall Study|Failure to Meet Randomization Criteria|1|||
13105632|NCT03320850|25880461|FG006|Overall Study|Failure to Meet Randomization Criteria|0|||
13105633|NCT03320850|25880462|FG007|Overall Study|Failure to Meet Randomization Criteria|0|||
13105634|NCT03320850|25880463|FG008|Overall Study|Failure to Meet Randomization Criteria|0|||
13105635|NCT03320850|25880464|FG009|Overall Study|Failure to Meet Randomization Criteria|0|||
13105636|NCT03320850|25880455|FG000|Overall Study|Adverse Event|0|||
13105637|NCT03320850|25880456|FG001|Overall Study|Adverse Event|0|||
13105638|NCT03320850|25880457|FG002|Overall Study|Adverse Event|0|||
13105639|NCT03320850|25880458|FG003|Overall Study|Adverse Event|0|||
13105640|NCT03320850|25880459|FG004|Overall Study|Adverse Event|0|||
13105641|NCT03320850|25880460|FG005|Overall Study|Adverse Event|2|||
13105642|NCT03320850|25880461|FG006|Overall Study|Adverse Event|1|||
13105643|NCT03320850|25880462|FG007|Overall Study|Adverse Event|0|||
13105644|NCT03320850|25880463|FG008|Overall Study|Adverse Event|2|||
13105645|NCT03320850|25880464|FG009|Overall Study|Adverse Event|0|||
13105646|NCT03320850|25880455|FG000|Overall Study|Reason Not Specified|0|||
13105647|NCT03320850|25880456|FG001|Overall Study|Reason Not Specified|0|||
13105648|NCT03320850|25880457|FG002|Overall Study|Reason Not Specified|0|||
13105649|NCT03320850|25880458|FG003|Overall Study|Reason Not Specified|0|||
13105650|NCT03320850|25880459|FG004|Overall Study|Reason Not Specified|0|||
13105651|NCT03320850|25880460|FG005|Overall Study|Reason Not Specified|1|||
13105652|NCT03320850|25880461|FG006|Overall Study|Reason Not Specified|0|||
13105653|NCT03320850|25880462|FG007|Overall Study|Reason Not Specified|0|||
13105654|NCT03320850|25880463|FG008|Overall Study|Reason Not Specified|0|||
13105655|NCT03320850|25880464|FG009|Overall Study|Reason Not Specified|1|||
13105656|NCT03320824|25880487|FG000|Overall Study|Withdrawal by Subject|8|||
13105657|NCT03320824|25880488|FG001|Overall Study|Withdrawal by Subject|1|||
13105658|NCT03320824|25880487|FG000|Overall Study|Lost to Follow-up|10|||
13105659|NCT03320824|25880488|FG001|Overall Study|Lost to Follow-up|1|||
13105660|NCT03320824|25880487|FG000|Overall Study|moved out of state|0|||
13105661|NCT03320824|25880488|FG001|Overall Study|moved out of state|1|||
13105662|NCT03320824|25880487|FG000|Overall Study|could not complete final visit|0|||
13105663|NCT03320824|25880488|FG001|Overall Study|could not complete final visit|1|||
13105664|NCT03320564|25880494|FG000|Overall Study|Protocol Violation|1|||
13105665|NCT03320369|25880505|FG000|Overall Study|Adverse Event|1|||
13105666|NCT03320369|25880505|FG000|Overall Study|Withdrawal by Subject|2|||
13105667|NCT03320330|25880544|FG000|Overall Study|Lack of Efficacy|5|||
13105668|NCT03320330|25880545|FG001|Overall Study|Lack of Efficacy|5|||
13160693|NCT02438787|26085131|FG000|Overall Study|Lost to Follow-up|0|||
13160694|NCT02438787|26085132|FG001|Overall Study|Lost to Follow-up|1|||
13160695|NCT02438787|26085133|FG002|Overall Study|Lost to Follow-up|0|||
13105669|NCT03320330|25880546|FG002|Overall Study|Lack of Efficacy|14|||
13160696|NCT02438787|26085131|FG000|Overall Study|Protocol Violation|0|||
13222818|NCT01802775|26286956|FG000|Overall Study|Adverse Event|1|||
13160697|NCT02438787|26085132|FG001|Overall Study|Protocol Violation|0|||
13160698|NCT02438787|26085133|FG002|Overall Study|Protocol Violation|1|||
13160699|NCT02438787|26085131|FG000|Overall Study|Withdrawal by Subject|15|||
13160700|NCT02438787|26085132|FG001|Overall Study|Withdrawal by Subject|7|||
13160701|NCT02438787|26085133|FG002|Overall Study|Withdrawal by Subject|10|||
13160702|NCT02438787|26085131|FG000|Overall Study|Study discontinued by sponsor|64|||
13160703|NCT02438787|26085132|FG001|Overall Study|Study discontinued by sponsor|72|||
13160704|NCT02438787|26085133|FG002|Overall Study|Study discontinued by sponsor|69|||
13105670|NCT03320330|25880544|FG000|Overall Study|Physician Decision|1|||
13105671|NCT03320330|25880545|FG001|Overall Study|Physician Decision|0|||
13105672|NCT03320330|25880546|FG002|Overall Study|Physician Decision|0|||
13105673|NCT03320057|25880559|FG000|Overall Study|Lost to Follow-up|4|||
13105674|NCT03320057|25880560|FG001|Overall Study|Lost to Follow-up|17|||
13105675|NCT03320057|25880559|FG000|Overall Study|Did not take mifepristone or misoprostol|2|||
13105676|NCT03320057|25880560|FG001|Overall Study|Did not take mifepristone or misoprostol|0|||
13105677|NCT03319953|25880599|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1|||
13105678|NCT03319953|25880600|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
13105679|NCT03319953|25880601|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
13105680|NCT03319953|25880602|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
13105681|NCT03319953|25880599|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0|||
13105682|NCT03319953|25880600|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0|||
13105683|NCT03319953|25880601|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1|||
13105684|NCT03319953|25880602|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1|||
13133090|NCT02778399|25986515|FG002|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
13133091|NCT02778399|25986516|FG003|Week 12 to Week 24 Treatment Period|Adverse Event|1|||
13133092|NCT02778399|25986517|FG004|Week 12 to Week 24 Treatment Period|Adverse Event|3|||
13133093|NCT02778399|25986518|FG005|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
13133094|NCT02778399|25986513|FG000|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
13133095|NCT02778399|25986514|FG001|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
13133096|NCT02778399|25986515|FG002|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|0|||
13133097|NCT02778399|25986516|FG003|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
13133098|NCT02778399|25986517|FG004|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
13133099|NCT02778399|25986518|FG005|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
13133100|NCT02778399|25986513|FG000|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
13133101|NCT02778399|25986514|FG001|Week 12 to Week 24 Treatment Period|Protocol Violation|1|||
13133102|NCT02778399|25986515|FG002|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
13133103|NCT02778399|25986516|FG003|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
13133104|NCT02778399|25986517|FG004|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
13133105|NCT02778399|25986518|FG005|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
13133106|NCT02778399|25986513|FG000|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
13133107|NCT02778399|25986514|FG001|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
13133108|NCT02778399|25986515|FG002|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
13133109|NCT02778399|25986516|FG003|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
13133110|NCT02778399|25986517|FG004|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
13133111|NCT02778399|25986518|FG005|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
13133112|NCT02778399|25986513|FG000|Week 12 to Week 24 Treatment Period|Pregnancy|1|||
13133113|NCT02778399|25986514|FG001|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
13133114|NCT02778399|25986515|FG002|Week 12 to Week 24 Treatment Period|Pregnancy|2|||
13133115|NCT02778399|25986516|FG003|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
13133116|NCT02778399|25986517|FG004|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
13133117|NCT02778399|25986518|FG005|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
13133118|NCT02778399|25986513|FG000|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
13133119|NCT02778399|25986514|FG001|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
13133120|NCT02778399|25986515|FG002|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
13133121|NCT02778399|25986516|FG003|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
13133122|NCT02778399|25986517|FG004|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
13133123|NCT02778399|25986518|FG005|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
13133124|NCT02778100|25986554|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1|||
13133125|NCT02778100|25986555|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0|||
13133126|NCT02778074|25986568|FG000|Overall Study|Lost to Follow-up|7|||
13133127|NCT02778074|25986569|FG001|Overall Study|Lost to Follow-up|10|||
13133128|NCT02777970|25986601|FG000|Overall Study|Lost to Follow-up|0|||
13133129|NCT02777970|25986602|FG001|Overall Study|Lost to Follow-up|1|||
13133130|NCT02777970|25986603|FG002|Overall Study|Lost to Follow-up|0|||
13133131|NCT02777970|25986601|FG000|Overall Study|Protocol Violation|1|||
13133132|NCT02777970|25986602|FG001|Overall Study|Protocol Violation|0|||
13133133|NCT02777970|25986603|FG002|Overall Study|Protocol Violation|0|||
13133134|NCT02777918|25986628|FG000|Overall Study|Medical reasons|1|||
13133135|NCT02777918|25986629|FG001|Overall Study|Medical reasons|2|||
13160705|NCT02438787|26085131|FG000|Overall Study|Other|0|||
13160706|NCT02438787|26085132|FG001|Overall Study|Other|1|||
13105685|NCT03319732|25880611|FG000|Overall Study|Adverse Event|40|||
13105686|NCT03319732|25880611|FG000|Overall Study|Withdrawal by Subject|50|||
13105687|NCT03319732|25880611|FG000|Overall Study|MS relapse|10|||
13105688|NCT03319732|25880611|FG000|Overall Study|reason not specified|5|||
13105689|NCT03319719|25880627|FG000|Overall Study|Lost to Follow-up|1|||
13105690|NCT03319212|25880659|FG000|Overall Study|Discontinued as moving out of local area|0|||
13105691|NCT03319212|25880660|FG001|Overall Study|Discontinued as moving out of local area|1|||
13160707|NCT02438787|26085133|FG002|Overall Study|Other|0|||
13160708|NCT02438787|26085131|FG000|Overall Study|Site terminated by sponsor|0|||
13160709|NCT02438787|26085132|FG001|Overall Study|Site terminated by sponsor|0|||
13160710|NCT02438787|26085133|FG002|Overall Study|Site terminated by sponsor|1|||
13160711|NCT02438384|26085160|FG000|Overall Study|Lost to Follow-up|8|||
13160712|NCT02438384|26085161|FG001|Overall Study|Lost to Follow-up|6|||
13160713|NCT02438384|26085162|FG002|Overall Study|Lost to Follow-up|4|||
13160714|NCT02438371|26085229|FG000|Overall Study|Lost to Follow-up|3|||
13160715|NCT02438371|26085230|FG001|Overall Study|Lost to Follow-up|2|||
13160716|NCT02438371|26085229|FG000|Overall Study|Withdrawal by Subject|1|||
13160717|NCT02438371|26085230|FG001|Overall Study|Withdrawal by Subject|1|||
13160718|NCT02438280|26085245|FG000|Overall Study|Physician Decision|1|||
13160719|NCT02438280|26085246|FG001|Overall Study|Physician Decision|0|||
13160720|NCT02438137|26085261|FG000|Overall Study|Lost to Follow-up|3|||
13160721|NCT02438137|26085262|FG001|Overall Study|Lost to Follow-up|2|||
13160722|NCT02438137|26085261|FG000|Overall Study|Adverse Event|1|||
13160723|NCT02438137|26085262|FG001|Overall Study|Adverse Event|0|||
13160724|NCT02438137|26085261|FG000|Overall Study|Withdrawal by Subject|4|||
13160725|NCT02438137|26085262|FG001|Overall Study|Withdrawal by Subject|3|||
13160726|NCT02438137|26085261|FG000|Overall Study|Physician Decision|0|||
13160727|NCT02438137|26085262|FG001|Overall Study|Physician Decision|1|||
13160728|NCT02437903|26085272|FG000|Overall Study|Adverse Event|1|||
13160729|NCT02437903|26085272|FG000|Overall Study|Withdrawal by Subject|1|||
13160730|NCT02437903|26085272|FG000|Overall Study|Lost to Follow-up|3|||
13160731|NCT02437890|26085499|FG000|Overall Study|Non-compliance to study drug|0|||
13160732|NCT02437890|26085500|FG001|Overall Study|Non-compliance to study drug|1|||
13160733|NCT02437890|26085501|FG002|Overall Study|Non-compliance to study drug|0|||
13160734|NCT02437890|26085502|FG003|Overall Study|Non-compliance to study drug|0|||
13160735|NCT02437890|26085503|FG004|Overall Study|Non-compliance to study drug|1|||
13160736|NCT02437890|26085499|FG000|Overall Study|Sponsor's decision|1|||
13160737|NCT02437890|26085500|FG001|Overall Study|Sponsor's decision|1|||
13160738|NCT02437890|26085501|FG002|Overall Study|Sponsor's decision|4|||
13160739|NCT02437890|26085502|FG003|Overall Study|Sponsor's decision|0|||
13160740|NCT02437890|26085503|FG004|Overall Study|Sponsor's decision|2|||
13160741|NCT02437890|26085499|FG000|Overall Study|Physician Decision|0|||
13160742|NCT02437890|26085500|FG001|Overall Study|Physician Decision|0|||
13160743|NCT02437890|26085501|FG002|Overall Study|Physician Decision|0|||
13160744|NCT02437890|26085502|FG003|Overall Study|Physician Decision|1|||
13160745|NCT02437890|26085503|FG004|Overall Study|Physician Decision|0|||
13160746|NCT02437890|26085499|FG000|Overall Study|Unable to attend visit(s)|1|||
13160747|NCT02437890|26085500|FG001|Overall Study|Unable to attend visit(s)|0|||
13160748|NCT02437890|26085501|FG002|Overall Study|Unable to attend visit(s)|0|||
13160749|NCT02437890|26085502|FG003|Overall Study|Unable to attend visit(s)|0|||
13160750|NCT02437890|26085503|FG004|Overall Study|Unable to attend visit(s)|0|||
13160751|NCT02437890|26085499|FG000|Overall Study|Lack of Efficacy|1|||
13105692|NCT03319212|25880659|FG000|Overall Study|Adverse Event|2|||
13105693|NCT03319212|25880660|FG001|Overall Study|Adverse Event|2|||
13105694|NCT03319212|25880659|FG000|Overall Study|Withdrawal by Subject|0|||
13105695|NCT03319212|25880660|FG001|Overall Study|Withdrawal by Subject|1|||
13105696|NCT03319212|25880659|FG000|Overall Study|Lost to Follow-up|0|||
13105697|NCT03319212|25880660|FG001|Overall Study|Lost to Follow-up|1|||
13105698|NCT03319212|25880659|FG000|Overall Study|Physician Decision|1|||
13105699|NCT03319212|25880660|FG001|Overall Study|Physician Decision|0|||
13105700|NCT03318783|25880691|FG000|Overall Study|Withdrawal by Subject|0|||
13105701|NCT03318783|25880692|FG001|Overall Study|Withdrawal by Subject|1|||
13105702|NCT03318783|25880691|FG000|Overall Study|Death|0|||
13105703|NCT03318783|25880692|FG001|Overall Study|Death|1|||
13105704|NCT03318315|25880793|FG000|Overall Study|Lost to Follow-up|3|||
13105705|NCT03318315|25880794|FG001|Overall Study|Lost to Follow-up|2|||
13160752|NCT02437890|26085500|FG001|Overall Study|Lack of Efficacy|3|||
13105706|NCT03318315|25880795|FG002|Overall Study|Lost to Follow-up|1|||
13105707|NCT03318315|25880793|FG000|Overall Study|Protocol Violation|1|||
13105708|NCT03318315|25880794|FG001|Overall Study|Protocol Violation|1|||
13105709|NCT03318315|25880795|FG002|Overall Study|Protocol Violation|1|||
13160753|NCT02437890|26085501|FG002|Overall Study|Lack of Efficacy|0|||
13160754|NCT02437890|26085502|FG003|Overall Study|Lack of Efficacy|3|||
13160755|NCT02437890|26085503|FG004|Overall Study|Lack of Efficacy|1|||
13160756|NCT02437890|26085499|FG000|Overall Study|Adverse Event|4|||
13160757|NCT02437890|26085500|FG001|Overall Study|Adverse Event|9|||
13160758|NCT02437890|26085501|FG002|Overall Study|Adverse Event|5|||
13160759|NCT02437890|26085502|FG003|Overall Study|Adverse Event|11|||
13160760|NCT02437890|26085503|FG004|Overall Study|Adverse Event|7|||
13105710|NCT03318315|25880793|FG000|Overall Study|Withdrawal by Subject|0|||
13105711|NCT03318315|25880794|FG001|Overall Study|Withdrawal by Subject|0|||
13105712|NCT03318315|25880795|FG002|Overall Study|Withdrawal by Subject|2|||
13105713|NCT03318003|25880810|FG000|Overall Study|Withdrawal by Subject|1|||
13105714|NCT03318003|25880811|FG001|Overall Study|Withdrawal by Subject|1|||
13105715|NCT03318003|25880810|FG000|Overall Study|fetal loss|0|||
13105716|NCT03318003|25880811|FG001|Overall Study|fetal loss|1|||
13105717|NCT03317496|25880871|FG000|Phase 1b Lead-in: Treatment|Adverse Event|2|||
13105718|NCT03317496|25880872|FG001|Phase 1b Lead-in: Treatment|Adverse Event|4|||
13105719|NCT03317496|25880873|FG002|Phase 1b Lead-in: Treatment|Adverse Event|1|||
13105720|NCT03317496|25880874|FG003|Phase 1b Lead-in: Treatment|Adverse Event|0|||
13105721|NCT03317496|25880875|FG004|Phase 1b Lead-in: Treatment|Adverse Event|0|||
13105722|NCT03317496|25880871|FG000|Phase 1b Lead-in: Treatment|Physician Decision|1|||
13105723|NCT03317496|25880872|FG001|Phase 1b Lead-in: Treatment|Physician Decision|1|||
13105724|NCT03317496|25880873|FG002|Phase 1b Lead-in: Treatment|Physician Decision|0|||
13160761|NCT02437890|26085499|FG000|Overall Study|Withdrawal by Subject|1|||
13160762|NCT02437890|26085500|FG001|Overall Study|Withdrawal by Subject|2|||
13160763|NCT02437890|26085501|FG002|Overall Study|Withdrawal by Subject|6|||
13160764|NCT02437890|26085502|FG003|Overall Study|Withdrawal by Subject|5|||
13160765|NCT02437890|26085503|FG004|Overall Study|Withdrawal by Subject|5|||
13160766|NCT02437890|26085499|FG000|Overall Study|Death|0|||
13160767|NCT02437890|26085500|FG001|Overall Study|Death|0|||
13160768|NCT02437890|26085501|FG002|Overall Study|Death|0|||
13160769|NCT02437890|26085502|FG003|Overall Study|Death|2|||
13160770|NCT02437890|26085503|FG004|Overall Study|Death|0|||
13160771|NCT02437864|26085524|FG000|Overall Study|Protocol Violation|4|||
13160772|NCT02437864|26085525|FG001|Overall Study|Protocol Violation|0|||
13160773|NCT02437513|26085535|FG000|Overall Study|Withdrawal by Subject|2|||
13160774|NCT02437409|26085546|FG000|Overall Study|Withdrawal by Subject|3|||
13160775|NCT02437409|26085546|FG000|Overall Study|Screening failure|12|||
13160776|NCT02437318|26085559|FG000|Overall Study|Progressive disease|173|||
13160777|NCT02437318|26085560|FG001|Overall Study|Progressive disease|208|||
13160778|NCT02437318|26085559|FG000|Overall Study|Subject/guardian decision|22|||
13160779|NCT02437318|26085560|FG001|Overall Study|Subject/guardian decision|10|||
13160780|NCT02437318|26085559|FG000|Overall Study|Physician Decision|11|||
13160781|NCT02437318|26085560|FG001|Overall Study|Physician Decision|10|||
13160782|NCT02437318|26085559|FG000|Overall Study|Adverse Event|14|||
13160783|NCT02437318|26085560|FG001|Overall Study|Adverse Event|3|||
13160784|NCT02437318|26085559|FG000|Overall Study|Death|4|||
13160785|NCT02437318|26085560|FG001|Overall Study|Death|4|||
13160786|NCT02437318|26085559|FG000|Overall Study|Protocol Violation|5|||
13160787|NCT02437318|26085560|FG001|Overall Study|Protocol Violation|6|||
13160788|NCT02437318|26085559|FG000|Overall Study|Untreated|0|||
13160789|NCT02437318|26085560|FG001|Overall Study|Untreated|1|||
13160790|NCT02437305|26085575|FG000|Overall Study|Lost to Follow-up|18|||
13160791|NCT02437305|26085576|FG001|Overall Study|Lost to Follow-up|12|||
13160792|NCT02437188|26085597|FG000|Overall Study|Randomized but did not receive surgery|4|||
13160793|NCT02437188|26085598|FG001|Overall Study|Randomized but did not receive surgery|8|||
13160794|NCT02437188|26085597|FG000|Overall Study|Adverse Event|0|||
13160795|NCT02437188|26085598|FG001|Overall Study|Adverse Event|1|||
13160796|NCT02437162|26085726|FG000|Overall Study|Protocol Violation|0|||
13160797|NCT02437162|26085727|FG001|Overall Study|Protocol Violation|1|||
13160798|NCT02437162|26085728|FG002|Overall Study|Protocol Violation|0|||
13160799|NCT02437162|26085726|FG000|Overall Study|Randomized but not treated|0|||
13160800|NCT02437162|26085727|FG001|Overall Study|Randomized but not treated|0|||
13160801|NCT02437162|26085728|FG002|Overall Study|Randomized but not treated|1|||
13160802|NCT02437162|26085726|FG000|Overall Study|Study discontinued by Sponsor|93|||
13160803|NCT02437162|26085727|FG001|Overall Study|Study discontinued by Sponsor|98|||
13160804|NCT02437162|26085728|FG002|Overall Study|Study discontinued by Sponsor|97|||
13160805|NCT02437162|26085726|FG000|Overall Study|Withdrawal by Subject|13|||
13160806|NCT02437162|26085727|FG001|Overall Study|Withdrawal by Subject|7|||
13160807|NCT02437162|26085728|FG002|Overall Study|Withdrawal by Subject|9|||
13160808|NCT02437162|26085726|FG000|Overall Study|Adverse Event|0|||
13160809|NCT02437162|26085727|FG001|Overall Study|Adverse Event|1|||
13160810|NCT02437162|26085728|FG002|Overall Study|Adverse Event|0|||
13160811|NCT02437162|26085726|FG000|Overall Study|Lost to Follow-up|1|||
13160812|NCT02437162|26085727|FG001|Overall Study|Lost to Follow-up|0|||
13160813|NCT02437162|26085728|FG002|Overall Study|Lost to Follow-up|1|||
13160814|NCT02437162|26085726|FG000|Overall Study|Death|0|||
13160815|NCT02437162|26085727|FG001|Overall Study|Death|1|||
13160816|NCT02437162|26085728|FG002|Overall Study|Death|0|||
13160817|NCT02437162|26085726|FG000|Overall Study|Other|0|||
13105725|NCT03317496|25880874|FG003|Phase 1b Lead-in: Treatment|Physician Decision|0|||
13160818|NCT02437162|26085727|FG001|Overall Study|Other|0|||
13160819|NCT02437162|26085728|FG002|Overall Study|Other|1|||
13160820|NCT02437084|26085739|FG000|Overall Study|Withdrawal by Subject|2|||
13160821|NCT02437084|26085739|FG000|Overall Study|Physician Decision|1|||
13160822|NCT02436915|26085766|FG000|Overall Study|Withdrawal by Subject|0|||
13160823|NCT02436915|26085767|FG001|Overall Study|Withdrawal by Subject|1|||
13160824|NCT02436889|26085790|FG000|Overall Study|No improvement in symptoms|1|||
13160825|NCT02436889|26085791|FG001|Overall Study|No improvement in symptoms|0|||
13160826|NCT02436889|26085790|FG000|Overall Study|Does not like/could not tolerate medicat|0|||
13160827|NCT02436889|26085791|FG001|Overall Study|Does not like/could not tolerate medicat|1|||
13160828|NCT02436876|26085822|FG000|Overall Study|Lost to Follow-up|0|||
13160829|NCT02436876|26085823|FG001|Overall Study|Lost to Follow-up|1|||
13160830|NCT02436876|26085824|FG002|Overall Study|Lost to Follow-up|1|||
13160831|NCT02436876|26085825|FG003|Overall Study|Lost to Follow-up|1|||
13160832|NCT02436876|26085822|FG000|Overall Study|Withdrawal by Subject|1|||
13160833|NCT02436876|26085823|FG001|Overall Study|Withdrawal by Subject|0|||
13160834|NCT02436876|26085824|FG002|Overall Study|Withdrawal by Subject|0|||
13160835|NCT02436876|26085825|FG003|Overall Study|Withdrawal by Subject|1|||
13160836|NCT02436876|26085822|FG000|Overall Study|Physician Decision|0|||
13105726|NCT03317496|25880875|FG004|Phase 1b Lead-in: Treatment|Physician Decision|0|||
13105727|NCT03317496|25880871|FG000|Phase 1b Lead-in: Treatment|Death|0|||
13105728|NCT03317496|25880872|FG001|Phase 1b Lead-in: Treatment|Death|0|||
13105729|NCT03317496|25880873|FG002|Phase 1b Lead-in: Treatment|Death|1|||
13105730|NCT03317496|25880874|FG003|Phase 1b Lead-in: Treatment|Death|0|||
13105731|NCT03317496|25880875|FG004|Phase 1b Lead-in: Treatment|Death|0|||
13105732|NCT03317496|25880871|FG000|Phase 1b Lead-in: Treatment|Progressive Disease|1|||
13105733|NCT03317496|25880872|FG001|Phase 1b Lead-in: Treatment|Progressive Disease|6|||
13105734|NCT03317496|25880873|FG002|Phase 1b Lead-in: Treatment|Progressive Disease|3|||
13160837|NCT02436876|26085823|FG001|Overall Study|Physician Decision|2|||
13160838|NCT02436876|26085824|FG002|Overall Study|Physician Decision|1|||
13160839|NCT02436876|26085825|FG003|Overall Study|Physician Decision|0|||
13160840|NCT02436876|26085822|FG000|Overall Study|Inadequate amount of study drug available for randomization|0|||
13160841|NCT02436876|26085823|FG001|Overall Study|Inadequate amount of study drug available for randomization|1|||
13160842|NCT02436876|26085824|FG002|Overall Study|Inadequate amount of study drug available for randomization|0|||
13160843|NCT02436876|26085825|FG003|Overall Study|Inadequate amount of study drug available for randomization|0|||
13160844|NCT02436811|26085843|FG000|Overall Study|Lost to Follow-up|2|||
13160845|NCT02436811|26085844|FG001|Overall Study|Lost to Follow-up|9|||
13160846|NCT02436811|26085845|FG002|Overall Study|Lost to Follow-up|7|||
13160847|NCT02436759|26085860|FG000|Overall Study|Adverse Event|3|||
13160848|NCT02436759|26085861|FG001|Overall Study|Adverse Event|0|||
13160849|NCT02436759|26085860|FG000|Overall Study|Protocol Violation|1|||
13160850|NCT02436759|26085861|FG001|Overall Study|Protocol Violation|0|||
13160851|NCT02436759|26085860|FG000|Overall Study|Withdrawal by Subject|0|||
13160852|NCT02436759|26085861|FG001|Overall Study|Withdrawal by Subject|1|||
13160853|NCT02436681|26085874|FG000|Overall Study|Lost to Follow-up|10|||
13160854|NCT02436681|26085874|FG000|Overall Study|Withdrawal by Subject|2|||
13160855|NCT02436681|26085874|FG000|Overall Study|Death|2|||
13160856|NCT02436577|26085946|FG000|Overall Study|Protocol Deviation|0|||
13160857|NCT02436577|26085947|FG001|Overall Study|Protocol Deviation|1|||
13160858|NCT02436577|26085948|FG002|Overall Study|Protocol Deviation|0|||
13160859|NCT02436577|26085949|FG003|Overall Study|Protocol Deviation|0|||
13160860|NCT02436577|26085950|FG004|Overall Study|Protocol Deviation|0|||
13160861|NCT02436577|26085951|FG005|Overall Study|Protocol Deviation|0|||
13160862|NCT02436408|26085960|FG000|Overall Study|Death|1|||
13160863|NCT02436356|26085999|FG000|Overall Study|Excluded by MRI Screening|0|||
13160864|NCT02436356|26086000|FG001|Overall Study|Excluded by MRI Screening|0|||
13160865|NCT02436356|26086001|FG002|Overall Study|Excluded by MRI Screening|2|||
13160866|NCT02436356|26085999|FG000|Overall Study|Lost to Follow-up|0|||
13160867|NCT02436356|26086000|FG001|Overall Study|Lost to Follow-up|1|||
13160868|NCT02436356|26086001|FG002|Overall Study|Lost to Follow-up|0|||
13160869|NCT02436356|26085999|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1|||
13160870|NCT02436356|26086000|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0|||
13160871|NCT02436356|26086001|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0|||
13160872|NCT02436356|26085999|FG000|Overall Study|Excluded due to other medical conditions|3|||
13160873|NCT02436356|26086000|FG001|Overall Study|Excluded due to other medical conditions|0|||
13160874|NCT02436356|26086001|FG002|Overall Study|Excluded due to other medical conditions|0|||
13160875|NCT02436356|26085999|FG000|Overall Study|Withdrawal by Subject|1|||
13160876|NCT02436356|26086000|FG001|Overall Study|Withdrawal by Subject|0|||
13160877|NCT02436356|26086001|FG002|Overall Study|Withdrawal by Subject|0|||
13222819|NCT01802775|26286957|FG001|Overall Study|Adverse Event|1|||
13160878|NCT02436330|26086050|FG000|Cohort 1|Lost to Follow-up|5|||
13160879|NCT02436330|26086051|FG001|Cohort 1|Lost to Follow-up|2|||
13160880|NCT02436330|26086050|FG000|Cohort 1|Withdrawal by Subject|0|||
13160881|NCT02436330|26086051|FG001|Cohort 1|Withdrawal by Subject|1|||
13160882|NCT02436330|26086050|FG000|Cohort 2|Lost to Follow-up|2|||
13160883|NCT02436330|26086051|FG001|Cohort 2|Lost to Follow-up|0|||
13160884|NCT02436330|26086050|FG000|Cohort 2|Withdrawal by Subject|2|||
13160885|NCT02436330|26086051|FG001|Cohort 2|Withdrawal by Subject|3|||
13105735|NCT03317496|25880874|FG003|Phase 1b Lead-in: Treatment|Progressive Disease|4|||
13160886|NCT02436330|26086050|FG000|Cohort 3|Lost to Follow-up|1|||
13160887|NCT02436330|26086051|FG001|Cohort 3|Lost to Follow-up|0|||
13160888|NCT02436330|26086050|FG000|Cohort 3|Withdrawal by Subject|4|||
13160889|NCT02436330|26086051|FG001|Cohort 3|Withdrawal by Subject|0|||
13160890|NCT02436330|26086050|FG000|Cohort 4|Lost to Follow-up|1|||
13160891|NCT02436330|26086051|FG001|Cohort 4|Lost to Follow-up|0|||
13160892|NCT02436330|26086050|FG000|Cohort 4|Withdrawal by Subject|1|||
13160893|NCT02436330|26086051|FG001|Cohort 4|Withdrawal by Subject|0|||
13160894|NCT02436330|26086050|FG000|Cohort 5|Lost to Follow-up|3|||
13160895|NCT02436330|26086051|FG001|Cohort 5|Lost to Follow-up|2|||
13160896|NCT02436330|26086050|FG000|Cohort 5|Withdrawal by Subject|3|||
13160897|NCT02436330|26086051|FG001|Cohort 5|Withdrawal by Subject|2|||
13160898|NCT02436330|26086050|FG000|Cohort 6|Lost to Follow-up|2|||
13160899|NCT02436330|26086051|FG001|Cohort 6|Lost to Follow-up|0|||
13160900|NCT02436330|26086050|FG000|Cohort 6|Withdrawal by Subject|1|||
13160901|NCT02436330|26086051|FG001|Cohort 6|Withdrawal by Subject|1|||
13160902|NCT02436304|26086076|FG000|Overall Study|Lost to Follow-up|0|||
13160903|NCT02436304|26086077|FG001|Overall Study|Lost to Follow-up|1|||
13160904|NCT02436304|26086078|FG002|Overall Study|Lost to Follow-up|0|||
13160905|NCT02436304|26086076|FG000|Overall Study|Withdrawal by Subject|0|||
13160906|NCT02436304|26086077|FG001|Overall Study|Withdrawal by Subject|1|||
13160907|NCT02436304|26086078|FG002|Overall Study|Withdrawal by Subject|0|||
13160908|NCT02436304|26086076|FG000|Overall Study|Randomized in error didn't meet I/E crit|0|||
13160909|NCT02436304|26086077|FG001|Overall Study|Randomized in error didn't meet I/E crit|0|||
13160910|NCT02436304|26086078|FG002|Overall Study|Randomized in error didn't meet I/E crit|1|||
13160911|NCT02436239|26086113|FG000|Open-Lable Treatment Period|Adverse Event|12|||
13160912|NCT02436239|26086114|FG001|Open-Lable Treatment Period|Adverse Event|3|||
13160913|NCT02436239|26086115|FG002|Open-Lable Treatment Period|Adverse Event|4|||
13160914|NCT02436239|26086116|FG003|Open-Lable Treatment Period|Adverse Event|2|||
13160915|NCT02436239|26086113|FG000|Open-Lable Treatment Period|Lack of Efficacy|1|||
13160916|NCT02436239|26086114|FG001|Open-Lable Treatment Period|Lack of Efficacy|6|||
13160917|NCT02436239|26086115|FG002|Open-Lable Treatment Period|Lack of Efficacy|6|||
13160918|NCT02436239|26086116|FG003|Open-Lable Treatment Period|Lack of Efficacy|1|||
13160919|NCT02436239|26086113|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10|||
13160920|NCT02436239|26086114|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15|||
13160921|NCT02436239|26086115|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9|||
13160922|NCT02436239|26086116|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0|||
13160923|NCT02436239|26086113|FG000|Open-Lable Treatment Period|Lost to Follow-up|4|||
13160924|NCT02436239|26086114|FG001|Open-Lable Treatment Period|Lost to Follow-up|2|||
13160925|NCT02436239|26086115|FG002|Open-Lable Treatment Period|Lost to Follow-up|4|||
13160926|NCT02436239|26086116|FG003|Open-Lable Treatment Period|Lost to Follow-up|1|||
13160927|NCT02436239|26086113|FG000|Open-Lable Treatment Period|Protocol Violation|0|||
13160928|NCT02436239|26086114|FG001|Open-Lable Treatment Period|Protocol Violation|1|||
13160929|NCT02436239|26086115|FG002|Open-Lable Treatment Period|Protocol Violation|1|||
13105736|NCT03317496|25880875|FG004|Phase 1b Lead-in: Treatment|Progressive Disease|0|||
13160930|NCT02436239|26086116|FG003|Open-Lable Treatment Period|Protocol Violation|0|||
13160931|NCT02436239|26086113|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5|||
13160932|NCT02436239|26086114|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6|||
13160933|NCT02436239|26086115|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3|||
13160934|NCT02436239|26086116|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1|||
13160935|NCT02436239|26086113|FG000|Open-Lable Treatment Period|Other Reason|1|||
13160936|NCT02436239|26086114|FG001|Open-Lable Treatment Period|Other Reason|1|||
13160937|NCT02436239|26086115|FG002|Open-Lable Treatment Period|Other Reason|0|||
13160938|NCT02436239|26086116|FG003|Open-Lable Treatment Period|Other Reason|0|||
13160939|NCT02436239|26086113|FG000|Down-Taper Period|Withdrawal by Subject|4|||
13105737|NCT03317496|25880871|FG000|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
13105738|NCT03317496|25880872|FG001|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
13105739|NCT03317496|25880873|FG002|Phase 1b Lead-in: Treatment|Global deterioration of health status|1|||
13105740|NCT03317496|25880874|FG003|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
13105741|NCT03317496|25880875|FG004|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
13105742|NCT03317496|25880871|FG000|Phase 1b Lead-in: Treatment|Other|0|||
13105743|NCT03317496|25880872|FG001|Phase 1b Lead-in: Treatment|Other|1|||
13105744|NCT03317496|25880873|FG002|Phase 1b Lead-in: Treatment|Other|0|||
13105745|NCT03317496|25880874|FG003|Phase 1b Lead-in: Treatment|Other|0|||
13105746|NCT03317496|25880875|FG004|Phase 1b Lead-in: Treatment|Other|0|||
13105747|NCT03317496|25880871|FG000|Phase 1b Lead-in: Treatment|Ongoing|2|||
13105748|NCT03317496|25880872|FG001|Phase 1b Lead-in: Treatment|Ongoing|1|||
13105749|NCT03317496|25880873|FG002|Phase 1b Lead-in: Treatment|Ongoing|0|||
13105750|NCT03317496|25880874|FG003|Phase 1b Lead-in: Treatment|Ongoing|2|||
13160940|NCT02436239|26086114|FG001|Down-Taper Period|Withdrawal by Subject|4|||
13160941|NCT02436239|26086115|FG002|Down-Taper Period|Withdrawal by Subject|1|||
13160942|NCT02436239|26086116|FG003|Down-Taper Period|Withdrawal by Subject|2|||
13160943|NCT02436200|26086123|FG000|Overall Study|Significant outlier|1|||
13485478|NCT02906020|27032880|FG013|Part 1: Dose Escalation Period|Adverse Event|0|||
13105751|NCT03317496|25880875|FG004|Phase 1b Lead-in: Treatment|Ongoing|0|||
13105752|NCT03317496|25880871|FG000|Phase 1b Lead-in: Follow-up|Death|2|||
13160944|NCT02436135|26086154|FG000|Overall Study|Progressive Disease|3|||
13160945|NCT02436135|26086155|FG001|Overall Study|Progressive Disease|1|||
13160946|NCT02436135|26086154|FG000|Overall Study|Investigator Discretion|1|||
13160947|NCT02436135|26086155|FG001|Overall Study|Investigator Discretion|2|||
13160948|NCT02436135|26086154|FG000|Overall Study|Adverse Event|1|||
13160949|NCT02436135|26086155|FG001|Overall Study|Adverse Event|0|||
13160950|NCT02436135|26086154|FG000|Overall Study|Withdrawal by Participant|1|||
13160951|NCT02436135|26086155|FG001|Overall Study|Withdrawal by Participant|0|||
13160952|NCT02436135|26086154|FG000|Overall Study|Study Terminated By Sponsor|0|||
13160953|NCT02436135|26086155|FG001|Overall Study|Study Terminated By Sponsor|1|||
13160954|NCT02436005|26086220|FG000|Second Intervention|Adverse Event|0|||
13160955|NCT02436005|26086221|FG001|Second Intervention|Adverse Event|1|||
13160956|NCT02435992|26086299|FG000|Overall Study|non compliance with protocol|2|||
13160957|NCT02435992|26086300|FG001|Overall Study|non compliance with protocol|0|||
13160958|NCT02435992|26086301|FG002|Overall Study|non compliance with protocol|1|||
13160959|NCT02435992|26086302|FG003|Overall Study|non compliance with protocol|0|||
13160960|NCT02435992|26086303|FG004|Overall Study|non compliance with protocol|0|||
13160961|NCT02435992|26086299|FG000|Overall Study|Adverse Event|11|||
13160962|NCT02435992|26086300|FG001|Overall Study|Adverse Event|6|||
13160963|NCT02435992|26086301|FG002|Overall Study|Adverse Event|12|||
13160964|NCT02435992|26086302|FG003|Overall Study|Adverse Event|0|||
13160965|NCT02435992|26086303|FG004|Overall Study|Adverse Event|0|||
13160966|NCT02435992|26086299|FG000|Overall Study|Lack of Efficacy|4|||
13160967|NCT02435992|26086300|FG001|Overall Study|Lack of Efficacy|10|||
13160968|NCT02435992|26086301|FG002|Overall Study|Lack of Efficacy|9|||
13160969|NCT02435992|26086302|FG003|Overall Study|Lack of Efficacy|0|||
13160970|NCT02435992|26086303|FG004|Overall Study|Lack of Efficacy|0|||
13160971|NCT02435992|26086299|FG000|Overall Study|Withdrawal by Subject|10|||
13160972|NCT02435992|26086300|FG001|Overall Study|Withdrawal by Subject|8|||
13160973|NCT02435992|26086301|FG002|Overall Study|Withdrawal by Subject|20|||
13160974|NCT02435992|26086302|FG003|Overall Study|Withdrawal by Subject|0|||
13105753|NCT03317496|25880872|FG001|Phase 1b Lead-in: Follow-up|Death|7|||
13105754|NCT03317496|25880873|FG002|Phase 1b Lead-in: Follow-up|Death|4|||
13105755|NCT03317496|25880874|FG003|Phase 1b Lead-in: Follow-up|Death|3|||
13105756|NCT03317496|25880875|FG004|Phase 1b Lead-in: Follow-up|Death|0|||
13105757|NCT03317496|25880871|FG000|Phase 1b Lead-in: Follow-up|Lost to Follow-up|1|||
13105758|NCT03317496|25880872|FG001|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
13105759|NCT03317496|25880873|FG002|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
13105760|NCT03317496|25880874|FG003|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
13133136|NCT02777918|25986628|FG000|Overall Study|Too busy / stressed|1|||
13133137|NCT02777918|25986629|FG001|Overall Study|Too busy / stressed|1|||
13133138|NCT02777918|25986628|FG000|Overall Study|Withdrawal by Subject|1|||
13133139|NCT02777918|25986629|FG001|Overall Study|Withdrawal by Subject|1|||
13133140|NCT02777827|25986788|FG000|Washout Between Periods 3 and 4|Protocol Violation|0|||
13133141|NCT02777827|25986789|FG001|Washout Between Periods 3 and 4|Protocol Violation|0|||
13133142|NCT02777827|25986790|FG002|Washout Between Periods 3 and 4|Protocol Violation|1|||
13133143|NCT02777827|25986791|FG003|Washout Between Periods 3 and 4|Protocol Violation|0|||
13133144|NCT02777827|25986792|FG004|Washout Between Periods 3 and 4|Protocol Violation|0|||
13133145|NCT02777827|25986793|FG005|Washout Between Periods 3 and 4|Protocol Violation|0|||
13133146|NCT02777593|25986821|FG000|Overall Study|Still in study|66|||
13133147|NCT02777593|25986822|FG001|Overall Study|Still in study|105|||
13133148|NCT02777593|25986823|FG002|Overall Study|Still in study|10|||
13133149|NCT02777593|25986824|FG003|Overall Study|Still in study|8|||
13133150|NCT02777593|25986825|FG004|Overall Study|Still in study|6|||
13133151|NCT02777593|25986821|FG000|Overall Study|Death|11|||
13133152|NCT02777593|25986822|FG001|Overall Study|Death|19|||
13133153|NCT02777593|25986823|FG002|Overall Study|Death|0|||
13133154|NCT02777593|25986824|FG003|Overall Study|Death|4|||
13133155|NCT02777593|25986825|FG004|Overall Study|Death|0|||
13133156|NCT02777593|25986821|FG000|Overall Study|Withdrawal by Subject|5|||
13133157|NCT02777593|25986822|FG001|Overall Study|Withdrawal by Subject|1|||
13133158|NCT02777593|25986823|FG002|Overall Study|Withdrawal by Subject|0|||
13133159|NCT02777593|25986824|FG003|Overall Study|Withdrawal by Subject|1|||
13133160|NCT02777593|25986825|FG004|Overall Study|Withdrawal by Subject|0|||
13133161|NCT02777593|25986821|FG000|Overall Study|Lost to Follow-up|1|||
13133162|NCT02777593|25986822|FG001|Overall Study|Lost to Follow-up|6|||
13133163|NCT02777593|25986823|FG002|Overall Study|Lost to Follow-up|0|||
13133164|NCT02777593|25986824|FG003|Overall Study|Lost to Follow-up|0|||
13133165|NCT02777593|25986825|FG004|Overall Study|Lost to Follow-up|0|||
13133166|NCT02777593|25986821|FG000|Overall Study|Physician Decision|0|||
13133167|NCT02777593|25986822|FG001|Overall Study|Physician Decision|1|||
13133168|NCT02777593|25986823|FG002|Overall Study|Physician Decision|0|||
13133169|NCT02777593|25986824|FG003|Overall Study|Physician Decision|0|||
13133170|NCT02777593|25986825|FG004|Overall Study|Physician Decision|0|||
13133171|NCT02777593|25986821|FG000|Overall Study|Discontinued due to Other|2|||
13133172|NCT02777593|25986822|FG001|Overall Study|Discontinued due to Other|0|||
13160975|NCT02435992|26086303|FG004|Overall Study|Withdrawal by Subject|0|||
13160976|NCT02435992|26086299|FG000|Overall Study|Other Reason|1|||
13160977|NCT02435992|26086300|FG001|Overall Study|Other Reason|0|||
13160978|NCT02435992|26086301|FG002|Overall Study|Other Reason|0|||
13160979|NCT02435992|26086302|FG003|Overall Study|Other Reason|0|||
13160980|NCT02435992|26086303|FG004|Overall Study|Other Reason|0|||
13160981|NCT02435992|26086299|FG000|Overall Study|Physician Decision|0|||
13160982|NCT02435992|26086300|FG001|Overall Study|Physician Decision|0|||
13160983|NCT02435992|26086301|FG002|Overall Study|Physician Decision|1|||
13160984|NCT02435992|26086302|FG003|Overall Study|Physician Decision|0|||
13160985|NCT02435992|26086303|FG004|Overall Study|Physician Decision|0|||
13160986|NCT02435966|26086321|FG000|Overall Study|Withdrawal by Subject|0|||
13160987|NCT02435966|26086322|FG001|Overall Study|Withdrawal by Subject|1|||
13160988|NCT02435966|26086323|FG002|Overall Study|Withdrawal by Subject|0|||
13160989|NCT02435914|26086358|FG000|Overall Study|Ocular Adverse Event|1|||
13160990|NCT02435914|26086359|FG001|Overall Study|Ocular Adverse Event|0|||
13160991|NCT02435914|26086360|FG002|Overall Study|Ocular Adverse Event|0|||
13160992|NCT02435914|26086361|FG003|Overall Study|Ocular Adverse Event|0|||
13160993|NCT02435914|26086358|FG000|Overall Study|Withdrawal by Subject|0|||
13160994|NCT02435914|26086359|FG001|Overall Study|Withdrawal by Subject|1|||
13160995|NCT02435914|26086360|FG002|Overall Study|Withdrawal by Subject|0|||
13160996|NCT02435914|26086361|FG003|Overall Study|Withdrawal by Subject|0|||
13160997|NCT02435914|26086358|FG000|Overall Study|Other Miscellaneous Reason|0|||
13160998|NCT02435914|26086359|FG001|Overall Study|Other Miscellaneous Reason|0|||
13160999|NCT02435914|26086360|FG002|Overall Study|Other Miscellaneous Reason|1|||
13161000|NCT02435914|26086361|FG003|Overall Study|Other Miscellaneous Reason|0|||
13205431|NCT01965652|26231734|FG000|Overall Study|Other - Miscellaneous|18|||
13205432|NCT01965652|26231735|FG001|Overall Study|Other - Miscellaneous|21|||
13205433|NCT01965652|26231734|FG000|Overall Study|Pregnancy|0|||
13205434|NCT01965652|26231735|FG001|Overall Study|Pregnancy|1|||
13205435|NCT01965600|26231784|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
13205436|NCT01965600|26231785|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3|||
13205437|NCT01965600|26231786|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2|||
13205438|NCT01965600|26231787|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
13205439|NCT01965600|26231784|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
13205440|NCT01965600|26231785|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1|||
13205441|NCT01965600|26231786|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
13205442|NCT01965600|26231787|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
13205443|NCT01965600|26231784|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1|||
13205444|NCT01965600|26231785|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
13205445|NCT01965600|26231786|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
13205446|NCT01965600|26231787|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
13205447|NCT01965600|26231784|FG000|Washout Period of Approximately 15 Days|Adverse Event|0|||
13205448|NCT01965600|26231785|FG001|Washout Period of Approximately 15 Days|Adverse Event|0|||
13205449|NCT01965600|26231786|FG002|Washout Period of Approximately 15 Days|Adverse Event|0|||
13205450|NCT01965600|26231787|FG003|Washout Period of Approximately 15 Days|Adverse Event|1|||
13205451|NCT01965600|26231784|FG000|Second Intervention|Study terminated by Sponsor|0|||
13205452|NCT01965600|26231785|FG001|Second Intervention|Study terminated by Sponsor|0|||
13205453|NCT01965600|26231786|FG002|Second Intervention|Study terminated by Sponsor|2|||
13105761|NCT03317496|25880875|FG004|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
13105762|NCT03317496|25880871|FG000|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
13105763|NCT03317496|25880872|FG001|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
13105764|NCT03317496|25880873|FG002|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|1|||
13105765|NCT03317496|25880874|FG003|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
13105766|NCT03317496|25880875|FG004|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
13105767|NCT03317496|25880871|FG000|Phase 1b Lead-in: Follow-up|Other|1|||
13105768|NCT03317496|25880872|FG001|Phase 1b Lead-in: Follow-up|Other|3|||
13105769|NCT03317496|25880873|FG002|Phase 1b Lead-in: Follow-up|Other|0|||
13105770|NCT03317496|25880874|FG003|Phase 1b Lead-in: Follow-up|Other|1|||
13105771|NCT03317496|25880875|FG004|Phase 1b Lead-in: Follow-up|Other|0|||
13105772|NCT03317496|25880871|FG000|Phase 1b Lead-in: Follow-up|Ongoing|0|||
13105773|NCT03317496|25880872|FG001|Phase 1b Lead-in: Follow-up|Ongoing|1|||
13105774|NCT03317496|25880873|FG002|Phase 1b Lead-in: Follow-up|Ongoing|0|||
13105775|NCT03317496|25880874|FG003|Phase 1b Lead-in: Follow-up|Ongoing|0|||
13205454|NCT01965600|26231787|FG003|Second Intervention|Study terminated by Sponsor|2|||
13205455|NCT01965535|26231808|FG000|Overall Study|Lack of Efficacy|2|||
13205456|NCT01965535|26231809|FG001|Overall Study|Lack of Efficacy|1|||
13205457|NCT01965431|26231829|FG000|Overall Study|Adverse Event|0|||
13205458|NCT01965431|26231830|FG001|Overall Study|Adverse Event|1|||
13205459|NCT01965431|26231831|FG002|Overall Study|Adverse Event|0|||
13205460|NCT01965431|26231832|FG003|Overall Study|Adverse Event|0|||
13105776|NCT03317496|25880875|FG004|Phase 1b Lead-in: Follow-up|Ongoing|0|||
13161001|NCT02435849|26086367|FG000|Overall Study|Enrolled but not infused|18|||
13161002|NCT02435849|26086367|FG000|Overall Study|Death|16|||
13161003|NCT02435849|26086367|FG000|Overall Study|Lack of Efficacy|9|||
13161004|NCT02435849|26086367|FG000|Overall Study|New therapy for study indication|7|||
13161005|NCT02435849|26086367|FG000|Overall Study|Subject/guardian decision|2|||
13161006|NCT02435849|26086367|FG000|Overall Study|Study follow-up ongoing|45|||
13161007|NCT02435836|26086385|FG000|Overall Study|Lost to Follow-up|21|||
13161008|NCT02435836|26086385|FG000|Overall Study|Lack of Efficacy|1|||
13161009|NCT02435836|26086385|FG000|Overall Study|Withdrawal by Subject|236|||
13161010|NCT02435836|26086385|FG000|Overall Study|Insufficient Clinical Response|26|||
13161011|NCT02435836|26086385|FG000|Overall Study|Adverse Event|44|||
13161012|NCT02435836|26086385|FG000|Overall Study|Sponsor discontinued trial|167|||
13161013|NCT02435836|26086385|FG000|Overall Study|Noncompliance|27|||
13161014|NCT02435836|26086385|FG000|Overall Study|Protocol Violation|6|||
13161015|NCT02435836|26086385|FG000|Overall Study|Met Withdrawal Criteria|7|||
13161016|NCT02435836|26086385|FG000|Overall Study|AE of Worsening Schizophrenia|96|||
13161017|NCT02435680|26086429|FG000|Overall Study|Physician Decision|3|||
13161018|NCT02435680|26086430|FG001|Overall Study|Physician Decision|0|||
13161019|NCT02435680|26086431|FG002|Overall Study|Physician Decision|0|||
13161020|NCT02435680|26086429|FG000|Overall Study|subject / guardian decision|0|||
13161021|NCT02435680|26086430|FG001|Overall Study|subject / guardian decision|3|||
13161022|NCT02435680|26086431|FG002|Overall Study|subject / guardian decision|2|||
13161023|NCT02435680|26086429|FG000|Overall Study|Adverse Event|8|||
13161024|NCT02435680|26086430|FG001|Overall Study|Adverse Event|3|||
13161025|NCT02435680|26086431|FG002|Overall Study|Adverse Event|2|||
13161026|NCT02435680|26086429|FG000|Overall Study|progressive disease|10|||
13161027|NCT02435680|26086430|FG001|Overall Study|progressive disease|7|||
13161028|NCT02435680|26086431|FG002|Overall Study|progressive disease|11|||
13161029|NCT02435680|26086429|FG000|Overall Study|not treated|0|||
13161030|NCT02435680|26086430|FG001|Overall Study|not treated|0|||
13161031|NCT02435680|26086431|FG002|Overall Study|not treated|1|||
13161032|NCT02435381|26086458|FG000|Overall Study|Lost to Follow-up|2|||
13161033|NCT02435381|26086459|FG001|Overall Study|Lost to Follow-up|1|||
13161034|NCT02435277|26086486|FG000|Overall Study|Adverse Event|1|||
13161035|NCT02435277|26086487|FG001|Overall Study|Adverse Event|1|||
13161036|NCT02435277|26086488|FG002|Overall Study|Adverse Event|0|||
13161037|NCT02435277|26086489|FG003|Overall Study|Adverse Event|0|||
13161038|NCT02435277|26086486|FG000|Overall Study|Withdrawal by Subject|1|||
13161039|NCT02435277|26086487|FG001|Overall Study|Withdrawal by Subject|0|||
13161040|NCT02435277|26086488|FG002|Overall Study|Withdrawal by Subject|0|||
13161041|NCT02435277|26086489|FG003|Overall Study|Withdrawal by Subject|0|||
13161042|NCT02435147|26086496|FG000|Overall Study|non-evaluable DXA scan|11|||
13161043|NCT02435069|26086522|FG000|Dose Response - First Intervention|Adverse Event|0|||
13161044|NCT02435069|26086523|FG001|Dose Response - First Intervention|Adverse Event|1|||
13161045|NCT02435069|26086524|FG002|Dose Response - First Intervention|Adverse Event|1|||
13161046|NCT02435069|26086525|FG003|Dose Response - First Intervention|Adverse Event|0|||
13161047|NCT02435069|26086526|FG004|Dose Response - First Intervention|Adverse Event|0|||
13161048|NCT02435069|26086522|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0|||
13161049|NCT02435069|26086523|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0|||
13161050|NCT02435069|26086524|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0|||
13161051|NCT02435069|26086525|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0|||
13161052|NCT02435069|26086526|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1|||
13161053|NCT02434939|26086545|FG000|Overall Study|Lack of Efficacy|34|||
13161054|NCT02434939|26086546|FG001|Overall Study|Lack of Efficacy|48|||
13161055|NCT02434939|26086545|FG000|Overall Study|Withdrawal by Subject|3|||
13161056|NCT02434939|26086546|FG001|Overall Study|Withdrawal by Subject|0|||
13161057|NCT02434939|26086545|FG000|Overall Study|Adverse Event|0|||
13161058|NCT02434939|26086546|FG001|Overall Study|Adverse Event|1|||
13161059|NCT02434770|26086591|FG000|Week 1 to Week 18|Lost to Follow-up|0|||
13161060|NCT02434770|26086592|FG001|Week 1 to Week 18|Lost to Follow-up|0|||
13161061|NCT02434770|26086593|FG002|Week 1 to Week 18|Lost to Follow-up|2|||
13161062|NCT02434770|26086591|FG000|Week 1 to Week 18|Withdrawal by Subject|6|||
13161063|NCT02434770|26086592|FG001|Week 1 to Week 18|Withdrawal by Subject|12|||
13161064|NCT02434770|26086593|FG002|Week 1 to Week 18|Withdrawal by Subject|5|||
13161065|NCT02434770|26086591|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8|||
13161066|NCT02434770|26086592|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10|||
13161067|NCT02434770|26086593|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9|||
13161068|NCT02434770|26086591|FG000|Week 1 to Week 18|Relocated Out of Study Area|0|||
13161069|NCT02434770|26086592|FG001|Week 1 to Week 18|Relocated Out of Study Area|0|||
13161070|NCT02434770|26086593|FG002|Week 1 to Week 18|Relocated Out of Study Area|1|||
13161071|NCT02434770|26086591|FG000|Week 1 to Week 18|Death|1|||
13161072|NCT02434770|26086592|FG001|Week 1 to Week 18|Death|0|||
13161073|NCT02434770|26086593|FG002|Week 1 to Week 18|Death|0|||
13222820|NCT01802775|26286956|FG000|Overall Study|Withdrawal by Subject|3|||
13161074|NCT02434770|26086591|FG000|Week 18 to Week|Lost to Follow-up|2|||
13161075|NCT02434770|26086592|FG001|Week 18 to Week|Lost to Follow-up|2|||
13161076|NCT02434770|26086593|FG002|Week 18 to Week|Lost to Follow-up|1|||
13161077|NCT02434770|26086591|FG000|Week 18 to Week|Withdrawal by Subject|0|||
13161078|NCT02434770|26086592|FG001|Week 18 to Week|Withdrawal by Subject|0|||
13161079|NCT02434770|26086593|FG002|Week 18 to Week|Withdrawal by Subject|2|||
13161080|NCT02434770|26086591|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6|||
13161081|NCT02434770|26086592|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6|||
13161082|NCT02434770|26086593|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3|||
13161083|NCT02434471|26086602|FG000|Overall Study|Physician Decision|9|||
13161084|NCT02434328|26086672|FG000|Overall Study|Adverse Event|9|||
13161085|NCT02434328|26086673|FG001|Overall Study|Adverse Event|4|||
13161086|NCT02434328|26086672|FG000|Overall Study|Lack of Efficacy|0|||
13161087|NCT02434328|26086673|FG001|Overall Study|Lack of Efficacy|2|||
13161088|NCT02434328|26086672|FG000|Overall Study|Physician Decision|0|||
13161089|NCT02434328|26086673|FG001|Overall Study|Physician Decision|1|||
13161090|NCT02434328|26086672|FG000|Overall Study|Withdrawal by Subject|12|||
13161091|NCT02434328|26086673|FG001|Overall Study|Withdrawal by Subject|21|||
13161092|NCT02434328|26086672|FG000|Overall Study|Death|4|||
13161093|NCT02434328|26086673|FG001|Overall Study|Death|7|||
13161094|NCT02434328|26086672|FG000|Overall Study|Lost to Follow-up|1|||
13161095|NCT02434328|26086673|FG001|Overall Study|Lost to Follow-up|6|||
13161096|NCT02434328|26086672|FG000|Overall Study|Other|4|||
13161097|NCT02434328|26086673|FG001|Overall Study|Other|1|||
13161098|NCT02434081|26086684|FG000|Overall Study|Death (never started treatment)|2|||
13161099|NCT02434081|26086684|FG000|Overall Study|Death|2|||
13161100|NCT02434081|26086684|FG000|Overall Study|Progression|20|||
13161101|NCT02434081|26086684|FG000|Overall Study|Adverse Event|20|||
13161102|NCT02434081|26086684|FG000|Overall Study|Physician Decision|2|||
13161103|NCT02434081|26086684|FG000|Overall Study|Withdrawal by Subject|1|||
13161104|NCT02434081|26086684|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1|||
13161105|NCT02433834|26086744|FG000|Overall Study|Protocol-specified criteria|7|||
13161106|NCT02433834|26086744|FG000|Overall Study|Protocol Violation|3|||
13161107|NCT02433834|26086744|FG000|Overall Study|Lost to Follow-up|6|||
13161108|NCT02433834|26086744|FG000|Overall Study|Withdrawal by Subject|14|||
13161109|NCT02433834|26086744|FG000|Overall Study|Adverse Event|6|||
13161110|NCT02433834|26086744|FG000|Overall Study|Physician Decision|1|||
13161111|NCT02433678|26086783|FG000|Overall Study|Lost to Follow-up|1|||
13161112|NCT02433678|26086784|FG001|Overall Study|Lost to Follow-up|2|||
13161113|NCT02433483|26086798|FG000|Overall Study|Unacceptable toxicity|1|||
13161114|NCT02433483|26086798|FG000|Overall Study|Other antineoplastic therapy/HSCT|1|||
13161115|NCT02433379|26086808|FG000|Overall Study|Screen Failures|55|||
13161116|NCT02433379|26086808|FG000|Overall Study|Death|57|||
13161117|NCT02433379|26086808|FG000|Overall Study|Total Withdrawals|209|||
13161118|NCT02433340|26087713|FG000|Overall Study|Adverse Event|0|||
13161119|NCT02433340|26087714|FG001|Overall Study|Adverse Event|0|||
13161120|NCT02433340|26087715|FG002|Overall Study|Adverse Event|1|||
13161121|NCT02433340|26087716|FG003|Overall Study|Adverse Event|0|||
13161122|NCT02433340|26087713|FG000|Overall Study|Withdrawal by Subject|1|||
13161123|NCT02433340|26087714|FG001|Overall Study|Withdrawal by Subject|0|||
13161124|NCT02433340|26087715|FG002|Overall Study|Withdrawal by Subject|1|||
13161125|NCT02433340|26087716|FG003|Overall Study|Withdrawal by Subject|2|||
13161126|NCT02433340|26087713|FG000|Overall Study|Lost to Follow-up|0|||
13161127|NCT02433340|26087714|FG001|Overall Study|Lost to Follow-up|1|||
13161128|NCT02433340|26087715|FG002|Overall Study|Lost to Follow-up|0|||
13161129|NCT02433340|26087716|FG003|Overall Study|Lost to Follow-up|0|||
13161130|NCT02433340|26087713|FG000|Overall Study|Required Alternative/Prohibited Therapy|1|||
13161131|NCT02433340|26087714|FG001|Overall Study|Required Alternative/Prohibited Therapy|0|||
13161132|NCT02433340|26087715|FG002|Overall Study|Required Alternative/Prohibited Therapy|0|||
13161133|NCT02433340|26087716|FG003|Overall Study|Required Alternative/Prohibited Therapy|0|||
13161134|NCT02433340|26087713|FG000|Overall Study|Other|0|||
13161135|NCT02433340|26087714|FG001|Overall Study|Other|1|||
13161136|NCT02433340|26087715|FG002|Overall Study|Other|0|||
13161137|NCT02433340|26087716|FG003|Overall Study|Other|0|||
13161138|NCT02433288|26087737|FG000|Overall Study|Severe non-compliance to protocol|13|||
13161139|NCT02433288|26087738|FG001|Overall Study|Severe non-compliance to protocol|7|||
13161140|NCT02433288|26087737|FG000|Overall Study|Eligibility criteria not fullfilled|7|||
13161141|NCT02433288|26087738|FG001|Overall Study|Eligibility criteria not fullfilled|3|||
13161142|NCT02433288|26087737|FG000|Overall Study|Withdrawal by Subject|101|||
13161143|NCT02433288|26087738|FG001|Overall Study|Withdrawal by Subject|99|||
13161144|NCT02433288|26087737|FG000|Overall Study|Lost to Follow-up|2|||
13161145|NCT02433288|26087738|FG001|Overall Study|Lost to Follow-up|14|||
13161146|NCT02433288|26087737|FG000|Overall Study|Death|0|||
13161147|NCT02433288|26087738|FG001|Overall Study|Death|3|||
13161148|NCT02433210|26087834|FG000|Overall Study|Physician Decision|1|||
13161149|NCT02433210|26087835|FG001|Overall Study|Physician Decision|0|||
13161150|NCT02433210|26087836|FG002|Overall Study|Physician Decision|0|||
13161151|NCT02433080|26087869|FG000|Overall Study|Lost to Follow-up|1|||
13161152|NCT02433080|26087870|FG001|Overall Study|Lost to Follow-up|2|||
13161153|NCT02433080|26087869|FG000|Overall Study|Withdrawal by Subject|0|||
13161154|NCT02433080|26087870|FG001|Overall Study|Withdrawal by Subject|2|||
13161155|NCT02432846|26087987|FG000|Overall Study (4 Arms/Strata)|Death|3|||
13161156|NCT02432846|26087988|FG001|Overall Study (4 Arms/Strata)|Death|2|||
13161157|NCT02432846|26087989|FG002|Overall Study (4 Arms/Strata)|Death|4|||
13161158|NCT02432846|26087990|FG003|Overall Study (4 Arms/Strata)|Death|3|||
13161159|NCT02432846|26087991|FG004|Overall Study (4 Arms/Strata)|Death|0|||
13161160|NCT02432846|26087992|FG005|Overall Study (4 Arms/Strata)|Death|0|||
13161161|NCT02432846|26087987|FG000|Overall Study (4 Arms/Strata)|Adverse Event|0|||
13161162|NCT02432846|26087988|FG001|Overall Study (4 Arms/Strata)|Adverse Event|1|||
13161163|NCT02432846|26087989|FG002|Overall Study (4 Arms/Strata)|Adverse Event|1|||
13161164|NCT02432846|26087990|FG003|Overall Study (4 Arms/Strata)|Adverse Event|0|||
13161165|NCT02432846|26087991|FG004|Overall Study (4 Arms/Strata)|Adverse Event|0|||
13161166|NCT02432846|26087992|FG005|Overall Study (4 Arms/Strata)|Adverse Event|0|||
13161167|NCT02432846|26087987|FG000|Overall Study (4 Arms/Strata)|Physician Decision|2|||
13161168|NCT02432846|26087988|FG001|Overall Study (4 Arms/Strata)|Physician Decision|0|||
13161169|NCT02432846|26087989|FG002|Overall Study (4 Arms/Strata)|Physician Decision|0|||
13161170|NCT02432846|26087990|FG003|Overall Study (4 Arms/Strata)|Physician Decision|0|||
13161171|NCT02432846|26087991|FG004|Overall Study (4 Arms/Strata)|Physician Decision|0|||
13161172|NCT02432846|26087992|FG005|Overall Study (4 Arms/Strata)|Physician Decision|0|||
13161173|NCT02432846|26087987|FG000|Overall Study (4 Arms/Strata)|Withdrawal by Subject|2|||
13161174|NCT02432846|26087988|FG001|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
13161175|NCT02432846|26087989|FG002|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
13161176|NCT02432846|26087990|FG003|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
13161177|NCT02432846|26087991|FG004|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
13161178|NCT02432846|26087992|FG005|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
13161179|NCT02432846|26087987|FG000|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
13161180|NCT02432846|26087988|FG001|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
13161181|NCT02432846|26087989|FG002|Overall Study (4 Arms/Strata)|Other (reason not specified)|2|||
13161182|NCT02432846|26087990|FG003|Overall Study (4 Arms/Strata)|Other (reason not specified)|1|||
13161183|NCT02432846|26087991|FG004|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
13161184|NCT02432846|26087992|FG005|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
13161185|NCT02432846|26087987|FG000|Overall Study (4 Arms/Strata)|Disease progression|8|||
13161186|NCT02432846|26087988|FG001|Overall Study (4 Arms/Strata)|Disease progression|5|||
13161187|NCT02432846|26087989|FG002|Overall Study (4 Arms/Strata)|Disease progression|15|||
13161188|NCT02432846|26087990|FG003|Overall Study (4 Arms/Strata)|Disease progression|9|||
13161189|NCT02432846|26087991|FG004|Overall Study (4 Arms/Strata)|Disease progression|0|||
13105777|NCT03317496|25880871|FG000|Phase 2: Treatment|Adverse Event|0|||
13105778|NCT03317496|25880872|FG001|Phase 2: Treatment|Adverse Event|0|||
13105779|NCT03317496|25880873|FG002|Phase 2: Treatment|Adverse Event|0|||
13105780|NCT03317496|25880874|FG003|Phase 2: Treatment|Adverse Event|0|||
13105781|NCT03317496|25880875|FG004|Phase 2: Treatment|Adverse Event|4|||
13105782|NCT03317496|25880871|FG000|Phase 2: Treatment|Death|0|||
13105783|NCT03317496|25880872|FG001|Phase 2: Treatment|Death|0|||
13105784|NCT03317496|25880873|FG002|Phase 2: Treatment|Death|0|||
13105785|NCT03317496|25880874|FG003|Phase 2: Treatment|Death|0|||
13105786|NCT03317496|25880875|FG004|Phase 2: Treatment|Death|1|||
13161190|NCT02432846|26087992|FG005|Overall Study (4 Arms/Strata)|Disease progression|0|||
13161191|NCT02432846|26087987|FG000|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
13161192|NCT02432846|26087988|FG001|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
13161193|NCT02432846|26087989|FG002|Overall Study (4 Arms/Strata)|Lost to Follow-up|1|||
13161194|NCT02432846|26087990|FG003|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
13161195|NCT02432846|26087991|FG004|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
13161196|NCT02432846|26087992|FG005|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
13161197|NCT02432846|26087987|FG000|Overall Study (2 Total/Combined Groups)|Death|0|||
13161198|NCT02432846|26087988|FG001|Overall Study (2 Total/Combined Groups)|Death|0|||
13161199|NCT02432846|26087989|FG002|Overall Study (2 Total/Combined Groups)|Death|0|||
13161200|NCT02432846|26087990|FG003|Overall Study (2 Total/Combined Groups)|Death|0|||
13161201|NCT02432846|26087991|FG004|Overall Study (2 Total/Combined Groups)|Death|7|||
13161202|NCT02432846|26087992|FG005|Overall Study (2 Total/Combined Groups)|Death|5|||
13161203|NCT02432846|26087987|FG000|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
13161204|NCT02432846|26087988|FG001|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
13161205|NCT02432846|26087989|FG002|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
13161206|NCT02432846|26087990|FG003|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
13161207|NCT02432846|26087991|FG004|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
13161208|NCT02432846|26087992|FG005|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
13161209|NCT02432846|26087987|FG000|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
13161210|NCT02432846|26087988|FG001|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
13161211|NCT02432846|26087989|FG002|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
13105787|NCT03317496|25880871|FG000|Phase 2: Treatment|Physician Decision|0|||
13105788|NCT03317496|25880872|FG001|Phase 2: Treatment|Physician Decision|0|||
13161212|NCT02432846|26087990|FG003|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
13161213|NCT02432846|26087991|FG004|Overall Study (2 Total/Combined Groups)|Physician Decision|2|||
13161214|NCT02432846|26087992|FG005|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
13161215|NCT02432846|26087987|FG000|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
13161216|NCT02432846|26087988|FG001|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
13161217|NCT02432846|26087989|FG002|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
13161218|NCT02432846|26087990|FG003|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
13161219|NCT02432846|26087991|FG004|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|3|||
13161220|NCT02432846|26087992|FG005|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|1|||
13161221|NCT02432846|26087987|FG000|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
13161222|NCT02432846|26087988|FG001|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
13161223|NCT02432846|26087989|FG002|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
13161224|NCT02432846|26087990|FG003|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
13161225|NCT02432846|26087991|FG004|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|2|||
13161226|NCT02432846|26087992|FG005|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|1|||
13161227|NCT02432846|26087987|FG000|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
13161228|NCT02432846|26087988|FG001|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
13161229|NCT02432846|26087989|FG002|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
13161230|NCT02432846|26087990|FG003|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
13161231|NCT02432846|26087991|FG004|Overall Study (2 Total/Combined Groups)|Disease progression|23|||
13161232|NCT02432846|26087992|FG005|Overall Study (2 Total/Combined Groups)|Disease progression|14|||
13161233|NCT02432846|26087987|FG000|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
13161234|NCT02432846|26087988|FG001|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
13161235|NCT02432846|26087989|FG002|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
13161236|NCT02432846|26087990|FG003|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
13161237|NCT02432846|26087991|FG004|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|1|||
13161238|NCT02432846|26087992|FG005|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
13161239|NCT02432703|26088025|FG000|Overall Study|Adverse Event|1|||
13161240|NCT02432703|26088026|FG001|Overall Study|Adverse Event|4|||
13161241|NCT02432703|26088025|FG000|Overall Study|Lack of Efficacy|1|||
13161242|NCT02432703|26088026|FG001|Overall Study|Lack of Efficacy|0|||
13161243|NCT02432703|26088025|FG000|Overall Study|Lost to Follow-up|5|||
13161244|NCT02432703|26088026|FG001|Overall Study|Lost to Follow-up|3|||
13161245|NCT02432703|26088025|FG000|Overall Study|Withdrawal by Subject|9|||
13105789|NCT03317496|25880873|FG002|Phase 2: Treatment|Physician Decision|0|||
13161246|NCT02432703|26088026|FG001|Overall Study|Withdrawal by Subject|6|||
13161247|NCT02432703|26088025|FG000|Overall Study|Other|6|||
13161248|NCT02432703|26088026|FG001|Overall Study|Other|5|||
13161249|NCT02432235|26088249|FG000|Overall Study|Death|1|||
13161250|NCT02432235|26088250|FG001|Overall Study|Death|1|||
13161251|NCT02432235|26088251|FG002|Overall Study|Death|2|||
13161252|NCT02432235|26088252|FG003|Overall Study|Death|2|||
13161253|NCT02432235|26088253|FG004|Overall Study|Death|1|||
13161254|NCT02432235|26088254|FG005|Overall Study|Death|3|||
13161255|NCT02432235|26088255|FG006|Overall Study|Death|11|||
13161256|NCT02432235|26088256|FG007|Overall Study|Death|15|||
13161257|NCT02432235|26088257|FG008|Overall Study|Death|15|||
13161258|NCT02432235|26088258|FG009|Overall Study|Death|3|||
13161259|NCT02432235|26088259|FG010|Overall Study|Death|1|||
13161260|NCT02432235|26088260|FG011|Overall Study|Death|0|||
13161261|NCT02432235|26088249|FG000|Overall Study|Withdrawal by Subject|0|||
13105790|NCT03317496|25880874|FG003|Phase 2: Treatment|Physician Decision|0|||
13105791|NCT03317496|25880875|FG004|Phase 2: Treatment|Physician Decision|1|||
13105792|NCT03317496|25880871|FG000|Phase 2: Treatment|Progressive Disease|0|||
13105793|NCT03317496|25880872|FG001|Phase 2: Treatment|Progressive Disease|0|||
13105794|NCT03317496|25880873|FG002|Phase 2: Treatment|Progressive Disease|0|||
13105795|NCT03317496|25880874|FG003|Phase 2: Treatment|Progressive Disease|0|||
13105796|NCT03317496|25880875|FG004|Phase 2: Treatment|Progressive Disease|18|||
13105797|NCT03317496|25880871|FG000|Phase 2: Treatment|Withdrawal by Subject|0|||
13105798|NCT03317496|25880872|FG001|Phase 2: Treatment|Withdrawal by Subject|0|||
13161262|NCT02432235|26088250|FG001|Overall Study|Withdrawal by Subject|1|||
13161263|NCT02432235|26088251|FG002|Overall Study|Withdrawal by Subject|0|||
13161264|NCT02432235|26088252|FG003|Overall Study|Withdrawal by Subject|0|||
13161265|NCT02432235|26088253|FG004|Overall Study|Withdrawal by Subject|0|||
13161266|NCT02432235|26088254|FG005|Overall Study|Withdrawal by Subject|2|||
13161267|NCT02432235|26088255|FG006|Overall Study|Withdrawal by Subject|5|||
13161268|NCT02432235|26088256|FG007|Overall Study|Withdrawal by Subject|3|||
13161269|NCT02432235|26088257|FG008|Overall Study|Withdrawal by Subject|1|||
13161270|NCT02432235|26088258|FG009|Overall Study|Withdrawal by Subject|0|||
13161271|NCT02432235|26088259|FG010|Overall Study|Withdrawal by Subject|0|||
13161272|NCT02432235|26088260|FG011|Overall Study|Withdrawal by Subject|0|||
13161273|NCT02432235|26088249|FG000|Overall Study|Lost to Follow-up|0|||
13161274|NCT02432235|26088250|FG001|Overall Study|Lost to Follow-up|0|||
13161275|NCT02432235|26088251|FG002|Overall Study|Lost to Follow-up|0|||
13161276|NCT02432235|26088252|FG003|Overall Study|Lost to Follow-up|0|||
13161277|NCT02432235|26088253|FG004|Overall Study|Lost to Follow-up|0|||
13161278|NCT02432235|26088254|FG005|Overall Study|Lost to Follow-up|1|||
13161279|NCT02432235|26088255|FG006|Overall Study|Lost to Follow-up|0|||
13161280|NCT02432235|26088256|FG007|Overall Study|Lost to Follow-up|0|||
13161281|NCT02432235|26088257|FG008|Overall Study|Lost to Follow-up|1|||
13161282|NCT02432235|26088258|FG009|Overall Study|Lost to Follow-up|0|||
13161283|NCT02432235|26088259|FG010|Overall Study|Lost to Follow-up|0|||
13161284|NCT02432235|26088260|FG011|Overall Study|Lost to Follow-up|0|||
13161285|NCT02432235|26088249|FG000|Overall Study|Miscellaneous|0|||
13161286|NCT02432235|26088250|FG001|Overall Study|Miscellaneous|0|||
13161287|NCT02432235|26088251|FG002|Overall Study|Miscellaneous|0|||
13161288|NCT02432235|26088252|FG003|Overall Study|Miscellaneous|0|||
13161289|NCT02432235|26088253|FG004|Overall Study|Miscellaneous|1|||
13161290|NCT02432235|26088254|FG005|Overall Study|Miscellaneous|6|||
13161291|NCT02432235|26088255|FG006|Overall Study|Miscellaneous|2|||
13161292|NCT02432235|26088256|FG007|Overall Study|Miscellaneous|2|||
13161293|NCT02432235|26088257|FG008|Overall Study|Miscellaneous|4|||
13161294|NCT02432235|26088258|FG009|Overall Study|Miscellaneous|0|||
13161295|NCT02432235|26088259|FG010|Overall Study|Miscellaneous|0|||
13161296|NCT02432235|26088260|FG011|Overall Study|Miscellaneous|1|||
13161297|NCT02432196|26088270|FG000|Overall Study|Not Implanted with Device|1|||
13161298|NCT02432196|26088270|FG000|Overall Study|Death|2|||
13161299|NCT02432196|26088270|FG000|Overall Study|Reoperation|3|||
13161300|NCT02432196|26088270|FG000|Overall Study|On Study|20|||
13161301|NCT02432144|26088277|FG000|Overall Study|Participant Non-Compliance|1|||
13161302|NCT02432105|26088302|FG000|Overall Study|Lost to Follow-up|1|||
13161303|NCT02432105|26088303|FG001|Overall Study|Lost to Follow-up|1|||
13161304|NCT02432105|26088304|FG002|Overall Study|Lost to Follow-up|0|||
13161305|NCT02432105|26088302|FG000|Overall Study|Withdrawal by Subject|1|||
13161306|NCT02432105|26088303|FG001|Overall Study|Withdrawal by Subject|0|||
13161307|NCT02432105|26088304|FG002|Overall Study|Withdrawal by Subject|1|||
13161308|NCT02432105|26088302|FG000|Overall Study|Culture positive for yeast|0|||
13161309|NCT02432105|26088303|FG001|Overall Study|Culture positive for yeast|1|||
13161310|NCT02432105|26088304|FG002|Overall Study|Culture positive for yeast|0|||
13161311|NCT02432105|26088302|FG000|Overall Study|Randomized in error|0|||
13161312|NCT02432105|26088303|FG001|Overall Study|Randomized in error|0|||
13161313|NCT02432105|26088304|FG002|Overall Study|Randomized in error|2|||
13161314|NCT02432040|26088331|FG000|Overall Study|Lack of Efficacy|3|||
13161315|NCT02432040|26088332|FG001|Overall Study|Lack of Efficacy|0|||
13161316|NCT02432040|26088331|FG000|Overall Study|Lost to Follow-up|4|||
13161317|NCT02432040|26088332|FG001|Overall Study|Lost to Follow-up|5|||
13161318|NCT02432040|26088331|FG000|Overall Study|Physician Decision|1|||
13161319|NCT02432040|26088332|FG001|Overall Study|Physician Decision|1|||
13161320|NCT02431806|26088359|FG000|Double-blind Treatment Period|Did not Receive Treatment|1|||
13161321|NCT02431806|26088360|FG001|Double-blind Treatment Period|Did not Receive Treatment|2|||
13161322|NCT02431806|26088361|FG002|Double-blind Treatment Period|Did not Receive Treatment|1|||
13161323|NCT02431806|26088362|FG003|Double-blind Treatment Period|Did not Receive Treatment|1|||
13161324|NCT02431806|26088359|FG000|Double-blind Treatment Period|Adverse Event|4|||
13161325|NCT02431806|26088360|FG001|Double-blind Treatment Period|Adverse Event|7|||
13161326|NCT02431806|26088361|FG002|Double-blind Treatment Period|Adverse Event|11|||
13161327|NCT02431806|26088362|FG003|Double-blind Treatment Period|Adverse Event|7|||
13161328|NCT02431806|26088359|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
13161329|NCT02431806|26088360|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
13161330|NCT02431806|26088361|FG002|Double-blind Treatment Period|Lack of Efficacy|2|||
13161331|NCT02431806|26088362|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
13161332|NCT02431806|26088359|FG000|Double-blind Treatment Period|Withdrawal of Consent|10|||
13161333|NCT02431806|26088360|FG001|Double-blind Treatment Period|Withdrawal of Consent|7|||
13161334|NCT02431806|26088361|FG002|Double-blind Treatment Period|Withdrawal of Consent|5|||
13161335|NCT02431806|26088362|FG003|Double-blind Treatment Period|Withdrawal of Consent|5|||
13161336|NCT02431806|26088359|FG000|Double-blind Treatment Period|Lost to Follow-up|7|||
13161337|NCT02431806|26088360|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
13161338|NCT02431806|26088361|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
13161339|NCT02431806|26088362|FG003|Double-blind Treatment Period|Lost to Follow-up|8|||
13161340|NCT02431806|26088359|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
13161341|NCT02431806|26088360|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0|||
13161342|NCT02431806|26088361|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3|||
13161343|NCT02431806|26088362|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
13161344|NCT02431806|26088359|FG000|Double-blind Treatment Period|Reason Not Specified|0|||
13161345|NCT02431806|26088360|FG001|Double-blind Treatment Period|Reason Not Specified|1|||
13485479|NCT02906020|27032881|FG014|Part 1: Dose Escalation Period|Adverse Event|0|||
13161346|NCT02431806|26088361|FG002|Double-blind Treatment Period|Reason Not Specified|5|||
13161347|NCT02431806|26088362|FG003|Double-blind Treatment Period|Reason Not Specified|2|||
13161348|NCT02431793|26088392|FG000|Overall Study|Ineligible doe to not filling Rx|11|||
13161349|NCT02431793|26088393|FG001|Overall Study|Ineligible doe to not filling Rx|7|||
13161350|NCT02431793|26088394|FG002|Overall Study|Ineligible doe to not filling Rx|8|||
13161351|NCT02431793|26088392|FG000|Overall Study|Withdrawal by Subject|7|||
13161352|NCT02431793|26088393|FG001|Overall Study|Withdrawal by Subject|5|||
13161353|NCT02431793|26088394|FG002|Overall Study|Withdrawal by Subject|5|||
13161354|NCT02431793|26088392|FG000|Overall Study|Lost to Follow-up|101|||
13161355|NCT02431793|26088393|FG001|Overall Study|Lost to Follow-up|122|||
13161356|NCT02431793|26088394|FG002|Overall Study|Lost to Follow-up|104|||
13161357|NCT02431676|26088418|FG000|Overall Study|no lab obtained|0|||
13161358|NCT02431676|26088419|FG001|Overall Study|no lab obtained|1|||
13161359|NCT02431676|26088420|FG002|Overall Study|no lab obtained|2|||
13161360|NCT02431559|26088479|FG000|Overall Study|Adverse Event|0|||
13161361|NCT02431559|26088480|FG001|Overall Study|Adverse Event|1|||
13161362|NCT02431559|26088481|FG002|Overall Study|Adverse Event|0|||
13161363|NCT02431559|26088482|FG003|Overall Study|Adverse Event|4|||
13161364|NCT02431559|26088479|FG000|Overall Study|Progressive disease|2|||
13161365|NCT02431559|26088480|FG001|Overall Study|Progressive disease|1|||
13161366|NCT02431559|26088481|FG002|Overall Study|Progressive disease|4|||
13161367|NCT02431559|26088482|FG003|Overall Study|Progressive disease|22|||
13161368|NCT02431559|26088479|FG000|Overall Study|Withdrawal by Subject|0|||
13161369|NCT02431559|26088480|FG001|Overall Study|Withdrawal by Subject|1|||
13161370|NCT02431559|26088481|FG002|Overall Study|Withdrawal by Subject|0|||
13161371|NCT02431559|26088482|FG003|Overall Study|Withdrawal by Subject|4|||
13161372|NCT02431559|26088479|FG000|Overall Study|Physician Decision|0|||
13161373|NCT02431559|26088480|FG001|Overall Study|Physician Decision|0|||
13161374|NCT02431559|26088481|FG002|Overall Study|Physician Decision|0|||
13161375|NCT02431559|26088482|FG003|Overall Study|Physician Decision|1|||
13161376|NCT02431533|26088521|FG000|Overall Study|Withdrawal by Subject|1|||
13161377|NCT02431533|26088522|FG001|Overall Study|Withdrawal by Subject|3|||
13161378|NCT02431533|26088521|FG000|Overall Study|Developed Exclusionary criteria|1|||
13161379|NCT02431533|26088522|FG001|Overall Study|Developed Exclusionary criteria|0|||
13161380|NCT02431468|26088552|FG000|Overall Study|Adverse Event|2|||
13161381|NCT02431468|26088553|FG001|Overall Study|Adverse Event|4|||
13105799|NCT03317496|25880873|FG002|Phase 2: Treatment|Withdrawal by Subject|0|||
13105800|NCT03317496|25880874|FG003|Phase 2: Treatment|Withdrawal by Subject|0|||
13105801|NCT03317496|25880875|FG004|Phase 2: Treatment|Withdrawal by Subject|1|||
13105802|NCT03317496|25880871|FG000|Phase 2: Treatment|Other|0|||
13105803|NCT03317496|25880872|FG001|Phase 2: Treatment|Other|0|||
13105804|NCT03317496|25880873|FG002|Phase 2: Treatment|Other|0|||
13105805|NCT03317496|25880874|FG003|Phase 2: Treatment|Other|0|||
13105806|NCT03317496|25880875|FG004|Phase 2: Treatment|Other|2|||
13105807|NCT03317496|25880871|FG000|Phase 2: Treatment|Ongoing|0|||
13105808|NCT03317496|25880872|FG001|Phase 2: Treatment|Ongoing|0|||
13105809|NCT03317496|25880873|FG002|Phase 2: Treatment|Ongoing|0|||
13105810|NCT03317496|25880874|FG003|Phase 2: Treatment|Ongoing|0|||
13105811|NCT03317496|25880875|FG004|Phase 2: Treatment|Ongoing|8|||
13105812|NCT03317496|25880871|FG000|Phase 2: Follow-up|Death|0|||
13105813|NCT03317496|25880872|FG001|Phase 2: Follow-up|Death|0|||
13105814|NCT03317496|25880873|FG002|Phase 2: Follow-up|Death|0|||
13105815|NCT03317496|25880874|FG003|Phase 2: Follow-up|Death|0|||
13105816|NCT03317496|25880875|FG004|Phase 2: Follow-up|Death|16|||
13105817|NCT03317496|25880871|FG000|Phase 2: Follow-up|Withdrawal by Subject|0|||
13105818|NCT03317496|25880872|FG001|Phase 2: Follow-up|Withdrawal by Subject|0|||
13105819|NCT03317496|25880873|FG002|Phase 2: Follow-up|Withdrawal by Subject|0|||
13105820|NCT03317496|25880874|FG003|Phase 2: Follow-up|Withdrawal by Subject|0|||
13105821|NCT03317496|25880875|FG004|Phase 2: Follow-up|Withdrawal by Subject|1|||
13105822|NCT03317496|25880871|FG000|Phase 2: Follow-up|Lost to Follow-up|0|||
13105823|NCT03317496|25880872|FG001|Phase 2: Follow-up|Lost to Follow-up|0|||
13105824|NCT03317496|25880873|FG002|Phase 2: Follow-up|Lost to Follow-up|0|||
13105825|NCT03317496|25880874|FG003|Phase 2: Follow-up|Lost to Follow-up|0|||
13105826|NCT03317496|25880875|FG004|Phase 2: Follow-up|Lost to Follow-up|1|||
13105827|NCT03317496|25880871|FG000|Phase 2: Follow-up|Other|0|||
13161382|NCT02431468|26088554|FG002|Overall Study|Adverse Event|5|||
13161383|NCT02431468|26088552|FG000|Overall Study|Withdrawal by Subject|4|||
13161384|NCT02431468|26088553|FG001|Overall Study|Withdrawal by Subject|12|||
13161385|NCT02431468|26088554|FG002|Overall Study|Withdrawal by Subject|2|||
13161386|NCT02431468|26088552|FG000|Overall Study|noncompliance, investigator termination,|2|||
13161387|NCT02431468|26088553|FG001|Overall Study|noncompliance, investigator termination,|2|||
13161388|NCT02431468|26088554|FG002|Overall Study|noncompliance, investigator termination,|2|||
13161389|NCT02431260|26088688|FG000|Overall Study|Subject Decision|0|||
13161390|NCT02431260|26088689|FG001|Overall Study|Subject Decision|1|||
13161391|NCT02431260|26088690|FG002|Overall Study|Subject Decision|1|||
13161392|NCT02431260|26088691|FG003|Overall Study|Subject Decision|0|||
13105828|NCT03317496|25880872|FG001|Phase 2: Follow-up|Other|0|||
13161393|NCT02431260|26088692|FG004|Overall Study|Subject Decision|0|||
13161394|NCT02431260|26088693|FG005|Overall Study|Subject Decision|0|||
13161395|NCT02431260|26088694|FG006|Overall Study|Subject Decision|0|||
13161396|NCT02431260|26088695|FG007|Overall Study|Subject Decision|0|||
13161397|NCT02431260|26088696|FG008|Overall Study|Subject Decision|1|||
13161398|NCT02431260|26088697|FG009|Overall Study|Subject Decision|1|||
13161399|NCT02431260|26088698|FG010|Overall Study|Subject Decision|0|||
13161400|NCT02431260|26088699|FG011|Overall Study|Subject Decision|1|||
13161401|NCT02431260|26088700|FG012|Overall Study|Subject Decision|0|||
13161402|NCT02431260|26088701|FG013|Overall Study|Subject Decision|0|||
13161403|NCT02431260|26088688|FG000|Overall Study|Death|4|||
13161404|NCT02431260|26088689|FG001|Overall Study|Death|4|||
13161405|NCT02431260|26088690|FG002|Overall Study|Death|3|||
13161406|NCT02431260|26088691|FG003|Overall Study|Death|4|||
13161407|NCT02431260|26088692|FG004|Overall Study|Death|2|||
13161408|NCT02431260|26088693|FG005|Overall Study|Death|2|||
13161409|NCT02431260|26088694|FG006|Overall Study|Death|3|||
13161410|NCT02431260|26088695|FG007|Overall Study|Death|1|||
13161411|NCT02431260|26088696|FG008|Overall Study|Death|6|||
13161412|NCT02431260|26088697|FG009|Overall Study|Death|6|||
13161413|NCT02431260|26088698|FG010|Overall Study|Death|3|||
13161414|NCT02431260|26088699|FG011|Overall Study|Death|2|||
13161415|NCT02431260|26088700|FG012|Overall Study|Death|5|||
13161416|NCT02431260|26088701|FG013|Overall Study|Death|1|||
13161417|NCT02431260|26088688|FG000|Overall Study|Lost to Follow-up|0|||
13161418|NCT02431260|26088689|FG001|Overall Study|Lost to Follow-up|0|||
13161419|NCT02431260|26088690|FG002|Overall Study|Lost to Follow-up|0|||
13161420|NCT02431260|26088691|FG003|Overall Study|Lost to Follow-up|0|||
13161421|NCT02431260|26088692|FG004|Overall Study|Lost to Follow-up|0|||
13161422|NCT02431260|26088693|FG005|Overall Study|Lost to Follow-up|1|||
13161423|NCT02431260|26088694|FG006|Overall Study|Lost to Follow-up|0|||
13161424|NCT02431260|26088695|FG007|Overall Study|Lost to Follow-up|0|||
13161425|NCT02431260|26088696|FG008|Overall Study|Lost to Follow-up|0|||
13161426|NCT02431260|26088697|FG009|Overall Study|Lost to Follow-up|0|||
13161427|NCT02431260|26088698|FG010|Overall Study|Lost to Follow-up|0|||
13161428|NCT02431260|26088699|FG011|Overall Study|Lost to Follow-up|0|||
13161429|NCT02431260|26088700|FG012|Overall Study|Lost to Follow-up|0|||
13161430|NCT02431260|26088701|FG013|Overall Study|Lost to Follow-up|0|||
13161431|NCT02431260|26088688|FG000|Overall Study|Study Terminated by the Sponsor|0|||
13161432|NCT02431260|26088689|FG001|Overall Study|Study Terminated by the Sponsor|0|||
13161433|NCT02431260|26088690|FG002|Overall Study|Study Terminated by the Sponsor|2|||
13161434|NCT02431260|26088691|FG003|Overall Study|Study Terminated by the Sponsor|1|||
13161435|NCT02431260|26088692|FG004|Overall Study|Study Terminated by the Sponsor|1|||
13161436|NCT02431260|26088693|FG005|Overall Study|Study Terminated by the Sponsor|0|||
13161437|NCT02431260|26088694|FG006|Overall Study|Study Terminated by the Sponsor|1|||
13161438|NCT02431260|26088695|FG007|Overall Study|Study Terminated by the Sponsor|2|||
13161439|NCT02431260|26088696|FG008|Overall Study|Study Terminated by the Sponsor|1|||
13161440|NCT02431260|26088697|FG009|Overall Study|Study Terminated by the Sponsor|1|||
13161441|NCT02431260|26088698|FG010|Overall Study|Study Terminated by the Sponsor|1|||
13161442|NCT02431260|26088699|FG011|Overall Study|Study Terminated by the Sponsor|0|||
13161443|NCT02431260|26088700|FG012|Overall Study|Study Terminated by the Sponsor|4|||
13161444|NCT02431260|26088701|FG013|Overall Study|Study Terminated by the Sponsor|0|||
13161445|NCT02431260|26088688|FG000|Overall Study|Physician Decision|0|||
13161446|NCT02431260|26088689|FG001|Overall Study|Physician Decision|0|||
13161447|NCT02431260|26088690|FG002|Overall Study|Physician Decision|0|||
13161448|NCT02431260|26088691|FG003|Overall Study|Physician Decision|0|||
13161449|NCT02431260|26088692|FG004|Overall Study|Physician Decision|0|||
13161450|NCT02431260|26088693|FG005|Overall Study|Physician Decision|1|||
13161451|NCT02431260|26088694|FG006|Overall Study|Physician Decision|0|||
13161452|NCT02431260|26088695|FG007|Overall Study|Physician Decision|0|||
13161453|NCT02431260|26088696|FG008|Overall Study|Physician Decision|0|||
13161454|NCT02431260|26088697|FG009|Overall Study|Physician Decision|0|||
13161455|NCT02431260|26088698|FG010|Overall Study|Physician Decision|0|||
13161456|NCT02431260|26088699|FG011|Overall Study|Physician Decision|0|||
13161457|NCT02431260|26088700|FG012|Overall Study|Physician Decision|0|||
13161458|NCT02431260|26088701|FG013|Overall Study|Physician Decision|0|||
13161459|NCT02431260|26088688|FG000|Overall Study|Other Unspecified|0|||
13161460|NCT02431260|26088689|FG001|Overall Study|Other Unspecified|0|||
13161461|NCT02431260|26088690|FG002|Overall Study|Other Unspecified|0|||
13161462|NCT02431260|26088691|FG003|Overall Study|Other Unspecified|0|||
13161463|NCT02431260|26088692|FG004|Overall Study|Other Unspecified|0|||
13161464|NCT02431260|26088693|FG005|Overall Study|Other Unspecified|0|||
13161465|NCT02431260|26088694|FG006|Overall Study|Other Unspecified|0|||
13161466|NCT02431260|26088695|FG007|Overall Study|Other Unspecified|0|||
13161467|NCT02431260|26088696|FG008|Overall Study|Other Unspecified|0|||
13161468|NCT02431260|26088697|FG009|Overall Study|Other Unspecified|0|||
13161469|NCT02431260|26088698|FG010|Overall Study|Other Unspecified|0|||
13161470|NCT02431260|26088699|FG011|Overall Study|Other Unspecified|1|||
13161471|NCT02431260|26088700|FG012|Overall Study|Other Unspecified|1|||
13161472|NCT02431260|26088701|FG013|Overall Study|Other Unspecified|0|||
13161473|NCT02431247|26088825|FG000|BL to EOE-Test and BL to Switch- Control|Other|11|||
13161474|NCT02431247|26088826|FG001|BL to EOE-Test and BL to Switch- Control|Other|2|||
13161475|NCT02431247|26088827|FG002|BL to EOE-Test and BL to Switch- Control|Other|0|||
13161476|NCT02431247|26088825|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17|||
13161477|NCT02431247|26088826|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8|||
13161478|NCT02431247|26088827|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0|||
13161479|NCT02431247|26088825|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9|||
13161480|NCT02431247|26088826|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4|||
13161481|NCT02431247|26088827|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0|||
13161482|NCT02431247|26088825|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
13161483|NCT02431247|26088826|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
13161484|NCT02431247|26088827|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0|||
13161485|NCT02431247|26088825|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12|||
13161486|NCT02431247|26088826|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16|||
13161487|NCT02431247|26088827|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0|||
13161488|NCT02431247|26088825|FG000|BL to EOE-Test and BL to Switch- Control|Death|0|||
13161489|NCT02431247|26088826|FG001|BL to EOE-Test and BL to Switch- Control|Death|1|||
13161490|NCT02431247|26088827|FG002|BL to EOE-Test and BL to Switch- Control|Death|0|||
13161491|NCT02431247|26088825|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14|||
13161492|NCT02431247|26088826|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9|||
13161493|NCT02431247|26088827|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0|||
13161494|NCT02431247|26088825|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2|||
13161495|NCT02431247|26088826|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
13161496|NCT02431247|26088827|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
13161497|NCT02431247|26088825|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
13161498|NCT02431247|26088826|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
13161499|NCT02431247|26088827|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4|||
13161500|NCT02431247|26088825|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
13161501|NCT02431247|26088826|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
13161502|NCT02431247|26088827|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12|||
13161503|NCT02431247|26088825|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
13161504|NCT02431247|26088826|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
13161505|NCT02431247|26088827|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
13161506|NCT02431247|26088825|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
13161507|NCT02431247|26088826|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
13161508|NCT02431247|26088827|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5|||
13161509|NCT02431247|26088825|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
13161510|NCT02431247|26088826|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
13161511|NCT02431247|26088827|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
13161512|NCT02431247|26088825|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
13161513|NCT02431247|26088826|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
13161514|NCT02431247|26088827|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10|||
13161515|NCT02430870|26088924|FG000|Part 2|Voluntary Withdrawal|0|||
13161516|NCT02430870|26088925|FG001|Part 2|Voluntary Withdrawal|0|||
13161517|NCT02430870|26088926|FG002|Part 2|Voluntary Withdrawal|0|||
13161518|NCT02430870|26088927|FG003|Part 2|Voluntary Withdrawal|0|||
13161519|NCT02430870|26088928|FG004|Part 2|Voluntary Withdrawal|0|||
13161520|NCT02430870|26088929|FG005|Part 2|Voluntary Withdrawal|0|||
13161521|NCT02430870|26088930|FG006|Part 2|Voluntary Withdrawal|1|||
13161522|NCT02430870|26088931|FG007|Part 2|Voluntary Withdrawal|0|||
13161523|NCT02430870|26088924|FG000|Part 2|Other Reason Not Specified|0|||
13161524|NCT02430870|26088925|FG001|Part 2|Other Reason Not Specified|0|||
13161525|NCT02430870|26088926|FG002|Part 2|Other Reason Not Specified|0|||
13161526|NCT02430870|26088927|FG003|Part 2|Other Reason Not Specified|0|||
13161527|NCT02430870|26088928|FG004|Part 2|Other Reason Not Specified|0|||
13161528|NCT02430870|26088929|FG005|Part 2|Other Reason Not Specified|0|||
13161529|NCT02430870|26088930|FG006|Part 2|Other Reason Not Specified|0|||
13161530|NCT02430870|26088931|FG007|Part 2|Other Reason Not Specified|1|||
13161531|NCT02430532|26088952|FG000|Overall Study|Sponsor Decision to Stop Study Early|30|||
13161532|NCT02430532|26088953|FG001|Overall Study|Sponsor Decision to Stop Study Early|25|||
13161533|NCT02430532|26088952|FG000|Overall Study|Consent Withdrawn|0|||
13161534|NCT02430532|26088953|FG001|Overall Study|Consent Withdrawn|2|||
13161535|NCT02430532|26088952|FG000|Overall Study|Adverse Event|0|||
13161536|NCT02430532|26088953|FG001|Overall Study|Adverse Event|1|||
13161537|NCT02430480|26088971|FG000|Overall Study|Death|1|||
13161538|NCT02430480|26088971|FG000|Overall Study|Anesthesia concerns|1|||
13161539|NCT02430480|26088971|FG000|Overall Study|Progressed on treatment|1|||
13161540|NCT02430311|26089011|FG000|Part A|Adverse Event|0|||
13161541|NCT02430311|26089012|FG001|Part A|Adverse Event|1|||
13161542|NCT02430311|26089011|FG000|Part A|Withdrawal by Subject|1|||
13161543|NCT02430311|26089012|FG001|Part A|Withdrawal by Subject|0|||
13161544|NCT02430311|26089011|FG000|Part B|Meet study-specific withdrawal criteria|6|||
13161545|NCT02430311|26089012|FG001|Part B|Meet study-specific withdrawal criteria|6|||
13161546|NCT02430311|26089011|FG000|Part B|Withdrawal by Subject|2|||
13161547|NCT02430311|26089012|FG001|Part B|Withdrawal by Subject|2|||
13161548|NCT02430311|26089011|FG000|Part B|Adverse Event|1|||
13161549|NCT02430311|26089012|FG001|Part B|Adverse Event|0|||
13161550|NCT02430311|26089011|FG000|Part B|Death|1|||
13161551|NCT02430311|26089012|FG001|Part B|Death|0|||
13161552|NCT02429934|26089043|FG000|Overall Study|Withdrawal by Subject|0|||
13161553|NCT02429934|26089044|FG001|Overall Study|Withdrawal by Subject|2|||
13161554|NCT02429934|26089043|FG000|Overall Study|Adverse Event|2|||
13161555|NCT02429934|26089044|FG001|Overall Study|Adverse Event|0|||
13161556|NCT02429934|26089043|FG000|Overall Study|Lost to Follow-up|1|||
13161557|NCT02429934|26089044|FG001|Overall Study|Lost to Follow-up|1|||
13161558|NCT02429934|26089043|FG000|Overall Study|Physician Decision|1|||
13161559|NCT02429934|26089044|FG001|Overall Study|Physician Decision|0|||
13161560|NCT02429856|26089067|FG000|Overall Study|Death|12|||
13161561|NCT02429856|26089068|FG001|Overall Study|Death|13|||
13161562|NCT02429856|26089067|FG000|Overall Study|Lost to Follow-up|6|||
13161563|NCT02429856|26089068|FG001|Overall Study|Lost to Follow-up|5|||
13161564|NCT02429856|26089067|FG000|Overall Study|Withdrawal by Subject|1|||
13161565|NCT02429856|26089068|FG001|Overall Study|Withdrawal by Subject|1|||
13161566|NCT02429830|26089077|FG000|Overall Study|Lost to Follow-up|1|||
13161567|NCT02429830|26089077|FG000|Overall Study|Device Explant|2|||
13161568|NCT02429778|26089096|FG000|Overall Study|Lost to Follow-up|2|||
13161569|NCT02429778|26089097|FG001|Overall Study|Lost to Follow-up|0|||
13161570|NCT02429778|26089096|FG000|Overall Study|Withdrawal by Subject|5|||
13161571|NCT02429778|26089097|FG001|Overall Study|Withdrawal by Subject|0|||
13161572|NCT02429427|26089116|FG000|Overall Study|Adverse Event|220|||
13161573|NCT02429427|26089117|FG001|Overall Study|Adverse Event|92|||
13161574|NCT02429427|26089116|FG000|Overall Study|Protocol Violation|10|||
13161575|NCT02429427|26089117|FG001|Overall Study|Protocol Violation|6|||
13161576|NCT02429427|26089116|FG000|Overall Study|Lost to Follow-up|15|||
13161577|NCT02429427|26089117|FG001|Overall Study|Lost to Follow-up|6|||
13161578|NCT02429427|26089116|FG000|Overall Study|Withdrawal by Subject|64|||
13161579|NCT02429427|26089117|FG001|Overall Study|Withdrawal by Subject|34|||
13161580|NCT02429427|26089116|FG000|Overall Study|Other|62|||
13161581|NCT02429427|26089117|FG001|Overall Study|Other|41|||
13161582|NCT02429414|26089136|FG000|Overall Study|Physician Decision|0|||
13161583|NCT02429414|26089137|FG001|Overall Study|Physician Decision|1|||
13161584|NCT02429310|26089152|FG000|Overall Study|Lost to Follow-up|1|||
13161585|NCT02429310|26089153|FG001|Overall Study|Lost to Follow-up|2|||
13161586|NCT02429310|26089152|FG000|Overall Study|Protocol Violation|1|||
13161587|NCT02429310|26089153|FG001|Overall Study|Protocol Violation|1|||
13161588|NCT02429258|26089186|FG000|Overall Study|Withdrawal by Subject|2|||
13161589|NCT02429258|26089187|FG001|Overall Study|Withdrawal by Subject|0|||
13161590|NCT02429258|26089186|FG000|Overall Study|Protocol Violation|0|||
13161591|NCT02429258|26089187|FG001|Overall Study|Protocol Violation|1|||
13161592|NCT02428855|26089196|FG000|Overall Study|Withdrawal by Subject|2|||
13161593|NCT02428699|26089227|FG000|Washout Period 1|Screen Failure|1|||
13161594|NCT02428699|26089228|FG001|Washout Period 1|Screen Failure|2|||
13161595|NCT02428608|26089235|FG000|Overall Study|Pregnancy|2|||
13161596|NCT02428608|26089235|FG000|Overall Study|Lost to Follow-up|37|||
13161597|NCT02428608|26089235|FG000|Overall Study|Withdrawal by Subject|2|||
13161598|NCT02428608|26089235|FG000|Overall Study|scheduling conflicts|15|||
13161599|NCT02428608|26089235|FG000|Overall Study|moved away|10|||
13161600|NCT02428608|26089235|FG000|Overall Study|Death|1|||
13161601|NCT02428608|26089235|FG000|Overall Study|various|16|||
13161602|NCT02428413|26089254|FG000|Overall Study|Device to measure WAG malfunctioned|3|||
13161603|NCT02428413|26089255|FG001|Overall Study|Device to measure WAG malfunctioned|5|||
13161604|NCT02428413|26089254|FG000|Overall Study|Protocol Violation|1|||
13161605|NCT02428413|26089255|FG001|Overall Study|Protocol Violation|2|||
13161606|NCT02428413|26089254|FG000|Overall Study|Case Cancelled|2|||
13161607|NCT02428413|26089255|FG001|Overall Study|Case Cancelled|0|||
13161608|NCT02428413|26089254|FG000|Overall Study|Missed Cases|1|||
13161609|NCT02428413|26089255|FG001|Overall Study|Missed Cases|2|||
13161610|NCT02428413|26089254|FG000|Overall Study|Nurse Refusal|1|||
13161611|NCT02428413|26089255|FG001|Overall Study|Nurse Refusal|0|||
13161612|NCT02428296|26089267|FG000|Overall Study|Adverse Event|7|||
13161613|NCT02428296|26089267|FG000|Overall Study|Withdrawal by Subject|2|||
13161614|NCT02428231|26089288|FG000|Overall Study|Other|10|||
13161615|NCT02428231|26089289|FG001|Overall Study|Other|16|||
13161616|NCT02428231|26089288|FG000|Overall Study|Required Symptomatic Therapy|0|||
13161617|NCT02428231|26089289|FG001|Overall Study|Required Symptomatic Therapy|1|||
13161618|NCT02428231|26089288|FG000|Overall Study|Adverse Event|3|||
13161619|NCT02428231|26089289|FG001|Overall Study|Adverse Event|0|||
13161620|NCT02427984|26089313|FG000|Overall Study|Lost to Follow-up|13|||
13161621|NCT02427984|26089314|FG001|Overall Study|Lost to Follow-up|5|||
13161622|NCT02427984|26089315|FG002|Overall Study|Lost to Follow-up|18|||
13161623|NCT02427958|26089322|FG000|Overall Study|Pretreatment Event (PTE) or AE|3|||
13161624|NCT02427958|26089322|FG000|Overall Study|Lost to Follow-up|6|||
13161625|NCT02427958|26089322|FG000|Overall Study|Withdrawal by Subject|14|||
13161626|NCT02427958|26089322|FG000|Overall Study|Lack of Efficacy|1|||
13161627|NCT02427841|26089328|FG000|Overall Study|Physician Decision|8|||
13161628|NCT02427802|26089361|FG000|Overall Study|Adverse Event|11|||
13161629|NCT02427802|26089362|FG001|Overall Study|Adverse Event|3|||
13161630|NCT02427802|26089363|FG002|Overall Study|Adverse Event|7|||
13161631|NCT02427802|26089361|FG000|Overall Study|Death|0|||
13161632|NCT02427802|26089362|FG001|Overall Study|Death|4|||
13161633|NCT02427802|26089363|FG002|Overall Study|Death|1|||
13161634|NCT02427802|26089361|FG000|Overall Study|Lost to Follow-up|13|||
13161635|NCT02427802|26089362|FG001|Overall Study|Lost to Follow-up|8|||
13161636|NCT02427802|26089363|FG002|Overall Study|Lost to Follow-up|8|||
13161637|NCT02427802|26089361|FG000|Overall Study|Physician Decision|4|||
13161638|NCT02427802|26089362|FG001|Overall Study|Physician Decision|2|||
13161639|NCT02427802|26089363|FG002|Overall Study|Physician Decision|4|||
13161640|NCT02427802|26089361|FG000|Overall Study|Withdrawal by Subject|10|||
13161641|NCT02427802|26089362|FG001|Overall Study|Withdrawal by Subject|5|||
13161642|NCT02427802|26089363|FG002|Overall Study|Withdrawal by Subject|11|||
13161643|NCT02427802|26089361|FG000|Overall Study|Protocol Violation|3|||
13161644|NCT02427802|26089362|FG001|Overall Study|Protocol Violation|1|||
13161645|NCT02427802|26089363|FG002|Overall Study|Protocol Violation|1|||
13161646|NCT02427802|26089361|FG000|Overall Study|protocol specific treatment unrelated|18|||
13161647|NCT02427802|26089362|FG001|Overall Study|protocol specific treatment unrelated|11|||
13161648|NCT02427802|26089363|FG002|Overall Study|protocol specific treatment unrelated|11|||
13161649|NCT02427646|26089378|FG000|Overall Study|Lack of Efficacy|2|||
13161650|NCT02427646|26089379|FG001|Overall Study|Lack of Efficacy|3|||
13161651|NCT02427646|26089378|FG000|Overall Study|Physician Decision|1|||
13161652|NCT02427646|26089379|FG001|Overall Study|Physician Decision|4|||
13161653|NCT02427646|26089378|FG000|Overall Study|Protocol Violation|3|||
13161654|NCT02427646|26089379|FG001|Overall Study|Protocol Violation|3|||
13161655|NCT02427646|26089378|FG000|Overall Study|Bothersome hand weakness|2|||
13161656|NCT02427646|26089379|FG001|Overall Study|Bothersome hand weakness|4|||
13161657|NCT02427607|26089385|FG000|Overall Study|Withdrawal by Subject|1|||
13161658|NCT02427477|26089400|FG000|Period 1|Adverse Event|1|||
13161659|NCT02427477|26089401|FG001|Period 1|Adverse Event|0|||
13161660|NCT02427464|26089422|FG000|Overall Study|Adverse Event|6|||
13161661|NCT02427464|26089423|FG001|Overall Study|Adverse Event|1|||
13161662|NCT02427464|26089422|FG000|Overall Study|Lost to Follow-up|16|||
13161663|NCT02427464|26089423|FG001|Overall Study|Lost to Follow-up|5|||
13161664|NCT02427464|26089422|FG000|Overall Study|Physician Decision|2|||
13161665|NCT02427464|26089423|FG001|Overall Study|Physician Decision|0|||
13161666|NCT02427464|26089422|FG000|Overall Study|Withdrawal by Subject|10|||
13161667|NCT02427464|26089423|FG001|Overall Study|Withdrawal by Subject|8|||
13161668|NCT02427464|26089422|FG000|Overall Study|Noncompliance|16|||
13161669|NCT02427464|26089423|FG001|Overall Study|Noncompliance|10|||
13161670|NCT02427399|26089461|FG000|Overall Study|Protocol Violation|14|||
13161671|NCT02427399|26089462|FG001|Overall Study|Protocol Violation|16|||
13161672|NCT02427399|26089463|FG002|Overall Study|Protocol Violation|12|||
13161673|NCT02427399|26089464|FG003|Overall Study|Protocol Violation|18|||
13161674|NCT02427399|26089465|FG004|Overall Study|Protocol Violation|15|||
13161675|NCT02427100|26089480|FG000|Overall Study|Lost to Follow-up|0|||
13161676|NCT02427100|26089481|FG001|Overall Study|Lost to Follow-up|2|||
13161677|NCT02426918|26089511|FG000|Overall Study|Adverse Event|2|||
13161678|NCT02426918|26089512|FG001|Overall Study|Adverse Event|2|||
13161679|NCT02426918|26089513|FG002|Overall Study|Adverse Event|0|||
13161680|NCT02426918|26089511|FG000|Overall Study|Physician Decision|1|||
13161681|NCT02426918|26089512|FG001|Overall Study|Physician Decision|1|||
13161682|NCT02426918|26089513|FG002|Overall Study|Physician Decision|1|||
13161683|NCT02426918|26089511|FG000|Overall Study|Withdrawal by Subject|5|||
13161684|NCT02426918|26089512|FG001|Overall Study|Withdrawal by Subject|5|||
13161685|NCT02426918|26089513|FG002|Overall Study|Withdrawal by Subject|4|||
13161686|NCT02426918|26089511|FG000|Overall Study|Other|9|||
13161687|NCT02426918|26089512|FG001|Overall Study|Other|11|||
13161688|NCT02426918|26089513|FG002|Overall Study|Other|9|||
13161689|NCT02426684|26089522|FG000|Overall Study|Physician Decision|1|||
13161690|NCT02426580|26089535|FG000|Overall Study|Death|2|||
13161691|NCT02426580|26089536|FG001|Overall Study|Death|2|||
13161692|NCT02426580|26089535|FG000|Overall Study|Lost to Follow-up|0|||
13161693|NCT02426580|26089536|FG001|Overall Study|Lost to Follow-up|9|||
13161694|NCT02426580|26089535|FG000|Overall Study|transfer to hemodialysis|5|||
13161695|NCT02426580|26089536|FG001|Overall Study|transfer to hemodialysis|5|||
13161696|NCT02426580|26089535|FG000|Overall Study|Kidney transplant|3|||
13161697|NCT02426580|26089536|FG001|Overall Study|Kidney transplant|0|||
13161698|NCT02426580|26089535|FG000|Overall Study|Allergic to egg white|1|||
13161699|NCT02426580|26089536|FG001|Overall Study|Allergic to egg white|0|||
13161700|NCT02426541|26089553|FG000|Overall Study|Protocol Violation|1|||
13161701|NCT02426541|26089554|FG001|Overall Study|Protocol Violation|0|||
13161702|NCT02426138|26089599|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
13161703|NCT02426138|26089600|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
13161704|NCT02426125|26089631|FG000|Overall Study|Lost to Follow-up|12|||
13161705|NCT02426125|26089632|FG001|Overall Study|Lost to Follow-up|10|||
13161706|NCT02426125|26089631|FG000|Overall Study|Protocol Violation|1|||
13161707|NCT02426125|26089632|FG001|Overall Study|Protocol Violation|0|||
13161708|NCT02426125|26089631|FG000|Overall Study|Withdrawal by Subject|16|||
13161709|NCT02426125|26089632|FG001|Overall Study|Withdrawal by Subject|16|||
13161710|NCT02426086|26089688|FG000|Overall Study|Death|33|||
13161711|NCT02426086|26089689|FG001|Overall Study|Death|36|||
13161712|NCT02426086|26089688|FG000|Overall Study|Lost to Follow-up|2|||
13161713|NCT02426086|26089689|FG001|Overall Study|Lost to Follow-up|0|||
13161714|NCT02426086|26089688|FG000|Overall Study|Study Terminated by Sponsor|5|||
13161715|NCT02426086|26089689|FG001|Overall Study|Study Terminated by Sponsor|14|||
13161716|NCT02426086|26089688|FG000|Overall Study|Withdrawal by Subject|8|||
13161717|NCT02426086|26089689|FG001|Overall Study|Withdrawal by Subject|9|||
13161718|NCT02425904|26089708|FG000|Overall Study|Lost to Follow-up|1|||
13161719|NCT02425904|26089709|FG001|Overall Study|Lost to Follow-up|0|||
13161720|NCT02425904|26089708|FG000|Overall Study|Withdrawal by Subject|2|||
13161721|NCT02425904|26089709|FG001|Overall Study|Withdrawal by Subject|0|||
13161722|NCT02425904|26089708|FG000|Overall Study|Death|0|||
13161723|NCT02425904|26089709|FG001|Overall Study|Death|3|||
13161724|NCT02425826|26089750|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5|||
13161725|NCT02425826|26089751|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2|||
13161726|NCT02425826|26089752|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0|||
13161727|NCT02425826|26089750|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
13161728|NCT02425826|26089751|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1|||
13161729|NCT02425826|26089752|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
13161730|NCT02425826|26089750|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9|||
13161731|NCT02425826|26089751|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1|||
13161732|NCT02425826|26089752|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0|||
13161733|NCT02425826|26089750|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10|||
13161734|NCT02425826|26089751|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4|||
13161735|NCT02425826|26089752|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0|||
13161736|NCT02425826|26089750|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3|||
13161737|NCT02425826|26089751|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1|||
13161738|NCT02425826|26089752|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0|||
13161739|NCT02425826|26089750|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7|||
13161740|NCT02425826|26089751|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0|||
13161741|NCT02425826|26089752|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2|||
13161742|NCT02425826|26089750|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8|||
13161743|NCT02425826|26089751|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0|||
13161744|NCT02425826|26089752|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6|||
13161745|NCT02425826|26089750|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12|||
13161746|NCT02425826|26089751|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0|||
13161747|NCT02425826|26089752|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4|||
13161748|NCT02425826|26089750|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8|||
13161749|NCT02425826|26089751|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0|||
13161750|NCT02425826|26089752|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1|||
13161751|NCT02425826|26089750|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
13161752|NCT02425826|26089751|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
13161753|NCT02425826|26089752|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1|||
13161754|NCT02425111|26089773|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2|||
13161755|NCT02425111|26089773|FG000|Part A: Treatment Period|Lack of Efficacy|15|||
13161756|NCT02425111|26089773|FG000|Part A: Treatment Period|Voluntary Withdrawal|4|||
13161757|NCT02425111|26089773|FG000|Part A: Treatment Period|Lost to Follow-up|2|||
13161758|NCT02425111|26089773|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3|||
13161759|NCT02425111|26089773|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7|||
13161760|NCT02425098|26089822|FG000|Overall Study|Lost to Follow-up|7|||
13161761|NCT02425098|26089823|FG001|Overall Study|Lost to Follow-up|7|||
13161762|NCT02425098|26089822|FG000|Overall Study|Withdrawal by Subject|4|||
13161763|NCT02425098|26089823|FG001|Overall Study|Withdrawal by Subject|8|||
13161764|NCT02425098|26089822|FG000|Overall Study|Pregnancy|2|||
13161765|NCT02425098|26089823|FG001|Overall Study|Pregnancy|0|||
13161766|NCT02425098|26089822|FG000|Overall Study|Reason not Specified|0|||
13161767|NCT02425098|26089823|FG001|Overall Study|Reason not Specified|1|||
13161768|NCT02424734|26089850|FG000|Overall Study|Treatment stopped to be discharged home|2|||
13161769|NCT02424734|26089851|FG001|Overall Study|Treatment stopped to be discharged home|2|||
13161770|NCT02424734|26089852|FG002|Overall Study|Treatment stopped to be discharged home|0|||
13222821|NCT01802775|26286957|FG001|Overall Study|Withdrawal by Subject|5|||
13222822|NCT01802775|26286956|FG000|Overall Study|Lost to Follow-up|1|||
13222823|NCT01802775|26286957|FG001|Overall Study|Lost to Follow-up|2|||
13161771|NCT02424630|26089867|FG000|Overall Study|No rotator cuff tear|1|||
13161772|NCT02424630|26089868|FG001|Overall Study|No rotator cuff tear|2|||
13161773|NCT02424630|26089867|FG000|Overall Study|Open procedure|0|||
13161774|NCT02424630|26089868|FG001|Overall Study|Open procedure|1|||
13161775|NCT02424591|26089885|FG000|Overall Study|Protocol Violation|2|||
13161776|NCT02424591|26089886|FG001|Overall Study|Protocol Violation|3|||
13161777|NCT02424578|26089899|FG000|Overall Study|Withdrawal by Subject|0|||
13161778|NCT02424578|26089900|FG001|Overall Study|Withdrawal by Subject|1|||
13161779|NCT02424565|26089909|FG000|Period 1 (D0)|Protocol Violation|0|||
13161780|NCT02424565|26089910|FG001|Period 1 (D0)|Protocol Violation|1|||
13161781|NCT02424539|26089982|FG000|Overall Study|Adverse Event|0|||
13161782|NCT02424539|26089983|FG001|Overall Study|Adverse Event|0|||
13161783|NCT02424539|26089984|FG002|Overall Study|Adverse Event|1|||
13161784|NCT02424539|26089982|FG000|Overall Study|Physician Decision|0|||
13161785|NCT02424539|26089983|FG001|Overall Study|Physician Decision|0|||
13161786|NCT02424539|26089984|FG002|Overall Study|Physician Decision|1|||
13161787|NCT02424539|26089982|FG000|Overall Study|Withdrawal by Subject|3|||
13161788|NCT02424539|26089983|FG001|Overall Study|Withdrawal by Subject|1|||
13161789|NCT02424539|26089984|FG002|Overall Study|Withdrawal by Subject|0|||
13161790|NCT02424539|26089982|FG000|Overall Study|Other: Reached stopping criteria|11|||
13161791|NCT02424539|26089983|FG001|Overall Study|Other: Reached stopping criteria|7|||
13161792|NCT02424539|26089984|FG002|Overall Study|Other: Reached stopping criteria|6|||
13161793|NCT02424383|26089997|FG000|Overall Study|Withdrawal by Subject|32|||
13161794|NCT02424383|26089997|FG000|Overall Study|Death|170|||
13161795|NCT02424383|26089997|FG000|Overall Study|Sponsor's decision|3|||
13161796|NCT02424383|26089997|FG000|Overall Study|Investigator's decision|44|||
13161797|NCT02424383|26089997|FG000|Overall Study|Lost to Follow-up|81|||
13161798|NCT02424383|26089997|FG000|Overall Study|Other|7|||
13161799|NCT02424383|26089997|FG000|Overall Study|Ineligible for Major Protocol Deviation|39|||
13161800|NCT02424344|26090014|FG000|Overall Study|Lack of Efficacy|0|||
13161801|NCT02424344|26090015|FG001|Overall Study|Lack of Efficacy|1|||
13161802|NCT02424344|26090014|FG000|Overall Study|Withdrawal by Subject|2|||
13161803|NCT02424344|26090015|FG001|Overall Study|Withdrawal by Subject|1|||
13161804|NCT02424344|26090014|FG000|Overall Study|Lost to Follow-up|1|||
13161805|NCT02424344|26090015|FG001|Overall Study|Lost to Follow-up|0|||
13161806|NCT02424344|26090014|FG000|Overall Study|Adverse Event|4|||
13161807|NCT02424344|26090015|FG001|Overall Study|Adverse Event|8|||
13161808|NCT02424253|26090030|FG000|Overall Study|Other, unspecified|1|||
13161809|NCT02424253|26090031|FG001|Overall Study|Other, unspecified|0|||
13161810|NCT02424253|26090030|FG000|Overall Study|Compliance problems|1|||
13161811|NCT02424253|26090031|FG001|Overall Study|Compliance problems|0|||
13161812|NCT02424253|26090030|FG000|Overall Study|Physician Decision|2|||
13161813|NCT02424253|26090031|FG001|Overall Study|Physician Decision|0|||
13161814|NCT02424253|26090030|FG000|Overall Study|Lack of Efficacy|0|||
13161815|NCT02424253|26090031|FG001|Overall Study|Lack of Efficacy|7|||
13161816|NCT02424253|26090030|FG000|Overall Study|Adverse Event|2|||
13161817|NCT02424253|26090031|FG001|Overall Study|Adverse Event|0|||
13161818|NCT02424253|26090030|FG000|Overall Study|Consent withdrawn by subject|4|||
13161819|NCT02424253|26090031|FG001|Overall Study|Consent withdrawn by subject|1|||
13161820|NCT02424253|26090030|FG000|Overall Study|Lost to Follow-up|1|||
13161821|NCT02424253|26090031|FG001|Overall Study|Lost to Follow-up|1|||
13161822|NCT02424149|26090052|FG000|Overall Study|surgery cancelled|2|||
13161823|NCT02424149|26090053|FG001|Overall Study|surgery cancelled|0|||
13161824|NCT02424149|26090052|FG000|Overall Study|Withdrawal by Subject|0|||
13161825|NCT02424149|26090053|FG001|Overall Study|Withdrawal by Subject|1|||
13161826|NCT02424097|26090068|FG000|Overall Study|Lost to Follow-up|1|||
13161827|NCT02424097|26090069|FG001|Overall Study|Lost to Follow-up|2|||
13161828|NCT02423798|26090077|FG000|Overall Study|Withdrawal by Subject|3|||
13161829|NCT02423343|26090133|FG000|Overall Study|Withdrawal by Subject|0|||
13161830|NCT02423343|26090134|FG001|Overall Study|Withdrawal by Subject|1|||
13161831|NCT02423343|26090135|FG002|Overall Study|Withdrawal by Subject|0|||
13161832|NCT02423343|26090136|FG003|Overall Study|Withdrawal by Subject|0|||
13161833|NCT02423343|26090137|FG004|Overall Study|Withdrawal by Subject|0|||
13161834|NCT02423343|26090138|FG005|Overall Study|Withdrawal by Subject|0|||
13161835|NCT02423343|26090133|FG000|Overall Study|Progressive Disease|0|||
13161836|NCT02423343|26090134|FG001|Overall Study|Progressive Disease|0|||
13161837|NCT02423343|26090135|FG002|Overall Study|Progressive Disease|0|||
13161838|NCT02423343|26090136|FG003|Overall Study|Progressive Disease|0|||
13161839|NCT02423343|26090137|FG004|Overall Study|Progressive Disease|2|||
13161840|NCT02423343|26090138|FG005|Overall Study|Progressive Disease|0|||
13161841|NCT02423343|26090133|FG000|Overall Study|Adverse Event|0|||
13161842|NCT02423343|26090134|FG001|Overall Study|Adverse Event|0|||
13161843|NCT02423343|26090135|FG002|Overall Study|Adverse Event|0|||
13161844|NCT02423343|26090136|FG003|Overall Study|Adverse Event|0|||
13161845|NCT02423343|26090137|FG004|Overall Study|Adverse Event|2|||
13161846|NCT02423343|26090138|FG005|Overall Study|Adverse Event|0|||
13161847|NCT02423343|26090133|FG000|Overall Study|Death|0|||
13161848|NCT02423343|26090134|FG001|Overall Study|Death|0|||
13161849|NCT02423343|26090135|FG002|Overall Study|Death|0|||
13161850|NCT02423343|26090136|FG003|Overall Study|Death|0|||
13161851|NCT02423343|26090137|FG004|Overall Study|Death|1|||
13161852|NCT02423343|26090138|FG005|Overall Study|Death|0|||
13161853|NCT02423291|26090144|FG000|Overall Study|Lack of Efficacy|14|||
13161854|NCT02423291|26090144|FG000|Overall Study|Adverse Event|1|||
13161855|NCT02423109|26090155|FG000|Lens 1|Adverse Event|1|||
13161856|NCT02423109|26090156|FG001|Lens 1|Adverse Event|0|||
13161857|NCT02422303|26090169|FG000|Overall Study|Lost to Follow-up|1|||
13161858|NCT02422303|26090170|FG001|Overall Study|Lost to Follow-up|1|||
13161859|NCT02422264|26090221|FG000|Overall Study|Serious Adverse Event|1|||
13161860|NCT02422264|26090222|FG001|Overall Study|Serious Adverse Event|0|||
13161861|NCT02422264|26090221|FG000|Overall Study|Withdrawal by Subject|1|||
13161862|NCT02422264|26090222|FG001|Overall Study|Withdrawal by Subject|2|||
13161863|NCT02422264|26090221|FG000|Overall Study|Migrated/moved from study area|3|||
13161864|NCT02422264|26090222|FG001|Overall Study|Migrated/moved from study area|1|||
13161865|NCT02422264|26090221|FG000|Overall Study|Subject vaccinated outside of the study|0|||
13161866|NCT02422264|26090222|FG001|Overall Study|Subject vaccinated outside of the study|1|||
13161867|NCT02422186|26090251|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
13161868|NCT02422186|26090252|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
13161869|NCT02422186|26090251|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0|||
13161870|NCT02422186|26090252|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
13161871|NCT02422186|26090251|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
13161872|NCT02422186|26090252|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2|||
13161873|NCT02422186|26090251|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3|||
13161874|NCT02422186|26090252|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
13161875|NCT02422186|26090251|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4|||
13161876|NCT02422186|26090252|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
13161877|NCT02422186|26090251|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
13161878|NCT02422186|26090252|FG001|Double-blind Induction Phase (4 Weeks)|Other|0|||
13161879|NCT02422186|26090251|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1|||
13161880|NCT02422186|26090252|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0|||
13161881|NCT02422186|26090251|FG000|Follow-up Phase (2 Weeks)|Other|3|||
13161882|NCT02422186|26090252|FG001|Follow-up Phase (2 Weeks)|Other|0|||
13161883|NCT02421952|26090261|FG000|Overall Study|Diary Not Returned|93|||
13161884|NCT02421952|26090261|FG000|Overall Study|Failed seriation task|13|||
13161885|NCT02421952|26090261|FG000|Overall Study|Subject uncooperative for baseline test|2|||
13161886|NCT02421952|26090261|FG000|Overall Study|Surgery cancelled|1|||
13161887|NCT02421887|26090292|FG000|Overall Study|Lost to Follow-up|5|||
13161888|NCT02421887|26090293|FG001|Overall Study|Lost to Follow-up|0|||
13161889|NCT02421887|26090292|FG000|Overall Study|Withdrawal by Subject|8|||
13161890|NCT02421887|26090293|FG001|Overall Study|Withdrawal by Subject|5|||
13161891|NCT02421887|26090292|FG000|Overall Study|Physician Decision|2|||
13161892|NCT02421887|26090293|FG001|Overall Study|Physician Decision|4|||
13161893|NCT02421887|26090292|FG000|Overall Study|Adverse Event|2|||
13161894|NCT02421887|26090293|FG001|Overall Study|Adverse Event|0|||
13161895|NCT02421666|26090306|FG000|6-month Follow-up|Lost to Follow-up|8|||
13161896|NCT02421666|26090307|FG001|6-month Follow-up|Lost to Follow-up|7|||
13161897|NCT02421666|26090306|FG000|6-month Follow-up|Withdrawal by Subject|5|||
13161898|NCT02421666|26090307|FG001|6-month Follow-up|Withdrawal by Subject|6|||
13161899|NCT02421666|26090306|FG000|12-month Follow-up|Lost to Follow-up|5|||
13161900|NCT02421666|26090307|FG001|12-month Follow-up|Lost to Follow-up|5|||
13161901|NCT02421666|26090306|FG000|12-month Follow-up|Withdrawal by Subject|6|||
13161902|NCT02421666|26090307|FG001|12-month Follow-up|Withdrawal by Subject|11|||
13161903|NCT02421601|26090314|FG000|Overall Study|Adverse Event|4|||
13161904|NCT02421601|26090314|FG000|Overall Study|Lack of Efficacy|5|||
13161905|NCT02421601|26090314|FG000|Overall Study|Physician Decision|1|||
13161906|NCT02421601|26090314|FG000|Overall Study|Withdrawal by Subject|31|||
13161907|NCT02421601|26090314|FG000|Overall Study|Others|41|||
13161908|NCT02421588|26090341|FG000|Overall Study|Non-treatment-related AE|8|||
13161909|NCT02421588|26090342|FG001|Overall Study|Non-treatment-related AE|8|||
13161910|NCT02421588|26090341|FG000|Overall Study|Progressive disease|152|||
13161911|NCT02421588|26090342|FG001|Overall Study|Progressive disease|135|||
13161912|NCT02421588|26090341|FG000|Overall Study|Death|11|||
13161913|NCT02421588|26090342|FG001|Overall Study|Death|3|||
13161914|NCT02421588|26090341|FG000|Overall Study|Physician Decision|8|||
13161915|NCT02421588|26090342|FG001|Overall Study|Physician Decision|17|||
13161916|NCT02421588|26090341|FG000|Overall Study|Other reason not specified|3|||
13161917|NCT02421588|26090342|FG001|Overall Study|Other reason not specified|1|||
13161918|NCT02421588|26090341|FG000|Overall Study|Symptomatic deterioration|13|||
13161919|NCT02421588|26090342|FG001|Overall Study|Symptomatic deterioration|19|||
13161920|NCT02421588|26090341|FG000|Overall Study|Treatment-related AE|10|||
13161921|NCT02421588|26090342|FG001|Overall Study|Treatment-related AE|14|||
13161922|NCT02421588|26090341|FG000|Overall Study|Withdrawal by Subject|14|||
13161923|NCT02421588|26090342|FG001|Overall Study|Withdrawal by Subject|16|||
13161924|NCT02421588|26090341|FG000|Overall Study|Not treated|2|||
13161925|NCT02421588|26090342|FG001|Overall Study|Not treated|8|||
13161926|NCT02421510|26090381|FG000|Overall Study|Other|4|||
13161927|NCT02421510|26090382|FG001|Overall Study|Other|2|||
13161928|NCT02421510|26090383|FG002|Overall Study|Other|3|||
13161929|NCT02421510|26090381|FG000|Overall Study|Protocol Violation|1|||
13161930|NCT02421510|26090382|FG001|Overall Study|Protocol Violation|2|||
13161931|NCT02421510|26090383|FG002|Overall Study|Protocol Violation|0|||
13161932|NCT02421510|26090381|FG000|Overall Study|Death|1|||
13161933|NCT02421510|26090382|FG001|Overall Study|Death|0|||
13161934|NCT02421510|26090383|FG002|Overall Study|Death|0|||
13161935|NCT02421510|26090381|FG000|Overall Study|Noncompliance with study drug|1|||
13161936|NCT02421510|26090382|FG001|Overall Study|Noncompliance with study drug|0|||
13161937|NCT02421510|26090383|FG002|Overall Study|Noncompliance with study drug|0|||
13161938|NCT02421510|26090381|FG000|Overall Study|Physician Decision|1|||
13161939|NCT02421510|26090382|FG001|Overall Study|Physician Decision|1|||
13161940|NCT02421510|26090383|FG002|Overall Study|Physician Decision|3|||
13161941|NCT02421510|26090381|FG000|Overall Study|Adverse Event|9|||
13161942|NCT02421510|26090382|FG001|Overall Study|Adverse Event|10|||
13161943|NCT02421510|26090383|FG002|Overall Study|Adverse Event|18|||
13161944|NCT02421510|26090381|FG000|Overall Study|Pregnancy|1|||
13161945|NCT02421510|26090382|FG001|Overall Study|Pregnancy|1|||
13161946|NCT02421510|26090383|FG002|Overall Study|Pregnancy|0|||
13161947|NCT02421510|26090381|FG000|Overall Study|Withdrawal by Subject|14|||
13161948|NCT02421510|26090382|FG001|Overall Study|Withdrawal by Subject|18|||
13161949|NCT02421510|26090383|FG002|Overall Study|Withdrawal by Subject|12|||
13161950|NCT02421510|26090381|FG000|Overall Study|Lost to Follow-up|1|||
13161951|NCT02421510|26090382|FG001|Overall Study|Lost to Follow-up|1|||
13161952|NCT02421510|26090383|FG002|Overall Study|Lost to Follow-up|0|||
13161953|NCT02421419|26090410|FG000|Overall Study|Physician Decision|0|||
13161954|NCT02421419|26090411|FG001|Overall Study|Physician Decision|0|||
13161955|NCT02421419|26090412|FG002|Overall Study|Physician Decision|1|||
13161956|NCT02421172|26090445|FG000|Period 1|Adverse Event|1|||
13161957|NCT02421172|26090446|FG001|Period 1|Adverse Event|0|||
13161958|NCT02421172|26090447|FG002|Period 1|Adverse Event|0|||
13161959|NCT02421172|26090448|FG003|Period 1|Adverse Event|0|||
13161960|NCT02421172|26090449|FG004|Period 1|Adverse Event|0|||
13161961|NCT02421172|26090445|FG000|Period 1|Lost to Follow-up|3|||
13161962|NCT02421172|26090446|FG001|Period 1|Lost to Follow-up|1|||
13161963|NCT02421172|26090447|FG002|Period 1|Lost to Follow-up|0|||
13161964|NCT02421172|26090448|FG003|Period 1|Lost to Follow-up|0|||
13161965|NCT02421172|26090449|FG004|Period 1|Lost to Follow-up|0|||
13161966|NCT02421172|26090445|FG000|Period 1|Patient/guardian decision|0|||
13161967|NCT02421172|26090446|FG001|Period 1|Patient/guardian decision|1|||
13161968|NCT02421172|26090447|FG002|Period 1|Patient/guardian decision|0|||
13161969|NCT02421172|26090448|FG003|Period 1|Patient/guardian decision|0|||
13161970|NCT02421172|26090449|FG004|Period 1|Patient/guardian decision|0|||
13161971|NCT02421172|26090445|FG000|Period 2|Adverse Event|0|||
13161972|NCT02421172|26090446|FG001|Period 2|Adverse Event|0|||
13161973|NCT02421172|26090447|FG002|Period 2|Adverse Event|4|||
13161974|NCT02421172|26090448|FG003|Period 2|Adverse Event|0|||
13161975|NCT02421172|26090449|FG004|Period 2|Adverse Event|0|||
13161976|NCT02421172|26090445|FG000|Period 2|Lost to Follow-up|0|||
13161977|NCT02421172|26090446|FG001|Period 2|Lost to Follow-up|0|||
13161978|NCT02421172|26090447|FG002|Period 2|Lost to Follow-up|0|||
13161979|NCT02421172|26090448|FG003|Period 2|Lost to Follow-up|1|||
13161980|NCT02421172|26090449|FG004|Period 2|Lost to Follow-up|0|||
13161981|NCT02421172|26090445|FG000|Period 2|Patient/guardian decision|0|||
13161982|NCT02421172|26090446|FG001|Period 2|Patient/guardian decision|0|||
13161983|NCT02421172|26090447|FG002|Period 2|Patient/guardian decision|3|||
13161984|NCT02421172|26090448|FG003|Period 2|Patient/guardian decision|2|||
13161985|NCT02421172|26090449|FG004|Period 2|Patient/guardian decision|1|||
13205461|NCT01965431|26231833|FG004|Overall Study|Adverse Event|0|||
13205462|NCT01965431|26231834|FG005|Overall Study|Adverse Event|0|||
13205463|NCT01965431|26231829|FG000|Overall Study|Other than stated above|6|||
13205464|NCT01965431|26231830|FG001|Overall Study|Other than stated above|5|||
13205465|NCT01965431|26231831|FG002|Overall Study|Other than stated above|6|||
13205466|NCT01965431|26231832|FG003|Overall Study|Other than stated above|6|||
13205467|NCT01965431|26231833|FG004|Overall Study|Other than stated above|6|||
13222824|NCT01802632|26286990|FG000|Overall Study|Death|28|||
13222825|NCT01802632|26286991|FG001|Overall Study|Death|1|||
13222826|NCT01802632|26286992|FG002|Overall Study|Death|38|||
13222827|NCT01802632|26286993|FG003|Overall Study|Death|0|||
13222828|NCT01802632|26286994|FG004|Overall Study|Death|2|||
13222829|NCT01802632|26286995|FG005|Overall Study|Death|0|||
13222830|NCT01802632|26286990|FG000|Overall Study|Withdrawal by Subject|4|||
13222831|NCT01802632|26286991|FG001|Overall Study|Withdrawal by Subject|2|||
13222832|NCT01802632|26286992|FG002|Overall Study|Withdrawal by Subject|7|||
13222833|NCT01802632|26286993|FG003|Overall Study|Withdrawal by Subject|3|||
13205468|NCT01965431|26231834|FG005|Overall Study|Other than stated above|6|||
13205469|NCT01965327|26231841|FG000|Overall Study|Physician Decision|2|||
13205470|NCT01965262|26231906|FG000|Second Intervention (7 Days)|Discontinued|0|||
13205471|NCT01965262|26231907|FG001|Second Intervention (7 Days)|Discontinued|1|||
13205472|NCT01965262|26231906|FG000|Second Intervention (7 Days)|Poor lens fit|0|||
13205473|NCT01965262|26231907|FG001|Second Intervention (7 Days)|Poor lens fit|9|||
13222834|NCT01802632|26286994|FG004|Overall Study|Withdrawal by Subject|0|||
13161986|NCT02421120|26090459|FG000|Overall Study|Adverse Event|1|||
13161987|NCT02420717|26090484|FG000|Overall Study|Did not receive all study medication|2|||
13161988|NCT02420717|26090485|FG001|Overall Study|Did not receive all study medication|0|||
13161989|NCT02420717|26090486|FG002|Overall Study|Did not receive all study medication|0|||
13161990|NCT02420691|26090496|FG000|Overall Study|Adverse Event|3|||
13161991|NCT02420691|26090496|FG000|Overall Study|Withdrawal by Subject|3|||
13161992|NCT02420379|26090521|FG000|Overall Study|Withdrawal by Subject|0|||
13161993|NCT02420379|26090522|FG001|Overall Study|Withdrawal by Subject|3|||
13161994|NCT02420379|26090521|FG000|Overall Study|Unable to complete due to schooling|0|||
13161995|NCT02420379|26090522|FG001|Overall Study|Unable to complete due to schooling|1|||
13161996|NCT02420379|26090521|FG000|Overall Study|Transitioned to commercial drug|1|||
13161997|NCT02420379|26090522|FG001|Overall Study|Transitioned to commercial drug|0|||
13161998|NCT02420353|26090621|FG000|Overall Study|Withdrawal by Subject|0|||
13161999|NCT02420353|26090622|FG001|Overall Study|Withdrawal by Subject|1|||
13162000|NCT02420327|26090658|FG000|Overall Study|Adverse Event|7|||
13162001|NCT02420327|26090658|FG000|Overall Study|Pregnancy|1|||
13162002|NCT02420327|26090658|FG000|Overall Study|Withdrawal by Subject|6|||
13162003|NCT02420327|26090658|FG000|Overall Study|Lost to Follow-up|1|||
13162004|NCT02420327|26090658|FG000|Overall Study|Protocol Violation|1|||
13162005|NCT02420262|26090679|FG000|Overall Study|Adverse Event|1|||
13162006|NCT02420262|26090680|FG001|Overall Study|Adverse Event|0|||
13162007|NCT02420262|26090679|FG000|Overall Study|Withdrawal by Subject|1|||
13162008|NCT02420262|26090680|FG001|Overall Study|Withdrawal by Subject|4|||
13162009|NCT02420262|26090679|FG000|Overall Study|Unclassified|0|||
13162010|NCT02420262|26090680|FG001|Overall Study|Unclassified|1|||
13162011|NCT02420223|26090705|FG000|Overall Study|Adverse Event|1|||
13162012|NCT02420223|26090706|FG001|Overall Study|Adverse Event|0|||
13162013|NCT02420223|26090705|FG000|Overall Study|Physician Decision|0|||
13162014|NCT02420223|26090706|FG001|Overall Study|Physician Decision|2|||
13162015|NCT02420119|26090712|FG000|Overall Study|insufficient laboratory data|5|||
13162016|NCT02420093|26090733|FG000|Overall Study|Withdrawal by Subject|1|||
13162017|NCT02420093|26090734|FG001|Overall Study|Withdrawal by Subject|1|||
13162018|NCT02419937|26090747|FG000|Overall Study|Lost to Follow-up|1|||
13162019|NCT02419937|26090748|FG001|Overall Study|Lost to Follow-up|0|||
13162020|NCT02419755|26090779|FG000|Overall Study|Death|1|||
13162021|NCT02419755|26090780|FG001|Overall Study|Death|3|||
13162022|NCT02419755|26090779|FG000|Overall Study|Relapse|0|||
13162023|NCT02419755|26090780|FG001|Overall Study|Relapse|1|||
13162024|NCT02419755|26090779|FG000|Overall Study|Ineligible|1|||
13162025|NCT02419755|26090780|FG001|Overall Study|Ineligible|0|||
13162026|NCT02419755|26090779|FG000|Overall Study|Withdrawal by Subject|1|||
13162027|NCT02419755|26090780|FG001|Overall Study|Withdrawal by Subject|0|||
13162028|NCT02419612|26090807|FG000|Short-term Treatment Period|Adverse Event|1|||
13162029|NCT02419612|26090808|FG001|Short-term Treatment Period|Adverse Event|1|||
13162030|NCT02419612|26090807|FG000|Short-term Treatment Period|Death|0|||
13162031|NCT02419612|26090808|FG001|Short-term Treatment Period|Death|2|||
13162032|NCT02419612|26090807|FG000|Short-term Treatment Period|Lost to Follow-up|6|||
13162033|NCT02419612|26090808|FG001|Short-term Treatment Period|Lost to Follow-up|6|||
13162034|NCT02419612|26090807|FG000|Short-term Treatment Period|Withdrawal by Subject|9|||
13162035|NCT02419612|26090808|FG001|Short-term Treatment Period|Withdrawal by Subject|9|||
13162036|NCT02419612|26090807|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
13162037|NCT02419612|26090808|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
13162038|NCT02419612|26090807|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0|||
13162039|NCT02419612|26090808|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2|||
13162040|NCT02419612|26090807|FG000|Short-term Treatment Period|Worsening of liver function|0|||
13162041|NCT02419612|26090808|FG001|Short-term Treatment Period|Worsening of liver function|1|||
13162042|NCT02419612|26090807|FG000|Short-term Treatment Period|Subject moved out of state|0|||
13485480|NCT02906020|27032882|FG015|Part 1: Dose Escalation Period|Adverse Event|0|||
13162043|NCT02419612|26090808|FG001|Short-term Treatment Period|Subject moved out of state|1|||
13162044|NCT02419612|26090807|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1|||
13162045|NCT02419612|26090808|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1|||
13162046|NCT02419612|26090807|FG000|Long-term Treatment Period|Lost to Follow-up|6|||
13162047|NCT02419612|26090808|FG001|Long-term Treatment Period|Lost to Follow-up|4|||
13162048|NCT02419612|26090807|FG000|Long-term Treatment Period|Lack of Efficacy|1|||
13162049|NCT02419612|26090808|FG001|Long-term Treatment Period|Lack of Efficacy|1|||
13162050|NCT02419612|26090807|FG000|Long-term Treatment Period|Death|0|||
13162051|NCT02419612|26090808|FG001|Long-term Treatment Period|Death|1|||
13162052|NCT02419612|26090807|FG000|Long-term Treatment Period|Adverse Event|0|||
13162053|NCT02419612|26090808|FG001|Long-term Treatment Period|Adverse Event|5|||
13162054|NCT02419612|26090807|FG000|Long-term Treatment Period|Other|4|||
13162055|NCT02419612|26090808|FG001|Long-term Treatment Period|Other|4|||
13162056|NCT02419612|26090807|FG000|Long-term Treatment Period|Subject Decision|2|||
13162057|NCT02419612|26090808|FG001|Long-term Treatment Period|Subject Decision|4|||
13162058|NCT02419612|26090807|FG000|Long-term Treatment Period|Withdrawal by Subject|8|||
13162059|NCT02419612|26090808|FG001|Long-term Treatment Period|Withdrawal by Subject|2|||
13162060|NCT02419573|26090827|FG000|Overall Study|Lost to Follow-up|3|||
13162061|NCT02419573|26090828|FG001|Overall Study|Lost to Follow-up|0|||
13162062|NCT02419573|26090827|FG000|Overall Study|Withdrawal by Subject|1|||
13162063|NCT02419573|26090828|FG001|Overall Study|Withdrawal by Subject|0|||
13162064|NCT02419508|26090853|FG000|Overall Study|Adverse Event|9|||
13162065|NCT02419508|26090854|FG001|Overall Study|Adverse Event|3|||
13162066|NCT02419508|26090853|FG000|Overall Study|Withdrawal by Subject|1|||
13162067|NCT02419508|26090854|FG001|Overall Study|Withdrawal by Subject|0|||
13162068|NCT02419508|26090853|FG000|Overall Study|Other - Reason not specified|0|||
13162069|NCT02419508|26090854|FG001|Overall Study|Other - Reason not specified|1|||
13162070|NCT02419469|26090860|FG000|Overall Study|Withdrawal by Subject|1|||
13162071|NCT02419313|26090873|FG000|First Intervention|Lost to Follow-up|2|||
13162072|NCT02419313|26090874|FG001|First Intervention|Lost to Follow-up|0|||
13162073|NCT02419313|26090873|FG000|Second Intervention|Lost to Follow-up|1|||
13162074|NCT02419313|26090874|FG001|Second Intervention|Lost to Follow-up|0|||
13162075|NCT02419001|26090891|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1|||
13162076|NCT02419001|26090892|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0|||
13162077|NCT02418949|26090919|FG000|Overall Study|Withdrawal by Subject|1|||
13162078|NCT02418949|26090920|FG001|Overall Study|Withdrawal by Subject|0|||
13162079|NCT02418949|26090921|FG002|Overall Study|Withdrawal by Subject|1|||
13162080|NCT02418949|26090922|FG003|Overall Study|Withdrawal by Subject|1|||
13162081|NCT02418949|26090919|FG000|Overall Study|Lost to Follow-up|1|||
13162082|NCT02418949|26090920|FG001|Overall Study|Lost to Follow-up|0|||
13162083|NCT02418949|26090921|FG002|Overall Study|Lost to Follow-up|1|||
13162084|NCT02418949|26090922|FG003|Overall Study|Lost to Follow-up|0|||
13162085|NCT02418949|26090919|FG000|Overall Study|Physician Decision|1|||
13162086|NCT02418949|26090920|FG001|Overall Study|Physician Decision|1|||
13162087|NCT02418949|26090921|FG002|Overall Study|Physician Decision|1|||
13162088|NCT02418949|26090922|FG003|Overall Study|Physician Decision|0|||
13162089|NCT02418910|26090928|FG000|Overall Study|Lost to Follow-up|3|||
13162090|NCT02418910|26090928|FG000|Overall Study|Withdrawal by Subject|4|||
13162091|NCT02418845|26090949|FG000|Overall Study|Lost to Follow-up|7|||
13105829|NCT03317496|25880873|FG002|Phase 2: Follow-up|Other|0|||
13105830|NCT03317496|25880874|FG003|Phase 2: Follow-up|Other|0|||
13162092|NCT02418845|26090950|FG001|Overall Study|Lost to Follow-up|2|||
13162093|NCT02418845|26090949|FG000|Overall Study|Lack of Efficacy|0|||
13162094|NCT02418845|26090950|FG001|Overall Study|Lack of Efficacy|3|||
13162095|NCT02418845|26090949|FG000|Overall Study|Physician Decision|5|||
13162096|NCT02418845|26090950|FG001|Overall Study|Physician Decision|5|||
13162097|NCT02418845|26090949|FG000|Overall Study|Protocol Violation|1|||
13162098|NCT02418845|26090950|FG001|Overall Study|Protocol Violation|0|||
13162099|NCT02418845|26090949|FG000|Overall Study|Withdrawal by Subject|3|||
13162100|NCT02418845|26090950|FG001|Overall Study|Withdrawal by Subject|2|||
13162101|NCT02418819|26091003|FG000|Overall Study|Adverse Event|0|||
13105831|NCT03317496|25880875|FG004|Phase 2: Follow-up|Other|6|||
13105832|NCT03317496|25880871|FG000|Phase 2: Follow-up|Ongoing|0|||
13105833|NCT03317496|25880872|FG001|Phase 2: Follow-up|Ongoing|0|||
13105834|NCT03317496|25880873|FG002|Phase 2: Follow-up|Ongoing|0|||
13105835|NCT03317496|25880874|FG003|Phase 2: Follow-up|Ongoing|0|||
13105836|NCT03317496|25880875|FG004|Phase 2: Follow-up|Ongoing|1|||
13105837|NCT03317379|25880905|FG000|Overall Study|Lost to Follow-up|0|||
13105838|NCT03317379|25880906|FG001|Overall Study|Lost to Follow-up|3|||
13105839|NCT03317379|25880907|FG002|Overall Study|Lost to Follow-up|2|||
13105840|NCT03316911|25880946|FG000|Overall Study|Lost to Follow-up|33|||
13105841|NCT03316911|25880947|FG001|Overall Study|Lost to Follow-up|29|||
13105842|NCT03316547|25880982|FG000|Overall Study|Death|3|||
13105843|NCT03316547|25880983|FG001|Overall Study|Death|1|||
13105844|NCT03316547|25880982|FG000|Overall Study|Lost to Follow-up|6|||
13105845|NCT03316547|25880983|FG001|Overall Study|Lost to Follow-up|6|||
13105846|NCT03316547|25880982|FG000|Overall Study|Withdrawal by Subject|3|||
13162102|NCT02418819|26091004|FG001|Overall Study|Adverse Event|0|||
13105847|NCT03316547|25880983|FG001|Overall Study|Withdrawal by Subject|2|||
13105848|NCT03316547|25880982|FG000|Overall Study|Transfer to another hospital|6|||
13162103|NCT02418819|26091005|FG002|Overall Study|Adverse Event|1|||
13162104|NCT02418819|26091006|FG003|Overall Study|Adverse Event|0|||
13162105|NCT02418819|26091003|FG000|Overall Study|Lost to Follow-up|1|||
13162106|NCT02418819|26091004|FG001|Overall Study|Lost to Follow-up|0|||
13105849|NCT03316547|25880983|FG001|Overall Study|Transfer to another hospital|4|||
13105850|NCT03316170|25880999|FG000|Overall Study|Death|1|||
13162107|NCT02418819|26091005|FG002|Overall Study|Lost to Follow-up|0|||
13162108|NCT02418819|26091006|FG003|Overall Study|Lost to Follow-up|0|||
13162109|NCT02418819|26091003|FG000|Overall Study|No longer meets eligibility criteria|0|||
13162110|NCT02418819|26091004|FG001|Overall Study|No longer meets eligibility criteria|0|||
13162111|NCT02418819|26091005|FG002|Overall Study|No longer meets eligibility criteria|1|||
13162112|NCT02418819|26091006|FG003|Overall Study|No longer meets eligibility criteria|0|||
13162113|NCT02418819|26091003|FG000|Overall Study|No longer willing to participate|0|||
13162114|NCT02418819|26091004|FG001|Overall Study|No longer willing to participate|0|||
13162115|NCT02418819|26091005|FG002|Overall Study|No longer willing to participate|2|||
13162116|NCT02418819|26091006|FG003|Overall Study|No longer willing to participate|1|||
13162117|NCT02418754|26091049|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
13162118|NCT02418754|26091050|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2|||
13162119|NCT02418754|26091051|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
13162120|NCT02418754|26091052|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
13162121|NCT02418754|26091053|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
13162122|NCT02418754|26091049|FG000|Period 1 (Day 1 to Week 12)|Death|1|||
13162123|NCT02418754|26091050|FG001|Period 1 (Day 1 to Week 12)|Death|0|||
13162124|NCT02418754|26091051|FG002|Period 1 (Day 1 to Week 12)|Death|0|||
13162125|NCT02418754|26091052|FG003|Period 1 (Day 1 to Week 12)|Death|0|||
13162126|NCT02418754|26091053|FG004|Period 1 (Day 1 to Week 12)|Death|0|||
13162127|NCT02418754|26091049|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1|||
13162128|NCT02418754|26091050|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
13162129|NCT02418754|26091051|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
13162130|NCT02418754|26091052|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
13162131|NCT02418754|26091053|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
13162132|NCT02418754|26091049|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
13162133|NCT02418754|26091050|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2|||
13162134|NCT02418754|26091051|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1|||
13162135|NCT02418754|26091052|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
13162136|NCT02418754|26091053|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
13162137|NCT02418754|26091049|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
13162138|NCT02418754|26091050|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
13162139|NCT02418754|26091051|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1|||
13162140|NCT02418754|26091052|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
13162141|NCT02418754|26091053|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
13162142|NCT02418754|26091049|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3|||
13162143|NCT02418754|26091050|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7|||
13162144|NCT02418754|26091051|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6|||
13162145|NCT02418754|26091052|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
13162146|NCT02418754|26091053|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
13162147|NCT02418754|26091049|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1|||
13162148|NCT02418754|26091050|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
13162149|NCT02418754|26091051|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
13162150|NCT02418754|26091052|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
13162151|NCT02418754|26091053|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
13162152|NCT02418754|26091049|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
13162153|NCT02418754|26091050|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28|||
13162154|NCT02418754|26091051|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
13162155|NCT02418754|26091052|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21|||
13162156|NCT02418754|26091053|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24|||
13162157|NCT02418754|26091049|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3|||
13162158|NCT02418754|26091050|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
13162159|NCT02418754|26091051|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
13162160|NCT02418754|26091052|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1|||
13105851|NCT03316170|25881000|FG001|Overall Study|Death|0|||
13105852|NCT03316170|25880999|FG000|Overall Study|Lost to Follow-up|6|||
13105853|NCT03316170|25881000|FG001|Overall Study|Lost to Follow-up|7|||
13105854|NCT03316131|25881021|FG000|Treatment Period 2|Protocol deviation|1|||
13105855|NCT03316131|25881022|FG001|Treatment Period 2|Protocol deviation|0|||
13105856|NCT03315793|25881043|FG000|Overall Study|Adverse Event|4|||
13162161|NCT02418754|26091053|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0|||
13162162|NCT02418754|26091049|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0|||
13162163|NCT02418754|26091050|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
13162164|NCT02418754|26091051|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
13162165|NCT02418754|26091052|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
13162166|NCT02418754|26091053|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
13162167|NCT02418754|26091049|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
13105857|NCT03315793|25881044|FG001|Overall Study|Adverse Event|2|||
13105858|NCT03315793|25881043|FG000|Overall Study|Protocol Deviation|1|||
13105859|NCT03315793|25881044|FG001|Overall Study|Protocol Deviation|0|||
13105860|NCT03315793|25881043|FG000|Overall Study|Difficult for regular visit|0|||
13105861|NCT03315793|25881044|FG001|Overall Study|Difficult for regular visit|1|||
13105862|NCT03315689|25881079|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1|||
13105863|NCT03315689|25881080|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0|||
13105864|NCT03315689|25881079|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0|||
13105865|NCT03315689|25881080|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2|||
13162168|NCT02418754|26091050|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
13162169|NCT02418754|26091051|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
13162170|NCT02418754|26091052|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
13162171|NCT02418754|26091053|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
13162172|NCT02418585|26091098|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
13162173|NCT02418585|26091099|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
13162174|NCT02418585|26091098|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
13162175|NCT02418585|26091099|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
13162176|NCT02418585|26091098|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4|||
13162177|NCT02418585|26091099|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7|||
13162178|NCT02418585|26091098|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2|||
13162179|NCT02418585|26091099|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0|||
13162180|NCT02418585|26091098|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9|||
13162181|NCT02418585|26091099|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1|||
13162182|NCT02418585|26091098|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0|||
13162183|NCT02418585|26091099|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1|||
13162184|NCT02418585|26091098|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
13105866|NCT03315689|25881079|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0|||
13105867|NCT03315689|25881080|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1|||
13105868|NCT03315286|25881103|FG000|Overall Study|Lost to Follow-up|0|||
13105869|NCT03315286|25881104|FG001|Overall Study|Lost to Follow-up|3|||
13105870|NCT03315286|25881103|FG000|Overall Study|Withdrawal by Subject|1|||
13162185|NCT02418585|26091099|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
13162186|NCT02418585|26091098|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6|||
13162187|NCT02418585|26091099|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
13162188|NCT02418585|26091098|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6|||
13162189|NCT02418585|26091099|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17|||
13162190|NCT02418585|26091098|FG000|Follow-up Phase (24 Weeks)|Other|3|||
13162191|NCT02418585|26091099|FG001|Follow-up Phase (24 Weeks)|Other|2|||
13162192|NCT02418468|26091112|FG000|Overall Study|Adverse Event|1|||
13162193|NCT02418468|26091113|FG001|Overall Study|Adverse Event|0|||
13162194|NCT02418468|26091112|FG000|Overall Study|Withdrawal of informed consent|1|||
13162195|NCT02418468|26091113|FG001|Overall Study|Withdrawal of informed consent|1|||
13162196|NCT02418455|26091136|FG000|48-Week Treatment Period|Other- Not Specified|1|||
13162197|NCT02418455|26091136|FG000|Continuation Period|Sponsor Decision|7|||
13162198|NCT02418182|26091155|FG000|Overall Study|Unable to re-consent|18|||
13162199|NCT02418182|26091156|FG001|Overall Study|Unable to re-consent|15|||
13162200|NCT02418182|26091155|FG000|Overall Study|Lost to Follow-up|0|||
13162201|NCT02418182|26091156|FG001|Overall Study|Lost to Follow-up|2|||
13162202|NCT02418156|26091162|FG000|Overall Study|Lost to Follow-up|12|||
13162203|NCT02418156|26091162|FG000|Overall Study|Death|2|||
13162204|NCT02418156|26091162|FG000|Overall Study|Physician Decision|1|||
13162205|NCT02418156|26091162|FG000|Overall Study|Withdrawal by Subject|1|||
13105871|NCT03315286|25881104|FG001|Overall Study|Withdrawal by Subject|0|||
13105872|NCT03315286|25881103|FG000|Overall Study|Protocol Violation|0|||
13105873|NCT03315286|25881104|FG001|Overall Study|Protocol Violation|1|||
13105874|NCT03315208|25881133|FG000|Overall Study|Lost to Follow-up|11|||
13162206|NCT02418156|26091162|FG000|Overall Study|Subject refused to return|1|||
13162207|NCT02418000|26091296|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2|||
13162208|NCT02418000|26091297|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
13162209|NCT02418000|26091298|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
13162210|NCT02418000|26091299|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
13162211|NCT02418000|26091300|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
13162212|NCT02418000|26091296|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4|||
13162213|NCT02418000|26091297|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
13162214|NCT02418000|26091298|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
13162215|NCT02418000|26091299|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
13162216|NCT02418000|26091300|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
13162217|NCT02418000|26091296|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1|||
13162218|NCT02418000|26091297|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
13162219|NCT02418000|26091298|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
13162220|NCT02418000|26091299|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
13162221|NCT02418000|26091300|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
13162222|NCT02418000|26091296|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
13105875|NCT03315208|25881134|FG001|Overall Study|Lost to Follow-up|6|||
13105876|NCT03315208|25881133|FG000|Overall Study|Withdrawal by Subject|2|||
13162223|NCT02418000|26091297|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1|||
13162224|NCT02418000|26091298|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
13162225|NCT02418000|26091299|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
13162226|NCT02418000|26091300|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
13162227|NCT02418000|26091296|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
13162228|NCT02418000|26091297|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9|||
13162229|NCT02418000|26091298|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
13162230|NCT02418000|26091299|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
13162231|NCT02418000|26091300|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
13162232|NCT02418000|26091296|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
13162233|NCT02418000|26091297|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
13162234|NCT02418000|26091298|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
13162235|NCT02418000|26091299|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
13162236|NCT02418000|26091300|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
13162237|NCT02418000|26091296|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
13162238|NCT02418000|26091297|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
13162239|NCT02418000|26091298|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
13162240|NCT02418000|26091299|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
13162241|NCT02418000|26091300|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
13162242|NCT02418000|26091296|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
13162243|NCT02418000|26091297|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
13162244|NCT02418000|26091298|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
13162245|NCT02418000|26091299|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
13162246|NCT02418000|26091300|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1|||
13162247|NCT02418000|26091296|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
13162248|NCT02418000|26091297|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
13162249|NCT02418000|26091298|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
13105877|NCT03315208|25881134|FG001|Overall Study|Withdrawal by Subject|0|||
13105878|NCT03315130|25881188|FG000|Main Portion (12 Weeks)|Subject withdrew consent|0|||
13105879|NCT03315130|25881189|FG001|Main Portion (12 Weeks)|Subject withdrew consent|1|||
13105880|NCT03315130|25881190|FG002|Main Portion (12 Weeks)|Subject withdrew consent|0|||
13105881|NCT03315130|25881191|FG003|Main Portion (12 Weeks)|Subject withdrew consent|0|||
13105882|NCT03315130|25881188|FG000|Main Portion (12 Weeks)|Lost to Follow-up|0|||
13105883|NCT03315130|25881189|FG001|Main Portion (12 Weeks)|Lost to Follow-up|1|||
13105884|NCT03315130|25881190|FG002|Main Portion (12 Weeks)|Lost to Follow-up|0|||
13105885|NCT03315130|25881191|FG003|Main Portion (12 Weeks)|Lost to Follow-up|0|||
13105886|NCT03315130|25881188|FG000|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|1|||
13105887|NCT03315130|25881189|FG001|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
13105888|NCT03315130|25881190|FG002|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
13105889|NCT03315130|25881191|FG003|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
13105890|NCT03315130|25881188|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
13105891|NCT03315130|25881189|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|1|||
13105892|NCT03315130|25881190|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
13105893|NCT03315130|25881191|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
13105894|NCT03315130|25881188|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
13105895|NCT03315130|25881189|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|1|||
13105896|NCT03315130|25881190|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
13105897|NCT03315130|25881191|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
13105898|NCT03315130|25881188|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
13105899|NCT03315130|25881189|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|2|||
13105900|NCT03315130|25881190|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
13105901|NCT03315130|25881191|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|1|||
13105902|NCT03314857|25881199|FG000|Overall Study|Death|4|||
13105903|NCT03314857|25881199|FG000|Overall Study|Physician Decision|1|||
13105904|NCT03314662|25881252|FG000|Overall Study|Withdrawal by Subject|1|||
13105905|NCT03314662|25881253|FG001|Overall Study|Withdrawal by Subject|1|||
13105906|NCT03314662|25881254|FG002|Overall Study|Withdrawal by Subject|1|||
13105907|NCT03314662|25881252|FG000|Overall Study|Lost to Follow-up|5|||
13105908|NCT03314662|25881253|FG001|Overall Study|Lost to Follow-up|4|||
13105909|NCT03314662|25881254|FG002|Overall Study|Lost to Follow-up|4|||
13105910|NCT03314662|25881252|FG000|Overall Study|Death|2|||
13105911|NCT03314662|25881253|FG001|Overall Study|Death|0|||
13105912|NCT03314662|25881254|FG002|Overall Study|Death|0|||
13105913|NCT03314519|25881271|FG000|Overall Study|Protocol Violation|3|||
13105914|NCT03314519|25881272|FG001|Overall Study|Protocol Violation|2|||
13105915|NCT03314233|25881285|FG000|Overall Study|No longer eligible at time of delivery|1|||
13105916|NCT03313310|25881330|FG000|Phase 2|Lost to Follow-up|4|||
13105917|NCT03313310|25881331|FG001|Phase 2|Lost to Follow-up|0|||
13105918|NCT03313310|25881330|FG000|Phase 3|Lost to Follow-up|0|||
13105919|NCT03313310|25881331|FG001|Phase 3|Lost to Follow-up|1|||
13105920|NCT03313076|25881378|FG000|Overall Study|Withdrawal by Subject|2|||
13105921|NCT03313076|25881379|FG001|Overall Study|Withdrawal by Subject|0|||
13105922|NCT03313076|25881380|FG002|Overall Study|Withdrawal by Subject|0|||
13105923|NCT03313076|25881381|FG003|Overall Study|Withdrawal by Subject|0|||
13162250|NCT02418000|26091299|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
13162251|NCT02418000|26091300|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
13162252|NCT02417961|26091312|FG000|Overall Study|Adverse Event|1|||
13162253|NCT02417961|26091312|FG000|Overall Study|Lost to Follow-up|1|||
13162254|NCT02417961|26091312|FG000|Overall Study|Withdrawal by Subject|2|||
13162255|NCT02417935|26091343|FG000|Treatment Period|Adverse Event|12|||
13162256|NCT02417935|26091344|FG001|Treatment Period|Adverse Event|10|||
13162257|NCT02417935|26091343|FG000|Treatment Period|Lost to Follow-up|1|||
13162258|NCT02417935|26091344|FG001|Treatment Period|Lost to Follow-up|0|||
13222835|NCT01802632|26286995|FG005|Overall Study|Withdrawal by Subject|1|||
13105924|NCT03313076|25881378|FG000|Overall Study|Lost to Follow-up|0|||
13105925|NCT03313076|25881379|FG001|Overall Study|Lost to Follow-up|2|||
13105926|NCT03313076|25881380|FG002|Overall Study|Lost to Follow-up|2|||
13105927|NCT03313076|25881381|FG003|Overall Study|Lost to Follow-up|2|||
13105928|NCT03313050|25881432|FG000|Stage 2: 12 Months|Adverse Event|0|||
13105929|NCT03313050|25881433|FG001|Stage 2: 12 Months|Adverse Event|0|||
13105930|NCT03313050|25881434|FG002|Stage 2: 12 Months|Adverse Event|0|||
13105931|NCT03313050|25881435|FG003|Stage 2: 12 Months|Adverse Event|1|||
13105932|NCT03313050|25881432|FG000|Stage 2: 12 Months|Death|0|||
13105933|NCT03313050|25881433|FG001|Stage 2: 12 Months|Death|0|||
13105934|NCT03313050|25881434|FG002|Stage 2: 12 Months|Death|3|||
13105935|NCT03313050|25881435|FG003|Stage 2: 12 Months|Death|0|||
13105936|NCT03313050|25881432|FG000|Stage 2: 12 Months|Lost to Follow-up|0|||
13105937|NCT03313050|25881433|FG001|Stage 2: 12 Months|Lost to Follow-up|0|||
13105938|NCT03313050|25881434|FG002|Stage 2: 12 Months|Lost to Follow-up|1|||
13105939|NCT03313050|25881435|FG003|Stage 2: 12 Months|Lost to Follow-up|5|||
13105940|NCT03313050|25881432|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
13105941|NCT03313050|25881433|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
13105942|NCT03313050|25881434|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
13105943|NCT03313050|25881435|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3|||
13105944|NCT03313050|25881432|FG000|Stage 2: 12 Months|Protocol deviation|0|||
13105945|NCT03313050|25881433|FG001|Stage 2: 12 Months|Protocol deviation|0|||
13105946|NCT03313050|25881434|FG002|Stage 2: 12 Months|Protocol deviation|7|||
13105947|NCT03313050|25881435|FG003|Stage 2: 12 Months|Protocol deviation|7|||
13105948|NCT03313050|25881432|FG000|Stage 2: 12 Months|Withdrawal by Subject|0|||
13105949|NCT03313050|25881433|FG001|Stage 2: 12 Months|Withdrawal by Subject|0|||
13105950|NCT03313050|25881434|FG002|Stage 2: 12 Months|Withdrawal by Subject|0|||
13105951|NCT03313050|25881435|FG003|Stage 2: 12 Months|Withdrawal by Subject|3|||
13105952|NCT03313050|25881432|FG000|Stage 2: 12 Months|Other|0|||
13105953|NCT03313050|25881433|FG001|Stage 2: 12 Months|Other|0|||
13105954|NCT03313050|25881434|FG002|Stage 2: 12 Months|Other|0|||
13222836|NCT01802632|26286990|FG000|Overall Study|Objective Disease Progression|1|||
13222837|NCT01802632|26286991|FG001|Overall Study|Objective Disease Progression|12|||
13162259|NCT02417935|26091343|FG000|Treatment Period|Entry Criteria not met|0|||
13162260|NCT02417935|26091344|FG001|Treatment Period|Entry Criteria not met|1|||
13162261|NCT02417935|26091343|FG000|Treatment Period|Protocol Violation|2|||
13162262|NCT02417935|26091344|FG001|Treatment Period|Protocol Violation|1|||
13162263|NCT02417935|26091343|FG000|Treatment Period|Withdrawal by Subject|3|||
13162264|NCT02417935|26091344|FG001|Treatment Period|Withdrawal by Subject|3|||
13162265|NCT02417935|26091343|FG000|Treatment Period|Physician Decision|3|||
13162266|NCT02417935|26091344|FG001|Treatment Period|Physician Decision|1|||
13162267|NCT02417753|26091356|FG000|Overall Study|Death|1|||
13162268|NCT02417441|26091382|FG000|Overall Study|Inconclusive due to missing data|52|||
13162269|NCT02417441|26091383|FG001|Overall Study|Inconclusive due to missing data|19|||
13162270|NCT02417246|26091410|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
13162271|NCT02417246|26091411|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
13162272|NCT02417246|26091410|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1|||
13162273|NCT02417246|26091411|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0|||
13162274|NCT02417246|26091410|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2|||
13162275|NCT02417246|26091411|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3|||
13162276|NCT02417246|26091410|FG000|Phase 2 1st Generic Administered|Physician Decision|1|||
13162277|NCT02417246|26091411|FG001|Phase 2 1st Generic Administered|Physician Decision|0|||
13162278|NCT02417233|26091444|FG000|Overall Study|Death|4|||
13162279|NCT02417233|26091445|FG001|Overall Study|Death|10|||
13162280|NCT02417233|26091446|FG002|Overall Study|Death|14|||
13162281|NCT02417233|26091444|FG000|Overall Study|Lost to Follow-up|27|||
13222838|NCT01802632|26286992|FG002|Overall Study|Objective Disease Progression|104|||
13105955|NCT03313050|25881435|FG003|Stage 2: 12 Months|Other|1|||
13105956|NCT03313037|25881464|FG000|Overall Study|Protocol Violation|4|||
13105957|NCT03313037|25881465|FG001|Overall Study|Protocol Violation|1|||
13105958|NCT03313037|25881464|FG000|Overall Study|Other|1|||
13105959|NCT03313037|25881465|FG001|Overall Study|Other|1|||
13105960|NCT03313037|25881464|FG000|Overall Study|Withdrawal by Subject|4|||
13105961|NCT03313037|25881465|FG001|Overall Study|Withdrawal by Subject|3|||
13105962|NCT03313037|25881464|FG000|Overall Study|No longer meets eligibility criteria|1|||
13162282|NCT02417233|26091445|FG001|Overall Study|Lost to Follow-up|39|||
13162283|NCT02417233|26091446|FG002|Overall Study|Lost to Follow-up|34|||
13162284|NCT02417233|26091444|FG000|Overall Study|Protocol Violation|2|||
13162285|NCT02417233|26091445|FG001|Overall Study|Protocol Violation|0|||
13162286|NCT02417233|26091446|FG002|Overall Study|Protocol Violation|2|||
13162287|NCT02417233|26091444|FG000|Overall Study|Withdrawal by Subject|2|||
13162288|NCT02417233|26091445|FG001|Overall Study|Withdrawal by Subject|1|||
13162289|NCT02417233|26091446|FG002|Overall Study|Withdrawal by Subject|8|||
13162290|NCT02417233|26091444|FG000|Overall Study|Relocation out of study area|1|||
13162291|NCT02417233|26091445|FG001|Overall Study|Relocation out of study area|0|||
13162292|NCT02417233|26091446|FG002|Overall Study|Relocation out of study area|1|||
13162293|NCT02417233|26091444|FG000|Overall Study|Mentally unstable|0|||
13162294|NCT02417233|26091445|FG001|Overall Study|Mentally unstable|1|||
13162295|NCT02417233|26091446|FG002|Overall Study|Mentally unstable|0|||
13162296|NCT02417064|26091512|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1|||
13162297|NCT02417064|26091513|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7|||
13162298|NCT02417064|26091514|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
13162299|NCT02417064|26091512|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
13162300|NCT02417064|26091513|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
13162301|NCT02417064|26091514|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0|||
13162302|NCT02417064|26091512|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
13162303|NCT02417064|26091513|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
13162304|NCT02417064|26091514|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
13162305|NCT02417064|26091512|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2|||
13162306|NCT02417064|26091513|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
13162307|NCT02417064|26091514|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
13162308|NCT02417064|26091512|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
13162309|NCT02417064|26091513|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5|||
13162310|NCT02417064|26091514|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
13162311|NCT02417064|26091512|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
13162312|NCT02417064|26091513|FG001|Double-blind Induction Phase (4 Weeks)|Other|4|||
13162313|NCT02417064|26091514|FG002|Double-blind Induction Phase (4 Weeks)|Other|2|||
13162314|NCT02417064|26091512|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0|||
13162315|NCT02417064|26091513|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2|||
13162316|NCT02417064|26091514|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1|||
13162317|NCT02417064|26091512|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
13162318|NCT02417064|26091513|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
13162319|NCT02417064|26091514|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1|||
13162320|NCT02417064|26091512|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
13162321|NCT02417064|26091513|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9|||
13162322|NCT02417064|26091514|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2|||
13162323|NCT02417064|26091512|FG000|Follow-up Phase (24 Weeks)|PI Decision|34|||
13162324|NCT02417064|26091513|FG001|Follow-up Phase (24 Weeks)|PI Decision|29|||
13162325|NCT02417064|26091514|FG002|Follow-up Phase (24 Weeks)|PI Decision|44|||
13162326|NCT02417064|26091512|FG000|Follow-up Phase (24 Weeks)|Other|2|||
13162327|NCT02417064|26091513|FG001|Follow-up Phase (24 Weeks)|Other|2|||
13162328|NCT02417064|26091514|FG002|Follow-up Phase (24 Weeks)|Other|3|||
13162329|NCT02416934|26091533|FG000|Overall Study|given steroids|1|||
13162330|NCT02416934|26091534|FG001|Overall Study|given steroids|2|||
13162331|NCT02416934|26091533|FG000|Overall Study|Lost to Follow-up|0|||
13162332|NCT02416934|26091534|FG001|Overall Study|Lost to Follow-up|2|||
13162333|NCT02416934|26091533|FG000|Overall Study|Withdrawal by Subject|1|||
13162334|NCT02416934|26091534|FG001|Overall Study|Withdrawal by Subject|0|||
13162335|NCT02416934|26091533|FG000|Overall Study|recruited during continuing renewal proc|0|||
13162336|NCT02416934|26091534|FG001|Overall Study|recruited during continuing renewal proc|1|||
13162337|NCT02416934|26091533|FG000|Overall Study|Protocol Violation|0|||
13162338|NCT02416934|26091534|FG001|Overall Study|Protocol Violation|1|||
13162339|NCT02416934|26091533|FG000|Overall Study|surgery started late|0|||
13162340|NCT02416934|26091534|FG001|Overall Study|surgery started late|1|||
13162341|NCT02416934|26091533|FG000|Overall Study|re-operation|1|||
13162342|NCT02416934|26091534|FG001|Overall Study|re-operation|0|||
13162343|NCT02416908|26091560|FG000|Dose Escalation Phase|Adverse Event|0|||
13162344|NCT02416908|26091561|FG001|Dose Escalation Phase|Adverse Event|0|||
13162345|NCT02416908|26091562|FG002|Dose Escalation Phase|Adverse Event|3|||
13162346|NCT02416908|26091563|FG003|Dose Escalation Phase|Adverse Event|0|||
13162347|NCT02416908|26091560|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
13162348|NCT02416908|26091561|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
13162349|NCT02416908|26091562|FG002|Dose Escalation Phase|Withdrawal by Subject|1|||
13162350|NCT02416908|26091563|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
13162351|NCT02416791|26091611|FG000|6 Months|Lost to Follow-up|0|||
13162352|NCT02416791|26091612|FG001|6 Months|Lost to Follow-up|0|||
13162353|NCT02416791|26091613|FG002|6 Months|Lost to Follow-up|1|||
13162354|NCT02416453|26091739|FG000|Overall Study|Adverse Event|0|||
13162355|NCT02416453|26091740|FG001|Overall Study|Adverse Event|0|||
13162356|NCT02416453|26091741|FG002|Overall Study|Adverse Event|0|||
13162357|NCT02416453|26091742|FG003|Overall Study|Adverse Event|2|||
13162358|NCT02416453|26091743|FG004|Overall Study|Adverse Event|0|||
13162359|NCT02416453|26091744|FG005|Overall Study|Adverse Event|1|||
13162360|NCT02416453|26091745|FG006|Overall Study|Adverse Event|0|||
13162361|NCT02416453|26091746|FG007|Overall Study|Adverse Event|0|||
13162362|NCT02416453|26091747|FG008|Overall Study|Adverse Event|0|||
13162363|NCT02416453|26091748|FG009|Overall Study|Adverse Event|0|||
13162364|NCT02416453|26091749|FG010|Overall Study|Adverse Event|0|||
13162365|NCT02416453|26091739|FG000|Overall Study|Lost to Follow-up|1|||
13162366|NCT02416453|26091740|FG001|Overall Study|Lost to Follow-up|3|||
13162367|NCT02416453|26091741|FG002|Overall Study|Lost to Follow-up|0|||
13162368|NCT02416453|26091742|FG003|Overall Study|Lost to Follow-up|8|||
13162369|NCT02416453|26091743|FG004|Overall Study|Lost to Follow-up|0|||
13162370|NCT02416453|26091744|FG005|Overall Study|Lost to Follow-up|5|||
13162371|NCT02416453|26091745|FG006|Overall Study|Lost to Follow-up|1|||
13162372|NCT02416453|26091746|FG007|Overall Study|Lost to Follow-up|3|||
13162373|NCT02416453|26091747|FG008|Overall Study|Lost to Follow-up|1|||
13162374|NCT02416453|26091748|FG009|Overall Study|Lost to Follow-up|0|||
13162375|NCT02416453|26091749|FG010|Overall Study|Lost to Follow-up|0|||
13162376|NCT02416453|26091739|FG000|Overall Study|Physician Decision|0|||
13162377|NCT02416453|26091740|FG001|Overall Study|Physician Decision|0|||
13162378|NCT02416453|26091741|FG002|Overall Study|Physician Decision|0|||
13162379|NCT02416453|26091742|FG003|Overall Study|Physician Decision|0|||
13162380|NCT02416453|26091743|FG004|Overall Study|Physician Decision|0|||
13162381|NCT02416453|26091744|FG005|Overall Study|Physician Decision|1|||
13162382|NCT02416453|26091745|FG006|Overall Study|Physician Decision|1|||
13162383|NCT02416453|26091746|FG007|Overall Study|Physician Decision|1|||
13162384|NCT02416453|26091747|FG008|Overall Study|Physician Decision|0|||
13162385|NCT02416453|26091748|FG009|Overall Study|Physician Decision|0|||
13162386|NCT02416453|26091749|FG010|Overall Study|Physician Decision|0|||
13162387|NCT02416453|26091739|FG000|Overall Study|Withdrawal by Subject|2|||
13162388|NCT02416453|26091740|FG001|Overall Study|Withdrawal by Subject|0|||
13162389|NCT02416453|26091741|FG002|Overall Study|Withdrawal by Subject|0|||
13162390|NCT02416453|26091742|FG003|Overall Study|Withdrawal by Subject|5|||
13162391|NCT02416453|26091743|FG004|Overall Study|Withdrawal by Subject|1|||
13162392|NCT02416453|26091744|FG005|Overall Study|Withdrawal by Subject|8|||
13162393|NCT02416453|26091745|FG006|Overall Study|Withdrawal by Subject|0|||
13162394|NCT02416453|26091746|FG007|Overall Study|Withdrawal by Subject|8|||
13162395|NCT02416453|26091747|FG008|Overall Study|Withdrawal by Subject|4|||
13162396|NCT02416453|26091748|FG009|Overall Study|Withdrawal by Subject|0|||
13162397|NCT02416453|26091749|FG010|Overall Study|Withdrawal by Subject|0|||
13162398|NCT02416453|26091739|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
13162399|NCT02416453|26091740|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
13162400|NCT02416453|26091741|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1|||
13162401|NCT02416453|26091742|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
13162402|NCT02416453|26091743|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
13162403|NCT02416453|26091744|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
13162404|NCT02416453|26091745|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
13162405|NCT02416453|26091746|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
13162406|NCT02416453|26091747|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
13162407|NCT02416453|26091748|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
13162408|NCT02416453|26091749|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
13162409|NCT02416453|26091739|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
13162410|NCT02416453|26091740|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
13162411|NCT02416453|26091741|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
13162412|NCT02416453|26091742|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
13162413|NCT02416453|26091743|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
13162414|NCT02416453|26091744|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1|||
13162415|NCT02416453|26091745|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
13162416|NCT02416453|26091746|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
13162417|NCT02416453|26091747|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
13162418|NCT02416453|26091748|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
13162419|NCT02416453|26091749|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
13162420|NCT02416180|26091758|FG000|Overall Study|Withdrawal by Subject|1|||
13162421|NCT02415959|26091806|FG000|Overall Study|Adverse Event|0|||
13162422|NCT02415959|26091807|FG001|Overall Study|Adverse Event|1|||
13162423|NCT02415959|26091808|FG002|Overall Study|Adverse Event|0|||
13162424|NCT02415959|26091809|FG003|Overall Study|Adverse Event|0|||
13162425|NCT02415959|26091810|FG004|Overall Study|Adverse Event|0|||
13162426|NCT02415959|26091806|FG000|Overall Study|Protocol Violation|0|||
13162427|NCT02415959|26091807|FG001|Overall Study|Protocol Violation|0|||
13162428|NCT02415959|26091808|FG002|Overall Study|Protocol Violation|0|||
13162429|NCT02415959|26091809|FG003|Overall Study|Protocol Violation|1|||
13162430|NCT02415959|26091810|FG004|Overall Study|Protocol Violation|0|||
13162431|NCT02415595|26091882|FG000|Overall Study|Administrative reason by sponsor|39|||
13162432|NCT02415595|26091883|FG001|Overall Study|Administrative reason by sponsor|40|||
13162433|NCT02415595|26091884|FG002|Overall Study|Administrative reason by sponsor|41|||
13162434|NCT02415595|26091885|FG003|Overall Study|Administrative reason by sponsor|39|||
13162435|NCT02415595|26091882|FG000|Overall Study|Adverse Event|1|||
13162436|NCT02415595|26091883|FG001|Overall Study|Adverse Event|3|||
13162437|NCT02415595|26091884|FG002|Overall Study|Adverse Event|5|||
13162438|NCT02415595|26091885|FG003|Overall Study|Adverse Event|10|||
13162439|NCT02415595|26091882|FG000|Overall Study|Lack of Efficacy|4|||
13162440|NCT02415595|26091883|FG001|Overall Study|Lack of Efficacy|4|||
13162441|NCT02415595|26091884|FG002|Overall Study|Lack of Efficacy|0|||
13162442|NCT02415595|26091885|FG003|Overall Study|Lack of Efficacy|0|||
13162443|NCT02415595|26091882|FG000|Overall Study|Lost to Follow-up|1|||
13162444|NCT02415595|26091883|FG001|Overall Study|Lost to Follow-up|3|||
13162445|NCT02415595|26091884|FG002|Overall Study|Lost to Follow-up|1|||
13162446|NCT02415595|26091885|FG003|Overall Study|Lost to Follow-up|1|||
13162447|NCT02415595|26091882|FG000|Overall Study|Poor/Non-compliance|1|||
13162448|NCT02415595|26091883|FG001|Overall Study|Poor/Non-compliance|0|||
13162449|NCT02415595|26091884|FG002|Overall Study|Poor/Non-compliance|1|||
13162450|NCT02415595|26091885|FG003|Overall Study|Poor/Non-compliance|0|||
13162451|NCT02415595|26091882|FG000|Overall Study|Reached stopping criteria|0|||
13162452|NCT02415595|26091883|FG001|Overall Study|Reached stopping criteria|1|||
13162453|NCT02415595|26091884|FG002|Overall Study|Reached stopping criteria|1|||
13162454|NCT02415595|26091885|FG003|Overall Study|Reached stopping criteria|0|||
13162455|NCT02415595|26091882|FG000|Overall Study|Withdrawal by Subject|4|||
13162456|NCT02415595|26091883|FG001|Overall Study|Withdrawal by Subject|0|||
13162457|NCT02415595|26091884|FG002|Overall Study|Withdrawal by Subject|1|||
13162458|NCT02415595|26091885|FG003|Overall Study|Withdrawal by Subject|3|||
13162459|NCT02415595|26091882|FG000|Overall Study|Other|0|||
13162460|NCT02415595|26091883|FG001|Overall Study|Other|1|||
13162461|NCT02415595|26091884|FG002|Overall Study|Other|1|||
13162462|NCT02415595|26091885|FG003|Overall Study|Other|0|||
13162463|NCT02415556|26091932|FG000|Overall Study|Adverse Event|3|||
13162464|NCT02415556|26091933|FG001|Overall Study|Adverse Event|4|||
13162465|NCT02415556|26091934|FG002|Overall Study|Adverse Event|2|||
13162466|NCT02415556|26091935|FG003|Overall Study|Adverse Event|4|||
13162467|NCT02415556|26091932|FG000|Overall Study|Lost to Follow-up|4|||
13162468|NCT02415556|26091933|FG001|Overall Study|Lost to Follow-up|5|||
13162469|NCT02415556|26091934|FG002|Overall Study|Lost to Follow-up|4|||
13162470|NCT02415556|26091935|FG003|Overall Study|Lost to Follow-up|1|||
13162471|NCT02415556|26091932|FG000|Overall Study|Withdrawal by Subject|13|||
13162472|NCT02415556|26091933|FG001|Overall Study|Withdrawal by Subject|4|||
13162473|NCT02415556|26091934|FG002|Overall Study|Withdrawal by Subject|14|||
13162474|NCT02415556|26091935|FG003|Overall Study|Withdrawal by Subject|12|||
13162475|NCT02415556|26091932|FG000|Overall Study|Physician Decision|1|||
13162476|NCT02415556|26091933|FG001|Overall Study|Physician Decision|3|||
13162477|NCT02415556|26091934|FG002|Overall Study|Physician Decision|1|||
13162478|NCT02415556|26091935|FG003|Overall Study|Physician Decision|2|||
13162479|NCT02415556|26091932|FG000|Overall Study|Censored - study completion|4|||
13162480|NCT02415556|26091933|FG001|Overall Study|Censored - study completion|5|||
13162481|NCT02415556|26091934|FG002|Overall Study|Censored - study completion|1|||
13162482|NCT02415556|26091935|FG003|Overall Study|Censored - study completion|0|||
13162483|NCT02415556|26091932|FG000|Overall Study|Family-related issues|0|||
13162484|NCT02415556|26091933|FG001|Overall Study|Family-related issues|0|||
13162485|NCT02415556|26091934|FG002|Overall Study|Family-related issues|0|||
13162486|NCT02415556|26091935|FG003|Overall Study|Family-related issues|1|||
13162487|NCT02415400|26091972|FG000|Overall Study|Adverse Event|0|||
13162488|NCT02415400|26091973|FG001|Overall Study|Adverse Event|1|||
13162489|NCT02415400|26091974|FG002|Overall Study|Adverse Event|1|||
13162490|NCT02415400|26091975|FG003|Overall Study|Adverse Event|2|||
13162491|NCT02415400|26091972|FG000|Overall Study|Participant request to stop therapy|4|||
13162492|NCT02415400|26091973|FG001|Overall Study|Participant request to stop therapy|3|||
13162493|NCT02415400|26091974|FG002|Overall Study|Participant request to stop therapy|8|||
13162494|NCT02415400|26091975|FG003|Overall Study|Participant request to stop therapy|6|||
13162495|NCT02415400|26091972|FG000|Overall Study|Participant withdrew consent|14|||
13162496|NCT02415400|26091973|FG001|Overall Study|Participant withdrew consent|12|||
13162497|NCT02415400|26091974|FG002|Overall Study|Participant withdrew consent|30|||
13162498|NCT02415400|26091975|FG003|Overall Study|Participant withdrew consent|21|||
13162499|NCT02415400|26091972|FG000|Overall Study|Death|39|||
13162500|NCT02415400|26091973|FG001|Overall Study|Death|41|||
13162501|NCT02415400|26091974|FG002|Overall Study|Death|35|||
13162502|NCT02415400|26091975|FG003|Overall Study|Death|42|||
13162503|NCT02415400|26091972|FG000|Overall Study|Lost to Follow-up|3|||
13162504|NCT02415400|26091973|FG001|Overall Study|Lost to Follow-up|3|||
13162505|NCT02415400|26091974|FG002|Overall Study|Lost to Follow-up|2|||
13162506|NCT02415400|26091975|FG003|Overall Study|Lost to Follow-up|5|||
13162507|NCT02415400|26091972|FG000|Overall Study|Poor/Non-Compliance|0|||
13162508|NCT02415400|26091973|FG001|Overall Study|Poor/Non-Compliance|1|||
13162509|NCT02415400|26091974|FG002|Overall Study|Poor/Non-Compliance|3|||
13162510|NCT02415400|26091975|FG003|Overall Study|Poor/Non-Compliance|4|||
13162511|NCT02415400|26091972|FG000|Overall Study|Participant no longer meets criteria|2|||
13162512|NCT02415400|26091973|FG001|Overall Study|Participant no longer meets criteria|0|||
13222839|NCT01802632|26286993|FG003|Overall Study|Objective Disease Progression|6|||
13222840|NCT01802632|26286994|FG004|Overall Study|Objective Disease Progression|4|||
13105963|NCT03313037|25881465|FG001|Overall Study|No longer meets eligibility criteria|7|||
13105964|NCT03313037|25881464|FG000|Overall Study|Lost to Follow-up|9|||
13105965|NCT03313037|25881465|FG001|Overall Study|Lost to Follow-up|8|||
13105966|NCT03313037|25881464|FG000|Overall Study|Randomized but not treated|1|||
13162513|NCT02415400|26091974|FG002|Overall Study|Participant no longer meets criteria|0|||
13162514|NCT02415400|26091975|FG003|Overall Study|Participant no longer meets criteria|1|||
13162515|NCT02415400|26091972|FG000|Overall Study|Participant doesn't answer phone|1|||
13162516|NCT02415400|26091973|FG001|Overall Study|Participant doesn't answer phone|0|||
13162517|NCT02415400|26091974|FG002|Overall Study|Participant doesn't answer phone|0|||
13162518|NCT02415400|26091975|FG003|Overall Study|Participant doesn't answer phone|0|||
13162519|NCT02415400|26091972|FG000|Overall Study|Participant wanted home visits|1|||
13162520|NCT02415400|26091973|FG001|Overall Study|Participant wanted home visits|0|||
13162521|NCT02415400|26091974|FG002|Overall Study|Participant wanted home visits|0|||
13162522|NCT02415400|26091975|FG003|Overall Study|Participant wanted home visits|0|||
13162523|NCT02415400|26091972|FG000|Overall Study|Randomized in error|2|||
13162524|NCT02415400|26091973|FG001|Overall Study|Randomized in error|0|||
13162525|NCT02415400|26091974|FG002|Overall Study|Randomized in error|0|||
13162526|NCT02415400|26091975|FG003|Overall Study|Randomized in error|0|||
13162527|NCT02415400|26091972|FG000|Overall Study|No study drug on site|0|||
13162528|NCT02415400|26091973|FG001|Overall Study|No study drug on site|1|||
13162529|NCT02415400|26091974|FG002|Overall Study|No study drug on site|0|||
13162530|NCT02415400|26091975|FG003|Overall Study|No study drug on site|0|||
13162531|NCT02415400|26091972|FG000|Overall Study|Stroke and stroke rehabilitation|0|||
13162532|NCT02415400|26091973|FG001|Overall Study|Stroke and stroke rehabilitation|0|||
13162533|NCT02415400|26091974|FG002|Overall Study|Stroke and stroke rehabilitation|1|||
13162534|NCT02415400|26091975|FG003|Overall Study|Stroke and stroke rehabilitation|0|||
13162535|NCT02415400|26091972|FG000|Overall Study|Coagulation values cannot be set|0|||
13162536|NCT02415400|26091973|FG001|Overall Study|Coagulation values cannot be set|0|||
13162537|NCT02415400|26091974|FG002|Overall Study|Coagulation values cannot be set|1|||
13162538|NCT02415400|26091975|FG003|Overall Study|Coagulation values cannot be set|0|||
13162539|NCT02415400|26091972|FG000|Overall Study|State regulations prevent participation|0|||
13162540|NCT02415400|26091973|FG001|Overall Study|State regulations prevent participation|0|||
13105967|NCT03313037|25881465|FG001|Overall Study|Randomized but not treated|0|||
13105968|NCT03312933|25881471|FG000|Overall Study|Protocol Violation|15|||
13105969|NCT03312933|25881471|FG000|Overall Study|Lost to Follow-up|36|||
13105970|NCT03312933|25881471|FG000|Overall Study|Withdrawal by Subject|3|||
13105971|NCT03312907|25881570|FG000|Overall Study|Adverse Event|1|||
13162541|NCT02415400|26091974|FG002|Overall Study|State regulations prevent participation|1|||
13162542|NCT02415400|26091975|FG003|Overall Study|State regulations prevent participation|0|||
13162543|NCT02415400|26091972|FG000|Overall Study|Poor treatment monitoring|0|||
13162544|NCT02415400|26091973|FG001|Overall Study|Poor treatment monitoring|0|||
13162545|NCT02415400|26091974|FG002|Overall Study|Poor treatment monitoring|1|||
13162546|NCT02415400|26091975|FG003|Overall Study|Poor treatment monitoring|0|||
13162547|NCT02415400|26091972|FG000|Overall Study|Participant in jail|0|||
13162548|NCT02415400|26091973|FG001|Overall Study|Participant in jail|0|||
13162549|NCT02415400|26091974|FG002|Overall Study|Participant in jail|1|||
13162550|NCT02415400|26091975|FG003|Overall Study|Participant in jail|0|||
13162551|NCT02415400|26091972|FG000|Overall Study|Investigator decision|0|||
13162552|NCT02415400|26091973|FG001|Overall Study|Investigator decision|0|||
13162553|NCT02415400|26091974|FG002|Overall Study|Investigator decision|1|||
13162554|NCT02415400|26091975|FG003|Overall Study|Investigator decision|1|||
13162555|NCT02415400|26091972|FG000|Overall Study|Site closure; participant won't transfer|0|||
13162556|NCT02415400|26091973|FG001|Overall Study|Site closure; participant won't transfer|0|||
13162557|NCT02415400|26091974|FG002|Overall Study|Site closure; participant won't transfer|0|||
13162558|NCT02415400|26091975|FG003|Overall Study|Site closure; participant won't transfer|1|||
13222841|NCT01802632|26286995|FG005|Overall Study|Objective Disease Progression|4|||
13105972|NCT03312907|25881571|FG001|Overall Study|Adverse Event|6|||
13105973|NCT03312907|25881572|FG002|Overall Study|Adverse Event|1|||
13105974|NCT03312907|25881570|FG000|Overall Study|Protocol Violation|2|||
13105975|NCT03312907|25881571|FG001|Overall Study|Protocol Violation|3|||
13105976|NCT03312907|25881572|FG002|Overall Study|Protocol Violation|4|||
13105977|NCT03312907|25881570|FG000|Overall Study|Lost to Follow-up|2|||
13105978|NCT03312907|25881571|FG001|Overall Study|Lost to Follow-up|3|||
13105979|NCT03312907|25881572|FG002|Overall Study|Lost to Follow-up|2|||
13105980|NCT03312907|25881570|FG000|Overall Study|Physician Decision|3|||
13105981|NCT03312907|25881571|FG001|Overall Study|Physician Decision|4|||
13105982|NCT03312907|25881572|FG002|Overall Study|Physician Decision|2|||
13162559|NCT02415127|26091996|FG000|Overall Study|Adverse Event|1|||
13162560|NCT02415127|26091997|FG001|Overall Study|Adverse Event|0|||
13162561|NCT02414958|26092036|FG000|Overall Study|Adverse Event|6|||
13162562|NCT02414958|26092037|FG001|Overall Study|Adverse Event|6|||
13162563|NCT02414958|26092038|FG002|Overall Study|Adverse Event|3|||
13162564|NCT02414958|26092036|FG000|Overall Study|Protocol Violation|10|||
13162565|NCT02414958|26092037|FG001|Overall Study|Protocol Violation|3|||
13162566|NCT02414958|26092038|FG002|Overall Study|Protocol Violation|1|||
13162567|NCT02414958|26092036|FG000|Overall Study|Lost to Follow-up|7|||
13162568|NCT02414958|26092037|FG001|Overall Study|Lost to Follow-up|4|||
13162569|NCT02414958|26092038|FG002|Overall Study|Lost to Follow-up|0|||
13162570|NCT02414958|26092036|FG000|Overall Study|Withdrawal by Subject|5|||
13162571|NCT02414958|26092037|FG001|Overall Study|Withdrawal by Subject|3|||
13162572|NCT02414958|26092038|FG002|Overall Study|Withdrawal by Subject|5|||
13162573|NCT02414958|26092036|FG000|Overall Study|Other than specified|4|||
13162574|NCT02414958|26092037|FG001|Overall Study|Other than specified|4|||
13162575|NCT02414958|26092038|FG002|Overall Study|Other than specified|5|||
13162576|NCT02414932|26092053|FG000|Overall Study|Withdrawal by Subject|2|||
13162577|NCT02414932|26092054|FG001|Overall Study|Withdrawal by Subject|3|||
13162578|NCT02414932|26092053|FG000|Overall Study|Adverse Event|1|||
13162579|NCT02414932|26092054|FG001|Overall Study|Adverse Event|0|||
13162580|NCT02414854|26092229|FG000|Overall Study|Adverse Event|9|||
13162581|NCT02414854|26092230|FG001|Overall Study|Adverse Event|7|||
13162582|NCT02414854|26092231|FG002|Overall Study|Adverse Event|1|||
13162583|NCT02414854|26092232|FG003|Overall Study|Adverse Event|12|||
13162584|NCT02414854|26092229|FG000|Overall Study|Poor compliance to protocol|1|||
13162585|NCT02414854|26092230|FG001|Overall Study|Poor compliance to protocol|1|||
13162586|NCT02414854|26092231|FG002|Overall Study|Poor compliance to protocol|2|||
13162587|NCT02414854|26092232|FG003|Overall Study|Poor compliance to protocol|2|||
13162588|NCT02414854|26092229|FG000|Overall Study|Other than specified above|12|||
13162589|NCT02414854|26092230|FG001|Overall Study|Other than specified above|37|||
13162590|NCT02414854|26092231|FG002|Overall Study|Other than specified above|17|||
13162591|NCT02414854|26092232|FG003|Overall Study|Other than specified above|37|||
13162592|NCT02414841|26092247|FG000|Overall Study|Withdrawal by Subject|7|||
13162593|NCT02414841|26092248|FG001|Overall Study|Withdrawal by Subject|5|||
13162594|NCT02414841|26092247|FG000|Overall Study|Lost to Follow-up|13|||
13162595|NCT02414841|26092248|FG001|Overall Study|Lost to Follow-up|6|||
13162596|NCT02414841|26092247|FG000|Overall Study|Death|17|||
13162597|NCT02414841|26092248|FG001|Overall Study|Death|14|||
13162598|NCT02414841|26092247|FG000|Overall Study|Received a Kidney Transplant|13|||
13162599|NCT02414841|26092248|FG001|Overall Study|Received a Kidney Transplant|4|||
13162600|NCT02414841|26092247|FG000|Overall Study|Randomized But Not Treated|6|||
13162601|NCT02414841|26092248|FG001|Overall Study|Randomized But Not Treated|4|||
13162602|NCT02414828|26092299|FG000|Overall Study|Lost to Follow-up|0|||
13162603|NCT02414828|26092300|FG001|Overall Study|Lost to Follow-up|1|||
13162604|NCT02414828|26092301|FG002|Overall Study|Lost to Follow-up|1|||
13162605|NCT02414828|26092302|FG003|Overall Study|Lost to Follow-up|2|||
13162606|NCT02414152|26092308|FG000|Overall Study|Withdrawal by Subject|1|||
13162607|NCT02414152|26092308|FG000|Overall Study|Lack of Efficacy|1|||
13162608|NCT02413996|26092337|FG000|Overall Study|not comfortable with the intervention|9|||
13162609|NCT02413996|26092338|FG001|Overall Study|not comfortable with the intervention|2|||
13162610|NCT02413593|26092349|FG000|Overall Study|Lost to Follow-up|3|||
13162611|NCT02413593|26092349|FG000|Overall Study|Adverse Event|1|||
13162612|NCT02413489|26092379|FG000|Overall Study|Death|11|||
13162613|NCT02413489|26092380|FG001|Overall Study|Death|3|||
13162614|NCT02413489|26092381|FG002|Overall Study|Death|4|||
13162615|NCT02413489|26092379|FG000|Overall Study|Withdrawal by Subject|2|||
13162616|NCT02413489|26092380|FG001|Overall Study|Withdrawal by Subject|0|||
13162617|NCT02413489|26092381|FG002|Overall Study|Withdrawal by Subject|0|||
13162618|NCT02413489|26092379|FG000|Overall Study|Study Terminated By Sponsor|2|||
13162619|NCT02413489|26092380|FG001|Overall Study|Study Terminated By Sponsor|13|||
13162620|NCT02413489|26092381|FG002|Overall Study|Study Terminated By Sponsor|1|||
13162621|NCT02413398|26092400|FG000|Overall Study|Lost to Follow-up|2|||
13162622|NCT02413398|26092401|FG001|Overall Study|Lost to Follow-up|4|||
13162623|NCT02413398|26092400|FG000|Overall Study|Withdrawal by Subject|1|||
13162624|NCT02413398|26092401|FG001|Overall Study|Withdrawal by Subject|1|||
13162625|NCT02413398|26092400|FG000|Overall Study|Other Eligibility criteria|1|||
13162626|NCT02413398|26092401|FG001|Overall Study|Other Eligibility criteria|2|||
13162627|NCT02413372|26092458|FG000|Treatment|Lost to Follow-up|0|||
13162628|NCT02413372|26092459|FG001|Treatment|Lost to Follow-up|2|||
13162629|NCT02413372|26092460|FG002|Treatment|Lost to Follow-up|1|||
13162630|NCT02413372|26092458|FG000|Treatment|Withdrawal by Subject|1|||
13162631|NCT02413372|26092459|FG001|Treatment|Withdrawal by Subject|0|||
13162632|NCT02413372|26092460|FG002|Treatment|Withdrawal by Subject|0|||
13162633|NCT02413372|26092458|FG000|Follow-up|Lost to Follow-up|1|||
13162634|NCT02413372|26092459|FG001|Follow-up|Lost to Follow-up|1|||
13162635|NCT02413372|26092460|FG002|Follow-up|Lost to Follow-up|0|||
13162636|NCT02413372|26092458|FG000|Follow-up|Subject Withdrew Consent|1|||
13162637|NCT02413372|26092459|FG001|Follow-up|Subject Withdrew Consent|0|||
13162638|NCT02413372|26092460|FG002|Follow-up|Subject Withdrew Consent|1|||
13162639|NCT02413372|26092458|FG000|Follow-up|Subject unable to return for visit|0|||
13162640|NCT02413372|26092459|FG001|Follow-up|Subject unable to return for visit|0|||
13162641|NCT02413372|26092460|FG002|Follow-up|Subject unable to return for visit|1|||
13162642|NCT02413346|26092473|FG000|Overall Study|Adverse Event|6|||
13105983|NCT03312907|25881570|FG000|Overall Study|Withdrawal by Subject|9|||
13105984|NCT03312907|25881571|FG001|Overall Study|Withdrawal by Subject|14|||
13105985|NCT03312907|25881572|FG002|Overall Study|Withdrawal by Subject|10|||
13105986|NCT03312543|25881653|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0|||
13105987|NCT03312543|25881654|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2|||
13105988|NCT03312543|25881653|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1|||
13105989|NCT03312543|25881654|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2|||
13162643|NCT02413346|26092474|FG001|Overall Study|Adverse Event|6|||
13162644|NCT02413346|26092473|FG000|Overall Study|Withdrawal by Subject|30|||
13162645|NCT02413346|26092474|FG001|Overall Study|Withdrawal by Subject|40|||
13162646|NCT02413346|26092473|FG000|Overall Study|Lost to Follow-up|17|||
13162647|NCT02413346|26092474|FG001|Overall Study|Lost to Follow-up|21|||
13162648|NCT02413346|26092473|FG000|Overall Study|Protocol Violation|2|||
13162649|NCT02413346|26092474|FG001|Overall Study|Protocol Violation|0|||
13162650|NCT02413346|26092473|FG000|Overall Study|Other Miscellaneous Reasons|4|||
13162651|NCT02413346|26092474|FG001|Overall Study|Other Miscellaneous Reasons|3|||
13162652|NCT02413333|26092493|FG000|Period 1|Adverse Event|1|||
13162653|NCT02413333|26092494|FG001|Period 1|Adverse Event|0|||
13162654|NCT02413333|26092493|FG000|Period 1|Reason Not Specified|0|||
13162655|NCT02413333|26092494|FG001|Period 1|Reason Not Specified|1|||
13162656|NCT02413333|26092493|FG000|Period 2|Protocol Deviation|1|||
13162657|NCT02413333|26092494|FG001|Period 2|Protocol Deviation|0|||
13162658|NCT02413294|26092514|FG000|Overall Study|Withdrawal by Subject|1|||
13162659|NCT02413255|26092914|FG000|Overall Study|Voluntary Withdrawal|0|||
13162660|NCT02413255|26092915|FG001|Overall Study|Voluntary Withdrawal|0|||
13162661|NCT02413255|26092916|FG002|Overall Study|Voluntary Withdrawal|0|||
13162662|NCT02413255|26092917|FG003|Overall Study|Voluntary Withdrawal|0|||
13162663|NCT02413255|26092918|FG004|Overall Study|Voluntary Withdrawal|0|||
13162664|NCT02413255|26092919|FG005|Overall Study|Voluntary Withdrawal|0|||
13162665|NCT02413255|26092920|FG006|Overall Study|Voluntary Withdrawal|0|||
13162666|NCT02413255|26092921|FG007|Overall Study|Voluntary Withdrawal|0|||
13162667|NCT02413255|26092922|FG008|Overall Study|Voluntary Withdrawal|0|||
13162668|NCT02413255|26092923|FG009|Overall Study|Voluntary Withdrawal|0|||
13162669|NCT02413255|26092924|FG010|Overall Study|Voluntary Withdrawal|0|||
13162670|NCT02413255|26092925|FG011|Overall Study|Voluntary Withdrawal|0|||
13162671|NCT02413255|26092926|FG012|Overall Study|Voluntary Withdrawal|0|||
13162672|NCT02413255|26092927|FG013|Overall Study|Voluntary Withdrawal|0|||
13162673|NCT02413255|26092928|FG014|Overall Study|Voluntary Withdrawal|1|||
13162674|NCT02413255|26092929|FG015|Overall Study|Voluntary Withdrawal|0|||
13162675|NCT02413255|26092930|FG016|Overall Study|Voluntary Withdrawal|0|||
13162676|NCT02413229|26092973|FG000|Overall Study|Adverse Event|0|||
13162677|NCT02413229|26092974|FG001|Overall Study|Adverse Event|0|||
13162678|NCT02413229|26092975|FG002|Overall Study|Adverse Event|0|||
13162679|NCT02413229|26092976|FG003|Overall Study|Adverse Event|1|||
13162680|NCT02413229|26092977|FG004|Overall Study|Adverse Event|0|||
13162681|NCT02413229|26092978|FG005|Overall Study|Adverse Event|0|||
13162682|NCT02413229|26092979|FG006|Overall Study|Adverse Event|0|||
13162683|NCT02413229|26092980|FG007|Overall Study|Adverse Event|1|||
13162684|NCT02413229|26092973|FG000|Overall Study|Lost to Follow-up|0|||
13162685|NCT02413229|26092974|FG001|Overall Study|Lost to Follow-up|0|||
13162686|NCT02413229|26092975|FG002|Overall Study|Lost to Follow-up|1|||
13162687|NCT02413229|26092976|FG003|Overall Study|Lost to Follow-up|0|||
13162688|NCT02413229|26092977|FG004|Overall Study|Lost to Follow-up|2|||
13162689|NCT02413229|26092978|FG005|Overall Study|Lost to Follow-up|0|||
13162690|NCT02413229|26092979|FG006|Overall Study|Lost to Follow-up|0|||
13162691|NCT02413229|26092980|FG007|Overall Study|Lost to Follow-up|0|||
13162692|NCT02413229|26092973|FG000|Overall Study|Withdrawal by Subject|1|||
13162693|NCT02413229|26092974|FG001|Overall Study|Withdrawal by Subject|1|||
13162694|NCT02413229|26092975|FG002|Overall Study|Withdrawal by Subject|0|||
13162695|NCT02413229|26092976|FG003|Overall Study|Withdrawal by Subject|0|||
13162696|NCT02413229|26092977|FG004|Overall Study|Withdrawal by Subject|1|||
13162697|NCT02413229|26092978|FG005|Overall Study|Withdrawal by Subject|0|||
13162698|NCT02413229|26092979|FG006|Overall Study|Withdrawal by Subject|0|||
13162699|NCT02413229|26092980|FG007|Overall Study|Withdrawal by Subject|2|||
13162700|NCT02413229|26092973|FG000|Overall Study|Progressive Disease|0|||
13162701|NCT02413229|26092974|FG001|Overall Study|Progressive Disease|0|||
13162702|NCT02413229|26092975|FG002|Overall Study|Progressive Disease|0|||
13162703|NCT02413229|26092976|FG003|Overall Study|Progressive Disease|0|||
13162704|NCT02413229|26092977|FG004|Overall Study|Progressive Disease|0|||
13162705|NCT02413229|26092978|FG005|Overall Study|Progressive Disease|0|||
13162706|NCT02413229|26092979|FG006|Overall Study|Progressive Disease|0|||
13162707|NCT02413229|26092980|FG007|Overall Study|Progressive Disease|1|||
13162708|NCT02412878|26093001|FG000|Overall Study|Withdrawal by Subject|19|||
13162709|NCT02412878|26093002|FG001|Overall Study|Withdrawal by Subject|10|||
13162710|NCT02412878|26093001|FG000|Overall Study|Lost to Follow-up|2|||
13162711|NCT02412878|26093002|FG001|Overall Study|Lost to Follow-up|3|||
13162712|NCT02412852|26093041|FG000|Overall Study|Withdrawal by Subject|0|||
13162713|NCT02412852|26093042|FG001|Overall Study|Withdrawal by Subject|1|||
13162714|NCT02412852|26093043|FG002|Overall Study|Withdrawal by Subject|0|||
13162715|NCT02412852|26093044|FG003|Overall Study|Withdrawal by Subject|0|||
13162716|NCT02412852|26093041|FG000|Overall Study|Physician Decision|0|||
13162717|NCT02412852|26093042|FG001|Overall Study|Physician Decision|0|||
13162718|NCT02412852|26093043|FG002|Overall Study|Physician Decision|0|||
13162719|NCT02412852|26093044|FG003|Overall Study|Physician Decision|1|||
13162720|NCT02412761|26093059|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
13162721|NCT02412761|26093060|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
13162722|NCT02412761|26093061|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
13162723|NCT02412761|26093062|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
13162724|NCT02412761|26093063|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
13162725|NCT02412761|26093064|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
13162726|NCT02412735|26093103|FG000|Overall Study|Adverse Event|0|||
13162727|NCT02412735|26093104|FG001|Overall Study|Adverse Event|1|||
13162728|NCT02412735|26093105|FG002|Overall Study|Adverse Event|2|||
13162729|NCT02412735|26093103|FG000|Overall Study|Withdrawal by Subject|23|||
13162730|NCT02412735|26093104|FG001|Overall Study|Withdrawal by Subject|27|||
13162731|NCT02412735|26093105|FG002|Overall Study|Withdrawal by Subject|22|||
13162732|NCT02412735|26093103|FG000|Overall Study|Investigator Decision|3|||
13162733|NCT02412735|26093104|FG001|Overall Study|Investigator Decision|3|||
13162734|NCT02412735|26093105|FG002|Overall Study|Investigator Decision|2|||
13162735|NCT02412735|26093103|FG000|Overall Study|Lost to Follow-up|17|||
13162736|NCT02412735|26093104|FG001|Overall Study|Lost to Follow-up|11|||
13162737|NCT02412735|26093105|FG002|Overall Study|Lost to Follow-up|18|||
13162738|NCT02412735|26093103|FG000|Overall Study|Reason not Specified|3|||
13162739|NCT02412735|26093104|FG001|Overall Study|Reason not Specified|2|||
13162740|NCT02412735|26093105|FG002|Overall Study|Reason not Specified|2|||
13162741|NCT02412722|26093192|FG000|Overall Study|Adverse Event|0|||
13162742|NCT02412722|26093193|FG001|Overall Study|Adverse Event|2|||
13162743|NCT02412722|26093194|FG002|Overall Study|Adverse Event|0|||
13162744|NCT02412722|26093195|FG003|Overall Study|Adverse Event|3|||
13162745|NCT02412722|26093196|FG004|Overall Study|Adverse Event|0|||
13162746|NCT02412722|26093197|FG005|Overall Study|Adverse Event|3|||
13162747|NCT02412722|26093192|FG000|Overall Study|Progressive Disease|6|||
13162748|NCT02412722|26093193|FG001|Overall Study|Progressive Disease|4|||
13162749|NCT02412722|26093194|FG002|Overall Study|Progressive Disease|4|||
13162750|NCT02412722|26093195|FG003|Overall Study|Progressive Disease|9|||
13162751|NCT02412722|26093196|FG004|Overall Study|Progressive Disease|3|||
13162752|NCT02412722|26093197|FG005|Overall Study|Progressive Disease|3|||
13162753|NCT02412722|26093192|FG000|Overall Study|Withdrawal by Subject|2|||
13162754|NCT02412722|26093193|FG001|Overall Study|Withdrawal by Subject|0|||
13162755|NCT02412722|26093194|FG002|Overall Study|Withdrawal by Subject|1|||
13162756|NCT02412722|26093195|FG003|Overall Study|Withdrawal by Subject|2|||
13162757|NCT02412722|26093196|FG004|Overall Study|Withdrawal by Subject|1|||
13162758|NCT02412722|26093197|FG005|Overall Study|Withdrawal by Subject|1|||
13162759|NCT02412722|26093192|FG000|Overall Study|Lost to Follow-up|0|||
13162760|NCT02412722|26093193|FG001|Overall Study|Lost to Follow-up|0|||
13162761|NCT02412722|26093194|FG002|Overall Study|Lost to Follow-up|0|||
13162762|NCT02412722|26093195|FG003|Overall Study|Lost to Follow-up|0|||
13162763|NCT02412722|26093196|FG004|Overall Study|Lost to Follow-up|1|||
13162764|NCT02412722|26093197|FG005|Overall Study|Lost to Follow-up|0|||
13162765|NCT02412722|26093192|FG000|Overall Study|Received drug in run-in and discontinued|0|||
13162766|NCT02412722|26093193|FG001|Overall Study|Received drug in run-in and discontinued|2|||
13162767|NCT02412722|26093194|FG002|Overall Study|Received drug in run-in and discontinued|0|||
13162768|NCT02412722|26093195|FG003|Overall Study|Received drug in run-in and discontinued|0|||
13162769|NCT02412722|26093196|FG004|Overall Study|Received drug in run-in and discontinued|0|||
13162770|NCT02412722|26093197|FG005|Overall Study|Received drug in run-in and discontinued|0|||
13162771|NCT02412722|26093192|FG000|Overall Study|Reason not Specified|3|||
13162772|NCT02412722|26093193|FG001|Overall Study|Reason not Specified|0|||
13162773|NCT02412722|26093194|FG002|Overall Study|Reason not Specified|2|||
13162774|NCT02412722|26093195|FG003|Overall Study|Reason not Specified|1|||
13162775|NCT02412722|26093196|FG004|Overall Study|Reason not Specified|2|||
13162776|NCT02412722|26093197|FG005|Overall Study|Reason not Specified|6|||
13162777|NCT02412670|26093222|FG000|Overall Study|Adverse Event|4|||
13162778|NCT02412670|26093223|FG001|Overall Study|Adverse Event|1|||
13162779|NCT02412670|26093222|FG000|Overall Study|Physician Decision|1|||
13162780|NCT02412670|26093223|FG001|Overall Study|Physician Decision|0|||
13162781|NCT02412670|26093222|FG000|Overall Study|Withdrawal by Subject|1|||
13162782|NCT02412670|26093223|FG001|Overall Study|Withdrawal by Subject|0|||
13162783|NCT02412670|26093222|FG000|Overall Study|Ineligible|1|||
13162784|NCT02412670|26093223|FG001|Overall Study|Ineligible|0|||
13162785|NCT02412657|26093241|FG000|Overall Study|Lost to Follow-up|1|||
13162786|NCT02412657|26093242|FG001|Overall Study|Lost to Follow-up|0|||
13162787|NCT02412657|26093243|FG002|Overall Study|Lost to Follow-up|0|||
13162788|NCT02412657|26093241|FG000|Overall Study|Protocol Violation|0|||
13162789|NCT02412657|26093242|FG001|Overall Study|Protocol Violation|2|||
13162790|NCT02412657|26093243|FG002|Overall Study|Protocol Violation|3|||
13162791|NCT02412631|26093264|FG000|Overall Study|Adverse Event|1|||
13162792|NCT02412631|26093265|FG001|Overall Study|Adverse Event|2|||
13162793|NCT02412631|26093264|FG000|Overall Study|Lost to Follow-up|5|||
13162794|NCT02412631|26093265|FG001|Overall Study|Lost to Follow-up|9|||
13162795|NCT02412631|26093264|FG000|Overall Study|Withdrawal by Subject|9|||
13162796|NCT02412631|26093265|FG001|Overall Study|Withdrawal by Subject|3|||
13162797|NCT02412631|26093264|FG000|Overall Study|Early stop by FDA|5|||
13162798|NCT02412631|26093265|FG001|Overall Study|Early stop by FDA|2|||
13162799|NCT02412631|26093264|FG000|Overall Study|Unspecified reason|6|||
13162800|NCT02412631|26093265|FG001|Overall Study|Unspecified reason|8|||
13162801|NCT02412618|26093280|FG000|Overall Study|Withdrawal by Subject|1|||
13162802|NCT02412618|26093281|FG001|Overall Study|Withdrawal by Subject|1|||
13162803|NCT02412618|26093280|FG000|Overall Study|Expulsion|1|||
13162804|NCT02412618|26093281|FG001|Overall Study|Expulsion|1|||
13162805|NCT02412488|26093287|FG000|Overall Study|Lost to Follow-up|10|||
13162806|NCT02412488|26093287|FG000|Overall Study|Withdrawal by Subject|5|||
13162807|NCT02412488|26093287|FG000|Overall Study|Physician Decision|1|||
13162808|NCT02412488|26093287|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1|||
13162809|NCT02412488|26093287|FG000|Overall Study|Reveal LINQ explant|1|||
13162810|NCT02412436|26093303|FG000|Overall Study|Protocol-mandated Discontinuation|7|||
13162811|NCT02412436|26093303|FG000|Overall Study|Lost to Follow-up|6|||
13162812|NCT02412436|26093303|FG000|Overall Study|Unable to get to clinic|3|||
13162813|NCT02412436|26093303|FG000|Overall Study|Death|1|||
13162814|NCT02412436|26093303|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
13162815|NCT02412371|26093345|FG000|Overall Study|Withdrawal by Subject|0|||
13162816|NCT02412371|26093346|FG001|Overall Study|Withdrawal by Subject|2|||
13162817|NCT02412371|26093347|FG002|Overall Study|Withdrawal by Subject|0|||
13162818|NCT02412371|26093348|FG003|Overall Study|Withdrawal by Subject|1|||
13162819|NCT02412371|26093349|FG004|Overall Study|Withdrawal by Subject|1|||
13162820|NCT02412371|26093350|FG005|Overall Study|Withdrawal by Subject|0|||
13162821|NCT02412371|26093345|FG000|Overall Study|Sponsor Discontinued Study|1|||
13162822|NCT02412371|26093346|FG001|Overall Study|Sponsor Discontinued Study|4|||
13162823|NCT02412371|26093347|FG002|Overall Study|Sponsor Discontinued Study|6|||
13162824|NCT02412371|26093348|FG003|Overall Study|Sponsor Discontinued Study|4|||
13162825|NCT02412371|26093349|FG004|Overall Study|Sponsor Discontinued Study|5|||
13162826|NCT02412371|26093350|FG005|Overall Study|Sponsor Discontinued Study|0|||
13162827|NCT02412371|26093345|FG000|Overall Study|Death|4|||
13162828|NCT02412371|26093346|FG001|Overall Study|Death|2|||
13162829|NCT02412371|26093347|FG002|Overall Study|Death|1|||
13162830|NCT02412371|26093348|FG003|Overall Study|Death|3|||
13162831|NCT02412371|26093349|FG004|Overall Study|Death|5|||
13162832|NCT02412371|26093350|FG005|Overall Study|Death|2|||
13162833|NCT02412371|26093345|FG000|Overall Study|Other|2|||
13162834|NCT02412371|26093346|FG001|Overall Study|Other|1|||
13162835|NCT02412371|26093347|FG002|Overall Study|Other|0|||
13162836|NCT02412371|26093348|FG003|Overall Study|Other|0|||
13162837|NCT02412371|26093349|FG004|Overall Study|Other|1|||
13162838|NCT02412371|26093350|FG005|Overall Study|Other|3|||
13162839|NCT02412111|26093377|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1|||
13162840|NCT02412111|26093378|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
13162841|NCT02412111|26093379|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
13162842|NCT02412111|26093377|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2|||
13162843|NCT02412111|26093378|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
13162844|NCT02412111|26093379|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
13162845|NCT02412111|26093377|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0|||
13162846|NCT02412111|26093378|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0|||
13162847|NCT02412111|26093379|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2|||
13162848|NCT02412111|26093377|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
13162849|NCT02412111|26093378|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
13162850|NCT02412111|26093379|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1|||
13162851|NCT02412111|26093377|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
13162852|NCT02412111|26093378|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
13162853|NCT02412111|26093379|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1|||
13162854|NCT02412111|26093377|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
13162855|NCT02412111|26093378|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1|||
13162856|NCT02412111|26093379|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
13162857|NCT02412111|26093377|FG000|Active Comparator Period (8 Weeks)|Other|0|||
13162858|NCT02412111|26093378|FG001|Active Comparator Period (8 Weeks)|Other|0|||
13162859|NCT02412111|26093379|FG002|Active Comparator Period (8 Weeks)|Other|2|||
13162860|NCT02411747|26093392|FG000|Overall Study|Withdrawal by Subject|1|||
13162861|NCT02411747|26093393|FG001|Overall Study|Withdrawal by Subject|0|||
13162862|NCT02411747|26093392|FG000|Overall Study|Protocol Violation|2|||
13162863|NCT02411747|26093393|FG001|Overall Study|Protocol Violation|4|||
13162864|NCT02411591|26093433|FG000|Overall Study|Adverse Event|0|||
13162865|NCT02411591|26093434|FG001|Overall Study|Adverse Event|4|||
13162866|NCT02411591|26093435|FG002|Overall Study|Adverse Event|2|||
13162867|NCT02411591|26093433|FG000|Overall Study|Withdrawal by Subject|0|||
13162868|NCT02411591|26093434|FG001|Overall Study|Withdrawal by Subject|3|||
13162869|NCT02411591|26093435|FG002|Overall Study|Withdrawal by Subject|0|||
13162870|NCT02411591|26093433|FG000|Overall Study|Physician Decision|0|||
13162871|NCT02411591|26093434|FG001|Overall Study|Physician Decision|3|||
13162872|NCT02411591|26093435|FG002|Overall Study|Physician Decision|1|||
13162873|NCT02411578|26093482|FG000|Crossover Trial Phase|Pregnancy|0|||
13162874|NCT02411578|26093483|FG001|Crossover Trial Phase|Pregnancy|1|||
13162875|NCT02411539|26093565|FG000|Overall Study|Lost to Follow-up|2|||
13162876|NCT02411539|26093566|FG001|Overall Study|Lost to Follow-up|0|||
13162877|NCT02411539|26093565|FG000|Overall Study|Confounding medical condition|0|||
13162878|NCT02411539|26093566|FG001|Overall Study|Confounding medical condition|1|||
13162879|NCT02411448|26093605|FG000|Overall Study|Withdrawal by Subject|1|||
13162880|NCT02411448|26093606|FG001|Overall Study|Withdrawal by Subject|14|||
13162881|NCT02411448|26093607|FG002|Overall Study|Withdrawal by Subject|9|||
13162882|NCT02411448|26093605|FG000|Overall Study|Other|0|||
13162883|NCT02411448|26093606|FG001|Overall Study|Other|2|||
13162884|NCT02411448|26093607|FG002|Overall Study|Other|0|||
13162885|NCT02411448|26093605|FG000|Overall Study|Did not receive study treatment|0|||
13162886|NCT02411448|26093606|FG001|Overall Study|Did not receive study treatment|3|||
13162887|NCT02411448|26093607|FG002|Overall Study|Did not receive study treatment|0|||
13162888|NCT02411448|26093605|FG000|Overall Study|Alive on study treatment|3|||
13162889|NCT02411448|26093606|FG001|Overall Study|Alive on study treatment|64|||
13162890|NCT02411448|26093607|FG002|Overall Study|Alive on study treatment|43|||
13162891|NCT02411396|26093622|FG000|Overall Study|Lost to Follow-up|31|||
13162892|NCT02411396|26093622|FG000|Overall Study|Death|10|||
13162893|NCT02411292|26093630|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16|||
13162894|NCT02411292|26093630|FG000|Overall Study|Death|2|||
13162895|NCT02411292|26093630|FG000|Overall Study|Lost to Follow-up|3|||
13162896|NCT02411201|26093643|FG000|Overall Study|Adverse Event|2|||
13162897|NCT02411201|26093643|FG000|Overall Study|Withdrawal by Subject|2|||
13162898|NCT02411201|26093643|FG000|Overall Study|Age group completed|2|||
13162899|NCT02411110|26093658|FG000|Treatment Period 1|Adverse Event|4|||
13162900|NCT02411110|26093659|FG001|Treatment Period 1|Adverse Event|2|||
13162901|NCT02411110|26093658|FG000|Treatment Period 1|Lost to Follow-up|1|||
13162902|NCT02411110|26093659|FG001|Treatment Period 1|Lost to Follow-up|0|||
13162903|NCT02411110|26093658|FG000|Treatment Period 1|Personal Reasons|2|||
13162904|NCT02411110|26093659|FG001|Treatment Period 1|Personal Reasons|5|||
13162905|NCT02411110|26093658|FG000|Treatment Period 1|Other Miscellaneous Reasons|2|||
13162906|NCT02411110|26093659|FG001|Treatment Period 1|Other Miscellaneous Reasons|0|||
13162907|NCT02411110|26093658|FG000|Treatment Period 2|Adverse Event|1|||
13162908|NCT02411110|26093659|FG001|Treatment Period 2|Adverse Event|0|||
13162909|NCT02411110|26093658|FG000|Treatment Period 2|Lost to Follow-up|0|||
13162910|NCT02411110|26093659|FG001|Treatment Period 2|Lost to Follow-up|2|||
13162911|NCT02411110|26093658|FG000|Treatment Period 2|Personal Reasons|0|||
13162912|NCT02411110|26093659|FG001|Treatment Period 2|Personal Reasons|2|||
13162913|NCT02411084|26093679|FG000|Overall Study|Lack of Efficacy|6|||
13162914|NCT02411084|26093680|FG001|Overall Study|Lack of Efficacy|3|||
13162915|NCT02411084|26093679|FG000|Overall Study|Death|5|||
13162916|NCT02411084|26093680|FG001|Overall Study|Death|4|||
13162917|NCT02411084|26093679|FG000|Overall Study|Adverse Event|2|||
13162918|NCT02411084|26093680|FG001|Overall Study|Adverse Event|1|||
13162919|NCT02411084|26093679|FG000|Overall Study|Other reasons|0|||
13162920|NCT02411084|26093680|FG001|Overall Study|Other reasons|5|||
13162921|NCT02410954|26093693|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6|||
13162922|NCT02410954|26093694|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0|||
13162923|NCT02410954|26093693|FG000|Overall Study|Instrument malfunction generated unusable data|8|||
13162924|NCT02410954|26093694|FG001|Overall Study|Instrument malfunction generated unusable data|0|||
13162925|NCT02410902|26093709|FG000|Overall Study|Adverse Event|2|||
13162926|NCT02410902|26093710|FG001|Overall Study|Adverse Event|3|||
13162927|NCT02410902|26093709|FG000|Overall Study|Lost to Follow-up|4|||
13162928|NCT02410902|26093710|FG001|Overall Study|Lost to Follow-up|1|||
13162929|NCT02410902|26093709|FG000|Overall Study|Protocol Violation|1|||
13162930|NCT02410902|26093710|FG001|Overall Study|Protocol Violation|4|||
13162931|NCT02410902|26093709|FG000|Overall Study|Withdrawal by Subject|6|||
13162932|NCT02410902|26093710|FG001|Overall Study|Withdrawal by Subject|8|||
13162933|NCT02410902|26093709|FG000|Overall Study|Non-Compliance|8|||
13162934|NCT02410902|26093710|FG001|Overall Study|Non-Compliance|2|||
13162935|NCT02410837|26093734|FG000|Overall Study|Death|387|||
13162936|NCT02410837|26093734|FG000|Overall Study|Lost to Follow-up|50|||
13162937|NCT02410837|26093734|FG000|Overall Study|Withdrawal by Subject|44|||
13162938|NCT02410837|26093734|FG000|Overall Study|Physician Decision|6|||
13162939|NCT02410837|26093734|FG000|Overall Study|Moved to nursing home, cannot communicat|1|||
13162940|NCT02410824|26093769|FG000|First Intervention (One Week)|Headache|0|||
13162941|NCT02410824|26093770|FG001|First Intervention (One Week)|Headache|1|||
13162942|NCT02410811|26093797|FG000|Overall Study|Withdrawal by Subject|0|||
13162943|NCT02410811|26093798|FG001|Overall Study|Withdrawal by Subject|0|||
13162944|NCT02410811|26093799|FG002|Overall Study|Withdrawal by Subject|1|||
13162945|NCT02410811|26093800|FG003|Overall Study|Withdrawal by Subject|0|||
13162946|NCT02410772|26093824|FG000|Overall Study|Death|3|||
13162947|NCT02410772|26093825|FG001|Overall Study|Death|4|||
13162948|NCT02410772|26093826|FG002|Overall Study|Death|8|||
13162949|NCT02410772|26093824|FG000|Overall Study|Lost to Follow-up|31|||
13162950|NCT02410772|26093825|FG001|Overall Study|Lost to Follow-up|23|||
13162951|NCT02410772|26093826|FG002|Overall Study|Lost to Follow-up|22|||
13162952|NCT02410772|26093824|FG000|Overall Study|Pregnancy|8|||
13162953|NCT02410772|26093825|FG001|Overall Study|Pregnancy|4|||
13162954|NCT02410772|26093826|FG002|Overall Study|Pregnancy|5|||
13162955|NCT02410772|26093824|FG000|Overall Study|Protocol Violation|8|||
13162956|NCT02410772|26093825|FG001|Overall Study|Protocol Violation|8|||
13162957|NCT02410772|26093826|FG002|Overall Study|Protocol Violation|4|||
13162958|NCT02410772|26093824|FG000|Overall Study|Baseline Drug Resistance|49|||
13162959|NCT02410772|26093825|FG001|Overall Study|Baseline Drug Resistance|40|||
13162960|NCT02410772|26093826|FG002|Overall Study|Baseline Drug Resistance|51|||
13162961|NCT02410772|26093824|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4|||
13162962|NCT02410772|26093825|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6|||
13162963|NCT02410772|26093826|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3|||
13162964|NCT02410772|26093824|FG000|Overall Study|Reinfection with a new strain of MTB|0|||
13162965|NCT02410772|26093825|FG001|Overall Study|Reinfection with a new strain of MTB|1|||
13162966|NCT02410772|26093826|FG002|Overall Study|Reinfection with a new strain of MTB|0|||
13162967|NCT02484651|26093845|FG000|Overall Study|Patients' data files were corrupted.|1|||
13162968|NCT02484651|26093846|FG001|Overall Study|Patients' data files were corrupted.|1|||
13162969|NCT02484651|26093845|FG000|Overall Study|BIS monitoring failed.|1|||
13162970|NCT02484651|26093846|FG001|Overall Study|BIS monitoring failed.|1|||
13162971|NCT02484651|26093845|FG000|Overall Study|Time of the procedure less than 90 min.|1|||
13162972|NCT02484651|26093846|FG001|Overall Study|Time of the procedure less than 90 min.|2|||
13162973|NCT02460224|26094612|FG000|Overall Study|Adverse Event|0|||
13162974|NCT02460224|26094613|FG001|Overall Study|Adverse Event|0|||
13162975|NCT02460224|26094614|FG002|Overall Study|Adverse Event|0|||
13162976|NCT02460224|26094615|FG003|Overall Study|Adverse Event|0|||
13162977|NCT02460224|26094616|FG004|Overall Study|Adverse Event|0|||
13162978|NCT02460224|26094617|FG005|Overall Study|Adverse Event|0|||
13162979|NCT02460224|26094618|FG006|Overall Study|Adverse Event|1|||
13162980|NCT02460224|26094619|FG007|Overall Study|Adverse Event|0|||
13162981|NCT02460224|26094620|FG008|Overall Study|Adverse Event|0|||
13162982|NCT02460224|26094621|FG009|Overall Study|Adverse Event|0|||
13162983|NCT02460224|26094622|FG010|Overall Study|Adverse Event|0|||
13162984|NCT02460224|26094623|FG011|Overall Study|Adverse Event|0|||
13162985|NCT02460224|26094624|FG012|Overall Study|Adverse Event|1|||
13162986|NCT02460224|26094625|FG013|Overall Study|Adverse Event|0|||
13162987|NCT02460224|26094626|FG014|Overall Study|Adverse Event|0|||
13162988|NCT02460224|26094627|FG015|Overall Study|Adverse Event|0|||
13162989|NCT02460224|26094628|FG016|Overall Study|Adverse Event|1|||
13162990|NCT02460224|26094629|FG017|Overall Study|Adverse Event|0|||
13162991|NCT02460224|26094630|FG018|Overall Study|Adverse Event|1|||
13162992|NCT02460224|26094631|FG019|Overall Study|Adverse Event|0|||
13162993|NCT02460224|26094632|FG020|Overall Study|Adverse Event|1|||
13162994|NCT02460224|26094633|FG021|Overall Study|Adverse Event|1|||
13162995|NCT02460224|26094634|FG022|Overall Study|Adverse Event|1|||
13162996|NCT02460224|26094635|FG023|Overall Study|Adverse Event|0|||
13162997|NCT02460224|26094636|FG024|Overall Study|Adverse Event|0|||
13162998|NCT02460224|26094637|FG025|Overall Study|Adverse Event|0|||
13162999|NCT02460224|26094638|FG026|Overall Study|Adverse Event|11|||
13163000|NCT02460224|26094639|FG027|Overall Study|Adverse Event|1|||
13163001|NCT02460224|26094640|FG028|Overall Study|Adverse Event|6|||
13163002|NCT02460224|26094612|FG000|Overall Study|Death|0|||
13163003|NCT02460224|26094613|FG001|Overall Study|Death|0|||
13163004|NCT02460224|26094614|FG002|Overall Study|Death|0|||
13163005|NCT02460224|26094615|FG003|Overall Study|Death|0|||
13163006|NCT02460224|26094616|FG004|Overall Study|Death|0|||
13163007|NCT02460224|26094617|FG005|Overall Study|Death|2|||
13163008|NCT02460224|26094618|FG006|Overall Study|Death|1|||
13163009|NCT02460224|26094619|FG007|Overall Study|Death|0|||
13163010|NCT02460224|26094620|FG008|Overall Study|Death|0|||
13163011|NCT02460224|26094621|FG009|Overall Study|Death|1|||
13163012|NCT02460224|26094622|FG010|Overall Study|Death|0|||
13163013|NCT02460224|26094623|FG011|Overall Study|Death|0|||
13163014|NCT02460224|26094624|FG012|Overall Study|Death|0|||
13163015|NCT02460224|26094625|FG013|Overall Study|Death|1|||
13163016|NCT02460224|26094626|FG014|Overall Study|Death|0|||
13163017|NCT02460224|26094627|FG015|Overall Study|Death|0|||
13163018|NCT02460224|26094628|FG016|Overall Study|Death|2|||
13163019|NCT02460224|26094629|FG017|Overall Study|Death|1|||
13163020|NCT02460224|26094630|FG018|Overall Study|Death|0|||
13163021|NCT02460224|26094631|FG019|Overall Study|Death|2|||
13163022|NCT02460224|26094632|FG020|Overall Study|Death|0|||
13163023|NCT02460224|26094633|FG021|Overall Study|Death|0|||
13163024|NCT02460224|26094634|FG022|Overall Study|Death|0|||
13163025|NCT02460224|26094635|FG023|Overall Study|Death|0|||
13163026|NCT02460224|26094636|FG024|Overall Study|Death|1|||
13163027|NCT02460224|26094637|FG025|Overall Study|Death|1|||
13163028|NCT02460224|26094638|FG026|Overall Study|Death|5|||
13163029|NCT02460224|26094639|FG027|Overall Study|Death|0|||
13163030|NCT02460224|26094640|FG028|Overall Study|Death|1|||
13163031|NCT02460224|26094612|FG000|Overall Study|Lost to Follow-up|0|||
13163032|NCT02460224|26094613|FG001|Overall Study|Lost to Follow-up|0|||
13163033|NCT02460224|26094614|FG002|Overall Study|Lost to Follow-up|0|||
13163034|NCT02460224|26094615|FG003|Overall Study|Lost to Follow-up|0|||
13163035|NCT02460224|26094616|FG004|Overall Study|Lost to Follow-up|0|||
13163036|NCT02460224|26094617|FG005|Overall Study|Lost to Follow-up|0|||
13163037|NCT02460224|26094618|FG006|Overall Study|Lost to Follow-up|0|||
13163038|NCT02460224|26094619|FG007|Overall Study|Lost to Follow-up|0|||
13163039|NCT02460224|26094620|FG008|Overall Study|Lost to Follow-up|0|||
13163040|NCT02460224|26094621|FG009|Overall Study|Lost to Follow-up|0|||
13163041|NCT02460224|26094622|FG010|Overall Study|Lost to Follow-up|0|||
13163042|NCT02460224|26094623|FG011|Overall Study|Lost to Follow-up|0|||
13163043|NCT02460224|26094624|FG012|Overall Study|Lost to Follow-up|0|||
13163044|NCT02460224|26094625|FG013|Overall Study|Lost to Follow-up|0|||
13163045|NCT02460224|26094626|FG014|Overall Study|Lost to Follow-up|0|||
13163046|NCT02460224|26094627|FG015|Overall Study|Lost to Follow-up|0|||
13163047|NCT02460224|26094628|FG016|Overall Study|Lost to Follow-up|0|||
13163048|NCT02460224|26094629|FG017|Overall Study|Lost to Follow-up|0|||
13163049|NCT02460224|26094630|FG018|Overall Study|Lost to Follow-up|0|||
13163050|NCT02460224|26094631|FG019|Overall Study|Lost to Follow-up|0|||
13163051|NCT02460224|26094632|FG020|Overall Study|Lost to Follow-up|0|||
13163052|NCT02460224|26094633|FG021|Overall Study|Lost to Follow-up|0|||
13163053|NCT02460224|26094634|FG022|Overall Study|Lost to Follow-up|1|||
13163054|NCT02460224|26094635|FG023|Overall Study|Lost to Follow-up|0|||
13163055|NCT02460224|26094636|FG024|Overall Study|Lost to Follow-up|0|||
13163056|NCT02460224|26094637|FG025|Overall Study|Lost to Follow-up|0|||
13163057|NCT02460224|26094638|FG026|Overall Study|Lost to Follow-up|0|||
13163058|NCT02460224|26094639|FG027|Overall Study|Lost to Follow-up|0|||
13163059|NCT02460224|26094640|FG028|Overall Study|Lost to Follow-up|0|||
13163060|NCT02460224|26094612|FG000|Overall Study|Physician Decision|0|||
13163061|NCT02460224|26094613|FG001|Overall Study|Physician Decision|1|||
13163062|NCT02460224|26094614|FG002|Overall Study|Physician Decision|0|||
13163063|NCT02460224|26094615|FG003|Overall Study|Physician Decision|0|||
13163064|NCT02460224|26094616|FG004|Overall Study|Physician Decision|1|||
13163065|NCT02460224|26094617|FG005|Overall Study|Physician Decision|0|||
13163066|NCT02460224|26094618|FG006|Overall Study|Physician Decision|0|||
13163067|NCT02460224|26094619|FG007|Overall Study|Physician Decision|1|||
13163068|NCT02460224|26094620|FG008|Overall Study|Physician Decision|0|||
13163069|NCT02460224|26094621|FG009|Overall Study|Physician Decision|0|||
13163070|NCT02460224|26094622|FG010|Overall Study|Physician Decision|0|||
13163071|NCT02460224|26094623|FG011|Overall Study|Physician Decision|1|||
13163072|NCT02460224|26094624|FG012|Overall Study|Physician Decision|0|||
13163073|NCT02460224|26094625|FG013|Overall Study|Physician Decision|1|||
13163074|NCT02460224|26094626|FG014|Overall Study|Physician Decision|0|||
13163075|NCT02460224|26094627|FG015|Overall Study|Physician Decision|0|||
13163076|NCT02460224|26094628|FG016|Overall Study|Physician Decision|2|||
13163077|NCT02460224|26094629|FG017|Overall Study|Physician Decision|1|||
13163078|NCT02460224|26094630|FG018|Overall Study|Physician Decision|1|||
13163079|NCT02460224|26094631|FG019|Overall Study|Physician Decision|2|||
13163080|NCT02460224|26094632|FG020|Overall Study|Physician Decision|1|||
13163081|NCT02460224|26094633|FG021|Overall Study|Physician Decision|1|||
13163082|NCT02460224|26094634|FG022|Overall Study|Physician Decision|0|||
13163083|NCT02460224|26094635|FG023|Overall Study|Physician Decision|0|||
13163084|NCT02460224|26094636|FG024|Overall Study|Physician Decision|1|||
13163085|NCT02460224|26094637|FG025|Overall Study|Physician Decision|0|||
13163086|NCT02460224|26094638|FG026|Overall Study|Physician Decision|14|||
13163087|NCT02460224|26094639|FG027|Overall Study|Physician Decision|1|||
13163088|NCT02460224|26094640|FG028|Overall Study|Physician Decision|6|||
13163089|NCT02460224|26094612|FG000|Overall Study|Progressive disease|15|||
13163090|NCT02460224|26094613|FG001|Overall Study|Progressive disease|11|||
13163091|NCT02460224|26094614|FG002|Overall Study|Progressive disease|5|||
13163092|NCT02460224|26094615|FG003|Overall Study|Progressive disease|6|||
13163093|NCT02460224|26094616|FG004|Overall Study|Progressive disease|3|||
13163094|NCT02460224|26094617|FG005|Overall Study|Progressive disease|26|||
13163095|NCT02460224|26094618|FG006|Overall Study|Progressive disease|28|||
13163096|NCT02460224|26094619|FG007|Overall Study|Progressive disease|4|||
13163097|NCT02460224|26094620|FG008|Overall Study|Progressive disease|5|||
13163098|NCT02460224|26094621|FG009|Overall Study|Progressive disease|9|||
13163099|NCT02460224|26094622|FG010|Overall Study|Progressive disease|5|||
13163100|NCT02460224|26094623|FG011|Overall Study|Progressive disease|4|||
13163101|NCT02460224|26094624|FG012|Overall Study|Progressive disease|5|||
13163102|NCT02460224|26094625|FG013|Overall Study|Progressive disease|4|||
13163103|NCT02460224|26094626|FG014|Overall Study|Progressive disease|5|||
13163104|NCT02460224|26094627|FG015|Overall Study|Progressive disease|5|||
13163105|NCT02460224|26094628|FG016|Overall Study|Progressive disease|15|||
13163106|NCT02460224|26094629|FG017|Overall Study|Progressive disease|3|||
13163107|NCT02460224|26094630|FG018|Overall Study|Progressive disease|8|||
13163108|NCT02460224|26094631|FG019|Overall Study|Progressive disease|3|||
13163109|NCT02460224|26094632|FG020|Overall Study|Progressive disease|4|||
13163110|NCT02460224|26094633|FG021|Overall Study|Progressive disease|9|||
13163111|NCT02460224|26094634|FG022|Overall Study|Progressive disease|4|||
13163112|NCT02460224|26094635|FG023|Overall Study|Progressive disease|11|||
13163113|NCT02460224|26094636|FG024|Overall Study|Progressive disease|4|||
13163114|NCT02460224|26094637|FG025|Overall Study|Progressive disease|5|||
13163115|NCT02460224|26094638|FG026|Overall Study|Progressive disease|85|||
13163116|NCT02460224|26094639|FG027|Overall Study|Progressive disease|17|||
13163117|NCT02460224|26094640|FG028|Overall Study|Progressive disease|77|||
13163118|NCT02460224|26094612|FG000|Overall Study|Subject/guardian decision|2|||
13163119|NCT02460224|26094613|FG001|Overall Study|Subject/guardian decision|0|||
13163120|NCT02460224|26094614|FG002|Overall Study|Subject/guardian decision|1|||
13163121|NCT02460224|26094615|FG003|Overall Study|Subject/guardian decision|0|||
13163122|NCT02460224|26094616|FG004|Overall Study|Subject/guardian decision|2|||
13163123|NCT02460224|26094617|FG005|Overall Study|Subject/guardian decision|2|||
13163124|NCT02460224|26094618|FG006|Overall Study|Subject/guardian decision|0|||
13163125|NCT02460224|26094619|FG007|Overall Study|Subject/guardian decision|0|||
13163126|NCT02460224|26094620|FG008|Overall Study|Subject/guardian decision|1|||
13163127|NCT02460224|26094621|FG009|Overall Study|Subject/guardian decision|1|||
13163128|NCT02460224|26094622|FG010|Overall Study|Subject/guardian decision|0|||
13163129|NCT02460224|26094623|FG011|Overall Study|Subject/guardian decision|1|||
13163130|NCT02460224|26094624|FG012|Overall Study|Subject/guardian decision|0|||
13485481|NCT02906020|27032867|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0|||
13485482|NCT02906020|27032868|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0|||
13485483|NCT02906020|27032869|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0|||
13485484|NCT02906020|27032870|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0|||
13485485|NCT02906020|27032871|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0|||
13485486|NCT02906020|27032872|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0|||
13105990|NCT03312543|25881653|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3|||
13105991|NCT03312543|25881654|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4|||
13105992|NCT03312543|25881653|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1|||
13105993|NCT03312543|25881654|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1|||
13105994|NCT03312543|25881653|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1|||
13105995|NCT03312543|25881654|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1|||
13105996|NCT03312543|25881653|FG000|Regression (Week 12 to Week 24)|Death|0|||
13105997|NCT03312543|25881654|FG001|Regression (Week 12 to Week 24)|Death|1|||
13485487|NCT02906020|27032873|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0|||
13485488|NCT02906020|27032874|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0|||
13485489|NCT02906020|27032875|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6|||
13485490|NCT02906020|27032876|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15|||
13485491|NCT02906020|27032877|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0|||
13485492|NCT02906020|27032878|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0|||
13485493|NCT02906020|27032879|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0|||
13485494|NCT02906020|27032880|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0|||
13485495|NCT02906020|27032881|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0|||
13485496|NCT02906020|27032882|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0|||
13485497|NCT02906020|27032867|FG000|Part 2: Double-blind Treatment Period|Other|0|||
13485498|NCT02906020|27032868|FG001|Part 2: Double-blind Treatment Period|Other|0|||
13485499|NCT02906020|27032869|FG002|Part 2: Double-blind Treatment Period|Other|0|||
13485500|NCT02906020|27032870|FG003|Part 2: Double-blind Treatment Period|Other|0|||
13485501|NCT02906020|27032871|FG004|Part 2: Double-blind Treatment Period|Other|0|||
13485502|NCT02906020|27032872|FG005|Part 2: Double-blind Treatment Period|Other|0|||
13485503|NCT02906020|27032873|FG006|Part 2: Double-blind Treatment Period|Other|0|||
13485504|NCT02906020|27032874|FG007|Part 2: Double-blind Treatment Period|Other|0|||
13485505|NCT02906020|27032875|FG008|Part 2: Double-blind Treatment Period|Other|6|||
13485506|NCT02906020|27032876|FG009|Part 2: Double-blind Treatment Period|Other|10|||
13485507|NCT02906020|27032877|FG010|Part 2: Double-blind Treatment Period|Other|0|||
13485508|NCT02906020|27032878|FG011|Part 2: Double-blind Treatment Period|Other|0|||
13163131|NCT02460224|26094625|FG013|Overall Study|Subject/guardian decision|0|||
13163132|NCT02460224|26094626|FG014|Overall Study|Subject/guardian decision|0|||
13485509|NCT02906020|27032879|FG012|Part 2: Double-blind Treatment Period|Other|0|||
13485510|NCT02906020|27032880|FG013|Part 2: Double-blind Treatment Period|Other|0|||
13485511|NCT02906020|27032881|FG014|Part 2: Double-blind Treatment Period|Other|0|||
13485512|NCT02906020|27032882|FG015|Part 2: Double-blind Treatment Period|Other|0|||
13485513|NCT02906020|27032867|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0|||
13105998|NCT03312231|25881872|FG000|Overall Study|Lost to Follow-up|2|||
13105999|NCT03312231|25881873|FG001|Overall Study|Lost to Follow-up|6|||
13106000|NCT03312231|25881874|FG002|Overall Study|Lost to Follow-up|1|||
13106001|NCT03312231|25881875|FG003|Overall Study|Lost to Follow-up|3|||
13106002|NCT03312231|25881876|FG004|Overall Study|Lost to Follow-up|1|||
13106003|NCT03312231|25881872|FG000|Overall Study|Withdrawal by Subject|0|||
13106004|NCT03312231|25881873|FG001|Overall Study|Withdrawal by Subject|3|||
13106005|NCT03312231|25881874|FG002|Overall Study|Withdrawal by Subject|1|||
13106006|NCT03312231|25881875|FG003|Overall Study|Withdrawal by Subject|0|||
13106007|NCT03312231|25881876|FG004|Overall Study|Withdrawal by Subject|0|||
13106008|NCT03312231|25881872|FG000|Overall Study|Death|0|||
13106009|NCT03312231|25881873|FG001|Overall Study|Death|1|||
13106010|NCT03312231|25881874|FG002|Overall Study|Death|1|||
13106011|NCT03312231|25881875|FG003|Overall Study|Death|0|||
13106012|NCT03312231|25881876|FG004|Overall Study|Death|0|||
13106013|NCT03312231|25881872|FG000|Overall Study|Study Vaccination not Received|1|||
13106014|NCT03312231|25881873|FG001|Overall Study|Study Vaccination not Received|1|||
13106015|NCT03312231|25881874|FG002|Overall Study|Study Vaccination not Received|1|||
13106016|NCT03312231|25881875|FG003|Overall Study|Study Vaccination not Received|0|||
13106017|NCT03312231|25881876|FG004|Overall Study|Study Vaccination not Received|0|||
13106018|NCT03312218|25881889|FG000|Overall Study|Never signed in to access the app|54|||
13106019|NCT03312218|25881890|FG001|Overall Study|Never signed in to access the app|58|||
13106020|NCT03312114|25881897|FG000|Overall Study|All the five enrolled dropped out of the|5|||
13106021|NCT03311841|25882014|FG000|14-day Wash-out|Adverse Event|0|||
13106022|NCT03311841|25882015|FG001|14-day Wash-out|Adverse Event|1|||
13106023|NCT03311841|25882016|FG002|14-day Wash-out|Adverse Event|0|||
13106024|NCT03311841|25882017|FG003|14-day Wash-out|Adverse Event|0|||
13106025|NCT03311841|25882018|FG004|14-day Wash-out|Adverse Event|0|||
13163133|NCT02460224|26094627|FG015|Overall Study|Subject/guardian decision|1|||
13163134|NCT02460224|26094628|FG016|Overall Study|Subject/guardian decision|0|||
13163135|NCT02460224|26094629|FG017|Overall Study|Subject/guardian decision|1|||
13485514|NCT02906020|27032868|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0|||
13485515|NCT02906020|27032869|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0|||
13485516|NCT02906020|27032870|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0|||
13485517|NCT02906020|27032871|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0|||
13485518|NCT02906020|27032872|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0|||
13485519|NCT02906020|27032873|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0|||
13485520|NCT02906020|27032874|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0|||
13485521|NCT02906020|27032875|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0|||
13485522|NCT02906020|27032876|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0|||
13106026|NCT03311841|25882014|FG000|14-day Wash-out|Non-Compliance With Study Drug|0|||
13163136|NCT02460224|26094630|FG018|Overall Study|Subject/guardian decision|2|||
13163137|NCT02460224|26094631|FG019|Overall Study|Subject/guardian decision|0|||
13163138|NCT02460224|26094632|FG020|Overall Study|Subject/guardian decision|0|||
13163139|NCT02460224|26094633|FG021|Overall Study|Subject/guardian decision|1|||
13163140|NCT02460224|26094634|FG022|Overall Study|Subject/guardian decision|0|||
13163141|NCT02460224|26094635|FG023|Overall Study|Subject/guardian decision|0|||
13163142|NCT02460224|26094636|FG024|Overall Study|Subject/guardian decision|0|||
13163143|NCT02460224|26094637|FG025|Overall Study|Subject/guardian decision|0|||
13163144|NCT02460224|26094638|FG026|Overall Study|Subject/guardian decision|6|||
13163145|NCT02460224|26094639|FG027|Overall Study|Subject/guardian decision|2|||
13163146|NCT02460224|26094640|FG028|Overall Study|Subject/guardian decision|3|||
13163147|NCT02410551|26094647|FG000|Overall Study|Adverse Event|1|||
13163148|NCT02410551|26094647|FG000|Overall Study|Withdrawal by Subject|1|||
13163149|NCT02410551|26094647|FG000|Overall Study|FDA Clinical hold-patients taken off|2|||
13163150|NCT02410278|26094680|FG000|Run-in Period|Adverse Event|5|||
13163151|NCT02410278|26094681|FG001|Run-in Period|Adverse Event|0|||
13163152|NCT02410278|26094682|FG002|Run-in Period|Adverse Event|0|||
13163153|NCT02410278|26094680|FG000|Run-in Period|GSRS Threshold Not Met|30|||
13163154|NCT02410278|26094681|FG001|Run-in Period|GSRS Threshold Not Met|0|||
13163155|NCT02410278|26094682|FG002|Run-in Period|GSRS Threshold Not Met|0|||
13163156|NCT02410278|26094680|FG000|Run-in Period|Lost to Follow-up|1|||
13163157|NCT02410278|26094681|FG001|Run-in Period|Lost to Follow-up|0|||
13163158|NCT02410278|26094682|FG002|Run-in Period|Lost to Follow-up|0|||
13163159|NCT02410278|26094680|FG000|Run-in Period|Withdrawal by Subject|1|||
13106027|NCT03311841|25882015|FG001|14-day Wash-out|Non-Compliance With Study Drug|0|||
13106028|NCT03311841|25882016|FG002|14-day Wash-out|Non-Compliance With Study Drug|0|||
13106029|NCT03311841|25882017|FG003|14-day Wash-out|Non-Compliance With Study Drug|1|||
13106030|NCT03311841|25882018|FG004|14-day Wash-out|Non-Compliance With Study Drug|0|||
13485523|NCT02906020|27032877|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0|||
13106031|NCT03311724|25882068|FG000|Overall Study|Physician Decision|0|||
13106032|NCT03311724|25882069|FG001|Overall Study|Physician Decision|0|||
13106033|NCT03311724|25882070|FG002|Overall Study|Physician Decision|0|||
13106034|NCT03311724|25882071|FG003|Overall Study|Physician Decision|1|||
13106035|NCT03311724|25882068|FG000|Overall Study|Protocol Violation|1|||
13106036|NCT03311724|25882069|FG001|Overall Study|Protocol Violation|0|||
13106037|NCT03311724|25882070|FG002|Overall Study|Protocol Violation|1|||
13106038|NCT03311724|25882071|FG003|Overall Study|Protocol Violation|0|||
13106039|NCT03311724|25882068|FG000|Overall Study|Withdrawal by Subject|1|||
13106040|NCT03311724|25882069|FG001|Overall Study|Withdrawal by Subject|1|||
13106041|NCT03311724|25882070|FG002|Overall Study|Withdrawal by Subject|0|||
13106042|NCT03311724|25882071|FG003|Overall Study|Withdrawal by Subject|0|||
13106043|NCT03311724|25882068|FG000|Overall Study|Lost to Follow-up|1|||
13106044|NCT03311724|25882069|FG001|Overall Study|Lost to Follow-up|0|||
13106045|NCT03311724|25882070|FG002|Overall Study|Lost to Follow-up|0|||
13106046|NCT03311724|25882071|FG003|Overall Study|Lost to Follow-up|0|||
13106047|NCT03311724|25882068|FG000|Overall Study|Sponsor Decision|0|||
13106048|NCT03311724|25882069|FG001|Overall Study|Sponsor Decision|0|||
13106049|NCT03311724|25882070|FG002|Overall Study|Sponsor Decision|1|||
13106050|NCT03311724|25882071|FG003|Overall Study|Sponsor Decision|0|||
13106051|NCT03311659|25882088|FG000|Overall Study|Protocol Violation|1|||
13106052|NCT03311646|25882097|FG000|Overall Study|Physician Decision|1|||
13106053|NCT03311646|25882097|FG000|Overall Study|Withdrawal by Subject|5|||
13106054|NCT03311646|25882097|FG000|Overall Study|Lost to Follow-up|5|||
13106055|NCT03311646|25882097|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4|||
13106056|NCT03311373|25882153|FG000|Overall Study|Adverse Event|1|||
13106057|NCT03311373|25882153|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
13106058|NCT03311373|25882153|FG000|Overall Study|Lost to Follow-up|1|||
13106059|NCT03311373|25882153|FG000|Overall Study|Physician Decision|1|||
13106060|NCT03311373|25882153|FG000|Overall Study|Withdrawal by Subject|3|||
13106061|NCT03311230|25882188|FG000|Overall Study|Withdrawal by Subject|1|||
13106062|NCT03311230|25882189|FG001|Overall Study|Withdrawal by Subject|4|||
13163160|NCT02410278|26094681|FG001|Run-in Period|Withdrawal by Subject|0|||
13163161|NCT02410278|26094682|FG002|Run-in Period|Withdrawal by Subject|0|||
13163162|NCT02410278|26094680|FG000|Run-in Period|Pregnancy|1|||
13163163|NCT02410278|26094681|FG001|Run-in Period|Pregnancy|0|||
13163164|NCT02410278|26094682|FG002|Run-in Period|Pregnancy|0|||
13163165|NCT02410278|26094680|FG000|Study Treatment Period|Adverse Event|0|||
13163166|NCT02410278|26094681|FG001|Study Treatment Period|Adverse Event|6|||
13163167|NCT02410278|26094682|FG002|Study Treatment Period|Adverse Event|3|||
13163168|NCT02410278|26094680|FG000|Study Treatment Period|Physician Decision|0|||
13163169|NCT02410278|26094681|FG001|Study Treatment Period|Physician Decision|0|||
13163170|NCT02410278|26094682|FG002|Study Treatment Period|Physician Decision|1|||
13163171|NCT02410278|26094680|FG000|Study Treatment Period|Withdrawal by Subject|0|||
13163172|NCT02410278|26094681|FG001|Study Treatment Period|Withdrawal by Subject|1|||
13163173|NCT02410278|26094682|FG002|Study Treatment Period|Withdrawal by Subject|0|||
13163174|NCT02410278|26094680|FG000|Study Treatment Period|Other|0|||
13163175|NCT02410278|26094681|FG001|Study Treatment Period|Other|3|||
13163176|NCT02410278|26094682|FG002|Study Treatment Period|Other|0|||
13163177|NCT02410278|26094680|FG000|Study Treatment Period|GSRS Threshold Not Met|0|||
13163178|NCT02410278|26094681|FG001|Study Treatment Period|GSRS Threshold Not Met|1|||
13163179|NCT02410278|26094682|FG002|Study Treatment Period|GSRS Threshold Not Met|0|||
13163180|NCT02410252|26094690|FG000|Overall Study|Withdrawal by Subject|4|||
13163181|NCT02410252|26094690|FG000|Overall Study|Physician Decision|2|||
13163182|NCT02410200|26094703|FG000|Overall Study|Adverse Event|2|||
13163183|NCT02409732|26094713|FG000|Overall Study|Withdrawal by Subject|4|||
13163184|NCT02409732|26094713|FG000|Overall Study|Lost to Follow-up|2|||
13163185|NCT02409719|26094730|FG000|Overall Study|Lost to Follow-up|3|||
13163186|NCT02409719|26094731|FG001|Overall Study|Lost to Follow-up|3|||
13163187|NCT02409680|26094778|FG000|Overall Study|Lost to Follow-up|15|||
13163188|NCT02409680|26094779|FG001|Overall Study|Lost to Follow-up|30|||
13205474|NCT01965262|26231906|FG000|Second Intervention (7 Days)|Poor visual acuity|1|||
13205475|NCT01965262|26231907|FG001|Second Intervention (7 Days)|Poor visual acuity|0|||
13205476|NCT01965158|26231928|FG000|Overall Study|Adverse Event|14|||
13205477|NCT01965158|26231929|FG001|Overall Study|Adverse Event|5|||
13205478|NCT01965158|26231928|FG000|Overall Study|Withdrawal by Subject|16|||
13205479|NCT01965158|26231929|FG001|Overall Study|Withdrawal by Subject|24|||
13205480|NCT01965158|26231928|FG000|Overall Study|Lost to Follow-up|7|||
13205481|NCT01965158|26231929|FG001|Overall Study|Lost to Follow-up|5|||
13205482|NCT01965158|26231928|FG000|Overall Study|Protocol Violation|1|||
13205483|NCT01965158|26231929|FG001|Overall Study|Protocol Violation|1|||
13205484|NCT01965158|26231928|FG000|Overall Study|Other - Miscellaneous|3|||
13205485|NCT01965158|26231929|FG001|Overall Study|Other - Miscellaneous|0|||
13106063|NCT03311230|25882190|FG002|Overall Study|Withdrawal by Subject|2|||
13106064|NCT03311230|25882191|FG003|Overall Study|Withdrawal by Subject|7|||
13106065|NCT03311230|25882188|FG000|Overall Study|Unrelated injury|0|||
13106066|NCT03311230|25882189|FG001|Overall Study|Unrelated injury|1|||
13106067|NCT03311230|25882190|FG002|Overall Study|Unrelated injury|0|||
13163189|NCT02409667|26094824|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6|||
13163190|NCT02409667|26094825|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
13163191|NCT02409667|26094826|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
13163192|NCT02409667|26094827|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
13163193|NCT02409667|26094828|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
13163194|NCT02409667|26094824|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6|||
13163195|NCT02409667|26094825|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
13163196|NCT02409667|26094826|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
13163197|NCT02409667|26094827|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
13163198|NCT02409667|26094828|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
13163199|NCT02409667|26094824|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20|||
13163200|NCT02409667|26094825|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
13163201|NCT02409667|26094826|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
13163202|NCT02409667|26094827|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
13163203|NCT02409667|26094828|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
13163204|NCT02409667|26094824|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1|||
13163205|NCT02409667|26094825|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
13163206|NCT02409667|26094826|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
13163207|NCT02409667|26094827|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
13106068|NCT03311230|25882191|FG003|Overall Study|Unrelated injury|0|||
13106069|NCT03310970|25882205|FG000|Overall Study|Withdrawal by Subject|0|||
13106070|NCT03310970|25882206|FG001|Overall Study|Withdrawal by Subject|1|||
13106071|NCT03310775|25882229|FG000|Overall Study|Lost to Follow-up|2|||
13106072|NCT03310775|25882230|FG001|Overall Study|Lost to Follow-up|3|||
13106073|NCT03310775|25882229|FG000|Overall Study|aggravation of depression|0|||
13106074|NCT03310775|25882230|FG001|Overall Study|aggravation of depression|1|||
13106075|NCT03310723|25882245|FG000|Overall Study|Withdrawal by Subject|0|||
13106076|NCT03310723|25882246|FG001|Overall Study|Withdrawal by Subject|1|||
13106077|NCT03310723|25882245|FG000|Overall Study|Protocol Violation|0|||
13106078|NCT03310723|25882246|FG001|Overall Study|Protocol Violation|2|||
13106079|NCT03310580|25882267|FG000|Overall Study|Adverse Event|0|||
13163208|NCT02409667|26094828|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
13163209|NCT02409667|26094824|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4|||
13163210|NCT02409667|26094825|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
13163211|NCT02409667|26094826|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
13163212|NCT02409667|26094827|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
13163213|NCT02409667|26094828|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
13163214|NCT02409667|26094824|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5|||
13163215|NCT02409667|26094825|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
13163216|NCT02409667|26094826|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
13163217|NCT02409667|26094827|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
13163218|NCT02409667|26094828|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
13163219|NCT02409667|26094824|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6|||
13163220|NCT02409667|26094825|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
13163221|NCT02409667|26094826|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
13163222|NCT02409667|26094827|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
13163223|NCT02409667|26094828|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
13163224|NCT02409667|26094824|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48|||
13163225|NCT02409667|26094825|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
13163226|NCT02409667|26094826|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
13163227|NCT02409667|26094827|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
13163228|NCT02409667|26094828|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
13163229|NCT02409667|26094824|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25|||
13163230|NCT02409667|26094825|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
13163231|NCT02409667|26094826|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
13163232|NCT02409667|26094827|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
13163233|NCT02409667|26094828|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
13163234|NCT02409667|26094824|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
13163235|NCT02409667|26094825|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7|||
13163236|NCT02409667|26094826|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4|||
13163237|NCT02409667|26094827|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3|||
13163238|NCT02409667|26094828|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
13106080|NCT03310580|25882268|FG001|Overall Study|Adverse Event|1|||
13106081|NCT03310580|25882269|FG002|Overall Study|Adverse Event|0|||
13106082|NCT03310411|25882292|FG000|Period 1|Adverse Event|0|||
13106083|NCT03310411|25882293|FG001|Period 1|Adverse Event|0|||
13163239|NCT02409667|26094824|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
13163240|NCT02409667|26094825|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
13163241|NCT02409667|26094826|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
13163242|NCT02409667|26094827|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2|||
13163243|NCT02409667|26094828|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
13163244|NCT02409667|26094824|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0|||
13163245|NCT02409667|26094825|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7|||
13163246|NCT02409667|26094826|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4|||
13163247|NCT02409667|26094827|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1|||
13163248|NCT02409667|26094828|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2|||
13163249|NCT02409667|26094824|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
13163250|NCT02409667|26094825|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5|||
13163251|NCT02409667|26094826|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4|||
13163252|NCT02409667|26094827|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
13163253|NCT02409667|26094828|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
13163254|NCT02409667|26094824|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
13163255|NCT02409667|26094825|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4|||
13163256|NCT02409667|26094826|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5|||
13163257|NCT02409667|26094827|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2|||
13163258|NCT02409667|26094828|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
13163259|NCT02409667|26094824|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
13163260|NCT02409667|26094825|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
13163261|NCT02409667|26094826|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
13163262|NCT02409667|26094827|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
13163263|NCT02409667|26094828|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
13163264|NCT02409667|26094824|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
13163265|NCT02409667|26094825|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
13163266|NCT02409667|26094826|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3|||
13163267|NCT02409667|26094827|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
13163268|NCT02409667|26094828|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
13163269|NCT02409368|26094868|FG000|ECOG Reclassification|Adverse event unrelated to study drug|17|||
13163270|NCT02409368|26094869|FG001|ECOG Reclassification|Adverse event unrelated to study drug|49|||
13163271|NCT02409368|26094870|FG002|ECOG Reclassification|Adverse event unrelated to study drug|12|||
13163272|NCT02409368|26094871|FG003|ECOG Reclassification|Adverse event unrelated to study drug|0|||
13163273|NCT02409368|26094868|FG000|ECOG Reclassification|Death|1|||
13163274|NCT02409368|26094869|FG001|ECOG Reclassification|Death|5|||
13163275|NCT02409368|26094870|FG002|ECOG Reclassification|Death|0|||
13163276|NCT02409368|26094871|FG003|ECOG Reclassification|Death|0|||
13163277|NCT02409368|26094868|FG000|ECOG Reclassification|Disease Progression|113|||
13163278|NCT02409368|26094869|FG001|ECOG Reclassification|Disease Progression|382|||
13163279|NCT02409368|26094870|FG002|ECOG Reclassification|Disease Progression|70|||
13163280|NCT02409368|26094871|FG003|ECOG Reclassification|Disease Progression|1|||
13163281|NCT02409368|26094868|FG000|ECOG Reclassification|Lost to Follow-up|1|||
13163282|NCT02409368|26094869|FG001|ECOG Reclassification|Lost to Follow-up|5|||
13163283|NCT02409368|26094870|FG002|ECOG Reclassification|Lost to Follow-up|0|||
13163284|NCT02409368|26094871|FG003|ECOG Reclassification|Lost to Follow-up|0|||
13163285|NCT02409368|26094868|FG000|ECOG Reclassification|Maximum clinical benefit|6|||
13163286|NCT02409368|26094869|FG001|ECOG Reclassification|Maximum clinical benefit|5|||
13163287|NCT02409368|26094870|FG002|ECOG Reclassification|Maximum clinical benefit|0|||
13163288|NCT02409368|26094871|FG003|ECOG Reclassification|Maximum clinical benefit|0|||
13163289|NCT02409368|26094868|FG000|ECOG Reclassification|Poor/non-compliance|0|||
13163290|NCT02409368|26094869|FG001|ECOG Reclassification|Poor/non-compliance|3|||
13163291|NCT02409368|26094870|FG002|ECOG Reclassification|Poor/non-compliance|2|||
13163292|NCT02409368|26094871|FG003|ECOG Reclassification|Poor/non-compliance|0|||
13163293|NCT02409368|26094868|FG000|ECOG Reclassification|Study drug toxicity|17|||
13163294|NCT02409368|26094869|FG001|ECOG Reclassification|Study drug toxicity|42|||
13163295|NCT02409368|26094870|FG002|ECOG Reclassification|Study drug toxicity|7|||
13163296|NCT02409368|26094871|FG003|ECOG Reclassification|Study drug toxicity|0|||
13163297|NCT02409368|26094868|FG000|ECOG Reclassification|Participant no longer meets study criteria|3|||
13163298|NCT02409368|26094869|FG001|ECOG Reclassification|Participant no longer meets study criteria|8|||
13163299|NCT02409368|26094870|FG002|ECOG Reclassification|Participant no longer meets study criteria|3|||
13163300|NCT02409368|26094871|FG003|ECOG Reclassification|Participant no longer meets study criteria|0|||
13163301|NCT02409368|26094868|FG000|ECOG Reclassification|Participant request to discontinue study treatment|6|||
13163302|NCT02409368|26094869|FG001|ECOG Reclassification|Participant request to discontinue study treatment|6|||
13163303|NCT02409368|26094870|FG002|ECOG Reclassification|Participant request to discontinue study treatment|2|||
13163304|NCT02409368|26094871|FG003|ECOG Reclassification|Participant request to discontinue study treatment|0|||
13205486|NCT01964976|26231947|FG000|Overall Study|Protocol Violation|31|||
13163305|NCT02409368|26094868|FG000|ECOG Reclassification|Participant withdrew consent|2|||
13163306|NCT02409368|26094869|FG001|ECOG Reclassification|Participant withdrew consent|3|||
13163307|NCT02409368|26094870|FG002|ECOG Reclassification|Participant withdrew consent|4|||
13163308|NCT02409368|26094871|FG003|ECOG Reclassification|Participant withdrew consent|0|||
13163309|NCT02409368|26094868|FG000|ECOG Reclassification|Other Reasons|5|||
13163310|NCT02409368|26094869|FG001|ECOG Reclassification|Other Reasons|26|||
13163311|NCT02409368|26094870|FG002|ECOG Reclassification|Other Reasons|2|||
13163312|NCT02409368|26094871|FG003|ECOG Reclassification|Other Reasons|0|||
13163313|NCT02409368|26094868|FG000|ECOG Reclassification|Administrative reason by sponsor|1|||
13163314|NCT02409368|26094869|FG001|ECOG Reclassification|Administrative reason by sponsor|3|||
13163315|NCT02409368|26094870|FG002|ECOG Reclassification|Administrative reason by sponsor|0|||
13163316|NCT02409368|26094871|FG003|ECOG Reclassification|Administrative reason by sponsor|0|||
13163317|NCT02409355|26094884|FG000|Overall Study|Withdrawal by Subject|1|||
13163318|NCT02409355|26094885|FG001|Overall Study|Withdrawal by Subject|0|||
13163319|NCT02409355|26094884|FG000|Overall Study|Death|1|||
13163320|NCT02409355|26094885|FG001|Overall Study|Death|1|||
13163321|NCT02409355|26094884|FG000|Overall Study|Study terminated by Sponsor|2|||
13163322|NCT02409355|26094885|FG001|Overall Study|Study terminated by Sponsor|3|||
13163323|NCT02408887|26094918|FG000|Overall Study|Participant was inevaluable due to advanced cancer|1|||
13163324|NCT02408887|26094919|FG001|Overall Study|Participant was inevaluable due to advanced cancer|0|||
13163325|NCT02408887|26094918|FG000|Overall Study|Participant was inevaluable due to benign pathology.|0|||
13163326|NCT02408887|26094919|FG001|Overall Study|Participant was inevaluable due to benign pathology.|1|||
13163327|NCT02408523|26094946|FG000|Overall Study|Adverse Event|4|||
13163328|NCT02408523|26094947|FG001|Overall Study|Adverse Event|10|||
13163329|NCT02408523|26094946|FG000|Overall Study|Lack of Efficacy|0|||
13163330|NCT02408523|26094947|FG001|Overall Study|Lack of Efficacy|1|||
13163331|NCT02408523|26094946|FG000|Overall Study|Protocol Violation|1|||
13163332|NCT02408523|26094947|FG001|Overall Study|Protocol Violation|2|||
13163333|NCT02408523|26094946|FG000|Overall Study|Lost to Follow-up|2|||
13163334|NCT02408523|26094947|FG001|Overall Study|Lost to Follow-up|3|||
13163335|NCT02408523|26094946|FG000|Overall Study|Withdrawal by Subject|3|||
13163336|NCT02408523|26094947|FG001|Overall Study|Withdrawal by Subject|1|||
13163337|NCT02408523|26094946|FG000|Overall Study|Sponsor request|1|||
13222842|NCT01802632|26286990|FG000|Overall Study|Ongoing Study at Data Cut-off|168|||
13163338|NCT02408523|26094947|FG001|Overall Study|Sponsor request|0|||
13163339|NCT02408523|26094946|FG000|Overall Study|Did not satisfy extension conditions|0|||
13163340|NCT02408523|26094947|FG001|Overall Study|Did not satisfy extension conditions|1|||
13163341|NCT02408484|26094981|FG000|Overall Study|Withdrawal by Subject|3|||
13163342|NCT02408484|26094981|FG000|Overall Study|Not treated during study period|1|||
13163343|NCT02408120|26095014|FG000|Overall Study|Withdrawal by Subject|0|||
13163344|NCT02408120|26095015|FG001|Overall Study|Withdrawal by Subject|1|||
13163345|NCT02408120|26095014|FG000|Overall Study|Treatment Refusal|1|||
13163346|NCT02408120|26095015|FG001|Overall Study|Treatment Refusal|0|||
13163347|NCT02408120|26095014|FG000|Overall Study|Received Steroids|1|||
13163348|NCT02408120|26095015|FG001|Overall Study|Received Steroids|1|||
13163349|NCT02408120|26095014|FG000|Overall Study|Discharged same day|1|||
13163350|NCT02408120|26095015|FG001|Overall Study|Discharged same day|1|||
13163351|NCT02408120|26095014|FG000|Overall Study|Did not receive insulin|1|||
13163352|NCT02408120|26095015|FG001|Overall Study|Did not receive insulin|2|||
13163353|NCT02408068|26095045|FG000|Treatment 3 (1.5 Days)|Adverse Event|0|||
13163354|NCT02408068|26095046|FG001|Treatment 3 (1.5 Days)|Adverse Event|0|||
13163355|NCT02408068|26095047|FG002|Treatment 3 (1.5 Days)|Adverse Event|1|||
13163356|NCT02408068|26095048|FG003|Treatment 3 (1.5 Days)|Adverse Event|0|||
13163357|NCT02408068|26095049|FG004|Treatment 3 (1.5 Days)|Adverse Event|0|||
13163358|NCT02408068|26095050|FG005|Treatment 3 (1.5 Days)|Adverse Event|0|||
13163359|NCT02408016|26095074|FG000|Overall Study|Death|6|||
13163360|NCT02408016|26095075|FG001|Overall Study|Death|1|||
13163361|NCT02408016|26095076|FG002|Overall Study|Death|0|||
13163362|NCT02408016|26095074|FG000|Overall Study|Physician Decision|0|||
13163363|NCT02408016|26095075|FG001|Overall Study|Physician Decision|2|||
13163364|NCT02408016|26095076|FG002|Overall Study|Physician Decision|0|||
13163365|NCT02407990|26095165|FG000|Overall Study|Death|2|||
13163366|NCT02407990|26095166|FG001|Overall Study|Death|22|||
13163367|NCT02407990|26095167|FG002|Overall Study|Death|23|||
13163368|NCT02407990|26095168|FG003|Overall Study|Death|7|||
13163369|NCT02407990|26095169|FG004|Overall Study|Death|17|||
13163370|NCT02407990|26095170|FG005|Overall Study|Death|16|||
13163371|NCT02407990|26095171|FG006|Overall Study|Death|10|||
13163372|NCT02407990|26095172|FG007|Overall Study|Death|248|||
13163373|NCT02407990|26095165|FG000|Overall Study|Lost to Follow-up|0|||
13163374|NCT02407990|26095166|FG001|Overall Study|Lost to Follow-up|1|||
13163375|NCT02407990|26095167|FG002|Overall Study|Lost to Follow-up|0|||
13163376|NCT02407990|26095168|FG003|Overall Study|Lost to Follow-up|0|||
13163377|NCT02407990|26095169|FG004|Overall Study|Lost to Follow-up|0|||
13163378|NCT02407990|26095170|FG005|Overall Study|Lost to Follow-up|0|||
13163379|NCT02407990|26095171|FG006|Overall Study|Lost to Follow-up|0|||
13163380|NCT02407990|26095172|FG007|Overall Study|Lost to Follow-up|17|||
13163381|NCT02407990|26095165|FG000|Overall Study|Progressive Disease|0|||
13163382|NCT02407990|26095166|FG001|Overall Study|Progressive Disease|0|||
13163383|NCT02407990|26095167|FG002|Overall Study|Progressive Disease|0|||
13163384|NCT02407990|26095168|FG003|Overall Study|Progressive Disease|0|||
13163385|NCT02407990|26095169|FG004|Overall Study|Progressive Disease|0|||
13163386|NCT02407990|26095170|FG005|Overall Study|Progressive Disease|0|||
13163387|NCT02407990|26095171|FG006|Overall Study|Progressive Disease|0|||
13163388|NCT02407990|26095172|FG007|Overall Study|Progressive Disease|1|||
13163389|NCT02407990|26095165|FG000|Overall Study|Withdrawal by Subject|0|||
13163390|NCT02407990|26095166|FG001|Overall Study|Withdrawal by Subject|0|||
13163391|NCT02407990|26095167|FG002|Overall Study|Withdrawal by Subject|0|||
13163392|NCT02407990|26095168|FG003|Overall Study|Withdrawal by Subject|0|||
13163393|NCT02407990|26095169|FG004|Overall Study|Withdrawal by Subject|1|||
13163394|NCT02407990|26095170|FG005|Overall Study|Withdrawal by Subject|0|||
13163395|NCT02407990|26095171|FG006|Overall Study|Withdrawal by Subject|0|||
13163396|NCT02407990|26095172|FG007|Overall Study|Withdrawal by Subject|30|||
13163397|NCT02407990|26095165|FG000|Overall Study|Study Terminated by Sponsor|1|||
13163398|NCT02407990|26095166|FG001|Overall Study|Study Terminated by Sponsor|3|||
13163399|NCT02407990|26095167|FG002|Overall Study|Study Terminated by Sponsor|3|||
13163400|NCT02407990|26095168|FG003|Overall Study|Study Terminated by Sponsor|0|||
13163401|NCT02407990|26095169|FG004|Overall Study|Study Terminated by Sponsor|3|||
13163402|NCT02407990|26095170|FG005|Overall Study|Study Terminated by Sponsor|4|||
13163403|NCT02407990|26095171|FG006|Overall Study|Study Terminated by Sponsor|3|||
13163404|NCT02407990|26095172|FG007|Overall Study|Study Terminated by Sponsor|37|||
13163405|NCT02407990|26095165|FG000|Overall Study|Logistics|0|||
13163406|NCT02407990|26095166|FG001|Overall Study|Logistics|0|||
13163407|NCT02407990|26095167|FG002|Overall Study|Logistics|0|||
13163408|NCT02407990|26095168|FG003|Overall Study|Logistics|0|||
13163409|NCT02407990|26095169|FG004|Overall Study|Logistics|0|||
13163410|NCT02407990|26095170|FG005|Overall Study|Logistics|0|||
13163411|NCT02407990|26095171|FG006|Overall Study|Logistics|0|||
13163412|NCT02407990|26095172|FG007|Overall Study|Logistics|1|||
13163413|NCT02407990|26095165|FG000|Overall Study|Rolled into long-term extension study|0|||
13163414|NCT02407990|26095166|FG001|Overall Study|Rolled into long-term extension study|0|||
13163415|NCT02407990|26095167|FG002|Overall Study|Rolled into long-term extension study|0|||
13163416|NCT02407990|26095168|FG003|Overall Study|Rolled into long-term extension study|0|||
13163417|NCT02407990|26095169|FG004|Overall Study|Rolled into long-term extension study|0|||
13163418|NCT02407990|26095170|FG005|Overall Study|Rolled into long-term extension study|0|||
13163419|NCT02407990|26095171|FG006|Overall Study|Rolled into long-term extension study|0|||
13163420|NCT02407990|26095172|FG007|Overall Study|Rolled into long-term extension study|1|||
13163421|NCT02407704|26095219|FG000|Overall Study|Lost to Follow-up|0|||
13163422|NCT02407704|26095220|FG001|Overall Study|Lost to Follow-up|0|||
13163423|NCT02407704|26095221|FG002|Overall Study|Lost to Follow-up|0|||
13163424|NCT02407704|26095222|FG003|Overall Study|Lost to Follow-up|2|||
13163425|NCT02407704|26095219|FG000|Overall Study|Protocol Violation|0|||
13163426|NCT02407704|26095220|FG001|Overall Study|Protocol Violation|0|||
13163427|NCT02407704|26095221|FG002|Overall Study|Protocol Violation|0|||
13163428|NCT02407704|26095222|FG003|Overall Study|Protocol Violation|1|||
13163429|NCT02407704|26095219|FG000|Overall Study|Withdrawal by Subject|0|||
13163430|NCT02407704|26095220|FG001|Overall Study|Withdrawal by Subject|0|||
13163431|NCT02407704|26095221|FG002|Overall Study|Withdrawal by Subject|1|||
13163432|NCT02407704|26095222|FG003|Overall Study|Withdrawal by Subject|0|||
13163433|NCT02407457|26095235|FG000|1 Month|Death|3|||
13163434|NCT02407457|26095236|FG001|1 Month|Death|0|||
13163435|NCT02407457|26095235|FG000|1 Month|Lost to Follow-up|1|||
13163436|NCT02407457|26095236|FG001|1 Month|Lost to Follow-up|1|||
13163437|NCT02407457|26095235|FG000|1 Month|missed visit|2|||
13163438|NCT02407457|26095236|FG001|1 Month|missed visit|6|||
13163439|NCT02407457|26095235|FG000|6-Month|Death|2|||
13163440|NCT02407457|26095236|FG001|6-Month|Death|8|||
13163441|NCT02407457|26095235|FG000|6-Month|Lost to Follow-up|2|||
13163442|NCT02407457|26095236|FG001|6-Month|Lost to Follow-up|2|||
13163443|NCT02407457|26095235|FG000|6-Month|missed visit|15|||
13163444|NCT02407457|26095236|FG001|6-Month|missed visit|12|||
13163445|NCT02407457|26095235|FG000|6-Month|Over Due|1|||
13163446|NCT02407457|26095236|FG001|6-Month|Over Due|2|||
13163447|NCT02407457|26095235|FG000|6-Month|Open Repair|0|||
13163448|NCT02407457|26095236|FG001|6-Month|Open Repair|1|||
13163449|NCT02407457|26095235|FG000|1 Year|Death|6|||
13163450|NCT02407457|26095236|FG001|1 Year|Death|11|||
13163451|NCT02407457|26095235|FG000|1 Year|Lost to Follow-up|3|||
13163452|NCT02407457|26095236|FG001|1 Year|Lost to Follow-up|2|||
13163453|NCT02407457|26095235|FG000|1 Year|Missed Visit|18|||
13163454|NCT02407457|26095236|FG001|1 Year|Missed Visit|10|||
13163455|NCT02407457|26095235|FG000|1 Year|Over Due|6|||
13163456|NCT02407457|26095236|FG001|1 Year|Over Due|4|||
13163457|NCT02407457|26095235|FG000|1 Year|Open Repair|0|||
13163458|NCT02407457|26095236|FG001|1 Year|Open Repair|1|||
13163459|NCT02407457|26095235|FG000|2-year|Death|14|||
13163460|NCT02407457|26095236|FG001|2-year|Death|8|||
13163461|NCT02407457|26095235|FG000|2-year|Lost to Follow-up|6|||
13163462|NCT02407457|26095236|FG001|2-year|Lost to Follow-up|9|||
13163463|NCT02407457|26095235|FG000|2-year|Missed Visit|13|||
13163464|NCT02407457|26095236|FG001|2-year|Missed Visit|11|||
13163465|NCT02407457|26095235|FG000|2-year|Over Due|1|||
13163466|NCT02407457|26095236|FG001|2-year|Over Due|5|||
13163467|NCT02407457|26095235|FG000|2-year|Open Repair|0|||
13163468|NCT02407457|26095236|FG001|2-year|Open Repair|2|||
13163469|NCT02407457|26095235|FG000|3-year|Death|11|||
13163470|NCT02407457|26095236|FG001|3-year|Death|10|||
13163471|NCT02407457|26095235|FG000|3-year|Lost to Follow-up|6|||
13163472|NCT02407457|26095236|FG001|3-year|Lost to Follow-up|9|||
13163473|NCT02407457|26095235|FG000|3-year|Missed Visit|21|||
13163474|NCT02407457|26095236|FG001|3-year|Missed Visit|16|||
13163475|NCT02407457|26095235|FG000|3-year|Over Due|4|||
13163476|NCT02407457|26095236|FG001|3-year|Over Due|3|||
13163477|NCT02407457|26095235|FG000|4-year|Death|14|||
13163478|NCT02407457|26095236|FG001|4-year|Death|7|||
13106084|NCT03310411|25882294|FG002|Period 1|Adverse Event|0|||
13106085|NCT03310411|25882295|FG003|Period 1|Adverse Event|1|||
13106086|NCT03310268|25882316|FG000|Overall Study|(Not specified)|1|||
13106087|NCT03310268|25882317|FG001|Overall Study|(Not specified)|5|||
13106088|NCT03310268|25882318|FG002|Overall Study|(Not specified)|0|||
13106089|NCT03310021|25882521|FG000|Overall Study|Withdrawal by Subject|0|||
13106090|NCT03310021|25882522|FG001|Overall Study|Withdrawal by Subject|0|||
13106091|NCT03310021|25882523|FG002|Overall Study|Withdrawal by Subject|0|||
13106092|NCT03310021|25882524|FG003|Overall Study|Withdrawal by Subject|0|||
13106093|NCT03310021|25882525|FG004|Overall Study|Withdrawal by Subject|0|||
13106094|NCT03310021|25882526|FG005|Overall Study|Withdrawal by Subject|0|||
13106095|NCT03310021|25882527|FG006|Overall Study|Withdrawal by Subject|1|||
13106096|NCT03310021|25882528|FG007|Overall Study|Withdrawal by Subject|0|||
13106097|NCT03310021|25882529|FG008|Overall Study|Withdrawal by Subject|0|||
13106098|NCT03310021|25882530|FG009|Overall Study|Withdrawal by Subject|0|||
13106099|NCT03310021|25882531|FG010|Overall Study|Withdrawal by Subject|0|||
13106100|NCT03310021|25882532|FG011|Overall Study|Withdrawal by Subject|0|||
13106101|NCT03310021|25882533|FG012|Overall Study|Withdrawal by Subject|0|||
13106102|NCT03310021|25882534|FG013|Overall Study|Withdrawal by Subject|0|||
13163479|NCT02407457|26095235|FG000|4-year|Lost to Follow-up|9|||
13163480|NCT02407457|26095236|FG001|4-year|Lost to Follow-up|12|||
13163481|NCT02407457|26095235|FG000|4-year|Over Due|10|||
13163482|NCT02407457|26095236|FG001|4-year|Over Due|5|||
13163483|NCT02407457|26095235|FG000|4-year|Missed Visit|13|||
13163484|NCT02407457|26095236|FG001|4-year|Missed Visit|13|||
13163485|NCT02407457|26095235|FG000|4-year|Pending visit|19|||
13163486|NCT02407457|26095236|FG001|4-year|Pending visit|14|||
13106103|NCT03310021|25882535|FG014|Overall Study|Withdrawal by Subject|0|||
13106104|NCT03310021|25882536|FG015|Overall Study|Withdrawal by Subject|0|||
13106105|NCT03310021|25882537|FG016|Overall Study|Withdrawal by Subject|0|||
13106106|NCT03310021|25882538|FG017|Overall Study|Withdrawal by Subject|0|||
13106107|NCT03310021|25882539|FG018|Overall Study|Withdrawal by Subject|0|||
13106108|NCT03310021|25882540|FG019|Overall Study|Withdrawal by Subject|0|||
13106109|NCT03310021|25882521|FG000|Overall Study|Lost to Follow-up|0|||
13106110|NCT03310021|25882522|FG001|Overall Study|Lost to Follow-up|0|||
13106111|NCT03310021|25882523|FG002|Overall Study|Lost to Follow-up|0|||
13106112|NCT03310021|25882524|FG003|Overall Study|Lost to Follow-up|0|||
13106113|NCT03310021|25882525|FG004|Overall Study|Lost to Follow-up|0|||
13106114|NCT03310021|25882526|FG005|Overall Study|Lost to Follow-up|0|||
13106115|NCT03310021|25882527|FG006|Overall Study|Lost to Follow-up|0|||
13106116|NCT03310021|25882528|FG007|Overall Study|Lost to Follow-up|0|||
13106117|NCT03310021|25882529|FG008|Overall Study|Lost to Follow-up|0|||
13106118|NCT03310021|25882530|FG009|Overall Study|Lost to Follow-up|0|||
13106119|NCT03310021|25882531|FG010|Overall Study|Lost to Follow-up|1|||
13106120|NCT03310021|25882532|FG011|Overall Study|Lost to Follow-up|0|||
13106121|NCT03310021|25882533|FG012|Overall Study|Lost to Follow-up|0|||
13106122|NCT03310021|25882534|FG013|Overall Study|Lost to Follow-up|0|||
13106123|NCT03310021|25882535|FG014|Overall Study|Lost to Follow-up|0|||
13106124|NCT03310021|25882536|FG015|Overall Study|Lost to Follow-up|0|||
13106125|NCT03310021|25882537|FG016|Overall Study|Lost to Follow-up|0|||
13106126|NCT03310021|25882538|FG017|Overall Study|Lost to Follow-up|0|||
13106127|NCT03310021|25882539|FG018|Overall Study|Lost to Follow-up|0|||
13106128|NCT03310021|25882540|FG019|Overall Study|Lost to Follow-up|0|||
13106129|NCT03309943|25882573|FG000|Overall Study|Withdrawal by Subject|0|||
13106130|NCT03309943|25882574|FG001|Overall Study|Withdrawal by Subject|1|||
13106131|NCT03309943|25882573|FG000|Overall Study|Inappropriate behavior towards staff|0|||
13106132|NCT03309943|25882574|FG001|Overall Study|Inappropriate behavior towards staff|1|||
13106133|NCT03309696|25882591|FG000|Overall Study|Analysis of TEP data could not be completed|0|||
13106134|NCT03309696|25882592|FG001|Overall Study|Analysis of TEP data could not be completed|5|||
13163487|NCT02407457|26095235|FG000|4-year|Not Due|16|||
13163488|NCT02407457|26095236|FG001|4-year|Not Due|10|||
13106135|NCT03309696|25882593|FG002|Overall Study|Analysis of TEP data could not be completed|0|||
13163489|NCT02407457|26095235|FG000|5-year|Death|6|||
13163490|NCT02407457|26095236|FG001|5-year|Death|1|||
13163491|NCT02407457|26095235|FG000|5-year|Lost to Follow-up|4|||
13106136|NCT03309696|25882594|FG003|Overall Study|Analysis of TEP data could not be completed|0|||
13106137|NCT03309605|25882723|FG000|Overall Study|Adverse Event|0|||
13106138|NCT03309605|25882724|FG001|Overall Study|Adverse Event|0|||
13106139|NCT03309605|25882725|FG002|Overall Study|Adverse Event|0|||
13106140|NCT03309605|25882726|FG003|Overall Study|Adverse Event|1|||
13106141|NCT03309605|25882727|FG004|Overall Study|Adverse Event|0|||
13106142|NCT03309605|25882728|FG005|Overall Study|Adverse Event|0|||
13106143|NCT03309605|25882729|FG006|Overall Study|Adverse Event|2|||
13106144|NCT03309605|25882730|FG007|Overall Study|Adverse Event|1|||
13106145|NCT03309605|25882723|FG000|Overall Study|Withdrawal by Subject|0|||
13106146|NCT03309605|25882724|FG001|Overall Study|Withdrawal by Subject|0|||
13106147|NCT03309605|25882725|FG002|Overall Study|Withdrawal by Subject|0|||
13106148|NCT03309605|25882726|FG003|Overall Study|Withdrawal by Subject|0|||
13106149|NCT03309605|25882727|FG004|Overall Study|Withdrawal by Subject|1|||
13106150|NCT03309605|25882728|FG005|Overall Study|Withdrawal by Subject|0|||
13106151|NCT03309605|25882729|FG006|Overall Study|Withdrawal by Subject|1|||
13106152|NCT03309605|25882730|FG007|Overall Study|Withdrawal by Subject|1|||
13106153|NCT03309202|25882825|FG000|Overall Study|Lost to Follow-up|1|||
13106154|NCT03309202|25882826|FG001|Overall Study|Lost to Follow-up|0|||
13106155|NCT03309202|25882827|FG002|Overall Study|Lost to Follow-up|0|||
13106156|NCT03309202|25882828|FG003|Overall Study|Lost to Follow-up|0|||
13106157|NCT03309020|25882858|FG000|Overall Study|Death|1|||
13106158|NCT03309020|25882859|FG001|Overall Study|Death|0|||
13106159|NCT03309020|25882858|FG000|Overall Study|Did not undergo surgery|2|||
13106160|NCT03309020|25882859|FG001|Overall Study|Did not undergo surgery|1|||
13106161|NCT03308968|25882943|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3|||
13106162|NCT03308968|25882944|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1|||
13106163|NCT03308968|25882945|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4|||
13106164|NCT03308968|25882943|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
13106165|NCT03308968|25882944|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
13163492|NCT02407457|26095236|FG001|5-year|Lost to Follow-up|4|||
13163493|NCT02407457|26095235|FG000|5-year|Missed Visit|10|||
13163494|NCT02407457|26095236|FG001|5-year|Missed Visit|9|||
13163495|NCT02407457|26095235|FG000|5-year|Pending Visit|18|||
13163496|NCT02407457|26095236|FG001|5-year|Pending Visit|17|||
13163497|NCT02407457|26095235|FG000|5-year|Not Due|54|||
13163498|NCT02407457|26095236|FG001|5-year|Not Due|46|||
13163499|NCT02407249|26095246|FG000|Overall Study|Did not complete 12-month follow-up|13|||
13163500|NCT02407249|26095246|FG000|Overall Study|Not treated|13|||
13163501|NCT02407223|26095299|FG000|Overall Study|Adverse Event|1|||
13163502|NCT02407223|26095300|FG001|Overall Study|Adverse Event|0|||
13163503|NCT02407223|26095301|FG002|Overall Study|Adverse Event|1|||
13163504|NCT02407223|26095299|FG000|Overall Study|Lack of Efficacy|6|||
13163505|NCT02407223|26095300|FG001|Overall Study|Lack of Efficacy|6|||
13163506|NCT02407223|26095301|FG002|Overall Study|Lack of Efficacy|4|||
13163507|NCT02407223|26095299|FG000|Overall Study|Lost to Follow-up|1|||
13163508|NCT02407223|26095300|FG001|Overall Study|Lost to Follow-up|0|||
13163509|NCT02407223|26095301|FG002|Overall Study|Lost to Follow-up|2|||
13163510|NCT02407223|26095299|FG000|Overall Study|Withdrawal by Subject|2|||
13163511|NCT02407223|26095300|FG001|Overall Study|Withdrawal by Subject|4|||
13163512|NCT02407223|26095301|FG002|Overall Study|Withdrawal by Subject|4|||
13163513|NCT02407223|26095299|FG000|Overall Study|Study Terminated by Sponsor|77|||
13163514|NCT02407223|26095300|FG001|Overall Study|Study Terminated by Sponsor|80|||
13163515|NCT02407223|26095301|FG002|Overall Study|Study Terminated by Sponsor|86|||
13163516|NCT02407223|26095299|FG000|Overall Study|Subject Refused Further Study Treatment|0|||
13163517|NCT02407223|26095300|FG001|Overall Study|Subject Refused Further Study Treatment|1|||
13163518|NCT02407223|26095301|FG002|Overall Study|Subject Refused Further Study Treatment|0|||
13163519|NCT02407223|26095299|FG000|Overall Study|Other|29|||
13163520|NCT02407223|26095300|FG001|Overall Study|Other|27|||
13163521|NCT02407223|26095301|FG002|Overall Study|Other|25|||
13163522|NCT02407054|26095326|FG000|Overall Study|Adverse Event|1|||
13163523|NCT02407054|26095327|FG001|Overall Study|Adverse Event|4|||
13163524|NCT02407054|26095328|FG002|Overall Study|Adverse Event|1|||
13163525|NCT02407054|26095326|FG000|Overall Study|Non-compliance with Study|0|||
13163526|NCT02407054|26095327|FG001|Overall Study|Non-compliance with Study|2|||
13163527|NCT02407054|26095328|FG002|Overall Study|Non-compliance with Study|1|||
13163528|NCT02407054|26095326|FG000|Overall Study|Physician Decision|1|||
13163529|NCT02407054|26095327|FG001|Overall Study|Physician Decision|3|||
13163530|NCT02407054|26095328|FG002|Overall Study|Physician Decision|3|||
13163531|NCT02407054|26095326|FG000|Overall Study|Withdrawal by Subject|5|||
13163532|NCT02407054|26095327|FG001|Overall Study|Withdrawal by Subject|9|||
13163533|NCT02407054|26095328|FG002|Overall Study|Withdrawal by Subject|2|||
13163534|NCT02406742|26095376|FG000|Overall Study|Progression of Disease|5|||
13163535|NCT02406742|26095377|FG001|Overall Study|Progression of Disease|1|||
13163536|NCT02406742|26095378|FG002|Overall Study|Progression of Disease|6|||
13163537|NCT02406742|26095376|FG000|Overall Study|Adverse Event|3|||
13163538|NCT02406742|26095377|FG001|Overall Study|Adverse Event|0|||
13163539|NCT02406742|26095378|FG002|Overall Study|Adverse Event|2|||
13163540|NCT02406742|26095376|FG000|Overall Study|Death|1|||
13163541|NCT02406742|26095377|FG001|Overall Study|Death|0|||
13163542|NCT02406742|26095378|FG002|Overall Study|Death|0|||
13163543|NCT02406742|26095376|FG000|Overall Study|Lack of Efficacy|0|||
13163544|NCT02406742|26095377|FG001|Overall Study|Lack of Efficacy|0|||
13163545|NCT02406742|26095378|FG002|Overall Study|Lack of Efficacy|1|||
13163546|NCT02406742|26095376|FG000|Overall Study|Withdrawal by Participant|1|||
13163547|NCT02406742|26095377|FG001|Overall Study|Withdrawal by Participant|2|||
13163548|NCT02406742|26095378|FG002|Overall Study|Withdrawal by Participant|0|||
13163549|NCT02406742|26095376|FG000|Overall Study|Physician Decision|1|||
13163550|NCT02406742|26095377|FG001|Overall Study|Physician Decision|2|||
13163551|NCT02406742|26095378|FG002|Overall Study|Physician Decision|1|||
13163552|NCT02406742|26095376|FG000|Overall Study|Transition to other treatment|2|||
13163553|NCT02406742|26095377|FG001|Overall Study|Transition to other treatment|0|||
13163554|NCT02406742|26095378|FG002|Overall Study|Transition to other treatment|1|||
13163555|NCT02406742|26095376|FG000|Overall Study|Other Reasons|1|||
13163556|NCT02406742|26095377|FG001|Overall Study|Other Reasons|11|||
13163557|NCT02406742|26095378|FG002|Overall Study|Other Reasons|5|||
13163558|NCT02406677|26095397|FG000|Overall Study|Death|16|||
13163559|NCT02406677|26095398|FG001|Overall Study|Death|8|||
13163560|NCT02406677|26095397|FG000|Overall Study|Discharged without P2Y12|1|||
13163561|NCT02406677|26095398|FG001|Overall Study|Discharged without P2Y12|3|||
13163562|NCT02406677|26095397|FG000|Overall Study|Discharged on prasugrel|283|||
13163563|NCT02406677|26095398|FG001|Overall Study|Discharged on prasugrel|587|||
13163564|NCT02406677|26095397|FG000|Overall Study|Withdrawal by Subject|1|||
13163565|NCT02406677|26095398|FG001|Overall Study|Withdrawal by Subject|0|||
13163566|NCT02406651|26095408|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3|||
13163567|NCT02406612|26095427|FG000|Overall Study|Screening Failure|3|||
13163568|NCT02406612|26095428|FG001|Overall Study|Screening Failure|0|||
13163569|NCT02406612|26095427|FG000|Overall Study|Intra-procedural Exclusion|1|||
13163570|NCT02406612|26095428|FG001|Overall Study|Intra-procedural Exclusion|3|||
13163571|NCT02406612|26095427|FG000|Overall Study|Guidewire Failure|0|||
13163572|NCT02406612|26095428|FG001|Overall Study|Guidewire Failure|1|||
13163573|NCT02406586|26095512|FG000|Overall Study|Lost to Follow-up|0|||
13163574|NCT02406586|26095513|FG001|Overall Study|Lost to Follow-up|4|||
13163575|NCT02406586|26095514|FG002|Overall Study|Lost to Follow-up|2|||
13163576|NCT02406586|26095512|FG000|Overall Study|Withdrawal by Subject|1|||
13163577|NCT02406586|26095513|FG001|Overall Study|Withdrawal by Subject|0|||
13163578|NCT02406586|26095514|FG002|Overall Study|Withdrawal by Subject|0|||
13163579|NCT02406261|26095533|FG000|Period 1|Lost to Follow-up|2|||
13163580|NCT02406261|26095534|FG001|Period 1|Lost to Follow-up|0|||
13163581|NCT02406261|26095533|FG000|Period 1|Adverse Event|1|||
13163582|NCT02406261|26095534|FG001|Period 1|Adverse Event|0|||
13163583|NCT02406261|26095533|FG000|Period 2|Physician Decision|0|||
13163584|NCT02406261|26095534|FG001|Period 2|Physician Decision|1|||
13106166|NCT03308968|25882945|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3|||
13106167|NCT03308968|25882943|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6|||
13106168|NCT03308968|25882944|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0|||
13106169|NCT03308968|25882945|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2|||
13106170|NCT03308968|25882943|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
13106171|NCT03308968|25882944|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
13106172|NCT03308968|25882945|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0|||
13106173|NCT03308968|25882943|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1|||
13106174|NCT03308968|25882944|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
13106175|NCT03308968|25882945|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
13106176|NCT03308968|25882943|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
13106177|NCT03308968|25882944|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
13106178|NCT03308968|25882945|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0|||
13106179|NCT03308968|25882943|FG000|Double-Blind Period (12 Weeks)|Other than specified|1|||
13106180|NCT03308968|25882944|FG001|Double-Blind Period (12 Weeks)|Other than specified|0|||
13106181|NCT03308968|25882945|FG002|Double-Blind Period (12 Weeks)|Other than specified|2|||
13106182|NCT03308968|25882943|FG000|Open-Label Period (12 Weeks)|Other than specified|1|||
13106183|NCT03308968|25882944|FG001|Open-Label Period (12 Weeks)|Other than specified|2|||
13106184|NCT03308968|25882945|FG002|Open-Label Period (12 Weeks)|Other than specified|1|||
13106185|NCT03308968|25882943|FG000|Open-Label Period (12 Weeks)|Adverse Event|4|||
13163585|NCT02406261|26095533|FG000|Period 2|Protocol Violation|0|||
13163586|NCT02406261|26095534|FG001|Period 2|Protocol Violation|1|||
13163587|NCT02406261|26095533|FG000|Period 2|Withdrawal by Subject|0|||
13163588|NCT02406261|26095534|FG001|Period 2|Withdrawal by Subject|1|||
13163589|NCT02406248|26095544|FG000|Overall Study|Death|7|||
13163590|NCT02406248|26095544|FG000|Overall Study|Withdrawal by Subject|2|||
13163591|NCT02405962|26095585|FG000|Overall Study|Lost to Follow-up|1|||
13163592|NCT02405962|26095586|FG001|Overall Study|Lost to Follow-up|4|||
13163593|NCT02405962|26095585|FG000|Overall Study|A participant has moved to another place|0|||
13163594|NCT02405962|26095586|FG001|Overall Study|A participant has moved to another place|1|||
13163595|NCT02405780|26095658|FG000|Period I|Adverse Event|8|||
13163596|NCT02405780|26095659|FG001|Period I|Adverse Event|0|||
13163597|NCT02405780|26095660|FG002|Period I|Adverse Event|3|||
13163598|NCT02405780|26095661|FG003|Period I|Adverse Event|7|||
13163599|NCT02405780|26095658|FG000|Period I|Medical reasons|1|||
13163600|NCT02405780|26095659|FG001|Period I|Medical reasons|1|||
13163601|NCT02405780|26095660|FG002|Period I|Medical reasons|0|||
13163602|NCT02405780|26095661|FG003|Period I|Medical reasons|1|||
13106186|NCT03308968|25882944|FG001|Open-Label Period (12 Weeks)|Adverse Event|1|||
13106187|NCT03308968|25882945|FG002|Open-Label Period (12 Weeks)|Adverse Event|1|||
13106188|NCT03308968|25882943|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
13106189|NCT03308968|25882944|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
13106190|NCT03308968|25882945|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7|||
13106191|NCT03308968|25882943|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0|||
13106192|NCT03308968|25882944|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1|||
13106193|NCT03308968|25882945|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1|||
13106194|NCT03308968|25882943|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
13106195|NCT03308968|25882944|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
13106196|NCT03308968|25882945|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1|||
13106197|NCT03308968|25882943|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0|||
13106198|NCT03308968|25882944|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
13106199|NCT03308968|25882945|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
13106200|NCT03308968|25882943|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1|||
13106201|NCT03308968|25882944|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2|||
13106202|NCT03308968|25882945|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0|||
13106203|NCT03308942|25883008|FG000|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
13106204|NCT03308942|25883009|FG001|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
13163603|NCT02405780|26095658|FG000|Period I|Screening Failure|1|||
13163604|NCT02405780|26095659|FG001|Period I|Screening Failure|0|||
13163605|NCT02405780|26095660|FG002|Period I|Screening Failure|1|||
13163606|NCT02405780|26095661|FG003|Period I|Screening Failure|0|||
13163607|NCT02405780|26095658|FG000|Period I|Withdrawal by Subject|9|||
13163608|NCT02405780|26095659|FG001|Period I|Withdrawal by Subject|1|||
13163609|NCT02405780|26095660|FG002|Period I|Withdrawal by Subject|3|||
13163610|NCT02405780|26095661|FG003|Period I|Withdrawal by Subject|4|||
13163611|NCT02405780|26095658|FG000|Period I|Non-compliance with study procedures|8|||
13163612|NCT02405780|26095659|FG001|Period I|Non-compliance with study procedures|6|||
13163613|NCT02405780|26095660|FG002|Period I|Non-compliance with study procedures|8|||
13163614|NCT02405780|26095661|FG003|Period I|Non-compliance with study procedures|11|||
13163615|NCT02405780|26095658|FG000|Period II|Adverse Event|3|||
13163616|NCT02405780|26095659|FG001|Period II|Adverse Event|5|||
13163617|NCT02405780|26095660|FG002|Period II|Adverse Event|4|||
13163618|NCT02405780|26095661|FG003|Period II|Adverse Event|11|||
13163619|NCT02405780|26095658|FG000|Period II|Medical reason|0|||
13163620|NCT02405780|26095659|FG001|Period II|Medical reason|1|||
13163621|NCT02405780|26095660|FG002|Period II|Medical reason|0|||
13163622|NCT02405780|26095661|FG003|Period II|Medical reason|0|||
13163623|NCT02405780|26095658|FG000|Period II|Pregnancy|0|||
13163624|NCT02405780|26095659|FG001|Period II|Pregnancy|0|||
13106205|NCT03308942|25883010|FG002|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|2|||
13106206|NCT03308942|25883011|FG003|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
13106207|NCT03308942|25883012|FG004|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
13106208|NCT03308942|25883008|FG000|Stage 1 (Up to a Maximum of 45 Months)|Death|11|||
13106209|NCT03308942|25883009|FG001|Stage 1 (Up to a Maximum of 45 Months)|Death|16|||
13106210|NCT03308942|25883010|FG002|Stage 1 (Up to a Maximum of 45 Months)|Death|1|||
13106211|NCT03308942|25883011|FG003|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
13106212|NCT03308942|25883012|FG004|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
13106213|NCT03308942|25883008|FG000|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
13106214|NCT03308942|25883009|FG001|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|1|||
13106215|NCT03308942|25883010|FG002|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
13106216|NCT03308942|25883011|FG003|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
13106217|NCT03308942|25883012|FG004|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
13106218|NCT03308942|25883008|FG000|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|3|||
13106219|NCT03308942|25883009|FG001|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|1|||
13163625|NCT02405780|26095660|FG002|Period II|Pregnancy|1|||
13163626|NCT02405780|26095661|FG003|Period II|Pregnancy|0|||
13163627|NCT02405780|26095658|FG000|Period II|Withdrawal by Subject|7|||
13163628|NCT02405780|26095659|FG001|Period II|Withdrawal by Subject|4|||
13163629|NCT02405780|26095660|FG002|Period II|Withdrawal by Subject|0|||
13163630|NCT02405780|26095661|FG003|Period II|Withdrawal by Subject|3|||
13163631|NCT02405780|26095658|FG000|Period II|Non-compliance with study procedures|5|||
13163632|NCT02405780|26095659|FG001|Period II|Non-compliance with study procedures|2|||
13163633|NCT02405780|26095660|FG002|Period II|Non-compliance with study procedures|7|||
13163634|NCT02405780|26095661|FG003|Period II|Non-compliance with study procedures|4|||
13106220|NCT03308942|25883010|FG002|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
13106221|NCT03308942|25883011|FG003|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
13106222|NCT03308942|25883012|FG004|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
13106223|NCT03308942|25883008|FG000|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
13106224|NCT03308942|25883009|FG001|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
13106225|NCT03308942|25883010|FG002|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
13106226|NCT03308942|25883011|FG003|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|3|||
13106227|NCT03308942|25883012|FG004|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
13106228|NCT03308942|25883008|FG000|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
13106229|NCT03308942|25883009|FG001|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
13106230|NCT03308942|25883010|FG002|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
13106231|NCT03308942|25883011|FG003|Stage 2 (Up to a Maximum of 29 Months)|Death|6|||
13106232|NCT03308942|25883012|FG004|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
13106233|NCT03308942|25883008|FG000|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
13106234|NCT03308942|25883009|FG001|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
13106235|NCT03308942|25883010|FG002|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
13106236|NCT03308942|25883011|FG003|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|3|||
13106237|NCT03308942|25883012|FG004|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
13106238|NCT03308825|25883051|FG000|Overall Study|Lost to Follow-up|2|||
13106239|NCT03308825|25883052|FG001|Overall Study|Lost to Follow-up|2|||
13106240|NCT03308825|25883053|FG002|Overall Study|Lost to Follow-up|1|||
13106241|NCT03308825|25883054|FG003|Overall Study|Lost to Follow-up|0|||
13106242|NCT03308825|25883051|FG000|Overall Study|Protocol Violation|0|||
13106243|NCT03308825|25883052|FG001|Overall Study|Protocol Violation|2|||
13106244|NCT03308825|25883053|FG002|Overall Study|Protocol Violation|0|||
13106245|NCT03308825|25883054|FG003|Overall Study|Protocol Violation|0|||
13106246|NCT03308786|25883067|FG000|Overall Study|study terminated after discussion with Safety Monitoring Committee|9|||
13106247|NCT03307837|25883118|FG000|Overall Study|Withdrawal by Subject|0|||
13106248|NCT03307837|25883119|FG001|Overall Study|Withdrawal by Subject|0|||
13106249|NCT03307837|25883120|FG002|Overall Study|Withdrawal by Subject|1|||
13106250|NCT03307837|25883121|FG003|Overall Study|Withdrawal by Subject|0|||
13106251|NCT03307837|25883122|FG004|Overall Study|Withdrawal by Subject|0|||
13106252|NCT03307837|25883123|FG005|Overall Study|Withdrawal by Subject|1|||
13106253|NCT03307837|25883118|FG000|Overall Study|Lost to Follow-up|1|||
13106254|NCT03307837|25883119|FG001|Overall Study|Lost to Follow-up|1|||
13106255|NCT03307837|25883120|FG002|Overall Study|Lost to Follow-up|0|||
13106256|NCT03307837|25883121|FG003|Overall Study|Lost to Follow-up|0|||
13106257|NCT03307837|25883122|FG004|Overall Study|Lost to Follow-up|0|||
13106258|NCT03307837|25883123|FG005|Overall Study|Lost to Follow-up|1|||
13106259|NCT03307252|25883192|FG000|Part 2, Period 1|Treatment not received|0|||
13106260|NCT03307252|25883193|FG001|Part 2, Period 1|Treatment not received|0|||
13106261|NCT03307252|25883194|FG002|Part 2, Period 1|Treatment not received|0|||
13106262|NCT03307252|25883195|FG003|Part 2, Period 1|Treatment not received|0|||
13106263|NCT03307252|25883196|FG004|Part 2, Period 1|Treatment not received|0|||
13106264|NCT03307252|25883197|FG005|Part 2, Period 1|Treatment not received|1|||
13106265|NCT03307252|25883198|FG006|Part 2, Period 1|Treatment not received|0|||
13106266|NCT03307252|25883199|FG007|Part 2, Period 1|Treatment not received|0|||
13106267|NCT03307252|25883200|FG008|Part 2, Period 1|Treatment not received|0|||
13106268|NCT03307252|25883201|FG009|Part 2, Period 1|Treatment not received|0|||
13106269|NCT03307252|25883202|FG010|Part 2, Period 1|Treatment not received|0|||
13106270|NCT03307252|25883192|FG000|Part 2, Period 3|Other than listed|0|||
13106271|NCT03307252|25883193|FG001|Part 2, Period 3|Other than listed|0|||
13106272|NCT03307252|25883194|FG002|Part 2, Period 3|Other than listed|0|||
13222843|NCT01802632|26286991|FG001|Overall Study|Ongoing Study at Data Cut-off|16|||
13222844|NCT01802632|26286992|FG002|Overall Study|Ongoing Study at Data Cut-off|115|||
13222845|NCT01802632|26286993|FG003|Overall Study|Ongoing Study at Data Cut-off|50|||
13222846|NCT01802632|26286994|FG004|Overall Study|Ongoing Study at Data Cut-off|6|||
13222847|NCT01802632|26286995|FG005|Overall Study|Ongoing Study at Data Cut-off|22|||
13222848|NCT01802632|26286990|FG000|Overall Study|Other (not specified)|0|||
13222849|NCT01802632|26286991|FG001|Overall Study|Other (not specified)|0|||
13222850|NCT01802632|26286992|FG002|Overall Study|Other (not specified)|7|||
13222851|NCT01802632|26286993|FG003|Overall Study|Other (not specified)|1|||
13222852|NCT01802632|26286994|FG004|Overall Study|Other (not specified)|0|||
13106273|NCT03307252|25883195|FG003|Part 2, Period 3|Other than listed|0|||
13106274|NCT03307252|25883196|FG004|Part 2, Period 3|Other than listed|1|||
13106275|NCT03307252|25883197|FG005|Part 2, Period 3|Other than listed|0|||
13106276|NCT03307252|25883198|FG006|Part 2, Period 3|Other than listed|0|||
13106277|NCT03307252|25883199|FG007|Part 2, Period 3|Other than listed|0|||
13106278|NCT03307252|25883200|FG008|Part 2, Period 3|Other than listed|0|||
13106279|NCT03307252|25883201|FG009|Part 2, Period 3|Other than listed|0|||
13106280|NCT03307252|25883202|FG010|Part 2, Period 3|Other than listed|0|||
13106281|NCT03307252|25883192|FG000|Part 2, Period 4|Other than listed|0|||
13106282|NCT03307252|25883193|FG001|Part 2, Period 4|Other than listed|0|||
13163635|NCT02405442|26095700|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0|||
13163636|NCT02405442|26095701|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2|||
13163637|NCT02405442|26095702|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4|||
13163638|NCT02405442|26095703|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1|||
13163639|NCT02405442|26095700|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
13163640|NCT02405442|26095701|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1|||
13163641|NCT02405442|26095702|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2|||
13163642|NCT02405442|26095703|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
13163643|NCT02405442|26095700|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
13163644|NCT02405442|26095701|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
13163645|NCT02405442|26095702|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
13163646|NCT02405442|26095703|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
13163647|NCT02405442|26095700|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
13163648|NCT02405442|26095701|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1|||
13163649|NCT02405442|26095702|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
13163650|NCT02405442|26095703|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
13163651|NCT02405442|26095700|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27|||
13106283|NCT03307252|25883194|FG002|Part 2, Period 4|Other than listed|0|||
13106284|NCT03307252|25883195|FG003|Part 2, Period 4|Other than listed|0|||
13106285|NCT03307252|25883196|FG004|Part 2, Period 4|Other than listed|0|||
13106286|NCT03307252|25883197|FG005|Part 2, Period 4|Other than listed|0|||
13106287|NCT03307252|25883198|FG006|Part 2, Period 4|Other than listed|1|||
13106288|NCT03307252|25883199|FG007|Part 2, Period 4|Other than listed|0|||
13106289|NCT03307252|25883200|FG008|Part 2, Period 4|Other than listed|0|||
13106290|NCT03307252|25883201|FG009|Part 2, Period 4|Other than listed|0|||
13106291|NCT03307252|25883202|FG010|Part 2, Period 4|Other than listed|0|||
13106292|NCT03307252|25883192|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
13106293|NCT03307252|25883193|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
13163652|NCT02405442|26095701|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
13163653|NCT02405442|26095702|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
13163654|NCT02405442|26095703|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13|||
13163655|NCT02405442|26095700|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14|||
13163656|NCT02405442|26095701|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
13163657|NCT02405442|26095702|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
13163658|NCT02405442|26095703|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2|||
13163659|NCT02405442|26095700|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6|||
13163660|NCT02405442|26095701|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1|||
13163661|NCT02405442|26095702|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2|||
13163662|NCT02405442|26095703|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6|||
13163663|NCT02405442|26095700|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0|||
13163664|NCT02405442|26095701|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1|||
13163665|NCT02405442|26095702|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3|||
13163666|NCT02405442|26095703|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2|||
13163667|NCT02405442|26095700|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
13163668|NCT02405442|26095701|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2|||
13163669|NCT02405442|26095702|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
13163670|NCT02405442|26095703|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
13222853|NCT01802632|26286995|FG005|Overall Study|Other (not specified)|1|||
13222854|NCT01802580|26287013|FG000|Overall Study|Physician Decision|1|||
13222855|NCT01802580|26287014|FG001|Overall Study|Physician Decision|0|||
13222856|NCT01802580|26287013|FG000|Overall Study|Protocol Violation|2|||
13222857|NCT01802580|26287014|FG001|Overall Study|Protocol Violation|0|||
13222858|NCT01802580|26287013|FG000|Overall Study|Withdrawal by Subject|5|||
13222859|NCT01802580|26287014|FG001|Overall Study|Withdrawal by Subject|6|||
13222860|NCT01802580|26287013|FG000|Overall Study|Other|1|||
13222861|NCT01802580|26287014|FG001|Overall Study|Other|3|||
13222862|NCT01802580|26287013|FG000|Overall Study|Lack of Efficacy|0|||
13222863|NCT01802580|26287014|FG001|Overall Study|Lack of Efficacy|2|||
13222864|NCT01802515|26287035|FG000|Overall Study|Withdrawal by Subject|3|||
13222865|NCT01802515|26287036|FG001|Overall Study|Withdrawal by Subject|0|||
13222866|NCT01802515|26287037|FG002|Overall Study|Withdrawal by Subject|0|||
13222867|NCT01802437|26287054|FG000|Overall Study|Lost to Follow-up|1|||
13222868|NCT01802437|26287055|FG001|Overall Study|Lost to Follow-up|0|||
13222869|NCT01802437|26287054|FG000|Overall Study|Withdrawal by Subject|3|||
13222870|NCT01802437|26287055|FG001|Overall Study|Withdrawal by Subject|4|||
13222871|NCT01802411|26287072|FG000|Overall Study|Death|2|||
13222872|NCT01802411|26287073|FG001|Overall Study|Death|1|||
13222873|NCT01802411|26287072|FG000|Overall Study|Adverse Event|2|||
13222874|NCT01802411|26287073|FG001|Overall Study|Adverse Event|7|||
13222875|NCT01802411|26287072|FG000|Overall Study|Lack of Efficacy|8|||
13222876|NCT01802411|26287073|FG001|Overall Study|Lack of Efficacy|10|||
13222877|NCT01802411|26287072|FG000|Overall Study|Withdrawal by Subject|0|||
13222878|NCT01802411|26287073|FG001|Overall Study|Withdrawal by Subject|2|||
13222879|NCT01802411|26287072|FG000|Overall Study|Planned pleurodesis as part of the proc|1|||
13222880|NCT01802411|26287073|FG001|Overall Study|Planned pleurodesis as part of the proc|0|||
13222881|NCT01802411|26287072|FG000|Overall Study|Surgery aborted after bronchoscopy|1|||
13222882|NCT01802411|26287073|FG001|Overall Study|Surgery aborted after bronchoscopy|0|||
13222883|NCT01802411|26287072|FG000|Overall Study|Proc changed to video-asst thorascopic|0|||
13222884|NCT01802411|26287073|FG001|Overall Study|Proc changed to video-asst thorascopic|1|||
13222885|NCT01802385|26287100|FG000|Overall Study|Death|106|||
13222886|NCT01802385|26287101|FG001|Overall Study|Death|120|||
13222887|NCT01802333|26287138|FG000|Overall Study|Ineligible|2|||
13222888|NCT01802333|26287139|FG001|Overall Study|Ineligible|6|||
13222889|NCT01802333|26287140|FG002|Overall Study|Ineligible|8|||
13222890|NCT01802333|26287138|FG000|Overall Study|Adverse Event|1|||
13106294|NCT03307252|25883194|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
13106295|NCT03307252|25883195|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
13106296|NCT03307252|25883196|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
13106297|NCT03307252|25883197|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
13106298|NCT03307252|25883198|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
13106299|NCT03307252|25883199|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
13106300|NCT03307252|25883200|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
13106301|NCT03307252|25883201|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
13106302|NCT03307252|25883202|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1|||
13106303|NCT03307174|25883227|FG000|Overall Study|Unplanned ICU Administrion|5|||
13163671|NCT02405442|26095700|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
13163672|NCT02405442|26095701|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1|||
13163673|NCT02405442|26095702|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
13163674|NCT02405442|26095703|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
13163675|NCT02405442|26095700|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
13163676|NCT02405442|26095701|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1|||
13163677|NCT02405442|26095702|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
13163678|NCT02405442|26095703|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
13163679|NCT02405442|26095700|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
13163680|NCT02405442|26095701|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1|||
13163681|NCT02405442|26095702|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
13163682|NCT02405442|26095703|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
13163683|NCT02405442|26095700|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
13163684|NCT02405442|26095701|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1|||
13163685|NCT02405442|26095702|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
13163686|NCT02405442|26095703|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
13163687|NCT02405442|26095700|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1|||
13163688|NCT02405442|26095701|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
13163689|NCT02405442|26095702|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
13163690|NCT02405442|26095703|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
13163691|NCT02405091|26095734|FG000|Overall Study|Adverse Event|16|||
13163692|NCT02405091|26095735|FG001|Overall Study|Adverse Event|10|||
13163693|NCT02405091|26095736|FG002|Overall Study|Adverse Event|0|||
13163694|NCT02405091|26095734|FG000|Overall Study|Protocol Violation|1|||
13163695|NCT02405091|26095735|FG001|Overall Study|Protocol Violation|0|||
13163696|NCT02405091|26095736|FG002|Overall Study|Protocol Violation|0|||
13163697|NCT02405091|26095734|FG000|Overall Study|Noncompliance|1|||
13163698|NCT02405091|26095735|FG001|Overall Study|Noncompliance|6|||
13163699|NCT02405091|26095736|FG002|Overall Study|Noncompliance|2|||
13163700|NCT02405091|26095734|FG000|Overall Study|Withdrawal by Subject|4|||
13163701|NCT02405091|26095735|FG001|Overall Study|Withdrawal by Subject|8|||
13163702|NCT02405091|26095736|FG002|Overall Study|Withdrawal by Subject|0|||
13163703|NCT02405091|26095734|FG000|Overall Study|Death|0|||
13163704|NCT02405091|26095735|FG001|Overall Study|Death|1|||
13163705|NCT02405091|26095736|FG002|Overall Study|Death|0|||
13163706|NCT02405091|26095734|FG000|Overall Study|Lost to Follow-up|5|||
13163707|NCT02405091|26095735|FG001|Overall Study|Lost to Follow-up|6|||
13163708|NCT02405091|26095736|FG002|Overall Study|Lost to Follow-up|0|||
13163709|NCT02405091|26095734|FG000|Overall Study|Physician Decision|2|||
13163710|NCT02405091|26095735|FG001|Overall Study|Physician Decision|2|||
13163711|NCT02405091|26095736|FG002|Overall Study|Physician Decision|0|||
13163712|NCT02404805|26095764|FG000|Overall Study|Withdrawal by Subject|1|||
13163713|NCT02404805|26095765|FG001|Overall Study|Withdrawal by Subject|0|||
13222891|NCT01802333|26287139|FG001|Overall Study|Adverse Event|8|||
13222892|NCT01802333|26287140|FG002|Overall Study|Adverse Event|8|||
13163714|NCT02404805|26095766|FG002|Overall Study|Withdrawal by Subject|0|||
13163715|NCT02404805|26095767|FG003|Overall Study|Withdrawal by Subject|0|||
13163716|NCT02404805|26095768|FG004|Overall Study|Withdrawal by Subject|0|||
13163717|NCT02404805|26095769|FG005|Overall Study|Withdrawal by Subject|0|||
13163718|NCT02404649|26095784|FG000|Overall Study|Adverse Event|1|||
13163719|NCT02404649|26095785|FG001|Overall Study|Adverse Event|2|||
13163720|NCT02404545|26095799|FG000|Overall Study|Sponsor Termination|6|||
13163721|NCT02404545|26095800|FG001|Overall Study|Sponsor Termination|6|||
13163722|NCT02404493|26096047|FG000|Overall Study|Adverse Event|1|||
13163723|NCT02404493|26096048|FG001|Overall Study|Adverse Event|1|||
13163724|NCT02404441|26096251|FG000|Phase 1 Part|Adverse Event|1|||
13163725|NCT02404441|26096252|FG001|Phase 1 Part|Adverse Event|0|||
13163726|NCT02404441|26096253|FG002|Phase 1 Part|Adverse Event|0|||
13163727|NCT02404441|26096254|FG003|Phase 1 Part|Adverse Event|0|||
13106304|NCT03307174|25883228|FG001|Overall Study|Unplanned ICU Administrion|3|||
13106305|NCT03307174|25883227|FG000|Overall Study|Aborted Surgery|1|||
13106306|NCT03307174|25883228|FG001|Overall Study|Aborted Surgery|2|||
13106307|NCT03307174|25883227|FG000|Overall Study|Hypotension|6|||
13106308|NCT03307174|25883228|FG001|Overall Study|Hypotension|0|||
13106309|NCT03307174|25883227|FG000|Overall Study|Nonfunctional epidural|1|||
13106310|NCT03307174|25883228|FG001|Overall Study|Nonfunctional epidural|1|||
13106311|NCT03307174|25883227|FG000|Overall Study|Planned epidural removal|1|||
13106312|NCT03307174|25883228|FG001|Overall Study|Planned epidural removal|0|||
13106313|NCT03307174|25883227|FG000|Overall Study|Intrathecal catheter placement|0|||
13106314|NCT03307174|25883228|FG001|Overall Study|Intrathecal catheter placement|1|||
13106315|NCT03306433|25883241|FG000|Overall Study|Lost to Follow-up|3|||
13106316|NCT03306433|25883241|FG000|Overall Study|Patient did not have teeth extracted|1|||
13106317|NCT03306433|25883241|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3|||
13106318|NCT03306277|25883250|FG000|Overall Study|Death|1|||
13106319|NCT03306277|25883250|FG000|Overall Study|Adverse Event|1|||
13106320|NCT03306277|25883250|FG000|Overall Study|Withdrawal by Subject|1|||
13106321|NCT03306043|25883258|FG000|Overall Study|Adverse Event|1|||
13106322|NCT03306043|25883258|FG000|Overall Study|Lost to Follow-up|1|||
13106323|NCT03306043|25883258|FG000|Overall Study|Withdrawal by Subject|2|||
13106324|NCT03305809|25883356|FG000|Overall Study|Adverse Event|2|||
13163728|NCT02404441|26096255|FG004|Phase 1 Part|Adverse Event|0|||
13163729|NCT02404441|26096256|FG005|Phase 1 Part|Adverse Event|0|||
13163730|NCT02404441|26096257|FG006|Phase 1 Part|Adverse Event|0|||
13163731|NCT02404441|26096258|FG007|Phase 1 Part|Adverse Event|0|||
13163732|NCT02404441|26096259|FG008|Phase 1 Part|Adverse Event|0|||
13163733|NCT02404441|26096260|FG009|Phase 1 Part|Adverse Event|0|||
13163734|NCT02404441|26096251|FG000|Phase 1 Part|Physician Decision|0|||
13163735|NCT02404441|26096252|FG001|Phase 1 Part|Physician Decision|1|||
13163736|NCT02404441|26096253|FG002|Phase 1 Part|Physician Decision|0|||
13163737|NCT02404441|26096254|FG003|Phase 1 Part|Physician Decision|0|||
13163738|NCT02404441|26096255|FG004|Phase 1 Part|Physician Decision|0|||
13163739|NCT02404441|26096256|FG005|Phase 1 Part|Physician Decision|0|||
13163740|NCT02404441|26096257|FG006|Phase 1 Part|Physician Decision|0|||
13163741|NCT02404441|26096258|FG007|Phase 1 Part|Physician Decision|0|||
13163742|NCT02404441|26096259|FG008|Phase 1 Part|Physician Decision|0|||
13163743|NCT02404441|26096260|FG009|Phase 1 Part|Physician Decision|0|||
13163744|NCT02404441|26096251|FG000|Phase 1 Part|Progressive Disease|14|||
13163745|NCT02404441|26096252|FG001|Phase 1 Part|Progressive Disease|11|||
13163746|NCT02404441|26096253|FG002|Phase 1 Part|Progressive Disease|7|||
13163747|NCT02404441|26096254|FG003|Phase 1 Part|Progressive Disease|6|||
13163748|NCT02404441|26096255|FG004|Phase 1 Part|Progressive Disease|9|||
13163749|NCT02404441|26096256|FG005|Phase 1 Part|Progressive Disease|0|||
13163750|NCT02404441|26096257|FG006|Phase 1 Part|Progressive Disease|0|||
13163751|NCT02404441|26096258|FG007|Phase 1 Part|Progressive Disease|0|||
13163752|NCT02404441|26096259|FG008|Phase 1 Part|Progressive Disease|0|||
13163753|NCT02404441|26096260|FG009|Phase 1 Part|Progressive Disease|0|||
13163754|NCT02404441|26096251|FG000|Phase 1 Part|Subject/Guardian Decision|0|||
13163755|NCT02404441|26096252|FG001|Phase 1 Part|Subject/Guardian Decision|2|||
13163756|NCT02404441|26096253|FG002|Phase 1 Part|Subject/Guardian Decision|3|||
13163757|NCT02404441|26096254|FG003|Phase 1 Part|Subject/Guardian Decision|0|||
13163758|NCT02404441|26096255|FG004|Phase 1 Part|Subject/Guardian Decision|0|||
13163759|NCT02404441|26096256|FG005|Phase 1 Part|Subject/Guardian Decision|0|||
13163760|NCT02404441|26096257|FG006|Phase 1 Part|Subject/Guardian Decision|0|||
13163761|NCT02404441|26096258|FG007|Phase 1 Part|Subject/Guardian Decision|0|||
13163762|NCT02404441|26096259|FG008|Phase 1 Part|Subject/Guardian Decision|0|||
13163763|NCT02404441|26096260|FG009|Phase 1 Part|Subject/Guardian Decision|0|||
13163764|NCT02404441|26096251|FG000|Phase 1 Part|Death|1|||
13106325|NCT03305809|25883357|FG001|Overall Study|Adverse Event|2|||
13163765|NCT02404441|26096252|FG001|Phase 1 Part|Death|1|||
13163766|NCT02404441|26096253|FG002|Phase 1 Part|Death|1|||
13163767|NCT02404441|26096254|FG003|Phase 1 Part|Death|0|||
13163768|NCT02404441|26096255|FG004|Phase 1 Part|Death|1|||
13163769|NCT02404441|26096256|FG005|Phase 1 Part|Death|0|||
13163770|NCT02404441|26096257|FG006|Phase 1 Part|Death|0|||
13163771|NCT02404441|26096258|FG007|Phase 1 Part|Death|0|||
13106326|NCT03305809|25883358|FG002|Overall Study|Adverse Event|6|||
13106327|NCT03305809|25883359|FG003|Overall Study|Adverse Event|6|||
13106328|NCT03305809|25883356|FG000|Overall Study|Death|0|||
13106329|NCT03305809|25883357|FG001|Overall Study|Death|0|||
13106330|NCT03305809|25883358|FG002|Overall Study|Death|1|||
13106331|NCT03305809|25883359|FG003|Overall Study|Death|1|||
13106332|NCT03305809|25883356|FG000|Overall Study|Lost to Follow-up|1|||
13106333|NCT03305809|25883357|FG001|Overall Study|Lost to Follow-up|2|||
13106334|NCT03305809|25883358|FG002|Overall Study|Lost to Follow-up|0|||
13106335|NCT03305809|25883359|FG003|Overall Study|Lost to Follow-up|0|||
13106336|NCT03305809|25883356|FG000|Overall Study|Sponsor Decision|1|||
13106337|NCT03305809|25883357|FG001|Overall Study|Sponsor Decision|0|||
13106338|NCT03305809|25883358|FG002|Overall Study|Sponsor Decision|1|||
13106339|NCT03305809|25883359|FG003|Overall Study|Sponsor Decision|8|||
13106340|NCT03305809|25883356|FG000|Overall Study|Physician Decision|0|||
13106341|NCT03305809|25883357|FG001|Overall Study|Physician Decision|0|||
13106342|NCT03305809|25883358|FG002|Overall Study|Physician Decision|2|||
13106343|NCT03305809|25883359|FG003|Overall Study|Physician Decision|4|||
13106344|NCT03305809|25883356|FG000|Overall Study|Progressive Disease|0|||
13106345|NCT03305809|25883357|FG001|Overall Study|Progressive Disease|0|||
13163772|NCT02404441|26096259|FG008|Phase 1 Part|Death|0|||
13163773|NCT02404441|26096260|FG009|Phase 1 Part|Death|0|||
13163774|NCT02404441|26096251|FG000|Phase 2 Part|Adverse Event|0|||
13163775|NCT02404441|26096252|FG001|Phase 2 Part|Adverse Event|0|||
13163776|NCT02404441|26096253|FG002|Phase 2 Part|Adverse Event|0|||
13163777|NCT02404441|26096254|FG003|Phase 2 Part|Adverse Event|0|||
13163778|NCT02404441|26096255|FG004|Phase 2 Part|Adverse Event|0|||
13163779|NCT02404441|26096256|FG005|Phase 2 Part|Adverse Event|2|||
13163780|NCT02404441|26096257|FG006|Phase 2 Part|Adverse Event|3|||
13163781|NCT02404441|26096258|FG007|Phase 2 Part|Adverse Event|3|||
13163782|NCT02404441|26096259|FG008|Phase 2 Part|Adverse Event|6|||
13163783|NCT02404441|26096260|FG009|Phase 2 Part|Adverse Event|1|||
13163784|NCT02404441|26096251|FG000|Phase 2 Part|Physician Decision|0|||
13163785|NCT02404441|26096252|FG001|Phase 2 Part|Physician Decision|0|||
13163786|NCT02404441|26096253|FG002|Phase 2 Part|Physician Decision|0|||
13163787|NCT02404441|26096254|FG003|Phase 2 Part|Physician Decision|0|||
13163788|NCT02404441|26096255|FG004|Phase 2 Part|Physician Decision|0|||
13163789|NCT02404441|26096256|FG005|Phase 2 Part|Physician Decision|7|||
13163790|NCT02404441|26096257|FG006|Phase 2 Part|Physician Decision|9|||
13163791|NCT02404441|26096258|FG007|Phase 2 Part|Physician Decision|2|||
13163792|NCT02404441|26096259|FG008|Phase 2 Part|Physician Decision|1|||
13163793|NCT02404441|26096260|FG009|Phase 2 Part|Physician Decision|3|||
13163794|NCT02404441|26096251|FG000|Phase 2 Part|Progressive disease|0|||
13163795|NCT02404441|26096252|FG001|Phase 2 Part|Progressive disease|0|||
13163796|NCT02404441|26096253|FG002|Phase 2 Part|Progressive disease|0|||
13163797|NCT02404441|26096254|FG003|Phase 2 Part|Progressive disease|0|||
13163798|NCT02404441|26096255|FG004|Phase 2 Part|Progressive disease|0|||
13163799|NCT02404441|26096256|FG005|Phase 2 Part|Progressive disease|43|||
13163800|NCT02404441|26096257|FG006|Phase 2 Part|Progressive disease|32|||
13163801|NCT02404441|26096258|FG007|Phase 2 Part|Progressive disease|31|||
13163802|NCT02404441|26096259|FG008|Phase 2 Part|Progressive disease|39|||
13163803|NCT02404441|26096260|FG009|Phase 2 Part|Progressive disease|27|||
13163804|NCT02404441|26096251|FG000|Phase 2 Part|Subject/guardian decision|0|||
13163805|NCT02404441|26096252|FG001|Phase 2 Part|Subject/guardian decision|0|||
13163806|NCT02404441|26096253|FG002|Phase 2 Part|Subject/guardian decision|0|||
13163807|NCT02404441|26096254|FG003|Phase 2 Part|Subject/guardian decision|0|||
13163808|NCT02404441|26096255|FG004|Phase 2 Part|Subject/guardian decision|0|||
13163809|NCT02404441|26096256|FG005|Phase 2 Part|Subject/guardian decision|3|||
13163810|NCT02404441|26096257|FG006|Phase 2 Part|Subject/guardian decision|9|||
13163811|NCT02404441|26096258|FG007|Phase 2 Part|Subject/guardian decision|0|||
13163812|NCT02404441|26096259|FG008|Phase 2 Part|Subject/guardian decision|3|||
13163813|NCT02404441|26096260|FG009|Phase 2 Part|Subject/guardian decision|2|||
13163814|NCT02404441|26096251|FG000|Phase 2 Part|Death|0|||
13163815|NCT02404441|26096252|FG001|Phase 2 Part|Death|0|||
13163816|NCT02404441|26096253|FG002|Phase 2 Part|Death|0|||
13163817|NCT02404441|26096254|FG003|Phase 2 Part|Death|0|||
13163818|NCT02404441|26096255|FG004|Phase 2 Part|Death|0|||
13163819|NCT02404441|26096256|FG005|Phase 2 Part|Death|4|||
13163820|NCT02404441|26096257|FG006|Phase 2 Part|Death|8|||
13163821|NCT02404441|26096258|FG007|Phase 2 Part|Death|4|||
13163822|NCT02404441|26096259|FG008|Phase 2 Part|Death|10|||
13163823|NCT02404441|26096260|FG009|Phase 2 Part|Death|9|||
13163824|NCT02404389|26096312|FG000|Overall Study|Adverse Event|1|||
13163825|NCT02404389|26096313|FG001|Overall Study|Adverse Event|0|||
13163826|NCT02404389|26096314|FG002|Overall Study|Adverse Event|1|||
13163827|NCT02404389|26096315|FG003|Overall Study|Adverse Event|0|||
13163828|NCT02404389|26096316|FG004|Overall Study|Adverse Event|2|||
13163829|NCT02404389|26096312|FG000|Overall Study|Subject/guardian decision|1|||
13163830|NCT02404389|26096313|FG001|Overall Study|Subject/guardian decision|0|||
13163831|NCT02404389|26096314|FG002|Overall Study|Subject/guardian decision|0|||
13106346|NCT03305809|25883358|FG002|Overall Study|Progressive Disease|1|||
13106347|NCT03305809|25883359|FG003|Overall Study|Progressive Disease|0|||
13106348|NCT03305809|25883356|FG000|Overall Study|Protocol Violation|1|||
13106349|NCT03305809|25883357|FG001|Overall Study|Protocol Violation|0|||
13106350|NCT03305809|25883358|FG002|Overall Study|Protocol Violation|2|||
13106351|NCT03305809|25883359|FG003|Overall Study|Protocol Violation|3|||
13106352|NCT03305809|25883356|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
13106353|NCT03305809|25883357|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
13106354|NCT03305809|25883358|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
13106355|NCT03305809|25883359|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2|||
13106356|NCT03305809|25883356|FG000|Overall Study|Withdrawal by Subject|2|||
13106357|NCT03305809|25883357|FG001|Overall Study|Withdrawal by Subject|4|||
13106358|NCT03305809|25883358|FG002|Overall Study|Withdrawal by Subject|5|||
13106359|NCT03305809|25883359|FG003|Overall Study|Withdrawal by Subject|2|||
13106360|NCT03305809|25883356|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
13106361|NCT03305809|25883357|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
13106362|NCT03305809|25883358|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
13106363|NCT03305809|25883359|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
13106364|NCT03305770|25883374|FG000|Overall Study|Physician Decision - prior to dispense|0|||
13106365|NCT03305770|25883375|FG001|Overall Study|Physician Decision - prior to dispense|1|||
13106366|NCT03305770|25883374|FG000|Overall Study|Subject moved|1|||
13106367|NCT03305770|25883375|FG001|Overall Study|Subject moved|0|||
13106368|NCT03305731|25883386|FG000|Overall Study|Protocol Violation|1|||
13106369|NCT03305666|25883403|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2|||
13106370|NCT03305666|25883404|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0|||
13106371|NCT03305575|25883423|FG000|Overall Study|Physician Decision|1|||
13106372|NCT03305575|25883424|FG001|Overall Study|Physician Decision|0|||
13106373|NCT03305419|25883579|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
13106374|NCT03305419|25883580|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1|||
13106375|NCT03305419|25883581|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
13106376|NCT03305419|25883582|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
13106377|NCT03305419|25883583|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
13106378|NCT03305419|25883584|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
13106379|NCT03305419|25883585|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
13106380|NCT03305419|25883586|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
13106381|NCT03305419|25883579|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1|||
13106382|NCT03305419|25883580|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
13106383|NCT03305419|25883581|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
13106384|NCT03305419|25883582|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
13106385|NCT03305419|25883583|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
13106386|NCT03305419|25883584|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
13106387|NCT03305419|25883585|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
13106388|NCT03305419|25883586|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
13106389|NCT03305419|25883579|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1|||
13106390|NCT03305419|25883580|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
13106391|NCT03305419|25883581|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
13106392|NCT03305419|25883582|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
13106393|NCT03305419|25883583|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
13106394|NCT03305419|25883584|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
13106395|NCT03305419|25883585|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
13106396|NCT03305419|25883586|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
13106397|NCT03305419|25883579|FG000|Part B (14 Days)|Adverse Event|0|||
13106398|NCT03305419|25883580|FG001|Part B (14 Days)|Adverse Event|0|||
13106399|NCT03305419|25883581|FG002|Part B (14 Days)|Adverse Event|0|||
13106400|NCT03305419|25883582|FG003|Part B (14 Days)|Adverse Event|0|||
13106401|NCT03305419|25883583|FG004|Part B (14 Days)|Adverse Event|1|||
13106402|NCT03305419|25883584|FG005|Part B (14 Days)|Adverse Event|2|||
13106403|NCT03305419|25883585|FG006|Part B (14 Days)|Adverse Event|4|||
13106404|NCT03305419|25883586|FG007|Part B (14 Days)|Adverse Event|0|||
13106405|NCT03305419|25883579|FG000|Part B (14 Days)|Physician Decision|0|||
13106406|NCT03305419|25883580|FG001|Part B (14 Days)|Physician Decision|0|||
13106407|NCT03305419|25883581|FG002|Part B (14 Days)|Physician Decision|0|||
13106408|NCT03305419|25883582|FG003|Part B (14 Days)|Physician Decision|0|||
13106409|NCT03305419|25883583|FG004|Part B (14 Days)|Physician Decision|2|||
13106410|NCT03305419|25883584|FG005|Part B (14 Days)|Physician Decision|8|||
13106411|NCT03305419|25883585|FG006|Part B (14 Days)|Physician Decision|1|||
13106412|NCT03305419|25883586|FG007|Part B (14 Days)|Physician Decision|0|||
13106413|NCT03305081|25883601|FG000|Overall Study|Lost to Follow-up|10|||
13106414|NCT03305081|25883602|FG001|Overall Study|Lost to Follow-up|15|||
13163832|NCT02404389|26096315|FG003|Overall Study|Subject/guardian decision|1|||
13163833|NCT02404389|26096316|FG004|Overall Study|Subject/guardian decision|1|||
13106415|NCT03305055|25883625|FG000|Overall Study|Withdrawal by Subject|0|||
13106416|NCT03305055|25883626|FG001|Overall Study|Withdrawal by Subject|1|||
13106417|NCT03305055|25883625|FG000|Overall Study|Adverse Event|1|||
13106418|NCT03305055|25883626|FG001|Overall Study|Adverse Event|1|||
13106419|NCT03304873|25883641|FG000|Overall Study|Lost to Follow-up|1|||
13106420|NCT03304873|25883642|FG001|Overall Study|Lost to Follow-up|8|||
13106421|NCT03304626|25883661|FG000|Overall Study|Adverse Event|1|||
13106422|NCT03304626|25883662|FG001|Overall Study|Adverse Event|0|||
13106423|NCT03304626|25883661|FG000|Overall Study|Lack of Efficacy|1|||
13106424|NCT03304626|25883662|FG001|Overall Study|Lack of Efficacy|1|||
13106425|NCT03304522|25883690|FG000|Overall Study|Adverse Event|0|||
13106426|NCT03304522|25883691|FG001|Overall Study|Adverse Event|4|||
13106427|NCT03304522|25883690|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
13106428|NCT03304522|25883691|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
13106429|NCT03304522|25883690|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
13106430|NCT03304522|25883691|FG001|Overall Study|Withdrawal of consent (for other reason)|2|||
13106431|NCT03304522|25883690|FG000|Overall Study|Other|0|||
13106432|NCT03304522|25883691|FG001|Overall Study|Other|1|||
13106433|NCT03304184|25883708|FG000|Overall Study|Withdrawal by Subject|1|||
13106434|NCT03304184|25883709|FG001|Overall Study|Withdrawal by Subject|2|||
13163834|NCT02404350|26096372|FG000|Overall Study|Adverse Event|2|||
13163835|NCT02404350|26096373|FG001|Overall Study|Adverse Event|2|||
13163836|NCT02404350|26096374|FG002|Overall Study|Adverse Event|3|||
13163837|NCT02404350|26096375|FG003|Overall Study|Adverse Event|9|||
13163838|NCT02404350|26096372|FG000|Overall Study|Lack of Efficacy|3|||
13163839|NCT02404350|26096373|FG001|Overall Study|Lack of Efficacy|1|||
13163840|NCT02404350|26096374|FG002|Overall Study|Lack of Efficacy|0|||
13163841|NCT02404350|26096375|FG003|Overall Study|Lack of Efficacy|3|||
13163842|NCT02404350|26096372|FG000|Overall Study|Lost to Follow-up|2|||
13163843|NCT02404350|26096373|FG001|Overall Study|Lost to Follow-up|0|||
13163844|NCT02404350|26096374|FG002|Overall Study|Lost to Follow-up|0|||
13163845|NCT02404350|26096375|FG003|Overall Study|Lost to Follow-up|1|||
13163846|NCT02404350|26096372|FG000|Overall Study|Physician Decision|1|||
13163847|NCT02404350|26096373|FG001|Overall Study|Physician Decision|0|||
13163848|NCT02404350|26096374|FG002|Overall Study|Physician Decision|0|||
13163849|NCT02404350|26096375|FG003|Overall Study|Physician Decision|2|||
13163850|NCT02404350|26096372|FG000|Overall Study|Pregnancy|0|||
13163851|NCT02404350|26096373|FG001|Overall Study|Pregnancy|0|||
13163852|NCT02404350|26096374|FG002|Overall Study|Pregnancy|0|||
13163853|NCT02404350|26096375|FG003|Overall Study|Pregnancy|1|||
13163854|NCT02404350|26096372|FG000|Overall Study|Withdrawal by Subject|7|||
13163855|NCT02404350|26096373|FG001|Overall Study|Withdrawal by Subject|3|||
13106435|NCT03303521|25883726|FG000|Overall Study|Withdrawal by Subject|2|||
13106436|NCT03303521|25883727|FG001|Overall Study|Withdrawal by Subject|0|||
13106437|NCT03303521|25883726|FG000|Overall Study|Death|1|||
13163856|NCT02404350|26096374|FG002|Overall Study|Withdrawal by Subject|3|||
13163857|NCT02404350|26096375|FG003|Overall Study|Withdrawal by Subject|19|||
13163858|NCT02404350|26096372|FG000|Overall Study|Due to Non-compliance with treatment|0|||
13163859|NCT02404350|26096373|FG001|Overall Study|Due to Non-compliance with treatment|0|||
13163860|NCT02404350|26096374|FG002|Overall Study|Due to Non-compliance with treatment|0|||
13163861|NCT02404350|26096375|FG003|Overall Study|Due to Non-compliance with treatment|1|||
13163862|NCT02404350|26096372|FG000|Overall Study|Due to Technical problems|0|||
13163863|NCT02404350|26096373|FG001|Overall Study|Due to Technical problems|0|||
13163864|NCT02404350|26096374|FG002|Overall Study|Due to Technical problems|0|||
13163865|NCT02404350|26096375|FG003|Overall Study|Due to Technical problems|1|||
13163866|NCT02404311|26096493|FG000|Part A: Month 0-18|Death|2|||
13163867|NCT02404311|26096494|FG001|Part A: Month 0-18|Death|0|||
13163868|NCT02404311|26096495|FG002|Part A: Month 0-18|Death|0|||
13163869|NCT02404311|26096496|FG003|Part A: Month 0-18|Death|0|||
13163870|NCT02404311|26096497|FG004|Part A: Month 0-18|Death|0|||
13163871|NCT02404311|26096493|FG000|Part A: Month 0-18|Physician Decision|1|||
13163872|NCT02404311|26096494|FG001|Part A: Month 0-18|Physician Decision|0|||
13163873|NCT02404311|26096495|FG002|Part A: Month 0-18|Physician Decision|0|||
13163874|NCT02404311|26096496|FG003|Part A: Month 0-18|Physician Decision|0|||
13106438|NCT03303521|25883727|FG001|Overall Study|Death|0|||
13163875|NCT02404311|26096497|FG004|Part A: Month 0-18|Physician Decision|0|||
13163876|NCT02404311|26096493|FG000|Part A: Month 0-18|Lost to Follow-up|4|||
13163877|NCT02404311|26096494|FG001|Part A: Month 0-18|Lost to Follow-up|2|||
13163878|NCT02404311|26096495|FG002|Part A: Month 0-18|Lost to Follow-up|0|||
13163879|NCT02404311|26096496|FG003|Part A: Month 0-18|Lost to Follow-up|0|||
13163880|NCT02404311|26096497|FG004|Part A: Month 0-18|Lost to Follow-up|0|||
13163881|NCT02404311|26096493|FG000|Part A: Month 0-18|Withdrawal by Subject|6|||
13163882|NCT02404311|26096494|FG001|Part A: Month 0-18|Withdrawal by Subject|2|||
13163883|NCT02404311|26096495|FG002|Part A: Month 0-18|Withdrawal by Subject|0|||
13163884|NCT02404311|26096496|FG003|Part A: Month 0-18|Withdrawal by Subject|0|||
13163885|NCT02404311|26096497|FG004|Part A: Month 0-18|Withdrawal by Subject|0|||
13163886|NCT02404311|26096493|FG000|Part A: Month 0-18|HIV Infection|6|||
13163887|NCT02404311|26096494|FG001|Part A: Month 0-18|HIV Infection|2|||
13163888|NCT02404311|26096495|FG002|Part A: Month 0-18|HIV Infection|0|||
13163889|NCT02404311|26096496|FG003|Part A: Month 0-18|HIV Infection|0|||
13163890|NCT02404311|26096497|FG004|Part A: Month 0-18|HIV Infection|0|||
13163891|NCT02404311|26096493|FG000|Part A: Month 0-18|Participant unable to adhere|7|||
13163892|NCT02404311|26096494|FG001|Part A: Month 0-18|Participant unable to adhere|0|||
13163893|NCT02404311|26096495|FG002|Part A: Month 0-18|Participant unable to adhere|0|||
13163894|NCT02404311|26096496|FG003|Part A: Month 0-18|Participant unable to adhere|0|||
13106439|NCT03303521|25883726|FG000|Overall Study|Kidney transplantation|0|||
13106440|NCT03303521|25883727|FG001|Overall Study|Kidney transplantation|1|||
13106441|NCT03303521|25883726|FG000|Overall Study|Investigational product discontinuation|0|||
13106442|NCT03303521|25883727|FG001|Overall Study|Investigational product discontinuation|1|||
13106443|NCT03303521|25883726|FG000|Overall Study|Transferred to non-study dialysis center|1|||
13106444|NCT03303521|25883727|FG001|Overall Study|Transferred to non-study dialysis center|0|||
13106445|NCT03303521|25883726|FG000|Overall Study|Non-comliance to study protocol|0|||
13106446|NCT03303521|25883727|FG001|Overall Study|Non-comliance to study protocol|1|||
13106447|NCT03303521|25883726|FG000|Overall Study|Adverse Event|1|||
13106448|NCT03303521|25883727|FG001|Overall Study|Adverse Event|0|||
13106449|NCT03303469|25883735|FG000|Overall Study|Lost to Follow-up|2|||
13106450|NCT03303417|25883752|FG000|Overall Study|Withdrawal by Subject|1|||
13163895|NCT02404311|26096497|FG004|Part A: Month 0-18|Participant unable to adhere|0|||
13163896|NCT02404220|26096536|FG000|Overall Study|Adverse Event|0|||
13163897|NCT02404220|26096537|FG001|Overall Study|Adverse Event|0|||
13163898|NCT02404220|26096538|FG002|Overall Study|Adverse Event|1|||
13163899|NCT02404220|26096539|FG003|Overall Study|Adverse Event|0|||
13163900|NCT02404220|26096536|FG000|Overall Study|Death|5|||
13163901|NCT02404220|26096537|FG001|Overall Study|Death|5|||
13163902|NCT02404220|26096538|FG002|Overall Study|Death|3|||
13163903|NCT02404220|26096539|FG003|Overall Study|Death|8|||
13163904|NCT02404220|26096536|FG000|Overall Study|Progressive Disease|0|||
13163905|NCT02404220|26096537|FG001|Overall Study|Progressive Disease|0|||
13163906|NCT02404220|26096538|FG002|Overall Study|Progressive Disease|1|||
13163907|NCT02404220|26096539|FG003|Overall Study|Progressive Disease|1|||
13163908|NCT02404220|26096536|FG000|Overall Study|Study Terminated by Sponsor|0|||
13163909|NCT02404220|26096537|FG001|Overall Study|Study Terminated by Sponsor|0|||
13163910|NCT02404220|26096538|FG002|Overall Study|Study Terminated by Sponsor|2|||
13163911|NCT02404220|26096539|FG003|Overall Study|Study Terminated by Sponsor|1|||
13163912|NCT02404220|26096536|FG000|Overall Study|Withdrawal by Subject|0|||
13163913|NCT02404220|26096537|FG001|Overall Study|Withdrawal by Subject|1|||
13163914|NCT02404220|26096538|FG002|Overall Study|Withdrawal by Subject|0|||
13163915|NCT02404220|26096539|FG003|Overall Study|Withdrawal by Subject|0|||
13163916|NCT02404220|26096536|FG000|Overall Study|Enrolled but Never Treated|0|||
13163917|NCT02404220|26096537|FG001|Overall Study|Enrolled but Never Treated|2|||
13163918|NCT02404220|26096538|FG002|Overall Study|Enrolled but Never Treated|0|||
13163919|NCT02404220|26096539|FG003|Overall Study|Enrolled but Never Treated|0|||
13163920|NCT02404103|26096566|FG000|Overall Study|Adverse Event|1|||
13163921|NCT02404103|26096567|FG001|Overall Study|Adverse Event|0|||
13163922|NCT02404103|26096566|FG000|Overall Study|Lost to Follow-up|3|||
13163923|NCT02404103|26096567|FG001|Overall Study|Lost to Follow-up|3|||
13163924|NCT02404025|26096598|FG000|Overall Study|Adverse Event|1|||
13163925|NCT02404025|26096598|FG000|Overall Study|Lack of Efficacy|3|||
13163926|NCT02403817|26096617|FG000|Overall Study|Withdrawal by Subject|5|||
13163927|NCT02403817|26096618|FG001|Overall Study|Withdrawal by Subject|0|||
13163928|NCT02403674|26096664|FG000|Overall Study|Adverse Event|10|||
13163929|NCT02403674|26096665|FG001|Overall Study|Adverse Event|23|||
13163930|NCT02403674|26096664|FG000|Overall Study|Death|1|||
13163931|NCT02403674|26096665|FG001|Overall Study|Death|3|||
13163932|NCT02403674|26096664|FG000|Overall Study|Lack of Efficacy|18|||
13163933|NCT02403674|26096665|FG001|Overall Study|Lack of Efficacy|10|||
13163934|NCT02403674|26096664|FG000|Overall Study|Lost to Follow-up|6|||
13163935|NCT02403674|26096665|FG001|Overall Study|Lost to Follow-up|7|||
13163936|NCT02403674|26096664|FG000|Overall Study|Noncompliance with study drug|1|||
13163937|NCT02403674|26096665|FG001|Overall Study|Noncompliance with study drug|2|||
13163938|NCT02403674|26096664|FG000|Overall Study|Withdrawal by Subject|8|||
13163939|NCT02403674|26096665|FG001|Overall Study|Withdrawal by Subject|11|||
13163940|NCT02403674|26096664|FG000|Overall Study|Physician Decision|2|||
13163941|NCT02403674|26096665|FG001|Overall Study|Physician Decision|2|||
13163942|NCT02403674|26096664|FG000|Overall Study|Not treated with study drug|4|||
13163943|NCT02403674|26096665|FG001|Overall Study|Not treated with study drug|2|||
13163944|NCT02403674|26096664|FG000|Overall Study|Pregnancy|1|||
13163945|NCT02403674|26096665|FG001|Overall Study|Pregnancy|1|||
13163946|NCT02403674|26096664|FG000|Overall Study|Protocol Violation|4|||
13163947|NCT02403674|26096665|FG001|Overall Study|Protocol Violation|2|||
13163948|NCT02403635|26096733|FG000|Overall Study|Not eligible|9|||
13163949|NCT02403271|26096748|FG000|Period 1|Other varied reasons|1|||
13163950|NCT02403271|26096749|FG001|Period 1|Other varied reasons|0|||
13163951|NCT02403271|26096748|FG000|Period 2|Withdrawal by Subject|0|||
13163952|NCT02403271|26096749|FG001|Period 2|Withdrawal by Subject|14|||
13163953|NCT02403271|26096748|FG000|Period 2|Death|0|||
13163954|NCT02403271|26096749|FG001|Period 2|Death|84|||
13163955|NCT02403271|26096748|FG000|Period 2|Lost to Follow-up|0|||
13163956|NCT02403271|26096749|FG001|Period 2|Lost to Follow-up|2|||
13163957|NCT02403271|26096748|FG000|Period 2|Study Terminated by Sponsor|0|||
13163958|NCT02403271|26096749|FG001|Period 2|Study Terminated by Sponsor|14|||
13163959|NCT02403271|26096748|FG000|Period 2|Other varied reasons|0|||
13163960|NCT02403271|26096749|FG001|Period 2|Other varied reasons|10|||
13163961|NCT02403206|26096765|FG000|Overall Study|Lost to Follow-up|4|||
13163962|NCT02403206|26096766|FG001|Overall Study|Lost to Follow-up|3|||
13163963|NCT02403206|26096765|FG000|Overall Study|Physician Decision|2|||
13163964|NCT02403206|26096766|FG001|Overall Study|Physician Decision|0|||
13163965|NCT02403206|26096765|FG000|Overall Study|Withdrawal by Subject|3|||
13163966|NCT02403206|26096766|FG001|Overall Study|Withdrawal by Subject|3|||
13163967|NCT02403206|26096765|FG000|Overall Study|Reason not given|2|||
13163968|NCT02403206|26096766|FG001|Overall Study|Reason not given|4|||
13163969|NCT02403180|26096781|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0|||
13163970|NCT02403180|26096782|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1|||
13163971|NCT02403180|26096781|FG000|Period 2 (5 Days)|Withdrawal by Subject|0|||
13163972|NCT02403180|26096782|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
13163973|NCT02402933|26096791|FG000|Overall Study|Withdrawal by Subject|4|||
13163974|NCT02402933|26096791|FG000|Overall Study|Discontinued; Site Termination|10|||
13163975|NCT02402907|26096816|FG000|Overall Study|Delivered vaginally|9|||
13163976|NCT02402907|26096817|FG001|Overall Study|Delivered vaginally|3|||
13163977|NCT02402907|26096816|FG000|Overall Study|Delivered outside of Sinai|1|||
13163978|NCT02402907|26096817|FG001|Overall Study|Delivered outside of Sinai|1|||
13163979|NCT02402907|26096816|FG000|Overall Study|Lost to follow up after C-Section|10|||
13163980|NCT02402907|26096817|FG001|Overall Study|Lost to follow up after C-Section|23|||
13163981|NCT02402322|26096859|FG000|Pretreatment|Withdrawal by Subject|3|||
13163982|NCT02402322|26096860|FG001|Pretreatment|Withdrawal by Subject|1|||
13163983|NCT02402322|26096861|FG002|Pretreatment|Withdrawal by Subject|1|||
13163984|NCT02402322|26096859|FG000|Follow-up|Withdrawal by Subject|6|||
13163985|NCT02402322|26096860|FG001|Follow-up|Withdrawal by Subject|3|||
13163986|NCT02402322|26096861|FG002|Follow-up|Withdrawal by Subject|24|||
13163987|NCT02402218|26096894|FG000|Overall Study|Did not pickup study medication|12|||
13163988|NCT02402218|26096895|FG001|Overall Study|Did not pickup study medication|9|||
13163989|NCT02402218|26096896|FG002|Overall Study|Did not pickup study medication|13|||
13163990|NCT02402218|26096894|FG000|Overall Study|Lack of Efficacy|0|||
13163991|NCT02402218|26096895|FG001|Overall Study|Lack of Efficacy|1|||
13163992|NCT02402218|26096896|FG002|Overall Study|Lack of Efficacy|1|||
13163993|NCT02402218|26096894|FG000|Overall Study|Death|1|||
13163994|NCT02402218|26096895|FG001|Overall Study|Death|0|||
13163995|NCT02402218|26096896|FG002|Overall Study|Death|0|||
13163996|NCT02402218|26096894|FG000|Overall Study|Reinfection|0|||
13163997|NCT02402218|26096895|FG001|Overall Study|Reinfection|0|||
13163998|NCT02402218|26096896|FG002|Overall Study|Reinfection|1|||
13163999|NCT02402218|26096894|FG000|Overall Study|Adverse Event|0|||
13164000|NCT02402218|26096895|FG001|Overall Study|Adverse Event|2|||
13164001|NCT02402218|26096896|FG002|Overall Study|Adverse Event|1|||
13164002|NCT02402218|26096894|FG000|Overall Study|Withdrawal by Subject|1|||
13164003|NCT02402218|26096895|FG001|Overall Study|Withdrawal by Subject|1|||
13164004|NCT02402218|26096896|FG002|Overall Study|Withdrawal by Subject|1|||
13164005|NCT02402166|26096919|FG000|Overall Study|Adverse Event|2|||
13164006|NCT02402166|26096919|FG000|Overall Study|Withdrawal by Subject|2|||
13164007|NCT02402166|26096919|FG000|Overall Study|Lost to Follow-up|1|||
13164008|NCT02401867|26096926|FG000|Specimen Collection|Didn't receive 1 or more tests|10|||
13164009|NCT02401867|26096926|FG000|Analysis|Cervical assay could not be conducted|9|||
13164010|NCT02401672|26096945|FG000|Overall Study|Withdrawal by Subject|1|||
13164011|NCT02401672|26096946|FG001|Overall Study|Withdrawal by Subject|3|||
13164012|NCT02401529|26096977|FG000|Overall Study|Lost to Follow-up|2|||
13106451|NCT03303417|25883753|FG001|Overall Study|Withdrawal by Subject|1|||
13106452|NCT03303105|25883770|FG000|Overall Study|Adverse Event|0|||
13106453|NCT03303105|25883771|FG001|Overall Study|Adverse Event|2|||
13106454|NCT03303105|25883770|FG000|Overall Study|Lack of Efficacy|1|||
13106455|NCT03303105|25883771|FG001|Overall Study|Lack of Efficacy|0|||
13106456|NCT03303105|25883770|FG000|Overall Study|Protocol Violation|1|||
13106457|NCT03303105|25883771|FG001|Overall Study|Protocol Violation|0|||
13106458|NCT03303105|25883770|FG000|Overall Study|Withdrawal by Subject|0|||
13106459|NCT03303105|25883771|FG001|Overall Study|Withdrawal by Subject|2|||
13106460|NCT03303092|25883801|FG000|Overall Study|Adverse Event|1|||
13106461|NCT03303092|25883802|FG001|Overall Study|Adverse Event|0|||
13106462|NCT03303092|25883803|FG002|Overall Study|Adverse Event|1|||
13106463|NCT03303092|25883801|FG000|Overall Study|Protocol Violation|1|||
13164013|NCT02401529|26096978|FG001|Overall Study|Lost to Follow-up|1|||
13164014|NCT02401529|26096977|FG000|Overall Study|Physician Decision|2|||
13164015|NCT02401529|26096978|FG001|Overall Study|Physician Decision|6|||
13164016|NCT02401529|26096977|FG000|Overall Study|Protocol Violation|5|||
13106464|NCT03303092|25883802|FG001|Overall Study|Protocol Violation|5|||
13106465|NCT03303092|25883803|FG002|Overall Study|Protocol Violation|1|||
13106466|NCT03303092|25883801|FG000|Overall Study|Withdrawal by Subject|1|||
13106467|NCT03303092|25883802|FG001|Overall Study|Withdrawal by Subject|1|||
13106468|NCT03303092|25883803|FG002|Overall Study|Withdrawal by Subject|3|||
13106469|NCT03303079|25883836|FG000|Overall Study|Adverse Event|0|||
13106470|NCT03303079|25883837|FG001|Overall Study|Adverse Event|1|||
13106471|NCT03303079|25883838|FG002|Overall Study|Adverse Event|3|||
13106472|NCT03303079|25883836|FG000|Overall Study|Protocol Violation|5|||
13106473|NCT03303079|25883837|FG001|Overall Study|Protocol Violation|4|||
13106474|NCT03303079|25883838|FG002|Overall Study|Protocol Violation|7|||
13106475|NCT03303079|25883836|FG000|Overall Study|Withdrawal by Subject|2|||
13106476|NCT03303079|25883837|FG001|Overall Study|Withdrawal by Subject|4|||
13106477|NCT03303079|25883838|FG002|Overall Study|Withdrawal by Subject|2|||
13106478|NCT03303079|25883836|FG000|Overall Study|Other than specified|0|||
13106479|NCT03303079|25883837|FG001|Overall Study|Other than specified|2|||
13106480|NCT03303079|25883838|FG002|Overall Study|Other than specified|0|||
13106481|NCT03302975|25883846|FG000|Overall Study|Lost to Follow-up|4|||
13106482|NCT03302936|25883863|FG000|Overall Study|Protocol Violation|3|||
13164017|NCT02401529|26096978|FG001|Overall Study|Protocol Violation|0|||
13164018|NCT02401412|26096993|FG000|Overall Study|Lost to Follow-up|1|||
13164019|NCT02401412|26096994|FG001|Overall Study|Lost to Follow-up|0|||
13164020|NCT02401412|26096993|FG000|Overall Study|Discontinued Intervention|15|||
13164021|NCT02401412|26096994|FG001|Overall Study|Discontinued Intervention|21|||
13164022|NCT02401412|26096993|FG000|Overall Study|Withdrawal by Subject|4|||
13164023|NCT02401412|26096994|FG001|Overall Study|Withdrawal by Subject|4|||
13164024|NCT02401412|26096993|FG000|Overall Study|Subject withdrawal prior to intervention|0|||
13164025|NCT02401412|26096994|FG001|Overall Study|Subject withdrawal prior to intervention|1|||
13164026|NCT02401412|26096993|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10|||
13164027|NCT02401412|26096994|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6|||
13164028|NCT02401308|26097011|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0|||
13164029|NCT02401308|26097012|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1|||
13164030|NCT02401256|26097020|FG000|Overall Study|Adverse Event|5|||
13164031|NCT02401256|26097020|FG000|Overall Study|Withdrawal by Subject|12|||
13164032|NCT02401230|26097063|FG000|Overall Study|Adverse Event|3|||
13164033|NCT02401230|26097064|FG001|Overall Study|Adverse Event|2|||
13164034|NCT02401230|26097065|FG002|Overall Study|Adverse Event|0|||
13164035|NCT02401230|26097063|FG000|Overall Study|Withdrawal by Subject|2|||
13164036|NCT02401230|26097064|FG001|Overall Study|Withdrawal by Subject|1|||
13164037|NCT02401230|26097065|FG002|Overall Study|Withdrawal by Subject|1|||
13164038|NCT02401230|26097063|FG000|Overall Study|Lost to Follow-up|1|||
13164039|NCT02401230|26097064|FG001|Overall Study|Lost to Follow-up|3|||
13164040|NCT02401230|26097065|FG002|Overall Study|Lost to Follow-up|3|||
13164041|NCT02400905|26097082|FG000|Overall Study|Death|24|||
13164042|NCT02400905|26097082|FG000|Overall Study|Lost to Follow-up|18|||
13164043|NCT02400905|26097082|FG000|Overall Study|Withdrawal by Subject|16|||
13164044|NCT02400905|26097082|FG000|Overall Study|Physician Decision|4|||
13164045|NCT02400905|26097082|FG000|Overall Study|Other|1|||
13164046|NCT02400749|26097103|FG000|Week 0 -16|Withdrawal by Subject|5|||
13164047|NCT02400749|26097104|FG001|Week 0 -16|Withdrawal by Subject|5|||
13164048|NCT02400749|26097103|FG000|Week 0 -16|Adverse Event|3|||
13164049|NCT02400749|26097104|FG001|Week 0 -16|Adverse Event|1|||
13164050|NCT02400749|26097103|FG000|Week 0 -16|Lost to Follow-up|2|||
13164051|NCT02400749|26097104|FG001|Week 0 -16|Lost to Follow-up|0|||
13164052|NCT02400749|26097103|FG000|Week 0 -16|Protocol Violation|1|||
13164053|NCT02400749|26097104|FG001|Week 0 -16|Protocol Violation|0|||
13164054|NCT02400749|26097103|FG000|Week 17 - 32|Withdrawal by Subject|3|||
13164055|NCT02400749|26097104|FG001|Week 17 - 32|Withdrawal by Subject|2|||
13164056|NCT02400749|26097103|FG000|Week 17 - 32|Adverse Event|2|||
13164057|NCT02400749|26097104|FG001|Week 17 - 32|Adverse Event|1|||
13164058|NCT02400580|26097127|FG000|Overall Study|Withdrawal by Subject|1|||
13164059|NCT02400580|26097128|FG001|Overall Study|Withdrawal by Subject|1|||
13164060|NCT02400580|26097127|FG000|Overall Study|Adverse Event|1|||
13164061|NCT02400580|26097128|FG001|Overall Study|Adverse Event|0|||
13164062|NCT02400476|26097173|FG000|Overall Study|Adverse Event|57|||
13164063|NCT02400476|26097174|FG001|Overall Study|Adverse Event|10|||
13164064|NCT02400476|26097175|FG002|Overall Study|Adverse Event|22|||
13164065|NCT02400476|26097176|FG003|Overall Study|Adverse Event|19|||
13164066|NCT02400476|26097177|FG004|Overall Study|Adverse Event|5|||
13164067|NCT02400476|26097178|FG005|Overall Study|Adverse Event|8|||
13164068|NCT02400476|26097173|FG000|Overall Study|Withdrawal by Subject|4|||
13164069|NCT02400476|26097174|FG001|Overall Study|Withdrawal by Subject|1|||
13164070|NCT02400476|26097175|FG002|Overall Study|Withdrawal by Subject|12|||
13164071|NCT02400476|26097176|FG003|Overall Study|Withdrawal by Subject|7|||
13164072|NCT02400476|26097177|FG004|Overall Study|Withdrawal by Subject|5|||
13164073|NCT02400476|26097178|FG005|Overall Study|Withdrawal by Subject|5|||
13106483|NCT03302936|25883864|FG001|Overall Study|Protocol Violation|4|||
13164074|NCT02400476|26097173|FG000|Overall Study|Lost to Follow-up|0|||
13164075|NCT02400476|26097174|FG001|Overall Study|Lost to Follow-up|0|||
13164076|NCT02400476|26097175|FG002|Overall Study|Lost to Follow-up|0|||
13164077|NCT02400476|26097176|FG003|Overall Study|Lost to Follow-up|1|||
13164078|NCT02400476|26097177|FG004|Overall Study|Lost to Follow-up|3|||
13164079|NCT02400476|26097178|FG005|Overall Study|Lost to Follow-up|1|||
13164080|NCT02400476|26097173|FG000|Overall Study|Physician Decision|0|||
13164081|NCT02400476|26097174|FG001|Overall Study|Physician Decision|0|||
13164082|NCT02400476|26097175|FG002|Overall Study|Physician Decision|1|||
13164083|NCT02400476|26097176|FG003|Overall Study|Physician Decision|1|||
13164084|NCT02400476|26097177|FG004|Overall Study|Physician Decision|0|||
13164085|NCT02400476|26097178|FG005|Overall Study|Physician Decision|1|||
13164086|NCT02400476|26097173|FG000|Overall Study|Other, Disease Progression|0|||
13164087|NCT02400476|26097174|FG001|Overall Study|Other, Disease Progression|1|||
13164088|NCT02400476|26097175|FG002|Overall Study|Other, Disease Progression|2|||
13164089|NCT02400476|26097176|FG003|Overall Study|Other, Disease Progression|1|||
13164090|NCT02400476|26097177|FG004|Overall Study|Other, Disease Progression|2|||
13164091|NCT02400476|26097178|FG005|Overall Study|Other, Disease Progression|1|||
13164092|NCT02400476|26097173|FG000|Overall Study|Other, Decreased Quality of Life|0|||
13164093|NCT02400476|26097174|FG001|Overall Study|Other, Decreased Quality of Life|0|||
13164094|NCT02400476|26097175|FG002|Overall Study|Other, Decreased Quality of Life|2|||
13164095|NCT02400476|26097176|FG003|Overall Study|Other, Decreased Quality of Life|0|||
13164096|NCT02400476|26097177|FG004|Overall Study|Other, Decreased Quality of Life|0|||
13164097|NCT02400476|26097178|FG005|Overall Study|Other, Decreased Quality of Life|0|||
13164098|NCT02400476|26097173|FG000|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
13164099|NCT02400476|26097174|FG001|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
13164100|NCT02400476|26097175|FG002|Overall Study|Other, Noncompliance to Protocol Requirements|2|||
13164101|NCT02400476|26097176|FG003|Overall Study|Other, Noncompliance to Protocol Requirements|1|||
13164102|NCT02400476|26097177|FG004|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
13164103|NCT02400476|26097178|FG005|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
13164104|NCT02400346|26097184|FG000|Overall Study|Adverse Event|24|||
13164105|NCT02400346|26097184|FG000|Overall Study|Lack of Efficacy|9|||
13164106|NCT02400346|26097184|FG000|Overall Study|Non-compliance with IMP|1|||
13164107|NCT02400346|26097184|FG000|Overall Study|Withdrawal by Subject|7|||
13164108|NCT02400346|26097184|FG000|Overall Study|Administrative or other reason(s)|2|||
13164109|NCT02400346|26097184|FG000|Overall Study|Lost to Follow-up|1|||
13164110|NCT02400333|26097255|FG000|Overall Study|Withdrawal by Subject|0|||
13164111|NCT02400333|26097256|FG001|Overall Study|Withdrawal by Subject|1|||
13164112|NCT02400333|26097257|FG002|Overall Study|Withdrawal by Subject|0|||
13164113|NCT02400333|26097258|FG003|Overall Study|Withdrawal by Subject|1|||
13164114|NCT02400333|26097255|FG000|Overall Study|Protocol Violation|1|||
13164115|NCT02400333|26097256|FG001|Overall Study|Protocol Violation|0|||
13164116|NCT02400333|26097257|FG002|Overall Study|Protocol Violation|2|||
13164117|NCT02400333|26097258|FG003|Overall Study|Protocol Violation|1|||
13164118|NCT02400307|26097285|FG000|Overall Study|Enrolled and Never Dosed|1|||
13164119|NCT02400307|26097286|FG001|Overall Study|Enrolled and Never Dosed|0|||
13164120|NCT02399475|26097305|FG000|Overall Study|Physician Decision|1|||
13164121|NCT02399475|26097306|FG001|Overall Study|Physician Decision|0|||
13164122|NCT02399449|26097323|FG000|Overall Study|Withdrawal by Subject|3|||
13164123|NCT02399449|26097324|FG001|Overall Study|Withdrawal by Subject|9|||
13164124|NCT02399449|26097323|FG000|Overall Study|Physician Decision|0|||
13164125|NCT02399449|26097324|FG001|Overall Study|Physician Decision|1|||
13164126|NCT02399254|26097333|FG000|Overall Study|Physician Decision|2|||
13164127|NCT02399163|26097359|FG000|Overall Study|Adverse Event|2|||
13164128|NCT02399163|26097359|FG000|Overall Study|Protocol Deviation|2|||
13164129|NCT02399163|26097359|FG000|Overall Study|Withdrawal by Participant|5|||
13164130|NCT02398227|26097374|FG000|Overall Study|Lost to Follow-up|21|||
13164131|NCT02398227|26097375|FG001|Overall Study|Lost to Follow-up|12|||
13164132|NCT02398227|26097374|FG000|Overall Study|Withdrawal by Subject|5|||
13164133|NCT02398227|26097375|FG001|Overall Study|Withdrawal by Subject|6|||
13164134|NCT02398227|26097374|FG000|Overall Study|Removed from treatment and dropped out|1|||
13164135|NCT02398227|26097375|FG001|Overall Study|Removed from treatment and dropped out|0|||
13164136|NCT02398188|26097392|FG000|Overall Study|Adverse Event|2|||
13164137|NCT02398188|26097393|FG001|Overall Study|Adverse Event|3|||
13164138|NCT02398188|26097392|FG000|Overall Study|Lost to Follow-up|5|||
13164139|NCT02398188|26097393|FG001|Overall Study|Lost to Follow-up|0|||
13164140|NCT02398188|26097392|FG000|Overall Study|Non-compliance|4|||
13164141|NCT02398188|26097393|FG001|Overall Study|Non-compliance|4|||
13164142|NCT02398188|26097392|FG000|Overall Study|Protocol Violation|6|||
13164143|NCT02398188|26097393|FG001|Overall Study|Protocol Violation|10|||
13164144|NCT02398188|26097392|FG000|Overall Study|Sponsor Decision|2|||
13164145|NCT02398188|26097393|FG001|Overall Study|Sponsor Decision|1|||
13164146|NCT02398188|26097392|FG000|Overall Study|Pregnancy|1|||
13164147|NCT02398188|26097393|FG001|Overall Study|Pregnancy|0|||
13164148|NCT02398188|26097392|FG000|Overall Study|Withdrawal by Subject|7|||
13164149|NCT02398188|26097393|FG001|Overall Study|Withdrawal by Subject|16|||
13106484|NCT03302559|25883880|FG000|Overall Study|Adverse Event|2|||
13106485|NCT03302559|25883880|FG000|Overall Study|Lost to Follow-up|1|||
13106486|NCT03302559|25883880|FG000|Overall Study|Withdrew Consent|3|||
13106487|NCT03302247|25883887|FG000|Overall Study|the study has closed prematurely|2|||
13106488|NCT03302247|25883887|FG000|Overall Study|Death|1|||
13106489|NCT03302234|25883915|FG000|Overall Study|Death|137|||
13106490|NCT03302234|25883916|FG001|Overall Study|Death|135|||
13106491|NCT03302234|25883915|FG000|Overall Study|Withdrawal by Subject|1|||
13106492|NCT03302234|25883916|FG001|Overall Study|Withdrawal by Subject|1|||
13106493|NCT03302234|25883915|FG000|Overall Study|Laryngeal carcinoma|0|||
13106494|NCT03302234|25883916|FG001|Overall Study|Laryngeal carcinoma|1|||
13106495|NCT03301844|25883937|FG000|Overall Study|suspected colon cancer|1|||
13106496|NCT03301844|25883938|FG001|Overall Study|suspected colon cancer|1|||
13106497|NCT03301831|25883959|FG000|Overall Study|Lost to Follow-up|5|||
13106498|NCT03301831|25883960|FG001|Overall Study|Lost to Follow-up|3|||
13106499|NCT03301831|25883959|FG000|Overall Study|Protocol Violation|4|||
13106500|NCT03301831|25883960|FG001|Overall Study|Protocol Violation|0|||
13106501|NCT03301831|25883959|FG000|Overall Study|Withdrawal by Subject|11|||
13106502|NCT03301831|25883960|FG001|Overall Study|Withdrawal by Subject|0|||
13106503|NCT03301740|25884007|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1|||
13106504|NCT03301740|25884008|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0|||
13106505|NCT03301740|25884007|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1|||
13106506|NCT03301740|25884008|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0|||
13106507|NCT03301714|25884032|FG000|Overall Study|Lost to Follow-up|10|||
13106508|NCT03301714|25884033|FG001|Overall Study|Lost to Follow-up|4|||
13106509|NCT03301714|25884034|FG002|Overall Study|Lost to Follow-up|4|||
13106510|NCT03301714|25884032|FG000|Overall Study|Did not receive allocated intervention|0|||
13106511|NCT03301714|25884033|FG001|Overall Study|Did not receive allocated intervention|2|||
13106512|NCT03301714|25884034|FG002|Overall Study|Did not receive allocated intervention|3|||
13106513|NCT03301649|25884059|FG000|Overall Study|Need alternate therapy due to live lice|17|||
13106514|NCT03301649|25884060|FG001|Overall Study|Need alternate therapy due to live lice|25|||
13106515|NCT03301649|25884061|FG002|Overall Study|Need alternate therapy due to live lice|81|||
13106516|NCT03301649|25884059|FG000|Overall Study|Lost to Follow-up|11|||
13106517|NCT03301649|25884060|FG001|Overall Study|Lost to Follow-up|11|||
13106518|NCT03301649|25884061|FG002|Overall Study|Lost to Follow-up|3|||
13106519|NCT03301649|25884059|FG000|Overall Study|Protocol Violation|0|||
13106520|NCT03301649|25884060|FG001|Overall Study|Protocol Violation|1|||
13106521|NCT03301649|25884061|FG002|Overall Study|Protocol Violation|1|||
13106522|NCT03301649|25884059|FG000|Overall Study|Withdrawal by Subject|10|||
13106523|NCT03301649|25884060|FG001|Overall Study|Withdrawal by Subject|4|||
13106524|NCT03301649|25884061|FG002|Overall Study|Withdrawal by Subject|0|||
13106525|NCT03301649|25884059|FG000|Overall Study|Other than specified|5|||
13106526|NCT03301649|25884060|FG001|Overall Study|Other than specified|3|||
13106527|NCT03301649|25884061|FG002|Overall Study|Other than specified|0|||
13106528|NCT03301623|25884084|FG000|Overall Study|Death|3|||
13106529|NCT03301623|25884085|FG001|Overall Study|Death|1|||
13106530|NCT03301623|25884084|FG000|Overall Study|Withdrawal by Subject|11|||
13106531|NCT03301623|25884085|FG001|Overall Study|Withdrawal by Subject|13|||
13106532|NCT03301623|25884084|FG000|Overall Study|Lost to Follow-up|3|||
13106533|NCT03301623|25884085|FG001|Overall Study|Lost to Follow-up|1|||
13106534|NCT03301155|25884106|FG000|Overall Study|Сompliance with exclusion criteria|8|||
13106535|NCT03301155|25884107|FG001|Overall Study|Сompliance with exclusion criteria|7|||
13106536|NCT03300570|25884124|FG000|Overall Study|Adverse Event|0|||
13106537|NCT03300570|25884125|FG001|Overall Study|Adverse Event|1|||
13106538|NCT03300570|25884124|FG000|Overall Study|Withdrawal by Subject|1|||
13106539|NCT03300570|25884125|FG001|Overall Study|Withdrawal by Subject|0|||
13106540|NCT03300570|25884124|FG000|Overall Study|Inadequate bowel prep|1|||
13106541|NCT03300570|25884125|FG001|Overall Study|Inadequate bowel prep|0|||
13106542|NCT03300050|25884509|FG000|Overall Study|Lost to Follow-up|2|||
13106543|NCT03300050|25884510|FG001|Overall Study|Lost to Follow-up|1|||
13106544|NCT03300050|25884511|FG002|Overall Study|Lost to Follow-up|0|||
13106545|NCT03300050|25884512|FG003|Overall Study|Lost to Follow-up|0|||
13106546|NCT03300050|25884513|FG004|Overall Study|Lost to Follow-up|1|||
13106547|NCT03300050|25884509|FG000|Overall Study|Withdrawal by Subject|1|||
13106548|NCT03300050|25884510|FG001|Overall Study|Withdrawal by Subject|1|||
13106549|NCT03300050|25884511|FG002|Overall Study|Withdrawal by Subject|1|||
13106550|NCT03300050|25884512|FG003|Overall Study|Withdrawal by Subject|0|||
13106551|NCT03300050|25884513|FG004|Overall Study|Withdrawal by Subject|0|||
13106552|NCT03300050|25884509|FG000|Overall Study|Death|0|||
13106553|NCT03300050|25884510|FG001|Overall Study|Death|0|||
13106554|NCT03300050|25884511|FG002|Overall Study|Death|1|||
13106555|NCT03300050|25884512|FG003|Overall Study|Death|0|||
13106556|NCT03300050|25884513|FG004|Overall Study|Death|0|||
13106557|NCT03300050|25884509|FG000|Overall Study|Not Eligible at Randomization|0|||
13106558|NCT03300050|25884510|FG001|Overall Study|Not Eligible at Randomization|0|||
13106559|NCT03300050|25884511|FG002|Overall Study|Not Eligible at Randomization|1|||
13106560|NCT03300050|25884512|FG003|Overall Study|Not Eligible at Randomization|1|||
13164150|NCT02397915|26097448|FG000|Period 1|Protocol Violation|0|||
13164151|NCT02397915|26097449|FG001|Period 1|Protocol Violation|1|||
13164152|NCT02397915|26097450|FG002|Period 1|Protocol Violation|0|||
13164153|NCT02397915|26097451|FG003|Period 1|Protocol Violation|0|||
13164154|NCT02397915|26097448|FG000|Period 1|Physician Decision|1|||
13164155|NCT02397915|26097449|FG001|Period 1|Physician Decision|0|||
13164156|NCT02397915|26097450|FG002|Period 1|Physician Decision|0|||
13164157|NCT02397915|26097451|FG003|Period 1|Physician Decision|0|||
13164158|NCT02397889|26097474|FG000|Overall Study|Physician Decision|1|||
13164159|NCT02397889|26097475|FG001|Overall Study|Physician Decision|0|||
13164160|NCT02397837|26097506|FG000|Overall Study|Withdrawal by Subject|6|||
13164161|NCT02397837|26097507|FG001|Overall Study|Withdrawal by Subject|5|||
13164162|NCT02397837|26097506|FG000|Overall Study|Physician Decision|1|||
13164163|NCT02397837|26097507|FG001|Overall Study|Physician Decision|1|||
13164164|NCT02397694|26097552|FG000|Double-Blinded Phase|Adverse Event|1|||
13164165|NCT02397694|26097553|FG001|Double-Blinded Phase|Adverse Event|0|||
13164166|NCT02397694|26097552|FG000|Double-Blinded Phase|Non-compliance with study drug|0|||
13164167|NCT02397694|26097553|FG001|Double-Blinded Phase|Non-compliance with study drug|2|||
13164168|NCT02397694|26097552|FG000|Double-Blinded Phase|Withdrawal by Subject|1|||
13164169|NCT02397694|26097553|FG001|Double-Blinded Phase|Withdrawal by Subject|0|||
13164170|NCT02397694|26097552|FG000|Double-Blinded Phase|Lost to Follow-up|1|||
13164171|NCT02397694|26097553|FG001|Double-Blinded Phase|Lost to Follow-up|1|||
13164172|NCT02397694|26097552|FG000|Open Label Extension Phase|Protocol Violation|1|||
13164173|NCT02397694|26097553|FG001|Open Label Extension Phase|Protocol Violation|0|||
13164174|NCT02397694|26097552|FG000|Open Label Extension Phase|Withdrew Consent|3|||
13164175|NCT02397694|26097553|FG001|Open Label Extension Phase|Withdrew Consent|1|||
13164176|NCT02397694|26097552|FG000|Open Label Extension Phase|Lost to Follow-up|4|||
13164177|NCT02397694|26097553|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
13164178|NCT02397655|26097559|FG000|Overall Study|data not completed|1301|||
13164179|NCT02397473|26097594|FG000|Treatment Phase|Adverse Event|1|||
13164180|NCT02397473|26097595|FG001|Treatment Phase|Adverse Event|2|||
13164181|NCT02397473|26097594|FG000|Treatment Phase|Lack of Efficacy|8|||
13164182|NCT02397473|26097595|FG001|Treatment Phase|Lack of Efficacy|1|||
13164183|NCT02397473|26097594|FG000|Treatment Phase|Lost to Follow-up|1|||
13164184|NCT02397473|26097595|FG001|Treatment Phase|Lost to Follow-up|0|||
13164185|NCT02397473|26097594|FG000|Treatment Phase|Withdrawal by Subject|2|||
13164186|NCT02397473|26097595|FG001|Treatment Phase|Withdrawal by Subject|1|||
13164187|NCT02397473|26097594|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0|||
13164188|NCT02397473|26097595|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3|||
13164189|NCT02397473|26097594|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
13164190|NCT02397473|26097595|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
13164191|NCT02397473|26097594|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
13164192|NCT02397473|26097595|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
13164193|NCT02397473|26097594|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
13164194|NCT02397473|26097595|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
13164195|NCT02397473|26097594|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
13164196|NCT02397473|26097595|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
13164197|NCT02397460|26097738|FG000|Treatment Period 2|Adverse Event|0|||
13164198|NCT02397460|26097739|FG001|Treatment Period 2|Adverse Event|0|||
13164199|NCT02397460|26097740|FG002|Treatment Period 2|Adverse Event|0|||
13164200|NCT02397460|26097741|FG003|Treatment Period 2|Adverse Event|0|||
13164201|NCT02397460|26097742|FG004|Treatment Period 2|Adverse Event|0|||
13164202|NCT02397460|26097743|FG005|Treatment Period 2|Adverse Event|0|||
13164203|NCT02397460|26097744|FG006|Treatment Period 2|Adverse Event|0|||
13164204|NCT02397460|26097745|FG007|Treatment Period 2|Adverse Event|1|||
13164205|NCT02397460|26097738|FG000|Treatment Period 4|Adverse Event|0|||
13164206|NCT02397460|26097739|FG001|Treatment Period 4|Adverse Event|1|||
13164207|NCT02397460|26097740|FG002|Treatment Period 4|Adverse Event|0|||
13164208|NCT02397460|26097741|FG003|Treatment Period 4|Adverse Event|0|||
13164209|NCT02397460|26097742|FG004|Treatment Period 4|Adverse Event|0|||
13164210|NCT02397460|26097743|FG005|Treatment Period 4|Adverse Event|0|||
13164211|NCT02397460|26097744|FG006|Treatment Period 4|Adverse Event|0|||
13164212|NCT02397460|26097745|FG007|Treatment Period 4|Adverse Event|0|||
13164213|NCT02397460|26097738|FG000|Treatment Period 4|Physician Decision|0|||
13164214|NCT02397460|26097739|FG001|Treatment Period 4|Physician Decision|0|||
13164215|NCT02397460|26097740|FG002|Treatment Period 4|Physician Decision|0|||
13164216|NCT02397460|26097741|FG003|Treatment Period 4|Physician Decision|0|||
13164217|NCT02397460|26097742|FG004|Treatment Period 4|Physician Decision|1|||
13164218|NCT02397460|26097743|FG005|Treatment Period 4|Physician Decision|0|||
13164219|NCT02397460|26097744|FG006|Treatment Period 4|Physician Decision|0|||
13164220|NCT02397460|26097745|FG007|Treatment Period 4|Physician Decision|0|||
13164221|NCT02397447|26097798|FG000|Overall Study|Lost to Follow-up|2|||
13164222|NCT02397447|26097799|FG001|Overall Study|Lost to Follow-up|2|||
13164223|NCT02397408|26097819|FG000|Overall Study|Physician Decision|4|||
13164224|NCT02397408|26097819|FG000|Overall Study|Surgery not completed within protocol timeframe|2|||
13164225|NCT02397278|26097840|FG000|Overall Study|Withdrawal by Subject|0|||
13164226|NCT02397278|26097841|FG001|Overall Study|Withdrawal by Subject|2|||
13164227|NCT02397278|26097840|FG000|Overall Study|Deemed ineligible following surgery|1|||
13164228|NCT02397278|26097841|FG001|Overall Study|Deemed ineligible following surgery|1|||
13164229|NCT02397096|26097878|FG000|Day 1 to Week 24|Adverse Event|7|||
13164230|NCT02397096|26097879|FG001|Day 1 to Week 24|Adverse Event|1|||
13164231|NCT02397096|26097878|FG000|Day 1 to Week 24|Death|1|||
13164232|NCT02397096|26097879|FG001|Day 1 to Week 24|Death|0|||
13164233|NCT02397096|26097878|FG000|Day 1 to Week 24|Lack of Efficacy|0|||
13164234|NCT02397096|26097879|FG001|Day 1 to Week 24|Lack of Efficacy|1|||
13164235|NCT02397096|26097878|FG000|Day 1 to Week 24|Lost to Follow-up|3|||
13164236|NCT02397096|26097879|FG001|Day 1 to Week 24|Lost to Follow-up|4|||
13164237|NCT02397096|26097878|FG000|Day 1 to Week 24|Physician Decision|2|||
13164238|NCT02397096|26097879|FG001|Day 1 to Week 24|Physician Decision|3|||
13164239|NCT02397096|26097878|FG000|Day 1 to Week 24|Protocol Violation|1|||
13164240|NCT02397096|26097879|FG001|Day 1 to Week 24|Protocol Violation|4|||
13164241|NCT02397096|26097878|FG000|Day 1 to Week 24|Withdrawal by Subject|6|||
13164242|NCT02397096|26097879|FG001|Day 1 to Week 24|Withdrawal by Subject|1|||
13164243|NCT02397096|26097878|FG000|Week 24 to Week 48|Adverse Event|6|||
13164244|NCT02397096|26097879|FG001|Week 24 to Week 48|Adverse Event|2|||
13164245|NCT02397096|26097878|FG000|Week 24 to Week 48|Lack of Efficacy|5|||
13164246|NCT02397096|26097879|FG001|Week 24 to Week 48|Lack of Efficacy|1|||
13164247|NCT02397096|26097878|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0|||
13164248|NCT02397096|26097879|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1|||
13164249|NCT02397096|26097878|FG000|Week 24 to Week 48|Physician Decision|2|||
13164250|NCT02397096|26097879|FG001|Week 24 to Week 48|Physician Decision|1|||
13164251|NCT02397096|26097878|FG000|Week 24 to Week 48|Withdrawal by Subject|5|||
13164252|NCT02397096|26097879|FG001|Week 24 to Week 48|Withdrawal by Subject|2|||
13164253|NCT02397096|26097878|FG000|Week 24 to Week 48|Lost to Follow-up|2|||
13164254|NCT02397096|26097879|FG001|Week 24 to Week 48|Lost to Follow-up|0|||
13164255|NCT02397096|26097878|FG000|Study Extensions|Ongoing|399|||
13164256|NCT02397096|26097879|FG001|Study Extensions|Ongoing|202|||
13164257|NCT02397057|26097904|FG000|Overall Study|Withdrawal by Subject|6|||
13164258|NCT02397057|26097905|FG001|Overall Study|Withdrawal by Subject|7|||
13164259|NCT02397057|26097904|FG000|Overall Study|Lost to Follow-up|4|||
13164260|NCT02397057|26097905|FG001|Overall Study|Lost to Follow-up|3|||
13164261|NCT02397057|26097904|FG000|Overall Study|Death|1|||
13164262|NCT02397057|26097905|FG001|Overall Study|Death|0|||
13164263|NCT02397057|26097904|FG000|Overall Study|Adverse Event|0|||
13164264|NCT02397057|26097905|FG001|Overall Study|Adverse Event|1|||
13164265|NCT02397057|26097904|FG000|Overall Study|Physician Decision|0|||
13164266|NCT02397057|26097905|FG001|Overall Study|Physician Decision|1|||
13164267|NCT02397057|26097904|FG000|Overall Study|Subject did not receive study drug|0|||
13164268|NCT02397057|26097905|FG001|Overall Study|Subject did not receive study drug|1|||
13164269|NCT02396953|26097965|FG000|Overall Study|Withdrawal by Subject|0|||
13164270|NCT02396953|26097966|FG001|Overall Study|Withdrawal by Subject|0|||
13164271|NCT02396953|26097967|FG002|Overall Study|Withdrawal by Subject|1|||
13164272|NCT02396953|26097965|FG000|Overall Study|Insulin like Growth Factor-1 increased|3|||
13164273|NCT02396953|26097966|FG001|Overall Study|Insulin like Growth Factor-1 increased|2|||
13164274|NCT02396953|26097967|FG002|Overall Study|Insulin like Growth Factor-1 increased|2|||
13164275|NCT02396953|26097965|FG000|Overall Study|Personal Reasons|1|||
13164276|NCT02396953|26097966|FG001|Overall Study|Personal Reasons|1|||
13164277|NCT02396953|26097967|FG002|Overall Study|Personal Reasons|0|||
13164278|NCT02396849|26097982|FG000|Overall Study|Lost to Follow-up|1|||
13164279|NCT02396849|26097983|FG001|Overall Study|Lost to Follow-up|1|||
13164280|NCT02396849|26097982|FG000|Overall Study|Did not tolerate intervention|1|||
13164281|NCT02396849|26097983|FG001|Overall Study|Did not tolerate intervention|1|||
13164282|NCT02396758|26098110|FG000|Overall Study|Withdrawal by Subject|2|||
13164283|NCT02396758|26098111|FG001|Overall Study|Withdrawal by Subject|0|||
13164284|NCT02396758|26098112|FG002|Overall Study|Withdrawal by Subject|0|||
13164285|NCT02396758|26098113|FG003|Overall Study|Withdrawal by Subject|1|||
13164286|NCT02396758|26098110|FG000|Overall Study|Lost to Follow-up|8|||
13164287|NCT02396758|26098111|FG001|Overall Study|Lost to Follow-up|5|||
13164288|NCT02396758|26098112|FG002|Overall Study|Lost to Follow-up|3|||
13164289|NCT02396758|26098113|FG003|Overall Study|Lost to Follow-up|3|||
13164290|NCT02396758|26098110|FG000|Overall Study|Death|1|||
13164291|NCT02396758|26098111|FG001|Overall Study|Death|1|||
13164292|NCT02396758|26098112|FG002|Overall Study|Death|0|||
13164293|NCT02396758|26098113|FG003|Overall Study|Death|1|||
13164294|NCT02396758|26098110|FG000|Overall Study|Randomized but not treated|1|||
13164295|NCT02396758|26098111|FG001|Overall Study|Randomized but not treated|0|||
13164296|NCT02396758|26098112|FG002|Overall Study|Randomized but not treated|1|||
13164297|NCT02396758|26098113|FG003|Overall Study|Randomized but not treated|0|||
13164298|NCT02396537|26098126|FG000|Overall Study|Protocol Violation|0|||
13164299|NCT02396537|26098127|FG001|Overall Study|Protocol Violation|1|||
13164300|NCT02396420|26098149|FG000|Overall Study|Death|1|||
13164301|NCT02396316|26098166|FG000|Overall Study|Physician Decision|1|||
13164302|NCT02396316|26098167|FG001|Overall Study|Physician Decision|0|||
13164303|NCT02396316|26098166|FG000|Overall Study|Progressive disease|6|||
13106561|NCT03300050|25884513|FG004|Overall Study|Not Eligible at Randomization|0|||
13106562|NCT03300024|25884572|FG000|Overall Study|Physician Decision|4|||
13106563|NCT03300024|25884573|FG001|Overall Study|Physician Decision|6|||
13106564|NCT03299881|25884586|FG000|Overall Study|Study Termination|17|||
13106565|NCT03299881|25884587|FG001|Overall Study|Study Termination|13|||
13106566|NCT03299686|25884610|FG000|Treatment Epoch|Subject/Guardian Decision|2|||
13106567|NCT03299686|25884611|FG001|Treatment Epoch|Subject/Guardian Decision|0|||
13106568|NCT03299686|25884610|FG000|Treatment Epoch|Physician Decision|1|||
13106569|NCT03299686|25884611|FG001|Treatment Epoch|Physician Decision|0|||
13106570|NCT03299686|25884610|FG000|Treatment Epoch|Adverse Event|8|||
13106571|NCT03299686|25884611|FG001|Treatment Epoch|Adverse Event|4|||
13106572|NCT03299686|25884610|FG000|Follow-up Epoch|Subject/Guardian Decision|0|||
13106573|NCT03299686|25884611|FG001|Follow-up Epoch|Subject/Guardian Decision|1|||
13106574|NCT03299244|25884643|FG000|Overall Study|Withdrawal by Subject|34|||
13106575|NCT03299244|25884644|FG001|Overall Study|Withdrawal by Subject|29|||
13106576|NCT03299244|25884643|FG000|Overall Study|Decision by Sponsor|4|||
13106577|NCT03299244|25884644|FG001|Overall Study|Decision by Sponsor|5|||
13106578|NCT03299244|25884643|FG000|Overall Study|Death|9|||
13106579|NCT03299244|25884644|FG001|Overall Study|Death|4|||
13106580|NCT03299101|25884667|FG000|Overall Study|Lost to Follow-up|1|||
13106581|NCT03299101|25884667|FG000|Overall Study|Withdrawal by Subject|5|||
13106582|NCT03299101|25884667|FG000|Overall Study|Surgery was changed|3|||
13106583|NCT03299101|25884667|FG000|Overall Study|Not enough time to complete prehab|1|||
13106584|NCT03298984|25884700|FG000|Overall Study|Physician Decision|1|||
13106585|NCT03298984|25884701|FG001|Overall Study|Physician Decision|0|||
13106586|NCT03298984|25884702|FG002|Overall Study|Physician Decision|0|||
13106587|NCT03298984|25884703|FG003|Overall Study|Physician Decision|6|||
13106588|NCT03298984|25884700|FG000|Overall Study|Lack of Efficacy|0|||
13106589|NCT03298984|25884701|FG001|Overall Study|Lack of Efficacy|1|||
13106590|NCT03298984|25884702|FG002|Overall Study|Lack of Efficacy|1|||
13106591|NCT03298984|25884703|FG003|Overall Study|Lack of Efficacy|4|||
13106592|NCT03298984|25884700|FG000|Overall Study|Relapsed disease (following remission)|0|||
13106593|NCT03298984|25884701|FG001|Overall Study|Relapsed disease (following remission)|0|||
13106594|NCT03298984|25884702|FG002|Overall Study|Relapsed disease (following remission)|1|||
13106595|NCT03298984|25884703|FG003|Overall Study|Relapsed disease (following remission)|1|||
13106596|NCT03298984|25884700|FG000|Overall Study|Adverse Event|0|||
13106597|NCT03298984|25884701|FG001|Overall Study|Adverse Event|0|||
13106598|NCT03298984|25884702|FG002|Overall Study|Adverse Event|0|||
13106599|NCT03298984|25884703|FG003|Overall Study|Adverse Event|1|||
13106600|NCT03298984|25884700|FG000|Overall Study|Death|0|||
13106601|NCT03298984|25884701|FG001|Overall Study|Death|0|||
13106602|NCT03298984|25884702|FG002|Overall Study|Death|0|||
13106603|NCT03298984|25884703|FG003|Overall Study|Death|2|||
13106604|NCT03298984|25884700|FG000|Overall Study|Insurance Company Decision|0|||
13106605|NCT03298984|25884701|FG001|Overall Study|Insurance Company Decision|0|||
13106606|NCT03298984|25884702|FG002|Overall Study|Insurance Company Decision|0|||
13106607|NCT03298984|25884703|FG003|Overall Study|Insurance Company Decision|1|||
13106608|NCT03298867|25884726|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
13106609|NCT03298867|25884727|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
13106610|NCT03298867|25884726|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
13106611|NCT03298867|25884727|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
13106612|NCT03298867|25884726|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1|||
13106613|NCT03298867|25884727|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9|||
13106614|NCT03298867|25884726|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0|||
13106615|NCT03298867|25884727|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1|||
13106616|NCT03298867|25884726|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0|||
13106617|NCT03298867|25884727|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1|||
13106618|NCT03298867|25884726|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0|||
13106619|NCT03298867|25884727|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2|||
13106620|NCT03298867|25884726|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0|||
13106621|NCT03298867|25884727|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1|||
13106622|NCT03298867|25884726|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0|||
13106623|NCT03298867|25884727|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2|||
13106624|NCT03298867|25884726|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0|||
13106625|NCT03298867|25884727|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1|||
13106626|NCT03298412|25884737|FG000|Run-in Period|Other, Not Specified|1|||
13106627|NCT03298412|25884737|FG000|Run-in Period|Disease Progression|1|||
13106628|NCT03298412|25884737|FG000|Run-in Period|Ineligibility Determined|1|||
13106629|NCT03298412|25884737|FG000|Run-in Period|Decision by Sponsor|6|||
13133173|NCT02777593|25986823|FG002|Overall Study|Discontinued due to Other|0|||
13133174|NCT02777593|25986824|FG003|Overall Study|Discontinued due to Other|0|||
13133175|NCT02777593|25986825|FG004|Overall Study|Discontinued due to Other|0|||
13133176|NCT02777554|25986868|FG000|Overall Study|Adverse Event|4|||
13106630|NCT03297398|25884773|FG000|Overall Study|Sponsor's decision|6|||
13106631|NCT03297398|25884774|FG001|Overall Study|Sponsor's decision|9|||
13106632|NCT03297398|25884775|FG002|Overall Study|Sponsor's decision|7|||
13106633|NCT03297398|25884773|FG000|Overall Study|Adverse Event|1|||
13106634|NCT03297398|25884774|FG001|Overall Study|Adverse Event|4|||
13106635|NCT03297398|25884775|FG002|Overall Study|Adverse Event|4|||
13106636|NCT03297398|25884773|FG000|Overall Study|Withdrawal by Subject|1|||
13106637|NCT03297398|25884774|FG001|Overall Study|Withdrawal by Subject|2|||
13106638|NCT03297398|25884775|FG002|Overall Study|Withdrawal by Subject|2|||
13106639|NCT03297398|25884773|FG000|Overall Study|Protocol Violation|0|||
13106640|NCT03297398|25884774|FG001|Overall Study|Protocol Violation|2|||
13106641|NCT03297398|25884775|FG002|Overall Study|Protocol Violation|0|||
13106642|NCT03297398|25884773|FG000|Overall Study|Physician Decision|0|||
13164304|NCT02396316|26098167|FG001|Overall Study|Progressive disease|3|||
13164305|NCT02396316|26098166|FG000|Overall Study|Protocol Violation|0|||
13164306|NCT02396316|26098167|FG001|Overall Study|Protocol Violation|1|||
13164307|NCT02396316|26098166|FG000|Overall Study|Treatment unblinded|0|||
13164308|NCT02396316|26098167|FG001|Overall Study|Treatment unblinded|1|||
13164309|NCT02396212|26098188|FG000|Overall Study|Adverse Event|1|||
13164310|NCT02396212|26098188|FG000|Overall Study|Lack of Efficacy|2|||
13164311|NCT02395822|26098198|FG000|Overall Study|Withdrawal by Subject|1|||
13164312|NCT02395822|26098198|FG000|Overall Study|Death|1|||
13164313|NCT02395653|26098207|FG000|Overall Study|Exclusion Criteria Met at Screening|4|||
13164314|NCT02395653|26098207|FG000|Overall Study|Consent Withdrawn at Screening|1|||
13164315|NCT02395653|26098207|FG000|Overall Study|SSEC Application But With 0 Dose|1|||
13164316|NCT02395653|26098207|FG000|Overall Study|Investigator Decision at Screening|1|||
13164317|NCT02395653|26098207|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3|||
13106643|NCT03297398|25884774|FG001|Overall Study|Physician Decision|0|||
13164318|NCT02395653|26098207|FG000|Overall Study|Withdrawal by Subject|1|||
13164319|NCT02395653|26098207|FG000|Overall Study|Lost to Follow-up|1|||
13164320|NCT02395627|26098243|FG000|Overall Study|Withdrawal by Subject|0|||
13164321|NCT02395627|26098244|FG001|Overall Study|Withdrawal by Subject|2|||
13164322|NCT02395627|26098245|FG002|Overall Study|Withdrawal by Subject|0|||
13164323|NCT02395627|26098243|FG000|Overall Study|Did not receive pembrolizumab|3|||
13164324|NCT02395627|26098244|FG001|Overall Study|Did not receive pembrolizumab|1|||
13164325|NCT02395627|26098245|FG002|Overall Study|Did not receive pembrolizumab|0|||
13164326|NCT02395536|26098258|FG000|Overall Study|Lost to Follow-up|4|||
13164327|NCT02395536|26098259|FG001|Overall Study|Lost to Follow-up|4|||
13164328|NCT02395536|26098258|FG000|Overall Study|Death|2|||
13164329|NCT02395536|26098259|FG001|Overall Study|Death|0|||
13164330|NCT02395536|26098258|FG000|Overall Study|Physician Decision|4|||
13164331|NCT02395536|26098259|FG001|Overall Study|Physician Decision|6|||
13164332|NCT02395536|26098258|FG000|Overall Study|Withdrawal by Subject|9|||
13164333|NCT02395536|26098259|FG001|Overall Study|Withdrawal by Subject|17|||
13164334|NCT02395536|26098258|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1|||
13164335|NCT02395536|26098259|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2|||
13164336|NCT02395536|26098258|FG000|Overall Study|Insurance issue|0|||
13164337|NCT02395536|26098259|FG001|Overall Study|Insurance issue|1|||
13106644|NCT03297398|25884775|FG002|Overall Study|Physician Decision|1|||
13106645|NCT03297398|25884773|FG000|Overall Study|Lost to Follow-up|0|||
13106646|NCT03297398|25884774|FG001|Overall Study|Lost to Follow-up|0|||
13106647|NCT03297398|25884775|FG002|Overall Study|Lost to Follow-up|1|||
13106648|NCT03297294|25884819|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30|||
13106649|NCT03297294|25884820|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31|||
13106650|NCT03297294|25884821|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
13106651|NCT03297294|25884822|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
13106652|NCT03297294|25884823|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
13106653|NCT03297294|25884819|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
13106654|NCT03297294|25884820|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
13106655|NCT03297294|25884821|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
13106656|NCT03297294|25884822|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
13106657|NCT03297294|25884823|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
13106658|NCT03297294|25884819|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
13106659|NCT03297294|25884820|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1|||
13164338|NCT02395471|26098281|FG000|Overall Study|Lost to Follow-up|2|||
13164339|NCT02395471|26098282|FG001|Overall Study|Lost to Follow-up|0|||
13164340|NCT02395471|26098281|FG000|Overall Study|Withdrawal by Subject|2|||
13164341|NCT02395471|26098282|FG001|Overall Study|Withdrawal by Subject|1|||
13106660|NCT03297294|25884821|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0|||
13106661|NCT03297294|25884822|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
13106662|NCT03297294|25884823|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
13106663|NCT03297294|25884819|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1|||
13106664|NCT03297294|25884820|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1|||
13106665|NCT03297294|25884821|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0|||
13106666|NCT03297294|25884822|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
13106667|NCT03297294|25884823|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
13106668|NCT03297294|25884819|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
13106669|NCT03297294|25884820|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
13106670|NCT03297294|25884821|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
13106671|NCT03297294|25884822|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1|||
13106672|NCT03297294|25884823|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
13106673|NCT03297216|25884864|FG000|Overall Study|Death|0|||
13106674|NCT03297216|25884865|FG001|Overall Study|Death|1|||
13106675|NCT03297216|25884864|FG000|Overall Study|Miscarriage|0|||
13106676|NCT03297216|25884865|FG001|Overall Study|Miscarriage|2|||
13106677|NCT03297216|25884864|FG000|Overall Study|Lost to Follow-up|3|||
13164342|NCT02395471|26098281|FG000|Overall Study|Physician Decision|1|||
13164343|NCT02395471|26098282|FG001|Overall Study|Physician Decision|0|||
13164344|NCT02395471|26098281|FG000|Overall Study|Protocol Violation|0|||
13164345|NCT02395471|26098282|FG001|Overall Study|Protocol Violation|1|||
13164346|NCT02395471|26098281|FG000|Overall Study|Failure to swollow sponge twice|1|||
13164347|NCT02395471|26098282|FG001|Overall Study|Failure to swollow sponge twice|0|||
13164348|NCT02395471|26098281|FG000|Overall Study|Patient did not return for procedure|0|||
13164349|NCT02395471|26098282|FG001|Overall Study|Patient did not return for procedure|1|||
13164350|NCT02395471|26098281|FG000|Overall Study|Subject not eligible|1|||
13164351|NCT02395471|26098282|FG001|Overall Study|Subject not eligible|0|||
13164352|NCT02395302|26098288|FG000|Overall Study|Screen Failure|3|||
13164353|NCT02395302|26098288|FG000|Overall Study|Run In Failure|7|||
13164354|NCT02395302|26098288|FG000|Overall Study|Withdrawal by Subject|2|||
13164355|NCT02395302|26098288|FG000|Overall Study|Physician Decision|2|||
13164356|NCT02395172|26098330|FG000|Overall Study|Participants randomized but not treated|3|||
13164357|NCT02395172|26098331|FG001|Overall Study|Participants randomized but not treated|31|||
13164358|NCT02395133|26098430|FG000|Overall Study|Adverse Event|4|||
13164359|NCT02395133|26098431|FG001|Overall Study|Adverse Event|1|||
13164360|NCT02395133|26098432|FG002|Overall Study|Adverse Event|3|||
13164361|NCT02395133|26098433|FG003|Overall Study|Adverse Event|0|||
13164362|NCT02395133|26098430|FG000|Overall Study|Lack of Efficacy|1|||
13164363|NCT02395133|26098431|FG001|Overall Study|Lack of Efficacy|0|||
13106678|NCT03297216|25884865|FG001|Overall Study|Lost to Follow-up|2|||
13106679|NCT03297021|25884895|FG000|Overall Study|Incomplete/illegible data sheet|4|||
13106680|NCT03297021|25884896|FG001|Overall Study|Incomplete/illegible data sheet|2|||
13106681|NCT03297021|25884897|FG002|Overall Study|Incomplete/illegible data sheet|3|||
13106682|NCT03297021|25884895|FG000|Overall Study|Missing Post-Op Data|1|||
13106683|NCT03297021|25884896|FG001|Overall Study|Missing Post-Op Data|2|||
13106684|NCT03297021|25884897|FG002|Overall Study|Missing Post-Op Data|1|||
13106685|NCT03296566|25884918|FG000|Overall Study|Lost to Follow-up|19|||
13106686|NCT03296566|25884919|FG001|Overall Study|Lost to Follow-up|46|||
13106687|NCT03296566|25884918|FG000|Overall Study|Withdrawal by Subject|0|||
13106688|NCT03296566|25884919|FG001|Overall Study|Withdrawal by Subject|3|||
13106689|NCT03296527|25885052|FG000|Overall Study|Adverse Event|15|||
13106690|NCT03296527|25885053|FG001|Overall Study|Adverse Event|33|||
13106691|NCT03296527|25885052|FG000|Overall Study|Protocol Deviation|4|||
13106692|NCT03296527|25885053|FG001|Overall Study|Protocol Deviation|0|||
13106693|NCT03296527|25885052|FG000|Overall Study|Subject withdrew consent|3|||
13106694|NCT03296527|25885053|FG001|Overall Study|Subject withdrew consent|1|||
13106695|NCT03296527|25885052|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9|||
13106696|NCT03296527|25885053|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14|||
13106697|NCT03296527|25885052|FG000|Overall Study|Discontinuations due to withdrawal from trial|2|||
13106698|NCT03296527|25885053|FG001|Overall Study|Discontinuations due to withdrawal from trial|3|||
13106699|NCT03296527|25885052|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0|||
13106700|NCT03296527|25885053|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2|||
13106701|NCT03296527|25885052|FG000|Overall Study|Discontinuation due to liquid in uterus|1|||
13106702|NCT03296527|25885053|FG001|Overall Study|Discontinuation due to liquid in uterus|0|||
13106703|NCT03296527|25885052|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1|||
13106704|NCT03296527|25885053|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0|||
13106705|NCT03295721|25885078|FG000|Overall Study|Adverse Event|1|||
13106706|NCT03295721|25885079|FG001|Overall Study|Adverse Event|0|||
13106707|NCT03295721|25885080|FG002|Overall Study|Adverse Event|0|||
13106708|NCT03295721|25885078|FG000|Overall Study|Lost to Follow-up|1|||
13106709|NCT03295721|25885079|FG001|Overall Study|Lost to Follow-up|1|||
13106710|NCT03295721|25885080|FG002|Overall Study|Lost to Follow-up|1|||
13106711|NCT03295721|25885078|FG000|Overall Study|Withdrawal by Subject|1|||
13106712|NCT03295721|25885079|FG001|Overall Study|Withdrawal by Subject|0|||
13106713|NCT03295721|25885080|FG002|Overall Study|Withdrawal by Subject|1|||
13164364|NCT02395133|26098432|FG002|Overall Study|Lack of Efficacy|1|||
13106714|NCT03295721|25885078|FG000|Overall Study|Death|0|||
13164365|NCT02395133|26098433|FG003|Overall Study|Lack of Efficacy|1|||
13106715|NCT03295721|25885079|FG001|Overall Study|Death|0|||
13106716|NCT03295721|25885080|FG002|Overall Study|Death|1|||
13106717|NCT03295318|25885131|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1|||
13106718|NCT03295318|25885132|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
13106719|NCT03295318|25885133|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
13106720|NCT03295318|25885131|FG000|Overall Study|Death|1|||
13106721|NCT03295318|25885132|FG001|Overall Study|Death|1|||
13106722|NCT03295318|25885133|FG002|Overall Study|Death|1|||
13106723|NCT03295318|25885131|FG000|Overall Study|Protocol Violation|4|||
13106724|NCT03295318|25885132|FG001|Overall Study|Protocol Violation|3|||
13164366|NCT02395133|26098430|FG000|Overall Study|Protocol Violation|1|||
13164367|NCT02395133|26098431|FG001|Overall Study|Protocol Violation|1|||
13164368|NCT02395133|26098432|FG002|Overall Study|Protocol Violation|0|||
13164369|NCT02395133|26098433|FG003|Overall Study|Protocol Violation|3|||
13164370|NCT02395133|26098430|FG000|Overall Study|Lost to Follow-up|0|||
13164371|NCT02395133|26098431|FG001|Overall Study|Lost to Follow-up|1|||
13164372|NCT02395133|26098432|FG002|Overall Study|Lost to Follow-up|1|||
13164373|NCT02395133|26098433|FG003|Overall Study|Lost to Follow-up|0|||
13164374|NCT02395133|26098430|FG000|Overall Study|Pregnancy|0|||
13164375|NCT02395133|26098431|FG001|Overall Study|Pregnancy|0|||
13164376|NCT02395133|26098432|FG002|Overall Study|Pregnancy|3|||
13106725|NCT03295318|25885133|FG002|Overall Study|Protocol Violation|3|||
13164377|NCT02395133|26098433|FG003|Overall Study|Pregnancy|0|||
13164378|NCT02395133|26098430|FG000|Overall Study|Consent withdrawn with no reason given|1|||
13164379|NCT02395133|26098431|FG001|Overall Study|Consent withdrawn with no reason given|3|||
13164380|NCT02395133|26098432|FG002|Overall Study|Consent withdrawn with no reason given|0|||
13164381|NCT02395133|26098433|FG003|Overall Study|Consent withdrawn with no reason given|2|||
13164382|NCT02395133|26098430|FG000|Overall Study|Consent withdrawn with personal reason|0|||
13164383|NCT02395133|26098431|FG001|Overall Study|Consent withdrawn with personal reason|1|||
13164384|NCT02395133|26098432|FG002|Overall Study|Consent withdrawn with personal reason|0|||
13164385|NCT02395133|26098433|FG003|Overall Study|Consent withdrawn with personal reason|3|||
13164386|NCT02395133|26098430|FG000|Overall Study|Sponsor decision|2|||
13164387|NCT02395133|26098431|FG001|Overall Study|Sponsor decision|0|||
13164388|NCT02395133|26098432|FG002|Overall Study|Sponsor decision|0|||
13164389|NCT02395133|26098433|FG003|Overall Study|Sponsor decision|1|||
13164390|NCT02395133|26098430|FG000|Overall Study|Other than specified above|5|||
13164391|NCT02395133|26098431|FG001|Overall Study|Other than specified above|2|||
13164392|NCT02395133|26098432|FG002|Overall Study|Other than specified above|2|||
13164393|NCT02395133|26098433|FG003|Overall Study|Other than specified above|4|||
13164394|NCT02395081|26098487|FG000|Overall Study|Withdrawal by Subject|1|||
13164395|NCT02395081|26098488|FG001|Overall Study|Withdrawal by Subject|1|||
13164396|NCT02395081|26098489|FG002|Overall Study|Withdrawal by Subject|0|||
13164397|NCT02395081|26098487|FG000|Overall Study|Moved where blood couldn't be collected|4|||
13164398|NCT02395081|26098488|FG001|Overall Study|Moved where blood couldn't be collected|1|||
13164399|NCT02395081|26098489|FG002|Overall Study|Moved where blood couldn't be collected|3|||
13164400|NCT02395081|26098487|FG000|Overall Study|Fetal Loss|2|||
13164401|NCT02395081|26098488|FG001|Overall Study|Fetal Loss|3|||
13164402|NCT02395081|26098489|FG002|Overall Study|Fetal Loss|1|||
13164403|NCT02395055|26098516|FG000|Overall Study|Withdrawal by Subject|7|||
13164404|NCT02395055|26098517|FG001|Overall Study|Withdrawal by Subject|3|||
13164405|NCT02395042|26098544|FG000|Treatment 1 Period|Adverse Event|1|||
13164406|NCT02395042|26098545|FG001|Treatment 1 Period|Adverse Event|3|||
13164407|NCT02395042|26098546|FG002|Treatment 1 Period|Adverse Event|1|||
13164408|NCT02395042|26098544|FG000|Treatment 1 Period|Lack of Efficacy|1|||
13164409|NCT02395042|26098545|FG001|Treatment 1 Period|Lack of Efficacy|1|||
13164410|NCT02395042|26098546|FG002|Treatment 1 Period|Lack of Efficacy|0|||
13164411|NCT02395042|26098544|FG000|Treatment 1 Period|Lost to Follow-up|1|||
13164412|NCT02395042|26098545|FG001|Treatment 1 Period|Lost to Follow-up|0|||
13164413|NCT02395042|26098546|FG002|Treatment 1 Period|Lost to Follow-up|0|||
13164414|NCT02395042|26098544|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0|||
13164415|NCT02395042|26098545|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2|||
13164416|NCT02395042|26098546|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1|||
13164417|NCT02395042|26098544|FG000|Treatment 2 Period|Lack of Efficacy|1|||
13164418|NCT02395042|26098545|FG001|Treatment 2 Period|Lack of Efficacy|1|||
13164419|NCT02395042|26098546|FG002|Treatment 2 Period|Lack of Efficacy|0|||
13164420|NCT02394925|26098552|FG000|Overall Study|Adverse Event|1|||
13164421|NCT02394925|26098552|FG000|Overall Study|Lens Discomfort|3|||
13164422|NCT02394925|26098552|FG000|Overall Study|Lens handling difficulities|5|||
13164423|NCT02394925|26098552|FG000|Overall Study|Lost to Follow-up|9|||
13164424|NCT02394925|26098552|FG000|Overall Study|Protocol Violation|5|||
13164425|NCT02394925|26098552|FG000|Overall Study|No longer meet eligibility criteria|1|||
13164426|NCT02394925|26098552|FG000|Overall Study|Unsatisfactory Visual Response|5|||
13205487|NCT01964963|26231955|FG000|Overall Study|Case Report Forms Uncollected|888|||
13205488|NCT01964963|26231955|FG000|Overall Study|Protocol Deviation|50|||
13205489|NCT01964963|26231955|FG000|Overall Study|Data Reliability was not Assured|5|||
13205490|NCT01964950|26231973|FG000|Overall Study|Protocol Violation|25|||
13164427|NCT02394808|26098563|FG000|Period 1|Unsatisfactory lens fitting|0|||
13106726|NCT03295318|25885131|FG000|Overall Study|Withdrawal by Subject|0|||
13106727|NCT03295318|25885132|FG001|Overall Study|Withdrawal by Subject|0|||
13106728|NCT03295318|25885133|FG002|Overall Study|Withdrawal by Subject|1|||
13106729|NCT03295318|25885131|FG000|Overall Study|Subject discontinued due to travel|0|||
13106730|NCT03295318|25885132|FG001|Overall Study|Subject discontinued due to travel|1|||
13106731|NCT03295318|25885133|FG002|Overall Study|Subject discontinued due to travel|0|||
13106732|NCT03295201|25885192|FG000|Overall Study|Lost to Follow-up|1|||
13164428|NCT02394808|26098564|FG001|Period 1|Unsatisfactory lens fitting|1|||
13164429|NCT02394808|26098563|FG000|Period 2|Lost to Follow-up|1|||
13164430|NCT02394808|26098564|FG001|Period 2|Lost to Follow-up|0|||
13164431|NCT02394756|26098582|FG000|Period 1|Lens Discomfort|0|||
13164432|NCT02394756|26098583|FG001|Period 1|Lens Discomfort|0|||
13164433|NCT02394756|26098584|FG002|Period 1|Lens Discomfort|0|||
13164434|NCT02394756|26098585|FG003|Period 1|Lens Discomfort|0|||
13164435|NCT02394756|26098586|FG004|Period 1|Lens Discomfort|0|||
13164436|NCT02394756|26098587|FG005|Period 1|Lens Discomfort|1|||
13164437|NCT02394756|26098582|FG000|Period 1|Withdrawal by Subject|0|||
13164438|NCT02394756|26098583|FG001|Period 1|Withdrawal by Subject|1|||
13164439|NCT02394756|26098584|FG002|Period 1|Withdrawal by Subject|1|||
13164440|NCT02394756|26098585|FG003|Period 1|Withdrawal by Subject|1|||
13164441|NCT02394756|26098586|FG004|Period 1|Withdrawal by Subject|0|||
13164442|NCT02394756|26098587|FG005|Period 1|Withdrawal by Subject|0|||
13164443|NCT02394756|26098582|FG000|Period 2|Unsatisfactory Visual Response|0|||
13164444|NCT02394756|26098583|FG001|Period 2|Unsatisfactory Visual Response|0|||
13164445|NCT02394756|26098584|FG002|Period 2|Unsatisfactory Visual Response|0|||
13164446|NCT02394756|26098585|FG003|Period 2|Unsatisfactory Visual Response|0|||
13164447|NCT02394756|26098586|FG004|Period 2|Unsatisfactory Visual Response|1|||
13164448|NCT02394756|26098587|FG005|Period 2|Unsatisfactory Visual Response|0|||
13164449|NCT02394730|26098628|FG000|Overall Study|Lost to Follow-up|1|||
13164450|NCT02394730|26098629|FG001|Overall Study|Lost to Follow-up|0|||
13164451|NCT02394730|26098628|FG000|Overall Study|Withdrawal by Subject|0|||
13164452|NCT02394730|26098629|FG001|Overall Study|Withdrawal by Subject|1|||
13164453|NCT02394665|26098659|FG000|Overall Study|Physician Decision|1|||
13164454|NCT02394665|26098660|FG001|Overall Study|Physician Decision|0|||
13164455|NCT02394665|26098661|FG002|Overall Study|Physician Decision|0|||
13164456|NCT02394600|26098676|FG000|Overall Study|Adverse Event|3|||
13164457|NCT02394600|26098677|FG001|Overall Study|Adverse Event|0|||
13164458|NCT02394600|26098676|FG000|Overall Study|Lost to Follow-up|0|||
13164459|NCT02394600|26098677|FG001|Overall Study|Lost to Follow-up|1|||
13106733|NCT03295201|25885193|FG001|Overall Study|Lost to Follow-up|1|||
13164460|NCT02394600|26098676|FG000|Overall Study|Withdrawal by Subject|0|||
13164461|NCT02394600|26098677|FG001|Overall Study|Withdrawal by Subject|1|||
13164462|NCT02394600|26098676|FG000|Overall Study|Protocol Violation|1|||
13164463|NCT02394600|26098677|FG001|Overall Study|Protocol Violation|0|||
13164464|NCT02394561|26098706|FG000|CORE Phase|Adverse Event|7|||
13164465|NCT02394561|26098707|FG001|CORE Phase|Adverse Event|9|||
13164466|NCT02394561|26098706|FG000|CORE Phase|Death|0|||
13164467|NCT02394561|26098707|FG001|CORE Phase|Death|1|||
13164468|NCT02394561|26098706|FG000|CORE Phase|Pregnancy|1|||
13164469|NCT02394561|26098707|FG001|CORE Phase|Pregnancy|0|||
13164470|NCT02394561|26098706|FG000|CORE Phase|Lost to Follow-up|1|||
13164471|NCT02394561|26098707|FG001|CORE Phase|Lost to Follow-up|0|||
13164472|NCT02394561|26098706|FG000|CORE Phase|Physician Decision|1|||
13164473|NCT02394561|26098707|FG001|CORE Phase|Physician Decision|1|||
13164474|NCT02394561|26098706|FG000|CORE Phase|Withdrawal by Subject|2|||
13164475|NCT02394561|26098707|FG001|CORE Phase|Withdrawal by Subject|2|||
13164476|NCT02394561|26098706|FG000|CORE Phase|Lack of Efficacy|1|||
13164477|NCT02394561|26098707|FG001|CORE Phase|Lack of Efficacy|6|||
13164478|NCT02394561|26098706|FG000|Extension Phase|Adverse Event|6|||
13164479|NCT02394561|26098707|FG001|Extension Phase|Adverse Event|1|||
13164480|NCT02394561|26098706|FG000|Extension Phase|Death|0|||
13164481|NCT02394561|26098707|FG001|Extension Phase|Death|1|||
13164482|NCT02394561|26098706|FG000|Extension Phase|Protocol Violation|1|||
13164483|NCT02394561|26098707|FG001|Extension Phase|Protocol Violation|0|||
13164484|NCT02394561|26098706|FG000|Extension Phase|Lost to Follow-up|1|||
13164485|NCT02394561|26098707|FG001|Extension Phase|Lost to Follow-up|0|||
13164486|NCT02394561|26098706|FG000|Extension Phase|Physician Decision|0|||
13164487|NCT02394561|26098707|FG001|Extension Phase|Physician Decision|2|||
13106734|NCT03295201|25885192|FG000|Overall Study|Hospital admission|0|||
13106735|NCT03295201|25885193|FG001|Overall Study|Hospital admission|1|||
13106736|NCT03294941|25885209|FG000|Overall Study|Withdrawal by Subject|0|||
13106737|NCT03294941|25885210|FG001|Overall Study|Withdrawal by Subject|2|||
13106738|NCT03294681|25885216|FG000|Overall Study|Withdrawal by Subject|1|||
13106739|NCT03294538|25885241|FG000|Overall Study|Adverse Event|0|||
13164488|NCT02394561|26098706|FG000|Extension Phase|Withdrawal by Subject|0|||
13164489|NCT02394561|26098707|FG001|Extension Phase|Withdrawal by Subject|5|||
13164490|NCT02394561|26098706|FG000|Extension Phase|Lack of Efficacy|3|||
13164491|NCT02394561|26098707|FG001|Extension Phase|Lack of Efficacy|3|||
13164492|NCT02394340|26098714|FG000|Overall Study|Failed drug screen test|1|||
13106740|NCT03294538|25885242|FG001|Overall Study|Adverse Event|1|||
13106741|NCT03294538|25885243|FG002|Overall Study|Adverse Event|1|||
13106742|NCT03294538|25885241|FG000|Overall Study|Lost to Follow-up|1|||
13106743|NCT03294538|25885242|FG001|Overall Study|Lost to Follow-up|0|||
13106744|NCT03294538|25885243|FG002|Overall Study|Lost to Follow-up|0|||
13106745|NCT03294538|25885241|FG000|Overall Study|Outside of Visit Window|4|||
13106746|NCT03294538|25885242|FG001|Overall Study|Outside of Visit Window|4|||
13164493|NCT02394340|26098714|FG000|Overall Study|Adverse Event|1|||
13164494|NCT02394275|26098721|FG000|Overall Study|Adverse Event|22|||
13164495|NCT02394275|26098721|FG000|Overall Study|Lost to Follow-up|7|||
13164496|NCT02394028|26099068|FG000|Induction Phase|Adverse Event|2|||
13164497|NCT02394028|26099069|FG001|Induction Phase|Adverse Event|4|||
13164498|NCT02394028|26099070|FG002|Induction Phase|Adverse Event|1|||
13164499|NCT02394028|26099071|FG003|Induction Phase|Adverse Event|2|||
13164500|NCT02394028|26099072|FG004|Induction Phase|Adverse Event|5|||
13164501|NCT02394028|26099073|FG005|Induction Phase|Adverse Event|2|||
13164502|NCT02394028|26099074|FG006|Induction Phase|Adverse Event|0|||
13164503|NCT02394028|26099075|FG007|Induction Phase|Adverse Event|0|||
13164504|NCT02394028|26099076|FG008|Induction Phase|Adverse Event|0|||
13164505|NCT02394028|26099077|FG009|Induction Phase|Adverse Event|0|||
13164506|NCT02394028|26099078|FG010|Induction Phase|Adverse Event|0|||
13164507|NCT02394028|26099068|FG000|Induction Phase|Lack of Efficacy|3|||
13164508|NCT02394028|26099069|FG001|Induction Phase|Lack of Efficacy|6|||
13164509|NCT02394028|26099070|FG002|Induction Phase|Lack of Efficacy|2|||
13164510|NCT02394028|26099071|FG003|Induction Phase|Lack of Efficacy|17|||
13164511|NCT02394028|26099072|FG004|Induction Phase|Lack of Efficacy|14|||
13164512|NCT02394028|26099073|FG005|Induction Phase|Lack of Efficacy|8|||
13164513|NCT02394028|26099074|FG006|Induction Phase|Lack of Efficacy|17|||
13106747|NCT03294538|25885243|FG002|Overall Study|Outside of Visit Window|1|||
13164514|NCT02394028|26099075|FG007|Induction Phase|Lack of Efficacy|23|||
13164515|NCT02394028|26099076|FG008|Induction Phase|Lack of Efficacy|0|||
13164516|NCT02394028|26099077|FG009|Induction Phase|Lack of Efficacy|0|||
13164517|NCT02394028|26099078|FG010|Induction Phase|Lack of Efficacy|0|||
13164518|NCT02394028|26099068|FG000|Induction Phase|Lost to Follow-up|1|||
13164519|NCT02394028|26099069|FG001|Induction Phase|Lost to Follow-up|0|||
13164520|NCT02394028|26099070|FG002|Induction Phase|Lost to Follow-up|0|||
13164521|NCT02394028|26099071|FG003|Induction Phase|Lost to Follow-up|1|||
13164522|NCT02394028|26099072|FG004|Induction Phase|Lost to Follow-up|0|||
13164523|NCT02394028|26099073|FG005|Induction Phase|Lost to Follow-up|0|||
13164524|NCT02394028|26099074|FG006|Induction Phase|Lost to Follow-up|1|||
13164525|NCT02394028|26099075|FG007|Induction Phase|Lost to Follow-up|0|||
13164526|NCT02394028|26099076|FG008|Induction Phase|Lost to Follow-up|0|||
13164527|NCT02394028|26099077|FG009|Induction Phase|Lost to Follow-up|0|||
13164528|NCT02394028|26099078|FG010|Induction Phase|Lost to Follow-up|0|||
13164529|NCT02394028|26099068|FG000|Induction Phase|Non-compliance|0|||
13164530|NCT02394028|26099069|FG001|Induction Phase|Non-compliance|1|||
13164531|NCT02394028|26099070|FG002|Induction Phase|Non-compliance|3|||
13164532|NCT02394028|26099071|FG003|Induction Phase|Non-compliance|1|||
13164533|NCT02394028|26099072|FG004|Induction Phase|Non-compliance|3|||
13164534|NCT02394028|26099073|FG005|Induction Phase|Non-compliance|0|||
13164535|NCT02394028|26099074|FG006|Induction Phase|Non-compliance|1|||
13164536|NCT02394028|26099075|FG007|Induction Phase|Non-compliance|1|||
13164537|NCT02394028|26099076|FG008|Induction Phase|Non-compliance|0|||
13164538|NCT02394028|26099077|FG009|Induction Phase|Non-compliance|0|||
13164539|NCT02394028|26099078|FG010|Induction Phase|Non-compliance|0|||
13164540|NCT02394028|26099068|FG000|Induction Phase|Physician Decision|0|||
13164541|NCT02394028|26099069|FG001|Induction Phase|Physician Decision|0|||
13164542|NCT02394028|26099070|FG002|Induction Phase|Physician Decision|1|||
13164543|NCT02394028|26099071|FG003|Induction Phase|Physician Decision|4|||
13164544|NCT02394028|26099072|FG004|Induction Phase|Physician Decision|0|||
13164545|NCT02394028|26099073|FG005|Induction Phase|Physician Decision|2|||
13164546|NCT02394028|26099074|FG006|Induction Phase|Physician Decision|1|||
13164547|NCT02394028|26099075|FG007|Induction Phase|Physician Decision|0|||
13164548|NCT02394028|26099076|FG008|Induction Phase|Physician Decision|0|||
13164549|NCT02394028|26099077|FG009|Induction Phase|Physician Decision|0|||
13164550|NCT02394028|26099078|FG010|Induction Phase|Physician Decision|0|||
13164551|NCT02394028|26099068|FG000|Induction Phase|Protocol Violation|0|||
13164552|NCT02394028|26099069|FG001|Induction Phase|Protocol Violation|2|||
13164553|NCT02394028|26099070|FG002|Induction Phase|Protocol Violation|0|||
13106748|NCT03294317|25885258|FG000|Overall Study|Physician Decision|1|||
13106749|NCT03294317|25885258|FG000|Overall Study|Withdrawal by Subject|6|||
13164554|NCT02394028|26099071|FG003|Induction Phase|Protocol Violation|3|||
13164555|NCT02394028|26099072|FG004|Induction Phase|Protocol Violation|0|||
13164556|NCT02394028|26099073|FG005|Induction Phase|Protocol Violation|1|||
13164557|NCT02394028|26099074|FG006|Induction Phase|Protocol Violation|1|||
13164558|NCT02394028|26099075|FG007|Induction Phase|Protocol Violation|0|||
13164559|NCT02394028|26099076|FG008|Induction Phase|Protocol Violation|0|||
13164560|NCT02394028|26099077|FG009|Induction Phase|Protocol Violation|0|||
13164561|NCT02394028|26099078|FG010|Induction Phase|Protocol Violation|0|||
13106750|NCT03294317|25885258|FG000|Overall Study|Lost to Follow-up|1|||
13106751|NCT03294317|25885258|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1|||
13106752|NCT03294317|25885258|FG000|Overall Study|Failed HB lead implant|8|||
13106753|NCT03294317|25885258|FG000|Overall Study|Received CRT instead|1|||
13106754|NCT03294317|25885258|FG000|Overall Study|Exited after lead revision|2|||
13106755|NCT03293654|25885306|FG000|Overall Study|Lost to Follow-up|0|||
13106756|NCT03293654|25885307|FG001|Overall Study|Lost to Follow-up|1|||
13164562|NCT02394028|26099068|FG000|Induction Phase|Withdrawal by Subject|1|||
13164563|NCT02394028|26099069|FG001|Induction Phase|Withdrawal by Subject|2|||
13164564|NCT02394028|26099070|FG002|Induction Phase|Withdrawal by Subject|4|||
13164565|NCT02394028|26099071|FG003|Induction Phase|Withdrawal by Subject|6|||
13164566|NCT02394028|26099072|FG004|Induction Phase|Withdrawal by Subject|7|||
13164567|NCT02394028|26099073|FG005|Induction Phase|Withdrawal by Subject|4|||
13164568|NCT02394028|26099074|FG006|Induction Phase|Withdrawal by Subject|3|||
13164569|NCT02394028|26099075|FG007|Induction Phase|Withdrawal by Subject|6|||
13164570|NCT02394028|26099076|FG008|Induction Phase|Withdrawal by Subject|0|||
13164571|NCT02394028|26099077|FG009|Induction Phase|Withdrawal by Subject|0|||
13164572|NCT02394028|26099078|FG010|Induction Phase|Withdrawal by Subject|0|||
13164573|NCT02394028|26099068|FG000|Induction Phase|Early withdrawal and roll over to a different study|0|||
13164574|NCT02394028|26099069|FG001|Induction Phase|Early withdrawal and roll over to a different study|0|||
13164575|NCT02394028|26099070|FG002|Induction Phase|Early withdrawal and roll over to a different study|0|||
13164576|NCT02394028|26099071|FG003|Induction Phase|Early withdrawal and roll over to a different study|0|||
13164577|NCT02394028|26099072|FG004|Induction Phase|Early withdrawal and roll over to a different study|0|||
13164578|NCT02394028|26099073|FG005|Induction Phase|Early withdrawal and roll over to a different study|0|||
13164579|NCT02394028|26099074|FG006|Induction Phase|Early withdrawal and roll over to a different study|1|||
13164580|NCT02394028|26099075|FG007|Induction Phase|Early withdrawal and roll over to a different study|0|||
13164581|NCT02394028|26099076|FG008|Induction Phase|Early withdrawal and roll over to a different study|0|||
13164582|NCT02394028|26099077|FG009|Induction Phase|Early withdrawal and roll over to a different study|0|||
13164583|NCT02394028|26099078|FG010|Induction Phase|Early withdrawal and roll over to a different study|0|||
13164584|NCT02394028|26099068|FG000|Induction Phase|Sponsor decision|0|||
13164585|NCT02394028|26099069|FG001|Induction Phase|Sponsor decision|1|||
13164586|NCT02394028|26099070|FG002|Induction Phase|Sponsor decision|2|||
13164587|NCT02394028|26099071|FG003|Induction Phase|Sponsor decision|0|||
13164588|NCT02394028|26099072|FG004|Induction Phase|Sponsor decision|0|||
13164589|NCT02394028|26099073|FG005|Induction Phase|Sponsor decision|0|||
13164590|NCT02394028|26099074|FG006|Induction Phase|Sponsor decision|0|||
13164591|NCT02394028|26099075|FG007|Induction Phase|Sponsor decision|0|||
13164592|NCT02394028|26099076|FG008|Induction Phase|Sponsor decision|0|||
13164593|NCT02394028|26099077|FG009|Induction Phase|Sponsor decision|0|||
13164594|NCT02394028|26099078|FG010|Induction Phase|Sponsor decision|0|||
13164595|NCT02394028|26099068|FG000|Induction Phase|Technical reason|0|||
13164596|NCT02394028|26099069|FG001|Induction Phase|Technical reason|0|||
13164597|NCT02394028|26099070|FG002|Induction Phase|Technical reason|0|||
13164598|NCT02394028|26099071|FG003|Induction Phase|Technical reason|1|||
13106757|NCT03293654|25885308|FG002|Overall Study|Lost to Follow-up|0|||
13106758|NCT03293485|25885319|FG000|Overall Study|Death|1|||
13106759|NCT03293485|25885319|FG000|Overall Study|Screen Failure|2|||
13106760|NCT03293485|25885319|FG000|Overall Study|Withdrawal by Subject|2|||
13106761|NCT03293394|25885346|FG000|Follow-up (6 Months)|Adverse Event|4|||
13106762|NCT03293394|25885347|FG001|Follow-up (6 Months)|Adverse Event|2|||
13106763|NCT03292913|25885364|FG000|Overall Study|Death|9|||
13106764|NCT03292913|25885365|FG001|Overall Study|Death|3|||
13106765|NCT03292913|25885364|FG000|Overall Study|Lost to Follow-up|49|||
13106766|NCT03292913|25885365|FG001|Overall Study|Lost to Follow-up|49|||
13106767|NCT03292913|25885364|FG000|Overall Study|Withdrawal by Subject|2|||
13106768|NCT03292913|25885365|FG001|Overall Study|Withdrawal by Subject|0|||
13106769|NCT03292913|25885364|FG000|Overall Study|Clinic closed due to COVID|22|||
13106770|NCT03292913|25885365|FG001|Overall Study|Clinic closed due to COVID|36|||
13106771|NCT03292653|25885404|FG000|Overall Study|Adverse Event|0|||
13106772|NCT03292653|25885405|FG001|Overall Study|Adverse Event|0|||
13106773|NCT03292653|25885406|FG002|Overall Study|Adverse Event|1|||
13106774|NCT03292653|25885404|FG000|Overall Study|Did not Receive Treatment|1|||
13106775|NCT03292653|25885405|FG001|Overall Study|Did not Receive Treatment|0|||
13106776|NCT03292653|25885406|FG002|Overall Study|Did not Receive Treatment|0|||
13106777|NCT03292640|25885423|FG000|Overall Study|Withdrawal by Subject|17|||
13106778|NCT03292640|25885424|FG001|Overall Study|Withdrawal by Subject|16|||
13106779|NCT03292640|25885423|FG000|Overall Study|Adverse Event|20|||
13106780|NCT03292640|25885424|FG001|Overall Study|Adverse Event|2|||
13106781|NCT03292640|25885423|FG000|Overall Study|Lost to Follow-up|24|||
13106782|NCT03292640|25885424|FG001|Overall Study|Lost to Follow-up|24|||
13106783|NCT03292588|25885461|FG000|Overall Study|Death|1|||
13106784|NCT03292588|25885462|FG001|Overall Study|Death|0|||
13106785|NCT03292588|25885461|FG000|Overall Study|Lost to Follow-up|12|||
13106786|NCT03292588|25885462|FG001|Overall Study|Lost to Follow-up|16|||
13164599|NCT02394028|26099072|FG004|Induction Phase|Technical reason|0|||
13164600|NCT02394028|26099073|FG005|Induction Phase|Technical reason|0|||
13164601|NCT02394028|26099074|FG006|Induction Phase|Technical reason|0|||
13164602|NCT02394028|26099075|FG007|Induction Phase|Technical reason|0|||
13164603|NCT02394028|26099076|FG008|Induction Phase|Technical reason|0|||
13164604|NCT02394028|26099077|FG009|Induction Phase|Technical reason|0|||
13164605|NCT02394028|26099078|FG010|Induction Phase|Technical reason|0|||
13164606|NCT02394028|26099068|FG000|Induction Phase|:ack of calculation|0|||
13164607|NCT02394028|26099069|FG001|Induction Phase|:ack of calculation|0|||
13164608|NCT02394028|26099070|FG002|Induction Phase|:ack of calculation|0|||
13164609|NCT02394028|26099071|FG003|Induction Phase|:ack of calculation|0|||
13164610|NCT02394028|26099072|FG004|Induction Phase|:ack of calculation|0|||
13164611|NCT02394028|26099073|FG005|Induction Phase|:ack of calculation|0|||
13164612|NCT02394028|26099074|FG006|Induction Phase|:ack of calculation|0|||
13164613|NCT02394028|26099075|FG007|Induction Phase|:ack of calculation|1|||
13164614|NCT02394028|26099076|FG008|Induction Phase|:ack of calculation|0|||
13164615|NCT02394028|26099077|FG009|Induction Phase|:ack of calculation|0|||
13164616|NCT02394028|26099078|FG010|Induction Phase|:ack of calculation|0|||
13164617|NCT02394028|26099068|FG000|Maintenance Phase|Protocol Violation|0|||
13164618|NCT02394028|26099069|FG001|Maintenance Phase|Protocol Violation|0|||
13164619|NCT02394028|26099070|FG002|Maintenance Phase|Protocol Violation|0|||
13164620|NCT02394028|26099071|FG003|Maintenance Phase|Protocol Violation|0|||
13164621|NCT02394028|26099072|FG004|Maintenance Phase|Protocol Violation|0|||
13164622|NCT02394028|26099073|FG005|Maintenance Phase|Protocol Violation|0|||
13164623|NCT02394028|26099074|FG006|Maintenance Phase|Protocol Violation|0|||
13164624|NCT02394028|26099075|FG007|Maintenance Phase|Protocol Violation|0|||
13164625|NCT02394028|26099076|FG008|Maintenance Phase|Protocol Violation|0|||
13164626|NCT02394028|26099077|FG009|Maintenance Phase|Protocol Violation|0|||
13164627|NCT02394028|26099078|FG010|Maintenance Phase|Protocol Violation|1|||
13164628|NCT02394028|26099068|FG000|Maintenance Phase|Physician Decision|0|||
13164629|NCT02394028|26099069|FG001|Maintenance Phase|Physician Decision|0|||
13164630|NCT02394028|26099070|FG002|Maintenance Phase|Physician Decision|0|||
13164631|NCT02394028|26099071|FG003|Maintenance Phase|Physician Decision|0|||
13164632|NCT02394028|26099072|FG004|Maintenance Phase|Physician Decision|0|||
13164633|NCT02394028|26099073|FG005|Maintenance Phase|Physician Decision|0|||
13164634|NCT02394028|26099074|FG006|Maintenance Phase|Physician Decision|0|||
13164635|NCT02394028|26099075|FG007|Maintenance Phase|Physician Decision|0|||
13164636|NCT02394028|26099076|FG008|Maintenance Phase|Physician Decision|1|||
13164637|NCT02394028|26099077|FG009|Maintenance Phase|Physician Decision|3|||
13164638|NCT02394028|26099078|FG010|Maintenance Phase|Physician Decision|2|||
13164639|NCT02394028|26099068|FG000|Maintenance Phase|Lack of Efficacy|0|||
13164640|NCT02394028|26099069|FG001|Maintenance Phase|Lack of Efficacy|0|||
13164641|NCT02394028|26099070|FG002|Maintenance Phase|Lack of Efficacy|0|||
13164642|NCT02394028|26099071|FG003|Maintenance Phase|Lack of Efficacy|0|||
13164643|NCT02394028|26099072|FG004|Maintenance Phase|Lack of Efficacy|0|||
13164644|NCT02394028|26099073|FG005|Maintenance Phase|Lack of Efficacy|0|||
13164645|NCT02394028|26099074|FG006|Maintenance Phase|Lack of Efficacy|0|||
13164646|NCT02394028|26099075|FG007|Maintenance Phase|Lack of Efficacy|0|||
13164647|NCT02394028|26099076|FG008|Maintenance Phase|Lack of Efficacy|7|||
13164648|NCT02394028|26099077|FG009|Maintenance Phase|Lack of Efficacy|25|||
13164649|NCT02394028|26099078|FG010|Maintenance Phase|Lack of Efficacy|33|||
13164650|NCT02394028|26099068|FG000|Maintenance Phase|Death|0|||
13164651|NCT02394028|26099069|FG001|Maintenance Phase|Death|0|||
13164652|NCT02394028|26099070|FG002|Maintenance Phase|Death|0|||
13164653|NCT02394028|26099071|FG003|Maintenance Phase|Death|0|||
13164654|NCT02394028|26099072|FG004|Maintenance Phase|Death|0|||
13164655|NCT02394028|26099073|FG005|Maintenance Phase|Death|0|||
13164656|NCT02394028|26099074|FG006|Maintenance Phase|Death|0|||
13164657|NCT02394028|26099075|FG007|Maintenance Phase|Death|0|||
13164658|NCT02394028|26099076|FG008|Maintenance Phase|Death|0|||
13164659|NCT02394028|26099077|FG009|Maintenance Phase|Death|0|||
13164660|NCT02394028|26099078|FG010|Maintenance Phase|Death|1|||
13164661|NCT02394028|26099068|FG000|Maintenance Phase|Adverse Event|0|||
13164662|NCT02394028|26099069|FG001|Maintenance Phase|Adverse Event|0|||
13164663|NCT02394028|26099070|FG002|Maintenance Phase|Adverse Event|0|||
13164664|NCT02394028|26099071|FG003|Maintenance Phase|Adverse Event|0|||
13164665|NCT02394028|26099072|FG004|Maintenance Phase|Adverse Event|0|||
13164666|NCT02394028|26099073|FG005|Maintenance Phase|Adverse Event|0|||
13164667|NCT02394028|26099074|FG006|Maintenance Phase|Adverse Event|0|||
13164668|NCT02394028|26099075|FG007|Maintenance Phase|Adverse Event|0|||
13164669|NCT02394028|26099076|FG008|Maintenance Phase|Adverse Event|1|||
13164670|NCT02394028|26099077|FG009|Maintenance Phase|Adverse Event|1|||
13164671|NCT02394028|26099078|FG010|Maintenance Phase|Adverse Event|3|||
13164672|NCT02394028|26099068|FG000|Maintenance Phase|Site closure|0|||
13164673|NCT02394028|26099069|FG001|Maintenance Phase|Site closure|0|||
13164674|NCT02394028|26099070|FG002|Maintenance Phase|Site closure|0|||
13164675|NCT02394028|26099071|FG003|Maintenance Phase|Site closure|0|||
13164676|NCT02394028|26099072|FG004|Maintenance Phase|Site closure|0|||
13164677|NCT02394028|26099073|FG005|Maintenance Phase|Site closure|0|||
13164678|NCT02394028|26099074|FG006|Maintenance Phase|Site closure|0|||
13164679|NCT02394028|26099075|FG007|Maintenance Phase|Site closure|0|||
13164680|NCT02394028|26099076|FG008|Maintenance Phase|Site closure|0|||
13164681|NCT02394028|26099077|FG009|Maintenance Phase|Site closure|1|||
13164682|NCT02394028|26099078|FG010|Maintenance Phase|Site closure|0|||
13164683|NCT02394028|26099068|FG000|Maintenance Phase|Withdrawal by Subject|0|||
13164684|NCT02394028|26099069|FG001|Maintenance Phase|Withdrawal by Subject|0|||
13164685|NCT02394028|26099070|FG002|Maintenance Phase|Withdrawal by Subject|0|||
13164686|NCT02394028|26099071|FG003|Maintenance Phase|Withdrawal by Subject|0|||
13106787|NCT03292588|25885461|FG000|Overall Study|Physician Decision|0|||
13106788|NCT03292588|25885462|FG001|Overall Study|Physician Decision|1|||
13164687|NCT02394028|26099072|FG004|Maintenance Phase|Withdrawal by Subject|0|||
13164688|NCT02394028|26099073|FG005|Maintenance Phase|Withdrawal by Subject|0|||
13164689|NCT02394028|26099074|FG006|Maintenance Phase|Withdrawal by Subject|0|||
13164690|NCT02394028|26099075|FG007|Maintenance Phase|Withdrawal by Subject|0|||
13164691|NCT02394028|26099076|FG008|Maintenance Phase|Withdrawal by Subject|3|||
13164692|NCT02394028|26099077|FG009|Maintenance Phase|Withdrawal by Subject|12|||
13164693|NCT02394028|26099078|FG010|Maintenance Phase|Withdrawal by Subject|12|||
13106789|NCT03292588|25885461|FG000|Overall Study|Withdrawal by Subject|4|||
13106790|NCT03292588|25885462|FG001|Overall Study|Withdrawal by Subject|4|||
13106791|NCT03292588|25885461|FG000|Overall Study|Move out of town|1|||
13106792|NCT03292588|25885462|FG001|Overall Study|Move out of town|0|||
13106793|NCT03292588|25885461|FG000|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
13106794|NCT03292588|25885462|FG001|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
13106795|NCT03292432|25885493|FG000|Overall Study|Lost to Follow-up|11|||
13106796|NCT03292432|25885494|FG001|Overall Study|Lost to Follow-up|8|||
13106797|NCT03292432|25885493|FG000|Overall Study|Death|2|||
13106798|NCT03292432|25885494|FG001|Overall Study|Death|1|||
13106799|NCT03292432|25885493|FG000|Overall Study|Withdrawal by Subject|1|||
13106800|NCT03292432|25885494|FG001|Overall Study|Withdrawal by Subject|2|||
13106801|NCT03292432|25885493|FG000|Overall Study|Site closed before any data collected|1|||
13106802|NCT03292432|25885494|FG001|Overall Study|Site closed before any data collected|0|||
13106803|NCT03292406|25885527|FG000|Overall Study|Progressive Disease|6|||
13106804|NCT03292406|25885528|FG001|Overall Study|Progressive Disease|3|||
13106805|NCT03292406|25885529|FG002|Overall Study|Progressive Disease|4|||
13106806|NCT03292406|25885527|FG000|Overall Study|Adverse Event|7|||
13164694|NCT02393950|26099150|FG000|Overall Study|Adverse Event|1|||
13164695|NCT02393950|26099151|FG001|Overall Study|Adverse Event|0|||
13164696|NCT02393950|26099150|FG000|Overall Study|Withdrawal by Subject|0|||
13164697|NCT02393950|26099151|FG001|Overall Study|Withdrawal by Subject|1|||
13164698|NCT02393755|26099168|FG000|Overall Study|Withdrawal by Subject|0|||
13164699|NCT02393755|26099169|FG001|Overall Study|Withdrawal by Subject|3|||
13164700|NCT02393755|26099168|FG000|Overall Study|Adverse Event|0|||
13164701|NCT02393755|26099169|FG001|Overall Study|Adverse Event|2|||
13164702|NCT02393755|26099168|FG000|Overall Study|Physician Decision|0|||
13164703|NCT02393755|26099169|FG001|Overall Study|Physician Decision|2|||
13164704|NCT02393547|26099178|FG000|Overall Study|Adverse Event|2|||
13164705|NCT02393547|26099178|FG000|Overall Study|Withdrawal by Subject|3|||
13164706|NCT02393547|26099178|FG000|Overall Study|Lost to Follow-up|1|||
13164707|NCT02393209|26099243|FG000|Overall Study|Study Terminated by Sponsor|1|||
13164708|NCT02393209|26099244|FG001|Overall Study|Study Terminated by Sponsor|1|||
13164709|NCT02393209|26099245|FG002|Overall Study|Study Terminated by Sponsor|0|||
13164710|NCT02393209|26099246|FG003|Overall Study|Study Terminated by Sponsor|0|||
13164711|NCT02393209|26099243|FG000|Overall Study|Withdrawal by Patient|1|||
13164712|NCT02393209|26099244|FG001|Overall Study|Withdrawal by Patient|0|||
13164713|NCT02393209|26099245|FG002|Overall Study|Withdrawal by Patient|0|||
13164714|NCT02393209|26099246|FG003|Overall Study|Withdrawal by Patient|0|||
13164715|NCT02393209|26099243|FG000|Overall Study|Death|2|||
13164716|NCT02393209|26099244|FG001|Overall Study|Death|2|||
13164717|NCT02393209|26099245|FG002|Overall Study|Death|0|||
13164718|NCT02393209|26099246|FG003|Overall Study|Death|0|||
13164719|NCT02393209|26099243|FG000|Overall Study|Death due to Disease Progression|2|||
13164720|NCT02393209|26099244|FG001|Overall Study|Death due to Disease Progression|2|||
13164721|NCT02393209|26099245|FG002|Overall Study|Death due to Disease Progression|0|||
13164722|NCT02393209|26099246|FG003|Overall Study|Death due to Disease Progression|0|||
13164723|NCT02393209|26099243|FG000|Overall Study|Death from Legionella Infection|0|||
13164724|NCT02393209|26099244|FG001|Overall Study|Death from Legionella Infection|1|||
13164725|NCT02393209|26099245|FG002|Overall Study|Death from Legionella Infection|0|||
13164726|NCT02393209|26099246|FG003|Overall Study|Death from Legionella Infection|0|||
13164727|NCT02393209|26099243|FG000|Overall Study|Patient Seen by Another Oncologist|0|||
13164728|NCT02393209|26099244|FG001|Overall Study|Patient Seen by Another Oncologist|1|||
13164729|NCT02393209|26099245|FG002|Overall Study|Patient Seen by Another Oncologist|0|||
13164730|NCT02393209|26099246|FG003|Overall Study|Patient Seen by Another Oncologist|0|||
13164731|NCT02393209|26099243|FG000|Overall Study|Lost to Follow-up|0|||
13106807|NCT03292406|25885528|FG001|Overall Study|Adverse Event|1|||
13106808|NCT03292406|25885529|FG002|Overall Study|Adverse Event|4|||
13164732|NCT02393209|26099244|FG001|Overall Study|Lost to Follow-up|1|||
13164733|NCT02393209|26099245|FG002|Overall Study|Lost to Follow-up|0|||
13164734|NCT02393209|26099246|FG003|Overall Study|Lost to Follow-up|0|||
13164735|NCT02392624|26099269|FG000|Overall Study|Withdrawal by Subject|15|||
13164736|NCT02392624|26099270|FG001|Overall Study|Withdrawal by Subject|12|||
13164737|NCT02392624|26099271|FG002|Overall Study|Withdrawal by Subject|9|||
13164738|NCT02392624|26099269|FG000|Overall Study|Adverse Event|4|||
13164739|NCT02392624|26099270|FG001|Overall Study|Adverse Event|1|||
13164740|NCT02392624|26099271|FG002|Overall Study|Adverse Event|2|||
13164741|NCT02392624|26099269|FG000|Overall Study|Pregnancy|1|||
13164742|NCT02392624|26099270|FG001|Overall Study|Pregnancy|0|||
13164743|NCT02392624|26099271|FG002|Overall Study|Pregnancy|0|||
13164744|NCT02392624|26099269|FG000|Overall Study|Protocol Violation|0|||
13164745|NCT02392624|26099270|FG001|Overall Study|Protocol Violation|0|||
13164746|NCT02392624|26099271|FG002|Overall Study|Protocol Violation|1|||
13164747|NCT02392624|26099269|FG000|Overall Study|Sponsor/Investigator Decision|2|||
13164748|NCT02392624|26099270|FG001|Overall Study|Sponsor/Investigator Decision|1|||
13164749|NCT02392624|26099271|FG002|Overall Study|Sponsor/Investigator Decision|0|||
13164750|NCT02392624|26099269|FG000|Overall Study|Other|49|||
13164751|NCT02392624|26099270|FG001|Overall Study|Other|1|||
13164752|NCT02392624|26099271|FG002|Overall Study|Other|1|||
13164753|NCT02392611|26099373|FG000|Overall Study|Adverse Event|0|||
13164754|NCT02392611|26099374|FG001|Overall Study|Adverse Event|0|||
13164755|NCT02392611|26099375|FG002|Overall Study|Adverse Event|0|||
13164756|NCT02392611|26099376|FG003|Overall Study|Adverse Event|1|||
13164757|NCT02392611|26099377|FG004|Overall Study|Adverse Event|0|||
13164758|NCT02392611|26099378|FG005|Overall Study|Adverse Event|0|||
13164759|NCT02392611|26099379|FG006|Overall Study|Adverse Event|0|||
13164760|NCT02392611|26099380|FG007|Overall Study|Adverse Event|0|||
13164761|NCT02392611|26099381|FG008|Overall Study|Adverse Event|0|||
13164762|NCT02392611|26099373|FG000|Overall Study|Progressive disease|0|||
13164763|NCT02392611|26099374|FG001|Overall Study|Progressive disease|0|||
13164764|NCT02392611|26099375|FG002|Overall Study|Progressive disease|0|||
13164765|NCT02392611|26099376|FG003|Overall Study|Progressive disease|2|||
13164766|NCT02392611|26099377|FG004|Overall Study|Progressive disease|1|||
13164767|NCT02392611|26099378|FG005|Overall Study|Progressive disease|0|||
13164768|NCT02392611|26099379|FG006|Overall Study|Progressive disease|0|||
13164769|NCT02392611|26099380|FG007|Overall Study|Progressive disease|0|||
13164770|NCT02392611|26099381|FG008|Overall Study|Progressive disease|0|||
13164771|NCT02392611|26099373|FG000|Overall Study|Death|1|||
13164772|NCT02392611|26099374|FG001|Overall Study|Death|0|||
13164773|NCT02392611|26099375|FG002|Overall Study|Death|0|||
13164774|NCT02392611|26099376|FG003|Overall Study|Death|0|||
13164775|NCT02392611|26099377|FG004|Overall Study|Death|0|||
13164776|NCT02392611|26099378|FG005|Overall Study|Death|1|||
13164777|NCT02392611|26099379|FG006|Overall Study|Death|0|||
13164778|NCT02392611|26099380|FG007|Overall Study|Death|0|||
13164779|NCT02392611|26099381|FG008|Overall Study|Death|0|||
13164780|NCT02392611|26099373|FG000|Overall Study|Withdrawal by Subject|0|||
13164781|NCT02392611|26099374|FG001|Overall Study|Withdrawal by Subject|0|||
13164782|NCT02392611|26099375|FG002|Overall Study|Withdrawal by Subject|0|||
13164783|NCT02392611|26099376|FG003|Overall Study|Withdrawal by Subject|1|||
13164784|NCT02392611|26099377|FG004|Overall Study|Withdrawal by Subject|0|||
13164785|NCT02392611|26099378|FG005|Overall Study|Withdrawal by Subject|0|||
13164786|NCT02392611|26099379|FG006|Overall Study|Withdrawal by Subject|0|||
13164787|NCT02392611|26099380|FG007|Overall Study|Withdrawal by Subject|0|||
13164788|NCT02392611|26099381|FG008|Overall Study|Withdrawal by Subject|0|||
13164789|NCT02392611|26099373|FG000|Overall Study|Lost to Follow-up|0|||
13164790|NCT02392611|26099374|FG001|Overall Study|Lost to Follow-up|0|||
13164791|NCT02392611|26099375|FG002|Overall Study|Lost to Follow-up|0|||
13164792|NCT02392611|26099376|FG003|Overall Study|Lost to Follow-up|0|||
13164793|NCT02392611|26099377|FG004|Overall Study|Lost to Follow-up|0|||
13164794|NCT02392611|26099378|FG005|Overall Study|Lost to Follow-up|0|||
13164795|NCT02392611|26099379|FG006|Overall Study|Lost to Follow-up|1|||
13164796|NCT02392611|26099380|FG007|Overall Study|Lost to Follow-up|0|||
13164797|NCT02392611|26099381|FG008|Overall Study|Lost to Follow-up|0|||
13164798|NCT02392611|26099373|FG000|Overall Study|Enrolled, not treated|0|||
13164799|NCT02392611|26099374|FG001|Overall Study|Enrolled, not treated|0|||
13164800|NCT02392611|26099375|FG002|Overall Study|Enrolled, not treated|0|||
13164801|NCT02392611|26099376|FG003|Overall Study|Enrolled, not treated|2|||
13164802|NCT02392611|26099377|FG004|Overall Study|Enrolled, not treated|0|||
13164803|NCT02392611|26099378|FG005|Overall Study|Enrolled, not treated|0|||
13164804|NCT02392611|26099379|FG006|Overall Study|Enrolled, not treated|0|||
13164805|NCT02392611|26099380|FG007|Overall Study|Enrolled, not treated|0|||
13164806|NCT02392611|26099381|FG008|Overall Study|Enrolled, not treated|0|||
13164807|NCT02392507|26099398|FG000|Induction Regimen|Death|3|||
13164808|NCT02392507|26099398|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1|||
13164809|NCT02392507|26099398|FG000|Induction Regimen|Physician Decision|1|||
13164810|NCT02392507|26099398|FG000|Induction Regimen|Withdrawal by Subject|2|||
13164811|NCT02392507|26099398|FG000|Maintenance Regimen|Death|1|||
13164812|NCT02392507|26099398|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1|||
13164813|NCT02392481|26099433|FG000|Overall Study|Adverse Event|0|||
13164814|NCT02392481|26099434|FG001|Overall Study|Adverse Event|0|||
13164815|NCT02392481|26099435|FG002|Overall Study|Adverse Event|1|||
13164816|NCT02392481|26099436|FG003|Overall Study|Adverse Event|2|||
13164817|NCT02392481|26099433|FG000|Overall Study|Withdrawal by Subject|0|||
13164818|NCT02392481|26099434|FG001|Overall Study|Withdrawal by Subject|0|||
13164819|NCT02392481|26099435|FG002|Overall Study|Withdrawal by Subject|1|||
13164820|NCT02392481|26099436|FG003|Overall Study|Withdrawal by Subject|0|||
13164821|NCT02392403|26099450|FG000|Overall Study|Adverse Event|1|||
13164822|NCT02392403|26099450|FG000|Overall Study|Death|1|||
13164823|NCT02392403|26099450|FG000|Overall Study|Withdrawal by Subject|1|||
13164824|NCT02392377|26099481|FG000|Overall Study|Withdrawal by Subject|0|||
13164825|NCT02392377|26099482|FG001|Overall Study|Withdrawal by Subject|1|||
13164826|NCT02392247|26099489|FG000|Overall Study|Withdrawal by Subject|1|||
13164827|NCT02392247|26099489|FG000|Overall Study|Surgery cancelled; no data|1|||
13164828|NCT02392234|26099530|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
13164829|NCT02392234|26099531|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
13164830|NCT02392234|26099532|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
13164831|NCT02392234|26099533|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
13164832|NCT02392234|26099534|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
13164833|NCT02392234|26099535|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
13164834|NCT02392234|26099530|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
13164835|NCT02392234|26099531|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
13164836|NCT02392234|26099532|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
13164837|NCT02392234|26099533|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
13164838|NCT02392234|26099534|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2|||
13164839|NCT02392234|26099535|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
13164840|NCT02392234|26099530|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
13164841|NCT02392234|26099531|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
13164842|NCT02392234|26099532|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
13164843|NCT02392234|26099533|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
13164844|NCT02392234|26099534|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
13164845|NCT02392234|26099535|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
13164846|NCT02392234|26099530|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
13164847|NCT02392234|26099531|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
13164848|NCT02392234|26099532|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
13164849|NCT02392234|26099533|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
13164850|NCT02392234|26099534|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
13164851|NCT02392234|26099535|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
13164852|NCT02392234|26099530|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
13164853|NCT02392234|26099531|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
13164854|NCT02392234|26099532|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
13164855|NCT02392234|26099533|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
13164856|NCT02392234|26099534|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
13164857|NCT02392234|26099535|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1|||
13164858|NCT02392234|26099530|FG000|Treatment Period 1 (8 Weeks)|Other|1|||
13164859|NCT02392234|26099531|FG001|Treatment Period 1 (8 Weeks)|Other|0|||
13164860|NCT02392234|26099532|FG002|Treatment Period 1 (8 Weeks)|Other|0|||
13164861|NCT02392234|26099533|FG003|Treatment Period 1 (8 Weeks)|Other|0|||
13164862|NCT02392234|26099534|FG004|Treatment Period 1 (8 Weeks)|Other|0|||
13164863|NCT02392234|26099535|FG005|Treatment Period 1 (8 Weeks)|Other|0|||
13164864|NCT02392234|26099530|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
13164865|NCT02392234|26099531|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
13164866|NCT02392234|26099532|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
13164867|NCT02392234|26099533|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
13164868|NCT02392234|26099534|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
13164869|NCT02392234|26099535|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
13164870|NCT02392234|26099530|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1|||
13164871|NCT02392234|26099531|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
13164872|NCT02392234|26099532|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
13133177|NCT02777554|25986869|FG001|Overall Study|Adverse Event|4|||
13133178|NCT02777554|25986870|FG002|Overall Study|Adverse Event|0|||
13133179|NCT02777554|25986871|FG003|Overall Study|Adverse Event|1|||
13133180|NCT02777554|25986872|FG004|Overall Study|Adverse Event|0|||
13133181|NCT02777554|25986873|FG005|Overall Study|Adverse Event|0|||
13133182|NCT02777554|25986868|FG000|Overall Study|Withdrawal by Subject|3|||
13133183|NCT02777554|25986869|FG001|Overall Study|Withdrawal by Subject|1|||
13133184|NCT02777554|25986870|FG002|Overall Study|Withdrawal by Subject|1|||
13133185|NCT02777554|25986871|FG003|Overall Study|Withdrawal by Subject|0|||
13133186|NCT02777554|25986872|FG004|Overall Study|Withdrawal by Subject|0|||
13133187|NCT02777554|25986873|FG005|Overall Study|Withdrawal by Subject|0|||
13164873|NCT02392234|26099533|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
13164874|NCT02392234|26099534|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
13164875|NCT02392234|26099535|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
13164876|NCT02392195|26099543|FG000|Overall Study|Lost to Follow-up|4|||
13164877|NCT02392195|26099543|FG000|Overall Study|Withdrawal by Subject|4|||
13164878|NCT02392104|26099556|FG000|Overall Study|discontinuation of warfarin|3|||
13164879|NCT02392104|26099556|FG000|Overall Study|bleeding event|1|||
13164880|NCT02392104|26099556|FG000|Overall Study|transferred care to another doctor|2|||
13164881|NCT02392104|26099556|FG000|Overall Study|INR goal range changed|1|||
13164882|NCT02392104|26099556|FG000|Overall Study|admitted to skilled nursing facility|3|||
13164883|NCT02392104|26099556|FG000|Overall Study|INRs drawn by visiting nurse services|1|||
13164884|NCT02392000|26099566|FG000|Overall Study|Greater than mild sleep apnea exclusion|18|||
13164885|NCT02392000|26099566|FG000|Overall Study|Withdrawal by Subject|1|||
13164886|NCT02392000|26099566|FG000|Overall Study|Lost to Follow-up|8|||
13164887|NCT02391961|26099591|FG000|First Intervention (4 Weeks)|Adverse Event|2|||
13164888|NCT02391961|26099592|FG001|First Intervention (4 Weeks)|Adverse Event|0|||
13164889|NCT02391961|26099591|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
13164890|NCT02391961|26099592|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
13164891|NCT02391961|26099591|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
13164892|NCT02391961|26099592|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
13164893|NCT02391948|26099700|FG000|6-month Assessment|Death|0|||
13164894|NCT02391948|26099701|FG001|6-month Assessment|Death|0|||
13164895|NCT02391948|26099702|FG002|6-month Assessment|Death|0|||
13164896|NCT02391948|26099703|FG003|6-month Assessment|Death|0|||
13164897|NCT02391948|26099704|FG004|6-month Assessment|Death|1|||
13164898|NCT02391948|26099700|FG000|6-month Assessment|Withdrawal by Subject|0|||
13164899|NCT02391948|26099701|FG001|6-month Assessment|Withdrawal by Subject|0|||
13164900|NCT02391948|26099702|FG002|6-month Assessment|Withdrawal by Subject|1|||
13164901|NCT02391948|26099703|FG003|6-month Assessment|Withdrawal by Subject|2|||
13164902|NCT02391948|26099704|FG004|6-month Assessment|Withdrawal by Subject|0|||
13164903|NCT02391948|26099700|FG000|6-month Assessment|Lost to Follow-up|4|||
13164904|NCT02391948|26099701|FG001|6-month Assessment|Lost to Follow-up|5|||
13164905|NCT02391948|26099702|FG002|6-month Assessment|Lost to Follow-up|2|||
13164906|NCT02391948|26099703|FG003|6-month Assessment|Lost to Follow-up|3|||
13164907|NCT02391948|26099704|FG004|6-month Assessment|Lost to Follow-up|1|||
13164908|NCT02391948|26099700|FG000|6-month Assessment|Medical issue/illness|1|||
13164909|NCT02391948|26099701|FG001|6-month Assessment|Medical issue/illness|1|||
13164910|NCT02391948|26099702|FG002|6-month Assessment|Medical issue/illness|0|||
13164911|NCT02391948|26099703|FG003|6-month Assessment|Medical issue/illness|0|||
13164912|NCT02391948|26099704|FG004|6-month Assessment|Medical issue/illness|0|||
13164913|NCT02391948|26099700|FG000|6-month Assessment|Not able to schedule visit in timeframe|6|||
13164914|NCT02391948|26099701|FG001|6-month Assessment|Not able to schedule visit in timeframe|8|||
13164915|NCT02391948|26099702|FG002|6-month Assessment|Not able to schedule visit in timeframe|4|||
13164916|NCT02391948|26099703|FG003|6-month Assessment|Not able to schedule visit in timeframe|5|||
13164917|NCT02391948|26099704|FG004|6-month Assessment|Not able to schedule visit in timeframe|0|||
13164918|NCT02391948|26099700|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68|||
13164919|NCT02391948|26099701|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42|||
13164920|NCT02391948|26099702|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24|||
13164921|NCT02391948|26099703|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35|||
13164922|NCT02391948|26099704|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24|||
13164923|NCT02391948|26099700|FG000|12-month Assessment|Death|0|||
13164924|NCT02391948|26099701|FG001|12-month Assessment|Death|0|||
13164925|NCT02391948|26099702|FG002|12-month Assessment|Death|0|||
13164926|NCT02391948|26099703|FG003|12-month Assessment|Death|1|||
13164927|NCT02391948|26099704|FG004|12-month Assessment|Death|0|||
13164928|NCT02391948|26099700|FG000|12-month Assessment|Withdrawal by Subject|1|||
13164929|NCT02391948|26099701|FG001|12-month Assessment|Withdrawal by Subject|0|||
13164930|NCT02391948|26099702|FG002|12-month Assessment|Withdrawal by Subject|0|||
13164931|NCT02391948|26099703|FG003|12-month Assessment|Withdrawal by Subject|1|||
13164932|NCT02391948|26099704|FG004|12-month Assessment|Withdrawal by Subject|0|||
13164933|NCT02391948|26099700|FG000|12-month Assessment|Lost to Follow-up|5|||
13164934|NCT02391948|26099701|FG001|12-month Assessment|Lost to Follow-up|4|||
13164935|NCT02391948|26099702|FG002|12-month Assessment|Lost to Follow-up|4|||
13164936|NCT02391948|26099703|FG003|12-month Assessment|Lost to Follow-up|4|||
13164937|NCT02391948|26099704|FG004|12-month Assessment|Lost to Follow-up|5|||
13164938|NCT02391948|26099700|FG000|12-month Assessment|Medical issue/illness|0|||
13164939|NCT02391948|26099701|FG001|12-month Assessment|Medical issue/illness|1|||
13164940|NCT02391948|26099702|FG002|12-month Assessment|Medical issue/illness|0|||
13164941|NCT02391948|26099703|FG003|12-month Assessment|Medical issue/illness|1|||
13164942|NCT02391948|26099704|FG004|12-month Assessment|Medical issue/illness|0|||
13164943|NCT02391948|26099700|FG000|12-month Assessment|Not able to schedule visit in timeframe|2|||
13164944|NCT02391948|26099701|FG001|12-month Assessment|Not able to schedule visit in timeframe|4|||
13164945|NCT02391948|26099702|FG002|12-month Assessment|Not able to schedule visit in timeframe|0|||
13164946|NCT02391948|26099703|FG003|12-month Assessment|Not able to schedule visit in timeframe|2|||
13164947|NCT02391948|26099704|FG004|12-month Assessment|Not able to schedule visit in timeframe|1|||
13164948|NCT02391948|26099700|FG000|18-month Assessment|Death|0|||
13164949|NCT02391948|26099701|FG001|18-month Assessment|Death|0|||
13164950|NCT02391948|26099702|FG002|18-month Assessment|Death|0|||
13164951|NCT02391948|26099703|FG003|18-month Assessment|Death|1|||
13164952|NCT02391948|26099704|FG004|18-month Assessment|Death|1|||
13164953|NCT02391948|26099700|FG000|18-month Assessment|Withdrawal by Subject|1|||
13164954|NCT02391948|26099701|FG001|18-month Assessment|Withdrawal by Subject|0|||
13164955|NCT02391948|26099702|FG002|18-month Assessment|Withdrawal by Subject|0|||
13164956|NCT02391948|26099703|FG003|18-month Assessment|Withdrawal by Subject|1|||
13164957|NCT02391948|26099704|FG004|18-month Assessment|Withdrawal by Subject|0|||
13164958|NCT02391948|26099700|FG000|18-month Assessment|Lost to Follow-up|2|||
13164959|NCT02391948|26099701|FG001|18-month Assessment|Lost to Follow-up|6|||
13164960|NCT02391948|26099702|FG002|18-month Assessment|Lost to Follow-up|2|||
13164961|NCT02391948|26099703|FG003|18-month Assessment|Lost to Follow-up|2|||
13164962|NCT02391948|26099704|FG004|18-month Assessment|Lost to Follow-up|3|||
13164963|NCT02391948|26099700|FG000|18-month Assessment|Not able to schedule visit in timeframe|3|||
13164964|NCT02391948|26099701|FG001|18-month Assessment|Not able to schedule visit in timeframe|3|||
13164965|NCT02391948|26099702|FG002|18-month Assessment|Not able to schedule visit in timeframe|2|||
13164966|NCT02391948|26099703|FG003|18-month Assessment|Not able to schedule visit in timeframe|1|||
13164967|NCT02391948|26099704|FG004|18-month Assessment|Not able to schedule visit in timeframe|4|||
13164968|NCT02391948|26099700|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66|||
13164969|NCT02391948|26099701|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41|||
13164970|NCT02391948|26099702|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
13164971|NCT02391948|26099703|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31|||
13164972|NCT02391948|26099704|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
13164973|NCT02391948|26099700|FG000|24-month Assessment|Death|0|||
13164974|NCT02391948|26099701|FG001|24-month Assessment|Death|0|||
13164975|NCT02391948|26099702|FG002|24-month Assessment|Death|0|||
13164976|NCT02391948|26099703|FG003|24-month Assessment|Death|0|||
13164977|NCT02391948|26099704|FG004|24-month Assessment|Death|1|||
13164978|NCT02391948|26099700|FG000|24-month Assessment|Withdrawal by Subject|1|||
13164979|NCT02391948|26099701|FG001|24-month Assessment|Withdrawal by Subject|1|||
13164980|NCT02391948|26099702|FG002|24-month Assessment|Withdrawal by Subject|0|||
13164981|NCT02391948|26099703|FG003|24-month Assessment|Withdrawal by Subject|0|||
13164982|NCT02391948|26099704|FG004|24-month Assessment|Withdrawal by Subject|1|||
13164983|NCT02391948|26099700|FG000|24-month Assessment|Lost to Follow-up|5|||
13164984|NCT02391948|26099701|FG001|24-month Assessment|Lost to Follow-up|4|||
13164985|NCT02391948|26099702|FG002|24-month Assessment|Lost to Follow-up|0|||
13164986|NCT02391948|26099703|FG003|24-month Assessment|Lost to Follow-up|0|||
13164987|NCT02391948|26099704|FG004|24-month Assessment|Lost to Follow-up|0|||
13164988|NCT02391948|26099700|FG000|24-month Assessment|Medical issue/illness|0|||
13164989|NCT02391948|26099701|FG001|24-month Assessment|Medical issue/illness|0|||
13164990|NCT02391948|26099702|FG002|24-month Assessment|Medical issue/illness|1|||
13164991|NCT02391948|26099703|FG003|24-month Assessment|Medical issue/illness|0|||
13164992|NCT02391948|26099704|FG004|24-month Assessment|Medical issue/illness|0|||
13164993|NCT02391948|26099700|FG000|24-month Assessment|Not able to schedule visit in timeframe|8|||
13164994|NCT02391948|26099701|FG001|24-month Assessment|Not able to schedule visit in timeframe|5|||
13164995|NCT02391948|26099702|FG002|24-month Assessment|Not able to schedule visit in timeframe|2|||
13164996|NCT02391948|26099703|FG003|24-month Assessment|Not able to schedule visit in timeframe|9|||
13164997|NCT02391948|26099704|FG004|24-month Assessment|Not able to schedule visit in timeframe|8|||
13164998|NCT02391584|26099726|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1|||
13164999|NCT02391584|26099727|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2|||
13165000|NCT02391584|26099726|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1|||
13165001|NCT02391584|26099727|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0|||
13165002|NCT02391584|26099726|FG000|3 Month|Lost to Follow-up|1|||
13165003|NCT02391584|26099727|FG001|3 Month|Lost to Follow-up|0|||
13165004|NCT02391584|26099726|FG000|6 Month|Withdrawal by Subject|1|||
13165005|NCT02391584|26099727|FG001|6 Month|Withdrawal by Subject|0|||
13165006|NCT02391584|26099726|FG000|12 Month (End of Study)|Lost to Follow-up|2|||
13165007|NCT02391584|26099727|FG001|12 Month (End of Study)|Lost to Follow-up|0|||
13165008|NCT02391545|26099752|FG000|Overall Study|Death|0|||
13165009|NCT02391545|26099753|FG001|Overall Study|Death|2|||
13165010|NCT02391545|26099752|FG000|Overall Study|Lost to Follow-up|0|||
13165011|NCT02391545|26099753|FG001|Overall Study|Lost to Follow-up|1|||
13165012|NCT02391545|26099752|FG000|Overall Study|Termination of study by sponsor|20|||
13165013|NCT02391545|26099753|FG001|Overall Study|Termination of study by sponsor|20|||
13165014|NCT02391545|26099752|FG000|Overall Study|Withdrawal by Subject|0|||
13165015|NCT02391545|26099753|FG001|Overall Study|Withdrawal by Subject|1|||
13165016|NCT02391545|26099752|FG000|Overall Study|Other Reasons|6|||
13165017|NCT02391545|26099753|FG001|Overall Study|Other Reasons|4|||
13165018|NCT02391363|26099824|FG000|Overall Study|Lost to Follow-up|5|||
13165019|NCT02391363|26099825|FG001|Overall Study|Lost to Follow-up|5|||
13165020|NCT02391363|26099824|FG000|Overall Study|Withdrawal by Subject|6|||
13165021|NCT02391363|26099825|FG001|Overall Study|Withdrawal by Subject|3|||
13165022|NCT02391337|26099866|FG000|6 Months Follow-up|Death|5|||
13165023|NCT02391337|26099867|FG001|6 Months Follow-up|Death|4|||
13165024|NCT02391337|26099866|FG000|6 Months Follow-up|Withdrawal by Subject|1|||
13165025|NCT02391337|26099867|FG001|6 Months Follow-up|Withdrawal by Subject|1|||
13165026|NCT02391337|26099866|FG000|12 Months Follow-up|Death|2|||
13165027|NCT02391337|26099867|FG001|12 Months Follow-up|Death|0|||
13165028|NCT02391337|26099866|FG000|12 Months Follow-up|Withdrawal by Subject|0|||
13165029|NCT02391337|26099867|FG001|12 Months Follow-up|Withdrawal by Subject|1|||
13165030|NCT02391337|26099866|FG000|12 Months Follow-up|Lost to Follow-up|0|||
13165031|NCT02391337|26099867|FG001|12 Months Follow-up|Lost to Follow-up|2|||
13165032|NCT02391311|26099882|FG000|Overall Study|Lost to Follow-up|2|||
13165033|NCT02391311|26099883|FG001|Overall Study|Lost to Follow-up|1|||
13165034|NCT02391311|26099882|FG000|Overall Study|deemed ineligible after baseline|1|||
13165035|NCT02391311|26099883|FG001|Overall Study|deemed ineligible after baseline|1|||
13165036|NCT02391116|26099939|FG000|Treatment|Withdrawal by Subject|1|||
13165037|NCT02391116|26099939|FG000|Treatment|Protocol Violation|1|||
13165038|NCT02391116|26099939|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9|||
13165039|NCT02391116|26099939|FG000|Treatment|AE with Clinical PD|3|||
13165040|NCT02391116|26099939|FG000|Safety Follow-up|Adverse Event|1|||
13165041|NCT02391116|26099939|FG000|Safety Follow-up|Withdrawal by Subject|4|||
13165042|NCT02391116|26099939|FG000|Safety Follow-up|Switching to Other Therapy|4|||
13165043|NCT02391116|26099939|FG000|Safety Follow-up|No Follow Up|1|||
13165044|NCT02391116|26099939|FG000|Safety Follow-up|Deterioration of General Conditions|3|||
13165045|NCT02391116|26099939|FG000|Active Follow-up|Withdrawal by Subject|1|||
13165046|NCT02391116|26099939|FG000|Active Follow-up|Switching to Other Therapy|2|||
13165047|NCT02391116|26099939|FG000|Survival Follow-up|Withdrawal by Subject|3|||
13165048|NCT02391116|26099939|FG000|Survival Follow-up|Switching to Other Therapy|1|||
13165049|NCT02391038|26100057|FG000|Overall Study|Progressive disease|3|||
13165050|NCT02391038|26100058|FG001|Overall Study|Progressive disease|3|||
13165051|NCT02391038|26100059|FG002|Overall Study|Progressive disease|6|||
13165052|NCT02390557|26100077|FG000|Wave 2|Survey non-respondent|72|||
13165053|NCT02390557|26100078|FG001|Wave 2|Survey non-respondent|41|||
13165054|NCT02390557|26100079|FG002|Wave 2|Survey non-respondent|23|||
13165055|NCT02390531|26100219|FG000|Overall Study|Death|0|||
13165056|NCT02390531|26100220|FG001|Overall Study|Death|2|||
13165057|NCT02390531|26100221|FG002|Overall Study|Death|0|||
13165058|NCT02390531|26100222|FG003|Overall Study|Death|1|||
13165059|NCT02390531|26100223|FG004|Overall Study|Death|0|||
13165060|NCT02390531|26100224|FG005|Overall Study|Death|0|||
13165061|NCT02390531|26100225|FG006|Overall Study|Death|0|||
13165062|NCT02390531|26100226|FG007|Overall Study|Death|1|||
13165063|NCT02390531|26100219|FG000|Overall Study|Protocol Violation|0|||
13165064|NCT02390531|26100220|FG001|Overall Study|Protocol Violation|0|||
13165065|NCT02390531|26100221|FG002|Overall Study|Protocol Violation|0|||
13165066|NCT02390531|26100222|FG003|Overall Study|Protocol Violation|0|||
13165067|NCT02390531|26100223|FG004|Overall Study|Protocol Violation|1|||
13165068|NCT02390531|26100224|FG005|Overall Study|Protocol Violation|0|||
13165069|NCT02390531|26100225|FG006|Overall Study|Protocol Violation|2|||
13165070|NCT02390531|26100226|FG007|Overall Study|Protocol Violation|0|||
13165071|NCT02390362|26100241|FG000|Overall Study|Withdrawal by Subject|0|||
13165072|NCT02390362|26100242|FG001|Overall Study|Withdrawal by Subject|1|||
13165073|NCT02390245|26100256|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0|||
13165074|NCT02390245|26100257|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|103|||
13165075|NCT02390245|26100258|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104|||
13165076|NCT02390245|26100256|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0|||
13165077|NCT02390245|26100257|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|95|||
13165078|NCT02390245|26100258|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|106|||
13165079|NCT02390219|26100270|FG000|Overall Study|Death|1|||
13165080|NCT02390219|26100270|FG000|Overall Study|Physician Decision|1|||
13165081|NCT02390219|26100270|FG000|Overall Study|Adverse Event|6|||
13165082|NCT02390219|26100270|FG000|Overall Study|Withdrawal by Subject|1|||
13165083|NCT02390219|26100270|FG000|Overall Study|Lost to Follow-up|2|||
13165084|NCT02390219|26100270|FG000|Overall Study|Other|2|||
13165085|NCT02390167|26100291|FG000|Overall Study|Lost to Follow-up|1|||
13165086|NCT02390076|26100312|FG000|Overall Study|Lost to Follow-up|2|||
13165087|NCT02390076|26100313|FG001|Overall Study|Lost to Follow-up|1|||
13165088|NCT02390076|26100314|FG002|Overall Study|Lost to Follow-up|4|||
13165089|NCT02389998|26100331|FG000|Overall Study|car accident|1|||
13165090|NCT02389998|26100332|FG001|Overall Study|car accident|0|||
13165091|NCT02389894|26100410|FG000|Overall Study|Death|4|||
13165092|NCT02389894|26100411|FG001|Overall Study|Death|5|||
13165093|NCT02389894|26100412|FG002|Overall Study|Death|3|||
13165094|NCT02389894|26100410|FG000|Overall Study|Withdrawal by Subject|2|||
13165095|NCT02389894|26100411|FG001|Overall Study|Withdrawal by Subject|4|||
13165096|NCT02389894|26100412|FG002|Overall Study|Withdrawal by Subject|5|||
13165097|NCT02389894|26100410|FG000|Overall Study|Lost to Follow-up|2|||
13165098|NCT02389894|26100411|FG001|Overall Study|Lost to Follow-up|1|||
13165099|NCT02389894|26100412|FG002|Overall Study|Lost to Follow-up|1|||
13165100|NCT02389829|26100431|FG000|Overall Study|Lost to Follow-up|0|||
13165101|NCT02389829|26100432|FG001|Overall Study|Lost to Follow-up|1|||
13165102|NCT02389816|26100474|FG000|Overall Study|Randomized but Not Treated|1|||
13165103|NCT02389816|26100475|FG001|Overall Study|Randomized but Not Treated|0|||
13165104|NCT02389816|26100476|FG002|Overall Study|Randomized but Not Treated|0|||
13165105|NCT02389816|26100474|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4|||
13165106|NCT02389816|26100475|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
13165107|NCT02389816|26100476|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7|||
13165108|NCT02389816|26100474|FG000|Overall Study|Major Protocol Deviation|1|||
13165109|NCT02389816|26100475|FG001|Overall Study|Major Protocol Deviation|0|||
13165110|NCT02389816|26100476|FG002|Overall Study|Major Protocol Deviation|0|||
13165111|NCT02389816|26100474|FG000|Overall Study|Lost to Follow-up|1|||
13165112|NCT02389816|26100475|FG001|Overall Study|Lost to Follow-up|0|||
13165113|NCT02389816|26100476|FG002|Overall Study|Lost to Follow-up|0|||
13165114|NCT02389816|26100474|FG000|Overall Study|Withdrawal of Consent|6|||
13165115|NCT02389816|26100475|FG001|Overall Study|Withdrawal of Consent|4|||
13165116|NCT02389816|26100476|FG002|Overall Study|Withdrawal of Consent|4|||
13165117|NCT02389816|26100474|FG000|Overall Study|Lack of Efficacy|1|||
13165118|NCT02389816|26100475|FG001|Overall Study|Lack of Efficacy|0|||
13165119|NCT02389816|26100476|FG002|Overall Study|Lack of Efficacy|0|||
13165120|NCT02389816|26100474|FG000|Overall Study|Non Compliance with Study Drug|1|||
13165121|NCT02389816|26100475|FG001|Overall Study|Non Compliance with Study Drug|1|||
13165122|NCT02389816|26100476|FG002|Overall Study|Non Compliance with Study Drug|1|||
13165123|NCT02389816|26100474|FG000|Overall Study|Reason not Specified|0|||
13106809|NCT03292406|25885527|FG000|Overall Study|Withdrawal by Subject|0|||
13106810|NCT03292406|25885528|FG001|Overall Study|Withdrawal by Subject|7|||
13106811|NCT03292406|25885529|FG002|Overall Study|Withdrawal by Subject|2|||
13106812|NCT03292406|25885527|FG000|Overall Study|Protocol Violation|0|||
13106813|NCT03292406|25885528|FG001|Overall Study|Protocol Violation|1|||
13106814|NCT03292406|25885529|FG002|Overall Study|Protocol Violation|1|||
13106815|NCT03292406|25885527|FG000|Overall Study|Other|0|||
13106816|NCT03292406|25885528|FG001|Overall Study|Other|1|||
13106817|NCT03292406|25885529|FG002|Overall Study|Other|2|||
13106818|NCT03292016|25885586|FG000|Second Washout|Adverse Event|0|||
13106819|NCT03292016|25885587|FG001|Second Washout|Adverse Event|1|||
13106820|NCT03292016|25885588|FG002|Second Washout|Adverse Event|0|||
13106821|NCT03292016|25885589|FG003|Second Washout|Adverse Event|0|||
13106822|NCT03292016|25885590|FG004|Second Washout|Adverse Event|0|||
13106823|NCT03292016|25885591|FG005|Second Washout|Adverse Event|0|||
13106824|NCT03291808|25885597|FG000|Overall Study|Lost to Follow-up|6|||
13106825|NCT03291808|25885597|FG000|Overall Study|Research burden|4|||
13106826|NCT03291587|25885616|FG000|Overall Study|Lost to Follow-up|62|||
13106827|NCT03291587|25885617|FG001|Overall Study|Lost to Follow-up|43|||
13106828|NCT03291587|25885616|FG000|Overall Study|Refused to Answer|5|||
13106829|NCT03291587|25885617|FG001|Overall Study|Refused to Answer|2|||
13106830|NCT03291587|25885616|FG000|Overall Study|Death|2|||
13106831|NCT03291587|25885617|FG001|Overall Study|Death|4|||
13106832|NCT03291587|25885616|FG000|Overall Study|Not interested in participating|8|||
13106833|NCT03291587|25885617|FG001|Overall Study|Not interested in participating|6|||
13106834|NCT03291587|25885616|FG000|Overall Study|Too busy to participate|4|||
13106835|NCT03291587|25885617|FG001|Overall Study|Too busy to participate|2|||
13106836|NCT03291288|25885662|FG000|Drug-drug Interaction Phase|Adverse Event|2|||
13106837|NCT03291288|25885663|FG001|Drug-drug Interaction Phase|Adverse Event|0|||
13106838|NCT03291288|25885662|FG000|Drug-drug Interaction Phase|Disease progression|1|||
13106839|NCT03291288|25885663|FG001|Drug-drug Interaction Phase|Disease progression|0|||
13106840|NCT03291288|25885662|FG000|Drug-drug Interaction Phase|Other|3|||
13106841|NCT03291288|25885663|FG001|Drug-drug Interaction Phase|Other|0|||
13106842|NCT03291288|25885662|FG000|Pexidartinib Only|Ongoing|0|||
13106843|NCT03291288|25885663|FG001|Pexidartinib Only|Ongoing|2|||
13106844|NCT03290300|25885676|FG000|Overall Study|Lost to Follow-up|3|||
13106845|NCT03289676|25885693|FG000|Overall Study|Withdrawal by Subject|2|||
13106846|NCT03289676|25885694|FG001|Overall Study|Withdrawal by Subject|0|||
13106847|NCT03289676|25885693|FG000|Overall Study|Protocol Violation|2|||
13106848|NCT03289676|25885694|FG001|Overall Study|Protocol Violation|0|||
13106849|NCT03289676|25885693|FG000|Overall Study|Lost to Follow-up|0|||
13106850|NCT03289676|25885694|FG001|Overall Study|Lost to Follow-up|1|||
13106851|NCT03289533|25885717|FG000|Overall Study|Death|12|||
13106852|NCT03289533|25885717|FG000|Overall Study|Terminated from study by sponsor|10|||
13106853|NCT03289455|25885763|FG000|Overall Study|Death|1|||
13106854|NCT03289455|25885764|FG001|Overall Study|Death|0|||
13106855|NCT03289455|25885765|FG002|Overall Study|Death|0|||
13106856|NCT03289455|25885763|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0|||
13106857|NCT03289455|25885764|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1|||
13106858|NCT03289455|25885765|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0|||
13106859|NCT03289455|25885763|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
13165124|NCT02389816|26100475|FG001|Overall Study|Reason not Specified|2|||
13165125|NCT02389816|26100476|FG002|Overall Study|Reason not Specified|0|||
13165126|NCT02389764|26100483|FG000|Overall Study|Lack of Efficacy|9|||
13165127|NCT02389621|26100520|FG000|Treatment Period|Withdrawal by Subject|1|||
13165128|NCT02389621|26100521|FG001|Treatment Period|Withdrawal by Subject|1|||
13165129|NCT02389621|26100520|FG000|Posttreatment Period|Adverse Event|3|||
13165130|NCT02389621|26100521|FG001|Posttreatment Period|Adverse Event|1|||
13165131|NCT02389621|26100520|FG000|Posttreatment Period|Withdrawal by Subject|3|||
13165132|NCT02389621|26100521|FG001|Posttreatment Period|Withdrawal by Subject|2|||
13165133|NCT02389621|26100520|FG000|Posttreatment Period|Lost to Follow-up|1|||
13165134|NCT02389621|26100521|FG001|Posttreatment Period|Lost to Follow-up|1|||
13165135|NCT02389621|26100520|FG000|Posttreatment Period|Other - Miscellaneous|2|||
13165136|NCT02389621|26100521|FG001|Posttreatment Period|Other - Miscellaneous|0|||
13165137|NCT02389452|26100541|FG000|Overall Study|Lost to Follow-up|13|||
13165138|NCT02389452|26100541|FG000|Overall Study|Adverse Event|1|||
13165139|NCT02389452|26100541|FG000|Overall Study|Withdrawal by Subject|5|||
13165140|NCT02389452|26100541|FG000|Overall Study|Enrolled but Not Eligible for Study|6|||
13165141|NCT02388997|26100566|FG000|Overall Study|Adverse Event|1|||
13165142|NCT02388997|26100567|FG001|Overall Study|Adverse Event|2|||
13165143|NCT02388997|26100566|FG000|Overall Study|Withdrawal by Subject|2|||
13165144|NCT02388997|26100567|FG001|Overall Study|Withdrawal by Subject|1|||
13165145|NCT02388997|26100566|FG000|Overall Study|Lung function exclusion criteria|0|||
13165146|NCT02388997|26100567|FG001|Overall Study|Lung function exclusion criteria|2|||
13165147|NCT02388997|26100566|FG000|Overall Study|Tested positive for virus during run-in|0|||
13165148|NCT02388997|26100567|FG001|Overall Study|Tested positive for virus during run-in|1|||
13165149|NCT02388932|26100579|FG000|Overall Study|Death|1|||
13165150|NCT02388776|26100586|FG000|Overall Study|Death|1|||
13165151|NCT02388776|26100586|FG000|Overall Study|Lost to Follow-up|1|||
13165152|NCT02388763|26100600|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
13165153|NCT02388763|26100601|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
13106860|NCT03289455|25885764|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
13165154|NCT02388763|26100600|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
13165155|NCT02388763|26100601|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
13165156|NCT02388737|26100643|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
13165157|NCT02388737|26100644|FG001|Overall Study|Pretreatment Event/Adverse Event|11|||
13165158|NCT02388737|26100645|FG002|Overall Study|Pretreatment Event/Adverse Event|12|||
13106861|NCT03289455|25885765|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1|||
13106862|NCT03289455|25885763|FG000|Overall Study|Progressive disease|3|||
13106863|NCT03289455|25885764|FG001|Overall Study|Progressive disease|4|||
13106864|NCT03289455|25885765|FG002|Overall Study|Progressive disease|5|||
13106865|NCT03289208|25885792|FG000|Overall Study|Adverse Event|1|||
13106866|NCT03289208|25885793|FG001|Overall Study|Adverse Event|0|||
13106867|NCT03289208|25885794|FG002|Overall Study|Adverse Event|0|||
13106868|NCT03289143|25885856|FG000|Overall Study|Caregiver Unavailability|1|||
13106869|NCT03289143|25885857|FG001|Overall Study|Caregiver Unavailability|1|||
13106870|NCT03289143|25885858|FG002|Overall Study|Caregiver Unavailability|0|||
13106871|NCT03289143|25885859|FG003|Overall Study|Caregiver Unavailability|0|||
13106872|NCT03289143|25885856|FG000|Overall Study|Research Department Closure|0|||
13106873|NCT03289143|25885857|FG001|Overall Study|Research Department Closure|0|||
13106874|NCT03289143|25885858|FG002|Overall Study|Research Department Closure|1|||
13106875|NCT03289143|25885859|FG003|Overall Study|Research Department Closure|0|||
13106876|NCT03289143|25885856|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0|||
13106877|NCT03289143|25885857|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0|||
13106878|NCT03289143|25885858|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1|||
13106879|NCT03289143|25885859|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0|||
13106880|NCT03289143|25885856|FG000|Overall Study|Medical Monitor Decision|1|||
13106881|NCT03289143|25885857|FG001|Overall Study|Medical Monitor Decision|0|||
13106882|NCT03289143|25885858|FG002|Overall Study|Medical Monitor Decision|0|||
13165159|NCT02388737|26100643|FG000|Overall Study|Major Protocol Deviation|18|||
13165160|NCT02388737|26100644|FG001|Overall Study|Major Protocol Deviation|25|||
13165161|NCT02388737|26100645|FG002|Overall Study|Major Protocol Deviation|22|||
13165162|NCT02388737|26100643|FG000|Overall Study|Lost to Follow-up|5|||
13165163|NCT02388737|26100644|FG001|Overall Study|Lost to Follow-up|1|||
13165164|NCT02388737|26100645|FG002|Overall Study|Lost to Follow-up|4|||
13165165|NCT02388737|26100643|FG000|Overall Study|Voluntary Withdrawal|10|||
13165166|NCT02388737|26100644|FG001|Overall Study|Voluntary Withdrawal|18|||
13165167|NCT02388737|26100645|FG002|Overall Study|Voluntary Withdrawal|17|||
13165168|NCT02388737|26100643|FG000|Overall Study|Lack of Efficacy|3|||
13165169|NCT02388737|26100644|FG001|Overall Study|Lack of Efficacy|0|||
13106883|NCT03289143|25885859|FG003|Overall Study|Medical Monitor Decision|0|||
13106884|NCT03289143|25885856|FG000|Overall Study|Participant Non-Compliance|0|||
13165170|NCT02388737|26100645|FG002|Overall Study|Lack of Efficacy|3|||
13165171|NCT02388737|26100643|FG000|Overall Study|Reason Not Specified|5|||
13165172|NCT02388737|26100644|FG001|Overall Study|Reason Not Specified|5|||
13165173|NCT02388737|26100645|FG002|Overall Study|Reason Not Specified|4|||
13165174|NCT02388724|26100674|FG000|Overall Study|Reason not Specified|0|||
13106885|NCT03289143|25885857|FG001|Overall Study|Participant Non-Compliance|0|||
13106886|NCT03289143|25885858|FG002|Overall Study|Participant Non-Compliance|1|||
13106887|NCT03289143|25885859|FG003|Overall Study|Participant Non-Compliance|0|||
13106888|NCT03289143|25885856|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
13106889|NCT03289143|25885857|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
13106890|NCT03289143|25885858|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1|||
13106891|NCT03289143|25885859|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
13106892|NCT03289143|25885856|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
13106893|NCT03289143|25885857|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
13165175|NCT02388724|26100675|FG001|Overall Study|Reason not Specified|1|||
13165176|NCT02388724|26100674|FG000|Overall Study|Major Protocol Deviation|3|||
13165177|NCT02388724|26100675|FG001|Overall Study|Major Protocol Deviation|3|||
13165178|NCT02388724|26100674|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
13165179|NCT02388724|26100675|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
13165180|NCT02388724|26100674|FG000|Overall Study|Voluntary Withdrawal|6|||
13165181|NCT02388724|26100675|FG001|Overall Study|Voluntary Withdrawal|5|||
13165182|NCT02388724|26100674|FG000|Overall Study|Randomized but not Treated|0|||
13165183|NCT02388724|26100675|FG001|Overall Study|Randomized but not Treated|2|||
13165184|NCT02388347|26100756|FG000|Overall Study|Withdrawal by Subject|0|||
13165185|NCT02388347|26100757|FG001|Overall Study|Withdrawal by Subject|0|||
13165186|NCT02388347|26100758|FG002|Overall Study|Withdrawal by Subject|1|||
13106894|NCT03289143|25885858|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1|||
13106895|NCT03289143|25885859|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
13106896|NCT03289143|25885856|FG000|Overall Study|Caregiver Passed Away|1|||
13106897|NCT03289143|25885857|FG001|Overall Study|Caregiver Passed Away|0|||
13106898|NCT03289143|25885858|FG002|Overall Study|Caregiver Passed Away|0|||
13106899|NCT03289143|25885859|FG003|Overall Study|Caregiver Passed Away|0|||
13106900|NCT03289143|25885856|FG000|Overall Study|Physician Decision|0|||
13106901|NCT03289143|25885857|FG001|Overall Study|Physician Decision|2|||
13106902|NCT03289143|25885858|FG002|Overall Study|Physician Decision|2|||
13106903|NCT03289143|25885859|FG003|Overall Study|Physician Decision|2|||
13106904|NCT03289143|25885856|FG000|Overall Study|Protocol Deviation|2|||
13106905|NCT03289143|25885857|FG001|Overall Study|Protocol Deviation|1|||
13106906|NCT03289143|25885858|FG002|Overall Study|Protocol Deviation|3|||
13106907|NCT03289143|25885859|FG003|Overall Study|Protocol Deviation|1|||
13106908|NCT03289143|25885856|FG000|Overall Study|Study Terminated By Sponsor|101|||
13106909|NCT03289143|25885857|FG001|Overall Study|Study Terminated By Sponsor|75|||
13106910|NCT03289143|25885858|FG002|Overall Study|Study Terminated By Sponsor|100|||
13106911|NCT03289143|25885859|FG003|Overall Study|Study Terminated By Sponsor|69|||
13106912|NCT03289143|25885856|FG000|Overall Study|Withdrawal by Subject|14|||
13106913|NCT03289143|25885857|FG001|Overall Study|Withdrawal by Subject|6|||
13106914|NCT03289143|25885858|FG002|Overall Study|Withdrawal by Subject|14|||
13106915|NCT03289143|25885859|FG003|Overall Study|Withdrawal by Subject|12|||
13106916|NCT03289143|25885856|FG000|Overall Study|Adverse Event|10|||
13106917|NCT03289143|25885857|FG001|Overall Study|Adverse Event|7|||
13106918|NCT03289143|25885858|FG002|Overall Study|Adverse Event|6|||
13106919|NCT03289143|25885859|FG003|Overall Study|Adverse Event|5|||
13106920|NCT03289143|25885856|FG000|Overall Study|Death|2|||
13106921|NCT03289143|25885857|FG001|Overall Study|Death|0|||
13106922|NCT03289143|25885858|FG002|Overall Study|Death|2|||
13106923|NCT03289143|25885859|FG003|Overall Study|Death|1|||
13106924|NCT03289143|25885856|FG000|Overall Study|Lost to Follow-up|2|||
13106925|NCT03289143|25885857|FG001|Overall Study|Lost to Follow-up|1|||
13106926|NCT03289143|25885858|FG002|Overall Study|Lost to Follow-up|1|||
13106927|NCT03289143|25885859|FG003|Overall Study|Lost to Follow-up|0|||
13106928|NCT03289143|25885856|FG000|Overall Study|Participant No Longer Has Study Partner|0|||
13165187|NCT02388347|26100759|FG003|Overall Study|Withdrawal by Subject|0|||
13165188|NCT02388347|26100760|FG004|Overall Study|Withdrawal by Subject|0|||
13165189|NCT02388295|26100784|FG000|Dose Escalation Week 1|Adverse Event|1|||
13165190|NCT02388295|26100785|FG001|Dose Escalation Week 1|Adverse Event|2|||
13165191|NCT02388295|26100786|FG002|Dose Escalation Week 1|Adverse Event|1|||
13165192|NCT02388295|26100784|FG000|Dose Escalation Week 1|Determined not eligible|1|||
13165193|NCT02388295|26100785|FG001|Dose Escalation Week 1|Determined not eligible|1|||
13165194|NCT02388295|26100786|FG002|Dose Escalation Week 1|Determined not eligible|1|||
13165195|NCT02388295|26100784|FG000|Dose Escalation Week 2|Protocol Violation|0|||
13165196|NCT02388295|26100785|FG001|Dose Escalation Week 2|Protocol Violation|1|||
13165197|NCT02388295|26100786|FG002|Dose Escalation Week 2|Protocol Violation|0|||
13165198|NCT02388295|26100784|FG000|Dose Escalation Week 2|Determined not eligible|1|||
13165199|NCT02388295|26100785|FG001|Dose Escalation Week 2|Determined not eligible|1|||
13165200|NCT02388295|26100786|FG002|Dose Escalation Week 2|Determined not eligible|1|||
13165201|NCT02388295|26100784|FG000|Treatment Weeks 3 to 12|Adverse Event|1|||
13165202|NCT02388295|26100785|FG001|Treatment Weeks 3 to 12|Adverse Event|1|||
13165203|NCT02388295|26100786|FG002|Treatment Weeks 3 to 12|Adverse Event|0|||
13106929|NCT03289143|25885857|FG001|Overall Study|Participant No Longer Has Study Partner|0|||
13106930|NCT03289143|25885858|FG002|Overall Study|Participant No Longer Has Study Partner|0|||
13106931|NCT03289143|25885859|FG003|Overall Study|Participant No Longer Has Study Partner|1|||
13106932|NCT03289143|25885856|FG000|Overall Study|Withdrawal by Caregiver|0|||
13106933|NCT03289143|25885857|FG001|Overall Study|Withdrawal by Caregiver|1|||
13106934|NCT03289143|25885858|FG002|Overall Study|Withdrawal by Caregiver|0|||
13106935|NCT03289143|25885859|FG003|Overall Study|Withdrawal by Caregiver|0|||
13106936|NCT03289143|25885856|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
13106937|NCT03289143|25885857|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
13165204|NCT02388269|26100828|FG000|Overall Study|Adverse Event|2|||
13165205|NCT02388269|26100829|FG001|Overall Study|Adverse Event|0|||
13106938|NCT03289143|25885858|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1|||
13106939|NCT03289143|25885859|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
13106940|NCT03289143|25885856|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
13106941|NCT03289143|25885857|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
13106942|NCT03289143|25885858|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
13106943|NCT03289143|25885859|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1|||
13106944|NCT03288987|25885882|FG000|Overall Study|Protocol Violation|10|||
13106945|NCT03288987|25885883|FG001|Overall Study|Protocol Violation|4|||
13106946|NCT03288779|25885890|FG000|Overall Study|Withdrawal by Subject|3|||
13106947|NCT03288714|25885913|FG000|Overall Study|Lost to Follow-up|2|||
13165206|NCT02388269|26100830|FG002|Overall Study|Adverse Event|0|||
13106948|NCT03288714|25885914|FG001|Overall Study|Lost to Follow-up|1|||
13106949|NCT03288714|25885913|FG000|Overall Study|Non-compliance with study schedule|2|||
13106950|NCT03288714|25885914|FG001|Overall Study|Non-compliance with study schedule|0|||
13165207|NCT02388269|26100828|FG000|Overall Study|Withdrawal by Subject|1|||
13106951|NCT03288714|25885913|FG000|Overall Study|Withdrawal by Subject|3|||
13106952|NCT03288714|25885914|FG001|Overall Study|Withdrawal by Subject|1|||
13165208|NCT02388269|26100829|FG001|Overall Study|Withdrawal by Subject|2|||
13165209|NCT02388269|26100830|FG002|Overall Study|Withdrawal by Subject|0|||
13165210|NCT02388269|26100828|FG000|Overall Study|less than 50% stimulations|1|||
13165211|NCT02388269|26100829|FG001|Overall Study|less than 50% stimulations|0|||
13165212|NCT02388269|26100830|FG002|Overall Study|less than 50% stimulations|0|||
13165213|NCT02388269|26100828|FG000|Overall Study|no diary data|3|||
13165214|NCT02388269|26100829|FG001|Overall Study|no diary data|0|||
13165215|NCT02388269|26100830|FG002|Overall Study|no diary data|0|||
13165216|NCT02388269|26100828|FG000|Overall Study|Protocol Violation|2|||
13165217|NCT02388269|26100829|FG001|Overall Study|Protocol Violation|0|||
13165218|NCT02388269|26100830|FG002|Overall Study|Protocol Violation|0|||
13165219|NCT02388269|26100828|FG000|Overall Study|Screen Failure|0|||
13165220|NCT02388269|26100829|FG001|Overall Study|Screen Failure|0|||
13165221|NCT02388269|26100830|FG002|Overall Study|Screen Failure|10|||
13165222|NCT02388191|26100851|FG000|Overall Study|Patient did not receive IUD|1|||
13165223|NCT02388191|26100852|FG001|Overall Study|Patient did not receive IUD|0|||
13165224|NCT02388165|26100889|FG000|Overall Study|Study terminated by sponsor|5|||
13165225|NCT02388165|26100890|FG001|Overall Study|Study terminated by sponsor|5|||
13165226|NCT02388165|26100889|FG000|Overall Study|Other|11|||
13165227|NCT02388165|26100890|FG001|Overall Study|Other|13|||
13165228|NCT02388165|26100889|FG000|Overall Study|No longer meet eligibility criteria|40|||
13165229|NCT02388165|26100890|FG001|Overall Study|No longer meet eligibility criteria|43|||
13165230|NCT02388165|26100889|FG000|Overall Study|Withdrawal of consent|31|||
13165231|NCT02388165|26100890|FG001|Overall Study|Withdrawal of consent|32|||
13165232|NCT02388165|26100889|FG000|Overall Study|Lost to Follow-up|19|||
13165233|NCT02388165|26100890|FG001|Overall Study|Lost to Follow-up|20|||
13165234|NCT02388165|26100889|FG000|Overall Study|Death|13|||
13165235|NCT02388165|26100890|FG001|Overall Study|Death|10|||
13165236|NCT02388165|26100889|FG000|Overall Study|Adverse Event|3|||
13106953|NCT03288714|25885913|FG000|Overall Study|Clinical Worsening|2|||
13106954|NCT03288714|25885914|FG001|Overall Study|Clinical Worsening|1|||
13106955|NCT03288714|25885913|FG000|Overall Study|Adverse Event|1|||
13106956|NCT03288714|25885914|FG001|Overall Study|Adverse Event|0|||
13106957|NCT03288142|25885949|FG000|Overall Study|Lost to Follow-up|22|||
13106958|NCT03288142|25885950|FG001|Overall Study|Lost to Follow-up|15|||
13106959|NCT03287869|25885963|FG000|Overall Study|Adverse Event|14|||
13106960|NCT03287869|25885964|FG001|Overall Study|Adverse Event|12|||
13106961|NCT03287869|25885963|FG000|Overall Study|Lack of Efficacy|1|||
13106962|NCT03287869|25885964|FG001|Overall Study|Lack of Efficacy|0|||
13106963|NCT03287869|25885963|FG000|Overall Study|Lost to Follow-up|13|||
13106964|NCT03287869|25885964|FG001|Overall Study|Lost to Follow-up|19|||
13165237|NCT02388165|26100890|FG001|Overall Study|Adverse Event|5|||
13165238|NCT02388165|26100889|FG000|Overall Study|Did not meet entrance criteria|5|||
13165239|NCT02388165|26100890|FG001|Overall Study|Did not meet entrance criteria|2|||
13165240|NCT02388074|26100896|FG000|Overall Study|Lost in Transit|2|||
13165241|NCT02388074|26100896|FG000|Overall Study|Sample Not Returned|1|||
13165242|NCT02387983|26100910|FG000|Overall Study|Adverse Event|4|||
13106965|NCT03287869|25885963|FG000|Overall Study|Non-Compliance With Study Drug|5|||
13106966|NCT03287869|25885964|FG001|Overall Study|Non-Compliance With Study Drug|9|||
13106967|NCT03287869|25885963|FG000|Overall Study|Progressive Disease|1|||
13106968|NCT03287869|25885964|FG001|Overall Study|Progressive Disease|0|||
13106969|NCT03287869|25885963|FG000|Overall Study|Protocol Deviation|2|||
13106970|NCT03287869|25885964|FG001|Overall Study|Protocol Deviation|1|||
13106971|NCT03287869|25885963|FG000|Overall Study|Withdrawal by Subject|36|||
13106972|NCT03287869|25885964|FG001|Overall Study|Withdrawal by Subject|43|||
13106973|NCT03287869|25885963|FG000|Overall Study|Early Closure of the Site|0|||
13106974|NCT03287869|25885964|FG001|Overall Study|Early Closure of the Site|1|||
13165243|NCT02387983|26100910|FG000|Overall Study|Protocol Violation|1|||
13106975|NCT03287869|25885963|FG000|Overall Study|Physician Decision|5|||
13106976|NCT03287869|25885964|FG001|Overall Study|Physician Decision|5|||
13165244|NCT02387983|26100910|FG000|Overall Study|Withdrawal by Subject|2|||
13165245|NCT02387970|26100935|FG000|Overall Study|Did not complete 1-year follow up|1|||
13165246|NCT02387970|26100936|FG001|Overall Study|Did not complete 1-year follow up|2|||
13165247|NCT02387957|26100957|FG000|Overall Study|The study was discontinued|21|||
13165248|NCT02387957|26100958|FG001|Overall Study|The study was discontinued|21|||
13165249|NCT02387957|26100959|FG002|Overall Study|The study was discontinued|20|||
13165250|NCT02387840|26101004|FG000|Overall Study|Death|0|||
13165251|NCT02387840|26101005|FG001|Overall Study|Death|0|||
13165252|NCT02387840|26101006|FG002|Overall Study|Death|0|||
13165253|NCT02387840|26101007|FG003|Overall Study|Death|0|||
13165254|NCT02387840|26101008|FG004|Overall Study|Death|0|||
13165255|NCT02387840|26101009|FG005|Overall Study|Death|1|||
13106977|NCT03287869|25885963|FG000|Overall Study|Reason not Specified|6|||
13106978|NCT03287869|25885964|FG001|Overall Study|Reason not Specified|3|||
13106979|NCT03287804|25885979|FG000|Overall Study|Death|1|||
13106980|NCT03287804|25885979|FG000|Overall Study|Physician Decision|2|||
13165256|NCT02387762|26101022|FG000|Overall Study|Withdrawal by Subject|1|||
13165257|NCT02387762|26101023|FG001|Overall Study|Withdrawal by Subject|0|||
13165258|NCT02387580|26101074|FG000|Overall Study|Withdrawal by Subject|0|||
13165259|NCT02387580|26101075|FG001|Overall Study|Withdrawal by Subject|0|||
13165260|NCT02387580|26101076|FG002|Overall Study|Withdrawal by Subject|0|||
13165261|NCT02387580|26101077|FG003|Overall Study|Withdrawal by Subject|1|||
13165262|NCT02387580|26101078|FG004|Overall Study|Withdrawal by Subject|0|||
13165263|NCT02387580|26101079|FG005|Overall Study|Withdrawal by Subject|0|||
13165264|NCT02387372|26101132|FG000|Overall Study|Not Treated|1|||
13165265|NCT02387372|26101133|FG001|Overall Study|Not Treated|0|||
13165266|NCT02387216|26101158|FG000|Overall Study|Progressive disease|2|||
13165267|NCT02387216|26101159|FG001|Overall Study|Progressive disease|0|||
13165268|NCT02387216|26101158|FG000|Overall Study|Withdrawal by Subject|3|||
13165269|NCT02387216|26101159|FG001|Overall Study|Withdrawal by Subject|5|||
13165270|NCT02387216|26101158|FG000|Overall Study|Physician Decision|2|||
13165271|NCT02387216|26101159|FG001|Overall Study|Physician Decision|0|||
13165272|NCT02387216|26101158|FG000|Overall Study|Sponsor Decision|28|||
13165273|NCT02387216|26101159|FG001|Overall Study|Sponsor Decision|12|||
13165274|NCT02387216|26101158|FG000|Overall Study|Death|60|||
13165275|NCT02387216|26101159|FG001|Overall Study|Death|23|||
13165276|NCT02387216|26101158|FG000|Overall Study|Other|5|||
13165277|NCT02387216|26101159|FG001|Overall Study|Other|4|||
13165278|NCT02387216|26101158|FG000|Overall Study|Lost to Follow-up|0|||
13165279|NCT02387216|26101159|FG001|Overall Study|Lost to Follow-up|3|||
13165280|NCT02387164|26101188|FG000|Overall Study|Lost to Follow-up|2|||
13165281|NCT02387164|26101189|FG001|Overall Study|Lost to Follow-up|0|||
13165282|NCT02387164|26101188|FG000|Overall Study|Diagnosed|1|||
13165283|NCT02387164|26101189|FG001|Overall Study|Diagnosed|2|||
13165284|NCT02386839|26101280|FG000|Overall Study|Death|1|||
13165285|NCT02386839|26101281|FG001|Overall Study|Death|0|||
13165286|NCT02386839|26101280|FG000|Overall Study|Withdrawal by Subject|9|||
13165287|NCT02386839|26101281|FG001|Overall Study|Withdrawal by Subject|10|||
13165288|NCT02386839|26101280|FG000|Overall Study|Lost to Follow-up|4|||
13165289|NCT02386839|26101281|FG001|Overall Study|Lost to Follow-up|4|||
13165290|NCT02386839|26101280|FG000|Overall Study|Other (Site Terminated by Sponsor)|1|||
13165291|NCT02386839|26101281|FG001|Overall Study|Other (Site Terminated by Sponsor)|0|||
13165292|NCT02386839|26101280|FG000|Overall Study|Other (Covid 19 Pandemic)|0|||
13165293|NCT02386839|26101281|FG001|Overall Study|Other (Covid 19 Pandemic)|1|||
13165294|NCT02386839|26101280|FG000|Overall Study|Other (unspecified)|1|||
13165295|NCT02386839|26101281|FG001|Overall Study|Other (unspecified)|0|||
13165296|NCT02386345|26101291|FG000|Overall Study|Not treated|14|||
13165297|NCT02386345|26101291|FG000|Overall Study|Lost to Follow-up|1|||
13165298|NCT02386345|26101291|FG000|Overall Study|Adverse Event|5|||
13165299|NCT02386345|26101291|FG000|Overall Study|Repeat Procedure|10|||
13165300|NCT02386345|26101291|FG000|Overall Study|Did not complete 12-month follow-up|72|||
13106981|NCT03287804|25885979|FG000|Overall Study|Progressive disease|8|||
13165301|NCT02386189|26101316|FG000|Overall Study|Lost to Follow-up|2|||
13165302|NCT02386189|26101317|FG001|Overall Study|Lost to Follow-up|3|||
13165303|NCT02386189|26101316|FG000|Overall Study|Withdrawal by Subject|1|||
13165304|NCT02386189|26101317|FG001|Overall Study|Withdrawal by Subject|0|||
13165305|NCT02386189|26101316|FG000|Overall Study|Death|1|||
13165306|NCT02386189|26101317|FG001|Overall Study|Death|0|||
13165307|NCT02386098|26101410|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30|||
13106982|NCT03287791|25886000|FG000|Overall Study|Insufficient Therapeutic Response|0|||
13106983|NCT03287791|25886001|FG001|Overall Study|Insufficient Therapeutic Response|0|||
13106984|NCT03287791|25886002|FG002|Overall Study|Insufficient Therapeutic Response|1|||
13106985|NCT03287791|25886000|FG000|Overall Study|Adverse Event|0|||
13106986|NCT03287791|25886001|FG001|Overall Study|Adverse Event|4|||
13106987|NCT03287791|25886002|FG002|Overall Study|Adverse Event|3|||
13106988|NCT03287791|25886000|FG000|Overall Study|Withdrawal by Subject|12|||
13106989|NCT03287791|25886001|FG001|Overall Study|Withdrawal by Subject|12|||
13106990|NCT03287791|25886002|FG002|Overall Study|Withdrawal by Subject|17|||
13106991|NCT03287791|25886000|FG000|Overall Study|Missed more than 6 consecutive doses|3|||
13106992|NCT03287791|25886001|FG001|Overall Study|Missed more than 6 consecutive doses|2|||
13106993|NCT03287791|25886002|FG002|Overall Study|Missed more than 6 consecutive doses|2|||
13106994|NCT03287791|25886000|FG000|Overall Study|Lost to Follow-up|8|||
13106995|NCT03287791|25886001|FG001|Overall Study|Lost to Follow-up|14|||
13106996|NCT03287791|25886002|FG002|Overall Study|Lost to Follow-up|11|||
13106997|NCT03287791|25886000|FG000|Overall Study|Protocol Violation|7|||
13106998|NCT03287791|25886001|FG001|Overall Study|Protocol Violation|2|||
13106999|NCT03287791|25886002|FG002|Overall Study|Protocol Violation|1|||
13107000|NCT03287791|25886000|FG000|Overall Study|Participant was enrolled at 2 sites|1|||
13107001|NCT03287791|25886001|FG001|Overall Study|Participant was enrolled at 2 sites|0|||
13107002|NCT03287791|25886002|FG002|Overall Study|Participant was enrolled at 2 sites|1|||
13107003|NCT03287791|25886000|FG000|Overall Study|Too much time between 2 visits|0|||
13107004|NCT03287791|25886001|FG001|Overall Study|Too much time between 2 visits|1|||
13107005|NCT03287791|25886002|FG002|Overall Study|Too much time between 2 visits|0|||
13107006|NCT03287791|25886000|FG000|Overall Study|Non-compliance|0|||
13107007|NCT03287791|25886001|FG001|Overall Study|Non-compliance|1|||
13107008|NCT03287791|25886002|FG002|Overall Study|Non-compliance|0|||
13107009|NCT03287791|25886000|FG000|Overall Study|Did not meet inclusion criteria|1|||
13107010|NCT03287791|25886001|FG001|Overall Study|Did not meet inclusion criteria|0|||
13107011|NCT03287791|25886002|FG002|Overall Study|Did not meet inclusion criteria|0|||
13107012|NCT03287635|25886010|FG000|Overall Study|Lost to Follow-up|5|||
13107013|NCT03287635|25886010|FG000|Overall Study|Withdrawal by Subject|1|||
13107014|NCT03287635|25886010|FG000|Overall Study|Physician Decision|1|||
13107015|NCT03287622|25886037|FG000|Overall Study|Withdrawal by Subject|1|||
13107016|NCT03287622|25886038|FG001|Overall Study|Withdrawal by Subject|0|||
13107017|NCT03287622|25886037|FG000|Overall Study|Lost to Follow-up|27|||
13107018|NCT03287622|25886038|FG001|Overall Study|Lost to Follow-up|15|||
13107019|NCT03287622|25886037|FG000|Overall Study|No prescripion after surgery|28|||
13107020|NCT03287622|25886038|FG001|Overall Study|No prescripion after surgery|31|||
13107021|NCT03287622|25886037|FG000|Overall Study|prolonged Length of stay|2|||
13107022|NCT03287622|25886038|FG001|Overall Study|prolonged Length of stay|0|||
13107023|NCT03287622|25886037|FG000|Overall Study|surgery related|0|||
13107024|NCT03287622|25886038|FG001|Overall Study|surgery related|2|||
13107025|NCT03287219|25886090|FG000|Overall Study|Protocol Violation|0|||
13107026|NCT03287219|25886091|FG001|Overall Study|Protocol Violation|2|||
13107027|NCT03287089|25886108|FG000|Overall Study|Lost to Follow-up|0|||
13107028|NCT03287089|25886109|FG001|Overall Study|Lost to Follow-up|2|||
13107029|NCT03287089|25886108|FG000|Overall Study|Physician Decision|0|||
13107030|NCT03287089|25886109|FG001|Overall Study|Physician Decision|2|||
13107031|NCT03287089|25886108|FG000|Overall Study|Withdrawal by Subject|0|||
13107032|NCT03287089|25886109|FG001|Overall Study|Withdrawal by Subject|2|||
13107033|NCT03286751|25886136|FG000|Washout Period 1|Withdrawal by Subject|0|||
13107034|NCT03286751|25886137|FG001|Washout Period 1|Withdrawal by Subject|0|||
13107035|NCT03286751|25886138|FG002|Washout Period 1|Withdrawal by Subject|0|||
13107036|NCT03286751|25886139|FG003|Washout Period 1|Withdrawal by Subject|0|||
13107037|NCT03286751|25886140|FG004|Washout Period 1|Withdrawal by Subject|1|||
13107038|NCT03286751|25886141|FG005|Washout Period 1|Withdrawal by Subject|0|||
13107039|NCT03286751|25886136|FG000|Washout Period 2|Personal Reasons|0|||
13107040|NCT03286751|25886137|FG001|Washout Period 2|Personal Reasons|1|||
13107041|NCT03286751|25886138|FG002|Washout Period 2|Personal Reasons|0|||
13107042|NCT03286751|25886139|FG003|Washout Period 2|Personal Reasons|0|||
13107043|NCT03286751|25886140|FG004|Washout Period 2|Personal Reasons|0|||
13107044|NCT03286751|25886141|FG005|Washout Period 2|Personal Reasons|0|||
13107045|NCT03286751|25886136|FG000|Washout Period 5|Adverse Event|0|||
13107046|NCT03286751|25886137|FG001|Washout Period 5|Adverse Event|0|||
13107047|NCT03286751|25886138|FG002|Washout Period 5|Adverse Event|0|||
13107048|NCT03286751|25886139|FG003|Washout Period 5|Adverse Event|0|||
13107049|NCT03286751|25886140|FG004|Washout Period 5|Adverse Event|1|||
13107050|NCT03286751|25886141|FG005|Washout Period 5|Adverse Event|0|||
13107051|NCT03286543|25886190|FG000|Consented|Screen failure before randomization|2|||
13107052|NCT03286543|25886191|FG001|Consented|Screen failure before randomization|0|||
13107053|NCT03286543|25886192|FG002|Consented|Screen failure before randomization|0|||
13107054|NCT03286543|25886190|FG000|Consented|Screen failure before enrollment|4|||
13107055|NCT03286543|25886191|FG001|Consented|Screen failure before enrollment|0|||
13165308|NCT02386098|26101411|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29|||
13165309|NCT02386098|26101412|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
13165310|NCT02386098|26101413|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
13165311|NCT02386098|26101414|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
13165312|NCT02386098|26101410|FG000|Stage 1 (96 Weeks)|Adverse Event|2|||
13165313|NCT02386098|26101411|FG001|Stage 1 (96 Weeks)|Adverse Event|1|||
13165314|NCT02386098|26101412|FG002|Stage 1 (96 Weeks)|Adverse Event|0|||
13165315|NCT02386098|26101413|FG003|Stage 1 (96 Weeks)|Adverse Event|0|||
13165316|NCT02386098|26101414|FG004|Stage 1 (96 Weeks)|Adverse Event|0|||
13165317|NCT02386098|26101410|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
13165318|NCT02386098|26101411|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
13165319|NCT02386098|26101412|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
13165320|NCT02386098|26101413|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
13165321|NCT02386098|26101414|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
13165322|NCT02386098|26101410|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
13107056|NCT03286543|25886192|FG002|Consented|Screen failure before enrollment|0|||
13107057|NCT03286543|25886190|FG000|Consented|TKA cancelled after enrollment|1|||
13107058|NCT03286543|25886191|FG001|Consented|TKA cancelled after enrollment|0|||
13165323|NCT02386098|26101411|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2|||
13165324|NCT02386098|26101412|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
13107059|NCT03286543|25886192|FG002|Consented|TKA cancelled after enrollment|0|||
13107060|NCT03286543|25886190|FG000|Consented|Withdrawn from study|12|||
13165325|NCT02386098|26101413|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
13165326|NCT02386098|26101414|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
13165327|NCT02386098|26101410|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3|||
13165328|NCT02386098|26101411|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1|||
13165329|NCT02386098|26101412|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
13165330|NCT02386098|26101413|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
13165331|NCT02386098|26101414|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
13165332|NCT02386098|26101410|FG000|Stage 1 (96 Weeks)|Other|1|||
13165333|NCT02386098|26101411|FG001|Stage 1 (96 Weeks)|Other|0|||
13165334|NCT02386098|26101412|FG002|Stage 1 (96 Weeks)|Other|0|||
13165335|NCT02386098|26101413|FG003|Stage 1 (96 Weeks)|Other|0|||
13165336|NCT02386098|26101414|FG004|Stage 1 (96 Weeks)|Other|0|||
13165337|NCT02386098|26101410|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5|||
13165338|NCT02386098|26101411|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8|||
13165339|NCT02386098|26101412|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
13165340|NCT02386098|26101413|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
13165341|NCT02386098|26101414|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
13165342|NCT02385799|26101455|FG000|Overall Study|Lost to Follow-up|1|||
13165343|NCT02385799|26101456|FG001|Overall Study|Lost to Follow-up|2|||
13165344|NCT02385799|26101455|FG000|Overall Study|Adverse Event|4|||
13165345|NCT02385799|26101456|FG001|Overall Study|Adverse Event|2|||
13165346|NCT02385799|26101455|FG000|Overall Study|Withdrawal by Subject|0|||
13165347|NCT02385799|26101456|FG001|Overall Study|Withdrawal by Subject|4|||
13165348|NCT02385708|26101469|FG000|Overall Study|Withdrawal by Subject|0|||
13165349|NCT02385708|26101470|FG001|Overall Study|Withdrawal by Subject|2|||
13165350|NCT02385708|26101469|FG000|Overall Study|Withdrawn - surgery canceled|2|||
13165351|NCT02385708|26101470|FG001|Overall Study|Withdrawn - surgery canceled|5|||
13165352|NCT02385708|26101469|FG000|Overall Study|Investigator decision|5|||
13165353|NCT02385708|26101470|FG001|Overall Study|Investigator decision|7|||
13165354|NCT02385708|26101469|FG000|Overall Study|Protocol Violation|1|||
13165355|NCT02385708|26101470|FG001|Overall Study|Protocol Violation|1|||
13165356|NCT02385669|26101477|FG000|Overall Study|Adverse Event|2|||
13165357|NCT02385526|26101495|FG000|Overall Study|Withdrawal by Subject|0|||
13165358|NCT02385526|26101496|FG001|Overall Study|Withdrawal by Subject|2|||
13165359|NCT02385526|26101497|FG002|Overall Study|Withdrawal by Subject|0|||
13165360|NCT02385526|26101495|FG000|Overall Study|Lost to Follow-up|0|||
13165361|NCT02385526|26101496|FG001|Overall Study|Lost to Follow-up|1|||
13165362|NCT02385526|26101497|FG002|Overall Study|Lost to Follow-up|0|||
13107061|NCT03286543|25886191|FG001|Consented|Withdrawn from study|0|||
13107062|NCT03286543|25886192|FG002|Consented|Withdrawn from study|0|||
13165363|NCT02385526|26101495|FG000|Overall Study|Physician Decision|1|||
13165364|NCT02385526|26101496|FG001|Overall Study|Physician Decision|0|||
13165365|NCT02385526|26101497|FG002|Overall Study|Physician Decision|0|||
13165366|NCT02385526|26101495|FG000|Overall Study|Protocol Violation|1|||
13165367|NCT02385526|26101496|FG001|Overall Study|Protocol Violation|0|||
13165368|NCT02385526|26101497|FG002|Overall Study|Protocol Violation|0|||
13165369|NCT02385084|26101515|FG000|Period 2|Protocol Violation|0|||
13165370|NCT02385084|26101516|FG001|Period 2|Protocol Violation|0|||
13165371|NCT02385084|26101517|FG002|Period 2|Protocol Violation|1|||
13107063|NCT03286543|25886190|FG000|Study Enrollment|TKA cancelled after enrollment|0|||
13165372|NCT02385084|26101518|FG003|Period 2|Protocol Violation|0|||
13165373|NCT02385084|26101519|FG004|Period 2|Protocol Violation|0|||
13165374|NCT02385084|26101520|FG005|Period 2|Protocol Violation|0|||
13165375|NCT02384993|26101556|FG000|Overall Study|Adverse Event|0|||
13165376|NCT02384993|26101557|FG001|Overall Study|Adverse Event|1|||
13165377|NCT02384941|26101596|FG000|Overall Study|Adverse Event|11|||
13165378|NCT02384941|26101597|FG001|Overall Study|Adverse Event|13|||
13165379|NCT02384941|26101598|FG002|Overall Study|Adverse Event|17|||
13165380|NCT02384941|26101596|FG000|Overall Study|Lost to Follow-up|3|||
13165381|NCT02384941|26101597|FG001|Overall Study|Lost to Follow-up|2|||
13165382|NCT02384941|26101598|FG002|Overall Study|Lost to Follow-up|1|||
13165383|NCT02384941|26101596|FG000|Overall Study|Non-Compliance With Study Drug|2|||
13165384|NCT02384941|26101597|FG001|Overall Study|Non-Compliance With Study Drug|0|||
13165385|NCT02384941|26101598|FG002|Overall Study|Non-Compliance With Study Drug|1|||
13165386|NCT02384941|26101596|FG000|Overall Study|Physician Decision|1|||
13165387|NCT02384941|26101597|FG001|Overall Study|Physician Decision|1|||
13165388|NCT02384941|26101598|FG002|Overall Study|Physician Decision|0|||
13165389|NCT02384941|26101596|FG000|Overall Study|Protocol Violation|3|||
13165390|NCT02384941|26101597|FG001|Overall Study|Protocol Violation|0|||
13165391|NCT02384941|26101598|FG002|Overall Study|Protocol Violation|0|||
13165392|NCT02384941|26101596|FG000|Overall Study|Withdrawal by Subject|26|||
13165393|NCT02384941|26101597|FG001|Overall Study|Withdrawal by Subject|19|||
13165394|NCT02384941|26101598|FG002|Overall Study|Withdrawal by Subject|20|||
13165395|NCT02384941|26101596|FG000|Overall Study|Pregnancy|0|||
13165396|NCT02384941|26101597|FG001|Overall Study|Pregnancy|0|||
13165397|NCT02384941|26101598|FG002|Overall Study|Pregnancy|1|||
13165398|NCT02384941|26101596|FG000|Overall Study|Other than specified above|4|||
13165399|NCT02384941|26101597|FG001|Overall Study|Other than specified above|0|||
13165400|NCT02384941|26101598|FG002|Overall Study|Other than specified above|1|||
13165401|NCT02384850|26101619|FG000|Overall Study|Withdrawal by Subject|2|||
13165402|NCT02384850|26101620|FG001|Overall Study|Withdrawal by Subject|2|||
13165403|NCT02384538|26101645|FG000|Overall Study|Adverse Event|1|||
13165404|NCT02384538|26101646|FG001|Overall Study|Adverse Event|4|||
13165405|NCT02384538|26101645|FG000|Overall Study|Lack of Efficacy|4|||
13165406|NCT02384538|26101646|FG001|Overall Study|Lack of Efficacy|4|||
13165407|NCT02384538|26101645|FG000|Overall Study|Withdrew Consent|0|||
13165408|NCT02384538|26101646|FG001|Overall Study|Withdrew Consent|4|||
13165409|NCT02384538|26101645|FG000|Overall Study|Other|1|||
13165410|NCT02384538|26101646|FG001|Overall Study|Other|3|||
13165411|NCT02384460|26101671|FG000|Overall Study|Protocol Violation|0|||
13165412|NCT02384460|26101672|FG001|Overall Study|Protocol Violation|1|||
13165413|NCT02384460|26101671|FG000|Overall Study|Returned to previous therapeutic regimen|0|||
13165414|NCT02384460|26101672|FG001|Overall Study|Returned to previous therapeutic regimen|1|||
13165415|NCT02384460|26101671|FG000|Overall Study|Adverse Event|5|||
13165416|NCT02384460|26101672|FG001|Overall Study|Adverse Event|2|||
13165417|NCT02384460|26101671|FG000|Overall Study|Withdrawal by Subject|0|||
13165418|NCT02384460|26101672|FG001|Overall Study|Withdrawal by Subject|3|||
13165419|NCT02384460|26101671|FG000|Overall Study|Elective medical treatment|1|||
13165420|NCT02384460|26101672|FG001|Overall Study|Elective medical treatment|0|||
13165421|NCT02384460|26101671|FG000|Overall Study|Non-compliance|1|||
13165422|NCT02384460|26101672|FG001|Overall Study|Non-compliance|0|||
13165423|NCT02384395|26101681|FG000|Overall Study|Physician Decision|4|||
13165424|NCT02384395|26101681|FG000|Overall Study|Withdrawal by Subject|3|||
13165425|NCT02384395|26101681|FG000|Overall Study|Lost to Follow-up|3|||
13165426|NCT02384382|26101688|FG000|Overall Study|Transitioned to study-NCT02960022|5|||
13165427|NCT02384382|26101688|FG000|Overall Study|Death|1|||
13165428|NCT02384382|26101688|FG000|Overall Study|Adverse Event|1|||
13165429|NCT02384382|26101688|FG000|Overall Study|Disease progression|16|||
13165430|NCT02383966|26101713|FG000|Overall Study|Ongoing at clinical cut-off date|25|||
13165431|NCT02383966|26101714|FG001|Overall Study|Ongoing at clinical cut-off date|4|||
13165432|NCT02383966|26101713|FG000|Overall Study|Randomized, but not treated|1|||
13165433|NCT02383966|26101714|FG001|Overall Study|Randomized, but not treated|3|||
13165434|NCT02383940|26101735|FG000|Overall Study|Adverse Event|1|||
13165435|NCT02383940|26101736|FG001|Overall Study|Adverse Event|0|||
13165436|NCT02383940|26101735|FG000|Overall Study|Lost to Follow-up|2|||
13165437|NCT02383940|26101736|FG001|Overall Study|Lost to Follow-up|2|||
13165438|NCT02383940|26101735|FG000|Overall Study|Physician Decision|2|||
13165439|NCT02383940|26101736|FG001|Overall Study|Physician Decision|0|||
13165440|NCT02383940|26101735|FG000|Overall Study|Withdrawal by Subject|1|||
13165441|NCT02383940|26101736|FG001|Overall Study|Withdrawal by Subject|1|||
13165442|NCT02383940|26101735|FG000|Overall Study|Randomized but not treated|2|||
13165443|NCT02383940|26101736|FG001|Overall Study|Randomized but not treated|0|||
13165444|NCT02383940|26101735|FG000|Overall Study|Other than specified above|1|||
13165445|NCT02383940|26101736|FG001|Overall Study|Other than specified above|0|||
13165446|NCT02383862|26101774|FG000|3 Month Follow up|Lost to Follow-up|23|||
13165447|NCT02383862|26101775|FG001|3 Month Follow up|Lost to Follow-up|21|||
13165448|NCT02383758|26101794|FG000|Overall Study|Withdrawal by Subject|0|||
13165449|NCT02383758|26101795|FG001|Overall Study|Withdrawal by Subject|2|||
13165450|NCT02383589|26101825|FG000|Treatment Period|Adverse Event|1|||
13165451|NCT02383589|26101826|FG001|Treatment Period|Adverse Event|3|||
13165452|NCT02383589|26101825|FG000|Treatment Period|Lost to Follow-up|0|||
13165453|NCT02383589|26101826|FG001|Treatment Period|Lost to Follow-up|1|||
13165454|NCT02383589|26101825|FG000|Treatment Period|Withdrawal by Subject|0|||
13165455|NCT02383589|26101826|FG001|Treatment Period|Withdrawal by Subject|5|||
13165456|NCT02383589|26101825|FG000|Treatment Period|Non-compliance with study drug|0|||
13165457|NCT02383589|26101826|FG001|Treatment Period|Non-compliance with study drug|1|||
13165458|NCT02383589|26101825|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2|||
13165459|NCT02383589|26101826|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4|||
13165460|NCT02383589|26101825|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5|||
13165461|NCT02383589|26101826|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0|||
13165462|NCT02383589|26101825|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0|||
13165463|NCT02383589|26101826|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1|||
13165464|NCT02383576|26101847|FG000|Overall Study|Death|53|||
13165465|NCT02383576|26101848|FG001|Overall Study|Death|33|||
13165466|NCT02383576|26101847|FG000|Overall Study|Lost to Follow-up|7|||
13165467|NCT02383576|26101848|FG001|Overall Study|Lost to Follow-up|1|||
13165468|NCT02383576|26101847|FG000|Overall Study|Withdrew Consent|1|||
13165469|NCT02383576|26101848|FG001|Overall Study|Withdrew Consent|6|||
13165470|NCT02383576|26101847|FG000|Overall Study|Investigator's Decision|0|||
13165471|NCT02383576|26101848|FG001|Overall Study|Investigator's Decision|1|||
13165472|NCT02383576|26101847|FG000|Overall Study|Administrative/Other|2|||
13165473|NCT02383576|26101848|FG001|Overall Study|Administrative/Other|4|||
13165474|NCT02383472|26101869|FG000|Overall Study|Withdrawal by Subject|1|||
13165475|NCT02383472|26101870|FG001|Overall Study|Withdrawal by Subject|1|||
13165476|NCT02383433|26101876|FG000|Overall Study|Disease progression|2|||
13165477|NCT02383355|26101897|FG000|Overall Study|Adverse Event|2|||
13165478|NCT02383355|26101898|FG001|Overall Study|Adverse Event|0|||
13165479|NCT02383173|26101927|FG000|Overall Study|Palliative Care Team withdrew|0|||
13165480|NCT02383173|26101928|FG001|Overall Study|Palliative Care Team withdrew|2|||
13165481|NCT02383056|26101945|FG000|Overall Study|Adverse Event|1|||
13165482|NCT02383056|26101946|FG001|Overall Study|Adverse Event|0|||
13165483|NCT02383056|26101945|FG000|Overall Study|Lost to Follow-up|0|||
13165484|NCT02383056|26101946|FG001|Overall Study|Lost to Follow-up|2|||
13165485|NCT02383017|26101975|FG000|Overall Study|Injury Sustained Outside Study|1|||
13165486|NCT02383017|26101976|FG001|Overall Study|Injury Sustained Outside Study|0|||
13165487|NCT02383017|26101975|FG000|Overall Study|Compliance|3|||
13165488|NCT02383017|26101976|FG001|Overall Study|Compliance|2|||
13165489|NCT02383017|26101975|FG000|Overall Study|Found to be Hypogonadal|1|||
13165490|NCT02383017|26101976|FG001|Overall Study|Found to be Hypogonadal|0|||
13165491|NCT02382991|26101993|FG000|Overall Study|Adverse Event|1|||
13165492|NCT02382991|26101994|FG001|Overall Study|Adverse Event|2|||
13165493|NCT02382991|26101993|FG000|Overall Study|Lost to Follow-up|1|||
13165494|NCT02382991|26101994|FG001|Overall Study|Lost to Follow-up|0|||
13165495|NCT02382991|26101993|FG000|Overall Study|Withdrawal by Subject|0|||
13165496|NCT02382991|26101994|FG001|Overall Study|Withdrawal by Subject|1|||
13165497|NCT02382939|26102012|FG000|Overall Study|Adverse Event|1|||
13165498|NCT02382939|26102013|FG001|Overall Study|Adverse Event|1|||
13165499|NCT02382939|26102012|FG000|Overall Study|Withdrawal by Subject|2|||
13165500|NCT02382939|26102013|FG001|Overall Study|Withdrawal by Subject|2|||
13165501|NCT02382796|26102020|FG000|Overall Study|Global deterioration of health status|1|||
13165502|NCT02382796|26102020|FG000|Overall Study|Objective progression or relapse|3|||
13165503|NCT02382796|26102020|FG000|Overall Study|Commercial dacomitinib became available|3|||
13205491|NCT01964924|26231998|FG000|Trametinib Monotherapy|Progression|19|||
13205492|NCT01964924|26231999|FG001|Trametinib Monotherapy|Progression|0|||
13205493|NCT01964898|26232026|FG000|Overall Study|ineligible post-randomization|1|||
13205494|NCT01964898|26232027|FG001|Overall Study|ineligible post-randomization|1|||
13205495|NCT01964898|26232026|FG000|Overall Study|did not receive the allocated interventi|2|||
13205496|NCT01964898|26232027|FG001|Overall Study|did not receive the allocated interventi|1|||
13205497|NCT01964898|26232026|FG000|Overall Study|Lost to Follow-up|3|||
13205498|NCT01964898|26232027|FG001|Overall Study|Lost to Follow-up|5|||
13205499|NCT01964898|26232026|FG000|Overall Study|Withdrawal by Subject|1|||
13205500|NCT01964898|26232027|FG001|Overall Study|Withdrawal by Subject|0|||
13205501|NCT01964755|26232042|FG000|Overall Study|Death|2|||
13205502|NCT01964716|26232085|FG000|Overall Study|Withdrawal by Subject|2|||
13205503|NCT01964716|26232086|FG001|Overall Study|Withdrawal by Subject|3|||
13205504|NCT01964716|26232085|FG000|Overall Study|Lost to Follow-up|1|||
13205505|NCT01964716|26232086|FG001|Overall Study|Lost to Follow-up|2|||
13205506|NCT01964716|26232085|FG000|Overall Study|No longer met eligibility criteria|1|||
13205507|NCT01964716|26232086|FG001|Overall Study|No longer met eligibility criteria|1|||
13205508|NCT01964716|26232085|FG000|Overall Study|Death|1|||
13205509|NCT01964716|26232086|FG001|Overall Study|Death|0|||
13205510|NCT01964560|26232095|FG000|Overall Study|Adverse Event|23|||
13205511|NCT01964560|26232095|FG000|Overall Study|Lack of Efficacy|46|||
13205512|NCT01964560|26232095|FG000|Overall Study|Protocol deviation|2|||
13205513|NCT01964560|26232095|FG000|Overall Study|Lost to Follow-up|4|||
13205514|NCT01964560|26232095|FG000|Overall Study|Withdrawal by Subject|64|||
13205515|NCT01964560|26232095|FG000|Overall Study|Surgery-hemispherotomy|1|||
13165504|NCT02382640|26102071|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1|||
13165505|NCT02382640|26102072|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
13165506|NCT02382640|26102073|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
13165507|NCT02382640|26102074|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
13165508|NCT02382276|26102096|FG000|Overall Study|Withdrawal by Subject|4|||
13165509|NCT02382276|26102097|FG001|Overall Study|Withdrawal by Subject|8|||
13165510|NCT02382276|26102098|FG002|Overall Study|Withdrawal by Subject|5|||
13165511|NCT02382276|26102096|FG000|Overall Study|Adverse Event|7|||
13165512|NCT02382276|26102097|FG001|Overall Study|Adverse Event|2|||
13165513|NCT02382276|26102098|FG002|Overall Study|Adverse Event|32|||
13165514|NCT02382276|26102096|FG000|Overall Study|Physician Decision|0|||
13165515|NCT02382276|26102097|FG001|Overall Study|Physician Decision|0|||
13165516|NCT02382276|26102098|FG002|Overall Study|Physician Decision|2|||
13165517|NCT02382133|26102105|FG000|Overall Study|Death|22|||
13165518|NCT02382133|26102105|FG000|Overall Study|transfer out of ICU|4|||
13165519|NCT02382133|26102105|FG000|Overall Study|Physician Decision|2|||
13165520|NCT02382133|26102105|FG000|Overall Study|arterial catheter loss|4|||
13165521|NCT02382133|26102105|FG000|Overall Study|pressure injury both sites|1|||
13165522|NCT02382016|26102136|FG000|Double-blind (DB) Treatment Period|Physician Decision|3|||
13165523|NCT02382016|26102137|FG001|Double-blind (DB) Treatment Period|Physician Decision|0|||
13165524|NCT02382016|26102136|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1|||
13165525|NCT02382016|26102137|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0|||
13165526|NCT02382016|26102136|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0|||
13165527|NCT02382016|26102137|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1|||
13165528|NCT02382016|26102136|FG000|Open-label (OL) Treatment Period|Physician Decision|3|||
13165529|NCT02382016|26102137|FG001|Open-label (OL) Treatment Period|Physician Decision|0|||
13165530|NCT02382016|26102136|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2|||
13165531|NCT02382016|26102137|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0|||
13165532|NCT02382016|26102136|FG000|Open-label (OL) Treatment Period|Death|4|||
13165533|NCT02382016|26102137|FG001|Open-label (OL) Treatment Period|Death|0|||
13165534|NCT02382016|26102136|FG000|OL Extension Period|Physician Decision|3|||
13165535|NCT02382016|26102137|FG001|OL Extension Period|Physician Decision|0|||
13165536|NCT02382016|26102136|FG000|OL Extension Period|Death|2|||
13165537|NCT02382016|26102137|FG001|OL Extension Period|Death|0|||
13165538|NCT02382016|26102136|FG000|OL Extension Period|Withdrawal by Subject|1|||
13165539|NCT02382016|26102137|FG001|OL Extension Period|Withdrawal by Subject|0|||
13165540|NCT02381795|26102143|FG000|Overall Study|Withdrawal by Subject|1|||
13165541|NCT02381795|26102143|FG000|Overall Study|Study Terminated|2|||
13165542|NCT02380859|26102184|FG000|Overall Study|Withdrawal by Subject|2|||
13165543|NCT02380859|26102185|FG001|Overall Study|Withdrawal by Subject|0|||
13165544|NCT02380742|26102204|FG000|Overall Study|Withdrawal by Subject|1|||
13165545|NCT02380742|26102205|FG001|Overall Study|Withdrawal by Subject|0|||
13165546|NCT02380703|26102232|FG000|Overall Study|Withdrawal by Subject|12|||
13165547|NCT02380703|26102233|FG001|Overall Study|Withdrawal by Subject|9|||
13165548|NCT02380703|26102232|FG000|Overall Study|Lost to Follow-up|12|||
13165549|NCT02380703|26102233|FG001|Overall Study|Lost to Follow-up|12|||
13165550|NCT02380703|26102232|FG000|Overall Study|Caregiver death|1|||
13165551|NCT02380703|26102233|FG001|Overall Study|Caregiver death|0|||
13165552|NCT02380703|26102232|FG000|Overall Study|Person with dementia (PWD) death|7|||
13165553|NCT02380703|26102233|FG001|Overall Study|Person with dementia (PWD) death|8|||
13165554|NCT02380703|26102232|FG000|Overall Study|Entered Long-term Care|4|||
13165555|NCT02380703|26102233|FG001|Overall Study|Entered Long-term Care|7|||
13165556|NCT02380690|26102276|FG000|Overall Study|Lost to Follow-up|14|||
13165557|NCT02380690|26102277|FG001|Overall Study|Lost to Follow-up|4|||
13165558|NCT02380690|26102276|FG000|Overall Study|Withdrawal by Subject|20|||
13165559|NCT02380690|26102277|FG001|Overall Study|Withdrawal by Subject|8|||
13165560|NCT02380677|26102362|FG000|Overall Study|Adverse Event|0|||
13165561|NCT02380677|26102363|FG001|Overall Study|Adverse Event|0|||
13165562|NCT02380677|26102364|FG002|Overall Study|Adverse Event|0|||
13165563|NCT02380677|26102365|FG003|Overall Study|Adverse Event|1|||
13165564|NCT02380677|26102366|FG004|Overall Study|Adverse Event|1|||
13165565|NCT02380677|26102367|FG005|Overall Study|Adverse Event|4|||
13165566|NCT02380677|26102368|FG006|Overall Study|Adverse Event|2|||
13165567|NCT02380677|26102369|FG007|Overall Study|Adverse Event|2|||
13165568|NCT02380677|26102370|FG008|Overall Study|Adverse Event|2|||
13165569|NCT02380677|26102371|FG009|Overall Study|Adverse Event|1|||
13165570|NCT02380677|26102372|FG010|Overall Study|Adverse Event|2|||
13165571|NCT02380677|26102373|FG011|Overall Study|Adverse Event|1|||
13165572|NCT02380677|26102362|FG000|Overall Study|Physician Decision|1|||
13165573|NCT02380677|26102363|FG001|Overall Study|Physician Decision|0|||
13165574|NCT02380677|26102364|FG002|Overall Study|Physician Decision|1|||
13165575|NCT02380677|26102365|FG003|Overall Study|Physician Decision|1|||
13165576|NCT02380677|26102366|FG004|Overall Study|Physician Decision|0|||
13165577|NCT02380677|26102367|FG005|Overall Study|Physician Decision|0|||
13165578|NCT02380677|26102368|FG006|Overall Study|Physician Decision|0|||
13165579|NCT02380677|26102369|FG007|Overall Study|Physician Decision|0|||
13165580|NCT02380677|26102370|FG008|Overall Study|Physician Decision|0|||
13165581|NCT02380677|26102371|FG009|Overall Study|Physician Decision|0|||
13165582|NCT02380677|26102372|FG010|Overall Study|Physician Decision|0|||
13165583|NCT02380677|26102373|FG011|Overall Study|Physician Decision|0|||
13165584|NCT02380677|26102362|FG000|Overall Study|Lack of Efficacy|0|||
13165585|NCT02380677|26102363|FG001|Overall Study|Lack of Efficacy|1|||
13165586|NCT02380677|26102364|FG002|Overall Study|Lack of Efficacy|2|||
13165587|NCT02380677|26102365|FG003|Overall Study|Lack of Efficacy|0|||
13165588|NCT02380677|26102366|FG004|Overall Study|Lack of Efficacy|4|||
13165589|NCT02380677|26102367|FG005|Overall Study|Lack of Efficacy|1|||
13165590|NCT02380677|26102368|FG006|Overall Study|Lack of Efficacy|1|||
13165591|NCT02380677|26102369|FG007|Overall Study|Lack of Efficacy|2|||
13165592|NCT02380677|26102370|FG008|Overall Study|Lack of Efficacy|2|||
13165593|NCT02380677|26102371|FG009|Overall Study|Lack of Efficacy|0|||
13165594|NCT02380677|26102372|FG010|Overall Study|Lack of Efficacy|2|||
13165595|NCT02380677|26102373|FG011|Overall Study|Lack of Efficacy|1|||
13165596|NCT02380677|26102362|FG000|Overall Study|Withdrawal by Subject|0|||
13165597|NCT02380677|26102363|FG001|Overall Study|Withdrawal by Subject|0|||
13165598|NCT02380677|26102364|FG002|Overall Study|Withdrawal by Subject|0|||
13165599|NCT02380677|26102365|FG003|Overall Study|Withdrawal by Subject|0|||
13165600|NCT02380677|26102366|FG004|Overall Study|Withdrawal by Subject|0|||
13165601|NCT02380677|26102367|FG005|Overall Study|Withdrawal by Subject|0|||
13165602|NCT02380677|26102368|FG006|Overall Study|Withdrawal by Subject|0|||
13165603|NCT02380677|26102369|FG007|Overall Study|Withdrawal by Subject|0|||
13165604|NCT02380677|26102370|FG008|Overall Study|Withdrawal by Subject|0|||
13165605|NCT02380677|26102371|FG009|Overall Study|Withdrawal by Subject|1|||
13165606|NCT02380677|26102372|FG010|Overall Study|Withdrawal by Subject|0|||
13165607|NCT02380677|26102373|FG011|Overall Study|Withdrawal by Subject|3|||
13165608|NCT02380677|26102362|FG000|Overall Study|Other|0|||
13165609|NCT02380677|26102363|FG001|Overall Study|Other|0|||
13165610|NCT02380677|26102364|FG002|Overall Study|Other|0|||
13165611|NCT02380677|26102365|FG003|Overall Study|Other|1|||
13165612|NCT02380677|26102366|FG004|Overall Study|Other|1|||
13165613|NCT02380677|26102367|FG005|Overall Study|Other|1|||
13165614|NCT02380677|26102368|FG006|Overall Study|Other|0|||
13165615|NCT02380677|26102369|FG007|Overall Study|Other|0|||
13165616|NCT02380677|26102370|FG008|Overall Study|Other|0|||
13165617|NCT02380677|26102371|FG009|Overall Study|Other|0|||
13165618|NCT02380677|26102372|FG010|Overall Study|Other|0|||
13165619|NCT02380677|26102373|FG011|Overall Study|Other|0|||
13165620|NCT02380287|26102498|FG000|Overall Study|Adverse Event|0|||
13165621|NCT02380287|26102499|FG001|Overall Study|Adverse Event|0|||
13165622|NCT02380287|26102500|FG002|Overall Study|Adverse Event|1|||
13165623|NCT02380287|26102501|FG003|Overall Study|Adverse Event|0|||
13165624|NCT02380287|26102502|FG004|Overall Study|Adverse Event|0|||
13165625|NCT02380287|26102503|FG005|Overall Study|Adverse Event|0|||
13165626|NCT02380287|26102504|FG006|Overall Study|Adverse Event|0|||
13165627|NCT02380287|26102505|FG007|Overall Study|Adverse Event|0|||
13165628|NCT02380248|26102512|FG000|Overall Study|Lost to Follow-up|11|||
13165629|NCT02380248|26102512|FG000|Overall Study|Withdrawal by Subject|3|||
13165630|NCT02379923|26102528|FG000|Overall Study|Death|5|||
13165631|NCT02379728|26102591|FG000|Overall Study|Lost to Follow-up|1|||
13165632|NCT02379728|26102592|FG001|Overall Study|Lost to Follow-up|0|||
13165633|NCT02379728|26102593|FG002|Overall Study|Lost to Follow-up|3|||
13165634|NCT02379728|26102594|FG003|Overall Study|Lost to Follow-up|0|||
13165635|NCT02379728|26102591|FG000|Overall Study|Withdrawal by Subject|5|||
13165636|NCT02379728|26102592|FG001|Overall Study|Withdrawal by Subject|0|||
13165637|NCT02379728|26102593|FG002|Overall Study|Withdrawal by Subject|5|||
13165638|NCT02379728|26102594|FG003|Overall Study|Withdrawal by Subject|3|||
13165639|NCT02379728|26102591|FG000|Overall Study|Protocol Violation|0|||
13165640|NCT02379728|26102592|FG001|Overall Study|Protocol Violation|0|||
13165641|NCT02379728|26102593|FG002|Overall Study|Protocol Violation|2|||
13165642|NCT02379728|26102594|FG003|Overall Study|Protocol Violation|0|||
13165643|NCT02379637|26102609|FG000|Overall Study|Protocol Violation|0|||
13165644|NCT02379637|26102610|FG001|Overall Study|Protocol Violation|1|||
13165645|NCT02379637|26102609|FG000|Overall Study|Adverse Event|1|||
13165646|NCT02379637|26102610|FG001|Overall Study|Adverse Event|0|||
13165647|NCT02379637|26102609|FG000|Overall Study|Withdrawal by Subject|1|||
13165648|NCT02379637|26102610|FG001|Overall Study|Withdrawal by Subject|0|||
13165649|NCT02379390|26102645|FG000|Overall Study|Adverse Event|1|||
13165650|NCT02379390|26102646|FG001|Overall Study|Adverse Event|1|||
13165651|NCT02379390|26102645|FG000|Overall Study|Investigator's decision|1|||
13165652|NCT02379390|26102646|FG001|Overall Study|Investigator's decision|0|||
13165653|NCT02379390|26102645|FG000|Overall Study|Study Termination|0|||
13165654|NCT02379390|26102646|FG001|Overall Study|Study Termination|1|||
13165655|NCT02379221|26102663|FG000|Overall Study|Lost to Follow-up|1|||
13165656|NCT02379091|26102712|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
13165657|NCT02379091|26102713|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
13165658|NCT02379091|26102714|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
13165659|NCT02379091|26102715|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
13165660|NCT02379091|26102712|FG000|Overall Study|Principal Investigator Discretion|0|||
13165661|NCT02379091|26102713|FG001|Overall Study|Principal Investigator Discretion|1|||
13165662|NCT02379091|26102714|FG002|Overall Study|Principal Investigator Discretion|0|||
13165663|NCT02379091|26102715|FG003|Overall Study|Principal Investigator Discretion|0|||
13165664|NCT02379091|26102712|FG000|Overall Study|Lost to Follow-up|0|||
13165665|NCT02379091|26102713|FG001|Overall Study|Lost to Follow-up|0|||
13165666|NCT02379091|26102714|FG002|Overall Study|Lost to Follow-up|0|||
13165667|NCT02379091|26102715|FG003|Overall Study|Lost to Follow-up|1|||
13165668|NCT02379091|26102712|FG000|Overall Study|Voluntary Withdrawal|2|||
13165669|NCT02379091|26102713|FG001|Overall Study|Voluntary Withdrawal|5|||
13165670|NCT02379091|26102714|FG002|Overall Study|Voluntary Withdrawal|2|||
13165671|NCT02379091|26102715|FG003|Overall Study|Voluntary Withdrawal|4|||
13165672|NCT02379091|26102712|FG000|Overall Study|Study Termination|7|||
13165673|NCT02379091|26102713|FG001|Overall Study|Study Termination|2|||
13165674|NCT02379091|26102714|FG002|Overall Study|Study Termination|5|||
13165675|NCT02379091|26102715|FG003|Overall Study|Study Termination|8|||
13165676|NCT02379091|26102712|FG000|Overall Study|Lack of Efficacy|3|||
13165677|NCT02379091|26102713|FG001|Overall Study|Lack of Efficacy|0|||
13165678|NCT02379091|26102714|FG002|Overall Study|Lack of Efficacy|0|||
13165679|NCT02379091|26102715|FG003|Overall Study|Lack of Efficacy|0|||
13165680|NCT02379078|26102736|FG000|Overall Study|Lost to Follow-up|33|||
13165681|NCT02379078|26102737|FG001|Overall Study|Lost to Follow-up|30|||
13165682|NCT02379078|26102736|FG000|Overall Study|Withdrawal by Subject|6|||
13165683|NCT02379078|26102737|FG001|Overall Study|Withdrawal by Subject|5|||
13165684|NCT02379052|26102782|FG000|Overall Study|Protocol Violation|0|||
13165685|NCT02379052|26102783|FG001|Overall Study|Protocol Violation|1|||
13165686|NCT02379052|26102782|FG000|Overall Study|Adverse Event|0|||
13165687|NCT02379052|26102783|FG001|Overall Study|Adverse Event|1|||
13165688|NCT02379052|26102782|FG000|Overall Study|Physician Decision|1|||
13165689|NCT02379052|26102783|FG001|Overall Study|Physician Decision|1|||
13165690|NCT02379052|26102782|FG000|Overall Study|Withdrawal by Subject|2|||
13165691|NCT02379052|26102783|FG001|Overall Study|Withdrawal by Subject|0|||
13165692|NCT02379052|26102782|FG000|Overall Study|Lost to Follow-up|2|||
13165693|NCT02379052|26102783|FG001|Overall Study|Lost to Follow-up|1|||
13165694|NCT02379052|26102782|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1|||
13165695|NCT02379052|26102783|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0|||
13165696|NCT02379052|26102782|FG000|Overall Study|Subject was Incarcerated|0|||
13165697|NCT02379052|26102783|FG001|Overall Study|Subject was Incarcerated|1|||
13165698|NCT02378961|26102826|FG000|Overall Study|Lack of Efficacy|4|||
13165699|NCT02378961|26102827|FG001|Overall Study|Lack of Efficacy|2|||
13165700|NCT02378961|26102828|FG002|Overall Study|Lack of Efficacy|0|||
13165701|NCT02378961|26102829|FG003|Overall Study|Lack of Efficacy|1|||
13165702|NCT02378961|26102826|FG000|Overall Study|Death|0|||
13165703|NCT02378961|26102827|FG001|Overall Study|Death|0|||
13165704|NCT02378961|26102828|FG002|Overall Study|Death|1|||
13165705|NCT02378961|26102829|FG003|Overall Study|Death|0|||
13165706|NCT02378935|26102902|FG000|Overall Study|Lack of Efficacy|10|||
13165707|NCT02378935|26102903|FG001|Overall Study|Lack of Efficacy|0|||
13165708|NCT02378935|26102904|FG002|Overall Study|Lack of Efficacy|2|||
13165709|NCT02378935|26102905|FG003|Overall Study|Lack of Efficacy|6|||
13165710|NCT02378935|26102906|FG004|Overall Study|Lack of Efficacy|0|||
13165711|NCT02378935|26102907|FG005|Overall Study|Lack of Efficacy|0|||
13222893|NCT01802333|26287138|FG000|Overall Study|Withdrawal by Subject|6|||
13107064|NCT03286543|25886191|FG001|Study Enrollment|TKA cancelled after enrollment|0|||
13107065|NCT03286543|25886192|FG002|Study Enrollment|TKA cancelled after enrollment|1|||
13107066|NCT03286543|25886190|FG000|Study Enrollment|Withdrawn from study|0|||
13107067|NCT03286543|25886191|FG001|Study Enrollment|Withdrawn from study|6|||
13107068|NCT03286543|25886192|FG002|Study Enrollment|Withdrawn from study|6|||
13107069|NCT03286400|25886207|FG000|Overall Study|Death|10|||
13107070|NCT03286400|25886207|FG000|Overall Study|Lost to Follow-up|10|||
13107071|NCT03286400|25886207|FG000|Overall Study|Physician Decision|1|||
13107072|NCT03286400|25886207|FG000|Overall Study|Scheduling difficulty|4|||
13107073|NCT03286218|25886262|FG000|Qualification Phase Period 1|Adverse Event|1|||
13107074|NCT03286218|25886263|FG001|Qualification Phase Period 1|Adverse Event|0|||
13107075|NCT03286218|25886264|FG002|Qualification Phase Period 1|Adverse Event|0|||
13107076|NCT03286218|25886265|FG003|Qualification Phase Period 1|Adverse Event|0|||
13107077|NCT03286218|25886266|FG004|Qualification Phase Period 1|Adverse Event|0|||
13107078|NCT03286218|25886267|FG005|Qualification Phase Period 1|Adverse Event|0|||
13165712|NCT02378935|26102908|FG006|Overall Study|Lack of Efficacy|0|||
13165713|NCT02378935|26102902|FG000|Overall Study|Death|0|||
13165714|NCT02378935|26102903|FG001|Overall Study|Death|0|||
13165715|NCT02378935|26102904|FG002|Overall Study|Death|1|||
13165716|NCT02378935|26102905|FG003|Overall Study|Death|0|||
13165717|NCT02378935|26102906|FG004|Overall Study|Death|0|||
13165718|NCT02378935|26102907|FG005|Overall Study|Death|0|||
13165719|NCT02378935|26102908|FG006|Overall Study|Death|0|||
13165720|NCT02378883|26102921|FG000|Enrollment|Subject did not meet Inclusion criteria|6|||
13165721|NCT02378883|26102921|FG000|Enrollment|Attempt to use Apollo was not performed|3|||
13107079|NCT03286218|25886268|FG006|Qualification Phase Period 1|Adverse Event|0|||
13107080|NCT03286218|25886269|FG007|Qualification Phase Period 1|Adverse Event|0|||
13107081|NCT03286218|25886270|FG008|Qualification Phase Period 1|Adverse Event|0|||
13165722|NCT02378883|26102921|FG000|30 Day Follow-Up|Withdrawal by Subject|1|||
13165723|NCT02378883|26102921|FG000|30 Day Follow-Up|Physician Decision|2|||
13165724|NCT02378883|26102921|FG000|30 Day Follow-Up|Missed Visit|2|||
13165725|NCT02378883|26102921|FG000|30 Day Follow-Up|Death|1|||
13165726|NCT02378883|26102921|FG000|12 Months Follow-Up|Lost to Follow-up|3|||
13165727|NCT02378883|26102921|FG000|12 Months Follow-Up|Death|2|||
13165728|NCT02378662|26102934|FG000|Overall Study|Early Discontinuation|2|||
13165729|NCT02378662|26102935|FG001|Overall Study|Early Discontinuation|0|||
13165730|NCT02378506|26102954|FG000|Overall Study|Lack of Efficacy|3|||
13165731|NCT02378506|26102954|FG000|Overall Study|Withdrawal by Subject|4|||
13165732|NCT02378506|26102954|FG000|Overall Study|Protocol Violation|2|||
13165733|NCT02378506|26102954|FG000|Overall Study|Death|1|||
13165734|NCT02378506|26102954|FG000|Overall Study|Adverse Event|14|||
13165735|NCT02378506|26102954|FG000|Overall Study|Randomized But Not Treated|1|||
13165736|NCT02378480|26102973|FG000|Overall Study|Physician Decision|1|||
13165737|NCT02378480|26102974|FG001|Overall Study|Physician Decision|1|||
13165738|NCT02378480|26102973|FG000|Overall Study|Death|1|||
13165739|NCT02378480|26102974|FG001|Overall Study|Death|2|||
13165740|NCT02378480|26102973|FG000|Overall Study|Randomized, but Not Treated|6|||
13165741|NCT02378480|26102974|FG001|Overall Study|Randomized, but Not Treated|4|||
13165742|NCT02378480|26102973|FG000|Overall Study|Adverse Event|0|||
13165743|NCT02378480|26102974|FG001|Overall Study|Adverse Event|1|||
13165744|NCT02378480|26102973|FG000|Overall Study|Missed EOT/PTE Visit|1|||
13165745|NCT02378480|26102974|FG001|Overall Study|Missed EOT/PTE Visit|2|||
13165746|NCT02378480|26102973|FG000|Overall Study|Withdrawal by Subject|9|||
13165747|NCT02378480|26102974|FG001|Overall Study|Withdrawal by Subject|4|||
13165748|NCT02378480|26102973|FG000|Overall Study|Lost to Follow-up|10|||
13165749|NCT02378480|26102974|FG001|Overall Study|Lost to Follow-up|18|||
13165750|NCT02378220|26103011|FG000|Overall Study|Death|6|||
13165751|NCT02378220|26103012|FG001|Overall Study|Death|1|||
13165752|NCT02377921|26103041|FG000|Overall Study|Subject non-compliance|1|||
13165753|NCT02377921|26103042|FG001|Overall Study|Subject non-compliance|1|||
13165754|NCT02377817|26103111|FG000|Overall Study|Transportation/childcare barriers.|2|||
13165755|NCT02377817|26103112|FG001|Overall Study|Transportation/childcare barriers.|0|||
13165756|NCT02377817|26103111|FG000|Overall Study|Unrelated injury prevented lateral sleep|1|||
13165757|NCT02377817|26103112|FG001|Overall Study|Unrelated injury prevented lateral sleep|0|||
13165758|NCT02377466|26103235|FG000|Overall Study|Other: Randomized and not treated|0|||
13165759|NCT02377466|26103236|FG001|Overall Study|Other: Randomized and not treated|2|||
13165760|NCT02377427|26103306|FG000|Part A (Up to Week 20)|Physician Decision|1|||
13165761|NCT02377427|26103307|FG001|Part A (Up to Week 20)|Physician Decision|0|||
13165762|NCT02377427|26103308|FG002|Part A (Up to Week 20)|Physician Decision|0|||
13165763|NCT02377427|26103309|FG003|Part A (Up to Week 20)|Physician Decision|0|||
13165764|NCT02377427|26103310|FG004|Part A (Up to Week 20)|Physician Decision|0|||
13165765|NCT02377427|26103306|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1|||
13165766|NCT02377427|26103307|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
13165767|NCT02377427|26103308|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
13165768|NCT02377427|26103309|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
13165769|NCT02377427|26103310|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
13165770|NCT02377427|26103306|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2|||
13165771|NCT02377427|26103307|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0|||
13165772|NCT02377427|26103308|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0|||
13165773|NCT02377427|26103309|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0|||
13165774|NCT02377427|26103310|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0|||
13165775|NCT02377427|26103306|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
13165776|NCT02377427|26103307|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
13165777|NCT02377427|26103308|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1|||
13165778|NCT02377427|26103309|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
13165779|NCT02377427|26103310|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
13165780|NCT02377362|26103557|FG000|Part A Second Treatment|Protocol Violation|0|||
13165781|NCT02377362|26103558|FG001|Part A Second Treatment|Protocol Violation|0|||
13165782|NCT02377362|26103559|FG002|Part A Second Treatment|Protocol Violation|0|||
13165783|NCT02377362|26103560|FG003|Part A Second Treatment|Protocol Violation|0|||
13165784|NCT02377362|26103561|FG004|Part A Second Treatment|Protocol Violation|1|||
13165785|NCT02377362|26103562|FG005|Part A Second Treatment|Protocol Violation|0|||
13165786|NCT02377362|26103563|FG006|Part A Second Treatment|Protocol Violation|0|||
13107082|NCT03286218|25886271|FG009|Qualification Phase Period 1|Adverse Event|0|||
13107083|NCT03286218|25886272|FG010|Qualification Phase Period 1|Adverse Event|0|||
13107084|NCT03286218|25886273|FG011|Qualification Phase Period 1|Adverse Event|0|||
13165787|NCT02377362|26103564|FG007|Part A Second Treatment|Protocol Violation|0|||
13107085|NCT03286218|25886262|FG000|Qualification Phase Period 1|Withdrawal by Subject|0|||
13165788|NCT02377362|26103565|FG008|Part A Second Treatment|Protocol Violation|0|||
13165789|NCT02377362|26103566|FG009|Part A Second Treatment|Protocol Violation|0|||
13165790|NCT02377362|26103567|FG010|Part A Second Treatment|Protocol Violation|0|||
13165791|NCT02377362|26103568|FG011|Part A Second Treatment|Protocol Violation|0|||
13165792|NCT02377362|26103569|FG012|Part A Second Treatment|Protocol Violation|0|||
13165793|NCT02377362|26103557|FG000|Part A Third Treatment|Highest dose level 1200 not used|0|||
13165794|NCT02377362|26103558|FG001|Part A Third Treatment|Highest dose level 1200 not used|0|||
13165795|NCT02377362|26103559|FG002|Part A Third Treatment|Highest dose level 1200 not used|0|||
13165796|NCT02377362|26103560|FG003|Part A Third Treatment|Highest dose level 1200 not used|4|||
13165797|NCT02377362|26103561|FG004|Part A Third Treatment|Highest dose level 1200 not used|3|||
13165798|NCT02377362|26103562|FG005|Part A Third Treatment|Highest dose level 1200 not used|4|||
13165799|NCT02377362|26103563|FG006|Part A Third Treatment|Highest dose level 1200 not used|0|||
13165800|NCT02377362|26103564|FG007|Part A Third Treatment|Highest dose level 1200 not used|0|||
13165801|NCT02377362|26103565|FG008|Part A Third Treatment|Highest dose level 1200 not used|0|||
13165802|NCT02377362|26103566|FG009|Part A Third Treatment|Highest dose level 1200 not used|0|||
13165803|NCT02377362|26103567|FG010|Part A Third Treatment|Highest dose level 1200 not used|0|||
13165804|NCT02377362|26103568|FG011|Part A Third Treatment|Highest dose level 1200 not used|0|||
13165805|NCT02377362|26103569|FG012|Part A Third Treatment|Highest dose level 1200 not used|0|||
13165806|NCT02377362|26103557|FG000|Part B Overall|Protocol Violation|0|||
13165807|NCT02377362|26103558|FG001|Part B Overall|Protocol Violation|0|||
13165808|NCT02377362|26103559|FG002|Part B Overall|Protocol Violation|0|||
13165809|NCT02377362|26103560|FG003|Part B Overall|Protocol Violation|0|||
13165810|NCT02377362|26103561|FG004|Part B Overall|Protocol Violation|0|||
13165811|NCT02377362|26103562|FG005|Part B Overall|Protocol Violation|0|||
13165812|NCT02377362|26103563|FG006|Part B Overall|Protocol Violation|0|||
13165813|NCT02377362|26103564|FG007|Part B Overall|Protocol Violation|0|||
13165814|NCT02377362|26103565|FG008|Part B Overall|Protocol Violation|0|||
13165815|NCT02377362|26103566|FG009|Part B Overall|Protocol Violation|1|||
13165816|NCT02377362|26103567|FG010|Part B Overall|Protocol Violation|0|||
13165817|NCT02377362|26103568|FG011|Part B Overall|Protocol Violation|0|||
13165818|NCT02377362|26103569|FG012|Part B Overall|Protocol Violation|0|||
13165819|NCT02377362|26103557|FG000|Part B Overall|Adverse Event|0|||
13165820|NCT02377362|26103558|FG001|Part B Overall|Adverse Event|0|||
13165821|NCT02377362|26103559|FG002|Part B Overall|Adverse Event|0|||
13165822|NCT02377362|26103560|FG003|Part B Overall|Adverse Event|0|||
13165823|NCT02377362|26103561|FG004|Part B Overall|Adverse Event|0|||
13165824|NCT02377362|26103562|FG005|Part B Overall|Adverse Event|0|||
13165825|NCT02377362|26103563|FG006|Part B Overall|Adverse Event|1|||
13165826|NCT02377362|26103564|FG007|Part B Overall|Adverse Event|1|||
13165827|NCT02377362|26103565|FG008|Part B Overall|Adverse Event|0|||
13165828|NCT02377362|26103566|FG009|Part B Overall|Adverse Event|0|||
13165829|NCT02377362|26103567|FG010|Part B Overall|Adverse Event|0|||
13165830|NCT02377362|26103568|FG011|Part B Overall|Adverse Event|0|||
13165831|NCT02377362|26103569|FG012|Part B Overall|Adverse Event|0|||
13165832|NCT02377362|26103557|FG000|Part B Overall|Withdrawal by Subject|0|||
13165833|NCT02377362|26103558|FG001|Part B Overall|Withdrawal by Subject|0|||
13165834|NCT02377362|26103559|FG002|Part B Overall|Withdrawal by Subject|0|||
13165835|NCT02377362|26103560|FG003|Part B Overall|Withdrawal by Subject|0|||
13165836|NCT02377362|26103561|FG004|Part B Overall|Withdrawal by Subject|0|||
13165837|NCT02377362|26103562|FG005|Part B Overall|Withdrawal by Subject|0|||
13165838|NCT02377362|26103563|FG006|Part B Overall|Withdrawal by Subject|1|||
13165839|NCT02377362|26103564|FG007|Part B Overall|Withdrawal by Subject|0|||
13165840|NCT02377362|26103565|FG008|Part B Overall|Withdrawal by Subject|0|||
13165841|NCT02377362|26103566|FG009|Part B Overall|Withdrawal by Subject|0|||
13165842|NCT02377362|26103567|FG010|Part B Overall|Withdrawal by Subject|0|||
13165843|NCT02377362|26103568|FG011|Part B Overall|Withdrawal by Subject|1|||
13165844|NCT02377362|26103569|FG012|Part B Overall|Withdrawal by Subject|0|||
13165845|NCT02377349|26103614|FG000|Overall Study|Serious Adverse Event|1|||
13165846|NCT02377349|26103615|FG001|Overall Study|Serious Adverse Event|0|||
13165847|NCT02377349|26103614|FG000|Overall Study|Protocol Violation|3|||
13165848|NCT02377349|26103615|FG001|Overall Study|Protocol Violation|2|||
13165849|NCT02377349|26103614|FG000|Overall Study|Withdrawal by Subject|5|||
13165850|NCT02377349|26103615|FG001|Overall Study|Withdrawal by Subject|3|||
13165851|NCT02377349|26103614|FG000|Overall Study|Lost to follow-up (partial vaccination)|1|||
13165852|NCT02377349|26103615|FG001|Overall Study|Lost to follow-up (partial vaccination)|0|||
13165853|NCT02377349|26103614|FG000|Overall Study|Lost to follow-up (complete vaccination)|6|||
13165854|NCT02377349|26103615|FG001|Overall Study|Lost to follow-up (complete vaccination)|5|||
13165855|NCT02377349|26103614|FG000|Overall Study|Other|0|||
13165856|NCT02377349|26103615|FG001|Overall Study|Other|1|||
13165857|NCT02377063|26103621|FG000|Overall Study|Non-compliance|5|||
13165858|NCT02376790|26103747|FG000|Overall Study|Withdrawal by Subject|43|||
13165859|NCT02376790|26103748|FG001|Overall Study|Withdrawal by Subject|36|||
13165860|NCT02376790|26103749|FG002|Overall Study|Withdrawal by Subject|37|||
13222894|NCT01802333|26287139|FG001|Overall Study|Withdrawal by Subject|6|||
13165861|NCT02376790|26103747|FG000|Overall Study|Decision by Sponsor|2|||
13165862|NCT02376790|26103748|FG001|Overall Study|Decision by Sponsor|1|||
13165863|NCT02376790|26103749|FG002|Overall Study|Decision by Sponsor|4|||
13165864|NCT02376790|26103747|FG000|Overall Study|Lost to Follow-up|15|||
13107086|NCT03286218|25886263|FG001|Qualification Phase Period 1|Withdrawal by Subject|1|||
13165865|NCT02376790|26103748|FG001|Overall Study|Lost to Follow-up|10|||
13165866|NCT02376790|26103749|FG002|Overall Study|Lost to Follow-up|12|||
13165867|NCT02376166|26103776|FG000|Overall Study|Adverse Event|1|||
13165868|NCT02376166|26103776|FG000|Overall Study|Discontinued metformin early|2|||
13165869|NCT02375971|26103826|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
13165870|NCT02375971|26103827|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
13165871|NCT02375971|26103828|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2|||
13165872|NCT02375971|26103826|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1|||
13165873|NCT02375971|26103827|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1|||
13165874|NCT02375971|26103828|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1|||
13165875|NCT02375971|26103826|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
13165876|NCT02375971|26103827|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
13165877|NCT02375971|26103828|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1|||
13165878|NCT02375971|26103826|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0|||
13165879|NCT02375971|26103827|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0|||
13165880|NCT02375971|26103828|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1|||
13165881|NCT02375971|26103826|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1|||
13165882|NCT02375971|26103827|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
13165883|NCT02375971|26103828|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
13165884|NCT02375971|26103826|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
13165885|NCT02375971|26103827|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0|||
13165886|NCT02375971|26103828|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
13165887|NCT02375971|26103826|FG000|Follow-Up Phase (up to Day 169)|Death|4|||
13165888|NCT02375971|26103827|FG001|Follow-Up Phase (up to Day 169)|Death|4|||
13165889|NCT02375971|26103828|FG002|Follow-Up Phase (up to Day 169)|Death|4|||
13165890|NCT02375971|26103826|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
13165891|NCT02375971|26103827|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
13165892|NCT02375971|26103828|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0|||
13165893|NCT02375724|26103845|FG000|Overall Study|Lack of Efficacy|1|||
13165894|NCT02375724|26103846|FG001|Overall Study|Lack of Efficacy|1|||
13165895|NCT02375724|26103845|FG000|Overall Study|Withdrawal by Subject|1|||
13165896|NCT02375724|26103846|FG001|Overall Study|Withdrawal by Subject|1|||
13165897|NCT02375724|26103845|FG000|Overall Study|Lost to Follow-up|1|||
13165898|NCT02375724|26103846|FG001|Overall Study|Lost to Follow-up|0|||
13165899|NCT02375724|26103845|FG000|Overall Study|Protocol Violation|1|||
13165900|NCT02375724|26103846|FG001|Overall Study|Protocol Violation|0|||
13165901|NCT02375724|26103845|FG000|Overall Study|Adverse Event|2|||
13165902|NCT02375724|26103846|FG001|Overall Study|Adverse Event|4|||
13165903|NCT02375698|26103861|FG000|Overall Study|Withdrawal by Subject|0|||
13165904|NCT02375698|26103862|FG001|Overall Study|Withdrawal by Subject|2|||
13165905|NCT02375698|26103861|FG000|Overall Study|Physician Decision|2|||
13165906|NCT02375698|26103862|FG001|Overall Study|Physician Decision|0|||
13165907|NCT02375672|26103872|FG000|Overall Study|remain on follow up|20|||
13165908|NCT02375373|26103878|FG000|Overall Study|Withdrawal by Subject|11|||
13165909|NCT02375347|26103884|FG000|Overall Study|Protocol Violation|1|||
13165910|NCT02374957|26103917|FG000|Overall Study|Patient did not complete forms correctly|1|||
13165911|NCT02374957|26103918|FG001|Overall Study|Patient did not complete forms correctly|0|||
13165912|NCT02374918|26103957|FG000|Overall Study|Protocol Violation|2|||
13165913|NCT02374918|26103958|FG001|Overall Study|Protocol Violation|0|||
13165914|NCT02374918|26103959|FG002|Overall Study|Protocol Violation|2|||
13165915|NCT02374918|26103960|FG003|Overall Study|Protocol Violation|1|||
13165916|NCT02374918|26103957|FG000|Overall Study|Withdrawal by Subject|1|||
13165917|NCT02374918|26103958|FG001|Overall Study|Withdrawal by Subject|1|||
13165918|NCT02374918|26103959|FG002|Overall Study|Withdrawal by Subject|1|||
13165919|NCT02374918|26103960|FG003|Overall Study|Withdrawal by Subject|0|||
13107087|NCT03286218|25886264|FG002|Qualification Phase Period 1|Withdrawal by Subject|0|||
13107088|NCT03286218|25886265|FG003|Qualification Phase Period 1|Withdrawal by Subject|0|||
13107089|NCT03286218|25886266|FG004|Qualification Phase Period 1|Withdrawal by Subject|0|||
13107090|NCT03286218|25886267|FG005|Qualification Phase Period 1|Withdrawal by Subject|0|||
13107091|NCT03286218|25886268|FG006|Qualification Phase Period 1|Withdrawal by Subject|0|||
13107092|NCT03286218|25886269|FG007|Qualification Phase Period 1|Withdrawal by Subject|0|||
13107093|NCT03286218|25886270|FG008|Qualification Phase Period 1|Withdrawal by Subject|0|||
13107094|NCT03286218|25886271|FG009|Qualification Phase Period 1|Withdrawal by Subject|0|||
13107095|NCT03286218|25886272|FG010|Qualification Phase Period 1|Withdrawal by Subject|0|||
13165920|NCT02374918|26103957|FG000|Overall Study|Lack of Efficacy|0|||
13165921|NCT02374918|26103958|FG001|Overall Study|Lack of Efficacy|0|||
13165922|NCT02374918|26103959|FG002|Overall Study|Lack of Efficacy|1|||
13165923|NCT02374918|26103960|FG003|Overall Study|Lack of Efficacy|1|||
13165924|NCT02374853|26103983|FG000|Overall Study|Surgery Cancelled|5|||
13165925|NCT02374853|26103984|FG001|Overall Study|Surgery Cancelled|11|||
13165926|NCT02374671|26104000|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
13165927|NCT02374671|26104001|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
13165928|NCT02374671|26104002|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4|||
13165929|NCT02374671|26104000|FG000|Observation (Deferred Implantation)|Adverse Event|0|||
13165930|NCT02374671|26104001|FG001|Observation (Deferred Implantation)|Adverse Event|0|||
13165931|NCT02374671|26104002|FG002|Observation (Deferred Implantation)|Adverse Event|1|||
13165932|NCT02374671|26104000|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17|||
13165933|NCT02374671|26104001|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
13165934|NCT02374671|26104002|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2|||
13165935|NCT02374671|26104000|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7|||
13165936|NCT02374671|26104001|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0|||
13165937|NCT02374671|26104002|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1|||
13165938|NCT02374671|26104000|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
13165939|NCT02374671|26104001|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
13165940|NCT02374671|26104002|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
13165941|NCT02374593|26104019|FG000|Overall Study|non-compliant|2|||
13165942|NCT02374593|26104020|FG001|Overall Study|non-compliant|0|||
13165943|NCT02374463|26104043|FG000|Overall Study|Withdrawal by Subject|3|||
13165944|NCT02374463|26104044|FG001|Overall Study|Withdrawal by Subject|3|||
13165945|NCT02374346|26104052|FG000|Overall Study|operated or discharged during weekend|48|||
13165946|NCT02374307|26104086|FG000|3-months Follow-up|Lost to Follow-up|1|||
13165947|NCT02374307|26104087|FG001|3-months Follow-up|Lost to Follow-up|2|||
13165948|NCT02374307|26104086|FG000|3-months Follow-up|Withdrawal by Subject|1|||
13165949|NCT02374307|26104087|FG001|3-months Follow-up|Withdrawal by Subject|4|||
13165950|NCT02374307|26104086|FG000|3-months Follow-up|Death|1|||
13165951|NCT02374307|26104087|FG001|3-months Follow-up|Death|2|||
13165952|NCT02374307|26104086|FG000|3-months Follow-up|Missed first follow-up|5|||
13165953|NCT02374307|26104087|FG001|3-months Follow-up|Missed first follow-up|1|||
13165954|NCT02374307|26104086|FG000|6-months Follow-up|Lost to Follow-up|1|||
13165955|NCT02374307|26104087|FG001|6-months Follow-up|Lost to Follow-up|2|||
13165956|NCT02374307|26104086|FG000|6-months Follow-up|Death|2|||
13165957|NCT02374307|26104087|FG001|6-months Follow-up|Death|1|||
13165958|NCT02374307|26104086|FG000|6-months Follow-up|Withdrawal by Subject|0|||
13165959|NCT02374307|26104087|FG001|6-months Follow-up|Withdrawal by Subject|3|||
13165960|NCT02374255|26104118|FG000|Overall Study|Withdrawal by Subject|2|||
13165961|NCT02374255|26104119|FG001|Overall Study|Withdrawal by Subject|0|||
13165962|NCT02374255|26104120|FG002|Overall Study|Withdrawal by Subject|0|||
13165963|NCT02374255|26104121|FG003|Overall Study|Withdrawal by Subject|0|||
13165964|NCT02374099|26104144|FG000|Overall Study|Adverse Event|1|||
13165965|NCT02374099|26104145|FG001|Overall Study|Adverse Event|0|||
13165966|NCT02374099|26104144|FG000|Overall Study|Progressive Disease|35|||
13165967|NCT02374099|26104145|FG001|Overall Study|Progressive Disease|40|||
13165968|NCT02374099|26104144|FG000|Overall Study|Withdrawal by Subject|5|||
13165969|NCT02374099|26104145|FG001|Overall Study|Withdrawal by Subject|1|||
13165970|NCT02374099|26104144|FG000|Overall Study|Miscellaneous|2|||
13165971|NCT02374099|26104145|FG001|Overall Study|Miscellaneous|3|||
13165972|NCT02374099|26104144|FG000|Overall Study|Randomized, but not treated|2|||
13165973|NCT02374099|26104145|FG001|Overall Study|Randomized, but not treated|1|||
13165974|NCT02374099|26104144|FG000|Overall Study|Study Terminated by Sponsor|3|||
13165975|NCT02374099|26104145|FG001|Overall Study|Study Terminated by Sponsor|4|||
13165976|NCT02374021|26104166|FG000|Overall Study|Adverse Event|1|||
13165977|NCT02374021|26104167|FG001|Overall Study|Adverse Event|0|||
13165978|NCT02374021|26104166|FG000|Overall Study|Lost to Follow-up|3|||
13165979|NCT02374021|26104167|FG001|Overall Study|Lost to Follow-up|2|||
13165980|NCT02374021|26104166|FG000|Overall Study|Physician Decision|0|||
13165981|NCT02374021|26104167|FG001|Overall Study|Physician Decision|3|||
13165982|NCT02374021|26104166|FG000|Overall Study|Withdrawal by Subject|6|||
13165983|NCT02374021|26104167|FG001|Overall Study|Withdrawal by Subject|5|||
13165984|NCT02374021|26104166|FG000|Overall Study|Poor Adherence|0|||
13165985|NCT02374021|26104167|FG001|Overall Study|Poor Adherence|1|||
13165986|NCT02374021|26104166|FG000|Overall Study|Scan protocol not followed|0|||
13165987|NCT02374021|26104167|FG001|Overall Study|Scan protocol not followed|1|||
13165988|NCT02374021|26104166|FG000|Overall Study|Poor quality scan/scan not able to be analyzed|13|||
13165989|NCT02374021|26104167|FG001|Overall Study|Poor quality scan/scan not able to be analyzed|9|||
13165990|NCT02373202|26104230|FG000|Overall Study|Adverse Event|2|||
13165991|NCT02373202|26104231|FG001|Overall Study|Adverse Event|5|||
13165992|NCT02373202|26104232|FG002|Overall Study|Adverse Event|2|||
13165993|NCT02373202|26104233|FG003|Overall Study|Adverse Event|1|||
13165994|NCT02373202|26104230|FG000|Overall Study|Lack of Efficacy|0|||
13165995|NCT02373202|26104231|FG001|Overall Study|Lack of Efficacy|0|||
13165996|NCT02373202|26104232|FG002|Overall Study|Lack of Efficacy|1|||
13165997|NCT02373202|26104233|FG003|Overall Study|Lack of Efficacy|0|||
13165998|NCT02373202|26104230|FG000|Overall Study|Other|0|||
13165999|NCT02373202|26104231|FG001|Overall Study|Other|1|||
13166000|NCT02373202|26104232|FG002|Overall Study|Other|0|||
13166001|NCT02373202|26104233|FG003|Overall Study|Other|0|||
13166002|NCT02373098|26104265|FG000|Overall Study|Lost to Follow-up|1|||
13166003|NCT02373098|26104266|FG001|Overall Study|Lost to Follow-up|0|||
13166004|NCT02373098|26104265|FG000|Overall Study|Protocol Violation|3|||
13166005|NCT02373098|26104266|FG001|Overall Study|Protocol Violation|0|||
13166006|NCT02373098|26104265|FG000|Overall Study|Withdrawal by Subject|5|||
13166007|NCT02373098|26104266|FG001|Overall Study|Withdrawal by Subject|0|||
13166008|NCT02373098|26104265|FG000|Overall Study|Adverse Event|3|||
13166009|NCT02373098|26104266|FG001|Overall Study|Adverse Event|0|||
13166010|NCT02372799|26104287|FG000|Treatment Period|Adverse Event|3|||
13166011|NCT02372799|26104288|FG001|Treatment Period|Adverse Event|10|||
13166012|NCT02372799|26104289|FG002|Treatment Period|Adverse Event|6|||
13166013|NCT02372799|26104287|FG000|Treatment Period|Insufficient therapeutic response|2|||
13166014|NCT02372799|26104288|FG001|Treatment Period|Insufficient therapeutic response|2|||
13166015|NCT02372799|26104289|FG002|Treatment Period|Insufficient therapeutic response|0|||
13166016|NCT02372799|26104287|FG000|Treatment Period|Withdrawal by Subject|10|||
13166017|NCT02372799|26104288|FG001|Treatment Period|Withdrawal by Subject|10|||
13166018|NCT02372799|26104289|FG002|Treatment Period|Withdrawal by Subject|2|||
13166019|NCT02372799|26104287|FG000|Treatment Period|Lost to Follow-up|11|||
13166020|NCT02372799|26104288|FG001|Treatment Period|Lost to Follow-up|5|||
13166021|NCT02372799|26104289|FG002|Treatment Period|Lost to Follow-up|3|||
13166022|NCT02372799|26104287|FG000|Treatment Period|Protocol Violation|3|||
13166023|NCT02372799|26104288|FG001|Treatment Period|Protocol Violation|0|||
13166024|NCT02372799|26104289|FG002|Treatment Period|Protocol Violation|0|||
13166025|NCT02372799|26104287|FG000|Treatment Period|Non-compliance with study drug|4|||
13166026|NCT02372799|26104288|FG001|Treatment Period|Non-compliance with study drug|4|||
13166027|NCT02372799|26104289|FG002|Treatment Period|Non-compliance with study drug|4|||
13166028|NCT02372799|26104287|FG000|Treatment Period|Miscellaneous Reasons|1|||
13166029|NCT02372799|26104288|FG001|Treatment Period|Miscellaneous Reasons|1|||
13166030|NCT02372799|26104289|FG002|Treatment Period|Miscellaneous Reasons|0|||
13166031|NCT02372799|26104287|FG000|Down-taper Period|Lost to Follow-up|1|||
13166032|NCT02372799|26104288|FG001|Down-taper Period|Lost to Follow-up|2|||
13166033|NCT02372799|26104289|FG002|Down-taper Period|Lost to Follow-up|2|||
13166034|NCT02372396|26104302|FG000|Overall Study|Lost to Follow-up|7|||
13166035|NCT02372396|26104303|FG001|Overall Study|Lost to Follow-up|9|||
13166036|NCT02372383|26104346|FG000|First Intervention (1 Day)|Unable to collect blood|0|||
13166037|NCT02372383|26104347|FG001|First Intervention (1 Day)|Unable to collect blood|1|||
13166038|NCT02372383|26104348|FG002|First Intervention (1 Day)|Unable to collect blood|0|||
13166039|NCT02372253|26104371|FG000|Overall Study|Non Compliance|2|||
13166040|NCT02372253|26104372|FG001|Overall Study|Non Compliance|0|||
13166041|NCT02372071|26104379|FG000|Overall Study|Protocol Violation|18|||
13166042|NCT02372058|26104387|FG000|Overall Study|Withdrawal by Subject|3|||
13166043|NCT02372006|26104429|FG000|Overall Study|Progressive disease|8|||
13166044|NCT02372006|26104430|FG001|Overall Study|Progressive disease|7|||
13166045|NCT02372006|26104431|FG002|Overall Study|Progressive disease|34|||
13166046|NCT02372006|26104429|FG000|Overall Study|Dose limiting toxicity|0|||
13166047|NCT02372006|26104430|FG001|Overall Study|Dose limiting toxicity|1|||
13166048|NCT02372006|26104431|FG002|Overall Study|Dose limiting toxicity|0|||
13166049|NCT02372006|26104429|FG000|Overall Study|Adverse Event|0|||
13166050|NCT02372006|26104430|FG001|Overall Study|Adverse Event|0|||
13166051|NCT02372006|26104431|FG002|Overall Study|Adverse Event|3|||
13166052|NCT02372006|26104429|FG000|Overall Study|Withdrawal by Subject|0|||
13166053|NCT02372006|26104430|FG001|Overall Study|Withdrawal by Subject|1|||
13166054|NCT02372006|26104431|FG002|Overall Study|Withdrawal by Subject|1|||
13166055|NCT02372006|26104429|FG000|Overall Study|Other reason for not completing|0|||
13166056|NCT02372006|26104430|FG001|Overall Study|Other reason for not completing|0|||
13166057|NCT02372006|26104431|FG002|Overall Study|Other reason for not completing|1|||
13166058|NCT02371980|26104464|FG000|Open-label Period|Pretreatment Event/Adverse Event|63|||
13166059|NCT02371980|26104465|FG001|Open-label Period|Pretreatment Event/Adverse Event|0|||
13166060|NCT02371980|26104466|FG002|Open-label Period|Pretreatment Event/Adverse Event|0|||
13166061|NCT02371980|26104467|FG003|Open-label Period|Pretreatment Event/Adverse Event|0|||
13166062|NCT02371980|26104468|FG004|Open-label Period|Pretreatment Event/Adverse Event|0|||
13166063|NCT02371980|26104464|FG000|Open-label Period|Significant Protocol Deviation|19|||
13166064|NCT02371980|26104465|FG001|Open-label Period|Significant Protocol Deviation|0|||
13166065|NCT02371980|26104466|FG002|Open-label Period|Significant Protocol Deviation|0|||
13166066|NCT02371980|26104467|FG003|Open-label Period|Significant Protocol Deviation|0|||
13166067|NCT02371980|26104468|FG004|Open-label Period|Significant Protocol Deviation|0|||
13166068|NCT02371980|26104464|FG000|Open-label Period|Noncompliance with Study Drug|10|||
13166069|NCT02371980|26104465|FG001|Open-label Period|Noncompliance with Study Drug|0|||
13166070|NCT02371980|26104466|FG002|Open-label Period|Noncompliance with Study Drug|0|||
13166071|NCT02371980|26104467|FG003|Open-label Period|Noncompliance with Study Drug|0|||
13166072|NCT02371980|26104468|FG004|Open-label Period|Noncompliance with Study Drug|0|||
13166073|NCT02371980|26104464|FG000|Open-label Period|Lost to Follow-up|55|||
13166074|NCT02371980|26104465|FG001|Open-label Period|Lost to Follow-up|0|||
13166075|NCT02371980|26104466|FG002|Open-label Period|Lost to Follow-up|0|||
13166076|NCT02371980|26104467|FG003|Open-label Period|Lost to Follow-up|0|||
13166077|NCT02371980|26104468|FG004|Open-label Period|Lost to Follow-up|0|||
13166078|NCT02371980|26104464|FG000|Open-label Period|Voluntary Withdrawal|91|||
13166079|NCT02371980|26104465|FG001|Open-label Period|Voluntary Withdrawal|0|||
13166080|NCT02371980|26104466|FG002|Open-label Period|Voluntary Withdrawal|0|||
13166081|NCT02371980|26104467|FG003|Open-label Period|Voluntary Withdrawal|0|||
13166082|NCT02371980|26104468|FG004|Open-label Period|Voluntary Withdrawal|0|||
13166083|NCT02371980|26104464|FG000|Open-label Period|Pregnancy|1|||
13166084|NCT02371980|26104465|FG001|Open-label Period|Pregnancy|0|||
13166085|NCT02371980|26104466|FG002|Open-label Period|Pregnancy|0|||
13166086|NCT02371980|26104467|FG003|Open-label Period|Pregnancy|0|||
13166087|NCT02371980|26104468|FG004|Open-label Period|Pregnancy|0|||
13166088|NCT02371980|26104464|FG000|Open-label Period|Lack of Efficacy|116|||
13166089|NCT02371980|26104465|FG001|Open-label Period|Lack of Efficacy|0|||
13166090|NCT02371980|26104466|FG002|Open-label Period|Lack of Efficacy|0|||
13166091|NCT02371980|26104467|FG003|Open-label Period|Lack of Efficacy|0|||
13166092|NCT02371980|26104468|FG004|Open-label Period|Lack of Efficacy|0|||
13166093|NCT02371980|26104464|FG000|Open-label Period|Did not Meet Randomization Criteria|162|||
13166094|NCT02371980|26104465|FG001|Open-label Period|Did not Meet Randomization Criteria|0|||
13166095|NCT02371980|26104466|FG002|Open-label Period|Did not Meet Randomization Criteria|0|||
13166096|NCT02371980|26104467|FG003|Open-label Period|Did not Meet Randomization Criteria|0|||
13166097|NCT02371980|26104468|FG004|Open-label Period|Did not Meet Randomization Criteria|0|||
13166098|NCT02371980|26104464|FG000|Open-label Period|Reason not Specified|9|||
13166099|NCT02371980|26104465|FG001|Open-label Period|Reason not Specified|0|||
13166100|NCT02371980|26104466|FG002|Open-label Period|Reason not Specified|0|||
13166101|NCT02371980|26104467|FG003|Open-label Period|Reason not Specified|0|||
13166102|NCT02371980|26104468|FG004|Open-label Period|Reason not Specified|0|||
13166103|NCT02371980|26104464|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0|||
13166104|NCT02371980|26104465|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4|||
13166105|NCT02371980|26104466|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3|||
13166106|NCT02371980|26104467|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2|||
13166107|NCT02371980|26104468|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9|||
13166108|NCT02371980|26104464|FG000|Double-blind Period|Significant Protocol Deviation|0|||
13166109|NCT02371980|26104465|FG001|Double-blind Period|Significant Protocol Deviation|2|||
13166110|NCT02371980|26104466|FG002|Double-blind Period|Significant Protocol Deviation|7|||
13166111|NCT02371980|26104467|FG003|Double-blind Period|Significant Protocol Deviation|3|||
13166112|NCT02371980|26104468|FG004|Double-blind Period|Significant Protocol Deviation|3|||
13166113|NCT02371980|26104464|FG000|Double-blind Period|Noncompliance with Study Drug|0|||
13166114|NCT02371980|26104465|FG001|Double-blind Period|Noncompliance with Study Drug|1|||
13166115|NCT02371980|26104466|FG002|Double-blind Period|Noncompliance with Study Drug|2|||
13166116|NCT02371980|26104467|FG003|Double-blind Period|Noncompliance with Study Drug|2|||
13166117|NCT02371980|26104468|FG004|Double-blind Period|Noncompliance with Study Drug|3|||
13166118|NCT02371980|26104464|FG000|Double-blind Period|Lost to Follow-up|0|||
13166119|NCT02371980|26104465|FG001|Double-blind Period|Lost to Follow-up|8|||
13166120|NCT02371980|26104466|FG002|Double-blind Period|Lost to Follow-up|8|||
13166121|NCT02371980|26104467|FG003|Double-blind Period|Lost to Follow-up|6|||
13166122|NCT02371980|26104468|FG004|Double-blind Period|Lost to Follow-up|5|||
13166123|NCT02371980|26104464|FG000|Double-blind Period|Voluntary Withdrawal|0|||
13166124|NCT02371980|26104465|FG001|Double-blind Period|Voluntary Withdrawal|12|||
13166125|NCT02371980|26104466|FG002|Double-blind Period|Voluntary Withdrawal|8|||
13166126|NCT02371980|26104467|FG003|Double-blind Period|Voluntary Withdrawal|9|||
13166127|NCT02371980|26104468|FG004|Double-blind Period|Voluntary Withdrawal|11|||
13166128|NCT02371980|26104464|FG000|Double-blind Period|Relapse|0|||
13222895|NCT01802333|26287140|FG002|Overall Study|Withdrawal by Subject|5|||
13166129|NCT02371980|26104465|FG001|Double-blind Period|Relapse|50|||
13166130|NCT02371980|26104466|FG002|Double-blind Period|Relapse|25|||
13166131|NCT02371980|26104467|FG003|Double-blind Period|Relapse|25|||
13166132|NCT02371980|26104468|FG004|Double-blind Period|Relapse|26|||
13166133|NCT02371980|26104464|FG000|Double-blind Period|Reason not Specified|0|||
13166134|NCT02371980|26104465|FG001|Double-blind Period|Reason not Specified|3|||
13166135|NCT02371980|26104466|FG002|Double-blind Period|Reason not Specified|3|||
13166136|NCT02371980|26104467|FG003|Double-blind Period|Reason not Specified|2|||
13166137|NCT02371980|26104468|FG004|Double-blind Period|Reason not Specified|1|||
13166138|NCT02371980|26104464|FG000|Double-blind Period|Missing|0|||
13166139|NCT02371980|26104465|FG001|Double-blind Period|Missing|1|||
13166140|NCT02371980|26104466|FG002|Double-blind Period|Missing|0|||
13166141|NCT02371980|26104467|FG003|Double-blind Period|Missing|0|||
13166142|NCT02371980|26104468|FG004|Double-blind Period|Missing|0|||
13166143|NCT02371759|26104703|FG000|Overall Study|Protocol Violation|3|||
13222896|NCT01802333|26287138|FG000|Overall Study|Progression/relapse|1|||
13166144|NCT02371759|26104704|FG001|Overall Study|Protocol Violation|1|||
13166145|NCT02371759|26104705|FG002|Overall Study|Protocol Violation|1|||
13166146|NCT02371759|26104706|FG003|Overall Study|Protocol Violation|0|||
13166147|NCT02371759|26104707|FG004|Overall Study|Protocol Violation|3|||
13166148|NCT02371759|26104708|FG005|Overall Study|Protocol Violation|1|||
13166149|NCT02371759|26104709|FG006|Overall Study|Protocol Violation|0|||
13166150|NCT02371759|26104710|FG007|Overall Study|Protocol Violation|3|||
13166151|NCT02371759|26104703|FG000|Overall Study|Withdrawal by Subject|0|||
13166152|NCT02371759|26104704|FG001|Overall Study|Withdrawal by Subject|0|||
13166153|NCT02371759|26104705|FG002|Overall Study|Withdrawal by Subject|0|||
13166154|NCT02371759|26104706|FG003|Overall Study|Withdrawal by Subject|0|||
13166155|NCT02371759|26104707|FG004|Overall Study|Withdrawal by Subject|0|||
13166156|NCT02371759|26104708|FG005|Overall Study|Withdrawal by Subject|0|||
13166157|NCT02371759|26104709|FG006|Overall Study|Withdrawal by Subject|0|||
13166158|NCT02371759|26104710|FG007|Overall Study|Withdrawal by Subject|1|||
13166159|NCT02371746|26104748|FG000|Overall Study|Consent withdrawn|0|||
13166160|NCT02371746|26104749|FG001|Overall Study|Consent withdrawn|0|||
13166161|NCT02371746|26104750|FG002|Overall Study|Consent withdrawn|0|||
13166162|NCT02371746|26104751|FG003|Overall Study|Consent withdrawn|0|||
13166163|NCT02371746|26104752|FG004|Overall Study|Consent withdrawn|0|||
13166164|NCT02371746|26104753|FG005|Overall Study|Consent withdrawn|0|||
13166165|NCT02371746|26104754|FG006|Overall Study|Consent withdrawn|1|||
13166166|NCT02371629|26104795|FG000|Overall Study|Patient decision|14|||
13166167|NCT02371629|26104796|FG001|Overall Study|Patient decision|10|||
13166168|NCT02371629|26104795|FG000|Overall Study|Adverse Event|8|||
13166169|NCT02371629|26104796|FG001|Overall Study|Adverse Event|8|||
13166170|NCT02371629|26104795|FG000|Overall Study|Physician Decision|2|||
13166171|NCT02371629|26104796|FG001|Overall Study|Physician Decision|3|||
13166172|NCT02371629|26104795|FG000|Overall Study|Death|1|||
13166173|NCT02371629|26104796|FG001|Overall Study|Death|1|||
13166174|NCT02371629|26104795|FG000|Overall Study|Noncompliance with study treatment|1|||
13166175|NCT02371629|26104796|FG001|Overall Study|Noncompliance with study treatment|0|||
13166176|NCT02371629|26104795|FG000|Overall Study|Lack of Efficacy|0|||
13166177|NCT02371629|26104796|FG001|Overall Study|Lack of Efficacy|2|||
13166178|NCT02371629|26104795|FG000|Overall Study|Protocol deviation|0|||
13166179|NCT02371629|26104796|FG001|Overall Study|Protocol deviation|1|||
13166180|NCT02371616|26104815|FG000|Overall Study|Protocol Violation|2|||
13166181|NCT02371616|26104816|FG001|Overall Study|Protocol Violation|1|||
13166182|NCT02371616|26104815|FG000|Overall Study|Adverse Event|0|||
13166183|NCT02371616|26104816|FG001|Overall Study|Adverse Event|1|||
13166184|NCT02371616|26104815|FG000|Overall Study|Withdrawal of Consent|1|||
13166185|NCT02371616|26104816|FG001|Overall Study|Withdrawal of Consent|0|||
13166186|NCT02371616|26104815|FG000|Overall Study|Other (Not specified)|1|||
13166187|NCT02371616|26104816|FG001|Overall Study|Other (Not specified)|5|||
13166188|NCT02371369|26104875|FG000|Part 1|Physician Decision|0|||
13166189|NCT02371369|26104876|FG001|Part 1|Physician Decision|3|||
13166190|NCT02371369|26104875|FG000|Part 1|Adverse Event|8|||
13166191|NCT02371369|26104876|FG001|Part 1|Adverse Event|0|||
13166192|NCT02371369|26104875|FG000|Part 1|Withdrawal by Subject|1|||
13166193|NCT02371369|26104876|FG001|Part 1|Withdrawal by Subject|6|||
13166194|NCT02371369|26104875|FG000|Part 1|Disease progression|0|||
13166195|NCT02371369|26104876|FG001|Part 1|Disease progression|1|||
13166196|NCT02371369|26104875|FG000|Part 1|Protocol Violation|0|||
13166197|NCT02371369|26104876|FG001|Part 1|Protocol Violation|1|||
13166198|NCT02371369|26104875|FG000|Part 2|Adverse Event|6|||
13222897|NCT01802333|26287139|FG001|Overall Study|Progression/relapse|3|||
13222898|NCT01802333|26287140|FG002|Overall Study|Progression/relapse|0|||
13222899|NCT01802333|26287138|FG000|Overall Study|Death|7|||
13222900|NCT01802333|26287139|FG001|Overall Study|Death|14|||
13222901|NCT01802333|26287140|FG002|Overall Study|Death|13|||
13222902|NCT01802333|26287138|FG000|Overall Study|Other - not protocol specified|32|||
13222903|NCT01802333|26287139|FG001|Overall Study|Other - not protocol specified|22|||
13222904|NCT01802333|26287140|FG002|Overall Study|Other - not protocol specified|24|||
13222905|NCT01802333|26287138|FG000|Overall Study|Did not start treatment|0|||
13222906|NCT01802333|26287139|FG001|Overall Study|Did not start treatment|2|||
13222907|NCT01802333|26287140|FG002|Overall Study|Did not start treatment|5|||
13166199|NCT02371369|26104876|FG001|Part 2|Adverse Event|5|||
13166200|NCT02371369|26104875|FG000|Part 2|Withdrawal by Subject|16|||
13166201|NCT02371369|26104876|FG001|Part 2|Withdrawal by Subject|6|||
13166202|NCT02371369|26104875|FG000|Part 2|Investigator decision|1|||
13166203|NCT02371369|26104876|FG001|Part 2|Investigator decision|2|||
13166204|NCT02371369|26104875|FG000|Part 2|Death|0|||
13166205|NCT02371369|26104876|FG001|Part 2|Death|1|||
13166206|NCT02371369|26104875|FG000|Part 2|Disease progression|1|||
13166207|NCT02371369|26104876|FG001|Part 2|Disease progression|0|||
13166208|NCT02371369|26104875|FG000|Part 2|Subject Noncompliance|1|||
13166209|NCT02371369|26104876|FG001|Part 2|Subject Noncompliance|0|||
13166210|NCT02371369|26104875|FG000|Part 2|Lost to Follow-up|1|||
13166211|NCT02371369|26104876|FG001|Part 2|Lost to Follow-up|1|||
13166212|NCT02371369|26104875|FG000|Part 2|Subject transitioned to commercial supply|6|||
13166213|NCT02371369|26104876|FG001|Part 2|Subject transitioned to commercial supply|4|||
13166214|NCT02371369|26104875|FG000|Part 2|Subject transitioned to another DS pexidartinib protocol|15|||
13166215|NCT02371369|26104876|FG001|Part 2|Subject transitioned to another DS pexidartinib protocol|9|||
13166216|NCT02371369|26104875|FG000|Part 2|Surgical resection of tumor|1|||
13166217|NCT02371369|26104876|FG001|Part 2|Surgical resection of tumor|1|||
13166218|NCT02371369|26104875|FG000|Part 2|Other|0|||
13166219|NCT02371369|26104876|FG001|Part 2|Other|1|||
13166220|NCT02370914|26104882|FG000|Overall Study|Protocol Violation|2|||
13166221|NCT02370888|26104900|FG000|Overall Study|disease progression|2|||
13166222|NCT02370888|26104900|FG000|Overall Study|did not meet chimerism criteria|6|||
13166223|NCT02370784|26104919|FG000|Overall Study|Patient started prohibited medication|0|||
13166224|NCT02370784|26104920|FG001|Overall Study|Patient started prohibited medication|1|||
13166225|NCT02370667|26104992|FG000|Overall Study|Lost to Follow-up|0|||
13166226|NCT02370667|26104993|FG001|Overall Study|Lost to Follow-up|1|||
13166227|NCT02370667|26104994|FG002|Overall Study|Lost to Follow-up|0|||
13166228|NCT02370641|26105007|FG000|Overall Study|dropped study|4|||
13166229|NCT02370641|26105008|FG001|Overall Study|dropped study|2|||
13166230|NCT02370615|26105052|FG000|Overall Study|Adverse Event|1|||
13166231|NCT02370615|26105053|FG001|Overall Study|Adverse Event|0|||
13166232|NCT02370602|26105163|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
13166233|NCT02370602|26105164|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
13166234|NCT02370602|26105165|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
13166235|NCT02370602|26105166|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
13166236|NCT02370602|26105167|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
13166237|NCT02370602|26105168|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
13166238|NCT02370537|26105225|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
13166239|NCT02370537|26105226|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1|||
13166240|NCT02370537|26105227|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
13166241|NCT02370537|26105225|FG000|Part A (Open-label Recruitment)|Adverse Event|0|||
13166242|NCT02370537|26105226|FG001|Part A (Open-label Recruitment)|Adverse Event|0|||
13166243|NCT02370537|26105227|FG002|Part A (Open-label Recruitment)|Adverse Event|1|||
13166244|NCT02370537|26105225|FG000|Part B|Not randomised to receive treatment|1|||
13166245|NCT02370537|26105226|FG001|Part B|Not randomised to receive treatment|2|||
13166246|NCT02370537|26105227|FG002|Part B|Not randomised to receive treatment|259|||
13166247|NCT02370537|26105225|FG000|Part B|Withdrawal by Subject|0|||
13166248|NCT02370537|26105226|FG001|Part B|Withdrawal by Subject|1|||
13166249|NCT02370537|26105227|FG002|Part B|Withdrawal by Subject|0|||
13166250|NCT02370511|26105254|FG000|Overall Study|Death|10|||
13166251|NCT02370511|26105255|FG001|Overall Study|Death|7|||
13166252|NCT02370511|26105256|FG002|Overall Study|Death|1|||
13166253|NCT02370511|26105254|FG000|Overall Study|Withdrawal by Subject|2|||
13166254|NCT02370511|26105255|FG001|Overall Study|Withdrawal by Subject|0|||
13166255|NCT02370511|26105256|FG002|Overall Study|Withdrawal by Subject|0|||
13166256|NCT02370511|26105254|FG000|Overall Study|Lost to Follow-up|0|||
13166257|NCT02370511|26105255|FG001|Overall Study|Lost to Follow-up|4|||
13166258|NCT02370511|26105256|FG002|Overall Study|Lost to Follow-up|0|||
13166259|NCT02370498|26105316|FG000|Overall Study|Adverse Event|10|||
13166260|NCT02370498|26105317|FG001|Overall Study|Adverse Event|8|||
13166261|NCT02370498|26105316|FG000|Overall Study|Death|263|||
13166262|NCT02370498|26105317|FG001|Overall Study|Death|265|||
13166263|NCT02370498|26105316|FG000|Overall Study|Protocol Violation|1|||
13166264|NCT02370498|26105317|FG001|Overall Study|Protocol Violation|2|||
13107096|NCT03286218|25886273|FG011|Qualification Phase Period 1|Withdrawal by Subject|0|||
13107097|NCT03286218|25886262|FG000|Qualification Phase Period 2|Adverse Event|0|||
13107098|NCT03286218|25886263|FG001|Qualification Phase Period 2|Adverse Event|1|||
13107099|NCT03286218|25886264|FG002|Qualification Phase Period 2|Adverse Event|0|||
13107100|NCT03286218|25886265|FG003|Qualification Phase Period 2|Adverse Event|0|||
13107101|NCT03286218|25886266|FG004|Qualification Phase Period 2|Adverse Event|0|||
13107102|NCT03286218|25886267|FG005|Qualification Phase Period 2|Adverse Event|0|||
13107103|NCT03286218|25886268|FG006|Qualification Phase Period 2|Adverse Event|0|||
13107104|NCT03286218|25886269|FG007|Qualification Phase Period 2|Adverse Event|0|||
13107105|NCT03286218|25886270|FG008|Qualification Phase Period 2|Adverse Event|0|||
13107106|NCT03286218|25886271|FG009|Qualification Phase Period 2|Adverse Event|0|||
13107107|NCT03286218|25886272|FG010|Qualification Phase Period 2|Adverse Event|0|||
13107108|NCT03286218|25886273|FG011|Qualification Phase Period 2|Adverse Event|0|||
13107109|NCT03286218|25886262|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14|||
13107110|NCT03286218|25886263|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15|||
13107111|NCT03286218|25886264|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
13107112|NCT03286218|25886265|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
13166265|NCT02370498|26105316|FG000|Overall Study|Withdrawal by Subject|7|||
13166266|NCT02370498|26105317|FG001|Overall Study|Withdrawal by Subject|12|||
13166267|NCT02370498|26105316|FG000|Overall Study|Sponsor's decision|15|||
13166268|NCT02370498|26105317|FG001|Overall Study|Sponsor's decision|9|||
13166269|NCT02370420|26105334|FG000|Overall Study|Physician Decision|3|||
13166270|NCT02370420|26105335|FG001|Overall Study|Physician Decision|3|||
13166271|NCT02370420|26105334|FG000|Overall Study|Lost to Follow-up|11|||
13107113|NCT03286218|25886266|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
13166272|NCT02370420|26105335|FG001|Overall Study|Lost to Follow-up|9|||
13166273|NCT02370394|26105356|FG000|Overall Study|Lost to Follow-up|2|||
13166274|NCT02370394|26105357|FG001|Overall Study|Lost to Follow-up|1|||
13166275|NCT02370394|26105356|FG000|Overall Study|Withdrawal by Subject|0|||
13166276|NCT02370394|26105357|FG001|Overall Study|Withdrawal by Subject|1|||
13166277|NCT02370368|26105374|FG000|Overall Study|Adverse Event|1|||
13166278|NCT02370368|26105375|FG001|Overall Study|Adverse Event|2|||
13166279|NCT02370368|26105374|FG000|Overall Study|Withdrawal by Subject|5|||
13166280|NCT02370368|26105375|FG001|Overall Study|Withdrawal by Subject|4|||
13166281|NCT02370251|26105383|FG000|Overall Study|Received less than 8 days of Omegaven|7|||
13166282|NCT02370251|26105383|FG000|Overall Study|Death|4|||
13166283|NCT02370238|26105410|FG000|Overall Study|Death|42|||
13166284|NCT02370238|26105411|FG001|Overall Study|Death|35|||
13166285|NCT02370238|26105410|FG000|Overall Study|Lost to Follow-up|1|||
13166286|NCT02370238|26105411|FG001|Overall Study|Lost to Follow-up|3|||
13166287|NCT02370238|26105410|FG000|Overall Study|Withdrawal by Subject|2|||
13166288|NCT02370238|26105411|FG001|Overall Study|Withdrawal by Subject|6|||
13166289|NCT02370238|26105410|FG000|Overall Study|Other|2|||
13166290|NCT02370238|26105411|FG001|Overall Study|Other|1|||
13166291|NCT02370160|26105437|FG000|Overall Study|Death|3|||
13166292|NCT02370160|26105438|FG001|Overall Study|Death|4|||
13166293|NCT02370160|26105439|FG002|Overall Study|Death|1|||
13166294|NCT02370121|26105484|FG000|Overall Study|Lost to Follow-up|1|||
13166295|NCT02370121|26105485|FG001|Overall Study|Lost to Follow-up|1|||
13166296|NCT02370095|26105522|FG000|Overall Study|Withdrawal by Subject|0|||
13166297|NCT02370095|26105523|FG001|Overall Study|Withdrawal by Subject|1|||
13166298|NCT02370043|26105659|FG000|Overall Study|Withdrawal by Subject|0|||
13166299|NCT02370043|26105660|FG001|Overall Study|Withdrawal by Subject|0|||
13166300|NCT02370043|26105661|FG002|Overall Study|Withdrawal by Subject|0|||
13166301|NCT02370043|26105662|FG003|Overall Study|Withdrawal by Subject|0|||
13166302|NCT02370043|26105663|FG004|Overall Study|Withdrawal by Subject|1|||
13166303|NCT02370043|26105664|FG005|Overall Study|Withdrawal by Subject|1|||
13166304|NCT02369874|26105721|FG000|Overall Study|Lost to Follow-up|2|||
13166305|NCT02369874|26105722|FG001|Overall Study|Lost to Follow-up|2|||
13166306|NCT02369874|26105723|FG002|Overall Study|Lost to Follow-up|2|||
13166307|NCT02369874|26105721|FG000|Overall Study|Withdrawal by Subject|7|||
13166308|NCT02369874|26105722|FG001|Overall Study|Withdrawal by Subject|9|||
13166309|NCT02369874|26105723|FG002|Overall Study|Withdrawal by Subject|27|||
13166310|NCT02369874|26105721|FG000|Overall Study|Miscellaneous|1|||
13166311|NCT02369874|26105722|FG001|Overall Study|Miscellaneous|1|||
13166312|NCT02369874|26105723|FG002|Overall Study|Miscellaneous|0|||
13166313|NCT02369874|26105721|FG000|Overall Study|On Treatment/Off Study|34|||
13166314|NCT02369874|26105722|FG001|Overall Study|On Treatment/Off Study|45|||
13166315|NCT02369874|26105723|FG002|Overall Study|On Treatment/Off Study|32|||
13166316|NCT02369848|26105739|FG000|Overall Study|Death|1|||
13166317|NCT02369848|26105739|FG000|Overall Study|Withdrawal by Subject|2|||
13166318|NCT02369848|26105739|FG000|Overall Study|Lost to Follow-up|1|||
13166319|NCT02369510|26105778|FG000|Overall Study|Spilled Medication|1|||
13166320|NCT02369510|26105779|FG001|Overall Study|Spilled Medication|2|||
13166321|NCT02369510|26105780|FG002|Overall Study|Spilled Medication|1|||
13166322|NCT02369510|26105778|FG000|Overall Study|Epidural Activation|1|||
13166323|NCT02369510|26105779|FG001|Overall Study|Epidural Activation|1|||
13166324|NCT02369510|26105780|FG002|Overall Study|Epidural Activation|5|||
13166325|NCT02369341|26105841|FG000|Overall Study|Migrated/moved from study area|1|||
13166326|NCT02369341|26105842|FG001|Overall Study|Migrated/moved from study area|0|||
13166327|NCT02369159|26105887|FG000|Overall Study|Adverse Event|0|||
13166328|NCT02369159|26105888|FG001|Overall Study|Adverse Event|1|||
13222908|NCT01802320|26287150|FG000|Overall Study|Death|1|||
13166329|NCT02369159|26105887|FG000|Overall Study|Lost to Follow-up|1|||
13166330|NCT02369159|26105888|FG001|Overall Study|Lost to Follow-up|1|||
13166331|NCT02369159|26105887|FG000|Overall Study|Withdrawal by Subject|7|||
13166332|NCT02369159|26105888|FG001|Overall Study|Withdrawal by Subject|0|||
13166333|NCT02368691|26105901|FG000|Overall Study|Death|13|||
13107114|NCT03286218|25886267|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
13107115|NCT03286218|25886268|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
13107116|NCT03286218|25886269|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
13107117|NCT03286218|25886270|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
13107118|NCT03286218|25886271|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
13107119|NCT03286218|25886272|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
13107120|NCT03286218|25886273|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
13107121|NCT03286218|25886262|FG000|Qualification Phase Period 2|Lost to Follow-up|0|||
13107122|NCT03286218|25886263|FG001|Qualification Phase Period 2|Lost to Follow-up|1|||
13107123|NCT03286218|25886264|FG002|Qualification Phase Period 2|Lost to Follow-up|0|||
13107124|NCT03286218|25886265|FG003|Qualification Phase Period 2|Lost to Follow-up|0|||
13166334|NCT02368691|26105901|FG000|Overall Study|Lack of Efficacy|15|||
13166335|NCT02368691|26105901|FG000|Overall Study|Physician Decision|4|||
13166336|NCT02368314|26105918|FG000|Overall Study|Withdrawal by Subject|2|||
13166337|NCT02368314|26105919|FG001|Overall Study|Withdrawal by Subject|1|||
13166338|NCT02368314|26105918|FG000|Overall Study|Adverse Event|1|||
13166339|NCT02368314|26105919|FG001|Overall Study|Adverse Event|2|||
13166340|NCT02368210|26105942|FG000|Overall Study|Withdrawal by Subject|1|||
13166341|NCT02368210|26105943|FG001|Overall Study|Withdrawal by Subject|0|||
13166342|NCT02368210|26105942|FG000|Overall Study|Adverse Event|0|||
13166343|NCT02368210|26105943|FG001|Overall Study|Adverse Event|1|||
13166344|NCT02367911|26105958|FG000|Overall Study|Withdrawal by Subject|3|||
13166345|NCT02367911|26105959|FG001|Overall Study|Withdrawal by Subject|2|||
13166346|NCT02367911|26105958|FG000|Overall Study|Lost to Follow-up|2|||
13166347|NCT02367911|26105959|FG001|Overall Study|Lost to Follow-up|2|||
13166348|NCT02367885|26106034|FG000|Overall Study|Lost to Follow-up|1|||
13166349|NCT02367885|26106035|FG001|Overall Study|Lost to Follow-up|0|||
13166350|NCT02367885|26106036|FG002|Overall Study|Lost to Follow-up|0|||
13166351|NCT02367885|26106034|FG000|Overall Study|Withdrawal by Subject|1|||
13166352|NCT02367885|26106035|FG001|Overall Study|Withdrawal by Subject|0|||
13166353|NCT02367885|26106036|FG002|Overall Study|Withdrawal by Subject|0|||
13166354|NCT02367833|26106060|FG000|Overall Study|Withdrawal by Subject|1|||
13166355|NCT02367833|26106061|FG001|Overall Study|Withdrawal by Subject|1|||
13166356|NCT02367833|26106062|FG002|Overall Study|Withdrawal by Subject|0|||
13166357|NCT02367781|26106108|FG000|Overall Study|Withdrawal by Subject|20|||
13166358|NCT02367781|26106109|FG001|Overall Study|Withdrawal by Subject|13|||
13166359|NCT02367781|26106108|FG000|Overall Study|Protocol Violation|0|||
13166360|NCT02367781|26106109|FG001|Overall Study|Protocol Violation|1|||
13166361|NCT02367781|26106108|FG000|Overall Study|Physician Decision|7|||
13166362|NCT02367781|26106109|FG001|Overall Study|Physician Decision|0|||
13166363|NCT02367781|26106108|FG000|Overall Study|Randomized in Error|5|||
13166364|NCT02367781|26106109|FG001|Overall Study|Randomized in Error|4|||
13166365|NCT02367781|26106108|FG000|Overall Study|Non-Compliance|1|||
13166366|NCT02367781|26106109|FG001|Overall Study|Non-Compliance|0|||
13166367|NCT02367781|26106108|FG000|Overall Study|Lost to Follow-up|1|||
13166368|NCT02367781|26106109|FG001|Overall Study|Lost to Follow-up|2|||
13166369|NCT02367781|26106108|FG000|Overall Study|Death|330|||
13166370|NCT02367781|26106109|FG001|Overall Study|Death|176|||
13166371|NCT02367781|26106108|FG000|Overall Study|Patient Moving to Roll-Over Study|17|||
13166372|NCT02367781|26106109|FG001|Overall Study|Patient Moving to Roll-Over Study|5|||
13166373|NCT02367781|26106108|FG000|Overall Study|Prolonged Hospitalization|1|||
13166374|NCT02367781|26106109|FG001|Overall Study|Prolonged Hospitalization|0|||
13166375|NCT02367781|26106108|FG000|Overall Study|Death Prior First Dose|1|||
13166376|NCT02367781|26106109|FG001|Overall Study|Death Prior First Dose|0|||
13166377|NCT02367781|26106108|FG000|Overall Study|Administrative-Change Facility|1|||
13166378|NCT02367781|26106109|FG001|Overall Study|Administrative-Change Facility|0|||
13166379|NCT02367781|26106108|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78|||
13166380|NCT02367781|26106109|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29|||
13166381|NCT02367781|26106108|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14|||
13166382|NCT02367781|26106109|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9|||
13166383|NCT02367781|26106108|FG000|Overall Study|Study Terminated by Sponsor|3|||
13166384|NCT02367781|26106109|FG001|Overall Study|Study Terminated by Sponsor|1|||
13166385|NCT02367781|26106108|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1|||
13166386|NCT02367781|26106109|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0|||
13166387|NCT02367781|26106108|FG000|Overall Study|Sponsor Decision|2|||
13166388|NCT02367781|26106109|FG001|Overall Study|Sponsor Decision|0|||
13166389|NCT02367781|26106108|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1|||
13166390|NCT02367781|26106109|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0|||
13166391|NCT02367729|26106132|FG000|Overall Study|Organic disorder diagnosed|2|||
13166392|NCT02367729|26106133|FG001|Overall Study|Organic disorder diagnosed|1|||
13166393|NCT02367729|26106132|FG000|Overall Study|Adverse Event|1|||
13166394|NCT02367729|26106133|FG001|Overall Study|Adverse Event|2|||
13166395|NCT02367729|26106132|FG000|Overall Study|Withdrawal by Subject|0|||
13166396|NCT02367729|26106133|FG001|Overall Study|Withdrawal by Subject|5|||
13205516|NCT01964560|26232095|FG000|Overall Study|Surgery|1|||
13205517|NCT01964560|26232095|FG000|Overall Study|Seizures appeared resolved with epilepsy surgery|1|||
13205518|NCT01964560|26232095|FG000|Overall Study|Patient and Investigator choice|1|||
13205519|NCT01964560|26232095|FG000|Overall Study|Patient was prescribed CBD|1|||
13205520|NCT01964560|26232095|FG000|Overall Study|Participant moved to another country|1|||
13205521|NCT01964521|26232102|FG000|Overall Study|Lost to Follow-up|4|||
13205522|NCT01964378|26232141|FG000|Overall Study|Disc. due to death before first dosing|0|||
13205523|NCT01964378|26232142|FG001|Overall Study|Disc. due to death before first dosing|1|||
13205524|NCT01964378|26232141|FG000|Overall Study|Disc. due to AE before first dosing|1|||
13205525|NCT01964378|26232142|FG001|Overall Study|Disc. due to AE before first dosing|0|||
13205526|NCT01964378|26232141|FG000|Overall Study|Death|3|||
13205527|NCT01964378|26232142|FG001|Overall Study|Death|2|||
13166397|NCT02367716|26106142|FG000|Overall Study|Patient did not meet inclusion criteria|1|||
13166398|NCT02367521|26106201|FG000|Overall Study|severe headache after intervention|2|||
13166399|NCT02367521|26106202|FG001|Overall Study|severe headache after intervention|0|||
13166400|NCT02367521|26106201|FG000|Overall Study|unable to find transportation|2|||
13166401|NCT02367521|26106202|FG001|Overall Study|unable to find transportation|0|||
13166402|NCT02367352|26106243|FG000|Overall Study|Progressive disease|7|||
13166403|NCT02367352|26106244|FG001|Overall Study|Progressive disease|0|||
13166404|NCT02367352|26106245|FG002|Overall Study|Progressive disease|0|||
13166405|NCT02367352|26106243|FG000|Overall Study|Participant Received Alternative Therapy|1|||
13166406|NCT02367352|26106244|FG001|Overall Study|Participant Received Alternative Therapy|0|||
13166407|NCT02367352|26106245|FG002|Overall Study|Participant Received Alternative Therapy|0|||
13166408|NCT02367352|26106243|FG000|Overall Study|Adverse Event|1|||
13166409|NCT02367352|26106244|FG001|Overall Study|Adverse Event|0|||
13166410|NCT02367352|26106245|FG002|Overall Study|Adverse Event|0|||
13166411|NCT02367131|26106253|FG000|Overall Study|Adverse Event|64|||
13166412|NCT02367131|26106253|FG000|Overall Study|No visit since the first visit|4|||
13166413|NCT02367131|26106253|FG000|Overall Study|Request by patient|54|||
13166414|NCT02367131|26106253|FG000|Overall Study|Improvement/remission|2|||
13166415|NCT02367131|26106253|FG000|Overall Study|No change/progressive disease|78|||
13166416|NCT02367131|26106253|FG000|Overall Study|Other than stated above|20|||
13166417|NCT02366936|26106260|FG000|Overall Study|Withdrawal by Subject|2|||
13166418|NCT02366936|26106260|FG000|Overall Study|Lost to Follow-up|4|||
13166419|NCT02366936|26106260|FG000|Overall Study|Physician Decision|2|||
13166420|NCT02366923|26106275|FG000|Overall Study|Withdrawal by Subject|1|||
13166421|NCT02366923|26106275|FG000|Overall Study|Positive Slit Lamp Findings|2|||
13166422|NCT02366923|26106275|FG000|Overall Study|High Astigmatism|3|||
13166423|NCT02366910|26106289|FG000|Overall Study|Withdrawal by Subject|2|||
13166424|NCT02366910|26106289|FG000|Overall Study|Screen Failure|3|||
13166425|NCT02366767|26106306|FG000|Overall Study|left for home after 1 day at camp|1|||
13166426|NCT02366767|26106307|FG001|Overall Study|left for home after 1 day at camp|0|||
13166427|NCT02366689|26106340|FG000|Overall Study|Withdrawal by Subject|1|||
13166428|NCT02366689|26106341|FG001|Overall Study|Withdrawal by Subject|0|||
13166429|NCT02366689|26106342|FG002|Overall Study|Withdrawal by Subject|1|||
13166430|NCT02366689|26106340|FG000|Overall Study|Lost to Follow-up|3|||
13166431|NCT02366689|26106341|FG001|Overall Study|Lost to Follow-up|2|||
13166432|NCT02366689|26106342|FG002|Overall Study|Lost to Follow-up|0|||
13166433|NCT02366689|26106340|FG000|Overall Study|Pregnancy|0|||
13166434|NCT02366689|26106341|FG001|Overall Study|Pregnancy|1|||
13166435|NCT02366689|26106342|FG002|Overall Study|Pregnancy|1|||
13166436|NCT02366637|26106369|FG000|First Intervention Period|Adverse Event|0|||
13166437|NCT02366637|26106370|FG001|First Intervention Period|Adverse Event|1|||
13166438|NCT02366637|26106369|FG000|First Intervention Period|Study Terminated by Sponsor|6|||
13166439|NCT02366637|26106370|FG001|First Intervention Period|Study Terminated by Sponsor|4|||
13166440|NCT02366637|26106369|FG000|Second Intervention Period|Study Terminated by Sponsor|1|||
13166441|NCT02366637|26106370|FG001|Second Intervention Period|Study Terminated by Sponsor|1|||
13166442|NCT02366468|26106395|FG000|Overall Study|Adverse Event|2|||
13166443|NCT02366468|26106396|FG001|Overall Study|Adverse Event|0|||
13166444|NCT02366468|26106395|FG000|Overall Study|Withdrawal by Subject|1|||
13166445|NCT02366468|26106396|FG001|Overall Study|Withdrawal by Subject|5|||
13166446|NCT02366468|26106395|FG000|Overall Study|Lost to Follow-up|2|||
13166447|NCT02366468|26106396|FG001|Overall Study|Lost to Follow-up|0|||
13166448|NCT02366468|26106395|FG000|Overall Study|Death|1|||
13166449|NCT02366468|26106396|FG001|Overall Study|Death|2|||
13166450|NCT02366468|26106395|FG000|Overall Study|Other|0|||
13166451|NCT02366468|26106396|FG001|Overall Study|Other|2|||
13166452|NCT02366312|26106409|FG000|Overall Study|Lost to Follow-up|0|||
13166453|NCT02366312|26106410|FG001|Overall Study|Lost to Follow-up|1|||
13166454|NCT02366195|26106430|FG000|Overall Study|Protocol-specified criteria|3|||
13166455|NCT02366195|26106430|FG000|Overall Study|Withdrawal by Subject|9|||
13166456|NCT02366195|26106430|FG000|Overall Study|Lost to Follow-up|1|||
13166457|NCT02366195|26106430|FG000|Overall Study|Death|41|||
13166458|NCT02366143|26106506|FG000|Overall Study|Death|307|||
13166459|NCT02366143|26106507|FG001|Overall Study|Death|278|||
13166460|NCT02366143|26106508|FG002|Overall Study|Death|280|||
13166461|NCT02366143|26106506|FG000|Overall Study|Lost to Follow-up|2|||
13166462|NCT02366143|26106507|FG001|Overall Study|Lost to Follow-up|4|||
13166463|NCT02366143|26106508|FG002|Overall Study|Lost to Follow-up|2|||
13166464|NCT02366143|26106506|FG000|Overall Study|Physician Decision|1|||
13166465|NCT02366143|26106507|FG001|Overall Study|Physician Decision|2|||
13166466|NCT02366143|26106508|FG002|Overall Study|Physician Decision|1|||
13166467|NCT02366143|26106506|FG000|Overall Study|Protocol Violation|0|||
13166468|NCT02366143|26106507|FG001|Overall Study|Protocol Violation|0|||
13166469|NCT02366143|26106508|FG002|Overall Study|Protocol Violation|2|||
13166470|NCT02366143|26106506|FG000|Overall Study|Withdrawal by Subject|16|||
13166471|NCT02366143|26106507|FG001|Overall Study|Withdrawal by Subject|17|||
13166472|NCT02366143|26106508|FG002|Overall Study|Withdrawal by Subject|22|||
13166473|NCT02366143|26106506|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
13166474|NCT02366143|26106507|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6|||
13166475|NCT02366143|26106508|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
13166476|NCT02366143|26106506|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
13166477|NCT02366143|26106507|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1|||
13166478|NCT02366143|26106508|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
13166479|NCT02366143|26106506|FG000|Overall Study|Randomization Error|1|||
13166480|NCT02366143|26106507|FG001|Overall Study|Randomization Error|0|||
13166481|NCT02366143|26106508|FG002|Overall Study|Randomization Error|0|||
13166482|NCT02366143|26106506|FG000|Overall Study|PI Move and Site Closure|1|||
13166483|NCT02366143|26106507|FG001|Overall Study|PI Move and Site Closure|0|||
13166484|NCT02366143|26106508|FG002|Overall Study|PI Move and Site Closure|1|||
13166485|NCT02366143|26106506|FG000|Overall Study|Study Terminated By Sponsor|0|||
13166486|NCT02366143|26106507|FG001|Overall Study|Study Terminated By Sponsor|0|||
13166487|NCT02366143|26106508|FG002|Overall Study|Study Terminated By Sponsor|2|||
13166488|NCT02366143|26106506|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70|||
13166489|NCT02366143|26106507|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57|||
13166490|NCT02366143|26106508|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52|||
13166491|NCT02366143|26106506|FG000|Overall Study|Patient moved to roll-over study|1|||
13166492|NCT02366143|26106507|FG001|Overall Study|Patient moved to roll-over study|19|||
13166493|NCT02366143|26106508|FG002|Overall Study|Patient moved to roll-over study|28|||
13166494|NCT02366143|26106506|FG000|Overall Study|Patient moved to commercial stock|0|||
13166495|NCT02366143|26106507|FG001|Overall Study|Patient moved to commercial stock|0|||
13166496|NCT02366143|26106508|FG002|Overall Study|Patient moved to commercial stock|1|||
13166497|NCT02366143|26106506|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
13166498|NCT02366143|26106507|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
13166499|NCT02366143|26106508|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1|||
13166500|NCT02366143|26106506|FG000|Overall Study|Patient rolling over to patient assistance program|0|||
13166501|NCT02366143|26106507|FG001|Overall Study|Patient rolling over to patient assistance program|0|||
13166502|NCT02366143|26106508|FG002|Overall Study|Patient rolling over to patient assistance program|1|||
13166503|NCT02366143|26106506|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
13166504|NCT02366143|26106507|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
13166505|NCT02366143|26106508|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1|||
13166506|NCT02366143|26106506|FG000|Overall Study|Requester's instructions|1|||
13166507|NCT02366143|26106507|FG001|Overall Study|Requester's instructions|1|||
13166508|NCT02366143|26106508|FG002|Overall Study|Requester's instructions|1|||
13166509|NCT02366143|26106506|FG000|Overall Study|Uneligible|0|||
13166510|NCT02366143|26106507|FG001|Overall Study|Uneligible|1|||
13166511|NCT02366143|26106508|FG002|Overall Study|Uneligible|0|||
13166512|NCT02366143|26106506|FG000|Overall Study|Post Trial Migration|0|||
13166513|NCT02366143|26106507|FG001|Overall Study|Post Trial Migration|1|||
13166514|NCT02366143|26106508|FG002|Overall Study|Post Trial Migration|0|||
13166515|NCT02366143|26106506|FG000|Overall Study|Patient moving onto PTAP commercial stock|0|||
13166516|NCT02366143|26106507|FG001|Overall Study|Patient moving onto PTAP commercial stock|1|||
13166517|NCT02366143|26106508|FG002|Overall Study|Patient moving onto PTAP commercial stock|0|||
13166518|NCT02366143|26106506|FG000|Overall Study|Patient switched to PTAP|0|||
13166519|NCT02366143|26106507|FG001|Overall Study|Patient switched to PTAP|1|||
13166520|NCT02366143|26106508|FG002|Overall Study|Patient switched to PTAP|0|||
13166521|NCT02366143|26106506|FG000|Overall Study|Patient moved to commercial atezolizumab use|0|||
13166522|NCT02366143|26106507|FG001|Overall Study|Patient moved to commercial atezolizumab use|11|||
13166523|NCT02366143|26106508|FG002|Overall Study|Patient moved to commercial atezolizumab use|7|||
13166524|NCT02366130|26106515|FG000|Overall Study|Withdrawal by Subject|3|||
13166525|NCT02366130|26106515|FG000|Overall Study|Ineligible|6|||
13166526|NCT02366091|26106558|FG000|Overall Study|Withdrawal by Subject|3|||
13166527|NCT02366091|26106559|FG001|Overall Study|Withdrawal by Subject|7|||
13166528|NCT02366091|26106560|FG002|Overall Study|Withdrawal by Subject|3|||
13166529|NCT02366091|26106561|FG003|Overall Study|Withdrawal by Subject|1|||
13166530|NCT02365636|26106615|FG000|Overall Study|Adverse Event|3|||
13166531|NCT02365636|26106616|FG001|Overall Study|Adverse Event|3|||
13166532|NCT02365636|26106617|FG002|Overall Study|Adverse Event|2|||
13166533|NCT02365636|26106615|FG000|Overall Study|Protocol Violation|1|||
13166534|NCT02365636|26106616|FG001|Overall Study|Protocol Violation|4|||
13166535|NCT02365636|26106617|FG002|Overall Study|Protocol Violation|0|||
13166536|NCT02365636|26106615|FG000|Overall Study|Lost to Follow-up|0|||
13166537|NCT02365636|26106616|FG001|Overall Study|Lost to Follow-up|0|||
13166538|NCT02365636|26106617|FG002|Overall Study|Lost to Follow-up|1|||
13166539|NCT02365636|26106615|FG000|Overall Study|Other|2|||
13166540|NCT02365636|26106616|FG001|Overall Study|Other|0|||
13166541|NCT02365636|26106617|FG002|Overall Study|Other|0|||
13166542|NCT02365584|26106648|FG000|Overall Study|Adverse Event|2|||
13166543|NCT02365584|26106649|FG001|Overall Study|Adverse Event|2|||
13107125|NCT03286218|25886266|FG004|Qualification Phase Period 2|Lost to Follow-up|0|||
13166544|NCT02365584|26106648|FG000|Overall Study|Withdrawal by Subject|1|||
13166545|NCT02365584|26106649|FG001|Overall Study|Withdrawal by Subject|0|||
13166546|NCT02365584|26106648|FG000|Overall Study|Disease Progression|9|||
13166547|NCT02365584|26106649|FG001|Overall Study|Disease Progression|12|||
13166548|NCT02365558|26106663|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1|||
13166549|NCT02365558|26106664|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0|||
13166550|NCT02365558|26106663|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0|||
13166551|NCT02365558|26106664|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1|||
13166552|NCT02365519|26106693|FG000|Randomized and Treated|Adverse Event|0|||
13166553|NCT02365519|26106694|FG001|Randomized and Treated|Adverse Event|1|||
13166554|NCT02365519|26106695|FG002|Randomized and Treated|Adverse Event|0|||
13166555|NCT02365519|26106693|FG000|Randomized and Treated|Withdrawal by Subject|0|||
13166556|NCT02365519|26106694|FG001|Randomized and Treated|Withdrawal by Subject|1|||
13166557|NCT02365519|26106695|FG002|Randomized and Treated|Withdrawal by Subject|1|||
13166558|NCT02365506|26106734|FG000|Overall Study|Investigator's Discretion|0|||
13166559|NCT02365506|26106735|FG001|Overall Study|Investigator's Discretion|0|||
13166560|NCT02365506|26106736|FG002|Overall Study|Investigator's Discretion|1|||
13166561|NCT02365480|26106761|FG000|Overall Study|Withdrawal by Subject|2|||
13166562|NCT02365480|26106762|FG001|Overall Study|Withdrawal by Subject|0|||
13166563|NCT02365467|26106769|FG000|Overall Study|Death|3|||
13166564|NCT02365298|26106788|FG000|Period 2|incorrect Rx dispensed|1|||
13166565|NCT02365298|26106789|FG001|Period 2|incorrect Rx dispensed|0|||
13166566|NCT02365298|26106788|FG000|Period 2|Discontinued at request of Sponsor|1|||
13166567|NCT02365298|26106789|FG001|Period 2|Discontinued at request of Sponsor|0|||
13166568|NCT02365298|26106788|FG000|Period 2|Test Article longer available|0|||
13166569|NCT02365298|26106789|FG001|Period 2|Test Article longer available|1|||
13166570|NCT02365298|26106788|FG000|Period 2|Protocol Violation|0|||
13166571|NCT02365298|26106789|FG001|Period 2|Protocol Violation|1|||
13166572|NCT02365285|26106816|FG000|Overall Study|Physician Decision|0|||
13166573|NCT02365285|26106817|FG001|Overall Study|Physician Decision|1|||
13166574|NCT02365285|26106818|FG002|Overall Study|Physician Decision|1|||
13166575|NCT02365285|26106819|FG003|Overall Study|Physician Decision|0|||
13166576|NCT02365285|26106816|FG000|Overall Study|Adverse Event|0|||
13166577|NCT02365285|26106817|FG001|Overall Study|Adverse Event|0|||
13166578|NCT02365285|26106818|FG002|Overall Study|Adverse Event|0|||
13166579|NCT02365285|26106819|FG003|Overall Study|Adverse Event|2|||
13166580|NCT02365233|26106837|FG000|Overall Study|IRB withheld the data|1|||
13166581|NCT02365233|26106838|FG001|Overall Study|IRB withheld the data|2|||
13166582|NCT02365233|26106839|FG002|Overall Study|IRB withheld the data|2|||
13166583|NCT02365207|26106845|FG000|Overall Study|Withdrawal by Subject|1|||
13166584|NCT02365207|26106845|FG000|Overall Study|Physician Decision|1|||
13166585|NCT02365064|26106868|FG000|Overall Study|Patients met baseline exclusion requirem|2|||
13166586|NCT02365064|26106869|FG001|Overall Study|Patients met baseline exclusion requirem|15|||
13166587|NCT02365064|26106868|FG000|Overall Study|Withdrawal by Subject|6|||
13166588|NCT02365064|26106869|FG001|Overall Study|Withdrawal by Subject|9|||
13166589|NCT02365064|26106868|FG000|Overall Study|Treatment intolerance|2|||
13166590|NCT02365064|26106869|FG001|Overall Study|Treatment intolerance|4|||
13107126|NCT03286218|25886267|FG005|Qualification Phase Period 2|Lost to Follow-up|0|||
13107127|NCT03286218|25886268|FG006|Qualification Phase Period 2|Lost to Follow-up|0|||
13107128|NCT03286218|25886269|FG007|Qualification Phase Period 2|Lost to Follow-up|0|||
13107129|NCT03286218|25886270|FG008|Qualification Phase Period 2|Lost to Follow-up|0|||
13107130|NCT03286218|25886271|FG009|Qualification Phase Period 2|Lost to Follow-up|0|||
13107131|NCT03286218|25886272|FG010|Qualification Phase Period 2|Lost to Follow-up|0|||
13107132|NCT03286218|25886273|FG011|Qualification Phase Period 2|Lost to Follow-up|0|||
13107133|NCT03286218|25886262|FG000|Qualification Phase Period 2|Protocol Violation|2|||
13107134|NCT03286218|25886263|FG001|Qualification Phase Period 2|Protocol Violation|0|||
13107135|NCT03286218|25886264|FG002|Qualification Phase Period 2|Protocol Violation|0|||
13107136|NCT03286218|25886265|FG003|Qualification Phase Period 2|Protocol Violation|0|||
13107137|NCT03286218|25886266|FG004|Qualification Phase Period 2|Protocol Violation|0|||
13107138|NCT03286218|25886267|FG005|Qualification Phase Period 2|Protocol Violation|0|||
13107139|NCT03286218|25886268|FG006|Qualification Phase Period 2|Protocol Violation|0|||
13107140|NCT03286218|25886269|FG007|Qualification Phase Period 2|Protocol Violation|0|||
13107141|NCT03286218|25886270|FG008|Qualification Phase Period 2|Protocol Violation|0|||
13107142|NCT03286218|25886271|FG009|Qualification Phase Period 2|Protocol Violation|0|||
13107143|NCT03286218|25886272|FG010|Qualification Phase Period 2|Protocol Violation|0|||
13107144|NCT03286218|25886273|FG011|Qualification Phase Period 2|Protocol Violation|0|||
13107145|NCT03286218|25886262|FG000|Qualification Phase Period 2|Withdrawal by Subject|1|||
13107146|NCT03286218|25886263|FG001|Qualification Phase Period 2|Withdrawal by Subject|2|||
13166591|NCT02364999|26106899|FG000|Overall Study|Death|136|||
13166592|NCT02364999|26106900|FG001|Overall Study|Death|138|||
13166593|NCT02364999|26106899|FG000|Overall Study|Lost to Follow-up|10|||
13166594|NCT02364999|26106900|FG001|Overall Study|Lost to Follow-up|15|||
13166595|NCT02364999|26106899|FG000|Overall Study|Protocol Violation|3|||
13166596|NCT02364999|26106900|FG001|Overall Study|Protocol Violation|2|||
13166597|NCT02364999|26106899|FG000|Overall Study|Withdrawal by Subject|14|||
13166598|NCT02364999|26106900|FG001|Overall Study|Withdrawal by Subject|14|||
13166599|NCT02364999|26106899|FG000|Overall Study|Other|0|||
13166600|NCT02364999|26106900|FG001|Overall Study|Other|1|||
13166601|NCT02364999|26106899|FG000|Overall Study|Randomized but did not receive treatment|2|||
13166602|NCT02364999|26106900|FG001|Overall Study|Randomized but did not receive treatment|3|||
13166603|NCT02364947|26106975|FG000|Overall Study|Withdrawal by Subject|10|||
13166604|NCT02364947|26106976|FG001|Overall Study|Withdrawal by Subject|8|||
13166605|NCT02364947|26106977|FG002|Overall Study|Withdrawal by Subject|9|||
13166606|NCT02364947|26106975|FG000|Overall Study|Adverse Event|45|||
13166607|NCT02364947|26106976|FG001|Overall Study|Adverse Event|33|||
13166608|NCT02364947|26106977|FG002|Overall Study|Adverse Event|11|||
13166609|NCT02364947|26106975|FG000|Overall Study|Protocol Violation|1|||
13166610|NCT02364947|26106976|FG001|Overall Study|Protocol Violation|1|||
13166611|NCT02364947|26106977|FG002|Overall Study|Protocol Violation|1|||
13166612|NCT02364947|26106975|FG000|Overall Study|Physician Decision|3|||
13166613|NCT02364947|26106976|FG001|Overall Study|Physician Decision|2|||
13166614|NCT02364947|26106977|FG002|Overall Study|Physician Decision|5|||
13166615|NCT02364947|26106975|FG000|Overall Study|Death|0|||
13166616|NCT02364947|26106976|FG001|Overall Study|Death|1|||
13166617|NCT02364947|26106977|FG002|Overall Study|Death|0|||
13166618|NCT02364388|26106984|FG000|Overall Study|Protocol Violation|1|||
13166619|NCT02364388|26106984|FG000|Overall Study|Technical Failure|3|||
13166620|NCT02364388|26106984|FG000|Overall Study|No OA/US data|2|||
13166621|NCT02364388|26106984|FG000|Overall Study|No Biopsy|2|||
13166622|NCT02364336|26107004|FG000|Overall Study|Adverse Event|0|||
13166623|NCT02364336|26107005|FG001|Overall Study|Adverse Event|1|||
13166624|NCT02364180|26107011|FG000|Overall Study|Screen Fail|1|||
13166625|NCT02364037|26107032|FG000|Overall Study|Withdrawal by Subject|7|||
13166626|NCT02364037|26107033|FG001|Overall Study|Withdrawal by Subject|4|||
13166627|NCT02364037|26107032|FG000|Overall Study|Lost to Follow-up|37|||
13166628|NCT02364037|26107033|FG001|Overall Study|Lost to Follow-up|49|||
13166629|NCT02363959|26107056|FG000|Overall Study|Medical instability|1|||
13166630|NCT02363959|26107057|FG001|Overall Study|Medical instability|0|||
13166631|NCT02363946|26107283|FG000|Overall Study|Lost to Follow-up|0|||
13166632|NCT02363946|26107284|FG001|Overall Study|Lost to Follow-up|0|||
13166633|NCT02363946|26107285|FG002|Overall Study|Lost to Follow-up|0|||
13166634|NCT02363946|26107286|FG003|Overall Study|Lost to Follow-up|0|||
13166635|NCT02363946|26107287|FG004|Overall Study|Lost to Follow-up|0|||
13166636|NCT02363946|26107288|FG005|Overall Study|Lost to Follow-up|0|||
13166637|NCT02363946|26107289|FG006|Overall Study|Lost to Follow-up|0|||
13107147|NCT03286218|25886264|FG002|Qualification Phase Period 2|Withdrawal by Subject|0|||
13107148|NCT03286218|25886265|FG003|Qualification Phase Period 2|Withdrawal by Subject|0|||
13107149|NCT03286218|25886266|FG004|Qualification Phase Period 2|Withdrawal by Subject|0|||
13107150|NCT03286218|25886267|FG005|Qualification Phase Period 2|Withdrawal by Subject|0|||
13107151|NCT03286218|25886268|FG006|Qualification Phase Period 2|Withdrawal by Subject|0|||
13107152|NCT03286218|25886269|FG007|Qualification Phase Period 2|Withdrawal by Subject|0|||
13107153|NCT03286218|25886270|FG008|Qualification Phase Period 2|Withdrawal by Subject|0|||
13107154|NCT03286218|25886271|FG009|Qualification Phase Period 2|Withdrawal by Subject|0|||
13107155|NCT03286218|25886272|FG010|Qualification Phase Period 2|Withdrawal by Subject|0|||
13107156|NCT03286218|25886273|FG011|Qualification Phase Period 2|Withdrawal by Subject|0|||
13107157|NCT03286218|25886262|FG000|Treatment Phase Period 1|Withdrawal by Subject|0|||
13107158|NCT03286218|25886263|FG001|Treatment Phase Period 1|Withdrawal by Subject|0|||
13107159|NCT03286218|25886264|FG002|Treatment Phase Period 1|Withdrawal by Subject|1|||
13107160|NCT03286218|25886265|FG003|Treatment Phase Period 1|Withdrawal by Subject|1|||
13107161|NCT03286218|25886266|FG004|Treatment Phase Period 1|Withdrawal by Subject|0|||
13107162|NCT03286218|25886267|FG005|Treatment Phase Period 1|Withdrawal by Subject|1|||
13107163|NCT03286218|25886268|FG006|Treatment Phase Period 1|Withdrawal by Subject|0|||
13107164|NCT03286218|25886269|FG007|Treatment Phase Period 1|Withdrawal by Subject|0|||
13107165|NCT03286218|25886270|FG008|Treatment Phase Period 1|Withdrawal by Subject|0|||
13107166|NCT03286218|25886271|FG009|Treatment Phase Period 1|Withdrawal by Subject|0|||
13107167|NCT03286218|25886272|FG010|Treatment Phase Period 1|Withdrawal by Subject|0|||
13107168|NCT03286218|25886273|FG011|Treatment Phase Period 1|Withdrawal by Subject|1|||
13107169|NCT03286218|25886262|FG000|Treatment Phase Period 4|Withdrawal by Subject|0|||
13107170|NCT03286218|25886263|FG001|Treatment Phase Period 4|Withdrawal by Subject|0|||
13107171|NCT03286218|25886264|FG002|Treatment Phase Period 4|Withdrawal by Subject|0|||
13107172|NCT03286218|25886265|FG003|Treatment Phase Period 4|Withdrawal by Subject|0|||
13107173|NCT03286218|25886266|FG004|Treatment Phase Period 4|Withdrawal by Subject|0|||
13166638|NCT02363946|26107290|FG007|Overall Study|Lost to Follow-up|1|||
13166639|NCT02363946|26107291|FG008|Overall Study|Lost to Follow-up|0|||
13166640|NCT02363946|26107292|FG009|Overall Study|Lost to Follow-up|0|||
13166641|NCT02363946|26107293|FG010|Overall Study|Lost to Follow-up|0|||
13166642|NCT02363946|26107294|FG011|Overall Study|Lost to Follow-up|0|||
13166643|NCT02363946|26107295|FG012|Overall Study|Lost to Follow-up|0|||
13166644|NCT02363738|26107314|FG000|Overall Study|Adverse Event|5|||
13166645|NCT02363738|26107315|FG001|Overall Study|Adverse Event|2|||
13107174|NCT03286218|25886267|FG005|Treatment Phase Period 4|Withdrawal by Subject|0|||
13107175|NCT03286218|25886268|FG006|Treatment Phase Period 4|Withdrawal by Subject|0|||
13107176|NCT03286218|25886269|FG007|Treatment Phase Period 4|Withdrawal by Subject|0|||
13107177|NCT03286218|25886270|FG008|Treatment Phase Period 4|Withdrawal by Subject|0|||
13107178|NCT03286218|25886271|FG009|Treatment Phase Period 4|Withdrawal by Subject|0|||
13107179|NCT03286218|25886272|FG010|Treatment Phase Period 4|Withdrawal by Subject|0|||
13166646|NCT02363738|26107314|FG000|Overall Study|Lack of Efficacy|1|||
13166647|NCT02363738|26107315|FG001|Overall Study|Lack of Efficacy|2|||
13166648|NCT02363738|26107314|FG000|Overall Study|Lost to Follow-up|2|||
13166649|NCT02363738|26107315|FG001|Overall Study|Lost to Follow-up|1|||
13166650|NCT02363686|26107321|FG000|Overall Study|Withdrawal by Subject|22|||
13166651|NCT02363686|26107321|FG000|Overall Study|incomplete FEES examinations|13|||
13166652|NCT02363478|26107330|FG000|Overall Study|Lost to Follow-up|4|||
13166653|NCT02363478|26107330|FG000|Overall Study|Adverse Event|4|||
13166654|NCT02363439|26107336|FG000|Overall Study|Lack of Efficacy|4|||
13166655|NCT02363322|26107353|FG000|Overall Study|Lost to Follow-up|1|||
13166656|NCT02363322|26107354|FG001|Overall Study|Lost to Follow-up|0|||
13166657|NCT02363283|26107364|FG000|Overall Study|Withdrawal by Subject|1|||
13166658|NCT02363283|26107364|FG000|Overall Study|Not eligible due to transaminitis|1|||
13166659|NCT02362789|26107379|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1|||
13166660|NCT02362789|26107380|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
13166661|NCT02362789|26107381|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
13166662|NCT02362789|26107379|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1|||
13166663|NCT02362789|26107380|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
13166664|NCT02362789|26107381|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
13166665|NCT02362789|26107379|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0|||
13166666|NCT02362789|26107380|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2|||
13166667|NCT02362789|26107381|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6|||
13166668|NCT02362789|26107379|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0|||
13166669|NCT02362789|26107380|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1|||
13166670|NCT02362789|26107381|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4|||
13166671|NCT02362789|26107379|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0|||
13166672|NCT02362789|26107380|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1|||
13166673|NCT02362789|26107381|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2|||
13166674|NCT02362724|26107424|FG000|Overall Study|Withdrawal by Subject|3|||
13166675|NCT02362724|26107425|FG001|Overall Study|Withdrawal by Subject|1|||
13166676|NCT02362724|26107424|FG000|Overall Study|Adverse Event|3|||
13166677|NCT02362724|26107425|FG001|Overall Study|Adverse Event|0|||
13166678|NCT02362646|26107440|FG000|Overall Study|Death|15|||
13166679|NCT02362646|26107441|FG001|Overall Study|Death|8|||
13166680|NCT02362646|26107440|FG000|Overall Study|Withdrawal by Subject|2|||
13166681|NCT02362646|26107441|FG001|Overall Study|Withdrawal by Subject|2|||
13166682|NCT02362646|26107440|FG000|Overall Study|received transplant|21|||
13166683|NCT02362646|26107441|FG001|Overall Study|received transplant|14|||
13166684|NCT02362503|26107476|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0|||
13166685|NCT02362503|26107477|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2|||
13166686|NCT02362503|26107478|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0|||
13166687|NCT02362503|26107476|FG000|Double-blind Period-Up to 8 Days|Death|1|||
13166688|NCT02362503|26107477|FG001|Double-blind Period-Up to 8 Days|Death|0|||
13166689|NCT02362503|26107478|FG002|Double-blind Period-Up to 8 Days|Death|0|||
13166690|NCT02362503|26107476|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
13166691|NCT02362503|26107477|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1|||
13166692|NCT02362503|26107478|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
13166693|NCT02362503|26107476|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
13166694|NCT02362503|26107477|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1|||
13166695|NCT02362503|26107478|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
13166696|NCT02362503|26107476|FG000|Open Label Period-Up to 96 Weeks|Other|0|||
13166697|NCT02362503|26107477|FG001|Open Label Period-Up to 96 Weeks|Other|1|||
13166698|NCT02362503|26107478|FG002|Open Label Period-Up to 96 Weeks|Other|1|||
13107180|NCT03286218|25886273|FG011|Treatment Phase Period 4|Withdrawal by Subject|1|||
13107181|NCT03285958|25886295|FG000|Overall Study|Lost to Follow-up|1|||
13107182|NCT03285958|25886296|FG001|Overall Study|Lost to Follow-up|1|||
13107183|NCT03285958|25886295|FG000|Overall Study|Withdrawal by Subject|1|||
13107184|NCT03285958|25886296|FG001|Overall Study|Withdrawal by Subject|0|||
13107185|NCT03285958|25886295|FG000|Overall Study|Not able to attend required orientation|3|||
13107186|NCT03285958|25886296|FG001|Overall Study|Not able to attend required orientation|0|||
13107187|NCT03285711|25886325|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2|||
13107188|NCT03285711|25886326|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1|||
13107189|NCT03285711|25886327|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0|||
13166699|NCT02362503|26107476|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0|||
13166700|NCT02362503|26107477|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
13166701|NCT02362503|26107478|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
13166702|NCT02362503|26107476|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
13166703|NCT02362503|26107477|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1|||
13166704|NCT02362503|26107478|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
13166705|NCT02362503|26107476|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3|||
13166706|NCT02362503|26107477|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8|||
13166707|NCT02362503|26107478|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6|||
13166708|NCT02362503|26107476|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4|||
13166709|NCT02362503|26107477|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3|||
13166710|NCT02362503|26107478|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1|||
13166711|NCT02362503|26107476|FG000|Open Label Period-Up to 96 Weeks|Death|1|||
13166712|NCT02362503|26107477|FG001|Open Label Period-Up to 96 Weeks|Death|7|||
13166713|NCT02362503|26107478|FG002|Open Label Period-Up to 96 Weeks|Death|15|||
13166714|NCT02362503|26107476|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0|||
13166715|NCT02362503|26107477|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5|||
13166716|NCT02362503|26107478|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1|||
13166717|NCT02362503|26107476|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3|||
13166718|NCT02362503|26107477|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2|||
13166719|NCT02362503|26107478|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4|||
13166720|NCT02362503|26107476|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3|||
13166721|NCT02362503|26107477|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9|||
13166722|NCT02362503|26107478|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6|||
13166723|NCT02362503|26107476|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54|||
13166724|NCT02362503|26107477|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159|||
13166725|NCT02362503|26107478|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61|||
13166726|NCT02362451|26107495|FG000|Overall Study|Withdrawal by Subject|0|||
13166727|NCT02362451|26107496|FG001|Overall Study|Withdrawal by Subject|1|||
13166728|NCT02362451|26107495|FG000|Overall Study|Lack of Efficacy|2|||
13166729|NCT02362451|26107496|FG001|Overall Study|Lack of Efficacy|0|||
13166730|NCT02362451|26107495|FG000|Overall Study|Progression|1|||
13166731|NCT02362451|26107496|FG001|Overall Study|Progression|0|||
13166732|NCT02362451|26107495|FG000|Overall Study|Participant chose other therapy.|1|||
13166733|NCT02362451|26107496|FG001|Overall Study|Participant chose other therapy.|0|||
13166734|NCT02362425|26107627|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2|||
13166735|NCT02362425|26107628|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
13166736|NCT02362425|26107629|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
13166737|NCT02362425|26107630|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
13166738|NCT02362425|26107627|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1|||
13166739|NCT02362425|26107628|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
13166740|NCT02362425|26107629|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
13166741|NCT02362425|26107630|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
13166742|NCT02362425|26107627|FG000|Phase 1 (up to 6 Months)|Screening failure|1|||
13166743|NCT02362425|26107628|FG001|Phase 1 (up to 6 Months)|Screening failure|0|||
13166744|NCT02362425|26107629|FG002|Phase 1 (up to 6 Months)|Screening failure|0|||
13166745|NCT02362425|26107630|FG003|Phase 1 (up to 6 Months)|Screening failure|0|||
13166746|NCT02362425|26107627|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3|||
13166747|NCT02362425|26107628|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
13166748|NCT02362425|26107629|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
13166749|NCT02362425|26107630|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
13166750|NCT02362425|26107627|FG000|Phase 1 (up to 6 Months)|Study closure|9|||
13166751|NCT02362425|26107628|FG001|Phase 1 (up to 6 Months)|Study closure|0|||
13166752|NCT02362425|26107629|FG002|Phase 1 (up to 6 Months)|Study closure|0|||
13107190|NCT03285711|25886328|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0|||
13107191|NCT03285711|25886325|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1|||
13107192|NCT03285711|25886326|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
13107193|NCT03285711|25886327|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
13107194|NCT03285711|25886328|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
13107195|NCT03285711|25886325|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
13107196|NCT03285711|25886326|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
13107197|NCT03285711|25886327|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1|||
13107198|NCT03285711|25886328|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
13107199|NCT03285711|25886325|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
13107200|NCT03285711|25886326|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1|||
13107201|NCT03285711|25886327|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
13107202|NCT03285711|25886328|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
13107203|NCT03285646|25886366|FG000|Overall Study|Adverse Event|1|||
13107204|NCT03285646|25886367|FG001|Overall Study|Adverse Event|0|||
13166753|NCT02362425|26107630|FG003|Phase 1 (up to 6 Months)|Study closure|0|||
13166754|NCT02362425|26107627|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
13166755|NCT02362425|26107628|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
13166756|NCT02362425|26107629|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
13166757|NCT02362425|26107630|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2|||
13166758|NCT02362425|26107627|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
13166759|NCT02362425|26107628|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
13166760|NCT02362425|26107629|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
13166761|NCT02362425|26107630|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1|||
13107205|NCT03285646|25886366|FG000|Overall Study|Withdrawal by Subject|10|||
13166762|NCT02362425|26107627|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
13166763|NCT02362425|26107628|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
13166764|NCT02362425|26107629|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1|||
13166765|NCT02362425|26107630|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
13166766|NCT02362412|26107659|FG000|Treatment Period III|Lost to Follow-up|0|||
13166767|NCT02362412|26107660|FG001|Treatment Period III|Lost to Follow-up|1|||
13166768|NCT02362360|26107669|FG000|Period 1|Lack of Efficacy|1|||
13166769|NCT02362360|26107670|FG001|Period 1|Lack of Efficacy|0|||
13166770|NCT02362360|26107669|FG000|Period 1|Withdrawal by Subject|2|||
13166771|NCT02362360|26107670|FG001|Period 1|Withdrawal by Subject|1|||
13166772|NCT02362282|26107683|FG000|Overall Study|Withdrawal by Subject|1|||
13166773|NCT02362282|26107684|FG001|Overall Study|Withdrawal by Subject|0|||
13166774|NCT02362269|26107697|FG000|Overall Study|Moved|1|||
13107206|NCT03285646|25886367|FG001|Overall Study|Withdrawal by Subject|2|||
13107207|NCT03285646|25886366|FG000|Overall Study|Lost to Follow-up|2|||
13107208|NCT03285646|25886367|FG001|Overall Study|Lost to Follow-up|1|||
13107209|NCT03285646|25886366|FG000|Overall Study|Investigator/Sponsor Decision|0|||
13166775|NCT02362269|26107698|FG001|Overall Study|Moved|0|||
13166776|NCT02362269|26107697|FG000|Overall Study|Lost to Follow-up|0|||
13166777|NCT02362269|26107698|FG001|Overall Study|Lost to Follow-up|6|||
13166778|NCT02361762|26107735|FG000|Overall Study|Withdrawal by Subject|0|||
13166779|NCT02361762|26107736|FG001|Overall Study|Withdrawal by Subject|1|||
13166780|NCT02361762|26107735|FG000|Overall Study|Lost to Follow-up|0|||
13166781|NCT02361762|26107736|FG001|Overall Study|Lost to Follow-up|1|||
13166782|NCT02361580|26107753|FG000|Overall Study|Lost to Follow-up|6|||
13166783|NCT02361580|26107754|FG001|Overall Study|Lost to Follow-up|3|||
13166784|NCT02361346|26107903|FG000|Part 1 and 2 ( Up to Day 112)|Death|0|||
13166785|NCT02361346|26107904|FG001|Part 1 and 2 ( Up to Day 112)|Death|0|||
13166786|NCT02361346|26107905|FG002|Part 1 and 2 ( Up to Day 112)|Death|0|||
13166787|NCT02361346|26107906|FG003|Part 1 and 2 ( Up to Day 112)|Death|1|||
13166788|NCT02361346|26107907|FG004|Part 1 and 2 ( Up to Day 112)|Death|0|||
13166789|NCT02361346|26107908|FG005|Part 1 and 2 ( Up to Day 112)|Death|0|||
13166790|NCT02361346|26107909|FG006|Part 1 and 2 ( Up to Day 112)|Death|0|||
13166791|NCT02361346|26107910|FG007|Part 1 and 2 ( Up to Day 112)|Death|0|||
13166792|NCT02361346|26107911|FG008|Part 1 and 2 ( Up to Day 112)|Death|0|||
13166793|NCT02361346|26107903|FG000|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
13166794|NCT02361346|26107904|FG001|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
13166795|NCT02361346|26107905|FG002|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
13166796|NCT02361346|26107906|FG003|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
13166797|NCT02361346|26107907|FG004|Part 1 and 2 ( Up to Day 112)|Adverse Event|2|||
13166798|NCT02361346|26107908|FG005|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
13166799|NCT02361346|26107909|FG006|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
13166800|NCT02361346|26107910|FG007|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
13166801|NCT02361346|26107911|FG008|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
13166802|NCT02361346|26107903|FG000|Part 3 (Up to Day 112)|Adverse Event|0|||
13166803|NCT02361346|26107904|FG001|Part 3 (Up to Day 112)|Adverse Event|0|||
13166804|NCT02361346|26107905|FG002|Part 3 (Up to Day 112)|Adverse Event|0|||
13166805|NCT02361346|26107906|FG003|Part 3 (Up to Day 112)|Adverse Event|0|||
13166806|NCT02361346|26107907|FG004|Part 3 (Up to Day 112)|Adverse Event|0|||
13107210|NCT03285646|25886367|FG001|Overall Study|Investigator/Sponsor Decision|1|||
13107211|NCT03285594|25886409|FG000|Overall Study|At the Participant's Own Request|10|||
13107212|NCT03285594|25886410|FG001|Overall Study|At the Participant's Own Request|5|||
13107213|NCT03285594|25886411|FG002|Overall Study|At the Participant's Own Request|21|||
13107214|NCT03285594|25886409|FG000|Overall Study|Adverse Event|2|||
13107215|NCT03285594|25886410|FG001|Overall Study|Adverse Event|2|||
13107216|NCT03285594|25886411|FG002|Overall Study|Adverse Event|6|||
13107217|NCT03285594|25886409|FG000|Overall Study|Poor Compliance to Protocol|0|||
13107218|NCT03285594|25886410|FG001|Overall Study|Poor Compliance to Protocol|0|||
13107219|NCT03285594|25886411|FG002|Overall Study|Poor Compliance to Protocol|1|||
13107220|NCT03285594|25886409|FG000|Overall Study|Lost to Follow-up|0|||
13107221|NCT03285594|25886410|FG001|Overall Study|Lost to Follow-up|0|||
13107222|NCT03285594|25886411|FG002|Overall Study|Lost to Follow-up|1|||
13107223|NCT03285594|25886409|FG000|Overall Study|Reason Not Specified|3|||
13166807|NCT02361346|26107908|FG005|Part 3 (Up to Day 112)|Adverse Event|0|||
13166808|NCT02361346|26107909|FG006|Part 3 (Up to Day 112)|Adverse Event|0|||
13166809|NCT02361346|26107910|FG007|Part 3 (Up to Day 112)|Adverse Event|1|||
13166810|NCT02361346|26107911|FG008|Part 3 (Up to Day 112)|Adverse Event|0|||
13166811|NCT02361346|26107903|FG000|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
13166812|NCT02361346|26107904|FG001|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
13166813|NCT02361346|26107905|FG002|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
13166814|NCT02361346|26107906|FG003|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
13166815|NCT02361346|26107907|FG004|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
13166816|NCT02361346|26107908|FG005|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
13166817|NCT02361346|26107909|FG006|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
13166818|NCT02361346|26107910|FG007|Part 3 (Up to Day 112)|Withdrawal by Subject|1|||
13166819|NCT02361346|26107911|FG008|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
13166820|NCT02361346|26107903|FG000|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
13166821|NCT02361346|26107904|FG001|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
13166822|NCT02361346|26107905|FG002|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
13166823|NCT02361346|26107906|FG003|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
13166824|NCT02361346|26107907|FG004|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
13166825|NCT02361346|26107908|FG005|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
13166826|NCT02361346|26107909|FG006|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
13166827|NCT02361346|26107910|FG007|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|7|||
13166828|NCT02361346|26107911|FG008|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
13166829|NCT02361346|26107903|FG000|Part 3 (Up to Day 112)|Clinical disease progression|0|||
13166830|NCT02361346|26107904|FG001|Part 3 (Up to Day 112)|Clinical disease progression|0|||
13166831|NCT02361346|26107905|FG002|Part 3 (Up to Day 112)|Clinical disease progression|0|||
13166832|NCT02361346|26107906|FG003|Part 3 (Up to Day 112)|Clinical disease progression|0|||
13166833|NCT02361346|26107907|FG004|Part 3 (Up to Day 112)|Clinical disease progression|0|||
13166834|NCT02361346|26107908|FG005|Part 3 (Up to Day 112)|Clinical disease progression|0|||
13166835|NCT02361346|26107909|FG006|Part 3 (Up to Day 112)|Clinical disease progression|0|||
13166836|NCT02361346|26107910|FG007|Part 3 (Up to Day 112)|Clinical disease progression|2|||
13166837|NCT02361346|26107911|FG008|Part 3 (Up to Day 112)|Clinical disease progression|0|||
13166838|NCT02361307|26107924|FG000|Overall Study|Unstable medical condition.|0|||
13166839|NCT02361307|26107925|FG001|Overall Study|Unstable medical condition.|1|||
13166840|NCT02361216|26107944|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0|||
13166841|NCT02361216|26107945|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1|||
13166842|NCT02361216|26107944|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1|||
13166843|NCT02361216|26107945|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2|||
13166844|NCT02361216|26107944|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1|||
13166845|NCT02361216|26107945|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0|||
13166846|NCT02361216|26107944|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6|||
13166847|NCT02361216|26107945|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11|||
13166848|NCT02361216|26107944|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
13166849|NCT02361216|26107945|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
13166850|NCT02361216|26107944|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0|||
13166851|NCT02361216|26107945|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2|||
13166852|NCT02360995|26107978|FG000|Overall Study|Lost to Follow-up|2|||
13166853|NCT02360995|26107979|FG001|Overall Study|Lost to Follow-up|0|||
13166854|NCT02360995|26107980|FG002|Overall Study|Lost to Follow-up|2|||
13166855|NCT02360995|26107978|FG000|Overall Study|Withdrawal by Subject|0|||
13166856|NCT02360995|26107979|FG001|Overall Study|Withdrawal by Subject|1|||
13166857|NCT02360995|26107980|FG002|Overall Study|Withdrawal by Subject|0|||
13166858|NCT02360605|26107997|FG000|Overall Study|Withdrawal by Subject|4|||
13166859|NCT02360605|26107998|FG001|Overall Study|Withdrawal by Subject|9|||
13166860|NCT02360605|26107997|FG000|Overall Study|Lost to Follow-up|7|||
13166861|NCT02360605|26107998|FG001|Overall Study|Lost to Follow-up|8|||
13166862|NCT02360605|26107997|FG000|Overall Study|Death|0|||
13166863|NCT02360605|26107998|FG001|Overall Study|Death|1|||
13166864|NCT02360475|26108069|FG000|Overall Study|Lost to Follow-up|4|||
13166865|NCT02360475|26108070|FG001|Overall Study|Lost to Follow-up|12|||
13166866|NCT02360475|26108071|FG002|Overall Study|Lost to Follow-up|6|||
13107224|NCT03285594|25886410|FG001|Overall Study|Reason Not Specified|4|||
13107225|NCT03285594|25886411|FG002|Overall Study|Reason Not Specified|8|||
13107226|NCT03285490|25886445|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
13107227|NCT03285490|25886446|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1|||
13107228|NCT03285490|25886445|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18|||
13107229|NCT03285490|25886446|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60|||
13107230|NCT03285477|25886480|FG000|Treatment and Response Assessment Period|Death|1|||
13107231|NCT03285477|25886481|FG001|Treatment and Response Assessment Period|Death|0|||
13166867|NCT02360475|26108072|FG003|Overall Study|Lost to Follow-up|4|||
13166868|NCT02360475|26108069|FG000|Overall Study|Withdrawal by Subject|0|||
13166869|NCT02360475|26108070|FG001|Overall Study|Withdrawal by Subject|1|||
13166870|NCT02360475|26108071|FG002|Overall Study|Withdrawal by Subject|2|||
13166871|NCT02360475|26108072|FG003|Overall Study|Withdrawal by Subject|0|||
13166872|NCT02360475|26108069|FG000|Overall Study|Migrated/moved from study area|0|||
13166873|NCT02360475|26108070|FG001|Overall Study|Migrated/moved from study area|0|||
13166874|NCT02360475|26108071|FG002|Overall Study|Migrated/moved from study area|0|||
13166875|NCT02360475|26108072|FG003|Overall Study|Migrated/moved from study area|1|||
13166876|NCT02360397|26108081|FG000|Overall Study|Incomplete screening|3|||
13166877|NCT02360397|26108081|FG000|Overall Study|Adverse Event|1|||
13166878|NCT02360293|26108100|FG000|Overall Study|Lost to Follow-up|73|||
13166879|NCT02360293|26108101|FG001|Overall Study|Lost to Follow-up|95|||
13166880|NCT02360293|26108100|FG000|Overall Study|Withdrawal by Subject|2|||
13166881|NCT02360293|26108101|FG001|Overall Study|Withdrawal by Subject|1|||
13166882|NCT02360293|26108100|FG000|Overall Study|Excluded|1|||
13166883|NCT02360293|26108101|FG001|Overall Study|Excluded|0|||
13166884|NCT02360280|26108120|FG000|Overall Study|Withdrawal by Subject|2|||
13166885|NCT02360280|26108121|FG001|Overall Study|Withdrawal by Subject|0|||
13166886|NCT02360280|26108120|FG000|Overall Study|Adverse Event|0|||
13166887|NCT02360280|26108121|FG001|Overall Study|Adverse Event|1|||
13166888|NCT02360280|26108120|FG000|Overall Study|Lost to Follow-up|1|||
13166889|NCT02360280|26108121|FG001|Overall Study|Lost to Follow-up|0|||
13166890|NCT02360228|26108157|FG000|Overall Study|Withdrawal by Subject|1|||
13166891|NCT02360228|26108158|FG001|Overall Study|Withdrawal by Subject|0|||
13166892|NCT02360228|26108159|FG002|Overall Study|Withdrawal by Subject|0|||
13166893|NCT02360228|26108157|FG000|Overall Study|Self-discontinued medication|0|||
13107232|NCT03285477|25886480|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1|||
13107233|NCT03285477|25886481|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0|||
13107234|NCT03285477|25886480|FG000|Recurrence Follow-up Period|Lost to Follow-up|0|||
13107235|NCT03285477|25886481|FG001|Recurrence Follow-up Period|Lost to Follow-up|1|||
13107236|NCT03285477|25886480|FG000|Recurrence Follow-up Period|Withdrawal of consent|1|||
13107237|NCT03285477|25886481|FG001|Recurrence Follow-up Period|Withdrawal of consent|3|||
13107238|NCT03285477|25886480|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5|||
13107239|NCT03285477|25886481|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51|||
13107240|NCT03285308|25886515|FG000|Overall Study|Adverse Event|3|||
13107241|NCT03285308|25886516|FG001|Overall Study|Adverse Event|7|||
13107242|NCT03285308|25886515|FG000|Overall Study|Withdrawal by Subject|8|||
13107243|NCT03285308|25886516|FG001|Overall Study|Withdrawal by Subject|9|||
13107244|NCT03285308|25886515|FG000|Overall Study|Lost to Follow-up|3|||
13107245|NCT03285308|25886516|FG001|Overall Study|Lost to Follow-up|1|||
13107246|NCT03285308|25886515|FG000|Overall Study|Protocol Deviation|6|||
13107247|NCT03285308|25886516|FG001|Overall Study|Protocol Deviation|5|||
13107248|NCT03285308|25886515|FG000|Overall Study|Reason not Specified|0|||
13107249|NCT03285308|25886516|FG001|Overall Study|Reason not Specified|1|||
13107250|NCT03285295|25886561|FG000|Alinity s HBsAg|Protocol Violation|11|||
13107251|NCT03285295|25886562|FG001|Alinity s HBsAg|Protocol Violation|0|||
13107252|NCT03285295|25886563|FG002|Alinity s HBsAg|Protocol Violation|0|||
13107253|NCT03285295|25886564|FG003|Alinity s HBsAg|Protocol Violation|0|||
13107254|NCT03285295|25886565|FG004|Alinity s HBsAg|Protocol Violation|0|||
13107255|NCT03285295|25886561|FG000|Alinity s HBsAg|No Result on Comparator Assay|17|||
13107256|NCT03285295|25886562|FG001|Alinity s HBsAg|No Result on Comparator Assay|0|||
13107257|NCT03285295|25886563|FG002|Alinity s HBsAg|No Result on Comparator Assay|0|||
13166894|NCT02360228|26108158|FG001|Overall Study|Self-discontinued medication|1|||
13166895|NCT02360228|26108159|FG002|Overall Study|Self-discontinued medication|0|||
13166896|NCT02360228|26108157|FG000|Overall Study|Unstable symptoms during screening|0|||
13166897|NCT02360228|26108158|FG001|Overall Study|Unstable symptoms during screening|0|||
13166898|NCT02360228|26108159|FG002|Overall Study|Unstable symptoms during screening|1|||
13166899|NCT02360111|26108169|FG000|Overall Study|Death|2|||
13166900|NCT02360098|26108180|FG000|Overall Study|Physician Decision|7|||
13166901|NCT02359994|26108195|FG000|Overall Population Study|Adverse Event|1|||
13166902|NCT02359994|26108196|FG001|Overall Population Study|Adverse Event|1|||
13166903|NCT02359994|26108195|FG000|Overall Population Study|Death|1|||
13166904|NCT02359994|26108196|FG001|Overall Population Study|Death|5|||
13166905|NCT02359994|26108195|FG000|Overall Population Study|Lost to Follow-up|1|||
13166906|NCT02359994|26108196|FG001|Overall Population Study|Lost to Follow-up|1|||
13166907|NCT02359994|26108195|FG000|Overall Population Study|Withdrawal by Subject|1|||
13166908|NCT02359994|26108196|FG001|Overall Population Study|Withdrawal by Subject|0|||
13166909|NCT02359994|26108195|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1|||
13166910|NCT02359994|26108196|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0|||
13166911|NCT02359994|26108195|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0|||
13166912|NCT02359994|26108196|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1|||
13166913|NCT02359994|26108195|FG000|Extended Oncology 24-Month Survival|Death|19|||
13166914|NCT02359994|26108196|FG001|Extended Oncology 24-Month Survival|Death|21|||
13166915|NCT02359994|26108195|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1|||
13166916|NCT02359994|26108196|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0|||
13166917|NCT02359903|26108211|FG000|Overall Study|Adverse Event|0|||
13166918|NCT02359903|26108212|FG001|Overall Study|Adverse Event|2|||
13166919|NCT02359890|26108221|FG000|Overall Study|Not meeting eligibility|4|||
13166920|NCT02359890|26108221|FG000|Overall Study|Never treated with study catheter|6|||
13166921|NCT02359877|26108284|FG000|Overall Study|Withdrawal by Subject|1|||
13166922|NCT02359877|26108285|FG001|Overall Study|Withdrawal by Subject|0|||
13166923|NCT02359877|26108286|FG002|Overall Study|Withdrawal by Subject|0|||
13166924|NCT02359877|26108287|FG003|Overall Study|Withdrawal by Subject|2|||
13166925|NCT02359877|26108284|FG000|Overall Study|Adverse Event|0|||
13166926|NCT02359877|26108285|FG001|Overall Study|Adverse Event|0|||
13166927|NCT02359877|26108286|FG002|Overall Study|Adverse Event|0|||
13166928|NCT02359877|26108287|FG003|Overall Study|Adverse Event|1|||
13166929|NCT02359851|26108297|FG000|Overall Study|Death|1|||
13166930|NCT02359851|26108297|FG000|Overall Study|Disease progression|1|||
13166931|NCT02359552|26108324|FG000|Overall Study|Lost to Follow-up|3|||
13166932|NCT02359552|26108325|FG001|Overall Study|Lost to Follow-up|4|||
13166933|NCT02359435|26108338|FG000|Overall Study|Lost to Follow-up|4|||
13166934|NCT02359435|26108339|FG001|Overall Study|Lost to Follow-up|4|||
13166935|NCT02359045|26108579|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
13166936|NCT02359045|26108580|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
13166937|NCT02359045|26108579|FG000|Overall Study|Lost to Follow-up|1|||
13166938|NCT02359045|26108580|FG001|Overall Study|Lost to Follow-up|1|||
13166939|NCT02359045|26108579|FG000|Overall Study|Adverse Event|0|||
13166940|NCT02359045|26108580|FG001|Overall Study|Adverse Event|1|||
13166941|NCT02358863|26108586|FG000|Overall Study|Physician Decision|3|||
13166942|NCT02358668|26108736|FG000|Overall Study|Adverse Event|2|||
13166943|NCT02358668|26108737|FG001|Overall Study|Adverse Event|0|||
13166944|NCT02358668|26108738|FG002|Overall Study|Adverse Event|0|||
13166945|NCT02358668|26108736|FG000|Overall Study|Withdrawal by Subject|0|||
13166946|NCT02358668|26108737|FG001|Overall Study|Withdrawal by Subject|1|||
13166947|NCT02358668|26108738|FG002|Overall Study|Withdrawal by Subject|0|||
13166948|NCT02358538|26108781|FG000|Through Week 26|Adverse Event|0|||
13166949|NCT02358538|26108782|FG001|Through Week 26|Adverse Event|1|||
13166950|NCT02358538|26108783|FG002|Through Week 26|Adverse Event|1|||
13166951|NCT02358538|26108784|FG003|Through Week 26|Adverse Event|2|||
13166952|NCT02358538|26108781|FG000|Through Week 26|Lack of Efficacy|1|||
13166953|NCT02358538|26108782|FG001|Through Week 26|Lack of Efficacy|1|||
13166954|NCT02358538|26108783|FG002|Through Week 26|Lack of Efficacy|3|||
13166955|NCT02358538|26108784|FG003|Through Week 26|Lack of Efficacy|3|||
13166956|NCT02358538|26108781|FG000|Through Week 26|Withdrawal by Subject|1|||
13166957|NCT02358538|26108782|FG001|Through Week 26|Withdrawal by Subject|0|||
13166958|NCT02358538|26108783|FG002|Through Week 26|Withdrawal by Subject|0|||
13166959|NCT02358538|26108784|FG003|Through Week 26|Withdrawal by Subject|0|||
13166960|NCT02358538|26108781|FG000|Through Week 26|Non-Compliance|0|||
13166961|NCT02358538|26108782|FG001|Through Week 26|Non-Compliance|0|||
13166962|NCT02358538|26108783|FG002|Through Week 26|Non-Compliance|1|||
13166963|NCT02358538|26108784|FG003|Through Week 26|Non-Compliance|0|||
13166964|NCT02358538|26108781|FG000|Through Week 26|Family did not see benefit from IP|1|||
13166965|NCT02358538|26108782|FG001|Through Week 26|Family did not see benefit from IP|0|||
13166966|NCT02358538|26108783|FG002|Through Week 26|Family did not see benefit from IP|0|||
13166967|NCT02358538|26108784|FG003|Through Week 26|Family did not see benefit from IP|0|||
13166968|NCT02358538|26108781|FG000|52 Week Extension Period|Lack of Efficacy|0|||
13166969|NCT02358538|26108782|FG001|52 Week Extension Period|Lack of Efficacy|0|||
13166970|NCT02358538|26108783|FG002|52 Week Extension Period|Lack of Efficacy|2|||
13166971|NCT02358538|26108784|FG003|52 Week Extension Period|Lack of Efficacy|4|||
13166972|NCT02358473|26108795|FG000|Overall Study|Disease Progession|6|||
13166973|NCT02358473|26108795|FG000|Overall Study|Adverse Event|3|||
13166974|NCT02358473|26108795|FG000|Overall Study|Withdrawal by Subject|2|||
13166975|NCT02358473|26108795|FG000|Overall Study|Physician Decision|2|||
13166976|NCT02358369|26108848|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35|||
13166977|NCT02358369|26108849|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
13166978|NCT02358369|26108850|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
13166979|NCT02358369|26108851|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
13166980|NCT02358369|26108852|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
13166981|NCT02358369|26108848|FG000|Treatment Period A/B|Adverse Event|0|||
13166982|NCT02358369|26108849|FG001|Treatment Period A/B|Adverse Event|0|||
13166983|NCT02358369|26108850|FG002|Treatment Period A/B|Adverse Event|1|||
13166984|NCT02358369|26108851|FG003|Treatment Period A/B|Adverse Event|2|||
13166985|NCT02358369|26108852|FG004|Treatment Period A/B|Adverse Event|0|||
13166986|NCT02358369|26108848|FG000|Treatment Period A/B|Death|0|||
13166987|NCT02358369|26108849|FG001|Treatment Period A/B|Death|0|||
13166988|NCT02358369|26108850|FG002|Treatment Period A/B|Death|1|||
13166989|NCT02358369|26108851|FG003|Treatment Period A/B|Death|0|||
13166990|NCT02358369|26108852|FG004|Treatment Period A/B|Death|0|||
13166991|NCT02358369|26108848|FG000|Treatment Period A/B|Withdrawal by Subject|0|||
13166992|NCT02358369|26108849|FG001|Treatment Period A/B|Withdrawal by Subject|2|||
13166993|NCT02358369|26108850|FG002|Treatment Period A/B|Withdrawal by Subject|0|||
13166994|NCT02358369|26108851|FG003|Treatment Period A/B|Withdrawal by Subject|2|||
13166995|NCT02358369|26108852|FG004|Treatment Period A/B|Withdrawal by Subject|0|||
13166996|NCT02358369|26108848|FG000|Treatment Period C|Adverse Event|0|||
13166997|NCT02358369|26108849|FG001|Treatment Period C|Adverse Event|0|||
13166998|NCT02358369|26108850|FG002|Treatment Period C|Adverse Event|0|||
13166999|NCT02358369|26108851|FG003|Treatment Period C|Adverse Event|0|||
13167000|NCT02358369|26108852|FG004|Treatment Period C|Adverse Event|7|||
13167001|NCT02358343|26108903|FG000|Screening Intervention|Death|0|||
13167002|NCT02358343|26108904|FG001|Screening Intervention|Death|2|||
13167003|NCT02358343|26108905|FG002|Screening Intervention|Death|0|||
13167004|NCT02358343|26108906|FG003|Screening Intervention|Death|0|||
13167005|NCT02358343|26108907|FG004|Screening Intervention|Death|0|||
13167006|NCT02358343|26108903|FG000|Screening Intervention|Withdrawal by Subject|1|||
13167007|NCT02358343|26108904|FG001|Screening Intervention|Withdrawal by Subject|0|||
13167008|NCT02358343|26108905|FG002|Screening Intervention|Withdrawal by Subject|0|||
13167009|NCT02358343|26108906|FG003|Screening Intervention|Withdrawal by Subject|0|||
13167010|NCT02358343|26108907|FG004|Screening Intervention|Withdrawal by Subject|0|||
13167011|NCT02358343|26108903|FG000|Screening Intervention|Determined Ineligible|5|||
13167012|NCT02358343|26108904|FG001|Screening Intervention|Determined Ineligible|6|||
13167013|NCT02358343|26108905|FG002|Screening Intervention|Determined Ineligible|0|||
13167014|NCT02358343|26108906|FG003|Screening Intervention|Determined Ineligible|0|||
13167015|NCT02358343|26108907|FG004|Screening Intervention|Determined Ineligible|0|||
13167016|NCT02358343|26108903|FG000|Comparative Efficacy Trial / Observation|Death|0|||
13167017|NCT02358343|26108904|FG001|Comparative Efficacy Trial / Observation|Death|0|||
13167018|NCT02358343|26108905|FG002|Comparative Efficacy Trial / Observation|Death|2|||
13167019|NCT02358343|26108906|FG003|Comparative Efficacy Trial / Observation|Death|0|||
13167020|NCT02358343|26108907|FG004|Comparative Efficacy Trial / Observation|Death|0|||
13167021|NCT02358343|26108903|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
13167022|NCT02358343|26108904|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
13167023|NCT02358343|26108905|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
13167024|NCT02358343|26108906|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
13107258|NCT03285295|25886564|FG003|Alinity s HBsAg|No Result on Comparator Assay|0|||
13107259|NCT03285295|25886565|FG004|Alinity s HBsAg|No Result on Comparator Assay|0|||
13107260|NCT03285295|25886561|FG000|Alinity s HBsAg|No Results Generated|74|||
13107261|NCT03285295|25886562|FG001|Alinity s HBsAg|No Results Generated|6|||
13167025|NCT02358343|26108907|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
13167026|NCT02358343|26108903|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
13107262|NCT03285295|25886563|FG002|Alinity s HBsAg|No Results Generated|0|||
13107263|NCT03285295|25886564|FG003|Alinity s HBsAg|No Results Generated|0|||
13107264|NCT03285295|25886565|FG004|Alinity s HBsAg|No Results Generated|0|||
13107265|NCT03285295|25886561|FG000|Alinity s HTLV I/II|Protocol Violation|6|||
13107266|NCT03285295|25886562|FG001|Alinity s HTLV I/II|Protocol Violation|0|||
13167027|NCT02358343|26108904|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
13167028|NCT02358343|26108905|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1|||
13167029|NCT02358343|26108906|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
13167030|NCT02358343|26108907|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
13167031|NCT02358044|26108930|FG000|Overall Study|Adverse Event|0|||
13167032|NCT02358044|26108931|FG001|Overall Study|Adverse Event|1|||
13167033|NCT02358044|26108930|FG000|Overall Study|Lost to Follow-up|2|||
13167034|NCT02358044|26108931|FG001|Overall Study|Lost to Follow-up|1|||
13167035|NCT02358044|26108930|FG000|Overall Study|Physician Decision|0|||
13167036|NCT02358044|26108931|FG001|Overall Study|Physician Decision|1|||
13167037|NCT02358044|26108930|FG000|Overall Study|Withdrawal by Subject|0|||
13167038|NCT02358044|26108931|FG001|Overall Study|Withdrawal by Subject|4|||
13167039|NCT02357979|26108948|FG000|Overall Study|Lost to Follow-up|5|||
13167040|NCT02357979|26108949|FG001|Overall Study|Lost to Follow-up|5|||
13167041|NCT02357940|26109080|FG000|Overall Study|Adverse Event|0|||
13167042|NCT02357940|26109081|FG001|Overall Study|Adverse Event|1|||
13167043|NCT02357940|26109080|FG000|Overall Study|Investigator's judgement|0|||
13167044|NCT02357940|26109081|FG001|Overall Study|Investigator's judgement|1|||
13167045|NCT02357901|26109142|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161|||
13167046|NCT02357901|26109143|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
13167047|NCT02357901|26109144|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
13167048|NCT02357901|26109145|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
13167049|NCT02357901|26109142|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0|||
13167050|NCT02357901|26109143|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26|||
13107267|NCT03285295|25886563|FG002|Alinity s HTLV I/II|Protocol Violation|0|||
13167051|NCT02357901|26109144|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23|||
13167052|NCT02357901|26109145|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12|||
13167053|NCT02357901|26109142|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
13167054|NCT02357901|26109143|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20|||
13167055|NCT02357901|26109144|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21|||
13167056|NCT02357901|26109145|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18|||
13167057|NCT02357901|26109142|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0|||
13167058|NCT02357901|26109143|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3|||
13167059|NCT02357901|26109144|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5|||
13167060|NCT02357901|26109145|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18|||
13167061|NCT02357901|26109142|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0|||
13167062|NCT02357901|26109143|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6|||
13167063|NCT02357901|26109144|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10|||
13167064|NCT02357901|26109145|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2|||
13167065|NCT02357901|26109142|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
13167066|NCT02357901|26109143|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2|||
13167067|NCT02357901|26109144|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5|||
13167068|NCT02357901|26109145|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
13167069|NCT02357901|26109142|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0|||
13167070|NCT02357901|26109143|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
13167071|NCT02357901|26109144|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
13167072|NCT02357901|26109145|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3|||
13167073|NCT02357901|26109142|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
13167074|NCT02357901|26109143|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
13167075|NCT02357901|26109144|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
13167076|NCT02357901|26109145|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
13167077|NCT02357901|26109142|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
13167078|NCT02357901|26109143|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1|||
13167079|NCT02357901|26109144|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
13167080|NCT02357901|26109145|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3|||
13167081|NCT02357901|26109142|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
13167082|NCT02357901|26109143|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
13167083|NCT02357901|26109144|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
13167084|NCT02357901|26109145|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
13167085|NCT02357901|26109142|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0|||
13167086|NCT02357901|26109143|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17|||
13167087|NCT02357901|26109144|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6|||
13167088|NCT02357901|26109145|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7|||
13167089|NCT02357810|26109161|FG000|Registered and Started Treatment|Withdrawal by Subject|1|||
13167090|NCT02357810|26109161|FG000|Registered and Started Treatment|Found not to be eligible for the study|26|||
13167091|NCT02357810|26109161|FG000|Reached 12 Weeks Response|Adverse Event|5|||
13167092|NCT02357810|26109161|FG000|Reached 12 Weeks Response|Progressive Disease|39|||
13167093|NCT02357810|26109161|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8|||
13167094|NCT02357810|26109161|FG000|Reached 12 Weeks Response|Protocol Violation|1|||
13167095|NCT02357810|26109161|FG000|Reached 12 Weeks Response|Death|1|||
13167096|NCT02357810|26109161|FG000|Reached 12 Weeks Response|Physician Decision|1|||
13167097|NCT02357810|26109161|FG000|Reached 12 Weeks Response|Other|1|||
13167098|NCT02357810|26109161|FG000|12 Week Response and Further Treatment|Adverse Event|5|||
13167099|NCT02357810|26109161|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1|||
13167100|NCT02357810|26109161|FG000|12 Week Response and Further Treatment|Progressive Disease|15|||
13167101|NCT02357810|26109161|FG000|12 Week Response and Further Treatment|Wound Complications|1|||
13167102|NCT02357810|26109161|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4|||
13167103|NCT02357810|26109161|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3|||
13167104|NCT02357576|26109212|FG000|Treatment Period|Withdrawal by Subject|0|||
13167105|NCT02357576|26109213|FG001|Treatment Period|Withdrawal by Subject|1|||
13167106|NCT02357576|26109212|FG000|Treatment Period|Physician Decision|0|||
13167107|NCT02357576|26109213|FG001|Treatment Period|Physician Decision|1|||
13167108|NCT02357576|26109212|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
13167109|NCT02357576|26109213|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
13167110|NCT02357576|26109212|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1|||
13167111|NCT02357576|26109213|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0|||
13167112|NCT02357576|26109212|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1|||
13167113|NCT02357576|26109213|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4|||
13167114|NCT02357576|26109212|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2|||
13167115|NCT02357576|26109213|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0|||
13167116|NCT02357459|26109265|FG000|Overall Study|Adverse Event|0|||
13167117|NCT02357459|26109266|FG001|Overall Study|Adverse Event|1|||
13167118|NCT02357459|26109267|FG002|Overall Study|Adverse Event|1|||
13167119|NCT02357459|26109265|FG000|Overall Study|Withdrawal by Subject|5|||
13167120|NCT02357459|26109266|FG001|Overall Study|Withdrawal by Subject|3|||
13167121|NCT02357459|26109267|FG002|Overall Study|Withdrawal by Subject|3|||
13167122|NCT02357459|26109265|FG000|Overall Study|Physician Decision|0|||
13167123|NCT02357459|26109266|FG001|Overall Study|Physician Decision|2|||
13167124|NCT02357459|26109267|FG002|Overall Study|Physician Decision|0|||
13167125|NCT02357459|26109265|FG000|Overall Study|Protocol Violation|1|||
13167126|NCT02357459|26109266|FG001|Overall Study|Protocol Violation|1|||
13167127|NCT02357459|26109267|FG002|Overall Study|Protocol Violation|0|||
13167128|NCT02357459|26109265|FG000|Overall Study|Lost to Follow-up|1|||
13167129|NCT02357459|26109266|FG001|Overall Study|Lost to Follow-up|3|||
13167130|NCT02357459|26109267|FG002|Overall Study|Lost to Follow-up|0|||
13167131|NCT02357459|26109265|FG000|Overall Study|Lack of Efficacy|7|||
13167132|NCT02357459|26109266|FG001|Overall Study|Lack of Efficacy|4|||
13167133|NCT02357459|26109267|FG002|Overall Study|Lack of Efficacy|4|||
13167134|NCT02357459|26109265|FG000|Overall Study|Patient Relocated|2|||
13167135|NCT02357459|26109266|FG001|Overall Study|Patient Relocated|0|||
13167136|NCT02357459|26109267|FG002|Overall Study|Patient Relocated|0|||
13167137|NCT02357459|26109265|FG000|Overall Study|Instruction from PCP|1|||
13167138|NCT02357459|26109266|FG001|Overall Study|Instruction from PCP|0|||
13167139|NCT02357459|26109267|FG002|Overall Study|Instruction from PCP|0|||
13107268|NCT03285295|25886564|FG003|Alinity s HTLV I/II|Protocol Violation|0|||
13107269|NCT03285295|25886565|FG004|Alinity s HTLV I/II|Protocol Violation|0|||
13107270|NCT03285295|25886561|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15|||
13107271|NCT03285295|25886562|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
13107272|NCT03285295|25886563|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
13107273|NCT03285295|25886564|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
13107274|NCT03285295|25886565|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
13107275|NCT03285295|25886561|FG000|Alinity s HTLV I/II|No Results Generated|70|||
13107276|NCT03285295|25886562|FG001|Alinity s HTLV I/II|No Results Generated|0|||
13107277|NCT03285295|25886563|FG002|Alinity s HTLV I/II|No Results Generated|0|||
13107278|NCT03285295|25886564|FG003|Alinity s HTLV I/II|No Results Generated|0|||
13107279|NCT03285295|25886565|FG004|Alinity s HTLV I/II|No Results Generated|0|||
13107280|NCT03285295|25886561|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4|||
13107281|NCT03285295|25886562|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
13107282|NCT03285295|25886563|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
13107283|NCT03285295|25886564|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
13107284|NCT03285295|25886565|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
13107285|NCT03285295|25886561|FG000|Alinity s Anti-HCV|Protocol Violation|12|||
13107286|NCT03285295|25886562|FG001|Alinity s Anti-HCV|Protocol Violation|0|||
13107287|NCT03285295|25886563|FG002|Alinity s Anti-HCV|Protocol Violation|0|||
13107288|NCT03285295|25886564|FG003|Alinity s Anti-HCV|Protocol Violation|0|||
13107289|NCT03285295|25886565|FG004|Alinity s Anti-HCV|Protocol Violation|0|||
13107290|NCT03285295|25886561|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13|||
13167140|NCT02357459|26109265|FG000|Overall Study|Incarceration|0|||
13167141|NCT02357459|26109266|FG001|Overall Study|Incarceration|0|||
13167142|NCT02357459|26109267|FG002|Overall Study|Incarceration|1|||
13167143|NCT02357459|26109265|FG000|Overall Study|Pre-planned Knee surgery|0|||
13167144|NCT02357459|26109266|FG001|Overall Study|Pre-planned Knee surgery|0|||
13167145|NCT02357459|26109267|FG002|Overall Study|Pre-planned Knee surgery|2|||
13167146|NCT02357459|26109265|FG000|Overall Study|Job Commitments|0|||
13167147|NCT02357459|26109266|FG001|Overall Study|Job Commitments|0|||
13167148|NCT02357459|26109267|FG002|Overall Study|Job Commitments|1|||
13167149|NCT02357420|26109298|FG000|Overall Study|Adverse Event|3|||
13167150|NCT02357420|26109299|FG001|Overall Study|Adverse Event|3|||
13167151|NCT02357420|26109300|FG002|Overall Study|Adverse Event|8|||
13167152|NCT02357420|26109301|FG003|Overall Study|Adverse Event|9|||
13167153|NCT02357420|26109298|FG000|Overall Study|Investigator Decision|1|||
13167154|NCT02357420|26109299|FG001|Overall Study|Investigator Decision|0|||
13167155|NCT02357420|26109300|FG002|Overall Study|Investigator Decision|0|||
13167156|NCT02357420|26109301|FG003|Overall Study|Investigator Decision|0|||
13167157|NCT02357420|26109298|FG000|Overall Study|Prohibited Medication|1|||
13167158|NCT02357420|26109299|FG001|Overall Study|Prohibited Medication|1|||
13167159|NCT02357420|26109300|FG002|Overall Study|Prohibited Medication|0|||
13167160|NCT02357420|26109301|FG003|Overall Study|Prohibited Medication|0|||
13167161|NCT02357420|26109298|FG000|Overall Study|Protocol Non-compliance|0|||
13167162|NCT02357420|26109299|FG001|Overall Study|Protocol Non-compliance|0|||
13167163|NCT02357420|26109300|FG002|Overall Study|Protocol Non-compliance|0|||
13167164|NCT02357420|26109301|FG003|Overall Study|Protocol Non-compliance|1|||
13167165|NCT02357420|26109298|FG000|Overall Study|Withdrawn Consent|4|||
13167166|NCT02357420|26109299|FG001|Overall Study|Withdrawn Consent|8|||
13167167|NCT02357420|26109300|FG002|Overall Study|Withdrawn Consent|6|||
13167168|NCT02357420|26109301|FG003|Overall Study|Withdrawn Consent|6|||
13167169|NCT02357420|26109298|FG000|Overall Study|Lost to Follow-up|3|||
13167170|NCT02357420|26109299|FG001|Overall Study|Lost to Follow-up|0|||
13167171|NCT02357420|26109300|FG002|Overall Study|Lost to Follow-up|2|||
13167172|NCT02357420|26109301|FG003|Overall Study|Lost to Follow-up|3|||
13167173|NCT02357368|26109336|FG000|Overall Study|Lost to Follow-up|0|||
13167174|NCT02357368|26109337|FG001|Overall Study|Lost to Follow-up|0|||
13167175|NCT02357368|26109338|FG002|Overall Study|Lost to Follow-up|0|||
13167176|NCT02357368|26109339|FG003|Overall Study|Lost to Follow-up|1|||
13167177|NCT02357368|26109336|FG000|Overall Study|Pregnancy|3|||
13167178|NCT02357368|26109337|FG001|Overall Study|Pregnancy|2|||
13167179|NCT02357368|26109338|FG002|Overall Study|Pregnancy|0|||
13167180|NCT02357368|26109339|FG003|Overall Study|Pregnancy|0|||
13167181|NCT02357368|26109336|FG000|Overall Study|Withdrawal by Subject|3|||
13167182|NCT02357368|26109337|FG001|Overall Study|Withdrawal by Subject|1|||
13167183|NCT02357368|26109338|FG002|Overall Study|Withdrawal by Subject|1|||
13167184|NCT02357368|26109339|FG003|Overall Study|Withdrawal by Subject|2|||
13167185|NCT02357342|26109356|FG000|First 6 Months|Death|2|||
13167186|NCT02357342|26109357|FG001|First 6 Months|Death|0|||
13167187|NCT02357147|26109374|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
13167188|NCT02357147|26109375|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
13167189|NCT02357147|26109374|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0|||
13167190|NCT02357147|26109375|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1|||
13167191|NCT02357147|26109374|FG000|Combination Treatment Phase|Investigator Discretion|1|||
13167192|NCT02357147|26109375|FG001|Combination Treatment Phase|Investigator Discretion|1|||
13167193|NCT02357147|26109374|FG000|Combination Treatment Phase|Withdrawal by Subject|4|||
13167194|NCT02357147|26109375|FG001|Combination Treatment Phase|Withdrawal by Subject|2|||
13167195|NCT02357147|26109374|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4|||
13167196|NCT02357147|26109375|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1|||
13167197|NCT02357147|26109374|FG000|Combination Treatment Phase|Adverse Event|12|||
13167198|NCT02357147|26109375|FG001|Combination Treatment Phase|Adverse Event|4|||
13167199|NCT02357147|26109374|FG000|Combination Treatment Phase|Death|1|||
13167200|NCT02357147|26109375|FG001|Combination Treatment Phase|Death|1|||
13167201|NCT02357147|26109374|FG000|Combination Treatment Phase|Sponsor Decision|0|||
13167202|NCT02357147|26109375|FG001|Combination Treatment Phase|Sponsor Decision|12|||
13167203|NCT02357147|26109374|FG000|Combination Treatment Phase|Other|1|||
13167204|NCT02357147|26109375|FG001|Combination Treatment Phase|Other|0|||
13167205|NCT02357147|26109374|FG000|Combination Treatment Phase|Not treated|0|||
13167206|NCT02357147|26109375|FG001|Combination Treatment Phase|Not treated|2|||
13167207|NCT02357147|26109374|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15|||
13167208|NCT02357147|26109375|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10|||
13167209|NCT02357147|26109374|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
13167210|NCT02357147|26109375|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1|||
13167211|NCT02357147|26109374|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10|||
13167212|NCT02357147|26109375|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0|||
13167213|NCT02357147|26109374|FG000|Maintenance Treatment Phase|Adverse Event|0|||
13167214|NCT02357147|26109375|FG001|Maintenance Treatment Phase|Adverse Event|3|||
13167215|NCT02357147|26109374|FG000|Maintenance Treatment Phase|Sponsor Decision|0|||
13167216|NCT02357147|26109375|FG001|Maintenance Treatment Phase|Sponsor Decision|15|||
13167217|NCT02357147|26109374|FG000|Maintenance Treatment Phase|Not Treated|1|||
13167218|NCT02357147|26109375|FG001|Maintenance Treatment Phase|Not Treated|0|||
13167219|NCT02356783|26109390|FG000|Overall Study|Lost to Follow-up|1|||
13167220|NCT02356783|26109391|FG001|Overall Study|Lost to Follow-up|3|||
13167221|NCT02356588|26109430|FG000|Overall Study|Lack of Efficacy|4|||
13167222|NCT02356588|26109431|FG001|Overall Study|Lack of Efficacy|10|||
13167223|NCT02356588|26109430|FG000|Overall Study|Adverse Event|0|||
13167224|NCT02356588|26109431|FG001|Overall Study|Adverse Event|2|||
13167225|NCT02356588|26109430|FG000|Overall Study|Withdrawal by Subject|1|||
13167226|NCT02356588|26109431|FG001|Overall Study|Withdrawal by Subject|0|||
13167227|NCT02356588|26109430|FG000|Overall Study|Protocol Violation|0|||
13167228|NCT02356588|26109431|FG001|Overall Study|Protocol Violation|1|||
13167229|NCT02356562|26109448|FG000|Overall Study|Withdrawal by Subject|0|||
13167230|NCT02356562|26109449|FG001|Overall Study|Withdrawal by Subject|1|||
13167231|NCT02356562|26109448|FG000|Overall Study|Re-entered treatment in a previous study|1|||
13167232|NCT02356562|26109449|FG001|Overall Study|Re-entered treatment in a previous study|0|||
13167233|NCT02356562|26109448|FG000|Overall Study|site closure|1|||
13167234|NCT02356562|26109449|FG001|Overall Study|site closure|0|||
13167235|NCT02356211|26109462|FG000|Overall Study|Withdrawal by Subject|2|||
13167236|NCT02356211|26109463|FG001|Overall Study|Withdrawal by Subject|2|||
13167237|NCT02356211|26109462|FG000|Overall Study|ineligible|1|||
13167238|NCT02356211|26109463|FG001|Overall Study|ineligible|8|||
13167239|NCT02355743|26109471|FG000|Overall Study|Withdrawal by Subject|1|||
13167240|NCT02355743|26109471|FG000|Overall Study|Lost to Follow-up|1|||
13167241|NCT02355691|26109486|FG000|Overall Study|Loss of Research Personnel|7|||
13167242|NCT02355691|26109487|FG001|Overall Study|Loss of Research Personnel|9|||
13167243|NCT02355665|26109926|FG000|Overall Study|Adverse Event|16|||
13167244|NCT02355665|26109927|FG001|Overall Study|Adverse Event|24|||
13167245|NCT02355665|26109926|FG000|Overall Study|Protocol Violation|2|||
13167246|NCT02355665|26109927|FG001|Overall Study|Protocol Violation|0|||
13167247|NCT02355665|26109926|FG000|Overall Study|Withdrawal by Subject|90|||
13167248|NCT02355665|26109927|FG001|Overall Study|Withdrawal by Subject|100|||
13167249|NCT02355665|26109926|FG000|Overall Study|Lost to Follow-up|131|||
13167250|NCT02355665|26109927|FG001|Overall Study|Lost to Follow-up|103|||
13167251|NCT02355665|26109926|FG000|Overall Study|Death|4|||
13167252|NCT02355665|26109927|FG001|Overall Study|Death|2|||
13167253|NCT02355665|26109926|FG000|Overall Study|Compliance, PI decision, move, eligible|6|||
13167254|NCT02355665|26109927|FG001|Overall Study|Compliance, PI decision, move, eligible|3|||
13167255|NCT02355028|26109967|FG000|Overall Study|Adverse Event|2|||
13167256|NCT02355028|26109968|FG001|Overall Study|Adverse Event|0|||
13167257|NCT02355028|26109967|FG000|Overall Study|Withdrawal by Subject|1|||
13167258|NCT02355028|26109968|FG001|Overall Study|Withdrawal by Subject|1|||
13167259|NCT02355028|26109967|FG000|Overall Study|Deemed ineligible after randomization|8|||
13167260|NCT02355028|26109968|FG001|Overall Study|Deemed ineligible after randomization|4|||
13167261|NCT02354976|26109987|FG000|Overall Study|Other - reason not specified|1|||
13167262|NCT02354976|26109988|FG001|Overall Study|Other - reason not specified|0|||
13167263|NCT02354976|26109989|FG002|Overall Study|Other - reason not specified|1|||
13167264|NCT02354976|26109987|FG000|Overall Study|Study-specifc withdrawal criteria|0|||
13167265|NCT02354976|26109988|FG001|Overall Study|Study-specifc withdrawal criteria|1|||
13167266|NCT02354976|26109989|FG002|Overall Study|Study-specifc withdrawal criteria|0|||
13167267|NCT02354976|26109987|FG000|Overall Study|Adverse Event|1|||
13167268|NCT02354976|26109988|FG001|Overall Study|Adverse Event|0|||
13167269|NCT02354976|26109989|FG002|Overall Study|Adverse Event|2|||
13205528|NCT01964378|26232141|FG000|Overall Study|Adverse Event|12|||
13205529|NCT01964378|26232142|FG001|Overall Study|Adverse Event|5|||
13205530|NCT01964378|26232141|FG000|Overall Study|Lack of Efficacy|0|||
13205531|NCT01964378|26232142|FG001|Overall Study|Lack of Efficacy|1|||
13205532|NCT01964378|26232141|FG000|Overall Study|Protocol Violation|0|||
13205533|NCT01964378|26232142|FG001|Overall Study|Protocol Violation|1|||
13205534|NCT01964378|26232141|FG000|Overall Study|Lost to Follow-up|0|||
13205535|NCT01964378|26232142|FG001|Overall Study|Lost to Follow-up|1|||
13205536|NCT01964378|26232141|FG000|Overall Study|Withdrawal by Subject|7|||
13205537|NCT01964378|26232142|FG001|Overall Study|Withdrawal by Subject|5|||
13205538|NCT01964378|26232141|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
13205539|NCT01964378|26232142|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
13205540|NCT01964378|26232141|FG000|Overall Study|Other|1|||
13205541|NCT01964378|26232142|FG001|Overall Study|Other|2|||
13205542|NCT01964352|26232185|FG000|Overall Study|Adverse Event|13|||
13205543|NCT01964352|26232186|FG001|Overall Study|Adverse Event|3|||
13205544|NCT01964352|26232187|FG002|Overall Study|Adverse Event|4|||
13205545|NCT01964352|26232188|FG003|Overall Study|Adverse Event|3|||
13205546|NCT01964352|26232185|FG000|Overall Study|Lack of Efficacy|6|||
13205547|NCT01964352|26232186|FG001|Overall Study|Lack of Efficacy|0|||
13205548|NCT01964352|26232187|FG002|Overall Study|Lack of Efficacy|0|||
13205549|NCT01964352|26232188|FG003|Overall Study|Lack of Efficacy|0|||
13205550|NCT01964352|26232185|FG000|Overall Study|Protocol Violation|2|||
13205551|NCT01964352|26232186|FG001|Overall Study|Protocol Violation|4|||
13205552|NCT01964352|26232187|FG002|Overall Study|Protocol Violation|0|||
13205553|NCT01964352|26232188|FG003|Overall Study|Protocol Violation|2|||
13205554|NCT01964352|26232185|FG000|Overall Study|Lost to Follow-up|1|||
13205555|NCT01964352|26232186|FG001|Overall Study|Lost to Follow-up|0|||
13205556|NCT01964352|26232187|FG002|Overall Study|Lost to Follow-up|0|||
13107291|NCT03285295|25886562|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
13107292|NCT03285295|25886563|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
13107293|NCT03285295|25886564|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
13107294|NCT03285295|25886565|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
13107295|NCT03285295|25886561|FG000|Alinity s Anti-HCV|No Results Generated|71|||
13107296|NCT03285295|25886562|FG001|Alinity s Anti-HCV|No Results Generated|0|||
13107297|NCT03285295|25886563|FG002|Alinity s Anti-HCV|No Results Generated|0|||
13107298|NCT03285295|25886564|FG003|Alinity s Anti-HCV|No Results Generated|0|||
13107299|NCT03285295|25886565|FG004|Alinity s Anti-HCV|No Results Generated|0|||
13107300|NCT03285295|25886561|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18|||
13107301|NCT03285295|25886562|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
13107302|NCT03285295|25886563|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
13107303|NCT03285295|25886564|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
13107304|NCT03285295|25886565|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
13107305|NCT03285295|25886561|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11|||
13107306|NCT03285295|25886562|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
13107307|NCT03285295|25886563|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
13107308|NCT03285295|25886564|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
13205557|NCT01964352|26232188|FG003|Overall Study|Lost to Follow-up|1|||
13167270|NCT02354690|26109999|FG000|Overall Study|Physician Decision|1|||
13167271|NCT02354599|26110088|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
13167272|NCT02354599|26110089|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
13167273|NCT02354599|26110090|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
13167274|NCT02354599|26110091|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
13167275|NCT02354599|26110092|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
13167276|NCT02354599|26110093|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
13167277|NCT02354599|26110088|FG000|Overall Study|Withdrawal by Subject|1|||
13167278|NCT02354599|26110089|FG001|Overall Study|Withdrawal by Subject|1|||
13167279|NCT02354599|26110090|FG002|Overall Study|Withdrawal by Subject|0|||
13167280|NCT02354599|26110091|FG003|Overall Study|Withdrawal by Subject|0|||
13167281|NCT02354599|26110092|FG004|Overall Study|Withdrawal by Subject|0|||
13167282|NCT02354599|26110093|FG005|Overall Study|Withdrawal by Subject|0|||
13167283|NCT02354586|26110111|FG000|Overall Study|Death|230|||
13167284|NCT02354586|26110111|FG000|Overall Study|Withdrawal by Subject|59|||
13167285|NCT02354586|26110111|FG000|Overall Study|Lost to Follow-up|11|||
13167286|NCT02354586|26110111|FG000|Overall Study|Sponsor decision|51|||
13167287|NCT02354586|26110111|FG000|Overall Study|Site closure|2|||
13167288|NCT02354586|26110111|FG000|Overall Study|Intercurrent illness|1|||
13167289|NCT02354586|26110111|FG000|Overall Study|Protocol Violation|3|||
13167290|NCT02354586|26110111|FG000|Overall Study|Physician Decision|13|||
13167291|NCT02354586|26110111|FG000|Overall Study|Lack of Efficacy|86|||
13167292|NCT02354586|26110111|FG000|Overall Study|Adverse Event|7|||
13167293|NCT02354508|26110199|FG000|Period 1: Core Phase|Adverse Event|1|||
13167294|NCT02354508|26110200|FG001|Period 1: Core Phase|Adverse Event|1|||
13167295|NCT02354508|26110201|FG002|Period 1: Core Phase|Adverse Event|2|||
13167296|NCT02354508|26110199|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1|||
13167297|NCT02354508|26110200|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0|||
13167298|NCT02354508|26110201|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2|||
13167299|NCT02354508|26110199|FG000|Period 1: Core Phase|Withdrawal by Subject|0|||
13167300|NCT02354508|26110200|FG001|Period 1: Core Phase|Withdrawal by Subject|1|||
13167301|NCT02354508|26110201|FG002|Period 1: Core Phase|Withdrawal by Subject|2|||
13167302|NCT02354508|26110199|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1|||
13167303|NCT02354508|26110200|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3|||
13167304|NCT02354508|26110201|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2|||
13167305|NCT02354508|26110199|FG000|Period 2: Extension Phase|Withdrawal by Subject|0|||
13167306|NCT02354508|26110200|FG001|Period 2: Extension Phase|Withdrawal by Subject|1|||
13167307|NCT02354508|26110201|FG002|Period 2: Extension Phase|Withdrawal by Subject|0|||
13167308|NCT02354508|26110199|FG000|Period 2: Extension Phase|Physician Decision|5|||
13167309|NCT02354508|26110200|FG001|Period 2: Extension Phase|Physician Decision|0|||
13167310|NCT02354508|26110201|FG002|Period 2: Extension Phase|Physician Decision|1|||
13167311|NCT02354508|26110199|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1|||
13167312|NCT02354508|26110200|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
13167313|NCT02354508|26110201|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
13167314|NCT02354508|26110199|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
13167315|NCT02354508|26110200|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1|||
13167316|NCT02354508|26110201|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
13167317|NCT02354508|26110199|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3|||
13167318|NCT02354508|26110200|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0|||
13167319|NCT02354508|26110201|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1|||
13107309|NCT03285295|25886565|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
13107310|NCT03285295|25886561|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16|||
13107311|NCT03285295|25886562|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
13107312|NCT03285295|25886563|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
13107313|NCT03285295|25886564|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
13107314|NCT03285295|25886565|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
13107315|NCT03285295|25886561|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72|||
13107316|NCT03285295|25886562|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
13107317|NCT03285295|25886563|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
13107318|NCT03285295|25886564|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
13107319|NCT03285295|25886565|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
13167320|NCT02354417|26110207|FG000|Overall Study|Physician Decision|1|||
13167321|NCT02354235|26110228|FG000|Overall Study|Adverse Event|2|||
13167322|NCT02354235|26110229|FG001|Overall Study|Adverse Event|2|||
13167323|NCT02354235|26110228|FG000|Overall Study|Physician Decision|0|||
13167324|NCT02354235|26110229|FG001|Overall Study|Physician Decision|1|||
13167325|NCT02354235|26110228|FG000|Overall Study|Withdrawal by Subject|1|||
13167326|NCT02354235|26110229|FG001|Overall Study|Withdrawal by Subject|3|||
13167327|NCT02354235|26110228|FG000|Overall Study|Conflict with the stopping criteria|0|||
13167328|NCT02354235|26110229|FG001|Overall Study|Conflict with the stopping criteria|1|||
13167329|NCT02354222|26110250|FG000|Overall Study|Adverse Event|0|||
13167330|NCT02354222|26110251|FG001|Overall Study|Adverse Event|3|||
13167331|NCT02354222|26110250|FG000|Overall Study|Physician Decision|1|||
13167332|NCT02354222|26110251|FG001|Overall Study|Physician Decision|1|||
13167333|NCT02354222|26110250|FG000|Overall Study|Pregnancy|1|||
13167334|NCT02354222|26110251|FG001|Overall Study|Pregnancy|0|||
13167335|NCT02354222|26110250|FG000|Overall Study|Withdrawal by Subject|2|||
13167336|NCT02354222|26110251|FG001|Overall Study|Withdrawal by Subject|3|||
13167337|NCT02354222|26110250|FG000|Overall Study|Conflict with the stopping criteria|0|||
13167338|NCT02354222|26110251|FG001|Overall Study|Conflict with the stopping criteria|4|||
13167339|NCT02353871|26110278|FG000|Overall Study|Protocol deviation|0|||
13167340|NCT02353871|26110279|FG001|Overall Study|Protocol deviation|1|||
13167341|NCT02353871|26110278|FG000|Overall Study|Consent withdrawn|1|||
13167342|NCT02353871|26110279|FG001|Overall Study|Consent withdrawn|8|||
13167343|NCT02353871|26110278|FG000|Overall Study|Lost to Follow-up|2|||
13167344|NCT02353871|26110279|FG001|Overall Study|Lost to Follow-up|0|||
13167345|NCT02353572|26110285|FG000|Overall Study|Withdrawal by Subject|1|||
13167346|NCT02353572|26110285|FG000|Overall Study|Study terminated|2|||
13167347|NCT02353468|26110291|FG000|Overall Study|Study terminated|3|||
13167348|NCT02353442|26110312|FG000|Overall Study|Withdrawal by Subject|3|||
13167349|NCT02353442|26110313|FG001|Overall Study|Withdrawal by Subject|4|||
13167350|NCT02353169|26110344|FG000|Overall Study|QTc > 450 msec|1|||
13167351|NCT02353169|26110345|FG001|Overall Study|QTc > 450 msec|1|||
13167352|NCT02353169|26110346|FG002|Overall Study|QTc > 450 msec|1|||
13167353|NCT02353169|26110347|FG003|Overall Study|QTc > 450 msec|1|||
13167354|NCT02353169|26110344|FG000|Overall Study|OR team declined|2|||
13167355|NCT02353169|26110345|FG001|Overall Study|OR team declined|0|||
13167356|NCT02353169|26110346|FG002|Overall Study|OR team declined|0|||
13167357|NCT02353169|26110347|FG003|Overall Study|OR team declined|0|||
13167358|NCT02353169|26110344|FG000|Overall Study|Inhalational induction|0|||
13167359|NCT02353169|26110345|FG001|Overall Study|Inhalational induction|2|||
13167360|NCT02353169|26110346|FG002|Overall Study|Inhalational induction|0|||
13167361|NCT02353169|26110347|FG003|Overall Study|Inhalational induction|0|||
13167362|NCT02353169|26110344|FG000|Overall Study|ECG data error|0|||
13167363|NCT02353169|26110345|FG001|Overall Study|ECG data error|3|||
13167364|NCT02353169|26110346|FG002|Overall Study|ECG data error|2|||
13167365|NCT02353169|26110347|FG003|Overall Study|ECG data error|2|||
13167366|NCT02353169|26110344|FG000|Overall Study|Pre-op medication|0|||
13167367|NCT02353169|26110345|FG001|Overall Study|Pre-op medication|0|||
13167368|NCT02353169|26110346|FG002|Overall Study|Pre-op medication|1|||
13167369|NCT02353169|26110347|FG003|Overall Study|Pre-op medication|0|||
13167370|NCT02352779|26110365|FG000|Overall Study|Personal Issues|1|||
13167371|NCT02352779|26110366|FG001|Overall Study|Personal Issues|1|||
13167372|NCT02352779|26110367|FG002|Overall Study|Personal Issues|0|||
13167373|NCT02352779|26110365|FG000|Overall Study|Too Many Forms|2|||
13167374|NCT02352779|26110366|FG001|Overall Study|Too Many Forms|0|||
13167375|NCT02352779|26110367|FG002|Overall Study|Too Many Forms|0|||
13167376|NCT02352779|26110365|FG000|Overall Study|Feeling Overwhelmed|1|||
13167377|NCT02352779|26110366|FG001|Overall Study|Feeling Overwhelmed|0|||
13167378|NCT02352779|26110367|FG002|Overall Study|Feeling Overwhelmed|0|||
13167379|NCT02352779|26110365|FG000|Overall Study|Disliked Intervention|1|||
13167380|NCT02352779|26110366|FG001|Overall Study|Disliked Intervention|0|||
13167381|NCT02352779|26110367|FG002|Overall Study|Disliked Intervention|0|||
13167382|NCT02352779|26110365|FG000|Overall Study|Changed Mind|1|||
13167383|NCT02352779|26110366|FG001|Overall Study|Changed Mind|0|||
13167384|NCT02352779|26110367|FG002|Overall Study|Changed Mind|0|||
13167385|NCT02352779|26110365|FG000|Overall Study|Study Related Symptoms|1|||
13167386|NCT02352779|26110366|FG001|Overall Study|Study Related Symptoms|0|||
13167387|NCT02352779|26110367|FG002|Overall Study|Study Related Symptoms|0|||
13167388|NCT02352779|26110365|FG000|Overall Study|Absence of Symptoms|1|||
13167389|NCT02352779|26110366|FG001|Overall Study|Absence of Symptoms|0|||
13167390|NCT02352779|26110367|FG002|Overall Study|Absence of Symptoms|0|||
13167391|NCT02352779|26110365|FG000|Overall Study|Other Medical Reason|0|||
13167392|NCT02352779|26110366|FG001|Overall Study|Other Medical Reason|0|||
13167393|NCT02352779|26110367|FG002|Overall Study|Other Medical Reason|1|||
13167394|NCT02352779|26110365|FG000|Overall Study|No Reason|0|||
13167395|NCT02352779|26110366|FG001|Overall Study|No Reason|0|||
13167396|NCT02352779|26110367|FG002|Overall Study|No Reason|1|||
13167397|NCT02352493|26110610|FG000|Overall Study|Pregnancy|0|||
13167398|NCT02352493|26110611|FG001|Overall Study|Pregnancy|0|||
13167399|NCT02352493|26110612|FG002|Overall Study|Pregnancy|0|||
13167400|NCT02352493|26110613|FG003|Overall Study|Pregnancy|0|||
13167401|NCT02352493|26110614|FG004|Overall Study|Pregnancy|0|||
13167402|NCT02352493|26110615|FG005|Overall Study|Pregnancy|0|||
13167403|NCT02352493|26110616|FG006|Overall Study|Pregnancy|1|||
13167404|NCT02352493|26110617|FG007|Overall Study|Pregnancy|0|||
13167405|NCT02352493|26110618|FG008|Overall Study|Pregnancy|1|||
13167406|NCT02352493|26110619|FG009|Overall Study|Pregnancy|0|||
13167407|NCT02352493|26110620|FG010|Overall Study|Pregnancy|0|||
13167408|NCT02352493|26110621|FG011|Overall Study|Pregnancy|0|||
13167409|NCT02352493|26110622|FG012|Overall Study|Pregnancy|0|||
13167410|NCT02352493|26110623|FG013|Overall Study|Pregnancy|0|||
13167411|NCT02352493|26110624|FG014|Overall Study|Pregnancy|0|||
13167412|NCT02352493|26110625|FG015|Overall Study|Pregnancy|0|||
13167413|NCT02352493|26110626|FG016|Overall Study|Pregnancy|0|||
13167414|NCT02352493|26110627|FG017|Overall Study|Pregnancy|0|||
13167415|NCT02352493|26110610|FG000|Overall Study|Withdrawal by Subject|0|||
13167416|NCT02352493|26110611|FG001|Overall Study|Withdrawal by Subject|0|||
13167417|NCT02352493|26110612|FG002|Overall Study|Withdrawal by Subject|0|||
13167418|NCT02352493|26110613|FG003|Overall Study|Withdrawal by Subject|0|||
13167419|NCT02352493|26110614|FG004|Overall Study|Withdrawal by Subject|0|||
13167420|NCT02352493|26110615|FG005|Overall Study|Withdrawal by Subject|0|||
13167421|NCT02352493|26110616|FG006|Overall Study|Withdrawal by Subject|0|||
13167422|NCT02352493|26110617|FG007|Overall Study|Withdrawal by Subject|0|||
13167423|NCT02352493|26110618|FG008|Overall Study|Withdrawal by Subject|1|||
13167424|NCT02352493|26110619|FG009|Overall Study|Withdrawal by Subject|0|||
13167425|NCT02352493|26110620|FG010|Overall Study|Withdrawal by Subject|0|||
13485524|NCT02906020|27032878|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0|||
13485525|NCT02906020|27032879|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10|||
13485526|NCT02906020|27032880|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4|||
13485527|NCT02906020|27032881|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0|||
13485528|NCT02906020|27032882|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0|||
13167426|NCT02352493|26110621|FG011|Overall Study|Withdrawal by Subject|0|||
13167427|NCT02352493|26110622|FG012|Overall Study|Withdrawal by Subject|0|||
13167428|NCT02352493|26110623|FG013|Overall Study|Withdrawal by Subject|0|||
13167429|NCT02352493|26110624|FG014|Overall Study|Withdrawal by Subject|1|||
13167430|NCT02352493|26110625|FG015|Overall Study|Withdrawal by Subject|0|||
13167431|NCT02352493|26110626|FG016|Overall Study|Withdrawal by Subject|0|||
13167432|NCT02352493|26110627|FG017|Overall Study|Withdrawal by Subject|0|||
13167433|NCT02352493|26110610|FG000|Overall Study|Lost to Follow-up|0|||
13167434|NCT02352493|26110611|FG001|Overall Study|Lost to Follow-up|0|||
13167435|NCT02352493|26110612|FG002|Overall Study|Lost to Follow-up|0|||
13167436|NCT02352493|26110613|FG003|Overall Study|Lost to Follow-up|0|||
13167437|NCT02352493|26110614|FG004|Overall Study|Lost to Follow-up|0|||
13167438|NCT02352493|26110615|FG005|Overall Study|Lost to Follow-up|0|||
13167439|NCT02352493|26110616|FG006|Overall Study|Lost to Follow-up|0|||
13167440|NCT02352493|26110617|FG007|Overall Study|Lost to Follow-up|0|||
13167441|NCT02352493|26110618|FG008|Overall Study|Lost to Follow-up|0|||
13167442|NCT02352493|26110619|FG009|Overall Study|Lost to Follow-up|1|||
13167443|NCT02352493|26110620|FG010|Overall Study|Lost to Follow-up|0|||
13167444|NCT02352493|26110621|FG011|Overall Study|Lost to Follow-up|0|||
13167445|NCT02352493|26110622|FG012|Overall Study|Lost to Follow-up|1|||
13167446|NCT02352493|26110623|FG013|Overall Study|Lost to Follow-up|2|||
13167447|NCT02352493|26110624|FG014|Overall Study|Lost to Follow-up|0|||
13167448|NCT02352493|26110625|FG015|Overall Study|Lost to Follow-up|0|||
13167449|NCT02352493|26110626|FG016|Overall Study|Lost to Follow-up|0|||
13167450|NCT02352493|26110627|FG017|Overall Study|Lost to Follow-up|0|||
13167451|NCT02352090|26110666|FG000|Overall Study|general malaise|1|||
13167452|NCT02352090|26110667|FG001|Overall Study|general malaise|0|||
13167453|NCT02352090|26110668|FG002|Overall Study|general malaise|0|||
13167454|NCT02352090|26110666|FG000|Overall Study|non-specified mild side-effects|0|||
13167455|NCT02352090|26110667|FG001|Overall Study|non-specified mild side-effects|0|||
13167456|NCT02352090|26110668|FG002|Overall Study|non-specified mild side-effects|2|||
13167457|NCT02351960|26110694|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
13167458|NCT02351960|26110695|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
13167459|NCT02351960|26110694|FG000|Overall Study|Voluntary Withdrawal|5|||
13167460|NCT02351960|26110695|FG001|Overall Study|Voluntary Withdrawal|4|||
13167461|NCT02351960|26110694|FG000|Overall Study|Significant Protocol Deviation|0|||
13167462|NCT02351960|26110695|FG001|Overall Study|Significant Protocol Deviation|5|||
13167463|NCT02351934|26110718|FG000|Allocation|POD weight<pre-op weight|3|||
13167464|NCT02351934|26110719|FG001|Allocation|POD weight<pre-op weight|0|||
13167465|NCT02351934|26110718|FG000|Allocation|Hypotension preventing administration|2|||
13167466|NCT02351934|26110719|FG001|Allocation|Hypotension preventing administration|0|||
13167467|NCT02351934|26110718|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1|||
13167468|NCT02351934|26110719|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0|||
13167469|NCT02351934|26110718|FG000|Follow-Up|POD weight<pre-op weight|3|||
13167470|NCT02351934|26110719|FG001|Follow-Up|POD weight<pre-op weight|0|||
13167471|NCT02351934|26110718|FG000|Follow-Up|Acute Kidney Injury|1|||
13167472|NCT02351934|26110719|FG001|Follow-Up|Acute Kidney Injury|0|||
13167473|NCT02351934|26110718|FG000|Follow-Up|Early dismissal|3|||
13167474|NCT02351934|26110719|FG001|Follow-Up|Early dismissal|0|||
13167475|NCT02351934|26110718|FG000|Follow-Up|Hypotension|3|||
13167476|NCT02351934|26110719|FG001|Follow-Up|Hypotension|0|||
13167477|NCT02351934|26110718|FG000|Follow-Up|No documentation|2|||
13167478|NCT02351934|26110719|FG001|Follow-Up|No documentation|0|||
13167479|NCT02351934|26110718|FG000|Follow-Up|1 ERAS Component Noncompliant|0|||
13167480|NCT02351934|26110719|FG001|Follow-Up|1 ERAS Component Noncompliant|6|||
13167481|NCT02351934|26110718|FG000|Follow-Up|2 ERAS Components Noncompliant|0|||
13167482|NCT02351934|26110719|FG001|Follow-Up|2 ERAS Components Noncompliant|4|||
13167483|NCT02351856|26110740|FG000|Overall Study|Adverse Event|2|||
13167484|NCT02351856|26110740|FG000|Overall Study|Physician Decision|5|||
13167485|NCT02351856|26110740|FG000|Overall Study|Study terminated by sponsor|1|||
13167486|NCT02351817|26110750|FG000|Period 1|Adverse Event|1|||
13167487|NCT02351817|26110751|FG001|Period 1|Adverse Event|2|||
13167488|NCT02351817|26110750|FG000|Period 1|Lack of Efficacy|0|||
13167489|NCT02351817|26110751|FG001|Period 1|Lack of Efficacy|1|||
13167490|NCT02351817|26110750|FG000|Period 2|Adverse Event|0|||
13167491|NCT02351817|26110751|FG001|Period 2|Adverse Event|2|||
13167492|NCT02351817|26110750|FG000|Period 2|Protocol Violation|1|||
13167493|NCT02351817|26110751|FG001|Period 2|Protocol Violation|0|||
13167494|NCT02351349|26110774|FG000|Overall Study|Withdrawal by Subject|2|||
13167495|NCT02351349|26110775|FG001|Overall Study|Withdrawal by Subject|3|||
13167496|NCT02351180|26110798|FG000|Overall Study|Withdrawal by Subject|1|||
13167497|NCT02351180|26110799|FG001|Overall Study|Withdrawal by Subject|0|||
13167498|NCT02351167|26110851|FG000|Overall Study|Withdrawal by Subject|19|||
13167499|NCT02351167|26110852|FG001|Overall Study|Withdrawal by Subject|18|||
13167500|NCT02351167|26110853|FG002|Overall Study|Withdrawal by Subject|21|||
13167501|NCT02350478|26110876|FG000|Overall Study|Lost to Follow-up|5|||
13167502|NCT02350478|26110877|FG001|Overall Study|Lost to Follow-up|1|||
13167503|NCT02350309|26110935|FG000|Treatment Period 1 (2 Days)|Physician Decision|0|||
13167504|NCT02350309|26110936|FG001|Treatment Period 1 (2 Days)|Physician Decision|0|||
13167505|NCT02350309|26110937|FG002|Treatment Period 1 (2 Days)|Physician Decision|1|||
13167506|NCT02350309|26110938|FG003|Treatment Period 1 (2 Days)|Physician Decision|0|||
13167507|NCT02350309|26110939|FG004|Treatment Period 1 (2 Days)|Physician Decision|0|||
13167508|NCT02350309|26110940|FG005|Treatment Period 1 (2 Days)|Physician Decision|0|||
13167509|NCT02350309|26110935|FG000|Treatment Period 4 (2 Days)|Death in the Family|0|||
13167510|NCT02350309|26110936|FG001|Treatment Period 4 (2 Days)|Death in the Family|0|||
13167511|NCT02350309|26110937|FG002|Treatment Period 4 (2 Days)|Death in the Family|0|||
13167512|NCT02350309|26110938|FG003|Treatment Period 4 (2 Days)|Death in the Family|0|||
13167513|NCT02350309|26110939|FG004|Treatment Period 4 (2 Days)|Death in the Family|0|||
13167514|NCT02350309|26110940|FG005|Treatment Period 4 (2 Days)|Death in the Family|1|||
13167515|NCT02350127|26110986|FG000|4-Month Assessment|Withdrawal by Subject|10|||
13167516|NCT02350127|26110987|FG001|4-Month Assessment|Withdrawal by Subject|9|||
13167517|NCT02350127|26110986|FG000|4-Month Assessment|Death|1|||
13167518|NCT02350127|26110987|FG001|4-Month Assessment|Death|0|||
13167519|NCT02350127|26110986|FG000|8-Month Assessment|Death|1|||
13167520|NCT02350127|26110987|FG001|8-Month Assessment|Death|1|||
13167521|NCT02350127|26110986|FG000|8-Month Assessment|Withdrawal by Subject|5|||
13167522|NCT02350127|26110987|FG001|8-Month Assessment|Withdrawal by Subject|8|||
13167523|NCT02349789|26110998|FG000|Overall Study|Withdrawal by Subject|2|||
13167524|NCT02349711|26111017|FG000|Overall Study|Withdrawal by Subject|2|||
13167525|NCT02349711|26111018|FG001|Overall Study|Withdrawal by Subject|1|||
13167526|NCT02349711|26111017|FG000|Overall Study|Lost to Follow-up|1|||
13167527|NCT02349711|26111018|FG001|Overall Study|Lost to Follow-up|1|||
13167528|NCT02349633|26111368|FG000|Overall Study|Death|0|||
13167529|NCT02349633|26111369|FG001|Overall Study|Death|1|||
13167530|NCT02349633|26111370|FG002|Overall Study|Death|0|||
13167531|NCT02349633|26111371|FG003|Overall Study|Death|0|||
13167532|NCT02349633|26111372|FG004|Overall Study|Death|0|||
13167533|NCT02349633|26111373|FG005|Overall Study|Death|1|||
13167534|NCT02349633|26111374|FG006|Overall Study|Death|1|||
13167535|NCT02349633|26111375|FG007|Overall Study|Death|1|||
13167536|NCT02349633|26111376|FG008|Overall Study|Death|0|||
13167537|NCT02349633|26111377|FG009|Overall Study|Death|1|||
13167538|NCT02349633|26111378|FG010|Overall Study|Death|0|||
13167539|NCT02349633|26111379|FG011|Overall Study|Death|0|||
13167540|NCT02349633|26111380|FG012|Overall Study|Death|0|||
13167541|NCT02349633|26111381|FG013|Overall Study|Death|0|||
13167542|NCT02349633|26111368|FG000|Overall Study|Withdrawal by Subject|0|||
13167543|NCT02349633|26111369|FG001|Overall Study|Withdrawal by Subject|0|||
13167544|NCT02349633|26111370|FG002|Overall Study|Withdrawal by Subject|0|||
13167545|NCT02349633|26111371|FG003|Overall Study|Withdrawal by Subject|1|||
13167546|NCT02349633|26111372|FG004|Overall Study|Withdrawal by Subject|0|||
13167547|NCT02349633|26111373|FG005|Overall Study|Withdrawal by Subject|0|||
13167548|NCT02349633|26111374|FG006|Overall Study|Withdrawal by Subject|0|||
13107320|NCT03285295|25886561|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11|||
13167549|NCT02349633|26111375|FG007|Overall Study|Withdrawal by Subject|2|||
13107321|NCT03285295|25886562|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
13107322|NCT03285295|25886563|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
13107323|NCT03285295|25886564|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
13107324|NCT03285295|25886565|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
13107325|NCT03285295|25886561|FG000|Alinity s Anti-HBc|Protocol Violation|8|||
13107326|NCT03285295|25886562|FG001|Alinity s Anti-HBc|Protocol Violation|0|||
13107327|NCT03285295|25886563|FG002|Alinity s Anti-HBc|Protocol Violation|0|||
13167550|NCT02349633|26111376|FG008|Overall Study|Withdrawal by Subject|2|||
13167551|NCT02349633|26111377|FG009|Overall Study|Withdrawal by Subject|1|||
13167552|NCT02349633|26111378|FG010|Overall Study|Withdrawal by Subject|0|||
13167553|NCT02349633|26111379|FG011|Overall Study|Withdrawal by Subject|0|||
13167554|NCT02349633|26111380|FG012|Overall Study|Withdrawal by Subject|0|||
13167555|NCT02349633|26111381|FG013|Overall Study|Withdrawal by Subject|0|||
13167556|NCT02349633|26111368|FG000|Overall Study|Withdrawal of informed consent|0|||
13167557|NCT02349633|26111369|FG001|Overall Study|Withdrawal of informed consent|0|||
13167558|NCT02349633|26111370|FG002|Overall Study|Withdrawal of informed consent|0|||
13167559|NCT02349633|26111371|FG003|Overall Study|Withdrawal of informed consent|1|||
13167560|NCT02349633|26111372|FG004|Overall Study|Withdrawal of informed consent|1|||
13167561|NCT02349633|26111373|FG005|Overall Study|Withdrawal of informed consent|0|||
13167562|NCT02349633|26111374|FG006|Overall Study|Withdrawal of informed consent|0|||
13167563|NCT02349633|26111375|FG007|Overall Study|Withdrawal of informed consent|3|||
13167564|NCT02349633|26111376|FG008|Overall Study|Withdrawal of informed consent|0|||
13167565|NCT02349633|26111377|FG009|Overall Study|Withdrawal of informed consent|0|||
13167566|NCT02349633|26111378|FG010|Overall Study|Withdrawal of informed consent|0|||
13167567|NCT02349633|26111379|FG011|Overall Study|Withdrawal of informed consent|0|||
13167568|NCT02349633|26111380|FG012|Overall Study|Withdrawal of informed consent|0|||
13167569|NCT02349633|26111381|FG013|Overall Study|Withdrawal of informed consent|0|||
13167570|NCT02349633|26111368|FG000|Overall Study|Transition to compassionate use|0|||
13167571|NCT02349633|26111369|FG001|Overall Study|Transition to compassionate use|0|||
13167572|NCT02349633|26111370|FG002|Overall Study|Transition to compassionate use|0|||
13167573|NCT02349633|26111371|FG003|Overall Study|Transition to compassionate use|0|||
13167574|NCT02349633|26111372|FG004|Overall Study|Transition to compassionate use|1|||
13167575|NCT02349633|26111373|FG005|Overall Study|Transition to compassionate use|0|||
13167576|NCT02349633|26111374|FG006|Overall Study|Transition to compassionate use|0|||
13167577|NCT02349633|26111375|FG007|Overall Study|Transition to compassionate use|3|||
13167578|NCT02349633|26111376|FG008|Overall Study|Transition to compassionate use|0|||
13167579|NCT02349633|26111377|FG009|Overall Study|Transition to compassionate use|1|||
13167580|NCT02349633|26111378|FG010|Overall Study|Transition to compassionate use|0|||
13167581|NCT02349633|26111379|FG011|Overall Study|Transition to compassionate use|0|||
13167582|NCT02349633|26111380|FG012|Overall Study|Transition to compassionate use|0|||
13167583|NCT02349633|26111381|FG013|Overall Study|Transition to compassionate use|0|||
13167584|NCT02349633|26111368|FG000|Overall Study|Early termination of survival follow-up|0|||
13167585|NCT02349633|26111369|FG001|Overall Study|Early termination of survival follow-up|0|||
13167586|NCT02349633|26111370|FG002|Overall Study|Early termination of survival follow-up|0|||
13167587|NCT02349633|26111371|FG003|Overall Study|Early termination of survival follow-up|0|||
13167588|NCT02349633|26111372|FG004|Overall Study|Early termination of survival follow-up|0|||
13167589|NCT02349633|26111373|FG005|Overall Study|Early termination of survival follow-up|0|||
13167590|NCT02349633|26111374|FG006|Overall Study|Early termination of survival follow-up|0|||
13167591|NCT02349633|26111375|FG007|Overall Study|Early termination of survival follow-up|4|||
13167592|NCT02349633|26111376|FG008|Overall Study|Early termination of survival follow-up|0|||
13167593|NCT02349633|26111377|FG009|Overall Study|Early termination of survival follow-up|0|||
13107328|NCT03285295|25886564|FG003|Alinity s Anti-HBc|Protocol Violation|0|||
13107329|NCT03285295|25886565|FG004|Alinity s Anti-HBc|Protocol Violation|0|||
13107330|NCT03285295|25886561|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13|||
13107331|NCT03285295|25886562|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1|||
13167594|NCT02349633|26111378|FG010|Overall Study|Early termination of survival follow-up|0|||
13167595|NCT02349633|26111379|FG011|Overall Study|Early termination of survival follow-up|0|||
13167596|NCT02349633|26111380|FG012|Overall Study|Early termination of survival follow-up|0|||
13167597|NCT02349633|26111381|FG013|Overall Study|Early termination of survival follow-up|0|||
13107332|NCT03285295|25886563|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
13107333|NCT03285295|25886564|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
13107334|NCT03285295|25886565|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
13107335|NCT03285295|25886561|FG000|Alinity s Anti-HBc|No Results Generated|70|||
13107336|NCT03285295|25886562|FG001|Alinity s Anti-HBc|No Results Generated|0|||
13167598|NCT02349633|26111368|FG000|Overall Study|Termination by sponsor|0|||
13167599|NCT02349633|26111369|FG001|Overall Study|Termination by sponsor|0|||
13167600|NCT02349633|26111370|FG002|Overall Study|Termination by sponsor|0|||
13167601|NCT02349633|26111371|FG003|Overall Study|Termination by sponsor|0|||
13167602|NCT02349633|26111372|FG004|Overall Study|Termination by sponsor|0|||
13167603|NCT02349633|26111373|FG005|Overall Study|Termination by sponsor|0|||
13167604|NCT02349633|26111374|FG006|Overall Study|Termination by sponsor|0|||
13167605|NCT02349633|26111375|FG007|Overall Study|Termination by sponsor|1|||
13167606|NCT02349633|26111376|FG008|Overall Study|Termination by sponsor|0|||
13167607|NCT02349633|26111377|FG009|Overall Study|Termination by sponsor|2|||
13167608|NCT02349633|26111378|FG010|Overall Study|Termination by sponsor|0|||
13167609|NCT02349633|26111379|FG011|Overall Study|Termination by sponsor|0|||
13167610|NCT02349633|26111380|FG012|Overall Study|Termination by sponsor|0|||
13167611|NCT02349633|26111381|FG013|Overall Study|Termination by sponsor|0|||
13167612|NCT02349633|26111368|FG000|Overall Study|Other|0|||
13167613|NCT02349633|26111369|FG001|Overall Study|Other|0|||
13167614|NCT02349633|26111370|FG002|Overall Study|Other|0|||
13167615|NCT02349633|26111371|FG003|Overall Study|Other|0|||
13167616|NCT02349633|26111372|FG004|Overall Study|Other|0|||
13167617|NCT02349633|26111373|FG005|Overall Study|Other|0|||
13167618|NCT02349633|26111374|FG006|Overall Study|Other|0|||
13167619|NCT02349633|26111375|FG007|Overall Study|Other|2|||
13167620|NCT02349633|26111376|FG008|Overall Study|Other|0|||
13167621|NCT02349633|26111377|FG009|Overall Study|Other|0|||
13167622|NCT02349633|26111378|FG010|Overall Study|Other|0|||
13167623|NCT02349633|26111379|FG011|Overall Study|Other|0|||
13167624|NCT02349633|26111380|FG012|Overall Study|Other|0|||
13167625|NCT02349633|26111381|FG013|Overall Study|Other|0|||
13167626|NCT02349542|26111388|FG000|Overall Study|Withdrawal by Subject|5|||
13167627|NCT02349451|26111437|FG000|Overall Study|Withdrawal by Subject|0|||
13167628|NCT02349451|26111438|FG001|Overall Study|Withdrawal by Subject|1|||
13167629|NCT02349451|26111439|FG002|Overall Study|Withdrawal by Subject|2|||
13167630|NCT02349451|26111440|FG003|Overall Study|Withdrawal by Subject|1|||
13167631|NCT02349425|26111625|FG000|Period 1|Adverse Event|1|||
13167632|NCT02349425|26111626|FG001|Period 1|Adverse Event|1|||
13167633|NCT02349425|26111627|FG002|Period 1|Adverse Event|0|||
13167634|NCT02349425|26111628|FG003|Period 1|Adverse Event|0|||
13167635|NCT02349425|26111625|FG000|Period 2|Adverse Event|0|||
13167636|NCT02349425|26111626|FG001|Period 2|Adverse Event|1|||
13167637|NCT02349425|26111627|FG002|Period 2|Adverse Event|1|||
13167638|NCT02349425|26111628|FG003|Period 2|Adverse Event|0|||
13167639|NCT02349412|26111649|FG000|Overall Study|Withdrawal by Subject|7|||
13167640|NCT02349412|26111650|FG001|Overall Study|Withdrawal by Subject|7|||
13167641|NCT02349386|26111701|FG000|24-Week Double-Blind Main Study|Adverse Event|0|||
13167642|NCT02349386|26111702|FG001|24-Week Double-Blind Main Study|Adverse Event|0|||
13167643|NCT02349386|26111703|FG002|24-Week Double-Blind Main Study|Adverse Event|1|||
13167644|NCT02349386|26111704|FG003|24-Week Double-Blind Main Study|Adverse Event|1|||
13167645|NCT02349386|26111701|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
13167646|NCT02349386|26111702|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
13167647|NCT02349386|26111703|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2|||
13167648|NCT02349386|26111704|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7|||
13167649|NCT02349386|26111701|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
13167650|NCT02349386|26111702|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
13167651|NCT02349386|26111703|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1|||
13167652|NCT02349386|26111704|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
13167653|NCT02349386|26111701|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
13167654|NCT02349386|26111702|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
13167655|NCT02349386|26111703|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1|||
13167656|NCT02349386|26111704|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
13167657|NCT02349386|26111701|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
13167658|NCT02349386|26111702|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
13167659|NCT02349386|26111703|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
13167660|NCT02349386|26111704|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
13167661|NCT02349386|26111701|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
13167662|NCT02349386|26111702|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
13167663|NCT02349386|26111703|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1|||
13167664|NCT02349386|26111704|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
13167665|NCT02349360|26111719|FG000|Overall Study|Withdrawal by Subject|0|||
13167666|NCT02349360|26111720|FG001|Overall Study|Withdrawal by Subject|1|||
13167667|NCT02349295|26111836|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7|||
13167668|NCT02349295|26111837|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
13167669|NCT02349295|26111838|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
13167670|NCT02349295|26111839|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
13167671|NCT02349295|26111840|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
13167672|NCT02349295|26111841|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
13167673|NCT02349295|26111842|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
13167674|NCT02349295|26111843|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
13167675|NCT02349295|26111844|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
13167676|NCT02349295|26111845|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
13167677|NCT02349295|26111846|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
13167678|NCT02349295|26111847|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
13167679|NCT02349295|26111848|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
13167680|NCT02349295|26111849|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
13167681|NCT02349295|26111836|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4|||
13167682|NCT02349295|26111837|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2|||
13167683|NCT02349295|26111838|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9|||
13167684|NCT02349295|26111839|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
13167685|NCT02349295|26111840|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
13167686|NCT02349295|26111841|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
13167687|NCT02349295|26111842|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
13167688|NCT02349295|26111843|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
13167689|NCT02349295|26111844|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
13167690|NCT02349295|26111845|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
13167691|NCT02349295|26111846|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
13167692|NCT02349295|26111847|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
13167693|NCT02349295|26111848|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
13167694|NCT02349295|26111849|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
13167695|NCT02349295|26111836|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
13167696|NCT02349295|26111837|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
13167697|NCT02349295|26111838|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7|||
13167698|NCT02349295|26111839|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
13167699|NCT02349295|26111840|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
13167700|NCT02349295|26111841|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
13167701|NCT02349295|26111842|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
13167702|NCT02349295|26111843|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
13167703|NCT02349295|26111844|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
13167704|NCT02349295|26111845|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
13167705|NCT02349295|26111846|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
13167706|NCT02349295|26111847|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
13167707|NCT02349295|26111848|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
13167708|NCT02349295|26111849|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
13167709|NCT02349295|26111836|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
13167710|NCT02349295|26111837|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
13167711|NCT02349295|26111838|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2|||
13167712|NCT02349295|26111839|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
13167713|NCT02349295|26111840|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
13167714|NCT02349295|26111841|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
13167715|NCT02349295|26111842|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
13167716|NCT02349295|26111843|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
13167717|NCT02349295|26111844|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
13167718|NCT02349295|26111845|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
13167719|NCT02349295|26111846|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
13167720|NCT02349295|26111847|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
13167721|NCT02349295|26111848|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
13167722|NCT02349295|26111849|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
13167723|NCT02349295|26111836|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
13167724|NCT02349295|26111837|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
13167725|NCT02349295|26111838|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
13167726|NCT02349295|26111839|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
13167727|NCT02349295|26111840|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
13167728|NCT02349295|26111841|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
13167729|NCT02349295|26111842|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
13167730|NCT02349295|26111843|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
13167731|NCT02349295|26111844|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
13167732|NCT02349295|26111845|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
13167733|NCT02349295|26111846|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
13167734|NCT02349295|26111847|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
13167735|NCT02349295|26111848|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
13167736|NCT02349295|26111849|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
13167737|NCT02349295|26111836|FG000|IR (Week 16-24)|Lack of Efficacy|0|||
13167738|NCT02349295|26111837|FG001|IR (Week 16-24)|Lack of Efficacy|0|||
13167739|NCT02349295|26111838|FG002|IR (Week 16-24)|Lack of Efficacy|0|||
13167740|NCT02349295|26111839|FG003|IR (Week 16-24)|Lack of Efficacy|1|||
13167741|NCT02349295|26111840|FG004|IR (Week 16-24)|Lack of Efficacy|0|||
13167742|NCT02349295|26111841|FG005|IR (Week 16-24)|Lack of Efficacy|0|||
13167743|NCT02349295|26111842|FG006|IR (Week 16-24)|Lack of Efficacy|0|||
13167744|NCT02349295|26111843|FG007|IR (Week 16-24)|Lack of Efficacy|0|||
13167745|NCT02349295|26111844|FG008|IR (Week 16-24)|Lack of Efficacy|0|||
13167746|NCT02349295|26111845|FG009|IR (Week 16-24)|Lack of Efficacy|0|||
13167747|NCT02349295|26111846|FG010|IR (Week 16-24)|Lack of Efficacy|0|||
13167748|NCT02349295|26111847|FG011|IR (Week 16-24)|Lack of Efficacy|0|||
13167749|NCT02349295|26111848|FG012|IR (Week 16-24)|Lack of Efficacy|0|||
13167750|NCT02349295|26111849|FG013|IR (Week 16-24)|Lack of Efficacy|0|||
13167751|NCT02349295|26111836|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
13167752|NCT02349295|26111837|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
13167753|NCT02349295|26111838|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
13167754|NCT02349295|26111839|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
13167755|NCT02349295|26111840|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
13167756|NCT02349295|26111841|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
13167757|NCT02349295|26111842|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
13167758|NCT02349295|26111843|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32|||
13167759|NCT02349295|26111844|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25|||
13167760|NCT02349295|26111845|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19|||
13167761|NCT02349295|26111846|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18|||
13167762|NCT02349295|26111847|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
13167763|NCT02349295|26111848|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
13167764|NCT02349295|26111849|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
13167765|NCT02349295|26111836|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
13167766|NCT02349295|26111837|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
13167767|NCT02349295|26111838|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
13167768|NCT02349295|26111839|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
13167769|NCT02349295|26111840|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
13167770|NCT02349295|26111841|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
13167771|NCT02349295|26111842|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
13167772|NCT02349295|26111843|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
13167773|NCT02349295|26111844|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
13167774|NCT02349295|26111845|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
13167775|NCT02349295|26111846|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
13167776|NCT02349295|26111847|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
13167777|NCT02349295|26111848|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
13167778|NCT02349295|26111849|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
13167779|NCT02349295|26111836|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
13167780|NCT02349295|26111837|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
13167781|NCT02349295|26111838|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
13167782|NCT02349295|26111839|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
13167783|NCT02349295|26111840|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
13167784|NCT02349295|26111841|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
13167785|NCT02349295|26111842|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
13167786|NCT02349295|26111843|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2|||
13167787|NCT02349295|26111844|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
13167788|NCT02349295|26111845|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3|||
13167789|NCT02349295|26111846|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
13167790|NCT02349295|26111847|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
13167791|NCT02349295|26111848|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
13167792|NCT02349295|26111849|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
13167793|NCT02349295|26111836|FG000|Long-Term Extension Period (Week 24-156)|Death|0|||
13167794|NCT02349295|26111837|FG001|Long-Term Extension Period (Week 24-156)|Death|0|||
13167795|NCT02349295|26111838|FG002|Long-Term Extension Period (Week 24-156)|Death|0|||
13167796|NCT02349295|26111839|FG003|Long-Term Extension Period (Week 24-156)|Death|0|||
13167797|NCT02349295|26111840|FG004|Long-Term Extension Period (Week 24-156)|Death|0|||
13167798|NCT02349295|26111841|FG005|Long-Term Extension Period (Week 24-156)|Death|0|||
13167799|NCT02349295|26111842|FG006|Long-Term Extension Period (Week 24-156)|Death|0|||
13167800|NCT02349295|26111843|FG007|Long-Term Extension Period (Week 24-156)|Death|1|||
13167801|NCT02349295|26111844|FG008|Long-Term Extension Period (Week 24-156)|Death|1|||
13167802|NCT02349295|26111845|FG009|Long-Term Extension Period (Week 24-156)|Death|1|||
13167803|NCT02349295|26111846|FG010|Long-Term Extension Period (Week 24-156)|Death|0|||
13167804|NCT02349295|26111847|FG011|Long-Term Extension Period (Week 24-156)|Death|0|||
13167805|NCT02349295|26111848|FG012|Long-Term Extension Period (Week 24-156)|Death|0|||
13167806|NCT02349295|26111849|FG013|Long-Term Extension Period (Week 24-156)|Death|0|||
13167807|NCT02349295|26111836|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
13167808|NCT02349295|26111837|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
13167809|NCT02349295|26111838|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
13167810|NCT02349295|26111839|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
13167811|NCT02349295|26111840|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
13167812|NCT02349295|26111841|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
13167813|NCT02349295|26111842|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
13167814|NCT02349295|26111843|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4|||
13167815|NCT02349295|26111844|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2|||
13167816|NCT02349295|26111845|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1|||
13167817|NCT02349295|26111846|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3|||
13167818|NCT02349295|26111847|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
13167819|NCT02349295|26111848|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
13107337|NCT03285295|25886563|FG002|Alinity s Anti-HBc|No Results Generated|0|||
13107338|NCT03285295|25886564|FG003|Alinity s Anti-HBc|No Results Generated|0|||
13107339|NCT03285295|25886565|FG004|Alinity s Anti-HBc|No Results Generated|0|||
13107340|NCT03285295|25886561|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14|||
13107341|NCT03285295|25886562|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
13107342|NCT03285295|25886563|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
13107343|NCT03285295|25886564|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
13107344|NCT03285295|25886565|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
13107345|NCT03285295|25886561|FG000|Alinity s Chagas|Protocol Violation|76|||
13107346|NCT03285295|25886562|FG001|Alinity s Chagas|Protocol Violation|0|||
13107347|NCT03285295|25886563|FG002|Alinity s Chagas|Protocol Violation|0|||
13107348|NCT03285295|25886564|FG003|Alinity s Chagas|Protocol Violation|0|||
13107349|NCT03285295|25886565|FG004|Alinity s Chagas|Protocol Violation|0|||
13107350|NCT03285295|25886561|FG000|Alinity s Chagas|No Results on Comparator Assay|38|||
13107351|NCT03285295|25886562|FG001|Alinity s Chagas|No Results on Comparator Assay|0|||
13107352|NCT03285295|25886563|FG002|Alinity s Chagas|No Results on Comparator Assay|0|||
13167820|NCT02349295|26111849|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
13167821|NCT02349295|26111836|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
13167822|NCT02349295|26111837|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
13167823|NCT02349295|26111838|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
13167824|NCT02349295|26111839|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
13167825|NCT02349295|26111840|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
13167826|NCT02349295|26111841|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
13167827|NCT02349295|26111842|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
13167828|NCT02349295|26111843|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
13167829|NCT02349295|26111844|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
13167830|NCT02349295|26111845|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
13167831|NCT02349295|26111846|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
13167832|NCT02349295|26111847|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
13167833|NCT02349295|26111848|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
13167834|NCT02349295|26111849|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
13167835|NCT02349295|26111836|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
13167836|NCT02349295|26111837|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
13167837|NCT02349295|26111838|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
13167838|NCT02349295|26111839|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
13167839|NCT02349295|26111840|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
13167840|NCT02349295|26111841|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
13167841|NCT02349295|26111842|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
13167842|NCT02349295|26111843|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
13167843|NCT02349295|26111844|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
13167844|NCT02349295|26111845|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
13167845|NCT02349295|26111846|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
13167846|NCT02349295|26111847|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
13167847|NCT02349295|26111848|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
13167848|NCT02349295|26111849|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
13167849|NCT02349295|26111836|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
13167850|NCT02349295|26111837|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
13167851|NCT02349295|26111838|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
13167852|NCT02349295|26111839|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
13167853|NCT02349295|26111840|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
13167854|NCT02349295|26111841|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
13167855|NCT02349295|26111842|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
13167856|NCT02349295|26111843|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
13167857|NCT02349295|26111844|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
13167858|NCT02349295|26111845|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
13167859|NCT02349295|26111846|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
13167860|NCT02349295|26111847|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
13167861|NCT02349295|26111848|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5|||
13167862|NCT02349295|26111849|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
13167863|NCT02349295|26111836|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
13167864|NCT02349295|26111837|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
13222909|NCT01802320|26287150|FG000|Overall Study|Withdrawal by Subject|1|||
13167865|NCT02349295|26111838|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
13167866|NCT02349295|26111839|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
13167867|NCT02349295|26111840|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
13167868|NCT02349295|26111841|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
13167869|NCT02349295|26111842|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
13167870|NCT02349295|26111843|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
13167871|NCT02349295|26111844|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
13167872|NCT02349295|26111845|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
13167873|NCT02349295|26111846|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
13167874|NCT02349295|26111847|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1|||
13167875|NCT02349295|26111848|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2|||
13167876|NCT02349295|26111849|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
13167877|NCT02349295|26111836|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
13167878|NCT02349295|26111837|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
13167879|NCT02349295|26111838|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
13167880|NCT02349295|26111839|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
13167881|NCT02349295|26111840|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
13167882|NCT02349295|26111841|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
13167883|NCT02349295|26111842|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
13167884|NCT02349295|26111843|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
13167885|NCT02349295|26111844|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
13167886|NCT02349295|26111845|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
13167887|NCT02349295|26111846|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
13167888|NCT02349295|26111847|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
13167889|NCT02349295|26111848|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
13167890|NCT02349295|26111849|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
13107353|NCT03285295|25886564|FG003|Alinity s Chagas|No Results on Comparator Assay|0|||
13107354|NCT03285295|25886565|FG004|Alinity s Chagas|No Results on Comparator Assay|0|||
13167891|NCT02349295|26111836|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
13167892|NCT02349295|26111837|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
13167893|NCT02349295|26111838|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
13167894|NCT02349295|26111839|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
13167895|NCT02349295|26111840|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
13167896|NCT02349295|26111841|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
13167897|NCT02349295|26111842|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
13167898|NCT02349295|26111843|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
13167899|NCT02349295|26111844|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
13167900|NCT02349295|26111845|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
13167901|NCT02349295|26111846|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
13167902|NCT02349295|26111847|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2|||
13167903|NCT02349295|26111848|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
13167904|NCT02349295|26111849|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
13167905|NCT02349295|26111836|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
13167906|NCT02349295|26111837|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
13167907|NCT02349295|26111838|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
13167908|NCT02349295|26111839|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
13167909|NCT02349295|26111840|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
13167910|NCT02349295|26111841|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
13167911|NCT02349295|26111842|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
13167912|NCT02349295|26111843|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
13167913|NCT02349295|26111844|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
13167914|NCT02349295|26111845|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
13107355|NCT03285295|25886561|FG000|Alinity s Chagas|No Results Generated|105|||
13107356|NCT03285295|25886562|FG001|Alinity s Chagas|No Results Generated|0|||
13107357|NCT03285295|25886563|FG002|Alinity s Chagas|No Results Generated|0|||
13107358|NCT03285295|25886564|FG003|Alinity s Chagas|No Results Generated|0|||
13107359|NCT03285295|25886565|FG004|Alinity s Chagas|No Results Generated|0|||
13107360|NCT03285295|25886561|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13|||
13107361|NCT03285295|25886562|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
13107362|NCT03285295|25886563|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
13107363|NCT03285295|25886564|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
13107364|NCT03285295|25886565|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
13107365|NCT03285113|25886574|FG000|Overall Study|Unable to implant leads|2|||
13107366|NCT03284229|25886589|FG000|Overall Study|Lost to Follow-up|3|||
13107367|NCT03283709|25886626|FG000|Overall Study|trial terminated|0|||
13107368|NCT03283709|25886627|FG001|Overall Study|trial terminated|1|||
13107369|NCT03283696|25886660|FG000|Overall Study|Physician Decision|5|||
13167915|NCT02349295|26111846|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
13167916|NCT02349295|26111847|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4|||
13167917|NCT02349295|26111848|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
13167918|NCT02349295|26111849|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
13167919|NCT02349061|26111875|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4|||
13167920|NCT02349061|26111876|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3|||
13167921|NCT02349061|26111877|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0|||
13167922|NCT02349061|26111875|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1|||
13167923|NCT02349061|26111876|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
13167924|NCT02349061|26111877|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
13167925|NCT02349061|26111875|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1|||
13167926|NCT02349061|26111876|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
13167927|NCT02349061|26111877|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
13167928|NCT02349061|26111875|FG000|Main Study: PCP (Up to Week 24)|Other|1|||
13167929|NCT02349061|26111876|FG001|Main Study: PCP (Up to Week 24)|Other|1|||
13167930|NCT02349061|26111877|FG002|Main Study: PCP (Up to Week 24)|Other|0|||
13167931|NCT02349061|26111875|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2|||
13167932|NCT02349061|26111876|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
13167933|NCT02349061|26111877|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
13167934|NCT02349061|26111875|FG000|Main Study: Week 24 to 56|Adverse Event|0|||
13167935|NCT02349061|26111876|FG001|Main Study: Week 24 to 56|Adverse Event|2|||
13167936|NCT02349061|26111877|FG002|Main Study: Week 24 to 56|Adverse Event|1|||
13167937|NCT02349061|26111875|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0|||
13167938|NCT02349061|26111876|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1|||
13167939|NCT02349061|26111877|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0|||
13167940|NCT02349061|26111875|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
13167941|NCT02349061|26111876|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
13167942|NCT02349061|26111877|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1|||
13167943|NCT02349061|26111875|FG000|Main Study: Week 24 to 56|Physician Decision|0|||
13167944|NCT02349061|26111876|FG001|Main Study: Week 24 to 56|Physician Decision|0|||
13167945|NCT02349061|26111877|FG002|Main Study: Week 24 to 56|Physician Decision|1|||
13167946|NCT02349061|26111875|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
13167947|NCT02349061|26111876|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3|||
13167948|NCT02349061|26111877|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
13167949|NCT02349061|26111875|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
13167950|NCT02349061|26111876|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
13167951|NCT02349061|26111877|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1|||
13167952|NCT02349061|26111875|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0|||
13167953|NCT02349061|26111876|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2|||
13167954|NCT02349061|26111877|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1|||
13167955|NCT02349061|26111875|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
13167956|NCT02349061|26111876|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
13167957|NCT02349061|26111877|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1|||
13167958|NCT02349048|26111904|FG000|Overall Study|Withdrawal by Subject|4|||
13167959|NCT02349048|26111905|FG001|Overall Study|Withdrawal by Subject|0|||
13167960|NCT02349048|26111904|FG000|Overall Study|Lost to Follow-up|1|||
13167961|NCT02349048|26111905|FG001|Overall Study|Lost to Follow-up|0|||
13167962|NCT02348840|26111930|FG000|Overall Study|Withdrawal by Subject|2|||
13167963|NCT02348840|26111931|FG001|Overall Study|Withdrawal by Subject|1|||
13167964|NCT02348840|26111932|FG002|Overall Study|Withdrawal by Subject|0|||
13167965|NCT02348840|26111933|FG003|Overall Study|Withdrawal by Subject|0|||
13167966|NCT02348723|26111952|FG000|Overall Study|No ablation|21|||
13167967|NCT02348723|26111953|FG001|Overall Study|No ablation|20|||
13167968|NCT02348723|26111952|FG000|Overall Study|Non-compliant with Protocol|1|||
13167969|NCT02348723|26111953|FG001|Overall Study|Non-compliant with Protocol|0|||
13167970|NCT02348723|26111952|FG000|Overall Study|Lost to Follow-up|1|||
13167971|NCT02348723|26111953|FG001|Overall Study|Lost to Follow-up|1|||
13167972|NCT02348723|26111952|FG000|Overall Study|Consent withdrawn|1|||
13167973|NCT02348723|26111953|FG001|Overall Study|Consent withdrawn|3|||
13167974|NCT02348723|26111952|FG000|Overall Study|Reason other than specified|1|||
13167975|NCT02348723|26111953|FG001|Overall Study|Reason other than specified|1|||
13167976|NCT02348723|26111952|FG000|Overall Study|Adverse Event|3|||
13167977|NCT02348723|26111953|FG001|Overall Study|Adverse Event|1|||
13167978|NCT02348489|26111982|FG000|Overall Study|Death|336|||
13167979|NCT02348489|26111983|FG001|Overall Study|Death|335|||
13167980|NCT02348489|26111982|FG000|Overall Study|Withdrawal by Subject|14|||
13167981|NCT02348489|26111983|FG001|Overall Study|Withdrawal by Subject|27|||
13167982|NCT02348489|26111982|FG000|Overall Study|Lost to Follow-up|3|||
13167983|NCT02348489|26111983|FG001|Overall Study|Lost to Follow-up|5|||
13167984|NCT02348216|26112130|FG000|Overall Study|Death|4|||
13167985|NCT02348216|26112131|FG001|Overall Study|Death|27|||
13167986|NCT02348216|26112132|FG002|Overall Study|Death|3|||
13167987|NCT02348216|26112133|FG003|Overall Study|Death|18|||
13167988|NCT02348216|26112134|FG004|Overall Study|Death|9|||
13167989|NCT02348216|26112135|FG005|Overall Study|Death|23|||
13167990|NCT02348216|26112136|FG006|Overall Study|Death|6|||
13167991|NCT02348216|26112130|FG000|Overall Study|Full consent withdrawal|0|||
13167992|NCT02348216|26112131|FG001|Overall Study|Full consent withdrawal|0|||
13167993|NCT02348216|26112132|FG002|Overall Study|Full consent withdrawal|0|||
13167994|NCT02348216|26112133|FG003|Overall Study|Full consent withdrawal|1|||
13167995|NCT02348216|26112134|FG004|Overall Study|Full consent withdrawal|0|||
13167996|NCT02348216|26112135|FG005|Overall Study|Full consent withdrawal|0|||
13167997|NCT02348216|26112136|FG006|Overall Study|Full consent withdrawal|1|||
13167998|NCT02348216|26112130|FG000|Overall Study|Lost to Follow-up|0|||
13167999|NCT02348216|26112131|FG001|Overall Study|Lost to Follow-up|0|||
13168000|NCT02348216|26112132|FG002|Overall Study|Lost to Follow-up|0|||
13168001|NCT02348216|26112133|FG003|Overall Study|Lost to Follow-up|0|||
13168002|NCT02348216|26112134|FG004|Overall Study|Lost to Follow-up|0|||
13168003|NCT02348216|26112135|FG005|Overall Study|Lost to Follow-up|0|||
13168004|NCT02348216|26112136|FG006|Overall Study|Lost to Follow-up|1|||
13168005|NCT02348216|26112130|FG000|Overall Study|Still on study|3|||
13168006|NCT02348216|26112131|FG001|Overall Study|Still on study|50|||
13168007|NCT02348216|26112132|FG002|Overall Study|Still on study|21|||
13168008|NCT02348216|26112133|FG003|Overall Study|Still on study|19|||
13168009|NCT02348216|26112134|FG004|Overall Study|Still on study|32|||
13168010|NCT02348216|26112135|FG005|Overall Study|Still on study|27|||
13168011|NCT02348216|26112136|FG006|Overall Study|Still on study|32|||
13168012|NCT02348216|26112130|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1|||
13168013|NCT02348216|26112131|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
13168014|NCT02348216|26112132|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6|||
13168015|NCT02348216|26112133|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
13168016|NCT02348216|26112134|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5|||
13168017|NCT02348216|26112135|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8|||
13168018|NCT02348216|26112136|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2|||
13168019|NCT02348008|26112157|FG000|Overall Study|Adverse Event|2|||
13168020|NCT02348008|26112158|FG001|Overall Study|Adverse Event|3|||
13168021|NCT02348008|26112159|FG002|Overall Study|Adverse Event|3|||
13168022|NCT02348008|26112157|FG000|Overall Study|Disease Progression|1|||
13168023|NCT02348008|26112158|FG001|Overall Study|Disease Progression|5|||
13168024|NCT02348008|26112159|FG002|Overall Study|Disease Progression|16|||
13168025|NCT02348008|26112157|FG000|Overall Study|Withdrawal by Subject|0|||
13168026|NCT02348008|26112158|FG001|Overall Study|Withdrawal by Subject|1|||
13168027|NCT02348008|26112159|FG002|Overall Study|Withdrawal by Subject|0|||
13168028|NCT02348008|26112157|FG000|Overall Study|Symptomatic Deterioration|0|||
13168029|NCT02348008|26112158|FG001|Overall Study|Symptomatic Deterioration|1|||
13168030|NCT02348008|26112159|FG002|Overall Study|Symptomatic Deterioration|0|||
13168031|NCT02347943|26112177|FG000|Overall Study|Study was cancelled|140|||
13168032|NCT02347943|26112178|FG001|Overall Study|Study was cancelled|67|||
13168033|NCT02347943|26112179|FG002|Overall Study|Study was cancelled|45|||
13168034|NCT02347813|26112194|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
13168035|NCT02347813|26112195|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
13168036|NCT02347813|26112194|FG000|First Intervention, 24 Weeks|Adverse Event|1|||
13168037|NCT02347813|26112195|FG001|First Intervention, 24 Weeks|Adverse Event|1|||
13168038|NCT02347787|26112261|FG000|6 Month Follow-Up|Lost to Follow-up|63|||
13168039|NCT02347787|26112262|FG001|6 Month Follow-Up|Lost to Follow-up|47|||
13168040|NCT02347787|26112261|FG000|6 Month Follow-Up|Withdrawal by Subject|3|||
13168041|NCT02347787|26112262|FG001|6 Month Follow-Up|Withdrawal by Subject|9|||
13168042|NCT02347787|26112261|FG000|9 Month Follow-Up|Lost to Follow-up|52|||
13168043|NCT02347787|26112262|FG001|9 Month Follow-Up|Lost to Follow-up|59|||
13168044|NCT02347787|26112261|FG000|9 Month Follow-Up|Withdrawal by Subject|9|||
13168045|NCT02347787|26112262|FG001|9 Month Follow-Up|Withdrawal by Subject|12|||
13168046|NCT02347774|26112325|FG000|Study Participation|Lost to Follow-up|3|||
13168047|NCT02347774|26112326|FG001|Study Participation|Lost to Follow-up|6|||
13168048|NCT02347774|26112327|FG002|Study Participation|Lost to Follow-up|2|||
13168049|NCT02347774|26112325|FG000|Study Participation|Withdrawal by Subject|8|||
13168050|NCT02347774|26112326|FG001|Study Participation|Withdrawal by Subject|9|||
13168051|NCT02347774|26112327|FG002|Study Participation|Withdrawal by Subject|15|||
13168052|NCT02347774|26112325|FG000|Study Participation|Adverse Event|1|||
13168053|NCT02347774|26112326|FG001|Study Participation|Adverse Event|4|||
13168054|NCT02347774|26112327|FG002|Study Participation|Adverse Event|6|||
13168055|NCT02347774|26112325|FG000|Study Participation|withdrew consent|1|||
13168056|NCT02347774|26112326|FG001|Study Participation|withdrew consent|1|||
13168057|NCT02347774|26112327|FG002|Study Participation|withdrew consent|1|||
13168058|NCT02347774|26112325|FG000|Study Participation|Met Prolonged QT criteria|1|||
13168059|NCT02347774|26112326|FG001|Study Participation|Met Prolonged QT criteria|0|||
13168060|NCT02347774|26112327|FG002|Study Participation|Met Prolonged QT criteria|0|||
13168061|NCT02347774|26112325|FG000|Study Participation|non-compliance with study drug|0|||
13168062|NCT02347774|26112326|FG001|Study Participation|non-compliance with study drug|1|||
13168063|NCT02347774|26112327|FG002|Study Participation|non-compliance with study drug|0|||
13168064|NCT02347774|26112325|FG000|Study Participation|incarceration|1|||
13168065|NCT02347774|26112326|FG001|Study Participation|incarceration|0|||
13168066|NCT02347774|26112327|FG002|Study Participation|incarceration|0|||
13168067|NCT02347774|26112325|FG000|Study Participation|randomized in error|0|||
13168068|NCT02347774|26112326|FG001|Study Participation|randomized in error|0|||
13168069|NCT02347774|26112327|FG002|Study Participation|randomized in error|1|||
13168070|NCT02347774|26112325|FG000|On Study Treatment|Adverse Event|9|||
13168071|NCT02347774|26112326|FG001|On Study Treatment|Adverse Event|15|||
13168072|NCT02347774|26112327|FG002|On Study Treatment|Adverse Event|19|||
13168073|NCT02347774|26112325|FG000|On Study Treatment|Lack of Efficacy|3|||
13168074|NCT02347774|26112326|FG001|On Study Treatment|Lack of Efficacy|0|||
13168075|NCT02347774|26112327|FG002|On Study Treatment|Lack of Efficacy|2|||
13168076|NCT02347774|26112325|FG000|On Study Treatment|non-complicance with study medication|0|||
13168077|NCT02347774|26112326|FG001|On Study Treatment|non-complicance with study medication|2|||
13168078|NCT02347774|26112327|FG002|On Study Treatment|non-complicance with study medication|0|||
13168079|NCT02347774|26112325|FG000|On Study Treatment|Protocol Violation|0|||
13168080|NCT02347774|26112326|FG001|On Study Treatment|Protocol Violation|0|||
13168081|NCT02347774|26112327|FG002|On Study Treatment|Protocol Violation|1|||
13168082|NCT02347774|26112325|FG000|On Study Treatment|withdrew consent|9|||
13168083|NCT02347774|26112326|FG001|On Study Treatment|withdrew consent|8|||
13168084|NCT02347774|26112327|FG002|On Study Treatment|withdrew consent|12|||
13168085|NCT02347774|26112325|FG000|On Study Treatment|Lost to Follow-up|2|||
13168086|NCT02347774|26112326|FG001|On Study Treatment|Lost to Follow-up|6|||
13168087|NCT02347774|26112327|FG002|On Study Treatment|Lost to Follow-up|1|||
13168088|NCT02347774|26112325|FG000|On Study Treatment|Met Prolonged QT criteria|1|||
13168089|NCT02347774|26112326|FG001|On Study Treatment|Met Prolonged QT criteria|0|||
13168090|NCT02347774|26112327|FG002|On Study Treatment|Met Prolonged QT criteria|0|||
13168091|NCT02347774|26112325|FG000|On Study Treatment|ranomized in error|0|||
13168092|NCT02347774|26112326|FG001|On Study Treatment|ranomized in error|0|||
13168093|NCT02347774|26112327|FG002|On Study Treatment|ranomized in error|1|||
13168094|NCT02347761|26112396|FG000|All Collected|Death|1|||
13168095|NCT02347761|26112397|FG001|All Collected|Death|0|||
13168096|NCT02347761|26112398|FG002|All Collected|Death|0|||
13168097|NCT02347761|26112396|FG000|All Collected|Lost to Follow-up|3|||
13168098|NCT02347761|26112397|FG001|All Collected|Lost to Follow-up|2|||
13168099|NCT02347761|26112398|FG002|All Collected|Lost to Follow-up|3|||
13168100|NCT02347761|26112396|FG000|All Collected|Withdrawal by Subject|11|||
13168101|NCT02347761|26112397|FG001|All Collected|Withdrawal by Subject|11|||
13168102|NCT02347761|26112398|FG002|All Collected|Withdrawal by Subject|22|||
13168103|NCT02347761|26112396|FG000|All Collected|invetigator disretion|2|||
13168104|NCT02347761|26112397|FG001|All Collected|invetigator disretion|0|||
13168105|NCT02347761|26112398|FG002|All Collected|invetigator disretion|0|||
13168106|NCT02347761|26112396|FG000|All Collected|instillation site pain|0|||
13168107|NCT02347761|26112397|FG001|All Collected|instillation site pain|0|||
13168108|NCT02347761|26112398|FG002|All Collected|instillation site pain|1|||
13168109|NCT02347761|26112396|FG000|All Collected|exacerbation of COPD|0|||
13168110|NCT02347761|26112397|FG001|All Collected|exacerbation of COPD|0|||
13168111|NCT02347761|26112398|FG002|All Collected|exacerbation of COPD|1|||
13168112|NCT02347761|26112396|FG000|All Collected|moved/travel|0|||
13168113|NCT02347761|26112397|FG001|All Collected|moved/travel|1|||
13168114|NCT02347761|26112398|FG002|All Collected|moved/travel|0|||
13168115|NCT02347761|26112396|FG000|On Study Treatment|Lack of Efficacy|2|||
13168116|NCT02347761|26112397|FG001|On Study Treatment|Lack of Efficacy|3|||
13168117|NCT02347761|26112398|FG002|On Study Treatment|Lack of Efficacy|4|||
13168118|NCT02347761|26112396|FG000|On Study Treatment|non-compliance with study medication|0|||
13168119|NCT02347761|26112397|FG001|On Study Treatment|non-compliance with study medication|0|||
13168120|NCT02347761|26112398|FG002|On Study Treatment|non-compliance with study medication|2|||
13168121|NCT02347761|26112396|FG000|On Study Treatment|Withdrawal by Subject|7|||
13168122|NCT02347761|26112397|FG001|On Study Treatment|Withdrawal by Subject|3|||
13168123|NCT02347761|26112398|FG002|On Study Treatment|Withdrawal by Subject|5|||
13168124|NCT02347761|26112396|FG000|On Study Treatment|move/travel|2|||
13168125|NCT02347761|26112397|FG001|On Study Treatment|move/travel|6|||
13168126|NCT02347761|26112398|FG002|On Study Treatment|move/travel|5|||
13168127|NCT02347761|26112396|FG000|On Study Treatment|dissastisfaction with device|2|||
13168128|NCT02347761|26112397|FG001|On Study Treatment|dissastisfaction with device|1|||
13168129|NCT02347761|26112398|FG002|On Study Treatment|dissastisfaction with device|4|||
13168130|NCT02347761|26112396|FG000|On Study Treatment|Lost to Follow-up|2|||
13168131|NCT02347761|26112397|FG001|On Study Treatment|Lost to Follow-up|1|||
13168132|NCT02347761|26112398|FG002|On Study Treatment|Lost to Follow-up|1|||
13168133|NCT02347761|26112396|FG000|On Study Treatment|investigator discretion|2|||
13168134|NCT02347761|26112397|FG001|On Study Treatment|investigator discretion|0|||
13168135|NCT02347761|26112398|FG002|On Study Treatment|investigator discretion|0|||
13168136|NCT02347761|26112396|FG000|On Study Treatment|durg not working|0|||
13168137|NCT02347761|26112397|FG001|On Study Treatment|durg not working|1|||
13168138|NCT02347761|26112398|FG002|On Study Treatment|durg not working|1|||
13168139|NCT02347761|26112396|FG000|On Study Treatment|Adverse Event|10|||
13168140|NCT02347761|26112397|FG001|On Study Treatment|Adverse Event|8|||
13168141|NCT02347761|26112398|FG002|On Study Treatment|Adverse Event|20|||
13168142|NCT02347657|26112430|FG000|Overall Study|Physician Decision|0|||
13168143|NCT02347657|26112431|FG001|Overall Study|Physician Decision|1|||
13168144|NCT02347657|26112430|FG000|Overall Study|Adverse Event|8|||
13168145|NCT02347657|26112431|FG001|Overall Study|Adverse Event|4|||
13168146|NCT02347657|26112430|FG000|Overall Study|Withdrawal by Subject|6|||
13168147|NCT02347657|26112431|FG001|Overall Study|Withdrawal by Subject|7|||
13168148|NCT02347657|26112430|FG000|Overall Study|Randomized but not treated|1|||
13168149|NCT02347657|26112431|FG001|Overall Study|Randomized but not treated|0|||
13168150|NCT02347657|26112430|FG000|Overall Study|Other|3|||
13168151|NCT02347657|26112431|FG001|Overall Study|Other|3|||
13168152|NCT02347631|26112446|FG000|First Intervention (2 Months)|Adverse Event|1|||
13168153|NCT02347631|26112447|FG001|First Intervention (2 Months)|Adverse Event|1|||
13168154|NCT02347631|26112446|FG000|First Intervention (2 Months)|Pregnancy|1|||
13168155|NCT02347631|26112447|FG001|First Intervention (2 Months)|Pregnancy|0|||
13168156|NCT02347631|26112446|FG000|First Intervention (2 Months)|Moved out of area|0|||
13168157|NCT02347631|26112447|FG001|First Intervention (2 Months)|Moved out of area|2|||
13168158|NCT02347631|26112446|FG000|First Intervention (2 Months)|Lost to Follow-up|5|||
13168159|NCT02347631|26112447|FG001|First Intervention (2 Months)|Lost to Follow-up|3|||
13168160|NCT02347631|26112446|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2|||
13168161|NCT02347631|26112447|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2|||
13168162|NCT02347631|26112446|FG000|Washout 2 (1 Month)|Lost to Follow-up|0|||
13168163|NCT02347631|26112447|FG001|Washout 2 (1 Month)|Lost to Follow-up|1|||
13168164|NCT02347631|26112446|FG000|Second Intervention (2 Months)|Lost to Follow-up|7|||
13168165|NCT02347631|26112447|FG001|Second Intervention (2 Months)|Lost to Follow-up|4|||
13168166|NCT02347631|26112446|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6|||
13168167|NCT02347631|26112447|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0|||
13168168|NCT02347527|26112474|FG000|Overall Study|MRI not completed due to technical difficulties|1|||
13168169|NCT02347527|26112475|FG001|Overall Study|MRI not completed due to technical difficulties|0|||
13168170|NCT02347527|26112476|FG002|Overall Study|MRI not completed due to technical difficulties|0|||
13168171|NCT02347527|26112477|FG003|Overall Study|MRI not completed due to technical difficulties|0|||
13168172|NCT02347527|26112474|FG000|Overall Study|MRI stopped due to participant anxiety|0|||
13168173|NCT02347527|26112475|FG001|Overall Study|MRI stopped due to participant anxiety|1|||
13168174|NCT02347527|26112476|FG002|Overall Study|MRI stopped due to participant anxiety|0|||
13168175|NCT02347527|26112477|FG003|Overall Study|MRI stopped due to participant anxiety|0|||
13168176|NCT02347527|26112474|FG000|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
13168177|NCT02347527|26112475|FG001|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
13168178|NCT02347527|26112476|FG002|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
13168179|NCT02347527|26112477|FG003|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
13168180|NCT02347527|26112474|FG000|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
13168181|NCT02347527|26112475|FG001|Overall Study|Excluded from analyses due to technical difficulties during the study visit|0|||
13168182|NCT02347527|26112476|FG002|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
13168183|NCT02347527|26112477|FG003|Overall Study|Excluded from analyses due to technical difficulties during the study visit|2|||
13168184|NCT02347527|26112474|FG000|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
13168185|NCT02347527|26112475|FG001|Overall Study|Excluded from analyses due to non-compliance with study procedures|1|||
13168186|NCT02347527|26112476|FG002|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
13168187|NCT02347527|26112477|FG003|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
13107370|NCT03283696|25886661|FG001|Overall Study|Physician Decision|6|||
13168188|NCT02347332|26112498|FG000|Overall Study|Not treated|5|||
13168189|NCT02347332|26112499|FG001|Overall Study|Not treated|2|||
13168190|NCT02347332|26112498|FG000|Overall Study|Progressive disease|141|||
13168191|NCT02347332|26112499|FG001|Overall Study|Progressive disease|159|||
13107371|NCT03283696|25886660|FG000|Overall Study|Withdrawal by Subject|2|||
13107372|NCT03283696|25886661|FG001|Overall Study|Withdrawal by Subject|0|||
13107373|NCT03283566|25886678|FG000|Overall Study|Lost to Follow-up|1|||
13107374|NCT03283566|25886679|FG001|Overall Study|Lost to Follow-up|2|||
13107375|NCT03283553|25886716|FG000|Patient Participant Flow|Death|5|||
13107376|NCT03283553|25886717|FG001|Patient Participant Flow|Death|10|||
13107377|NCT03283553|25886716|FG000|Patient Participant Flow|Withdrawal by Subject|4|||
13107378|NCT03283553|25886717|FG001|Patient Participant Flow|Withdrawal by Subject|2|||
13107379|NCT03283553|25886716|FG000|Patient Participant Flow|Lost to Follow-up|1|||
13107380|NCT03283553|25886717|FG001|Patient Participant Flow|Lost to Follow-up|1|||
13107381|NCT03283553|25886716|FG000|Care Partner Participant Flow|Withdrawal by Subject|4|||
13107382|NCT03283553|25886717|FG001|Care Partner Participant Flow|Withdrawal by Subject|3|||
13107383|NCT03283553|25886716|FG000|Care Partner Participant Flow|Lost to Follow-up|1|||
13168192|NCT02347332|26112498|FG000|Overall Study|Adverse Event|50|||
13168193|NCT02347332|26112499|FG001|Overall Study|Adverse Event|41|||
13168194|NCT02347332|26112498|FG000|Overall Study|Death (Unknown, Various reasons)|6|||
13168195|NCT02347332|26112499|FG001|Overall Study|Death (Unknown, Various reasons)|6|||
13168196|NCT02347332|26112498|FG000|Overall Study|Protocol Violation|1|||
13168197|NCT02347332|26112499|FG001|Overall Study|Protocol Violation|1|||
13168198|NCT02347332|26112498|FG000|Overall Study|Lost to Follow-up|2|||
13168199|NCT02347332|26112499|FG001|Overall Study|Lost to Follow-up|1|||
13168200|NCT02347332|26112498|FG000|Overall Study|Physician Decision|4|||
13168201|NCT02347332|26112499|FG001|Overall Study|Physician Decision|3|||
13168202|NCT02347332|26112498|FG000|Overall Study|Withdrawal by Subject|20|||
13168203|NCT02347332|26112499|FG001|Overall Study|Withdrawal by Subject|14|||
13168204|NCT02347332|26112498|FG000|Overall Study|Protocol requirement|1|||
13168205|NCT02347332|26112499|FG001|Overall Study|Protocol requirement|1|||
13168206|NCT02347332|26112498|FG000|Overall Study|Switch Post-Trial program|0|||
13168207|NCT02347332|26112499|FG001|Overall Study|Switch Post-Trial program|1|||
13168208|NCT02347189|26112516|FG000|Overall Study|No implant attempted of study device|9|||
13168209|NCT02347189|26112516|FG000|Overall Study|No primary outcome data available|2|||
13168210|NCT02347176|26112575|FG000|Overall Study|Lost to Follow-up|2|||
13168211|NCT02347176|26112576|FG001|Overall Study|Lost to Follow-up|3|||
13168212|NCT02347176|26112577|FG002|Overall Study|Lost to Follow-up|1|||
13168213|NCT02347176|26112578|FG003|Overall Study|Lost to Follow-up|1|||
13168214|NCT02347176|26112575|FG000|Overall Study|Withdrawal by Subject|9|||
13168215|NCT02347176|26112576|FG001|Overall Study|Withdrawal by Subject|5|||
13168216|NCT02347176|26112577|FG002|Overall Study|Withdrawal by Subject|5|||
13168217|NCT02347176|26112578|FG003|Overall Study|Withdrawal by Subject|3|||
13168218|NCT02347176|26112575|FG000|Overall Study|Other|1|||
13168219|NCT02347176|26112576|FG001|Overall Study|Other|2|||
13168220|NCT02347176|26112577|FG002|Overall Study|Other|2|||
13168221|NCT02347176|26112578|FG003|Overall Study|Other|0|||
13168222|NCT02347098|26112597|FG000|Overall Study|Death|1|||
13168223|NCT02347098|26112598|FG001|Overall Study|Death|0|||
13168224|NCT02347098|26112597|FG000|Overall Study|Withdrawal by Subject|1|||
13168225|NCT02347098|26112598|FG001|Overall Study|Withdrawal by Subject|0|||
13168226|NCT02347098|26112597|FG000|Overall Study|Lost to Follow-up|2|||
13168227|NCT02347098|26112598|FG001|Overall Study|Lost to Follow-up|2|||
13168228|NCT02347098|26112597|FG000|Overall Study|Refuse Follow-up Visit|1|||
13168229|NCT02347098|26112598|FG001|Overall Study|Refuse Follow-up Visit|5|||
13168230|NCT02347098|26112597|FG000|Overall Study|no visit due to illness|2|||
13168231|NCT02347098|26112598|FG001|Overall Study|no visit due to illness|1|||
13168232|NCT02347085|26112622|FG000|Overall Study|Adverse Event|2|||
13168233|NCT02347085|26112622|FG000|Overall Study|Lack of Efficacy|1|||
13168234|NCT02347085|26112622|FG000|Overall Study|Withdrawal by Subject|4|||
13168235|NCT02347085|26112622|FG000|Overall Study|Lost to Follow-up|1|||
13168236|NCT02347085|26112622|FG000|Overall Study|Protocol Criteria|2|||
13168237|NCT02347072|26112656|FG000|Overall Study|Adverse Event|2|||
13168238|NCT02347072|26112656|FG000|Overall Study|Withdrawal by Subject|6|||
13107384|NCT03283553|25886717|FG001|Care Partner Participant Flow|Lost to Follow-up|1|||
13107385|NCT03283553|25886716|FG000|Care Partner Participant Flow|Discontinued because patient death|5|||
13168239|NCT02347072|26112656|FG000|Overall Study|Physician Decision|1|||
13168240|NCT02347072|26112656|FG000|Overall Study|Lost to Follow-up|2|||
13168241|NCT02347072|26112656|FG000|Overall Study|Protocol Violation|1|||
13168242|NCT02347072|26112656|FG000|Overall Study|Disc due to Protocol-specified Criteria|6|||
13168243|NCT02346877|26112673|FG000|Overall Study|Adverse Event|1|||
13168244|NCT02346877|26112674|FG001|Overall Study|Adverse Event|0|||
13168245|NCT02346877|26112673|FG000|Overall Study|Administrative Decision|1|||
13168246|NCT02346877|26112674|FG001|Overall Study|Administrative Decision|0|||
13168247|NCT02346877|26112673|FG000|Overall Study|Sponsor Decision|12|||
13168248|NCT02346877|26112674|FG001|Overall Study|Sponsor Decision|0|||
13168249|NCT02346877|26112673|FG000|Overall Study|Missing|5|||
13168250|NCT02346877|26112674|FG001|Overall Study|Missing|0|||
13168251|NCT02346721|26112685|FG000|Overall Study|Withdrew Consent|3|||
13168252|NCT02346721|26112685|FG000|Overall Study|Lack of Efficacy|1|||
13107386|NCT03283553|25886717|FG001|Care Partner Participant Flow|Discontinued because patient death|11|||
13107387|NCT03283319|25886876|FG000|Overall Study|Lost to Follow-up|5|||
13107388|NCT03283319|25886877|FG001|Overall Study|Lost to Follow-up|4|||
13107389|NCT03283319|25886878|FG002|Overall Study|Lost to Follow-up|5|||
13107390|NCT03283319|25886879|FG003|Overall Study|Lost to Follow-up|5|||
13107391|NCT03283319|25886880|FG004|Overall Study|Lost to Follow-up|4|||
13107392|NCT03283319|25886881|FG005|Overall Study|Lost to Follow-up|3|||
13107393|NCT03283319|25886876|FG000|Overall Study|Withdrawal by Subject|2|||
13107394|NCT03283319|25886877|FG001|Overall Study|Withdrawal by Subject|2|||
13107395|NCT03283319|25886878|FG002|Overall Study|Withdrawal by Subject|2|||
13107396|NCT03283319|25886879|FG003|Overall Study|Withdrawal by Subject|1|||
13168253|NCT02346708|26112700|FG000|Overall Study|Adverse Event|2|||
13168254|NCT02346708|26112701|FG001|Overall Study|Adverse Event|0|||
13168255|NCT02346708|26112700|FG000|Overall Study|Protocol Violation|0|||
13168256|NCT02346708|26112701|FG001|Overall Study|Protocol Violation|1|||
13168257|NCT02346370|26112756|FG000|Overall Study|Not treated|1|||
13168258|NCT02346370|26112757|FG001|Overall Study|Not treated|0|||
13168259|NCT02346370|26112758|FG002|Overall Study|Not treated|0|||
13168260|NCT02346370|26112756|FG000|Overall Study|Withdrawal of consent|1|||
13168261|NCT02346370|26112757|FG001|Overall Study|Withdrawal of consent|0|||
13168262|NCT02346370|26112758|FG002|Overall Study|Withdrawal of consent|0|||
13168263|NCT02346370|26112756|FG000|Overall Study|Death|1|||
13168264|NCT02346370|26112757|FG001|Overall Study|Death|3|||
13168265|NCT02346370|26112758|FG002|Overall Study|Death|1|||
13168266|NCT02346370|26112756|FG000|Overall Study|Sponsor discontinued study|5|||
13168267|NCT02346370|26112757|FG001|Overall Study|Sponsor discontinued study|0|||
13168268|NCT02346370|26112758|FG002|Overall Study|Sponsor discontinued study|2|||
13168269|NCT02346370|26112756|FG000|Overall Study|Radiologic progression|0|||
13168270|NCT02346370|26112757|FG001|Overall Study|Radiologic progression|0|||
13168271|NCT02346370|26112758|FG002|Overall Study|Radiologic progression|1|||
13168272|NCT02346370|26112756|FG000|Overall Study|Physician Decision|0|||
13168273|NCT02346370|26112757|FG001|Overall Study|Physician Decision|1|||
13168274|NCT02346370|26112758|FG002|Overall Study|Physician Decision|0|||
13168275|NCT02346240|26112828|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0|||
13168276|NCT02346240|26112829|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4|||
13168277|NCT02346240|26112830|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1|||
13168278|NCT02346240|26112831|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1|||
13168279|NCT02346240|26112832|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0|||
13168280|NCT02346240|26112833|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0|||
13168281|NCT02346240|26112834|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0|||
13168282|NCT02346240|26112835|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0|||
13168283|NCT02346240|26112836|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0|||
13168284|NCT02346240|26112837|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0|||
13168285|NCT02346240|26112838|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0|||
13168286|NCT02346240|26112839|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0|||
13168287|NCT02346240|26112840|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0|||
13168288|NCT02346240|26112841|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0|||
13168289|NCT02346240|26112842|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0|||
13168290|NCT02346240|26112843|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0|||
13168291|NCT02346240|26112844|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0|||
13168292|NCT02346240|26112845|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0|||
13168293|NCT02346240|26112846|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0|||
13168294|NCT02346240|26112847|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0|||
13168295|NCT02346240|26112848|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0|||
13168296|NCT02346240|26112849|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0|||
13107397|NCT03283319|25886880|FG004|Overall Study|Withdrawal by Subject|0|||
13107398|NCT03283319|25886881|FG005|Overall Study|Withdrawal by Subject|1|||
13107399|NCT03283319|25886876|FG000|Overall Study|BARDA regulatory agency or IRB decision|0|||
13107400|NCT03283319|25886877|FG001|Overall Study|BARDA regulatory agency or IRB decision|0|||
13107401|NCT03283319|25886878|FG002|Overall Study|BARDA regulatory agency or IRB decision|0|||
13107402|NCT03283319|25886879|FG003|Overall Study|BARDA regulatory agency or IRB decision|1|||
13107403|NCT03283319|25886880|FG004|Overall Study|BARDA regulatory agency or IRB decision|0|||
13107404|NCT03283319|25886881|FG005|Overall Study|BARDA regulatory agency or IRB decision|0|||
13107405|NCT03283098|25886924|FG000|Overall Study|Withdrawal by Subject|0|||
13168297|NCT02346240|26112850|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0|||
13168298|NCT02346240|26112851|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0|||
13168299|NCT02346240|26112828|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
13168300|NCT02346240|26112829|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1|||
13168301|NCT02346240|26112830|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
13168302|NCT02346240|26112831|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
13107406|NCT03283098|25886925|FG001|Overall Study|Withdrawal by Subject|1|||
13168303|NCT02346240|26112832|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
13168304|NCT02346240|26112833|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
13168305|NCT02346240|26112834|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
13168306|NCT02346240|26112835|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
13168307|NCT02346240|26112836|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
13168308|NCT02346240|26112837|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
13107407|NCT03282357|25886934|FG000|Overall Study|Lost to Follow-up|3|||
13107408|NCT03282357|25886934|FG000|Overall Study|Withdrawal by Subject|4|||
13107409|NCT03282357|25886934|FG000|Overall Study|Adverse Event|1|||
13107410|NCT03282357|25886934|FG000|Overall Study|Other|9|||
13107411|NCT03282240|25886996|FG000|Overall Study|Adverse Event|2|||
13107412|NCT03282240|25886997|FG001|Overall Study|Adverse Event|2|||
13107413|NCT03282240|25886998|FG002|Overall Study|Adverse Event|0|||
13107414|NCT03282240|25886996|FG000|Overall Study|Lost to Follow-up|3|||
13107415|NCT03282240|25886997|FG001|Overall Study|Lost to Follow-up|0|||
13168309|NCT02346240|26112838|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
13168310|NCT02346240|26112839|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
13168311|NCT02346240|26112840|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
13168312|NCT02346240|26112841|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
13168313|NCT02346240|26112842|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
13168314|NCT02346240|26112843|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
13168315|NCT02346240|26112844|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
13168316|NCT02346240|26112845|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
13168317|NCT02346240|26112846|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
13168318|NCT02346240|26112847|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
13168319|NCT02346240|26112848|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
13168320|NCT02346240|26112849|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
13168321|NCT02346240|26112850|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
13168322|NCT02346240|26112851|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
13168323|NCT02346240|26112828|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
13168324|NCT02346240|26112829|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1|||
13168325|NCT02346240|26112830|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
13168326|NCT02346240|26112831|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
13168327|NCT02346240|26112832|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
13168328|NCT02346240|26112833|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
13168329|NCT02346240|26112834|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
13168330|NCT02346240|26112835|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
13168331|NCT02346240|26112836|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
13168332|NCT02346240|26112837|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
13168333|NCT02346240|26112838|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
13168334|NCT02346240|26112839|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
13222910|NCT01802281|26287209|FG000|Overall Study|Death|1|||
13107416|NCT03282240|25886998|FG002|Overall Study|Lost to Follow-up|0|||
13107417|NCT03282240|25886996|FG000|Overall Study|Protocol Deviation|4|||
13107418|NCT03282240|25886997|FG001|Overall Study|Protocol Deviation|1|||
13107419|NCT03282240|25886998|FG002|Overall Study|Protocol Deviation|2|||
13107420|NCT03282240|25886996|FG000|Overall Study|Withdrawal by Subject|1|||
13107421|NCT03282240|25886997|FG001|Overall Study|Withdrawal by Subject|0|||
13107422|NCT03282240|25886998|FG002|Overall Study|Withdrawal by Subject|1|||
13107423|NCT03282227|25887010|FG000|Overall Study|Exposure Goals Achieved|60|||
13107424|NCT03282227|25887010|FG000|Overall Study|Non-compliance w/ protocol requirements|79|||
13107425|NCT03282227|25887010|FG000|Overall Study|Adverse Event|15|||
13107426|NCT03282227|25887010|FG000|Overall Study|Lost to Follow-up|21|||
13107427|NCT03282227|25887010|FG000|Overall Study|Withdrawal by Subject|20|||
13107428|NCT03282227|25887010|FG000|Overall Study|Lack of Efficacy|12|||
13107429|NCT03282227|25887010|FG000|Overall Study|Sponsor decision|3|||
13107430|NCT03282227|25887010|FG000|Overall Study|Physician Decision|2|||
13107431|NCT03282227|25887010|FG000|Overall Study|Pregnancy|2|||
13107432|NCT03282227|25887010|FG000|Overall Study|Other|1|||
13107433|NCT03282123|25887017|FG000|Overall Study|Withdrawal by Subject|5|||
13107434|NCT03281876|25887094|FG000|Overall Study|Adverse Event|4|||
13107435|NCT03281876|25887095|FG001|Overall Study|Adverse Event|15|||
13107436|NCT03281876|25887094|FG000|Overall Study|Lost to Follow-up|1|||
13107437|NCT03281876|25887095|FG001|Overall Study|Lost to Follow-up|4|||
13107438|NCT03281876|25887094|FG000|Overall Study|Withdrawal by Subject|11|||
13107439|NCT03281876|25887095|FG001|Overall Study|Withdrawal by Subject|15|||
13107440|NCT03281876|25887094|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
13107441|NCT03281876|25887095|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
13107442|NCT03281876|25887094|FG000|Overall Study|OTHER|5|||
13107443|NCT03281876|25887095|FG001|Overall Study|OTHER|5|||
13107444|NCT03281668|25887121|FG000|Overall Study|Physician Decision|1|||
13107445|NCT03281668|25887121|FG000|Overall Study|scheduling conflict, family circumstance|2|||
13107446|NCT03281668|25887121|FG000|Overall Study|Withdrawal by Subject|4|||
13107447|NCT03281668|25887121|FG000|Overall Study|Lost to Follow-up|1|||
13107448|NCT03281577|25887165|FG000|Overall Study|Adverse Event|0|||
13107449|NCT03281577|25887166|FG001|Overall Study|Adverse Event|0|||
13107450|NCT03281577|25887167|FG002|Overall Study|Adverse Event|0|||
13107451|NCT03281577|25887168|FG003|Overall Study|Adverse Event|1|||
13107452|NCT03281577|25887165|FG000|Overall Study|Withdrawal by Subject|1|||
13107453|NCT03281577|25887166|FG001|Overall Study|Withdrawal by Subject|0|||
13107454|NCT03281577|25887167|FG002|Overall Study|Withdrawal by Subject|0|||
13107455|NCT03281577|25887168|FG003|Overall Study|Withdrawal by Subject|0|||
13107456|NCT03281304|25887217|FG000|Overall Study|Adverse Event|5|||
13107457|NCT03281304|25887218|FG001|Overall Study|Adverse Event|2|||
13107458|NCT03281304|25887217|FG000|Overall Study|Lack of Efficacy|2|||
13107459|NCT03281304|25887218|FG001|Overall Study|Lack of Efficacy|0|||
13107460|NCT03281304|25887217|FG000|Overall Study|Pregnancy|1|||
13107461|NCT03281304|25887218|FG001|Overall Study|Pregnancy|0|||
13168335|NCT02346240|26112840|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
13168336|NCT02346240|26112841|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
13168337|NCT02346240|26112842|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
13168338|NCT02346240|26112843|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
13168339|NCT02346240|26112844|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
13168340|NCT02346240|26112845|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
13168341|NCT02346240|26112846|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
13168342|NCT02346240|26112847|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
13168343|NCT02346240|26112848|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
13168344|NCT02346240|26112849|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
13168345|NCT02346240|26112850|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
13168346|NCT02346240|26112851|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
13168347|NCT02346240|26112828|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
13168348|NCT02346240|26112829|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2|||
13168349|NCT02346240|26112830|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
13168350|NCT02346240|26112831|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3|||
13168351|NCT02346240|26112832|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
13168352|NCT02346240|26112833|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
13168353|NCT02346240|26112834|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
13168354|NCT02346240|26112835|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
13168355|NCT02346240|26112836|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
13168356|NCT02346240|26112837|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
13168357|NCT02346240|26112838|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
13168358|NCT02346240|26112839|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
13168359|NCT02346240|26112840|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
13168360|NCT02346240|26112841|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
13168361|NCT02346240|26112842|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
13168362|NCT02346240|26112843|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
13168363|NCT02346240|26112844|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
13168364|NCT02346240|26112845|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
13168365|NCT02346240|26112846|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
13168366|NCT02346240|26112847|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
13168367|NCT02346240|26112848|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
13168368|NCT02346240|26112849|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
13168369|NCT02346240|26112850|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
13168370|NCT02346240|26112851|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
13168371|NCT02346240|26112828|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1|||
13168372|NCT02346240|26112829|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
13168373|NCT02346240|26112830|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3|||
13168374|NCT02346240|26112831|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
13168375|NCT02346240|26112832|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
13168376|NCT02346240|26112833|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
13168377|NCT02346240|26112834|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
13168378|NCT02346240|26112835|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
13168379|NCT02346240|26112836|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
13168380|NCT02346240|26112837|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
13168381|NCT02346240|26112838|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
13168382|NCT02346240|26112839|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
13168383|NCT02346240|26112840|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
13168384|NCT02346240|26112841|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
13168385|NCT02346240|26112842|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
13168386|NCT02346240|26112843|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
13168387|NCT02346240|26112844|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
13168388|NCT02346240|26112845|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
13168389|NCT02346240|26112846|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
13168390|NCT02346240|26112847|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
13168391|NCT02346240|26112848|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
13168392|NCT02346240|26112849|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
13168393|NCT02346240|26112850|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
13168394|NCT02346240|26112851|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
13168395|NCT02346240|26112828|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0|||
13168396|NCT02346240|26112829|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1|||
13168397|NCT02346240|26112830|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0|||
13168398|NCT02346240|26112831|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1|||
13168399|NCT02346240|26112832|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0|||
13168400|NCT02346240|26112833|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0|||
13168401|NCT02346240|26112834|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0|||
13168402|NCT02346240|26112835|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0|||
13168403|NCT02346240|26112836|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0|||
13168404|NCT02346240|26112837|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0|||
13168405|NCT02346240|26112838|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0|||
13168406|NCT02346240|26112839|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0|||
13168407|NCT02346240|26112840|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0|||
13168408|NCT02346240|26112841|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0|||
13168409|NCT02346240|26112842|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0|||
13168410|NCT02346240|26112843|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0|||
13168411|NCT02346240|26112844|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0|||
13168412|NCT02346240|26112845|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0|||
13168413|NCT02346240|26112846|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0|||
13168414|NCT02346240|26112847|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0|||
13168415|NCT02346240|26112848|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0|||
13168416|NCT02346240|26112849|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0|||
13168417|NCT02346240|26112850|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0|||
13168418|NCT02346240|26112851|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0|||
13168419|NCT02346240|26112828|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
13168420|NCT02346240|26112829|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
13168421|NCT02346240|26112830|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1|||
13168422|NCT02346240|26112831|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
13168423|NCT02346240|26112832|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
13168424|NCT02346240|26112833|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
13168425|NCT02346240|26112834|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
13168426|NCT02346240|26112835|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
13168427|NCT02346240|26112836|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
13168428|NCT02346240|26112837|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
13168429|NCT02346240|26112838|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
13168430|NCT02346240|26112839|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
13168431|NCT02346240|26112840|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
13168432|NCT02346240|26112841|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
13168433|NCT02346240|26112842|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
13168434|NCT02346240|26112843|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
13168435|NCT02346240|26112844|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
13168436|NCT02346240|26112845|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
13168437|NCT02346240|26112846|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
13168438|NCT02346240|26112847|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
13168439|NCT02346240|26112848|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
13168440|NCT02346240|26112849|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
13168441|NCT02346240|26112850|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
13168442|NCT02346240|26112851|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
13168443|NCT02346240|26112828|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
13168444|NCT02346240|26112829|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
13168445|NCT02346240|26112830|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
13168446|NCT02346240|26112831|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
13168447|NCT02346240|26112832|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
13168448|NCT02346240|26112833|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
13168449|NCT02346240|26112834|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
13168450|NCT02346240|26112835|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
13168451|NCT02346240|26112836|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
13168452|NCT02346240|26112837|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
13168453|NCT02346240|26112838|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
13168454|NCT02346240|26112839|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
13168455|NCT02346240|26112840|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
13168456|NCT02346240|26112841|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
13168457|NCT02346240|26112842|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
13168458|NCT02346240|26112843|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
13168459|NCT02346240|26112844|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
13168460|NCT02346240|26112845|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
13168461|NCT02346240|26112846|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
13168462|NCT02346240|26112847|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
13168463|NCT02346240|26112848|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
13168464|NCT02346240|26112849|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
13168465|NCT02346240|26112850|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
13168466|NCT02346240|26112851|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
13168467|NCT02346240|26112828|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
13168468|NCT02346240|26112829|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
13168469|NCT02346240|26112830|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
13168470|NCT02346240|26112831|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
13168471|NCT02346240|26112832|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
13168472|NCT02346240|26112833|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
13168473|NCT02346240|26112834|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
13168474|NCT02346240|26112835|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
13168475|NCT02346240|26112836|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
13168476|NCT02346240|26112837|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
13168477|NCT02346240|26112838|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
13168478|NCT02346240|26112839|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
13168479|NCT02346240|26112840|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
13168480|NCT02346240|26112841|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
13168481|NCT02346240|26112842|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
13168482|NCT02346240|26112843|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3|||
13168483|NCT02346240|26112844|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
13168484|NCT02346240|26112845|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
13168485|NCT02346240|26112846|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
13168486|NCT02346240|26112847|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
13168487|NCT02346240|26112848|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
13168488|NCT02346240|26112849|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
13168489|NCT02346240|26112850|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
13168490|NCT02346240|26112851|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
13168491|NCT02346240|26112828|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
13168492|NCT02346240|26112829|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
13168493|NCT02346240|26112830|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
13168494|NCT02346240|26112831|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
13168495|NCT02346240|26112832|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
13168496|NCT02346240|26112833|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
13168497|NCT02346240|26112834|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
13168498|NCT02346240|26112835|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
13168499|NCT02346240|26112836|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
13168500|NCT02346240|26112837|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
13168501|NCT02346240|26112838|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
13168502|NCT02346240|26112839|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
13168503|NCT02346240|26112840|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
13168504|NCT02346240|26112841|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
13168505|NCT02346240|26112842|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
13168506|NCT02346240|26112843|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
13168507|NCT02346240|26112844|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
13168508|NCT02346240|26112845|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
13168509|NCT02346240|26112846|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
13168510|NCT02346240|26112847|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
13168511|NCT02346240|26112848|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
13168512|NCT02346240|26112849|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
13168513|NCT02346240|26112850|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
13168514|NCT02346240|26112851|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
13168515|NCT02346240|26112828|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
13168516|NCT02346240|26112829|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
13168517|NCT02346240|26112830|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
13168518|NCT02346240|26112831|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
13168519|NCT02346240|26112832|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
13168520|NCT02346240|26112833|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
13168521|NCT02346240|26112834|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
13168522|NCT02346240|26112835|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
13168523|NCT02346240|26112836|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
13168524|NCT02346240|26112837|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
13168525|NCT02346240|26112838|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
13168526|NCT02346240|26112839|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
13168527|NCT02346240|26112840|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
13168528|NCT02346240|26112841|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
13168529|NCT02346240|26112842|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5|||
13168530|NCT02346240|26112843|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
13168531|NCT02346240|26112844|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
13168532|NCT02346240|26112845|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
13168533|NCT02346240|26112846|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
13168534|NCT02346240|26112847|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
13168535|NCT02346240|26112848|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
13168536|NCT02346240|26112849|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
13168537|NCT02346240|26112850|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
13168538|NCT02346240|26112851|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
13168539|NCT02346240|26112828|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
13168540|NCT02346240|26112829|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
13168541|NCT02346240|26112830|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
13168542|NCT02346240|26112831|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
13168543|NCT02346240|26112832|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
13168544|NCT02346240|26112833|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
13168545|NCT02346240|26112834|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
13168546|NCT02346240|26112835|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
13168547|NCT02346240|26112836|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
13168548|NCT02346240|26112837|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
13168549|NCT02346240|26112838|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
13168550|NCT02346240|26112839|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
13168551|NCT02346240|26112840|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
13168552|NCT02346240|26112841|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
13168553|NCT02346240|26112842|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
13168554|NCT02346240|26112843|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8|||
13168555|NCT02346240|26112844|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4|||
13168556|NCT02346240|26112845|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
13168557|NCT02346240|26112846|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
13168558|NCT02346240|26112847|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
13168559|NCT02346240|26112848|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
13168560|NCT02346240|26112849|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
13168561|NCT02346240|26112850|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
13168562|NCT02346240|26112851|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
13168563|NCT02346240|26112828|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
13168564|NCT02346240|26112829|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
13168565|NCT02346240|26112830|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
13168566|NCT02346240|26112831|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
13168567|NCT02346240|26112832|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
13168568|NCT02346240|26112833|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
13168569|NCT02346240|26112834|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1|||
13168570|NCT02346240|26112835|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
13168571|NCT02346240|26112836|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
13168572|NCT02346240|26112837|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
13168573|NCT02346240|26112838|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
13168574|NCT02346240|26112839|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
13168575|NCT02346240|26112840|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
13168576|NCT02346240|26112841|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
13168577|NCT02346240|26112842|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
13168578|NCT02346240|26112843|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
13168579|NCT02346240|26112844|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
13168580|NCT02346240|26112845|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
13168581|NCT02346240|26112846|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
13168582|NCT02346240|26112847|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
13168583|NCT02346240|26112848|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
13168584|NCT02346240|26112849|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
13168585|NCT02346240|26112850|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
13168586|NCT02346240|26112851|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
13168587|NCT02346240|26112828|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
13168588|NCT02346240|26112829|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
13168589|NCT02346240|26112830|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
13168590|NCT02346240|26112831|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
13168591|NCT02346240|26112832|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
13168592|NCT02346240|26112833|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
13168593|NCT02346240|26112834|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
13168594|NCT02346240|26112835|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
13168595|NCT02346240|26112836|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
13168596|NCT02346240|26112837|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
13168597|NCT02346240|26112838|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
13168598|NCT02346240|26112839|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
13168599|NCT02346240|26112840|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
13168600|NCT02346240|26112841|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
13168601|NCT02346240|26112842|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
13168602|NCT02346240|26112843|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
13168603|NCT02346240|26112844|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
13168604|NCT02346240|26112845|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
13168605|NCT02346240|26112846|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
13168606|NCT02346240|26112847|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
13168607|NCT02346240|26112848|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
13168608|NCT02346240|26112849|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
13168609|NCT02346240|26112850|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
13168610|NCT02346240|26112851|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
13168611|NCT02346240|26112828|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
13168612|NCT02346240|26112829|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
13168613|NCT02346240|26112830|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
13168614|NCT02346240|26112831|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
13168615|NCT02346240|26112832|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
13168616|NCT02346240|26112833|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
13168617|NCT02346240|26112834|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
13168618|NCT02346240|26112835|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
13168619|NCT02346240|26112836|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
13168620|NCT02346240|26112837|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1|||
13168621|NCT02346240|26112838|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
13168622|NCT02346240|26112839|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
13168623|NCT02346240|26112840|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
13168624|NCT02346240|26112841|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
13168625|NCT02346240|26112842|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
13168626|NCT02346240|26112843|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
13168627|NCT02346240|26112844|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
13168628|NCT02346240|26112845|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
13168629|NCT02346240|26112846|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
13168630|NCT02346240|26112847|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
13168631|NCT02346240|26112848|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
13168632|NCT02346240|26112849|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
13168633|NCT02346240|26112850|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
13168634|NCT02346240|26112851|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
13168635|NCT02346240|26112828|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
13168636|NCT02346240|26112829|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
13168637|NCT02346240|26112830|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
13168638|NCT02346240|26112831|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
13168639|NCT02346240|26112832|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
13168640|NCT02346240|26112833|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
13168641|NCT02346240|26112834|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
13168642|NCT02346240|26112835|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
13168643|NCT02346240|26112836|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
13168644|NCT02346240|26112837|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
13168645|NCT02346240|26112838|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1|||
13168646|NCT02346240|26112839|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
13168647|NCT02346240|26112840|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
13168648|NCT02346240|26112841|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
13168649|NCT02346240|26112842|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
13168650|NCT02346240|26112843|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
13168651|NCT02346240|26112844|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
13168652|NCT02346240|26112845|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
13168653|NCT02346240|26112846|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
13168654|NCT02346240|26112847|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
13168655|NCT02346240|26112848|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
13168656|NCT02346240|26112849|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
13168657|NCT02346240|26112850|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
13168658|NCT02346240|26112851|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
13168659|NCT02346240|26112828|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
13168660|NCT02346240|26112829|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
13168661|NCT02346240|26112830|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
13168662|NCT02346240|26112831|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
13168663|NCT02346240|26112832|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
13168664|NCT02346240|26112833|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
13168665|NCT02346240|26112834|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
13168666|NCT02346240|26112835|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
13168667|NCT02346240|26112836|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
13168668|NCT02346240|26112837|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
13168669|NCT02346240|26112838|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
13168670|NCT02346240|26112839|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
13168671|NCT02346240|26112840|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
13168672|NCT02346240|26112841|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
13168673|NCT02346240|26112842|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1|||
13168674|NCT02346240|26112843|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
13168675|NCT02346240|26112844|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
13168676|NCT02346240|26112845|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
13168677|NCT02346240|26112846|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
13168678|NCT02346240|26112847|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
13168679|NCT02346240|26112848|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
13168680|NCT02346240|26112849|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
13168681|NCT02346240|26112850|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
13168682|NCT02346240|26112851|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
13168683|NCT02346240|26112828|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
13168684|NCT02346240|26112829|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
13168685|NCT02346240|26112830|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
13168686|NCT02346240|26112831|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
13168687|NCT02346240|26112832|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
13168688|NCT02346240|26112833|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
13168689|NCT02346240|26112834|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
13168690|NCT02346240|26112835|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
13168691|NCT02346240|26112836|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
13168692|NCT02346240|26112837|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
13168693|NCT02346240|26112838|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
13168694|NCT02346240|26112839|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
13168695|NCT02346240|26112840|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
13168696|NCT02346240|26112841|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
13168697|NCT02346240|26112842|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1|||
13168698|NCT02346240|26112843|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
13168699|NCT02346240|26112844|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
13168700|NCT02346240|26112845|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
13168701|NCT02346240|26112846|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
13168702|NCT02346240|26112847|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
13222911|NCT01802281|26287210|FG001|Overall Study|Death|2|||
13168703|NCT02346240|26112848|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
13168704|NCT02346240|26112849|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
13168705|NCT02346240|26112850|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
13168706|NCT02346240|26112851|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
13168707|NCT02346240|26112828|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
13168708|NCT02346240|26112829|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
13168709|NCT02346240|26112830|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
13168710|NCT02346240|26112831|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
13168711|NCT02346240|26112832|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
13168712|NCT02346240|26112833|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
13168713|NCT02346240|26112834|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
13168714|NCT02346240|26112835|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
13168715|NCT02346240|26112836|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
13168716|NCT02346240|26112837|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
13168717|NCT02346240|26112838|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
13168718|NCT02346240|26112839|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
13168719|NCT02346240|26112840|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
13168720|NCT02346240|26112841|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
13168721|NCT02346240|26112842|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1|||
13168722|NCT02346240|26112843|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
13168723|NCT02346240|26112844|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
13168724|NCT02346240|26112845|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
13168725|NCT02346240|26112846|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
13168726|NCT02346240|26112847|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
13168727|NCT02346240|26112848|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
13168728|NCT02346240|26112849|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
13168729|NCT02346240|26112850|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
13168730|NCT02346240|26112851|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
13168731|NCT02346240|26112828|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
13168732|NCT02346240|26112829|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
13168733|NCT02346240|26112830|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
13168734|NCT02346240|26112831|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
13168735|NCT02346240|26112832|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
13168736|NCT02346240|26112833|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
13168737|NCT02346240|26112834|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
13168738|NCT02346240|26112835|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
13168739|NCT02346240|26112836|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
13168740|NCT02346240|26112837|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
13168741|NCT02346240|26112838|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
13168742|NCT02346240|26112839|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
13168743|NCT02346240|26112840|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
13168744|NCT02346240|26112841|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
13168745|NCT02346240|26112842|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
13168746|NCT02346240|26112843|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
13168747|NCT02346240|26112844|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
13168748|NCT02346240|26112845|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1|||
13168749|NCT02346240|26112846|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6|||
13168750|NCT02346240|26112847|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2|||
13107462|NCT03281304|25887217|FG000|Overall Study|Withdrawal by Subject|5|||
13107463|NCT03281304|25887218|FG001|Overall Study|Withdrawal by Subject|10|||
13107464|NCT03280615|25887235|FG000|Overall Study|Lost to Follow-up|1|||
13107465|NCT03280615|25887236|FG001|Overall Study|Lost to Follow-up|2|||
13107466|NCT03280615|25887235|FG000|Overall Study|Adverse Event|1|||
13107467|NCT03280615|25887236|FG001|Overall Study|Adverse Event|1|||
13107468|NCT03280615|25887235|FG000|Overall Study|Withdrawal by Subject|2|||
13107469|NCT03280615|25887236|FG001|Overall Study|Withdrawal by Subject|2|||
13107470|NCT03280550|25887293|FG000|Overall Study|Withdrawal by Subject|2|||
13107471|NCT03280550|25887294|FG001|Overall Study|Withdrawal by Subject|2|||
13107472|NCT03280550|25887293|FG000|Overall Study|Physician Decision|0|||
13107473|NCT03280550|25887294|FG001|Overall Study|Physician Decision|1|||
13107474|NCT03280537|25887351|FG000|Overall Study|Withdrawal by Subject|2|||
13107475|NCT03280537|25887352|FG001|Overall Study|Withdrawal by Subject|4|||
13168751|NCT02346240|26112848|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
13168752|NCT02346240|26112849|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13|||
13168753|NCT02346240|26112850|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
13168754|NCT02346240|26112851|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
13168755|NCT02346240|26112828|FG000|Open-Label Period (Week 48 to Week 144)|Death|0|||
13168756|NCT02346240|26112829|FG001|Open-Label Period (Week 48 to Week 144)|Death|0|||
13168757|NCT02346240|26112830|FG002|Open-Label Period (Week 48 to Week 144)|Death|0|||
13168758|NCT02346240|26112831|FG003|Open-Label Period (Week 48 to Week 144)|Death|0|||
13107476|NCT03280381|25887367|FG000|Overall Study|Physician Decision|0|||
13107477|NCT03280381|25887368|FG001|Overall Study|Physician Decision|2|||
13107478|NCT03280264|25887378|FG000|Overall Study|Adverse Event|1|||
13107479|NCT03280264|25887378|FG000|Overall Study|Physician Decision|1|||
13107480|NCT03280264|25887378|FG000|Overall Study|Withdrawal by Subject|1|||
13107481|NCT03280121|25887386|FG000|Overall Study|Physician Decision|1|||
13107482|NCT03280121|25887386|FG000|Overall Study|Lost to Follow-up|1|||
13107483|NCT03280121|25887386|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4|||
13107484|NCT03280108|25887424|FG000|Overall Study|Lost to Follow-up|2|||
13107485|NCT03280108|25887425|FG001|Overall Study|Lost to Follow-up|0|||
13107486|NCT03278626|25887432|FG000|Overall Study|Death|2|||
13168759|NCT02346240|26112832|FG004|Open-Label Period (Week 48 to Week 144)|Death|0|||
13168760|NCT02346240|26112833|FG005|Open-Label Period (Week 48 to Week 144)|Death|0|||
13168761|NCT02346240|26112834|FG006|Open-Label Period (Week 48 to Week 144)|Death|0|||
13168762|NCT02346240|26112835|FG007|Open-Label Period (Week 48 to Week 144)|Death|0|||
13168763|NCT02346240|26112836|FG008|Open-Label Period (Week 48 to Week 144)|Death|0|||
13168764|NCT02346240|26112837|FG009|Open-Label Period (Week 48 to Week 144)|Death|0|||
13168765|NCT02346240|26112838|FG010|Open-Label Period (Week 48 to Week 144)|Death|0|||
13168766|NCT02346240|26112839|FG011|Open-Label Period (Week 48 to Week 144)|Death|0|||
13168767|NCT02346240|26112840|FG012|Open-Label Period (Week 48 to Week 144)|Death|0|||
13168768|NCT02346240|26112841|FG013|Open-Label Period (Week 48 to Week 144)|Death|0|||
13168769|NCT02346240|26112842|FG014|Open-Label Period (Week 48 to Week 144)|Death|0|||
13168770|NCT02346240|26112843|FG015|Open-Label Period (Week 48 to Week 144)|Death|0|||
13168771|NCT02346240|26112844|FG016|Open-Label Period (Week 48 to Week 144)|Death|0|||
13168772|NCT02346240|26112845|FG017|Open-Label Period (Week 48 to Week 144)|Death|0|||
13168773|NCT02346240|26112846|FG018|Open-Label Period (Week 48 to Week 144)|Death|1|||
13168774|NCT02346240|26112847|FG019|Open-Label Period (Week 48 to Week 144)|Death|1|||
13107487|NCT03278626|25887432|FG000|Overall Study|Toxicity|1|||
13107488|NCT03278626|25887432|FG000|Overall Study|Disease Progression|2|||
13107489|NCT03278613|25887555|FG000|Overall Study|Lost to Follow-up|3|||
13107490|NCT03278613|25887556|FG001|Overall Study|Lost to Follow-up|1|||
13107491|NCT03278028|25887569|FG000|Overall Study|Lost to Follow-up|1|||
13107492|NCT03278028|25887570|FG001|Overall Study|Lost to Follow-up|0|||
13107493|NCT03278028|25887569|FG000|Overall Study|Withdrawal by Subject|3|||
13107494|NCT03278028|25887570|FG001|Overall Study|Withdrawal by Subject|1|||
13107495|NCT03278028|25887569|FG000|Overall Study|Pregnancy|0|||
13168775|NCT02346240|26112848|FG020|Open-Label Period (Week 48 to Week 144)|Death|0|||
13168776|NCT02346240|26112849|FG021|Open-Label Period (Week 48 to Week 144)|Death|1|||
13168777|NCT02346240|26112850|FG022|Open-Label Period (Week 48 to Week 144)|Death|0|||
13168778|NCT02346240|26112851|FG023|Open-Label Period (Week 48 to Week 144)|Death|0|||
13168779|NCT02346240|26112828|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
13168780|NCT02346240|26112829|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
13168781|NCT02346240|26112830|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
13168782|NCT02346240|26112831|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
13168783|NCT02346240|26112832|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
13168784|NCT02346240|26112833|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
13168785|NCT02346240|26112834|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
13168786|NCT02346240|26112835|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
13168787|NCT02346240|26112836|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
13168788|NCT02346240|26112837|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
13168789|NCT02346240|26112838|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
13168790|NCT02346240|26112839|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
13168791|NCT02346240|26112840|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
13168792|NCT02346240|26112841|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
13168793|NCT02346240|26112842|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
13168794|NCT02346240|26112843|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
13168795|NCT02346240|26112844|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
13168796|NCT02346240|26112845|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
13168797|NCT02346240|26112846|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
13107496|NCT03278028|25887570|FG001|Overall Study|Pregnancy|1|||
13107497|NCT03277846|25887583|FG000|Overall Study|Inpatient stay too brief|12|||
13168798|NCT02346240|26112847|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
13168799|NCT02346240|26112848|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
13107498|NCT03277846|25887584|FG001|Overall Study|Inpatient stay too brief|11|||
13107499|NCT03277794|25887623|FG000|Overall Study|Lost to Follow-up|2|||
13107500|NCT03277794|25887624|FG001|Overall Study|Lost to Follow-up|4|||
13107501|NCT03277794|25887623|FG000|Overall Study|Withdrew due to high acuity|1|||
13168800|NCT02346240|26112849|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
13168801|NCT02346240|26112850|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
13168802|NCT02346240|26112851|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
13168803|NCT02346240|26112828|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
13168804|NCT02346240|26112829|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
13168805|NCT02346240|26112830|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
13168806|NCT02346240|26112831|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
13168807|NCT02346240|26112832|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
13168808|NCT02346240|26112833|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
13168809|NCT02346240|26112834|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
13168810|NCT02346240|26112835|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
13168811|NCT02346240|26112836|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
13168812|NCT02346240|26112837|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
13168813|NCT02346240|26112838|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
13168814|NCT02346240|26112839|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
13168815|NCT02346240|26112840|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
13168816|NCT02346240|26112841|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
13168817|NCT02346240|26112842|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
13168818|NCT02346240|26112843|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
13107502|NCT03277794|25887624|FG001|Overall Study|Withdrew due to high acuity|0|||
13107503|NCT03277352|25887638|FG000|Overall Study|Study Terminated By Sponsor|2|||
13107504|NCT03277352|25887638|FG000|Overall Study|Withdrawal by Subject|4|||
13107505|NCT03277352|25887638|FG000|Overall Study|Death|4|||
13107506|NCT03276975|25887663|FG000|Overall Study|Withdrawal by Subject|1|||
13107507|NCT03276975|25887664|FG001|Overall Study|Withdrawal by Subject|0|||
13107508|NCT03276728|25887713|FG000|Overall Study|Lost to Follow-up|0|||
13107509|NCT03276728|25887714|FG001|Overall Study|Lost to Follow-up|0|||
13107510|NCT03276728|25887715|FG002|Overall Study|Lost to Follow-up|2|||
13107511|NCT03276728|25887716|FG003|Overall Study|Lost to Follow-up|2|||
13107512|NCT03276728|25887717|FG004|Overall Study|Lost to Follow-up|0|||
13107513|NCT03276728|25887718|FG005|Overall Study|Lost to Follow-up|0|||
13107514|NCT03276728|25887719|FG006|Overall Study|Lost to Follow-up|0|||
13107515|NCT03276728|25887720|FG007|Overall Study|Lost to Follow-up|0|||
13107516|NCT03276728|25887713|FG000|Overall Study|Withdrawal by Subject|0|||
13107517|NCT03276728|25887714|FG001|Overall Study|Withdrawal by Subject|0|||
13168819|NCT02346240|26112844|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
13168820|NCT02346240|26112845|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
13168821|NCT02346240|26112846|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
13168822|NCT02346240|26112847|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
13168823|NCT02346240|26112848|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
13168824|NCT02346240|26112849|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1|||
13168825|NCT02346240|26112850|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
13168826|NCT02346240|26112851|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
13168827|NCT02346240|26112828|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
13168828|NCT02346240|26112829|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
13168829|NCT02346240|26112830|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
13168830|NCT02346240|26112831|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
13168831|NCT02346240|26112832|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
13168832|NCT02346240|26112833|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
13168833|NCT02346240|26112834|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
13168834|NCT02346240|26112835|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
13168835|NCT02346240|26112836|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
13168836|NCT02346240|26112837|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
13168837|NCT02346240|26112838|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
13168838|NCT02346240|26112839|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
13168839|NCT02346240|26112840|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
13168840|NCT02346240|26112841|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
13168841|NCT02346240|26112842|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
13107518|NCT03276728|25887715|FG002|Overall Study|Withdrawal by Subject|0|||
13107519|NCT03276728|25887716|FG003|Overall Study|Withdrawal by Subject|3|||
13168842|NCT02346240|26112843|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
13107520|NCT03276728|25887717|FG004|Overall Study|Withdrawal by Subject|0|||
13107521|NCT03276728|25887718|FG005|Overall Study|Withdrawal by Subject|0|||
13107522|NCT03276728|25887719|FG006|Overall Study|Withdrawal by Subject|0|||
13168843|NCT02346240|26112844|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
13168844|NCT02346240|26112845|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
13168845|NCT02346240|26112846|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
13168846|NCT02346240|26112847|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
13168847|NCT02346240|26112848|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
13168848|NCT02346240|26112849|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
13168849|NCT02346240|26112850|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
13168850|NCT02346240|26112851|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
13168851|NCT02346240|26112828|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
13168852|NCT02346240|26112829|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
13168853|NCT02346240|26112830|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
13168854|NCT02346240|26112831|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
13168855|NCT02346240|26112832|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
13168856|NCT02346240|26112833|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
13168857|NCT02346240|26112834|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
13168858|NCT02346240|26112835|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
13168859|NCT02346240|26112836|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
13168860|NCT02346240|26112837|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
13168861|NCT02346240|26112838|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
13168862|NCT02346240|26112839|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
13168863|NCT02346240|26112840|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
13168864|NCT02346240|26112841|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
13168865|NCT02346240|26112842|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
13168866|NCT02346240|26112843|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
13168867|NCT02346240|26112844|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
13168868|NCT02346240|26112845|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
13168869|NCT02346240|26112846|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
13168870|NCT02346240|26112847|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
13168871|NCT02346240|26112848|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
13168872|NCT02346240|26112849|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10|||
13168873|NCT02346240|26112850|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
13168874|NCT02346240|26112851|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
13168875|NCT02346240|26112828|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
13168876|NCT02346240|26112829|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
13168877|NCT02346240|26112830|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
13168878|NCT02346240|26112831|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
13107523|NCT03276728|25887720|FG007|Overall Study|Withdrawal by Subject|0|||
13107524|NCT03276728|25887713|FG000|Overall Study|Decision by sponsor|0|||
13107525|NCT03276728|25887714|FG001|Overall Study|Decision by sponsor|0|||
13107526|NCT03276728|25887715|FG002|Overall Study|Decision by sponsor|0|||
13107527|NCT03276728|25887716|FG003|Overall Study|Decision by sponsor|0|||
13107528|NCT03276728|25887717|FG004|Overall Study|Decision by sponsor|1|||
13107529|NCT03276728|25887718|FG005|Overall Study|Decision by sponsor|0|||
13107530|NCT03276728|25887719|FG006|Overall Study|Decision by sponsor|2|||
13107531|NCT03276728|25887720|FG007|Overall Study|Decision by sponsor|1|||
13107532|NCT03276078|25887749|FG000|Overall Study|Adverse Event|1|||
13107533|NCT03276026|25887766|FG000|Overall Study|Protocol Violation|1|||
13107534|NCT03276026|25887767|FG001|Overall Study|Protocol Violation|0|||
13107535|NCT03275389|25888360|FG000|Overall Study|Lost to Follow-up|10|||
13107536|NCT03275389|25888361|FG001|Overall Study|Lost to Follow-up|10|||
13107537|NCT03275389|25888362|FG002|Overall Study|Lost to Follow-up|19|||
13107538|NCT03275389|25888363|FG003|Overall Study|Lost to Follow-up|12|||
13107539|NCT03275389|25888364|FG004|Overall Study|Lost to Follow-up|11|||
13107540|NCT03275389|25888365|FG005|Overall Study|Lost to Follow-up|12|||
13107541|NCT03275389|25888366|FG006|Overall Study|Lost to Follow-up|21|||
13107542|NCT03275389|25888367|FG007|Overall Study|Lost to Follow-up|15|||
13107543|NCT03275389|25888368|FG008|Overall Study|Lost to Follow-up|12|||
13107544|NCT03275389|25888369|FG009|Overall Study|Lost to Follow-up|14|||
13107545|NCT03275389|25888360|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
13107546|NCT03275389|25888361|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
13107547|NCT03275389|25888362|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
13107548|NCT03275389|25888363|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
13107549|NCT03275389|25888364|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
13107550|NCT03275389|25888365|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
13107551|NCT03275389|25888366|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
13107552|NCT03275389|25888367|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
13107553|NCT03275389|25888368|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
13168879|NCT02346240|26112832|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
13168880|NCT02346240|26112833|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
13168881|NCT02346240|26112834|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
13168882|NCT02346240|26112835|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
13168883|NCT02346240|26112836|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
13168884|NCT02346240|26112837|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
13168885|NCT02346240|26112838|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
13168886|NCT02346240|26112839|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
13168887|NCT02346240|26112840|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
13168888|NCT02346240|26112841|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
13168889|NCT02346240|26112842|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
13168890|NCT02346240|26112843|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
13168891|NCT02346240|26112844|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
13168892|NCT02346240|26112845|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
13168893|NCT02346240|26112846|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
13168894|NCT02346240|26112847|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
13168895|NCT02346240|26112848|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
13168896|NCT02346240|26112849|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4|||
13168897|NCT02346240|26112850|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
13168898|NCT02346240|26112851|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3|||
13168899|NCT02346240|26112828|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
13168900|NCT02346240|26112829|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
13168901|NCT02346240|26112830|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
13168902|NCT02346240|26112831|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
13168903|NCT02346240|26112832|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
13168904|NCT02346240|26112833|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
13168905|NCT02346240|26112834|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
13168906|NCT02346240|26112835|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
13168907|NCT02346240|26112836|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
13168908|NCT02346240|26112837|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
13168909|NCT02346240|26112838|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
13168910|NCT02346240|26112839|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
13168911|NCT02346240|26112840|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
13168912|NCT02346240|26112841|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
13168913|NCT02346240|26112842|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
13168914|NCT02346240|26112843|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
13168915|NCT02346240|26112844|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
13168916|NCT02346240|26112845|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
13168917|NCT02346240|26112846|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1|||
13168918|NCT02346240|26112847|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
13168919|NCT02346240|26112848|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
13168920|NCT02346240|26112849|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
13168921|NCT02346240|26112850|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
13168922|NCT02346240|26112851|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
13168923|NCT02346136|26112890|FG000|Overall Study|Withdrawal by Subject|7|||
13168924|NCT02346136|26112891|FG001|Overall Study|Withdrawal by Subject|5|||
13168925|NCT02346136|26112890|FG000|Overall Study|Death|1|||
13168926|NCT02346136|26112891|FG001|Overall Study|Death|0|||
13168927|NCT02346136|26112890|FG000|Overall Study|Study termination|14|||
13168928|NCT02346136|26112891|FG001|Overall Study|Study termination|18|||
13168929|NCT02345889|26112970|FG000|Overall Study|Inadequate Bowel Prep|17|||
13168930|NCT02345889|26112971|FG001|Overall Study|Inadequate Bowel Prep|16|||
13168931|NCT02345889|26112972|FG002|Overall Study|Inadequate Bowel Prep|18|||
13168932|NCT02345889|26112973|FG003|Overall Study|Inadequate Bowel Prep|14|||
13168933|NCT02345889|26112970|FG000|Overall Study|Polyposis identified during procedure|1|||
13168934|NCT02345889|26112971|FG001|Overall Study|Polyposis identified during procedure|1|||
13168935|NCT02345889|26112972|FG002|Overall Study|Polyposis identified during procedure|0|||
13168936|NCT02345889|26112973|FG003|Overall Study|Polyposis identified during procedure|1|||
13168937|NCT02345889|26112970|FG000|Overall Study|Recognized ineligible post-randomization|1|||
13168938|NCT02345889|26112971|FG001|Overall Study|Recognized ineligible post-randomization|0|||
13168939|NCT02345889|26112972|FG002|Overall Study|Recognized ineligible post-randomization|2|||
13168940|NCT02345889|26112973|FG003|Overall Study|Recognized ineligible post-randomization|1|||
13168941|NCT02345889|26112970|FG000|Overall Study|Ulcerative Colitis identified|1|||
13168942|NCT02345889|26112971|FG001|Overall Study|Ulcerative Colitis identified|0|||
13168943|NCT02345889|26112972|FG002|Overall Study|Ulcerative Colitis identified|0|||
13168944|NCT02345889|26112973|FG003|Overall Study|Ulcerative Colitis identified|0|||
13168945|NCT02345889|26112970|FG000|Overall Study|Cecum not intubated|1|||
13168946|NCT02345889|26112971|FG001|Overall Study|Cecum not intubated|0|||
13168947|NCT02345889|26112972|FG002|Overall Study|Cecum not intubated|0|||
13168948|NCT02345889|26112973|FG003|Overall Study|Cecum not intubated|0|||
13168949|NCT02345811|26113006|FG000|First Intervention|Withdrawal by Subject|1|||
13168950|NCT02345811|26113007|FG001|First Intervention|Withdrawal by Subject|1|||
13168951|NCT02345512|26113028|FG000|Overall Study|Adverse Event|1|||
13168952|NCT02345512|26113028|FG000|Overall Study|Withdrawal by Subject|1|||
13168953|NCT02345434|26113049|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5|||
13168954|NCT02345434|26113050|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2|||
13168955|NCT02345330|26113062|FG000|Overall Study|Death|1|||
13168956|NCT02345330|26113062|FG000|Overall Study|Progressive Disease|2|||
13168957|NCT02345252|26113095|FG000|Double-Blind Phase|Adverse Event|2|||
13168958|NCT02345252|26113096|FG001|Double-Blind Phase|Adverse Event|3|||
13168959|NCT02345252|26113095|FG000|Double-Blind Phase|Death|1|||
13168960|NCT02345252|26113096|FG001|Double-Blind Phase|Death|2|||
13168961|NCT02345252|26113095|FG000|Double-Blind Phase|Lack of Efficacy|1|||
13168962|NCT02345252|26113096|FG001|Double-Blind Phase|Lack of Efficacy|0|||
13168963|NCT02345252|26113095|FG000|Double-Blind Phase|Investigator's Discretion|4|||
13168964|NCT02345252|26113096|FG001|Double-Blind Phase|Investigator's Discretion|6|||
13168965|NCT02345252|26113095|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
13168966|NCT02345252|26113096|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
13168967|NCT02345252|26113095|FG000|Double-Blind Phase|Protocol Violation|2|||
13168968|NCT02345252|26113096|FG001|Double-Blind Phase|Protocol Violation|1|||
13168969|NCT02345252|26113095|FG000|Double-Blind Phase|Withdrew Consent|21|||
13168970|NCT02345252|26113096|FG001|Double-Blind Phase|Withdrew Consent|23|||
13168971|NCT02345252|26113095|FG000|Double-Blind Phase|Lost to Follow-up|8|||
13168972|NCT02345252|26113096|FG001|Double-Blind Phase|Lost to Follow-up|10|||
13168973|NCT02345252|26113095|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
13168974|NCT02345252|26113096|FG001|Double-Blind Phase|Randomized but Never Treated|2|||
13168975|NCT02345226|26113133|FG000|Double-Blind Phase|Adverse Event|5|||
13168976|NCT02345226|26113134|FG001|Double-Blind Phase|Adverse Event|6|||
13168977|NCT02345226|26113133|FG000|Double-Blind Phase|Death|3|||
13168978|NCT02345226|26113134|FG001|Double-Blind Phase|Death|0|||
13168979|NCT02345226|26113133|FG000|Double-Blind Phase|Pregnancy|0|||
13485529|NCT02906020|27032867|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
13168980|NCT02345226|26113134|FG001|Double-Blind Phase|Pregnancy|1|||
13168981|NCT02345226|26113133|FG000|Double-Blind Phase|Lack of Efficacy|1|||
13168982|NCT02345226|26113134|FG001|Double-Blind Phase|Lack of Efficacy|0|||
13107554|NCT03275389|25888369|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
13107555|NCT03275389|25888360|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
13168983|NCT02345226|26113133|FG000|Double-Blind Phase|Investigator's Discretion|4|||
13168984|NCT02345226|26113134|FG001|Double-Blind Phase|Investigator's Discretion|3|||
13168985|NCT02345226|26113133|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
13168986|NCT02345226|26113134|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
13168987|NCT02345226|26113133|FG000|Double-Blind Phase|Withdrew Consent|41|||
13168988|NCT02345226|26113134|FG001|Double-Blind Phase|Withdrew Consent|39|||
13168989|NCT02345226|26113133|FG000|Double-Blind Phase|Lost to Follow-up|12|||
13168990|NCT02345226|26113134|FG001|Double-Blind Phase|Lost to Follow-up|16|||
13168991|NCT02345226|26113133|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
13168992|NCT02345226|26113134|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
13168993|NCT02345226|26113133|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
13168994|NCT02345226|26113134|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
13168995|NCT02345161|26113243|FG000|Overall Study|Withdrawal by Subject|25|||
13168996|NCT02345161|26113244|FG001|Overall Study|Withdrawal by Subject|33|||
13168997|NCT02345161|26113243|FG000|Overall Study|Adverse Event|16|||
13107556|NCT03275389|25888361|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
13107557|NCT03275389|25888362|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
13107558|NCT03275389|25888363|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
13107559|NCT03275389|25888364|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
13107560|NCT03275389|25888365|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
13107561|NCT03275389|25888366|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
13107562|NCT03275389|25888367|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
13107563|NCT03275389|25888368|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
13107564|NCT03275389|25888369|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
13168998|NCT02345161|26113244|FG001|Overall Study|Adverse Event|19|||
13168999|NCT02345161|26113243|FG000|Overall Study|Physician Decision|4|||
13169000|NCT02345161|26113244|FG001|Overall Study|Physician Decision|4|||
13169001|NCT02345161|26113243|FG000|Overall Study|Lost to Follow-up|0|||
13169002|NCT02345161|26113244|FG001|Overall Study|Lost to Follow-up|1|||
13169003|NCT02344745|26113263|FG000|Overall Study|Data collection sheets were lost|2|||
13169004|NCT02344745|26113264|FG001|Overall Study|Data collection sheets were lost|0|||
13169005|NCT02344576|26113320|FG000|Enrollment|Agreed to Medical Record Review Only|7|||
13169006|NCT02344576|26113321|FG001|Enrollment|Agreed to Medical Record Review Only|8|||
13169007|NCT02344576|26113322|FG002|Enrollment|Agreed to Medical Record Review Only|0|||
13169008|NCT02344576|26113323|FG003|Enrollment|Agreed to Medical Record Review Only|0|||
13169009|NCT02344576|26113320|FG000|1-Month Follow-Up|Death|13|||
13169010|NCT02344576|26113321|FG001|1-Month Follow-Up|Death|8|||
13169011|NCT02344576|26113322|FG002|1-Month Follow-Up|Death|0|||
13169012|NCT02344576|26113323|FG003|1-Month Follow-Up|Death|0|||
13169013|NCT02344576|26113320|FG000|1-Month Follow-Up|Withdrawal by Subject|3|||
13169014|NCT02344576|26113321|FG001|1-Month Follow-Up|Withdrawal by Subject|14|||
13169015|NCT02344576|26113322|FG002|1-Month Follow-Up|Withdrawal by Subject|8|||
13169016|NCT02344576|26113323|FG003|1-Month Follow-Up|Withdrawal by Subject|10|||
13169017|NCT02344576|26113320|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
13169018|NCT02344576|26113321|FG001|1-Month Follow-Up|Lost to Follow-up|5|||
13169019|NCT02344576|26113322|FG002|1-Month Follow-Up|Lost to Follow-up|11|||
13169020|NCT02344576|26113323|FG003|1-Month Follow-Up|Lost to Follow-up|3|||
13169021|NCT02344576|26113320|FG000|6-Month Follow-Up|Death|14|||
13169022|NCT02344576|26113321|FG001|6-Month Follow-Up|Death|14|||
13169023|NCT02344576|26113322|FG002|6-Month Follow-Up|Death|0|||
13107565|NCT03275389|25888360|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
13107566|NCT03275389|25888361|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
13107567|NCT03275389|25888362|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
13107568|NCT03275389|25888363|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
13107569|NCT03275389|25888364|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
13107570|NCT03275389|25888365|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
13107571|NCT03275389|25888366|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
13107572|NCT03275389|25888367|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
13107573|NCT03275389|25888368|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
13107574|NCT03275389|25888369|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
13107575|NCT03275389|25888360|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
13107576|NCT03275389|25888361|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
13107577|NCT03275389|25888362|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
13169024|NCT02344576|26113323|FG003|6-Month Follow-Up|Death|0|||
13169025|NCT02344576|26113320|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
13169026|NCT02344576|26113321|FG001|6-Month Follow-Up|Withdrawal by Subject|0|||
13169027|NCT02344576|26113322|FG002|6-Month Follow-Up|Withdrawal by Subject|1|||
13169028|NCT02344576|26113323|FG003|6-Month Follow-Up|Withdrawal by Subject|2|||
13169029|NCT02344576|26113320|FG000|6-Month Follow-Up|Lost to Follow-up|4|||
13169030|NCT02344576|26113321|FG001|6-Month Follow-Up|Lost to Follow-up|5|||
13169031|NCT02344576|26113322|FG002|6-Month Follow-Up|Lost to Follow-up|13|||
13169032|NCT02344576|26113323|FG003|6-Month Follow-Up|Lost to Follow-up|6|||
13169033|NCT02344342|26113358|FG000|Overall Study|Industry partner dropped out|11|||
13169034|NCT02344342|26113359|FG001|Overall Study|Industry partner dropped out|9|||
13169035|NCT02344342|26113360|FG002|Overall Study|Industry partner dropped out|14|||
13169036|NCT02344342|26113361|FG003|Overall Study|Industry partner dropped out|10|||
13169037|NCT02344173|26113369|FG000|Procedure|Ablation Procedure Not Performed|7|||
13169038|NCT02344173|26113369|FG000|12-month Visit|Death|8|||
13169039|NCT02344173|26113369|FG000|12-month Visit|Withdrawal by Subject|30|||
13169040|NCT02344173|26113369|FG000|12-month Visit|Lost to Follow-up|58|||
13169041|NCT02344004|26113394|FG000|Overall Study|Adverse Event|11|||
13169042|NCT02344004|26113395|FG001|Overall Study|Adverse Event|1|||
13169043|NCT02344004|26113394|FG000|Overall Study|Death|9|||
13169044|NCT02344004|26113395|FG001|Overall Study|Death|7|||
13169045|NCT02344004|26113394|FG000|Overall Study|Physician Decision|4|||
13169046|NCT02344004|26113395|FG001|Overall Study|Physician Decision|1|||
13169047|NCT02344004|26113394|FG000|Overall Study|Withdrawal by Subject|22|||
13169048|NCT02344004|26113395|FG001|Overall Study|Withdrawal by Subject|5|||
13169049|NCT02344004|26113394|FG000|Overall Study|Rescue Medication|2|||
13169050|NCT02344004|26113395|FG001|Overall Study|Rescue Medication|0|||
13169051|NCT02344004|26113394|FG000|Overall Study|Other Not Specified|12|||
13169052|NCT02344004|26113395|FG001|Overall Study|Other Not Specified|0|||
13169053|NCT02344004|26113394|FG000|Overall Study|Protocol Violation|1|||
13169054|NCT02344004|26113395|FG001|Overall Study|Protocol Violation|0|||
13169055|NCT02343952|26113404|FG000|Study Treatment|Disease Progression|23|||
13169056|NCT02343952|26113404|FG000|Study Treatment|Death|3|||
13169057|NCT02343952|26113404|FG000|Study Treatment|Adverse Event|19|||
13169058|NCT02343952|26113404|FG000|Study Treatment|Withdrawal by Subject|7|||
13169059|NCT02343952|26113404|FG000|Study Treatment|other complicating Diseases|1|||
13169060|NCT02343952|26113404|FG000|Follow up|Withdrawal by Subject|3|||
13169061|NCT02343952|26113404|FG000|Follow up|Death|33|||
13169062|NCT02343952|26113404|FG000|Follow up|Patient does not meet eligibility for study.|1|||
13169063|NCT02343952|26113404|FG000|Follow up|Research department closed by the practice.|5|||
13169064|NCT02343952|26113404|FG000|Follow up|Patient went home to Russia|1|||
13169065|NCT02343952|26113404|FG000|Follow up|Disease Progression|1|||
13169066|NCT02343952|26113404|FG000|Follow up|study terminated|1|||
13169067|NCT02343939|26113542|FG000|Overall Study|Death|0|||
13169068|NCT02343939|26113543|FG001|Overall Study|Death|15|||
13169069|NCT02343939|26113544|FG002|Overall Study|Death|4|||
13169070|NCT02343939|26113545|FG003|Overall Study|Death|2|||
13169071|NCT02343939|26113546|FG004|Overall Study|Death|5|||
13169072|NCT02343939|26113547|FG005|Overall Study|Death|11|||
13169073|NCT02343939|26113548|FG006|Overall Study|Death|8|||
13169074|NCT02343939|26113549|FG007|Overall Study|Death|22|||
13169075|NCT02343939|26113550|FG008|Overall Study|Death|1|||
13169076|NCT02343939|26113542|FG000|Overall Study|Study terminated by sponsor|0|||
13169077|NCT02343939|26113543|FG001|Overall Study|Study terminated by sponsor|27|||
13169078|NCT02343939|26113544|FG002|Overall Study|Study terminated by sponsor|0|||
13169079|NCT02343939|26113545|FG003|Overall Study|Study terminated by sponsor|1|||
13169080|NCT02343939|26113546|FG004|Overall Study|Study terminated by sponsor|1|||
13169081|NCT02343939|26113547|FG005|Overall Study|Study terminated by sponsor|5|||
13169082|NCT02343939|26113548|FG006|Overall Study|Study terminated by sponsor|3|||
13169083|NCT02343939|26113549|FG007|Overall Study|Study terminated by sponsor|4|||
13169084|NCT02343939|26113550|FG008|Overall Study|Study terminated by sponsor|0|||
13169085|NCT02343939|26113542|FG000|Overall Study|Withdrew consent|3|||
13169086|NCT02343939|26113543|FG001|Overall Study|Withdrew consent|6|||
13169087|NCT02343939|26113544|FG002|Overall Study|Withdrew consent|1|||
13169088|NCT02343939|26113545|FG003|Overall Study|Withdrew consent|2|||
13169089|NCT02343939|26113546|FG004|Overall Study|Withdrew consent|2|||
13169090|NCT02343939|26113547|FG005|Overall Study|Withdrew consent|0|||
13169091|NCT02343939|26113548|FG006|Overall Study|Withdrew consent|0|||
13169092|NCT02343939|26113549|FG007|Overall Study|Withdrew consent|8|||
13169093|NCT02343939|26113550|FG008|Overall Study|Withdrew consent|6|||
13169094|NCT02343939|26113542|FG000|Overall Study|Treatment failure|0|||
13169095|NCT02343939|26113543|FG001|Overall Study|Treatment failure|0|||
13169096|NCT02343939|26113544|FG002|Overall Study|Treatment failure|0|||
13169097|NCT02343939|26113545|FG003|Overall Study|Treatment failure|0|||
13169098|NCT02343939|26113546|FG004|Overall Study|Treatment failure|0|||
13169099|NCT02343939|26113547|FG005|Overall Study|Treatment failure|0|||
13169100|NCT02343939|26113548|FG006|Overall Study|Treatment failure|2|||
13169101|NCT02343939|26113549|FG007|Overall Study|Treatment failure|1|||
13169102|NCT02343939|26113550|FG008|Overall Study|Treatment failure|0|||
13169103|NCT02343939|26113542|FG000|Overall Study|Investigator's discretion|0|||
13169104|NCT02343939|26113543|FG001|Overall Study|Investigator's discretion|0|||
13107578|NCT03275389|25888363|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
13107579|NCT03275389|25888364|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
13107580|NCT03275389|25888365|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
13169105|NCT02343939|26113544|FG002|Overall Study|Investigator's discretion|0|||
13169106|NCT02343939|26113545|FG003|Overall Study|Investigator's discretion|1|||
13169107|NCT02343939|26113546|FG004|Overall Study|Investigator's discretion|0|||
13107581|NCT03275389|25888366|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
13107582|NCT03275389|25888367|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
13107583|NCT03275389|25888368|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
13107584|NCT03275389|25888369|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
13107585|NCT03275389|25888360|FG000|Overall Study|Other|0|||
13107586|NCT03275389|25888361|FG001|Overall Study|Other|4|||
13107587|NCT03275389|25888362|FG002|Overall Study|Other|3|||
13107588|NCT03275389|25888363|FG003|Overall Study|Other|2|||
13107589|NCT03275389|25888364|FG004|Overall Study|Other|2|||
13107590|NCT03275389|25888365|FG005|Overall Study|Other|2|||
13107591|NCT03275389|25888366|FG006|Overall Study|Other|0|||
13107592|NCT03275389|25888367|FG007|Overall Study|Other|0|||
13107593|NCT03275389|25888368|FG008|Overall Study|Other|1|||
13107594|NCT03275389|25888369|FG009|Overall Study|Other|0|||
13107595|NCT03275350|25888406|FG000|Overall Study|Lost to Follow-up|4|||
13107596|NCT03275350|25888407|FG001|Overall Study|Lost to Follow-up|6|||
13107597|NCT03275350|25888406|FG000|Overall Study|Death|2|||
13107598|NCT03275350|25888407|FG001|Overall Study|Death|1|||
13107599|NCT03275350|25888406|FG000|Overall Study|Physician Decision|1|||
13107600|NCT03275350|25888407|FG001|Overall Study|Physician Decision|0|||
13107601|NCT03275350|25888406|FG000|Overall Study|Incarcerated|1|||
13107602|NCT03275350|25888407|FG001|Overall Study|Incarcerated|1|||
13107603|NCT03275246|25888418|FG000|Overall Study|Protocol Violation|5|||
13107604|NCT03275246|25888418|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1|||
13107605|NCT03274986|25888456|FG000|Overall Study|Withdrawal by Subject|0|||
13107606|NCT03274986|25888457|FG001|Overall Study|Withdrawal by Subject|1|||
13107607|NCT03274986|25888456|FG000|Overall Study|Lost to Follow-up|0|||
13107608|NCT03274986|25888457|FG001|Overall Study|Lost to Follow-up|1|||
13107609|NCT03274687|25888492|FG000|Overall Study|Protocol Violation|1|||
13107610|NCT03274687|25888493|FG001|Overall Study|Protocol Violation|1|||
13169108|NCT02343939|26113547|FG005|Overall Study|Investigator's discretion|0|||
13169109|NCT02343939|26113548|FG006|Overall Study|Investigator's discretion|1|||
13169110|NCT02343939|26113549|FG007|Overall Study|Investigator's discretion|0|||
13169111|NCT02343939|26113550|FG008|Overall Study|Investigator's discretion|0|||
13169112|NCT02343939|26113542|FG000|Overall Study|Adverse Event|0|||
13169113|NCT02343939|26113543|FG001|Overall Study|Adverse Event|0|||
13169114|NCT02343939|26113544|FG002|Overall Study|Adverse Event|0|||
13169115|NCT02343939|26113545|FG003|Overall Study|Adverse Event|0|||
13169116|NCT02343939|26113546|FG004|Overall Study|Adverse Event|0|||
13169117|NCT02343939|26113547|FG005|Overall Study|Adverse Event|1|||
13169118|NCT02343939|26113548|FG006|Overall Study|Adverse Event|0|||
13169119|NCT02343939|26113549|FG007|Overall Study|Adverse Event|0|||
13169120|NCT02343939|26113550|FG008|Overall Study|Adverse Event|0|||
13169121|NCT02343939|26113542|FG000|Overall Study|Never Treated With ENTO|0|||
13169122|NCT02343939|26113543|FG001|Overall Study|Never Treated With ENTO|0|||
13169123|NCT02343939|26113544|FG002|Overall Study|Never Treated With ENTO|0|||
13169124|NCT02343939|26113545|FG003|Overall Study|Never Treated With ENTO|0|||
13107611|NCT03274466|25888512|FG000|Overall Study|Withdrawal by Subject|7|||
13107612|NCT03274466|25888513|FG001|Overall Study|Withdrawal by Subject|3|||
13107613|NCT03274466|25888512|FG000|Overall Study|Protocol Specified Withdrawal|5|||
13107614|NCT03274466|25888513|FG001|Overall Study|Protocol Specified Withdrawal|11|||
13107615|NCT03274466|25888512|FG000|Overall Study|Lost to Follow-up|5|||
13107616|NCT03274466|25888513|FG001|Overall Study|Lost to Follow-up|7|||
13107617|NCT03274466|25888512|FG000|Overall Study|Subject Non-compliance|0|||
13107618|NCT03274466|25888513|FG001|Overall Study|Subject Non-compliance|1|||
13107619|NCT03274466|25888512|FG000|Overall Study|Adverse Event|3|||
13107620|NCT03274466|25888513|FG001|Overall Study|Adverse Event|3|||
13107621|NCT03274466|25888512|FG000|Overall Study|Physician Decision|0|||
13107622|NCT03274466|25888513|FG001|Overall Study|Physician Decision|1|||
13169125|NCT02343939|26113546|FG004|Overall Study|Never Treated With ENTO|0|||
13169126|NCT02343939|26113547|FG005|Overall Study|Never Treated With ENTO|0|||
13169127|NCT02343939|26113548|FG006|Overall Study|Never Treated With ENTO|1|||
13169128|NCT02343939|26113549|FG007|Overall Study|Never Treated With ENTO|2|||
13169129|NCT02343939|26113550|FG008|Overall Study|Never Treated With ENTO|0|||
13169130|NCT02343549|26113562|FG000|Overall Study|Death|11|||
13169131|NCT02343549|26113562|FG000|Overall Study|Withdrawal by Subject|2|||
13169132|NCT02343458|26113649|FG000|Overall Study|Adverse Event|15|||
13169133|NCT02343458|26113650|FG001|Overall Study|Adverse Event|14|||
13169134|NCT02343458|26113651|FG002|Overall Study|Adverse Event|15|||
13169135|NCT02343458|26113652|FG003|Overall Study|Adverse Event|3|||
13169136|NCT02343458|26113649|FG000|Overall Study|Lack of Efficacy|3|||
13169137|NCT02343458|26113650|FG001|Overall Study|Lack of Efficacy|8|||
13169138|NCT02343458|26113651|FG002|Overall Study|Lack of Efficacy|4|||
13169139|NCT02343458|26113652|FG003|Overall Study|Lack of Efficacy|8|||
13107623|NCT03274466|25888512|FG000|Overall Study|Protocol Violation|3|||
13107624|NCT03274466|25888513|FG001|Overall Study|Protocol Violation|3|||
13107625|NCT03274453|25888536|FG000|Overall Study|Lost to Follow-up|2|||
13107626|NCT03274453|25888537|FG001|Overall Study|Lost to Follow-up|5|||
13107627|NCT03274453|25888538|FG002|Overall Study|Lost to Follow-up|4|||
13169140|NCT02343458|26113649|FG000|Overall Study|Withdrawal by Subject|18|||
13169141|NCT02343458|26113650|FG001|Overall Study|Withdrawal by Subject|17|||
13169142|NCT02343458|26113651|FG002|Overall Study|Withdrawal by Subject|23|||
13169143|NCT02343458|26113652|FG003|Overall Study|Withdrawal by Subject|14|||
13169144|NCT02343458|26113649|FG000|Overall Study|Physician Decision|1|||
13169145|NCT02343458|26113650|FG001|Overall Study|Physician Decision|4|||
13169146|NCT02343458|26113651|FG002|Overall Study|Physician Decision|2|||
13169147|NCT02343458|26113652|FG003|Overall Study|Physician Decision|2|||
13169148|NCT02343458|26113649|FG000|Overall Study|Lost to Follow-up|5|||
13169149|NCT02343458|26113650|FG001|Overall Study|Lost to Follow-up|5|||
13169150|NCT02343458|26113651|FG002|Overall Study|Lost to Follow-up|3|||
13169151|NCT02343458|26113652|FG003|Overall Study|Lost to Follow-up|1|||
13169152|NCT02343458|26113649|FG000|Overall Study|Protocol Violation|2|||
13169153|NCT02343458|26113650|FG001|Overall Study|Protocol Violation|5|||
13169154|NCT02343458|26113651|FG002|Overall Study|Protocol Violation|2|||
13169155|NCT02343458|26113652|FG003|Overall Study|Protocol Violation|2|||
13169156|NCT02343458|26113649|FG000|Overall Study|Protocol Specified Criteria|17|||
13169157|NCT02343458|26113650|FG001|Overall Study|Protocol Specified Criteria|13|||
13169158|NCT02343458|26113651|FG002|Overall Study|Protocol Specified Criteria|14|||
13169159|NCT02343458|26113652|FG003|Overall Study|Protocol Specified Criteria|8|||
13169160|NCT02343406|26113701|FG000|Overall Study|Progressive disease|72|||
13169161|NCT02343406|26113702|FG001|Overall Study|Progressive disease|70|||
13169162|NCT02343406|26113703|FG002|Overall Study|Progressive disease|43|||
13169163|NCT02343406|26113704|FG003|Overall Study|Progressive disease|15|||
13169164|NCT02343406|26113705|FG004|Overall Study|Progressive disease|5|||
13169165|NCT02343406|26113701|FG000|Overall Study|Adverse Event|6|||
13169166|NCT02343406|26113702|FG001|Overall Study|Adverse Event|8|||
13107628|NCT03274453|25888539|FG003|Overall Study|Lost to Follow-up|1|||
13107629|NCT03274453|25888536|FG000|Overall Study|Physician Decision|2|||
13169167|NCT02343406|26113703|FG002|Overall Study|Adverse Event|6|||
13169168|NCT02343406|26113704|FG003|Overall Study|Adverse Event|3|||
13169169|NCT02343406|26113705|FG004|Overall Study|Adverse Event|0|||
13169170|NCT02343406|26113701|FG000|Overall Study|Withdrawal by Subject|6|||
13169171|NCT02343406|26113702|FG001|Overall Study|Withdrawal by Subject|4|||
13169172|NCT02343406|26113703|FG002|Overall Study|Withdrawal by Subject|8|||
13169173|NCT02343406|26113704|FG003|Overall Study|Withdrawal by Subject|3|||
13169174|NCT02343406|26113705|FG004|Overall Study|Withdrawal by Subject|0|||
13169175|NCT02343406|26113701|FG000|Overall Study|Death|2|||
13169176|NCT02343406|26113702|FG001|Overall Study|Death|1|||
13169177|NCT02343406|26113703|FG002|Overall Study|Death|0|||
13169178|NCT02343406|26113704|FG003|Overall Study|Death|0|||
13169179|NCT02343406|26113705|FG004|Overall Study|Death|0|||
13169180|NCT02343406|26113701|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
13169181|NCT02343406|26113702|FG001|Overall Study|Start of a new anti-cancer treatment|1|||
13169182|NCT02343406|26113703|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
13169183|NCT02343406|26113704|FG003|Overall Study|Start of a new anti-cancer treatment|1|||
13169184|NCT02343406|26113705|FG004|Overall Study|Start of a new anti-cancer treatment|0|||
13169185|NCT02343406|26113701|FG000|Overall Study|Other primary malignancy|0|||
13169186|NCT02343406|26113702|FG001|Overall Study|Other primary malignancy|1|||
13169187|NCT02343406|26113703|FG002|Overall Study|Other primary malignancy|0|||
13169188|NCT02343406|26113704|FG003|Overall Study|Other primary malignancy|0|||
13169189|NCT02343406|26113705|FG004|Overall Study|Other primary malignancy|0|||
13169190|NCT02343406|26113701|FG000|Overall Study|Other, not specified|2|||
13169191|NCT02343406|26113702|FG001|Overall Study|Other, not specified|1|||
13107630|NCT03274453|25888537|FG001|Overall Study|Physician Decision|0|||
13107631|NCT03274453|25888538|FG002|Overall Study|Physician Decision|0|||
13107632|NCT03274453|25888539|FG003|Overall Study|Physician Decision|3|||
13107633|NCT03274453|25888536|FG000|Overall Study|Surgery Cancelled|0|||
13107634|NCT03274453|25888537|FG001|Overall Study|Surgery Cancelled|1|||
13107635|NCT03274453|25888538|FG002|Overall Study|Surgery Cancelled|0|||
13107636|NCT03274453|25888539|FG003|Overall Study|Surgery Cancelled|0|||
13107637|NCT03274440|25888557|FG000|Overall Study|Time commitment too great|1|||
13107638|NCT03274440|25888558|FG001|Overall Study|Time commitment too great|0|||
13107639|NCT03274440|25888559|FG002|Overall Study|Time commitment too great|0|||
13107640|NCT03274440|25888560|FG003|Overall Study|Time commitment too great|1|||
13107641|NCT03274440|25888561|FG004|Overall Study|Time commitment too great|0|||
13107642|NCT03274440|25888562|FG005|Overall Study|Time commitment too great|0|||
13169192|NCT02343406|26113703|FG002|Overall Study|Other, not specified|1|||
13169193|NCT02343406|26113704|FG003|Overall Study|Other, not specified|4|||
13169194|NCT02343406|26113705|FG004|Overall Study|Other, not specified|0|||
13169195|NCT02343263|26113741|FG000|Overall Study|Physician Decision|5|||
13169196|NCT02343263|26113742|FG001|Overall Study|Physician Decision|3|||
13169197|NCT02343263|26113743|FG002|Overall Study|Physician Decision|1|||
13169198|NCT02343159|26113778|FG000|Overall Study|Early Study Termination|16|||
13169199|NCT02343159|26113779|FG001|Overall Study|Early Study Termination|19|||
13169200|NCT02343159|26113780|FG002|Overall Study|Early Study Termination|23|||
13169201|NCT02343159|26113778|FG000|Overall Study|Physician Decision|2|||
13169202|NCT02343159|26113779|FG001|Overall Study|Physician Decision|0|||
13169203|NCT02343159|26113780|FG002|Overall Study|Physician Decision|1|||
13169204|NCT02343159|26113778|FG000|Overall Study|Withdrawal by Subject|3|||
13169205|NCT02343159|26113779|FG001|Overall Study|Withdrawal by Subject|0|||
13169206|NCT02343159|26113780|FG002|Overall Study|Withdrawal by Subject|2|||
13169207|NCT02343159|26113778|FG000|Overall Study|Lost to Follow-up|0|||
13169208|NCT02343159|26113779|FG001|Overall Study|Lost to Follow-up|2|||
13169209|NCT02343159|26113780|FG002|Overall Study|Lost to Follow-up|2|||
13169210|NCT02343159|26113778|FG000|Overall Study|Adverse Event|4|||
13169211|NCT02343159|26113779|FG001|Overall Study|Adverse Event|4|||
13169212|NCT02343159|26113780|FG002|Overall Study|Adverse Event|2|||
13169213|NCT02343159|26113778|FG000|Overall Study|Sponsor Decision|0|||
13169214|NCT02343159|26113779|FG001|Overall Study|Sponsor Decision|1|||
13169215|NCT02343159|26113780|FG002|Overall Study|Sponsor Decision|0|||
13169216|NCT02343159|26113778|FG000|Overall Study|Enrollment Error|1|||
13169217|NCT02343159|26113779|FG001|Overall Study|Enrollment Error|0|||
13169218|NCT02343159|26113780|FG002|Overall Study|Enrollment Error|0|||
13169219|NCT02343120|26113865|FG000|Part 1: Dose Escalation|Sponsor decision|1|||
13169220|NCT02343120|26113866|FG001|Part 1: Dose Escalation|Sponsor decision|2|||
13169221|NCT02343120|26113867|FG002|Part 1: Dose Escalation|Sponsor decision|3|||
13169222|NCT02343120|26113868|FG003|Part 1: Dose Escalation|Sponsor decision|2|||
13169223|NCT02343120|26113869|FG004|Part 1: Dose Escalation|Sponsor decision|0|||
13169224|NCT02343120|26113865|FG000|Part 1: Dose Escalation|Death|1|||
13169225|NCT02343120|26113866|FG001|Part 1: Dose Escalation|Death|2|||
13169226|NCT02343120|26113867|FG002|Part 1: Dose Escalation|Death|2|||
13169227|NCT02343120|26113868|FG003|Part 1: Dose Escalation|Death|2|||
13169228|NCT02343120|26113869|FG004|Part 1: Dose Escalation|Death|1|||
13169229|NCT02343120|26113865|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
13169230|NCT02343120|26113866|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
13169231|NCT02343120|26113867|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
13169232|NCT02343120|26113868|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
13169233|NCT02343120|26113869|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
13169234|NCT02343120|26113865|FG000|Part 2: Expansion|Sponsor decision|0|||
13107643|NCT03274076|25888599|FG000|24 Weeks Double Blind|Withdrawal by Subject|0|||
13169235|NCT02343120|26113866|FG001|Part 2: Expansion|Sponsor decision|0|||
13169236|NCT02343120|26113867|FG002|Part 2: Expansion|Sponsor decision|0|||
13169237|NCT02343120|26113868|FG003|Part 2: Expansion|Sponsor decision|165|||
13169238|NCT02343120|26113869|FG004|Part 2: Expansion|Sponsor decision|67|||
13169239|NCT02343120|26113865|FG000|Part 2: Expansion|Death|0|||
13169240|NCT02343120|26113866|FG001|Part 2: Expansion|Death|0|||
13169241|NCT02343120|26113867|FG002|Part 2: Expansion|Death|0|||
13169242|NCT02343120|26113868|FG003|Part 2: Expansion|Death|74|||
13169243|NCT02343120|26113869|FG004|Part 2: Expansion|Death|17|||
13169244|NCT02343120|26113865|FG000|Part 2: Expansion|Withdrawal by Subject|0|||
13169245|NCT02343120|26113866|FG001|Part 2: Expansion|Withdrawal by Subject|0|||
13169246|NCT02343120|26113867|FG002|Part 2: Expansion|Withdrawal by Subject|0|||
13169247|NCT02343120|26113868|FG003|Part 2: Expansion|Withdrawal by Subject|28|||
13169248|NCT02343120|26113869|FG004|Part 2: Expansion|Withdrawal by Subject|2|||
13169249|NCT02343120|26113865|FG000|Part 2: Expansion|Lost to Follow-up|0|||
13169250|NCT02343120|26113866|FG001|Part 2: Expansion|Lost to Follow-up|0|||
13169251|NCT02343120|26113867|FG002|Part 2: Expansion|Lost to Follow-up|0|||
13169252|NCT02343120|26113868|FG003|Part 2: Expansion|Lost to Follow-up|5|||
13169253|NCT02343120|26113869|FG004|Part 2: Expansion|Lost to Follow-up|2|||
13169254|NCT02343120|26113865|FG000|Part 2: Expansion|Other|0|||
13169255|NCT02343120|26113866|FG001|Part 2: Expansion|Other|0|||
13169256|NCT02343120|26113867|FG002|Part 2: Expansion|Other|0|||
13169257|NCT02343120|26113868|FG003|Part 2: Expansion|Other|1|||
13169258|NCT02343120|26113869|FG004|Part 2: Expansion|Other|5|||
13169259|NCT02343120|26113865|FG000|Part 2: Expansion|Adverse Event|0|||
13169260|NCT02343120|26113866|FG001|Part 2: Expansion|Adverse Event|0|||
13169261|NCT02343120|26113867|FG002|Part 2: Expansion|Adverse Event|0|||
13169262|NCT02343120|26113868|FG003|Part 2: Expansion|Adverse Event|1|||
13169263|NCT02343120|26113869|FG004|Part 2: Expansion|Adverse Event|1|||
13169264|NCT02343003|26113892|FG000|Overall Study|Withdrawal by Subject|9|||
13169265|NCT02343003|26113893|FG001|Overall Study|Withdrawal by Subject|4|||
13169266|NCT02343003|26113892|FG000|Overall Study|Lost to Follow-up|5|||
13169267|NCT02343003|26113893|FG001|Overall Study|Lost to Follow-up|1|||
13169268|NCT02343003|26113892|FG000|Overall Study|Protocol Violation|1|||
13169269|NCT02343003|26113893|FG001|Overall Study|Protocol Violation|0|||
13169270|NCT02343003|26113892|FG000|Overall Study|Death|0|||
13169271|NCT02343003|26113893|FG001|Overall Study|Death|1|||
13169272|NCT02343003|26113892|FG000|Overall Study|exclusion criteria met|1|||
13169273|NCT02343003|26113893|FG001|Overall Study|exclusion criteria met|1|||
13169274|NCT02343003|26113892|FG000|Overall Study|terminated by sponsor|2|||
13169275|NCT02343003|26113893|FG001|Overall Study|terminated by sponsor|0|||
13169276|NCT02342886|26113926|FG000|Overall Study|Treatment non-compliance|1|||
13169277|NCT02342886|26113927|FG001|Overall Study|Treatment non-compliance|0|||
13169278|NCT02342886|26113928|FG002|Overall Study|Treatment non-compliance|0|||
13169279|NCT02342886|26113929|FG003|Overall Study|Treatment non-compliance|1|||
13169280|NCT02342886|26113930|FG004|Overall Study|Treatment non-compliance|0|||
13169281|NCT02342886|26113926|FG000|Overall Study|Late exclusion: rifampicin resistance|1|||
13169282|NCT02342886|26113927|FG001|Overall Study|Late exclusion: rifampicin resistance|0|||
13169283|NCT02342886|26113928|FG002|Overall Study|Late exclusion: rifampicin resistance|0|||
13169284|NCT02342886|26113929|FG003|Overall Study|Late exclusion: rifampicin resistance|0|||
13169285|NCT02342886|26113930|FG004|Overall Study|Late exclusion: rifampicin resistance|0|||
13169286|NCT02342886|26113926|FG000|Overall Study|Adverse event/specific toxicity|4|||
13169287|NCT02342886|26113927|FG001|Overall Study|Adverse event/specific toxicity|3|||
13169288|NCT02342886|26113928|FG002|Overall Study|Adverse event/specific toxicity|11|||
13169289|NCT02342886|26113929|FG003|Overall Study|Adverse event/specific toxicity|2|||
13169290|NCT02342886|26113930|FG004|Overall Study|Adverse event/specific toxicity|1|||
13169291|NCT02342886|26113926|FG000|Overall Study|Lost to Follow-up|1|||
13169292|NCT02342886|26113927|FG001|Overall Study|Lost to Follow-up|0|||
13169293|NCT02342886|26113928|FG002|Overall Study|Lost to Follow-up|0|||
13169294|NCT02342886|26113929|FG003|Overall Study|Lost to Follow-up|0|||
13169295|NCT02342886|26113930|FG004|Overall Study|Lost to Follow-up|0|||
13169296|NCT02342886|26113926|FG000|Overall Study|Death|1|||
13169297|NCT02342886|26113927|FG001|Overall Study|Death|2|||
13169298|NCT02342886|26113928|FG002|Overall Study|Death|1|||
13169299|NCT02342886|26113929|FG003|Overall Study|Death|0|||
13169300|NCT02342886|26113930|FG004|Overall Study|Death|1|||
13169301|NCT02342886|26113926|FG000|Overall Study|Withdrawal by Subject|0|||
13169302|NCT02342886|26113927|FG001|Overall Study|Withdrawal by Subject|1|||
13169303|NCT02342886|26113928|FG002|Overall Study|Withdrawal by Subject|0|||
13169304|NCT02342886|26113929|FG003|Overall Study|Withdrawal by Subject|1|||
13169305|NCT02342886|26113930|FG004|Overall Study|Withdrawal by Subject|0|||
13169306|NCT02342886|26113926|FG000|Overall Study|Investigator/sponsor decision|0|||
13169307|NCT02342886|26113927|FG001|Overall Study|Investigator/sponsor decision|2|||
13169308|NCT02342886|26113928|FG002|Overall Study|Investigator/sponsor decision|0|||
13169309|NCT02342886|26113929|FG003|Overall Study|Investigator/sponsor decision|3|||
13169310|NCT02342886|26113930|FG004|Overall Study|Investigator/sponsor decision|1|||
13222912|NCT01802281|26287209|FG000|Overall Study|Withdrawal by Subject|2|||
13169311|NCT02342886|26113926|FG000|Overall Study|Pregnancy|0|||
13169312|NCT02342886|26113927|FG001|Overall Study|Pregnancy|0|||
13169313|NCT02342886|26113928|FG002|Overall Study|Pregnancy|2|||
13169314|NCT02342886|26113929|FG003|Overall Study|Pregnancy|0|||
13169315|NCT02342886|26113930|FG004|Overall Study|Pregnancy|0|||
13169316|NCT02342886|26113926|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0|||
13169317|NCT02342886|26113927|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0|||
13169318|NCT02342886|26113928|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1|||
13169319|NCT02342886|26113929|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0|||
13169320|NCT02342886|26113930|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0|||
13169321|NCT02342886|26113926|FG000|Overall Study|Protocol Violation|0|||
13169322|NCT02342886|26113927|FG001|Overall Study|Protocol Violation|0|||
13169323|NCT02342886|26113928|FG002|Overall Study|Protocol Violation|0|||
13169324|NCT02342886|26113929|FG003|Overall Study|Protocol Violation|2|||
13169325|NCT02342886|26113930|FG004|Overall Study|Protocol Violation|0|||
13169326|NCT02342743|26113943|FG000|Baseline Period|Withdrawal by Subject|3|||
13169327|NCT02342743|26113943|FG000|Baseline Period|Lost to Follow-up|2|||
13169328|NCT02342743|26113943|FG000|Baseline Period|Change in prophylactic medication|3|||
13169329|NCT02342743|26113943|FG000|Baseline Period|Screening failure regarding baseline|7|||
13169330|NCT02342743|26113943|FG000|Treatment Period|Withdrawal by Subject|2|||
13222913|NCT01802281|26287210|FG001|Overall Study|Withdrawal by Subject|1|||
13107644|NCT03274076|25888600|FG001|24 Weeks Double Blind|Withdrawal by Subject|1|||
13107645|NCT03274076|25888601|FG002|24 Weeks Double Blind|Withdrawal by Subject|0|||
13107646|NCT03274076|25888602|FG003|24 Weeks Double Blind|Withdrawal by Subject|0|||
13107647|NCT03274076|25888599|FG000|24 Weeks Open Label|Adverse Event|0|||
13107648|NCT03274076|25888600|FG001|24 Weeks Open Label|Adverse Event|0|||
13107649|NCT03274076|25888601|FG002|24 Weeks Open Label|Adverse Event|2|||
13107650|NCT03274076|25888602|FG003|24 Weeks Open Label|Adverse Event|0|||
13107651|NCT03274076|25888599|FG000|24 Weeks Open Label|Withdrawal by Subject|0|||
13169331|NCT02342743|26113943|FG000|Treatment Period|Lost to Follow-up|8|||
13169332|NCT02342743|26113943|FG000|Treatment Period|Change in prophylactic medication|1|||
13169333|NCT02342704|26113976|FG000|Overall Study|Physician Decision|0|||
13169334|NCT02342704|26113977|FG001|Overall Study|Physician Decision|3|||
13169335|NCT02342704|26113976|FG000|Overall Study|Sponsor Termination|49|||
13169336|NCT02342704|26113977|FG001|Overall Study|Sponsor Termination|43|||
13169337|NCT02342704|26113976|FG000|Overall Study|Other|0|||
13169338|NCT02342704|26113977|FG001|Overall Study|Other|1|||
13169339|NCT02342704|26113976|FG000|Overall Study|Withdrawal by Subject|1|||
13169340|NCT02342704|26113977|FG001|Overall Study|Withdrawal by Subject|0|||
13169341|NCT02342704|26113976|FG000|Overall Study|Lost to Follow-up|2|||
13169342|NCT02342704|26113977|FG001|Overall Study|Lost to Follow-up|1|||
13169343|NCT02342704|26113976|FG000|Overall Study|Adverse Event|1|||
13169344|NCT02342704|26113977|FG001|Overall Study|Adverse Event|3|||
13169345|NCT02342678|26114004|FG000|Overall Study|Lost to Follow-up|0|||
13169346|NCT02342678|26114005|FG001|Overall Study|Lost to Follow-up|1|||
13169347|NCT02342678|26114004|FG000|Overall Study|Too busy to complete study|0|||
13169348|NCT02342678|26114005|FG001|Overall Study|Too busy to complete study|2|||
13169349|NCT02342678|26114004|FG000|Overall Study|Family illness/emergency|0|||
13169350|NCT02342678|26114005|FG001|Overall Study|Family illness/emergency|1|||
13169351|NCT02342678|26114004|FG000|Overall Study|Illness/medical reason|1|||
13169352|NCT02342678|26114005|FG001|Overall Study|Illness/medical reason|1|||
13169353|NCT02342639|26114022|FG000|Overall Study|Acute illness, unrelated to study drug|2|||
13169354|NCT02342639|26114023|FG001|Overall Study|Acute illness, unrelated to study drug|3|||
13169355|NCT02342639|26114022|FG000|Overall Study|Protocol Violation|0|||
13169356|NCT02342639|26114023|FG001|Overall Study|Protocol Violation|2|||
13169357|NCT02342548|26114071|FG000|Overall Study|Adverse Event|12|||
13169358|NCT02342548|26114072|FG001|Overall Study|Adverse Event|17|||
13169359|NCT02342548|26114073|FG002|Overall Study|Adverse Event|13|||
13169360|NCT02342548|26114071|FG000|Overall Study|Lost to Follow-up|0|||
13169361|NCT02342548|26114072|FG001|Overall Study|Lost to Follow-up|1|||
13169362|NCT02342548|26114073|FG002|Overall Study|Lost to Follow-up|0|||
13169363|NCT02342548|26114071|FG000|Overall Study|Study terminated by sponsor|20|||
13169364|NCT02342548|26114072|FG001|Overall Study|Study terminated by sponsor|39|||
13169365|NCT02342548|26114073|FG002|Overall Study|Study terminated by sponsor|25|||
13169366|NCT02342548|26114071|FG000|Overall Study|Protocol Violation|0|||
13169367|NCT02342548|26114072|FG001|Overall Study|Protocol Violation|1|||
13169368|NCT02342548|26114073|FG002|Overall Study|Protocol Violation|0|||
13169369|NCT02342548|26114071|FG000|Overall Study|Withdrawal by Subject|1|||
13169370|NCT02342548|26114072|FG001|Overall Study|Withdrawal by Subject|3|||
13169371|NCT02342548|26114073|FG002|Overall Study|Withdrawal by Subject|4|||
13169372|NCT02342548|26114071|FG000|Overall Study|Other|1|||
13107652|NCT03274076|25888600|FG001|24 Weeks Open Label|Withdrawal by Subject|0|||
13169373|NCT02342548|26114072|FG001|Overall Study|Other|1|||
13169374|NCT02342548|26114073|FG002|Overall Study|Other|1|||
13169375|NCT02342418|26114088|FG000|Overall Study|Adverse Event|0|||
13169376|NCT02342418|26114089|FG001|Overall Study|Adverse Event|1|||
13169377|NCT02342288|26114102|FG000|Overall Study|no protocol anesthesiologist available|3|||
13169378|NCT02342288|26114103|FG001|Overall Study|no protocol anesthesiologist available|2|||
13169379|NCT02342288|26114102|FG000|Overall Study|anesthesia leak in system|1|||
13169380|NCT02342288|26114103|FG001|Overall Study|anesthesia leak in system|0|||
13169381|NCT02342288|26114102|FG000|Overall Study|Withdrawal by Subject|1|||
13169382|NCT02342288|26114103|FG001|Overall Study|Withdrawal by Subject|0|||
13169383|NCT02342288|26114102|FG000|Overall Study|coordinator contaminated with blood|0|||
13169384|NCT02342288|26114103|FG001|Overall Study|coordinator contaminated with blood|1|||
13169385|NCT02342288|26114102|FG000|Overall Study|subject cannot tolerate numbing drops|0|||
13169386|NCT02342288|26114103|FG001|Overall Study|subject cannot tolerate numbing drops|1|||
13169387|NCT02342288|26114102|FG000|Overall Study|coordinator not available|0|||
13169388|NCT02342288|26114103|FG001|Overall Study|coordinator not available|2|||
13169389|NCT02342223|26114114|FG000|Overall Study|Lost to Follow-up|1|||
13169390|NCT02342171|26114137|FG000|Overall Study|Death|4|||
13169391|NCT02342171|26114138|FG001|Overall Study|Death|87|||
13169392|NCT02342171|26114137|FG000|Overall Study|Received favipiravir|10|||
13169393|NCT02342171|26114138|FG001|Overall Study|Received favipiravir|0|||
13169394|NCT02342171|26114137|FG000|Overall Study|Missing cycle treshold value|1|||
13169395|NCT02342171|26114138|FG001|Overall Study|Missing cycle treshold value|0|||
13169396|NCT02342171|26114137|FG000|Overall Study|Unknown outcome|0|||
13169397|NCT02342171|26114138|FG001|Overall Study|Unknown outcome|1|||
13169398|NCT02342171|26114137|FG000|Overall Study|Missing age data|0|||
13169399|NCT02342171|26114138|FG001|Overall Study|Missing age data|1|||
13169400|NCT02341625|26114336|FG000|Overall Study|Disease Progression|2|||
13169401|NCT02341625|26114337|FG001|Overall Study|Disease Progression|2|||
13169402|NCT02341625|26114338|FG002|Overall Study|Disease Progression|3|||
13169403|NCT02341625|26114339|FG003|Overall Study|Disease Progression|6|||
13169404|NCT02341625|26114340|FG004|Overall Study|Disease Progression|7|||
13169405|NCT02341625|26114341|FG005|Overall Study|Disease Progression|7|||
13169406|NCT02341625|26114342|FG006|Overall Study|Disease Progression|28|||
13169407|NCT02341625|26114343|FG007|Overall Study|Disease Progression|5|||
13169408|NCT02341625|26114344|FG008|Overall Study|Disease Progression|4|||
13169409|NCT02341625|26114345|FG009|Overall Study|Disease Progression|19|||
13169410|NCT02341625|26114336|FG000|Overall Study|Study Drug Toxicity|0|||
13169411|NCT02341625|26114337|FG001|Overall Study|Study Drug Toxicity|0|||
13169412|NCT02341625|26114338|FG002|Overall Study|Study Drug Toxicity|0|||
13169413|NCT02341625|26114339|FG003|Overall Study|Study Drug Toxicity|1|||
13169414|NCT02341625|26114340|FG004|Overall Study|Study Drug Toxicity|0|||
13169415|NCT02341625|26114341|FG005|Overall Study|Study Drug Toxicity|3|||
13169416|NCT02341625|26114342|FG006|Overall Study|Study Drug Toxicity|10|||
13169417|NCT02341625|26114343|FG007|Overall Study|Study Drug Toxicity|0|||
13169418|NCT02341625|26114344|FG008|Overall Study|Study Drug Toxicity|0|||
13169419|NCT02341625|26114345|FG009|Overall Study|Study Drug Toxicity|3|||
13169420|NCT02341625|26114336|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0|||
13169421|NCT02341625|26114337|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
13169422|NCT02341625|26114338|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0|||
13169423|NCT02341625|26114339|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
13169424|NCT02341625|26114340|FG004|Overall Study|Adverse Event Unrelated to Study Drug|0|||
13169425|NCT02341625|26114341|FG005|Overall Study|Adverse Event Unrelated to Study Drug|0|||
13169426|NCT02341625|26114342|FG006|Overall Study|Adverse Event Unrelated to Study Drug|2|||
13169427|NCT02341625|26114343|FG007|Overall Study|Adverse Event Unrelated to Study Drug|1|||
13169428|NCT02341625|26114344|FG008|Overall Study|Adverse Event Unrelated to Study Drug|0|||
13169429|NCT02341625|26114345|FG009|Overall Study|Adverse Event Unrelated to Study Drug|2|||
13169430|NCT02341625|26114336|FG000|Overall Study|Participant Request to Discontinue Study Treatment|0|||
13169431|NCT02341625|26114337|FG001|Overall Study|Participant Request to Discontinue Study Treatment|0|||
13169432|NCT02341625|26114338|FG002|Overall Study|Participant Request to Discontinue Study Treatment|0|||
13169433|NCT02341625|26114339|FG003|Overall Study|Participant Request to Discontinue Study Treatment|0|||
13169434|NCT02341625|26114340|FG004|Overall Study|Participant Request to Discontinue Study Treatment|0|||
13169435|NCT02341625|26114341|FG005|Overall Study|Participant Request to Discontinue Study Treatment|0|||
13107653|NCT03274076|25888601|FG002|24 Weeks Open Label|Withdrawal by Subject|0|||
13107654|NCT03274076|25888602|FG003|24 Weeks Open Label|Withdrawal by Subject|1|||
13107655|NCT03273946|25888610|FG000|Overall Study|Withdrawal by Subject|5|||
13107656|NCT03273946|25888610|FG000|Overall Study|Unwillingness of the guardian|1|||
13107657|NCT03273946|25888610|FG000|Overall Study|Participant refused to use the drug|2|||
13107658|NCT03273946|25888610|FG000|Overall Study|Participant relative refused to use drug|1|||
13107659|NCT03273907|25888624|FG000|Overall Study|Death|1|||
13107660|NCT03273907|25888624|FG000|Overall Study|Lost to Follow-up|4|||
13107661|NCT03273907|25888624|FG000|Overall Study|Withdrawal by Subject|2|||
13107662|NCT03273907|25888624|FG000|Overall Study|COVID 19|2|||
13107663|NCT03273387|25888641|FG000|Overall Study|Death|2|||
13107664|NCT03273387|25888642|FG001|Overall Study|Death|2|||
13107665|NCT03273387|25888641|FG000|Overall Study|Withdrawal by Subject|1|||
13107666|NCT03273387|25888642|FG001|Overall Study|Withdrawal by Subject|1|||
13133188|NCT02777554|25986868|FG000|Overall Study|Discharged early due to hurricane|22|||
13133189|NCT02777554|25986869|FG001|Overall Study|Discharged early due to hurricane|20|||
13107667|NCT03273257|25888673|FG000|Overall Study|Death|0|||
13107668|NCT03273257|25888674|FG001|Overall Study|Death|1|||
13107669|NCT03273257|25888673|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
13107670|NCT03273257|25888674|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
13107671|NCT03273257|25888673|FG000|Overall Study|Study terminated|3|||
13107672|NCT03273257|25888674|FG001|Overall Study|Study terminated|2|||
13107673|NCT03273166|25888681|FG000|Overall Study|Withdrawn prior to Completion|31|||
13107674|NCT03273153|25888721|FG000|Overall Study|Adverse Event|1|||
13107675|NCT03273153|25888722|FG001|Overall Study|Adverse Event|2|||
13107676|NCT03273153|25888721|FG000|Overall Study|Missing|0|||
13107677|NCT03273153|25888722|FG001|Overall Study|Missing|2|||
13107678|NCT03273153|25888721|FG000|Overall Study|Other|3|||
13107679|NCT03273153|25888722|FG001|Overall Study|Other|2|||
13107680|NCT03273153|25888721|FG000|Overall Study|Symptomatic Deterioration|0|||
13107681|NCT03273153|25888722|FG001|Overall Study|Symptomatic Deterioration|1|||
13107682|NCT03273153|25888721|FG000|Overall Study|Progressive Disease|6|||
13107683|NCT03273153|25888722|FG001|Overall Study|Progressive Disease|5|||
13107684|NCT03273153|25888721|FG000|Overall Study|Physician Decision|1|||
13107685|NCT03273153|25888722|FG001|Overall Study|Physician Decision|3|||
13107686|NCT03273153|25888721|FG000|Overall Study|Study Terminated by Sponsor|112|||
13107687|NCT03273153|25888722|FG001|Overall Study|Study Terminated by Sponsor|102|||
13107688|NCT03273153|25888721|FG000|Overall Study|Withdrawal by Subject|26|||
13107689|NCT03273153|25888722|FG001|Overall Study|Withdrawal by Subject|25|||
13107690|NCT03273153|25888721|FG000|Overall Study|Protocol Deviation|3|||
13107691|NCT03273153|25888722|FG001|Overall Study|Protocol Deviation|0|||
13107692|NCT03273153|25888721|FG000|Overall Study|Lost to Follow-up|6|||
13107693|NCT03273153|25888722|FG001|Overall Study|Lost to Follow-up|11|||
13107694|NCT03273153|25888721|FG000|Overall Study|Death|66|||
13107695|NCT03273153|25888722|FG001|Overall Study|Death|69|||
13107696|NCT03272347|25888789|FG000|Overall Study|Death|0|||
13169436|NCT02341625|26114342|FG006|Overall Study|Participant Request to Discontinue Study Treatment|6|||
13169437|NCT02341625|26114343|FG007|Overall Study|Participant Request to Discontinue Study Treatment|2|||
13169438|NCT02341625|26114344|FG008|Overall Study|Participant Request to Discontinue Study Treatment|0|||
13169439|NCT02341625|26114345|FG009|Overall Study|Participant Request to Discontinue Study Treatment|0|||
13169440|NCT02341625|26114336|FG000|Overall Study|Participant Withdrew Consent|0|||
13169441|NCT02341625|26114337|FG001|Overall Study|Participant Withdrew Consent|0|||
13169442|NCT02341625|26114338|FG002|Overall Study|Participant Withdrew Consent|0|||
13169443|NCT02341625|26114339|FG003|Overall Study|Participant Withdrew Consent|1|||
13169444|NCT02341625|26114340|FG004|Overall Study|Participant Withdrew Consent|0|||
13169445|NCT02341625|26114341|FG005|Overall Study|Participant Withdrew Consent|0|||
13169446|NCT02341625|26114342|FG006|Overall Study|Participant Withdrew Consent|0|||
13169447|NCT02341625|26114343|FG007|Overall Study|Participant Withdrew Consent|0|||
13169448|NCT02341625|26114344|FG008|Overall Study|Participant Withdrew Consent|0|||
13169449|NCT02341625|26114345|FG009|Overall Study|Participant Withdrew Consent|0|||
13169450|NCT02341625|26114336|FG000|Overall Study|Completed Treatment as per Protocol|0|||
13169451|NCT02341625|26114337|FG001|Overall Study|Completed Treatment as per Protocol|0|||
13169452|NCT02341625|26114338|FG002|Overall Study|Completed Treatment as per Protocol|0|||
13169453|NCT02341625|26114339|FG003|Overall Study|Completed Treatment as per Protocol|0|||
13169454|NCT02341625|26114340|FG004|Overall Study|Completed Treatment as per Protocol|0|||
13169455|NCT02341625|26114341|FG005|Overall Study|Completed Treatment as per Protocol|0|||
13169456|NCT02341625|26114342|FG006|Overall Study|Completed Treatment as per Protocol|0|||
13169457|NCT02341625|26114343|FG007|Overall Study|Completed Treatment as per Protocol|0|||
13169458|NCT02341625|26114344|FG008|Overall Study|Completed Treatment as per Protocol|0|||
13169459|NCT02341625|26114345|FG009|Overall Study|Completed Treatment as per Protocol|1|||
13169460|NCT02341625|26114336|FG000|Overall Study|Other Reasons|0|||
13169461|NCT02341625|26114337|FG001|Overall Study|Other Reasons|0|||
13169462|NCT02341625|26114338|FG002|Overall Study|Other Reasons|0|||
13169463|NCT02341625|26114339|FG003|Overall Study|Other Reasons|0|||
13169464|NCT02341625|26114340|FG004|Overall Study|Other Reasons|1|||
13169465|NCT02341625|26114341|FG005|Overall Study|Other Reasons|0|||
13169466|NCT02341625|26114342|FG006|Overall Study|Other Reasons|5|||
13169467|NCT02341625|26114343|FG007|Overall Study|Other Reasons|0|||
13169468|NCT02341625|26114344|FG008|Overall Study|Other Reasons|0|||
13169469|NCT02341625|26114345|FG009|Overall Study|Other Reasons|2|||
13169470|NCT02341625|26114336|FG000|Overall Study|Not Reported|0|||
13169471|NCT02341625|26114337|FG001|Overall Study|Not Reported|0|||
13169472|NCT02341625|26114338|FG002|Overall Study|Not Reported|0|||
13169473|NCT02341625|26114339|FG003|Overall Study|Not Reported|0|||
13169474|NCT02341625|26114340|FG004|Overall Study|Not Reported|0|||
13169475|NCT02341625|26114341|FG005|Overall Study|Not Reported|0|||
13169476|NCT02341625|26114342|FG006|Overall Study|Not Reported|0|||
13107697|NCT03272347|25888790|FG001|Overall Study|Death|0|||
13107698|NCT03272347|25888791|FG002|Overall Study|Death|0|||
13107699|NCT03272347|25888792|FG003|Overall Study|Death|1|||
13107700|NCT03272347|25888789|FG000|Overall Study|Lost to Follow-up|1|||
13107701|NCT03272347|25888790|FG001|Overall Study|Lost to Follow-up|0|||
13169477|NCT02341625|26114343|FG007|Overall Study|Not Reported|0|||
13169478|NCT02341625|26114344|FG008|Overall Study|Not Reported|0|||
13169479|NCT02341625|26114345|FG009|Overall Study|Not Reported|3|||
13169480|NCT02341482|26114373|FG000|Overall Study|Adverse Event|1|||
13169481|NCT02341456|26114505|FG000|Overall Study|Disease progression|2|||
13169482|NCT02341456|26114506|FG001|Overall Study|Disease progression|3|||
13169483|NCT02341456|26114507|FG002|Overall Study|Disease progression|1|||
13169484|NCT02341456|26114505|FG000|Overall Study|Death|1|||
13169485|NCT02341456|26114506|FG001|Overall Study|Death|1|||
13169486|NCT02341456|26114507|FG002|Overall Study|Death|1|||
13169487|NCT02341456|26114505|FG000|Overall Study|Withdrawal by Subject|0|||
13169488|NCT02341456|26114506|FG001|Overall Study|Withdrawal by Subject|1|||
13169489|NCT02341456|26114507|FG002|Overall Study|Withdrawal by Subject|1|||
13169490|NCT02341456|26114505|FG000|Overall Study|Moved to local access programme.|0|||
13169491|NCT02341456|26114506|FG001|Overall Study|Moved to local access programme.|1|||
13169492|NCT02341456|26114507|FG002|Overall Study|Moved to local access programme.|1|||
13169493|NCT02341456|26114505|FG000|Overall Study|Physician Decision|1|||
13169494|NCT02341456|26114506|FG001|Overall Study|Physician Decision|0|||
13169495|NCT02341456|26114507|FG002|Overall Study|Physician Decision|0|||
13169496|NCT02341417|26114559|FG000|Overall Study|Withdrawal by Subject|0|||
13169497|NCT02341417|26114560|FG001|Overall Study|Withdrawal by Subject|2|||
13169498|NCT02341417|26114561|FG002|Overall Study|Withdrawal by Subject|0|||
13169499|NCT02341417|26114559|FG000|Overall Study|Decision by sponsor|2|||
13169500|NCT02341417|26114560|FG001|Overall Study|Decision by sponsor|0|||
13169501|NCT02341417|26114561|FG002|Overall Study|Decision by sponsor|0|||
13169502|NCT02341417|26114559|FG000|Overall Study|Death|0|||
13169503|NCT02341417|26114560|FG001|Overall Study|Death|0|||
13169504|NCT02341417|26114561|FG002|Overall Study|Death|1|||
13169505|NCT02340975|26114692|FG000|Overall Study|Death|6|||
13169506|NCT02340975|26114693|FG001|Overall Study|Death|23|||
13169507|NCT02340975|26114694|FG002|Overall Study|Death|21|||
13169508|NCT02340975|26114695|FG003|Overall Study|Death|7|||
13169509|NCT02340975|26114696|FG004|Overall Study|Death|21|||
13169510|NCT02340975|26114697|FG005|Overall Study|Death|13|||
13169511|NCT02340975|26114692|FG000|Overall Study|Lost to Follow-up|0|||
13169512|NCT02340975|26114693|FG001|Overall Study|Lost to Follow-up|0|||
13169513|NCT02340975|26114694|FG002|Overall Study|Lost to Follow-up|0|||
13169514|NCT02340975|26114695|FG003|Overall Study|Lost to Follow-up|0|||
13169515|NCT02340975|26114696|FG004|Overall Study|Lost to Follow-up|2|||
13169516|NCT02340975|26114697|FG005|Overall Study|Lost to Follow-up|0|||
13169517|NCT02340975|26114692|FG000|Overall Study|Withdrawal by Subject|0|||
13169518|NCT02340975|26114693|FG001|Overall Study|Withdrawal by Subject|0|||
13169519|NCT02340975|26114694|FG002|Overall Study|Withdrawal by Subject|3|||
13169520|NCT02340975|26114695|FG003|Overall Study|Withdrawal by Subject|3|||
13169521|NCT02340975|26114696|FG004|Overall Study|Withdrawal by Subject|2|||
13169522|NCT02340975|26114697|FG005|Overall Study|Withdrawal by Subject|0|||
13169523|NCT02340975|26114692|FG000|Overall Study|Other|0|||
13169524|NCT02340975|26114693|FG001|Overall Study|Other|4|||
13169525|NCT02340975|26114694|FG002|Overall Study|Other|0|||
13169526|NCT02340975|26114695|FG003|Overall Study|Other|2|||
13169527|NCT02340975|26114696|FG004|Overall Study|Other|0|||
13169528|NCT02340975|26114697|FG005|Overall Study|Other|6|||
13169529|NCT02340962|26114724|FG000|Overall Study|Lost to Follow-up|1|||
13169530|NCT02340962|26114725|FG001|Overall Study|Lost to Follow-up|0|||
13205558|NCT01964352|26232185|FG000|Overall Study|Withdrawal by Subject|4|||
13205559|NCT01964352|26232186|FG001|Overall Study|Withdrawal by Subject|2|||
13205560|NCT01964352|26232187|FG002|Overall Study|Withdrawal by Subject|1|||
13205561|NCT01964352|26232188|FG003|Overall Study|Withdrawal by Subject|0|||
13205562|NCT01964352|26232185|FG000|Overall Study|Other than stated above|0|||
13205563|NCT01964352|26232186|FG001|Overall Study|Other than stated above|2|||
13205564|NCT01964352|26232187|FG002|Overall Study|Other than stated above|1|||
13205565|NCT01964352|26232188|FG003|Overall Study|Other than stated above|2|||
13205566|NCT01964326|26232197|FG000|Overall Study|Adverse Event|48|||
13205567|NCT01964326|26232197|FG000|Overall Study|Death|2|||
13205568|NCT01964326|26232197|FG000|Overall Study|Protocol Violation|4|||
13205569|NCT01964326|26232197|FG000|Overall Study|Lost to Follow-up|88|||
13205570|NCT01964326|26232197|FG000|Overall Study|Withdrawal by Subject|87|||
13205571|NCT01964326|26232197|FG000|Overall Study|Pregnancy|1|||
13205572|NCT01964326|26232197|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
13205573|NCT01964326|26232197|FG000|Overall Study|Physician Decision|55|||
13205574|NCT01964326|26232197|FG000|Overall Study|Investigator Discretion|1|||
13205575|NCT01964326|26232197|FG000|Overall Study|Other|9|||
13205576|NCT01964326|26232197|FG000|Overall Study|Did not meet eligibility criteria|1|||
13205577|NCT01964300|26232216|FG000|Overall Study|Ineligible after enrollment|0|||
13222914|NCT01802281|26287209|FG000|Overall Study|Ineligible|5|||
13205578|NCT01964300|26232217|FG001|Overall Study|Ineligible after enrollment|1|||
13205579|NCT01964300|26232216|FG000|Overall Study|Adverse Event|1|||
13205580|NCT01964300|26232217|FG001|Overall Study|Adverse Event|1|||
13205581|NCT01964300|26232216|FG000|Overall Study|Lack of Efficacy|3|||
13205582|NCT01964300|26232217|FG001|Overall Study|Lack of Efficacy|5|||
13169531|NCT02340949|26114748|FG000|Overall Study|Adverse Event|4|||
13169532|NCT02340949|26114749|FG001|Overall Study|Adverse Event|2|||
13169533|NCT02340949|26114748|FG000|Overall Study|Withdrawal by Subject|2|||
13169534|NCT02340949|26114749|FG001|Overall Study|Withdrawal by Subject|0|||
13169535|NCT02340949|26114748|FG000|Overall Study|Progression disease|6|||
13169536|NCT02340949|26114749|FG001|Overall Study|Progression disease|2|||
13169537|NCT02340949|26114748|FG000|Overall Study|Death|3|||
13169538|NCT02340949|26114749|FG001|Overall Study|Death|0|||
13169539|NCT02340949|26114748|FG000|Overall Study|Physician Decision|1|||
13169540|NCT02340949|26114749|FG001|Overall Study|Physician Decision|0|||
13169541|NCT02340819|26114778|FG000|Overall Study|Adverse Event|1|||
13169542|NCT02340819|26114778|FG000|Overall Study|Withdrawal by Subject|2|||
13169543|NCT02340819|26114778|FG000|Overall Study|Discontinued with other reason|1|||
13169544|NCT02340806|26114811|FG000|Overall Study|Protocol Violation|2|||
13169545|NCT02340806|26114812|FG001|Overall Study|Protocol Violation|0|||
13169546|NCT02340806|26114811|FG000|Overall Study|epidural catheter replaced|2|||
13169547|NCT02340806|26114812|FG001|Overall Study|epidural catheter replaced|1|||
13169548|NCT02340806|26114811|FG000|Overall Study|history of chronic pain medication|1|||
13169549|NCT02340806|26114812|FG001|Overall Study|history of chronic pain medication|0|||
13169550|NCT02340806|26114811|FG000|Overall Study|re-dose < 90 min of CSE|1|||
13169551|NCT02340806|26114812|FG001|Overall Study|re-dose < 90 min of CSE|3|||
13169552|NCT02340780|26114819|FG000|Overall Study|Ineligible|1|||
13169553|NCT02340663|26114882|FG000|Overall Study|Lost to Follow-up|1|||
13169554|NCT02340663|26114883|FG001|Overall Study|Lost to Follow-up|0|||
13169555|NCT02340663|26114882|FG000|Overall Study|Protocol Violation|1|||
13169556|NCT02340663|26114883|FG001|Overall Study|Protocol Violation|0|||
13169557|NCT02340663|26114882|FG000|Overall Study|Withdrawal by Subject|3|||
13169558|NCT02340663|26114883|FG001|Overall Study|Withdrawal by Subject|1|||
13169559|NCT02340520|26114890|FG000|Overall Study|Lost to Follow-up|1|||
13169560|NCT02340520|26114890|FG000|Overall Study|Patient did not take drug as specified|1|||
13169561|NCT02340520|26114890|FG000|Overall Study|Withdrawal by Subject|1|||
13169562|NCT02340221|26114935|FG000|Overall Study|Death|100|||
13169563|NCT02340221|26114936|FG001|Overall Study|Death|197|||
13169564|NCT02340221|26114935|FG000|Overall Study|Withdrawal by Participant|24|||
13169565|NCT02340221|26114936|FG001|Overall Study|Withdrawal by Participant|37|||
13169566|NCT02340221|26114935|FG000|Overall Study|Lost to Follow-up|4|||
13169567|NCT02340221|26114936|FG001|Overall Study|Lost to Follow-up|15|||
13169568|NCT02340221|26114935|FG000|Overall Study|Reason Not Specified|85|||
13169569|NCT02340221|26114936|FG001|Overall Study|Reason Not Specified|165|||
13169570|NCT02340221|26114935|FG000|Overall Study|Study Terminated by Sponsor|1|||
13169571|NCT02340221|26114936|FG001|Overall Study|Study Terminated by Sponsor|3|||
13169572|NCT02340078|26114943|FG000|Overall Study|Protocol Violation|1|||
13169573|NCT02340000|26114977|FG000|Time Period 1|Withdrawal by Subject|6|||
13169574|NCT02340000|26114978|FG001|Time Period 1|Withdrawal by Subject|8|||
13169575|NCT02340000|26114977|FG000|Time Period 1|Lost to Follow-up|6|||
13169576|NCT02340000|26114978|FG001|Time Period 1|Lost to Follow-up|7|||
13169577|NCT02340000|26114977|FG000|Time Period 2|Withdrawal by Subject|9|||
13169578|NCT02340000|26114978|FG001|Time Period 2|Withdrawal by Subject|7|||
13169579|NCT02340000|26114977|FG000|Time Period 2|Lost to Follow-up|10|||
13169580|NCT02340000|26114978|FG001|Time Period 2|Lost to Follow-up|8|||
13169581|NCT02339909|26114999|FG000|Overall Study|Became ineligible after randomisation|89|||
13169582|NCT02339909|26115000|FG001|Overall Study|Became ineligible after randomisation|63|||
13169583|NCT02339909|26115001|FG002|Overall Study|Became ineligible after randomisation|71|||
13169584|NCT02339584|26115014|FG000|Overall Study|Adverse Event|11|||
13169585|NCT02339584|26115015|FG001|Overall Study|Adverse Event|7|||
13169586|NCT02339584|26115014|FG000|Overall Study|Lack of Efficacy|0|||
13169587|NCT02339584|26115015|FG001|Overall Study|Lack of Efficacy|1|||
13169588|NCT02339584|26115014|FG000|Overall Study|Physician Decision|1|||
13169589|NCT02339584|26115015|FG001|Overall Study|Physician Decision|2|||
13169590|NCT02339584|26115014|FG000|Overall Study|Protocol Violation|1|||
13169591|NCT02339584|26115015|FG001|Overall Study|Protocol Violation|1|||
13169592|NCT02339584|26115014|FG000|Overall Study|Withdrawal by Subject|2|||
13169593|NCT02339584|26115015|FG001|Overall Study|Withdrawal by Subject|4|||
13169594|NCT02339506|26115026|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0|||
13169595|NCT02339506|26115027|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1|||
13169596|NCT02339506|26115026|FG000|Washout (Period 2)|Withdrawal by Subject|2|||
13169597|NCT02339506|26115027|FG001|Washout (Period 2)|Withdrawal by Subject|0|||
13169598|NCT02339285|26115063|FG000|Overall Study|Withdrawal by Subject|0|||
13169599|NCT02339285|26115064|FG001|Overall Study|Withdrawal by Subject|1|||
13169600|NCT02339285|26115065|FG002|Overall Study|Withdrawal by Subject|1|||
13169601|NCT02339285|26115063|FG000|Overall Study|Lost to Follow-up|1|||
13169602|NCT02339285|26115064|FG001|Overall Study|Lost to Follow-up|1|||
13169603|NCT02339285|26115065|FG002|Overall Study|Lost to Follow-up|1|||
13169604|NCT02339285|26115063|FG000|Overall Study|Protocol Deviation|0|||
13169605|NCT02339285|26115064|FG001|Overall Study|Protocol Deviation|1|||
13169606|NCT02339285|26115065|FG002|Overall Study|Protocol Deviation|0|||
13169607|NCT02339155|26115099|FG000|Overall Study|Adverse Event|0|||
13169608|NCT02339155|26115100|FG001|Overall Study|Adverse Event|6|||
13169609|NCT02339155|26115099|FG000|Overall Study|Death|1|||
13169610|NCT02339155|26115100|FG001|Overall Study|Death|1|||
13169611|NCT02339155|26115099|FG000|Overall Study|Lost to Follow-up|8|||
13169612|NCT02339155|26115100|FG001|Overall Study|Lost to Follow-up|9|||
13169613|NCT02339155|26115099|FG000|Overall Study|Physician Decision|2|||
13169614|NCT02339155|26115100|FG001|Overall Study|Physician Decision|1|||
13169615|NCT02339155|26115099|FG000|Overall Study|Withdrawal by Subject|4|||
13169616|NCT02339155|26115100|FG001|Overall Study|Withdrawal by Subject|4|||
13169617|NCT02338999|26115129|FG000|First Intervention|Withdrawal by Subject|3|||
13169618|NCT02338999|26115130|FG001|First Intervention|Withdrawal by Subject|1|||
13169619|NCT02338999|26115129|FG000|Washout Period|Withdrawal by Subject|0|||
13169620|NCT02338999|26115130|FG001|Washout Period|Withdrawal by Subject|2|||
13169621|NCT02338999|26115129|FG000|Second Intervention|Withdrawal by Subject|0|||
13169622|NCT02338999|26115130|FG001|Second Intervention|Withdrawal by Subject|2|||
13169623|NCT02338882|26115173|FG000|Overall Study|Death|1|||
13169624|NCT02338882|26115174|FG001|Overall Study|Death|0|||
13169625|NCT02338882|26115173|FG000|Overall Study|Lost to Follow-up|6|||
13169626|NCT02338882|26115174|FG001|Overall Study|Lost to Follow-up|3|||
13169627|NCT02338843|26115187|FG000|Overall Study|Adverse Event|2|||
13169628|NCT02338843|26115188|FG001|Overall Study|Adverse Event|1|||
13169629|NCT02338843|26115187|FG000|Overall Study|Death|40|||
13169630|NCT02338843|26115188|FG001|Overall Study|Death|53|||
13169631|NCT02338843|26115187|FG000|Overall Study|Physician Decision|1|||
13169632|NCT02338843|26115188|FG001|Overall Study|Physician Decision|0|||
13169633|NCT02338843|26115187|FG000|Overall Study|Withdrawal by Subject|0|||
13169634|NCT02338843|26115188|FG001|Overall Study|Withdrawal by Subject|2|||
13169635|NCT02338843|26115187|FG000|Overall Study|Subject Recovered|0|||
13169636|NCT02338843|26115188|FG001|Overall Study|Subject Recovered|2|||
13169637|NCT02338843|26115187|FG000|Overall Study|Discontinued prior to randomizat|1|||
13169638|NCT02338843|26115188|FG001|Overall Study|Discontinued prior to randomizat|0|||
13169639|NCT02338492|26115204|FG000|Overall Study|Death|32|||
13169640|NCT02338492|26115204|FG000|Overall Study|Adverse Event|3|||
13169641|NCT02338492|26115204|FG000|Overall Study|Lost to Follow-up|4|||
13169642|NCT02338492|26115204|FG000|Overall Study|Reason not captured above|6|||
13169643|NCT02338362|26115225|FG000|Overall Study|Withdrawal by Subject|1|||
13169644|NCT02338362|26115226|FG001|Overall Study|Withdrawal by Subject|1|||
13169645|NCT02338193|26115289|FG000|Overall Study|Withdrawal by Subject|0|||
13169646|NCT02338193|26115290|FG001|Overall Study|Withdrawal by Subject|0|||
13169647|NCT02338193|26115291|FG002|Overall Study|Withdrawal by Subject|2|||
13169648|NCT02338193|26115289|FG000|Overall Study|Pregnancy|0|||
13169649|NCT02338193|26115290|FG001|Overall Study|Pregnancy|1|||
13169650|NCT02338193|26115291|FG002|Overall Study|Pregnancy|1|||
13169651|NCT02338193|26115289|FG000|Overall Study|Noncompliant with visits|2|||
13169652|NCT02338193|26115290|FG001|Overall Study|Noncompliant with visits|2|||
13169653|NCT02338193|26115291|FG002|Overall Study|Noncompliant with visits|7|||
13169654|NCT02338193|26115289|FG000|Overall Study|moved out of state|0|||
13169655|NCT02338193|26115290|FG001|Overall Study|moved out of state|1|||
13169656|NCT02338193|26115291|FG002|Overall Study|moved out of state|0|||
13169657|NCT02338193|26115289|FG000|Overall Study|intolerant of side effects|1|||
13169658|NCT02338193|26115290|FG001|Overall Study|intolerant of side effects|0|||
13169659|NCT02338193|26115291|FG002|Overall Study|intolerant of side effects|0|||
13169660|NCT02338154|26115389|FG000|Overall Study|Death|46|||
13169661|NCT02338154|26115389|FG000|Overall Study|Valve Implant Failure|17|||
13169662|NCT02338154|26115389|FG000|Overall Study|Valve Explant|11|||
13169663|NCT02338154|26115389|FG000|Overall Study|Withdrawal by Subject or by Investigator|10|||
13169664|NCT02338154|26115389|FG000|Overall Study|Lost to Follow-up|8|||
13169665|NCT02338154|26115389|FG000|Overall Study|Other Reason|3|||
13169666|NCT02338154|26115389|FG000|Overall Study|Patients Without Exit Form|47|||
13169667|NCT02338154|26115389|FG000|Overall Study|Missing Exit Reason on Exit Form|1|||
13169668|NCT02337946|26115415|FG000|Protocol Treatment 1 Period|Adverse Event|7|||
13169669|NCT02337946|26115416|FG001|Protocol Treatment 1 Period|Adverse Event|0|||
13169670|NCT02337946|26115417|FG002|Protocol Treatment 1 Period|Adverse Event|0|||
13169671|NCT02337946|26115415|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1|||
13169672|NCT02337946|26115416|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
13169673|NCT02337946|26115417|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
13169674|NCT02337946|26115415|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6|||
13169675|NCT02337946|26115416|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
13169676|NCT02337946|26115417|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
13169677|NCT02337946|26115415|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15|||
13169678|NCT02337946|26115416|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0|||
13169679|NCT02337946|26115417|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0|||
13169680|NCT02337946|26115415|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3|||
13169681|NCT02337946|26115416|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
13169682|NCT02337946|26115417|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
13169683|NCT02337946|26115415|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9|||
13169684|NCT02337946|26115416|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
13169685|NCT02337946|26115417|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
13169686|NCT02337946|26115415|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1|||
13169687|NCT02337946|26115416|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
13169688|NCT02337946|26115417|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
13169689|NCT02337946|26115415|FG000|Protocol Treatment 1 Period|Reason not specified|8|||
13169690|NCT02337946|26115416|FG001|Protocol Treatment 1 Period|Reason not specified|0|||
13169691|NCT02337946|26115417|FG002|Protocol Treatment 1 Period|Reason not specified|0|||
13169692|NCT02337946|26115415|FG000|In-between Period|Without Informed Consent|1|||
13169693|NCT02337946|26115416|FG001|In-between Period|Without Informed Consent|0|||
13169694|NCT02337946|26115417|FG002|In-between Period|Without Informed Consent|0|||
13169695|NCT02337946|26115415|FG000|Protocol Treatment 2 Period|Adverse Event|0|||
13169696|NCT02337946|26115416|FG001|Protocol Treatment 2 Period|Adverse Event|9|||
13169697|NCT02337946|26115417|FG002|Protocol Treatment 2 Period|Adverse Event|9|||
13169698|NCT02337946|26115415|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0|||
13169699|NCT02337946|26115416|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3|||
13169700|NCT02337946|26115417|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1|||
13169701|NCT02337946|26115415|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0|||
13169702|NCT02337946|26115416|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29|||
13169703|NCT02337946|26115417|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29|||
13169704|NCT02337946|26115415|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
13169705|NCT02337946|26115416|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1|||
13169706|NCT02337946|26115417|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
13169707|NCT02337946|26115415|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0|||
13169708|NCT02337946|26115416|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5|||
13169709|NCT02337946|26115417|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7|||
13169710|NCT02337946|26115415|FG000|Protocol Treatment 2 Period|Reason not specified|0|||
13169711|NCT02337946|26115416|FG001|Protocol Treatment 2 Period|Reason not specified|4|||
13169712|NCT02337946|26115417|FG002|Protocol Treatment 2 Period|Reason not specified|4|||
13169713|NCT02337907|26115471|FG000|Overall Study|Other than listed|1|||
13169714|NCT02337907|26115472|FG001|Overall Study|Other than listed|0|||
13169715|NCT02337907|26115473|FG002|Overall Study|Other than listed|0|||
13169716|NCT02337907|26115474|FG003|Overall Study|Other than listed|1|||
13169717|NCT02337907|26115475|FG004|Overall Study|Other than listed|1|||
13169718|NCT02337907|26115476|FG005|Overall Study|Other than listed|0|||
13169719|NCT02337907|26115471|FG000|Overall Study|Withdrawal by Subject|2|||
13169720|NCT02337907|26115472|FG001|Overall Study|Withdrawal by Subject|3|||
13169721|NCT02337907|26115473|FG002|Overall Study|Withdrawal by Subject|0|||
13169722|NCT02337907|26115474|FG003|Overall Study|Withdrawal by Subject|2|||
13169723|NCT02337907|26115475|FG004|Overall Study|Withdrawal by Subject|5|||
13169724|NCT02337907|26115476|FG005|Overall Study|Withdrawal by Subject|0|||
13169725|NCT02337907|26115471|FG000|Overall Study|Lost to Follow-up|0|||
13169726|NCT02337907|26115472|FG001|Overall Study|Lost to Follow-up|0|||
13169727|NCT02337907|26115473|FG002|Overall Study|Lost to Follow-up|0|||
13169728|NCT02337907|26115474|FG003|Overall Study|Lost to Follow-up|0|||
13169729|NCT02337907|26115475|FG004|Overall Study|Lost to Follow-up|0|||
13169730|NCT02337907|26115476|FG005|Overall Study|Lost to Follow-up|1|||
13169731|NCT02337907|26115471|FG000|Overall Study|Adverse Event|1|||
13169732|NCT02337907|26115472|FG001|Overall Study|Adverse Event|1|||
13169733|NCT02337907|26115473|FG002|Overall Study|Adverse Event|1|||
13169734|NCT02337907|26115474|FG003|Overall Study|Adverse Event|1|||
13169735|NCT02337907|26115475|FG004|Overall Study|Adverse Event|4|||
13169736|NCT02337907|26115476|FG005|Overall Study|Adverse Event|0|||
13169737|NCT02337764|26115489|FG000|Overall Study|Pretreatment Event/Adverse Event|46|||
13169738|NCT02337764|26115489|FG000|Overall Study|Voluntary Withdrawal|12|||
13169739|NCT02337764|26115489|FG000|Overall Study|Lack of Efficacy|2|||
13169740|NCT02337751|26115512|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
13169741|NCT02337751|26115513|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
13169742|NCT02337751|26115512|FG000|Overall Study|Voluntary Withdrawal|6|||
13169743|NCT02337751|26115513|FG001|Overall Study|Voluntary Withdrawal|8|||
13169744|NCT02337751|26115512|FG000|Overall Study|Lack of Efficacy|2|||
13169745|NCT02337751|26115513|FG001|Overall Study|Lack of Efficacy|5|||
13169746|NCT02337751|26115512|FG000|Overall Study|Investigator's Judgement|1|||
13169747|NCT02337751|26115513|FG001|Overall Study|Investigator's Judgement|0|||
13169748|NCT02337738|26115561|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
13169749|NCT02337738|26115562|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1|||
13169750|NCT02337738|26115563|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
13169751|NCT02337738|26115561|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
13169752|NCT02337738|26115562|FG001|Overall Study|Pretreatment Event/Adverse Event|18|||
13169753|NCT02337738|26115563|FG002|Overall Study|Pretreatment Event/Adverse Event|21|||
13169754|NCT02337738|26115561|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
13169755|NCT02337738|26115562|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1|||
13169756|NCT02337738|26115563|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
13169757|NCT02337738|26115561|FG000|Overall Study|Voluntary Withdrawal|10|||
13169758|NCT02337738|26115562|FG001|Overall Study|Voluntary Withdrawal|5|||
13169759|NCT02337738|26115563|FG002|Overall Study|Voluntary Withdrawal|2|||
13107702|NCT03272347|25888791|FG002|Overall Study|Lost to Follow-up|5|||
13107703|NCT03272347|25888792|FG003|Overall Study|Lost to Follow-up|1|||
13107704|NCT03272347|25888789|FG000|Overall Study|Physician Decision|4|||
13107705|NCT03272347|25888790|FG001|Overall Study|Physician Decision|2|||
13107706|NCT03272347|25888791|FG002|Overall Study|Physician Decision|5|||
13107707|NCT03272347|25888792|FG003|Overall Study|Physician Decision|4|||
13107708|NCT03272347|25888789|FG000|Overall Study|Screen Failure|1|||
13107709|NCT03272347|25888790|FG001|Overall Study|Screen Failure|0|||
13107710|NCT03272347|25888791|FG002|Overall Study|Screen Failure|0|||
13169760|NCT02337738|26115561|FG000|Overall Study|Lack of Efficacy|2|||
13169761|NCT02337738|26115562|FG001|Overall Study|Lack of Efficacy|4|||
13169762|NCT02337738|26115563|FG002|Overall Study|Lack of Efficacy|0|||
13169763|NCT02337738|26115561|FG000|Overall Study|Investigator's Judgment|1|||
13169764|NCT02337738|26115562|FG001|Overall Study|Investigator's Judgment|1|||
13169765|NCT02337738|26115563|FG002|Overall Study|Investigator's Judgment|3|||
13169766|NCT02337725|26115592|FG000|Overall Study|Pretreatment Event/AE before Treatment|0|||
13169767|NCT02337725|26115593|FG001|Overall Study|Pretreatment Event/AE before Treatment|1|||
13169768|NCT02337725|26115592|FG000|Overall Study|Pretreatment Event/AE in Treatment|8|||
13169769|NCT02337725|26115593|FG001|Overall Study|Pretreatment Event/AE in Treatment|3|||
13169770|NCT02337725|26115592|FG000|Overall Study|Major Protocol Deviation|0|||
13169771|NCT02337725|26115593|FG001|Overall Study|Major Protocol Deviation|1|||
13169772|NCT02337725|26115592|FG000|Overall Study|Voluntary Withdrawal|14|||
13169773|NCT02337725|26115593|FG001|Overall Study|Voluntary Withdrawal|3|||
13169774|NCT02337725|26115592|FG000|Overall Study|Lack of Efficacy|4|||
13169775|NCT02337725|26115593|FG001|Overall Study|Lack of Efficacy|0|||
13169776|NCT02337491|26115614|FG000|Overall Study|Death|1|||
13169777|NCT02337491|26115615|FG001|Overall Study|Death|1|||
13169778|NCT02337491|26115614|FG000|Overall Study|Adverse Event|0|||
13169779|NCT02337491|26115615|FG001|Overall Study|Adverse Event|1|||
13169780|NCT02337491|26115614|FG000|Overall Study|Withdrawal by Subject|3|||
13169781|NCT02337491|26115615|FG001|Overall Study|Withdrawal by Subject|0|||
13169782|NCT02337491|26115614|FG000|Overall Study|Progressive Disease|44|||
13169783|NCT02337491|26115615|FG001|Overall Study|Progressive Disease|28|||
13169784|NCT02337491|26115614|FG000|Overall Study|On Treatment|2|||
13169785|NCT02337491|26115615|FG001|Overall Study|On Treatment|0|||
13169786|NCT02337478|26115623|FG000|Overall Study|Lack of Efficacy|5|||
13169787|NCT02337387|26115652|FG000|Overall Study|Adverse Event|0|||
13169788|NCT02337387|26115653|FG001|Overall Study|Adverse Event|1|||
13169789|NCT02337387|26115654|FG002|Overall Study|Adverse Event|0|||
13169790|NCT02337387|26115655|FG003|Overall Study|Adverse Event|0|||
13169791|NCT02337387|26115652|FG000|Overall Study|Sponsor Decision to Terminate Study|14|||
13169792|NCT02337387|26115653|FG001|Overall Study|Sponsor Decision to Terminate Study|7|||
13169793|NCT02337387|26115654|FG002|Overall Study|Sponsor Decision to Terminate Study|3|||
13169794|NCT02337387|26115655|FG003|Overall Study|Sponsor Decision to Terminate Study|3|||
13169795|NCT02337361|26115680|FG000|3-month Follow-up|Lost to Follow-up|19|||
13169796|NCT02337361|26115681|FG001|3-month Follow-up|Lost to Follow-up|14|||
13169797|NCT02337361|26115680|FG000|6-month Follow-up|Lost to Follow-up|2|||
13169798|NCT02337361|26115681|FG001|6-month Follow-up|Lost to Follow-up|4|||
13169799|NCT02336737|26115690|FG000|Overall Study|Withdrawal by Subject|5|||
13169800|NCT02336737|26115690|FG000|Overall Study|Physician Decision|8|||
13169801|NCT02336607|26115757|FG000|Overall Study|Physician Decision|1|||
13169802|NCT02336607|26115758|FG001|Overall Study|Physician Decision|4|||
13169803|NCT02336607|26115759|FG002|Overall Study|Physician Decision|3|||
13169804|NCT02336607|26115760|FG003|Overall Study|Physician Decision|15|||
13169805|NCT02336607|26115757|FG000|Overall Study|Lack of Efficacy|1|||
13169806|NCT02336607|26115758|FG001|Overall Study|Lack of Efficacy|0|||
13169807|NCT02336607|26115759|FG002|Overall Study|Lack of Efficacy|0|||
13169808|NCT02336607|26115760|FG003|Overall Study|Lack of Efficacy|2|||
13169809|NCT02336607|26115757|FG000|Overall Study|Lost to Follow-up|2|||
13169810|NCT02336607|26115758|FG001|Overall Study|Lost to Follow-up|1|||
13169811|NCT02336607|26115759|FG002|Overall Study|Lost to Follow-up|0|||
13169812|NCT02336607|26115760|FG003|Overall Study|Lost to Follow-up|21|||
13169813|NCT02336607|26115757|FG000|Overall Study|Protocol Violation|0|||
13169814|NCT02336607|26115758|FG001|Overall Study|Protocol Violation|1|||
13169815|NCT02336607|26115759|FG002|Overall Study|Protocol Violation|1|||
13169816|NCT02336607|26115760|FG003|Overall Study|Protocol Violation|3|||
13169817|NCT02336607|26115757|FG000|Overall Study|Adverse Event|0|||
13169818|NCT02336607|26115758|FG001|Overall Study|Adverse Event|2|||
13169819|NCT02336607|26115759|FG002|Overall Study|Adverse Event|2|||
13169820|NCT02336607|26115760|FG003|Overall Study|Adverse Event|26|||
13169821|NCT02336607|26115757|FG000|Overall Study|Withdrawal by Subject|0|||
13169822|NCT02336607|26115758|FG001|Overall Study|Withdrawal by Subject|2|||
13169823|NCT02336607|26115759|FG002|Overall Study|Withdrawal by Subject|0|||
13107711|NCT03272347|25888792|FG003|Overall Study|Screen Failure|0|||
13107712|NCT03272347|25888789|FG000|Overall Study|Withdrawal by Subject|3|||
13169824|NCT02336607|26115760|FG003|Overall Study|Withdrawal by Subject|20|||
13169825|NCT02336555|26115775|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
13169826|NCT02336555|26115776|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
13169827|NCT02336555|26115775|FG000|Treatment Period 1 (28 Days)|Physician Decision|2|||
13169828|NCT02336555|26115776|FG001|Treatment Period 1 (28 Days)|Physician Decision|0|||
13169829|NCT02336555|26115775|FG000|Treatment Period 2 (28 Days)|Adverse Event|0|||
13169830|NCT02336555|26115776|FG001|Treatment Period 2 (28 Days)|Adverse Event|1|||
13169831|NCT02336451|26115936|FG000|Overall Study|Adverse Event|1|||
13169832|NCT02336451|26115937|FG001|Overall Study|Adverse Event|2|||
13169833|NCT02336451|26115938|FG002|Overall Study|Adverse Event|0|||
13169834|NCT02336451|26115939|FG003|Overall Study|Adverse Event|6|||
13169835|NCT02336451|26115940|FG004|Overall Study|Adverse Event|4|||
13169836|NCT02336451|26115936|FG000|Overall Study|Death|6|||
13169837|NCT02336451|26115937|FG001|Overall Study|Death|2|||
13169838|NCT02336451|26115938|FG002|Overall Study|Death|3|||
13169839|NCT02336451|26115939|FG003|Overall Study|Death|6|||
13169840|NCT02336451|26115940|FG004|Overall Study|Death|6|||
13169841|NCT02336451|26115936|FG000|Overall Study|Physician Decision|9|||
13169842|NCT02336451|26115937|FG001|Overall Study|Physician Decision|6|||
13169843|NCT02336451|26115938|FG002|Overall Study|Physician Decision|7|||
13169844|NCT02336451|26115939|FG003|Overall Study|Physician Decision|16|||
13169845|NCT02336451|26115940|FG004|Overall Study|Physician Decision|3|||
13169846|NCT02336451|26115936|FG000|Overall Study|Progressive disease|23|||
13169847|NCT02336451|26115937|FG001|Overall Study|Progressive disease|26|||
13169848|NCT02336451|26115938|FG002|Overall Study|Progressive disease|2|||
13169849|NCT02336451|26115939|FG003|Overall Study|Progressive disease|14|||
13169850|NCT02336451|26115940|FG004|Overall Study|Progressive disease|4|||
13169851|NCT02336451|26115936|FG000|Overall Study|Protocol Violation|1|||
13169852|NCT02336451|26115937|FG001|Overall Study|Protocol Violation|0|||
13169853|NCT02336451|26115938|FG002|Overall Study|Protocol Violation|0|||
13169854|NCT02336451|26115939|FG003|Overall Study|Protocol Violation|0|||
13169855|NCT02336451|26115940|FG004|Overall Study|Protocol Violation|0|||
13169856|NCT02336451|26115936|FG000|Overall Study|Patient/guardian decision|2|||
13169857|NCT02336451|26115937|FG001|Overall Study|Patient/guardian decision|4|||
13169858|NCT02336451|26115938|FG002|Overall Study|Patient/guardian decision|0|||
13169859|NCT02336451|26115939|FG003|Overall Study|Patient/guardian decision|2|||
13169860|NCT02336451|26115940|FG004|Overall Study|Patient/guardian decision|1|||
13169861|NCT02336425|26116003|FG000|Overall Study|Study terminated.|2|||
13169862|NCT02336425|26116004|FG001|Overall Study|Study terminated.|2|||
13169863|NCT02336425|26116005|FG002|Overall Study|Study terminated.|3|||
13169864|NCT02336425|26116006|FG003|Overall Study|Study terminated.|3|||
13169865|NCT02336373|26116023|FG000|Overall Study|Protocol closed early|4|||
13169866|NCT02336373|26116023|FG000|Overall Study|Physician Decision|14|||
13169867|NCT02336282|26116049|FG000|Overall Study|Unrelated illness|1|||
13169868|NCT02336282|26116049|FG000|Overall Study|Uncomfortable with technology|1|||
13169869|NCT02336282|26116049|FG000|Overall Study|Lost to Follow-up|1|||
13169870|NCT02336282|26116049|FG000|Overall Study|Not enough time to complete sessions|2|||
13169871|NCT02336230|26116060|FG000|Overall Study|Adverse Event|1|||
13169872|NCT02336230|26116060|FG000|Overall Study|Withdrawal of consent|1|||
13169873|NCT02336230|26116060|FG000|Overall Study|Death|9|||
13169874|NCT02336230|26116060|FG000|Overall Study|Dose not received due to shipping delay|1|||
13169875|NCT02336230|26116060|FG000|Overall Study|Discontinuation of MSC infusion|1|||
13169876|NCT02336178|26116148|FG000|Overall Study|Lost to Follow-up|1|||
13169877|NCT02336178|26116148|FG000|Overall Study|Protocol Violation|1|||
13169878|NCT02336178|26116148|FG000|Overall Study|Withdrawal by Subject|1|||
13169879|NCT02336178|26116148|FG000|Overall Study|Other|1|||
13169880|NCT02336165|26116206|FG000|Overall Study|Death|3|||
13169881|NCT02336165|26116207|FG001|Overall Study|Death|0|||
13169882|NCT02336165|26116208|FG002|Overall Study|Death|0|||
13169883|NCT02336165|26116209|FG003|Overall Study|Death|0|||
13169884|NCT02336165|26116210|FG004|Overall Study|Death|1|||
13169885|NCT02336165|26116206|FG000|Overall Study|Physician Decision|2|||
13169886|NCT02336165|26116207|FG001|Overall Study|Physician Decision|2|||
13169887|NCT02336165|26116208|FG002|Overall Study|Physician Decision|1|||
13169888|NCT02336165|26116209|FG003|Overall Study|Physician Decision|1|||
13169889|NCT02336165|26116210|FG004|Overall Study|Physician Decision|0|||
13169890|NCT02336165|26116206|FG000|Overall Study|Withdrawal by Subject|0|||
13169891|NCT02336165|26116207|FG001|Overall Study|Withdrawal by Subject|0|||
13169892|NCT02336165|26116208|FG002|Overall Study|Withdrawal by Subject|1|||
13169893|NCT02336165|26116209|FG003|Overall Study|Withdrawal by Subject|0|||
13169894|NCT02336165|26116210|FG004|Overall Study|Withdrawal by Subject|1|||
13169895|NCT02336165|26116206|FG000|Overall Study|Adverse Event|4|||
13169896|NCT02336165|26116207|FG001|Overall Study|Adverse Event|1|||
13169897|NCT02336165|26116208|FG002|Overall Study|Adverse Event|2|||
13169898|NCT02336165|26116209|FG003|Overall Study|Adverse Event|4|||
13169899|NCT02336165|26116210|FG004|Overall Study|Adverse Event|1|||
13169900|NCT02336165|26116206|FG000|Overall Study|Progressive disease|23|||
13169901|NCT02336165|26116207|FG001|Overall Study|Progressive disease|22|||
13169902|NCT02336165|26116208|FG002|Overall Study|Progressive disease|27|||
13169903|NCT02336165|26116209|FG003|Overall Study|Progressive disease|24|||
13169904|NCT02336165|26116210|FG004|Overall Study|Progressive disease|19|||
13169905|NCT02336165|26116206|FG000|Overall Study|Non-compliance|1|||
13169906|NCT02336165|26116207|FG001|Overall Study|Non-compliance|0|||
13169907|NCT02336165|26116208|FG002|Overall Study|Non-compliance|0|||
13169908|NCT02336165|26116209|FG003|Overall Study|Non-compliance|1|||
13169909|NCT02336165|26116210|FG004|Overall Study|Non-compliance|0|||
13169910|NCT02336165|26116206|FG000|Overall Study|Other|1|||
13169911|NCT02336165|26116207|FG001|Overall Study|Other|0|||
13169912|NCT02336165|26116208|FG002|Overall Study|Other|0|||
13169913|NCT02336165|26116209|FG003|Overall Study|Other|1|||
13169914|NCT02336165|26116210|FG004|Overall Study|Other|0|||
13169915|NCT02336074|26116234|FG000|Overall Study|Adverse Event|0|||
13169916|NCT02336074|26116235|FG001|Overall Study|Adverse Event|2|||
13169917|NCT02335983|26116336|FG000|Overall Study|Sponsor Decision|0|||
13169918|NCT02335983|26116337|FG001|Overall Study|Sponsor Decision|0|||
13169919|NCT02335983|26116338|FG002|Overall Study|Sponsor Decision|1|||
13169920|NCT02335983|26116339|FG003|Overall Study|Sponsor Decision|1|||
13169921|NCT02335983|26116340|FG004|Overall Study|Sponsor Decision|0|||
13169922|NCT02335983|26116341|FG005|Overall Study|Sponsor Decision|1|||
13169923|NCT02335983|26116336|FG000|Overall Study|Withdrawal by Subject|3|||
13169924|NCT02335983|26116337|FG001|Overall Study|Withdrawal by Subject|2|||
13169925|NCT02335983|26116338|FG002|Overall Study|Withdrawal by Subject|2|||
13169926|NCT02335983|26116339|FG003|Overall Study|Withdrawal by Subject|1|||
13169927|NCT02335983|26116340|FG004|Overall Study|Withdrawal by Subject|3|||
13169928|NCT02335983|26116341|FG005|Overall Study|Withdrawal by Subject|9|||
13169929|NCT02335983|26116336|FG000|Overall Study|Death|0|||
13169930|NCT02335983|26116337|FG001|Overall Study|Death|0|||
13169931|NCT02335983|26116338|FG002|Overall Study|Death|2|||
13169932|NCT02335983|26116339|FG003|Overall Study|Death|0|||
13169933|NCT02335983|26116340|FG004|Overall Study|Death|0|||
13169934|NCT02335983|26116341|FG005|Overall Study|Death|0|||
13169935|NCT02335983|26116336|FG000|Overall Study|Lost to Follow-up|0|||
13169936|NCT02335983|26116337|FG001|Overall Study|Lost to Follow-up|0|||
13169937|NCT02335983|26116338|FG002|Overall Study|Lost to Follow-up|0|||
13169938|NCT02335983|26116339|FG003|Overall Study|Lost to Follow-up|0|||
13169939|NCT02335983|26116340|FG004|Overall Study|Lost to Follow-up|0|||
13169940|NCT02335983|26116341|FG005|Overall Study|Lost to Follow-up|1|||
13169941|NCT02335983|26116336|FG000|Overall Study|Protocol Specified Criteria|5|||
13169942|NCT02335983|26116337|FG001|Overall Study|Protocol Specified Criteria|7|||
13169943|NCT02335983|26116338|FG002|Overall Study|Protocol Specified Criteria|27|||
13169944|NCT02335983|26116339|FG003|Overall Study|Protocol Specified Criteria|7|||
13169945|NCT02335983|26116340|FG004|Overall Study|Protocol Specified Criteria|5|||
13169946|NCT02335983|26116341|FG005|Overall Study|Protocol Specified Criteria|21|||
13169947|NCT02335658|26116358|FG000|Overall Study|Adverse Event|18|||
13169948|NCT02335658|26116359|FG001|Overall Study|Adverse Event|12|||
13169949|NCT02335658|26116358|FG000|Overall Study|Lack of Efficacy|4|||
13169950|NCT02335658|26116359|FG001|Overall Study|Lack of Efficacy|5|||
13169951|NCT02335658|26116358|FG000|Overall Study|Pregnancy|1|||
13169952|NCT02335658|26116359|FG001|Overall Study|Pregnancy|0|||
13169953|NCT02335658|26116358|FG000|Overall Study|Withdrawal by Subject|13|||
13169954|NCT02335658|26116359|FG001|Overall Study|Withdrawal by Subject|21|||
13169955|NCT02335658|26116358|FG000|Overall Study|non-compliance|2|||
13169956|NCT02335658|26116359|FG001|Overall Study|non-compliance|3|||
13169957|NCT02335658|26116358|FG000|Overall Study|other reason|2|||
13169958|NCT02335658|26116359|FG001|Overall Study|other reason|3|||
13169959|NCT02335489|26116365|FG000|Overall Study|Sponsor terminated study|4|||
13169960|NCT02335489|26116365|FG000|Overall Study|Lost to Follow-up|1|||
13169961|NCT02335489|26116365|FG000|Overall Study|Withdrawal by Subject|2|||
13169962|NCT02335489|26116365|FG000|Overall Study|Physician Decision|2|||
13169963|NCT02335489|26116365|FG000|Overall Study|Lack of Efficacy|1|||
13169964|NCT02335450|26116377|FG000|Overall Study|Pregnancy|1|||
13169965|NCT02335424|26116412|FG000|Overall Study|Withdrawal by Subject|12|||
13169966|NCT02335424|26116412|FG000|Overall Study|Ongoing In Study|89|||
13169967|NCT02335424|26116412|FG000|Overall Study|Adverse Event|25|||
13169968|NCT02335424|26116412|FG000|Overall Study|Death|239|||
13169969|NCT02335424|26116412|FG000|Overall Study|Lost to Follow-up|2|||
13169970|NCT02335424|26116412|FG000|Overall Study|Physician Decision|3|||
13169971|NCT02335424|26116412|FG000|Overall Study|Not treated|4|||
13169972|NCT02335411|26116472|FG000|Overall Study|Death|223|||
13169973|NCT02335411|26116473|FG001|Overall Study|Death|22|||
13169974|NCT02335411|26116474|FG002|Overall Study|Death|26|||
13169975|NCT02335411|26116472|FG000|Overall Study|Physician Decision|3|||
13169976|NCT02335411|26116473|FG001|Overall Study|Physician Decision|0|||
13169977|NCT02335411|26116474|FG002|Overall Study|Physician Decision|0|||
13169978|NCT02335411|26116472|FG000|Overall Study|Protocol Violation|1|||
13169979|NCT02335411|26116473|FG001|Overall Study|Protocol Violation|0|||
13169980|NCT02335411|26116474|FG002|Overall Study|Protocol Violation|0|||
13169981|NCT02335411|26116472|FG000|Overall Study|Withdrawal by Subject|11|||
13169982|NCT02335411|26116473|FG001|Overall Study|Withdrawal by Subject|0|||
13169983|NCT02335411|26116474|FG002|Overall Study|Withdrawal by Subject|3|||
13169984|NCT02335411|26116472|FG000|Overall Study|Sponsor Decision|12|||
13169985|NCT02335411|26116473|FG001|Overall Study|Sponsor Decision|3|||
13169986|NCT02335411|26116474|FG002|Overall Study|Sponsor Decision|2|||
13169987|NCT02335411|26116472|FG000|Overall Study|Adverse Event|9|||
13169988|NCT02335411|26116473|FG001|Overall Study|Adverse Event|0|||
13169989|NCT02335411|26116474|FG002|Overall Study|Adverse Event|0|||
13169990|NCT02335346|26116488|FG000|Overall Study|Adverse Event|11|||
13169991|NCT02335346|26116488|FG000|Overall Study|Withdrawal by Subject|1|||
13169992|NCT02335242|26116505|FG000|Randomized Phase (20 Weeks)|Withdrawal by Subject|1|||
13169993|NCT02335242|26116506|FG001|Randomized Phase (20 Weeks)|Withdrawal by Subject|0|||
13169994|NCT02335242|26116505|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
13169995|NCT02335242|26116506|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
13169996|NCT02335242|26116505|FG000|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
13169997|NCT02335242|26116506|FG001|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
13169998|NCT02334748|26116513|FG000|Overall Study|Adverse Event|1|||
13169999|NCT02334748|26116513|FG000|Overall Study|Inclusion in the CACZ8852306 study|1|||
13170000|NCT02334748|26116513|FG000|Overall Study|Patient no longer required study drug|2|||
13170001|NCT02334748|26116513|FG000|Overall Study|Lack of Efficacy|4|||
13170002|NCT02334683|26116530|FG000|First 12 Week Period|Lost to Follow-up|1|||
13170003|NCT02334683|26116531|FG001|First 12 Week Period|Lost to Follow-up|0|||
13170004|NCT02334683|26116530|FG000|Second 12 Week Period|Adverse Event|0|||
13170005|NCT02334683|26116531|FG001|Second 12 Week Period|Adverse Event|1|||
13170006|NCT02334423|26116550|FG000|Overall Study|Protocol Violation|10|||
13170007|NCT02334423|26116551|FG001|Overall Study|Protocol Violation|3|||
13170008|NCT02334384|26116564|FG000|Overall Study|Lost to Follow-up|1|||
13170009|NCT02334384|26116565|FG001|Overall Study|Lost to Follow-up|1|||
13170010|NCT02334306|26116592|FG000|Double-blind Period|Adverse Event|0|||
13170011|NCT02334306|26116593|FG001|Double-blind Period|Adverse Event|1|||
13170012|NCT02334306|26116592|FG000|Double-blind Period|Withdrawal by Subject|1|||
13170013|NCT02334306|26116593|FG001|Double-blind Period|Withdrawal by Subject|1|||
13170014|NCT02334215|26116662|FG000|Overall Study|Death|1|||
13170015|NCT02334215|26116663|FG001|Overall Study|Death|1|||
13170016|NCT02334215|26116664|FG002|Overall Study|Death|0|||
13170017|NCT02334215|26116662|FG000|Overall Study|Lost to Follow-up|1|||
13170018|NCT02334215|26116663|FG001|Overall Study|Lost to Follow-up|0|||
13170019|NCT02334215|26116664|FG002|Overall Study|Lost to Follow-up|4|||
13170020|NCT02334215|26116662|FG000|Overall Study|Withdrawal by Subject|2|||
13170021|NCT02334215|26116663|FG001|Overall Study|Withdrawal by Subject|2|||
13170022|NCT02334215|26116664|FG002|Overall Study|Withdrawal by Subject|1|||
13170023|NCT02334215|26116662|FG000|Overall Study|Not released from incarceration on time|3|||
13170024|NCT02334215|26116663|FG001|Overall Study|Not released from incarceration on time|3|||
13170025|NCT02334215|26116664|FG002|Overall Study|Not released from incarceration on time|3|||
13170026|NCT02334215|26116662|FG000|Overall Study|Incarcerated|0|||
13170027|NCT02334215|26116663|FG001|Overall Study|Incarcerated|0|||
13170028|NCT02334215|26116664|FG002|Overall Study|Incarcerated|7|||
13170029|NCT02333630|26116683|FG000|Overall Study|Lost to Follow-up|5|||
13170030|NCT02333630|26116684|FG001|Overall Study|Lost to Follow-up|2|||
13170031|NCT02333487|26116705|FG000|Overall Study|Adverse Event|0|||
13170032|NCT02333487|26116706|FG001|Overall Study|Adverse Event|2|||
13170033|NCT02333487|26116707|FG002|Overall Study|Adverse Event|0|||
13170034|NCT02333383|26116719|FG000|Overall Study|Adalimumab discontinuation|21|||
13170035|NCT02333383|26116719|FG000|Overall Study|Lost to Follow-up|15|||
13170036|NCT02333383|26116719|FG000|Overall Study|Withdrawal by Subject|3|||
13170037|NCT02333383|26116719|FG000|Overall Study|Transfer to another hospital|2|||
13170038|NCT02333331|26116758|FG000|Overall Study|Adverse Event|1|||
13170039|NCT02333331|26116759|FG001|Overall Study|Adverse Event|0|||
13170040|NCT02333331|26116760|FG002|Overall Study|Adverse Event|4|||
13170041|NCT02333331|26116761|FG003|Overall Study|Adverse Event|1|||
13170042|NCT02333331|26116758|FG000|Overall Study|Death|0|||
13170043|NCT02333331|26116759|FG001|Overall Study|Death|0|||
13170044|NCT02333331|26116760|FG002|Overall Study|Death|2|||
13170045|NCT02333331|26116761|FG003|Overall Study|Death|0|||
13170046|NCT02333331|26116758|FG000|Overall Study|Lost to Follow-up|0|||
13170047|NCT02333331|26116759|FG001|Overall Study|Lost to Follow-up|0|||
13170048|NCT02333331|26116760|FG002|Overall Study|Lost to Follow-up|1|||
13170049|NCT02333331|26116761|FG003|Overall Study|Lost to Follow-up|0|||
13170050|NCT02333331|26116758|FG000|Overall Study|Physician Decision|0|||
13170051|NCT02333331|26116759|FG001|Overall Study|Physician Decision|1|||
13170052|NCT02333331|26116760|FG002|Overall Study|Physician Decision|0|||
13170053|NCT02333331|26116761|FG003|Overall Study|Physician Decision|0|||
13170054|NCT02333331|26116758|FG000|Overall Study|Protocol Deviation|0|||
13170055|NCT02333331|26116759|FG001|Overall Study|Protocol Deviation|3|||
13170056|NCT02333331|26116760|FG002|Overall Study|Protocol Deviation|2|||
13170057|NCT02333331|26116761|FG003|Overall Study|Protocol Deviation|1|||
13170058|NCT02333331|26116758|FG000|Overall Study|Patient/Guardian Decision|1|||
13170059|NCT02333331|26116759|FG001|Overall Study|Patient/Guardian Decision|2|||
13170060|NCT02333331|26116760|FG002|Overall Study|Patient/Guardian Decision|9|||
13170061|NCT02333331|26116761|FG003|Overall Study|Patient/Guardian Decision|1|||
13170062|NCT02332915|26116779|FG000|Overall Study|Moved out of region|3|||
13170063|NCT02332915|26116780|FG001|Overall Study|Moved out of region|0|||
13170064|NCT02332915|26116779|FG000|Overall Study|Unrelated illness|1|||
13170065|NCT02332915|26116780|FG001|Overall Study|Unrelated illness|1|||
13170066|NCT02332915|26116779|FG000|Overall Study|Travel distance prohibitive|0|||
13170067|NCT02332915|26116780|FG001|Overall Study|Travel distance prohibitive|1|||
13170068|NCT02332915|26116779|FG000|Overall Study|did not meet inclusion criteria|2|||
13170069|NCT02332915|26116780|FG001|Overall Study|did not meet inclusion criteria|4|||
13170070|NCT02332889|26116786|FG000|Overall Study|Physician Decision|1|||
13170071|NCT02332876|26116799|FG000|Overall Study|Lost to Follow-up|1|||
13170072|NCT02332876|26116800|FG001|Overall Study|Lost to Follow-up|1|||
13170073|NCT02332824|26116857|FG000|Overall Study|Pretreatment Event/Adverse Event|4|||
13170074|NCT02332824|26116858|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
13170075|NCT02332824|26116859|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
13170076|NCT02332824|26116860|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
13170077|NCT02332824|26116861|FG004|Overall Study|Pretreatment Event/Adverse Event|4|||
13170078|NCT02332824|26116862|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
13170079|NCT02332824|26116857|FG000|Overall Study|Voluntary Withdrawal|1|||
13170080|NCT02332824|26116858|FG001|Overall Study|Voluntary Withdrawal|0|||
13170081|NCT02332824|26116859|FG002|Overall Study|Voluntary Withdrawal|0|||
13170082|NCT02332824|26116860|FG003|Overall Study|Voluntary Withdrawal|0|||
13170083|NCT02332824|26116861|FG004|Overall Study|Voluntary Withdrawal|0|||
13170084|NCT02332824|26116862|FG005|Overall Study|Voluntary Withdrawal|0|||
13170085|NCT02332824|26116857|FG000|Overall Study|Inconvenient schedule|1|||
13170086|NCT02332824|26116858|FG001|Overall Study|Inconvenient schedule|1|||
13170087|NCT02332824|26116859|FG002|Overall Study|Inconvenient schedule|0|||
13170088|NCT02332824|26116860|FG003|Overall Study|Inconvenient schedule|0|||
13170089|NCT02332824|26116861|FG004|Overall Study|Inconvenient schedule|0|||
13170090|NCT02332824|26116862|FG005|Overall Study|Inconvenient schedule|0|||
13170091|NCT02332824|26116857|FG000|Overall Study|Transfer|0|||
13170092|NCT02332824|26116858|FG001|Overall Study|Transfer|0|||
13170093|NCT02332824|26116859|FG002|Overall Study|Transfer|1|||
13170094|NCT02332824|26116860|FG003|Overall Study|Transfer|1|||
13170095|NCT02332824|26116861|FG004|Overall Study|Transfer|0|||
13170096|NCT02332824|26116862|FG005|Overall Study|Transfer|0|||
13170097|NCT02332798|26116922|FG000|Overall Study|Unwilling to Participate in Study|0|||
13170098|NCT02332798|26116923|FG001|Overall Study|Unwilling to Participate in Study|1|||
13170099|NCT02332798|26116924|FG002|Overall Study|Unwilling to Participate in Study|1|||
13170100|NCT02332798|26116922|FG000|Overall Study|Positive Urine Drug Test|0|||
13170101|NCT02332798|26116923|FG001|Overall Study|Positive Urine Drug Test|1|||
13170102|NCT02332798|26116924|FG002|Overall Study|Positive Urine Drug Test|0|||
13170103|NCT02332798|26116922|FG000|Overall Study|Abnormal Laboratory Findings|1|||
13170104|NCT02332798|26116923|FG001|Overall Study|Abnormal Laboratory Findings|0|||
13170105|NCT02332798|26116924|FG002|Overall Study|Abnormal Laboratory Findings|0|||
13170106|NCT02332720|26117112|FG000|Part A and Part B|Lost to Follow-up|1|||
13170107|NCT02332720|26117113|FG001|Part A and Part B|Lost to Follow-up|0|||
13170108|NCT02332720|26117114|FG002|Part A and Part B|Lost to Follow-up|0|||
13170109|NCT02332720|26117115|FG003|Part A and Part B|Lost to Follow-up|0|||
13170110|NCT02332720|26117116|FG004|Part A and Part B|Lost to Follow-up|0|||
13170111|NCT02332720|26117117|FG005|Part A and Part B|Lost to Follow-up|2|||
13170112|NCT02332720|26117118|FG006|Part A and Part B|Lost to Follow-up|1|||
13170113|NCT02332720|26117119|FG007|Part A and Part B|Lost to Follow-up|1|||
13170114|NCT02332720|26117120|FG008|Part A and Part B|Lost to Follow-up|0|||
13170115|NCT02332720|26117121|FG009|Part A and Part B|Lost to Follow-up|0|||
13170116|NCT02332720|26117122|FG010|Part A and Part B|Lost to Follow-up|0|||
13170117|NCT02332720|26117123|FG011|Part A and Part B|Lost to Follow-up|0|||
13170118|NCT02332720|26117124|FG012|Part A and Part B|Lost to Follow-up|0|||
13170119|NCT02332720|26117125|FG013|Part A and Part B|Lost to Follow-up|0|||
13170120|NCT02332720|26117126|FG014|Part A and Part B|Lost to Follow-up|0|||
13170121|NCT02332720|26117127|FG015|Part A and Part B|Lost to Follow-up|1|||
13170122|NCT02332720|26117128|FG016|Part A and Part B|Lost to Follow-up|0|||
13170123|NCT02332720|26117129|FG017|Part A and Part B|Lost to Follow-up|0|||
13170124|NCT02332720|26117130|FG018|Part A and Part B|Lost to Follow-up|0|||
13170125|NCT02332720|26117131|FG019|Part A and Part B|Lost to Follow-up|0|||
13170126|NCT02332720|26117132|FG020|Part A and Part B|Lost to Follow-up|0|||
13170127|NCT02332720|26117133|FG021|Part A and Part B|Lost to Follow-up|0|||
13170128|NCT02332720|26117134|FG022|Part A and Part B|Lost to Follow-up|0|||
13170129|NCT02332720|26117112|FG000|Part A and Part B|Adverse Event|0|||
13170130|NCT02332720|26117113|FG001|Part A and Part B|Adverse Event|0|||
13170131|NCT02332720|26117114|FG002|Part A and Part B|Adverse Event|0|||
13170132|NCT02332720|26117115|FG003|Part A and Part B|Adverse Event|0|||
13170133|NCT02332720|26117116|FG004|Part A and Part B|Adverse Event|0|||
13170134|NCT02332720|26117117|FG005|Part A and Part B|Adverse Event|0|||
13170135|NCT02332720|26117118|FG006|Part A and Part B|Adverse Event|0|||
13170136|NCT02332720|26117119|FG007|Part A and Part B|Adverse Event|0|||
13170137|NCT02332720|26117120|FG008|Part A and Part B|Adverse Event|0|||
13170138|NCT02332720|26117121|FG009|Part A and Part B|Adverse Event|0|||
13170139|NCT02332720|26117122|FG010|Part A and Part B|Adverse Event|0|||
13170140|NCT02332720|26117123|FG011|Part A and Part B|Adverse Event|0|||
13170141|NCT02332720|26117124|FG012|Part A and Part B|Adverse Event|0|||
13170142|NCT02332720|26117125|FG013|Part A and Part B|Adverse Event|0|||
13170143|NCT02332720|26117126|FG014|Part A and Part B|Adverse Event|0|||
13170144|NCT02332720|26117127|FG015|Part A and Part B|Adverse Event|0|||
13170145|NCT02332720|26117128|FG016|Part A and Part B|Adverse Event|0|||
13170146|NCT02332720|26117129|FG017|Part A and Part B|Adverse Event|1|||
13170147|NCT02332720|26117130|FG018|Part A and Part B|Adverse Event|0|||
13170148|NCT02332720|26117131|FG019|Part A and Part B|Adverse Event|0|||
13170149|NCT02332720|26117132|FG020|Part A and Part B|Adverse Event|0|||
13170150|NCT02332720|26117133|FG021|Part A and Part B|Adverse Event|0|||
13170151|NCT02332720|26117134|FG022|Part A and Part B|Adverse Event|0|||
13170152|NCT02332720|26117112|FG000|Part A and Part B|Physician Decision|0|||
13170153|NCT02332720|26117113|FG001|Part A and Part B|Physician Decision|0|||
13170154|NCT02332720|26117114|FG002|Part A and Part B|Physician Decision|0|||
13170155|NCT02332720|26117115|FG003|Part A and Part B|Physician Decision|0|||
13170156|NCT02332720|26117116|FG004|Part A and Part B|Physician Decision|0|||
13170157|NCT02332720|26117117|FG005|Part A and Part B|Physician Decision|0|||
13170158|NCT02332720|26117118|FG006|Part A and Part B|Physician Decision|0|||
13170159|NCT02332720|26117119|FG007|Part A and Part B|Physician Decision|0|||
13170160|NCT02332720|26117120|FG008|Part A and Part B|Physician Decision|0|||
13170161|NCT02332720|26117121|FG009|Part A and Part B|Physician Decision|0|||
13170162|NCT02332720|26117122|FG010|Part A and Part B|Physician Decision|0|||
13170163|NCT02332720|26117123|FG011|Part A and Part B|Physician Decision|0|||
13170164|NCT02332720|26117124|FG012|Part A and Part B|Physician Decision|0|||
13170165|NCT02332720|26117125|FG013|Part A and Part B|Physician Decision|0|||
13170166|NCT02332720|26117126|FG014|Part A and Part B|Physician Decision|0|||
13170167|NCT02332720|26117127|FG015|Part A and Part B|Physician Decision|0|||
13170168|NCT02332720|26117128|FG016|Part A and Part B|Physician Decision|0|||
13170169|NCT02332720|26117129|FG017|Part A and Part B|Physician Decision|0|||
13170170|NCT02332720|26117130|FG018|Part A and Part B|Physician Decision|1|||
13170171|NCT02332720|26117131|FG019|Part A and Part B|Physician Decision|0|||
13170172|NCT02332720|26117132|FG020|Part A and Part B|Physician Decision|0|||
13170173|NCT02332720|26117133|FG021|Part A and Part B|Physician Decision|0|||
13170174|NCT02332720|26117134|FG022|Part A and Part B|Physician Decision|0|||
13170175|NCT02332720|26117112|FG000|Part A and Part B|Withdrawal by Subject|0|||
13170176|NCT02332720|26117113|FG001|Part A and Part B|Withdrawal by Subject|0|||
13170177|NCT02332720|26117114|FG002|Part A and Part B|Withdrawal by Subject|0|||
13170178|NCT02332720|26117115|FG003|Part A and Part B|Withdrawal by Subject|0|||
13170179|NCT02332720|26117116|FG004|Part A and Part B|Withdrawal by Subject|0|||
13170180|NCT02332720|26117117|FG005|Part A and Part B|Withdrawal by Subject|1|||
13170181|NCT02332720|26117118|FG006|Part A and Part B|Withdrawal by Subject|0|||
13170182|NCT02332720|26117119|FG007|Part A and Part B|Withdrawal by Subject|0|||
13170183|NCT02332720|26117120|FG008|Part A and Part B|Withdrawal by Subject|0|||
13170184|NCT02332720|26117121|FG009|Part A and Part B|Withdrawal by Subject|0|||
13170185|NCT02332720|26117122|FG010|Part A and Part B|Withdrawal by Subject|0|||
13170186|NCT02332720|26117123|FG011|Part A and Part B|Withdrawal by Subject|0|||
13170187|NCT02332720|26117124|FG012|Part A and Part B|Withdrawal by Subject|0|||
13170188|NCT02332720|26117125|FG013|Part A and Part B|Withdrawal by Subject|0|||
13170189|NCT02332720|26117126|FG014|Part A and Part B|Withdrawal by Subject|0|||
13170190|NCT02332720|26117127|FG015|Part A and Part B|Withdrawal by Subject|0|||
13170191|NCT02332720|26117128|FG016|Part A and Part B|Withdrawal by Subject|0|||
13170192|NCT02332720|26117129|FG017|Part A and Part B|Withdrawal by Subject|0|||
13170193|NCT02332720|26117130|FG018|Part A and Part B|Withdrawal by Subject|0|||
13170194|NCT02332720|26117131|FG019|Part A and Part B|Withdrawal by Subject|1|||
13170195|NCT02332720|26117132|FG020|Part A and Part B|Withdrawal by Subject|0|||
13170196|NCT02332720|26117133|FG021|Part A and Part B|Withdrawal by Subject|0|||
13170197|NCT02332720|26117134|FG022|Part A and Part B|Withdrawal by Subject|0|||
13170198|NCT02332707|26117281|FG000|Overall Study|Adverse Event|0|||
13170199|NCT02332707|26117282|FG001|Overall Study|Adverse Event|0|||
13170200|NCT02332707|26117283|FG002|Overall Study|Adverse Event|0|||
13170201|NCT02332707|26117284|FG003|Overall Study|Adverse Event|0|||
13170202|NCT02332707|26117285|FG004|Overall Study|Adverse Event|0|||
13170203|NCT02332707|26117286|FG005|Overall Study|Adverse Event|0|||
13170204|NCT02332707|26117287|FG006|Overall Study|Adverse Event|0|||
13170205|NCT02332707|26117288|FG007|Overall Study|Adverse Event|0|||
13170206|NCT02332707|26117289|FG008|Overall Study|Adverse Event|0|||
13170207|NCT02332707|26117290|FG009|Overall Study|Adverse Event|0|||
13170208|NCT02332707|26117291|FG010|Overall Study|Adverse Event|0|||
13170209|NCT02332707|26117292|FG011|Overall Study|Adverse Event|0|||
13170210|NCT02332707|26117293|FG012|Overall Study|Adverse Event|1|||
13170211|NCT02332707|26117294|FG013|Overall Study|Adverse Event|0|||
13170212|NCT02332707|26117295|FG014|Overall Study|Adverse Event|0|||
13170213|NCT02332707|26117296|FG015|Overall Study|Adverse Event|0|||
13170214|NCT02332707|26117297|FG016|Overall Study|Adverse Event|0|||
13170215|NCT02332707|26117298|FG017|Overall Study|Adverse Event|0|||
13170216|NCT02332707|26117281|FG000|Overall Study|Lost to Follow-up|0|||
13170217|NCT02332707|26117282|FG001|Overall Study|Lost to Follow-up|0|||
13170218|NCT02332707|26117283|FG002|Overall Study|Lost to Follow-up|0|||
13170219|NCT02332707|26117284|FG003|Overall Study|Lost to Follow-up|0|||
13170220|NCT02332707|26117285|FG004|Overall Study|Lost to Follow-up|0|||
13170221|NCT02332707|26117286|FG005|Overall Study|Lost to Follow-up|1|||
13170222|NCT02332707|26117287|FG006|Overall Study|Lost to Follow-up|0|||
13170223|NCT02332707|26117288|FG007|Overall Study|Lost to Follow-up|0|||
13170224|NCT02332707|26117289|FG008|Overall Study|Lost to Follow-up|0|||
13170225|NCT02332707|26117290|FG009|Overall Study|Lost to Follow-up|0|||
13170226|NCT02332707|26117291|FG010|Overall Study|Lost to Follow-up|2|||
13170227|NCT02332707|26117292|FG011|Overall Study|Lost to Follow-up|0|||
13170228|NCT02332707|26117293|FG012|Overall Study|Lost to Follow-up|3|||
13170229|NCT02332707|26117294|FG013|Overall Study|Lost to Follow-up|0|||
13170230|NCT02332707|26117295|FG014|Overall Study|Lost to Follow-up|0|||
13170231|NCT02332707|26117296|FG015|Overall Study|Lost to Follow-up|0|||
13170232|NCT02332707|26117297|FG016|Overall Study|Lost to Follow-up|0|||
13170233|NCT02332707|26117298|FG017|Overall Study|Lost to Follow-up|0|||
13170234|NCT02332707|26117281|FG000|Overall Study|Physician Decision|0|||
13170235|NCT02332707|26117282|FG001|Overall Study|Physician Decision|0|||
13170236|NCT02332707|26117283|FG002|Overall Study|Physician Decision|0|||
13170237|NCT02332707|26117284|FG003|Overall Study|Physician Decision|1|||
13170238|NCT02332707|26117285|FG004|Overall Study|Physician Decision|0|||
13170239|NCT02332707|26117286|FG005|Overall Study|Physician Decision|0|||
13170240|NCT02332707|26117287|FG006|Overall Study|Physician Decision|0|||
13170241|NCT02332707|26117288|FG007|Overall Study|Physician Decision|0|||
13170242|NCT02332707|26117289|FG008|Overall Study|Physician Decision|0|||
13170243|NCT02332707|26117290|FG009|Overall Study|Physician Decision|0|||
13170244|NCT02332707|26117291|FG010|Overall Study|Physician Decision|0|||
13170245|NCT02332707|26117292|FG011|Overall Study|Physician Decision|0|||
13170246|NCT02332707|26117293|FG012|Overall Study|Physician Decision|1|||
13170247|NCT02332707|26117294|FG013|Overall Study|Physician Decision|0|||
13170248|NCT02332707|26117295|FG014|Overall Study|Physician Decision|0|||
13170249|NCT02332707|26117296|FG015|Overall Study|Physician Decision|0|||
13170250|NCT02332707|26117297|FG016|Overall Study|Physician Decision|0|||
13170251|NCT02332707|26117298|FG017|Overall Study|Physician Decision|0|||
13170252|NCT02332707|26117281|FG000|Overall Study|Withdrawal by Subject|0|||
13170253|NCT02332707|26117282|FG001|Overall Study|Withdrawal by Subject|0|||
13170254|NCT02332707|26117283|FG002|Overall Study|Withdrawal by Subject|1|||
13170255|NCT02332707|26117284|FG003|Overall Study|Withdrawal by Subject|0|||
13170256|NCT02332707|26117285|FG004|Overall Study|Withdrawal by Subject|0|||
13170257|NCT02332707|26117286|FG005|Overall Study|Withdrawal by Subject|0|||
13170258|NCT02332707|26117287|FG006|Overall Study|Withdrawal by Subject|0|||
13170259|NCT02332707|26117288|FG007|Overall Study|Withdrawal by Subject|0|||
13170260|NCT02332707|26117289|FG008|Overall Study|Withdrawal by Subject|0|||
13170261|NCT02332707|26117290|FG009|Overall Study|Withdrawal by Subject|3|||
13170262|NCT02332707|26117291|FG010|Overall Study|Withdrawal by Subject|0|||
13170263|NCT02332707|26117292|FG011|Overall Study|Withdrawal by Subject|0|||
13170264|NCT02332707|26117293|FG012|Overall Study|Withdrawal by Subject|0|||
13170265|NCT02332707|26117294|FG013|Overall Study|Withdrawal by Subject|0|||
13170266|NCT02332707|26117295|FG014|Overall Study|Withdrawal by Subject|0|||
13170267|NCT02332707|26117296|FG015|Overall Study|Withdrawal by Subject|0|||
13170268|NCT02332707|26117297|FG016|Overall Study|Withdrawal by Subject|0|||
13170269|NCT02332707|26117298|FG017|Overall Study|Withdrawal by Subject|0|||
13170270|NCT02332655|26117305|FG000|Overall Study|Lack of Efficacy|1|||
13170271|NCT02332590|26117421|FG000|DB Period (up to 24 Weeks)|Adverse Event|15|||
13170272|NCT02332590|26117422|FG001|DB Period (up to 24 Weeks)|Adverse Event|11|||
13170273|NCT02332590|26117421|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4|||
13170274|NCT02332590|26117422|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2|||
13170275|NCT02332590|26117421|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3|||
13170276|NCT02332590|26117422|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1|||
13107713|NCT03272347|25888790|FG001|Overall Study|Withdrawal by Subject|1|||
13107714|NCT03272347|25888791|FG002|Overall Study|Withdrawal by Subject|2|||
13107715|NCT03272347|25888792|FG003|Overall Study|Withdrawal by Subject|1|||
13107716|NCT03272347|25888789|FG000|Overall Study|Status Not Recorded|22|||
13107717|NCT03272347|25888790|FG001|Overall Study|Status Not Recorded|26|||
13107718|NCT03272347|25888791|FG002|Overall Study|Status Not Recorded|19|||
13107719|NCT03272347|25888792|FG003|Overall Study|Status Not Recorded|22|||
13107720|NCT03271528|25888845|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1|||
13107721|NCT03271528|25888846|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0|||
13107722|NCT03271528|25888845|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1|||
13107723|NCT03271528|25888846|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0|||
13170277|NCT02332590|26117421|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1|||
13170278|NCT02332590|26117422|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0|||
13170279|NCT02332590|26117421|FG000|DB Period (up to 24 Weeks)|Other than specified above|6|||
13170280|NCT02332590|26117422|FG001|DB Period (up to 24 Weeks)|Other than specified above|5|||
13107724|NCT03271528|25888845|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
13107725|NCT03271528|25888846|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
13107726|NCT03271528|25888845|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0|||
13107727|NCT03271528|25888846|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1|||
13107728|NCT03271528|25888845|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
13170281|NCT02332590|26117421|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20|||
13170282|NCT02332590|26117422|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23|||
13170283|NCT02332590|26117421|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2|||
13170284|NCT02332590|26117422|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6|||
13170285|NCT02332590|26117421|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5|||
13170286|NCT02332590|26117422|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1|||
13170287|NCT02332590|26117421|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20|||
13170288|NCT02332590|26117422|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15|||
13170289|NCT02332291|26117446|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3|||
13170290|NCT02332291|26117447|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5|||
13170291|NCT02332291|26117446|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0|||
13170292|NCT02332291|26117447|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4|||
13170293|NCT02332291|26117446|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1|||
13170294|NCT02332291|26117447|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0|||
13170295|NCT02332291|26117446|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2|||
13170296|NCT02332291|26117447|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7|||
13170297|NCT02332291|26117446|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0|||
13170298|NCT02332291|26117447|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1|||
13170299|NCT02332291|26117446|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1|||
13170300|NCT02332291|26117447|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0|||
13170301|NCT02332239|26117467|FG000|Overall Study|Lost to Follow-up|4|||
13170302|NCT02332239|26117468|FG001|Overall Study|Lost to Follow-up|6|||
13170303|NCT02332187|26117483|FG000|Overall Study|Withdrawal by Subject|2|||
13170304|NCT02332187|26117484|FG001|Overall Study|Withdrawal by Subject|2|||
13170305|NCT02332187|26117483|FG000|Overall Study|Adverse Event|0|||
13170306|NCT02332187|26117484|FG001|Overall Study|Adverse Event|1|||
13170307|NCT02331680|26117505|FG000|Overall Study|Adverse Event|3|||
13170308|NCT02331680|26117506|FG001|Overall Study|Adverse Event|0|||
13170309|NCT02331680|26117507|FG002|Overall Study|Adverse Event|2|||
13170310|NCT02331680|26117505|FG000|Overall Study|Physician Decision|1|||
13170311|NCT02331680|26117506|FG001|Overall Study|Physician Decision|1|||
13170312|NCT02331680|26117507|FG002|Overall Study|Physician Decision|2|||
13170313|NCT02331680|26117505|FG000|Overall Study|Withdrawal by Subject|0|||
13170314|NCT02331680|26117506|FG001|Overall Study|Withdrawal by Subject|1|||
13170315|NCT02331680|26117507|FG002|Overall Study|Withdrawal by Subject|2|||
13170316|NCT02331680|26117505|FG000|Overall Study|Met withdrawal criteria|2|||
13170317|NCT02331680|26117506|FG001|Overall Study|Met withdrawal criteria|2|||
13170318|NCT02331680|26117507|FG002|Overall Study|Met withdrawal criteria|5|||
13170319|NCT02331680|26117505|FG000|Overall Study|Non-compliance with study drug|0|||
13170320|NCT02331680|26117506|FG001|Overall Study|Non-compliance with study drug|0|||
13170321|NCT02331680|26117507|FG002|Overall Study|Non-compliance with study drug|1|||
13170322|NCT02331680|26117505|FG000|Overall Study|Protocol Violation|0|||
13170323|NCT02331680|26117506|FG001|Overall Study|Protocol Violation|0|||
13170324|NCT02331680|26117507|FG002|Overall Study|Protocol Violation|3|||
13170325|NCT02331446|26117590|FG000|Overall Study|Lost to Follow-up|2|||
13170326|NCT02331446|26117591|FG001|Overall Study|Lost to Follow-up|1|||
13170327|NCT02331446|26117592|FG002|Overall Study|Lost to Follow-up|0|||
13170328|NCT02331446|26117593|FG003|Overall Study|Lost to Follow-up|1|||
13170329|NCT02331446|26117590|FG000|Overall Study|Personal Problem|2|||
13170330|NCT02331446|26117591|FG001|Overall Study|Personal Problem|0|||
13170331|NCT02331446|26117592|FG002|Overall Study|Personal Problem|0|||
13170332|NCT02331446|26117593|FG003|Overall Study|Personal Problem|0|||
13170333|NCT02331446|26117590|FG000|Overall Study|Disease|0|||
13170334|NCT02331446|26117591|FG001|Overall Study|Disease|2|||
13170335|NCT02331446|26117592|FG002|Overall Study|Disease|2|||
13170336|NCT02331446|26117593|FG003|Overall Study|Disease|1|||
13170337|NCT02331446|26117590|FG000|Overall Study|Physician Decision|0|||
13170338|NCT02331446|26117591|FG001|Overall Study|Physician Decision|1|||
13170339|NCT02331446|26117592|FG002|Overall Study|Physician Decision|0|||
13170340|NCT02331446|26117593|FG003|Overall Study|Physician Decision|1|||
13170341|NCT02331446|26117590|FG000|Overall Study|Lost before baseline analysis|0|||
13170342|NCT02331446|26117591|FG001|Overall Study|Lost before baseline analysis|1|||
13170343|NCT02331446|26117592|FG002|Overall Study|Lost before baseline analysis|1|||
13170344|NCT02331446|26117593|FG003|Overall Study|Lost before baseline analysis|0|||
13170345|NCT02331394|26117606|FG000|Overall Study|Disease progression|1|||
13107729|NCT03271528|25888846|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
13107730|NCT03271528|25888845|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1|||
13170346|NCT02331368|26117614|FG000|Overall Study|Withdrawal by Subject|3|||
13170347|NCT02330549|26117734|FG000|Overall Study|Adverse Event|1|||
13170348|NCT02330549|26117735|FG001|Overall Study|Adverse Event|0|||
13170349|NCT02330549|26117734|FG000|Overall Study|Subject withdrew consent|2|||
13170350|NCT02330549|26117735|FG001|Overall Study|Subject withdrew consent|1|||
13170351|NCT02330549|26117734|FG000|Overall Study|Failure to meet randomization criteria|1|||
13170352|NCT02330549|26117735|FG001|Overall Study|Failure to meet randomization criteria|0|||
13170353|NCT02330081|26117756|FG000|Overall Study|Adverse Event|1|||
13170354|NCT02330081|26117756|FG000|Overall Study|Donation did not meet criteria|1|||
13170355|NCT02330081|26117756|FG000|Overall Study|Protocol Violation|6|||
13170356|NCT02330055|26117781|FG000|Overall Study|technical issues|2|||
13170357|NCT02330055|26117782|FG001|Overall Study|technical issues|0|||
13170358|NCT02330055|26117781|FG000|Overall Study|participant forgot to wear device|5|||
13170359|NCT02330055|26117782|FG001|Overall Study|participant forgot to wear device|5|||
13170360|NCT02330055|26117781|FG000|Overall Study|data for less than 60 minutes|3|||
13170361|NCT02330055|26117782|FG001|Overall Study|data for less than 60 minutes|3|||
13170362|NCT02330055|26117781|FG000|Overall Study|participant did not sleep|0|||
13170363|NCT02330055|26117782|FG001|Overall Study|participant did not sleep|1|||
13170364|NCT02329743|26117803|FG000|Overall Study|Adverse Event|1|||
13170365|NCT02329743|26117804|FG001|Overall Study|Adverse Event|1|||
13170366|NCT02329743|26117805|FG002|Overall Study|Adverse Event|3|||
13170367|NCT02329743|26117803|FG000|Overall Study|Lost to Follow-up|1|||
13170368|NCT02329743|26117804|FG001|Overall Study|Lost to Follow-up|0|||
13170369|NCT02329743|26117805|FG002|Overall Study|Lost to Follow-up|1|||
13170370|NCT02329743|26117803|FG000|Overall Study|Withdrawal by Subject|4|||
13107731|NCT03271528|25888846|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0|||
13107732|NCT03271528|25888845|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1|||
13107733|NCT03271528|25888846|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0|||
13107734|NCT03271307|25888916|FG000|Overall Study|Lost to Follow-up|0|||
13170371|NCT02329743|26117804|FG001|Overall Study|Withdrawal by Subject|4|||
13170372|NCT02329743|26117805|FG002|Overall Study|Withdrawal by Subject|1|||
13170373|NCT02329743|26117803|FG000|Overall Study|Other|0|||
13170374|NCT02329743|26117804|FG001|Overall Study|Other|2|||
13170375|NCT02329743|26117805|FG002|Overall Study|Other|3|||
13170376|NCT02329730|26117900|FG000|Overall Study|Protocol Violation|0|||
13170377|NCT02329730|26117901|FG001|Overall Study|Protocol Violation|0|||
13170378|NCT02329730|26117902|FG002|Overall Study|Protocol Violation|0|||
13170379|NCT02329730|26117903|FG003|Overall Study|Protocol Violation|0|||
13170380|NCT02329730|26117904|FG004|Overall Study|Protocol Violation|2|||
13170381|NCT02329730|26117905|FG005|Overall Study|Protocol Violation|2|||
13170382|NCT02329730|26117906|FG006|Overall Study|Protocol Violation|0|||
13170383|NCT02329730|26117907|FG007|Overall Study|Protocol Violation|0|||
13170384|NCT02329730|26117908|FG008|Overall Study|Protocol Violation|0|||
13170385|NCT02329730|26117909|FG009|Overall Study|Protocol Violation|0|||
13170386|NCT02329730|26117910|FG010|Overall Study|Protocol Violation|0|||
13170387|NCT02329730|26117911|FG011|Overall Study|Protocol Violation|0|||
13170388|NCT02329730|26117900|FG000|Overall Study|Withdrawal by Subject|0|||
13170389|NCT02329730|26117901|FG001|Overall Study|Withdrawal by Subject|0|||
13170390|NCT02329730|26117902|FG002|Overall Study|Withdrawal by Subject|0|||
13170391|NCT02329730|26117903|FG003|Overall Study|Withdrawal by Subject|0|||
13170392|NCT02329730|26117904|FG004|Overall Study|Withdrawal by Subject|1|||
13170393|NCT02329730|26117905|FG005|Overall Study|Withdrawal by Subject|0|||
13170394|NCT02329730|26117906|FG006|Overall Study|Withdrawal by Subject|1|||
13170395|NCT02329730|26117907|FG007|Overall Study|Withdrawal by Subject|1|||
13170396|NCT02329730|26117908|FG008|Overall Study|Withdrawal by Subject|1|||
13170397|NCT02329730|26117909|FG009|Overall Study|Withdrawal by Subject|1|||
13170398|NCT02329730|26117910|FG010|Overall Study|Withdrawal by Subject|0|||
13170399|NCT02329730|26117911|FG011|Overall Study|Withdrawal by Subject|0|||
13170400|NCT02329431|26117934|FG000|Overall Study|Lost to Follow-up|20|||
13170401|NCT02329431|26117935|FG001|Overall Study|Lost to Follow-up|13|||
13170402|NCT02329327|26117970|FG000|Overall Study|Death|78|||
13170403|NCT02329327|26117971|FG001|Overall Study|Death|0|||
13170404|NCT02329327|26117970|FG000|Overall Study|Withdrawal by Subject|3|||
13170405|NCT02329327|26117971|FG001|Overall Study|Withdrawal by Subject|0|||
13170406|NCT02329327|26117970|FG000|Overall Study|Lost to Follow-up|4|||
13170407|NCT02329327|26117971|FG001|Overall Study|Lost to Follow-up|0|||
13170408|NCT02329223|26118012|FG000|Overall Study|Withdrawal by Subject|1|||
13170409|NCT02329223|26118013|FG001|Overall Study|Withdrawal by Subject|2|||
13170410|NCT02329223|26118014|FG002|Overall Study|Withdrawal by Subject|5|||
13170411|NCT02329223|26118012|FG000|Overall Study|Physician Decision|0|||
13170412|NCT02329223|26118013|FG001|Overall Study|Physician Decision|0|||
13170413|NCT02329223|26118014|FG002|Overall Study|Physician Decision|1|||
13170414|NCT02329223|26118012|FG000|Overall Study|Adverse Event|0|||
13170415|NCT02329223|26118013|FG001|Overall Study|Adverse Event|1|||
13107735|NCT03271307|25888917|FG001|Overall Study|Lost to Follow-up|0|||
13107736|NCT03271307|25888918|FG002|Overall Study|Lost to Follow-up|0|||
13107737|NCT03271307|25888919|FG003|Overall Study|Lost to Follow-up|28|||
13170416|NCT02329223|26118014|FG002|Overall Study|Adverse Event|0|||
13170417|NCT02328937|26118032|FG000|Period 1|Lost to Follow-up|0|||
13107738|NCT03271307|25888920|FG004|Overall Study|Lost to Follow-up|91|||
13170418|NCT02328937|26118033|FG001|Period 1|Lost to Follow-up|0|||
13170419|NCT02328937|26118034|FG002|Period 1|Lost to Follow-up|0|||
13170420|NCT02328937|26118035|FG003|Period 1|Lost to Follow-up|1|||
13170421|NCT02328937|26118036|FG004|Period 1|Lost to Follow-up|0|||
13170422|NCT02328937|26118037|FG005|Period 1|Lost to Follow-up|0|||
13170423|NCT02328937|26118032|FG000|Period 2|Adverse Event|0|||
13170424|NCT02328937|26118033|FG001|Period 2|Adverse Event|0|||
13170425|NCT02328937|26118034|FG002|Period 2|Adverse Event|1|||
13170426|NCT02328937|26118035|FG003|Period 2|Adverse Event|0|||
13170427|NCT02328937|26118036|FG004|Period 2|Adverse Event|0|||
13170428|NCT02328937|26118037|FG005|Period 2|Adverse Event|0|||
13170429|NCT02328547|26118082|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
13170430|NCT02328547|26118083|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0|||
13170431|NCT02328547|26118082|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
13170432|NCT02328547|26118083|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
13170433|NCT02328326|26118136|FG000|Overall Study|Withdrawal by Subject|10|||
13170434|NCT02328326|26118137|FG001|Overall Study|Withdrawal by Subject|3|||
13170435|NCT02328326|26118136|FG000|Overall Study|Death|2|||
13170436|NCT02328326|26118137|FG001|Overall Study|Death|1|||
13170437|NCT02328326|26118136|FG000|Overall Study|Lost to Follow-up|10|||
13170438|NCT02328326|26118137|FG001|Overall Study|Lost to Follow-up|4|||
13170439|NCT02328105|26118148|FG000|Overall Study|Death|6|||
13107739|NCT03271151|25888937|FG000|Overall Study|Lost to Follow-up|1|||
13107740|NCT03271151|25888938|FG001|Overall Study|Lost to Follow-up|3|||
13107741|NCT03271151|25888937|FG000|Overall Study|Withdrawal by Subject|1|||
13170440|NCT02328105|26118148|FG000|Overall Study|Withdrawal by Subject|1|||
13170441|NCT02328105|26118148|FG000|Overall Study|Still On Study in Follow-Up|4|||
13170442|NCT02328040|26118159|FG000|First Intervention (2 Days)|Withdrawal by Subject|1|||
13170443|NCT02328040|26118160|FG001|First Intervention (2 Days)|Withdrawal by Subject|1|||
13170444|NCT02328027|26118182|FG000|Overall Study|Withdrawal by Subject|0|||
13170445|NCT02328027|26118183|FG001|Overall Study|Withdrawal by Subject|1|||
13170446|NCT02327325|26118213|FG000|Overall Study|Withdrawal by Subject|1|||
13170447|NCT02327325|26118214|FG001|Overall Study|Withdrawal by Subject|4|||
13170448|NCT02327325|26118215|FG002|Overall Study|Withdrawal by Subject|4|||
13170449|NCT02327325|26118213|FG000|Overall Study|Excluded by Study Team|0|||
13170450|NCT02327325|26118214|FG001|Overall Study|Excluded by Study Team|0|||
13170451|NCT02327325|26118215|FG002|Overall Study|Excluded by Study Team|1|||
13170452|NCT02327260|26118257|FG000|Overall Study|Lost to Follow-up|2|||
13170453|NCT02327260|26118258|FG001|Overall Study|Lost to Follow-up|3|||
13170454|NCT02327260|26118259|FG002|Overall Study|Lost to Follow-up|2|||
13170455|NCT02327260|26118257|FG000|Overall Study|invalid phone number|1|||
13170456|NCT02327260|26118258|FG001|Overall Study|invalid phone number|1|||
13170457|NCT02327260|26118259|FG002|Overall Study|invalid phone number|0|||
13170458|NCT02327260|26118257|FG000|Overall Study|non-adherence to protocol|2|||
13170459|NCT02327260|26118258|FG001|Overall Study|non-adherence to protocol|0|||
13170460|NCT02327260|26118259|FG002|Overall Study|non-adherence to protocol|0|||
13170461|NCT02327260|26118257|FG000|Overall Study|cognitive concerns|1|||
13170462|NCT02327260|26118258|FG001|Overall Study|cognitive concerns|0|||
13170463|NCT02327260|26118259|FG002|Overall Study|cognitive concerns|0|||
13170464|NCT02327169|26118526|FG000|Overall Study|Progressive Disease|1|||
13170465|NCT02327169|26118527|FG001|Overall Study|Progressive Disease|3|||
13170466|NCT02327169|26118528|FG002|Overall Study|Progressive Disease|4|||
13170467|NCT02327169|26118529|FG003|Overall Study|Progressive Disease|3|||
13170468|NCT02327169|26118530|FG004|Overall Study|Progressive Disease|4|||
13170469|NCT02327169|26118531|FG005|Overall Study|Progressive Disease|3|||
13170470|NCT02327169|26118532|FG006|Overall Study|Progressive Disease|3|||
13170471|NCT02327169|26118533|FG007|Overall Study|Progressive Disease|3|||
13170472|NCT02327169|26118534|FG008|Overall Study|Progressive Disease|4|||
13170473|NCT02327169|26118535|FG009|Overall Study|Progressive Disease|4|||
13170474|NCT02327169|26118536|FG010|Overall Study|Progressive Disease|4|||
13107742|NCT03271151|25888938|FG001|Overall Study|Withdrawal by Subject|0|||
13107743|NCT03270657|25888946|FG000|Overall Study|Withdrawal by Subject|1|||
13107744|NCT03270644|25888969|FG000|Day 1 Lasmiditan Reference|Physician Decision|1|||
13107745|NCT03270644|25888969|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1|||
13107746|NCT03270085|25888986|FG000|Overall Study|Withdrawal by Subject|1|||
13107747|NCT03270085|25888987|FG001|Overall Study|Withdrawal by Subject|0|||
13107748|NCT03269552|25888996|FG000|Overall Study|Adverse Event|2|||
13107749|NCT03268941|25889074|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
13170475|NCT02327169|26118537|FG011|Overall Study|Progressive Disease|3|||
13170476|NCT02327169|26118538|FG012|Overall Study|Progressive Disease|1|||
13170477|NCT02327169|26118539|FG013|Overall Study|Progressive Disease|3|||
13170478|NCT02327169|26118540|FG014|Overall Study|Progressive Disease|3|||
13170479|NCT02327169|26118526|FG000|Overall Study|Adverse Event|2|||
13170480|NCT02327169|26118527|FG001|Overall Study|Adverse Event|0|||
13170481|NCT02327169|26118528|FG002|Overall Study|Adverse Event|1|||
13170482|NCT02327169|26118529|FG003|Overall Study|Adverse Event|0|||
13107750|NCT03268941|25889075|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
13107751|NCT03268941|25889076|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
13107752|NCT03268941|25889077|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1|||
13107753|NCT03268941|25889078|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
13170483|NCT02327169|26118530|FG004|Overall Study|Adverse Event|1|||
13170484|NCT02327169|26118531|FG005|Overall Study|Adverse Event|0|||
13170485|NCT02327169|26118532|FG006|Overall Study|Adverse Event|0|||
13170486|NCT02327169|26118533|FG007|Overall Study|Adverse Event|0|||
13170487|NCT02327169|26118534|FG008|Overall Study|Adverse Event|0|||
13170488|NCT02327169|26118535|FG009|Overall Study|Adverse Event|2|||
13170489|NCT02327169|26118536|FG010|Overall Study|Adverse Event|0|||
13170490|NCT02327169|26118537|FG011|Overall Study|Adverse Event|3|||
13170491|NCT02327169|26118538|FG012|Overall Study|Adverse Event|0|||
13170492|NCT02327169|26118539|FG013|Overall Study|Adverse Event|2|||
13170493|NCT02327169|26118540|FG014|Overall Study|Adverse Event|1|||
13170494|NCT02327169|26118526|FG000|Overall Study|Symptomatic Deterioration|0|||
13170495|NCT02327169|26118527|FG001|Overall Study|Symptomatic Deterioration|0|||
13170496|NCT02327169|26118528|FG002|Overall Study|Symptomatic Deterioration|1|||
13170497|NCT02327169|26118529|FG003|Overall Study|Symptomatic Deterioration|0|||
13170498|NCT02327169|26118530|FG004|Overall Study|Symptomatic Deterioration|1|||
13170499|NCT02327169|26118531|FG005|Overall Study|Symptomatic Deterioration|1|||
13170500|NCT02327169|26118532|FG006|Overall Study|Symptomatic Deterioration|0|||
13170501|NCT02327169|26118533|FG007|Overall Study|Symptomatic Deterioration|0|||
13170502|NCT02327169|26118534|FG008|Overall Study|Symptomatic Deterioration|2|||
13107754|NCT03268941|25889079|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
13107755|NCT03268941|25889080|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
13170503|NCT02327169|26118535|FG009|Overall Study|Symptomatic Deterioration|1|||
13170504|NCT02327169|26118536|FG010|Overall Study|Symptomatic Deterioration|0|||
13170505|NCT02327169|26118537|FG011|Overall Study|Symptomatic Deterioration|0|||
13170506|NCT02327169|26118538|FG012|Overall Study|Symptomatic Deterioration|0|||
13170507|NCT02327169|26118539|FG013|Overall Study|Symptomatic Deterioration|2|||
13170508|NCT02327169|26118540|FG014|Overall Study|Symptomatic Deterioration|1|||
13170509|NCT02327169|26118526|FG000|Overall Study|Reason Not Specified|0|||
13170510|NCT02327169|26118527|FG001|Overall Study|Reason Not Specified|0|||
13170511|NCT02327169|26118528|FG002|Overall Study|Reason Not Specified|1|||
13170512|NCT02327169|26118529|FG003|Overall Study|Reason Not Specified|0|||
13170513|NCT02327169|26118530|FG004|Overall Study|Reason Not Specified|0|||
13170514|NCT02327169|26118531|FG005|Overall Study|Reason Not Specified|0|||
13170515|NCT02327169|26118532|FG006|Overall Study|Reason Not Specified|0|||
13170516|NCT02327169|26118533|FG007|Overall Study|Reason Not Specified|0|||
13170517|NCT02327169|26118534|FG008|Overall Study|Reason Not Specified|0|||
13170518|NCT02327169|26118535|FG009|Overall Study|Reason Not Specified|1|||
13170519|NCT02327169|26118536|FG010|Overall Study|Reason Not Specified|2|||
13107756|NCT03268941|25889074|FG000|Part 1 (Days 1 to 9)|Adverse Event|0|||
13107757|NCT03268941|25889075|FG001|Part 1 (Days 1 to 9)|Adverse Event|0|||
13107758|NCT03268941|25889076|FG002|Part 1 (Days 1 to 9)|Adverse Event|0|||
13107759|NCT03268941|25889077|FG003|Part 1 (Days 1 to 9)|Adverse Event|1|||
13107760|NCT03268941|25889078|FG004|Part 1 (Days 1 to 9)|Adverse Event|0|||
13170520|NCT02327169|26118537|FG011|Overall Study|Reason Not Specified|1|||
13170521|NCT02327169|26118538|FG012|Overall Study|Reason Not Specified|0|||
13170522|NCT02327169|26118539|FG013|Overall Study|Reason Not Specified|0|||
13170523|NCT02327169|26118540|FG014|Overall Study|Reason Not Specified|2|||
13170524|NCT02327169|26118526|FG000|Overall Study|Withdrawal by Subject|1|||
13170525|NCT02327169|26118527|FG001|Overall Study|Withdrawal by Subject|0|||
13170526|NCT02327169|26118528|FG002|Overall Study|Withdrawal by Subject|0|||
13107761|NCT03268941|25889079|FG005|Part 1 (Days 1 to 9)|Adverse Event|0|||
13107762|NCT03268941|25889080|FG006|Part 1 (Days 1 to 9)|Adverse Event|0|||
13107763|NCT03268941|25889074|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1|||
13107764|NCT03268941|25889075|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
13107765|NCT03268941|25889076|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
13107766|NCT03268941|25889077|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
13107767|NCT03268941|25889078|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
13107768|NCT03268941|25889079|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
13107769|NCT03268941|25889080|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
13107770|NCT03268941|25889074|FG000|Part 2: Days 17 to 25|Reason not specified|0|||
13107771|NCT03268941|25889075|FG001|Part 2: Days 17 to 25|Reason not specified|0|||
13170527|NCT02327169|26118529|FG003|Overall Study|Withdrawal by Subject|0|||
13170528|NCT02327169|26118530|FG004|Overall Study|Withdrawal by Subject|1|||
13170529|NCT02327169|26118531|FG005|Overall Study|Withdrawal by Subject|0|||
13170530|NCT02327169|26118532|FG006|Overall Study|Withdrawal by Subject|0|||
13170531|NCT02327169|26118533|FG007|Overall Study|Withdrawal by Subject|1|||
13170532|NCT02327169|26118534|FG008|Overall Study|Withdrawal by Subject|0|||
13170533|NCT02327169|26118535|FG009|Overall Study|Withdrawal by Subject|0|||
13170534|NCT02327169|26118536|FG010|Overall Study|Withdrawal by Subject|0|||
13170535|NCT02327169|26118537|FG011|Overall Study|Withdrawal by Subject|0|||
13170536|NCT02327169|26118538|FG012|Overall Study|Withdrawal by Subject|0|||
13170537|NCT02327169|26118539|FG013|Overall Study|Withdrawal by Subject|0|||
13170538|NCT02327169|26118540|FG014|Overall Study|Withdrawal by Subject|3|||
13170539|NCT02327169|26118526|FG000|Overall Study|Lost to Follow-up|0|||
13170540|NCT02327169|26118527|FG001|Overall Study|Lost to Follow-up|0|||
13107772|NCT03268941|25889076|FG002|Part 2: Days 17 to 25|Reason not specified|0|||
13170541|NCT02327169|26118528|FG002|Overall Study|Lost to Follow-up|0|||
13170542|NCT02327169|26118529|FG003|Overall Study|Lost to Follow-up|0|||
13170543|NCT02327169|26118530|FG004|Overall Study|Lost to Follow-up|1|||
13170544|NCT02327169|26118531|FG005|Overall Study|Lost to Follow-up|0|||
13170545|NCT02327169|26118532|FG006|Overall Study|Lost to Follow-up|0|||
13170546|NCT02327169|26118533|FG007|Overall Study|Lost to Follow-up|0|||
13170547|NCT02327169|26118534|FG008|Overall Study|Lost to Follow-up|0|||
13170548|NCT02327169|26118535|FG009|Overall Study|Lost to Follow-up|0|||
13170549|NCT02327169|26118536|FG010|Overall Study|Lost to Follow-up|0|||
13170550|NCT02327169|26118537|FG011|Overall Study|Lost to Follow-up|0|||
13170551|NCT02327169|26118538|FG012|Overall Study|Lost to Follow-up|0|||
13170552|NCT02327169|26118539|FG013|Overall Study|Lost to Follow-up|0|||
13170553|NCT02327169|26118540|FG014|Overall Study|Lost to Follow-up|0|||
13170554|NCT02327130|26118549|FG000|Overall Study|Discharged in less than 5 days|5|||
13170555|NCT02327130|26118549|FG000|Overall Study|Physician Decision|2|||
13170556|NCT02327130|26118549|FG000|Overall Study|Unable to provide breath sample|1|||
13170557|NCT02327130|26118549|FG000|Overall Study|Incorrectly place ventilator adaptor|1|||
13170558|NCT02327130|26118549|FG000|Overall Study|Met exclusion criteria|3|||
13170559|NCT02327013|26118734|FG000|Overall Study|Adverse Event|4|||
13170560|NCT02327013|26118735|FG001|Overall Study|Adverse Event|4|||
13170561|NCT02327013|26118736|FG002|Overall Study|Adverse Event|3|||
13170562|NCT02327013|26118737|FG003|Overall Study|Adverse Event|0|||
13170563|NCT02327013|26118738|FG004|Overall Study|Adverse Event|1|||
13170564|NCT02327013|26118734|FG000|Overall Study|Lack of Efficacy|2|||
13170565|NCT02327013|26118735|FG001|Overall Study|Lack of Efficacy|0|||
13170566|NCT02327013|26118736|FG002|Overall Study|Lack of Efficacy|5|||
13170567|NCT02327013|26118737|FG003|Overall Study|Lack of Efficacy|0|||
13170568|NCT02327013|26118738|FG004|Overall Study|Lack of Efficacy|1|||
13170569|NCT02327013|26118734|FG000|Overall Study|Non-compliance with IMP|1|||
13170570|NCT02327013|26118735|FG001|Overall Study|Non-compliance with IMP|2|||
13170571|NCT02327013|26118736|FG002|Overall Study|Non-compliance with IMP|7|||
13170572|NCT02327013|26118737|FG003|Overall Study|Non-compliance with IMP|0|||
13170573|NCT02327013|26118738|FG004|Overall Study|Non-compliance with IMP|0|||
13170574|NCT02327013|26118734|FG000|Overall Study|Withdrawal of Consent|1|||
13170575|NCT02327013|26118735|FG001|Overall Study|Withdrawal of Consent|0|||
13170576|NCT02327013|26118736|FG002|Overall Study|Withdrawal of Consent|3|||
13170577|NCT02327013|26118737|FG003|Overall Study|Withdrawal of Consent|0|||
13170578|NCT02327013|26118738|FG004|Overall Study|Withdrawal of Consent|0|||
13170579|NCT02327013|26118734|FG000|Overall Study|Lost to Follow-up|2|||
13170580|NCT02327013|26118735|FG001|Overall Study|Lost to Follow-up|4|||
13170581|NCT02327013|26118736|FG002|Overall Study|Lost to Follow-up|5|||
13170582|NCT02327013|26118737|FG003|Overall Study|Lost to Follow-up|0|||
13170583|NCT02327013|26118738|FG004|Overall Study|Lost to Follow-up|0|||
13170584|NCT02327013|26118734|FG000|Overall Study|Administrative or other reason(s)|1|||
13107773|NCT03268941|25889077|FG003|Part 2: Days 17 to 25|Reason not specified|0|||
13107774|NCT03268941|25889078|FG004|Part 2: Days 17 to 25|Reason not specified|0|||
13107775|NCT03268941|25889079|FG005|Part 2: Days 17 to 25|Reason not specified|0|||
13107776|NCT03268941|25889080|FG006|Part 2: Days 17 to 25|Reason not specified|1|||
13107777|NCT03268941|25889074|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
13107778|NCT03268941|25889075|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
13107779|NCT03268941|25889076|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
13107780|NCT03268941|25889077|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
13107781|NCT03268941|25889078|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
13107782|NCT03268941|25889079|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
13107783|NCT03268941|25889080|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1|||
13107784|NCT03268746|25889104|FG000|Overall Study|Withdrawal by Subject|1|||
13107785|NCT03268590|25889113|FG000|Overall Study|Previously unknown exclusion criteria|1|||
13107786|NCT03267940|25889232|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1|||
13107787|NCT03267940|25889233|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2|||
13107788|NCT03267940|25889234|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
13170585|NCT02327013|26118735|FG001|Overall Study|Administrative or other reason(s)|5|||
13170586|NCT02327013|26118736|FG002|Overall Study|Administrative or other reason(s)|11|||
13170587|NCT02327013|26118737|FG003|Overall Study|Administrative or other reason(s)|1|||
13170588|NCT02327013|26118738|FG004|Overall Study|Administrative or other reason(s)|1|||
13170589|NCT02327013|26118734|FG000|Overall Study|Protocol Violation|0|||
13170590|NCT02327013|26118735|FG001|Overall Study|Protocol Violation|0|||
13170591|NCT02327013|26118736|FG002|Overall Study|Protocol Violation|3|||
13170592|NCT02327013|26118737|FG003|Overall Study|Protocol Violation|0|||
13170593|NCT02327013|26118738|FG004|Overall Study|Protocol Violation|1|||
13170594|NCT02327013|26118734|FG000|Overall Study|Withdrawal before treatment|2|||
13170595|NCT02327013|26118735|FG001|Overall Study|Withdrawal before treatment|1|||
13170596|NCT02327013|26118736|FG002|Overall Study|Withdrawal before treatment|5|||
13170597|NCT02327013|26118737|FG003|Overall Study|Withdrawal before treatment|0|||
13170598|NCT02327013|26118738|FG004|Overall Study|Withdrawal before treatment|0|||
13170599|NCT02326883|26118756|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84|||
13170600|NCT02326883|26118757|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85|||
13170601|NCT02326883|26118758|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69|||
13170602|NCT02326597|26118783|FG000|Overall Study|Lost to Follow-up|42|||
13170603|NCT02326597|26118784|FG001|Overall Study|Lost to Follow-up|32|||
13170604|NCT02326467|26118791|FG000|Overall Study|Withdrawal by Subject|1|||
13170605|NCT02326298|26118832|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
13170606|NCT02326298|26118833|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
13170607|NCT02326298|26118834|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
13170608|NCT02326298|26118835|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
13170609|NCT02326298|26118836|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
13170610|NCT02326298|26118837|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
13170611|NCT02326298|26118838|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
13170612|NCT02326298|26118839|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
13170613|NCT02326298|26118840|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
13170614|NCT02326298|26118841|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
13170615|NCT02326298|26118842|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
13170616|NCT02326298|26118843|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
13170617|NCT02326298|26118844|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
13170618|NCT02326298|26118845|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
13170619|NCT02326298|26118832|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1|||
13170620|NCT02326298|26118833|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
13170621|NCT02326298|26118834|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
13170622|NCT02326298|26118835|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
13170623|NCT02326298|26118836|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
13170624|NCT02326298|26118837|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
13170625|NCT02326298|26118838|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
13170626|NCT02326298|26118839|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
13170627|NCT02326298|26118840|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
13170628|NCT02326298|26118841|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
13170629|NCT02326298|26118842|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
13170630|NCT02326298|26118843|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
13170631|NCT02326298|26118844|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
13170632|NCT02326298|26118845|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
13170633|NCT02326298|26118832|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
13170634|NCT02326298|26118833|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
13170635|NCT02326298|26118834|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
13170636|NCT02326298|26118835|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
13170637|NCT02326298|26118836|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
13170638|NCT02326298|26118837|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
13170639|NCT02326298|26118838|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
13170640|NCT02326298|26118839|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
13107789|NCT03267940|25889235|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
13107790|NCT03267940|25889236|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
13107791|NCT03267940|25889237|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
13107792|NCT03267940|25889232|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
13107793|NCT03267940|25889233|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1|||
13107794|NCT03267940|25889234|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
13107795|NCT03267940|25889235|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
13170641|NCT02326298|26118840|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
13170642|NCT02326298|26118841|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
13170643|NCT02326298|26118842|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
13170644|NCT02326298|26118843|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
13170645|NCT02326298|26118844|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
13170646|NCT02326298|26118845|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
13170647|NCT02326298|26118832|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
13170648|NCT02326298|26118833|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
13170649|NCT02326298|26118834|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
13222915|NCT01802281|26287210|FG001|Overall Study|Ineligible|3|||
13222916|NCT01802216|26287225|FG000|4 Month Visit|Participant did not show to visit|3|||
13170650|NCT02326298|26118835|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
13170651|NCT02326298|26118836|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
13170652|NCT02326298|26118837|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
13170653|NCT02326298|26118838|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
13170654|NCT02326298|26118839|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
13170655|NCT02326298|26118840|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
13170656|NCT02326298|26118841|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
13170657|NCT02326298|26118842|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
13170658|NCT02326298|26118843|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
13170659|NCT02326298|26118844|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
13170660|NCT02326298|26118845|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
13170661|NCT02326298|26118832|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
13170662|NCT02326298|26118833|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
13170663|NCT02326298|26118834|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2|||
13170664|NCT02326298|26118835|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
13170665|NCT02326298|26118836|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
13170666|NCT02326298|26118837|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
13170667|NCT02326298|26118838|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
13170668|NCT02326298|26118839|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
13170669|NCT02326298|26118840|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
13170670|NCT02326298|26118841|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
13170671|NCT02326298|26118842|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
13170672|NCT02326298|26118843|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
13170673|NCT02326298|26118844|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
13170674|NCT02326298|26118845|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
13170675|NCT02326298|26118832|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
13107796|NCT03267940|25889236|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
13107797|NCT03267940|25889237|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
13170676|NCT02326298|26118833|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
13170677|NCT02326298|26118834|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
13170678|NCT02326298|26118835|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
13170679|NCT02326298|26118836|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
13170680|NCT02326298|26118837|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
13170681|NCT02326298|26118838|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
13170682|NCT02326298|26118839|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
13170683|NCT02326298|26118840|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
13170684|NCT02326298|26118841|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
13170685|NCT02326298|26118842|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
13170686|NCT02326298|26118843|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
13170687|NCT02326298|26118844|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
13170688|NCT02326298|26118845|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
13170689|NCT02326298|26118832|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
13170690|NCT02326298|26118833|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
13170691|NCT02326298|26118834|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
13170692|NCT02326298|26118835|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
13170693|NCT02326298|26118836|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
13170694|NCT02326298|26118837|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1|||
13170695|NCT02326298|26118838|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2|||
13170696|NCT02326298|26118839|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
13170697|NCT02326298|26118840|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4|||
13107798|NCT03267940|25889232|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
13107799|NCT03267940|25889233|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1|||
13107800|NCT03267940|25889234|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
13107801|NCT03267940|25889235|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
13107802|NCT03267940|25889236|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
13107803|NCT03267940|25889237|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
13107804|NCT03267940|25889232|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7|||
13107805|NCT03267940|25889233|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3|||
13107806|NCT03267940|25889234|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
13107807|NCT03267940|25889235|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
13107808|NCT03267940|25889236|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
13170698|NCT02326298|26118841|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
13170699|NCT02326298|26118842|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
13170700|NCT02326298|26118843|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
13170701|NCT02326298|26118844|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
13170702|NCT02326298|26118845|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
13107809|NCT03267940|25889237|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
13107810|NCT03267940|25889232|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
13170703|NCT02326298|26118832|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
13170704|NCT02326298|26118833|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
13170705|NCT02326298|26118834|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
13170706|NCT02326298|26118835|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
13170707|NCT02326298|26118836|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
13170708|NCT02326298|26118837|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1|||
13170709|NCT02326298|26118838|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
13170710|NCT02326298|26118839|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
13170711|NCT02326298|26118840|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
13170712|NCT02326298|26118841|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
13170713|NCT02326298|26118842|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
13170714|NCT02326298|26118843|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
13170715|NCT02326298|26118844|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
13170716|NCT02326298|26118845|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
13170717|NCT02326298|26118832|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
13170718|NCT02326298|26118833|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
13170719|NCT02326298|26118834|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
13170720|NCT02326298|26118835|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
13170721|NCT02326298|26118836|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
13170722|NCT02326298|26118837|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
13170723|NCT02326298|26118838|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
13170724|NCT02326298|26118839|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
13170725|NCT02326298|26118840|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
13170726|NCT02326298|26118841|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
13170727|NCT02326298|26118842|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
13170728|NCT02326298|26118843|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
13170729|NCT02326298|26118844|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
13170730|NCT02326298|26118845|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
13170731|NCT02326298|26118832|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
13170732|NCT02326298|26118833|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
13170733|NCT02326298|26118834|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
13170734|NCT02326298|26118835|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
13170735|NCT02326298|26118836|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
13170736|NCT02326298|26118837|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
13170737|NCT02326298|26118838|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
13170738|NCT02326298|26118839|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1|||
13170739|NCT02326298|26118840|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
13170740|NCT02326298|26118841|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
13170741|NCT02326298|26118842|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
13170742|NCT02326298|26118843|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
13170743|NCT02326298|26118844|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
13170744|NCT02326298|26118845|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
13170745|NCT02326298|26118832|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
13170746|NCT02326298|26118833|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
13170747|NCT02326298|26118834|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
13170748|NCT02326298|26118835|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
13170749|NCT02326298|26118836|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
13170750|NCT02326298|26118837|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
13107811|NCT03267940|25889233|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
13107812|NCT03267940|25889234|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
13107813|NCT03267940|25889235|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3|||
13107814|NCT03267940|25889236|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2|||
13107815|NCT03267940|25889237|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
13133190|NCT02777554|25986870|FG002|Overall Study|Discharged early due to hurricane|0|||
13170751|NCT02326298|26118838|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
13170752|NCT02326298|26118839|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
13170753|NCT02326298|26118840|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
13170754|NCT02326298|26118841|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
13170755|NCT02326298|26118842|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
13170756|NCT02326298|26118843|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
13170757|NCT02326298|26118844|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
13170758|NCT02326298|26118845|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
13170759|NCT02326298|26118832|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
13170760|NCT02326298|26118833|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
13170761|NCT02326298|26118834|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
13170762|NCT02326298|26118835|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
13170763|NCT02326298|26118836|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
13170764|NCT02326298|26118837|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
13170765|NCT02326298|26118838|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
13170766|NCT02326298|26118839|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
13170767|NCT02326298|26118840|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
13170768|NCT02326298|26118841|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
13170769|NCT02326298|26118842|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
13170770|NCT02326298|26118843|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
13170771|NCT02326298|26118844|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
13170772|NCT02326298|26118845|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
13170773|NCT02326298|26118832|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
13170774|NCT02326298|26118833|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
13170775|NCT02326298|26118834|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
13170776|NCT02326298|26118835|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
13170777|NCT02326298|26118836|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
13170778|NCT02326298|26118837|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2|||
13170779|NCT02326298|26118838|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
13170780|NCT02326298|26118839|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
13170781|NCT02326298|26118840|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
13170782|NCT02326298|26118841|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
13170783|NCT02326298|26118842|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
13170784|NCT02326298|26118843|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
13170785|NCT02326298|26118844|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
13170786|NCT02326298|26118845|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
13170787|NCT02326298|26118832|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
13170788|NCT02326298|26118833|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
13170789|NCT02326298|26118834|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
13170790|NCT02326298|26118835|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
13170791|NCT02326298|26118836|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
13170792|NCT02326298|26118837|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
13170793|NCT02326298|26118838|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
13170794|NCT02326298|26118839|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
13170795|NCT02326298|26118840|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
13170796|NCT02326298|26118841|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
13170797|NCT02326298|26118842|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
13170798|NCT02326298|26118843|FG011|Open-label Period (Week 48 to Week 144)|Death|1|||
13170799|NCT02326298|26118844|FG012|Open-label Period (Week 48 to Week 144)|Death|0|||
13170800|NCT02326298|26118845|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
13170801|NCT02326298|26118832|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
13170802|NCT02326298|26118833|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
13170803|NCT02326298|26118834|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
13170804|NCT02326298|26118835|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
13170805|NCT02326298|26118836|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
13170806|NCT02326298|26118837|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
13170807|NCT02326298|26118838|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
13170808|NCT02326298|26118839|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
13170809|NCT02326298|26118840|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
13170810|NCT02326298|26118841|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
13170811|NCT02326298|26118842|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
13170812|NCT02326298|26118843|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
13170813|NCT02326298|26118844|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
13170814|NCT02326298|26118845|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
13170815|NCT02326298|26118832|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
13170816|NCT02326298|26118833|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
13170817|NCT02326298|26118834|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
13170818|NCT02326298|26118835|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
13170819|NCT02326298|26118836|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
13170820|NCT02326298|26118837|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
13170821|NCT02326298|26118838|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
13170822|NCT02326298|26118839|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
13170823|NCT02326298|26118840|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
13170824|NCT02326298|26118841|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
13170825|NCT02326298|26118842|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
13170826|NCT02326298|26118843|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
13170827|NCT02326298|26118844|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
13170828|NCT02326298|26118845|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
13170829|NCT02326298|26118832|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
13170830|NCT02326298|26118833|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
13170831|NCT02326298|26118834|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
13170832|NCT02326298|26118835|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
13170833|NCT02326298|26118836|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
13170834|NCT02326298|26118837|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
13170835|NCT02326298|26118838|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
13170836|NCT02326298|26118839|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
13170837|NCT02326298|26118840|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
13170838|NCT02326298|26118841|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
13170839|NCT02326298|26118842|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
13170840|NCT02326298|26118843|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
13170841|NCT02326298|26118844|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
13170842|NCT02326298|26118845|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2|||
13170843|NCT02326298|26118832|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
13170844|NCT02326298|26118833|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
13170845|NCT02326298|26118834|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
13170846|NCT02326298|26118835|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
13170847|NCT02326298|26118836|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
13170848|NCT02326298|26118837|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
13170849|NCT02326298|26118838|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
13170850|NCT02326298|26118839|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
13170851|NCT02326298|26118840|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
13170852|NCT02326298|26118841|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
13170853|NCT02326298|26118842|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
13170854|NCT02326298|26118843|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7|||
13170855|NCT02326298|26118844|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
13170856|NCT02326298|26118845|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
13170857|NCT02326298|26118832|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
13170858|NCT02326298|26118833|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
13170859|NCT02326298|26118834|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
13170860|NCT02326298|26118835|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
13170861|NCT02326298|26118836|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
13170862|NCT02326298|26118837|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
13170863|NCT02326298|26118838|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
13170864|NCT02326298|26118839|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
13170865|NCT02326298|26118840|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
13170866|NCT02326298|26118841|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
13170867|NCT02326298|26118842|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
13170868|NCT02326298|26118843|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2|||
13107816|NCT03267940|25889232|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
13107817|NCT03267940|25889233|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
13107818|NCT03267940|25889234|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
13107819|NCT03267940|25889235|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1|||
13107820|NCT03267940|25889236|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
13107821|NCT03267940|25889237|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
13107822|NCT03267940|25889232|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
13107823|NCT03267940|25889233|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
13107824|NCT03267940|25889234|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2|||
13107825|NCT03267940|25889235|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
13107826|NCT03267940|25889236|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
13107827|NCT03267940|25889237|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
13107828|NCT03267940|25889232|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
13107829|NCT03267940|25889233|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
13107830|NCT03267940|25889234|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7|||
13107831|NCT03267940|25889235|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4|||
13107832|NCT03267940|25889236|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5|||
13170869|NCT02326298|26118844|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7|||
13170870|NCT02326298|26118845|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
13170871|NCT02326298|26118832|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
13170872|NCT02326298|26118833|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
13170873|NCT02326298|26118834|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
13170874|NCT02326298|26118835|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
13170875|NCT02326298|26118836|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
13170876|NCT02326298|26118837|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
13170877|NCT02326298|26118838|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
13170878|NCT02326298|26118839|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
13170879|NCT02326298|26118840|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
13170880|NCT02326298|26118841|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
13170881|NCT02326298|26118842|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
13170882|NCT02326298|26118843|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
13170883|NCT02326298|26118844|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
13170884|NCT02326298|26118845|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
13170885|NCT02326272|26118887|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
13170886|NCT02326272|26118888|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3|||
13170887|NCT02326272|26118889|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
13170888|NCT02326272|26118890|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
13170889|NCT02326272|26118891|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
13170890|NCT02326272|26118892|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
13170891|NCT02326272|26118893|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
13170892|NCT02326272|26118894|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
13170893|NCT02326272|26118895|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
13170894|NCT02326272|26118896|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
13170895|NCT02326272|26118897|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
13170896|NCT02326272|26118898|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
13170897|NCT02326272|26118899|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
13170898|NCT02326272|26118900|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
13170899|NCT02326272|26118901|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
13170900|NCT02326272|26118887|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
13170901|NCT02326272|26118888|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2|||
13170902|NCT02326272|26118889|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
13170903|NCT02326272|26118890|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
13170904|NCT02326272|26118891|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
13170905|NCT02326272|26118892|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
13170906|NCT02326272|26118893|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
13170907|NCT02326272|26118894|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
13170908|NCT02326272|26118895|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
13170909|NCT02326272|26118896|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
13170910|NCT02326272|26118897|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
13170911|NCT02326272|26118898|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
13170912|NCT02326272|26118899|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
13170913|NCT02326272|26118900|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
13170914|NCT02326272|26118901|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
13170915|NCT02326272|26118887|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
13170916|NCT02326272|26118888|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
13170917|NCT02326272|26118889|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
13170918|NCT02326272|26118890|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
13170919|NCT02326272|26118891|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
13170920|NCT02326272|26118892|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
13170921|NCT02326272|26118893|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
13170922|NCT02326272|26118894|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
13170923|NCT02326272|26118895|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
13170924|NCT02326272|26118896|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
13485530|NCT02906020|27032868|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
13170925|NCT02326272|26118897|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
13170926|NCT02326272|26118898|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
13170927|NCT02326272|26118899|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
13170928|NCT02326272|26118900|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
13170929|NCT02326272|26118901|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
13170930|NCT02326272|26118887|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
13170931|NCT02326272|26118888|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
13170932|NCT02326272|26118889|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1|||
13170933|NCT02326272|26118890|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
13170934|NCT02326272|26118891|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
13170935|NCT02326272|26118892|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
13170936|NCT02326272|26118893|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
13170937|NCT02326272|26118894|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
13170938|NCT02326272|26118895|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
13170939|NCT02326272|26118896|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
13170940|NCT02326272|26118897|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
13170941|NCT02326272|26118898|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
13170942|NCT02326272|26118899|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
13170943|NCT02326272|26118900|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
13170944|NCT02326272|26118901|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
13170945|NCT02326272|26118887|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
13170946|NCT02326272|26118888|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
13170947|NCT02326272|26118889|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1|||
13170948|NCT02326272|26118890|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
13170949|NCT02326272|26118891|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
13170950|NCT02326272|26118892|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
13107833|NCT03267940|25889237|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3|||
13107834|NCT03267940|25889232|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0|||
13107835|NCT03267940|25889233|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0|||
13107836|NCT03267940|25889234|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10|||
13107837|NCT03267940|25889235|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13|||
13107838|NCT03267940|25889236|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0|||
13107839|NCT03267940|25889237|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6|||
13107840|NCT03267576|25889278|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0|||
13107841|NCT03267576|25889279|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1|||
13170951|NCT02326272|26118893|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
13170952|NCT02326272|26118894|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
13170953|NCT02326272|26118895|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
13170954|NCT02326272|26118896|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
13170955|NCT02326272|26118897|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
13170956|NCT02326272|26118898|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
13170957|NCT02326272|26118899|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
13170958|NCT02326272|26118900|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
13170959|NCT02326272|26118901|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
13170960|NCT02326272|26118887|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
13170961|NCT02326272|26118888|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
13170962|NCT02326272|26118889|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1|||
13170963|NCT02326272|26118890|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
13170964|NCT02326272|26118891|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
13170965|NCT02326272|26118892|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
13170966|NCT02326272|26118893|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
13170967|NCT02326272|26118894|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
13170968|NCT02326272|26118895|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
13170969|NCT02326272|26118896|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
13170970|NCT02326272|26118897|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
13170971|NCT02326272|26118898|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
13170972|NCT02326272|26118899|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
13170973|NCT02326272|26118900|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
13170974|NCT02326272|26118901|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
13170975|NCT02326272|26118887|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
13107842|NCT03267576|25889278|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
13170976|NCT02326272|26118888|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
13170977|NCT02326272|26118889|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1|||
13170978|NCT02326272|26118890|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
13170979|NCT02326272|26118891|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
13170980|NCT02326272|26118892|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
13170981|NCT02326272|26118893|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
13170982|NCT02326272|26118894|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
13170983|NCT02326272|26118895|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
13170984|NCT02326272|26118896|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
13170985|NCT02326272|26118897|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
13170986|NCT02326272|26118898|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
13170987|NCT02326272|26118899|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
13170988|NCT02326272|26118900|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
13170989|NCT02326272|26118901|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
13170990|NCT02326272|26118887|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
13170991|NCT02326272|26118888|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
13170992|NCT02326272|26118889|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
13170993|NCT02326272|26118890|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
13170994|NCT02326272|26118891|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
13170995|NCT02326272|26118892|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3|||
13170996|NCT02326272|26118893|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
13170997|NCT02326272|26118894|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
13170998|NCT02326272|26118895|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
13170999|NCT02326272|26118896|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
13171000|NCT02326272|26118897|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
13171001|NCT02326272|26118898|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
13171002|NCT02326272|26118899|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
13171003|NCT02326272|26118900|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
13171004|NCT02326272|26118901|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
13171005|NCT02326272|26118887|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
13171006|NCT02326272|26118888|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
13171007|NCT02326272|26118889|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
13171008|NCT02326272|26118890|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
13171009|NCT02326272|26118891|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
13171010|NCT02326272|26118892|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2|||
13171011|NCT02326272|26118893|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
13171012|NCT02326272|26118894|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
13171013|NCT02326272|26118895|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
13171014|NCT02326272|26118896|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
13171015|NCT02326272|26118897|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
13171016|NCT02326272|26118898|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
13171017|NCT02326272|26118899|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
13171018|NCT02326272|26118900|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
13171019|NCT02326272|26118901|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
13171020|NCT02326272|26118887|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
13171021|NCT02326272|26118888|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
13171022|NCT02326272|26118889|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
13171023|NCT02326272|26118890|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
13171024|NCT02326272|26118891|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
13171025|NCT02326272|26118892|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
13171026|NCT02326272|26118893|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
13171027|NCT02326272|26118894|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
13171028|NCT02326272|26118895|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
13171029|NCT02326272|26118896|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
13171030|NCT02326272|26118897|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
13171031|NCT02326272|26118898|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
13171032|NCT02326272|26118899|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
13171033|NCT02326272|26118900|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
13171034|NCT02326272|26118901|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
13171035|NCT02326272|26118887|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
13171036|NCT02326272|26118888|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
13171037|NCT02326272|26118889|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
13171038|NCT02326272|26118890|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
13171039|NCT02326272|26118891|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
13171040|NCT02326272|26118892|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
13171041|NCT02326272|26118893|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
13171042|NCT02326272|26118894|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
13171043|NCT02326272|26118895|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
13171044|NCT02326272|26118896|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
13171045|NCT02326272|26118897|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
13171046|NCT02326272|26118898|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
13107843|NCT03267576|25889279|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
13107844|NCT03267511|25889304|FG000|Overall Study|Lost to Follow-up|0|||
13107845|NCT03267511|25889305|FG001|Overall Study|Lost to Follow-up|0|||
13107846|NCT03267511|25889306|FG002|Overall Study|Lost to Follow-up|0|||
13107847|NCT03267511|25889307|FG003|Overall Study|Lost to Follow-up|1|||
13107848|NCT03267264|25889337|FG000|Overall Study|Withdrawal by Subject|1|||
13107849|NCT03267264|25889338|FG001|Overall Study|Withdrawal by Subject|0|||
13107850|NCT03267264|25889339|FG002|Overall Study|Withdrawal by Subject|2|||
13107851|NCT03267264|25889340|FG003|Overall Study|Withdrawal by Subject|4|||
13107852|NCT03267212|25889355|FG000|First Intervention|Lost to Follow-up|0|||
13107853|NCT03267212|25889356|FG001|First Intervention|Lost to Follow-up|2|||
13107854|NCT03267212|25889355|FG000|First Intervention|Withdrawal by Subject|1|||
13107855|NCT03267212|25889356|FG001|First Intervention|Withdrawal by Subject|1|||
13107856|NCT03267212|25889355|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1|||
13171047|NCT02326272|26118899|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
13171048|NCT02326272|26118900|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
13171049|NCT02326272|26118901|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
13171050|NCT02326272|26118887|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
13171051|NCT02326272|26118888|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
13171052|NCT02326272|26118889|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
13171053|NCT02326272|26118890|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
13171054|NCT02326272|26118891|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
13171055|NCT02326272|26118892|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
13171056|NCT02326272|26118893|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
13171057|NCT02326272|26118894|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1|||
13171058|NCT02326272|26118895|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
13171059|NCT02326272|26118896|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
13171060|NCT02326272|26118897|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
13171061|NCT02326272|26118898|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
13171062|NCT02326272|26118899|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
13171063|NCT02326272|26118900|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
13171064|NCT02326272|26118901|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
13171065|NCT02326272|26118887|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
13171066|NCT02326272|26118888|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
13171067|NCT02326272|26118889|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
13171068|NCT02326272|26118890|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
13171069|NCT02326272|26118891|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
13171070|NCT02326272|26118892|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
13171071|NCT02326272|26118893|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
13171072|NCT02326272|26118894|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
13171073|NCT02326272|26118895|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
13171074|NCT02326272|26118896|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
13171075|NCT02326272|26118897|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
13171076|NCT02326272|26118898|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
13171077|NCT02326272|26118899|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
13171078|NCT02326272|26118900|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
13171079|NCT02326272|26118901|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
13171080|NCT02326272|26118887|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
13171081|NCT02326272|26118888|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
13222917|NCT01802216|26287226|FG001|4 Month Visit|Participant did not show to visit|4|||
13222918|NCT01802216|26287225|FG000|8 Month Visit|Participant did not show to visit|3|||
13222919|NCT01802216|26287226|FG001|8 Month Visit|Participant did not show to visit|5|||
13171082|NCT02326272|26118889|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
13171083|NCT02326272|26118890|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
13171084|NCT02326272|26118891|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
13171085|NCT02326272|26118892|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
13171086|NCT02326272|26118893|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
13171087|NCT02326272|26118894|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
13171088|NCT02326272|26118895|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1|||
13171089|NCT02326272|26118896|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
13171090|NCT02326272|26118897|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
13171091|NCT02326272|26118898|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
13171092|NCT02326272|26118899|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
13171093|NCT02326272|26118900|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
13171094|NCT02326272|26118901|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
13171095|NCT02326272|26118887|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
13171096|NCT02326272|26118888|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
13171097|NCT02326272|26118889|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
13171098|NCT02326272|26118890|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
13171099|NCT02326272|26118891|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
13171100|NCT02326272|26118892|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
13171101|NCT02326272|26118893|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
13171102|NCT02326272|26118894|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
13171103|NCT02326272|26118895|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
13171104|NCT02326272|26118896|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
13171105|NCT02326272|26118897|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
13171106|NCT02326272|26118898|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
13171107|NCT02326272|26118899|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
13171108|NCT02326272|26118900|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
13171109|NCT02326272|26118901|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
13171110|NCT02326272|26118887|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
13171111|NCT02326272|26118888|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
13171112|NCT02326272|26118889|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
13171113|NCT02326272|26118890|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
13171114|NCT02326272|26118891|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
13171115|NCT02326272|26118892|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1|||
13171116|NCT02326272|26118893|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
13171117|NCT02326272|26118894|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
13171118|NCT02326272|26118895|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
13171119|NCT02326272|26118896|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
13171120|NCT02326272|26118897|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
13171121|NCT02326272|26118898|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
13171122|NCT02326272|26118899|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
13171123|NCT02326272|26118900|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
13171124|NCT02326272|26118901|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
13171125|NCT02326272|26118887|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
13171126|NCT02326272|26118888|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
13171127|NCT02326272|26118889|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
13171128|NCT02326272|26118890|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
13171129|NCT02326272|26118891|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
13171130|NCT02326272|26118892|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
13171131|NCT02326272|26118893|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1|||
13171132|NCT02326272|26118894|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
13171133|NCT02326272|26118895|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
13171134|NCT02326272|26118896|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
13171135|NCT02326272|26118897|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
13171136|NCT02326272|26118898|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
13171137|NCT02326272|26118899|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
13171138|NCT02326272|26118900|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
13171139|NCT02326272|26118901|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
13171140|NCT02326272|26118887|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
13171141|NCT02326272|26118888|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
13171142|NCT02326272|26118889|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
13171143|NCT02326272|26118890|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
13171144|NCT02326272|26118891|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
13171145|NCT02326272|26118892|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
13171146|NCT02326272|26118893|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
13171147|NCT02326272|26118894|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
13171148|NCT02326272|26118895|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
13171149|NCT02326272|26118896|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
13171150|NCT02326272|26118897|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
13171151|NCT02326272|26118898|FG011|Open-label Period (Week 48 to Week 144)|Death|0|||
13171152|NCT02326272|26118899|FG012|Open-label Period (Week 48 to Week 144)|Death|1|||
13171153|NCT02326272|26118900|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
13171154|NCT02326272|26118901|FG014|Open-label Period (Week 48 to Week 144)|Death|0|||
13171155|NCT02326272|26118887|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
13107857|NCT03267212|25889356|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0|||
13171156|NCT02326272|26118888|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
13171157|NCT02326272|26118889|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
13171158|NCT02326272|26118890|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
13171159|NCT02326272|26118891|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
13171160|NCT02326272|26118892|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
13171161|NCT02326272|26118893|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
13171162|NCT02326272|26118894|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
13171163|NCT02326272|26118895|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
13171164|NCT02326272|26118896|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
13171165|NCT02326272|26118897|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
13171166|NCT02326272|26118898|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8|||
13171167|NCT02326272|26118899|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
13171168|NCT02326272|26118900|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
13171169|NCT02326272|26118901|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
13171170|NCT02326272|26118887|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
13171171|NCT02326272|26118888|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
13171172|NCT02326272|26118889|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
13171173|NCT02326272|26118890|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
13171174|NCT02326272|26118891|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
13171175|NCT02326272|26118892|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
13171176|NCT02326272|26118893|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
13171177|NCT02326272|26118894|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
13171178|NCT02326272|26118895|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
13171179|NCT02326272|26118896|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
13171180|NCT02326272|26118897|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
13171181|NCT02326272|26118898|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
13171182|NCT02326272|26118899|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
13171183|NCT02326272|26118900|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
13171184|NCT02326272|26118901|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
13171185|NCT02326272|26118887|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
13171186|NCT02326272|26118888|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
13171187|NCT02326272|26118889|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
13171188|NCT02326272|26118890|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
13171189|NCT02326272|26118891|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
13171190|NCT02326272|26118892|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
13171191|NCT02326272|26118893|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
13171192|NCT02326272|26118894|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
13107858|NCT03266172|25889611|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1|||
13107859|NCT03266172|25889612|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
13107860|NCT03266172|25889613|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
13107861|NCT03266172|25889611|FG000|Part A: Washout Period (7 Days)|Adverse Event|1|||
13107862|NCT03266172|25889612|FG001|Part A: Washout Period (7 Days)|Adverse Event|0|||
13107863|NCT03266172|25889613|FG002|Part A: Washout Period (7 Days)|Adverse Event|0|||
13107864|NCT03266172|25889611|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1|||
13107865|NCT03266172|25889612|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
13107866|NCT03266172|25889613|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
13107867|NCT03266172|25889611|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
13107868|NCT03266172|25889612|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2|||
13107869|NCT03266172|25889613|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
13107870|NCT03266172|25889611|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
13107871|NCT03266172|25889612|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
13107872|NCT03266172|25889613|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
13107873|NCT03266172|25889611|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
13107874|NCT03266172|25889612|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
13107875|NCT03266172|25889613|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
13107876|NCT03266107|25889627|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1|||
13107877|NCT03266107|25889627|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2|||
13107878|NCT03266107|25889627|FG000|3-Month Follow-up Visit|Lost to Follow-up|1|||
13107879|NCT03266107|25889627|FG000|12-Month Follow-up Visit|Lost to Follow-up|1|||
13107880|NCT03266094|25889647|FG000|Overall Study|Lost to Follow-up|1|||
13107881|NCT03266094|25889647|FG000|Overall Study|Withdrawal by Subject|1|||
13107882|NCT03265938|25889660|FG000|Overall Study|Withdrawal by Subject|1|||
13107883|NCT03265938|25889660|FG000|Overall Study|Physician Decision|1|||
13107884|NCT03265938|25889660|FG000|Overall Study|friable mass|6|||
13107885|NCT03265600|25889691|FG000|Overall Study|Lost to Follow-up|17|||
13107886|NCT03265600|25889692|FG001|Overall Study|Lost to Follow-up|5|||
13107887|NCT03265600|25889691|FG000|Overall Study|Withdrawal by Subject|4|||
13107888|NCT03265600|25889692|FG001|Overall Study|Withdrawal by Subject|2|||
13107889|NCT03265600|25889691|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3|||
13107890|NCT03265600|25889692|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5|||
13107891|NCT03265132|25889803|FG000|Overall Study|Adverse Event|0|||
13107892|NCT03265132|25889804|FG001|Overall Study|Adverse Event|1|||
13107893|NCT03265132|25889803|FG000|Overall Study|Lack of Efficacy|0|||
13107894|NCT03265132|25889804|FG001|Overall Study|Lack of Efficacy|2|||
13107895|NCT03265132|25889803|FG000|Overall Study|Progressive disease|0|||
13171193|NCT02326272|26118895|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
13171194|NCT02326272|26118896|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
13171195|NCT02326272|26118897|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
13171196|NCT02326272|26118898|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1|||
13171197|NCT02326272|26118899|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
13171198|NCT02326272|26118900|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
13171199|NCT02326272|26118901|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
13171200|NCT02326272|26118887|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
13171201|NCT02326272|26118888|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
13171202|NCT02326272|26118889|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
13171203|NCT02326272|26118890|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
13171204|NCT02326272|26118891|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
13107896|NCT03265132|25889804|FG001|Overall Study|Progressive disease|2|||
13107897|NCT03265132|25889803|FG000|Overall Study|Withdrawal by Subject|0|||
13107898|NCT03265132|25889804|FG001|Overall Study|Withdrawal by Subject|1|||
13107899|NCT03265119|25889819|FG000|Overall Study|Adverse Event|2|||
13107900|NCT03265119|25889820|FG001|Overall Study|Adverse Event|1|||
13107901|NCT03265119|25889819|FG000|Overall Study|Lack of Efficacy|3|||
13171205|NCT02326272|26118892|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
13171206|NCT02326272|26118893|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
13171207|NCT02326272|26118894|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
13171208|NCT02326272|26118895|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
13171209|NCT02326272|26118896|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
13171210|NCT02326272|26118897|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
13171211|NCT02326272|26118898|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
13171212|NCT02326272|26118899|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
13171213|NCT02326272|26118900|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
13171214|NCT02326272|26118901|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
13171215|NCT02326272|26118887|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
13171216|NCT02326272|26118888|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
13171217|NCT02326272|26118889|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
13171218|NCT02326272|26118890|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
13171219|NCT02326272|26118891|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
13171220|NCT02326272|26118892|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
13171221|NCT02326272|26118893|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
13171222|NCT02326272|26118894|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
13171223|NCT02326272|26118895|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
13171224|NCT02326272|26118896|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
13171225|NCT02326272|26118897|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
13171226|NCT02326272|26118898|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
13107902|NCT03265119|25889820|FG001|Overall Study|Lack of Efficacy|0|||
13107903|NCT03265119|25889819|FG000|Overall Study|Protocol Violation|1|||
13107904|NCT03265119|25889820|FG001|Overall Study|Protocol Violation|2|||
13107905|NCT03265119|25889819|FG000|Overall Study|Withdrawal by Subject|2|||
13107906|NCT03265119|25889820|FG001|Overall Study|Withdrawal by Subject|4|||
13107907|NCT03265119|25889819|FG000|Overall Study|Lost to Follow-up|1|||
13171227|NCT02326272|26118899|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
13171228|NCT02326272|26118900|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
13171229|NCT02326272|26118901|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
13171230|NCT02326272|26118887|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
13171231|NCT02326272|26118888|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
13171232|NCT02326272|26118889|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
13171233|NCT02326272|26118890|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
13171234|NCT02326272|26118891|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
13171235|NCT02326272|26118892|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
13171236|NCT02326272|26118893|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
13171237|NCT02326272|26118894|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
13171238|NCT02326272|26118895|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
13171239|NCT02326272|26118896|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
13171240|NCT02326272|26118897|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
13171241|NCT02326272|26118898|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1|||
13171242|NCT02326272|26118899|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
13171243|NCT02326272|26118900|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
13171244|NCT02326272|26118901|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
13171245|NCT02326272|26118887|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
13171246|NCT02326272|26118888|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
13171247|NCT02326272|26118889|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
13171248|NCT02326272|26118890|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
13171249|NCT02326272|26118891|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
13171250|NCT02326272|26118892|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
13171251|NCT02326272|26118893|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
13171252|NCT02326272|26118894|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
13171253|NCT02326272|26118895|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
13171254|NCT02326272|26118896|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
13171255|NCT02326272|26118897|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
13171256|NCT02326272|26118898|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1|||
13171257|NCT02326272|26118899|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
13171258|NCT02326272|26118900|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
13171259|NCT02326272|26118901|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
13171260|NCT02326272|26118887|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
13171261|NCT02326272|26118888|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
13171262|NCT02326272|26118889|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
13171263|NCT02326272|26118890|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
13171264|NCT02326272|26118891|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
13171265|NCT02326272|26118892|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
13171266|NCT02326272|26118893|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
13171267|NCT02326272|26118894|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
13171268|NCT02326272|26118895|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
13171269|NCT02326272|26118896|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
13171270|NCT02326272|26118897|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
13171271|NCT02326272|26118898|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
13171272|NCT02326272|26118899|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1|||
13171273|NCT02326272|26118900|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
13171274|NCT02326272|26118901|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
13205583|NCT01964300|26232216|FG000|Overall Study|Withdrawal by Subject|0|||
13205584|NCT01964300|26232217|FG001|Overall Study|Withdrawal by Subject|1|||
13205585|NCT01964300|26232216|FG000|Overall Study|To receive alternative therapy|1|||
13205586|NCT01964300|26232217|FG001|Overall Study|To receive alternative therapy|2|||
13205587|NCT01964300|26232216|FG000|Overall Study|Enlargement of cyst requiring drainage|1|||
13205588|NCT01964300|26232217|FG001|Overall Study|Enlargement of cyst requiring drainage|0|||
13205589|NCT01964300|26232216|FG000|Overall Study|Weight criteria not met|0|||
13205590|NCT01964300|26232217|FG001|Overall Study|Weight criteria not met|1|||
13205591|NCT01964222|26232238|FG000|Overall Study|Lost to Follow-up|7|||
13205592|NCT01964222|26232239|FG001|Overall Study|Lost to Follow-up|5|||
13205593|NCT01964222|26232238|FG000|Overall Study|Withdrawal by Subject|6|||
13205594|NCT01964222|26232239|FG001|Overall Study|Withdrawal by Subject|6|||
13205595|NCT01964222|26232238|FG000|Overall Study|Screening Failure|2|||
13205596|NCT01964222|26232239|FG001|Overall Study|Screening Failure|0|||
13205597|NCT01964105|26232257|FG000|Overall Study|Lost to Follow-up|2|||
13205598|NCT01964105|26232258|FG001|Overall Study|Lost to Follow-up|13|||
13205599|NCT01964105|26232259|FG002|Overall Study|Lost to Follow-up|0|||
13205600|NCT01963780|26232269|FG000|Overall Study|Death|7|||
13205601|NCT01963767|26232284|FG000|Overall Study|Withdrawal by Subject|4|||
13205602|NCT01963767|26232285|FG001|Overall Study|Withdrawal by Subject|2|||
13205603|NCT01963767|26232284|FG000|Overall Study|Adverse Event|2|||
13205604|NCT01963767|26232285|FG001|Overall Study|Adverse Event|0|||
13205605|NCT01963728|26232300|FG000|Overall Study|Study terminated early|0|||
13205606|NCT01963728|26232301|FG001|Overall Study|Study terminated early|1|||
13205607|NCT01963676|26232316|FG000|Overall Study|Withdrawal by Subject|1|||
13171275|NCT02326220|26118960|FG000|Double-blind Treatment Period|Adverse Event|1|||
13171276|NCT02326220|26118961|FG001|Double-blind Treatment Period|Adverse Event|2|||
13171277|NCT02326220|26118962|FG002|Double-blind Treatment Period|Adverse Event|0|||
13171278|NCT02326220|26118960|FG000|Double-blind Treatment Period|Protocol Violation|0|||
13171279|NCT02326220|26118961|FG001|Double-blind Treatment Period|Protocol Violation|1|||
13171280|NCT02326220|26118962|FG002|Double-blind Treatment Period|Protocol Violation|0|||
13171281|NCT02326220|26118960|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
13171282|NCT02326220|26118961|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
13171283|NCT02326220|26118962|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
13171284|NCT02326220|26118960|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
13171285|NCT02326220|26118961|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
13171286|NCT02326220|26118962|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
13171287|NCT02326220|26118960|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
13171288|NCT02326220|26118961|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
13171289|NCT02326220|26118962|FG002|Open-label Treatment Period|Lost to Follow-up|1|||
13171290|NCT02326155|26118985|FG000|Overall Study|Adverse Event|21|||
13171291|NCT02326155|26118986|FG001|Overall Study|Adverse Event|5|||
13171292|NCT02326155|26118985|FG000|Overall Study|Death|3|||
13171293|NCT02326155|26118986|FG001|Overall Study|Death|0|||
13171294|NCT02326155|26118985|FG000|Overall Study|Lack of Efficacy|49|||
13171295|NCT02326155|26118986|FG001|Overall Study|Lack of Efficacy|5|||
13171296|NCT02326155|26118985|FG000|Overall Study|Lost to Follow-up|14|||
13171297|NCT02326155|26118986|FG001|Overall Study|Lost to Follow-up|3|||
13171298|NCT02326155|26118985|FG000|Overall Study|Protocol Violation|2|||
13171299|NCT02326155|26118986|FG001|Overall Study|Protocol Violation|0|||
13171300|NCT02326155|26118985|FG000|Overall Study|Withdrawal by Subject|34|||
13171301|NCT02326155|26118986|FG001|Overall Study|Withdrawal by Subject|11|||
13171302|NCT02326155|26118985|FG000|Overall Study|Disease progression|37|||
13171303|NCT02326155|26118986|FG001|Overall Study|Disease progression|4|||
13171304|NCT02326155|26118985|FG000|Overall Study|Study close|188|||
13171305|NCT02326155|26118986|FG001|Overall Study|Study close|21|||
13171306|NCT02326155|26118985|FG000|Overall Study|except for study close|46|||
13171307|NCT02326155|26118986|FG001|Overall Study|except for study close|13|||
13171308|NCT02326025|26119025|FG000|Overall Study|Adverse Event|3|||
13171309|NCT02326025|26119026|FG001|Overall Study|Adverse Event|0|||
13171310|NCT02326025|26119025|FG000|Overall Study|Physician Decision|1|||
13171311|NCT02326025|26119026|FG001|Overall Study|Physician Decision|2|||
13171312|NCT02326025|26119025|FG000|Overall Study|Physician and Participant Decision|1|||
13171313|NCT02326025|26119026|FG001|Overall Study|Physician and Participant Decision|0|||
13171314|NCT02326025|26119025|FG000|Overall Study|Withdrawal by Subject|0|||
13171315|NCT02326025|26119026|FG001|Overall Study|Withdrawal by Subject|2|||
13171316|NCT02326025|26119025|FG000|Overall Study|Protocol Violation|0|||
13171317|NCT02326025|26119026|FG001|Overall Study|Protocol Violation|1|||
13171318|NCT02325791|26119058|FG000|Overall Study|Adverse Event|0|||
13171319|NCT02325791|26119059|FG001|Overall Study|Adverse Event|1|||
13171320|NCT02325791|26119060|FG002|Overall Study|Adverse Event|1|||
13171321|NCT02325791|26119061|FG003|Overall Study|Adverse Event|0|||
13171322|NCT02325791|26119058|FG000|Overall Study|Death|0|||
13171323|NCT02325791|26119059|FG001|Overall Study|Death|3|||
13171324|NCT02325791|26119060|FG002|Overall Study|Death|0|||
13171325|NCT02325791|26119061|FG003|Overall Study|Death|1|||
13171326|NCT02325791|26119058|FG000|Overall Study|Lost to Follow-up|0|||
13171327|NCT02325791|26119059|FG001|Overall Study|Lost to Follow-up|15|||
13171328|NCT02325791|26119060|FG002|Overall Study|Lost to Follow-up|14|||
13171329|NCT02325791|26119061|FG003|Overall Study|Lost to Follow-up|9|||
13171330|NCT02325791|26119058|FG000|Overall Study|Physician Decision|0|||
13171331|NCT02325791|26119059|FG001|Overall Study|Physician Decision|1|||
13171332|NCT02325791|26119060|FG002|Overall Study|Physician Decision|1|||
13171333|NCT02325791|26119061|FG003|Overall Study|Physician Decision|0|||
13171334|NCT02325791|26119058|FG000|Overall Study|Protocol Violation|0|||
13171335|NCT02325791|26119059|FG001|Overall Study|Protocol Violation|0|||
13171336|NCT02325791|26119060|FG002|Overall Study|Protocol Violation|1|||
13171337|NCT02325791|26119061|FG003|Overall Study|Protocol Violation|0|||
13171338|NCT02325791|26119058|FG000|Overall Study|Withdrawal by Subject|0|||
13171339|NCT02325791|26119059|FG001|Overall Study|Withdrawal by Subject|5|||
13171340|NCT02325791|26119060|FG002|Overall Study|Withdrawal by Subject|8|||
13171341|NCT02325791|26119061|FG003|Overall Study|Withdrawal by Subject|16|||
13171342|NCT02325739|26119209|FG000|Phase I Part|Adverse Event|1|||
13171343|NCT02325739|26119210|FG001|Phase I Part|Adverse Event|0|||
13171344|NCT02325739|26119211|FG002|Phase I Part|Adverse Event|1|||
13171345|NCT02325739|26119212|FG003|Phase I Part|Adverse Event|2|||
13171346|NCT02325739|26119213|FG004|Phase I Part|Adverse Event|3|||
13171347|NCT02325739|26119214|FG005|Phase I Part|Adverse Event|1|||
13171348|NCT02325739|26119215|FG006|Phase I Part|Adverse Event|0|||
13171349|NCT02325739|26119216|FG007|Phase I Part|Adverse Event|2|||
13171350|NCT02325739|26119217|FG008|Phase I Part|Adverse Event|0|||
13171351|NCT02325739|26119218|FG009|Phase I Part|Adverse Event|0|||
13171352|NCT02325739|26119219|FG010|Phase I Part|Adverse Event|0|||
13171353|NCT02325739|26119209|FG000|Phase I Part|Progressive disease|9|||
13171354|NCT02325739|26119210|FG001|Phase I Part|Progressive disease|6|||
13171355|NCT02325739|26119211|FG002|Phase I Part|Progressive disease|3|||
13171356|NCT02325739|26119212|FG003|Phase I Part|Progressive disease|23|||
13171357|NCT02325739|26119213|FG004|Phase I Part|Progressive disease|14|||
13171358|NCT02325739|26119214|FG005|Phase I Part|Progressive disease|6|||
13171359|NCT02325739|26119215|FG006|Phase I Part|Progressive disease|6|||
13171360|NCT02325739|26119216|FG007|Phase I Part|Progressive disease|3|||
13171361|NCT02325739|26119217|FG008|Phase I Part|Progressive disease|0|||
13171362|NCT02325739|26119218|FG009|Phase I Part|Progressive disease|0|||
13171363|NCT02325739|26119219|FG010|Phase I Part|Progressive disease|0|||
13171364|NCT02325739|26119209|FG000|Phase I Part|Subject/guardian decision|1|||
13171365|NCT02325739|26119210|FG001|Phase I Part|Subject/guardian decision|0|||
13171366|NCT02325739|26119211|FG002|Phase I Part|Subject/guardian decision|1|||
13171367|NCT02325739|26119212|FG003|Phase I Part|Subject/guardian decision|1|||
13171368|NCT02325739|26119213|FG004|Phase I Part|Subject/guardian decision|0|||
13171369|NCT02325739|26119214|FG005|Phase I Part|Subject/guardian decision|0|||
13171370|NCT02325739|26119215|FG006|Phase I Part|Subject/guardian decision|0|||
13107908|NCT03265119|25889820|FG001|Overall Study|Lost to Follow-up|0|||
13107909|NCT03265119|25889819|FG000|Overall Study|Lack of Compliance|1|||
13107910|NCT03265119|25889820|FG001|Overall Study|Lack of Compliance|0|||
13107911|NCT03264456|25889829|FG000|Overall Study|Withdrawal by Subject|3|||
13107912|NCT03264456|25889829|FG000|Overall Study|Lost to Follow-up|1|||
13107913|NCT03264066|25889902|FG000|Overall Study|Adverse Event|1|||
13107914|NCT03264066|25889903|FG001|Overall Study|Adverse Event|1|||
13107915|NCT03264066|25889904|FG002|Overall Study|Adverse Event|0|||
13107916|NCT03264066|25889905|FG003|Overall Study|Adverse Event|0|||
13107917|NCT03264066|25889906|FG004|Overall Study|Adverse Event|0|||
13107918|NCT03264066|25889907|FG005|Overall Study|Adverse Event|0|||
13107919|NCT03264066|25889902|FG000|Overall Study|Death|12|||
13107920|NCT03264066|25889903|FG001|Overall Study|Death|12|||
13107921|NCT03264066|25889904|FG002|Overall Study|Death|8|||
13107922|NCT03264066|25889905|FG003|Overall Study|Death|10|||
13107923|NCT03264066|25889906|FG004|Overall Study|Death|6|||
13107924|NCT03264066|25889907|FG005|Overall Study|Death|1|||
13107925|NCT03264066|25889902|FG000|Overall Study|Lost to Follow-up|1|||
13171371|NCT02325739|26119216|FG007|Phase I Part|Subject/guardian decision|1|||
13171372|NCT02325739|26119217|FG008|Phase I Part|Subject/guardian decision|0|||
13171373|NCT02325739|26119218|FG009|Phase I Part|Subject/guardian decision|0|||
13171374|NCT02325739|26119219|FG010|Phase I Part|Subject/guardian decision|0|||
13171375|NCT02325739|26119209|FG000|Phase I Part|Death|0|||
13171376|NCT02325739|26119210|FG001|Phase I Part|Death|0|||
13171377|NCT02325739|26119211|FG002|Phase I Part|Death|0|||
13171378|NCT02325739|26119212|FG003|Phase I Part|Death|0|||
13171379|NCT02325739|26119213|FG004|Phase I Part|Death|2|||
13171380|NCT02325739|26119214|FG005|Phase I Part|Death|0|||
13171381|NCT02325739|26119215|FG006|Phase I Part|Death|0|||
13171382|NCT02325739|26119216|FG007|Phase I Part|Death|0|||
13171383|NCT02325739|26119217|FG008|Phase I Part|Death|0|||
13171384|NCT02325739|26119218|FG009|Phase I Part|Death|0|||
13171385|NCT02325739|26119219|FG010|Phase I Part|Death|0|||
13171386|NCT02325739|26119209|FG000|Phase II Part|Adverse Event|0|||
13171387|NCT02325739|26119210|FG001|Phase II Part|Adverse Event|0|||
13171388|NCT02325739|26119211|FG002|Phase II Part|Adverse Event|0|||
13171389|NCT02325739|26119212|FG003|Phase II Part|Adverse Event|0|||
13171390|NCT02325739|26119213|FG004|Phase II Part|Adverse Event|0|||
13171391|NCT02325739|26119214|FG005|Phase II Part|Adverse Event|0|||
13171392|NCT02325739|26119215|FG006|Phase II Part|Adverse Event|0|||
13171393|NCT02325739|26119216|FG007|Phase II Part|Adverse Event|0|||
13171394|NCT02325739|26119217|FG008|Phase II Part|Adverse Event|4|||
13171395|NCT02325739|26119218|FG009|Phase II Part|Adverse Event|5|||
13171396|NCT02325739|26119219|FG010|Phase II Part|Adverse Event|1|||
13171397|NCT02325739|26119209|FG000|Phase II Part|Physician Decision|0|||
13171398|NCT02325739|26119210|FG001|Phase II Part|Physician Decision|0|||
13171399|NCT02325739|26119211|FG002|Phase II Part|Physician Decision|0|||
13107926|NCT03264066|25889903|FG001|Overall Study|Lost to Follow-up|0|||
13107927|NCT03264066|25889904|FG002|Overall Study|Lost to Follow-up|0|||
13107928|NCT03264066|25889905|FG003|Overall Study|Lost to Follow-up|0|||
13107929|NCT03264066|25889906|FG004|Overall Study|Lost to Follow-up|0|||
13107930|NCT03264066|25889907|FG005|Overall Study|Lost to Follow-up|0|||
13107931|NCT03264066|25889902|FG000|Overall Study|Progressive Disease|0|||
13107932|NCT03264066|25889903|FG001|Overall Study|Progressive Disease|2|||
13107933|NCT03264066|25889904|FG002|Overall Study|Progressive Disease|1|||
13107934|NCT03264066|25889905|FG003|Overall Study|Progressive Disease|0|||
13107935|NCT03264066|25889906|FG004|Overall Study|Progressive Disease|0|||
13171400|NCT02325739|26119212|FG003|Phase II Part|Physician Decision|0|||
13171401|NCT02325739|26119213|FG004|Phase II Part|Physician Decision|0|||
13171402|NCT02325739|26119214|FG005|Phase II Part|Physician Decision|0|||
13171403|NCT02325739|26119215|FG006|Phase II Part|Physician Decision|0|||
13171404|NCT02325739|26119216|FG007|Phase II Part|Physician Decision|0|||
13171405|NCT02325739|26119217|FG008|Phase II Part|Physician Decision|0|||
13171406|NCT02325739|26119218|FG009|Phase II Part|Physician Decision|1|||
13107936|NCT03264066|25889907|FG005|Overall Study|Progressive Disease|0|||
13107937|NCT03264066|25889902|FG000|Overall Study|Study Terminated by Sponsor|5|||
13107938|NCT03264066|25889903|FG001|Overall Study|Study Terminated by Sponsor|5|||
13107939|NCT03264066|25889904|FG002|Overall Study|Study Terminated by Sponsor|8|||
13107940|NCT03264066|25889905|FG003|Overall Study|Study Terminated by Sponsor|5|||
13107941|NCT03264066|25889906|FG004|Overall Study|Study Terminated by Sponsor|1|||
13107942|NCT03264066|25889907|FG005|Overall Study|Study Terminated by Sponsor|2|||
13107943|NCT03264066|25889902|FG000|Overall Study|Withdrawal by Subject|1|||
13107944|NCT03264066|25889903|FG001|Overall Study|Withdrawal by Subject|0|||
13107945|NCT03264066|25889904|FG002|Overall Study|Withdrawal by Subject|0|||
13107946|NCT03264066|25889905|FG003|Overall Study|Withdrawal by Subject|5|||
13107947|NCT03264066|25889906|FG004|Overall Study|Withdrawal by Subject|0|||
13107948|NCT03264066|25889907|FG005|Overall Study|Withdrawal by Subject|0|||
13107949|NCT03263806|25889926|FG000|Overall Study|Elevated Troponin (failed screen)|1|||
13107950|NCT03263806|25889927|FG001|Overall Study|Elevated Troponin (failed screen)|0|||
13107951|NCT03263806|25889926|FG000|Overall Study|Withdrawal by Subject|0|||
13107952|NCT03263806|25889927|FG001|Overall Study|Withdrawal by Subject|1|||
13171407|NCT02325739|26119219|FG010|Phase II Part|Physician Decision|0|||
13171408|NCT02325739|26119209|FG000|Phase II Part|Progressive disease|0|||
13171409|NCT02325739|26119210|FG001|Phase II Part|Progressive disease|0|||
13171410|NCT02325739|26119211|FG002|Phase II Part|Progressive disease|0|||
13171411|NCT02325739|26119212|FG003|Phase II Part|Progressive disease|0|||
13171412|NCT02325739|26119213|FG004|Phase II Part|Progressive disease|0|||
13171413|NCT02325739|26119214|FG005|Phase II Part|Progressive disease|0|||
13171414|NCT02325739|26119215|FG006|Phase II Part|Progressive disease|0|||
13171415|NCT02325739|26119216|FG007|Phase II Part|Progressive disease|0|||
13171416|NCT02325739|26119217|FG008|Phase II Part|Progressive disease|22|||
13171417|NCT02325739|26119218|FG009|Phase II Part|Progressive disease|29|||
13171418|NCT02325739|26119219|FG010|Phase II Part|Progressive disease|18|||
13171419|NCT02325739|26119209|FG000|Phase II Part|Subject/guardian decision|0|||
13171420|NCT02325739|26119210|FG001|Phase II Part|Subject/guardian decision|0|||
13171421|NCT02325739|26119211|FG002|Phase II Part|Subject/guardian decision|0|||
13171422|NCT02325739|26119212|FG003|Phase II Part|Subject/guardian decision|0|||
13171423|NCT02325739|26119213|FG004|Phase II Part|Subject/guardian decision|0|||
13171424|NCT02325739|26119214|FG005|Phase II Part|Subject/guardian decision|0|||
13171425|NCT02325739|26119215|FG006|Phase II Part|Subject/guardian decision|0|||
13171426|NCT02325739|26119216|FG007|Phase II Part|Subject/guardian decision|0|||
13171427|NCT02325739|26119217|FG008|Phase II Part|Subject/guardian decision|4|||
13171428|NCT02325739|26119218|FG009|Phase II Part|Subject/guardian decision|1|||
13171429|NCT02325739|26119219|FG010|Phase II Part|Subject/guardian decision|1|||
13171430|NCT02325713|26119361|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
13171431|NCT02325713|26119362|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
13171432|NCT02325713|26119363|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
13171433|NCT02325713|26119364|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
13171434|NCT02325713|26119365|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
13171435|NCT02325713|26119366|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
13171436|NCT02325713|26119367|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
13171437|NCT02325713|26119368|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
13171438|NCT02325713|26119369|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
13171439|NCT02325713|26119370|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
13171440|NCT02325713|26119371|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1|||
13171441|NCT02325713|26119372|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
13171442|NCT02325713|26119373|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
13171443|NCT02325713|26119374|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
13171444|NCT02325713|26119375|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
13171445|NCT02325713|26119376|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
13171446|NCT02325713|26119361|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1|||
13171447|NCT02325713|26119362|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
13171448|NCT02325713|26119363|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
13171449|NCT02325713|26119364|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
13171450|NCT02325713|26119365|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
13171451|NCT02325713|26119366|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
13171452|NCT02325713|26119367|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
13171453|NCT02325713|26119368|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
13171454|NCT02325713|26119369|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
13171455|NCT02325713|26119370|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
13171456|NCT02325713|26119371|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
13171457|NCT02325713|26119372|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
13107953|NCT03263806|25889926|FG000|Overall Study|Study Termination|5|||
13171458|NCT02325713|26119373|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
13171459|NCT02325713|26119374|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
13171460|NCT02325713|26119375|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
13171461|NCT02325713|26119376|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
13171462|NCT02325713|26119361|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
13171463|NCT02325713|26119362|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
13171464|NCT02325713|26119363|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
13171465|NCT02325713|26119364|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
13171466|NCT02325713|26119365|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
13171467|NCT02325713|26119366|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
13171468|NCT02325713|26119367|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
13171469|NCT02325713|26119368|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
13171470|NCT02325713|26119369|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
13171471|NCT02325713|26119370|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1|||
13171472|NCT02325713|26119371|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
13171473|NCT02325713|26119372|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
13171474|NCT02325713|26119373|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
13171475|NCT02325713|26119374|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
13171476|NCT02325713|26119375|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
13171477|NCT02325713|26119376|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
13171478|NCT02325518|26119392|FG000|Overall Study|Adverse Event|4|||
13171479|NCT02325518|26119393|FG001|Overall Study|Adverse Event|1|||
13171480|NCT02325518|26119392|FG000|Overall Study|Physician Decision|0|||
13171481|NCT02325518|26119393|FG001|Overall Study|Physician Decision|1|||
13171482|NCT02325518|26119392|FG000|Overall Study|Withdrawal by Subject|0|||
13171483|NCT02325518|26119393|FG001|Overall Study|Withdrawal by Subject|1|||
13171484|NCT02325414|26119412|FG000|Overall Study|Withdrawal by Subject|3|||
13171485|NCT02325414|26119413|FG001|Overall Study|Withdrawal by Subject|1|||
13171486|NCT02325414|26119412|FG000|Overall Study|Lost to Follow-up|5|||
13171487|NCT02325414|26119413|FG001|Overall Study|Lost to Follow-up|5|||
13171488|NCT02325401|26119437|FG000|Overall Study|Withdrawal by Subject|0|||
13171489|NCT02325401|26119438|FG001|Overall Study|Withdrawal by Subject|1|||
13171490|NCT02325401|26119439|FG002|Overall Study|Withdrawal by Subject|1|||
13171491|NCT02325219|26119623|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6|||
13171492|NCT02325219|26119624|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1|||
13171493|NCT02325219|26119625|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0|||
13171494|NCT02325219|26119626|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0|||
13171495|NCT02325219|26119627|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0|||
13171496|NCT02325219|26119623|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6|||
13171497|NCT02325219|26119624|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
13171498|NCT02325219|26119625|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
13171499|NCT02325219|26119626|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
13171500|NCT02325219|26119627|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
13171501|NCT02325219|26119623|FG000|Controlled Period (Week 0 - 16)|Other|0|||
13171502|NCT02325219|26119624|FG001|Controlled Period (Week 0 - 16)|Other|0|||
13171503|NCT02325219|26119625|FG002|Controlled Period (Week 0 - 16)|Other|1|||
13171504|NCT02325219|26119626|FG003|Controlled Period (Week 0 - 16)|Other|0|||
13171505|NCT02325219|26119627|FG004|Controlled Period (Week 0 - 16)|Other|0|||
13171506|NCT02325219|26119623|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
13171507|NCT02325219|26119624|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
13171508|NCT02325219|26119625|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
13171509|NCT02325219|26119626|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
13171510|NCT02325219|26119627|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
13171511|NCT02325219|26119623|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
13171512|NCT02325219|26119624|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2|||
13171513|NCT02325219|26119625|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
13171514|NCT02325219|26119626|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
13171515|NCT02325219|26119627|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
13171516|NCT02325219|26119623|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
13171517|NCT02325219|26119624|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
13171518|NCT02325219|26119625|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
13171519|NCT02325219|26119626|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
13171520|NCT02325219|26119627|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
13171521|NCT02324842|26119666|FG000|Overall Study|Lost to Follow-up|1|||
13171522|NCT02324842|26119667|FG001|Overall Study|Lost to Follow-up|1|||
13171523|NCT02324842|26119668|FG002|Overall Study|Lost to Follow-up|2|||
13171524|NCT02324699|26119677|FG000|Overall Study|study terminated|1|||
13171525|NCT02324569|26119708|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
13171526|NCT02324569|26119709|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
13171527|NCT02324569|26119708|FG000|Overall Study|Voluntary Withdrawal|3|||
13171528|NCT02324569|26119709|FG001|Overall Study|Voluntary Withdrawal|6|||
13171529|NCT02324569|26119708|FG000|Overall Study|Lack of Efficacy|2|||
13171530|NCT02324569|26119709|FG001|Overall Study|Lack of Efficacy|3|||
13171531|NCT02324569|26119708|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0|||
13171532|NCT02324569|26119709|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2|||
13171533|NCT02324569|26119708|FG000|Overall Study|Inconvenient Schedule|2|||
13171534|NCT02324569|26119709|FG001|Overall Study|Inconvenient Schedule|0|||
13171535|NCT02324465|26119728|FG000|Overall Study|device failure|0|||
13171536|NCT02324465|26119729|FG001|Overall Study|device failure|1|||
13171537|NCT02324361|26119748|FG000|Overall Study|Lost to Follow-up|5|||
13171538|NCT02324361|26119749|FG001|Overall Study|Lost to Follow-up|2|||
13171539|NCT02324270|26119769|FG000|Overall Study|Withdrawal by Subject|0|||
13171540|NCT02324270|26119770|FG001|Overall Study|Withdrawal by Subject|1|||
13171541|NCT02324270|26119771|FG002|Overall Study|Withdrawal by Subject|0|||
13171542|NCT02324270|26119769|FG000|Overall Study|Lost to Follow-up|4|||
13171543|NCT02324270|26119770|FG001|Overall Study|Lost to Follow-up|3|||
13171544|NCT02324270|26119771|FG002|Overall Study|Lost to Follow-up|4|||
13171545|NCT02324270|26119769|FG000|Overall Study|Protocol Violation|0|||
13171546|NCT02324270|26119770|FG001|Overall Study|Protocol Violation|1|||
13171547|NCT02324270|26119771|FG002|Overall Study|Protocol Violation|1|||
13171548|NCT02324270|26119769|FG000|Overall Study|Non Compliance with Study Drug|1|||
13171549|NCT02324270|26119770|FG001|Overall Study|Non Compliance with Study Drug|2|||
13171550|NCT02324270|26119771|FG002|Overall Study|Non Compliance with Study Drug|0|||
13171551|NCT02324205|26119783|FG000|Overall Study|Withdrawal by Subject|37|||
13171552|NCT02324153|26119800|FG000|Overall Study|Withdrawal by Subject|4|||
13171553|NCT02324153|26119801|FG001|Overall Study|Withdrawal by Subject|1|||
13171554|NCT02324153|26119800|FG000|Overall Study|Surgery postponed after randomization|3|||
13171555|NCT02324153|26119801|FG001|Overall Study|Surgery postponed after randomization|0|||
13171556|NCT02324153|26119800|FG000|Overall Study|Developed delirium preoperatively|1|||
13171557|NCT02324153|26119801|FG001|Overall Study|Developed delirium preoperatively|0|||
13171558|NCT02324049|26119807|FG000|Part C|Study terminated|11|||
13171559|NCT02323646|26119861|FG000|Treatment Course 1|Adverse Event|1|||
13171560|NCT02323646|26119862|FG001|Treatment Course 1|Adverse Event|0|||
13171561|NCT02323646|26119863|FG002|Treatment Course 1|Adverse Event|1|||
13171562|NCT02323646|26119861|FG000|Treatment Course 1|Heavy Bleeding|1|||
13171563|NCT02323646|26119862|FG001|Treatment Course 1|Heavy Bleeding|1|||
13171564|NCT02323646|26119863|FG002|Treatment Course 1|Heavy Bleeding|0|||
13171565|NCT02323646|26119861|FG000|Treatment Course 1|Lost to Follow-up|1|||
13171566|NCT02323646|26119862|FG001|Treatment Course 1|Lost to Follow-up|0|||
13171567|NCT02323646|26119863|FG002|Treatment Course 1|Lost to Follow-up|2|||
13171568|NCT02323646|26119861|FG000|Treatment Course 1|Withdrawal by Subject|0|||
13171569|NCT02323646|26119862|FG001|Treatment Course 1|Withdrawal by Subject|2|||
13171570|NCT02323646|26119863|FG002|Treatment Course 1|Withdrawal by Subject|0|||
13171571|NCT02323646|26119861|FG000|Treatment Course 2|Adverse Event|1|||
13171572|NCT02323646|26119862|FG001|Treatment Course 2|Adverse Event|0|||
13171573|NCT02323646|26119863|FG002|Treatment Course 2|Adverse Event|1|||
13171574|NCT02323646|26119861|FG000|Treatment Course 2|Lost to Follow-up|0|||
13171575|NCT02323646|26119862|FG001|Treatment Course 2|Lost to Follow-up|0|||
13171576|NCT02323646|26119863|FG002|Treatment Course 2|Lost to Follow-up|1|||
13171577|NCT02323646|26119861|FG000|Treatment Course 2|Non-compliance|0|||
13171578|NCT02323646|26119862|FG001|Treatment Course 2|Non-compliance|1|||
13171579|NCT02323646|26119863|FG002|Treatment Course 2|Non-compliance|1|||
13171580|NCT02323334|26119973|FG000|Period 3|Lost to Follow-up|0|||
13171581|NCT02323334|26119974|FG001|Period 3|Lost to Follow-up|0|||
13171582|NCT02323334|26119975|FG002|Period 3|Lost to Follow-up|1|||
13171583|NCT02323334|26119976|FG003|Period 3|Lost to Follow-up|0|||
13171584|NCT02323334|26119977|FG004|Period 3|Lost to Follow-up|0|||
13171585|NCT02323334|26119978|FG005|Period 3|Lost to Follow-up|0|||
13171586|NCT02323334|26119979|FG006|Period 3|Lost to Follow-up|0|||
13171587|NCT02323334|26119980|FG007|Period 3|Lost to Follow-up|0|||
13171588|NCT02323334|26119981|FG008|Period 3|Lost to Follow-up|0|||
13171589|NCT02323334|26119982|FG009|Period 3|Lost to Follow-up|0|||
13171590|NCT02323334|26119983|FG010|Period 3|Lost to Follow-up|0|||
13171591|NCT02323334|26119984|FG011|Period 3|Lost to Follow-up|0|||
13171592|NCT02323334|26119985|FG012|Period 3|Lost to Follow-up|0|||
13171593|NCT02323334|26119986|FG013|Period 3|Lost to Follow-up|0|||
13171594|NCT02323334|26119987|FG014|Period 3|Lost to Follow-up|0|||
13171595|NCT02323334|26119988|FG015|Period 3|Lost to Follow-up|0|||
13171596|NCT02323334|26119989|FG016|Period 3|Lost to Follow-up|0|||
13171597|NCT02323334|26119973|FG000|Period 3|Withdrawal by Subject|1|||
13171598|NCT02323334|26119974|FG001|Period 3|Withdrawal by Subject|0|||
13171599|NCT02323334|26119975|FG002|Period 3|Withdrawal by Subject|0|||
13171600|NCT02323334|26119976|FG003|Period 3|Withdrawal by Subject|0|||
13171601|NCT02323334|26119977|FG004|Period 3|Withdrawal by Subject|0|||
13171602|NCT02323334|26119978|FG005|Period 3|Withdrawal by Subject|0|||
13171603|NCT02323334|26119979|FG006|Period 3|Withdrawal by Subject|0|||
13171604|NCT02323334|26119980|FG007|Period 3|Withdrawal by Subject|0|||
13171605|NCT02323334|26119981|FG008|Period 3|Withdrawal by Subject|0|||
13171606|NCT02323334|26119982|FG009|Period 3|Withdrawal by Subject|0|||
13171607|NCT02323334|26119983|FG010|Period 3|Withdrawal by Subject|0|||
13171608|NCT02323334|26119984|FG011|Period 3|Withdrawal by Subject|0|||
13171609|NCT02323334|26119985|FG012|Period 3|Withdrawal by Subject|0|||
13171610|NCT02323334|26119986|FG013|Period 3|Withdrawal by Subject|0|||
13171611|NCT02323334|26119987|FG014|Period 3|Withdrawal by Subject|0|||
13171612|NCT02323334|26119988|FG015|Period 3|Withdrawal by Subject|0|||
13171613|NCT02323334|26119989|FG016|Period 3|Withdrawal by Subject|0|||
13171614|NCT02323204|26120052|FG000|Baseline Survey Completion|Withdrawal by Subject|10|||
13171615|NCT02323204|26120053|FG001|Baseline Survey Completion|Withdrawal by Subject|9|||
13171616|NCT02323204|26120054|FG002|Baseline Survey Completion|Withdrawal by Subject|5|||
13171617|NCT02323204|26120055|FG003|Baseline Survey Completion|Withdrawal by Subject|3|||
13171618|NCT02323204|26120052|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29|||
13171619|NCT02323204|26120053|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28|||
13171620|NCT02323204|26120054|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39|||
13171621|NCT02323204|26120055|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35|||
13171622|NCT02323204|26120052|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12|||
13171623|NCT02323204|26120053|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8|||
13171624|NCT02323204|26120054|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3|||
13171625|NCT02323204|26120055|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2|||
13171626|NCT02323204|26120052|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
13171627|NCT02323204|26120053|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35|||
13171628|NCT02323204|26120054|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
13171629|NCT02323204|26120055|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34|||
13171630|NCT02323204|26120052|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
13171631|NCT02323204|26120053|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8|||
13171632|NCT02323204|26120054|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
13171633|NCT02323204|26120055|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2|||
13171634|NCT02323204|26120052|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54|||
13171635|NCT02323204|26120053|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45|||
13171636|NCT02323204|26120054|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41|||
13171637|NCT02323204|26120055|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42|||
13171638|NCT02323204|26120052|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
13171639|NCT02323204|26120053|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
13171640|NCT02323204|26120054|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
13171641|NCT02323204|26120055|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
13171642|NCT02323204|26120052|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49|||
13171643|NCT02323204|26120053|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50|||
13171644|NCT02323204|26120054|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38|||
13171645|NCT02323204|26120055|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43|||
13171646|NCT02323204|26120052|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
13171647|NCT02323204|26120053|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
13171648|NCT02323204|26120054|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3|||
13171649|NCT02323204|26120055|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1|||
13171650|NCT02323113|26120165|FG000|Overall Study|Adverse Event|3|||
13171651|NCT02323113|26120166|FG001|Overall Study|Adverse Event|3|||
13171652|NCT02323113|26120167|FG002|Overall Study|Adverse Event|2|||
13171653|NCT02323113|26120168|FG003|Overall Study|Adverse Event|5|||
13171654|NCT02323113|26120169|FG004|Overall Study|Adverse Event|8|||
13171655|NCT02323113|26120170|FG005|Overall Study|Adverse Event|3|||
13171656|NCT02323113|26120171|FG006|Overall Study|Adverse Event|6|||
13171657|NCT02323113|26120172|FG007|Overall Study|Adverse Event|0|||
13171658|NCT02323113|26120165|FG000|Overall Study|Progressive Disease|0|||
13171659|NCT02323113|26120166|FG001|Overall Study|Progressive Disease|1|||
13171660|NCT02323113|26120167|FG002|Overall Study|Progressive Disease|1|||
13171661|NCT02323113|26120168|FG003|Overall Study|Progressive Disease|0|||
13171662|NCT02323113|26120169|FG004|Overall Study|Progressive Disease|0|||
13171663|NCT02323113|26120170|FG005|Overall Study|Progressive Disease|3|||
13171664|NCT02323113|26120171|FG006|Overall Study|Progressive Disease|0|||
13171665|NCT02323113|26120172|FG007|Overall Study|Progressive Disease|0|||
13171666|NCT02323113|26120165|FG000|Overall Study|Symptomatic Deterioration|0|||
13171667|NCT02323113|26120166|FG001|Overall Study|Symptomatic Deterioration|0|||
13171668|NCT02323113|26120167|FG002|Overall Study|Symptomatic Deterioration|1|||
13171669|NCT02323113|26120168|FG003|Overall Study|Symptomatic Deterioration|0|||
13171670|NCT02323113|26120169|FG004|Overall Study|Symptomatic Deterioration|1|||
13171671|NCT02323113|26120170|FG005|Overall Study|Symptomatic Deterioration|0|||
13171672|NCT02323113|26120171|FG006|Overall Study|Symptomatic Deterioration|0|||
13171673|NCT02323113|26120172|FG007|Overall Study|Symptomatic Deterioration|0|||
13171674|NCT02323113|26120165|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
13171675|NCT02323113|26120166|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
13171676|NCT02323113|26120167|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
13171677|NCT02323113|26120168|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
13171678|NCT02323113|26120169|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
13171679|NCT02323113|26120170|FG005|Overall Study|Unsatisfactory Therapeutic Response|2|||
13171680|NCT02323113|26120171|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
13171681|NCT02323113|26120172|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
13171682|NCT02323113|26120165|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
13171683|NCT02323113|26120166|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1|||
13171684|NCT02323113|26120167|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
13171685|NCT02323113|26120168|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
13171686|NCT02323113|26120169|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
13171687|NCT02323113|26120170|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
13171688|NCT02323113|26120171|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
13171689|NCT02323113|26120172|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
13171690|NCT02322892|26120193|FG000|Overall Study|Surgery cancelled|1|||
13171691|NCT02322892|26120194|FG001|Overall Study|Surgery cancelled|2|||
13171692|NCT02322892|26120193|FG000|Overall Study|Met exclusion criteria|0|||
13171693|NCT02322892|26120194|FG001|Overall Study|Met exclusion criteria|1|||
13171694|NCT02322892|26120193|FG000|Overall Study|Protocol Violation|1|||
13171695|NCT02322892|26120194|FG001|Overall Study|Protocol Violation|0|||
13171696|NCT02322879|26120207|FG000|First Intervention|Physician Decision|1|||
13171697|NCT02322879|26120208|FG001|First Intervention|Physician Decision|0|||
13171698|NCT02322866|26120237|FG000|Overall Study|Adverse Event|6|||
13171699|NCT02322866|26120238|FG001|Overall Study|Adverse Event|11|||
13171700|NCT02322866|26120237|FG000|Overall Study|Withdrawal of Consent|16|||
13171701|NCT02322866|26120238|FG001|Overall Study|Withdrawal of Consent|25|||
13171702|NCT02322866|26120237|FG000|Overall Study|Lost to Follow-up|36|||
13171703|NCT02322866|26120238|FG001|Overall Study|Lost to Follow-up|39|||
13171704|NCT02322866|26120237|FG000|Overall Study|Protocol Violation|1|||
13171705|NCT02322866|26120238|FG001|Overall Study|Protocol Violation|0|||
13171706|NCT02322866|26120237|FG000|Overall Study|Noncompliance with Treatment|3|||
13171707|NCT02322866|26120238|FG001|Overall Study|Noncompliance with Treatment|4|||
13171708|NCT02322866|26120237|FG000|Overall Study|Lack of Efficacy|3|||
13171709|NCT02322866|26120238|FG001|Overall Study|Lack of Efficacy|1|||
13171710|NCT02322866|26120237|FG000|Overall Study|Other Miscellaneous Reasons|6|||
13171711|NCT02322866|26120238|FG001|Overall Study|Other Miscellaneous Reasons|6|||
13171712|NCT02322814|26120265|FG000|Overall Study|Ongoing Study|0|||
13171713|NCT02322814|26120266|FG001|Overall Study|Ongoing Study|13|||
13171714|NCT02322814|26120267|FG002|Overall Study|Ongoing Study|14|||
13171715|NCT02322814|26120268|FG003|Overall Study|Ongoing Study|20|||
13171716|NCT02322814|26120269|FG004|Overall Study|Ongoing Study|22|||
13171717|NCT02322814|26120265|FG000|Overall Study|Progressive Disease|0|||
13171718|NCT02322814|26120266|FG001|Overall Study|Progressive Disease|2|||
13171719|NCT02322814|26120267|FG002|Overall Study|Progressive Disease|0|||
13171720|NCT02322814|26120268|FG003|Overall Study|Progressive Disease|1|||
13171721|NCT02322814|26120269|FG004|Overall Study|Progressive Disease|0|||
13171722|NCT02322814|26120265|FG000|Overall Study|Lost to Follow-up|1|||
13171723|NCT02322814|26120266|FG001|Overall Study|Lost to Follow-up|2|||
13171724|NCT02322814|26120267|FG002|Overall Study|Lost to Follow-up|1|||
13171725|NCT02322814|26120268|FG003|Overall Study|Lost to Follow-up|0|||
13171726|NCT02322814|26120269|FG004|Overall Study|Lost to Follow-up|0|||
13171727|NCT02322814|26120265|FG000|Overall Study|Other|2|||
13171728|NCT02322814|26120266|FG001|Overall Study|Other|0|||
13171729|NCT02322814|26120267|FG002|Overall Study|Other|0|||
13171730|NCT02322814|26120268|FG003|Overall Study|Other|0|||
13171731|NCT02322814|26120269|FG004|Overall Study|Other|0|||
13171732|NCT02322814|26120265|FG000|Overall Study|Protocol Violation|1|||
13171733|NCT02322814|26120266|FG001|Overall Study|Protocol Violation|0|||
13171734|NCT02322814|26120267|FG002|Overall Study|Protocol Violation|0|||
13171735|NCT02322814|26120268|FG003|Overall Study|Protocol Violation|0|||
13171736|NCT02322814|26120269|FG004|Overall Study|Protocol Violation|0|||
13171737|NCT02322814|26120265|FG000|Overall Study|Death|7|||
13171738|NCT02322814|26120266|FG001|Overall Study|Death|22|||
13171739|NCT02322814|26120267|FG002|Overall Study|Death|30|||
13171740|NCT02322814|26120268|FG003|Overall Study|Death|10|||
13171741|NCT02322814|26120269|FG004|Overall Study|Death|6|||
13171742|NCT02322814|26120265|FG000|Overall Study|Withdrawal by Subject|5|||
13171743|NCT02322814|26120266|FG001|Overall Study|Withdrawal by Subject|4|||
13171744|NCT02322814|26120267|FG002|Overall Study|Withdrawal by Subject|2|||
13171745|NCT02322814|26120268|FG003|Overall Study|Withdrawal by Subject|1|||
13171746|NCT02322814|26120269|FG004|Overall Study|Withdrawal by Subject|3|||
13171747|NCT02322775|26120302|FG000|Overall Study|Adverse Event|1|||
13171748|NCT02322775|26120303|FG001|Overall Study|Adverse Event|0|||
13171749|NCT02322775|26120302|FG000|Overall Study|Lost to Follow-up|0|||
13171750|NCT02322775|26120303|FG001|Overall Study|Lost to Follow-up|1|||
13171751|NCT02322775|26120302|FG000|Overall Study|Protocol Violation|1|||
13171752|NCT02322775|26120303|FG001|Overall Study|Protocol Violation|0|||
13171753|NCT02322775|26120302|FG000|Overall Study|Withdrawal by Subject|3|||
13171754|NCT02322775|26120303|FG001|Overall Study|Withdrawal by Subject|4|||
13171755|NCT02322775|26120302|FG000|Overall Study|Not willing to perform all FU visits|0|||
13171756|NCT02322775|26120303|FG001|Overall Study|Not willing to perform all FU visits|1|||
13171757|NCT02322749|26120333|FG000|Period 2|Adverse Event|0|||
13171758|NCT02322749|26120334|FG001|Period 2|Adverse Event|0|||
13171759|NCT02322749|26120335|FG002|Period 2|Adverse Event|0|||
13171760|NCT02322749|26120336|FG003|Period 2|Adverse Event|1|||
13171761|NCT02322749|26120337|FG004|Period 2|Adverse Event|0|||
13171762|NCT02322749|26120338|FG005|Period 2|Adverse Event|0|||
13171763|NCT02322749|26120333|FG000|Period 2|Withdrawal by Subject|0|||
13171764|NCT02322749|26120334|FG001|Period 2|Withdrawal by Subject|0|||
13171765|NCT02322749|26120335|FG002|Period 2|Withdrawal by Subject|0|||
13171766|NCT02322749|26120336|FG003|Period 2|Withdrawal by Subject|1|||
13171767|NCT02322749|26120337|FG004|Period 2|Withdrawal by Subject|0|||
13171768|NCT02322749|26120338|FG005|Period 2|Withdrawal by Subject|0|||
13171769|NCT02322749|26120333|FG000|Period 3|Withdrawal by Subject|0|||
13171770|NCT02322749|26120334|FG001|Period 3|Withdrawal by Subject|0|||
13171771|NCT02322749|26120335|FG002|Period 3|Withdrawal by Subject|1|||
13171772|NCT02322749|26120336|FG003|Period 3|Withdrawal by Subject|0|||
13171773|NCT02322749|26120337|FG004|Period 3|Withdrawal by Subject|0|||
13171774|NCT02322749|26120338|FG005|Period 3|Withdrawal by Subject|0|||
13171775|NCT02322411|26120363|FG000|Overall Study|Lost to Follow-up|4|||
13171776|NCT02322411|26120364|FG001|Overall Study|Lost to Follow-up|7|||
13171777|NCT02322411|26120363|FG000|Overall Study|Withdrawal by Subject|1|||
13171778|NCT02322411|26120364|FG001|Overall Study|Withdrawal by Subject|0|||
13171779|NCT02322281|26120395|FG000|Overall Study|Progressive Disease|42|||
13171780|NCT02322281|26120396|FG001|Overall Study|Progressive Disease|14|||
13171781|NCT02322281|26120397|FG002|Overall Study|Progressive Disease|49|||
13171782|NCT02322281|26120395|FG000|Overall Study|Adverse Event|3|||
13171783|NCT02322281|26120396|FG001|Overall Study|Adverse Event|4|||
13171784|NCT02322281|26120397|FG002|Overall Study|Adverse Event|6|||
13171785|NCT02322281|26120395|FG000|Overall Study|Death|3|||
13171786|NCT02322281|26120396|FG001|Overall Study|Death|3|||
13171787|NCT02322281|26120397|FG002|Overall Study|Death|3|||
13171788|NCT02322281|26120395|FG000|Overall Study|Withdrawal by Subject|1|||
13171789|NCT02322281|26120396|FG001|Overall Study|Withdrawal by Subject|1|||
13171790|NCT02322281|26120397|FG002|Overall Study|Withdrawal by Subject|6|||
13171791|NCT02322281|26120395|FG000|Overall Study|Physician Decision|2|||
13171792|NCT02322281|26120396|FG001|Overall Study|Physician Decision|0|||
13171793|NCT02322281|26120397|FG002|Overall Study|Physician Decision|5|||
13171794|NCT02322281|26120395|FG000|Overall Study|Study Terminated by Sponsor|2|||
13171795|NCT02322281|26120396|FG001|Overall Study|Study Terminated by Sponsor|0|||
13171796|NCT02322281|26120397|FG002|Overall Study|Study Terminated by Sponsor|0|||
13171797|NCT02322281|26120395|FG000|Overall Study|Missing|0|||
13171798|NCT02322281|26120396|FG001|Overall Study|Missing|0|||
13171799|NCT02322281|26120397|FG002|Overall Study|Missing|1|||
13171800|NCT02322281|26120395|FG000|Overall Study|Miscellaneous|0|||
13171801|NCT02322281|26120396|FG001|Overall Study|Miscellaneous|0|||
13171802|NCT02322281|26120397|FG002|Overall Study|Miscellaneous|4|||
13171803|NCT02322229|26120409|FG000|Overall Study|Physician Decision|2|||
13171804|NCT02322216|26120423|FG000|Overall Study|Adverse Event|1|||
13171805|NCT02322216|26120424|FG001|Overall Study|Adverse Event|0|||
13171806|NCT02322216|26120423|FG000|Overall Study|Withdrawal by Subject|1|||
13171807|NCT02322216|26120424|FG001|Overall Study|Withdrawal by Subject|4|||
13171808|NCT02322190|26120435|FG000|Overall Study|Death on study|1|||
13171809|NCT02322190|26120436|FG001|Overall Study|Death on study|0|||
13171810|NCT02322125|26120450|FG000|Overall Study|Withdrawal by Subject|2|||
13171811|NCT02322047|26120485|FG000|Overall Study|Physician Decision|1|||
13171812|NCT02322047|26120486|FG001|Overall Study|Physician Decision|0|||
13171813|NCT02322047|26120487|FG002|Overall Study|Physician Decision|0|||
13171814|NCT02322047|26120488|FG003|Overall Study|Physician Decision|0|||
13171815|NCT02322047|26120485|FG000|Overall Study|Withdrawal by Subject|1|||
13171816|NCT02322047|26120486|FG001|Overall Study|Withdrawal by Subject|0|||
13171817|NCT02322047|26120487|FG002|Overall Study|Withdrawal by Subject|0|||
13171818|NCT02322047|26120488|FG003|Overall Study|Withdrawal by Subject|1|||
13171819|NCT02322047|26120485|FG000|Overall Study|Adverse Event|0|||
13171820|NCT02322047|26120486|FG001|Overall Study|Adverse Event|1|||
13171821|NCT02322047|26120487|FG002|Overall Study|Adverse Event|0|||
13171822|NCT02322047|26120488|FG003|Overall Study|Adverse Event|0|||
13171823|NCT02322047|26120485|FG000|Overall Study|Lost to Follow-up|0|||
13171824|NCT02322047|26120486|FG001|Overall Study|Lost to Follow-up|0|||
13171825|NCT02322047|26120487|FG002|Overall Study|Lost to Follow-up|1|||
13171826|NCT02322047|26120488|FG003|Overall Study|Lost to Follow-up|1|||
13171827|NCT02322021|26120551|FG000|Core Phase|Adverse Event|1|||
13171828|NCT02322021|26120552|FG001|Core Phase|Adverse Event|3|||
13171829|NCT02322021|26120553|FG002|Core Phase|Adverse Event|4|||
13171830|NCT02322021|26120554|FG003|Core Phase|Adverse Event|2|||
13171831|NCT02322021|26120555|FG004|Core Phase|Adverse Event|0|||
13171832|NCT02322021|26120551|FG000|Core Phase|Participant Choice|4|||
13171833|NCT02322021|26120552|FG001|Core Phase|Participant Choice|5|||
13171834|NCT02322021|26120553|FG002|Core Phase|Participant Choice|4|||
13171835|NCT02322021|26120554|FG003|Core Phase|Participant Choice|2|||
13171836|NCT02322021|26120555|FG004|Core Phase|Participant Choice|0|||
13171837|NCT02322021|26120551|FG000|Core Phase|Lost to Follow-up|0|||
13171838|NCT02322021|26120552|FG001|Core Phase|Lost to Follow-up|0|||
13171839|NCT02322021|26120553|FG002|Core Phase|Lost to Follow-up|0|||
13171840|NCT02322021|26120554|FG003|Core Phase|Lost to Follow-up|1|||
13171841|NCT02322021|26120555|FG004|Core Phase|Lost to Follow-up|0|||
13171842|NCT02322021|26120551|FG000|Core Phase|Other|0|||
13171843|NCT02322021|26120552|FG001|Core Phase|Other|0|||
13171844|NCT02322021|26120553|FG002|Core Phase|Other|1|||
13171845|NCT02322021|26120554|FG003|Core Phase|Other|0|||
13171846|NCT02322021|26120555|FG004|Core Phase|Other|0|||
13171847|NCT02322021|26120551|FG000|Extension Phase|Adverse Event|0|||
13171848|NCT02322021|26120552|FG001|Extension Phase|Adverse Event|0|||
13171849|NCT02322021|26120553|FG002|Extension Phase|Adverse Event|0|||
13171850|NCT02322021|26120554|FG003|Extension Phase|Adverse Event|0|||
13171851|NCT02322021|26120555|FG004|Extension Phase|Adverse Event|3|||
13171852|NCT02322021|26120551|FG000|Extension Phase|Participant Choice|0|||
13171853|NCT02322021|26120552|FG001|Extension Phase|Participant Choice|0|||
13171854|NCT02322021|26120553|FG002|Extension Phase|Participant Choice|0|||
13171855|NCT02322021|26120554|FG003|Extension Phase|Participant Choice|0|||
13171856|NCT02322021|26120555|FG004|Extension Phase|Participant Choice|6|||
13171857|NCT02322021|26120551|FG000|Extension Phase|Other|0|||
13171858|NCT02322021|26120552|FG001|Extension Phase|Other|0|||
13171859|NCT02322021|26120553|FG002|Extension Phase|Other|0|||
13171860|NCT02322021|26120554|FG003|Extension Phase|Other|0|||
13171861|NCT02322021|26120555|FG004|Extension Phase|Other|3|||
13171862|NCT02322021|26120551|FG000|Extension Phase|Lost to Follow-up|0|||
13171863|NCT02322021|26120552|FG001|Extension Phase|Lost to Follow-up|0|||
13171864|NCT02322021|26120553|FG002|Extension Phase|Lost to Follow-up|0|||
13171865|NCT02322021|26120554|FG003|Extension Phase|Lost to Follow-up|0|||
13171866|NCT02322021|26120555|FG004|Extension Phase|Lost to Follow-up|1|||
13171867|NCT02322021|26120551|FG000|Extension Phase|Study terminated by sponsor|0|||
13171868|NCT02322021|26120552|FG001|Extension Phase|Study terminated by sponsor|0|||
13171869|NCT02322021|26120553|FG002|Extension Phase|Study terminated by sponsor|0|||
13171870|NCT02322021|26120554|FG003|Extension Phase|Study terminated by sponsor|0|||
13171871|NCT02322021|26120555|FG004|Extension Phase|Study terminated by sponsor|28|||
13171872|NCT02321930|26120565|FG000|Overall Study|Lost to Follow-up|1|||
13171873|NCT02321800|26120620|FG000|Overall Study|Withdrawal by Subject|3|||
13171874|NCT02321800|26120621|FG001|Overall Study|Withdrawal by Subject|3|||
13171875|NCT02321800|26120620|FG000|Overall Study|Death|1|||
13171876|NCT02321800|26120621|FG001|Overall Study|Death|0|||
13171877|NCT02321800|26120620|FG000|Overall Study|Protocol Violation|1|||
13171878|NCT02321800|26120621|FG001|Overall Study|Protocol Violation|0|||
13171879|NCT02321800|26120620|FG000|Overall Study|Lost to Follow-up|10|||
13171880|NCT02321800|26120621|FG001|Overall Study|Lost to Follow-up|4|||
13171881|NCT02321800|26120620|FG000|Overall Study|Adverse Event|2|||
13171882|NCT02321800|26120621|FG001|Overall Study|Adverse Event|3|||
13171883|NCT02321800|26120620|FG000|Overall Study|Other, Miscellaneous|3|||
13171884|NCT02321800|26120621|FG001|Overall Study|Other, Miscellaneous|1|||
13171885|NCT02321514|26120628|FG000|Overall Study|Death|15|||
13171886|NCT02321514|26120628|FG000|Overall Study|Missed Visit|7|||
13171887|NCT02321514|26120628|FG000|Overall Study|Study Exit|3|||
13171888|NCT02321462|26120655|FG000|Overall Study|Withdrawal by Subject|5|||
13171889|NCT02321462|26120656|FG001|Overall Study|Withdrawal by Subject|2|||
13171890|NCT02321462|26120655|FG000|Overall Study|Subject withdrawn before any treatment|1|||
13171891|NCT02321462|26120656|FG001|Overall Study|Subject withdrawn before any treatment|1|||
13171892|NCT02321436|26120679|FG000|Overall Study|Withdrawal by Subject|1|||
13171893|NCT02321436|26120680|FG001|Overall Study|Withdrawal by Subject|0|||
13171894|NCT02321436|26120679|FG000|Overall Study|Lost to Follow-up|0|||
13171895|NCT02321436|26120680|FG001|Overall Study|Lost to Follow-up|1|||
13171896|NCT02321319|26120686|FG000|Overall Study|Product discontinued|5|||
13171897|NCT02320903|26120729|FG000|Overall Study|Withdrawal by Subject|0|||
13171898|NCT02320903|26120730|FG001|Overall Study|Withdrawal by Subject|9|||
13171899|NCT02320903|26120731|FG002|Overall Study|Withdrawal by Subject|9|||
13171900|NCT02320903|26120729|FG000|Overall Study|Exited therapy; no longer eligible|8|||
13171901|NCT02320903|26120730|FG001|Overall Study|Exited therapy; no longer eligible|2|||
13171902|NCT02320903|26120731|FG002|Overall Study|Exited therapy; no longer eligible|2|||
13171903|NCT02320903|26120729|FG000|Overall Study|Lost to Follow-up|0|||
13171904|NCT02320903|26120730|FG001|Overall Study|Lost to Follow-up|5|||
13171905|NCT02320903|26120731|FG002|Overall Study|Lost to Follow-up|5|||
13171906|NCT02320721|26120766|FG000|Overall Study|Adverse Event|6|||
13171907|NCT02320721|26120767|FG001|Overall Study|Adverse Event|6|||
13171908|NCT02320721|26120766|FG000|Overall Study|Lack of Efficacy|2|||
13171909|NCT02320721|26120767|FG001|Overall Study|Lack of Efficacy|0|||
13171910|NCT02320721|26120766|FG000|Overall Study|Poor compliance to protocol|3|||
13171911|NCT02320721|26120767|FG001|Overall Study|Poor compliance to protocol|7|||
13171912|NCT02320721|26120766|FG000|Overall Study|Randomized but not treated|0|||
13171913|NCT02320721|26120767|FG001|Overall Study|Randomized but not treated|1|||
13171914|NCT02320721|26120766|FG000|Overall Study|Hypoglycemia|1|||
13171915|NCT02320721|26120767|FG001|Overall Study|Hypoglycemia|0|||
13171916|NCT02320721|26120766|FG000|Overall Study|Other than specified above|15|||
13171917|NCT02320721|26120767|FG001|Overall Study|Other than specified above|20|||
13171918|NCT02320487|26120787|FG000|Overall Study|Reason not Specified|1|||
13171919|NCT02320487|26120787|FG000|Overall Study|Physician Decision|5|||
13171920|NCT02320487|26120787|FG000|Overall Study|Withdrawal by Subject|1|||
13171921|NCT02320487|26120787|FG000|Overall Study|Death|3|||
13171922|NCT02320487|26120787|FG000|Overall Study|Adverse Event|11|||
13171923|NCT02320396|26120824|FG000|Overall Study|Adverse Event|2|||
13171924|NCT02320396|26120825|FG001|Overall Study|Adverse Event|2|||
13171925|NCT02320396|26120824|FG000|Overall Study|Pregnancy|0|||
13171926|NCT02320396|26120825|FG001|Overall Study|Pregnancy|1|||
13171927|NCT02320396|26120824|FG000|Overall Study|Protocol Violation|0|||
13171928|NCT02320396|26120825|FG001|Overall Study|Protocol Violation|1|||
13171929|NCT02320396|26120824|FG000|Overall Study|Withdrawal by Subject|2|||
13171930|NCT02320396|26120825|FG001|Overall Study|Withdrawal by Subject|0|||
13171931|NCT02320253|26120870|FG000|Overall Study|Withdrawal by Subject|3|||
13171932|NCT02320253|26120871|FG001|Overall Study|Withdrawal by Subject|0|||
13171933|NCT02320253|26120872|FG002|Overall Study|Withdrawal by Subject|0|||
13171934|NCT02320253|26120870|FG000|Overall Study|Lost to Follow-up|2|||
13171935|NCT02320253|26120871|FG001|Overall Study|Lost to Follow-up|2|||
13171936|NCT02320253|26120872|FG002|Overall Study|Lost to Follow-up|1|||
13171937|NCT02320253|26120870|FG000|Overall Study|Death|1|||
13171938|NCT02320253|26120871|FG001|Overall Study|Death|0|||
13171939|NCT02320253|26120872|FG002|Overall Study|Death|1|||
13171940|NCT02320149|26120917|FG000|Overall Study|Adverse Event|3|||
13171941|NCT02320149|26120918|FG001|Overall Study|Adverse Event|7|||
13171942|NCT02320149|26120917|FG000|Overall Study|Withdrawal of Consent|28|||
13171943|NCT02320149|26120918|FG001|Overall Study|Withdrawal of Consent|32|||
13171944|NCT02320149|26120917|FG000|Overall Study|Lost to Follow-up|21|||
13171945|NCT02320149|26120918|FG001|Overall Study|Lost to Follow-up|34|||
13171946|NCT02320149|26120917|FG000|Overall Study|Protocol Violation|2|||
13171947|NCT02320149|26120918|FG001|Overall Study|Protocol Violation|1|||
13171948|NCT02320149|26120917|FG000|Overall Study|Noncompliance with Study Treatment|7|||
13171949|NCT02320149|26120918|FG001|Overall Study|Noncompliance with Study Treatment|2|||
13171950|NCT02320149|26120917|FG000|Overall Study|Lack of Efficacy|0|||
13171951|NCT02320149|26120918|FG001|Overall Study|Lack of Efficacy|1|||
13171952|NCT02320149|26120917|FG000|Overall Study|Other Miscellaneous Reasons|2|||
13107954|NCT03263806|25889927|FG001|Overall Study|Study Termination|6|||
13107955|NCT03263780|25889936|FG000|Overall Study|Withdrawal by Subject|3|||
13107956|NCT03263780|25889936|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7|||
13107957|NCT03263702|25889969|FG000|Overall Study|Lost to Follow-up|2|||
13107958|NCT03263702|25889970|FG001|Overall Study|Lost to Follow-up|2|||
13107959|NCT03263702|25889969|FG000|Overall Study|Withdrawal by Subject|1|||
13107960|NCT03263702|25889970|FG001|Overall Study|Withdrawal by Subject|2|||
13107961|NCT03263442|25890019|FG000|Inpatient Phase|Death|1|||
13107962|NCT03263442|25890020|FG001|Inpatient Phase|Death|0|||
13107963|NCT03263442|25890019|FG000|Inpatient Phase|Withdrawal by Subject|1|||
13107964|NCT03263442|25890020|FG001|Inpatient Phase|Withdrawal by Subject|0|||
13107965|NCT03263442|25890019|FG000|Inpatient Phase|Inadequate Drug Exposure|0|||
13107966|NCT03263442|25890020|FG001|Inpatient Phase|Inadequate Drug Exposure|1|||
13107967|NCT03263442|25890019|FG000|1-month Follow-Up|Lost to Follow-up|1|||
13107968|NCT03263442|25890020|FG001|1-month Follow-Up|Lost to Follow-up|0|||
13107969|NCT03263442|25890019|FG000|3-month Follow-Up|Lost to Follow-up|1|||
13107970|NCT03263442|25890020|FG001|3-month Follow-Up|Lost to Follow-up|3|||
13107971|NCT03263442|25890019|FG000|6-month Follow-Up|Lost to Follow-up|2|||
13107972|NCT03263442|25890020|FG001|6-month Follow-Up|Lost to Follow-up|2|||
13107973|NCT03262441|25890030|FG000|Overall Study|Withdrawal by Subject|1|||
13107974|NCT03262389|25890037|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1|||
13107975|NCT03262389|25890037|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1|||
13107976|NCT03262389|25890037|FG000|Overall Study|opted out of PET/MR|1|||
13107977|NCT03262233|25890072|FG000|Overall Study|Withdrawal by Subject|12|||
13107978|NCT03262233|25890073|FG001|Overall Study|Withdrawal by Subject|8|||
13107979|NCT03262233|25890074|FG002|Overall Study|Withdrawal by Subject|21|||
13107980|NCT03262233|25890075|FG003|Overall Study|Withdrawal by Subject|13|||
13107981|NCT03262233|25890072|FG000|Overall Study|Declined due to shock|1|||
13107982|NCT03262233|25890073|FG001|Overall Study|Declined due to shock|2|||
13107983|NCT03262233|25890074|FG002|Overall Study|Declined due to shock|2|||
13107984|NCT03262233|25890075|FG003|Overall Study|Declined due to shock|3|||
13107985|NCT03262233|25890072|FG000|Overall Study|Protocol Violation|5|||
13171953|NCT02320149|26120918|FG001|Overall Study|Other Miscellaneous Reasons|3|||
13171954|NCT02320123|26120947|FG000|Overall Study|Lost to Follow-up|4|||
13171955|NCT02320123|26120948|FG001|Overall Study|Lost to Follow-up|6|||
13171956|NCT02320123|26120947|FG000|Overall Study|Death|6|||
13171957|NCT02320123|26120948|FG001|Overall Study|Death|5|||
13107986|NCT03262233|25890073|FG001|Overall Study|Protocol Violation|10|||
13107987|NCT03262233|25890074|FG002|Overall Study|Protocol Violation|2|||
13107988|NCT03262233|25890075|FG003|Overall Study|Protocol Violation|13|||
13107989|NCT03262233|25890072|FG000|Overall Study|data collection artifact|0|||
13107990|NCT03262233|25890073|FG001|Overall Study|data collection artifact|1|||
13107991|NCT03262233|25890074|FG002|Overall Study|data collection artifact|0|||
13107992|NCT03262233|25890075|FG003|Overall Study|data collection artifact|0|||
13107993|NCT03262038|25890094|FG000|Overall Study|Withdrawal by Subject|0|||
13107994|NCT03262038|25890095|FG001|Overall Study|Withdrawal by Subject|1|||
13107995|NCT03262012|25890126|FG000|Overall Study|Withdrawal by Subject|15|||
13107996|NCT03262012|25890127|FG001|Overall Study|Withdrawal by Subject|13|||
13107997|NCT03262012|25890128|FG002|Overall Study|Withdrawal by Subject|8|||
13171958|NCT02320058|26120987|FG000|Overall Study|Death|25|||
13171959|NCT02320058|26120988|FG001|Overall Study|Death|10|||
13171960|NCT02320058|26120987|FG000|Overall Study|Lost to Follow-up|4|||
13171961|NCT02320058|26120988|FG001|Overall Study|Lost to Follow-up|0|||
13171962|NCT02320058|26120987|FG000|Overall Study|Other reasons|4|||
13171963|NCT02320058|26120988|FG001|Overall Study|Other reasons|1|||
13171964|NCT02320058|26120987|FG000|Overall Study|Withdrawal by Subject|8|||
13171965|NCT02320058|26120988|FG001|Overall Study|Withdrawal by Subject|2|||
13171966|NCT02320058|26120987|FG000|Overall Study|Not reported|1|||
13171967|NCT02320058|26120988|FG001|Overall Study|Not reported|0|||
13171968|NCT02319759|26121093|FG000|Week 0 - 16|Lack of Efficacy|1|||
13171969|NCT02319759|26121094|FG001|Week 0 - 16|Lack of Efficacy|0|||
13171970|NCT02319759|26121095|FG002|Week 0 - 16|Lack of Efficacy|0|||
13171971|NCT02319759|26121096|FG003|Week 0 - 16|Lack of Efficacy|0|||
13171972|NCT02319759|26121097|FG004|Week 0 - 16|Lack of Efficacy|0|||
13171973|NCT02319759|26121093|FG000|Week 0 - 16|Not met all Inclusion Criteria|0|||
13171974|NCT02319759|26121094|FG001|Week 0 - 16|Not met all Inclusion Criteria|0|||
13171975|NCT02319759|26121095|FG002|Week 0 - 16|Not met all Inclusion Criteria|1|||
13171976|NCT02319759|26121096|FG003|Week 0 - 16|Not met all Inclusion Criteria|0|||
13171977|NCT02319759|26121097|FG004|Week 0 - 16|Not met all Inclusion Criteria|0|||
13171978|NCT02319759|26121093|FG000|Week 16 - 24|Lack of Efficacy|1|||
13171979|NCT02319759|26121094|FG001|Week 16 - 24|Lack of Efficacy|0|||
13171980|NCT02319759|26121095|FG002|Week 16 - 24|Lack of Efficacy|1|||
13171981|NCT02319759|26121096|FG003|Week 16 - 24|Lack of Efficacy|0|||
13171982|NCT02319759|26121097|FG004|Week 16 - 24|Lack of Efficacy|0|||
13171983|NCT02319759|26121093|FG000|Week 16 - 24|Lost to Follow-up|1|||
13171984|NCT02319759|26121094|FG001|Week 16 - 24|Lost to Follow-up|0|||
13171985|NCT02319759|26121095|FG002|Week 16 - 24|Lost to Follow-up|0|||
13171986|NCT02319759|26121096|FG003|Week 16 - 24|Lost to Follow-up|0|||
13171987|NCT02319759|26121097|FG004|Week 16 - 24|Lost to Follow-up|0|||
13171988|NCT02319759|26121093|FG000|Week 16 - 24|Withdrawal by Subject|0|||
13171989|NCT02319759|26121094|FG001|Week 16 - 24|Withdrawal by Subject|0|||
13171990|NCT02319759|26121095|FG002|Week 16 - 24|Withdrawal by Subject|2|||
13171991|NCT02319759|26121096|FG003|Week 16 - 24|Withdrawal by Subject|0|||
13171992|NCT02319759|26121097|FG004|Week 16 - 24|Withdrawal by Subject|0|||
13171993|NCT02319759|26121093|FG000|Week 24 - 56|Adverse Event|0|||
13171994|NCT02319759|26121094|FG001|Week 24 - 56|Adverse Event|0|||
13171995|NCT02319759|26121095|FG002|Week 24 - 56|Adverse Event|2|||
13171996|NCT02319759|26121096|FG003|Week 24 - 56|Adverse Event|0|||
13171997|NCT02319759|26121097|FG004|Week 24 - 56|Adverse Event|0|||
13171998|NCT02319759|26121093|FG000|Week 24 - 56|Lack of Efficacy|0|||
13171999|NCT02319759|26121094|FG001|Week 24 - 56|Lack of Efficacy|0|||
13172000|NCT02319759|26121095|FG002|Week 24 - 56|Lack of Efficacy|0|||
13172001|NCT02319759|26121096|FG003|Week 24 - 56|Lack of Efficacy|2|||
13172002|NCT02319759|26121097|FG004|Week 24 - 56|Lack of Efficacy|1|||
13172003|NCT02319759|26121093|FG000|Week 24 - 56|Withdrawal by Subject|0|||
13172004|NCT02319759|26121094|FG001|Week 24 - 56|Withdrawal by Subject|1|||
13172005|NCT02319759|26121095|FG002|Week 24 - 56|Withdrawal by Subject|0|||
13172006|NCT02319759|26121096|FG003|Week 24 - 56|Withdrawal by Subject|0|||
13172007|NCT02319759|26121097|FG004|Week 24 - 56|Withdrawal by Subject|0|||
13172008|NCT02319759|26121093|FG000|Week 24 - 56|Lost to Follow-up|0|||
13172009|NCT02319759|26121094|FG001|Week 24 - 56|Lost to Follow-up|0|||
13172010|NCT02319759|26121095|FG002|Week 24 - 56|Lost to Follow-up|0|||
13172011|NCT02319759|26121096|FG003|Week 24 - 56|Lost to Follow-up|0|||
13172012|NCT02319759|26121097|FG004|Week 24 - 56|Lost to Follow-up|1|||
13172013|NCT02319668|26121116|FG000|Overall Study|Other (Not specified)|0|||
13172014|NCT02319668|26121117|FG001|Overall Study|Other (Not specified)|2|||
13172015|NCT02319642|26121142|FG000|Overall Study|Adverse Event|2|||
13172016|NCT02319642|26121143|FG001|Overall Study|Adverse Event|4|||
13172017|NCT02319642|26121142|FG000|Overall Study|Lack of Efficacy|1|||
13172018|NCT02319642|26121143|FG001|Overall Study|Lack of Efficacy|1|||
13172019|NCT02319642|26121142|FG000|Overall Study|Withdrawal by Subject|1|||
13172020|NCT02319642|26121143|FG001|Overall Study|Withdrawal by Subject|1|||
13172021|NCT02319525|26121168|FG000|Overall Study|Withdrawal by Subject|2|||
13172022|NCT02319525|26121169|FG001|Overall Study|Withdrawal by Subject|1|||
13172023|NCT02319148|26121240|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0|||
13172024|NCT02319148|26121241|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0|||
13172025|NCT02319148|26121242|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1|||
13172026|NCT02319148|26121243|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1|||
13172027|NCT02319148|26121240|FG000|Second Intervention Period|No longer willing to participate|0|||
13172028|NCT02319148|26121241|FG001|Second Intervention Period|No longer willing to participate|1|||
13172029|NCT02319148|26121242|FG002|Second Intervention Period|No longer willing to participate|0|||
13172030|NCT02319148|26121243|FG003|Second Intervention Period|No longer willing to participate|0|||
13172031|NCT02319148|26121240|FG000|Second Intervention Period|Other|0|||
13172032|NCT02319148|26121241|FG001|Second Intervention Period|Other|0|||
13172033|NCT02319148|26121242|FG002|Second Intervention Period|Other|0|||
13172034|NCT02319148|26121243|FG003|Second Intervention Period|Other|1|||
13172035|NCT02319044|26121307|FG000|Overall Study|Death, PI/sponsor decision, med history|0|||
13172036|NCT02319044|26121308|FG001|Overall Study|Death, PI/sponsor decision, med history|1|||
13172037|NCT02319044|26121309|FG002|Overall Study|Death, PI/sponsor decision, med history|4|||
13172038|NCT02319044|26121307|FG000|Overall Study|Withdrawal by Subject|3|||
13172039|NCT02319044|26121308|FG001|Overall Study|Withdrawal by Subject|3|||
13172040|NCT02319044|26121309|FG002|Overall Study|Withdrawal by Subject|6|||
13172041|NCT02319044|26121307|FG000|Overall Study|Condition under investigation worsened|100|||
13172042|NCT02319044|26121308|FG001|Overall Study|Condition under investigation worsened|50|||
13172043|NCT02319044|26121309|FG002|Overall Study|Condition under investigation worsened|46|||
13172044|NCT02319044|26121307|FG000|Overall Study|Adverse Event|17|||
13172045|NCT02319044|26121308|FG001|Overall Study|Adverse Event|2|||
13172046|NCT02319044|26121309|FG002|Overall Study|Adverse Event|8|||
13172047|NCT02319044|26121307|FG000|Overall Study|Study specific discontinuation criteria|2|||
13172048|NCT02319044|26121308|FG001|Overall Study|Study specific discontinuation criteria|2|||
13172049|NCT02319044|26121309|FG002|Overall Study|Study specific discontinuation criteria|1|||
13172050|NCT02319044|26121307|FG000|Overall Study|Not treated|0|||
13172051|NCT02319044|26121308|FG001|Overall Study|Not treated|2|||
13172052|NCT02319044|26121309|FG002|Overall Study|Not treated|2|||
13172053|NCT02319031|26121326|FG000|Treatment Period|Death|1|||
13172054|NCT02319031|26121327|FG001|Treatment Period|Death|0|||
13172055|NCT02318940|26121346|FG000|Overall Study|lost the record|1|||
13172056|NCT02318940|26121347|FG001|Overall Study|lost the record|0|||
13172057|NCT02318797|26121392|FG000|Overall Study|Death|3|||
13172058|NCT02318797|26121393|FG001|Overall Study|Death|6|||
13172059|NCT02318797|26121392|FG000|Overall Study|Lost to Follow-up|85|||
13172060|NCT02318797|26121393|FG001|Overall Study|Lost to Follow-up|96|||
13172061|NCT02318719|26121419|FG000|Double-blind Phase|Adverse Event|7|||
13172062|NCT02318719|26121420|FG001|Double-blind Phase|Adverse Event|6|||
13172063|NCT02318719|26121421|FG002|Double-blind Phase|Adverse Event|12|||
13172064|NCT02318719|26121422|FG003|Double-blind Phase|Adverse Event|4|||
13172065|NCT02318719|26121423|FG004|Double-blind Phase|Adverse Event|0|||
13172066|NCT02318719|26121419|FG000|Double-blind Phase|Lack of Efficacy|5|||
13172067|NCT02318719|26121420|FG001|Double-blind Phase|Lack of Efficacy|0|||
13172068|NCT02318719|26121421|FG002|Double-blind Phase|Lack of Efficacy|1|||
13172069|NCT02318719|26121422|FG003|Double-blind Phase|Lack of Efficacy|1|||
13172070|NCT02318719|26121423|FG004|Double-blind Phase|Lack of Efficacy|0|||
13172071|NCT02318719|26121419|FG000|Double-blind Phase|Protocol Violation|0|||
13172072|NCT02318719|26121420|FG001|Double-blind Phase|Protocol Violation|1|||
13172073|NCT02318719|26121421|FG002|Double-blind Phase|Protocol Violation|3|||
13172074|NCT02318719|26121422|FG003|Double-blind Phase|Protocol Violation|0|||
13172075|NCT02318719|26121423|FG004|Double-blind Phase|Protocol Violation|0|||
13172076|NCT02318719|26121419|FG000|Double-blind Phase|Withdrawal by Subject|25|||
13172077|NCT02318719|26121420|FG001|Double-blind Phase|Withdrawal by Subject|7|||
13172078|NCT02318719|26121421|FG002|Double-blind Phase|Withdrawal by Subject|9|||
13172079|NCT02318719|26121422|FG003|Double-blind Phase|Withdrawal by Subject|10|||
13172080|NCT02318719|26121423|FG004|Double-blind Phase|Withdrawal by Subject|0|||
13172081|NCT02318719|26121419|FG000|Double-blind Phase|Other|1|||
13172082|NCT02318719|26121420|FG001|Double-blind Phase|Other|2|||
13172083|NCT02318719|26121421|FG002|Double-blind Phase|Other|0|||
13172084|NCT02318719|26121422|FG003|Double-blind Phase|Other|0|||
13172085|NCT02318719|26121423|FG004|Double-blind Phase|Other|0|||
13172086|NCT02318719|26121419|FG000|Open-label Extension Phase|Adverse Event|0|||
13172087|NCT02318719|26121420|FG001|Open-label Extension Phase|Adverse Event|0|||
13172088|NCT02318719|26121421|FG002|Open-label Extension Phase|Adverse Event|0|||
13172089|NCT02318719|26121422|FG003|Open-label Extension Phase|Adverse Event|0|||
13172090|NCT02318719|26121423|FG004|Open-label Extension Phase|Adverse Event|15|||
13172091|NCT02318719|26121419|FG000|Open-label Extension Phase|Death|0|||
13172092|NCT02318719|26121420|FG001|Open-label Extension Phase|Death|0|||
13172093|NCT02318719|26121421|FG002|Open-label Extension Phase|Death|0|||
13172094|NCT02318719|26121422|FG003|Open-label Extension Phase|Death|0|||
13172095|NCT02318719|26121423|FG004|Open-label Extension Phase|Death|1|||
13172096|NCT02318719|26121419|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
13172097|NCT02318719|26121420|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
13172098|NCT02318719|26121421|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
13172099|NCT02318719|26121422|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
13172100|NCT02318719|26121423|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
13172101|NCT02318719|26121419|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
13172102|NCT02318719|26121420|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
13172103|NCT02318719|26121421|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
13172104|NCT02318719|26121422|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
13172105|NCT02318719|26121423|FG004|Open-label Extension Phase|Withdrawal by Subject|31|||
13172106|NCT02318719|26121419|FG000|Open-label Extension Phase|Other|0|||
13172107|NCT02318719|26121420|FG001|Open-label Extension Phase|Other|0|||
13172108|NCT02318719|26121421|FG002|Open-label Extension Phase|Other|0|||
13172109|NCT02318719|26121422|FG003|Open-label Extension Phase|Other|0|||
13172110|NCT02318719|26121423|FG004|Open-label Extension Phase|Other|7|||
13172111|NCT02318706|26121449|FG000|Double-blind Phase|Adverse Event|7|||
13172112|NCT02318706|26121450|FG001|Double-blind Phase|Adverse Event|4|||
13172113|NCT02318706|26121451|FG002|Double-blind Phase|Adverse Event|3|||
13172114|NCT02318706|26121452|FG003|Double-blind Phase|Adverse Event|10|||
13172115|NCT02318706|26121453|FG004|Double-blind Phase|Adverse Event|0|||
13172116|NCT02318706|26121449|FG000|Double-blind Phase|Lost to Follow-up|1|||
13172117|NCT02318706|26121450|FG001|Double-blind Phase|Lost to Follow-up|0|||
13172118|NCT02318706|26121451|FG002|Double-blind Phase|Lost to Follow-up|0|||
13107998|NCT03262012|25890129|FG003|Overall Study|Withdrawal by Subject|7|||
13107999|NCT03262012|25890126|FG000|Overall Study|Adverse Event|10|||
13108000|NCT03262012|25890127|FG001|Overall Study|Adverse Event|12|||
13108001|NCT03262012|25890128|FG002|Overall Study|Adverse Event|4|||
13108002|NCT03262012|25890129|FG003|Overall Study|Adverse Event|6|||
13108003|NCT03262012|25890126|FG000|Overall Study|Physician Decision|2|||
13108004|NCT03262012|25890127|FG001|Overall Study|Physician Decision|5|||
13108005|NCT03262012|25890128|FG002|Overall Study|Physician Decision|1|||
13108006|NCT03262012|25890129|FG003|Overall Study|Physician Decision|0|||
13108007|NCT03262012|25890126|FG000|Overall Study|Lack of Efficacy|0|||
13108008|NCT03262012|25890127|FG001|Overall Study|Lack of Efficacy|5|||
13108009|NCT03262012|25890128|FG002|Overall Study|Lack of Efficacy|1|||
13108010|NCT03262012|25890129|FG003|Overall Study|Lack of Efficacy|2|||
13108011|NCT03262012|25890126|FG000|Overall Study|Protocol Discontinuation Criteria|0|||
13108012|NCT03262012|25890127|FG001|Overall Study|Protocol Discontinuation Criteria|1|||
13108013|NCT03262012|25890128|FG002|Overall Study|Protocol Discontinuation Criteria|0|||
13108014|NCT03262012|25890129|FG003|Overall Study|Protocol Discontinuation Criteria|0|||
13108015|NCT03261947|25890211|FG000|Overall Study|Death|10|||
13108016|NCT03261947|25890212|FG001|Overall Study|Death|13|||
13172119|NCT02318706|26121452|FG003|Double-blind Phase|Lost to Follow-up|0|||
13172120|NCT02318706|26121453|FG004|Double-blind Phase|Lost to Follow-up|0|||
13172121|NCT02318706|26121449|FG000|Double-blind Phase|Protocol Violation|4|||
13172122|NCT02318706|26121450|FG001|Double-blind Phase|Protocol Violation|2|||
13172123|NCT02318706|26121451|FG002|Double-blind Phase|Protocol Violation|4|||
13172124|NCT02318706|26121452|FG003|Double-blind Phase|Protocol Violation|3|||
13172125|NCT02318706|26121453|FG004|Double-blind Phase|Protocol Violation|0|||
13172126|NCT02318706|26121449|FG000|Double-blind Phase|Withdrawal by Subject|9|||
13172127|NCT02318706|26121450|FG001|Double-blind Phase|Withdrawal by Subject|5|||
13108017|NCT03261947|25890213|FG002|Overall Study|Death|17|||
13108018|NCT03261947|25890214|FG003|Overall Study|Death|12|||
13108019|NCT03261947|25890215|FG004|Overall Study|Death|8|||
13108020|NCT03261947|25890211|FG000|Overall Study|Lost to Follow-up|0|||
13172128|NCT02318706|26121451|FG002|Double-blind Phase|Withdrawal by Subject|7|||
13172129|NCT02318706|26121452|FG003|Double-blind Phase|Withdrawal by Subject|10|||
13172130|NCT02318706|26121453|FG004|Double-blind Phase|Withdrawal by Subject|0|||
13172131|NCT02318706|26121449|FG000|Double-blind Phase|Other|4|||
13172132|NCT02318706|26121450|FG001|Double-blind Phase|Other|1|||
13172133|NCT02318706|26121451|FG002|Double-blind Phase|Other|2|||
13172134|NCT02318706|26121452|FG003|Double-blind Phase|Other|1|||
13172135|NCT02318706|26121453|FG004|Double-blind Phase|Other|0|||
13172136|NCT02318706|26121449|FG000|Double-blind Phase|Death|0|||
13172137|NCT02318706|26121450|FG001|Double-blind Phase|Death|0|||
13172138|NCT02318706|26121451|FG002|Double-blind Phase|Death|2|||
13172139|NCT02318706|26121452|FG003|Double-blind Phase|Death|0|||
13172140|NCT02318706|26121453|FG004|Double-blind Phase|Death|0|||
13172141|NCT02318706|26121449|FG000|Open-label Extension Phase|Adverse Event|0|||
13172142|NCT02318706|26121450|FG001|Open-label Extension Phase|Adverse Event|0|||
13172143|NCT02318706|26121451|FG002|Open-label Extension Phase|Adverse Event|0|||
13172144|NCT02318706|26121452|FG003|Open-label Extension Phase|Adverse Event|0|||
13172145|NCT02318706|26121453|FG004|Open-label Extension Phase|Adverse Event|21|||
13172146|NCT02318706|26121449|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
13172147|NCT02318706|26121450|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
13172148|NCT02318706|26121451|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
13172149|NCT02318706|26121452|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
13172150|NCT02318706|26121453|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
13172151|NCT02318706|26121449|FG000|Open-label Extension Phase|Death|0|||
13172152|NCT02318706|26121450|FG001|Open-label Extension Phase|Death|0|||
13172153|NCT02318706|26121451|FG002|Open-label Extension Phase|Death|0|||
13172154|NCT02318706|26121452|FG003|Open-label Extension Phase|Death|0|||
13172155|NCT02318706|26121453|FG004|Open-label Extension Phase|Death|1|||
13172156|NCT02318706|26121449|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
13172157|NCT02318706|26121450|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
13172158|NCT02318706|26121451|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
13172159|NCT02318706|26121452|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
13172160|NCT02318706|26121453|FG004|Open-label Extension Phase|Withdrawal by Subject|19|||
13172161|NCT02318693|26121474|FG000|Overall Study|Protocol Violation|0|||
13172162|NCT02318693|26121475|FG001|Overall Study|Protocol Violation|1|||
13172163|NCT02318667|26121493|FG000|Overall Study|Adverse Event|1|||
13108021|NCT03261947|25890212|FG001|Overall Study|Lost to Follow-up|0|||
13108022|NCT03261947|25890213|FG002|Overall Study|Lost to Follow-up|2|||
13172164|NCT02318667|26121493|FG000|Overall Study|Lack of Efficacy|6|||
13172165|NCT02318667|26121493|FG000|Overall Study|Protocol Violation|2|||
13108023|NCT03261947|25890214|FG003|Overall Study|Lost to Follow-up|1|||
13108024|NCT03261947|25890215|FG004|Overall Study|Lost to Follow-up|0|||
13108025|NCT03261947|25890211|FG000|Overall Study|Withdrawal by Subject|0|||
13108026|NCT03261947|25890212|FG001|Overall Study|Withdrawal by Subject|0|||
13172166|NCT02318602|26121534|FG000|Overall Study|Adverse Event|0|||
13172167|NCT02318602|26121535|FG001|Overall Study|Adverse Event|1|||
13172168|NCT02318602|26121536|FG002|Overall Study|Adverse Event|1|||
13172169|NCT02318602|26121534|FG000|Overall Study|Withdrawal by Subject|0|||
13172170|NCT02318602|26121535|FG001|Overall Study|Withdrawal by Subject|3|||
13172171|NCT02318602|26121536|FG002|Overall Study|Withdrawal by Subject|0|||
13172172|NCT02318602|26121534|FG000|Overall Study|Death|1|||
13172173|NCT02318602|26121535|FG001|Overall Study|Death|0|||
13172174|NCT02318602|26121536|FG002|Overall Study|Death|0|||
13172175|NCT02318602|26121534|FG000|Overall Study|Guardian decision to withdraw|0|||
13172176|NCT02318602|26121535|FG001|Overall Study|Guardian decision to withdraw|0|||
13172177|NCT02318602|26121536|FG002|Overall Study|Guardian decision to withdraw|1|||
13172178|NCT02318368|26121551|FG000|Overall Study|Withdrawal by Subject|2|||
13172179|NCT02318368|26121552|FG001|Overall Study|Withdrawal by Subject|0|||
13172180|NCT02318368|26121551|FG000|Overall Study|Study terminated by the sponsor|5|||
13172181|NCT02318368|26121552|FG001|Overall Study|Study terminated by the sponsor|2|||
13172182|NCT02318368|26121551|FG000|Overall Study|Death|0|||
13172183|NCT02318368|26121552|FG001|Overall Study|Death|1|||
13172184|NCT02318134|26121579|FG000|Overall Study|Withdrawal by Subject|2|||
13172185|NCT02318134|26121580|FG001|Overall Study|Withdrawal by Subject|1|||
13172186|NCT02318095|26121589|FG000|Overall Study|Adverse Event|1|||
13172187|NCT02317809|26121642|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2|||
13172188|NCT02317809|26121643|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0|||
13172189|NCT02317809|26121642|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1|||
13172190|NCT02317809|26121643|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0|||
13172191|NCT02317705|26121650|FG000|Overall Study|Withdrawal by Subject|3|||
13108027|NCT03261947|25890213|FG002|Overall Study|Withdrawal by Subject|3|||
13172192|NCT02317705|26121650|FG000|Overall Study|Physician Decision|1|||
13172193|NCT02317705|26121650|FG000|Overall Study|Drug not usable|1|||
13172194|NCT02317627|26121746|FG000|Overall Study|Withdrawal by Subject|0|||
13172195|NCT02317627|26121747|FG001|Overall Study|Withdrawal by Subject|1|||
13172196|NCT02317627|26121748|FG002|Overall Study|Withdrawal by Subject|1|||
13172197|NCT02317627|26121746|FG000|Overall Study|Lost to Follow-up|2|||
13172198|NCT02317627|26121747|FG001|Overall Study|Lost to Follow-up|0|||
13172199|NCT02317627|26121748|FG002|Overall Study|Lost to Follow-up|0|||
13172200|NCT02317627|26121746|FG000|Overall Study|Stopped by Investigator|0|||
13172201|NCT02317627|26121747|FG001|Overall Study|Stopped by Investigator|1|||
13172202|NCT02317627|26121748|FG002|Overall Study|Stopped by Investigator|0|||
13172203|NCT02317627|26121746|FG000|Overall Study|Adverse Event|0|||
13172204|NCT02317627|26121747|FG001|Overall Study|Adverse Event|2|||
13172205|NCT02317627|26121748|FG002|Overall Study|Adverse Event|3|||
13172206|NCT02317627|26121746|FG000|Overall Study|Non-compliance with study drug|0|||
13172207|NCT02317627|26121747|FG001|Overall Study|Non-compliance with study drug|1|||
13108028|NCT03261947|25890214|FG003|Overall Study|Withdrawal by Subject|0|||
13172208|NCT02317627|26121748|FG002|Overall Study|Non-compliance with study drug|0|||
13172209|NCT02317614|26121771|FG000|Overall Study|Lost to Follow-up|1|||
13172210|NCT02317614|26121772|FG001|Overall Study|Lost to Follow-up|1|||
13172211|NCT02317614|26121771|FG000|Overall Study|Withdrawal by Subject|1|||
13108029|NCT03261947|25890215|FG004|Overall Study|Withdrawal by Subject|1|||
13108030|NCT03261947|25890211|FG000|Overall Study|Site Terminated by Sponsor|0|||
13108031|NCT03261947|25890212|FG001|Overall Study|Site Terminated by Sponsor|0|||
13172212|NCT02317614|26121772|FG001|Overall Study|Withdrawal by Subject|0|||
13172213|NCT02317614|26121771|FG000|Overall Study|Death|1|||
13172214|NCT02317614|26121772|FG001|Overall Study|Death|1|||
13172215|NCT02317575|26121802|FG000|Period 1|Difficulty with venous cannulation|0|||
13172216|NCT02317575|26121803|FG001|Period 1|Difficulty with venous cannulation|1|||
13172217|NCT02317575|26121804|FG002|Period 1|Difficulty with venous cannulation|0|||
13172218|NCT02317575|26121805|FG003|Period 1|Difficulty with venous cannulation|0|||
13172219|NCT02317575|26121806|FG004|Period 1|Difficulty with venous cannulation|0|||
13172220|NCT02317575|26121802|FG000|Period 1|Withdrawal by Subject|1|||
13172221|NCT02317575|26121803|FG001|Period 1|Withdrawal by Subject|0|||
13172222|NCT02317575|26121804|FG002|Period 1|Withdrawal by Subject|0|||
13172223|NCT02317575|26121805|FG003|Period 1|Withdrawal by Subject|0|||
13172224|NCT02317575|26121806|FG004|Period 1|Withdrawal by Subject|0|||
13172225|NCT02317562|26121812|FG000|Overall Study|Physician Decision|1|||
13172226|NCT02317562|26121812|FG000|Overall Study|early termination of the study|8|||
13172227|NCT02317562|26121812|FG000|Overall Study|Lack of Efficacy|4|||
13172228|NCT02317562|26121812|FG000|Overall Study|Withdrawal by Subject|1|||
13172229|NCT02317510|26121847|FG000|Overall Study|Adverse Event|0|||
13172230|NCT02317510|26121848|FG001|Overall Study|Adverse Event|1|||
13172231|NCT02317432|26121871|FG000|Overall Study|Death|4|||
13172232|NCT02317432|26121872|FG001|Overall Study|Death|1|||
13172233|NCT02317432|26121871|FG000|Overall Study|Lost to Follow-up|0|||
13172234|NCT02317432|26121872|FG001|Overall Study|Lost to Follow-up|5|||
13172235|NCT02317432|26121871|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27|||
13172236|NCT02317432|26121872|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0|||
13172237|NCT02317016|26121900|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1|||
13172238|NCT02317016|26121900|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1|||
13172239|NCT02317016|26121900|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1|||
13172240|NCT02317016|26121900|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23|||
13172241|NCT02317016|26121900|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1|||
13172242|NCT02317016|26121900|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2|||
13172243|NCT02317016|26121900|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5|||
13172244|NCT02316847|26121916|FG000|Overall Study|Adverse Event|0|||
13172245|NCT02316847|26121917|FG001|Overall Study|Adverse Event|3|||
13172246|NCT02316847|26121916|FG000|Overall Study|Lost to Follow-up|0|||
13172247|NCT02316847|26121917|FG001|Overall Study|Lost to Follow-up|2|||
13172248|NCT02316847|26121916|FG000|Overall Study|Physician Decision|0|||
13172249|NCT02316847|26121917|FG001|Overall Study|Physician Decision|1|||
13172250|NCT02316847|26121916|FG000|Overall Study|Pregnancy|0|||
13172251|NCT02316847|26121917|FG001|Overall Study|Pregnancy|1|||
13172252|NCT02316847|26121916|FG000|Overall Study|Withdrawal by Subject|2|||
13172253|NCT02316847|26121917|FG001|Overall Study|Withdrawal by Subject|9|||
13172254|NCT02316847|26121916|FG000|Overall Study|Noncompliance with study drug|0|||
13172255|NCT02316847|26121917|FG001|Overall Study|Noncompliance with study drug|3|||
13172256|NCT02316847|26121916|FG000|Overall Study|Withdrawn due to termination by Sponsor|7|||
13172257|NCT02316847|26121917|FG001|Overall Study|Withdrawn due to termination by Sponsor|67|||
13172258|NCT02316769|26121932|FG000|Overall Study|Physician Decision|1|||
13172259|NCT02316769|26121933|FG001|Overall Study|Physician Decision|0|||
13172260|NCT02316769|26121932|FG000|Overall Study|Withdrawal by Subject|1|||
13172261|NCT02316769|26121933|FG001|Overall Study|Withdrawal by Subject|0|||
13172262|NCT02316717|26122071|FG000|Overall Study|Adverse Event|2|||
13172263|NCT02316717|26122072|FG001|Overall Study|Adverse Event|2|||
13172264|NCT02316717|26122073|FG002|Overall Study|Adverse Event|0|||
13172265|NCT02316717|26122071|FG000|Overall Study|Lost to Follow-up|1|||
13172266|NCT02316717|26122072|FG001|Overall Study|Lost to Follow-up|2|||
13172267|NCT02316717|26122073|FG002|Overall Study|Lost to Follow-up|1|||
13172268|NCT02316717|26122071|FG000|Overall Study|Non compliance|3|||
13172269|NCT02316717|26122072|FG001|Overall Study|Non compliance|1|||
13172270|NCT02316717|26122073|FG002|Overall Study|Non compliance|0|||
13172271|NCT02316717|26122071|FG000|Overall Study|Protocol Violation|2|||
13172272|NCT02316717|26122072|FG001|Overall Study|Protocol Violation|0|||
13172273|NCT02316717|26122073|FG002|Overall Study|Protocol Violation|0|||
13172274|NCT02316717|26122071|FG000|Overall Study|Withdrawal by Subject|2|||
13172275|NCT02316717|26122072|FG001|Overall Study|Withdrawal by Subject|1|||
13172276|NCT02316717|26122073|FG002|Overall Study|Withdrawal by Subject|1|||
13172277|NCT02316717|26122071|FG000|Overall Study|Death|0|||
13172278|NCT02316717|26122072|FG001|Overall Study|Death|0|||
13172279|NCT02316717|26122073|FG002|Overall Study|Death|1|||
13172280|NCT02316717|26122071|FG000|Overall Study|Physician Decision|0|||
13172281|NCT02316717|26122072|FG001|Overall Study|Physician Decision|1|||
13172282|NCT02316717|26122073|FG002|Overall Study|Physician Decision|0|||
13172283|NCT02316717|26122071|FG000|Overall Study|TBC|1|||
13172284|NCT02316717|26122072|FG001|Overall Study|TBC|0|||
13172285|NCT02316717|26122073|FG002|Overall Study|TBC|0|||
13172286|NCT02316613|26122112|FG000|Overall Study|Death|63|||
13172287|NCT02316613|26122112|FG000|Overall Study|Lost to Follow-up|9|||
13172288|NCT02316613|26122112|FG000|Overall Study|Lymphoma transformation|2|||
13172289|NCT02316613|26122112|FG000|Overall Study|Participant moved/changed medical team|11|||
13172290|NCT02316613|26122112|FG000|Overall Study|No data and duplicate cases|5|||
13172291|NCT02316613|26122112|FG000|Overall Study|Did not met selection criteria|14|||
13172292|NCT02316548|26122129|FG000|Overall Study|Protocol Violation|0|||
13172293|NCT02316548|26122130|FG001|Overall Study|Protocol Violation|1|||
13172294|NCT02316353|26122155|FG000|Overall Study|Pregnancy|1|||
13172295|NCT02316353|26122156|FG001|Overall Study|Pregnancy|3|||
13172296|NCT02316353|26122155|FG000|Overall Study|Adverse Event|1|||
13172297|NCT02316353|26122156|FG001|Overall Study|Adverse Event|3|||
13172298|NCT02316353|26122155|FG000|Overall Study|Withdrawal by Subject|6|||
13172299|NCT02316353|26122156|FG001|Overall Study|Withdrawal by Subject|2|||
13172300|NCT02316223|26122186|FG000|Overall Study|Lack of Efficacy|0|||
13172301|NCT02316223|26122187|FG001|Overall Study|Lack of Efficacy|1|||
13172302|NCT02316223|26122188|FG002|Overall Study|Lack of Efficacy|1|||
13172303|NCT02316223|26122186|FG000|Overall Study|Lost to Follow-up|27|||
13172304|NCT02316223|26122187|FG001|Overall Study|Lost to Follow-up|34|||
13172305|NCT02316223|26122188|FG002|Overall Study|Lost to Follow-up|36|||
13172306|NCT02316223|26122186|FG000|Overall Study|COPD Diagnosis|3|||
13172307|NCT02316223|26122187|FG001|Overall Study|COPD Diagnosis|2|||
13172308|NCT02316223|26122188|FG002|Overall Study|COPD Diagnosis|3|||
13172309|NCT02316223|26122186|FG000|Overall Study|Reside outside study area|1|||
13172310|NCT02316223|26122187|FG001|Overall Study|Reside outside study area|1|||
13172311|NCT02316223|26122188|FG002|Overall Study|Reside outside study area|1|||
13172312|NCT02316223|26122186|FG000|Overall Study|No asthma|2|||
13172313|NCT02316223|26122187|FG001|Overall Study|No asthma|0|||
13172314|NCT02316223|26122188|FG002|Overall Study|No asthma|0|||
13172315|NCT02316223|26122186|FG000|Overall Study|Discontinued by PI|11|||
13172316|NCT02316223|26122187|FG001|Overall Study|Discontinued by PI|19|||
13172317|NCT02316223|26122188|FG002|Overall Study|Discontinued by PI|3|||
13172318|NCT02316171|26122203|FG000|Overall Study|difficulties with urinary catheter|1|||
13172319|NCT02316171|26122204|FG001|Overall Study|difficulties with urinary catheter|0|||
13172320|NCT02316171|26122205|FG002|Overall Study|difficulties with urinary catheter|0|||
13172321|NCT02316171|26122206|FG003|Overall Study|difficulties with urinary catheter|0|||
13172322|NCT02315664|26122233|FG000|Overall Study|Lost to Follow-up|1|||
13172323|NCT02315664|26122234|FG001|Overall Study|Lost to Follow-up|1|||
13172324|NCT02315664|26122233|FG000|Overall Study|Withdrawal by Subject|0|||
13172325|NCT02315664|26122234|FG001|Overall Study|Withdrawal by Subject|3|||
13172326|NCT02315625|26122255|FG000|First Intervention|Disease Progression|1|||
13172327|NCT02315625|26122256|FG001|First Intervention|Disease Progression|0|||
13172328|NCT02315625|26122255|FG000|Second Intervention|Physician Decision|2|||
13172329|NCT02315625|26122256|FG001|Second Intervention|Physician Decision|1|||
13172330|NCT02315625|26122255|FG000|Second Intervention|Study closure|1|||
13172331|NCT02315625|26122256|FG001|Second Intervention|Study closure|0|||
13172332|NCT02315625|26122255|FG000|Second Intervention|Disease Progression|1|||
13172333|NCT02315625|26122256|FG001|Second Intervention|Disease Progression|0|||
13172334|NCT02315560|26122263|FG000|Overall Study|noncompliance by subjects|3|||
13172335|NCT02315066|26122665|FG000|Overall Study|Lost to Follow-up|0|||
13172336|NCT02315066|26122666|FG001|Overall Study|Lost to Follow-up|1|||
13172337|NCT02315066|26122667|FG002|Overall Study|Lost to Follow-up|1|||
13172338|NCT02315066|26122668|FG003|Overall Study|Lost to Follow-up|0|||
13172339|NCT02315066|26122669|FG004|Overall Study|Lost to Follow-up|1|||
13172340|NCT02315066|26122670|FG005|Overall Study|Lost to Follow-up|0|||
13172341|NCT02315066|26122671|FG006|Overall Study|Lost to Follow-up|2|||
13172342|NCT02315066|26122672|FG007|Overall Study|Lost to Follow-up|1|||
13172343|NCT02315066|26122673|FG008|Overall Study|Lost to Follow-up|0|||
13172344|NCT02315066|26122674|FG009|Overall Study|Lost to Follow-up|0|||
13172345|NCT02315066|26122675|FG010|Overall Study|Lost to Follow-up|1|||
13172346|NCT02315066|26122676|FG011|Overall Study|Lost to Follow-up|2|||
13172347|NCT02315066|26122677|FG012|Overall Study|Lost to Follow-up|0|||
13172348|NCT02315066|26122678|FG013|Overall Study|Lost to Follow-up|4|||
13172349|NCT02315066|26122665|FG000|Overall Study|Death|2|||
13172350|NCT02315066|26122666|FG001|Overall Study|Death|7|||
13172351|NCT02315066|26122667|FG002|Overall Study|Death|6|||
13172352|NCT02315066|26122668|FG003|Overall Study|Death|11|||
13172353|NCT02315066|26122669|FG004|Overall Study|Death|10|||
13172354|NCT02315066|26122670|FG005|Overall Study|Death|3|||
13172355|NCT02315066|26122671|FG006|Overall Study|Death|9|||
13172356|NCT02315066|26122672|FG007|Overall Study|Death|9|||
13172357|NCT02315066|26122673|FG008|Overall Study|Death|10|||
13172358|NCT02315066|26122674|FG009|Overall Study|Death|8|||
13172359|NCT02315066|26122675|FG010|Overall Study|Death|10|||
13172360|NCT02315066|26122676|FG011|Overall Study|Death|7|||
13172361|NCT02315066|26122677|FG012|Overall Study|Death|8|||
13172362|NCT02315066|26122678|FG013|Overall Study|Death|21|||
13172363|NCT02315066|26122665|FG000|Overall Study|Other|0|||
13172364|NCT02315066|26122666|FG001|Overall Study|Other|0|||
13172365|NCT02315066|26122667|FG002|Overall Study|Other|0|||
13172366|NCT02315066|26122668|FG003|Overall Study|Other|0|||
13172367|NCT02315066|26122669|FG004|Overall Study|Other|0|||
13172368|NCT02315066|26122670|FG005|Overall Study|Other|0|||
13172369|NCT02315066|26122671|FG006|Overall Study|Other|0|||
13172370|NCT02315066|26122672|FG007|Overall Study|Other|1|||
13172371|NCT02315066|26122673|FG008|Overall Study|Other|1|||
13172372|NCT02315066|26122674|FG009|Overall Study|Other|2|||
13172373|NCT02315066|26122675|FG010|Overall Study|Other|0|||
13172374|NCT02315066|26122676|FG011|Overall Study|Other|0|||
13172375|NCT02315066|26122677|FG012|Overall Study|Other|0|||
13172376|NCT02315066|26122678|FG013|Overall Study|Other|0|||
13172377|NCT02315066|26122665|FG000|Overall Study|Subject refused further follow-up|0|||
13172378|NCT02315066|26122666|FG001|Overall Study|Subject refused further follow-up|2|||
13172379|NCT02315066|26122667|FG002|Overall Study|Subject refused further follow-up|2|||
13172380|NCT02315066|26122668|FG003|Overall Study|Subject refused further follow-up|0|||
13172381|NCT02315066|26122669|FG004|Overall Study|Subject refused further follow-up|0|||
13172382|NCT02315066|26122670|FG005|Overall Study|Subject refused further follow-up|0|||
13172383|NCT02315066|26122671|FG006|Overall Study|Subject refused further follow-up|2|||
13172384|NCT02315066|26122672|FG007|Overall Study|Subject refused further follow-up|3|||
13172385|NCT02315066|26122673|FG008|Overall Study|Subject refused further follow-up|0|||
13172386|NCT02315066|26122674|FG009|Overall Study|Subject refused further follow-up|1|||
13172387|NCT02315066|26122675|FG010|Overall Study|Subject refused further follow-up|1|||
13172388|NCT02315066|26122676|FG011|Overall Study|Subject refused further follow-up|2|||
13172389|NCT02315066|26122677|FG012|Overall Study|Subject refused further follow-up|2|||
13172390|NCT02315066|26122678|FG013|Overall Study|Subject refused further follow-up|4|||
13172391|NCT02315066|26122665|FG000|Overall Study|Study ongoing at date of cut-off|0|||
13172392|NCT02315066|26122666|FG001|Overall Study|Study ongoing at date of cut-off|0|||
13172393|NCT02315066|26122667|FG002|Overall Study|Study ongoing at date of cut-off|0|||
13172394|NCT02315066|26122668|FG003|Overall Study|Study ongoing at date of cut-off|0|||
13172395|NCT02315066|26122669|FG004|Overall Study|Study ongoing at date of cut-off|0|||
13172396|NCT02315066|26122670|FG005|Overall Study|Study ongoing at date of cut-off|0|||
13172397|NCT02315066|26122671|FG006|Overall Study|Study ongoing at date of cut-off|0|||
13172398|NCT02315066|26122672|FG007|Overall Study|Study ongoing at date of cut-off|0|||
13172399|NCT02315066|26122673|FG008|Overall Study|Study ongoing at date of cut-off|0|||
13172400|NCT02315066|26122674|FG009|Overall Study|Study ongoing at date of cut-off|0|||
13172401|NCT02315066|26122675|FG010|Overall Study|Study ongoing at date of cut-off|0|||
13172402|NCT02315066|26122676|FG011|Overall Study|Study ongoing at date of cut-off|0|||
13172403|NCT02315066|26122677|FG012|Overall Study|Study ongoing at date of cut-off|0|||
13172404|NCT02315066|26122678|FG013|Overall Study|Study ongoing at date of cut-off|1|||
13172405|NCT02314780|26122711|FG000|Overall Study|organizational reasons|0|||
13172406|NCT02314780|26122712|FG001|Overall Study|organizational reasons|2|||
13172407|NCT02314780|26122713|FG002|Overall Study|organizational reasons|0|||
13172408|NCT02314780|26122711|FG000|Overall Study|Adverse Event|0|||
13172409|NCT02314780|26122712|FG001|Overall Study|Adverse Event|1|||
13172410|NCT02314780|26122713|FG002|Overall Study|Adverse Event|0|||
13172411|NCT02314728|26122728|FG000|Overall Study|Protocol Violation|1|||
13172412|NCT02314728|26122729|FG001|Overall Study|Protocol Violation|0|||
13172413|NCT02314728|26122728|FG000|Overall Study|Lost to Follow-up|0|||
13172414|NCT02314728|26122729|FG001|Overall Study|Lost to Follow-up|1|||
13172415|NCT02314637|26122746|FG000|Overall Study|Adverse Event|4|||
13172416|NCT02314637|26122747|FG001|Overall Study|Adverse Event|8|||
13172417|NCT02314637|26122746|FG000|Overall Study|Lack of Efficacy|1|||
13172418|NCT02314637|26122747|FG001|Overall Study|Lack of Efficacy|0|||
13172419|NCT02314637|26122746|FG000|Overall Study|Physician Decision|5|||
13172420|NCT02314637|26122747|FG001|Overall Study|Physician Decision|2|||
13172421|NCT02314637|26122746|FG000|Overall Study|Withdrawal by Subject|5|||
13172422|NCT02314637|26122747|FG001|Overall Study|Withdrawal by Subject|4|||
13172423|NCT02314637|26122746|FG000|Overall Study|Other Reason|1|||
13172424|NCT02314637|26122747|FG001|Overall Study|Other Reason|0|||
13172425|NCT02314143|26122801|FG000|Overall Study|Adverse Event|0|||
13172426|NCT02314143|26122802|FG001|Overall Study|Adverse Event|6|||
13172427|NCT02314143|26122803|FG002|Overall Study|Adverse Event|4|||
13108032|NCT03261947|25890213|FG002|Overall Study|Site Terminated by Sponsor|4|||
13108033|NCT03261947|25890214|FG003|Overall Study|Site Terminated by Sponsor|7|||
13108034|NCT03261947|25890215|FG004|Overall Study|Site Terminated by Sponsor|5|||
13108035|NCT03261947|25890211|FG000|Overall Study|Reason not Specified|2|||
13108036|NCT03261947|25890212|FG001|Overall Study|Reason not Specified|0|||
13108037|NCT03261947|25890213|FG002|Overall Study|Reason not Specified|4|||
13108038|NCT03261947|25890214|FG003|Overall Study|Reason not Specified|1|||
13108039|NCT03261947|25890215|FG004|Overall Study|Reason not Specified|3|||
13108040|NCT03261531|25890233|FG000|Overall Study|Withdrawal by Subject|4|||
13108041|NCT03261336|25890241|FG000|Overall Study|Adverse Event|1|||
13108042|NCT03261167|25890284|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0|||
13108043|NCT03261167|25890285|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3|||
13108044|NCT03261167|25890284|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3|||
13108045|NCT03261167|25890285|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1|||
13108046|NCT03261167|25890284|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1|||
13108047|NCT03261167|25890285|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0|||
13108048|NCT03261167|25890284|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1|||
13108049|NCT03261167|25890285|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0|||
13108050|NCT03261167|25890284|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
13108051|NCT03261167|25890285|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
13108052|NCT03261037|25890372|FG000|Overall Study|Withdrawal by Subject|2|||
13108053|NCT03261037|25890373|FG001|Overall Study|Withdrawal by Subject|13|||
13172428|NCT02314143|26122801|FG000|Overall Study|Other (Study Closed/Terminated)|5|||
13172429|NCT02314143|26122802|FG001|Overall Study|Other (Study Closed/Terminated)|3|||
13172430|NCT02314143|26122803|FG002|Overall Study|Other (Study Closed/Terminated)|4|||
13172431|NCT02314143|26122801|FG000|Overall Study|Physician Decision|2|||
13172432|NCT02314143|26122802|FG001|Overall Study|Physician Decision|1|||
13172433|NCT02314143|26122803|FG002|Overall Study|Physician Decision|0|||
13172434|NCT02314143|26122801|FG000|Overall Study|Withdrawal by Subject|1|||
13172435|NCT02314143|26122802|FG001|Overall Study|Withdrawal by Subject|0|||
13172436|NCT02314143|26122803|FG002|Overall Study|Withdrawal by Subject|1|||
13172437|NCT02314117|26122838|FG000|Overall Study|Lost to Follow-up|9|||
13172438|NCT02314117|26122839|FG001|Overall Study|Lost to Follow-up|14|||
13172439|NCT02314117|26122838|FG000|Overall Study|Withdrawal by Subject|3|||
13172440|NCT02314117|26122839|FG001|Overall Study|Withdrawal by Subject|2|||
13172441|NCT02314052|26122914|FG000|Cycle One|Adverse Event|0|||
13172442|NCT02314052|26122915|FG001|Cycle One|Adverse Event|0|||
13172443|NCT02314052|26122916|FG002|Cycle One|Adverse Event|0|||
13172444|NCT02314052|26122917|FG003|Cycle One|Adverse Event|1|||
13172445|NCT02314052|26122918|FG004|Cycle One|Adverse Event|0|||
13172446|NCT02314052|26122919|FG005|Cycle One|Adverse Event|0|||
13172447|NCT02313909|26122946|FG000|Overall Study|Consent withdrawn by participant|33|||
13172448|NCT02313909|26122947|FG001|Overall Study|Consent withdrawn by participant|33|||
13172449|NCT02313909|26122946|FG000|Overall Study|Lost to Follow-up|24|||
13172450|NCT02313909|26122947|FG001|Overall Study|Lost to Follow-up|17|||
13172451|NCT02313766|26122971|FG000|Overall Study|surgery cancelled|1|||
13172452|NCT02313766|26122972|FG001|Overall Study|surgery cancelled|0|||
13172453|NCT02313766|26122973|FG002|Overall Study|surgery cancelled|0|||
13172454|NCT02313766|26122971|FG000|Overall Study|Lost to Follow-up|0|||
13172455|NCT02313766|26122972|FG001|Overall Study|Lost to Follow-up|2|||
13172456|NCT02313766|26122973|FG002|Overall Study|Lost to Follow-up|0|||
13172457|NCT02313766|26122971|FG000|Overall Study|Adverse Event|0|||
13172458|NCT02313766|26122972|FG001|Overall Study|Adverse Event|1|||
13172459|NCT02313766|26122973|FG002|Overall Study|Adverse Event|0|||
13172460|NCT02313558|26122992|FG000|Overall Study|Withdrawal by Subject|2|||
13172461|NCT02313558|26122993|FG001|Overall Study|Withdrawal by Subject|0|||
13172462|NCT02313558|26122992|FG000|Overall Study|Lost to Follow-up|4|||
13172463|NCT02313558|26122993|FG001|Overall Study|Lost to Follow-up|4|||
13172464|NCT02313233|26123020|FG000|Overall Study|Withdrawal by Subject|1|||
13172465|NCT02313233|26123021|FG001|Overall Study|Withdrawal by Subject|2|||
13172466|NCT02313233|26123020|FG000|Overall Study|Administrative reason|1|||
13172467|NCT02313233|26123021|FG001|Overall Study|Administrative reason|1|||
13205608|NCT01963676|26232317|FG001|Overall Study|Withdrawal by Subject|0|||
13205609|NCT01963611|26232390|FG000|Overall Study|Adverse Event|1|||
13205610|NCT01963611|26232391|FG001|Overall Study|Adverse Event|1|||
13205611|NCT01963611|26232392|FG002|Overall Study|Adverse Event|3|||
13205612|NCT01963611|26232393|FG003|Overall Study|Adverse Event|4|||
13205613|NCT01963611|26232394|FG004|Overall Study|Adverse Event|3|||
13205614|NCT01963611|26232390|FG000|Overall Study|Protocol Violation|0|||
13205615|NCT01963611|26232391|FG001|Overall Study|Protocol Violation|0|||
13108054|NCT03261037|25890374|FG002|Overall Study|Withdrawal by Subject|0|||
13108055|NCT03261037|25890375|FG003|Overall Study|Withdrawal by Subject|18|||
13108056|NCT03261037|25890372|FG000|Overall Study|Non-compliance with study procedures|0|||
13108057|NCT03261037|25890373|FG001|Overall Study|Non-compliance with study procedures|2|||
13108058|NCT03261037|25890374|FG002|Overall Study|Non-compliance with study procedures|0|||
13108059|NCT03261037|25890375|FG003|Overall Study|Non-compliance with study procedures|6|||
13108060|NCT03261037|25890372|FG000|Overall Study|Participant moving away and can no longer be in study|0|||
13108061|NCT03261037|25890373|FG001|Overall Study|Participant moving away and can no longer be in study|1|||
13108062|NCT03261037|25890374|FG002|Overall Study|Participant moving away and can no longer be in study|0|||
13108063|NCT03261037|25890375|FG003|Overall Study|Participant moving away and can no longer be in study|0|||
13108064|NCT03261037|25890372|FG000|Overall Study|Participant came out of study due to investigator discretion|0|||
13108065|NCT03261037|25890373|FG001|Overall Study|Participant came out of study due to investigator discretion|2|||
13108066|NCT03261037|25890374|FG002|Overall Study|Participant came out of study due to investigator discretion|0|||
13108067|NCT03261037|25890375|FG003|Overall Study|Participant came out of study due to investigator discretion|0|||
13108068|NCT03261037|25890372|FG000|Overall Study|Diagnosed but protocol deviation|1|||
13108069|NCT03261037|25890373|FG001|Overall Study|Diagnosed but protocol deviation|0|||
13108070|NCT03261037|25890374|FG002|Overall Study|Diagnosed but protocol deviation|0|||
13108071|NCT03261037|25890375|FG003|Overall Study|Diagnosed but protocol deviation|0|||
13108072|NCT03261037|25890372|FG000|Overall Study|Participant did not want to continue the study|0|||
13205616|NCT01963611|26232392|FG002|Overall Study|Protocol Violation|0|||
13205617|NCT01963611|26232393|FG003|Overall Study|Protocol Violation|1|||
13205618|NCT01963611|26232394|FG004|Overall Study|Protocol Violation|0|||
13205619|NCT01963611|26232390|FG000|Overall Study|Lack of Efficacy|0|||
13205620|NCT01963611|26232391|FG001|Overall Study|Lack of Efficacy|0|||
13205621|NCT01963611|26232392|FG002|Overall Study|Lack of Efficacy|0|||
13205622|NCT01963611|26232393|FG003|Overall Study|Lack of Efficacy|1|||
13108073|NCT03261037|25890373|FG001|Overall Study|Participant did not want to continue the study|1|||
13108074|NCT03261037|25890374|FG002|Overall Study|Participant did not want to continue the study|0|||
13172468|NCT02313155|26123076|FG000|Overall Study|Lost to Follow-up|0|||
13172469|NCT02313155|26123077|FG001|Overall Study|Lost to Follow-up|1|||
13172470|NCT02312934|26123092|FG000|Overall Study|Lost to Follow-up|1|||
13172471|NCT02312934|26123093|FG001|Overall Study|Lost to Follow-up|0|||
13172472|NCT02312934|26123092|FG000|Overall Study|Physician Decision|1|||
13172473|NCT02312934|26123093|FG001|Overall Study|Physician Decision|0|||
13108075|NCT03261037|25890375|FG003|Overall Study|Participant did not want to continue the study|0|||
13172474|NCT02312856|26123099|FG000|Overall Study|Death|1|||
13172475|NCT02312856|26123099|FG000|Overall Study|Lost to Follow-up|3|||
13172476|NCT02312687|26123129|FG000|Overall Study|Other, Not Specified|1|||
13172477|NCT02312219|26123144|FG000|Overall Study|Withdrawal by Subject|1|||
13172478|NCT02312219|26123145|FG001|Overall Study|Withdrawal by Subject|2|||
13172479|NCT02312219|26123144|FG000|Overall Study|could not schedule imaging in time|0|||
13172480|NCT02312219|26123145|FG001|Overall Study|could not schedule imaging in time|2|||
13172481|NCT02312219|26123144|FG000|Overall Study|Other|0|||
13172482|NCT02312219|26123145|FG001|Overall Study|Other|1|||
13172483|NCT02312219|26123144|FG000|Overall Study|Not randomized. Ineligible|0|||
13172484|NCT02312219|26123145|FG001|Overall Study|Not randomized. Ineligible|1|||
13172485|NCT02312206|26123158|FG000|Overall Study|Adverse Event|3|||
13172486|NCT02312206|26123159|FG001|Overall Study|Adverse Event|6|||
13172487|NCT02312206|26123158|FG000|Overall Study|Withdrawal by Subject|7|||
13172488|NCT02312206|26123159|FG001|Overall Study|Withdrawal by Subject|6|||
13172489|NCT02312206|26123158|FG000|Overall Study|Physician Decision|7|||
13172490|NCT02312206|26123159|FG001|Overall Study|Physician Decision|6|||
13172491|NCT02312206|26123158|FG000|Overall Study|Death|30|||
13172492|NCT02312206|26123159|FG001|Overall Study|Death|36|||
13172493|NCT02312206|26123158|FG000|Overall Study|Study Terminated by Sponsor|81|||
13172494|NCT02312206|26123159|FG001|Overall Study|Study Terminated by Sponsor|74|||
13172495|NCT02312206|26123158|FG000|Overall Study|Disease Progression|1|||
13172496|NCT02312206|26123159|FG001|Overall Study|Disease Progression|0|||
13172497|NCT02312206|26123158|FG000|Overall Study|Patient progression and new therapy|1|||
13172498|NCT02312206|26123159|FG001|Overall Study|Patient progression and new therapy|0|||
13172499|NCT02312206|26123158|FG000|Overall Study|Patient transferred to hospice|0|||
13172500|NCT02312206|26123159|FG001|Overall Study|Patient transferred to hospice|1|||
13172501|NCT02312206|26123158|FG000|Overall Study|Subject missed 3 consecutive tx visits|0|||
13172502|NCT02312206|26123159|FG001|Overall Study|Subject missed 3 consecutive tx visits|1|||
13108076|NCT03261037|25890372|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
13108077|NCT03261037|25890373|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
13108078|NCT03261037|25890374|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
13108079|NCT03261037|25890375|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1|||
13172503|NCT02312063|26123174|FG000|Overall Study|Withdrawal by Subject|0|||
13172504|NCT02312063|26123175|FG001|Overall Study|Withdrawal by Subject|1|||
13172505|NCT02311894|26123186|FG000|Overall Study|Discontinued in error|1|||
13172506|NCT02311894|26123186|FG000|Overall Study|Lost to Follow-up|1|||
13172507|NCT02311894|26123186|FG000|Overall Study|Adverse Event|1|||
13172508|NCT02311894|26123186|FG000|Overall Study|Withdrawal by Subject|1|||
13172509|NCT02311881|26123231|FG000|Overall Study|Did not meet the study criteria|2|||
13172510|NCT02311881|26123232|FG001|Overall Study|Did not meet the study criteria|2|||
13172511|NCT02311881|26123233|FG002|Overall Study|Did not meet the study criteria|0|||
13172512|NCT02311881|26123231|FG000|Overall Study|Adverse Event|7|||
13172513|NCT02311881|26123232|FG001|Overall Study|Adverse Event|15|||
13172514|NCT02311881|26123233|FG002|Overall Study|Adverse Event|8|||
13172515|NCT02311881|26123231|FG000|Overall Study|Lost to Follow-up|3|||
13172516|NCT02311881|26123232|FG001|Overall Study|Lost to Follow-up|3|||
13172517|NCT02311881|26123233|FG002|Overall Study|Lost to Follow-up|2|||
13172518|NCT02311881|26123231|FG000|Overall Study|Protocol Violation|1|||
13172519|NCT02311881|26123232|FG001|Overall Study|Protocol Violation|2|||
13172520|NCT02311881|26123233|FG002|Overall Study|Protocol Violation|3|||
13172521|NCT02311881|26123231|FG000|Overall Study|Withdrawal of consent|14|||
13172522|NCT02311881|26123232|FG001|Overall Study|Withdrawal of consent|16|||
13172523|NCT02311881|26123233|FG002|Overall Study|Withdrawal of consent|17|||
13172524|NCT02311881|26123231|FG000|Overall Study|Other|0|||
13172525|NCT02311881|26123232|FG001|Overall Study|Other|0|||
13172526|NCT02311881|26123233|FG002|Overall Study|Other|1|||
13172527|NCT02311881|26123231|FG000|Overall Study|Lack of Efficacy|1|||
13172528|NCT02311881|26123232|FG001|Overall Study|Lack of Efficacy|2|||
13172529|NCT02311881|26123233|FG002|Overall Study|Lack of Efficacy|0|||
13172530|NCT02311881|26123231|FG000|Overall Study|Subject has border line pregnancy test|1|||
13172531|NCT02311881|26123232|FG001|Overall Study|Subject has border line pregnancy test|0|||
13172532|NCT02311881|26123233|FG002|Overall Study|Subject has border line pregnancy test|0|||
13172533|NCT02311881|26123231|FG000|Overall Study|Withdrawal by Subject|3|||
13172534|NCT02311881|26123232|FG001|Overall Study|Withdrawal by Subject|1|||
13172535|NCT02311881|26123233|FG002|Overall Study|Withdrawal by Subject|4|||
13172536|NCT02311881|26123231|FG000|Overall Study|Sponsor Decision|1|||
13172537|NCT02311881|26123232|FG001|Overall Study|Sponsor Decision|1|||
13172538|NCT02311881|26123233|FG002|Overall Study|Sponsor Decision|1|||
13172539|NCT02311881|26123231|FG000|Overall Study|Protocol Deviation|1|||
13172540|NCT02311881|26123232|FG001|Overall Study|Protocol Deviation|0|||
13172541|NCT02311881|26123233|FG002|Overall Study|Protocol Deviation|0|||
13172542|NCT02311881|26123231|FG000|Overall Study|Non-Compliance|1|||
13172543|NCT02311881|26123232|FG001|Overall Study|Non-Compliance|0|||
13108080|NCT03261037|25890372|FG000|Overall Study|Participant presented clinical improvement|0|||
13108081|NCT03261037|25890373|FG001|Overall Study|Participant presented clinical improvement|2|||
13172544|NCT02311881|26123233|FG002|Overall Study|Non-Compliance|2|||
13172545|NCT02311881|26123231|FG000|Overall Study|Physician Decision|0|||
13172546|NCT02311881|26123232|FG001|Overall Study|Physician Decision|0|||
13172547|NCT02311881|26123233|FG002|Overall Study|Physician Decision|1|||
13172548|NCT02311881|26123231|FG000|Overall Study|Medical Monitor Discretion|0|||
13172549|NCT02311881|26123232|FG001|Overall Study|Medical Monitor Discretion|0|||
13172550|NCT02311881|26123233|FG002|Overall Study|Medical Monitor Discretion|1|||
13108082|NCT03261037|25890374|FG002|Overall Study|Participant presented clinical improvement|0|||
13108083|NCT03261037|25890375|FG003|Overall Study|Participant presented clinical improvement|0|||
13108084|NCT03261037|25890372|FG000|Overall Study|Technical difficulties|0|||
13108085|NCT03261037|25890373|FG001|Overall Study|Technical difficulties|0|||
13108086|NCT03261037|25890374|FG002|Overall Study|Technical difficulties|0|||
13172551|NCT02311881|26123231|FG000|Overall Study|Participant taking another medication|0|||
13172552|NCT02311881|26123232|FG001|Overall Study|Participant taking another medication|0|||
13172553|NCT02311881|26123233|FG002|Overall Study|Participant taking another medication|1|||
13172554|NCT02311881|26123231|FG000|Overall Study|Serious Adverse Event|0|||
13172555|NCT02311881|26123232|FG001|Overall Study|Serious Adverse Event|1|||
13172556|NCT02311881|26123233|FG002|Overall Study|Serious Adverse Event|0|||
13172557|NCT02311478|26123241|FG000|Overall Study|Withdrawal by Subject|1|||
13172558|NCT02311478|26123241|FG000|Overall Study|Lost to Follow-up|5|||
13172559|NCT02311478|26123241|FG000|Overall Study|Failed IUD Insertion|1|||
13172560|NCT02311361|26123288|FG000|Overall Study|Did not receive treatment|0|||
13172561|NCT02311361|26123289|FG001|Overall Study|Did not receive treatment|1|||
13172562|NCT02311361|26123290|FG002|Overall Study|Did not receive treatment|0|||
13172563|NCT02311361|26123291|FG003|Overall Study|Did not receive treatment|1|||
13172564|NCT02311153|26123314|FG000|Overall Study|Lost to Follow-up|5|||
13172565|NCT02311153|26123315|FG001|Overall Study|Lost to Follow-up|7|||
13172566|NCT02310906|26123407|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
13172567|NCT02310906|26123408|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
13172568|NCT02310906|26123409|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
13172569|NCT02310906|26123410|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2|||
13172570|NCT02310906|26123407|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
13172571|NCT02310906|26123408|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
13172572|NCT02310906|26123409|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2|||
13172573|NCT02310906|26123410|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4|||
13172574|NCT02310906|26123407|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
13172575|NCT02310906|26123408|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
13172576|NCT02310906|26123409|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
13172577|NCT02310906|26123410|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1|||
13172578|NCT02310906|26123407|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
13172579|NCT02310906|26123408|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
13172580|NCT02310906|26123409|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
13172581|NCT02310906|26123410|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1|||
13172582|NCT02310789|26123417|FG000|Overall Study|Adverse Event|1|||
13172583|NCT02310763|26123619|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
13172584|NCT02310763|26123620|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
13172585|NCT02310763|26123621|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
13172586|NCT02310763|26123619|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0|||
13172587|NCT02310763|26123620|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
13172588|NCT02310763|26123621|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
13172589|NCT02310763|26123619|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1|||
13172590|NCT02310763|26123620|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
13172591|NCT02310763|26123621|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
13172592|NCT02310763|26123619|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1|||
13172593|NCT02310763|26123620|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
13172594|NCT02310763|26123621|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
13172595|NCT02310763|26123619|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
13172596|NCT02310763|26123620|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
13172597|NCT02310763|26123621|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
13485531|NCT02906020|27032869|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
13172598|NCT02310750|26124099|FG000|HP Period 1|Lost to Follow-up|0|||
13172599|NCT02310750|26124100|FG001|HP Period 1|Lost to Follow-up|0|||
13172600|NCT02310750|26124101|FG002|HP Period 1|Lost to Follow-up|0|||
13172601|NCT02310750|26124102|FG003|HP Period 1|Lost to Follow-up|0|||
13172602|NCT02310750|26124103|FG004|HP Period 1|Lost to Follow-up|0|||
13172603|NCT02310750|26124104|FG005|HP Period 1|Lost to Follow-up|0|||
13172604|NCT02310750|26124105|FG006|HP Period 1|Lost to Follow-up|1|||
13108087|NCT03261037|25890375|FG003|Overall Study|Technical difficulties|1|||
13108088|NCT03261037|25890372|FG000|Overall Study|Equipment failed to work|0|||
13172605|NCT02310750|26124106|FG007|HP Period 1|Lost to Follow-up|0|||
13172606|NCT02310750|26124107|FG008|HP Period 1|Lost to Follow-up|0|||
13172607|NCT02310750|26124108|FG009|HP Period 1|Lost to Follow-up|0|||
13172608|NCT02310750|26124109|FG010|HP Period 1|Lost to Follow-up|0|||
13172609|NCT02310750|26124110|FG011|HP Period 1|Lost to Follow-up|0|||
13172610|NCT02310750|26124111|FG012|HP Period 1|Lost to Follow-up|0|||
13172611|NCT02310750|26124112|FG013|HP Period 1|Lost to Follow-up|0|||
13172612|NCT02310750|26124113|FG014|HP Period 1|Lost to Follow-up|0|||
13172613|NCT02310750|26124114|FG015|HP Period 1|Lost to Follow-up|0|||
13172614|NCT02310750|26124099|FG000|HP Period 1|Withdrawal by Subject|1|||
13172615|NCT02310750|26124100|FG001|HP Period 1|Withdrawal by Subject|0|||
13172616|NCT02310750|26124101|FG002|HP Period 1|Withdrawal by Subject|0|||
13172617|NCT02310750|26124102|FG003|HP Period 1|Withdrawal by Subject|1|||
13172618|NCT02310750|26124103|FG004|HP Period 1|Withdrawal by Subject|0|||
13172619|NCT02310750|26124104|FG005|HP Period 1|Withdrawal by Subject|0|||
13172620|NCT02310750|26124105|FG006|HP Period 1|Withdrawal by Subject|0|||
13172621|NCT02310750|26124106|FG007|HP Period 1|Withdrawal by Subject|0|||
13172622|NCT02310750|26124107|FG008|HP Period 1|Withdrawal by Subject|0|||
13172623|NCT02310750|26124108|FG009|HP Period 1|Withdrawal by Subject|0|||
13172624|NCT02310750|26124109|FG010|HP Period 1|Withdrawal by Subject|0|||
13172625|NCT02310750|26124110|FG011|HP Period 1|Withdrawal by Subject|0|||
13172626|NCT02310750|26124111|FG012|HP Period 1|Withdrawal by Subject|0|||
13172627|NCT02310750|26124112|FG013|HP Period 1|Withdrawal by Subject|0|||
13172628|NCT02310750|26124113|FG014|HP Period 1|Withdrawal by Subject|0|||
13172629|NCT02310750|26124114|FG015|HP Period 1|Withdrawal by Subject|0|||
13172630|NCT02310750|26124099|FG000|HP Washout 1|Lost to Follow-up|0|||
13172631|NCT02310750|26124100|FG001|HP Washout 1|Lost to Follow-up|0|||
13172632|NCT02310750|26124101|FG002|HP Washout 1|Lost to Follow-up|1|||
13172633|NCT02310750|26124102|FG003|HP Washout 1|Lost to Follow-up|1|||
13172634|NCT02310750|26124103|FG004|HP Washout 1|Lost to Follow-up|2|||
13172635|NCT02310750|26124104|FG005|HP Washout 1|Lost to Follow-up|2|||
13172636|NCT02310750|26124105|FG006|HP Washout 1|Lost to Follow-up|3|||
13172637|NCT02310750|26124106|FG007|HP Washout 1|Lost to Follow-up|0|||
13172638|NCT02310750|26124107|FG008|HP Washout 1|Lost to Follow-up|0|||
13172639|NCT02310750|26124108|FG009|HP Washout 1|Lost to Follow-up|0|||
13172640|NCT02310750|26124109|FG010|HP Washout 1|Lost to Follow-up|0|||
13172641|NCT02310750|26124110|FG011|HP Washout 1|Lost to Follow-up|0|||
13172642|NCT02310750|26124111|FG012|HP Washout 1|Lost to Follow-up|0|||
13172643|NCT02310750|26124112|FG013|HP Washout 1|Lost to Follow-up|0|||
13172644|NCT02310750|26124113|FG014|HP Washout 1|Lost to Follow-up|0|||
13172645|NCT02310750|26124114|FG015|HP Washout 1|Lost to Follow-up|0|||
13172646|NCT02310750|26124099|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
13172647|NCT02310750|26124100|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
13172648|NCT02310750|26124101|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
13172649|NCT02310750|26124102|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
13172650|NCT02310750|26124103|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
13172651|NCT02310750|26124104|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2|||
13172652|NCT02310750|26124105|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
13172653|NCT02310750|26124106|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
13172654|NCT02310750|26124107|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6|||
13108089|NCT03261037|25890373|FG001|Overall Study|Equipment failed to work|0|||
13108090|NCT03261037|25890374|FG002|Overall Study|Equipment failed to work|0|||
13108091|NCT03261037|25890375|FG003|Overall Study|Equipment failed to work|1|||
13108092|NCT03261037|25890372|FG000|Overall Study|End of study for participant and no follow up|0|||
13108093|NCT03261037|25890373|FG001|Overall Study|End of study for participant and no follow up|0|||
13108094|NCT03261037|25890374|FG002|Overall Study|End of study for participant and no follow up|0|||
13108095|NCT03261037|25890375|FG003|Overall Study|End of study for participant and no follow up|1|||
13108096|NCT03261037|25890372|FG000|Overall Study|Participant was too weak to continue in study|1|||
13108097|NCT03261037|25890373|FG001|Overall Study|Participant was too weak to continue in study|0|||
13108098|NCT03261037|25890374|FG002|Overall Study|Participant was too weak to continue in study|0|||
13108099|NCT03261037|25890375|FG003|Overall Study|Participant was too weak to continue in study|0|||
13108100|NCT03260894|25890392|FG000|Overall Study|Death|6|||
13108101|NCT03260894|25890393|FG001|Overall Study|Death|8|||
13108102|NCT03260894|25890392|FG000|Overall Study|Withdrawal by Subject|4|||
13108103|NCT03260894|25890393|FG001|Overall Study|Withdrawal by Subject|11|||
13172655|NCT02310750|26124108|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
13172656|NCT02310750|26124109|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
13108104|NCT03260894|25890392|FG000|Overall Study|On-going at clinical cut off date|36|||
13108105|NCT03260894|25890393|FG001|Overall Study|On-going at clinical cut off date|31|||
13108106|NCT03260868|25890438|FG000|Overall Study|Poor Compliance to Protocol|0|||
13108107|NCT03260868|25890439|FG001|Overall Study|Poor Compliance to Protocol|2|||
13108108|NCT03260868|25890438|FG000|Overall Study|Study Terminated By Sponsor|2|||
13108109|NCT03260868|25890439|FG001|Overall Study|Study Terminated By Sponsor|1|||
13108110|NCT03260868|25890438|FG000|Overall Study|Other than specified above|1|||
13108111|NCT03260868|25890439|FG001|Overall Study|Other than specified above|0|||
13108112|NCT03260205|25890516|FG000|Overall Study|Adverse Event|2|||
13172657|NCT02310750|26124110|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
13172658|NCT02310750|26124111|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
13172659|NCT02310750|26124112|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
13172660|NCT02310750|26124113|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
13172661|NCT02310750|26124114|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
13172662|NCT02310750|26124099|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
13172663|NCT02310750|26124100|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
13172664|NCT02310750|26124101|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
13172665|NCT02310750|26124102|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
13172666|NCT02310750|26124103|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
13172667|NCT02310750|26124104|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
13172668|NCT02310750|26124105|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
13172669|NCT02310750|26124106|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
13172670|NCT02310750|26124107|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
13172671|NCT02310750|26124108|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1|||
13172672|NCT02310750|26124109|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
13172673|NCT02310750|26124110|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
13172674|NCT02310750|26124111|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
13172675|NCT02310750|26124112|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
13172676|NCT02310750|26124113|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
13172677|NCT02310750|26124114|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
13172678|NCT02310750|26124099|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
13172679|NCT02310750|26124100|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
13172680|NCT02310750|26124101|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
13172681|NCT02310750|26124102|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
13172682|NCT02310750|26124103|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
13172683|NCT02310750|26124104|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
13172684|NCT02310750|26124105|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
13172685|NCT02310750|26124106|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
13172686|NCT02310750|26124107|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
13172687|NCT02310750|26124108|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
13172688|NCT02310750|26124109|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
13172689|NCT02310750|26124110|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
13172690|NCT02310750|26124111|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
13172691|NCT02310750|26124112|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
13172692|NCT02310750|26124113|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
13172693|NCT02310750|26124114|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
13172694|NCT02310750|26124099|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
13172695|NCT02310750|26124100|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
13172696|NCT02310750|26124101|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
13172697|NCT02310750|26124102|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
13172698|NCT02310750|26124103|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
13172699|NCT02310750|26124104|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
13172700|NCT02310750|26124105|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
13172701|NCT02310750|26124106|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
13172702|NCT02310750|26124107|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
13172703|NCT02310750|26124108|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
13172704|NCT02310750|26124109|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
13172705|NCT02310750|26124110|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
13172706|NCT02310750|26124111|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
13172707|NCT02310750|26124112|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
13172708|NCT02310750|26124113|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
13108113|NCT03260205|25890517|FG001|Overall Study|Adverse Event|0|||
13108114|NCT03260205|25890518|FG002|Overall Study|Adverse Event|2|||
13108115|NCT03260205|25890519|FG003|Overall Study|Adverse Event|2|||
13108116|NCT03260205|25890520|FG004|Overall Study|Adverse Event|4|||
13108117|NCT03260205|25890516|FG000|Overall Study|Lost to Follow-up|2|||
13108118|NCT03260205|25890517|FG001|Overall Study|Lost to Follow-up|2|||
13108119|NCT03260205|25890518|FG002|Overall Study|Lost to Follow-up|1|||
13108120|NCT03260205|25890519|FG003|Overall Study|Lost to Follow-up|1|||
13108121|NCT03260205|25890520|FG004|Overall Study|Lost to Follow-up|5|||
13108122|NCT03260205|25890516|FG000|Overall Study|Protocol Violation|0|||
13108123|NCT03260205|25890517|FG001|Overall Study|Protocol Violation|0|||
13108124|NCT03260205|25890518|FG002|Overall Study|Protocol Violation|2|||
13108125|NCT03260205|25890519|FG003|Overall Study|Protocol Violation|0|||
13108126|NCT03260205|25890520|FG004|Overall Study|Protocol Violation|1|||
13108127|NCT03260205|25890516|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4|||
13108128|NCT03260205|25890517|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5|||
13172709|NCT02310750|26124114|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
13172710|NCT02310750|26124099|FG000|HP Washout 2|Lost to Follow-up|0|||
13172711|NCT02310750|26124100|FG001|HP Washout 2|Lost to Follow-up|0|||
13172712|NCT02310750|26124101|FG002|HP Washout 2|Lost to Follow-up|0|||
13172713|NCT02310750|26124102|FG003|HP Washout 2|Lost to Follow-up|0|||
13172714|NCT02310750|26124103|FG004|HP Washout 2|Lost to Follow-up|1|||
13172715|NCT02310750|26124104|FG005|HP Washout 2|Lost to Follow-up|0|||
13172716|NCT02310750|26124105|FG006|HP Washout 2|Lost to Follow-up|7|||
13172717|NCT02310750|26124106|FG007|HP Washout 2|Lost to Follow-up|0|||
13172718|NCT02310750|26124107|FG008|HP Washout 2|Lost to Follow-up|0|||
13172719|NCT02310750|26124108|FG009|HP Washout 2|Lost to Follow-up|0|||
13172720|NCT02310750|26124109|FG010|HP Washout 2|Lost to Follow-up|0|||
13172721|NCT02310750|26124110|FG011|HP Washout 2|Lost to Follow-up|0|||
13172722|NCT02310750|26124111|FG012|HP Washout 2|Lost to Follow-up|0|||
13172723|NCT02310750|26124112|FG013|HP Washout 2|Lost to Follow-up|0|||
13172724|NCT02310750|26124113|FG014|HP Washout 2|Lost to Follow-up|0|||
13172725|NCT02310750|26124114|FG015|HP Washout 2|Lost to Follow-up|0|||
13172726|NCT02310672|26124127|FG000|Overall Study|Death|1|||
13172727|NCT02310672|26124127|FG000|Overall Study|Lost to Follow-up|1|||
13172728|NCT02310672|26124127|FG000|Overall Study|Withdrawal by Subject|1|||
13172729|NCT02310672|26124127|FG000|Overall Study|Sponsor's decision|12|||
13172730|NCT02310646|26124158|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1|||
13172731|NCT02310646|26124159|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0|||
13172732|NCT02310646|26124158|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1|||
13172733|NCT02310646|26124159|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0|||
13172734|NCT02310581|26124206|FG000|Overall Study|Adverse Event|1|||
13172735|NCT02310581|26124207|FG001|Overall Study|Adverse Event|1|||
13172736|NCT02310581|26124208|FG002|Overall Study|Adverse Event|1|||
13172737|NCT02310581|26124209|FG003|Overall Study|Adverse Event|0|||
13172738|NCT02310581|26124206|FG000|Overall Study|Withdrawal by Subject|2|||
13172739|NCT02310581|26124207|FG001|Overall Study|Withdrawal by Subject|1|||
13172740|NCT02310581|26124208|FG002|Overall Study|Withdrawal by Subject|0|||
13108129|NCT03260205|25890518|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1|||
13108130|NCT03260205|25890519|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0|||
13172741|NCT02310581|26124209|FG003|Overall Study|Withdrawal by Subject|1|||
13172742|NCT02310568|26124303|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
13172743|NCT02310568|26124304|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
13172744|NCT02310568|26124305|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
13172745|NCT02310568|26124306|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
13172746|NCT02310568|26124307|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1|||
13172747|NCT02310568|26124303|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1|||
13172748|NCT02310568|26124304|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
13172749|NCT02310568|26124305|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
13172750|NCT02310568|26124306|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
13172751|NCT02310568|26124307|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
13172752|NCT02310568|26124303|FG000|Stage 1 ( 4 Weeks)|Other|1|||
13172753|NCT02310568|26124304|FG001|Stage 1 ( 4 Weeks)|Other|1|||
13172754|NCT02310568|26124305|FG002|Stage 1 ( 4 Weeks)|Other|0|||
13172755|NCT02310568|26124306|FG003|Stage 1 ( 4 Weeks)|Other|0|||
13172756|NCT02310568|26124307|FG004|Stage 1 ( 4 Weeks)|Other|0|||
13172757|NCT02310568|26124303|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1|||
13172758|NCT02310568|26124304|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1|||
13172759|NCT02310568|26124305|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1|||
13172760|NCT02310568|26124306|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0|||
13172761|NCT02310568|26124307|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0|||
13172762|NCT02310568|26124303|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
13172763|NCT02310568|26124304|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
13172764|NCT02310568|26124305|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
13172765|NCT02310568|26124306|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1|||
13172766|NCT02310568|26124307|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
13172767|NCT02310568|26124303|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
13172768|NCT02310568|26124304|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
13172769|NCT02310568|26124305|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
13172770|NCT02310568|26124306|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1|||
13172771|NCT02310568|26124307|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
13172772|NCT02310568|26124303|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
13172773|NCT02310568|26124304|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
13172774|NCT02310568|26124305|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
13172775|NCT02310568|26124306|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
13172776|NCT02310568|26124307|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
13172777|NCT02310568|26124303|FG000|Stage 2 (4 Weeks)|Other|0|||
13172778|NCT02310568|26124304|FG001|Stage 2 (4 Weeks)|Other|1|||
13172779|NCT02310568|26124305|FG002|Stage 2 (4 Weeks)|Other|1|||
13172780|NCT02310568|26124306|FG003|Stage 2 (4 Weeks)|Other|0|||
13172781|NCT02310568|26124307|FG004|Stage 2 (4 Weeks)|Other|0|||
13172782|NCT02310568|26124303|FG000|Stage 2 (4 Weeks)|Adverse Event|0|||
13172783|NCT02310568|26124304|FG001|Stage 2 (4 Weeks)|Adverse Event|0|||
13172784|NCT02310568|26124305|FG002|Stage 2 (4 Weeks)|Adverse Event|0|||
13172785|NCT02310568|26124306|FG003|Stage 2 (4 Weeks)|Adverse Event|1|||
13172786|NCT02310568|26124307|FG004|Stage 2 (4 Weeks)|Adverse Event|1|||
13172787|NCT02310568|26124303|FG000|Stage 2 (4 Weeks)|Protocol Violation|0|||
13172788|NCT02310568|26124304|FG001|Stage 2 (4 Weeks)|Protocol Violation|0|||
13172789|NCT02310568|26124305|FG002|Stage 2 (4 Weeks)|Protocol Violation|0|||
13172790|NCT02310568|26124306|FG003|Stage 2 (4 Weeks)|Protocol Violation|1|||
13172791|NCT02310568|26124307|FG004|Stage 2 (4 Weeks)|Protocol Violation|0|||
13172792|NCT02310568|26124303|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
13172793|NCT02310568|26124304|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
13172794|NCT02310568|26124305|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
13172795|NCT02310568|26124306|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2|||
13172796|NCT02310568|26124307|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
13172797|NCT02310126|26124320|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0|||
13172798|NCT02310126|26124321|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1|||
13172799|NCT02310126|26124320|FG000|Period 1 (15 Minutes)|Protocol Violation|0|||
13172800|NCT02310126|26124321|FG001|Period 1 (15 Minutes)|Protocol Violation|1|||
13172801|NCT02310100|26124328|FG000|Overall Study|Physician Decision|3|||
13172802|NCT02310100|26124328|FG000|Overall Study|Withdrawal by Subject|10|||
13172803|NCT02310100|26124328|FG000|Overall Study|Enrollment closure|1|||
13172804|NCT02310100|26124328|FG000|Overall Study|Unapproved ablation operator|1|||
13172805|NCT02310100|26124328|FG000|Overall Study|Visit compliance|1|||
13172806|NCT02310100|26124328|FG000|Overall Study|Lost to Follow-up|2|||
13172807|NCT02309723|26124352|FG000|Overall Study|Withdrawal by Subject|24|||
13172808|NCT02309723|26124353|FG001|Overall Study|Withdrawal by Subject|23|||
13172809|NCT02309723|26124354|FG002|Overall Study|Withdrawal by Subject|24|||
13172810|NCT02309515|26124373|FG000|Overall Study|Withdrawal by Subject|0|||
13172811|NCT02309515|26124374|FG001|Overall Study|Withdrawal by Subject|1|||
13172812|NCT02309411|26124403|FG000|Overall Study|Physician Decision|1|||
13172813|NCT02309411|26124404|FG001|Overall Study|Physician Decision|0|||
13172814|NCT02309411|26124405|FG002|Overall Study|Physician Decision|0|||
13172815|NCT02309411|26124403|FG000|Overall Study|Withdrawal by Subject|1|||
13172816|NCT02309411|26124404|FG001|Overall Study|Withdrawal by Subject|1|||
13172817|NCT02309411|26124405|FG002|Overall Study|Withdrawal by Subject|0|||
13172818|NCT02309372|26124424|FG000|Overall Study|Lost to Follow-up|3|||
13172819|NCT02309372|26124425|FG001|Overall Study|Lost to Follow-up|2|||
13172820|NCT02309359|26124568|FG000|Overall Study|Adverse Event|4|||
13172821|NCT02309359|26124569|FG001|Overall Study|Adverse Event|5|||
13172822|NCT02309359|26124570|FG002|Overall Study|Adverse Event|5|||
13172823|NCT02309359|26124571|FG003|Overall Study|Adverse Event|4|||
13172824|NCT02309359|26124572|FG004|Overall Study|Adverse Event|4|||
13172825|NCT02309359|26124568|FG000|Overall Study|Death|1|||
13172826|NCT02309359|26124569|FG001|Overall Study|Death|0|||
13172827|NCT02309359|26124570|FG002|Overall Study|Death|0|||
13172828|NCT02309359|26124571|FG003|Overall Study|Death|0|||
13172829|NCT02309359|26124572|FG004|Overall Study|Death|0|||
13172830|NCT02309359|26124568|FG000|Overall Study|Withdrawal by Subject|2|||
13172831|NCT02309359|26124569|FG001|Overall Study|Withdrawal by Subject|2|||
13172832|NCT02309359|26124570|FG002|Overall Study|Withdrawal by Subject|4|||
13172833|NCT02309359|26124571|FG003|Overall Study|Withdrawal by Subject|4|||
13172834|NCT02309359|26124572|FG004|Overall Study|Withdrawal by Subject|0|||
13172835|NCT02309359|26124568|FG000|Overall Study|Lack of Efficacy|3|||
13172836|NCT02309359|26124569|FG001|Overall Study|Lack of Efficacy|1|||
13172837|NCT02309359|26124570|FG002|Overall Study|Lack of Efficacy|0|||
13172838|NCT02309359|26124571|FG003|Overall Study|Lack of Efficacy|0|||
13172839|NCT02309359|26124572|FG004|Overall Study|Lack of Efficacy|3|||
13172840|NCT02309359|26124568|FG000|Overall Study|Lost to Follow-up|0|||
13172841|NCT02309359|26124569|FG001|Overall Study|Lost to Follow-up|0|||
13172842|NCT02309359|26124570|FG002|Overall Study|Lost to Follow-up|0|||
13172843|NCT02309359|26124571|FG003|Overall Study|Lost to Follow-up|1|||
13172844|NCT02309359|26124572|FG004|Overall Study|Lost to Follow-up|0|||
13172845|NCT02309359|26124568|FG000|Overall Study|Other|2|||
13172846|NCT02309359|26124569|FG001|Overall Study|Other|0|||
13172847|NCT02309359|26124570|FG002|Overall Study|Other|2|||
13172848|NCT02309359|26124571|FG003|Overall Study|Other|3|||
13172849|NCT02309359|26124572|FG004|Overall Study|Other|2|||
13172850|NCT02309294|26124578|FG000|Overall Study|Withdrawal by Subject|2|||
13172851|NCT02309138|26124605|FG000|Overall Study|Withdrawal by Subject|44|||
13172852|NCT02309138|26124606|FG001|Overall Study|Withdrawal by Subject|15|||
13172853|NCT02309138|26124605|FG000|Overall Study|Protocol Violation|4|||
13172854|NCT02309138|26124606|FG001|Overall Study|Protocol Violation|2|||
13172855|NCT02309138|26124605|FG000|Overall Study|delivered before visit 2|0|||
13172856|NCT02309138|26124606|FG001|Overall Study|delivered before visit 2|1|||
13172857|NCT02309112|26124637|FG000|Overall Study|Withdrawal by Subject|1|||
13172858|NCT02309112|26124638|FG001|Overall Study|Withdrawal by Subject|0|||
13172859|NCT02309112|26124639|FG002|Overall Study|Withdrawal by Subject|1|||
13172860|NCT02309112|26124637|FG000|Overall Study|Lost to Follow-up|0|||
13172861|NCT02309112|26124638|FG001|Overall Study|Lost to Follow-up|1|||
13172862|NCT02309112|26124639|FG002|Overall Study|Lost to Follow-up|0|||
13172863|NCT02309099|26124692|FG000|Overall Study|Adverse Event|2|||
13172864|NCT02309099|26124693|FG001|Overall Study|Adverse Event|0|||
13172865|NCT02308748|26124716|FG000|Period 1|Withdrawal by Subject|0|||
13172866|NCT02308748|26124717|FG001|Period 1|Withdrawal by Subject|0|||
13172867|NCT02308748|26124718|FG002|Period 1|Withdrawal by Subject|1|||
13172868|NCT02308748|26124719|FG003|Period 1|Withdrawal by Subject|0|||
13172869|NCT02308748|26124720|FG004|Period 1|Withdrawal by Subject|0|||
13172870|NCT02308748|26124721|FG005|Period 1|Withdrawal by Subject|0|||
13172871|NCT02308748|26124722|FG006|Period 1|Withdrawal by Subject|0|||
13172872|NCT02308748|26124723|FG007|Period 1|Withdrawal by Subject|0|||
13172873|NCT02308748|26124724|FG008|Period 1|Withdrawal by Subject|0|||
13172874|NCT02308748|26124725|FG009|Period 1|Withdrawal by Subject|0|||
13172875|NCT02308748|26124716|FG000|Period 2|Adverse Event|0|||
13172876|NCT02308748|26124717|FG001|Period 2|Adverse Event|0|||
13172877|NCT02308748|26124718|FG002|Period 2|Adverse Event|0|||
13172878|NCT02308748|26124719|FG003|Period 2|Adverse Event|0|||
13172879|NCT02308748|26124720|FG004|Period 2|Adverse Event|0|||
13172880|NCT02308748|26124721|FG005|Period 2|Adverse Event|0|||
13172881|NCT02308748|26124722|FG006|Period 2|Adverse Event|0|||
13172882|NCT02308748|26124723|FG007|Period 2|Adverse Event|1|||
13172883|NCT02308748|26124724|FG008|Period 2|Adverse Event|0|||
13172884|NCT02308748|26124725|FG009|Period 2|Adverse Event|0|||
13172885|NCT02308748|26124716|FG000|Period 3|Protocol Violation|0|||
13172886|NCT02308748|26124717|FG001|Period 3|Protocol Violation|0|||
13172887|NCT02308748|26124718|FG002|Period 3|Protocol Violation|0|||
13172888|NCT02308748|26124719|FG003|Period 3|Protocol Violation|0|||
13172889|NCT02308748|26124720|FG004|Period 3|Protocol Violation|0|||
13172890|NCT02308748|26124721|FG005|Period 3|Protocol Violation|0|||
13172891|NCT02308748|26124722|FG006|Period 3|Protocol Violation|0|||
13172892|NCT02308748|26124723|FG007|Period 3|Protocol Violation|0|||
13172893|NCT02308748|26124724|FG008|Period 3|Protocol Violation|0|||
13172894|NCT02308748|26124725|FG009|Period 3|Protocol Violation|1|||
13172895|NCT02308748|26124716|FG000|Period 5|Adverse Event|1|||
13172896|NCT02308748|26124717|FG001|Period 5|Adverse Event|0|||
13172897|NCT02308748|26124718|FG002|Period 5|Adverse Event|0|||
13172898|NCT02308748|26124719|FG003|Period 5|Adverse Event|0|||
13172899|NCT02308748|26124720|FG004|Period 5|Adverse Event|0|||
13172900|NCT02308748|26124721|FG005|Period 5|Adverse Event|0|||
13172901|NCT02308748|26124722|FG006|Period 5|Adverse Event|0|||
13172902|NCT02308748|26124723|FG007|Period 5|Adverse Event|0|||
13172903|NCT02308748|26124724|FG008|Period 5|Adverse Event|1|||
13172904|NCT02308748|26124725|FG009|Period 5|Adverse Event|0|||
13172905|NCT02308735|26124748|FG000|Overall Study|Physician Decision|2|||
13172906|NCT02308735|26124749|FG001|Overall Study|Physician Decision|0|||
13172907|NCT02308735|26124750|FG002|Overall Study|Physician Decision|0|||
13172908|NCT02308735|26124751|FG003|Overall Study|Physician Decision|2|||
13172909|NCT02308696|26124784|FG000|Overall Study|Lost to Follow-up|28|||
13172910|NCT02308696|26124785|FG001|Overall Study|Lost to Follow-up|21|||
13172911|NCT02308696|26124784|FG000|Overall Study|Death|8|||
13172912|NCT02308696|26124785|FG001|Overall Study|Death|4|||
13172913|NCT02308696|26124784|FG000|Overall Study|Moved to a Higher Level of Care|17|||
13172914|NCT02308696|26124785|FG001|Overall Study|Moved to a Higher Level of Care|6|||
13172915|NCT02308540|26124872|FG000|Overall Study|Lost to Follow-up|0|||
13172916|NCT02308540|26124873|FG001|Overall Study|Lost to Follow-up|0|||
13172917|NCT02308540|26124874|FG002|Overall Study|Lost to Follow-up|0|||
13172918|NCT02308540|26124875|FG003|Overall Study|Lost to Follow-up|0|||
13172919|NCT02308540|26124876|FG004|Overall Study|Lost to Follow-up|0|||
13172920|NCT02308540|26124877|FG005|Overall Study|Lost to Follow-up|1|||
13172921|NCT02308488|26124884|FG000|Overall Study|Withdrawal by Subject|2|||
13172922|NCT02308228|26124903|FG000|Overall Study|Adverse Event|3|||
13172923|NCT02308228|26124904|FG001|Overall Study|Adverse Event|4|||
13172924|NCT02308228|26124903|FG000|Overall Study|Withdrawal by Subject|5|||
13172925|NCT02308228|26124904|FG001|Overall Study|Withdrawal by Subject|3|||
13172926|NCT02308163|26125225|FG000|Overall Study|Not fulfill eligible criteria|1|||
13172927|NCT02308163|26125226|FG001|Overall Study|Not fulfill eligible criteria|2|||
13172928|NCT02308163|26125227|FG002|Overall Study|Not fulfill eligible criteria|0|||
13172929|NCT02308163|26125228|FG003|Overall Study|Not fulfill eligible criteria|1|||
13172930|NCT02308163|26125229|FG004|Overall Study|Not fulfill eligible criteria|1|||
13172931|NCT02308163|26125225|FG000|Overall Study|Adverse Event|9|||
13172932|NCT02308163|26125226|FG001|Overall Study|Adverse Event|5|||
13172933|NCT02308163|26125227|FG002|Overall Study|Adverse Event|2|||
13172934|NCT02308163|26125228|FG003|Overall Study|Adverse Event|2|||
13172935|NCT02308163|26125229|FG004|Overall Study|Adverse Event|11|||
13172936|NCT02308163|26125225|FG000|Overall Study|Lack of Efficacy|11|||
13172937|NCT02308163|26125226|FG001|Overall Study|Lack of Efficacy|3|||
13172938|NCT02308163|26125227|FG002|Overall Study|Lack of Efficacy|8|||
13172939|NCT02308163|26125228|FG003|Overall Study|Lack of Efficacy|4|||
13172940|NCT02308163|26125229|FG004|Overall Study|Lack of Efficacy|6|||
13172941|NCT02308163|26125225|FG000|Overall Study|Withdrawal of consent|2|||
13172942|NCT02308163|26125226|FG001|Overall Study|Withdrawal of consent|3|||
13172943|NCT02308163|26125227|FG002|Overall Study|Withdrawal of consent|0|||
13172944|NCT02308163|26125228|FG003|Overall Study|Withdrawal of consent|2|||
13172945|NCT02308163|26125229|FG004|Overall Study|Withdrawal of consent|6|||
13172946|NCT02308163|26125225|FG000|Overall Study|Protocol Violation|3|||
13172947|NCT02308163|26125226|FG001|Overall Study|Protocol Violation|3|||
13172948|NCT02308163|26125227|FG002|Overall Study|Protocol Violation|3|||
13172949|NCT02308163|26125228|FG003|Overall Study|Protocol Violation|2|||
13172950|NCT02308163|26125229|FG004|Overall Study|Protocol Violation|5|||
13172951|NCT02308163|26125225|FG000|Overall Study|Lab data met discontinuation criteria|3|||
13172952|NCT02308163|26125226|FG001|Overall Study|Lab data met discontinuation criteria|0|||
13172953|NCT02308163|26125227|FG002|Overall Study|Lab data met discontinuation criteria|0|||
13172954|NCT02308163|26125228|FG003|Overall Study|Lab data met discontinuation criteria|2|||
13172955|NCT02308163|26125229|FG004|Overall Study|Lab data met discontinuation criteria|0|||
13172956|NCT02308163|26125225|FG000|Overall Study|Miscellaneous|2|||
13172957|NCT02308163|26125226|FG001|Overall Study|Miscellaneous|2|||
13172958|NCT02308163|26125227|FG002|Overall Study|Miscellaneous|1|||
13172959|NCT02308163|26125228|FG003|Overall Study|Miscellaneous|0|||
13172960|NCT02308163|26125229|FG004|Overall Study|Miscellaneous|5|||
13172961|NCT02308124|26125259|FG000|Overall Study|Lost to Follow-up|6|||
13172962|NCT02308124|26125260|FG001|Overall Study|Lost to Follow-up|6|||
13172963|NCT02308124|26125261|FG002|Overall Study|Lost to Follow-up|6|||
13172964|NCT02308124|26125259|FG000|Overall Study|Adverse Event|0|||
13172965|NCT02308124|26125260|FG001|Overall Study|Adverse Event|2|||
13172966|NCT02308124|26125261|FG002|Overall Study|Adverse Event|2|||
13172967|NCT02308046|26125282|FG000|Overall Study|Negative yeast culture at Baseline|32|||
13172968|NCT02308046|26125283|FG001|Overall Study|Negative yeast culture at Baseline|33|||
13172969|NCT02308046|26125282|FG000|Overall Study|Positive for STD at Baseline|1|||
13172970|NCT02308046|26125283|FG001|Overall Study|Positive for STD at Baseline|2|||
13172971|NCT02308046|26125282|FG000|Overall Study|Lost to Follow-up|1|||
13172972|NCT02308046|26125283|FG001|Overall Study|Lost to Follow-up|3|||
13172973|NCT02308033|26125304|FG000|Overall Study|Normal Gram stain at Baseline|13|||
13172974|NCT02308033|26125305|FG001|Overall Study|Normal Gram stain at Baseline|10|||
13172975|NCT02308033|26125304|FG000|Overall Study|Positive for STD at Baseline|7|||
13172976|NCT02308033|26125305|FG001|Overall Study|Positive for STD at Baseline|4|||
13172977|NCT02308033|26125304|FG000|Overall Study|Lost to Follow-up|6|||
13172978|NCT02308033|26125305|FG001|Overall Study|Lost to Follow-up|5|||
13172979|NCT02308020|26125378|FG000|Overall Study|Lost to Follow-up|1|||
13172980|NCT02308020|26125379|FG001|Overall Study|Lost to Follow-up|7|||
13172981|NCT02308020|26125380|FG002|Overall Study|Lost to Follow-up|0|||
13172982|NCT02308020|26125381|FG003|Overall Study|Lost to Follow-up|0|||
13172983|NCT02308020|26125382|FG004|Overall Study|Lost to Follow-up|1|||
13172984|NCT02308020|26125383|FG005|Overall Study|Lost to Follow-up|2|||
13172985|NCT02308020|26125378|FG000|Overall Study|Sponsor Decision|0|||
13172986|NCT02308020|26125379|FG001|Overall Study|Sponsor Decision|8|||
13172987|NCT02308020|26125380|FG002|Overall Study|Sponsor Decision|0|||
13172988|NCT02308020|26125381|FG003|Overall Study|Sponsor Decision|2|||
13172989|NCT02308020|26125382|FG004|Overall Study|Sponsor Decision|2|||
13172990|NCT02308020|26125383|FG005|Overall Study|Sponsor Decision|1|||
13172991|NCT02308020|26125378|FG000|Overall Study|Withdrawal by Subject|3|||
13172992|NCT02308020|26125379|FG001|Overall Study|Withdrawal by Subject|5|||
13172993|NCT02308020|26125380|FG002|Overall Study|Withdrawal by Subject|3|||
13172994|NCT02308020|26125381|FG003|Overall Study|Withdrawal by Subject|2|||
13172995|NCT02308020|26125382|FG004|Overall Study|Withdrawal by Subject|1|||
13172996|NCT02308020|26125383|FG005|Overall Study|Withdrawal by Subject|2|||
13172997|NCT02308007|26125416|FG000|Overall Study|Normal Gram stain or neg yeast culture|66|||
13172998|NCT02308007|26125417|FG001|Overall Study|Normal Gram stain or neg yeast culture|64|||
13172999|NCT02308007|26125418|FG002|Overall Study|Normal Gram stain or neg yeast culture|67|||
13173000|NCT02308007|26125416|FG000|Overall Study|Positive for STD at Baseline|7|||
13173001|NCT02308007|26125417|FG001|Overall Study|Positive for STD at Baseline|11|||
13173002|NCT02308007|26125418|FG002|Overall Study|Positive for STD at Baseline|7|||
13173003|NCT02308007|26125416|FG000|Overall Study|Lost to Follow-up|3|||
13173004|NCT02308007|26125417|FG001|Overall Study|Lost to Follow-up|0|||
13173005|NCT02308007|26125418|FG002|Overall Study|Lost to Follow-up|1|||
13173006|NCT02307682|26125528|FG000|Overall Study|Adverse Event|9|||
13173007|NCT02307682|26125529|FG001|Overall Study|Adverse Event|8|||
13173008|NCT02307682|26125530|FG002|Overall Study|Adverse Event|12|||
13173009|NCT02307682|26125528|FG000|Overall Study|Lack of Efficacy|1|||
13173010|NCT02307682|26125529|FG001|Overall Study|Lack of Efficacy|0|||
13173011|NCT02307682|26125530|FG002|Overall Study|Lack of Efficacy|1|||
13173012|NCT02307682|26125528|FG000|Overall Study|Physician Decision|2|||
13173013|NCT02307682|26125529|FG001|Overall Study|Physician Decision|2|||
13173014|NCT02307682|26125530|FG002|Overall Study|Physician Decision|8|||
13108131|NCT03260205|25890520|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2|||
13108132|NCT03260205|25890516|FG000|Overall Study|Other: Unspecified|0|||
13108133|NCT03260205|25890517|FG001|Overall Study|Other: Unspecified|0|||
13108134|NCT03260205|25890518|FG002|Overall Study|Other: Unspecified|3|||
13173015|NCT02307682|26125528|FG000|Overall Study|Progressive Disease|1|||
13173016|NCT02307682|26125529|FG001|Overall Study|Progressive Disease|0|||
13173017|NCT02307682|26125530|FG002|Overall Study|Progressive Disease|0|||
13173018|NCT02307682|26125528|FG000|Overall Study|Withdrawal by Subject|26|||
13173019|NCT02307682|26125529|FG001|Overall Study|Withdrawal by Subject|34|||
13173020|NCT02307682|26125530|FG002|Overall Study|Withdrawal by Subject|23|||
13173021|NCT02307682|26125528|FG000|Overall Study|Death|9|||
13173022|NCT02307682|26125529|FG001|Overall Study|Death|7|||
13173023|NCT02307682|26125530|FG002|Overall Study|Death|12|||
13173024|NCT02307682|26125528|FG000|Overall Study|Lost to Follow-up|1|||
13173025|NCT02307682|26125529|FG001|Overall Study|Lost to Follow-up|5|||
13173026|NCT02307682|26125530|FG002|Overall Study|Lost to Follow-up|6|||
13173027|NCT02307682|26125528|FG000|Overall Study|Protocol Deviation|0|||
13173028|NCT02307682|26125529|FG001|Overall Study|Protocol Deviation|0|||
13173029|NCT02307682|26125530|FG002|Overall Study|Protocol Deviation|2|||
13173030|NCT02307682|26125528|FG000|Overall Study|Other|1|||
13108135|NCT03260205|25890519|FG003|Overall Study|Other: Unspecified|1|||
13108136|NCT03260205|25890520|FG004|Overall Study|Other: Unspecified|1|||
13108137|NCT03260205|25890516|FG000|Overall Study|Participant Who Did Not Received AnyDose|1|||
13108138|NCT03260205|25890517|FG001|Overall Study|Participant Who Did Not Received AnyDose|1|||
13108139|NCT03260205|25890518|FG002|Overall Study|Participant Who Did Not Received AnyDose|2|||
13173031|NCT02307682|26125529|FG001|Overall Study|Other|1|||
13173032|NCT02307682|26125530|FG002|Overall Study|Other|0|||
13173033|NCT02307513|26125579|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4|||
13173034|NCT02307513|26125580|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3|||
13173035|NCT02307513|26125579|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8|||
13173036|NCT02307513|26125580|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0|||
13173037|NCT02307513|26125579|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1|||
13173038|NCT02307513|26125580|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0|||
13173039|NCT02307513|26125579|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5|||
13173040|NCT02307513|26125580|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4|||
13173041|NCT02307513|26125579|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1|||
13173042|NCT02307513|26125580|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0|||
13173043|NCT02307513|26125579|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
13173044|NCT02307513|26125580|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
13173045|NCT02307513|26125579|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0|||
13173046|NCT02307513|26125580|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1|||
13173047|NCT02307513|26125579|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4|||
13173048|NCT02307513|26125580|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9|||
13173049|NCT02307513|26125579|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
13173050|NCT02307513|26125580|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
13173051|NCT02307513|26125579|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
13173052|NCT02307513|26125580|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
13173053|NCT02307513|26125579|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
13173054|NCT02307513|26125580|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
13173055|NCT02307513|26125579|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1|||
13173056|NCT02307513|26125580|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0|||
13173057|NCT02307513|26125579|FG000|Long-term Extension|Physician Decision|1|||
13173058|NCT02307513|26125580|FG001|Long-term Extension|Physician Decision|0|||
13173059|NCT02307370|26125593|FG000|Overall Study|Death|5|||
13173060|NCT02307370|26125593|FG000|Overall Study|Lost to Follow-up|1|||
13173061|NCT02307370|26125593|FG000|Overall Study|Withdrawal by Subject|1|||
13173062|NCT02307370|26125593|FG000|Overall Study|Declined Addendum ICF|6|||
13173063|NCT02307370|26125593|FG000|Overall Study|No response during telephone contact|5|||
13173064|NCT02307370|26125593|FG000|Overall Study|Protocol Violation|1|||
13173065|NCT02307266|26125611|FG000|Overall Study|Adverse Event|3|||
13173066|NCT02307266|26125612|FG001|Overall Study|Adverse Event|1|||
13173067|NCT02307266|26125613|FG002|Overall Study|Adverse Event|5|||
13173068|NCT02307266|26125611|FG000|Overall Study|Withdrawal by Subject|2|||
13173069|NCT02307266|26125612|FG001|Overall Study|Withdrawal by Subject|0|||
13173070|NCT02307266|26125613|FG002|Overall Study|Withdrawal by Subject|1|||
13173071|NCT02307266|26125611|FG000|Overall Study|Lost to Follow-up|3|||
13173072|NCT02307266|26125612|FG001|Overall Study|Lost to Follow-up|0|||
13173073|NCT02307266|26125613|FG002|Overall Study|Lost to Follow-up|0|||
13173074|NCT02306850|26125620|FG000|Overall Study|Lack of Efficacy|2|||
13205623|NCT01963611|26232394|FG004|Overall Study|Lack of Efficacy|0|||
13173075|NCT02306694|26125632|FG000|Overall Study|Withdrawal by Subject|3|||
13173076|NCT02306694|26125632|FG000|Overall Study|Lost to Follow-up|1|||
13173077|NCT02306265|26125640|FG000|Overall Study|Withdrawal by Subject|1|||
13108140|NCT03260205|25890519|FG003|Overall Study|Participant Who Did Not Received AnyDose|3|||
13173078|NCT02305888|26125667|FG000|Overall Study|Lost to Follow-up|0|||
13173079|NCT02305888|26125668|FG001|Overall Study|Lost to Follow-up|0|||
13173080|NCT02305888|26125669|FG002|Overall Study|Lost to Follow-up|1|||
13173081|NCT02305888|26125667|FG000|Overall Study|Adverse Event|0|||
13173082|NCT02305888|26125668|FG001|Overall Study|Adverse Event|1|||
13173083|NCT02305888|26125669|FG002|Overall Study|Adverse Event|0|||
13173084|NCT02305849|26125912|FG000|Overall Study|Adverse Event|10|||
13173085|NCT02305849|26125913|FG001|Overall Study|Adverse Event|12|||
13173086|NCT02305849|26125914|FG002|Overall Study|Adverse Event|7|||
13173087|NCT02305849|26125915|FG003|Overall Study|Adverse Event|3|||
13173088|NCT02305849|26125912|FG000|Overall Study|Lack of Efficacy|10|||
13173089|NCT02305849|26125913|FG001|Overall Study|Lack of Efficacy|6|||
13173090|NCT02305849|26125914|FG002|Overall Study|Lack of Efficacy|3|||
13173091|NCT02305849|26125915|FG003|Overall Study|Lack of Efficacy|9|||
13173092|NCT02305849|26125912|FG000|Overall Study|Withdrawal by Subject|2|||
13173093|NCT02305849|26125913|FG001|Overall Study|Withdrawal by Subject|2|||
13173094|NCT02305849|26125914|FG002|Overall Study|Withdrawal by Subject|1|||
13173095|NCT02305849|26125915|FG003|Overall Study|Withdrawal by Subject|4|||
13173096|NCT02305849|26125912|FG000|Overall Study|Lost to Follow-up|0|||
13173097|NCT02305849|26125913|FG001|Overall Study|Lost to Follow-up|2|||
13173098|NCT02305849|26125914|FG002|Overall Study|Lost to Follow-up|0|||
13173099|NCT02305849|26125915|FG003|Overall Study|Lost to Follow-up|0|||
13173100|NCT02305849|26125912|FG000|Overall Study|Protocol Violation|3|||
13173101|NCT02305849|26125913|FG001|Overall Study|Protocol Violation|2|||
13173102|NCT02305849|26125914|FG002|Overall Study|Protocol Violation|1|||
13173103|NCT02305849|26125915|FG003|Overall Study|Protocol Violation|1|||
13173104|NCT02305849|26125912|FG000|Overall Study|Lab data met discontinuation criteria|0|||
13173105|NCT02305849|26125913|FG001|Overall Study|Lab data met discontinuation criteria|1|||
13173106|NCT02305849|26125914|FG002|Overall Study|Lab data met discontinuation criteria|2|||
13173107|NCT02305849|26125915|FG003|Overall Study|Lab data met discontinuation criteria|1|||
13173108|NCT02305849|26125912|FG000|Overall Study|Miscellaneous|1|||
13173109|NCT02305849|26125913|FG001|Overall Study|Miscellaneous|2|||
13173110|NCT02305849|26125914|FG002|Overall Study|Miscellaneous|4|||
13173111|NCT02305849|26125915|FG003|Overall Study|Miscellaneous|1|||
13173112|NCT02305849|26125912|FG000|Overall Study|Not fulfill eligibility criteria|1|||
13173113|NCT02305849|26125913|FG001|Overall Study|Not fulfill eligibility criteria|1|||
13173114|NCT02305849|26125914|FG002|Overall Study|Not fulfill eligibility criteria|0|||
13173115|NCT02305849|26125915|FG003|Overall Study|Not fulfill eligibility criteria|0|||
13173116|NCT02305797|26125930|FG000|Overall Study|Adverse Event|11|||
13173117|NCT02305797|26125931|FG001|Overall Study|Adverse Event|2|||
13173118|NCT02305797|26125930|FG000|Overall Study|Withdrawal by Subject|9|||
13173119|NCT02305797|26125931|FG001|Overall Study|Withdrawal by Subject|10|||
13173120|NCT02305797|26125930|FG000|Overall Study|Lack of Efficacy|6|||
13173121|NCT02305797|26125931|FG001|Overall Study|Lack of Efficacy|0|||
13173122|NCT02305797|26125930|FG000|Overall Study|Lost to Follow-up|5|||
13173123|NCT02305797|26125931|FG001|Overall Study|Lost to Follow-up|11|||
13173124|NCT02305797|26125930|FG000|Overall Study|Pregnancy|0|||
13173125|NCT02305797|26125931|FG001|Overall Study|Pregnancy|2|||
13173126|NCT02305797|26125930|FG000|Overall Study|Noncompliance|14|||
13173127|NCT02305797|26125931|FG001|Overall Study|Noncompliance|12|||
13173128|NCT02305797|26125930|FG000|Overall Study|Reason not collected|0|||
13173129|NCT02305797|26125931|FG001|Overall Study|Reason not collected|1|||
13173130|NCT02305758|26125948|FG000|Overall Study|Death|27|||
13173131|NCT02305758|26125949|FG001|Overall Study|Death|27|||
13173132|NCT02305758|26125948|FG000|Overall Study|Withdrew consent|9|||
13173133|NCT02305758|26125949|FG001|Overall Study|Withdrew consent|2|||
13108141|NCT03260205|25890520|FG004|Overall Study|Participant Who Did Not Received AnyDose|1|||
13108142|NCT03259789|25890553|FG000|Overall Study|Adverse Event|3|||
13108143|NCT03259789|25890554|FG001|Overall Study|Adverse Event|2|||
13108144|NCT03259789|25890555|FG002|Overall Study|Adverse Event|1|||
13108145|NCT03259789|25890553|FG000|Overall Study|Withdrawal by Subject|9|||
13108146|NCT03259789|25890554|FG001|Overall Study|Withdrawal by Subject|5|||
13173134|NCT02305758|26125948|FG000|Overall Study|Lost to Follow-up|6|||
13173135|NCT02305758|26125949|FG001|Overall Study|Lost to Follow-up|1|||
13173136|NCT02305758|26125948|FG000|Overall Study|Study Terminated by Sponsor|21|||
13173137|NCT02305758|26125949|FG001|Overall Study|Study Terminated by Sponsor|34|||
13173138|NCT02305758|26125948|FG000|Overall Study|Other, not specified|2|||
13173139|NCT02305758|26125949|FG001|Overall Study|Other, not specified|1|||
13173140|NCT02305563|26126086|FG000|Treatment Period|Disease progression|0|||
13173141|NCT02305563|26126087|FG001|Treatment Period|Disease progression|0|||
13173142|NCT02305563|26126088|FG002|Treatment Period|Disease progression|15|||
13173143|NCT02305563|26126089|FG003|Treatment Period|Disease progression|6|||
13108147|NCT03259789|25890555|FG002|Overall Study|Withdrawal by Subject|1|||
13173144|NCT02305563|26126090|FG004|Treatment Period|Disease progression|6|||
13173145|NCT02305563|26126086|FG000|Treatment Period|Study drug toxicity|0|||
13173146|NCT02305563|26126087|FG001|Treatment Period|Study drug toxicity|0|||
13173147|NCT02305563|26126088|FG002|Treatment Period|Study drug toxicity|0|||
13173148|NCT02305563|26126089|FG003|Treatment Period|Study drug toxicity|1|||
13173149|NCT02305563|26126090|FG004|Treatment Period|Study drug toxicity|2|||
13173150|NCT02305563|26126086|FG000|Treatment Period|Death|0|||
13173151|NCT02305563|26126087|FG001|Treatment Period|Death|0|||
13173152|NCT02305563|26126088|FG002|Treatment Period|Death|1|||
13173153|NCT02305563|26126089|FG003|Treatment Period|Death|2|||
13173154|NCT02305563|26126090|FG004|Treatment Period|Death|1|||
13173155|NCT02305563|26126086|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
13173156|NCT02305563|26126087|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
13173157|NCT02305563|26126088|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7|||
13173158|NCT02305563|26126089|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1|||
13173159|NCT02305563|26126090|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2|||
13173160|NCT02305563|26126086|FG000|Treatment Period|Participant request to stop therapy|0|||
13173161|NCT02305563|26126087|FG001|Treatment Period|Participant request to stop therapy|2|||
13173162|NCT02305563|26126088|FG002|Treatment Period|Participant request to stop therapy|0|||
13173163|NCT02305563|26126089|FG003|Treatment Period|Participant request to stop therapy|1|||
13173164|NCT02305563|26126090|FG004|Treatment Period|Participant request to stop therapy|0|||
13173165|NCT02305563|26126086|FG000|Treatment Period|Participant withdrew consent|0|||
13173166|NCT02305563|26126087|FG001|Treatment Period|Participant withdrew consent|0|||
13173167|NCT02305563|26126088|FG002|Treatment Period|Participant withdrew consent|1|||
13173168|NCT02305563|26126089|FG003|Treatment Period|Participant withdrew consent|1|||
13173169|NCT02305563|26126090|FG004|Treatment Period|Participant withdrew consent|1|||
13173170|NCT02305563|26126086|FG000|Treatment Period|Maximum clinical benefit|0|||
13173171|NCT02305563|26126087|FG001|Treatment Period|Maximum clinical benefit|0|||
13173172|NCT02305563|26126088|FG002|Treatment Period|Maximum clinical benefit|0|||
13108148|NCT03259789|25890553|FG000|Overall Study|Lost to Follow-up|5|||
13173173|NCT02305563|26126089|FG003|Treatment Period|Maximum clinical benefit|0|||
13173174|NCT02305563|26126090|FG004|Treatment Period|Maximum clinical benefit|1|||
13173175|NCT02305563|26126086|FG000|Treatment Period|Poor/non-compliance|0|||
13173176|NCT02305563|26126087|FG001|Treatment Period|Poor/non-compliance|0|||
13173177|NCT02305563|26126088|FG002|Treatment Period|Poor/non-compliance|0|||
13173178|NCT02305563|26126089|FG003|Treatment Period|Poor/non-compliance|0|||
13173179|NCT02305563|26126090|FG004|Treatment Period|Poor/non-compliance|1|||
13173180|NCT02305563|26126086|FG000|Treatment Period|Administrative reason by Sponsor|0|||
13173181|NCT02305563|26126087|FG001|Treatment Period|Administrative reason by Sponsor|0|||
13173182|NCT02305563|26126088|FG002|Treatment Period|Administrative reason by Sponsor|0|||
13173183|NCT02305563|26126089|FG003|Treatment Period|Administrative reason by Sponsor|0|||
13173184|NCT02305563|26126090|FG004|Treatment Period|Administrative reason by Sponsor|1|||
13173185|NCT02305563|26126086|FG000|Treatment Period|other reason|2|||
13173186|NCT02305563|26126087|FG001|Treatment Period|other reason|0|||
13173187|NCT02305563|26126088|FG002|Treatment Period|other reason|2|||
13173188|NCT02305563|26126089|FG003|Treatment Period|other reason|2|||
13173189|NCT02305563|26126090|FG004|Treatment Period|other reason|1|||
13173190|NCT02305563|26126086|FG000|Treatment Period|Randomized but not treated|0|||
13173191|NCT02305563|26126087|FG001|Treatment Period|Randomized but not treated|0|||
13173192|NCT02305563|26126088|FG002|Treatment Period|Randomized but not treated|0|||
13173193|NCT02305563|26126089|FG003|Treatment Period|Randomized but not treated|0|||
13173194|NCT02305563|26126090|FG004|Treatment Period|Randomized but not treated|2|||
13173195|NCT02305563|26126086|FG000|Treatment Period|added ULO, then disease progression|0|||
13173196|NCT02305563|26126087|FG001|Treatment Period|added ULO, then disease progression|0|||
13173197|NCT02305563|26126088|FG002|Treatment Period|added ULO, then disease progression|0|||
13173198|NCT02305563|26126089|FG003|Treatment Period|added ULO, then disease progression|0|||
13173199|NCT02305563|26126090|FG004|Treatment Period|added ULO, then disease progression|4|||
13173200|NCT02305563|26126086|FG000|Treatment Period|added ULO; then other reason|0|||
13173201|NCT02305563|26126087|FG001|Treatment Period|added ULO; then other reason|0|||
13173202|NCT02305563|26126088|FG002|Treatment Period|added ULO; then other reason|0|||
13173203|NCT02305563|26126089|FG003|Treatment Period|added ULO; then other reason|0|||
13173204|NCT02305563|26126090|FG004|Treatment Period|added ULO; then other reason|1|||
13173205|NCT02305563|26126086|FG000|Treatment Period|added ULO, then request to stop|0|||
13108149|NCT03259789|25890554|FG001|Overall Study|Lost to Follow-up|9|||
13108150|NCT03259789|25890555|FG002|Overall Study|Lost to Follow-up|4|||
13108151|NCT03259789|25890553|FG000|Overall Study|Physician Decision|0|||
13108152|NCT03259789|25890554|FG001|Overall Study|Physician Decision|1|||
13108153|NCT03259789|25890555|FG002|Overall Study|Physician Decision|0|||
13108154|NCT03259555|25890570|FG000|Overall Study|Adverse Event|6|||
13108155|NCT03259555|25890571|FG001|Overall Study|Adverse Event|4|||
13108156|NCT03259555|25890570|FG000|Overall Study|Lack of Efficacy|6|||
13108157|NCT03259555|25890571|FG001|Overall Study|Lack of Efficacy|4|||
13108158|NCT03259555|25890570|FG000|Overall Study|Lost to Follow-up|0|||
13108159|NCT03259555|25890571|FG001|Overall Study|Lost to Follow-up|2|||
13108160|NCT03259555|25890570|FG000|Overall Study|Non-Compliance With Study Drug|1|||
13108161|NCT03259555|25890571|FG001|Overall Study|Non-Compliance With Study Drug|0|||
13173206|NCT02305563|26126087|FG001|Treatment Period|added ULO, then request to stop|0|||
13173207|NCT02305563|26126088|FG002|Treatment Period|added ULO, then request to stop|0|||
13173208|NCT02305563|26126089|FG003|Treatment Period|added ULO, then request to stop|0|||
13173209|NCT02305563|26126090|FG004|Treatment Period|added ULO, then request to stop|1|||
13173210|NCT02305563|26126086|FG000|Follow-up Period|Death|0|||
13173211|NCT02305563|26126087|FG001|Follow-up Period|Death|0|||
13173212|NCT02305563|26126088|FG002|Follow-up Period|Death|5|||
13173213|NCT02305563|26126089|FG003|Follow-up Period|Death|4|||
13173214|NCT02305563|26126090|FG004|Follow-up Period|Death|7|||
13173215|NCT02305563|26126086|FG000|Follow-up Period|Participant withdrew consent|0|||
13173216|NCT02305563|26126087|FG001|Follow-up Period|Participant withdrew consent|0|||
13173217|NCT02305563|26126088|FG002|Follow-up Period|Participant withdrew consent|2|||
13173218|NCT02305563|26126089|FG003|Follow-up Period|Participant withdrew consent|1|||
13173219|NCT02305563|26126090|FG004|Follow-up Period|Participant withdrew consent|0|||
13173220|NCT02305563|26126086|FG000|Follow-up Period|other reason|0|||
13173221|NCT02305563|26126087|FG001|Follow-up Period|other reason|0|||
13173222|NCT02305563|26126088|FG002|Follow-up Period|other reason|0|||
13173223|NCT02305563|26126089|FG003|Follow-up Period|other reason|0|||
13173224|NCT02305563|26126090|FG004|Follow-up Period|other reason|1|||
13173225|NCT02305563|26126086|FG000|Follow-up Period|Followup no longer required per protocol|3|||
13173226|NCT02305563|26126087|FG001|Follow-up Period|Followup no longer required per protocol|3|||
13173227|NCT02305563|26126088|FG002|Follow-up Period|Followup no longer required per protocol|4|||
13173228|NCT02305563|26126089|FG003|Follow-up Period|Followup no longer required per protocol|1|||
13173229|NCT02305563|26126090|FG004|Follow-up Period|Followup no longer required per protocol|4|||
13173230|NCT02305446|26126097|FG000|Overall Study|Adverse Event|1|||
13173231|NCT02305381|26126136|FG000|Overall Study|Unclassified|5|||
13173232|NCT02305381|26126137|FG001|Overall Study|Unclassified|5|||
13173233|NCT02305381|26126138|FG002|Overall Study|Unclassified|7|||
13173234|NCT02305238|26126163|FG000|Overall Study|Death|2|||
13173235|NCT02305238|26126164|FG001|Overall Study|Death|1|||
13173236|NCT02305238|26126165|FG002|Overall Study|Death|0|||
13173237|NCT02305238|26126163|FG000|Overall Study|Progressive disease|4|||
13173238|NCT02305238|26126164|FG001|Overall Study|Progressive disease|4|||
13173239|NCT02305238|26126165|FG002|Overall Study|Progressive disease|0|||
13173240|NCT02305238|26126163|FG000|Overall Study|Logistical difficulties|1|||
13108162|NCT03259555|25890570|FG000|Overall Study|Progressive Disease|0|||
13108163|NCT03259555|25890571|FG001|Overall Study|Progressive Disease|2|||
13173241|NCT02305238|26126164|FG001|Overall Study|Logistical difficulties|3|||
13173242|NCT02305238|26126165|FG002|Overall Study|Logistical difficulties|0|||
13173243|NCT02305238|26126163|FG000|Overall Study|Protocol Violation|0|||
13173244|NCT02305238|26126164|FG001|Overall Study|Protocol Violation|3|||
13173245|NCT02305238|26126165|FG002|Overall Study|Protocol Violation|0|||
13173246|NCT02305238|26126163|FG000|Overall Study|Physician Decision|2|||
13173247|NCT02305238|26126164|FG001|Overall Study|Physician Decision|1|||
13173248|NCT02305238|26126165|FG002|Overall Study|Physician Decision|0|||
13173249|NCT02305238|26126163|FG000|Overall Study|Adverse Event|4|||
13173250|NCT02305238|26126164|FG001|Overall Study|Adverse Event|2|||
13173251|NCT02305238|26126165|FG002|Overall Study|Adverse Event|0|||
13173252|NCT02305238|26126163|FG000|Overall Study|Withdrawal by Subject|3|||
13173253|NCT02305238|26126164|FG001|Overall Study|Withdrawal by Subject|4|||
13173254|NCT02305238|26126165|FG002|Overall Study|Withdrawal by Subject|0|||
13173255|NCT02305238|26126163|FG000|Overall Study|Randomized failure|0|||
13173256|NCT02305238|26126164|FG001|Overall Study|Randomized failure|0|||
13173257|NCT02305238|26126165|FG002|Overall Study|Randomized failure|8|||
13173258|NCT02305238|26126163|FG000|Overall Study|Required procedure failed|0|||
13173259|NCT02305238|26126164|FG001|Overall Study|Required procedure failed|1|||
13173260|NCT02305238|26126165|FG002|Overall Study|Required procedure failed|0|||
13173261|NCT02304926|26126216|FG000|Overall Study|Lost to Follow-up|2|||
13173262|NCT02304926|26126217|FG001|Overall Study|Lost to Follow-up|1|||
13173263|NCT02304705|26126230|FG000|Overall Study|Withdrawal by Subject|2|||
13173264|NCT02304705|26126231|FG001|Overall Study|Withdrawal by Subject|0|||
13173265|NCT02304705|26126230|FG000|Overall Study|Physician Decision|2|||
13173266|NCT02304705|26126231|FG001|Overall Study|Physician Decision|4|||
13173267|NCT02304705|26126230|FG000|Overall Study|Death|0|||
13173268|NCT02304705|26126231|FG001|Overall Study|Death|1|||
13173269|NCT02304705|26126230|FG000|Overall Study|Lost to Follow-up|0|||
13173270|NCT02304705|26126231|FG001|Overall Study|Lost to Follow-up|2|||
13108164|NCT03259555|25890570|FG000|Overall Study|Withdrawal by Subject|19|||
13108165|NCT03259555|25890571|FG001|Overall Study|Withdrawal by Subject|16|||
13108166|NCT03259555|25890570|FG000|Overall Study|Physician Decision|1|||
13108167|NCT03259555|25890571|FG001|Overall Study|Physician Decision|2|||
13108168|NCT03259555|25890570|FG000|Overall Study|Other|1|||
13108169|NCT03259555|25890571|FG001|Overall Study|Other|0|||
13108170|NCT03259490|25890600|FG000|Period 1|Withdrawal by Subject|0|||
13108171|NCT03259490|25890601|FG001|Period 1|Withdrawal by Subject|1|||
13173271|NCT02304484|26126238|FG000|Overall Study|Death|9|||
13173272|NCT02304484|26126238|FG000|Overall Study|Withdrawal by Subject|14|||
13173273|NCT02304484|26126238|FG000|Overall Study|Lost to Follow-up|2|||
13173274|NCT02304380|26126307|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
13173275|NCT02304380|26126308|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
13173276|NCT02304380|26126309|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
13173277|NCT02304380|26126310|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34|||
13173278|NCT02304380|26126311|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
13173279|NCT02304380|26126312|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
13173280|NCT02304367|26126372|FG000|Overall Study|Lack of Response to Bruosumab|1|||
13173281|NCT02304367|26126372|FG000|Overall Study|Sponsor Decision|3|||
13173282|NCT02304367|26126372|FG000|Overall Study|Death|2|||
13173283|NCT02304367|26126372|FG000|Overall Study|Physician Decision|1|||
13173284|NCT02304367|26126372|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1|||
13173285|NCT02304302|26126407|FG000|Overall Study|Adverse Event|2|||
13173286|NCT02304302|26126408|FG001|Overall Study|Adverse Event|3|||
13173287|NCT02304302|26126407|FG000|Overall Study|Lost to Follow-up|1|||
13173288|NCT02304302|26126408|FG001|Overall Study|Lost to Follow-up|4|||
13173289|NCT02304302|26126407|FG000|Overall Study|Removed from analysis due to low medication compliance|0|||
13173290|NCT02304302|26126408|FG001|Overall Study|Removed from analysis due to low medication compliance|1|||
13173291|NCT02303704|26126431|FG000|Overall Study|Protocol Violation|5|||
13173292|NCT02303704|26126432|FG001|Overall Study|Protocol Violation|9|||
13173293|NCT02303574|26126679|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
13173294|NCT02303574|26126680|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
13173295|NCT02303574|26126681|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1|||
13173296|NCT02303574|26126682|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
13173297|NCT02303574|26126683|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
13173298|NCT02303574|26126684|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
13173299|NCT02303574|26126685|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
13173300|NCT02303574|26126686|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
13173301|NCT02303574|26126687|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
13173302|NCT02303574|26126688|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
13173303|NCT02303574|26126679|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
13173304|NCT02303574|26126680|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
13173305|NCT02303574|26126681|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
13173306|NCT02303574|26126682|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
13173307|NCT02303574|26126683|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
13173308|NCT02303574|26126684|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
13173309|NCT02303574|26126685|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
13173310|NCT02303574|26126686|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1|||
13173311|NCT02303574|26126687|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
13173312|NCT02303574|26126688|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
13173313|NCT02303262|26126696|FG000|Overall Study|Withdrawal by Subject|2|||
13173314|NCT02303041|26126717|FG000|Overall Study|Adverse Event|1|||
13173315|NCT02303041|26126718|FG001|Overall Study|Adverse Event|2|||
13173316|NCT02302859|26126731|FG000|Overall Study|Lost Phone|1|||
13173317|NCT02302859|26126732|FG001|Overall Study|Lost Phone|1|||
13173318|NCT02302859|26126731|FG000|Overall Study|Withdrawal by Subject|0|||
13173319|NCT02302859|26126732|FG001|Overall Study|Withdrawal by Subject|1|||
13173320|NCT02302846|26126738|FG000|Overall Study|Withdrawal by Subject|1|||
13173321|NCT02302807|26126790|FG000|Overall Study|Withdrawal by Subject|28|||
13173322|NCT02302807|26126791|FG001|Overall Study|Withdrawal by Subject|11|||
13173323|NCT02302807|26126790|FG000|Overall Study|Lost to Follow-up|4|||
13173324|NCT02302807|26126791|FG001|Overall Study|Lost to Follow-up|6|||
13173325|NCT02302807|26126790|FG000|Overall Study|Death|397|||
13173326|NCT02302807|26126791|FG001|Overall Study|Death|385|||
13173327|NCT02302807|26126790|FG000|Overall Study|Study Terminated By Sponsor|35|||
13173328|NCT02302807|26126791|FG001|Overall Study|Study Terminated By Sponsor|64|||
13173329|NCT02302807|26126790|FG000|Overall Study|Physician Decision|0|||
13173330|NCT02302807|26126791|FG001|Overall Study|Physician Decision|1|||
13173331|NCT02302716|26126824|FG000|Overall Study|Adverse Event|1|||
13173332|NCT02302716|26126825|FG001|Overall Study|Adverse Event|1|||
13173333|NCT02302716|26126824|FG000|Overall Study|Death|0|||
13173334|NCT02302716|26126825|FG001|Overall Study|Death|1|||
13173335|NCT02302716|26126824|FG000|Overall Study|Lack of Efficacy|0|||
13173336|NCT02302716|26126825|FG001|Overall Study|Lack of Efficacy|1|||
13173337|NCT02302716|26126824|FG000|Overall Study|Lost to Follow-up|2|||
13173338|NCT02302716|26126825|FG001|Overall Study|Lost to Follow-up|4|||
13173339|NCT02302716|26126824|FG000|Overall Study|Physician Decision|3|||
13173340|NCT02302716|26126825|FG001|Overall Study|Physician Decision|4|||
13173341|NCT02302716|26126824|FG000|Overall Study|Withdrawal by Subject|13|||
13173342|NCT02302716|26126825|FG001|Overall Study|Withdrawal by Subject|7|||
13173343|NCT02302716|26126824|FG000|Overall Study|Protocol Violation|0|||
13173344|NCT02302716|26126825|FG001|Overall Study|Protocol Violation|1|||
13173345|NCT02302339|26126869|FG000|Overall Study|Lost to Follow-up|1|||
13173346|NCT02302339|26126870|FG001|Overall Study|Lost to Follow-up|0|||
13173347|NCT02302339|26126871|FG002|Overall Study|Lost to Follow-up|0|||
13173348|NCT02302339|26126872|FG003|Overall Study|Lost to Follow-up|0|||
13173349|NCT02302339|26126869|FG000|Overall Study|Withdrawal by Subject|0|||
13173350|NCT02302339|26126870|FG001|Overall Study|Withdrawal by Subject|2|||
13173351|NCT02302339|26126871|FG002|Overall Study|Withdrawal by Subject|1|||
13173352|NCT02302339|26126872|FG003|Overall Study|Withdrawal by Subject|0|||
13173353|NCT02302222|26126885|FG000|Overall Study|Physician Decision|0|||
13173354|NCT02302222|26126886|FG001|Overall Study|Physician Decision|4|||
13173355|NCT02302222|26126885|FG000|Overall Study|Lost to Follow-up|1|||
13173356|NCT02302222|26126886|FG001|Overall Study|Lost to Follow-up|0|||
13173357|NCT02302222|26126885|FG000|Overall Study|Treatment discontinued before day 5|0|||
13173358|NCT02302222|26126886|FG001|Overall Study|Treatment discontinued before day 5|1|||
13173359|NCT02302222|26126885|FG000|Overall Study|Withdrawn prior to any treatment|0|||
13173360|NCT02302222|26126886|FG001|Overall Study|Withdrawn prior to any treatment|1|||
13173361|NCT02302066|26126941|FG000|Overall Study|Adverse Event|1|||
13173362|NCT02302066|26126942|FG001|Overall Study|Adverse Event|1|||
13173363|NCT02302066|26126943|FG002|Overall Study|Adverse Event|3|||
13173364|NCT02302066|26126944|FG003|Overall Study|Adverse Event|0|||
13173365|NCT02302066|26126941|FG000|Overall Study|Lost to Follow-up|4|||
13173366|NCT02302066|26126942|FG001|Overall Study|Lost to Follow-up|5|||
13173367|NCT02302066|26126943|FG002|Overall Study|Lost to Follow-up|24|||
13173368|NCT02302066|26126944|FG003|Overall Study|Lost to Follow-up|7|||
13173369|NCT02302066|26126941|FG000|Overall Study|Withdrawal by Subject|25|||
13173370|NCT02302066|26126942|FG001|Overall Study|Withdrawal by Subject|58|||
13173371|NCT02302066|26126943|FG002|Overall Study|Withdrawal by Subject|124|||
13173372|NCT02302066|26126944|FG003|Overall Study|Withdrawal by Subject|33|||
13173373|NCT02302066|26126941|FG000|Overall Study|Pregnancy|2|||
13173374|NCT02302066|26126942|FG001|Overall Study|Pregnancy|10|||
13173375|NCT02302066|26126943|FG002|Overall Study|Pregnancy|12|||
13173376|NCT02302066|26126944|FG003|Overall Study|Pregnancy|0|||
13173377|NCT02302066|26126941|FG000|Overall Study|Reason Not Specified|1|||
13173378|NCT02302066|26126942|FG001|Overall Study|Reason Not Specified|1|||
13173379|NCT02302066|26126943|FG002|Overall Study|Reason Not Specified|9|||
13173380|NCT02302066|26126944|FG003|Overall Study|Reason Not Specified|1|||
13173381|NCT02301988|26126981|FG000|Overall Study|Withdrawal by Subject|2|||
13173382|NCT02301988|26126982|FG001|Overall Study|Withdrawal by Subject|1|||
13173383|NCT02301988|26126981|FG000|Overall Study|Physician Decision|2|||
13173384|NCT02301988|26126982|FG001|Overall Study|Physician Decision|2|||
13173385|NCT02301988|26126981|FG000|Overall Study|Unknown Reason|1|||
13173386|NCT02301988|26126982|FG001|Overall Study|Unknown Reason|3|||
13173387|NCT02301988|26126981|FG000|Overall Study|Lack of Efficacy|3|||
13173388|NCT02301988|26126982|FG001|Overall Study|Lack of Efficacy|2|||
13173389|NCT02301988|26126981|FG000|Overall Study|Death|1|||
13173390|NCT02301988|26126982|FG001|Overall Study|Death|0|||
13173391|NCT02301988|26126981|FG000|Overall Study|Adverse Event|1|||
13173392|NCT02301988|26126982|FG001|Overall Study|Adverse Event|1|||
13173393|NCT02301975|26127018|FG000|Overall Study|Adverse Event|8|||
13173394|NCT02301975|26127019|FG001|Overall Study|Adverse Event|3|||
13173395|NCT02301975|26127020|FG002|Overall Study|Adverse Event|2|||
13173396|NCT02301975|26127018|FG000|Overall Study|Lack of Efficacy|1|||
13173397|NCT02301975|26127019|FG001|Overall Study|Lack of Efficacy|1|||
13173398|NCT02301975|26127020|FG002|Overall Study|Lack of Efficacy|1|||
13173399|NCT02301975|26127018|FG000|Overall Study|Protocol Violation|3|||
13173400|NCT02301975|26127019|FG001|Overall Study|Protocol Violation|5|||
13173401|NCT02301975|26127020|FG002|Overall Study|Protocol Violation|3|||
13173402|NCT02301975|26127018|FG000|Overall Study|Lost to Follow-up|0|||
13173403|NCT02301975|26127019|FG001|Overall Study|Lost to Follow-up|2|||
13173404|NCT02301975|26127020|FG002|Overall Study|Lost to Follow-up|2|||
13173405|NCT02301975|26127018|FG000|Overall Study|Physician Decision|4|||
13173406|NCT02301975|26127019|FG001|Overall Study|Physician Decision|2|||
13173407|NCT02301975|26127020|FG002|Overall Study|Physician Decision|3|||
13173408|NCT02301975|26127018|FG000|Overall Study|Withdrawal by Subject|15|||
13173409|NCT02301975|26127019|FG001|Overall Study|Withdrawal by Subject|12|||
13173410|NCT02301975|26127020|FG002|Overall Study|Withdrawal by Subject|11|||
13173411|NCT02301936|26127049|FG000|Overall Study|Lost to Follow-up|1|||
13173412|NCT02301936|26127050|FG001|Overall Study|Lost to Follow-up|0|||
13173413|NCT02301897|26127107|FG000|Treatment Course 1|Non-Compliance|0|||
13173414|NCT02301897|26127108|FG001|Treatment Course 1|Non-Compliance|0|||
13173415|NCT02301897|26127109|FG002|Treatment Course 1|Non-Compliance|1|||
13173416|NCT02301897|26127107|FG000|Treatment Course 1|Adverse Event|1|||
13173417|NCT02301897|26127108|FG001|Treatment Course 1|Adverse Event|1|||
13173418|NCT02301897|26127109|FG002|Treatment Course 1|Adverse Event|0|||
13173419|NCT02301897|26127107|FG000|Treatment Course 1|Lost to Follow-up|1|||
13173420|NCT02301897|26127108|FG001|Treatment Course 1|Lost to Follow-up|2|||
13173421|NCT02301897|26127109|FG002|Treatment Course 1|Lost to Follow-up|1|||
13173422|NCT02301897|26127107|FG000|Treatment Course 1|Withdrawal by Sponsor|0|||
13173423|NCT02301897|26127108|FG001|Treatment Course 1|Withdrawal by Sponsor|0|||
13173424|NCT02301897|26127109|FG002|Treatment Course 1|Withdrawal by Sponsor|2|||
13173425|NCT02301897|26127107|FG000|Treatment Course 1|Withdrawal by Subject|0|||
13173426|NCT02301897|26127108|FG001|Treatment Course 1|Withdrawal by Subject|0|||
13173427|NCT02301897|26127109|FG002|Treatment Course 1|Withdrawal by Subject|2|||
13173428|NCT02301897|26127107|FG000|Treatment Course 1|Other Miscellaneous Reasons|1|||
13173429|NCT02301897|26127108|FG001|Treatment Course 1|Other Miscellaneous Reasons|0|||
13173430|NCT02301897|26127109|FG002|Treatment Course 1|Other Miscellaneous Reasons|0|||
13173431|NCT02301897|26127107|FG000|Treatment Course 2|Lost to Follow-up|0|||
13173432|NCT02301897|26127108|FG001|Treatment Course 2|Lost to Follow-up|2|||
13173433|NCT02301897|26127109|FG002|Treatment Course 2|Lost to Follow-up|0|||
13173434|NCT02301897|26127107|FG000|Treatment Course 2|Pregnancy|0|||
13173435|NCT02301897|26127108|FG001|Treatment Course 2|Pregnancy|1|||
13173436|NCT02301897|26127109|FG002|Treatment Course 2|Pregnancy|1|||
13173437|NCT02301897|26127107|FG000|Treatment Course 2|Withdrawal by Subject|0|||
13173438|NCT02301897|26127108|FG001|Treatment Course 2|Withdrawal by Subject|2|||
13173439|NCT02301897|26127109|FG002|Treatment Course 2|Withdrawal by Subject|0|||
13173440|NCT02301897|26127107|FG000|Treatment Course 2|Other Miscellaneous Reasons|1|||
13173441|NCT02301897|26127108|FG001|Treatment Course 2|Other Miscellaneous Reasons|0|||
13173442|NCT02301897|26127109|FG002|Treatment Course 2|Other Miscellaneous Reasons|0|||
13173443|NCT02301624|26127125|FG000|Blind Induction Phase|Withdrawal by Subject|1|||
13173444|NCT02301624|26127126|FG001|Blind Induction Phase|Withdrawal by Subject|0|||
13173445|NCT02301624|26127125|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4|||
13173446|NCT02301624|26127126|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8|||
13173447|NCT02301624|26127125|FG000|Open-label Maintenance Phase|Adverse Event|2|||
13173448|NCT02301624|26127126|FG001|Open-label Maintenance Phase|Adverse Event|5|||
13173449|NCT02301624|26127125|FG000|Open-label Maintenance Phase|Physician Decision|3|||
13173450|NCT02301624|26127126|FG001|Open-label Maintenance Phase|Physician Decision|3|||
13173451|NCT02301624|26127125|FG000|Open-label Maintenance Phase|Death|2|||
13173452|NCT02301624|26127126|FG001|Open-label Maintenance Phase|Death|1|||
13173453|NCT02301624|26127125|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1|||
13173454|NCT02301624|26127126|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0|||
13173455|NCT02301546|26127139|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7|||
13173456|NCT02301546|26127140|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8|||
13173457|NCT02301546|26127139|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10|||
13173458|NCT02301546|26127140|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7|||
13173459|NCT02301546|26127139|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1|||
13173460|NCT02301546|26127140|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0|||
13173461|NCT02301546|26127139|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
13173462|NCT02301546|26127140|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
13173463|NCT02301546|26127139|FG000|Long Term Effectiveness (~1 Year)|Death|2|||
13173464|NCT02301546|26127140|FG001|Long Term Effectiveness (~1 Year)|Death|0|||
13173465|NCT02301546|26127139|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6|||
13173466|NCT02301546|26127140|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2|||
13173467|NCT02301546|26127139|FG000|Long Term Effectiveness (~1 Year)|moved away|1|||
13173468|NCT02301546|26127140|FG001|Long Term Effectiveness (~1 Year)|moved away|2|||
13173469|NCT02301429|26127146|FG000|Overall Study|not acceptable vascular anatomy|3|||
13173470|NCT02301403|26127159|FG000|Overall Study|Withdrawal by Subject|28|||
13173471|NCT02301403|26127160|FG001|Overall Study|Withdrawal by Subject|41|||
13173472|NCT02301390|26127179|FG000|Overall Study|Withdrawal by Subject|3|||
13173473|NCT02301390|26127180|FG001|Overall Study|Withdrawal by Subject|5|||
13173474|NCT02301390|26127179|FG000|Overall Study|Protocol Violation|1|||
13173475|NCT02301390|26127180|FG001|Overall Study|Protocol Violation|0|||
13173476|NCT02301390|26127179|FG000|Overall Study|Physician Decision|1|||
13173477|NCT02301390|26127180|FG001|Overall Study|Physician Decision|0|||
13173478|NCT02301390|26127179|FG000|Overall Study|Lost to Follow-up|0|||
13173479|NCT02301390|26127180|FG001|Overall Study|Lost to Follow-up|1|||
13173480|NCT02301390|26127179|FG000|Overall Study|Death|2|||
13173481|NCT02301390|26127180|FG001|Overall Study|Death|2|||
13173482|NCT02301390|26127179|FG000|Overall Study|Procedure not completed|0|||
13173483|NCT02301390|26127180|FG001|Overall Study|Procedure not completed|4|||
13173484|NCT02301390|26127179|FG000|Overall Study|Missed multiple visits|1|||
13173485|NCT02301390|26127180|FG001|Overall Study|Missed multiple visits|1|||
13173486|NCT02301390|26127179|FG000|Overall Study|study terminated|2|||
13173487|NCT02301390|26127180|FG001|Overall Study|study terminated|0|||
13173488|NCT02301169|26127201|FG000|Overall Study|Adverse Event|1|||
13173489|NCT02301169|26127202|FG001|Overall Study|Adverse Event|0|||
13173490|NCT02301156|26127227|FG000|Overall Study|Adverse Event|13|||
13173491|NCT02301156|26127228|FG001|Overall Study|Adverse Event|14|||
13173492|NCT02301156|26127227|FG000|Overall Study|Death|1|||
13173493|NCT02301156|26127228|FG001|Overall Study|Death|5|||
13173494|NCT02301156|26127227|FG000|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
13173495|NCT02301156|26127228|FG001|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
13173496|NCT02301156|26127227|FG000|Overall Study|Site Terminated by Sponsor at the End of Study|27|||
13173497|NCT02301156|26127228|FG001|Overall Study|Site Terminated by Sponsor at the End of Study|16|||
13173498|NCT02301156|26127227|FG000|Overall Study|Withdrawal of Consent by Subject|4|||
13173499|NCT02301156|26127228|FG001|Overall Study|Withdrawal of Consent by Subject|12|||
13173500|NCT02301156|26127227|FG000|Overall Study|Reason not Specified|6|||
13173501|NCT02301156|26127228|FG001|Overall Study|Reason not Specified|3|||
13173502|NCT02301143|26127247|FG000|Induction Period|Enrolled But Not Treated|1|||
13173503|NCT02301143|26127248|FG001|Induction Period|Enrolled But Not Treated|0|||
13173504|NCT02301143|26127247|FG000|Induction Period|Death|1|||
13173505|NCT02301143|26127248|FG001|Induction Period|Death|0|||
13173506|NCT02301143|26127247|FG000|Induction Period|Adverse Event|22|||
13173507|NCT02301143|26127248|FG001|Induction Period|Adverse Event|0|||
13173508|NCT02301143|26127247|FG000|Induction Period|Progressive Disease|8|||
13173509|NCT02301143|26127248|FG001|Induction Period|Progressive Disease|0|||
13173510|NCT02301143|26127247|FG000|Induction Period|Withdrawal by Subject|3|||
13173511|NCT02301143|26127248|FG001|Induction Period|Withdrawal by Subject|0|||
13173512|NCT02301143|26127247|FG000|Induction Period|Noncompliance with Study Drug|1|||
13173513|NCT02301143|26127248|FG001|Induction Period|Noncompliance with Study Drug|0|||
13173514|NCT02301143|26127247|FG000|Induction Period|Physician Decision|4|||
13173515|NCT02301143|26127248|FG001|Induction Period|Physician Decision|0|||
13173516|NCT02301143|26127247|FG000|Induction Period|Symptomatic Deterioration|2|||
13173517|NCT02301143|26127248|FG001|Induction Period|Symptomatic Deterioration|0|||
13173518|NCT02301143|26127247|FG000|Induction Period|Protocol Violation|2|||
13173519|NCT02301143|26127248|FG001|Induction Period|Protocol Violation|0|||
13173520|NCT02301143|26127247|FG000|Induction Period|Other|1|||
13173521|NCT02301143|26127248|FG001|Induction Period|Other|0|||
13173522|NCT02301143|26127247|FG000|Investigator's Choice|Adverse Event|0|||
13173523|NCT02301143|26127248|FG001|Investigator's Choice|Adverse Event|3|||
13173524|NCT02301143|26127247|FG000|Investigator's Choice|Progressive Disease|0|||
13173525|NCT02301143|26127248|FG001|Investigator's Choice|Progressive Disease|3|||
13173526|NCT02301143|26127247|FG000|Investigator's Choice|Noncompliance With Study Drug|0|||
13173527|NCT02301143|26127248|FG001|Investigator's Choice|Noncompliance With Study Drug|1|||
13173528|NCT02301143|26127247|FG000|Investigator's Choice|Symptomatic Deterioration|0|||
13173529|NCT02301143|26127248|FG001|Investigator's Choice|Symptomatic Deterioration|1|||
13173530|NCT02301143|26127247|FG000|Investigator's Choice|Other|0|||
13173531|NCT02301143|26127248|FG001|Investigator's Choice|Other|1|||
13173532|NCT02301143|26127247|FG000|Investigator's Choice|Unresectable Surgery|0|||
13173533|NCT02301143|26127248|FG001|Investigator's Choice|Unresectable Surgery|1|||
13173534|NCT02300987|26127274|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1|||
13173535|NCT02300987|26127275|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0|||
13173536|NCT02300987|26127274|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2|||
13173537|NCT02300987|26127275|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0|||
13173538|NCT02300987|26127274|FG000|Primary Phase : Prior to Cross-over|progressive disease|3|||
13173539|NCT02300987|26127275|FG001|Primary Phase : Prior to Cross-over|progressive disease|2|||
13173540|NCT02300987|26127274|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1|||
13173541|NCT02300987|26127275|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0|||
13173542|NCT02300987|26127274|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0|||
13173543|NCT02300987|26127275|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1|||
13173544|NCT02300610|26127300|FG000|Overall Study|Withdrawal by Subject|1|||
13173545|NCT02300610|26127301|FG001|Overall Study|Withdrawal by Subject|0|||
13173546|NCT02300610|26127302|FG002|Overall Study|Withdrawal by Subject|1|||
13173547|NCT02300558|26127315|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6|||
13173548|NCT02300558|26127315|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2|||
13173549|NCT02300558|26127315|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1|||
13173550|NCT02300558|26127315|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29|||
13173551|NCT02300311|26127334|FG000|Overall Study|Other than the reason specified|1|||
13173552|NCT02300311|26127335|FG001|Overall Study|Other than the reason specified|0|||
13173553|NCT02300311|26127334|FG000|Overall Study|Refused to continue taking medication|18|||
13173554|NCT02300311|26127335|FG001|Overall Study|Refused to continue taking medication|0|||
13173555|NCT02300298|26127348|FG000|Disposition for Nintedanib|Progressive disease|10|||
13173556|NCT02300298|26127349|FG001|Disposition for Nintedanib|Progressive disease|0|||
13173557|NCT02300298|26127348|FG000|Disposition for Docetaxel|Progressive disease|0|||
13173558|NCT02300298|26127349|FG001|Disposition for Docetaxel|Progressive disease|6|||
13173559|NCT02300298|26127348|FG000|Disposition for Docetaxel|other adverse event|0|||
13173560|NCT02300298|26127349|FG001|Disposition for Docetaxel|other adverse event|4|||
13173561|NCT02300259|26127388|FG000|Period 1|Adverse Event|0|||
13173562|NCT02300259|26127389|FG001|Period 1|Adverse Event|0|||
13173563|NCT02300259|26127390|FG002|Period 1|Adverse Event|1|||
13173564|NCT02300259|26127388|FG000|Period 1|Withdrawal by Subject|0|||
13173565|NCT02300259|26127389|FG001|Period 1|Withdrawal by Subject|0|||
13173566|NCT02300259|26127390|FG002|Period 1|Withdrawal by Subject|1|||
13173567|NCT02300259|26127388|FG000|Period 2|Adverse Event|1|||
13173568|NCT02300259|26127389|FG001|Period 2|Adverse Event|0|||
13173569|NCT02300259|26127390|FG002|Period 2|Adverse Event|0|||
13173570|NCT02300259|26127388|FG000|Period 2|Withdrawal by Subject|0|||
13173571|NCT02300259|26127389|FG001|Period 2|Withdrawal by Subject|0|||
13173572|NCT02300259|26127390|FG002|Period 2|Withdrawal by Subject|1|||
13173573|NCT02300233|26127421|FG000|Overall Study|Adverse Event or Serious Adverse Event|3|||
13173574|NCT02300233|26127422|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
13173575|NCT02300233|26127423|FG002|Overall Study|Adverse Event or Serious Adverse Event|14|||
13173576|NCT02300233|26127421|FG000|Overall Study|Withdrawal by Subject|1|||
13173577|NCT02300233|26127422|FG001|Overall Study|Withdrawal by Subject|0|||
13173578|NCT02300233|26127423|FG002|Overall Study|Withdrawal by Subject|3|||
13173579|NCT02300233|26127421|FG000|Overall Study|Investigator Judgement|0|||
13173580|NCT02300233|26127422|FG001|Overall Study|Investigator Judgement|0|||
13173581|NCT02300233|26127423|FG002|Overall Study|Investigator Judgement|1|||
13173582|NCT02300233|26127421|FG000|Overall Study|Reason Not Specified|0|||
13173583|NCT02300233|26127422|FG001|Overall Study|Reason Not Specified|0|||
13173584|NCT02300233|26127423|FG002|Overall Study|Reason Not Specified|5|||
13173585|NCT02300220|26127446|FG000|Overall Study|Lost to Follow-up|1|||
13173586|NCT02300220|26127447|FG001|Overall Study|Lost to Follow-up|2|||
13173587|NCT02300220|26127446|FG000|Overall Study|Death|1|||
13173588|NCT02300220|26127447|FG001|Overall Study|Death|1|||
13173589|NCT02300220|26127446|FG000|Overall Study|Adverse Event|1|||
13173590|NCT02300220|26127447|FG001|Overall Study|Adverse Event|1|||
13173591|NCT02300220|26127446|FG000|Overall Study|Protocol Violation|1|||
13173592|NCT02300220|26127447|FG001|Overall Study|Protocol Violation|0|||
13173593|NCT02300220|26127446|FG000|Overall Study|Withdrawal by Subject|0|||
13173594|NCT02300220|26127447|FG001|Overall Study|Withdrawal by Subject|2|||
13173595|NCT02300220|26127446|FG000|Overall Study|Did not tolerate IMP|0|||
13173596|NCT02300220|26127447|FG001|Overall Study|Did not tolerate IMP|1|||
13173597|NCT02300129|26127462|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
13173598|NCT02300129|26127463|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1|||
13173599|NCT02300129|26127464|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
13173600|NCT02300129|26127465|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
13173601|NCT02300129|26127462|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
13173602|NCT02300129|26127463|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
13173603|NCT02300129|26127464|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
13173604|NCT02300129|26127465|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1|||
13173605|NCT02300129|26127462|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1|||
13173606|NCT02300129|26127463|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
13173607|NCT02300129|26127464|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
13173608|NCT02300129|26127465|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
13173609|NCT02300103|26127476|FG000|Overall Study|Lack of Efficacy|3|||
13173610|NCT02300103|26127476|FG000|Overall Study|Protocol Violation|1|||
13173611|NCT02300103|26127476|FG000|Overall Study|Withdrew Consent|2|||
13173612|NCT02299934|26127489|FG000|Overall Study|Termination of study|13|||
13173613|NCT02299635|26127510|FG000|Overall Study|Adverse Event|2|||
13173614|NCT02299635|26127510|FG000|Overall Study|Death|1|||
13173615|NCT02299635|26127510|FG000|Overall Study|Global deterioration of health status|1|||
13173616|NCT02299635|26127510|FG000|Overall Study|Objective progression or relapse|10|||
13173617|NCT02299635|26127510|FG000|Overall Study|Withdrawal by Subject|2|||
13173618|NCT02299635|26127510|FG000|Overall Study|Other|3|||
13205624|NCT01963611|26232390|FG000|Overall Study|Withdrawal by Subject|3|||
13205625|NCT01963611|26232391|FG001|Overall Study|Withdrawal by Subject|2|||
13205626|NCT01963611|26232392|FG002|Overall Study|Withdrawal by Subject|1|||
13205627|NCT01963611|26232393|FG003|Overall Study|Withdrawal by Subject|1|||
13205628|NCT01963611|26232394|FG004|Overall Study|Withdrawal by Subject|3|||
13205629|NCT01963611|26232390|FG000|Overall Study|Other|47|||
13205630|NCT01963611|26232391|FG001|Overall Study|Other|46|||
13205631|NCT01963611|26232392|FG002|Overall Study|Other|48|||
13205632|NCT01963611|26232393|FG003|Overall Study|Other|45|||
13205633|NCT01963611|26232394|FG004|Overall Study|Other|45|||
13205634|NCT01963403|26232413|FG000|Overall Study|Lost to Follow-up|2|||
13205635|NCT01963403|26232414|FG001|Overall Study|Lost to Follow-up|3|||
13205636|NCT01963403|26232413|FG000|Overall Study|Implant removal|0|||
13205637|NCT01963403|26232414|FG001|Overall Study|Implant removal|1|||
13205638|NCT01963260|26232497|FG000|Overall Study|Withdrawal by Subject|2|||
13205639|NCT01963260|26232498|FG001|Overall Study|Withdrawal by Subject|0|||
13205640|NCT01963260|26232499|FG002|Overall Study|Withdrawal by Subject|0|||
13205641|NCT01963260|26232500|FG003|Overall Study|Withdrawal by Subject|1|||
13205642|NCT01963260|26232501|FG004|Overall Study|Withdrawal by Subject|2|||
13205643|NCT01963260|26232502|FG005|Overall Study|Withdrawal by Subject|0|||
13205644|NCT01963260|26232503|FG006|Overall Study|Withdrawal by Subject|0|||
13205645|NCT01963260|26232504|FG007|Overall Study|Withdrawal by Subject|0|||
13205646|NCT01963260|26232505|FG008|Overall Study|Withdrawal by Subject|0|||
13205647|NCT01963260|26232506|FG009|Overall Study|Withdrawal by Subject|0|||
13205648|NCT01963117|26232517|FG000|Overall Study|Death|1|||
13205649|NCT01962987|26232535|FG000|Overall Study|Adverse Event|4|||
13205650|NCT01962987|26232536|FG001|Overall Study|Adverse Event|4|||
13173619|NCT02299427|26127525|FG000|Overall Study|Withdrawal by Subject|1|||
13173620|NCT02299427|26127526|FG001|Overall Study|Withdrawal by Subject|0|||
13173621|NCT02299427|26127525|FG000|Overall Study|Lost to Follow-up|1|||
13173622|NCT02299427|26127526|FG001|Overall Study|Lost to Follow-up|3|||
13173623|NCT02299427|26127525|FG000|Overall Study|not adherent to dog website use|21|||
13173624|NCT02299427|26127526|FG001|Overall Study|not adherent to dog website use|0|||
13173625|NCT02299388|26127541|FG000|Overall Study|Withdrawal by Subject|0|||
13173626|NCT02299388|26127542|FG001|Overall Study|Withdrawal by Subject|1|||
13173627|NCT02299375|26127597|FG000|Overall Study|Adverse Event, serious fatal|1|||
13173628|NCT02299375|26127598|FG001|Overall Study|Adverse Event, serious fatal|3|||
13173629|NCT02299375|26127597|FG000|Overall Study|Adverse Event, non-fatal|8|||
13173630|NCT02299375|26127598|FG001|Overall Study|Adverse Event, non-fatal|9|||
13173631|NCT02299375|26127597|FG000|Overall Study|Lack of Efficacy|1|||
13173632|NCT02299375|26127598|FG001|Overall Study|Lack of Efficacy|3|||
13173633|NCT02299375|26127597|FG000|Overall Study|Protocol Violation|1|||
13173634|NCT02299375|26127598|FG001|Overall Study|Protocol Violation|3|||
13173635|NCT02299375|26127597|FG000|Overall Study|Other: Met stopping criteria|1|||
13173636|NCT02299375|26127598|FG001|Overall Study|Other: Met stopping criteria|0|||
13173637|NCT02299375|26127597|FG000|Overall Study|Other: Study closed/terminated|66|||
13173638|NCT02299375|26127598|FG001|Overall Study|Other: Study closed/terminated|55|||
13173639|NCT02299375|26127597|FG000|Overall Study|Lost to Follow-up|0|||
13173640|NCT02299375|26127598|FG001|Overall Study|Lost to Follow-up|2|||
13173641|NCT02299375|26127597|FG000|Overall Study|Physician Decision|1|||
13173642|NCT02299375|26127598|FG001|Overall Study|Physician Decision|1|||
13173643|NCT02299375|26127597|FG000|Overall Study|Withdrawal by Subject|1|||
13173644|NCT02299375|26127598|FG001|Overall Study|Withdrawal by Subject|4|||
13173645|NCT02299336|26127616|FG000|Overall Study|Withdrawal by Subject|11|||
13173646|NCT02299336|26127616|FG000|Overall Study|Adverse Event|1|||
13173647|NCT02299336|26127616|FG000|Overall Study|Death|1|||
13173648|NCT02299336|26127616|FG000|Overall Study|Lost to Follow-up|1|||
13173649|NCT02299206|26127626|FG000|Overall Study|Lost to Follow-up|1|||
13173650|NCT02299206|26127626|FG000|Overall Study|Withdrawal by Subject|1|||
13173651|NCT02299167|26127636|FG000|Overall Study|patients were excluded from the study|11|||
13173652|NCT02299076|26127651|FG000|Overall Study|Fraudulent Entries|20|||
13173653|NCT02299076|26127652|FG001|Overall Study|Fraudulent Entries|14|||
13173654|NCT02298946|26127683|FG000|Overall Study|Did not receive treatment|2|||
13173655|NCT02298946|26127684|FG001|Overall Study|Did not receive treatment|0|||
13173656|NCT02298946|26127683|FG000|Overall Study|Unevaluable|2|||
13173657|NCT02298946|26127684|FG001|Overall Study|Unevaluable|1|||
13173658|NCT02298868|26127698|FG000|Overall Study|Adverse Event|1|||
13173659|NCT02298868|26127698|FG000|Overall Study|Death|1|||
13173660|NCT02298868|26127698|FG000|Overall Study|Patient underwent transplant|1|||
13173661|NCT02298192|26127717|FG000|Overall Study|Unclassified|3|||
13173662|NCT02298192|26127718|FG001|Overall Study|Unclassified|2|||
13173663|NCT02298192|26127717|FG000|Overall Study|Withdrawal criteria|2|||
13173664|NCT02298192|26127718|FG001|Overall Study|Withdrawal criteria|0|||
13173665|NCT02298192|26127717|FG000|Overall Study|Withdrawal by Subject|6|||
13173666|NCT02298192|26127718|FG001|Overall Study|Withdrawal by Subject|1|||
13173667|NCT02298192|26127717|FG000|Overall Study|Lost to Follow-up|2|||
13173668|NCT02298192|26127718|FG001|Overall Study|Lost to Follow-up|1|||
13173669|NCT02298192|26127717|FG000|Overall Study|Adverse Event|6|||
13173670|NCT02298192|26127718|FG001|Overall Study|Adverse Event|2|||
13173671|NCT02298179|26127997|FG000|Overall Study|Lost to Follow-up|0|||
13173672|NCT02298179|26127998|FG001|Overall Study|Lost to Follow-up|0|||
13173673|NCT02298179|26127999|FG002|Overall Study|Lost to Follow-up|1|||
13173674|NCT02298179|26128000|FG003|Overall Study|Lost to Follow-up|0|||
13173675|NCT02298179|26128001|FG004|Overall Study|Lost to Follow-up|0|||
13173676|NCT02298179|26128002|FG005|Overall Study|Lost to Follow-up|0|||
13173677|NCT02298179|26128003|FG006|Overall Study|Lost to Follow-up|0|||
13173678|NCT02298179|26128004|FG007|Overall Study|Lost to Follow-up|1|||
13173679|NCT02298179|26128005|FG008|Overall Study|Lost to Follow-up|0|||
13173680|NCT02298179|26128006|FG009|Overall Study|Lost to Follow-up|0|||
13173681|NCT02298179|26128007|FG010|Overall Study|Lost to Follow-up|0|||
13173682|NCT02298179|26128008|FG011|Overall Study|Lost to Follow-up|0|||
13173683|NCT02298023|26128047|FG000|Overall Study|Withdrawal by Subject|1|||
13173684|NCT02298023|26128048|FG001|Overall Study|Withdrawal by Subject|0|||
13173685|NCT02298023|26128049|FG002|Overall Study|Withdrawal by Subject|0|||
13173686|NCT02297841|26128055|FG000|Overall Study|Withdrawal by Subject|1|||
13173687|NCT02297841|26128055|FG000|Overall Study|Protocol Violation|7|||
13173688|NCT02297815|26128078|FG000|Overall Study|Lost to Follow-up|236|||
13173689|NCT02297815|26128079|FG001|Overall Study|Lost to Follow-up|140|||
13173690|NCT02297503|26128111|FG000|Overall Study|Withdrawal by Subject|1|||
13173691|NCT02297503|26128112|FG001|Overall Study|Withdrawal by Subject|1|||
13173692|NCT02297503|26128111|FG000|Overall Study|Protocol Violation|1|||
13173693|NCT02297503|26128112|FG001|Overall Study|Protocol Violation|0|||
13173694|NCT02297503|26128111|FG000|Overall Study|Pregnancy|0|||
13173695|NCT02297503|26128112|FG001|Overall Study|Pregnancy|1|||
13173696|NCT02297503|26128111|FG000|Overall Study|Lost to Follow-up|0|||
13173697|NCT02297503|26128112|FG001|Overall Study|Lost to Follow-up|1|||
13173698|NCT02297503|26128111|FG000|Overall Study|Medical reason|0|||
13173699|NCT02297503|26128112|FG001|Overall Study|Medical reason|1|||
13173700|NCT02296931|26128125|FG000|Overall Study|Protocol Violation|0|||
13173701|NCT02296931|26128126|FG001|Overall Study|Protocol Violation|2|||
13173702|NCT02296892|26128153|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7|||
13173703|NCT02296892|26128154|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4|||
13173704|NCT02296892|26128155|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4|||
13108172|NCT03259490|25890600|FG000|Period 2|Protocol Violation|1|||
13108173|NCT03259490|25890601|FG001|Period 2|Protocol Violation|0|||
13108174|NCT03259334|25890688|FG000|Overall Study|Adverse Event|3|||
13108175|NCT03259334|25890689|FG001|Overall Study|Adverse Event|8|||
13173705|NCT02296892|26128153|FG000|Overall Study|Lost to Follow-up|5|||
13173706|NCT02296892|26128154|FG001|Overall Study|Lost to Follow-up|0|||
13173707|NCT02296892|26128155|FG002|Overall Study|Lost to Follow-up|1|||
13173708|NCT02296840|26128170|FG000|Overall Study|Adverse Event|1|||
13173709|NCT02296840|26128171|FG001|Overall Study|Adverse Event|1|||
13173710|NCT02296840|26128170|FG000|Overall Study|Protocol Violation|2|||
13173711|NCT02296840|26128171|FG001|Overall Study|Protocol Violation|1|||
13173712|NCT02296840|26128170|FG000|Overall Study|Lost to Follow-up|6|||
13173713|NCT02296840|26128171|FG001|Overall Study|Lost to Follow-up|17|||
13173714|NCT02296476|26128234|FG000|Overall Study|Disease Progression|6|||
13173715|NCT02296476|26128235|FG001|Overall Study|Disease Progression|4|||
13173716|NCT02296476|26128236|FG002|Overall Study|Disease Progression|2|||
13173717|NCT02296424|26128256|FG000|Part 1|New therapy for study indication|0|||
13173718|NCT02296424|26128257|FG001|Part 1|New therapy for study indication|1|||
13173719|NCT02296424|26128258|FG002|Part 1|New therapy for study indication|0|||
13173720|NCT02296424|26128259|FG003|Part 1|New therapy for study indication|0|||
13173721|NCT02296424|26128256|FG000|Part 1|Protocol Violation|0|||
13173722|NCT02296424|26128257|FG001|Part 1|Protocol Violation|1|||
13173723|NCT02296424|26128258|FG002|Part 1|Protocol Violation|0|||
13173724|NCT02296424|26128259|FG003|Part 1|Protocol Violation|0|||
13173725|NCT02296424|26128256|FG000|Part 1|Withdrawal by Subject|0|||
13173726|NCT02296424|26128257|FG001|Part 1|Withdrawal by Subject|2|||
13173727|NCT02296424|26128258|FG002|Part 1|Withdrawal by Subject|0|||
13173728|NCT02296424|26128259|FG003|Part 1|Withdrawal by Subject|0|||
13173729|NCT02296424|26128256|FG000|Part 1|Study terminated by sponsor|0|||
13173730|NCT02296424|26128257|FG001|Part 1|Study terminated by sponsor|1|||
13173731|NCT02296424|26128258|FG002|Part 1|Study terminated by sponsor|0|||
13173732|NCT02296424|26128259|FG003|Part 1|Study terminated by sponsor|0|||
13173733|NCT02296424|26128256|FG000|Part 1|Adverse Event|2|||
13173734|NCT02296424|26128257|FG001|Part 1|Adverse Event|11|||
13173735|NCT02296424|26128258|FG002|Part 1|Adverse Event|0|||
13173736|NCT02296424|26128259|FG003|Part 1|Adverse Event|0|||
13173737|NCT02296424|26128256|FG000|Part 1|Lack of Efficacy|5|||
13173738|NCT02296424|26128257|FG001|Part 1|Lack of Efficacy|17|||
13173739|NCT02296424|26128258|FG002|Part 1|Lack of Efficacy|0|||
13173740|NCT02296424|26128259|FG003|Part 1|Lack of Efficacy|0|||
13173741|NCT02296424|26128256|FG000|Part 1|16 directly started part II|16|||
13173742|NCT02296424|26128257|FG001|Part 1|16 directly started part II|0|||
13173743|NCT02296424|26128258|FG002|Part 1|16 directly started part II|0|||
13173744|NCT02296424|26128259|FG003|Part 1|16 directly started part II|0|||
13173745|NCT02296424|26128256|FG000|Part 2|Lack of Efficacy|0|||
13173746|NCT02296424|26128257|FG001|Part 2|Lack of Efficacy|0|||
13173747|NCT02296424|26128258|FG002|Part 2|Lack of Efficacy|1|||
13173748|NCT02296424|26128259|FG003|Part 2|Lack of Efficacy|0|||
13173749|NCT02296424|26128256|FG000|Part 2|Adverse Event|0|||
13173750|NCT02296424|26128257|FG001|Part 2|Adverse Event|0|||
13173751|NCT02296424|26128258|FG002|Part 2|Adverse Event|1|||
13173752|NCT02296424|26128259|FG003|Part 2|Adverse Event|0|||
13173753|NCT02296424|26128256|FG000|Part 2|Lost to Follow-up|0|||
13173754|NCT02296424|26128257|FG001|Part 2|Lost to Follow-up|0|||
13173755|NCT02296424|26128258|FG002|Part 2|Lost to Follow-up|1|||
13108176|NCT03259334|25890690|FG002|Overall Study|Adverse Event|5|||
13108177|NCT03259334|25890688|FG000|Overall Study|Withdrawal by Subject|4|||
13108178|NCT03259334|25890689|FG001|Overall Study|Withdrawal by Subject|2|||
13173756|NCT02296424|26128259|FG003|Part 2|Lost to Follow-up|0|||
13173757|NCT02296320|26128303|FG000|Overall Study|Withdrawal by Subject|4|||
13173758|NCT02296320|26128304|FG001|Overall Study|Withdrawal by Subject|0|||
13173759|NCT02296320|26128305|FG002|Overall Study|Withdrawal by Subject|2|||
13173760|NCT02296320|26128303|FG000|Overall Study|Death|24|||
13173761|NCT02296320|26128304|FG001|Overall Study|Death|3|||
13173762|NCT02296320|26128305|FG002|Overall Study|Death|27|||
13173763|NCT02296320|26128303|FG000|Overall Study|Lost to Follow-up|5|||
13173764|NCT02296320|26128304|FG001|Overall Study|Lost to Follow-up|2|||
13173765|NCT02296320|26128305|FG002|Overall Study|Lost to Follow-up|7|||
13173766|NCT02296320|26128303|FG000|Overall Study|Not treated|2|||
13173767|NCT02296320|26128304|FG001|Overall Study|Not treated|0|||
13108179|NCT03259334|25890690|FG002|Overall Study|Withdrawal by Subject|4|||
13173768|NCT02296320|26128305|FG002|Overall Study|Not treated|0|||
13173769|NCT02296320|26128303|FG000|Overall Study|Not - specified|0|||
13173770|NCT02296320|26128304|FG001|Overall Study|Not - specified|0|||
13173771|NCT02296320|26128305|FG002|Overall Study|Not - specified|1|||
13173772|NCT02296242|26128343|FG000|Overall Study|Death|1|||
13173773|NCT02296242|26128344|FG001|Overall Study|Death|1|||
13173774|NCT02296242|26128345|FG002|Overall Study|Death|1|||
13173775|NCT02296242|26128346|FG003|Overall Study|Death|1|||
13173776|NCT02296242|26128347|FG004|Overall Study|Death|1|||
13173777|NCT02296242|26128343|FG000|Overall Study|Withdrawal by Subject|0|||
13173778|NCT02296242|26128344|FG001|Overall Study|Withdrawal by Subject|0|||
13173779|NCT02296242|26128345|FG002|Overall Study|Withdrawal by Subject|1|||
13173780|NCT02296242|26128346|FG003|Overall Study|Withdrawal by Subject|1|||
13173781|NCT02296242|26128347|FG004|Overall Study|Withdrawal by Subject|3|||
13173782|NCT02296242|26128343|FG000|Overall Study|Disease Progression|1|||
13173783|NCT02296242|26128344|FG001|Overall Study|Disease Progression|3|||
13173784|NCT02296242|26128345|FG002|Overall Study|Disease Progression|2|||
13173785|NCT02296242|26128346|FG003|Overall Study|Disease Progression|8|||
13173786|NCT02296242|26128347|FG004|Overall Study|Disease Progression|11|||
13173787|NCT02296242|26128343|FG000|Overall Study|Unacceptable Toxicity|0|||
13173788|NCT02296242|26128344|FG001|Overall Study|Unacceptable Toxicity|0|||
13108180|NCT03259334|25890688|FG000|Overall Study|Physician Decision|1|||
13108181|NCT03259334|25890689|FG001|Overall Study|Physician Decision|0|||
13173789|NCT02296242|26128345|FG002|Overall Study|Unacceptable Toxicity|0|||
13173790|NCT02296242|26128346|FG003|Overall Study|Unacceptable Toxicity|0|||
13173791|NCT02296242|26128347|FG004|Overall Study|Unacceptable Toxicity|1|||
13173792|NCT02296242|26128343|FG000|Overall Study|Patient Condition Changed|0|||
13173793|NCT02296242|26128344|FG001|Overall Study|Patient Condition Changed|0|||
13173794|NCT02296242|26128345|FG002|Overall Study|Patient Condition Changed|2|||
13173795|NCT02296242|26128346|FG003|Overall Study|Patient Condition Changed|0|||
13173796|NCT02296242|26128347|FG004|Overall Study|Patient Condition Changed|1|||
13173797|NCT02296242|26128343|FG000|Overall Study|At Least 3 Drug Interruptions|0|||
13173798|NCT02296242|26128344|FG001|Overall Study|At Least 3 Drug Interruptions|0|||
13173799|NCT02296242|26128345|FG002|Overall Study|At Least 3 Drug Interruptions|1|||
13173800|NCT02296242|26128346|FG003|Overall Study|At Least 3 Drug Interruptions|1|||
13173801|NCT02296242|26128347|FG004|Overall Study|At Least 3 Drug Interruptions|1|||
13173802|NCT02296242|26128343|FG000|Overall Study|Lost to Follow-up|1|||
13173803|NCT02296242|26128344|FG001|Overall Study|Lost to Follow-up|0|||
13173804|NCT02296242|26128345|FG002|Overall Study|Lost to Follow-up|0|||
13173805|NCT02296242|26128346|FG003|Overall Study|Lost to Follow-up|0|||
13173806|NCT02296242|26128347|FG004|Overall Study|Lost to Follow-up|0|||
13173807|NCT02296242|26128343|FG000|Overall Study|Need for Hydroxyurea|2|||
13173808|NCT02296242|26128344|FG001|Overall Study|Need for Hydroxyurea|0|||
13222920|NCT01802216|26287225|FG000|12 Month Visit|Participant did not show to visit|3|||
13108182|NCT03259334|25890690|FG002|Overall Study|Physician Decision|0|||
13108183|NCT03259334|25890688|FG000|Overall Study|Lost to Follow-up|0|||
13108184|NCT03259334|25890689|FG001|Overall Study|Lost to Follow-up|2|||
13108185|NCT03259334|25890690|FG002|Overall Study|Lost to Follow-up|1|||
13108186|NCT03259334|25890688|FG000|Overall Study|Protocol Deviation|0|||
13108187|NCT03259334|25890689|FG001|Overall Study|Protocol Deviation|3|||
13108188|NCT03259334|25890690|FG002|Overall Study|Protocol Deviation|2|||
13108189|NCT03259334|25890688|FG000|Overall Study|Lack of Efficacy|2|||
13108190|NCT03259334|25890689|FG001|Overall Study|Lack of Efficacy|0|||
13108191|NCT03259334|25890690|FG002|Overall Study|Lack of Efficacy|1|||
13108192|NCT03259334|25890688|FG000|Overall Study|Randomized but never treated|0|||
13108193|NCT03259334|25890689|FG001|Overall Study|Randomized but never treated|2|||
13108194|NCT03259334|25890690|FG002|Overall Study|Randomized but never treated|0|||
13108195|NCT03259308|25890777|FG000|Overall Study|Adverse Event|5|||
13108196|NCT03259308|25890778|FG001|Overall Study|Adverse Event|4|||
13108197|NCT03259308|25890779|FG002|Overall Study|Adverse Event|1|||
13108198|NCT03259308|25890777|FG000|Overall Study|Withdrawal by Subject|2|||
13108199|NCT03259308|25890778|FG001|Overall Study|Withdrawal by Subject|1|||
13108200|NCT03259308|25890779|FG002|Overall Study|Withdrawal by Subject|3|||
13108201|NCT03259308|25890777|FG000|Overall Study|Lost to Follow-up|0|||
13108202|NCT03259308|25890778|FG001|Overall Study|Lost to Follow-up|0|||
13108203|NCT03259308|25890779|FG002|Overall Study|Lost to Follow-up|1|||
13108204|NCT03259308|25890777|FG000|Overall Study|Pregnancy|0|||
13108205|NCT03259308|25890778|FG001|Overall Study|Pregnancy|0|||
13108206|NCT03259308|25890779|FG002|Overall Study|Pregnancy|1|||
13108207|NCT03259308|25890777|FG000|Overall Study|Protocol Deviation|0|||
13108208|NCT03259308|25890778|FG001|Overall Study|Protocol Deviation|3|||
13108209|NCT03259308|25890779|FG002|Overall Study|Protocol Deviation|0|||
13108210|NCT03259308|25890777|FG000|Overall Study|Lack of Efficacy|0|||
13108211|NCT03259308|25890778|FG001|Overall Study|Lack of Efficacy|0|||
13108212|NCT03259308|25890779|FG002|Overall Study|Lack of Efficacy|1|||
13173809|NCT02296242|26128345|FG002|Overall Study|Need for Hydroxyurea|0|||
13173810|NCT02296242|26128346|FG003|Overall Study|Need for Hydroxyurea|0|||
13173811|NCT02296242|26128347|FG004|Overall Study|Need for Hydroxyurea|0|||
13173812|NCT02296242|26128343|FG000|Overall Study|Screened for Other Protocol|0|||
13173813|NCT02296242|26128344|FG001|Overall Study|Screened for Other Protocol|1|||
13173814|NCT02296242|26128345|FG002|Overall Study|Screened for Other Protocol|0|||
13173815|NCT02296242|26128346|FG003|Overall Study|Screened for Other Protocol|0|||
13173816|NCT02296242|26128347|FG004|Overall Study|Screened for Other Protocol|0|||
13173817|NCT02296242|26128343|FG000|Overall Study|Physician Decision|0|||
13173818|NCT02296242|26128344|FG001|Overall Study|Physician Decision|1|||
13173819|NCT02296242|26128345|FG002|Overall Study|Physician Decision|0|||
13173820|NCT02296242|26128346|FG003|Overall Study|Physician Decision|1|||
13173821|NCT02296242|26128347|FG004|Overall Study|Physician Decision|0|||
13173822|NCT02296242|26128343|FG000|Overall Study|Alternative Treatment|0|||
13173823|NCT02296242|26128344|FG001|Overall Study|Alternative Treatment|0|||
13173824|NCT02296242|26128345|FG002|Overall Study|Alternative Treatment|0|||
13173825|NCT02296242|26128346|FG003|Overall Study|Alternative Treatment|1|||
13173826|NCT02296242|26128347|FG004|Overall Study|Alternative Treatment|0|||
13173827|NCT02296242|26128343|FG000|Overall Study|Adverse Event|0|||
13173828|NCT02296242|26128344|FG001|Overall Study|Adverse Event|0|||
13173829|NCT02296242|26128345|FG002|Overall Study|Adverse Event|0|||
13173830|NCT02296242|26128346|FG003|Overall Study|Adverse Event|1|||
13173831|NCT02296242|26128347|FG004|Overall Study|Adverse Event|0|||
13173832|NCT02296242|26128343|FG000|Overall Study|Lack of Efficacy|0|||
13173833|NCT02296242|26128344|FG001|Overall Study|Lack of Efficacy|0|||
13173834|NCT02296242|26128345|FG002|Overall Study|Lack of Efficacy|0|||
13173835|NCT02296242|26128346|FG003|Overall Study|Lack of Efficacy|0|||
13173836|NCT02296242|26128347|FG004|Overall Study|Lack of Efficacy|3|||
13173837|NCT02296190|26128379|FG000|Overall Study|Lost to Follow-up|0|||
13173838|NCT02296190|26128380|FG001|Overall Study|Lost to Follow-up|0|||
13173839|NCT02296190|26128381|FG002|Overall Study|Lost to Follow-up|0|||
13173840|NCT02296190|26128382|FG003|Overall Study|Lost to Follow-up|0|||
13173841|NCT02296190|26128383|FG004|Overall Study|Lost to Follow-up|1|||
13173842|NCT02296190|26128384|FG005|Overall Study|Lost to Follow-up|0|||
13173843|NCT02296190|26128379|FG000|Overall Study|Failure to induce PSVT|6|||
13173844|NCT02296190|26128380|FG001|Overall Study|Failure to induce PSVT|10|||
13173845|NCT02296190|26128381|FG002|Overall Study|Failure to induce PSVT|5|||
13173846|NCT02296190|26128382|FG003|Overall Study|Failure to induce PSVT|13|||
13173847|NCT02296190|26128383|FG004|Overall Study|Failure to induce PSVT|8|||
13173848|NCT02296190|26128384|FG005|Overall Study|Failure to induce PSVT|0|||
13173849|NCT02296190|26128379|FG000|Overall Study|Physician Decision|1|||
13173850|NCT02296190|26128380|FG001|Overall Study|Physician Decision|1|||
13173851|NCT02296190|26128381|FG002|Overall Study|Physician Decision|0|||
13173852|NCT02296190|26128382|FG003|Overall Study|Physician Decision|1|||
13173853|NCT02296190|26128383|FG004|Overall Study|Physician Decision|2|||
13173854|NCT02296190|26128384|FG005|Overall Study|Physician Decision|0|||
13173855|NCT02296190|26128379|FG000|Overall Study|Withdrawal by Subject|0|||
13173856|NCT02296190|26128380|FG001|Overall Study|Withdrawal by Subject|1|||
13173857|NCT02296190|26128381|FG002|Overall Study|Withdrawal by Subject|0|||
13173858|NCT02296190|26128382|FG003|Overall Study|Withdrawal by Subject|0|||
13173859|NCT02296190|26128383|FG004|Overall Study|Withdrawal by Subject|0|||
13173860|NCT02296190|26128384|FG005|Overall Study|Withdrawal by Subject|0|||
13173861|NCT02296190|26128379|FG000|Overall Study|PSVT < 5 minutes|5|||
13173862|NCT02296190|26128380|FG001|Overall Study|PSVT < 5 minutes|6|||
13173863|NCT02296190|26128381|FG002|Overall Study|PSVT < 5 minutes|6|||
13173864|NCT02296190|26128382|FG003|Overall Study|PSVT < 5 minutes|6|||
13173865|NCT02296190|26128383|FG004|Overall Study|PSVT < 5 minutes|5|||
13173866|NCT02296190|26128384|FG005|Overall Study|PSVT < 5 minutes|0|||
13173867|NCT02296190|26128379|FG000|Overall Study|Patient was given Propofol|0|||
13173868|NCT02296190|26128380|FG001|Overall Study|Patient was given Propofol|1|||
13173869|NCT02296190|26128381|FG002|Overall Study|Patient was given Propofol|0|||
13173870|NCT02296190|26128382|FG003|Overall Study|Patient was given Propofol|1|||
13173871|NCT02296190|26128383|FG004|Overall Study|Patient was given Propofol|0|||
13173872|NCT02296190|26128384|FG005|Overall Study|Patient was given Propofol|0|||
13173873|NCT02296190|26128379|FG000|Overall Study|Patient with Atrial Tachycardia|0|||
13173874|NCT02296190|26128380|FG001|Overall Study|Patient with Atrial Tachycardia|0|||
13173875|NCT02296190|26128381|FG002|Overall Study|Patient with Atrial Tachycardia|0|||
13173876|NCT02296190|26128382|FG003|Overall Study|Patient with Atrial Tachycardia|1|||
13173877|NCT02296190|26128383|FG004|Overall Study|Patient with Atrial Tachycardia|0|||
13173878|NCT02296190|26128384|FG005|Overall Study|Patient with Atrial Tachycardia|0|||
13173879|NCT02296190|26128379|FG000|Overall Study|Blood pressure <100 after sedation|0|||
13173880|NCT02296190|26128380|FG001|Overall Study|Blood pressure <100 after sedation|0|||
13173881|NCT02296190|26128381|FG002|Overall Study|Blood pressure <100 after sedation|0|||
13173882|NCT02296190|26128382|FG003|Overall Study|Blood pressure <100 after sedation|1|||
13173883|NCT02296190|26128383|FG004|Overall Study|Blood pressure <100 after sedation|0|||
13173884|NCT02296190|26128384|FG005|Overall Study|Blood pressure <100 after sedation|0|||
13173885|NCT02296190|26128379|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0|||
13173886|NCT02296190|26128380|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1|||
13173887|NCT02296190|26128381|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1|||
13173888|NCT02296190|26128382|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0|||
13173889|NCT02296190|26128383|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0|||
13173890|NCT02296190|26128384|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0|||
13173891|NCT02296190|26128379|FG000|Overall Study|Patient on antiarrhythmic medication|1|||
13173892|NCT02296190|26128380|FG001|Overall Study|Patient on antiarrhythmic medication|0|||
13173893|NCT02296190|26128381|FG002|Overall Study|Patient on antiarrhythmic medication|0|||
13173894|NCT02296190|26128382|FG003|Overall Study|Patient on antiarrhythmic medication|0|||
13173895|NCT02296190|26128383|FG004|Overall Study|Patient on antiarrhythmic medication|0|||
13173896|NCT02296190|26128384|FG005|Overall Study|Patient on antiarrhythmic medication|0|||
13173897|NCT02296190|26128379|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
13173898|NCT02296190|26128380|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1|||
13173899|NCT02296190|26128381|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
13173900|NCT02296190|26128382|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
13173901|NCT02296190|26128383|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
13173902|NCT02296190|26128384|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
13173903|NCT02296190|26128379|FG000|Overall Study|Lab result not available in time|1|||
13173904|NCT02296190|26128380|FG001|Overall Study|Lab result not available in time|0|||
13173905|NCT02296190|26128381|FG002|Overall Study|Lab result not available in time|0|||
13173906|NCT02296190|26128382|FG003|Overall Study|Lab result not available in time|0|||
13173907|NCT02296190|26128383|FG004|Overall Study|Lab result not available in time|0|||
13173908|NCT02296190|26128384|FG005|Overall Study|Lab result not available in time|0|||
13173909|NCT02296138|26128405|FG000|Overall Study|Adverse Event|348|||
13173910|NCT02296138|26128406|FG001|Overall Study|Adverse Event|259|||
13173911|NCT02296138|26128405|FG000|Overall Study|Lack of Efficacy|59|||
13173912|NCT02296138|26128406|FG001|Overall Study|Lack of Efficacy|37|||
13173913|NCT02296138|26128405|FG000|Overall Study|Protocol Violation|35|||
13173914|NCT02296138|26128406|FG001|Overall Study|Protocol Violation|36|||
13173915|NCT02296138|26128405|FG000|Overall Study|Lost to Follow-up|9|||
13173916|NCT02296138|26128406|FG001|Overall Study|Lost to Follow-up|12|||
13173917|NCT02296138|26128405|FG000|Overall Study|Withdrawal by Subject|184|||
13173918|NCT02296138|26128406|FG001|Overall Study|Withdrawal by Subject|131|||
13173919|NCT02296138|26128405|FG000|Overall Study|Not Treated|1|||
13173920|NCT02296138|26128406|FG001|Overall Study|Not Treated|1|||
13173921|NCT02296138|26128405|FG000|Overall Study|Patients with data irregularities|10|||
13173922|NCT02296138|26128406|FG001|Overall Study|Patients with data irregularities|11|||
13173923|NCT02296138|26128405|FG000|Overall Study|Other than specified|15|||
13173924|NCT02296138|26128406|FG001|Overall Study|Other than specified|13|||
13173925|NCT02296112|26128421|FG000|Overall Study|Disease progression|7|||
13173926|NCT02296112|26128421|FG000|Overall Study|Toxicity|1|||
13173927|NCT02296112|26128421|FG000|Overall Study|Began an alternate therapy|1|||
13173928|NCT02295995|26128439|FG000|Overall Study|Lost to Follow-up|5|||
13173929|NCT02295995|26128440|FG001|Overall Study|Lost to Follow-up|1|||
13108213|NCT03259087|25890921|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0|||
13108214|NCT03259087|25890922|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0|||
13108215|NCT03259087|25890923|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0|||
13108216|NCT03259087|25890924|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0|||
13108217|NCT03259087|25890925|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1|||
13108218|NCT03259087|25890921|FG000|Period 2 of Part 2|Adverse Event|0|||
13108219|NCT03259087|25890922|FG001|Period 2 of Part 2|Adverse Event|0|||
13108220|NCT03259087|25890923|FG002|Period 2 of Part 2|Adverse Event|0|||
13108221|NCT03259087|25890924|FG003|Period 2 of Part 2|Adverse Event|0|||
13108222|NCT03259087|25890925|FG004|Period 2 of Part 2|Adverse Event|1|||
13108223|NCT03258814|25890986|FG000|Overall Study|Early Termination|4|||
13108224|NCT03258814|25890987|FG001|Overall Study|Early Termination|3|||
13108225|NCT03258814|25890988|FG002|Overall Study|Early Termination|10|||
13108226|NCT03258762|25891055|FG000|Overall Study|Lost to Follow-up|0|||
13108227|NCT03258762|25891056|FG001|Overall Study|Lost to Follow-up|1|||
13108228|NCT03258710|25891097|FG000|Overall Study|Adverse Event|1|||
13108229|NCT03258710|25891097|FG000|Overall Study|Protocol-defined stopping criteria|1|||
13108230|NCT03258710|25891097|FG000|Overall Study|Physician Decision|1|||
13108231|NCT03257995|25891152|FG000|Overall Study|Adverse Event|0|||
13108232|NCT03257995|25891153|FG001|Overall Study|Adverse Event|1|||
13108233|NCT03257995|25891154|FG002|Overall Study|Adverse Event|0|||
13108234|NCT03257995|25891155|FG003|Overall Study|Adverse Event|0|||
13108235|NCT03257995|25891156|FG004|Overall Study|Adverse Event|0|||
13108236|NCT03257995|25891157|FG005|Overall Study|Adverse Event|0|||
13108237|NCT03257995|25891152|FG000|Overall Study|Protocol deviation|0|||
13108238|NCT03257995|25891153|FG001|Overall Study|Protocol deviation|0|||
13108239|NCT03257995|25891154|FG002|Overall Study|Protocol deviation|0|||
13108240|NCT03257995|25891155|FG003|Overall Study|Protocol deviation|0|||
13108241|NCT03257995|25891156|FG004|Overall Study|Protocol deviation|0|||
13108242|NCT03257995|25891157|FG005|Overall Study|Protocol deviation|2|||
13108243|NCT03257865|25891172|FG000|Overall Study|Adverse Event|4|||
13108244|NCT03257865|25891173|FG001|Overall Study|Adverse Event|8|||
13108245|NCT03257865|25891172|FG000|Overall Study|Lack of Efficacy|1|||
13108246|NCT03257865|25891173|FG001|Overall Study|Lack of Efficacy|2|||
13108247|NCT03257865|25891172|FG000|Overall Study|Non-compliance with Study Drug|0|||
13108248|NCT03257865|25891173|FG001|Overall Study|Non-compliance with Study Drug|2|||
13173930|NCT02295774|26128447|FG000|Overall Study|Physician Decision|1|||
13173931|NCT02295774|26128447|FG000|Overall Study|Withdrawal by Subject|2|||
13173932|NCT02295644|26128478|FG000|Overall Study|Did not meet inclusion criterion|0|||
13173933|NCT02295644|26128479|FG001|Overall Study|Did not meet inclusion criterion|0|||
13173934|NCT02295644|26128480|FG002|Overall Study|Did not meet inclusion criterion|1|||
13173935|NCT02295644|26128481|FG003|Overall Study|Did not meet inclusion criterion|2|||
13222921|NCT01802216|26287226|FG001|12 Month Visit|Participant did not show to visit|4|||
13222922|NCT01802073|26287249|FG000|Overall Study|Lost to Follow-up|0|||
13222923|NCT01802073|26287250|FG001|Overall Study|Lost to Follow-up|1|||
13222924|NCT01802073|26287249|FG000|Overall Study|Non-compliant|4|||
13222925|NCT01802073|26287250|FG001|Overall Study|Non-compliant|2|||
13222926|NCT01802073|26287249|FG000|Overall Study|Withdrawal by Subject|1|||
13108249|NCT03257865|25891172|FG000|Overall Study|Withdrawal by Subject|23|||
13222927|NCT01802073|26287250|FG001|Overall Study|Withdrawal by Subject|1|||
13222928|NCT01802073|26287249|FG000|Overall Study|Physician Decision|0|||
13222929|NCT01802073|26287250|FG001|Overall Study|Physician Decision|7|||
13222930|NCT01801982|26287262|FG000|Overall Study|Lost to Follow-up|1|||
13222931|NCT01801930|26287293|FG000|Overall Study|Clear progression of the primary disease is observed|6|||
13222932|NCT01801930|26287294|FG001|Overall Study|Clear progression of the primary disease is observed|5|||
13222933|NCT01801930|26287295|FG002|Overall Study|Clear progression of the primary disease is observed|6|||
13222934|NCT01801930|26287296|FG003|Overall Study|Clear progression of the primary disease is observed|6|||
13222935|NCT01801930|26287293|FG000|Overall Study|DLT occurs|0|||
13222936|NCT01801930|26287294|FG001|Overall Study|DLT occurs|1|||
13222937|NCT01801930|26287295|FG002|Overall Study|DLT occurs|0|||
13222938|NCT01801930|26287296|FG003|Overall Study|DLT occurs|0|||
13222939|NCT01801917|26287329|FG000|Period 1 - Randomized|Adverse Event|1|||
13222940|NCT01801917|26287330|FG001|Period 1 - Randomized|Adverse Event|0|||
13222941|NCT01801917|26287331|FG002|Period 1 - Randomized|Adverse Event|1|||
13222942|NCT01801917|26287332|FG003|Period 1 - Randomized|Adverse Event|0|||
13222943|NCT01801865|26287339|FG000|Overall Study|Patients scanned on another MRI scanner|35|||
13222944|NCT01801865|26287339|FG000|Overall Study|Physician Decision|7|||
13222945|NCT01801735|26287345|FG000|Overall Study|Adverse Event|79|||
13222946|NCT01801735|26287345|FG000|Overall Study|Lack of Efficacy|28|||
13222947|NCT01801735|26287345|FG000|Overall Study|Withdrawal by Subject|27|||
13222948|NCT01801735|26287345|FG000|Overall Study|Protocol Violation|25|||
13222949|NCT01801735|26287345|FG000|Overall Study|Lost to Follow-up|15|||
13222950|NCT01801735|26287345|FG000|Overall Study|Non-compliance with Trial Drug|13|||
13222951|NCT01801735|26287345|FG000|Overall Study|Physician Decision|3|||
13222952|NCT01801735|26287345|FG000|Overall Study|Death|1|||
13108250|NCT03257865|25891173|FG001|Overall Study|Withdrawal by Subject|17|||
13108251|NCT03257865|25891172|FG000|Overall Study|Physician Decision|3|||
13108252|NCT03257865|25891173|FG001|Overall Study|Physician Decision|1|||
13222953|NCT01801735|26287345|FG000|Overall Study|Other, including site closure|19|||
13222954|NCT01801475|26287368|FG000|Overall Study|Withdrawal by Subject|0|||
13222955|NCT01801475|26287369|FG001|Overall Study|Withdrawal by Subject|0|||
13222956|NCT01801475|26287370|FG002|Overall Study|Withdrawal by Subject|0|||
13222957|NCT01801475|26287371|FG003|Overall Study|Withdrawal by Subject|0|||
13222958|NCT01801475|26287372|FG004|Overall Study|Withdrawal by Subject|1|||
13222959|NCT01801436|26287406|FG000|Overall Study|Withdrawal by Subject|3|||
13222960|NCT01801436|26287406|FG000|Overall Study|Adverse Event|2|||
13222961|NCT01801436|26287406|FG000|Overall Study|Progressive disease|4|||
13222962|NCT01801358|26287543|FG000|Overall Study|Adverse Event|0|||
13222963|NCT01801358|26287544|FG001|Overall Study|Adverse Event|2|||
13222964|NCT01801358|26287545|FG002|Overall Study|Adverse Event|1|||
13222965|NCT01801358|26287546|FG003|Overall Study|Adverse Event|0|||
13222966|NCT01801358|26287547|FG004|Overall Study|Adverse Event|0|||
13222967|NCT01801358|26287548|FG005|Overall Study|Adverse Event|1|||
13222968|NCT01801358|26287543|FG000|Overall Study|Physician Decision|0|||
13222969|NCT01801358|26287544|FG001|Overall Study|Physician Decision|0|||
13222970|NCT01801358|26287545|FG002|Overall Study|Physician Decision|1|||
13108253|NCT03257865|25891172|FG000|Overall Study|Other|0|||
13108254|NCT03257865|25891173|FG001|Overall Study|Other|1|||
13108255|NCT03257865|25891172|FG000|Overall Study|Lost to Follow-up|4|||
13108256|NCT03257865|25891173|FG001|Overall Study|Lost to Follow-up|4|||
13108257|NCT03257813|25891200|FG000|Overall Study|Protocol Violation|6|||
13108258|NCT03257813|25891201|FG001|Overall Study|Protocol Violation|3|||
13108259|NCT03257657|25891235|FG000|Overall Study|Lost to Follow-up|0|||
13108260|NCT03257657|25891236|FG001|Overall Study|Lost to Follow-up|3|||
13108261|NCT03257657|25891235|FG000|Overall Study|Withdrawn|0|||
13173936|NCT02295280|26128494|FG000|Overall Study|Adverse Event|0|||
13173937|NCT02295280|26128495|FG001|Overall Study|Adverse Event|1|||
13173938|NCT02295020|26128532|FG000|Overall Study|Adverse Event|0|||
13173939|NCT02295020|26128533|FG001|Overall Study|Adverse Event|1|||
13173940|NCT02295020|26128532|FG000|Overall Study|Withdrawal by Subject|3|||
13222971|NCT01801358|26287546|FG003|Overall Study|Physician Decision|0|||
13222972|NCT01801358|26287547|FG004|Overall Study|Physician Decision|0|||
13222973|NCT01801358|26287548|FG005|Overall Study|Physician Decision|0|||
13222974|NCT01801358|26287543|FG000|Overall Study|Progressive Disease|6|||
13108262|NCT03257657|25891236|FG001|Overall Study|Withdrawn|1|||
13108263|NCT03257657|25891235|FG000|Overall Study|Noted not eligible right after enrolled|0|||
13108264|NCT03257657|25891236|FG001|Overall Study|Noted not eligible right after enrolled|1|||
13108265|NCT03257631|25891283|FG000|Overall Study|Death|8|||
13108266|NCT03257631|25891284|FG001|Overall Study|Death|5|||
13108267|NCT03257631|25891285|FG002|Overall Study|Death|13|||
13108268|NCT03257631|25891286|FG003|Overall Study|Death|5|||
13108269|NCT03257631|25891283|FG000|Overall Study|Progressive Disease|0|||
13108270|NCT03257631|25891284|FG001|Overall Study|Progressive Disease|0|||
13108271|NCT03257631|25891285|FG002|Overall Study|Progressive Disease|1|||
13108272|NCT03257631|25891286|FG003|Overall Study|Progressive Disease|0|||
13108273|NCT03257631|25891283|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
13108274|NCT03257631|25891284|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
13108275|NCT03257631|25891285|FG002|Overall Study|Withdrawal by Parent/Guardian|4|||
13108276|NCT03257631|25891286|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
13108277|NCT03257631|25891283|FG000|Overall Study|Lost to Follow-up|0|||
13108278|NCT03257631|25891284|FG001|Overall Study|Lost to Follow-up|0|||
13108279|NCT03257631|25891285|FG002|Overall Study|Lost to Follow-up|1|||
13108280|NCT03257631|25891286|FG003|Overall Study|Lost to Follow-up|0|||
13108281|NCT03257631|25891283|FG000|Overall Study|Still on Study|3|||
13108282|NCT03257631|25891284|FG001|Overall Study|Still on Study|2|||
13108283|NCT03257631|25891285|FG002|Overall Study|Still on Study|4|||
13108284|NCT03257631|25891286|FG003|Overall Study|Still on Study|4|||
13108285|NCT03257410|25891433|FG000|Overall Study|Adverse Event|2|||
13108286|NCT03257410|25891434|FG001|Overall Study|Adverse Event|3|||
13108287|NCT03257410|25891433|FG000|Overall Study|Protocol Violation|1|||
13173941|NCT02295020|26128533|FG001|Overall Study|Withdrawal by Subject|2|||
13108288|NCT03257410|25891434|FG001|Overall Study|Protocol Violation|2|||
13108289|NCT03257410|25891433|FG000|Overall Study|Lost to Follow-up|1|||
13173942|NCT02294981|26128539|FG000|Overall Study|Lost to Follow-up|1|||
13173943|NCT02294786|26128591|FG000|Overall Study|Withdrawal by Subject|0|||
13173944|NCT02294786|26128592|FG001|Overall Study|Withdrawal by Subject|1|||
13173945|NCT02294786|26128591|FG000|Overall Study|Physician Decision|6|||
13173946|NCT02294786|26128592|FG001|Overall Study|Physician Decision|7|||
13173947|NCT02294786|26128591|FG000|Overall Study|Lost to Follow-up|1|||
13173948|NCT02294786|26128592|FG001|Overall Study|Lost to Follow-up|2|||
13173949|NCT02294786|26128591|FG000|Overall Study|Protocol Violation|1|||
13173950|NCT02294786|26128592|FG001|Overall Study|Protocol Violation|0|||
13173951|NCT02294786|26128591|FG000|Overall Study|Adverse Event|1|||
13173952|NCT02294786|26128592|FG001|Overall Study|Adverse Event|1|||
13173953|NCT02294786|26128591|FG000|Overall Study|Death|2|||
13173954|NCT02294786|26128592|FG001|Overall Study|Death|3|||
13173955|NCT02294773|26128613|FG000|Overall Study|Withdrawal by Subject|0|||
13173956|NCT02294773|26128614|FG001|Overall Study|Withdrawal by Subject|2|||
13173957|NCT02294734|26128671|FG000|Overall Study|Adverse Event|5|||
13173958|NCT02294734|26128672|FG001|Overall Study|Adverse Event|5|||
13173959|NCT02294734|26128671|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1|||
13173960|NCT02294734|26128672|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0|||
13173961|NCT02294734|26128671|FG000|Overall Study|Lost to Follow-up|2|||
13173962|NCT02294734|26128672|FG001|Overall Study|Lost to Follow-up|0|||
13173963|NCT02294734|26128671|FG000|Overall Study|Physician Decision|2|||
13173964|NCT02294734|26128672|FG001|Overall Study|Physician Decision|1|||
13173965|NCT02294734|26128671|FG000|Overall Study|Withdrawal by Subject|4|||
13173966|NCT02294734|26128672|FG001|Overall Study|Withdrawal by Subject|2|||
13173967|NCT02294682|26128719|FG000|Overall Study|Could not swallow pills|1|||
13173968|NCT02294682|26128720|FG001|Overall Study|Could not swallow pills|0|||
13173969|NCT02294604|26128747|FG000|Overall Study|Did not provide samples for culture|0|||
13173970|NCT02294604|26128748|FG001|Overall Study|Did not provide samples for culture|1|||
13108290|NCT03257410|25891434|FG001|Overall Study|Lost to Follow-up|0|||
13108291|NCT03257410|25891433|FG000|Overall Study|Withdrawal by Subject|1|||
13108292|NCT03257410|25891434|FG001|Overall Study|Withdrawal by Subject|2|||
13108293|NCT03257410|25891433|FG000|Overall Study|Physician Decision|1|||
13108294|NCT03257410|25891434|FG001|Overall Study|Physician Decision|1|||
13108295|NCT03257410|25891433|FG000|Overall Study|Renal transplantation|2|||
13108296|NCT03257410|25891434|FG001|Overall Study|Renal transplantation|0|||
13108297|NCT03257410|25891433|FG000|Overall Study|Switch to peritoneal dialysis|1|||
13108298|NCT03257410|25891434|FG001|Overall Study|Switch to peritoneal dialysis|0|||
13108299|NCT03257410|25891433|FG000|Overall Study|Death|3|||
13108300|NCT03257410|25891434|FG001|Overall Study|Death|2|||
13108301|NCT03257410|25891433|FG000|Overall Study|Change to another dialysis center|2|||
13108302|NCT03257410|25891434|FG001|Overall Study|Change to another dialysis center|2|||
13108303|NCT03257410|25891433|FG000|Overall Study|Missing 3 consecutive study treatments|5|||
13173971|NCT02294604|26128749|FG002|Overall Study|Did not provide samples for culture|0|||
13173972|NCT02294604|26128747|FG000|Overall Study|Culture contamination|1|||
13173973|NCT02294604|26128748|FG001|Overall Study|Culture contamination|2|||
13173974|NCT02294604|26128749|FG002|Overall Study|Culture contamination|0|||
13173975|NCT02294474|26128778|FG000|Overall Study|Adverse Event|7|||
13173976|NCT02294474|26128779|FG001|Overall Study|Adverse Event|7|||
13173977|NCT02294474|26128778|FG000|Overall Study|Lack of Efficacy|2|||
13173978|NCT02294474|26128779|FG001|Overall Study|Lack of Efficacy|1|||
13173979|NCT02294474|26128778|FG000|Overall Study|Protocol Violation|4|||
13173980|NCT02294474|26128779|FG001|Overall Study|Protocol Violation|2|||
13173981|NCT02294474|26128778|FG000|Overall Study|Other than specified above|12|||
13173982|NCT02294474|26128779|FG001|Overall Study|Other than specified above|12|||
13173983|NCT02294396|26128862|FG000|Overall Study|Adverse Event|26|||
13173984|NCT02294396|26128863|FG001|Overall Study|Adverse Event|25|||
13173985|NCT02294396|26128864|FG002|Overall Study|Adverse Event|21|||
13173986|NCT02294396|26128865|FG003|Overall Study|Adverse Event|24|||
13173987|NCT02294396|26128862|FG000|Overall Study|Electrocardiogram adviser's judgment|1|||
13173988|NCT02294396|26128863|FG001|Overall Study|Electrocardiogram adviser's judgment|0|||
13173989|NCT02294396|26128864|FG002|Overall Study|Electrocardiogram adviser's judgment|0|||
13173990|NCT02294396|26128865|FG003|Overall Study|Electrocardiogram adviser's judgment|1|||
13173991|NCT02294396|26128862|FG000|Overall Study|Withdrawal by Subject|8|||
13173992|NCT02294396|26128863|FG001|Overall Study|Withdrawal by Subject|6|||
13173993|NCT02294396|26128864|FG002|Overall Study|Withdrawal by Subject|6|||
13173994|NCT02294396|26128865|FG003|Overall Study|Withdrawal by Subject|8|||
13173995|NCT02294396|26128862|FG000|Overall Study|Lost to Follow-up|0|||
13173996|NCT02294396|26128863|FG001|Overall Study|Lost to Follow-up|0|||
13173997|NCT02294396|26128864|FG002|Overall Study|Lost to Follow-up|1|||
13173998|NCT02294396|26128865|FG003|Overall Study|Lost to Follow-up|1|||
13173999|NCT02294396|26128862|FG000|Overall Study|Protocol Deviation|3|||
13174000|NCT02294396|26128863|FG001|Overall Study|Protocol Deviation|2|||
13174001|NCT02294396|26128864|FG002|Overall Study|Protocol Deviation|2|||
13174002|NCT02294396|26128865|FG003|Overall Study|Protocol Deviation|1|||
13174003|NCT02294396|26128862|FG000|Overall Study|Miscellaneous|2|||
13174004|NCT02294396|26128863|FG001|Overall Study|Miscellaneous|0|||
13174005|NCT02294396|26128864|FG002|Overall Study|Miscellaneous|5|||
13174006|NCT02294396|26128865|FG003|Overall Study|Miscellaneous|2|||
13174007|NCT02294318|26128884|FG000|Overall Study|Worsening of drinking|3|||
13174008|NCT02294318|26128885|FG001|Overall Study|Worsening of drinking|0|||
13174009|NCT02294318|26128884|FG000|Overall Study|Not exposed to intervention|0|||
13174010|NCT02294318|26128885|FG001|Overall Study|Not exposed to intervention|2|||
13174011|NCT02294227|26128919|FG000|Overall Study|Death|0|||
13174012|NCT02294227|26128920|FG001|Overall Study|Death|0|||
13174013|NCT02294227|26128921|FG002|Overall Study|Death|1|||
13174014|NCT02294227|26128919|FG000|Overall Study|Subject/Guardian Decision|6|||
13174015|NCT02294227|26128920|FG001|Overall Study|Subject/Guardian Decision|3|||
13174016|NCT02294227|26128921|FG002|Overall Study|Subject/Guardian Decision|7|||
13174017|NCT02294227|26128919|FG000|Overall Study|Physician Decision|1|||
13174018|NCT02294227|26128920|FG001|Overall Study|Physician Decision|2|||
13174019|NCT02294227|26128921|FG002|Overall Study|Physician Decision|1|||
13174020|NCT02294227|26128919|FG000|Overall Study|Lost to Follow-up|1|||
13174021|NCT02294227|26128920|FG001|Overall Study|Lost to Follow-up|0|||
13174022|NCT02294227|26128921|FG002|Overall Study|Lost to Follow-up|0|||
13174023|NCT02294227|26128919|FG000|Overall Study|Lack of Efficacy|11|||
13174024|NCT02294227|26128920|FG001|Overall Study|Lack of Efficacy|12|||
13174025|NCT02294227|26128921|FG002|Overall Study|Lack of Efficacy|8|||
13174026|NCT02294227|26128919|FG000|Overall Study|Adverse Event|6|||
13174027|NCT02294227|26128920|FG001|Overall Study|Adverse Event|8|||
13174028|NCT02294227|26128921|FG002|Overall Study|Adverse Event|2|||
13174029|NCT02294175|26128952|FG000|Overall Study|Withdrawal by Subject|1|||
13174030|NCT02294175|26128953|FG001|Overall Study|Withdrawal by Subject|2|||
13174031|NCT02294175|26128952|FG000|Overall Study|pt taking excluded medication|3|||
13174032|NCT02294175|26128953|FG001|Overall Study|pt taking excluded medication|1|||
13174033|NCT02294175|26128952|FG000|Overall Study|Protocol Violation|1|||
13174034|NCT02294175|26128953|FG001|Overall Study|Protocol Violation|0|||
13174035|NCT02294175|26128952|FG000|Overall Study|Lost to Follow-up|0|||
13174036|NCT02294175|26128953|FG001|Overall Study|Lost to Follow-up|1|||
13174037|NCT02294175|26128952|FG000|Overall Study|wound healed|0|||
13174038|NCT02294175|26128953|FG001|Overall Study|wound healed|2|||
13174039|NCT02294058|26129001|FG000|Overall Study|Adverse Event|16|||
13174040|NCT02294058|26129002|FG001|Overall Study|Adverse Event|7|||
13174041|NCT02294058|26129003|FG002|Overall Study|Adverse Event|13|||
13174042|NCT02294058|26129001|FG000|Overall Study|Lack of Efficacy|3|||
13174043|NCT02294058|26129002|FG001|Overall Study|Lack of Efficacy|3|||
13174044|NCT02294058|26129003|FG002|Overall Study|Lack of Efficacy|0|||
13174045|NCT02294058|26129001|FG000|Overall Study|Lost to Follow-up|1|||
13174046|NCT02294058|26129002|FG001|Overall Study|Lost to Follow-up|0|||
13174047|NCT02294058|26129003|FG002|Overall Study|Lost to Follow-up|2|||
13174048|NCT02294058|26129001|FG000|Overall Study|Withdrawal by Subject|10|||
13174049|NCT02294058|26129002|FG001|Overall Study|Withdrawal by Subject|14|||
13174050|NCT02294058|26129003|FG002|Overall Study|Withdrawal by Subject|13|||
13174051|NCT02294058|26129001|FG000|Overall Study|Physician Decision|2|||
13174052|NCT02294058|26129002|FG001|Overall Study|Physician Decision|1|||
13174053|NCT02294058|26129003|FG002|Overall Study|Physician Decision|0|||
13174054|NCT02294058|26129001|FG000|Overall Study|Miscellaneous|4|||
13174055|NCT02294058|26129002|FG001|Overall Study|Miscellaneous|1|||
13174056|NCT02294058|26129003|FG002|Overall Study|Miscellaneous|1|||
13174057|NCT02294019|26129010|FG000|Overall Study|Adverse Event|2|||
13174058|NCT02294019|26129010|FG000|Overall Study|Protocol Violation|68|||
13174059|NCT02294019|26129010|FG000|Overall Study|Lost to Follow-up|31|||
13174060|NCT02294019|26129010|FG000|Overall Study|Other|1|||
13174061|NCT02294019|26129010|FG000|Overall Study|Withdrawal by Subject|1|||
13174062|NCT02293993|26129065|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
13174063|NCT02293993|26129066|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
13174064|NCT02293993|26129067|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
13174065|NCT02293993|26129068|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
13174066|NCT02293993|26129065|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
13174067|NCT02293993|26129066|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2|||
13174068|NCT02293993|26129067|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1|||
13174069|NCT02293993|26129068|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
13174070|NCT02293993|26129065|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
13174071|NCT02293993|26129066|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
13174072|NCT02293993|26129067|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1|||
13174073|NCT02293993|26129068|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
13174074|NCT02293993|26129065|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
13108304|NCT03257410|25891434|FG001|Overall Study|Missing 3 consecutive study treatments|6|||
13174075|NCT02293993|26129066|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
13174076|NCT02293993|26129067|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3|||
13174077|NCT02293993|26129068|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1|||
13174078|NCT02293993|26129065|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
13174079|NCT02293993|26129066|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1|||
13174080|NCT02293993|26129067|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
13174081|NCT02293993|26129068|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
13174082|NCT02293902|26129139|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5|||
13174083|NCT02293902|26129140|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6|||
13174084|NCT02293902|26129141|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8|||
13174085|NCT02293902|26129142|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
13174086|NCT02293902|26129143|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
13174087|NCT02293902|26129139|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5|||
13174088|NCT02293902|26129140|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1|||
13174089|NCT02293902|26129141|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2|||
13174090|NCT02293902|26129142|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
13174091|NCT02293902|26129143|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
13174092|NCT02293902|26129139|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1|||
13174093|NCT02293902|26129140|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
13174094|NCT02293902|26129141|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
13174095|NCT02293902|26129142|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
13174096|NCT02293902|26129143|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
13174097|NCT02293902|26129139|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0|||
13174098|NCT02293902|26129140|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7|||
13174099|NCT02293902|26129141|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
13174100|NCT02293902|26129142|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
13174101|NCT02293902|26129143|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6|||
13174102|NCT02293902|26129139|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
13174103|NCT02293902|26129140|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
13108305|NCT03257410|25891433|FG000|Overall Study|Miscellaneous|2|||
13108306|NCT03257410|25891434|FG001|Overall Study|Miscellaneous|2|||
13108307|NCT03257410|25891433|FG000|Overall Study|Other|0|||
13108308|NCT03257410|25891434|FG001|Overall Study|Other|1|||
13108309|NCT03257371|25891443|FG000|Overall Study|Lost to Follow-up|1|||
13108310|NCT03257358|25891550|FG000|Overall Study|Adverse Event|25|||
13108311|NCT03257358|25891551|FG001|Overall Study|Adverse Event|12|||
13108312|NCT03257358|25891550|FG000|Overall Study|Lack of Efficacy|1|||
13108313|NCT03257358|25891551|FG001|Overall Study|Lack of Efficacy|1|||
13108314|NCT03257358|25891550|FG000|Overall Study|Lost to Follow-up|12|||
13108315|NCT03257358|25891551|FG001|Overall Study|Lost to Follow-up|4|||
13108316|NCT03257358|25891550|FG000|Overall Study|Non-compliance with fingolimod treatment|4|||
13108317|NCT03257358|25891551|FG001|Overall Study|Non-compliance with fingolimod treatment|2|||
13108318|NCT03257358|25891550|FG000|Overall Study|Physician Decision|2|||
13108319|NCT03257358|25891551|FG001|Overall Study|Physician Decision|2|||
13174104|NCT02293902|26129141|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
13174105|NCT02293902|26129142|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
13174106|NCT02293902|26129143|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
13174107|NCT02293863|26129216|FG000|Overall Study|Death|4|||
13174108|NCT02293863|26129217|FG001|Overall Study|Death|6|||
13174109|NCT02293863|26129218|FG002|Overall Study|Death|4|||
13174110|NCT02293863|26129216|FG000|Overall Study|Lost to Follow-up|2|||
13174111|NCT02293863|26129217|FG001|Overall Study|Lost to Follow-up|2|||
13174112|NCT02293863|26129218|FG002|Overall Study|Lost to Follow-up|2|||
13174113|NCT02293863|26129216|FG000|Overall Study|Withdrawal by Subject|3|||
13174114|NCT02293863|26129217|FG001|Overall Study|Withdrawal by Subject|3|||
13174115|NCT02293863|26129218|FG002|Overall Study|Withdrawal by Subject|1|||
13174116|NCT02293863|26129216|FG000|Overall Study|Reason Not Specified|0|||
13174117|NCT02293863|26129217|FG001|Overall Study|Reason Not Specified|2|||
13174118|NCT02293863|26129218|FG002|Overall Study|Reason Not Specified|2|||
13174119|NCT02293837|26129301|FG000|Overall Study|Lost to Follow-up|0|||
13174120|NCT02293837|26129302|FG001|Overall Study|Lost to Follow-up|2|||
13174121|NCT02293837|26129303|FG002|Overall Study|Lost to Follow-up|1|||
13174122|NCT02293837|26129304|FG003|Overall Study|Lost to Follow-up|0|||
13174123|NCT02293837|26129301|FG000|Overall Study|Withdrawal by Subject|2|||
13174124|NCT02293837|26129302|FG001|Overall Study|Withdrawal by Subject|1|||
13174125|NCT02293837|26129303|FG002|Overall Study|Withdrawal by Subject|2|||
13174126|NCT02293837|26129304|FG003|Overall Study|Withdrawal by Subject|1|||
13174127|NCT02293837|26129301|FG000|Overall Study|COVID-19 Related|1|||
13174128|NCT02293837|26129302|FG001|Overall Study|COVID-19 Related|1|||
13174129|NCT02293837|26129303|FG002|Overall Study|COVID-19 Related|0|||
13174130|NCT02293837|26129304|FG003|Overall Study|COVID-19 Related|0|||
13174131|NCT02293837|26129301|FG000|Overall Study|Participant ill and could not be infused|0|||
13174132|NCT02293837|26129302|FG001|Overall Study|Participant ill and could not be infused|0|||
13174133|NCT02293837|26129303|FG002|Overall Study|Participant ill and could not be infused|1|||
13174134|NCT02293837|26129304|FG003|Overall Study|Participant ill and could not be infused|0|||
13174135|NCT02293538|26129324|FG000|Overall Study|Adverse Event|0|||
13174136|NCT02293538|26129325|FG001|Overall Study|Adverse Event|1|||
13174137|NCT02293538|26129324|FG000|Overall Study|Lost to Follow-up|1|||
13174138|NCT02293538|26129325|FG001|Overall Study|Lost to Follow-up|0|||
13174139|NCT02293538|26129324|FG000|Overall Study|Withdrawal by Subject|0|||
13174140|NCT02293538|26129325|FG001|Overall Study|Withdrawal by Subject|1|||
13174141|NCT02293499|26129367|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
13174142|NCT02293499|26129368|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
13174143|NCT02293499|26129369|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10|||
13174144|NCT02293499|26129367|FG000|Intervention - Camp|Withdrawal by Subject|3|||
13174145|NCT02293499|26129368|FG001|Intervention - Camp|Withdrawal by Subject|6|||
13174146|NCT02293499|26129369|FG002|Intervention - Camp|Withdrawal by Subject|2|||
13174147|NCT02293499|26129367|FG000|Intervention - Camp|these are those not showing up at camp|24|||
13174148|NCT02293499|26129368|FG001|Intervention - Camp|these are those not showing up at camp|28|||
13174149|NCT02293499|26129369|FG002|Intervention - Camp|these are those not showing up at camp|4|||
13174150|NCT02293499|26129367|FG000|3 Month Follow Up|Withdrawal by Subject|1|||
13174151|NCT02293499|26129368|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
13174152|NCT02293499|26129369|FG002|3 Month Follow Up|Withdrawal by Subject|4|||
13174153|NCT02293499|26129367|FG000|3 Month Follow Up|Lost to Follow-up|14|||
13174154|NCT02293499|26129368|FG001|3 Month Follow Up|Lost to Follow-up|15|||
13174155|NCT02293499|26129369|FG002|3 Month Follow Up|Lost to Follow-up|6|||
13174156|NCT02293499|26129367|FG000|6 Month Follow Up|Lost to Follow-up|17|||
13174157|NCT02293499|26129368|FG001|6 Month Follow Up|Lost to Follow-up|27|||
13174158|NCT02293499|26129369|FG002|6 Month Follow Up|Lost to Follow-up|6|||
13174159|NCT02293499|26129367|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
13174160|NCT02293499|26129368|FG001|6 Month Follow Up|Withdrawal by Subject|0|||
13174161|NCT02293499|26129369|FG002|6 Month Follow Up|Withdrawal by Subject|1|||
13174162|NCT02293499|26129367|FG000|9 Month Follow Up|Withdrawal by Subject|2|||
13174163|NCT02293499|26129368|FG001|9 Month Follow Up|Withdrawal by Subject|0|||
13174164|NCT02293499|26129369|FG002|9 Month Follow Up|Withdrawal by Subject|0|||
13174165|NCT02293499|26129367|FG000|9 Month Follow Up|Lost to Follow-up|24|||
13174166|NCT02293499|26129368|FG001|9 Month Follow Up|Lost to Follow-up|28|||
13174167|NCT02293499|26129369|FG002|9 Month Follow Up|Lost to Follow-up|4|||
13174168|NCT02293499|26129367|FG000|12 Month Follow Up|Lost to Follow-up|26|||
13174169|NCT02293499|26129368|FG001|12 Month Follow Up|Lost to Follow-up|25|||
13174170|NCT02293499|26129369|FG002|12 Month Follow Up|Lost to Follow-up|6|||
13174171|NCT02293499|26129367|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
13174172|NCT02293499|26129368|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
13174173|NCT02293499|26129369|FG002|12 Month Follow Up|Withdrawal by Subject|0|||
13174174|NCT02293499|26129367|FG000|15 Month Follow Up|Lost to Follow-up|22|||
13174175|NCT02293499|26129368|FG001|15 Month Follow Up|Lost to Follow-up|22|||
13174176|NCT02293499|26129369|FG002|15 Month Follow Up|Lost to Follow-up|7|||
13174177|NCT02293460|26129375|FG000|Overall Study|Protocol Violation|1|||
13174178|NCT02293460|26129375|FG000|Overall Study|Lack of Efficacy|2|||
13174179|NCT02293460|26129375|FG000|Overall Study|Adverse Event|2|||
13174180|NCT02293460|26129375|FG000|Overall Study|Withdrawal by Subject|1|||
13174181|NCT02293395|26129388|FG000|Overall Study|Lost to Follow-up|1|||
13174182|NCT02293395|26129389|FG001|Overall Study|Lost to Follow-up|0|||
13174183|NCT02293395|26129388|FG000|Overall Study|Withdrawal by Subject|8|||
13174184|NCT02293395|26129389|FG001|Overall Study|Withdrawal by Subject|7|||
13174185|NCT02293005|26129398|FG000|Overall Study|Adverse Event|2|||
13174186|NCT02293005|26129398|FG000|Overall Study|Death|4|||
13174187|NCT02293005|26129398|FG000|Overall Study|Lost to Follow-up|1|||
13174188|NCT02293005|26129398|FG000|Overall Study|Withdrawal by Subject|2|||
13174189|NCT02293005|26129398|FG000|Overall Study|Progression|17|||
13174190|NCT02292927|26129419|FG000|Overall Study|Protocol Violation|13|||
13174191|NCT02292927|26129420|FG001|Overall Study|Protocol Violation|7|||
13174192|NCT02292849|26129438|FG000|Overall Study|Lost to Follow-up|0|||
13174193|NCT02292849|26129439|FG001|Overall Study|Lost to Follow-up|2|||
13174194|NCT02292849|26129440|FG002|Overall Study|Lost to Follow-up|2|||
13174195|NCT02292849|26129438|FG000|Overall Study|Physician Decision|4|||
13174196|NCT02292849|26129439|FG001|Overall Study|Physician Decision|0|||
13174197|NCT02292849|26129440|FG002|Overall Study|Physician Decision|0|||
13174198|NCT02292784|26129515|FG000|Overall Study|Lost to Follow-up|1|||
13174199|NCT02292784|26129516|FG001|Overall Study|Lost to Follow-up|17|||
13174200|NCT02292784|26129517|FG002|Overall Study|Lost to Follow-up|18|||
13174201|NCT02292784|26129515|FG000|Overall Study|Withdrawal by Subject|0|||
13174202|NCT02292784|26129516|FG001|Overall Study|Withdrawal by Subject|3|||
13174203|NCT02292784|26129517|FG002|Overall Study|Withdrawal by Subject|3|||
13174204|NCT02292771|26129614|FG000|Overall Study|Withdrawal by Subject|2|||
13174205|NCT02292771|26129615|FG001|Overall Study|Withdrawal by Subject|1|||
13174206|NCT02292771|26129614|FG000|Overall Study|Lost to Follow-up|2|||
13174207|NCT02292771|26129615|FG001|Overall Study|Lost to Follow-up|1|||
13174208|NCT02292719|26129660|FG000|Overall Study|Withdrawal by Subject|0|||
13174209|NCT02292719|26129661|FG001|Overall Study|Withdrawal by Subject|0|||
13108320|NCT03257358|25891550|FG000|Overall Study|Protocol Violation|5|||
13108321|NCT03257358|25891551|FG001|Overall Study|Protocol Violation|3|||
13108322|NCT03257358|25891550|FG000|Overall Study|Technical problems|4|||
13108323|NCT03257358|25891551|FG001|Overall Study|Technical problems|1|||
13108324|NCT03257358|25891550|FG000|Overall Study|Withdrawal by Subject|8|||
13108325|NCT03257358|25891551|FG001|Overall Study|Withdrawal by Subject|3|||
13108326|NCT03257358|25891550|FG000|Overall Study|Withdrawal of informed consent|9|||
13108327|NCT03257358|25891551|FG001|Overall Study|Withdrawal of informed consent|5|||
13108328|NCT03257358|25891550|FG000|Overall Study|New therapy for study indication|1|||
13108329|NCT03257358|25891551|FG001|Overall Study|New therapy for study indication|0|||
13108330|NCT03257358|25891550|FG000|Overall Study|No longer requires treatment|0|||
13108331|NCT03257358|25891551|FG001|Overall Study|No longer requires treatment|1|||
13108332|NCT03257267|25891576|FG000|Overall Study|Adverse Event|9|||
13108333|NCT03257267|25891577|FG001|Overall Study|Adverse Event|7|||
13108334|NCT03257267|25891576|FG000|Overall Study|Death|92|||
13174210|NCT02292719|26129662|FG002|Overall Study|Withdrawal by Subject|0|||
13174211|NCT02292719|26129663|FG003|Overall Study|Withdrawal by Subject|1|||
13174212|NCT02292719|26129664|FG004|Overall Study|Withdrawal by Subject|1|||
13174213|NCT02292719|26129665|FG005|Overall Study|Withdrawal by Subject|0|||
13174214|NCT02292719|26129660|FG000|Overall Study|Subject enrolled in new study.|0|||
13174215|NCT02292719|26129661|FG001|Overall Study|Subject enrolled in new study.|0|||
13174216|NCT02292719|26129662|FG002|Overall Study|Subject enrolled in new study.|1|||
13174217|NCT02292719|26129663|FG003|Overall Study|Subject enrolled in new study.|0|||
13174218|NCT02292719|26129664|FG004|Overall Study|Subject enrolled in new study.|0|||
13174219|NCT02292719|26129665|FG005|Overall Study|Subject enrolled in new study.|0|||
13174220|NCT02292446|26129680|FG000|Overall Study|Adverse Event|12|||
13174221|NCT02292446|26129680|FG000|Overall Study|Death|1|||
13174222|NCT02292446|26129680|FG000|Overall Study|Disease progression|2|||
13174223|NCT02292446|26129680|FG000|Overall Study|Subject/guardian decision|2|||
13174224|NCT02292446|26129680|FG000|Overall Study|Withdrawal by Subject|3|||
13174225|NCT02292238|26129703|FG000|Overall Study|Protocol Violation|1|||
13174226|NCT02292238|26129704|FG001|Overall Study|Protocol Violation|2|||
13174227|NCT02292238|26129703|FG000|Overall Study|Withdrawal by Subject|2|||
13174228|NCT02292238|26129704|FG001|Overall Study|Withdrawal by Subject|1|||
13174229|NCT02292238|26129703|FG000|Overall Study|Lost to Follow-up|1|||
13174230|NCT02292238|26129704|FG001|Overall Study|Lost to Follow-up|0|||
13174231|NCT02292238|26129703|FG000|Overall Study|Physician Decision|0|||
13174232|NCT02292238|26129704|FG001|Overall Study|Physician Decision|1|||
13174233|NCT02292212|26129738|FG000|ViE Phase|Withdrawal by Subject|1|||
13174234|NCT02292212|26129738|FG000|ViE Phase|Protocol Violation|2|||
13108335|NCT03257267|25891577|FG001|Overall Study|Death|95|||
13174235|NCT02291913|26129749|FG000|Overall Study|Progressive Disease|32|||
13174236|NCT02291913|26129749|FG000|Overall Study|Adverse Event|11|||
13174237|NCT02291913|26129749|FG000|Overall Study|Death|2|||
13174238|NCT02291913|26129749|FG000|Overall Study|Physician Decision|1|||
13174239|NCT02291913|26129749|FG000|Overall Study|Withdrawal by Subject|1|||
13174240|NCT02291913|26129749|FG000|Overall Study|Protocol Violation|1|||
13174241|NCT02291861|26129800|FG000|Overall Study|Adverse Event|2|||
13174242|NCT02291861|26129801|FG001|Overall Study|Adverse Event|4|||
13174243|NCT02291861|26129802|FG002|Overall Study|Adverse Event|1|||
13174244|NCT02291861|26129803|FG003|Overall Study|Adverse Event|2|||
13174245|NCT02291861|26129800|FG000|Overall Study|Death|0|||
13174246|NCT02291861|26129801|FG001|Overall Study|Death|0|||
13174247|NCT02291861|26129802|FG002|Overall Study|Death|1|||
13174248|NCT02291861|26129803|FG003|Overall Study|Death|1|||
13108336|NCT03257267|25891576|FG000|Overall Study|Lost to Follow-up|2|||
13108337|NCT03257267|25891577|FG001|Overall Study|Lost to Follow-up|2|||
13108338|NCT03257267|25891576|FG000|Overall Study|Non-compliance with Study Drug|0|||
13174249|NCT02291861|26129800|FG000|Overall Study|Protocol Violation|1|||
13174250|NCT02291861|26129801|FG001|Overall Study|Protocol Violation|0|||
13174251|NCT02291861|26129802|FG002|Overall Study|Protocol Violation|0|||
13174252|NCT02291861|26129803|FG003|Overall Study|Protocol Violation|1|||
13174253|NCT02291861|26129800|FG000|Overall Study|Withdrawal by Subject|1|||
13174254|NCT02291861|26129801|FG001|Overall Study|Withdrawal by Subject|2|||
13174255|NCT02291861|26129802|FG002|Overall Study|Withdrawal by Subject|1|||
13174256|NCT02291861|26129803|FG003|Overall Study|Withdrawal by Subject|4|||
13174257|NCT02291861|26129800|FG000|Overall Study|Noncompliance|1|||
13174258|NCT02291861|26129801|FG001|Overall Study|Noncompliance|1|||
13174259|NCT02291861|26129802|FG002|Overall Study|Noncompliance|2|||
13174260|NCT02291861|26129803|FG003|Overall Study|Noncompliance|1|||
13174261|NCT02291861|26129800|FG000|Overall Study|Lost to Follow-up|2|||
13174262|NCT02291861|26129801|FG001|Overall Study|Lost to Follow-up|1|||
13174263|NCT02291861|26129802|FG002|Overall Study|Lost to Follow-up|4|||
13174264|NCT02291861|26129803|FG003|Overall Study|Lost to Follow-up|0|||
13174265|NCT02291861|26129800|FG000|Overall Study|Other|0|||
13174266|NCT02291861|26129801|FG001|Overall Study|Other|0|||
13174267|NCT02291861|26129802|FG002|Overall Study|Other|0|||
13174268|NCT02291861|26129803|FG003|Overall Study|Other|1|||
13174269|NCT02291679|26129842|FG000|Overall Study|Adverse Event|2|||
13174270|NCT02291679|26129843|FG001|Overall Study|Adverse Event|12|||
13174271|NCT02291679|26129844|FG002|Overall Study|Adverse Event|19|||
13174272|NCT02291679|26129842|FG000|Overall Study|Protocol Violation|5|||
13174273|NCT02291679|26129843|FG001|Overall Study|Protocol Violation|1|||
13174274|NCT02291679|26129844|FG002|Overall Study|Protocol Violation|7|||
13174275|NCT02291679|26129842|FG000|Overall Study|Withdrew Consent|18|||
13174276|NCT02291679|26129843|FG001|Overall Study|Withdrew Consent|10|||
13174277|NCT02291679|26129844|FG002|Overall Study|Withdrew Consent|15|||
13174278|NCT02291679|26129842|FG000|Overall Study|Lost to Follow-up|12|||
13174279|NCT02291679|26129843|FG001|Overall Study|Lost to Follow-up|10|||
13174280|NCT02291679|26129844|FG002|Overall Study|Lost to Follow-up|9|||
13174281|NCT02291679|26129842|FG000|Overall Study|Insufficient Therapeutic Response|5|||
13174282|NCT02291679|26129843|FG001|Overall Study|Insufficient Therapeutic Response|5|||
13174283|NCT02291679|26129844|FG002|Overall Study|Insufficient Therapeutic Response|7|||
13174284|NCT02291679|26129842|FG000|Overall Study|Other|2|||
13108339|NCT03257267|25891577|FG001|Overall Study|Non-compliance with Study Drug|1|||
13108340|NCT03257267|25891576|FG000|Overall Study|Participant Decision|34|||
13108341|NCT03257267|25891577|FG001|Overall Study|Participant Decision|42|||
13108342|NCT03257267|25891576|FG000|Overall Study|Physician Decision|1|||
13108343|NCT03257267|25891577|FG001|Overall Study|Physician Decision|3|||
13108344|NCT03257267|25891576|FG000|Overall Study|Disease Progression|98|||
13108345|NCT03257267|25891577|FG001|Overall Study|Disease Progression|117|||
13108346|NCT03257267|25891576|FG000|Overall Study|Withdrawal of Consent|8|||
13108347|NCT03257267|25891577|FG001|Overall Study|Withdrawal of Consent|26|||
13108348|NCT03257267|25891576|FG000|Overall Study|Study Ongoing|53|||
13108349|NCT03257267|25891577|FG001|Overall Study|Study Ongoing|11|||
13174285|NCT02291679|26129843|FG001|Overall Study|Other|4|||
13174286|NCT02291679|26129844|FG002|Overall Study|Other|2|||
13174287|NCT02291614|26130056|FG000|Overall Study|Lost to Follow-up|0|||
13174288|NCT02291614|26130057|FG001|Overall Study|Lost to Follow-up|0|||
13174289|NCT02291614|26130058|FG002|Overall Study|Lost to Follow-up|0|||
13174290|NCT02291614|26130059|FG003|Overall Study|Lost to Follow-up|0|||
13174291|NCT02291614|26130060|FG004|Overall Study|Lost to Follow-up|0|||
13174292|NCT02291614|26130061|FG005|Overall Study|Lost to Follow-up|0|||
13174293|NCT02291614|26130062|FG006|Overall Study|Lost to Follow-up|0|||
13174294|NCT02291614|26130063|FG007|Overall Study|Lost to Follow-up|1|||
13222975|NCT01801358|26287544|FG001|Overall Study|Progressive Disease|4|||
13108350|NCT03256851|25891592|FG000|Overall Study|Withdrawal by Subject|1|||
13108351|NCT03256851|25891593|FG001|Overall Study|Withdrawal by Subject|0|||
13174295|NCT02291614|26130064|FG008|Overall Study|Lost to Follow-up|0|||
13174296|NCT02291614|26130065|FG009|Overall Study|Lost to Follow-up|0|||
13174297|NCT02291614|26130066|FG010|Overall Study|Lost to Follow-up|0|||
13174298|NCT02291614|26130056|FG000|Overall Study|Withdrawal by Subject|0|||
13174299|NCT02291614|26130057|FG001|Overall Study|Withdrawal by Subject|1|||
13174300|NCT02291614|26130058|FG002|Overall Study|Withdrawal by Subject|0|||
13174301|NCT02291614|26130059|FG003|Overall Study|Withdrawal by Subject|0|||
13174302|NCT02291614|26130060|FG004|Overall Study|Withdrawal by Subject|0|||
13174303|NCT02291614|26130061|FG005|Overall Study|Withdrawal by Subject|0|||
13174304|NCT02291614|26130062|FG006|Overall Study|Withdrawal by Subject|0|||
13174305|NCT02291614|26130063|FG007|Overall Study|Withdrawal by Subject|0|||
13174306|NCT02291614|26130064|FG008|Overall Study|Withdrawal by Subject|0|||
13174307|NCT02291614|26130065|FG009|Overall Study|Withdrawal by Subject|2|||
13174308|NCT02291614|26130066|FG010|Overall Study|Withdrawal by Subject|2|||
13174309|NCT02291614|26130056|FG000|Overall Study|Decision by sponsor|0|||
13174310|NCT02291614|26130057|FG001|Overall Study|Decision by sponsor|0|||
13174311|NCT02291614|26130058|FG002|Overall Study|Decision by sponsor|0|||
13174312|NCT02291614|26130059|FG003|Overall Study|Decision by sponsor|1|||
13174313|NCT02291614|26130060|FG004|Overall Study|Decision by sponsor|0|||
13174314|NCT02291614|26130061|FG005|Overall Study|Decision by sponsor|0|||
13174315|NCT02291614|26130062|FG006|Overall Study|Decision by sponsor|0|||
13174316|NCT02291614|26130063|FG007|Overall Study|Decision by sponsor|0|||
13174317|NCT02291614|26130064|FG008|Overall Study|Decision by sponsor|0|||
13174318|NCT02291614|26130065|FG009|Overall Study|Decision by sponsor|0|||
13174319|NCT02291614|26130066|FG010|Overall Study|Decision by sponsor|0|||
13174320|NCT02291614|26130056|FG000|Overall Study|Death|0|||
13174321|NCT02291614|26130057|FG001|Overall Study|Death|0|||
13174322|NCT02291614|26130058|FG002|Overall Study|Death|1|||
13174323|NCT02291614|26130059|FG003|Overall Study|Death|0|||
13174324|NCT02291614|26130060|FG004|Overall Study|Death|1|||
13174325|NCT02291614|26130061|FG005|Overall Study|Death|1|||
13174326|NCT02291614|26130062|FG006|Overall Study|Death|1|||
13174327|NCT02291614|26130063|FG007|Overall Study|Death|0|||
13174328|NCT02291614|26130064|FG008|Overall Study|Death|0|||
13174329|NCT02291614|26130065|FG009|Overall Study|Death|0|||
13174330|NCT02291614|26130066|FG010|Overall Study|Death|0|||
13174331|NCT02291601|26130081|FG000|Abdomen|Did not qualify|333|||
13174332|NCT02291601|26130082|FG001|Abdomen|Did not qualify|54|||
13174333|NCT02291601|26130083|FG002|Abdomen|Did not qualify|339|||
13174334|NCT02291601|26130081|FG000|Groin|Did not qualify|183|||
13174335|NCT02291601|26130082|FG001|Groin|Did not qualify|30|||
13174336|NCT02291601|26130083|FG002|Groin|Did not qualify|177|||
13174337|NCT02291549|26130108|FG000|Overall Study|Lost to Follow-up|1|||
13174338|NCT02291549|26130109|FG001|Overall Study|Lost to Follow-up|0|||
13174339|NCT02291549|26130108|FG000|Overall Study|Withdrawal by Subject|0|||
13174340|NCT02291549|26130109|FG001|Overall Study|Withdrawal by Subject|1|||
13174341|NCT02291510|26130136|FG000|Overall Study|Adverse Event|0|||
13174342|NCT02291510|26130137|FG001|Overall Study|Adverse Event|0|||
13174343|NCT02291510|26130138|FG002|Overall Study|Adverse Event|0|||
13174344|NCT02291510|26130139|FG003|Overall Study|Adverse Event|1|||
13174345|NCT02291432|26130154|FG000|Overall Study|Withdrawal by Subject|2|||
13174346|NCT02291419|26130177|FG000|Overall Study|Early study termination|1|||
13174347|NCT02291419|26130178|FG001|Overall Study|Early study termination|5|||
13174348|NCT02291289|26130261|FG000|Induction Treatment|Not Dosed|2|||
13174349|NCT02291289|26130262|FG001|Induction Treatment|Not Dosed|0|||
13174350|NCT02291289|26130263|FG002|Induction Treatment|Not Dosed|0|||
13174351|NCT02291289|26130264|FG003|Induction Treatment|Not Dosed|9|||
13174352|NCT02291289|26130265|FG004|Induction Treatment|Not Dosed|0|||
13174353|NCT02291289|26130266|FG005|Induction Treatment|Not Dosed|0|||
13174354|NCT02291289|26130267|FG006|Induction Treatment|Not Dosed|0|||
13108352|NCT03256695|25891603|FG000|Overall Study|Adverse Event|8|||
13108353|NCT03256695|25891603|FG000|Overall Study|Death|2|||
13108354|NCT03256695|25891603|FG000|Overall Study|Withdrawal by Subject|14|||
13108355|NCT03256695|25891603|FG000|Overall Study|Non-compliance with study drug|1|||
13174355|NCT02291289|26130268|FG007|Induction Treatment|Not Dosed|0|||
13174356|NCT02291289|26130269|FG008|Induction Treatment|Not Dosed|0|||
13174357|NCT02291289|26130270|FG009|Induction Treatment|Not Dosed|1|||
13174358|NCT02291289|26130271|FG010|Induction Treatment|Not Dosed|0|||
13174359|NCT02291289|26130272|FG011|Induction Treatment|Not Dosed|0|||
13108356|NCT03256695|25891603|FG000|Overall Study|Lost to Follow-up|3|||
13108357|NCT03256695|25891603|FG000|Overall Study|Lack of Efficacy|3|||
13108358|NCT03256695|25891603|FG000|Overall Study|Protocol Violation|5|||
13108359|NCT03256695|25891603|FG000|Overall Study|Other than specified|3|||
13108360|NCT03256578|25891666|FG000|Overall Study|Excluded Post Randomization|66|||
13108361|NCT03256578|25891667|FG001|Overall Study|Excluded Post Randomization|56|||
13108362|NCT03256552|25891691|FG000|Overall Study|Protocol Violation|1|||
13108363|NCT03256552|25891691|FG000|Overall Study|Physician Decision|1|||
13108364|NCT03256552|25891691|FG000|Overall Study|Adverse Event|1|||
13108365|NCT03256552|25891691|FG000|Overall Study|Withdrawal by Subject|2|||
13108366|NCT03256526|25891721|FG000|Overall Study|Adverse Event|1|||
13108367|NCT03256526|25891722|FG001|Overall Study|Adverse Event|0|||
13174360|NCT02291289|26130261|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
13174361|NCT02291289|26130262|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0|||
13174362|NCT02291289|26130263|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0|||
13174363|NCT02291289|26130264|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0|||
13222976|NCT01801358|26287545|FG002|Overall Study|Progressive Disease|4|||
13174364|NCT02291289|26130265|FG004|Maintenance Treatment Phase|Withdrawal by Subject|13|||
13174365|NCT02291289|26130266|FG005|Maintenance Treatment Phase|Withdrawal by Subject|11|||
13174366|NCT02291289|26130267|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0|||
13174367|NCT02291289|26130268|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0|||
13174368|NCT02291289|26130269|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0|||
13174369|NCT02291289|26130270|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0|||
13174370|NCT02291289|26130271|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2|||
13174371|NCT02291289|26130272|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3|||
13174372|NCT02291289|26130261|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
13174373|NCT02291289|26130262|FG001|Maintenance Treatment Phase|Protocol Violation|1|||
13174374|NCT02291289|26130263|FG002|Maintenance Treatment Phase|Protocol Violation|0|||
13174375|NCT02291289|26130264|FG003|Maintenance Treatment Phase|Protocol Violation|0|||
13174376|NCT02291289|26130265|FG004|Maintenance Treatment Phase|Protocol Violation|2|||
13174377|NCT02291289|26130266|FG005|Maintenance Treatment Phase|Protocol Violation|1|||
13174378|NCT02291289|26130267|FG006|Maintenance Treatment Phase|Protocol Violation|0|||
13174379|NCT02291289|26130268|FG007|Maintenance Treatment Phase|Protocol Violation|0|||
13174380|NCT02291289|26130269|FG008|Maintenance Treatment Phase|Protocol Violation|0|||
13174381|NCT02291289|26130270|FG009|Maintenance Treatment Phase|Protocol Violation|0|||
13174382|NCT02291289|26130271|FG010|Maintenance Treatment Phase|Protocol Violation|0|||
13174383|NCT02291289|26130272|FG011|Maintenance Treatment Phase|Protocol Violation|0|||
13174384|NCT02291289|26130261|FG000|Maintenance Treatment Phase|Death|0|||
13174385|NCT02291289|26130262|FG001|Maintenance Treatment Phase|Death|23|||
13174386|NCT02291289|26130263|FG002|Maintenance Treatment Phase|Death|13|||
13174387|NCT02291289|26130264|FG003|Maintenance Treatment Phase|Death|0|||
13174388|NCT02291289|26130265|FG004|Maintenance Treatment Phase|Death|185|||
13174389|NCT02291289|26130266|FG005|Maintenance Treatment Phase|Death|100|||
13174390|NCT02291289|26130267|FG006|Maintenance Treatment Phase|Death|0|||
13174391|NCT02291289|26130268|FG007|Maintenance Treatment Phase|Death|1|||
13174392|NCT02291289|26130269|FG008|Maintenance Treatment Phase|Death|1|||
13174393|NCT02291289|26130270|FG009|Maintenance Treatment Phase|Death|0|||
13174394|NCT02291289|26130271|FG010|Maintenance Treatment Phase|Death|26|||
13174395|NCT02291289|26130272|FG011|Maintenance Treatment Phase|Death|11|||
13174396|NCT02291289|26130261|FG000|Maintenance Treatment Phase|Adverse Event|0|||
13174397|NCT02291289|26130262|FG001|Maintenance Treatment Phase|Adverse Event|0|||
13174398|NCT02291289|26130263|FG002|Maintenance Treatment Phase|Adverse Event|0|||
13174399|NCT02291289|26130264|FG003|Maintenance Treatment Phase|Adverse Event|0|||
13174400|NCT02291289|26130265|FG004|Maintenance Treatment Phase|Adverse Event|1|||
13174401|NCT02291289|26130266|FG005|Maintenance Treatment Phase|Adverse Event|0|||
13174402|NCT02291289|26130267|FG006|Maintenance Treatment Phase|Adverse Event|0|||
13174403|NCT02291289|26130268|FG007|Maintenance Treatment Phase|Adverse Event|0|||
13174404|NCT02291289|26130269|FG008|Maintenance Treatment Phase|Adverse Event|0|||
13174405|NCT02291289|26130270|FG009|Maintenance Treatment Phase|Adverse Event|0|||
13174406|NCT02291289|26130271|FG010|Maintenance Treatment Phase|Adverse Event|0|||
13174407|NCT02291289|26130272|FG011|Maintenance Treatment Phase|Adverse Event|0|||
13174408|NCT02291289|26130261|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
13174409|NCT02291289|26130262|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
13174410|NCT02291289|26130263|FG002|Maintenance Treatment Phase|Lost to Follow-up|0|||
13174411|NCT02291289|26130264|FG003|Maintenance Treatment Phase|Lost to Follow-up|0|||
13174412|NCT02291289|26130265|FG004|Maintenance Treatment Phase|Lost to Follow-up|12|||
13174413|NCT02291289|26130266|FG005|Maintenance Treatment Phase|Lost to Follow-up|3|||
13174414|NCT02291289|26130267|FG006|Maintenance Treatment Phase|Lost to Follow-up|0|||
13174415|NCT02291289|26130268|FG007|Maintenance Treatment Phase|Lost to Follow-up|1|||
13174416|NCT02291289|26130269|FG008|Maintenance Treatment Phase|Lost to Follow-up|0|||
13174417|NCT02291289|26130270|FG009|Maintenance Treatment Phase|Lost to Follow-up|0|||
13174418|NCT02291289|26130271|FG010|Maintenance Treatment Phase|Lost to Follow-up|2|||
13174419|NCT02291289|26130272|FG011|Maintenance Treatment Phase|Lost to Follow-up|1|||
13174420|NCT02291289|26130261|FG000|Maintenance Treatment Phase|Other|0|||
13174421|NCT02291289|26130262|FG001|Maintenance Treatment Phase|Other|0|||
13174422|NCT02291289|26130263|FG002|Maintenance Treatment Phase|Other|1|||
13174423|NCT02291289|26130264|FG003|Maintenance Treatment Phase|Other|0|||
13174424|NCT02291289|26130265|FG004|Maintenance Treatment Phase|Other|29|||
13174425|NCT02291289|26130266|FG005|Maintenance Treatment Phase|Other|8|||
13174426|NCT02291289|26130267|FG006|Maintenance Treatment Phase|Other|0|||
13174427|NCT02291289|26130268|FG007|Maintenance Treatment Phase|Other|0|||
13174428|NCT02291289|26130269|FG008|Maintenance Treatment Phase|Other|1|||
13174429|NCT02291289|26130270|FG009|Maintenance Treatment Phase|Other|0|||
13174430|NCT02291289|26130271|FG010|Maintenance Treatment Phase|Other|0|||
13174431|NCT02291289|26130272|FG011|Maintenance Treatment Phase|Other|0|||
13174432|NCT02291289|26130261|FG000|Maintenance Treatment Phase|Physician Decision|0|||
13174433|NCT02291289|26130262|FG001|Maintenance Treatment Phase|Physician Decision|0|||
13174434|NCT02291289|26130263|FG002|Maintenance Treatment Phase|Physician Decision|0|||
13174435|NCT02291289|26130264|FG003|Maintenance Treatment Phase|Physician Decision|0|||
13174436|NCT02291289|26130265|FG004|Maintenance Treatment Phase|Physician Decision|2|||
13174437|NCT02291289|26130266|FG005|Maintenance Treatment Phase|Physician Decision|0|||
13174438|NCT02291289|26130267|FG006|Maintenance Treatment Phase|Physician Decision|0|||
13222977|NCT01801358|26287546|FG003|Overall Study|Progressive Disease|5|||
13108368|NCT03256526|25891723|FG002|Overall Study|Adverse Event|1|||
13108369|NCT03256526|25891721|FG000|Overall Study|Lost to Follow-up|1|||
13108370|NCT03256526|25891722|FG001|Overall Study|Lost to Follow-up|0|||
13108371|NCT03256526|25891723|FG002|Overall Study|Lost to Follow-up|2|||
13108372|NCT03255980|25891746|FG000|Overall Study|Grade =>3 Skin Toxicity|1|||
13108373|NCT03255980|25891747|FG001|Overall Study|Grade =>3 Skin Toxicity|4|||
13108374|NCT03255980|25891748|FG002|Overall Study|Grade =>3 Skin Toxicity|6|||
13108375|NCT03255980|25891749|FG003|Overall Study|Grade =>3 Skin Toxicity|5|||
13108376|NCT03255980|25891746|FG000|Overall Study|Adverse Event|1|||
13108377|NCT03255980|25891747|FG001|Overall Study|Adverse Event|1|||
13108378|NCT03255980|25891748|FG002|Overall Study|Adverse Event|0|||
13108379|NCT03255980|25891749|FG003|Overall Study|Adverse Event|1|||
13108380|NCT03255980|25891746|FG000|Overall Study|Lack of compliance to study or assessmen|0|||
13108381|NCT03255980|25891747|FG001|Overall Study|Lack of compliance to study or assessmen|1|||
13108382|NCT03255980|25891748|FG002|Overall Study|Lack of compliance to study or assessmen|0|||
13108383|NCT03255980|25891749|FG003|Overall Study|Lack of compliance to study or assessmen|0|||
13108384|NCT03255980|25891746|FG000|Overall Study|Lost to Follow-up|1|||
13108385|NCT03255980|25891747|FG001|Overall Study|Lost to Follow-up|1|||
13108386|NCT03255980|25891748|FG002|Overall Study|Lost to Follow-up|0|||
13108387|NCT03255980|25891749|FG003|Overall Study|Lost to Follow-up|3|||
13108388|NCT03255980|25891746|FG000|Overall Study|Withdrawal by Subject|0|||
13108389|NCT03255980|25891747|FG001|Overall Study|Withdrawal by Subject|1|||
13108390|NCT03255980|25891748|FG002|Overall Study|Withdrawal by Subject|0|||
13108391|NCT03255980|25891749|FG003|Overall Study|Withdrawal by Subject|3|||
13108392|NCT03255941|25891784|FG000|Overall Study|Not eligible or refused injection|37|||
13108393|NCT03255941|25891785|FG001|Overall Study|Not eligible or refused injection|44|||
13108394|NCT03255941|25891786|FG002|Overall Study|Not eligible or refused injection|5|||
13108395|NCT03255941|25891787|FG003|Overall Study|Not eligible or refused injection|6|||
13108396|NCT03255941|25891784|FG000|Overall Study|Did not complete exit interview|1|||
13108397|NCT03255941|25891785|FG001|Overall Study|Did not complete exit interview|2|||
13108398|NCT03255941|25891786|FG002|Overall Study|Did not complete exit interview|0|||
13108399|NCT03255941|25891787|FG003|Overall Study|Did not complete exit interview|0|||
13108400|NCT03255824|25891822|FG000|Overall Study|Under-sedation|2|||
13108401|NCT03255824|25891823|FG001|Overall Study|Under-sedation|1|||
13108402|NCT03255733|25891830|FG000|Overall Study|Lost to Follow-up|4|||
13108403|NCT03255655|25891845|FG000|Overall Study|Lost to Follow-up|7|||
13108404|NCT03255655|25891846|FG001|Overall Study|Lost to Follow-up|4|||
13108405|NCT03255629|25891896|FG000|Overall Study|Adverse Event|1|||
13108406|NCT03255629|25891897|FG001|Overall Study|Adverse Event|0|||
13108407|NCT03255629|25891896|FG000|Overall Study|did not experience hypoglycemia|2|||
13108408|NCT03255629|25891897|FG001|Overall Study|did not experience hypoglycemia|1|||
13108409|NCT03255382|25892072|FG000|Overall Study|Adverse Event|3|||
13108410|NCT03255382|25892073|FG001|Overall Study|Adverse Event|0|||
13108411|NCT03255382|25892072|FG000|Overall Study|Lost to Follow-up|2|||
13108412|NCT03255382|25892073|FG001|Overall Study|Lost to Follow-up|0|||
13108413|NCT03255382|25892072|FG000|Overall Study|Withdrawal by Subject|2|||
13108414|NCT03255382|25892073|FG001|Overall Study|Withdrawal by Subject|0|||
13108415|NCT03255382|25892072|FG000|Overall Study|Other|6|||
13108416|NCT03255382|25892073|FG001|Overall Study|Other|0|||
13108417|NCT03255291|25892123|FG000|Overall Study|Determined to be ineligible|10|||
13108418|NCT03255291|25892124|FG001|Overall Study|Determined to be ineligible|12|||
13108419|NCT03255291|25892125|FG002|Overall Study|Determined to be ineligible|6|||
13108420|NCT03255291|25892126|FG003|Overall Study|Determined to be ineligible|6|||
13108421|NCT03255291|25892127|FG004|Overall Study|Determined to be ineligible|5|||
13108422|NCT03255291|25892128|FG005|Overall Study|Determined to be ineligible|10|||
13108423|NCT03255291|25892123|FG000|Overall Study|Baseline data collection issues|3|||
13108424|NCT03255291|25892124|FG001|Overall Study|Baseline data collection issues|0|||
13108425|NCT03255291|25892125|FG002|Overall Study|Baseline data collection issues|0|||
13108426|NCT03255291|25892126|FG003|Overall Study|Baseline data collection issues|0|||
13108427|NCT03255291|25892127|FG004|Overall Study|Baseline data collection issues|2|||
13108428|NCT03255291|25892128|FG005|Overall Study|Baseline data collection issues|0|||
13108429|NCT03255187|25892175|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1|||
13108430|NCT03255187|25892176|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3|||
13108431|NCT03255187|25892175|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0|||
13108432|NCT03255187|25892176|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1|||
13108433|NCT03254602|25892184|FG000|Overall Study|Lost to Follow-up|4|||
13108434|NCT03254485|25892215|FG000|Overall Study|Adverse Event|3|||
13108435|NCT03254485|25892216|FG001|Overall Study|Adverse Event|0|||
13108436|NCT03254485|25892217|FG002|Overall Study|Adverse Event|0|||
13108437|NCT03254485|25892218|FG003|Overall Study|Adverse Event|6|||
13108438|NCT03254485|25892215|FG000|Overall Study|Protocol Violation|6|||
13108439|NCT03254485|25892216|FG001|Overall Study|Protocol Violation|0|||
13108440|NCT03254485|25892217|FG002|Overall Study|Protocol Violation|0|||
13108441|NCT03254485|25892218|FG003|Overall Study|Protocol Violation|2|||
13174439|NCT02291289|26130268|FG007|Maintenance Treatment Phase|Physician Decision|0|||
13174440|NCT02291289|26130269|FG008|Maintenance Treatment Phase|Physician Decision|0|||
13174441|NCT02291289|26130270|FG009|Maintenance Treatment Phase|Physician Decision|0|||
13174442|NCT02291289|26130271|FG010|Maintenance Treatment Phase|Physician Decision|0|||
13174443|NCT02291289|26130272|FG011|Maintenance Treatment Phase|Physician Decision|1|||
13174444|NCT02291289|26130261|FG000|Maintenance Treatment Phase|Multiple Reasons|0|||
13174445|NCT02291289|26130262|FG001|Maintenance Treatment Phase|Multiple Reasons|0|||
13174446|NCT02291289|26130263|FG002|Maintenance Treatment Phase|Multiple Reasons|0|||
13174447|NCT02291289|26130264|FG003|Maintenance Treatment Phase|Multiple Reasons|0|||
13174448|NCT02291289|26130265|FG004|Maintenance Treatment Phase|Multiple Reasons|4|||
13174449|NCT02291289|26130266|FG005|Maintenance Treatment Phase|Multiple Reasons|1|||
13174450|NCT02291289|26130267|FG006|Maintenance Treatment Phase|Multiple Reasons|0|||
13174451|NCT02291289|26130268|FG007|Maintenance Treatment Phase|Multiple Reasons|0|||
13174452|NCT02291289|26130269|FG008|Maintenance Treatment Phase|Multiple Reasons|0|||
13174453|NCT02291289|26130270|FG009|Maintenance Treatment Phase|Multiple Reasons|0|||
13174454|NCT02291289|26130271|FG010|Maintenance Treatment Phase|Multiple Reasons|0|||
13174455|NCT02291289|26130272|FG011|Maintenance Treatment Phase|Multiple Reasons|0|||
13174456|NCT02291289|26130261|FG000|Maintenance Treatment Phase|No Treatment Received|0|||
13174457|NCT02291289|26130262|FG001|Maintenance Treatment Phase|No Treatment Received|0|||
13174458|NCT02291289|26130263|FG002|Maintenance Treatment Phase|No Treatment Received|2|||
13174459|NCT02291289|26130264|FG003|Maintenance Treatment Phase|No Treatment Received|0|||
13174460|NCT02291289|26130265|FG004|Maintenance Treatment Phase|No Treatment Received|4|||
13174461|NCT02291289|26130266|FG005|Maintenance Treatment Phase|No Treatment Received|5|||
13174462|NCT02291289|26130267|FG006|Maintenance Treatment Phase|No Treatment Received|0|||
13174463|NCT02291289|26130268|FG007|Maintenance Treatment Phase|No Treatment Received|0|||
13174464|NCT02291289|26130269|FG008|Maintenance Treatment Phase|No Treatment Received|0|||
13174465|NCT02291289|26130270|FG009|Maintenance Treatment Phase|No Treatment Received|0|||
13174466|NCT02291289|26130271|FG010|Maintenance Treatment Phase|No Treatment Received|1|||
13174467|NCT02291289|26130272|FG011|Maintenance Treatment Phase|No Treatment Received|0|||
13174468|NCT02291237|26130295|FG000|Overall Study|Study Terminated by Sponsor|72|||
13174469|NCT02291237|26130296|FG001|Overall Study|Study Terminated by Sponsor|67|||
13174470|NCT02291237|26130295|FG000|Overall Study|Adverse Event|1|||
13174471|NCT02291237|26130296|FG001|Overall Study|Adverse Event|3|||
13174472|NCT02291237|26130295|FG000|Overall Study|Investigator's Discretion|0|||
13108442|NCT03254485|25892215|FG000|Overall Study|Withdrawal by Subject|1|||
13174473|NCT02291237|26130296|FG001|Overall Study|Investigator's Discretion|3|||
13174474|NCT02291237|26130295|FG000|Overall Study|Withdrew Consent|11|||
13108443|NCT03254485|25892216|FG001|Overall Study|Withdrawal by Subject|0|||
13108444|NCT03254485|25892217|FG002|Overall Study|Withdrawal by Subject|0|||
13108445|NCT03254485|25892218|FG003|Overall Study|Withdrawal by Subject|4|||
13108446|NCT03254485|25892215|FG000|Overall Study|Death|0|||
13108447|NCT03254485|25892216|FG001|Overall Study|Death|0|||
13108448|NCT03254485|25892217|FG002|Overall Study|Death|0|||
13108449|NCT03254485|25892218|FG003|Overall Study|Death|1|||
13108450|NCT03254485|25892215|FG000|Overall Study|Lost to Follow-up|1|||
13108451|NCT03254485|25892216|FG001|Overall Study|Lost to Follow-up|0|||
13108452|NCT03254485|25892217|FG002|Overall Study|Lost to Follow-up|0|||
13108453|NCT03254485|25892218|FG003|Overall Study|Lost to Follow-up|0|||
13108454|NCT03254485|25892215|FG000|Overall Study|Other|1|||
13108455|NCT03254485|25892216|FG001|Overall Study|Other|0|||
13108456|NCT03254485|25892217|FG002|Overall Study|Other|0|||
13108457|NCT03254485|25892218|FG003|Overall Study|Other|2|||
13108458|NCT03254459|25892243|FG000|Overall Study|Adverse Event|7|||
13108459|NCT03254459|25892244|FG001|Overall Study|Adverse Event|20|||
13108460|NCT03254459|25892243|FG000|Overall Study|Withdrawal by Subject Consent|3|||
13108461|NCT03254459|25892244|FG001|Overall Study|Withdrawal by Subject Consent|1|||
13174475|NCT02291237|26130296|FG001|Overall Study|Withdrew Consent|11|||
13174476|NCT02291237|26130295|FG000|Overall Study|Lost to Follow-up|0|||
13174477|NCT02291237|26130296|FG001|Overall Study|Lost to Follow-up|2|||
13174478|NCT02291237|26130295|FG000|Overall Study|Subject Required Prohibited Medication|2|||
13174479|NCT02291237|26130296|FG001|Overall Study|Subject Required Prohibited Medication|0|||
13174480|NCT02291029|26130359|FG000|Overall Study|Withdrawal by Subject|0|||
13174481|NCT02291029|26130360|FG001|Overall Study|Withdrawal by Subject|0|||
13174482|NCT02291029|26130361|FG002|Overall Study|Withdrawal by Subject|1|||
13174483|NCT02291029|26130362|FG003|Overall Study|Withdrawal by Subject|0|||
13174484|NCT02291029|26130363|FG004|Overall Study|Withdrawal by Subject|0|||
13174485|NCT02291029|26130364|FG005|Overall Study|Withdrawal by Subject|0|||
13174486|NCT02291029|26130359|FG000|Overall Study|Adverse Event|0|||
13174487|NCT02291029|26130360|FG001|Overall Study|Adverse Event|1|||
13174488|NCT02291029|26130361|FG002|Overall Study|Adverse Event|0|||
13174489|NCT02291029|26130362|FG003|Overall Study|Adverse Event|0|||
13174490|NCT02291029|26130363|FG004|Overall Study|Adverse Event|0|||
13174491|NCT02291029|26130364|FG005|Overall Study|Adverse Event|0|||
13174492|NCT02290925|26130383|FG000|First Period of Three Months|Lost to Follow-up|2|||
13108462|NCT03254459|25892243|FG000|Overall Study|Lost to Follow-up|0|||
13174493|NCT02290925|26130384|FG001|First Period of Three Months|Lost to Follow-up|1|||
13174494|NCT02290925|26130383|FG000|First Period of Three Months|Death|1|||
13174495|NCT02290925|26130384|FG001|First Period of Three Months|Death|0|||
13174496|NCT02290925|26130383|FG000|First Period of Three Months|Insulin Started|1|||
13174497|NCT02290925|26130384|FG001|First Period of Three Months|Insulin Started|1|||
13174498|NCT02290925|26130383|FG000|Second Period of 3 Months|Lost to Follow-up|1|||
13174499|NCT02290925|26130384|FG001|Second Period of 3 Months|Lost to Follow-up|3|||
13174500|NCT02290925|26130383|FG000|Second Period of 3 Months|insulin started|0|||
13174501|NCT02290925|26130384|FG001|Second Period of 3 Months|insulin started|1|||
13174502|NCT02290873|26130411|FG000|Overall Study|Withdrawal by Subject|0|||
13174503|NCT02290873|26130412|FG001|Overall Study|Withdrawal by Subject|1|||
13174504|NCT02290873|26130413|FG002|Overall Study|Withdrawal by Subject|1|||
13174505|NCT02290873|26130411|FG000|Overall Study|Nellcor device error|1|||
13174506|NCT02290873|26130412|FG001|Overall Study|Nellcor device error|0|||
13174507|NCT02290873|26130413|FG002|Overall Study|Nellcor device error|0|||
13174508|NCT02290873|26130411|FG000|Overall Study|Esophagogastroduodenoscopy was added|1|||
13174509|NCT02290873|26130412|FG001|Overall Study|Esophagogastroduodenoscopy was added|0|||
13174510|NCT02290873|26130413|FG002|Overall Study|Esophagogastroduodenoscopy was added|0|||
13174511|NCT02290873|26130411|FG000|Overall Study|Protocol Violation|0|||
13174512|NCT02290873|26130412|FG001|Overall Study|Protocol Violation|0|||
13174513|NCT02290873|26130413|FG002|Overall Study|Protocol Violation|1|||
13174514|NCT02290821|26130426|FG000|Overall Study|Withdrawal by Subject|1|||
13174515|NCT02290821|26130427|FG001|Overall Study|Withdrawal by Subject|1|||
13174516|NCT02290821|26130426|FG000|Overall Study|Unable or unwilling to cooperate with|2|||
13174517|NCT02290821|26130427|FG001|Overall Study|Unable or unwilling to cooperate with|0|||
13174518|NCT02290821|26130426|FG000|Overall Study|Lost to Follow-up|3|||
13174519|NCT02290821|26130427|FG001|Overall Study|Lost to Follow-up|2|||
13174520|NCT02290691|26130448|FG000|Overall Study|Noncompliance|0|||
13174521|NCT02290691|26130449|FG001|Overall Study|Noncompliance|1|||
13174522|NCT02290691|26130448|FG000|Overall Study|Withdrawal by Subject|1|||
13174523|NCT02290691|26130449|FG001|Overall Study|Withdrawal by Subject|1|||
13174524|NCT02290691|26130448|FG000|Overall Study|Lost to Follow-up|7|||
13174525|NCT02290691|26130449|FG001|Overall Study|Lost to Follow-up|7|||
13174526|NCT02290405|26130462|FG000|Overall Study|Withdrawal by Subject|1|||
13174527|NCT02290405|26130463|FG001|Overall Study|Withdrawal by Subject|0|||
13174528|NCT02290340|26130519|FG000|Overall Study|Lost to Follow-up|0|||
13174529|NCT02290340|26130520|FG001|Overall Study|Lost to Follow-up|0|||
13174530|NCT02290340|26130521|FG002|Overall Study|Lost to Follow-up|0|||
13174531|NCT02290340|26130522|FG003|Overall Study|Lost to Follow-up|1|||
13174532|NCT02290340|26130519|FG000|Overall Study|Withdrawal by Subject|1|||
13174533|NCT02290340|26130520|FG001|Overall Study|Withdrawal by Subject|0|||
13174534|NCT02290340|26130521|FG002|Overall Study|Withdrawal by Subject|0|||
13174535|NCT02290340|26130522|FG003|Overall Study|Withdrawal by Subject|0|||
13174536|NCT02290340|26130519|FG000|Overall Study|Other|1|||
13174537|NCT02290340|26130520|FG001|Overall Study|Other|0|||
13174538|NCT02290340|26130521|FG002|Overall Study|Other|0|||
13174539|NCT02290340|26130522|FG003|Overall Study|Other|1|||
13174540|NCT02290223|26130587|FG000|6 Months|Lost to Follow-up|9|||
13174541|NCT02290223|26130588|FG001|6 Months|Lost to Follow-up|6|||
13174542|NCT02290223|26130587|FG000|6 Months|Withdrawal by Subject|5|||
13174543|NCT02290223|26130588|FG001|6 Months|Withdrawal by Subject|0|||
13174544|NCT02290223|26130587|FG000|6 Months|deceased (not related to study)|2|||
13174545|NCT02290223|26130588|FG001|6 Months|deceased (not related to study)|0|||
13174546|NCT02290223|26130587|FG000|12 Months|Lost to Follow-up|16|||
13174547|NCT02290223|26130588|FG001|12 Months|Lost to Follow-up|10|||
13174548|NCT02290223|26130587|FG000|12 Months|Refusal|0|||
13174549|NCT02290223|26130588|FG001|12 Months|Refusal|1|||
13174550|NCT02290028|26130608|FG000|Overall Study|Death|217|||
13174551|NCT02290028|26130608|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186|||
13174552|NCT02290028|26130608|FG000|Overall Study|No longer under care of study physician|76|||
13108463|NCT03254459|25892244|FG001|Overall Study|Lost to Follow-up|1|||
13108464|NCT03254459|25892243|FG000|Overall Study|Miscellaneous|0|||
13108465|NCT03254459|25892244|FG001|Overall Study|Miscellaneous|1|||
13108466|NCT03254134|25892259|FG000|Overall Study|Not eligible patients|599|||
13108467|NCT03254134|25892260|FG001|Overall Study|Not eligible patients|3630|||
13108468|NCT03254108|25892293|FG000|Overall Study|Adverse Event|0|||
13108469|NCT03254108|25892294|FG001|Overall Study|Adverse Event|2|||
13108470|NCT03254108|25892295|FG002|Overall Study|Adverse Event|0|||
13108471|NCT03254108|25892296|FG003|Overall Study|Adverse Event|1|||
13174553|NCT02290028|26130608|FG000|Overall Study|Sentus lead or required CRT-D explanted|55|||
13174554|NCT02290028|26130608|FG000|Overall Study|Withdrawal by Subject|52|||
13174555|NCT02290028|26130608|FG000|Overall Study|Study site closure|44|||
13485532|NCT02906020|27032870|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
13108472|NCT03254108|25892297|FG004|Overall Study|Adverse Event|1|||
13174556|NCT02290028|26130608|FG000|Overall Study|Lost to Follow-up|34|||
13174557|NCT02290028|26130608|FG000|Overall Study|Miscellaneous|10|||
13174558|NCT02290028|26130608|FG000|Overall Study|Transition to EP PASSION|1295|||
13174559|NCT02290028|26130608|FG000|Overall Study|Planned study completion at 12 months|257|||
13174560|NCT02289963|26130663|FG000|Overall Study|Adverse Event|1|||
13174561|NCT02289963|26130664|FG001|Overall Study|Adverse Event|2|||
13174562|NCT02289963|26130663|FG000|Overall Study|Poor compliance to protocol|1|||
13174563|NCT02289963|26130664|FG001|Overall Study|Poor compliance to protocol|0|||
13174564|NCT02289963|26130663|FG000|Overall Study|Withdrawal by Subject|1|||
13174565|NCT02289963|26130664|FG001|Overall Study|Withdrawal by Subject|0|||
13174566|NCT02289963|26130663|FG000|Overall Study|Last injection missed|2|||
13174567|NCT02289963|26130664|FG001|Overall Study|Last injection missed|2|||
13174568|NCT02289963|26130663|FG000|Overall Study|End treatment visit outside visit window|0|||
13174569|NCT02289963|26130664|FG001|Overall Study|End treatment visit outside visit window|4|||
13174570|NCT02289963|26130663|FG000|Overall Study|Other than specified above|0|||
13174571|NCT02289963|26130664|FG001|Overall Study|Other than specified above|2|||
13174572|NCT02289950|26130687|FG000|Overall Study|Progressive disease by RECIST 1.1|99|||
13174573|NCT02289950|26130688|FG001|Overall Study|Progressive disease by RECIST 1.1|52|||
13174574|NCT02289950|26130687|FG000|Overall Study|Progressive disease by Clinical Assessment|4|||
13174575|NCT02289950|26130688|FG001|Overall Study|Progressive disease by Clinical Assessment|4|||
13174576|NCT02289950|26130687|FG000|Overall Study|Lost to Follow-up|1|||
13174577|NCT02289950|26130688|FG001|Overall Study|Lost to Follow-up|0|||
13174578|NCT02289950|26130687|FG000|Overall Study|Physician Decision|9|||
13174579|NCT02289950|26130688|FG001|Overall Study|Physician Decision|3|||
13174580|NCT02289950|26130687|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9|||
13174581|NCT02289950|26130688|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2|||
13174582|NCT02289950|26130687|FG000|Overall Study|Withdrawal by Subject|1|||
13174583|NCT02289950|26130688|FG001|Overall Study|Withdrawal by Subject|3|||
13174584|NCT02289950|26130687|FG000|Overall Study|Test article held for greater than 28 days|0|||
13174585|NCT02289950|26130688|FG001|Overall Study|Test article held for greater than 28 days|1|||
13174586|NCT02289950|26130687|FG000|Overall Study|Adverse Event|11|||
13174587|NCT02289950|26130688|FG001|Overall Study|Adverse Event|3|||
13174588|NCT02289950|26130687|FG000|Overall Study|Death|1|||
13174589|NCT02289950|26130688|FG001|Overall Study|Death|1|||
13174590|NCT02289950|26130687|FG000|Overall Study|Other|5|||
13174591|NCT02289950|26130688|FG001|Overall Study|Other|2|||
13174592|NCT02289950|26130687|FG000|Overall Study|Not Treated|2|||
13174593|NCT02289950|26130688|FG001|Overall Study|Not Treated|1|||
13174594|NCT02289898|26130705|FG000|Overall Study|Death|5|||
13174595|NCT02289898|26130706|FG001|Overall Study|Death|4|||
13174596|NCT02289898|26130707|FG002|Overall Study|Death|3|||
13174597|NCT02289898|26130705|FG000|Overall Study|Physician Decision|2|||
13174598|NCT02289898|26130706|FG001|Overall Study|Physician Decision|5|||
13174599|NCT02289898|26130707|FG002|Overall Study|Physician Decision|2|||
13174600|NCT02289898|26130705|FG000|Overall Study|Withdrawal by Subject|0|||
13174601|NCT02289898|26130706|FG001|Overall Study|Withdrawal by Subject|4|||
13174602|NCT02289898|26130707|FG002|Overall Study|Withdrawal by Subject|1|||
13174603|NCT02289898|26130705|FG000|Overall Study|Adverse Event|3|||
13174604|NCT02289898|26130706|FG001|Overall Study|Adverse Event|5|||
13174605|NCT02289898|26130707|FG002|Overall Study|Adverse Event|5|||
13174606|NCT02289898|26130705|FG000|Overall Study|Disease progression|34|||
13174607|NCT02289898|26130706|FG001|Overall Study|Disease progression|28|||
13174608|NCT02289898|26130707|FG002|Overall Study|Disease progression|34|||
13174609|NCT02289898|26130705|FG000|Overall Study|Use of another anticancer therapy|0|||
13174610|NCT02289898|26130706|FG001|Overall Study|Use of another anticancer therapy|0|||
13174611|NCT02289898|26130707|FG002|Overall Study|Use of another anticancer therapy|1|||
13174612|NCT02289898|26130705|FG000|Overall Study|Other|8|||
13174613|NCT02289898|26130706|FG001|Overall Study|Other|7|||
13174614|NCT02289898|26130707|FG002|Overall Study|Other|10|||
13174615|NCT02289833|26130743|FG000|Overall Study|Study discontinuation|0|||
13174616|NCT02289833|26130744|FG001|Overall Study|Study discontinuation|1|||
13174617|NCT02289833|26130743|FG000|Overall Study|Lost to Follow-up|4|||
13174618|NCT02289833|26130744|FG001|Overall Study|Lost to Follow-up|0|||
13174619|NCT02289833|26130743|FG000|Overall Study|Death|23|||
13174620|NCT02289833|26130744|FG001|Overall Study|Death|16|||
13174621|NCT02289820|26130877|FG000|Overall Study|Withdrawal by Subject|2|||
13174622|NCT02289820|26130878|FG001|Overall Study|Withdrawal by Subject|1|||
13174623|NCT02289820|26130879|FG002|Overall Study|Withdrawal by Subject|2|||
13174624|NCT02289820|26130880|FG003|Overall Study|Withdrawal by Subject|1|||
13174625|NCT02289820|26130881|FG004|Overall Study|Withdrawal by Subject|0|||
13174626|NCT02289820|26130882|FG005|Overall Study|Withdrawal by Subject|0|||
13174627|NCT02289820|26130883|FG006|Overall Study|Withdrawal by Subject|1|||
13174628|NCT02289820|26130877|FG000|Overall Study|Death|0|||
13174629|NCT02289820|26130878|FG001|Overall Study|Death|0|||
13174630|NCT02289820|26130879|FG002|Overall Study|Death|1|||
13174631|NCT02289820|26130880|FG003|Overall Study|Death|0|||
13174632|NCT02289820|26130881|FG004|Overall Study|Death|0|||
13174633|NCT02289820|26130882|FG005|Overall Study|Death|0|||
13174634|NCT02289820|26130883|FG006|Overall Study|Death|0|||
13174635|NCT02289820|26130877|FG000|Overall Study|Lost to Follow-up|0|||
13174636|NCT02289820|26130878|FG001|Overall Study|Lost to Follow-up|0|||
13174637|NCT02289820|26130879|FG002|Overall Study|Lost to Follow-up|3|||
13174638|NCT02289820|26130880|FG003|Overall Study|Lost to Follow-up|1|||
13174639|NCT02289820|26130881|FG004|Overall Study|Lost to Follow-up|0|||
13174640|NCT02289820|26130882|FG005|Overall Study|Lost to Follow-up|1|||
13174641|NCT02289820|26130883|FG006|Overall Study|Lost to Follow-up|1|||
13174642|NCT02289820|26130877|FG000|Overall Study|withdrawal of consent|0|||
13174643|NCT02289820|26130878|FG001|Overall Study|withdrawal of consent|1|||
13174644|NCT02289820|26130879|FG002|Overall Study|withdrawal of consent|0|||
13174645|NCT02289820|26130880|FG003|Overall Study|withdrawal of consent|0|||
13174646|NCT02289820|26130881|FG004|Overall Study|withdrawal of consent|0|||
13174647|NCT02289820|26130882|FG005|Overall Study|withdrawal of consent|0|||
13174648|NCT02289820|26130883|FG006|Overall Study|withdrawal of consent|0|||
13174649|NCT02289742|26130909|FG000|First Wear Period|Adverse event prior to treatment|0|||
13174650|NCT02289742|26130910|FG001|First Wear Period|Adverse event prior to treatment|1|||
13174651|NCT02289742|26130911|FG002|First Wear Period|Adverse event prior to treatment|0|||
13174652|NCT02289742|26130912|FG003|First Wear Period|Adverse event prior to treatment|0|||
13174653|NCT02289742|26130909|FG000|First Wear Period|Adverse Event|0|||
13174654|NCT02289742|26130910|FG001|First Wear Period|Adverse Event|0|||
13174655|NCT02289742|26130911|FG002|First Wear Period|Adverse Event|1|||
13174656|NCT02289742|26130912|FG003|First Wear Period|Adverse Event|0|||
13174657|NCT02289742|26130909|FG000|First Wear Period|Other prior to treatment|0|||
13174658|NCT02289742|26130910|FG001|First Wear Period|Other prior to treatment|0|||
13174659|NCT02289742|26130911|FG002|First Wear Period|Other prior to treatment|0|||
13174660|NCT02289742|26130912|FG003|First Wear Period|Other prior to treatment|1|||
13174661|NCT02289742|26130909|FG000|Third Wear Period|Adverse Event|0|||
13174662|NCT02289742|26130910|FG001|Third Wear Period|Adverse Event|1|||
13174663|NCT02289742|26130911|FG002|Third Wear Period|Adverse Event|0|||
13174664|NCT02289742|26130912|FG003|Third Wear Period|Adverse Event|0|||
13174665|NCT02289742|26130909|FG000|Third Wear Period|Reason not given|0|||
13174666|NCT02289742|26130910|FG001|Third Wear Period|Reason not given|0|||
13174667|NCT02289742|26130911|FG002|Third Wear Period|Reason not given|0|||
13174668|NCT02289742|26130912|FG003|Third Wear Period|Reason not given|1|||
13174669|NCT02289729|26130968|FG000|Overall Study|Lack of Efficacy|3|||
13174670|NCT02289729|26130968|FG000|Overall Study|Very Narrow Therapeutic Margin|1|||
13174671|NCT02289729|26130968|FG000|Overall Study|Withdrawal by Subject|1|||
13174672|NCT02289729|26130968|FG000|Overall Study|Death|1|||
13174673|NCT02289690|26131085|FG000|Overall Study|Adverse Event Related to Progression|0|||
13174674|NCT02289690|26131086|FG001|Overall Study|Adverse Event Related to Progression|1|||
13174675|NCT02289690|26131087|FG002|Overall Study|Adverse Event Related to Progression|1|||
13174676|NCT02289690|26131088|FG003|Overall Study|Adverse Event Related to Progression|0|||
13174677|NCT02289690|26131089|FG004|Overall Study|Adverse Event Related to Progression|1|||
13174678|NCT02289690|26131090|FG005|Overall Study|Adverse Event Related to Progression|0|||
13174679|NCT02289690|26131091|FG006|Overall Study|Adverse Event Related to Progression|1|||
13174680|NCT02289690|26131092|FG007|Overall Study|Adverse Event Related to Progression|0|||
13174681|NCT02289690|26131093|FG008|Overall Study|Adverse Event Related to Progression|0|||
13174682|NCT02289690|26131094|FG009|Overall Study|Adverse Event Related to Progression|0|||
13174683|NCT02289690|26131085|FG000|Overall Study|Withdrawal by Subject|1|||
13174684|NCT02289690|26131086|FG001|Overall Study|Withdrawal by Subject|0|||
13174685|NCT02289690|26131087|FG002|Overall Study|Withdrawal by Subject|0|||
13174686|NCT02289690|26131088|FG003|Overall Study|Withdrawal by Subject|0|||
13174687|NCT02289690|26131089|FG004|Overall Study|Withdrawal by Subject|1|||
13174688|NCT02289690|26131090|FG005|Overall Study|Withdrawal by Subject|1|||
13174689|NCT02289690|26131091|FG006|Overall Study|Withdrawal by Subject|0|||
13174690|NCT02289690|26131092|FG007|Overall Study|Withdrawal by Subject|0|||
13174691|NCT02289690|26131093|FG008|Overall Study|Withdrawal by Subject|4|||
13174692|NCT02289690|26131094|FG009|Overall Study|Withdrawal by Subject|2|||
13174693|NCT02289690|26131085|FG000|Overall Study|Progressive Disease, Per Protocol|3|||
13174694|NCT02289690|26131086|FG001|Overall Study|Progressive Disease, Per Protocol|2|||
13174695|NCT02289690|26131087|FG002|Overall Study|Progressive Disease, Per Protocol|3|||
13174696|NCT02289690|26131088|FG003|Overall Study|Progressive Disease, Per Protocol|2|||
13174697|NCT02289690|26131089|FG004|Overall Study|Progressive Disease, Per Protocol|5|||
13174698|NCT02289690|26131090|FG005|Overall Study|Progressive Disease, Per Protocol|13|||
13174699|NCT02289690|26131091|FG006|Overall Study|Progressive Disease, Per Protocol|2|||
13174700|NCT02289690|26131092|FG007|Overall Study|Progressive Disease, Per Protocol|0|||
13174701|NCT02289690|26131093|FG008|Overall Study|Progressive Disease, Per Protocol|0|||
13174702|NCT02289690|26131094|FG009|Overall Study|Progressive Disease, Per Protocol|0|||
13174703|NCT02289690|26131085|FG000|Overall Study|Lost to Follow-up|0|||
13174704|NCT02289690|26131086|FG001|Overall Study|Lost to Follow-up|0|||
13174705|NCT02289690|26131087|FG002|Overall Study|Lost to Follow-up|0|||
13174706|NCT02289690|26131088|FG003|Overall Study|Lost to Follow-up|0|||
13174707|NCT02289690|26131089|FG004|Overall Study|Lost to Follow-up|0|||
13174708|NCT02289690|26131090|FG005|Overall Study|Lost to Follow-up|0|||
13174709|NCT02289690|26131091|FG006|Overall Study|Lost to Follow-up|0|||
13174710|NCT02289690|26131092|FG007|Overall Study|Lost to Follow-up|1|||
13174711|NCT02289690|26131093|FG008|Overall Study|Lost to Follow-up|0|||
13174712|NCT02289690|26131094|FG009|Overall Study|Lost to Follow-up|2|||
13174713|NCT02289690|26131085|FG000|Overall Study|Death|0|||
13174714|NCT02289690|26131086|FG001|Overall Study|Death|0|||
13174715|NCT02289690|26131087|FG002|Overall Study|Death|0|||
13174716|NCT02289690|26131088|FG003|Overall Study|Death|0|||
13174717|NCT02289690|26131089|FG004|Overall Study|Death|0|||
13174718|NCT02289690|26131090|FG005|Overall Study|Death|0|||
13174719|NCT02289690|26131091|FG006|Overall Study|Death|0|||
13174720|NCT02289690|26131092|FG007|Overall Study|Death|49|||
13174721|NCT02289690|26131093|FG008|Overall Study|Death|45|||
13174722|NCT02289690|26131094|FG009|Overall Study|Death|41|||
13174723|NCT02289690|26131085|FG000|Overall Study|Sponsor Discontinued Study|0|||
13174724|NCT02289690|26131086|FG001|Overall Study|Sponsor Discontinued Study|0|||
13174725|NCT02289690|26131087|FG002|Overall Study|Sponsor Discontinued Study|0|||
13174726|NCT02289690|26131088|FG003|Overall Study|Sponsor Discontinued Study|0|||
13174727|NCT02289690|26131089|FG004|Overall Study|Sponsor Discontinued Study|0|||
13174728|NCT02289690|26131090|FG005|Overall Study|Sponsor Discontinued Study|0|||
13174729|NCT02289690|26131091|FG006|Overall Study|Sponsor Discontinued Study|0|||
13174730|NCT02289690|26131092|FG007|Overall Study|Sponsor Discontinued Study|9|||
13174731|NCT02289690|26131093|FG008|Overall Study|Sponsor Discontinued Study|7|||
13174732|NCT02289690|26131094|FG009|Overall Study|Sponsor Discontinued Study|15|||
13174733|NCT02289690|26131085|FG000|Overall Study|Other|0|||
13174734|NCT02289690|26131086|FG001|Overall Study|Other|0|||
13174735|NCT02289690|26131087|FG002|Overall Study|Other|0|||
13174736|NCT02289690|26131088|FG003|Overall Study|Other|1|||
13174737|NCT02289690|26131089|FG004|Overall Study|Other|1|||
13174738|NCT02289690|26131090|FG005|Overall Study|Other|0|||
13174739|NCT02289690|26131091|FG006|Overall Study|Other|1|||
13174740|NCT02289690|26131092|FG007|Overall Study|Other|2|||
13174741|NCT02289690|26131093|FG008|Overall Study|Other|3|||
13174742|NCT02289690|26131094|FG009|Overall Study|Other|1|||
13174743|NCT02289469|26131109|FG000|Overall Study|Unable to match a control|6|||
13174744|NCT02289469|26131110|FG001|Overall Study|Unable to match a control|0|||
13174745|NCT02289456|26131132|FG000|Induction Period|Death|2|||
13174746|NCT02289456|26131132|FG000|Induction Period|Adverse Event|11|||
13174747|NCT02289456|26131132|FG000|Induction Period|Progressive Disease (PD)|4|||
13174748|NCT02289456|26131132|FG000|Induction Period|Symptomatic Deterioration|4|||
13174749|NCT02289456|26131132|FG000|Induction Period|Withdrawal by Subject|2|||
13174750|NCT02289456|26131132|FG000|Induction Period|Miscellaneous|1|||
13174751|NCT02289456|26131132|FG000|Monotherapy Period|Death|1|||
13174752|NCT02289456|26131132|FG000|Monotherapy Period|Adverse Event|1|||
13174753|NCT02289456|26131132|FG000|Monotherapy Period|Progressive Disease (PD)|8|||
13174754|NCT02289456|26131132|FG000|Monotherapy Period|Symptomatic Deterioration|1|||
13174755|NCT02289456|26131132|FG000|Monotherapy Period|Withdrawal by Subject|2|||
13174756|NCT02289456|26131132|FG000|Monotherapy Period|Study Terminated by Sponsor|2|||
13174757|NCT02289456|26131132|FG000|Monotherapy Period|Miscellaneous|1|||
13174758|NCT02289417|26131194|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3|||
13174759|NCT02289417|26131195|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
13174760|NCT02289417|26131196|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1|||
13174761|NCT02289417|26131197|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
13174762|NCT02289417|26131198|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
13174763|NCT02289417|26131199|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
13174764|NCT02289417|26131200|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
13174765|NCT02289417|26131201|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
13174766|NCT02289417|26131202|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
13174767|NCT02289417|26131194|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1|||
13174768|NCT02289417|26131195|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3|||
13174769|NCT02289417|26131196|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2|||
13174770|NCT02289417|26131197|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
13174771|NCT02289417|26131198|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
13174772|NCT02289417|26131199|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
13174773|NCT02289417|26131200|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
13174774|NCT02289417|26131201|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
13174775|NCT02289417|26131202|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
13174776|NCT02289417|26131194|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
13174777|NCT02289417|26131195|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1|||
13174778|NCT02289417|26131196|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
13174779|NCT02289417|26131197|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
13174780|NCT02289417|26131198|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
13174781|NCT02289417|26131199|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
13174782|NCT02289417|26131200|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
13174783|NCT02289417|26131201|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
13174784|NCT02289417|26131202|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
13174785|NCT02289417|26131194|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3|||
13174786|NCT02289417|26131195|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
13174787|NCT02289417|26131196|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
13174788|NCT02289417|26131197|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
13174789|NCT02289417|26131198|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
13174790|NCT02289417|26131199|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
13174791|NCT02289417|26131200|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
13174792|NCT02289417|26131201|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
13174793|NCT02289417|26131202|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
13174794|NCT02289417|26131194|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
13174795|NCT02289417|26131195|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
13174796|NCT02289417|26131196|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4|||
13174797|NCT02289417|26131197|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
13174798|NCT02289417|26131198|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
13174799|NCT02289417|26131199|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
13174800|NCT02289417|26131200|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
13174801|NCT02289417|26131201|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
13174802|NCT02289417|26131202|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
13174803|NCT02289417|26131194|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
13174804|NCT02289417|26131195|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
13174805|NCT02289417|26131196|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1|||
13174806|NCT02289417|26131197|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
13174807|NCT02289417|26131198|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
13174808|NCT02289417|26131199|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
13174809|NCT02289417|26131200|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
13174810|NCT02289417|26131201|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
13174811|NCT02289417|26131202|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
13174812|NCT02289417|26131194|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
13174813|NCT02289417|26131195|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1|||
13174814|NCT02289417|26131196|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4|||
13174815|NCT02289417|26131197|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6|||
13174816|NCT02289417|26131198|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2|||
13174817|NCT02289417|26131199|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3|||
13174818|NCT02289417|26131200|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
13174819|NCT02289417|26131201|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
13174820|NCT02289417|26131202|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
13174821|NCT02289417|26131194|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
13174822|NCT02289417|26131195|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
13174823|NCT02289417|26131196|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
13174824|NCT02289417|26131197|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
13174825|NCT02289417|26131198|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
13174826|NCT02289417|26131199|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
13174827|NCT02289417|26131200|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
13174828|NCT02289417|26131201|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
13174829|NCT02289417|26131202|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
13174830|NCT02289417|26131194|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
13174831|NCT02289417|26131195|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
13108473|NCT03254108|25892293|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
13174832|NCT02289417|26131196|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
13174833|NCT02289417|26131197|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
13174834|NCT02289417|26131198|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
13174835|NCT02289417|26131199|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
13174836|NCT02289417|26131200|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1|||
13174837|NCT02289417|26131201|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
13174838|NCT02289417|26131202|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
13174839|NCT02289417|26131194|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
13174840|NCT02289417|26131195|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
13174841|NCT02289417|26131196|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
13174842|NCT02289417|26131197|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
13108474|NCT03254108|25892294|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
13108475|NCT03254108|25892295|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
13108476|NCT03254108|25892296|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
13108477|NCT03254108|25892297|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2|||
13108478|NCT03253796|25892359|FG000|Period 1: Run-In|Adverse Event|4|||
13108479|NCT03253796|25892360|FG001|Period 1: Run-In|Adverse Event|0|||
13108480|NCT03253796|25892361|FG002|Period 1: Run-In|Adverse Event|0|||
13174843|NCT02289417|26131198|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
13174844|NCT02289417|26131199|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
13174845|NCT02289417|26131200|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
13174846|NCT02289417|26131201|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
13174847|NCT02289417|26131202|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
13174848|NCT02289417|26131194|FG000|Extension Phase Weeks 52-104|Adverse Event|0|||
13174849|NCT02289417|26131195|FG001|Extension Phase Weeks 52-104|Adverse Event|0|||
13108481|NCT03253796|25892362|FG003|Period 1: Run-In|Adverse Event|0|||
13108482|NCT03253796|25892363|FG004|Period 1: Run-In|Adverse Event|0|||
13108483|NCT03253796|25892359|FG000|Period 1: Run-In|Lack of Efficacy|1|||
13108484|NCT03253796|25892360|FG001|Period 1: Run-In|Lack of Efficacy|0|||
13174850|NCT02289417|26131196|FG002|Extension Phase Weeks 52-104|Adverse Event|0|||
13174851|NCT02289417|26131197|FG003|Extension Phase Weeks 52-104|Adverse Event|0|||
13108485|NCT03253796|25892361|FG002|Period 1: Run-In|Lack of Efficacy|0|||
13108486|NCT03253796|25892362|FG003|Period 1: Run-In|Lack of Efficacy|0|||
13174852|NCT02289417|26131198|FG004|Extension Phase Weeks 52-104|Adverse Event|0|||
13174853|NCT02289417|26131199|FG005|Extension Phase Weeks 52-104|Adverse Event|0|||
13174854|NCT02289417|26131200|FG006|Extension Phase Weeks 52-104|Adverse Event|0|||
13174855|NCT02289417|26131201|FG007|Extension Phase Weeks 52-104|Adverse Event|2|||
13174856|NCT02289417|26131202|FG008|Extension Phase Weeks 52-104|Adverse Event|3|||
13174857|NCT02289417|26131194|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
13174858|NCT02289417|26131195|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
13174859|NCT02289417|26131196|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
13174860|NCT02289417|26131197|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
13174861|NCT02289417|26131198|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
13174862|NCT02289417|26131199|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
13174863|NCT02289417|26131200|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
13174864|NCT02289417|26131201|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
13174865|NCT02289417|26131202|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
13174866|NCT02289417|26131194|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
13174867|NCT02289417|26131195|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
13174868|NCT02289417|26131196|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
13174869|NCT02289417|26131197|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
13174870|NCT02289417|26131198|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
13174871|NCT02289417|26131199|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
13174872|NCT02289417|26131200|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
13174873|NCT02289417|26131201|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2|||
13174874|NCT02289417|26131202|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1|||
13174875|NCT02289417|26131194|FG000|Extension Phase Weeks 52-104|Miscellaneous|0|||
13174876|NCT02289417|26131195|FG001|Extension Phase Weeks 52-104|Miscellaneous|0|||
13174877|NCT02289417|26131196|FG002|Extension Phase Weeks 52-104|Miscellaneous|0|||
13174878|NCT02289417|26131197|FG003|Extension Phase Weeks 52-104|Miscellaneous|0|||
13174879|NCT02289417|26131198|FG004|Extension Phase Weeks 52-104|Miscellaneous|0|||
13174880|NCT02289417|26131199|FG005|Extension Phase Weeks 52-104|Miscellaneous|0|||
13174881|NCT02289417|26131200|FG006|Extension Phase Weeks 52-104|Miscellaneous|0|||
13174882|NCT02289417|26131201|FG007|Extension Phase Weeks 52-104|Miscellaneous|1|||
13174883|NCT02289417|26131202|FG008|Extension Phase Weeks 52-104|Miscellaneous|0|||
13174884|NCT02289352|26131223|FG000|Overall Study|Withdrawal by Subject|1|||
13174885|NCT02289352|26131224|FG001|Overall Study|Withdrawal by Subject|1|||
13174886|NCT02289352|26131225|FG002|Overall Study|Withdrawal by Subject|0|||
13174887|NCT02289079|26131244|FG000|Overall Study|Physician Decision|2|||
13174888|NCT02289079|26131245|FG001|Overall Study|Physician Decision|0|||
13174889|NCT02289079|26131244|FG000|Overall Study|Lost to Follow-up|0|||
13174890|NCT02289079|26131245|FG001|Overall Study|Lost to Follow-up|1|||
13174891|NCT02288559|26131282|FG000|Overall Study|Adverse Event|1|||
13174892|NCT02288559|26131283|FG001|Overall Study|Adverse Event|1|||
13108487|NCT03253796|25892363|FG004|Period 1: Run-In|Lack of Efficacy|0|||
13108488|NCT03253796|25892359|FG000|Period 1: Run-In|Lack of Qualifying Event|98|||
13108489|NCT03253796|25892360|FG001|Period 1: Run-In|Lack of Qualifying Event|0|||
13174893|NCT02288559|26131284|FG002|Overall Study|Adverse Event|5|||
13174894|NCT02288559|26131285|FG003|Overall Study|Adverse Event|0|||
13174895|NCT02288559|26131282|FG000|Overall Study|Death|0|||
13174896|NCT02288559|26131283|FG001|Overall Study|Death|0|||
13174897|NCT02288559|26131284|FG002|Overall Study|Death|1|||
13174898|NCT02288559|26131285|FG003|Overall Study|Death|0|||
13174899|NCT02288559|26131282|FG000|Overall Study|Lost to Follow-up|0|||
13174900|NCT02288559|26131283|FG001|Overall Study|Lost to Follow-up|0|||
13174901|NCT02288559|26131284|FG002|Overall Study|Lost to Follow-up|0|||
13174902|NCT02288559|26131285|FG003|Overall Study|Lost to Follow-up|1|||
13174903|NCT02288559|26131282|FG000|Overall Study|Withdrawal by Subject|0|||
13108490|NCT03253796|25892361|FG002|Period 1: Run-In|Lack of Qualifying Event|0|||
13108491|NCT03253796|25892362|FG003|Period 1: Run-In|Lack of Qualifying Event|0|||
13108492|NCT03253796|25892363|FG004|Period 1: Run-In|Lack of Qualifying Event|0|||
13174904|NCT02288559|26131283|FG001|Overall Study|Withdrawal by Subject|0|||
13174905|NCT02288559|26131284|FG002|Overall Study|Withdrawal by Subject|2|||
13174906|NCT02288559|26131285|FG003|Overall Study|Withdrawal by Subject|1|||
13174907|NCT02288559|26131282|FG000|Overall Study|Reason Not Specified|0|||
13174908|NCT02288559|26131283|FG001|Overall Study|Reason Not Specified|0|||
13174909|NCT02288559|26131284|FG002|Overall Study|Reason Not Specified|3|||
13174910|NCT02288559|26131285|FG003|Overall Study|Reason Not Specified|0|||
13174911|NCT02288325|26131296|FG000|Run-in Period|Adverse Event|48|||
13174912|NCT02288325|26131297|FG001|Run-in Period|Adverse Event|0|||
13174913|NCT02288325|26131298|FG002|Run-in Period|Adverse Event|0|||
13174914|NCT02288325|26131296|FG000|Run-in Period|Lack of Efficacy|16|||
13174915|NCT02288325|26131297|FG001|Run-in Period|Lack of Efficacy|0|||
13174916|NCT02288325|26131298|FG002|Run-in Period|Lack of Efficacy|0|||
13174917|NCT02288325|26131296|FG000|Run-in Period|Withdrawal of Consent|28|||
13174918|NCT02288325|26131297|FG001|Run-in Period|Withdrawal of Consent|0|||
13174919|NCT02288325|26131298|FG002|Run-in Period|Withdrawal of Consent|0|||
13174920|NCT02288325|26131296|FG000|Run-in Period|Lost to Follow-up|25|||
13174921|NCT02288325|26131297|FG001|Run-in Period|Lost to Follow-up|0|||
13174922|NCT02288325|26131298|FG002|Run-in Period|Lost to Follow-up|0|||
13174923|NCT02288325|26131296|FG000|Run-in Period|Protocol Violation|17|||
13174924|NCT02288325|26131297|FG001|Run-in Period|Protocol Violation|0|||
13174925|NCT02288325|26131298|FG002|Run-in Period|Protocol Violation|0|||
13174926|NCT02288325|26131296|FG000|Run-in Period|Non-Compliance With Study Drug|3|||
13174927|NCT02288325|26131297|FG001|Run-in Period|Non-Compliance With Study Drug|0|||
13174928|NCT02288325|26131298|FG002|Run-in Period|Non-Compliance With Study Drug|0|||
13174929|NCT02288325|26131296|FG000|Run-in Period|Reason not Specified|8|||
13174930|NCT02288325|26131297|FG001|Run-in Period|Reason not Specified|0|||
13174931|NCT02288325|26131298|FG002|Run-in Period|Reason not Specified|0|||
13174932|NCT02288325|26131296|FG000|Stabilization Period|Adverse Event|13|||
13174933|NCT02288325|26131297|FG001|Stabilization Period|Adverse Event|0|||
13174934|NCT02288325|26131298|FG002|Stabilization Period|Adverse Event|0|||
13174935|NCT02288325|26131296|FG000|Stabilization Period|Lack of Efficacy|22|||
13174936|NCT02288325|26131297|FG001|Stabilization Period|Lack of Efficacy|0|||
13174937|NCT02288325|26131298|FG002|Stabilization Period|Lack of Efficacy|0|||
13174938|NCT02288325|26131296|FG000|Stabilization Period|Withdrawal of Consent|23|||
13174939|NCT02288325|26131297|FG001|Stabilization Period|Withdrawal of Consent|0|||
13174940|NCT02288325|26131298|FG002|Stabilization Period|Withdrawal of Consent|0|||
13174941|NCT02288325|26131296|FG000|Stabilization Period|Lost to Follow-up|12|||
13174942|NCT02288325|26131297|FG001|Stabilization Period|Lost to Follow-up|0|||
13174943|NCT02288325|26131298|FG002|Stabilization Period|Lost to Follow-up|0|||
13174944|NCT02288325|26131296|FG000|Stabilization Period|Protocol Violation|8|||
13174945|NCT02288325|26131297|FG001|Stabilization Period|Protocol Violation|0|||
13174946|NCT02288325|26131298|FG002|Stabilization Period|Protocol Violation|0|||
13174947|NCT02288325|26131296|FG000|Stabilization Period|Non-Compliance With Study Drug|5|||
13174948|NCT02288325|26131297|FG001|Stabilization Period|Non-Compliance With Study Drug|0|||
13174949|NCT02288325|26131298|FG002|Stabilization Period|Non-Compliance With Study Drug|0|||
13174950|NCT02288325|26131296|FG000|Stabilization Period|Reason not Specified|15|||
13174951|NCT02288325|26131297|FG001|Stabilization Period|Reason not Specified|0|||
13174952|NCT02288325|26131298|FG002|Stabilization Period|Reason not Specified|0|||
13174953|NCT02288325|26131296|FG000|Double-blind Treatment Period|Adverse Event|0|||
13174954|NCT02288325|26131297|FG001|Double-blind Treatment Period|Adverse Event|2|||
13174955|NCT02288325|26131298|FG002|Double-blind Treatment Period|Adverse Event|5|||
13174956|NCT02288325|26131296|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
13174957|NCT02288325|26131297|FG001|Double-blind Treatment Period|Withdrawal of Consent|8|||
13174958|NCT02288325|26131298|FG002|Double-blind Treatment Period|Withdrawal of Consent|8|||
13174959|NCT02288325|26131296|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
13174960|NCT02288325|26131297|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
13174961|NCT02288325|26131298|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
13174962|NCT02288325|26131296|FG000|Double-blind Treatment Period|Protocol Violation|0|||
13174963|NCT02288325|26131297|FG001|Double-blind Treatment Period|Protocol Violation|1|||
13174964|NCT02288325|26131298|FG002|Double-blind Treatment Period|Protocol Violation|2|||
13174965|NCT02288325|26131296|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0|||
13174966|NCT02288325|26131297|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1|||
13174967|NCT02288325|26131298|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4|||
13174968|NCT02288325|26131296|FG000|Double-blind Treatment Period|Multiple Reasons|0|||
13174969|NCT02288325|26131297|FG001|Double-blind Treatment Period|Multiple Reasons|8|||
13174970|NCT02288325|26131298|FG002|Double-blind Treatment Period|Multiple Reasons|2|||
13174971|NCT02288312|26131325|FG000|Overall Study|Pregnancy|1|||
13174972|NCT02288312|26131326|FG001|Overall Study|Pregnancy|0|||
13174973|NCT02288312|26131327|FG002|Overall Study|Pregnancy|0|||
13174974|NCT02288182|26131346|FG000|Overall Study|Adverse Event|0|||
13174975|NCT02288182|26131347|FG001|Overall Study|Adverse Event|1|||
13174976|NCT02288182|26131346|FG000|Overall Study|Lost to Follow-up|0|||
13174977|NCT02288182|26131347|FG001|Overall Study|Lost to Follow-up|1|||
13174978|NCT02288091|26131357|FG000|Overall Study|Lost to Follow-up|1|||
13174979|NCT02288091|26131357|FG000|Overall Study|Screen fail|7|||
13174980|NCT02287922|26131459|FG000|Overall Study|Adverse Event|1|||
13174981|NCT02287922|26131460|FG001|Overall Study|Adverse Event|1|||
13174982|NCT02287922|26131461|FG002|Overall Study|Adverse Event|3|||
13174983|NCT02287922|26131462|FG003|Overall Study|Adverse Event|4|||
13174984|NCT02287922|26131459|FG000|Overall Study|Withdrawal by Subject|1|||
13174985|NCT02287922|26131460|FG001|Overall Study|Withdrawal by Subject|1|||
13174986|NCT02287922|26131461|FG002|Overall Study|Withdrawal by Subject|1|||
13174987|NCT02287922|26131462|FG003|Overall Study|Withdrawal by Subject|2|||
13174988|NCT02287922|26131459|FG000|Overall Study|Lost to Follow-up|0|||
13174989|NCT02287922|26131460|FG001|Overall Study|Lost to Follow-up|0|||
13174990|NCT02287922|26131461|FG002|Overall Study|Lost to Follow-up|1|||
13174991|NCT02287922|26131462|FG003|Overall Study|Lost to Follow-up|0|||
13174992|NCT02287922|26131459|FG000|Overall Study|Sponsor's decision|0|||
13174993|NCT02287922|26131460|FG001|Overall Study|Sponsor's decision|0|||
13174994|NCT02287922|26131461|FG002|Overall Study|Sponsor's decision|0|||
13174995|NCT02287922|26131462|FG003|Overall Study|Sponsor's decision|1|||
13174996|NCT02287922|26131459|FG000|Overall Study|Other|1|||
13174997|NCT02287922|26131460|FG001|Overall Study|Other|0|||
13174998|NCT02287922|26131461|FG002|Overall Study|Other|2|||
13174999|NCT02287922|26131462|FG003|Overall Study|Other|0|||
13175000|NCT02287896|26131485|FG000|Second Injection Visit|Withdrawal by Subject|0|||
13175001|NCT02287896|26131486|FG001|Second Injection Visit|Withdrawal by Subject|1|||
13205651|NCT01962987|26232537|FG002|Overall Study|Adverse Event|0|||
13205652|NCT01962987|26232535|FG000|Overall Study|Lost to Follow-up|0|||
13205653|NCT01962987|26232536|FG001|Overall Study|Lost to Follow-up|0|||
13205654|NCT01962987|26232537|FG002|Overall Study|Lost to Follow-up|1|||
13205655|NCT01962987|26232535|FG000|Overall Study|Non compliance with dosing requirements|4|||
13205656|NCT01962987|26232536|FG001|Overall Study|Non compliance with dosing requirements|2|||
13205657|NCT01962987|26232537|FG002|Overall Study|Non compliance with dosing requirements|0|||
13205658|NCT01962987|26232535|FG000|Overall Study|Miscellaneous|1|||
13205659|NCT01962987|26232536|FG001|Overall Study|Miscellaneous|9|||
13205660|NCT01962987|26232537|FG002|Overall Study|Miscellaneous|2|||
13205661|NCT01962987|26232535|FG000|Overall Study|Restricted medication|5|||
13205662|NCT01962987|26232536|FG001|Overall Study|Restricted medication|1|||
13205663|NCT01962987|26232537|FG002|Overall Study|Restricted medication|1|||
13205664|NCT01962987|26232535|FG000|Overall Study|Serious Adverse Event|1|||
13205665|NCT01962987|26232536|FG001|Overall Study|Serious Adverse Event|0|||
13205666|NCT01962987|26232537|FG002|Overall Study|Serious Adverse Event|0|||
13205667|NCT01962987|26232535|FG000|Overall Study|Withdrawal by Subject|11|||
13205668|NCT01962987|26232536|FG001|Overall Study|Withdrawal by Subject|10|||
13205669|NCT01962987|26232537|FG002|Overall Study|Withdrawal by Subject|6|||
13108493|NCT03253796|25892359|FG000|Period 1: Run-In|Protocol Violation|5|||
13108494|NCT03253796|25892360|FG001|Period 1: Run-In|Protocol Violation|0|||
13108495|NCT03253796|25892361|FG002|Period 1: Run-In|Protocol Violation|0|||
13108496|NCT03253796|25892362|FG003|Period 1: Run-In|Protocol Violation|0|||
13108497|NCT03253796|25892363|FG004|Period 1: Run-In|Protocol Violation|0|||
13108498|NCT03253796|25892359|FG000|Period 1: Run-In|Withdrawal by Subject|8|||
13205670|NCT01962987|26232535|FG000|Overall Study|Randomized in Error|4|||
13205671|NCT01962987|26232536|FG001|Overall Study|Randomized in Error|2|||
13205672|NCT01962987|26232537|FG002|Overall Study|Randomized in Error|2|||
13205673|NCT01962974|26232545|FG000|Overall Study|Study termination|7|||
13205674|NCT01962948|26232568|FG000|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
13205675|NCT01962948|26232569|FG001|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
13205676|NCT01962948|26232570|FG002|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|6|||
13205677|NCT01962948|26232571|FG003|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|0|||
13205678|NCT01962922|26232600|FG000|PK Portion Day 7|Withdrawal by Subject|3|||
13205679|NCT01962922|26232601|FG001|PK Portion Day 7|Withdrawal by Subject|0|||
13205680|NCT01962922|26232600|FG000|PK Portion Day 7|non-compliance|1|||
13205681|NCT01962922|26232601|FG001|PK Portion Day 7|non-compliance|0|||
13205682|NCT01962922|26232600|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4|||
13205683|NCT01962922|26232601|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3|||
13205684|NCT01962922|26232600|FG000|Extendion Portion (up to Month 6)|Physician Decision|1|||
13205685|NCT01962922|26232601|FG001|Extendion Portion (up to Month 6)|Physician Decision|0|||
13205686|NCT01962896|26232610|FG000|Overall Study|Lack of Efficacy|4|||
13205687|NCT01962493|26232637|FG000|Overall Study|Adverse Event|1|||
13205688|NCT01962493|26232638|FG001|Overall Study|Adverse Event|2|||
13205689|NCT01962493|26232637|FG000|Overall Study|Protocol Violation|0|||
13108499|NCT03253796|25892360|FG001|Period 1: Run-In|Withdrawal by Subject|0|||
13108500|NCT03253796|25892361|FG002|Period 1: Run-In|Withdrawal by Subject|0|||
13108501|NCT03253796|25892362|FG003|Period 1: Run-In|Withdrawal by Subject|0|||
13108502|NCT03253796|25892363|FG004|Period 1: Run-In|Withdrawal by Subject|0|||
13108503|NCT03253796|25892359|FG000|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
13175002|NCT02287883|26131503|FG000|Overall Study|Death|8|||
13175003|NCT02287883|26131504|FG001|Overall Study|Death|7|||
13175004|NCT02287883|26131503|FG000|Overall Study|No longer eligible|222|||
13175005|NCT02287883|26131504|FG001|Overall Study|No longer eligible|182|||
13175006|NCT02287883|26131503|FG000|Overall Study|Non-response to survey|229|||
13175007|NCT02287883|26131504|FG001|Overall Study|Non-response to survey|237|||
13175008|NCT02287623|26131527|FG000|Overall Study|Protocol Violation|0|||
13108504|NCT03253796|25892360|FG001|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
13108505|NCT03253796|25892361|FG002|Period 2: Withdrawal vs Continued Tx|Adverse Event|2|||
13175009|NCT02287623|26131528|FG001|Overall Study|Protocol Violation|1|||
13175010|NCT02287610|26131563|FG000|Overall Study|Lost to Follow-up|3|||
13175011|NCT02287610|26131563|FG000|Overall Study|Withdrawal by Subject|8|||
13175012|NCT02287610|26131563|FG000|Overall Study|Excluded-investigator non-responsiveness|5|||
13175013|NCT02287584|26131593|FG000|the Double-blind Phase|Adverse Event|17|||
13175014|NCT02287584|26131594|FG001|the Double-blind Phase|Adverse Event|17|||
13175015|NCT02287584|26131595|FG002|the Double-blind Phase|Adverse Event|12|||
13175016|NCT02287584|26131596|FG003|the Double-blind Phase|Adverse Event|0|||
13175017|NCT02287584|26131597|FG004|the Double-blind Phase|Adverse Event|0|||
13175018|NCT02287584|26131598|FG005|the Double-blind Phase|Adverse Event|0|||
13175019|NCT02287584|26131593|FG000|the Double-blind Phase|Lack of Efficacy|18|||
13175020|NCT02287584|26131594|FG001|the Double-blind Phase|Lack of Efficacy|8|||
13175021|NCT02287584|26131595|FG002|the Double-blind Phase|Lack of Efficacy|8|||
13175022|NCT02287584|26131596|FG003|the Double-blind Phase|Lack of Efficacy|0|||
13175023|NCT02287584|26131597|FG004|the Double-blind Phase|Lack of Efficacy|0|||
13175024|NCT02287584|26131598|FG005|the Double-blind Phase|Lack of Efficacy|0|||
13175025|NCT02287584|26131593|FG000|the Double-blind Phase|Lost to Follow-up|0|||
13175026|NCT02287584|26131594|FG001|the Double-blind Phase|Lost to Follow-up|1|||
13175027|NCT02287584|26131595|FG002|the Double-blind Phase|Lost to Follow-up|1|||
13175028|NCT02287584|26131596|FG003|the Double-blind Phase|Lost to Follow-up|0|||
13175029|NCT02287584|26131597|FG004|the Double-blind Phase|Lost to Follow-up|0|||
13175030|NCT02287584|26131598|FG005|the Double-blind Phase|Lost to Follow-up|0|||
13175031|NCT02287584|26131593|FG000|the Double-blind Phase|Withdrawal by Subject|17|||
13175032|NCT02287584|26131594|FG001|the Double-blind Phase|Withdrawal by Subject|17|||
13175033|NCT02287584|26131595|FG002|the Double-blind Phase|Withdrawal by Subject|11|||
13175034|NCT02287584|26131596|FG003|the Double-blind Phase|Withdrawal by Subject|0|||
13175035|NCT02287584|26131597|FG004|the Double-blind Phase|Withdrawal by Subject|0|||
13175036|NCT02287584|26131598|FG005|the Double-blind Phase|Withdrawal by Subject|0|||
13175037|NCT02287584|26131593|FG000|the Double-blind Phase|Pregnancy|0|||
13175038|NCT02287584|26131594|FG001|the Double-blind Phase|Pregnancy|1|||
13175039|NCT02287584|26131595|FG002|the Double-blind Phase|Pregnancy|0|||
13175040|NCT02287584|26131596|FG003|the Double-blind Phase|Pregnancy|0|||
13175041|NCT02287584|26131597|FG004|the Double-blind Phase|Pregnancy|0|||
13175042|NCT02287584|26131598|FG005|the Double-blind Phase|Pregnancy|0|||
13175043|NCT02287584|26131593|FG000|the Double-blind Phase|Protocol Violation|0|||
13175044|NCT02287584|26131594|FG001|the Double-blind Phase|Protocol Violation|3|||
13175045|NCT02287584|26131595|FG002|the Double-blind Phase|Protocol Violation|0|||
13175046|NCT02287584|26131596|FG003|the Double-blind Phase|Protocol Violation|0|||
13175047|NCT02287584|26131597|FG004|the Double-blind Phase|Protocol Violation|0|||
13175048|NCT02287584|26131598|FG005|the Double-blind Phase|Protocol Violation|0|||
13175049|NCT02287584|26131593|FG000|the Double-blind Phase|other reasons|0|||
13175050|NCT02287584|26131594|FG001|the Double-blind Phase|other reasons|0|||
13175051|NCT02287584|26131595|FG002|the Double-blind Phase|other reasons|1|||
13175052|NCT02287584|26131596|FG003|the Double-blind Phase|other reasons|0|||
13175053|NCT02287584|26131597|FG004|the Double-blind Phase|other reasons|0|||
13108506|NCT03253796|25892362|FG003|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
13108507|NCT03253796|25892363|FG004|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
13108508|NCT03253796|25892359|FG000|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
13175054|NCT02287584|26131598|FG005|the Double-blind Phase|other reasons|0|||
13175055|NCT02287584|26131593|FG000|the Open-label Phase|Did not receive drug|0|||
13175056|NCT02287584|26131594|FG001|the Open-label Phase|Did not receive drug|0|||
13175057|NCT02287584|26131595|FG002|the Open-label Phase|Did not receive drug|0|||
13175058|NCT02287584|26131596|FG003|the Open-label Phase|Did not receive drug|7|||
13175059|NCT02287584|26131597|FG004|the Open-label Phase|Did not receive drug|6|||
13175060|NCT02287584|26131598|FG005|the Open-label Phase|Did not receive drug|4|||
13175061|NCT02287584|26131593|FG000|the Open-label Phase|Adverse Event|0|||
13175062|NCT02287584|26131594|FG001|the Open-label Phase|Adverse Event|0|||
13175063|NCT02287584|26131595|FG002|the Open-label Phase|Adverse Event|0|||
13175064|NCT02287584|26131596|FG003|the Open-label Phase|Adverse Event|15|||
13175065|NCT02287584|26131597|FG004|the Open-label Phase|Adverse Event|12|||
13108509|NCT03253796|25892360|FG001|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
13108510|NCT03253796|25892361|FG002|Period 2: Withdrawal vs Continued Tx|Physician Decision|1|||
13175066|NCT02287584|26131598|FG005|the Open-label Phase|Adverse Event|16|||
13175067|NCT02287584|26131593|FG000|the Open-label Phase|Lack of Efficacy|0|||
13175068|NCT02287584|26131594|FG001|the Open-label Phase|Lack of Efficacy|0|||
13175069|NCT02287584|26131595|FG002|the Open-label Phase|Lack of Efficacy|0|||
13175070|NCT02287584|26131596|FG003|the Open-label Phase|Lack of Efficacy|8|||
13175071|NCT02287584|26131597|FG004|the Open-label Phase|Lack of Efficacy|3|||
13175072|NCT02287584|26131598|FG005|the Open-label Phase|Lack of Efficacy|7|||
13175073|NCT02287584|26131593|FG000|the Open-label Phase|Lost to Follow-up|0|||
13175074|NCT02287584|26131594|FG001|the Open-label Phase|Lost to Follow-up|0|||
13175075|NCT02287584|26131595|FG002|the Open-label Phase|Lost to Follow-up|0|||
13175076|NCT02287584|26131596|FG003|the Open-label Phase|Lost to Follow-up|4|||
13108511|NCT03253796|25892362|FG003|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
13108512|NCT03253796|25892363|FG004|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
13108513|NCT03253796|25892359|FG000|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
13108514|NCT03253796|25892360|FG001|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
13175077|NCT02287584|26131597|FG004|the Open-label Phase|Lost to Follow-up|1|||
13175078|NCT02287584|26131598|FG005|the Open-label Phase|Lost to Follow-up|2|||
13175079|NCT02287584|26131593|FG000|the Open-label Phase|Withdrawal by Subject|0|||
13175080|NCT02287584|26131594|FG001|the Open-label Phase|Withdrawal by Subject|0|||
13175081|NCT02287584|26131595|FG002|the Open-label Phase|Withdrawal by Subject|0|||
13175082|NCT02287584|26131596|FG003|the Open-label Phase|Withdrawal by Subject|18|||
13175083|NCT02287584|26131597|FG004|the Open-label Phase|Withdrawal by Subject|29|||
13175084|NCT02287584|26131598|FG005|the Open-label Phase|Withdrawal by Subject|21|||
13175085|NCT02287584|26131593|FG000|the Open-label Phase|non-compliance|0|||
13175086|NCT02287584|26131594|FG001|the Open-label Phase|non-compliance|0|||
13175087|NCT02287584|26131595|FG002|the Open-label Phase|non-compliance|0|||
13175088|NCT02287584|26131596|FG003|the Open-label Phase|non-compliance|2|||
13175089|NCT02287584|26131597|FG004|the Open-label Phase|non-compliance|5|||
13175090|NCT02287584|26131598|FG005|the Open-label Phase|non-compliance|1|||
13175091|NCT02287584|26131593|FG000|the Open-label Phase|other reasons|0|||
13175092|NCT02287584|26131594|FG001|the Open-label Phase|other reasons|0|||
13175093|NCT02287584|26131595|FG002|the Open-label Phase|other reasons|0|||
13175094|NCT02287584|26131596|FG003|the Open-label Phase|other reasons|3|||
13175095|NCT02287584|26131597|FG004|the Open-label Phase|other reasons|6|||
13175096|NCT02287584|26131598|FG005|the Open-label Phase|other reasons|6|||
13175097|NCT02287467|26131647|FG000|Overall Study|Protocol Violation|12|||
13175098|NCT02287467|26131648|FG001|Overall Study|Protocol Violation|9|||
13175099|NCT02287402|26131665|FG000|Treatment Period|Adverse Event|17|||
13175100|NCT02287402|26131665|FG000|Treatment Period|Voluntary Withdrawal|10|||
13175101|NCT02287402|26131665|FG000|Follow-up|Lost to Follow-up|1|||
13175102|NCT02287402|26131665|FG000|Follow-up|Voluntary Withdrawal|2|||
13175103|NCT02287233|26131717|FG000|Overall Study|Adverse Event Not Related to Progression|1|||
13175104|NCT02287233|26131718|FG001|Overall Study|Adverse Event Not Related to Progression|2|||
13175105|NCT02287233|26131719|FG002|Overall Study|Adverse Event Not Related to Progression|10|||
13175106|NCT02287233|26131717|FG000|Overall Study|Adverse Event Related to Progression|0|||
13175107|NCT02287233|26131718|FG001|Overall Study|Adverse Event Related to Progression|2|||
13175108|NCT02287233|26131719|FG002|Overall Study|Adverse Event Related to Progression|8|||
13175109|NCT02287233|26131717|FG000|Overall Study|Physician Decision|1|||
13175110|NCT02287233|26131718|FG001|Overall Study|Physician Decision|2|||
13175111|NCT02287233|26131719|FG002|Overall Study|Physician Decision|4|||
13175112|NCT02287233|26131717|FG000|Overall Study|Progressive Disease with Death|0|||
13175113|NCT02287233|26131718|FG001|Overall Study|Progressive Disease with Death|0|||
13175114|NCT02287233|26131719|FG002|Overall Study|Progressive Disease with Death|10|||
13175115|NCT02287233|26131717|FG000|Overall Study|Progressive Disease Without Death|2|||
13175116|NCT02287233|26131718|FG001|Overall Study|Progressive Disease Without Death|3|||
13175117|NCT02287233|26131719|FG002|Overall Study|Progressive Disease Without Death|20|||
13175118|NCT02287233|26131717|FG000|Overall Study|Withdrawal by Subject|1|||
13175119|NCT02287233|26131718|FG001|Overall Study|Withdrawal by Subject|1|||
13175120|NCT02287233|26131719|FG002|Overall Study|Withdrawal by Subject|7|||
13175121|NCT02287233|26131717|FG000|Overall Study|Other|3|||
13175122|NCT02287233|26131718|FG001|Overall Study|Other|0|||
13175123|NCT02287233|26131719|FG002|Overall Study|Other|15|||
13175124|NCT02287233|26131717|FG000|Overall Study|Did Not Receive Treatment|0|||
13108515|NCT03253796|25892361|FG002|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|2|||
13108516|NCT03253796|25892362|FG003|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|3|||
13108517|NCT03253796|25892363|FG004|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
13108518|NCT03253796|25892359|FG000|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
13175125|NCT02287233|26131718|FG001|Overall Study|Did Not Receive Treatment|0|||
13175126|NCT02287233|26131719|FG002|Overall Study|Did Not Receive Treatment|2|||
13175127|NCT02287038|26131734|FG000|Overall Study|Stopped attending appointments|3|||
13175128|NCT02287038|26131735|FG001|Overall Study|Stopped attending appointments|2|||
13175129|NCT02287038|26131734|FG000|Overall Study|Anxiety after starting medication|0|||
13175130|NCT02287038|26131735|FG001|Overall Study|Anxiety after starting medication|1|||
13175131|NCT02287038|26131734|FG000|Overall Study|Nausea after starting medication|1|||
13175132|NCT02287038|26131735|FG001|Overall Study|Nausea after starting medication|0|||
13175133|NCT02287038|26131734|FG000|Overall Study|Abnormal ECG after starting medication|1|||
13175134|NCT02287038|26131735|FG001|Overall Study|Abnormal ECG after starting medication|0|||
13175135|NCT02287025|26131751|FG000|Overall Study|Not treated|2|||
13175136|NCT02287025|26131752|FG001|Overall Study|Not treated|0|||
13175137|NCT02287025|26131751|FG000|Overall Study|Progression of disease|3|||
13175138|NCT02287025|26131752|FG001|Overall Study|Progression of disease|2|||
13175139|NCT02287025|26131751|FG000|Overall Study|Adverse Event|2|||
13175140|NCT02287025|26131752|FG001|Overall Study|Adverse Event|4|||
13175141|NCT02287025|26131751|FG000|Overall Study|Withdrawal by Subject|2|||
13175142|NCT02287025|26131752|FG001|Overall Study|Withdrawal by Subject|2|||
13175143|NCT02287025|26131751|FG000|Overall Study|Screening failed|1|||
13175144|NCT02287025|26131752|FG001|Overall Study|Screening failed|1|||
13175145|NCT02286960|26131771|FG000|Overall Study|Lost to Follow-up|3|||
13175146|NCT02286960|26131772|FG001|Overall Study|Lost to Follow-up|3|||
13175147|NCT02286947|26131783|FG000|Overall Study|Withdrawal by Subject|2|||
13175148|NCT02286895|26131832|FG000|Assessed for Measles Seroconversion|Protocol Violation|1|||
13175149|NCT02286895|26131833|FG001|Assessed for Measles Seroconversion|Protocol Violation|4|||
13175150|NCT02286895|26131832|FG000|Assessed for Measles Seroconversion|Missing measurement|6|||
13175151|NCT02286895|26131833|FG001|Assessed for Measles Seroconversion|Missing measurement|3|||
13175152|NCT02286895|26131832|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41|||
13175153|NCT02286895|26131833|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32|||
13175154|NCT02286843|26131839|FG000|Overall Study|Not Treated|4|||
13175155|NCT02286843|26131839|FG000|Overall Study|Protocol Violation|1|||
13175156|NCT02286843|26131839|FG000|Overall Study|Withdrawal by Subject|1|||
13175157|NCT02286713|26131858|FG000|One Week Follow-Up|Death|1|||
13175158|NCT02286713|26131859|FG001|One Week Follow-Up|Death|0|||
13175159|NCT02286713|26131858|FG000|One Week Follow-Up|Lost to Follow-up|17|||
13175160|NCT02286713|26131859|FG001|One Week Follow-Up|Lost to Follow-up|21|||
13175161|NCT02286713|26131858|FG000|One Week Follow-Up|Withdrawal by Subject|6|||
13175162|NCT02286713|26131859|FG001|One Week Follow-Up|Withdrawal by Subject|3|||
13175163|NCT02286713|26131858|FG000|Three Month Follow-Up|Death|1|||
13175164|NCT02286713|26131859|FG001|Three Month Follow-Up|Death|1|||
13175165|NCT02286713|26131858|FG000|Three Month Follow-Up|Lost to Follow-up|26|||
13175166|NCT02286713|26131859|FG001|Three Month Follow-Up|Lost to Follow-up|24|||
13175167|NCT02286713|26131858|FG000|Three Month Follow-Up|Withdrawal by Subject|1|||
13175168|NCT02286713|26131859|FG001|Three Month Follow-Up|Withdrawal by Subject|1|||
13175169|NCT02286713|26131858|FG000|Six Month Follow-Up|Death|2|||
13175170|NCT02286713|26131859|FG001|Six Month Follow-Up|Death|0|||
13175171|NCT02286713|26131858|FG000|Six Month Follow-Up|Lost to Follow-up|30|||
13175172|NCT02286713|26131859|FG001|Six Month Follow-Up|Lost to Follow-up|27|||
13175173|NCT02286466|26131878|FG000|Overall Study|Death|1|||
13175174|NCT02286466|26131879|FG001|Overall Study|Death|3|||
13175175|NCT02286466|26131878|FG000|Overall Study|Withdrawal by Subject|5|||
13175176|NCT02286466|26131879|FG001|Overall Study|Withdrawal by Subject|2|||
13175177|NCT02286466|26131878|FG000|Overall Study|Lost to Follow-up|1|||
13175178|NCT02286466|26131879|FG001|Overall Study|Lost to Follow-up|4|||
13175179|NCT02286466|26131878|FG000|Overall Study|Declined Clinician Assessment|0|||
13175180|NCT02286466|26131879|FG001|Overall Study|Declined Clinician Assessment|1|||
13175181|NCT02286193|26131886|FG000|Overall Study|Referred: CRS unable to make contact|62|||
13175182|NCT02286193|26131886|FG000|Overall Study|Referred: unable to reach/resource sent|104|||
13175183|NCT02286193|26131886|FG000|Overall Study|Referred: Declined service|38|||
13175184|NCT02286102|26131903|FG000|Overall Study|Screen Failure|1|||
13175185|NCT02286102|26131904|FG001|Overall Study|Screen Failure|1|||
13175186|NCT02285998|26131935|FG000|Overall Study|Adverse Event|9|||
13175187|NCT02285998|26131936|FG001|Overall Study|Adverse Event|8|||
13175188|NCT02285998|26131935|FG000|Overall Study|Physician Decision|1|||
13175189|NCT02285998|26131936|FG001|Overall Study|Physician Decision|2|||
13175190|NCT02285998|26131935|FG000|Overall Study|Lost to Follow-up|176|||
13175191|NCT02285998|26131936|FG001|Overall Study|Lost to Follow-up|172|||
13175192|NCT02285998|26131935|FG000|Overall Study|Withdrawal by Subject|53|||
13175193|NCT02285998|26131936|FG001|Overall Study|Withdrawal by Subject|61|||
13175194|NCT02285998|26131935|FG000|Overall Study|Other Reasons|7|||
13175195|NCT02285998|26131936|FG001|Overall Study|Other Reasons|10|||
13175196|NCT02285920|26132011|FG000|Overall Study|Kidney transplantation|2|||
13175197|NCT02285920|26132012|FG001|Overall Study|Kidney transplantation|2|||
13175198|NCT02285920|26132013|FG002|Overall Study|Kidney transplantation|2|||
13175199|NCT02285920|26132014|FG003|Overall Study|Kidney transplantation|0|||
13175200|NCT02285920|26132011|FG000|Overall Study|Change to peritoneal dialysis|0|||
13175201|NCT02285920|26132012|FG001|Overall Study|Change to peritoneal dialysis|0|||
13175202|NCT02285920|26132013|FG002|Overall Study|Change to peritoneal dialysis|1|||
13175203|NCT02285920|26132014|FG003|Overall Study|Change to peritoneal dialysis|0|||
13175204|NCT02285920|26132011|FG000|Overall Study|Transfer to non-participating unit|0|||
13175205|NCT02285920|26132012|FG001|Overall Study|Transfer to non-participating unit|1|||
13175206|NCT02285920|26132013|FG002|Overall Study|Transfer to non-participating unit|0|||
13175207|NCT02285920|26132014|FG003|Overall Study|Transfer to non-participating unit|0|||
13175208|NCT02285920|26132011|FG000|Overall Study|Dialysis discontinuation|0|||
13175209|NCT02285920|26132012|FG001|Overall Study|Dialysis discontinuation|1|||
13175210|NCT02285920|26132013|FG002|Overall Study|Dialysis discontinuation|0|||
13175211|NCT02285920|26132014|FG003|Overall Study|Dialysis discontinuation|0|||
13175212|NCT02285920|26132011|FG000|Overall Study|Death|2|||
13175213|NCT02285920|26132012|FG001|Overall Study|Death|0|||
13175214|NCT02285920|26132013|FG002|Overall Study|Death|2|||
13175215|NCT02285920|26132014|FG003|Overall Study|Death|1|||
13175216|NCT02285855|26132027|FG000|Overall Study|Withdrawal by Subject|2|||
13175217|NCT02285855|26132028|FG001|Overall Study|Withdrawal by Subject|1|||
13175218|NCT02285777|26132087|FG000|Overall Study|Withdrawal by Subject|1|||
13175219|NCT02285777|26132088|FG001|Overall Study|Withdrawal by Subject|1|||
13175220|NCT02285777|26132087|FG000|Overall Study|Lost to Follow-up|4|||
13175221|NCT02285777|26132088|FG001|Overall Study|Lost to Follow-up|2|||
13175222|NCT02285361|26132097|FG000|Overall Study|Protocol Violation|43|||
13175223|NCT02285361|26132097|FG000|Overall Study|Lost to Follow-up|5|||
13175224|NCT02285361|26132097|FG000|Overall Study|Not taken GIOTRIF|2|||
13175225|NCT02285361|26132097|FG000|Overall Study|Consented prior to the contract date|1|||
13175226|NCT02285270|26132105|FG000|Overall Study|Lost to Follow-up|1|||
13175227|NCT02285270|26132105|FG000|Overall Study|Physician Decision|3|||
13175228|NCT02285270|26132105|FG000|Overall Study|Determined to be ineligible|1|||
13175229|NCT02285166|26132136|FG000|Overall Study|Case Report Forms Uncollected|564|||
13175230|NCT02285166|26132136|FG000|Overall Study|Protocol Deviation|402|||
13175231|NCT02285153|26132155|FG000|Overall Study|Adverse Event|1|||
13175232|NCT02285153|26132156|FG001|Overall Study|Adverse Event|0|||
13175233|NCT02285114|26132229|FG000|Overall Study|Investigator's Discretion|0|||
13175234|NCT02285114|26132230|FG001|Overall Study|Investigator's Discretion|2|||
13175235|NCT02285114|26132231|FG002|Overall Study|Investigator's Discretion|0|||
13175236|NCT02285114|26132229|FG000|Overall Study|Withdrew Consent|0|||
13175237|NCT02285114|26132230|FG001|Overall Study|Withdrew Consent|0|||
13175238|NCT02285114|26132231|FG002|Overall Study|Withdrew Consent|1|||
13175239|NCT02285114|26132229|FG000|Overall Study|Enrolled but not treated|1|||
13175240|NCT02285114|26132230|FG001|Overall Study|Enrolled but not treated|0|||
13175241|NCT02285114|26132231|FG002|Overall Study|Enrolled but not treated|0|||
13175242|NCT02285114|26132229|FG000|Overall Study|Still on study|21|||
13175243|NCT02285114|26132230|FG001|Overall Study|Still on study|5|||
13175244|NCT02285114|26132231|FG002|Overall Study|Still on study|2|||
13175245|NCT02285062|26132274|FG000|Overall Study|Withdrawal by Subject|12|||
13175246|NCT02285062|26132275|FG001|Overall Study|Withdrawal by Subject|17|||
13175247|NCT02285062|26132274|FG000|Overall Study|Death|58|||
13175248|NCT02285062|26132275|FG001|Overall Study|Death|62|||
13175249|NCT02285062|26132274|FG000|Overall Study|Lost to Follow-up|8|||
13175250|NCT02285062|26132275|FG001|Overall Study|Lost to Follow-up|5|||
13175251|NCT02285010|26132296|FG000|Overall Study|not abdominal hysterectomy|2|||
13175252|NCT02285010|26132297|FG001|Overall Study|not abdominal hysterectomy|0|||
13175253|NCT02285010|26132296|FG000|Overall Study|Not spinal anesthesia|3|||
13175254|NCT02285010|26132297|FG001|Overall Study|Not spinal anesthesia|1|||
13175255|NCT02284906|26132318|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
13175256|NCT02284906|26132319|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
13175257|NCT02284906|26132320|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
13175258|NCT02284906|26132318|FG000|Overall Study|Major Protocol Deviation|0|||
13175259|NCT02284906|26132319|FG001|Overall Study|Major Protocol Deviation|1|||
13175260|NCT02284906|26132320|FG002|Overall Study|Major Protocol Deviation|0|||
13175261|NCT02284906|26132318|FG000|Overall Study|Voluntary Withdrawal|2|||
13175262|NCT02284906|26132319|FG001|Overall Study|Voluntary Withdrawal|4|||
13175263|NCT02284906|26132320|FG002|Overall Study|Voluntary Withdrawal|5|||
13175264|NCT02284906|26132318|FG000|Overall Study|Study Termination|0|||
13175265|NCT02284906|26132319|FG001|Overall Study|Study Termination|11|||
13175266|NCT02284906|26132320|FG002|Overall Study|Study Termination|14|||
13175267|NCT02284906|26132318|FG000|Overall Study|Reason not Specified|1|||
13175268|NCT02284906|26132319|FG001|Overall Study|Reason not Specified|1|||
13175269|NCT02284906|26132320|FG002|Overall Study|Reason not Specified|0|||
13175270|NCT02284893|26132339|FG000|26 Week (Short Term)|Adverse Event|1|||
13175271|NCT02284893|26132340|FG001|26 Week (Short Term)|Adverse Event|9|||
13175272|NCT02284893|26132339|FG000|26 Week (Short Term)|Discontinuation by the subject|2|||
13175273|NCT02284893|26132340|FG001|26 Week (Short Term)|Discontinuation by the subject|2|||
13175274|NCT02284893|26132339|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7|||
13175275|NCT02284893|26132340|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10|||
13175276|NCT02284893|26132339|FG000|26 Week (Short Term)|Lost to Follow-up|3|||
13175277|NCT02284893|26132340|FG001|26 Week (Short Term)|Lost to Follow-up|1|||
13175278|NCT02284893|26132339|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5|||
13175279|NCT02284893|26132340|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8|||
13175280|NCT02284893|26132339|FG000|26 Week (Short Term)|Other|1|||
13175281|NCT02284893|26132340|FG001|26 Week (Short Term)|Other|1|||
13175282|NCT02284893|26132339|FG000|52 Week (Long Term)|Adverse Event|3|||
13175283|NCT02284893|26132340|FG001|52 Week (Long Term)|Adverse Event|1|||
13175284|NCT02284893|26132339|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0|||
13175285|NCT02284893|26132340|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1|||
13175286|NCT02284893|26132339|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4|||
13175287|NCT02284893|26132340|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6|||
13175288|NCT02284893|26132339|FG000|52 Week (Long Term)|Lost to Follow-up|2|||
13175289|NCT02284893|26132340|FG001|52 Week (Long Term)|Lost to Follow-up|2|||
13175290|NCT02284893|26132339|FG000|52 Week (Long Term)|Non-Compliance|2|||
13175291|NCT02284893|26132340|FG001|52 Week (Long Term)|Non-Compliance|3|||
13175292|NCT02284373|26132358|FG000|Overall Study|Withdrawal by Subject|0|||
13175293|NCT02284373|26132359|FG001|Overall Study|Withdrawal by Subject|1|||
13175294|NCT02284373|26132360|FG002|Overall Study|Withdrawal by Subject|0|||
13175295|NCT02284373|26132358|FG000|Overall Study|Other|0|||
13175296|NCT02284373|26132359|FG001|Overall Study|Other|1|||
13175297|NCT02284373|26132360|FG002|Overall Study|Other|0|||
13175298|NCT02284373|26132358|FG000|Overall Study|Lost to Follow-up|0|||
13175299|NCT02284373|26132359|FG001|Overall Study|Lost to Follow-up|1|||
13175300|NCT02284373|26132360|FG002|Overall Study|Lost to Follow-up|0|||
13175301|NCT02284347|26132368|FG000|Overall Study|Lost to Follow-up|2|||
13175302|NCT02284347|26132368|FG000|Overall Study|Withdrawn prior to treatment|1|||
13175303|NCT02284243|26132393|FG000|Overall Study|Lack of Efficacy|3|||
13175304|NCT02284243|26132394|FG001|Overall Study|Lack of Efficacy|3|||
13175305|NCT02284243|26132393|FG000|Overall Study|Adverse Event|1|||
13175306|NCT02284243|26132394|FG001|Overall Study|Adverse Event|0|||
13175307|NCT02284178|26132421|FG000|Overall Study|Met exclusion criteria|49|||
13175308|NCT02284178|26132422|FG001|Overall Study|Met exclusion criteria|54|||
13175309|NCT02284009|26132471|FG000|Overall Study|Adverse Event|3|||
13175310|NCT02284009|26132472|FG001|Overall Study|Adverse Event|0|||
13175311|NCT02284009|26132471|FG000|Overall Study|Lost to Follow-up|1|||
13175312|NCT02284009|26132472|FG001|Overall Study|Lost to Follow-up|3|||
13175313|NCT02284009|26132471|FG000|Overall Study|Physician Decision|0|||
13175314|NCT02284009|26132472|FG001|Overall Study|Physician Decision|2|||
13175315|NCT02284009|26132471|FG000|Overall Study|Withdrawal by Subject|2|||
13175316|NCT02284009|26132472|FG001|Overall Study|Withdrawal by Subject|5|||
13175317|NCT02283788|26132495|FG000|Overall Study|Adverse Event|1|||
13175318|NCT02283788|26132496|FG001|Overall Study|Adverse Event|3|||
13175319|NCT02283788|26132497|FG002|Overall Study|Adverse Event|5|||
13175320|NCT02283788|26132498|FG003|Overall Study|Adverse Event|1|||
13175321|NCT02283788|26132495|FG000|Overall Study|Withdrawal by Subject|0|||
13175322|NCT02283788|26132496|FG001|Overall Study|Withdrawal by Subject|1|||
13175323|NCT02283788|26132497|FG002|Overall Study|Withdrawal by Subject|0|||
13175324|NCT02283788|26132498|FG003|Overall Study|Withdrawal by Subject|1|||
13175325|NCT02283762|26132523|FG000|Main Treatment Phase (MT)|Adverse Event|9|||
13175326|NCT02283762|26132524|FG001|Main Treatment Phase (MT)|Adverse Event|9|||
13175327|NCT02283762|26132523|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1|||
13175328|NCT02283762|26132524|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0|||
13175329|NCT02283762|26132523|FG000|Main Treatment Phase (MT)|Physician Decision|1|||
13175330|NCT02283762|26132524|FG001|Main Treatment Phase (MT)|Physician Decision|1|||
13175331|NCT02283762|26132523|FG000|Main Treatment Phase (MT)|Pregnancy|0|||
13175332|NCT02283762|26132524|FG001|Main Treatment Phase (MT)|Pregnancy|1|||
13175333|NCT02283762|26132523|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7|||
13175334|NCT02283762|26132524|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4|||
13175335|NCT02283762|26132523|FG000|Long-term Extension Phase (LTE)|Adverse Event|2|||
13175336|NCT02283762|26132524|FG001|Long-term Extension Phase (LTE)|Adverse Event|6|||
13175337|NCT02283762|26132523|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
13175338|NCT02283762|26132524|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
13175339|NCT02283762|26132523|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1|||
13175340|NCT02283762|26132524|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0|||
13175341|NCT02283762|26132523|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4|||
13175342|NCT02283762|26132524|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3|||
13175343|NCT02283762|26132523|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1|||
13175344|NCT02283762|26132524|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1|||
13175345|NCT02283762|26132523|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0|||
13175346|NCT02283762|26132524|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1|||
13175347|NCT02283762|26132523|FG000|Long-term Extension Phase (LTE)|Physician Decision|1|||
13175348|NCT02283762|26132524|FG001|Long-term Extension Phase (LTE)|Physician Decision|2|||
13175349|NCT02283658|26132535|FG000|Overall Study|Withdrawal by Subject|1|||
13175350|NCT02283411|26132545|FG000|Overall Study|Withdrawal by Subject|3|||
13175351|NCT02283411|26132545|FG000|Overall Study|Screen Failed|28|||
13175352|NCT02283294|26132560|FG000|Overall Study|Lost to Follow-up|1|||
13175353|NCT02283294|26132561|FG001|Overall Study|Lost to Follow-up|1|||
13175354|NCT02283294|26132560|FG000|Overall Study|Withdrawal by Subject|1|||
13175355|NCT02283294|26132561|FG001|Overall Study|Withdrawal by Subject|6|||
13175356|NCT02283294|26132560|FG000|Overall Study|Protocol Violation|1|||
13175357|NCT02283294|26132561|FG001|Overall Study|Protocol Violation|0|||
13175358|NCT02283294|26132560|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0|||
13175359|NCT02283294|26132561|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1|||
13175360|NCT02283268|26132624|FG000|Overall Study|Withdrawal by Subject|1|||
13175361|NCT02282982|26132641|FG000|Overall Study|Lost to Follow-up|15|||
13175362|NCT02282982|26132641|FG000|Overall Study|Withdrew consent|2|||
13175363|NCT02282982|26132641|FG000|Overall Study|Death|4|||
13175364|NCT02282982|26132641|FG000|Overall Study|Lack of product|156|||
13175365|NCT02282982|26132641|FG000|Overall Study|Palivizumab is ended|11|||
13175366|NCT02282982|26132641|FG000|Overall Study|Other, not specified|18|||
13175367|NCT02282917|26132654|FG000|Overall Study|Withdrawal by Subject|1|||
13175368|NCT02282917|26132654|FG000|Overall Study|Screen Failure/Not Eligible|1|||
13175369|NCT02282813|26132681|FG000|Overall Study|Withdrawal by Subject|4|||
13175370|NCT02282813|26132682|FG001|Overall Study|Withdrawal by Subject|5|||
13175371|NCT02282813|26132683|FG002|Overall Study|Withdrawal by Subject|0|||
13175372|NCT02282813|26132681|FG000|Overall Study|Adverse Event|3|||
13175373|NCT02282813|26132682|FG001|Overall Study|Adverse Event|10|||
13175374|NCT02282813|26132683|FG002|Overall Study|Adverse Event|1|||
13175375|NCT02282813|26132681|FG000|Overall Study|Subject non-compliance|1|||
13175376|NCT02282813|26132682|FG001|Overall Study|Subject non-compliance|4|||
13175377|NCT02282813|26132683|FG002|Overall Study|Subject non-compliance|0|||
13175378|NCT02282813|26132681|FG000|Overall Study|Physician Decision|0|||
13175379|NCT02282813|26132682|FG001|Overall Study|Physician Decision|3|||
13175380|NCT02282813|26132683|FG002|Overall Study|Physician Decision|1|||
13175381|NCT02282813|26132681|FG000|Overall Study|Lost to Follow-up|2|||
13175382|NCT02282813|26132682|FG001|Overall Study|Lost to Follow-up|0|||
13175383|NCT02282813|26132683|FG002|Overall Study|Lost to Follow-up|1|||
13175384|NCT02282813|26132681|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1|||
13175385|NCT02282813|26132682|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0|||
13175386|NCT02282813|26132683|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0|||
13175387|NCT02282813|26132681|FG000|Overall Study|Lack of Efficacy|1|||
13175388|NCT02282813|26132682|FG001|Overall Study|Lack of Efficacy|0|||
13175389|NCT02282813|26132683|FG002|Overall Study|Lack of Efficacy|0|||
13175390|NCT02282813|26132681|FG000|Overall Study|Administrative reasons|0|||
13175391|NCT02282813|26132682|FG001|Overall Study|Administrative reasons|1|||
13175392|NCT02282813|26132683|FG002|Overall Study|Administrative reasons|0|||
13175393|NCT02282631|26132728|FG000|Overall Study|Lost to Follow-up|2|||
13175394|NCT02282631|26132729|FG001|Overall Study|Lost to Follow-up|0|||
13175395|NCT02282605|26132759|FG000|Overall Study|negative SA result on Day -1|3|||
13175396|NCT02282605|26132760|FG001|Overall Study|negative SA result on Day -1|0|||
13175397|NCT02282605|26132761|FG002|Overall Study|negative SA result on Day -1|0|||
13175398|NCT02282527|26132778|FG000|Overall Study|Lost to Follow-up|0|||
13175399|NCT02282527|26132779|FG001|Overall Study|Lost to Follow-up|1|||
13175400|NCT02282527|26132778|FG000|Overall Study|Lack of home health aid|1|||
13175401|NCT02282527|26132779|FG001|Overall Study|Lack of home health aid|0|||
13175402|NCT02282345|26132795|FG000|Overall Study|Progression|0|||
13175403|NCT02282345|26132796|FG001|Overall Study|Progression|1|||
13175404|NCT02282293|26132821|FG000|Overall Study|Lost to Follow-up|2|||
13175405|NCT02282293|26132822|FG001|Overall Study|Lost to Follow-up|2|||
13175406|NCT02282293|26132821|FG000|Overall Study|Unable to comply with study procedures|1|||
13175407|NCT02282293|26132822|FG001|Overall Study|Unable to comply with study procedures|0|||
13175408|NCT02282293|26132821|FG000|Overall Study|Moved out of study area|0|||
13175409|NCT02282293|26132822|FG001|Overall Study|Moved out of study area|1|||
13175410|NCT02282163|26132837|FG000|Overall Study|Protocol Violation|1|||
13175411|NCT02282020|26132889|FG000|Overall Study|Objective Disease Progression|128|||
13175412|NCT02282020|26132890|FG001|Overall Study|Objective Disease Progression|30|||
13175413|NCT02282020|26132889|FG000|Overall Study|Adverse Event|18|||
13175414|NCT02282020|26132890|FG001|Overall Study|Adverse Event|15|||
13175415|NCT02282020|26132889|FG000|Overall Study|Withdrawal by Subject|7|||
13175416|NCT02282020|26132890|FG001|Overall Study|Withdrawal by Subject|10|||
13175417|NCT02282020|26132889|FG000|Overall Study|Miscellaneous|5|||
13175418|NCT02282020|26132890|FG001|Overall Study|Miscellaneous|19|||
13175419|NCT02282020|26132889|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
13175420|NCT02282020|26132890|FG001|Overall Study|Severe Non-compliance to Protocol|0|||
13175421|NCT02282020|26132889|FG000|Overall Study|Developed Discontinuation Criteria|0|||
13175422|NCT02282020|26132890|FG001|Overall Study|Developed Discontinuation Criteria|2|||
13175423|NCT02282020|26132889|FG000|Overall Study|Withdrew Consent Prior to Dosing|0|||
13175424|NCT02282020|26132890|FG001|Overall Study|Withdrew Consent Prior to Dosing|12|||
13175425|NCT02281773|26132963|FG000|Overall Study|Adverse Event|6|||
13175426|NCT02281773|26132964|FG001|Overall Study|Adverse Event|1|||
13175427|NCT02281773|26132965|FG002|Overall Study|Adverse Event|4|||
13175428|NCT02281773|26132966|FG003|Overall Study|Adverse Event|8|||
13175429|NCT02281773|26132967|FG004|Overall Study|Adverse Event|9|||
13175430|NCT02281773|26132963|FG000|Overall Study|Protocol Violation|1|||
13175431|NCT02281773|26132964|FG001|Overall Study|Protocol Violation|0|||
13175432|NCT02281773|26132965|FG002|Overall Study|Protocol Violation|0|||
13175433|NCT02281773|26132966|FG003|Overall Study|Protocol Violation|2|||
13175434|NCT02281773|26132967|FG004|Overall Study|Protocol Violation|2|||
13175435|NCT02281773|26132963|FG000|Overall Study|Lost to Follow-up|2|||
13175436|NCT02281773|26132964|FG001|Overall Study|Lost to Follow-up|2|||
13175437|NCT02281773|26132965|FG002|Overall Study|Lost to Follow-up|6|||
13175438|NCT02281773|26132966|FG003|Overall Study|Lost to Follow-up|2|||
13175439|NCT02281773|26132967|FG004|Overall Study|Lost to Follow-up|10|||
13175440|NCT02281773|26132963|FG000|Overall Study|Withdrawal by Subject|2|||
13175441|NCT02281773|26132964|FG001|Overall Study|Withdrawal by Subject|8|||
13175442|NCT02281773|26132965|FG002|Overall Study|Withdrawal by Subject|6|||
13175443|NCT02281773|26132966|FG003|Overall Study|Withdrawal by Subject|6|||
13175444|NCT02281773|26132967|FG004|Overall Study|Withdrawal by Subject|8|||
13175445|NCT02281773|26132963|FG000|Overall Study|Other Reason|0|||
13175446|NCT02281773|26132964|FG001|Overall Study|Other Reason|4|||
13175447|NCT02281773|26132965|FG002|Overall Study|Other Reason|2|||
13175448|NCT02281773|26132966|FG003|Overall Study|Other Reason|3|||
13175449|NCT02281773|26132967|FG004|Overall Study|Other Reason|1|||
13175450|NCT02281760|26132979|FG000|Overall Study|Withdrawal by Subject|1|||
13175451|NCT02281552|26133024|FG000|Overall Study|Medication error|1|||
13175452|NCT02281552|26133025|FG001|Overall Study|Medication error|0|||
13175453|NCT02281552|26133024|FG000|Overall Study|Insufficient clinical response|0|||
13175454|NCT02281552|26133025|FG001|Overall Study|Insufficient clinical response|1|||
13175455|NCT02281552|26133024|FG000|Overall Study|Adverse Event|3|||
13175456|NCT02281552|26133025|FG001|Overall Study|Adverse Event|9|||
13175457|NCT02281357|26133044|FG000|Overall Study|Adverse Event|2|||
13175458|NCT02281357|26133045|FG001|Overall Study|Adverse Event|1|||
13175459|NCT02281357|26133044|FG000|Overall Study|Lost to Follow-up|1|||
13175460|NCT02281357|26133045|FG001|Overall Study|Lost to Follow-up|0|||
13175461|NCT02281357|26133044|FG000|Overall Study|Withdrawal by Subject|4|||
13175462|NCT02281357|26133045|FG001|Overall Study|Withdrawal by Subject|3|||
13175463|NCT02281318|26133064|FG000|Overall Study|Adverse Event|2|||
13175464|NCT02281318|26133065|FG001|Overall Study|Adverse Event|2|||
13175465|NCT02281318|26133064|FG000|Overall Study|Lack of Efficacy|2|||
13175466|NCT02281318|26133065|FG001|Overall Study|Lack of Efficacy|0|||
13175467|NCT02281318|26133064|FG000|Overall Study|Lost to Follow-up|2|||
13175468|NCT02281318|26133065|FG001|Overall Study|Lost to Follow-up|1|||
13175469|NCT02281318|26133064|FG000|Overall Study|Physician Decision|2|||
13175470|NCT02281318|26133065|FG001|Overall Study|Physician Decision|0|||
13175471|NCT02281318|26133064|FG000|Overall Study|Withdrawal by Subject|6|||
13175472|NCT02281318|26133065|FG001|Overall Study|Withdrawal by Subject|2|||
13175473|NCT02280863|26133097|FG000|Integrated Platform|Met stopping criteria|0|||
13175474|NCT02280863|26133098|FG001|Integrated Platform|Met stopping criteria|1|||
13175475|NCT02280499|26133106|FG000|Overall Study|Death|14|||
13175476|NCT02280499|26133106|FG000|Overall Study|Lost to Follow-up|42|||
13175477|NCT02280499|26133106|FG000|Overall Study|Adverse Event|5|||
13175478|NCT02280473|26133127|FG000|Overall Study|Adverse Event|1|||
13175479|NCT02280473|26133128|FG001|Overall Study|Adverse Event|1|||
13175480|NCT02280473|26133127|FG000|Overall Study|Lack of Efficacy|0|||
13175481|NCT02280473|26133128|FG001|Overall Study|Lack of Efficacy|1|||
13175482|NCT02280473|26133127|FG000|Overall Study|Lost to Follow-up|0|||
13175483|NCT02280473|26133128|FG001|Overall Study|Lost to Follow-up|1|||
13175484|NCT02280421|26133197|FG000|Washout (2 Weeks)|Adverse Event|0|||
13175485|NCT02280421|26133198|FG001|Washout (2 Weeks)|Adverse Event|1|||
13175486|NCT02280421|26133197|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
13175487|NCT02280421|26133198|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
13175488|NCT02280408|26133281|FG000|Overall Study|Lost to Follow-up|0|||
13175489|NCT02280408|26133282|FG001|Overall Study|Lost to Follow-up|2|||
13175490|NCT02280408|26133283|FG002|Overall Study|Lost to Follow-up|0|||
13175491|NCT02280408|26133284|FG003|Overall Study|Lost to Follow-up|0|||
13175492|NCT02280304|26133308|FG000|Overall Study|Lost to Follow-up|7|||
13175493|NCT02280304|26133309|FG001|Overall Study|Lost to Follow-up|8|||
13175494|NCT02280291|26133334|FG000|Overall Study|Lost to Follow-up|2|||
13175495|NCT02280291|26133335|FG001|Overall Study|Lost to Follow-up|1|||
13175496|NCT02280291|26133336|FG002|Overall Study|Lost to Follow-up|3|||
13175497|NCT02280291|26133337|FG003|Overall Study|Lost to Follow-up|8|||
13175498|NCT02280291|26133334|FG000|Overall Study|Protocol Violation|1|||
13175499|NCT02280291|26133335|FG001|Overall Study|Protocol Violation|0|||
13175500|NCT02280291|26133336|FG002|Overall Study|Protocol Violation|0|||
13175501|NCT02280291|26133337|FG003|Overall Study|Protocol Violation|0|||
13175502|NCT02280291|26133334|FG000|Overall Study|Other|1|||
13175503|NCT02280291|26133335|FG001|Overall Study|Other|1|||
13175504|NCT02280291|26133336|FG002|Overall Study|Other|0|||
13175505|NCT02280291|26133337|FG003|Overall Study|Other|0|||
13175506|NCT02280187|26133355|FG000|Overall Study|Lost to Follow-up|218|||
13175507|NCT02280096|26133390|FG000|Overall Study|Pregnancy|1|||
13175508|NCT02280096|26133391|FG001|Overall Study|Pregnancy|0|||
13175509|NCT02280096|26133390|FG000|Overall Study|Functional neurological disorder|1|||
13175510|NCT02280096|26133391|FG001|Overall Study|Functional neurological disorder|0|||
13175511|NCT02280096|26133390|FG000|Overall Study|Lack of attachment|0|||
13175512|NCT02280096|26133391|FG001|Overall Study|Lack of attachment|1|||
13175513|NCT02280044|26133406|FG000|Overall Study|Planned alternate|0|||
13175514|NCT02280044|26133407|FG001|Overall Study|Planned alternate|2|||
13175515|NCT02279862|26133430|FG000|Overall Study|Study drug toxicity|3|||
13175516|NCT02279862|26133431|FG001|Overall Study|Study drug toxicity|6|||
13175517|NCT02279862|26133430|FG000|Overall Study|No longer meets criteria|0|||
13175518|NCT02279862|26133431|FG001|Overall Study|No longer meets criteria|1|||
13175519|NCT02279862|26133430|FG000|Overall Study|Administrative reason by sponsor|0|||
13175520|NCT02279862|26133431|FG001|Overall Study|Administrative reason by sponsor|1|||
13175521|NCT02279862|26133430|FG000|Overall Study|Disease progression|5|||
13175522|NCT02279862|26133431|FG001|Overall Study|Disease progression|2|||
13175523|NCT02279862|26133430|FG000|Overall Study|Study closed by sponsor|16|||
13175524|NCT02279862|26133431|FG001|Overall Study|Study closed by sponsor|13|||
13175525|NCT02279862|26133430|FG000|Overall Study|Other|1|||
13175526|NCT02279862|26133431|FG001|Overall Study|Other|2|||
13175527|NCT02279862|26133430|FG000|Overall Study|Withdrawal by Subject|1|||
13175528|NCT02279862|26133431|FG001|Overall Study|Withdrawal by Subject|0|||
13175529|NCT02279732|26133448|FG000|Overall Study|Death|23|||
13175530|NCT02279732|26133449|FG001|Overall Study|Death|20|||
13175531|NCT02279732|26133448|FG000|Overall Study|Disease Progression|13|||
13175532|NCT02279732|26133449|FG001|Overall Study|Disease Progression|3|||
13175533|NCT02279732|26133448|FG000|Overall Study|Withdrawal by Subject|2|||
13175534|NCT02279732|26133449|FG001|Overall Study|Withdrawal by Subject|7|||
13175535|NCT02279732|26133448|FG000|Overall Study|Adverse Event|1|||
13175536|NCT02279732|26133449|FG001|Overall Study|Adverse Event|2|||
13175537|NCT02279732|26133448|FG000|Overall Study|Administrative Reason By Sponsor|0|||
13175538|NCT02279732|26133449|FG001|Overall Study|Administrative Reason By Sponsor|2|||
13175539|NCT02279732|26133448|FG000|Overall Study|Study Drug Toxicity|2|||
13175540|NCT02279732|26133449|FG001|Overall Study|Study Drug Toxicity|0|||
13175541|NCT02279732|26133448|FG000|Overall Study|Lost to Follow-up|0|||
13175542|NCT02279732|26133449|FG001|Overall Study|Lost to Follow-up|1|||
13175543|NCT02279732|26133448|FG000|Overall Study|Maximum Clinical Benefit|1|||
13175544|NCT02279732|26133449|FG001|Overall Study|Maximum Clinical Benefit|0|||
13175545|NCT02279732|26133448|FG000|Overall Study|Subject Requested to Discontinue|0|||
13175546|NCT02279732|26133449|FG001|Overall Study|Subject Requested to Discontinue|1|||
13175547|NCT02279732|26133448|FG000|Overall Study|Other|53|||
13175548|NCT02279732|26133449|FG001|Overall Study|Other|67|||
13175549|NCT02279732|26133448|FG000|Overall Study|Other|3|||
13175550|NCT02279732|26133449|FG001|Overall Study|Other|3|||
13175551|NCT02279719|26133510|FG000|Overall Study|Patients randomized but never treated|0|||
13175552|NCT02279719|26133511|FG001|Overall Study|Patients randomized but never treated|0|||
13175553|NCT02279719|26133512|FG002|Overall Study|Patients randomized but never treated|0|||
13175554|NCT02279719|26133513|FG003|Overall Study|Patients randomized but never treated|0|||
13175555|NCT02279719|26133514|FG004|Overall Study|Patients randomized but never treated|3|||
13175556|NCT02279719|26133515|FG005|Overall Study|Patients randomized but never treated|0|||
13175557|NCT02279719|26133516|FG006|Overall Study|Patients randomized but never treated|3|||
13175558|NCT02279524|26133555|FG000|Overall Study|Withdrawal by Subject|3|||
13175559|NCT02279524|26133556|FG001|Overall Study|Withdrawal by Subject|6|||
13175560|NCT02279524|26133557|FG002|Overall Study|Withdrawal by Subject|3|||
13175561|NCT02279524|26133555|FG000|Overall Study|Adverse Event|4|||
13175562|NCT02279524|26133556|FG001|Overall Study|Adverse Event|3|||
13175563|NCT02279524|26133557|FG002|Overall Study|Adverse Event|2|||
13175564|NCT02279524|26133555|FG000|Overall Study|Lost to Follow-up|1|||
13175565|NCT02279524|26133556|FG001|Overall Study|Lost to Follow-up|1|||
13175566|NCT02279524|26133557|FG002|Overall Study|Lost to Follow-up|0|||
13175567|NCT02279524|26133555|FG000|Overall Study|Disallowed medication|1|||
13175568|NCT02279524|26133556|FG001|Overall Study|Disallowed medication|1|||
13175569|NCT02279524|26133557|FG002|Overall Study|Disallowed medication|2|||
13175570|NCT02279524|26133555|FG000|Overall Study|Bariatric surgery|1|||
13175571|NCT02279524|26133556|FG001|Overall Study|Bariatric surgery|0|||
13175572|NCT02279524|26133557|FG002|Overall Study|Bariatric surgery|0|||
13175573|NCT02279498|26133573|FG000|Overall Study|Adverse Event|3|||
13175574|NCT02279498|26133574|FG001|Overall Study|Adverse Event|0|||
13175575|NCT02279498|26133573|FG000|Overall Study|Lack of Efficacy|4|||
13175576|NCT02279498|26133574|FG001|Overall Study|Lack of Efficacy|0|||
13175577|NCT02279498|26133573|FG000|Overall Study|Lost to Follow-up|0|||
13175578|NCT02279498|26133574|FG001|Overall Study|Lost to Follow-up|1|||
13175579|NCT02279498|26133573|FG000|Overall Study|Withdrawal by Subject|9|||
13175580|NCT02279498|26133574|FG001|Overall Study|Withdrawal by Subject|2|||
13175581|NCT02279498|26133573|FG000|Overall Study|Undefined|2|||
13175582|NCT02279498|26133574|FG001|Overall Study|Undefined|1|||
13175583|NCT02279420|26133580|FG000|Overall Study|Lost to Follow-up|23|||
13175584|NCT02279407|26133604|FG000|Overall Study|Couldn't swallow IP; noncompliance|0|||
13175585|NCT02279407|26133605|FG001|Overall Study|Couldn't swallow IP; noncompliance|0|||
13175586|NCT02279407|26133606|FG002|Overall Study|Couldn't swallow IP; noncompliance|2|||
13175587|NCT02279407|26133607|FG003|Overall Study|Couldn't swallow IP; noncompliance|0|||
13175588|NCT02279407|26133604|FG000|Overall Study|Withdrawal by Subject|1|||
13175589|NCT02279407|26133605|FG001|Overall Study|Withdrawal by Subject|0|||
13175590|NCT02279407|26133606|FG002|Overall Study|Withdrawal by Subject|1|||
13175591|NCT02279407|26133607|FG003|Overall Study|Withdrawal by Subject|1|||
13175592|NCT02279407|26133604|FG000|Overall Study|Adverse Event|1|||
13175593|NCT02279407|26133605|FG001|Overall Study|Adverse Event|1|||
13175594|NCT02279407|26133606|FG002|Overall Study|Adverse Event|2|||
13175595|NCT02279407|26133607|FG003|Overall Study|Adverse Event|0|||
13175596|NCT02279173|26133626|FG000|Overall Study|Protocol-specified Criteria|67|||
13175597|NCT02279173|26133626|FG000|Overall Study|Withdrawal by Subject|20|||
13175598|NCT02279173|26133626|FG000|Overall Study|Decision by Sponsor|4|||
13175599|NCT02279173|26133626|FG000|Overall Study|Lost to Follow-up|3|||
13175600|NCT02279043|26133666|FG000|Overall Study|Post-rand. exclusion - not eligible|1|||
13175601|NCT02279043|26133667|FG001|Overall Study|Post-rand. exclusion - not eligible|1|||
13175602|NCT02279043|26133668|FG002|Overall Study|Post-rand. exclusion - not eligible|0|||
13175603|NCT02279043|26133666|FG000|Overall Study|Lost to Follow-up|46|||
13175604|NCT02279043|26133667|FG001|Overall Study|Lost to Follow-up|88|||
13175605|NCT02279043|26133668|FG002|Overall Study|Lost to Follow-up|0|||
13175606|NCT02278952|26133680|FG000|Overall Study|Insufficient Sample|6|||
13175607|NCT02278939|26133699|FG000|Overall Study|lack of time|1|||
13175608|NCT02278939|26133700|FG001|Overall Study|lack of time|0|||
13175609|NCT02278939|26133699|FG000|Overall Study|Lost to Follow-up|1|||
13175610|NCT02278939|26133700|FG001|Overall Study|Lost to Follow-up|1|||
13175611|NCT02278939|26133699|FG000|Overall Study|death in family|1|||
13175612|NCT02278939|26133700|FG001|Overall Study|death in family|0|||
13175613|NCT02278939|26133699|FG000|Overall Study|family emergency unable to commit|2|||
13175614|NCT02278939|26133700|FG001|Overall Study|family emergency unable to commit|0|||
13175615|NCT02278614|26133713|FG000|Overall Study|Withdrawal by Subject|3|||
13175616|NCT02278614|26133714|FG001|Overall Study|Withdrawal by Subject|5|||
13175617|NCT02278614|26133713|FG000|Overall Study|Adverse Event|1|||
13175618|NCT02278614|26133714|FG001|Overall Study|Adverse Event|0|||
13175619|NCT02278614|26133713|FG000|Overall Study|left eye was not eligible|1|||
13175620|NCT02278614|26133714|FG001|Overall Study|left eye was not eligible|0|||
13175621|NCT02278471|26133743|FG000|Overall Study|Lost to Follow-up|6|||
13175622|NCT02278471|26133744|FG001|Overall Study|Lost to Follow-up|15|||
13175623|NCT02278471|26133743|FG000|Overall Study|Death|2|||
13175624|NCT02278471|26133744|FG001|Overall Study|Death|2|||
13175625|NCT02278471|26133743|FG000|Overall Study|Withdrawal by Subject|0|||
13175626|NCT02278471|26133744|FG001|Overall Study|Withdrawal by Subject|3|||
13175627|NCT02278367|26133759|FG000|Overall Study|Physician Decision|5|||
13175628|NCT02278367|26133760|FG001|Overall Study|Physician Decision|0|||
13175629|NCT02278367|26133759|FG000|Overall Study|Withdrawal by Subject|5|||
13175630|NCT02278367|26133760|FG001|Overall Study|Withdrawal by Subject|0|||
13175631|NCT02278354|26133779|FG000|Overall Study|Lost to Follow-up|2|||
13175632|NCT02278354|26133780|FG001|Overall Study|Lost to Follow-up|2|||
13175633|NCT02278354|26133779|FG000|Overall Study|Withdrawal by Subject|0|||
13175634|NCT02278354|26133780|FG001|Overall Study|Withdrawal by Subject|1|||
13175635|NCT02278354|26133779|FG000|Overall Study|<10 professional fights|2|||
13175636|NCT02278354|26133780|FG001|Overall Study|<10 professional fights|0|||
13175637|NCT02278341|26133881|FG000|Overall Study|Randomized but never received study drug|1|||
13175638|NCT02278341|26133882|FG001|Overall Study|Randomized but never received study drug|1|||
13175639|NCT02278341|26133881|FG000|Overall Study|Adverse Event|3|||
13175640|NCT02278341|26133882|FG001|Overall Study|Adverse Event|0|||
13175641|NCT02278341|26133881|FG000|Overall Study|Death|68|||
13175642|NCT02278341|26133882|FG001|Overall Study|Death|56|||
13175643|NCT02278341|26133881|FG000|Overall Study|Withdrawal by Subject|30|||
13175644|NCT02278341|26133882|FG001|Overall Study|Withdrawal by Subject|19|||
13175645|NCT02278341|26133881|FG000|Overall Study|Lost to Follow-up|0|||
13175646|NCT02278341|26133882|FG001|Overall Study|Lost to Follow-up|1|||
13175647|NCT02278341|26133881|FG000|Overall Study|Physician Decision|1|||
13175648|NCT02278341|26133882|FG001|Overall Study|Physician Decision|1|||
13175649|NCT02278341|26133881|FG000|Overall Study|Miscellaneous|15|||
13175650|NCT02278341|26133882|FG001|Overall Study|Miscellaneous|14|||
13175651|NCT02278328|26133896|FG000|Neuropsych Screening|found ineligible on neuropsych|1|||
13175652|NCT02278328|26133897|FG001|Neuropsych Screening|found ineligible on neuropsych|0|||
13175653|NCT02278328|26133898|FG002|Neuropsych Screening|found ineligible on neuropsych|0|||
13175654|NCT02278328|26133896|FG000|Neuropsych Screening|Withdrawal by Subject|0|||
13175655|NCT02278328|26133897|FG001|Neuropsych Screening|Withdrawal by Subject|1|||
13175656|NCT02278328|26133898|FG002|Neuropsych Screening|Withdrawal by Subject|0|||
13175657|NCT02278328|26133896|FG000|Neuropsych Screening|incomplete consent|0|||
13175658|NCT02278328|26133897|FG001|Neuropsych Screening|incomplete consent|0|||
13175659|NCT02278328|26133898|FG002|Neuropsych Screening|incomplete consent|2|||
13175660|NCT02278263|26133934|FG000|Overall Study|Protocol Violation|7|||
13175661|NCT02278263|26133935|FG001|Overall Study|Protocol Violation|0|||
13175662|NCT02278263|26133936|FG002|Overall Study|Protocol Violation|9|||
13175663|NCT02278003|26133951|FG000|Overall Study|Withdrawal by Subject|11|||
13175664|NCT02278003|26133952|FG001|Overall Study|Withdrawal by Subject|0|||
13175665|NCT02278003|26133951|FG000|Overall Study|Not Treated|1|||
13175666|NCT02278003|26133952|FG001|Overall Study|Not Treated|0|||
13175667|NCT02278003|26133951|FG000|Overall Study|Recognition task improperly completed|7|||
13175668|NCT02278003|26133952|FG001|Overall Study|Recognition task improperly completed|0|||
13175669|NCT02277990|26133971|FG000|Overall Study|Death|170|||
13175670|NCT02277990|26133972|FG001|Overall Study|Death|188|||
13175671|NCT02277990|26133971|FG000|Overall Study|Withdrawal by Subject|64|||
13175672|NCT02277990|26133972|FG001|Overall Study|Withdrawal by Subject|53|||
13175673|NCT02277990|26133971|FG000|Overall Study|Physician Decision|40|||
13175674|NCT02277990|26133972|FG001|Overall Study|Physician Decision|34|||
13175675|NCT02277990|26133971|FG000|Overall Study|Lost to Follow-up|66|||
13175676|NCT02277990|26133972|FG001|Overall Study|Lost to Follow-up|69|||
13175677|NCT02277990|26133971|FG000|Overall Study|Had other reason|26|||
13175678|NCT02277990|26133972|FG001|Overall Study|Had other reason|32|||
13175679|NCT02277769|26134050|FG000|Overall Study|Protocol Violation|3|||
13175680|NCT02277769|26134051|FG001|Overall Study|Protocol Violation|3|||
13175681|NCT02277769|26134052|FG002|Overall Study|Protocol Violation|5|||
13175682|NCT02277769|26134050|FG000|Overall Study|Lack of Efficacy|17|||
13175683|NCT02277769|26134051|FG001|Overall Study|Lack of Efficacy|0|||
13175684|NCT02277769|26134052|FG002|Overall Study|Lack of Efficacy|4|||
13175685|NCT02277769|26134050|FG000|Overall Study|Adverse Event|14|||
13175686|NCT02277769|26134051|FG001|Overall Study|Adverse Event|2|||
13175687|NCT02277769|26134052|FG002|Overall Study|Adverse Event|4|||
13175688|NCT02277769|26134050|FG000|Overall Study|Other than specified above|12|||
13175689|NCT02277769|26134051|FG001|Overall Study|Other than specified above|8|||
13175690|NCT02277769|26134052|FG002|Overall Study|Other than specified above|5|||
13175691|NCT02277743|26134130|FG000|Overall Study|Protocol Violation|1|||
13175692|NCT02277743|26134131|FG001|Overall Study|Protocol Violation|1|||
13175693|NCT02277743|26134132|FG002|Overall Study|Protocol Violation|1|||
13175694|NCT02277743|26134130|FG000|Overall Study|Adverse Event|10|||
13175695|NCT02277743|26134131|FG001|Overall Study|Adverse Event|6|||
13175696|NCT02277743|26134132|FG002|Overall Study|Adverse Event|6|||
13175697|NCT02277743|26134130|FG000|Overall Study|Lack of Efficacy|11|||
13108519|NCT03253796|25892360|FG001|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
13108520|NCT03253796|25892361|FG002|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|1|||
13108521|NCT03253796|25892362|FG003|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
13108522|NCT03253796|25892363|FG004|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
13108523|NCT03253796|25892359|FG000|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
13108524|NCT03253796|25892360|FG001|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|10|||
13108525|NCT03253796|25892361|FG002|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|15|||
13108526|NCT03253796|25892362|FG003|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|38|||
13108527|NCT03253796|25892363|FG004|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
13108528|NCT03253796|25892359|FG000|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
13108529|NCT03253796|25892360|FG001|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
13108530|NCT03253796|25892361|FG002|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
13108531|NCT03253796|25892362|FG003|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
13108532|NCT03253796|25892363|FG004|Period 2: Open-Label Retreatment|Withdrawal by Subject|5|||
13108533|NCT03253094|25892408|FG000|Overall Study|Adverse Event|2|||
13108534|NCT03253094|25892409|FG001|Overall Study|Adverse Event|0|||
13108535|NCT03253094|25892410|FG002|Overall Study|Adverse Event|0|||
13108536|NCT03253094|25892411|FG003|Overall Study|Adverse Event|0|||
13108537|NCT03253094|25892412|FG004|Overall Study|Adverse Event|0|||
13108538|NCT03253094|25892413|FG005|Overall Study|Adverse Event|0|||
13108539|NCT03253094|25892408|FG000|Overall Study|Lack of Efficacy|0|||
13108540|NCT03253094|25892409|FG001|Overall Study|Lack of Efficacy|0|||
13108541|NCT03253094|25892410|FG002|Overall Study|Lack of Efficacy|2|||
13108542|NCT03253094|25892411|FG003|Overall Study|Lack of Efficacy|1|||
13175698|NCT02277743|26134131|FG001|Overall Study|Lack of Efficacy|4|||
13175699|NCT02277743|26134132|FG002|Overall Study|Lack of Efficacy|3|||
13175700|NCT02277743|26134130|FG000|Overall Study|Other than specified above|18|||
13175701|NCT02277743|26134131|FG001|Overall Study|Other than specified above|5|||
13175702|NCT02277743|26134132|FG002|Overall Study|Other than specified above|16|||
13175703|NCT02277691|26134144|FG000|Overall Study|Pretreatment Event/Adverse Event|33|||
13175704|NCT02277691|26134144|FG000|Overall Study|Voluntary Withdrawal|7|||
13175705|NCT02277691|26134144|FG000|Overall Study|Lack of Efficacy|5|||
13175706|NCT02277691|26134144|FG000|Overall Study|Used Other Antihypertensive Drug|1|||
13175707|NCT02277119|26134171|FG000|Overall Study|Lack of Efficacy|1|||
13175708|NCT02277119|26134172|FG001|Overall Study|Lack of Efficacy|1|||
13175709|NCT02277119|26134173|FG002|Overall Study|Lack of Efficacy|1|||
13175710|NCT02277119|26134171|FG000|Overall Study|Protocol Violation|2|||
13175711|NCT02277119|26134172|FG001|Overall Study|Protocol Violation|3|||
13175712|NCT02277119|26134173|FG002|Overall Study|Protocol Violation|7|||
13175713|NCT02276872|26134257|FG000|Overall Study|Adverse Event|1|||
13175714|NCT02276872|26134258|FG001|Overall Study|Adverse Event|0|||
13175715|NCT02276872|26134259|FG002|Overall Study|Adverse Event|0|||
13175716|NCT02276807|26134280|FG000|Overall Study|Withdrawal by Subject|8|||
13175717|NCT02276807|26134281|FG001|Overall Study|Withdrawal by Subject|7|||
13175718|NCT02276807|26134280|FG000|Overall Study|Lost to Follow-up|10|||
13175719|NCT02276807|26134281|FG001|Overall Study|Lost to Follow-up|10|||
13175720|NCT02276612|26134308|FG000|Overall Study|Death|1|||
13175721|NCT02276612|26134309|FG001|Overall Study|Death|0|||
13175722|NCT02276612|26134308|FG000|Overall Study|Pregnancy|1|||
13175723|NCT02276612|26134309|FG001|Overall Study|Pregnancy|0|||
13175724|NCT02276612|26134308|FG000|Overall Study|Withdrew Consent|1|||
13175725|NCT02276612|26134309|FG001|Overall Study|Withdrew Consent|0|||
13175726|NCT02276612|26134308|FG000|Overall Study|Lost to Follow-up|1|||
13175727|NCT02276612|26134309|FG001|Overall Study|Lost to Follow-up|0|||
13175728|NCT02276560|26134327|FG000|Overall Study|Adverse Event|1|||
13175729|NCT02276560|26134328|FG001|Overall Study|Adverse Event|0|||
13175730|NCT02276560|26134329|FG002|Overall Study|Adverse Event|0|||
13175731|NCT02276482|26134358|FG000|Overall Study|Adverse Event|1|||
13175732|NCT02276482|26134359|FG001|Overall Study|Adverse Event|0|||
13175733|NCT02276482|26134358|FG000|Overall Study|Withdrawal by Subject|1|||
13175734|NCT02276482|26134359|FG001|Overall Study|Withdrawal by Subject|0|||
13175735|NCT02276482|26134358|FG000|Overall Study|Gram-negative infection|1|||
13175736|NCT02276482|26134359|FG001|Overall Study|Gram-negative infection|0|||
13175737|NCT02276482|26134358|FG000|Overall Study|Reason not specified|0|||
13175738|NCT02276482|26134359|FG001|Overall Study|Reason not specified|1|||
13175739|NCT02276222|26134390|FG000|Overall Study|Adverse Event|62|||
13175740|NCT02276222|26134391|FG001|Overall Study|Adverse Event|11|||
13175741|NCT02276222|26134390|FG000|Overall Study|Death|3|||
13175742|NCT02276222|26134391|FG001|Overall Study|Death|4|||
13175743|NCT02276222|26134390|FG000|Overall Study|Lack of Efficacy|13|||
13175744|NCT02276222|26134391|FG001|Overall Study|Lack of Efficacy|3|||
13175745|NCT02276222|26134390|FG000|Overall Study|Protocol Violation|3|||
13175746|NCT02276222|26134391|FG001|Overall Study|Protocol Violation|2|||
13175747|NCT02276222|26134390|FG000|Overall Study|Withdrawal by Subject|79|||
13175748|NCT02276222|26134391|FG001|Overall Study|Withdrawal by Subject|33|||
13175749|NCT02276222|26134390|FG000|Overall Study|non compliance with study medication|6|||
13108543|NCT03253094|25892412|FG004|Overall Study|Lack of Efficacy|2|||
13108544|NCT03253094|25892413|FG005|Overall Study|Lack of Efficacy|1|||
13108545|NCT03253094|25892408|FG000|Overall Study|Lost to Follow-up|0|||
13108546|NCT03253094|25892409|FG001|Overall Study|Lost to Follow-up|0|||
13108547|NCT03253094|25892410|FG002|Overall Study|Lost to Follow-up|1|||
13108548|NCT03253094|25892411|FG003|Overall Study|Lost to Follow-up|1|||
13108549|NCT03253094|25892412|FG004|Overall Study|Lost to Follow-up|0|||
13108550|NCT03253094|25892413|FG005|Overall Study|Lost to Follow-up|1|||
13108551|NCT03253094|25892408|FG000|Overall Study|Physician Decision|1|||
13108552|NCT03253094|25892409|FG001|Overall Study|Physician Decision|0|||
13108553|NCT03253094|25892410|FG002|Overall Study|Physician Decision|0|||
13108554|NCT03253094|25892411|FG003|Overall Study|Physician Decision|1|||
13108555|NCT03253094|25892412|FG004|Overall Study|Physician Decision|0|||
13108556|NCT03253094|25892413|FG005|Overall Study|Physician Decision|2|||
13108557|NCT03253094|25892408|FG000|Overall Study|Withdrawal by Subject|1|||
13108558|NCT03253094|25892409|FG001|Overall Study|Withdrawal by Subject|2|||
13108559|NCT03253094|25892410|FG002|Overall Study|Withdrawal by Subject|1|||
13108560|NCT03253094|25892411|FG003|Overall Study|Withdrawal by Subject|0|||
13108561|NCT03253094|25892412|FG004|Overall Study|Withdrawal by Subject|3|||
13108562|NCT03253094|25892413|FG005|Overall Study|Withdrawal by Subject|0|||
13108563|NCT03253094|25892408|FG000|Overall Study|Other|0|||
13108564|NCT03253094|25892409|FG001|Overall Study|Other|1|||
13175750|NCT02276222|26134391|FG001|Overall Study|non compliance with study medication|2|||
13175751|NCT02276222|26134390|FG000|Overall Study|sponsor decision|0|||
13175752|NCT02276222|26134391|FG001|Overall Study|sponsor decision|3|||
13175753|NCT02276222|26134390|FG000|Overall Study|Lost to Follow-up|15|||
13175754|NCT02276222|26134391|FG001|Overall Study|Lost to Follow-up|5|||
13175755|NCT02276222|26134390|FG000|Overall Study|Physician Decision|2|||
13175756|NCT02276222|26134391|FG001|Overall Study|Physician Decision|1|||
13175757|NCT02276222|26134390|FG000|Overall Study|sheduling conflict|1|||
13175758|NCT02276222|26134391|FG001|Overall Study|sheduling conflict|0|||
13175759|NCT02276222|26134390|FG000|Overall Study|subject withdrew after randomization|1|||
13175760|NCT02276222|26134391|FG001|Overall Study|subject withdrew after randomization|0|||
13175761|NCT02276053|26134409|FG000|Overall Study|Death|2|||
13175762|NCT02276053|26134409|FG000|Overall Study|Adverse Event|5|||
13175763|NCT02276053|26134409|FG000|Overall Study|Lack of Efficacy|2|||
13175764|NCT02276053|26134409|FG000|Overall Study|Withdrawal by Subject|1|||
13175765|NCT02276053|26134409|FG000|Overall Study|Patient does not meet selection criteria|3|||
13175766|NCT02276053|26134409|FG000|Overall Study|Patient needs to increase baseline AED|1|||
13175767|NCT02276040|26134415|FG000|Overall Study|Physician Decision|15|||
13175768|NCT02276027|26134470|FG000|Overall Study|Death|1|||
13175769|NCT02276027|26134471|FG001|Overall Study|Death|0|||
13175770|NCT02276027|26134472|FG002|Overall Study|Death|0|||
13175771|NCT02276027|26134473|FG003|Overall Study|Death|2|||
13175772|NCT02276027|26134470|FG000|Overall Study|Physician Decision|0|||
13175773|NCT02276027|26134471|FG001|Overall Study|Physician Decision|0|||
13175774|NCT02276027|26134472|FG002|Overall Study|Physician Decision|0|||
13108565|NCT03253094|25892410|FG002|Overall Study|Other|2|||
13108566|NCT03253094|25892411|FG003|Overall Study|Other|1|||
13108567|NCT03253094|25892412|FG004|Overall Study|Other|0|||
13175775|NCT02276027|26134473|FG003|Overall Study|Physician Decision|1|||
13175776|NCT02276027|26134470|FG000|Overall Study|Progressive disease|1|||
13175777|NCT02276027|26134471|FG001|Overall Study|Progressive disease|13|||
13175778|NCT02276027|26134472|FG002|Overall Study|Progressive disease|12|||
13175779|NCT02276027|26134473|FG003|Overall Study|Progressive disease|14|||
13175780|NCT02276027|26134470|FG000|Overall Study|Subject/guardian decision|0|||
13175781|NCT02276027|26134471|FG001|Overall Study|Subject/guardian decision|1|||
13175782|NCT02276027|26134472|FG002|Overall Study|Subject/guardian decision|0|||
13175783|NCT02276027|26134473|FG003|Overall Study|Subject/guardian decision|3|||
13175784|NCT02276027|26134470|FG000|Overall Study|Adverse Event|0|||
13175785|NCT02276027|26134471|FG001|Overall Study|Adverse Event|2|||
13175786|NCT02276027|26134472|FG002|Overall Study|Adverse Event|8|||
13175787|NCT02276027|26134473|FG003|Overall Study|Adverse Event|2|||
13175788|NCT02275819|26134494|FG000|Overall Study|Adverse Event|0|||
13175789|NCT02275819|26134495|FG001|Overall Study|Adverse Event|1|||
13205690|NCT01962493|26232638|FG001|Overall Study|Protocol Violation|1|||
13205691|NCT01962493|26232637|FG000|Overall Study|Withdrawal by Subject|4|||
13205692|NCT01962493|26232638|FG001|Overall Study|Withdrawal by Subject|2|||
13205693|NCT01962441|26232678|FG000|Randomized Period|Randomized but Never Treated|4|||
13205694|NCT01962441|26232679|FG001|Randomized Period|Randomized but Never Treated|2|||
13205695|NCT01962441|26232680|FG002|Randomized Period|Randomized but Never Treated|3|||
13205696|NCT01962441|26232678|FG000|Randomized Period|Lost to Follow-up|2|||
13205697|NCT01962441|26232679|FG001|Randomized Period|Lost to Follow-up|4|||
13205698|NCT01962441|26232680|FG002|Randomized Period|Lost to Follow-up|4|||
13205699|NCT01962441|26232678|FG000|Randomized Period|Withdrew Consent|3|||
13108568|NCT03253094|25892413|FG005|Overall Study|Other|0|||
13205700|NCT01962441|26232679|FG001|Randomized Period|Withdrew Consent|3|||
13205701|NCT01962441|26232680|FG002|Randomized Period|Withdrew Consent|2|||
13205702|NCT01962441|26232678|FG000|Randomized Period|Adverse Event|1|||
13108569|NCT03252522|25892466|FG000|Overall Study|Adverse Event|3|||
13108570|NCT03252522|25892467|FG001|Overall Study|Adverse Event|1|||
13108571|NCT03252522|25892468|FG002|Overall Study|Adverse Event|0|||
13108572|NCT03252522|25892466|FG000|Overall Study|Unable to swallow pills|4|||
13108573|NCT03252522|25892467|FG001|Overall Study|Unable to swallow pills|1|||
13108574|NCT03252522|25892468|FG002|Overall Study|Unable to swallow pills|0|||
13108575|NCT03252522|25892466|FG000|Overall Study|Commenced stimulant medication|1|||
13108576|NCT03252522|25892467|FG001|Overall Study|Commenced stimulant medication|1|||
13205703|NCT01962441|26232679|FG001|Randomized Period|Adverse Event|1|||
13205704|NCT01962441|26232680|FG002|Randomized Period|Adverse Event|0|||
13205705|NCT01962441|26232678|FG000|Randomized Period|Death|0|||
13205706|NCT01962441|26232679|FG001|Randomized Period|Death|0|||
13205707|NCT01962441|26232680|FG002|Randomized Period|Death|2|||
13205708|NCT01962441|26232678|FG000|Randomized Period|Protocol Violation|0|||
13205709|NCT01962441|26232679|FG001|Randomized Period|Protocol Violation|1|||
13205710|NCT01962441|26232680|FG002|Randomized Period|Protocol Violation|0|||
13205711|NCT01962441|26232678|FG000|Retreatment Substudy|Lack of Efficacy|1|||
13205712|NCT01962441|26232679|FG001|Retreatment Substudy|Lack of Efficacy|0|||
13205713|NCT01962441|26232680|FG002|Retreatment Substudy|Lack of Efficacy|0|||
13205714|NCT01962441|26232678|FG000|Retreatment Substudy|Lost to Follow-up|1|||
13205715|NCT01962441|26232679|FG001|Retreatment Substudy|Lost to Follow-up|0|||
13205716|NCT01962441|26232680|FG002|Retreatment Substudy|Lost to Follow-up|0|||
13205717|NCT01962298|26232713|FG000|Overall Study|Protocol Violation|1|||
13205718|NCT01962298|26232714|FG001|Overall Study|Protocol Violation|0|||
13205719|NCT01962298|26232715|FG002|Overall Study|Protocol Violation|1|||
13205720|NCT01962298|26232716|FG003|Overall Study|Protocol Violation|1|||
13205721|NCT01962298|26232717|FG004|Overall Study|Protocol Violation|0|||
13205722|NCT01962298|26232713|FG000|Overall Study|Data quality insufficient|2|||
13205723|NCT01962298|26232714|FG001|Overall Study|Data quality insufficient|0|||
13205724|NCT01962298|26232715|FG002|Overall Study|Data quality insufficient|3|||
13205725|NCT01962298|26232716|FG003|Overall Study|Data quality insufficient|1|||
13205726|NCT01962298|26232717|FG004|Overall Study|Data quality insufficient|4|||
13205727|NCT01962298|26232713|FG000|Overall Study|Insufficient data|0|||
13205728|NCT01962298|26232714|FG001|Overall Study|Insufficient data|2|||
13205729|NCT01962298|26232715|FG002|Overall Study|Insufficient data|1|||
13205730|NCT01962298|26232716|FG003|Overall Study|Insufficient data|0|||
13205731|NCT01962298|26232717|FG004|Overall Study|Insufficient data|1|||
13205732|NCT01962298|26232713|FG000|Overall Study|Incorrect data recorded|0|||
13205733|NCT01962298|26232714|FG001|Overall Study|Incorrect data recorded|1|||
13205734|NCT01962298|26232715|FG002|Overall Study|Incorrect data recorded|0|||
13205735|NCT01962298|26232716|FG003|Overall Study|Incorrect data recorded|0|||
13205736|NCT01962298|26232717|FG004|Overall Study|Incorrect data recorded|0|||
13205737|NCT01962298|26232713|FG000|Overall Study|Physician Decision|0|||
13205738|NCT01962298|26232714|FG001|Overall Study|Physician Decision|1|||
13205739|NCT01962298|26232715|FG002|Overall Study|Physician Decision|0|||
13108577|NCT03252522|25892468|FG002|Overall Study|Commenced stimulant medication|0|||
13205740|NCT01962298|26232716|FG003|Overall Study|Physician Decision|0|||
13205741|NCT01962298|26232717|FG004|Overall Study|Physician Decision|1|||
13205742|NCT01962207|26232832|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2|||
13205743|NCT01962207|26232833|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1|||
13175790|NCT02275780|26134538|FG000|Base Study: 96 Weeks|Adverse Event|6|||
13175791|NCT02275780|26134539|FG001|Base Study: 96 Weeks|Adverse Event|14|||
13175792|NCT02275780|26134538|FG000|Base Study: 96 Weeks|Death|3|||
13175793|NCT02275780|26134539|FG001|Base Study: 96 Weeks|Death|1|||
13175794|NCT02275780|26134538|FG000|Base Study: 96 Weeks|Lack of Efficacy|21|||
13175795|NCT02275780|26134539|FG001|Base Study: 96 Weeks|Lack of Efficacy|32|||
13175796|NCT02275780|26134538|FG000|Base Study: 96 Weeks|Lost to Follow-up|28|||
13175797|NCT02275780|26134539|FG001|Base Study: 96 Weeks|Lost to Follow-up|24|||
13175798|NCT02275780|26134538|FG000|Base Study: 96 Weeks|Protocol Violation|1|||
13175799|NCT02275780|26134539|FG001|Base Study: 96 Weeks|Protocol Violation|6|||
13175800|NCT02275780|26134538|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19|||
13175801|NCT02275780|26134539|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22|||
13108578|NCT03252522|25892466|FG000|Overall Study|Protocol Violation|1|||
13108579|NCT03252522|25892467|FG001|Overall Study|Protocol Violation|0|||
13108580|NCT03252522|25892468|FG002|Overall Study|Protocol Violation|0|||
13108581|NCT03252145|25892539|FG000|Overall Study|Withdrawal by Subject|1|||
13108582|NCT03252145|25892540|FG001|Overall Study|Withdrawal by Subject|0|||
13108583|NCT03252145|25892539|FG000|Overall Study|Complicating Disease|1|||
13108584|NCT03252145|25892540|FG001|Overall Study|Complicating Disease|2|||
13108585|NCT03252015|25892589|FG000|Overall Study|Withdrawal by Subject|0|||
13175802|NCT02275780|26134538|FG000|Base Study: 96 Weeks|Noncompliance with drug|9|||
13175803|NCT02275780|26134539|FG001|Base Study: 96 Weeks|Noncompliance with drug|6|||
13175804|NCT02275780|26134538|FG000|Base Study: 96 Weeks|Physician Decision|2|||
13175805|NCT02275780|26134539|FG001|Base Study: 96 Weeks|Physician Decision|4|||
13175806|NCT02275780|26134538|FG000|Base Study: 96 Weeks|Pregnancy|2|||
13175807|NCT02275780|26134539|FG001|Base Study: 96 Weeks|Pregnancy|1|||
13175808|NCT02275780|26134538|FG000|Base Study: 96 Weeks|Randomized not treated|2|||
13175809|NCT02275780|26134539|FG001|Base Study: 96 Weeks|Randomized not treated|1|||
13175810|NCT02275780|26134538|FG000|Extension Study: up to 192 Weeks|Ongoing|260|||
13175811|NCT02275780|26134539|FG001|Extension Study: up to 192 Weeks|Ongoing|233|||
13175812|NCT02275611|26134564|FG000|Inpatient Withdrawal|Withdrawal by Subject|1|||
13175813|NCT02275611|26134565|FG001|Inpatient Withdrawal|Withdrawal by Subject|0|||
13175814|NCT02275611|26134566|FG002|Inpatient Withdrawal|Withdrawal by Subject|0|||
13175815|NCT02275611|26134567|FG003|Inpatient Withdrawal|Withdrawal by Subject|0|||
13175816|NCT02275481|26134580|FG000|Overall Study|Death|2|||
13175817|NCT02275481|26134581|FG001|Overall Study|Death|1|||
13175818|NCT02275481|26134580|FG000|Overall Study|Lost to Follow-up|2|||
13175819|NCT02275481|26134581|FG001|Overall Study|Lost to Follow-up|0|||
13175820|NCT02275481|26134580|FG000|Overall Study|Withdrawal by Subject|3|||
13175821|NCT02275481|26134581|FG001|Overall Study|Withdrawal by Subject|0|||
13175822|NCT02275481|26134580|FG000|Overall Study|all other reasons combined|2|||
13175823|NCT02275481|26134581|FG001|Overall Study|all other reasons combined|1|||
13175824|NCT02275481|26134580|FG000|Overall Study|Physician Decision|0|||
13175825|NCT02275481|26134581|FG001|Overall Study|Physician Decision|1|||
13175826|NCT02275364|26134613|FG000|Period 1|Withdrawal by Subject|1|||
13175827|NCT02275364|26134614|FG001|Period 1|Withdrawal by Subject|0|||
13175828|NCT02275364|26134613|FG000|Period 1|Other reason|1|||
13175829|NCT02275364|26134614|FG001|Period 1|Other reason|0|||
13175830|NCT02275338|26134628|FG000|Overall Study|Adverse Event|15|||
13108586|NCT03252015|25892590|FG001|Overall Study|Withdrawal by Subject|1|||
13175831|NCT02275338|26134628|FG000|Overall Study|Lack of Efficacy|3|||
13175832|NCT02275338|26134628|FG000|Overall Study|Withdrawal by Subject|4|||
13175833|NCT02275338|26134628|FG000|Overall Study|Disease progression (death)|1|||
13175834|NCT02275338|26134628|FG000|Overall Study|Ineligible to start Phase 2|4|||
13175835|NCT02275338|26134628|FG000|Overall Study|Reason not specified|5|||
13175836|NCT02275338|26134628|FG000|Overall Study|Does not meet entry criteria|1|||
13175837|NCT02275117|26134751|FG000|Overall Study|Adverse Event|0|||
13175838|NCT02275117|26134752|FG001|Overall Study|Adverse Event|0|||
13175839|NCT02275117|26134753|FG002|Overall Study|Adverse Event|0|||
13175840|NCT02275117|26134754|FG003|Overall Study|Adverse Event|0|||
13175841|NCT02275117|26134755|FG004|Overall Study|Adverse Event|1|||
13175842|NCT02275117|26134751|FG000|Overall Study|Lack of Efficacy|6|||
13175843|NCT02275117|26134752|FG001|Overall Study|Lack of Efficacy|7|||
13175844|NCT02275117|26134753|FG002|Overall Study|Lack of Efficacy|5|||
13175845|NCT02275117|26134754|FG003|Overall Study|Lack of Efficacy|2|||
13175846|NCT02275117|26134755|FG004|Overall Study|Lack of Efficacy|10|||
13175847|NCT02275117|26134751|FG000|Overall Study|Lost to Follow-up|11|||
13175848|NCT02275117|26134752|FG001|Overall Study|Lost to Follow-up|16|||
13175849|NCT02275117|26134753|FG002|Overall Study|Lost to Follow-up|15|||
13175850|NCT02275117|26134754|FG003|Overall Study|Lost to Follow-up|16|||
13175851|NCT02275117|26134755|FG004|Overall Study|Lost to Follow-up|8|||
13175852|NCT02275117|26134751|FG000|Overall Study|Physician Decision|0|||
13175853|NCT02275117|26134752|FG001|Overall Study|Physician Decision|1|||
13175854|NCT02275117|26134753|FG002|Overall Study|Physician Decision|1|||
13108587|NCT03252015|25892591|FG002|Overall Study|Withdrawal by Subject|1|||
13108588|NCT03252015|25892592|FG003|Overall Study|Withdrawal by Subject|0|||
13175855|NCT02275117|26134754|FG003|Overall Study|Physician Decision|0|||
13175856|NCT02275117|26134755|FG004|Overall Study|Physician Decision|1|||
13175857|NCT02275117|26134751|FG000|Overall Study|Protocol Violation|1|||
13175858|NCT02275117|26134752|FG001|Overall Study|Protocol Violation|0|||
13175859|NCT02275117|26134753|FG002|Overall Study|Protocol Violation|1|||
13175860|NCT02275117|26134754|FG003|Overall Study|Protocol Violation|1|||
13175861|NCT02275117|26134755|FG004|Overall Study|Protocol Violation|0|||
13175862|NCT02275117|26134751|FG000|Overall Study|Withdrawal by Subject|6|||
13175863|NCT02275117|26134752|FG001|Overall Study|Withdrawal by Subject|4|||
13175864|NCT02275117|26134753|FG002|Overall Study|Withdrawal by Subject|7|||
13175865|NCT02275117|26134754|FG003|Overall Study|Withdrawal by Subject|3|||
13175866|NCT02275117|26134755|FG004|Overall Study|Withdrawal by Subject|3|||
13175867|NCT02275117|26134751|FG000|Overall Study|Terminated by Sponsor|4|||
13175868|NCT02275117|26134752|FG001|Overall Study|Terminated by Sponsor|4|||
13175869|NCT02275117|26134753|FG002|Overall Study|Terminated by Sponsor|4|||
13175870|NCT02275117|26134754|FG003|Overall Study|Terminated by Sponsor|6|||
13175871|NCT02275117|26134755|FG004|Overall Study|Terminated by Sponsor|4|||
13175872|NCT02275117|26134751|FG000|Overall Study|Worsening of Study Indication|0|||
13175873|NCT02275117|26134752|FG001|Overall Study|Worsening of Study Indication|1|||
13175874|NCT02275117|26134753|FG002|Overall Study|Worsening of Study Indication|2|||
13175875|NCT02275117|26134754|FG003|Overall Study|Worsening of Study Indication|0|||
13175876|NCT02275117|26134755|FG004|Overall Study|Worsening of Study Indication|0|||
13175877|NCT02275117|26134751|FG000|Overall Study|Study Burden|5|||
13175878|NCT02275117|26134752|FG001|Overall Study|Study Burden|4|||
13175879|NCT02275117|26134753|FG002|Overall Study|Study Burden|7|||
13175880|NCT02275117|26134754|FG003|Overall Study|Study Burden|5|||
13175881|NCT02275117|26134755|FG004|Overall Study|Study Burden|7|||
13175882|NCT02275117|26134751|FG000|Overall Study|Other|1|||
13175883|NCT02275117|26134752|FG001|Overall Study|Other|0|||
13175884|NCT02275117|26134753|FG002|Overall Study|Other|0|||
13175885|NCT02275117|26134754|FG003|Overall Study|Other|0|||
13175886|NCT02275117|26134755|FG004|Overall Study|Other|2|||
13175887|NCT02275065|26134852|FG000|Overall Study|Randomized but not treated|1|||
13175888|NCT02275065|26134853|FG001|Overall Study|Randomized but not treated|0|||
13175889|NCT02275065|26134854|FG002|Overall Study|Randomized but not treated|1|||
13175890|NCT02275065|26134855|FG003|Overall Study|Randomized but not treated|1|||
13175891|NCT02275065|26134856|FG004|Overall Study|Randomized but not treated|0|||
13175892|NCT02275052|26134873|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
13175893|NCT02275052|26134874|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
13175894|NCT02275052|26134875|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
13175895|NCT02275052|26134876|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
13175896|NCT02275052|26134873|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
13175897|NCT02275052|26134874|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1|||
13175898|NCT02275052|26134875|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
13175899|NCT02275052|26134876|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
13175900|NCT02275052|26134873|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6|||
13175901|NCT02275052|26134874|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4|||
13175902|NCT02275052|26134875|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
13175903|NCT02275052|26134876|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
13175904|NCT02275052|26134873|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1|||
13175905|NCT02275052|26134874|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
13175906|NCT02275052|26134875|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
13175907|NCT02275052|26134876|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
13175908|NCT02275052|26134873|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2|||
13175909|NCT02275052|26134874|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
13175910|NCT02275052|26134875|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
13175911|NCT02275052|26134876|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
13175912|NCT02275052|26134873|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3|||
13175913|NCT02275052|26134874|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
13175914|NCT02275052|26134875|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
13175915|NCT02275052|26134876|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
13175916|NCT02275052|26134873|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1|||
13175917|NCT02275052|26134874|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0|||
13175918|NCT02275052|26134875|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0|||
13175919|NCT02275052|26134876|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0|||
13175920|NCT02275052|26134873|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
13175921|NCT02275052|26134874|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
13175922|NCT02275052|26134875|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3|||
13175923|NCT02275052|26134876|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2|||
13175924|NCT02275052|26134873|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
13175925|NCT02275052|26134874|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
13175926|NCT02275052|26134875|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
13175927|NCT02275052|26134876|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4|||
13175928|NCT02275052|26134873|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
13175929|NCT02275052|26134874|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
13175930|NCT02275052|26134875|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
13175931|NCT02275052|26134876|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6|||
13175932|NCT02275052|26134873|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
13175933|NCT02275052|26134874|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
13175934|NCT02275052|26134875|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
13175935|NCT02275052|26134876|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2|||
13175936|NCT02275026|26134889|FG000|Overall Study|Ineligible after cognitive baseline testing|11|||
13175937|NCT02275026|26134889|FG000|Overall Study|Withdrawal by Subject|4|||
13175938|NCT02275026|26134889|FG000|Overall Study|Ineligible due to medical history|13|||
13175939|NCT02275026|26134889|FG000|Overall Study|MRI malfunction precluded testing|1|||
13175940|NCT02275026|26134889|FG000|Overall Study|Ineligible after MRI findings|1|||
13175941|NCT02275026|26134889|FG000|Overall Study|Lost to Follow-up|2|||
13175942|NCT02275026|26134889|FG000|Overall Study|Scanner failure|1|||
13175943|NCT02274948|26134910|FG000|Overall Study|Lost to Follow-up|28|||
13175944|NCT02274948|26134911|FG001|Overall Study|Lost to Follow-up|25|||
13175945|NCT02274948|26134910|FG000|Overall Study|Withdrawal by Subject|64|||
13175946|NCT02274948|26134911|FG001|Overall Study|Withdrawal by Subject|58|||
13175947|NCT02274948|26134910|FG000|Overall Study|Stopped on family Practitioner advice|2|||
13175948|NCT02274948|26134911|FG001|Overall Study|Stopped on family Practitioner advice|5|||
13175949|NCT02274948|26134910|FG000|Overall Study|Left the area|4|||
13175950|NCT02274948|26134911|FG001|Overall Study|Left the area|3|||
13175951|NCT02274857|26134931|FG000|Overall Study|Adverse Event|1|||
13175952|NCT02274857|26134932|FG001|Overall Study|Adverse Event|0|||
13175953|NCT02274857|26134931|FG000|Overall Study|Death|1|||
13175954|NCT02274857|26134932|FG001|Overall Study|Death|2|||
13175955|NCT02274857|26134931|FG000|Overall Study|Lost to Follow-up|3|||
13175956|NCT02274857|26134932|FG001|Overall Study|Lost to Follow-up|0|||
13175957|NCT02274857|26134931|FG000|Overall Study|Physician Decision|2|||
13175958|NCT02274857|26134932|FG001|Overall Study|Physician Decision|0|||
13175959|NCT02274857|26134931|FG000|Overall Study|Trial screen failure|0|||
13175960|NCT02274857|26134932|FG001|Overall Study|Trial screen failure|2|||
13175961|NCT02274857|26134931|FG000|Overall Study|Withdrawal by Subject|11|||
13175962|NCT02274857|26134932|FG001|Overall Study|Withdrawal by Subject|2|||
13175963|NCT02274857|26134931|FG000|Overall Study|Other|2|||
13175964|NCT02274857|26134932|FG001|Overall Study|Other|0|||
13175965|NCT02274792|26134942|FG000|Overall Study|Withdrawal by Subject|13|||
13175966|NCT02274792|26134942|FG000|Overall Study|Lost to Follow-up|8|||
13175967|NCT02274792|26134942|FG000|Overall Study|Protocol Specified Criteria|2|||
13175968|NCT02274792|26134942|FG000|Overall Study|Sponsor Decision|2|||
13175969|NCT02274766|26134957|FG000|Overall Study|Withdrawal by Subject|3|||
13175970|NCT02274766|26134958|FG001|Overall Study|Withdrawal by Subject|6|||
13175971|NCT02274766|26134957|FG000|Overall Study|Did Not Receive Study Drug|1|||
13175972|NCT02274766|26134958|FG001|Overall Study|Did Not Receive Study Drug|1|||
13175973|NCT02274766|26134957|FG000|Overall Study|Subject Unwilling to Proceed|0|||
13175974|NCT02274766|26134958|FG001|Overall Study|Subject Unwilling to Proceed|1|||
13175975|NCT02274766|26134957|FG000|Overall Study|Adverse Event|0|||
13175976|NCT02274766|26134958|FG001|Overall Study|Adverse Event|1|||
13175977|NCT02274558|26134982|FG000|Overall Study|Adverse Event|2|||
13175978|NCT02274558|26134983|FG001|Overall Study|Adverse Event|4|||
13175979|NCT02274558|26134984|FG002|Overall Study|Adverse Event|2|||
13175980|NCT02274558|26134982|FG000|Overall Study|Non-compliance|2|||
13175981|NCT02274558|26134983|FG001|Overall Study|Non-compliance|1|||
13175982|NCT02274558|26134984|FG002|Overall Study|Non-compliance|0|||
13175983|NCT02274558|26134982|FG000|Overall Study|Withdrawal by Subject|1|||
13175984|NCT02274558|26134983|FG001|Overall Study|Withdrawal by Subject|5|||
13175985|NCT02274558|26134984|FG002|Overall Study|Withdrawal by Subject|4|||
13175986|NCT02274558|26134982|FG000|Overall Study|Death|0|||
13175987|NCT02274558|26134983|FG001|Overall Study|Death|0|||
13175988|NCT02274558|26134984|FG002|Overall Study|Death|1|||
13175989|NCT02274558|26134982|FG000|Overall Study|Lost to Follow-up|2|||
13175990|NCT02274558|26134983|FG001|Overall Study|Lost to Follow-up|1|||
13175991|NCT02274558|26134984|FG002|Overall Study|Lost to Follow-up|1|||
13175992|NCT02274558|26134982|FG000|Overall Study|Physician Decision|0|||
13175993|NCT02274558|26134983|FG001|Overall Study|Physician Decision|2|||
13175994|NCT02274558|26134984|FG002|Overall Study|Physician Decision|1|||
13175995|NCT02274493|26134993|FG000|Overall Study|Withdrawal by Subject|1|||
13175996|NCT02274311|26135001|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1|||
13175997|NCT02274038|26135011|FG000|Overall Study|Death|1|||
13175998|NCT02273973|26135058|FG000|Overall Study|Adverse Event|4|||
13175999|NCT02273973|26135059|FG001|Overall Study|Adverse Event|0|||
13176000|NCT02273973|26135058|FG000|Overall Study|Withdrawal by Subject|2|||
13176001|NCT02273973|26135059|FG001|Overall Study|Withdrawal by Subject|3|||
13176002|NCT02273973|26135058|FG000|Overall Study|Death|1|||
13176003|NCT02273973|26135059|FG001|Overall Study|Death|0|||
13176004|NCT02273973|26135058|FG000|Overall Study|Non-compliance|1|||
13176005|NCT02273973|26135059|FG001|Overall Study|Non-compliance|0|||
13176006|NCT02273973|26135058|FG000|Overall Study|Protocol Violation|1|||
13176007|NCT02273973|26135059|FG001|Overall Study|Protocol Violation|0|||
13176008|NCT02273973|26135058|FG000|Overall Study|Progression of disease|0|||
13176009|NCT02273973|26135059|FG001|Overall Study|Progression of disease|2|||
13176010|NCT02273973|26135058|FG000|Overall Study|Lost to Follow-up|0|||
13176011|NCT02273973|26135059|FG001|Overall Study|Lost to Follow-up|1|||
13176012|NCT02273973|26135058|FG000|Overall Study|Physician Decision|0|||
13176013|NCT02273973|26135059|FG001|Overall Study|Physician Decision|1|||
13176014|NCT02273973|26135058|FG000|Overall Study|Reason not specified|0|||
13176015|NCT02273973|26135059|FG001|Overall Study|Reason not specified|1|||
13176016|NCT02273960|26135114|FG000|Short Term Period|Lost to Follow-up|1|||
13176017|NCT02273960|26135115|FG001|Short Term Period|Lost to Follow-up|0|||
13176018|NCT02273960|26135116|FG002|Short Term Period|Lost to Follow-up|0|||
13176019|NCT02273960|26135117|FG003|Short Term Period|Lost to Follow-up|0|||
13176020|NCT02273960|26135114|FG000|Short Term Period|Lack of Efficacy|0|||
13176021|NCT02273960|26135115|FG001|Short Term Period|Lack of Efficacy|0|||
13176022|NCT02273960|26135116|FG002|Short Term Period|Lack of Efficacy|0|||
13176023|NCT02273960|26135117|FG003|Short Term Period|Lack of Efficacy|1|||
13176024|NCT02273960|26135114|FG000|Short Term Period|ST complete, not entering LTE|4|||
13176025|NCT02273960|26135115|FG001|Short Term Period|ST complete, not entering LTE|6|||
13176026|NCT02273960|26135116|FG002|Short Term Period|ST complete, not entering LTE|4|||
13176027|NCT02273960|26135117|FG003|Short Term Period|ST complete, not entering LTE|5|||
13176028|NCT02273960|26135114|FG000|Long Term Extension|Death|0|||
13176029|NCT02273960|26135115|FG001|Long Term Extension|Death|0|||
13176030|NCT02273960|26135116|FG002|Long Term Extension|Death|0|||
13176031|NCT02273960|26135117|FG003|Long Term Extension|Death|1|||
13176032|NCT02273908|26135146|FG000|Overall Study|Adverse Event|16|||
13176033|NCT02273908|26135147|FG001|Overall Study|Adverse Event|0|||
13176034|NCT02273908|26135146|FG000|Overall Study|Lost to Follow-up|10|||
13176035|NCT02273908|26135147|FG001|Overall Study|Lost to Follow-up|1|||
13176036|NCT02273908|26135146|FG000|Overall Study|Did not meet entrance criteria|3|||
13108589|NCT03252015|25892589|FG000|Overall Study|Adverse Event|1|||
13108590|NCT03252015|25892590|FG001|Overall Study|Adverse Event|0|||
13108591|NCT03252015|25892591|FG002|Overall Study|Adverse Event|0|||
13108592|NCT03252015|25892592|FG003|Overall Study|Adverse Event|1|||
13108593|NCT03251963|25892609|FG000|Overall Study|inappropriate Xa level timing|6|||
13108594|NCT03251963|25892610|FG001|Overall Study|inappropriate Xa level timing|3|||
13108595|NCT03251963|25892609|FG000|Overall Study|no peak Xa level drawn|2|||
13108596|NCT03251963|25892610|FG001|Overall Study|no peak Xa level drawn|0|||
13108597|NCT03251963|25892609|FG000|Overall Study|bled prior to Xa level|1|||
13176037|NCT02273908|26135147|FG001|Overall Study|Did not meet entrance criteria|2|||
13176038|NCT02273908|26135146|FG000|Overall Study|Withdrawal by Subject|4|||
13176039|NCT02273908|26135147|FG001|Overall Study|Withdrawal by Subject|2|||
13176040|NCT02273752|26135160|FG000|Overall Study|Trial was terminated early|2|||
13176041|NCT02273739|26135263|FG000|Overall Study|Progression of Disease|3|||
13176042|NCT02273739|26135264|FG001|Overall Study|Progression of Disease|4|||
13176043|NCT02273739|26135265|FG002|Overall Study|Progression of Disease|5|||
13176044|NCT02273739|26135266|FG003|Overall Study|Progression of Disease|2|||
13176045|NCT02273739|26135263|FG000|Overall Study|Death|0|||
13176046|NCT02273739|26135264|FG001|Overall Study|Death|0|||
13176047|NCT02273739|26135265|FG002|Overall Study|Death|0|||
13176048|NCT02273739|26135266|FG003|Overall Study|Death|2|||
13176049|NCT02273739|26135263|FG000|Overall Study|Adverse Event|0|||
13176050|NCT02273739|26135264|FG001|Overall Study|Adverse Event|0|||
13176051|NCT02273739|26135265|FG002|Overall Study|Adverse Event|0|||
13176052|NCT02273739|26135266|FG003|Overall Study|Adverse Event|1|||
13176053|NCT02273739|26135263|FG000|Overall Study|Withdrawal by Subject|0|||
13176054|NCT02273739|26135264|FG001|Overall Study|Withdrawal by Subject|0|||
13176055|NCT02273739|26135265|FG002|Overall Study|Withdrawal by Subject|2|||
13176056|NCT02273739|26135266|FG003|Overall Study|Withdrawal by Subject|1|||
13176057|NCT02273739|26135263|FG000|Overall Study|Physician Decision|0|||
13176058|NCT02273739|26135264|FG001|Overall Study|Physician Decision|0|||
13176059|NCT02273739|26135265|FG002|Overall Study|Physician Decision|0|||
13176060|NCT02273739|26135266|FG003|Overall Study|Physician Decision|1|||
13176061|NCT02273726|26135299|FG000|Overall Study|Death|70|||
13176062|NCT02273726|26135300|FG001|Overall Study|Death|62|||
13108598|NCT03251963|25892610|FG001|Overall Study|bled prior to Xa level|2|||
13176063|NCT02273726|26135299|FG000|Overall Study|Withdrawal by Subject|41|||
13176064|NCT02273726|26135300|FG001|Overall Study|Withdrawal by Subject|29|||
13176065|NCT02273726|26135299|FG000|Overall Study|Kidney transplant|31|||
13176066|NCT02273726|26135300|FG001|Overall Study|Kidney transplant|39|||
13176067|NCT02273726|26135299|FG000|Overall Study|Physician Decision|30|||
13176068|NCT02273726|26135300|FG001|Overall Study|Physician Decision|15|||
13176069|NCT02273726|26135299|FG000|Overall Study|Adverse Event|27|||
13176070|NCT02273726|26135300|FG001|Overall Study|Adverse Event|9|||
13176071|NCT02273726|26135299|FG000|Overall Study|Lost to Follow-up|6|||
13176072|NCT02273726|26135300|FG001|Overall Study|Lost to Follow-up|3|||
13176073|NCT02273726|26135299|FG000|Overall Study|Lack of Efficacy|6|||
13176074|NCT02273726|26135300|FG001|Overall Study|Lack of Efficacy|1|||
13176075|NCT02273726|26135299|FG000|Overall Study|Protocol Violation|4|||
13176076|NCT02273726|26135300|FG001|Overall Study|Protocol Violation|0|||
13176077|NCT02273726|26135299|FG000|Overall Study|Other than specified|28|||
13176078|NCT02273726|26135300|FG001|Overall Study|Other than specified|30|||
13176079|NCT02273596|26135334|FG000|24-Week Treatment Period|Adverse Event|3|||
13176080|NCT02273596|26135334|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1|||
13176081|NCT02273596|26135334|FG000|24-Week Treatment Period|Participant was unable to Come|1|||
13176082|NCT02273596|26135334|FG000|24-Week Treatment Period|Physician Decision|1|||
13176083|NCT02273596|26135334|FG000|24-Week Treatment Period|Protocol Deviation|1|||
13176084|NCT02273596|26135334|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19|||
13176085|NCT02273596|26135334|FG000|Extension Period|Participant Withdrew for Personal Reasons|1|||
13176086|NCT02273596|26135334|FG000|Extension Period|Lost to Follow-up|1|||
13222978|NCT01801358|26287547|FG004|Overall Study|Progressive Disease|6|||
13108599|NCT03251482|25892698|FG000|Overall Study|Withdrawal by Subject|0|||
13108600|NCT03251482|25892699|FG001|Overall Study|Withdrawal by Subject|1|||
13108601|NCT03251482|25892700|FG002|Overall Study|Withdrawal by Subject|0|||
13108602|NCT03251482|25892701|FG003|Overall Study|Withdrawal by Subject|0|||
13108603|NCT03251482|25892702|FG004|Overall Study|Withdrawal by Subject|0|||
13108604|NCT03250273|25892735|FG000|Overall Study|Disease Progression|2|||
13108605|NCT03250273|25892736|FG001|Overall Study|Disease Progression|9|||
13108606|NCT03250273|25892735|FG000|Overall Study|Adverse Event|0|||
13108607|NCT03250273|25892736|FG001|Overall Study|Adverse Event|1|||
13108608|NCT03250273|25892735|FG000|Overall Study|Death|0|||
13108609|NCT03250273|25892736|FG001|Overall Study|Death|1|||
13108610|NCT03250273|25892735|FG000|Overall Study|Failed to Maintain Eligibility|0|||
13108611|NCT03250273|25892736|FG001|Overall Study|Failed to Maintain Eligibility|1|||
13108612|NCT03250182|25892762|FG000|Overall Study|Withdrawal by Subject|1|||
13108613|NCT03249935|25892770|FG000|Overall Study|Discharged from facility early|36|||
13108614|NCT03249935|25892770|FG000|Overall Study|Negative for chlamydia at enrollment|4|||
13108615|NCT03249935|25892770|FG000|Overall Study|Protocol Violation|5|||
13108616|NCT03249909|25892815|FG000|Overall Study|Withdrawal by Subject|3|||
13108617|NCT03249909|25892816|FG001|Overall Study|Withdrawal by Subject|0|||
13108618|NCT03249909|25892817|FG002|Overall Study|Withdrawal by Subject|0|||
13108619|NCT03249909|25892815|FG000|Overall Study|Adverse Event|3|||
13108620|NCT03249909|25892816|FG001|Overall Study|Adverse Event|0|||
13108621|NCT03249909|25892817|FG002|Overall Study|Adverse Event|0|||
13108622|NCT03249909|25892815|FG000|Overall Study|Lost to Follow-up|0|||
13108623|NCT03249909|25892816|FG001|Overall Study|Lost to Follow-up|1|||
13108624|NCT03249909|25892817|FG002|Overall Study|Lost to Follow-up|0|||
13108625|NCT03249454|25892849|FG000|Overall Study|Withdrawal by Subject|0|||
13108626|NCT03249454|25892850|FG001|Overall Study|Withdrawal by Subject|0|||
13108627|NCT03249454|25892851|FG002|Overall Study|Withdrawal by Subject|0|||
13108628|NCT03249454|25892852|FG003|Overall Study|Withdrawal by Subject|0|||
13108629|NCT03249454|25892853|FG004|Overall Study|Withdrawal by Subject|0|||
13108630|NCT03249454|25892854|FG005|Overall Study|Withdrawal by Subject|0|||
13108631|NCT03249454|25892855|FG006|Overall Study|Withdrawal by Subject|0|||
13108632|NCT03249454|25892856|FG007|Overall Study|Withdrawal by Subject|0|||
13108633|NCT03249454|25892857|FG008|Overall Study|Withdrawal by Subject|0|||
13108634|NCT03249454|25892858|FG009|Overall Study|Withdrawal by Subject|1|||
13108635|NCT03249454|25892859|FG010|Overall Study|Withdrawal by Subject|1|||
13108636|NCT03248882|25892912|FG000|Overall Study|Adverse Event|3|||
13108637|NCT03248882|25892913|FG001|Overall Study|Adverse Event|3|||
13108638|NCT03248882|25892914|FG002|Overall Study|Adverse Event|2|||
13108639|NCT03248882|25892915|FG003|Overall Study|Adverse Event|6|||
13108640|NCT03248882|25892916|FG004|Overall Study|Adverse Event|9|||
13108641|NCT03248882|25892912|FG000|Overall Study|Lost to Follow-up|0|||
13108642|NCT03248882|25892913|FG001|Overall Study|Lost to Follow-up|0|||
13108643|NCT03248882|25892914|FG002|Overall Study|Lost to Follow-up|0|||
13108644|NCT03248882|25892915|FG003|Overall Study|Lost to Follow-up|0|||
13108645|NCT03248882|25892916|FG004|Overall Study|Lost to Follow-up|1|||
13108646|NCT03248882|25892912|FG000|Overall Study|Protocol Violation|2|||
13108647|NCT03248882|25892913|FG001|Overall Study|Protocol Violation|0|||
13108648|NCT03248882|25892914|FG002|Overall Study|Protocol Violation|2|||
13108649|NCT03248882|25892915|FG003|Overall Study|Protocol Violation|0|||
13108650|NCT03248882|25892916|FG004|Overall Study|Protocol Violation|1|||
13108651|NCT03248882|25892912|FG000|Overall Study|Withdrawal by Subject|2|||
13108652|NCT03248882|25892913|FG001|Overall Study|Withdrawal by Subject|2|||
13108653|NCT03248882|25892914|FG002|Overall Study|Withdrawal by Subject|3|||
13108654|NCT03248882|25892915|FG003|Overall Study|Withdrawal by Subject|4|||
13108655|NCT03248882|25892916|FG004|Overall Study|Withdrawal by Subject|2|||
13108656|NCT03248492|25892970|FG000|Overall Study|Ongoing|23|||
13108657|NCT03248492|25892971|FG001|Overall Study|Ongoing|26|||
13176087|NCT02273596|26135334|FG000|Extension Period|Protocol Deviation|1|||
13176088|NCT02273180|26135363|FG000|Overall Study|Adverse Event|2|||
13176089|NCT02273180|26135364|FG001|Overall Study|Adverse Event|2|||
13176090|NCT02273180|26135363|FG000|Overall Study|Lack of Efficacy|1|||
13176091|NCT02273180|26135364|FG001|Overall Study|Lack of Efficacy|0|||
13176092|NCT02273180|26135363|FG000|Overall Study|Protocol Violation|1|||
13176093|NCT02273180|26135364|FG001|Overall Study|Protocol Violation|7|||
13176094|NCT02273180|26135363|FG000|Overall Study|Randomized but not treated|1|||
13176095|NCT02273180|26135364|FG001|Overall Study|Randomized but not treated|0|||
13176096|NCT02273180|26135363|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1|||
13176097|NCT02273180|26135364|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0|||
13176098|NCT02273180|26135363|FG000|Overall Study|Other than specified above|21|||
13176099|NCT02273180|26135364|FG001|Overall Study|Other than specified above|10|||
13176100|NCT02273167|26135397|FG000|Overall Study|Adverse Event|1|||
13176101|NCT02273167|26135398|FG001|Overall Study|Adverse Event|0|||
13176102|NCT02273167|26135399|FG002|Overall Study|Adverse Event|0|||
13176103|NCT02273167|26135397|FG000|Overall Study|Protocol Violation|3|||
13176104|NCT02273167|26135398|FG001|Overall Study|Protocol Violation|1|||
13176105|NCT02273167|26135399|FG002|Overall Study|Protocol Violation|1|||
13176106|NCT02273167|26135397|FG000|Overall Study|Lost to Follow-up|0|||
13176107|NCT02273167|26135398|FG001|Overall Study|Lost to Follow-up|1|||
13176108|NCT02273167|26135399|FG002|Overall Study|Lost to Follow-up|1|||
13176109|NCT02273167|26135397|FG000|Overall Study|Withdrawal by Subject|10|||
13176110|NCT02273167|26135398|FG001|Overall Study|Withdrawal by Subject|12|||
13176111|NCT02273167|26135399|FG002|Overall Study|Withdrawal by Subject|11|||
13176112|NCT02273167|26135397|FG000|Overall Study|Various|10|||
13176113|NCT02273167|26135398|FG001|Overall Study|Various|9|||
13176114|NCT02273167|26135399|FG002|Overall Study|Various|8|||
13176115|NCT02273141|26135422|FG000|Overall Study|Adverse Event|0|||
13176116|NCT02273141|26135423|FG001|Overall Study|Adverse Event|1|||
13176117|NCT02273141|26135422|FG000|Overall Study|Lost to Follow-up|1|||
13176118|NCT02273141|26135423|FG001|Overall Study|Lost to Follow-up|3|||
13176119|NCT02273141|26135422|FG000|Overall Study|Withdrawal by Subject|10|||
13176120|NCT02273141|26135423|FG001|Overall Study|Withdrawal by Subject|15|||
13176121|NCT02273141|26135422|FG000|Overall Study|Various|6|||
13176122|NCT02273141|26135423|FG001|Overall Study|Various|6|||
13176123|NCT02273050|26135459|FG000|Overall Study|Adverse Event|4|||
13176124|NCT02273050|26135460|FG001|Overall Study|Adverse Event|3|||
13176125|NCT02273050|26135461|FG002|Overall Study|Adverse Event|3|||
13176126|NCT02273050|26135459|FG000|Overall Study|Death|0|||
13176127|NCT02273050|26135460|FG001|Overall Study|Death|0|||
13176128|NCT02273050|26135461|FG002|Overall Study|Death|1|||
13176129|NCT02273050|26135459|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0|||
13176130|NCT02273050|26135460|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1|||
13108658|NCT03248492|25892972|FG002|Overall Study|Ongoing|3|||
13108659|NCT03248492|25892973|FG003|Overall Study|Ongoing|85|||
13108660|NCT03248492|25892974|FG004|Overall Study|Ongoing|2|||
13108661|NCT03248492|25892970|FG000|Overall Study|Progressive disease per RECIST v1.1|16|||
13108662|NCT03248492|25892971|FG001|Overall Study|Progressive disease per RECIST v1.1|12|||
13108663|NCT03248492|25892972|FG002|Overall Study|Progressive disease per RECIST v1.1|9|||
13108664|NCT03248492|25892973|FG003|Overall Study|Progressive disease per RECIST v1.1|22|||
13108665|NCT03248492|25892974|FG004|Overall Study|Progressive disease per RECIST v1.1|0|||
13108666|NCT03248492|25892970|FG000|Overall Study|Adverse Event|6|||
13108667|NCT03248492|25892971|FG001|Overall Study|Adverse Event|6|||
13108668|NCT03248492|25892972|FG002|Overall Study|Adverse Event|8|||
13108669|NCT03248492|25892973|FG003|Overall Study|Adverse Event|8|||
13108670|NCT03248492|25892974|FG004|Overall Study|Adverse Event|1|||
13108671|NCT03248492|25892970|FG000|Overall Study|Withdrawal by Subject|3|||
13108672|NCT03248492|25892971|FG001|Overall Study|Withdrawal by Subject|3|||
13108673|NCT03248492|25892972|FG002|Overall Study|Withdrawal by Subject|0|||
13108674|NCT03248492|25892973|FG003|Overall Study|Withdrawal by Subject|3|||
13108675|NCT03248492|25892974|FG004|Overall Study|Withdrawal by Subject|1|||
13108676|NCT03248492|25892970|FG000|Overall Study|Physician Decision|1|||
13108677|NCT03248492|25892971|FG001|Overall Study|Physician Decision|0|||
13108678|NCT03248492|25892972|FG002|Overall Study|Physician Decision|1|||
13108679|NCT03248492|25892973|FG003|Overall Study|Physician Decision|2|||
13108680|NCT03248492|25892974|FG004|Overall Study|Physician Decision|0|||
13108681|NCT03248492|25892970|FG000|Overall Study|Death|1|||
13108682|NCT03248492|25892971|FG001|Overall Study|Death|0|||
13108683|NCT03248492|25892972|FG002|Overall Study|Death|0|||
13108684|NCT03248492|25892973|FG003|Overall Study|Death|6|||
13108685|NCT03248492|25892974|FG004|Overall Study|Death|0|||
13176131|NCT02273050|26135461|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1|||
13176132|NCT02273050|26135459|FG000|Overall Study|Lack of Efficacy|0|||
13176133|NCT02273050|26135460|FG001|Overall Study|Lack of Efficacy|1|||
13176134|NCT02273050|26135461|FG002|Overall Study|Lack of Efficacy|1|||
13176135|NCT02273050|26135459|FG000|Overall Study|Withdrawal by Subject|17|||
13176136|NCT02273050|26135460|FG001|Overall Study|Withdrawal by Subject|14|||
13176137|NCT02273050|26135461|FG002|Overall Study|Withdrawal by Subject|16|||
13176138|NCT02273050|26135459|FG000|Overall Study|Lost to Follow-up|0|||
13108686|NCT03248492|25892970|FG000|Overall Study|Other|0|||
13108687|NCT03248492|25892971|FG001|Overall Study|Other|1|||
13108688|NCT03248492|25892972|FG002|Overall Study|Other|0|||
13176139|NCT02273050|26135460|FG001|Overall Study|Lost to Follow-up|2|||
13176140|NCT02273050|26135461|FG002|Overall Study|Lost to Follow-up|3|||
13176141|NCT02273050|26135459|FG000|Overall Study|Protocol Violation|3|||
13176142|NCT02273050|26135460|FG001|Overall Study|Protocol Violation|1|||
13176143|NCT02273050|26135461|FG002|Overall Study|Protocol Violation|4|||
13176144|NCT02273037|26135478|FG000|Overall Study|Lost to Follow-up|1|||
13176145|NCT02273037|26135479|FG001|Overall Study|Lost to Follow-up|0|||
13176146|NCT02273037|26135478|FG000|Overall Study|Delivered before monitoring initiated|1|||
13176147|NCT02273037|26135479|FG001|Overall Study|Delivered before monitoring initiated|3|||
13176148|NCT02273037|26135478|FG000|Overall Study|Breech delivery|2|||
13176149|NCT02273037|26135479|FG001|Overall Study|Breech delivery|3|||
13176150|NCT02273037|26135478|FG000|Overall Study|Multiple delivery|2|||
13176151|NCT02273037|26135479|FG001|Overall Study|Multiple delivery|2|||
13176152|NCT02273037|26135478|FG000|Overall Study|Other complication|2|||
13176153|NCT02273037|26135479|FG001|Overall Study|Other complication|0|||
13176154|NCT02272985|26135486|FG000|Overall Study|Withdrawal by Subject|1|||
13176155|NCT02272985|26135486|FG000|Overall Study|hip fracture|1|||
13176156|NCT02272985|26135486|FG000|Overall Study|kidney transplantation|1|||
13176157|NCT02272842|26135505|FG000|Overall Study|Lost to Follow-up|8|||
13176158|NCT02272842|26135506|FG001|Overall Study|Lost to Follow-up|8|||
13176159|NCT02272842|26135505|FG000|Overall Study|Withdrawal by Subject|8|||
13176160|NCT02272842|26135506|FG001|Overall Study|Withdrawal by Subject|2|||
13176161|NCT02272816|26135514|FG000|Overall Study|Adverse Event|1|||
13176162|NCT02272803|26135532|FG000|Overall Study|Disease progression|16|||
13176163|NCT02272803|26135533|FG001|Overall Study|Disease progression|8|||
13176164|NCT02272803|26135532|FG000|Overall Study|Adverse Event unrelated to study drug|3|||
13176165|NCT02272803|26135533|FG001|Overall Study|Adverse Event unrelated to study drug|5|||
13176166|NCT02272803|26135532|FG000|Overall Study|Study drug toxicity|4|||
13176167|NCT02272803|26135533|FG001|Overall Study|Study drug toxicity|9|||
13176168|NCT02272803|26135532|FG000|Overall Study|Participant request to discontinue study treatment|3|||
13176169|NCT02272803|26135533|FG001|Overall Study|Participant request to discontinue study treatment|7|||
13176170|NCT02272803|26135532|FG000|Overall Study|Maximum clinical benefit|4|||
13176171|NCT02272803|26135533|FG001|Overall Study|Maximum clinical benefit|2|||
13176172|NCT02272803|26135532|FG000|Overall Study|Poor/non-compliance|2|||
13176173|NCT02272803|26135533|FG001|Overall Study|Poor/non-compliance|2|||
13176174|NCT02272803|26135532|FG000|Overall Study|Withdrawal by Subject|2|||
13176175|NCT02272803|26135533|FG001|Overall Study|Withdrawal by Subject|1|||
13176176|NCT02272803|26135532|FG000|Overall Study|Death|0|||
13176177|NCT02272803|26135533|FG001|Overall Study|Death|1|||
13176178|NCT02272803|26135532|FG000|Overall Study|Other reasons|1|||
13108689|NCT03248492|25892973|FG003|Overall Study|Other|4|||
13108690|NCT03248492|25892974|FG004|Overall Study|Other|0|||
13108691|NCT03248037|25892987|FG000|Overall Study|Withdrawal by Subject|6|||
13108692|NCT03248037|25892988|FG001|Overall Study|Withdrawal by Subject|9|||
13108693|NCT03248037|25892987|FG000|Overall Study|Adverse Event|15|||
13176179|NCT02272803|26135533|FG001|Overall Study|Other reasons|3|||
13176180|NCT02272803|26135532|FG000|Overall Study|Administrative reason by sponsor|5|||
13176181|NCT02272803|26135533|FG001|Overall Study|Administrative reason by sponsor|4|||
13176182|NCT02272777|26135546|FG000|Overall Study|Adverse Event|0|||
13176183|NCT02272777|26135547|FG001|Overall Study|Adverse Event|1|||
13176184|NCT02272777|26135546|FG000|Overall Study|Withdrawal by Subject|0|||
13176185|NCT02272777|26135547|FG001|Overall Study|Withdrawal by Subject|3|||
13176186|NCT02272777|26135546|FG000|Overall Study|Lost to Follow-up|2|||
13176187|NCT02272777|26135547|FG001|Overall Study|Lost to Follow-up|0|||
13176188|NCT02272777|26135546|FG000|Overall Study|Other|2|||
13176189|NCT02272777|26135547|FG001|Overall Study|Other|0|||
13176190|NCT02272725|26135564|FG000|Overall Study|equipment malfunction|2|||
13176191|NCT02272725|26135565|FG001|Overall Study|equipment malfunction|0|||
13176192|NCT02272634|26135637|FG000|Overall Study|Adverse Event|1|||
13176193|NCT02272634|26135638|FG001|Overall Study|Adverse Event|0|||
13176194|NCT02272634|26135639|FG002|Overall Study|Adverse Event|0|||
13176195|NCT02272634|26135637|FG000|Overall Study|Protocol Violation|0|||
13176196|NCT02272634|26135638|FG001|Overall Study|Protocol Violation|0|||
13176197|NCT02272634|26135639|FG002|Overall Study|Protocol Violation|1|||
13176198|NCT02272634|26135637|FG000|Overall Study|Withdrawal by Subject|0|||
13176199|NCT02272634|26135638|FG001|Overall Study|Withdrawal by Subject|1|||
13176200|NCT02272634|26135639|FG002|Overall Study|Withdrawal by Subject|0|||
13176201|NCT02272413|26135662|FG000|Randomized Through Treatment Start|Not treated|3|||
13176202|NCT02272413|26135663|FG001|Randomized Through Treatment Start|Not treated|5|||
13176203|NCT02272413|26135662|FG000|Pre-switch Period|Adverse Event|38|||
13176204|NCT02272413|26135663|FG001|Pre-switch Period|Adverse Event|37|||
13176205|NCT02272413|26135662|FG000|Pre-switch Period|Death|26|||
13176206|NCT02272413|26135663|FG001|Pre-switch Period|Death|26|||
13108694|NCT03248037|25892988|FG001|Overall Study|Adverse Event|0|||
13176207|NCT02272413|26135662|FG000|Pre-switch Period|Withdrawal by Subject|27|||
13176208|NCT02272413|26135663|FG001|Pre-switch Period|Withdrawal by Subject|15|||
13176209|NCT02272413|26135662|FG000|Pre-switch Period|Physician Decision|6|||
13176210|NCT02272413|26135663|FG001|Pre-switch Period|Physician Decision|18|||
13176211|NCT02272413|26135662|FG000|Pre-switch Period|Progressive disease|185|||
13176212|NCT02272413|26135663|FG001|Pre-switch Period|Progressive disease|173|||
13176213|NCT02272413|26135662|FG000|Pre-switch Period|Lost to Follow-up|0|||
13108695|NCT03247816|25893020|FG000|Overall Study|Adverse Event|12|||
13108696|NCT03247816|25893020|FG000|Overall Study|Physician Decision|3|||
13108697|NCT03247816|25893020|FG000|Overall Study|Lack of Efficacy|1|||
13108698|NCT03247816|25893020|FG000|Overall Study|Lost to Follow-up|10|||
13108699|NCT03247816|25893020|FG000|Overall Study|Missing Feraccru stop date|3|||
13133191|NCT02777554|25986871|FG003|Overall Study|Discharged early due to hurricane|0|||
13133192|NCT02777554|25986872|FG004|Overall Study|Discharged early due to hurricane|0|||
13133193|NCT02777554|25986873|FG005|Overall Study|Discharged early due to hurricane|0|||
13133194|NCT02777554|25986868|FG000|Overall Study|Other - Miscellaneous|1|||
13133195|NCT02777554|25986869|FG001|Overall Study|Other - Miscellaneous|0|||
13133196|NCT02777554|25986870|FG002|Overall Study|Other - Miscellaneous|0|||
13133197|NCT02777554|25986871|FG003|Overall Study|Other - Miscellaneous|0|||
13133198|NCT02777554|25986872|FG004|Overall Study|Other - Miscellaneous|0|||
13133199|NCT02777554|25986873|FG005|Overall Study|Other - Miscellaneous|0|||
13133200|NCT02777333|25986904|FG000|Overall Study|Withdrawal by Subject|0|||
13133201|NCT02777333|25986905|FG001|Overall Study|Withdrawal by Subject|1|||
13133202|NCT02777333|25986904|FG000|Overall Study|Lost to Follow-up|0|||
13133203|NCT02777333|25986905|FG001|Overall Study|Lost to Follow-up|1|||
13133204|NCT02777242|25986911|FG000|Overall Study|Other|2|||
13133205|NCT02777242|25986911|FG000|Overall Study|Lost to Follow-up|1|||
13133206|NCT02777242|25986911|FG000|Overall Study|Multiple|1|||
13133207|NCT02777242|25986911|FG000|Overall Study|Sponsor's request|1|||
13133208|NCT02777242|25986911|FG000|Overall Study|Withdrawal by Subject|1|||
13133209|NCT02777125|25986932|FG000|Overall Study|Consent form violation|14|||
13133210|NCT02777125|25986933|FG001|Overall Study|Consent form violation|12|||
13176214|NCT02272413|26135663|FG001|Pre-switch Period|Lost to Follow-up|2|||
13176215|NCT02272413|26135662|FG000|Pre-switch Period|Protocol Violation|1|||
13176216|NCT02272413|26135663|FG001|Pre-switch Period|Protocol Violation|0|||
13176217|NCT02272413|26135662|FG000|Pre-switch Period|Other than listed|10|||
13176218|NCT02272413|26135663|FG001|Pre-switch Period|Other than listed|11|||
13176219|NCT02272413|26135662|FG000|Post-switch Period|Adverse Event|4|||
13176220|NCT02272413|26135663|FG001|Post-switch Period|Adverse Event|4|||
13176221|NCT02272413|26135662|FG000|Post-switch Period|Death|3|||
13176222|NCT02272413|26135663|FG001|Post-switch Period|Death|2|||
13176223|NCT02272413|26135662|FG000|Post-switch Period|Withdrawal by Subject|1|||
13176224|NCT02272413|26135663|FG001|Post-switch Period|Withdrawal by Subject|2|||
13176225|NCT02272413|26135662|FG000|Post-switch Period|Physician Decision|1|||
13176226|NCT02272413|26135663|FG001|Post-switch Period|Physician Decision|1|||
13176227|NCT02272413|26135662|FG000|Post-switch Period|Progressive disease|21|||
13176228|NCT02272413|26135663|FG001|Post-switch Period|Progressive disease|21|||
13176229|NCT02272413|26135662|FG000|Post-switch Period|Study terminated by sponsor|8|||
13176230|NCT02272413|26135663|FG001|Post-switch Period|Study terminated by sponsor|11|||
13176231|NCT02272413|26135662|FG000|Post-switch Period|Other than listed|4|||
13176232|NCT02272413|26135663|FG001|Post-switch Period|Other than listed|5|||
13176233|NCT02271984|26135763|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
13176234|NCT02271984|26135764|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
13176235|NCT02271984|26135765|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
13176236|NCT02271984|26135766|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
13176237|NCT02271984|26135767|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
13176238|NCT02271984|26135768|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
13176239|NCT02271984|26135769|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
13176240|NCT02271984|26135770|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
13176241|NCT02271984|26135771|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
13176242|NCT02271984|26135772|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
13176243|NCT02271984|26135773|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
13176244|NCT02271984|26135774|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
13176245|NCT02271945|26135817|FG000|Overall Study|Death|3|||
13176246|NCT02271945|26135818|FG001|Overall Study|Death|3|||
13176247|NCT02271945|26135817|FG000|Overall Study|Withdrawal by Subject|1|||
13176248|NCT02271945|26135818|FG001|Overall Study|Withdrawal by Subject|1|||
13176249|NCT02271945|26135817|FG000|Overall Study|Other|1|||
13176250|NCT02271945|26135818|FG001|Overall Study|Other|1|||
13176251|NCT02271880|26135855|FG000|Overall Study|Premature discontinuation of study|3|||
13176252|NCT02271880|26135856|FG001|Overall Study|Premature discontinuation of study|4|||
13176253|NCT02271854|26135865|FG000|Overall Study|Withdrawal by Subject|2|||
13176254|NCT02271854|26135865|FG000|Overall Study|Unable or unwilling to cooperate with st|1|||
13176255|NCT02271854|26135865|FG000|Overall Study|Lost to Follow-up|1|||
13176256|NCT02271594|26135886|FG000|Overall Study|Study closed; recruiting failure|19|||
13222979|NCT01801358|26287548|FG005|Overall Study|Progressive Disease|5|||
13133211|NCT02777125|25986932|FG000|Overall Study|Assent form violation|21|||
13176257|NCT02271594|26135887|FG001|Overall Study|Study closed; recruiting failure|12|||
13176258|NCT02271529|26135893|FG000|Overall Study|Withdrawal by Subject|1|||
13176259|NCT02270983|26135926|FG000|Overall Study|Adverse Event|3|||
13176260|NCT02270983|26135927|FG001|Overall Study|Adverse Event|2|||
13176261|NCT02270983|26135928|FG002|Overall Study|Adverse Event|6|||
13176262|NCT02270983|26135926|FG000|Overall Study|Lack of Efficacy|2|||
13176263|NCT02270983|26135927|FG001|Overall Study|Lack of Efficacy|1|||
13176264|NCT02270983|26135928|FG002|Overall Study|Lack of Efficacy|1|||
13176265|NCT02270983|26135926|FG000|Overall Study|Withdrawal by Subject|1|||
13176266|NCT02270983|26135927|FG001|Overall Study|Withdrawal by Subject|0|||
13176267|NCT02270983|26135928|FG002|Overall Study|Withdrawal by Subject|2|||
13176268|NCT02270983|26135926|FG000|Overall Study|Lost to Follow-up|1|||
13176269|NCT02270983|26135927|FG001|Overall Study|Lost to Follow-up|1|||
13176270|NCT02270983|26135928|FG002|Overall Study|Lost to Follow-up|2|||
13176271|NCT02270983|26135926|FG000|Overall Study|Protocol Violation|1|||
13176272|NCT02270983|26135927|FG001|Overall Study|Protocol Violation|1|||
13176273|NCT02270983|26135928|FG002|Overall Study|Protocol Violation|1|||
13176274|NCT02270983|26135926|FG000|Overall Study|family emergency|0|||
13176275|NCT02270983|26135927|FG001|Overall Study|family emergency|1|||
13176276|NCT02270983|26135928|FG002|Overall Study|family emergency|0|||
13176277|NCT02270983|26135926|FG000|Overall Study|study procedure non-compliance|1|||
13176278|NCT02270983|26135927|FG001|Overall Study|study procedure non-compliance|0|||
13176279|NCT02270983|26135928|FG002|Overall Study|study procedure non-compliance|0|||
13176280|NCT02270983|26135926|FG000|Overall Study|moved away from study site|0|||
13176281|NCT02270983|26135927|FG001|Overall Study|moved away from study site|1|||
13176282|NCT02270983|26135928|FG002|Overall Study|moved away from study site|0|||
13176283|NCT02270944|26135951|FG000|Overall Study|Lost to Follow-up|9|||
13176284|NCT02270944|26135952|FG001|Overall Study|Lost to Follow-up|4|||
13176285|NCT02270944|26135951|FG000|Overall Study|Withdrawal by Subject|2|||
13176286|NCT02270944|26135952|FG001|Overall Study|Withdrawal by Subject|1|||
13176287|NCT02270736|26136004|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
13176288|NCT02270736|26136005|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1|||
13176289|NCT02270736|26136006|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
13176290|NCT02270736|26136007|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
13176291|NCT02270736|26136008|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
13176292|NCT02270736|26136004|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2|||
13176293|NCT02270736|26136005|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
13176294|NCT02270736|26136006|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1|||
13176295|NCT02270736|26136007|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
13176296|NCT02270736|26136008|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
13176297|NCT02270736|26136004|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
13176298|NCT02270736|26136005|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1|||
13176299|NCT02270736|26136006|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
13176300|NCT02270736|26136007|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
13176301|NCT02270736|26136008|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
13176302|NCT02270736|26136004|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
13176303|NCT02270736|26136005|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
13176304|NCT02270736|26136006|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1|||
13176305|NCT02270736|26136007|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
13176306|NCT02270736|26136008|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
13176307|NCT02270736|26136004|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
13176308|NCT02270736|26136005|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
13176309|NCT02270736|26136006|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
13176310|NCT02270736|26136007|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1|||
13176311|NCT02270736|26136008|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
13176312|NCT02270736|26136004|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
13176313|NCT02270736|26136005|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
13176314|NCT02270736|26136006|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
13176315|NCT02270736|26136007|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2|||
13176316|NCT02270736|26136008|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
13176317|NCT02270736|26136004|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
13176318|NCT02270736|26136005|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
13176319|NCT02270736|26136006|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
13176320|NCT02270736|26136007|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4|||
13176321|NCT02270736|26136008|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
13176322|NCT02270736|26136004|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
13176323|NCT02270736|26136005|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
13176324|NCT02270736|26136006|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
13176325|NCT02270736|26136007|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16|||
13176326|NCT02270736|26136008|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
13176327|NCT02270736|26136004|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
13176328|NCT02270736|26136005|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
13176329|NCT02270736|26136006|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
13176330|NCT02270736|26136007|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2|||
13176331|NCT02270736|26136008|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
13176332|NCT02270684|26136021|FG000|Overall Study|Lost to Follow-up|0|||
13176333|NCT02270684|26136022|FG001|Overall Study|Lost to Follow-up|3|||
13176334|NCT02270684|26136021|FG000|Overall Study|Study terminated|1|||
13176335|NCT02270684|26136022|FG001|Overall Study|Study terminated|0|||
13176336|NCT02270671|26136043|FG000|Overall Study|Withdrawal by Subject|1|||
13176337|NCT02270671|26136044|FG001|Overall Study|Withdrawal by Subject|1|||
13176338|NCT02270671|26136043|FG000|Overall Study|Protocol Violation|0|||
13176339|NCT02270671|26136044|FG001|Overall Study|Protocol Violation|1|||
13176340|NCT02270671|26136043|FG000|Overall Study|Missed Post-intervention Data Collection|2|||
13176341|NCT02270671|26136044|FG001|Overall Study|Missed Post-intervention Data Collection|2|||
13176342|NCT02270671|26136043|FG000|Overall Study|Lost to Follow-up|2|||
13176343|NCT02270671|26136044|FG001|Overall Study|Lost to Follow-up|1|||
13176344|NCT02270515|26136061|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1|||
13176345|NCT02270515|26136061|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5|||
13176346|NCT02270515|26136061|FG000|Intervention Period 1: 0-6 Months|Received transplant|3|||
13176347|NCT02270515|26136061|FG000|Intervention Period 1: 0-6 Months|Death|7|||
13176348|NCT02270515|26136061|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2|||
13176349|NCT02270515|26136061|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7|||
13176350|NCT02270515|26136061|FG000|Intervention Period 2: 6-12 Months|Received transplant|1|||
13176351|NCT02270515|26136061|FG000|Intervention Period 2: 6-12 Months|Death|5|||
13176352|NCT02270515|26136061|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17|||
13176353|NCT02270515|26136061|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1|||
13176354|NCT02270515|26136061|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2|||
13176355|NCT02270515|26136061|FG000|Intervention Period 3: 12-18 Months|Received transplant|2|||
13176356|NCT02270515|26136061|FG000|Intervention Period 3: 12-18 Months|Death|3|||
13176357|NCT02270515|26136061|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16|||
13176358|NCT02270450|26136108|FG000|Overall Study|Refusal unrelated to adverse event|3|||
13176359|NCT02270450|26136109|FG001|Overall Study|Refusal unrelated to adverse event|1|||
13176360|NCT02270450|26136110|FG002|Overall Study|Refusal unrelated to adverse event|5|||
13176361|NCT02270450|26136111|FG003|Overall Study|Refusal unrelated to adverse event|14|||
13176362|NCT02270450|26136108|FG000|Overall Study|Progression/relapse|1|||
13176363|NCT02270450|26136109|FG001|Overall Study|Progression/relapse|2|||
13176364|NCT02270450|26136110|FG002|Overall Study|Progression/relapse|4|||
13176365|NCT02270450|26136111|FG003|Overall Study|Progression/relapse|9|||
13176366|NCT02270450|26136108|FG000|Overall Study|Death|19|||
13176367|NCT02270450|26136109|FG001|Overall Study|Death|19|||
13176368|NCT02270450|26136110|FG002|Overall Study|Death|31|||
13176369|NCT02270450|26136111|FG003|Overall Study|Death|59|||
13176370|NCT02270242|26136126|FG000|Overall Study|Withdrawal by Subject|18|||
13176371|NCT02270242|26136127|FG001|Overall Study|Withdrawal by Subject|25|||
13176372|NCT02270242|26136126|FG000|Overall Study|Lost to Follow-up|41|||
13176373|NCT02270242|26136127|FG001|Overall Study|Lost to Follow-up|27|||
13176374|NCT02270242|26136126|FG000|Overall Study|Physician Decision|0|||
13176375|NCT02270242|26136127|FG001|Overall Study|Physician Decision|1|||
13176376|NCT02269943|26136162|FG000|Treatment Period|Death|0|||
13176377|NCT02269943|26136163|FG001|Treatment Period|Death|1|||
13176378|NCT02269943|26136162|FG000|Treatment Period|Adverse Event|1|||
13176379|NCT02269943|26136163|FG001|Treatment Period|Adverse Event|10|||
13176380|NCT02269943|26136162|FG000|Treatment Period|Progressive Disease|5|||
13176381|NCT02269943|26136163|FG001|Treatment Period|Progressive Disease|17|||
13176382|NCT02269943|26136162|FG000|Treatment Period|Symptomatic Deterioration|0|||
13176383|NCT02269943|26136163|FG001|Treatment Period|Symptomatic Deterioration|2|||
13176384|NCT02269943|26136162|FG000|Follow-Up Survival Period|Death|3|||
13176385|NCT02269943|26136163|FG001|Follow-Up Survival Period|Death|16|||
13176386|NCT02269943|26136162|FG000|Follow-Up Survival Period|Lost to Follow-up|0|||
13176387|NCT02269943|26136163|FG001|Follow-Up Survival Period|Lost to Follow-up|2|||
13176388|NCT02269943|26136162|FG000|Follow-Up Survival Period|Alive|2|||
13176389|NCT02269943|26136163|FG001|Follow-Up Survival Period|Alive|8|||
13176390|NCT02269787|26136176|FG000|Overall Study|Lost to Follow-up|20|||
13176391|NCT02269787|26136177|FG001|Overall Study|Lost to Follow-up|6|||
13176392|NCT02269787|26136176|FG000|Overall Study|Death|2|||
13176393|NCT02269787|26136177|FG001|Overall Study|Death|3|||
13176394|NCT02269787|26136176|FG000|Overall Study|Incapacitated|0|||
13176395|NCT02269787|26136177|FG001|Overall Study|Incapacitated|1|||
13176396|NCT02269709|26136184|FG000|Time of Enrollment|Withdrawal by Subject|3|||
13176397|NCT02269709|26136184|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1|||
13176398|NCT02269709|26136184|FG000|Six Month Follow-up|Lost to Follow-up|12|||
13176399|NCT02269670|26136194|FG000|Overall Study|All subjects have not completed all research related interventions|3|||
13176400|NCT02269657|26136210|FG000|Overall Study|Protocol Violation|3|||
13176401|NCT02269475|26136228|FG000|Overall Study|Meet Exclusion Criteria No. 17|3|||
13176402|NCT02269475|26136229|FG001|Overall Study|Meet Exclusion Criteria No. 17|0|||
13176403|NCT02269475|26136228|FG000|Overall Study|Withdrawal by Subject|0|||
13176404|NCT02269475|26136229|FG001|Overall Study|Withdrawal by Subject|1|||
13176405|NCT02269423|26136304|FG000|Overall Study|Discontinued due to change in residence|0|||
13176406|NCT02269423|26136305|FG001|Overall Study|Discontinued due to change in residence|1|||
13176407|NCT02269423|26136306|FG002|Overall Study|Discontinued due to change in residence|0|||
13176408|NCT02269423|26136307|FG003|Overall Study|Discontinued due to change in residence|1|||
13176409|NCT02269241|26136321|FG000|Overall Study|Lost to Follow-up|269|||
13176410|NCT02269241|26136321|FG000|Overall Study|Withdrawal by Subject|155|||
13176411|NCT02269241|26136321|FG000|Overall Study|Protocol Violation|1|||
13176412|NCT02269241|26136321|FG000|Overall Study|Physician Decision|7|||
13176413|NCT02269241|26136321|FG000|Overall Study|Pregnancy|15|||
13176414|NCT02269241|26136321|FG000|Overall Study|Wish for pregnancy|5|||
13176415|NCT02269241|26136321|FG000|Overall Study|Development of an exclusion criteria|16|||
13176416|NCT02269241|26136321|FG000|Overall Study|Adverse Event|113|||
13176417|NCT02269241|26136321|FG000|Overall Study|At the specific request of the sponsor|20|||
13176418|NCT02269241|26136321|FG000|Overall Study|Several reasons not classified|53|||
13176419|NCT02269241|26136321|FG000|Overall Study|Screening failures|546|||
13176420|NCT02269163|26136340|FG000|Overall Study|Lost to Follow-up|1|||
13176421|NCT02269163|26136341|FG001|Overall Study|Lost to Follow-up|0|||
13176422|NCT02269163|26136340|FG000|Overall Study|Major protocol violation|0|||
13176423|NCT02269163|26136341|FG001|Overall Study|Major protocol violation|1|||
13176424|NCT02269163|26136340|FG000|Overall Study|Other|2|||
13176425|NCT02269163|26136341|FG001|Overall Study|Other|2|||
13176426|NCT02269163|26136340|FG000|Overall Study|Withdrawal by Subject|0|||
13176427|NCT02269163|26136341|FG001|Overall Study|Withdrawal by Subject|3|||
13176428|NCT02269163|26136340|FG000|Overall Study|Physician Decision|0|||
13176429|NCT02269163|26136341|FG001|Overall Study|Physician Decision|1|||
13176430|NCT02269124|26136362|FG000|Overall Study|Lost to Follow-up|1|||
13176431|NCT02269124|26136363|FG001|Overall Study|Lost to Follow-up|0|||
13176432|NCT02269124|26136362|FG000|Overall Study|Withdrawal by Subject|0|||
13176433|NCT02269124|26136363|FG001|Overall Study|Withdrawal by Subject|2|||
13176434|NCT02269098|26136384|FG000|Overall Study|Lost to Follow-up|14|||
13176435|NCT02269098|26136385|FG001|Overall Study|Lost to Follow-up|9|||
13176436|NCT02268916|26136407|FG000|Overall Study|Lost to Follow-up|1|||
13176437|NCT02268916|26136408|FG001|Overall Study|Lost to Follow-up|1|||
13176438|NCT02268916|26136407|FG000|Overall Study|Withdrawal by Subject|6|||
13176439|NCT02268916|26136408|FG001|Overall Study|Withdrawal by Subject|5|||
13176440|NCT02268916|26136407|FG000|Overall Study|Participant did not have diabetes|1|||
13176441|NCT02268916|26136408|FG001|Overall Study|Participant did not have diabetes|0|||
13176442|NCT02268916|26136407|FG000|Overall Study|Did not complete home monitoring activities after baseline visit|9|||
13176443|NCT02268916|26136408|FG001|Overall Study|Did not complete home monitoring activities after baseline visit|4|||
13176444|NCT02268864|26136440|FG000|Overall Study|Withdrawal by Subject|2|||
13176445|NCT02268864|26136441|FG001|Overall Study|Withdrawal by Subject|0|||
13176446|NCT02268864|26136442|FG002|Overall Study|Withdrawal by Subject|0|||
13176447|NCT02268864|26136440|FG000|Overall Study|Death|0|||
13176448|NCT02268864|26136441|FG001|Overall Study|Death|1|||
13176449|NCT02268864|26136442|FG002|Overall Study|Death|0|||
13176450|NCT02268851|26136475|FG000|Overall Study|Death|0|||
13176451|NCT02268851|26136476|FG001|Overall Study|Death|0|||
13176452|NCT02268851|26136477|FG002|Overall Study|Death|0|||
13108700|NCT03247686|25893037|FG000|Overall Study|Withdrawal by Subject|1|||
13176453|NCT02268851|26136478|FG003|Overall Study|Death|1|||
13176454|NCT02268851|26136479|FG004|Overall Study|Death|2|||
13108701|NCT03247686|25893038|FG001|Overall Study|Withdrawal by Subject|2|||
13176455|NCT02268851|26136480|FG005|Overall Study|Death|1|||
13176456|NCT02268851|26136475|FG000|Overall Study|Adverse Event|0|||
13176457|NCT02268851|26136476|FG001|Overall Study|Adverse Event|0|||
13176458|NCT02268851|26136477|FG002|Overall Study|Adverse Event|0|||
13176459|NCT02268851|26136478|FG003|Overall Study|Adverse Event|0|||
13176460|NCT02268851|26136479|FG004|Overall Study|Adverse Event|2|||
13176461|NCT02268851|26136480|FG005|Overall Study|Adverse Event|2|||
13176462|NCT02268851|26136475|FG000|Overall Study|Withdrawal by Subject|0|||
13176463|NCT02268851|26136476|FG001|Overall Study|Withdrawal by Subject|0|||
13176464|NCT02268851|26136477|FG002|Overall Study|Withdrawal by Subject|0|||
13176465|NCT02268851|26136478|FG003|Overall Study|Withdrawal by Subject|2|||
13176466|NCT02268851|26136479|FG004|Overall Study|Withdrawal by Subject|0|||
13176467|NCT02268851|26136480|FG005|Overall Study|Withdrawal by Subject|1|||
13176468|NCT02268851|26136475|FG000|Overall Study|Progressive Disease|1|||
13176469|NCT02268851|26136476|FG001|Overall Study|Progressive Disease|3|||
13176470|NCT02268851|26136477|FG002|Overall Study|Progressive Disease|0|||
13108702|NCT03247673|25893068|FG000|Overall Study|Withdrawal by Subject|1|||
13108703|NCT03247673|25893069|FG001|Overall Study|Withdrawal by Subject|0|||
13108704|NCT03247673|25893070|FG002|Overall Study|Withdrawal by Subject|3|||
13108705|NCT03247673|25893068|FG000|Overall Study|Lost to Follow-up|0|||
13108706|NCT03247673|25893069|FG001|Overall Study|Lost to Follow-up|0|||
13108707|NCT03247673|25893070|FG002|Overall Study|Lost to Follow-up|1|||
13176471|NCT02268851|26136478|FG003|Overall Study|Progressive Disease|0|||
13176472|NCT02268851|26136479|FG004|Overall Study|Progressive Disease|1|||
13176473|NCT02268851|26136480|FG005|Overall Study|Progressive Disease|4|||
13176474|NCT02268851|26136475|FG000|Overall Study|Physician Decision|0|||
13176475|NCT02268851|26136476|FG001|Overall Study|Physician Decision|0|||
13176476|NCT02268851|26136477|FG002|Overall Study|Physician Decision|1|||
13176477|NCT02268851|26136478|FG003|Overall Study|Physician Decision|0|||
13176478|NCT02268851|26136479|FG004|Overall Study|Physician Decision|0|||
13176479|NCT02268851|26136480|FG005|Overall Study|Physician Decision|1|||
13176480|NCT02268851|26136475|FG000|Overall Study|Patient Compliance|0|||
13176481|NCT02268851|26136476|FG001|Overall Study|Patient Compliance|0|||
13176482|NCT02268851|26136477|FG002|Overall Study|Patient Compliance|0|||
13176483|NCT02268851|26136478|FG003|Overall Study|Patient Compliance|0|||
13176484|NCT02268851|26136479|FG004|Overall Study|Patient Compliance|1|||
13176485|NCT02268851|26136480|FG005|Overall Study|Patient Compliance|1|||
13176486|NCT02268851|26136475|FG000|Overall Study|Co-Morbid Condition|0|||
13176487|NCT02268851|26136476|FG001|Overall Study|Co-Morbid Condition|0|||
13176488|NCT02268851|26136477|FG002|Overall Study|Co-Morbid Condition|0|||
13176489|NCT02268851|26136478|FG003|Overall Study|Co-Morbid Condition|0|||
13176490|NCT02268851|26136479|FG004|Overall Study|Co-Morbid Condition|1|||
13176491|NCT02268851|26136480|FG005|Overall Study|Co-Morbid Condition|1|||
13176492|NCT02268812|26136523|FG000|Overall Study|Adverse Event|8|||
13176493|NCT02268812|26136524|FG001|Overall Study|Adverse Event|26|||
13176494|NCT02268812|26136525|FG002|Overall Study|Adverse Event|7|||
13176495|NCT02268812|26136526|FG003|Overall Study|Adverse Event|10|||
13176496|NCT02268812|26136523|FG000|Overall Study|Protocol deviation|0|||
13176497|NCT02268812|26136524|FG001|Overall Study|Protocol deviation|0|||
13176498|NCT02268812|26136525|FG002|Overall Study|Protocol deviation|1|||
13176499|NCT02268812|26136526|FG003|Overall Study|Protocol deviation|0|||
13176500|NCT02268812|26136523|FG000|Overall Study|Withdrawal by Subject|0|||
13176501|NCT02268812|26136524|FG001|Overall Study|Withdrawal by Subject|1|||
13176502|NCT02268812|26136525|FG002|Overall Study|Withdrawal by Subject|0|||
13176503|NCT02268812|26136526|FG003|Overall Study|Withdrawal by Subject|0|||
13176504|NCT02268812|26136523|FG000|Overall Study|Physician Decision|3|||
13176505|NCT02268812|26136524|FG001|Overall Study|Physician Decision|1|||
13176506|NCT02268812|26136525|FG002|Overall Study|Physician Decision|0|||
13176507|NCT02268812|26136526|FG003|Overall Study|Physician Decision|1|||
13176508|NCT02268812|26136523|FG000|Overall Study|Other|5|||
13176509|NCT02268812|26136524|FG001|Overall Study|Other|4|||
13176510|NCT02268812|26136525|FG002|Overall Study|Other|1|||
13176511|NCT02268812|26136526|FG003|Overall Study|Other|3|||
13176512|NCT02268786|26136539|FG000|Overall Study|No Euploid Embryos available|42|||
13108708|NCT03247556|25893112|FG000|Overall Study|Adverse Event|1|||
13176513|NCT02268786|26136540|FG001|Overall Study|No Euploid Embryos available|0|||
13176514|NCT02268786|26136539|FG000|Overall Study|Withdrawal by Subject|7|||
13176515|NCT02268786|26136540|FG001|Overall Study|Withdrawal by Subject|14|||
13176516|NCT02268786|26136539|FG000|Overall Study|Thaw Failure|6|||
13176517|NCT02268786|26136540|FG001|Overall Study|Thaw Failure|4|||
13176518|NCT02268786|26136539|FG000|Overall Study|Protocol Violation|1|||
13176519|NCT02268786|26136540|FG001|Overall Study|Protocol Violation|0|||
13176520|NCT02268526|26136571|FG000|Overall Study|Adverse Event|0|||
13176521|NCT02268526|26136572|FG001|Overall Study|Adverse Event|2|||
13176522|NCT02268526|26136573|FG002|Overall Study|Adverse Event|1|||
13176523|NCT02268526|26136571|FG000|Overall Study|Death|1|||
13176524|NCT02268526|26136572|FG001|Overall Study|Death|11|||
13176525|NCT02268526|26136573|FG002|Overall Study|Death|0|||
13176526|NCT02268526|26136571|FG000|Overall Study|protocol deviation|0|||
13176527|NCT02268526|26136572|FG001|Overall Study|protocol deviation|1|||
13176528|NCT02268526|26136573|FG002|Overall Study|protocol deviation|0|||
13176529|NCT02268526|26136571|FG000|Overall Study|Physician Decision|0|||
13176530|NCT02268526|26136572|FG001|Overall Study|Physician Decision|0|||
13176531|NCT02268526|26136573|FG002|Overall Study|Physician Decision|1|||
13176532|NCT02268526|26136571|FG000|Overall Study|Subject/guardian decision|0|||
13176533|NCT02268526|26136572|FG001|Overall Study|Subject/guardian decision|7|||
13176534|NCT02268526|26136573|FG002|Overall Study|Subject/guardian decision|3|||
13176535|NCT02268396|26136584|FG000|Overall Study|Adverse Event|3|||
13176536|NCT02268396|26136584|FG000|Overall Study|Administrative|2|||
13108709|NCT03247556|25893113|FG001|Overall Study|Adverse Event|4|||
13108710|NCT03247556|25893114|FG002|Overall Study|Adverse Event|5|||
13108711|NCT03247556|25893112|FG000|Overall Study|Lost to Follow-up|5|||
13108712|NCT03247556|25893113|FG001|Overall Study|Lost to Follow-up|5|||
13108713|NCT03247556|25893114|FG002|Overall Study|Lost to Follow-up|4|||
13108714|NCT03247556|25893112|FG000|Overall Study|Consent Withdrawn by Caregiver|4|||
13108715|NCT03247556|25893113|FG001|Overall Study|Consent Withdrawn by Caregiver|1|||
13108716|NCT03247556|25893114|FG002|Overall Study|Consent Withdrawn by Caregiver|5|||
13108717|NCT03247556|25893112|FG000|Overall Study|Assent/consent Withdrawn by Subject|0|||
13176537|NCT02268396|26136584|FG000|Overall Study|Withdrawal by Subject|1|||
13176538|NCT02268396|26136584|FG000|Overall Study|Lost to Follow-up|2|||
13176539|NCT02268396|26136584|FG000|Overall Study|Protocol-Specified Criteria|2|||
13176540|NCT02268396|26136584|FG000|Overall Study|2 Subjects no Day 29 Assessment|2|||
13176541|NCT02268214|26136620|FG000|Overall Study|Subject no longer meets study criteria|0|||
13176542|NCT02268214|26136621|FG001|Overall Study|Subject no longer meets study criteria|2|||
13176543|NCT02268214|26136622|FG002|Overall Study|Subject no longer meets study criteria|0|||
13176544|NCT02268214|26136620|FG000|Overall Study|Pregnancy|2|||
13176545|NCT02268214|26136621|FG001|Overall Study|Pregnancy|2|||
13176546|NCT02268214|26136622|FG002|Overall Study|Pregnancy|1|||
13176547|NCT02268214|26136620|FG000|Overall Study|Lost to Follow-up|3|||
13176548|NCT02268214|26136621|FG001|Overall Study|Lost to Follow-up|3|||
13176549|NCT02268214|26136622|FG002|Overall Study|Lost to Follow-up|4|||
13176550|NCT02268214|26136620|FG000|Overall Study|Lack of Efficacy|1|||
13176551|NCT02268214|26136621|FG001|Overall Study|Lack of Efficacy|0|||
13176552|NCT02268214|26136622|FG002|Overall Study|Lack of Efficacy|2|||
13176553|NCT02268214|26136620|FG000|Overall Study|Adverse Event|11|||
13176554|NCT02268214|26136621|FG001|Overall Study|Adverse Event|14|||
13176555|NCT02268214|26136622|FG002|Overall Study|Adverse Event|9|||
13176556|NCT02268214|26136620|FG000|Overall Study|Withdrawal by Subject|4|||
13176557|NCT02268214|26136621|FG001|Overall Study|Withdrawal by Subject|5|||
13176558|NCT02268214|26136622|FG002|Overall Study|Withdrawal by Subject|10|||
13176559|NCT02268214|26136620|FG000|Overall Study|Subject request to discontinue treatment|10|||
13176560|NCT02268214|26136621|FG001|Overall Study|Subject request to discontinue treatment|8|||
13176561|NCT02268214|26136622|FG002|Overall Study|Subject request to discontinue treatment|6|||
13176562|NCT02268214|26136620|FG000|Overall Study|Poor/non-compliance|2|||
13176563|NCT02268214|26136621|FG001|Overall Study|Poor/non-compliance|1|||
13176564|NCT02268214|26136622|FG002|Overall Study|Poor/non-compliance|2|||
13176565|NCT02268214|26136620|FG000|Overall Study|Other reasons|7|||
13176566|NCT02268214|26136621|FG001|Overall Study|Other reasons|3|||
13176567|NCT02268214|26136622|FG002|Overall Study|Other reasons|3|||
13176568|NCT02268214|26136620|FG000|Overall Study|Not entering long-term period|2|||
13176569|NCT02268214|26136621|FG001|Overall Study|Not entering long-term period|3|||
13176570|NCT02268214|26136622|FG002|Overall Study|Not entering long-term period|5|||
13176571|NCT02268084|26136649|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0|||
13176572|NCT02268084|26136650|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3|||
13176573|NCT02268084|26136649|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9|||
13176574|NCT02268084|26136650|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4|||
13176575|NCT02268058|26136685|FG000|Overall Study|Protocol Violation|1|||
13176576|NCT02268058|26136686|FG001|Overall Study|Protocol Violation|0|||
13176577|NCT02268058|26136687|FG002|Overall Study|Protocol Violation|0|||
13176578|NCT02268058|26136688|FG003|Overall Study|Protocol Violation|0|||
13176579|NCT02268045|26136717|FG000|Overall Study|Death|4|||
13176580|NCT02268045|26136718|FG001|Overall Study|Death|4|||
13176581|NCT02268045|26136717|FG000|Overall Study|Disease Progression|2|||
13176582|NCT02268045|26136718|FG001|Overall Study|Disease Progression|1|||
13176583|NCT02268045|26136717|FG000|Overall Study|Adverse Event|7|||
13176584|NCT02268045|26136718|FG001|Overall Study|Adverse Event|7|||
13176585|NCT02268045|26136717|FG000|Overall Study|Withdrawal by Subject|2|||
13176586|NCT02268045|26136718|FG001|Overall Study|Withdrawal by Subject|6|||
13176587|NCT02268045|26136717|FG000|Overall Study|Physician Decision|0|||
13176588|NCT02268045|26136718|FG001|Overall Study|Physician Decision|1|||
13176589|NCT02268045|26136717|FG000|Overall Study|Protocol Violation|1|||
13176590|NCT02268045|26136718|FG001|Overall Study|Protocol Violation|1|||
13108718|NCT03247556|25893113|FG001|Overall Study|Assent/consent Withdrawn by Subject|2|||
13108719|NCT03247556|25893114|FG002|Overall Study|Assent/consent Withdrawn by Subject|2|||
13108720|NCT03247556|25893112|FG000|Overall Study|Protocol Violation|2|||
13108721|NCT03247556|25893113|FG001|Overall Study|Protocol Violation|0|||
13108722|NCT03247556|25893114|FG002|Overall Study|Protocol Violation|1|||
13108723|NCT03247556|25893112|FG000|Overall Study|Subject did not meet inclusion criteria|0|||
13108724|NCT03247556|25893113|FG001|Overall Study|Subject did not meet inclusion criteria|0|||
13108725|NCT03247556|25893114|FG002|Overall Study|Subject did not meet inclusion criteria|1|||
13108726|NCT03247543|25893156|FG000|Overall Study|Adverse Event|3|||
13108727|NCT03247543|25893157|FG001|Overall Study|Adverse Event|6|||
13108728|NCT03247543|25893158|FG002|Overall Study|Adverse Event|4|||
13108729|NCT03247543|25893156|FG000|Overall Study|Lost to Follow-up|10|||
13108730|NCT03247543|25893157|FG001|Overall Study|Lost to Follow-up|7|||
13108731|NCT03247543|25893158|FG002|Overall Study|Lost to Follow-up|8|||
13108732|NCT03247543|25893156|FG000|Overall Study|Consent withdrawn by caregiver|2|||
13108733|NCT03247543|25893157|FG001|Overall Study|Consent withdrawn by caregiver|2|||
13108734|NCT03247543|25893158|FG002|Overall Study|Consent withdrawn by caregiver|9|||
13108735|NCT03247543|25893156|FG000|Overall Study|Withdrawal by Subject|0|||
13108736|NCT03247543|25893157|FG001|Overall Study|Withdrawal by Subject|0|||
13108737|NCT03247543|25893158|FG002|Overall Study|Withdrawal by Subject|1|||
13108738|NCT03247543|25893156|FG000|Overall Study|Failure to Follow study procedures|1|||
13108739|NCT03247543|25893157|FG001|Overall Study|Failure to Follow study procedures|3|||
13108740|NCT03247543|25893158|FG002|Overall Study|Failure to Follow study procedures|1|||
13108741|NCT03247543|25893156|FG000|Overall Study|Lack of Efficacy|1|||
13108742|NCT03247543|25893157|FG001|Overall Study|Lack of Efficacy|0|||
13108743|NCT03247543|25893158|FG002|Overall Study|Lack of Efficacy|0|||
13108744|NCT03247543|25893156|FG000|Overall Study|Non-compliance with study visits|0|||
13108745|NCT03247543|25893157|FG001|Overall Study|Non-compliance with study visits|1|||
13108746|NCT03247543|25893158|FG002|Overall Study|Non-compliance with study visits|0|||
13108747|NCT03247530|25893200|FG000|Overall Study|Withdrawal by caregiver|19|||
13108748|NCT03247530|25893201|FG001|Overall Study|Withdrawal by caregiver|8|||
13108749|NCT03247530|25893202|FG002|Overall Study|Withdrawal by caregiver|10|||
13108750|NCT03247530|25893200|FG000|Overall Study|Lost to Follow-up|3|||
13108751|NCT03247530|25893201|FG001|Overall Study|Lost to Follow-up|9|||
13108752|NCT03247530|25893202|FG002|Overall Study|Lost to Follow-up|6|||
13108753|NCT03247530|25893200|FG000|Overall Study|Adverse Event|2|||
13176591|NCT02267824|26136731|FG000|Overall Study|Pregnancy|1|||
13176592|NCT02267824|26136732|FG001|Overall Study|Pregnancy|1|||
13176593|NCT02267824|26136731|FG000|Overall Study|Lost to Follow-up|4|||
13176594|NCT02267824|26136732|FG001|Overall Study|Lost to Follow-up|0|||
13176595|NCT02267824|26136731|FG000|Overall Study|Protocol Violation|3|||
13176596|NCT02267824|26136732|FG001|Overall Study|Protocol Violation|0|||
13176597|NCT02267824|26136731|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2|||
13176598|NCT02267824|26136732|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0|||
13176599|NCT02267746|26136756|FG000|Overall Study|Adverse Event|0|||
13176600|NCT02267746|26136757|FG001|Overall Study|Adverse Event|2|||
13176601|NCT02267746|26136758|FG002|Overall Study|Adverse Event|1|||
13176602|NCT02267746|26136756|FG000|Overall Study|Protocol Violation|8|||
13176603|NCT02267746|26136757|FG001|Overall Study|Protocol Violation|7|||
13176604|NCT02267746|26136758|FG002|Overall Study|Protocol Violation|3|||
13176605|NCT02267746|26136756|FG000|Overall Study|Lack of Efficacy|11|||
13176606|NCT02267746|26136757|FG001|Overall Study|Lack of Efficacy|11|||
13176607|NCT02267746|26136758|FG002|Overall Study|Lack of Efficacy|15|||
13176608|NCT02267746|26136756|FG000|Overall Study|Protocol Violation|1|||
13176609|NCT02267746|26136757|FG001|Overall Study|Protocol Violation|2|||
13176610|NCT02267746|26136758|FG002|Overall Study|Protocol Violation|1|||
13176611|NCT02267746|26136756|FG000|Overall Study|Miscellaneous|1|||
13176612|NCT02267746|26136757|FG001|Overall Study|Miscellaneous|0|||
13176613|NCT02267746|26136758|FG002|Overall Study|Miscellaneous|1|||
13176614|NCT02267317|26136821|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1|||
13176615|NCT02267317|26136822|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
13176616|NCT02267317|26136823|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
13176617|NCT02267317|26136824|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
13108754|NCT03247530|25893201|FG001|Overall Study|Adverse Event|5|||
13108755|NCT03247530|25893202|FG002|Overall Study|Adverse Event|2|||
13108756|NCT03247530|25893200|FG000|Overall Study|Failure to follow procedure|1|||
13108757|NCT03247530|25893201|FG001|Overall Study|Failure to follow procedure|1|||
13176618|NCT02267317|26136825|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
13176619|NCT02267317|26136826|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
13176620|NCT02267317|26136821|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1|||
13176621|NCT02267317|26136822|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
13176622|NCT02267317|26136823|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
13176623|NCT02267317|26136824|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
13176624|NCT02267317|26136825|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
13176625|NCT02267317|26136826|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
13108758|NCT03247530|25893202|FG002|Overall Study|Failure to follow procedure|1|||
13176626|NCT02267278|26136833|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1|||
13176627|NCT02267278|26136833|FG000|Overall Study|transformation to acute leukemia (AML)|1|||
13176628|NCT02267278|26136833|FG000|Overall Study|Developed new cancer diagnoses|2|||
13176629|NCT02267278|26136833|FG000|Overall Study|prescribed prohibited medication|1|||
13176630|NCT02267187|26136841|FG000|Overall Study|Physician Decision|2|||
13176631|NCT02267187|26136841|FG000|Overall Study|Screen fail|3|||
13176632|NCT02267135|26136879|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1|||
13176633|NCT02267135|26136880|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3|||
13176634|NCT02267135|26136879|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0|||
13176635|NCT02267135|26136880|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1|||
13176636|NCT02267135|26136879|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1|||
13176637|NCT02267135|26136880|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1|||
13176638|NCT02267135|26136879|FG000|Period 2 (Randomized Set)|Adverse Event|2|||
13176639|NCT02267135|26136880|FG001|Period 2 (Randomized Set)|Adverse Event|0|||
13176640|NCT02267135|26136879|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1|||
13176641|NCT02267135|26136880|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0|||
13176642|NCT02266888|26136921|FG000|Overall Study|Death|2|||
13176643|NCT02266888|26136922|FG001|Overall Study|Death|2|||
13176644|NCT02266888|26136923|FG002|Overall Study|Death|4|||
13176645|NCT02266888|26136924|FG003|Overall Study|Death|2|||
13176646|NCT02266888|26136921|FG000|Overall Study|Physician Decision|0|||
13176647|NCT02266888|26136922|FG001|Overall Study|Physician Decision|1|||
13176648|NCT02266888|26136923|FG002|Overall Study|Physician Decision|2|||
13176649|NCT02266888|26136924|FG003|Overall Study|Physician Decision|2|||
13176650|NCT02266888|26136921|FG000|Overall Study|Study Terminated|5|||
13176651|NCT02266888|26136922|FG001|Overall Study|Study Terminated|1|||
13176652|NCT02266888|26136923|FG002|Overall Study|Study Terminated|0|||
13176653|NCT02266888|26136924|FG003|Overall Study|Study Terminated|0|||
13176654|NCT02266888|26136921|FG000|Overall Study|No Longer Eligible|0|||
13176655|NCT02266888|26136922|FG001|Overall Study|No Longer Eligible|0|||
13176656|NCT02266888|26136923|FG002|Overall Study|No Longer Eligible|0|||
13176657|NCT02266888|26136924|FG003|Overall Study|No Longer Eligible|2|||
13176658|NCT02266888|26136921|FG000|Overall Study|Randomization Closed|0|||
13176659|NCT02266888|26136922|FG001|Overall Study|Randomization Closed|0|||
13176660|NCT02266888|26136923|FG002|Overall Study|Randomization Closed|4|||
13176661|NCT02266888|26136924|FG003|Overall Study|Randomization Closed|0|||
13176662|NCT02266888|26136921|FG000|Overall Study|Personnel unavailable at transplant|0|||
13176663|NCT02266888|26136922|FG001|Overall Study|Personnel unavailable at transplant|0|||
13176664|NCT02266888|26136923|FG002|Overall Study|Personnel unavailable at transplant|0|||
13176665|NCT02266888|26136924|FG003|Overall Study|Personnel unavailable at transplant|1|||
13176666|NCT02266888|26136921|FG000|Overall Study|Transfer of care|0|||
13108759|NCT03247530|25893200|FG000|Overall Study|Withdrawal by Subject|1|||
13108760|NCT03247530|25893201|FG001|Overall Study|Withdrawal by Subject|1|||
13108761|NCT03247530|25893202|FG002|Overall Study|Withdrawal by Subject|0|||
13108762|NCT03247530|25893200|FG000|Overall Study|Study medication misuse|0|||
13108763|NCT03247530|25893201|FG001|Overall Study|Study medication misuse|1|||
13108764|NCT03247530|25893202|FG002|Overall Study|Study medication misuse|0|||
13108765|NCT03247530|25893200|FG000|Overall Study|Other, multiple categories|1|||
13108766|NCT03247530|25893201|FG001|Overall Study|Other, multiple categories|3|||
13108767|NCT03247530|25893202|FG002|Overall Study|Other, multiple categories|1|||
13108768|NCT03247517|25893244|FG000|Overall Study|Adverse Event|0|||
13108769|NCT03247517|25893245|FG001|Overall Study|Adverse Event|4|||
13108770|NCT03247517|25893246|FG002|Overall Study|Adverse Event|2|||
13108771|NCT03247517|25893244|FG000|Overall Study|Lost to Follow-up|2|||
13108772|NCT03247517|25893245|FG001|Overall Study|Lost to Follow-up|6|||
13108773|NCT03247517|25893246|FG002|Overall Study|Lost to Follow-up|4|||
13108774|NCT03247517|25893244|FG000|Overall Study|Consent withdrawn by caregiver|1|||
13108775|NCT03247517|25893245|FG001|Overall Study|Consent withdrawn by caregiver|4|||
13108776|NCT03247517|25893246|FG002|Overall Study|Consent withdrawn by caregiver|7|||
13108777|NCT03247517|25893244|FG000|Overall Study|Assent/consent withdrawn by subject|2|||
13108778|NCT03247517|25893245|FG001|Overall Study|Assent/consent withdrawn by subject|3|||
13108779|NCT03247517|25893246|FG002|Overall Study|Assent/consent withdrawn by subject|1|||
13176667|NCT02266888|26136922|FG001|Overall Study|Transfer of care|0|||
13176668|NCT02266888|26136923|FG002|Overall Study|Transfer of care|1|||
13176669|NCT02266888|26136924|FG003|Overall Study|Transfer of care|0|||
13176670|NCT02266875|26136941|FG000|Overall Study|Withdrawal by Subject|9|||
13176671|NCT02266875|26136942|FG001|Overall Study|Withdrawal by Subject|0|||
13176672|NCT02266875|26136941|FG000|Overall Study|Lost to Follow-up|2|||
13176673|NCT02266875|26136942|FG001|Overall Study|Lost to Follow-up|0|||
13176674|NCT02266706|26137161|FG000|Overall Study|Withdrawal by Subject|0|||
13176675|NCT02266706|26137162|FG001|Overall Study|Withdrawal by Subject|1|||
13176676|NCT02266706|26137163|FG002|Overall Study|Withdrawal by Subject|1|||
13176677|NCT02266706|26137164|FG003|Overall Study|Withdrawal by Subject|0|||
13176678|NCT02266706|26137165|FG004|Overall Study|Withdrawal by Subject|0|||
13176679|NCT02266706|26137166|FG005|Overall Study|Withdrawal by Subject|1|||
13176680|NCT02266706|26137167|FG006|Overall Study|Withdrawal by Subject|0|||
13176681|NCT02266706|26137168|FG007|Overall Study|Withdrawal by Subject|0|||
13176682|NCT02266706|26137169|FG008|Overall Study|Withdrawal by Subject|0|||
13176683|NCT02266706|26137161|FG000|Overall Study|Screen failure|0|||
13176684|NCT02266706|26137162|FG001|Overall Study|Screen failure|0|||
13176685|NCT02266706|26137163|FG002|Overall Study|Screen failure|0|||
13176686|NCT02266706|26137164|FG003|Overall Study|Screen failure|0|||
13176687|NCT02266706|26137165|FG004|Overall Study|Screen failure|0|||
13176688|NCT02266706|26137166|FG005|Overall Study|Screen failure|1|||
13176689|NCT02266706|26137167|FG006|Overall Study|Screen failure|1|||
13176690|NCT02266706|26137168|FG007|Overall Study|Screen failure|0|||
13176691|NCT02266706|26137169|FG008|Overall Study|Screen failure|0|||
13176692|NCT02266706|26137161|FG000|Overall Study|Enrollment in another study|0|||
13176693|NCT02266706|26137162|FG001|Overall Study|Enrollment in another study|0|||
13176694|NCT02266706|26137163|FG002|Overall Study|Enrollment in another study|0|||
13176695|NCT02266706|26137164|FG003|Overall Study|Enrollment in another study|1|||
13176696|NCT02266706|26137165|FG004|Overall Study|Enrollment in another study|0|||
13176697|NCT02266706|26137166|FG005|Overall Study|Enrollment in another study|0|||
13108780|NCT03247517|25893244|FG000|Overall Study|Protocol Violation|0|||
13176698|NCT02266706|26137167|FG006|Overall Study|Enrollment in another study|0|||
13176699|NCT02266706|26137168|FG007|Overall Study|Enrollment in another study|0|||
13176700|NCT02266706|26137169|FG008|Overall Study|Enrollment in another study|0|||
13176701|NCT02266433|26137290|FG000|Overall Study|Lost to Follow-up|54|||
13176702|NCT02266433|26137291|FG001|Overall Study|Lost to Follow-up|46|||
13176703|NCT02266433|26137290|FG000|Overall Study|Withdrawal by Subject|5|||
13176704|NCT02266433|26137291|FG001|Overall Study|Withdrawal by Subject|7|||
13176705|NCT02266381|26137318|FG000|Overall Study|Physician Decision|3|||
13176706|NCT02266381|26137319|FG001|Overall Study|Physician Decision|5|||
13176707|NCT02266381|26137320|FG002|Overall Study|Physician Decision|4|||
13176708|NCT02266225|26137343|FG000|Overall Study|Lost to Follow-up|2|||
13176709|NCT02266225|26137343|FG000|Overall Study|Death|1|||
13176710|NCT02266225|26137343|FG000|Overall Study|Withdrawal by Subject|13|||
13176711|NCT02266147|26137386|FG000|PART 1: Dose Escalation|Physician Decision|0|||
13176712|NCT02266147|26137387|FG001|PART 1: Dose Escalation|Physician Decision|0|||
13176713|NCT02266147|26137388|FG002|PART 1: Dose Escalation|Physician Decision|1|||
13176714|NCT02266147|26137389|FG003|PART 1: Dose Escalation|Physician Decision|0|||
13176715|NCT02266147|26137386|FG000|PART 1: Dose Escalation|Lack of Efficacy|0|||
13176716|NCT02266147|26137387|FG001|PART 1: Dose Escalation|Lack of Efficacy|2|||
13176717|NCT02266147|26137388|FG002|PART 1: Dose Escalation|Lack of Efficacy|1|||
13176718|NCT02266147|26137389|FG003|PART 1: Dose Escalation|Lack of Efficacy|1|||
13176719|NCT02266147|26137386|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
13176720|NCT02266147|26137387|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
13176721|NCT02266147|26137388|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1|||
13176722|NCT02266147|26137389|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3|||
13176723|NCT02266147|26137386|FG000|PART 1: Dose Escalation|Other|1|||
13176724|NCT02266147|26137387|FG001|PART 1: Dose Escalation|Other|1|||
13176725|NCT02266147|26137388|FG002|PART 1: Dose Escalation|Other|0|||
13176726|NCT02266147|26137389|FG003|PART 1: Dose Escalation|Other|0|||
13176727|NCT02266147|26137386|FG000|PART 2: Dose Expansion|Lack of Efficacy|1|||
13176728|NCT02266147|26137387|FG001|PART 2: Dose Expansion|Lack of Efficacy|0|||
13176729|NCT02266147|26137388|FG002|PART 2: Dose Expansion|Lack of Efficacy|0|||
13176730|NCT02266147|26137389|FG003|PART 2: Dose Expansion|Lack of Efficacy|1|||
13176731|NCT02266147|26137386|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6|||
13176732|NCT02266147|26137387|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
13176733|NCT02266147|26137388|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
13176734|NCT02266147|26137389|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8|||
13176735|NCT02266004|26137406|FG000|Overall Study|unrelated adverse event|1|||
13176736|NCT02266004|26137406|FG000|Overall Study|Physician Decision|1|||
13176737|NCT02265952|26137435|FG000|Open Label Extension (OLE) Period|Physician Decision|0|||
13176738|NCT02265952|26137436|FG001|Open Label Extension (OLE) Period|Physician Decision|7|||
13176739|NCT02265952|26137435|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
13176740|NCT02265952|26137436|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1|||
13176741|NCT02265796|26137453|FG000|Overall Study|Death|1|||
13176742|NCT02265796|26137454|FG001|Overall Study|Death|0|||
13176743|NCT02265796|26137453|FG000|Overall Study|started on excluded medication|1|||
13176744|NCT02265796|26137454|FG001|Overall Study|started on excluded medication|0|||
13176745|NCT02265796|26137453|FG000|Overall Study|Withdrawal by Subject|1|||
13176746|NCT02265796|26137454|FG001|Overall Study|Withdrawal by Subject|1|||
13176747|NCT02265744|26137647|FG000|Overall Study|Poor/Non-compliance|1|||
13176748|NCT02265744|26137648|FG001|Overall Study|Poor/Non-compliance|1|||
13176749|NCT02265744|26137649|FG002|Overall Study|Poor/Non-compliance|0|||
13176750|NCT02265744|26137650|FG003|Overall Study|Poor/Non-compliance|0|||
13176751|NCT02265744|26137651|FG004|Overall Study|Poor/Non-compliance|2|||
13176752|NCT02265744|26137647|FG000|Overall Study|Lost to Follow-up|0|||
13176753|NCT02265744|26137648|FG001|Overall Study|Lost to Follow-up|0|||
13176754|NCT02265744|26137649|FG002|Overall Study|Lost to Follow-up|0|||
13176755|NCT02265744|26137650|FG003|Overall Study|Lost to Follow-up|1|||
13176756|NCT02265744|26137651|FG004|Overall Study|Lost to Follow-up|0|||
13176757|NCT02265744|26137647|FG000|Overall Study|Death|0|||
13176758|NCT02265744|26137648|FG001|Overall Study|Death|0|||
13176759|NCT02265744|26137649|FG002|Overall Study|Death|0|||
13176760|NCT02265744|26137650|FG003|Overall Study|Death|2|||
13176761|NCT02265744|26137651|FG004|Overall Study|Death|0|||
13176762|NCT02265744|26137647|FG000|Overall Study|Withdrawal by Subject|2|||
13176763|NCT02265744|26137648|FG001|Overall Study|Withdrawal by Subject|0|||
13176764|NCT02265744|26137649|FG002|Overall Study|Withdrawal by Subject|0|||
13176765|NCT02265744|26137650|FG003|Overall Study|Withdrawal by Subject|2|||
13176766|NCT02265744|26137651|FG004|Overall Study|Withdrawal by Subject|0|||
13176767|NCT02265744|26137647|FG000|Overall Study|Participant request to discontinue|2|||
13176768|NCT02265744|26137648|FG001|Overall Study|Participant request to discontinue|2|||
13176769|NCT02265744|26137649|FG002|Overall Study|Participant request to discontinue|2|||
13176770|NCT02265744|26137650|FG003|Overall Study|Participant request to discontinue|0|||
13176771|NCT02265744|26137651|FG004|Overall Study|Participant request to discontinue|0|||
13176772|NCT02265744|26137647|FG000|Overall Study|Adverse Event|8|||
13176773|NCT02265744|26137648|FG001|Overall Study|Adverse Event|4|||
13176774|NCT02265744|26137649|FG002|Overall Study|Adverse Event|9|||
13176775|NCT02265744|26137650|FG003|Overall Study|Adverse Event|8|||
13176776|NCT02265744|26137651|FG004|Overall Study|Adverse Event|2|||
13176777|NCT02265744|26137647|FG000|Overall Study|Lack of Efficacy|2|||
13176778|NCT02265744|26137648|FG001|Overall Study|Lack of Efficacy|4|||
13176779|NCT02265744|26137649|FG002|Overall Study|Lack of Efficacy|3|||
13176780|NCT02265744|26137650|FG003|Overall Study|Lack of Efficacy|4|||
13176781|NCT02265744|26137651|FG004|Overall Study|Lack of Efficacy|5|||
13176782|NCT02265744|26137647|FG000|Overall Study|Reason not provided by Investigator|1|||
13176783|NCT02265744|26137648|FG001|Overall Study|Reason not provided by Investigator|0|||
13176784|NCT02265744|26137649|FG002|Overall Study|Reason not provided by Investigator|0|||
13176785|NCT02265744|26137650|FG003|Overall Study|Reason not provided by Investigator|2|||
13176786|NCT02265744|26137651|FG004|Overall Study|Reason not provided by Investigator|0|||
13176787|NCT02265744|26137647|FG000|Overall Study|Administrative reason by sponsor|3|||
13176788|NCT02265744|26137648|FG001|Overall Study|Administrative reason by sponsor|2|||
13176789|NCT02265744|26137649|FG002|Overall Study|Administrative reason by sponsor|2|||
13176790|NCT02265744|26137650|FG003|Overall Study|Administrative reason by sponsor|3|||
13176791|NCT02265744|26137651|FG004|Overall Study|Administrative reason by sponsor|3|||
13176792|NCT02265744|26137647|FG000|Overall Study|Subject no longer meets study criteria|0|||
13176793|NCT02265744|26137648|FG001|Overall Study|Subject no longer meets study criteria|0|||
13176794|NCT02265744|26137649|FG002|Overall Study|Subject no longer meets study criteria|0|||
13176795|NCT02265744|26137650|FG003|Overall Study|Subject no longer meets study criteria|0|||
13176796|NCT02265744|26137651|FG004|Overall Study|Subject no longer meets study criteria|1|||
13176797|NCT02265744|26137647|FG000|Overall Study|Pregnancy|1|||
13176798|NCT02265744|26137648|FG001|Overall Study|Pregnancy|2|||
13176799|NCT02265744|26137649|FG002|Overall Study|Pregnancy|1|||
13176800|NCT02265744|26137650|FG003|Overall Study|Pregnancy|1|||
13176801|NCT02265744|26137651|FG004|Overall Study|Pregnancy|0|||
13176802|NCT02265705|26137688|FG000|Treatment Period Week 0-24|Adverse Event|3|||
13176803|NCT02265705|26137689|FG001|Treatment Period Week 0-24|Adverse Event|2|||
13176804|NCT02265705|26137690|FG002|Treatment Period Week 0-24|Adverse Event|0|||
13176805|NCT02265705|26137691|FG003|Treatment Period Week 0-24|Adverse Event|0|||
13176806|NCT02265705|26137692|FG004|Treatment Period Week 0-24|Adverse Event|0|||
13176807|NCT02265705|26137693|FG005|Treatment Period Week 0-24|Adverse Event|0|||
13176808|NCT02265705|26137694|FG006|Treatment Period Week 0-24|Adverse Event|0|||
13176809|NCT02265705|26137688|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
13176810|NCT02265705|26137689|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
13176811|NCT02265705|26137690|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
13176812|NCT02265705|26137691|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
13176813|NCT02265705|26137692|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
13176814|NCT02265705|26137693|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
13176815|NCT02265705|26137694|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
13176816|NCT02265705|26137688|FG000|Treatment Period Week 0-24|Physician Decision|1|||
13176817|NCT02265705|26137689|FG001|Treatment Period Week 0-24|Physician Decision|0|||
13176818|NCT02265705|26137690|FG002|Treatment Period Week 0-24|Physician Decision|0|||
13176819|NCT02265705|26137691|FG003|Treatment Period Week 0-24|Physician Decision|0|||
13176820|NCT02265705|26137692|FG004|Treatment Period Week 0-24|Physician Decision|0|||
13176821|NCT02265705|26137693|FG005|Treatment Period Week 0-24|Physician Decision|0|||
13176822|NCT02265705|26137694|FG006|Treatment Period Week 0-24|Physician Decision|0|||
13176823|NCT02265705|26137688|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7|||
13176824|NCT02265705|26137689|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5|||
13176825|NCT02265705|26137690|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0|||
13176826|NCT02265705|26137691|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0|||
13176827|NCT02265705|26137692|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0|||
13176828|NCT02265705|26137693|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0|||
13176829|NCT02265705|26137694|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0|||
13176830|NCT02265705|26137688|FG000|Treatment Period Week 0-24|Lack of Efficacy|0|||
13176831|NCT02265705|26137689|FG001|Treatment Period Week 0-24|Lack of Efficacy|1|||
13176832|NCT02265705|26137690|FG002|Treatment Period Week 0-24|Lack of Efficacy|0|||
13176833|NCT02265705|26137691|FG003|Treatment Period Week 0-24|Lack of Efficacy|0|||
13176834|NCT02265705|26137692|FG004|Treatment Period Week 0-24|Lack of Efficacy|0|||
13176835|NCT02265705|26137693|FG005|Treatment Period Week 0-24|Lack of Efficacy|0|||
13176836|NCT02265705|26137694|FG006|Treatment Period Week 0-24|Lack of Efficacy|0|||
13176837|NCT02265705|26137688|FG000|Rescue Period|Withdrawal by Subject|0|||
13176838|NCT02265705|26137689|FG001|Rescue Period|Withdrawal by Subject|0|||
13176839|NCT02265705|26137690|FG002|Rescue Period|Withdrawal by Subject|1|||
13176840|NCT02265705|26137691|FG003|Rescue Period|Withdrawal by Subject|0|||
13176841|NCT02265705|26137692|FG004|Rescue Period|Withdrawal by Subject|0|||
13176842|NCT02265705|26137693|FG005|Rescue Period|Withdrawal by Subject|0|||
13176843|NCT02265705|26137694|FG006|Rescue Period|Withdrawal by Subject|0|||
13176844|NCT02265705|26137688|FG000|Rescue Period|Death|0|||
13176845|NCT02265705|26137689|FG001|Rescue Period|Death|0|||
13176846|NCT02265705|26137690|FG002|Rescue Period|Death|1|||
13176847|NCT02265705|26137691|FG003|Rescue Period|Death|0|||
13176848|NCT02265705|26137692|FG004|Rescue Period|Death|0|||
13176849|NCT02265705|26137693|FG005|Rescue Period|Death|0|||
13176850|NCT02265705|26137694|FG006|Rescue Period|Death|0|||
13176851|NCT02265705|26137688|FG000|Rescue Period|Lack of Efficacy|0|||
13176852|NCT02265705|26137689|FG001|Rescue Period|Lack of Efficacy|0|||
13176853|NCT02265705|26137690|FG002|Rescue Period|Lack of Efficacy|1|||
13176854|NCT02265705|26137691|FG003|Rescue Period|Lack of Efficacy|0|||
13176855|NCT02265705|26137692|FG004|Rescue Period|Lack of Efficacy|0|||
13176856|NCT02265705|26137693|FG005|Rescue Period|Lack of Efficacy|0|||
13176857|NCT02265705|26137694|FG006|Rescue Period|Lack of Efficacy|0|||
13176858|NCT02265705|26137688|FG000|Open Label Period|Adverse Event|0|||
13176859|NCT02265705|26137689|FG001|Open Label Period|Adverse Event|0|||
13176860|NCT02265705|26137690|FG002|Open Label Period|Adverse Event|0|||
13176861|NCT02265705|26137691|FG003|Open Label Period|Adverse Event|2|||
13176862|NCT02265705|26137692|FG004|Open Label Period|Adverse Event|2|||
13176863|NCT02265705|26137693|FG005|Open Label Period|Adverse Event|0|||
13176864|NCT02265705|26137694|FG006|Open Label Period|Adverse Event|0|||
13108781|NCT03247517|25893245|FG001|Overall Study|Protocol Violation|2|||
13108782|NCT03247517|25893246|FG002|Overall Study|Protocol Violation|0|||
13108783|NCT03247517|25893244|FG000|Overall Study|Multiple reasons|3|||
13108784|NCT03247517|25893245|FG001|Overall Study|Multiple reasons|1|||
13108785|NCT03247517|25893246|FG002|Overall Study|Multiple reasons|0|||
13108786|NCT03246724|25893285|FG000|Overall Study|Withdrawal by Subject|5|||
13108787|NCT03246724|25893286|FG001|Overall Study|Withdrawal by Subject|2|||
13108788|NCT03246724|25893287|FG002|Overall Study|Withdrawal by Subject|4|||
13108789|NCT03246724|25893288|FG003|Overall Study|Withdrawal by Subject|2|||
13108790|NCT03246724|25893285|FG000|Overall Study|Ineligible on day of surgery|7|||
13108791|NCT03246724|25893286|FG001|Overall Study|Ineligible on day of surgery|2|||
13108792|NCT03246724|25893287|FG002|Overall Study|Ineligible on day of surgery|0|||
13108793|NCT03246724|25893288|FG003|Overall Study|Ineligible on day of surgery|3|||
13108794|NCT03246724|25893285|FG000|Overall Study|Study completed before surgical date|2|||
13108795|NCT03246724|25893286|FG001|Overall Study|Study completed before surgical date|1|||
13108796|NCT03246724|25893287|FG002|Overall Study|Study completed before surgical date|8|||
13108797|NCT03246724|25893288|FG003|Overall Study|Study completed before surgical date|1|||
13108798|NCT03246724|25893285|FG000|Overall Study|Transferred to other arm|0|||
13108799|NCT03246724|25893286|FG001|Overall Study|Transferred to other arm|0|||
13108800|NCT03246724|25893287|FG002|Overall Study|Transferred to other arm|1|||
13108801|NCT03246724|25893288|FG003|Overall Study|Transferred to other arm|0|||
13108802|NCT03246724|25893285|FG000|Overall Study|Unable to obtain medication timely|0|||
13108803|NCT03246724|25893286|FG001|Overall Study|Unable to obtain medication timely|2|||
13108804|NCT03246724|25893287|FG002|Overall Study|Unable to obtain medication timely|2|||
13108805|NCT03246724|25893288|FG003|Overall Study|Unable to obtain medication timely|1|||
13108806|NCT03246724|25893285|FG000|Overall Study|Re-consented to participate|0|||
13108807|NCT03246724|25893286|FG001|Overall Study|Re-consented to participate|0|||
13108808|NCT03246724|25893287|FG002|Overall Study|Re-consented to participate|0|||
13108809|NCT03246724|25893288|FG003|Overall Study|Re-consented to participate|1|||
13108810|NCT03246672|25893296|FG000|Overall Study|Lost to Follow-up|2|||
13108811|NCT03246646|25893309|FG000|Overall Study|deemed ineligible and administratively withdrawn|1|||
13108812|NCT03246646|25893310|FG001|Overall Study|deemed ineligible and administratively withdrawn|0|||
13108813|NCT03246646|25893309|FG000|Overall Study|Withdrawal by Subject|3|||
13108814|NCT03246646|25893310|FG001|Overall Study|Withdrawal by Subject|0|||
13108815|NCT03246646|25893309|FG000|Overall Study|Lost to Follow-up|7|||
13108816|NCT03246646|25893310|FG001|Overall Study|Lost to Follow-up|0|||
13108817|NCT03246152|25893318|FG000|Overall Study|Lost to Follow-up|2|||
13108818|NCT03246152|25893318|FG000|Overall Study|Protocol Violation|1|||
13108819|NCT03246061|25893333|FG000|Overall Study|Still in follow-up|15|||
13108820|NCT03246061|25893334|FG001|Overall Study|Still in follow-up|21|||
13108821|NCT03245736|25893343|FG000|Overall Study|Adverse Event|1|||
13108822|NCT03245736|25893343|FG000|Overall Study|Progressive Disease|4|||
13108823|NCT03245723|25893358|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1|||
13108824|NCT03245723|25893359|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0|||
13108825|NCT03245723|25893358|FG000|Overall Study|Claustrophobia from wearing the mask|1|||
13108826|NCT03245723|25893359|FG001|Overall Study|Claustrophobia from wearing the mask|0|||
13108827|NCT03245723|25893358|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2|||
13108828|NCT03245723|25893359|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0|||
13108829|NCT03245723|25893358|FG000|Overall Study|Image acquisition/reconstruction failure|1|||
13108830|NCT03245723|25893359|FG001|Overall Study|Image acquisition/reconstruction failure|1|||
13108831|NCT03245619|25893664|FG000|Part A (Up to Day 22)|Physician Decision|4|||
13108832|NCT03245619|25893665|FG001|Part A (Up to Day 22)|Physician Decision|6|||
13108833|NCT03245619|25893666|FG002|Part A (Up to Day 22)|Physician Decision|6|||
13108834|NCT03245619|25893667|FG003|Part A (Up to Day 22)|Physician Decision|0|||
13108835|NCT03245619|25893668|FG004|Part A (Up to Day 22)|Physician Decision|0|||
13108836|NCT03245619|25893669|FG005|Part A (Up to Day 22)|Physician Decision|0|||
13108837|NCT03245619|25893670|FG006|Part A (Up to Day 22)|Physician Decision|0|||
13108838|NCT03245619|25893671|FG007|Part A (Up to Day 22)|Physician Decision|0|||
13108839|NCT03245619|25893672|FG008|Part A (Up to Day 22)|Physician Decision|0|||
13108840|NCT03245619|25893673|FG009|Part A (Up to Day 22)|Physician Decision|0|||
13108841|NCT03245619|25893674|FG010|Part A (Up to Day 22)|Physician Decision|0|||
13108842|NCT03245619|25893675|FG011|Part A (Up to Day 22)|Physician Decision|0|||
13176865|NCT02265705|26137688|FG000|Open Label Period|Physician Decision|0|||
13485533|NCT02906020|27032871|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
13108843|NCT03245619|25893676|FG012|Part A (Up to Day 22)|Physician Decision|0|||
13108844|NCT03245619|25893677|FG013|Part A (Up to Day 22)|Physician Decision|0|||
13108845|NCT03245619|25893678|FG014|Part A (Up to Day 22)|Physician Decision|0|||
13108846|NCT03245619|25893679|FG015|Part A (Up to Day 22)|Physician Decision|0|||
13108847|NCT03245619|25893680|FG016|Part A (Up to Day 22)|Physician Decision|0|||
13108848|NCT03245450|25893765|FG000|Overall Study|Radiological disease progression|3|||
13108849|NCT03245450|25893766|FG001|Overall Study|Radiological disease progression|3|||
13108850|NCT03245450|25893767|FG002|Overall Study|Radiological disease progression|2|||
13108851|NCT03245450|25893768|FG003|Overall Study|Radiological disease progression|2|||
13108852|NCT03245450|25893769|FG004|Overall Study|Radiological disease progression|7|||
13108853|NCT03245450|25893770|FG005|Overall Study|Radiological disease progression|6|||
13108854|NCT03245450|25893771|FG006|Overall Study|Radiological disease progression|6|||
13108855|NCT03245450|25893765|FG000|Overall Study|Clinical disease progression|0|||
13108856|NCT03245450|25893766|FG001|Overall Study|Clinical disease progression|0|||
13108857|NCT03245450|25893767|FG002|Overall Study|Clinical disease progression|1|||
13108858|NCT03245450|25893768|FG003|Overall Study|Clinical disease progression|0|||
13108859|NCT03245450|25893769|FG004|Overall Study|Clinical disease progression|0|||
13108860|NCT03245450|25893770|FG005|Overall Study|Clinical disease progression|2|||
13108861|NCT03245450|25893771|FG006|Overall Study|Clinical disease progression|0|||
13108862|NCT03245450|25893765|FG000|Overall Study|Other|0|||
13108863|NCT03245450|25893766|FG001|Overall Study|Other|0|||
13108864|NCT03245450|25893767|FG002|Overall Study|Other|0|||
13108865|NCT03245450|25893768|FG003|Overall Study|Other|1|||
13108866|NCT03245450|25893769|FG004|Overall Study|Other|1|||
13108867|NCT03245450|25893770|FG005|Overall Study|Other|1|||
13108868|NCT03245450|25893771|FG006|Overall Study|Other|1|||
13108869|NCT03245450|25893765|FG000|Overall Study|Withdrawal by Subject|0|||
13108870|NCT03245450|25893766|FG001|Overall Study|Withdrawal by Subject|1|||
13108871|NCT03245450|25893767|FG002|Overall Study|Withdrawal by Subject|0|||
13108872|NCT03245450|25893768|FG003|Overall Study|Withdrawal by Subject|0|||
13108873|NCT03245450|25893769|FG004|Overall Study|Withdrawal by Subject|0|||
13108874|NCT03245450|25893770|FG005|Overall Study|Withdrawal by Subject|0|||
13108875|NCT03245450|25893771|FG006|Overall Study|Withdrawal by Subject|0|||
13108876|NCT03245450|25893765|FG000|Overall Study|Adverse Event|0|||
13108877|NCT03245450|25893766|FG001|Overall Study|Adverse Event|0|||
13108878|NCT03245450|25893767|FG002|Overall Study|Adverse Event|0|||
13108879|NCT03245450|25893768|FG003|Overall Study|Adverse Event|0|||
13108880|NCT03245450|25893769|FG004|Overall Study|Adverse Event|1|||
13108881|NCT03245450|25893770|FG005|Overall Study|Adverse Event|0|||
13108882|NCT03245450|25893771|FG006|Overall Study|Adverse Event|2|||
13108883|NCT03245398|25893800|FG000|Overall Study|Travelled to another island|1|||
13108884|NCT03245398|25893801|FG001|Overall Study|Travelled to another island|0|||
13108885|NCT03244917|25893820|FG000|Overall Study|Lost to Follow-up|2|||
13108886|NCT03244917|25893821|FG001|Overall Study|Lost to Follow-up|2|||
13108887|NCT03244800|25893892|FG000|Overall Study|Adverse Event|0|||
13108888|NCT03244800|25893893|FG001|Overall Study|Adverse Event|1|||
13108889|NCT03244800|25893894|FG002|Overall Study|Adverse Event|0|||
13108890|NCT03244800|25893895|FG003|Overall Study|Adverse Event|1|||
13108891|NCT03244800|25893892|FG000|Overall Study|Withdrew treatment|0|||
13108892|NCT03244800|25893893|FG001|Overall Study|Withdrew treatment|0|||
13108893|NCT03244800|25893894|FG002|Overall Study|Withdrew treatment|0|||
13108894|NCT03244800|25893895|FG003|Overall Study|Withdrew treatment|1|||
13108895|NCT03244618|25893918|FG000|Overall Study|Lost to Follow-up|3|||
13108896|NCT03244618|25893919|FG001|Overall Study|Lost to Follow-up|4|||
13108897|NCT03244618|25893918|FG000|Overall Study|Protocol Violation|4|||
13108898|NCT03244618|25893919|FG001|Overall Study|Protocol Violation|3|||
13108899|NCT03244618|25893918|FG000|Overall Study|Withdrawal by Subject|0|||
13108900|NCT03244618|25893919|FG001|Overall Study|Withdrawal by Subject|2|||
13108901|NCT03243630|25893929|FG000|Overall Study|Protocol Violation|1|||
13108902|NCT03243630|25893929|FG000|Overall Study|Physician Decision|1|||
13108903|NCT03243305|25893936|FG000|Overall Study|Lost to Follow-up|250|||
13108904|NCT03243305|25893936|FG000|Overall Study|Withdrawal by Subject|170|||
13108905|NCT03243305|25893936|FG000|Overall Study|Pregnancy|104|||
13108906|NCT03243305|25893936|FG000|Overall Study|Non-Compliance with Study Drug|38|||
13108907|NCT03243305|25893936|FG000|Overall Study|Adverse Event|23|||
13108908|NCT03243305|25893936|FG000|Overall Study|No sexually active|26|||
13108909|NCT03243305|25893936|FG000|Overall Study|Physician Decision|22|||
13108910|NCT03243305|25893936|FG000|Overall Study|Protocol Violation|22|||
13108911|NCT03243305|25893936|FG000|Overall Study|Study method no longer primary method|12|||
13108912|NCT03243305|25893936|FG000|Overall Study|Study Terminated by Sponsor|1|||
13108913|NCT03243305|25893936|FG000|Overall Study|Early terminations|267|||
13108914|NCT03243084|25893953|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1|||
13108915|NCT03243084|25893954|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0|||
13108916|NCT03242928|25893972|FG000|Overall Study|Adverse Event|2|||
13108917|NCT03242928|25893973|FG001|Overall Study|Adverse Event|1|||
13108918|NCT03242928|25893972|FG000|Overall Study|Lost to Follow-up|2|||
13108919|NCT03242928|25893973|FG001|Overall Study|Lost to Follow-up|0|||
13108920|NCT03242928|25893972|FG000|Overall Study|Physician Decision|0|||
13176866|NCT02265705|26137689|FG001|Open Label Period|Physician Decision|0|||
13176867|NCT02265705|26137690|FG002|Open Label Period|Physician Decision|0|||
13176868|NCT02265705|26137691|FG003|Open Label Period|Physician Decision|0|||
13176869|NCT02265705|26137692|FG004|Open Label Period|Physician Decision|1|||
13176870|NCT02265705|26137693|FG005|Open Label Period|Physician Decision|0|||
13176871|NCT02265705|26137694|FG006|Open Label Period|Physician Decision|0|||
13176872|NCT02265705|26137688|FG000|Open Label Period|Withdrawal by Subject|0|||
13176873|NCT02265705|26137689|FG001|Open Label Period|Withdrawal by Subject|0|||
13176874|NCT02265705|26137690|FG002|Open Label Period|Withdrawal by Subject|0|||
13176875|NCT02265705|26137691|FG003|Open Label Period|Withdrawal by Subject|0|||
13176876|NCT02265705|26137692|FG004|Open Label Period|Withdrawal by Subject|2|||
13108921|NCT03242928|25893973|FG001|Overall Study|Physician Decision|1|||
13108922|NCT03242928|25893972|FG000|Overall Study|Withdrawal by Subject|5|||
13108923|NCT03242928|25893973|FG001|Overall Study|Withdrawal by Subject|3|||
13108924|NCT03242863|25893997|FG000|Study Week 1|Withdrawal by Subject|0|||
13108925|NCT03242863|25893998|FG001|Study Week 1|Withdrawal by Subject|1|||
13176877|NCT02265705|26137693|FG005|Open Label Period|Withdrawal by Subject|0|||
13176878|NCT02265705|26137694|FG006|Open Label Period|Withdrawal by Subject|0|||
13176879|NCT02265705|26137688|FG000|Follow-up Period|Sponsor Decision|0|||
13176880|NCT02265705|26137689|FG001|Follow-up Period|Sponsor Decision|0|||
13176881|NCT02265705|26137690|FG002|Follow-up Period|Sponsor Decision|0|||
13176882|NCT02265705|26137691|FG003|Follow-up Period|Sponsor Decision|0|||
13176883|NCT02265705|26137692|FG004|Follow-up Period|Sponsor Decision|0|||
13108926|NCT03242863|25893999|FG002|Study Week 1|Withdrawal by Subject|0|||
13108927|NCT03242863|25894000|FG003|Study Week 1|Withdrawal by Subject|0|||
13176884|NCT02265705|26137693|FG005|Follow-up Period|Sponsor Decision|1|||
13176885|NCT02265705|26137694|FG006|Follow-up Period|Sponsor Decision|6|||
13176886|NCT02265705|26137688|FG000|Follow-up Period|Adverse Event|0|||
13176887|NCT02265705|26137689|FG001|Follow-up Period|Adverse Event|0|||
13176888|NCT02265705|26137690|FG002|Follow-up Period|Adverse Event|0|||
13176889|NCT02265705|26137691|FG003|Follow-up Period|Adverse Event|0|||
13176890|NCT02265705|26137692|FG004|Follow-up Period|Adverse Event|0|||
13176891|NCT02265705|26137693|FG005|Follow-up Period|Adverse Event|0|||
13176892|NCT02265705|26137694|FG006|Follow-up Period|Adverse Event|3|||
13176893|NCT02265705|26137688|FG000|Follow-up Period|Physician Decision|0|||
13176894|NCT02265705|26137689|FG001|Follow-up Period|Physician Decision|0|||
13176895|NCT02265705|26137690|FG002|Follow-up Period|Physician Decision|0|||
13176896|NCT02265705|26137691|FG003|Follow-up Period|Physician Decision|0|||
13176897|NCT02265705|26137692|FG004|Follow-up Period|Physician Decision|0|||
13176898|NCT02265705|26137693|FG005|Follow-up Period|Physician Decision|0|||
13176899|NCT02265705|26137694|FG006|Follow-up Period|Physician Decision|1|||
13176900|NCT02265705|26137688|FG000|Follow-up Period|Withdrawal by Subject|0|||
13176901|NCT02265705|26137689|FG001|Follow-up Period|Withdrawal by Subject|0|||
13176902|NCT02265705|26137690|FG002|Follow-up Period|Withdrawal by Subject|0|||
13176903|NCT02265705|26137691|FG003|Follow-up Period|Withdrawal by Subject|0|||
13176904|NCT02265705|26137692|FG004|Follow-up Period|Withdrawal by Subject|0|||
13176905|NCT02265705|26137693|FG005|Follow-up Period|Withdrawal by Subject|0|||
13176906|NCT02265705|26137694|FG006|Follow-up Period|Withdrawal by Subject|1|||
13176907|NCT02265510|26137825|FG000|Overall Study|Withdrawal by Subject|1|||
13176908|NCT02265510|26137826|FG001|Overall Study|Withdrawal by Subject|1|||
13176909|NCT02265510|26137827|FG002|Overall Study|Withdrawal by Subject|2|||
13176910|NCT02265510|26137828|FG003|Overall Study|Withdrawal by Subject|1|||
13176911|NCT02265510|26137829|FG004|Overall Study|Withdrawal by Subject|0|||
13176912|NCT02265510|26137830|FG005|Overall Study|Withdrawal by Subject|2|||
13176913|NCT02265510|26137831|FG006|Overall Study|Withdrawal by Subject|0|||
13176914|NCT02265510|26137832|FG007|Overall Study|Withdrawal by Subject|2|||
13176915|NCT02265510|26137833|FG008|Overall Study|Withdrawal by Subject|0|||
13176916|NCT02265510|26137834|FG009|Overall Study|Withdrawal by Subject|0|||
13176917|NCT02265510|26137835|FG010|Overall Study|Withdrawal by Subject|0|||
13176918|NCT02265510|26137836|FG011|Overall Study|Withdrawal by Subject|0|||
13176919|NCT02265510|26137837|FG012|Overall Study|Withdrawal by Subject|1|||
13176920|NCT02265510|26137838|FG013|Overall Study|Withdrawal by Subject|0|||
13176921|NCT02265510|26137825|FG000|Overall Study|Disease Progression|0|||
13176922|NCT02265510|26137826|FG001|Overall Study|Disease Progression|1|||
13176923|NCT02265510|26137827|FG002|Overall Study|Disease Progression|2|||
13108928|NCT03242863|25894001|FG004|Study Week 1|Withdrawal by Subject|3|||
13108929|NCT03242863|25894002|FG005|Study Week 1|Withdrawal by Subject|0|||
13108930|NCT03242759|25894051|FG000|Overall Study|Adverse Event|5|||
13108931|NCT03242759|25894052|FG001|Overall Study|Adverse Event|1|||
13108932|NCT03242759|25894051|FG000|Overall Study|Withdrawal by Subject|4|||
13108933|NCT03242759|25894052|FG001|Overall Study|Withdrawal by Subject|3|||
13108934|NCT03242759|25894051|FG000|Overall Study|Lost to Follow-up|3|||
13108935|NCT03242759|25894052|FG001|Overall Study|Lost to Follow-up|1|||
13108936|NCT03242759|25894051|FG000|Overall Study|Administrative problems|1|||
13108937|NCT03242759|25894052|FG001|Overall Study|Administrative problems|1|||
13108938|NCT03242759|25894051|FG000|Overall Study|Death|22|||
13176924|NCT02265510|26137828|FG003|Overall Study|Disease Progression|1|||
13176925|NCT02265510|26137829|FG004|Overall Study|Disease Progression|1|||
13176926|NCT02265510|26137830|FG005|Overall Study|Disease Progression|0|||
13176927|NCT02265510|26137831|FG006|Overall Study|Disease Progression|0|||
13176928|NCT02265510|26137832|FG007|Overall Study|Disease Progression|0|||
13176929|NCT02265510|26137833|FG008|Overall Study|Disease Progression|0|||
13176930|NCT02265510|26137834|FG009|Overall Study|Disease Progression|0|||
13176931|NCT02265510|26137835|FG010|Overall Study|Disease Progression|0|||
13176932|NCT02265510|26137836|FG011|Overall Study|Disease Progression|0|||
13176933|NCT02265510|26137837|FG012|Overall Study|Disease Progression|0|||
13176934|NCT02265510|26137838|FG013|Overall Study|Disease Progression|0|||
13176935|NCT02265510|26137825|FG000|Overall Study|Death|2|||
13176936|NCT02265510|26137826|FG001|Overall Study|Death|0|||
13176937|NCT02265510|26137827|FG002|Overall Study|Death|2|||
13176938|NCT02265510|26137828|FG003|Overall Study|Death|2|||
13176939|NCT02265510|26137829|FG004|Overall Study|Death|1|||
13176940|NCT02265510|26137830|FG005|Overall Study|Death|3|||
13176941|NCT02265510|26137831|FG006|Overall Study|Death|2|||
13176942|NCT02265510|26137832|FG007|Overall Study|Death|1|||
13176943|NCT02265510|26137833|FG008|Overall Study|Death|3|||
13176944|NCT02265510|26137834|FG009|Overall Study|Death|3|||
13176945|NCT02265510|26137835|FG010|Overall Study|Death|4|||
13176946|NCT02265510|26137836|FG011|Overall Study|Death|12|||
13176947|NCT02265510|26137837|FG012|Overall Study|Death|7|||
13176948|NCT02265510|26137838|FG013|Overall Study|Death|6|||
13176949|NCT02265510|26137825|FG000|Overall Study|Lost to Follow-up|0|||
13176950|NCT02265510|26137826|FG001|Overall Study|Lost to Follow-up|0|||
13176951|NCT02265510|26137827|FG002|Overall Study|Lost to Follow-up|0|||
13176952|NCT02265510|26137828|FG003|Overall Study|Lost to Follow-up|0|||
13176953|NCT02265510|26137829|FG004|Overall Study|Lost to Follow-up|1|||
13176954|NCT02265510|26137830|FG005|Overall Study|Lost to Follow-up|0|||
13176955|NCT02265510|26137831|FG006|Overall Study|Lost to Follow-up|0|||
13176956|NCT02265510|26137832|FG007|Overall Study|Lost to Follow-up|0|||
13176957|NCT02265510|26137833|FG008|Overall Study|Lost to Follow-up|0|||
13176958|NCT02265510|26137834|FG009|Overall Study|Lost to Follow-up|2|||
13176959|NCT02265510|26137835|FG010|Overall Study|Lost to Follow-up|0|||
13176960|NCT02265510|26137836|FG011|Overall Study|Lost to Follow-up|0|||
13176961|NCT02265510|26137837|FG012|Overall Study|Lost to Follow-up|0|||
13176962|NCT02265510|26137838|FG013|Overall Study|Lost to Follow-up|2|||
13176963|NCT02265510|26137825|FG000|Overall Study|Other|0|||
13176964|NCT02265510|26137826|FG001|Overall Study|Other|1|||
13176965|NCT02265510|26137827|FG002|Overall Study|Other|0|||
13176966|NCT02265510|26137828|FG003|Overall Study|Other|0|||
13176967|NCT02265510|26137829|FG004|Overall Study|Other|0|||
13176968|NCT02265510|26137830|FG005|Overall Study|Other|0|||
13176969|NCT02265510|26137831|FG006|Overall Study|Other|0|||
13176970|NCT02265510|26137832|FG007|Overall Study|Other|0|||
13176971|NCT02265510|26137833|FG008|Overall Study|Other|0|||
13176972|NCT02265510|26137834|FG009|Overall Study|Other|0|||
13176973|NCT02265510|26137835|FG010|Overall Study|Other|0|||
13176974|NCT02265510|26137836|FG011|Overall Study|Other|0|||
13176975|NCT02265510|26137837|FG012|Overall Study|Other|0|||
13176976|NCT02265510|26137838|FG013|Overall Study|Other|0|||
13176977|NCT02265510|26137825|FG000|Overall Study|Study Terminated by Sponsor|0|||
13176978|NCT02265510|26137826|FG001|Overall Study|Study Terminated by Sponsor|0|||
13176979|NCT02265510|26137827|FG002|Overall Study|Study Terminated by Sponsor|0|||
13176980|NCT02265510|26137828|FG003|Overall Study|Study Terminated by Sponsor|0|||
13176981|NCT02265510|26137829|FG004|Overall Study|Study Terminated by Sponsor|0|||
13176982|NCT02265510|26137830|FG005|Overall Study|Study Terminated by Sponsor|1|||
13176983|NCT02265510|26137831|FG006|Overall Study|Study Terminated by Sponsor|1|||
13176984|NCT02265510|26137832|FG007|Overall Study|Study Terminated by Sponsor|1|||
13176985|NCT02265510|26137833|FG008|Overall Study|Study Terminated by Sponsor|1|||
13176986|NCT02265510|26137834|FG009|Overall Study|Study Terminated by Sponsor|2|||
13176987|NCT02265510|26137835|FG010|Overall Study|Study Terminated by Sponsor|1|||
13176988|NCT02265510|26137836|FG011|Overall Study|Study Terminated by Sponsor|4|||
13176989|NCT02265510|26137837|FG012|Overall Study|Study Terminated by Sponsor|1|||
13176990|NCT02265510|26137838|FG013|Overall Study|Study Terminated by Sponsor|2|||
13176991|NCT02265237|26137870|FG000|As Treated (Overall Study)|Adverse Event|1|||
13176992|NCT02265237|26137871|FG001|As Treated (Overall Study)|Adverse Event|1|||
13176993|NCT02265237|26137872|FG002|As Treated (Overall Study)|Adverse Event|0|||
13176994|NCT02265237|26137873|FG003|As Treated (Overall Study)|Adverse Event|0|||
13176995|NCT02265237|26137870|FG000|As Treated (Overall Study)|Withdrawal by Subject|1|||
13176996|NCT02265237|26137871|FG001|As Treated (Overall Study)|Withdrawal by Subject|0|||
13176997|NCT02265237|26137872|FG002|As Treated (Overall Study)|Withdrawal by Subject|1|||
13176998|NCT02265237|26137873|FG003|As Treated (Overall Study)|Withdrawal by Subject|0|||
13176999|NCT02265237|26137870|FG000|As Treated (Overall Study)|Lost to Follow-up|1|||
13177000|NCT02265237|26137871|FG001|As Treated (Overall Study)|Lost to Follow-up|2|||
13177001|NCT02265237|26137872|FG002|As Treated (Overall Study)|Lost to Follow-up|6|||
13177002|NCT02265237|26137873|FG003|As Treated (Overall Study)|Lost to Follow-up|0|||
13177003|NCT02265237|26137870|FG000|As Treated (Overall Study)|Other|2|||
13177004|NCT02265237|26137871|FG001|As Treated (Overall Study)|Other|0|||
13177005|NCT02265237|26137872|FG002|As Treated (Overall Study)|Other|3|||
13177006|NCT02265237|26137873|FG003|As Treated (Overall Study)|Other|1|||
13177007|NCT02264990|26137896|FG000|Overall Study|Death|255|||
13177008|NCT02264990|26137897|FG001|Overall Study|Death|250|||
13177009|NCT02264990|26137896|FG000|Overall Study|Withdrawal by Subject|4|||
13177010|NCT02264990|26137897|FG001|Overall Study|Withdrawal by Subject|5|||
13177011|NCT02264990|26137896|FG000|Overall Study|Lost to Follow-up|1|||
13177012|NCT02264990|26137897|FG001|Overall Study|Lost to Follow-up|3|||
13177013|NCT02264990|26137896|FG000|Overall Study|Other|0|||
13177014|NCT02264990|26137897|FG001|Overall Study|Other|1|||
13177015|NCT02264977|26137907|FG000|Overall Study|Death|3|||
13177016|NCT02264977|26137907|FG000|Overall Study|Physician Decision|1|||
13177017|NCT02264977|26137907|FG000|Overall Study|Refuse to return|1|||
13177018|NCT02264821|26137928|FG000|Overall Study|Protocol Violation|1|||
13177019|NCT02264821|26137929|FG001|Overall Study|Protocol Violation|3|||
13177020|NCT02264821|26137930|FG002|Overall Study|Protocol Violation|6|||
13177021|NCT02264639|26137962|FG000|Overall Study|Death (after completing single-dose phase)|1|||
13177022|NCT02264639|26137963|FG001|Overall Study|Death (after completing single-dose phase)|0|||
13177023|NCT02264639|26137964|FG002|Overall Study|Death (after completing single-dose phase)|0|||
13177024|NCT02264639|26137965|FG003|Overall Study|Death (after completing single-dose phase)|0|||
13177025|NCT02264639|26137966|FG004|Overall Study|Death (after completing single-dose phase)|0|||
13177026|NCT02264639|26137962|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1|||
13177027|NCT02264639|26137963|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
13177028|NCT02264639|26137964|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
13177029|NCT02264639|26137965|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
13177030|NCT02264639|26137966|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
13177031|NCT02264639|26137962|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0|||
13177032|NCT02264639|26137963|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0|||
13177033|NCT02264639|26137964|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1|||
13177034|NCT02264639|26137965|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0|||
13177035|NCT02264639|26137966|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0|||
13177036|NCT02264639|26137962|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
13177037|NCT02264639|26137963|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
13177038|NCT02264639|26137964|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
13177039|NCT02264639|26137965|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
13177040|NCT02264639|26137966|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1|||
13177041|NCT02264574|26138009|FG000|Overall Study|Death|21|||
13177042|NCT02264574|26138010|FG001|Overall Study|Death|21|||
13177043|NCT02264574|26138009|FG000|Overall Study|Withdrawal by Subject|8|||
13177044|NCT02264574|26138010|FG001|Overall Study|Withdrawal by Subject|6|||
13177045|NCT02264574|26138009|FG000|Overall Study|Other, Not Specified|0|||
13177046|NCT02264574|26138010|FG001|Overall Study|Other, Not Specified|3|||
13177047|NCT02263547|26138017|FG000|Overall Study|Adverse Event|1|||
13177048|NCT02263547|26138017|FG000|Overall Study|Lost to Follow-up|2|||
13177049|NCT02263508|26138075|FG000|Overall Study|Withdrawal by Subject|1|||
13177050|NCT02263508|26138076|FG001|Overall Study|Withdrawal by Subject|23|||
13177051|NCT02263508|26138077|FG002|Overall Study|Withdrawal by Subject|17|||
13177052|NCT02263508|26138075|FG000|Overall Study|Sponsor Decision|12|||
13177053|NCT02263508|26138076|FG001|Overall Study|Sponsor Decision|165|||
13177054|NCT02263508|26138077|FG002|Overall Study|Sponsor Decision|182|||
13177055|NCT02263508|26138075|FG000|Overall Study|Lost to Follow-up|2|||
13177056|NCT02263508|26138076|FG001|Overall Study|Lost to Follow-up|7|||
13177057|NCT02263508|26138077|FG002|Overall Study|Lost to Follow-up|7|||
13177058|NCT02263508|26138075|FG000|Overall Study|Death|6|||
13177059|NCT02263508|26138076|FG001|Overall Study|Death|151|||
13177060|NCT02263508|26138077|FG002|Overall Study|Death|140|||
13205744|NCT01962207|26232834|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5|||
13205745|NCT01962207|26232835|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2|||
13205746|NCT01962207|26232832|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2|||
13205747|NCT01962207|26232833|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
13205748|NCT01962207|26232834|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4|||
13205749|NCT01962207|26232835|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
13205750|NCT01962207|26232832|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
13205751|NCT01962207|26232833|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5|||
13205752|NCT01962207|26232834|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18|||
13205753|NCT01962207|26232835|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
13205754|NCT01962207|26232832|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
13205755|NCT01962207|26232833|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
13205756|NCT01962207|26232834|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3|||
13205757|NCT01962207|26232835|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1|||
13205758|NCT01962207|26232832|FG000|Persistence Phase (5 Years)|Adverse Event|0|||
13205759|NCT01962207|26232833|FG001|Persistence Phase (5 Years)|Adverse Event|0|||
13205760|NCT01962207|26232834|FG002|Persistence Phase (5 Years)|Adverse Event|1|||
13177061|NCT02263365|26138096|FG000|Overall Study|Physician Decision|22|||
13177062|NCT02263365|26138097|FG001|Overall Study|Physician Decision|18|||
13177063|NCT02263326|26138124|FG000|Overall Study|Lost to Follow-up|1|||
13177064|NCT02263326|26138125|FG001|Overall Study|Lost to Follow-up|1|||
13177065|NCT02263079|26138161|FG000|Overall Study|Physician Decision|1|||
13177066|NCT02263079|26138162|FG001|Overall Study|Physician Decision|0|||
13177067|NCT02263079|26138163|FG002|Overall Study|Physician Decision|0|||
13177068|NCT02263079|26138161|FG000|Overall Study|Withdrawal by Subject|2|||
13177069|NCT02263079|26138162|FG001|Overall Study|Withdrawal by Subject|8|||
13177070|NCT02263079|26138163|FG002|Overall Study|Withdrawal by Subject|0|||
13177071|NCT02262754|26138246|FG000|Overall Study|Adverse Event|3|||
13177072|NCT02262754|26138247|FG001|Overall Study|Adverse Event|4|||
13177073|NCT02262754|26138248|FG002|Overall Study|Adverse Event|0|||
13177074|NCT02262754|26138246|FG000|Overall Study|Lack of Efficacy|2|||
13177075|NCT02262754|26138247|FG001|Overall Study|Lack of Efficacy|0|||
13177076|NCT02262754|26138248|FG002|Overall Study|Lack of Efficacy|1|||
13177077|NCT02262754|26138246|FG000|Overall Study|Lost to Follow-up|0|||
13177078|NCT02262754|26138247|FG001|Overall Study|Lost to Follow-up|0|||
13177079|NCT02262754|26138248|FG002|Overall Study|Lost to Follow-up|1|||
13108939|NCT03242759|25894052|FG001|Overall Study|Death|0|||
13108940|NCT03242759|25894051|FG000|Overall Study|Change visit schedule|0|||
13177080|NCT02262754|26138246|FG000|Overall Study|No longer meets eligibility criteria|0|||
13177081|NCT02262754|26138247|FG001|Overall Study|No longer meets eligibility criteria|1|||
13177082|NCT02262754|26138248|FG002|Overall Study|No longer meets eligibility criteria|0|||
13108941|NCT03242759|25894052|FG001|Overall Study|Change visit schedule|1|||
13108942|NCT03242434|25894067|FG000|Overall Study|Death|0|||
13108943|NCT03242434|25894068|FG001|Overall Study|Death|2|||
13108944|NCT03242252|25894113|FG000|Overall Study|At the Participant's own Request|18|||
13108945|NCT03242252|25894114|FG001|Overall Study|At the Participant's own Request|10|||
13108946|NCT03242252|25894115|FG002|Overall Study|At the Participant's own Request|15|||
13108947|NCT03242252|25894113|FG000|Overall Study|Adverse Event|8|||
13108948|NCT03242252|25894114|FG001|Overall Study|Adverse Event|6|||
13108949|NCT03242252|25894115|FG002|Overall Study|Adverse Event|9|||
13108950|NCT03242252|25894113|FG000|Overall Study|Poor Compliance to Protocol|0|||
13177083|NCT02262754|26138246|FG000|Overall Study|Study terminated by sponsor|5|||
13177084|NCT02262754|26138247|FG001|Overall Study|Study terminated by sponsor|4|||
13177085|NCT02262754|26138248|FG002|Overall Study|Study terminated by sponsor|4|||
13177086|NCT02262754|26138246|FG000|Overall Study|Protocol Violation|1|||
13177087|NCT02262754|26138247|FG001|Overall Study|Protocol Violation|0|||
13177088|NCT02262754|26138248|FG002|Overall Study|Protocol Violation|0|||
13177089|NCT02262754|26138246|FG000|Overall Study|Withdrawal by Subject|1|||
13177090|NCT02262754|26138247|FG001|Overall Study|Withdrawal by Subject|0|||
13177091|NCT02262754|26138248|FG002|Overall Study|Withdrawal by Subject|1|||
13177092|NCT02262754|26138246|FG000|Overall Study|Other|4|||
13177093|NCT02262754|26138247|FG001|Overall Study|Other|0|||
13177094|NCT02262754|26138248|FG002|Overall Study|Other|2|||
13177095|NCT02262728|26138285|FG000|Follow-up Phase (3 Years)|Death|0|||
13177096|NCT02262728|26138286|FG001|Follow-up Phase (3 Years)|Death|1|||
13177097|NCT02262728|26138285|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4|||
13177098|NCT02262728|26138286|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1|||
13177099|NCT02262728|26138285|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0|||
13177100|NCT02262728|26138286|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1|||
13177101|NCT02262377|26138308|FG000|Overall Study|Lost to Follow-up|5|||
13177102|NCT02262377|26138309|FG001|Overall Study|Lost to Follow-up|6|||
13177103|NCT02262377|26138308|FG000|Overall Study|Found ineligible after enrollment|3|||
13177104|NCT02262377|26138309|FG001|Overall Study|Found ineligible after enrollment|0|||
13177105|NCT02262377|26138308|FG000|Overall Study|Withdrawal by Subject|4|||
13177106|NCT02262377|26138309|FG001|Overall Study|Withdrawal by Subject|0|||
13108951|NCT03242252|25894114|FG001|Overall Study|Poor Compliance to Protocol|2|||
13177107|NCT02262364|26138318|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1|||
13177108|NCT02262260|26138343|FG000|Overall Study|Adverse Event|4|||
13108952|NCT03242252|25894115|FG002|Overall Study|Poor Compliance to Protocol|3|||
13108953|NCT03242252|25894113|FG000|Overall Study|Study Terminated by Sponsor|1|||
13108954|NCT03242252|25894114|FG001|Overall Study|Study Terminated by Sponsor|0|||
13108955|NCT03242252|25894115|FG002|Overall Study|Study Terminated by Sponsor|0|||
13108956|NCT03242252|25894113|FG000|Overall Study|Reason not Specified|4|||
13177109|NCT02262260|26138344|FG001|Overall Study|Adverse Event|1|||
13177110|NCT02262260|26138343|FG000|Overall Study|Withdrawal of consent|4|||
13177111|NCT02262260|26138344|FG001|Overall Study|Withdrawal of consent|2|||
13177112|NCT02262260|26138343|FG000|Overall Study|Lost to Follow-up|1|||
13177113|NCT02262260|26138344|FG001|Overall Study|Lost to Follow-up|2|||
13177114|NCT02262260|26138343|FG000|Overall Study|Protocol deviation|2|||
13177115|NCT02262260|26138344|FG001|Overall Study|Protocol deviation|5|||
13177116|NCT02261974|26138365|FG000|Overall Study|Withdrawal by Subject|3|||
13177117|NCT02261974|26138366|FG001|Overall Study|Withdrawal by Subject|2|||
13177118|NCT02261974|26138365|FG000|Overall Study|Pregnancy|0|||
13177119|NCT02261974|26138366|FG001|Overall Study|Pregnancy|1|||
13108957|NCT03242252|25894114|FG001|Overall Study|Reason not Specified|4|||
13108958|NCT03242252|25894115|FG002|Overall Study|Reason not Specified|1|||
13108959|NCT03242252|25894113|FG000|Overall Study|Lost to Follow-up|5|||
13108960|NCT03242252|25894114|FG001|Overall Study|Lost to Follow-up|1|||
13108961|NCT03242252|25894115|FG002|Overall Study|Lost to Follow-up|4|||
13108962|NCT03242018|25894161|FG000|Overall Study|Adverse Event|7|||
13108963|NCT03242018|25894162|FG001|Overall Study|Adverse Event|7|||
13108964|NCT03242018|25894163|FG002|Overall Study|Adverse Event|6|||
13108965|NCT03242018|25894161|FG000|Overall Study|Lost to Follow-up|2|||
13108966|NCT03242018|25894162|FG001|Overall Study|Lost to Follow-up|2|||
13177120|NCT02261974|26138365|FG000|Overall Study|Missed treatment cut-off date|6|||
13177121|NCT02261974|26138366|FG001|Overall Study|Missed treatment cut-off date|3|||
13177122|NCT02261974|26138365|FG000|Overall Study|Received partial treatment; FU to 1 mo|3|||
13108967|NCT03242018|25894163|FG002|Overall Study|Lost to Follow-up|2|||
13177123|NCT02261974|26138366|FG001|Overall Study|Received partial treatment; FU to 1 mo|1|||
13177124|NCT02261974|26138365|FG000|Overall Study|Lost to Follow-up|2|||
13177125|NCT02261974|26138366|FG001|Overall Study|Lost to Follow-up|0|||
13177126|NCT02261974|26138365|FG000|Overall Study|Adverse Event|1|||
13177127|NCT02261974|26138366|FG001|Overall Study|Adverse Event|0|||
13177128|NCT02261493|26138402|FG000|Overall Study|Noncompliance|0|||
13177129|NCT02261493|26138403|FG001|Overall Study|Noncompliance|0|||
13177130|NCT02261493|26138404|FG002|Overall Study|Noncompliance|2|||
13177131|NCT02261493|26138402|FG000|Overall Study|Physician Decision|0|||
13177132|NCT02261493|26138403|FG001|Overall Study|Physician Decision|1|||
13177133|NCT02261493|26138404|FG002|Overall Study|Physician Decision|0|||
13177134|NCT02261493|26138402|FG000|Overall Study|Undisclosed alcohol abuse|0|||
13177135|NCT02261493|26138403|FG001|Overall Study|Undisclosed alcohol abuse|1|||
13177136|NCT02261493|26138404|FG002|Overall Study|Undisclosed alcohol abuse|0|||
13177137|NCT02261493|26138402|FG000|Overall Study|Protocol Violation|1|||
13177138|NCT02261493|26138403|FG001|Overall Study|Protocol Violation|0|||
13177139|NCT02261493|26138404|FG002|Overall Study|Protocol Violation|0|||
13177140|NCT02261493|26138402|FG000|Overall Study|Personal Reasons|14|||
13177141|NCT02261493|26138403|FG001|Overall Study|Personal Reasons|14|||
13177142|NCT02261493|26138404|FG002|Overall Study|Personal Reasons|16|||
13177143|NCT02261493|26138402|FG000|Overall Study|Lost to Follow-up|14|||
13177144|NCT02261493|26138403|FG001|Overall Study|Lost to Follow-up|27|||
13177145|NCT02261493|26138404|FG002|Overall Study|Lost to Follow-up|8|||
13177146|NCT02261493|26138402|FG000|Overall Study|Pregnancy|1|||
13177147|NCT02261493|26138403|FG001|Overall Study|Pregnancy|2|||
13177148|NCT02261493|26138404|FG002|Overall Study|Pregnancy|0|||
13177149|NCT02261493|26138402|FG000|Overall Study|Lack of Efficacy|0|||
13177150|NCT02261493|26138403|FG001|Overall Study|Lack of Efficacy|1|||
13177151|NCT02261493|26138404|FG002|Overall Study|Lack of Efficacy|0|||
13177152|NCT02261493|26138402|FG000|Overall Study|Adverse Event|0|||
13177153|NCT02261493|26138403|FG001|Overall Study|Adverse Event|1|||
13177154|NCT02261493|26138404|FG002|Overall Study|Adverse Event|0|||
13177155|NCT02261467|26138429|FG000|Overall Study|Enrolled in Error|1|||
13177156|NCT02261467|26138430|FG001|Overall Study|Enrolled in Error|0|||
13177157|NCT02261467|26138429|FG000|Overall Study|Protocol Violation|0|||
13177158|NCT02261467|26138430|FG001|Overall Study|Protocol Violation|1|||
13177159|NCT02261467|26138429|FG000|Overall Study|Personal Reasons|17|||
13177160|NCT02261467|26138430|FG001|Overall Study|Personal Reasons|22|||
13177161|NCT02261467|26138429|FG000|Overall Study|Lost to Follow-up|2|||
13108968|NCT03242018|25894161|FG000|Overall Study|At the Participant's Own Request|5|||
13108969|NCT03242018|25894162|FG001|Overall Study|At the Participant's Own Request|1|||
13108970|NCT03242018|25894163|FG002|Overall Study|At the Participant's Own Request|4|||
13108971|NCT03242018|25894161|FG000|Overall Study|Reason Not Specified|3|||
13108972|NCT03242018|25894162|FG001|Overall Study|Reason Not Specified|4|||
13108973|NCT03242018|25894163|FG002|Overall Study|Reason Not Specified|1|||
13108974|NCT03242018|25894161|FG000|Overall Study|Study Terminated by Sponsor|1|||
13108975|NCT03242018|25894162|FG001|Overall Study|Study Terminated by Sponsor|0|||
13108976|NCT03242018|25894163|FG002|Overall Study|Study Terminated by Sponsor|1|||
13108977|NCT03241927|25894186|FG000|Overall Study|study terminated|1|||
13108978|NCT03241927|25894187|FG001|Overall Study|study terminated|0|||
13108979|NCT03241368|25894196|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25|||
13108980|NCT03241368|25894196|FG000|Overall Study|Lost to Follow-up|1|||
13177162|NCT02261467|26138430|FG001|Overall Study|Lost to Follow-up|13|||
13177163|NCT02261467|26138429|FG000|Overall Study|Adverse Event|1|||
13177164|NCT02261467|26138430|FG001|Overall Study|Adverse Event|1|||
13177165|NCT02260986|26138556|FG000|Overall Study|Adverse Event|24|||
13177166|NCT02260986|26138557|FG001|Overall Study|Adverse Event|0|||
13177167|NCT02260986|26138558|FG002|Overall Study|Adverse Event|11|||
13177168|NCT02260986|26138556|FG000|Overall Study|Lack of Efficacy|27|||
13177169|NCT02260986|26138557|FG001|Overall Study|Lack of Efficacy|3|||
13177170|NCT02260986|26138558|FG002|Overall Study|Lack of Efficacy|0|||
13177171|NCT02260986|26138556|FG000|Overall Study|Protocol Violation|14|||
13177172|NCT02260986|26138557|FG001|Overall Study|Protocol Violation|5|||
13177173|NCT02260986|26138558|FG002|Overall Study|Protocol Violation|16|||
13485534|NCT02906020|27032872|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
13177174|NCT02260986|26138556|FG000|Overall Study|Car accident|0|||
13177175|NCT02260986|26138557|FG001|Overall Study|Car accident|0|||
13177176|NCT02260986|26138558|FG002|Overall Study|Car accident|1|||
13177177|NCT02260986|26138556|FG000|Overall Study|Withdrawal by Subject|17|||
13177178|NCT02260986|26138557|FG001|Overall Study|Withdrawal by Subject|4|||
13177179|NCT02260986|26138558|FG002|Overall Study|Withdrawal by Subject|9|||
13177180|NCT02260986|26138556|FG000|Overall Study|Incorrect randomization|0|||
13177181|NCT02260986|26138557|FG001|Overall Study|Incorrect randomization|1|||
13177182|NCT02260986|26138558|FG002|Overall Study|Incorrect randomization|0|||
13177183|NCT02260986|26138556|FG000|Overall Study|Lack of investigation product supply|2|||
13177184|NCT02260986|26138557|FG001|Overall Study|Lack of investigation product supply|0|||
13177185|NCT02260986|26138558|FG002|Overall Study|Lack of investigation product supply|1|||
13177186|NCT02260986|26138556|FG000|Overall Study|Lost to Follow-up|4|||
13177187|NCT02260986|26138557|FG001|Overall Study|Lost to Follow-up|0|||
13177188|NCT02260986|26138558|FG002|Overall Study|Lost to Follow-up|3|||
13177189|NCT02260986|26138556|FG000|Overall Study|Pregnancy|2|||
13177190|NCT02260986|26138557|FG001|Overall Study|Pregnancy|0|||
13177191|NCT02260986|26138558|FG002|Overall Study|Pregnancy|0|||
13177192|NCT02260934|26138601|FG000|Overall Study|Lost to Follow-up|2|||
13177193|NCT02260934|26138602|FG001|Overall Study|Lost to Follow-up|1|||
13177194|NCT02260934|26138601|FG000|Overall Study|Withdrawal by Subject|0|||
13177195|NCT02260934|26138602|FG001|Overall Study|Withdrawal by Subject|2|||
13177196|NCT02260934|26138601|FG000|Overall Study|Participant Relocated|1|||
13177197|NCT02260934|26138602|FG001|Overall Study|Participant Relocated|0|||
13177198|NCT02260934|26138601|FG000|Overall Study|Site error|0|||
13177199|NCT02260934|26138602|FG001|Overall Study|Site error|1|||
13177200|NCT02260921|26138631|FG000|Overall Study|Adverse Event|1|||
13177201|NCT02260921|26138632|FG001|Overall Study|Adverse Event|0|||
13177202|NCT02260921|26138631|FG000|Overall Study|Lost to Follow-up|4|||
13177203|NCT02260921|26138632|FG001|Overall Study|Lost to Follow-up|3|||
13177204|NCT02260921|26138631|FG000|Overall Study|Withdraw Consent|4|||
13177205|NCT02260921|26138632|FG001|Overall Study|Withdraw Consent|1|||
13108981|NCT03241368|25894196|FG000|Overall Study|Physician Decision|6|||
13177206|NCT02260921|26138631|FG000|Overall Study|Death|1|||
13177207|NCT02260921|26138632|FG001|Overall Study|Death|0|||
13108982|NCT03241368|25894196|FG000|Overall Study|Withdrawal by Subject|6|||
13177208|NCT02260921|26138631|FG000|Overall Study|Prohibited Treatment for Knee Pain|4|||
13177209|NCT02260921|26138632|FG001|Overall Study|Prohibited Treatment for Knee Pain|0|||
13177210|NCT02260882|26138661|FG000|Overall Study|Protocol Violation|0|||
13177211|NCT02260882|26138662|FG001|Overall Study|Protocol Violation|1|||
13177212|NCT02260817|26138715|FG000|Overall Study|Lost to Follow-up|0|||
13177213|NCT02260817|26138716|FG001|Overall Study|Lost to Follow-up|14|||
13177214|NCT02260817|26138715|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0|||
13177215|NCT02260817|26138716|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7|||
13177216|NCT02260817|26138715|FG000|Overall Study|Observation, no biopsy|0|||
13177217|NCT02260817|26138716|FG001|Overall Study|Observation, no biopsy|1|||
13177218|NCT02260817|26138715|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0|||
13177219|NCT02260817|26138716|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1|||
13177220|NCT02260817|26138715|FG000|Overall Study|Protocol Violation|0|||
13177221|NCT02260817|26138716|FG001|Overall Study|Protocol Violation|14|||
13177222|NCT02260804|26138743|FG000|Induction Study Period|Protocol Violation|2|||
13177223|NCT02260804|26138744|FG001|Induction Study Period|Protocol Violation|0|||
13177224|NCT02260804|26138743|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6|||
13177225|NCT02260804|26138744|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9|||
13177226|NCT02260804|26138743|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3|||
13177227|NCT02260804|26138744|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1|||
13177228|NCT02260804|26138743|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1|||
13177229|NCT02260804|26138744|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3|||
13177230|NCT02260804|26138743|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1|||
13177231|NCT02260804|26138744|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0|||
13177232|NCT02260804|26138743|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1|||
13177233|NCT02260804|26138744|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0|||
13177234|NCT02260804|26138743|FG000|1st Year of the Maintenance Period (MP1)|Death|0|||
13108983|NCT03241368|25894196|FG000|Overall Study|Protocol Violation|1|||
13108984|NCT03241342|25894214|FG000|Overall Study|Adverse Event|5|||
13108985|NCT03241342|25894215|FG001|Overall Study|Adverse Event|8|||
13108986|NCT03241342|25894216|FG002|Overall Study|Adverse Event|4|||
13108987|NCT03241342|25894214|FG000|Overall Study|Lack of Efficacy|0|||
13108988|NCT03241342|25894215|FG001|Overall Study|Lack of Efficacy|0|||
13108989|NCT03241342|25894216|FG002|Overall Study|Lack of Efficacy|1|||
13108990|NCT03241342|25894214|FG000|Overall Study|noncompliance with study drug|2|||
13108991|NCT03241342|25894215|FG001|Overall Study|noncompliance with study drug|1|||
13108992|NCT03241342|25894216|FG002|Overall Study|noncompliance with study drug|1|||
13108993|NCT03241342|25894214|FG000|Overall Study|sponsor decision|0|||
13108994|NCT03241342|25894215|FG001|Overall Study|sponsor decision|1|||
13177235|NCT02260804|26138744|FG001|1st Year of the Maintenance Period (MP1)|Death|1|||
13177236|NCT02260804|26138743|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0|||
13177237|NCT02260804|26138744|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1|||
13177238|NCT02260804|26138743|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6|||
13177239|NCT02260804|26138744|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5|||
13177240|NCT02260804|26138743|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3|||
13177241|NCT02260804|26138744|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0|||
13177242|NCT02260804|26138743|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0|||
13177243|NCT02260804|26138744|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1|||
13177244|NCT02260791|26138787|FG000|Overall Study|Lost to Follow-up|4|||
13177245|NCT02260791|26138788|FG001|Overall Study|Lost to Follow-up|4|||
13177246|NCT02260791|26138787|FG000|Overall Study|Lack of Efficacy|2|||
13177247|NCT02260791|26138788|FG001|Overall Study|Lack of Efficacy|1|||
13177248|NCT02260791|26138787|FG000|Overall Study|Adverse Event|13|||
13177249|NCT02260791|26138788|FG001|Overall Study|Adverse Event|9|||
13177250|NCT02260791|26138787|FG000|Overall Study|Death|1|||
13177251|NCT02260791|26138788|FG001|Overall Study|Death|0|||
13177252|NCT02260791|26138787|FG000|Overall Study|Withdrawal by Subject|11|||
13177253|NCT02260791|26138788|FG001|Overall Study|Withdrawal by Subject|16|||
13177254|NCT02260791|26138787|FG000|Overall Study|Screen failure|0|||
13177255|NCT02260791|26138788|FG001|Overall Study|Screen failure|1|||
13108995|NCT03241342|25894216|FG002|Overall Study|sponsor decision|2|||
13108996|NCT03241342|25894214|FG000|Overall Study|not reported|15|||
13108997|NCT03241342|25894215|FG001|Overall Study|not reported|21|||
13108998|NCT03241342|25894216|FG002|Overall Study|not reported|19|||
13108999|NCT03241173|25894359|FG000|Overall Study|Death|3|||
13109000|NCT03241173|25894360|FG001|Overall Study|Death|2|||
13109001|NCT03241173|25894361|FG002|Overall Study|Death|4|||
13177256|NCT02260791|26138787|FG000|Overall Study|Protocol deviation|2|||
13177257|NCT02260791|26138788|FG001|Overall Study|Protocol deviation|3|||
13177258|NCT02260648|26138824|FG000|Overall Study|Adverse Event|3|||
13177259|NCT02260648|26138825|FG001|Overall Study|Adverse Event|0|||
13177260|NCT02260648|26138826|FG002|Overall Study|Adverse Event|1|||
13177261|NCT02260648|26138824|FG000|Overall Study|Withdrawal by Subject|1|||
13177262|NCT02260648|26138825|FG001|Overall Study|Withdrawal by Subject|1|||
13109002|NCT03241173|25894362|FG003|Overall Study|Death|4|||
13109003|NCT03241173|25894363|FG004|Overall Study|Death|2|||
13177263|NCT02260648|26138826|FG002|Overall Study|Withdrawal by Subject|0|||
13177264|NCT02260648|26138824|FG000|Overall Study|Protocol Violation|1|||
13177265|NCT02260648|26138825|FG001|Overall Study|Protocol Violation|0|||
13177266|NCT02260648|26138826|FG002|Overall Study|Protocol Violation|0|||
13177267|NCT02260648|26138824|FG000|Overall Study|Discontinue Due to Study Termination|13|||
13177268|NCT02260648|26138825|FG001|Overall Study|Discontinue Due to Study Termination|12|||
13177269|NCT02260648|26138826|FG002|Overall Study|Discontinue Due to Study Termination|7|||
13177270|NCT02260635|26138853|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1|||
13177271|NCT02260635|26138854|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2|||
13177272|NCT02260635|26138853|FG000|Open-Label Extension|Study Termination|25|||
13177273|NCT02260635|26138854|FG001|Open-Label Extension|Study Termination|25|||
13177274|NCT02260635|26138853|FG000|Open-Label Extension|Withdrawal by Subject|1|||
13177275|NCT02260635|26138854|FG001|Open-Label Extension|Withdrawal by Subject|0|||
13177276|NCT02260492|26138878|FG000|Overall Study|Adverse Event|6|||
13177277|NCT02260492|26138879|FG001|Overall Study|Adverse Event|1|||
13177278|NCT02260492|26138880|FG002|Overall Study|Adverse Event|2|||
13177279|NCT02260492|26138878|FG000|Overall Study|Death|0|||
13177280|NCT02260492|26138879|FG001|Overall Study|Death|1|||
13177281|NCT02260492|26138880|FG002|Overall Study|Death|0|||
13177282|NCT02260492|26138878|FG000|Overall Study|Lost to Follow-up|12|||
13177283|NCT02260492|26138879|FG001|Overall Study|Lost to Follow-up|9|||
13177284|NCT02260492|26138880|FG002|Overall Study|Lost to Follow-up|0|||
13177285|NCT02260492|26138878|FG000|Overall Study|Physician Decision|2|||
13177286|NCT02260492|26138879|FG001|Overall Study|Physician Decision|0|||
13177287|NCT02260492|26138880|FG002|Overall Study|Physician Decision|1|||
13485535|NCT02906020|27032873|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
13109004|NCT03241173|25894364|FG005|Overall Study|Death|2|||
13109005|NCT03241173|25894365|FG006|Overall Study|Death|3|||
13109006|NCT03241173|25894366|FG007|Overall Study|Death|1|||
13109007|NCT03241173|25894367|FG008|Overall Study|Death|0|||
13109008|NCT03241173|25894368|FG009|Overall Study|Death|5|||
13109009|NCT03241173|25894369|FG010|Overall Study|Death|4|||
13109010|NCT03241173|25894370|FG011|Overall Study|Death|3|||
13177288|NCT02260492|26138878|FG000|Overall Study|Withdrawal by Subject|3|||
13177289|NCT02260492|26138879|FG001|Overall Study|Withdrawal by Subject|2|||
13177290|NCT02260492|26138880|FG002|Overall Study|Withdrawal by Subject|2|||
13177291|NCT02260388|26138919|FG000|Overall Study|Lost to Follow-up|2|||
13177292|NCT02260388|26138920|FG001|Overall Study|Lost to Follow-up|8|||
13177293|NCT02260388|26138921|FG002|Overall Study|Lost to Follow-up|3|||
13177294|NCT02260388|26138922|FG003|Overall Study|Lost to Follow-up|4|||
13177295|NCT02260258|26138948|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2|||
13177296|NCT02260258|26138949|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1|||
13177297|NCT02260180|26138970|FG000|Overall Study|Adverse Event|2|||
13177298|NCT02260180|26138971|FG001|Overall Study|Adverse Event|0|||
13177299|NCT02260180|26138972|FG002|Overall Study|Adverse Event|1|||
13177300|NCT02260154|26138988|FG000|Overall Study|Screening failure|2|||
13177301|NCT02259582|26139006|FG000|Overall Study|Physician Decision|0|||
13177302|NCT02259582|26139007|FG001|Overall Study|Physician Decision|1|||
13177303|NCT02259582|26139008|FG002|Overall Study|Physician Decision|0|||
13177304|NCT02259582|26139006|FG000|Overall Study|Death|0|||
13177305|NCT02259582|26139007|FG001|Overall Study|Death|0|||
13177306|NCT02259582|26139008|FG002|Overall Study|Death|1|||
13177307|NCT02259582|26139006|FG000|Overall Study|Adverse Event|1|||
13177308|NCT02259582|26139007|FG001|Overall Study|Adverse Event|0|||
13177309|NCT02259582|26139008|FG002|Overall Study|Adverse Event|1|||
13177310|NCT02259582|26139006|FG000|Overall Study|Withdrawal by Subject|0|||
13177311|NCT02259582|26139007|FG001|Overall Study|Withdrawal by Subject|0|||
13177312|NCT02259582|26139008|FG002|Overall Study|Withdrawal by Subject|1|||
13177313|NCT02259582|26139006|FG000|Overall Study|Disease progression|14|||
13109011|NCT03241173|25894371|FG012|Overall Study|Death|0|||
13177314|NCT02259582|26139007|FG001|Overall Study|Disease progression|15|||
13177315|NCT02259582|26139008|FG002|Overall Study|Disease progression|17|||
13109012|NCT03241173|25894372|FG013|Overall Study|Death|0|||
13109013|NCT03241173|25894373|FG014|Overall Study|Death|0|||
13109014|NCT03241173|25894359|FG000|Overall Study|Withdrawal by Subject|0|||
13109015|NCT03241173|25894360|FG001|Overall Study|Withdrawal by Subject|0|||
13109016|NCT03241173|25894361|FG002|Overall Study|Withdrawal by Subject|1|||
13109017|NCT03241173|25894362|FG003|Overall Study|Withdrawal by Subject|0|||
13177316|NCT02259582|26139006|FG000|Overall Study|Lack of Subject Adherence to Protocol|1|||
13177317|NCT02259582|26139007|FG001|Overall Study|Lack of Subject Adherence to Protocol|1|||
13177318|NCT02259582|26139008|FG002|Overall Study|Lack of Subject Adherence to Protocol|1|||
13177319|NCT02259400|26139047|FG000|Overall Study|Death|0|||
13177320|NCT02259400|26139048|FG001|Overall Study|Death|2|||
13177321|NCT02259348|26139062|FG000|Overall Study|Donors|6|||
13177322|NCT02259348|26139062|FG000|Overall Study|Death|4|||
13177323|NCT02259231|26139100|FG000|Overall Study|Adverse Event|1|||
13177324|NCT02259231|26139101|FG001|Overall Study|Adverse Event|1|||
13177325|NCT02259231|26139102|FG002|Overall Study|Adverse Event|2|||
13177326|NCT02259231|26139103|FG003|Overall Study|Adverse Event|0|||
13177327|NCT02259231|26139104|FG004|Overall Study|Adverse Event|0|||
13177328|NCT02259231|26139105|FG005|Overall Study|Adverse Event|0|||
13177329|NCT02259231|26139106|FG006|Overall Study|Adverse Event|0|||
13177330|NCT02259231|26139100|FG000|Overall Study|Progressive Disease|4|||
13177331|NCT02259231|26139101|FG001|Overall Study|Progressive Disease|5|||
13177332|NCT02259231|26139102|FG002|Overall Study|Progressive Disease|4|||
13177333|NCT02259231|26139103|FG003|Overall Study|Progressive Disease|5|||
13177334|NCT02259231|26139104|FG004|Overall Study|Progressive Disease|4|||
13177335|NCT02259231|26139105|FG005|Overall Study|Progressive Disease|5|||
13177336|NCT02259231|26139106|FG006|Overall Study|Progressive Disease|4|||
13177337|NCT02259231|26139100|FG000|Overall Study|Sponsor termination of study|1|||
13177338|NCT02259231|26139101|FG001|Overall Study|Sponsor termination of study|0|||
13177339|NCT02259231|26139102|FG002|Overall Study|Sponsor termination of study|0|||
13177340|NCT02259231|26139103|FG003|Overall Study|Sponsor termination of study|1|||
13177341|NCT02259231|26139104|FG004|Overall Study|Sponsor termination of study|2|||
13177342|NCT02259231|26139105|FG005|Overall Study|Sponsor termination of study|1|||
13109018|NCT03241173|25894363|FG004|Overall Study|Withdrawal by Subject|0|||
13109019|NCT03241173|25894364|FG005|Overall Study|Withdrawal by Subject|1|||
13109020|NCT03241173|25894365|FG006|Overall Study|Withdrawal by Subject|0|||
13109021|NCT03241173|25894366|FG007|Overall Study|Withdrawal by Subject|0|||
13109022|NCT03241173|25894367|FG008|Overall Study|Withdrawal by Subject|0|||
13109023|NCT03241173|25894368|FG009|Overall Study|Withdrawal by Subject|0|||
13109024|NCT03241173|25894369|FG010|Overall Study|Withdrawal by Subject|0|||
13109025|NCT03241173|25894370|FG011|Overall Study|Withdrawal by Subject|0|||
13109026|NCT03241173|25894371|FG012|Overall Study|Withdrawal by Subject|0|||
13109027|NCT03241173|25894372|FG013|Overall Study|Withdrawal by Subject|0|||
13109028|NCT03241173|25894373|FG014|Overall Study|Withdrawal by Subject|0|||
13109029|NCT03241173|25894359|FG000|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
13109030|NCT03241173|25894360|FG001|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
13109031|NCT03241173|25894361|FG002|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
13109032|NCT03241173|25894362|FG003|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
13109033|NCT03241173|25894363|FG004|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
13109034|NCT03241173|25894364|FG005|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
13177343|NCT02259231|26139106|FG006|Overall Study|Sponsor termination of study|1|||
13177344|NCT02259114|26139179|FG000|Overall Study|Progressive Disease|14|||
13177345|NCT02259114|26139180|FG001|Overall Study|Progressive Disease|2|||
13177346|NCT02259114|26139181|FG002|Overall Study|Progressive Disease|10|||
13177347|NCT02259114|26139182|FG003|Overall Study|Progressive Disease|2|||
13177348|NCT02259114|26139183|FG004|Overall Study|Progressive Disease|5|||
13177349|NCT02259114|26139179|FG000|Overall Study|Adverse Event|2|||
13177350|NCT02259114|26139180|FG001|Overall Study|Adverse Event|1|||
13177351|NCT02259114|26139181|FG002|Overall Study|Adverse Event|0|||
13177352|NCT02259114|26139182|FG003|Overall Study|Adverse Event|0|||
13177353|NCT02259114|26139183|FG004|Overall Study|Adverse Event|1|||
13177354|NCT02259114|26139179|FG000|Overall Study|Death|3|||
13177355|NCT02259114|26139180|FG001|Overall Study|Death|0|||
13177356|NCT02259114|26139181|FG002|Overall Study|Death|1|||
13177357|NCT02259114|26139182|FG003|Overall Study|Death|0|||
13177358|NCT02259114|26139183|FG004|Overall Study|Death|0|||
13177359|NCT02259114|26139179|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
13177360|NCT02259114|26139180|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
13177361|NCT02259114|26139181|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1|||
13177362|NCT02259114|26139182|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
13177363|NCT02259114|26139183|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
13177364|NCT02259114|26139179|FG000|Overall Study|Withdrawal by Subject|0|||
13177365|NCT02259114|26139180|FG001|Overall Study|Withdrawal by Subject|0|||
13177366|NCT02259114|26139181|FG002|Overall Study|Withdrawal by Subject|1|||
13177367|NCT02259114|26139182|FG003|Overall Study|Withdrawal by Subject|1|||
13177368|NCT02259114|26139183|FG004|Overall Study|Withdrawal by Subject|0|||
13177369|NCT02259114|26139179|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
13177370|NCT02259114|26139180|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
13177371|NCT02259114|26139181|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
13177372|NCT02259114|26139182|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
13177373|NCT02259114|26139183|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
13177374|NCT02259114|26139179|FG000|Overall Study|Not Treated|1|||
13177375|NCT02259114|26139180|FG001|Overall Study|Not Treated|0|||
13177376|NCT02259114|26139181|FG002|Overall Study|Not Treated|0|||
13177377|NCT02259114|26139182|FG003|Overall Study|Not Treated|0|||
13177378|NCT02259114|26139183|FG004|Overall Study|Not Treated|0|||
13177379|NCT02259088|26139235|FG000|Overall Study|Adverse Event|6|||
13177380|NCT02259088|26139236|FG001|Overall Study|Adverse Event|4|||
13177381|NCT02259088|26139235|FG000|Overall Study|Lost to Follow-up|2|||
13177382|NCT02259088|26139236|FG001|Overall Study|Lost to Follow-up|0|||
13177383|NCT02259088|26139235|FG000|Overall Study|Death|2|||
13177384|NCT02259088|26139236|FG001|Overall Study|Death|0|||
13177385|NCT02259088|26139235|FG000|Overall Study|Physician Decision|5|||
13177386|NCT02259088|26139236|FG001|Overall Study|Physician Decision|2|||
13177387|NCT02259088|26139235|FG000|Overall Study|Protocol deviation|5|||
13177388|NCT02259088|26139236|FG001|Overall Study|Protocol deviation|0|||
13177389|NCT02259088|26139235|FG000|Overall Study|Subject/guardian decision|8|||
13177390|NCT02259088|26139236|FG001|Overall Study|Subject/guardian decision|8|||
13177391|NCT02259010|26139263|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5|||
13177392|NCT02258659|26139278|FG000|Overall Study|Withdrawal by Subject|1|||
13177393|NCT02258529|26139292|FG000|Overall Study|Study Terminated by Sponsor|9|||
13177394|NCT02258529|26139292|FG000|Overall Study|Adverse Event|1|||
13177395|NCT02258464|26139321|FG000|Overall Study|Progressive disease (PD)|9|||
13177396|NCT02258464|26139322|FG001|Overall Study|Progressive disease (PD)|17|||
13177397|NCT02258464|26139321|FG000|Overall Study|Study drug never administered|1|||
13177398|NCT02258464|26139322|FG001|Overall Study|Study drug never administered|1|||
13177399|NCT02258464|26139321|FG000|Overall Study|AE not related to clinical PD|1|||
13177400|NCT02258464|26139322|FG001|Overall Study|AE not related to clinical PD|3|||
13177401|NCT02258464|26139321|FG000|Overall Study|Withdrawal by Subject|5|||
13177402|NCT02258464|26139322|FG001|Overall Study|Withdrawal by Subject|4|||
13177403|NCT02258464|26139321|FG000|Overall Study|AE related to clinical PD|1|||
13177404|NCT02258464|26139322|FG001|Overall Study|AE related to clinical PD|0|||
13177405|NCT02258334|26139361|FG000|Overall Study|Adverse Event|1|||
13177406|NCT02258334|26139362|FG001|Overall Study|Adverse Event|0|||
13177407|NCT02258334|26139363|FG002|Overall Study|Adverse Event|0|||
13177408|NCT02258334|26139364|FG003|Overall Study|Adverse Event|0|||
13177409|NCT02258074|26139391|FG000|Overall Study|Withdrawal by Subject|1|||
13177410|NCT02258074|26139392|FG001|Overall Study|Withdrawal by Subject|0|||
13177411|NCT02258074|26139393|FG002|Overall Study|Withdrawal by Subject|0|||
13177412|NCT02258074|26139394|FG003|Overall Study|Withdrawal by Subject|0|||
13177413|NCT02257684|26139404|FG000|Overall Study|Adverse Event|2|||
13177414|NCT02257684|26139404|FG000|Overall Study|Lack of Efficacy|1|||
13177415|NCT02257684|26139404|FG000|Overall Study|Sponsor's Decision|1|||
13177416|NCT02257632|26139423|FG000|Overall Study|Withdrawal by Subject|0|||
13177417|NCT02257632|26139424|FG001|Overall Study|Withdrawal by Subject|1|||
13177418|NCT02257632|26139423|FG000|Overall Study|Adverse Event|1|||
13177419|NCT02257632|26139424|FG001|Overall Study|Adverse Event|2|||
13177420|NCT02257567|26139695|FG000|Overall Study|Adverse Event|0|||
13177421|NCT02257567|26139696|FG001|Overall Study|Adverse Event|0|||
13177422|NCT02257567|26139697|FG002|Overall Study|Adverse Event|0|||
13177423|NCT02257567|26139698|FG003|Overall Study|Adverse Event|1|||
13177424|NCT02257567|26139699|FG004|Overall Study|Adverse Event|1|||
13177425|NCT02257567|26139700|FG005|Overall Study|Adverse Event|0|||
13177426|NCT02257567|26139701|FG006|Overall Study|Adverse Event|0|||
13177427|NCT02257567|26139702|FG007|Overall Study|Adverse Event|0|||
13177428|NCT02257567|26139703|FG008|Overall Study|Adverse Event|1|||
13177429|NCT02257567|26139704|FG009|Overall Study|Adverse Event|0|||
13177430|NCT02257567|26139705|FG010|Overall Study|Adverse Event|0|||
13177431|NCT02257567|26139695|FG000|Overall Study|Death|2|||
13177432|NCT02257567|26139696|FG001|Overall Study|Death|2|||
13177433|NCT02257567|26139697|FG002|Overall Study|Death|2|||
13177434|NCT02257567|26139698|FG003|Overall Study|Death|4|||
13177435|NCT02257567|26139699|FG004|Overall Study|Death|15|||
13177436|NCT02257567|26139700|FG005|Overall Study|Death|11|||
13177437|NCT02257567|26139701|FG006|Overall Study|Death|26|||
13177438|NCT02257567|26139702|FG007|Overall Study|Death|30|||
13177439|NCT02257567|26139703|FG008|Overall Study|Death|2|||
13177440|NCT02257567|26139704|FG009|Overall Study|Death|18|||
13109035|NCT03241173|25894365|FG006|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
13109036|NCT03241173|25894366|FG007|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
13109037|NCT03241173|25894367|FG008|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
13177441|NCT02257567|26139705|FG010|Overall Study|Death|65|||
13177442|NCT02257567|26139695|FG000|Overall Study|Lost to Follow-up|0|||
13177443|NCT02257567|26139696|FG001|Overall Study|Lost to Follow-up|0|||
13177444|NCT02257567|26139697|FG002|Overall Study|Lost to Follow-up|0|||
13177445|NCT02257567|26139698|FG003|Overall Study|Lost to Follow-up|0|||
13177446|NCT02257567|26139699|FG004|Overall Study|Lost to Follow-up|2|||
13177447|NCT02257567|26139700|FG005|Overall Study|Lost to Follow-up|2|||
13177448|NCT02257567|26139701|FG006|Overall Study|Lost to Follow-up|0|||
13177449|NCT02257567|26139702|FG007|Overall Study|Lost to Follow-up|0|||
13177450|NCT02257567|26139703|FG008|Overall Study|Lost to Follow-up|0|||
13177451|NCT02257567|26139704|FG009|Overall Study|Lost to Follow-up|1|||
13109038|NCT03241173|25894368|FG009|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
13109039|NCT03241173|25894369|FG010|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
13109040|NCT03241173|25894370|FG011|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|3|||
13109041|NCT03241173|25894371|FG012|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
13109042|NCT03241173|25894372|FG013|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
13109043|NCT03241173|25894373|FG014|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
13109044|NCT03241173|25894359|FG000|Overall Study|Lost to Follow-up|0|||
13109045|NCT03241173|25894360|FG001|Overall Study|Lost to Follow-up|0|||
13109046|NCT03241173|25894361|FG002|Overall Study|Lost to Follow-up|0|||
13109047|NCT03241173|25894362|FG003|Overall Study|Lost to Follow-up|0|||
13109048|NCT03241173|25894363|FG004|Overall Study|Lost to Follow-up|1|||
13109049|NCT03241173|25894364|FG005|Overall Study|Lost to Follow-up|0|||
13109050|NCT03241173|25894365|FG006|Overall Study|Lost to Follow-up|0|||
13109051|NCT03241173|25894366|FG007|Overall Study|Lost to Follow-up|0|||
13109052|NCT03241173|25894367|FG008|Overall Study|Lost to Follow-up|0|||
13109053|NCT03241173|25894368|FG009|Overall Study|Lost to Follow-up|1|||
13109054|NCT03241173|25894369|FG010|Overall Study|Lost to Follow-up|0|||
13109055|NCT03241173|25894370|FG011|Overall Study|Lost to Follow-up|0|||
13109056|NCT03241173|25894371|FG012|Overall Study|Lost to Follow-up|0|||
13109057|NCT03241173|25894372|FG013|Overall Study|Lost to Follow-up|0|||
13109058|NCT03241173|25894373|FG014|Overall Study|Lost to Follow-up|0|||
13109059|NCT03240692|25894387|FG000|Overall Study|Physician Decision|1|||
13109060|NCT03240692|25894387|FG000|Overall Study|Withdrawal by Subject|1|||
13109061|NCT03240575|25894420|FG000|Overall Study|Adverse Event|0|||
13109062|NCT03240575|25894421|FG001|Overall Study|Adverse Event|2|||
13177452|NCT02257567|26139705|FG010|Overall Study|Lost to Follow-up|1|||
13177453|NCT02257567|26139695|FG000|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
13177454|NCT02257567|26139696|FG001|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
13177455|NCT02257567|26139697|FG002|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
13177456|NCT02257567|26139698|FG003|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
13177457|NCT02257567|26139699|FG004|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|1|||
13177458|NCT02257567|26139700|FG005|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
13177459|NCT02257567|26139701|FG006|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|2|||
13177460|NCT02257567|26139702|FG007|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
13177461|NCT02257567|26139703|FG008|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
13177462|NCT02257567|26139704|FG009|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
13205761|NCT01962207|26232835|FG003|Persistence Phase (5 Years)|Adverse Event|0|||
13177463|NCT02257567|26139705|FG010|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
13177464|NCT02257567|26139695|FG000|Overall Study|Physician Decision|0|||
13177465|NCT02257567|26139696|FG001|Overall Study|Physician Decision|0|||
13177466|NCT02257567|26139697|FG002|Overall Study|Physician Decision|0|||
13177467|NCT02257567|26139698|FG003|Overall Study|Physician Decision|0|||
13177468|NCT02257567|26139699|FG004|Overall Study|Physician Decision|0|||
13177469|NCT02257567|26139700|FG005|Overall Study|Physician Decision|0|||
13177470|NCT02257567|26139701|FG006|Overall Study|Physician Decision|0|||
13177471|NCT02257567|26139702|FG007|Overall Study|Physician Decision|2|||
13177472|NCT02257567|26139703|FG008|Overall Study|Physician Decision|0|||
13177473|NCT02257567|26139704|FG009|Overall Study|Physician Decision|1|||
13177474|NCT02257567|26139705|FG010|Overall Study|Physician Decision|0|||
13177475|NCT02257567|26139695|FG000|Overall Study|Withdrawal by Subject|0|||
13177476|NCT02257567|26139696|FG001|Overall Study|Withdrawal by Subject|0|||
13177477|NCT02257567|26139697|FG002|Overall Study|Withdrawal by Subject|2|||
13177478|NCT02257567|26139698|FG003|Overall Study|Withdrawal by Subject|0|||
13177479|NCT02257567|26139699|FG004|Overall Study|Withdrawal by Subject|0|||
13177480|NCT02257567|26139700|FG005|Overall Study|Withdrawal by Subject|6|||
13177481|NCT02257567|26139701|FG006|Overall Study|Withdrawal by Subject|6|||
13177482|NCT02257567|26139702|FG007|Overall Study|Withdrawal by Subject|6|||
13177483|NCT02257567|26139703|FG008|Overall Study|Withdrawal by Subject|1|||
13177484|NCT02257567|26139704|FG009|Overall Study|Withdrawal by Subject|1|||
13177485|NCT02257567|26139705|FG010|Overall Study|Withdrawal by Subject|10|||
13177487|NCT02257489|26139776|FG000|Overall Study|Withdrawal by Subject|0|||
13177488|NCT02257489|26139777|FG001|Overall Study|Withdrawal by Subject|0|||
13177489|NCT02257489|26139778|FG002|Overall Study|Withdrawal by Subject|0|||
13177490|NCT02257489|26139779|FG003|Overall Study|Withdrawal by Subject|1|||
13177491|NCT02257489|26139780|FG004|Overall Study|Withdrawal by Subject|0|||
13177492|NCT02257489|26139781|FG005|Overall Study|Withdrawal by Subject|0|||
13177493|NCT02257489|26139782|FG006|Overall Study|Withdrawal by Subject|0|||
13177494|NCT02257489|26139783|FG007|Overall Study|Withdrawal by Subject|0|||
13177495|NCT02257489|26139784|FG008|Overall Study|Withdrawal by Subject|0|||
13177496|NCT02257385|26139799|FG000|Overall Study|Adverse Event|12|||
13177497|NCT02257385|26139800|FG001|Overall Study|Adverse Event|8|||
13177498|NCT02257385|26139799|FG000|Overall Study|Lack of Efficacy|1|||
13177499|NCT02257385|26139800|FG001|Overall Study|Lack of Efficacy|2|||
13177500|NCT02257385|26139799|FG000|Overall Study|Protocol Violation|5|||
13177501|NCT02257385|26139800|FG001|Overall Study|Protocol Violation|7|||
13177502|NCT02257385|26139799|FG000|Overall Study|Lost to Follow-up|0|||
13177503|NCT02257385|26139800|FG001|Overall Study|Lost to Follow-up|1|||
13177504|NCT02257385|26139799|FG000|Overall Study|Withdrawal by Subject|4|||
13177505|NCT02257385|26139800|FG001|Overall Study|Withdrawal by Subject|4|||
13177506|NCT02257372|26139815|FG000|Overall Study|Adverse Event|3|||
13177507|NCT02257372|26139816|FG001|Overall Study|Adverse Event|7|||
13177508|NCT02257372|26139815|FG000|Overall Study|Lack of Efficacy|2|||
13177509|NCT02257372|26139816|FG001|Overall Study|Lack of Efficacy|1|||
13177510|NCT02257372|26139815|FG000|Overall Study|Protocol Violation|1|||
13177511|NCT02257372|26139816|FG001|Overall Study|Protocol Violation|1|||
13177512|NCT02257372|26139815|FG000|Overall Study|Lost to Follow-up|0|||
13177513|NCT02257372|26139816|FG001|Overall Study|Lost to Follow-up|1|||
13177514|NCT02257372|26139815|FG000|Overall Study|Withdrew consent|1|||
13177515|NCT02257372|26139816|FG001|Overall Study|Withdrew consent|0|||
13177516|NCT02256982|26139829|FG000|Overall Study|Disease Progression|0|||
13177517|NCT02256982|26139830|FG001|Overall Study|Disease Progression|1|||
13177518|NCT02256969|26139857|FG000|Overall Study|Screenfailed or withdrew|2|||
13177519|NCT02256969|26139858|FG001|Overall Study|Screenfailed or withdrew|1|||
13177520|NCT02256969|26139859|FG002|Overall Study|Screenfailed or withdrew|1|||
13177521|NCT02256917|26139880|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1|||
13177522|NCT02256917|26139880|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1|||
13177523|NCT02256917|26139880|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1|||
13177524|NCT02256917|26139880|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1|||
13177525|NCT02256917|26139880|FG000|Prophylactic Treatment Phase II|Discontinued medication|1|||
13177526|NCT02256891|26139911|FG000|Overall Study|Death|0|||
13177527|NCT02256891|26139912|FG001|Overall Study|Death|2|||
13177528|NCT02256891|26139911|FG000|Overall Study|Lost to Follow-up|0|||
13177529|NCT02256891|26139912|FG001|Overall Study|Lost to Follow-up|3|||
13177530|NCT02256891|26139911|FG000|Overall Study|Physician Decision|7|||
13177531|NCT02256891|26139912|FG001|Overall Study|Physician Decision|3|||
13177532|NCT02256891|26139911|FG000|Overall Study|Screen Fail|5|||
13177533|NCT02256891|26139912|FG001|Overall Study|Screen Fail|4|||
13177534|NCT02256891|26139911|FG000|Overall Study|Equipment Malfunction|0|||
13177535|NCT02256891|26139912|FG001|Overall Study|Equipment Malfunction|1|||
13177536|NCT02256839|26139925|FG000|Overall Study|Did not meet Eligibility Criteria|2|||
13177537|NCT02256839|26139926|FG001|Overall Study|Did not meet Eligibility Criteria|3|||
13177538|NCT02256553|26139937|FG000|Period I|Adverse Event|5|||
13177539|NCT02256553|26139937|FG000|Period I|Protocol Violation|1|||
13177540|NCT02256553|26139937|FG000|Period II|Adverse Event|1|||
13177541|NCT02256553|26139937|FG000|Period II|Subject Moved|1|||
13177542|NCT02256553|26139937|FG000|Period III|Adverse Event|3|||
13177543|NCT02256540|26139955|FG000|Overall Study|Withdrawal by Subject|0|||
13177544|NCT02256540|26139956|FG001|Overall Study|Withdrawal by Subject|1|||
13177545|NCT02256540|26139957|FG002|Overall Study|Withdrawal by Subject|1|||
13177546|NCT02256540|26139955|FG000|Overall Study|Back pain preventing exercise|0|||
13177547|NCT02256540|26139956|FG001|Overall Study|Back pain preventing exercise|0|||
13177548|NCT02256540|26139957|FG002|Overall Study|Back pain preventing exercise|1|||
13177549|NCT02256488|26139984|FG000|Overall Study|Lost to Follow-up|6|||
13177550|NCT02256488|26139985|FG001|Overall Study|Lost to Follow-up|6|||
13177551|NCT02256488|26139986|FG002|Overall Study|Lost to Follow-up|9|||
13177552|NCT02256488|26139987|FG003|Overall Study|Lost to Follow-up|3|||
13177553|NCT02256488|26139984|FG000|Overall Study|OTHER|1|||
13177554|NCT02256488|26139985|FG001|Overall Study|OTHER|0|||
13177555|NCT02256488|26139986|FG002|Overall Study|OTHER|1|||
13177556|NCT02256488|26139987|FG003|Overall Study|OTHER|1|||
13177557|NCT02256488|26139984|FG000|Overall Study|Withdrawal by Subject|1|||
13177558|NCT02256488|26139985|FG001|Overall Study|Withdrawal by Subject|0|||
13177559|NCT02256488|26139986|FG002|Overall Study|Withdrawal by Subject|0|||
13177560|NCT02256488|26139987|FG003|Overall Study|Withdrawal by Subject|2|||
13177561|NCT02256436|26140039|FG000|Overall Study|Adverse Event|9|||
13177562|NCT02256436|26140040|FG001|Overall Study|Adverse Event|14|||
13177563|NCT02256436|26140039|FG000|Overall Study|Death|216|||
13177564|NCT02256436|26140040|FG001|Overall Study|Death|208|||
13177565|NCT02256436|26140039|FG000|Overall Study|Lost to Follow-up|1|||
13177566|NCT02256436|26140040|FG001|Overall Study|Lost to Follow-up|2|||
13177567|NCT02256436|26140039|FG000|Overall Study|Physician Decision|1|||
13177568|NCT02256436|26140040|FG001|Overall Study|Physician Decision|0|||
13177569|NCT02256436|26140039|FG000|Overall Study|Protocol Violation|0|||
13177570|NCT02256436|26140040|FG001|Overall Study|Protocol Violation|1|||
13177571|NCT02256436|26140039|FG000|Overall Study|Withdrawal by Subject|26|||
13177572|NCT02256436|26140040|FG001|Overall Study|Withdrawal by Subject|10|||
13177573|NCT02256436|26140039|FG000|Overall Study|Transferred to Extension Study|11|||
13177574|NCT02256436|26140040|FG001|Overall Study|Transferred to Extension Study|23|||
13177575|NCT02256436|26140039|FG000|Overall Study|Did Not Continue on Extension Study|8|||
13177576|NCT02256436|26140040|FG001|Overall Study|Did Not Continue on Extension Study|12|||
13177577|NCT02256384|26140051|FG000|Overall Study|Withdrawal by Subject|12|||
13177578|NCT02256384|26140051|FG000|Overall Study|Equipment not capturing data|2|||
13177579|NCT02256267|26140062|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1|||
13177580|NCT02256267|26140062|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1|||
13177581|NCT02255981|26140074|FG000|Overall Study|Lost to Follow-up|3|||
13177582|NCT02255981|26140074|FG000|Overall Study|Withdrawal by Subject|1|||
13177583|NCT02255760|26140142|FG000|Overall Study|Lost to Follow-up|0|||
13177584|NCT02255760|26140143|FG001|Overall Study|Lost to Follow-up|1|||
13177585|NCT02255760|26140144|FG002|Overall Study|Lost to Follow-up|0|||
13177586|NCT02255760|26140145|FG003|Overall Study|Lost to Follow-up|0|||
13177587|NCT02255760|26140146|FG004|Overall Study|Lost to Follow-up|0|||
13177588|NCT02255656|26140218|FG000|Overall Study|Adverse Event|11|||
13177589|NCT02255656|26140218|FG000|Overall Study|Poor compliance to protocol|3|||
13177590|NCT02255656|26140218|FG000|Overall Study|Lost to Follow-up|30|||
13177591|NCT02255656|26140218|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300|||
13177592|NCT02255656|26140218|FG000|Overall Study|Other|126|||
13177593|NCT02255565|26140287|FG000|Overall Study|Withdrawal by Subject|0|||
13177594|NCT02255565|26140288|FG001|Overall Study|Withdrawal by Subject|1|||
13177595|NCT02255565|26140289|FG002|Overall Study|Withdrawal by Subject|0|||
13177596|NCT02255552|26140312|FG000|Overall Study|Participants enrolled into another study|0|||
13177597|NCT02255552|26140313|FG001|Overall Study|Participants enrolled into another study|11|||
13177598|NCT02255552|26140312|FG000|Overall Study|Withdrawal by Subject|1|||
13177599|NCT02255552|26140313|FG001|Overall Study|Withdrawal by Subject|4|||
13177600|NCT02255500|26140336|FG000|Overall Study|Withdrawal by Subject|1|||
13177601|NCT02255500|26140337|FG001|Overall Study|Withdrawal by Subject|0|||
13177602|NCT02255474|26140364|FG000|Overall Study|Lost to Follow-up|1|||
13177603|NCT02255474|26140365|FG001|Overall Study|Lost to Follow-up|1|||
13177604|NCT02255474|26140366|FG002|Overall Study|Lost to Follow-up|3|||
13177605|NCT02255474|26140364|FG000|Overall Study|Withdrawal by Subject|1|||
13177606|NCT02255474|26140365|FG001|Overall Study|Withdrawal by Subject|1|||
13177607|NCT02255474|26140366|FG002|Overall Study|Withdrawal by Subject|0|||
13177608|NCT02255461|26140454|FG000|Overall Study|Adverse Event|0|||
13177609|NCT02255461|26140455|FG001|Overall Study|Adverse Event|1|||
13177610|NCT02255461|26140456|FG002|Overall Study|Adverse Event|0|||
13177611|NCT02255461|26140457|FG003|Overall Study|Adverse Event|0|||
13177612|NCT02255461|26140458|FG004|Overall Study|Adverse Event|1|||
13177613|NCT02255461|26140454|FG000|Overall Study|Withdrawal by Subject|0|||
13177614|NCT02255461|26140455|FG001|Overall Study|Withdrawal by Subject|0|||
13177615|NCT02255461|26140456|FG002|Overall Study|Withdrawal by Subject|1|||
13177616|NCT02255461|26140457|FG003|Overall Study|Withdrawal by Subject|0|||
13177617|NCT02255461|26140458|FG004|Overall Study|Withdrawal by Subject|1|||
13177618|NCT02255461|26140454|FG000|Overall Study|Not meet dose reduction BSA requirement|0|||
13177619|NCT02255461|26140455|FG001|Overall Study|Not meet dose reduction BSA requirement|1|||
13177620|NCT02255461|26140456|FG002|Overall Study|Not meet dose reduction BSA requirement|0|||
13177621|NCT02255461|26140457|FG003|Overall Study|Not meet dose reduction BSA requirement|0|||
13177622|NCT02255461|26140458|FG004|Overall Study|Not meet dose reduction BSA requirement|0|||
13177623|NCT02255422|26140503|FG000|Overall Study|Withdrawal by Subject|0|||
13177624|NCT02255422|26140504|FG001|Overall Study|Withdrawal by Subject|0|||
13177625|NCT02255422|26140505|FG002|Overall Study|Withdrawal by Subject|0|||
13177626|NCT02255422|26140506|FG003|Overall Study|Withdrawal by Subject|0|||
13177627|NCT02255422|26140507|FG004|Overall Study|Withdrawal by Subject|0|||
13177628|NCT02255422|26140508|FG005|Overall Study|Withdrawal by Subject|0|||
13177629|NCT02255422|26140509|FG006|Overall Study|Withdrawal by Subject|2|||
13177630|NCT02255422|26140503|FG000|Overall Study|Lost to Follow-up|0|||
13177631|NCT02255422|26140504|FG001|Overall Study|Lost to Follow-up|0|||
13177632|NCT02255422|26140505|FG002|Overall Study|Lost to Follow-up|1|||
13177633|NCT02255422|26140506|FG003|Overall Study|Lost to Follow-up|0|||
13177634|NCT02255422|26140507|FG004|Overall Study|Lost to Follow-up|0|||
13177635|NCT02255422|26140508|FG005|Overall Study|Lost to Follow-up|0|||
13177636|NCT02255422|26140509|FG006|Overall Study|Lost to Follow-up|0|||
13177637|NCT02255279|26140542|FG000|Overall Study|Lost to Follow-up|2|||
13177638|NCT02255279|26140543|FG001|Overall Study|Lost to Follow-up|2|||
13177639|NCT02255279|26140542|FG000|Overall Study|Protocol Violation|0|||
13177640|NCT02255279|26140543|FG001|Overall Study|Protocol Violation|1|||
13177641|NCT02255279|26140542|FG000|Overall Study|Withdrawal by Subject|3|||
13177642|NCT02255279|26140543|FG001|Overall Study|Withdrawal by Subject|6|||
13177643|NCT02255149|26140549|FG000|Overall Study|Lost to Follow-up|2|||
13177644|NCT02255149|26140549|FG000|Overall Study|Withdrawal by Subject|1|||
13177645|NCT02255149|26140549|FG000|Overall Study|Withdrawal by PI|1|||
13177646|NCT02255149|26140549|FG000|Overall Study|Implant Failure|1|||
13177647|NCT02255097|26140573|FG000|Overall Study|Death|151|||
13177648|NCT02255097|26140573|FG000|Overall Study|Lost to Follow-up|5|||
13177649|NCT02255097|26140573|FG000|Overall Study|Participation in Study Discontinued by Sponsor|8|||
13177650|NCT02255097|26140573|FG000|Overall Study|Withdrawal by Subject|7|||
13177651|NCT02255097|26140573|FG000|Overall Study|Allocated but not treated|1|||
13177652|NCT02254772|26140581|FG000|Overall Study|Ineligible|1|||
13177653|NCT02254772|26140581|FG000|Overall Study|Withdrawal by Subject|1|||
13177654|NCT02254681|26140593|FG000|Overall Study|Lack of Efficacy|6|||
13177655|NCT02254551|26140603|FG000|Dose Escalation|Physician Decision|1|||
13177656|NCT02254551|26140603|FG000|Dose Escalation|Dose-limiting toxicity|2|||
13177657|NCT02254486|26140626|FG000|Overall Study|Adverse Event|1|||
13177658|NCT02254486|26140627|FG001|Overall Study|Adverse Event|1|||
13177659|NCT02254486|26140626|FG000|Overall Study|Lack of Efficacy|1|||
13177660|NCT02254486|26140627|FG001|Overall Study|Lack of Efficacy|0|||
13177661|NCT02254486|26140626|FG000|Overall Study|Lost to Follow-up|2|||
13177662|NCT02254486|26140627|FG001|Overall Study|Lost to Follow-up|4|||
13177663|NCT02254486|26140626|FG000|Overall Study|Protocol Violation|1|||
13177664|NCT02254486|26140627|FG001|Overall Study|Protocol Violation|2|||
13177665|NCT02254486|26140626|FG000|Overall Study|Withdrawal by Subject|17|||
13177666|NCT02254486|26140627|FG001|Overall Study|Withdrawal by Subject|15|||
13177667|NCT02254486|26140626|FG000|Overall Study|GFR<60mL/min|16|||
13177668|NCT02254486|26140627|FG001|Overall Study|GFR<60mL/min|21|||
13177669|NCT02254486|26140626|FG000|Overall Study|Various|12|||
13177670|NCT02254486|26140627|FG001|Overall Study|Various|12|||
13177671|NCT02254460|26140636|FG000|Overall Study|Adverse Event|1|||
13177672|NCT02254460|26140637|FG001|Overall Study|Adverse Event|0|||
13205762|NCT01962207|26232832|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21|||
13205763|NCT01962207|26232833|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7|||
13205764|NCT01962207|26232834|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13|||
13205765|NCT01962207|26232835|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5|||
13205766|NCT01962103|26232963|FG000|Phase 1|Adverse Event|4|||
13205767|NCT01962103|26232964|FG001|Phase 1|Adverse Event|0|||
13205768|NCT01962103|26232965|FG002|Phase 1|Adverse Event|2|||
13205769|NCT01962103|26232966|FG003|Phase 1|Adverse Event|1|||
13205770|NCT01962103|26232967|FG004|Phase 1|Adverse Event|2|||
13205771|NCT01962103|26232968|FG005|Phase 1|Adverse Event|2|||
13205772|NCT01962103|26232969|FG006|Phase 1|Adverse Event|0|||
13205773|NCT01962103|26232970|FG007|Phase 1|Adverse Event|0|||
13205774|NCT01962103|26232971|FG008|Phase 1|Adverse Event|0|||
13205775|NCT01962103|26232963|FG000|Phase 1|Progressive Disease|8|||
13205776|NCT01962103|26232964|FG001|Phase 1|Progressive Disease|6|||
13205777|NCT01962103|26232965|FG002|Phase 1|Progressive Disease|8|||
13205778|NCT01962103|26232966|FG003|Phase 1|Progressive Disease|4|||
13205779|NCT01962103|26232967|FG004|Phase 1|Progressive Disease|5|||
13205780|NCT01962103|26232968|FG005|Phase 1|Progressive Disease|4|||
13205781|NCT01962103|26232969|FG006|Phase 1|Progressive Disease|0|||
13205782|NCT01962103|26232970|FG007|Phase 1|Progressive Disease|0|||
13205783|NCT01962103|26232971|FG008|Phase 1|Progressive Disease|0|||
13205784|NCT01962103|26232963|FG000|Phase 1|Withdrawal by Subject|0|||
13177673|NCT04969276|26140706|FG000|Overall Study|Protocol Deviation|0|||
13177674|NCT04969276|26140707|FG001|Overall Study|Protocol Deviation|1|||
13177675|NCT04969276|26140708|FG002|Overall Study|Protocol Deviation|0|||
13177676|NCT04969276|26140706|FG000|Overall Study|Withdrawal by Subject|1|||
13177677|NCT04969276|26140707|FG001|Overall Study|Withdrawal by Subject|10|||
13177678|NCT04969276|26140708|FG002|Overall Study|Withdrawal by Subject|0|||
13177679|NCT04969276|26140706|FG000|Overall Study|Lost to Follow-up|0|||
13177680|NCT04969276|26140707|FG001|Overall Study|Lost to Follow-up|1|||
13177681|NCT04969276|26140708|FG002|Overall Study|Lost to Follow-up|0|||
13177682|NCT04887948|26140744|FG000|Overall Study|Death|1|||
13177683|NCT04887948|26140745|FG001|Overall Study|Death|0|||
13177684|NCT04887948|26140746|FG002|Overall Study|Death|0|||
13177685|NCT04887948|26140744|FG000|Overall Study|Lost to Follow-up|1|||
13177686|NCT04887948|26140745|FG001|Overall Study|Lost to Follow-up|0|||
13177687|NCT04887948|26140746|FG002|Overall Study|Lost to Follow-up|3|||
13177688|NCT04887948|26140744|FG000|Overall Study|Physician Decision|0|||
13177689|NCT04887948|26140745|FG001|Overall Study|Physician Decision|4|||
13177690|NCT04887948|26140746|FG002|Overall Study|Physician Decision|1|||
13177691|NCT04887948|26140744|FG000|Overall Study|Protocol Violation|1|||
13177692|NCT04887948|26140745|FG001|Overall Study|Protocol Violation|1|||
13177693|NCT04887948|26140746|FG002|Overall Study|Protocol Violation|0|||
13177694|NCT04887948|26140744|FG000|Overall Study|Withdrawal by Subject|0|||
13177695|NCT04887948|26140745|FG001|Overall Study|Withdrawal by Subject|6|||
13177696|NCT04887948|26140746|FG002|Overall Study|Withdrawal by Subject|1|||
13177697|NCT04887948|26140744|FG000|Overall Study|No longer met eligibility criteria|1|||
13177698|NCT04887948|26140745|FG001|Overall Study|No longer met eligibility criteria|2|||
13177699|NCT04887948|26140746|FG002|Overall Study|No longer met eligibility criteria|1|||
13177700|NCT04887948|26140744|FG000|Overall Study|Other|2|||
13177701|NCT04887948|26140745|FG001|Overall Study|Other|1|||
13177702|NCT04887948|26140746|FG002|Overall Study|Other|1|||
13177703|NCT04662073|26140803|FG000|Overall Study|Withdrawal by Subject|1|||
13177704|NCT04662073|26140804|FG001|Overall Study|Withdrawal by Subject|0|||
13177705|NCT04354870|26140885|FG000|Overall Study|Lost to Follow-up|32|||
13177706|NCT04354870|26140886|FG001|Overall Study|Lost to Follow-up|12|||
13177707|NCT04354870|26140885|FG000|Overall Study|Withdrawal by Subject|10|||
13177708|NCT04354870|26140886|FG001|Overall Study|Withdrawal by Subject|16|||
13177709|NCT04354870|26140885|FG000|Overall Study|Did not complete all study visits|6|||
13177710|NCT04354870|26140886|FG001|Overall Study|Did not complete all study visits|5|||
13177711|NCT04199793|26140919|FG000|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
13177712|NCT04199793|26140920|FG001|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
13177713|NCT04199793|26140919|FG000|Overall Study|Withdrawal by Subject|1|||
13177714|NCT04199793|26140920|FG001|Overall Study|Withdrawal by Subject|1|||
13177715|NCT04183335|26140973|FG000|Overall Study|Adverse Event|1|||
13177716|NCT04183335|26140974|FG001|Overall Study|Adverse Event|0|||
13177717|NCT04183335|26140973|FG000|Overall Study|Withdrawal by Subject|12|||
13177718|NCT04183335|26140974|FG001|Overall Study|Withdrawal by Subject|3|||
13177719|NCT03966053|26140980|FG000|Overall Study|Withdrawal by subject prior to starting study drug.|1|||
13177720|NCT03883906|26140988|FG000|Overall Study|Withdrawal by Subject|2|||
13177721|NCT03883906|26140988|FG000|Overall Study|Physician Decision|5|||
13177722|NCT03875092|26141025|FG000|Overall Study|Adverse Event|2|||
13177723|NCT03875092|26141026|FG001|Overall Study|Adverse Event|5|||
13177724|NCT03875092|26141025|FG000|Overall Study|Death|28|||
13177725|NCT03875092|26141026|FG001|Overall Study|Death|41|||
13177726|NCT03875092|26141025|FG000|Overall Study|Ongoing in Study|35|||
13177727|NCT03875092|26141026|FG001|Overall Study|Ongoing in Study|14|||
13177728|NCT03775486|26141071|FG000|Initial Therapy Phase|Other reason provided|0|||
13177729|NCT03775486|26141072|FG001|Initial Therapy Phase|Other reason provided|15|||
13177730|NCT03775486|26141071|FG000|Initial Therapy Phase|Condition under investigation worsened|0|||
13177731|NCT03775486|26141072|FG001|Initial Therapy Phase|Condition under investigation worsened|67|||
13177732|NCT03775486|26141071|FG000|Initial Therapy Phase|Protocol Violation|0|||
13177733|NCT03775486|26141072|FG001|Initial Therapy Phase|Protocol Violation|2|||
13177734|NCT03775486|26141071|FG000|Initial Therapy Phase|Adverse Event|0|||
13177735|NCT03775486|26141072|FG001|Initial Therapy Phase|Adverse Event|34|||
13177736|NCT03775486|26141071|FG000|Initial Therapy Phase|Withdrawal by Subject|0|||
13177737|NCT03775486|26141072|FG001|Initial Therapy Phase|Withdrawal by Subject|14|||
13177738|NCT03775486|26141071|FG000|Maintenance Phase|Withdrawal by Subject|13|||
13177739|NCT03775486|26141072|FG001|Maintenance Phase|Withdrawal by Subject|12|||
13177740|NCT03775486|26141071|FG000|Maintenance Phase|Death|44|||
13177741|NCT03775486|26141072|FG001|Maintenance Phase|Death|45|||
13177742|NCT03774875|26141154|FG000|Placebo-controlled Period (Week 1-16)|Adverse Event|8|||
13177743|NCT03774875|26141155|FG001|Placebo-controlled Period (Week 1-16)|Adverse Event|16|||
13177744|NCT03774875|26141154|FG000|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|2|||
13177745|NCT03774875|26141155|FG001|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|4|||
13177746|NCT03774875|26141154|FG000|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|12|||
13177747|NCT03774875|26141155|FG001|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|10|||
13205785|NCT01962103|26232964|FG001|Phase 1|Withdrawal by Subject|0|||
13177748|NCT03774875|26141154|FG000|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|0|||
13177749|NCT03774875|26141155|FG001|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|2|||
13177750|NCT03774875|26141154|FG000|Placebo-controlled Period (Week 1-16)|Protocol Deviation|0|||
13177751|NCT03774875|26141155|FG001|Placebo-controlled Period (Week 1-16)|Protocol Deviation|1|||
13177752|NCT03774875|26141154|FG000|Placebo-controlled Period (Week 1-16)|Reason Unknown|1|||
13177753|NCT03774875|26141155|FG001|Placebo-controlled Period (Week 1-16)|Reason Unknown|0|||
13177754|NCT03774875|26141154|FG000|Apremilast Extension Period (Week 16-52)|Adverse Event|6|||
13177755|NCT03774875|26141155|FG001|Apremilast Extension Period (Week 16-52)|Adverse Event|9|||
13177756|NCT03774875|26141154|FG000|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|2|||
13177757|NCT03774875|26141155|FG001|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|11|||
13177758|NCT03774875|26141154|FG000|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|7|||
13177759|NCT03774875|26141155|FG001|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|20|||
13177760|NCT03774875|26141154|FG000|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|0|||
13177761|NCT03774875|26141155|FG001|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|2|||
13177762|NCT03774875|26141154|FG000|Apremilast Extension Period (Week 16-52)|Other|1|||
13177763|NCT03774875|26141155|FG001|Apremilast Extension Period (Week 16-52)|Other|1|||
13109063|NCT03240575|25894422|FG002|Overall Study|Adverse Event|0|||
13109064|NCT03240575|25894423|FG003|Overall Study|Adverse Event|1|||
13109065|NCT03240575|25894420|FG000|Overall Study|Withdrawal by Subject|2|||
13109066|NCT03240575|25894421|FG001|Overall Study|Withdrawal by Subject|11|||
13109067|NCT03240575|25894422|FG002|Overall Study|Withdrawal by Subject|0|||
13109068|NCT03240575|25894423|FG003|Overall Study|Withdrawal by Subject|1|||
13109069|NCT03240575|25894420|FG000|Overall Study|Other|0|||
13109070|NCT03240575|25894421|FG001|Overall Study|Other|1|||
13109071|NCT03240575|25894422|FG002|Overall Study|Other|0|||
13109072|NCT03240575|25894423|FG003|Overall Study|Other|0|||
13109073|NCT03240133|25894457|FG000|Overall Study|Withdrawal by Subject|0|||
13109074|NCT03240133|25894458|FG001|Overall Study|Withdrawal by Subject|1|||
13109075|NCT03240133|25894459|FG002|Overall Study|Withdrawal by Subject|0|||
13109076|NCT03240133|25894457|FG000|Overall Study|Adverse Event|1|||
13177764|NCT03774875|26141154|FG000|Apremilast Extension Period (Week 16-52)|Protocol Deviation|0|||
13177765|NCT03774875|26141155|FG001|Apremilast Extension Period (Week 16-52)|Protocol Deviation|1|||
13177766|NCT03774875|26141154|FG000|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|0|||
13177767|NCT03774875|26141155|FG001|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|3|||
13177768|NCT03597464|26141196|FG000|Overall Study|Withdrawal by Subject|4|||
13177769|NCT03597464|26141197|FG001|Overall Study|Withdrawal by Subject|5|||
13177770|NCT03597464|26141196|FG000|Overall Study|Lost to Follow-up|3|||
13177771|NCT03597464|26141197|FG001|Overall Study|Lost to Follow-up|1|||
13177772|NCT03597464|26141196|FG000|Overall Study|Pregnancy|3|||
13177773|NCT03597464|26141197|FG001|Overall Study|Pregnancy|1|||
13177774|NCT03597464|26141196|FG000|Overall Study|Lack of Efficacy|2|||
13177775|NCT03597464|26141197|FG001|Overall Study|Lack of Efficacy|0|||
13177776|NCT03597464|26141196|FG000|Overall Study|Physician Decision|2|||
13177777|NCT03597464|26141197|FG001|Overall Study|Physician Decision|2|||
13177778|NCT03597464|26141196|FG000|Overall Study|Protocol Violation|1|||
13177779|NCT03597464|26141197|FG001|Overall Study|Protocol Violation|1|||
13177780|NCT03597464|26141196|FG000|Overall Study|Adverse Event|0|||
13177781|NCT03597464|26141197|FG001|Overall Study|Adverse Event|2|||
13177782|NCT03597464|26141196|FG000|Overall Study|Death|0|||
13177783|NCT03597464|26141197|FG001|Overall Study|Death|3|||
13177784|NCT03576131|26141340|FG000|Overall Study|Investigator decision|0|||
13177785|NCT03576131|26141341|FG001|Overall Study|Investigator decision|0|||
13177786|NCT03576131|26141342|FG002|Overall Study|Investigator decision|0|||
13177787|NCT03576131|26141343|FG003|Overall Study|Investigator decision|1|||
13177788|NCT03576131|26141344|FG004|Overall Study|Investigator decision|0|||
13177789|NCT03576131|26141345|FG005|Overall Study|Investigator decision|1|||
13177790|NCT03576131|26141346|FG006|Overall Study|Investigator decision|0|||
13177791|NCT03576131|26141347|FG007|Overall Study|Investigator decision|0|||
13177792|NCT03576131|26141340|FG000|Overall Study|Withdrawal by Subject|1|||
13177793|NCT03576131|26141341|FG001|Overall Study|Withdrawal by Subject|1|||
13177794|NCT03576131|26141342|FG002|Overall Study|Withdrawal by Subject|0|||
13177795|NCT03576131|26141343|FG003|Overall Study|Withdrawal by Subject|1|||
13177796|NCT03576131|26141344|FG004|Overall Study|Withdrawal by Subject|2|||
13177797|NCT03576131|26141345|FG005|Overall Study|Withdrawal by Subject|3|||
13177798|NCT03576131|26141346|FG006|Overall Study|Withdrawal by Subject|1|||
13177799|NCT03576131|26141347|FG007|Overall Study|Withdrawal by Subject|0|||
13177800|NCT03576131|26141340|FG000|Overall Study|Death|3|||
13177801|NCT03576131|26141341|FG001|Overall Study|Death|3|||
13177802|NCT03576131|26141342|FG002|Overall Study|Death|1|||
13177803|NCT03576131|26141343|FG003|Overall Study|Death|5|||
13177804|NCT03576131|26141344|FG004|Overall Study|Death|4|||
13177805|NCT03576131|26141345|FG005|Overall Study|Death|1|||
13177806|NCT03576131|26141346|FG006|Overall Study|Death|0|||
13485536|NCT02906020|27032874|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
13177807|NCT03576131|26141347|FG007|Overall Study|Death|1|||
13177808|NCT03576131|26141340|FG000|Overall Study|New anti-cancer treatment|5|||
13177809|NCT03576131|26141341|FG001|Overall Study|New anti-cancer treatment|1|||
13177810|NCT03576131|26141342|FG002|Overall Study|New anti-cancer treatment|2|||
13177811|NCT03576131|26141343|FG003|Overall Study|New anti-cancer treatment|3|||
13177812|NCT03576131|26141344|FG004|Overall Study|New anti-cancer treatment|0|||
13177813|NCT03576131|26141345|FG005|Overall Study|New anti-cancer treatment|0|||
13177814|NCT03576131|26141346|FG006|Overall Study|New anti-cancer treatment|0|||
13177815|NCT03576131|26141347|FG007|Overall Study|New anti-cancer treatment|0|||
13177816|NCT03576131|26141340|FG000|Overall Study|Unspecified reason|0|||
13177817|NCT03576131|26141341|FG001|Overall Study|Unspecified reason|0|||
13177818|NCT03576131|26141342|FG002|Overall Study|Unspecified reason|1|||
13177819|NCT03576131|26141343|FG003|Overall Study|Unspecified reason|1|||
13177820|NCT03576131|26141344|FG004|Overall Study|Unspecified reason|1|||
13177821|NCT03576131|26141345|FG005|Overall Study|Unspecified reason|1|||
13177822|NCT03576131|26141346|FG006|Overall Study|Unspecified reason|0|||
13177823|NCT03576131|26141347|FG007|Overall Study|Unspecified reason|0|||
13177824|NCT03576131|26141340|FG000|Overall Study|Subject non-compliance|0|||
13177825|NCT03576131|26141341|FG001|Overall Study|Subject non-compliance|0|||
13177826|NCT03576131|26141342|FG002|Overall Study|Subject non-compliance|0|||
13177827|NCT03576131|26141343|FG003|Overall Study|Subject non-compliance|0|||
13177828|NCT03576131|26141344|FG004|Overall Study|Subject non-compliance|0|||
13177829|NCT03576131|26141345|FG005|Overall Study|Subject non-compliance|1|||
13177830|NCT03576131|26141346|FG006|Overall Study|Subject non-compliance|0|||
13177831|NCT03576131|26141347|FG007|Overall Study|Subject non-compliance|0|||
13177832|NCT03544138|26141437|FG000|Overall Study|Lost to Follow-up|29|||
13205786|NCT01962103|26232965|FG002|Phase 1|Withdrawal by Subject|0|||
13205787|NCT01962103|26232966|FG003|Phase 1|Withdrawal by Subject|2|||
13205788|NCT01962103|26232967|FG004|Phase 1|Withdrawal by Subject|0|||
13205789|NCT01962103|26232968|FG005|Phase 1|Withdrawal by Subject|0|||
13205790|NCT01962103|26232969|FG006|Phase 1|Withdrawal by Subject|0|||
13205791|NCT01962103|26232970|FG007|Phase 1|Withdrawal by Subject|0|||
13205792|NCT01962103|26232971|FG008|Phase 1|Withdrawal by Subject|0|||
13205793|NCT01962103|26232963|FG000|Phase 1|Withdrawal by Parent/Guardian|0|||
13205794|NCT01962103|26232964|FG001|Phase 1|Withdrawal by Parent/Guardian|0|||
13205795|NCT01962103|26232965|FG002|Phase 1|Withdrawal by Parent/Guardian|2|||
13205796|NCT01962103|26232966|FG003|Phase 1|Withdrawal by Parent/Guardian|1|||
13205797|NCT01962103|26232967|FG004|Phase 1|Withdrawal by Parent/Guardian|0|||
13205798|NCT01962103|26232968|FG005|Phase 1|Withdrawal by Parent/Guardian|0|||
13205799|NCT01962103|26232969|FG006|Phase 1|Withdrawal by Parent/Guardian|0|||
13205800|NCT01962103|26232970|FG007|Phase 1|Withdrawal by Parent/Guardian|0|||
13205801|NCT01962103|26232971|FG008|Phase 1|Withdrawal by Parent/Guardian|0|||
13205802|NCT01962103|26232963|FG000|Phase 1|Physician Decision|0|||
13205803|NCT01962103|26232964|FG001|Phase 1|Physician Decision|0|||
13205804|NCT01962103|26232965|FG002|Phase 1|Physician Decision|0|||
13205805|NCT01962103|26232966|FG003|Phase 1|Physician Decision|1|||
13205806|NCT01962103|26232967|FG004|Phase 1|Physician Decision|0|||
13205807|NCT01962103|26232968|FG005|Phase 1|Physician Decision|0|||
13205808|NCT01962103|26232969|FG006|Phase 1|Physician Decision|0|||
13109077|NCT03240133|25894458|FG001|Overall Study|Adverse Event|1|||
13109078|NCT03240133|25894459|FG002|Overall Study|Adverse Event|0|||
13109079|NCT03240133|25894457|FG000|Overall Study|Rash|1|||
13109080|NCT03240133|25894458|FG001|Overall Study|Rash|0|||
13109081|NCT03240133|25894459|FG002|Overall Study|Rash|0|||
13109082|NCT03240133|25894457|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1|||
13109083|NCT03240133|25894458|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
13109084|NCT03240133|25894459|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
13109085|NCT03240133|25894457|FG000|Overall Study|Intercurrent illness.|0|||
13109086|NCT03240133|25894458|FG001|Overall Study|Intercurrent illness.|1|||
13109087|NCT03240133|25894459|FG002|Overall Study|Intercurrent illness.|0|||
13205809|NCT01962103|26232970|FG007|Phase 1|Physician Decision|0|||
13205810|NCT01962103|26232971|FG008|Phase 1|Physician Decision|0|||
13205811|NCT01962103|26232963|FG000|Phase 1|Symptomatic Deterioration|3|||
13205812|NCT01962103|26232964|FG001|Phase 1|Symptomatic Deterioration|2|||
13205813|NCT01962103|26232965|FG002|Phase 1|Symptomatic Deterioration|2|||
13205814|NCT01962103|26232966|FG003|Phase 1|Symptomatic Deterioration|2|||
13205815|NCT01962103|26232967|FG004|Phase 1|Symptomatic Deterioration|1|||
13205816|NCT01962103|26232968|FG005|Phase 1|Symptomatic Deterioration|1|||
13205817|NCT01962103|26232969|FG006|Phase 1|Symptomatic Deterioration|0|||
13205818|NCT01962103|26232970|FG007|Phase 1|Symptomatic Deterioration|0|||
13205819|NCT01962103|26232971|FG008|Phase 1|Symptomatic Deterioration|0|||
13205820|NCT01962103|26232963|FG000|Phase 1|Miscellaneous|1|||
13205821|NCT01962103|26232964|FG001|Phase 1|Miscellaneous|0|||
13205822|NCT01962103|26232965|FG002|Phase 1|Miscellaneous|0|||
13205823|NCT01962103|26232966|FG003|Phase 1|Miscellaneous|0|||
13205824|NCT01962103|26232967|FG004|Phase 1|Miscellaneous|0|||
13205825|NCT01962103|26232968|FG005|Phase 1|Miscellaneous|0|||
13205826|NCT01962103|26232969|FG006|Phase 1|Miscellaneous|0|||
13205827|NCT01962103|26232970|FG007|Phase 1|Miscellaneous|0|||
13205828|NCT01962103|26232971|FG008|Phase 1|Miscellaneous|0|||
13177833|NCT03496662|26141509|FG000|Overall Study|Adverse Event|1|||
13177834|NCT03496662|26141510|FG001|Overall Study|Adverse Event|0|||
13177835|NCT03496662|26141511|FG002|Overall Study|Adverse Event|1|||
13177836|NCT03496662|26141509|FG000|Overall Study|Physician Decision|1|||
13177837|NCT03496662|26141510|FG001|Overall Study|Physician Decision|0|||
13177838|NCT03496662|26141511|FG002|Overall Study|Physician Decision|3|||
13177839|NCT03496662|26141509|FG000|Overall Study|Withdrawal by Subject|0|||
13177840|NCT03496662|26141510|FG001|Overall Study|Withdrawal by Subject|0|||
13177841|NCT03496662|26141511|FG002|Overall Study|Withdrawal by Subject|2|||
13177842|NCT03496662|26141509|FG000|Overall Study|Death|0|||
13177843|NCT03496662|26141510|FG001|Overall Study|Death|0|||
13177844|NCT03496662|26141511|FG002|Overall Study|Death|2|||
13177845|NCT03496662|26141509|FG000|Overall Study|Noncompliance|0|||
13177846|NCT03496662|26141510|FG001|Overall Study|Noncompliance|0|||
13177847|NCT03496662|26141511|FG002|Overall Study|Noncompliance|1|||
13177848|NCT03432260|26141564|FG000|Overall Study|Lost to Follow-up|1|||
13177849|NCT03432260|26141565|FG001|Overall Study|Lost to Follow-up|1|||
13177850|NCT03432260|26141566|FG002|Overall Study|Lost to Follow-up|0|||
13177851|NCT03432260|26141567|FG003|Overall Study|Lost to Follow-up|0|||
13177852|NCT03432260|26141568|FG004|Overall Study|Lost to Follow-up|1|||
13177853|NCT03347188|26141609|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
13177854|NCT03347188|26141610|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
13177855|NCT03347188|26141609|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
13109088|NCT03240133|25894457|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
13177856|NCT03347188|26141610|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8|||
13177857|NCT03347188|26141609|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7|||
13177858|NCT03347188|26141610|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
13109089|NCT03240133|25894458|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
13109090|NCT03240133|25894459|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1|||
13109091|NCT03240081|25894474|FG000|Overall Study|Withdrawal by Subject|0|||
13109092|NCT03240081|25894475|FG001|Overall Study|Withdrawal by Subject|2|||
13109093|NCT03240081|25894474|FG000|Overall Study|Lost to Follow-up|0|||
13109094|NCT03240081|25894475|FG001|Overall Study|Lost to Follow-up|1|||
13109095|NCT03239873|25894526|FG000|Overall Study|Lost to Follow-up|15|||
13109096|NCT03239873|25894527|FG001|Overall Study|Lost to Follow-up|16|||
13109097|NCT03239873|25894526|FG000|Overall Study|Physician Decision|1|||
13109098|NCT03239873|25894527|FG001|Overall Study|Physician Decision|0|||
13109099|NCT03239873|25894526|FG000|Overall Study|Withdrawal by Parent/Guardian|12|||
13109100|NCT03239873|25894527|FG001|Overall Study|Withdrawal by Parent/Guardian|11|||
13109101|NCT03239873|25894526|FG000|Overall Study|Withdrawal by Subject|2|||
13109102|NCT03239873|25894527|FG001|Overall Study|Withdrawal by Subject|0|||
13109103|NCT03239873|25894526|FG000|Overall Study|Contraindication to study medication|1|||
13109104|NCT03239873|25894527|FG001|Overall Study|Contraindication to study medication|0|||
13109105|NCT03239873|25894526|FG000|Overall Study|Protocol Violation|1|||
13109106|NCT03239873|25894527|FG001|Overall Study|Protocol Violation|0|||
13109107|NCT03239483|25894548|FG000|Overall Study|Lost to Follow-up|1|||
13109108|NCT03239483|25894549|FG001|Overall Study|Lost to Follow-up|0|||
13109109|NCT03239483|25894548|FG000|Overall Study|Withdrawal by Subject|1|||
13109110|NCT03239483|25894549|FG001|Overall Study|Withdrawal by Subject|0|||
13109111|NCT03239470|25894556|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1|||
13109112|NCT03239470|25894557|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0|||
13109113|NCT03238963|25894574|FG000|Overall Study|Prohibited medication given due to hospital stay|1|||
13109114|NCT03238963|25894575|FG001|Overall Study|Prohibited medication given due to hospital stay|0|||
13109115|NCT03238963|25894574|FG000|Overall Study|Withdrawal by Subject|1|||
13109116|NCT03238963|25894575|FG001|Overall Study|Withdrawal by Subject|1|||
13109117|NCT03238963|25894574|FG000|Overall Study|Lost to Follow-up|1|||
13109118|NCT03238963|25894575|FG001|Overall Study|Lost to Follow-up|0|||
13109119|NCT03238963|25894574|FG000|Overall Study|Protocol Violation|1|||
13109120|NCT03238963|25894575|FG001|Overall Study|Protocol Violation|1|||
13109121|NCT03238963|25894574|FG000|Overall Study|Adverse Event|1|||
13109122|NCT03238963|25894575|FG001|Overall Study|Adverse Event|0|||
13109123|NCT03238924|25894592|FG000|Overall Study|Withdrawal by Subject|2|||
13109124|NCT03238924|25894593|FG001|Overall Study|Withdrawal by Subject|2|||
13109125|NCT03238911|25894640|FG000|Overall Study|Withdrawal by Subject|1|||
13109126|NCT03238911|25894641|FG001|Overall Study|Withdrawal by Subject|2|||
13177859|NCT03347188|26141609|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
13177860|NCT03347188|26141610|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
13177861|NCT03347188|26141609|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1|||
13177862|NCT03347188|26141610|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2|||
13177863|NCT03347188|26141609|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26|||
13177864|NCT03347188|26141610|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28|||
13177865|NCT03347188|26141609|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1|||
13177866|NCT03347188|26141610|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0|||
13177867|NCT03347188|26141609|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0|||
13177868|NCT03347188|26141610|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1|||
13177869|NCT03213691|26141618|FG000|Overall Study|Adverse Event|2|||
13177870|NCT03213691|26141618|FG000|Overall Study|Death|3|||
13177871|NCT03213691|26141618|FG000|Overall Study|Physician Decision|1|||
13177872|NCT03213691|26141618|FG000|Overall Study|Progressive Disease|14|||
13177873|NCT03213691|26141618|FG000|Overall Study|Ineligible|1|||
13177874|NCT03172494|26141809|FG000|Overall Study|Adverse Event|5|||
13177875|NCT03172494|26141810|FG001|Overall Study|Adverse Event|1|||
13177876|NCT03172494|26141811|FG002|Overall Study|Adverse Event|15|||
13177877|NCT03172494|26141809|FG000|Overall Study|Protocol Violation|3|||
13177878|NCT03172494|26141810|FG001|Overall Study|Protocol Violation|2|||
13177879|NCT03172494|26141811|FG002|Overall Study|Protocol Violation|1|||
13177880|NCT03172494|26141809|FG000|Overall Study|Lack of Efficacy|0|||
13177881|NCT03172494|26141810|FG001|Overall Study|Lack of Efficacy|0|||
13177882|NCT03172494|26141811|FG002|Overall Study|Lack of Efficacy|4|||
13177883|NCT03172494|26141809|FG000|Overall Study|Pregnancy|0|||
13177884|NCT03172494|26141810|FG001|Overall Study|Pregnancy|1|||
13177885|NCT03172494|26141811|FG002|Overall Study|Pregnancy|0|||
13177886|NCT03172494|26141809|FG000|Overall Study|Withdrawal by Subject|10|||
13177887|NCT03172494|26141810|FG001|Overall Study|Withdrawal by Subject|8|||
13177888|NCT03172494|26141811|FG002|Overall Study|Withdrawal by Subject|8|||
13177889|NCT03172494|26141809|FG000|Overall Study|Severe hypoglycaemic episode|0|||
13177890|NCT03172494|26141810|FG001|Overall Study|Severe hypoglycaemic episode|0|||
13177891|NCT03172494|26141811|FG002|Overall Study|Severe hypoglycaemic episode|1|||
13177892|NCT03172494|26141809|FG000|Overall Study|Non-compliance towards treatment|2|||
13177893|NCT03172494|26141810|FG001|Overall Study|Non-compliance towards treatment|0|||
13109127|NCT03238911|25894640|FG000|Overall Study|Lost to Follow-up|2|||
13109128|NCT03238911|25894641|FG001|Overall Study|Lost to Follow-up|1|||
13109129|NCT03238781|25894698|FG000|Overall Study|Adverse Event|1|||
13109130|NCT03238781|25894699|FG001|Overall Study|Adverse Event|1|||
13177894|NCT03172494|26141811|FG002|Overall Study|Non-compliance towards treatment|0|||
13177895|NCT03052725|26141898|FG000|Overall Study|Adverse Event|2|||
13177896|NCT03052725|26141899|FG001|Overall Study|Adverse Event|0|||
13177897|NCT03052725|26141898|FG000|Overall Study|Withdrawal by Subject|3|||
13177898|NCT03052725|26141899|FG001|Overall Study|Withdrawal by Subject|4|||
13177899|NCT03052725|26141898|FG000|Overall Study|Pregnancy|0|||
13177900|NCT03052725|26141899|FG001|Overall Study|Pregnancy|1|||
13177901|NCT03052725|26141898|FG000|Overall Study|Site closure|0|||
13177902|NCT03052725|26141899|FG001|Overall Study|Site closure|1|||
13177903|NCT03052725|26141898|FG000|Overall Study|Study terminated by sponsor|143|||
13177904|NCT03052725|26141899|FG001|Overall Study|Study terminated by sponsor|144|||
13177905|NCT03042468|26141975|FG000|Overall Study|Death|0|||
13177906|NCT03042468|26141976|FG001|Overall Study|Death|1|||
13177907|NCT03042468|26141977|FG002|Overall Study|Death|1|||
13177908|NCT03042468|26141978|FG003|Overall Study|Death|0|||
13177909|NCT03042468|26141979|FG004|Overall Study|Death|0|||
13177910|NCT03042468|26141980|FG005|Overall Study|Death|0|||
13177911|NCT03042468|26141975|FG000|Overall Study|Withdrawal by Subject|0|||
13177912|NCT03042468|26141976|FG001|Overall Study|Withdrawal by Subject|0|||
13177913|NCT03042468|26141977|FG002|Overall Study|Withdrawal by Subject|0|||
13177914|NCT03042468|26141978|FG003|Overall Study|Withdrawal by Subject|0|||
13109131|NCT03238781|25894700|FG002|Overall Study|Adverse Event|2|||
13109132|NCT03238781|25894698|FG000|Overall Study|Lost to Follow-up|2|||
13177915|NCT03042468|26141979|FG004|Overall Study|Withdrawal by Subject|0|||
13177916|NCT03042468|26141980|FG005|Overall Study|Withdrawal by Subject|1|||
13177917|NCT03042468|26141975|FG000|Overall Study|Lost to Follow-up|0|||
13177918|NCT03042468|26141976|FG001|Overall Study|Lost to Follow-up|0|||
13177919|NCT03042468|26141977|FG002|Overall Study|Lost to Follow-up|0|||
13177920|NCT03042468|26141978|FG003|Overall Study|Lost to Follow-up|0|||
13177921|NCT03042468|26141979|FG004|Overall Study|Lost to Follow-up|1|||
13177922|NCT03042468|26141980|FG005|Overall Study|Lost to Follow-up|1|||
13205829|NCT01962103|26232963|FG000|Phase 2|Adverse Event|0|||
13205830|NCT01962103|26232964|FG001|Phase 2|Adverse Event|0|||
13109133|NCT03238781|25894699|FG001|Overall Study|Lost to Follow-up|1|||
13109134|NCT03238781|25894700|FG002|Overall Study|Lost to Follow-up|2|||
13109135|NCT03238781|25894698|FG000|Overall Study|Withdrawal by Subject|23|||
13205831|NCT01962103|26232965|FG002|Phase 2|Adverse Event|0|||
13205832|NCT01962103|26232966|FG003|Phase 2|Adverse Event|0|||
13205833|NCT01962103|26232967|FG004|Phase 2|Adverse Event|0|||
13205834|NCT01962103|26232968|FG005|Phase 2|Adverse Event|0|||
13205835|NCT01962103|26232969|FG006|Phase 2|Adverse Event|1|||
13205836|NCT01962103|26232970|FG007|Phase 2|Adverse Event|0|||
13205837|NCT01962103|26232971|FG008|Phase 2|Adverse Event|3|||
13205838|NCT01962103|26232963|FG000|Phase 2|Progressive Disease|0|||
13205839|NCT01962103|26232964|FG001|Phase 2|Progressive Disease|0|||
13205840|NCT01962103|26232965|FG002|Phase 2|Progressive Disease|0|||
13205841|NCT01962103|26232966|FG003|Phase 2|Progressive Disease|0|||
13205842|NCT01962103|26232967|FG004|Phase 2|Progressive Disease|0|||
13177923|NCT02775435|26142064|FG000|Overall Study|Adverse Event|48|||
13177924|NCT02775435|26142065|FG001|Overall Study|Adverse Event|25|||
13177925|NCT02775435|26142064|FG000|Overall Study|Lost to Follow-up|0|||
13177926|NCT02775435|26142065|FG001|Overall Study|Lost to Follow-up|2|||
13177927|NCT02775435|26142064|FG000|Overall Study|Physician Decision|5|||
13177928|NCT02775435|26142065|FG001|Overall Study|Physician Decision|6|||
13177929|NCT02775435|26142064|FG000|Overall Study|Withdrawal by Subject|5|||
13177930|NCT02775435|26142065|FG001|Overall Study|Withdrawal by Subject|9|||
13177931|NCT02775435|26142064|FG000|Overall Study|Progressive Disease|86|||
13177932|NCT02775435|26142065|FG001|Overall Study|Progressive Disease|140|||
13177933|NCT02775435|26142064|FG000|Overall Study|Clinical Progression|13|||
13177934|NCT02775435|26142065|FG001|Overall Study|Clinical Progression|26|||
13177935|NCT02775435|26142064|FG000|Overall Study|Ongoing in Study|121|||
13177936|NCT02775435|26142065|FG001|Overall Study|Ongoing in Study|72|||
13109136|NCT03238781|25894699|FG001|Overall Study|Withdrawal by Subject|14|||
13109137|NCT03238781|25894700|FG002|Overall Study|Withdrawal by Subject|16|||
13109138|NCT03238781|25894698|FG000|Overall Study|Decision by sponsor|0|||
13109139|NCT03238781|25894699|FG001|Overall Study|Decision by sponsor|1|||
13109140|NCT03238781|25894700|FG002|Overall Study|Decision by sponsor|0|||
13109141|NCT03238651|25894783|FG000|Overall Study|Other|0|||
13109142|NCT03238651|25894784|FG001|Overall Study|Other|0|||
13109143|NCT03238651|25894785|FG002|Overall Study|Other|0|||
13109144|NCT03238651|25894786|FG003|Overall Study|Other|0|||
13109145|NCT03238651|25894787|FG004|Overall Study|Other|1|||
13109146|NCT03238651|25894783|FG000|Overall Study|Progressive Disease|2|||
13109147|NCT03238651|25894784|FG001|Overall Study|Progressive Disease|2|||
13177937|NCT02775435|26142064|FG000|Overall Study|Not Treated|0|||
13177938|NCT02775435|26142065|FG001|Overall Study|Not Treated|1|||
13177939|NCT02728102|26142139|FG000|Overall Study|Death|3|||
13177940|NCT02728102|26142140|FG001|Overall Study|Death|0|||
13177941|NCT02728102|26142141|FG002|Overall Study|Death|1|||
13177942|NCT02728102|26142139|FG000|Overall Study|Withdrawal by Subject|0|||
13177943|NCT02728102|26142140|FG001|Overall Study|Withdrawal by Subject|2|||
13177944|NCT02728102|26142141|FG002|Overall Study|Withdrawal by Subject|3|||
13177945|NCT02728102|26142139|FG000|Overall Study|Physician Decision|1|||
13177946|NCT02728102|26142140|FG001|Overall Study|Physician Decision|1|||
13177947|NCT02728102|26142141|FG002|Overall Study|Physician Decision|0|||
13177948|NCT02728102|26142139|FG000|Overall Study|Investigational study drug permanently discontinued|3|||
13177949|NCT02728102|26142140|FG001|Overall Study|Investigational study drug permanently discontinued|1|||
13177950|NCT02728102|26142141|FG002|Overall Study|Investigational study drug permanently discontinued|0|||
13177951|NCT02728102|26142139|FG000|Overall Study|Covid|0|||
13177952|NCT02728102|26142140|FG001|Overall Study|Covid|0|||
13177953|NCT02728102|26142141|FG002|Overall Study|Covid|1|||
13177954|NCT02706730|26142147|FG000|Overall Study|Adverse Event|3|||
13177955|NCT02706730|26142147|FG000|Overall Study|Lack of Efficacy|5|||
13177956|NCT02706730|26142147|FG000|Overall Study|Withdrawal by Subject|11|||
13177957|NCT02706730|26142147|FG000|Overall Study|Study Terminated by Sponsor|11|||
13177958|NCT02706730|26142147|FG000|Overall Study|Subject chose not to receive injection|3|||
13177959|NCT02488759|26142219|FG000|Overall Study|Disease progression|74|||
13177960|NCT02488759|26142220|FG001|Overall Study|Disease progression|110|||
13177961|NCT02488759|26142221|FG002|Overall Study|Disease progression|62|||
13177962|NCT02488759|26142222|FG003|Overall Study|Disease progression|7|||
13177963|NCT02488759|26142223|FG004|Overall Study|Disease progression|4|||
13177964|NCT02488759|26142224|FG005|Overall Study|Disease progression|2|||
13177965|NCT02488759|26142219|FG000|Overall Study|Study drug toxicity|11|||
13177966|NCT02488759|26142220|FG001|Overall Study|Study drug toxicity|33|||
13177967|NCT02488759|26142221|FG002|Overall Study|Study drug toxicity|31|||
13177968|NCT02488759|26142222|FG003|Overall Study|Study drug toxicity|0|||
13177969|NCT02488759|26142223|FG004|Overall Study|Study drug toxicity|0|||
13177970|NCT02488759|26142224|FG005|Overall Study|Study drug toxicity|2|||
13177971|NCT02488759|26142219|FG000|Overall Study|Adverse event unrelated to study drug|9|||
13177972|NCT02488759|26142220|FG001|Overall Study|Adverse event unrelated to study drug|11|||
13177973|NCT02488759|26142221|FG002|Overall Study|Adverse event unrelated to study drug|7|||
13177974|NCT02488759|26142222|FG003|Overall Study|Adverse event unrelated to study drug|0|||
13177975|NCT02488759|26142223|FG004|Overall Study|Adverse event unrelated to study drug|1|||
13177976|NCT02488759|26142224|FG005|Overall Study|Adverse event unrelated to study drug|0|||
13177977|NCT02488759|26142219|FG000|Overall Study|Participant request to discontinue study treatment|7|||
13177978|NCT02488759|26142220|FG001|Overall Study|Participant request to discontinue study treatment|8|||
13177979|NCT02488759|26142221|FG002|Overall Study|Participant request to discontinue study treatment|4|||
13177980|NCT02488759|26142222|FG003|Overall Study|Participant request to discontinue study treatment|0|||
13177981|NCT02488759|26142223|FG004|Overall Study|Participant request to discontinue study treatment|0|||
13177982|NCT02488759|26142224|FG005|Overall Study|Participant request to discontinue study treatment|0|||
13177983|NCT02488759|26142219|FG000|Overall Study|Withdrawal by Subject|2|||
13177984|NCT02488759|26142220|FG001|Overall Study|Withdrawal by Subject|0|||
13177985|NCT02488759|26142221|FG002|Overall Study|Withdrawal by Subject|3|||
13109148|NCT03238651|25894785|FG002|Overall Study|Progressive Disease|2|||
13177986|NCT02488759|26142222|FG003|Overall Study|Withdrawal by Subject|0|||
13177987|NCT02488759|26142223|FG004|Overall Study|Withdrawal by Subject|0|||
13177988|NCT02488759|26142224|FG005|Overall Study|Withdrawal by Subject|2|||
13177989|NCT02488759|26142219|FG000|Overall Study|Lost to Follow-up|0|||
13177990|NCT02488759|26142220|FG001|Overall Study|Lost to Follow-up|1|||
13177991|NCT02488759|26142221|FG002|Overall Study|Lost to Follow-up|2|||
13177992|NCT02488759|26142222|FG003|Overall Study|Lost to Follow-up|0|||
13177993|NCT02488759|26142223|FG004|Overall Study|Lost to Follow-up|0|||
13109149|NCT03238651|25894786|FG003|Overall Study|Progressive Disease|2|||
13109150|NCT03238651|25894787|FG004|Overall Study|Progressive Disease|0|||
13109151|NCT03238651|25894783|FG000|Overall Study|Withdrawal by Subject|0|||
13109152|NCT03238651|25894784|FG001|Overall Study|Withdrawal by Subject|1|||
13109153|NCT03238651|25894785|FG002|Overall Study|Withdrawal by Subject|0|||
13109154|NCT03238651|25894786|FG003|Overall Study|Withdrawal by Subject|1|||
13109155|NCT03238651|25894787|FG004|Overall Study|Withdrawal by Subject|0|||
13109156|NCT03238651|25894783|FG000|Overall Study|Adverse Event|1|||
13109157|NCT03238651|25894784|FG001|Overall Study|Adverse Event|3|||
13109158|NCT03238651|25894785|FG002|Overall Study|Adverse Event|2|||
13109159|NCT03238651|25894786|FG003|Overall Study|Adverse Event|0|||
13109160|NCT03238651|25894787|FG004|Overall Study|Adverse Event|0|||
13109161|NCT03238417|25894834|FG000|Overall|non-response|955|||
13109162|NCT03238417|25894835|FG001|Overall|non-response|1920|||
13109163|NCT03238417|25894834|FG000|Overall|partial completion|48|||
13177994|NCT02488759|26142224|FG005|Overall Study|Lost to Follow-up|0|||
13177995|NCT02488759|26142219|FG000|Overall Study|Maximum clinical benefit|3|||
13109164|NCT03238417|25894835|FG001|Overall|partial completion|68|||
13109165|NCT03238417|25894834|FG000|Baseline|Partial completion|17|||
13109166|NCT03238417|25894835|FG001|Baseline|Partial completion|48|||
13109167|NCT03238417|25894834|FG000|Baseline|non-response|372|||
13109168|NCT03238417|25894835|FG001|Baseline|non-response|669|||
13109169|NCT03238417|25894834|FG000|12-month|non-response|296|||
13109170|NCT03238417|25894835|FG001|12-month|non-response|669|||
13109171|NCT03238417|25894834|FG000|12-month|partial completion|23|||
13109172|NCT03238417|25894835|FG001|12-month|partial completion|37|||
13109173|NCT03238417|25894834|FG000|24-month|non-response|287|||
13109174|NCT03238417|25894835|FG001|24-month|non-response|594|||
13109175|NCT03238417|25894834|FG000|24-month|partial completion|8|||
13109176|NCT03238417|25894835|FG001|24-month|partial completion|31|||
13109177|NCT03238352|25894856|FG000|Overall Study|Lost to Follow-up|0|||
13109178|NCT03238352|25894857|FG001|Overall Study|Lost to Follow-up|2|||
13177996|NCT02488759|26142220|FG001|Overall Study|Maximum clinical benefit|0|||
13177997|NCT02488759|26142221|FG002|Overall Study|Maximum clinical benefit|1|||
13177998|NCT02488759|26142222|FG003|Overall Study|Maximum clinical benefit|0|||
13177999|NCT02488759|26142223|FG004|Overall Study|Maximum clinical benefit|0|||
13178000|NCT02488759|26142224|FG005|Overall Study|Maximum clinical benefit|0|||
13178001|NCT02488759|26142219|FG000|Overall Study|Completed treatment|0|||
13178002|NCT02488759|26142220|FG001|Overall Study|Completed treatment|0|||
13178003|NCT02488759|26142221|FG002|Overall Study|Completed treatment|0|||
13178004|NCT02488759|26142222|FG003|Overall Study|Completed treatment|0|||
13178005|NCT02488759|26142223|FG004|Overall Study|Completed treatment|0|||
13178006|NCT02488759|26142224|FG005|Overall Study|Completed treatment|116|||
13178007|NCT02488759|26142219|FG000|Overall Study|Other reasons|5|||
13178008|NCT02488759|26142220|FG001|Overall Study|Other reasons|32|||
13178009|NCT02488759|26142221|FG002|Overall Study|Other reasons|21|||
13178010|NCT02488759|26142222|FG003|Overall Study|Other reasons|1|||
13178011|NCT02488759|26142223|FG004|Overall Study|Other reasons|1|||
13178012|NCT02488759|26142224|FG005|Overall Study|Other reasons|1|||
13178013|NCT02412306|26142300|FG000|Overall Study|Lost to Follow-up|0|||
13178014|NCT02412306|26142301|FG001|Overall Study|Lost to Follow-up|1|||
13178015|NCT02412306|26142302|FG002|Overall Study|Lost to Follow-up|0|||
13178016|NCT02412306|26142303|FG003|Overall Study|Lost to Follow-up|0|||
13178017|NCT02412306|26142304|FG004|Overall Study|Lost to Follow-up|0|||
13178018|NCT02412306|26142300|FG000|Overall Study|Withdrawal by Subject|0|||
13178019|NCT02412306|26142301|FG001|Overall Study|Withdrawal by Subject|0|||
13178020|NCT02412306|26142302|FG002|Overall Study|Withdrawal by Subject|1|||
13178021|NCT02412306|26142303|FG003|Overall Study|Withdrawal by Subject|0|||
13178022|NCT02412306|26142304|FG004|Overall Study|Withdrawal by Subject|0|||
13178023|NCT02412306|26142300|FG000|Overall Study|Death|5|||
13178024|NCT02412306|26142301|FG001|Overall Study|Death|7|||
13178025|NCT02412306|26142302|FG002|Overall Study|Death|15|||
13178026|NCT02412306|26142303|FG003|Overall Study|Death|0|||
13178027|NCT02412306|26142304|FG004|Overall Study|Death|2|||
13178028|NCT02049866|26142375|FG000|Overall Study|Withdrawal by Subject|1|||
13205843|NCT01962103|26232968|FG005|Phase 2|Progressive Disease|0|||
13205844|NCT01962103|26232969|FG006|Phase 2|Progressive Disease|11|||
13205845|NCT01962103|26232970|FG007|Phase 2|Progressive Disease|12|||
13205846|NCT01962103|26232971|FG008|Phase 2|Progressive Disease|11|||
13205847|NCT01962103|26232963|FG000|Phase 2|Symptomatic Deterioration|0|||
13205848|NCT01962103|26232964|FG001|Phase 2|Symptomatic Deterioration|0|||
13109179|NCT03238352|25894858|FG002|Overall Study|Lost to Follow-up|1|||
13205849|NCT01962103|26232965|FG002|Phase 2|Symptomatic Deterioration|0|||
13178029|NCT01942135|26142426|FG000|Overall Study|Adverse Event|9|||
13178030|NCT01942135|26142427|FG001|Overall Study|Adverse Event|3|||
13178031|NCT01942135|26142426|FG000|Overall Study|Global deterioration of health status|8|||
13178032|NCT01942135|26142427|FG001|Overall Study|Global deterioration of health status|3|||
13178033|NCT01942135|26142426|FG000|Overall Study|Randomized Not Treated|2|||
13178034|NCT01942135|26142427|FG001|Overall Study|Randomized Not Treated|2|||
13178035|NCT01942135|26142426|FG000|Overall Study|Death|0|||
13178036|NCT01942135|26142427|FG001|Overall Study|Death|1|||
13178037|NCT01942135|26142426|FG000|Overall Study|ObjectiveProgression+Progressive Disease|85|||
13178038|NCT01942135|26142427|FG001|Overall Study|ObjectiveProgression+Progressive Disease|87|||
13178039|NCT01942135|26142426|FG000|Overall Study|Participant Refused toContinue Treatment|1|||
13178040|NCT01942135|26142427|FG001|Overall Study|Participant Refused toContinue Treatment|1|||
13178041|NCT01942135|26142426|FG000|Overall Study|Withdrawal by Subject|4|||
13178042|NCT01942135|26142427|FG001|Overall Study|Withdrawal by Subject|2|||
13178043|NCT01942135|26142426|FG000|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|238|||
13178044|NCT01942135|26142427|FG001|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|75|||
13178045|NCT01575834|26142522|FG000|Overall Study|Withdrawal by Subject|352|||
13178046|NCT01575834|26142523|FG001|Overall Study|Withdrawal by Subject|390|||
13178047|NCT01575834|26142522|FG000|Overall Study|Death|81|||
13178048|NCT01575834|26142523|FG001|Overall Study|Death|74|||
13178049|NCT01575834|26142522|FG000|Overall Study|Other|70|||
13178050|NCT01575834|26142523|FG001|Overall Study|Other|70|||
13178051|NCT01575834|26142522|FG000|Overall Study|Adverse Event|63|||
13178052|NCT01575834|26142523|FG001|Overall Study|Adverse Event|61|||
13178053|NCT01575834|26142522|FG000|Overall Study|Lost to Follow-up|55|||
13178054|NCT01575834|26142523|FG001|Overall Study|Lost to Follow-up|68|||
13178055|NCT01575834|26142522|FG000|Overall Study|Noncompliance|52|||
13178056|NCT01575834|26142523|FG001|Overall Study|Noncompliance|27|||
13178057|NCT01575834|26142522|FG000|Overall Study|Administrative decision|15|||
13178058|NCT01575834|26142523|FG001|Overall Study|Administrative decision|33|||
13178059|NCT01575834|26142522|FG000|Overall Study|Ineligibility Determined|5|||
13178060|NCT01575834|26142523|FG001|Overall Study|Ineligibility Determined|8|||
13178061|NCT01575834|26142522|FG000|Overall Study|Protocol Deviation|4|||
13178062|NCT01575834|26142523|FG001|Overall Study|Protocol Deviation|3|||
13178063|NCT01575834|26142522|FG000|Overall Study|Requirement for Alternative Therapy|2|||
13178064|NCT01575834|26142523|FG001|Overall Study|Requirement for Alternative Therapy|4|||
13178065|NCT01269463|26142580|FG000|First Intervention|Withdrawal by Subject|1|||
13178066|NCT01269463|26142581|FG001|First Intervention|Withdrawal by Subject|0|||
13178067|NCT01269463|26142580|FG000|First Intervention|Adverse Event|1|||
13178068|NCT01269463|26142581|FG001|First Intervention|Adverse Event|0|||
13178069|NCT01269463|26142580|FG000|First Intervention|Lack of Efficacy|0|||
13178070|NCT01269463|26142581|FG001|First Intervention|Lack of Efficacy|1|||
13178071|NCT01269463|26142580|FG000|First Intervention|Physician Decision|0|||
13178072|NCT01269463|26142581|FG001|First Intervention|Physician Decision|1|||
13178073|NCT01177397|26142754|FG000|Overall Study|Protocol Violation|0|||
13178074|NCT01177397|26142755|FG001|Overall Study|Protocol Violation|0|||
13178075|NCT01177397|26142756|FG002|Overall Study|Protocol Violation|0|||
13178076|NCT01177397|26142757|FG003|Overall Study|Protocol Violation|0|||
13178077|NCT01177397|26142758|FG004|Overall Study|Protocol Violation|0|||
13178078|NCT01177397|26142759|FG005|Overall Study|Protocol Violation|1|||
13178079|NCT01177397|26142760|FG006|Overall Study|Protocol Violation|0|||
13178080|NCT01177397|26142761|FG007|Overall Study|Protocol Violation|0|||
13178081|NCT01177397|26142762|FG008|Overall Study|Protocol Violation|0|||
13178082|NCT01177397|26142763|FG009|Overall Study|Protocol Violation|0|||
13178083|NCT01177397|26142764|FG010|Overall Study|Protocol Violation|0|||
13178084|NCT01177397|26142765|FG011|Overall Study|Protocol Violation|0|||
13178085|NCT01177397|26142754|FG000|Overall Study|Lost to Follow-up|0|||
13178086|NCT01177397|26142755|FG001|Overall Study|Lost to Follow-up|0|||
13178087|NCT01177397|26142756|FG002|Overall Study|Lost to Follow-up|0|||
13178088|NCT01177397|26142757|FG003|Overall Study|Lost to Follow-up|0|||
13178089|NCT01177397|26142758|FG004|Overall Study|Lost to Follow-up|1|||
13178090|NCT01177397|26142759|FG005|Overall Study|Lost to Follow-up|0|||
13178091|NCT01177397|26142760|FG006|Overall Study|Lost to Follow-up|0|||
13178092|NCT01177397|26142761|FG007|Overall Study|Lost to Follow-up|2|||
13178093|NCT01177397|26142762|FG008|Overall Study|Lost to Follow-up|0|||
13178094|NCT01177397|26142763|FG009|Overall Study|Lost to Follow-up|0|||
13178095|NCT01177397|26142764|FG010|Overall Study|Lost to Follow-up|0|||
13178096|NCT01177397|26142765|FG011|Overall Study|Lost to Follow-up|0|||
13178097|NCT01177397|26142754|FG000|Overall Study|Death|0|||
13178098|NCT01177397|26142755|FG001|Overall Study|Death|0|||
13178099|NCT01177397|26142756|FG002|Overall Study|Death|1|||
13178100|NCT01177397|26142757|FG003|Overall Study|Death|1|||
13178101|NCT01177397|26142758|FG004|Overall Study|Death|0|||
13178102|NCT01177397|26142759|FG005|Overall Study|Death|0|||
13178103|NCT01177397|26142760|FG006|Overall Study|Death|0|||
13178104|NCT01177397|26142761|FG007|Overall Study|Death|5|||
13178105|NCT01177397|26142762|FG008|Overall Study|Death|2|||
13178106|NCT01177397|26142763|FG009|Overall Study|Death|1|||
13178107|NCT01177397|26142764|FG010|Overall Study|Death|0|||
13178108|NCT01177397|26142765|FG011|Overall Study|Death|0|||
13178109|NCT01177397|26142754|FG000|Overall Study|Withdrawal by Subject|0|||
13178110|NCT01177397|26142755|FG001|Overall Study|Withdrawal by Subject|0|||
13178111|NCT01177397|26142756|FG002|Overall Study|Withdrawal by Subject|1|||
13178112|NCT01177397|26142757|FG003|Overall Study|Withdrawal by Subject|1|||
13178113|NCT01177397|26142758|FG004|Overall Study|Withdrawal by Subject|1|||
13178114|NCT01177397|26142759|FG005|Overall Study|Withdrawal by Subject|2|||
13178115|NCT01177397|26142760|FG006|Overall Study|Withdrawal by Subject|0|||
13178116|NCT01177397|26142761|FG007|Overall Study|Withdrawal by Subject|5|||
13178117|NCT01177397|26142762|FG008|Overall Study|Withdrawal by Subject|9|||
13178118|NCT01177397|26142763|FG009|Overall Study|Withdrawal by Subject|1|||
13178119|NCT01177397|26142764|FG010|Overall Study|Withdrawal by Subject|1|||
13178120|NCT01177397|26142765|FG011|Overall Study|Withdrawal by Subject|0|||
13178121|NCT01177397|26142754|FG000|Overall Study|Adverse Event|0|||
13178122|NCT01177397|26142755|FG001|Overall Study|Adverse Event|0|||
13178123|NCT01177397|26142756|FG002|Overall Study|Adverse Event|1|||
13178124|NCT01177397|26142757|FG003|Overall Study|Adverse Event|2|||
13178125|NCT01177397|26142758|FG004|Overall Study|Adverse Event|0|||
13178126|NCT01177397|26142759|FG005|Overall Study|Adverse Event|12|||
13178127|NCT01177397|26142760|FG006|Overall Study|Adverse Event|1|||
13178128|NCT01177397|26142761|FG007|Overall Study|Adverse Event|14|||
13178129|NCT01177397|26142762|FG008|Overall Study|Adverse Event|8|||
13178130|NCT01177397|26142763|FG009|Overall Study|Adverse Event|6|||
13178131|NCT01177397|26142764|FG010|Overall Study|Adverse Event|3|||
13178132|NCT01177397|26142765|FG011|Overall Study|Adverse Event|7|||
13178133|NCT01177397|26142754|FG000|Overall Study|Disease progression|1|||
13178134|NCT01177397|26142755|FG001|Overall Study|Disease progression|2|||
13178135|NCT01177397|26142756|FG002|Overall Study|Disease progression|5|||
13178136|NCT01177397|26142757|FG003|Overall Study|Disease progression|5|||
13178137|NCT01177397|26142758|FG004|Overall Study|Disease progression|4|||
13178138|NCT01177397|26142759|FG005|Overall Study|Disease progression|10|||
13178139|NCT01177397|26142760|FG006|Overall Study|Disease progression|10|||
13178140|NCT01177397|26142761|FG007|Overall Study|Disease progression|21|||
13178141|NCT01177397|26142762|FG008|Overall Study|Disease progression|18|||
13178142|NCT01177397|26142763|FG009|Overall Study|Disease progression|12|||
13178143|NCT01177397|26142764|FG010|Overall Study|Disease progression|10|||
13178144|NCT01177397|26142765|FG011|Overall Study|Disease progression|8|||
13178145|NCT01177397|26142754|FG000|Overall Study|Other reasons|0|||
13178146|NCT01177397|26142755|FG001|Overall Study|Other reasons|0|||
13178147|NCT01177397|26142756|FG002|Overall Study|Other reasons|1|||
13178148|NCT01177397|26142757|FG003|Overall Study|Other reasons|0|||
13178149|NCT01177397|26142758|FG004|Overall Study|Other reasons|1|||
13178150|NCT01177397|26142759|FG005|Overall Study|Other reasons|1|||
13178151|NCT01177397|26142760|FG006|Overall Study|Other reasons|2|||
13178152|NCT01177397|26142761|FG007|Overall Study|Other reasons|6|||
13178153|NCT01177397|26142762|FG008|Overall Study|Other reasons|10|||
13178154|NCT01177397|26142763|FG009|Overall Study|Other reasons|8|||
13178155|NCT01177397|26142764|FG010|Overall Study|Other reasons|0|||
13178156|NCT01177397|26142765|FG011|Overall Study|Other reasons|2|||
13178157|NCT01068249|26142775|FG000|Overall Study|Death|1|||
13178158|NCT01068249|26142775|FG000|Overall Study|Withdrawal by Subject|3|||
13178159|NCT01038778|26142799|FG000|Overall Study|Withdrawal by Subject|0|||
13178160|NCT01038778|26142800|FG001|Overall Study|Withdrawal by Subject|2|||
13178161|NCT01038778|26142801|FG002|Overall Study|Withdrawal by Subject|3|||
13178162|NCT00942331|26142864|FG000|Overall Study|Did not start treatment|15|||
13178163|NCT00942331|26142865|FG001|Overall Study|Did not start treatment|22|||
13178164|NCT00864227|26142882|FG000|Overall Study|Withdrawal by Subject|1|||
13178165|NCT00864227|26142882|FG000|Overall Study|Disease Relapse/Progression|3|||
13178166|NCT00646204|26142897|FG000|Overall Study|Adverse Event|3|||
13178167|NCT00646204|26142898|FG001|Overall Study|Adverse Event|0|||
13178168|NCT00646204|26142897|FG000|Overall Study|Withdrawal by Subject|1|||
13178169|NCT00646204|26142898|FG001|Overall Study|Withdrawal by Subject|0|||
13178170|NCT00432679|26142950|FG000|Overall Study|Adverse Event|2|||
13178171|NCT00432679|26142951|FG001|Overall Study|Adverse Event|1|||
13178172|NCT00432679|26142950|FG000|Overall Study|Withdrawal by Subject|3|||
13178173|NCT00432679|26142951|FG001|Overall Study|Withdrawal by Subject|2|||
13485537|NCT02906020|27032875|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
13178206|NCT00098475|26143087|FG000|Step 1|Progressive disease|33|||
13178207|NCT00098475|26143088|FG001|Step 1|Progressive disease|35|||
13178208|NCT00098475|26143089|FG002|Step 1|Progressive disease|2|||
13178209|NCT00098475|26143090|FG003|Step 1|Progressive disease|1|||
13178210|NCT00098475|26143087|FG000|Step 1|Adverse Event|56|||
13178211|NCT00098475|26143088|FG001|Step 1|Adverse Event|37|||
13178212|NCT00098475|26143089|FG002|Step 1|Adverse Event|0|||
13178213|NCT00098475|26143090|FG003|Step 1|Adverse Event|1|||
13178214|NCT00098475|26143087|FG000|Step 1|Death|8|||
13178215|NCT00098475|26143088|FG001|Step 1|Death|5|||
13178216|NCT00098475|26143089|FG002|Step 1|Death|0|||
13178217|NCT00098475|26143090|FG003|Step 1|Death|1|||
13178218|NCT00098475|26143087|FG000|Step 1|Withdrawal by Subject|14|||
13178219|NCT00098475|26143088|FG001|Step 1|Withdrawal by Subject|11|||
13178220|NCT00098475|26143089|FG002|Step 1|Withdrawal by Subject|0|||
13178221|NCT00098475|26143090|FG003|Step 1|Withdrawal by Subject|0|||
13178222|NCT00098475|26143087|FG000|Step 1|Physician Decision|5|||
13178223|NCT00098475|26143088|FG001|Step 1|Physician Decision|2|||
13178224|NCT00098475|26143089|FG002|Step 1|Physician Decision|0|||
13178225|NCT00098475|26143090|FG003|Step 1|Physician Decision|0|||
13178226|NCT00098475|26143087|FG000|Step 1|Alternative therapy|31|||
13178227|NCT00098475|26143088|FG001|Step 1|Alternative therapy|43|||
13178228|NCT00098475|26143089|FG002|Step 1|Alternative therapy|1|||
13178229|NCT00098475|26143090|FG003|Step 1|Alternative therapy|0|||
13178230|NCT00098475|26143087|FG000|Step 1|Other disease|2|||
13178231|NCT00098475|26143088|FG001|Step 1|Other disease|1|||
13178232|NCT00098475|26143089|FG002|Step 1|Other disease|1|||
13178233|NCT00098475|26143090|FG003|Step 1|Other disease|0|||
13178234|NCT00098475|26143087|FG000|Step 1|Never started treatment|0|||
13178235|NCT00098475|26143088|FG001|Step 1|Never started treatment|2|||
13178236|NCT00098475|26143089|FG002|Step 1|Never started treatment|0|||
13178237|NCT00098475|26143090|FG003|Step 1|Never started treatment|0|||
13178238|NCT00098475|26143087|FG000|Step 1|Still on treatment as of this analysis|14|||
13178239|NCT00098475|26143088|FG001|Step 1|Still on treatment as of this analysis|27|||
13178240|NCT00098475|26143089|FG002|Step 1|Still on treatment as of this analysis|0|||
13178241|NCT00098475|26143090|FG003|Step 1|Still on treatment as of this analysis|0|||
13178242|NCT00098475|26143087|FG000|Step 1|Knee surgery|1|||
13178243|NCT00098475|26143088|FG001|Step 1|Knee surgery|0|||
13178244|NCT00098475|26143089|FG002|Step 1|Knee surgery|0|||
13178245|NCT00098475|26143090|FG003|Step 1|Knee surgery|0|||
13178246|NCT00098475|26143087|FG000|Step 1|Complications|1|||
13178247|NCT00098475|26143088|FG001|Step 1|Complications|0|||
13178248|NCT00098475|26143089|FG002|Step 1|Complications|0|||
13178249|NCT00098475|26143090|FG003|Step 1|Complications|0|||
13178250|NCT00098475|26143087|FG000|Step 1|Cannot comply due to other tx|0|||
13178251|NCT00098475|26143088|FG001|Step 1|Cannot comply due to other tx|1|||
13178252|NCT00098475|26143089|FG002|Step 1|Cannot comply due to other tx|0|||
13178253|NCT00098475|26143090|FG003|Step 1|Cannot comply due to other tx|0|||
13178254|NCT00098475|26143087|FG000|Step 1|Both patient and physician's decision|2|||
13178255|NCT00098475|26143088|FG001|Step 1|Both patient and physician's decision|1|||
13178256|NCT00098475|26143089|FG002|Step 1|Both patient and physician's decision|0|||
13178257|NCT00098475|26143090|FG003|Step 1|Both patient and physician's decision|0|||
13178258|NCT00098475|26143087|FG000|Step 1|Incorrect disease assessment|2|||
13178259|NCT00098475|26143088|FG001|Step 1|Incorrect disease assessment|0|||
13178260|NCT00098475|26143089|FG002|Step 1|Incorrect disease assessment|0|||
13178261|NCT00098475|26143090|FG003|Step 1|Incorrect disease assessment|0|||
13178262|NCT00098475|26143087|FG000|Step 1|Off treatment for > specified timeframe|1|||
13178263|NCT00098475|26143088|FG001|Step 1|Off treatment for > specified timeframe|1|||
13178264|NCT00098475|26143089|FG002|Step 1|Off treatment for > specified timeframe|0|||
13178265|NCT00098475|26143090|FG003|Step 1|Off treatment for > specified timeframe|0|||
13178266|NCT00098475|26143087|FG000|Step 1|Declining performance status|0|||
13178267|NCT00098475|26143088|FG001|Step 1|Declining performance status|1|||
13178268|NCT00098475|26143089|FG002|Step 1|Declining performance status|0|||
13178269|NCT00098475|26143090|FG003|Step 1|Declining performance status|0|||
13178270|NCT00098475|26143087|FG000|Step 1|Insurance issue|0|||
13178271|NCT00098475|26143088|FG001|Step 1|Insurance issue|1|||
13178272|NCT00098475|26143089|FG002|Step 1|Insurance issue|0|||
13178273|NCT00098475|26143090|FG003|Step 1|Insurance issue|0|||
13178274|NCT00098475|26143087|FG000|Step 1|Rising paraprotein|0|||
13178275|NCT00098475|26143088|FG001|Step 1|Rising paraprotein|1|||
13178276|NCT00098475|26143089|FG002|Step 1|Rising paraprotein|0|||
13178277|NCT00098475|26143090|FG003|Step 1|Rising paraprotein|0|||
13178278|NCT00098475|26143087|FG000|Step 1|Referred to other physicians|0|||
13178279|NCT00098475|26143088|FG001|Step 1|Referred to other physicians|1|||
13178280|NCT00098475|26143089|FG002|Step 1|Referred to other physicians|0|||
13178281|NCT00098475|26143090|FG003|Step 1|Referred to other physicians|0|||
13178282|NCT00098475|26143087|FG000|Step 1|Criteria to continue treatment not met|0|||
13178283|NCT00098475|26143088|FG001|Step 1|Criteria to continue treatment not met|1|||
13178284|NCT00098475|26143089|FG002|Step 1|Criteria to continue treatment not met|0|||
13178285|NCT00098475|26143090|FG003|Step 1|Criteria to continue treatment not met|0|||
13178286|NCT00098475|26143087|FG000|Step 1|Misinterpretation of lab data|0|||
13178287|NCT00098475|26143088|FG001|Step 1|Misinterpretation of lab data|1|||
13222980|NCT01801358|26287543|FG000|Overall Study|Withdrawal by Subject|0|||
13178288|NCT00098475|26143089|FG002|Step 1|Misinterpretation of lab data|0|||
13178289|NCT00098475|26143090|FG003|Step 1|Misinterpretation of lab data|0|||
13178290|NCT00098475|26143087|FG000|Step 1|Patient fell with fracture|1|||
13178291|NCT00098475|26143088|FG001|Step 1|Patient fell with fracture|0|||
13178292|NCT00098475|26143089|FG002|Step 1|Patient fell with fracture|0|||
13178293|NCT00098475|26143090|FG003|Step 1|Patient fell with fracture|0|||
13178294|NCT00098475|26143087|FG000|Step 1|Not documented|0|||
13178295|NCT00098475|26143088|FG001|Step 1|Not documented|1|||
13178296|NCT00098475|26143089|FG002|Step 1|Not documented|0|||
13178297|NCT00098475|26143090|FG003|Step 1|Not documented|0|||
13178298|NCT00098475|26143087|FG000|Step 2|Disease progression|1|||
13178299|NCT00098475|26143088|FG001|Step 2|Disease progression|4|||
13178300|NCT00098475|26143089|FG002|Step 2|Disease progression|0|||
13178301|NCT00098475|26143090|FG003|Step 2|Disease progression|0|||
13178302|NCT00098475|26143087|FG000|Step 2|Adverse Event|2|||
13178303|NCT00098475|26143088|FG001|Step 2|Adverse Event|0|||
13178304|NCT00098475|26143089|FG002|Step 2|Adverse Event|0|||
13178305|NCT00098475|26143090|FG003|Step 2|Adverse Event|0|||
13178306|NCT00098475|26143087|FG000|Step 2|Withdrawal by Subject|0|||
13178307|NCT00098475|26143088|FG001|Step 2|Withdrawal by Subject|2|||
13178308|NCT00098475|26143089|FG002|Step 2|Withdrawal by Subject|0|||
13178309|NCT00098475|26143090|FG003|Step 2|Withdrawal by Subject|0|||
13178310|NCT00098475|26143087|FG000|Step 2|Physician Decision|0|||
13178311|NCT00098475|26143088|FG001|Step 2|Physician Decision|1|||
13178312|NCT00098475|26143089|FG002|Step 2|Physician Decision|0|||
13178313|NCT00098475|26143090|FG003|Step 2|Physician Decision|0|||
13178314|NCT00098475|26143087|FG000|Step 2|Alternative therapy|1|||
13178315|NCT00098475|26143088|FG001|Step 2|Alternative therapy|2|||
13178316|NCT00098475|26143089|FG002|Step 2|Alternative therapy|0|||
13178317|NCT00098475|26143090|FG003|Step 2|Alternative therapy|0|||
13178318|NCT00098475|26143087|FG000|Step 2|Never started treatment|1|||
13178319|NCT00098475|26143088|FG001|Step 2|Never started treatment|1|||
13178320|NCT00098475|26143089|FG002|Step 2|Never started treatment|0|||
13178321|NCT00098475|26143090|FG003|Step 2|Never started treatment|0|||
13205850|NCT01962103|26232966|FG003|Phase 2|Symptomatic Deterioration|0|||
13205851|NCT01962103|26232967|FG004|Phase 2|Symptomatic Deterioration|0|||
13205852|NCT01962103|26232968|FG005|Phase 2|Symptomatic Deterioration|0|||
13205853|NCT01962103|26232969|FG006|Phase 2|Symptomatic Deterioration|2|||
13205854|NCT01962103|26232970|FG007|Phase 2|Symptomatic Deterioration|2|||
13205855|NCT01962103|26232971|FG008|Phase 2|Symptomatic Deterioration|0|||
13205856|NCT01961882|26232986|FG000|Overall Study|Adverse Event|3|||
13205857|NCT01961882|26232987|FG001|Overall Study|Adverse Event|2|||
13205858|NCT01961882|26232986|FG000|Overall Study|Physician Decision|1|||
13205859|NCT01961882|26232987|FG001|Overall Study|Physician Decision|0|||
13205860|NCT01961882|26232986|FG000|Overall Study|Withdrawal by Subject|4|||
13205861|NCT01961882|26232987|FG001|Overall Study|Withdrawal by Subject|1|||
13205862|NCT01961882|26232986|FG000|Overall Study|Relapse of AML|39|||
13205863|NCT01961882|26232987|FG001|Overall Study|Relapse of AML|37|||
13205864|NCT01961882|26232986|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2|||
13205865|NCT01961882|26232987|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2|||
13205866|NCT01961882|26232986|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1|||
13205867|NCT01961882|26232987|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0|||
13205868|NCT01961687|26233001|FG000|Overall Study|Lost to Follow-up|19|||
13205869|NCT01961687|26233001|FG000|Overall Study|Re-operation|17|||
13205870|NCT01961687|26233001|FG000|Overall Study|Death|7|||
13205871|NCT01961687|26233001|FG000|Overall Study|Withdrawal by Subject|6|||
13205872|NCT01961687|26233001|FG000|Overall Study|Adverse Event|6|||
13178322|NCT04867382|26143109|FG000|Overall Study|Did not complete the survey|2|||
13178323|NCT04867382|26143110|FG001|Overall Study|Did not complete the survey|1|||
13178324|NCT04274894|26143116|FG000|Overall Study|Adverse Event|7|||
13178325|NCT04274894|26143116|FG000|Overall Study|Withdrew consent|5|||
13178326|NCT04274894|26143116|FG000|Overall Study|Lost to Follow-up|9|||
13178327|NCT04274894|26143116|FG000|Overall Study|COVID-19 infection|1|||
13178328|NCT04274894|26143116|FG000|Overall Study|Other, not specified|20|||
13178329|NCT04158648|26143144|FG000|Overall Study|Ongoing in the Study|69|||
13178330|NCT04158648|26143144|FG000|Overall Study|Withdrawal by Subject|4|||
13178331|NCT04152200|26143186|FG000|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|6|||
13178332|NCT04152200|26143187|FG001|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|15|||
13178333|NCT03777436|26143212|FG000|Placebo-controlled Phase|Adverse Event|8|||
13178334|NCT03777436|26143213|FG001|Placebo-controlled Phase|Adverse Event|10|||
13178335|NCT03777436|26143214|FG002|Placebo-controlled Phase|Adverse Event|0|||
13178336|NCT03777436|26143212|FG000|Placebo-controlled Phase|Lack of Efficacy|0|||
13178337|NCT03777436|26143213|FG001|Placebo-controlled Phase|Lack of Efficacy|1|||
13178338|NCT03777436|26143214|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
13178339|NCT03777436|26143212|FG000|Placebo-controlled Phase|Withdrawal by Subject|19|||
13178340|NCT03777436|26143213|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
13178341|NCT03777436|26143214|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
13178342|NCT03777436|26143212|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
13178343|NCT03777436|26143213|FG001|Placebo-controlled Phase|Non-compliance with study drug|2|||
13178344|NCT03777436|26143214|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
13178345|NCT03777436|26143212|FG000|Placebo-controlled Phase|Lost to Follow-up|7|||
13178346|NCT03777436|26143213|FG001|Placebo-controlled Phase|Lost to Follow-up|7|||
13178347|NCT03777436|26143214|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
13178348|NCT03777436|26143212|FG000|Placebo-controlled Phase|Physician Decision|0|||
13178349|NCT03777436|26143213|FG001|Placebo-controlled Phase|Physician Decision|1|||
13178350|NCT03777436|26143214|FG002|Placebo-controlled Phase|Physician Decision|0|||
13178351|NCT03777436|26143212|FG000|Placebo-controlled Phase|Due to COVID-19 control measures|1|||
13178352|NCT03777436|26143213|FG001|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
13178353|NCT03777436|26143214|FG002|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
13178354|NCT03777436|26143212|FG000|Apremilast Extension Phase|Adverse Event|0|||
13178355|NCT03777436|26143213|FG001|Apremilast Extension Phase|Adverse Event|0|||
13178356|NCT03777436|26143214|FG002|Apremilast Extension Phase|Adverse Event|6|||
13178357|NCT03777436|26143212|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
13178358|NCT03777436|26143213|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
13178359|NCT03777436|26143214|FG002|Apremilast Extension Phase|Lack of Efficacy|1|||
13178360|NCT03777436|26143212|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
13178361|NCT03777436|26143213|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
13178362|NCT03777436|26143214|FG002|Apremilast Extension Phase|Withdrawal by Subject|13|||
13178363|NCT03777436|26143212|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
13178364|NCT03777436|26143213|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
13178365|NCT03777436|26143214|FG002|Apremilast Extension Phase|Lost to Follow-up|7|||
13178366|NCT03777436|26143212|FG000|Apremilast Extension Phase|Miscellaneous|0|||
13178367|NCT03777436|26143213|FG001|Apremilast Extension Phase|Miscellaneous|0|||
13178368|NCT03777436|26143214|FG002|Apremilast Extension Phase|Miscellaneous|1|||
13178369|NCT03759379|26143233|FG000|Treatment Period|Remained in this Period at Time of Data Cut|119|||
13178370|NCT03759379|26143234|FG001|Treatment Period|Remained in this Period at Time of Data Cut|38|||
13178371|NCT03759379|26143233|FG000|Treatment Period|Death|2|||
13178372|NCT03759379|26143234|FG001|Treatment Period|Death|3|||
13178373|NCT03759379|26143233|FG000|Treatment Period|Lost to Follow-up|1|||
13178374|NCT03759379|26143234|FG001|Treatment Period|Lost to Follow-up|0|||
13178375|NCT03759379|26143233|FG000|Treatment Period|Physician Decision|0|||
13178376|NCT03759379|26143234|FG001|Treatment Period|Physician Decision|1|||
13178377|NCT03686397|26143247|FG000|Overall Study|Lack of Efficacy|3|||
13178378|NCT03686397|26143248|FG001|Overall Study|Lack of Efficacy|5|||
13178379|NCT03686397|26143247|FG000|Overall Study|Adverse Event|0|||
13178380|NCT03686397|26143248|FG001|Overall Study|Adverse Event|1|||
13178381|NCT03686397|26143247|FG000|Overall Study|Protocol Violation|0|||
13178382|NCT03686397|26143248|FG001|Overall Study|Protocol Violation|1|||
13178383|NCT03686397|26143247|FG000|Overall Study|Withdrawal by Subject|0|||
13178384|NCT03686397|26143248|FG001|Overall Study|Withdrawal by Subject|1|||
13178385|NCT03686397|26143247|FG000|Overall Study|covid pandemic, bacterial ear culture|2|||
13178386|NCT03686397|26143248|FG001|Overall Study|covid pandemic, bacterial ear culture|0|||
13178387|NCT03659136|26143271|FG000|Overall Study|COVID-19 related|1|||
13178388|NCT03659136|26143272|FG001|Overall Study|COVID-19 related|1|||
13178389|NCT03659136|26143271|FG000|Overall Study|Withdrawal by Subject|0|||
13178390|NCT03659136|26143272|FG001|Overall Study|Withdrawal by Subject|6|||
13178391|NCT03659136|26143271|FG000|Overall Study|Adverse Event|4|||
13178392|NCT03659136|26143272|FG001|Overall Study|Adverse Event|7|||
13222981|NCT01801358|26287544|FG001|Overall Study|Withdrawal by Subject|0|||
13178393|NCT03659136|26143271|FG000|Overall Study|Progressive disease|34|||
13178394|NCT03659136|26143272|FG001|Overall Study|Progressive disease|24|||
13178395|NCT03659136|26143271|FG000|Overall Study|Not treated|2|||
13178396|NCT03659136|26143272|FG001|Overall Study|Not treated|0|||
13178397|NCT03659136|26143271|FG000|Overall Study|Not specified above|2|||
13178398|NCT03659136|26143272|FG001|Overall Study|Not specified above|1|||
13178399|NCT03575897|26143311|FG000|Overall Study|Lost to Follow-up|12|||
13178400|NCT03575897|26143312|FG001|Overall Study|Lost to Follow-up|13|||
13178401|NCT03350035|26143342|FG000|Overall Study|Lack of Efficacy|2|||
13178402|NCT03350035|26143343|FG001|Overall Study|Lack of Efficacy|0|||
13178403|NCT03350035|26143344|FG002|Overall Study|Lack of Efficacy|0|||
13178404|NCT03350035|26143342|FG000|Overall Study|Subject discharged to hospice|0|||
13178405|NCT03350035|26143343|FG001|Overall Study|Subject discharged to hospice|0|||
13178406|NCT03350035|26143344|FG002|Overall Study|Subject discharged to hospice|1|||
13178407|NCT03097991|26143435|FG000|Overall Study|Didn't meet study criteria|8|||
13178408|NCT03097991|26143436|FG001|Overall Study|Didn't meet study criteria|0|||
13178409|NCT03097991|26143435|FG000|Overall Study|Withdrawal by Subject|12|||
13178410|NCT03097991|26143436|FG001|Overall Study|Withdrawal by Subject|6|||
13178411|NCT03097991|26143435|FG000|Overall Study|Death of Baby|3|||
13178412|NCT03097991|26143436|FG001|Overall Study|Death of Baby|1|||
13178413|NCT03097991|26143435|FG000|Overall Study|Lost to Follow-up|24|||
13178414|NCT03097991|26143436|FG001|Overall Study|Lost to Follow-up|38|||
13178415|NCT03097991|26143435|FG000|Overall Study|Adverse Event|3|||
13178416|NCT03097991|26143436|FG001|Overall Study|Adverse Event|5|||
13178417|NCT02978222|26143455|FG000|Overall Study|Withdrawal by Subject|2|||
13178418|NCT02978222|26143456|FG001|Overall Study|Withdrawal by Subject|2|||
13178419|NCT02978222|26143455|FG000|Overall Study|Physician Decision|2|||
13178420|NCT02978222|26143456|FG001|Overall Study|Physician Decision|0|||
13178421|NCT02978222|26143455|FG000|Overall Study|Adverse Event|0|||
13178422|NCT02978222|26143456|FG001|Overall Study|Adverse Event|1|||
13178423|NCT02978222|26143455|FG000|Overall Study|Death|1|||
13178424|NCT02978222|26143456|FG001|Overall Study|Death|0|||
13178425|NCT02978222|26143455|FG000|Overall Study|Disease Progression|32|||
13178426|NCT02978222|26143456|FG001|Overall Study|Disease Progression|32|||
13178427|NCT02978222|26143455|FG000|Overall Study|Early Study Termination|24|||
13178428|NCT02978222|26143456|FG001|Overall Study|Early Study Termination|21|||
13178429|NCT02623205|26143474|FG000|Overall Study|Lost to Follow-Up or Discontinued Intervention|4|||
13178430|NCT02623205|26143475|FG001|Overall Study|Lost to Follow-Up or Discontinued Intervention|3|||
13205873|NCT01961687|26233001|FG000|Overall Study|Moved to area without study site|2|||
13205874|NCT01961687|26233001|FG000|Overall Study|Sponsor decision|2|||
13205875|NCT01961687|26233001|FG000|Overall Study|Physician Decision|1|||
13205876|NCT01961687|26233001|FG000|Overall Study|Unable to meet follow-up requirements|1|||
13205877|NCT01961609|26233062|FG000|Initiation|Missing|3|||
13205878|NCT01961609|26233063|FG001|Initiation|Missing|2|||
13205879|NCT01961609|26233064|FG002|Initiation|Missing|0|||
13205880|NCT01961609|26233065|FG003|Initiation|Missing|0|||
13205881|NCT01961609|26233062|FG000|Initiation|Protocol deviation|1|||
13205882|NCT01961609|26233063|FG001|Initiation|Protocol deviation|0|||
13205883|NCT01961609|26233064|FG002|Initiation|Protocol deviation|0|||
13205884|NCT01961609|26233065|FG003|Initiation|Protocol deviation|0|||
13205885|NCT01961609|26233062|FG000|Initiation|Death|0|||
13205886|NCT01961609|26233063|FG001|Initiation|Death|1|||
13205887|NCT01961609|26233064|FG002|Initiation|Death|0|||
13205888|NCT01961609|26233065|FG003|Initiation|Death|0|||
13205889|NCT01961609|26233062|FG000|Initiation|Administrative problems|1|||
13205890|NCT01961609|26233063|FG001|Initiation|Administrative problems|0|||
13205891|NCT01961609|26233064|FG002|Initiation|Administrative problems|0|||
13205892|NCT01961609|26233065|FG003|Initiation|Administrative problems|0|||
13205893|NCT01961609|26233062|FG000|Initiation|Withdrawal by Subject|1|||
13205894|NCT01961609|26233063|FG001|Initiation|Withdrawal by Subject|2|||
13205895|NCT01961609|26233064|FG002|Initiation|Withdrawal by Subject|0|||
13205896|NCT01961609|26233065|FG003|Initiation|Withdrawal by Subject|0|||
13205897|NCT01961609|26233062|FG000|Initiation|Lack of Efficacy|2|||
13205898|NCT01961609|26233063|FG001|Initiation|Lack of Efficacy|1|||
13205899|NCT01961609|26233064|FG002|Initiation|Lack of Efficacy|0|||
13205900|NCT01961609|26233065|FG003|Initiation|Lack of Efficacy|0|||
13205901|NCT01961609|26233062|FG000|Initiation|Abnormal lab values|0|||
13205902|NCT01961609|26233063|FG001|Initiation|Abnormal lab values|1|||
13205903|NCT01961609|26233064|FG002|Initiation|Abnormal lab values|0|||
13205904|NCT01961609|26233065|FG003|Initiation|Abnormal lab values|0|||
13205905|NCT01961609|26233062|FG000|Initiation|Adverse Event|3|||
13205906|NCT01961609|26233063|FG001|Initiation|Adverse Event|5|||
13205907|NCT01961609|26233064|FG002|Initiation|Adverse Event|0|||
13205908|NCT01961609|26233065|FG003|Initiation|Adverse Event|0|||
13205909|NCT01961609|26233062|FG000|Initiation|Randomized but not treated|1|||
13205910|NCT01961609|26233063|FG001|Initiation|Randomized but not treated|1|||
13205911|NCT01961609|26233064|FG002|Initiation|Randomized but not treated|0|||
13205912|NCT01961609|26233065|FG003|Initiation|Randomized but not treated|0|||
13205913|NCT01961609|26233062|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1|||
13178431|NCT02138110|26143494|FG000|Enrolled for Scaffold Implantation|Physician Decision|1|||
13178432|NCT02138110|26143494|FG000|Overall Scaffold Implantation|Death|3|||
13178433|NCT02101281|26143541|FG000|Overall Study|Adverse Event|0|||
13178434|NCT02101281|26143542|FG001|Overall Study|Adverse Event|1|||
13178435|NCT02254421|26143568|FG000|Overall Study|Randomized but Not Treated|1|||
13178436|NCT02254421|26143569|FG001|Overall Study|Randomized but Not Treated|0|||
13178437|NCT02254421|26143568|FG000|Overall Study|Death|0|||
13109180|NCT03238352|25894856|FG000|Overall Study|Withdrawal by Subject|0|||
13109181|NCT03238352|25894857|FG001|Overall Study|Withdrawal by Subject|1|||
13109182|NCT03238352|25894858|FG002|Overall Study|Withdrawal by Subject|0|||
13109183|NCT03238001|25894883|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2|||
13109184|NCT03238001|25894883|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2|||
13109185|NCT03238001|25894883|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16|||
13109186|NCT03238001|25894883|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2|||
13109187|NCT03238001|25894883|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3|||
13109188|NCT03238001|25894883|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3|||
13178438|NCT02254421|26143569|FG001|Overall Study|Death|2|||
13178439|NCT02254421|26143568|FG000|Overall Study|Withdrew Consent|1|||
13178440|NCT02254421|26143569|FG001|Overall Study|Withdrew Consent|1|||
13109189|NCT03238001|25894883|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1|||
13178441|NCT02254408|26143586|FG000|Overall Study|Randomized But Not Treated|1|||
13178442|NCT02254408|26143587|FG001|Overall Study|Randomized But Not Treated|3|||
13178443|NCT02254408|26143586|FG000|Overall Study|Adverse Event|1|||
13178444|NCT02254408|26143587|FG001|Overall Study|Adverse Event|0|||
13178445|NCT02254408|26143586|FG000|Overall Study|Death|2|||
13178446|NCT02254408|26143587|FG001|Overall Study|Death|3|||
13178447|NCT02254408|26143586|FG000|Overall Study|Investigator's Discretion|0|||
13178448|NCT02254408|26143587|FG001|Overall Study|Investigator's Discretion|1|||
13178449|NCT02254408|26143586|FG000|Overall Study|Withdrawal by Subject|3|||
13178450|NCT02254408|26143587|FG001|Overall Study|Withdrawal by Subject|3|||
13178451|NCT02254408|26143586|FG000|Overall Study|Lost to Follow-up|1|||
13178452|NCT02254408|26143587|FG001|Overall Study|Lost to Follow-up|0|||
13178453|NCT02254304|26143651|FG000|Overall Study|Adverse Event|2|||
13178454|NCT02254304|26143652|FG001|Overall Study|Adverse Event|1|||
13178455|NCT02254304|26143651|FG000|Overall Study|Lost to Follow-up|2|||
13178456|NCT02254304|26143652|FG001|Overall Study|Lost to Follow-up|2|||
13178457|NCT02254304|26143651|FG000|Overall Study|Protocol Violation|1|||
13178458|NCT02254304|26143652|FG001|Overall Study|Protocol Violation|0|||
13178459|NCT02254304|26143651|FG000|Overall Study|Withdrawal by Subject|3|||
13178460|NCT02254304|26143652|FG001|Overall Study|Withdrawal by Subject|0|||
13178461|NCT02254304|26143651|FG000|Overall Study|Injection site pain and Injection fear|1|||
13178462|NCT02254304|26143652|FG001|Overall Study|Injection site pain and Injection fear|0|||
13178463|NCT02254304|26143651|FG000|Overall Study|Personal causes|4|||
13178464|NCT02254304|26143652|FG001|Overall Study|Personal causes|1|||
13178465|NCT02254304|26143651|FG000|Overall Study|Personal decision|1|||
13178466|NCT02254304|26143652|FG001|Overall Study|Personal decision|0|||
13178467|NCT02254291|26143676|FG000|Overall Study|Withdrawal by Subject|0|||
13178468|NCT02254291|26143677|FG001|Overall Study|Withdrawal by Subject|3|||
13178469|NCT02254291|26143678|FG002|Overall Study|Withdrawal by Subject|1|||
13178470|NCT02254291|26143676|FG000|Overall Study|Missing follow-up information|0|||
13178471|NCT02254291|26143677|FG001|Overall Study|Missing follow-up information|0|||
13178472|NCT02254291|26143678|FG002|Overall Study|Missing follow-up information|1|||
13178473|NCT02254278|26143702|FG000|Overall Study|Protocol Violation|1|||
13178474|NCT02254278|26143703|FG001|Overall Study|Protocol Violation|1|||
13178475|NCT02253992|26143777|FG000|Overall Study|Study drug toxicity|1|||
13178476|NCT02253992|26143778|FG001|Overall Study|Study drug toxicity|0|||
13178477|NCT02253992|26143779|FG002|Overall Study|Study drug toxicity|10|||
13178478|NCT02253992|26143777|FG000|Overall Study|Disease progression|4|||
13178479|NCT02253992|26143778|FG001|Overall Study|Disease progression|3|||
13178480|NCT02253992|26143779|FG002|Overall Study|Disease progression|98|||
13109190|NCT03238001|25894883|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4|||
13109191|NCT03237481|25894908|FG000|Overall Study|Lost to Follow-up|1|||
13109192|NCT03237481|25894909|FG001|Overall Study|Lost to Follow-up|0|||
13109193|NCT03237481|25894910|FG002|Overall Study|Lost to Follow-up|0|||
13109194|NCT03237481|25894908|FG000|Overall Study|Protocol Violation|1|||
13109195|NCT03237481|25894909|FG001|Overall Study|Protocol Violation|0|||
13178481|NCT02253992|26143777|FG000|Overall Study|Withdrawal by Subject|0|||
13178482|NCT02253992|26143778|FG001|Overall Study|Withdrawal by Subject|0|||
13178483|NCT02253992|26143779|FG002|Overall Study|Withdrawal by Subject|3|||
13178484|NCT02253992|26143777|FG000|Overall Study|Adverse Event|0|||
13178485|NCT02253992|26143778|FG001|Overall Study|Adverse Event|0|||
13178486|NCT02253992|26143779|FG002|Overall Study|Adverse Event|8|||
13178487|NCT02253992|26143777|FG000|Overall Study|Death|0|||
13178488|NCT02253992|26143778|FG001|Overall Study|Death|0|||
13178489|NCT02253992|26143779|FG002|Overall Study|Death|1|||
13178490|NCT02253992|26143777|FG000|Overall Study|Subject discontinued study drug|1|||
13178491|NCT02253992|26143778|FG001|Overall Study|Subject discontinued study drug|0|||
13178492|NCT02253992|26143779|FG002|Overall Study|Subject discontinued study drug|1|||
13178493|NCT02253992|26143777|FG000|Overall Study|Completed treatment as per protocol|0|||
13178494|NCT02253992|26143778|FG001|Overall Study|Completed treatment as per protocol|1|||
13178495|NCT02253992|26143779|FG002|Overall Study|Completed treatment as per protocol|22|||
13178496|NCT02253992|26143777|FG000|Overall Study|Other|0|||
13178497|NCT02253992|26143778|FG001|Overall Study|Other|0|||
13178498|NCT02253992|26143779|FG002|Overall Study|Other|1|||
13178499|NCT02253654|26143806|FG000|Overall Study|Withdrawal by Subject|12|||
13178500|NCT02253654|26143807|FG001|Overall Study|Withdrawal by Subject|4|||
13178501|NCT02253654|26143806|FG000|Overall Study|Decision by Sponsor|1|||
13178502|NCT02253654|26143807|FG001|Overall Study|Decision by Sponsor|1|||
13178503|NCT02253654|26143806|FG000|Overall Study|Lost to Follow-up|2|||
13178504|NCT02253654|26143807|FG001|Overall Study|Lost to Follow-up|5|||
13178505|NCT02253654|26143806|FG000|Overall Study|Death|4|||
13178506|NCT02253654|26143807|FG001|Overall Study|Death|7|||
13178507|NCT02253654|26143806|FG000|Overall Study|Did Not Receive Study Treatment|4|||
13178508|NCT02253654|26143807|FG001|Overall Study|Did Not Receive Study Treatment|1|||
13178509|NCT02253433|26143824|FG000|Overall Study|Unable to Contact|9|||
13178510|NCT02253433|26143825|FG001|Overall Study|Unable to Contact|16|||
13178511|NCT02253433|26143824|FG000|Overall Study|Death|1|||
13109196|NCT03237481|25894910|FG002|Overall Study|Protocol Violation|0|||
13178512|NCT02253433|26143825|FG001|Overall Study|Death|1|||
13178513|NCT02253433|26143824|FG000|Overall Study|No Longer Interested|3|||
13178514|NCT02253433|26143825|FG001|Overall Study|No Longer Interested|15|||
13178515|NCT02253433|26143824|FG000|Overall Study|Out of Study Area|2|||
13178516|NCT02253433|26143825|FG001|Overall Study|Out of Study Area|7|||
13178517|NCT02253433|26143824|FG000|Overall Study|Uncomfortable with home visitors|0|||
13178518|NCT02253433|26143825|FG001|Overall Study|Uncomfortable with home visitors|3|||
13178519|NCT02253433|26143824|FG000|Overall Study|Unstable Housing/Homeless|0|||
13178520|NCT02253433|26143825|FG001|Overall Study|Unstable Housing/Homeless|7|||
13178521|NCT02253433|26143824|FG000|Overall Study|Too Busy|0|||
13178522|NCT02253433|26143825|FG001|Overall Study|Too Busy|4|||
13178523|NCT02253433|26143824|FG000|Overall Study|Medical or Other Concerns|1|||
13178524|NCT02253433|26143825|FG001|Overall Study|Medical or Other Concerns|2|||
13178525|NCT02253147|26143859|FG000|Overall Study|Protocol Violation|30|||
13178526|NCT02253147|26143859|FG000|Overall Study|Did not consent to study extension|9|||
13178527|NCT02253147|26143859|FG000|Overall Study|Conditional re-treatment at W52|5|||
13178528|NCT02253147|26143859|FG000|Overall Study|Lost to Follow-up|2|||
13178529|NCT02253147|26143859|FG000|Overall Study|Withdrawal by Subject|1|||
13178530|NCT02252965|26143893|FG000|Overall Study|Adverse Event|9|||
13178531|NCT02252965|26143894|FG001|Overall Study|Adverse Event|14|||
13178532|NCT02252965|26143893|FG000|Overall Study|Lost to Follow-up|16|||
13178533|NCT02252965|26143894|FG001|Overall Study|Lost to Follow-up|8|||
13178534|NCT02252965|26143893|FG000|Overall Study|Protocol Violation|4|||
13178535|NCT02252965|26143894|FG001|Overall Study|Protocol Violation|5|||
13178536|NCT02252965|26143893|FG000|Overall Study|Lack of Efficacy|0|||
13178537|NCT02252965|26143894|FG001|Overall Study|Lack of Efficacy|2|||
13178538|NCT02252965|26143893|FG000|Overall Study|Withdrawal by Subject|7|||
13178539|NCT02252965|26143894|FG001|Overall Study|Withdrawal by Subject|9|||
13178540|NCT02252965|26143893|FG000|Overall Study|Other|4|||
13178541|NCT02252965|26143894|FG001|Overall Study|Other|5|||
13178542|NCT02252939|26143905|FG000|Overall Study|Lost to Follow-up|3|||
13178543|NCT02252588|26143922|FG000|Overall Study|Withdrawal by Subject|4|||
13109197|NCT03237481|25894908|FG000|Overall Study|Withdrawal by Subject|3|||
13109198|NCT03237481|25894909|FG001|Overall Study|Withdrawal by Subject|2|||
13109199|NCT03237481|25894910|FG002|Overall Study|Withdrawal by Subject|1|||
13109200|NCT03237065|25894957|FG000|Overall Study|Adverse Event|0|||
13109201|NCT03237065|25894958|FG001|Overall Study|Adverse Event|2|||
13109202|NCT03237065|25894957|FG000|Overall Study|Protocol Violation|0|||
13109203|NCT03237065|25894958|FG001|Overall Study|Protocol Violation|1|||
13109204|NCT03237065|25894957|FG000|Overall Study|Withdrawal by Subject|3|||
13109205|NCT03237065|25894958|FG001|Overall Study|Withdrawal by Subject|0|||
13109206|NCT03237065|25894957|FG000|Overall Study|Lost to Follow-up|1|||
13109207|NCT03237065|25894958|FG001|Overall Study|Lost to Follow-up|0|||
13109208|NCT03237065|25894957|FG000|Overall Study|Unable to obtain venous access|0|||
13109209|NCT03237065|25894958|FG001|Overall Study|Unable to obtain venous access|1|||
13178544|NCT02252588|26143923|FG001|Overall Study|Withdrawal by Subject|0|||
13178545|NCT02252536|26143962|FG000|Overall Study|Lost to Follow-up|5|||
13178546|NCT02252536|26143963|FG001|Overall Study|Lost to Follow-up|3|||
13178547|NCT02252406|26143978|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2|||
13178548|NCT02252406|26143979|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3|||
13178549|NCT02252406|26143978|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1|||
13178550|NCT02252406|26143979|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0|||
13178551|NCT02252406|26143978|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1|||
13178552|NCT02252406|26143979|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0|||
13178553|NCT02252406|26143978|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
13178554|NCT02252406|26143979|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
13178555|NCT02252406|26143978|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2|||
13178556|NCT02252406|26143979|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0|||
13178557|NCT02252146|26143985|FG000|Overall Study|Lack of Efficacy|4|||
13178558|NCT02252146|26143985|FG000|Overall Study|Entered hospice care|1|||
13178559|NCT02252146|26143985|FG000|Overall Study|Inability to travel to study site|1|||
13178560|NCT02252081|26144004|FG000|Overall Study|Withdrawal by Subject|2|||
13178561|NCT02252081|26144005|FG001|Overall Study|Withdrawal by Subject|1|||
13178562|NCT02252081|26144004|FG000|Overall Study|Adverse Event|4|||
13178563|NCT02252081|26144005|FG001|Overall Study|Adverse Event|1|||
13178564|NCT02252081|26144004|FG000|Overall Study|non compliance & others|0|||
13178565|NCT02252081|26144005|FG001|Overall Study|non compliance & others|2|||
13178566|NCT02252042|26144050|FG000|Overall Study|Death|170|||
13178567|NCT02252042|26144051|FG001|Overall Study|Death|192|||
13178568|NCT02252042|26144050|FG000|Overall Study|Physician Decision|0|||
13178569|NCT02252042|26144051|FG001|Overall Study|Physician Decision|1|||
13178570|NCT02252042|26144050|FG000|Overall Study|Withdrawal by Subject|13|||
13178571|NCT02252042|26144051|FG001|Overall Study|Withdrawal by Subject|20|||
13178572|NCT02252042|26144050|FG000|Overall Study|Ongoing in study|64|||
13178573|NCT02252042|26144051|FG001|Overall Study|Ongoing in study|35|||
13178574|NCT02252016|26144070|FG000|Overall Study|Lost to Follow-up|2|||
13178575|NCT02252016|26144071|FG001|Overall Study|Lost to Follow-up|1|||
13178576|NCT02252016|26144070|FG000|Overall Study|Physician Decision|1|||
13178577|NCT02252016|26144071|FG001|Overall Study|Physician Decision|0|||
13178578|NCT02252016|26144070|FG000|Overall Study|Withdrawal by Subject|0|||
13178579|NCT02252016|26144071|FG001|Overall Study|Withdrawal by Subject|2|||
13178580|NCT02251990|26144093|FG000|Period 1 (Double-blind [DB])|Adverse Event|1|||
13178581|NCT02251990|26144094|FG001|Period 1 (Double-blind [DB])|Adverse Event|1|||
13178582|NCT02251990|26144093|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5|||
13178583|NCT02251990|26144094|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0|||
13178584|NCT02251990|26144093|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1|||
13178585|NCT02251990|26144094|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0|||
13178586|NCT02251990|26144093|FG000|Period 1 (Double-blind [DB])|Not Treated|1|||
13178587|NCT02251990|26144094|FG001|Period 1 (Double-blind [DB])|Not Treated|0|||
13178588|NCT02251990|26144093|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0|||
13178589|NCT02251990|26144094|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1|||
13178590|NCT02251990|26144093|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0|||
13178591|NCT02251990|26144094|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2|||
13178592|NCT02251912|26144111|FG000|Overall Study|Withdrawal by Subject|2|||
13178593|NCT02251912|26144112|FG001|Overall Study|Withdrawal by Subject|3|||
13178594|NCT02251912|26144111|FG000|Overall Study|Adverse Event|0|||
13178595|NCT02251912|26144112|FG001|Overall Study|Adverse Event|2|||
13178596|NCT02251743|26144125|FG000|Overall Study|Withdrawal by Subject|1|||
13178597|NCT02251743|26144126|FG001|Overall Study|Withdrawal by Subject|1|||
13178598|NCT02251717|26144145|FG000|Overall Study|Adverse Event|0|||
13178599|NCT02251717|26144146|FG001|Overall Study|Adverse Event|1|||
13178600|NCT02251717|26144145|FG000|Overall Study|Withdrew Consent|1|||
13178601|NCT02251717|26144146|FG001|Overall Study|Withdrew Consent|0|||
13178602|NCT02251652|26144158|FG000|Overall Study|Withdrawal by Subject|1|||
13178603|NCT02251275|26144186|FG000|Overall Study|Adverse Event|23|||
13178604|NCT02251275|26144187|FG001|Overall Study|Adverse Event|60|||
13178605|NCT02251275|26144188|FG002|Overall Study|Adverse Event|28|||
13178606|NCT02251275|26144189|FG003|Overall Study|Adverse Event|0|||
13178607|NCT02251275|26144190|FG004|Overall Study|Adverse Event|0|||
13178608|NCT02251275|26144186|FG000|Overall Study|Lost to Follow-up|5|||
13178609|NCT02251275|26144187|FG001|Overall Study|Lost to Follow-up|6|||
13178610|NCT02251275|26144188|FG002|Overall Study|Lost to Follow-up|4|||
13178611|NCT02251275|26144189|FG003|Overall Study|Lost to Follow-up|0|||
13178612|NCT02251275|26144190|FG004|Overall Study|Lost to Follow-up|0|||
13178613|NCT02251275|26144186|FG000|Overall Study|Physician Decision|19|||
13178614|NCT02251275|26144187|FG001|Overall Study|Physician Decision|30|||
13222982|NCT01801358|26287545|FG002|Overall Study|Withdrawal by Subject|0|||
13178615|NCT02251275|26144188|FG002|Overall Study|Physician Decision|26|||
13178616|NCT02251275|26144189|FG003|Overall Study|Physician Decision|0|||
13178617|NCT02251275|26144190|FG004|Overall Study|Physician Decision|1|||
13178618|NCT02251275|26144186|FG000|Overall Study|Protocol Deviation|0|||
13178619|NCT02251275|26144187|FG001|Overall Study|Protocol Deviation|0|||
13178620|NCT02251275|26144188|FG002|Overall Study|Protocol Deviation|1|||
13178621|NCT02251275|26144189|FG003|Overall Study|Protocol Deviation|0|||
13178622|NCT02251275|26144190|FG004|Overall Study|Protocol Deviation|0|||
13178623|NCT02251275|26144186|FG000|Overall Study|Withdrawal by Subject|25|||
13178624|NCT02251275|26144187|FG001|Overall Study|Withdrawal by Subject|51|||
13178625|NCT02251275|26144188|FG002|Overall Study|Withdrawal by Subject|35|||
13178626|NCT02251275|26144189|FG003|Overall Study|Withdrawal by Subject|1|||
13178627|NCT02251275|26144190|FG004|Overall Study|Withdrawal by Subject|0|||
13178628|NCT02250651|26144229|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0|||
13178629|NCT02250651|26144230|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
13178630|NCT02250651|26144231|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
13178631|NCT02250651|26144229|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
13178632|NCT02250651|26144230|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
13178633|NCT02250651|26144231|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
13178634|NCT02250651|26144229|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2|||
13178635|NCT02250651|26144230|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3|||
13178636|NCT02250651|26144231|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5|||
13178637|NCT02250651|26144229|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1|||
13178638|NCT02250651|26144230|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
13178639|NCT02250651|26144231|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
13178640|NCT02250651|26144229|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
13178641|NCT02250651|26144230|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
13178642|NCT02250651|26144231|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1|||
13178643|NCT02250651|26144229|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
13178644|NCT02250651|26144230|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1|||
13178645|NCT02250651|26144231|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3|||
13178646|NCT02250651|26144229|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4|||
13178647|NCT02250651|26144230|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1|||
13178648|NCT02250651|26144231|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0|||
13178649|NCT02250651|26144229|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
13178650|NCT02250651|26144230|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
13178651|NCT02250651|26144231|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3|||
13178652|NCT02250651|26144229|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
13178653|NCT02250651|26144230|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3|||
13178654|NCT02250651|26144231|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
13178655|NCT02250651|26144229|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
13178656|NCT02250651|26144230|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1|||
13178657|NCT02250651|26144231|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
13178658|NCT02250651|26144229|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
13178659|NCT02250651|26144230|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1|||
13178660|NCT02250651|26144231|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
13178661|NCT02250651|26144229|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4|||
13178662|NCT02250651|26144230|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
13178663|NCT02250651|26144231|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
13178664|NCT02250651|26144229|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
13178665|NCT02250651|26144230|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2|||
13178666|NCT02250651|26144231|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
13178667|NCT02250651|26144229|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
13178668|NCT02250651|26144230|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0|||
13178669|NCT02250651|26144231|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
13178670|NCT02250651|26144229|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2|||
13178671|NCT02250651|26144230|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
13178672|NCT02250651|26144231|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
13178673|NCT02250443|26144246|FG000|Overall Study|Administrative problems|7|||
13178674|NCT02250443|26144246|FG000|Overall Study|Adverse Event|3|||
13178675|NCT02250274|26144269|FG000|Overall Study|Insufficient blood draw amount|7|||
13178676|NCT02250274|26144270|FG001|Overall Study|Insufficient blood draw amount|6|||
13178677|NCT02250183|26144281|FG000|Overall Study|Withdrawal by Subject|2|||
13178678|NCT02250183|26144281|FG000|Overall Study|Adverse Event|5|||
13178679|NCT02250183|26144281|FG000|Overall Study|Lost to Follow-up|1|||
13178680|NCT02249949|26144290|FG000|Overall Study|Cancelled prior to treatment|2|||
13178681|NCT02249832|26144304|FG000|Overall Study|Withdrawal by Subject|3|||
13178682|NCT02249832|26144304|FG000|Overall Study|Lost to Follow-up|10|||
13178683|NCT02249767|26144322|FG000|Overall Study|Did not use medication|8|||
13178684|NCT02249767|26144323|FG001|Overall Study|Did not use medication|9|||
13178685|NCT02249767|26144324|FG002|Overall Study|Did not use medication|8|||
13178686|NCT02249182|26144426|FG000|Treatment Phase|Lost to Follow-up|4|||
13178687|NCT02249182|26144427|FG001|Treatment Phase|Lost to Follow-up|0|||
13178688|NCT02249182|26144428|FG002|Treatment Phase|Lost to Follow-up|0|||
13178689|NCT02249182|26144429|FG003|Treatment Phase|Lost to Follow-up|0|||
13178690|NCT02249182|26144430|FG004|Treatment Phase|Lost to Follow-up|0|||
13178691|NCT02249091|26144457|FG000|Overall Study|Lack of Efficacy|8|||
13178692|NCT02249091|26144458|FG001|Overall Study|Lack of Efficacy|3|||
13178693|NCT02249091|26144457|FG000|Overall Study|Physician Decision|4|||
13178694|NCT02249091|26144458|FG001|Overall Study|Physician Decision|1|||
13178695|NCT02249091|26144457|FG000|Overall Study|Withdrawal by Subject|2|||
13178696|NCT02249091|26144458|FG001|Overall Study|Withdrawal by Subject|2|||
13178697|NCT02249091|26144457|FG000|Overall Study|Death|3|||
13178698|NCT02249091|26144458|FG001|Overall Study|Death|4|||
13178699|NCT02249091|26144457|FG000|Overall Study|Adverse Event|1|||
13178700|NCT02249091|26144458|FG001|Overall Study|Adverse Event|0|||
13178701|NCT02249091|26144457|FG000|Overall Study|Stable disease with following SCT|0|||
13178702|NCT02249091|26144458|FG001|Overall Study|Stable disease with following SCT|1|||
13178703|NCT02249091|26144457|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0|||
13178704|NCT02249091|26144458|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1|||
13178705|NCT02249091|26144457|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1|||
13178706|NCT02249091|26144458|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0|||
13178707|NCT02249091|26144457|FG000|Overall Study|Refractory AML|1|||
13178708|NCT02249091|26144458|FG001|Overall Study|Refractory AML|1|||
13178709|NCT02248974|26144541|FG000|1-Day Follow-Up|Lost to Follow-up|4|||
13178710|NCT02248974|26144542|FG001|1-Day Follow-Up|Lost to Follow-up|0|||
13178711|NCT02248974|26144541|FG000|1-Day Follow-Up|Withdrawal by Subject|5|||
13178712|NCT02248974|26144542|FG001|1-Day Follow-Up|Withdrawal by Subject|0|||
13178713|NCT02248974|26144541|FG000|1-Day Follow-Up|Enrolled in another study|1|||
13178714|NCT02248974|26144542|FG001|1-Day Follow-Up|Enrolled in another study|0|||
13178715|NCT02248974|26144541|FG000|1-Week Follow-Up|Became ineligible for LVAD|4|||
13178716|NCT02248974|26144542|FG001|1-Week Follow-Up|Became ineligible for LVAD|1|||
13178717|NCT02248974|26144541|FG000|1-Week Follow-Up|Enrolled in another study|1|||
13178718|NCT02248974|26144542|FG001|1-Week Follow-Up|Enrolled in another study|1|||
13178719|NCT02248974|26144541|FG000|1-Week Follow-Up|Transferred to another facility|1|||
13178720|NCT02248974|26144542|FG001|1-Week Follow-Up|Transferred to another facility|0|||
13178721|NCT02248974|26144541|FG000|1-Week Follow-Up|Cognitive Difficulty|1|||
13178722|NCT02248974|26144542|FG001|1-Week Follow-Up|Cognitive Difficulty|0|||
13178723|NCT02248974|26144541|FG000|1-Week Follow-Up|Death|1|||
13178724|NCT02248974|26144542|FG001|1-Week Follow-Up|Death|1|||
13178725|NCT02248974|26144541|FG000|1-Week Follow-Up|Excluded because of age|0|||
13178726|NCT02248974|26144542|FG001|1-Week Follow-Up|Excluded because of age|1|||
13178727|NCT02248974|26144541|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0|||
13178728|NCT02248974|26144542|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1|||
13178729|NCT02248974|26144541|FG000|1-Week Follow-Up|Timing: implanted before survey|0|||
13178730|NCT02248974|26144542|FG001|1-Week Follow-Up|Timing: implanted before survey|2|||
13178731|NCT02248974|26144541|FG000|1-Week Follow-Up|Withdrawal by Subject|0|||
13178732|NCT02248974|26144542|FG001|1-Week Follow-Up|Withdrawal by Subject|2|||
13178733|NCT02248974|26144541|FG000|1-Week Follow-Up|Lost to Follow-up|0|||
13178734|NCT02248974|26144542|FG001|1-Week Follow-Up|Lost to Follow-up|8|||
13178735|NCT02248974|26144541|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
13178736|NCT02248974|26144542|FG001|1-Month Follow-Up|Lost to Follow-up|3|||
13178737|NCT02248961|26144567|FG000|Overall Study|Adverse Event|1|||
13178738|NCT02248961|26144568|FG001|Overall Study|Adverse Event|0|||
13178739|NCT02248961|26144567|FG000|Overall Study|Withdrawal by Subject|1|||
13178740|NCT02248961|26144568|FG001|Overall Study|Withdrawal by Subject|2|||
13178741|NCT02248961|26144567|FG000|Overall Study|Unmet inclusion/exclusion criteria|1|||
13178742|NCT02248961|26144568|FG001|Overall Study|Unmet inclusion/exclusion criteria|0|||
13178743|NCT02248857|26144607|FG000|3 Month|Withdrawal by Subject|9|||
13178744|NCT02248857|26144608|FG001|3 Month|Withdrawal by Subject|3|||
13178745|NCT02248857|26144609|FG002|3 Month|Withdrawal by Subject|4|||
13178746|NCT02248857|26144607|FG000|3 Month|Unable to reach for 3 month|35|||
13178747|NCT02248857|26144608|FG001|3 Month|Unable to reach for 3 month|29|||
13178748|NCT02248857|26144609|FG002|3 Month|Unable to reach for 3 month|26|||
13178749|NCT02248857|26144607|FG000|3 Month|Partially completed, unable to finish|2|||
13178750|NCT02248857|26144608|FG001|3 Month|Partially completed, unable to finish|2|||
13178751|NCT02248857|26144609|FG002|3 Month|Partially completed, unable to finish|1|||
13178752|NCT02248857|26144607|FG000|6 Month|Lost to Follow-up|27|||
13178753|NCT02248857|26144608|FG001|6 Month|Lost to Follow-up|26|||
13178754|NCT02248857|26144609|FG002|6 Month|Lost to Follow-up|15|||
13178755|NCT02248857|26144607|FG000|6 Month|Partially completed, unable to finish|0|||
13178756|NCT02248857|26144608|FG001|6 Month|Partially completed, unable to finish|1|||
13178757|NCT02248857|26144609|FG002|6 Month|Partially completed, unable to finish|0|||
13178758|NCT02248857|26144607|FG000|6 Month|Withdrawal by Subject|0|||
13178759|NCT02248857|26144608|FG001|6 Month|Withdrawal by Subject|2|||
13178760|NCT02248857|26144609|FG002|6 Month|Withdrawal by Subject|2|||
13178761|NCT02248857|26144607|FG000|6 Month|Death|1|||
13178762|NCT02248857|26144608|FG001|6 Month|Death|0|||
13178763|NCT02248857|26144609|FG002|6 Month|Death|0|||
13178764|NCT02248818|26144773|FG000|Screening|Protocol Violation|0|||
13178765|NCT02248818|26144774|FG001|Screening|Protocol Violation|0|||
13178766|NCT02248818|26144775|FG002|Screening|Protocol Violation|0|||
13178767|NCT02248818|26144776|FG003|Screening|Protocol Violation|0|||
13178768|NCT02248818|26144777|FG004|Screening|Protocol Violation|0|||
13178769|NCT02248818|26144778|FG005|Screening|Protocol Violation|0|||
13178770|NCT02248818|26144779|FG006|Screening|Protocol Violation|0|||
13178771|NCT02248818|26144780|FG007|Screening|Protocol Violation|0|||
13178772|NCT02248818|26144781|FG008|Screening|Protocol Violation|7|||
13178773|NCT02248818|26144773|FG000|Screening|Study fully enrolled|0|||
13178774|NCT02248818|26144774|FG001|Screening|Study fully enrolled|0|||
13178775|NCT02248818|26144775|FG002|Screening|Study fully enrolled|0|||
13178776|NCT02248818|26144776|FG003|Screening|Study fully enrolled|0|||
13178777|NCT02248818|26144777|FG004|Screening|Study fully enrolled|0|||
13178778|NCT02248818|26144778|FG005|Screening|Study fully enrolled|0|||
13178779|NCT02248818|26144779|FG006|Screening|Study fully enrolled|0|||
13178780|NCT02248818|26144780|FG007|Screening|Study fully enrolled|0|||
13178781|NCT02248818|26144781|FG008|Screening|Study fully enrolled|14|||
13178782|NCT02248818|26144773|FG000|Screening|Physician Decision|0|||
13178783|NCT02248818|26144774|FG001|Screening|Physician Decision|0|||
13178784|NCT02248818|26144775|FG002|Screening|Physician Decision|0|||
13178785|NCT02248818|26144776|FG003|Screening|Physician Decision|0|||
13222983|NCT01801358|26287546|FG003|Overall Study|Withdrawal by Subject|1|||
13178786|NCT02248818|26144777|FG004|Screening|Physician Decision|0|||
13178787|NCT02248818|26144778|FG005|Screening|Physician Decision|0|||
13178788|NCT02248818|26144779|FG006|Screening|Physician Decision|0|||
13178789|NCT02248818|26144780|FG007|Screening|Physician Decision|0|||
13178790|NCT02248818|26144781|FG008|Screening|Physician Decision|73|||
13178791|NCT02248818|26144773|FG000|Screening|Withdrawal by Subject|0|||
13178792|NCT02248818|26144774|FG001|Screening|Withdrawal by Subject|0|||
13178793|NCT02248818|26144775|FG002|Screening|Withdrawal by Subject|0|||
13178794|NCT02248818|26144776|FG003|Screening|Withdrawal by Subject|0|||
13178795|NCT02248818|26144777|FG004|Screening|Withdrawal by Subject|0|||
13178796|NCT02248818|26144778|FG005|Screening|Withdrawal by Subject|0|||
13178797|NCT02248818|26144779|FG006|Screening|Withdrawal by Subject|0|||
13178798|NCT02248818|26144780|FG007|Screening|Withdrawal by Subject|0|||
13178799|NCT02248818|26144781|FG008|Screening|Withdrawal by Subject|6|||
13178800|NCT02248818|26144773|FG000|Screening|Lost to Follow-up|0|||
13178801|NCT02248818|26144774|FG001|Screening|Lost to Follow-up|0|||
13178802|NCT02248818|26144775|FG002|Screening|Lost to Follow-up|0|||
13178803|NCT02248818|26144776|FG003|Screening|Lost to Follow-up|0|||
13178804|NCT02248818|26144777|FG004|Screening|Lost to Follow-up|0|||
13178805|NCT02248818|26144778|FG005|Screening|Lost to Follow-up|0|||
13178806|NCT02248818|26144779|FG006|Screening|Lost to Follow-up|0|||
13178807|NCT02248818|26144780|FG007|Screening|Lost to Follow-up|0|||
13178808|NCT02248818|26144781|FG008|Screening|Lost to Follow-up|7|||
13178809|NCT02248818|26144773|FG000|Randomised Study|Administrative - randomization error|0|||
13178810|NCT02248818|26144774|FG001|Randomised Study|Administrative - randomization error|0|||
13178811|NCT02248818|26144775|FG002|Randomised Study|Administrative - randomization error|0|||
13178812|NCT02248818|26144776|FG003|Randomised Study|Administrative - randomization error|0|||
13178813|NCT02248818|26144777|FG004|Randomised Study|Administrative - randomization error|0|||
13178814|NCT02248818|26144778|FG005|Randomised Study|Administrative - randomization error|8|||
13178815|NCT02248818|26144779|FG006|Randomised Study|Administrative - randomization error|0|||
13178816|NCT02248818|26144780|FG007|Randomised Study|Administrative - randomization error|0|||
13178817|NCT02248818|26144781|FG008|Randomised Study|Administrative - randomization error|0|||
13178818|NCT02248675|26144800|FG000|Overall Study|Lost to Follow-up|3|||
13178819|NCT02248675|26144801|FG001|Overall Study|Lost to Follow-up|1|||
13178820|NCT02248649|26144818|FG000|Overall Study|Death|7|||
13178821|NCT02248649|26144819|FG001|Overall Study|Death|11|||
13178822|NCT02248649|26144818|FG000|Overall Study|Lost to Follow-up|14|||
13178823|NCT02248649|26144819|FG001|Overall Study|Lost to Follow-up|10|||
13178824|NCT02248480|26144864|FG000|Overall Study|Lack of Efficacy|4|||
13178825|NCT02248480|26144865|FG001|Overall Study|Lack of Efficacy|6|||
13178826|NCT02248480|26144864|FG000|Overall Study|Adverse Event|11|||
13178827|NCT02248480|26144865|FG001|Overall Study|Adverse Event|2|||
13178828|NCT02248480|26144864|FG000|Overall Study|Withdrawal by Subject|2|||
13178829|NCT02248480|26144865|FG001|Overall Study|Withdrawal by Subject|4|||
13178830|NCT02248480|26144864|FG000|Overall Study|Entry Criteria Not Met|0|||
13109210|NCT03237013|25895015|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43|||
13109211|NCT03237013|25895016|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30|||
13109212|NCT03237013|25895017|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37|||
13109213|NCT03236779|25895036|FG000|Overall Study|Lost to Follow-up|13|||
13109214|NCT03236779|25895037|FG001|Overall Study|Lost to Follow-up|21|||
13109215|NCT03236506|25895067|FG000|Overall Study|Death|1|||
13109216|NCT03236506|25895068|FG001|Overall Study|Death|1|||
13109217|NCT03236506|25895069|FG002|Overall Study|Death|1|||
13109218|NCT03236506|25895067|FG000|Overall Study|Withdrawal by Subject|3|||
13109219|NCT03236506|25895068|FG001|Overall Study|Withdrawal by Subject|3|||
13109220|NCT03236506|25895069|FG002|Overall Study|Withdrawal by Subject|4|||
13109221|NCT03236506|25895067|FG000|Overall Study|Did not initiate treatment|2|||
13109222|NCT03236506|25895068|FG001|Overall Study|Did not initiate treatment|1|||
13109223|NCT03236506|25895069|FG002|Overall Study|Did not initiate treatment|2|||
13178831|NCT02248480|26144865|FG001|Overall Study|Entry Criteria Not Met|1|||
13178832|NCT02248480|26144864|FG000|Overall Study|Other:Physician Decision|0|||
13178833|NCT02248480|26144865|FG001|Overall Study|Other:Physician Decision|1|||
13178834|NCT02247960|26144882|FG000|Patient Consent and Randomization|Physician Decision|2|||
13178835|NCT02247960|26144883|FG001|Patient Consent and Randomization|Physician Decision|2|||
13178836|NCT02247960|26144882|FG000|Patient Consent and Randomization|Withdrawal by Subject|0|||
13178837|NCT02247960|26144883|FG001|Patient Consent and Randomization|Withdrawal by Subject|4|||
13109224|NCT03236246|25895136|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8|||
13109225|NCT03236246|25895137|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7|||
13109226|NCT03236246|25895136|FG000|24-Week Dose Titration Period|Lost to Follow-up|0|||
13109227|NCT03236246|25895137|FG001|24-Week Dose Titration Period|Lost to Follow-up|2|||
13109228|NCT03236246|25895136|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3|||
13109229|NCT03236246|25895137|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2|||
13109230|NCT03236246|25895136|FG000|24-Week Dose Titration Period|Investigator Judgement|1|||
13109231|NCT03236246|25895137|FG001|24-Week Dose Titration Period|Investigator Judgement|1|||
13109232|NCT03236246|25895136|FG000|24-Week Dose Titration Period|Prohibited Therapy|1|||
13109233|NCT03236246|25895137|FG001|24-Week Dose Titration Period|Prohibited Therapy|1|||
13178838|NCT02247960|26144882|FG000|Catheter Removed|Lost to Follow-up|7|||
13109234|NCT03236246|25895136|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0|||
13109235|NCT03236246|25895137|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1|||
13109236|NCT03236246|25895136|FG000|24-Week Dose Titration Period|Death|3|||
13178839|NCT02247960|26144883|FG001|Catheter Removed|Lost to Follow-up|10|||
13178840|NCT02247804|26144922|FG000|Treatment Period 1|Adverse Event|9|||
13178841|NCT02247804|26144923|FG001|Treatment Period 1|Adverse Event|2|||
13178842|NCT02247804|26144924|FG002|Treatment Period 1|Adverse Event|0|||
13178843|NCT02247804|26144922|FG000|Treatment Period 1|Lack of Efficacy|0|||
13178844|NCT02247804|26144923|FG001|Treatment Period 1|Lack of Efficacy|0|||
13178845|NCT02247804|26144924|FG002|Treatment Period 1|Lack of Efficacy|2|||
13178846|NCT02247804|26144922|FG000|Treatment Period 1|Lost to Follow-up|1|||
13178847|NCT02247804|26144923|FG001|Treatment Period 1|Lost to Follow-up|0|||
13178848|NCT02247804|26144924|FG002|Treatment Period 1|Lost to Follow-up|2|||
13178849|NCT02247804|26144922|FG000|Treatment Period 1|Personal Reasons|7|||
13178850|NCT02247804|26144923|FG001|Treatment Period 1|Personal Reasons|1|||
13178851|NCT02247804|26144924|FG002|Treatment Period 1|Personal Reasons|2|||
13178852|NCT02247804|26144922|FG000|Treatment Period 1|Protocol Deviation|0|||
13178853|NCT02247804|26144923|FG001|Treatment Period 1|Protocol Deviation|0|||
13178854|NCT02247804|26144924|FG002|Treatment Period 1|Protocol Deviation|1|||
13178855|NCT02247804|26144922|FG000|Treatment Period 1|Randomized but not Treated|5|||
13178856|NCT02247804|26144923|FG001|Treatment Period 1|Randomized but not Treated|1|||
13178857|NCT02247804|26144924|FG002|Treatment Period 1|Randomized but not Treated|1|||
13178858|NCT02247804|26144922|FG000|Treatment Period 2|Adverse Event|6|||
13109237|NCT03236246|25895137|FG001|24-Week Dose Titration Period|Death|1|||
13109238|NCT03236246|25895136|FG000|24-Week Dose Titration Period|Protocol Violation|0|||
13109239|NCT03236246|25895137|FG001|24-Week Dose Titration Period|Protocol Violation|2|||
13109240|NCT03236246|25895136|FG000|24-Week Dose Titration Period|Adverse Event|7|||
13109241|NCT03236246|25895137|FG001|24-Week Dose Titration Period|Adverse Event|8|||
13109242|NCT03236246|25895136|FG000|24-Week Dose Titration Period|Captured as Other|1|||
13109243|NCT03236246|25895137|FG001|24-Week Dose Titration Period|Captured as Other|2|||
13109244|NCT03236246|25895136|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1|||
13178859|NCT02247804|26144923|FG001|Treatment Period 2|Adverse Event|3|||
13178860|NCT02247804|26144924|FG002|Treatment Period 2|Adverse Event|3|||
13178861|NCT02247804|26144922|FG000|Treatment Period 2|Lack of Efficacy|0|||
13178862|NCT02247804|26144923|FG001|Treatment Period 2|Lack of Efficacy|0|||
13178863|NCT02247804|26144924|FG002|Treatment Period 2|Lack of Efficacy|1|||
13178864|NCT02247804|26144922|FG000|Treatment Period 2|Lost to Follow-up|0|||
13178865|NCT02247804|26144923|FG001|Treatment Period 2|Lost to Follow-up|1|||
13178866|NCT02247804|26144924|FG002|Treatment Period 2|Lost to Follow-up|1|||
13109245|NCT03236246|25895137|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3|||
13178867|NCT02247804|26144922|FG000|Treatment Period 2|Personal Reasons|2|||
13178868|NCT02247804|26144923|FG001|Treatment Period 2|Personal Reasons|1|||
13178869|NCT02247804|26144924|FG002|Treatment Period 2|Personal Reasons|1|||
13178870|NCT02247804|26144922|FG000|Treatment Period 2|Reason not Specified|0|||
13178871|NCT02247804|26144923|FG001|Treatment Period 2|Reason not Specified|0|||
13178872|NCT02247804|26144924|FG002|Treatment Period 2|Reason not Specified|2|||
13178873|NCT02247804|26144922|FG000|Treatment Period 3|Adverse Event|4|||
13178874|NCT02247804|26144923|FG001|Treatment Period 3|Adverse Event|3|||
13178875|NCT02247804|26144924|FG002|Treatment Period 3|Adverse Event|3|||
13178876|NCT02247804|26144922|FG000|Treatment Period 3|Lack of Efficacy|0|||
13178877|NCT02247804|26144923|FG001|Treatment Period 3|Lack of Efficacy|1|||
13178878|NCT02247804|26144924|FG002|Treatment Period 3|Lack of Efficacy|0|||
13178879|NCT02247804|26144922|FG000|Treatment Period 3|Lost to Follow-up|1|||
13178880|NCT02247804|26144923|FG001|Treatment Period 3|Lost to Follow-up|2|||
13178881|NCT02247804|26144924|FG002|Treatment Period 3|Lost to Follow-up|2|||
13178882|NCT02247804|26144922|FG000|Treatment Period 3|Personal Reasons|4|||
13178883|NCT02247804|26144923|FG001|Treatment Period 3|Personal Reasons|3|||
13178884|NCT02247804|26144924|FG002|Treatment Period 3|Personal Reasons|2|||
13178885|NCT02247804|26144922|FG000|Treatment Period 3|Reason not Specified|2|||
13178886|NCT02247804|26144923|FG001|Treatment Period 3|Reason not Specified|1|||
13178887|NCT02247804|26144924|FG002|Treatment Period 3|Reason not Specified|3|||
13178888|NCT02247531|26144981|FG000|Overall Study|Adverse Event|3|||
13178889|NCT02247531|26144982|FG001|Overall Study|Adverse Event|4|||
13178890|NCT02247531|26144983|FG002|Overall Study|Adverse Event|9|||
13178891|NCT02247531|26144981|FG000|Overall Study|Death|8|||
13178892|NCT02247531|26144982|FG001|Overall Study|Death|9|||
13178893|NCT02247531|26144983|FG002|Overall Study|Death|5|||
13178894|NCT02247531|26144981|FG000|Overall Study|Lost to Follow-up|1|||
13178895|NCT02247531|26144982|FG001|Overall Study|Lost to Follow-up|8|||
13178896|NCT02247531|26144983|FG002|Overall Study|Lost to Follow-up|3|||
13109246|NCT03236246|25895136|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
13109247|NCT03236246|25895137|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
13178897|NCT02247531|26144981|FG000|Overall Study|Non-compliance|2|||
13178898|NCT02247531|26144982|FG001|Overall Study|Non-compliance|2|||
13178899|NCT02247531|26144983|FG002|Overall Study|Non-compliance|0|||
13178900|NCT02247531|26144981|FG000|Overall Study|Withdrawal by Subject|26|||
13178901|NCT02247531|26144982|FG001|Overall Study|Withdrawal by Subject|31|||
13178902|NCT02247531|26144983|FG002|Overall Study|Withdrawal by Subject|25|||
13178903|NCT02247531|26144981|FG000|Overall Study|Study Terminated by Sponsor|64|||
13178904|NCT02247531|26144982|FG001|Overall Study|Study Terminated by Sponsor|66|||
13178905|NCT02247531|26144983|FG002|Overall Study|Study Terminated by Sponsor|62|||
13178906|NCT02247531|26144981|FG000|Overall Study|Physician Decision|0|||
13178907|NCT02247531|26144982|FG001|Overall Study|Physician Decision|2|||
13178908|NCT02247531|26144983|FG002|Overall Study|Physician Decision|2|||
13178909|NCT02247531|26144981|FG000|Overall Study|Unspecified Reason|2|||
13178910|NCT02247531|26144982|FG001|Overall Study|Unspecified Reason|3|||
13178911|NCT02247531|26144983|FG002|Overall Study|Unspecified Reason|4|||
13178912|NCT02247479|26145040|FG000|Overall Study|Adverse Event|8|||
13178913|NCT02247479|26145041|FG001|Overall Study|Adverse Event|9|||
13178914|NCT02247479|26145042|FG002|Overall Study|Adverse Event|8|||
13178915|NCT02247479|26145040|FG000|Overall Study|Death|5|||
13178916|NCT02247479|26145041|FG001|Overall Study|Death|4|||
13178917|NCT02247479|26145042|FG002|Overall Study|Death|6|||
13178918|NCT02247479|26145040|FG000|Overall Study|Lost to Follow-up|3|||
13178919|NCT02247479|26145041|FG001|Overall Study|Lost to Follow-up|3|||
13178920|NCT02247479|26145042|FG002|Overall Study|Lost to Follow-up|1|||
13178921|NCT02247479|26145040|FG000|Overall Study|Non-compliance|0|||
13178922|NCT02247479|26145041|FG001|Overall Study|Non-compliance|0|||
13178923|NCT02247479|26145042|FG002|Overall Study|Non-compliance|1|||
13178924|NCT02247479|26145040|FG000|Overall Study|Withdrawal by Subject|25|||
13178925|NCT02247479|26145041|FG001|Overall Study|Withdrawal by Subject|29|||
13178926|NCT02247479|26145042|FG002|Overall Study|Withdrawal by Subject|24|||
13178927|NCT02247479|26145040|FG000|Overall Study|Study Terminated by Sponsor|98|||
13178928|NCT02247479|26145041|FG001|Overall Study|Study Terminated by Sponsor|88|||
13178929|NCT02247479|26145042|FG002|Overall Study|Study Terminated by Sponsor|94|||
13178930|NCT02247479|26145040|FG000|Overall Study|Physician Decision|1|||
13178931|NCT02247479|26145041|FG001|Overall Study|Physician Decision|0|||
13109248|NCT03236246|25895136|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1|||
13178932|NCT02247479|26145042|FG002|Overall Study|Physician Decision|2|||
13178933|NCT02247479|26145040|FG000|Overall Study|Unspecified Reason|2|||
13178934|NCT02247479|26145041|FG001|Overall Study|Unspecified Reason|5|||
13178935|NCT02247479|26145042|FG002|Overall Study|Unspecified Reason|2|||
13109249|NCT03236246|25895137|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0|||
13109250|NCT03236246|25895136|FG000|24-Week Dose Maintenance Period|Death|0|||
13109251|NCT03236246|25895137|FG001|24-Week Dose Maintenance Period|Death|1|||
13109252|NCT03236246|25895136|FG000|24-Week Dose Maintenance Period|Adverse Event|0|||
13205914|NCT01961609|26233063|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
13205915|NCT01961609|26233064|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3|||
13205916|NCT01961609|26233065|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
13205917|NCT01961609|26233062|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3|||
13205918|NCT01961609|26233063|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
13205919|NCT01961609|26233064|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1|||
13205920|NCT01961609|26233065|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
13205921|NCT01961609|26233062|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
13205922|NCT01961609|26233063|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
13205923|NCT01961609|26233064|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
13205924|NCT01961609|26233065|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
13205925|NCT01961609|26233062|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13|||
13205926|NCT01961609|26233063|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4|||
13205927|NCT01961609|26233064|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10|||
13205928|NCT01961609|26233065|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0|||
13109253|NCT03236246|25895137|FG001|24-Week Dose Maintenance Period|Adverse Event|1|||
13205929|NCT01961609|26233062|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
13205930|NCT01961609|26233063|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
13178936|NCT02247466|26145067|FG000|Overall Study|Procedure changed to open surgery|0|||
13178937|NCT02247466|26145068|FG001|Overall Study|Procedure changed to open surgery|3|||
13178938|NCT02247440|26145080|FG000|Overall Study|Withdrawal by Subject|1|||
13178939|NCT02247440|26145080|FG000|Overall Study|Lack of Efficacy|3|||
13178940|NCT02247401|26145107|FG000|Overall Study|Adverse Event|1|||
13178941|NCT02247401|26145108|FG001|Overall Study|Adverse Event|0|||
13178942|NCT02247401|26145109|FG002|Overall Study|Adverse Event|0|||
13178943|NCT02247401|26145107|FG000|Overall Study|Withdrawal by Subject|4|||
13178944|NCT02247401|26145108|FG001|Overall Study|Withdrawal by Subject|1|||
13178945|NCT02247401|26145109|FG002|Overall Study|Withdrawal by Subject|1|||
13109254|NCT03235726|25895316|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
13109255|NCT03235726|25895317|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
13109256|NCT03235726|25895318|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
13109257|NCT03235726|25895319|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
13178946|NCT02247401|26145107|FG000|Overall Study|Lost to Follow-up|1|||
13178947|NCT02247401|26145108|FG001|Overall Study|Lost to Follow-up|1|||
13178948|NCT02247401|26145109|FG002|Overall Study|Lost to Follow-up|1|||
13178949|NCT02247011|26145132|FG000|Overall Study|Poor quality of radiological results|125|||
13178950|NCT02246998|26145255|FG000|Overall Study|Adverse Event|0|||
13178951|NCT02246998|26145256|FG001|Overall Study|Adverse Event|1|||
13178952|NCT02246998|26145257|FG002|Overall Study|Adverse Event|1|||
13178953|NCT02246998|26145258|FG003|Overall Study|Adverse Event|0|||
13178954|NCT02246998|26145255|FG000|Overall Study|Lost to Follow-up|1|||
13178955|NCT02246998|26145256|FG001|Overall Study|Lost to Follow-up|0|||
13178956|NCT02246998|26145257|FG002|Overall Study|Lost to Follow-up|0|||
13178957|NCT02246998|26145258|FG003|Overall Study|Lost to Follow-up|1|||
13178958|NCT02246998|26145255|FG000|Overall Study|Randomized but Never Dosed|1|||
13178959|NCT02246998|26145256|FG001|Overall Study|Randomized but Never Dosed|2|||
13178960|NCT02246998|26145257|FG002|Overall Study|Randomized but Never Dosed|2|||
13178961|NCT02246998|26145258|FG003|Overall Study|Randomized but Never Dosed|1|||
13178962|NCT02246777|26145273|FG000|Overall Study|Adverse Event|2|||
13178963|NCT02246777|26145273|FG000|Overall Study|Change of residence|1|||
13178964|NCT02246764|26145291|FG000|Overall Study|Adverse Event|15|||
13178965|NCT02246764|26145292|FG001|Overall Study|Adverse Event|29|||
13109258|NCT03235726|25895320|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1|||
13178966|NCT02246764|26145293|FG002|Overall Study|Adverse Event|1|||
13178967|NCT02246764|26145291|FG000|Overall Study|Withdrawal by Subject|0|||
13178968|NCT02246764|26145292|FG001|Overall Study|Withdrawal by Subject|0|||
13178969|NCT02246764|26145293|FG002|Overall Study|Withdrawal by Subject|1|||
13178970|NCT02246764|26145291|FG000|Overall Study|Disallowed Concomitant Medication|1|||
13178971|NCT02246764|26145292|FG001|Overall Study|Disallowed Concomitant Medication|0|||
13178972|NCT02246764|26145293|FG002|Overall Study|Disallowed Concomitant Medication|0|||
13178973|NCT02246764|26145291|FG000|Overall Study|Physician Decision|0|||
13178974|NCT02246764|26145292|FG001|Overall Study|Physician Decision|2|||
13178975|NCT02246764|26145293|FG002|Overall Study|Physician Decision|1|||
13109259|NCT03235726|25895321|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
13109260|NCT03235726|25895322|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
13109261|NCT03235726|25895323|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
13109262|NCT03235726|25895324|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
13109263|NCT03235726|25895325|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
13109264|NCT03235726|25895316|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
13109265|NCT03235726|25895317|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
13109266|NCT03235726|25895318|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
13109267|NCT03235726|25895319|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
13109268|NCT03235726|25895320|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1|||
13178976|NCT02246764|26145291|FG000|Overall Study|Protocol Violation|2|||
13178977|NCT02246764|26145292|FG001|Overall Study|Protocol Violation|1|||
13178978|NCT02246764|26145293|FG002|Overall Study|Protocol Violation|1|||
13178979|NCT02246673|26145414|FG000|Overall Study|Sponsor Decision|1|||
13178980|NCT02246673|26145415|FG001|Overall Study|Sponsor Decision|0|||
13178981|NCT02246673|26145416|FG002|Overall Study|Sponsor Decision|0|||
13178982|NCT02246673|26145417|FG003|Overall Study|Sponsor Decision|0|||
13178983|NCT02246673|26145418|FG004|Overall Study|Sponsor Decision|0|||
13178984|NCT02246673|26145414|FG000|Overall Study|Withdrawal by Subject|0|||
13178985|NCT02246673|26145415|FG001|Overall Study|Withdrawal by Subject|0|||
13178986|NCT02246673|26145416|FG002|Overall Study|Withdrawal by Subject|0|||
13178987|NCT02246673|26145417|FG003|Overall Study|Withdrawal by Subject|0|||
13178988|NCT02246673|26145418|FG004|Overall Study|Withdrawal by Subject|1|||
13178989|NCT02246673|26145414|FG000|Overall Study|Lost to Follow-up|0|||
13178990|NCT02246673|26145415|FG001|Overall Study|Lost to Follow-up|0|||
13178991|NCT02246673|26145416|FG002|Overall Study|Lost to Follow-up|0|||
13178992|NCT02246673|26145417|FG003|Overall Study|Lost to Follow-up|1|||
13178993|NCT02246673|26145418|FG004|Overall Study|Lost to Follow-up|0|||
13178994|NCT02246673|26145414|FG000|Overall Study|Protocol Violation|0|||
13109269|NCT03235726|25895321|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
13109270|NCT03235726|25895322|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
13109271|NCT03235726|25895323|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
13109272|NCT03235726|25895324|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
13109273|NCT03235726|25895325|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
13109274|NCT03235544|25895373|FG000|Overall Study|Participants Still Ongoing in the Study|1|||
13109275|NCT03235544|25895374|FG001|Overall Study|Participants Still Ongoing in the Study|13|||
13109276|NCT03235544|25895375|FG002|Overall Study|Participants Still Ongoing in the Study|19|||
13109277|NCT03235544|25895376|FG003|Overall Study|Participants Still Ongoing in the Study|55|||
13109278|NCT03235544|25895373|FG000|Overall Study|Death|11|||
13109279|NCT03235544|25895374|FG001|Overall Study|Death|23|||
13109280|NCT03235544|25895375|FG002|Overall Study|Death|11|||
13178995|NCT02246673|26145415|FG001|Overall Study|Protocol Violation|0|||
13178996|NCT02246673|26145416|FG002|Overall Study|Protocol Violation|0|||
13178997|NCT02246673|26145417|FG003|Overall Study|Protocol Violation|1|||
13178998|NCT02246673|26145418|FG004|Overall Study|Protocol Violation|0|||
13178999|NCT02246660|26145436|FG000|Overall Study|Withdrawal by Subject|0|||
13179000|NCT02246660|26145437|FG001|Overall Study|Withdrawal by Subject|1|||
13179001|NCT02246660|26145438|FG002|Overall Study|Withdrawal by Subject|0|||
13179002|NCT02246660|26145436|FG000|Overall Study|Death|0|||
13179003|NCT02246660|26145437|FG001|Overall Study|Death|0|||
13179004|NCT02246660|26145438|FG002|Overall Study|Death|1|||
13179005|NCT02246647|26145477|FG000|Overall Study|Withdrawal by Subject|1|||
13179006|NCT02246647|26145478|FG001|Overall Study|Withdrawal by Subject|1|||
13179007|NCT02246621|26145511|FG000|Overall Study|Withdrawal by Subject|28|||
13179008|NCT02246621|26145512|FG001|Overall Study|Withdrawal by Subject|16|||
13179009|NCT02246621|26145511|FG000|Overall Study|Lost to Follow-up|1|||
13179010|NCT02246621|26145512|FG001|Overall Study|Lost to Follow-up|0|||
13179011|NCT02246621|26145511|FG000|Overall Study|On Study Treatment/ Follow Up|236|||
13179012|NCT02246621|26145512|FG001|Overall Study|On Study Treatment/ Follow Up|119|||
13179013|NCT02246582|26145521|FG000|Overall Study|Withdrawal by Subject|3|||
13179014|NCT02246582|26145522|FG001|Overall Study|Withdrawal by Subject|4|||
13179015|NCT02246478|26145559|FG000|Multiple-dose Phase|Protocol Violation|1|||
13179016|NCT02246478|26145560|FG001|Multiple-dose Phase|Protocol Violation|0|||
13179017|NCT02246478|26145561|FG002|Multiple-dose Phase|Protocol Violation|0|||
13179018|NCT02246478|26145562|FG003|Multiple-dose Phase|Protocol Violation|1|||
13205931|NCT01961609|26233064|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3|||
13205932|NCT01961609|26233065|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0|||
13205933|NCT01961609|26233062|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
13205934|NCT01961609|26233063|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
13205935|NCT01961609|26233064|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1|||
13205936|NCT01961609|26233065|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
13205937|NCT01961609|26233062|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7|||
13205938|NCT01961609|26233063|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5|||
13205939|NCT01961609|26233064|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0|||
13205940|NCT01961609|26233065|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4|||
13205941|NCT01961609|26233062|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
13205942|NCT01961609|26233063|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
13205943|NCT01961609|26233064|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1|||
13205944|NCT01961609|26233065|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
13205945|NCT01961609|26233062|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1|||
13205946|NCT01961609|26233063|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
13205947|NCT01961609|26233064|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
13205948|NCT01961609|26233065|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
13205949|NCT01961609|26233062|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
13205950|NCT01961609|26233063|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1|||
13205951|NCT01961609|26233064|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
13205952|NCT01961609|26233065|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
13205953|NCT01961609|26233062|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
13205954|NCT01961609|26233063|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0|||
13205955|NCT01961609|26233064|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
13205956|NCT01961609|26233065|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1|||
13205957|NCT01961609|26233062|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1|||
13205958|NCT01961609|26233063|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
13205959|NCT01961609|26233064|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
13205960|NCT01961609|26233065|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2|||
13205961|NCT01961544|26233072|FG000|Overall Study|Protocol Violation|1|||
13205962|NCT01961544|26233072|FG000|Overall Study|Withdrawal by Subject|7|||
13205963|NCT01961544|26233072|FG000|Overall Study|Adverse Event|1|||
13205964|NCT01961544|26233072|FG000|Overall Study|Physician Decision|2|||
13205965|NCT01961544|26233072|FG000|Overall Study|Poor Tolerance|1|||
13179019|NCT02246439|26145605|FG000|Overall Study|Adverse Event|3|||
13179020|NCT02246439|26145606|FG001|Overall Study|Adverse Event|0|||
13179021|NCT02246439|26145605|FG000|Overall Study|Lost to Follow-up|7|||
13179022|NCT02246439|26145606|FG001|Overall Study|Lost to Follow-up|5|||
13179023|NCT02246439|26145605|FG000|Overall Study|Protocol Violation|0|||
13179024|NCT02246439|26145606|FG001|Overall Study|Protocol Violation|2|||
13179025|NCT02246439|26145605|FG000|Overall Study|Physician Decision|0|||
13179026|NCT02246439|26145606|FG001|Overall Study|Physician Decision|1|||
13179027|NCT02246439|26145605|FG000|Overall Study|Unkonwn|1|||
13179028|NCT02246439|26145606|FG001|Overall Study|Unkonwn|3|||
13179029|NCT02246439|26145605|FG000|Overall Study|Withdrawal by Subject|1|||
13179030|NCT02246439|26145606|FG001|Overall Study|Withdrawal by Subject|0|||
13179031|NCT02246218|26145671|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
13179032|NCT02246218|26145672|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
13179033|NCT02246218|26145671|FG000|Overall Study|Stopping Rule: Liver Transplant|2|||
13179034|NCT02246218|26145672|FG001|Overall Study|Stopping Rule: Liver Transplant|4|||
13179035|NCT02246218|26145671|FG000|Overall Study|Adverse Event|1|||
13179036|NCT02246218|26145672|FG001|Overall Study|Adverse Event|1|||
13179037|NCT02246218|26145671|FG000|Overall Study|Lost to Follow-up|1|||
13179038|NCT02246218|26145672|FG001|Overall Study|Lost to Follow-up|0|||
13179039|NCT02246166|26145713|FG000|Overall Study|Protocol Violation|1|||
13179040|NCT02246166|26145714|FG001|Overall Study|Protocol Violation|0|||
13179041|NCT02246114|26145727|FG000|Overall Study|miscarriage|1|||
13179042|NCT02246114|26145728|FG001|Overall Study|miscarriage|0|||
13179043|NCT02245737|26145793|FG000|Overall Study|Adverse Event|23|||
13179044|NCT02245737|26145794|FG001|Overall Study|Adverse Event|26|||
13179045|NCT02245737|26145795|FG002|Overall Study|Adverse Event|33|||
13179046|NCT02245737|26145793|FG000|Overall Study|Condition Worsened|9|||
13179047|NCT02245737|26145794|FG001|Overall Study|Condition Worsened|10|||
13179048|NCT02245737|26145795|FG002|Overall Study|Condition Worsened|9|||
13179049|NCT02245737|26145793|FG000|Overall Study|Death|2|||
13179050|NCT02245737|26145794|FG001|Overall Study|Death|4|||
13179051|NCT02245737|26145795|FG002|Overall Study|Death|4|||
13109281|NCT03235544|25895376|FG003|Overall Study|Death|20|||
13109282|NCT03235544|25895373|FG000|Overall Study|Lost to Follow-up|0|||
13109283|NCT03235544|25895374|FG001|Overall Study|Lost to Follow-up|1|||
13109284|NCT03235544|25895375|FG002|Overall Study|Lost to Follow-up|0|||
13109285|NCT03235544|25895376|FG003|Overall Study|Lost to Follow-up|1|||
13109286|NCT03235544|25895373|FG000|Overall Study|Withdrawal by Participant|0|||
13109287|NCT03235544|25895374|FG001|Overall Study|Withdrawal by Participant|0|||
13109288|NCT03235544|25895375|FG002|Overall Study|Withdrawal by Participant|1|||
13109289|NCT03235544|25895376|FG003|Overall Study|Withdrawal by Participant|0|||
13109290|NCT03235544|25895373|FG000|Overall Study|Reason not Specified|0|||
13109291|NCT03235544|25895374|FG001|Overall Study|Reason not Specified|4|||
13109292|NCT03235544|25895375|FG002|Overall Study|Reason not Specified|0|||
13109293|NCT03235544|25895376|FG003|Overall Study|Reason not Specified|1|||
13109294|NCT03235349|25895385|FG000|Overall Study|Adverse Event|1|||
13109295|NCT03235349|25895385|FG000|Overall Study|Other|1|||
13109296|NCT03235284|25895412|FG000|Overall Study|Adverse Event|1|||
13109297|NCT03235284|25895413|FG001|Overall Study|Adverse Event|2|||
13109298|NCT03235284|25895414|FG002|Overall Study|Adverse Event|1|||
13109299|NCT03235154|25895422|FG000|Overall Study|Withdrawal by Subject|1|||
13179052|NCT02245737|26145793|FG000|Overall Study|Eligibility Criteria No Longer Met|2|||
13179053|NCT02245737|26145794|FG001|Overall Study|Eligibility Criteria No Longer Met|4|||
13179054|NCT02245737|26145795|FG002|Overall Study|Eligibility Criteria No Longer Met|4|||
13179055|NCT02245737|26145793|FG000|Overall Study|Initiation of Symptomatic AD medication|2|||
13179056|NCT02245737|26145794|FG001|Overall Study|Initiation of Symptomatic AD medication|0|||
13179057|NCT02245737|26145795|FG002|Overall Study|Initiation of Symptomatic AD medication|0|||
13179058|NCT02245737|26145793|FG000|Overall Study|Lost to Follow-up|2|||
13179059|NCT02245737|26145794|FG001|Overall Study|Lost to Follow-up|5|||
13179060|NCT02245737|26145795|FG002|Overall Study|Lost to Follow-up|4|||
13179061|NCT02245737|26145793|FG000|Overall Study|Other-determined by Investigator|9|||
13179062|NCT02245737|26145794|FG001|Overall Study|Other-determined by Investigator|10|||
13179063|NCT02245737|26145795|FG002|Overall Study|Other-determined by Investigator|10|||
13179064|NCT02245737|26145793|FG000|Overall Study|Physician Decision|6|||
13179065|NCT02245737|26145794|FG001|Overall Study|Physician Decision|3|||
13179066|NCT02245737|26145795|FG002|Overall Study|Physician Decision|6|||
13179067|NCT02245737|26145793|FG000|Overall Study|Protocol Violation|3|||
13109300|NCT03235154|25895422|FG000|Overall Study|Adverse Event|1|||
13109301|NCT03235154|25895422|FG000|Overall Study|Lost to Follow-up|2|||
13109302|NCT03235115|25895449|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
13109303|NCT03235115|25895450|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
13109304|NCT03235115|25895451|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
13109305|NCT03235115|25895452|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
13109306|NCT03235115|25895453|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
13179068|NCT02245737|26145794|FG001|Overall Study|Protocol Violation|2|||
13179069|NCT02245737|26145795|FG002|Overall Study|Protocol Violation|3|||
13109307|NCT03235115|25895454|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1|||
13109308|NCT03235089|25895493|FG000|Overall Study|Lost to Follow-up|1|||
13109309|NCT03235089|25895494|FG001|Overall Study|Lost to Follow-up|1|||
13109310|NCT03235089|25895493|FG000|Overall Study|Physician Decision|2|||
13109311|NCT03235089|25895494|FG001|Overall Study|Physician Decision|2|||
13109312|NCT03235050|25895569|FG000|Overall Study|Adverse Event|0|||
13109313|NCT03235050|25895570|FG001|Overall Study|Adverse Event|0|||
13109314|NCT03235050|25895571|FG002|Overall Study|Adverse Event|1|||
13109315|NCT03235050|25895572|FG003|Overall Study|Adverse Event|4|||
13109316|NCT03235050|25895573|FG004|Overall Study|Adverse Event|1|||
13109317|NCT03235050|25895569|FG000|Overall Study|Death|0|||
13109318|NCT03235050|25895570|FG001|Overall Study|Death|0|||
13179070|NCT02245737|26145793|FG000|Overall Study|Withdrawal by Subject|40|||
13179071|NCT02245737|26145794|FG001|Overall Study|Withdrawal by Subject|41|||
13179072|NCT02245737|26145795|FG002|Overall Study|Withdrawal by Subject|44|||
13179073|NCT02245737|26145793|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10|||
13179074|NCT02245737|26145794|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20|||
13179075|NCT02245737|26145795|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22|||
13179076|NCT02245737|26145793|FG000|Overall Study|Sponsor Decision|445|||
13179077|NCT02245737|26145794|FG001|Overall Study|Sponsor Decision|430|||
13179078|NCT02245737|26145795|FG002|Overall Study|Sponsor Decision|432|||
13179079|NCT02245620|26145814|FG000|Overall Study|Physician Decision|1|||
13179080|NCT02245620|26145815|FG001|Overall Study|Physician Decision|1|||
13179081|NCT02245568|26145821|FG000|Overall Study|Study terminated by Sponsor|346|||
13179082|NCT02245568|26145821|FG000|Overall Study|Adverse Event|144|||
13179083|NCT02245568|26145821|FG000|Overall Study|Lack of Efficacy|98|||
13179084|NCT02245568|26145821|FG000|Overall Study|Withdrawal by Caregiver|85|||
13179085|NCT02245568|26145821|FG000|Overall Study|Withdrawal by Subject|77|||
13179086|NCT02245568|26145821|FG000|Overall Study|Withdrawal by Legal Representative|31|||
13179087|NCT02245568|26145821|FG000|Overall Study|Missing (Site closure)|16|||
13179088|NCT02245568|26145821|FG000|Overall Study|Physician Decision|14|||
13179089|NCT02245568|26145821|FG000|Overall Study|Non-compliance with study drug|11|||
13179090|NCT02245568|26145821|FG000|Overall Study|Death|9|||
13179091|NCT02245568|26145821|FG000|Overall Study|Blue staining|6|||
13179092|NCT02245568|26145821|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6|||
13179093|NCT02245568|26145821|FG000|Overall Study|Intolerance/dosing issues/interruption|5|||
13179094|NCT02245568|26145821|FG000|Overall Study|Lost to Follow-up|5|||
13179095|NCT02245412|26145848|FG000|Treatment Period|Death|1|||
13179096|NCT02245412|26145849|FG001|Treatment Period|Death|1|||
13179097|NCT02245412|26145850|FG002|Treatment Period|Death|0|||
13179098|NCT02245412|26145848|FG000|Treatment Period|Physician Decision|1|||
13179099|NCT02245412|26145849|FG001|Treatment Period|Physician Decision|1|||
13179100|NCT02245412|26145850|FG002|Treatment Period|Physician Decision|0|||
13179101|NCT02245412|26145848|FG000|Treatment Period|Withdrawal by Subject|2|||
13179102|NCT02245412|26145849|FG001|Treatment Period|Withdrawal by Subject|1|||
13179103|NCT02245412|26145850|FG002|Treatment Period|Withdrawal by Subject|0|||
13179104|NCT02245412|26145848|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1|||
13179105|NCT02245412|26145849|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0|||
13179106|NCT02245412|26145850|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0|||
13179107|NCT02245412|26145848|FG000|Follow-Up Period|Death|4|||
13179108|NCT02245412|26145849|FG001|Follow-Up Period|Death|2|||
13179109|NCT02245412|26145850|FG002|Follow-Up Period|Death|1|||
13179110|NCT02245412|26145848|FG000|Follow-Up Period|Physician Decision|1|||
13179111|NCT02245412|26145849|FG001|Follow-Up Period|Physician Decision|0|||
13179112|NCT02245412|26145850|FG002|Follow-Up Period|Physician Decision|0|||
13179113|NCT02245412|26145848|FG000|Follow-Up Period|Other - Terminated by Sponsor|0|||
13179114|NCT02245412|26145849|FG001|Follow-Up Period|Other - Terminated by Sponsor|0|||
13179115|NCT02245412|26145850|FG002|Follow-Up Period|Other - Terminated by Sponsor|1|||
13179116|NCT02244996|26145869|FG000|Overall Study|Lack of Efficacy|2|||
13179117|NCT02244996|26145870|FG001|Overall Study|Lack of Efficacy|6|||
13179118|NCT02244957|26145921|FG000|Overall Study|Lack of Efficacy|1|||
13179119|NCT02244957|26145922|FG001|Overall Study|Lack of Efficacy|0|||
13179120|NCT02244944|26145930|FG000|Overall Study|Withdrawal by Subject|1|||
13179121|NCT02244944|26145930|FG000|Overall Study|Study Terminated|1|||
13179122|NCT02244619|26145955|FG000|Overall Study|Did not receive study intervention|8|||
13179123|NCT02244619|26145956|FG001|Overall Study|Did not receive study intervention|21|||
13179124|NCT02244580|26145966|FG000|Overall Study|No cancer tissues available|241|||
13179125|NCT02244424|26145979|FG000|Overall Study|Lost to Follow-up|20|||
13179126|NCT02244424|26145980|FG001|Overall Study|Lost to Follow-up|10|||
13179127|NCT02243865|26146009|FG000|Overall Study|Protocol Violation|1|||
13179128|NCT02243865|26146010|FG001|Overall Study|Protocol Violation|3|||
13179129|NCT02243865|26146009|FG000|Overall Study|Lost to Follow-up|1|||
13179130|NCT02243865|26146010|FG001|Overall Study|Lost to Follow-up|1|||
13179131|NCT02243865|26146009|FG000|Overall Study|Withdrawal by Subject|1|||
13179132|NCT02243865|26146010|FG001|Overall Study|Withdrawal by Subject|0|||
13179133|NCT02243865|26146009|FG000|Overall Study|Adverse Event|1|||
13109319|NCT03235050|25895571|FG002|Overall Study|Death|0|||
13179134|NCT02243865|26146010|FG001|Overall Study|Adverse Event|1|||
13179135|NCT02243696|26146022|FG000|Overall Study|Death|282|||
13179136|NCT02243696|26146022|FG000|Overall Study|Withdrawal by Subject|79|||
13179137|NCT02243696|26146022|FG000|Overall Study|Lost to Follow-up|57|||
13179138|NCT02243696|26146022|FG000|Overall Study|Subject No Longer has Study System|42|||
13179139|NCT02243696|26146022|FG000|Overall Study|Subject Withdrawn by Investigator|273|||
13179140|NCT02243696|26146022|FG000|Overall Study|Study Terminated for EP PASSION|961|||
13179141|NCT02243631|26146035|FG000|Overall Study|no synovial fluid on second aspirate|0|||
13179142|NCT02243631|26146036|FG001|Overall Study|no synovial fluid on second aspirate|1|||
13179143|NCT02243371|26146061|FG000|Overall Study|Progressive Disease (clinic & radio)|35|||
13179144|NCT02243371|26146062|FG001|Overall Study|Progressive Disease (clinic & radio)|24|||
13179145|NCT02243371|26146061|FG000|Overall Study|Death (unrelated)|2|||
13179146|NCT02243371|26146062|FG001|Overall Study|Death (unrelated)|4|||
13179147|NCT02243371|26146061|FG000|Overall Study|Adverse Event (unrelated)|0|||
13179148|NCT02243371|26146062|FG001|Overall Study|Adverse Event (unrelated)|1|||
13179149|NCT02243371|26146061|FG000|Overall Study|Lack of Clinical Benefit|0|||
13179150|NCT02243371|26146062|FG001|Overall Study|Lack of Clinical Benefit|1|||
13179151|NCT02243371|26146061|FG000|Overall Study|Withdrawal by Subject|0|||
13179152|NCT02243371|26146062|FG001|Overall Study|Withdrawal by Subject|2|||
13179153|NCT02243293|26146207|FG000|Overall Study|Adverse Event|1|||
13179154|NCT02243293|26146208|FG001|Overall Study|Adverse Event|0|||
13179155|NCT02243293|26146209|FG002|Overall Study|Adverse Event|0|||
13179156|NCT02243293|26146210|FG003|Overall Study|Adverse Event|0|||
13179157|NCT02243293|26146211|FG004|Overall Study|Adverse Event|0|||
13179158|NCT02243293|26146212|FG005|Overall Study|Adverse Event|0|||
13179159|NCT02243293|26146213|FG006|Overall Study|Adverse Event|0|||
13179160|NCT02243293|26146214|FG007|Overall Study|Adverse Event|0|||
13179161|NCT02243293|26146215|FG008|Overall Study|Adverse Event|0|||
13179162|NCT02243293|26146216|FG009|Overall Study|Adverse Event|0|||
13179163|NCT02243293|26146217|FG010|Overall Study|Adverse Event|0|||
13179164|NCT02243293|26146218|FG011|Overall Study|Adverse Event|0|||
13179165|NCT02243293|26146219|FG012|Overall Study|Adverse Event|0|||
13179166|NCT02243293|26146220|FG013|Overall Study|Adverse Event|0|||
13179167|NCT02243293|26146221|FG014|Overall Study|Adverse Event|0|||
13179168|NCT02243293|26146222|FG015|Overall Study|Adverse Event|1|||
13179169|NCT02243293|26146223|FG016|Overall Study|Adverse Event|0|||
13179170|NCT02243293|26146224|FG017|Overall Study|Adverse Event|0|||
13179171|NCT02243293|26146225|FG018|Overall Study|Adverse Event|0|||
13179172|NCT02243293|26146226|FG019|Overall Study|Adverse Event|0|||
13179173|NCT02243293|26146227|FG020|Overall Study|Adverse Event|1|||
13179174|NCT02243293|26146228|FG021|Overall Study|Adverse Event|0|||
13179175|NCT02243293|26146207|FG000|Overall Study|Withdrawal by Subject|1|||
13179176|NCT02243293|26146208|FG001|Overall Study|Withdrawal by Subject|0|||
13179177|NCT02243293|26146209|FG002|Overall Study|Withdrawal by Subject|0|||
13179178|NCT02243293|26146210|FG003|Overall Study|Withdrawal by Subject|0|||
13179179|NCT02243293|26146211|FG004|Overall Study|Withdrawal by Subject|0|||
13179180|NCT02243293|26146212|FG005|Overall Study|Withdrawal by Subject|0|||
13179181|NCT02243293|26146213|FG006|Overall Study|Withdrawal by Subject|0|||
13179182|NCT02243293|26146214|FG007|Overall Study|Withdrawal by Subject|0|||
13179183|NCT02243293|26146215|FG008|Overall Study|Withdrawal by Subject|0|||
13179184|NCT02243293|26146216|FG009|Overall Study|Withdrawal by Subject|1|||
13179185|NCT02243293|26146217|FG010|Overall Study|Withdrawal by Subject|0|||
13179186|NCT02243293|26146218|FG011|Overall Study|Withdrawal by Subject|1|||
13179187|NCT02243293|26146219|FG012|Overall Study|Withdrawal by Subject|0|||
13179188|NCT02243293|26146220|FG013|Overall Study|Withdrawal by Subject|0|||
13179189|NCT02243293|26146221|FG014|Overall Study|Withdrawal by Subject|0|||
13179190|NCT02243293|26146222|FG015|Overall Study|Withdrawal by Subject|0|||
13179191|NCT02243293|26146223|FG016|Overall Study|Withdrawal by Subject|0|||
13179192|NCT02243293|26146224|FG017|Overall Study|Withdrawal by Subject|0|||
13179193|NCT02243293|26146225|FG018|Overall Study|Withdrawal by Subject|0|||
13179194|NCT02243293|26146226|FG019|Overall Study|Withdrawal by Subject|0|||
13179195|NCT02243293|26146227|FG020|Overall Study|Withdrawal by Subject|0|||
13179196|NCT02243293|26146228|FG021|Overall Study|Withdrawal by Subject|1|||
13179197|NCT02243293|26146207|FG000|Overall Study|Lost to Follow-up|0|||
13179198|NCT02243293|26146208|FG001|Overall Study|Lost to Follow-up|1|||
13179199|NCT02243293|26146209|FG002|Overall Study|Lost to Follow-up|1|||
13179200|NCT02243293|26146210|FG003|Overall Study|Lost to Follow-up|1|||
13179201|NCT02243293|26146211|FG004|Overall Study|Lost to Follow-up|0|||
13179202|NCT02243293|26146212|FG005|Overall Study|Lost to Follow-up|0|||
13179203|NCT02243293|26146213|FG006|Overall Study|Lost to Follow-up|3|||
13179204|NCT02243293|26146214|FG007|Overall Study|Lost to Follow-up|0|||
13179205|NCT02243293|26146215|FG008|Overall Study|Lost to Follow-up|0|||
13179206|NCT02243293|26146216|FG009|Overall Study|Lost to Follow-up|0|||
13179207|NCT02243293|26146217|FG010|Overall Study|Lost to Follow-up|0|||
13179208|NCT02243293|26146218|FG011|Overall Study|Lost to Follow-up|2|||
13179209|NCT02243293|26146219|FG012|Overall Study|Lost to Follow-up|0|||
13179210|NCT02243293|26146220|FG013|Overall Study|Lost to Follow-up|0|||
13179211|NCT02243293|26146221|FG014|Overall Study|Lost to Follow-up|0|||
13179212|NCT02243293|26146222|FG015|Overall Study|Lost to Follow-up|0|||
13179213|NCT02243293|26146223|FG016|Overall Study|Lost to Follow-up|3|||
13179214|NCT02243293|26146224|FG017|Overall Study|Lost to Follow-up|1|||
13179215|NCT02243293|26146225|FG018|Overall Study|Lost to Follow-up|0|||
13179216|NCT02243293|26146226|FG019|Overall Study|Lost to Follow-up|0|||
13179217|NCT02243293|26146227|FG020|Overall Study|Lost to Follow-up|1|||
13179218|NCT02243293|26146228|FG021|Overall Study|Lost to Follow-up|2|||
13179219|NCT02243293|26146207|FG000|Overall Study|Enrolled into a Re-treatment Study|0|||
13179220|NCT02243293|26146208|FG001|Overall Study|Enrolled into a Re-treatment Study|0|||
13179221|NCT02243293|26146209|FG002|Overall Study|Enrolled into a Re-treatment Study|0|||
13179222|NCT02243293|26146210|FG003|Overall Study|Enrolled into a Re-treatment Study|0|||
13179223|NCT02243293|26146211|FG004|Overall Study|Enrolled into a Re-treatment Study|0|||
13179224|NCT02243293|26146212|FG005|Overall Study|Enrolled into a Re-treatment Study|0|||
13179225|NCT02243293|26146213|FG006|Overall Study|Enrolled into a Re-treatment Study|0|||
13179226|NCT02243293|26146214|FG007|Overall Study|Enrolled into a Re-treatment Study|0|||
13179227|NCT02243293|26146215|FG008|Overall Study|Enrolled into a Re-treatment Study|0|||
13179228|NCT02243293|26146216|FG009|Overall Study|Enrolled into a Re-treatment Study|0|||
13179229|NCT02243293|26146217|FG010|Overall Study|Enrolled into a Re-treatment Study|0|||
13179230|NCT02243293|26146218|FG011|Overall Study|Enrolled into a Re-treatment Study|0|||
13179231|NCT02243293|26146219|FG012|Overall Study|Enrolled into a Re-treatment Study|0|||
13179232|NCT02243293|26146220|FG013|Overall Study|Enrolled into a Re-treatment Study|0|||
13179233|NCT02243293|26146221|FG014|Overall Study|Enrolled into a Re-treatment Study|1|||
13179234|NCT02243293|26146222|FG015|Overall Study|Enrolled into a Re-treatment Study|0|||
13179235|NCT02243293|26146223|FG016|Overall Study|Enrolled into a Re-treatment Study|0|||
13179236|NCT02243293|26146224|FG017|Overall Study|Enrolled into a Re-treatment Study|0|||
13179237|NCT02243293|26146225|FG018|Overall Study|Enrolled into a Re-treatment Study|0|||
13179238|NCT02243293|26146226|FG019|Overall Study|Enrolled into a Re-treatment Study|0|||
13179239|NCT02243293|26146227|FG020|Overall Study|Enrolled into a Re-treatment Study|0|||
13179240|NCT02243293|26146228|FG021|Overall Study|Enrolled into a Re-treatment Study|0|||
13179241|NCT02243293|26146207|FG000|Overall Study|Randomized but did'nt receive study drug|0|||
13179242|NCT02243293|26146208|FG001|Overall Study|Randomized but did'nt receive study drug|0|||
13179243|NCT02243293|26146209|FG002|Overall Study|Randomized but did'nt receive study drug|0|||
13179244|NCT02243293|26146210|FG003|Overall Study|Randomized but did'nt receive study drug|0|||
13179245|NCT02243293|26146211|FG004|Overall Study|Randomized but did'nt receive study drug|1|||
13179246|NCT02243293|26146212|FG005|Overall Study|Randomized but did'nt receive study drug|0|||
13179247|NCT02243293|26146213|FG006|Overall Study|Randomized but did'nt receive study drug|0|||
13179248|NCT02243293|26146214|FG007|Overall Study|Randomized but did'nt receive study drug|0|||
13179249|NCT02243293|26146215|FG008|Overall Study|Randomized but did'nt receive study drug|0|||
13179250|NCT02243293|26146216|FG009|Overall Study|Randomized but did'nt receive study drug|1|||
13179251|NCT02243293|26146217|FG010|Overall Study|Randomized but did'nt receive study drug|0|||
13109320|NCT03235050|25895572|FG003|Overall Study|Death|2|||
13109321|NCT03235050|25895573|FG004|Overall Study|Death|1|||
13109322|NCT03235050|25895569|FG000|Overall Study|Lost to Follow-up|1|||
13179252|NCT02243293|26146218|FG011|Overall Study|Randomized but did'nt receive study drug|0|||
13179253|NCT02243293|26146219|FG012|Overall Study|Randomized but did'nt receive study drug|0|||
13179254|NCT02243293|26146220|FG013|Overall Study|Randomized but did'nt receive study drug|0|||
13179255|NCT02243293|26146221|FG014|Overall Study|Randomized but did'nt receive study drug|0|||
13179256|NCT02243293|26146222|FG015|Overall Study|Randomized but did'nt receive study drug|0|||
13179257|NCT02243293|26146223|FG016|Overall Study|Randomized but did'nt receive study drug|0|||
13179258|NCT02243293|26146224|FG017|Overall Study|Randomized but did'nt receive study drug|0|||
13179259|NCT02243293|26146225|FG018|Overall Study|Randomized but did'nt receive study drug|0|||
13179260|NCT02243293|26146226|FG019|Overall Study|Randomized but did'nt receive study drug|1|||
13179261|NCT02243293|26146227|FG020|Overall Study|Randomized but did'nt receive study drug|0|||
13179262|NCT02243293|26146228|FG021|Overall Study|Randomized but did'nt receive study drug|0|||
13179263|NCT02243280|26146313|FG000|Treated|Adverse Event|1|||
13179264|NCT02243280|26146314|FG001|Treated|Adverse Event|0|||
13109323|NCT03235050|25895570|FG001|Overall Study|Lost to Follow-up|2|||
13109324|NCT03235050|25895571|FG002|Overall Study|Lost to Follow-up|1|||
13109325|NCT03235050|25895572|FG003|Overall Study|Lost to Follow-up|2|||
13109326|NCT03235050|25895573|FG004|Overall Study|Lost to Follow-up|0|||
13109327|NCT03235050|25895569|FG000|Overall Study|Withdrawal by Subject|3|||
13109328|NCT03235050|25895570|FG001|Overall Study|Withdrawal by Subject|2|||
13109329|NCT03235050|25895571|FG002|Overall Study|Withdrawal by Subject|2|||
13109330|NCT03235050|25895572|FG003|Overall Study|Withdrawal by Subject|5|||
13109331|NCT03235050|25895573|FG004|Overall Study|Withdrawal by Subject|7|||
13109332|NCT03235050|25895569|FG000|Overall Study|Other reasons|0|||
13109333|NCT03235050|25895570|FG001|Overall Study|Other reasons|1|||
13109334|NCT03235050|25895571|FG002|Overall Study|Other reasons|0|||
13109335|NCT03235050|25895572|FG003|Overall Study|Other reasons|1|||
13109336|NCT03235050|25895573|FG004|Overall Study|Other reasons|2|||
13109337|NCT03235024|25895600|FG000|Overall Study|Adverse Event|2|||
13109338|NCT03235024|25895601|FG001|Overall Study|Adverse Event|2|||
13179265|NCT02243280|26146315|FG002|Treated|Adverse Event|0|||
13179266|NCT02243280|26146316|FG003|Treated|Adverse Event|0|||
13179267|NCT02243280|26146317|FG004|Treated|Adverse Event|0|||
13179268|NCT02243280|26146318|FG005|Treated|Adverse Event|0|||
13179269|NCT02243280|26146319|FG006|Treated|Adverse Event|0|||
13179270|NCT02243280|26146320|FG007|Treated|Adverse Event|0|||
13179271|NCT02243280|26146321|FG008|Treated|Adverse Event|0|||
13179272|NCT02243280|26146322|FG009|Treated|Adverse Event|0|||
13179273|NCT02243280|26146323|FG010|Treated|Adverse Event|1|||
13179274|NCT02243280|26146313|FG000|Treated|Lost to Follow-up|0|||
13179275|NCT02243280|26146314|FG001|Treated|Lost to Follow-up|0|||
13179276|NCT02243280|26146315|FG002|Treated|Lost to Follow-up|0|||
13179277|NCT02243280|26146316|FG003|Treated|Lost to Follow-up|0|||
13109339|NCT03235024|25895600|FG000|Overall Study|Death|1|||
13179278|NCT02243280|26146317|FG004|Treated|Lost to Follow-up|0|||
13179279|NCT02243280|26146318|FG005|Treated|Lost to Follow-up|0|||
13179280|NCT02243280|26146319|FG006|Treated|Lost to Follow-up|0|||
13179281|NCT02243280|26146320|FG007|Treated|Lost to Follow-up|0|||
13179282|NCT02243280|26146321|FG008|Treated|Lost to Follow-up|1|||
13179283|NCT02243280|26146322|FG009|Treated|Lost to Follow-up|0|||
13179284|NCT02243280|26146323|FG010|Treated|Lost to Follow-up|2|||
13179285|NCT02243202|26146370|FG000|Overall Study|Adverse Event|5|||
13179286|NCT02243202|26146371|FG001|Overall Study|Adverse Event|6|||
13179287|NCT02243202|26146372|FG002|Overall Study|Adverse Event|10|||
13179288|NCT02243202|26146373|FG003|Overall Study|Adverse Event|4|||
13179289|NCT02243202|26146370|FG000|Overall Study|Lost to Follow-up|9|||
13179290|NCT02243202|26146371|FG001|Overall Study|Lost to Follow-up|9|||
13179291|NCT02243202|26146372|FG002|Overall Study|Lost to Follow-up|14|||
13179292|NCT02243202|26146373|FG003|Overall Study|Lost to Follow-up|11|||
13179293|NCT02243202|26146370|FG000|Overall Study|Protocol Violation|3|||
13179294|NCT02243202|26146371|FG001|Overall Study|Protocol Violation|1|||
13179295|NCT02243202|26146372|FG002|Overall Study|Protocol Violation|2|||
13179296|NCT02243202|26146373|FG003|Overall Study|Protocol Violation|1|||
13179297|NCT02243202|26146370|FG000|Overall Study|Withdrawal by Subject|7|||
13179298|NCT02243202|26146371|FG001|Overall Study|Withdrawal by Subject|6|||
13179299|NCT02243202|26146372|FG002|Overall Study|Withdrawal by Subject|4|||
13179300|NCT02243202|26146373|FG003|Overall Study|Withdrawal by Subject|4|||
13179301|NCT02243202|26146370|FG000|Overall Study|Other|1|||
13179302|NCT02243202|26146371|FG001|Overall Study|Other|3|||
13179303|NCT02243202|26146372|FG002|Overall Study|Other|1|||
13179304|NCT02243202|26146373|FG003|Overall Study|Other|2|||
13179305|NCT02243202|26146370|FG000|Overall Study|Randomized but not received treatment|0|||
13179306|NCT02243202|26146371|FG001|Overall Study|Randomized but not received treatment|0|||
13179307|NCT02243202|26146372|FG002|Overall Study|Randomized but not received treatment|0|||
13179308|NCT02243202|26146373|FG003|Overall Study|Randomized but not received treatment|1|||
13109340|NCT03235024|25895601|FG001|Overall Study|Death|0|||
13179309|NCT02243176|26146402|FG000|Overall Study|Other reason|1|||
13179310|NCT02243176|26146403|FG001|Overall Study|Other reason|2|||
13179311|NCT02243176|26146402|FG000|Overall Study|protocol specified withdrawal critera|1|||
13179312|NCT02243176|26146403|FG001|Overall Study|protocol specified withdrawal critera|3|||
13179313|NCT02243176|26146402|FG000|Overall Study|Protocol Violation|2|||
13179314|NCT02243176|26146403|FG001|Overall Study|Protocol Violation|1|||
13179315|NCT02243176|26146402|FG000|Overall Study|Withdrawal by Subject|8|||
13179316|NCT02243176|26146403|FG001|Overall Study|Withdrawal by Subject|7|||
13179317|NCT02243176|26146402|FG000|Overall Study|Adverse Event|2|||
13179318|NCT02243176|26146403|FG001|Overall Study|Adverse Event|2|||
13179319|NCT02243046|26146436|FG000|Overall Study|Lost to Follow-up|1|||
13179320|NCT02243046|26146437|FG001|Overall Study|Lost to Follow-up|1|||
13179321|NCT02243046|26146438|FG002|Overall Study|Lost to Follow-up|4|||
13179322|NCT02242981|26146448|FG000|Overall Study|Withdrawal by Subject|1|||
13179323|NCT02242903|26146498|FG000|Overall Study|Withdrawal by Subject|1|||
13179324|NCT02242903|26146499|FG001|Overall Study|Withdrawal by Subject|0|||
13179325|NCT02242903|26146500|FG002|Overall Study|Withdrawal by Subject|0|||
13179326|NCT02242903|26146501|FG003|Overall Study|Withdrawal by Subject|0|||
13179327|NCT02242903|26146502|FG004|Overall Study|Withdrawal by Subject|0|||
13109341|NCT03235024|25895600|FG000|Overall Study|Lost to Follow-up|2|||
13109342|NCT03235024|25895601|FG001|Overall Study|Lost to Follow-up|5|||
13109343|NCT03235024|25895600|FG000|Overall Study|Protocol Violation|1|||
13109344|NCT03235024|25895601|FG001|Overall Study|Protocol Violation|0|||
13109345|NCT03235024|25895600|FG000|Overall Study|Withdrawal by Subject|0|||
13109346|NCT03235024|25895601|FG001|Overall Study|Withdrawal by Subject|3|||
13109347|NCT03234907|25895624|FG000|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
13109348|NCT03234907|25895625|FG001|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
13179328|NCT02242903|26146503|FG005|Overall Study|Withdrawal by Subject|0|||
13179329|NCT02242903|26146504|FG006|Overall Study|Withdrawal by Subject|0|||
13179330|NCT02242643|26146543|FG000|Overall Study|Protocol Violation|1|||
13179331|NCT02242643|26146544|FG001|Overall Study|Protocol Violation|2|||
13179332|NCT02242643|26146543|FG000|Overall Study|Withdrawal by Subject|15|||
13179333|NCT02242643|26146544|FG001|Overall Study|Withdrawal by Subject|10|||
13179334|NCT02242643|26146543|FG000|Overall Study|Migrated/moved from study area|1|||
13179335|NCT02242643|26146544|FG001|Overall Study|Migrated/moved from study area|3|||
13109349|NCT03234907|25895626|FG002|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
13179336|NCT02242643|26146543|FG000|Overall Study|Lost to Follow-up|54|||
13179337|NCT02242643|26146544|FG001|Overall Study|Lost to Follow-up|61|||
13179338|NCT02242643|26146543|FG000|Overall Study|Child placed in foster care by family|0|||
13179339|NCT02242643|26146544|FG001|Overall Study|Child placed in foster care by family|1|||
13179340|NCT02242643|26146543|FG000|Overall Study|Non-compliance|1|||
13179341|NCT02242643|26146544|FG001|Overall Study|Non-compliance|0|||
13179342|NCT02242643|26146543|FG000|Overall Study|Consent withdrawal by parent|1|||
13179343|NCT02242643|26146544|FG001|Overall Study|Consent withdrawal by parent|0|||
13179344|NCT02242643|26146543|FG000|Overall Study|Protocol requirements not followed|1|||
13179345|NCT02242643|26146544|FG001|Overall Study|Protocol requirements not followed|0|||
13179346|NCT02242643|26146543|FG000|Overall Study|Language barrier|1|||
13179347|NCT02242643|26146544|FG001|Overall Study|Language barrier|0|||
13179348|NCT02242643|26146543|FG000|Overall Study|Withdrawal by subject at Visit 2|0|||
13179349|NCT02242643|26146544|FG001|Overall Study|Withdrawal by subject at Visit 2|1|||
13179350|NCT02242487|26146565|FG000|Overall Study|Adverse Event|13|||
13179351|NCT02242487|26146566|FG001|Overall Study|Adverse Event|15|||
13179352|NCT02242487|26146565|FG000|Overall Study|Lack of Efficacy|4|||
13179353|NCT02242487|26146566|FG001|Overall Study|Lack of Efficacy|6|||
13179354|NCT02242487|26146565|FG000|Overall Study|Protocol Violation|2|||
13179355|NCT02242487|26146566|FG001|Overall Study|Protocol Violation|0|||
13179356|NCT02242487|26146565|FG000|Overall Study|Lost to Follow-up|2|||
13179357|NCT02242487|26146566|FG001|Overall Study|Lost to Follow-up|1|||
13179358|NCT02242487|26146565|FG000|Overall Study|Other - Miscellaneous|4|||
13179359|NCT02242487|26146566|FG001|Overall Study|Other - Miscellaneous|6|||
13179360|NCT02242487|26146565|FG000|Overall Study|Withdrawal by Subject|37|||
13179361|NCT02242487|26146566|FG001|Overall Study|Withdrawal by Subject|19|||
13179362|NCT02242435|26146581|FG000|Overall Study|Lost to Follow-up|3|||
13179363|NCT02242435|26146582|FG001|Overall Study|Lost to Follow-up|4|||
13179364|NCT02242435|26146581|FG000|Overall Study|Adverse Event|3|||
13179365|NCT02242435|26146582|FG001|Overall Study|Adverse Event|2|||
13179366|NCT02242435|26146581|FG000|Overall Study|Withdrawal by Subject|13|||
13179367|NCT02242435|26146582|FG001|Overall Study|Withdrawal by Subject|8|||
13179368|NCT02242435|26146581|FG000|Overall Study|Death|0|||
13179369|NCT02242435|26146582|FG001|Overall Study|Death|1|||
13179370|NCT02242435|26146581|FG000|Overall Study|Protocol Violation|1|||
13179371|NCT02242435|26146582|FG001|Overall Study|Protocol Violation|0|||
13179372|NCT02242435|26146581|FG000|Overall Study|Physician Decision|0|||
13179373|NCT02242435|26146582|FG001|Overall Study|Physician Decision|1|||
13179374|NCT02242305|26146607|FG000|Overall Study|Without spasm-like pain during 3 weeks|1|||
13179375|NCT02242305|26146608|FG001|Overall Study|Without spasm-like pain during 3 weeks|4|||
13179376|NCT02242305|26146607|FG000|Overall Study|Adverse Event|1|||
13179377|NCT02242305|26146608|FG001|Overall Study|Adverse Event|0|||
13179378|NCT02242305|26146607|FG000|Overall Study|Non-compliance dosing regimen or visit|2|||
13179379|NCT02242305|26146608|FG001|Overall Study|Non-compliance dosing regimen or visit|2|||
13179380|NCT02242305|26146607|FG000|Overall Study|Subject withdraws inform consent|0|||
13179381|NCT02242305|26146608|FG001|Overall Study|Subject withdraws inform consent|4|||
13179382|NCT02242305|26146607|FG000|Overall Study|Lost to Follow-up|2|||
13179383|NCT02242305|26146608|FG001|Overall Study|Lost to Follow-up|0|||
13179384|NCT02242201|26146650|FG000|Overall Study|preoperative identified neuropathy|2|||
13179385|NCT02242201|26146651|FG001|Overall Study|preoperative identified neuropathy|0|||
13179386|NCT02242201|26146652|FG002|Overall Study|preoperative identified neuropathy|0|||
13179387|NCT02242201|26146650|FG000|Overall Study|planned post-op anticoagulation|1|||
13179388|NCT02242201|26146651|FG001|Overall Study|planned post-op anticoagulation|0|||
13179389|NCT02242201|26146652|FG002|Overall Study|planned post-op anticoagulation|0|||
13179390|NCT02242201|26146650|FG000|Overall Study|changed surgical procedure|1|||
13179391|NCT02242201|26146651|FG001|Overall Study|changed surgical procedure|0|||
13109350|NCT03234907|25895627|FG003|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
13109351|NCT03234907|25895628|FG004|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
13109352|NCT03234907|25895629|FG005|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
13109353|NCT03234907|25895624|FG000|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|6|||
13109354|NCT03234907|25895625|FG001|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|4|||
13109355|NCT03234907|25895626|FG002|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
13109356|NCT03234907|25895627|FG003|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
13109357|NCT03234907|25895628|FG004|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
13109358|NCT03234907|25895629|FG005|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
13109359|NCT03234907|25895624|FG000|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|2|||
13109360|NCT03234907|25895625|FG001|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
13109361|NCT03234907|25895626|FG002|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
13109362|NCT03234907|25895627|FG003|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
13109363|NCT03234907|25895628|FG004|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
13109364|NCT03234907|25895629|FG005|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
13179392|NCT02242201|26146652|FG002|Overall Study|changed surgical procedure|0|||
13179393|NCT02242201|26146650|FG000|Overall Study|postponed surgery|0|||
13179394|NCT02242201|26146651|FG001|Overall Study|postponed surgery|0|||
13179395|NCT02242201|26146652|FG002|Overall Study|postponed surgery|1|||
13179396|NCT02242201|26146650|FG000|Overall Study|preoperative opioid consumption|0|||
13179397|NCT02242201|26146651|FG001|Overall Study|preoperative opioid consumption|1|||
13179398|NCT02242201|26146652|FG002|Overall Study|preoperative opioid consumption|0|||
13179399|NCT02242045|26146670|FG000|Overall Study|Investigator's Discretion|1|||
13179400|NCT02242045|26146670|FG000|Overall Study|Progressive Disease|2|||
13179401|NCT02242045|26146670|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1|||
13179402|NCT02242045|26146670|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2|||
13179403|NCT02241889|26146712|FG000|Overall Study|device issues|0|||
13179404|NCT02241889|26146713|FG001|Overall Study|device issues|0|||
13179405|NCT02241889|26146714|FG002|Overall Study|device issues|1|||
13179406|NCT02241889|26146715|FG003|Overall Study|device issues|0|||
13179407|NCT02241889|26146716|FG004|Overall Study|device issues|0|||
13179408|NCT02241889|26146717|FG005|Overall Study|device issues|0|||
13179409|NCT02241889|26146712|FG000|Overall Study|Withdrawal by Subject|0|||
13179410|NCT02241889|26146713|FG001|Overall Study|Withdrawal by Subject|0|||
13179411|NCT02241889|26146714|FG002|Overall Study|Withdrawal by Subject|0|||
13179412|NCT02241889|26146715|FG003|Overall Study|Withdrawal by Subject|0|||
13179413|NCT02241889|26146716|FG004|Overall Study|Withdrawal by Subject|0|||
13179414|NCT02241889|26146717|FG005|Overall Study|Withdrawal by Subject|1|||
13179415|NCT02241785|26146727|FG000|Overall Study|Sponsor Termination|43|||
13179416|NCT02241785|26146727|FG000|Overall Study|Withdrawal by Subject|1|||
13179417|NCT02241785|26146727|FG000|Overall Study|Lost to Follow-up|2|||
13179418|NCT02241785|26146727|FG000|Overall Study|Adverse Event|1|||
13179419|NCT02241733|26146746|FG000|Overall Study|Lost to Follow-up|9|||
13179420|NCT02241733|26146747|FG001|Overall Study|Lost to Follow-up|4|||
13179421|NCT02241733|26146746|FG000|Overall Study|Physician Decision|6|||
13179422|NCT02241733|26146747|FG001|Overall Study|Physician Decision|2|||
13179423|NCT02241733|26146746|FG000|Overall Study|Withdrawal by Subject|0|||
13179424|NCT02241733|26146747|FG001|Overall Study|Withdrawal by Subject|2|||
13179425|NCT02241733|26146746|FG000|Overall Study|Death|0|||
13179426|NCT02241733|26146747|FG001|Overall Study|Death|2|||
13179427|NCT02241551|26146774|FG000|Overall Study|Adverse Event|1|||
13179428|NCT02241551|26146775|FG001|Overall Study|Adverse Event|0|||
13179429|NCT02241512|26146794|FG000|Overall Study|Pump malfunction, drug not delivered|1|||
13179430|NCT02241512|26146795|FG001|Overall Study|Pump malfunction, drug not delivered|0|||
13179431|NCT02241343|26146802|FG000|Overall Study|Adverse Event|1|||
13179432|NCT02241187|26146809|FG000|Overall Study|Protocol closed due to lack of accrual.|2|||
13179433|NCT02240706|26146882|FG000|Overall Study|Lack of Efficacy|2|||
13179434|NCT02240706|26146883|FG001|Overall Study|Lack of Efficacy|2|||
13179435|NCT02240706|26146884|FG002|Overall Study|Lack of Efficacy|2|||
13179436|NCT02240706|26146885|FG003|Overall Study|Lack of Efficacy|2|||
13179437|NCT02240706|26146886|FG004|Overall Study|Lack of Efficacy|5|||
13179438|NCT02240706|26146887|FG005|Overall Study|Lack of Efficacy|0|||
13179439|NCT02240706|26146888|FG006|Overall Study|Lack of Efficacy|0|||
13179440|NCT02240706|26146882|FG000|Overall Study|Adverse Event|1|||
13179441|NCT02240706|26146883|FG001|Overall Study|Adverse Event|0|||
13179442|NCT02240706|26146884|FG002|Overall Study|Adverse Event|1|||
13179443|NCT02240706|26146885|FG003|Overall Study|Adverse Event|0|||
13179444|NCT02240706|26146886|FG004|Overall Study|Adverse Event|2|||
13179445|NCT02240706|26146887|FG005|Overall Study|Adverse Event|0|||
13179446|NCT02240706|26146888|FG006|Overall Study|Adverse Event|0|||
13179447|NCT02240706|26146882|FG000|Overall Study|Progressive disease|0|||
13179448|NCT02240706|26146883|FG001|Overall Study|Progressive disease|0|||
13179449|NCT02240706|26146884|FG002|Overall Study|Progressive disease|0|||
13179450|NCT02240706|26146885|FG003|Overall Study|Progressive disease|0|||
13179451|NCT02240706|26146886|FG004|Overall Study|Progressive disease|1|||
13179452|NCT02240706|26146887|FG005|Overall Study|Progressive disease|0|||
13179453|NCT02240706|26146888|FG006|Overall Study|Progressive disease|0|||
13179454|NCT02240706|26146882|FG000|Overall Study|Dose limiting toxicity|0|||
13179455|NCT02240706|26146883|FG001|Overall Study|Dose limiting toxicity|0|||
13179456|NCT02240706|26146884|FG002|Overall Study|Dose limiting toxicity|0|||
13179457|NCT02240706|26146885|FG003|Overall Study|Dose limiting toxicity|0|||
13179458|NCT02240706|26146886|FG004|Overall Study|Dose limiting toxicity|1|||
13179459|NCT02240706|26146887|FG005|Overall Study|Dose limiting toxicity|0|||
13179460|NCT02240706|26146888|FG006|Overall Study|Dose limiting toxicity|0|||
13179461|NCT02240706|26146882|FG000|Overall Study|Refused to continue taking medication|0|||
13179462|NCT02240706|26146883|FG001|Overall Study|Refused to continue taking medication|1|||
13179463|NCT02240706|26146884|FG002|Overall Study|Refused to continue taking medication|3|||
13179464|NCT02240706|26146885|FG003|Overall Study|Refused to continue taking medication|1|||
13179465|NCT02240706|26146886|FG004|Overall Study|Refused to continue taking medication|2|||
13179466|NCT02240706|26146887|FG005|Overall Study|Refused to continue taking medication|0|||
13179467|NCT02240706|26146888|FG006|Overall Study|Refused to continue taking medication|0|||
13179468|NCT02240706|26146882|FG000|Overall Study|Insurance billing concerns|0|||
13179469|NCT02240706|26146883|FG001|Overall Study|Insurance billing concerns|0|||
13179470|NCT02240706|26146884|FG002|Overall Study|Insurance billing concerns|0|||
13179471|NCT02240706|26146885|FG003|Overall Study|Insurance billing concerns|1|||
13179472|NCT02240706|26146886|FG004|Overall Study|Insurance billing concerns|0|||
13179473|NCT02240706|26146887|FG005|Overall Study|Insurance billing concerns|0|||
13179474|NCT02240706|26146888|FG006|Overall Study|Insurance billing concerns|0|||
13179475|NCT02240693|26146938|FG000|Overall Study|Adverse Event|0|||
13179476|NCT02240693|26146939|FG001|Overall Study|Adverse Event|0|||
13179477|NCT02240693|26146940|FG002|Overall Study|Adverse Event|0|||
13179478|NCT02240693|26146941|FG003|Overall Study|Adverse Event|0|||
13179479|NCT02240693|26146942|FG004|Overall Study|Adverse Event|1|||
13179480|NCT02240693|26146938|FG000|Overall Study|Withdrawal by Subject|0|||
13179481|NCT02240693|26146939|FG001|Overall Study|Withdrawal by Subject|0|||
13179482|NCT02240693|26146940|FG002|Overall Study|Withdrawal by Subject|2|||
13179483|NCT02240693|26146941|FG003|Overall Study|Withdrawal by Subject|1|||
13179484|NCT02240693|26146942|FG004|Overall Study|Withdrawal by Subject|0|||
13179485|NCT02240693|26146938|FG000|Overall Study|Other than specified|0|||
13179486|NCT02240693|26146939|FG001|Overall Study|Other than specified|0|||
13179487|NCT02240693|26146940|FG002|Overall Study|Other than specified|2|||
13179488|NCT02240693|26146941|FG003|Overall Study|Other than specified|0|||
13179489|NCT02240693|26146942|FG004|Overall Study|Other than specified|0|||
13179490|NCT02240680|26146969|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
13179491|NCT02240680|26146970|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
13179492|NCT02240680|26146971|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
13179493|NCT02240680|26146972|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
13179494|NCT02240680|26146969|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4|||
13179495|NCT02240680|26146970|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1|||
13179496|NCT02240680|26146971|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
13179497|NCT02240680|26146972|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
13179498|NCT02240680|26146969|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1|||
13179499|NCT02240680|26146970|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
13179500|NCT02240680|26146971|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
13179501|NCT02240680|26146972|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
13179502|NCT02240680|26146969|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3|||
13179503|NCT02240680|26146970|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1|||
13179504|NCT02240680|26146971|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
13179505|NCT02240680|26146972|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
13179506|NCT02240680|26146969|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1|||
13179507|NCT02240680|26146970|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0|||
13179508|NCT02240680|26146971|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0|||
13179509|NCT02240680|26146972|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0|||
13179510|NCT02240680|26146969|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
13179511|NCT02240680|26146970|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
13179512|NCT02240680|26146971|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6|||
13179513|NCT02240680|26146972|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7|||
13179514|NCT02240680|26146969|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
13179515|NCT02240680|26146970|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
13179516|NCT02240680|26146971|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1|||
13179517|NCT02240680|26146972|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
13179518|NCT02240680|26146969|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
13179519|NCT02240680|26146970|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
13179520|NCT02240680|26146971|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1|||
13179521|NCT02240680|26146972|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
13179522|NCT02240628|26146987|FG000|Overall Study|Physician Decision|6|||
13179523|NCT02240628|26146988|FG001|Overall Study|Physician Decision|5|||
13179524|NCT02240368|26147015|FG000|Overall Study|Surgery lasted less then 20 minutes|1|||
13179525|NCT02240368|26147016|FG001|Overall Study|Surgery lasted less then 20 minutes|0|||
13179526|NCT02240368|26147017|FG002|Overall Study|Surgery lasted less then 20 minutes|0|||
13179527|NCT02240368|26147015|FG000|Overall Study|Entropy failed to detect more than 50%|0|||
13179528|NCT02240368|26147016|FG001|Overall Study|Entropy failed to detect more than 50%|0|||
13179529|NCT02240368|26147017|FG002|Overall Study|Entropy failed to detect more than 50%|1|||
13179530|NCT02240121|26147050|FG000|Overall Study|Protocol Violation|1|||
13179531|NCT02240121|26147051|FG001|Overall Study|Protocol Violation|2|||
13179532|NCT02240121|26147050|FG000|Overall Study|Physician Decision|0|||
13179533|NCT02240121|26147051|FG001|Overall Study|Physician Decision|1|||
13179534|NCT02240121|26147050|FG000|Overall Study|Change in protocol interpretation|1|||
13179535|NCT02240121|26147051|FG001|Overall Study|Change in protocol interpretation|0|||
13179536|NCT02240121|26147050|FG000|Overall Study|Lack of Efficacy|2|||
13179537|NCT02240121|26147051|FG001|Overall Study|Lack of Efficacy|3|||
13179538|NCT02240121|26147050|FG000|Overall Study|Site closed|1|||
13179539|NCT02240121|26147051|FG001|Overall Study|Site closed|1|||
13109365|NCT03234907|25895624|FG000|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
13109366|NCT03234907|25895625|FG001|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
13109367|NCT03234907|25895626|FG002|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
13109368|NCT03234907|25895627|FG003|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
13109369|NCT03234907|25895628|FG004|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
13109370|NCT03234907|25895629|FG005|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
13109371|NCT03234907|25895624|FG000|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
13109372|NCT03234907|25895625|FG001|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
13109373|NCT03234907|25895626|FG002|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
13179540|NCT02240121|26147050|FG000|Overall Study|Pregnancy|1|||
13179541|NCT02240121|26147051|FG001|Overall Study|Pregnancy|0|||
13179542|NCT02240121|26147050|FG000|Overall Study|Adverse Event|2|||
13179543|NCT02240121|26147051|FG001|Overall Study|Adverse Event|4|||
13179544|NCT02240121|26147050|FG000|Overall Study|Withdrawal by Subject|6|||
13179545|NCT02240121|26147051|FG001|Overall Study|Withdrawal by Subject|2|||
13179546|NCT02240121|26147050|FG000|Overall Study|Lost to Follow-up|3|||
13179547|NCT02240121|26147051|FG001|Overall Study|Lost to Follow-up|4|||
13179548|NCT02240121|26147050|FG000|Overall Study|Other than specified|1|||
13179549|NCT02240121|26147051|FG001|Overall Study|Other than specified|3|||
13179550|NCT02240108|26147084|FG000|Overall Study|Other than specified|8|||
13179551|NCT02240108|26147085|FG001|Overall Study|Other than specified|6|||
13179552|NCT02240108|26147084|FG000|Overall Study|Adverse Event|1|||
13179553|NCT02240108|26147085|FG001|Overall Study|Adverse Event|9|||
13179554|NCT02240108|26147084|FG000|Overall Study|Pregnancy|1|||
13179555|NCT02240108|26147085|FG001|Overall Study|Pregnancy|0|||
13179556|NCT02240108|26147084|FG000|Overall Study|Withdrawal by Subject|4|||
13179557|NCT02240108|26147085|FG001|Overall Study|Withdrawal by Subject|9|||
13179558|NCT02240108|26147084|FG000|Overall Study|StudyTerminated by Sponsor|0|||
13179559|NCT02240108|26147085|FG001|Overall Study|StudyTerminated by Sponsor|1|||
13179560|NCT02239978|26147107|FG000|Overall Study|Withdrawal by Subject|2|||
13179561|NCT02239978|26147108|FG001|Overall Study|Withdrawal by Subject|0|||
13179562|NCT02239939|26147129|FG000|Overall Study|Adverse Event|1|||
13179563|NCT02239939|26147130|FG001|Overall Study|Adverse Event|0|||
13179564|NCT02239939|26147129|FG000|Overall Study|Withdrawal by Subject|1|||
13179565|NCT02239939|26147130|FG001|Overall Study|Withdrawal by Subject|1|||
13179566|NCT02239939|26147129|FG000|Overall Study|Lost to Follow-up|0|||
13179567|NCT02239939|26147130|FG001|Overall Study|Lost to Follow-up|1|||
13179568|NCT02239926|26147145|FG000|Overall Study|Withdrawal by Subject|0|||
13179569|NCT02239926|26147146|FG001|Overall Study|Withdrawal by Subject|1|||
13179570|NCT02239692|26147169|FG000|Overall Study|Incomplete colonoscopy|1|||
13179571|NCT02239692|26147170|FG001|Overall Study|Incomplete colonoscopy|2|||
13179572|NCT02239692|26147169|FG000|Overall Study|Adverse Event|0|||
13179573|NCT02239692|26147170|FG001|Overall Study|Adverse Event|1|||
13179574|NCT02239692|26147169|FG000|Overall Study|Physician Decision|0|||
13179575|NCT02239692|26147170|FG001|Overall Study|Physician Decision|1|||
13109374|NCT03234907|25895627|FG003|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|4|||
13109375|NCT03234907|25895628|FG004|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|3|||
13109376|NCT03234907|25895629|FG005|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|7|||
13109377|NCT03234907|25895624|FG000|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
13109378|NCT03234907|25895625|FG001|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
13109379|NCT03234907|25895626|FG002|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|1|||
13109380|NCT03234907|25895627|FG003|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
13109381|NCT03234907|25895628|FG004|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
13109382|NCT03234907|25895629|FG005|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|4|||
13109383|NCT03234907|25895624|FG000|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
13109384|NCT03234907|25895625|FG001|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
13109385|NCT03234907|25895626|FG002|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
13109386|NCT03234907|25895627|FG003|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
13109387|NCT03234907|25895628|FG004|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
13109388|NCT03234907|25895629|FG005|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|10|||
13109389|NCT03234608|25895650|FG000|Overall Study|Lost to Follow-up|23|||
13179576|NCT02239692|26147169|FG000|Overall Study|Lost to Follow-up|1|||
13179577|NCT02239692|26147170|FG001|Overall Study|Lost to Follow-up|4|||
13179578|NCT02239692|26147169|FG000|Overall Study|Withdrawal by Subject|3|||
13179579|NCT02239692|26147170|FG001|Overall Study|Withdrawal by Subject|5|||
13179580|NCT02239692|26147169|FG000|Overall Study|Other reason|1|||
13179581|NCT02239692|26147170|FG001|Overall Study|Other reason|0|||
13179582|NCT02239679|26147392|FG000|Overall Study|Lost to Follow-up|1|||
13179583|NCT02239679|26147393|FG001|Overall Study|Lost to Follow-up|0|||
13179584|NCT02239679|26147394|FG002|Overall Study|Lost to Follow-up|0|||
13179585|NCT02239679|26147392|FG000|Overall Study|Withdrawal by Subject|2|||
13179586|NCT02239679|26147393|FG001|Overall Study|Withdrawal by Subject|3|||
13109390|NCT03234608|25895651|FG001|Overall Study|Lost to Follow-up|21|||
13109391|NCT03234465|25895664|FG000|Overall Study|Adverse Event|4|||
13109392|NCT03234465|25895665|FG001|Overall Study|Adverse Event|2|||
13179587|NCT02239679|26147394|FG002|Overall Study|Withdrawal by Subject|1|||
13179588|NCT02239640|26147406|FG000|Overall Study|Withdrawal by Subject|3|||
13179589|NCT02239640|26147406|FG000|Overall Study|Lost to Follow-up|72|||
13179590|NCT02239640|26147406|FG000|Overall Study|Death|142|||
13179591|NCT02239601|26147431|FG000|Overall Study|Withdrawal by Subject|3|||
13179592|NCT02239601|26147432|FG001|Overall Study|Withdrawal by Subject|4|||
13179593|NCT02239601|26147431|FG000|Overall Study|Protocol Violation|4|||
13179594|NCT02239601|26147432|FG001|Overall Study|Protocol Violation|2|||
13179595|NCT02239536|26147447|FG000|Overall Study|Non-neoplastic polyp|23|||
13179596|NCT02239536|26147448|FG001|Overall Study|Non-neoplastic polyp|17|||
13179597|NCT02239510|26147467|FG000|Overall Study|Lost to Follow-up|2|||
13179598|NCT02239510|26147468|FG001|Overall Study|Lost to Follow-up|1|||
13179599|NCT02239328|26147474|FG000|Overall Study|Benign disease noted at time of surgery|6|||
13179600|NCT02239328|26147474|FG000|Overall Study|Equipment or website malfunction|2|||
13179601|NCT02239263|26147482|FG000|Overall Study|Protocol Violation|6|||
13179602|NCT02239224|26147549|FG000|Overall Study|Administrative|0|||
13179603|NCT02239224|26147550|FG001|Overall Study|Administrative|0|||
13179604|NCT02239224|26147551|FG002|Overall Study|Administrative|3|||
13179605|NCT02239224|26147552|FG003|Overall Study|Administrative|1|||
13179606|NCT02239120|26147583|FG000|Overall Study|Death|56|||
13179607|NCT02239120|26147584|FG001|Overall Study|Death|58|||
13179608|NCT02239120|26147583|FG000|Overall Study|Lost to Follow-up|19|||
13179609|NCT02239120|26147584|FG001|Overall Study|Lost to Follow-up|14|||
13179610|NCT02239094|26147591|FG000|Overall Study|Withdrawal by Subject|1|||
13179611|NCT02239094|26147591|FG000|Overall Study|Remitted before started|1|||
13179612|NCT02238626|26147636|FG000|Overall Study|Adverse Event|3|||
13179613|NCT02238626|26147637|FG001|Overall Study|Adverse Event|5|||
13179614|NCT02238626|26147638|FG002|Overall Study|Adverse Event|0|||
13179615|NCT02238626|26147639|FG003|Overall Study|Adverse Event|3|||
13179616|NCT02238626|26147636|FG000|Overall Study|Lost to Follow-up|2|||
13179617|NCT02238626|26147637|FG001|Overall Study|Lost to Follow-up|4|||
13179618|NCT02238626|26147638|FG002|Overall Study|Lost to Follow-up|2|||
13179619|NCT02238626|26147639|FG003|Overall Study|Lost to Follow-up|2|||
13179620|NCT02238626|26147636|FG000|Overall Study|Withdrawal by Subject|0|||
13179621|NCT02238626|26147637|FG001|Overall Study|Withdrawal by Subject|3|||
13179622|NCT02238626|26147638|FG002|Overall Study|Withdrawal by Subject|0|||
13179623|NCT02238626|26147639|FG003|Overall Study|Withdrawal by Subject|1|||
13179624|NCT02238626|26147636|FG000|Overall Study|Death|0|||
13179625|NCT02238626|26147637|FG001|Overall Study|Death|0|||
13179626|NCT02238626|26147638|FG002|Overall Study|Death|1|||
13179627|NCT02238626|26147639|FG003|Overall Study|Death|1|||
13179628|NCT02238626|26147636|FG000|Overall Study|Other|0|||
13179629|NCT02238626|26147637|FG001|Overall Study|Other|2|||
13179630|NCT02238626|26147638|FG002|Overall Study|Other|0|||
13179631|NCT02238626|26147639|FG003|Overall Study|Other|0|||
13179632|NCT02238483|26147682|FG000|Overall Study|Withdrawal by Subject|2|||
13179633|NCT02238483|26147683|FG001|Overall Study|Withdrawal by Subject|7|||
13179634|NCT02238483|26147682|FG000|Overall Study|Lost to Follow-up|1|||
13179635|NCT02238483|26147683|FG001|Overall Study|Lost to Follow-up|1|||
13179636|NCT02238483|26147682|FG000|Overall Study|Protocol Violation|1|||
13179637|NCT02238483|26147683|FG001|Overall Study|Protocol Violation|2|||
13179638|NCT02238483|26147682|FG000|Overall Study|Death|1|||
13179639|NCT02238483|26147683|FG001|Overall Study|Death|0|||
13179640|NCT02238483|26147682|FG000|Overall Study|Adverse Event|7|||
13179641|NCT02238483|26147683|FG001|Overall Study|Adverse Event|3|||
13179642|NCT02238483|26147682|FG000|Overall Study|Withdrawn due to physician decision|1|||
13179643|NCT02238483|26147683|FG001|Overall Study|Withdrawn due to physician decision|0|||
13179644|NCT02238483|26147682|FG000|Overall Study|Completion status not recorded|1|||
13179645|NCT02238483|26147683|FG001|Overall Study|Completion status not recorded|1|||
13109393|NCT03234465|25895664|FG000|Overall Study|Death|0|||
13109394|NCT03234465|25895665|FG001|Overall Study|Death|1|||
13109395|NCT03234465|25895664|FG000|Overall Study|Lost to Follow-up|1|||
13109396|NCT03234465|25895665|FG001|Overall Study|Lost to Follow-up|1|||
13109397|NCT03234465|25895664|FG000|Overall Study|Withdrawal by Subject|12|||
13179646|NCT02238483|26147682|FG000|Overall Study|Illness in family member|1|||
13179647|NCT02238483|26147683|FG001|Overall Study|Illness in family member|0|||
13179648|NCT02238379|26147716|FG000|Overall Study|Lost to Follow-up|1|||
13179649|NCT02238379|26147717|FG001|Overall Study|Lost to Follow-up|0|||
13179650|NCT02238080|26147733|FG000|Overall Study|Death|13|||
13179651|NCT02238080|26147733|FG000|Overall Study|Treatment interrupted|6|||
13179652|NCT02238080|26147733|FG000|Overall Study|Withdrawal by Subject|2|||
13179653|NCT02238080|26147733|FG000|Overall Study|Other|4|||
13179654|NCT02238067|26147758|FG000|Overall Study|Not completed survey at Month 6|45|||
13179655|NCT02237911|26147782|FG000|Overall Study|Withdrawal by Subject|4|||
13179656|NCT02237911|26147783|FG001|Overall Study|Withdrawal by Subject|7|||
13179657|NCT02237911|26147784|FG002|Overall Study|Withdrawal by Subject|2|||
13179658|NCT02237911|26147782|FG000|Overall Study|Lost to Follow-up|3|||
13179659|NCT02237911|26147783|FG001|Overall Study|Lost to Follow-up|1|||
13179660|NCT02237911|26147784|FG002|Overall Study|Lost to Follow-up|1|||
13179661|NCT02237196|26147839|FG000|Overall Study|Adverse Event|0|||
13179662|NCT02237196|26147840|FG001|Overall Study|Adverse Event|1|||
13179663|NCT02237196|26147841|FG002|Overall Study|Adverse Event|1|||
13179664|NCT02237196|26147842|FG003|Overall Study|Adverse Event|0|||
13179665|NCT02237196|26147839|FG000|Overall Study|Lost to Follow-up|4|||
13179666|NCT02237196|26147840|FG001|Overall Study|Lost to Follow-up|2|||
13179667|NCT02237196|26147841|FG002|Overall Study|Lost to Follow-up|4|||
13179668|NCT02237196|26147842|FG003|Overall Study|Lost to Follow-up|6|||
13179669|NCT02237196|26147839|FG000|Overall Study|Physician Decision|2|||
13179670|NCT02237196|26147840|FG001|Overall Study|Physician Decision|0|||
13179671|NCT02237196|26147841|FG002|Overall Study|Physician Decision|0|||
13179672|NCT02237196|26147842|FG003|Overall Study|Physician Decision|1|||
13179673|NCT02237196|26147839|FG000|Overall Study|Pregnancy|0|||
13179674|NCT02237196|26147840|FG001|Overall Study|Pregnancy|0|||
13179675|NCT02237196|26147841|FG002|Overall Study|Pregnancy|1|||
13179676|NCT02237196|26147842|FG003|Overall Study|Pregnancy|1|||
13179677|NCT02237196|26147839|FG000|Overall Study|Withdrawal by Subject|1|||
13179678|NCT02237196|26147840|FG001|Overall Study|Withdrawal by Subject|1|||
13179679|NCT02237196|26147841|FG002|Overall Study|Withdrawal by Subject|4|||
13179680|NCT02237196|26147842|FG003|Overall Study|Withdrawal by Subject|1|||
13179681|NCT02237196|26147839|FG000|Overall Study|Site Error|1|||
13179682|NCT02237196|26147840|FG001|Overall Study|Site Error|2|||
13179683|NCT02237196|26147841|FG002|Overall Study|Site Error|0|||
13179684|NCT02237196|26147842|FG003|Overall Study|Site Error|2|||
13179685|NCT02237157|26147854|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3|||
13179686|NCT02237157|26147855|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
13179687|NCT02237157|26147856|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
13179688|NCT02237157|26147857|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
13179689|NCT02237157|26147854|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1|||
13179690|NCT02237157|26147855|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
13179691|NCT02237157|26147856|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
13179692|NCT02237157|26147857|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
13179693|NCT02237118|26147878|FG000|Overall Study|Protocol Violation|0|||
13109398|NCT03234465|25895665|FG001|Overall Study|Withdrawal by Subject|27|||
13109399|NCT03234465|25895664|FG000|Overall Study|Symptomatic deterioration|0|||
13109400|NCT03234465|25895665|FG001|Overall Study|Symptomatic deterioration|1|||
13109401|NCT03234465|25895664|FG000|Overall Study|Non-compliance|2|||
13109402|NCT03234465|25895665|FG001|Overall Study|Non-compliance|0|||
13109403|NCT03234465|25895664|FG000|Overall Study|Other|14|||
13109404|NCT03234465|25895665|FG001|Overall Study|Other|8|||
13109405|NCT03234036|25895778|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
13109406|NCT03234036|25895779|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
13109407|NCT03234036|25895780|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
13109408|NCT03234036|25895781|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
13109409|NCT03233529|25895825|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1|||
13109410|NCT03233529|25895825|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1|||
13109411|NCT03233438|25895898|FG000|Overall Study|Lost to Follow-up|4|||
13109412|NCT03233438|25895899|FG001|Overall Study|Lost to Follow-up|9|||
13109413|NCT03233438|25895898|FG000|Overall Study|Withdrawal by Subject|2|||
13109414|NCT03233438|25895899|FG001|Overall Study|Withdrawal by Subject|1|||
13109415|NCT03233438|25895898|FG000|Overall Study|No recording of dalbavancin|0|||
13109416|NCT03233438|25895899|FG001|Overall Study|No recording of dalbavancin|1|||
13109417|NCT03233308|25895913|FG000|Overall Study|Adverse Event|1|||
13109418|NCT03233308|25895913|FG000|Overall Study|Protocol Violation|1|||
13109419|NCT03233230|25896080|FG000|Overall Study|Adverse Event|6|||
13109420|NCT03233230|25896081|FG001|Overall Study|Adverse Event|3|||
13109421|NCT03233230|25896082|FG002|Overall Study|Adverse Event|6|||
13109422|NCT03233230|25896083|FG003|Overall Study|Adverse Event|3|||
13109423|NCT03233230|25896080|FG000|Overall Study|Protocol Violation|1|||
13109424|NCT03233230|25896081|FG001|Overall Study|Protocol Violation|2|||
13109425|NCT03233230|25896082|FG002|Overall Study|Protocol Violation|1|||
13109426|NCT03233230|25896083|FG003|Overall Study|Protocol Violation|1|||
13109427|NCT03233230|25896080|FG000|Overall Study|Lack of Efficacy|1|||
13109428|NCT03233230|25896081|FG001|Overall Study|Lack of Efficacy|0|||
13109429|NCT03233230|25896082|FG002|Overall Study|Lack of Efficacy|0|||
13109430|NCT03233230|25896083|FG003|Overall Study|Lack of Efficacy|0|||
13109431|NCT03233230|25896080|FG000|Overall Study|Other|5|||
13109432|NCT03233230|25896081|FG001|Overall Study|Other|5|||
13179694|NCT02237118|26147879|FG001|Overall Study|Protocol Violation|1|||
13179695|NCT02237118|26147878|FG000|Overall Study|consent withdrawn|1|||
13179696|NCT02237118|26147879|FG001|Overall Study|consent withdrawn|0|||
13179697|NCT02237001|26147893|FG000|Overall Study|Lost to Follow-up|2|||
13179698|NCT02237001|26147893|FG000|Overall Study|Withdrawal by Subject|1|||
13179699|NCT02237001|26147893|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3|||
13109433|NCT03233230|25896082|FG002|Overall Study|Other|5|||
13109434|NCT03233230|25896083|FG003|Overall Study|Other|3|||
13109435|NCT03233230|25896080|FG000|Overall Study|Withdrawal by Subject|2|||
13109436|NCT03233230|25896081|FG001|Overall Study|Withdrawal by Subject|2|||
13109437|NCT03233230|25896082|FG002|Overall Study|Withdrawal by Subject|0|||
13109438|NCT03233230|25896083|FG003|Overall Study|Withdrawal by Subject|1|||
13109439|NCT03233230|25896080|FG000|Overall Study|Lost to Follow-up|0|||
13109440|NCT03233230|25896081|FG001|Overall Study|Lost to Follow-up|3|||
13109441|NCT03233230|25896082|FG002|Overall Study|Lost to Follow-up|0|||
13109442|NCT03233230|25896083|FG003|Overall Study|Lost to Follow-up|0|||
13109443|NCT03233048|25896099|FG000|Overall Study|Withdrawal by Subject|1|||
13109444|NCT03233009|25896144|FG000|Overall Study|Lost to Follow-up|1|||
13109445|NCT03232983|25896162|FG000|Period 1|Physician Decision|0|||
13109446|NCT03232983|25896163|FG001|Period 1|Physician Decision|0|||
13109447|NCT03232983|25896164|FG002|Period 1|Physician Decision|1|||
13109448|NCT03232983|25896165|FG003|Period 1|Physician Decision|0|||
13109449|NCT03232983|25896162|FG000|Washout Period 2|Physician Decision|0|||
13109450|NCT03232983|25896163|FG001|Washout Period 2|Physician Decision|0|||
13109451|NCT03232983|25896164|FG002|Washout Period 2|Physician Decision|1|||
13109452|NCT03232983|25896165|FG003|Washout Period 2|Physician Decision|0|||
13109453|NCT03232983|25896162|FG000|Washout Period 2|Withdrawal by Subject|0|||
13109454|NCT03232983|25896163|FG001|Washout Period 2|Withdrawal by Subject|0|||
13109455|NCT03232983|25896164|FG002|Washout Period 2|Withdrawal by Subject|0|||
13109456|NCT03232983|25896165|FG003|Washout Period 2|Withdrawal by Subject|1|||
13109457|NCT03232983|25896162|FG000|Period 4|Withdrawal by Subject|1|||
13109458|NCT03232983|25896163|FG001|Period 4|Withdrawal by Subject|0|||
13109459|NCT03232983|25896164|FG002|Period 4|Withdrawal by Subject|0|||
13109460|NCT03232983|25896165|FG003|Period 4|Withdrawal by Subject|0|||
13109461|NCT03232567|25896200|FG000|Overall Study|Withdrawal by Subject|0|||
13109462|NCT03232567|25896201|FG001|Overall Study|Withdrawal by Subject|1|||
13109463|NCT03232567|25896202|FG002|Overall Study|Withdrawal by Subject|0|||
13109464|NCT03232567|25896203|FG003|Overall Study|Withdrawal by Subject|0|||
13109465|NCT03232333|25896215|FG000|Overall Study|Infection or Osteomyelitis|9|||
13109466|NCT03232333|25896215|FG000|Overall Study|Lost to Follow-up|4|||
13109467|NCT03232333|25896215|FG000|Overall Study|Withdrawal by Subject|2|||
13179700|NCT02237001|26147893|FG000|Overall Study|Re-operation|4|||
13179701|NCT02237001|26147893|FG000|Overall Study|Incarceration|1|||
13179702|NCT02236988|26148081|FG000|Overall Study|Lost to Follow-up|0|||
13179703|NCT02236988|26148082|FG001|Overall Study|Lost to Follow-up|0|||
13179704|NCT02236988|26148083|FG002|Overall Study|Lost to Follow-up|0|||
13179705|NCT02236988|26148084|FG003|Overall Study|Lost to Follow-up|1|||
13179706|NCT02236988|26148081|FG000|Overall Study|Unable to Comply with Study Visits|0|||
13179707|NCT02236988|26148082|FG001|Overall Study|Unable to Comply with Study Visits|0|||
13179708|NCT02236988|26148083|FG002|Overall Study|Unable to Comply with Study Visits|0|||
13179709|NCT02236988|26148084|FG003|Overall Study|Unable to Comply with Study Visits|2|||
13179710|NCT02236611|26148097|FG000|Overall Study|Adverse Event|10|||
13179711|NCT02236611|26148098|FG001|Overall Study|Adverse Event|16|||
13179712|NCT02236611|26148097|FG000|Overall Study|Lack of Efficacy|4|||
13179713|NCT02236611|26148098|FG001|Overall Study|Lack of Efficacy|7|||
13179714|NCT02236611|26148097|FG000|Overall Study|Lost to Follow-up|0|||
13179715|NCT02236611|26148098|FG001|Overall Study|Lost to Follow-up|2|||
13179716|NCT02236611|26148097|FG000|Overall Study|Protocol deviation|3|||
13179717|NCT02236611|26148098|FG001|Overall Study|Protocol deviation|5|||
13179718|NCT02236611|26148097|FG000|Overall Study|Withdrew consent|9|||
13179719|NCT02236611|26148098|FG001|Overall Study|Withdrew consent|4|||
13179720|NCT02236598|26148117|FG000|Overall Study|Adverse Event|0|||
13179721|NCT02236598|26148118|FG001|Overall Study|Adverse Event|1|||
13179722|NCT02236598|26148117|FG000|Overall Study|Withdrawal by Subject|0|||
13179723|NCT02236598|26148118|FG001|Overall Study|Withdrawal by Subject|1|||
13179724|NCT02236559|26148151|FG000|Overall Study|Met Exclusion|3|||
13179725|NCT02236559|26148152|FG001|Overall Study|Met Exclusion|6|||
13179726|NCT02236559|26148151|FG000|Overall Study|Did not Meet Inclusion|3|||
13179727|NCT02236559|26148152|FG001|Overall Study|Did not Meet Inclusion|3|||
13179728|NCT02236559|26148151|FG000|Overall Study|Subject Did Not Consent|4|||
13179729|NCT02236559|26148152|FG001|Overall Study|Subject Did Not Consent|2|||
13179730|NCT02236559|26148151|FG000|Overall Study|Physician Decision|1|||
13179731|NCT02236559|26148152|FG001|Overall Study|Physician Decision|1|||
13179732|NCT02236559|26148151|FG000|Overall Study|Withdrawal by Subject|1|||
13179733|NCT02236559|26148152|FG001|Overall Study|Withdrawal by Subject|0|||
13179734|NCT02236520|26148175|FG000|Overall Study|Physician Decision|0|||
13179735|NCT02236520|26148176|FG001|Overall Study|Physician Decision|5|||
13109468|NCT03232281|25896242|FG000|Overall Study|Adverse Event|1|||
13109469|NCT03232281|25896243|FG001|Overall Study|Adverse Event|1|||
13109470|NCT03232281|25896242|FG000|Overall Study|Withdrawal by Subject|5|||
13109471|NCT03232281|25896243|FG001|Overall Study|Withdrawal by Subject|4|||
13179736|NCT02236520|26148177|FG002|Overall Study|Physician Decision|0|||
13179737|NCT02236520|26148178|FG003|Overall Study|Physician Decision|0|||
13179738|NCT02236520|26148175|FG000|Overall Study|Withdrawal by Subject|1|||
13179739|NCT02236520|26148176|FG001|Overall Study|Withdrawal by Subject|0|||
13179740|NCT02236520|26148177|FG002|Overall Study|Withdrawal by Subject|0|||
13179741|NCT02236520|26148178|FG003|Overall Study|Withdrawal by Subject|1|||
13485538|NCT02906020|27032876|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
13109472|NCT03232281|25896242|FG000|Overall Study|Protocol Deviation|1|||
13109473|NCT03232281|25896243|FG001|Overall Study|Protocol Deviation|1|||
13109474|NCT03231943|25896719|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
13109475|NCT03231943|25896720|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
13179742|NCT02236520|26148175|FG000|Overall Study|Pregnancy|1|||
13179743|NCT02236520|26148176|FG001|Overall Study|Pregnancy|0|||
13179744|NCT02236520|26148177|FG002|Overall Study|Pregnancy|0|||
13179745|NCT02236520|26148178|FG003|Overall Study|Pregnancy|0|||
13179746|NCT02236130|26148193|FG000|Overall Study|Lost to Follow-up|7|||
13179747|NCT02236130|26148194|FG001|Overall Study|Lost to Follow-up|12|||
13179748|NCT02235454|26148200|FG000|Overall Study|Withdrawal by Subject|2|||
13179749|NCT02235311|26148219|FG000|Overall Study|Lost to Follow-up|0|||
13179750|NCT02235311|26148220|FG001|Overall Study|Lost to Follow-up|1|||
13179751|NCT02235311|26148219|FG000|Overall Study|Protocol Violation|0|||
13179752|NCT02235311|26148220|FG001|Overall Study|Protocol Violation|1|||
13179753|NCT02235298|26148235|FG000|Overall Study|Lost to Follow-up|6|||
13179754|NCT02235298|26148236|FG001|Overall Study|Lost to Follow-up|5|||
13179755|NCT02235298|26148235|FG000|Overall Study|Adverse Event|2|||
13179756|NCT02235298|26148236|FG001|Overall Study|Adverse Event|2|||
13179757|NCT02235298|26148235|FG000|Overall Study|Withdrawal by Subject|0|||
13179758|NCT02235298|26148236|FG001|Overall Study|Withdrawal by Subject|1|||
13179759|NCT02235077|26148269|FG000|Overall Study|Death|5|||
13179760|NCT02235077|26148270|FG001|Overall Study|Death|7|||
13179761|NCT02235077|26148269|FG000|Overall Study|Lost to Follow-up|5|||
13179762|NCT02235077|26148270|FG001|Overall Study|Lost to Follow-up|6|||
13179763|NCT02235077|26148269|FG000|Overall Study|Withdrawal by Subject|8|||
13179764|NCT02235077|26148270|FG001|Overall Study|Withdrawal by Subject|5|||
13179765|NCT02235077|26148269|FG000|Overall Study|Physician Decision|0|||
13179766|NCT02235077|26148270|FG001|Overall Study|Physician Decision|1|||
13179767|NCT02234622|26148295|FG000|Overall Study|Withdrawal by Subject|16|||
13179768|NCT02234622|26148296|FG001|Overall Study|Withdrawal by Subject|22|||
13179769|NCT02234622|26148295|FG000|Overall Study|Lost to Follow-up|27|||
13179770|NCT02234622|26148296|FG001|Overall Study|Lost to Follow-up|14|||
13179771|NCT02234596|26148304|FG000|Overall Study|Participant not treated|2|||
13179772|NCT02234583|26148339|FG000|Overall Study|Adverse Event|172|||
13179773|NCT02234583|26148340|FG001|Overall Study|Adverse Event|156|||
13179774|NCT02234583|26148339|FG000|Overall Study|Withdrawal by Subject|109|||
13179775|NCT02234583|26148340|FG001|Overall Study|Withdrawal by Subject|157|||
13179776|NCT02234583|26148339|FG000|Overall Study|Lost to Follow-up|0|||
13179777|NCT02234583|26148340|FG001|Overall Study|Lost to Follow-up|1|||
13179778|NCT02234583|26148339|FG000|Overall Study|Lack of Efficacy|58|||
13179779|NCT02234583|26148340|FG001|Overall Study|Lack of Efficacy|103|||
13179780|NCT02234583|26148339|FG000|Overall Study|Protocol Violation|35|||
13179781|NCT02234583|26148340|FG001|Overall Study|Protocol Violation|42|||
13179782|NCT02234583|26148339|FG000|Overall Study|Other|39|||
13179783|NCT02234583|26148340|FG001|Overall Study|Other|97|||
13179784|NCT02234479|26148353|FG000|Overall Study|Withdrawal by Subject|1|||
13179785|NCT02234479|26148354|FG001|Overall Study|Withdrawal by Subject|3|||
13179786|NCT02234362|26148373|FG000|Overall Study|Not eligible after first screening visit|17|||
13179787|NCT02234362|26148373|FG000|Overall Study|Lost to Follow-up|6|||
13179788|NCT02234362|26148373|FG000|Overall Study|Withdrawal by Subject|3|||
13179789|NCT02234284|26148428|FG000|Overall Study|Death|4|||
13179790|NCT02234284|26148429|FG001|Overall Study|Death|2|||
13179791|NCT02234284|26148428|FG000|Overall Study|Withdrawal by Subject|1|||
13179792|NCT02234284|26148429|FG001|Overall Study|Withdrawal by Subject|0|||
13109476|NCT03231943|25896721|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
13109477|NCT03231943|25896722|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
13109478|NCT03231943|25896723|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
13109479|NCT03231943|25896724|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
13109480|NCT03231943|25896725|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
13109481|NCT03231943|25896726|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
13109482|NCT03231943|25896727|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
13109483|NCT03231943|25896728|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
13109484|NCT03231943|25896729|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
13109485|NCT03231943|25896730|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
13109486|NCT03231943|25896731|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
13109487|NCT03231943|25896719|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
13179793|NCT02234284|26148428|FG000|Overall Study|Lost to Follow-up|20|||
13179794|NCT02234284|26148429|FG001|Overall Study|Lost to Follow-up|7|||
13179795|NCT02234141|26148527|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
13179796|NCT02234141|26148528|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
13179797|NCT02234141|26148529|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
13179798|NCT02234141|26148530|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
13179799|NCT02234141|26148531|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
13179800|NCT02234141|26148532|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
13179801|NCT02234141|26148533|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
13179802|NCT02234141|26148527|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0|||
13179803|NCT02234141|26148528|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2|||
13179804|NCT02234141|26148529|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0|||
13179805|NCT02234141|26148530|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0|||
13179806|NCT02234141|26148531|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0|||
13179807|NCT02234141|26148532|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0|||
13179808|NCT02234141|26148533|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0|||
13179809|NCT02234141|26148527|FG000|Treatment Period (24 Weeks)|Death|1|||
13179810|NCT02234141|26148528|FG001|Treatment Period (24 Weeks)|Death|2|||
13179811|NCT02234141|26148529|FG002|Treatment Period (24 Weeks)|Death|0|||
13179812|NCT02234141|26148530|FG003|Treatment Period (24 Weeks)|Death|1|||
13179813|NCT02234141|26148531|FG004|Treatment Period (24 Weeks)|Death|0|||
13179814|NCT02234141|26148532|FG005|Treatment Period (24 Weeks)|Death|0|||
13179815|NCT02234141|26148533|FG006|Treatment Period (24 Weeks)|Death|0|||
13179816|NCT02234141|26148527|FG000|Treatment Period (24 Weeks)|Adverse Event|3|||
13179817|NCT02234141|26148528|FG001|Treatment Period (24 Weeks)|Adverse Event|1|||
13179818|NCT02234141|26148529|FG002|Treatment Period (24 Weeks)|Adverse Event|2|||
13179819|NCT02234141|26148530|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
13179820|NCT02234141|26148531|FG004|Treatment Period (24 Weeks)|Adverse Event|0|||
13179821|NCT02234141|26148532|FG005|Treatment Period (24 Weeks)|Adverse Event|0|||
13179822|NCT02234141|26148533|FG006|Treatment Period (24 Weeks)|Adverse Event|0|||
13179823|NCT02234141|26148527|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0|||
13179824|NCT02234141|26148528|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1|||
13179825|NCT02234141|26148529|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0|||
13179826|NCT02234141|26148530|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0|||
13179827|NCT02234141|26148531|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0|||
13179828|NCT02234141|26148532|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0|||
13179829|NCT02234141|26148533|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0|||
13179830|NCT02234141|26148527|FG000|Long-Term Treatment Period|Death|0|||
13179831|NCT02234141|26148528|FG001|Long-Term Treatment Period|Death|0|||
13179832|NCT02234141|26148529|FG002|Long-Term Treatment Period|Death|0|||
13109488|NCT03231943|25896720|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1|||
13109489|NCT03231943|25896721|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
13109490|NCT03231943|25896722|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
13109491|NCT03231943|25896723|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
13109492|NCT03231943|25896724|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
13109493|NCT03231943|25896725|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
13109494|NCT03231943|25896726|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
13109495|NCT03231943|25896727|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
13109496|NCT03231943|25896728|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
13109497|NCT03231943|25896729|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
13109498|NCT03231943|25896730|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
13109499|NCT03231943|25896731|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
13109500|NCT03231943|25896719|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1|||
13109501|NCT03231943|25896720|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
13109502|NCT03231943|25896721|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
13109503|NCT03231943|25896722|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
13109504|NCT03231943|25896723|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
13109505|NCT03231943|25896724|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
13109506|NCT03231943|25896725|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
13109507|NCT03231943|25896726|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
13109508|NCT03231943|25896727|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
13109509|NCT03231943|25896728|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
13109510|NCT03231943|25896729|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
13179833|NCT02234141|26148530|FG003|Long-Term Treatment Period|Death|0|||
13179834|NCT02234141|26148531|FG004|Long-Term Treatment Period|Death|0|||
13179835|NCT02234141|26148532|FG005|Long-Term Treatment Period|Death|1|||
13179836|NCT02234141|26148533|FG006|Long-Term Treatment Period|Death|0|||
13179837|NCT02234141|26148527|FG000|Long-Term Treatment Period|Investigator's discretion|1|||
13179838|NCT02234141|26148528|FG001|Long-Term Treatment Period|Investigator's discretion|3|||
13179839|NCT02234141|26148529|FG002|Long-Term Treatment Period|Investigator's discretion|2|||
13179840|NCT02234141|26148530|FG003|Long-Term Treatment Period|Investigator's discretion|0|||
13179841|NCT02234141|26148531|FG004|Long-Term Treatment Period|Investigator's discretion|0|||
13179842|NCT02234141|26148532|FG005|Long-Term Treatment Period|Investigator's discretion|0|||
13179843|NCT02234141|26148533|FG006|Long-Term Treatment Period|Investigator's discretion|1|||
13179844|NCT02234141|26148527|FG000|Long-Term Treatment Period|Adverse Event|4|||
13179845|NCT02234141|26148528|FG001|Long-Term Treatment Period|Adverse Event|0|||
13179846|NCT02234141|26148529|FG002|Long-Term Treatment Period|Adverse Event|5|||
13179847|NCT02234141|26148530|FG003|Long-Term Treatment Period|Adverse Event|0|||
13179848|NCT02234141|26148531|FG004|Long-Term Treatment Period|Adverse Event|1|||
13179849|NCT02234141|26148532|FG005|Long-Term Treatment Period|Adverse Event|1|||
13179850|NCT02234141|26148533|FG006|Long-Term Treatment Period|Adverse Event|1|||
13179851|NCT02234141|26148527|FG000|Long-Term Treatment Period|Withdrew Consent|0|||
13179852|NCT02234141|26148528|FG001|Long-Term Treatment Period|Withdrew Consent|1|||
13179853|NCT02234141|26148529|FG002|Long-Term Treatment Period|Withdrew Consent|1|||
13179854|NCT02234141|26148530|FG003|Long-Term Treatment Period|Withdrew Consent|0|||
13179855|NCT02234141|26148531|FG004|Long-Term Treatment Period|Withdrew Consent|0|||
13179856|NCT02234141|26148532|FG005|Long-Term Treatment Period|Withdrew Consent|0|||
13179857|NCT02234141|26148533|FG006|Long-Term Treatment Period|Withdrew Consent|0|||
13179858|NCT02234141|26148527|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28|||
13179859|NCT02234141|26148528|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27|||
13179860|NCT02234141|26148529|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25|||
13179861|NCT02234141|26148530|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0|||
13179862|NCT02234141|26148531|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9|||
13179863|NCT02234141|26148532|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10|||
13179864|NCT02234141|26148533|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8|||
13179865|NCT02234063|26148560|FG000|Overall Study|Lost to Follow-up|235|||
13179866|NCT02234063|26148561|FG001|Overall Study|Lost to Follow-up|42|||
13179867|NCT02234063|26148560|FG000|Overall Study|Withdrawal by Subject|20|||
13179868|NCT02234063|26148561|FG001|Overall Study|Withdrawal by Subject|1|||
13179869|NCT02233946|26148580|FG000|Baseline|Withdrawal by Subject|2|||
13179870|NCT02233946|26148581|FG001|Baseline|Withdrawal by Subject|0|||
13179871|NCT02233946|26148580|FG000|3-months Follow-up|Lost to Follow-up|53|||
13179872|NCT02233946|26148581|FG001|3-months Follow-up|Lost to Follow-up|29|||
13179873|NCT02233946|26148580|FG000|6-months Follow-up|Lost to Follow-up|21|||
13179874|NCT02233946|26148581|FG001|6-months Follow-up|Lost to Follow-up|2|||
13179875|NCT02233946|26148580|FG000|9-month Follow-up|Lost to Follow-up|20|||
13179876|NCT02233946|26148581|FG001|9-month Follow-up|Lost to Follow-up|11|||
13179877|NCT02233946|26148580|FG000|12-month Follow-up|Lost to Follow-up|28|||
13179878|NCT02233946|26148581|FG001|12-month Follow-up|Lost to Follow-up|11|||
13179879|NCT02233803|26148594|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1|||
13179880|NCT02233803|26148595|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0|||
13179881|NCT02233803|26148594|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0|||
13179882|NCT02233803|26148595|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1|||
13179883|NCT02233803|26148594|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
13179884|NCT02233803|26148595|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
13179885|NCT02233803|26148594|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0|||
13179886|NCT02233803|26148595|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1|||
13179887|NCT02233803|26148594|FG000|Washout Period (4-Wks)|Lost to Follow-up|0|||
13179888|NCT02233803|26148595|FG001|Washout Period (4-Wks)|Lost to Follow-up|1|||
13179889|NCT02233803|26148594|FG000|Washout Period (4-Wks)|Physician Decision|1|||
13179890|NCT02233803|26148595|FG001|Washout Period (4-Wks)|Physician Decision|0|||
13179891|NCT02233803|26148594|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1|||
13179892|NCT02233803|26148595|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1|||
13179893|NCT02233803|26148594|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1|||
13179894|NCT02233803|26148595|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0|||
13179895|NCT02233803|26148594|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1|||
13179896|NCT02233803|26148595|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2|||
13179897|NCT02233738|26148772|FG000|Overall Study|Lost to Follow-up|5|||
13179898|NCT02233738|26148773|FG001|Overall Study|Lost to Follow-up|12|||
13179899|NCT02233738|26148772|FG000|Overall Study|Death|0|||
13179900|NCT02233738|26148773|FG001|Overall Study|Death|1|||
13179901|NCT02233738|26148772|FG000|Overall Study|Withdrawal by Subject|0|||
13179902|NCT02233738|26148773|FG001|Overall Study|Withdrawal by Subject|1|||
13179903|NCT02233738|26148772|FG000|Overall Study|Did not return after Baseline|3|||
13179904|NCT02233738|26148773|FG001|Overall Study|Did not return after Baseline|2|||
13179905|NCT02233647|26148804|FG000|Overall Study|Adverse Event|1|||
13179906|NCT02233543|26148815|FG000|Period 1|Withdrawal by Subject|1|||
13179907|NCT02233543|26148816|FG001|Period 1|Withdrawal by Subject|0|||
13179908|NCT02233543|26148815|FG000|Period 1|Participants required other treatment.|2|||
13179909|NCT02233543|26148816|FG001|Period 1|Participants required other treatment.|3|||
13179910|NCT02233543|26148815|FG000|Period 2|Adverse Event|1|||
13179911|NCT02233543|26148816|FG001|Period 2|Adverse Event|0|||
13179912|NCT02233543|26148815|FG000|Period 2|Participant required other treatment.|0|||
13179913|NCT02233543|26148816|FG001|Period 2|Participant required other treatment.|1|||
13179914|NCT02233543|26148815|FG000|Period 2|COPD exacerbation|1|||
13179915|NCT02233543|26148816|FG001|Period 2|COPD exacerbation|0|||
13179916|NCT02233413|26148835|FG000|Overall Study|Lost to Follow-up|7|||
13179917|NCT02233413|26148836|FG001|Overall Study|Lost to Follow-up|9|||
13179918|NCT02233413|26148835|FG000|Overall Study|Withdrawal by Subject|4|||
13179919|NCT02233413|26148836|FG001|Overall Study|Withdrawal by Subject|5|||
13179920|NCT02233309|26148842|FG000|Overall Study|Physician Decision|5|||
13179921|NCT02232984|26148853|FG000|Overall Study|Withdrawal by Subject|5|||
13179922|NCT02232984|26148853|FG000|Overall Study|Death|1|||
13179923|NCT02232984|26148853|FG000|Overall Study|Investigator withdrawal|10|||
13179924|NCT02232984|26148853|FG000|Overall Study|Device implant unsuccessful|53|||
13179925|NCT02232984|26148853|FG000|Overall Study|not disclosed by site|7|||
13179926|NCT02232984|26148853|FG000|Overall Study|Protocol Violation|1|||
13179927|NCT02232893|26148866|FG000|Overall Study|Withdrawal by Subject|4|||
13179928|NCT02232893|26148867|FG001|Overall Study|Withdrawal by Subject|1|||
13179929|NCT02232893|26148866|FG000|Overall Study|Adverse Event|0|||
13179930|NCT02232893|26148867|FG001|Overall Study|Adverse Event|1|||
13179931|NCT02232893|26148866|FG000|Overall Study|Sponsor request early termination|0|||
13179932|NCT02232893|26148867|FG001|Overall Study|Sponsor request early termination|1|||
13179933|NCT02232893|26148866|FG000|Overall Study|Developed exclusion criteria|0|||
13179934|NCT02232893|26148867|FG001|Overall Study|Developed exclusion criteria|1|||
13179935|NCT02232893|26148866|FG000|Overall Study|Other|0|||
13179936|NCT02232893|26148867|FG001|Overall Study|Other|3|||
13179937|NCT02232880|26148876|FG000|Overall Study|study stopped prior to randomization|1|||
13179938|NCT02232802|26148947|FG000|Period 1|Sponsor request|1|||
13179939|NCT02232802|26148948|FG001|Period 1|Sponsor request|0|||
13179940|NCT02232802|26148947|FG000|Period 1|Adverse Event|1|||
13179941|NCT02232802|26148948|FG001|Period 1|Adverse Event|1|||
13179942|NCT02232698|26148976|FG000|Overall Study|Pregnancy|1|||
13179943|NCT02232698|26148977|FG001|Overall Study|Pregnancy|1|||
13179944|NCT02232698|26148976|FG000|Overall Study|Met exclusion criteria|1|||
13179945|NCT02232698|26148977|FG001|Overall Study|Met exclusion criteria|1|||
13179946|NCT02232698|26148976|FG000|Overall Study|Had device-associated symptoms|7|||
13179947|NCT02232698|26148977|FG001|Overall Study|Had device-associated symptoms|0|||
13179948|NCT02232698|26148976|FG000|Overall Study|Non-compliance with study device|1|||
13179949|NCT02232698|26148977|FG001|Overall Study|Non-compliance with study device|4|||
13179950|NCT02232698|26148976|FG000|Overall Study|Allocated to control group|0|||
13179951|NCT02232698|26148977|FG001|Overall Study|Allocated to control group|3|||
13179952|NCT02232698|26148976|FG000|Overall Study|Withdrawal by Subject|0|||
13179953|NCT02232698|26148977|FG001|Overall Study|Withdrawal by Subject|11|||
13179954|NCT02232425|26149014|FG000|Overall Study|Lost to Follow-up|6|||
13179955|NCT02232425|26149015|FG001|Overall Study|Lost to Follow-up|2|||
13179956|NCT02232425|26149014|FG000|Overall Study|Adverse Event|2|||
13179957|NCT02232425|26149015|FG001|Overall Study|Adverse Event|0|||
13179958|NCT02232425|26149014|FG000|Overall Study|Withdrawal by Subject|5|||
13179959|NCT02232425|26149015|FG001|Overall Study|Withdrawal by Subject|6|||
13179960|NCT02232425|26149014|FG000|Overall Study|Lack of Efficacy|1|||
13179961|NCT02232425|26149015|FG001|Overall Study|Lack of Efficacy|0|||
13205966|NCT01961544|26233072|FG000|Overall Study|Aggravation of Steral Pain|1|||
13205967|NCT01961349|26233093|FG000|Overall Study|Withdrawal by Subject|1|||
13205968|NCT01961349|26233094|FG001|Overall Study|Withdrawal by Subject|4|||
13205969|NCT01961349|26233095|FG002|Overall Study|Withdrawal by Subject|0|||
13205970|NCT01961349|26233093|FG000|Overall Study|Adverse Event|0|||
13205971|NCT01961349|26233094|FG001|Overall Study|Adverse Event|0|||
13205972|NCT01961349|26233095|FG002|Overall Study|Adverse Event|1|||
13205973|NCT01961349|26233093|FG000|Overall Study|registration error, personal reason etc|2|||
13205974|NCT01961349|26233094|FG001|Overall Study|registration error, personal reason etc|2|||
13205975|NCT01961349|26233095|FG002|Overall Study|registration error, personal reason etc|1|||
13205976|NCT01961323|26233103|FG000|Overall Study|Withdrawal by Subject|7|||
13205977|NCT01961323|26233103|FG000|Overall Study|Lost to Follow-up|8|||
13205978|NCT01961323|26233103|FG000|Overall Study|screen failure|34|||
13205979|NCT01961297|26233124|FG000|Overall Study|unconfirmed diagnosis of SD|2|||
13205980|NCT01961297|26233125|FG001|Overall Study|unconfirmed diagnosis of SD|1|||
13205981|NCT01961115|26233170|FG000|Overall Study|Disease Progression|1|||
13205982|NCT01961115|26233171|FG001|Overall Study|Disease Progression|0|||
13205983|NCT01961115|26233172|FG002|Overall Study|Disease Progression|3|||
13205984|NCT01961115|26233170|FG000|Overall Study|Adverse Event|1|||
13205985|NCT01961115|26233171|FG001|Overall Study|Adverse Event|0|||
13205986|NCT01961115|26233172|FG002|Overall Study|Adverse Event|1|||
13205987|NCT01960998|26233207|FG000|Overall Study|Lost to Follow-up|3|||
13205988|NCT01960998|26233208|FG001|Overall Study|Lost to Follow-up|7|||
13205989|NCT01960998|26233207|FG000|Overall Study|Death|0|||
13205990|NCT01960998|26233208|FG001|Overall Study|Death|1|||
13205991|NCT01960998|26233207|FG000|Overall Study|Withdrawal by Subject|8|||
13205992|NCT01960998|26233208|FG001|Overall Study|Withdrawal by Subject|2|||
13205993|NCT01960998|26233207|FG000|Overall Study|lost computer access|0|||
13205994|NCT01960998|26233208|FG001|Overall Study|lost computer access|1|||
13205995|NCT01960907|26233225|FG000|Overall Study|Death|4|||
13205996|NCT01960907|26233226|FG001|Overall Study|Death|3|||
13205997|NCT01960907|26233225|FG000|Overall Study|Withdrawal by Subject|32|||
13205998|NCT01960907|26233226|FG001|Overall Study|Withdrawal by Subject|42|||
13205999|NCT01960855|26233274|FG000|Overall Study|Subject noncompliant|1|||
13206000|NCT01960855|26233275|FG001|Overall Study|Subject noncompliant|0|||
13179962|NCT02232243|26149034|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
13179963|NCT02232243|26149035|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1|||
13179964|NCT02232243|26149036|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
13179965|NCT02232178|26149063|FG000|Overall Study|Lost to Follow-up|0|||
13179966|NCT02232178|26149064|FG001|Overall Study|Lost to Follow-up|1|||
13179967|NCT02232178|26149065|FG002|Overall Study|Lost to Follow-up|0|||
13179968|NCT02232178|26149063|FG000|Overall Study|ineligibility|0|||
13179969|NCT02232178|26149064|FG001|Overall Study|ineligibility|0|||
13179970|NCT02232178|26149065|FG002|Overall Study|ineligibility|1|||
13179971|NCT02232178|26149063|FG000|Overall Study|surgical complication|1|||
13179972|NCT02232178|26149064|FG001|Overall Study|surgical complication|0|||
13179973|NCT02232178|26149065|FG002|Overall Study|surgical complication|0|||
13179974|NCT02232074|26149118|FG000|Overall Study|Withdrawal by Subject|5|||
13179975|NCT02232074|26149119|FG001|Overall Study|Withdrawal by Subject|3|||
13179976|NCT02232074|26149118|FG000|Overall Study|No legal concerns at baseline|36|||
13179977|NCT02232074|26149119|FG001|Overall Study|No legal concerns at baseline|41|||
13179978|NCT02232074|26149118|FG000|Overall Study|deemed ineligible|0|||
13179979|NCT02232074|26149119|FG001|Overall Study|deemed ineligible|1|||
13179980|NCT02232061|26149125|FG000|Overall Study|Administrative problems|1|||
13179981|NCT02232061|26149125|FG000|Overall Study|Withdrawal by Subject|1|||
13179982|NCT02231918|26149197|FG000|Overall Study|Withdrawal by Subject|0|||
13179983|NCT02231918|26149198|FG001|Overall Study|Withdrawal by Subject|1|||
13179984|NCT02231918|26149199|FG002|Overall Study|Withdrawal by Subject|0|||
13179985|NCT02231918|26149197|FG000|Overall Study|Adverse Event|0|||
13179986|NCT02231918|26149198|FG001|Overall Study|Adverse Event|0|||
13179987|NCT02231918|26149199|FG002|Overall Study|Adverse Event|1|||
13179988|NCT02231892|26149226|FG000|Overall Study|Lost to Follow-up|1|||
13179989|NCT02231892|26149227|FG001|Overall Study|Lost to Follow-up|0|||
13179990|NCT02231892|26149228|FG002|Overall Study|Lost to Follow-up|3|||
13179991|NCT02231892|26149226|FG000|Overall Study|Withdrawal by Subject|4|||
13179992|NCT02231892|26149227|FG001|Overall Study|Withdrawal by Subject|3|||
13179993|NCT02231892|26149228|FG002|Overall Study|Withdrawal by Subject|15|||
13179994|NCT02231892|26149226|FG000|Overall Study|Physician Decision|0|||
13179995|NCT02231892|26149227|FG001|Overall Study|Physician Decision|2|||
13179996|NCT02231892|26149228|FG002|Overall Study|Physician Decision|4|||
13179997|NCT02231892|26149226|FG000|Overall Study|Motor activity when stimulating ante ACC|4|||
13179998|NCT02231892|26149227|FG001|Overall Study|Motor activity when stimulating ante ACC|7|||
13179999|NCT02231892|26149228|FG002|Overall Study|Motor activity when stimulating ante ACC|12|||
13180000|NCT02231892|26149226|FG000|Overall Study|Participant motor threshold was >83%|0|||
13180001|NCT02231892|26149227|FG001|Overall Study|Participant motor threshold was >83%|0|||
13180002|NCT02231892|26149228|FG002|Overall Study|Participant motor threshold was >83%|9|||
13180003|NCT02231892|26149226|FG000|Overall Study|Could not find motor threshold|2|||
13180004|NCT02231892|26149227|FG001|Overall Study|Could not find motor threshold|0|||
13180005|NCT02231892|26149228|FG002|Overall Study|Could not find motor threshold|1|||
13180006|NCT02231892|26149226|FG000|Overall Study|Could not find reliable motor hotspot|0|||
13180007|NCT02231892|26149227|FG001|Overall Study|Could not find reliable motor hotspot|0|||
13180008|NCT02231892|26149228|FG002|Overall Study|Could not find reliable motor hotspot|1|||
13180009|NCT02231580|26149291|FG000|Overall Study|Adverse Event|5|||
13180010|NCT02231580|26149292|FG001|Overall Study|Adverse Event|0|||
13180011|NCT02231164|26149305|FG000|Overall Study|Adverse Event|1|||
13180012|NCT02231164|26149306|FG001|Overall Study|Adverse Event|1|||
13180013|NCT02231164|26149305|FG000|Overall Study|Lack of Efficacy|4|||
13180014|NCT02231164|26149306|FG001|Overall Study|Lack of Efficacy|3|||
13180015|NCT02231164|26149305|FG000|Overall Study|Withdrawal by Subject|1|||
13180016|NCT02231164|26149306|FG001|Overall Study|Withdrawal by Subject|2|||
13180017|NCT02230956|26149336|FG000|Overall Study|Adverse Event|1|||
13180018|NCT02230956|26149337|FG001|Overall Study|Adverse Event|1|||
13180019|NCT02230956|26149338|FG002|Overall Study|Adverse Event|0|||
13180020|NCT02230956|26149336|FG000|Overall Study|Lack of Efficacy|1|||
13180021|NCT02230956|26149337|FG001|Overall Study|Lack of Efficacy|1|||
13180022|NCT02230956|26149338|FG002|Overall Study|Lack of Efficacy|1|||
13180023|NCT02230956|26149336|FG000|Overall Study|Lost to Follow-up|1|||
13180024|NCT02230956|26149337|FG001|Overall Study|Lost to Follow-up|1|||
13180025|NCT02230956|26149338|FG002|Overall Study|Lost to Follow-up|2|||
13180026|NCT02230956|26149336|FG000|Overall Study|Personal Reasons|2|||
13180027|NCT02230956|26149337|FG001|Overall Study|Personal Reasons|1|||
13222984|NCT01801358|26287547|FG004|Overall Study|Withdrawal by Subject|0|||
13222985|NCT01801358|26287548|FG005|Overall Study|Withdrawal by Subject|2|||
13180028|NCT02230956|26149338|FG002|Overall Study|Personal Reasons|1|||
13180029|NCT02230956|26149336|FG000|Overall Study|Protocol Violation|0|||
13180030|NCT02230956|26149337|FG001|Overall Study|Protocol Violation|1|||
13180031|NCT02230956|26149338|FG002|Overall Study|Protocol Violation|1|||
13180032|NCT02230956|26149336|FG000|Overall Study|Other Miscellaneous Reason|0|||
13180033|NCT02230956|26149337|FG001|Overall Study|Other Miscellaneous Reason|1|||
13180034|NCT02230956|26149338|FG002|Overall Study|Other Miscellaneous Reason|2|||
13180035|NCT02230904|26149365|FG000|Overall Study|Safety follow up could not take place|0|||
13180036|NCT02230904|26149366|FG001|Overall Study|Safety follow up could not take place|1|||
13180037|NCT02230891|26149393|FG000|Baseline|Did not meet inclusion|0|||
13180038|NCT02230891|26149394|FG001|Baseline|Did not meet inclusion|1|||
13180039|NCT02230891|26149395|FG002|Baseline|Did not meet inclusion|1|||
13180040|NCT02230891|26149393|FG000|2 Week|Withdrawal by Subject|2|||
13180041|NCT02230891|26149394|FG001|2 Week|Withdrawal by Subject|2|||
13180042|NCT02230891|26149395|FG002|2 Week|Withdrawal by Subject|0|||
13180043|NCT02230891|26149393|FG000|2 Week|Consent withdrawn|1|||
13180044|NCT02230891|26149394|FG001|2 Week|Consent withdrawn|0|||
13180045|NCT02230891|26149395|FG002|2 Week|Consent withdrawn|0|||
13180046|NCT02230891|26149393|FG000|6 Month|Withdrawal by Subject|1|||
13180047|NCT02230891|26149394|FG001|6 Month|Withdrawal by Subject|1|||
13180048|NCT02230891|26149395|FG002|6 Month|Withdrawal by Subject|1|||
13180049|NCT02230891|26149393|FG000|6 Month|Physician Decision|0|||
13180050|NCT02230891|26149394|FG001|6 Month|Physician Decision|2|||
13180051|NCT02230891|26149395|FG002|6 Month|Physician Decision|0|||
13180052|NCT02230891|26149393|FG000|12 Month|Death|1|||
13180053|NCT02230891|26149394|FG001|12 Month|Death|0|||
13180054|NCT02230891|26149395|FG002|12 Month|Death|0|||
13180055|NCT02230891|26149393|FG000|12 Month|Lost to Follow-up|0|||
13180056|NCT02230891|26149394|FG001|12 Month|Lost to Follow-up|1|||
13109511|NCT03231943|25896730|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
13109512|NCT03231943|25896731|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
13109513|NCT03231943|25896719|FG000|Part 2|Adverse Event|0|||
13109514|NCT03231943|25896720|FG001|Part 2|Adverse Event|0|||
13109515|NCT03231943|25896721|FG002|Part 2|Adverse Event|0|||
13109516|NCT03231943|25896722|FG003|Part 2|Adverse Event|0|||
13109517|NCT03231943|25896723|FG004|Part 2|Adverse Event|0|||
13109518|NCT03231943|25896724|FG005|Part 2|Adverse Event|0|||
13109519|NCT03231943|25896725|FG006|Part 2|Adverse Event|0|||
13109520|NCT03231943|25896726|FG007|Part 2|Adverse Event|0|||
13109521|NCT03231943|25896727|FG008|Part 2|Adverse Event|0|||
13109522|NCT03231943|25896728|FG009|Part 2|Adverse Event|0|||
13109523|NCT03231943|25896729|FG010|Part 2|Adverse Event|1|||
13109524|NCT03231943|25896730|FG011|Part 2|Adverse Event|0|||
13109525|NCT03231943|25896731|FG012|Part 2|Adverse Event|0|||
13109526|NCT03231943|25896719|FG000|Part 2|Withdrawal by Subject|0|||
13109527|NCT03231943|25896720|FG001|Part 2|Withdrawal by Subject|0|||
13109528|NCT03231943|25896721|FG002|Part 2|Withdrawal by Subject|0|||
13109529|NCT03231943|25896722|FG003|Part 2|Withdrawal by Subject|0|||
13109530|NCT03231943|25896723|FG004|Part 2|Withdrawal by Subject|0|||
13109531|NCT03231943|25896724|FG005|Part 2|Withdrawal by Subject|0|||
13109532|NCT03231943|25896725|FG006|Part 2|Withdrawal by Subject|0|||
13109533|NCT03231943|25896726|FG007|Part 2|Withdrawal by Subject|0|||
13109534|NCT03231943|25896727|FG008|Part 2|Withdrawal by Subject|0|||
13109535|NCT03231943|25896728|FG009|Part 2|Withdrawal by Subject|0|||
13109536|NCT03231943|25896729|FG010|Part 2|Withdrawal by Subject|0|||
13109537|NCT03231943|25896730|FG011|Part 2|Withdrawal by Subject|1|||
13109538|NCT03231943|25896731|FG012|Part 2|Withdrawal by Subject|0|||
13109539|NCT03231800|25896752|FG000|Overall Study|Lost to Follow-up|0|||
13109540|NCT03231800|25896753|FG001|Overall Study|Lost to Follow-up|2|||
13109541|NCT03231800|25896752|FG000|Overall Study|Protocol Violation|1|||
13109542|NCT03231800|25896753|FG001|Overall Study|Protocol Violation|1|||
13109543|NCT03231800|25896752|FG000|Overall Study|reason not provided|2|||
13109544|NCT03231800|25896753|FG001|Overall Study|reason not provided|0|||
13109545|NCT03231709|25896778|FG000|Treatment Period 1|Reason not Specified|0|||
13109546|NCT03231709|25896779|FG001|Treatment Period 1|Reason not Specified|1|||
13109547|NCT03231709|25896778|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0|||
13109548|NCT03231709|25896779|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1|||
13109549|NCT03231371|25896786|FG000|Overall Study|Withdrawal by Subject|1|||
13109550|NCT03231371|25896786|FG000|Overall Study|chose or were ineligible to have MRI|12|||
13109551|NCT03231228|25896801|FG000|Overall Study|Lost to Follow-up|2|||
13109552|NCT03231228|25896802|FG001|Overall Study|Lost to Follow-up|0|||
13109553|NCT03231228|25896801|FG000|Overall Study|Physician Decision|1|||
13109554|NCT03231228|25896802|FG001|Overall Study|Physician Decision|0|||
13109555|NCT03230864|25896829|FG000|Prospective Confirmation (PC) Period|Adverse Event|3|||
13109556|NCT03230864|25896830|FG001|Prospective Confirmation (PC) Period|Adverse Event|0|||
13109557|NCT03230864|25896831|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
13109558|NCT03230864|25896832|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
13109559|NCT03230864|25896829|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
13180057|NCT02230891|26149395|FG002|12 Month|Lost to Follow-up|0|||
13180058|NCT02230891|26149393|FG000|12 Month|Withdrawal by Subject|0|||
13180059|NCT02230891|26149394|FG001|12 Month|Withdrawal by Subject|2|||
13180060|NCT02230891|26149395|FG002|12 Month|Withdrawal by Subject|0|||
13180061|NCT02230891|26149393|FG000|18 Month End of Study|Death|0|||
13180062|NCT02230891|26149394|FG001|18 Month End of Study|Death|0|||
13180063|NCT02230891|26149395|FG002|18 Month End of Study|Death|1|||
13180064|NCT02230891|26149393|FG000|18 Month End of Study|Hear failure, lost to follow up|1|||
13180065|NCT02230891|26149394|FG001|18 Month End of Study|Hear failure, lost to follow up|0|||
13180066|NCT02230891|26149395|FG002|18 Month End of Study|Hear failure, lost to follow up|0|||
13109560|NCT03230864|25896830|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
13109561|NCT03230864|25896831|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
13109562|NCT03230864|25896832|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
13109563|NCT03230864|25896829|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1|||
13109564|NCT03230864|25896830|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2|||
13180067|NCT02230683|26149412|FG000|Overall Study|Adverse Event|1|||
13180068|NCT02230670|26149429|FG000|Overall Study|Adverse Event|1|||
13180069|NCT02230670|26149430|FG001|Overall Study|Adverse Event|2|||
13180070|NCT02230670|26149429|FG000|Overall Study|Withdrawal by Subject|2|||
13180071|NCT02230670|26149430|FG001|Overall Study|Withdrawal by Subject|2|||
13180072|NCT02230670|26149429|FG000|Overall Study|Physician Decision|0|||
13180073|NCT02230670|26149430|FG001|Overall Study|Physician Decision|1|||
13180074|NCT02230670|26149429|FG000|Overall Study|Protocol Violation|0|||
13180075|NCT02230670|26149430|FG001|Overall Study|Protocol Violation|1|||
13180076|NCT02230670|26149429|FG000|Overall Study|Progression to Child-Pugh C|1|||
13180077|NCT02230670|26149430|FG001|Overall Study|Progression to Child-Pugh C|2|||
13180078|NCT02230527|26149443|FG000|Overall Study|Withdrawal by Subject|1|||
13180079|NCT02230527|26149444|FG001|Overall Study|Withdrawal by Subject|1|||
13180080|NCT02230527|26149443|FG000|Overall Study|Death|1|||
13180081|NCT02230527|26149444|FG001|Overall Study|Death|0|||
13180082|NCT02230527|26149443|FG000|Overall Study|Lost to Follow-up|2|||
13180083|NCT02230527|26149444|FG001|Overall Study|Lost to Follow-up|1|||
13180084|NCT02230527|26149443|FG000|Overall Study|Other|1|||
13180085|NCT02230527|26149444|FG001|Overall Study|Other|0|||
13180086|NCT02230410|26149450|FG000|Overall Study|Screen Failure|3|||
13180087|NCT02230384|26149475|FG000|Phase 1|Lost to Follow-up|1|||
13180088|NCT02230384|26149476|FG001|Phase 1|Lost to Follow-up|0|||
13180089|NCT02230384|26149475|FG000|Phase 1|Physician Decision|0|||
13180090|NCT02230384|26149476|FG001|Phase 1|Physician Decision|1|||
13180091|NCT02230384|26149475|FG000|Phase 2 - Switch|Withdrawal by Subject|0|||
13180092|NCT02230384|26149476|FG001|Phase 2 - Switch|Withdrawal by Subject|1|||
13180093|NCT02230384|26149475|FG000|Phase 2 - Switch|Lost to Follow-up|1|||
13180094|NCT02230384|26149476|FG001|Phase 2 - Switch|Lost to Follow-up|0|||
13180095|NCT02230384|26149475|FG000|Phase 2 - Switch|Adverse Event|2|||
13180096|NCT02230384|26149476|FG001|Phase 2 - Switch|Adverse Event|0|||
13180097|NCT02230332|26149499|FG000|Overall Study|Adverse Event|2|||
13109565|NCT03230864|25896831|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
13109566|NCT03230864|25896832|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
13109567|NCT03230864|25896829|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4|||
13109568|NCT03230864|25896830|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1|||
13109569|NCT03230864|25896831|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
13109570|NCT03230864|25896832|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
13109571|NCT03230864|25896829|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14|||
13109572|NCT03230864|25896830|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5|||
13109573|NCT03230864|25896831|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
13109574|NCT03230864|25896832|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
13109575|NCT03230864|25896829|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
13109576|NCT03230864|25896830|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
13109577|NCT03230864|25896831|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
13109578|NCT03230864|25896832|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
13109579|NCT03230864|25896829|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1|||
13109580|NCT03230864|25896830|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
13109581|NCT03230864|25896831|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
13109582|NCT03230864|25896832|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
13109583|NCT03230864|25896829|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0|||
13109584|NCT03230864|25896830|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0|||
13109585|NCT03230864|25896831|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5|||
13109586|NCT03230864|25896832|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1|||
13109587|NCT03230864|25896829|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
13109588|NCT03230864|25896830|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
13109589|NCT03230864|25896831|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
13109590|NCT03230864|25896832|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
13109591|NCT03230864|25896829|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
13109592|NCT03230864|25896830|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
13109593|NCT03230864|25896831|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2|||
13109594|NCT03230864|25896832|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
13109595|NCT03230838|25896855|FG000|Overall Study|Withdrawal by Subject|3|||
13109596|NCT03230838|25896856|FG001|Overall Study|Withdrawal by Subject|0|||
13109597|NCT03230838|25896855|FG000|Overall Study|Temperature excursion|1|||
13180098|NCT02230332|26149500|FG001|Overall Study|Adverse Event|1|||
13180099|NCT02230332|26149499|FG000|Overall Study|Lost to Follow-up|1|||
13180100|NCT02230332|26149500|FG001|Overall Study|Lost to Follow-up|0|||
13180101|NCT02230332|26149499|FG000|Overall Study|Protocol Violation|1|||
13180102|NCT02230332|26149500|FG001|Overall Study|Protocol Violation|0|||
13180103|NCT02230306|26149513|FG000|Overall Study|Did not receive study treatment|1|||
13180104|NCT02230254|26149519|FG000|Overall Study|Lost to Follow-up|3|||
13180105|NCT02230189|26149538|FG000|Overall Study|Withdrawal by Subject|3|||
13180106|NCT02230189|26149539|FG001|Overall Study|Withdrawal by Subject|0|||
13180107|NCT02230189|26149540|FG002|Overall Study|Withdrawal by Subject|1|||
13180108|NCT02230189|26149538|FG000|Overall Study|Lost to Follow-up|1|||
13180109|NCT02230189|26149539|FG001|Overall Study|Lost to Follow-up|0|||
13180110|NCT02230189|26149540|FG002|Overall Study|Lost to Follow-up|0|||
13180111|NCT02230189|26149538|FG000|Overall Study|Physician Decision|1|||
13180112|NCT02230189|26149539|FG001|Overall Study|Physician Decision|0|||
13180113|NCT02230189|26149540|FG002|Overall Study|Physician Decision|0|||
13180114|NCT02230085|26149546|FG000|Overall Study|Physician Decision|1|||
13180115|NCT02230085|26149546|FG000|Overall Study|Withdrawal by Subject|3|||
13180116|NCT02229864|26149569|FG000|Overall Study|Death|2|||
13180117|NCT02229864|26149569|FG000|Overall Study|Lost to Follow-up|1|||
13180118|NCT02229851|26150015|FG000|Main Phase (Double-blind Phase)|Unclassified|1|||
13180119|NCT02229851|26150016|FG001|Main Phase (Double-blind Phase)|Unclassified|2|||
13180120|NCT02229851|26150017|FG002|Main Phase (Double-blind Phase)|Unclassified|0|||
13180121|NCT02229851|26150018|FG003|Main Phase (Double-blind Phase)|Unclassified|0|||
13180122|NCT02229851|26150019|FG004|Main Phase (Double-blind Phase)|Unclassified|0|||
13180123|NCT02229851|26150020|FG005|Main Phase (Double-blind Phase)|Unclassified|0|||
13180124|NCT02229851|26150021|FG006|Main Phase (Double-blind Phase)|Unclassified|0|||
13180125|NCT02229851|26150015|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
13180126|NCT02229851|26150016|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1|||
13180127|NCT02229851|26150017|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
13180128|NCT02229851|26150018|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
13180129|NCT02229851|26150019|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
13180130|NCT02229851|26150020|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
13180131|NCT02229851|26150021|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
13180132|NCT02229851|26150015|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
13180133|NCT02229851|26150016|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12|||
13180134|NCT02229851|26150017|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
13180135|NCT02229851|26150018|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
13180136|NCT02229851|26150019|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
13180137|NCT02229851|26150020|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
13180138|NCT02229851|26150021|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
13180139|NCT02229851|26150015|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0|||
13180140|NCT02229851|26150016|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0|||
13180141|NCT02229851|26150017|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2|||
13180142|NCT02229851|26150018|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0|||
13180143|NCT02229851|26150019|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0|||
13180144|NCT02229851|26150020|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0|||
13180145|NCT02229851|26150021|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0|||
13180146|NCT02229851|26150015|FG000|Main Phase (Double-blind Phase)|Death|1|||
13180147|NCT02229851|26150016|FG001|Main Phase (Double-blind Phase)|Death|1|||
13180148|NCT02229851|26150017|FG002|Main Phase (Double-blind Phase)|Death|0|||
13180149|NCT02229851|26150018|FG003|Main Phase (Double-blind Phase)|Death|0|||
13180150|NCT02229851|26150019|FG004|Main Phase (Double-blind Phase)|Death|0|||
13180151|NCT02229851|26150020|FG005|Main Phase (Double-blind Phase)|Death|0|||
13180152|NCT02229851|26150021|FG006|Main Phase (Double-blind Phase)|Death|0|||
13180153|NCT02229851|26150015|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
13180154|NCT02229851|26150016|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
13180155|NCT02229851|26150017|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
13180156|NCT02229851|26150018|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
13180157|NCT02229851|26150019|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
13180158|NCT02229851|26150020|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
13180159|NCT02229851|26150021|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
13180160|NCT02229851|26150015|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
13180161|NCT02229851|26150016|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
13180162|NCT02229851|26150017|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
13180163|NCT02229851|26150018|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
13180164|NCT02229851|26150019|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4|||
13180165|NCT02229851|26150020|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3|||
13180166|NCT02229851|26150021|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
13180167|NCT02229851|26150015|FG000|Extension Phase (Open-label Phase)|Death|0|||
13180168|NCT02229851|26150016|FG001|Extension Phase (Open-label Phase)|Death|0|||
13180169|NCT02229851|26150017|FG002|Extension Phase (Open-label Phase)|Death|0|||
13485539|NCT02906020|27032877|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
13180170|NCT02229851|26150018|FG003|Extension Phase (Open-label Phase)|Death|1|||
13180171|NCT02229851|26150019|FG004|Extension Phase (Open-label Phase)|Death|0|||
13180172|NCT02229851|26150020|FG005|Extension Phase (Open-label Phase)|Death|1|||
13109598|NCT03230838|25896856|FG001|Overall Study|Temperature excursion|0|||
13180173|NCT02229851|26150021|FG006|Extension Phase (Open-label Phase)|Death|1|||
13180174|NCT02229552|26150027|FG000|Baseline|Withdrawal by Subject|6|||
13180175|NCT02229552|26150027|FG000|1-year Follow up|Withdrawal by Subject|7|||
13180176|NCT02229552|26150027|FG000|1-year Follow up|Lost to Follow-up|18|||
13180177|NCT02229552|26150027|FG000|2-Year Follow up|Withdrawal by Subject|9|||
13180178|NCT02229552|26150027|FG000|2-Year Follow up|Lost to Follow-up|17|||
13180179|NCT02229539|26150045|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
13180180|NCT02229539|26150046|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1|||
13180181|NCT02229539|26150047|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
13180182|NCT02229539|26150045|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
13109599|NCT03230292|25896888|FG000|Overall Study|Adverse Event|1|||
13109600|NCT03230292|25896888|FG000|Overall Study|Protocol Violation|1|||
13109601|NCT03230292|25896888|FG000|Overall Study|Lost to Follow-up|1|||
13109602|NCT03230292|25896888|FG000|Overall Study|Withdrawal by Subject|3|||
13109603|NCT03229759|25896896|FG000|Overall Study|Screen Failure|30|||
13109604|NCT03229486|25896921|FG000|Overall Study|Protocol Violation|0|||
13109605|NCT03229486|25896922|FG001|Overall Study|Protocol Violation|1|||
13109606|NCT03229109|25896945|FG000|Overall Study|Withdrawal by Subject|0|||
13109607|NCT03229109|25896946|FG001|Overall Study|Withdrawal by Subject|0|||
13109608|NCT03229109|25896947|FG002|Overall Study|Withdrawal by Subject|0|||
13109609|NCT03229109|25896948|FG003|Overall Study|Withdrawal by Subject|1|||
13109610|NCT03228836|25896956|FG000|Overall Study|Adverse Event|3|||
13109611|NCT03228836|25896956|FG000|Overall Study|Withdrawal by Subject|1|||
13109612|NCT03228836|25896956|FG000|Overall Study|Death|1|||
13109613|NCT03228836|25896956|FG000|Overall Study|Physician Decision|1|||
13109614|NCT03228836|25896956|FG000|Overall Study|Disease Progression|7|||
13109615|NCT03228836|25896956|FG000|Overall Study|Other|4|||
13109616|NCT03228433|25897050|FG000|Overall Study|Lost to Follow-up|1|||
13109617|NCT03228433|25897051|FG001|Overall Study|Lost to Follow-up|0|||
13109618|NCT03228433|25897052|FG002|Overall Study|Lost to Follow-up|0|||
13109619|NCT03228433|25897053|FG003|Overall Study|Lost to Follow-up|0|||
13109620|NCT03228433|25897054|FG004|Overall Study|Lost to Follow-up|0|||
13109621|NCT03228433|25897055|FG005|Overall Study|Lost to Follow-up|0|||
13109622|NCT03228433|25897050|FG000|Overall Study|Positive alcohol test|0|||
13109623|NCT03228433|25897051|FG001|Overall Study|Positive alcohol test|0|||
13109624|NCT03228433|25897052|FG002|Overall Study|Positive alcohol test|0|||
13180183|NCT02229539|26150046|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
13180184|NCT02229539|26150047|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1|||
13180185|NCT02229539|26150045|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
13180186|NCT02229539|26150046|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
13180187|NCT02229539|26150047|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1|||
13180188|NCT02229539|26150045|FG000|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|3|||
13180189|NCT02229539|26150046|FG001|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|4|||
13180190|NCT02229539|26150047|FG002|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|1|||
13180191|NCT02229539|26150045|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
13180192|NCT02229539|26150046|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
13180193|NCT02229539|26150047|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6|||
13180194|NCT02229539|26150045|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2|||
13180195|NCT02229539|26150046|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
13180196|NCT02229539|26150047|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
13180197|NCT02229539|26150045|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0|||
13180198|NCT02229539|26150046|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
13180199|NCT02229539|26150047|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
13180200|NCT02229539|26150045|FG000|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0|||
13180201|NCT02229539|26150046|FG001|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0|||
13180202|NCT02229539|26150047|FG002|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|3|||
13180203|NCT02229539|26150045|FG000|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|2|||
13180204|NCT02229539|26150046|FG001|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|1|||
13180205|NCT02229539|26150047|FG002|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|0|||
13180206|NCT02229396|26150086|FG000|Overall Study|Adverse Event|6|||
13109625|NCT03228433|25897053|FG003|Overall Study|Positive alcohol test|1|||
13109626|NCT03228433|25897054|FG004|Overall Study|Positive alcohol test|0|||
13109627|NCT03228433|25897055|FG005|Overall Study|Positive alcohol test|0|||
13109628|NCT03228420|25897068|FG000|Overall Study|Lost to Follow-up|5|||
13109629|NCT03228420|25897069|FG001|Overall Study|Lost to Follow-up|3|||
13109630|NCT03228420|25897068|FG000|Overall Study|Withdrawal by Subject|10|||
13109631|NCT03228420|25897069|FG001|Overall Study|Withdrawal by Subject|0|||
13180207|NCT02229396|26150087|FG001|Overall Study|Adverse Event|12|||
13180208|NCT02229396|26150088|FG002|Overall Study|Adverse Event|12|||
13109632|NCT03228420|25897068|FG000|Overall Study|Adverse Event|5|||
13109633|NCT03228420|25897069|FG001|Overall Study|Adverse Event|2|||
13109634|NCT03228212|25897088|FG000|Period 1|Adverse Event|1|||
13180209|NCT02229396|26150086|FG000|Overall Study|Death|2|||
13180210|NCT02229396|26150087|FG001|Overall Study|Death|3|||
13180211|NCT02229396|26150088|FG002|Overall Study|Death|1|||
13180212|NCT02229396|26150086|FG000|Overall Study|Lost to Follow-up|14|||
13180213|NCT02229396|26150087|FG001|Overall Study|Lost to Follow-up|14|||
13180214|NCT02229396|26150088|FG002|Overall Study|Lost to Follow-up|21|||
13180215|NCT02229396|26150086|FG000|Overall Study|Protocol Violation|2|||
13180216|NCT02229396|26150087|FG001|Overall Study|Protocol Violation|1|||
13180217|NCT02229396|26150088|FG002|Overall Study|Protocol Violation|0|||
13180218|NCT02229396|26150086|FG000|Overall Study|Patient Incorrectly Randomized|0|||
13180219|NCT02229396|26150087|FG001|Overall Study|Patient Incorrectly Randomized|0|||
13180220|NCT02229396|26150088|FG002|Overall Study|Patient Incorrectly Randomized|1|||
13180221|NCT02229396|26150086|FG000|Overall Study|Other|10|||
13180222|NCT02229396|26150087|FG001|Overall Study|Other|18|||
13180223|NCT02229396|26150088|FG002|Overall Study|Other|15|||
13180224|NCT02229396|26150086|FG000|Overall Study|Withdrawal by Subject|42|||
13180225|NCT02229396|26150087|FG001|Overall Study|Withdrawal by Subject|28|||
13180226|NCT02229396|26150088|FG002|Overall Study|Withdrawal by Subject|41|||
13180227|NCT02229396|26150086|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
13180228|NCT02229396|26150087|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
13180229|NCT02229396|26150088|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
13180230|NCT02229396|26150086|FG000|Overall Study|Withdrew; No Record on Termination Page|2|||
13180231|NCT02229396|26150087|FG001|Overall Study|Withdrew; No Record on Termination Page|0|||
13180232|NCT02229396|26150088|FG002|Overall Study|Withdrew; No Record on Termination Page|1|||
13180233|NCT02229383|26150113|FG000|Overall Study|Adverse Event|7|||
13109635|NCT03228212|25897089|FG001|Period 1|Adverse Event|0|||
13180234|NCT02229383|26150114|FG001|Overall Study|Adverse Event|4|||
13180235|NCT02229383|26150113|FG000|Overall Study|Death|0|||
13180236|NCT02229383|26150114|FG001|Overall Study|Death|1|||
13109636|NCT03228212|25897088|FG000|Period 1|no longer meets eligibility criteria|0|||
13109637|NCT03228212|25897089|FG001|Period 1|no longer meets eligibility criteria|1|||
13180237|NCT02229383|26150113|FG000|Overall Study|Lost to Follow-up|5|||
13180238|NCT02229383|26150114|FG001|Overall Study|Lost to Follow-up|3|||
13180239|NCT02229383|26150113|FG000|Overall Study|Withdrawal by Subject|4|||
13180240|NCT02229383|26150114|FG001|Overall Study|Withdrawal by Subject|6|||
13180241|NCT02229383|26150113|FG000|Overall Study|Did not receive treatment|1|||
13180242|NCT02229383|26150114|FG001|Overall Study|Did not receive treatment|0|||
13180243|NCT02229383|26150113|FG000|Overall Study|Other|3|||
13180244|NCT02229383|26150114|FG001|Overall Study|Other|8|||
13180245|NCT02229227|26150204|FG000|Overall Study|Adverse Event|14|||
13180246|NCT02229227|26150205|FG001|Overall Study|Adverse Event|9|||
13180247|NCT02229227|26150204|FG000|Overall Study|Lack of Efficacy|3|||
13180248|NCT02229227|26150205|FG001|Overall Study|Lack of Efficacy|3|||
13180249|NCT02229227|26150204|FG000|Overall Study|Protocol Violation|6|||
13180250|NCT02229227|26150205|FG001|Overall Study|Protocol Violation|8|||
13180251|NCT02229227|26150204|FG000|Overall Study|Protocol defined stopping criteria|1|||
13180252|NCT02229227|26150205|FG001|Overall Study|Protocol defined stopping criteria|3|||
13180253|NCT02229227|26150204|FG000|Overall Study|Lost to Follow-up|3|||
13180254|NCT02229227|26150205|FG001|Overall Study|Lost to Follow-up|3|||
13180255|NCT02229227|26150204|FG000|Overall Study|Study terminated by sponsor|11|||
13180256|NCT02229227|26150205|FG001|Overall Study|Study terminated by sponsor|11|||
13180257|NCT02229227|26150204|FG000|Overall Study|Withdrawal by Subject|8|||
13180258|NCT02229227|26150205|FG001|Overall Study|Withdrawal by Subject|12|||
13180259|NCT02229227|26150204|FG000|Overall Study|Other|0|||
13180260|NCT02229227|26150205|FG001|Overall Study|Other|1|||
13180261|NCT02229227|26150204|FG000|Overall Study|Physician Decision|5|||
13109638|NCT03228212|25897088|FG000|Period 2|Lost to Follow-up|1|||
13109639|NCT03228212|25897089|FG001|Period 2|Lost to Follow-up|0|||
13109640|NCT03227861|25897121|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4|||
13109641|NCT03227861|25897121|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
13109642|NCT03227861|25897121|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1|||
13109643|NCT03227861|25897121|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1|||
13109644|NCT03227861|25897121|FG000|Main Study Period (Week 0 to Week 48)|Other|5|||
13109645|NCT03227861|25897121|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55|||
13109646|NCT03227861|25897121|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16|||
13109647|NCT03227861|25897121|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6|||
13180262|NCT02229227|26150205|FG001|Overall Study|Physician Decision|12|||
13180263|NCT02229214|26150232|FG000|Overall Study|Adverse Event|2|||
13180264|NCT02229214|26150233|FG001|Overall Study|Adverse Event|0|||
13180265|NCT02229214|26150232|FG000|Overall Study|Withdrawal by Subject|4|||
13180266|NCT02229214|26150233|FG001|Overall Study|Withdrawal by Subject|0|||
13180267|NCT02228980|26150268|FG000|Overall Study|Adverse Event|14|||
13180268|NCT02228980|26150269|FG001|Overall Study|Adverse Event|0|||
13180269|NCT02228980|26150270|FG002|Overall Study|Adverse Event|0|||
13180270|NCT02228980|26150271|FG003|Overall Study|Adverse Event|0|||
13180271|NCT02228980|26150268|FG000|Overall Study|Protocol Violation|7|||
13180272|NCT02228980|26150269|FG001|Overall Study|Protocol Violation|0|||
13180273|NCT02228980|26150270|FG002|Overall Study|Protocol Violation|0|||
13180274|NCT02228980|26150271|FG003|Overall Study|Protocol Violation|0|||
13180275|NCT02228980|26150268|FG000|Overall Study|Withdrawal by Subject|3|||
13180276|NCT02228980|26150269|FG001|Overall Study|Withdrawal by Subject|3|||
13180277|NCT02228980|26150270|FG002|Overall Study|Withdrawal by Subject|2|||
13180278|NCT02228980|26150271|FG003|Overall Study|Withdrawal by Subject|3|||
13180279|NCT02228967|26150322|FG000|Overall Study|Lost to Follow-up|146|||
13180280|NCT02228967|26150323|FG001|Overall Study|Lost to Follow-up|142|||
13180281|NCT02228967|26150322|FG000|Overall Study|Withdrawal by Subject|13|||
13180282|NCT02228967|26150323|FG001|Overall Study|Withdrawal by Subject|18|||
13180283|NCT02228720|26150333|FG000|Open Label - Day 30|Lost to Follow-up|1|||
13180284|NCT02228590|26150348|FG000|Overall Study|Withdrawal by Subject|1|||
13180285|NCT02228564|26150365|FG000|Overall Study|Withdrawal by Subject|10|||
13180286|NCT02228564|26150365|FG000|Overall Study|Death|11|||
13180287|NCT02228564|26150365|FG000|Overall Study|Physician Decision|5|||
13180288|NCT02228564|26150365|FG000|Overall Study|Lost to Follow-up|17|||
13180289|NCT02228564|26150365|FG000|Overall Study|Other|6|||
13180290|NCT02228460|26150390|FG000|Overall Study|Adverse Event|1|||
13180291|NCT02228460|26150390|FG000|Overall Study|Lost to Follow-up|1|||
13180292|NCT02228395|26150458|FG000|First Intervention Period|No longer willing to participate|1|||
13180293|NCT02228395|26150459|FG001|First Intervention Period|No longer willing to participate|0|||
13180294|NCT02228395|26150460|FG002|First Intervention Period|No longer willing to participate|0|||
13180295|NCT02228395|26150458|FG000|First Intervention Period|Unable to comply with study dates|0|||
13180296|NCT02228395|26150459|FG001|First Intervention Period|Unable to comply with study dates|1|||
13180297|NCT02228395|26150460|FG002|First Intervention Period|Unable to comply with study dates|1|||
13180298|NCT02228096|26150566|FG000|Overall Study|Study terminated by Sponsor|24|||
13180299|NCT02228096|26150566|FG000|Overall Study|Lack of Efficacy|18|||
13180300|NCT02228096|26150566|FG000|Overall Study|Death|12|||
13180301|NCT02228096|26150566|FG000|Overall Study|Physician Decision|3|||
13180302|NCT02228096|26150566|FG000|Overall Study|Subject/guardian decision|2|||
13180303|NCT02228096|26150566|FG000|Overall Study|New therapy for study indication|1|||
13180304|NCT02228096|26150566|FG000|Overall Study|Enrolled, not infused|11|||
13180305|NCT02227875|26150591|FG000|Overall Study|Protocol Violation|10|||
13180306|NCT02227875|26150592|FG001|Overall Study|Protocol Violation|7|||
13180307|NCT02227875|26150591|FG000|Overall Study|Other|1|||
13180308|NCT02227875|26150592|FG001|Overall Study|Other|3|||
13180309|NCT02227875|26150591|FG000|Overall Study|Physician Decision|1|||
13180310|NCT02227875|26150592|FG001|Overall Study|Physician Decision|0|||
13180311|NCT02227875|26150591|FG000|Overall Study|Adverse Event|3|||
13180312|NCT02227875|26150592|FG001|Overall Study|Adverse Event|0|||
13180313|NCT02227875|26150591|FG000|Overall Study|Withdrawal by Subject|12|||
13180314|NCT02227875|26150592|FG001|Overall Study|Withdrawal by Subject|13|||
13180315|NCT02227875|26150591|FG000|Overall Study|Lost to Follow-up|10|||
13180316|NCT02227875|26150592|FG001|Overall Study|Lost to Follow-up|10|||
13180317|NCT02227862|26150629|FG000|Overall Study|Protocol Violation|7|||
13180318|NCT02227862|26150630|FG001|Overall Study|Protocol Violation|9|||
13180319|NCT02227862|26150629|FG000|Overall Study|Other|0|||
13180320|NCT02227862|26150630|FG001|Overall Study|Other|2|||
13180321|NCT02227862|26150629|FG000|Overall Study|Adverse Event|4|||
13180322|NCT02227862|26150630|FG001|Overall Study|Adverse Event|3|||
13180323|NCT02227862|26150629|FG000|Overall Study|Withdrawal by Subject|7|||
13180324|NCT02227862|26150630|FG001|Overall Study|Withdrawal by Subject|6|||
13180325|NCT02227862|26150629|FG000|Overall Study|Lost to Follow-up|1|||
13180326|NCT02227862|26150630|FG001|Overall Study|Lost to Follow-up|2|||
13180327|NCT02227849|26150640|FG000|Overall Study|Adverse Event|4|||
13180328|NCT02227849|26150640|FG000|Overall Study|Physician Decision|1|||
13180329|NCT02227849|26150640|FG000|Overall Study|Withdrawal by Subject|3|||
13180330|NCT02227784|26150689|FG000|Double-Blind Phase|Adverse Event|3|||
13180331|NCT02227784|26150690|FG001|Double-Blind Phase|Adverse Event|2|||
13180332|NCT02227784|26150691|FG002|Double-Blind Phase|Adverse Event|1|||
13180333|NCT02227784|26150692|FG003|Double-Blind Phase|Adverse Event|3|||
13180334|NCT02227784|26150693|FG004|Double-Blind Phase|Adverse Event|0|||
13180335|NCT02227784|26150689|FG000|Double-Blind Phase|Physician Decision|1|||
13180336|NCT02227784|26150690|FG001|Double-Blind Phase|Physician Decision|0|||
13180337|NCT02227784|26150691|FG002|Double-Blind Phase|Physician Decision|0|||
13180338|NCT02227784|26150692|FG003|Double-Blind Phase|Physician Decision|1|||
13180339|NCT02227784|26150693|FG004|Double-Blind Phase|Physician Decision|0|||
13180340|NCT02227784|26150689|FG000|Double-Blind Phase|Protocol Violation|0|||
13180341|NCT02227784|26150690|FG001|Double-Blind Phase|Protocol Violation|0|||
13180342|NCT02227784|26150691|FG002|Double-Blind Phase|Protocol Violation|1|||
13180343|NCT02227784|26150692|FG003|Double-Blind Phase|Protocol Violation|1|||
13180344|NCT02227784|26150693|FG004|Double-Blind Phase|Protocol Violation|0|||
13180345|NCT02227784|26150689|FG000|Double-Blind Phase|Sponsor Decision|34|||
13180346|NCT02227784|26150690|FG001|Double-Blind Phase|Sponsor Decision|15|||
13180347|NCT02227784|26150691|FG002|Double-Blind Phase|Sponsor Decision|14|||
13180348|NCT02227784|26150692|FG003|Double-Blind Phase|Sponsor Decision|32|||
13180349|NCT02227784|26150693|FG004|Double-Blind Phase|Sponsor Decision|0|||
13180350|NCT02227784|26150689|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
13180351|NCT02227784|26150690|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
13180352|NCT02227784|26150691|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
13180353|NCT02227784|26150692|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
13180354|NCT02227784|26150693|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
13180355|NCT02227784|26150689|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0|||
13180356|NCT02227784|26150690|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0|||
13180357|NCT02227784|26150691|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0|||
13180358|NCT02227784|26150692|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0|||
13180359|NCT02227784|26150693|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1|||
13180360|NCT02227784|26150689|FG000|Open-Label Extension Phase (OLE)|Death|0|||
13180361|NCT02227784|26150690|FG001|Open-Label Extension Phase (OLE)|Death|0|||
13180362|NCT02227784|26150691|FG002|Open-Label Extension Phase (OLE)|Death|0|||
13180363|NCT02227784|26150692|FG003|Open-Label Extension Phase (OLE)|Death|0|||
13180364|NCT02227784|26150693|FG004|Open-Label Extension Phase (OLE)|Death|1|||
13180365|NCT02227784|26150689|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
13180366|NCT02227784|26150690|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
13180367|NCT02227784|26150691|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
13180368|NCT02227784|26150692|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
13180369|NCT02227784|26150693|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243|||
13180370|NCT02227784|26150689|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
13180371|NCT02227784|26150690|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
13180372|NCT02227784|26150691|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
13180373|NCT02227784|26150692|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
13180374|NCT02227784|26150693|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3|||
13180375|NCT02227446|26150706|FG000|Overall Study|not eligible post randomization|18|||
13180376|NCT02227446|26150707|FG001|Overall Study|not eligible post randomization|29|||
13180377|NCT02227446|26150706|FG000|Overall Study|Withdrawal by Subject|4|||
13180378|NCT02227446|26150707|FG001|Overall Study|Withdrawal by Subject|5|||
13180379|NCT02227368|26150722|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0|||
13180380|NCT02227368|26150723|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4|||
13180381|NCT02227368|26150722|FG000|Overall Study|Lost to Follow-up|1|||
13180382|NCT02227368|26150723|FG001|Overall Study|Lost to Follow-up|0|||
13180383|NCT02227368|26150722|FG000|Overall Study|Adverse Event|1|||
13180384|NCT02227368|26150723|FG001|Overall Study|Adverse Event|0|||
13180385|NCT02227108|26150752|FG000|Overall Study|Did not receive treatment|2|||
13180386|NCT02227108|26150752|FG000|Overall Study|Other|3|||
13180387|NCT02227108|26150752|FG000|Overall Study|Progressive disease|17|||
13180388|NCT02227108|26150752|FG000|Overall Study|Initiation of alternative therapy|2|||
13180389|NCT02227108|26150752|FG000|Overall Study|Investigator discretion|1|||
13180390|NCT02227108|26150752|FG000|Overall Study|Adverse Event|6|||
13180391|NCT02226653|26150781|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1|||
13180392|NCT02226653|26150782|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0|||
13180393|NCT02226653|26150781|FG000|Treatment Period 5 Fed State|Adverse Event|0|||
13180394|NCT02226653|26150782|FG001|Treatment Period 5 Fed State|Adverse Event|1|||
13180395|NCT02226562|26150805|FG000|Overall Study|Lost to Follow-up|0|||
13180396|NCT02226562|26150806|FG001|Overall Study|Lost to Follow-up|1|||
13180397|NCT02226549|26150823|FG000|Overall Study|Randomized but Never Treated|1|||
13180398|NCT02226549|26150824|FG001|Overall Study|Randomized but Never Treated|0|||
13180399|NCT02226549|26150823|FG000|Overall Study|Lost to Follow-up|0|||
13180400|NCT02226549|26150824|FG001|Overall Study|Lost to Follow-up|1|||
13180401|NCT02226198|26150901|FG000|Lead-in Phase|Protocol Violation|1|||
13180402|NCT02226198|26150902|FG001|Lead-in Phase|Protocol Violation|0|||
13180403|NCT02226198|26150903|FG002|Lead-in Phase|Protocol Violation|0|||
13180404|NCT02226198|26150901|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
13180405|NCT02226198|26150902|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1|||
13180406|NCT02226198|26150903|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
13180407|NCT02226172|26150936|FG000|Overall Study|Participant refused further follow-up|4|||
13180408|NCT02226172|26150936|FG000|Overall Study|Other|5|||
13180409|NCT02226172|26150936|FG000|Overall Study|Death|1|||
13180410|NCT02226172|26150936|FG000|Overall Study|Study terminated by sponsor|1|||
13180411|NCT02226172|26150936|FG000|Overall Study|Adverse Event|6|||
13180412|NCT02226120|26150942|FG000|Overall Study|Adverse Event|60|||
13180413|NCT02226120|26150942|FG000|Overall Study|Death|172|||
13180414|NCT02226120|26150942|FG000|Overall Study|Study terminated by sponsor|1|||
13180415|NCT02226120|26150942|FG000|Overall Study|Technical problems|4|||
13180416|NCT02226120|26150942|FG000|Overall Study|Lost to Follow-up|13|||
13180417|NCT02226120|26150942|FG000|Overall Study|Physician Decision|21|||
13180418|NCT02226120|26150942|FG000|Overall Study|Withdrawal by parent/guardian|36|||
13180419|NCT02226120|26150942|FG000|Overall Study|Non-compliance with study drug|10|||
13180420|NCT02226120|26150942|FG000|Overall Study|Protocol deviation|1|||
13180421|NCT02226120|26150942|FG000|Overall Study|missing treatment disposition pages|2|||
13180422|NCT02226003|26150984|FG000|Overall Study|Lost to Follow-up|2|||
13180423|NCT02226003|26150985|FG001|Overall Study|Lost to Follow-up|1|||
13180424|NCT02226003|26150986|FG002|Overall Study|Lost to Follow-up|3|||
13180425|NCT02226003|26150984|FG000|Overall Study|Withdrawal by Subject|0|||
13180426|NCT02226003|26150985|FG001|Overall Study|Withdrawal by Subject|0|||
13180427|NCT02226003|26150986|FG002|Overall Study|Withdrawal by Subject|3|||
13180428|NCT02225743|26150992|FG000|Overall Study|Withdrawal by Subject|18|||
13180429|NCT02225665|26151011|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1|||
13180430|NCT02225665|26151012|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0|||
13180431|NCT02225665|26151011|FG000|Overall Study|Subject restarted HAART prior to month 18.|0|||
13180432|NCT02225665|26151012|FG001|Overall Study|Subject restarted HAART prior to month 18.|1|||
13180433|NCT02225587|26151045|FG000|Overall Study|Adverse Event|5|||
13180434|NCT02225587|26151046|FG001|Overall Study|Adverse Event|5|||
13180435|NCT02225587|26151045|FG000|Overall Study|Lost to Follow-up|5|||
13180436|NCT02225587|26151046|FG001|Overall Study|Lost to Follow-up|5|||
13180437|NCT02225587|26151045|FG000|Overall Study|Non-Compliance With Study Drug|1|||
13180438|NCT02225587|26151046|FG001|Overall Study|Non-Compliance With Study Drug|0|||
13180439|NCT02225587|26151045|FG000|Overall Study|Physician Decision|2|||
13180440|NCT02225587|26151046|FG001|Overall Study|Physician Decision|0|||
13180441|NCT02225587|26151045|FG000|Overall Study|Protocol Violation|1|||
13180442|NCT02225587|26151046|FG001|Overall Study|Protocol Violation|0|||
13180443|NCT02225587|26151045|FG000|Overall Study|Participant Moved|1|||
13180444|NCT02225587|26151046|FG001|Overall Study|Participant Moved|0|||
13180445|NCT02225587|26151045|FG000|Overall Study|Withdrawal by Subject|13|||
13180446|NCT02225587|26151046|FG001|Overall Study|Withdrawal by Subject|28|||
13180447|NCT02225353|26151079|FG000|Overall Study|Lost to Follow-up|0|||
13180448|NCT02225353|26151080|FG001|Overall Study|Lost to Follow-up|1|||
13180449|NCT02225353|26151081|FG002|Overall Study|Lost to Follow-up|3|||
13180450|NCT02225353|26151079|FG000|Overall Study|Protocol Violation|4|||
13180451|NCT02225353|26151080|FG001|Overall Study|Protocol Violation|5|||
13180452|NCT02225353|26151081|FG002|Overall Study|Protocol Violation|12|||
13180453|NCT02225223|26151098|FG000|Overall Study|Death|10|||
13180454|NCT02225223|26151099|FG001|Overall Study|Death|1|||
13180455|NCT02225223|26151098|FG000|Overall Study|Lost to Follow-up|5|||
13180456|NCT02225223|26151099|FG001|Overall Study|Lost to Follow-up|0|||
13180457|NCT02225223|26151098|FG000|Overall Study|Other|1|||
13180458|NCT02225223|26151099|FG001|Overall Study|Other|2|||
13180459|NCT02225223|26151098|FG000|Overall Study|Physician Decision|1|||
13180460|NCT02225223|26151099|FG001|Overall Study|Physician Decision|0|||
13180461|NCT02225223|26151098|FG000|Overall Study|Withdrawal by Subject|2|||
13180462|NCT02225223|26151099|FG001|Overall Study|Withdrawal by Subject|2|||
13180463|NCT02224846|26151126|FG000|Period 1 (Month 3)|Adverse Event|2|||
13180464|NCT02224846|26151127|FG001|Period 1 (Month 3)|Adverse Event|1|||
13180465|NCT02224846|26151126|FG000|Period 1 (Month 3)|Lost to Follow-up|3|||
13180466|NCT02224846|26151127|FG001|Period 1 (Month 3)|Lost to Follow-up|8|||
13180467|NCT02224846|26151126|FG000|Period 1 (Month 3)|Protocol Violation|4|||
13180468|NCT02224846|26151127|FG001|Period 1 (Month 3)|Protocol Violation|8|||
13180469|NCT02224846|26151126|FG000|Period 1 (Month 3)|Withdrawal by Subject|8|||
13180470|NCT02224846|26151127|FG001|Period 1 (Month 3)|Withdrawal by Subject|18|||
13180471|NCT02224846|26151126|FG000|Period 1 (Month 3)|Sponsor Decision|2|||
13180472|NCT02224846|26151127|FG001|Period 1 (Month 3)|Sponsor Decision|1|||
13180473|NCT02224846|26151126|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1|||
13180474|NCT02224846|26151127|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2|||
13180475|NCT02224846|26151126|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3|||
13180476|NCT02224846|26151127|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5|||
13180477|NCT02224846|26151126|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0|||
13180478|NCT02224846|26151127|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3|||
13180479|NCT02224846|26151126|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15|||
13180480|NCT02224846|26151127|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19|||
13180481|NCT02224846|26151126|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0|||
13180482|NCT02224846|26151127|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2|||
13180483|NCT02224846|26151126|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3|||
13180484|NCT02224846|26151127|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4|||
13180485|NCT02224846|26151126|FG000|Period 2 (Month 12 to Month 24)|Death|1|||
13180486|NCT02224846|26151127|FG001|Period 2 (Month 12 to Month 24)|Death|0|||
13180487|NCT02224846|26151126|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7|||
13180488|NCT02224846|26151127|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13|||
13180489|NCT02224846|26151126|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4|||
13180490|NCT02224846|26151127|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11|||
13180491|NCT02224846|26151126|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25|||
13222986|NCT01801280|26287571|FG000|Period 1|Withdrawal by Subject|0|||
13180492|NCT02224846|26151127|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43|||
13180493|NCT02224846|26151126|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0|||
13180494|NCT02224846|26151127|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2|||
13180495|NCT02224846|26151126|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2|||
13180496|NCT02224846|26151127|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1|||
13180497|NCT02224755|26151158|FG000|Randomization to Device Implant|Withdrawn prior to implant|7|||
13180498|NCT02224755|26151159|FG001|Randomization to Device Implant|Withdrawn prior to implant|1|||
13180499|NCT02224755|26151158|FG000|Two Year Follow up Post-implant|Death|103|||
13180500|NCT02224755|26151159|FG001|Two Year Follow up Post-implant|Death|98|||
13180501|NCT02224755|26151158|FG000|Two Year Follow up Post-implant|Heart transplant|137|||
13180502|NCT02224755|26151159|FG001|Two Year Follow up Post-implant|Heart transplant|119|||
13180503|NCT02224755|26151158|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
13180504|NCT02224755|26151159|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
13180505|NCT02224755|26151158|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15|||
13180506|NCT02224755|26151159|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6|||
13180507|NCT02224703|26151186|FG000|Overall Study|Adverse Event|0|||
13180508|NCT02224703|26151187|FG001|Overall Study|Adverse Event|5|||
13180509|NCT02224703|26151188|FG002|Overall Study|Adverse Event|0|||
13180510|NCT02224703|26151186|FG000|Overall Study|Withdrawn by investigator|1|||
13180511|NCT02224703|26151187|FG001|Overall Study|Withdrawn by investigator|0|||
13180512|NCT02224703|26151188|FG002|Overall Study|Withdrawn by investigator|0|||
13180513|NCT02224703|26151186|FG000|Overall Study|Advised by medical monitor|1|||
13180514|NCT02224703|26151187|FG001|Overall Study|Advised by medical monitor|0|||
13180515|NCT02224703|26151188|FG002|Overall Study|Advised by medical monitor|0|||
13180516|NCT02224703|26151186|FG000|Overall Study|Withdrawn by parent/guardian|0|||
13180517|NCT02224703|26151187|FG001|Overall Study|Withdrawn by parent/guardian|1|||
13180518|NCT02224703|26151188|FG002|Overall Study|Withdrawn by parent/guardian|0|||
13180519|NCT02224703|26151186|FG000|Overall Study|Lack of Efficacy|1|||
13180520|NCT02224703|26151187|FG001|Overall Study|Lack of Efficacy|0|||
13180521|NCT02224703|26151188|FG002|Overall Study|Lack of Efficacy|0|||
13180522|NCT02224690|26151207|FG000|Overall Study|Adverse Event|8|||
13180523|NCT02224690|26151208|FG001|Overall Study|Adverse Event|1|||
13180524|NCT02224690|26151207|FG000|Overall Study|Met Withdrawal Criteria|4|||
13180525|NCT02224690|26151208|FG001|Overall Study|Met Withdrawal Criteria|0|||
13180526|NCT02224690|26151207|FG000|Overall Study|Use of G-tube|1|||
13180527|NCT02224690|26151208|FG001|Overall Study|Use of G-tube|0|||
13180528|NCT02224690|26151207|FG000|Overall Study|Did not meet eligibility criteria|1|||
13180529|NCT02224690|26151208|FG001|Overall Study|Did not meet eligibility criteria|0|||
13180530|NCT02224664|26151294|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5|||
13180531|NCT02224664|26151295|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
13180532|NCT02224664|26151296|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
13180533|NCT02224664|26151297|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
13180534|NCT02224664|26151298|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
13180535|NCT02224664|26151294|FG000|Dose Escalation Period (21 Days)|Adverse Event|0|||
13180536|NCT02224664|26151295|FG001|Dose Escalation Period (21 Days)|Adverse Event|0|||
13180537|NCT02224664|26151296|FG002|Dose Escalation Period (21 Days)|Adverse Event|2|||
13180538|NCT02224664|26151297|FG003|Dose Escalation Period (21 Days)|Adverse Event|2|||
13180539|NCT02224664|26151298|FG004|Dose Escalation Period (21 Days)|Adverse Event|7|||
13180540|NCT02224664|26151294|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
13180541|NCT02224664|26151295|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
13180542|NCT02224664|26151296|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
13180543|NCT02224664|26151297|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1|||
13180544|NCT02224664|26151298|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4|||
13180545|NCT02224638|26151313|FG000|Overall Study|Adverse Event|1|||
13180546|NCT02224638|26151314|FG001|Overall Study|Adverse Event|1|||
13180547|NCT02224625|26151328|FG000|Irritation|Adverse Event|6|||
13180548|NCT02224625|26151328|FG000|Sensitization|Adverse Event|55|||
13180549|NCT02224599|26151336|FG000|Overall Study|Physician Decision|1|||
13180550|NCT02224599|26151336|FG000|Overall Study|Progression of Disease|1|||
13180551|NCT02224560|26151363|FG000|Overall Study|Protocol Deviation|1|||
13180552|NCT02224560|26151364|FG001|Overall Study|Protocol Deviation|0|||
13180553|NCT02224560|26151365|FG002|Overall Study|Protocol Deviation|0|||
13180554|NCT02224560|26151363|FG000|Overall Study|Withdrawal by Subject|2|||
13180555|NCT02224560|26151364|FG001|Overall Study|Withdrawal by Subject|0|||
13180556|NCT02224560|26151365|FG002|Overall Study|Withdrawal by Subject|1|||
13180557|NCT02224560|26151363|FG000|Overall Study|Met Withdrawal Criteria|1|||
13180558|NCT02224560|26151364|FG001|Overall Study|Met Withdrawal Criteria|0|||
13180559|NCT02224560|26151365|FG002|Overall Study|Met Withdrawal Criteria|0|||
13180560|NCT02224560|26151363|FG000|Overall Study|Adverse Event|4|||
13180561|NCT02224560|26151364|FG001|Overall Study|Adverse Event|1|||
13180562|NCT02224560|26151365|FG002|Overall Study|Adverse Event|1|||
13180563|NCT02224560|26151363|FG000|Overall Study|Withdrawn by Investigator|1|||
13222987|NCT01801280|26287572|FG001|Period 1|Withdrawal by Subject|1|||
13180564|NCT02224560|26151364|FG001|Overall Study|Withdrawn by Investigator|1|||
13180565|NCT02224560|26151365|FG002|Overall Study|Withdrawn by Investigator|0|||
13180566|NCT02224391|26151390|FG000|Overall Study|Lost to Follow-up|26|||
13180567|NCT02224391|26151391|FG001|Overall Study|Lost to Follow-up|19|||
13180568|NCT02224391|26151390|FG000|Overall Study|Withdrawal by Subject|6|||
13180569|NCT02224391|26151391|FG001|Overall Study|Withdrawal by Subject|5|||
13180570|NCT02224274|26151408|FG000|Overall Study|Death|1|||
13180571|NCT02224274|26151409|FG001|Overall Study|Death|0|||
13180572|NCT02224157|26151440|FG000|Overall Study|Severe non-compliance to protocol|2|||
13180573|NCT02224157|26151441|FG001|Overall Study|Severe non-compliance to protocol|2|||
13180574|NCT02224157|26151440|FG000|Overall Study|Other|13|||
13180575|NCT02224157|26151441|FG001|Overall Study|Other|10|||
13180576|NCT02224157|26151440|FG000|Overall Study|Subject decision|58|||
13180577|NCT02224157|26151441|FG001|Overall Study|Subject decision|50|||
13180578|NCT02224157|26151440|FG000|Overall Study|Prematurely closed site|4|||
13180579|NCT02224157|26151441|FG001|Overall Study|Prematurely closed site|2|||
13180580|NCT02224157|26151440|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
13180581|NCT02224157|26151441|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
13180582|NCT02224157|26151440|FG000|Overall Study|Lost to Follow-up|27|||
13180583|NCT02224157|26151441|FG001|Overall Study|Lost to Follow-up|35|||
13180584|NCT02224157|26151440|FG000|Overall Study|Death|1|||
13180585|NCT02224157|26151441|FG001|Overall Study|Death|1|||
13180586|NCT02224157|26151440|FG000|Overall Study|Adverse Event|1|||
13180587|NCT02224157|26151441|FG001|Overall Study|Adverse Event|3|||
13180588|NCT02224053|26151475|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11|||
13180589|NCT02224053|26151475|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4|||
13180590|NCT02224053|26151475|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3|||
13180591|NCT02224053|26151475|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1|||
13180592|NCT02224053|26151475|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2|||
13180593|NCT02223858|26151492|FG000|Overall Study|Death|1|||
13180594|NCT02223858|26151493|FG001|Overall Study|Death|1|||
13180595|NCT02223858|26151492|FG000|Overall Study|Lost to Follow-up|6|||
13180596|NCT02223858|26151493|FG001|Overall Study|Lost to Follow-up|11|||
13180597|NCT02223858|26151492|FG000|Overall Study|Withdrawal by Subject|8|||
13180598|NCT02223858|26151493|FG001|Overall Study|Withdrawal by Subject|5|||
13180599|NCT02223858|26151492|FG000|Overall Study|Refused|9|||
13180600|NCT02223858|26151493|FG001|Overall Study|Refused|9|||
13180601|NCT02223793|26151514|FG000|Overall Study|Lost to Follow-up|10|||
13180602|NCT02223793|26151515|FG001|Overall Study|Lost to Follow-up|1|||
13180603|NCT02223793|26151516|FG002|Overall Study|Lost to Follow-up|2|||
13180604|NCT02223793|26151514|FG000|Overall Study|Withdrawal by Subject|3|||
13180605|NCT02223793|26151515|FG001|Overall Study|Withdrawal by Subject|2|||
13180606|NCT02223793|26151516|FG002|Overall Study|Withdrawal by Subject|3|||
13180607|NCT02223793|26151514|FG000|Overall Study|Moved/studycenter unable to participate|4|||
13180608|NCT02223793|26151515|FG001|Overall Study|Moved/studycenter unable to participate|6|||
13180609|NCT02223793|26151516|FG002|Overall Study|Moved/studycenter unable to participate|8|||
13180610|NCT02223754|26151543|FG000|Period 1|Adverse Event|1|||
13180611|NCT02223754|26151544|FG001|Period 1|Adverse Event|0|||
13180612|NCT02223754|26151543|FG000|Period 1|Lost to Follow-up|0|||
13180613|NCT02223754|26151544|FG001|Period 1|Lost to Follow-up|1|||
13180614|NCT02223754|26151543|FG000|Period 1|Protocol Violation|2|||
13180615|NCT02223754|26151544|FG001|Period 1|Protocol Violation|4|||
13180616|NCT02223754|26151543|FG000|Period 1|Withdrawal by Subject|0|||
13180617|NCT02223754|26151544|FG001|Period 1|Withdrawal by Subject|4|||
13180618|NCT02223754|26151543|FG000|Period 1|Test Article No Longer Available|1|||
13180619|NCT02223754|26151544|FG001|Period 1|Test Article No Longer Available|5|||
13180620|NCT02223754|26151543|FG000|Period 1|Unsatisfactory Visual Response|0|||
13180621|NCT02223754|26151544|FG001|Period 1|Unsatisfactory Visual Response|1|||
13180622|NCT02223754|26151543|FG000|Period 2|Adverse Event|0|||
13180623|NCT02223754|26151544|FG001|Period 2|Adverse Event|1|||
13180624|NCT02223754|26151543|FG000|Period 2|Protocol Violation|1|||
13180625|NCT02223754|26151544|FG001|Period 2|Protocol Violation|0|||
13180626|NCT02223754|26151543|FG000|Period 2|Lens Discomfort|1|||
13180627|NCT02223754|26151544|FG001|Period 2|Lens Discomfort|1|||
13180628|NCT02223754|26151543|FG000|Period 2|Lost to Follow-up|1|||
13180629|NCT02223754|26151544|FG001|Period 2|Lost to Follow-up|0|||
13180630|NCT02223754|26151543|FG000|Period 2|Test Article No Longer Available|0|||
13180631|NCT02223754|26151544|FG001|Period 2|Test Article No Longer Available|1|||
13180632|NCT02223715|26151553|FG000|Overall Study|Death|31|||
13180633|NCT02223715|26151553|FG000|Overall Study|Lost to Follow-up|73|||
13180634|NCT02223390|26151568|FG000|Overall Study|Lost to Follow-up|9|||
13180635|NCT02223390|26151569|FG001|Overall Study|Lost to Follow-up|4|||
13180636|NCT02223364|26151629|FG000|Overall Study|Protocol Violation|3|||
13180637|NCT02223364|26151630|FG001|Overall Study|Protocol Violation|0|||
13180638|NCT02223364|26151631|FG002|Overall Study|Protocol Violation|3|||
13180639|NCT02223364|26151629|FG000|Overall Study|subject expired before surgery|1|||
13180640|NCT02223364|26151630|FG001|Overall Study|subject expired before surgery|0|||
13180641|NCT02223364|26151631|FG002|Overall Study|subject expired before surgery|0|||
13180642|NCT02223364|26151629|FG000|Overall Study|Physician Decision|1|||
13180643|NCT02223364|26151630|FG001|Overall Study|Physician Decision|0|||
13180644|NCT02223364|26151631|FG002|Overall Study|Physician Decision|0|||
13180645|NCT02222922|26152007|FG000|Overall Study|Death|0|||
13180646|NCT02222922|26152008|FG001|Overall Study|Death|0|||
13180647|NCT02222922|26152009|FG002|Overall Study|Death|0|||
13180648|NCT02222922|26152010|FG003|Overall Study|Death|0|||
13180649|NCT02222922|26152011|FG004|Overall Study|Death|13|||
13180650|NCT02222922|26152012|FG005|Overall Study|Death|0|||
13180651|NCT02222922|26152013|FG006|Overall Study|Death|0|||
13180652|NCT02222922|26152014|FG007|Overall Study|Death|0|||
13180653|NCT02222922|26152015|FG008|Overall Study|Death|2|||
13180654|NCT02222922|26152007|FG000|Overall Study|Lost to Follow-up|0|||
13180655|NCT02222922|26152008|FG001|Overall Study|Lost to Follow-up|0|||
13180656|NCT02222922|26152009|FG002|Overall Study|Lost to Follow-up|1|||
13180657|NCT02222922|26152010|FG003|Overall Study|Lost to Follow-up|0|||
13180658|NCT02222922|26152011|FG004|Overall Study|Lost to Follow-up|9|||
13180659|NCT02222922|26152012|FG005|Overall Study|Lost to Follow-up|1|||
13180660|NCT02222922|26152013|FG006|Overall Study|Lost to Follow-up|0|||
13180661|NCT02222922|26152014|FG007|Overall Study|Lost to Follow-up|0|||
13180662|NCT02222922|26152015|FG008|Overall Study|Lost to Follow-up|0|||
13180663|NCT02222922|26152007|FG000|Overall Study|Other|0|||
13180664|NCT02222922|26152008|FG001|Overall Study|Other|0|||
13180665|NCT02222922|26152009|FG002|Overall Study|Other|0|||
13180666|NCT02222922|26152010|FG003|Overall Study|Other|2|||
13180667|NCT02222922|26152011|FG004|Overall Study|Other|10|||
13180668|NCT02222922|26152012|FG005|Overall Study|Other|2|||
13180669|NCT02222922|26152013|FG006|Overall Study|Other|2|||
13180670|NCT02222922|26152014|FG007|Overall Study|Other|4|||
13180671|NCT02222922|26152015|FG008|Overall Study|Other|1|||
13180672|NCT02222922|26152007|FG000|Overall Study|Participant refused further follow-up|1|||
13180673|NCT02222922|26152008|FG001|Overall Study|Participant refused further follow-up|0|||
13180674|NCT02222922|26152009|FG002|Overall Study|Participant refused further follow-up|0|||
13180675|NCT02222922|26152010|FG003|Overall Study|Participant refused further follow-up|1|||
13180676|NCT02222922|26152011|FG004|Overall Study|Participant refused further follow-up|6|||
13180677|NCT02222922|26152012|FG005|Overall Study|Participant refused further follow-up|0|||
13180678|NCT02222922|26152013|FG006|Overall Study|Participant refused further follow-up|0|||
13180679|NCT02222922|26152014|FG007|Overall Study|Participant refused further follow-up|0|||
13180680|NCT02222922|26152015|FG008|Overall Study|Participant refused further follow-up|3|||
13180681|NCT02222896|26152030|FG000|Abdomen|Did not qualify|34|||
13180682|NCT02222896|26152031|FG001|Abdomen|Did not qualify|10|||
13180683|NCT02222896|26152032|FG002|Abdomen|Did not qualify|32|||
13180684|NCT02222896|26152030|FG000|Groin|Did not qualify|43|||
13180685|NCT02222896|26152031|FG001|Groin|Did not qualify|9|||
13180686|NCT02222896|26152032|FG002|Groin|Did not qualify|40|||
13180687|NCT02222818|26152046|FG000|Period 1|Eligibility criteria not met|0|||
13180688|NCT02222818|26152047|FG001|Period 1|Eligibility criteria not met|3|||
13180689|NCT02222714|26152102|FG000|Overall Study|Death|0|||
13180690|NCT02222714|26152103|FG001|Overall Study|Death|2|||
13180691|NCT02222714|26152104|FG002|Overall Study|Death|3|||
13180692|NCT02222714|26152105|FG003|Overall Study|Death|4|||
13180693|NCT02222714|26152106|FG004|Overall Study|Death|6|||
13180694|NCT02222714|26152102|FG000|Overall Study|Withdrawal by Subject|0|||
13180695|NCT02222714|26152103|FG001|Overall Study|Withdrawal by Subject|0|||
13180696|NCT02222714|26152104|FG002|Overall Study|Withdrawal by Subject|1|||
13180697|NCT02222714|26152105|FG003|Overall Study|Withdrawal by Subject|0|||
13180698|NCT02222714|26152106|FG004|Overall Study|Withdrawal by Subject|1|||
13180699|NCT02222688|26152166|FG000|Overall Study|Withdrawal by Subject|0|||
13180700|NCT02222688|26152167|FG001|Overall Study|Withdrawal by Subject|0|||
13180701|NCT02222688|26152168|FG002|Overall Study|Withdrawal by Subject|0|||
13180702|NCT02222688|26152169|FG003|Overall Study|Withdrawal by Subject|2|||
13180703|NCT02222688|26152170|FG004|Overall Study|Withdrawal by Subject|1|||
13180704|NCT02222688|26152171|FG005|Overall Study|Withdrawal by Subject|0|||
13180705|NCT02222688|26152172|FG006|Overall Study|Withdrawal by Subject|1|||
13180706|NCT02222688|26152166|FG000|Overall Study|Disease progression|1|||
13180707|NCT02222688|26152167|FG001|Overall Study|Disease progression|0|||
13180708|NCT02222688|26152168|FG002|Overall Study|Disease progression|0|||
13180709|NCT02222688|26152169|FG003|Overall Study|Disease progression|0|||
13180710|NCT02222688|26152170|FG004|Overall Study|Disease progression|0|||
13180711|NCT02222688|26152171|FG005|Overall Study|Disease progression|0|||
13180712|NCT02222688|26152172|FG006|Overall Study|Disease progression|0|||
13180713|NCT02222558|26152193|FG000|Period 1: Single Dose|Withdrawal by Subject|4|||
13180714|NCT02222558|26152194|FG001|Period 1: Single Dose|Withdrawal by Subject|0|||
13180715|NCT02222558|26152195|FG002|Period 1: Single Dose|Withdrawal by Subject|0|||
13180716|NCT02222558|26152196|FG003|Period 1: Single Dose|Withdrawal by Subject|0|||
13180717|NCT02222558|26152197|FG004|Period 1: Single Dose|Withdrawal by Subject|0|||
13180718|NCT02222558|26152198|FG005|Period 1: Single Dose|Withdrawal by Subject|0|||
13180719|NCT02222558|26152193|FG000|Period 3|Withdrawal by Subject|0|||
13180720|NCT02222558|26152194|FG001|Period 3|Withdrawal by Subject|0|||
13180721|NCT02222558|26152195|FG002|Period 3|Withdrawal by Subject|0|||
13180722|NCT02222558|26152196|FG003|Period 3|Withdrawal by Subject|0|||
13180723|NCT02222558|26152197|FG004|Period 3|Withdrawal by Subject|0|||
13180724|NCT02222558|26152198|FG005|Period 3|Withdrawal by Subject|1|||
13180725|NCT02222493|26152321|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
13109648|NCT03227861|25897121|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1|||
13109649|NCT03227861|25897121|FG000|Extension Period (Week 48 to Week 96)|Other|2|||
13109650|NCT03227692|25897156|FG000|Overall Study|Protocol Violation|1|||
13109651|NCT03227692|25897157|FG001|Overall Study|Protocol Violation|1|||
13109652|NCT03227692|25897156|FG000|Overall Study|Lost to Follow-up|4|||
13109653|NCT03227692|25897157|FG001|Overall Study|Lost to Follow-up|2|||
13109654|NCT03227692|25897156|FG000|Overall Study|Adverse Event|0|||
13109655|NCT03227692|25897157|FG001|Overall Study|Adverse Event|2|||
13109656|NCT03227445|25897186|FG000|Period 1 (28 Days)|Adverse Event|1|||
13109657|NCT03227445|25897187|FG001|Period 1 (28 Days)|Adverse Event|2|||
13109658|NCT03227445|25897188|FG002|Period 1 (28 Days)|Adverse Event|0|||
13109659|NCT03227445|25897189|FG003|Period 1 (28 Days)|Adverse Event|1|||
13109660|NCT03227445|25897186|FG000|Period 1 (28 Days)|Protocol Violation|1|||
13109661|NCT03227445|25897187|FG001|Period 1 (28 Days)|Protocol Violation|0|||
13109662|NCT03227445|25897188|FG002|Period 1 (28 Days)|Protocol Violation|0|||
13109663|NCT03227445|25897189|FG003|Period 1 (28 Days)|Protocol Violation|0|||
13109664|NCT03227445|25897186|FG000|Period 1 (28 Days)|Withdrawal by Subject|0|||
13109665|NCT03227445|25897187|FG001|Period 1 (28 Days)|Withdrawal by Subject|0|||
13109666|NCT03227445|25897188|FG002|Period 1 (28 Days)|Withdrawal by Subject|1|||
13109667|NCT03227445|25897189|FG003|Period 1 (28 Days)|Withdrawal by Subject|1|||
13180726|NCT02222493|26152322|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
13180727|NCT02222493|26152321|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0|||
13180728|NCT02222493|26152322|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1|||
13180729|NCT02222493|26152321|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11|||
13180730|NCT02222493|26152322|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9|||
13180731|NCT02222493|26152321|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5|||
13180732|NCT02222493|26152322|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1|||
13180733|NCT02222493|26152321|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0|||
13180734|NCT02222493|26152322|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7|||
13180735|NCT02222493|26152321|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1|||
13180736|NCT02222493|26152322|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0|||
13180737|NCT02222493|26152321|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2|||
13180738|NCT02222493|26152322|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0|||
13180739|NCT02222493|26152321|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18|||
13180740|NCT02222493|26152322|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20|||
13180741|NCT02222493|26152321|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4|||
13180742|NCT02222493|26152322|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0|||
13180743|NCT02222493|26152321|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1|||
13180744|NCT02222493|26152322|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0|||
13180745|NCT02222493|26152321|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1|||
13180746|NCT02222493|26152322|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0|||
13180747|NCT02222493|26152321|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22|||
13180748|NCT02222493|26152322|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9|||
13180749|NCT02222493|26152321|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3|||
13180750|NCT02222493|26152322|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0|||
13180751|NCT02222493|26152321|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1|||
13180752|NCT02222493|26152322|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0|||
13180753|NCT02222493|26152321|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6|||
13180754|NCT02222493|26152322|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4|||
13180755|NCT02222493|26152321|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
13180756|NCT02222493|26152322|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
13180757|NCT02222493|26152321|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9|||
13180758|NCT02222493|26152322|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3|||
13180759|NCT02222493|26152321|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3|||
13180760|NCT02222493|26152322|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0|||
13180761|NCT02222493|26152321|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14|||
13180762|NCT02222493|26152322|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0|||
13180763|NCT02222493|26152321|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4|||
13180764|NCT02222493|26152322|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0|||
13180765|NCT02222493|26152321|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1|||
13206001|NCT01960855|26233276|FG002|Overall Study|Subject noncompliant|0|||
13109668|NCT03227445|25897186|FG000|Period 2 (28 Days)|Adverse Event|1|||
13109669|NCT03227445|25897187|FG001|Period 2 (28 Days)|Adverse Event|0|||
13180766|NCT02222493|26152322|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0|||
13180767|NCT02222493|26152321|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9|||
13180768|NCT02222493|26152322|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0|||
13180769|NCT02222246|26152357|FG000|Overall Study|No Emergency Department Visits|27|||
13180770|NCT02222246|26152358|FG001|Overall Study|No Emergency Department Visits|26|||
13180771|NCT02222246|26152357|FG000|Overall Study|Physician Decision|0|||
13180772|NCT02222246|26152358|FG001|Overall Study|Physician Decision|1|||
13180773|NCT02222207|26152367|FG000|Overall Study|Death|1|||
13180774|NCT02222207|26152367|FG000|Overall Study|Other reasons|2|||
13180775|NCT02222207|26152367|FG000|Overall Study|Adverse Event|1|||
13180776|NCT02221882|26152426|FG000|Overall Study|Withdrawal by Subject|0|||
13180777|NCT02221882|26152427|FG001|Overall Study|Withdrawal by Subject|0|||
13180778|NCT02221882|26152428|FG002|Overall Study|Withdrawal by Subject|4|||
13180779|NCT02221882|26152429|FG003|Overall Study|Withdrawal by Subject|2|||
13180780|NCT02221882|26152430|FG004|Overall Study|Withdrawal by Subject|2|||
13180781|NCT02221882|26152431|FG005|Overall Study|Withdrawal by Subject|2|||
13180782|NCT02221882|26152426|FG000|Overall Study|Death|0|||
13180783|NCT02221882|26152427|FG001|Overall Study|Death|1|||
13180784|NCT02221882|26152428|FG002|Overall Study|Death|0|||
13180785|NCT02221882|26152429|FG003|Overall Study|Death|0|||
13180786|NCT02221882|26152430|FG004|Overall Study|Death|0|||
13180787|NCT02221882|26152431|FG005|Overall Study|Death|0|||
13180788|NCT02221674|26152455|FG000|Overall Study|Lost to Follow-up|1|||
13180789|NCT02221674|26152456|FG001|Overall Study|Lost to Follow-up|0|||
13180790|NCT02221674|26152457|FG002|Overall Study|Lost to Follow-up|0|||
13180791|NCT02221648|26152474|FG000|Overall Study|Withdrawal by Subject|3|||
13180792|NCT02221648|26152475|FG001|Overall Study|Withdrawal by Subject|3|||
13180793|NCT02221284|26152513|FG000|Overall Study|Case Report Forms Uncollected|56|||
13180794|NCT02221284|26152513|FG000|Overall Study|Protocol Deviation|5|||
13180795|NCT02220998|26152536|FG000|Overall Study|Randomized but Never Treated|1|||
13180796|NCT02220998|26152537|FG001|Overall Study|Randomized but Never Treated|2|||
13180797|NCT02220998|26152536|FG000|Overall Study|Death|2|||
13180798|NCT02220998|26152537|FG001|Overall Study|Death|0|||
13180799|NCT02220998|26152536|FG000|Overall Study|Lack of Efficacy|0|||
13180800|NCT02220998|26152537|FG001|Overall Study|Lack of Efficacy|5|||
13180801|NCT02220998|26152536|FG000|Overall Study|Lost to Follow-up|4|||
13180802|NCT02220998|26152537|FG001|Overall Study|Lost to Follow-up|4|||
13180803|NCT02220920|26152558|FG000|Overall Study|Adverse Event|1|||
13180804|NCT02220920|26152559|FG001|Overall Study|Adverse Event|0|||
13180805|NCT02220920|26152558|FG000|Overall Study|Lack of Efficacy|0|||
13180806|NCT02220920|26152559|FG001|Overall Study|Lack of Efficacy|1|||
13180807|NCT02220920|26152558|FG000|Overall Study|Withdrawal by Subject|1|||
13180808|NCT02220920|26152559|FG001|Overall Study|Withdrawal by Subject|0|||
13180809|NCT02220920|26152558|FG000|Overall Study|Conflict with the stopping criteria|1|||
13180810|NCT02220920|26152559|FG001|Overall Study|Conflict with the stopping criteria|2|||
13180811|NCT02220907|26152568|FG000|Overall Study|Adverse Event|7|||
13180812|NCT02220907|26152568|FG000|Overall Study|Physician Decision|1|||
13180813|NCT02220907|26152568|FG000|Overall Study|Withdrawal by Subject|2|||
13180814|NCT02220907|26152568|FG000|Overall Study|Conflict with the stopping criteria|1|||
13180815|NCT02220894|26152601|FG000|Overall Study|Adverse Event|118|||
13180816|NCT02220894|26152602|FG001|Overall Study|Adverse Event|70|||
13180817|NCT02220894|26152601|FG000|Overall Study|Death|252|||
13180818|NCT02220894|26152602|FG001|Overall Study|Death|368|||
13180819|NCT02220894|26152601|FG000|Overall Study|Lost to Follow-up|0|||
13180820|NCT02220894|26152602|FG001|Overall Study|Lost to Follow-up|2|||
13180821|NCT02220894|26152601|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
13180822|NCT02220894|26152602|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
13180823|NCT02220894|26152601|FG000|Overall Study|Withdrawal by Subject|2|||
13180824|NCT02220894|26152602|FG001|Overall Study|Withdrawal by Subject|13|||
13180825|NCT02220894|26152601|FG000|Overall Study|Ongoing in Study|265|||
13180826|NCT02220894|26152602|FG001|Overall Study|Ongoing in Study|183|||
13180827|NCT02220764|26152619|FG000|Overall Study|Lost to Follow-up|3|||
13180828|NCT02220764|26152620|FG001|Overall Study|Lost to Follow-up|1|||
13180829|NCT02220764|26152619|FG000|Overall Study|Death|1|||
13180830|NCT02220764|26152620|FG001|Overall Study|Death|0|||
13180831|NCT02220725|26152661|FG000|Overall Study|Lost to Follow-up|0|||
13180832|NCT02220725|26152662|FG001|Overall Study|Lost to Follow-up|0|||
13180833|NCT02220725|26152663|FG002|Overall Study|Lost to Follow-up|0|||
13180834|NCT02220725|26152664|FG003|Overall Study|Lost to Follow-up|1|||
13180835|NCT02220725|26152661|FG000|Overall Study|Withdrawal by Subject|0|||
13180836|NCT02220725|26152662|FG001|Overall Study|Withdrawal by Subject|0|||
13180837|NCT02220725|26152663|FG002|Overall Study|Withdrawal by Subject|0|||
13180838|NCT02220725|26152664|FG003|Overall Study|Withdrawal by Subject|1|||
13180839|NCT02220712|26152674|FG000|Overall Study|Adverse Event|1|||
13180840|NCT02220712|26152674|FG000|Overall Study|Withdrawal by Subject|2|||
13180841|NCT02220712|26152674|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1|||
13180842|NCT02220205|26152689|FG000|Overall Study|Withdrawal by Subject|1|||
13180843|NCT02220205|26152690|FG001|Overall Study|Withdrawal by Subject|0|||
13180844|NCT02219932|26152711|FG000|Overall Study|Other|5|||
13180845|NCT02219932|26152712|FG001|Overall Study|Other|11|||
13180846|NCT02219932|26152711|FG000|Overall Study|Death|1|||
13180847|NCT02219932|26152712|FG001|Overall Study|Death|1|||
13180848|NCT02219932|26152711|FG000|Overall Study|Investigator Decision|0|||
13180849|NCT02219932|26152712|FG001|Overall Study|Investigator Decision|1|||
13180850|NCT02219932|26152711|FG000|Overall Study|Consent Withdrawn|11|||
13180851|NCT02219932|26152712|FG001|Overall Study|Consent Withdrawn|7|||
13180852|NCT02219932|26152711|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10|||
13180853|NCT02219932|26152712|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2|||
13180854|NCT02219932|26152711|FG000|Overall Study|Protocol Violation|10|||
13180855|NCT02219932|26152712|FG001|Overall Study|Protocol Violation|6|||
13180856|NCT02219932|26152711|FG000|Overall Study|Pregnancy|1|||
13180857|NCT02219932|26152712|FG001|Overall Study|Pregnancy|0|||
13180858|NCT02219932|26152711|FG000|Overall Study|Lost to Follow-up|4|||
13180859|NCT02219932|26152712|FG001|Overall Study|Lost to Follow-up|2|||
13180860|NCT02219932|26152711|FG000|Overall Study|Adverse Event|23|||
13180861|NCT02219932|26152712|FG001|Overall Study|Adverse Event|21|||
13180862|NCT02219685|26152763|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
13180863|NCT02219685|26152764|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
13180864|NCT02219685|26152763|FG000|Blinded Treatment Phase|Withdrew Consent|1|||
13180865|NCT02219685|26152764|FG001|Blinded Treatment Phase|Withdrew Consent|0|||
13180866|NCT02219477|26152800|FG000|Overall Study|Adverse Event|0|||
13180867|NCT02219477|26152801|FG001|Overall Study|Adverse Event|1|||
13180868|NCT02219477|26152802|FG002|Overall Study|Adverse Event|1|||
13180869|NCT02219477|26152800|FG000|Overall Study|Withdrawal by Subject|0|||
13180870|NCT02219477|26152801|FG001|Overall Study|Withdrawal by Subject|1|||
13180871|NCT02219477|26152802|FG002|Overall Study|Withdrawal by Subject|0|||
13206002|NCT01960855|26233277|FG003|Overall Study|Subject noncompliant|0|||
13206003|NCT01960855|26233278|FG004|Overall Study|Subject noncompliant|0|||
13206004|NCT01960855|26233274|FG000|Overall Study|Adverse Event|2|||
13206005|NCT01960855|26233275|FG001|Overall Study|Adverse Event|0|||
13206006|NCT01960855|26233276|FG002|Overall Study|Adverse Event|6|||
13206007|NCT01960855|26233277|FG003|Overall Study|Adverse Event|2|||
13206008|NCT01960855|26233278|FG004|Overall Study|Adverse Event|2|||
13206009|NCT01960855|26233274|FG000|Overall Study|Lack of Efficacy|1|||
13206010|NCT01960855|26233275|FG001|Overall Study|Lack of Efficacy|1|||
13206011|NCT01960855|26233276|FG002|Overall Study|Lack of Efficacy|0|||
13206012|NCT01960855|26233277|FG003|Overall Study|Lack of Efficacy|0|||
13206013|NCT01960855|26233278|FG004|Overall Study|Lack of Efficacy|0|||
13206014|NCT01960855|26233274|FG000|Overall Study|Other|2|||
13206015|NCT01960855|26233275|FG001|Overall Study|Other|1|||
13206016|NCT01960855|26233276|FG002|Overall Study|Other|1|||
13206017|NCT01960855|26233277|FG003|Overall Study|Other|1|||
13206018|NCT01960855|26233278|FG004|Overall Study|Other|0|||
13206019|NCT01960855|26233274|FG000|Overall Study|Consent withdrawn by subject|3|||
13206020|NCT01960855|26233275|FG001|Overall Study|Consent withdrawn by subject|1|||
13206021|NCT01960855|26233276|FG002|Overall Study|Consent withdrawn by subject|2|||
13206022|NCT01960855|26233277|FG003|Overall Study|Consent withdrawn by subject|1|||
13206023|NCT01960855|26233278|FG004|Overall Study|Consent withdrawn by subject|1|||
13206024|NCT01960855|26233274|FG000|Overall Study|Lost to Follow-up|2|||
13206025|NCT01960855|26233275|FG001|Overall Study|Lost to Follow-up|1|||
13206026|NCT01960855|26233276|FG002|Overall Study|Lost to Follow-up|0|||
13206027|NCT01960855|26233277|FG003|Overall Study|Lost to Follow-up|0|||
13206028|NCT01960855|26233278|FG004|Overall Study|Lost to Follow-up|2|||
13206029|NCT01960842|26233303|FG000|Overall Study|Adverse Event|1|||
13206030|NCT01960842|26233303|FG000|Overall Study|Withdrawal by Subject|2|||
13206031|NCT01960816|26233311|FG000|Overall Study|Lost to Follow-up|1|||
13206032|NCT01960790|26233323|FG000|Overall Study|Survey forms could not be recovered|3|||
13206033|NCT01960790|26233323|FG000|Overall Study|Treat with Humira outside survey period|3|||
13206034|NCT01960790|26233323|FG000|Overall Study|Transferred to another hospital|4|||
13206035|NCT01960790|26233323|FG000|Overall Study|Unevaluable for safety|1|||
13206036|NCT01960725|26233352|FG000|Overall Study|Lost to Follow-up|4|||
13206037|NCT01960725|26233353|FG001|Overall Study|Lost to Follow-up|3|||
13206038|NCT01960725|26233352|FG000|Overall Study|Withdrawal by Subject|1|||
13206039|NCT01960725|26233353|FG001|Overall Study|Withdrawal by Subject|0|||
13206040|NCT01960725|26233352|FG000|Overall Study|unable to obtain blood sample|1|||
13206041|NCT01960725|26233353|FG001|Overall Study|unable to obtain blood sample|2|||
13206042|NCT01960413|26233366|FG000|Overall Study|Withdrawal by Subject|1|||
13206043|NCT01960413|26233367|FG001|Overall Study|Withdrawal by Subject|1|||
13206044|NCT01960413|26233366|FG000|Overall Study|Physician Decision|1|||
13206045|NCT01960413|26233367|FG001|Overall Study|Physician Decision|0|||
13206046|NCT01960413|26233366|FG000|Overall Study|Lost to Follow-up|2|||
13206047|NCT01960413|26233367|FG001|Overall Study|Lost to Follow-up|0|||
13206048|NCT01960348|26233392|FG000|Overall Study|Adverse event, not serious|2|||
13206049|NCT01960348|26233393|FG001|Overall Study|Adverse event, not serious|2|||
13206050|NCT01960348|26233392|FG000|Overall Study|Adverse event, serious fatal|6|||
13206051|NCT01960348|26233393|FG001|Overall Study|Adverse event, serious fatal|5|||
13180872|NCT02219464|26152817|FG000|Overall Study|Withdrawal by Subject|1|||
13180873|NCT02219464|26152818|FG001|Overall Study|Withdrawal by Subject|0|||
13180874|NCT02219464|26152817|FG000|Overall Study|case cancelled|1|||
13180875|NCT02219464|26152818|FG001|Overall Study|case cancelled|0|||
13180876|NCT02219464|26152817|FG000|Overall Study|catheter malfunction|1|||
13180877|NCT02219464|26152818|FG001|Overall Study|catheter malfunction|0|||
13180878|NCT02219334|26152835|FG000|Overall Study|Withdrawal by Subject|1|||
13180879|NCT02219334|26152836|FG001|Overall Study|Withdrawal by Subject|0|||
13180880|NCT02219334|26152835|FG000|Overall Study|Protocol Violation|7|||
13180881|NCT02219334|26152836|FG001|Overall Study|Protocol Violation|3|||
13180882|NCT02219308|26152851|FG000|Overall Study|Withdrawal by Subject|1|||
13180883|NCT02219308|26152852|FG001|Overall Study|Withdrawal by Subject|2|||
13180884|NCT02219087|26152877|FG000|Overall Study|Randomization envelope pulled out of seq|0|||
13180885|NCT02219087|26152878|FG001|Overall Study|Randomization envelope pulled out of seq|1|||
13180886|NCT02219048|26152909|FG000|Overall Study|Adverse Event|2|||
13180887|NCT02219048|26152910|FG001|Overall Study|Adverse Event|5|||
13180888|NCT02219048|26152909|FG000|Overall Study|No longer meets eligibility criteria|1|||
13180889|NCT02219048|26152910|FG001|Overall Study|No longer meets eligibility criteria|0|||
13180890|NCT02219048|26152909|FG000|Overall Study|Study terminated by sponsor|16|||
13180891|NCT02219048|26152910|FG001|Overall Study|Study terminated by sponsor|15|||
13180892|NCT02219048|26152909|FG000|Overall Study|Withdrawal by Subject|2|||
13180893|NCT02219048|26152910|FG001|Overall Study|Withdrawal by Subject|0|||
13180894|NCT02219048|26152909|FG000|Overall Study|Other|0|||
13180895|NCT02219048|26152910|FG001|Overall Study|Other|1|||
13180896|NCT02219009|26152927|FG000|Overall Study|Withdrawal by Subject|5|||
13180897|NCT02219009|26152928|FG001|Overall Study|Withdrawal by Subject|1|||
13180898|NCT02219009|26152927|FG000|Overall Study|Adverse Event|2|||
13180899|NCT02219009|26152928|FG001|Overall Study|Adverse Event|4|||
13180900|NCT02219009|26152927|FG000|Overall Study|Lost to Follow-up|2|||
13180901|NCT02219009|26152928|FG001|Overall Study|Lost to Follow-up|2|||
13180902|NCT02219009|26152927|FG000|Overall Study|Protocol deviation|1|||
13180903|NCT02219009|26152928|FG001|Overall Study|Protocol deviation|0|||
13180904|NCT02219009|26152927|FG000|Overall Study|Physician Decision|0|||
13180905|NCT02219009|26152928|FG001|Overall Study|Physician Decision|1|||
13180906|NCT02218736|26152945|FG000|Overall Study|Withdrawal by Subject|10|||
13180907|NCT02218736|26152946|FG001|Overall Study|Withdrawal by Subject|9|||
13180908|NCT02218736|26152945|FG000|Overall Study|Protocol Violation|2|||
13180909|NCT02218736|26152946|FG001|Overall Study|Protocol Violation|0|||
13180910|NCT02218541|26152963|FG000|Overall Study|Lost to Follow-up|2|||
13180911|NCT02218541|26152964|FG001|Overall Study|Lost to Follow-up|1|||
13180912|NCT02218541|26152963|FG000|Overall Study|Implant Failure|4|||
13180913|NCT02218541|26152964|FG001|Overall Study|Implant Failure|1|||
13180914|NCT02218489|26152987|FG000|Overall Study|Withdrawal by Subject|4|||
13180915|NCT02218489|26152988|FG001|Overall Study|Withdrawal by Subject|3|||
13180916|NCT02218489|26152987|FG000|Overall Study|Lost to Follow-up|1|||
13180917|NCT02218489|26152988|FG001|Overall Study|Lost to Follow-up|0|||
13180918|NCT02218372|26153051|FG000|Overall Study|Adverse Event|1|||
13180919|NCT02218372|26153052|FG001|Overall Study|Adverse Event|1|||
13180920|NCT02218372|26153051|FG000|Overall Study|Miscellaneous|2|||
13180921|NCT02218372|26153052|FG001|Overall Study|Miscellaneous|1|||
13180922|NCT02218372|26153051|FG000|Overall Study|Randomized but did not receive treatment|2|||
13180923|NCT02218372|26153052|FG001|Overall Study|Randomized but did not receive treatment|3|||
13180924|NCT02218372|26153051|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
13180925|NCT02218372|26153052|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
13180926|NCT02218268|26153061|FG000|24 Hour Washout|Physician Decision|11|||
13180927|NCT02218268|26153062|FG001|24 Hour Washout|Physician Decision|9|||
13180928|NCT02218216|26153078|FG000|Overall Study|Study terminated before completed|6|||
13180929|NCT02218216|26153079|FG001|Overall Study|Study terminated before completed|0|||
13180930|NCT02218216|26153080|FG002|Overall Study|Study terminated before completed|0|||
13180931|NCT02218008|26153137|FG000|Stage 1 (S1)|Adverse Event|6|||
13180932|NCT02218008|26153138|FG001|Stage 1 (S1)|Adverse Event|5|||
13180933|NCT02218008|26153139|FG002|Stage 1 (S1)|Adverse Event|11|||
13180934|NCT02218008|26153140|FG003|Stage 1 (S1)|Adverse Event|0|||
13180935|NCT02218008|26153141|FG004|Stage 1 (S1)|Adverse Event|0|||
13180936|NCT02218008|26153142|FG005|Stage 1 (S1)|Adverse Event|0|||
13180937|NCT02218008|26153137|FG000|Stage 1 (S1)|Withdrawal by Subject|6|||
13180938|NCT02218008|26153138|FG001|Stage 1 (S1)|Withdrawal by Subject|1|||
13180939|NCT02218008|26153139|FG002|Stage 1 (S1)|Withdrawal by Subject|1|||
13180940|NCT02218008|26153140|FG003|Stage 1 (S1)|Withdrawal by Subject|0|||
13180941|NCT02218008|26153141|FG004|Stage 1 (S1)|Withdrawal by Subject|0|||
13180942|NCT02218008|26153142|FG005|Stage 1 (S1)|Withdrawal by Subject|0|||
13180943|NCT02218008|26153137|FG000|Stage 1 (S1)|Lack of Efficacy|3|||
13180944|NCT02218008|26153138|FG001|Stage 1 (S1)|Lack of Efficacy|0|||
13180945|NCT02218008|26153139|FG002|Stage 1 (S1)|Lack of Efficacy|0|||
13180946|NCT02218008|26153140|FG003|Stage 1 (S1)|Lack of Efficacy|0|||
13180947|NCT02218008|26153141|FG004|Stage 1 (S1)|Lack of Efficacy|0|||
13180948|NCT02218008|26153142|FG005|Stage 1 (S1)|Lack of Efficacy|0|||
13180949|NCT02218008|26153137|FG000|Stage 1 (S1)|Lost to Follow-up|3|||
13180950|NCT02218008|26153138|FG001|Stage 1 (S1)|Lost to Follow-up|0|||
13180951|NCT02218008|26153139|FG002|Stage 1 (S1)|Lost to Follow-up|1|||
13180952|NCT02218008|26153140|FG003|Stage 1 (S1)|Lost to Follow-up|0|||
13180953|NCT02218008|26153141|FG004|Stage 1 (S1)|Lost to Follow-up|0|||
13180954|NCT02218008|26153142|FG005|Stage 1 (S1)|Lost to Follow-up|0|||
13180955|NCT02218008|26153137|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2|||
13180956|NCT02218008|26153138|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1|||
13180957|NCT02218008|26153139|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0|||
13180958|NCT02218008|26153140|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0|||
13180959|NCT02218008|26153141|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0|||
13180960|NCT02218008|26153142|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0|||
13180961|NCT02218008|26153137|FG000|Stage 1 (S1)|Non-compliance; drug use|1|||
13180962|NCT02218008|26153138|FG001|Stage 1 (S1)|Non-compliance; drug use|0|||
13180963|NCT02218008|26153139|FG002|Stage 1 (S1)|Non-compliance; drug use|0|||
13180964|NCT02218008|26153140|FG003|Stage 1 (S1)|Non-compliance; drug use|0|||
13180965|NCT02218008|26153141|FG004|Stage 1 (S1)|Non-compliance; drug use|0|||
13180966|NCT02218008|26153142|FG005|Stage 1 (S1)|Non-compliance; drug use|0|||
13180967|NCT02218008|26153137|FG000|Stage 1 (S1)|Pregnancy|0|||
13180968|NCT02218008|26153138|FG001|Stage 1 (S1)|Pregnancy|0|||
13180969|NCT02218008|26153139|FG002|Stage 1 (S1)|Pregnancy|1|||
13180970|NCT02218008|26153140|FG003|Stage 1 (S1)|Pregnancy|0|||
13180971|NCT02218008|26153141|FG004|Stage 1 (S1)|Pregnancy|0|||
13180972|NCT02218008|26153142|FG005|Stage 1 (S1)|Pregnancy|0|||
13180973|NCT02218008|26153137|FG000|Stage 1 (S1)|Protocol Violation|0|||
13180974|NCT02218008|26153138|FG001|Stage 1 (S1)|Protocol Violation|0|||
13180975|NCT02218008|26153139|FG002|Stage 1 (S1)|Protocol Violation|1|||
13180976|NCT02218008|26153140|FG003|Stage 1 (S1)|Protocol Violation|0|||
13180977|NCT02218008|26153141|FG004|Stage 1 (S1)|Protocol Violation|0|||
13180978|NCT02218008|26153142|FG005|Stage 1 (S1)|Protocol Violation|0|||
13180979|NCT02218008|26153137|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1|||
13180980|NCT02218008|26153138|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
13180981|NCT02218008|26153139|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
13180982|NCT02218008|26153140|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
13180983|NCT02218008|26153141|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
13180984|NCT02218008|26153142|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
13180985|NCT02218008|26153137|FG000|Stage 2 (S2)|Adverse Event|0|||
13180986|NCT02218008|26153138|FG001|Stage 2 (S2)|Adverse Event|0|||
13180987|NCT02218008|26153139|FG002|Stage 2 (S2)|Adverse Event|0|||
13180988|NCT02218008|26153140|FG003|Stage 2 (S2)|Adverse Event|2|||
13180989|NCT02218008|26153141|FG004|Stage 2 (S2)|Adverse Event|3|||
13180990|NCT02218008|26153142|FG005|Stage 2 (S2)|Adverse Event|3|||
13180991|NCT02218008|26153137|FG000|Stage 2 (S2)|Withdrawal by Subject|0|||
13180992|NCT02218008|26153138|FG001|Stage 2 (S2)|Withdrawal by Subject|0|||
13180993|NCT02218008|26153139|FG002|Stage 2 (S2)|Withdrawal by Subject|0|||
13180994|NCT02218008|26153140|FG003|Stage 2 (S2)|Withdrawal by Subject|1|||
13180995|NCT02218008|26153141|FG004|Stage 2 (S2)|Withdrawal by Subject|1|||
13180996|NCT02218008|26153142|FG005|Stage 2 (S2)|Withdrawal by Subject|0|||
13180997|NCT02218008|26153137|FG000|Stage 2 (S2)|Lack of Efficacy|0|||
13180998|NCT02218008|26153138|FG001|Stage 2 (S2)|Lack of Efficacy|0|||
13180999|NCT02218008|26153139|FG002|Stage 2 (S2)|Lack of Efficacy|0|||
13181000|NCT02218008|26153140|FG003|Stage 2 (S2)|Lack of Efficacy|0|||
13181001|NCT02218008|26153141|FG004|Stage 2 (S2)|Lack of Efficacy|0|||
13181002|NCT02218008|26153142|FG005|Stage 2 (S2)|Lack of Efficacy|2|||
13181003|NCT02218008|26153137|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
13181004|NCT02218008|26153138|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
13181005|NCT02218008|26153139|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
13181006|NCT02218008|26153140|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1|||
13181007|NCT02218008|26153141|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
13181008|NCT02218008|26153142|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
13181009|NCT02218008|26153137|FG000|Stage 2 (S2)|Lost to Follow-up|0|||
13181010|NCT02218008|26153138|FG001|Stage 2 (S2)|Lost to Follow-up|0|||
13181011|NCT02218008|26153139|FG002|Stage 2 (S2)|Lost to Follow-up|0|||
13181012|NCT02218008|26153140|FG003|Stage 2 (S2)|Lost to Follow-up|0|||
13181013|NCT02218008|26153141|FG004|Stage 2 (S2)|Lost to Follow-up|0|||
13181014|NCT02218008|26153142|FG005|Stage 2 (S2)|Lost to Follow-up|1|||
13181015|NCT02217982|26153157|FG000|Overall Study|Trial discontinued|1|||
13181016|NCT02217982|26153158|FG001|Overall Study|Trial discontinued|0|||
13181017|NCT02217982|26153157|FG000|Overall Study|Adverse Event|0|||
13181018|NCT02217982|26153158|FG001|Overall Study|Adverse Event|1|||
13181019|NCT02217878|26153245|FG000|Overall Study|required morphine due to chest pain|1|||
13181020|NCT02217878|26153246|FG001|Overall Study|required morphine due to chest pain|2|||
13181021|NCT02217878|26153245|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1|||
13181022|NCT02217878|26153246|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0|||
13181023|NCT02217566|26153257|FG000|Overall Study|Lost to Follow-up|2|||
13181024|NCT02217566|26153257|FG000|Overall Study|Death|3|||
13181025|NCT02217566|26153257|FG000|Overall Study|Early study termination|6|||
13181026|NCT02217527|26153274|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1|||
13181027|NCT02217527|26153275|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3|||
13181028|NCT02217527|26153274|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0|||
13181029|NCT02217527|26153275|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1|||
13181030|NCT02217501|26153290|FG000|Overall Study|Death|3|||
13181031|NCT02217501|26153291|FG001|Overall Study|Death|4|||
13181032|NCT02217475|26153416|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
13181033|NCT02217475|26153417|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1|||
13181034|NCT02217475|26153418|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
13181035|NCT02217475|26153416|FG000|Treatment Period 1 (Year 1)|Adverse Event|4|||
13181036|NCT02217475|26153417|FG001|Treatment Period 1 (Year 1)|Adverse Event|5|||
13181037|NCT02217475|26153418|FG002|Treatment Period 1 (Year 1)|Adverse Event|9|||
13181038|NCT02217475|26153416|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1|||
13181039|NCT02217475|26153417|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
13181040|NCT02217475|26153418|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
13181041|NCT02217475|26153416|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5|||
13181042|NCT02217475|26153417|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2|||
13181043|NCT02217475|26153418|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11|||
13181044|NCT02217475|26153416|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
13181045|NCT02217475|26153417|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
13181046|NCT02217475|26153418|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1|||
13181047|NCT02217475|26153416|FG000|Discontinued After Period 1|Adverse Event|1|||
13181048|NCT02217475|26153417|FG001|Discontinued After Period 1|Adverse Event|2|||
13181049|NCT02217475|26153418|FG002|Discontinued After Period 1|Adverse Event|0|||
13181050|NCT02217475|26153416|FG000|Discontinued After Period 1|Participant Withdrew Consent|1|||
13181051|NCT02217475|26153417|FG001|Discontinued After Period 1|Participant Withdrew Consent|1|||
13181052|NCT02217475|26153418|FG002|Discontinued After Period 1|Participant Withdrew Consent|2|||
13181053|NCT02217475|26153416|FG000|Discontinued After Period 1|Physician Decision|0|||
13181054|NCT02217475|26153417|FG001|Discontinued After Period 1|Physician Decision|0|||
13181055|NCT02217475|26153418|FG002|Discontinued After Period 1|Physician Decision|1|||
13181056|NCT02217475|26153416|FG000|Treatment Period 2 (Year 2)|Adverse Event|0|||
13181057|NCT02217475|26153417|FG001|Treatment Period 2 (Year 2)|Adverse Event|1|||
13181058|NCT02217475|26153418|FG002|Treatment Period 2 (Year 2)|Adverse Event|5|||
13181059|NCT02217475|26153416|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0|||
13181060|NCT02217475|26153417|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1|||
13181061|NCT02217475|26153418|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2|||
13181062|NCT02217475|26153416|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
13181063|NCT02217475|26153417|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0|||
13181064|NCT02217475|26153418|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
13181065|NCT02217475|26153416|FG000|Treatment Period 2 (Year 2)|Physician Decision|0|||
13181066|NCT02217475|26153417|FG001|Treatment Period 2 (Year 2)|Physician Decision|0|||
13181067|NCT02217475|26153418|FG002|Treatment Period 2 (Year 2)|Physician Decision|2|||
13181068|NCT02217475|26153416|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
13181069|NCT02217475|26153417|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
13181070|NCT02217475|26153418|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1|||
13181071|NCT02217436|26153433|FG000|Overall Study|Protocol Violation|1|||
13181072|NCT02217436|26153434|FG001|Overall Study|Protocol Violation|1|||
13181073|NCT02217436|26153433|FG000|Overall Study|Incomplete data|0|||
13181074|NCT02217436|26153434|FG001|Overall Study|Incomplete data|1|||
13181075|NCT02217410|26153467|FG000|Overall Study|Graft Loss|0|||
13181076|NCT02217410|26153468|FG001|Overall Study|Graft Loss|0|||
13181077|NCT02217410|26153469|FG002|Overall Study|Graft Loss|2|||
13181078|NCT02217410|26153467|FG000|Overall Study|Withdrawal by Subject|0|||
13181079|NCT02217410|26153468|FG001|Overall Study|Withdrawal by Subject|0|||
13181080|NCT02217410|26153469|FG002|Overall Study|Withdrawal by Subject|2|||
13181081|NCT02217410|26153467|FG000|Overall Study|Lost to Follow-up|0|||
13181082|NCT02217410|26153468|FG001|Overall Study|Lost to Follow-up|0|||
13181083|NCT02217410|26153469|FG002|Overall Study|Lost to Follow-up|1|||
13181084|NCT02217410|26153467|FG000|Overall Study|Lack of Efficacy|0|||
13181085|NCT02217410|26153468|FG001|Overall Study|Lack of Efficacy|1|||
13181086|NCT02217410|26153469|FG002|Overall Study|Lack of Efficacy|0|||
13181087|NCT02217410|26153467|FG000|Overall Study|Physician Decision|1|||
13181088|NCT02217410|26153468|FG001|Overall Study|Physician Decision|3|||
13181089|NCT02217410|26153469|FG002|Overall Study|Physician Decision|0|||
13181090|NCT02217345|26153484|FG000|Overall Study|Lost to Follow-up|2|||
13181091|NCT02217345|26153485|FG001|Overall Study|Lost to Follow-up|1|||
13181092|NCT02217345|26153484|FG000|Overall Study|Withdrawal by Subject|3|||
13181093|NCT02217345|26153485|FG001|Overall Study|Withdrawal by Subject|2|||
13181094|NCT02217345|26153484|FG000|Overall Study|Adverse Event|2|||
13181095|NCT02217345|26153485|FG001|Overall Study|Adverse Event|1|||
13181096|NCT02217345|26153484|FG000|Overall Study|Physician Decision|0|||
13181097|NCT02217345|26153485|FG001|Overall Study|Physician Decision|1|||
13181098|NCT02217332|26153498|FG000|Overall Study|Adverse Event|3|||
13181099|NCT02217332|26153498|FG000|Overall Study|Dose interruption >1 month|1|||
13181100|NCT02217332|26153498|FG000|Overall Study|Protocol Violation (eligibility)|1|||
13181101|NCT02217332|26153498|FG000|Overall Study|Withdrawal by Subject|1|||
13181102|NCT02217332|26153498|FG000|Overall Study|Lost to Follow-up|1|||
13181103|NCT02217280|26153505|FG000|Overall Study|Withdrawal by Subject|2|||
13181104|NCT02217280|26153505|FG000|Overall Study|Post-consent sceen fail|2|||
13181105|NCT02216812|26153526|FG000|Overall Study|Lost to Follow-up|10|||
13181106|NCT02216812|26153527|FG001|Overall Study|Lost to Follow-up|5|||
13181107|NCT02216773|26153544|FG000|Overall Study|Disease progression|4|||
13181108|NCT02216773|26153545|FG001|Overall Study|Disease progression|2|||
13181109|NCT02216773|26153544|FG000|Overall Study|Insufficient FLRV|4|||
13181110|NCT02216773|26153545|FG001|Overall Study|Insufficient FLRV|0|||
13181111|NCT02216773|26153544|FG000|Overall Study|Abandoned|4|||
13181112|NCT02216773|26153545|FG001|Overall Study|Abandoned|3|||
13181113|NCT02216591|26153562|FG000|Overall Study|Lost to Follow-up|0|||
13181114|NCT02216591|26153563|FG001|Overall Study|Lost to Follow-up|1|||
13181115|NCT02216526|26153683|FG000|Overall Study|Adverse Event|1|||
13181116|NCT02216526|26153684|FG001|Overall Study|Adverse Event|1|||
13181117|NCT02216526|26153685|FG002|Overall Study|Adverse Event|0|||
13181118|NCT02216526|26153683|FG000|Overall Study|Death|0|||
13181119|NCT02216526|26153684|FG001|Overall Study|Death|1|||
13181120|NCT02216526|26153685|FG002|Overall Study|Death|3|||
13181121|NCT02216526|26153683|FG000|Overall Study|Protocol Violation|2|||
13181122|NCT02216526|26153684|FG001|Overall Study|Protocol Violation|0|||
13181123|NCT02216526|26153685|FG002|Overall Study|Protocol Violation|2|||
13181124|NCT02216526|26153683|FG000|Overall Study|Hospitalization|2|||
13181125|NCT02216526|26153684|FG001|Overall Study|Hospitalization|1|||
13181126|NCT02216526|26153685|FG002|Overall Study|Hospitalization|3|||
13181127|NCT02216357|26153716|FG000|Overall Study|Inclusion or exclusion criteria not met|2|||
13181128|NCT02216357|26153717|FG001|Overall Study|Inclusion or exclusion criteria not met|1|||
13181129|NCT02216214|26153780|FG000|Overall Study|Randomized Never Received Study Drug|1|||
13181130|NCT02216214|26153781|FG001|Overall Study|Randomized Never Received Study Drug|0|||
13181131|NCT02216214|26153780|FG000|Overall Study|Adverse Event|10|||
13181132|NCT02216214|26153781|FG001|Overall Study|Adverse Event|8|||
13181133|NCT02216214|26153780|FG000|Overall Study|Lack of Efficacy|2|||
13181134|NCT02216214|26153781|FG001|Overall Study|Lack of Efficacy|2|||
13181135|NCT02216214|26153780|FG000|Overall Study|Lost to Follow-up|3|||
13181136|NCT02216214|26153781|FG001|Overall Study|Lost to Follow-up|2|||
13181137|NCT02216214|26153780|FG000|Overall Study|Protocol Violation|4|||
13181138|NCT02216214|26153781|FG001|Overall Study|Protocol Violation|2|||
13181139|NCT02216214|26153780|FG000|Overall Study|Withdrawal by Subject|22|||
13181140|NCT02216214|26153781|FG001|Overall Study|Withdrawal by Subject|20|||
13181141|NCT02216214|26153780|FG000|Overall Study|Study Terminated By Sponsor|0|||
13181142|NCT02216214|26153781|FG001|Overall Study|Study Terminated By Sponsor|1|||
13181143|NCT02216214|26153780|FG000|Overall Study|Miscellaneous|1|||
13181144|NCT02216214|26153781|FG001|Overall Study|Miscellaneous|1|||
13181145|NCT02216123|26153852|FG000|Overall Study|Lost to Follow-up|4|||
13181146|NCT02216123|26153853|FG001|Overall Study|Lost to Follow-up|2|||
13181147|NCT02216123|26153852|FG000|Overall Study|Withdrawal by Subject|2|||
13181148|NCT02216123|26153853|FG001|Overall Study|Withdrawal by Subject|0|||
13181149|NCT02216071|26153870|FG000|Overall Study|Withdrawal by Subject|7|||
13181150|NCT02216071|26153871|FG001|Overall Study|Withdrawal by Subject|2|||
13181151|NCT02216071|26153870|FG000|Overall Study|Lost to Follow-up|3|||
13181152|NCT02216071|26153871|FG001|Overall Study|Lost to Follow-up|3|||
13181153|NCT02216071|26153870|FG000|Overall Study|Protocol Violation|3|||
13181154|NCT02216071|26153871|FG001|Overall Study|Protocol Violation|5|||
13181155|NCT02216071|26153870|FG000|Overall Study|Other|2|||
13181156|NCT02216071|26153871|FG001|Overall Study|Other|2|||
13181157|NCT02215967|26153902|FG000|Overall Study|Patient became ineligible for treatment|0|||
13181158|NCT02215967|26153903|FG001|Overall Study|Patient became ineligible for treatment|0|||
13181159|NCT02215967|26153904|FG002|Overall Study|Patient became ineligible for treatment|0|||
13181160|NCT02215967|26153905|FG003|Overall Study|Patient became ineligible for treatment|3|||
13181161|NCT02215967|26153902|FG000|Overall Study|Patient did not get CAR T-Cells|0|||
13181162|NCT02215967|26153903|FG001|Overall Study|Patient did not get CAR T-Cells|0|||
13181163|NCT02215967|26153904|FG002|Overall Study|Patient did not get CAR T-Cells|1|||
13181164|NCT02215967|26153905|FG003|Overall Study|Patient did not get CAR T-Cells|0|||
13181165|NCT02215954|26153935|FG000|Overall Study|Adverse Event|0|||
13181166|NCT02215954|26153936|FG001|Overall Study|Adverse Event|0|||
13181167|NCT02215954|26153937|FG002|Overall Study|Adverse Event|1|||
13181168|NCT02215954|26153935|FG000|Overall Study|Withdrawal by Subject|0|||
13181169|NCT02215954|26153936|FG001|Overall Study|Withdrawal by Subject|0|||
13181170|NCT02215954|26153937|FG002|Overall Study|Withdrawal by Subject|2|||
13181171|NCT02215954|26153935|FG000|Overall Study|Not exposed|1|||
13181172|NCT02215954|26153936|FG001|Overall Study|Not exposed|1|||
13181173|NCT02215954|26153937|FG002|Overall Study|Not exposed|3|||
13181174|NCT02215616|26153964|FG000|Overall Study|Sponsor requested to stop study drug|0|||
13181175|NCT02215616|26153965|FG001|Overall Study|Sponsor requested to stop study drug|0|||
13222988|NCT01801280|26287573|FG002|Period 1|Withdrawal by Subject|0|||
13181176|NCT02215616|26153966|FG002|Overall Study|Sponsor requested to stop study drug|1|||
13181177|NCT02215616|26153967|FG003|Overall Study|Sponsor requested to stop study drug|4|||
13181178|NCT02215616|26153964|FG000|Overall Study|Death|1|||
13181179|NCT02215616|26153965|FG001|Overall Study|Death|0|||
13181180|NCT02215616|26153966|FG002|Overall Study|Death|0|||
13181181|NCT02215616|26153967|FG003|Overall Study|Death|0|||
13181182|NCT02215616|26153964|FG000|Overall Study|Adverse Event|7|||
13181183|NCT02215616|26153965|FG001|Overall Study|Adverse Event|4|||
13181184|NCT02215616|26153966|FG002|Overall Study|Adverse Event|9|||
13181185|NCT02215616|26153967|FG003|Overall Study|Adverse Event|2|||
13181186|NCT02215616|26153964|FG000|Overall Study|Withdrawal by Subject|1|||
13181187|NCT02215616|26153965|FG001|Overall Study|Withdrawal by Subject|8|||
13181188|NCT02215616|26153966|FG002|Overall Study|Withdrawal by Subject|2|||
13181189|NCT02215616|26153967|FG003|Overall Study|Withdrawal by Subject|5|||
13181190|NCT02215616|26153964|FG000|Overall Study|Non-compliance|0|||
13181191|NCT02215616|26153965|FG001|Overall Study|Non-compliance|2|||
13181192|NCT02215616|26153966|FG002|Overall Study|Non-compliance|1|||
13181193|NCT02215616|26153967|FG003|Overall Study|Non-compliance|0|||
13181194|NCT02215616|26153964|FG000|Overall Study|Protocol Violation|0|||
13181195|NCT02215616|26153965|FG001|Overall Study|Protocol Violation|2|||
13181196|NCT02215616|26153966|FG002|Overall Study|Protocol Violation|0|||
13181197|NCT02215616|26153967|FG003|Overall Study|Protocol Violation|0|||
13181198|NCT02215616|26153964|FG000|Overall Study|Lost to Follow-up|1|||
13181199|NCT02215616|26153965|FG001|Overall Study|Lost to Follow-up|1|||
13181200|NCT02215616|26153966|FG002|Overall Study|Lost to Follow-up|0|||
13181201|NCT02215616|26153967|FG003|Overall Study|Lost to Follow-up|1|||
13181202|NCT02215616|26153964|FG000|Overall Study|Other than specified|1|||
13181203|NCT02215616|26153965|FG001|Overall Study|Other than specified|0|||
13181204|NCT02215616|26153966|FG002|Overall Study|Other than specified|1|||
13181205|NCT02215616|26153967|FG003|Overall Study|Other than specified|1|||
13181206|NCT02215252|26154034|FG000|Overall Study|Adverse Event|1|||
13181207|NCT02215252|26154035|FG001|Overall Study|Adverse Event|5|||
13181208|NCT02215252|26154036|FG002|Overall Study|Adverse Event|2|||
13181209|NCT02215252|26154034|FG000|Overall Study|Lost to Follow-up|0|||
13181210|NCT02215252|26154035|FG001|Overall Study|Lost to Follow-up|0|||
13181211|NCT02215252|26154036|FG002|Overall Study|Lost to Follow-up|1|||
13181212|NCT02215252|26154034|FG000|Overall Study|Does not Meet Entrance Criteria|0|||
13181213|NCT02215252|26154035|FG001|Overall Study|Does not Meet Entrance Criteria|1|||
13181214|NCT02215252|26154036|FG002|Overall Study|Does not Meet Entrance Criteria|0|||
13181215|NCT02215252|26154034|FG000|Overall Study|Protocol Violation|0|||
13181216|NCT02215252|26154035|FG001|Overall Study|Protocol Violation|1|||
13181217|NCT02215252|26154036|FG002|Overall Study|Protocol Violation|0|||
13181218|NCT02215252|26154034|FG000|Overall Study|Withdrawal by Subject|1|||
13181219|NCT02215252|26154035|FG001|Overall Study|Withdrawal by Subject|0|||
13181220|NCT02215252|26154036|FG002|Overall Study|Withdrawal by Subject|0|||
13181221|NCT02215252|26154034|FG000|Overall Study|Other|0|||
13181222|NCT02215252|26154035|FG001|Overall Study|Other|1|||
13181223|NCT02215252|26154036|FG002|Overall Study|Other|1|||
13181224|NCT02214225|26154103|FG000|Overall Study|Lost to Follow-up|46|||
13181225|NCT02214225|26154104|FG001|Overall Study|Lost to Follow-up|18|||
13181226|NCT02214225|26154105|FG002|Overall Study|Lost to Follow-up|18|||
13181227|NCT02214225|26154103|FG000|Overall Study|Withdrawal by Subject|2|||
13181228|NCT02214225|26154104|FG001|Overall Study|Withdrawal by Subject|0|||
13181229|NCT02214225|26154105|FG002|Overall Study|Withdrawal by Subject|2|||
13181230|NCT02214225|26154103|FG000|Overall Study|Death|5|||
13181231|NCT02214225|26154104|FG001|Overall Study|Death|0|||
13181232|NCT02214225|26154105|FG002|Overall Study|Death|1|||
13181233|NCT02214225|26154103|FG000|Overall Study|randomized in error, not vaccinated|2|||
13181234|NCT02214225|26154104|FG001|Overall Study|randomized in error, not vaccinated|1|||
13181235|NCT02214225|26154105|FG002|Overall Study|randomized in error, not vaccinated|1|||
13181236|NCT02214186|26154134|FG000|Overall Study|Lost to Follow-up|1|||
13181237|NCT02214186|26154135|FG001|Overall Study|Lost to Follow-up|1|||
13181238|NCT02214186|26154134|FG000|Overall Study|Protocol Violation|1|||
13181239|NCT02214186|26154135|FG001|Overall Study|Protocol Violation|1|||
13181240|NCT02214121|26154222|FG000|Part A|Patient decision|2|||
13181241|NCT02214121|26154223|FG001|Part A|Patient decision|0|||
13181242|NCT02214121|26154224|FG002|Part A|Patient decision|0|||
13181243|NCT02214121|26154222|FG000|Part A|Dev. of study-specific withdrawal crit.|4|||
13181244|NCT02214121|26154223|FG001|Part A|Dev. of study-specific withdrawal crit.|0|||
13181245|NCT02214121|26154224|FG002|Part A|Dev. of study-specific withdrawal crit.|0|||
13181246|NCT02214121|26154222|FG000|Part A|Other|1|||
13181247|NCT02214121|26154223|FG001|Part A|Other|0|||
13181248|NCT02214121|26154224|FG002|Part A|Other|0|||
13181249|NCT02214121|26154222|FG000|Part B|Patient decision|0|||
13181250|NCT02214121|26154223|FG001|Part B|Patient decision|1|||
13181251|NCT02214121|26154224|FG002|Part B|Patient decision|0|||
13181252|NCT02214121|26154222|FG000|Part B|Dev. of study-specific withdrawal crit.|0|||
13181253|NCT02214121|26154223|FG001|Part B|Dev. of study-specific withdrawal crit.|2|||
13181254|NCT02214121|26154224|FG002|Part B|Dev. of study-specific withdrawal crit.|0|||
13181255|NCT02214121|26154222|FG000|Part B|Lost to Follow-up|0|||
13181256|NCT02214121|26154223|FG001|Part B|Lost to Follow-up|0|||
13181257|NCT02214121|26154224|FG002|Part B|Lost to Follow-up|1|||
13181258|NCT02213666|26154230|FG000|Overall Study|Withdrawal by Subject|1|||
13181259|NCT02213510|26154263|FG000|Overall Study|Death|0|||
13181260|NCT02213510|26154264|FG001|Overall Study|Death|1|||
13181261|NCT02213510|26154263|FG000|Overall Study|Lost to Follow-up|1|||
13181262|NCT02213510|26154264|FG001|Overall Study|Lost to Follow-up|0|||
13181263|NCT02213458|26154286|FG000|Overall Study|No longer meets criteria: caregiver deceased|4|||
13181264|NCT02213458|26154287|FG001|Overall Study|No longer meets criteria: caregiver deceased|0|||
13181265|NCT02213458|26154286|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4|||
13181266|NCT02213458|26154287|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0|||
13181267|NCT02213458|26154286|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2|||
13181268|NCT02213458|26154287|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0|||
13181269|NCT02213458|26154286|FG000|Overall Study|No longer meets criteria: patient moved out of state|10|||
13181270|NCT02213458|26154287|FG001|Overall Study|No longer meets criteria: patient moved out of state|0|||
13181271|NCT02213458|26154286|FG000|Overall Study|Refused re-consent|6|||
13181272|NCT02213458|26154287|FG001|Overall Study|Refused re-consent|0|||
13181273|NCT02213458|26154286|FG000|Overall Study|Lost to Follow-up|2|||
13181274|NCT02213458|26154287|FG001|Overall Study|Lost to Follow-up|2|||
13181275|NCT02213458|26154286|FG000|Overall Study|Withdrawal by Subject|26|||
13181276|NCT02213458|26154287|FG001|Overall Study|Withdrawal by Subject|8|||
13181277|NCT02213380|26154316|FG000|Underwent Randomization|Withdrawal by Subject|2|||
13181278|NCT02213380|26154317|FG001|Underwent Randomization|Withdrawal by Subject|0|||
13181279|NCT02213380|26154316|FG000|Underwent Randomization|Not treated|3|||
13181280|NCT02213380|26154317|FG001|Underwent Randomization|Not treated|3|||
13181281|NCT02213380|26154316|FG000|Per-protocol Analysis|Protocol Violation|32|||
13181282|NCT02213380|26154317|FG001|Per-protocol Analysis|Protocol Violation|36|||
13181283|NCT02213263|26154360|FG000|Overall Study|Insufficient clinical response|4|||
13181284|NCT02213263|26154361|FG001|Overall Study|Insufficient clinical response|3|||
13181285|NCT02213263|26154360|FG000|Overall Study|Lost to Follow-up|0|||
13181286|NCT02213263|26154361|FG001|Overall Study|Lost to Follow-up|1|||
13181287|NCT02213263|26154360|FG000|Overall Study|No longer willing to participate|3|||
13181288|NCT02213263|26154361|FG001|Overall Study|No longer willing to participate|4|||
13181289|NCT02213263|26154360|FG000|Overall Study|Progressive disease|20|||
13181290|NCT02213263|26154361|FG001|Overall Study|Progressive disease|14|||
13181291|NCT02213263|26154360|FG000|Overall Study|Protocol Violation|0|||
13181292|NCT02213263|26154361|FG001|Overall Study|Protocol Violation|1|||
13181293|NCT02213263|26154360|FG000|Overall Study|Adverse Event|1|||
13181294|NCT02213263|26154361|FG001|Overall Study|Adverse Event|3|||
13181295|NCT02213198|26154376|FG000|Baseline|No show for intake|7|||
13181296|NCT02213198|26154377|FG001|Baseline|No show for intake|9|||
13181297|NCT02213198|26154376|FG000|Baseline|Withdrawal by Subject|34|||
13181298|NCT02213198|26154377|FG001|Baseline|Withdrawal by Subject|11|||
13181299|NCT02213198|26154376|FG000|Baseline|transferred out of clinic|7|||
13181300|NCT02213198|26154377|FG001|Baseline|transferred out of clinic|9|||
13181301|NCT02213198|26154376|FG000|Baseline|Lost to Follow-up|40|||
13181302|NCT02213198|26154377|FG001|Baseline|Lost to Follow-up|21|||
13181303|NCT02213198|26154376|FG000|Baseline|incarcerated,violent|0|||
13181304|NCT02213198|26154377|FG001|Baseline|incarcerated,violent|1|||
13181305|NCT02213198|26154376|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
13181306|NCT02213198|26154377|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
13181307|NCT02213198|26154376|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3|||
13181308|NCT02213198|26154377|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2|||
13181309|NCT02213198|26154376|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1|||
13181310|NCT02213198|26154377|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0|||
13181311|NCT02213198|26154376|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68|||
13181312|NCT02213198|26154377|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25|||
13181313|NCT02213198|26154376|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17|||
13181314|NCT02213198|26154377|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10|||
13181315|NCT02213198|26154376|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23|||
13181316|NCT02213198|26154377|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7|||
13181317|NCT02213094|26154390|FG000|Overall Study|Adverse Event|1|||
13181318|NCT02213094|26154391|FG001|Overall Study|Adverse Event|0|||
13181319|NCT02213055|26154404|FG000|Overall Study|Protocol was not Followed at Enrollment|5|||
13181320|NCT02213055|26154405|FG001|Overall Study|Protocol was not Followed at Enrollment|0|||
13181321|NCT02213055|26154404|FG000|Overall Study|Protocol was not Followed during Study|1|||
13181322|NCT02213055|26154405|FG001|Overall Study|Protocol was not Followed during Study|0|||
13181323|NCT02213055|26154404|FG000|Overall Study|Documentation Issue at Enrollment|1|||
13181324|NCT02213055|26154405|FG001|Overall Study|Documentation Issue at Enrollment|0|||
13181325|NCT02213055|26154404|FG000|Overall Study|Documentation Issue during Study|10|||
13181326|NCT02213055|26154405|FG001|Overall Study|Documentation Issue during Study|0|||
13181327|NCT02213055|26154404|FG000|Overall Study|Did not have Live Lice|8|||
13181328|NCT02213055|26154405|FG001|Overall Study|Did not have Live Lice|0|||
13181329|NCT02213055|26154404|FG000|Overall Study|Had another Treatment during the Study|3|||
13181330|NCT02213055|26154405|FG001|Overall Study|Had another Treatment during the Study|0|||
13181331|NCT02213055|26154404|FG000|Overall Study|Did not meet Inclusion Criteria|6|||
13181332|NCT02213055|26154405|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
13181333|NCT02213055|26154404|FG000|Overall Study|Did not Return to School|5|||
13181334|NCT02213055|26154405|FG001|Overall Study|Did not Return to School|0|||
13181335|NCT02213042|26154438|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14|||
13181336|NCT02213042|26154439|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13|||
13181337|NCT02213042|26154440|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8|||
13181338|NCT02213042|26154438|FG000|Overall Study|Adverse Event|2|||
13181339|NCT02213042|26154439|FG001|Overall Study|Adverse Event|1|||
13181340|NCT02213042|26154440|FG002|Overall Study|Adverse Event|0|||
13181341|NCT02213042|26154438|FG000|Overall Study|Withdrawal by Subject|0|||
13181342|NCT02213042|26154439|FG001|Overall Study|Withdrawal by Subject|1|||
13181343|NCT02213042|26154440|FG002|Overall Study|Withdrawal by Subject|1|||
13181344|NCT02213042|26154438|FG000|Overall Study|Protocol Violation|1|||
13181345|NCT02213042|26154439|FG001|Overall Study|Protocol Violation|0|||
13181346|NCT02213042|26154440|FG002|Overall Study|Protocol Violation|0|||
13181347|NCT02213042|26154438|FG000|Overall Study|Investigator discretion|0|||
13181348|NCT02213042|26154439|FG001|Overall Study|Investigator discretion|0|||
13181349|NCT02213042|26154440|FG002|Overall Study|Investigator discretion|1|||
13181350|NCT02212730|26154469|FG000|Overall Study|Tumor not of the required cell histology|1|||
13181351|NCT02212730|26154470|FG001|Overall Study|Tumor not of the required cell histology|0|||
13181352|NCT02212730|26154469|FG000|Overall Study|Withdrawal by Subject|1|||
13181353|NCT02212730|26154470|FG001|Overall Study|Withdrawal by Subject|0|||
13181354|NCT02212730|26154469|FG000|Overall Study|Disease progression prior to RCC surgery|0|||
13181355|NCT02212730|26154470|FG001|Overall Study|Disease progression prior to RCC surgery|1|||
13181356|NCT02212678|26154476|FG000|Overall Study|Adverse Event|1|||
13181357|NCT02212457|26154619|FG000|Overall Study|Adverse Event|1|||
13181358|NCT02212457|26154620|FG001|Overall Study|Adverse Event|2|||
13181359|NCT02212457|26154621|FG002|Overall Study|Adverse Event|2|||
13181360|NCT02212457|26154622|FG003|Overall Study|Adverse Event|2|||
13181361|NCT02212457|26154623|FG004|Overall Study|Adverse Event|0|||
13181362|NCT02212457|26154624|FG005|Overall Study|Adverse Event|1|||
13181363|NCT02212457|26154619|FG000|Overall Study|Withdrawal by Subject|8|||
13181364|NCT02212457|26154620|FG001|Overall Study|Withdrawal by Subject|10|||
13181365|NCT02212457|26154621|FG002|Overall Study|Withdrawal by Subject|8|||
13181366|NCT02212457|26154622|FG003|Overall Study|Withdrawal by Subject|6|||
13181367|NCT02212457|26154623|FG004|Overall Study|Withdrawal by Subject|5|||
13181368|NCT02212457|26154624|FG005|Overall Study|Withdrawal by Subject|4|||
13181369|NCT02212457|26154619|FG000|Overall Study|Lost to Follow-up|6|||
13181370|NCT02212457|26154620|FG001|Overall Study|Lost to Follow-up|7|||
13181371|NCT02212457|26154621|FG002|Overall Study|Lost to Follow-up|4|||
13181372|NCT02212457|26154622|FG003|Overall Study|Lost to Follow-up|1|||
13181373|NCT02212457|26154623|FG004|Overall Study|Lost to Follow-up|8|||
13181374|NCT02212457|26154624|FG005|Overall Study|Lost to Follow-up|4|||
13109670|NCT03227445|25897188|FG002|Period 2 (28 Days)|Adverse Event|2|||
13109671|NCT03227445|25897189|FG003|Period 2 (28 Days)|Adverse Event|1|||
13109672|NCT03227445|25897186|FG000|Period 2 (28 Days)|Protocol Violation|0|||
13109673|NCT03227445|25897187|FG001|Period 2 (28 Days)|Protocol Violation|0|||
13109674|NCT03227445|25897188|FG002|Period 2 (28 Days)|Protocol Violation|0|||
13109675|NCT03227445|25897189|FG003|Period 2 (28 Days)|Protocol Violation|1|||
13109676|NCT03227445|25897186|FG000|Period 2 (28 Days)|Withdrawal by Subject|0|||
13109677|NCT03227445|25897187|FG001|Period 2 (28 Days)|Withdrawal by Subject|1|||
13109678|NCT03227445|25897188|FG002|Period 2 (28 Days)|Withdrawal by Subject|0|||
13109679|NCT03227445|25897189|FG003|Period 2 (28 Days)|Withdrawal by Subject|1|||
13109680|NCT03227224|25897379|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
13109681|NCT03227224|25897380|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
13109682|NCT03227224|25897381|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
13109683|NCT03227224|25897382|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
13109684|NCT03227224|25897379|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
13181375|NCT02212457|26154619|FG000|Overall Study|Protocol Violation|2|||
13181376|NCT02212457|26154620|FG001|Overall Study|Protocol Violation|1|||
13181377|NCT02212457|26154621|FG002|Overall Study|Protocol Violation|0|||
13181378|NCT02212457|26154622|FG003|Overall Study|Protocol Violation|1|||
13181379|NCT02212457|26154623|FG004|Overall Study|Protocol Violation|2|||
13181380|NCT02212457|26154624|FG005|Overall Study|Protocol Violation|3|||
13181381|NCT02212457|26154619|FG000|Overall Study|Other|2|||
13181382|NCT02212457|26154620|FG001|Overall Study|Other|1|||
13181383|NCT02212457|26154621|FG002|Overall Study|Other|2|||
13181384|NCT02212457|26154622|FG003|Overall Study|Other|1|||
13181385|NCT02212457|26154623|FG004|Overall Study|Other|0|||
13181386|NCT02212457|26154624|FG005|Overall Study|Other|1|||
13181387|NCT02212379|26154657|FG000|From Baseline to Week 48|Lack of Efficacy|1|||
13181388|NCT02212379|26154657|FG000|From Baseline to Week 48|Adverse Event|7|||
13181389|NCT02212379|26154657|FG000|From Baseline to Week 48|Withdrawal by Subject|1|||
13181390|NCT02212379|26154657|FG000|From Week 48 to Week 96|Lack of Efficacy|1|||
13181391|NCT02212379|26154657|FG000|From Week 48 to Week 96|Adverse Event|1|||
13181392|NCT02212379|26154657|FG000|From Week 48 to Week 96|Withdrawal by Subject|2|||
13181393|NCT02212301|26154668|FG000|Period 1|Lost to Follow-up|0|||
13181394|NCT02212301|26154669|FG001|Period 1|Lost to Follow-up|1|||
13181395|NCT02212197|26154702|FG000|Overall Study|Need for radiotherapy|1|||
13181396|NCT02212197|26154703|FG001|Overall Study|Need for radiotherapy|0|||
13181397|NCT02212197|26154704|FG002|Overall Study|Need for radiotherapy|0|||
13181398|NCT02211638|26154715|FG000|Overall Study|Case Report Forms Uncollected|291|||
13181399|NCT02211638|26154715|FG000|Overall Study|Protocol Violation|692|||
13181400|NCT02211313|26154728|FG000|Overall Study|Treatment Failure|5|||
13109685|NCT03227224|25897380|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
13109686|NCT03227224|25897381|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
13109687|NCT03227224|25897382|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
13109688|NCT03227224|25897379|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
13109689|NCT03227224|25897380|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
13109690|NCT03227224|25897381|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
13181401|NCT02211313|26154729|FG001|Overall Study|Treatment Failure|2|||
13181402|NCT02211313|26154728|FG000|Overall Study|No Follow up Questionnaires|1|||
13181403|NCT02211313|26154729|FG001|Overall Study|No Follow up Questionnaires|1|||
13181404|NCT02211261|26154884|FG000|Overall Study|Withdrawal by Subject|0|||
13181405|NCT02211261|26154885|FG001|Overall Study|Withdrawal by Subject|0|||
13181406|NCT02211261|26154886|FG002|Overall Study|Withdrawal by Subject|1|||
13181407|NCT02211261|26154887|FG003|Overall Study|Withdrawal by Subject|0|||
13181408|NCT02211261|26154888|FG004|Overall Study|Withdrawal by Subject|2|||
13181409|NCT02211261|26154889|FG005|Overall Study|Withdrawal by Subject|0|||
13181410|NCT02211261|26154890|FG006|Overall Study|Withdrawal by Subject|0|||
13181411|NCT02211261|26154891|FG007|Overall Study|Withdrawal by Subject|0|||
13181412|NCT02211261|26154892|FG008|Overall Study|Withdrawal by Subject|0|||
13181413|NCT02211261|26154893|FG009|Overall Study|Withdrawal by Subject|0|||
13181414|NCT02211261|26154894|FG010|Overall Study|Withdrawal by Subject|0|||
13181415|NCT02211261|26154884|FG000|Overall Study|Other|0|||
13181416|NCT02211261|26154885|FG001|Overall Study|Other|0|||
13181417|NCT02211261|26154886|FG002|Overall Study|Other|0|||
13181418|NCT02211261|26154887|FG003|Overall Study|Other|0|||
13181419|NCT02211261|26154888|FG004|Overall Study|Other|0|||
13181420|NCT02211261|26154889|FG005|Overall Study|Other|1|||
13181421|NCT02211261|26154890|FG006|Overall Study|Other|0|||
13181422|NCT02211261|26154891|FG007|Overall Study|Other|0|||
13181423|NCT02211261|26154892|FG008|Overall Study|Other|0|||
13181424|NCT02211261|26154893|FG009|Overall Study|Other|2|||
13181425|NCT02211261|26154894|FG010|Overall Study|Other|0|||
13181426|NCT02211261|26154884|FG000|Overall Study|Lost to Follow-up|0|||
13181427|NCT02211261|26154885|FG001|Overall Study|Lost to Follow-up|0|||
13109691|NCT03227224|25897382|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
13109692|NCT03227224|25897379|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
13109693|NCT03227224|25897380|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
13109694|NCT03227224|25897381|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
13109695|NCT03227224|25897382|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
13109696|NCT03227224|25897379|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
13109697|NCT03227224|25897380|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
13109698|NCT03227224|25897381|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1|||
13181428|NCT02211261|26154886|FG002|Overall Study|Lost to Follow-up|0|||
13181429|NCT02211261|26154887|FG003|Overall Study|Lost to Follow-up|0|||
13181430|NCT02211261|26154888|FG004|Overall Study|Lost to Follow-up|0|||
13181431|NCT02211261|26154889|FG005|Overall Study|Lost to Follow-up|0|||
13181432|NCT02211261|26154890|FG006|Overall Study|Lost to Follow-up|0|||
13181433|NCT02211261|26154891|FG007|Overall Study|Lost to Follow-up|1|||
13181434|NCT02211261|26154892|FG008|Overall Study|Lost to Follow-up|0|||
13181435|NCT02211261|26154893|FG009|Overall Study|Lost to Follow-up|0|||
13181436|NCT02211261|26154894|FG010|Overall Study|Lost to Follow-up|0|||
13181437|NCT02211209|26154921|FG000|Overall Study|Investigator judgment|0|||
13181438|NCT02211209|26154922|FG001|Overall Study|Investigator judgment|1|||
13181439|NCT02211209|26154921|FG000|Overall Study|Voluntary withdrawal|1|||
13181440|NCT02211209|26154922|FG001|Overall Study|Voluntary withdrawal|4|||
13181441|NCT02211209|26154921|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
13181442|NCT02211209|26154922|FG001|Overall Study|Adverse Event or Serious Adverse Event|9|||
13181443|NCT02211209|26154921|FG000|Overall Study|Reason Not Specified|1|||
13181444|NCT02211209|26154922|FG001|Overall Study|Reason Not Specified|0|||
13181445|NCT02211014|26154953|FG000|Overall Study|Adverse Event|0|||
13181446|NCT02211014|26154954|FG001|Overall Study|Adverse Event|2|||
13181447|NCT02211014|26154953|FG000|Overall Study|Physician Decision|1|||
13109699|NCT03227224|25897382|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
13109700|NCT03227224|25897379|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2|||
13109701|NCT03227224|25897380|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
13109702|NCT03227224|25897381|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
13109703|NCT03227224|25897382|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4|||
13109704|NCT03227224|25897379|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2|||
13109705|NCT03227224|25897380|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
13109706|NCT03227224|25897381|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
13109707|NCT03227224|25897382|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
13109708|NCT03227224|25897379|FG000|Double-blind Treatment Period (6 Weeks)|Other|4|||
13109709|NCT03227224|25897380|FG001|Double-blind Treatment Period (6 Weeks)|Other|0|||
13109710|NCT03227224|25897381|FG002|Double-blind Treatment Period (6 Weeks)|Other|1|||
13181448|NCT02211014|26154954|FG001|Overall Study|Physician Decision|2|||
13181449|NCT02211014|26154953|FG000|Overall Study|Started another cancer therapy|1|||
13181450|NCT02211014|26154954|FG001|Overall Study|Started another cancer therapy|0|||
13181451|NCT02211014|26154953|FG000|Overall Study|Withdrawal by Subject|0|||
13181452|NCT02211014|26154954|FG001|Overall Study|Withdrawal by Subject|1|||
13181453|NCT02211014|26154953|FG000|Overall Study|In agreement with patient, no benefit|0|||
13181454|NCT02211014|26154954|FG001|Overall Study|In agreement with patient, no benefit|1|||
13181455|NCT02210780|26154987|FG000|Overall Study|Adverse Event|0|||
13181456|NCT02210780|26154988|FG001|Overall Study|Adverse Event|5|||
13181457|NCT02210780|26154987|FG000|Overall Study|Lost to Follow-up|2|||
13181458|NCT02210780|26154988|FG001|Overall Study|Lost to Follow-up|1|||
13181459|NCT02210780|26154987|FG000|Overall Study|Withdrawal by Subject|1|||
13181460|NCT02210780|26154988|FG001|Overall Study|Withdrawal by Subject|1|||
13181461|NCT02210780|26154987|FG000|Overall Study|Physician Decision|1|||
13181462|NCT02210780|26154988|FG001|Overall Study|Physician Decision|0|||
13181463|NCT02210780|26154987|FG000|Overall Study|Protocol Violation|1|||
13181464|NCT02210780|26154988|FG001|Overall Study|Protocol Violation|0|||
13181465|NCT02210780|26154987|FG000|Overall Study|Other than specified above|0|||
13181466|NCT02210780|26154988|FG001|Overall Study|Other than specified above|1|||
13181467|NCT02210689|26155006|FG000|Overall Study|Withdrawal by Subject|7|||
13181468|NCT02210689|26155007|FG001|Overall Study|Withdrawal by Subject|4|||
13181469|NCT02210689|26155008|FG002|Overall Study|Withdrawal by Subject|2|||
13181470|NCT02210689|26155006|FG000|Overall Study|Adverse Event|0|||
13181471|NCT02210689|26155007|FG001|Overall Study|Adverse Event|1|||
13181472|NCT02210689|26155008|FG002|Overall Study|Adverse Event|0|||
13181473|NCT02210689|26155006|FG000|Overall Study|Protocol Violation|1|||
13181474|NCT02210689|26155007|FG001|Overall Study|Protocol Violation|0|||
13181475|NCT02210689|26155008|FG002|Overall Study|Protocol Violation|0|||
13181476|NCT02210689|26155006|FG000|Overall Study|Lost to Follow-up|11|||
13181477|NCT02210689|26155007|FG001|Overall Study|Lost to Follow-up|9|||
13181478|NCT02210689|26155008|FG002|Overall Study|Lost to Follow-up|5|||
13181479|NCT02210689|26155006|FG000|Overall Study|Pregnancy|0|||
13181480|NCT02210689|26155007|FG001|Overall Study|Pregnancy|1|||
13181481|NCT02210689|26155008|FG002|Overall Study|Pregnancy|0|||
13181482|NCT02210689|26155006|FG000|Overall Study|Lack of Efficacy|0|||
13181483|NCT02210689|26155007|FG001|Overall Study|Lack of Efficacy|1|||
13181484|NCT02210689|26155008|FG002|Overall Study|Lack of Efficacy|5|||
13181485|NCT02210689|26155006|FG000|Overall Study|Prohibited medication|2|||
13181486|NCT02210689|26155007|FG001|Overall Study|Prohibited medication|8|||
13181487|NCT02210689|26155008|FG002|Overall Study|Prohibited medication|1|||
13181488|NCT02210689|26155006|FG000|Overall Study|Negative Nugent score at baseline|6|||
13181489|NCT02210689|26155007|FG001|Overall Study|Negative Nugent score at baseline|2|||
13181490|NCT02210689|26155008|FG002|Overall Study|Negative Nugent score at baseline|2|||
13181491|NCT02210689|26155006|FG000|Overall Study|Other|25|||
13181492|NCT02210689|26155007|FG001|Overall Study|Other|21|||
13181493|NCT02210689|26155008|FG002|Overall Study|Other|8|||
13181494|NCT02210208|26155017|FG000|Period A (Graft Site)|Withdrawal by Subject|1|||
13181495|NCT02210208|26155017|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1|||
13181496|NCT02210208|26155017|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7|||
13181497|NCT02210091|26155096|FG000|Overall Study|Physician Decision|0|||
13181498|NCT02210091|26155097|FG001|Overall Study|Physician Decision|1|||
13181499|NCT02210091|26155096|FG000|Overall Study|Withdrawal by Sponsor|0|||
13181500|NCT02210091|26155097|FG001|Overall Study|Withdrawal by Sponsor|1|||
13181501|NCT02210000|26155126|FG000|Overall Study|Study Terminated|11|||
13181502|NCT02210000|26155127|FG001|Overall Study|Study Terminated|12|||
13181503|NCT02210000|26155126|FG000|Overall Study|Withdrawal by Subject|7|||
13181504|NCT02210000|26155127|FG001|Overall Study|Withdrawal by Subject|1|||
13181505|NCT02210000|26155126|FG000|Overall Study|Adverse Event|1|||
13181506|NCT02210000|26155127|FG001|Overall Study|Adverse Event|5|||
13181507|NCT02210000|26155126|FG000|Overall Study|Lost to Follow-up|0|||
13181508|NCT02210000|26155127|FG001|Overall Study|Lost to Follow-up|2|||
13181509|NCT02210000|26155126|FG000|Overall Study|Physician Decision|0|||
13181510|NCT02210000|26155127|FG001|Overall Study|Physician Decision|1|||
13181511|NCT02209766|26155187|FG000|Overall Study|Withdrawal by Subject|0|||
13181512|NCT02209766|26155188|FG001|Overall Study|Withdrawal by Subject|0|||
13181513|NCT02209766|26155189|FG002|Overall Study|Withdrawal by Subject|0|||
13181514|NCT02209766|26155190|FG003|Overall Study|Withdrawal by Subject|1|||
13181515|NCT02209766|26155191|FG004|Overall Study|Withdrawal by Subject|0|||
13181516|NCT02209597|26155203|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2|||
13181517|NCT02209597|26155203|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1|||
13181518|NCT02209597|26155203|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3|||
13181519|NCT02209597|26155203|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1|||
13181520|NCT02209506|26155294|FG000|Overall Study|Withdrawal by Subject|0|||
13181521|NCT02209506|26155295|FG001|Overall Study|Withdrawal by Subject|0|||
13181522|NCT02209506|26155296|FG002|Overall Study|Withdrawal by Subject|0|||
13181523|NCT02209506|26155297|FG003|Overall Study|Withdrawal by Subject|0|||
13181524|NCT02209506|26155298|FG004|Overall Study|Withdrawal by Subject|1|||
13181525|NCT02209454|26155315|FG000|Second Period|Adverse Event|1|||
13181526|NCT02209454|26155316|FG001|Second Period|Adverse Event|0|||
13181527|NCT02209181|26155491|FG000|Overall Study|Adverse Event|1|||
13181528|NCT02209181|26155492|FG001|Overall Study|Adverse Event|0|||
13181529|NCT02209181|26155493|FG002|Overall Study|Adverse Event|1|||
13181530|NCT02209181|26155494|FG003|Overall Study|Adverse Event|0|||
13181531|NCT02209181|26155491|FG000|Overall Study|Withdrawal by Subject|0|||
13181532|NCT02209181|26155492|FG001|Overall Study|Withdrawal by Subject|1|||
13181533|NCT02209181|26155493|FG002|Overall Study|Withdrawal by Subject|0|||
13181534|NCT02209181|26155494|FG003|Overall Study|Withdrawal by Subject|0|||
13181535|NCT02208999|26155522|FG000|Overall Study|Lost to Follow-up|1|||
13181536|NCT02208843|26155530|FG000|Overall Study|Clinical symptoms of progression|2|||
13181537|NCT02208843|26155530|FG000|Overall Study|Progression disease according to RECIST|24|||
13181538|NCT02208843|26155530|FG000|Overall Study|Adverse Event|12|||
13181539|NCT02208843|26155530|FG000|Overall Study|Protocol Violation|1|||
13181540|NCT02208843|26155530|FG000|Overall Study|Withdrawal by Subject|1|||
13181541|NCT02208843|26155530|FG000|Overall Study|Switched to commercial afatinib|20|||
13181542|NCT02208089|26155551|FG000|Overall Study|Withdrawal by Subject|1|||
13181543|NCT02208089|26155552|FG001|Overall Study|Withdrawal by Subject|0|||
13181544|NCT02208089|26155551|FG000|Overall Study|Lost to Follow-up|6|||
13181545|NCT02208089|26155552|FG001|Overall Study|Lost to Follow-up|0|||
13181546|NCT02208063|26155571|FG000|Overall Study|Death|3|||
13181547|NCT02208063|26155572|FG001|Overall Study|Death|5|||
13181548|NCT02208063|26155571|FG000|Overall Study|Not Specified in report|3|||
13181549|NCT02208063|26155572|FG001|Overall Study|Not Specified in report|4|||
13181550|NCT02208063|26155571|FG000|Overall Study|Withdrawal by Subject|5|||
13181551|NCT02208063|26155572|FG001|Overall Study|Withdrawal by Subject|2|||
13181552|NCT02208063|26155571|FG000|Overall Study|Lost to Follow-up|1|||
13181553|NCT02208063|26155572|FG001|Overall Study|Lost to Follow-up|0|||
13181554|NCT02208050|26155599|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1|||
13181555|NCT02208050|26155600|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0|||
13181556|NCT02207946|26155623|FG000|Overall Study|Lost to Follow-up|1|||
13181557|NCT02207946|26155624|FG001|Overall Study|Lost to Follow-up|0|||
13181558|NCT02207946|26155623|FG000|Overall Study|Adverse Event|0|||
13181559|NCT02207946|26155624|FG001|Overall Study|Adverse Event|1|||
13222989|NCT01801280|26287574|FG003|Period 1|Withdrawal by Subject|0|||
13222990|NCT01801280|26287571|FG000|Period 2|Withdrawal by Subject|1|||
13222991|NCT01801280|26287572|FG001|Period 2|Withdrawal by Subject|0|||
13222992|NCT01801280|26287573|FG002|Period 2|Withdrawal by Subject|0|||
13222993|NCT01801280|26287574|FG003|Period 2|Withdrawal by Subject|0|||
13222994|NCT01801280|26287571|FG000|Period 4|Protocol Violation|0|||
13222995|NCT01801280|26287572|FG001|Period 4|Protocol Violation|0|||
13222996|NCT01801280|26287573|FG002|Period 4|Protocol Violation|1|||
13222997|NCT01801280|26287574|FG003|Period 4|Protocol Violation|0|||
13222998|NCT01801111|26287615|FG000|Overall Study|Adverse Event|12|||
13222999|NCT01801111|26287615|FG000|Overall Study|Death|8|||
13223000|NCT01801111|26287615|FG000|Overall Study|Physician Decision|5|||
13223001|NCT01801111|26287615|FG000|Overall Study|Other|1|||
13223002|NCT01801111|26287615|FG000|Overall Study|Withdrawal by Subject|4|||
13223003|NCT01801111|26287615|FG000|Overall Study|Study Terminated by Sponsor|27|||
13223004|NCT01801111|26287615|FG000|Overall Study|Progressive Disease|81|||
13223005|NCT01801007|26287628|FG000|Overall Study|Adverse Event|2|||
13223006|NCT01801007|26287628|FG000|Overall Study|Lost to Follow-up|4|||
13181560|NCT02207907|26155647|FG000|Overall Study|Lost to Follow-up|3|||
13181561|NCT02207907|26155648|FG001|Overall Study|Lost to Follow-up|1|||
13181562|NCT02207907|26155647|FG000|Overall Study|Withdrawal by Subject|5|||
13181563|NCT02207907|26155648|FG001|Overall Study|Withdrawal by Subject|6|||
13181564|NCT02207907|26155647|FG000|Overall Study|Did not meet study criteria|3|||
13181565|NCT02207907|26155648|FG001|Overall Study|Did not meet study criteria|0|||
13181566|NCT02207907|26155647|FG000|Overall Study|Pregnancy|0|||
13223007|NCT01801007|26287628|FG000|Overall Study|Withdrawal by Subject|5|||
13223008|NCT01800968|26287677|FG000|Overall Study|Death|23|||
13223009|NCT01800968|26287678|FG001|Overall Study|Death|16|||
13223010|NCT01800968|26287677|FG000|Overall Study|Lost to Follow-up|5|||
13223011|NCT01800968|26287678|FG001|Overall Study|Lost to Follow-up|7|||
13223012|NCT01800968|26287677|FG000|Overall Study|Withdrawal by Subject|7|||
13223013|NCT01800968|26287678|FG001|Overall Study|Withdrawal by Subject|9|||
13223014|NCT01800968|26287677|FG000|Overall Study|Physician Decision|1|||
13223015|NCT01800968|26287678|FG001|Overall Study|Physician Decision|0|||
13223016|NCT01800916|26287698|FG000|Test Period 1 (1 Week)|Convex product user|0|||
13223017|NCT01800916|26287699|FG001|Test Period 1 (1 Week)|Convex product user|0|||
13223018|NCT01800916|26287700|FG002|Test Period 1 (1 Week)|Convex product user|0|||
13223019|NCT01800916|26287701|FG003|Test Period 1 (1 Week)|Convex product user|1|||
13181567|NCT02207907|26155648|FG001|Overall Study|Pregnancy|1|||
13181568|NCT02207829|26155661|FG000|Overall Study|Adverse Event|10|||
13181569|NCT02207829|26155662|FG001|Overall Study|Adverse Event|9|||
13181570|NCT02207829|26155661|FG000|Overall Study|Lack of Efficacy|7|||
13181571|NCT02207829|26155662|FG001|Overall Study|Lack of Efficacy|5|||
13181572|NCT02207829|26155661|FG000|Overall Study|Lost to Follow-up|2|||
13181573|NCT02207829|26155662|FG001|Overall Study|Lost to Follow-up|2|||
13181574|NCT02207829|26155661|FG000|Overall Study|Protocol deviation|5|||
13181575|NCT02207829|26155662|FG001|Overall Study|Protocol deviation|4|||
13181576|NCT02207829|26155661|FG000|Overall Study|Withdrew consent|18|||
13181577|NCT02207829|26155662|FG001|Overall Study|Withdrew consent|14|||
13181578|NCT02207816|26155815|FG000|Overall Study|Serious Adverse Event|0|||
13181579|NCT02207816|26155816|FG001|Overall Study|Serious Adverse Event|5|||
13181580|NCT02207816|26155817|FG002|Overall Study|Serious Adverse Event|2|||
13181581|NCT02207816|26155815|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
13181582|NCT02207816|26155816|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1|||
13181583|NCT02207816|26155817|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2|||
13181584|NCT02207816|26155815|FG000|Overall Study|Withdrawal by Subject|4|||
13181585|NCT02207816|26155816|FG001|Overall Study|Withdrawal by Subject|9|||
13181586|NCT02207816|26155817|FG002|Overall Study|Withdrawal by Subject|7|||
13181587|NCT02207816|26155815|FG000|Overall Study|Migrated/Moved From Study Area|41|||
13181588|NCT02207816|26155816|FG001|Overall Study|Migrated/Moved From Study Area|60|||
13181589|NCT02207816|26155817|FG002|Overall Study|Migrated/Moved From Study Area|51|||
13181590|NCT02207816|26155815|FG000|Overall Study|Lost to Follow-up|3|||
13181591|NCT02207816|26155816|FG001|Overall Study|Lost to Follow-up|9|||
13181592|NCT02207816|26155817|FG002|Overall Study|Lost to Follow-up|1|||
13181593|NCT02207816|26155815|FG000|Overall Study|Other|1|||
13181594|NCT02207816|26155816|FG001|Overall Study|Other|2|||
13181595|NCT02207816|26155817|FG002|Overall Study|Other|4|||
13181596|NCT02207725|26155858|FG000|Overall Study|Did Not Receive Treatment|0|||
13181597|NCT02207725|26155859|FG001|Overall Study|Did Not Receive Treatment|1|||
13181598|NCT02207725|26155860|FG002|Overall Study|Did Not Receive Treatment|1|||
13181599|NCT02207725|26155861|FG003|Overall Study|Did Not Receive Treatment|1|||
13181600|NCT02207634|26155880|FG000|Overall Study|Withdrawal by Subject|21|||
13181601|NCT02207634|26155881|FG001|Overall Study|Withdrawal by Subject|31|||
13181602|NCT02207634|26155880|FG000|Overall Study|Lost to Follow-up|1|||
13181603|NCT02207634|26155881|FG001|Overall Study|Lost to Follow-up|0|||
13181604|NCT02207621|26155902|FG000|Overall Study|Adverse Event|71|||
13181605|NCT02207621|26155903|FG001|Overall Study|Adverse Event|15|||
13181606|NCT02207621|26155904|FG002|Overall Study|Adverse Event|132|||
13181607|NCT02207621|26155902|FG000|Overall Study|Withdrawal by Subject|9|||
13181608|NCT02207621|26155903|FG001|Overall Study|Withdrawal by Subject|9|||
13181609|NCT02207621|26155904|FG002|Overall Study|Withdrawal by Subject|13|||
13181610|NCT02207621|26155902|FG000|Overall Study|Non-Compliant|3|||
13181611|NCT02207621|26155903|FG001|Overall Study|Non-Compliant|3|||
13181612|NCT02207621|26155904|FG002|Overall Study|Non-Compliant|1|||
13181613|NCT02207621|26155902|FG000|Overall Study|Lost to Follow-up|1|||
13181614|NCT02207621|26155903|FG001|Overall Study|Lost to Follow-up|0|||
13181615|NCT02207621|26155904|FG002|Overall Study|Lost to Follow-up|3|||
13181616|NCT02207621|26155902|FG000|Overall Study|Lack of Efficacy|10|||
13181617|NCT02207621|26155903|FG001|Overall Study|Lack of Efficacy|2|||
13181618|NCT02207621|26155904|FG002|Overall Study|Lack of Efficacy|4|||
13181619|NCT02207621|26155902|FG000|Overall Study|Disallowed Concurrent Medication|2|||
13181620|NCT02207621|26155903|FG001|Overall Study|Disallowed Concurrent Medication|5|||
13181621|NCT02207621|26155904|FG002|Overall Study|Disallowed Concurrent Medication|2|||
13181622|NCT02207621|26155902|FG000|Overall Study|Physician Decision|1|||
13181623|NCT02207621|26155903|FG001|Overall Study|Physician Decision|2|||
13181624|NCT02207621|26155904|FG002|Overall Study|Physician Decision|2|||
13181625|NCT02207621|26155902|FG000|Overall Study|Protocol Violation|4|||
13181626|NCT02207621|26155903|FG001|Overall Study|Protocol Violation|10|||
13181627|NCT02207621|26155904|FG002|Overall Study|Protocol Violation|6|||
13181628|NCT02207621|26155902|FG000|Overall Study|Death|2|||
13181629|NCT02207621|26155903|FG001|Overall Study|Death|0|||
13181630|NCT02207621|26155904|FG002|Overall Study|Death|0|||
13181631|NCT02207621|26155902|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2|||
13181632|NCT02207621|26155903|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1|||
13181633|NCT02207621|26155904|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5|||
13181634|NCT02207608|26155917|FG000|Overall Study|Adverse Event|1|||
13181635|NCT02207608|26155918|FG001|Overall Study|Adverse Event|0|||
13181636|NCT02207556|26155938|FG000|Overall Study|Physician Decision|1|||
13181637|NCT02207556|26155939|FG001|Overall Study|Physician Decision|0|||
13181638|NCT02207556|26155938|FG000|Overall Study|Withdrawal by Subject|1|||
13181639|NCT02207556|26155939|FG001|Overall Study|Withdrawal by Subject|0|||
13181640|NCT02207556|26155938|FG000|Overall Study|Death|0|||
13181641|NCT02207556|26155939|FG001|Overall Study|Death|5|||
13181642|NCT02207530|26155953|FG000|Overall Study|Worsening condition under investigation|78|||
13181643|NCT02207530|26155953|FG000|Overall Study|Patient decision to stop study treatment|5|||
13181644|NCT02207530|26155953|FG000|Overall Study|Adverse Event|8|||
13181645|NCT02207491|26155968|FG000|Overall Study|Adverse Event|20|||
13181646|NCT02207491|26155969|FG001|Overall Study|Adverse Event|4|||
13181647|NCT02207491|26155968|FG000|Overall Study|Withdrawal by Subject|3|||
13181648|NCT02207491|26155969|FG001|Overall Study|Withdrawal by Subject|2|||
13181649|NCT02207491|26155968|FG000|Overall Study|Non-compliant|0|||
13181650|NCT02207491|26155969|FG001|Overall Study|Non-compliant|1|||
13181651|NCT02207491|26155968|FG000|Overall Study|Lost to Follow-up|0|||
13181652|NCT02207491|26155969|FG001|Overall Study|Lost to Follow-up|1|||
13181653|NCT02207491|26155968|FG000|Overall Study|Lack of Efficacy|3|||
13181654|NCT02207491|26155969|FG001|Overall Study|Lack of Efficacy|0|||
13181655|NCT02207491|26155968|FG000|Overall Study|Physician Decision|2|||
13181656|NCT02207491|26155969|FG001|Overall Study|Physician Decision|0|||
13181657|NCT02207491|26155968|FG000|Overall Study|Protocol Violation|3|||
13181658|NCT02207491|26155969|FG001|Overall Study|Protocol Violation|5|||
13181659|NCT02207413|26156082|FG000|Overall Study|Withdrawal by Subject|1|||
13181660|NCT02207413|26156083|FG001|Overall Study|Withdrawal by Subject|0|||
13181661|NCT02207413|26156084|FG002|Overall Study|Withdrawal by Subject|0|||
13181662|NCT02207413|26156085|FG003|Overall Study|Withdrawal by Subject|0|||
13181663|NCT02207413|26156086|FG004|Overall Study|Withdrawal by Subject|3|||
13181664|NCT02207413|26156087|FG005|Overall Study|Withdrawal by Subject|7|||
13181665|NCT02207413|26156082|FG000|Overall Study|Lost to Follow-up|0|||
13181666|NCT02207413|26156083|FG001|Overall Study|Lost to Follow-up|0|||
13181667|NCT02207413|26156084|FG002|Overall Study|Lost to Follow-up|0|||
13181668|NCT02207413|26156085|FG003|Overall Study|Lost to Follow-up|1|||
13181669|NCT02207413|26156086|FG004|Overall Study|Lost to Follow-up|1|||
13181670|NCT02207413|26156087|FG005|Overall Study|Lost to Follow-up|5|||
13181671|NCT02207413|26156082|FG000|Overall Study|Adverse Event|0|||
13181672|NCT02207413|26156083|FG001|Overall Study|Adverse Event|0|||
13181673|NCT02207413|26156084|FG002|Overall Study|Adverse Event|0|||
13181674|NCT02207413|26156085|FG003|Overall Study|Adverse Event|0|||
13181675|NCT02207413|26156086|FG004|Overall Study|Adverse Event|2|||
13181676|NCT02207413|26156087|FG005|Overall Study|Adverse Event|1|||
13181677|NCT02207413|26156082|FG000|Overall Study|Migrated/moved from study area|0|||
13181678|NCT02207413|26156083|FG001|Overall Study|Migrated/moved from study area|0|||
13181679|NCT02207413|26156084|FG002|Overall Study|Migrated/moved from study area|0|||
13181680|NCT02207413|26156085|FG003|Overall Study|Migrated/moved from study area|0|||
13181681|NCT02207413|26156086|FG004|Overall Study|Migrated/moved from study area|1|||
13181682|NCT02207413|26156087|FG005|Overall Study|Migrated/moved from study area|0|||
13181683|NCT02207400|26156112|FG000|Overall Study|Adverse Event|1|||
13181684|NCT02207400|26156113|FG001|Overall Study|Adverse Event|1|||
13181685|NCT02207400|26156112|FG000|Overall Study|Lost to Follow-up|6|||
13181686|NCT02207400|26156113|FG001|Overall Study|Lost to Follow-up|7|||
13181687|NCT02207400|26156112|FG000|Overall Study|Protocol Violation|1|||
13181688|NCT02207400|26156113|FG001|Overall Study|Protocol Violation|1|||
13181689|NCT02207400|26156112|FG000|Overall Study|Withdrawal by Subject|8|||
13181690|NCT02207400|26156113|FG001|Overall Study|Withdrawal by Subject|4|||
13181691|NCT02207400|26156112|FG000|Overall Study|Positive Urine Pregnancy Test|0|||
13181692|NCT02207400|26156113|FG001|Overall Study|Positive Urine Pregnancy Test|1|||
13181693|NCT02207374|26156137|FG000|Overall Study|Withdrawal by Subject|5|||
13181694|NCT02207374|26156138|FG001|Overall Study|Withdrawal by Subject|9|||
13181695|NCT02207374|26156139|FG002|Overall Study|Withdrawal by Subject|4|||
13181696|NCT02207374|26156137|FG000|Overall Study|Death|1|||
13181697|NCT02207374|26156138|FG001|Overall Study|Death|0|||
13181698|NCT02207374|26156139|FG002|Overall Study|Death|1|||
13181699|NCT02207374|26156137|FG000|Overall Study|Missing follow-up information|0|||
13181700|NCT02207374|26156138|FG001|Overall Study|Missing follow-up information|1|||
13181701|NCT02207374|26156139|FG002|Overall Study|Missing follow-up information|1|||
13181702|NCT02207244|26156209|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2|||
13181703|NCT02207244|26156210|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9|||
13181704|NCT02207244|26156211|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4|||
13181705|NCT02207244|26156212|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
13181706|NCT02207244|26156213|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
13181707|NCT02207244|26156214|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
13181708|NCT02207244|26156215|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
13181709|NCT02207244|26156216|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
13181710|NCT02207244|26156217|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
13181711|NCT02207244|26156218|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
13181712|NCT02207244|26156219|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
13181713|NCT02207244|26156209|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4|||
13181714|NCT02207244|26156210|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
13181715|NCT02207244|26156211|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2|||
13181716|NCT02207244|26156212|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
13181717|NCT02207244|26156213|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
13181718|NCT02207244|26156214|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
13181719|NCT02207244|26156215|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
13181720|NCT02207244|26156216|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
13181721|NCT02207244|26156217|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
13181722|NCT02207244|26156218|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
13181723|NCT02207244|26156219|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
13181724|NCT02207244|26156209|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1|||
13181725|NCT02207244|26156210|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3|||
13181726|NCT02207244|26156211|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2|||
13181727|NCT02207244|26156212|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
13181728|NCT02207244|26156213|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
13181729|NCT02207244|26156214|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
13181730|NCT02207244|26156215|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
13181731|NCT02207244|26156216|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
13181732|NCT02207244|26156217|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
13181733|NCT02207244|26156218|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
13181734|NCT02207244|26156219|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
13181735|NCT02207244|26156209|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7|||
13181736|NCT02207244|26156210|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1|||
13181737|NCT02207244|26156211|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
13181738|NCT02207244|26156212|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
13181739|NCT02207244|26156213|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
13181740|NCT02207244|26156214|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
13181741|NCT02207244|26156215|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
13181742|NCT02207244|26156216|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
13181743|NCT02207244|26156217|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
13181744|NCT02207244|26156218|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
13181745|NCT02207244|26156219|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
13181746|NCT02207244|26156209|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
13181747|NCT02207244|26156210|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3|||
13181748|NCT02207244|26156211|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
13181749|NCT02207244|26156212|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
13181750|NCT02207244|26156213|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
13181751|NCT02207244|26156214|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
13181752|NCT02207244|26156215|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
13109711|NCT03227224|25897382|FG003|Double-blind Treatment Period (6 Weeks)|Other|0|||
13109712|NCT03227224|25897379|FG000|Follow-up Phase (2 Weeks)|Other|4|||
13109713|NCT03227224|25897380|FG001|Follow-up Phase (2 Weeks)|Other|4|||
13109714|NCT03227224|25897381|FG002|Follow-up Phase (2 Weeks)|Other|6|||
13109715|NCT03227224|25897382|FG003|Follow-up Phase (2 Weeks)|Other|3|||
13109716|NCT03227029|25897433|FG000|Overall Study|Child Wheezed (no treatment)|0|||
13109717|NCT03227029|25897434|FG001|Overall Study|Child Wheezed (no treatment)|1|||
13109718|NCT03227029|25897435|FG002|Overall Study|Child Wheezed (no treatment)|0|||
13109719|NCT03227029|25897433|FG000|Overall Study|No post RSV season visit due to COVID|3|||
13109720|NCT03227029|25897434|FG001|Overall Study|No post RSV season visit due to COVID|3|||
13109721|NCT03227029|25897435|FG002|Overall Study|No post RSV season visit due to COVID|2|||
13109722|NCT03227029|25897433|FG000|Overall Study|Not able to get to clinic|0|||
13109723|NCT03227029|25897434|FG001|Overall Study|Not able to get to clinic|0|||
13109724|NCT03227029|25897435|FG002|Overall Study|Not able to get to clinic|1|||
13109725|NCT03227029|25897433|FG000|Overall Study|Withdrawal by Subject|1|||
13109726|NCT03227029|25897434|FG001|Overall Study|Withdrawal by Subject|0|||
13109727|NCT03227029|25897435|FG002|Overall Study|Withdrawal by Subject|0|||
13109728|NCT03227029|25897433|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0|||
13181753|NCT02207244|26156216|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
13181754|NCT02207244|26156217|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
13181755|NCT02207244|26156218|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
13109729|NCT03227029|25897434|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0|||
13109730|NCT03227029|25897435|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1|||
13109731|NCT03226769|25897450|FG000|Overall Study|Withdrawal by Subject|0|||
13181756|NCT02207244|26156219|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
13181757|NCT02207244|26156209|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
13109732|NCT03226769|25897451|FG001|Overall Study|Withdrawal by Subject|1|||
13109733|NCT03226392|25897470|FG000|Overall Study|Protocol Deviation|1|||
13109734|NCT03226392|25897471|FG001|Overall Study|Protocol Deviation|0|||
13109735|NCT03226392|25897470|FG000|Overall Study|Physician Decision|1|||
13109736|NCT03226392|25897471|FG001|Overall Study|Physician Decision|0|||
13181758|NCT02207244|26156210|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1|||
13181759|NCT02207244|26156211|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2|||
13181760|NCT02207244|26156212|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
13181761|NCT02207244|26156213|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
13181762|NCT02207244|26156214|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
13181763|NCT02207244|26156215|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
13181764|NCT02207244|26156216|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
13181765|NCT02207244|26156217|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
13181766|NCT02207244|26156218|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
13181767|NCT02207244|26156219|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
13181768|NCT02207244|26156209|FG000|Placebo Controlled Period: Week 0-16|OTHER|0|||
13181769|NCT02207244|26156210|FG001|Placebo Controlled Period: Week 0-16|OTHER|1|||
13181770|NCT02207244|26156211|FG002|Placebo Controlled Period: Week 0-16|OTHER|0|||
13181771|NCT02207244|26156212|FG003|Placebo Controlled Period: Week 0-16|OTHER|0|||
13181772|NCT02207244|26156213|FG004|Placebo Controlled Period: Week 0-16|OTHER|0|||
13181773|NCT02207244|26156214|FG005|Placebo Controlled Period: Week 0-16|OTHER|0|||
13181774|NCT02207244|26156215|FG006|Placebo Controlled Period: Week 0-16|OTHER|0|||
13181775|NCT02207244|26156216|FG007|Placebo Controlled Period: Week 0-16|OTHER|0|||
13181776|NCT02207244|26156217|FG008|Placebo Controlled Period: Week 0-16|OTHER|0|||
13181777|NCT02207244|26156218|FG009|Placebo Controlled Period: Week 0-16|OTHER|0|||
13181778|NCT02207244|26156219|FG010|Placebo Controlled Period: Week 0-16|OTHER|0|||
13181779|NCT02207244|26156209|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
13181780|NCT02207244|26156210|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
13181781|NCT02207244|26156211|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
13181782|NCT02207244|26156212|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
13181783|NCT02207244|26156213|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3|||
13181784|NCT02207244|26156214|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2|||
13181785|NCT02207244|26156215|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
13181786|NCT02207244|26156216|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
13181787|NCT02207244|26156217|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
13181788|NCT02207244|26156218|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
13181789|NCT02207244|26156219|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
13181790|NCT02207244|26156209|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
13181791|NCT02207244|26156210|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
13181792|NCT02207244|26156211|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
13181793|NCT02207244|26156212|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
13181794|NCT02207244|26156213|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
13181795|NCT02207244|26156214|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2|||
13181796|NCT02207244|26156215|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
13181797|NCT02207244|26156216|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
13181798|NCT02207244|26156217|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
13181799|NCT02207244|26156218|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
13181800|NCT02207244|26156219|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
13181801|NCT02207244|26156209|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
13181802|NCT02207244|26156210|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
13181803|NCT02207244|26156211|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
13181804|NCT02207244|26156212|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1|||
13181805|NCT02207244|26156213|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
13181806|NCT02207244|26156214|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
13181807|NCT02207244|26156215|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
13181808|NCT02207244|26156216|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
13181809|NCT02207244|26156217|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
13181810|NCT02207244|26156218|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
13181811|NCT02207244|26156219|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
13181812|NCT02207244|26156209|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
13181813|NCT02207244|26156210|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
13109737|NCT03226392|25897470|FG000|Overall Study|Lost to Follow-up|1|||
13109738|NCT03226392|25897471|FG001|Overall Study|Lost to Follow-up|0|||
13109739|NCT03226392|25897470|FG000|Overall Study|Adverse Event|1|||
13109740|NCT03226392|25897471|FG001|Overall Study|Adverse Event|0|||
13181814|NCT02207244|26156211|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
13181815|NCT02207244|26156212|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
13181816|NCT02207244|26156213|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
13181817|NCT02207244|26156214|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2|||
13181818|NCT02207244|26156215|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
13181819|NCT02207244|26156216|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
13181820|NCT02207244|26156217|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
13181821|NCT02207244|26156218|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
13181822|NCT02207244|26156219|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
13181823|NCT02207244|26156209|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
13181824|NCT02207244|26156210|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
13181825|NCT02207244|26156211|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
13181826|NCT02207244|26156212|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
13181827|NCT02207244|26156213|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
13181828|NCT02207244|26156214|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
13181829|NCT02207244|26156215|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
13181830|NCT02207244|26156216|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
13181831|NCT02207244|26156217|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
13181832|NCT02207244|26156218|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
13181833|NCT02207244|26156219|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
13181834|NCT02207244|26156209|FG000|Placebo Crossover and ACP: Week 16-28|Other|0|||
13181835|NCT02207244|26156210|FG001|Placebo Crossover and ACP: Week 16-28|Other|0|||
13181836|NCT02207244|26156211|FG002|Placebo Crossover and ACP: Week 16-28|Other|0|||
13181837|NCT02207244|26156212|FG003|Placebo Crossover and ACP: Week 16-28|Other|1|||
13181838|NCT02207244|26156213|FG004|Placebo Crossover and ACP: Week 16-28|Other|0|||
13181839|NCT02207244|26156214|FG005|Placebo Crossover and ACP: Week 16-28|Other|0|||
13181840|NCT02207244|26156215|FG006|Placebo Crossover and ACP: Week 16-28|Other|0|||
13181841|NCT02207244|26156216|FG007|Placebo Crossover and ACP: Week 16-28|Other|0|||
13181842|NCT02207244|26156217|FG008|Placebo Crossover and ACP: Week 16-28|Other|0|||
13181843|NCT02207244|26156218|FG009|Placebo Crossover and ACP: Week 16-28|Other|0|||
13181844|NCT02207244|26156219|FG010|Placebo Crossover and ACP: Week 16-28|Other|0|||
13181845|NCT02207244|26156209|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
13181846|NCT02207244|26156210|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
13181847|NCT02207244|26156211|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
13181848|NCT02207244|26156212|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
13181849|NCT02207244|26156213|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
13181850|NCT02207244|26156214|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
13181851|NCT02207244|26156215|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1|||
13181852|NCT02207244|26156216|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5|||
13181853|NCT02207244|26156217|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3|||
13181854|NCT02207244|26156218|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2|||
13109741|NCT03226392|25897470|FG000|Overall Study|Technical Problems|0|||
13181855|NCT02207244|26156219|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
13181856|NCT02207244|26156209|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
13181857|NCT02207244|26156210|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
13181858|NCT02207244|26156211|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
13181859|NCT02207244|26156212|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
13181860|NCT02207244|26156213|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
13181861|NCT02207244|26156214|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
13181862|NCT02207244|26156215|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
13181863|NCT02207244|26156216|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2|||
13181864|NCT02207244|26156217|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
13181865|NCT02207244|26156218|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
13181866|NCT02207244|26156219|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
13109742|NCT03226392|25897471|FG001|Overall Study|Technical Problems|2|||
13109743|NCT03226392|25897470|FG000|Overall Study|Subject/Guardian Decision|7|||
13109744|NCT03226392|25897471|FG001|Overall Study|Subject/Guardian Decision|6|||
13109745|NCT03226353|25897493|FG000|Overall Study|Withdrawal by Subject|1|||
13109746|NCT03226353|25897493|FG000|Overall Study|Screen Failure|5|||
13109747|NCT03226275|25897552|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
13109748|NCT03226275|25897553|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
13109749|NCT03226275|25897554|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1|||
13109750|NCT03226275|25897555|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
13109751|NCT03226275|25897552|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
13109752|NCT03226275|25897553|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
13109753|NCT03226275|25897554|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
13181867|NCT02207244|26156209|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
13181868|NCT02207244|26156210|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
13181869|NCT02207244|26156211|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
13181870|NCT02207244|26156212|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
13181871|NCT02207244|26156213|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
13181872|NCT02207244|26156214|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
13181873|NCT02207244|26156215|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1|||
13181874|NCT02207244|26156216|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3|||
13181875|NCT02207244|26156217|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
13181876|NCT02207244|26156218|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
13109754|NCT03226275|25897555|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1|||
13181877|NCT02207244|26156219|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
13181878|NCT02207244|26156209|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
13181879|NCT02207244|26156210|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
13181880|NCT02207244|26156211|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
13181881|NCT02207244|26156212|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
13181882|NCT02207244|26156213|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
13181883|NCT02207244|26156214|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
13181884|NCT02207244|26156215|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
13133212|NCT02777125|25986933|FG001|Overall Study|Assent form violation|23|||
13133213|NCT02777125|25986932|FG000|Overall Study|Protocol Violation|8|||
13133214|NCT02777125|25986933|FG001|Overall Study|Protocol Violation|12|||
13181885|NCT02207244|26156216|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7|||
13181886|NCT02207244|26156217|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
13181887|NCT02207244|26156218|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
13181888|NCT02207244|26156219|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
13181889|NCT02207244|26156209|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
13181890|NCT02207244|26156210|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
13181891|NCT02207244|26156211|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
13181892|NCT02207244|26156212|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
13181893|NCT02207244|26156213|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
13181894|NCT02207244|26156214|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
13181895|NCT02207244|26156215|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
13181896|NCT02207244|26156216|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7|||
13181897|NCT02207244|26156217|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
13181898|NCT02207244|26156218|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
13181899|NCT02207244|26156219|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
13181900|NCT02207244|26156209|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
13181901|NCT02207244|26156210|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
13181902|NCT02207244|26156211|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
13181903|NCT02207244|26156212|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
13181904|NCT02207244|26156213|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
13181905|NCT02207244|26156214|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
13181906|NCT02207244|26156215|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
13181907|NCT02207244|26156216|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
13181908|NCT02207244|26156217|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
13181909|NCT02207244|26156218|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
13181910|NCT02207244|26156219|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
13181911|NCT02207244|26156209|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
13181912|NCT02207244|26156210|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
13181913|NCT02207244|26156211|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
13181914|NCT02207244|26156212|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
13181915|NCT02207244|26156213|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
13181916|NCT02207244|26156214|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
13181917|NCT02207244|26156215|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
13181918|NCT02207244|26156216|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
13181919|NCT02207244|26156217|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1|||
13181920|NCT02207244|26156218|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
13133215|NCT02777086|25986952|FG000|Overall Study|Lost to Follow-up|96|||
13133216|NCT02777086|25986953|FG001|Overall Study|Lost to Follow-up|99|||
13133217|NCT02776683|25986965|FG000|Pre-switch Period|Protocol Violation|1|||
13133218|NCT02776683|25986966|FG001|Pre-switch Period|Protocol Violation|0|||
13133219|NCT02776683|25986965|FG000|Pre-switch Period|Adverse Event|21|||
13133220|NCT02776683|25986966|FG001|Pre-switch Period|Adverse Event|0|||
13133221|NCT02776683|25986965|FG000|Pre-switch Period|Withdrawal by Subject|9|||
13181921|NCT02207244|26156219|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
13181922|NCT02207244|26156209|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0|||
13181923|NCT02207244|26156210|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0|||
13181924|NCT02207244|26156211|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0|||
13181925|NCT02207244|26156212|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0|||
13181926|NCT02207244|26156213|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0|||
13181927|NCT02207244|26156214|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0|||
13109755|NCT03226249|25897563|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1|||
13109756|NCT03226249|25897563|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29|||
13181928|NCT02207244|26156215|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0|||
13181929|NCT02207244|26156216|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2|||
13181930|NCT02207244|26156217|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0|||
13181931|NCT02207244|26156218|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0|||
13181932|NCT02207244|26156219|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0|||
13181933|NCT02207244|26156209|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
13181934|NCT02207244|26156210|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
13181935|NCT02207244|26156211|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
13181936|NCT02207244|26156212|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
13181937|NCT02207244|26156213|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
13181938|NCT02207244|26156214|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
13181939|NCT02207244|26156215|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8|||
13181940|NCT02207244|26156216|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
13181941|NCT02207244|26156217|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
13181942|NCT02207244|26156218|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
13181943|NCT02207244|26156219|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
13181944|NCT02207244|26156209|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
13181945|NCT02207244|26156210|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
13181946|NCT02207244|26156211|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
13181947|NCT02207244|26156212|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
13181948|NCT02207244|26156213|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
13181949|NCT02207244|26156214|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
13181950|NCT02207244|26156215|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
13181951|NCT02207244|26156216|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
13181952|NCT02207244|26156217|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10|||
13181953|NCT02207244|26156218|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
13181954|NCT02207244|26156219|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30|||
13181955|NCT02207244|26156209|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
13181956|NCT02207244|26156210|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
13181957|NCT02207244|26156211|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
13181958|NCT02207244|26156212|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
13181959|NCT02207244|26156213|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
13181960|NCT02207244|26156214|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
13181961|NCT02207244|26156215|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
13181962|NCT02207244|26156216|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
13181963|NCT02207244|26156217|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2|||
13181964|NCT02207244|26156218|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
13181965|NCT02207244|26156219|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3|||
13181966|NCT02207244|26156209|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
13181967|NCT02207244|26156210|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
13181968|NCT02207244|26156211|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
13181969|NCT02207244|26156212|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
13181970|NCT02207244|26156213|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
13181971|NCT02207244|26156214|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
13181972|NCT02207244|26156215|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
13181973|NCT02207244|26156216|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
13181974|NCT02207244|26156217|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5|||
13181975|NCT02207244|26156218|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
13181976|NCT02207244|26156219|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26|||
13109757|NCT03226249|25897563|FG000|Survival Follow-up|Patients still in follow-up.|30|||
13109758|NCT03225833|25897646|FG000|Overall Study|Adverse Event|0|||
13109759|NCT03225833|25897647|FG001|Overall Study|Adverse Event|1|||
13109760|NCT03225833|25897648|FG002|Overall Study|Adverse Event|2|||
13109761|NCT03225833|25897649|FG003|Overall Study|Adverse Event|0|||
13109762|NCT03225833|25897650|FG004|Overall Study|Adverse Event|0|||
13181977|NCT02207244|26156209|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
13181978|NCT02207244|26156210|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
13181979|NCT02207244|26156211|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
13181980|NCT02207244|26156212|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
13181981|NCT02207244|26156213|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
13181982|NCT02207244|26156214|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
13181983|NCT02207244|26156215|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
13181984|NCT02207244|26156216|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
13181985|NCT02207244|26156217|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12|||
13181986|NCT02207244|26156218|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
13181987|NCT02207244|26156219|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21|||
13181988|NCT02207244|26156209|FG000|Open-label Guselkumab: Week 72-264|Death|0|||
13181989|NCT02207244|26156210|FG001|Open-label Guselkumab: Week 72-264|Death|0|||
13181990|NCT02207244|26156211|FG002|Open-label Guselkumab: Week 72-264|Death|0|||
13181991|NCT02207244|26156212|FG003|Open-label Guselkumab: Week 72-264|Death|0|||
13181992|NCT02207244|26156213|FG004|Open-label Guselkumab: Week 72-264|Death|0|||
13181993|NCT02207244|26156214|FG005|Open-label Guselkumab: Week 72-264|Death|0|||
13181994|NCT02207244|26156215|FG006|Open-label Guselkumab: Week 72-264|Death|0|||
13181995|NCT02207244|26156216|FG007|Open-label Guselkumab: Week 72-264|Death|0|||
13181996|NCT02207244|26156217|FG008|Open-label Guselkumab: Week 72-264|Death|1|||
13181997|NCT02207244|26156218|FG009|Open-label Guselkumab: Week 72-264|Death|0|||
13181998|NCT02207244|26156219|FG010|Open-label Guselkumab: Week 72-264|Death|1|||
13181999|NCT02207244|26156209|FG000|Open-label Guselkumab: Week 72-264|Other|0|||
13182000|NCT02207244|26156210|FG001|Open-label Guselkumab: Week 72-264|Other|0|||
13182001|NCT02207244|26156211|FG002|Open-label Guselkumab: Week 72-264|Other|0|||
13182002|NCT02207244|26156212|FG003|Open-label Guselkumab: Week 72-264|Other|0|||
13182003|NCT02207244|26156213|FG004|Open-label Guselkumab: Week 72-264|Other|0|||
13182004|NCT02207244|26156214|FG005|Open-label Guselkumab: Week 72-264|Other|0|||
13182005|NCT02207244|26156215|FG006|Open-label Guselkumab: Week 72-264|Other|0|||
13182006|NCT02207244|26156216|FG007|Open-label Guselkumab: Week 72-264|Other|0|||
13182007|NCT02207244|26156217|FG008|Open-label Guselkumab: Week 72-264|Other|8|||
13182008|NCT02207244|26156218|FG009|Open-label Guselkumab: Week 72-264|Other|0|||
13182009|NCT02207244|26156219|FG010|Open-label Guselkumab: Week 72-264|Other|19|||
13182010|NCT02207244|26156209|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
13182011|NCT02207244|26156210|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
13182012|NCT02207244|26156211|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
13182013|NCT02207244|26156212|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
13182014|NCT02207244|26156213|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
13182015|NCT02207244|26156214|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
13182016|NCT02207244|26156215|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
13182017|NCT02207244|26156216|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
13182018|NCT02207244|26156217|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
13182019|NCT02207244|26156218|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
13182020|NCT02207244|26156219|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2|||
13182021|NCT02207231|26156276|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
13182022|NCT02207231|26156277|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4|||
13182023|NCT02207231|26156278|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
13182024|NCT02207231|26156279|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0|||
13182025|NCT02207231|26156276|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2|||
13182026|NCT02207231|26156277|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
13182027|NCT02207231|26156278|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1|||
13182028|NCT02207231|26156279|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
13182029|NCT02207231|26156276|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
13182030|NCT02207231|26156277|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
13182031|NCT02207231|26156278|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
13182032|NCT02207231|26156279|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0|||
13182033|NCT02207231|26156276|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2|||
13182034|NCT02207231|26156277|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
13182035|NCT02207231|26156278|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4|||
13182036|NCT02207231|26156279|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
13182037|NCT02207231|26156276|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
13182038|NCT02207231|26156277|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
13182039|NCT02207231|26156278|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1|||
13182040|NCT02207231|26156279|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
13182041|NCT02207231|26156276|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
13182042|NCT02207231|26156277|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2|||
13182043|NCT02207231|26156278|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1|||
13182044|NCT02207231|26156279|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
13182045|NCT02207231|26156276|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1|||
13182046|NCT02207231|26156277|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6|||
13182047|NCT02207231|26156278|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10|||
13182048|NCT02207231|26156279|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0|||
13182049|NCT02207231|26156276|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
13182050|NCT02207231|26156277|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
13182051|NCT02207231|26156278|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1|||
13182052|NCT02207231|26156279|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
13182053|NCT02207231|26156276|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
13182054|NCT02207231|26156277|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3|||
13182055|NCT02207231|26156278|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11|||
13182056|NCT02207231|26156279|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
13182057|NCT02207231|26156276|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1|||
13182058|NCT02207231|26156277|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2|||
13182059|NCT02207231|26156278|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5|||
13182060|NCT02207231|26156279|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0|||
13182061|NCT02207231|26156276|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1|||
13182062|NCT02207231|26156277|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4|||
13182063|NCT02207231|26156278|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10|||
13182064|NCT02207231|26156279|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0|||
13182065|NCT02207231|26156276|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
13182066|NCT02207231|26156277|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1|||
13182067|NCT02207231|26156278|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
13182068|NCT02207231|26156279|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
13182069|NCT02207231|26156276|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
13182070|NCT02207231|26156277|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
13182071|NCT02207231|26156278|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
13182072|NCT02207231|26156279|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
13182073|NCT02207231|26156276|FG000|Active Controlled Period: Week 16 - 48|Other|0|||
13182074|NCT02207231|26156277|FG001|Active Controlled Period: Week 16 - 48|Other|2|||
13182075|NCT02207231|26156278|FG002|Active Controlled Period: Week 16 - 48|Other|3|||
13182076|NCT02207231|26156279|FG003|Active Controlled Period: Week 16 - 48|Other|0|||
13182077|NCT02207231|26156276|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
13182078|NCT02207231|26156277|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
13182079|NCT02207231|26156278|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12|||
13182080|NCT02207231|26156279|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19|||
13182081|NCT02207231|26156276|FG000|Open-label Guselkumab: Week 48 - 264|Death|0|||
13182082|NCT02207231|26156277|FG001|Open-label Guselkumab: Week 48 - 264|Death|0|||
13182083|NCT02207231|26156278|FG002|Open-label Guselkumab: Week 48 - 264|Death|1|||
13182084|NCT02207231|26156279|FG003|Open-label Guselkumab: Week 48 - 264|Death|3|||
13182085|NCT02207231|26156276|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
13182086|NCT02207231|26156277|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
13182087|NCT02207231|26156278|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3|||
13182088|NCT02207231|26156279|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7|||
13182089|NCT02207231|26156276|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
13182090|NCT02207231|26156277|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
13182091|NCT02207231|26156278|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2|||
13182092|NCT02207231|26156279|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4|||
13182093|NCT02207231|26156276|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
13182094|NCT02207231|26156277|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
13182095|NCT02207231|26156278|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6|||
13182096|NCT02207231|26156279|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11|||
13182097|NCT02207231|26156276|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
13182098|NCT02207231|26156277|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
13182099|NCT02207231|26156278|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10|||
13182100|NCT02207231|26156279|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28|||
13182101|NCT02207231|26156276|FG000|Open-label Guselkumab: Week 48 - 264|Other|0|||
13182102|NCT02207231|26156277|FG001|Open-label Guselkumab: Week 48 - 264|Other|0|||
13182103|NCT02207231|26156278|FG002|Open-label Guselkumab: Week 48 - 264|Other|4|||
13182104|NCT02207231|26156279|FG003|Open-label Guselkumab: Week 48 - 264|Other|11|||
13182105|NCT02207088|26156287|FG000|Overall Study|Adverse Event|2|||
13182106|NCT02206828|26156316|FG000|Overall Study|Lost to Follow-up|7|||
13182107|NCT02206685|26156331|FG000|Overall Study|Surgery cancelled/changed|2|||
13182108|NCT02206685|26156332|FG001|Overall Study|Surgery cancelled/changed|3|||
13182109|NCT02206685|26156331|FG000|Overall Study|Withdrawal by Subject|1|||
13182110|NCT02206685|26156332|FG001|Overall Study|Withdrawal by Subject|2|||
13182111|NCT02206685|26156331|FG000|Overall Study|Protocol Violation|2|||
13182112|NCT02206685|26156332|FG001|Overall Study|Protocol Violation|2|||
13182113|NCT02206620|26156351|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
13182114|NCT02206620|26156352|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
13182115|NCT02206620|26156351|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
13182116|NCT02206620|26156352|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2|||
13182117|NCT02206607|26156410|FG000|Open-Label Run-In|Withdrawal by Subject|3|||
13182118|NCT02206607|26156411|FG001|Open-Label Run-In|Withdrawal by Subject|0|||
13182119|NCT02206607|26156412|FG002|Open-Label Run-In|Withdrawal by Subject|0|||
13182120|NCT02206607|26156413|FG003|Open-Label Run-In|Withdrawal by Subject|0|||
13182121|NCT02206607|26156414|FG004|Open-Label Run-In|Withdrawal by Subject|0|||
13182122|NCT02206607|26156410|FG000|Second Intervention Period|Insufficient Clinical Response|0|||
13182123|NCT02206607|26156411|FG001|Second Intervention Period|Insufficient Clinical Response|0|||
13182124|NCT02206607|26156412|FG002|Second Intervention Period|Insufficient Clinical Response|0|||
13182125|NCT02206607|26156413|FG003|Second Intervention Period|Insufficient Clinical Response|1|||
13182126|NCT02206607|26156414|FG004|Second Intervention Period|Insufficient Clinical Response|0|||
13182127|NCT02206152|26156422|FG000|Pre-Randomization|Withdrawal by Subject|2|||
13182128|NCT02206061|26156440|FG000|Overall Study|Withdrawal by Subject|4|||
13182129|NCT02206061|26156441|FG001|Overall Study|Withdrawal by Subject|7|||
13182130|NCT02206061|26156442|FG002|Overall Study|Withdrawal by Subject|1|||
13182131|NCT02206061|26156440|FG000|Overall Study|Lost to Follow-up|14|||
13182132|NCT02206061|26156441|FG001|Overall Study|Lost to Follow-up|7|||
13182133|NCT02206061|26156442|FG002|Overall Study|Lost to Follow-up|20|||
13182134|NCT02206048|26156449|FG000|Overall Study|Change in OR schedule and availability of study staff|1|||
13182135|NCT02205814|26156484|FG000|Overall Study|Lost to Follow-up|0|||
13182136|NCT02205814|26156485|FG001|Overall Study|Lost to Follow-up|0|||
13182137|NCT02205814|26156486|FG002|Overall Study|Lost to Follow-up|0|||
13182138|NCT02205814|26156487|FG003|Overall Study|Lost to Follow-up|1|||
13182139|NCT02205814|26156484|FG000|Overall Study|Lack of Efficacy|1|||
13182140|NCT02205814|26156485|FG001|Overall Study|Lack of Efficacy|0|||
13182141|NCT02205814|26156486|FG002|Overall Study|Lack of Efficacy|1|||
13182142|NCT02205814|26156487|FG003|Overall Study|Lack of Efficacy|1|||
13182143|NCT02205814|26156484|FG000|Overall Study|Physician Decision|0|||
13182144|NCT02205814|26156485|FG001|Overall Study|Physician Decision|0|||
13182145|NCT02205814|26156486|FG002|Overall Study|Physician Decision|1|||
13182146|NCT02205814|26156487|FG003|Overall Study|Physician Decision|0|||
13182147|NCT02205814|26156484|FG000|Overall Study|Protocol Violation|1|||
13182148|NCT02205814|26156485|FG001|Overall Study|Protocol Violation|0|||
13182149|NCT02205814|26156486|FG002|Overall Study|Protocol Violation|0|||
13182150|NCT02205814|26156487|FG003|Overall Study|Protocol Violation|1|||
13182151|NCT02205814|26156484|FG000|Overall Study|Withdrawal by Subject|0|||
13182152|NCT02205814|26156485|FG001|Overall Study|Withdrawal by Subject|1|||
13182153|NCT02205814|26156486|FG002|Overall Study|Withdrawal by Subject|2|||
13182154|NCT02205814|26156487|FG003|Overall Study|Withdrawal by Subject|1|||
13182155|NCT02205814|26156484|FG000|Overall Study|not compliant with study procedures|0|||
13182156|NCT02205814|26156485|FG001|Overall Study|not compliant with study procedures|0|||
13182157|NCT02205814|26156486|FG002|Overall Study|not compliant with study procedures|1|||
13182158|NCT02205814|26156487|FG003|Overall Study|not compliant with study procedures|0|||
13182159|NCT02205476|26156524|FG000|Overall Study|Study termination by Sponsor|7|||
13182160|NCT02205476|26156525|FG001|Overall Study|Study termination by Sponsor|3|||
13206052|NCT01960348|26233392|FG000|Overall Study|Adverse event, serious non-fatal|0|||
13206053|NCT01960348|26233393|FG001|Overall Study|Adverse event, serious non-fatal|3|||
13206054|NCT01960348|26233392|FG000|Overall Study|Withdrawal by Subject|1|||
13206055|NCT01960348|26233393|FG001|Overall Study|Withdrawal by Subject|11|||
13206056|NCT01960348|26233392|FG000|Overall Study|Physician Decision|0|||
13206057|NCT01960348|26233393|FG001|Overall Study|Physician Decision|1|||
13206058|NCT01960348|26233392|FG000|Overall Study|Protocol Violation|1|||
13206059|NCT01960348|26233393|FG001|Overall Study|Protocol Violation|0|||
13206060|NCT01960296|26233420|FG000|Overall Study|Postponed surgery|1|||
13206061|NCT01960296|26233421|FG001|Overall Study|Postponed surgery|0|||
13206062|NCT01960296|26233420|FG000|Overall Study|Received different procedure|1|||
13206063|NCT01960296|26233421|FG001|Overall Study|Received different procedure|3|||
13206064|NCT01960257|26233435|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12|||
13206065|NCT01960257|26233436|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
13206066|NCT01960257|26233437|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
13206067|NCT01960257|26233435|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3|||
13206068|NCT01960257|26233436|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
13206069|NCT01960257|26233437|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
13206070|NCT01960257|26233435|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1|||
13206071|NCT01960257|26233436|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0|||
13206072|NCT01960257|26233437|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0|||
13206073|NCT01960140|26233448|FG000|Period 2 (Days 3-18)|Adverse Event|2|||
13206074|NCT01960114|26233469|FG000|Overall Study|Adverse Event|1|||
13206075|NCT01960114|26233470|FG001|Overall Study|Adverse Event|0|||
13206076|NCT01960114|26233469|FG000|Overall Study|Could not swallow study medication|0|||
13206077|NCT01960114|26233470|FG001|Overall Study|Could not swallow study medication|1|||
13182161|NCT02205333|26156726|FG000|Overall Study|Death|5|||
13182162|NCT02205333|26156727|FG001|Overall Study|Death|6|||
13182163|NCT02205333|26156728|FG002|Overall Study|Death|2|||
13182164|NCT02205333|26156729|FG003|Overall Study|Death|6|||
13182165|NCT02205333|26156730|FG004|Overall Study|Death|5|||
13182166|NCT02205333|26156731|FG005|Overall Study|Death|3|||
13182167|NCT02205333|26156732|FG006|Overall Study|Death|3|||
13182168|NCT02205333|26156733|FG007|Overall Study|Death|2|||
13182169|NCT02205333|26156734|FG008|Overall Study|Death|0|||
13182170|NCT02205333|26156726|FG000|Overall Study|Withdrawal by Subject|1|||
13182171|NCT02205333|26156727|FG001|Overall Study|Withdrawal by Subject|0|||
13182172|NCT02205333|26156728|FG002|Overall Study|Withdrawal by Subject|0|||
13182173|NCT02205333|26156729|FG003|Overall Study|Withdrawal by Subject|1|||
13182174|NCT02205333|26156730|FG004|Overall Study|Withdrawal by Subject|0|||
13182175|NCT02205333|26156731|FG005|Overall Study|Withdrawal by Subject|0|||
13182176|NCT02205333|26156732|FG006|Overall Study|Withdrawal by Subject|2|||
13182177|NCT02205333|26156733|FG007|Overall Study|Withdrawal by Subject|0|||
13182178|NCT02205333|26156734|FG008|Overall Study|Withdrawal by Subject|0|||
13182179|NCT02204982|26156749|FG000|Overall Study|Patient ineligible-medical monitor|1|||
13182180|NCT02204982|26156750|FG001|Overall Study|Patient ineligible-medical monitor|0|||
13182181|NCT02204982|26156749|FG000|Overall Study|Withdrawal by Subject|1|||
13182182|NCT02204982|26156750|FG001|Overall Study|Withdrawal by Subject|0|||
13182183|NCT02204982|26156749|FG000|Overall Study|Adverse Event|1|||
13182184|NCT02204982|26156750|FG001|Overall Study|Adverse Event|0|||
13182185|NCT02204982|26156749|FG000|Overall Study|Adverse Event and Investigator decision|1|||
13182186|NCT02204982|26156750|FG001|Overall Study|Adverse Event and Investigator decision|0|||
13182187|NCT02204982|26156749|FG000|Overall Study|Physician Decision|0|||
13182188|NCT02204982|26156750|FG001|Overall Study|Physician Decision|2|||
13182189|NCT02204982|26156749|FG000|Overall Study|Protocol-Specified Disease Progression|0|||
13182190|NCT02204982|26156750|FG001|Overall Study|Protocol-Specified Disease Progression|4|||
13182191|NCT02204982|26156749|FG000|Overall Study|Termination of Study bySponsor|0|||
13182192|NCT02204982|26156750|FG001|Overall Study|Termination of Study bySponsor|1|||
13182193|NCT02204917|26156759|FG000|Overall Study|Protocol Violation|1|||
13182194|NCT02204579|26156813|FG000|Overall Study|Screen failures|2|||
13182195|NCT02204449|26156830|FG000|Overall Study|Lost to Follow-up|7|||
13182196|NCT02204449|26156831|FG001|Overall Study|Lost to Follow-up|9|||
13182197|NCT02204449|26156830|FG000|Overall Study|Death|0|||
13182198|NCT02204449|26156831|FG001|Overall Study|Death|1|||
13182199|NCT02204449|26156830|FG000|Overall Study|Withdrawal by Subject|0|||
13182200|NCT02204449|26156831|FG001|Overall Study|Withdrawal by Subject|1|||
13182201|NCT02204410|26156838|FG000|Overall Study|Lost to Follow-up|5|||
13182202|NCT02204410|26156838|FG000|Overall Study|Physician Decision|2|||
13182203|NCT02204410|26156838|FG000|Overall Study|Protocol Violation|1|||
13182204|NCT02204410|26156838|FG000|Overall Study|Withdrawal by Subject|3|||
13182205|NCT02204371|26156863|FG000|Overall Study|Adverse Event|1|||
13182206|NCT02204319|26156871|FG000|Overall Study|Pregnancy|1|||
13182207|NCT02204319|26156871|FG000|Overall Study|Withdrawal by Subject|2|||
13182208|NCT02204293|26156948|FG000|Core Study Part I|Met one or more exclusion criteria|1|||
13182209|NCT02204293|26156949|FG001|Core Study Part I|Met one or more exclusion criteria|0|||
13182210|NCT02204293|26156950|FG002|Core Study Part I|Met one or more exclusion criteria|0|||
13182211|NCT02204293|26156951|FG003|Core Study Part I|Met one or more exclusion criteria|0|||
13182212|NCT02204293|26156952|FG004|Core Study Part I|Met one or more exclusion criteria|0|||
13182213|NCT02204293|26156953|FG005|Core Study Part I|Met one or more exclusion criteria|0|||
13182214|NCT02204293|26156948|FG000|Core Study Part I|Adverse Event|1|||
13182215|NCT02204293|26156949|FG001|Core Study Part I|Adverse Event|0|||
13182216|NCT02204293|26156950|FG002|Core Study Part I|Adverse Event|0|||
13182217|NCT02204293|26156951|FG003|Core Study Part I|Adverse Event|0|||
13182218|NCT02204293|26156952|FG004|Core Study Part I|Adverse Event|0|||
13182219|NCT02204293|26156953|FG005|Core Study Part I|Adverse Event|0|||
13182220|NCT02204293|26156948|FG000|Core Study Part I|Physician Decision|0|||
13182221|NCT02204293|26156949|FG001|Core Study Part I|Physician Decision|3|||
13182222|NCT02204293|26156950|FG002|Core Study Part I|Physician Decision|0|||
13182223|NCT02204293|26156951|FG003|Core Study Part I|Physician Decision|0|||
13182224|NCT02204293|26156952|FG004|Core Study Part I|Physician Decision|0|||
13182225|NCT02204293|26156953|FG005|Core Study Part I|Physician Decision|0|||
13182226|NCT02204293|26156948|FG000|LTE Phase|Study Suspended|0|||
13182227|NCT02204293|26156949|FG001|LTE Phase|Study Suspended|0|||
13182228|NCT02204293|26156950|FG002|LTE Phase|Study Suspended|0|||
13182229|NCT02204293|26156951|FG003|LTE Phase|Study Suspended|0|||
13182230|NCT02204293|26156952|FG004|LTE Phase|Study Suspended|0|||
13182231|NCT02204293|26156953|FG005|LTE Phase|Study Suspended|7|||
13182232|NCT02204007|26156968|FG000|Overall Study|Surgery Canceled|1|||
13182233|NCT02204007|26156969|FG001|Overall Study|Surgery Canceled|1|||
13182234|NCT02203916|26156999|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
13182235|NCT02203916|26157000|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
13182236|NCT02203916|26157001|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
13182237|NCT02203916|26156999|FG000|Overall Study|Major Protocol Deviation|1|||
13182238|NCT02203916|26157000|FG001|Overall Study|Major Protocol Deviation|1|||
13182239|NCT02203916|26157001|FG002|Overall Study|Major Protocol Deviation|0|||
13182240|NCT02203916|26156999|FG000|Overall Study|Lost to Follow-up|0|||
13182241|NCT02203916|26157000|FG001|Overall Study|Lost to Follow-up|1|||
13182242|NCT02203916|26157001|FG002|Overall Study|Lost to Follow-up|0|||
13182243|NCT02203916|26156999|FG000|Overall Study|Voluntary Withdrawal|3|||
13182244|NCT02203916|26157000|FG001|Overall Study|Voluntary Withdrawal|3|||
13182245|NCT02203916|26157001|FG002|Overall Study|Voluntary Withdrawal|8|||
13182246|NCT02203916|26156999|FG000|Overall Study|Lack of Efficacy|3|||
13182247|NCT02203916|26157000|FG001|Overall Study|Lack of Efficacy|0|||
13182248|NCT02203916|26157001|FG002|Overall Study|Lack of Efficacy|0|||
13182249|NCT02203916|26156999|FG000|Overall Study|Reason Not Specified|0|||
13182250|NCT02203916|26157000|FG001|Overall Study|Reason Not Specified|2|||
13182251|NCT02203916|26157001|FG002|Overall Study|Reason Not Specified|1|||
13182252|NCT02203851|26157037|FG000|Overall Study|Lost to Follow-up|4|||
13182253|NCT02203851|26157037|FG000|Overall Study|Withdrawal by Subject|6|||
13182254|NCT02203851|26157037|FG000|Overall Study|Other|1|||
13182255|NCT02203838|26157080|FG000|Overall Study|Lack of Efficacy|7|||
13182256|NCT02203838|26157081|FG001|Overall Study|Lack of Efficacy|0|||
13182257|NCT02203838|26157082|FG002|Overall Study|Lack of Efficacy|1|||
13109763|NCT03225833|25897651|FG005|Overall Study|Adverse Event|2|||
13109764|NCT03225833|25897646|FG000|Overall Study|Withdrawal by Subject|1|||
13109765|NCT03225833|25897647|FG001|Overall Study|Withdrawal by Subject|0|||
13109766|NCT03225833|25897648|FG002|Overall Study|Withdrawal by Subject|0|||
13109767|NCT03225833|25897649|FG003|Overall Study|Withdrawal by Subject|0|||
13109768|NCT03225833|25897650|FG004|Overall Study|Withdrawal by Subject|1|||
13109769|NCT03225833|25897651|FG005|Overall Study|Withdrawal by Subject|0|||
13109770|NCT03225833|25897646|FG000|Overall Study|Termination of Study by Sponsor|4|||
13109771|NCT03225833|25897647|FG001|Overall Study|Termination of Study by Sponsor|0|||
13109772|NCT03225833|25897648|FG002|Overall Study|Termination of Study by Sponsor|0|||
13109773|NCT03225833|25897649|FG003|Overall Study|Termination of Study by Sponsor|0|||
13109774|NCT03225833|25897650|FG004|Overall Study|Termination of Study by Sponsor|0|||
13109775|NCT03225833|25897651|FG005|Overall Study|Termination of Study by Sponsor|7|||
13109776|NCT03225833|25897646|FG000|Overall Study|Sponsor Decision|0|||
13109777|NCT03225833|25897647|FG001|Overall Study|Sponsor Decision|0|||
13109778|NCT03225833|25897648|FG002|Overall Study|Sponsor Decision|0|||
13109779|NCT03225833|25897649|FG003|Overall Study|Sponsor Decision|0|||
13109780|NCT03225833|25897650|FG004|Overall Study|Sponsor Decision|0|||
13109781|NCT03225833|25897651|FG005|Overall Study|Sponsor Decision|1|||
13109782|NCT03224598|25897669|FG000|Overall Study|Lost to Follow-up|0|||
13109783|NCT03224598|25897670|FG001|Overall Study|Lost to Follow-up|2|||
13109784|NCT03224598|25897671|FG002|Overall Study|Lost to Follow-up|0|||
13109785|NCT03224598|25897669|FG000|Overall Study|Other|0|||
13109786|NCT03224598|25897670|FG001|Overall Study|Other|1|||
13109787|NCT03224598|25897671|FG002|Overall Study|Other|0|||
13109788|NCT03224325|25897754|FG000|Overall Study|Adverse Event|1|||
13109789|NCT03224325|25897755|FG001|Overall Study|Adverse Event|0|||
13109790|NCT03224325|25897756|FG002|Overall Study|Adverse Event|0|||
13109791|NCT03224325|25897757|FG003|Overall Study|Adverse Event|0|||
13109792|NCT03224325|25897758|FG004|Overall Study|Adverse Event|0|||
13109793|NCT03224325|25897759|FG005|Overall Study|Adverse Event|0|||
13109794|NCT03224325|25897760|FG006|Overall Study|Adverse Event|1|||
13109795|NCT03224325|25897754|FG000|Overall Study|Withdrawal by Subject|0|||
13109796|NCT03224325|25897755|FG001|Overall Study|Withdrawal by Subject|0|||
13109797|NCT03224325|25897756|FG002|Overall Study|Withdrawal by Subject|0|||
13109798|NCT03224325|25897757|FG003|Overall Study|Withdrawal by Subject|1|||
13109799|NCT03224325|25897758|FG004|Overall Study|Withdrawal by Subject|0|||
13109800|NCT03224325|25897759|FG005|Overall Study|Withdrawal by Subject|0|||
13109801|NCT03224325|25897760|FG006|Overall Study|Withdrawal by Subject|0|||
13109802|NCT03224234|25897817|FG000|Main Study|Lost to Follow-up|5|||
13109803|NCT03224234|25897818|FG001|Main Study|Lost to Follow-up|5|||
13109804|NCT03224182|25897837|FG000|Overall Study|Study Drug Not Instilled|6|||
13109805|NCT03224182|25897838|FG001|Overall Study|Study Drug Not Instilled|1|||
13109806|NCT03224182|25897837|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22|||
13109807|NCT03224182|25897838|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11|||
13109808|NCT03224182|25897837|FG000|Overall Study|Withdrew of Consent|4|||
13109809|NCT03224182|25897838|FG001|Overall Study|Withdrew of Consent|2|||
13109810|NCT03224182|25897837|FG000|Overall Study|Investigator Decision|3|||
13109811|NCT03224182|25897838|FG001|Overall Study|Investigator Decision|1|||
13109812|NCT03224182|25897837|FG000|Overall Study|Sponsor Decision|26|||
13109813|NCT03224182|25897838|FG001|Overall Study|Sponsor Decision|12|||
13109814|NCT03224182|25897837|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4|||
13109815|NCT03224182|25897838|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0|||
13109816|NCT03224182|25897837|FG000|Overall Study|Lost to Follow-up|1|||
13109817|NCT03224182|25897838|FG001|Overall Study|Lost to Follow-up|0|||
13182258|NCT02203838|26157083|FG003|Overall Study|Lack of Efficacy|1|||
13182259|NCT02203838|26157080|FG000|Overall Study|Adverse Event|46|||
13109818|NCT03224182|25897837|FG000|Overall Study|Participant Had Recurrence|11|||
13109819|NCT03224182|25897838|FG001|Overall Study|Participant Had Recurrence|5|||
13109820|NCT03224182|25897837|FG000|Overall Study|Death|0|||
13182260|NCT02203838|26157081|FG001|Overall Study|Adverse Event|6|||
13182261|NCT02203838|26157082|FG002|Overall Study|Adverse Event|3|||
13182262|NCT02203838|26157083|FG003|Overall Study|Adverse Event|2|||
13182263|NCT02203838|26157080|FG000|Overall Study|Lost to Follow-up|39|||
13182264|NCT02203838|26157081|FG001|Overall Study|Lost to Follow-up|3|||
13182265|NCT02203838|26157082|FG002|Overall Study|Lost to Follow-up|2|||
13182266|NCT02203838|26157083|FG003|Overall Study|Lost to Follow-up|1|||
13182267|NCT02203838|26157080|FG000|Overall Study|Protocol Violation|7|||
13182268|NCT02203838|26157081|FG001|Overall Study|Protocol Violation|3|||
13182269|NCT02203838|26157082|FG002|Overall Study|Protocol Violation|0|||
13182270|NCT02203838|26157083|FG003|Overall Study|Protocol Violation|0|||
13182271|NCT02203838|26157080|FG000|Overall Study|Withdrawal by Subject|83|||
13182272|NCT02203838|26157081|FG001|Overall Study|Withdrawal by Subject|10|||
13182273|NCT02203838|26157082|FG002|Overall Study|Withdrawal by Subject|8|||
13182274|NCT02203838|26157083|FG003|Overall Study|Withdrawal by Subject|11|||
13182275|NCT02203838|26157080|FG000|Overall Study|Physician Decision|27|||
13182276|NCT02203838|26157081|FG001|Overall Study|Physician Decision|0|||
13182277|NCT02203838|26157082|FG002|Overall Study|Physician Decision|2|||
13182278|NCT02203838|26157083|FG003|Overall Study|Physician Decision|3|||
13182279|NCT02203838|26157080|FG000|Overall Study|Other|1|||
13182280|NCT02203838|26157081|FG001|Overall Study|Other|0|||
13182281|NCT02203838|26157082|FG002|Overall Study|Other|0|||
13182282|NCT02203838|26157083|FG003|Overall Study|Other|0|||
13182283|NCT02203721|26157098|FG000|Overall Study|Lost to Follow-up|1|||
13182284|NCT02203721|26157099|FG001|Overall Study|Lost to Follow-up|0|||
13182285|NCT02203721|26157098|FG000|Overall Study|Death|0|||
13182286|NCT02203721|26157099|FG001|Overall Study|Death|2|||
13182287|NCT02203721|26157098|FG000|Overall Study|Illness|0|||
13182288|NCT02203721|26157099|FG001|Overall Study|Illness|1|||
13182289|NCT02203591|26157209|FG000|Overall Study|Did not meet treatment day baseline|147|||
13182290|NCT02203591|26157210|FG001|Overall Study|Did not meet treatment day baseline|141|||
13182291|NCT02203591|26157211|FG002|Overall Study|Did not meet treatment day baseline|150|||
13182292|NCT02203591|26157212|FG003|Overall Study|Did not meet treatment day baseline|45|||
13182293|NCT02203591|26157213|FG004|Overall Study|Did not meet treatment day baseline|33|||
13182294|NCT02203591|26157214|FG005|Overall Study|Did not meet treatment day baseline|35|||
13182295|NCT02203591|26157215|FG006|Overall Study|Did not meet treatment day baseline|29|||
13182296|NCT02203591|26157216|FG007|Overall Study|Did not meet treatment day baseline|12|||
13182297|NCT02203591|26157209|FG000|Overall Study|Discontinued early due to compromised test sites|0|||
13182298|NCT02203591|26157210|FG001|Overall Study|Discontinued early due to compromised test sites|1|||
13182299|NCT02203591|26157211|FG002|Overall Study|Discontinued early due to compromised test sites|1|||
13182300|NCT02203591|26157212|FG003|Overall Study|Discontinued early due to compromised test sites|0|||
13182301|NCT02203591|26157213|FG004|Overall Study|Discontinued early due to compromised test sites|1|||
13182302|NCT02203591|26157214|FG005|Overall Study|Discontinued early due to compromised test sites|0|||
13182303|NCT02203591|26157215|FG006|Overall Study|Discontinued early due to compromised test sites|0|||
13182304|NCT02203591|26157216|FG007|Overall Study|Discontinued early due to compromised test sites|1|||
13182305|NCT02203513|26157249|FG000|Overall Study|Refused further treatment|2|||
13182306|NCT02203513|26157250|FG001|Overall Study|Refused further treatment|0|||
13182307|NCT02203513|26157251|FG002|Overall Study|Refused further treatment|1|||
13182308|NCT02203513|26157252|FG003|Overall Study|Refused further treatment|0|||
13182309|NCT02203513|26157253|FG004|Overall Study|Refused further treatment|0|||
13182310|NCT02203513|26157249|FG000|Overall Study|Switched to alternative treatment|3|||
13182311|NCT02203513|26157250|FG001|Overall Study|Switched to alternative treatment|4|||
13182312|NCT02203513|26157251|FG002|Overall Study|Switched to alternative treatment|0|||
13182313|NCT02203513|26157252|FG003|Overall Study|Switched to alternative treatment|0|||
13182314|NCT02203513|26157253|FG004|Overall Study|Switched to alternative treatment|4|||
13182315|NCT02203513|26157249|FG000|Overall Study|Did not receive investigational product (IP)|0|||
13182316|NCT02203513|26157250|FG001|Overall Study|Did not receive investigational product (IP)|1|||
13109821|NCT03224182|25897838|FG001|Overall Study|Death|1|||
13109822|NCT03224182|25897837|FG000|Overall Study|Reason not Specified|3|||
13109823|NCT03224182|25897838|FG001|Overall Study|Reason not Specified|3|||
13109824|NCT03224182|25897837|FG000|Overall Study|Other|1|||
13109825|NCT03224182|25897838|FG001|Overall Study|Other|0|||
13109826|NCT03224130|25897863|FG000|Overall Study|consent issue|0|||
13109827|NCT03224130|25897864|FG001|Overall Study|consent issue|1|||
13109828|NCT03223909|25897903|FG000|Overall Study|Protocol Violation|48|||
13109829|NCT03223909|25897904|FG001|Overall Study|Protocol Violation|45|||
13109830|NCT03223909|25897905|FG002|Overall Study|Protocol Violation|16|||
13109831|NCT03223662|25897917|FG000|Overall Study|Physician Decision|1|||
13109832|NCT03223662|25897917|FG000|Overall Study|Study closure|1|||
13109833|NCT03222973|25897968|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3|||
13109834|NCT03222973|25897969|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
13182317|NCT02203513|26157251|FG002|Overall Study|Did not receive investigational product (IP)|0|||
13182318|NCT02203513|26157252|FG003|Overall Study|Did not receive investigational product (IP)|0|||
13182319|NCT02203513|26157253|FG004|Overall Study|Did not receive investigational product (IP)|0|||
13182320|NCT02203513|26157249|FG000|Overall Study|Death (unrelated to study therapy)|1|||
13182321|NCT02203513|26157250|FG001|Overall Study|Death (unrelated to study therapy)|3|||
13182322|NCT02203513|26157251|FG002|Overall Study|Death (unrelated to study therapy)|1|||
13182323|NCT02203513|26157252|FG003|Overall Study|Death (unrelated to study therapy)|0|||
13182324|NCT02203513|26157253|FG004|Overall Study|Death (unrelated to study therapy)|2|||
13182325|NCT02203513|26157249|FG000|Overall Study|Lost to Follow-up|0|||
13182326|NCT02203513|26157250|FG001|Overall Study|Lost to Follow-up|0|||
13182327|NCT02203513|26157251|FG002|Overall Study|Lost to Follow-up|1|||
13182328|NCT02203513|26157252|FG003|Overall Study|Lost to Follow-up|1|||
13182329|NCT02203513|26157253|FG004|Overall Study|Lost to Follow-up|0|||
13182330|NCT02203357|26157280|FG000|Overall Study|Lost to Follow-up|58|||
13182331|NCT02203357|26157281|FG001|Overall Study|Lost to Follow-up|66|||
13182332|NCT02203357|26157282|FG002|Overall Study|Lost to Follow-up|70|||
13182333|NCT02203331|26157351|FG000|Overall Study|Pregnancy|1|||
13182334|NCT02203331|26157352|FG001|Overall Study|Pregnancy|0|||
13182335|NCT02203331|26157353|FG002|Overall Study|Pregnancy|0|||
13182336|NCT02203331|26157354|FG003|Overall Study|Pregnancy|0|||
13182337|NCT02203331|26157355|FG004|Overall Study|Pregnancy|2|||
13182338|NCT02203331|26157356|FG005|Overall Study|Pregnancy|0|||
13182339|NCT02203331|26157351|FG000|Overall Study|Withdrawal by Subject|1|||
13182340|NCT02203331|26157352|FG001|Overall Study|Withdrawal by Subject|0|||
13182341|NCT02203331|26157353|FG002|Overall Study|Withdrawal by Subject|1|||
13182342|NCT02203331|26157354|FG003|Overall Study|Withdrawal by Subject|0|||
13182343|NCT02203331|26157355|FG004|Overall Study|Withdrawal by Subject|0|||
13182344|NCT02203331|26157356|FG005|Overall Study|Withdrawal by Subject|3|||
13182345|NCT02203331|26157351|FG000|Overall Study|Adverse Event|4|||
13182346|NCT02203331|26157352|FG001|Overall Study|Adverse Event|8|||
13182347|NCT02203331|26157353|FG002|Overall Study|Adverse Event|3|||
13182348|NCT02203331|26157354|FG003|Overall Study|Adverse Event|4|||
13182349|NCT02203331|26157355|FG004|Overall Study|Adverse Event|3|||
13182350|NCT02203331|26157356|FG005|Overall Study|Adverse Event|3|||
13182351|NCT02203331|26157351|FG000|Overall Study|Other Reasons|1|||
13182352|NCT02203331|26157352|FG001|Overall Study|Other Reasons|2|||
13182353|NCT02203331|26157353|FG002|Overall Study|Other Reasons|0|||
13182354|NCT02203331|26157354|FG003|Overall Study|Other Reasons|2|||
13182355|NCT02203331|26157355|FG004|Overall Study|Other Reasons|0|||
13182356|NCT02203331|26157356|FG005|Overall Study|Other Reasons|0|||
13182357|NCT02203331|26157351|FG000|Overall Study|Lack of Efficacy|0|||
13182358|NCT02203331|26157352|FG001|Overall Study|Lack of Efficacy|2|||
13182359|NCT02203331|26157353|FG002|Overall Study|Lack of Efficacy|1|||
13182360|NCT02203331|26157354|FG003|Overall Study|Lack of Efficacy|0|||
13182361|NCT02203331|26157355|FG004|Overall Study|Lack of Efficacy|0|||
13182362|NCT02203331|26157356|FG005|Overall Study|Lack of Efficacy|1|||
13182363|NCT02203331|26157351|FG000|Overall Study|Protocol Violation|0|||
13182364|NCT02203331|26157352|FG001|Overall Study|Protocol Violation|2|||
13182365|NCT02203331|26157353|FG002|Overall Study|Protocol Violation|0|||
13182366|NCT02203331|26157354|FG003|Overall Study|Protocol Violation|1|||
13182367|NCT02203331|26157355|FG004|Overall Study|Protocol Violation|1|||
13182368|NCT02203331|26157356|FG005|Overall Study|Protocol Violation|0|||
13182369|NCT02203331|26157351|FG000|Overall Study|Lost to Follow-up|0|||
13182370|NCT02203331|26157352|FG001|Overall Study|Lost to Follow-up|0|||
13182371|NCT02203331|26157353|FG002|Overall Study|Lost to Follow-up|0|||
13182372|NCT02203331|26157354|FG003|Overall Study|Lost to Follow-up|0|||
13182373|NCT02203331|26157355|FG004|Overall Study|Lost to Follow-up|1|||
13182374|NCT02203331|26157356|FG005|Overall Study|Lost to Follow-up|0|||
13182375|NCT02203149|26157405|FG000|Part 1|Adverse Event|0|||
13182376|NCT02203149|26157406|FG001|Part 1|Adverse Event|1|||
13109835|NCT03222973|25897970|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
13109836|NCT03222973|25897971|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
13109837|NCT03222973|25897968|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
13109838|NCT03222973|25897969|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
13109839|NCT03222973|25897970|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
13109840|NCT03222973|25897971|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
13109841|NCT03222973|25897968|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12|||
13109842|NCT03222973|25897969|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9|||
13109843|NCT03222973|25897970|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
13109844|NCT03222973|25897971|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
13182377|NCT02203149|26157407|FG002|Part 1|Adverse Event|0|||
13182378|NCT02203149|26157408|FG003|Part 1|Adverse Event|0|||
13182379|NCT02203149|26157409|FG004|Part 1|Adverse Event|0|||
13182380|NCT02203149|26157405|FG000|Part 2|Death|0|||
13182381|NCT02203149|26157406|FG001|Part 2|Death|0|||
13182382|NCT02203149|26157407|FG002|Part 2|Death|1|||
13182383|NCT02203149|26157408|FG003|Part 2|Death|1|||
13182384|NCT02203149|26157409|FG004|Part 2|Death|0|||
13182385|NCT02203149|26157405|FG000|Part 2|Withdrawal by Subject|0|||
13182386|NCT02203149|26157406|FG001|Part 2|Withdrawal by Subject|0|||
13182387|NCT02203149|26157407|FG002|Part 2|Withdrawal by Subject|0|||
13109845|NCT03222973|25897968|FG000|Part 1 (Week 0 to Week 72)|Death|0|||
13109846|NCT03222973|25897969|FG001|Part 1 (Week 0 to Week 72)|Death|1|||
13109847|NCT03222973|25897970|FG002|Part 1 (Week 0 to Week 72)|Death|0|||
13109848|NCT03222973|25897971|FG003|Part 1 (Week 0 to Week 72)|Death|0|||
13109849|NCT03222973|25897968|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
13109850|NCT03222973|25897969|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1|||
13109851|NCT03222973|25897970|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
13109852|NCT03222973|25897971|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
13109853|NCT03222973|25897968|FG000|Part 1 (Week 0 to Week 72)|Other|8|||
13109854|NCT03222973|25897969|FG001|Part 1 (Week 0 to Week 72)|Other|2|||
13109855|NCT03222973|25897970|FG002|Part 1 (Week 0 to Week 72)|Other|0|||
13109856|NCT03222973|25897971|FG003|Part 1 (Week 0 to Week 72)|Other|0|||
13109857|NCT03222973|25897968|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
13109858|NCT03222973|25897969|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
13109859|NCT03222973|25897970|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2|||
13109860|NCT03222973|25897971|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
13109861|NCT03222973|25897968|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
13109862|NCT03222973|25897969|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
13109863|NCT03222973|25897970|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10|||
13109864|NCT03222973|25897971|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11|||
13109865|NCT03222973|25897968|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
13109866|NCT03222973|25897969|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
13109867|NCT03222973|25897970|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2|||
13109868|NCT03222973|25897971|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1|||
13109869|NCT03222973|25897968|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
13109870|NCT03222973|25897969|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
13109871|NCT03222973|25897970|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2|||
13109872|NCT03222973|25897971|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1|||
13109873|NCT03222973|25897968|FG000|Part 2 (Week 73 to Week 168)|Other|0|||
13109874|NCT03222973|25897969|FG001|Part 2 (Week 73 to Week 168)|Other|0|||
13109875|NCT03222973|25897970|FG002|Part 2 (Week 73 to Week 168)|Other|84|||
13109876|NCT03222973|25897971|FG003|Part 2 (Week 73 to Week 168)|Other|100|||
13109877|NCT03222973|25897968|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
13109878|NCT03222973|25897969|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
13109879|NCT03222973|25897970|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1|||
13109880|NCT03222973|25897971|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
13109881|NCT03222583|25897989|FG000|Overall Study|Withdrawal by Subject|3|||
13109882|NCT03222583|25897990|FG001|Overall Study|Withdrawal by Subject|3|||
13109883|NCT03222583|25897989|FG000|Overall Study|Lost to Follow-up|1|||
13109884|NCT03222583|25897990|FG001|Overall Study|Lost to Follow-up|0|||
13109885|NCT03222583|25897989|FG000|Overall Study|Other|1|||
13109886|NCT03222583|25897990|FG001|Overall Study|Other|3|||
13109887|NCT03222349|25898017|FG000|Overall Study|Treatment B not done|5|||
13109888|NCT03222349|25898018|FG001|Overall Study|Treatment B not done|0|||
13109889|NCT03222349|25898017|FG000|Overall Study|Lost to Follow-up|1|||
13109890|NCT03222349|25898018|FG001|Overall Study|Lost to Follow-up|2|||
13109891|NCT03222349|25898017|FG000|Overall Study|Withdrawal by Subject|1|||
13109892|NCT03222349|25898018|FG001|Overall Study|Withdrawal by Subject|0|||
13109893|NCT03222349|25898017|FG000|Overall Study|Treatment A not done|0|||
13109894|NCT03222349|25898018|FG001|Overall Study|Treatment A not done|5|||
13109895|NCT03222349|25898017|FG000|Overall Study|Study terminated by sponsor|1|||
13109896|NCT03222349|25898018|FG001|Overall Study|Study terminated by sponsor|0|||
13109897|NCT03222141|25898026|FG000|Overall Study|Death|15|||
13109898|NCT03222141|25898026|FG000|Overall Study|Lost to Follow-up|3|||
13109899|NCT03221842|25898057|FG000|Period 1 (Open-label)|Adverse Event|4|||
13109900|NCT03221842|25898058|FG001|Period 1 (Open-label)|Adverse Event|0|||
13109901|NCT03221842|25898057|FG000|Period 1 (Open-label)|Physician Decision|2|||
13109902|NCT03221842|25898058|FG001|Period 1 (Open-label)|Physician Decision|0|||
13109903|NCT03221842|25898057|FG000|Period 1 (Open-label)|Lost to Follow-up|1|||
13109904|NCT03221842|25898058|FG001|Period 1 (Open-label)|Lost to Follow-up|0|||
13109905|NCT03221842|25898057|FG000|Period 1 (Open-label)|Terminated by sponsor|1|||
13109906|NCT03221842|25898058|FG001|Period 1 (Open-label)|Terminated by sponsor|0|||
13109907|NCT03221842|25898057|FG000|Period 1 (Open-label)|Other|2|||
13182388|NCT02203149|26157408|FG003|Part 2|Withdrawal by Subject|1|||
13182389|NCT02203149|26157409|FG004|Part 2|Withdrawal by Subject|0|||
13182390|NCT02203149|26157405|FG000|Part 2|Adverse Event|0|||
13182391|NCT02203149|26157406|FG001|Part 2|Adverse Event|0|||
13109908|NCT03221842|25898058|FG001|Period 1 (Open-label)|Other|0|||
13109909|NCT03221842|25898057|FG000|Period 2 (Randomized, Blinded)|Death|0|||
13109910|NCT03221842|25898058|FG001|Period 2 (Randomized, Blinded)|Death|1|||
13109911|NCT03221842|25898057|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1|||
13109912|NCT03221842|25898058|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0|||
13109913|NCT03221387|25898076|FG000|Overall Study|Lost to Follow-up|1|||
13182392|NCT02203149|26157407|FG002|Part 2|Adverse Event|0|||
13182393|NCT02203149|26157408|FG003|Part 2|Adverse Event|1|||
13182394|NCT02203149|26157409|FG004|Part 2|Adverse Event|1|||
13109914|NCT03221387|25898076|FG000|Overall Study|Lung transplant|1|||
13109915|NCT03220737|25898137|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
13109916|NCT03220737|25898138|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
13109917|NCT03220737|25898139|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
13109918|NCT03220737|25898140|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
13109919|NCT03220737|25898141|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
13109920|NCT03220737|25898142|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
13109921|NCT03220737|25898143|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
13109922|NCT03220737|25898137|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2|||
13109923|NCT03220737|25898138|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
13109924|NCT03220737|25898139|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6|||
13109925|NCT03220737|25898140|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
13109926|NCT03220737|25898141|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13|||
13109927|NCT03220737|25898142|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
13109928|NCT03220737|25898143|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0|||
13109929|NCT03220737|25898137|FG000|Main Study (Day 1 - 181)|Protocol Violation|0|||
13109930|NCT03220737|25898138|FG001|Main Study (Day 1 - 181)|Protocol Violation|0|||
13109931|NCT03220737|25898139|FG002|Main Study (Day 1 - 181)|Protocol Violation|1|||
13109932|NCT03220737|25898140|FG003|Main Study (Day 1 - 181)|Protocol Violation|1|||
13109933|NCT03220737|25898141|FG004|Main Study (Day 1 - 181)|Protocol Violation|3|||
13109934|NCT03220737|25898142|FG005|Main Study (Day 1 - 181)|Protocol Violation|0|||
13109935|NCT03220737|25898143|FG006|Main Study (Day 1 - 181)|Protocol Violation|1|||
13109936|NCT03220737|25898137|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
13109937|NCT03220737|25898138|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
13109938|NCT03220737|25898139|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1|||
13109939|NCT03220737|25898140|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
13109940|NCT03220737|25898141|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
13109941|NCT03220737|25898142|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
13109942|NCT03220737|25898143|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
13109943|NCT03220737|25898137|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
13109944|NCT03220737|25898138|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
13109945|NCT03220737|25898139|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
13109946|NCT03220737|25898140|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
13109947|NCT03220737|25898141|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2|||
13109948|NCT03220737|25898142|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
13109949|NCT03220737|25898143|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
13109950|NCT03220737|25898137|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1|||
13109951|NCT03220737|25898138|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
13109952|NCT03220737|25898139|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
13109953|NCT03220737|25898140|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
13109954|NCT03220737|25898141|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
13109955|NCT03220737|25898142|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
13109956|NCT03220737|25898143|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
13109957|NCT03220737|25898137|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9|||
13109958|NCT03220737|25898138|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
13109959|NCT03220737|25898139|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
13109960|NCT03220737|25898140|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
13109961|NCT03220737|25898141|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
13109962|NCT03220737|25898142|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
13109963|NCT03220737|25898143|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
13109964|NCT03220737|25898137|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1|||
13109965|NCT03220737|25898138|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
13182395|NCT02203071|26157432|FG000|Overall Study|Lost to Follow-up|3|||
13182396|NCT02203071|26157433|FG001|Overall Study|Lost to Follow-up|1|||
13182397|NCT02203032|26157452|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2|||
13182398|NCT02203032|26157453|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
13182399|NCT02203032|26157454|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
13182400|NCT02203032|26157455|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
13182401|NCT02203032|26157452|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1|||
13182402|NCT02203032|26157453|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
13182403|NCT02203032|26157454|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
13109966|NCT03220737|25898139|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
13109967|NCT03220737|25898140|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
13109968|NCT03220737|25898141|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
13109969|NCT03220737|25898142|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
13109970|NCT03220737|25898143|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
13109971|NCT03220581|25898163|FG000|Overall Study|Withdrawal by Subject|0|||
13182404|NCT02203032|26157455|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
13182405|NCT02203032|26157452|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3|||
13182406|NCT02203032|26157453|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
13182407|NCT02203032|26157454|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
13182408|NCT02203032|26157455|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
13182409|NCT02203032|26157452|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6|||
13182410|NCT02203032|26157453|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
13182411|NCT02203032|26157454|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
13182412|NCT02203032|26157455|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
13182413|NCT02203032|26157452|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4|||
13182414|NCT02203032|26157453|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
13182415|NCT02203032|26157454|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
13182416|NCT02203032|26157455|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
13182417|NCT02203032|26157452|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2|||
13182418|NCT02203032|26157453|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0|||
13182419|NCT02203032|26157454|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0|||
13182420|NCT02203032|26157455|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0|||
13182421|NCT02203032|26157452|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1|||
13182422|NCT02203032|26157453|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
13182423|NCT02203032|26157454|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
13182424|NCT02203032|26157455|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
13182425|NCT02203032|26157452|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0|||
13182426|NCT02203032|26157453|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2|||
13182427|NCT02203032|26157454|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3|||
13182428|NCT02203032|26157455|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8|||
13182429|NCT02203032|26157452|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0|||
13182430|NCT02203032|26157453|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8|||
13182431|NCT02203032|26157454|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19|||
13182432|NCT02203032|26157455|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20|||
13182433|NCT02203032|26157452|FG000|Blinded Phase (Week 16 to Week 44)|Other|0|||
13182434|NCT02203032|26157453|FG001|Blinded Phase (Week 16 to Week 44)|Other|4|||
13182435|NCT02203032|26157454|FG002|Blinded Phase (Week 16 to Week 44)|Other|1|||
13182436|NCT02203032|26157455|FG003|Blinded Phase (Week 16 to Week 44)|Other|15|||
13182437|NCT02203032|26157452|FG000|Blinded Phase (Week 16 to Week 44)|Death|0|||
13182438|NCT02203032|26157453|FG001|Blinded Phase (Week 16 to Week 44)|Death|0|||
13182439|NCT02203032|26157454|FG002|Blinded Phase (Week 16 to Week 44)|Death|0|||
13182440|NCT02203032|26157455|FG003|Blinded Phase (Week 16 to Week 44)|Death|1|||
13182441|NCT02203032|26157452|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0|||
13182442|NCT02203032|26157453|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1|||
13182443|NCT02203032|26157454|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3|||
13182444|NCT02203032|26157455|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2|||
13182445|NCT02202980|26157584|FG000|Overall Study|Lack of Efficacy|1|||
13182446|NCT02202980|26157585|FG001|Overall Study|Lack of Efficacy|0|||
13182447|NCT02202980|26157586|FG002|Overall Study|Lack of Efficacy|7|||
13182448|NCT02202980|26157587|FG003|Overall Study|Lack of Efficacy|0|||
13182449|NCT02202980|26157588|FG004|Overall Study|Lack of Efficacy|3|||
13182450|NCT02202980|26157589|FG005|Overall Study|Lack of Efficacy|1|||
13182451|NCT02202980|26157590|FG006|Overall Study|Lack of Efficacy|11|||
13182452|NCT02202980|26157591|FG007|Overall Study|Lack of Efficacy|2|||
13182453|NCT02202980|26157592|FG008|Overall Study|Lack of Efficacy|2|||
13182454|NCT02202980|26157593|FG009|Overall Study|Lack of Efficacy|0|||
13182455|NCT02202980|26157594|FG010|Overall Study|Lack of Efficacy|0|||
13182456|NCT02202980|26157595|FG011|Overall Study|Lack of Efficacy|3|||
13182457|NCT02202980|26157596|FG012|Overall Study|Lack of Efficacy|10|||
13182458|NCT02202980|26157597|FG013|Overall Study|Lack of Efficacy|0|||
13182459|NCT02202980|26157584|FG000|Overall Study|Protocol Violation|0|||
13182460|NCT02202980|26157585|FG001|Overall Study|Protocol Violation|0|||
13182461|NCT02202980|26157586|FG002|Overall Study|Protocol Violation|0|||
13182462|NCT02202980|26157587|FG003|Overall Study|Protocol Violation|3|||
13182463|NCT02202980|26157588|FG004|Overall Study|Protocol Violation|3|||
13182464|NCT02202980|26157589|FG005|Overall Study|Protocol Violation|0|||
13182465|NCT02202980|26157590|FG006|Overall Study|Protocol Violation|0|||
13182466|NCT02202980|26157591|FG007|Overall Study|Protocol Violation|0|||
13182467|NCT02202980|26157592|FG008|Overall Study|Protocol Violation|0|||
13182468|NCT02202980|26157593|FG009|Overall Study|Protocol Violation|0|||
13182469|NCT02202980|26157594|FG010|Overall Study|Protocol Violation|0|||
13182470|NCT02202980|26157595|FG011|Overall Study|Protocol Violation|0|||
13182471|NCT02202980|26157596|FG012|Overall Study|Protocol Violation|0|||
13182472|NCT02202980|26157597|FG013|Overall Study|Protocol Violation|0|||
13182473|NCT02202980|26157584|FG000|Overall Study|Lost to Follow-up|0|||
13182474|NCT02202980|26157585|FG001|Overall Study|Lost to Follow-up|1|||
13182475|NCT02202980|26157586|FG002|Overall Study|Lost to Follow-up|1|||
13182476|NCT02202980|26157587|FG003|Overall Study|Lost to Follow-up|1|||
13182477|NCT02202980|26157588|FG004|Overall Study|Lost to Follow-up|0|||
13109972|NCT03220581|25898164|FG001|Overall Study|Withdrawal by Subject|1|||
13109973|NCT03220581|25898163|FG000|Overall Study|Lost to Follow-up|3|||
13109974|NCT03220581|25898164|FG001|Overall Study|Lost to Follow-up|6|||
13109975|NCT03220217|25898241|FG000|Overall Study|Withdrawal by Subject|0|||
13109976|NCT03220217|25898242|FG001|Overall Study|Withdrawal by Subject|1|||
13109977|NCT03220217|25898243|FG002|Overall Study|Withdrawal by Subject|0|||
13109978|NCT03220217|25898241|FG000|Overall Study|Subject Missed Procedure|0|||
13109979|NCT03220217|25898242|FG001|Overall Study|Subject Missed Procedure|0|||
13109980|NCT03220217|25898243|FG002|Overall Study|Subject Missed Procedure|1|||
13109981|NCT03219723|25898250|FG000|Overall Study|Case Report Forms Uncollected|6|||
13109982|NCT03219723|25898250|FG000|Overall Study|Protocol Deviation|4|||
13109983|NCT03219372|25898277|FG000|Overall Study|Withdrawal by Subject|1|||
13109984|NCT03219372|25898278|FG001|Overall Study|Withdrawal by Subject|0|||
13109985|NCT03219216|25898291|FG000|Overall Study|Lost to Follow-up|0|||
13109986|NCT03219216|25898292|FG001|Overall Study|Lost to Follow-up|1|||
13109987|NCT03218787|25898309|FG000|Overall Study|Lost to Follow-up|12|||
13109988|NCT03218787|25898309|FG000|Overall Study|Withdrawal by Subject|72|||
13109989|NCT03218787|25898309|FG000|Overall Study|Physician Decision|11|||
13109990|NCT03218787|25898309|FG000|Overall Study|Death|111|||
13109991|NCT03218397|25898344|FG000|Overall Study|Prior positive blood culture|8|||
13109992|NCT03218397|25898345|FG001|Overall Study|Prior positive blood culture|13|||
13109993|NCT03218397|25898344|FG000|Overall Study|Comfort care|8|||
13109994|NCT03218397|25898345|FG001|Overall Study|Comfort care|5|||
13109995|NCT03218397|25898344|FG000|Overall Study|Comfort care and positive blood culture|1|||
13109996|NCT03218397|25898345|FG001|Overall Study|Comfort care and positive blood culture|0|||
13109997|NCT03218397|25898344|FG000|Overall Study|Comfort care and mixed culture|0|||
13109998|NCT03218397|25898345|FG001|Overall Study|Comfort care and mixed culture|1|||
13109999|NCT03218397|25898344|FG000|Overall Study|Mixed culture|2|||
13110000|NCT03218397|25898345|FG001|Overall Study|Mixed culture|2|||
13110001|NCT03218397|25898344|FG000|Overall Study|Inaccessible hospital records|2|||
13110002|NCT03218397|25898345|FG001|Overall Study|Inaccessible hospital records|5|||
13110003|NCT03218397|25898344|FG000|Overall Study|No gram-negative bacilli (GNB)|0|||
13110004|NCT03218397|25898345|FG001|Overall Study|No gram-negative bacilli (GNB)|2|||
13110005|NCT03218397|25898344|FG000|Overall Study|Randomized during laboratory off hours|2|||
13110006|NCT03218397|25898345|FG001|Overall Study|Randomized during laboratory off hours|1|||
13110007|NCT03217968|25898356|FG000|Overall Study|Withdrawal by Subject|4|||
13110008|NCT03217968|25898356|FG000|Overall Study|Lost to Follow-up|1|||
13110009|NCT03217968|25898356|FG000|Overall Study|Protocol Violation|6|||
13110010|NCT03217591|25898378|FG000|Overall Study|Adverse Event|1|||
13110011|NCT03217591|25898379|FG001|Overall Study|Adverse Event|2|||
13110012|NCT03217591|25898380|FG002|Overall Study|Adverse Event|6|||
13110013|NCT03217591|25898378|FG000|Overall Study|Withdrawal by Subject|0|||
13110014|NCT03217591|25898379|FG001|Overall Study|Withdrawal by Subject|1|||
13110015|NCT03217591|25898380|FG002|Overall Study|Withdrawal by Subject|3|||
13110016|NCT03217591|25898378|FG000|Overall Study|Lost to Follow-up|1|||
13110017|NCT03217591|25898379|FG001|Overall Study|Lost to Follow-up|0|||
13110018|NCT03217591|25898380|FG002|Overall Study|Lost to Follow-up|0|||
13110019|NCT03217591|25898378|FG000|Overall Study|Protocol Violation|1|||
13110020|NCT03217591|25898379|FG001|Overall Study|Protocol Violation|0|||
13110021|NCT03217591|25898380|FG002|Overall Study|Protocol Violation|1|||
13110022|NCT03217175|25898397|FG000|Overall Study|Physician Decision|4|||
13110023|NCT03217175|25898398|FG001|Overall Study|Physician Decision|1|||
13110024|NCT03216954|25898412|FG000|Overall Study|Adverse Event|0|||
13110025|NCT03216954|25898413|FG001|Overall Study|Adverse Event|0|||
13110026|NCT03216954|25898414|FG002|Overall Study|Adverse Event|1|||
13110027|NCT03216954|25898415|FG003|Overall Study|Adverse Event|0|||
13110028|NCT03216954|25898416|FG004|Overall Study|Adverse Event|1|||
13110029|NCT03216954|25898412|FG000|Overall Study|Withdrawal by Subject|2|||
13110030|NCT03216954|25898413|FG001|Overall Study|Withdrawal by Subject|0|||
13110031|NCT03216954|25898414|FG002|Overall Study|Withdrawal by Subject|0|||
13110032|NCT03216954|25898415|FG003|Overall Study|Withdrawal by Subject|0|||
13110033|NCT03216954|25898416|FG004|Overall Study|Withdrawal by Subject|0|||
13110034|NCT03216954|25898412|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
13110035|NCT03216954|25898413|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1|||
13110036|NCT03216954|25898414|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
13110037|NCT03216954|25898415|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
13110038|NCT03216954|25898416|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
13110039|NCT03216850|25898422|FG000|Overall Study|Pre-analytical error|6|||
13110040|NCT03216746|25898445|FG000|Overall Study|Lost to Follow-up|6|||
13110041|NCT03216746|25898446|FG001|Overall Study|Lost to Follow-up|8|||
13110042|NCT03216746|25898447|FG002|Overall Study|Lost to Follow-up|5|||
13182478|NCT02202980|26157589|FG005|Overall Study|Lost to Follow-up|0|||
13182479|NCT02202980|26157590|FG006|Overall Study|Lost to Follow-up|0|||
13182480|NCT02202980|26157591|FG007|Overall Study|Lost to Follow-up|1|||
13182481|NCT02202980|26157592|FG008|Overall Study|Lost to Follow-up|1|||
13182482|NCT02202980|26157593|FG009|Overall Study|Lost to Follow-up|0|||
13182483|NCT02202980|26157594|FG010|Overall Study|Lost to Follow-up|0|||
13182484|NCT02202980|26157595|FG011|Overall Study|Lost to Follow-up|0|||
13182485|NCT02202980|26157596|FG012|Overall Study|Lost to Follow-up|1|||
13182486|NCT02202980|26157597|FG013|Overall Study|Lost to Follow-up|0|||
13182487|NCT02202980|26157584|FG000|Overall Study|Withdrew Consent|0|||
13182488|NCT02202980|26157585|FG001|Overall Study|Withdrew Consent|1|||
13182489|NCT02202980|26157586|FG002|Overall Study|Withdrew Consent|2|||
13182490|NCT02202980|26157587|FG003|Overall Study|Withdrew Consent|0|||
13182491|NCT02202980|26157588|FG004|Overall Study|Withdrew Consent|0|||
13182492|NCT02202980|26157589|FG005|Overall Study|Withdrew Consent|0|||
13182493|NCT02202980|26157590|FG006|Overall Study|Withdrew Consent|0|||
13182494|NCT02202980|26157591|FG007|Overall Study|Withdrew Consent|0|||
13182495|NCT02202980|26157592|FG008|Overall Study|Withdrew Consent|1|||
13182496|NCT02202980|26157593|FG009|Overall Study|Withdrew Consent|0|||
13182497|NCT02202980|26157594|FG010|Overall Study|Withdrew Consent|0|||
13182498|NCT02202980|26157595|FG011|Overall Study|Withdrew Consent|0|||
13182499|NCT02202980|26157596|FG012|Overall Study|Withdrew Consent|0|||
13182500|NCT02202980|26157597|FG013|Overall Study|Withdrew Consent|0|||
13182501|NCT02202850|26157654|FG000|Overall Study|Other|2|||
13182502|NCT02202850|26157655|FG001|Overall Study|Other|2|||
13182503|NCT02202850|26157654|FG000|Overall Study|Enbrel treatment discontinued|15|||
13182504|NCT02202850|26157655|FG001|Overall Study|Enbrel treatment discontinued|3|||
13182505|NCT02202850|26157654|FG000|Overall Study|Lost to Follow-up|7|||
13182506|NCT02202850|26157655|FG001|Overall Study|Lost to Follow-up|1|||
13182507|NCT02202837|26157710|FG000|Overall Study|Enbrel treatment discontinued|36|||
13182508|NCT02202837|26157711|FG001|Overall Study|Enbrel treatment discontinued|4|||
13182509|NCT02202837|26157710|FG000|Overall Study|Other|10|||
13182510|NCT02202837|26157711|FG001|Overall Study|Other|0|||
13182511|NCT02202837|26157710|FG000|Overall Study|Lost to Follow-up|7|||
13182512|NCT02202837|26157711|FG001|Overall Study|Lost to Follow-up|1|||
13182513|NCT02202785|26157755|FG000|Overall Study|Study Terminated by Sponsor|1|||
13182514|NCT02202785|26157756|FG001|Overall Study|Study Terminated by Sponsor|6|||
13182515|NCT02202785|26157757|FG002|Overall Study|Study Terminated by Sponsor|4|||
13182516|NCT02202785|26157755|FG000|Overall Study|Withdrawal by Subject|0|||
13182517|NCT02202785|26157756|FG001|Overall Study|Withdrawal by Subject|1|||
13182518|NCT02202785|26157757|FG002|Overall Study|Withdrawal by Subject|0|||
13182519|NCT02202785|26157755|FG000|Overall Study|Lost to Follow-up|0|||
13182520|NCT02202785|26157756|FG001|Overall Study|Lost to Follow-up|1|||
13182521|NCT02202785|26157757|FG002|Overall Study|Lost to Follow-up|0|||
13182522|NCT02202785|26157755|FG000|Overall Study|Reason not Specified|10|||
13182523|NCT02202785|26157756|FG001|Overall Study|Reason not Specified|7|||
13182524|NCT02202785|26157757|FG002|Overall Study|Reason not Specified|13|||
13182525|NCT02202759|26157801|FG000|Overall Study|Study Terminated by Sponsor|3|||
13182526|NCT02202759|26157802|FG001|Overall Study|Study Terminated by Sponsor|3|||
13182527|NCT02202759|26157803|FG002|Overall Study|Study Terminated by Sponsor|3|||
13182528|NCT02202759|26157801|FG000|Overall Study|Withdrawal by Subject|2|||
13182529|NCT02202759|26157802|FG001|Overall Study|Withdrawal by Subject|1|||
13182530|NCT02202759|26157803|FG002|Overall Study|Withdrawal by Subject|1|||
13182531|NCT02202759|26157801|FG000|Overall Study|Reason not Specified|4|||
13182532|NCT02202759|26157802|FG001|Overall Study|Reason not Specified|11|||
13182533|NCT02202759|26157803|FG002|Overall Study|Reason not Specified|10|||
13182534|NCT02202616|26157816|FG000|Overall Study|Screen failed|24|||
13182535|NCT02202616|26157816|FG000|Overall Study|Adverse Event|32|||
13182536|NCT02202616|26157816|FG000|Overall Study|Protocol deviation|18|||
13182537|NCT02202616|26157816|FG000|Overall Study|Patient withdrew consent|12|||
13182538|NCT02202616|26157816|FG000|Overall Study|Lost to Follow-up|6|||
13182539|NCT02202616|26157816|FG000|Overall Study|Administrative problems|6|||
13182540|NCT02202616|26157816|FG000|Overall Study|Abnormal test procedure result|1|||
13182541|NCT02202616|26157816|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
13182542|NCT02202577|26157831|FG000|Overall Study|Lost to Follow-up|6|||
13182543|NCT02202577|26157832|FG001|Overall Study|Lost to Follow-up|16|||
13182544|NCT02202577|26157831|FG000|Overall Study|Protocol Violation|7|||
13182545|NCT02202577|26157832|FG001|Overall Study|Protocol Violation|3|||
13182546|NCT02202551|26157863|FG000|Overall Study|Adverse Event|8|||
13182547|NCT02202551|26157864|FG001|Overall Study|Adverse Event|19|||
13182548|NCT02202551|26157865|FG002|Overall Study|Adverse Event|5|||
13182549|NCT02202551|26157866|FG003|Overall Study|Adverse Event|9|||
13182550|NCT02202551|26157863|FG000|Overall Study|Death|3|||
13182551|NCT02202551|26157864|FG001|Overall Study|Death|2|||
13182552|NCT02202551|26157865|FG002|Overall Study|Death|1|||
13182553|NCT02202551|26157866|FG003|Overall Study|Death|1|||
13182554|NCT02202551|26157863|FG000|Overall Study|Lost to Follow-up|0|||
13182555|NCT02202551|26157864|FG001|Overall Study|Lost to Follow-up|1|||
13182556|NCT02202551|26157865|FG002|Overall Study|Lost to Follow-up|0|||
13182557|NCT02202551|26157866|FG003|Overall Study|Lost to Follow-up|1|||
13182558|NCT02202551|26157863|FG000|Overall Study|Needed to take excluded medication|0|||
13182559|NCT02202551|26157864|FG001|Overall Study|Needed to take excluded medication|2|||
13182560|NCT02202551|26157865|FG002|Overall Study|Needed to take excluded medication|0|||
13182561|NCT02202551|26157866|FG003|Overall Study|Needed to take excluded medication|1|||
13182562|NCT02202551|26157863|FG000|Overall Study|Subject moved away|0|||
13182563|NCT02202551|26157864|FG001|Overall Study|Subject moved away|1|||
13182564|NCT02202551|26157865|FG002|Overall Study|Subject moved away|0|||
13182565|NCT02202551|26157866|FG003|Overall Study|Subject moved away|0|||
13182566|NCT02202551|26157863|FG000|Overall Study|DBS surgery|3|||
13182567|NCT02202551|26157864|FG001|Overall Study|DBS surgery|0|||
13182568|NCT02202551|26157865|FG002|Overall Study|DBS surgery|0|||
13182569|NCT02202551|26157866|FG003|Overall Study|DBS surgery|0|||
13182570|NCT02202551|26157863|FG000|Overall Study|Dyskinesia upon taper|1|||
13182571|NCT02202551|26157864|FG001|Overall Study|Dyskinesia upon taper|0|||
13182572|NCT02202551|26157865|FG002|Overall Study|Dyskinesia upon taper|0|||
13182573|NCT02202551|26157866|FG003|Overall Study|Dyskinesia upon taper|0|||
13182574|NCT02202551|26157863|FG000|Overall Study|Lack of Efficacy|0|||
13182575|NCT02202551|26157864|FG001|Overall Study|Lack of Efficacy|1|||
13182576|NCT02202551|26157865|FG002|Overall Study|Lack of Efficacy|0|||
13182577|NCT02202551|26157866|FG003|Overall Study|Lack of Efficacy|0|||
13182578|NCT02202551|26157863|FG000|Overall Study|Physician Decision|1|||
13182579|NCT02202551|26157864|FG001|Overall Study|Physician Decision|0|||
13182580|NCT02202551|26157865|FG002|Overall Study|Physician Decision|0|||
13182581|NCT02202551|26157866|FG003|Overall Study|Physician Decision|0|||
13182582|NCT02202551|26157863|FG000|Overall Study|Site closure|3|||
13182583|NCT02202551|26157864|FG001|Overall Study|Site closure|0|||
13182584|NCT02202551|26157865|FG002|Overall Study|Site closure|0|||
13182585|NCT02202551|26157866|FG003|Overall Study|Site closure|1|||
13182586|NCT02202551|26157863|FG000|Overall Study|Unable to complete visits per protocol|1|||
13182587|NCT02202551|26157864|FG001|Overall Study|Unable to complete visits per protocol|0|||
13182588|NCT02202551|26157865|FG002|Overall Study|Unable to complete visits per protocol|0|||
13182589|NCT02202551|26157866|FG003|Overall Study|Unable to complete visits per protocol|0|||
13182590|NCT02202551|26157863|FG000|Overall Study|Worsening Dyskinesia|0|||
13182591|NCT02202551|26157864|FG001|Overall Study|Worsening Dyskinesia|0|||
13182592|NCT02202551|26157865|FG002|Overall Study|Worsening Dyskinesia|0|||
13182593|NCT02202551|26157866|FG003|Overall Study|Worsening Dyskinesia|1|||
13182594|NCT02202551|26157863|FG000|Overall Study|Protocol Violation|0|||
13182595|NCT02202551|26157864|FG001|Overall Study|Protocol Violation|1|||
13182596|NCT02202551|26157865|FG002|Overall Study|Protocol Violation|0|||
13182597|NCT02202551|26157866|FG003|Overall Study|Protocol Violation|0|||
13182598|NCT02202551|26157863|FG000|Overall Study|Sponsor's decision|2|||
13182599|NCT02202551|26157864|FG001|Overall Study|Sponsor's decision|0|||
13182600|NCT02202551|26157865|FG002|Overall Study|Sponsor's decision|0|||
13182601|NCT02202551|26157866|FG003|Overall Study|Sponsor's decision|0|||
13182602|NCT02202551|26157863|FG000|Overall Study|Subject unwilling to proceed|1|||
13182603|NCT02202551|26157864|FG001|Overall Study|Subject unwilling to proceed|5|||
13182604|NCT02202551|26157865|FG002|Overall Study|Subject unwilling to proceed|3|||
13182605|NCT02202551|26157866|FG003|Overall Study|Subject unwilling to proceed|5|||
13182606|NCT02202551|26157863|FG000|Overall Study|Subject consent withdrawn|0|||
13182607|NCT02202551|26157864|FG001|Overall Study|Subject consent withdrawn|3|||
13182608|NCT02202551|26157865|FG002|Overall Study|Subject consent withdrawn|1|||
13182609|NCT02202551|26157866|FG003|Overall Study|Subject consent withdrawn|2|||
13182610|NCT02202551|26157863|FG000|Overall Study|eGFR<50mL/min/m2|2|||
13182611|NCT02202551|26157864|FG001|Overall Study|eGFR<50mL/min/m2|2|||
13182612|NCT02202551|26157865|FG002|Overall Study|eGFR<50mL/min/m2|0|||
13182613|NCT02202551|26157866|FG003|Overall Study|eGFR<50mL/min/m2|1|||
13182614|NCT02202538|26157879|FG000|Overall Study|Withdrawal by Subject|5|||
13182615|NCT02202538|26157879|FG000|Overall Study|Did not meet all inclusion criteria|2|||
13182616|NCT02202538|26157879|FG000|Overall Study|Investigator Decision|1|||
13182617|NCT02202499|26157912|FG000|Overall Study|Cancer diagnosis|0|||
13182618|NCT02202499|26157913|FG001|Overall Study|Cancer diagnosis|0|||
13182619|NCT02202499|26157914|FG002|Overall Study|Cancer diagnosis|1|||
13182620|NCT02202499|26157912|FG000|Overall Study|Moved from area|0|||
13182621|NCT02202499|26157913|FG001|Overall Study|Moved from area|0|||
13182622|NCT02202499|26157914|FG002|Overall Study|Moved from area|1|||
13182623|NCT02202499|26157912|FG000|Overall Study|Declined before randomization|1|||
13182624|NCT02202499|26157913|FG001|Overall Study|Declined before randomization|0|||
13182625|NCT02202499|26157914|FG002|Overall Study|Declined before randomization|0|||
13182626|NCT02202499|26157912|FG000|Overall Study|Auto accident|1|||
13182627|NCT02202499|26157913|FG001|Overall Study|Auto accident|0|||
13182628|NCT02202499|26157914|FG002|Overall Study|Auto accident|0|||
13182629|NCT02202317|26157922|FG000|Overall Study|Lost to Follow-up|1|||
13182630|NCT02202161|26158101|FG000|Overall Study|Adverse Event|1|||
13182631|NCT02202161|26158102|FG001|Overall Study|Adverse Event|1|||
13182632|NCT02202161|26158103|FG002|Overall Study|Adverse Event|0|||
13182633|NCT02202161|26158104|FG003|Overall Study|Adverse Event|0|||
13182634|NCT02202161|26158105|FG004|Overall Study|Adverse Event|0|||
13182635|NCT02202161|26158106|FG005|Overall Study|Adverse Event|1|||
13182636|NCT02202161|26158107|FG006|Overall Study|Adverse Event|0|||
13182637|NCT02202161|26158108|FG007|Overall Study|Adverse Event|0|||
13182638|NCT02202161|26158101|FG000|Overall Study|Did not meet continuation criteria|0|||
13182639|NCT02202161|26158102|FG001|Overall Study|Did not meet continuation criteria|0|||
13182640|NCT02202161|26158103|FG002|Overall Study|Did not meet continuation criteria|0|||
13182641|NCT02202161|26158104|FG003|Overall Study|Did not meet continuation criteria|0|||
13110043|NCT03216746|25898448|FG003|Overall Study|Lost to Follow-up|6|||
13110044|NCT03216265|25898508|FG000|Overall Study|Adverse Event|2|||
13110045|NCT03216265|25898509|FG001|Overall Study|Adverse Event|0|||
13110046|NCT03216265|25898510|FG002|Overall Study|Adverse Event|2|||
13110047|NCT03216265|25898508|FG000|Overall Study|Lost to Follow-up|0|||
13110048|NCT03216265|25898509|FG001|Overall Study|Lost to Follow-up|1|||
13110049|NCT03216265|25898510|FG002|Overall Study|Lost to Follow-up|0|||
13110050|NCT03216265|25898508|FG000|Overall Study|Withdrawal by Subject|0|||
13110051|NCT03216265|25898509|FG001|Overall Study|Withdrawal by Subject|0|||
13110052|NCT03216265|25898510|FG002|Overall Study|Withdrawal by Subject|1|||
13110053|NCT03216226|25898555|FG000|Overall Study|Adverse Event|3|||
13110054|NCT03216226|25898556|FG001|Overall Study|Adverse Event|0|||
13110055|NCT03216226|25898555|FG000|Overall Study|Protocol Violation|1|||
13110056|NCT03216226|25898556|FG001|Overall Study|Protocol Violation|3|||
13182642|NCT02202161|26158105|FG004|Overall Study|Did not meet continuation criteria|0|||
13182643|NCT02202161|26158106|FG005|Overall Study|Did not meet continuation criteria|0|||
13182644|NCT02202161|26158107|FG006|Overall Study|Did not meet continuation criteria|0|||
13182645|NCT02202161|26158108|FG007|Overall Study|Did not meet continuation criteria|3|||
13182646|NCT02202161|26158101|FG000|Overall Study|Physician Decision|0|||
13182647|NCT02202161|26158102|FG001|Overall Study|Physician Decision|0|||
13182648|NCT02202161|26158103|FG002|Overall Study|Physician Decision|0|||
13182649|NCT02202161|26158104|FG003|Overall Study|Physician Decision|0|||
13182650|NCT02202161|26158105|FG004|Overall Study|Physician Decision|0|||
13182651|NCT02202161|26158106|FG005|Overall Study|Physician Decision|0|||
13182652|NCT02202161|26158107|FG006|Overall Study|Physician Decision|0|||
13182653|NCT02202161|26158108|FG007|Overall Study|Physician Decision|3|||
13182654|NCT02202161|26158101|FG000|Overall Study|Withdrawal by Subject|0|||
13182655|NCT02202161|26158102|FG001|Overall Study|Withdrawal by Subject|0|||
13182656|NCT02202161|26158103|FG002|Overall Study|Withdrawal by Subject|0|||
13182657|NCT02202161|26158104|FG003|Overall Study|Withdrawal by Subject|0|||
13182658|NCT02202161|26158105|FG004|Overall Study|Withdrawal by Subject|1|||
13182659|NCT02202161|26158106|FG005|Overall Study|Withdrawal by Subject|0|||
13182660|NCT02202161|26158107|FG006|Overall Study|Withdrawal by Subject|0|||
13182661|NCT02202161|26158108|FG007|Overall Study|Withdrawal by Subject|0|||
13182662|NCT02202109|26158125|FG000|Overall Study|Lost to Follow-up|88|||
13182663|NCT02202109|26158126|FG001|Overall Study|Lost to Follow-up|87|||
13182664|NCT02202109|26158125|FG000|Overall Study|Withdrawal by Subject|2|||
13182665|NCT02202109|26158126|FG001|Overall Study|Withdrawal by Subject|0|||
13182666|NCT02202031|26158179|FG000|Overall Study|Lost to Follow-up|1|||
13182667|NCT02202031|26158180|FG001|Overall Study|Lost to Follow-up|0|||
13182668|NCT02202031|26158179|FG000|Overall Study|Too Busy|1|||
13182669|NCT02202031|26158180|FG001|Overall Study|Too Busy|3|||
13182670|NCT02202031|26158179|FG000|Overall Study|Illness/Medical Reason|0|||
13182671|NCT02202031|26158180|FG001|Overall Study|Illness/Medical Reason|2|||
13182672|NCT02202031|26158179|FG000|Overall Study|Intolerance/Lack of Improvement|3|||
13182673|NCT02202031|26158180|FG001|Overall Study|Intolerance/Lack of Improvement|0|||
13182674|NCT02201953|26158203|FG000|Overall Study|Randomized but Never Treated|1|||
13182675|NCT02201953|26158204|FG001|Overall Study|Randomized but Never Treated|5|||
13182676|NCT02201953|26158203|FG000|Overall Study|Lack of Efficacy|9|||
13182677|NCT02201953|26158204|FG001|Overall Study|Lack of Efficacy|30|||
13182678|NCT02201953|26158203|FG000|Overall Study|Lost to Follow-up|8|||
13182679|NCT02201953|26158204|FG001|Overall Study|Lost to Follow-up|8|||
13182680|NCT02201953|26158203|FG000|Overall Study|Withdrew Consent|2|||
13110057|NCT03216226|25898555|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1|||
13182681|NCT02201953|26158204|FG001|Overall Study|Withdrew Consent|5|||
13110058|NCT03216226|25898556|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0|||
13110059|NCT03216226|25898555|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0|||
13110060|NCT03216226|25898556|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1|||
13110061|NCT03216226|25898555|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0|||
13182682|NCT02201953|26158203|FG000|Overall Study|Adverse Event|0|||
13182683|NCT02201953|26158204|FG001|Overall Study|Adverse Event|5|||
13182684|NCT02201953|26158203|FG000|Overall Study|Death|0|||
13182685|NCT02201953|26158204|FG001|Overall Study|Death|3|||
13182686|NCT02201940|26158227|FG000|Overall Study|Randomized/Enrolled but Never Treated|1|||
13182687|NCT02201940|26158228|FG001|Overall Study|Randomized/Enrolled but Never Treated|0|||
13182688|NCT02201940|26158227|FG000|Overall Study|Lack of Efficacy|2|||
13182689|NCT02201940|26158228|FG001|Overall Study|Lack of Efficacy|113|||
13182690|NCT02201940|26158227|FG000|Overall Study|Lost to Follow-up|5|||
13182691|NCT02201940|26158228|FG001|Overall Study|Lost to Follow-up|0|||
13182692|NCT02201940|26158227|FG000|Overall Study|Withdrew Consent|2|||
13182693|NCT02201940|26158228|FG001|Overall Study|Withdrew Consent|1|||
13182694|NCT02201940|26158227|FG000|Overall Study|Investigator's Discretion|1|||
13182695|NCT02201940|26158228|FG001|Overall Study|Investigator's Discretion|1|||
13182696|NCT02201940|26158227|FG000|Overall Study|Death|1|||
13182697|NCT02201940|26158228|FG001|Overall Study|Death|0|||
13182698|NCT02201940|26158227|FG000|Overall Study|Adverse Event|0|||
13182699|NCT02201940|26158228|FG001|Overall Study|Adverse Event|1|||
13182700|NCT02201901|26158267|FG000|Overall Study|Randomized but never treated|0|||
13182701|NCT02201901|26158268|FG001|Overall Study|Randomized but never treated|1|||
13182702|NCT02201901|26158269|FG002|Overall Study|Randomized but never treated|0|||
13182703|NCT02201901|26158267|FG000|Overall Study|Lack of Efficacy|7|||
13182704|NCT02201901|26158268|FG001|Overall Study|Lack of Efficacy|1|||
13182705|NCT02201901|26158269|FG002|Overall Study|Lack of Efficacy|6|||
13182706|NCT02201901|26158267|FG000|Overall Study|Death|3|||
13182707|NCT02201901|26158268|FG001|Overall Study|Death|3|||
13182708|NCT02201901|26158269|FG002|Overall Study|Death|3|||
13182709|NCT02201901|26158267|FG000|Overall Study|Lost to Follow-up|2|||
13182710|NCT02201901|26158268|FG001|Overall Study|Lost to Follow-up|3|||
13182711|NCT02201901|26158269|FG002|Overall Study|Lost to Follow-up|2|||
13182712|NCT02201901|26158267|FG000|Overall Study|Withdrew Consent|2|||
13182713|NCT02201901|26158268|FG001|Overall Study|Withdrew Consent|0|||
13182714|NCT02201901|26158269|FG002|Overall Study|Withdrew Consent|2|||
13182715|NCT02201901|26158267|FG000|Overall Study|Adverse Event|1|||
13182716|NCT02201901|26158268|FG001|Overall Study|Adverse Event|1|||
13182717|NCT02201901|26158269|FG002|Overall Study|Adverse Event|0|||
13182718|NCT02201784|26158290|FG000|Overall Study|Failure to achieve adequate block|2|||
13182719|NCT02201784|26158291|FG001|Overall Study|Failure to achieve adequate block|0|||
13182720|NCT02201771|26158324|FG000|Overall Study|Death|3|||
13182721|NCT02201771|26158325|FG001|Overall Study|Death|2|||
13182722|NCT02201771|26158326|FG002|Overall Study|Death|0|||
13182723|NCT02201771|26158324|FG000|Overall Study|Protocol Violation|10|||
13182724|NCT02201771|26158325|FG001|Overall Study|Protocol Violation|8|||
13182725|NCT02201771|26158326|FG002|Overall Study|Protocol Violation|10|||
13182726|NCT02201524|26158421|FG000|Overall Study|Adverse Event|0|||
13182727|NCT02201524|26158422|FG001|Overall Study|Adverse Event|2|||
13182728|NCT02201524|26158423|FG002|Overall Study|Adverse Event|1|||
13182729|NCT02201524|26158424|FG003|Overall Study|Adverse Event|0|||
13182730|NCT02201524|26158421|FG000|Overall Study|Insufficient clinical response|1|||
13182731|NCT02201524|26158422|FG001|Overall Study|Insufficient clinical response|0|||
13182732|NCT02201524|26158423|FG002|Overall Study|Insufficient clinical response|0|||
13182733|NCT02201524|26158424|FG003|Overall Study|Insufficient clinical response|0|||
13182734|NCT02201524|26158421|FG000|Overall Study|Lost to Follow-up|0|||
13182735|NCT02201524|26158422|FG001|Overall Study|Lost to Follow-up|0|||
13182736|NCT02201524|26158423|FG002|Overall Study|Lost to Follow-up|2|||
13182737|NCT02201524|26158424|FG003|Overall Study|Lost to Follow-up|0|||
13182738|NCT02201524|26158421|FG000|Overall Study|No longer meets eligibility criteria|0|||
13182739|NCT02201524|26158422|FG001|Overall Study|No longer meets eligibility criteria|0|||
13182740|NCT02201524|26158423|FG002|Overall Study|No longer meets eligibility criteria|0|||
13182741|NCT02201524|26158424|FG003|Overall Study|No longer meets eligibility criteria|2|||
13182742|NCT02201524|26158421|FG000|Overall Study|Protocol Violation|0|||
13182743|NCT02201524|26158422|FG001|Overall Study|Protocol Violation|0|||
13182744|NCT02201524|26158423|FG002|Overall Study|Protocol Violation|0|||
13182745|NCT02201524|26158424|FG003|Overall Study|Protocol Violation|1|||
13182746|NCT02201524|26158421|FG000|Overall Study|Withdrawal by Subject|0|||
13182747|NCT02201524|26158422|FG001|Overall Study|Withdrawal by Subject|0|||
13182748|NCT02201524|26158423|FG002|Overall Study|Withdrawal by Subject|1|||
13182749|NCT02201524|26158424|FG003|Overall Study|Withdrawal by Subject|1|||
13182750|NCT02201524|26158421|FG000|Overall Study|Other|1|||
13182751|NCT02201524|26158422|FG001|Overall Study|Other|1|||
13182752|NCT02201524|26158423|FG002|Overall Study|Other|0|||
13182753|NCT02201524|26158424|FG003|Overall Study|Other|0|||
13182754|NCT02201472|26158430|FG000|Overall Study|Lack of Efficacy|2|||
13182755|NCT02201329|26158440|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3|||
13182756|NCT02201329|26158440|FG000|Overall Study|Withdrawal by Subject|2|||
13182757|NCT02201290|26158446|FG000|Overall Study|Withdrawal by Subject|2|||
13182758|NCT02201290|26158446|FG000|Overall Study|Lack of Efficacy|2|||
13182759|NCT02201290|26158446|FG000|Overall Study|Adverse Event|1|||
13182760|NCT02201277|26158473|FG000|Overall Study|Death|3|||
13182761|NCT02201277|26158474|FG001|Overall Study|Death|4|||
13182762|NCT02201277|26158473|FG000|Overall Study|Lost to Follow-up|2|||
13182763|NCT02201277|26158474|FG001|Overall Study|Lost to Follow-up|1|||
13182764|NCT02201277|26158473|FG000|Overall Study|Failed retrieval|1|||
13182765|NCT02201277|26158474|FG001|Overall Study|Failed retrieval|0|||
13182766|NCT02201277|26158473|FG000|Overall Study|Physician Decision|1|||
13182767|NCT02201277|26158474|FG001|Overall Study|Physician Decision|0|||
13182768|NCT02201251|26158517|FG000|Overall Study|Adverse Event|1|||
13182769|NCT02201251|26158518|FG001|Overall Study|Adverse Event|1|||
13182770|NCT02201251|26158517|FG000|Overall Study|Protocol Violation|1|||
13182771|NCT02201251|26158518|FG001|Overall Study|Protocol Violation|0|||
13182772|NCT02201251|26158517|FG000|Overall Study|Noncompliance with Study Drug|0|||
13182773|NCT02201251|26158518|FG001|Overall Study|Noncompliance with Study Drug|1|||
13182774|NCT02201251|26158517|FG000|Overall Study|Withdrawal by Subject|2|||
13182775|NCT02201251|26158518|FG001|Overall Study|Withdrawal by Subject|1|||
13182776|NCT02200939|26158575|FG000|Overall Study|Participant withdrew consent|0|||
13182777|NCT02200939|26158576|FG001|Overall Study|Participant withdrew consent|1|||
13182778|NCT02200939|26158575|FG000|Overall Study|Lost to Follow-up|2|||
13182779|NCT02200939|26158576|FG001|Overall Study|Lost to Follow-up|9|||
13182780|NCT02200939|26158575|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0|||
13182781|NCT02200939|26158576|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1|||
13182782|NCT02200614|26158607|FG000|Double Blind Treatment|Adverse Event|86|||
13182783|NCT02200614|26158608|FG001|Double Blind Treatment|Adverse Event|48|||
13182784|NCT02200614|26158607|FG000|Double Blind Treatment|Confirmed metastasis|120|||
13182785|NCT02200614|26158608|FG001|Double Blind Treatment|Confirmed metastasis|140|||
13182786|NCT02200614|26158607|FG000|Double Blind Treatment|Judgment of the investigator|59|||
13182787|NCT02200614|26158608|FG001|Double Blind Treatment|Judgment of the investigator|99|||
13182788|NCT02200614|26158607|FG000|Double Blind Treatment|Metastasis by local reading|1|||
13182789|NCT02200614|26158608|FG001|Double Blind Treatment|Metastasis by local reading|3|||
13182790|NCT02200614|26158607|FG000|Double Blind Treatment|Other reason|6|||
13182791|NCT02200614|26158608|FG001|Double Blind Treatment|Other reason|2|||
13182792|NCT02200614|26158607|FG000|Double Blind Treatment|Personal reason|77|||
13182793|NCT02200614|26158608|FG001|Double Blind Treatment|Personal reason|85|||
13182794|NCT02200614|26158607|FG000|Double Blind Treatment|Protocol deviation|14|||
13182795|NCT02200614|26158608|FG001|Double Blind Treatment|Protocol deviation|7|||
13182796|NCT02200614|26158607|FG000|Double Blind Treatment|Not treated|1|||
13182797|NCT02200614|26158608|FG001|Double Blind Treatment|Not treated|0|||
13182798|NCT02200614|26158607|FG000|Open Label|Adverse Event|41|||
13182799|NCT02200614|26158608|FG001|Open Label|Adverse Event|11|||
13182800|NCT02200614|26158607|FG000|Open Label|Confirmed metastasis|1|||
13182801|NCT02200614|26158608|FG001|Open Label|Confirmed metastasis|0|||
13182802|NCT02200614|26158607|FG000|Open Label|Judgment of the investigator|29|||
13182803|NCT02200614|26158608|FG001|Open Label|Judgment of the investigator|2|||
13182804|NCT02200614|26158607|FG000|Open Label|Metastasis by local reading|138|||
13182805|NCT02200614|26158608|FG001|Open Label|Metastasis by local reading|27|||
13182806|NCT02200614|26158607|FG000|Open Label|Other reason|22|||
13182807|NCT02200614|26158608|FG001|Open Label|Other reason|4|||
13182808|NCT02200614|26158607|FG000|Open Label|Personal reason|60|||
13182809|NCT02200614|26158608|FG001|Open Label|Personal reason|8|||
13182810|NCT02200614|26158607|FG000|Open Label|Protocol deviation|3|||
13182811|NCT02200614|26158608|FG001|Open Label|Protocol deviation|2|||
13182812|NCT02200614|26158607|FG000|Open Label|Missing|2|||
13182813|NCT02200614|26158608|FG001|Open Label|Missing|2|||
13182814|NCT02200510|26158621|FG000|Overall Study|Death|1|||
13182815|NCT02200510|26158622|FG001|Overall Study|Death|1|||
13182816|NCT02200510|26158621|FG000|Overall Study|Protocol Violation|0|||
13182817|NCT02200510|26158622|FG001|Overall Study|Protocol Violation|1|||
13182818|NCT02200510|26158621|FG000|Overall Study|Lost to Follow-up|7|||
13182819|NCT02200510|26158622|FG001|Overall Study|Lost to Follow-up|1|||
13182820|NCT02200510|26158621|FG000|Overall Study|potential COI - joined study team|1|||
13182821|NCT02200510|26158622|FG001|Overall Study|potential COI - joined study team|0|||
13182822|NCT02200445|26158646|FG000|Overall Study|Lack of Efficacy|1|||
13182823|NCT02200445|26158647|FG001|Overall Study|Lack of Efficacy|2|||
13182824|NCT02200445|26158648|FG002|Overall Study|Lack of Efficacy|2|||
13182825|NCT02200445|26158646|FG000|Overall Study|Adverse Event|0|||
13182826|NCT02200445|26158647|FG001|Overall Study|Adverse Event|2|||
13182827|NCT02200445|26158648|FG002|Overall Study|Adverse Event|0|||
13182828|NCT02200211|26158757|FG000|Overall Study|Lost to Follow-up|7|||
13182829|NCT02200211|26158758|FG001|Overall Study|Lost to Follow-up|7|||
13182830|NCT02200211|26158759|FG002|Overall Study|Lost to Follow-up|1|||
13182831|NCT02200211|26158760|FG003|Overall Study|Lost to Follow-up|2|||
13182832|NCT02200211|26158757|FG000|Overall Study|Withdrawal by Subject|1|||
13182833|NCT02200211|26158758|FG001|Overall Study|Withdrawal by Subject|0|||
13182834|NCT02200211|26158759|FG002|Overall Study|Withdrawal by Subject|0|||
13182835|NCT02200211|26158760|FG003|Overall Study|Withdrawal by Subject|0|||
13182836|NCT02200042|26158783|FG000|Overall Study|Withdrawal by Subject|0|||
13182837|NCT02200042|26158784|FG001|Overall Study|Withdrawal by Subject|1|||
13182838|NCT02199795|26158803|FG000|Overall Study|no longer met inclusion criteria|1|||
13182839|NCT02199795|26158804|FG001|Overall Study|no longer met inclusion criteria|0|||
13182840|NCT02199795|26158803|FG000|Overall Study|withdrew due to shoulder pain|1|||
13182841|NCT02199795|26158804|FG001|Overall Study|withdrew due to shoulder pain|0|||
13182842|NCT02199509|26158819|FG000|Overall Study|Suicidal Ideation|0|||
13182843|NCT02199509|26158820|FG001|Overall Study|Suicidal Ideation|1|||
13182844|NCT02199509|26158819|FG000|Overall Study|Misunderstood titration schedule|1|||
13182845|NCT02199509|26158820|FG001|Overall Study|Misunderstood titration schedule|0|||
13223020|NCT01800916|26287702|FG004|Test Period 1 (1 Week)|Convex product user|0|||
13182846|NCT02199314|26158826|FG000|Overall Study|Withdrawal by Subject|6|||
13182847|NCT02199314|26158826|FG000|Overall Study|Physician Decision|10|||
13182848|NCT02199080|26158838|FG000|Overall Study|Protocol Violation|12|||
13182849|NCT02199028|26158854|FG000|Week 1|Adverse Event|1|||
13182850|NCT02199028|26158855|FG001|Week 1|Adverse Event|0|||
13182851|NCT02199028|26158854|FG000|Week 3|Adverse Event|1|||
13182852|NCT02199028|26158855|FG001|Week 3|Adverse Event|0|||
13182853|NCT02198963|26158866|FG000|Overall Study|Adverse Event|1|||
13182854|NCT02198963|26158866|FG000|Overall Study|Withdrawal by Subject|6|||
13182855|NCT02198794|26158889|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79|||
13182856|NCT02198794|26158890|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
13182857|NCT02198794|26158891|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
13182858|NCT02198794|26158892|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
13182859|NCT02198794|26158889|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33|||
13182860|NCT02198794|26158890|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
13182861|NCT02198794|26158891|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
13182862|NCT02198794|26158892|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
13182863|NCT02198794|26158889|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24|||
13182864|NCT02198794|26158890|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
13182865|NCT02198794|26158891|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
13182866|NCT02198794|26158892|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
13110062|NCT03216226|25898556|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1|||
13110063|NCT03215810|25898563|FG000|Overall Study|Still responding to nivolumab|1|||
13110064|NCT03215810|25898563|FG000|Overall Study|Insufficient TIL growth|1|||
13110065|NCT03215810|25898563|FG000|Overall Study|Decline in performance status|1|||
13110066|NCT03215810|25898563|FG000|Overall Study|Withdrawal by Subject|1|||
13182867|NCT02198794|26158889|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9|||
13182868|NCT02198794|26158890|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
13182869|NCT02198794|26158891|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
13182870|NCT02198794|26158892|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
13182871|NCT02198794|26158889|FG000|Part A: Open-Label (158 Weeks)|Death|8|||
13182872|NCT02198794|26158890|FG001|Part A: Open-Label (158 Weeks)|Death|0|||
13182873|NCT02198794|26158891|FG002|Part A: Open-Label (158 Weeks)|Death|0|||
13182874|NCT02198794|26158892|FG003|Part A: Open-Label (158 Weeks)|Death|0|||
13182875|NCT02198794|26158889|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3|||
13182876|NCT02198794|26158890|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
13182877|NCT02198794|26158891|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
13182878|NCT02198794|26158892|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
13182879|NCT02198794|26158889|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5|||
13182880|NCT02198794|26158890|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0|||
13182881|NCT02198794|26158891|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0|||
13182882|NCT02198794|26158892|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0|||
13182883|NCT02198794|26158889|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1|||
13182884|NCT02198794|26158890|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0|||
13182885|NCT02198794|26158891|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0|||
13182886|NCT02198794|26158892|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0|||
13182887|NCT02198794|26158889|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1|||
13182888|NCT02198794|26158890|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
13182889|NCT02198794|26158891|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
13182890|NCT02198794|26158892|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
13182891|NCT02198794|26158889|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142|||
13110067|NCT03215771|25898573|FG000|Overall Study|Withdrawal by Subject|2|||
13110068|NCT03215771|25898573|FG000|Overall Study|Physician Decision|1|||
13110069|NCT03215758|25898592|FG000|Overall Study|Technical Problems|1|||
13110070|NCT03215758|25898593|FG001|Overall Study|Technical Problems|0|||
13110071|NCT03215758|25898592|FG000|Overall Study|Protocol deviation|0|||
13110072|NCT03215758|25898593|FG001|Overall Study|Protocol deviation|1|||
13110073|NCT03215758|25898592|FG000|Overall Study|Physician Decision|0|||
13110074|NCT03215758|25898593|FG001|Overall Study|Physician Decision|1|||
13110075|NCT03215758|25898592|FG000|Overall Study|Death|0|||
13182892|NCT02198794|26158890|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
13182893|NCT02198794|26158891|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
13182894|NCT02198794|26158892|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
13182895|NCT02198794|26158889|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
13182896|NCT02198794|26158890|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3|||
13182897|NCT02198794|26158891|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1|||
13182898|NCT02198794|26158892|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
13182899|NCT02198794|26158889|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
13182900|NCT02198794|26158890|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
13182901|NCT02198794|26158891|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
13110076|NCT03215758|25898593|FG001|Overall Study|Death|1|||
13182902|NCT02198794|26158892|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
13182903|NCT02198794|26158889|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
13182904|NCT02198794|26158890|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
13182905|NCT02198794|26158891|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
13182906|NCT02198794|26158892|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3|||
13110077|NCT03215758|25898592|FG000|Overall Study|Adverse Event|1|||
13110078|NCT03215758|25898593|FG001|Overall Study|Adverse Event|2|||
13110079|NCT03215758|25898592|FG000|Overall Study|Subject/Guardian Decision|3|||
13110080|NCT03215758|25898593|FG001|Overall Study|Subject/Guardian Decision|3|||
13110081|NCT03215706|25898620|FG000|Randomization|Adverse Event unrelated to study drug|1|||
13110082|NCT03215706|25898621|FG001|Randomization|Adverse Event unrelated to study drug|0|||
13110083|NCT03215706|25898620|FG000|Randomization|participant withdrew consent|1|||
13110084|NCT03215706|25898621|FG001|Randomization|participant withdrew consent|3|||
13110085|NCT03215706|25898620|FG000|Randomization|no longer meets study criteria|1|||
13182907|NCT02198794|26158889|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
13182908|NCT02198794|26158890|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
13182909|NCT02198794|26158891|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
13182910|NCT02198794|26158892|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2|||
13182911|NCT02198794|26158889|FG000|Part C: Safety Assessment (52 Weeks)|Death|0|||
13182912|NCT02198794|26158890|FG001|Part C: Safety Assessment (52 Weeks)|Death|0|||
13182913|NCT02198794|26158891|FG002|Part C: Safety Assessment (52 Weeks)|Death|0|||
13182914|NCT02198794|26158892|FG003|Part C: Safety Assessment (52 Weeks)|Death|2|||
13182915|NCT02198664|26158924|FG000|Overall Study|Adverse Event|2|||
13182916|NCT02198664|26158925|FG001|Overall Study|Adverse Event|0|||
13182917|NCT02198664|26158924|FG000|Overall Study|Withdrawal by Subject|11|||
13182918|NCT02198664|26158925|FG001|Overall Study|Withdrawal by Subject|8|||
13182919|NCT02198664|26158924|FG000|Overall Study|Failure to tolerate|2|||
13182920|NCT02198664|26158925|FG001|Overall Study|Failure to tolerate|0|||
13182921|NCT02198664|26158924|FG000|Overall Study|Not stated|1|||
13182922|NCT02198664|26158925|FG001|Overall Study|Not stated|0|||
13182923|NCT02198651|26159014|FG000|Lead-in Period|Withdrew consent|13|||
13182924|NCT02198651|26159015|FG001|Lead-in Period|Withdrew consent|0|||
13182925|NCT02198651|26159016|FG002|Lead-in Period|Withdrew consent|0|||
13182926|NCT02198651|26159017|FG003|Lead-in Period|Withdrew consent|0|||
13182927|NCT02198651|26159018|FG004|Lead-in Period|Withdrew consent|0|||
13182928|NCT02198651|26159014|FG000|Lead-in Period|Adverse Event|2|||
13182929|NCT02198651|26159015|FG001|Lead-in Period|Adverse Event|0|||
13182930|NCT02198651|26159016|FG002|Lead-in Period|Adverse Event|0|||
13182931|NCT02198651|26159017|FG003|Lead-in Period|Adverse Event|0|||
13182932|NCT02198651|26159018|FG004|Lead-in Period|Adverse Event|0|||
13182933|NCT02198651|26159014|FG000|Lead-in Period|Other, not specified|22|||
13182934|NCT02198651|26159015|FG001|Lead-in Period|Other, not specified|0|||
13182935|NCT02198651|26159016|FG002|Lead-in Period|Other, not specified|0|||
13182936|NCT02198651|26159017|FG003|Lead-in Period|Other, not specified|0|||
13182937|NCT02198651|26159018|FG004|Lead-in Period|Other, not specified|0|||
13182938|NCT02198651|26159014|FG000|Double-blind Period|Withdrew consent|0|||
13182939|NCT02198651|26159015|FG001|Double-blind Period|Withdrew consent|4|||
13182940|NCT02198651|26159016|FG002|Double-blind Period|Withdrew consent|0|||
13182941|NCT02198651|26159017|FG003|Double-blind Period|Withdrew consent|0|||
13182942|NCT02198651|26159018|FG004|Double-blind Period|Withdrew consent|0|||
13182943|NCT02198651|26159014|FG000|Double-blind Period|Adverse Event|0|||
13182944|NCT02198651|26159015|FG001|Double-blind Period|Adverse Event|1|||
13182945|NCT02198651|26159016|FG002|Double-blind Period|Adverse Event|0|||
13182946|NCT02198651|26159017|FG003|Double-blind Period|Adverse Event|0|||
13182947|NCT02198651|26159018|FG004|Double-blind Period|Adverse Event|0|||
13182948|NCT02198651|26159014|FG000|Double-blind Period|Other, not specified|0|||
13182949|NCT02198651|26159015|FG001|Double-blind Period|Other, not specified|4|||
13182950|NCT02198651|26159016|FG002|Double-blind Period|Other, not specified|1|||
13182951|NCT02198651|26159017|FG003|Double-blind Period|Other, not specified|0|||
13182952|NCT02198651|26159018|FG004|Double-blind Period|Other, not specified|0|||
13182953|NCT02198651|26159014|FG000|Open-label Rescue Period|Withdrew consent|0|||
13182954|NCT02198651|26159015|FG001|Open-label Rescue Period|Withdrew consent|0|||
13182955|NCT02198651|26159016|FG002|Open-label Rescue Period|Withdrew consent|0|||
13182956|NCT02198651|26159017|FG003|Open-label Rescue Period|Withdrew consent|2|||
13182957|NCT02198651|26159018|FG004|Open-label Rescue Period|Withdrew consent|0|||
13182958|NCT02198651|26159014|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
13182959|NCT02198651|26159015|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
13182960|NCT02198651|26159016|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
13182961|NCT02198651|26159017|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1|||
13182962|NCT02198651|26159018|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
13182963|NCT02198235|26159045|FG000|Overall Study|Lost to Follow-up|3|||
13182964|NCT02198235|26159046|FG001|Overall Study|Lost to Follow-up|2|||
13182965|NCT02198235|26159047|FG002|Overall Study|Lost to Follow-up|2|||
13182966|NCT02198040|26159083|FG000|Overall Study|Work reasons|0|||
13182967|NCT02198040|26159084|FG001|Overall Study|Work reasons|1|||
13182968|NCT02198040|26159085|FG002|Overall Study|Work reasons|0|||
13182969|NCT02198040|26159083|FG000|Overall Study|Withdrawal by Subject|0|||
13182970|NCT02198040|26159084|FG001|Overall Study|Withdrawal by Subject|0|||
13182971|NCT02198040|26159085|FG002|Overall Study|Withdrawal by Subject|1|||
13182972|NCT02197897|26159091|FG000|Overall Study|not eligible|1|||
13182973|NCT02197806|26159114|FG000|Overall Study|Adverse Event|0|||
13182974|NCT02197806|26159115|FG001|Overall Study|Adverse Event|1|||
13182975|NCT02197806|26159116|FG002|Overall Study|Adverse Event|0|||
13182976|NCT02197806|26159117|FG003|Overall Study|Adverse Event|1|||
13182977|NCT02197520|26159136|FG000|Period 1|Withdrawal by Subject|1|||
13110086|NCT03215706|25898621|FG001|Randomization|no longer meets study criteria|4|||
13110087|NCT03215706|25898620|FG000|Randomization|other reasons|0|||
13110088|NCT03215706|25898621|FG001|Randomization|other reasons|2|||
13110089|NCT03215706|25898620|FG000|Treatment Period|Disease Progression|150|||
13182978|NCT02197520|26159137|FG001|Period 1|Withdrawal by Subject|0|||
13182979|NCT02197520|26159136|FG000|Period 2|Adverse Event|0|||
13182980|NCT02197520|26159137|FG001|Period 2|Adverse Event|2|||
13182981|NCT02197520|26159136|FG000|Period 2|Withdrawal by Subject|1|||
13182982|NCT02197520|26159137|FG001|Period 2|Withdrawal by Subject|0|||
13182983|NCT02197416|26159183|FG000|Overall Study|Other reasons|0|||
13110090|NCT03215706|25898621|FG001|Treatment Period|Disease Progression|142|||
13110091|NCT03215706|25898620|FG000|Treatment Period|Study Drug Toxicity|53|||
13110092|NCT03215706|25898621|FG001|Treatment Period|Study Drug Toxicity|21|||
13110093|NCT03215706|25898620|FG000|Treatment Period|Death|2|||
13110094|NCT03215706|25898621|FG001|Treatment Period|Death|1|||
13110095|NCT03215706|25898620|FG000|Treatment Period|Adverse event unrelated to study drug|24|||
13110096|NCT03215706|25898621|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
13110097|NCT03215706|25898620|FG000|Treatment Period|Request to D/C treatment|1|||
13110098|NCT03215706|25898621|FG001|Treatment Period|Request to D/C treatment|6|||
13110099|NCT03215706|25898620|FG000|Treatment Period|Participant withdrew consent|3|||
13110100|NCT03215706|25898621|FG001|Treatment Period|Participant withdrew consent|4|||
13110101|NCT03215706|25898620|FG000|Treatment Period|Lost to Follow-up|0|||
13110102|NCT03215706|25898621|FG001|Treatment Period|Lost to Follow-up|1|||
13110103|NCT03215706|25898620|FG000|Treatment Period|Other Reasons|4|||
13110104|NCT03215706|25898621|FG001|Treatment Period|Other Reasons|5|||
13110105|NCT03215706|25898620|FG000|Treatment Period|Ongoing in the treatment period|105|||
13110106|NCT03215706|25898621|FG001|Treatment Period|Ongoing in the treatment period|43|||
13110107|NCT03215667|25898628|FG000|Overall Study|Physician Decision|4|||
13110108|NCT03214952|25898642|FG000|Overall Study|Protocol Deviation|45|||
13182984|NCT02197416|26159184|FG001|Overall Study|Other reasons|2|||
13182985|NCT02197416|26159185|FG002|Overall Study|Other reasons|5|||
13182986|NCT02197416|26159183|FG000|Overall Study|Withdrawal by Subject|0|||
13182987|NCT02197416|26159184|FG001|Overall Study|Withdrawal by Subject|2|||
13182988|NCT02197416|26159185|FG002|Overall Study|Withdrawal by Subject|1|||
13182989|NCT02197416|26159183|FG000|Overall Study|Protocol Violation|1|||
13182990|NCT02197416|26159184|FG001|Overall Study|Protocol Violation|0|||
13182991|NCT02197416|26159185|FG002|Overall Study|Protocol Violation|1|||
13182992|NCT02197416|26159183|FG000|Overall Study|Adverse Event|0|||
13182993|NCT02197416|26159184|FG001|Overall Study|Adverse Event|0|||
13182994|NCT02197416|26159185|FG002|Overall Study|Adverse Event|1|||
13182995|NCT02197377|26159200|FG000|Overall Study|Insertion Failure|0|||
13182996|NCT02197377|26159201|FG001|Overall Study|Insertion Failure|3|||
13182997|NCT02197247|26159248|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2|||
13182998|NCT02197247|26159248|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2|||
13182999|NCT02197247|26159248|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5|||
13183000|NCT02197247|26159248|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2|||
13183001|NCT02197247|26159248|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2|||
13183002|NCT02197247|26159248|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1|||
13183003|NCT02197247|26159248|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1|||
13183004|NCT02197247|26159248|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9|||
13183005|NCT02197130|26159308|FG000|Overall Study|Adverse Event|13|||
13183006|NCT02197130|26159309|FG001|Overall Study|Adverse Event|4|||
13183007|NCT02197130|26159310|FG002|Overall Study|Adverse Event|23|||
13183008|NCT02197130|26159308|FG000|Overall Study|Death|0|||
13183009|NCT02197130|26159309|FG001|Overall Study|Death|1|||
13183010|NCT02197130|26159310|FG002|Overall Study|Death|0|||
13183011|NCT02197130|26159308|FG000|Overall Study|Lost to Follow-up|2|||
13183012|NCT02197130|26159309|FG001|Overall Study|Lost to Follow-up|0|||
13183013|NCT02197130|26159310|FG002|Overall Study|Lost to Follow-up|1|||
13183014|NCT02197130|26159308|FG000|Overall Study|Does not meet entrance criteria|0|||
13110109|NCT03214952|25898642|FG000|Overall Study|Case Report Forms Uncollected|13|||
13110110|NCT03214666|25898700|FG000|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
13183015|NCT02197130|26159309|FG001|Overall Study|Does not meet entrance criteria|0|||
13183016|NCT02197130|26159310|FG002|Overall Study|Does not meet entrance criteria|1|||
13183017|NCT02197130|26159308|FG000|Overall Study|Withdrawal by Subject|0|||
13183018|NCT02197130|26159309|FG001|Overall Study|Withdrawal by Subject|3|||
13183019|NCT02197130|26159310|FG002|Overall Study|Withdrawal by Subject|4|||
13183020|NCT02197130|26159308|FG000|Overall Study|Other|1|||
13183021|NCT02197130|26159309|FG001|Overall Study|Other|0|||
13183022|NCT02197130|26159310|FG002|Overall Study|Other|3|||
13183023|NCT02196714|26159435|FG000|Overall Study|Protocol Violation|0|||
13183024|NCT02196714|26159436|FG001|Overall Study|Protocol Violation|0|||
13183025|NCT02196714|26159437|FG002|Overall Study|Protocol Violation|1|||
13183026|NCT02196714|26159438|FG003|Overall Study|Protocol Violation|0|||
13183027|NCT02196701|26159500|FG000|Overall Study|Adverse Event|1|||
13183028|NCT02196701|26159500|FG000|Overall Study|Lost to Follow-up|1|||
13183029|NCT02196701|26159500|FG000|Overall Study|Non-adherence to Protocol|1|||
13183030|NCT02196675|26159530|FG000|Overall Study|Withdrawal by Subject|1|||
13183031|NCT02196675|26159531|FG001|Overall Study|Withdrawal by Subject|0|||
13183032|NCT02196675|26159532|FG002|Overall Study|Withdrawal by Subject|0|||
13183033|NCT02196675|26159530|FG000|Overall Study|Intra-operative surgical exclusion|1|||
13183034|NCT02196675|26159531|FG001|Overall Study|Intra-operative surgical exclusion|1|||
13183035|NCT02196675|26159532|FG002|Overall Study|Intra-operative surgical exclusion|0|||
13183036|NCT02196675|26159530|FG000|Overall Study|Protocol Violation|0|||
13183037|NCT02196675|26159531|FG001|Overall Study|Protocol Violation|1|||
13183038|NCT02196675|26159532|FG002|Overall Study|Protocol Violation|0|||
13183039|NCT02196675|26159530|FG000|Overall Study|Death|0|||
13183040|NCT02196675|26159531|FG001|Overall Study|Death|0|||
13183041|NCT02196675|26159532|FG002|Overall Study|Death|1|||
13183042|NCT02196558|26159556|FG000|Treatment Phase (12 Weeks)|Adverse Event|0|||
13183043|NCT02196558|26159557|FG001|Treatment Phase (12 Weeks)|Adverse Event|2|||
13183044|NCT02196558|26159558|FG002|Treatment Phase (12 Weeks)|Adverse Event|0|||
13183045|NCT02196558|26159556|FG000|Treatment Phase (12 Weeks)|Participant Choice|0|||
13183046|NCT02196558|26159557|FG001|Treatment Phase (12 Weeks)|Participant Choice|1|||
13183047|NCT02196558|26159558|FG002|Treatment Phase (12 Weeks)|Participant Choice|1|||
13183048|NCT02196558|26159556|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0|||
13183049|NCT02196558|26159557|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0|||
13183050|NCT02196558|26159558|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1|||
13183051|NCT02196558|26159556|FG000|Extension Phase (40 Weeks)|Adverse Event|1|||
13183052|NCT02196558|26159557|FG001|Extension Phase (40 Weeks)|Adverse Event|2|||
13183053|NCT02196558|26159558|FG002|Extension Phase (40 Weeks)|Adverse Event|0|||
13183054|NCT02196558|26159556|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
13183055|NCT02196558|26159557|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
13183056|NCT02196558|26159558|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
13183057|NCT02196506|26159579|FG000|Phase A|Participant Met Withdrawal Criteria|34|||
13183058|NCT02196506|26159580|FG001|Phase A|Participant Met Withdrawal Criteria|0|||
13183059|NCT02196506|26159581|FG002|Phase A|Participant Met Withdrawal Criteria|0|||
13183060|NCT02196506|26159582|FG003|Phase A|Participant Met Withdrawal Criteria|0|||
13183061|NCT02196506|26159579|FG000|Phase A|Withdrawal by Subject|34|||
13183062|NCT02196506|26159580|FG001|Phase A|Withdrawal by Subject|0|||
13183063|NCT02196506|26159581|FG002|Phase A|Withdrawal by Subject|0|||
13183064|NCT02196506|26159582|FG003|Phase A|Withdrawal by Subject|0|||
13183065|NCT02196506|26159579|FG000|Phase A|Adverse Event|22|||
13183066|NCT02196506|26159580|FG001|Phase A|Adverse Event|0|||
13183067|NCT02196506|26159581|FG002|Phase A|Adverse Event|0|||
13183068|NCT02196506|26159582|FG003|Phase A|Adverse Event|0|||
13183069|NCT02196506|26159579|FG000|Phase A|Lost to Follow-up|9|||
13183070|NCT02196506|26159580|FG001|Phase A|Lost to Follow-up|0|||
13183071|NCT02196506|26159581|FG002|Phase A|Lost to Follow-up|0|||
13183072|NCT02196506|26159582|FG003|Phase A|Lost to Follow-up|0|||
13183073|NCT02196506|26159579|FG000|Phase A|Protocol deviation|12|||
13183074|NCT02196506|26159580|FG001|Phase A|Protocol deviation|0|||
13183075|NCT02196506|26159581|FG002|Phase A|Protocol deviation|0|||
13183076|NCT02196506|26159582|FG003|Phase A|Protocol deviation|0|||
13183077|NCT02196506|26159579|FG000|Phase A|Participant withdrawn by investigator|10|||
13183078|NCT02196506|26159580|FG001|Phase A|Participant withdrawn by investigator|0|||
13183079|NCT02196506|26159581|FG002|Phase A|Participant withdrawn by investigator|0|||
13183080|NCT02196506|26159582|FG003|Phase A|Participant withdrawn by investigator|0|||
13183081|NCT02196506|26159579|FG000|Phase B|Participant Met Withdrawal Criteria|0|||
13183082|NCT02196506|26159580|FG001|Phase B|Participant Met Withdrawal Criteria|0|||
13183083|NCT02196506|26159581|FG002|Phase B|Participant Met Withdrawal Criteria|1|||
13183084|NCT02196506|26159582|FG003|Phase B|Participant Met Withdrawal Criteria|0|||
13183085|NCT02196506|26159579|FG000|Phase B|Lack of Efficacy|0|||
13183086|NCT02196506|26159580|FG001|Phase B|Lack of Efficacy|1|||
13183087|NCT02196506|26159581|FG002|Phase B|Lack of Efficacy|2|||
13183088|NCT02196506|26159582|FG003|Phase B|Lack of Efficacy|0|||
13183089|NCT02196506|26159579|FG000|Phase B|Withdrawal by Participant|0|||
13183090|NCT02196506|26159580|FG001|Phase B|Withdrawal by Participant|8|||
13183091|NCT02196506|26159581|FG002|Phase B|Withdrawal by Participant|1|||
13183092|NCT02196506|26159582|FG003|Phase B|Withdrawal by Participant|0|||
13183093|NCT02196506|26159579|FG000|Phase B|Adverse Event|0|||
13183094|NCT02196506|26159580|FG001|Phase B|Adverse Event|4|||
13183095|NCT02196506|26159581|FG002|Phase B|Adverse Event|1|||
13183096|NCT02196506|26159582|FG003|Phase B|Adverse Event|0|||
13183097|NCT02196506|26159579|FG000|Phase B|Lost to Follow-up|0|||
13183098|NCT02196506|26159580|FG001|Phase B|Lost to Follow-up|2|||
13183099|NCT02196506|26159581|FG002|Phase B|Lost to Follow-up|1|||
13183100|NCT02196506|26159582|FG003|Phase B|Lost to Follow-up|0|||
13183101|NCT02196506|26159579|FG000|Phase A+|Participant Met Withdrawal Criteria|0|||
13183102|NCT02196506|26159580|FG001|Phase A+|Participant Met Withdrawal Criteria|0|||
13183103|NCT02196506|26159581|FG002|Phase A+|Participant Met Withdrawal Criteria|0|||
13183104|NCT02196506|26159582|FG003|Phase A+|Participant Met Withdrawal Criteria|1|||
13183105|NCT02196506|26159579|FG000|Phase A+|Withdrawal by Participant|0|||
13183106|NCT02196506|26159580|FG001|Phase A+|Withdrawal by Participant|0|||
13183107|NCT02196506|26159581|FG002|Phase A+|Withdrawal by Participant|0|||
13183108|NCT02196506|26159582|FG003|Phase A+|Withdrawal by Participant|5|||
13183109|NCT02196506|26159579|FG000|Phase A+|Adverse Event|0|||
13183110|NCT02196506|26159580|FG001|Phase A+|Adverse Event|0|||
13183111|NCT02196506|26159581|FG002|Phase A+|Adverse Event|0|||
13183112|NCT02196506|26159582|FG003|Phase A+|Adverse Event|1|||
13183113|NCT02196506|26159579|FG000|Phase A+|Lost to Follow-up|0|||
13183114|NCT02196506|26159580|FG001|Phase A+|Lost to Follow-up|0|||
13183115|NCT02196506|26159581|FG002|Phase A+|Lost to Follow-up|0|||
13183116|NCT02196506|26159582|FG003|Phase A+|Lost to Follow-up|6|||
13183117|NCT02196506|26159579|FG000|Phase A+|Participant withdrawn by investigator|0|||
13183118|NCT02196506|26159580|FG001|Phase A+|Participant withdrawn by investigator|0|||
13183119|NCT02196506|26159581|FG002|Phase A+|Participant withdrawn by investigator|0|||
13183120|NCT02196506|26159582|FG003|Phase A+|Participant withdrawn by investigator|1|||
13183121|NCT02196324|26159627|FG000|Overall Study|Withdrawal by Subject|8|||
13183122|NCT02196324|26159628|FG001|Overall Study|Withdrawal by Subject|4|||
13183123|NCT02196324|26159627|FG000|Overall Study|Adverse Event or Serious Adverse Event|6|||
13183124|NCT02196324|26159628|FG001|Overall Study|Adverse Event or Serious Adverse Event|3|||
13183125|NCT02196324|26159627|FG000|Overall Study|Occurrence of an Exclusion Criterion|0|||
13183126|NCT02196324|26159628|FG001|Overall Study|Occurrence of an Exclusion Criterion|1|||
13183127|NCT02196324|26159627|FG000|Overall Study|Other|1|||
13183128|NCT02196324|26159628|FG001|Overall Study|Other|0|||
13183129|NCT02196259|26159645|FG000|Overall Study|Researcher choice|0|||
13183130|NCT02196259|26159646|FG001|Overall Study|Researcher choice|0|||
13183131|NCT02196259|26159647|FG002|Overall Study|Researcher choice|1|||
13183132|NCT02196259|26159645|FG000|Overall Study|Partial data analysis|0|||
13183133|NCT02196259|26159646|FG001|Overall Study|Partial data analysis|3|||
13183134|NCT02196259|26159647|FG002|Overall Study|Partial data analysis|0|||
13183135|NCT02196077|26159696|FG000|Overall Study|Adverse Event|4|||
13183136|NCT02196077|26159696|FG000|Overall Study|Lack of Efficacy|1|||
13183137|NCT02196077|26159696|FG000|Overall Study|Withdrawal by Subject|14|||
13183138|NCT02196077|26159696|FG000|Overall Study|Physician Decision|1|||
13183139|NCT02196077|26159696|FG000|Overall Study|Lost to Follow-up|3|||
13183140|NCT02196077|26159696|FG000|Overall Study|Protocol Violation|24|||
13183141|NCT02196038|26159711|FG000|Overall Study|Death|16|||
13183142|NCT02196038|26159712|FG001|Overall Study|Death|21|||
13183143|NCT02196038|26159711|FG000|Overall Study|Withdrawal by Subject|0|||
13183144|NCT02196038|26159712|FG001|Overall Study|Withdrawal by Subject|1|||
13183145|NCT02196038|26159711|FG000|Overall Study|Lost to Follow-up|1|||
13183146|NCT02196038|26159712|FG001|Overall Study|Lost to Follow-up|0|||
13183147|NCT02195869|26159725|FG000|Overall Study|cGVHD Progression|5|||
13183148|NCT02195869|26159725|FG000|Overall Study|Malignancy Progression/relapse|2|||
13183149|NCT02195869|26159725|FG000|Overall Study|Adverse Event|15|||
13183150|NCT02195869|26159725|FG000|Overall Study|Withdrawal by Subject|7|||
13183151|NCT02195869|26159725|FG000|Overall Study|Physician Decision|4|||
13183152|NCT02195869|26159725|FG000|Overall Study|Study Terminated by Sponsor|7|||
13183153|NCT02195869|26159725|FG000|Overall Study|Noncompliance with study drug|2|||
13183154|NCT02195700|26159752|FG000|Overall Study|Protocol Violation|0|||
13183155|NCT02195700|26159753|FG001|Overall Study|Protocol Violation|2|||
13183156|NCT02195700|26159752|FG000|Overall Study|Noncompliance|1|||
13183157|NCT02195700|26159753|FG001|Overall Study|Noncompliance|0|||
13183158|NCT02195700|26159752|FG000|Overall Study|Adverse Event|1|||
13183159|NCT02195700|26159753|FG001|Overall Study|Adverse Event|2|||
13183160|NCT02195700|26159752|FG000|Overall Study|Withdrawal by Subject|3|||
13183161|NCT02195700|26159753|FG001|Overall Study|Withdrawal by Subject|2|||
13183162|NCT02195700|26159752|FG000|Overall Study|Lost to Follow-up|1|||
13183163|NCT02195700|26159753|FG001|Overall Study|Lost to Follow-up|1|||
13183164|NCT02195687|26159776|FG000|Overall Study|Personal Reasons|1|||
13183165|NCT02195687|26159777|FG001|Overall Study|Personal Reasons|1|||
13223021|NCT01800916|26287703|FG005|Test Period 1 (1 Week)|Convex product user|0|||
13223022|NCT01800916|26287704|FG006|Test Period 1 (1 Week)|Convex product user|0|||
13183166|NCT02195687|26159776|FG000|Overall Study|Lost to Follow-up|4|||
13183167|NCT02195687|26159777|FG001|Overall Study|Lost to Follow-up|1|||
13183168|NCT02195583|26159811|FG000|Overall Study|Lost to Follow-up|1|||
13183169|NCT02195583|26159811|FG000|Overall Study|Withdrawal by Subject|4|||
13183170|NCT02195583|26159811|FG000|Overall Study|Adverse Event|2|||
13183171|NCT02195583|26159811|FG000|Overall Study|Other Reason|2|||
13183172|NCT02195531|26159846|FG000|Overall Study|Withdrawal by Subject|1|||
13183173|NCT02195531|26159847|FG001|Overall Study|Withdrawal by Subject|1|||
13183174|NCT02195531|26159848|FG002|Overall Study|Withdrawal by Subject|1|||
13183175|NCT02195518|26159871|FG000|Overall Study|Adverse Event|1|||
13183176|NCT02195518|26159871|FG000|Overall Study|Protocol Violation|4|||
13183177|NCT02195518|26159871|FG000|Overall Study|Pregnancy|2|||
13183178|NCT02195518|26159871|FG000|Overall Study|Withdrawal by Subject|1|||
13183179|NCT02195518|26159871|FG000|Overall Study|Lost to Follow-up|1|||
13183180|NCT02195427|26159940|FG000|Overall Study|Did not consent to study extension|13|||
13183181|NCT02195427|26159941|FG001|Overall Study|Did not consent to study extension|9|||
13183182|NCT02195427|26159940|FG000|Overall Study|Withdrawal by Subject|4|||
13183183|NCT02195427|26159941|FG001|Overall Study|Withdrawal by Subject|2|||
13183184|NCT02195427|26159940|FG000|Overall Study|Lost to Follow-up|0|||
13183185|NCT02195427|26159941|FG001|Overall Study|Lost to Follow-up|1|||
13183186|NCT02195427|26159940|FG000|Overall Study|Protocol Violation|7|||
13183187|NCT02195427|26159941|FG001|Overall Study|Protocol Violation|14|||
13183188|NCT02195427|26159940|FG000|Overall Study|Conditional re-treatment at W52|2|||
13183189|NCT02195427|26159941|FG001|Overall Study|Conditional re-treatment at W52|1|||
13183190|NCT02195011|26159960|FG000|Overall Study|Adverse Event|4|||
13183191|NCT02195011|26159961|FG001|Overall Study|Adverse Event|0|||
13183192|NCT02195011|26159960|FG000|Overall Study|Progressive Disease|18|||
13183193|NCT02195011|26159961|FG001|Overall Study|Progressive Disease|1|||
13183194|NCT02195011|26159960|FG000|Overall Study|Withdrawal by Subject|3|||
13183195|NCT02195011|26159961|FG001|Overall Study|Withdrawal by Subject|0|||
13183196|NCT02194998|26160036|FG000|On-HCV Treatment|Did not pick up study medication|0|||
13183197|NCT02194998|26160037|FG001|On-HCV Treatment|Did not pick up study medication|1|||
13183198|NCT02194998|26160038|FG002|On-HCV Treatment|Did not pick up study medication|0|||
13183199|NCT02194998|26160039|FG003|On-HCV Treatment|Did not pick up study medication|0|||
13183200|NCT02194998|26160036|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
13183201|NCT02194998|26160037|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
13183202|NCT02194998|26160038|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
13183203|NCT02194998|26160039|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
13183204|NCT02194985|26160053|FG000|Overall Study|Adverse Event|1|||
13183205|NCT02194985|26160053|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3|||
13183206|NCT02194985|26160053|FG000|Overall Study|Physician Decision|4|||
13183207|NCT02194985|26160053|FG000|Overall Study|Lost to Follow-up|1|||
13183208|NCT02194985|26160053|FG000|Overall Study|Withdrawal by Subject|2|||
13183209|NCT02194933|26160112|FG000|Overall Study|Lost to Follow-up|1|||
13183210|NCT02194933|26160113|FG001|Overall Study|Lost to Follow-up|2|||
13183211|NCT02194933|26160112|FG000|Overall Study|Participant met withdrawal criteria|1|||
13183212|NCT02194933|26160113|FG001|Overall Study|Participant met withdrawal criteria|3|||
13183213|NCT02194933|26160112|FG000|Overall Study|Withdrawal by Subject|0|||
13183214|NCT02194933|26160113|FG001|Overall Study|Withdrawal by Subject|2|||
13183215|NCT02194933|26160112|FG000|Overall Study|Lack of Efficacy|1|||
13183216|NCT02194933|26160113|FG001|Overall Study|Lack of Efficacy|2|||
13183217|NCT02194699|26160225|FG000|Randomised|Did not receive treatment|1|||
13110111|NCT03214666|25898701|FG001|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
13110112|NCT03214666|25898702|FG002|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
13110113|NCT03214666|25898703|FG003|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
13110114|NCT03214666|25898704|FG004|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|1|||
13110115|NCT03214666|25898705|FG005|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
13110116|NCT03214640|25898736|FG000|Overall Study|Protocol Violation|1|||
13110117|NCT03214640|25898737|FG001|Overall Study|Protocol Violation|2|||
13110118|NCT03214640|25898738|FG002|Overall Study|Protocol Violation|1|||
13110119|NCT03214640|25898739|FG003|Overall Study|Protocol Violation|4|||
13110120|NCT03214588|25898814|FG000|Overall Study|Adverse Event|1|||
13110121|NCT03214588|25898815|FG001|Overall Study|Adverse Event|0|||
13110122|NCT03214588|25898816|FG002|Overall Study|Adverse Event|2|||
13110123|NCT03214588|25898814|FG000|Overall Study|Reason Not Specified|0|||
13183218|NCT02194699|26160226|FG001|Randomised|Did not receive treatment|5|||
13183219|NCT02194699|26160225|FG000|Randomised|Without potential for 52 weeks of IP|5|||
13183220|NCT02194699|26160226|FG001|Randomised|Without potential for 52 weeks of IP|5|||
13183221|NCT02194699|26160225|FG000|Randomised|Duplicate patient|2|||
13183222|NCT02194699|26160226|FG001|Randomised|Duplicate patient|1|||
13183223|NCT02194699|26160225|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4|||
13183224|NCT02194699|26160226|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3|||
13183225|NCT02194699|26160225|FG000|With Potential to Receive 52 Weeks of IP|Death|1|||
13183226|NCT02194699|26160226|FG001|With Potential to Receive 52 Weeks of IP|Death|3|||
13183227|NCT02194699|26160225|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5|||
13183228|NCT02194699|26160226|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8|||
13183229|NCT02194699|26160225|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
13183230|NCT02194699|26160226|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
13183231|NCT02194699|26160225|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14|||
13183232|NCT02194699|26160226|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20|||
13183233|NCT02194699|26160225|FG000|With Potential to Receive 52 Weeks of IP|Other|24|||
13183234|NCT02194699|26160226|FG001|With Potential to Receive 52 Weeks of IP|Other|16|||
13183235|NCT02194621|26160253|FG000|Overall Study|6 withdrew prior to randomization|2|||
13183236|NCT02194621|26160254|FG001|Overall Study|6 withdrew prior to randomization|2|||
13183237|NCT02194621|26160255|FG002|Overall Study|6 withdrew prior to randomization|2|||
13183238|NCT02194621|26160253|FG000|Overall Study|Withdrawal by Subject|4|||
13183239|NCT02194621|26160254|FG001|Overall Study|Withdrawal by Subject|4|||
13183240|NCT02194621|26160255|FG002|Overall Study|Withdrawal by Subject|7|||
13183241|NCT02194465|26160318|FG000|Overall Study|Adverse Event|6|||
13183242|NCT02194465|26160319|FG001|Overall Study|Adverse Event|1|||
13183243|NCT02194465|26160320|FG002|Overall Study|Adverse Event|4|||
13183244|NCT02194465|26160321|FG003|Overall Study|Adverse Event|4|||
13183245|NCT02194465|26160322|FG004|Overall Study|Adverse Event|4|||
13183246|NCT02194465|26160323|FG005|Overall Study|Adverse Event|2|||
13183247|NCT02194465|26160324|FG006|Overall Study|Adverse Event|0|||
13183248|NCT02194465|26160318|FG000|Overall Study|Lost to Follow-up|0|||
13183249|NCT02194465|26160319|FG001|Overall Study|Lost to Follow-up|0|||
13183250|NCT02194465|26160320|FG002|Overall Study|Lost to Follow-up|0|||
13183251|NCT02194465|26160321|FG003|Overall Study|Lost to Follow-up|1|||
13183252|NCT02194465|26160322|FG004|Overall Study|Lost to Follow-up|0|||
13183253|NCT02194465|26160323|FG005|Overall Study|Lost to Follow-up|1|||
13183254|NCT02194465|26160324|FG006|Overall Study|Lost to Follow-up|0|||
13183255|NCT02194465|26160318|FG000|Overall Study|Physician Decision|1|||
13183256|NCT02194465|26160319|FG001|Overall Study|Physician Decision|0|||
13183257|NCT02194465|26160320|FG002|Overall Study|Physician Decision|0|||
13183258|NCT02194465|26160321|FG003|Overall Study|Physician Decision|0|||
13183259|NCT02194465|26160322|FG004|Overall Study|Physician Decision|0|||
13183260|NCT02194465|26160323|FG005|Overall Study|Physician Decision|0|||
13183261|NCT02194465|26160324|FG006|Overall Study|Physician Decision|0|||
13183262|NCT02194465|26160318|FG000|Overall Study|Protocol Violation|1|||
13183263|NCT02194465|26160319|FG001|Overall Study|Protocol Violation|1|||
13183264|NCT02194465|26160320|FG002|Overall Study|Protocol Violation|2|||
13183265|NCT02194465|26160321|FG003|Overall Study|Protocol Violation|1|||
13183266|NCT02194465|26160322|FG004|Overall Study|Protocol Violation|1|||
13183267|NCT02194465|26160323|FG005|Overall Study|Protocol Violation|0|||
13183268|NCT02194465|26160324|FG006|Overall Study|Protocol Violation|0|||
13183269|NCT02194465|26160318|FG000|Overall Study|Withdrawal by Subject|1|||
13183270|NCT02194465|26160319|FG001|Overall Study|Withdrawal by Subject|3|||
13183271|NCT02194465|26160320|FG002|Overall Study|Withdrawal by Subject|1|||
13183272|NCT02194465|26160321|FG003|Overall Study|Withdrawal by Subject|2|||
13183273|NCT02194465|26160322|FG004|Overall Study|Withdrawal by Subject|2|||
13183274|NCT02194465|26160323|FG005|Overall Study|Withdrawal by Subject|1|||
13183275|NCT02194465|26160324|FG006|Overall Study|Withdrawal by Subject|2|||
13183276|NCT02194465|26160318|FG000|Overall Study|Discontinued follow-up period|0|||
13183277|NCT02194465|26160319|FG001|Overall Study|Discontinued follow-up period|2|||
13183278|NCT02194465|26160320|FG002|Overall Study|Discontinued follow-up period|1|||
13183279|NCT02194465|26160321|FG003|Overall Study|Discontinued follow-up period|0|||
13183280|NCT02194465|26160322|FG004|Overall Study|Discontinued follow-up period|2|||
13183281|NCT02194465|26160323|FG005|Overall Study|Discontinued follow-up period|0|||
13183282|NCT02194465|26160324|FG006|Overall Study|Discontinued follow-up period|0|||
13110124|NCT03214588|25898815|FG001|Overall Study|Reason Not Specified|1|||
13110125|NCT03214588|25898816|FG002|Overall Study|Reason Not Specified|0|||
13183283|NCT02194062|26160345|FG000|Overall Study|Lost to Follow-up|2|||
13183284|NCT02194062|26160346|FG001|Overall Study|Lost to Follow-up|2|||
13183285|NCT02194062|26160347|FG002|Overall Study|Lost to Follow-up|5|||
13183286|NCT02193880|26160354|FG000|Overall Study|patients did not collect enough HPC|3|||
13183287|NCT02193828|26160405|FG000|Overall Study|Withdrawal by Subject|0|||
13110126|NCT03214406|25898833|FG000|Overall Study|did not meet enrollment criteria|9|||
13110127|NCT03214406|25898834|FG001|Overall Study|did not meet enrollment criteria|13|||
13110128|NCT03214406|25898833|FG000|Overall Study|Withdrawal by Subject|1|||
13110129|NCT03214406|25898834|FG001|Overall Study|Withdrawal by Subject|0|||
13183288|NCT02193828|26160406|FG001|Overall Study|Withdrawal by Subject|0|||
13110130|NCT03214406|25898833|FG000|Overall Study|Lost to Follow-up|0|||
13110131|NCT03214406|25898834|FG001|Overall Study|Lost to Follow-up|2|||
13110132|NCT03214380|25898879|FG000|Lead-in|Adverse Event|3|||
13110133|NCT03214380|25898880|FG001|Lead-in|Adverse Event|0|||
13110134|NCT03214380|25898881|FG002|Lead-in|Adverse Event|0|||
13110135|NCT03214380|25898882|FG003|Lead-in|Adverse Event|1|||
13110136|NCT03214380|25898883|FG004|Lead-in|Adverse Event|0|||
13110137|NCT03214380|25898884|FG005|Lead-in|Adverse Event|0|||
13110138|NCT03214380|25898879|FG000|Lead-in|Lost to Follow-up|4|||
13183289|NCT02193828|26160407|FG002|Overall Study|Withdrawal by Subject|1|||
13183290|NCT02193828|26160408|FG003|Overall Study|Withdrawal by Subject|1|||
13183291|NCT02193776|26160435|FG000|Overall Study|Consent withdrawn|1|||
13183292|NCT02193776|26160436|FG001|Overall Study|Consent withdrawn|0|||
13183293|NCT02193776|26160437|FG002|Overall Study|Consent withdrawn|0|||
13183294|NCT02193776|26160438|FG003|Overall Study|Consent withdrawn|0|||
13183295|NCT02193776|26160435|FG000|Overall Study|Failure to comply with protocol|0|||
13183296|NCT02193776|26160436|FG001|Overall Study|Failure to comply with protocol|1|||
13183297|NCT02193776|26160437|FG002|Overall Study|Failure to comply with protocol|0|||
13183298|NCT02193776|26160438|FG003|Overall Study|Failure to comply with protocol|0|||
13183299|NCT02193776|26160435|FG000|Overall Study|Investigator/Sponsor decision|1|||
13183300|NCT02193776|26160436|FG001|Overall Study|Investigator/Sponsor decision|1|||
13183301|NCT02193776|26160437|FG002|Overall Study|Investigator/Sponsor decision|0|||
13183302|NCT02193776|26160438|FG003|Overall Study|Investigator/Sponsor decision|0|||
13183303|NCT02193776|26160435|FG000|Overall Study|Death|1|||
13183304|NCT02193776|26160436|FG001|Overall Study|Death|0|||
13183305|NCT02193776|26160437|FG002|Overall Study|Death|0|||
13183306|NCT02193776|26160438|FG003|Overall Study|Death|0|||
13183307|NCT02193776|26160435|FG000|Overall Study|Adverse event/Specific toxicity|5|||
13183308|NCT02193776|26160436|FG001|Overall Study|Adverse event/Specific toxicity|5|||
13183309|NCT02193776|26160437|FG002|Overall Study|Adverse event/Specific toxicity|2|||
13183310|NCT02193776|26160438|FG003|Overall Study|Adverse event/Specific toxicity|2|||
13183311|NCT02193178|26160487|FG000|Overall Study|Lost to Follow-up|1|||
13183312|NCT02193178|26160487|FG000|Overall Study|Dry eyes|1|||
13183313|NCT02193165|26160520|FG000|4 Week Product Use|Lost to Follow-up|1|||
13183314|NCT02193165|26160521|FG001|4 Week Product Use|Lost to Follow-up|1|||
13183315|NCT02193165|26160522|FG002|4 Week Product Use|Lost to Follow-up|1|||
13183316|NCT02193165|26160520|FG000|6 Week Product Use|Lost to Follow-up|0|||
13183317|NCT02193165|26160521|FG001|6 Week Product Use|Lost to Follow-up|1|||
13183318|NCT02193165|26160522|FG002|6 Week Product Use|Lost to Follow-up|0|||
13183319|NCT02193087|26160578|FG000|Overall Study|Adverse Event|2|||
13183320|NCT02193087|26160579|FG001|Overall Study|Adverse Event|0|||
13110139|NCT03214380|25898880|FG001|Lead-in|Lost to Follow-up|0|||
13110140|NCT03214380|25898881|FG002|Lead-in|Lost to Follow-up|0|||
13110141|NCT03214380|25898882|FG003|Lead-in|Lost to Follow-up|1|||
13110142|NCT03214380|25898883|FG004|Lead-in|Lost to Follow-up|0|||
13110143|NCT03214380|25898884|FG005|Lead-in|Lost to Follow-up|0|||
13110144|NCT03214380|25898879|FG000|Lead-in|Eligibility Criteria|3|||
13183321|NCT02193087|26160580|FG002|Overall Study|Adverse Event|0|||
13183322|NCT02193087|26160581|FG003|Overall Study|Adverse Event|11|||
13183323|NCT02193087|26160578|FG000|Overall Study|Lost to Follow-up|14|||
13183324|NCT02193087|26160579|FG001|Overall Study|Lost to Follow-up|6|||
13183325|NCT02193087|26160580|FG002|Overall Study|Lost to Follow-up|4|||
13183326|NCT02193087|26160581|FG003|Overall Study|Lost to Follow-up|37|||
13183327|NCT02193087|26160578|FG000|Overall Study|Protocol Violation|2|||
13183328|NCT02193087|26160579|FG001|Overall Study|Protocol Violation|0|||
13183329|NCT02193087|26160580|FG002|Overall Study|Protocol Violation|1|||
13183330|NCT02193087|26160581|FG003|Overall Study|Protocol Violation|2|||
13183331|NCT02193087|26160578|FG000|Overall Study|Withdrawal by Subject|10|||
13183332|NCT02193087|26160579|FG001|Overall Study|Withdrawal by Subject|3|||
13183333|NCT02193087|26160580|FG002|Overall Study|Withdrawal by Subject|1|||
13183334|NCT02193087|26160581|FG003|Overall Study|Withdrawal by Subject|19|||
13183335|NCT02193087|26160578|FG000|Overall Study|Other Reason Not Specified|7|||
13183336|NCT02193087|26160579|FG001|Overall Study|Other Reason Not Specified|2|||
13183337|NCT02193087|26160580|FG002|Overall Study|Other Reason Not Specified|1|||
13183338|NCT02193087|26160581|FG003|Overall Study|Other Reason Not Specified|9|||
13183339|NCT02193087|26160578|FG000|Overall Study|Did Not Receive Any Vaccination|2|||
13183340|NCT02193087|26160579|FG001|Overall Study|Did Not Receive Any Vaccination|3|||
13183341|NCT02193087|26160580|FG002|Overall Study|Did Not Receive Any Vaccination|0|||
13183342|NCT02193087|26160581|FG003|Overall Study|Did Not Receive Any Vaccination|1|||
13110145|NCT03214380|25898880|FG001|Lead-in|Eligibility Criteria|0|||
13110146|NCT03214380|25898881|FG002|Lead-in|Eligibility Criteria|0|||
13206078|NCT01959932|26233498|FG000|Overall Study|Withdrawal by Subject|1|||
13206079|NCT01959932|26233499|FG001|Overall Study|Withdrawal by Subject|0|||
13206080|NCT01959932|26233500|FG002|Overall Study|Withdrawal by Subject|0|||
13206081|NCT01959919|26233512|FG000|Overall Study|Did not meet the eligibility criteria|2|||
13206082|NCT01959880|26233547|FG000|Overall Study|Withdrawal by Subject|11|||
13206083|NCT01959880|26233548|FG001|Overall Study|Withdrawal by Subject|13|||
13206084|NCT01959880|26233549|FG002|Overall Study|Withdrawal by Subject|8|||
13206085|NCT01959880|26233550|FG003|Overall Study|Withdrawal by Subject|7|||
13110147|NCT03214380|25898882|FG003|Lead-in|Eligibility Criteria|0|||
13110148|NCT03214380|25898883|FG004|Lead-in|Eligibility Criteria|0|||
13110149|NCT03214380|25898884|FG005|Lead-in|Eligibility Criteria|0|||
13110150|NCT03214380|25898879|FG000|Lead-in|Physician Decision|6|||
13110151|NCT03214380|25898880|FG001|Lead-in|Physician Decision|0|||
13110152|NCT03214380|25898881|FG002|Lead-in|Physician Decision|0|||
13110153|NCT03214380|25898882|FG003|Lead-in|Physician Decision|0|||
13110154|NCT03214380|25898883|FG004|Lead-in|Physician Decision|0|||
13110155|NCT03214380|25898884|FG005|Lead-in|Physician Decision|0|||
13206086|NCT01959880|26233547|FG000|Overall Study|Death|1|||
13206087|NCT01959880|26233548|FG001|Overall Study|Death|10|||
13206088|NCT01959880|26233549|FG002|Overall Study|Death|1|||
13206089|NCT01959880|26233550|FG003|Overall Study|Death|2|||
13206090|NCT01959880|26233547|FG000|Overall Study|Lost to Follow-up|95|||
13183343|NCT02193074|26160620|FG000|Overall Study|Withdrawal by Subject|1|||
13183344|NCT02193074|26160621|FG001|Overall Study|Withdrawal by Subject|2|||
13183345|NCT02193074|26160620|FG000|Overall Study|Adverse Event|16|||
13183346|NCT02193074|26160621|FG001|Overall Study|Adverse Event|13|||
13183347|NCT02192970|26160636|FG000|Overall Study|Lost to Follow-up|6|||
13183348|NCT02192970|26160637|FG001|Overall Study|Lost to Follow-up|0|||
13183349|NCT02192905|26160650|FG000|Overall Study|Lost to Follow-up|1|||
13183350|NCT02192606|26160665|FG000|Overall Study|surgery type was changed|1|||
13183351|NCT02192606|26160666|FG001|Overall Study|surgery type was changed|1|||
13183352|NCT02192606|26160665|FG000|Overall Study|Physician Decision|1|||
13183353|NCT02192606|26160666|FG001|Overall Study|Physician Decision|2|||
13183354|NCT02192606|26160665|FG000|Overall Study|3D equipment rep unable to join|0|||
13183355|NCT02192606|26160666|FG001|Overall Study|3D equipment rep unable to join|1|||
13183356|NCT02192190|26160729|FG000|Overall Study|Adverse Event|1|||
13183357|NCT02192190|26160730|FG001|Overall Study|Adverse Event|1|||
13183358|NCT02192190|26160731|FG002|Overall Study|Adverse Event|0|||
13183359|NCT02192190|26160732|FG003|Overall Study|Adverse Event|0|||
13183360|NCT02192190|26160733|FG004|Overall Study|Adverse Event|0|||
13183361|NCT02192190|26160734|FG005|Overall Study|Adverse Event|0|||
13183362|NCT02192190|26160729|FG000|Overall Study|Lost to Follow-up|3|||
13183363|NCT02192190|26160730|FG001|Overall Study|Lost to Follow-up|3|||
13183364|NCT02192190|26160731|FG002|Overall Study|Lost to Follow-up|2|||
13183365|NCT02192190|26160732|FG003|Overall Study|Lost to Follow-up|1|||
13183366|NCT02192190|26160733|FG004|Overall Study|Lost to Follow-up|4|||
13183367|NCT02192190|26160734|FG005|Overall Study|Lost to Follow-up|3|||
13183368|NCT02192190|26160729|FG000|Overall Study|Physician Decision|2|||
13183369|NCT02192190|26160730|FG001|Overall Study|Physician Decision|0|||
13183370|NCT02192190|26160731|FG002|Overall Study|Physician Decision|0|||
13183371|NCT02192190|26160732|FG003|Overall Study|Physician Decision|0|||
13183372|NCT02192190|26160733|FG004|Overall Study|Physician Decision|0|||
13183373|NCT02192190|26160734|FG005|Overall Study|Physician Decision|0|||
13183374|NCT02192190|26160729|FG000|Overall Study|Terminated by Sponsor|43|||
13183375|NCT02192190|26160730|FG001|Overall Study|Terminated by Sponsor|23|||
13183376|NCT02192190|26160731|FG002|Overall Study|Terminated by Sponsor|20|||
13183377|NCT02192190|26160732|FG003|Overall Study|Terminated by Sponsor|23|||
13183378|NCT02192190|26160733|FG004|Overall Study|Terminated by Sponsor|21|||
13183379|NCT02192190|26160734|FG005|Overall Study|Terminated by Sponsor|23|||
13183380|NCT02192190|26160729|FG000|Overall Study|Withdrawal by Subject|4|||
13183381|NCT02192190|26160730|FG001|Overall Study|Withdrawal by Subject|1|||
13183382|NCT02192190|26160731|FG002|Overall Study|Withdrawal by Subject|2|||
13183383|NCT02192190|26160732|FG003|Overall Study|Withdrawal by Subject|1|||
13183384|NCT02192190|26160733|FG004|Overall Study|Withdrawal by Subject|5|||
13183385|NCT02192190|26160734|FG005|Overall Study|Withdrawal by Subject|3|||
13183386|NCT02192190|26160729|FG000|Overall Study|Could not Keep Visit Schedule|1|||
13183387|NCT02192190|26160730|FG001|Overall Study|Could not Keep Visit Schedule|0|||
13183388|NCT02192190|26160731|FG002|Overall Study|Could not Keep Visit Schedule|0|||
13183389|NCT02192190|26160732|FG003|Overall Study|Could not Keep Visit Schedule|0|||
13183390|NCT02192190|26160733|FG004|Overall Study|Could not Keep Visit Schedule|0|||
13183391|NCT02192190|26160734|FG005|Overall Study|Could not Keep Visit Schedule|0|||
13183392|NCT02192190|26160729|FG000|Overall Study|Positive Drug Screen|0|||
13183393|NCT02192190|26160730|FG001|Overall Study|Positive Drug Screen|0|||
13183394|NCT02192190|26160731|FG002|Overall Study|Positive Drug Screen|0|||
13183395|NCT02192190|26160732|FG003|Overall Study|Positive Drug Screen|1|||
13183396|NCT02192190|26160733|FG004|Overall Study|Positive Drug Screen|0|||
13183397|NCT02192190|26160734|FG005|Overall Study|Positive Drug Screen|0|||
13183398|NCT02192190|26160729|FG000|Overall Study|Inadequate Pain Relief|0|||
13183399|NCT02192190|26160730|FG001|Overall Study|Inadequate Pain Relief|1|||
13183400|NCT02192190|26160731|FG002|Overall Study|Inadequate Pain Relief|1|||
13183401|NCT02192190|26160732|FG003|Overall Study|Inadequate Pain Relief|0|||
13183402|NCT02192190|26160733|FG004|Overall Study|Inadequate Pain Relief|0|||
13183403|NCT02192190|26160734|FG005|Overall Study|Inadequate Pain Relief|0|||
13183404|NCT02192164|26160752|FG000|Overall Study|Other|8|||
13183405|NCT02192164|26160752|FG000|Overall Study|Withdrawal by Subject|1|||
13183406|NCT02192164|26160752|FG000|Overall Study|Physician Decision|4|||
13183407|NCT02192164|26160752|FG000|Overall Study|Did not meet the exclusion criteria|1|||
13183408|NCT02192099|26160758|FG000|Overall Study|Adverse Event|1|||
13183409|NCT02192099|26160758|FG000|Overall Study|Lost to Follow-up|2|||
13183410|NCT02192099|26160758|FG000|Overall Study|Physician Decision|1|||
13183411|NCT02192099|26160758|FG000|Overall Study|Pregnancy|1|||
13183412|NCT02192099|26160758|FG000|Overall Study|Protocol Violation|8|||
13183413|NCT02192099|26160758|FG000|Overall Study|Study Terminated by Sponsor|32|||
13183414|NCT02192099|26160758|FG000|Overall Study|Withdrawal by Subject|11|||
13183415|NCT02192099|26160758|FG000|Overall Study|Miscellaneous Reasons|5|||
13183416|NCT02191618|26160765|FG000|Overall Study|Withdrawal by Subject|3|||
13183417|NCT02191618|26160765|FG000|Overall Study|Missed Visit|4|||
13183418|NCT02191605|26160798|FG000|Overall Study|Lost to Follow-up|9|||
13183419|NCT02191605|26160799|FG001|Overall Study|Lost to Follow-up|4|||
13183420|NCT02191605|26160800|FG002|Overall Study|Lost to Follow-up|7|||
13183421|NCT02191605|26160801|FG003|Overall Study|Lost to Follow-up|3|||
13183422|NCT02191605|26160802|FG004|Overall Study|Lost to Follow-up|4|||
13183423|NCT02191579|26160821|FG000|Treatment 1|Multiple Reasons Specified|27|||
13183424|NCT02191579|26160822|FG001|Treatment 1|Multiple Reasons Specified|58|||
13183425|NCT02191579|26160821|FG000|Treatment 2|Multiple Reasons Specified|0|||
13183426|NCT02191579|26160822|FG001|Treatment 2|Multiple Reasons Specified|25|||
13183427|NCT02191397|26160887|FG000|Overall Study|Adverse Event|28|||
13183428|NCT02191397|26160888|FG001|Overall Study|Adverse Event|17|||
13183429|NCT02191397|26160887|FG000|Overall Study|Lack of Efficacy|10|||
13183430|NCT02191397|26160888|FG001|Overall Study|Lack of Efficacy|5|||
13183431|NCT02191397|26160887|FG000|Overall Study|Protocol Violation|0|||
13183432|NCT02191397|26160888|FG001|Overall Study|Protocol Violation|3|||
13183433|NCT02191397|26160887|FG000|Overall Study|Met protocol-defined stopping criteria|5|||
13183434|NCT02191397|26160888|FG001|Overall Study|Met protocol-defined stopping criteria|4|||
13183435|NCT02191397|26160887|FG000|Overall Study|Lost to Follow-up|10|||
13183436|NCT02191397|26160888|FG001|Overall Study|Lost to Follow-up|11|||
13183437|NCT02191397|26160887|FG000|Overall Study|Physician Decision|8|||
13183438|NCT02191397|26160888|FG001|Overall Study|Physician Decision|3|||
13183439|NCT02191397|26160887|FG000|Overall Study|Withdrawal by Subject|22|||
13183440|NCT02191397|26160888|FG001|Overall Study|Withdrawal by Subject|27|||
13183441|NCT02191267|26160909|FG000|Overall Study|Withdrawal by Subject|1|||
13183442|NCT02191267|26160910|FG001|Overall Study|Withdrawal by Subject|0|||
13183443|NCT02191267|26160911|FG002|Overall Study|Withdrawal by Subject|0|||
13183444|NCT02191137|26160941|FG000|Treatment|Death|4|||
13183445|NCT02191137|26160941|FG000|Treatment|Withdrawal by Subject|3|||
13183446|NCT02191137|26160941|FG000|Treatment|Adverse Event|2|||
13183447|NCT02191137|26160941|FG000|Treatment|Other|1|||
13183448|NCT02191137|26160941|FG000|Follow-up|Lost to Follow-up|2|||
13183449|NCT02191137|26160941|FG000|Follow-up|Ongoing/unknown|2|||
13183450|NCT02191137|26160941|FG000|Follow-up|Adverse Event|1|||
13183451|NCT02191046|26160954|FG000|Overall Study|low compliance|5|||
13183452|NCT02191046|26160955|FG001|Overall Study|low compliance|1|||
13183453|NCT02190604|26161202|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
13183454|NCT02190604|26161203|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
13183455|NCT02190604|26161204|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
13183456|NCT02190604|26161205|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
13183457|NCT02190604|26161206|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
13183458|NCT02190604|26161207|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
13183459|NCT02190604|26161208|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
13183460|NCT02190604|26161209|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
13183461|NCT02190604|26161210|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
13183462|NCT02190604|26161211|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
13183463|NCT02190604|26161212|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
13183464|NCT02190604|26161213|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
13183465|NCT02190604|26161214|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
13183466|NCT02190604|26161215|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
13183467|NCT02190604|26161216|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2|||
13183468|NCT02190604|26161217|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
13183469|NCT02190604|26161218|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
13183470|NCT02190604|26161219|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
13183471|NCT02190604|26161220|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
13183472|NCT02190604|26161202|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
13183473|NCT02190604|26161203|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
13183474|NCT02190604|26161204|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
13183475|NCT02190604|26161205|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
13183476|NCT02190604|26161206|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
13183477|NCT02190604|26161207|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
13183478|NCT02190604|26161208|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
13183479|NCT02190604|26161209|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
13183480|NCT02190604|26161210|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
13183481|NCT02190604|26161211|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
13183482|NCT02190604|26161212|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
13183483|NCT02190604|26161213|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
13183484|NCT02190604|26161214|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
13183485|NCT02190604|26161215|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1|||
13183486|NCT02190604|26161216|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
13183487|NCT02190604|26161217|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
13183488|NCT02190604|26161218|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
13183489|NCT02190604|26161219|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
13183490|NCT02190604|26161220|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
13183491|NCT02190591|26161237|FG000|Overall Study|Withdrawal by Subject|1|||
13183492|NCT02190591|26161238|FG001|Overall Study|Withdrawal by Subject|8|||
13183493|NCT02190591|26161237|FG000|Overall Study|Protocol Violation|1|||
13183494|NCT02190591|26161238|FG001|Overall Study|Protocol Violation|0|||
13183495|NCT02190591|26161237|FG000|Overall Study|did not use peanut ball as instructed|0|||
13183496|NCT02190591|26161238|FG001|Overall Study|did not use peanut ball as instructed|2|||
13183497|NCT02190591|26161237|FG000|Overall Study|face presentation so she was ineligible|0|||
13183498|NCT02190591|26161238|FG001|Overall Study|face presentation so she was ineligible|1|||
13183499|NCT02190435|26161253|FG000|Overall Study|First 12 patients were lead-ins|12|||
13183500|NCT02190435|26161254|FG001|Overall Study|First 12 patients were lead-ins|0|||
13183501|NCT02190435|26161253|FG000|Overall Study|3 consented screen fails|3|||
13183502|NCT02190435|26161254|FG001|Overall Study|3 consented screen fails|0|||
13183503|NCT02190279|26161283|FG000|Overall Study|Withdrawal consent|1|||
13183504|NCT02190279|26161284|FG001|Overall Study|Withdrawal consent|0|||
13183505|NCT02190279|26161285|FG002|Overall Study|Withdrawal consent|1|||
13183506|NCT02190279|26161283|FG000|Overall Study|Lost to Follow-up|2|||
13183507|NCT02190279|26161284|FG001|Overall Study|Lost to Follow-up|0|||
13183508|NCT02190279|26161285|FG002|Overall Study|Lost to Follow-up|0|||
13183509|NCT02190279|26161283|FG000|Overall Study|Refused further treatment|0|||
13183510|NCT02190279|26161284|FG001|Overall Study|Refused further treatment|0|||
13183511|NCT02190279|26161285|FG002|Overall Study|Refused further treatment|1|||
13183512|NCT02190279|26161283|FG000|Overall Study|Screening failure|0|||
13183513|NCT02190279|26161284|FG001|Overall Study|Screening failure|0|||
13183514|NCT02190279|26161285|FG002|Overall Study|Screening failure|1|||
13183515|NCT02189941|26161312|FG000|Overall Study|Non-compliance|0|||
13183516|NCT02189941|26161313|FG001|Overall Study|Non-compliance|0|||
13183517|NCT02189941|26161314|FG002|Overall Study|Non-compliance|1|||
13183518|NCT02189863|26161328|FG000|First 2 Weeks|Motion Sickness|4|||
13183519|NCT02189863|26161329|FG001|First 2 Weeks|Motion Sickness|2|||
13183520|NCT02189837|26161368|FG000|Overall Study|Withdrawal by Subject|2|||
13183521|NCT02189837|26161369|FG001|Overall Study|Withdrawal by Subject|1|||
13183522|NCT02189837|26161370|FG002|Overall Study|Withdrawal by Subject|3|||
13183523|NCT02189837|26161371|FG003|Overall Study|Withdrawal by Subject|1|||
13183524|NCT02189837|26161368|FG000|Overall Study|Sponsor Decision|0|||
13183525|NCT02189837|26161369|FG001|Overall Study|Sponsor Decision|0|||
13183526|NCT02189837|26161370|FG002|Overall Study|Sponsor Decision|0|||
13183527|NCT02189837|26161371|FG003|Overall Study|Sponsor Decision|1|||
13183528|NCT02189759|26161402|FG000|Overall Study|Lost to Follow-up|0|||
13183529|NCT02189759|26161403|FG001|Overall Study|Lost to Follow-up|0|||
13183530|NCT02189759|26161404|FG002|Overall Study|Lost to Follow-up|2|||
13183531|NCT02189759|26161405|FG003|Overall Study|Lost to Follow-up|5|||
13183532|NCT02189473|26161432|FG000|Overall Study|Death|22|||
13183533|NCT02189473|26161433|FG001|Overall Study|Death|23|||
13183534|NCT02189473|26161432|FG000|Overall Study|Lost to Follow-up|1|||
13183535|NCT02189473|26161433|FG001|Overall Study|Lost to Follow-up|2|||
13183536|NCT02189252|26161478|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
13183537|NCT02189252|26161479|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1|||
13183538|NCT02189252|26161480|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
13183539|NCT02189252|26161481|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
13183540|NCT02189252|26161478|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
13183541|NCT02189252|26161479|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1|||
13183542|NCT02189252|26161480|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
13183543|NCT02189252|26161481|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
13183544|NCT02188849|26161500|FG000|Overall Study|Lost to Follow-up|3|||
13183545|NCT02188849|26161501|FG001|Overall Study|Lost to Follow-up|8|||
13183546|NCT02188784|26161524|FG000|Overall Study|Death|3|||
13183547|NCT02188784|26161525|FG001|Overall Study|Death|1|||
13183548|NCT02188784|26161524|FG000|Overall Study|Lost to Follow-up|1|||
13183549|NCT02188784|26161525|FG001|Overall Study|Lost to Follow-up|0|||
13183550|NCT02188784|26161524|FG000|Overall Study|Withdrawal by Subject|3|||
13183551|NCT02188784|26161525|FG001|Overall Study|Withdrawal by Subject|9|||
13183552|NCT02188784|26161524|FG000|Overall Study|Physician Decision|2|||
13183553|NCT02188784|26161525|FG001|Overall Study|Physician Decision|3|||
13183554|NCT02188719|26161562|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
13183555|NCT02188719|26161563|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1|||
13183556|NCT02188719|26161564|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
13183557|NCT02188719|26161565|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
13183558|NCT02188589|26161573|FG000|Overall Study|Withdrawal by Subject|5|||
13183559|NCT02188485|26161590|FG000|Overall Study|Withdrawal by Subject|2|||
13183560|NCT02188485|26161591|FG001|Overall Study|Withdrawal by Subject|1|||
13183561|NCT02188485|26161590|FG000|Overall Study|PI withdrew, lack of capacity|0|||
13183562|NCT02188485|26161591|FG001|Overall Study|PI withdrew, lack of capacity|2|||
13183563|NCT02188459|26161616|FG000|Overall Study|Lost to Follow-up|3|||
13183564|NCT02188459|26161617|FG001|Overall Study|Lost to Follow-up|4|||
13183565|NCT02188459|26161616|FG000|Overall Study|Early Termination|0|||
13183566|NCT02188459|26161617|FG001|Overall Study|Early Termination|3|||
13183567|NCT02188303|26161670|FG000|Overall Study|Adverse Event|0|||
13183568|NCT02188303|26161671|FG001|Overall Study|Adverse Event|0|||
13183569|NCT02188303|26161672|FG002|Overall Study|Adverse Event|0|||
13183570|NCT02188303|26161673|FG003|Overall Study|Adverse Event|0|||
13183571|NCT02188303|26161674|FG004|Overall Study|Adverse Event|0|||
13183572|NCT02188303|26161675|FG005|Overall Study|Adverse Event|2|||
13183573|NCT02188303|26161676|FG006|Overall Study|Adverse Event|0|||
13183574|NCT02188303|26161677|FG007|Overall Study|Adverse Event|2|||
13183575|NCT02188303|26161670|FG000|Overall Study|Dose Termination Criteria Met|0|||
13183576|NCT02188303|26161671|FG001|Overall Study|Dose Termination Criteria Met|0|||
13183577|NCT02188303|26161672|FG002|Overall Study|Dose Termination Criteria Met|0|||
13183578|NCT02188303|26161673|FG003|Overall Study|Dose Termination Criteria Met|0|||
13183579|NCT02188303|26161674|FG004|Overall Study|Dose Termination Criteria Met|0|||
13183580|NCT02188303|26161675|FG005|Overall Study|Dose Termination Criteria Met|0|||
13183581|NCT02188303|26161676|FG006|Overall Study|Dose Termination Criteria Met|2|||
13183582|NCT02188303|26161677|FG007|Overall Study|Dose Termination Criteria Met|4|||
13183583|NCT02188160|26161698|FG000|Overall Study|Adverse Event|1|||
13183584|NCT02188160|26161699|FG001|Overall Study|Adverse Event|0|||
13183585|NCT02188160|26161698|FG000|Overall Study|Use of an excluded medication|0|||
13183586|NCT02188160|26161699|FG001|Overall Study|Use of an excluded medication|1|||
13183587|NCT02187861|26161822|FG000|Overall Study|Adverse Event|2|||
13183588|NCT02187861|26161823|FG001|Overall Study|Adverse Event|1|||
13183589|NCT02187861|26161824|FG002|Overall Study|Adverse Event|2|||
13183590|NCT02187861|26161825|FG003|Overall Study|Adverse Event|1|||
13183591|NCT02187861|26161822|FG000|Overall Study|Death|0|||
13183592|NCT02187861|26161823|FG001|Overall Study|Death|3|||
13183593|NCT02187861|26161824|FG002|Overall Study|Death|1|||
13183594|NCT02187861|26161825|FG003|Overall Study|Death|2|||
13183595|NCT02187861|26161822|FG000|Overall Study|Physician Decision|0|||
13183596|NCT02187861|26161823|FG001|Overall Study|Physician Decision|1|||
13183597|NCT02187861|26161824|FG002|Overall Study|Physician Decision|0|||
13183598|NCT02187861|26161825|FG003|Overall Study|Physician Decision|3|||
13183599|NCT02187861|26161822|FG000|Overall Study|Progressive Disease|4|||
13183600|NCT02187861|26161823|FG001|Overall Study|Progressive Disease|42|||
13183601|NCT02187861|26161824|FG002|Overall Study|Progressive Disease|19|||
13183602|NCT02187861|26161825|FG003|Overall Study|Progressive Disease|22|||
13183603|NCT02187861|26161822|FG000|Overall Study|Withdrawal by Subject|0|||
13183604|NCT02187861|26161823|FG001|Overall Study|Withdrawal by Subject|0|||
13183605|NCT02187861|26161824|FG002|Overall Study|Withdrawal by Subject|3|||
13183606|NCT02187861|26161825|FG003|Overall Study|Withdrawal by Subject|3|||
13183607|NCT02187861|26161822|FG000|Overall Study|Other|0|||
13183608|NCT02187861|26161823|FG001|Overall Study|Other|1|||
13183609|NCT02187861|26161824|FG002|Overall Study|Other|7|||
13183610|NCT02187861|26161825|FG003|Overall Study|Other|1|||
13183611|NCT02187809|26161837|FG000|Overall Study|The study was terminated|3|||
13183612|NCT02187783|26161848|FG000|Overall Study|Adverse Event|8|||
13183613|NCT02187783|26161848|FG000|Overall Study|Death|3|||
13183614|NCT02187783|26161848|FG000|Overall Study|Progressive disease|80|||
13183615|NCT02187783|26161848|FG000|Overall Study|Protocol Violation|3|||
13183616|NCT02187783|26161848|FG000|Overall Study|Physician Decision|2|||
13183617|NCT02187783|26161848|FG000|Overall Study|Withdrawal by Subject|9|||
13183618|NCT02187783|26161848|FG000|Overall Study|Study terminated by sponsor|1|||
13183619|NCT02187744|26161871|FG000|Study|Participant refused further follow-up|1|||
13183620|NCT02187744|26161872|FG001|Study|Participant refused further follow-up|0|||
13183621|NCT02187744|26161871|FG000|Study|Other|2|||
13183622|NCT02187744|26161872|FG001|Study|Other|1|||
13183623|NCT02187744|26161871|FG000|Study|Lost to Follow-up|0|||
13183624|NCT02187744|26161872|FG001|Study|Lost to Follow-up|2|||
13183625|NCT02187744|26161871|FG000|Study|Related adverse event, not serious|0|||
13183626|NCT02187744|26161872|FG001|Study|Related adverse event, not serious|2|||
13183627|NCT02187744|26161871|FG000|Study|Death|1|||
13183628|NCT02187744|26161872|FG001|Study|Death|0|||
13183629|NCT02187744|26161871|FG000|Study|Related adverse event, serious non-fatal|0|||
13183630|NCT02187744|26161872|FG001|Study|Related adverse event, serious non-fatal|1|||
13183631|NCT02187744|26161871|FG000|Treatment|Death|1|||
13183632|NCT02187744|26161872|FG001|Treatment|Death|0|||
13183633|NCT02187744|26161871|FG000|Treatment|Related adverse event, serious non-fatal|0|||
13183634|NCT02187744|26161872|FG001|Treatment|Related adverse event, serious non-fatal|1|||
13183635|NCT02187744|26161871|FG000|Treatment|Related adverse event, not serious|0|||
13183636|NCT02187744|26161872|FG001|Treatment|Related adverse event, not serious|2|||
13183637|NCT02187744|26161871|FG000|Treatment|Lost to Follow-up|0|||
13183638|NCT02187744|26161872|FG001|Treatment|Lost to Follow-up|1|||
13183639|NCT02187744|26161871|FG000|Treatment|Other|2|||
13183640|NCT02187744|26161872|FG001|Treatment|Other|0|||
13183641|NCT02187744|26161871|FG000|Treatment|Participant refused continued treatment|1|||
13183642|NCT02187744|26161872|FG001|Treatment|Participant refused continued treatment|1|||
13183643|NCT02187471|26161939|FG000|Overall Study|Protocol Violation|4|||
13183644|NCT02187471|26161940|FG001|Overall Study|Protocol Violation|5|||
13183645|NCT02187471|26161941|FG002|Overall Study|Protocol Violation|4|||
13183646|NCT02187471|26161942|FG003|Overall Study|Protocol Violation|4|||
13183647|NCT02187471|26161939|FG000|Overall Study|Missing|0|||
13183648|NCT02187471|26161940|FG001|Overall Study|Missing|0|||
13183649|NCT02187471|26161941|FG002|Overall Study|Missing|0|||
13183650|NCT02187471|26161942|FG003|Overall Study|Missing|1|||
13183651|NCT02187471|26161939|FG000|Overall Study|Lack of Efficacy|18|||
13183652|NCT02187471|26161940|FG001|Overall Study|Lack of Efficacy|9|||
13183653|NCT02187471|26161941|FG002|Overall Study|Lack of Efficacy|13|||
13183654|NCT02187471|26161942|FG003|Overall Study|Lack of Efficacy|11|||
13183655|NCT02187471|26161939|FG000|Overall Study|Adverse Event|24|||
13183656|NCT02187471|26161940|FG001|Overall Study|Adverse Event|34|||
13183657|NCT02187471|26161941|FG002|Overall Study|Adverse Event|44|||
13183658|NCT02187471|26161942|FG003|Overall Study|Adverse Event|36|||
13183659|NCT02187471|26161939|FG000|Overall Study|Withdrawal by Subject|23|||
13183660|NCT02187471|26161940|FG001|Overall Study|Withdrawal by Subject|29|||
13183661|NCT02187471|26161941|FG002|Overall Study|Withdrawal by Subject|22|||
13183662|NCT02187471|26161942|FG003|Overall Study|Withdrawal by Subject|24|||
13183663|NCT02187471|26161939|FG000|Overall Study|Other|7|||
13183664|NCT02187471|26161940|FG001|Overall Study|Other|5|||
13183665|NCT02187471|26161941|FG002|Overall Study|Other|3|||
13183666|NCT02187471|26161942|FG003|Overall Study|Other|4|||
13183667|NCT02187172|26162113|FG000|Overall Study|Lost to Follow-up|1|||
13183668|NCT02187172|26162114|FG001|Overall Study|Lost to Follow-up|2|||
13183669|NCT02187172|26162113|FG000|Overall Study|Lack of Efficacy|1|||
13183670|NCT02187172|26162114|FG001|Overall Study|Lack of Efficacy|2|||
13183671|NCT02187172|26162113|FG000|Overall Study|Adverse Event|0|||
13183672|NCT02187172|26162114|FG001|Overall Study|Adverse Event|1|||
13183673|NCT02187172|26162113|FG000|Overall Study|Physician Decision|1|||
13183674|NCT02187172|26162114|FG001|Overall Study|Physician Decision|1|||
13183675|NCT02187159|26162181|FG000|Overall Study|Protocol Violation|4|||
13183676|NCT02187159|26162182|FG001|Overall Study|Protocol Violation|6|||
13110156|NCT03214380|25898879|FG000|Lead-in|Protocol Deviation|7|||
13110157|NCT03214380|25898880|FG001|Lead-in|Protocol Deviation|0|||
13110158|NCT03214380|25898881|FG002|Lead-in|Protocol Deviation|0|||
13183677|NCT02187159|26162183|FG002|Overall Study|Protocol Violation|3|||
13183678|NCT02187159|26162184|FG003|Overall Study|Protocol Violation|4|||
13183679|NCT02187159|26162181|FG000|Overall Study|Lack of Efficacy|10|||
13183680|NCT02187159|26162182|FG001|Overall Study|Lack of Efficacy|5|||
13183681|NCT02187159|26162183|FG002|Overall Study|Lack of Efficacy|4|||
13183682|NCT02187159|26162184|FG003|Overall Study|Lack of Efficacy|7|||
13183683|NCT02187159|26162181|FG000|Overall Study|Adverse Event|28|||
13183684|NCT02187159|26162182|FG001|Overall Study|Adverse Event|33|||
13183685|NCT02187159|26162183|FG002|Overall Study|Adverse Event|42|||
13183686|NCT02187159|26162184|FG003|Overall Study|Adverse Event|50|||
13183687|NCT02187159|26162181|FG000|Overall Study|Withdrawal by Subject|24|||
13183688|NCT02187159|26162182|FG001|Overall Study|Withdrawal by Subject|28|||
13183689|NCT02187159|26162183|FG002|Overall Study|Withdrawal by Subject|25|||
13183690|NCT02187159|26162184|FG003|Overall Study|Withdrawal by Subject|26|||
13183691|NCT02187159|26162181|FG000|Overall Study|Other|3|||
13183692|NCT02187159|26162182|FG001|Overall Study|Other|7|||
13183693|NCT02187159|26162183|FG002|Overall Study|Other|3|||
13183694|NCT02187159|26162184|FG003|Overall Study|Other|9|||
13183695|NCT02187055|26162292|FG000|Overall Study|Lack of Efficacy|10|||
13183696|NCT02187055|26162293|FG001|Overall Study|Lack of Efficacy|3|||
13183697|NCT02187055|26162294|FG002|Overall Study|Lack of Efficacy|7|||
13183698|NCT02187055|26162292|FG000|Overall Study|Lost to Follow-up|2|||
13183699|NCT02187055|26162293|FG001|Overall Study|Lost to Follow-up|7|||
13183700|NCT02187055|26162294|FG002|Overall Study|Lost to Follow-up|3|||
13183701|NCT02187055|26162292|FG000|Overall Study|No longer meets eligibility criteria|0|||
13183702|NCT02187055|26162293|FG001|Overall Study|No longer meets eligibility criteria|2|||
13183703|NCT02187055|26162294|FG002|Overall Study|No longer meets eligibility criteria|0|||
13183704|NCT02187055|26162292|FG000|Overall Study|No longer willing to participate|6|||
13183705|NCT02187055|26162293|FG001|Overall Study|No longer willing to participate|8|||
13183706|NCT02187055|26162294|FG002|Overall Study|No longer willing to participate|10|||
13183707|NCT02187055|26162292|FG000|Overall Study|Other|5|||
13183708|NCT02187055|26162293|FG001|Overall Study|Other|6|||
13183709|NCT02187055|26162294|FG002|Overall Study|Other|3|||
13183710|NCT02187055|26162292|FG000|Overall Study|Protocol Violation|9|||
13110159|NCT03214380|25898882|FG003|Lead-in|Protocol Deviation|3|||
13110160|NCT03214380|25898883|FG004|Lead-in|Protocol Deviation|0|||
13110161|NCT03214380|25898884|FG005|Lead-in|Protocol Deviation|0|||
13110162|NCT03214380|25898879|FG000|Lead-in|Withdrawal by Subject|41|||
13110163|NCT03214380|25898880|FG001|Lead-in|Withdrawal by Subject|0|||
13110164|NCT03214380|25898881|FG002|Lead-in|Withdrawal by Subject|0|||
13110165|NCT03214380|25898882|FG003|Lead-in|Withdrawal by Subject|14|||
13110166|NCT03214380|25898883|FG004|Lead-in|Withdrawal by Subject|0|||
13110167|NCT03214380|25898884|FG005|Lead-in|Withdrawal by Subject|0|||
13110168|NCT03214380|25898879|FG000|Lead-in|Family Emergency|1|||
13110169|NCT03214380|25898880|FG001|Lead-in|Family Emergency|0|||
13110170|NCT03214380|25898881|FG002|Lead-in|Family Emergency|0|||
13183711|NCT02187055|26162293|FG001|Overall Study|Protocol Violation|9|||
13183712|NCT02187055|26162294|FG002|Overall Study|Protocol Violation|4|||
13110171|NCT03214380|25898882|FG003|Lead-in|Family Emergency|0|||
13183713|NCT02187055|26162292|FG000|Overall Study|Pregnancy|3|||
13183714|NCT02187055|26162293|FG001|Overall Study|Pregnancy|1|||
13110172|NCT03214380|25898883|FG004|Lead-in|Family Emergency|0|||
13110173|NCT03214380|25898884|FG005|Lead-in|Family Emergency|0|||
13110174|NCT03214380|25898879|FG000|Lead-in|Natural Disaster|9|||
13110175|NCT03214380|25898880|FG001|Lead-in|Natural Disaster|0|||
13110176|NCT03214380|25898881|FG002|Lead-in|Natural Disaster|0|||
13110177|NCT03214380|25898882|FG003|Lead-in|Natural Disaster|0|||
13110178|NCT03214380|25898883|FG004|Lead-in|Natural Disaster|0|||
13110179|NCT03214380|25898884|FG005|Lead-in|Natural Disaster|0|||
13110180|NCT03214380|25898879|FG000|Lead-in|Non Compliance|1|||
13110181|NCT03214380|25898880|FG001|Lead-in|Non Compliance|0|||
13110182|NCT03214380|25898881|FG002|Lead-in|Non Compliance|0|||
13110183|NCT03214380|25898882|FG003|Lead-in|Non Compliance|0|||
13110184|NCT03214380|25898883|FG004|Lead-in|Non Compliance|0|||
13110185|NCT03214380|25898884|FG005|Lead-in|Non Compliance|0|||
13110186|NCT03214380|25898879|FG000|Lead-in|Participant Schedule|2|||
13110187|NCT03214380|25898880|FG001|Lead-in|Participant Schedule|0|||
13110188|NCT03214380|25898881|FG002|Lead-in|Participant Schedule|0|||
13110189|NCT03214380|25898882|FG003|Lead-in|Participant Schedule|0|||
13183715|NCT02187055|26162294|FG002|Overall Study|Pregnancy|0|||
13183716|NCT02187055|26162292|FG000|Overall Study|Withdrawal by Subject|11|||
13183717|NCT02187055|26162293|FG001|Overall Study|Withdrawal by Subject|11|||
13183718|NCT02187055|26162294|FG002|Overall Study|Withdrawal by Subject|11|||
13183719|NCT02187055|26162292|FG000|Overall Study|Adverse Event|21|||
13183720|NCT02187055|26162293|FG001|Overall Study|Adverse Event|26|||
13183721|NCT02187055|26162294|FG002|Overall Study|Adverse Event|36|||
13183722|NCT02187055|26162292|FG000|Overall Study|Death|2|||
13183723|NCT02187055|26162293|FG001|Overall Study|Death|0|||
13183724|NCT02187055|26162294|FG002|Overall Study|Death|0|||
13183725|NCT02187042|26162343|FG000|Overall Study|Death|1|||
13183726|NCT02187042|26162344|FG001|Overall Study|Death|1|||
13183727|NCT02187042|26162343|FG000|Overall Study|Toxicity|6|||
13183728|NCT02187042|26162344|FG001|Overall Study|Toxicity|5|||
13183729|NCT02187042|26162343|FG000|Overall Study|Participant choice|1|||
13183730|NCT02187042|26162344|FG001|Overall Study|Participant choice|0|||
13183731|NCT02187042|26162343|FG000|Overall Study|Doctor choice|1|||
13183732|NCT02187042|26162344|FG001|Overall Study|Doctor choice|0|||
13183733|NCT02187042|26162343|FG000|Overall Study|Progressive disease|4|||
13183734|NCT02187042|26162344|FG001|Overall Study|Progressive disease|8|||
13183735|NCT02187029|26162429|FG000|Overall Study|Adverse Event|0|||
13183736|NCT02187029|26162430|FG001|Overall Study|Adverse Event|1|||
13183737|NCT02187029|26162431|FG002|Overall Study|Adverse Event|1|||
13183738|NCT02187029|26162432|FG003|Overall Study|Adverse Event|0|||
13183739|NCT02187029|26162429|FG000|Overall Study|Study Terminated by Sponsor|0|||
13183740|NCT02187029|26162430|FG001|Overall Study|Study Terminated by Sponsor|0|||
13183741|NCT02187029|26162431|FG002|Overall Study|Study Terminated by Sponsor|10|||
13183742|NCT02187029|26162432|FG003|Overall Study|Study Terminated by Sponsor|3|||
13183743|NCT02187029|26162429|FG000|Overall Study|Withdrawal by Subject|1|||
13183744|NCT02187029|26162430|FG001|Overall Study|Withdrawal by Subject|0|||
13183745|NCT02187029|26162431|FG002|Overall Study|Withdrawal by Subject|0|||
13183746|NCT02187029|26162432|FG003|Overall Study|Withdrawal by Subject|0|||
13183747|NCT02186873|26162462|FG000|Overall Study|Adverse Event|1|||
13183748|NCT02186873|26162463|FG001|Overall Study|Adverse Event|3|||
13183749|NCT02186873|26162462|FG000|Overall Study|Lack of Efficacy|0|||
13183750|NCT02186873|26162463|FG001|Overall Study|Lack of Efficacy|1|||
13183751|NCT02186873|26162462|FG000|Overall Study|Lost to Follow-up|1|||
13183752|NCT02186873|26162463|FG001|Overall Study|Lost to Follow-up|2|||
13183753|NCT02186873|26162462|FG000|Overall Study|Withdrawal by Subject|7|||
13183754|NCT02186873|26162463|FG001|Overall Study|Withdrawal by Subject|2|||
13183755|NCT02186821|26162475|FG000|Overall Study|Adverse Event|9|||
13183756|NCT02186821|26162475|FG000|Overall Study|Death|2|||
13183757|NCT02186821|26162475|FG000|Overall Study|Disease progression|32|||
13183758|NCT02186821|26162475|FG000|Overall Study|Protocol Violation|1|||
13183759|NCT02186821|26162475|FG000|Overall Study|Physician Decision|1|||
13183760|NCT02186821|26162475|FG000|Overall Study|Study terminated by sponsor|2|||
13183761|NCT02186652|26162507|FG000|Overall Study|Lost to Follow-up|2|||
13183762|NCT02186652|26162508|FG001|Overall Study|Lost to Follow-up|0|||
13183763|NCT02186561|26162520|FG000|Enrollment|Did Not Meet Inclusion Criteria|46|||
13183764|NCT02186561|26162520|FG000|Enrollment|Enrollment Cap Reached|5|||
13183765|NCT02186561|26162520|FG000|Enrollment|Insurance Denial|2|||
13183766|NCT02186561|26162520|FG000|Enrollment|Withdrawal by Subject|2|||
13183767|NCT02186561|26162520|FG000|Enrollment|Investigator Withdrew Consent|1|||
13183768|NCT02186561|26162520|FG000|30-Day Post Index Procedure Visit|Death|1|||
13183769|NCT02186561|26162520|FG000|1- Year Post Index Procedure Visit|Death|1|||
13183770|NCT02186561|26162520|FG000|1- Year Post Index Procedure Visit|Missed|1|||
13183771|NCT02186301|26162546|FG000|Overall Study|Progressive Disease|7|||
13183772|NCT02186301|26162547|FG001|Overall Study|Progressive Disease|22|||
13183773|NCT02186301|26162548|FG002|Overall Study|Progressive Disease|27|||
13110190|NCT03214380|25898883|FG004|Lead-in|Participant Schedule|0|||
13110191|NCT03214380|25898884|FG005|Lead-in|Participant Schedule|0|||
13183774|NCT02186301|26162546|FG000|Overall Study|Adverse Event|5|||
13183775|NCT02186301|26162547|FG001|Overall Study|Adverse Event|5|||
13183776|NCT02186301|26162548|FG002|Overall Study|Adverse Event|5|||
13183777|NCT02186301|26162546|FG000|Overall Study|Death|1|||
13183778|NCT02186301|26162547|FG001|Overall Study|Death|0|||
13183779|NCT02186301|26162548|FG002|Overall Study|Death|0|||
13183780|NCT02186301|26162546|FG000|Overall Study|Withdrawal by Subject|5|||
13183781|NCT02186301|26162547|FG001|Overall Study|Withdrawal by Subject|1|||
13183782|NCT02186301|26162548|FG002|Overall Study|Withdrawal by Subject|3|||
13183783|NCT02186301|26162546|FG000|Overall Study|Physician Decision|1|||
13183784|NCT02186301|26162547|FG001|Overall Study|Physician Decision|0|||
13183785|NCT02186301|26162548|FG002|Overall Study|Physician Decision|1|||
13183786|NCT02186301|26162546|FG000|Overall Study|Study Terminated by Sponsor|1|||
13183787|NCT02186301|26162547|FG001|Overall Study|Study Terminated by Sponsor|0|||
13183788|NCT02186301|26162548|FG002|Overall Study|Study Terminated by Sponsor|11|||
13183789|NCT02186301|26162546|FG000|Overall Study|Protocol Deviation|0|||
13183790|NCT02186301|26162547|FG001|Overall Study|Protocol Deviation|2|||
13183791|NCT02186301|26162548|FG002|Overall Study|Protocol Deviation|0|||
13183792|NCT02186301|26162546|FG000|Overall Study|Missing|0|||
13183793|NCT02186301|26162547|FG001|Overall Study|Missing|0|||
13183794|NCT02186301|26162548|FG002|Overall Study|Missing|2|||
13183795|NCT02186301|26162546|FG000|Overall Study|Other|0|||
13183796|NCT02186301|26162547|FG001|Overall Study|Other|0|||
13183797|NCT02186301|26162548|FG002|Overall Study|Other|1|||
13183798|NCT02186223|26162559|FG000|Overall Study|Not eligible for device placement|6|||
13183799|NCT02186223|26162559|FG000|Overall Study|Unable to obtain femoral access|3|||
13183800|NCT02186223|26162559|FG000|Overall Study|Death|3|||
13183801|NCT02186223|26162559|FG000|Overall Study|Device in place less than 48 hours|9|||
13183802|NCT02186171|26162582|FG000|Overall Study|Withdrawal by Subject|1|||
13183803|NCT02186171|26162583|FG001|Overall Study|Withdrawal by Subject|9|||
13183804|NCT02186171|26162582|FG000|Overall Study|Lost to Follow-up|2|||
13183805|NCT02186171|26162583|FG001|Overall Study|Lost to Follow-up|2|||
13183806|NCT02186171|26162582|FG000|Overall Study|Death|1|||
13183807|NCT02186171|26162583|FG001|Overall Study|Death|2|||
13183808|NCT02186171|26162582|FG000|Overall Study|Protocol-specified Criteria|0|||
13183809|NCT02186171|26162583|FG001|Overall Study|Protocol-specified Criteria|2|||
13183810|NCT02186015|26162610|FG000|Overall Study|Physician Decision|1|||
13183811|NCT02186015|26162611|FG001|Overall Study|Physician Decision|0|||
13183812|NCT02185794|26162702|FG000|Overall Study|Enrolled but Never Dosed|1|||
13183813|NCT02185794|26162703|FG001|Overall Study|Enrolled but Never Dosed|6|||
13183814|NCT02185794|26162704|FG002|Overall Study|Enrolled but Never Dosed|3|||
13183815|NCT02185794|26162705|FG003|Overall Study|Enrolled but Never Dosed|1|||
13183816|NCT02185794|26162706|FG004|Overall Study|Enrolled but Never Dosed|1|||
13183817|NCT02185794|26162707|FG005|Overall Study|Enrolled but Never Dosed|0|||
13183818|NCT02185794|26162702|FG000|Overall Study|Investigator's Discretion|1|||
13183819|NCT02185794|26162703|FG001|Overall Study|Investigator's Discretion|0|||
13183820|NCT02185794|26162704|FG002|Overall Study|Investigator's Discretion|1|||
13183821|NCT02185794|26162705|FG003|Overall Study|Investigator's Discretion|2|||
13183822|NCT02185794|26162706|FG004|Overall Study|Investigator's Discretion|2|||
13183823|NCT02185794|26162707|FG005|Overall Study|Investigator's Discretion|15|||
13183824|NCT02185794|26162702|FG000|Overall Study|Withdrew Consent|2|||
13183825|NCT02185794|26162703|FG001|Overall Study|Withdrew Consent|5|||
13183826|NCT02185794|26162704|FG002|Overall Study|Withdrew Consent|10|||
13183827|NCT02185794|26162705|FG003|Overall Study|Withdrew Consent|2|||
13183828|NCT02185794|26162706|FG004|Overall Study|Withdrew Consent|0|||
13183829|NCT02185794|26162707|FG005|Overall Study|Withdrew Consent|0|||
13183830|NCT02185794|26162702|FG000|Overall Study|Lost to Follow-up|1|||
13183831|NCT02185794|26162703|FG001|Overall Study|Lost to Follow-up|2|||
13183832|NCT02185794|26162704|FG002|Overall Study|Lost to Follow-up|2|||
13183833|NCT02185794|26162705|FG003|Overall Study|Lost to Follow-up|3|||
13183834|NCT02185794|26162706|FG004|Overall Study|Lost to Follow-up|0|||
13183835|NCT02185794|26162707|FG005|Overall Study|Lost to Follow-up|1|||
13183836|NCT02185534|26162741|FG000|First Period|Withdrawal by Subject|0|||
13183837|NCT02185534|26162742|FG001|First Period|Withdrawal by Subject|0|||
13183838|NCT02185534|26162743|FG002|First Period|Withdrawal by Subject|0|||
13183839|NCT02185534|26162744|FG003|First Period|Withdrawal by Subject|1|||
13183840|NCT02185534|26162745|FG004|First Period|Withdrawal by Subject|0|||
13183841|NCT02185534|26162746|FG005|First Period|Withdrawal by Subject|0|||
13183842|NCT02185534|26162741|FG000|First Washout Period|Withdrawal by Subject|1|||
13183843|NCT02185534|26162742|FG001|First Washout Period|Withdrawal by Subject|0|||
13183844|NCT02185534|26162743|FG002|First Washout Period|Withdrawal by Subject|0|||
13183845|NCT02185534|26162744|FG003|First Washout Period|Withdrawal by Subject|0|||
13183846|NCT02185534|26162745|FG004|First Washout Period|Withdrawal by Subject|1|||
13183847|NCT02185534|26162746|FG005|First Washout Period|Withdrawal by Subject|0|||
13183848|NCT02185534|26162741|FG000|First Washout Period|Protocol Violation|0|||
13183849|NCT02185534|26162742|FG001|First Washout Period|Protocol Violation|0|||
13183850|NCT02185534|26162743|FG002|First Washout Period|Protocol Violation|0|||
13183851|NCT02185534|26162744|FG003|First Washout Period|Protocol Violation|0|||
13183852|NCT02185534|26162745|FG004|First Washout Period|Protocol Violation|0|||
13183853|NCT02185534|26162746|FG005|First Washout Period|Protocol Violation|1|||
13183854|NCT02185521|26162753|FG000|Overall Study|Withdrawal by Subject|1|||
13183855|NCT02185521|26162753|FG000|Overall Study|Protocol Violation|1|||
13183856|NCT02185053|26162766|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1|||
13183857|NCT02185053|26162767|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
13183858|NCT02185053|26162768|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
13183859|NCT02185053|26162766|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2|||
13183860|NCT02185053|26162767|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
13183861|NCT02185053|26162768|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
13183862|NCT02185053|26162766|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
13183863|NCT02185053|26162767|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1|||
13183864|NCT02185053|26162768|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
13183865|NCT02185053|26162766|FG000|Donepezil Dose Escalation Phase|Adverse Event|0|||
13183866|NCT02185053|26162767|FG001|Donepezil Dose Escalation Phase|Adverse Event|1|||
13183867|NCT02185053|26162768|FG002|Donepezil Dose Escalation Phase|Adverse Event|0|||
13183868|NCT02185053|26162766|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
13183869|NCT02185053|26162767|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2|||
13183870|NCT02185053|26162768|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
13183871|NCT02185053|26162766|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
13183872|NCT02185053|26162767|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1|||
13183873|NCT02185053|26162768|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
13183874|NCT02185053|26162766|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
13183875|NCT02185053|26162767|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
13183876|NCT02185053|26162768|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1|||
13183877|NCT02185053|26162766|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
13183878|NCT02185053|26162767|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
13183879|NCT02185053|26162768|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2|||
13183880|NCT02185040|26162840|FG000|Part 1 Treatment Phase|Miscellaneous|0|||
13183881|NCT02185040|26162841|FG001|Part 1 Treatment Phase|Miscellaneous|0|||
13183882|NCT02185040|26162842|FG002|Part 1 Treatment Phase|Miscellaneous|1|||
13183883|NCT02185040|26162843|FG003|Part 1 Treatment Phase|Miscellaneous|0|||
13183884|NCT02185040|26162844|FG004|Part 1 Treatment Phase|Miscellaneous|0|||
13183885|NCT02185040|26162845|FG005|Part 1 Treatment Phase|Miscellaneous|0|||
13183886|NCT02185040|26162846|FG006|Part 1 Treatment Phase|Miscellaneous|0|||
13183887|NCT02185040|26162840|FG000|Part 1 Treatment Phase|Adverse Event|1|||
13183888|NCT02185040|26162841|FG001|Part 1 Treatment Phase|Adverse Event|0|||
13183889|NCT02185040|26162842|FG002|Part 1 Treatment Phase|Adverse Event|0|||
13183890|NCT02185040|26162843|FG003|Part 1 Treatment Phase|Adverse Event|2|||
13183891|NCT02185040|26162844|FG004|Part 1 Treatment Phase|Adverse Event|3|||
13183892|NCT02185040|26162845|FG005|Part 1 Treatment Phase|Adverse Event|0|||
13183893|NCT02185040|26162846|FG006|Part 1 Treatment Phase|Adverse Event|0|||
13183894|NCT02185040|26162840|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0|||
13183895|NCT02185040|26162841|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1|||
13183896|NCT02185040|26162842|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0|||
13183897|NCT02185040|26162843|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0|||
13183898|NCT02185040|26162844|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0|||
13183899|NCT02185040|26162845|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0|||
13183900|NCT02185040|26162846|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0|||
13183901|NCT02185040|26162840|FG000|Part 1 Treatment Phase|Lost to Follow-up|0|||
13183902|NCT02185040|26162841|FG001|Part 1 Treatment Phase|Lost to Follow-up|1|||
13183903|NCT02185040|26162842|FG002|Part 1 Treatment Phase|Lost to Follow-up|0|||
13183904|NCT02185040|26162843|FG003|Part 1 Treatment Phase|Lost to Follow-up|0|||
13183905|NCT02185040|26162844|FG004|Part 1 Treatment Phase|Lost to Follow-up|0|||
13183906|NCT02185040|26162845|FG005|Part 1 Treatment Phase|Lost to Follow-up|0|||
13183907|NCT02185040|26162846|FG006|Part 1 Treatment Phase|Lost to Follow-up|0|||
13183908|NCT02185040|26162840|FG000|Active Treatment Extension Phase|Miscellaneous|0|||
13183909|NCT02185040|26162841|FG001|Active Treatment Extension Phase|Miscellaneous|0|||
13183910|NCT02185040|26162842|FG002|Active Treatment Extension Phase|Miscellaneous|0|||
13183911|NCT02185040|26162843|FG003|Active Treatment Extension Phase|Miscellaneous|0|||
13183912|NCT02185040|26162844|FG004|Active Treatment Extension Phase|Miscellaneous|0|||
13183913|NCT02185040|26162845|FG005|Active Treatment Extension Phase|Miscellaneous|1|||
13206091|NCT01959880|26233548|FG001|Overall Study|Lost to Follow-up|18|||
13110192|NCT03214380|25898879|FG000|Treatment Period|Adverse Event|0|||
13110193|NCT03214380|25898880|FG001|Treatment Period|Adverse Event|1|||
13110194|NCT03214380|25898881|FG002|Treatment Period|Adverse Event|1|||
13110195|NCT03214380|25898882|FG003|Treatment Period|Adverse Event|0|||
13110196|NCT03214380|25898883|FG004|Treatment Period|Adverse Event|1|||
13110197|NCT03214380|25898884|FG005|Treatment Period|Adverse Event|0|||
13110198|NCT03214380|25898879|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
13110199|NCT03214380|25898880|FG001|Treatment Period|Non-Compliance with Study Drug|0|||
13110200|NCT03214380|25898881|FG002|Treatment Period|Non-Compliance with Study Drug|0|||
13110201|NCT03214380|25898882|FG003|Treatment Period|Non-Compliance with Study Drug|0|||
13110202|NCT03214380|25898883|FG004|Treatment Period|Non-Compliance with Study Drug|1|||
13110203|NCT03214380|25898884|FG005|Treatment Period|Non-Compliance with Study Drug|0|||
13110204|NCT03214380|25898879|FG000|Treatment Period|Withdrawal by Subject|0|||
13110205|NCT03214380|25898880|FG001|Treatment Period|Withdrawal by Subject|10|||
13110206|NCT03214380|25898881|FG002|Treatment Period|Withdrawal by Subject|8|||
13110207|NCT03214380|25898882|FG003|Treatment Period|Withdrawal by Subject|0|||
13110208|NCT03214380|25898883|FG004|Treatment Period|Withdrawal by Subject|7|||
13183914|NCT02185040|26162846|FG006|Active Treatment Extension Phase|Miscellaneous|0|||
13183915|NCT02185040|26162840|FG000|Active Treatment Extension Phase|Adverse Event|0|||
13183916|NCT02185040|26162841|FG001|Active Treatment Extension Phase|Adverse Event|0|||
13183917|NCT02185040|26162842|FG002|Active Treatment Extension Phase|Adverse Event|0|||
13183918|NCT02185040|26162843|FG003|Active Treatment Extension Phase|Adverse Event|0|||
13183919|NCT02185040|26162844|FG004|Active Treatment Extension Phase|Adverse Event|0|||
13183920|NCT02185040|26162845|FG005|Active Treatment Extension Phase|Adverse Event|1|||
13183921|NCT02185040|26162846|FG006|Active Treatment Extension Phase|Adverse Event|4|||
13183922|NCT02185040|26162840|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0|||
13183923|NCT02185040|26162841|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0|||
13183924|NCT02185040|26162842|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0|||
13183925|NCT02185040|26162843|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0|||
13183926|NCT02185040|26162844|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0|||
13183927|NCT02185040|26162845|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1|||
13183928|NCT02185040|26162846|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1|||
13183929|NCT02185040|26162840|FG000|Active Treatment Extension Phase|Lost to Follow-up|0|||
13183930|NCT02185040|26162841|FG001|Active Treatment Extension Phase|Lost to Follow-up|0|||
13183931|NCT02185040|26162842|FG002|Active Treatment Extension Phase|Lost to Follow-up|0|||
13183932|NCT02185040|26162843|FG003|Active Treatment Extension Phase|Lost to Follow-up|0|||
13183933|NCT02185040|26162844|FG004|Active Treatment Extension Phase|Lost to Follow-up|0|||
13183934|NCT02185040|26162845|FG005|Active Treatment Extension Phase|Lost to Follow-up|0|||
13183935|NCT02185040|26162846|FG006|Active Treatment Extension Phase|Lost to Follow-up|2|||
13183936|NCT02185014|26162852|FG000|Overall Study|Adverse Event|18|||
13183937|NCT02185014|26162852|FG000|Overall Study|Withdrew Consent|8|||
13183938|NCT02185014|26162852|FG000|Overall Study|Lost to Follow-up|4|||
13183939|NCT02185014|26162852|FG000|Overall Study|Lack of Efficacy|14|||
13183940|NCT02185014|26162852|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5|||
13183941|NCT02185014|26162852|FG000|Overall Study|Subject Noncompliance|1|||
13183942|NCT02185014|26162852|FG000|Overall Study|Other|4|||
13183943|NCT02184988|26162859|FG000|Overall Study|Pregnancy|2|||
13183944|NCT02184988|26162859|FG000|Overall Study|Adverse Event|2|||
13183945|NCT02184988|26162859|FG000|Overall Study|moving away/travelling/unable to complet|6|||
13183946|NCT02184988|26162859|FG000|Overall Study|work scheduling issues|4|||
13183947|NCT02184988|26162859|FG000|Overall Study|various other reasons|9|||
13183948|NCT02184988|26162859|FG000|Overall Study|Lost to Follow-up|32|||
13183949|NCT02184611|26162900|FG000|Overall Study|Lack of Efficacy|11|||
13183950|NCT02184611|26162901|FG001|Overall Study|Lack of Efficacy|15|||
13183951|NCT02184611|26162900|FG000|Overall Study|Withdrawal by Subject|5|||
13223023|NCT01800916|26287705|FG007|Test Period 1 (1 Week)|Convex product user|0|||
13110209|NCT03214380|25898884|FG005|Treatment Period|Withdrawal by Subject|11|||
13110210|NCT03214380|25898879|FG000|Treatment Period|Death|0|||
13110211|NCT03214380|25898880|FG001|Treatment Period|Death|1|||
13110212|NCT03214380|25898881|FG002|Treatment Period|Death|2|||
13110213|NCT03214380|25898882|FG003|Treatment Period|Death|0|||
13110214|NCT03214380|25898883|FG004|Treatment Period|Death|0|||
13110215|NCT03214380|25898884|FG005|Treatment Period|Death|0|||
13183952|NCT02184611|26162901|FG001|Overall Study|Withdrawal by Subject|6|||
13183953|NCT02184611|26162900|FG000|Overall Study|Adverse Event|4|||
13183954|NCT02184611|26162901|FG001|Overall Study|Adverse Event|5|||
13183955|NCT02184611|26162900|FG000|Overall Study|Protocol Violation|1|||
13183956|NCT02184611|26162901|FG001|Overall Study|Protocol Violation|1|||
13183957|NCT02184611|26162900|FG000|Overall Study|Protocol defined stopping criteria|0|||
13183958|NCT02184611|26162901|FG001|Overall Study|Protocol defined stopping criteria|1|||
13183959|NCT02184572|26162944|FG000|Overall Study|Lost to Follow-up|29|||
13183960|NCT02184572|26162945|FG001|Overall Study|Lost to Follow-up|21|||
13183961|NCT02184572|26162944|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1|||
13183962|NCT02184572|26162945|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0|||
13183963|NCT02184572|26162944|FG000|Overall Study|Loss Of Kaiser Insurance|1|||
13183964|NCT02184572|26162945|FG001|Overall Study|Loss Of Kaiser Insurance|0|||
13183965|NCT02184572|26162944|FG000|Overall Study|2nd blooddraw & diary card incomplete|1|||
13183966|NCT02184572|26162945|FG001|Overall Study|2nd blooddraw & diary card incomplete|0|||
13183967|NCT02184572|26162944|FG000|Overall Study|Traveling Outside The Country|1|||
13183968|NCT02184572|26162945|FG001|Overall Study|Traveling Outside The Country|0|||
13183969|NCT02184572|26162944|FG000|Overall Study|Withdrawal by Subject|14|||
13183970|NCT02184572|26162945|FG001|Overall Study|Withdrawal by Subject|9|||
13110216|NCT03214380|25898879|FG000|Treatment Period|Lost to Follow-up|0|||
13183971|NCT02184455|26162956|FG000|Overall Study|Lost to Follow-up|1|||
13183972|NCT02184442|26162975|FG000|Overall Study|Death|61|||
13183973|NCT02184442|26162976|FG001|Overall Study|Death|65|||
13183974|NCT02184442|26162975|FG000|Overall Study|Withdrawal by Subject|3|||
13183975|NCT02184442|26162976|FG001|Overall Study|Withdrawal by Subject|11|||
13183976|NCT02184156|26162995|FG000|Phase 2 20 Week Efficacy|Protocol Violation|0|||
13183977|NCT02184156|26162996|FG001|Phase 2 20 Week Efficacy|Protocol Violation|1|||
13183978|NCT02184156|26162995|FG000|Phase 2 20 Week Efficacy|Withdrawal by Subject|1|||
13183979|NCT02184156|26162996|FG001|Phase 2 20 Week Efficacy|Withdrawal by Subject|0|||
13183980|NCT02184143|26163015|FG000|Overall Study|Withdrawal by Subject|4|||
13183981|NCT02184143|26163016|FG001|Overall Study|Withdrawal by Subject|4|||
13183982|NCT02184143|26163015|FG000|Overall Study|Lost to Follow-up|5|||
13183983|NCT02184143|26163016|FG001|Overall Study|Lost to Follow-up|3|||
13183984|NCT02184143|26163015|FG000|Overall Study|Death|1|||
13183985|NCT02184143|26163016|FG001|Overall Study|Death|0|||
13183986|NCT02183675|26163057|FG000|Treatment Period 2 (10 Days)|Adverse Event|0|||
13183987|NCT02183675|26163058|FG001|Treatment Period 2 (10 Days)|Adverse Event|0|||
13183988|NCT02183675|26163059|FG002|Treatment Period 2 (10 Days)|Adverse Event|0|||
13183989|NCT02183675|26163060|FG003|Treatment Period 2 (10 Days)|Adverse Event|0|||
13183990|NCT02183675|26163061|FG004|Treatment Period 2 (10 Days)|Adverse Event|0|||
13183991|NCT02183675|26163062|FG005|Treatment Period 2 (10 Days)|Adverse Event|2|||
13183992|NCT02183519|26163075|FG000|Overall Study|computer error|3|||
13183993|NCT02183519|26163076|FG001|Overall Study|computer error|0|||
13183994|NCT02183519|26163075|FG000|Overall Study|Did not respond to cough inducter|0|||
13183995|NCT02183519|26163076|FG001|Overall Study|Did not respond to cough inducter|3|||
13183996|NCT02182999|26163097|FG000|Overall Study|Adverse Event|4|||
13183997|NCT02182999|26163098|FG001|Overall Study|Adverse Event|3|||
13183998|NCT02182999|26163097|FG000|Overall Study|Physician Decision|1|||
13183999|NCT02182999|26163098|FG001|Overall Study|Physician Decision|0|||
13184000|NCT02182973|26163115|FG000|Overall Study|Withdrawal by Subject|3|||
13184001|NCT02182973|26163116|FG001|Overall Study|Withdrawal by Subject|0|||
13184002|NCT02182947|26163129|FG000|Overall Study|Withdrawal by Subject|7|||
13184003|NCT02182947|26163129|FG000|Overall Study|Lost to Follow-up|3|||
13184004|NCT02182947|26163129|FG000|Overall Study|Failed screening activities|8|||
13184005|NCT02182895|26163156|FG000|Overall Study|Discharged from hospital within 24 hours|2|||
13184006|NCT02182895|26163157|FG001|Overall Study|Discharged from hospital within 24 hours|4|||
13184007|NCT02182843|26163164|FG000|Overall Study|Withdrawal by Subject|7|||
13184008|NCT02182843|26163164|FG000|Overall Study|Lost to Follow-up|2|||
13184009|NCT02182843|26163164|FG000|Overall Study|Adverse Event|1|||
13184010|NCT02182830|26163197|FG000|Overall Study|Not Treated|1|||
13110217|NCT03214380|25898880|FG001|Treatment Period|Lost to Follow-up|6|||
13110218|NCT03214380|25898881|FG002|Treatment Period|Lost to Follow-up|3|||
13184011|NCT02182830|26163198|FG001|Overall Study|Not Treated|1|||
13184012|NCT02182830|26163197|FG000|Overall Study|Trial stopped, reason missing|3|||
13184013|NCT02182830|26163198|FG001|Overall Study|Trial stopped, reason missing|3|||
13184014|NCT02182830|26163197|FG000|Overall Study|Consent withdrawn|8|||
13184015|NCT02182830|26163198|FG001|Overall Study|Consent withdrawn|8|||
13184016|NCT02182830|26163197|FG000|Overall Study|Lost to Follow-up|3|||
13184017|NCT02182830|26163198|FG001|Overall Study|Lost to Follow-up|3|||
13184018|NCT02182440|26163241|FG000|Overall Study|Adverse Event|0|||
13184019|NCT02182440|26163242|FG001|Overall Study|Adverse Event|1|||
13184020|NCT02182440|26163243|FG002|Overall Study|Adverse Event|0|||
13184021|NCT02182440|26163244|FG003|Overall Study|Adverse Event|0|||
13184022|NCT02182440|26163241|FG000|Overall Study|Death|31|||
13184023|NCT02182440|26163242|FG001|Overall Study|Death|8|||
13184024|NCT02182440|26163243|FG002|Overall Study|Death|5|||
13184025|NCT02182440|26163244|FG003|Overall Study|Death|16|||
13184026|NCT02182440|26163241|FG000|Overall Study|Protocol Violation|0|||
13184027|NCT02182440|26163242|FG001|Overall Study|Protocol Violation|1|||
13184028|NCT02182440|26163243|FG002|Overall Study|Protocol Violation|0|||
13184029|NCT02182440|26163244|FG003|Overall Study|Protocol Violation|0|||
13184030|NCT02182440|26163241|FG000|Overall Study|Physician Decision|1|||
13184031|NCT02182440|26163242|FG001|Overall Study|Physician Decision|0|||
13184032|NCT02182440|26163243|FG002|Overall Study|Physician Decision|0|||
13184033|NCT02182440|26163244|FG003|Overall Study|Physician Decision|0|||
13184034|NCT02182440|26163241|FG000|Overall Study|Withdrawal by Subject|1|||
13184035|NCT02182440|26163242|FG001|Overall Study|Withdrawal by Subject|1|||
13184036|NCT02182440|26163243|FG002|Overall Study|Withdrawal by Subject|3|||
13110219|NCT03214380|25898882|FG003|Treatment Period|Lost to Follow-up|0|||
13110220|NCT03214380|25898883|FG004|Treatment Period|Lost to Follow-up|0|||
13110221|NCT03214380|25898884|FG005|Treatment Period|Lost to Follow-up|0|||
13110222|NCT03214380|25898879|FG000|Treatment Period|Participant schedule|0|||
13110223|NCT03214380|25898880|FG001|Treatment Period|Participant schedule|0|||
13184037|NCT02182440|26163244|FG003|Overall Study|Withdrawal by Subject|4|||
13184038|NCT02182440|26163241|FG000|Overall Study|different, e.g adm other hospital|12|||
13184039|NCT02182440|26163242|FG001|Overall Study|different, e.g adm other hospital|3|||
13184040|NCT02182440|26163243|FG002|Overall Study|different, e.g adm other hospital|3|||
13184041|NCT02182440|26163244|FG003|Overall Study|different, e.g adm other hospital|10|||
13184042|NCT02181842|26163263|FG000|Overall Study|Case Report Forms Uncollected|2|||
13184043|NCT02181816|26163271|FG000|Overall Study|Case Report Forms Uncollected|38|||
13184044|NCT02181816|26163271|FG000|Overall Study|Protocol Deviation|21|||
13184045|NCT02181803|26163448|FG000|Overall Study|Withdrawal by Subject|0|||
13184046|NCT02181803|26163449|FG001|Overall Study|Withdrawal by Subject|2|||
13184047|NCT02181803|26163450|FG002|Overall Study|Withdrawal by Subject|0|||
13184048|NCT02181803|26163451|FG003|Overall Study|Withdrawal by Subject|0|||
13184049|NCT02181803|26163452|FG004|Overall Study|Withdrawal by Subject|0|||
13184050|NCT02181803|26163453|FG005|Overall Study|Withdrawal by Subject|0|||
13184051|NCT02181803|26163454|FG006|Overall Study|Withdrawal by Subject|0|||
13184052|NCT02181803|26163455|FG007|Overall Study|Withdrawal by Subject|0|||
13184053|NCT02181803|26163456|FG008|Overall Study|Withdrawal by Subject|0|||
13184054|NCT02181803|26163448|FG000|Overall Study|Physician Decision|0|||
13184055|NCT02181803|26163449|FG001|Overall Study|Physician Decision|0|||
13184056|NCT02181803|26163450|FG002|Overall Study|Physician Decision|0|||
13184057|NCT02181803|26163451|FG003|Overall Study|Physician Decision|1|||
13184058|NCT02181803|26163452|FG004|Overall Study|Physician Decision|0|||
13184059|NCT02181803|26163453|FG005|Overall Study|Physician Decision|0|||
13184060|NCT02181803|26163454|FG006|Overall Study|Physician Decision|0|||
13184061|NCT02181803|26163455|FG007|Overall Study|Physician Decision|1|||
13184062|NCT02181803|26163456|FG008|Overall Study|Physician Decision|0|||
13184063|NCT02181803|26163448|FG000|Overall Study|Adverse Event|0|||
13184064|NCT02181803|26163449|FG001|Overall Study|Adverse Event|2|||
13184065|NCT02181803|26163450|FG002|Overall Study|Adverse Event|0|||
13184066|NCT02181803|26163451|FG003|Overall Study|Adverse Event|1|||
13184067|NCT02181803|26163452|FG004|Overall Study|Adverse Event|0|||
13184068|NCT02181803|26163453|FG005|Overall Study|Adverse Event|0|||
13184069|NCT02181803|26163454|FG006|Overall Study|Adverse Event|1|||
13184070|NCT02181803|26163455|FG007|Overall Study|Adverse Event|0|||
13184071|NCT02181803|26163456|FG008|Overall Study|Adverse Event|0|||
13184072|NCT02181790|26163471|FG000|Overall Study|study terminated|2|||
13184073|NCT02181790|26163472|FG001|Overall Study|study terminated|0|||
13184074|NCT02181673|26163507|FG000|Up to Week 24|Adverse Event|2|||
13184075|NCT02181673|26163508|FG001|Up to Week 24|Adverse Event|0|||
13184076|NCT02181673|26163509|FG002|Up to Week 24|Adverse Event|3|||
13184077|NCT02181673|26163507|FG000|Up to Week 24|Death|1|||
13184078|NCT02181673|26163508|FG001|Up to Week 24|Death|0|||
13184079|NCT02181673|26163509|FG002|Up to Week 24|Death|0|||
13184080|NCT02181673|26163507|FG000|Up to Week 24|Lack of Efficacy|1|||
13184081|NCT02181673|26163508|FG001|Up to Week 24|Lack of Efficacy|0|||
13184082|NCT02181673|26163509|FG002|Up to Week 24|Lack of Efficacy|0|||
13184083|NCT02181673|26163507|FG000|Up to Week 24|Lost to Follow-up|1|||
13184084|NCT02181673|26163508|FG001|Up to Week 24|Lost to Follow-up|0|||
13184085|NCT02181673|26163509|FG002|Up to Week 24|Lost to Follow-up|0|||
13184086|NCT02181673|26163507|FG000|Up to Week 24|Physician Decision|0|||
13184087|NCT02181673|26163508|FG001|Up to Week 24|Physician Decision|0|||
13184088|NCT02181673|26163509|FG002|Up to Week 24|Physician Decision|3|||
13184089|NCT02181673|26163507|FG000|Up to Week 24|Withdrawal by Subject|10|||
13184090|NCT02181673|26163508|FG001|Up to Week 24|Withdrawal by Subject|0|||
13184091|NCT02181673|26163509|FG002|Up to Week 24|Withdrawal by Subject|1|||
13184092|NCT02181673|26163507|FG000|Up to Week 24|Other|2|||
13184093|NCT02181673|26163508|FG001|Up to Week 24|Other|0|||
13184094|NCT02181673|26163509|FG002|Up to Week 24|Other|3|||
13184095|NCT02181673|26163507|FG000|Up to Week 24|Randomized not Treated|0|||
13184096|NCT02181673|26163508|FG001|Up to Week 24|Randomized not Treated|0|||
13184097|NCT02181673|26163509|FG002|Up to Week 24|Randomized not Treated|1|||
13184098|NCT02181673|26163507|FG000|Week 24-Week 60|Adverse Event|0|||
13184099|NCT02181673|26163508|FG001|Week 24-Week 60|Adverse Event|4|||
13184100|NCT02181673|26163509|FG002|Week 24-Week 60|Adverse Event|10|||
13184101|NCT02181673|26163507|FG000|Week 24-Week 60|Other|0|||
13184102|NCT02181673|26163508|FG001|Week 24-Week 60|Other|2|||
13184103|NCT02181673|26163509|FG002|Week 24-Week 60|Other|1|||
13184104|NCT02181673|26163507|FG000|Week 24-Week 60|Withdrawal by Subject|0|||
13184105|NCT02181673|26163508|FG001|Week 24-Week 60|Withdrawal by Subject|2|||
13184106|NCT02181673|26163509|FG002|Week 24-Week 60|Withdrawal by Subject|2|||
13184107|NCT02181673|26163507|FG000|Week 24-Week 60|Pregnancy|0|||
13184108|NCT02181673|26163508|FG001|Week 24-Week 60|Pregnancy|0|||
13184109|NCT02181673|26163509|FG002|Week 24-Week 60|Pregnancy|1|||
13184110|NCT02181673|26163507|FG000|Week 24-Week 60|Lack of Efficacy|0|||
13184111|NCT02181673|26163508|FG001|Week 24-Week 60|Lack of Efficacy|0|||
13184112|NCT02181673|26163509|FG002|Week 24-Week 60|Lack of Efficacy|1|||
13184113|NCT02181673|26163507|FG000|Week 24-Week 60|Lost to Follow-up|0|||
13184114|NCT02181673|26163508|FG001|Week 24-Week 60|Lost to Follow-up|0|||
13184115|NCT02181673|26163509|FG002|Week 24-Week 60|Lost to Follow-up|1|||
13184116|NCT02181673|26163507|FG000|Week 24-Week 60|Physician Decision|0|||
13223024|NCT01800916|26287706|FG008|Test Period 1 (1 Week)|Convex product user|0|||
13184117|NCT02181673|26163508|FG001|Week 24-Week 60|Physician Decision|0|||
13184118|NCT02181673|26163509|FG002|Week 24-Week 60|Physician Decision|1|||
13184119|NCT02181634|26163522|FG000|Overall Study|Lack of Efficacy|33|||
13184120|NCT02181634|26163522|FG000|Overall Study|Adverse Event|17|||
13184121|NCT02181634|26163522|FG000|Overall Study|Physician Decision|8|||
13184122|NCT02181634|26163522|FG000|Overall Study|Withdrawal by Subject|5|||
13184123|NCT02181634|26163522|FG000|Overall Study|Death|2|||
13184124|NCT02181634|26163522|FG000|Overall Study|Treatment delayed greater than 4 weeks|3|||
13184125|NCT02181634|26163522|FG000|Overall Study|Ineligible|1|||
13184126|NCT02181634|26163522|FG000|Overall Study|Max number of dose reduction|1|||
13184127|NCT02181634|26163522|FG000|Overall Study|Symptomatic progression|1|||
13184128|NCT02181634|26163522|FG000|Overall Study|Patient opted to proceed to surgery|1|||
13184129|NCT02181556|26163530|FG000|Overall Study|Withdrawal by Subject|1|||
13184130|NCT02181504|26163560|FG000|Overall Study|Adverse Event|1|||
13184131|NCT02181504|26163561|FG001|Overall Study|Adverse Event|1|||
13184132|NCT02181504|26163562|FG002|Overall Study|Adverse Event|1|||
13184133|NCT02181296|26163581|FG000|Overall Study|Lost to Follow-up|7|||
13184134|NCT02181296|26163582|FG001|Overall Study|Lost to Follow-up|6|||
13184135|NCT02180724|26163601|FG000|Overall Study|Death|12|||
13184136|NCT02180724|26163602|FG001|Overall Study|Death|1|||
13184137|NCT02180724|26163601|FG000|Overall Study|Lost to Follow-up|1|||
13184138|NCT02180724|26163602|FG001|Overall Study|Lost to Follow-up|0|||
13184139|NCT02180724|26163601|FG000|Overall Study|Withdrawal by Subject|1|||
13184140|NCT02180724|26163602|FG001|Overall Study|Withdrawal by Subject|2|||
13184141|NCT02180724|26163601|FG000|Overall Study|Ongoing Study|78|||
13184142|NCT02180724|26163602|FG001|Overall Study|Ongoing Study|11|||
13184143|NCT02180672|26163633|FG000|Overall Study|Lost to Follow-up|5|||
13184144|NCT02180672|26163634|FG001|Overall Study|Lost to Follow-up|7|||
13184145|NCT02180659|26163661|FG000|Overall Study|Adverse Event|1|||
13184146|NCT02180659|26163662|FG001|Overall Study|Adverse Event|0|||
13184147|NCT02180659|26163661|FG000|Overall Study|Lost to Follow-up|4|||
13184148|NCT02180659|26163662|FG001|Overall Study|Lost to Follow-up|2|||
13184149|NCT02180659|26163661|FG000|Overall Study|Subject incarcerated during conduct|1|||
13184150|NCT02180659|26163662|FG001|Overall Study|Subject incarcerated during conduct|0|||
13184151|NCT02180659|26163661|FG000|Overall Study|Withdrawal by Subject|0|||
13184152|NCT02180659|26163662|FG001|Overall Study|Withdrawal by Subject|2|||
13184153|NCT02180659|26163661|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0|||
13184154|NCT02180659|26163662|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1|||
13184155|NCT02180438|26163679|FG000|Overall Study|Lost to Follow-up|1|||
13184156|NCT02180165|26163778|FG000|Overall Study|Not Treated|0|||
13184157|NCT02180165|26163779|FG001|Overall Study|Not Treated|0|||
13184158|NCT02180165|26163780|FG002|Overall Study|Not Treated|1|||
13184159|NCT02180165|26163781|FG003|Overall Study|Not Treated|0|||
13184160|NCT02180165|26163778|FG000|Overall Study|Adverse Event|7|||
13184161|NCT02180165|26163779|FG001|Overall Study|Adverse Event|0|||
13184162|NCT02180165|26163780|FG002|Overall Study|Adverse Event|18|||
13184163|NCT02180165|26163781|FG003|Overall Study|Adverse Event|3|||
13184164|NCT02180165|26163778|FG000|Overall Study|Lack of Efficacy|0|||
13184165|NCT02180165|26163779|FG001|Overall Study|Lack of Efficacy|1|||
13184166|NCT02180165|26163780|FG002|Overall Study|Lack of Efficacy|3|||
13184167|NCT02180165|26163781|FG003|Overall Study|Lack of Efficacy|2|||
13184168|NCT02180165|26163778|FG000|Overall Study|Physician Decision|1|||
13184169|NCT02180165|26163779|FG001|Overall Study|Physician Decision|0|||
13184170|NCT02180165|26163780|FG002|Overall Study|Physician Decision|5|||
13184171|NCT02180165|26163781|FG003|Overall Study|Physician Decision|0|||
13184172|NCT02180165|26163778|FG000|Overall Study|Withdrawal by Subject|3|||
13184173|NCT02180165|26163779|FG001|Overall Study|Withdrawal by Subject|0|||
13184174|NCT02180165|26163780|FG002|Overall Study|Withdrawal by Subject|2|||
13184175|NCT02180165|26163781|FG003|Overall Study|Withdrawal by Subject|1|||
13184176|NCT02180061|26163802|FG000|Overall Study|Adverse Event|4|||
13184177|NCT02180061|26163803|FG001|Overall Study|Adverse Event|2|||
13184178|NCT02180061|26163802|FG000|Overall Study|Clinical Progression|5|||
13184179|NCT02180061|26163803|FG001|Overall Study|Clinical Progression|1|||
13184180|NCT02180061|26163802|FG000|Overall Study|Progressive Disease|15|||
13184181|NCT02180061|26163803|FG001|Overall Study|Progressive Disease|5|||
13184182|NCT02180061|26163802|FG000|Overall Study|Physician Decision|1|||
13184183|NCT02180061|26163803|FG001|Overall Study|Physician Decision|0|||
13184184|NCT02179918|26163943|FG000|Overall Study|Death|0|||
13184185|NCT02179918|26163944|FG001|Overall Study|Death|0|||
13184186|NCT02179918|26163945|FG002|Overall Study|Death|0|||
13184187|NCT02179918|26163946|FG003|Overall Study|Death|1|||
13184188|NCT02179918|26163947|FG004|Overall Study|Death|0|||
13184189|NCT02179918|26163943|FG000|Overall Study|Lost to Follow-up|0|||
13184190|NCT02179918|26163944|FG001|Overall Study|Lost to Follow-up|0|||
13184191|NCT02179918|26163945|FG002|Overall Study|Lost to Follow-up|1|||
13184192|NCT02179918|26163946|FG003|Overall Study|Lost to Follow-up|0|||
13184193|NCT02179918|26163947|FG004|Overall Study|Lost to Follow-up|0|||
13184194|NCT02179918|26163943|FG000|Overall Study|Progressive Disease|4|||
13184195|NCT02179918|26163944|FG001|Overall Study|Progressive Disease|1|||
13184196|NCT02179918|26163945|FG002|Overall Study|Progressive Disease|1|||
13184197|NCT02179918|26163946|FG003|Overall Study|Progressive Disease|2|||
13184198|NCT02179918|26163947|FG004|Overall Study|Progressive Disease|6|||
13184199|NCT02179918|26163943|FG000|Overall Study|Other|0|||
13184200|NCT02179918|26163944|FG001|Overall Study|Other|1|||
13184201|NCT02179918|26163945|FG002|Overall Study|Other|0|||
13184202|NCT02179918|26163946|FG003|Overall Study|Other|0|||
13184203|NCT02179918|26163947|FG004|Overall Study|Other|1|||
13184204|NCT02179918|26163943|FG000|Overall Study|Subject refused further follow-up|0|||
13184205|NCT02179918|26163944|FG001|Overall Study|Subject refused further follow-up|1|||
13184206|NCT02179918|26163945|FG002|Overall Study|Subject refused further follow-up|0|||
13184207|NCT02179918|26163946|FG003|Overall Study|Subject refused further follow-up|0|||
13184208|NCT02179918|26163947|FG004|Overall Study|Subject refused further follow-up|1|||
13184209|NCT02179515|26163996|FG000|Overall Study|switched to alternative treatment|0|||
13184210|NCT02179515|26163997|FG001|Overall Study|switched to alternative treatment|1|||
13184211|NCT02179515|26163998|FG002|Overall Study|switched to alternative treatment|1|||
13184212|NCT02179515|26163996|FG000|Overall Study|Death|0|||
13184213|NCT02179515|26163997|FG001|Overall Study|Death|1|||
13184214|NCT02179515|26163998|FG002|Overall Study|Death|1|||
13184215|NCT02179515|26163996|FG000|Overall Study|refused further treatment|0|||
13184216|NCT02179515|26163997|FG001|Overall Study|refused further treatment|3|||
13184217|NCT02179515|26163998|FG002|Overall Study|refused further treatment|4|||
13184218|NCT02179515|26163996|FG000|Overall Study|Disease progression on study|2|||
13184219|NCT02179515|26163997|FG001|Overall Study|Disease progression on study|11|||
13184220|NCT02179515|26163998|FG002|Overall Study|Disease progression on study|8|||
13184221|NCT02179398|26164023|FG000|Overall Study|Lack of obligatory data|3|||
13184222|NCT02179398|26164024|FG001|Overall Study|Lack of obligatory data|3|||
13184223|NCT02179398|26164023|FG000|Overall Study|Lost to Follow-up|0|||
13184224|NCT02179398|26164024|FG001|Overall Study|Lost to Follow-up|1|||
13184225|NCT02179190|26164037|FG000|Enrollment|Exit Prior to Device Attempt|11|||
13184226|NCT02179190|26164037|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7|||
13184227|NCT02179190|26164037|FG000|Follow-Up Post Barrel VRD Implanted|Death|3|||
13184228|NCT02179190|26164037|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3|||
13184229|NCT02179190|26164037|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2|||
13184230|NCT02179190|26164037|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1|||
13184231|NCT02179177|26164056|FG000|Overall Study|Lost to Follow-up|1|||
13184232|NCT02179177|26164057|FG001|Overall Study|Lost to Follow-up|1|||
13184233|NCT02179177|26164056|FG000|Overall Study|Withdrawal by Subject|1|||
13184234|NCT02179177|26164057|FG001|Overall Study|Withdrawal by Subject|1|||
13184235|NCT02178995|26164142|FG000|Double Blind|Adverse Event|0|||
13184236|NCT02178995|26164143|FG001|Double Blind|Adverse Event|0|||
13184237|NCT02178995|26164144|FG002|Double Blind|Adverse Event|0|||
13184238|NCT02178995|26164145|FG003|Double Blind|Adverse Event|0|||
13184239|NCT02178995|26164146|FG004|Double Blind|Adverse Event|0|||
13184240|NCT02178995|26164147|FG005|Double Blind|Adverse Event|1|||
13184241|NCT02178995|26164148|FG006|Double Blind|Adverse Event|0|||
13184242|NCT02178995|26164149|FG007|Double Blind|Adverse Event|1|||
13184243|NCT02178995|26164150|FG008|Double Blind|Adverse Event|1|||
13184244|NCT02178995|26164142|FG000|Double Blind|Lost to Follow-up|0|||
13184245|NCT02178995|26164143|FG001|Double Blind|Lost to Follow-up|1|||
13184246|NCT02178995|26164144|FG002|Double Blind|Lost to Follow-up|0|||
13184247|NCT02178995|26164145|FG003|Double Blind|Lost to Follow-up|0|||
13184248|NCT02178995|26164146|FG004|Double Blind|Lost to Follow-up|0|||
13184249|NCT02178995|26164147|FG005|Double Blind|Lost to Follow-up|0|||
13184250|NCT02178995|26164148|FG006|Double Blind|Lost to Follow-up|0|||
13184251|NCT02178995|26164149|FG007|Double Blind|Lost to Follow-up|1|||
13184252|NCT02178995|26164150|FG008|Double Blind|Lost to Follow-up|0|||
13184253|NCT02178995|26164142|FG000|Open Label|Adverse Event|2|||
13223025|NCT01800916|26287698|FG000|Test Period 1 (1 Week)|Adverse Event|0|||
13184254|NCT02178995|26164143|FG001|Open Label|Adverse Event|0|||
13184255|NCT02178995|26164144|FG002|Open Label|Adverse Event|0|||
13184256|NCT02178995|26164145|FG003|Open Label|Adverse Event|0|||
13184257|NCT02178995|26164146|FG004|Open Label|Adverse Event|0|||
13184258|NCT02178995|26164147|FG005|Open Label|Adverse Event|0|||
13184259|NCT02178995|26164148|FG006|Open Label|Adverse Event|0|||
13184260|NCT02178995|26164149|FG007|Open Label|Adverse Event|0|||
13184261|NCT02178995|26164150|FG008|Open Label|Adverse Event|0|||
13184262|NCT02178956|26164171|FG000|Overall Study|Lost to Follow-up|4|||
13184263|NCT02178956|26164172|FG001|Overall Study|Lost to Follow-up|4|||
13184264|NCT02178956|26164171|FG000|Overall Study|Sponsor terminated study|49|||
13184265|NCT02178956|26164172|FG001|Overall Study|Sponsor terminated study|58|||
13184266|NCT02178956|26164171|FG000|Overall Study|Withdrawal by Subject|15|||
13184267|NCT02178956|26164172|FG001|Overall Study|Withdrawal by Subject|11|||
13184268|NCT02178956|26164171|FG000|Overall Study|Various Reasons|3|||
13184269|NCT02178956|26164172|FG001|Overall Study|Various Reasons|5|||
13184270|NCT02178787|26164187|FG000|Overall Study|Lost to Follow-up|1|||
13184271|NCT02178787|26164188|FG001|Overall Study|Lost to Follow-up|0|||
13184272|NCT02178787|26164187|FG000|Overall Study|Withdrawal by Subject|0|||
13184273|NCT02178787|26164188|FG001|Overall Study|Withdrawal by Subject|2|||
13184274|NCT02178787|26164187|FG000|Overall Study|No TCD window|3|||
13184275|NCT02178787|26164188|FG001|Overall Study|No TCD window|7|||
13184276|NCT02178787|26164187|FG000|Overall Study|Physician Decision|1|||
13184277|NCT02178787|26164188|FG001|Overall Study|Physician Decision|0|||
13485540|NCT02906020|27032878|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
13485541|NCT02906020|27032879|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7|||
13485542|NCT02906020|27032880|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4|||
13485543|NCT02906020|27032881|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
13485544|NCT02906020|27032882|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1|||
13485545|NCT02906020|27032867|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
13485546|NCT02906020|27032868|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
13485547|NCT02906020|27032869|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
13485548|NCT02906020|27032870|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
13485549|NCT02906020|27032871|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
13485550|NCT02906020|27032872|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
13485551|NCT02906020|27032873|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
13485552|NCT02906020|27032874|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
13485553|NCT02906020|27032875|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
13485554|NCT02906020|27032876|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
13485555|NCT02906020|27032877|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
13485556|NCT02906020|27032878|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
13184278|NCT02178709|26164201|FG000|Overall Study|Adverse Event|5|||
13184279|NCT02178709|26164201|FG000|Overall Study|Death|2|||
13184280|NCT02178709|26164201|FG000|Overall Study|Withdrawal by Subject|2|||
13184281|NCT02178709|26164201|FG000|Overall Study|Physician Decision|2|||
13184282|NCT02178709|26164201|FG000|Overall Study|Disease Progression|5|||
13184283|NCT02178592|26164248|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0|||
13184284|NCT02178592|26164249|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2|||
13184285|NCT02178592|26164248|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
13184286|NCT02178592|26164249|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
13184287|NCT02178592|26164248|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3|||
13184288|NCT02178592|26164249|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2|||
13184289|NCT02178592|26164248|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3|||
13184290|NCT02178592|26164249|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1|||
13184291|NCT02178592|26164248|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11|||
13184292|NCT02178592|26164249|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3|||
13184293|NCT02178592|26164248|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1|||
13184294|NCT02178592|26164249|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0|||
13184295|NCT02178592|26164248|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1|||
13184296|NCT02178592|26164249|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0|||
13184297|NCT02178592|26164248|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0|||
13184298|NCT02178592|26164249|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1|||
13184299|NCT02178592|26164248|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2|||
13184300|NCT02178592|26164249|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0|||
13184301|NCT02178592|26164248|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4|||
13184302|NCT02178592|26164249|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1|||
13184303|NCT02178592|26164248|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2|||
13184304|NCT02178592|26164249|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0|||
13184305|NCT02178592|26164248|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3|||
13184306|NCT02178592|26164249|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1|||
13184307|NCT02178566|26164262|FG000|Overall Study|patient did not complete due to noncompliance|0|||
13184308|NCT02178566|26164263|FG001|Overall Study|patient did not complete due to noncompliance|1|||
13184309|NCT02178553|26164282|FG000|Overall Study|Did not proceed to open thoracotomy|7|||
13184310|NCT02178553|26164283|FG001|Overall Study|Did not proceed to open thoracotomy|3|||
13184311|NCT02178553|26164282|FG000|Overall Study|Physician Decision|0|||
13184312|NCT02178553|26164283|FG001|Overall Study|Physician Decision|4|||
13184313|NCT02178553|26164282|FG000|Overall Study|Technical problem with injection|1|||
13184314|NCT02178553|26164283|FG001|Overall Study|Technical problem with injection|3|||
13206092|NCT01959880|26233549|FG002|Overall Study|Lost to Follow-up|15|||
13206093|NCT01959880|26233550|FG003|Overall Study|Lost to Follow-up|8|||
13206094|NCT01959880|26233547|FG000|Overall Study|Explantation w/o study device reimplant.|22|||
13206095|NCT01959880|26233548|FG001|Overall Study|Explantation w/o study device reimplant.|17|||
13206096|NCT01959880|26233549|FG002|Overall Study|Explantation w/o study device reimplant.|5|||
13206097|NCT01959880|26233550|FG003|Overall Study|Explantation w/o study device reimplant.|12|||
13206098|NCT01959880|26233547|FG000|Overall Study|Study completed early-FDA approved|1003|||
13206099|NCT01959880|26233548|FG001|Overall Study|Study completed early-FDA approved|311|||
13206100|NCT01959880|26233549|FG002|Overall Study|Study completed early-FDA approved|179|||
13206101|NCT01959880|26233550|FG003|Overall Study|Study completed early-FDA approved|152|||
13206102|NCT01959841|26233583|FG000|Overall Study|Adverse Event|1|||
13206103|NCT01959841|26233584|FG001|Overall Study|Adverse Event|3|||
13206104|NCT01959841|26233585|FG002|Overall Study|Adverse Event|2|||
13184315|NCT02178475|26164305|FG000|Overall Study|Withdrawal by Subject|7|||
13184316|NCT02178475|26164305|FG000|Overall Study|Lost to Follow-up|10|||
13184317|NCT02178475|26164305|FG000|Overall Study|Death|13|||
13184318|NCT02178475|26164305|FG000|Overall Study|Protocol-specified Criteria|99|||
13184319|NCT02178358|26164340|FG000|Overall Study|Withdrawal by Subject|0|||
13184320|NCT02178358|26164341|FG001|Overall Study|Withdrawal by Subject|2|||
13184321|NCT02178358|26164342|FG002|Overall Study|Withdrawal by Subject|2|||
13184322|NCT02178358|26164340|FG000|Overall Study|Lost to Follow-up|1|||
13184323|NCT02178358|26164341|FG001|Overall Study|Lost to Follow-up|0|||
13184324|NCT02178358|26164342|FG002|Overall Study|Lost to Follow-up|0|||
13184325|NCT02178059|26164361|FG000|Washout|Physician Decision|1|||
13184326|NCT02178059|26164362|FG001|Washout|Physician Decision|0|||
13184327|NCT02177942|26164391|FG000|Overall Study|Adverse Event|1|||
13184328|NCT02177942|26164392|FG001|Overall Study|Adverse Event|0|||
13184329|NCT02177942|26164391|FG000|Overall Study|Lost to Follow-up|1|||
13184330|NCT02177942|26164392|FG001|Overall Study|Lost to Follow-up|1|||
13184331|NCT02177942|26164391|FG000|Overall Study|Protocol Violation|4|||
13110224|NCT03214380|25898881|FG002|Treatment Period|Participant schedule|1|||
13110225|NCT03214380|25898882|FG003|Treatment Period|Participant schedule|0|||
13110226|NCT03214380|25898883|FG004|Treatment Period|Participant schedule|0|||
13110227|NCT03214380|25898884|FG005|Treatment Period|Participant schedule|0|||
13110228|NCT03214380|25898879|FG000|Treatment Period|Treatment Interruption|0|||
13110229|NCT03214380|25898880|FG001|Treatment Period|Treatment Interruption|0|||
13110230|NCT03214380|25898881|FG002|Treatment Period|Treatment Interruption|1|||
13184332|NCT02177942|26164392|FG001|Overall Study|Protocol Violation|6|||
13184333|NCT02177942|26164391|FG000|Overall Study|Withdrawal by Subject|71|||
13184334|NCT02177942|26164392|FG001|Overall Study|Withdrawal by Subject|81|||
13184335|NCT02177838|26164400|FG000|Overall Study|Withdrawal by Subject|1|||
13184336|NCT02177838|26164400|FG000|Overall Study|Physician Decision|1|||
13184337|NCT02177838|26164400|FG000|Overall Study|Death|1|||
13184338|NCT02177812|26164641|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
13184339|NCT02177812|26164642|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
13184340|NCT02177812|26164643|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
13184341|NCT02177812|26164644|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
13184342|NCT02177812|26164645|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
13184343|NCT02177812|26164646|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
13184344|NCT02177812|26164647|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2|||
13184345|NCT02177812|26164648|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
13184346|NCT02177812|26164649|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
13184347|NCT02177812|26164641|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
13184348|NCT02177812|26164642|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
13184349|NCT02177812|26164643|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
13184350|NCT02177812|26164644|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
13184351|NCT02177812|26164645|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
13184352|NCT02177812|26164646|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
13184353|NCT02177812|26164647|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
13184354|NCT02177812|26164648|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
13184355|NCT02177812|26164649|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
13184356|NCT02177812|26164641|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
13184357|NCT02177812|26164642|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
13184358|NCT02177812|26164643|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
13184359|NCT02177812|26164644|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
13184360|NCT02177812|26164645|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
13184361|NCT02177812|26164646|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
13184362|NCT02177812|26164647|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6|||
13184363|NCT02177812|26164648|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
13184364|NCT02177812|26164649|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
13184365|NCT02177786|26164676|FG000|Overall Study|Withdrew Consent|2|||
13184366|NCT02177786|26164677|FG001|Overall Study|Withdrew Consent|6|||
13184367|NCT02177786|26164678|FG002|Overall Study|Withdrew Consent|9|||
13184368|NCT02177786|26164679|FG003|Overall Study|Withdrew Consent|5|||
13184369|NCT02177786|26164676|FG000|Overall Study|Progression to End Stage Renal Disease|2|||
13184370|NCT02177786|26164677|FG001|Overall Study|Progression to End Stage Renal Disease|3|||
13184371|NCT02177786|26164678|FG002|Overall Study|Progression to End Stage Renal Disease|2|||
13184372|NCT02177786|26164679|FG003|Overall Study|Progression to End Stage Renal Disease|1|||
13184373|NCT02177786|26164676|FG000|Overall Study|Adverse Event|1|||
13184374|NCT02177786|26164677|FG001|Overall Study|Adverse Event|1|||
13184375|NCT02177786|26164678|FG002|Overall Study|Adverse Event|2|||
13184376|NCT02177786|26164679|FG003|Overall Study|Adverse Event|3|||
13184377|NCT02177786|26164676|FG000|Overall Study|Death|1|||
13184378|NCT02177786|26164677|FG001|Overall Study|Death|1|||
13184379|NCT02177786|26164678|FG002|Overall Study|Death|1|||
13184380|NCT02177786|26164679|FG003|Overall Study|Death|1|||
13184381|NCT02177786|26164676|FG000|Overall Study|Lost to Follow-up|0|||
13184382|NCT02177786|26164677|FG001|Overall Study|Lost to Follow-up|0|||
13110231|NCT03214380|25898882|FG003|Treatment Period|Treatment Interruption|0|||
13184383|NCT02177786|26164678|FG002|Overall Study|Lost to Follow-up|2|||
13184384|NCT02177786|26164679|FG003|Overall Study|Lost to Follow-up|2|||
13184385|NCT02177786|26164676|FG000|Overall Study|Non-Compliance with Study Drug|0|||
13184386|NCT02177786|26164677|FG001|Overall Study|Non-Compliance with Study Drug|1|||
13184387|NCT02177786|26164678|FG002|Overall Study|Non-Compliance with Study Drug|0|||
13184388|NCT02177786|26164679|FG003|Overall Study|Non-Compliance with Study Drug|1|||
13184389|NCT02177786|26164676|FG000|Overall Study|Protocol Violation|0|||
13184390|NCT02177786|26164677|FG001|Overall Study|Protocol Violation|0|||
13184391|NCT02177786|26164678|FG002|Overall Study|Protocol Violation|2|||
13184392|NCT02177786|26164679|FG003|Overall Study|Protocol Violation|0|||
13184393|NCT02177786|26164676|FG000|Overall Study|Progressive Disease|0|||
13184394|NCT02177786|26164677|FG001|Overall Study|Progressive Disease|1|||
13184395|NCT02177786|26164678|FG002|Overall Study|Progressive Disease|0|||
13184396|NCT02177786|26164679|FG003|Overall Study|Progressive Disease|0|||
13184397|NCT02177786|26164676|FG000|Overall Study|Missing study completion status|0|||
13184398|NCT02177786|26164677|FG001|Overall Study|Missing study completion status|1|||
13184399|NCT02177786|26164678|FG002|Overall Study|Missing study completion status|0|||
13184400|NCT02177786|26164679|FG003|Overall Study|Missing study completion status|0|||
13184401|NCT02177266|26164696|FG000|Overall Study|Adverse Event|0|||
13184402|NCT02177266|26164697|FG001|Overall Study|Adverse Event|1|||
13184403|NCT02177266|26164696|FG000|Overall Study|Withdrawal by Subject|1|||
13184404|NCT02177266|26164697|FG001|Overall Study|Withdrawal by Subject|0|||
13184405|NCT02177175|26164718|FG000|Overall Study|stopped trastuzumab so was taken off study|1|||
13110232|NCT03214380|25898883|FG004|Treatment Period|Treatment Interruption|0|||
13110233|NCT03214380|25898884|FG005|Treatment Period|Treatment Interruption|0|||
13110234|NCT03214367|25898950|FG000|Lead-in Period|Withdrawal by Subject|50|||
13110235|NCT03214367|25898951|FG001|Lead-in Period|Withdrawal by Subject|0|||
13110236|NCT03214367|25898952|FG002|Lead-in Period|Withdrawal by Subject|0|||
13110237|NCT03214367|25898953|FG003|Lead-in Period|Withdrawal by Subject|0|||
13110238|NCT03214367|25898954|FG004|Lead-in Period|Withdrawal by Subject|2|||
13110239|NCT03214367|25898955|FG005|Lead-in Period|Withdrawal by Subject|0|||
13110240|NCT03214367|25898956|FG006|Lead-in Period|Withdrawal by Subject|0|||
13110241|NCT03214367|25898957|FG007|Lead-in Period|Withdrawal by Subject|0|||
13184406|NCT02177175|26164719|FG001|Overall Study|stopped trastuzumab so was taken off study|0|||
13184407|NCT02177136|26164777|FG000|DB Phase|Withdrawal by Subject|2|||
13184408|NCT02177136|26164778|FG001|DB Phase|Withdrawal by Subject|0|||
13184409|NCT02177136|26164779|FG002|DB Phase|Withdrawal by Subject|0|||
13184410|NCT02177136|26164780|FG003|DB Phase|Withdrawal by Subject|0|||
13184411|NCT02177136|26164777|FG000|DB Phase|Discontinued Due to Pruritus|1|||
13184412|NCT02177136|26164778|FG001|DB Phase|Discontinued Due to Pruritus|3|||
13184413|NCT02177136|26164779|FG002|DB Phase|Discontinued Due to Pruritus|0|||
13184414|NCT02177136|26164780|FG003|DB Phase|Discontinued Due to Pruritus|0|||
13184415|NCT02177136|26164777|FG000|DB Phase|Adverse Event|3|||
13184416|NCT02177136|26164778|FG001|DB Phase|Adverse Event|2|||
13184417|NCT02177136|26164779|FG002|DB Phase|Adverse Event|3|||
13184418|NCT02177136|26164780|FG003|DB Phase|Adverse Event|0|||
13184419|NCT02177136|26164777|FG000|DB Phase|Protocol Violation|0|||
13184420|NCT02177136|26164778|FG001|DB Phase|Protocol Violation|0|||
13184421|NCT02177136|26164779|FG002|DB Phase|Protocol Violation|1|||
13184422|NCT02177136|26164780|FG003|DB Phase|Protocol Violation|0|||
13184423|NCT02177136|26164777|FG000|DB Phase|Withdrew Consent Prior to Dosing|1|||
13184424|NCT02177136|26164778|FG001|DB Phase|Withdrew Consent Prior to Dosing|0|||
13184425|NCT02177136|26164779|FG002|DB Phase|Withdrew Consent Prior to Dosing|0|||
13184426|NCT02177136|26164780|FG003|DB Phase|Withdrew Consent Prior to Dosing|0|||
13184427|NCT02177136|26164777|FG000|LTSE Phase|Withdrawal by Subject|0|||
13184428|NCT02177136|26164778|FG001|LTSE Phase|Withdrawal by Subject|0|||
13184429|NCT02177136|26164779|FG002|LTSE Phase|Withdrawal by Subject|0|||
13184430|NCT02177136|26164780|FG003|LTSE Phase|Withdrawal by Subject|6|||
13184431|NCT02177136|26164777|FG000|LTSE Phase|Adverse Event|0|||
13184432|NCT02177136|26164778|FG001|LTSE Phase|Adverse Event|0|||
13184433|NCT02177136|26164779|FG002|LTSE Phase|Adverse Event|0|||
13184434|NCT02177136|26164780|FG003|LTSE Phase|Adverse Event|10|||
13184435|NCT02177136|26164777|FG000|LTSE Phase|Discontinued Due to Pruritus|0|||
13184436|NCT02177136|26164778|FG001|LTSE Phase|Discontinued Due to Pruritus|0|||
13184437|NCT02177136|26164779|FG002|LTSE Phase|Discontinued Due to Pruritus|0|||
13184438|NCT02177136|26164780|FG003|LTSE Phase|Discontinued Due to Pruritus|4|||
13184439|NCT02177136|26164777|FG000|LTSE Phase|Physician Decision|0|||
13184440|NCT02177136|26164778|FG001|LTSE Phase|Physician Decision|0|||
13184441|NCT02177136|26164779|FG002|LTSE Phase|Physician Decision|0|||
13223026|NCT01800916|26287699|FG001|Test Period 1 (1 Week)|Adverse Event|0|||
13184442|NCT02177136|26164780|FG003|LTSE Phase|Physician Decision|2|||
13184443|NCT02177136|26164777|FG000|LTSE Phase|Lost to Follow-up|0|||
13184444|NCT02177136|26164778|FG001|LTSE Phase|Lost to Follow-up|0|||
13184445|NCT02177136|26164779|FG002|LTSE Phase|Lost to Follow-up|0|||
13184446|NCT02177136|26164780|FG003|LTSE Phase|Lost to Follow-up|1|||
13184447|NCT02177136|26164777|FG000|LTSE Phase|Participant Moved|0|||
13184448|NCT02177136|26164778|FG001|LTSE Phase|Participant Moved|0|||
13184449|NCT02177136|26164779|FG002|LTSE Phase|Participant Moved|0|||
13184450|NCT02177136|26164780|FG003|LTSE Phase|Participant Moved|1|||
13184451|NCT02177123|26164789|FG000|Overall Study|Lost to Follow-up|6|||
13184452|NCT02177123|26164789|FG000|Overall Study|Withdrawal by Subject|4|||
13184453|NCT02177123|26164789|FG000|Overall Study|Adverse Event|4|||
13184454|NCT02177123|26164789|FG000|Overall Study|Physician Decision|3|||
13184455|NCT02177123|26164789|FG000|Overall Study|Excluded by Sponsor - other reason|2|||
13184456|NCT02177123|26164789|FG000|Overall Study|Excluded for medical reasons|2|||
13184457|NCT02177123|26164789|FG000|Overall Study|Death|1|||
13184458|NCT02177123|26164789|FG000|Overall Study|Other|1|||
13184459|NCT02177123|26164789|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1|||
13110242|NCT03214367|25898950|FG000|Lead-in Period|Adverse Event|3|||
13110243|NCT03214367|25898951|FG001|Lead-in Period|Adverse Event|0|||
13110244|NCT03214367|25898952|FG002|Lead-in Period|Adverse Event|0|||
13110245|NCT03214367|25898953|FG003|Lead-in Period|Adverse Event|0|||
13110246|NCT03214367|25898954|FG004|Lead-in Period|Adverse Event|0|||
13110247|NCT03214367|25898955|FG005|Lead-in Period|Adverse Event|0|||
13184460|NCT02177032|26164836|FG000|Overall Study|ADMINISTRATIVE REASON|2|||
13184461|NCT02177032|26164837|FG001|Overall Study|ADMINISTRATIVE REASON|0|||
13184462|NCT02177032|26164838|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
13184463|NCT02177032|26164839|FG003|Overall Study|ADMINISTRATIVE REASON|0|||
13184464|NCT02177032|26164836|FG000|Overall Study|Lost to Follow-up|0|||
13184465|NCT02177032|26164837|FG001|Overall Study|Lost to Follow-up|2|||
13184466|NCT02177032|26164838|FG002|Overall Study|Lost to Follow-up|0|||
13184467|NCT02177032|26164839|FG003|Overall Study|Lost to Follow-up|0|||
13184468|NCT02177032|26164836|FG000|Overall Study|OTHER|2|||
13184469|NCT02177032|26164837|FG001|Overall Study|OTHER|0|||
13184470|NCT02177032|26164838|FG002|Overall Study|OTHER|1|||
13184471|NCT02177032|26164839|FG003|Overall Study|OTHER|0|||
13184472|NCT02177032|26164836|FG000|Overall Study|Withdrawal by Subject|1|||
13184473|NCT02177032|26164837|FG001|Overall Study|Withdrawal by Subject|0|||
13184474|NCT02177032|26164838|FG002|Overall Study|Withdrawal by Subject|1|||
13184475|NCT02177032|26164839|FG003|Overall Study|Withdrawal by Subject|0|||
13184476|NCT02176928|26164852|FG000|Overall Study|Lost to Follow-up|2|||
13184477|NCT02176928|26164853|FG001|Overall Study|Lost to Follow-up|4|||
13184478|NCT02176655|26164876|FG000|Overall Study|Subjects did not treat|6|||
13184479|NCT02176642|26164905|FG000|Overall Study|Withdrawal by Subject|0|||
13184480|NCT02176642|26164906|FG001|Overall Study|Withdrawal by Subject|1|||
13184481|NCT02176525|26165108|FG000|Overall Study|Adverse Event|0|||
13184482|NCT02176525|26165109|FG001|Overall Study|Adverse Event|0|||
13110248|NCT03214367|25898956|FG006|Lead-in Period|Adverse Event|0|||
13110249|NCT03214367|25898957|FG007|Lead-in Period|Adverse Event|0|||
13184483|NCT02176525|26165110|FG002|Overall Study|Adverse Event|0|||
13184484|NCT02176525|26165111|FG003|Overall Study|Adverse Event|1|||
13184485|NCT02176525|26165112|FG004|Overall Study|Adverse Event|1|||
13184486|NCT02176525|26165113|FG005|Overall Study|Adverse Event|0|||
13184487|NCT02176525|26165114|FG006|Overall Study|Adverse Event|1|||
13184488|NCT02176525|26165115|FG007|Overall Study|Adverse Event|0|||
13184489|NCT02176525|26165108|FG000|Overall Study|not treated|1|||
13184490|NCT02176525|26165109|FG001|Overall Study|not treated|0|||
13184491|NCT02176525|26165110|FG002|Overall Study|not treated|0|||
13184492|NCT02176525|26165111|FG003|Overall Study|not treated|0|||
13184493|NCT02176525|26165112|FG004|Overall Study|not treated|0|||
13184494|NCT02176525|26165113|FG005|Overall Study|not treated|1|||
13184495|NCT02176525|26165114|FG006|Overall Study|not treated|0|||
13184496|NCT02176525|26165115|FG007|Overall Study|not treated|0|||
13184497|NCT02176421|26165126|FG000|Overall Study|Lost to Follow-up|4|||
13184498|NCT02176421|26165126|FG000|Overall Study|Adverse Event|1|||
13184499|NCT02176356|26165145|FG000|Overall Study|Screen Failure|14|||
13184500|NCT02176356|26165145|FG000|Overall Study|Lost to Follow-up|4|||
13184501|NCT02176356|26165145|FG000|Overall Study|Personal Reasons|3|||
13184502|NCT02176356|26165145|FG000|Overall Study|Other Miscellaneous Reasons|2|||
13184503|NCT02176291|26165160|FG000|Overall Study|Death|1|||
13184504|NCT02176291|26165161|FG001|Overall Study|Death|0|||
13184505|NCT02176291|26165160|FG000|Overall Study|non compliance with protocol|2|||
13184506|NCT02176291|26165161|FG001|Overall Study|non compliance with protocol|0|||
13184507|NCT02176291|26165160|FG000|Overall Study|Withdrawal by Subject|2|||
13184508|NCT02176291|26165161|FG001|Overall Study|Withdrawal by Subject|0|||
13184509|NCT02176226|26165169|FG000|Overall Study|Lost to Follow-up|3|||
13184510|NCT02176226|26165169|FG000|Overall Study|Withdrew prior to treatment|6|||
13184511|NCT02176018|26165200|FG000|Overall Study|Adverse Event|0|||
13184512|NCT02176018|26165201|FG001|Overall Study|Adverse Event|2|||
13184513|NCT02176018|26165200|FG000|Overall Study|Lost to Follow-up|3|||
13184514|NCT02176018|26165201|FG001|Overall Study|Lost to Follow-up|1|||
13184515|NCT02176018|26165200|FG000|Overall Study|Protocol Violation|1|||
13184516|NCT02176018|26165201|FG001|Overall Study|Protocol Violation|1|||
13184517|NCT02176018|26165200|FG000|Overall Study|Withdrawal by Subject|1|||
13184518|NCT02176018|26165201|FG001|Overall Study|Withdrawal by Subject|2|||
13184519|NCT02175966|26165228|FG000|Follow-up Period|Lack of Efficacy|10|||
13184520|NCT02175966|26165229|FG001|Follow-up Period|Lack of Efficacy|6|||
13206105|NCT01959841|26233583|FG000|Overall Study|Lack of Efficacy|5|||
13184521|NCT02175771|26165313|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23|||
13184522|NCT02175771|26165314|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
13184523|NCT02175771|26165315|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
13184524|NCT02175771|26165316|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
13184525|NCT02175771|26165317|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
13184526|NCT02175771|26165318|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
13184527|NCT02175771|26165319|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
13184528|NCT02175771|26165320|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
13184529|NCT02175771|26165321|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
13184530|NCT02175771|26165313|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20|||
13184531|NCT02175771|26165314|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
13184532|NCT02175771|26165315|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
13184533|NCT02175771|26165316|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
13184534|NCT02175771|26165317|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
13184535|NCT02175771|26165318|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
13184536|NCT02175771|26165319|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
13184537|NCT02175771|26165320|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
13184538|NCT02175771|26165321|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
13184539|NCT02175771|26165313|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11|||
13184540|NCT02175771|26165314|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
13184541|NCT02175771|26165315|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
13184542|NCT02175771|26165316|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
13184543|NCT02175771|26165317|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
13184544|NCT02175771|26165318|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
13184545|NCT02175771|26165319|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
13184546|NCT02175771|26165320|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
13184547|NCT02175771|26165321|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
13184548|NCT02175771|26165313|FG000|Run-In Period (Pre-assignment)|Adverse Event|9|||
13184549|NCT02175771|26165314|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
13184550|NCT02175771|26165315|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
13184551|NCT02175771|26165316|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
13184552|NCT02175771|26165317|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
13110250|NCT03214367|25898950|FG000|Lead-in Period|Lost to Follow-up|12|||
13110251|NCT03214367|25898951|FG001|Lead-in Period|Lost to Follow-up|0|||
13184553|NCT02175771|26165318|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
13184554|NCT02175771|26165319|FG006|Run-In Period (Pre-assignment)|Adverse Event|0|||
13184555|NCT02175771|26165320|FG007|Run-In Period (Pre-assignment)|Adverse Event|0|||
13184556|NCT02175771|26165321|FG008|Run-In Period (Pre-assignment)|Adverse Event|0|||
13184557|NCT02175771|26165313|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7|||
13184558|NCT02175771|26165314|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
13184559|NCT02175771|26165315|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
13184560|NCT02175771|26165316|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
13184561|NCT02175771|26165317|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
13184562|NCT02175771|26165318|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
13184563|NCT02175771|26165319|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
13184564|NCT02175771|26165320|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
13184565|NCT02175771|26165321|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
13184566|NCT02175771|26165313|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
13184567|NCT02175771|26165314|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
13184568|NCT02175771|26165315|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
13184569|NCT02175771|26165316|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
13184570|NCT02175771|26165317|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
13184571|NCT02175771|26165318|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
13184572|NCT02175771|26165319|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
13184573|NCT02175771|26165320|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
13184574|NCT02175771|26165321|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
13184575|NCT02175771|26165313|FG000|Run-In Period (Pre-assignment)|Other|8|||
13184576|NCT02175771|26165314|FG001|Run-In Period (Pre-assignment)|Other|0|||
13223027|NCT01800916|26287700|FG002|Test Period 1 (1 Week)|Adverse Event|0|||
13110252|NCT03214367|25898952|FG002|Lead-in Period|Lost to Follow-up|0|||
13110253|NCT03214367|25898953|FG003|Lead-in Period|Lost to Follow-up|0|||
13110254|NCT03214367|25898954|FG004|Lead-in Period|Lost to Follow-up|0|||
13110255|NCT03214367|25898955|FG005|Lead-in Period|Lost to Follow-up|0|||
13110256|NCT03214367|25898956|FG006|Lead-in Period|Lost to Follow-up|0|||
13110257|NCT03214367|25898957|FG007|Lead-in Period|Lost to Follow-up|0|||
13110258|NCT03214367|25898950|FG000|Lead-in Period|Sponsor Decision|11|||
13184577|NCT02175771|26165315|FG002|Run-In Period (Pre-assignment)|Other|0|||
13184578|NCT02175771|26165316|FG003|Run-In Period (Pre-assignment)|Other|0|||
13184579|NCT02175771|26165317|FG004|Run-In Period (Pre-assignment)|Other|0|||
13184580|NCT02175771|26165318|FG005|Run-In Period (Pre-assignment)|Other|0|||
13184581|NCT02175771|26165319|FG006|Run-In Period (Pre-assignment)|Other|0|||
13184582|NCT02175771|26165320|FG007|Run-In Period (Pre-assignment)|Other|0|||
13184583|NCT02175771|26165321|FG008|Run-In Period (Pre-assignment)|Other|0|||
13184584|NCT02175771|26165313|FG000|Treatment Period|Adverse Event|0|||
13184585|NCT02175771|26165314|FG001|Treatment Period|Adverse Event|2|||
13184586|NCT02175771|26165315|FG002|Treatment Period|Adverse Event|1|||
13184587|NCT02175771|26165316|FG003|Treatment Period|Adverse Event|1|||
13184588|NCT02175771|26165317|FG004|Treatment Period|Adverse Event|1|||
13184589|NCT02175771|26165318|FG005|Treatment Period|Adverse Event|3|||
13184590|NCT02175771|26165319|FG006|Treatment Period|Adverse Event|2|||
13184591|NCT02175771|26165320|FG007|Treatment Period|Adverse Event|0|||
13184592|NCT02175771|26165321|FG008|Treatment Period|Adverse Event|1|||
13184593|NCT02175771|26165313|FG000|Treatment Period|Withdrawal by Subject|0|||
13184594|NCT02175771|26165314|FG001|Treatment Period|Withdrawal by Subject|9|||
13184595|NCT02175771|26165315|FG002|Treatment Period|Withdrawal by Subject|3|||
13184596|NCT02175771|26165316|FG003|Treatment Period|Withdrawal by Subject|6|||
13184597|NCT02175771|26165317|FG004|Treatment Period|Withdrawal by Subject|2|||
13184598|NCT02175771|26165318|FG005|Treatment Period|Withdrawal by Subject|4|||
13184599|NCT02175771|26165319|FG006|Treatment Period|Withdrawal by Subject|2|||
13184600|NCT02175771|26165320|FG007|Treatment Period|Withdrawal by Subject|9|||
13184601|NCT02175771|26165321|FG008|Treatment Period|Withdrawal by Subject|2|||
13184602|NCT02175771|26165313|FG000|Treatment Period|Noncompliance|0|||
13184603|NCT02175771|26165314|FG001|Treatment Period|Noncompliance|1|||
13184604|NCT02175771|26165315|FG002|Treatment Period|Noncompliance|2|||
13184605|NCT02175771|26165316|FG003|Treatment Period|Noncompliance|0|||
13184606|NCT02175771|26165317|FG004|Treatment Period|Noncompliance|0|||
13184607|NCT02175771|26165318|FG005|Treatment Period|Noncompliance|0|||
13184608|NCT02175771|26165319|FG006|Treatment Period|Noncompliance|0|||
13184609|NCT02175771|26165320|FG007|Treatment Period|Noncompliance|0|||
13184610|NCT02175771|26165321|FG008|Treatment Period|Noncompliance|1|||
13184611|NCT02175771|26165313|FG000|Treatment Period|Protocol Violation|0|||
13184612|NCT02175771|26165314|FG001|Treatment Period|Protocol Violation|0|||
13184613|NCT02175771|26165315|FG002|Treatment Period|Protocol Violation|0|||
13184614|NCT02175771|26165316|FG003|Treatment Period|Protocol Violation|0|||
13184615|NCT02175771|26165317|FG004|Treatment Period|Protocol Violation|0|||
13184616|NCT02175771|26165318|FG005|Treatment Period|Protocol Violation|0|||
13184617|NCT02175771|26165319|FG006|Treatment Period|Protocol Violation|0|||
13184618|NCT02175771|26165320|FG007|Treatment Period|Protocol Violation|1|||
13184619|NCT02175771|26165321|FG008|Treatment Period|Protocol Violation|0|||
13184620|NCT02175771|26165313|FG000|Treatment Period|Disease progression|0|||
13184621|NCT02175771|26165314|FG001|Treatment Period|Disease progression|0|||
13184622|NCT02175771|26165315|FG002|Treatment Period|Disease progression|0|||
13184623|NCT02175771|26165316|FG003|Treatment Period|Disease progression|0|||
13110259|NCT03214367|25898951|FG001|Lead-in Period|Sponsor Decision|0|||
13184624|NCT02175771|26165317|FG004|Treatment Period|Disease progression|0|||
13184625|NCT02175771|26165318|FG005|Treatment Period|Disease progression|0|||
13184626|NCT02175771|26165319|FG006|Treatment Period|Disease progression|0|||
13184627|NCT02175771|26165320|FG007|Treatment Period|Disease progression|2|||
13184628|NCT02175771|26165321|FG008|Treatment Period|Disease progression|0|||
13184629|NCT02175771|26165313|FG000|Treatment Period|Lost to Follow-up|0|||
13184630|NCT02175771|26165314|FG001|Treatment Period|Lost to Follow-up|3|||
13184631|NCT02175771|26165315|FG002|Treatment Period|Lost to Follow-up|1|||
13184632|NCT02175771|26165316|FG003|Treatment Period|Lost to Follow-up|3|||
13184633|NCT02175771|26165317|FG004|Treatment Period|Lost to Follow-up|1|||
13184634|NCT02175771|26165318|FG005|Treatment Period|Lost to Follow-up|2|||
13184635|NCT02175771|26165319|FG006|Treatment Period|Lost to Follow-up|1|||
13184636|NCT02175771|26165320|FG007|Treatment Period|Lost to Follow-up|2|||
13110260|NCT03214367|25898952|FG002|Lead-in Period|Sponsor Decision|0|||
13110261|NCT03214367|25898953|FG003|Lead-in Period|Sponsor Decision|0|||
13110262|NCT03214367|25898954|FG004|Lead-in Period|Sponsor Decision|0|||
13110263|NCT03214367|25898955|FG005|Lead-in Period|Sponsor Decision|0|||
13110264|NCT03214367|25898956|FG006|Lead-in Period|Sponsor Decision|0|||
13110265|NCT03214367|25898957|FG007|Lead-in Period|Sponsor Decision|0|||
13110266|NCT03214367|25898950|FG000|Lead-in Period|Physician Decision|12|||
13184637|NCT02175771|26165321|FG008|Treatment Period|Lost to Follow-up|2|||
13184638|NCT02175771|26165313|FG000|Treatment Period|Lack of Efficacy|0|||
13184639|NCT02175771|26165314|FG001|Treatment Period|Lack of Efficacy|0|||
13110267|NCT03214367|25898951|FG001|Lead-in Period|Physician Decision|0|||
13110268|NCT03214367|25898952|FG002|Lead-in Period|Physician Decision|0|||
13184640|NCT02175771|26165315|FG002|Treatment Period|Lack of Efficacy|0|||
13184641|NCT02175771|26165316|FG003|Treatment Period|Lack of Efficacy|0|||
13184642|NCT02175771|26165317|FG004|Treatment Period|Lack of Efficacy|0|||
13184643|NCT02175771|26165318|FG005|Treatment Period|Lack of Efficacy|1|||
13184644|NCT02175771|26165319|FG006|Treatment Period|Lack of Efficacy|0|||
13184645|NCT02175771|26165320|FG007|Treatment Period|Lack of Efficacy|1|||
13184646|NCT02175771|26165321|FG008|Treatment Period|Lack of Efficacy|0|||
13184647|NCT02175771|26165313|FG000|Treatment Period|Other|0|||
13184648|NCT02175771|26165314|FG001|Treatment Period|Other|1|||
13184649|NCT02175771|26165315|FG002|Treatment Period|Other|0|||
13184650|NCT02175771|26165316|FG003|Treatment Period|Other|3|||
13184651|NCT02175771|26165317|FG004|Treatment Period|Other|1|||
13184652|NCT02175771|26165318|FG005|Treatment Period|Other|0|||
13184653|NCT02175771|26165319|FG006|Treatment Period|Other|0|||
13184654|NCT02175771|26165320|FG007|Treatment Period|Other|2|||
13184655|NCT02175771|26165321|FG008|Treatment Period|Other|0|||
13184656|NCT02175758|26165443|FG000|Treatment Phase|Lost to Follow-up|0|||
13184657|NCT02175758|26165444|FG001|Treatment Phase|Lost to Follow-up|1|||
13184658|NCT02175758|26165445|FG002|Treatment Phase|Lost to Follow-up|0|||
13184659|NCT02175758|26165446|FG003|Treatment Phase|Lost to Follow-up|0|||
13184660|NCT02175758|26165447|FG004|Treatment Phase|Lost to Follow-up|0|||
13184661|NCT02175758|26165448|FG005|Treatment Phase|Lost to Follow-up|0|||
13184662|NCT02175758|26165443|FG000|Treatment Phase|Adverse Event|0|||
13184663|NCT02175758|26165444|FG001|Treatment Phase|Adverse Event|0|||
13184664|NCT02175758|26165445|FG002|Treatment Phase|Adverse Event|0|||
13184665|NCT02175758|26165446|FG003|Treatment Phase|Adverse Event|0|||
13184666|NCT02175758|26165447|FG004|Treatment Phase|Adverse Event|1|||
13184667|NCT02175758|26165448|FG005|Treatment Phase|Adverse Event|0|||
13184668|NCT02175745|26165455|FG000|Overall Study|Not Eligible|1|||
13184669|NCT02175641|26165482|FG000|Overall Study|Death|3|||
13184670|NCT02175641|26165483|FG001|Overall Study|Death|4|||
13184671|NCT02175641|26165482|FG000|Overall Study|Lost to Follow-up|4|||
13184672|NCT02175641|26165483|FG001|Overall Study|Lost to Follow-up|4|||
13184673|NCT02175641|26165482|FG000|Overall Study|Withdrawal by Subject|7|||
13184674|NCT02175641|26165483|FG001|Overall Study|Withdrawal by Subject|4|||
13184675|NCT02175641|26165482|FG000|Overall Study|Discharged from Supportive Housing Agenc|13|||
13184676|NCT02175641|26165483|FG001|Overall Study|Discharged from Supportive Housing Agenc|15|||
13184677|NCT02175641|26165482|FG000|Overall Study|Developed Contraindicated Condition|8|||
13184678|NCT02175641|26165483|FG001|Overall Study|Developed Contraindicated Condition|0|||
13184679|NCT02175368|26165490|FG000|Overall Study|Lost to Follow-up|1|||
13184680|NCT02175277|26165496|FG000|Overall Study|Protocol-specified Criteria|1|||
13184681|NCT02175225|26165535|FG000|Overall Study|Withdrawal by Subject|1|||
13184682|NCT02175225|26165536|FG001|Overall Study|Withdrawal by Subject|2|||
13184683|NCT02175225|26165535|FG000|Overall Study|Lost to Follow-up|6|||
13184684|NCT02175225|26165536|FG001|Overall Study|Lost to Follow-up|7|||
13184685|NCT02175225|26165535|FG000|Overall Study|Study drug not administered|1|||
13184686|NCT02175225|26165536|FG001|Overall Study|Study drug not administered|2|||
13184687|NCT02175199|26165552|FG000|Overall Study|Withdrawal by Subject|1|||
13184688|NCT02175199|26165553|FG001|Overall Study|Withdrawal by Subject|5|||
13184689|NCT02175199|26165552|FG000|Overall Study|Randomized in Error|1|||
13184690|NCT02175199|26165553|FG001|Overall Study|Randomized in Error|0|||
13184691|NCT02175199|26165552|FG000|Overall Study|Sponsor Decision|1|||
13184692|NCT02175199|26165553|FG001|Overall Study|Sponsor Decision|0|||
13184693|NCT02175121|26165696|FG000|Overall Study|Lack of Efficacy|1|||
13184694|NCT02175121|26165697|FG001|Overall Study|Lack of Efficacy|0|||
13184695|NCT02175121|26165698|FG002|Overall Study|Lack of Efficacy|0|||
13184696|NCT02175121|26165699|FG003|Overall Study|Lack of Efficacy|0|||
13184697|NCT02175121|26165700|FG004|Overall Study|Lack of Efficacy|0|||
13184698|NCT02175121|26165696|FG000|Overall Study|Lost to Follow-up|0|||
13184699|NCT02175121|26165697|FG001|Overall Study|Lost to Follow-up|1|||
13184700|NCT02175121|26165698|FG002|Overall Study|Lost to Follow-up|0|||
13184701|NCT02175121|26165699|FG003|Overall Study|Lost to Follow-up|1|||
13184702|NCT02175121|26165700|FG004|Overall Study|Lost to Follow-up|0|||
13184703|NCT02175121|26165696|FG000|Overall Study|Personal emergency|0|||
13184704|NCT02175121|26165697|FG001|Overall Study|Personal emergency|0|||
13184705|NCT02175121|26165698|FG002|Overall Study|Personal emergency|0|||
13184706|NCT02175121|26165699|FG003|Overall Study|Personal emergency|0|||
13184707|NCT02175121|26165700|FG004|Overall Study|Personal emergency|1|||
13184708|NCT02175121|26165696|FG000|Overall Study|Schedule conflict|0|||
13184709|NCT02175121|26165697|FG001|Overall Study|Schedule conflict|0|||
13184710|NCT02175121|26165698|FG002|Overall Study|Schedule conflict|1|||
13184711|NCT02175121|26165699|FG003|Overall Study|Schedule conflict|0|||
13184712|NCT02175121|26165700|FG004|Overall Study|Schedule conflict|0|||
13184713|NCT02175121|26165696|FG000|Overall Study|Time issues|0|||
13184714|NCT02175121|26165697|FG001|Overall Study|Time issues|0|||
13184715|NCT02175121|26165698|FG002|Overall Study|Time issues|1|||
13184716|NCT02175121|26165699|FG003|Overall Study|Time issues|0|||
13184717|NCT02175121|26165700|FG004|Overall Study|Time issues|0|||
13184718|NCT02174848|26165722|FG000|Overall Study|Adverse Event|2|||
13184719|NCT02174848|26165723|FG001|Overall Study|Adverse Event|1|||
13184720|NCT02174848|26165722|FG000|Overall Study|Withdrawal by Subject|3|||
13184721|NCT02174848|26165723|FG001|Overall Study|Withdrawal by Subject|3|||
13184722|NCT02174848|26165722|FG000|Overall Study|Lost to Follow-up|0|||
13184723|NCT02174848|26165723|FG001|Overall Study|Lost to Follow-up|1|||
13184724|NCT02174848|26165722|FG000|Overall Study|Worsening of disease|1|||
13184725|NCT02174848|26165723|FG001|Overall Study|Worsening of disease|1|||
13184726|NCT02174848|26165722|FG000|Overall Study|Unable to comply with study requirements|1|||
13184727|NCT02174848|26165723|FG001|Overall Study|Unable to comply with study requirements|0|||
13184728|NCT02174731|26165750|FG000|Overall Study|Participant decision|67|||
13184729|NCT02174731|26165751|FG001|Overall Study|Participant decision|64|||
13184730|NCT02174731|26165750|FG000|Overall Study|Incorrect enrolment before randomization|0|||
13184731|NCT02174731|26165751|FG001|Overall Study|Incorrect enrolment before randomization|1|||
13184732|NCT02174731|26165750|FG000|Overall Study|Missing|2|||
13184733|NCT02174731|26165751|FG001|Overall Study|Missing|0|||
13184734|NCT02174627|26165784|FG000|Overall Study|Missing|0|||
13184735|NCT02174627|26165785|FG001|Overall Study|Missing|1|||
13184736|NCT02174627|26165784|FG000|Overall Study|Incorrect enrolment before randomization|0|||
13110269|NCT03214367|25898953|FG003|Lead-in Period|Physician Decision|0|||
13110270|NCT03214367|25898954|FG004|Lead-in Period|Physician Decision|0|||
13110271|NCT03214367|25898955|FG005|Lead-in Period|Physician Decision|0|||
13110272|NCT03214367|25898956|FG006|Lead-in Period|Physician Decision|0|||
13110273|NCT03214367|25898957|FG007|Lead-in Period|Physician Decision|0|||
13110274|NCT03214367|25898950|FG000|Lead-in Period|Protocol Violation|5|||
13110275|NCT03214367|25898951|FG001|Lead-in Period|Protocol Violation|0|||
13110276|NCT03214367|25898952|FG002|Lead-in Period|Protocol Violation|0|||
13110277|NCT03214367|25898953|FG003|Lead-in Period|Protocol Violation|0|||
13184737|NCT02174627|26165785|FG001|Overall Study|Incorrect enrolment before randomization|1|||
13184738|NCT02174627|26165784|FG000|Overall Study|Participant decision|84|||
13184739|NCT02174627|26165785|FG001|Overall Study|Participant decision|128|||
13184740|NCT02174562|26165800|FG000|Overall Study|Withdrawal by Subject|7|||
13184741|NCT02174562|26165801|FG001|Overall Study|Withdrawal by Subject|2|||
13184742|NCT02174562|26165800|FG000|Overall Study|Death|2|||
13184743|NCT02174562|26165801|FG001|Overall Study|Death|0|||
13184744|NCT02174562|26165800|FG000|Overall Study|Lost to Follow-up|0|||
13184745|NCT02174562|26165801|FG001|Overall Study|Lost to Follow-up|3|||
13184746|NCT02174523|26165835|FG000|Overall Study|Withdrawal by Subject|1|||
13184747|NCT02174523|26165836|FG001|Overall Study|Withdrawal by Subject|0|||
13184748|NCT02174276|26165931|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1|||
13184749|NCT02174276|26165932|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
13184750|NCT02174276|26165933|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
13184751|NCT02174276|26165934|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
13184752|NCT02174276|26165931|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
13184753|NCT02174276|26165932|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
13184754|NCT02174276|26165933|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1|||
13184755|NCT02174276|26165934|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
13184756|NCT02174276|26165931|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
13184757|NCT02174276|26165932|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1|||
13184758|NCT02174276|26165933|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2|||
13110278|NCT03214367|25898954|FG004|Lead-in Period|Protocol Violation|0|||
13110279|NCT03214367|25898955|FG005|Lead-in Period|Protocol Violation|0|||
13110280|NCT03214367|25898956|FG006|Lead-in Period|Protocol Violation|0|||
13110281|NCT03214367|25898957|FG007|Lead-in Period|Protocol Violation|0|||
13110282|NCT03214367|25898950|FG000|Lead-in Period|Treatment Interruption|1|||
13184759|NCT02174276|26165934|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
13184760|NCT02174276|26165931|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
13184761|NCT02174276|26165932|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
13184762|NCT02174276|26165933|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1|||
13184763|NCT02174276|26165934|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
13184764|NCT02174276|26165931|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0|||
13184765|NCT02174276|26165932|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0|||
13184766|NCT02174276|26165933|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1|||
13184767|NCT02174276|26165934|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0|||
13184768|NCT02174276|26165931|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
13184769|NCT02174276|26165932|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0|||
13184770|NCT02174276|26165933|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
13184771|NCT02174276|26165934|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2|||
13184772|NCT02173769|26165947|FG000|Overall Study|Protocol Violation|4|||
13184773|NCT02173704|26165980|FG000|Overall Study|Adverse Event|1|||
13184774|NCT02173704|26165981|FG001|Overall Study|Adverse Event|0|||
13184775|NCT02173704|26165980|FG000|Overall Study|Lost to Follow-up|1|||
13184776|NCT02173704|26165981|FG001|Overall Study|Lost to Follow-up|0|||
13184777|NCT02173704|26165980|FG000|Overall Study|Other|1|||
13184778|NCT02173704|26165981|FG001|Overall Study|Other|0|||
13184779|NCT02173704|26165980|FG000|Overall Study|Protocol Violation|1|||
13184780|NCT02173704|26165981|FG001|Overall Study|Protocol Violation|0|||
13184781|NCT02173704|26165980|FG000|Overall Study|Withdrawal by Subject|9|||
13184782|NCT02173704|26165981|FG001|Overall Study|Withdrawal by Subject|4|||
13110283|NCT03214367|25898951|FG001|Lead-in Period|Treatment Interruption|0|||
13110284|NCT03214367|25898952|FG002|Lead-in Period|Treatment Interruption|0|||
13184783|NCT02173548|26166008|FG000|Overall Study|Lost to Follow-up|0|||
13184784|NCT02173548|26166009|FG001|Overall Study|Lost to Follow-up|2|||
13110285|NCT03214367|25898953|FG003|Lead-in Period|Treatment Interruption|0|||
13184785|NCT02173548|26166008|FG000|Overall Study|Withdrawal by Subject|1|||
13184786|NCT02173548|26166009|FG001|Overall Study|Withdrawal by Subject|0|||
13184787|NCT02173379|26166260|FG000|Overall Study|Lost to Follow-up|48|||
13184788|NCT02173379|26166261|FG001|Overall Study|Lost to Follow-up|34|||
13184789|NCT02173379|26166260|FG000|Overall Study|Withdrawal by Subject|14|||
13184790|NCT02173379|26166261|FG001|Overall Study|Withdrawal by Subject|17|||
13184791|NCT02173379|26166260|FG000|Overall Study|Physician Decision|7|||
13184792|NCT02173379|26166261|FG001|Overall Study|Physician Decision|4|||
13184793|NCT02173379|26166260|FG000|Overall Study|Death|22|||
13184794|NCT02173379|26166261|FG001|Overall Study|Death|22|||
13184795|NCT02173301|26166292|FG000|Overall Study|Adverse Event|7|||
13184796|NCT02173301|26166293|FG001|Overall Study|Adverse Event|8|||
13184797|NCT02173301|26166294|FG002|Overall Study|Adverse Event|13|||
13184798|NCT02173301|26166295|FG003|Overall Study|Adverse Event|5|||
13184799|NCT02173301|26166292|FG000|Overall Study|Withdrawal by Subject|8|||
13184800|NCT02173301|26166293|FG001|Overall Study|Withdrawal by Subject|10|||
13184801|NCT02173301|26166294|FG002|Overall Study|Withdrawal by Subject|4|||
13184802|NCT02173301|26166295|FG003|Overall Study|Withdrawal by Subject|8|||
13184803|NCT02173301|26166292|FG000|Overall Study|Lost to Follow-up|4|||
13184804|NCT02173301|26166293|FG001|Overall Study|Lost to Follow-up|4|||
13184805|NCT02173301|26166294|FG002|Overall Study|Lost to Follow-up|2|||
13184806|NCT02173301|26166295|FG003|Overall Study|Lost to Follow-up|2|||
13184807|NCT02173301|26166292|FG000|Overall Study|Protocol Violation|0|||
13184808|NCT02173301|26166293|FG001|Overall Study|Protocol Violation|1|||
13184809|NCT02173301|26166294|FG002|Overall Study|Protocol Violation|0|||
13184810|NCT02173301|26166295|FG003|Overall Study|Protocol Violation|0|||
13184811|NCT02173301|26166292|FG000|Overall Study|Physician Decision|0|||
13184812|NCT02173301|26166293|FG001|Overall Study|Physician Decision|0|||
13184813|NCT02173301|26166294|FG002|Overall Study|Physician Decision|1|||
13184814|NCT02173301|26166295|FG003|Overall Study|Physician Decision|0|||
13184815|NCT02173301|26166292|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1|||
13184816|NCT02173301|26166293|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
13184817|NCT02173301|26166294|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
13184818|NCT02173301|26166295|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
13184819|NCT02173158|26166311|FG000|Efficacy Phase|Adverse Event|1|||
13184820|NCT02173054|26166341|FG000|Overall Study|lack of compliance|1|||
13184821|NCT02173054|26166342|FG001|Overall Study|lack of compliance|0|||
13184822|NCT02173054|26166343|FG002|Overall Study|lack of compliance|0|||
13184823|NCT02173054|26166341|FG000|Overall Study|Withdrawal by Subject|0|||
13184824|NCT02173054|26166342|FG001|Overall Study|Withdrawal by Subject|0|||
13184825|NCT02173054|26166343|FG002|Overall Study|Withdrawal by Subject|1|||
13184826|NCT02172950|26166384|FG000|Overall Study|Physician Decision|3|||
13184827|NCT02172950|26166385|FG001|Overall Study|Physician Decision|3|||
13184828|NCT02172950|26166384|FG000|Overall Study|Lack of Efficacy|1|||
13184829|NCT02172950|26166385|FG001|Overall Study|Lack of Efficacy|0|||
13184830|NCT02172950|26166384|FG000|Overall Study|Adverse Event|4|||
13184831|NCT02172950|26166385|FG001|Overall Study|Adverse Event|1|||
13184832|NCT02172950|26166384|FG000|Overall Study|Withdrawal by Subject|10|||
13184833|NCT02172950|26166385|FG001|Overall Study|Withdrawal by Subject|0|||
13184834|NCT02172950|26166384|FG000|Overall Study|Protocol Violation|1|||
13184835|NCT02172950|26166385|FG001|Overall Study|Protocol Violation|0|||
13184836|NCT02172950|26166384|FG000|Overall Study|Lost to Follow-up|1|||
13184837|NCT02172950|26166385|FG001|Overall Study|Lost to Follow-up|0|||
13184838|NCT02172950|26166384|FG000|Overall Study|Death|1|||
13184839|NCT02172950|26166385|FG001|Overall Study|Death|0|||
13184840|NCT02172950|26166384|FG000|Overall Study|Patient traveling|1|||
13184841|NCT02172950|26166385|FG001|Overall Study|Patient traveling|0|||
13184842|NCT02172950|26166384|FG000|Overall Study|Patient went to other country|1|||
13184843|NCT02172950|26166385|FG001|Overall Study|Patient went to other country|0|||
13184844|NCT02172950|26166384|FG000|Overall Study|Patient relocated overseas|1|||
13184845|NCT02172950|26166385|FG001|Overall Study|Patient relocated overseas|1|||
13184846|NCT02172950|26166384|FG000|Overall Study|Patient moving|1|||
13184847|NCT02172950|26166385|FG001|Overall Study|Patient moving|0|||
13184848|NCT02172911|26166430|FG000|Overall Study|Serious Adverse Event|0|||
13184849|NCT02172911|26166431|FG001|Overall Study|Serious Adverse Event|1|||
13184850|NCT02172911|26166430|FG000|Overall Study|Progression of Disease|0|||
13184851|NCT02172911|26166431|FG001|Overall Study|Progression of Disease|1|||
13184852|NCT02172911|26166430|FG000|Overall Study|Loss of insurance coverage|1|||
13184853|NCT02172911|26166431|FG001|Overall Study|Loss of insurance coverage|0|||
13184854|NCT02172664|26166441|FG000|Overall Study|Lost to Follow-up|4|||
13184855|NCT02172664|26166442|FG001|Overall Study|Lost to Follow-up|4|||
13184856|NCT02172664|26166441|FG000|Overall Study|Death|1|||
13184857|NCT02172664|26166442|FG001|Overall Study|Death|1|||
13184858|NCT02172664|26166441|FG000|Overall Study|Moved out of area|1|||
13184859|NCT02172664|26166442|FG001|Overall Study|Moved out of area|1|||
13184860|NCT02172625|26166467|FG000|Overall Study|Adverse Event|0|||
13184861|NCT02172625|26166468|FG001|Overall Study|Adverse Event|1|||
13184862|NCT02172625|26166467|FG000|Overall Study|Pregnancy|0|||
13184863|NCT02172625|26166468|FG001|Overall Study|Pregnancy|1|||
13184864|NCT02172625|26166467|FG000|Overall Study|car accident|0|||
13184865|NCT02172625|26166468|FG001|Overall Study|car accident|1|||
13184866|NCT02172040|26166527|FG000|Overall Study|Adverse Event|0|||
13184867|NCT02172040|26166528|FG001|Overall Study|Adverse Event|2|||
13184868|NCT02172040|26166529|FG002|Overall Study|Adverse Event|0|||
13184869|NCT02172040|26166530|FG003|Overall Study|Adverse Event|0|||
13184870|NCT02172040|26166527|FG000|Overall Study|Protocol Violation|0|||
13184871|NCT02172040|26166528|FG001|Overall Study|Protocol Violation|1|||
13184872|NCT02172040|26166529|FG002|Overall Study|Protocol Violation|0|||
13184873|NCT02172040|26166530|FG003|Overall Study|Protocol Violation|0|||
13184874|NCT02172040|26166527|FG000|Overall Study|Withdrawal by Subject|0|||
13184875|NCT02172040|26166528|FG001|Overall Study|Withdrawal by Subject|0|||
13184876|NCT02172040|26166529|FG002|Overall Study|Withdrawal by Subject|1|||
13184877|NCT02172040|26166530|FG003|Overall Study|Withdrawal by Subject|0|||
13184878|NCT02172040|26166527|FG000|Overall Study|Not available for Day 13 & 14 visits|0|||
13184879|NCT02172040|26166528|FG001|Overall Study|Not available for Day 13 & 14 visits|0|||
13184880|NCT02172040|26166529|FG002|Overall Study|Not available for Day 13 & 14 visits|1|||
13184881|NCT02172040|26166530|FG003|Overall Study|Not available for Day 13 & 14 visits|0|||
13184882|NCT02172040|26166527|FG000|Overall Study|Family emergency abroad|0|||
13184883|NCT02172040|26166528|FG001|Overall Study|Family emergency abroad|0|||
13184884|NCT02172040|26166529|FG002|Overall Study|Family emergency abroad|0|||
13184885|NCT02172040|26166530|FG003|Overall Study|Family emergency abroad|1|||
13184886|NCT02171429|26166613|FG000|Overall Study|Other|0|||
13110286|NCT03214367|25898954|FG004|Lead-in Period|Treatment Interruption|0|||
13110287|NCT03214367|25898955|FG005|Lead-in Period|Treatment Interruption|0|||
13110288|NCT03214367|25898956|FG006|Lead-in Period|Treatment Interruption|0|||
13184887|NCT02171429|26166614|FG001|Overall Study|Other|1|||
13184888|NCT02171429|26166615|FG002|Overall Study|Other|1|||
13184889|NCT02171429|26166613|FG000|Overall Study|Non-Compliance|0|||
13184890|NCT02171429|26166614|FG001|Overall Study|Non-Compliance|0|||
13184891|NCT02171429|26166615|FG002|Overall Study|Non-Compliance|1|||
13184892|NCT02171429|26166613|FG000|Overall Study|Physician Decision|0|||
13184893|NCT02171429|26166614|FG001|Overall Study|Physician Decision|0|||
13184894|NCT02171429|26166615|FG002|Overall Study|Physician Decision|1|||
13184895|NCT02171429|26166613|FG000|Overall Study|Withdrawal by Subject|1|||
13184896|NCT02171429|26166614|FG001|Overall Study|Withdrawal by Subject|1|||
13184897|NCT02171429|26166615|FG002|Overall Study|Withdrawal by Subject|1|||
13184898|NCT02171429|26166613|FG000|Overall Study|Lost to Follow-up|0|||
13184899|NCT02171429|26166614|FG001|Overall Study|Lost to Follow-up|1|||
13184900|NCT02171429|26166615|FG002|Overall Study|Lost to Follow-up|0|||
13184901|NCT02171429|26166613|FG000|Overall Study|Death|0|||
13184902|NCT02171429|26166614|FG001|Overall Study|Death|0|||
13184903|NCT02171429|26166615|FG002|Overall Study|Death|1|||
13184904|NCT02171260|26166683|FG000|Overall Study|Death|0|||
13110289|NCT03214367|25898957|FG007|Lead-in Period|Treatment Interruption|0|||
13110290|NCT03214367|25898950|FG000|Treatment Period|Adverse Event|0|||
13110291|NCT03214367|25898951|FG001|Treatment Period|Adverse Event|1|||
13110292|NCT03214367|25898952|FG002|Treatment Period|Adverse Event|4|||
13110293|NCT03214367|25898953|FG003|Treatment Period|Adverse Event|2|||
13110294|NCT03214367|25898954|FG004|Treatment Period|Adverse Event|0|||
13110295|NCT03214367|25898955|FG005|Treatment Period|Adverse Event|0|||
13110296|NCT03214367|25898956|FG006|Treatment Period|Adverse Event|0|||
13110297|NCT03214367|25898957|FG007|Treatment Period|Adverse Event|0|||
13110298|NCT03214367|25898950|FG000|Treatment Period|Death|0|||
13110299|NCT03214367|25898951|FG001|Treatment Period|Death|1|||
13110300|NCT03214367|25898952|FG002|Treatment Period|Death|1|||
13110301|NCT03214367|25898953|FG003|Treatment Period|Death|1|||
13110302|NCT03214367|25898954|FG004|Treatment Period|Death|0|||
13110303|NCT03214367|25898955|FG005|Treatment Period|Death|0|||
13110304|NCT03214367|25898956|FG006|Treatment Period|Death|0|||
13110305|NCT03214367|25898957|FG007|Treatment Period|Death|0|||
13110306|NCT03214367|25898950|FG000|Treatment Period|Lost to Follow-up|0|||
13110307|NCT03214367|25898951|FG001|Treatment Period|Lost to Follow-up|5|||
13110308|NCT03214367|25898952|FG002|Treatment Period|Lost to Follow-up|3|||
13110309|NCT03214367|25898953|FG003|Treatment Period|Lost to Follow-up|2|||
13110310|NCT03214367|25898954|FG004|Treatment Period|Lost to Follow-up|0|||
13110311|NCT03214367|25898955|FG005|Treatment Period|Lost to Follow-up|2|||
13110312|NCT03214367|25898956|FG006|Treatment Period|Lost to Follow-up|1|||
13184905|NCT02171260|26166684|FG001|Overall Study|Death|0|||
13184906|NCT02171260|26166685|FG002|Overall Study|Death|0|||
13184907|NCT02171260|26166686|FG003|Overall Study|Death|1|||
13184908|NCT02171260|26166683|FG000|Overall Study|Physician Decision|1|||
13184909|NCT02171260|26166684|FG001|Overall Study|Physician Decision|0|||
13184910|NCT02171260|26166685|FG002|Overall Study|Physician Decision|1|||
13184911|NCT02171260|26166686|FG003|Overall Study|Physician Decision|0|||
13184912|NCT02171260|26166683|FG000|Overall Study|Withdrawal by Subject|1|||
13184913|NCT02171260|26166684|FG001|Overall Study|Withdrawal by Subject|0|||
13184914|NCT02171260|26166685|FG002|Overall Study|Withdrawal by Subject|0|||
13184915|NCT02171260|26166686|FG003|Overall Study|Withdrawal by Subject|0|||
13184916|NCT02171260|26166683|FG000|Overall Study|Evidence of progressive disease|4|||
13184917|NCT02171260|26166684|FG001|Overall Study|Evidence of progressive disease|6|||
13184918|NCT02171260|26166685|FG002|Overall Study|Evidence of progressive disease|4|||
13184919|NCT02171260|26166686|FG003|Overall Study|Evidence of progressive disease|4|||
13184920|NCT02171130|26166696|FG000|Overall Study|Death|1|||
13184921|NCT02171130|26166696|FG000|Overall Study|Discontinued; Clinical Material Issue|16|||
13184922|NCT02171130|26166696|FG000|Overall Study|Discontinued; Site Termination|5|||
13184923|NCT02171130|26166696|FG000|Overall Study|Withdrawal by Subject|3|||
13184924|NCT02171130|26166696|FG000|Overall Study|Physician Decision|1|||
13184925|NCT02171130|26166696|FG000|Overall Study|Lost to Follow-up|1|||
13184926|NCT02171130|26166696|FG000|Overall Study|Met Exclusion Criteria|1|||
13184927|NCT02171065|26166716|FG000|Overall Study|Withdrawal by Subject|1|||
13184928|NCT02171065|26166717|FG001|Overall Study|Withdrawal by Subject|0|||
13184929|NCT02171065|26166718|FG002|Overall Study|Withdrawal by Subject|0|||
13184930|NCT02171065|26166716|FG000|Overall Study|Lost to Follow-up|0|||
13184931|NCT02171065|26166717|FG001|Overall Study|Lost to Follow-up|0|||
13184932|NCT02171065|26166718|FG002|Overall Study|Lost to Follow-up|1|||
13184933|NCT02170779|26166747|FG000|Overall Study|Withdrawal by Subject|1|||
13184934|NCT02170779|26166748|FG001|Overall Study|Withdrawal by Subject|0|||
13184935|NCT02170779|26166747|FG000|Overall Study|Lost to Follow-up|0|||
13184936|NCT02170779|26166748|FG001|Overall Study|Lost to Follow-up|1|||
13184937|NCT02170727|26166781|FG000|Overall Study|Lost to Follow-up|1|||
13184938|NCT02170727|26166782|FG001|Overall Study|Lost to Follow-up|0|||
13184939|NCT02170727|26166781|FG000|Overall Study|Withdrawal by Subject|2|||
13184940|NCT02170727|26166782|FG001|Overall Study|Withdrawal by Subject|0|||
13184941|NCT02170688|26166815|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4|||
13184942|NCT02170688|26166816|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2|||
13184943|NCT02170688|26166817|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3|||
13184944|NCT02170688|26166818|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2|||
13184945|NCT02170688|26166819|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0|||
13184946|NCT02170688|26166815|FG000|Overall Study|Full dose not received|0|||
13184947|NCT02170688|26166816|FG001|Overall Study|Full dose not received|1|||
13184948|NCT02170688|26166817|FG002|Overall Study|Full dose not received|0|||
13184949|NCT02170688|26166818|FG003|Overall Study|Full dose not received|0|||
13184950|NCT02170688|26166819|FG004|Overall Study|Full dose not received|0|||
13184951|NCT02170688|26166815|FG000|Overall Study|Physician Decision|0|||
13184952|NCT02170688|26166816|FG001|Overall Study|Physician Decision|0|||
13184953|NCT02170688|26166817|FG002|Overall Study|Physician Decision|1|||
13184954|NCT02170688|26166818|FG003|Overall Study|Physician Decision|0|||
13184955|NCT02170688|26166819|FG004|Overall Study|Physician Decision|0|||
13184956|NCT02170389|26166826|FG000|Overall Study|Study terminated prior to start of treat|1|||
13184957|NCT02170298|26166841|FG000|Overall Study|Withdrawal by Subject|0|||
13184958|NCT02170298|26166842|FG001|Overall Study|Withdrawal by Subject|1|||
13184959|NCT02170298|26166841|FG000|Overall Study|unblinded, rerandomized to intervention|1|||
13184960|NCT02170298|26166842|FG001|Overall Study|unblinded, rerandomized to intervention|0|||
13184961|NCT02170207|26166852|FG000|Overall Study|Case report forms unavailable|5|||
13184962|NCT02170077|26166870|FG000|Overall Study|Withdrawal by Subject|3|||
13184963|NCT02170077|26166871|FG001|Overall Study|Withdrawal by Subject|4|||
13184964|NCT02170077|26166872|FG002|Overall Study|Withdrawal by Subject|2|||
13184965|NCT02170077|26166870|FG000|Overall Study|Adverse Event|4|||
13184966|NCT02170077|26166871|FG001|Overall Study|Adverse Event|4|||
13184967|NCT02170077|26166872|FG002|Overall Study|Adverse Event|4|||
13184968|NCT02170077|26166870|FG000|Overall Study|Lost to Follow-up|0|||
13184969|NCT02170077|26166871|FG001|Overall Study|Lost to Follow-up|1|||
13184970|NCT02170077|26166872|FG002|Overall Study|Lost to Follow-up|0|||
13184971|NCT02170077|26166870|FG000|Overall Study|Exclusion criteria|2|||
13184972|NCT02170077|26166871|FG001|Overall Study|Exclusion criteria|2|||
13184973|NCT02170077|26166872|FG002|Overall Study|Exclusion criteria|5|||
13184974|NCT02170077|26166870|FG000|Overall Study|Exacerbation of seizures|0|||
13184975|NCT02170077|26166871|FG001|Overall Study|Exacerbation of seizures|2|||
13184976|NCT02170077|26166872|FG002|Overall Study|Exacerbation of seizures|1|||
13184977|NCT02170064|26166896|FG000|Overall Study|Withdrawal by Subject|5|||
13184978|NCT02170064|26166897|FG001|Overall Study|Withdrawal by Subject|1|||
13184979|NCT02170064|26166898|FG002|Overall Study|Withdrawal by Subject|1|||
13184980|NCT02170064|26166896|FG000|Overall Study|Physician Decision|1|||
13184981|NCT02170064|26166897|FG001|Overall Study|Physician Decision|1|||
13184982|NCT02170064|26166898|FG002|Overall Study|Physician Decision|0|||
13184983|NCT02170051|26166925|FG000|Overall Study|Withdrawal by Subject|10|||
13184984|NCT02170051|26166926|FG001|Overall Study|Withdrawal by Subject|10|||
13184985|NCT02170051|26166925|FG000|Overall Study|Lost to Follow-up|1|||
13184986|NCT02170051|26166926|FG001|Overall Study|Lost to Follow-up|3|||
13184987|NCT02170025|26166941|FG000|Overall Study|Adverse Event|2|||
13184988|NCT02170025|26166942|FG001|Overall Study|Adverse Event|0|||
13184989|NCT02169830|26166960|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
13184990|NCT02169830|26166961|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
13184991|NCT02169830|26166962|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1|||
13184992|NCT02169830|26166960|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
13184993|NCT02169830|26166961|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
13184994|NCT02169830|26166962|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
13184995|NCT02169830|26166960|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
13184996|NCT02169830|26166961|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5|||
13184997|NCT02169830|26166962|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
13184998|NCT02169830|26166960|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
13184999|NCT02169830|26166961|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1|||
13185000|NCT02169830|26166962|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
13185001|NCT02169830|26166960|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
13185002|NCT02169830|26166961|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1|||
13185003|NCT02169830|26166962|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
13185004|NCT02169791|26166973|FG000|Overall Study|Death|6|||
13185005|NCT02169791|26166973|FG000|Overall Study|patient withdrew consent|1|||
13185006|NCT02169739|26166989|FG000|Overall Study|Lost to Follow-up|0|||
13185007|NCT02169739|26166990|FG001|Overall Study|Lost to Follow-up|4|||
13185008|NCT02169674|26167011|FG000|Overall Study|Withdrawal by Subject|2|||
13185009|NCT02169674|26167012|FG001|Overall Study|Withdrawal by Subject|1|||
13185010|NCT02169674|26167011|FG000|Overall Study|Seroprotected|30|||
13185011|NCT02169674|26167012|FG001|Overall Study|Seroprotected|76|||
13185012|NCT02169674|26167011|FG000|Overall Study|Lost to Follow-up|0|||
13185013|NCT02169674|26167012|FG001|Overall Study|Lost to Follow-up|1|||
13185014|NCT02169505|26167025|FG000|Overall Study|Withdrawal by Subject|1|||
13185015|NCT02169414|26167076|FG000|Overall Study|Withdrawal by Subject|1|||
13185016|NCT02169414|26167077|FG001|Overall Study|Withdrawal by Subject|0|||
13185017|NCT02169414|26167078|FG002|Overall Study|Withdrawal by Subject|0|||
13185018|NCT02169414|26167079|FG003|Overall Study|Withdrawal by Subject|0|||
13185019|NCT02169414|26167076|FG000|Overall Study|Adverse Event|0|||
13185020|NCT02169414|26167077|FG001|Overall Study|Adverse Event|1|||
13185021|NCT02169414|26167078|FG002|Overall Study|Adverse Event|0|||
13185022|NCT02169414|26167079|FG003|Overall Study|Adverse Event|0|||
13185023|NCT02169336|26167097|FG000|Overall Study|Lack of Efficacy|1|||
13185024|NCT02169336|26167098|FG001|Overall Study|Lack of Efficacy|1|||
13185025|NCT02169336|26167099|FG002|Overall Study|Lack of Efficacy|0|||
13185026|NCT02169336|26167097|FG000|Overall Study|Adverse Event|2|||
13185027|NCT02169336|26167098|FG001|Overall Study|Adverse Event|3|||
13185028|NCT02169336|26167099|FG002|Overall Study|Adverse Event|1|||
13185029|NCT02169336|26167097|FG000|Overall Study|Withdrawal by Subject|1|||
13185030|NCT02169336|26167098|FG001|Overall Study|Withdrawal by Subject|0|||
13185031|NCT02169336|26167099|FG002|Overall Study|Withdrawal by Subject|0|||
13185032|NCT02169336|26167097|FG000|Overall Study|Physician Decision|0|||
13185033|NCT02169336|26167098|FG001|Overall Study|Physician Decision|0|||
13185034|NCT02169336|26167099|FG002|Overall Study|Physician Decision|1|||
13185035|NCT02169336|26167097|FG000|Overall Study|Subject declined to continue dosing|0|||
13185036|NCT02169336|26167098|FG001|Overall Study|Subject declined to continue dosing|0|||
13185037|NCT02169336|26167099|FG002|Overall Study|Subject declined to continue dosing|1|||
13185038|NCT02169284|26167130|FG000|Overall Study|Physician Decision|0|||
13185039|NCT02169284|26167131|FG001|Overall Study|Physician Decision|1|||
13185040|NCT02169271|26167160|FG000|Overall Study|Protocol Violation|1|||
13185041|NCT02169271|26167161|FG001|Overall Study|Protocol Violation|2|||
13185042|NCT02169219|26167174|FG000|Overall Study|Lack of Efficacy|6|||
13185043|NCT02168946|26167217|FG000|Overall Study|Adverse Event|8|||
13185044|NCT02168946|26167218|FG001|Overall Study|Adverse Event|5|||
13185045|NCT02168946|26167217|FG000|Overall Study|Lost to Follow-up|3|||
13185046|NCT02168946|26167218|FG001|Overall Study|Lost to Follow-up|0|||
13185047|NCT02168946|26167217|FG000|Overall Study|Subject unable to come back for visits|1|||
13185048|NCT02168946|26167218|FG001|Overall Study|Subject unable to come back for visits|0|||
13185049|NCT02168842|26167281|FG000|Overall Study|Withdrawal by Subject|5|||
13185050|NCT02168842|26167282|FG001|Overall Study|Withdrawal by Subject|3|||
13185051|NCT02168842|26167281|FG000|Overall Study|Lost to Follow-up|0|||
13185052|NCT02168842|26167282|FG001|Overall Study|Lost to Follow-up|2|||
13185053|NCT02168842|26167281|FG000|Overall Study|Death|2|||
13185054|NCT02168842|26167282|FG001|Overall Study|Death|1|||
13185055|NCT02168842|26167281|FG000|Overall Study|Physician Decision|1|||
13185056|NCT02168842|26167282|FG001|Overall Study|Physician Decision|2|||
13185057|NCT02168816|26167297|FG000|Overall Study|Lost to Follow-up|2|||
13185058|NCT02168816|26167298|FG001|Overall Study|Lost to Follow-up|2|||
13185059|NCT02168803|26167335|FG000|Overall Study|Lost to Follow-up|1|||
13185060|NCT02168803|26167336|FG001|Overall Study|Lost to Follow-up|0|||
13185061|NCT02168803|26167337|FG002|Overall Study|Lost to Follow-up|1|||
13185062|NCT02168803|26167335|FG000|Overall Study|Withdrawal by Subject|1|||
13185063|NCT02168803|26167336|FG001|Overall Study|Withdrawal by Subject|1|||
13185064|NCT02168803|26167337|FG002|Overall Study|Withdrawal by Subject|2|||
13185065|NCT02168803|26167335|FG000|Overall Study|Physician Decision|0|||
13185066|NCT02168803|26167336|FG001|Overall Study|Physician Decision|1|||
13185067|NCT02168803|26167337|FG002|Overall Study|Physician Decision|0|||
13185068|NCT02168803|26167335|FG000|Overall Study|Adverse Event|0|||
13185069|NCT02168803|26167336|FG001|Overall Study|Adverse Event|1|||
13185070|NCT02168803|26167337|FG002|Overall Study|Adverse Event|1|||
13185071|NCT02168803|26167335|FG000|Overall Study|Death|0|||
13185072|NCT02168803|26167336|FG001|Overall Study|Death|0|||
13185073|NCT02168803|26167337|FG002|Overall Study|Death|1|||
13185074|NCT02168803|26167335|FG000|Overall Study|Sponsor Decision|0|||
13185075|NCT02168803|26167336|FG001|Overall Study|Sponsor Decision|0|||
13185076|NCT02168803|26167337|FG002|Overall Study|Sponsor Decision|1|||
13185077|NCT02168777|26167424|FG000|Overall Study|Withdrawal by Subject|1|||
13185078|NCT02168777|26167425|FG001|Overall Study|Withdrawal by Subject|0|||
13185079|NCT02168777|26167426|FG002|Overall Study|Withdrawal by Subject|2|||
13185080|NCT02168777|26167424|FG000|Overall Study|Adverse Event|1|||
13185081|NCT02168777|26167425|FG001|Overall Study|Adverse Event|0|||
13185082|NCT02168777|26167426|FG002|Overall Study|Adverse Event|1|||
13185083|NCT02168777|26167424|FG000|Overall Study|Disease recurrence|0|||
13185084|NCT02168777|26167425|FG001|Overall Study|Disease recurrence|0|||
13185085|NCT02168777|26167426|FG002|Overall Study|Disease recurrence|1|||
13185086|NCT02168777|26167424|FG000|Overall Study|Radiological disease progression|0|||
13185087|NCT02168777|26167425|FG001|Overall Study|Radiological disease progression|5|||
13185088|NCT02168777|26167426|FG002|Overall Study|Radiological disease progression|5|||
13185089|NCT02168777|26167424|FG000|Overall Study|Clinical disease progression|0|||
13185090|NCT02168777|26167425|FG001|Overall Study|Clinical disease progression|1|||
13185091|NCT02168777|26167426|FG002|Overall Study|Clinical disease progression|2|||
13185092|NCT02168777|26167424|FG000|Overall Study|Other reason|0|||
13185093|NCT02168777|26167425|FG001|Overall Study|Other reason|1|||
13185094|NCT02168777|26167426|FG002|Overall Study|Other reason|0|||
13185095|NCT02168491|26167434|FG000|Overall Study|Withdrawal by Subject|1|||
13185096|NCT02168478|26167440|FG000|Overall Study|Withdrawal by Subject|1|||
13185097|NCT02168478|26167440|FG000|Overall Study|Did Not Consent to Participation|2|||
13185098|NCT02168478|26167440|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1|||
13185099|NCT02168439|26167463|FG000|Overall Study|Protocol Violation|0|||
13185100|NCT02168439|26167464|FG001|Overall Study|Protocol Violation|2|||
13185101|NCT02168387|26167481|FG000|Overall Study|Planned exubation|6|||
13185102|NCT02168387|26167482|FG001|Overall Study|Planned exubation|3|||
13185103|NCT02168387|26167481|FG000|Overall Study|Death|1|||
13185104|NCT02168387|26167482|FG001|Overall Study|Death|0|||
13185105|NCT02168270|26167491|FG000|Overall Study|Lack of Efficacy|4|||
13185106|NCT02168101|26167520|FG000|Overall Study|Death|2|||
13185107|NCT02168101|26167521|FG001|Overall Study|Death|2|||
13185108|NCT02168101|26167522|FG002|Overall Study|Death|1|||
13185109|NCT02167893|26167533|FG000|Overall Study|Investigator transferred|85|||
13185110|NCT02167893|26167533|FG000|Overall Study|Investigator health reasons|10|||
13185111|NCT02167893|26167533|FG000|Overall Study|Case report forms not collected|68|||
13185112|NCT02167594|26167552|FG000|Overall Study|Withdrawal by Subject|2|||
13185113|NCT02167594|26167553|FG001|Overall Study|Withdrawal by Subject|0|||
13185114|NCT02167594|26167554|FG002|Overall Study|Withdrawal by Subject|0|||
13185115|NCT02167594|26167552|FG000|Overall Study|Death|0|||
13185116|NCT02167594|26167553|FG001|Overall Study|Death|1|||
13185117|NCT02167594|26167554|FG002|Overall Study|Death|0|||
13185118|NCT02167451|26167571|FG000|Overall Study|Withdrawal by Subject|1|||
13185119|NCT02167256|26167594|FG000|Overall Study|Adverse Event|13|||
13185120|NCT02167256|26167595|FG001|Overall Study|Adverse Event|6|||
13185121|NCT02167256|26167594|FG000|Overall Study|Withdrawal by Subject|4|||
13185122|NCT02167256|26167595|FG001|Overall Study|Withdrawal by Subject|4|||
13185123|NCT02167256|26167594|FG000|Overall Study|non-compliance|3|||
13185124|NCT02167256|26167595|FG001|Overall Study|non-compliance|0|||
13185125|NCT02167256|26167594|FG000|Overall Study|Study partner unable to participate|1|||
13185126|NCT02167256|26167595|FG001|Overall Study|Study partner unable to participate|0|||
13185127|NCT02167139|26167618|FG000|Randomised, Double-blind|Withdrawal by Subject|11|||
13185128|NCT02167139|26167619|FG001|Randomised, Double-blind|Withdrawal by Subject|8|||
13185129|NCT02167139|26167620|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
13185130|NCT02167139|26167621|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
13185131|NCT02167139|26167618|FG000|Randomised, Double-blind|Adverse Event|2|||
13185132|NCT02167139|26167619|FG001|Randomised, Double-blind|Adverse Event|9|||
13185133|NCT02167139|26167620|FG002|Randomised, Double-blind|Adverse Event|0|||
13185134|NCT02167139|26167621|FG003|Randomised, Double-blind|Adverse Event|0|||
13185135|NCT02167139|26167618|FG000|Randomised, Double-blind|Lack of Efficacy|1|||
13185136|NCT02167139|26167619|FG001|Randomised, Double-blind|Lack of Efficacy|2|||
13185137|NCT02167139|26167620|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
13185138|NCT02167139|26167621|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
13185139|NCT02167139|26167618|FG000|Randomised, Double-blind|Other|3|||
13185140|NCT02167139|26167619|FG001|Randomised, Double-blind|Other|0|||
13185141|NCT02167139|26167620|FG002|Randomised, Double-blind|Other|0|||
13185142|NCT02167139|26167621|FG003|Randomised, Double-blind|Other|0|||
13185143|NCT02167139|26167618|FG000|Transition-extension|Adverse Event|2|||
13185144|NCT02167139|26167619|FG001|Transition-extension|Adverse Event|0|||
13185145|NCT02167139|26167620|FG002|Transition-extension|Adverse Event|2|||
13185146|NCT02167139|26167621|FG003|Transition-extension|Adverse Event|3|||
13185147|NCT02167139|26167618|FG000|Transition-extension|Withdrawal by Subject|2|||
13185148|NCT02167139|26167619|FG001|Transition-extension|Withdrawal by Subject|0|||
13185149|NCT02167139|26167620|FG002|Transition-extension|Withdrawal by Subject|4|||
13185150|NCT02167139|26167621|FG003|Transition-extension|Withdrawal by Subject|1|||
13185151|NCT02167139|26167618|FG000|Transition-extension|Lack of Efficacy|0|||
13185152|NCT02167139|26167619|FG001|Transition-extension|Lack of Efficacy|0|||
13185153|NCT02167139|26167620|FG002|Transition-extension|Lack of Efficacy|1|||
13185154|NCT02167139|26167621|FG003|Transition-extension|Lack of Efficacy|1|||
13185155|NCT02167139|26167618|FG000|Transition-extension|Other|1|||
13185156|NCT02167139|26167619|FG001|Transition-extension|Other|0|||
13185157|NCT02167139|26167620|FG002|Transition-extension|Other|1|||
13185158|NCT02167139|26167621|FG003|Transition-extension|Other|0|||
13185159|NCT02167139|26167618|FG000|Transition-extension|Lost to Follow-up|1|||
13185160|NCT02167139|26167619|FG001|Transition-extension|Lost to Follow-up|0|||
13185161|NCT02167139|26167620|FG002|Transition-extension|Lost to Follow-up|0|||
13185162|NCT02167139|26167621|FG003|Transition-extension|Lost to Follow-up|0|||
13185163|NCT02167035|26167636|FG000|Overall Study|Adverse Event|2|||
13185164|NCT02167035|26167637|FG001|Overall Study|Adverse Event|2|||
13185165|NCT02167035|26167636|FG000|Overall Study|Lost to Follow-up|3|||
13185166|NCT02167035|26167637|FG001|Overall Study|Lost to Follow-up|3|||
13185167|NCT02167035|26167636|FG000|Overall Study|Randomized to incorrect Study Medication|0|||
13185168|NCT02167035|26167637|FG001|Overall Study|Randomized to incorrect Study Medication|1|||
13185169|NCT02166697|26167648|FG000|Overall Study|Protocol Violation|347|||
13185170|NCT02166606|26167655|FG000|Overall Study|Adverse Event|3|||
13185171|NCT02166606|26167655|FG000|Overall Study|Death|31|||
13185172|NCT02166606|26167655|FG000|Overall Study|Protocol Violation|7|||
13185173|NCT02166606|26167655|FG000|Overall Study|Lost to Follow-up|30|||
13185174|NCT02166606|26167655|FG000|Overall Study|Withdrawal by Subject|1|||
13185175|NCT02166606|26167655|FG000|Overall Study|Physician Decision|1|||
13185176|NCT02166606|26167655|FG000|Overall Study|Device upgrade|1|||
13185177|NCT02166606|26167655|FG000|Overall Study|Enrolled after End of Enrollment|4|||
13185178|NCT02166476|26167695|FG000|Overall Study|Withdrawal by Subject|5|||
13185179|NCT02166476|26167696|FG001|Overall Study|Withdrawal by Subject|7|||
13185180|NCT02166476|26167695|FG000|Overall Study|Adverse Event|3|||
13185181|NCT02166476|26167696|FG001|Overall Study|Adverse Event|3|||
13185182|NCT02166476|26167695|FG000|Overall Study|Lost to Follow-up|5|||
13185183|NCT02166476|26167696|FG001|Overall Study|Lost to Follow-up|10|||
13185184|NCT02166476|26167695|FG000|Overall Study|Physician Decision|1|||
13185185|NCT02166476|26167696|FG001|Overall Study|Physician Decision|0|||
13185186|NCT02166476|26167695|FG000|Overall Study|Unable to Come for Visit|0|||
13185187|NCT02166476|26167696|FG001|Overall Study|Unable to Come for Visit|3|||
13185188|NCT02166333|26167723|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4|||
13185189|NCT02166333|26167724|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
13185190|NCT02166333|26167725|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
13185191|NCT02166333|26167726|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
13185192|NCT02166333|26167727|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3|||
13185193|NCT02166333|26167728|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1|||
13185194|NCT02166333|26167723|FG000|Stage 1|Death|4|||
13185195|NCT02166333|26167724|FG001|Stage 1|Death|0|||
13185196|NCT02166333|26167725|FG002|Stage 1|Death|2|||
13185197|NCT02166333|26167726|FG003|Stage 1|Death|0|||
13185198|NCT02166333|26167727|FG004|Stage 1|Death|3|||
13185199|NCT02166333|26167728|FG005|Stage 1|Death|2|||
13185200|NCT02166333|26167723|FG000|Stage 1|Lost to Follow-up|12|||
13185201|NCT02166333|26167724|FG001|Stage 1|Lost to Follow-up|0|||
13185202|NCT02166333|26167725|FG002|Stage 1|Lost to Follow-up|6|||
13185203|NCT02166333|26167726|FG003|Stage 1|Lost to Follow-up|0|||
13185204|NCT02166333|26167727|FG004|Stage 1|Lost to Follow-up|3|||
13185205|NCT02166333|26167728|FG005|Stage 1|Lost to Follow-up|3|||
13185206|NCT02166333|26167723|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180|||
13185207|NCT02166333|26167724|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
13185208|NCT02166333|26167725|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63|||
13185209|NCT02166333|26167726|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
13185210|NCT02166333|26167727|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54|||
13185211|NCT02166333|26167728|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52|||
13185212|NCT02166333|26167723|FG000|Stage 2|Death|4|||
13185213|NCT02166333|26167724|FG001|Stage 2|Death|2|||
13185214|NCT02166333|26167725|FG002|Stage 2|Death|1|||
13185215|NCT02166333|26167726|FG003|Stage 2|Death|0|||
13185216|NCT02166333|26167727|FG004|Stage 2|Death|0|||
13185217|NCT02166333|26167728|FG005|Stage 2|Death|1|||
13185218|NCT02166333|26167723|FG000|Stage 2|Lost to Follow-up|23|||
13110313|NCT03214367|25898957|FG007|Treatment Period|Lost to Follow-up|0|||
13110314|NCT03214367|25898950|FG000|Treatment Period|Sponsor Decision|0|||
13110315|NCT03214367|25898951|FG001|Treatment Period|Sponsor Decision|3|||
13110316|NCT03214367|25898952|FG002|Treatment Period|Sponsor Decision|0|||
13110317|NCT03214367|25898953|FG003|Treatment Period|Sponsor Decision|0|||
13110318|NCT03214367|25898954|FG004|Treatment Period|Sponsor Decision|0|||
13185219|NCT02166333|26167724|FG001|Stage 2|Lost to Follow-up|4|||
13185220|NCT02166333|26167725|FG002|Stage 2|Lost to Follow-up|11|||
13185221|NCT02166333|26167726|FG003|Stage 2|Lost to Follow-up|9|||
13185222|NCT02166333|26167727|FG004|Stage 2|Lost to Follow-up|3|||
13185223|NCT02166333|26167728|FG005|Stage 2|Lost to Follow-up|6|||
13185224|NCT02166047|26167887|FG000|Overall Study|Withdrawal by Participant|0|||
13185225|NCT02166047|26167888|FG001|Overall Study|Withdrawal by Participant|1|||
13185226|NCT02166047|26167889|FG002|Overall Study|Withdrawal by Participant|2|||
13185227|NCT02166047|26167890|FG003|Overall Study|Withdrawal by Participant|0|||
13185228|NCT02166047|26167891|FG004|Overall Study|Withdrawal by Participant|0|||
13185229|NCT02166047|26167892|FG005|Overall Study|Withdrawal by Participant|0|||
13185230|NCT02166047|26167893|FG006|Overall Study|Withdrawal by Participant|1|||
13185231|NCT02166047|26167894|FG007|Overall Study|Withdrawal by Participant|0|||
13185232|NCT02166047|26167895|FG008|Overall Study|Withdrawal by Participant|0|||
13185233|NCT02166047|26167896|FG009|Overall Study|Withdrawal by Participant|0|||
13185234|NCT02166047|26167897|FG010|Overall Study|Withdrawal by Participant|0|||
13185235|NCT02166047|26167898|FG011|Overall Study|Withdrawal by Participant|0|||
13185236|NCT02166047|26167887|FG000|Overall Study|Adverse Event|0|||
13185237|NCT02166047|26167888|FG001|Overall Study|Adverse Event|0|||
13185238|NCT02166047|26167889|FG002|Overall Study|Adverse Event|0|||
13185239|NCT02166047|26167890|FG003|Overall Study|Adverse Event|0|||
13185240|NCT02166047|26167891|FG004|Overall Study|Adverse Event|1|||
13185241|NCT02166047|26167892|FG005|Overall Study|Adverse Event|0|||
13185242|NCT02166047|26167893|FG006|Overall Study|Adverse Event|1|||
13223028|NCT01800916|26287701|FG003|Test Period 1 (1 Week)|Adverse Event|0|||
13223029|NCT01800916|26287702|FG004|Test Period 1 (1 Week)|Adverse Event|1|||
13110319|NCT03214367|25898955|FG005|Treatment Period|Sponsor Decision|0|||
13110320|NCT03214367|25898956|FG006|Treatment Period|Sponsor Decision|0|||
13110321|NCT03214367|25898957|FG007|Treatment Period|Sponsor Decision|0|||
13110322|NCT03214367|25898950|FG000|Treatment Period|Physician Decision|0|||
13110323|NCT03214367|25898951|FG001|Treatment Period|Physician Decision|1|||
13110324|NCT03214367|25898952|FG002|Treatment Period|Physician Decision|2|||
13110325|NCT03214367|25898953|FG003|Treatment Period|Physician Decision|0|||
13110326|NCT03214367|25898954|FG004|Treatment Period|Physician Decision|0|||
13110327|NCT03214367|25898955|FG005|Treatment Period|Physician Decision|0|||
13110328|NCT03214367|25898956|FG006|Treatment Period|Physician Decision|0|||
13110329|NCT03214367|25898957|FG007|Treatment Period|Physician Decision|0|||
13110330|NCT03214367|25898950|FG000|Treatment Period|Protocol Violation|0|||
13110331|NCT03214367|25898951|FG001|Treatment Period|Protocol Violation|3|||
13110332|NCT03214367|25898952|FG002|Treatment Period|Protocol Violation|0|||
13110333|NCT03214367|25898953|FG003|Treatment Period|Protocol Violation|0|||
13110334|NCT03214367|25898954|FG004|Treatment Period|Protocol Violation|0|||
13110335|NCT03214367|25898955|FG005|Treatment Period|Protocol Violation|0|||
13110336|NCT03214367|25898956|FG006|Treatment Period|Protocol Violation|0|||
13110337|NCT03214367|25898957|FG007|Treatment Period|Protocol Violation|0|||
13110338|NCT03214367|25898950|FG000|Treatment Period|Withdrawal by Subject|0|||
13110339|NCT03214367|25898951|FG001|Treatment Period|Withdrawal by Subject|20|||
13110340|NCT03214367|25898952|FG002|Treatment Period|Withdrawal by Subject|23|||
13110341|NCT03214367|25898953|FG003|Treatment Period|Withdrawal by Subject|14|||
13110342|NCT03214367|25898954|FG004|Treatment Period|Withdrawal by Subject|0|||
13110343|NCT03214367|25898955|FG005|Treatment Period|Withdrawal by Subject|1|||
13110344|NCT03214367|25898956|FG006|Treatment Period|Withdrawal by Subject|1|||
13110345|NCT03214367|25898957|FG007|Treatment Period|Withdrawal by Subject|1|||
13110346|NCT03214224|25898968|FG000|Overall Study|Protocol Violation|1|||
13110347|NCT03214224|25898968|FG000|Overall Study|Withdrawal by Subject|2|||
13110348|NCT03214224|25898968|FG000|Overall Study|Practice controls or therapists|6|||
13110349|NCT03214198|25898978|FG000|Overall Study|Case Report Forms Uncollected|18|||
13110350|NCT03214198|25898978|FG000|Overall Study|Protocol Deviation|18|||
13110351|NCT03214094|25898988|FG000|Overall Study|Case Report Forms Uncollected|14|||
13110352|NCT03214094|25898988|FG000|Overall Study|Protocol Deviation|46|||
13110353|NCT03214081|25899005|FG000|Overall Study|Case Report Forms Uncollected|9|||
13110354|NCT03214081|25899005|FG000|Overall Study|Protocol Deviation|54|||
13110355|NCT03213938|25899040|FG000|Overall Study|Lost to Follow-up|4|||
13110356|NCT03213938|25899041|FG001|Overall Study|Lost to Follow-up|3|||
13110357|NCT03213938|25899040|FG000|Overall Study|Lack of Efficacy|1|||
13110358|NCT03213938|25899041|FG001|Overall Study|Lack of Efficacy|0|||
13110359|NCT03213938|25899040|FG000|Overall Study|Decline to participate|5|||
13110360|NCT03213938|25899041|FG001|Overall Study|Decline to participate|4|||
13110361|NCT03213938|25899040|FG000|Overall Study|Without reason|4|||
13185243|NCT02166047|26167894|FG007|Overall Study|Adverse Event|0|||
13185244|NCT02166047|26167895|FG008|Overall Study|Adverse Event|0|||
13185245|NCT02166047|26167896|FG009|Overall Study|Adverse Event|0|||
13185246|NCT02166047|26167897|FG010|Overall Study|Adverse Event|2|||
13185247|NCT02166047|26167898|FG011|Overall Study|Adverse Event|0|||
13185248|NCT02165826|26167965|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44|||
13185249|NCT02165826|26167966|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57|||
13185250|NCT02165826|26167967|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68|||
13185251|NCT02165826|26167965|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0|||
13185252|NCT02165826|26167966|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1|||
13185253|NCT02165826|26167967|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3|||
13185254|NCT02165826|26167965|FG000|Main Treatment Period|Lost to Follow-up|4|||
13185255|NCT02165826|26167966|FG001|Main Treatment Period|Lost to Follow-up|2|||
13185256|NCT02165826|26167967|FG002|Main Treatment Period|Lost to Follow-up|1|||
13185257|NCT02165826|26167965|FG000|Main Treatment Period|Voluntary Withdrawal|23|||
13185258|NCT02165826|26167966|FG001|Main Treatment Period|Voluntary Withdrawal|23|||
13185259|NCT02165826|26167967|FG002|Main Treatment Period|Voluntary Withdrawal|21|||
13185260|NCT02165826|26167965|FG000|Main Treatment Period|Lack of Efficacy|2|||
13185261|NCT02165826|26167966|FG001|Main Treatment Period|Lack of Efficacy|0|||
13185262|NCT02165826|26167967|FG002|Main Treatment Period|Lack of Efficacy|0|||
13185263|NCT02165826|26167965|FG000|Main Treatment Period|Reason Not Specified|8|||
13185264|NCT02165826|26167966|FG001|Main Treatment Period|Reason Not Specified|5|||
13185265|NCT02165826|26167967|FG002|Main Treatment Period|Reason Not Specified|16|||
13185266|NCT02165826|26167965|FG000|Main Treatment Period|Did Not Receive Study Drug|0|||
13185267|NCT02165826|26167966|FG001|Main Treatment Period|Did Not Receive Study Drug|2|||
13185268|NCT02165826|26167967|FG002|Main Treatment Period|Did Not Receive Study Drug|0|||
13185269|NCT02165826|26167965|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4|||
13185270|NCT02165826|26167966|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10|||
13185271|NCT02165826|26167967|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3|||
13185272|NCT02165826|26167965|FG000|Down-Titration Period|Voluntary Withdrawal|2|||
13185273|NCT02165826|26167966|FG001|Down-Titration Period|Voluntary Withdrawal|1|||
13185274|NCT02165826|26167967|FG002|Down-Titration Period|Voluntary Withdrawal|2|||
13185275|NCT02165826|26167965|FG000|Down-Titration Period|Reason Not Specified|1|||
13185276|NCT02165826|26167966|FG001|Down-Titration Period|Reason Not Specified|0|||
13185277|NCT02165826|26167967|FG002|Down-Titration Period|Reason Not Specified|2|||
13185278|NCT02165735|26168000|FG000|Overall Study|Lost to Follow-up|12|||
13185279|NCT02165735|26168001|FG001|Overall Study|Lost to Follow-up|10|||
13185280|NCT02165735|26168000|FG000|Overall Study|Withdrawal by Subject|3|||
13185281|NCT02165735|26168001|FG001|Overall Study|Withdrawal by Subject|0|||
13185282|NCT02165735|26168000|FG000|Overall Study|Participant indicated lack of time|1|||
13185283|NCT02165735|26168001|FG001|Overall Study|Participant indicated lack of time|3|||
13185284|NCT02165735|26168000|FG000|Overall Study|Protocol Violation|0|||
13185285|NCT02165735|26168001|FG001|Overall Study|Protocol Violation|1|||
13185286|NCT02165397|26168034|FG000|Overall Study|Death|7|||
13185287|NCT02165397|26168035|FG001|Overall Study|Death|10|||
13185288|NCT02165397|26168036|FG002|Overall Study|Death|8|||
13185289|NCT02165397|26168034|FG000|Overall Study|Lost to Follow-up|1|||
13185290|NCT02165397|26168035|FG001|Overall Study|Lost to Follow-up|3|||
13185291|NCT02165397|26168036|FG002|Overall Study|Lost to Follow-up|0|||
13185292|NCT02165397|26168034|FG000|Overall Study|Withdrawal by Subject|6|||
13185293|NCT02165397|26168035|FG001|Overall Study|Withdrawal by Subject|6|||
13185294|NCT02165397|26168036|FG002|Overall Study|Withdrawal by Subject|1|||
13185295|NCT02165397|26168034|FG000|Overall Study|Other, Not Specified|0|||
13185296|NCT02165397|26168035|FG001|Overall Study|Other, Not Specified|0|||
13185297|NCT02165397|26168036|FG002|Overall Study|Other, Not Specified|1|||
13185298|NCT02165202|26168049|FG000|Oral Phase|Refused further participation|5|||
13185299|NCT02165202|26168050|FG001|Oral Phase|Refused further participation|1|||
13185300|NCT02165202|26168049|FG000|Oral Phase|Study product Related Toxicity|1|||
13185301|NCT02165202|26168050|FG001|Oral Phase|Study product Related Toxicity|0|||
13185302|NCT02165202|26168049|FG000|Oral Phase|Unable to contact Participant|1|||
13185303|NCT02165202|26168050|FG001|Oral Phase|Unable to contact Participant|1|||
13185304|NCT02165202|26168049|FG000|Oral Phase|Clinical reasons|1|||
13185305|NCT02165202|26168050|FG001|Oral Phase|Clinical reasons|0|||
13185306|NCT02165202|26168049|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1|||
13185307|NCT02165202|26168050|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0|||
13185308|NCT02165202|26168049|FG000|Oral Phase|CMC advised termination|1|||
13185309|NCT02165202|26168050|FG001|Oral Phase|CMC advised termination|0|||
13185310|NCT02165202|26168049|FG000|Oral Phase|Relocated, no follow-up planned|1|||
13185311|NCT02165202|26168050|FG001|Oral Phase|Relocated, no follow-up planned|0|||
13185312|NCT02165202|26168049|FG000|Oral Phase|Abnormal EKG|0|||
13185313|NCT02165202|26168050|FG001|Oral Phase|Abnormal EKG|1|||
13185314|NCT02165202|26168049|FG000|Injection Phase|Abnormal Lab Value|5|||
13185315|NCT02165202|26168050|FG001|Injection Phase|Abnormal Lab Value|1|||
13185316|NCT02165202|26168049|FG000|Injection Phase|Reactive HIV or HIV Suspected|0|||
13185317|NCT02165202|26168050|FG001|Injection Phase|Reactive HIV or HIV Suspected|2|||
13206106|NCT01959841|26233584|FG001|Overall Study|Lack of Efficacy|0|||
13185318|NCT02165202|26168049|FG000|Injection Phase|Unable to attend within Visit Window|1|||
13185319|NCT02165202|26168050|FG001|Injection Phase|Unable to attend within Visit Window|0|||
13185320|NCT02165202|26168049|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0|||
13185321|NCT02165202|26168050|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1|||
13185322|NCT02165202|26168049|FG000|Injection Phase|End of Study|2|||
13185323|NCT02165202|26168050|FG001|Injection Phase|End of Study|1|||
13185324|NCT02165202|26168049|FG000|Injection Phase|Study Product related Toxicity|1|||
13185325|NCT02165202|26168050|FG001|Injection Phase|Study Product related Toxicity|0|||
13185326|NCT02165202|26168049|FG000|Injection Phase|No longer interested|0|||
13185327|NCT02165202|26168050|FG001|Injection Phase|No longer interested|1|||
13185328|NCT02165202|26168049|FG000|Injection Phase|Participant unwilling to comply|1|||
13185329|NCT02165202|26168050|FG001|Injection Phase|Participant unwilling to comply|0|||
13185330|NCT02164981|26168129|FG000|Started|Withdrawal by Subject|2|||
13185331|NCT02164981|26168130|FG001|Started|Withdrawal by Subject|1|||
13185332|NCT02164981|26168131|FG002|Started|Withdrawal by Subject|0|||
13185333|NCT02164981|26168129|FG000|Started|Protocol Violation|2|||
13185334|NCT02164981|26168130|FG001|Started|Protocol Violation|0|||
13185335|NCT02164981|26168131|FG002|Started|Protocol Violation|0|||
13185336|NCT02164981|26168129|FG000|Started|Adverse Event|1|||
13185337|NCT02164981|26168130|FG001|Started|Adverse Event|2|||
13185338|NCT02164981|26168131|FG002|Started|Adverse Event|0|||
13185339|NCT02164981|26168129|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
13185340|NCT02164981|26168130|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2|||
13185341|NCT02164981|26168131|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
13185342|NCT02164981|26168129|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2|||
13185343|NCT02164981|26168130|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1|||
13185344|NCT02164981|26168131|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0|||
13185345|NCT02164981|26168129|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
13185346|NCT02164981|26168130|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1|||
13185347|NCT02164981|26168131|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
13206107|NCT01959841|26233585|FG002|Overall Study|Lack of Efficacy|0|||
13206108|NCT01959841|26233583|FG000|Overall Study|Lost to Follow-up|1|||
13206109|NCT01959841|26233584|FG001|Overall Study|Lost to Follow-up|1|||
13206110|NCT01959841|26233585|FG002|Overall Study|Lost to Follow-up|0|||
13206111|NCT01959841|26233583|FG000|Overall Study|Physician Decision|0|||
13206112|NCT01959841|26233584|FG001|Overall Study|Physician Decision|2|||
13206113|NCT01959841|26233585|FG002|Overall Study|Physician Decision|3|||
13206114|NCT01959841|26233583|FG000|Overall Study|Protocol Violation|16|||
13206115|NCT01959841|26233584|FG001|Overall Study|Protocol Violation|23|||
13206116|NCT01959841|26233585|FG002|Overall Study|Protocol Violation|16|||
13206117|NCT01959841|26233583|FG000|Overall Study|Withdrawal by Subject|7|||
13206118|NCT01959841|26233584|FG001|Overall Study|Withdrawal by Subject|7|||
13206119|NCT01959841|26233585|FG002|Overall Study|Withdrawal by Subject|5|||
13206120|NCT01959841|26233583|FG000|Overall Study|Clinical laboratory value|2|||
13206121|NCT01959841|26233584|FG001|Overall Study|Clinical laboratory value|6|||
13206122|NCT01959841|26233585|FG002|Overall Study|Clinical laboratory value|6|||
13206123|NCT01959841|26233583|FG000|Overall Study|Platelet count below on day1 or 4|11|||
13206124|NCT01959841|26233584|FG001|Overall Study|Platelet count below on day1 or 4|15|||
13206125|NCT01959841|26233585|FG002|Overall Study|Platelet count below on day1 or 4|11|||
13206126|NCT01959698|26233638|FG000|Overall Study|Adverse Event|0|||
13206127|NCT01959698|26233639|FG001|Overall Study|Adverse Event|0|||
13206128|NCT01959698|26233640|FG002|Overall Study|Adverse Event|0|||
13206129|NCT01959698|26233641|FG003|Overall Study|Adverse Event|0|||
13206130|NCT01959698|26233642|FG004|Overall Study|Adverse Event|0|||
13206131|NCT01959698|26233643|FG005|Overall Study|Adverse Event|0|||
13206132|NCT01959698|26233644|FG006|Overall Study|Adverse Event|1|||
13206133|NCT01959698|26233638|FG000|Overall Study|Physician Decision|1|||
13206134|NCT01959698|26233639|FG001|Overall Study|Physician Decision|0|||
13206135|NCT01959698|26233640|FG002|Overall Study|Physician Decision|1|||
13206136|NCT01959698|26233641|FG003|Overall Study|Physician Decision|2|||
13206137|NCT01959698|26233642|FG004|Overall Study|Physician Decision|0|||
13206138|NCT01959698|26233643|FG005|Overall Study|Physician Decision|3|||
13206139|NCT01959698|26233644|FG006|Overall Study|Physician Decision|3|||
13206140|NCT01959672|26233655|FG000|Overall Study|Death|1|||
13206141|NCT01959607|26233677|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
13206142|NCT01959607|26233678|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
13206143|NCT01959607|26233679|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
13206144|NCT01959607|26233680|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
13206145|NCT01959581|26233686|FG000|Overall Study|Lost to Follow-up|5|||
13206146|NCT01959529|26233705|FG000|Overall Study|Adverse event (not hypoglycaemia)|0|||
13206147|NCT01959529|26233706|FG001|Overall Study|Adverse event (not hypoglycaemia)|1|||
13206148|NCT01959529|26233705|FG000|Overall Study|Lost to Follow-up|4|||
13206149|NCT01959529|26233706|FG001|Overall Study|Lost to Follow-up|1|||
13206150|NCT01959529|26233705|FG000|Overall Study|Other|70|||
13206151|NCT01959529|26233706|FG001|Overall Study|Other|68|||
13206152|NCT01959529|26233705|FG000|Overall Study|Hypoglycaemia|1|||
13206153|NCT01959529|26233706|FG001|Overall Study|Hypoglycaemia|1|||
13185348|NCT02164929|26168186|FG000|Overall Study|Converted to open procedure|1|||
13185349|NCT02164929|26168187|FG001|Overall Study|Converted to open procedure|0|||
13185350|NCT02164929|26168188|FG002|Overall Study|Converted to open procedure|0|||
13185351|NCT02164929|26168189|FG003|Overall Study|Converted to open procedure|2|||
13185352|NCT02164929|26168186|FG000|Overall Study|Failed regional block|0|||
13185353|NCT02164929|26168187|FG001|Overall Study|Failed regional block|0|||
13185354|NCT02164929|26168188|FG002|Overall Study|Failed regional block|1|||
13185355|NCT02164929|26168189|FG003|Overall Study|Failed regional block|0|||
13185356|NCT02164916|26168213|FG000|Overall Study|Adverse Event|3|||
13185357|NCT02164916|26168214|FG001|Overall Study|Adverse Event|8|||
13185358|NCT02164916|26168213|FG000|Overall Study|Death|1|||
13185359|NCT02164916|26168214|FG001|Overall Study|Death|1|||
13185360|NCT02164916|26168213|FG000|Overall Study|Refusal unrelated to adverse event|3|||
13185361|NCT02164916|26168214|FG001|Overall Study|Refusal unrelated to adverse event|7|||
13185362|NCT02164916|26168213|FG000|Overall Study|Progression|37|||
13185363|NCT02164916|26168214|FG001|Overall Study|Progression|26|||
13185364|NCT02164916|26168213|FG000|Overall Study|Not protocol specified|5|||
13185365|NCT02164916|26168214|FG001|Overall Study|Not protocol specified|1|||
13185366|NCT02164916|26168213|FG000|Overall Study|Reason under review|1|||
13185367|NCT02164916|26168214|FG001|Overall Study|Reason under review|6|||
13185368|NCT02164916|26168213|FG000|Overall Study|Not eligible|2|||
13185369|NCT02164916|26168214|FG001|Overall Study|Not eligible|5|||
13185370|NCT02164864|26168283|FG000|Overall Study|Trial disease worsening|7|||
13185371|NCT02164864|26168284|FG001|Overall Study|Trial disease worsening|5|||
13185372|NCT02164864|26168285|FG002|Overall Study|Trial disease worsening|1|||
13185373|NCT02164864|26168283|FG000|Overall Study|Other pre-existing disease worsening|6|||
13185374|NCT02164864|26168284|FG001|Overall Study|Other pre-existing disease worsening|4|||
13185375|NCT02164864|26168285|FG002|Overall Study|Other pre-existing disease worsening|9|||
13185376|NCT02164864|26168283|FG000|Overall Study|Other Adverse Event (AE)|52|||
13185377|NCT02164864|26168284|FG001|Overall Study|Other Adverse Event (AE)|32|||
13185378|NCT02164864|26168285|FG002|Overall Study|Other Adverse Event (AE)|49|||
13185379|NCT02164864|26168283|FG000|Overall Study|Protocol Violation|2|||
13185380|NCT02164864|26168284|FG001|Overall Study|Protocol Violation|4|||
13185381|NCT02164864|26168285|FG002|Overall Study|Protocol Violation|1|||
13185382|NCT02164864|26168283|FG000|Overall Study|Lost to Follow-up|4|||
13185383|NCT02164864|26168284|FG001|Overall Study|Lost to Follow-up|3|||
13185384|NCT02164864|26168285|FG002|Overall Study|Lost to Follow-up|2|||
13185385|NCT02164864|26168283|FG000|Overall Study|Consent withdrawn, not due to AE|21|||
13185386|NCT02164864|26168284|FG001|Overall Study|Consent withdrawn, not due to AE|8|||
13185387|NCT02164864|26168285|FG002|Overall Study|Consent withdrawn, not due to AE|56|||
13185388|NCT02164864|26168283|FG000|Overall Study|Other than stated|3|||
13185389|NCT02164864|26168284|FG001|Overall Study|Other than stated|4|||
13185390|NCT02164864|26168285|FG002|Overall Study|Other than stated|14|||
13185391|NCT02164539|26168350|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
13185392|NCT02164539|26168351|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
13185393|NCT02164539|26168352|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
13185394|NCT02164539|26168353|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
13185395|NCT02164539|26168354|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3|||
13185396|NCT02164539|26168355|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
13185397|NCT02164539|26168356|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
13185398|NCT02164539|26168350|FG000|Treatment Phase B (1 Week)|Adverse Event|0|||
13185399|NCT02164539|26168351|FG001|Treatment Phase B (1 Week)|Adverse Event|0|||
13185400|NCT02164539|26168352|FG002|Treatment Phase B (1 Week)|Adverse Event|0|||
13185401|NCT02164539|26168353|FG003|Treatment Phase B (1 Week)|Adverse Event|0|||
13185402|NCT02164539|26168354|FG004|Treatment Phase B (1 Week)|Adverse Event|2|||
13185403|NCT02164539|26168355|FG005|Treatment Phase B (1 Week)|Adverse Event|0|||
13185404|NCT02164539|26168356|FG006|Treatment Phase B (1 Week)|Adverse Event|0|||
13185405|NCT02164539|26168350|FG000|Treatment Phase B (1 Week)|Physician Decision|0|||
13185406|NCT02164539|26168351|FG001|Treatment Phase B (1 Week)|Physician Decision|0|||
13185407|NCT02164539|26168352|FG002|Treatment Phase B (1 Week)|Physician Decision|0|||
13185408|NCT02164539|26168353|FG003|Treatment Phase B (1 Week)|Physician Decision|0|||
13185409|NCT02164539|26168354|FG004|Treatment Phase B (1 Week)|Physician Decision|1|||
13185410|NCT02164539|26168355|FG005|Treatment Phase B (1 Week)|Physician Decision|0|||
13185411|NCT02164539|26168356|FG006|Treatment Phase B (1 Week)|Physician Decision|1|||
13185412|NCT02164539|26168350|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1|||
13185413|NCT02164539|26168351|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
13185414|NCT02164539|26168352|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
13185415|NCT02164539|26168353|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
13185416|NCT02164539|26168354|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
13185417|NCT02164539|26168355|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
13185418|NCT02164539|26168356|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
13185419|NCT02164539|26168350|FG000|Treatment Phase C (1 Week)|Adverse Event|0|||
13185420|NCT02164539|26168351|FG001|Treatment Phase C (1 Week)|Adverse Event|0|||
13185421|NCT02164539|26168352|FG002|Treatment Phase C (1 Week)|Adverse Event|0|||
13185422|NCT02164539|26168353|FG003|Treatment Phase C (1 Week)|Adverse Event|0|||
13185423|NCT02164539|26168354|FG004|Treatment Phase C (1 Week)|Adverse Event|0|||
13185424|NCT02164539|26168355|FG005|Treatment Phase C (1 Week)|Adverse Event|0|||
13185425|NCT02164539|26168356|FG006|Treatment Phase C (1 Week)|Adverse Event|1|||
13185426|NCT02164539|26168350|FG000|Treatment Phase C (1 Week)|Physician Decision|0|||
13185427|NCT02164539|26168351|FG001|Treatment Phase C (1 Week)|Physician Decision|0|||
13185428|NCT02164539|26168352|FG002|Treatment Phase C (1 Week)|Physician Decision|0|||
13185429|NCT02164539|26168353|FG003|Treatment Phase C (1 Week)|Physician Decision|0|||
13185430|NCT02164539|26168354|FG004|Treatment Phase C (1 Week)|Physician Decision|0|||
13185431|NCT02164539|26168355|FG005|Treatment Phase C (1 Week)|Physician Decision|0|||
13185432|NCT02164539|26168356|FG006|Treatment Phase C (1 Week)|Physician Decision|1|||
13185433|NCT02164513|26168388|FG000|Overall Study|Adverse Event|162|||
13185434|NCT02164513|26168389|FG001|Overall Study|Adverse Event|180|||
13185435|NCT02164513|26168390|FG002|Overall Study|Adverse Event|111|||
13185436|NCT02164513|26168388|FG000|Overall Study|Other: Study Closed or terminated|5|||
13185437|NCT02164513|26168389|FG001|Overall Study|Other: Study Closed or terminated|2|||
13185438|NCT02164513|26168390|FG002|Overall Study|Other: Study Closed or terminated|4|||
13185439|NCT02164513|26168388|FG000|Overall Study|Lost to Follow-up|30|||
13185440|NCT02164513|26168389|FG001|Overall Study|Lost to Follow-up|36|||
13185441|NCT02164513|26168390|FG002|Overall Study|Lost to Follow-up|22|||
13185442|NCT02164513|26168388|FG000|Overall Study|Physician Decision|47|||
13185443|NCT02164513|26168389|FG001|Overall Study|Physician Decision|57|||
13185444|NCT02164513|26168390|FG002|Overall Study|Physician Decision|28|||
13185445|NCT02164513|26168388|FG000|Overall Study|Withdrawal by Subject|192|||
13185446|NCT02164513|26168389|FG001|Overall Study|Withdrawal by Subject|261|||
13185447|NCT02164513|26168390|FG002|Overall Study|Withdrawal by Subject|130|||
13110362|NCT03213938|25899041|FG001|Overall Study|Without reason|5|||
13110363|NCT03213626|25899051|FG000|Overall Study|Adverse Event|1|||
13110364|NCT03213626|25899051|FG000|Overall Study|Progressive Disease|6|||
13110365|NCT03213509|25899069|FG000|Overall Study|Did not consent for verbal autopsy|4|||
13110366|NCT03213509|25899070|FG001|Overall Study|Did not consent for verbal autopsy|5|||
13110367|NCT03213457|25899117|FG000|Overall Study|Not Treated|1|||
13110368|NCT03213457|25899118|FG001|Overall Study|Not Treated|1|||
13110369|NCT03213457|25899119|FG002|Overall Study|Not Treated|0|||
13110370|NCT03213457|25899117|FG000|Overall Study|Adverse Event|16|||
13110371|NCT03213457|25899118|FG001|Overall Study|Adverse Event|9|||
13110372|NCT03213457|25899119|FG002|Overall Study|Adverse Event|41|||
13110373|NCT03213457|25899117|FG000|Overall Study|Non-Compliance With Study Drug|1|||
13110374|NCT03213457|25899118|FG001|Overall Study|Non-Compliance With Study Drug|2|||
13110375|NCT03213457|25899119|FG002|Overall Study|Non-Compliance With Study Drug|7|||
13185448|NCT02164513|26168388|FG000|Overall Study|Other: Reason not provided by site|1|||
13185449|NCT02164513|26168389|FG001|Overall Study|Other: Reason not provided by site|0|||
13185450|NCT02164513|26168390|FG002|Overall Study|Other: Reason not provided by site|0|||
13185451|NCT02164383|26168403|FG000|Overall Study|Lost to Follow-up|1|||
13185452|NCT02164383|26168404|FG001|Overall Study|Lost to Follow-up|0|||
13185453|NCT02164318|26168435|FG000|Overall Study|Withdrawal by Subject|0|||
13185454|NCT02164318|26168436|FG001|Overall Study|Withdrawal by Subject|1|||
13185455|NCT02164318|26168437|FG002|Overall Study|Withdrawal by Subject|0|||
13185456|NCT02164318|26168438|FG003|Overall Study|Withdrawal by Subject|1|||
13185457|NCT02163993|26168530|FG000|Treatment Period|Adverse Event|0|||
13185458|NCT02163993|26168531|FG001|Treatment Period|Adverse Event|1|||
13185459|NCT02163993|26168532|FG002|Treatment Period|Adverse Event|0|||
13185460|NCT02163993|26168533|FG003|Treatment Period|Adverse Event|0|||
13185461|NCT02163993|26168534|FG004|Treatment Period|Adverse Event|1|||
13185462|NCT02163993|26168530|FG000|Treatment Period|Lost to Follow-up|2|||
13185463|NCT02163993|26168531|FG001|Treatment Period|Lost to Follow-up|3|||
13185464|NCT02163993|26168532|FG002|Treatment Period|Lost to Follow-up|1|||
13185465|NCT02163993|26168533|FG003|Treatment Period|Lost to Follow-up|3|||
13185466|NCT02163993|26168534|FG004|Treatment Period|Lost to Follow-up|1|||
13185467|NCT02163993|26168530|FG000|Treatment Period|Physician Decision|1|||
13185468|NCT02163993|26168531|FG001|Treatment Period|Physician Decision|0|||
13185469|NCT02163993|26168532|FG002|Treatment Period|Physician Decision|0|||
13185470|NCT02163993|26168533|FG003|Treatment Period|Physician Decision|0|||
13185471|NCT02163993|26168534|FG004|Treatment Period|Physician Decision|0|||
13110376|NCT03213457|25899117|FG000|Overall Study|Non-Compliance Other, Not Specified|0|||
13110377|NCT03213457|25899118|FG001|Overall Study|Non-Compliance Other, Not Specified|1|||
13110378|NCT03213457|25899119|FG002|Overall Study|Non-Compliance Other, Not Specified|5|||
13185472|NCT02163993|26168530|FG000|Treatment Period|Protocol Violation|2|||
13185473|NCT02163993|26168531|FG001|Treatment Period|Protocol Violation|1|||
13185474|NCT02163993|26168532|FG002|Treatment Period|Protocol Violation|0|||
13185475|NCT02163993|26168533|FG003|Treatment Period|Protocol Violation|1|||
13185476|NCT02163993|26168534|FG004|Treatment Period|Protocol Violation|2|||
13185477|NCT02163993|26168530|FG000|Treatment Period|Withdrawal by Subject|6|||
13185478|NCT02163993|26168531|FG001|Treatment Period|Withdrawal by Subject|4|||
13185479|NCT02163993|26168532|FG002|Treatment Period|Withdrawal by Subject|1|||
13185480|NCT02163993|26168533|FG003|Treatment Period|Withdrawal by Subject|4|||
13185481|NCT02163993|26168534|FG004|Treatment Period|Withdrawal by Subject|1|||
13185482|NCT02163993|26168530|FG000|Treatment Period|Not treated|1|||
13185483|NCT02163993|26168531|FG001|Treatment Period|Not treated|0|||
13185484|NCT02163993|26168532|FG002|Treatment Period|Not treated|0|||
13185485|NCT02163993|26168533|FG003|Treatment Period|Not treated|1|||
13185486|NCT02163993|26168534|FG004|Treatment Period|Not treated|2|||
13185487|NCT02163993|26168530|FG000|Post-treatment Period|Adverse Event|0|||
13185488|NCT02163993|26168531|FG001|Post-treatment Period|Adverse Event|0|||
13185489|NCT02163993|26168532|FG002|Post-treatment Period|Adverse Event|1|||
13185490|NCT02163993|26168533|FG003|Post-treatment Period|Adverse Event|0|||
13185491|NCT02163993|26168534|FG004|Post-treatment Period|Adverse Event|0|||
13185492|NCT02163993|26168530|FG000|Post-treatment Period|Lost to Follow-up|2|||
13185493|NCT02163993|26168531|FG001|Post-treatment Period|Lost to Follow-up|2|||
13185494|NCT02163993|26168532|FG002|Post-treatment Period|Lost to Follow-up|3|||
13185495|NCT02163993|26168533|FG003|Post-treatment Period|Lost to Follow-up|1|||
13185496|NCT02163993|26168534|FG004|Post-treatment Period|Lost to Follow-up|0|||
13185497|NCT02163993|26168530|FG000|Post-treatment Period|Protocol Violation|0|||
13185498|NCT02163993|26168531|FG001|Post-treatment Period|Protocol Violation|0|||
13185499|NCT02163993|26168532|FG002|Post-treatment Period|Protocol Violation|0|||
13185500|NCT02163993|26168533|FG003|Post-treatment Period|Protocol Violation|0|||
13185501|NCT02163993|26168534|FG004|Post-treatment Period|Protocol Violation|1|||
13185502|NCT02163993|26168530|FG000|Post-treatment Period|Withdrawal by Subject|2|||
13185503|NCT02163993|26168531|FG001|Post-treatment Period|Withdrawal by Subject|4|||
13185504|NCT02163993|26168532|FG002|Post-treatment Period|Withdrawal by Subject|0|||
13185505|NCT02163993|26168533|FG003|Post-treatment Period|Withdrawal by Subject|1|||
13185506|NCT02163993|26168534|FG004|Post-treatment Period|Withdrawal by Subject|2|||
13185507|NCT02163915|26168603|FG000|Overall Study|Withdrawal by Subject|2|||
13185508|NCT02163915|26168604|FG001|Overall Study|Withdrawal by Subject|0|||
13185509|NCT02163915|26168605|FG002|Overall Study|Withdrawal by Subject|2|||
13185510|NCT02163915|26168606|FG003|Overall Study|Withdrawal by Subject|2|||
13185511|NCT02163915|26168607|FG004|Overall Study|Withdrawal by Subject|2|||
13185512|NCT02163915|26168603|FG000|Overall Study|Study termination|1|||
13185513|NCT02163915|26168604|FG001|Overall Study|Study termination|0|||
13185514|NCT02163915|26168605|FG002|Overall Study|Study termination|0|||
13185515|NCT02163915|26168606|FG003|Overall Study|Study termination|0|||
13185516|NCT02163915|26168607|FG004|Overall Study|Study termination|2|||
13185517|NCT02163915|26168603|FG000|Overall Study|Physician Decision|0|||
13185518|NCT02163915|26168604|FG001|Overall Study|Physician Decision|0|||
13185519|NCT02163915|26168605|FG002|Overall Study|Physician Decision|0|||
13185520|NCT02163915|26168606|FG003|Overall Study|Physician Decision|1|||
13185521|NCT02163915|26168607|FG004|Overall Study|Physician Decision|0|||
13185522|NCT02163902|26168630|FG000|Overall Study|Subject's Request|3|||
13223030|NCT01800916|26287703|FG005|Test Period 1 (1 Week)|Adverse Event|0|||
13185523|NCT02163902|26168631|FG001|Overall Study|Subject's Request|4|||
13185524|NCT02163902|26168630|FG000|Overall Study|Lost to Follow-up|6|||
13185525|NCT02163902|26168631|FG001|Overall Study|Lost to Follow-up|7|||
13185526|NCT02163902|26168630|FG000|Overall Study|Administrative Decision|2|||
13185527|NCT02163902|26168631|FG001|Overall Study|Administrative Decision|2|||
13185528|NCT02163759|26168714|FG000|Overall Study|Withdrawal by Subject|1|||
13185529|NCT02163759|26168715|FG001|Overall Study|Withdrawal by Subject|5|||
13185530|NCT02163759|26168716|FG002|Overall Study|Withdrawal by Subject|1|||
13185531|NCT02163759|26168714|FG000|Overall Study|Adverse Event|0|||
13185532|NCT02163759|26168715|FG001|Overall Study|Adverse Event|0|||
13185533|NCT02163759|26168716|FG002|Overall Study|Adverse Event|1|||
13185534|NCT02163759|26168714|FG000|Overall Study|Death|0|||
13185535|NCT02163759|26168715|FG001|Overall Study|Death|0|||
13185536|NCT02163759|26168716|FG002|Overall Study|Death|1|||
13185537|NCT02163538|26168739|FG000|Overall Study|Protocol Violation|1|||
13185538|NCT02163538|26168740|FG001|Overall Study|Protocol Violation|0|||
13185539|NCT02163538|26168739|FG000|Overall Study|Physician Decision|0|||
13185540|NCT02163538|26168740|FG001|Overall Study|Physician Decision|1|||
13185541|NCT02163499|26168750|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1|||
13185542|NCT02163499|26168750|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1|||
13185543|NCT02163499|26168750|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1|||
13185544|NCT02163499|26168750|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1|||
13185545|NCT02163499|26168750|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1|||
13185546|NCT02163499|26168750|FG000|Extended Dosing Phase: ZS|Adverse Event|51|||
13185547|NCT02163499|26168750|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40|||
13185548|NCT02163499|26168750|FG000|Extended Dosing Phase: ZS|Hypokalemia|9|||
13185549|NCT02163499|26168750|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5|||
13185550|NCT02163499|26168750|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7|||
13185551|NCT02163499|26168750|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81|||
13185552|NCT02163499|26168750|FG000|Extended Dosing Phase: ZS|Physician Decision|8|||
13185553|NCT02163499|26168750|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31|||
13185554|NCT02163499|26168750|FG000|Extended Dosing Phase: ZS|Protocol Violation|2|||
13185555|NCT02163499|26168750|FG000|Extended Dosing Phase: ZS|Death|8|||
13110379|NCT03213457|25899117|FG000|Overall Study|Withdrawal by Subject|18|||
13110380|NCT03213457|25899118|FG001|Overall Study|Withdrawal by Subject|7|||
13110381|NCT03213457|25899119|FG002|Overall Study|Withdrawal by Subject|35|||
13110382|NCT03213457|25899117|FG000|Overall Study|Lost to Follow-up|12|||
13110383|NCT03213457|25899118|FG001|Overall Study|Lost to Follow-up|12|||
13110384|NCT03213457|25899119|FG002|Overall Study|Lost to Follow-up|33|||
13110385|NCT03213457|25899117|FG000|Overall Study|Pregnancy|11|||
13110386|NCT03213457|25899118|FG001|Overall Study|Pregnancy|0|||
13185556|NCT02163499|26168750|FG000|Extended Dosing Phase: ZS|Subject Compliance|17|||
13185557|NCT02163499|26168750|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5|||
13185558|NCT02163499|26168750|FG000|Extended Dosing Phase: ZS|Various reasons|16|||
13185559|NCT02163447|26168821|FG000|Overall Study|Withdrawal by Subject|2|||
13185560|NCT02163447|26168822|FG001|Overall Study|Withdrawal by Subject|0|||
13185561|NCT02163447|26168823|FG002|Overall Study|Withdrawal by Subject|1|||
13185562|NCT02163447|26168821|FG000|Overall Study|Lost to Follow-up|1|||
13185563|NCT02163447|26168822|FG001|Overall Study|Lost to Follow-up|3|||
13185564|NCT02163447|26168823|FG002|Overall Study|Lost to Follow-up|0|||
13185565|NCT02163447|26168821|FG000|Overall Study|Moved out of study area|2|||
13185566|NCT02163447|26168822|FG001|Overall Study|Moved out of study area|3|||
13185567|NCT02163447|26168823|FG002|Overall Study|Moved out of study area|2|||
13185568|NCT02163447|26168821|FG000|Overall Study|Became HIV infected at time of delivery|1|||
13185569|NCT02163447|26168822|FG001|Overall Study|Became HIV infected at time of delivery|0|||
13185570|NCT02163447|26168823|FG002|Overall Study|Became HIV infected at time of delivery|0|||
13185571|NCT02163395|26168832|FG000|Overall Study|Withdrawal by Subject|1|||
13185572|NCT02163395|26168832|FG000|Overall Study|Lost to Follow-up|3|||
13185573|NCT02163395|26168832|FG000|Overall Study|Adverse Event|1|||
13185574|NCT02163226|26168849|FG000|Overall Study|Death|2|||
13185575|NCT02163226|26168850|FG001|Overall Study|Death|1|||
13185576|NCT02163226|26168849|FG000|Overall Study|Withdrawal by Subject|5|||
13185577|NCT02163226|26168850|FG001|Overall Study|Withdrawal by Subject|2|||
13185578|NCT02163226|26168849|FG000|Overall Study|Returned home, local radiotherapy|3|||
13185579|NCT02163226|26168850|FG001|Overall Study|Returned home, local radiotherapy|0|||
13185580|NCT02163226|26168849|FG000|Overall Study|Repeat imaging showed no disease|2|||
13185581|NCT02163226|26168850|FG001|Overall Study|Repeat imaging showed no disease|0|||
13185582|NCT02163226|26168849|FG000|Overall Study|Incomplete radiotherapy|3|||
13185583|NCT02163226|26168850|FG001|Overall Study|Incomplete radiotherapy|0|||
13185584|NCT02163226|26168849|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1|||
13185585|NCT02163226|26168850|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0|||
13185586|NCT02163226|26168849|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0|||
13185587|NCT02163226|26168850|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5|||
13185588|NCT02163226|26168849|FG000|Overall Study|ineligible|0|||
13185589|NCT02163226|26168850|FG001|Overall Study|ineligible|3|||
13185590|NCT02163187|26168865|FG000|Overall Study|Device removed|1|||
13185591|NCT02163187|26168866|FG001|Overall Study|Device removed|0|||
13185592|NCT02163187|26168865|FG000|Overall Study|Progressive disease|1|||
13185593|NCT02163187|26168866|FG001|Overall Study|Progressive disease|0|||
13185594|NCT02163057|26168893|FG000|Overall Study|Participant Refusal to Continue|2|||
13185595|NCT02163057|26168894|FG001|Overall Study|Participant Refusal to Continue|2|||
13185596|NCT02163057|26168893|FG000|Overall Study|Participant Significant Noncompliance|0|||
13185597|NCT02163057|26168894|FG001|Overall Study|Participant Significant Noncompliance|1|||
13185598|NCT02163057|26168893|FG000|Overall Study|Progression of Disease|1|||
13185599|NCT02163057|26168894|FG001|Overall Study|Progression of Disease|2|||
13185600|NCT02162862|26168915|FG000|Overall Study|Lost to Follow-up|0|||
13185601|NCT02162862|26168916|FG001|Overall Study|Lost to Follow-up|11|||
13185602|NCT02162862|26168917|FG002|Overall Study|Lost to Follow-up|0|||
13185603|NCT02162862|26168915|FG000|Overall Study|Subject did not feel the med was needed|0|||
13185604|NCT02162862|26168916|FG001|Overall Study|Subject did not feel the med was needed|0|||
13185605|NCT02162862|26168917|FG002|Overall Study|Subject did not feel the med was needed|4|||
13185606|NCT02162771|26168936|FG000|Core Study Period (Part 2)|Progressive Disease|2|||
13185607|NCT02162771|26168937|FG001|Core Study Period (Part 2)|Progressive Disease|3|||
13185608|NCT02162771|26168936|FG000|Core Study Period (Part 2)|Adverse Event|4|||
13185609|NCT02162771|26168937|FG001|Core Study Period (Part 2)|Adverse Event|1|||
13185610|NCT02162771|26168936|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1|||
13185611|NCT02162771|26168937|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2|||
13185612|NCT02162771|26168936|FG000|Core Study Period (Part 2)|Physician Decision|0|||
13185613|NCT02162771|26168937|FG001|Core Study Period (Part 2)|Physician Decision|2|||
13185614|NCT02162771|26168936|FG000|Core Study Period (Part 2)|Death|1|||
13185615|NCT02162771|26168937|FG001|Core Study Period (Part 2)|Death|0|||
13185616|NCT02162771|26168936|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11|||
13185617|NCT02162771|26168937|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13|||
13185618|NCT02162771|26168936|FG000|Maintenance Study Period (Part 2)|Adverse Event|3|||
13185619|NCT02162771|26168937|FG001|Maintenance Study Period (Part 2)|Adverse Event|3|||
13110387|NCT03213457|25899119|FG002|Overall Study|Pregnancy|7|||
13110388|NCT03213457|25899117|FG000|Overall Study|Protocol Violation|1|||
13185620|NCT02162771|26168936|FG000|Maintenance Study Period (Part 2)|Death|2|||
13185621|NCT02162771|26168937|FG001|Maintenance Study Period (Part 2)|Death|1|||
13185622|NCT02162771|26168936|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0|||
13185623|NCT02162771|26168937|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3|||
13185624|NCT02162771|26168936|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0|||
13185625|NCT02162771|26168937|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1|||
13185626|NCT02162771|26168936|FG000|Maintenance Study Period (Part 2)|Stable Disease|0|||
13185627|NCT02162771|26168937|FG001|Maintenance Study Period (Part 2)|Stable Disease|1|||
13185628|NCT02162758|26168956|FG000|Overall Study|Study termination|0|||
13185629|NCT02162758|26168957|FG001|Overall Study|Study termination|1|||
13185630|NCT02162719|26169006|FG000|Overall Study|Death|41|||
13185631|NCT02162719|26169007|FG001|Overall Study|Death|46|||
13185632|NCT02162719|26169006|FG000|Overall Study|Lost to Follow-up|1|||
13185633|NCT02162719|26169007|FG001|Overall Study|Lost to Follow-up|3|||
13185634|NCT02162719|26169006|FG000|Overall Study|Disease Progression|2|||
13185635|NCT02162719|26169007|FG001|Overall Study|Disease Progression|1|||
13185636|NCT02162719|26169006|FG000|Overall Study|Withdrawal by Subject|8|||
13185637|NCT02162719|26169007|FG001|Overall Study|Withdrawal by Subject|2|||
13185638|NCT02162719|26169006|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
13185639|NCT02162719|26169007|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
13185640|NCT02161757|26169075|FG000|Randomised Through Start Treatment|Did not receive treatment|3|||
13185641|NCT02161757|26169076|FG001|Randomised Through Start Treatment|Did not receive treatment|2|||
13185642|NCT02161757|26169077|FG002|Randomised Through Start Treatment|Did not receive treatment|0|||
13185643|NCT02161757|26169075|FG000|Treatment Through Study Completion|Adverse Event|1|||
13185644|NCT02161757|26169076|FG001|Treatment Through Study Completion|Adverse Event|1|||
13185645|NCT02161757|26169077|FG002|Treatment Through Study Completion|Adverse Event|0|||
13185646|NCT02161757|26169075|FG000|Treatment Through Study Completion|Protocol Violation|0|||
13185647|NCT02161757|26169076|FG001|Treatment Through Study Completion|Protocol Violation|1|||
13185648|NCT02161757|26169077|FG002|Treatment Through Study Completion|Protocol Violation|2|||
13185649|NCT02161757|26169075|FG000|Treatment Through Study Completion|Withdrawal by Subject|27|||
13185650|NCT02161757|26169076|FG001|Treatment Through Study Completion|Withdrawal by Subject|19|||
13185651|NCT02161757|26169077|FG002|Treatment Through Study Completion|Withdrawal by Subject|20|||
13185652|NCT02161757|26169075|FG000|Treatment Through Study Completion|Lost to Follow-up|7|||
13185653|NCT02161757|26169076|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
13185654|NCT02161757|26169077|FG002|Treatment Through Study Completion|Lost to Follow-up|4|||
13185655|NCT02161757|26169075|FG000|Treatment Through Study Completion|Other|20|||
13185656|NCT02161757|26169076|FG001|Treatment Through Study Completion|Other|19|||
13185657|NCT02161757|26169077|FG002|Treatment Through Study Completion|Other|12|||
13185658|NCT02161757|26169075|FG000|Treatment Through Study Completion|Death|2|||
13185659|NCT02161757|26169076|FG001|Treatment Through Study Completion|Death|1|||
13185660|NCT02161757|26169077|FG002|Treatment Through Study Completion|Death|1|||
13185661|NCT02161731|26169097|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0|||
13185662|NCT02161731|26169098|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1|||
13185663|NCT02161731|26169097|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0|||
13185664|NCT02161731|26169098|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1|||
13185665|NCT02161718|26169117|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2|||
13185666|NCT02161718|26169118|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0|||
13185667|NCT02161718|26169119|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0|||
13185668|NCT02161718|26169117|FG000|Open-Label ALKS 3831 Period|Physician Decision|1|||
13185669|NCT02161718|26169118|FG001|Open-Label ALKS 3831 Period|Physician Decision|0|||
13185670|NCT02161718|26169119|FG002|Open-Label ALKS 3831 Period|Physician Decision|0|||
13185671|NCT02161718|26169117|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1|||
13185672|NCT02161718|26169118|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
13185673|NCT02161718|26169119|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
13185674|NCT02161718|26169117|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1|||
13185675|NCT02161718|26169118|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
13185676|NCT02161718|26169119|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
13185677|NCT02161718|26169117|FG000|Open-Label ALKS 3831 Period|Adverse Event|3|||
13185678|NCT02161718|26169118|FG001|Open-Label ALKS 3831 Period|Adverse Event|0|||
13185679|NCT02161718|26169119|FG002|Open-Label ALKS 3831 Period|Adverse Event|0|||
13185680|NCT02161718|26169117|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4|||
13185681|NCT02161718|26169118|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
13185682|NCT02161718|26169119|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
13185683|NCT02161718|26169117|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3|||
13185684|NCT02161718|26169118|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
13185685|NCT02161718|26169119|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
13185686|NCT02161718|26169117|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6|||
13185687|NCT02161718|26169118|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
13185688|NCT02161718|26169119|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
13185689|NCT02161718|26169117|FG000|Post- Randomization Period|Withdrawal by Subject|0|||
13185690|NCT02161718|26169118|FG001|Post- Randomization Period|Withdrawal by Subject|23|||
13185691|NCT02161718|26169119|FG002|Post- Randomization Period|Withdrawal by Subject|18|||
13185692|NCT02161718|26169117|FG000|Post- Randomization Period|Lost to Follow-up|0|||
13185693|NCT02161718|26169118|FG001|Post- Randomization Period|Lost to Follow-up|9|||
13185694|NCT02161718|26169119|FG002|Post- Randomization Period|Lost to Follow-up|15|||
13185695|NCT02161718|26169117|FG000|Post- Randomization Period|Adverse Event|0|||
13185696|NCT02161718|26169118|FG001|Post- Randomization Period|Adverse Event|9|||
13185697|NCT02161718|26169119|FG002|Post- Randomization Period|Adverse Event|10|||
13185698|NCT02161718|26169117|FG000|Post- Randomization Period|Non- compliance with study drug|0|||
13185699|NCT02161718|26169118|FG001|Post- Randomization Period|Non- compliance with study drug|8|||
13185700|NCT02161718|26169119|FG002|Post- Randomization Period|Non- compliance with study drug|2|||
13185701|NCT02161718|26169117|FG000|Post- Randomization Period|Physician Decision|0|||
13185702|NCT02161718|26169118|FG001|Post- Randomization Period|Physician Decision|2|||
13185703|NCT02161718|26169119|FG002|Post- Randomization Period|Physician Decision|4|||
13185704|NCT02161718|26169117|FG000|Post- Randomization Period|Protocol Violation|0|||
13185705|NCT02161718|26169118|FG001|Post- Randomization Period|Protocol Violation|2|||
13185706|NCT02161718|26169119|FG002|Post- Randomization Period|Protocol Violation|3|||
13185707|NCT02161718|26169117|FG000|Post- Randomization Period|Lack of Efficacy|0|||
13185708|NCT02161718|26169118|FG001|Post- Randomization Period|Lack of Efficacy|0|||
13185709|NCT02161718|26169119|FG002|Post- Randomization Period|Lack of Efficacy|1|||
13185710|NCT02161718|26169117|FG000|Post- Randomization Period|Non-compliance with study procedures|0|||
13185711|NCT02161718|26169118|FG001|Post- Randomization Period|Non-compliance with study procedures|2|||
13185712|NCT02161718|26169119|FG002|Post- Randomization Period|Non-compliance with study procedures|4|||
13185713|NCT02161718|26169117|FG000|Post- Randomization Period|Received prohibitive treatment|0|||
13185714|NCT02161718|26169118|FG001|Post- Randomization Period|Received prohibitive treatment|1|||
13185715|NCT02161718|26169119|FG002|Post- Randomization Period|Received prohibitive treatment|2|||
13185716|NCT02161718|26169117|FG000|Post- Randomization Period|Relocation|0|||
13185717|NCT02161718|26169118|FG001|Post- Randomization Period|Relocation|3|||
13185718|NCT02161718|26169119|FG002|Post- Randomization Period|Relocation|0|||
13185719|NCT02161575|26169139|FG000|Overall Study|Protocol Violation|8|||
13185720|NCT02161575|26169139|FG000|Overall Study|Lack of Efficacy|1|||
13185721|NCT02161575|26169139|FG000|Overall Study|Adverse Event|2|||
13185722|NCT02161562|26169172|FG000|Overall Study|Withdrawal by Subject|5|||
13185723|NCT02161562|26169173|FG001|Overall Study|Withdrawal by Subject|8|||
13185724|NCT02161562|26169172|FG000|Overall Study|Protocol Violation|9|||
13185725|NCT02161562|26169173|FG001|Overall Study|Protocol Violation|4|||
13185726|NCT02161562|26169172|FG000|Overall Study|Pregnancy|1|||
13185727|NCT02161562|26169173|FG001|Overall Study|Pregnancy|2|||
13185728|NCT02161562|26169172|FG000|Overall Study|Lost to Follow-up|3|||
13185729|NCT02161562|26169173|FG001|Overall Study|Lost to Follow-up|1|||
13185730|NCT02161562|26169172|FG000|Overall Study|Lack of Efficacy|4|||
13185731|NCT02161562|26169173|FG001|Overall Study|Lack of Efficacy|1|||
13185732|NCT02161562|26169172|FG000|Overall Study|Adverse Event|1|||
13185733|NCT02161562|26169173|FG001|Overall Study|Adverse Event|1|||
13185734|NCT02161562|26169172|FG000|Overall Study|Participant moved back to home country|1|||
13185735|NCT02161562|26169173|FG001|Overall Study|Participant moved back to home country|0|||
13185736|NCT02161562|26169172|FG000|Overall Study|Withdrew due to being out of the country|1|||
13185737|NCT02161562|26169173|FG001|Overall Study|Withdrew due to being out of the country|0|||
13185738|NCT02161562|26169172|FG000|Overall Study|Participant moved out of province|1|||
13185739|NCT02161562|26169173|FG001|Overall Study|Participant moved out of province|0|||
13185740|NCT02161549|26169186|FG000|Overall Study|Physician Decision|6|||
13185741|NCT02161549|26169187|FG001|Overall Study|Physician Decision|2|||
13185742|NCT02161458|26169210|FG000|Overall Study|Withdrawal by Subject|0|||
13185743|NCT02161458|26169211|FG001|Overall Study|Withdrawal by Subject|4|||
13185744|NCT02161458|26169212|FG002|Overall Study|Withdrawal by Subject|4|||
13185745|NCT02161458|26169213|FG003|Overall Study|Withdrawal by Subject|0|||
13185746|NCT02161458|26169210|FG000|Overall Study|Lost to Follow-up|0|||
13185747|NCT02161458|26169211|FG001|Overall Study|Lost to Follow-up|2|||
13185748|NCT02161458|26169212|FG002|Overall Study|Lost to Follow-up|1|||
13185749|NCT02161458|26169213|FG003|Overall Study|Lost to Follow-up|0|||
13185750|NCT02161406|26169294|FG000|Overall Study|Death|2|||
13185751|NCT02161406|26169295|FG001|Overall Study|Death|1|||
13185752|NCT02161406|26169294|FG000|Overall Study|Lost to Follow-up|2|||
13185753|NCT02161406|26169295|FG001|Overall Study|Lost to Follow-up|1|||
13185754|NCT02161406|26169294|FG000|Overall Study|Withdrawal by Subject|2|||
13185755|NCT02161406|26169295|FG001|Overall Study|Withdrawal by Subject|4|||
13185756|NCT02161406|26169294|FG000|Overall Study|investigator withdrew subject|3|||
13185757|NCT02161406|26169295|FG001|Overall Study|investigator withdrew subject|1|||
13185758|NCT02161406|26169294|FG000|Overall Study|Lack of Efficacy|1|||
13185759|NCT02161406|26169295|FG001|Overall Study|Lack of Efficacy|1|||
13185760|NCT02161406|26169294|FG000|Overall Study|relocation|0|||
13185761|NCT02161406|26169295|FG001|Overall Study|relocation|1|||
13185762|NCT02161185|26169302|FG000|Treatment Phase|Administrative/Other|7|||
13185763|NCT02161146|26169331|FG000|Overall Study|Adverse Event|1|||
13185764|NCT02161146|26169332|FG001|Overall Study|Adverse Event|1|||
13185765|NCT02161146|26169333|FG002|Overall Study|Adverse Event|0|||
13185766|NCT02161146|26169334|FG003|Overall Study|Adverse Event|1|||
13185767|NCT02161146|26169335|FG004|Overall Study|Adverse Event|0|||
13185768|NCT02161146|26169331|FG000|Overall Study|Lost to Follow-up|0|||
13185769|NCT02161146|26169332|FG001|Overall Study|Lost to Follow-up|1|||
13185770|NCT02161146|26169333|FG002|Overall Study|Lost to Follow-up|0|||
13185771|NCT02161146|26169334|FG003|Overall Study|Lost to Follow-up|0|||
13185772|NCT02161146|26169335|FG004|Overall Study|Lost to Follow-up|0|||
13185773|NCT02161146|26169331|FG000|Overall Study|Personal Reasons|0|||
13185774|NCT02161146|26169332|FG001|Overall Study|Personal Reasons|1|||
13185775|NCT02161146|26169333|FG002|Overall Study|Personal Reasons|0|||
13185776|NCT02161146|26169334|FG003|Overall Study|Personal Reasons|2|||
13185777|NCT02161146|26169335|FG004|Overall Study|Personal Reasons|1|||
13185778|NCT02161146|26169331|FG000|Overall Study|Other Miscellaneous Reasons|0|||
13185779|NCT02161146|26169332|FG001|Overall Study|Other Miscellaneous Reasons|1|||
13185780|NCT02161146|26169333|FG002|Overall Study|Other Miscellaneous Reasons|0|||
13185781|NCT02161146|26169334|FG003|Overall Study|Other Miscellaneous Reasons|0|||
13185782|NCT02161146|26169335|FG004|Overall Study|Other Miscellaneous Reasons|0|||
13185783|NCT02161016|26169345|FG000|Overall Study|withdrawn by IRB|1|||
13185784|NCT02160977|26169362|FG000|Six Weeks After Surgery|Lost to Follow-up|1|||
13185785|NCT02160977|26169363|FG001|Six Weeks After Surgery|Lost to Follow-up|0|||
13185786|NCT02160977|26169362|FG000|Three Months After Surgery|Lost to Follow-up|0|||
13185787|NCT02160977|26169363|FG001|Three Months After Surgery|Lost to Follow-up|2|||
13110389|NCT03213457|25899118|FG001|Overall Study|Protocol Violation|1|||
13110390|NCT03213457|25899119|FG002|Overall Study|Protocol Violation|6|||
13110391|NCT03213457|25899117|FG000|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|4|||
13110392|NCT03213457|25899118|FG001|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|0|||
13110393|NCT03213457|25899119|FG002|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|2|||
13110394|NCT03213457|25899117|FG000|Overall Study|Dual Energy X-Ray Absorptiometry Finding|1|||
13110395|NCT03213457|25899118|FG001|Overall Study|Dual Energy X-Ray Absorptiometry Finding|1|||
13110396|NCT03213457|25899119|FG002|Overall Study|Dual Energy X-Ray Absorptiometry Finding|3|||
13185788|NCT02160977|26169362|FG000|Six Months After Surgery|Lost to Follow-up|2|||
13185789|NCT02160977|26169363|FG001|Six Months After Surgery|Lost to Follow-up|1|||
13185790|NCT02160899|26169402|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
13185791|NCT02160899|26169403|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
13185792|NCT02160899|26169404|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
13185793|NCT02160899|26169405|FG003|Overall Study|Adverse Event or Serious Adverse Event|1|||
13185794|NCT02160899|26169406|FG004|Overall Study|Adverse Event or Serious Adverse Event|2|||
13185795|NCT02160899|26169407|FG005|Overall Study|Adverse Event or Serious Adverse Event|0|||
13185796|NCT02160782|26169449|FG000|Open-label Period: Maralixibat|Adverse Event|2|||
13185797|NCT02160782|26169450|FG001|Open-label Period: Maralixibat|Adverse Event|0|||
13185798|NCT02160782|26169451|FG002|Open-label Period: Maralixibat|Adverse Event|0|||
13185799|NCT02160782|26169452|FG003|Open-label Period: Maralixibat|Adverse Event|0|||
13185800|NCT02160782|26169453|FG004|Open-label Period: Maralixibat|Adverse Event|0|||
13185801|NCT02160782|26169449|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
13185802|NCT02160782|26169450|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
13185803|NCT02160782|26169451|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
13185804|NCT02160782|26169452|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1|||
13185805|NCT02160782|26169453|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
13185806|NCT02160782|26169449|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
13185807|NCT02160782|26169450|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
13185808|NCT02160782|26169451|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
13223031|NCT01800916|26287704|FG006|Test Period 1 (1 Week)|Adverse Event|0|||
13223032|NCT01800916|26287705|FG007|Test Period 1 (1 Week)|Adverse Event|0|||
13223033|NCT01800916|26287706|FG008|Test Period 1 (1 Week)|Adverse Event|0|||
13223034|NCT01800903|26287719|FG000|Second Test Period|unable to catheterise|1|||
13223035|NCT01800903|26287720|FG001|Second Test Period|unable to catheterise|0|||
13223036|NCT01800903|26287721|FG002|Second Test Period|unable to catheterise|0|||
13223037|NCT01800903|26287722|FG003|Second Test Period|unable to catheterise|0|||
13223038|NCT01800903|26287723|FG004|Second Test Period|unable to catheterise|0|||
13223039|NCT01800903|26287724|FG005|Second Test Period|unable to catheterise|0|||
13223040|NCT01800201|26287743|FG000|Overall Study|Withdrawal by Subject|2|||
13223041|NCT01800201|26287744|FG001|Overall Study|Withdrawal by Subject|0|||
13223042|NCT01800201|26287743|FG000|Overall Study|patient privacy concerns|1|||
13223043|NCT01800201|26287744|FG001|Overall Study|patient privacy concerns|1|||
13223044|NCT01800201|26287743|FG000|Overall Study|did not want to use device|0|||
13223045|NCT01800201|26287744|FG001|Overall Study|did not want to use device|1|||
13223046|NCT01800201|26287743|FG000|Overall Study|PI withdrawal, cognitive concerns|0|||
13110397|NCT03213457|25899117|FG000|Overall Study|Lack of Efficacy|12|||
13223047|NCT01800201|26287744|FG001|Overall Study|PI withdrawal, cognitive concerns|1|||
13223048|NCT01800058|26287757|FG000|Overall Study|Lost to Follow-up|1|||
13223049|NCT01799993|26287796|FG000|Overall Study|"Didn't complete CRF page End of FU"|30|||
13223050|NCT01799993|26287797|FG001|Overall Study|"Didn't complete CRF page End of FU"|40|||
13223051|NCT01799993|26287796|FG000|Overall Study|Death|61|||
13110398|NCT03213457|25899118|FG001|Overall Study|Lack of Efficacy|2|||
13110399|NCT03213457|25899119|FG002|Overall Study|Lack of Efficacy|9|||
13110400|NCT03213457|25899117|FG000|Overall Study|Other, Not Specified|11|||
13110401|NCT03213457|25899118|FG001|Overall Study|Other, Not Specified|3|||
13110402|NCT03213457|25899119|FG002|Overall Study|Other, Not Specified|26|||
13110403|NCT03213366|25899152|FG000|Overall Study|Lost to Follow-up|9|||
13110404|NCT03213366|25899153|FG001|Overall Study|Lost to Follow-up|4|||
13110405|NCT03213210|25899163|FG000|Overall Study|Lost to Follow-up|2|||
13110406|NCT03213210|25899163|FG000|Overall Study|Study termination|3|||
13110407|NCT03212690|25899185|FG000|Overall Study|Protocol Violation|1|||
13110408|NCT03212521|25899194|FG000|Overall Study|Adverse Event|1|||
13110409|NCT03212521|25899194|FG000|Overall Study|Lost to Follow-up|4|||
13110410|NCT03212521|25899194|FG000|Overall Study|Withdrawal by Subject|1|||
13110411|NCT03212521|25899194|FG000|Overall Study|Other|1|||
13110412|NCT03212365|25899213|FG000|Overall Study|Discharged prior to Xa level|12|||
13110413|NCT03212365|25899214|FG001|Overall Study|Discharged prior to Xa level|8|||
13110414|NCT03212365|25899213|FG000|Overall Study|Bled requiring enoxaparin cessation|4|||
13110415|NCT03212365|25899214|FG001|Overall Study|Bled requiring enoxaparin cessation|2|||
13110416|NCT03212365|25899213|FG000|Overall Study|Refused study medication|3|||
13110417|NCT03212365|25899214|FG001|Overall Study|Refused study medication|0|||
13110418|NCT03212365|25899213|FG000|Overall Study|Initiated heparin infusion on floor|1|||
13110419|NCT03212365|25899214|FG001|Overall Study|Initiated heparin infusion on floor|1|||
13110420|NCT03212365|25899213|FG000|Overall Study|Unexpected return to OR|1|||
13110421|NCT03212365|25899214|FG001|Overall Study|Unexpected return to OR|1|||
13110422|NCT03212365|25899213|FG000|Overall Study|Medication distribution error|1|||
13110423|NCT03212365|25899214|FG001|Overall Study|Medication distribution error|0|||
13110424|NCT03212365|25899213|FG000|Overall Study|Required epidural placement|1|||
13110425|NCT03212365|25899214|FG001|Overall Study|Required epidural placement|0|||
13110426|NCT03212365|25899213|FG000|Overall Study|Withdrawal by Subject|0|||
13110427|NCT03212365|25899214|FG001|Overall Study|Withdrawal by Subject|1|||
13185809|NCT02160782|26169452|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5|||
13185810|NCT02160782|26169453|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
13185811|NCT02160782|26169449|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
13185812|NCT02160782|26169450|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
13185813|NCT02160782|26169451|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
13185814|NCT02160782|26169452|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
13185815|NCT02160782|26169453|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4|||
13185816|NCT02160782|26169449|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0|||
13185817|NCT02160782|26169450|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0|||
13185818|NCT02160782|26169451|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0|||
13185819|NCT02160782|26169452|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0|||
13185820|NCT02160782|26169453|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1|||
13185821|NCT02160782|26169449|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0|||
13185822|NCT02160782|26169450|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0|||
13185823|NCT02160782|26169451|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0|||
13185824|NCT02160782|26169452|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0|||
13185825|NCT02160782|26169453|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3|||
13185826|NCT02160782|26169449|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
13185827|NCT02160782|26169450|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
13185828|NCT02160782|26169451|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
13185829|NCT02160782|26169452|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
13185830|NCT02160782|26169453|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1|||
13185831|NCT02160626|26169477|FG000|Overall Study|Adverse Event|1|||
13185832|NCT02160626|26169478|FG001|Overall Study|Adverse Event|0|||
13185833|NCT02160626|26169479|FG002|Overall Study|Adverse Event|0|||
13185834|NCT02160626|26169477|FG000|Overall Study|Schedule not conducive to study visits|0|||
13185835|NCT02160626|26169478|FG001|Overall Study|Schedule not conducive to study visits|0|||
13185836|NCT02160626|26169479|FG002|Overall Study|Schedule not conducive to study visits|1|||
13185837|NCT02160626|26169477|FG000|Overall Study|Withdrawal by Subject|0|||
13223052|NCT01799993|26287797|FG001|Overall Study|Death|45|||
13110428|NCT03212365|25899213|FG000|Overall Study|developed acute renal failure|0|||
13110429|NCT03212365|25899214|FG001|Overall Study|developed acute renal failure|1|||
13110430|NCT03212326|25899221|FG000|Overall Study|Physician Decision|4|||
13110431|NCT03212261|25899229|FG000|Overall Study|Became ineligible d/t tech|2|||
13185838|NCT02160626|26169478|FG001|Overall Study|Withdrawal by Subject|1|||
13185839|NCT02160626|26169479|FG002|Overall Study|Withdrawal by Subject|0|||
13185840|NCT02160314|26169492|FG000|Overall Study|Adverse Event|0|||
13185841|NCT02160314|26169493|FG001|Overall Study|Adverse Event|6|||
13185842|NCT02160314|26169492|FG000|Overall Study|Protocol Violation|0|||
13185843|NCT02160314|26169493|FG001|Overall Study|Protocol Violation|4|||
13185844|NCT02160314|26169492|FG000|Overall Study|Withdrawal by Subject|1|||
13185845|NCT02160314|26169493|FG001|Overall Study|Withdrawal by Subject|2|||
13185846|NCT02160314|26169492|FG000|Overall Study|Lost to Follow-up|0|||
13185847|NCT02160314|26169493|FG001|Overall Study|Lost to Follow-up|1|||
13185848|NCT02160145|26169514|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23|||
13185849|NCT02160145|26169515|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0|||
13185850|NCT02160145|26169516|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0|||
13185851|NCT02160145|26169514|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126|||
13185852|NCT02160145|26169515|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
13185853|NCT02160145|26169516|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
13185854|NCT02160145|26169514|FG000|Randomized Double-blind Period|Subject decision|0|||
13110432|NCT03212261|25899229|FG000|Overall Study|Tech Trouble- No first study visit|1|||
13110433|NCT03212261|25899229|FG000|Overall Study|Lost to Follow-up|7|||
13110434|NCT03212261|25899229|FG000|Overall Study|Family Emergency|1|||
13110435|NCT03212261|25899229|FG000|Overall Study|Too busy/ No time|5|||
13110436|NCT03212144|25899242|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1|||
13110437|NCT03212144|25899243|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0|||
13110438|NCT03212144|25899242|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
13110439|NCT03212144|25899243|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
13110440|NCT03211858|25899300|FG000|Overall Study|Adverse Event|8|||
13110441|NCT03211858|25899301|FG001|Overall Study|Adverse Event|6|||
13110442|NCT03211858|25899300|FG000|Overall Study|Lack of Efficacy|0|||
13110443|NCT03211858|25899301|FG001|Overall Study|Lack of Efficacy|4|||
13185855|NCT02160145|26169515|FG001|Randomized Double-blind Period|Subject decision|21|||
13185856|NCT02160145|26169516|FG002|Randomized Double-blind Period|Subject decision|20|||
13185857|NCT02160145|26169514|FG000|Randomized Double-blind Period|Lost to Follow-up|0|||
13185858|NCT02160145|26169515|FG001|Randomized Double-blind Period|Lost to Follow-up|1|||
13185859|NCT02160145|26169516|FG002|Randomized Double-blind Period|Lost to Follow-up|3|||
13185860|NCT02160145|26169514|FG000|Randomized Double-blind Period|Physician Decision|0|||
13185861|NCT02160145|26169515|FG001|Randomized Double-blind Period|Physician Decision|7|||
13185862|NCT02160145|26169516|FG002|Randomized Double-blind Period|Physician Decision|5|||
13185863|NCT02160041|26169528|FG000|Overall Study|Adverse Event|11|||
13185864|NCT02160041|26169528|FG000|Overall Study|Death|2|||
13185865|NCT02160041|26169528|FG000|Overall Study|disease progression|57|||
13185866|NCT02160041|26169528|FG000|Overall Study|Protocol Violation|1|||
13185867|NCT02160041|26169528|FG000|Overall Study|non-compliance with study|1|||
13185868|NCT02160041|26169528|FG000|Overall Study|Physician Decision|3|||
13185869|NCT02160041|26169528|FG000|Overall Study|Withdrawal by Subject|8|||
13185870|NCT02160041|26169528|FG000|Overall Study|study terminated by by sponsor|1|||
13185871|NCT02160002|26169565|FG000|Overall Study|Withdrawal by Subject|2|||
13185872|NCT02160002|26169566|FG001|Overall Study|Withdrawal by Subject|1|||
13185873|NCT02159950|26169605|FG000|Overall Study|Adverse Event|0|||
13185874|NCT02159950|26169606|FG001|Overall Study|Adverse Event|1|||
13110444|NCT03211858|25899300|FG000|Overall Study|Poor compliance to protocol|6|||
13110445|NCT03211858|25899301|FG001|Overall Study|Poor compliance to protocol|2|||
13110446|NCT03211858|25899300|FG000|Overall Study|Non-serious Hypoglycemia|1|||
13110447|NCT03211858|25899301|FG001|Overall Study|Non-serious Hypoglycemia|0|||
13110448|NCT03211858|25899300|FG000|Overall Study|Other than specified above|22|||
13110449|NCT03211858|25899301|FG001|Overall Study|Other than specified above|21|||
13110450|NCT03211156|25899316|FG000|Overall Study|Withdrawal by Subject|0|||
13110451|NCT03211156|25899317|FG001|Overall Study|Withdrawal by Subject|2|||
13110452|NCT03211156|25899316|FG000|Overall Study|Lost to Follow-up|1|||
13110453|NCT03211156|25899317|FG001|Overall Study|Lost to Follow-up|1|||
13110454|NCT03211156|25899316|FG000|Overall Study|Adverse Event|1|||
13110455|NCT03211156|25899317|FG001|Overall Study|Adverse Event|0|||
13110456|NCT03210961|25899712|FG000|Overall Study|Adverse Event|0|||
13110457|NCT03210961|25899713|FG001|Overall Study|Adverse Event|0|||
13185875|NCT02159950|26169605|FG000|Overall Study|Progression|0|||
13185876|NCT02159950|26169606|FG001|Overall Study|Progression|1|||
13110458|NCT03210961|25899714|FG002|Overall Study|Adverse Event|0|||
13110459|NCT03210961|25899715|FG003|Overall Study|Adverse Event|0|||
13110460|NCT03210961|25899716|FG004|Overall Study|Adverse Event|0|||
13110461|NCT03210961|25899717|FG005|Overall Study|Adverse Event|0|||
13110462|NCT03210961|25899718|FG006|Overall Study|Adverse Event|0|||
13110463|NCT03210961|25899719|FG007|Overall Study|Adverse Event|0|||
13185877|NCT02159807|26169630|FG000|Overall Study|Adverse Event|0|||
13185878|NCT02159807|26169631|FG001|Overall Study|Adverse Event|0|||
13185879|NCT02159807|26169632|FG002|Overall Study|Adverse Event|1|||
13185880|NCT02159807|26169630|FG000|Overall Study|No CSF|1|||
13110464|NCT03210961|25899720|FG008|Overall Study|Adverse Event|0|||
13110465|NCT03210961|25899721|FG009|Overall Study|Adverse Event|0|||
13110466|NCT03210961|25899722|FG010|Overall Study|Adverse Event|0|||
13110467|NCT03210961|25899723|FG011|Overall Study|Adverse Event|0|||
13110468|NCT03210961|25899724|FG012|Overall Study|Adverse Event|0|||
13110469|NCT03210961|25899725|FG013|Overall Study|Adverse Event|1|||
13110470|NCT03210961|25899726|FG014|Overall Study|Adverse Event|0|||
13110471|NCT03210961|25899712|FG000|Overall Study|Lost to Follow-up|0|||
13110472|NCT03210961|25899713|FG001|Overall Study|Lost to Follow-up|0|||
13185881|NCT02159807|26169631|FG001|Overall Study|No CSF|1|||
13185882|NCT02159807|26169632|FG002|Overall Study|No CSF|1|||
13185883|NCT02159807|26169630|FG000|Overall Study|elevated blood pressure|0|||
13185884|NCT02159807|26169631|FG001|Overall Study|elevated blood pressure|0|||
13185885|NCT02159807|26169632|FG002|Overall Study|elevated blood pressure|1|||
13185886|NCT02159729|26169651|FG000|Overall Study|Adverse Event|0|||
13110473|NCT03210961|25899714|FG002|Overall Study|Lost to Follow-up|0|||
13110474|NCT03210961|25899715|FG003|Overall Study|Lost to Follow-up|0|||
13110475|NCT03210961|25899716|FG004|Overall Study|Lost to Follow-up|0|||
13110476|NCT03210961|25899717|FG005|Overall Study|Lost to Follow-up|0|||
13110477|NCT03210961|25899718|FG006|Overall Study|Lost to Follow-up|0|||
13110478|NCT03210961|25899719|FG007|Overall Study|Lost to Follow-up|0|||
13185887|NCT02159729|26169652|FG001|Overall Study|Adverse Event|1|||
13185888|NCT02159729|26169651|FG000|Overall Study|Subject's Request|13|||
13185889|NCT02159729|26169652|FG001|Overall Study|Subject's Request|10|||
13185890|NCT02159729|26169651|FG000|Overall Study|Lost to Follow-up|24|||
13185891|NCT02159729|26169652|FG001|Overall Study|Lost to Follow-up|9|||
13185892|NCT02159729|26169651|FG000|Overall Study|Non compliance|2|||
13185893|NCT02159729|26169652|FG001|Overall Study|Non compliance|0|||
13185894|NCT02159729|26169651|FG000|Overall Study|Other Unspecified|3|||
13185895|NCT02159729|26169652|FG001|Overall Study|Other Unspecified|1|||
13185896|NCT02159521|26169675|FG000|Overall Study|Enrolled but not treated|3|||
13185897|NCT02159521|26169675|FG000|Overall Study|Withdrawal by Subject|7|||
13185898|NCT02159521|26169675|FG000|Overall Study|Lost to Follow-up|6|||
13185899|NCT02159521|26169675|FG000|Overall Study|Death|1|||
13185900|NCT02159521|26169675|FG000|Overall Study|Other than specified|1|||
13185901|NCT02159482|26169682|FG000|Overall Study|Withdrawal by Subject|2|||
13185902|NCT02159482|26169682|FG000|Overall Study|Physician Decision|3|||
13185903|NCT02159469|26169689|FG000|Overall Study|Missing Completion status|1|||
13185904|NCT02159469|26169689|FG000|Overall Study|Adverse Event|5|||
13185905|NCT02159469|26169689|FG000|Overall Study|Non-compliance|2|||
13185906|NCT02159469|26169689|FG000|Overall Study|Withdrawal by Subject|9|||
13110479|NCT03210961|25899720|FG008|Overall Study|Lost to Follow-up|0|||
13110480|NCT03210961|25899721|FG009|Overall Study|Lost to Follow-up|0|||
13110481|NCT03210961|25899722|FG010|Overall Study|Lost to Follow-up|0|||
13185907|NCT02159469|26169689|FG000|Overall Study|Lost to Follow-up|1|||
13185908|NCT02159469|26169689|FG000|Overall Study|Sponsor's request|2|||
13185909|NCT02159469|26169689|FG000|Overall Study|Met Stopping Criteria|3|||
13185910|NCT02159469|26169689|FG000|Overall Study|Other|1|||
13185911|NCT02159469|26169689|FG000|Overall Study|Multiple|29|||
13185912|NCT02159365|26169696|FG000|Overall Study|Disease Progression|23|||
13185913|NCT02159365|26169696|FG000|Overall Study|Other reasons|11|||
13185914|NCT02159365|26169696|FG000|Overall Study|Administrative reason by Sponsor|9|||
13185915|NCT02159365|26169696|FG000|Overall Study|Adverse Event unrelated to study drug|9|||
13185916|NCT02159365|26169696|FG000|Overall Study|Study drug toxicity|7|||
13185917|NCT02159365|26169696|FG000|Overall Study|Maximum clinical benefit|3|||
13185918|NCT02159365|26169696|FG000|Overall Study|Subject request to discontinue treatment|3|||
13185919|NCT02159365|26169696|FG000|Overall Study|Subject withdrew consent|3|||
13185920|NCT02159365|26169696|FG000|Overall Study|Death|1|||
13185921|NCT02159365|26169696|FG000|Overall Study|Lost to Follow-up|1|||
13185922|NCT02159352|26169753|FG000|Overall Study|Adverse Event|3|||
13185923|NCT02159352|26169754|FG001|Overall Study|Adverse Event|1|||
13185924|NCT02159352|26169753|FG000|Overall Study|Withdrawal by Subject|0|||
13185925|NCT02159352|26169754|FG001|Overall Study|Withdrawal by Subject|1|||
13185926|NCT02159183|26169785|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2|||
13185927|NCT02159183|26169786|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1|||
13185928|NCT02159183|26169785|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1|||
13185929|NCT02159183|26169786|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0|||
13185930|NCT02159183|26169785|FG000|Analysis After the 36 Months Follow-up|Death|0|||
13185931|NCT02159183|26169786|FG001|Analysis After the 36 Months Follow-up|Death|1|||
13185932|NCT02159183|26169785|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1|||
13185933|NCT02159183|26169786|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0|||
13185934|NCT02159183|26169785|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2|||
13110482|NCT03210961|25899723|FG011|Overall Study|Lost to Follow-up|0|||
13110483|NCT03210961|25899724|FG012|Overall Study|Lost to Follow-up|0|||
13110484|NCT03210961|25899725|FG013|Overall Study|Lost to Follow-up|0|||
13110485|NCT03210961|25899726|FG014|Overall Study|Lost to Follow-up|1|||
13185935|NCT02159183|26169786|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1|||
13110486|NCT03210961|25899712|FG000|Overall Study|Withdrawal by Subject|0|||
13110487|NCT03210961|25899713|FG001|Overall Study|Withdrawal by Subject|0|||
13110488|NCT03210961|25899714|FG002|Overall Study|Withdrawal by Subject|0|||
13110489|NCT03210961|25899715|FG003|Overall Study|Withdrawal by Subject|0|||
13110490|NCT03210961|25899716|FG004|Overall Study|Withdrawal by Subject|0|||
13110491|NCT03210961|25899717|FG005|Overall Study|Withdrawal by Subject|0|||
13110492|NCT03210961|25899718|FG006|Overall Study|Withdrawal by Subject|0|||
13185936|NCT02159053|26169833|FG000|Overall Study|Death|2|||
13185937|NCT02159053|26169834|FG001|Overall Study|Death|0|||
13185938|NCT02159053|26169835|FG002|Overall Study|Death|1|||
13185939|NCT02159053|26169833|FG000|Overall Study|Physician Decision|0|||
13185940|NCT02159053|26169834|FG001|Overall Study|Physician Decision|1|||
13185941|NCT02159053|26169835|FG002|Overall Study|Physician Decision|1|||
13185942|NCT02159053|26169833|FG000|Overall Study|Lack of Efficacy|3|||
13185943|NCT02159053|26169834|FG001|Overall Study|Lack of Efficacy|4|||
13185944|NCT02159053|26169835|FG002|Overall Study|Lack of Efficacy|7|||
13185945|NCT02159053|26169833|FG000|Overall Study|Adverse Event|7|||
13185946|NCT02159053|26169834|FG001|Overall Study|Adverse Event|6|||
13185947|NCT02159053|26169835|FG002|Overall Study|Adverse Event|5|||
13185948|NCT02159053|26169833|FG000|Overall Study|Participants/guardian decision|8|||
13185949|NCT02159053|26169834|FG001|Overall Study|Participants/guardian decision|10|||
13185950|NCT02159053|26169835|FG002|Overall Study|Participants/guardian decision|6|||
13185951|NCT02159040|26169850|FG000|Overall Study|Death|1|||
13185952|NCT02158975|26169860|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1|||
13185953|NCT02158949|26169881|FG000|Overall Study|Withdrawal by Subject|1|||
13185954|NCT02158949|26169882|FG001|Overall Study|Withdrawal by Subject|0|||
13185955|NCT02158949|26169881|FG000|Overall Study|Lost to Follow-up|5|||
13185956|NCT02158949|26169882|FG001|Overall Study|Lost to Follow-up|11|||
13185957|NCT02158936|26169931|FG000|Overall Study|Study closed/ terminated|57|||
13185958|NCT02158936|26169932|FG001|Overall Study|Study closed/ terminated|77|||
13185959|NCT02158936|26169931|FG000|Overall Study|Azacitidine tx discontinued|53|||
13185960|NCT02158936|26169932|FG001|Overall Study|Azacitidine tx discontinued|46|||
13185961|NCT02158936|26169931|FG000|Overall Study|Adverse Event|39|||
13185962|NCT02158936|26169932|FG001|Overall Study|Adverse Event|24|||
13185963|NCT02158936|26169931|FG000|Overall Study|Withdrawal by Subject|15|||
13185964|NCT02158936|26169932|FG001|Overall Study|Withdrawal by Subject|16|||
13185965|NCT02158936|26169931|FG000|Overall Study|Physician Decision|15|||
13185966|NCT02158936|26169932|FG001|Overall Study|Physician Decision|13|||
13185967|NCT02158936|26169931|FG000|Overall Study|Lost to Follow-up|0|||
13185968|NCT02158936|26169932|FG001|Overall Study|Lost to Follow-up|1|||
13185969|NCT02158884|26169967|FG000|Baseline Assessment|Missed performance assessment|3|||
13185970|NCT02158884|26169967|FG000|Baseline Assessment|Missed SMFA|1|||
13185971|NCT02158884|26169967|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6|||
13185972|NCT02158884|26169967|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10|||
13185973|NCT02158884|26169967|FG000|6 Month Assessment|Missed SMFA|20|||
13185974|NCT02158884|26169967|FG000|12 Month Assessment|Missed SMFA|17|||
13185975|NCT02158806|26169994|FG000|Overall Study|Death|2|||
13185976|NCT02158806|26169995|FG001|Overall Study|Death|0|||
13185977|NCT02158806|26169994|FG000|Overall Study|Withdrawal by Subject|2|||
13185978|NCT02158806|26169995|FG001|Overall Study|Withdrawal by Subject|0|||
13185979|NCT02158806|26169994|FG000|Overall Study|Lost to Follow-up|0|||
13185980|NCT02158806|26169995|FG001|Overall Study|Lost to Follow-up|3|||
13185981|NCT02158806|26169994|FG000|Overall Study|Moved out of area|0|||
13185982|NCT02158806|26169995|FG001|Overall Study|Moved out of area|1|||
13185983|NCT02158806|26169994|FG000|Overall Study|Transferred to palliative care|0|||
13185984|NCT02158806|26169995|FG001|Overall Study|Transferred to palliative care|1|||
13185985|NCT02158728|26170001|FG000|Overall Study|no procedure according to CIP done|3|||
13185986|NCT02158728|26170001|FG000|Overall Study|no qualified dataset|24|||
13185987|NCT02158663|26170016|FG000|Overall Study|Withdrawal by Subject|5|||
13185988|NCT02158663|26170017|FG001|Overall Study|Withdrawal by Subject|4|||
13185989|NCT02158546|26170046|FG000|Overall Study|Physician Decision|0|||
13185990|NCT02158546|26170047|FG001|Overall Study|Physician Decision|1|||
13185991|NCT02158546|26170048|FG002|Overall Study|Physician Decision|0|||
13185992|NCT02158546|26170049|FG003|Overall Study|Physician Decision|0|||
13185993|NCT02158546|26170046|FG000|Overall Study|Non-compliance|0|||
13185994|NCT02158546|26170047|FG001|Overall Study|Non-compliance|1|||
13185995|NCT02158546|26170048|FG002|Overall Study|Non-compliance|0|||
13185996|NCT02158546|26170049|FG003|Overall Study|Non-compliance|1|||
13185997|NCT02158546|26170046|FG000|Overall Study|Failure to meet eligibility criteria|0|||
13185998|NCT02158546|26170047|FG001|Overall Study|Failure to meet eligibility criteria|1|||
13185999|NCT02158546|26170048|FG002|Overall Study|Failure to meet eligibility criteria|0|||
13186000|NCT02158546|26170049|FG003|Overall Study|Failure to meet eligibility criteria|0|||
13186001|NCT02158546|26170046|FG000|Overall Study|Lack of Efficacy|1|||
13186002|NCT02158546|26170047|FG001|Overall Study|Lack of Efficacy|1|||
13186003|NCT02158546|26170048|FG002|Overall Study|Lack of Efficacy|0|||
13186004|NCT02158546|26170049|FG003|Overall Study|Lack of Efficacy|0|||
13110493|NCT03210961|25899719|FG007|Overall Study|Withdrawal by Subject|0|||
13186005|NCT02158546|26170046|FG000|Overall Study|Adverse Event|2|||
13186006|NCT02158546|26170047|FG001|Overall Study|Adverse Event|2|||
13186007|NCT02158546|26170048|FG002|Overall Study|Adverse Event|0|||
13186008|NCT02158546|26170049|FG003|Overall Study|Adverse Event|0|||
13186009|NCT02158546|26170046|FG000|Overall Study|Withdrawal by Subject|6|||
13186010|NCT02158546|26170047|FG001|Overall Study|Withdrawal by Subject|2|||
13186011|NCT02158546|26170048|FG002|Overall Study|Withdrawal by Subject|1|||
13186012|NCT02158546|26170049|FG003|Overall Study|Withdrawal by Subject|0|||
13186013|NCT02158546|26170046|FG000|Overall Study|Lost to Follow-up|5|||
13186014|NCT02158546|26170047|FG001|Overall Study|Lost to Follow-up|4|||
13186015|NCT02158546|26170048|FG002|Overall Study|Lost to Follow-up|0|||
13485557|NCT02906020|27032879|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
13485558|NCT02906020|27032880|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
13485559|NCT02906020|27032881|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
13186016|NCT02158546|26170049|FG003|Overall Study|Lost to Follow-up|1|||
13186017|NCT02158546|26170046|FG000|Overall Study|Site Excluded|5|||
13186018|NCT02158546|26170047|FG001|Overall Study|Site Excluded|5|||
13186019|NCT02158546|26170048|FG002|Overall Study|Site Excluded|3|||
13186020|NCT02158546|26170049|FG003|Overall Study|Site Excluded|4|||
13186021|NCT02158533|26170094|FG000|Stage 1|Adverse Event|6|||
13186022|NCT02158533|26170095|FG001|Stage 1|Adverse Event|4|||
13186023|NCT02158533|26170096|FG002|Stage 1|Adverse Event|7|||
13186024|NCT02158533|26170097|FG003|Stage 1|Adverse Event|0|||
13186025|NCT02158533|26170098|FG004|Stage 1|Adverse Event|0|||
13186026|NCT02158533|26170099|FG005|Stage 1|Adverse Event|0|||
13186027|NCT02158533|26170094|FG000|Stage 1|Withdrawal by Subject|3|||
13186028|NCT02158533|26170095|FG001|Stage 1|Withdrawal by Subject|2|||
13186029|NCT02158533|26170096|FG002|Stage 1|Withdrawal by Subject|1|||
13186030|NCT02158533|26170097|FG003|Stage 1|Withdrawal by Subject|0|||
13186031|NCT02158533|26170098|FG004|Stage 1|Withdrawal by Subject|0|||
13186032|NCT02158533|26170099|FG005|Stage 1|Withdrawal by Subject|0|||
13186033|NCT02158533|26170094|FG000|Stage 1|Lack of Efficacy|1|||
13186034|NCT02158533|26170095|FG001|Stage 1|Lack of Efficacy|0|||
13186035|NCT02158533|26170096|FG002|Stage 1|Lack of Efficacy|0|||
13186036|NCT02158533|26170097|FG003|Stage 1|Lack of Efficacy|0|||
13186037|NCT02158533|26170098|FG004|Stage 1|Lack of Efficacy|0|||
13186038|NCT02158533|26170099|FG005|Stage 1|Lack of Efficacy|0|||
13186039|NCT02158533|26170094|FG000|Stage 1|Lost to Follow-up|3|||
13186040|NCT02158533|26170095|FG001|Stage 1|Lost to Follow-up|1|||
13186041|NCT02158533|26170096|FG002|Stage 1|Lost to Follow-up|0|||
13186042|NCT02158533|26170097|FG003|Stage 1|Lost to Follow-up|0|||
13186043|NCT02158533|26170098|FG004|Stage 1|Lost to Follow-up|0|||
13186044|NCT02158533|26170099|FG005|Stage 1|Lost to Follow-up|0|||
13186045|NCT02158533|26170094|FG000|Stage 1|Failure to Meet Eligibility Criteria|0|||
13186046|NCT02158533|26170095|FG001|Stage 1|Failure to Meet Eligibility Criteria|1|||
13186047|NCT02158533|26170096|FG002|Stage 1|Failure to Meet Eligibility Criteria|0|||
13186048|NCT02158533|26170097|FG003|Stage 1|Failure to Meet Eligibility Criteria|0|||
13186049|NCT02158533|26170098|FG004|Stage 1|Failure to Meet Eligibility Criteria|0|||
13186050|NCT02158533|26170099|FG005|Stage 1|Failure to Meet Eligibility Criteria|0|||
13186051|NCT02158533|26170094|FG000|Stage 1|Non-compliance with study visits|1|||
13186052|NCT02158533|26170095|FG001|Stage 1|Non-compliance with study visits|0|||
13186053|NCT02158533|26170096|FG002|Stage 1|Non-compliance with study visits|0|||
13186054|NCT02158533|26170097|FG003|Stage 1|Non-compliance with study visits|0|||
13186055|NCT02158533|26170098|FG004|Stage 1|Non-compliance with study visits|0|||
13186056|NCT02158533|26170099|FG005|Stage 1|Non-compliance with study visits|0|||
13186057|NCT02158533|26170094|FG000|Stage 2|Adverse Event|0|||
13186058|NCT02158533|26170095|FG001|Stage 2|Adverse Event|0|||
13186059|NCT02158533|26170096|FG002|Stage 2|Adverse Event|0|||
13186060|NCT02158533|26170097|FG003|Stage 2|Adverse Event|0|||
13186061|NCT02158533|26170098|FG004|Stage 2|Adverse Event|0|||
13186062|NCT02158533|26170099|FG005|Stage 2|Adverse Event|1|||
13186063|NCT02158533|26170094|FG000|Stage 2|Lack of Efficacy|0|||
13186064|NCT02158533|26170095|FG001|Stage 2|Lack of Efficacy|0|||
13186065|NCT02158533|26170096|FG002|Stage 2|Lack of Efficacy|0|||
13186066|NCT02158533|26170097|FG003|Stage 2|Lack of Efficacy|0|||
13186067|NCT02158533|26170098|FG004|Stage 2|Lack of Efficacy|1|||
13186068|NCT02158533|26170099|FG005|Stage 2|Lack of Efficacy|0|||
13186069|NCT02158533|26170094|FG000|Stage 2|Lost to Follow-up|0|||
13186070|NCT02158533|26170095|FG001|Stage 2|Lost to Follow-up|0|||
13186071|NCT02158533|26170096|FG002|Stage 2|Lost to Follow-up|0|||
13186072|NCT02158533|26170097|FG003|Stage 2|Lost to Follow-up|1|||
13186073|NCT02158533|26170098|FG004|Stage 2|Lost to Follow-up|1|||
13186074|NCT02158533|26170099|FG005|Stage 2|Lost to Follow-up|2|||
13186075|NCT02158533|26170094|FG000|Stage 2|Withdrawal by Subject|0|||
13186076|NCT02158533|26170095|FG001|Stage 2|Withdrawal by Subject|0|||
13186077|NCT02158533|26170096|FG002|Stage 2|Withdrawal by Subject|0|||
13186078|NCT02158533|26170097|FG003|Stage 2|Withdrawal by Subject|0|||
13186079|NCT02158533|26170098|FG004|Stage 2|Withdrawal by Subject|1|||
13186080|NCT02158533|26170099|FG005|Stage 2|Withdrawal by Subject|2|||
13186081|NCT02158533|26170094|FG000|Stage 2|Physician Decision|0|||
13186082|NCT02158533|26170095|FG001|Stage 2|Physician Decision|0|||
13186083|NCT02158533|26170096|FG002|Stage 2|Physician Decision|0|||
13186084|NCT02158533|26170097|FG003|Stage 2|Physician Decision|0|||
13186085|NCT02158533|26170098|FG004|Stage 2|Physician Decision|1|||
13186086|NCT02158533|26170099|FG005|Stage 2|Physician Decision|0|||
13186087|NCT02158533|26170094|FG000|Stage 2|Pregnancy|0|||
13186088|NCT02158533|26170095|FG001|Stage 2|Pregnancy|0|||
13186089|NCT02158533|26170096|FG002|Stage 2|Pregnancy|0|||
13186090|NCT02158533|26170097|FG003|Stage 2|Pregnancy|1|||
13186091|NCT02158533|26170098|FG004|Stage 2|Pregnancy|0|||
13186092|NCT02158533|26170099|FG005|Stage 2|Pregnancy|0|||
13186093|NCT02158533|26170094|FG000|Stage 2|Psychiatrist decision to try new tx|0|||
13186094|NCT02158533|26170095|FG001|Stage 2|Psychiatrist decision to try new tx|0|||
13186095|NCT02158533|26170096|FG002|Stage 2|Psychiatrist decision to try new tx|0|||
13186096|NCT02158533|26170097|FG003|Stage 2|Psychiatrist decision to try new tx|1|||
13186097|NCT02158533|26170098|FG004|Stage 2|Psychiatrist decision to try new tx|0|||
13186098|NCT02158533|26170099|FG005|Stage 2|Psychiatrist decision to try new tx|0|||
13186099|NCT02158533|26170094|FG000|Stage 2|Non-adherence with study visits|0|||
13186100|NCT02158533|26170095|FG001|Stage 2|Non-adherence with study visits|0|||
13186101|NCT02158533|26170096|FG002|Stage 2|Non-adherence with study visits|0|||
13186102|NCT02158533|26170097|FG003|Stage 2|Non-adherence with study visits|0|||
13186103|NCT02158533|26170098|FG004|Stage 2|Non-adherence with study visits|0|||
13186104|NCT02158533|26170099|FG005|Stage 2|Non-adherence with study visits|1|||
13186105|NCT02158442|26170112|FG000|Overall Study|Withdrawal by Subject|1|||
13186106|NCT02158442|26170113|FG001|Overall Study|Withdrawal by Subject|0|||
13186107|NCT02158442|26170112|FG000|Overall Study|Perfusion staff not available|1|||
13186108|NCT02158442|26170113|FG001|Overall Study|Perfusion staff not available|0|||
13186109|NCT02158364|26170120|FG000|Overall Study|Case report forms uncollected|10|||
13186110|NCT02158364|26170120|FG000|Overall Study|Protocol Deviation|50|||
13186111|NCT02158247|26170142|FG000|Overall Study|Invisible vocal cords|5|||
13186112|NCT02158039|26170149|FG000|Overall Study|Withdrawal by Subject|1|||
13186113|NCT02158039|26170149|FG000|Overall Study|Screen Failure|9|||
13186114|NCT02157948|26170166|FG000|Overall Study|Withdrawal by Subject|4|||
13186115|NCT02157948|26170167|FG001|Overall Study|Withdrawal by Subject|5|||
13186116|NCT02157948|26170166|FG000|Overall Study|Lost to Follow-up|3|||
13186117|NCT02157948|26170167|FG001|Overall Study|Lost to Follow-up|2|||
13186118|NCT02157948|26170166|FG000|Overall Study|Protocol Specified Criteria|2|||
13186119|NCT02157948|26170167|FG001|Overall Study|Protocol Specified Criteria|1|||
13186120|NCT02157948|26170166|FG000|Overall Study|Decision by Sponsor|0|||
13186121|NCT02157948|26170167|FG001|Overall Study|Decision by Sponsor|1|||
13186122|NCT02157935|26170190|FG000|Overall Study|Withdrawal by Subject|25|||
13186123|NCT02157935|26170191|FG001|Overall Study|Withdrawal by Subject|39|||
13186124|NCT02157935|26170190|FG000|Overall Study|Screen failure|1|||
13186125|NCT02157935|26170191|FG001|Overall Study|Screen failure|2|||
13186126|NCT02157935|26170190|FG000|Overall Study|Protocol Violation|1|||
13186127|NCT02157935|26170191|FG001|Overall Study|Protocol Violation|0|||
13186128|NCT02157935|26170190|FG000|Overall Study|Progressive disease|0|||
13186129|NCT02157935|26170191|FG001|Overall Study|Progressive disease|2|||
13186130|NCT02157935|26170190|FG000|Overall Study|Other|5|||
13186131|NCT02157935|26170191|FG001|Overall Study|Other|12|||
13186132|NCT02157935|26170190|FG000|Overall Study|Lack of Efficacy|0|||
13186133|NCT02157935|26170191|FG001|Overall Study|Lack of Efficacy|1|||
13186134|NCT02157935|26170190|FG000|Overall Study|Death|4|||
13186135|NCT02157935|26170191|FG001|Overall Study|Death|4|||
13186136|NCT02157935|26170190|FG000|Overall Study|Adverse Event|3|||
13186137|NCT02157935|26170191|FG001|Overall Study|Adverse Event|5|||
13186138|NCT02157779|26170246|FG000|Overall Study|Logistical|9|||
13186139|NCT02157779|26170247|FG001|Overall Study|Logistical|3|||
13186140|NCT02157779|26170246|FG000|Overall Study|Stopped attending, reason unknown|11|||
13186141|NCT02157779|26170247|FG001|Overall Study|Stopped attending, reason unknown|7|||
13186142|NCT02157779|26170246|FG000|Overall Study|No response to outreach after Baseline|1|||
13186143|NCT02157779|26170247|FG001|Overall Study|No response to outreach after Baseline|1|||
13186144|NCT02157779|26170246|FG000|Overall Study|Moved|1|||
13186145|NCT02157779|26170247|FG001|Overall Study|Moved|0|||
13186146|NCT02157779|26170246|FG000|Overall Study|Medical|1|||
13186147|NCT02157779|26170247|FG001|Overall Study|Medical|0|||
13186148|NCT02157779|26170246|FG000|Overall Study|Legal issue|1|||
13186149|NCT02157779|26170247|FG001|Overall Study|Legal issue|0|||
13186150|NCT02157519|26170272|FG000|Overall Study|Death|3|||
13186151|NCT02157519|26170273|FG001|Overall Study|Death|1|||
13186152|NCT02157519|26170272|FG000|Overall Study|Withdrawal by Subject|7|||
13186153|NCT02157519|26170273|FG001|Overall Study|Withdrawal by Subject|0|||
13186154|NCT02157519|26170272|FG000|Overall Study|Lost to Follow-up|1|||
13186155|NCT02157519|26170273|FG001|Overall Study|Lost to Follow-up|0|||
13186156|NCT02157506|26170346|FG000|Overall Study|Adverse Event|0|||
13186157|NCT02157506|26170347|FG001|Overall Study|Adverse Event|1|||
13186158|NCT02157506|26170348|FG002|Overall Study|Adverse Event|0|||
13186159|NCT02157506|26170349|FG003|Overall Study|Adverse Event|0|||
13186160|NCT02157506|26170350|FG004|Overall Study|Adverse Event|0|||
13186161|NCT02157506|26170346|FG000|Overall Study|Lost to Follow-up|0|||
13186162|NCT02157506|26170347|FG001|Overall Study|Lost to Follow-up|0|||
13186163|NCT02157506|26170348|FG002|Overall Study|Lost to Follow-up|1|||
13186164|NCT02157506|26170349|FG003|Overall Study|Lost to Follow-up|0|||
13186165|NCT02157506|26170350|FG004|Overall Study|Lost to Follow-up|0|||
13186166|NCT02157376|26170365|FG000|Overall Study|Death|10|||
13186167|NCT02157376|26170366|FG001|Overall Study|Death|4|||
13186168|NCT02157376|26170365|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
13186169|NCT02157376|26170366|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
13186170|NCT02157376|26170365|FG000|Overall Study|Withdrawal by Subject|3|||
13186171|NCT02157376|26170366|FG001|Overall Study|Withdrawal by Subject|8|||
13186172|NCT02157376|26170365|FG000|Overall Study|Not treated|8|||
13186173|NCT02157376|26170366|FG001|Overall Study|Not treated|3|||
13186174|NCT02157376|26170365|FG000|Overall Study|Investigator's misjudgement|1|||
13186175|NCT02157376|26170366|FG001|Overall Study|Investigator's misjudgement|2|||
13186176|NCT02157298|26170387|FG000|Overall Study|Adverse Event|1|||
13186177|NCT02157298|26170388|FG001|Overall Study|Adverse Event|0|||
13186178|NCT02157298|26170387|FG000|Overall Study|Subject no longer meets study criteria|1|||
13186179|NCT02157298|26170388|FG001|Overall Study|Subject no longer meets study criteria|2|||
13186180|NCT02157298|26170387|FG000|Overall Study|Poor/Non-compliance|1|||
13186181|NCT02157298|26170388|FG001|Overall Study|Poor/Non-compliance|0|||
13186182|NCT02157298|26170387|FG000|Overall Study|Withdrawal by Subject|1|||
13186183|NCT02157298|26170388|FG001|Overall Study|Withdrawal by Subject|0|||
13186184|NCT02157116|26170399|FG000|Overall Study|Withdrawal by Subject|4|||
13186185|NCT02157116|26170399|FG000|Overall Study|Physician Decision|3|||
13186186|NCT02157116|26170399|FG000|Overall Study|Failed Screening|2|||
13186187|NCT02156804|26170409|FG000|Overall Study|Withdrawal by Subject|1|||
13186188|NCT02156492|26170440|FG000|Period 1|No Reason Given|0|||
13186189|NCT02156492|26170441|FG001|Period 1|No Reason Given|1|||
13186190|NCT02156492|26170442|FG002|Period 1|No Reason Given|0|||
13186191|NCT02156492|26170440|FG000|Period 3|Adverse Event|0|||
13186192|NCT02156492|26170441|FG001|Period 3|Adverse Event|1|||
13186193|NCT02156492|26170442|FG002|Period 3|Adverse Event|0|||
13186194|NCT02156466|26170637|FG000|Overall Study|Adverse Event|0|||
13186195|NCT02156466|26170638|FG001|Overall Study|Adverse Event|0|||
13186196|NCT02156466|26170639|FG002|Overall Study|Adverse Event|1|||
13186197|NCT02156466|26170640|FG003|Overall Study|Adverse Event|1|||
13186198|NCT02156466|26170641|FG004|Overall Study|Adverse Event|0|||
13186199|NCT02156466|26170637|FG000|Overall Study|Quantiferon Positivity|0|||
13186200|NCT02156466|26170638|FG001|Overall Study|Quantiferon Positivity|0|||
13186201|NCT02156466|26170639|FG002|Overall Study|Quantiferon Positivity|0|||
13186202|NCT02156466|26170640|FG003|Overall Study|Quantiferon Positivity|1|||
13186203|NCT02156466|26170641|FG004|Overall Study|Quantiferon Positivity|0|||
13186204|NCT02156271|26170680|FG000|Overall Study|Physician Decision|4|||
13186205|NCT02156271|26170681|FG001|Overall Study|Physician Decision|3|||
13186206|NCT02156076|26170748|FG000|Treatment Period|no longer meets study criteria|0|||
13186207|NCT02156076|26170749|FG001|Treatment Period|no longer meets study criteria|0|||
13186208|NCT02156076|26170750|FG002|Treatment Period|no longer meets study criteria|1|||
13186209|NCT02156076|26170751|FG003|Treatment Period|no longer meets study criteria|0|||
13186210|NCT02156076|26170748|FG000|Treatment Period|Poor/non-compliance|0|||
13186211|NCT02156076|26170749|FG001|Treatment Period|Poor/non-compliance|1|||
13186212|NCT02156076|26170750|FG002|Treatment Period|Poor/non-compliance|0|||
13186213|NCT02156076|26170751|FG003|Treatment Period|Poor/non-compliance|0|||
13186214|NCT02156076|26170748|FG000|Treatment Period|Lost to Follow-up|0|||
13186215|NCT02156076|26170749|FG001|Treatment Period|Lost to Follow-up|0|||
13186216|NCT02156076|26170750|FG002|Treatment Period|Lost to Follow-up|0|||
13186217|NCT02156076|26170751|FG003|Treatment Period|Lost to Follow-up|1|||
13186218|NCT02156076|26170748|FG000|Treatment Period|Withdrawal by Subject|0|||
13186219|NCT02156076|26170749|FG001|Treatment Period|Withdrawal by Subject|0|||
13186220|NCT02156076|26170750|FG002|Treatment Period|Withdrawal by Subject|1|||
13186221|NCT02156076|26170751|FG003|Treatment Period|Withdrawal by Subject|0|||
13186222|NCT02156076|26170748|FG000|Treatment Period|Subject request to discontinue treatment|0|||
13186223|NCT02156076|26170749|FG001|Treatment Period|Subject request to discontinue treatment|1|||
13186224|NCT02156076|26170750|FG002|Treatment Period|Subject request to discontinue treatment|0|||
13186225|NCT02156076|26170751|FG003|Treatment Period|Subject request to discontinue treatment|0|||
13186226|NCT02156076|26170748|FG000|Treatment Period|Adverse Event|0|||
13186227|NCT02156076|26170749|FG001|Treatment Period|Adverse Event|0|||
13186228|NCT02156076|26170750|FG002|Treatment Period|Adverse Event|0|||
13186229|NCT02156076|26170751|FG003|Treatment Period|Adverse Event|1|||
13186230|NCT02156076|26170748|FG000|Follow-up Period|Withdrawal by Subject|1|||
13186231|NCT02156076|26170749|FG001|Follow-up Period|Withdrawal by Subject|0|||
13186232|NCT02156076|26170750|FG002|Follow-up Period|Withdrawal by Subject|0|||
13186233|NCT02156076|26170751|FG003|Follow-up Period|Withdrawal by Subject|0|||
13186234|NCT02155985|26170826|FG000|Overall Study|Withdrawal by Subject|0|||
13186235|NCT02155985|26170827|FG001|Overall Study|Withdrawal by Subject|0|||
13186236|NCT02155985|26170828|FG002|Overall Study|Withdrawal by Subject|1|||
13186237|NCT02155985|26170826|FG000|Overall Study|Lost to Follow-up|1|||
13186238|NCT02155985|26170827|FG001|Overall Study|Lost to Follow-up|0|||
13186239|NCT02155985|26170828|FG002|Overall Study|Lost to Follow-up|0|||
13186240|NCT02155881|26170855|FG000|Overall Study|Withdrawal by Subject|0|||
13186241|NCT02155881|26170856|FG001|Overall Study|Withdrawal by Subject|2|||
13186242|NCT02155881|26170855|FG000|Overall Study|Inappropriately randomized|2|||
13186243|NCT02155881|26170856|FG001|Overall Study|Inappropriately randomized|2|||
13186244|NCT02155829|26170881|FG000|Overall Study|Adverse Event|1|||
13186245|NCT02155829|26170882|FG001|Overall Study|Adverse Event|0|||
13186246|NCT02155829|26170881|FG000|Overall Study|Withdrawal by Subject|3|||
13186247|NCT02155829|26170882|FG001|Overall Study|Withdrawal by Subject|3|||
13186248|NCT02155829|26170881|FG000|Overall Study|Protocol Violation|2|||
13186249|NCT02155829|26170882|FG001|Overall Study|Protocol Violation|0|||
13186250|NCT02155738|26170913|FG000|Overall Study|Missing critical information|1|||
13186251|NCT02155738|26170914|FG001|Overall Study|Missing critical information|0|||
13186252|NCT02155738|26170915|FG002|Overall Study|Missing critical information|0|||
13186253|NCT02155738|26170916|FG003|Overall Study|Missing critical information|1|||
13186254|NCT02155712|26170929|FG000|Primary Objective|Death|3|||
13186255|NCT02155712|26170930|FG001|Primary Objective|Death|0|||
13186256|NCT02155712|26170929|FG000|Primary Objective|Lost to Follow-up|22|||
13186257|NCT02155712|26170930|FG001|Primary Objective|Lost to Follow-up|0|||
13186258|NCT02155712|26170929|FG000|Primary Objective|No 2-Year Forms but not Terminated|13|||
13186259|NCT02155712|26170930|FG001|Primary Objective|No 2-Year Forms but not Terminated|0|||
13186260|NCT02155712|26170929|FG000|Primary Objective|Revision/Removal of Tibial Baseplate|1|||
13186261|NCT02155712|26170930|FG001|Primary Objective|Revision/Removal of Tibial Baseplate|0|||
13186262|NCT02155712|26170929|FG000|Primary Objective|Withdrawal by Subject|21|||
13186263|NCT02155712|26170930|FG001|Primary Objective|Withdrawal by Subject|0|||
13186264|NCT02155660|26171024|FG000|Overall Study|Other Reason|8|||
13186265|NCT02155660|26171025|FG001|Overall Study|Other Reason|6|||
13186266|NCT02155660|26171026|FG002|Overall Study|Other Reason|10|||
13186267|NCT02155660|26171027|FG003|Overall Study|Other Reason|10|||
13186268|NCT02155660|26171024|FG000|Overall Study|Study-specific withdrawal criteria|0|||
13186269|NCT02155660|26171025|FG001|Overall Study|Study-specific withdrawal criteria|1|||
13186270|NCT02155660|26171026|FG002|Overall Study|Study-specific withdrawal criteria|1|||
13186271|NCT02155660|26171027|FG003|Overall Study|Study-specific withdrawal criteria|1|||
13223053|NCT01799993|26287796|FG000|Overall Study|Withdrawal by Subject|23|||
13186272|NCT02155660|26171024|FG000|Overall Study|Severe non-compliance|0|||
13186273|NCT02155660|26171025|FG001|Overall Study|Severe non-compliance|4|||
13186274|NCT02155660|26171026|FG002|Overall Study|Severe non-compliance|0|||
13186275|NCT02155660|26171027|FG003|Overall Study|Severe non-compliance|1|||
13186276|NCT02155660|26171024|FG000|Overall Study|Adverse Event|2|||
13186277|NCT02155660|26171025|FG001|Overall Study|Adverse Event|6|||
13186278|NCT02155660|26171026|FG002|Overall Study|Adverse Event|3|||
13186279|NCT02155660|26171027|FG003|Overall Study|Adverse Event|1|||
13186280|NCT02155660|26171024|FG000|Overall Study|Lost to Follow-up|3|||
13186281|NCT02155660|26171025|FG001|Overall Study|Lost to Follow-up|6|||
13186282|NCT02155660|26171026|FG002|Overall Study|Lost to Follow-up|5|||
13186283|NCT02155660|26171027|FG003|Overall Study|Lost to Follow-up|8|||
13186284|NCT02155660|26171024|FG000|Overall Study|Death|17|||
13186285|NCT02155660|26171025|FG001|Overall Study|Death|19|||
13186286|NCT02155660|26171026|FG002|Overall Study|Death|17|||
13186287|NCT02155660|26171027|FG003|Overall Study|Death|19|||
13186288|NCT02155660|26171024|FG000|Overall Study|Withdrawal by Subject|28|||
13186289|NCT02155660|26171025|FG001|Overall Study|Withdrawal by Subject|31|||
13186290|NCT02155660|26171026|FG002|Overall Study|Withdrawal by Subject|24|||
13186291|NCT02155660|26171027|FG003|Overall Study|Withdrawal by Subject|21|||
13186292|NCT02155647|26171060|FG000|Overall Study|Still on Treatment|26|||
13186293|NCT02155647|26171061|FG001|Overall Study|Still on Treatment|26|||
13186294|NCT02155647|26171060|FG000|Overall Study|Off-Treatment, but follow up ongoing|15|||
13186295|NCT02155647|26171061|FG001|Overall Study|Off-Treatment, but follow up ongoing|26|||
13186296|NCT02155608|26171100|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0|||
13186297|NCT02155608|26171101|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1|||
13186298|NCT02155608|26171100|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
13186299|NCT02155608|26171101|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
13186300|NCT02155322|26171108|FG000|Overall Study|Adverse Event|1|||
13186301|NCT02155322|26171108|FG000|Overall Study|Physician Decision|1|||
13186302|NCT02155322|26171108|FG000|Overall Study|Relapse/Recurrence|8|||
13223054|NCT01799993|26287797|FG001|Overall Study|Withdrawal by Subject|24|||
13186303|NCT02155322|26171108|FG000|Overall Study|Withdrawal by Subject|4|||
13186304|NCT02155309|26171123|FG000|Overall Study|Protocol Violation|0|||
13186305|NCT02155309|26171124|FG001|Overall Study|Protocol Violation|0|||
13186306|NCT02155309|26171125|FG002|Overall Study|Protocol Violation|1|||
13186307|NCT02155283|26171132|FG000|Overall Study|Lost to Follow-up|3|||
13186308|NCT02155283|26171132|FG000|Overall Study|Withdrawal by Subject|1|||
13186309|NCT02155283|26171132|FG000|Overall Study|Protocol Violation|3|||
13186310|NCT02154581|26171155|FG000|Overall Study|Lost to Follow-up|7|||
13186311|NCT02154581|26171156|FG001|Overall Study|Lost to Follow-up|8|||
13186312|NCT02154529|26171201|FG000|Overall Study|Death|1|||
13186313|NCT02154529|26171202|FG001|Overall Study|Death|1|||
13186314|NCT02154529|26171203|FG002|Overall Study|Death|5|||
13186315|NCT02154529|26171204|FG003|Overall Study|Death|1|||
13186316|NCT02154529|26171201|FG000|Overall Study|Termination of study by sponsor|2|||
13186317|NCT02154529|26171202|FG001|Overall Study|Termination of study by sponsor|2|||
13186318|NCT02154529|26171203|FG002|Overall Study|Termination of study by sponsor|3|||
13186319|NCT02154529|26171204|FG003|Overall Study|Termination of study by sponsor|1|||
13186320|NCT02154529|26171201|FG000|Overall Study|Lost to Follow-up|1|||
13186321|NCT02154529|26171202|FG001|Overall Study|Lost to Follow-up|0|||
13186322|NCT02154529|26171203|FG002|Overall Study|Lost to Follow-up|0|||
13186323|NCT02154529|26171204|FG003|Overall Study|Lost to Follow-up|0|||
13186324|NCT02154425|26171236|FG000|Screening Period|Adverse Event|1|||
13186325|NCT02154347|26171250|FG000|Double-blind Period|Adverse Event|1|||
13186326|NCT02154347|26171251|FG001|Double-blind Period|Adverse Event|2|||
13186327|NCT02154347|26171250|FG000|Double-blind Period|Lack of Efficacy|1|||
13186328|NCT02154347|26171251|FG001|Double-blind Period|Lack of Efficacy|0|||
13186329|NCT02154347|26171250|FG000|Double-blind Period|Physician Decision|0|||
13186330|NCT02154347|26171251|FG001|Double-blind Period|Physician Decision|1|||
13186331|NCT02154347|26171250|FG000|Double-blind Period|Withdrawal by Subject|1|||
13186332|NCT02154347|26171251|FG001|Double-blind Period|Withdrawal by Subject|1|||
13186333|NCT02154347|26171250|FG000|Open-label Period|Adverse Event|3|||
13186334|NCT02154347|26171251|FG001|Open-label Period|Adverse Event|4|||
13186335|NCT02154347|26171250|FG000|Open-label Period|Lack of Efficacy|4|||
13186336|NCT02154347|26171251|FG001|Open-label Period|Lack of Efficacy|19|||
13186337|NCT02154347|26171250|FG000|Open-label Period|Protocol Violation|0|||
13186338|NCT02154347|26171251|FG001|Open-label Period|Protocol Violation|1|||
13186339|NCT02154347|26171250|FG000|Open-label Period|Withdrawal by Subject|0|||
13186340|NCT02154347|26171251|FG001|Open-label Period|Withdrawal by Subject|1|||
13186341|NCT02154139|26171261|FG000|Overall Study|Injection not administered|2|||
13186342|NCT02154139|26171261|FG000|Overall Study|Other|2|||
13186343|NCT02154139|26171261|FG000|Overall Study|Investigator transferred|3|||
13186344|NCT02154087|26171267|FG000|Overall Study|Study Termination|1|||
13186345|NCT02154061|26171280|FG000|Overall Study|Pregnancy|1|||
13186346|NCT02154061|26171281|FG001|Overall Study|Pregnancy|0|||
13186347|NCT02154061|26171280|FG000|Overall Study|enrolled but not vaccinated|1|||
13186348|NCT02154061|26171281|FG001|Overall Study|enrolled but not vaccinated|0|||
13110494|NCT03210961|25899720|FG008|Overall Study|Withdrawal by Subject|0|||
13110495|NCT03210961|25899721|FG009|Overall Study|Withdrawal by Subject|0|||
13110496|NCT03210961|25899722|FG010|Overall Study|Withdrawal by Subject|0|||
13110497|NCT03210961|25899723|FG011|Overall Study|Withdrawal by Subject|0|||
13110498|NCT03210961|25899724|FG012|Overall Study|Withdrawal by Subject|0|||
13186349|NCT02153918|26171292|FG000|Overall Study|Refused further treatment|1|||
13186350|NCT02153905|26171315|FG000|Overall Study|Death|1|||
13186351|NCT02153905|26171316|FG001|Overall Study|Death|0|||
13186352|NCT02153827|26171337|FG000|Overall Study|Lost to Follow-up|3|||
13186353|NCT02153827|26171338|FG001|Overall Study|Lost to Follow-up|9|||
13186354|NCT02153788|26171363|FG000|Overall Study|Physician Decision|2|||
13186355|NCT02153788|26171364|FG001|Overall Study|Physician Decision|1|||
13206154|NCT01959529|26233705|FG000|Overall Study|Lack of glycaemic control|1|||
13206155|NCT01959529|26233706|FG001|Overall Study|Lack of glycaemic control|1|||
13206156|NCT01959516|26233717|FG000|Epoch 1|Adverse Event|4|||
13206157|NCT01959516|26233718|FG001|Epoch 1|Adverse Event|1|||
13206158|NCT01959516|26233717|FG000|Epoch 1|unsatisfactory therapeutic effect|1|||
13206159|NCT01959516|26233718|FG001|Epoch 1|unsatisfactory therapeutic effect|0|||
13206160|NCT01959516|26233717|FG000|Epoch 1|Subject withdrew consent|3|||
13206161|NCT01959516|26233718|FG001|Epoch 1|Subject withdrew consent|2|||
13206162|NCT01959516|26233717|FG000|Epoch 1|Administrative problems|1|||
13206163|NCT01959516|26233718|FG001|Epoch 1|Administrative problems|0|||
13206164|NCT01959516|26233717|FG000|Epoch 1|Use of prohibited treatment|1|||
13206165|NCT01959516|26233718|FG001|Epoch 1|Use of prohibited treatment|0|||
13206166|NCT01959516|26233717|FG000|Epoch 1|Moderate or severe COPD exacerbation|0|||
13206167|NCT01959516|26233718|FG001|Epoch 1|Moderate or severe COPD exacerbation|1|||
13206168|NCT01959516|26233717|FG000|Epoch 1|Protocol deviation|0|||
13206169|NCT01959516|26233718|FG001|Epoch 1|Protocol deviation|1|||
13206170|NCT01959516|26233717|FG000|Epoch 2|unsatisfactory therapeutic effect|1|||
13110499|NCT03210961|25899725|FG013|Overall Study|Withdrawal by Subject|0|||
13206171|NCT01959516|26233718|FG001|Epoch 2|unsatisfactory therapeutic effect|0|||
13110500|NCT03210961|25899726|FG014|Overall Study|Withdrawal by Subject|1|||
13110501|NCT03210961|25899712|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
13206172|NCT01959516|26233717|FG000|Epoch 2|Subject withdrew consent|1|||
13206173|NCT01959516|26233718|FG001|Epoch 2|Subject withdrew consent|0|||
13206174|NCT01959516|26233717|FG000|Epoch 2|Moderate or severe COPD exacerbation|0|||
13206175|NCT01959516|26233718|FG001|Epoch 2|Moderate or severe COPD exacerbation|1|||
13206176|NCT01959503|26233745|FG000|Overall Study|Death|2|||
13206177|NCT01959503|26233746|FG001|Overall Study|Death|1|||
13206178|NCT01959503|26233745|FG000|Overall Study|Randomized but not treated|1|||
13206179|NCT01959503|26233746|FG001|Overall Study|Randomized but not treated|1|||
13206180|NCT01959425|26233773|FG000|Overall Study|Withdrawal by Subject|5|||
13206181|NCT01959425|26233774|FG001|Overall Study|Withdrawal by Subject|4|||
13186356|NCT02153736|26171387|FG000|Overall Study|Lost to Follow-up|1|||
13186357|NCT02153736|26171388|FG001|Overall Study|Lost to Follow-up|0|||
13186358|NCT02153736|26171387|FG000|Overall Study|Medical status change made ineligible|1|||
13186359|NCT02153736|26171388|FG001|Overall Study|Medical status change made ineligible|0|||
13186360|NCT02153736|26171387|FG000|Overall Study|Death|0|||
13186361|NCT02153736|26171388|FG001|Overall Study|Death|1|||
13186362|NCT02153736|26171387|FG000|Overall Study|Withdrawal by Subject|0|||
13186363|NCT02153736|26171388|FG001|Overall Study|Withdrawal by Subject|1|||
13186364|NCT02153398|26171526|FG000|Overall Study|Withdrawal by Subject|1|||
13186365|NCT02153398|26171527|FG001|Overall Study|Withdrawal by Subject|0|||
13186366|NCT02153398|26171528|FG002|Overall Study|Withdrawal by Subject|0|||
13186367|NCT02153398|26171529|FG003|Overall Study|Withdrawal by Subject|0|||
13186368|NCT02153398|26171530|FG004|Overall Study|Withdrawal by Subject|0|||
13186369|NCT02153398|26171526|FG000|Overall Study|Adverse Event|0|||
13186370|NCT02153398|26171527|FG001|Overall Study|Adverse Event|0|||
13186371|NCT02153398|26171528|FG002|Overall Study|Adverse Event|1|||
13186372|NCT02153398|26171529|FG003|Overall Study|Adverse Event|1|||
13186373|NCT02153398|26171530|FG004|Overall Study|Adverse Event|0|||
13186374|NCT02153359|26171567|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0|||
13186375|NCT02153359|26171568|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2|||
13186376|NCT02153346|26171577|FG000|Overall Study|Lost to Follow-up|11|||
13186377|NCT02153112|26171880|FG000|Overall Study|Adverse Event|0|||
13186378|NCT02153112|26171881|FG001|Overall Study|Adverse Event|0|||
13186379|NCT02153112|26171882|FG002|Overall Study|Adverse Event|1|||
13186380|NCT02153112|26171883|FG003|Overall Study|Adverse Event|0|||
13186381|NCT02153112|26171884|FG004|Overall Study|Adverse Event|0|||
13186382|NCT02153112|26171885|FG005|Overall Study|Adverse Event|0|||
13186383|NCT02153112|26171886|FG006|Overall Study|Adverse Event|0|||
13186384|NCT02153112|26171887|FG007|Overall Study|Adverse Event|0|||
13186385|NCT02153112|26171888|FG008|Overall Study|Adverse Event|0|||
13186386|NCT02153112|26171889|FG009|Overall Study|Adverse Event|0|||
13186387|NCT02153112|26171880|FG000|Overall Study|Lost to Follow-up|1|||
13186388|NCT02153112|26171881|FG001|Overall Study|Lost to Follow-up|1|||
13186389|NCT02153112|26171882|FG002|Overall Study|Lost to Follow-up|0|||
13186390|NCT02153112|26171883|FG003|Overall Study|Lost to Follow-up|0|||
13186391|NCT02153112|26171884|FG004|Overall Study|Lost to Follow-up|2|||
13186392|NCT02153112|26171885|FG005|Overall Study|Lost to Follow-up|1|||
13186393|NCT02153112|26171886|FG006|Overall Study|Lost to Follow-up|1|||
13186394|NCT02153112|26171887|FG007|Overall Study|Lost to Follow-up|0|||
13186395|NCT02153112|26171888|FG008|Overall Study|Lost to Follow-up|1|||
13186396|NCT02153112|26171889|FG009|Overall Study|Lost to Follow-up|1|||
13186397|NCT02153112|26171880|FG000|Overall Study|Withdrawal by Subject|3|||
13186398|NCT02153112|26171881|FG001|Overall Study|Withdrawal by Subject|1|||
13186399|NCT02153112|26171882|FG002|Overall Study|Withdrawal by Subject|2|||
13186400|NCT02153112|26171883|FG003|Overall Study|Withdrawal by Subject|2|||
13186401|NCT02153112|26171884|FG004|Overall Study|Withdrawal by Subject|1|||
13186402|NCT02153112|26171885|FG005|Overall Study|Withdrawal by Subject|1|||
13186403|NCT02153112|26171886|FG006|Overall Study|Withdrawal by Subject|7|||
13186404|NCT02153112|26171887|FG007|Overall Study|Withdrawal by Subject|2|||
13186405|NCT02153112|26171888|FG008|Overall Study|Withdrawal by Subject|13|||
13186406|NCT02153112|26171889|FG009|Overall Study|Withdrawal by Subject|12|||
13186407|NCT02153112|26171880|FG000|Overall Study|Reason not Specified|0|||
13186408|NCT02153112|26171881|FG001|Overall Study|Reason not Specified|0|||
13186409|NCT02153112|26171882|FG002|Overall Study|Reason not Specified|0|||
13186410|NCT02153112|26171883|FG003|Overall Study|Reason not Specified|0|||
13186411|NCT02153112|26171884|FG004|Overall Study|Reason not Specified|0|||
13186412|NCT02153112|26171885|FG005|Overall Study|Reason not Specified|0|||
13186413|NCT02153112|26171886|FG006|Overall Study|Reason not Specified|0|||
13186414|NCT02153112|26171887|FG007|Overall Study|Reason not Specified|0|||
13186415|NCT02153112|26171888|FG008|Overall Study|Reason not Specified|1|||
13186416|NCT02153112|26171889|FG009|Overall Study|Reason not Specified|1|||
13186417|NCT02153086|26171905|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2|||
13186418|NCT02153086|26171905|FG000|Overall Study|Other|2|||
13186419|NCT02153073|26171920|FG000|Overall Study|Case Report Forms Uncollected|230|||
13186420|NCT02153073|26171920|FG000|Overall Study|Protocol Deviation|68|||
13186421|NCT02152761|26171954|FG000|Epoch: Treatment Epoch|Technical problems|0|||
13186422|NCT02152761|26171955|FG001|Epoch: Treatment Epoch|Technical problems|0|||
13186423|NCT02152761|26171956|FG002|Epoch: Treatment Epoch|Technical problems|0|||
13186424|NCT02152761|26171957|FG003|Epoch: Treatment Epoch|Technical problems|1|||
13186425|NCT02152761|26171954|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0|||
13186426|NCT02152761|26171955|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2|||
13186427|NCT02152761|26171956|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0|||
13186428|NCT02152761|26171957|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0|||
13186429|NCT02152761|26171954|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7|||
13186430|NCT02152761|26171955|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8|||
13186431|NCT02152761|26171956|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3|||
13186432|NCT02152761|26171957|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5|||
13186433|NCT02152761|26171954|FG000|Epoch: Treatment Epoch|Adverse Event|3|||
13186434|NCT02152761|26171955|FG001|Epoch: Treatment Epoch|Adverse Event|6|||
13186435|NCT02152761|26171956|FG002|Epoch: Treatment Epoch|Adverse Event|1|||
13186436|NCT02152761|26171957|FG003|Epoch: Treatment Epoch|Adverse Event|2|||
13186437|NCT02152761|26171954|FG000|Epoch: Treatment Epoch|Death|0|||
13186438|NCT02152761|26171955|FG001|Epoch: Treatment Epoch|Death|3|||
13186439|NCT02152761|26171956|FG002|Epoch: Treatment Epoch|Death|1|||
13186440|NCT02152761|26171957|FG003|Epoch: Treatment Epoch|Death|0|||
13186441|NCT02152761|26171954|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
13186442|NCT02152761|26171955|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
13186443|NCT02152761|26171956|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
13186444|NCT02152761|26171957|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
13186445|NCT02152761|26171954|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
13186446|NCT02152761|26171955|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3|||
13186447|NCT02152761|26171956|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0|||
13186448|NCT02152761|26171957|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
13186449|NCT02152761|26171954|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1|||
13186450|NCT02152761|26171955|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4|||
13186451|NCT02152761|26171956|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
13186452|NCT02152761|26171957|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
13186453|NCT02152761|26171954|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1|||
13186454|NCT02152761|26171955|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
13186455|NCT02152761|26171956|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
13186456|NCT02152761|26171957|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
13186457|NCT02152761|26171954|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1|||
13186458|NCT02152761|26171955|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0|||
13186459|NCT02152761|26171956|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0|||
13186460|NCT02152761|26171957|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1|||
13186461|NCT02152631|26171981|FG000|Overall Study|Adverse Event|32|||
13186462|NCT02152631|26171982|FG001|Overall Study|Adverse Event|4|||
13186463|NCT02152631|26171981|FG000|Overall Study|Withdrawal by Subject|13|||
13186464|NCT02152631|26171982|FG001|Overall Study|Withdrawal by Subject|16|||
13186465|NCT02152631|26171981|FG000|Overall Study|Noncompliance with study drug|1|||
13186466|NCT02152631|26171982|FG001|Overall Study|Noncompliance with study drug|0|||
13186467|NCT02152631|26171981|FG000|Overall Study|Physician Decision|1|||
13186468|NCT02152631|26171982|FG001|Overall Study|Physician Decision|2|||
13186469|NCT02152631|26171981|FG000|Overall Study|Lost to Follow-up|0|||
13186470|NCT02152631|26171982|FG001|Overall Study|Lost to Follow-up|1|||
13186471|NCT02152631|26171981|FG000|Overall Study|On Treatment|19|||
13186472|NCT02152631|26171982|FG001|Overall Study|On Treatment|3|||
13186473|NCT02152605|26171999|FG000|Overall Study|Adverse Event|6|||
13186474|NCT02152605|26172000|FG001|Overall Study|Adverse Event|8|||
13186475|NCT02152605|26171999|FG000|Overall Study|Lack of Efficacy|7|||
13186476|NCT02152605|26172000|FG001|Overall Study|Lack of Efficacy|4|||
13186477|NCT02152605|26171999|FG000|Overall Study|Protocol deviation|1|||
13186478|NCT02152605|26172000|FG001|Overall Study|Protocol deviation|4|||
13186479|NCT02152605|26171999|FG000|Overall Study|Lost to Follow-up|1|||
13186480|NCT02152605|26172000|FG001|Overall Study|Lost to Follow-up|0|||
13186481|NCT02152605|26171999|FG000|Overall Study|Withdrew consent|4|||
13186482|NCT02152605|26172000|FG001|Overall Study|Withdrew consent|2|||
13186483|NCT02152566|26172006|FG000|Overall Study|Lost to Follow-up|1|||
13186484|NCT02152566|26172006|FG000|Overall Study|Withdrawal by Subject|2|||
13186485|NCT02152384|26172027|FG000|Period 1|Withdrawal by Subject|0|||
13186486|NCT02152384|26172028|FG001|Period 1|Withdrawal by Subject|1|||
13186487|NCT02152384|26172027|FG000|Period 1|Adverse Event|1|||
13186488|NCT02152384|26172028|FG001|Period 1|Adverse Event|1|||
13186489|NCT02152371|26172071|FG000|Overall Study|Adverse Event|6|||
13186490|NCT02152371|26172072|FG001|Overall Study|Adverse Event|2|||
13186491|NCT02152371|26172071|FG000|Overall Study|Withdrawal by Subject|3|||
13186492|NCT02152371|26172072|FG001|Overall Study|Withdrawal by Subject|7|||
13186493|NCT02152371|26172071|FG000|Overall Study|Protocol Violation|2|||
13186494|NCT02152371|26172072|FG001|Overall Study|Protocol Violation|3|||
13186495|NCT02152371|26172071|FG000|Overall Study|Lost to Follow-up|1|||
13186496|NCT02152371|26172072|FG001|Overall Study|Lost to Follow-up|0|||
13186497|NCT02152371|26172071|FG000|Overall Study|Lack of Efficacy|0|||
13186498|NCT02152371|26172072|FG001|Overall Study|Lack of Efficacy|1|||
13186499|NCT02152371|26172071|FG000|Overall Study|Physician Decision|0|||
13186500|NCT02152371|26172072|FG001|Overall Study|Physician Decision|2|||
13186501|NCT02152371|26172071|FG000|Overall Study|Reason Not Given|0|||
13186502|NCT02152371|26172072|FG001|Overall Study|Reason Not Given|1|||
13186503|NCT02152345|26172091|FG000|Overall Study|Case Cancellations|2|||
13186504|NCT02152345|26172092|FG001|Overall Study|Case Cancellations|4|||
13186505|NCT02152345|26172091|FG000|Overall Study|Withdrawal by Subject|2|||
13186506|NCT02152345|26172092|FG001|Overall Study|Withdrawal by Subject|1|||
13186507|NCT02152163|26172105|FG000|Overall Study|Physician Decision|12|||
13186508|NCT02152163|26172106|FG001|Overall Study|Physician Decision|13|||
13186509|NCT02152137|26172116|FG000|Overall Study|Withdrawal by Subject|1|||
13186510|NCT02152137|26172116|FG000|Overall Study|Originally assigned to Arm B|3|||
13186511|NCT02152007|26172124|FG000|Overall Study|Withdrawal by Subject|1|||
13186512|NCT02151903|26172147|FG000|Overall Study|Withdrawal by Subject|1|||
13186513|NCT02151903|26172148|FG001|Overall Study|Withdrawal by Subject|0|||
13186514|NCT02151903|26172147|FG000|Overall Study|Progressive disease|2|||
13186515|NCT02151903|26172148|FG001|Overall Study|Progressive disease|1|||
13186516|NCT02151851|26172167|FG000|Overall Study|Lack of Efficacy|67|||
13186517|NCT02151851|26172168|FG001|Overall Study|Lack of Efficacy|94|||
13186518|NCT02151851|26172167|FG000|Overall Study|Protocol Violation|0|||
13186519|NCT02151851|26172168|FG001|Overall Study|Protocol Violation|1|||
13186520|NCT02151851|26172167|FG000|Overall Study|Withdrawal by Subject|2|||
13186521|NCT02151851|26172168|FG001|Overall Study|Withdrawal by Subject|5|||
13186522|NCT02151851|26172167|FG000|Overall Study|Medical impairment|1|||
13186523|NCT02151851|26172168|FG001|Overall Study|Medical impairment|0|||
13186524|NCT02151851|26172167|FG000|Overall Study|Low compliance to study visits|0|||
13186525|NCT02151851|26172168|FG001|Overall Study|Low compliance to study visits|1|||
13186526|NCT02151851|26172167|FG000|Overall Study|Subject entered into study in error|0|||
13186527|NCT02151851|26172168|FG001|Overall Study|Subject entered into study in error|1|||
13186528|NCT02151851|26172167|FG000|Overall Study|Adverse Event|6|||
13186529|NCT02151851|26172168|FG001|Overall Study|Adverse Event|28|||
13186530|NCT02151786|26172181|FG000|Overall Study|Unavailability of Case Report Form|26|||
13186531|NCT02151786|26172181|FG000|Overall Study|Outside the Contract Period|1|||
13186532|NCT02151786|26172181|FG000|Overall Study|Randomized, not Treated|1|||
13186533|NCT02151786|26172181|FG000|Overall Study|Unavailability of Information|8|||
13186534|NCT02151773|26172188|FG000|Overall Study|Protocol Deviation|64|||
13186535|NCT02151682|26172244|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
13186536|NCT02151682|26172245|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2|||
13186537|NCT02151682|26172246|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
13186538|NCT02151682|26172247|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
13186539|NCT02151682|26172248|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
13186540|NCT02151682|26172249|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
13186541|NCT02151682|26172244|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
13186542|NCT02151682|26172245|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1|||
13186543|NCT02151682|26172246|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
13186544|NCT02151682|26172247|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
13186545|NCT02151682|26172248|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
13186546|NCT02151682|26172249|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
13186547|NCT02151682|26172244|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
13186548|NCT02151682|26172245|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1|||
13186549|NCT02151682|26172246|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
13186550|NCT02151682|26172247|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
13186551|NCT02151682|26172248|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
13186552|NCT02151682|26172249|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
13186553|NCT02151682|26172244|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
13186554|NCT02151682|26172245|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
13186555|NCT02151682|26172246|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
13186556|NCT02151682|26172247|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
13186557|NCT02151682|26172248|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
13186558|NCT02151682|26172249|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
13186559|NCT02151682|26172244|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1|||
13186560|NCT02151682|26172245|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
13186561|NCT02151682|26172246|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
13186562|NCT02151682|26172247|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
13186563|NCT02151682|26172248|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
13186564|NCT02151682|26172249|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
13186565|NCT02151682|26172244|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
13186566|NCT02151682|26172245|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
13186567|NCT02151682|26172246|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3|||
13186568|NCT02151682|26172247|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
13186569|NCT02151682|26172248|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
13186570|NCT02151682|26172249|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
13186571|NCT02151682|26172244|FG000|Part 2: Tapent. Extension or Observation|Death|0|||
13186572|NCT02151682|26172245|FG001|Part 2: Tapent. Extension or Observation|Death|0|||
13186573|NCT02151682|26172246|FG002|Part 2: Tapent. Extension or Observation|Death|0|||
13186574|NCT02151682|26172247|FG003|Part 2: Tapent. Extension or Observation|Death|2|||
13186575|NCT02151682|26172248|FG004|Part 2: Tapent. Extension or Observation|Death|0|||
13186576|NCT02151682|26172249|FG005|Part 2: Tapent. Extension or Observation|Death|0|||
13186577|NCT02151682|26172244|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
13186578|NCT02151682|26172245|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
13186579|NCT02151682|26172246|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
13186580|NCT02151682|26172247|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
13186581|NCT02151682|26172248|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
13186582|NCT02151682|26172249|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
13186583|NCT02151682|26172244|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
13186584|NCT02151682|26172245|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
13186585|NCT02151682|26172246|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3|||
13186586|NCT02151682|26172247|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
13186587|NCT02151682|26172248|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
13186588|NCT02151682|26172249|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
13186589|NCT02151682|26172244|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
13186590|NCT02151682|26172245|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
13186591|NCT02151682|26172246|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1|||
13186592|NCT02151682|26172247|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
13186593|NCT02151682|26172248|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
13186594|NCT02151682|26172249|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
13186595|NCT02151682|26172244|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
13186596|NCT02151682|26172245|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
13186597|NCT02151682|26172246|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13|||
13186598|NCT02151682|26172247|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
13186599|NCT02151682|26172248|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
13186600|NCT02151682|26172249|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
13186601|NCT02151682|26172244|FG000|Part 2: Tapent. Extension or Observation|Missing|0|||
13186602|NCT02151682|26172245|FG001|Part 2: Tapent. Extension or Observation|Missing|0|||
13186603|NCT02151682|26172246|FG002|Part 2: Tapent. Extension or Observation|Missing|0|||
13186604|NCT02151682|26172247|FG003|Part 2: Tapent. Extension or Observation|Missing|1|||
13186605|NCT02151682|26172248|FG004|Part 2: Tapent. Extension or Observation|Missing|0|||
13186606|NCT02151682|26172249|FG005|Part 2: Tapent. Extension or Observation|Missing|0|||
13186607|NCT02151682|26172244|FG000|Part 2: Tapent. Extension or Observation|Various other|0|||
13186608|NCT02151682|26172245|FG001|Part 2: Tapent. Extension or Observation|Various other|0|||
13186609|NCT02151682|26172246|FG002|Part 2: Tapent. Extension or Observation|Various other|6|||
13186610|NCT02151682|26172247|FG003|Part 2: Tapent. Extension or Observation|Various other|0|||
13186611|NCT02151682|26172248|FG004|Part 2: Tapent. Extension or Observation|Various other|0|||
13186612|NCT02151682|26172249|FG005|Part 2: Tapent. Extension or Observation|Various other|0|||
13186613|NCT02151682|26172244|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
13186614|NCT02151682|26172245|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
13186615|NCT02151682|26172246|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1|||
13186616|NCT02151682|26172247|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
13186617|NCT02151682|26172248|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
13186618|NCT02151682|26172249|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
13186619|NCT02151682|26172244|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
13186620|NCT02151682|26172245|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
13186621|NCT02151682|26172246|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
13186622|NCT02151682|26172247|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
13186623|NCT02151682|26172248|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
13186624|NCT02151682|26172249|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1|||
13186625|NCT02151682|26172244|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
13186626|NCT02151682|26172245|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
13186627|NCT02151682|26172246|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
13186628|NCT02151682|26172247|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
13186629|NCT02151682|26172248|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
13186630|NCT02151682|26172249|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1|||
13186631|NCT02151682|26172244|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
13186632|NCT02151682|26172245|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
13186633|NCT02151682|26172246|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
13186634|NCT02151682|26172247|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
13186635|NCT02151682|26172248|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
13186636|NCT02151682|26172249|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3|||
13186637|NCT02151682|26172244|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
13186638|NCT02151682|26172245|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
13186639|NCT02151682|26172246|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
13186640|NCT02151682|26172247|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
13186641|NCT02151682|26172248|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
13186642|NCT02151682|26172249|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2|||
13186643|NCT02151643|26172302|FG000|Overall Study|Adverse Event|2|||
13186644|NCT02151643|26172303|FG001|Overall Study|Adverse Event|0|||
13186645|NCT02151643|26172304|FG002|Overall Study|Adverse Event|1|||
13186646|NCT02151643|26172305|FG003|Overall Study|Adverse Event|4|||
13186647|NCT02151643|26172306|FG004|Overall Study|Adverse Event|0|||
13186648|NCT02151643|26172302|FG000|Overall Study|Withdrawal by Subject|0|||
13186649|NCT02151643|26172303|FG001|Overall Study|Withdrawal by Subject|1|||
13186650|NCT02151643|26172304|FG002|Overall Study|Withdrawal by Subject|1|||
13186651|NCT02151643|26172305|FG003|Overall Study|Withdrawal by Subject|1|||
13186652|NCT02151643|26172306|FG004|Overall Study|Withdrawal by Subject|1|||
13110502|NCT03210961|25899713|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
13110503|NCT03210961|25899714|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
13110504|NCT03210961|25899715|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
13110505|NCT03210961|25899716|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
13110506|NCT03210961|25899717|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
13110507|NCT03210961|25899718|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
13110508|NCT03210961|25899719|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
13110509|NCT03210961|25899720|FG008|Overall Study|No Longer Meets Eligibility Criteria|0|||
13110510|NCT03210961|25899721|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
13110511|NCT03210961|25899722|FG010|Overall Study|No Longer Meets Eligibility Criteria|0|||
13110512|NCT03210961|25899723|FG011|Overall Study|No Longer Meets Eligibility Criteria|0|||
13110513|NCT03210961|25899724|FG012|Overall Study|No Longer Meets Eligibility Criteria|0|||
13110514|NCT03210961|25899725|FG013|Overall Study|No Longer Meets Eligibility Criteria|1|||
13110515|NCT03210961|25899726|FG014|Overall Study|No Longer Meets Eligibility Criteria|0|||
13110516|NCT03210961|25899712|FG000|Overall Study|Other|0|||
13110517|NCT03210961|25899713|FG001|Overall Study|Other|0|||
13110518|NCT03210961|25899714|FG002|Overall Study|Other|0|||
13186653|NCT02151643|26172302|FG000|Overall Study|Hyperphosphataemia|1|||
13186654|NCT02151643|26172303|FG001|Overall Study|Hyperphosphataemia|0|||
13186655|NCT02151643|26172304|FG002|Overall Study|Hyperphosphataemia|0|||
13186656|NCT02151643|26172305|FG003|Overall Study|Hyperphosphataemia|0|||
13186657|NCT02151643|26172306|FG004|Overall Study|Hyperphosphataemia|1|||
13186658|NCT02151643|26172302|FG000|Overall Study|High Ferritin levels|3|||
13186659|NCT02151643|26172303|FG001|Overall Study|High Ferritin levels|3|||
13186660|NCT02151643|26172304|FG002|Overall Study|High Ferritin levels|2|||
13186661|NCT02151643|26172305|FG003|Overall Study|High Ferritin levels|2|||
13186662|NCT02151643|26172306|FG004|Overall Study|High Ferritin levels|1|||
13186663|NCT02151591|26172323|FG000|Overall Study|Lost to Follow-up|6|||
13186664|NCT02151591|26172324|FG001|Overall Study|Lost to Follow-up|3|||
13186665|NCT02151461|26172375|FG000|Overall Study|Adverse Event|5|||
13186666|NCT02151461|26172376|FG001|Overall Study|Adverse Event|1|||
13186667|NCT02151461|26172377|FG002|Overall Study|Adverse Event|0|||
13186668|NCT02151461|26172378|FG003|Overall Study|Adverse Event|2|||
13186669|NCT02151461|26172375|FG000|Overall Study|Lost to Follow-up|0|||
13186670|NCT02151461|26172376|FG001|Overall Study|Lost to Follow-up|0|||
13186671|NCT02151461|26172377|FG002|Overall Study|Lost to Follow-up|1|||
13186672|NCT02151461|26172378|FG003|Overall Study|Lost to Follow-up|1|||
13186673|NCT02151461|26172375|FG000|Overall Study|Withdrawal by Subject|1|||
13186674|NCT02151461|26172376|FG001|Overall Study|Withdrawal by Subject|0|||
13186675|NCT02151461|26172377|FG002|Overall Study|Withdrawal by Subject|1|||
13186676|NCT02151461|26172378|FG003|Overall Study|Withdrawal by Subject|1|||
13186677|NCT02151461|26172375|FG000|Overall Study|Treatment discontinuation|0|||
13186678|NCT02151461|26172376|FG001|Overall Study|Treatment discontinuation|0|||
13186679|NCT02151461|26172377|FG002|Overall Study|Treatment discontinuation|1|||
13186680|NCT02151461|26172378|FG003|Overall Study|Treatment discontinuation|0|||
13186681|NCT02151266|26172414|FG000|Overall Study|Lost to Follow-up|1|||
13186682|NCT02151266|26172415|FG001|Overall Study|Lost to Follow-up|4|||
13186683|NCT02151266|26172416|FG002|Overall Study|Lost to Follow-up|1|||
13186684|NCT02151266|26172414|FG000|Overall Study|Did NOT receive intervention|3|||
13186685|NCT02151266|26172415|FG001|Overall Study|Did NOT receive intervention|6|||
13186686|NCT02151266|26172416|FG002|Overall Study|Did NOT receive intervention|2|||
13186687|NCT02151266|26172414|FG000|Overall Study|Not able to exercise|4|||
13186688|NCT02151266|26172415|FG001|Overall Study|Not able to exercise|5|||
13186689|NCT02151266|26172416|FG002|Overall Study|Not able to exercise|4|||
13186690|NCT02151149|26172447|FG000|Treatment Period|Death|2|||
13186691|NCT02151149|26172448|FG001|Treatment Period|Death|3|||
13186692|NCT02151149|26172447|FG000|Treatment Period|Adverse Event|17|||
13186693|NCT02151149|26172448|FG001|Treatment Period|Adverse Event|14|||
13186694|NCT02151149|26172447|FG000|Treatment Period|Progressive Disease|25|||
13186695|NCT02151149|26172448|FG001|Treatment Period|Progressive Disease|24|||
13186696|NCT02151149|26172447|FG000|Treatment Period|Symptomatic Deterioration|2|||
13186697|NCT02151149|26172448|FG001|Treatment Period|Symptomatic Deterioration|10|||
13186698|NCT02151149|26172447|FG000|Treatment Period|Withdrawal by Subject|13|||
13186699|NCT02151149|26172448|FG001|Treatment Period|Withdrawal by Subject|11|||
13186700|NCT02151149|26172447|FG000|Treatment Period|Miscellaneous|8|||
13186701|NCT02151149|26172448|FG001|Treatment Period|Miscellaneous|7|||
13186702|NCT02151149|26172447|FG000|Treatment Period|Participants randomized but not treated|3|||
13186703|NCT02151149|26172448|FG001|Treatment Period|Participants randomized but not treated|2|||
13186704|NCT02151149|26172447|FG000|Follow-Up Period|Lost to Follow-up|2|||
13186705|NCT02151149|26172448|FG001|Follow-Up Period|Lost to Follow-up|3|||
13186706|NCT02151149|26172447|FG000|Follow-Up Period|Death|37|||
13186707|NCT02151149|26172448|FG001|Follow-Up Period|Death|34|||
13186708|NCT02151110|26172563|FG000|Overall Study|Withdrawal by Subject|0|||
13186709|NCT02151110|26172564|FG001|Overall Study|Withdrawal by Subject|0|||
13186710|NCT02151110|26172565|FG002|Overall Study|Withdrawal by Subject|0|||
13186711|NCT02151110|26172566|FG003|Overall Study|Withdrawal by Subject|0|||
13186712|NCT02151110|26172567|FG004|Overall Study|Withdrawal by Subject|0|||
13186713|NCT02151110|26172568|FG005|Overall Study|Withdrawal by Subject|0|||
13186714|NCT02151110|26172569|FG006|Overall Study|Withdrawal by Subject|0|||
13186715|NCT02151110|26172570|FG007|Overall Study|Withdrawal by Subject|1|||
13186716|NCT02151110|26172563|FG000|Overall Study|Lost to Follow-up|0|||
13186717|NCT02151110|26172564|FG001|Overall Study|Lost to Follow-up|0|||
13186718|NCT02151110|26172565|FG002|Overall Study|Lost to Follow-up|0|||
13186719|NCT02151110|26172566|FG003|Overall Study|Lost to Follow-up|0|||
13186720|NCT02151110|26172567|FG004|Overall Study|Lost to Follow-up|0|||
13186721|NCT02151110|26172568|FG005|Overall Study|Lost to Follow-up|0|||
13186722|NCT02151110|26172569|FG006|Overall Study|Lost to Follow-up|0|||
13186723|NCT02151110|26172570|FG007|Overall Study|Lost to Follow-up|2|||
13186724|NCT02151058|26172612|FG000|Overall Study|Withdrawal by Subject|1|||
13186725|NCT02151058|26172613|FG001|Overall Study|Withdrawal by Subject|1|||
13186726|NCT02151058|26172614|FG002|Overall Study|Withdrawal by Subject|3|||
13186727|NCT02151058|26172612|FG000|Overall Study|Lost to Follow-up|1|||
13186728|NCT02151058|26172613|FG001|Overall Study|Lost to Follow-up|0|||
13186729|NCT02151058|26172614|FG002|Overall Study|Lost to Follow-up|2|||
13186730|NCT02150954|26172643|FG000|Overall Study|Protocol Violation|1|||
13186731|NCT02150954|26172644|FG001|Overall Study|Protocol Violation|0|||
13186732|NCT02150863|26172662|FG000|Overall Study|Lost to Follow-up|0|||
13186733|NCT02150863|26172663|FG001|Overall Study|Lost to Follow-up|1|||
13186734|NCT02150863|26172664|FG002|Overall Study|Lost to Follow-up|0|||
13186735|NCT02150343|26172715|FG000|Overall Study|Adverse Event|2|||
13186736|NCT02150343|26172716|FG001|Overall Study|Adverse Event|0|||
13186737|NCT02150343|26172717|FG002|Overall Study|Adverse Event|1|||
13186738|NCT02150343|26172718|FG003|Overall Study|Adverse Event|1|||
13186739|NCT02150343|26172715|FG000|Overall Study|Withdrawal by Subject|13|||
13186740|NCT02150343|26172716|FG001|Overall Study|Withdrawal by Subject|10|||
13186741|NCT02150343|26172717|FG002|Overall Study|Withdrawal by Subject|9|||
13186742|NCT02150343|26172718|FG003|Overall Study|Withdrawal by Subject|4|||
13186743|NCT02150343|26172715|FG000|Overall Study|Lost to Follow-up|4|||
13186744|NCT02150343|26172716|FG001|Overall Study|Lost to Follow-up|4|||
13186745|NCT02150343|26172717|FG002|Overall Study|Lost to Follow-up|2|||
13186746|NCT02150343|26172718|FG003|Overall Study|Lost to Follow-up|3|||
13186747|NCT02150343|26172715|FG000|Overall Study|Other|2|||
13186748|NCT02150343|26172716|FG001|Overall Study|Other|6|||
13186749|NCT02150343|26172717|FG002|Overall Study|Other|0|||
13186750|NCT02150343|26172718|FG003|Overall Study|Other|2|||
13186751|NCT02150213|26172725|FG000|Overall Study|Lost to Follow-up|1|||
13186752|NCT02150213|26172725|FG000|Overall Study|Withdrawal by Subject|1|||
13186753|NCT02150057|26172738|FG000|Overall Study|Lost to Follow-up|6|||
13186754|NCT02150057|26172739|FG001|Overall Study|Lost to Follow-up|4|||
13186755|NCT02149875|26172760|FG000|Overall Study|Lost to Follow-up|3|||
13186756|NCT02149875|26172761|FG001|Overall Study|Lost to Follow-up|4|||
13186757|NCT02149875|26172762|FG002|Overall Study|Lost to Follow-up|5|||
13186758|NCT02149875|26172760|FG000|Overall Study|Withdrawal by Subject|3|||
13186759|NCT02149875|26172761|FG001|Overall Study|Withdrawal by Subject|2|||
13186760|NCT02149875|26172762|FG002|Overall Study|Withdrawal by Subject|2|||
13186761|NCT02149875|26172760|FG000|Overall Study|Physician Decision|1|||
13186762|NCT02149875|26172761|FG001|Overall Study|Physician Decision|2|||
13186763|NCT02149875|26172762|FG002|Overall Study|Physician Decision|2|||
13186764|NCT02149836|26172771|FG000|Overall Study|Withdrawal by Subject|1|||
13186765|NCT02149810|26172802|FG000|Overall Study|Physician Decision|1|||
13186766|NCT02149810|26172803|FG001|Overall Study|Physician Decision|2|||
13186767|NCT02149810|26172802|FG000|Overall Study|Lost to Follow-up|2|||
13186768|NCT02149810|26172803|FG001|Overall Study|Lost to Follow-up|1|||
13186769|NCT02149810|26172802|FG000|Overall Study|Withdrawal by Subject|5|||
13186770|NCT02149810|26172803|FG001|Overall Study|Withdrawal by Subject|1|||
13186771|NCT02149420|26172863|FG000|Core Study|Administrative problems|0|||
13186772|NCT02149420|26172864|FG001|Core Study|Administrative problems|1|||
13186773|NCT02149420|26172865|FG002|Core Study|Administrative problems|2|||
13186774|NCT02149420|26172863|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1|||
13186775|NCT02149420|26172864|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
13186776|NCT02149420|26172865|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
13186777|NCT02149264|26172880|FG000|Overall Study|Withdrawal by Subject|9|||
13186778|NCT02149264|26172880|FG000|Overall Study|Adverse Event|7|||
13186779|NCT02149264|26172880|FG000|Overall Study|Physician Decision|3|||
13186780|NCT02149264|26172880|FG000|Overall Study|Protocol Violation|1|||
13186781|NCT02149199|26172955|FG000|Overall Study|Study specific withdrawal criteria|4|||
13186782|NCT02149199|26172956|FG001|Overall Study|Study specific withdrawal criteria|21|||
13186783|NCT02149199|26172957|FG002|Overall Study|Study specific withdrawal criteria|6|||
13186784|NCT02149199|26172955|FG000|Overall Study|Other|20|||
13186785|NCT02149199|26172956|FG001|Overall Study|Other|25|||
13186786|NCT02149199|26172957|FG002|Overall Study|Other|20|||
13186787|NCT02149199|26172955|FG000|Overall Study|Eligibility criteria not fulfilled|9|||
13186788|NCT02149199|26172956|FG001|Overall Study|Eligibility criteria not fulfilled|14|||
13186789|NCT02149199|26172957|FG002|Overall Study|Eligibility criteria not fulfilled|8|||
13186790|NCT02149199|26172955|FG000|Overall Study|Withdrawal by Subject|75|||
13186791|NCT02149199|26172956|FG001|Overall Study|Withdrawal by Subject|93|||
13186792|NCT02149199|26172957|FG002|Overall Study|Withdrawal by Subject|77|||
13186793|NCT02149199|26172955|FG000|Overall Study|Protocol Violation|16|||
13110519|NCT03210961|25899715|FG003|Overall Study|Other|1|||
13110520|NCT03210961|25899716|FG004|Overall Study|Other|0|||
13110521|NCT03210961|25899717|FG005|Overall Study|Other|0|||
13110522|NCT03210961|25899718|FG006|Overall Study|Other|1|||
13110523|NCT03210961|25899719|FG007|Overall Study|Other|0|||
13110524|NCT03210961|25899720|FG008|Overall Study|Other|0|||
13110525|NCT03210961|25899721|FG009|Overall Study|Other|0|||
13110526|NCT03210961|25899722|FG010|Overall Study|Other|1|||
13110527|NCT03210961|25899723|FG011|Overall Study|Other|0|||
13110528|NCT03210961|25899724|FG012|Overall Study|Other|2|||
13186794|NCT02149199|26172956|FG001|Overall Study|Protocol Violation|13|||
13186795|NCT02149199|26172957|FG002|Overall Study|Protocol Violation|15|||
13186796|NCT02149199|26172955|FG000|Overall Study|Lost to Follow-up|3|||
13186797|NCT02149199|26172956|FG001|Overall Study|Lost to Follow-up|12|||
13186798|NCT02149199|26172957|FG002|Overall Study|Lost to Follow-up|11|||
13186799|NCT02149199|26172955|FG000|Overall Study|Death|0|||
13186800|NCT02149199|26172956|FG001|Overall Study|Death|0|||
13186801|NCT02149199|26172957|FG002|Overall Study|Death|1|||
13186802|NCT02149199|26172955|FG000|Overall Study|Adverse Event|6|||
13186803|NCT02149199|26172956|FG001|Overall Study|Adverse Event|15|||
13186804|NCT02149199|26172957|FG002|Overall Study|Adverse Event|9|||
13186805|NCT02149108|26172976|FG000|Overall Study|Not treated|1|||
13186806|NCT02149108|26172977|FG001|Overall Study|Not treated|2|||
13186807|NCT02149108|26172976|FG000|Overall Study|Progressive Disease (PD)|324|||
13186808|NCT02149108|26172977|FG001|Overall Study|Progressive Disease (PD)|318|||
13186809|NCT02149108|26172976|FG000|Overall Study|Worsening/adverse event cancer disease|31|||
13186810|NCT02149108|26172977|FG001|Overall Study|Worsening/adverse event cancer disease|32|||
13186811|NCT02149108|26172976|FG000|Overall Study|Other Adverse Event (AE)|8|||
13186812|NCT02149108|26172977|FG001|Overall Study|Other Adverse Event (AE)|18|||
13186813|NCT02149108|26172976|FG000|Overall Study|Other not defined above|0|||
13186814|NCT02149108|26172977|FG001|Overall Study|Other not defined above|2|||
13186815|NCT02149108|26172976|FG000|Overall Study|Refusal to continue trial medication|15|||
13186816|NCT02149108|26172977|FG001|Overall Study|Refusal to continue trial medication|11|||
13186817|NCT02149108|26172976|FG000|Overall Study|Lost to Follow-up|1|||
13186818|NCT02149108|26172977|FG001|Overall Study|Lost to Follow-up|0|||
13186819|NCT02148952|26173040|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241|||
13186820|NCT02148952|26173041|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591|||
13186821|NCT02148952|26173040|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862|||
13186822|NCT02148952|26173041|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556|||
13186823|NCT02148952|26173040|FG000|Follow-Up|Lost to Follow-up|219|||
13186824|NCT02148952|26173041|FG001|Follow-Up|Lost to Follow-up|231|||
13186825|NCT02148952|26173040|FG000|Follow-Up|Withdrawal by Subject|46|||
13186826|NCT02148952|26173041|FG001|Follow-Up|Withdrawal by Subject|48|||
13186827|NCT02148718|26173064|FG000|Overall Study|Protocol Violation|26|||
13186828|NCT02148718|26173064|FG000|Overall Study|Discontinued Study Prematurely|5|||
13186829|NCT02148445|26173107|FG000|Overall Study|Death|1|||
13186830|NCT02148445|26173108|FG001|Overall Study|Death|3|||
13186831|NCT02148263|26173139|FG000|Overall Study|Withdrawal by Subject|3|||
13186832|NCT02148263|26173140|FG001|Overall Study|Withdrawal by Subject|2|||
13186833|NCT02148250|26173157|FG000|Screening|Withdrawal by Subject|5|||
13186834|NCT02148250|26173158|FG001|Screening|Withdrawal by Subject|0|||
13186835|NCT02148211|26173169|FG000|Overall Study|Lost to Follow-up|352|||
13186836|NCT02147691|26173220|FG000|Overall Study|Withdrawal by Subject|2|||
13186837|NCT02147691|26173221|FG001|Overall Study|Withdrawal by Subject|0|||
13186838|NCT02147691|26173220|FG000|Overall Study|Adverse Event|2|||
13110529|NCT03210961|25899725|FG013|Overall Study|Other|2|||
13186839|NCT02147691|26173221|FG001|Overall Study|Adverse Event|0|||
13186840|NCT02147691|26173220|FG000|Overall Study|Lost to Follow-up|0|||
13186841|NCT02147691|26173221|FG001|Overall Study|Lost to Follow-up|1|||
13110530|NCT03210961|25899726|FG014|Overall Study|Other|0|||
13186842|NCT02147626|26173246|FG000|Overall Study|Lost to Follow-up|4|||
13186843|NCT02147626|26173247|FG001|Overall Study|Lost to Follow-up|4|||
13186844|NCT02147626|26173246|FG000|Overall Study|Pregnancy|1|||
13186845|NCT02147626|26173247|FG001|Overall Study|Pregnancy|2|||
13186846|NCT02147626|26173246|FG000|Overall Study|Withdrawal by Subject|0|||
13186847|NCT02147626|26173247|FG001|Overall Study|Withdrawal by Subject|1|||
13186848|NCT02147587|26173274|FG000|Overall Study|Adverse Event|9|||
13186849|NCT02147587|26173275|FG001|Overall Study|Adverse Event|4|||
13186850|NCT02147587|26173274|FG000|Overall Study|Lack of Efficacy|2|||
13186851|NCT02147587|26173275|FG001|Overall Study|Lack of Efficacy|1|||
13186852|NCT02147561|26173283|FG000|Overall Study|Lost to Follow-up|3|||
13186853|NCT02147561|26173283|FG000|Overall Study|Subjects who didn't receive BOTOX|1|||
13186854|NCT02147353|26173308|FG000|Overall Study|Lost to Follow-up|2|||
13186855|NCT02147353|26173309|FG001|Overall Study|Lost to Follow-up|0|||
13186856|NCT02147353|26173308|FG000|Overall Study|unable to make visits|4|||
13186857|NCT02147353|26173309|FG001|Overall Study|unable to make visits|0|||
13186858|NCT02147353|26173308|FG000|Overall Study|medication noncompliance|3|||
13186859|NCT02147353|26173309|FG001|Overall Study|medication noncompliance|0|||
13186860|NCT02147288|26173330|FG000|Overall Study|post-operative hematoma|1|||
13186861|NCT02147288|26173331|FG001|Overall Study|post-operative hematoma|1|||
13186862|NCT02147288|26173332|FG002|Overall Study|post-operative hematoma|0|||
13186863|NCT02147288|26173333|FG003|Overall Study|post-operative hematoma|0|||
13186864|NCT02147288|26173334|FG004|Overall Study|post-operative hematoma|0|||
13186865|NCT02147288|26173335|FG005|Overall Study|post-operative hematoma|0|||
13186866|NCT02147288|26173336|FG006|Overall Study|post-operative hematoma|0|||
13186867|NCT02147288|26173337|FG007|Overall Study|post-operative hematoma|0|||
13186868|NCT02147288|26173338|FG008|Overall Study|post-operative hematoma|0|||
13186869|NCT02147288|26173339|FG009|Overall Study|post-operative hematoma|0|||
13186870|NCT02147288|26173330|FG000|Overall Study|complications from concurrent hernia rep|0|||
13186871|NCT02147288|26173331|FG001|Overall Study|complications from concurrent hernia rep|1|||
13186872|NCT02147288|26173332|FG002|Overall Study|complications from concurrent hernia rep|0|||
13186873|NCT02147288|26173333|FG003|Overall Study|complications from concurrent hernia rep|0|||
13186874|NCT02147288|26173334|FG004|Overall Study|complications from concurrent hernia rep|0|||
13186875|NCT02147288|26173335|FG005|Overall Study|complications from concurrent hernia rep|0|||
13186876|NCT02147288|26173336|FG006|Overall Study|complications from concurrent hernia rep|0|||
13186877|NCT02147288|26173337|FG007|Overall Study|complications from concurrent hernia rep|0|||
13186878|NCT02147288|26173338|FG008|Overall Study|complications from concurrent hernia rep|0|||
13186879|NCT02147288|26173339|FG009|Overall Study|complications from concurrent hernia rep|0|||
13186880|NCT02147197|26173366|FG000|Overall Study|Adverse Event|1|||
13186881|NCT02147197|26173367|FG001|Overall Study|Adverse Event|0|||
13186882|NCT02147197|26173368|FG002|Overall Study|Adverse Event|0|||
13186883|NCT02147197|26173366|FG000|Overall Study|Withdrawal of Consent|4|||
13186884|NCT02147197|26173367|FG001|Overall Study|Withdrawal of Consent|3|||
13186885|NCT02147197|26173368|FG002|Overall Study|Withdrawal of Consent|2|||
13186886|NCT02147197|26173366|FG000|Overall Study|Lost to Follow-up|2|||
13186887|NCT02147197|26173367|FG001|Overall Study|Lost to Follow-up|3|||
13186888|NCT02147197|26173368|FG002|Overall Study|Lost to Follow-up|1|||
13186889|NCT02147197|26173366|FG000|Overall Study|Protocol Violation|1|||
13186890|NCT02147197|26173367|FG001|Overall Study|Protocol Violation|0|||
13186891|NCT02147197|26173368|FG002|Overall Study|Protocol Violation|3|||
13186892|NCT02147197|26173366|FG000|Overall Study|Other Miscellaneous Reasons|1|||
13186893|NCT02147197|26173367|FG001|Overall Study|Other Miscellaneous Reasons|0|||
13186894|NCT02147197|26173368|FG002|Overall Study|Other Miscellaneous Reasons|3|||
13186895|NCT02147158|26173416|FG000|Treatment Course 1|Adverse Event|1|||
13186896|NCT02147158|26173417|FG001|Treatment Course 1|Adverse Event|4|||
13186897|NCT02147158|26173418|FG002|Treatment Course 1|Adverse Event|3|||
13186898|NCT02147158|26173419|FG003|Treatment Course 1|Adverse Event|4|||
13186899|NCT02147158|26173420|FG004|Treatment Course 1|Adverse Event|1|||
13186900|NCT02147158|26173421|FG005|Treatment Course 1|Adverse Event|2|||
13186901|NCT02147158|26173416|FG000|Treatment Course 1|Lost to Follow-up|2|||
13186902|NCT02147158|26173417|FG001|Treatment Course 1|Lost to Follow-up|4|||
13186903|NCT02147158|26173418|FG002|Treatment Course 1|Lost to Follow-up|3|||
13186904|NCT02147158|26173419|FG003|Treatment Course 1|Lost to Follow-up|3|||
13186905|NCT02147158|26173420|FG004|Treatment Course 1|Lost to Follow-up|2|||
13186906|NCT02147158|26173421|FG005|Treatment Course 1|Lost to Follow-up|4|||
13186907|NCT02147158|26173416|FG000|Treatment Course 1|Protocol Violation|0|||
13186908|NCT02147158|26173417|FG001|Treatment Course 1|Protocol Violation|0|||
13186909|NCT02147158|26173418|FG002|Treatment Course 1|Protocol Violation|1|||
13186910|NCT02147158|26173419|FG003|Treatment Course 1|Protocol Violation|1|||
13186911|NCT02147158|26173420|FG004|Treatment Course 1|Protocol Violation|0|||
13186912|NCT02147158|26173421|FG005|Treatment Course 1|Protocol Violation|0|||
13186913|NCT02147158|26173416|FG000|Treatment Course 1|Withdrawal of Consent|1|||
13186914|NCT02147158|26173417|FG001|Treatment Course 1|Withdrawal of Consent|1|||
13186915|NCT02147158|26173418|FG002|Treatment Course 1|Withdrawal of Consent|1|||
13186916|NCT02147158|26173419|FG003|Treatment Course 1|Withdrawal of Consent|5|||
13186917|NCT02147158|26173420|FG004|Treatment Course 1|Withdrawal of Consent|3|||
13186918|NCT02147158|26173421|FG005|Treatment Course 1|Withdrawal of Consent|2|||
13186919|NCT02147158|26173416|FG000|Off-Treatment Interval 1|Adverse Event|1|||
13186920|NCT02147158|26173417|FG001|Off-Treatment Interval 1|Adverse Event|0|||
13186921|NCT02147158|26173418|FG002|Off-Treatment Interval 1|Adverse Event|0|||
13186922|NCT02147158|26173419|FG003|Off-Treatment Interval 1|Adverse Event|1|||
13186923|NCT02147158|26173420|FG004|Off-Treatment Interval 1|Adverse Event|0|||
13186924|NCT02147158|26173421|FG005|Off-Treatment Interval 1|Adverse Event|0|||
13110531|NCT03210519|25899757|FG000|Overall Study|Adverse Event|2|||
13110532|NCT03210519|25899758|FG001|Overall Study|Adverse Event|0|||
13110533|NCT03210259|25899793|FG000|12-Week Run-in Period|Adverse Event|1|||
13110534|NCT03210259|25899794|FG001|12-Week Run-in Period|Adverse Event|0|||
13110535|NCT03210259|25899795|FG002|12-Week Run-in Period|Adverse Event|0|||
13110536|NCT03210259|25899793|FG000|12-Week Run-in Period|Death|1|||
13110537|NCT03210259|25899794|FG001|12-Week Run-in Period|Death|0|||
13110538|NCT03210259|25899795|FG002|12-Week Run-in Period|Death|0|||
13110539|NCT03210259|25899793|FG000|12-Week Run-in Period|Withdrawal by Subject|9|||
13110540|NCT03210259|25899794|FG001|12-Week Run-in Period|Withdrawal by Subject|0|||
13110541|NCT03210259|25899795|FG002|12-Week Run-in Period|Withdrawal by Subject|0|||
13110542|NCT03210259|25899793|FG000|12-Week Run-in Period|Lost to Follow-up|4|||
13110543|NCT03210259|25899794|FG001|12-Week Run-in Period|Lost to Follow-up|0|||
13110544|NCT03210259|25899795|FG002|12-Week Run-in Period|Lost to Follow-up|0|||
13110545|NCT03210259|25899793|FG000|12-Week Run-in Period|Lack of Efficacy|6|||
13110546|NCT03210259|25899794|FG001|12-Week Run-in Period|Lack of Efficacy|0|||
13110547|NCT03210259|25899795|FG002|12-Week Run-in Period|Lack of Efficacy|0|||
13110548|NCT03210259|25899793|FG000|48-Week Randomized Responder Period|Missed study visit|0|||
13110549|NCT03210259|25899794|FG001|48-Week Randomized Responder Period|Missed study visit|1|||
13110550|NCT03210259|25899795|FG002|48-Week Randomized Responder Period|Missed study visit|2|||
13110551|NCT03210259|25899793|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0|||
13110552|NCT03210259|25899794|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3|||
13110553|NCT03210259|25899795|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8|||
13110554|NCT03210259|25899793|FG000|48-Week Randomized Responder Period|Pregnancy|0|||
13110555|NCT03210259|25899794|FG001|48-Week Randomized Responder Period|Pregnancy|1|||
13110556|NCT03210259|25899795|FG002|48-Week Randomized Responder Period|Pregnancy|0|||
13110557|NCT03210259|25899793|FG000|48-Week Randomized Responder Period|Physician Decision|0|||
13110558|NCT03210259|25899794|FG001|48-Week Randomized Responder Period|Physician Decision|0|||
13110559|NCT03210259|25899795|FG002|48-Week Randomized Responder Period|Physician Decision|1|||
13110560|NCT03210259|25899793|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0|||
13110561|NCT03210259|25899794|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5|||
13110562|NCT03210259|25899795|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17|||
13110563|NCT03210259|25899793|FG000|48-Week Randomized Responder Period|Adverse Event|0|||
13110564|NCT03210259|25899794|FG001|48-Week Randomized Responder Period|Adverse Event|1|||
13110565|NCT03210259|25899795|FG002|48-Week Randomized Responder Period|Adverse Event|1|||
13110566|NCT03210220|25899808|FG000|Overall Study|Physician Decision|1|||
13110567|NCT03210220|25899809|FG001|Overall Study|Physician Decision|0|||
13110568|NCT03209973|25899822|FG000|Overall Study|Withdrawal by Subject|7|||
13110569|NCT03209973|25899822|FG000|Overall Study|Lost to Follow-up|2|||
13110570|NCT03209973|25899822|FG000|Overall Study|Death|8|||
13110571|NCT03209973|25899822|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32|||
13110572|NCT03209973|25899822|FG000|Overall Study|Sponsor Decision|18|||
13110573|NCT03209973|25899822|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1|||
13110574|NCT03209973|25899822|FG000|Overall Study|Participant Refused to Return to Treatment|2|||
13110575|NCT03209570|25899839|FG000|Overall Study|Death|1|||
13110576|NCT03209570|25899840|FG001|Overall Study|Death|0|||
13110577|NCT03209570|25899839|FG000|Overall Study|Incomplete Data|8|||
13110578|NCT03209570|25899840|FG001|Overall Study|Incomplete Data|10|||
13110579|NCT03209570|25899839|FG000|Overall Study|Protocol Violation|1|||
13110580|NCT03209570|25899840|FG001|Overall Study|Protocol Violation|0|||
13110581|NCT03209570|25899839|FG000|Overall Study|Withdrawal by Subject|0|||
13110582|NCT03209570|25899840|FG001|Overall Study|Withdrawal by Subject|3|||
13110583|NCT03209518|25899847|FG000|Overall Study|Case Report Forms Uncollected|1|||
13110584|NCT03209518|25899847|FG000|Overall Study|Protocol Deviation|1|||
13110585|NCT03209492|25899854|FG000|Overall Study|Case Report Forms Uncollected|5|||
13110586|NCT03209362|25899875|FG000|Overall Study|Adverse Event|0|||
13110587|NCT03209362|25899876|FG001|Overall Study|Adverse Event|1|||
13110588|NCT03209362|25899875|FG000|Overall Study|Lost to Follow-up|0|||
13110589|NCT03209362|25899876|FG001|Overall Study|Lost to Follow-up|1|||
13110590|NCT03209362|25899875|FG000|Overall Study|Withdrawal by Subject|2|||
13110591|NCT03209362|25899876|FG001|Overall Study|Withdrawal by Subject|0|||
13110592|NCT03209362|25899875|FG000|Overall Study|Other|0|||
13110593|NCT03209362|25899876|FG001|Overall Study|Other|1|||
13110594|NCT03208933|25899887|FG000|Overall Study|Death|3|||
13110595|NCT03208933|25899887|FG000|Overall Study|Withdrawal by Subject|3|||
13110596|NCT03208933|25899887|FG000|Overall Study|Adverse Event|1|||
13110597|NCT03208933|25899887|FG000|Overall Study|Lost to Follow-up|2|||
13110598|NCT03208933|25899887|FG000|Overall Study|Physician Decision|3|||
13110599|NCT03208933|25899887|FG000|Overall Study|Protocol Violation|1|||
13110600|NCT03208244|25899894|FG000|Overall Study|Death|1|||
13186925|NCT02147158|26173416|FG000|Off-Treatment Interval 1|Lost to Follow-up|2|||
13186926|NCT02147158|26173417|FG001|Off-Treatment Interval 1|Lost to Follow-up|1|||
13186927|NCT02147158|26173418|FG002|Off-Treatment Interval 1|Lost to Follow-up|3|||
13186928|NCT02147158|26173419|FG003|Off-Treatment Interval 1|Lost to Follow-up|2|||
13186929|NCT02147158|26173420|FG004|Off-Treatment Interval 1|Lost to Follow-up|4|||
13186930|NCT02147158|26173421|FG005|Off-Treatment Interval 1|Lost to Follow-up|2|||
13186931|NCT02147158|26173416|FG000|Off-Treatment Interval 1|Protocol Violation|1|||
13186932|NCT02147158|26173417|FG001|Off-Treatment Interval 1|Protocol Violation|0|||
13186933|NCT02147158|26173418|FG002|Off-Treatment Interval 1|Protocol Violation|2|||
13186934|NCT02147158|26173419|FG003|Off-Treatment Interval 1|Protocol Violation|0|||
13186935|NCT02147158|26173420|FG004|Off-Treatment Interval 1|Protocol Violation|1|||
13110601|NCT03208127|25899901|FG000|Overall Study|Death|1|||
13110602|NCT03208088|25899925|FG000|Period 2|Withdrawal by Subject|0|||
13110603|NCT03208088|25899926|FG001|Period 2|Withdrawal by Subject|0|||
13110604|NCT03208088|25899927|FG002|Period 2|Withdrawal by Subject|0|||
13186936|NCT02147158|26173421|FG005|Off-Treatment Interval 1|Protocol Violation|0|||
13186937|NCT02147158|26173416|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4|||
13186938|NCT02147158|26173417|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3|||
13186939|NCT02147158|26173418|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5|||
13186940|NCT02147158|26173419|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10|||
13186941|NCT02147158|26173420|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2|||
13186942|NCT02147158|26173421|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3|||
13186943|NCT02147158|26173416|FG000|Off-Treatment Interval 1|Lack of Efficacy|0|||
13186944|NCT02147158|26173417|FG001|Off-Treatment Interval 1|Lack of Efficacy|0|||
13186945|NCT02147158|26173418|FG002|Off-Treatment Interval 1|Lack of Efficacy|2|||
13186946|NCT02147158|26173419|FG003|Off-Treatment Interval 1|Lack of Efficacy|0|||
13186947|NCT02147158|26173420|FG004|Off-Treatment Interval 1|Lack of Efficacy|1|||
13186948|NCT02147158|26173421|FG005|Off-Treatment Interval 1|Lack of Efficacy|0|||
13186949|NCT02147158|26173416|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
13186950|NCT02147158|26173417|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
13186951|NCT02147158|26173418|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3|||
13186952|NCT02147158|26173419|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
13186953|NCT02147158|26173420|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
13186954|NCT02147158|26173421|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
13186955|NCT02147158|26173416|FG000|Treatment Course 2|Adverse Event|0|||
13186956|NCT02147158|26173417|FG001|Treatment Course 2|Adverse Event|4|||
13186957|NCT02147158|26173418|FG002|Treatment Course 2|Adverse Event|2|||
13186958|NCT02147158|26173419|FG003|Treatment Course 2|Adverse Event|1|||
13186959|NCT02147158|26173420|FG004|Treatment Course 2|Adverse Event|0|||
13186960|NCT02147158|26173421|FG005|Treatment Course 2|Adverse Event|1|||
13186961|NCT02147158|26173416|FG000|Treatment Course 2|Withdrawal of Consent|0|||
13186962|NCT02147158|26173417|FG001|Treatment Course 2|Withdrawal of Consent|1|||
13186963|NCT02147158|26173418|FG002|Treatment Course 2|Withdrawal of Consent|2|||
13186964|NCT02147158|26173419|FG003|Treatment Course 2|Withdrawal of Consent|3|||
13186965|NCT02147158|26173420|FG004|Treatment Course 2|Withdrawal of Consent|0|||
13186966|NCT02147158|26173421|FG005|Treatment Course 2|Withdrawal of Consent|0|||
13186967|NCT02147158|26173416|FG000|Treatment Course 2|Lost to Follow-up|1|||
13186968|NCT02147158|26173417|FG001|Treatment Course 2|Lost to Follow-up|0|||
13186969|NCT02147158|26173418|FG002|Treatment Course 2|Lost to Follow-up|1|||
13186970|NCT02147158|26173419|FG003|Treatment Course 2|Lost to Follow-up|1|||
13186971|NCT02147158|26173420|FG004|Treatment Course 2|Lost to Follow-up|0|||
13186972|NCT02147158|26173421|FG005|Treatment Course 2|Lost to Follow-up|1|||
13186973|NCT02147158|26173416|FG000|Off-Treatment Interval 2|Lack of Efficacy|0|||
13186974|NCT02147158|26173417|FG001|Off-Treatment Interval 2|Lack of Efficacy|1|||
13186975|NCT02147158|26173418|FG002|Off-Treatment Interval 2|Lack of Efficacy|1|||
13186976|NCT02147158|26173419|FG003|Off-Treatment Interval 2|Lack of Efficacy|0|||
13186977|NCT02147158|26173420|FG004|Off-Treatment Interval 2|Lack of Efficacy|0|||
13186978|NCT02147158|26173421|FG005|Off-Treatment Interval 2|Lack of Efficacy|0|||
13186979|NCT02147158|26173416|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4|||
13186980|NCT02147158|26173417|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0|||
13186981|NCT02147158|26173418|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5|||
13186982|NCT02147158|26173419|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4|||
13186983|NCT02147158|26173420|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0|||
13186984|NCT02147158|26173421|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1|||
13110605|NCT03208088|25899928|FG003|Period 2|Withdrawal by Subject|0|||
13110606|NCT03208088|25899929|FG004|Period 2|Withdrawal by Subject|0|||
13110607|NCT03208088|25899930|FG005|Period 2|Withdrawal by Subject|0|||
13110608|NCT03208088|25899931|FG006|Period 2|Withdrawal by Subject|0|||
13110609|NCT03208088|25899932|FG007|Period 2|Withdrawal by Subject|0|||
13186985|NCT02147158|26173416|FG000|Off-Treatment Interval 2|Lost to Follow-up|0|||
13110610|NCT03208088|25899933|FG008|Period 2|Withdrawal by Subject|1|||
13110611|NCT03208088|25899934|FG009|Period 2|Withdrawal by Subject|0|||
13110612|NCT03208088|25899925|FG000|Period 3|Unsatisfactory Test Article|0|||
13186986|NCT02147158|26173417|FG001|Off-Treatment Interval 2|Lost to Follow-up|0|||
13186987|NCT02147158|26173418|FG002|Off-Treatment Interval 2|Lost to Follow-up|3|||
13186988|NCT02147158|26173419|FG003|Off-Treatment Interval 2|Lost to Follow-up|2|||
13186989|NCT02147158|26173420|FG004|Off-Treatment Interval 2|Lost to Follow-up|2|||
13186990|NCT02147158|26173421|FG005|Off-Treatment Interval 2|Lost to Follow-up|2|||
13186991|NCT02147158|26173416|FG000|Off-Treatment Interval 2|Protocol Violation|0|||
13186992|NCT02147158|26173417|FG001|Off-Treatment Interval 2|Protocol Violation|0|||
13186993|NCT02147158|26173418|FG002|Off-Treatment Interval 2|Protocol Violation|0|||
13186994|NCT02147158|26173419|FG003|Off-Treatment Interval 2|Protocol Violation|1|||
13186995|NCT02147158|26173420|FG004|Off-Treatment Interval 2|Protocol Violation|0|||
13186996|NCT02147158|26173421|FG005|Off-Treatment Interval 2|Protocol Violation|0|||
13186997|NCT02147158|26173416|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
13186998|NCT02147158|26173417|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3|||
13186999|NCT02147158|26173418|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
13187000|NCT02147158|26173419|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4|||
13187001|NCT02147158|26173420|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
13187002|NCT02147158|26173421|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
13187003|NCT02147132|26173444|FG000|Overall Study|Lost to Follow-up|1|||
13187004|NCT02147132|26173445|FG001|Overall Study|Lost to Follow-up|0|||
13187005|NCT02147132|26173446|FG002|Overall Study|Lost to Follow-up|0|||
13187006|NCT02147132|26173447|FG003|Overall Study|Lost to Follow-up|0|||
13187007|NCT02147093|26173462|FG000|Period 1|Lost to Follow-up|0|||
13187008|NCT02147093|26173463|FG001|Period 1|Lost to Follow-up|1|||
13187009|NCT02147093|26173462|FG000|Period 2|Protocol Violation|2|||
13187010|NCT02147093|26173463|FG001|Period 2|Protocol Violation|0|||
13187011|NCT02147067|26173496|FG000|Overall Study|Withdrawal by Subject|2|||
13187012|NCT02147067|26173497|FG001|Overall Study|Withdrawal by Subject|2|||
13110613|NCT03208088|25899926|FG001|Period 3|Unsatisfactory Test Article|0|||
13110614|NCT03208088|25899927|FG002|Period 3|Unsatisfactory Test Article|0|||
13110615|NCT03208088|25899928|FG003|Period 3|Unsatisfactory Test Article|1|||
13110616|NCT03208088|25899929|FG004|Period 3|Unsatisfactory Test Article|0|||
13110617|NCT03208088|25899930|FG005|Period 3|Unsatisfactory Test Article|0|||
13110618|NCT03208088|25899931|FG006|Period 3|Unsatisfactory Test Article|0|||
13110619|NCT03208088|25899932|FG007|Period 3|Unsatisfactory Test Article|0|||
13110620|NCT03208088|25899933|FG008|Period 3|Unsatisfactory Test Article|0|||
13110621|NCT03208088|25899934|FG009|Period 3|Unsatisfactory Test Article|0|||
13110622|NCT03208088|25899925|FG000|Period 4|Unsatisfactory Test Article|0|||
13110623|NCT03208088|25899926|FG001|Period 4|Unsatisfactory Test Article|0|||
13110624|NCT03208088|25899927|FG002|Period 4|Unsatisfactory Test Article|0|||
13110625|NCT03208088|25899928|FG003|Period 4|Unsatisfactory Test Article|1|||
13110626|NCT03208088|25899929|FG004|Period 4|Unsatisfactory Test Article|0|||
13110627|NCT03208088|25899930|FG005|Period 4|Unsatisfactory Test Article|0|||
13187013|NCT02146599|26173503|FG000|Overall Study|Failed to meet inclusion criteria|5|||
13187014|NCT02146430|26173570|FG000|Overall Study|Protocol Violation|5|||
13187015|NCT02146430|26173571|FG001|Overall Study|Protocol Violation|4|||
13187016|NCT02146430|26173572|FG002|Overall Study|Protocol Violation|8|||
13187017|NCT02146430|26173573|FG003|Overall Study|Protocol Violation|6|||
13187018|NCT02146430|26173570|FG000|Overall Study|Lack of Efficacy|13|||
13187019|NCT02146430|26173571|FG001|Overall Study|Lack of Efficacy|11|||
13187020|NCT02146430|26173572|FG002|Overall Study|Lack of Efficacy|8|||
13187021|NCT02146430|26173573|FG003|Overall Study|Lack of Efficacy|5|||
13187022|NCT02146430|26173570|FG000|Overall Study|Adverse Event|20|||
13187023|NCT02146430|26173571|FG001|Overall Study|Adverse Event|40|||
13187024|NCT02146430|26173572|FG002|Overall Study|Adverse Event|32|||
13187025|NCT02146430|26173573|FG003|Overall Study|Adverse Event|49|||
13187026|NCT02146430|26173570|FG000|Overall Study|Reason missing or not reported|2|||
13187027|NCT02146430|26173571|FG001|Overall Study|Reason missing or not reported|3|||
13187028|NCT02146430|26173572|FG002|Overall Study|Reason missing or not reported|4|||
13187029|NCT02146430|26173573|FG003|Overall Study|Reason missing or not reported|5|||
13187030|NCT02146430|26173570|FG000|Overall Study|Withdrawal by Subject|27|||
13187031|NCT02146430|26173571|FG001|Overall Study|Withdrawal by Subject|29|||
13187032|NCT02146430|26173572|FG002|Overall Study|Withdrawal by Subject|30|||
13187033|NCT02146430|26173573|FG003|Overall Study|Withdrawal by Subject|34|||
13187034|NCT02146365|26173720|FG000|Overall Study|Lost to Follow-up|2|||
13187035|NCT02146365|26173721|FG001|Overall Study|Lost to Follow-up|1|||
13187036|NCT02146365|26173722|FG002|Overall Study|Lost to Follow-up|3|||
13187037|NCT02146365|26173723|FG003|Overall Study|Lost to Follow-up|3|||
13187038|NCT02146365|26173724|FG004|Overall Study|Lost to Follow-up|1|||
13187039|NCT02146365|26173725|FG005|Overall Study|Lost to Follow-up|1|||
13187040|NCT02146365|26173726|FG006|Overall Study|Lost to Follow-up|0|||
13187041|NCT02146365|26173727|FG007|Overall Study|Lost to Follow-up|1|||
13187042|NCT02146365|26173720|FG000|Overall Study|Withdrawal by Subject|1|||
13110628|NCT03208088|25899931|FG006|Period 4|Unsatisfactory Test Article|0|||
13110629|NCT03208088|25899932|FG007|Period 4|Unsatisfactory Test Article|0|||
13187043|NCT02146365|26173721|FG001|Overall Study|Withdrawal by Subject|2|||
13187044|NCT02146365|26173722|FG002|Overall Study|Withdrawal by Subject|1|||
13187045|NCT02146365|26173723|FG003|Overall Study|Withdrawal by Subject|5|||
13187046|NCT02146365|26173724|FG004|Overall Study|Withdrawal by Subject|1|||
13187047|NCT02146365|26173725|FG005|Overall Study|Withdrawal by Subject|0|||
13187048|NCT02146365|26173726|FG006|Overall Study|Withdrawal by Subject|0|||
13187049|NCT02146365|26173727|FG007|Overall Study|Withdrawal by Subject|0|||
13187050|NCT02146365|26173720|FG000|Overall Study|Unable to Comply with Protocol|0|||
13187051|NCT02146365|26173721|FG001|Overall Study|Unable to Comply with Protocol|1|||
13187052|NCT02146365|26173722|FG002|Overall Study|Unable to Comply with Protocol|1|||
13187053|NCT02146365|26173723|FG003|Overall Study|Unable to Comply with Protocol|0|||
13187054|NCT02146365|26173724|FG004|Overall Study|Unable to Comply with Protocol|0|||
13187055|NCT02146365|26173725|FG005|Overall Study|Unable to Comply with Protocol|0|||
13187056|NCT02146365|26173726|FG006|Overall Study|Unable to Comply with Protocol|0|||
13187057|NCT02146365|26173727|FG007|Overall Study|Unable to Comply with Protocol|0|||
13187058|NCT02146365|26173720|FG000|Overall Study|Other|1|||
13187059|NCT02146365|26173721|FG001|Overall Study|Other|0|||
13187060|NCT02146365|26173722|FG002|Overall Study|Other|2|||
13187061|NCT02146365|26173723|FG003|Overall Study|Other|1|||
13187062|NCT02146365|26173724|FG004|Overall Study|Other|0|||
13187063|NCT02146365|26173725|FG005|Overall Study|Other|0|||
13187064|NCT02146365|26173726|FG006|Overall Study|Other|0|||
13187065|NCT02146365|26173727|FG007|Overall Study|Other|0|||
13187066|NCT02146352|26173743|FG000|Overall Study|Death|1|||
13187067|NCT02146352|26173743|FG000|Overall Study|Patient entered hospice care|1|||
13187068|NCT02146326|26173918|FG000|Overall Study|Lost to Follow-up|3|||
13187069|NCT02146326|26173919|FG001|Overall Study|Lost to Follow-up|3|||
13187070|NCT02146326|26173920|FG002|Overall Study|Lost to Follow-up|11|||
13187071|NCT02146326|26173921|FG003|Overall Study|Lost to Follow-up|19|||
13187072|NCT02146326|26173918|FG000|Overall Study|Withdrawal by Subject|2|||
13187073|NCT02146326|26173919|FG001|Overall Study|Withdrawal by Subject|1|||
13187074|NCT02146326|26173920|FG002|Overall Study|Withdrawal by Subject|15|||
13187075|NCT02146326|26173921|FG003|Overall Study|Withdrawal by Subject|11|||
13187076|NCT02146326|26173918|FG000|Overall Study|Separated from mental health center|23|||
13187077|NCT02146326|26173919|FG001|Overall Study|Separated from mental health center|33|||
13187078|NCT02146326|26173920|FG002|Overall Study|Separated from mental health center|0|||
13187079|NCT02146326|26173921|FG003|Overall Study|Separated from mental health center|0|||
13187080|NCT02146326|26173918|FG000|Overall Study|Incarcerated|0|||
13187081|NCT02146326|26173919|FG001|Overall Study|Incarcerated|0|||
13187082|NCT02146326|26173920|FG002|Overall Study|Incarcerated|3|||
13187083|NCT02146326|26173921|FG003|Overall Study|Incarcerated|8|||
13187084|NCT02146326|26173918|FG000|Overall Study|Death|0|||
13187085|NCT02146326|26173919|FG001|Overall Study|Death|0|||
13187086|NCT02146326|26173920|FG002|Overall Study|Death|4|||
13187087|NCT02146326|26173921|FG003|Overall Study|Death|4|||
13187088|NCT02146326|26173918|FG000|Overall Study|Unable to complete interview|0|||
13187089|NCT02146326|26173919|FG001|Overall Study|Unable to complete interview|0|||
13187090|NCT02146326|26173920|FG002|Overall Study|Unable to complete interview|10|||
13187091|NCT02146326|26173921|FG003|Overall Study|Unable to complete interview|6|||
13187092|NCT02146274|26173930|FG000|Overall Study|Protocol Violation|73|||
13187093|NCT02146248|26173940|FG000|Overall Study|Withdrawal by Subject|2|||
13187094|NCT02146131|26173953|FG000|Overall Study|Physician Decision|61|||
13187095|NCT02146131|26173954|FG001|Overall Study|Physician Decision|56|||
13187096|NCT02146105|26173960|FG000|Overall Study|Adverse Event|1|||
13187097|NCT02146105|26173960|FG000|Overall Study|Withdrawal by Subject|5|||
13187098|NCT02145468|26174023|FG000|Overall Study|Withdrawal by Subject|5|||
13187099|NCT02145468|26174024|FG001|Overall Study|Withdrawal by Subject|8|||
13187100|NCT02145429|26174041|FG000|Overall Study|Death|4|||
13187101|NCT02145429|26174042|FG001|Overall Study|Death|5|||
13187102|NCT02145429|26174041|FG000|Overall Study|Lost to Follow-up|4|||
13187103|NCT02145429|26174042|FG001|Overall Study|Lost to Follow-up|3|||
13187104|NCT02145429|26174041|FG000|Overall Study|Withdrawal by Subject|8|||
13187105|NCT02145429|26174042|FG001|Overall Study|Withdrawal by Subject|3|||
13187106|NCT02145390|26174053|FG000|Overall Study|Withdrawal by Subject|1|||
13187107|NCT02145182|26174074|FG000|Overall Study|Adverse Event|4|||
13187108|NCT02145182|26174075|FG001|Overall Study|Adverse Event|1|||
13187109|NCT02145182|26174074|FG000|Overall Study|Death|7|||
13187110|NCT02145182|26174075|FG001|Overall Study|Death|7|||
13187111|NCT02145182|26174074|FG000|Overall Study|Lost to Follow-up|2|||
13187112|NCT02145182|26174075|FG001|Overall Study|Lost to Follow-up|2|||
13187113|NCT02145182|26174074|FG000|Overall Study|Pre-transplant Withdrawal|0|||
13187114|NCT02145182|26174075|FG001|Overall Study|Pre-transplant Withdrawal|2|||
13187115|NCT02145182|26174074|FG000|Overall Study|Withdrawal by Subject|5|||
13187116|NCT02145182|26174075|FG001|Overall Study|Withdrawal by Subject|4|||
13187117|NCT02145156|26174126|FG000|Overall Study|No match to vaccination records|60|||
13187118|NCT02145156|26174127|FG001|Overall Study|No match to vaccination records|52|||
13187119|NCT02145156|26174128|FG002|Overall Study|No match to vaccination records|41|||
13187120|NCT02145078|26174138|FG000|Overall Study|Death|1|||
13187121|NCT02145078|26174138|FG000|Overall Study|Reason not given|3|||
13187122|NCT02145026|26174147|FG000|Overall Study|Adverse Event|2|||
13187123|NCT02145026|26174147|FG000|Overall Study|Death|4|||
13187124|NCT02145026|26174147|FG000|Overall Study|Withdrawal by Subject|2|||
13187125|NCT02145026|26174147|FG000|Overall Study|Physician Decision|4|||
13187126|NCT02144701|26174170|FG000|Overall Study|development of relapse, GVHD or death|9|||
13187127|NCT02144701|26174171|FG001|Overall Study|development of relapse, GVHD or death|3|||
13187128|NCT02144610|26174206|FG000|Overall Study|Physician Decision|1|||
13187129|NCT02144610|26174207|FG001|Overall Study|Physician Decision|0|||
13187130|NCT02144610|26174206|FG000|Overall Study|Withdrawal by Subject|1|||
13187131|NCT02144610|26174207|FG001|Overall Study|Withdrawal by Subject|5|||
13187132|NCT02144610|26174206|FG000|Overall Study|Death|2|||
13187133|NCT02144610|26174207|FG001|Overall Study|Death|2|||
13187134|NCT02144610|26174206|FG000|Overall Study|Study Discontinuation by Sponsor|19|||
13187135|NCT02144610|26174207|FG001|Overall Study|Study Discontinuation by Sponsor|14|||
13187136|NCT02144610|26174206|FG000|Overall Study|Other|0|||
13187137|NCT02144610|26174207|FG001|Overall Study|Other|1|||
13187138|NCT02144337|26174224|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
13187139|NCT02144337|26174225|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
13187140|NCT02144337|26174224|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2|||
13187141|NCT02144337|26174225|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0|||
13187142|NCT02144337|26174224|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1|||
13187143|NCT02144337|26174225|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0|||
13187144|NCT02144337|26174224|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2|||
13187145|NCT02144337|26174225|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0|||
13187146|NCT02144337|26174224|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1|||
13187147|NCT02144337|26174225|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0|||
13187148|NCT02144285|26174326|FG000|Overall Study|Withdrawal by Subject|0|||
13187149|NCT02144285|26174327|FG001|Overall Study|Withdrawal by Subject|0|||
13187150|NCT02144285|26174328|FG002|Overall Study|Withdrawal by Subject|0|||
13187151|NCT02144285|26174329|FG003|Overall Study|Withdrawal by Subject|0|||
13187152|NCT02144285|26174330|FG004|Overall Study|Withdrawal by Subject|1|||
13187153|NCT02144285|26174331|FG005|Overall Study|Withdrawal by Subject|0|||
13187154|NCT02144285|26174332|FG006|Overall Study|Withdrawal by Subject|0|||
13187155|NCT02144285|26174333|FG007|Overall Study|Withdrawal by Subject|0|||
13187156|NCT02144285|26174334|FG008|Overall Study|Withdrawal by Subject|0|||
13187157|NCT02144285|26174335|FG009|Overall Study|Withdrawal by Subject|0|||
13110630|NCT03208088|25899933|FG008|Period 4|Unsatisfactory Test Article|0|||
13110631|NCT03208088|25899934|FG009|Period 4|Unsatisfactory Test Article|0|||
13110632|NCT03207763|25899965|FG000|Overall Study|Lost to Follow-up|1|||
13110633|NCT03207763|25899966|FG001|Overall Study|Lost to Follow-up|0|||
13110634|NCT03207750|25900015|FG000|Overall Study|Adverse Event|3|||
13110635|NCT03207750|25900016|FG001|Overall Study|Adverse Event|2|||
13187158|NCT02144220|26174345|FG000|Overall Study|technology incompatibility|9|||
13187159|NCT02144220|26174345|FG000|Overall Study|Lack of Efficacy|4|||
13187160|NCT02144220|26174345|FG000|Overall Study|Physician Decision|3|||
13187161|NCT02144220|26174345|FG000|Overall Study|Withdrawal by Subject|2|||
13187162|NCT02144220|26174345|FG000|Overall Study|Protocol Violation|1|||
13187163|NCT02144077|26174372|FG000|Overall Study|Withdrawal by Subject|3|||
13187164|NCT02144077|26174373|FG001|Overall Study|Withdrawal by Subject|3|||
13187165|NCT02144077|26174372|FG000|Overall Study|Adverse Event|2|||
13187166|NCT02144077|26174373|FG001|Overall Study|Adverse Event|3|||
13187167|NCT02144077|26174372|FG000|Overall Study|Lost to Follow-up|2|||
13187168|NCT02144077|26174373|FG001|Overall Study|Lost to Follow-up|2|||
13187169|NCT02144077|26174372|FG000|Overall Study|Protocol Violation|1|||
13187170|NCT02144077|26174373|FG001|Overall Study|Protocol Violation|2|||
13187171|NCT02144077|26174372|FG000|Overall Study|Death|0|||
13187172|NCT02144077|26174373|FG001|Overall Study|Death|1|||
13187173|NCT02144077|26174372|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2|||
13187174|NCT02144077|26174373|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0|||
13187175|NCT02144012|26174415|FG000|Overall Study|Adverse Event|1|||
13187176|NCT02144012|26174416|FG001|Overall Study|Adverse Event|0|||
13187177|NCT02144012|26174415|FG000|Overall Study|Death|1|||
13187178|NCT02144012|26174416|FG001|Overall Study|Death|0|||
13187179|NCT02144012|26174415|FG000|Overall Study|Withdrawal by Subject|11|||
13187180|NCT02144012|26174416|FG001|Overall Study|Withdrawal by Subject|3|||
13187181|NCT02144012|26174415|FG000|Overall Study|Study Terminated by Sponsor|18|||
13187182|NCT02144012|26174416|FG001|Overall Study|Study Terminated by Sponsor|12|||
13187183|NCT02144012|26174415|FG000|Overall Study|Other|3|||
13187184|NCT02144012|26174416|FG001|Overall Study|Other|0|||
13187185|NCT02143947|26174435|FG000|Overall Study|Lost to Follow-up|4|||
13187186|NCT02143947|26174436|FG001|Overall Study|Lost to Follow-up|2|||
13187187|NCT02143843|26174443|FG000|Overall Study|Adverse Event|8|||
13187188|NCT02143843|26174443|FG000|Overall Study|Lack of Efficacy|2|||
13110636|NCT03207750|25900015|FG000|Overall Study|Lost to Follow-up|21|||
13110637|NCT03207750|25900016|FG001|Overall Study|Lost to Follow-up|29|||
13110638|NCT03207750|25900015|FG000|Overall Study|Protocol Violation|0|||
13187189|NCT02143843|26174443|FG000|Overall Study|Withdrawal by Subject|2|||
13187190|NCT02143713|26174534|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1|||
13187191|NCT02143713|26174535|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2|||
13187192|NCT02143713|26174536|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5|||
13187193|NCT02143713|26174537|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4|||
13110639|NCT03207750|25900016|FG001|Overall Study|Protocol Violation|1|||
13110640|NCT03207750|25900015|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11|||
13110641|NCT03207750|25900016|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13|||
13187194|NCT02143713|26174534|FG000|Treatment Period (6 Months)|Adverse Event|7|||
13187195|NCT02143713|26174535|FG001|Treatment Period (6 Months)|Adverse Event|8|||
13187196|NCT02143713|26174536|FG002|Treatment Period (6 Months)|Adverse Event|8|||
13187197|NCT02143713|26174537|FG003|Treatment Period (6 Months)|Adverse Event|9|||
13187198|NCT02143713|26174534|FG000|Treatment Period (6 Months)|Lost to Follow-up|3|||
13187199|NCT02143713|26174535|FG001|Treatment Period (6 Months)|Lost to Follow-up|0|||
13187200|NCT02143713|26174536|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
13187201|NCT02143713|26174537|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
13187202|NCT02143713|26174534|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
13187203|NCT02143713|26174535|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
13187204|NCT02143713|26174536|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
13187205|NCT02143713|26174537|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
13187206|NCT02143713|26174534|FG000|Treatment Period (6 Months)|Pregnancy|0|||
13187207|NCT02143713|26174535|FG001|Treatment Period (6 Months)|Pregnancy|2|||
13187208|NCT02143713|26174536|FG002|Treatment Period (6 Months)|Pregnancy|2|||
13187209|NCT02143713|26174537|FG003|Treatment Period (6 Months)|Pregnancy|0|||
13187210|NCT02143713|26174534|FG000|Treatment Period (6 Months)|Non-compliance|1|||
13187211|NCT02143713|26174535|FG001|Treatment Period (6 Months)|Non-compliance|0|||
13187212|NCT02143713|26174536|FG002|Treatment Period (6 Months)|Non-compliance|0|||
13187213|NCT02143713|26174537|FG003|Treatment Period (6 Months)|Non-compliance|3|||
13187214|NCT02143713|26174534|FG000|Treatment Period (6 Months)|Other|3|||
13187215|NCT02143713|26174535|FG001|Treatment Period (6 Months)|Other|0|||
13187216|NCT02143713|26174536|FG002|Treatment Period (6 Months)|Other|3|||
13187217|NCT02143713|26174537|FG003|Treatment Period (6 Months)|Other|2|||
13187218|NCT02143713|26174534|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
13187219|NCT02143713|26174535|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
13187220|NCT02143713|26174536|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
13187221|NCT02143713|26174537|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4|||
13187222|NCT02143713|26174534|FG000|Treatment Period (6 Months)|Exclusionary Medication|2|||
13187223|NCT02143713|26174535|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
13187224|NCT02143713|26174536|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
13187225|NCT02143713|26174537|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
13187226|NCT02143713|26174534|FG000|Treatment Period (6 Months)|Lack of Efficacy|1|||
13187227|NCT02143713|26174535|FG001|Treatment Period (6 Months)|Lack of Efficacy|0|||
13187228|NCT02143713|26174536|FG002|Treatment Period (6 Months)|Lack of Efficacy|0|||
13187229|NCT02143713|26174537|FG003|Treatment Period (6 Months)|Lack of Efficacy|1|||
13187230|NCT02143713|26174534|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
13187231|NCT02143713|26174535|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7|||
13187232|NCT02143713|26174536|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
13187233|NCT02143713|26174537|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10|||
13187234|NCT02143713|26174534|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
13187235|NCT02143713|26174535|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
13187236|NCT02143713|26174536|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1|||
13187237|NCT02143713|26174537|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
13187238|NCT02143713|26174534|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3|||
13187239|NCT02143713|26174535|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
13187240|NCT02143713|26174536|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11|||
13110642|NCT03207750|25900015|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
13110643|NCT03207750|25900016|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10|||
13110644|NCT03207750|25900015|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10|||
13110645|NCT03207750|25900016|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5|||
13110646|NCT03207750|25900015|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1|||
13110647|NCT03207750|25900016|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2|||
13110648|NCT03207750|25900015|FG000|Overall Study|OTHER, NOT SPECIFIED|5|||
13110649|NCT03207750|25900016|FG001|Overall Study|OTHER, NOT SPECIFIED|4|||
13110650|NCT03207451|25900047|FG000|Overall Study|scheduling conflict|1|||
13110651|NCT03207451|25900048|FG001|Overall Study|scheduling conflict|0|||
13110652|NCT03207451|25900049|FG002|Overall Study|scheduling conflict|2|||
13110653|NCT03207451|25900050|FG003|Overall Study|scheduling conflict|2|||
13110654|NCT03207451|25900047|FG000|Overall Study|Adverse Event|0|||
13110655|NCT03207451|25900048|FG001|Overall Study|Adverse Event|0|||
13187241|NCT02143713|26174537|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
13187242|NCT02143713|26174534|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2|||
13187243|NCT02143713|26174535|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
13187244|NCT02143713|26174536|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
13187245|NCT02143713|26174537|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1|||
13187246|NCT02143713|26174534|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
13187247|NCT02143713|26174535|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
13187248|NCT02143713|26174536|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
13187249|NCT02143713|26174537|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
13187250|NCT02143713|26174534|FG000|Post-treatment Follow-up (12 Months)|Other|3|||
13187251|NCT02143713|26174535|FG001|Post-treatment Follow-up (12 Months)|Other|4|||
13187252|NCT02143713|26174536|FG002|Post-treatment Follow-up (12 Months)|Other|7|||
13187253|NCT02143713|26174537|FG003|Post-treatment Follow-up (12 Months)|Other|7|||
13187254|NCT02143583|26174558|FG000|Overall Study|Withdrawal by Subject|1|||
13187255|NCT02143583|26174559|FG001|Overall Study|Withdrawal by Subject|0|||
13187256|NCT02143583|26174560|FG002|Overall Study|Withdrawal by Subject|1|||
13187257|NCT02143583|26174558|FG000|Overall Study|husband illness|0|||
13187258|NCT02143583|26174559|FG001|Overall Study|husband illness|0|||
13187259|NCT02143583|26174560|FG002|Overall Study|husband illness|1|||
13187260|NCT02143141|26174577|FG000|Overall Study|pain scores at 24 hours not collected|1|||
13187261|NCT02143141|26174578|FG001|Overall Study|pain scores at 24 hours not collected|0|||
13187262|NCT02143102|26174593|FG000|Overall Study|Lost to Follow-up|11|||
13187263|NCT02143102|26174594|FG001|Overall Study|Lost to Follow-up|0|||
13187264|NCT02143024|26174607|FG000|Overall Study|Lost to Follow-up|1|||
13187265|NCT02143024|26174608|FG001|Overall Study|Lost to Follow-up|1|||
13187266|NCT02143024|26174607|FG000|Overall Study|Withdrawal by Subject|1|||
13187267|NCT02143024|26174608|FG001|Overall Study|Withdrawal by Subject|0|||
13187268|NCT02142894|26174614|FG000|Overall Study|Protocol Violation|8|||
13187269|NCT02142712|26174645|FG000|Overall Study|Lost to Follow-up|1|||
13187270|NCT02142712|26174646|FG001|Overall Study|Lost to Follow-up|1|||
13187271|NCT02142712|26174647|FG002|Overall Study|Lost to Follow-up|1|||
13187272|NCT02142712|26174648|FG003|Overall Study|Lost to Follow-up|0|||
13187273|NCT02142504|26174744|FG000|Overall Study|Protocol Violation|2|||
13187274|NCT02142504|26174745|FG001|Overall Study|Protocol Violation|1|||
13187275|NCT02142504|26174746|FG002|Overall Study|Protocol Violation|2|||
13187276|NCT02142504|26174744|FG000|Overall Study|Adverse Event|2|||
13187277|NCT02142504|26174745|FG001|Overall Study|Adverse Event|3|||
13187278|NCT02142504|26174746|FG002|Overall Study|Adverse Event|4|||
13187279|NCT02142504|26174744|FG000|Overall Study|Lost to Follow-up|12|||
13187280|NCT02142504|26174745|FG001|Overall Study|Lost to Follow-up|19|||
13187281|NCT02142504|26174746|FG002|Overall Study|Lost to Follow-up|17|||
13187282|NCT02142504|26174744|FG000|Overall Study|Withdrawal by Subject|7|||
13187283|NCT02142504|26174745|FG001|Overall Study|Withdrawal by Subject|9|||
13187284|NCT02142504|26174746|FG002|Overall Study|Withdrawal by Subject|11|||
13187285|NCT02142504|26174744|FG000|Overall Study|Pregnancy|4|||
13187286|NCT02142504|26174745|FG001|Overall Study|Pregnancy|4|||
13187287|NCT02142504|26174746|FG002|Overall Study|Pregnancy|2|||
13187288|NCT02142504|26174744|FG000|Overall Study|Physician Decision|0|||
13187289|NCT02142504|26174745|FG001|Overall Study|Physician Decision|1|||
13187290|NCT02142504|26174746|FG002|Overall Study|Physician Decision|3|||
13187291|NCT02142504|26174744|FG000|Overall Study|Reason Not Specified|4|||
13187292|NCT02142504|26174745|FG001|Overall Study|Reason Not Specified|5|||
13110656|NCT03207451|25900049|FG002|Overall Study|Adverse Event|0|||
13110657|NCT03207451|25900050|FG003|Overall Study|Adverse Event|1|||
13110658|NCT03207243|25900164|FG000|Overall Study|Adverse Event|2|||
13110659|NCT03207243|25900165|FG001|Overall Study|Adverse Event|2|||
13110660|NCT03207243|25900164|FG000|Overall Study|Loss of Asthma Control|47|||
13110661|NCT03207243|25900165|FG001|Overall Study|Loss of Asthma Control|31|||
13110662|NCT03207243|25900164|FG000|Overall Study|Withdrawal by Subject|2|||
13110663|NCT03207243|25900165|FG001|Overall Study|Withdrawal by Subject|4|||
13110664|NCT03207243|25900164|FG000|Overall Study|Physician Decision|1|||
13110665|NCT03207243|25900165|FG001|Overall Study|Physician Decision|1|||
13110666|NCT03207243|25900164|FG000|Overall Study|Lost to Follow-up|0|||
13110667|NCT03207243|25900165|FG001|Overall Study|Lost to Follow-up|1|||
13110668|NCT03207243|25900164|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7|||
13110669|NCT03207243|25900165|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2|||
13110670|NCT03207243|25900164|FG000|Overall Study|Protocol Violation|0|||
13110671|NCT03207243|25900165|FG001|Overall Study|Protocol Violation|3|||
13110672|NCT03206970|25900177|FG000|Overall Study|Death|21|||
13110673|NCT03206970|25900177|FG000|Overall Study|Withdrawal by Subject|13|||
13110674|NCT03206970|25900177|FG000|Overall Study|Lost to Follow-up|3|||
13110675|NCT03206970|25900177|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49|||
13110676|NCT03206918|25900188|FG000|Overall Study|Death|11|||
13110677|NCT03206918|25900188|FG000|Overall Study|Withdrawal by Subject|5|||
13187293|NCT02142504|26174746|FG002|Overall Study|Reason Not Specified|4|||
13187294|NCT02142387|26174763|FG000|Overall Study|<19 years old|49|||
13187295|NCT02142387|26174764|FG001|Overall Study|<19 years old|326|||
13187296|NCT02142387|26174763|FG000|Overall Study|non-cardiac etiology|504|||
13187297|NCT02142387|26174764|FG001|Overall Study|non-cardiac etiology|3431|||
13187298|NCT02142387|26174763|FG000|Overall Study|CPR not performed|74|||
13187299|NCT02142387|26174764|FG001|Overall Study|CPR not performed|473|||
13187300|NCT02142387|26174763|FG000|Overall Study|witnessed by paramedic|139|||
13187301|NCT02142387|26174764|FG001|Overall Study|witnessed by paramedic|917|||
13187302|NCT02142387|26174763|FG000|Overall Study|incomplete data|1|||
13187303|NCT02142387|26174764|FG001|Overall Study|incomplete data|9|||
13187304|NCT02142387|26174763|FG000|Overall Study|occurred not at home|298|||
13187305|NCT02142387|26174764|FG001|Overall Study|occurred not at home|2474|||
13187306|NCT02142283|26174791|FG000|Overall Study|Death|20|||
13187307|NCT02142283|26174792|FG001|Overall Study|Death|18|||
13187308|NCT02142283|26174791|FG000|Overall Study|Withdrawal by Subject|1|||
13187309|NCT02142283|26174792|FG001|Overall Study|Withdrawal by Subject|3|||
13187310|NCT02141997|26174843|FG000|Overall Study|Adverse Event|0|||
13187311|NCT02141997|26174844|FG001|Overall Study|Adverse Event|2|||
13187312|NCT02141997|26174845|FG002|Overall Study|Adverse Event|0|||
13187313|NCT02141997|26174846|FG003|Overall Study|Adverse Event|1|||
13187314|NCT02141997|26174843|FG000|Overall Study|Participant noncompliance|1|||
13187315|NCT02141997|26174844|FG001|Overall Study|Participant noncompliance|0|||
13187316|NCT02141997|26174845|FG002|Overall Study|Participant noncompliance|0|||
13187317|NCT02141997|26174846|FG003|Overall Study|Participant noncompliance|0|||
13187318|NCT02141997|26174843|FG000|Overall Study|Withdrew consent|1|||
13187319|NCT02141997|26174844|FG001|Overall Study|Withdrew consent|0|||
13187320|NCT02141997|26174845|FG002|Overall Study|Withdrew consent|3|||
13187321|NCT02141997|26174846|FG003|Overall Study|Withdrew consent|0|||
13187322|NCT02141997|26174843|FG000|Overall Study|Other|1|||
13187323|NCT02141997|26174844|FG001|Overall Study|Other|4|||
13187324|NCT02141997|26174845|FG002|Overall Study|Other|0|||
13187325|NCT02141997|26174846|FG003|Overall Study|Other|0|||
13187326|NCT02141984|26174855|FG000|Overall Study|Lack of Efficacy|2|||
13187327|NCT02141854|26174924|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25|||
13187328|NCT02141854|26174925|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
13187329|NCT02141854|26174926|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
13187330|NCT02141854|26174927|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
13187331|NCT02141854|26174928|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
13187332|NCT02141854|26174929|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
13187333|NCT02141854|26174924|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76|||
13187334|NCT02141854|26174925|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
13187335|NCT02141854|26174926|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
13187336|NCT02141854|26174927|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
13187337|NCT02141854|26174928|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
13187338|NCT02141854|26174929|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
13187339|NCT02141854|26174924|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14|||
13187340|NCT02141854|26174925|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
13187341|NCT02141854|26174926|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
13187342|NCT02141854|26174927|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
13187343|NCT02141854|26174928|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
13187344|NCT02141854|26174929|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
13187345|NCT02141854|26174924|FG000|Run-In Period (Pre-assignment)|Other|14|||
13187346|NCT02141854|26174925|FG001|Run-In Period (Pre-assignment)|Other|0|||
13187347|NCT02141854|26174926|FG002|Run-In Period (Pre-assignment)|Other|0|||
13187348|NCT02141854|26174927|FG003|Run-In Period (Pre-assignment)|Other|0|||
13187349|NCT02141854|26174928|FG004|Run-In Period (Pre-assignment)|Other|0|||
13187350|NCT02141854|26174929|FG005|Run-In Period (Pre-assignment)|Other|0|||
13187351|NCT02141854|26174924|FG000|Run-In Period (Pre-assignment)|Adverse Event|10|||
13187352|NCT02141854|26174925|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
13187353|NCT02141854|26174926|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
13187354|NCT02141854|26174927|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
13187355|NCT02141854|26174928|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
13187356|NCT02141854|26174929|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
13187357|NCT02141854|26174924|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9|||
13187358|NCT02141854|26174925|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
13187359|NCT02141854|26174926|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
13187360|NCT02141854|26174927|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
13187361|NCT02141854|26174928|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
13187362|NCT02141854|26174929|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
13187363|NCT02141854|26174924|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
13187364|NCT02141854|26174925|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
13206182|NCT01959425|26233773|FG000|Overall Study|Lost to Follow-up|1|||
13187365|NCT02141854|26174926|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
13187366|NCT02141854|26174927|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
13187367|NCT02141854|26174928|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
13187368|NCT02141854|26174929|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
13187369|NCT02141854|26174924|FG000|Treatment Period|Protocol Violation|0|||
13187370|NCT02141854|26174925|FG001|Treatment Period|Protocol Violation|1|||
13187371|NCT02141854|26174926|FG002|Treatment Period|Protocol Violation|0|||
13187372|NCT02141854|26174927|FG003|Treatment Period|Protocol Violation|2|||
13187373|NCT02141854|26174928|FG004|Treatment Period|Protocol Violation|2|||
13187374|NCT02141854|26174929|FG005|Treatment Period|Protocol Violation|1|||
13187375|NCT02141854|26174924|FG000|Treatment Period|Noncompliance|0|||
13187376|NCT02141854|26174925|FG001|Treatment Period|Noncompliance|0|||
13110678|NCT03206918|25900188|FG000|Overall Study|Study terminated by sponsor|12|||
13187377|NCT02141854|26174926|FG002|Treatment Period|Noncompliance|0|||
13187378|NCT02141854|26174927|FG003|Treatment Period|Noncompliance|1|||
13187379|NCT02141854|26174928|FG004|Treatment Period|Noncompliance|0|||
13187380|NCT02141854|26174929|FG005|Treatment Period|Noncompliance|0|||
13187381|NCT02141854|26174924|FG000|Treatment Period|Lack of Efficacy|0|||
13187382|NCT02141854|26174925|FG001|Treatment Period|Lack of Efficacy|0|||
13187383|NCT02141854|26174926|FG002|Treatment Period|Lack of Efficacy|0|||
13187384|NCT02141854|26174927|FG003|Treatment Period|Lack of Efficacy|1|||
13187385|NCT02141854|26174928|FG004|Treatment Period|Lack of Efficacy|1|||
13187386|NCT02141854|26174929|FG005|Treatment Period|Lack of Efficacy|7|||
13187387|NCT02141854|26174924|FG000|Treatment Period|Pregnancy|0|||
13187388|NCT02141854|26174925|FG001|Treatment Period|Pregnancy|1|||
13187389|NCT02141854|26174926|FG002|Treatment Period|Pregnancy|0|||
13110679|NCT03206918|25900188|FG000|Overall Study|Lost to Follow-up|3|||
13110680|NCT03206918|25900188|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60|||
13110681|NCT03206788|25900231|FG000|Overall Study|Withdrawal by Subject|0|||
13187390|NCT02141854|26174927|FG003|Treatment Period|Pregnancy|0|||
13187391|NCT02141854|26174928|FG004|Treatment Period|Pregnancy|0|||
13187392|NCT02141854|26174929|FG005|Treatment Period|Pregnancy|0|||
13187393|NCT02141854|26174924|FG000|Treatment Period|Other|0|||
13187394|NCT02141854|26174925|FG001|Treatment Period|Other|1|||
13187395|NCT02141854|26174926|FG002|Treatment Period|Other|2|||
13187396|NCT02141854|26174927|FG003|Treatment Period|Other|0|||
13187397|NCT02141854|26174928|FG004|Treatment Period|Other|1|||
13187398|NCT02141854|26174929|FG005|Treatment Period|Other|2|||
13187399|NCT02141854|26174924|FG000|Treatment Period|Adverse Event|0|||
13187400|NCT02141854|26174925|FG001|Treatment Period|Adverse Event|2|||
13187401|NCT02141854|26174926|FG002|Treatment Period|Adverse Event|2|||
13187402|NCT02141854|26174927|FG003|Treatment Period|Adverse Event|0|||
13187403|NCT02141854|26174928|FG004|Treatment Period|Adverse Event|2|||
13187404|NCT02141854|26174929|FG005|Treatment Period|Adverse Event|2|||
13187405|NCT02141854|26174924|FG000|Treatment Period|Withdrawal by Subject|0|||
13187406|NCT02141854|26174925|FG001|Treatment Period|Withdrawal by Subject|2|||
13187407|NCT02141854|26174926|FG002|Treatment Period|Withdrawal by Subject|3|||
13187408|NCT02141854|26174927|FG003|Treatment Period|Withdrawal by Subject|3|||
13187409|NCT02141854|26174928|FG004|Treatment Period|Withdrawal by Subject|4|||
13187410|NCT02141854|26174929|FG005|Treatment Period|Withdrawal by Subject|7|||
13187411|NCT02141854|26174924|FG000|Treatment Period|Disease progression|0|||
13187412|NCT02141854|26174925|FG001|Treatment Period|Disease progression|2|||
13187413|NCT02141854|26174926|FG002|Treatment Period|Disease progression|1|||
13187414|NCT02141854|26174927|FG003|Treatment Period|Disease progression|3|||
13187415|NCT02141854|26174928|FG004|Treatment Period|Disease progression|0|||
13187416|NCT02141854|26174929|FG005|Treatment Period|Disease progression|18|||
13187417|NCT02141854|26174924|FG000|Treatment Period|Lost to Follow-up|0|||
13110682|NCT03206788|25900232|FG001|Overall Study|Withdrawal by Subject|1|||
13110683|NCT03206788|25900231|FG000|Overall Study|Adverse Event|0|||
13187418|NCT02141854|26174925|FG001|Treatment Period|Lost to Follow-up|1|||
13187419|NCT02141854|26174926|FG002|Treatment Period|Lost to Follow-up|1|||
13187420|NCT02141854|26174927|FG003|Treatment Period|Lost to Follow-up|1|||
13187421|NCT02141854|26174928|FG004|Treatment Period|Lost to Follow-up|0|||
13187422|NCT02141854|26174929|FG005|Treatment Period|Lost to Follow-up|1|||
13187423|NCT02141672|26174995|FG000|Overall Study|Adverse Event|0|||
13187424|NCT02141672|26174996|FG001|Overall Study|Adverse Event|1|||
13187425|NCT02141672|26174997|FG002|Overall Study|Adverse Event|0|||
13187426|NCT02141672|26174995|FG000|Overall Study|Death|10|||
13187427|NCT02141672|26174996|FG001|Overall Study|Death|2|||
13187428|NCT02141672|26174997|FG002|Overall Study|Death|1|||
13187429|NCT02141672|26174995|FG000|Overall Study|Lack of Efficacy|0|||
13187430|NCT02141672|26174996|FG001|Overall Study|Lack of Efficacy|0|||
13110684|NCT03206788|25900232|FG001|Overall Study|Adverse Event|1|||
13110685|NCT03206788|25900231|FG000|Overall Study|Physician Decision|0|||
13110686|NCT03206788|25900232|FG001|Overall Study|Physician Decision|1|||
13110687|NCT03206749|25900269|FG000|Overall Study|Withdrawal of consent|5|||
13187431|NCT02141672|26174997|FG002|Overall Study|Lack of Efficacy|2|||
13187432|NCT02141672|26174995|FG000|Overall Study|Lost to Follow-up|1|||
13187433|NCT02141672|26174996|FG001|Overall Study|Lost to Follow-up|1|||
13187434|NCT02141672|26174997|FG002|Overall Study|Lost to Follow-up|3|||
13187435|NCT02141672|26174995|FG000|Overall Study|Physician Decision|1|||
13187436|NCT02141672|26174996|FG001|Overall Study|Physician Decision|2|||
13187437|NCT02141672|26174997|FG002|Overall Study|Physician Decision|5|||
13187438|NCT02141672|26174995|FG000|Overall Study|Protocol Violation|0|||
13187439|NCT02141672|26174996|FG001|Overall Study|Protocol Violation|0|||
13187440|NCT02141672|26174997|FG002|Overall Study|Protocol Violation|1|||
13187441|NCT02141672|26174995|FG000|Overall Study|Withdrawal by Subject|3|||
13187442|NCT02141672|26174996|FG001|Overall Study|Withdrawal by Subject|2|||
13187443|NCT02141672|26174997|FG002|Overall Study|Withdrawal by Subject|5|||
13187444|NCT02141672|26174995|FG000|Overall Study|refused to follow-up|1|||
13187445|NCT02141672|26174996|FG001|Overall Study|refused to follow-up|0|||
13187446|NCT02141672|26174997|FG002|Overall Study|refused to follow-up|1|||
13187447|NCT02141659|26175070|FG000|Overall Study|Major Protocol Deviation|0|||
13187448|NCT02141659|26175071|FG001|Overall Study|Major Protocol Deviation|1|||
13187449|NCT02141659|26175072|FG002|Overall Study|Major Protocol Deviation|0|||
13187450|NCT02141659|26175073|FG003|Overall Study|Major Protocol Deviation|0|||
13187451|NCT02141659|26175074|FG004|Overall Study|Major Protocol Deviation|0|||
13187452|NCT02141659|26175075|FG005|Overall Study|Major Protocol Deviation|0|||
13187453|NCT02141659|26175070|FG000|Overall Study|Lack of Efficacy|0|||
13187454|NCT02141659|26175071|FG001|Overall Study|Lack of Efficacy|0|||
13187455|NCT02141659|26175072|FG002|Overall Study|Lack of Efficacy|0|||
13187456|NCT02141659|26175073|FG003|Overall Study|Lack of Efficacy|0|||
13187457|NCT02141659|26175074|FG004|Overall Study|Lack of Efficacy|0|||
13187458|NCT02141659|26175075|FG005|Overall Study|Lack of Efficacy|1|||
13187459|NCT02141659|26175070|FG000|Overall Study|Pretreatment Event/ Adverse Event|0|||
13187460|NCT02141659|26175071|FG001|Overall Study|Pretreatment Event/ Adverse Event|0|||
13187461|NCT02141659|26175072|FG002|Overall Study|Pretreatment Event/ Adverse Event|0|||
13187462|NCT02141659|26175073|FG003|Overall Study|Pretreatment Event/ Adverse Event|0|||
13187463|NCT02141659|26175074|FG004|Overall Study|Pretreatment Event/ Adverse Event|2|||
13187464|NCT02141659|26175075|FG005|Overall Study|Pretreatment Event/ Adverse Event|1|||
13187465|NCT02141633|26175090|FG000|Overall Study|Physician Decision|1|||
13187466|NCT02141633|26175091|FG001|Overall Study|Physician Decision|0|||
13187467|NCT02141620|26175152|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1|||
13187468|NCT02141620|26175153|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0|||
13206183|NCT01959425|26233774|FG001|Overall Study|Lost to Follow-up|0|||
13206184|NCT01959425|26233773|FG000|Overall Study|Discontinued Subjects|6|||
13206185|NCT01959425|26233774|FG001|Overall Study|Discontinued Subjects|4|||
13206186|NCT01959412|26233819|FG000|Overall Study|Protocol deviation|1|||
13206187|NCT01959412|26233820|FG001|Overall Study|Protocol deviation|1|||
13206188|NCT01959412|26233821|FG002|Overall Study|Protocol deviation|0|||
13206189|NCT01959412|26233822|FG003|Overall Study|Protocol deviation|1|||
13206190|NCT01959412|26233823|FG004|Overall Study|Protocol deviation|3|||
13206191|NCT01959412|26233824|FG005|Overall Study|Protocol deviation|0|||
13206192|NCT01959412|26233819|FG000|Overall Study|Adverse Event|0|||
13206193|NCT01959412|26233820|FG001|Overall Study|Adverse Event|0|||
13206194|NCT01959412|26233821|FG002|Overall Study|Adverse Event|0|||
13206195|NCT01959412|26233822|FG003|Overall Study|Adverse Event|1|||
13206196|NCT01959412|26233823|FG004|Overall Study|Adverse Event|0|||
13206197|NCT01959412|26233824|FG005|Overall Study|Adverse Event|0|||
13206198|NCT01959347|26233935|FG000|Overall Study|Protocol Violation|9|||
13206199|NCT01959347|26233936|FG001|Overall Study|Protocol Violation|7|||
13206200|NCT01959334|26233953|FG000|Second Dose|Adverse Event|1|||
13206201|NCT01959334|26233954|FG001|Second Dose|Adverse Event|0|||
13206202|NCT01959334|26233953|FG000|Third Dose|Adverse Event|0|||
13206203|NCT01959334|26233954|FG001|Third Dose|Adverse Event|1|||
13206787|NCT01954121|26235528|FG001|Overall Study|Non-compliant patient|1|||
13206788|NCT01954121|26235527|FG000|Overall Study|Subject did not follow instructions|0|||
13206789|NCT01954121|26235528|FG001|Overall Study|Subject did not follow instructions|2|||
13206790|NCT01954082|26235553|FG000|Overall Study|Study Suspension|42|||
13206791|NCT01954082|26235554|FG001|Overall Study|Study Suspension|36|||
13206792|NCT01954082|26235553|FG000|Overall Study|Adverse Event|10|||
13206793|NCT01954082|26235554|FG001|Overall Study|Adverse Event|4|||
13206794|NCT01954082|26235553|FG000|Overall Study|Intolerance|0|||
13206795|NCT01954082|26235554|FG001|Overall Study|Intolerance|1|||
13206796|NCT01954082|26235553|FG000|Overall Study|Non-compliance|6|||
13206797|NCT01954082|26235554|FG001|Overall Study|Non-compliance|4|||
13206798|NCT01954082|26235553|FG000|Overall Study|Physician Decision|2|||
13206799|NCT01954082|26235554|FG001|Overall Study|Physician Decision|0|||
13206800|NCT01954082|26235553|FG000|Overall Study|Parent Decision|1|||
13206801|NCT01954082|26235554|FG001|Overall Study|Parent Decision|0|||
13206802|NCT01954082|26235553|FG000|Overall Study|Withdrawal by Subject|0|||
13206803|NCT01954082|26235554|FG001|Overall Study|Withdrawal by Subject|1|||
13206804|NCT01954082|26235553|FG000|Overall Study|Discontinued Early Prior to Transfer|3|||
13206805|NCT01954082|26235554|FG001|Overall Study|Discontinued Early Prior to Transfer|2|||
13206806|NCT01954082|26235553|FG000|Overall Study|Redirection of Care|0|||
13206807|NCT01954082|26235554|FG001|Overall Study|Redirection of Care|2|||
13206808|NCT01954082|26235553|FG000|Overall Study|Miscalculation of Final Dose Day|0|||
13187469|NCT02141516|26175211|FG000|Overall Study|Adverse Event|0|||
13187470|NCT02141516|26175212|FG001|Overall Study|Adverse Event|1|||
13187471|NCT02141516|26175213|FG002|Overall Study|Adverse Event|0|||
13187472|NCT02141516|26175211|FG000|Overall Study|Lost to Follow-up|0|||
13187473|NCT02141516|26175212|FG001|Overall Study|Lost to Follow-up|1|||
13187474|NCT02141516|26175213|FG002|Overall Study|Lost to Follow-up|0|||
13187475|NCT02141516|26175211|FG000|Overall Study|Other|0|||
13187476|NCT02141516|26175212|FG001|Overall Study|Other|3|||
13187477|NCT02141516|26175213|FG002|Overall Study|Other|0|||
13187478|NCT02141490|26175236|FG000|Overall Study|Screening failures|4|||
13187479|NCT02141490|26175237|FG001|Overall Study|Screening failures|0|||
13187480|NCT02141490|26175238|FG002|Overall Study|Screening failures|0|||
13187481|NCT02141399|26175244|FG000|Overall Study|Adverse Event|158|||
13187482|NCT02141399|26175244|FG000|Overall Study|Lack of Efficacy|62|||
13187483|NCT02141399|26175244|FG000|Overall Study|Lost to Follow-up|151|||
13187484|NCT02141399|26175244|FG000|Overall Study|Non-compliance with study drug|18|||
13187485|NCT02141399|26175244|FG000|Overall Study|Other|45|||
13187486|NCT02141399|26175244|FG000|Overall Study|Physician Decision|17|||
13187487|NCT02141399|26175244|FG000|Overall Study|Pregnancy|3|||
13187488|NCT02141399|26175244|FG000|Overall Study|Protocol Violation|38|||
13187489|NCT02141399|26175244|FG000|Overall Study|Withdrawal by Subject|238|||
13187490|NCT02141399|26175244|FG000|Overall Study|Failure to meet eligibility criteria|14|||
13187491|NCT02141360|26175260|FG000|Overall Study|Withdrawal by Subject|6|||
13187492|NCT02141360|26175261|FG001|Overall Study|Withdrawal by Subject|0|||
13187493|NCT02141360|26175262|FG002|Overall Study|Withdrawal by Subject|0|||
13187494|NCT02141360|26175260|FG000|Overall Study|Study Terminated before Visit|1|||
13187495|NCT02141360|26175261|FG001|Overall Study|Study Terminated before Visit|0|||
13187496|NCT02141360|26175262|FG002|Overall Study|Study Terminated before Visit|0|||
13187497|NCT02141295|26175306|FG000|Overall Study|Adverse Event|1|||
13187498|NCT02141295|26175307|FG001|Overall Study|Adverse Event|18|||
13187499|NCT02141295|26175308|FG002|Overall Study|Adverse Event|11|||
13187500|NCT02141295|26175306|FG000|Overall Study|Physician Decision|2|||
13187501|NCT02141295|26175307|FG001|Overall Study|Physician Decision|19|||
13187502|NCT02141295|26175308|FG002|Overall Study|Physician Decision|14|||
13187503|NCT02141295|26175306|FG000|Overall Study|Study terminated by sponsor|0|||
13187504|NCT02141295|26175307|FG001|Overall Study|Study terminated by sponsor|6|||
13187505|NCT02141295|26175308|FG002|Overall Study|Study terminated by sponsor|6|||
13187506|NCT02141295|26175306|FG000|Overall Study|Non-compliance|0|||
13187507|NCT02141295|26175307|FG001|Overall Study|Non-compliance|1|||
13187508|NCT02141295|26175308|FG002|Overall Study|Non-compliance|0|||
13187509|NCT02141295|26175306|FG000|Overall Study|Progressive disease|3|||
13187510|NCT02141295|26175307|FG001|Overall Study|Progressive disease|32|||
13187511|NCT02141295|26175308|FG002|Overall Study|Progressive disease|50|||
13187512|NCT02141295|26175306|FG000|Overall Study|Reason not specified|0|||
13187513|NCT02141295|26175307|FG001|Overall Study|Reason not specified|9|||
13187514|NCT02141295|26175308|FG002|Overall Study|Reason not specified|10|||
13187515|NCT02141295|26175306|FG000|Overall Study|Withdrawal by Subject|0|||
13187516|NCT02141295|26175307|FG001|Overall Study|Withdrawal by Subject|9|||
13187517|NCT02141295|26175308|FG002|Overall Study|Withdrawal by Subject|4|||
13187518|NCT02141217|26175333|FG000|Overall Study|Adverse Event|1|||
13187519|NCT02141217|26175334|FG001|Overall Study|Adverse Event|2|||
13187520|NCT02141217|26175333|FG000|Overall Study|Protocol Violation|1|||
13187521|NCT02141217|26175334|FG001|Overall Study|Protocol Violation|4|||
13187522|NCT02141217|26175333|FG000|Overall Study|Withdrawal by Subject|6|||
13187523|NCT02141217|26175334|FG001|Overall Study|Withdrawal by Subject|0|||
13187524|NCT02141217|26175333|FG000|Overall Study|Lost to Follow-up|1|||
13187525|NCT02141217|26175334|FG001|Overall Study|Lost to Follow-up|1|||
13187526|NCT02141217|26175333|FG000|Overall Study|Physician Decision|1|||
13187527|NCT02141217|26175334|FG001|Overall Study|Physician Decision|0|||
13187528|NCT02141217|26175333|FG000|Overall Study|Surgical Intervention|1|||
13187529|NCT02141217|26175334|FG001|Overall Study|Surgical Intervention|1|||
13187530|NCT02141204|26175355|FG000|Overall Study|Lost to Follow-up|2|||
13187531|NCT02141204|26175356|FG001|Overall Study|Lost to Follow-up|1|||
13187532|NCT02141204|26175355|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1|||
13187533|NCT02141204|26175356|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2|||
13187534|NCT02141204|26175355|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
13187535|NCT02141204|26175356|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5|||
13187536|NCT02141204|26175355|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9|||
13187537|NCT02141204|26175356|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7|||
13187538|NCT02140970|26175375|FG000|Overall Study|Lost to Follow-up|1|||
13187539|NCT02140970|26175376|FG001|Overall Study|Lost to Follow-up|2|||
13187540|NCT02140970|26175375|FG000|Overall Study|Misplaced consent, subject withdrawn|1|||
13187541|NCT02140970|26175376|FG001|Overall Study|Misplaced consent, subject withdrawn|0|||
13187542|NCT02140970|26175375|FG000|Overall Study|Did not meet inclusion criteria|0|||
13187543|NCT02140970|26175376|FG001|Overall Study|Did not meet inclusion criteria|1|||
13187544|NCT02140775|26175393|FG000|Overall Study|Withdrawal by Subject|30|||
13187545|NCT02140775|26175394|FG001|Overall Study|Withdrawal by Subject|7|||
13187546|NCT02140762|26175461|FG000|Overall Study|Adverse Event|1|||
13187547|NCT02140762|26175462|FG001|Overall Study|Adverse Event|1|||
13187548|NCT02140762|26175461|FG000|Overall Study|Lost to Follow-up|9|||
13187549|NCT02140762|26175462|FG001|Overall Study|Lost to Follow-up|5|||
13187550|NCT02140762|26175461|FG000|Overall Study|Protocol Violation|1|||
13187551|NCT02140762|26175462|FG001|Overall Study|Protocol Violation|1|||
13187552|NCT02140762|26175461|FG000|Overall Study|Withdrawal by Subject|6|||
13187553|NCT02140762|26175462|FG001|Overall Study|Withdrawal by Subject|4|||
13187554|NCT02140762|26175461|FG000|Overall Study|Other|0|||
13187555|NCT02140762|26175462|FG001|Overall Study|Other|1|||
13187556|NCT02140645|26175568|FG000|Overall Study|Not linked|5489|||
13187557|NCT02140645|26175569|FG001|Overall Study|Not linked|61654|||
13187558|NCT02140645|26175570|FG002|Overall Study|Not linked|4236|||
13187559|NCT02140645|26175571|FG003|Overall Study|Not linked|13833|||
13187560|NCT02140645|26175572|FG004|Overall Study|Not linked|3286|||
13187561|NCT02140645|26175573|FG005|Overall Study|Not linked|70896|||
13187562|NCT02140567|26175580|FG000|Overall Study|Problems with recording equipment|6|||
13187563|NCT02140411|26175591|FG000|Overall Study|Adverse Event|1|||
13187564|NCT02140164|26175608|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2|||
13187565|NCT02140060|26175642|FG000|Overall Study|Adverse Event|0|||
13187566|NCT02140060|26175643|FG001|Overall Study|Adverse Event|0|||
13187567|NCT02140060|26175644|FG002|Overall Study|Adverse Event|0|||
13110688|NCT03206749|25900270|FG001|Overall Study|Withdrawal of consent|3|||
13110689|NCT03206749|25900271|FG002|Overall Study|Withdrawal of consent|6|||
13110690|NCT03206749|25900269|FG000|Overall Study|Lost to Follow-up|0|||
13110691|NCT03206749|25900270|FG001|Overall Study|Lost to Follow-up|0|||
13110692|NCT03206749|25900271|FG002|Overall Study|Lost to Follow-up|1|||
13110693|NCT03206216|25900286|FG000|Overall Study|Withdrawal by Subject|0|||
13110694|NCT03206216|25900287|FG001|Overall Study|Withdrawal by Subject|1|||
13110695|NCT03205566|25900307|FG000|Phase 1|Protocol Violation|1|||
13110696|NCT03205566|25900308|FG001|Phase 1|Protocol Violation|1|||
13187568|NCT02140060|26175645|FG003|Overall Study|Adverse Event|1|||
13187569|NCT02140060|26175646|FG004|Overall Study|Adverse Event|1|||
13187570|NCT02140060|26175647|FG005|Overall Study|Adverse Event|1|||
13187571|NCT02140060|26175642|FG000|Overall Study|Lack of Efficacy|0|||
13187572|NCT02140060|26175643|FG001|Overall Study|Lack of Efficacy|0|||
13187573|NCT02140060|26175644|FG002|Overall Study|Lack of Efficacy|0|||
13187574|NCT02140060|26175645|FG003|Overall Study|Lack of Efficacy|1|||
13187575|NCT02140060|26175646|FG004|Overall Study|Lack of Efficacy|0|||
13187576|NCT02140060|26175647|FG005|Overall Study|Lack of Efficacy|0|||
13187577|NCT02139982|26175720|FG000|Overall Study|Lack of Efficacy|0|||
13187578|NCT02139982|26175721|FG001|Overall Study|Lack of Efficacy|1|||
13187579|NCT02139982|26175722|FG002|Overall Study|Lack of Efficacy|0|||
13187580|NCT02139982|26175723|FG003|Overall Study|Lack of Efficacy|1|||
13187581|NCT02139982|26175724|FG004|Overall Study|Lack of Efficacy|0|||
13187582|NCT02139982|26175725|FG005|Overall Study|Lack of Efficacy|0|||
13187583|NCT02139982|26175726|FG006|Overall Study|Lack of Efficacy|0|||
13187584|NCT02139982|26175727|FG007|Overall Study|Lack of Efficacy|0|||
13187585|NCT02139982|26175728|FG008|Overall Study|Lack of Efficacy|0|||
13187586|NCT02139982|26175729|FG009|Overall Study|Lack of Efficacy|0|||
13187587|NCT02139943|26175750|FG000|Overall Study|Adverse Event|0|||
13187588|NCT02139943|26175751|FG001|Overall Study|Adverse Event|1|||
13187589|NCT02139943|26175752|FG002|Overall Study|Adverse Event|2|||
13187590|NCT02139943|26175750|FG000|Overall Study|Lost to Follow-up|3|||
13187591|NCT02139943|26175751|FG001|Overall Study|Lost to Follow-up|2|||
13187592|NCT02139943|26175752|FG002|Overall Study|Lost to Follow-up|2|||
13187593|NCT02139943|26175750|FG000|Overall Study|Withdrawal by Subject|4|||
13187594|NCT02139943|26175751|FG001|Overall Study|Withdrawal by Subject|3|||
13187595|NCT02139943|26175752|FG002|Overall Study|Withdrawal by Subject|0|||
13187596|NCT02139943|26175750|FG000|Overall Study|Other|0|||
13187597|NCT02139943|26175751|FG001|Overall Study|Other|0|||
13187598|NCT02139943|26175752|FG002|Overall Study|Other|1|||
13187599|NCT02139943|26175750|FG000|Overall Study|Participant wishes to discontinue|2|||
13187600|NCT02139943|26175751|FG001|Overall Study|Participant wishes to discontinue|0|||
13187601|NCT02139943|26175752|FG002|Overall Study|Participant wishes to discontinue|0|||
13187602|NCT02139943|26175750|FG000|Overall Study|Participant in Poor Compliance|1|||
13110697|NCT03205488|25900332|FG000|Overall Study|Adverse Event|1|||
13110698|NCT03205488|25900333|FG001|Overall Study|Adverse Event|2|||
13110699|NCT03205488|25900334|FG002|Overall Study|Adverse Event|4|||
13110700|NCT03205488|25900332|FG000|Overall Study|Protocol Violation|0|||
13110701|NCT03205488|25900333|FG001|Overall Study|Protocol Violation|0|||
13110702|NCT03205488|25900334|FG002|Overall Study|Protocol Violation|1|||
13187603|NCT02139943|26175751|FG001|Overall Study|Participant in Poor Compliance|0|||
13187604|NCT02139943|26175752|FG002|Overall Study|Participant in Poor Compliance|1|||
13187605|NCT02139943|26175750|FG000|Overall Study|eGFR Withdrawal Criteria|0|||
13187606|NCT02139943|26175751|FG001|Overall Study|eGFR Withdrawal Criteria|0|||
13187607|NCT02139943|26175752|FG002|Overall Study|eGFR Withdrawal Criteria|1|||
13187608|NCT02139826|26175785|FG000|Overall Study|Adverse Event|1|||
13187609|NCT02139644|26175854|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70|||
13110703|NCT03205371|25900449|FG000|Overall Study|Withdrawal by Subject|4|||
13110704|NCT03205371|25900450|FG001|Overall Study|Withdrawal by Subject|1|||
13110705|NCT03205371|25900451|FG002|Overall Study|Withdrawal by Subject|0|||
13110706|NCT03205371|25900452|FG003|Overall Study|Withdrawal by Subject|0|||
13187610|NCT02139644|26175855|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
13187611|NCT02139644|26175856|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
13187612|NCT02139644|26175857|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
13187613|NCT02139644|26175858|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
13187614|NCT02139644|26175859|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
13187615|NCT02139644|26175854|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30|||
13187616|NCT02139644|26175855|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
13187617|NCT02139644|26175856|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
13187618|NCT02139644|26175857|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
13187619|NCT02139644|26175858|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
13187620|NCT02139644|26175859|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
13187621|NCT02139644|26175854|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12|||
13187622|NCT02139644|26175855|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
13187623|NCT02139644|26175856|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
13187624|NCT02139644|26175857|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
13187625|NCT02139644|26175858|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
13187626|NCT02139644|26175859|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
13187627|NCT02139644|26175854|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11|||
13187628|NCT02139644|26175855|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
13187629|NCT02139644|26175856|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
13187630|NCT02139644|26175857|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
13187631|NCT02139644|26175858|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
13187632|NCT02139644|26175859|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
13187633|NCT02139644|26175854|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8|||
13187634|NCT02139644|26175855|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
13187635|NCT02139644|26175856|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
13187636|NCT02139644|26175857|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
13187637|NCT02139644|26175858|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
13187638|NCT02139644|26175859|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
13187639|NCT02139644|26175854|FG000|Run-In Period (Pre-assignment)|Adverse Event|3|||
13187640|NCT02139644|26175855|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
13187641|NCT02139644|26175856|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
13187642|NCT02139644|26175857|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
13187643|NCT02139644|26175858|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
13187644|NCT02139644|26175859|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
13187645|NCT02139644|26175854|FG000|Run-In Period (Pre-assignment)|Other|6|||
13187646|NCT02139644|26175855|FG001|Run-In Period (Pre-assignment)|Other|0|||
13187647|NCT02139644|26175856|FG002|Run-In Period (Pre-assignment)|Other|0|||
13187648|NCT02139644|26175857|FG003|Run-In Period (Pre-assignment)|Other|0|||
13187649|NCT02139644|26175858|FG004|Run-In Period (Pre-assignment)|Other|0|||
13187650|NCT02139644|26175859|FG005|Run-In Period (Pre-assignment)|Other|0|||
13187651|NCT02139644|26175854|FG000|Treatment Period|Adverse Event|0|||
13187652|NCT02139644|26175855|FG001|Treatment Period|Adverse Event|0|||
13187653|NCT02139644|26175856|FG002|Treatment Period|Adverse Event|3|||
13187654|NCT02139644|26175857|FG003|Treatment Period|Adverse Event|2|||
13187655|NCT02139644|26175858|FG004|Treatment Period|Adverse Event|1|||
13110707|NCT03205371|25900453|FG004|Overall Study|Withdrawal by Subject|0|||
13110708|NCT03205371|25900454|FG005|Overall Study|Withdrawal by Subject|0|||
13110709|NCT03205371|25900455|FG006|Overall Study|Withdrawal by Subject|4|||
13110710|NCT03205371|25900456|FG007|Overall Study|Withdrawal by Subject|0|||
13110711|NCT03205371|25900457|FG008|Overall Study|Withdrawal by Subject|2|||
13110712|NCT03205371|25900458|FG009|Overall Study|Withdrawal by Subject|0|||
13110713|NCT03205371|25900459|FG010|Overall Study|Withdrawal by Subject|0|||
13110714|NCT03205371|25900460|FG011|Overall Study|Withdrawal by Subject|1|||
13110715|NCT03205371|25900449|FG000|Overall Study|Lost to Follow-up|0|||
13110716|NCT03205371|25900450|FG001|Overall Study|Lost to Follow-up|0|||
13110717|NCT03205371|25900451|FG002|Overall Study|Lost to Follow-up|0|||
13110718|NCT03205371|25900452|FG003|Overall Study|Lost to Follow-up|0|||
13110719|NCT03205371|25900453|FG004|Overall Study|Lost to Follow-up|0|||
13110720|NCT03205371|25900454|FG005|Overall Study|Lost to Follow-up|0|||
13110721|NCT03205371|25900455|FG006|Overall Study|Lost to Follow-up|5|||
13110722|NCT03205371|25900456|FG007|Overall Study|Lost to Follow-up|2|||
13110723|NCT03205371|25900457|FG008|Overall Study|Lost to Follow-up|3|||
13110724|NCT03205371|25900458|FG009|Overall Study|Lost to Follow-up|0|||
13110725|NCT03205371|25900459|FG010|Overall Study|Lost to Follow-up|0|||
13110726|NCT03205371|25900460|FG011|Overall Study|Lost to Follow-up|0|||
13110727|NCT03205371|25900449|FG000|Overall Study|Protocol Violation|0|||
13110728|NCT03205371|25900450|FG001|Overall Study|Protocol Violation|0|||
13187656|NCT02139644|26175859|FG005|Treatment Period|Adverse Event|6|||
13187657|NCT02139644|26175854|FG000|Treatment Period|Withdrawal by Subject|0|||
13223055|NCT01799993|26287796|FG000|Overall Study|Lost to Follow-up|5|||
13110729|NCT03205371|25900451|FG002|Overall Study|Protocol Violation|0|||
13110730|NCT03205371|25900452|FG003|Overall Study|Protocol Violation|0|||
13110731|NCT03205371|25900453|FG004|Overall Study|Protocol Violation|0|||
13110732|NCT03205371|25900454|FG005|Overall Study|Protocol Violation|0|||
13110733|NCT03205371|25900455|FG006|Overall Study|Protocol Violation|1|||
13110734|NCT03205371|25900456|FG007|Overall Study|Protocol Violation|0|||
13110735|NCT03205371|25900457|FG008|Overall Study|Protocol Violation|0|||
13110736|NCT03205371|25900458|FG009|Overall Study|Protocol Violation|0|||
13110737|NCT03205371|25900459|FG010|Overall Study|Protocol Violation|0|||
13110738|NCT03205371|25900460|FG011|Overall Study|Protocol Violation|0|||
13110739|NCT03205371|25900449|FG000|Overall Study|Adverse Event|0|||
13110740|NCT03205371|25900450|FG001|Overall Study|Adverse Event|0|||
13110741|NCT03205371|25900451|FG002|Overall Study|Adverse Event|0|||
13110742|NCT03205371|25900452|FG003|Overall Study|Adverse Event|0|||
13110743|NCT03205371|25900453|FG004|Overall Study|Adverse Event|0|||
13110744|NCT03205371|25900454|FG005|Overall Study|Adverse Event|0|||
13187658|NCT02139644|26175855|FG001|Treatment Period|Withdrawal by Subject|0|||
13187659|NCT02139644|26175856|FG002|Treatment Period|Withdrawal by Subject|2|||
13187660|NCT02139644|26175857|FG003|Treatment Period|Withdrawal by Subject|2|||
13187661|NCT02139644|26175858|FG004|Treatment Period|Withdrawal by Subject|3|||
13187662|NCT02139644|26175859|FG005|Treatment Period|Withdrawal by Subject|2|||
13187663|NCT02139644|26175854|FG000|Treatment Period|Non-compliance|0|||
13187664|NCT02139644|26175855|FG001|Treatment Period|Non-compliance|0|||
13187665|NCT02139644|26175856|FG002|Treatment Period|Non-compliance|0|||
13187666|NCT02139644|26175857|FG003|Treatment Period|Non-compliance|1|||
13187667|NCT02139644|26175858|FG004|Treatment Period|Non-compliance|0|||
13187668|NCT02139644|26175859|FG005|Treatment Period|Non-compliance|0|||
13187669|NCT02139644|26175854|FG000|Treatment Period|Protocol Violation|0|||
13187670|NCT02139644|26175855|FG001|Treatment Period|Protocol Violation|0|||
13187671|NCT02139644|26175856|FG002|Treatment Period|Protocol Violation|0|||
13187672|NCT02139644|26175857|FG003|Treatment Period|Protocol Violation|1|||
13187673|NCT02139644|26175858|FG004|Treatment Period|Protocol Violation|1|||
13187674|NCT02139644|26175859|FG005|Treatment Period|Protocol Violation|1|||
13187675|NCT02139644|26175854|FG000|Treatment Period|Disease progression|0|||
13187676|NCT02139644|26175855|FG001|Treatment Period|Disease progression|0|||
13187677|NCT02139644|26175856|FG002|Treatment Period|Disease progression|0|||
13187678|NCT02139644|26175857|FG003|Treatment Period|Disease progression|1|||
13187679|NCT02139644|26175858|FG004|Treatment Period|Disease progression|1|||
13187680|NCT02139644|26175859|FG005|Treatment Period|Disease progression|2|||
13187681|NCT02139644|26175854|FG000|Treatment Period|Lost to Follow-up|0|||
13187682|NCT02139644|26175855|FG001|Treatment Period|Lost to Follow-up|0|||
13187683|NCT02139644|26175856|FG002|Treatment Period|Lost to Follow-up|1|||
13187684|NCT02139644|26175857|FG003|Treatment Period|Lost to Follow-up|1|||
13187685|NCT02139644|26175858|FG004|Treatment Period|Lost to Follow-up|1|||
13187686|NCT02139644|26175859|FG005|Treatment Period|Lost to Follow-up|1|||
13187687|NCT02139644|26175854|FG000|Treatment Period|Lack of Efficacy|0|||
13187688|NCT02139644|26175855|FG001|Treatment Period|Lack of Efficacy|0|||
13187689|NCT02139644|26175856|FG002|Treatment Period|Lack of Efficacy|1|||
13187690|NCT02139644|26175857|FG003|Treatment Period|Lack of Efficacy|0|||
13187691|NCT02139644|26175858|FG004|Treatment Period|Lack of Efficacy|1|||
13187692|NCT02139644|26175859|FG005|Treatment Period|Lack of Efficacy|4|||
13187693|NCT02139644|26175854|FG000|Treatment Period|Other|0|||
13187694|NCT02139644|26175855|FG001|Treatment Period|Other|3|||
13187695|NCT02139644|26175856|FG002|Treatment Period|Other|1|||
13187696|NCT02139644|26175857|FG003|Treatment Period|Other|1|||
13187697|NCT02139644|26175858|FG004|Treatment Period|Other|0|||
13187698|NCT02139644|26175859|FG005|Treatment Period|Other|1|||
13187699|NCT02139592|26175867|FG000|Overall Study|Case Report Forms Uncollected|8|||
13187700|NCT02139306|26175898|FG000|Overall Study|Withdrawal by Subject|4|||
13187701|NCT02139306|26175899|FG001|Overall Study|Withdrawal by Subject|6|||
13187702|NCT02139306|26175898|FG000|Overall Study|Adverse Event|3|||
13187703|NCT02139306|26175899|FG001|Overall Study|Adverse Event|4|||
13187704|NCT02139306|26175898|FG000|Overall Study|Physician Decision|0|||
13187705|NCT02139306|26175899|FG001|Overall Study|Physician Decision|1|||
13187706|NCT02139306|26175898|FG000|Overall Study|Other Unspecified|2|||
13187707|NCT02139306|26175899|FG001|Overall Study|Other Unspecified|3|||
13223056|NCT01799993|26287797|FG001|Overall Study|Lost to Follow-up|8|||
13110745|NCT03205371|25900455|FG006|Overall Study|Adverse Event|0|||
13110746|NCT03205371|25900456|FG007|Overall Study|Adverse Event|1|||
13110747|NCT03205371|25900457|FG008|Overall Study|Adverse Event|0|||
13110748|NCT03205371|25900458|FG009|Overall Study|Adverse Event|0|||
13110749|NCT03205371|25900459|FG010|Overall Study|Adverse Event|0|||
13110750|NCT03205371|25900460|FG011|Overall Study|Adverse Event|0|||
13187708|NCT02139306|26175898|FG000|Overall Study|Protocol Violation|4|||
13187709|NCT02139306|26175899|FG001|Overall Study|Protocol Violation|0|||
13187710|NCT02139280|26175924|FG000|Overall Study|No longer eligible|2|||
13187711|NCT02139280|26175925|FG001|Overall Study|No longer eligible|0|||
13187712|NCT02139124|26175953|FG000|Overall Study|Adverse Event|2|||
13187713|NCT02139124|26175954|FG001|Overall Study|Adverse Event|0|||
13187714|NCT02139124|26175955|FG002|Overall Study|Adverse Event|1|||
13187715|NCT02139124|26175956|FG003|Overall Study|Adverse Event|2|||
13187716|NCT02139124|26175957|FG004|Overall Study|Adverse Event|5|||
13187717|NCT02139124|26175953|FG000|Overall Study|Withdrawal by Subject|2|||
13187718|NCT02139124|26175954|FG001|Overall Study|Withdrawal by Subject|2|||
13187719|NCT02139124|26175955|FG002|Overall Study|Withdrawal by Subject|2|||
13187720|NCT02139124|26175956|FG003|Overall Study|Withdrawal by Subject|2|||
13187721|NCT02139124|26175957|FG004|Overall Study|Withdrawal by Subject|3|||
13187722|NCT02139124|26175953|FG000|Overall Study|Protocol Violation|0|||
13187723|NCT02139124|26175954|FG001|Overall Study|Protocol Violation|0|||
13187724|NCT02139124|26175955|FG002|Overall Study|Protocol Violation|0|||
13187725|NCT02139124|26175956|FG003|Overall Study|Protocol Violation|1|||
13187726|NCT02139124|26175957|FG004|Overall Study|Protocol Violation|1|||
13187727|NCT02139124|26175953|FG000|Overall Study|non-compliant|1|||
13187728|NCT02139124|26175954|FG001|Overall Study|non-compliant|0|||
13187729|NCT02139124|26175955|FG002|Overall Study|non-compliant|0|||
13187730|NCT02139124|26175956|FG003|Overall Study|non-compliant|2|||
13187731|NCT02139124|26175957|FG004|Overall Study|non-compliant|0|||
13187732|NCT02139124|26175953|FG000|Overall Study|incarceration|0|||
13187733|NCT02139124|26175954|FG001|Overall Study|incarceration|0|||
13187734|NCT02139124|26175955|FG002|Overall Study|incarceration|1|||
13187735|NCT02139124|26175956|FG003|Overall Study|incarceration|0|||
13187736|NCT02139124|26175957|FG004|Overall Study|incarceration|0|||
13187737|NCT02139124|26175953|FG000|Overall Study|subject moved|1|||
13187738|NCT02139124|26175954|FG001|Overall Study|subject moved|0|||
13187739|NCT02139124|26175955|FG002|Overall Study|subject moved|0|||
13187740|NCT02139124|26175956|FG003|Overall Study|subject moved|0|||
13187741|NCT02139124|26175957|FG004|Overall Study|subject moved|0|||
13187742|NCT02139124|26175953|FG000|Overall Study|Lost to Follow-up|3|||
13187743|NCT02139124|26175954|FG001|Overall Study|Lost to Follow-up|2|||
13187744|NCT02139124|26175955|FG002|Overall Study|Lost to Follow-up|0|||
13187745|NCT02139124|26175956|FG003|Overall Study|Lost to Follow-up|5|||
13187746|NCT02139124|26175957|FG004|Overall Study|Lost to Follow-up|4|||
13187747|NCT02139046|26175995|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
13187748|NCT02139046|26175996|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
13187749|NCT02139046|26175997|FG002|Overall Study|Pretreatment Event/Adverse Event|10|||
13187750|NCT02139046|26175998|FG003|Overall Study|Pretreatment Event/Adverse Event|13|||
13187751|NCT02139046|26175999|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
13187752|NCT02139046|26175995|FG000|Overall Study|Major Protocol Deviation|9|||
13187753|NCT02139046|26175996|FG001|Overall Study|Major Protocol Deviation|10|||
13187754|NCT02139046|26175997|FG002|Overall Study|Major Protocol Deviation|16|||
13187755|NCT02139046|26175998|FG003|Overall Study|Major Protocol Deviation|12|||
13187756|NCT02139046|26175999|FG004|Overall Study|Major Protocol Deviation|6|||
13187757|NCT02139046|26175995|FG000|Overall Study|Lost to Follow-up|13|||
13187758|NCT02139046|26175996|FG001|Overall Study|Lost to Follow-up|16|||
13187759|NCT02139046|26175997|FG002|Overall Study|Lost to Follow-up|16|||
13187760|NCT02139046|26175998|FG003|Overall Study|Lost to Follow-up|18|||
13187761|NCT02139046|26175999|FG004|Overall Study|Lost to Follow-up|13|||
13187762|NCT02139046|26175995|FG000|Overall Study|Voluntary Withdrawal|20|||
13187763|NCT02139046|26175996|FG001|Overall Study|Voluntary Withdrawal|8|||
13187764|NCT02139046|26175997|FG002|Overall Study|Voluntary Withdrawal|10|||
13187765|NCT02139046|26175998|FG003|Overall Study|Voluntary Withdrawal|15|||
13187766|NCT02139046|26175999|FG004|Overall Study|Voluntary Withdrawal|16|||
13187767|NCT02139046|26175995|FG000|Overall Study|Lack of Efficacy|0|||
13187768|NCT02139046|26175996|FG001|Overall Study|Lack of Efficacy|1|||
13187769|NCT02139046|26175997|FG002|Overall Study|Lack of Efficacy|2|||
13187770|NCT02139046|26175998|FG003|Overall Study|Lack of Efficacy|1|||
13187771|NCT02139046|26175999|FG004|Overall Study|Lack of Efficacy|2|||
13187772|NCT02139046|26175995|FG000|Overall Study|Withdrawal due to a Gout Flare|1|||
13187773|NCT02139046|26175996|FG001|Overall Study|Withdrawal due to a Gout Flare|1|||
13187774|NCT02139046|26175997|FG002|Overall Study|Withdrawal due to a Gout Flare|1|||
13187775|NCT02139046|26175998|FG003|Overall Study|Withdrawal due to a Gout Flare|0|||
13187776|NCT02139046|26175999|FG004|Overall Study|Withdrawal due to a Gout Flare|1|||
13187777|NCT02139046|26175995|FG000|Overall Study|Other Miscellaneous Reasons|10|||
13187778|NCT02139046|26175996|FG001|Overall Study|Other Miscellaneous Reasons|9|||
13187779|NCT02139046|26175997|FG002|Overall Study|Other Miscellaneous Reasons|4|||
13187780|NCT02139046|26175998|FG003|Overall Study|Other Miscellaneous Reasons|9|||
13187781|NCT02139046|26175999|FG004|Overall Study|Other Miscellaneous Reasons|12|||
13187782|NCT02138916|26176070|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6|||
13485560|NCT02906020|27032882|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
13187783|NCT02138916|26176071|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9|||
13187784|NCT02138916|26176072|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7|||
13187785|NCT02138916|26176070|FG000|Overall Study|Death|14|||
13187786|NCT02138916|26176071|FG001|Overall Study|Death|11|||
13187787|NCT02138916|26176072|FG002|Overall Study|Death|12|||
13187788|NCT02138916|26176070|FG000|Overall Study|Withdrawal by Subject|27|||
13187789|NCT02138916|26176071|FG001|Overall Study|Withdrawal by Subject|31|||
13187790|NCT02138916|26176072|FG002|Overall Study|Withdrawal by Subject|32|||
13187791|NCT02138916|26176070|FG000|Overall Study|Study specific withdrawal criteria|0|||
13187792|NCT02138916|26176071|FG001|Overall Study|Study specific withdrawal criteria|0|||
13187793|NCT02138916|26176072|FG002|Overall Study|Study specific withdrawal criteria|1|||
13187794|NCT02138916|26176070|FG000|Overall Study|incorrect enrolment|1|||
13187795|NCT02138916|26176071|FG001|Overall Study|incorrect enrolment|1|||
13187796|NCT02138916|26176072|FG002|Overall Study|incorrect enrolment|0|||
13187797|NCT02138916|26176070|FG000|Overall Study|Severe non-compliance|1|||
13187798|NCT02138916|26176071|FG001|Overall Study|Severe non-compliance|2|||
13187799|NCT02138916|26176072|FG002|Overall Study|Severe non-compliance|1|||
13187800|NCT02138916|26176070|FG000|Overall Study|Lost to Follow-up|4|||
13187801|NCT02138916|26176071|FG001|Overall Study|Lost to Follow-up|2|||
13187802|NCT02138916|26176072|FG002|Overall Study|Lost to Follow-up|3|||
13187803|NCT02138916|26176070|FG000|Overall Study|Adverse Event|4|||
13187804|NCT02138916|26176071|FG001|Overall Study|Adverse Event|4|||
13187805|NCT02138916|26176072|FG002|Overall Study|Adverse Event|3|||
13187806|NCT02138890|26176119|FG000|Overall Study|Adverse Event|1|||
13187807|NCT02138890|26176120|FG001|Overall Study|Adverse Event|0|||
13187808|NCT02138838|26176143|FG000|Overall Study|Study Closure|7|||
13187809|NCT02138838|26176144|FG001|Overall Study|Study Closure|6|||
13187810|NCT02138838|26176143|FG000|Overall Study|Withdrawal by Subject|1|||
13187811|NCT02138838|26176144|FG001|Overall Study|Withdrawal by Subject|5|||
13187812|NCT02138825|26176165|FG000|Main Study Treatment|Adverse Event|11|||
13187813|NCT02138825|26176166|FG001|Main Study Treatment|Adverse Event|3|||
13187814|NCT02138825|26176165|FG000|Main Study Treatment|Death|1|||
13187815|NCT02138825|26176166|FG001|Main Study Treatment|Death|2|||
13187816|NCT02138825|26176165|FG000|Main Study Treatment|Protocol Violation|2|||
13187817|NCT02138825|26176166|FG001|Main Study Treatment|Protocol Violation|2|||
13187818|NCT02138825|26176165|FG000|Main Study Treatment|Sponsor decision|12|||
13187819|NCT02138825|26176166|FG001|Main Study Treatment|Sponsor decision|18|||
13187820|NCT02138825|26176165|FG000|Main Study Treatment|Study terminated by sponsor|10|||
13187821|NCT02138825|26176166|FG001|Main Study Treatment|Study terminated by sponsor|9|||
13187822|NCT02138825|26176165|FG000|Main Study Treatment|Withdrawal by Subject|3|||
13187823|NCT02138825|26176166|FG001|Main Study Treatment|Withdrawal by Subject|1|||
13187824|NCT02138825|26176165|FG000|Main Study Treatment|Medical decision|1|||
13187825|NCT02138825|26176166|FG001|Main Study Treatment|Medical decision|0|||
13187826|NCT02138825|26176165|FG000|Long-term Extension|Study termination by sponsor|32|||
13187827|NCT02138825|26176166|FG001|Long-term Extension|Study termination by sponsor|38|||
13187828|NCT02138825|26176165|FG000|Safety Follow-up|Adverse Event|4|||
13187829|NCT02138825|26176166|FG001|Safety Follow-up|Adverse Event|3|||
13187830|NCT02138825|26176165|FG000|Safety Follow-up|Death|11|||
13110751|NCT03205163|25900515|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1|||
13110752|NCT03205163|25900516|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0|||
13110753|NCT03205150|25900562|FG000|Overall Study|Protocol deviation|1|||
13110754|NCT03205150|25900563|FG001|Overall Study|Protocol deviation|3|||
13110755|NCT03205150|25900564|FG002|Overall Study|Protocol deviation|0|||
13187831|NCT02138825|26176166|FG001|Safety Follow-up|Death|5|||
13187832|NCT02138825|26176165|FG000|Safety Follow-up|Withdrawal by Subject|5|||
13187833|NCT02138825|26176166|FG001|Safety Follow-up|Withdrawal by Subject|3|||
13187834|NCT02138825|26176165|FG000|Safety Follow-up|clinic worsening|1|||
13187835|NCT02138825|26176166|FG001|Safety Follow-up|clinic worsening|0|||
13187836|NCT02138825|26176165|FG000|Safety Follow-up|withdrawal by PI|1|||
13187837|NCT02138825|26176166|FG001|Safety Follow-up|withdrawal by PI|0|||
13187838|NCT02138825|26176165|FG000|Safety Follow-up|logistical difficulties|0|||
13187839|NCT02138825|26176166|FG001|Safety Follow-up|logistical difficulties|1|||
13187840|NCT02138825|26176165|FG000|Safety Follow-up|progressive disease|0|||
13187841|NCT02138825|26176166|FG001|Safety Follow-up|progressive disease|2|||
13187842|NCT02138825|26176165|FG000|Safety Follow-up|too unwell to attend the visit|0|||
13187843|NCT02138825|26176166|FG001|Safety Follow-up|too unwell to attend the visit|1|||
13187844|NCT02138825|26176165|FG000|Safety Follow-up|treatment unblinded|0|||
13187845|NCT02138825|26176166|FG001|Safety Follow-up|treatment unblinded|1|||
13187846|NCT02138825|26176165|FG000|Safety Follow-up|withdrawn due to lung transplant|0|||
13187847|NCT02138825|26176166|FG001|Safety Follow-up|withdrawn due to lung transplant|1|||
13187848|NCT02138747|26176211|FG000|Treatment Period 1|Adverse Event|10|||
13110756|NCT03205150|25900562|FG000|Overall Study|Patient/guardian decision|0|||
13110757|NCT03205150|25900563|FG001|Overall Study|Patient/guardian decision|3|||
13110758|NCT03205150|25900564|FG002|Overall Study|Patient/guardian decision|0|||
13110759|NCT03205150|25900562|FG000|Overall Study|Adverse Event|1|||
13187849|NCT02138747|26176212|FG001|Treatment Period 1|Adverse Event|14|||
13187850|NCT02138747|26176213|FG002|Treatment Period 1|Adverse Event|2|||
13187851|NCT02138747|26176214|FG003|Treatment Period 1|Adverse Event|1|||
13187852|NCT02138747|26176211|FG000|Treatment Period 1|Lost to Follow-up|0|||
13187853|NCT02138747|26176212|FG001|Treatment Period 1|Lost to Follow-up|1|||
13187854|NCT02138747|26176213|FG002|Treatment Period 1|Lost to Follow-up|1|||
13187855|NCT02138747|26176214|FG003|Treatment Period 1|Lost to Follow-up|0|||
13187856|NCT02138747|26176211|FG000|Treatment Period 1|Protocol Violation|0|||
13187857|NCT02138747|26176212|FG001|Treatment Period 1|Protocol Violation|2|||
13187858|NCT02138747|26176213|FG002|Treatment Period 1|Protocol Violation|0|||
13187859|NCT02138747|26176214|FG003|Treatment Period 1|Protocol Violation|0|||
13187860|NCT02138747|26176211|FG000|Treatment Period 1|Withdrawal by Subject|8|||
13187861|NCT02138747|26176212|FG001|Treatment Period 1|Withdrawal by Subject|4|||
13187862|NCT02138747|26176213|FG002|Treatment Period 1|Withdrawal by Subject|1|||
13187863|NCT02138747|26176214|FG003|Treatment Period 1|Withdrawal by Subject|3|||
13187864|NCT02138747|26176211|FG000|Treatment Period 1|Other - Miscellaneous|2|||
13187865|NCT02138747|26176212|FG001|Treatment Period 1|Other - Miscellaneous|4|||
13187866|NCT02138747|26176213|FG002|Treatment Period 1|Other - Miscellaneous|0|||
13187867|NCT02138747|26176214|FG003|Treatment Period 1|Other - Miscellaneous|0|||
13187868|NCT02138747|26176211|FG000|Treatment Period 2|Adverse Event|6|||
13187869|NCT02138747|26176212|FG001|Treatment Period 2|Adverse Event|3|||
13187870|NCT02138747|26176213|FG002|Treatment Period 2|Adverse Event|1|||
13187871|NCT02138747|26176214|FG003|Treatment Period 2|Adverse Event|1|||
13187872|NCT02138747|26176211|FG000|Treatment Period 2|Lost to Follow-up|2|||
13187873|NCT02138747|26176212|FG001|Treatment Period 2|Lost to Follow-up|0|||
13187874|NCT02138747|26176213|FG002|Treatment Period 2|Lost to Follow-up|0|||
13187875|NCT02138747|26176214|FG003|Treatment Period 2|Lost to Follow-up|0|||
13187876|NCT02138747|26176211|FG000|Treatment Period 2|Protocol Violation|1|||
13187877|NCT02138747|26176212|FG001|Treatment Period 2|Protocol Violation|0|||
13187878|NCT02138747|26176213|FG002|Treatment Period 2|Protocol Violation|0|||
13187879|NCT02138747|26176214|FG003|Treatment Period 2|Protocol Violation|0|||
13187880|NCT02138747|26176211|FG000|Treatment Period 2|Withdrawal by Subject|5|||
13187881|NCT02138747|26176212|FG001|Treatment Period 2|Withdrawal by Subject|4|||
13187882|NCT02138747|26176213|FG002|Treatment Period 2|Withdrawal by Subject|1|||
13187883|NCT02138747|26176214|FG003|Treatment Period 2|Withdrawal by Subject|2|||
13187884|NCT02138747|26176211|FG000|Treatment Period 2|Other - Miscellaneous|3|||
13187885|NCT02138747|26176212|FG001|Treatment Period 2|Other - Miscellaneous|0|||
13187886|NCT02138747|26176213|FG002|Treatment Period 2|Other - Miscellaneous|0|||
13187887|NCT02138747|26176214|FG003|Treatment Period 2|Other - Miscellaneous|0|||
13187888|NCT02138253|26176249|FG000|Overall Study|Adverse Event|3|||
13187889|NCT02138253|26176250|FG001|Overall Study|Adverse Event|3|||
13187890|NCT02138253|26176249|FG000|Overall Study|Lost to Follow-up|2|||
13187891|NCT02138253|26176250|FG001|Overall Study|Lost to Follow-up|1|||
13187892|NCT02138253|26176249|FG000|Overall Study|Physician Decision|2|||
13187893|NCT02138253|26176250|FG001|Overall Study|Physician Decision|0|||
13187894|NCT02138253|26176249|FG000|Overall Study|Non compliance|1|||
13187895|NCT02138253|26176250|FG001|Overall Study|Non compliance|0|||
13187896|NCT02138253|26176249|FG000|Overall Study|Withdrawal by Subject|1|||
13187897|NCT02138253|26176250|FG001|Overall Study|Withdrawal by Subject|0|||
13187898|NCT02138214|26176281|FG000|Overall Study|Withdrawal by Subject|0|||
13187899|NCT02138214|26176282|FG001|Overall Study|Withdrawal by Subject|1|||
13187900|NCT02138214|26176283|FG002|Overall Study|Withdrawal by Subject|0|||
13187901|NCT02138214|26176281|FG000|Overall Study|Lost to Follow-up|0|||
13187902|NCT02138214|26176282|FG001|Overall Study|Lost to Follow-up|2|||
13187903|NCT02138214|26176283|FG002|Overall Study|Lost to Follow-up|4|||
13187904|NCT02138214|26176281|FG000|Overall Study|Screen Failure|0|||
13187905|NCT02138214|26176282|FG001|Overall Study|Screen Failure|1|||
13187906|NCT02138214|26176283|FG002|Overall Study|Screen Failure|0|||
13187907|NCT02138136|26176292|FG000|Overall Study|Protocol Violation|4|||
13187908|NCT02138136|26176292|FG000|Overall Study|Physician Decision|7|||
13187909|NCT02138136|26176292|FG000|Overall Study|Lack of Efficacy|35|||
13187910|NCT02138136|26176292|FG000|Overall Study|Pregnancy|2|||
13187911|NCT02138136|26176292|FG000|Overall Study|Adverse Event|18|||
13187912|NCT02138136|26176292|FG000|Overall Study|Withdrawal by Subject|36|||
13187913|NCT02138136|26176292|FG000|Overall Study|Lost to Follow-up|32|||
13187914|NCT02138136|26176292|FG000|Overall Study|Withdrawn by Sponsor|5|||
13187915|NCT02137837|26176328|FG000|Overall Study|Adverse Event|0|||
13187916|NCT02137837|26176329|FG001|Overall Study|Adverse Event|2|||
13187917|NCT02137837|26176330|FG002|Overall Study|Adverse Event|1|||
13187918|NCT02137837|26176328|FG000|Overall Study|Refusal unrelated to adverse event|2|||
13187919|NCT02137837|26176329|FG001|Overall Study|Refusal unrelated to adverse event|2|||
13187920|NCT02137837|26176330|FG002|Overall Study|Refusal unrelated to adverse event|1|||
13187921|NCT02137837|26176328|FG000|Overall Study|Progression/relapse|9|||
13187922|NCT02137837|26176329|FG001|Overall Study|Progression/relapse|7|||
13187923|NCT02137837|26176330|FG002|Overall Study|Progression/relapse|7|||
13187924|NCT02137837|26176328|FG000|Overall Study|Not protocol specified|2|||
13187925|NCT02137837|26176329|FG001|Overall Study|Not protocol specified|1|||
13187926|NCT02137837|26176330|FG002|Overall Study|Not protocol specified|3|||
13187927|NCT02137785|26176443|FG000|Overall Study|Lost to Follow-up|1|||
13187928|NCT02137785|26176444|FG001|Overall Study|Lost to Follow-up|0|||
13223057|NCT01799993|26287796|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5|||
13187929|NCT02137785|26176443|FG000|Overall Study|Withdrawal by Subject|1|||
13223058|NCT01799993|26287797|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3|||
13187930|NCT02137785|26176444|FG001|Overall Study|Withdrawal by Subject|4|||
13187931|NCT02137785|26176443|FG000|Overall Study|subject moved out of state|1|||
13187932|NCT02137785|26176444|FG001|Overall Study|subject moved out of state|0|||
13187933|NCT02137772|26176475|FG000|Overall Study|Adverse Event|6|||
13187934|NCT02137772|26176476|FG001|Overall Study|Adverse Event|3|||
13187935|NCT02137772|26176475|FG000|Overall Study|Death|71|||
13187936|NCT02137772|26176476|FG001|Overall Study|Death|44|||
13187937|NCT02137772|26176475|FG000|Overall Study|Lost to Follow-up|8|||
13187938|NCT02137772|26176476|FG001|Overall Study|Lost to Follow-up|4|||
13187939|NCT02137772|26176475|FG000|Overall Study|Physician Decision|15|||
13187940|NCT02137772|26176476|FG001|Overall Study|Physician Decision|5|||
13187941|NCT02137772|26176475|FG000|Overall Study|Withdrawal by Subject|28|||
13187942|NCT02137772|26176476|FG001|Overall Study|Withdrawal by Subject|17|||
13187943|NCT02137772|26176475|FG000|Overall Study|Non-compliance with study drug|1|||
13187944|NCT02137772|26176476|FG001|Overall Study|Non-compliance with study drug|0|||
13187945|NCT02137772|26176475|FG000|Overall Study|Not treated|3|||
13187946|NCT02137772|26176476|FG001|Overall Study|Not treated|2|||
13187947|NCT02137369|26176491|FG000|Overall Study|Withdrawal by Subject|3|||
13187948|NCT02137369|26176492|FG001|Overall Study|Withdrawal by Subject|2|||
13187949|NCT02137369|26176491|FG000|Overall Study|Adverse Event|2|||
13187950|NCT02137369|26176492|FG001|Overall Study|Adverse Event|0|||
13187951|NCT02137369|26176491|FG000|Overall Study|Lost to Follow-up|1|||
13187952|NCT02137369|26176492|FG001|Overall Study|Lost to Follow-up|0|||
13187953|NCT02137369|26176491|FG000|Overall Study|Moved away|2|||
13187954|NCT02137369|26176492|FG001|Overall Study|Moved away|0|||
13187955|NCT02137252|26176505|FG000|Overall Study|trial terminated early|2|||
13187956|NCT02137252|26176506|FG001|Overall Study|trial terminated early|1|||
13187957|NCT02137226|26176528|FG000|Period 1 (Initial Randomization)|Adverse Event|3|||
13187958|NCT02137226|26176529|FG001|Period 1 (Initial Randomization)|Adverse Event|3|||
13187959|NCT02137226|26176530|FG002|Period 1 (Initial Randomization)|Adverse Event|0|||
13187960|NCT02137226|26176531|FG003|Period 1 (Initial Randomization)|Adverse Event|0|||
13187961|NCT02137226|26176532|FG004|Period 1 (Initial Randomization)|Adverse Event|0|||
13187962|NCT02137226|26176528|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11|||
13187963|NCT02137226|26176529|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5|||
13187964|NCT02137226|26176530|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
13187965|NCT02137226|26176531|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
13187966|NCT02137226|26176532|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
13187967|NCT02137226|26176528|FG000|Period 1 (Initial Randomization)|Physician Decision|1|||
13187968|NCT02137226|26176529|FG001|Period 1 (Initial Randomization)|Physician Decision|3|||
13187969|NCT02137226|26176530|FG002|Period 1 (Initial Randomization)|Physician Decision|0|||
13187970|NCT02137226|26176531|FG003|Period 1 (Initial Randomization)|Physician Decision|0|||
13187971|NCT02137226|26176532|FG004|Period 1 (Initial Randomization)|Physician Decision|0|||
13187972|NCT02137226|26176528|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3|||
13187973|NCT02137226|26176529|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2|||
13187974|NCT02137226|26176530|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
13187975|NCT02137226|26176531|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
13187976|NCT02137226|26176532|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
13187977|NCT02137226|26176528|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1|||
13187978|NCT02137226|26176529|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
13187979|NCT02137226|26176530|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
13187980|NCT02137226|26176531|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
13187981|NCT02137226|26176532|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
13187982|NCT02137226|26176528|FG000|Period 1 (Initial Randomization)|Other Reason|1|||
13187983|NCT02137226|26176529|FG001|Period 1 (Initial Randomization)|Other Reason|3|||
13187984|NCT02137226|26176530|FG002|Period 1 (Initial Randomization)|Other Reason|0|||
13187985|NCT02137226|26176531|FG003|Period 1 (Initial Randomization)|Other Reason|0|||
13187986|NCT02137226|26176532|FG004|Period 1 (Initial Randomization)|Other Reason|0|||
13187987|NCT02137226|26176528|FG000|Period 2 (Re - Randomization)|Adverse Event|0|||
13187988|NCT02137226|26176529|FG001|Period 2 (Re - Randomization)|Adverse Event|0|||
13187989|NCT02137226|26176530|FG002|Period 2 (Re - Randomization)|Adverse Event|3|||
13187990|NCT02137226|26176531|FG003|Period 2 (Re - Randomization)|Adverse Event|1|||
13187991|NCT02137226|26176532|FG004|Period 2 (Re - Randomization)|Adverse Event|4|||
13187992|NCT02137226|26176528|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
13187993|NCT02137226|26176529|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
13187994|NCT02137226|26176530|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8|||
13187995|NCT02137226|26176531|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5|||
13187996|NCT02137226|26176532|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4|||
13187997|NCT02137226|26176528|FG000|Period 2 (Re - Randomization)|Physician Decision|0|||
13187998|NCT02137226|26176529|FG001|Period 2 (Re - Randomization)|Physician Decision|0|||
13187999|NCT02137226|26176530|FG002|Period 2 (Re - Randomization)|Physician Decision|0|||
13188000|NCT02137226|26176531|FG003|Period 2 (Re - Randomization)|Physician Decision|1|||
13223059|NCT01799993|26287796|FG000|Overall Study|Protocol driven decision point|0|||
13188001|NCT02137226|26176532|FG004|Period 2 (Re - Randomization)|Physician Decision|0|||
13188002|NCT02137226|26176528|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
13188003|NCT02137226|26176529|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
13188004|NCT02137226|26176530|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3|||
13188005|NCT02137226|26176531|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
13188006|NCT02137226|26176532|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
13188007|NCT02137226|26176528|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
13188008|NCT02137226|26176529|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
13188009|NCT02137226|26176530|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2|||
13188010|NCT02137226|26176531|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
13188011|NCT02137226|26176532|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
13188012|NCT02137226|26176528|FG000|Period 2 (Re - Randomization)|Other Reason|0|||
13188013|NCT02137226|26176529|FG001|Period 2 (Re - Randomization)|Other Reason|0|||
13188014|NCT02137226|26176530|FG002|Period 2 (Re - Randomization)|Other Reason|1|||
13188015|NCT02137226|26176531|FG003|Period 2 (Re - Randomization)|Other Reason|1|||
13188016|NCT02137226|26176532|FG004|Period 2 (Re - Randomization)|Other Reason|1|||
13188017|NCT02136914|26176553|FG000|Overall Study|Sponsor's Decision to Stop the Study|7|||
13188018|NCT02136914|26176554|FG001|Overall Study|Sponsor's Decision to Stop the Study|7|||
13188019|NCT02136914|26176553|FG000|Overall Study|Withdrawal by Subject|3|||
13188020|NCT02136914|26176554|FG001|Overall Study|Withdrawal by Subject|10|||
13188021|NCT02136914|26176553|FG000|Overall Study|Subject Unwilling to Proceed|7|||
13188022|NCT02136914|26176554|FG001|Overall Study|Subject Unwilling to Proceed|2|||
13188023|NCT02136914|26176553|FG000|Overall Study|Lost to Follow-up|1|||
13188024|NCT02136914|26176554|FG001|Overall Study|Lost to Follow-up|1|||
13188025|NCT02136914|26176553|FG000|Overall Study|Did Not Receive Study Drug|2|||
13188026|NCT02136914|26176554|FG001|Overall Study|Did Not Receive Study Drug|0|||
13188027|NCT02136914|26176553|FG000|Overall Study|Lack of Efficacy|1|||
13188028|NCT02136914|26176554|FG001|Overall Study|Lack of Efficacy|0|||
13188029|NCT02136914|26176553|FG000|Overall Study|Death|0|||
13188030|NCT02136914|26176554|FG001|Overall Study|Death|1|||
13188031|NCT02136680|26176575|FG000|Overall Study|No Longer Interested|1|||
13188032|NCT02136680|26176576|FG001|Overall Study|No Longer Interested|1|||
13188033|NCT02136680|26176575|FG000|Overall Study|No longer receiving care at clinic|3|||
13188034|NCT02136680|26176576|FG001|Overall Study|No longer receiving care at clinic|5|||
13188035|NCT02136680|26176575|FG000|Overall Study|Moved away|5|||
13188036|NCT02136680|26176576|FG001|Overall Study|Moved away|4|||
13188037|NCT02136680|26176575|FG000|Overall Study|Unable to schedule|17|||
13188038|NCT02136680|26176576|FG001|Overall Study|Unable to schedule|16|||
13188039|NCT02136680|26176575|FG000|Overall Study|Study ended before interview due|6|||
13188040|NCT02136680|26176576|FG001|Overall Study|Study ended before interview due|3|||
13188041|NCT02136576|26176594|FG000|Overall Study|Lost to Follow-up|2|||
13188042|NCT02136576|26176595|FG001|Overall Study|Lost to Follow-up|0|||
13188043|NCT02136576|26176596|FG002|Overall Study|Lost to Follow-up|0|||
13188044|NCT02135848|26176661|FG000|Overall Study|Adverse Event|2|||
13188045|NCT02135848|26176662|FG001|Overall Study|Adverse Event|0|||
13188046|NCT02135848|26176661|FG000|Overall Study|Withdrawal by Subject|1|||
13188047|NCT02135848|26176662|FG001|Overall Study|Withdrawal by Subject|1|||
13188048|NCT02135692|26176681|FG000|Overall Study|Adverse Event|3|||
13188049|NCT02135692|26176681|FG000|Overall Study|Lack of Efficacy|2|||
13188050|NCT02135692|26176681|FG000|Overall Study|Protocol Violation|2|||
13188051|NCT02135692|26176681|FG000|Overall Study|Subject met Liver Stopping Criteria|1|||
13188052|NCT02135692|26176681|FG000|Overall Study|Product commercially available|159|||
13188053|NCT02135692|26176681|FG000|Overall Study|Study closed/terminated|153|||
13188054|NCT02135692|26176681|FG000|Overall Study|Lost to Follow-up|4|||
13188055|NCT02135692|26176681|FG000|Overall Study|Withdrawal by Subject|15|||
13188056|NCT02135614|26176700|FG000|Overall Study|Randomized but Not Treated|2|||
13188057|NCT02135614|26176701|FG001|Overall Study|Randomized but Not Treated|1|||
13188058|NCT02135614|26176700|FG000|Overall Study|Adverse Event|0|||
13188059|NCT02135614|26176701|FG001|Overall Study|Adverse Event|1|||
13188060|NCT02135614|26176700|FG000|Overall Study|Death|1|||
13188061|NCT02135614|26176701|FG001|Overall Study|Death|0|||
13188062|NCT02135614|26176700|FG000|Overall Study|Investigator's Discretion|0|||
13188063|NCT02135614|26176701|FG001|Overall Study|Investigator's Discretion|1|||
13188064|NCT02135614|26176700|FG000|Overall Study|Withdrew Consent|2|||
13188065|NCT02135614|26176701|FG001|Overall Study|Withdrew Consent|2|||
13188066|NCT02135614|26176700|FG000|Overall Study|Lost to Follow-up|3|||
13188067|NCT02135614|26176701|FG001|Overall Study|Lost to Follow-up|0|||
13188068|NCT02135445|26176757|FG000|Overall Study|Lost to Follow-up|1|||
13188069|NCT02135445|26176758|FG001|Overall Study|Lost to Follow-up|0|||
13188070|NCT02135445|26176757|FG000|Overall Study|Withdrawal by Subject|1|||
13188071|NCT02135445|26176758|FG001|Overall Study|Withdrawal by Subject|0|||
13188072|NCT02135107|26176793|FG000|Treatment Period|Withdrawal by Subject|11|||
13188073|NCT02135107|26176794|FG001|Treatment Period|Withdrawal by Subject|0|||
13188074|NCT02135107|26176795|FG002|Treatment Period|Withdrawal by Subject|0|||
13188075|NCT02135107|26176796|FG003|Treatment Period|Withdrawal by Subject|0|||
13188076|NCT02135107|26176793|FG000|Treatment Period|Adverse Event|5|||
13188077|NCT02135107|26176794|FG001|Treatment Period|Adverse Event|2|||
13188078|NCT02135107|26176795|FG002|Treatment Period|Adverse Event|0|||
13188079|NCT02135107|26176796|FG003|Treatment Period|Adverse Event|0|||
13188080|NCT02135107|26176793|FG000|Treatment Period|Pregnancy|1|||
13188081|NCT02135107|26176794|FG001|Treatment Period|Pregnancy|0|||
13188082|NCT02135107|26176795|FG002|Treatment Period|Pregnancy|0|||
13188083|NCT02135107|26176796|FG003|Treatment Period|Pregnancy|0|||
13188084|NCT02135107|26176793|FG000|Treatment Period|Other|115|||
13188085|NCT02135107|26176794|FG001|Treatment Period|Other|24|||
13188086|NCT02135107|26176795|FG002|Treatment Period|Other|0|||
13188087|NCT02135107|26176796|FG003|Treatment Period|Other|0|||
13188088|NCT02135107|26176793|FG000|Maintenance Therapy Period|Adverse Event|0|||
13188089|NCT02135107|26176794|FG001|Maintenance Therapy Period|Adverse Event|0|||
13188090|NCT02135107|26176795|FG002|Maintenance Therapy Period|Adverse Event|3|||
13188091|NCT02135107|26176796|FG003|Maintenance Therapy Period|Adverse Event|7|||
13188092|NCT02135107|26176793|FG000|Maintenance Therapy Period|Withdrawal by Subject|0|||
13188093|NCT02135107|26176794|FG001|Maintenance Therapy Period|Withdrawal by Subject|0|||
13188094|NCT02135107|26176795|FG002|Maintenance Therapy Period|Withdrawal by Subject|5|||
13188095|NCT02135107|26176796|FG003|Maintenance Therapy Period|Withdrawal by Subject|4|||
13188096|NCT02135107|26176793|FG000|Maintenance Therapy Period|Pregnancy|0|||
13188097|NCT02135107|26176794|FG001|Maintenance Therapy Period|Pregnancy|0|||
13188098|NCT02135107|26176795|FG002|Maintenance Therapy Period|Pregnancy|0|||
13188099|NCT02135107|26176796|FG003|Maintenance Therapy Period|Pregnancy|1|||
13188100|NCT02135107|26176793|FG000|Maintenance Therapy Period|Other|0|||
13188101|NCT02135107|26176794|FG001|Maintenance Therapy Period|Other|0|||
13188102|NCT02135107|26176795|FG002|Maintenance Therapy Period|Other|7|||
13188103|NCT02135107|26176796|FG003|Maintenance Therapy Period|Other|8|||
13188104|NCT02134977|26176819|FG000|Overall Study|Protocol Deviation|102|||
13188105|NCT02134925|26176842|FG000|Overall Study|Withdrawal by Subject|1|||
13188106|NCT02134925|26176843|FG001|Overall Study|Withdrawal by Subject|0|||
13188107|NCT02134925|26176842|FG000|Overall Study|Cancel|1|||
13188108|NCT02134925|26176843|FG001|Overall Study|Cancel|6|||
13188109|NCT02134587|26176854|FG000|Overall Study|Did not completed all meetings|30|||
13188110|NCT02134353|26176885|FG000|Overall Study|Adverse Event|10|||
13188111|NCT02134353|26176886|FG001|Overall Study|Adverse Event|6|||
13188112|NCT02134353|26176885|FG000|Overall Study|Lost to Follow-up|1|||
13188113|NCT02134353|26176886|FG001|Overall Study|Lost to Follow-up|1|||
13188114|NCT02134353|26176885|FG000|Overall Study|Lack of Efficacy|2|||
13188115|NCT02134353|26176886|FG001|Overall Study|Lack of Efficacy|1|||
13188116|NCT02134353|26176885|FG000|Overall Study|Withdrawal by Subject|12|||
13188117|NCT02134353|26176886|FG001|Overall Study|Withdrawal by Subject|13|||
13188118|NCT02134353|26176885|FG000|Overall Study|Death|0|||
13188119|NCT02134353|26176886|FG001|Overall Study|Death|1|||
13188120|NCT02134353|26176885|FG000|Overall Study|Pregnancy|0|||
13188121|NCT02134353|26176886|FG001|Overall Study|Pregnancy|1|||
13188122|NCT02134353|26176885|FG000|Overall Study|Relocation|1|||
13188123|NCT02134353|26176886|FG001|Overall Study|Relocation|0|||
13188124|NCT02134353|26176885|FG000|Overall Study|Other - Patient's Choice|0|||
13188125|NCT02134353|26176886|FG001|Overall Study|Other - Patient's Choice|1|||
13188126|NCT02134028|26177067|FG000|Overall Study|Lack of Efficacy|1|||
13188127|NCT02134028|26177068|FG001|Overall Study|Lack of Efficacy|0|||
13188128|NCT02134028|26177069|FG002|Overall Study|Lack of Efficacy|3|||
13188129|NCT02134028|26177070|FG003|Overall Study|Lack of Efficacy|2|||
13188130|NCT02134028|26177071|FG004|Overall Study|Lack of Efficacy|1|||
13188131|NCT02134028|26177072|FG005|Overall Study|Lack of Efficacy|2|||
13188132|NCT02134028|26177073|FG006|Overall Study|Lack of Efficacy|1|||
13188133|NCT02134028|26177074|FG007|Overall Study|Lack of Efficacy|0|||
13188134|NCT02134028|26177067|FG000|Overall Study|Poor compliance to protocol|1|||
13188135|NCT02134028|26177068|FG001|Overall Study|Poor compliance to protocol|1|||
13188136|NCT02134028|26177069|FG002|Overall Study|Poor compliance to protocol|3|||
13188137|NCT02134028|26177070|FG003|Overall Study|Poor compliance to protocol|7|||
13188138|NCT02134028|26177071|FG004|Overall Study|Poor compliance to protocol|1|||
13188139|NCT02134028|26177072|FG005|Overall Study|Poor compliance to protocol|1|||
13188140|NCT02134028|26177073|FG006|Overall Study|Poor compliance to protocol|0|||
13188141|NCT02134028|26177074|FG007|Overall Study|Poor compliance to protocol|0|||
13188142|NCT02134028|26177067|FG000|Overall Study|Other unspecified|4|||
13188143|NCT02134028|26177068|FG001|Overall Study|Other unspecified|22|||
13188144|NCT02134028|26177069|FG002|Overall Study|Other unspecified|33|||
13188145|NCT02134028|26177070|FG003|Overall Study|Other unspecified|64|||
13188146|NCT02134028|26177071|FG004|Overall Study|Other unspecified|8|||
13188147|NCT02134028|26177072|FG005|Overall Study|Other unspecified|6|||
13188148|NCT02134028|26177073|FG006|Overall Study|Other unspecified|2|||
13188149|NCT02134028|26177074|FG007|Overall Study|Other unspecified|1|||
13188150|NCT02134028|26177067|FG000|Overall Study|Adverse Event|3|||
13188151|NCT02134028|26177068|FG001|Overall Study|Adverse Event|19|||
13188152|NCT02134028|26177069|FG002|Overall Study|Adverse Event|13|||
13188153|NCT02134028|26177070|FG003|Overall Study|Adverse Event|32|||
13188154|NCT02134028|26177071|FG004|Overall Study|Adverse Event|4|||
13188155|NCT02134028|26177072|FG005|Overall Study|Adverse Event|5|||
13188156|NCT02134028|26177073|FG006|Overall Study|Adverse Event|1|||
13188157|NCT02134028|26177074|FG007|Overall Study|Adverse Event|2|||
13188158|NCT02134015|26177101|FG000|Overall Study|Protocol Violation|0|||
13188159|NCT02134015|26177102|FG001|Overall Study|Protocol Violation|1|||
13188160|NCT02134015|26177101|FG000|Overall Study|Death|2|||
13188161|NCT02134015|26177102|FG001|Overall Study|Death|1|||
13188162|NCT02134015|26177101|FG000|Overall Study|Reason not provided|1|||
13188163|NCT02134015|26177102|FG001|Overall Study|Reason not provided|2|||
13188164|NCT02134015|26177101|FG000|Overall Study|Clinical progression|14|||
13188165|NCT02134015|26177102|FG001|Overall Study|Clinical progression|7|||
13188166|NCT02134015|26177101|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40|||
13188167|NCT02134015|26177102|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43|||
13188168|NCT02134015|26177101|FG000|Overall Study|Study terminated by sponsor|2|||
13188169|NCT02134015|26177102|FG001|Overall Study|Study terminated by sponsor|3|||
13188170|NCT02134015|26177101|FG000|Overall Study|Adverse Event|9|||
13188171|NCT02134015|26177102|FG001|Overall Study|Adverse Event|10|||
13188172|NCT02134015|26177101|FG000|Overall Study|Withdrawal by Subject|3|||
13188173|NCT02134015|26177102|FG001|Overall Study|Withdrawal by Subject|7|||
13188174|NCT02133924|26177115|FG000|Overall Study|Death|38|||
13188175|NCT02133924|26177115|FG000|Overall Study|Physician Decision|1|||
13188176|NCT02133924|26177115|FG000|Overall Study|Withdrawal by Subject|3|||
13188177|NCT02133742|26177144|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2|||
13188178|NCT02133742|26177144|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31|||
13188179|NCT02133742|26177144|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13|||
13188180|NCT02133742|26177144|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5|||
13188181|NCT02133742|26177144|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1|||
13188182|NCT02133664|26177163|FG000|Overall Study|Lost to Follow-up|2|||
13188183|NCT02133664|26177164|FG001|Overall Study|Lost to Follow-up|1|||
13188184|NCT02133664|26177163|FG000|Overall Study|Adverse Event|3|||
13188185|NCT02133664|26177164|FG001|Overall Study|Adverse Event|6|||
13188186|NCT02133508|26177174|FG000|Overall Study|Decision of Investigator or Sponsor|1|||
13188187|NCT02133508|26177174|FG000|Overall Study|Death|12|||
13188188|NCT02133508|26177174|FG000|Overall Study|Lost to Follow-up|2|||
13188189|NCT02133352|26177185|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6|||
13188190|NCT02133131|26177244|FG000|Overall Study|Adverse Event|0|||
13188191|NCT02133131|26177245|FG001|Overall Study|Adverse Event|0|||
13188192|NCT02133131|26177246|FG002|Overall Study|Adverse Event|0|||
13188193|NCT02133131|26177247|FG003|Overall Study|Adverse Event|1|||
13188194|NCT02133131|26177248|FG004|Overall Study|Adverse Event|0|||
13188195|NCT02133131|26177249|FG005|Overall Study|Adverse Event|0|||
13188196|NCT02133131|26177250|FG006|Overall Study|Adverse Event|0|||
13188197|NCT02133131|26177244|FG000|Overall Study|Lost to Follow-up|1|||
13188198|NCT02133131|26177245|FG001|Overall Study|Lost to Follow-up|0|||
13188199|NCT02133131|26177246|FG002|Overall Study|Lost to Follow-up|0|||
13188200|NCT02133131|26177247|FG003|Overall Study|Lost to Follow-up|1|||
13188201|NCT02133131|26177248|FG004|Overall Study|Lost to Follow-up|0|||
13188202|NCT02133131|26177249|FG005|Overall Study|Lost to Follow-up|0|||
13188203|NCT02133131|26177250|FG006|Overall Study|Lost to Follow-up|0|||
13188204|NCT02133131|26177244|FG000|Overall Study|Status not recorded|4|||
13188205|NCT02133131|26177245|FG001|Overall Study|Status not recorded|5|||
13188206|NCT02133131|26177246|FG002|Overall Study|Status not recorded|1|||
13188207|NCT02133131|26177247|FG003|Overall Study|Status not recorded|4|||
13188208|NCT02133131|26177248|FG004|Overall Study|Status not recorded|0|||
13188209|NCT02133131|26177249|FG005|Overall Study|Status not recorded|0|||
13188210|NCT02133131|26177250|FG006|Overall Study|Status not recorded|0|||
13188211|NCT02133131|26177244|FG000|Overall Study|Ongoing in study|0|||
13188212|NCT02133131|26177245|FG001|Overall Study|Ongoing in study|0|||
13188213|NCT02133131|26177246|FG002|Overall Study|Ongoing in study|0|||
13188214|NCT02133131|26177247|FG003|Overall Study|Ongoing in study|0|||
13188215|NCT02133131|26177248|FG004|Overall Study|Ongoing in study|15|||
13188216|NCT02133131|26177249|FG005|Overall Study|Ongoing in study|14|||
13188217|NCT02133131|26177250|FG006|Overall Study|Ongoing in study|11|||
13188218|NCT02133131|26177244|FG000|Overall Study|Protocol Violation|0|||
13188219|NCT02133131|26177245|FG001|Overall Study|Protocol Violation|0|||
13188220|NCT02133131|26177246|FG002|Overall Study|Protocol Violation|0|||
13188221|NCT02133131|26177247|FG003|Overall Study|Protocol Violation|0|||
13188222|NCT02133131|26177248|FG004|Overall Study|Protocol Violation|0|||
13188223|NCT02133131|26177249|FG005|Overall Study|Protocol Violation|0|||
13188224|NCT02133131|26177250|FG006|Overall Study|Protocol Violation|1|||
13188225|NCT02133001|26177303|FG000|Double Blind (Day 1-25)|Adverse Event|1|||
13188226|NCT02133001|26177304|FG001|Double Blind (Day 1-25)|Adverse Event|5|||
13188227|NCT02133001|26177303|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4|||
13188228|NCT02133001|26177304|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1|||
13188229|NCT02133001|26177303|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2|||
13188230|NCT02133001|26177304|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0|||
13188231|NCT02133001|26177303|FG000|Double Blind (Day 1-25)|Other|2|||
13188232|NCT02133001|26177304|FG001|Double Blind (Day 1-25)|Other|2|||
13188233|NCT02133001|26177303|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
13188234|NCT02133001|26177304|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
13188235|NCT02133001|26177303|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
13188236|NCT02133001|26177304|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
13188237|NCT02133001|26177303|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
13188238|NCT02133001|26177304|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
13188239|NCT02133001|26177303|FG000|Follow-Up Phase (Day 26-81)|Other|0|||
13188240|NCT02133001|26177304|FG001|Follow-Up Phase (Day 26-81)|Other|1|||
13188241|NCT02132949|26177345|FG000|Overall Study|Death|7|||
13188242|NCT02132949|26177346|FG001|Overall Study|Death|13|||
13188243|NCT02132949|26177345|FG000|Overall Study|Lost to Follow-up|14|||
13188244|NCT02132949|26177346|FG001|Overall Study|Lost to Follow-up|4|||
13188245|NCT02132949|26177345|FG000|Overall Study|Withdrawal by Subject|6|||
13188246|NCT02132949|26177346|FG001|Overall Study|Withdrawal by Subject|5|||
13188247|NCT02132949|26177345|FG000|Overall Study|Noncompliance|5|||
13188248|NCT02132949|26177346|FG001|Overall Study|Noncompliance|1|||
13188249|NCT02132949|26177345|FG000|Overall Study|Physician Decision|3|||
13188250|NCT02132949|26177346|FG001|Overall Study|Physician Decision|1|||
13188251|NCT02132949|26177345|FG000|Overall Study|Disease Progression|3|||
13188252|NCT02132949|26177346|FG001|Overall Study|Disease Progression|0|||
13188253|NCT02132949|26177345|FG000|Overall Study|Adverse Event|2|||
13188254|NCT02132949|26177346|FG001|Overall Study|Adverse Event|1|||
13188255|NCT02132949|26177345|FG000|Overall Study|Withdrew Prior to Treatment|1|||
13188256|NCT02132949|26177346|FG001|Overall Study|Withdrew Prior to Treatment|2|||
13188257|NCT02132949|26177345|FG000|Overall Study|Reason Unspecified|0|||
13188258|NCT02132949|26177346|FG001|Overall Study|Reason Unspecified|1|||
13188259|NCT02132767|26177373|FG000|Overall Study|Death|3|||
13188260|NCT02132767|26177374|FG001|Overall Study|Death|2|||
13188261|NCT02132767|26177373|FG000|Overall Study|Withdrawal by Subject|10|||
13188262|NCT02132767|26177374|FG001|Overall Study|Withdrawal by Subject|9|||
13188263|NCT02132767|26177373|FG000|Overall Study|Lost to Follow-up|4|||
13188264|NCT02132767|26177374|FG001|Overall Study|Lost to Follow-up|4|||
13188265|NCT02132754|26178199|FG000|Overall Study|Adverse Event|0|||
13188266|NCT02132754|26178200|FG001|Overall Study|Adverse Event|0|||
13188267|NCT02132754|26178201|FG002|Overall Study|Adverse Event|0|||
13188268|NCT02132754|26178202|FG003|Overall Study|Adverse Event|0|||
13188269|NCT02132754|26178203|FG004|Overall Study|Adverse Event|0|||
13188270|NCT02132754|26178204|FG005|Overall Study|Adverse Event|0|||
13188271|NCT02132754|26178205|FG006|Overall Study|Adverse Event|0|||
13188272|NCT02132754|26178206|FG007|Overall Study|Adverse Event|0|||
13188273|NCT02132754|26178207|FG008|Overall Study|Adverse Event|0|||
13188274|NCT02132754|26178208|FG009|Overall Study|Adverse Event|0|||
13188275|NCT02132754|26178209|FG010|Overall Study|Adverse Event|0|||
13188276|NCT02132754|26178210|FG011|Overall Study|Adverse Event|0|||
13188277|NCT02132754|26178211|FG012|Overall Study|Adverse Event|0|||
13188278|NCT02132754|26178212|FG013|Overall Study|Adverse Event|0|||
13188279|NCT02132754|26178213|FG014|Overall Study|Adverse Event|0|||
13188280|NCT02132754|26178214|FG015|Overall Study|Adverse Event|0|||
13188281|NCT02132754|26178215|FG016|Overall Study|Adverse Event|0|||
13188282|NCT02132754|26178216|FG017|Overall Study|Adverse Event|1|||
13188283|NCT02132754|26178217|FG018|Overall Study|Adverse Event|0|||
13188284|NCT02132754|26178218|FG019|Overall Study|Adverse Event|0|||
13188285|NCT02132754|26178219|FG020|Overall Study|Adverse Event|0|||
13188286|NCT02132754|26178220|FG021|Overall Study|Adverse Event|0|||
13188287|NCT02132754|26178221|FG022|Overall Study|Adverse Event|0|||
13188288|NCT02132754|26178222|FG023|Overall Study|Adverse Event|0|||
13188289|NCT02132754|26178223|FG024|Overall Study|Adverse Event|0|||
13188290|NCT02132754|26178224|FG025|Overall Study|Adverse Event|1|||
13188291|NCT02132754|26178225|FG026|Overall Study|Adverse Event|1|||
13223060|NCT01799993|26287797|FG001|Overall Study|Protocol driven decision point|3|||
13223061|NCT01799993|26287796|FG000|Overall Study|Protocol Violation|1|||
13223062|NCT01799993|26287797|FG001|Overall Study|Protocol Violation|1|||
13223063|NCT01799993|26287796|FG000|Overall Study|Deterioration of general conditions|2|||
13223064|NCT01799993|26287797|FG001|Overall Study|Deterioration of general conditions|0|||
13223065|NCT01799993|26287796|FG000|Overall Study|Screen failure|0|||
13223066|NCT01799993|26287797|FG001|Overall Study|Screen failure|1|||
13223067|NCT01799993|26287796|FG000|Overall Study|Adverse Event|1|||
13223068|NCT01799993|26287797|FG001|Overall Study|Adverse Event|0|||
13223069|NCT01799993|26287796|FG000|Overall Study|Lack of Efficacy|1|||
13223070|NCT01799993|26287797|FG001|Overall Study|Lack of Efficacy|0|||
13223071|NCT01799993|26287796|FG000|Overall Study|Recovery|0|||
13223072|NCT01799993|26287797|FG001|Overall Study|Recovery|1|||
13188292|NCT02132754|26178226|FG027|Overall Study|Adverse Event|0|||
13188293|NCT02132754|26178227|FG028|Overall Study|Adverse Event|0|||
13188294|NCT02132754|26178228|FG029|Overall Study|Adverse Event|0|||
13188295|NCT02132754|26178229|FG030|Overall Study|Adverse Event|1|||
13188296|NCT02132754|26178230|FG031|Overall Study|Adverse Event|0|||
13188297|NCT02132754|26178231|FG032|Overall Study|Adverse Event|1|||
13188298|NCT02132754|26178232|FG033|Overall Study|Adverse Event|1|||
13188299|NCT02132754|26178199|FG000|Overall Study|Clinical Progression|0|||
13223073|NCT01799993|26287796|FG000|Overall Study|Logistical difficulties|1|||
13223074|NCT01799993|26287797|FG001|Overall Study|Logistical difficulties|0|||
13223075|NCT01799993|26287796|FG000|Overall Study|Protocol deviation|1|||
13223076|NCT01799993|26287797|FG001|Overall Study|Protocol deviation|0|||
13223077|NCT01799993|26287796|FG000|Overall Study|Non-compliance with medical device|1|||
13223078|NCT01799993|26287797|FG001|Overall Study|Non-compliance with medical device|0|||
13223079|NCT01799993|26287796|FG000|Overall Study|Withdrawal by parent/guardian|0|||
13223080|NCT01799993|26287797|FG001|Overall Study|Withdrawal by parent/guardian|1|||
13223081|NCT01799993|26287796|FG000|Overall Study|Other|1|||
13223082|NCT01799993|26287797|FG001|Overall Study|Other|0|||
13223083|NCT01799993|26287796|FG000|Overall Study|Subject didn't return for follow-up|0|||
13223084|NCT01799993|26287797|FG001|Overall Study|Subject didn't return for follow-up|1|||
13223085|NCT01799941|26287853|FG000|Overall Study|Adverse Event|34|||
13223086|NCT01799941|26287853|FG000|Overall Study|Withdrawal by Subject|21|||
13223087|NCT01799941|26287853|FG000|Overall Study|Death|2|||
13223088|NCT01799941|26287853|FG000|Overall Study|Investigator Decision|4|||
13223089|NCT01799941|26287853|FG000|Overall Study|Lack of Efficacy|3|||
13223090|NCT01799941|26287853|FG000|Overall Study|Lost to Follow-up|17|||
13223091|NCT01799941|26287853|FG000|Overall Study|Other|15|||
13223092|NCT01799889|26287988|FG000|Overall Study|Adverse Event|4|||
13223093|NCT01799889|26287989|FG001|Overall Study|Adverse Event|4|||
13223094|NCT01799889|26287990|FG002|Overall Study|Adverse Event|5|||
13223095|NCT01799889|26287991|FG003|Overall Study|Adverse Event|1|||
13110760|NCT03205150|25900563|FG001|Overall Study|Adverse Event|1|||
13188300|NCT02132754|26178200|FG001|Overall Study|Clinical Progression|0|||
13188301|NCT02132754|26178201|FG002|Overall Study|Clinical Progression|0|||
13188302|NCT02132754|26178202|FG003|Overall Study|Clinical Progression|0|||
13188303|NCT02132754|26178203|FG004|Overall Study|Clinical Progression|0|||
13188304|NCT02132754|26178204|FG005|Overall Study|Clinical Progression|0|||
13188305|NCT02132754|26178205|FG006|Overall Study|Clinical Progression|0|||
13188306|NCT02132754|26178206|FG007|Overall Study|Clinical Progression|0|||
13188307|NCT02132754|26178207|FG008|Overall Study|Clinical Progression|0|||
13188308|NCT02132754|26178208|FG009|Overall Study|Clinical Progression|1|||
13188309|NCT02132754|26178209|FG010|Overall Study|Clinical Progression|0|||
13188310|NCT02132754|26178210|FG011|Overall Study|Clinical Progression|0|||
13188311|NCT02132754|26178211|FG012|Overall Study|Clinical Progression|0|||
13188312|NCT02132754|26178212|FG013|Overall Study|Clinical Progression|0|||
13188313|NCT02132754|26178213|FG014|Overall Study|Clinical Progression|0|||
13188314|NCT02132754|26178214|FG015|Overall Study|Clinical Progression|0|||
13188315|NCT02132754|26178215|FG016|Overall Study|Clinical Progression|1|||
13188316|NCT02132754|26178216|FG017|Overall Study|Clinical Progression|1|||
13188317|NCT02132754|26178217|FG018|Overall Study|Clinical Progression|0|||
13188318|NCT02132754|26178218|FG019|Overall Study|Clinical Progression|1|||
13188319|NCT02132754|26178219|FG020|Overall Study|Clinical Progression|0|||
13188320|NCT02132754|26178220|FG021|Overall Study|Clinical Progression|0|||
13188321|NCT02132754|26178221|FG022|Overall Study|Clinical Progression|1|||
13188322|NCT02132754|26178222|FG023|Overall Study|Clinical Progression|0|||
13188323|NCT02132754|26178223|FG024|Overall Study|Clinical Progression|1|||
13188324|NCT02132754|26178224|FG025|Overall Study|Clinical Progression|1|||
13188325|NCT02132754|26178225|FG026|Overall Study|Clinical Progression|0|||
13188326|NCT02132754|26178226|FG027|Overall Study|Clinical Progression|1|||
13188327|NCT02132754|26178227|FG028|Overall Study|Clinical Progression|1|||
13188328|NCT02132754|26178228|FG029|Overall Study|Clinical Progression|0|||
13188329|NCT02132754|26178229|FG030|Overall Study|Clinical Progression|1|||
13188330|NCT02132754|26178230|FG031|Overall Study|Clinical Progression|0|||
13110761|NCT03205150|25900564|FG002|Overall Study|Adverse Event|1|||
13110762|NCT03205150|25900562|FG000|Overall Study|Lost to Follow-up|0|||
13110763|NCT03205150|25900563|FG001|Overall Study|Lost to Follow-up|0|||
13110764|NCT03205150|25900564|FG002|Overall Study|Lost to Follow-up|1|||
13110765|NCT03205046|25900577|FG000|Overall Study|Death|10|||
13110766|NCT03205046|25900578|FG001|Overall Study|Death|6|||
13110767|NCT03205046|25900577|FG000|Overall Study|Withdrawal by Subject|1|||
13110768|NCT03205046|25900578|FG001|Overall Study|Withdrawal by Subject|2|||
13188331|NCT02132754|26178231|FG032|Overall Study|Clinical Progression|0|||
13188332|NCT02132754|26178232|FG033|Overall Study|Clinical Progression|2|||
13188333|NCT02132754|26178199|FG000|Overall Study|Death|0|||
13188334|NCT02132754|26178200|FG001|Overall Study|Death|0|||
13188335|NCT02132754|26178201|FG002|Overall Study|Death|0|||
13188336|NCT02132754|26178202|FG003|Overall Study|Death|0|||
13188337|NCT02132754|26178203|FG004|Overall Study|Death|0|||
13188338|NCT02132754|26178204|FG005|Overall Study|Death|0|||
13188339|NCT02132754|26178205|FG006|Overall Study|Death|0|||
13188340|NCT02132754|26178206|FG007|Overall Study|Death|0|||
13188341|NCT02132754|26178207|FG008|Overall Study|Death|0|||
13188342|NCT02132754|26178208|FG009|Overall Study|Death|0|||
13188343|NCT02132754|26178209|FG010|Overall Study|Death|0|||
13223096|NCT01799889|26287992|FG004|Overall Study|Adverse Event|11|||
13223097|NCT01799889|26287993|FG005|Overall Study|Adverse Event|1|||
13223098|NCT01799889|26287994|FG006|Overall Study|Adverse Event|5|||
13223099|NCT01799889|26287995|FG007|Overall Study|Adverse Event|2|||
13110769|NCT03205046|25900577|FG000|Overall Study|Lost to Follow-up|0|||
13110770|NCT03205046|25900578|FG001|Overall Study|Lost to Follow-up|1|||
13110771|NCT03205046|25900577|FG000|Overall Study|Study terminated by sponsor|2|||
13110772|NCT03205046|25900578|FG001|Overall Study|Study terminated by sponsor|1|||
13110773|NCT03204981|25900591|FG000|Overall Study|Physician Decision|2|||
13110774|NCT03204981|25900591|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4|||
13188344|NCT02132754|26178210|FG011|Overall Study|Death|0|||
13188345|NCT02132754|26178211|FG012|Overall Study|Death|0|||
13188346|NCT02132754|26178212|FG013|Overall Study|Death|0|||
13188347|NCT02132754|26178213|FG014|Overall Study|Death|0|||
13188348|NCT02132754|26178214|FG015|Overall Study|Death|1|||
13188349|NCT02132754|26178215|FG016|Overall Study|Death|0|||
13188350|NCT02132754|26178216|FG017|Overall Study|Death|0|||
13188351|NCT02132754|26178217|FG018|Overall Study|Death|0|||
13188352|NCT02132754|26178218|FG019|Overall Study|Death|1|||
13188353|NCT02132754|26178219|FG020|Overall Study|Death|0|||
13188354|NCT02132754|26178220|FG021|Overall Study|Death|1|||
13188355|NCT02132754|26178221|FG022|Overall Study|Death|0|||
13188356|NCT02132754|26178222|FG023|Overall Study|Death|0|||
13188357|NCT02132754|26178223|FG024|Overall Study|Death|0|||
13188358|NCT02132754|26178224|FG025|Overall Study|Death|0|||
13188359|NCT02132754|26178225|FG026|Overall Study|Death|1|||
13188360|NCT02132754|26178226|FG027|Overall Study|Death|0|||
13188361|NCT02132754|26178227|FG028|Overall Study|Death|0|||
13188362|NCT02132754|26178228|FG029|Overall Study|Death|0|||
13188363|NCT02132754|26178229|FG030|Overall Study|Death|0|||
13188364|NCT02132754|26178230|FG031|Overall Study|Death|0|||
13188365|NCT02132754|26178231|FG032|Overall Study|Death|0|||
13188366|NCT02132754|26178232|FG033|Overall Study|Death|2|||
13188367|NCT02132754|26178199|FG000|Overall Study|Excluded Medication|0|||
13110775|NCT03204812|25900601|FG000|Overall Study|Adverse Event|3|||
13110776|NCT03204539|25900630|FG000|Overall Study|Loss of funding|0|||
13110777|NCT03204539|25900631|FG001|Overall Study|Loss of funding|1|||
13110778|NCT03204279|25900649|FG000|Overall Study|Withdrawal by Subject|0|||
13110779|NCT03204279|25900650|FG001|Overall Study|Withdrawal by Subject|1|||
13110780|NCT03203473|25900671|FG000|Induction Phase|Never started primary treatment|2|||
13110781|NCT03203473|25900672|FG001|Induction Phase|Never started primary treatment|0|||
13110782|NCT03203473|25900673|FG002|Induction Phase|Never started primary treatment|0|||
13110783|NCT03203473|25900671|FG000|Induction Phase|Withdrew from study due to progressive disease|7|||
13110784|NCT03203473|25900672|FG001|Induction Phase|Withdrew from study due to progressive disease|0|||
13110785|NCT03203473|25900673|FG002|Induction Phase|Withdrew from study due to progressive disease|0|||
13110786|NCT03203473|25900671|FG000|Induction Phase|Withdrew from study due to toxicity|7|||
13110787|NCT03203473|25900672|FG001|Induction Phase|Withdrew from study due to toxicity|0|||
13110788|NCT03203473|25900673|FG002|Induction Phase|Withdrew from study due to toxicity|0|||
13110789|NCT03203473|25900671|FG000|Arm Allocation Phase|Still on Arm A-observation|0|||
13110790|NCT03203473|25900672|FG001|Arm Allocation Phase|Still on Arm A-observation|7|||
13110791|NCT03203473|25900673|FG002|Arm Allocation Phase|Still on Arm A-observation|0|||
13110792|NCT03203473|25900671|FG000|Arm Allocation Phase|started salvage therapy|0|||
13110793|NCT03203473|25900672|FG001|Arm Allocation Phase|started salvage therapy|5|||
13110794|NCT03203473|25900673|FG002|Arm Allocation Phase|started salvage therapy|0|||
13110795|NCT03203473|25900671|FG000|Arm Allocation Phase|Disease progression|0|||
13110796|NCT03203473|25900672|FG001|Arm Allocation Phase|Disease progression|0|||
13110797|NCT03203473|25900673|FG002|Arm Allocation Phase|Disease progression|37|||
13110798|NCT03203473|25900671|FG000|Arm Allocation Phase|Adverse Event|0|||
13110799|NCT03203473|25900672|FG001|Arm Allocation Phase|Adverse Event|0|||
13110800|NCT03203473|25900673|FG002|Arm Allocation Phase|Adverse Event|11|||
13110801|NCT03203473|25900671|FG000|Arm Allocation Phase|Physician Decision|0|||
13110802|NCT03203473|25900672|FG001|Arm Allocation Phase|Physician Decision|0|||
13110803|NCT03203473|25900673|FG002|Arm Allocation Phase|Physician Decision|3|||
13188368|NCT02132754|26178200|FG001|Overall Study|Excluded Medication|0|||
13188369|NCT02132754|26178201|FG002|Overall Study|Excluded Medication|0|||
13188370|NCT02132754|26178202|FG003|Overall Study|Excluded Medication|0|||
13188371|NCT02132754|26178203|FG004|Overall Study|Excluded Medication|0|||
13188372|NCT02132754|26178204|FG005|Overall Study|Excluded Medication|0|||
13188373|NCT02132754|26178205|FG006|Overall Study|Excluded Medication|0|||
13188374|NCT02132754|26178206|FG007|Overall Study|Excluded Medication|0|||
13188375|NCT02132754|26178207|FG008|Overall Study|Excluded Medication|0|||
13188376|NCT02132754|26178208|FG009|Overall Study|Excluded Medication|0|||
13188377|NCT02132754|26178209|FG010|Overall Study|Excluded Medication|0|||
13188378|NCT02132754|26178210|FG011|Overall Study|Excluded Medication|0|||
13188379|NCT02132754|26178211|FG012|Overall Study|Excluded Medication|0|||
13188380|NCT02132754|26178212|FG013|Overall Study|Excluded Medication|0|||
13188381|NCT02132754|26178213|FG014|Overall Study|Excluded Medication|0|||
13188382|NCT02132754|26178214|FG015|Overall Study|Excluded Medication|0|||
13188383|NCT02132754|26178215|FG016|Overall Study|Excluded Medication|0|||
13188384|NCT02132754|26178216|FG017|Overall Study|Excluded Medication|0|||
13188385|NCT02132754|26178217|FG018|Overall Study|Excluded Medication|0|||
13188386|NCT02132754|26178218|FG019|Overall Study|Excluded Medication|0|||
13188387|NCT02132754|26178219|FG020|Overall Study|Excluded Medication|1|||
13110804|NCT03203473|25900671|FG000|Arm Allocation Phase|Death|0|||
13110805|NCT03203473|25900672|FG001|Arm Allocation Phase|Death|0|||
13110806|NCT03203473|25900673|FG002|Arm Allocation Phase|Death|1|||
13110807|NCT03203473|25900671|FG000|Arm Allocation Phase|Developed 2nd cancer|0|||
13110808|NCT03203473|25900672|FG001|Arm Allocation Phase|Developed 2nd cancer|0|||
13110809|NCT03203473|25900673|FG002|Arm Allocation Phase|Developed 2nd cancer|1|||
13110810|NCT03203473|25900671|FG000|Arm Allocation Phase|Intercurrent illness|0|||
13110811|NCT03203473|25900672|FG001|Arm Allocation Phase|Intercurrent illness|0|||
13110812|NCT03203473|25900673|FG002|Arm Allocation Phase|Intercurrent illness|1|||
13110813|NCT03203473|25900671|FG000|Arm Allocation Phase|Still on arm-B treatment|0|||
13110814|NCT03203473|25900672|FG001|Arm Allocation Phase|Still on arm-B treatment|0|||
13110815|NCT03203473|25900673|FG002|Arm Allocation Phase|Still on arm-B treatment|3|||
13110816|NCT03203447|25900690|FG000|Overall Study|Withdrawal by Subject|2|||
13110817|NCT03203447|25900691|FG001|Overall Study|Withdrawal by Subject|1|||
13110818|NCT03203447|25900690|FG000|Overall Study|Lost to Follow-up|1|||
13110819|NCT03203447|25900691|FG001|Overall Study|Lost to Follow-up|10|||
13110820|NCT03203447|25900690|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159|||
13110821|NCT03203447|25900691|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152|||
13110822|NCT03203291|25900703|FG000|Overall Study|Withdrawal by Subject|1|||
13133222|NCT02776683|25986966|FG001|Pre-switch Period|Withdrawal by Subject|0|||
13133223|NCT02776683|25986965|FG000|Pre-switch Period|Physician Decision|7|||
13133224|NCT02776683|25986966|FG001|Pre-switch Period|Physician Decision|0|||
13133225|NCT02776683|25986965|FG000|Pre-switch Period|Progressive disease|39|||
13133226|NCT02776683|25986966|FG001|Pre-switch Period|Progressive disease|0|||
13133227|NCT02776683|25986965|FG000|Pre-switch Period|Other than listed|3|||
13133228|NCT02776683|25986966|FG001|Pre-switch Period|Other than listed|0|||
13133229|NCT02776683|25986965|FG000|Post-switch Period|Adverse Event|0|||
13133230|NCT02776683|25986966|FG001|Post-switch Period|Adverse Event|3|||
13188388|NCT02132754|26178220|FG021|Overall Study|Excluded Medication|0|||
13188389|NCT02132754|26178221|FG022|Overall Study|Excluded Medication|0|||
13188390|NCT02132754|26178222|FG023|Overall Study|Excluded Medication|0|||
13188391|NCT02132754|26178223|FG024|Overall Study|Excluded Medication|0|||
13133231|NCT02776683|25986965|FG000|Post-switch Period|Withdrawal by Subject|0|||
13188392|NCT02132754|26178224|FG025|Overall Study|Excluded Medication|0|||
13188393|NCT02132754|26178225|FG026|Overall Study|Excluded Medication|0|||
13188394|NCT02132754|26178226|FG027|Overall Study|Excluded Medication|0|||
13188395|NCT02132754|26178227|FG028|Overall Study|Excluded Medication|0|||
13188396|NCT02132754|26178228|FG029|Overall Study|Excluded Medication|0|||
13133232|NCT02776683|25986966|FG001|Post-switch Period|Withdrawal by Subject|2|||
13133233|NCT02776683|25986965|FG000|Post-switch Period|Physician Decision|0|||
13133234|NCT02776683|25986966|FG001|Post-switch Period|Physician Decision|3|||
13133235|NCT02776683|25986965|FG000|Post-switch Period|Progressive disease|0|||
13133236|NCT02776683|25986966|FG001|Post-switch Period|Progressive disease|20|||
13133237|NCT02776683|25986965|FG000|Post-switch Period|Other than listed|0|||
13133238|NCT02776683|25986966|FG001|Post-switch Period|Other than listed|15|||
13133239|NCT02776670|25986985|FG000|Overall Study|Adverse Event|0|||
13133240|NCT02776670|25986986|FG001|Overall Study|Adverse Event|2|||
13133241|NCT02776670|25986985|FG000|Overall Study|Protocol Violation|0|||
13133242|NCT02776670|25986986|FG001|Overall Study|Protocol Violation|2|||
13133243|NCT02776670|25986985|FG000|Overall Study|Withdrawal by Subject|0|||
13133244|NCT02776670|25986986|FG001|Overall Study|Withdrawal by Subject|1|||
13133245|NCT02776670|25986985|FG000|Overall Study|Other - Reason not given|0|||
13133246|NCT02776670|25986986|FG001|Overall Study|Other - Reason not given|1|||
13133247|NCT02776553|25987003|FG000|Overall Study|Lost to Follow-up|1|||
13133248|NCT02776553|25987004|FG001|Overall Study|Lost to Follow-up|0|||
13133249|NCT02776553|25987003|FG000|Overall Study|got liver transplant|1|||
13133250|NCT02776553|25987004|FG001|Overall Study|got liver transplant|2|||
13133251|NCT02776553|25987003|FG000|Overall Study|had other surgery|1|||
13133252|NCT02776553|25987004|FG001|Overall Study|had other surgery|0|||
13133253|NCT02776553|25987003|FG000|Overall Study|Protocol Violation|0|||
13133254|NCT02776553|25987004|FG001|Overall Study|Protocol Violation|1|||
13133255|NCT02776033|25987077|FG000|Overall Study|Withdrawal by Subject|0|||
13133256|NCT02776033|25987078|FG001|Overall Study|Withdrawal by Subject|0|||
13133257|NCT02776033|25987079|FG002|Overall Study|Withdrawal by Subject|2|||
13133258|NCT02776033|25987077|FG000|Overall Study|Physician Decision|2|||
13133259|NCT02776033|25987078|FG001|Overall Study|Physician Decision|0|||
13133260|NCT02776033|25987079|FG002|Overall Study|Physician Decision|0|||
13133261|NCT02776033|25987077|FG000|Overall Study|Lost to Follow-up|1|||
13133262|NCT02776033|25987078|FG001|Overall Study|Lost to Follow-up|0|||
13188397|NCT02132754|26178229|FG030|Overall Study|Excluded Medication|0|||
13188398|NCT02132754|26178230|FG031|Overall Study|Excluded Medication|0|||
13188399|NCT02132754|26178231|FG032|Overall Study|Excluded Medication|0|||
13188400|NCT02132754|26178232|FG033|Overall Study|Excluded Medication|1|||
13188401|NCT02132754|26178199|FG000|Overall Study|Physician Decision|0|||
13188402|NCT02132754|26178200|FG001|Overall Study|Physician Decision|0|||
13188403|NCT02132754|26178201|FG002|Overall Study|Physician Decision|0|||
13188404|NCT02132754|26178202|FG003|Overall Study|Physician Decision|0|||
13110823|NCT03202511|25900714|FG000|Overall Study|Withdrawal by Subject|1|||
13110824|NCT03202511|25900715|FG001|Overall Study|Withdrawal by Subject|0|||
13110825|NCT03201900|25900729|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9|||
13110826|NCT03201900|25900729|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1|||
13110827|NCT03201900|25900729|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6|||
13110828|NCT03201900|25900729|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2|||
13110829|NCT03201900|25900729|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6|||
13110830|NCT03201900|25900729|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11|||
13110831|NCT03201900|25900729|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2|||
13110832|NCT03201900|25900729|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1|||
13110833|NCT03201900|25900729|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1|||
13188405|NCT02132754|26178203|FG004|Overall Study|Physician Decision|0|||
13188406|NCT02132754|26178204|FG005|Overall Study|Physician Decision|0|||
13188407|NCT02132754|26178205|FG006|Overall Study|Physician Decision|0|||
13188408|NCT02132754|26178206|FG007|Overall Study|Physician Decision|0|||
13188409|NCT02132754|26178207|FG008|Overall Study|Physician Decision|0|||
13188410|NCT02132754|26178208|FG009|Overall Study|Physician Decision|1|||
13188411|NCT02132754|26178209|FG010|Overall Study|Physician Decision|0|||
13188412|NCT02132754|26178210|FG011|Overall Study|Physician Decision|1|||
13188413|NCT02132754|26178211|FG012|Overall Study|Physician Decision|1|||
13188414|NCT02132754|26178212|FG013|Overall Study|Physician Decision|0|||
13188415|NCT02132754|26178213|FG014|Overall Study|Physician Decision|0|||
13188416|NCT02132754|26178214|FG015|Overall Study|Physician Decision|1|||
13188417|NCT02132754|26178215|FG016|Overall Study|Physician Decision|0|||
13188418|NCT02132754|26178216|FG017|Overall Study|Physician Decision|0|||
13188419|NCT02132754|26178217|FG018|Overall Study|Physician Decision|0|||
13188420|NCT02132754|26178218|FG019|Overall Study|Physician Decision|0|||
13188421|NCT02132754|26178219|FG020|Overall Study|Physician Decision|0|||
13188422|NCT02132754|26178220|FG021|Overall Study|Physician Decision|0|||
13188423|NCT02132754|26178221|FG022|Overall Study|Physician Decision|0|||
13188424|NCT02132754|26178222|FG023|Overall Study|Physician Decision|0|||
13188425|NCT02132754|26178223|FG024|Overall Study|Physician Decision|1|||
13188426|NCT02132754|26178224|FG025|Overall Study|Physician Decision|0|||
13188427|NCT02132754|26178225|FG026|Overall Study|Physician Decision|0|||
13188428|NCT02132754|26178226|FG027|Overall Study|Physician Decision|0|||
13188429|NCT02132754|26178227|FG028|Overall Study|Physician Decision|0|||
13188430|NCT02132754|26178228|FG029|Overall Study|Physician Decision|0|||
13188431|NCT02132754|26178229|FG030|Overall Study|Physician Decision|0|||
13188432|NCT02132754|26178230|FG031|Overall Study|Physician Decision|1|||
13188433|NCT02132754|26178231|FG032|Overall Study|Physician Decision|0|||
13188434|NCT02132754|26178232|FG033|Overall Study|Physician Decision|3|||
13188435|NCT02132754|26178199|FG000|Overall Study|Progressive Disease|1|||
13188436|NCT02132754|26178200|FG001|Overall Study|Progressive Disease|1|||
13188437|NCT02132754|26178201|FG002|Overall Study|Progressive Disease|1|||
13188438|NCT02132754|26178202|FG003|Overall Study|Progressive Disease|1|||
13188439|NCT02132754|26178203|FG004|Overall Study|Progressive Disease|1|||
13188440|NCT02132754|26178204|FG005|Overall Study|Progressive Disease|1|||
13188441|NCT02132754|26178205|FG006|Overall Study|Progressive Disease|1|||
13188442|NCT02132754|26178206|FG007|Overall Study|Progressive Disease|1|||
13188443|NCT02132754|26178207|FG008|Overall Study|Progressive Disease|1|||
13188444|NCT02132754|26178208|FG009|Overall Study|Progressive Disease|3|||
13188445|NCT02132754|26178209|FG010|Overall Study|Progressive Disease|3|||
13188446|NCT02132754|26178210|FG011|Overall Study|Progressive Disease|2|||
13188447|NCT02132754|26178211|FG012|Overall Study|Progressive Disease|2|||
13188448|NCT02132754|26178212|FG013|Overall Study|Progressive Disease|3|||
13188449|NCT02132754|26178213|FG014|Overall Study|Progressive Disease|2|||
13188450|NCT02132754|26178214|FG015|Overall Study|Progressive Disease|1|||
13188451|NCT02132754|26178215|FG016|Overall Study|Progressive Disease|2|||
13188452|NCT02132754|26178216|FG017|Overall Study|Progressive Disease|1|||
13188453|NCT02132754|26178217|FG018|Overall Study|Progressive Disease|3|||
13188454|NCT02132754|26178218|FG019|Overall Study|Progressive Disease|1|||
13188455|NCT02132754|26178219|FG020|Overall Study|Progressive Disease|1|||
13188456|NCT02132754|26178220|FG021|Overall Study|Progressive Disease|3|||
13188457|NCT02132754|26178221|FG022|Overall Study|Progressive Disease|2|||
13110834|NCT03201900|25900729|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1|||
13110835|NCT03201900|25900729|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1|||
13110836|NCT03201900|25900729|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3|||
13110837|NCT03201900|25900729|FG000|Extension Phase (From Week 63 to 156)|Other|1|||
13110838|NCT03201809|25900746|FG000|Overall Study|Lost to Follow-up|2|||
13110839|NCT03201809|25900747|FG001|Overall Study|Lost to Follow-up|0|||
13110840|NCT03201562|25900765|FG000|Overall Study|Physician Decision|0|||
13110841|NCT03201562|25900766|FG001|Overall Study|Physician Decision|0|||
13110842|NCT03201562|25900767|FG002|Overall Study|Physician Decision|1|||
13110843|NCT03201562|25900765|FG000|Overall Study|Adverse Event|0|||
13188458|NCT02132754|26178222|FG023|Overall Study|Progressive Disease|3|||
13188459|NCT02132754|26178223|FG024|Overall Study|Progressive Disease|0|||
13188460|NCT02132754|26178224|FG025|Overall Study|Progressive Disease|1|||
13188461|NCT02132754|26178225|FG026|Overall Study|Progressive Disease|2|||
13110844|NCT03201562|25900766|FG001|Overall Study|Adverse Event|0|||
13110845|NCT03201562|25900767|FG002|Overall Study|Adverse Event|1|||
13110846|NCT03201562|25900765|FG000|Overall Study|Lost to Follow-up|0|||
13110847|NCT03201562|25900766|FG001|Overall Study|Lost to Follow-up|1|||
13110848|NCT03201562|25900767|FG002|Overall Study|Lost to Follow-up|2|||
13110849|NCT03201419|25901129|FG000|Overall Study|Adverse Event|3|||
13110850|NCT03201419|25901130|FG001|Overall Study|Adverse Event|1|||
13188462|NCT02132754|26178226|FG027|Overall Study|Progressive Disease|1|||
13188463|NCT02132754|26178227|FG028|Overall Study|Progressive Disease|2|||
13188464|NCT02132754|26178228|FG029|Overall Study|Progressive Disease|3|||
13188465|NCT02132754|26178229|FG030|Overall Study|Progressive Disease|1|||
13188466|NCT02132754|26178230|FG031|Overall Study|Progressive Disease|1|||
13188467|NCT02132754|26178231|FG032|Overall Study|Progressive Disease|3|||
13188468|NCT02132754|26178232|FG033|Overall Study|Progressive Disease|6|||
13188469|NCT02132754|26178199|FG000|Overall Study|Screen Failure|0|||
13188470|NCT02132754|26178200|FG001|Overall Study|Screen Failure|0|||
13188471|NCT02132754|26178201|FG002|Overall Study|Screen Failure|0|||
13188472|NCT02132754|26178202|FG003|Overall Study|Screen Failure|0|||
13188473|NCT02132754|26178203|FG004|Overall Study|Screen Failure|0|||
13188474|NCT02132754|26178204|FG005|Overall Study|Screen Failure|0|||
13188475|NCT02132754|26178205|FG006|Overall Study|Screen Failure|0|||
13188476|NCT02132754|26178206|FG007|Overall Study|Screen Failure|0|||
13188477|NCT02132754|26178207|FG008|Overall Study|Screen Failure|0|||
13188478|NCT02132754|26178208|FG009|Overall Study|Screen Failure|0|||
13188479|NCT02132754|26178209|FG010|Overall Study|Screen Failure|0|||
13188480|NCT02132754|26178210|FG011|Overall Study|Screen Failure|0|||
13188481|NCT02132754|26178211|FG012|Overall Study|Screen Failure|0|||
13188482|NCT02132754|26178212|FG013|Overall Study|Screen Failure|0|||
13188483|NCT02132754|26178213|FG014|Overall Study|Screen Failure|0|||
13188484|NCT02132754|26178214|FG015|Overall Study|Screen Failure|0|||
13188485|NCT02132754|26178215|FG016|Overall Study|Screen Failure|0|||
13188486|NCT02132754|26178216|FG017|Overall Study|Screen Failure|0|||
13188487|NCT02132754|26178217|FG018|Overall Study|Screen Failure|0|||
13188488|NCT02132754|26178218|FG019|Overall Study|Screen Failure|1|||
13188489|NCT02132754|26178219|FG020|Overall Study|Screen Failure|0|||
13188490|NCT02132754|26178220|FG021|Overall Study|Screen Failure|1|||
13188491|NCT02132754|26178221|FG022|Overall Study|Screen Failure|0|||
13188492|NCT02132754|26178222|FG023|Overall Study|Screen Failure|0|||
13110851|NCT03201419|25901131|FG002|Overall Study|Adverse Event|0|||
13110852|NCT03201419|25901132|FG003|Overall Study|Adverse Event|0|||
13110853|NCT03201419|25901133|FG004|Overall Study|Adverse Event|1|||
13110854|NCT03201419|25901134|FG005|Overall Study|Adverse Event|1|||
13110855|NCT03201419|25901135|FG006|Overall Study|Adverse Event|5|||
13110856|NCT03201419|25901136|FG007|Overall Study|Adverse Event|0|||
13110857|NCT03201419|25901137|FG008|Overall Study|Adverse Event|0|||
13110858|NCT03201419|25901129|FG000|Overall Study|Lost to Follow-up|1|||
13110859|NCT03201419|25901130|FG001|Overall Study|Lost to Follow-up|0|||
13110860|NCT03201419|25901131|FG002|Overall Study|Lost to Follow-up|0|||
13110861|NCT03201419|25901132|FG003|Overall Study|Lost to Follow-up|0|||
13110862|NCT03201419|25901133|FG004|Overall Study|Lost to Follow-up|0|||
13110863|NCT03201419|25901134|FG005|Overall Study|Lost to Follow-up|0|||
13110864|NCT03201419|25901135|FG006|Overall Study|Lost to Follow-up|0|||
13110865|NCT03201419|25901136|FG007|Overall Study|Lost to Follow-up|0|||
13110866|NCT03201419|25901137|FG008|Overall Study|Lost to Follow-up|0|||
13110867|NCT03201419|25901129|FG000|Overall Study|Protocol Deviation|0|||
13110868|NCT03201419|25901130|FG001|Overall Study|Protocol Deviation|0|||
13110869|NCT03201419|25901131|FG002|Overall Study|Protocol Deviation|0|||
13110870|NCT03201419|25901132|FG003|Overall Study|Protocol Deviation|0|||
13110871|NCT03201419|25901133|FG004|Overall Study|Protocol Deviation|0|||
13110872|NCT03201419|25901134|FG005|Overall Study|Protocol Deviation|0|||
13110873|NCT03201419|25901135|FG006|Overall Study|Protocol Deviation|1|||
13110874|NCT03201419|25901136|FG007|Overall Study|Protocol Deviation|0|||
13110875|NCT03201419|25901137|FG008|Overall Study|Protocol Deviation|0|||
13110876|NCT03201419|25901129|FG000|Overall Study|Withdrawal by Subject|4|||
13110877|NCT03201419|25901130|FG001|Overall Study|Withdrawal by Subject|2|||
13110878|NCT03201419|25901131|FG002|Overall Study|Withdrawal by Subject|1|||
13110879|NCT03201419|25901132|FG003|Overall Study|Withdrawal by Subject|0|||
13110880|NCT03201419|25901133|FG004|Overall Study|Withdrawal by Subject|0|||
13110881|NCT03201419|25901134|FG005|Overall Study|Withdrawal by Subject|0|||
13110882|NCT03201419|25901135|FG006|Overall Study|Withdrawal by Subject|0|||
13110883|NCT03201419|25901136|FG007|Overall Study|Withdrawal by Subject|1|||
13110884|NCT03201419|25901137|FG008|Overall Study|Withdrawal by Subject|2|||
13110885|NCT03201419|25901129|FG000|Overall Study|Other|0|||
13110886|NCT03201419|25901130|FG001|Overall Study|Other|0|||
13110887|NCT03201419|25901131|FG002|Overall Study|Other|1|||
13110888|NCT03201419|25901132|FG003|Overall Study|Other|0|||
13110889|NCT03201419|25901133|FG004|Overall Study|Other|0|||
13110890|NCT03201419|25901134|FG005|Overall Study|Other|0|||
13188493|NCT02132754|26178223|FG024|Overall Study|Screen Failure|0|||
13188494|NCT02132754|26178224|FG025|Overall Study|Screen Failure|0|||
13188495|NCT02132754|26178225|FG026|Overall Study|Screen Failure|0|||
13188496|NCT02132754|26178226|FG027|Overall Study|Screen Failure|0|||
13188497|NCT02132754|26178227|FG028|Overall Study|Screen Failure|0|||
13188498|NCT02132754|26178228|FG029|Overall Study|Screen Failure|0|||
13188499|NCT02132754|26178229|FG030|Overall Study|Screen Failure|0|||
13188500|NCT02132754|26178230|FG031|Overall Study|Screen Failure|0|||
13188501|NCT02132754|26178231|FG032|Overall Study|Screen Failure|0|||
13188502|NCT02132754|26178232|FG033|Overall Study|Screen Failure|0|||
13188503|NCT02132754|26178199|FG000|Overall Study|Transferred to Extension Study|0|||
13188504|NCT02132754|26178200|FG001|Overall Study|Transferred to Extension Study|0|||
13188505|NCT02132754|26178201|FG002|Overall Study|Transferred to Extension Study|0|||
13188506|NCT02132754|26178202|FG003|Overall Study|Transferred to Extension Study|0|||
13188507|NCT02132754|26178203|FG004|Overall Study|Transferred to Extension Study|0|||
13188508|NCT02132754|26178204|FG005|Overall Study|Transferred to Extension Study|0|||
13188509|NCT02132754|26178205|FG006|Overall Study|Transferred to Extension Study|0|||
13188510|NCT02132754|26178206|FG007|Overall Study|Transferred to Extension Study|0|||
13188511|NCT02132754|26178207|FG008|Overall Study|Transferred to Extension Study|0|||
13188512|NCT02132754|26178208|FG009|Overall Study|Transferred to Extension Study|0|||
13188513|NCT02132754|26178209|FG010|Overall Study|Transferred to Extension Study|0|||
13188514|NCT02132754|26178210|FG011|Overall Study|Transferred to Extension Study|0|||
13188515|NCT02132754|26178211|FG012|Overall Study|Transferred to Extension Study|0|||
13188516|NCT02132754|26178212|FG013|Overall Study|Transferred to Extension Study|0|||
13188517|NCT02132754|26178213|FG014|Overall Study|Transferred to Extension Study|0|||
13188518|NCT02132754|26178214|FG015|Overall Study|Transferred to Extension Study|0|||
13188519|NCT02132754|26178215|FG016|Overall Study|Transferred to Extension Study|0|||
13188520|NCT02132754|26178216|FG017|Overall Study|Transferred to Extension Study|0|||
13188521|NCT02132754|26178217|FG018|Overall Study|Transferred to Extension Study|0|||
13188522|NCT02132754|26178218|FG019|Overall Study|Transferred to Extension Study|0|||
13188523|NCT02132754|26178219|FG020|Overall Study|Transferred to Extension Study|0|||
13188524|NCT02132754|26178220|FG021|Overall Study|Transferred to Extension Study|0|||
13188525|NCT02132754|26178221|FG022|Overall Study|Transferred to Extension Study|0|||
13188526|NCT02132754|26178222|FG023|Overall Study|Transferred to Extension Study|0|||
13188527|NCT02132754|26178223|FG024|Overall Study|Transferred to Extension Study|0|||
13188528|NCT02132754|26178224|FG025|Overall Study|Transferred to Extension Study|0|||
13188529|NCT02132754|26178225|FG026|Overall Study|Transferred to Extension Study|0|||
13188530|NCT02132754|26178226|FG027|Overall Study|Transferred to Extension Study|0|||
13188531|NCT02132754|26178227|FG028|Overall Study|Transferred to Extension Study|0|||
13188532|NCT02132754|26178228|FG029|Overall Study|Transferred to Extension Study|0|||
13188533|NCT02132754|26178229|FG030|Overall Study|Transferred to Extension Study|0|||
13188534|NCT02132754|26178230|FG031|Overall Study|Transferred to Extension Study|0|||
13188535|NCT02132754|26178231|FG032|Overall Study|Transferred to Extension Study|0|||
13188536|NCT02132754|26178232|FG033|Overall Study|Transferred to Extension Study|6|||
13188537|NCT02132754|26178199|FG000|Overall Study|Withdrawal by Subject|0|||
13188538|NCT02132754|26178200|FG001|Overall Study|Withdrawal by Subject|0|||
13188539|NCT02132754|26178201|FG002|Overall Study|Withdrawal by Subject|0|||
13188540|NCT02132754|26178202|FG003|Overall Study|Withdrawal by Subject|0|||
13188541|NCT02132754|26178203|FG004|Overall Study|Withdrawal by Subject|0|||
13188542|NCT02132754|26178204|FG005|Overall Study|Withdrawal by Subject|0|||
13188543|NCT02132754|26178205|FG006|Overall Study|Withdrawal by Subject|0|||
13188544|NCT02132754|26178206|FG007|Overall Study|Withdrawal by Subject|0|||
13188545|NCT02132754|26178207|FG008|Overall Study|Withdrawal by Subject|0|||
13188546|NCT02132754|26178208|FG009|Overall Study|Withdrawal by Subject|1|||
13188547|NCT02132754|26178209|FG010|Overall Study|Withdrawal by Subject|0|||
13188548|NCT02132754|26178210|FG011|Overall Study|Withdrawal by Subject|0|||
13188549|NCT02132754|26178211|FG012|Overall Study|Withdrawal by Subject|1|||
13188550|NCT02132754|26178212|FG013|Overall Study|Withdrawal by Subject|0|||
13188551|NCT02132754|26178213|FG014|Overall Study|Withdrawal by Subject|1|||
13188552|NCT02132754|26178214|FG015|Overall Study|Withdrawal by Subject|2|||
13188553|NCT02132754|26178215|FG016|Overall Study|Withdrawal by Subject|1|||
13188554|NCT02132754|26178216|FG017|Overall Study|Withdrawal by Subject|0|||
13188555|NCT02132754|26178217|FG018|Overall Study|Withdrawal by Subject|0|||
13188556|NCT02132754|26178218|FG019|Overall Study|Withdrawal by Subject|0|||
13188557|NCT02132754|26178219|FG020|Overall Study|Withdrawal by Subject|1|||
13188558|NCT02132754|26178220|FG021|Overall Study|Withdrawal by Subject|0|||
13188559|NCT02132754|26178221|FG022|Overall Study|Withdrawal by Subject|0|||
13188560|NCT02132754|26178222|FG023|Overall Study|Withdrawal by Subject|0|||
13188561|NCT02132754|26178223|FG024|Overall Study|Withdrawal by Subject|1|||
13188562|NCT02132754|26178224|FG025|Overall Study|Withdrawal by Subject|0|||
13188563|NCT02132754|26178225|FG026|Overall Study|Withdrawal by Subject|0|||
13188564|NCT02132754|26178226|FG027|Overall Study|Withdrawal by Subject|1|||
13188565|NCT02132754|26178227|FG028|Overall Study|Withdrawal by Subject|0|||
13188566|NCT02132754|26178228|FG029|Overall Study|Withdrawal by Subject|0|||
13188567|NCT02132754|26178229|FG030|Overall Study|Withdrawal by Subject|0|||
13188568|NCT02132754|26178230|FG031|Overall Study|Withdrawal by Subject|1|||
13188569|NCT02132754|26178231|FG032|Overall Study|Withdrawal by Subject|0|||
13188570|NCT02132754|26178232|FG033|Overall Study|Withdrawal by Subject|2|||
13188571|NCT02132637|26178263|FG000|Study Period 1|Withdrawal by Subject|0|||
13188572|NCT02132637|26178264|FG001|Study Period 1|Withdrawal by Subject|4|||
13188573|NCT02132637|26178263|FG000|Study Period 1|Physician Decision|1|||
13188574|NCT02132637|26178264|FG001|Study Period 1|Physician Decision|0|||
13188575|NCT02132637|26178263|FG000|Study Period 2 (Crossover)|Adverse Event|0|||
13188576|NCT02132637|26178264|FG001|Study Period 2 (Crossover)|Adverse Event|1|||
13188577|NCT02132637|26178263|FG000|Study Period 2 (Crossover)|Physician Decision|2|||
13188578|NCT02132637|26178264|FG001|Study Period 2 (Crossover)|Physician Decision|0|||
13188579|NCT02132312|26178281|FG000|Overall Study|Adverse Event|2|||
13188580|NCT02132312|26178282|FG001|Overall Study|Adverse Event|0|||
13188581|NCT02132312|26178281|FG000|Overall Study|Physician Decision|1|||
13188582|NCT02132312|26178282|FG001|Overall Study|Physician Decision|1|||
13188583|NCT02132312|26178281|FG000|Overall Study|Protocol Violation|0|||
13188584|NCT02132312|26178282|FG001|Overall Study|Protocol Violation|1|||
13188585|NCT02132312|26178281|FG000|Overall Study|Withdrawal by Subject|1|||
13188586|NCT02132312|26178282|FG001|Overall Study|Withdrawal by Subject|0|||
13188587|NCT02132312|26178281|FG000|Overall Study|Lost to Follow-up|2|||
13188588|NCT02132312|26178282|FG001|Overall Study|Lost to Follow-up|1|||
13110891|NCT03201419|25901135|FG006|Overall Study|Other|0|||
13188589|NCT02132247|26178301|FG000|Overall Study|Protocol Violation|1|||
13188590|NCT02132247|26178302|FG001|Overall Study|Protocol Violation|0|||
13188591|NCT02132195|26178326|FG000|Initial Assignment|Relapsed|14|||
13188592|NCT02132195|26178327|FG001|Initial Assignment|Relapsed|0|||
13188593|NCT02132195|26178328|FG002|Initial Assignment|Relapsed|0|||
13188594|NCT02132195|26178326|FG000|Rescue Therapy|Relapsed|0|||
13188595|NCT02132195|26178327|FG001|Rescue Therapy|Relapsed|0|||
13188596|NCT02132195|26178328|FG002|Rescue Therapy|Relapsed|7|||
13188597|NCT02132195|26178326|FG000|Rescue Therapy|Physician Decision|0|||
13110892|NCT03201419|25901136|FG007|Overall Study|Other|0|||
13110893|NCT03201419|25901137|FG008|Overall Study|Other|0|||
13110894|NCT03201211|25901230|FG000|Overall Study|Adverse Event|1|||
13110895|NCT03201211|25901231|FG001|Overall Study|Adverse Event|0|||
13110896|NCT03201211|25901232|FG002|Overall Study|Adverse Event|0|||
13110897|NCT03201211|25901230|FG000|Overall Study|Protocol Violation|1|||
13110898|NCT03201211|25901231|FG001|Overall Study|Protocol Violation|0|||
13110899|NCT03201211|25901232|FG002|Overall Study|Protocol Violation|0|||
13110900|NCT03201211|25901230|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
13110901|NCT03201211|25901231|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
13110902|NCT03201211|25901232|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
13110903|NCT03201211|25901230|FG000|Overall Study|OTHER unknown reasons|0|||
13110904|NCT03201211|25901231|FG001|Overall Study|OTHER unknown reasons|1|||
13110905|NCT03201211|25901232|FG002|Overall Study|OTHER unknown reasons|0|||
13110906|NCT03201003|25901251|FG000|Overall Study|Adverse Event|14|||
13110907|NCT03201003|25901252|FG001|Overall Study|Adverse Event|1|||
13110908|NCT03201003|25901251|FG000|Overall Study|Other reasons|5|||
13110909|NCT03201003|25901252|FG001|Overall Study|Other reasons|1|||
13110910|NCT03201003|25901251|FG000|Overall Study|Withdrawal by Subject|4|||
13110911|NCT03201003|25901252|FG001|Overall Study|Withdrawal by Subject|1|||
13110912|NCT03201003|25901251|FG000|Overall Study|Lost to Follow-up|2|||
13110913|NCT03201003|25901252|FG001|Overall Study|Lost to Follow-up|0|||
13110914|NCT03201003|25901251|FG000|Overall Study|Protocol Violation|1|||
13110915|NCT03201003|25901252|FG001|Overall Study|Protocol Violation|0|||
13110916|NCT03200912|25901270|FG000|Overall Study|Adverse Event|3|||
13110917|NCT03200912|25901271|FG001|Overall Study|Adverse Event|0|||
13110918|NCT03200912|25901272|FG002|Overall Study|Adverse Event|0|||
13110919|NCT03200912|25901270|FG000|Overall Study|Withdrawal by Subject|1|||
13110920|NCT03200912|25901271|FG001|Overall Study|Withdrawal by Subject|2|||
13110921|NCT03200912|25901272|FG002|Overall Study|Withdrawal by Subject|4|||
13110922|NCT03200912|25901270|FG000|Overall Study|Non-compliance with study drug|0|||
13110923|NCT03200912|25901271|FG001|Overall Study|Non-compliance with study drug|1|||
13110924|NCT03200912|25901272|FG002|Overall Study|Non-compliance with study drug|0|||
13110925|NCT03200860|25901299|FG000|Overall Study|Withdrawal by Subject|1|||
13110926|NCT03200860|25901300|FG001|Overall Study|Withdrawal by Subject|0|||
13110927|NCT03200366|25901372|FG000|Patient Navigation Intervention Given|Death|0|||
13110928|NCT03200366|25901373|FG001|Patient Navigation Intervention Given|Death|2|||
13110929|NCT03200366|25901374|FG002|Patient Navigation Intervention Given|Death|0|||
13110930|NCT03200366|25901372|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0|||
13110931|NCT03200366|25901373|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25|||
13110932|NCT03200366|25901374|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0|||
13110933|NCT03200366|25901372|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
13110934|NCT03200366|25901373|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1|||
13110935|NCT03200366|25901374|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
13188598|NCT02132195|26178327|FG001|Rescue Therapy|Physician Decision|0|||
13188599|NCT02132195|26178328|FG002|Rescue Therapy|Physician Decision|1|||
13110936|NCT03200366|25901372|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
13110937|NCT03200366|25901373|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2|||
13110938|NCT03200366|25901374|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
13110939|NCT03200366|25901372|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0|||
13110940|NCT03200366|25901373|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1|||
13110941|NCT03200366|25901374|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0|||
13110942|NCT03200366|25901372|FG000|6 Month Post-Baseline Interview|Death|1|||
13110943|NCT03200366|25901373|FG001|6 Month Post-Baseline Interview|Death|1|||
13110944|NCT03200366|25901374|FG002|6 Month Post-Baseline Interview|Death|1|||
13188600|NCT02132195|26178326|FG000|Rescue Therapy|Withdrawal by Subject|0|||
13188601|NCT02132195|26178327|FG001|Rescue Therapy|Withdrawal by Subject|0|||
13188602|NCT02132195|26178328|FG002|Rescue Therapy|Withdrawal by Subject|1|||
13188603|NCT02132195|26178326|FG000|Rescue Therapy|Adverse Event|0|||
13188604|NCT02132195|26178327|FG001|Rescue Therapy|Adverse Event|0|||
13188605|NCT02132195|26178328|FG002|Rescue Therapy|Adverse Event|2|||
13188606|NCT02132130|26178392|FG000|Overall Study|Lost to Follow-up|0|||
13188607|NCT02132130|26178393|FG001|Overall Study|Lost to Follow-up|2|||
13188608|NCT02132130|26178394|FG002|Overall Study|Lost to Follow-up|0|||
13188609|NCT02132130|26178395|FG003|Overall Study|Lost to Follow-up|0|||
13188610|NCT02132130|26178392|FG000|Overall Study|Withdrawal by Subject|0|||
13188611|NCT02132130|26178393|FG001|Overall Study|Withdrawal by Subject|0|||
13188612|NCT02132130|26178394|FG002|Overall Study|Withdrawal by Subject|0|||
13188613|NCT02132130|26178395|FG003|Overall Study|Withdrawal by Subject|1|||
13188614|NCT02132117|26178418|FG000|Overall Study|Adverse Event|6|||
13188615|NCT02132117|26178419|FG001|Overall Study|Adverse Event|1|||
13188616|NCT02132117|26178418|FG000|Overall Study|Lost to Follow-up|2|||
13188617|NCT02132117|26178419|FG001|Overall Study|Lost to Follow-up|2|||
13188618|NCT02132117|26178418|FG000|Overall Study|Personal Reasons|1|||
13188619|NCT02132117|26178419|FG001|Overall Study|Personal Reasons|2|||
13188620|NCT02132117|26178418|FG000|Overall Study|Other Miscellaneous Reasons|2|||
13188621|NCT02132117|26178419|FG001|Overall Study|Other Miscellaneous Reasons|0|||
13188622|NCT02131766|26178432|FG000|Overall Study|Withdrawal by Subject|4|||
13188623|NCT02131662|26178492|FG000|Overall Study|Protocol Violation|1|||
13188624|NCT02131662|26178493|FG001|Overall Study|Protocol Violation|0|||
13188625|NCT02131662|26178494|FG002|Overall Study|Protocol Violation|0|||
13188626|NCT02131662|26178495|FG003|Overall Study|Protocol Violation|0|||
13188627|NCT02131662|26178496|FG004|Overall Study|Protocol Violation|0|||
13188628|NCT02131662|26178492|FG000|Overall Study|Other|2|||
13188629|NCT02131662|26178493|FG001|Overall Study|Other|4|||
13188630|NCT02131662|26178494|FG002|Overall Study|Other|3|||
13188631|NCT02131662|26178495|FG003|Overall Study|Other|3|||
13188632|NCT02131662|26178496|FG004|Overall Study|Other|4|||
13188633|NCT02131662|26178492|FG000|Overall Study|Adverse Event|0|||
13188634|NCT02131662|26178493|FG001|Overall Study|Adverse Event|1|||
13110945|NCT03200366|25901372|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27|||
13110946|NCT03200366|25901373|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21|||
13188635|NCT02131662|26178494|FG002|Overall Study|Adverse Event|1|||
13110947|NCT03200366|25901374|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17|||
13110948|NCT03200366|25901372|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
13110949|NCT03200366|25901373|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
13188636|NCT02131662|26178495|FG003|Overall Study|Adverse Event|1|||
13188637|NCT02131662|26178496|FG004|Overall Study|Adverse Event|3|||
13188638|NCT02131662|26178492|FG000|Overall Study|Pregnancy|0|||
13188639|NCT02131662|26178493|FG001|Overall Study|Pregnancy|1|||
13188640|NCT02131662|26178494|FG002|Overall Study|Pregnancy|0|||
13188641|NCT02131662|26178495|FG003|Overall Study|Pregnancy|1|||
13188642|NCT02131662|26178496|FG004|Overall Study|Pregnancy|0|||
13188643|NCT02131662|26178492|FG000|Overall Study|Wish for pregnancy|0|||
13188644|NCT02131662|26178493|FG001|Overall Study|Wish for pregnancy|0|||
13188645|NCT02131662|26178494|FG002|Overall Study|Wish for pregnancy|0|||
13188646|NCT02131662|26178495|FG003|Overall Study|Wish for pregnancy|0|||
13188647|NCT02131662|26178496|FG004|Overall Study|Wish for pregnancy|1|||
13188648|NCT02131662|26178492|FG000|Overall Study|Lack of Efficacy|1|||
13188649|NCT02131662|26178493|FG001|Overall Study|Lack of Efficacy|0|||
13188650|NCT02131662|26178494|FG002|Overall Study|Lack of Efficacy|0|||
13188651|NCT02131662|26178495|FG003|Overall Study|Lack of Efficacy|0|||
13188652|NCT02131662|26178496|FG004|Overall Study|Lack of Efficacy|1|||
13188653|NCT02131662|26178492|FG000|Overall Study|Withdrawal by Subject|1|||
13188654|NCT02131662|26178493|FG001|Overall Study|Withdrawal by Subject|5|||
13188655|NCT02131662|26178494|FG002|Overall Study|Withdrawal by Subject|1|||
13188656|NCT02131662|26178495|FG003|Overall Study|Withdrawal by Subject|5|||
13188657|NCT02131662|26178496|FG004|Overall Study|Withdrawal by Subject|6|||
13188658|NCT02131662|26178492|FG000|Overall Study|Lost to Follow-up|1|||
13188659|NCT02131662|26178493|FG001|Overall Study|Lost to Follow-up|3|||
13188660|NCT02131662|26178494|FG002|Overall Study|Lost to Follow-up|0|||
13188661|NCT02131662|26178495|FG003|Overall Study|Lost to Follow-up|9|||
13188662|NCT02131662|26178496|FG004|Overall Study|Lost to Follow-up|0|||
13188663|NCT02131662|26178492|FG000|Overall Study|Not treated|2|||
13188664|NCT02131662|26178493|FG001|Overall Study|Not treated|0|||
13188665|NCT02131662|26178494|FG002|Overall Study|Not treated|2|||
13188666|NCT02131662|26178495|FG003|Overall Study|Not treated|2|||
13188667|NCT02131662|26178496|FG004|Overall Study|Not treated|3|||
13188668|NCT02131636|26178519|FG000|Overall Study|Personal Reasons|4|||
13110950|NCT03200366|25901374|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0|||
13110951|NCT03200366|25901372|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1|||
13188669|NCT02131636|26178520|FG001|Overall Study|Personal Reasons|4|||
13188670|NCT02131636|26178519|FG000|Overall Study|Lost to Follow-up|4|||
13188671|NCT02131636|26178520|FG001|Overall Study|Lost to Follow-up|0|||
13188672|NCT02131636|26178519|FG000|Overall Study|Adverse Event|4|||
13188673|NCT02131636|26178520|FG001|Overall Study|Adverse Event|1|||
13188674|NCT02131532|26178541|FG000|Overall Study|Withdrawal by Subject|1|||
13188675|NCT02131532|26178541|FG000|Overall Study|Physician Decision|1|||
13188676|NCT02131532|26178541|FG000|Overall Study|Other health conditions|2|||
13188677|NCT02131324|26178554|FG000|Overall Study|Withdrawal by Subject|1|||
13188678|NCT02131324|26178555|FG001|Overall Study|Withdrawal by Subject|2|||
13188679|NCT02131324|26178554|FG000|Overall Study|Lost to Follow-up|1|||
13188680|NCT02131324|26178555|FG001|Overall Study|Lost to Follow-up|1|||
13188681|NCT02131311|26178567|FG000|Overall Study|Adverse Event|2|||
13188682|NCT02131311|26178567|FG000|Overall Study|Protocol Violation|1|||
13188683|NCT02131311|26178567|FG000|Overall Study|Lost to Follow-up|1|||
13188684|NCT02131272|26178592|FG000|Overall Study|Withdrawal by parent|0|||
13188685|NCT02131272|26178593|FG001|Overall Study|Withdrawal by parent|1|||
13188686|NCT02131272|26178592|FG000|Overall Study|Withdrawal by Subject|0|||
13188687|NCT02131272|26178593|FG001|Overall Study|Withdrawal by Subject|1|||
13188688|NCT02131272|26178592|FG000|Overall Study|Withdrawal Criteria|1|||
13188689|NCT02131272|26178593|FG001|Overall Study|Withdrawal Criteria|0|||
13188690|NCT02131259|26178600|FG000|Overall Study|Progressive disease|751|||
13188691|NCT02131259|26178600|FG000|Overall Study|Adverse Event|341|||
13188692|NCT02131259|26178600|FG000|Overall Study|Lost to Follow-up|7|||
13188693|NCT02131259|26178600|FG000|Overall Study|Relocation|32|||
13188694|NCT02131259|26178600|FG000|Overall Study|Other|63|||
13188695|NCT02131259|26178600|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22|||
13188696|NCT02131259|26178600|FG000|Overall Study|Progressive disease/relocation|1|||
13188697|NCT02131259|26178600|FG000|Overall Study|Progressive disease/other|2|||
13188698|NCT02131259|26178600|FG000|Overall Study|AE/lost to follow-up|1|||
13188699|NCT02131259|26178600|FG000|Overall Study|AE/other|1|||
13188700|NCT02131259|26178600|FG000|Overall Study|Progressive disease/AE/other|1|||
13188701|NCT02131259|26178600|FG000|Overall Study|Missing|3|||
13188702|NCT02131233|26178639|FG000|Overall Study|Not Treated|2|||
13188703|NCT02131233|26178640|FG001|Overall Study|Not Treated|3|||
13188704|NCT02131233|26178639|FG000|Overall Study|Adverse Event|7|||
13188705|NCT02131233|26178640|FG001|Overall Study|Adverse Event|6|||
13188706|NCT02131233|26178639|FG000|Overall Study|Death|0|||
13188707|NCT02131233|26178640|FG001|Overall Study|Death|1|||
13188708|NCT02131233|26178639|FG000|Overall Study|Lack of Efficacy|6|||
13188709|NCT02131233|26178640|FG001|Overall Study|Lack of Efficacy|3|||
13188710|NCT02131233|26178639|FG000|Overall Study|Lost to Follow-up|14|||
13110952|NCT03200366|25901373|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
13110953|NCT03200366|25901374|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
13110954|NCT03200366|25901372|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
13110955|NCT03200366|25901373|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
13110956|NCT03200366|25901374|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1|||
13110957|NCT03200366|25901372|FG000|9 Month Post-Baseline Interview|Death|1|||
13110958|NCT03200366|25901373|FG001|9 Month Post-Baseline Interview|Death|1|||
13110959|NCT03200366|25901374|FG002|9 Month Post-Baseline Interview|Death|1|||
13110960|NCT03200366|25901372|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23|||
13110961|NCT03200366|25901373|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18|||
13110962|NCT03200366|25901374|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9|||
13110963|NCT03200366|25901372|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
13110964|NCT03200366|25901373|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
13110965|NCT03200366|25901374|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1|||
13110966|NCT03200366|25901372|FG000|9 Month Post-Baseline Interview|Refused interview|0|||
13110967|NCT03200366|25901373|FG001|9 Month Post-Baseline Interview|Refused interview|2|||
13110968|NCT03200366|25901374|FG002|9 Month Post-Baseline Interview|Refused interview|0|||
13110969|NCT03199963|25901403|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
13110970|NCT03199963|25901404|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
13110971|NCT03199963|25901403|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9|||
13110972|NCT03199963|25901404|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2|||
13110973|NCT03199963|25901403|FG000|Blinded Phase - Overall Study|Adverse Event|10|||
13188711|NCT02131233|26178640|FG001|Overall Study|Lost to Follow-up|13|||
13188712|NCT02131233|26178639|FG000|Overall Study|Non-Compliance With Study Drug|8|||
13188713|NCT02131233|26178640|FG001|Overall Study|Non-Compliance With Study Drug|5|||
13188714|NCT02131233|26178639|FG000|Overall Study|Physician Decision|7|||
13188715|NCT02131233|26178640|FG001|Overall Study|Physician Decision|0|||
13188716|NCT02131233|26178639|FG000|Overall Study|Pregnancy|4|||
13188717|NCT02131233|26178640|FG001|Overall Study|Pregnancy|0|||
13188718|NCT02131233|26178639|FG000|Overall Study|Withdrawal by Subject|18|||
13188719|NCT02131233|26178640|FG001|Overall Study|Withdrawal by Subject|11|||
13188720|NCT02131155|26178659|FG000|Overall Study|Adverse Event|1|||
13188721|NCT02131155|26178660|FG001|Overall Study|Adverse Event|0|||
13188722|NCT02131155|26178659|FG000|Overall Study|Treatment completed|1|||
13188723|NCT02131155|26178660|FG001|Overall Study|Treatment completed|0|||
13188724|NCT02131155|26178659|FG000|Overall Study|Primary tumour recurrence|2|||
13188725|NCT02131155|26178660|FG001|Overall Study|Primary tumour recurrence|1|||
13188726|NCT02131155|26178659|FG000|Overall Study|Refused to continue study medication|1|||
13188727|NCT02131155|26178660|FG001|Overall Study|Refused to continue study medication|0|||
13188728|NCT02131155|26178659|FG000|Overall Study|Study early termination|20|||
13188729|NCT02131155|26178660|FG001|Overall Study|Study early termination|10|||
13188730|NCT02131129|26178683|FG000|Overall Study|Withdrawal by Subject|1|||
13188731|NCT02131129|26178684|FG001|Overall Study|Withdrawal by Subject|0|||
13188732|NCT02131064|26178731|FG000|Overall Study|Death|5|||
13223100|NCT01799889|26287996|FG008|Overall Study|Adverse Event|3|||
13223101|NCT01799889|26287997|FG009|Overall Study|Adverse Event|1|||
13223102|NCT01799889|26287998|FG010|Overall Study|Adverse Event|1|||
13223103|NCT01799889|26287999|FG011|Overall Study|Adverse Event|0|||
13223104|NCT01799889|26287988|FG000|Overall Study|Death|1|||
13223105|NCT01799889|26287989|FG001|Overall Study|Death|0|||
13223106|NCT01799889|26287990|FG002|Overall Study|Death|5|||
13223107|NCT01799889|26287991|FG003|Overall Study|Death|3|||
13223108|NCT01799889|26287992|FG004|Overall Study|Death|1|||
13223109|NCT01799889|26287993|FG005|Overall Study|Death|0|||
13223110|NCT01799889|26287994|FG006|Overall Study|Death|0|||
13223111|NCT01799889|26287995|FG007|Overall Study|Death|0|||
13223112|NCT01799889|26287996|FG008|Overall Study|Death|1|||
13223113|NCT01799889|26287997|FG009|Overall Study|Death|0|||
13223114|NCT01799889|26287998|FG010|Overall Study|Death|1|||
13223115|NCT01799889|26287999|FG011|Overall Study|Death|0|||
13223116|NCT01799889|26287988|FG000|Overall Study|Lack of Efficacy|1|||
13223117|NCT01799889|26287989|FG001|Overall Study|Lack of Efficacy|1|||
13223118|NCT01799889|26287990|FG002|Overall Study|Lack of Efficacy|0|||
13223119|NCT01799889|26287991|FG003|Overall Study|Lack of Efficacy|1|||
13223120|NCT01799889|26287992|FG004|Overall Study|Lack of Efficacy|2|||
13223121|NCT01799889|26287993|FG005|Overall Study|Lack of Efficacy|2|||
13223122|NCT01799889|26287994|FG006|Overall Study|Lack of Efficacy|0|||
13223123|NCT01799889|26287995|FG007|Overall Study|Lack of Efficacy|0|||
13223124|NCT01799889|26287996|FG008|Overall Study|Lack of Efficacy|2|||
13223125|NCT01799889|26287997|FG009|Overall Study|Lack of Efficacy|0|||
13223126|NCT01799889|26287998|FG010|Overall Study|Lack of Efficacy|1|||
13223127|NCT01799889|26287999|FG011|Overall Study|Lack of Efficacy|0|||
13223128|NCT01799889|26287988|FG000|Overall Study|Lost to Follow-up|0|||
13223129|NCT01799889|26287989|FG001|Overall Study|Lost to Follow-up|1|||
13223130|NCT01799889|26287990|FG002|Overall Study|Lost to Follow-up|0|||
13223131|NCT01799889|26287991|FG003|Overall Study|Lost to Follow-up|0|||
13223132|NCT01799889|26287992|FG004|Overall Study|Lost to Follow-up|0|||
13223133|NCT01799889|26287993|FG005|Overall Study|Lost to Follow-up|0|||
13223134|NCT01799889|26287994|FG006|Overall Study|Lost to Follow-up|0|||
13223135|NCT01799889|26287995|FG007|Overall Study|Lost to Follow-up|0|||
13223136|NCT01799889|26287996|FG008|Overall Study|Lost to Follow-up|0|||
13223137|NCT01799889|26287997|FG009|Overall Study|Lost to Follow-up|0|||
13223138|NCT01799889|26287998|FG010|Overall Study|Lost to Follow-up|0|||
13223139|NCT01799889|26287999|FG011|Overall Study|Lost to Follow-up|0|||
13223140|NCT01799889|26287988|FG000|Overall Study|Physician Decision|3|||
13223141|NCT01799889|26287989|FG001|Overall Study|Physician Decision|2|||
13223142|NCT01799889|26287990|FG002|Overall Study|Physician Decision|4|||
13223143|NCT01799889|26287991|FG003|Overall Study|Physician Decision|4|||
13223144|NCT01799889|26287992|FG004|Overall Study|Physician Decision|5|||
13223145|NCT01799889|26287993|FG005|Overall Study|Physician Decision|5|||
13223146|NCT01799889|26287994|FG006|Overall Study|Physician Decision|5|||
13223147|NCT01799889|26287995|FG007|Overall Study|Physician Decision|2|||
13223148|NCT01799889|26287996|FG008|Overall Study|Physician Decision|6|||
13223149|NCT01799889|26287997|FG009|Overall Study|Physician Decision|0|||
13223150|NCT01799889|26287998|FG010|Overall Study|Physician Decision|0|||
13223151|NCT01799889|26287999|FG011|Overall Study|Physician Decision|1|||
13223152|NCT01799889|26287988|FG000|Overall Study|Progressive Disease|30|||
13223153|NCT01799889|26287989|FG001|Overall Study|Progressive Disease|26|||
13223154|NCT01799889|26287990|FG002|Overall Study|Progressive Disease|25|||
13223155|NCT01799889|26287991|FG003|Overall Study|Progressive Disease|30|||
13223156|NCT01799889|26287992|FG004|Overall Study|Progressive Disease|23|||
13223157|NCT01799889|26287993|FG005|Overall Study|Progressive Disease|9|||
13223158|NCT01799889|26287994|FG006|Overall Study|Progressive Disease|8|||
13223159|NCT01799889|26287995|FG007|Overall Study|Progressive Disease|13|||
13223160|NCT01799889|26287996|FG008|Overall Study|Progressive Disease|18|||
13223161|NCT01799889|26287997|FG009|Overall Study|Progressive Disease|5|||
13223162|NCT01799889|26287998|FG010|Overall Study|Progressive Disease|3|||
13223163|NCT01799889|26287999|FG011|Overall Study|Progressive Disease|1|||
13223164|NCT01799889|26287988|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
13223165|NCT01799889|26287989|FG001|Overall Study|Specified Criteria for Withdrawal|1|||
13223166|NCT01799889|26287990|FG002|Overall Study|Specified Criteria for Withdrawal|1|||
13223167|NCT01799889|26287991|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
13223168|NCT01799889|26287992|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
13223169|NCT01799889|26287993|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
13223170|NCT01799889|26287994|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
13223171|NCT01799889|26287995|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
13188733|NCT02131064|26178732|FG001|Overall Study|Death|6|||
13188734|NCT02131064|26178731|FG000|Overall Study|Lost to Follow-up|4|||
13188735|NCT02131064|26178732|FG001|Overall Study|Lost to Follow-up|8|||
13188736|NCT02131064|26178731|FG000|Overall Study|Withdrawal by Subject|14|||
13188737|NCT02131064|26178732|FG001|Overall Study|Withdrawal by Subject|18|||
13188738|NCT02131064|26178731|FG000|Overall Study|Other|2|||
13188739|NCT02131064|26178732|FG001|Overall Study|Other|2|||
13188740|NCT02130986|26178749|FG000|Overall Study|Withdrawal by Subject|4|||
13110974|NCT03199963|25901404|FG001|Blinded Phase - Overall Study|Adverse Event|5|||
13110975|NCT03199963|25901403|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109|||
13110976|NCT03199963|25901404|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54|||
13110977|NCT03199963|25901403|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7|||
13110978|NCT03199963|25901404|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5|||
13110979|NCT03199963|25901403|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0|||
13110980|NCT03199963|25901404|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1|||
13110981|NCT03199911|25901423|FG000|Overall Study|Lost to Follow-up|5|||
13110982|NCT03199911|25901424|FG001|Overall Study|Lost to Follow-up|5|||
13110983|NCT03199911|25901423|FG000|Overall Study|Did not proceed with surgery|2|||
13110984|NCT03199911|25901424|FG001|Overall Study|Did not proceed with surgery|1|||
13110985|NCT03199391|25901437|FG000|Overall Study|Death|1|||
13110986|NCT03199391|25901437|FG000|Overall Study|Lost to Follow-up|3|||
13188741|NCT02130986|26178750|FG001|Overall Study|Withdrawal by Subject|4|||
13188742|NCT02130986|26178749|FG000|Overall Study|Lost to Follow-up|151|||
13188743|NCT02130986|26178750|FG001|Overall Study|Lost to Follow-up|160|||
13188744|NCT02130882|26178765|FG000|Overall Study|Withdrawal by Subject|0|||
13188745|NCT02130882|26178766|FG001|Overall Study|Withdrawal by Subject|1|||
13188746|NCT02130765|26178798|FG000|Overall Study|Did not receive treatment|4|||
13188747|NCT02130765|26178799|FG001|Overall Study|Did not receive treatment|0|||
13188748|NCT02130765|26178800|FG002|Overall Study|Did not receive treatment|0|||
13188749|NCT02130765|26178801|FG003|Overall Study|Did not receive treatment|0|||
13188750|NCT02130570|26178824|FG000|Overall Study|Death|3|||
13188751|NCT02130570|26178825|FG001|Overall Study|Death|5|||
13188752|NCT02130570|26178824|FG000|Overall Study|Withdrawal by Subject|6|||
13188753|NCT02130570|26178825|FG001|Overall Study|Withdrawal by Subject|3|||
13188754|NCT02130570|26178824|FG000|Overall Study|Part of practice that discontinued study|0|||
13188755|NCT02130570|26178825|FG001|Overall Study|Part of practice that discontinued study|5|||
13188756|NCT02130557|26178864|FG000|Overall Study|Withdrawal by Subject|12|||
13188757|NCT02130557|26178865|FG001|Overall Study|Withdrawal by Subject|12|||
13188758|NCT02130557|26178864|FG000|Overall Study|Investigator Request|0|||
13188759|NCT02130557|26178865|FG001|Overall Study|Investigator Request|2|||
13188760|NCT02130557|26178864|FG000|Overall Study|Deceased|14|||
13188761|NCT02130557|26178865|FG001|Overall Study|Deceased|14|||
13188762|NCT02130557|26178864|FG000|Overall Study|Lost to Follow-up|6|||
13188763|NCT02130557|26178865|FG001|Overall Study|Lost to Follow-up|7|||
13188764|NCT02130557|26178864|FG000|Overall Study|Other|2|||
13188765|NCT02130557|26178865|FG001|Overall Study|Other|1|||
13188766|NCT02130557|26178864|FG000|Overall Study|Missing|2|||
13188767|NCT02130557|26178865|FG001|Overall Study|Missing|1|||
13188768|NCT02130466|26179033|FG000|Overall Study|Death|4|||
13188769|NCT02130466|26179034|FG001|Overall Study|Death|1|||
13188770|NCT02130466|26179035|FG002|Overall Study|Death|1|||
13188771|NCT02130466|26179036|FG003|Overall Study|Death|3|||
13188772|NCT02130466|26179037|FG004|Overall Study|Death|2|||
13188773|NCT02130466|26179038|FG005|Overall Study|Death|30|||
13188774|NCT02130466|26179039|FG006|Overall Study|Death|45|||
13188775|NCT02130466|26179040|FG007|Overall Study|Death|2|||
13188776|NCT02130466|26179041|FG008|Overall Study|Death|3|||
13188777|NCT02130466|26179042|FG009|Overall Study|Death|4|||
13188778|NCT02130466|26179043|FG010|Overall Study|Death|5|||
13188779|NCT02130466|26179044|FG011|Overall Study|Death|3|||
13188780|NCT02130466|26179045|FG012|Overall Study|Death|11|||
13188781|NCT02130466|26179046|FG013|Overall Study|Death|7|||
13188782|NCT02130466|26179033|FG000|Overall Study|Lost to Follow-up|1|||
13188783|NCT02130466|26179034|FG001|Overall Study|Lost to Follow-up|0|||
13223172|NCT01799889|26287996|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
13188784|NCT02130466|26179035|FG002|Overall Study|Lost to Follow-up|0|||
13188785|NCT02130466|26179036|FG003|Overall Study|Lost to Follow-up|0|||
13188786|NCT02130466|26179037|FG004|Overall Study|Lost to Follow-up|0|||
13188787|NCT02130466|26179038|FG005|Overall Study|Lost to Follow-up|1|||
13188788|NCT02130466|26179039|FG006|Overall Study|Lost to Follow-up|0|||
13188789|NCT02130466|26179040|FG007|Overall Study|Lost to Follow-up|0|||
13188790|NCT02130466|26179041|FG008|Overall Study|Lost to Follow-up|0|||
13188791|NCT02130466|26179042|FG009|Overall Study|Lost to Follow-up|0|||
13188792|NCT02130466|26179043|FG010|Overall Study|Lost to Follow-up|0|||
13188793|NCT02130466|26179044|FG011|Overall Study|Lost to Follow-up|0|||
13188794|NCT02130466|26179045|FG012|Overall Study|Lost to Follow-up|1|||
13188795|NCT02130466|26179046|FG013|Overall Study|Lost to Follow-up|0|||
13188796|NCT02130466|26179033|FG000|Overall Study|Physician Decision|0|||
13188797|NCT02130466|26179034|FG001|Overall Study|Physician Decision|0|||
13110987|NCT03199391|25901437|FG000|Overall Study|Adverse Event|2|||
13188798|NCT02130466|26179035|FG002|Overall Study|Physician Decision|0|||
13188799|NCT02130466|26179036|FG003|Overall Study|Physician Decision|0|||
13188800|NCT02130466|26179037|FG004|Overall Study|Physician Decision|0|||
13188801|NCT02130466|26179038|FG005|Overall Study|Physician Decision|1|||
13188802|NCT02130466|26179039|FG006|Overall Study|Physician Decision|1|||
13188803|NCT02130466|26179040|FG007|Overall Study|Physician Decision|0|||
13188804|NCT02130466|26179041|FG008|Overall Study|Physician Decision|0|||
13110988|NCT03199391|25901437|FG000|Overall Study|Withdrawal by Subject|10|||
13110989|NCT03198767|25901498|FG000|Overall Study|Protocol Violation|0|||
13110990|NCT03198767|25901499|FG001|Overall Study|Protocol Violation|0|||
13110991|NCT03198767|25901500|FG002|Overall Study|Protocol Violation|0|||
13110992|NCT03198767|25901501|FG003|Overall Study|Protocol Violation|6|||
13110993|NCT03198767|25901502|FG004|Overall Study|Protocol Violation|0|||
13110994|NCT03198767|25901503|FG005|Overall Study|Protocol Violation|0|||
13110995|NCT03198767|25901504|FG006|Overall Study|Protocol Violation|0|||
13110996|NCT03198754|25901549|FG000|Overall Study|Withdrawal by Subject|5|||
13110997|NCT03198754|25901550|FG001|Overall Study|Withdrawal by Subject|4|||
13110998|NCT03198754|25901549|FG000|Overall Study|Lost to Follow-up|4|||
13110999|NCT03198754|25901550|FG001|Overall Study|Lost to Follow-up|3|||
13111000|NCT03198754|25901549|FG000|Overall Study|Ineligible|2|||
13111001|NCT03198754|25901550|FG001|Overall Study|Ineligible|1|||
13111002|NCT03198715|25901618|FG000|Overall Study|Death|0|||
13111003|NCT03198715|25901619|FG001|Overall Study|Death|0|||
13111004|NCT03198715|25901620|FG002|Overall Study|Death|1|||
13111005|NCT03198715|25901621|FG003|Overall Study|Death|0|||
13111006|NCT03198715|25901622|FG004|Overall Study|Death|2|||
13111007|NCT03198715|25901618|FG000|Overall Study|Other|0|||
13111008|NCT03198715|25901619|FG001|Overall Study|Other|1|||
13111009|NCT03198715|25901620|FG002|Overall Study|Other|1|||
13111010|NCT03198715|25901621|FG003|Overall Study|Other|0|||
13111011|NCT03198715|25901622|FG004|Overall Study|Other|0|||
13111012|NCT03198520|25901645|FG000|Overall Study|Physician Decision|2|||
13111013|NCT03198520|25901645|FG000|Overall Study|Protocol Violation|2|||
13111014|NCT03198520|25901645|FG000|Overall Study|Withdrawal by Subject|1|||
13111015|NCT03198520|25901645|FG000|Overall Study|Study Ended|1|||
13111016|NCT03198507|25901664|FG000|Overall Study|Withdrawal by Subject|1|||
13111017|NCT03198507|25901665|FG001|Overall Study|Withdrawal by Subject|0|||
13111018|NCT03197935|25901683|FG000|Overall Study|Death due to any cause|9|||
13111019|NCT03197935|25901684|FG001|Overall Study|Death due to any cause|7|||
13111020|NCT03197935|25901683|FG000|Overall Study|Lost to Follow-up|0|||
13111021|NCT03197935|25901684|FG001|Overall Study|Lost to Follow-up|3|||
13111022|NCT03197935|25901683|FG000|Overall Study|Physician Decision|0|||
13111023|NCT03197935|25901684|FG001|Overall Study|Physician Decision|1|||
13111024|NCT03197935|25901683|FG000|Overall Study|Withdrawal by Subject|11|||
13111025|NCT03197935|25901684|FG001|Overall Study|Withdrawal by Subject|7|||
13111026|NCT03197935|25901683|FG000|Overall Study|On-Going in Study|147|||
13111027|NCT03197935|25901684|FG001|Overall Study|On-Going in Study|146|||
13111028|NCT03197935|25901683|FG000|Overall Study|Did not receive any study treatment|1|||
13111029|NCT03197935|25901684|FG001|Overall Study|Did not receive any study treatment|1|||
13111030|NCT03197883|25901721|FG000|Overall Study|Adverse Event|1|||
13111031|NCT03197883|25901722|FG001|Overall Study|Adverse Event|1|||
13111032|NCT03197883|25901721|FG000|Overall Study|Lost to Follow-up|1|||
13111033|NCT03197883|25901722|FG001|Overall Study|Lost to Follow-up|0|||
13111034|NCT03197883|25901721|FG000|Overall Study|Protocol Violation|1|||
13111035|NCT03197883|25901722|FG001|Overall Study|Protocol Violation|0|||
13111036|NCT03197883|25901721|FG000|Overall Study|Other (Not Specified)|0|||
13111037|NCT03197883|25901722|FG001|Overall Study|Other (Not Specified)|5|||
13111038|NCT03197766|25901741|FG000|Overall Study|Withdrawal by Subject|2|||
13111039|NCT03197766|25901742|FG001|Overall Study|Withdrawal by Subject|0|||
13111040|NCT03197558|25901748|FG000|Overall Study|Tubes not placed|1|||
13188805|NCT02130466|26179042|FG009|Overall Study|Physician Decision|0|||
13188806|NCT02130466|26179043|FG010|Overall Study|Physician Decision|0|||
13188807|NCT02130466|26179044|FG011|Overall Study|Physician Decision|0|||
13188808|NCT02130466|26179045|FG012|Overall Study|Physician Decision|0|||
13111041|NCT03197376|25901828|FG000|Primary and Booster Phase|Adverse Event|0|||
13111042|NCT03197376|25901829|FG001|Primary and Booster Phase|Adverse Event|0|||
13188809|NCT02130466|26179046|FG013|Overall Study|Physician Decision|0|||
13188810|NCT02130466|26179033|FG000|Overall Study|Participation in Study Discontinued by Sponsor|1|||
13188811|NCT02130466|26179034|FG001|Overall Study|Participation in Study Discontinued by Sponsor|2|||
13188812|NCT02130466|26179035|FG002|Overall Study|Participation in Study Discontinued by Sponsor|1|||
13188813|NCT02130466|26179036|FG003|Overall Study|Participation in Study Discontinued by Sponsor|5|||
13188814|NCT02130466|26179037|FG004|Overall Study|Participation in Study Discontinued by Sponsor|0|||
13188815|NCT02130466|26179038|FG005|Overall Study|Participation in Study Discontinued by Sponsor|27|||
13188816|NCT02130466|26179039|FG006|Overall Study|Participation in Study Discontinued by Sponsor|14|||
13188817|NCT02130466|26179040|FG007|Overall Study|Participation in Study Discontinued by Sponsor|1|||
13188818|NCT02130466|26179041|FG008|Overall Study|Participation in Study Discontinued by Sponsor|0|||
13188819|NCT02130466|26179042|FG009|Overall Study|Participation in Study Discontinued by Sponsor|1|||
13188820|NCT02130466|26179043|FG010|Overall Study|Participation in Study Discontinued by Sponsor|1|||
13188821|NCT02130466|26179044|FG011|Overall Study|Participation in Study Discontinued by Sponsor|0|||
13188822|NCT02130466|26179045|FG012|Overall Study|Participation in Study Discontinued by Sponsor|0|||
13188823|NCT02130466|26179046|FG013|Overall Study|Participation in Study Discontinued by Sponsor|2|||
13188824|NCT02130466|26179033|FG000|Overall Study|Withdrawal by Subject|1|||
13188825|NCT02130466|26179034|FG001|Overall Study|Withdrawal by Subject|0|||
13188826|NCT02130466|26179035|FG002|Overall Study|Withdrawal by Subject|0|||
13111043|NCT03197376|25901830|FG002|Primary and Booster Phase|Adverse Event|0|||
13188827|NCT02130466|26179036|FG003|Overall Study|Withdrawal by Subject|0|||
13188828|NCT02130466|26179037|FG004|Overall Study|Withdrawal by Subject|0|||
13188829|NCT02130466|26179038|FG005|Overall Study|Withdrawal by Subject|1|||
13188830|NCT02130466|26179039|FG006|Overall Study|Withdrawal by Subject|0|||
13188831|NCT02130466|26179040|FG007|Overall Study|Withdrawal by Subject|0|||
13188832|NCT02130466|26179041|FG008|Overall Study|Withdrawal by Subject|1|||
13188833|NCT02130466|26179042|FG009|Overall Study|Withdrawal by Subject|0|||
13188834|NCT02130466|26179043|FG010|Overall Study|Withdrawal by Subject|0|||
13188835|NCT02130466|26179044|FG011|Overall Study|Withdrawal by Subject|0|||
13188836|NCT02130466|26179045|FG012|Overall Study|Withdrawal by Subject|0|||
13188837|NCT02130466|26179046|FG013|Overall Study|Withdrawal by Subject|0|||
13188838|NCT02130427|26179052|FG000|Overall Study|Imaging results not interpretable|30|||
13188839|NCT02130297|26179060|FG000|Overall Study|Lost to Follow-up|4|||
13188840|NCT02130284|26179073|FG000|Overall Study|Withdrawal by Subject|3|||
13188841|NCT02130284|26179073|FG000|Overall Study|Subject Withdrew Consent|1|||
13188842|NCT02130284|26179073|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1|||
13188843|NCT02130284|26179073|FG000|Overall Study|Subject was screened as backup for study|3|||
13188844|NCT02130284|26179073|FG000|Overall Study|Screen Failure|1|||
13188845|NCT02130193|26179145|FG000|Part B: 52-week Double-blind Period|Adverse Event|0|||
13188846|NCT02130193|26179146|FG001|Part B: 52-week Double-blind Period|Adverse Event|5|||
13188847|NCT02130193|26179147|FG002|Part B: 52-week Double-blind Period|Adverse Event|3|||
13188848|NCT02130193|26179145|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0|||
13188849|NCT02130193|26179146|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2|||
13188850|NCT02130193|26179147|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1|||
13188851|NCT02130193|26179145|FG000|Part B: 52-week Double-blind Period|Physician Decision|0|||
13188852|NCT02130193|26179146|FG001|Part B: 52-week Double-blind Period|Physician Decision|0|||
13188853|NCT02130193|26179147|FG002|Part B: 52-week Double-blind Period|Physician Decision|1|||
13188854|NCT02130193|26179145|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0|||
13188855|NCT02130193|26179146|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
13188856|NCT02130193|26179147|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
13188857|NCT02130024|26179186|FG000|Overall Study|Adverse Event|10|||
13111044|NCT03197376|25901831|FG003|Primary and Booster Phase|Adverse Event|1|||
13111045|NCT03197376|25901828|FG000|Primary and Booster Phase|Death|1|||
13111046|NCT03197376|25901829|FG001|Primary and Booster Phase|Death|0|||
13111047|NCT03197376|25901830|FG002|Primary and Booster Phase|Death|0|||
13111048|NCT03197376|25901831|FG003|Primary and Booster Phase|Death|2|||
13111049|NCT03197376|25901828|FG000|Primary and Booster Phase|Lost to Follow-up|0|||
13111050|NCT03197376|25901829|FG001|Primary and Booster Phase|Lost to Follow-up|0|||
13111051|NCT03197376|25901830|FG002|Primary and Booster Phase|Lost to Follow-up|1|||
13111052|NCT03197376|25901831|FG003|Primary and Booster Phase|Lost to Follow-up|0|||
13111053|NCT03197376|25901828|FG000|Primary and Booster Phase|Physician Decision|1|||
13111054|NCT03197376|25901829|FG001|Primary and Booster Phase|Physician Decision|0|||
13111055|NCT03197376|25901830|FG002|Primary and Booster Phase|Physician Decision|1|||
13111056|NCT03197376|25901831|FG003|Primary and Booster Phase|Physician Decision|3|||
13111057|NCT03197376|25901828|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11|||
13111058|NCT03197376|25901829|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10|||
13111059|NCT03197376|25901830|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14|||
13111060|NCT03197376|25901831|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11|||
13111061|NCT03197376|25901828|FG000|Primary and Booster Phase|Ineligibility criteria|1|||
13111062|NCT03197376|25901829|FG001|Primary and Booster Phase|Ineligibility criteria|1|||
13111063|NCT03197376|25901830|FG002|Primary and Booster Phase|Ineligibility criteria|4|||
13111064|NCT03197376|25901831|FG003|Primary and Booster Phase|Ineligibility criteria|2|||
13111065|NCT03197376|25901828|FG000|Primary and Booster Phase|Not vaccine related|1|||
13111066|NCT03197376|25901829|FG001|Primary and Booster Phase|Not vaccine related|2|||
13188858|NCT02130024|26179187|FG001|Overall Study|Adverse Event|11|||
13188859|NCT02130024|26179186|FG000|Overall Study|Death|2|||
13188860|NCT02130024|26179187|FG001|Overall Study|Death|2|||
13188861|NCT02130024|26179186|FG000|Overall Study|Lost to Follow-up|1|||
13188862|NCT02130024|26179187|FG001|Overall Study|Lost to Follow-up|1|||
13188863|NCT02130024|26179186|FG000|Overall Study|Physician Decision|1|||
13188864|NCT02130024|26179187|FG001|Overall Study|Physician Decision|3|||
13188865|NCT02130024|26179186|FG000|Overall Study|Protocol Deviation|4|||
13188866|NCT02130024|26179187|FG001|Overall Study|Protocol Deviation|0|||
13111067|NCT03197376|25901830|FG002|Primary and Booster Phase|Not vaccine related|0|||
13111068|NCT03197376|25901831|FG003|Primary and Booster Phase|Not vaccine related|6|||
13188867|NCT02130024|26179186|FG000|Overall Study|Site Administration Problems|1|||
13188868|NCT02130024|26179187|FG001|Overall Study|Site Administration Problems|0|||
13188869|NCT02130024|26179186|FG000|Overall Study|Subject Withdrew Consent|6|||
13188870|NCT02130024|26179187|FG001|Overall Study|Subject Withdrew Consent|14|||
13188871|NCT02129803|26179202|FG000|Overall Study|Protocol Violation|4|||
13188872|NCT02129803|26179203|FG001|Overall Study|Protocol Violation|0|||
13188873|NCT02129803|26179202|FG000|Overall Study|Physician Decision|0|||
13188874|NCT02129803|26179203|FG001|Overall Study|Physician Decision|1|||
13188875|NCT02129803|26179202|FG000|Overall Study|Difficulty sleeping|1|||
13188876|NCT02129803|26179203|FG001|Overall Study|Difficulty sleeping|0|||
13188877|NCT02129803|26179202|FG000|Overall Study|Morning headache|0|||
13188878|NCT02129803|26179203|FG001|Overall Study|Morning headache|1|||
13188879|NCT02129803|26179202|FG000|Overall Study|Withdrawal by Subject|1|||
13188880|NCT02129803|26179203|FG001|Overall Study|Withdrawal by Subject|1|||
13188881|NCT02129777|26179325|FG000|Double-Blind Period|Adverse Event|0|||
13188882|NCT02129777|26179326|FG001|Double-Blind Period|Adverse Event|0|||
13188883|NCT02129777|26179327|FG002|Double-Blind Period|Adverse Event|0|||
13188884|NCT02129777|26179328|FG003|Double-Blind Period|Adverse Event|0|||
13188885|NCT02129777|26179329|FG004|Double-Blind Period|Adverse Event|1|||
13188886|NCT02129777|26179330|FG005|Double-Blind Period|Adverse Event|0|||
13188887|NCT02129777|26179331|FG006|Double-Blind Period|Adverse Event|0|||
13188888|NCT02129777|26179325|FG000|Double-Blind Period|Lost to Follow-up|1|||
13188889|NCT02129777|26179326|FG001|Double-Blind Period|Lost to Follow-up|1|||
13188890|NCT02129777|26179327|FG002|Double-Blind Period|Lost to Follow-up|1|||
13188891|NCT02129777|26179328|FG003|Double-Blind Period|Lost to Follow-up|2|||
13188892|NCT02129777|26179329|FG004|Double-Blind Period|Lost to Follow-up|0|||
13188893|NCT02129777|26179330|FG005|Double-Blind Period|Lost to Follow-up|0|||
13188894|NCT02129777|26179331|FG006|Double-Blind Period|Lost to Follow-up|0|||
13188895|NCT02129777|26179325|FG000|Double-Blind Period|Withdrawal by Subject|2|||
13188896|NCT02129777|26179326|FG001|Double-Blind Period|Withdrawal by Subject|4|||
13188897|NCT02129777|26179327|FG002|Double-Blind Period|Withdrawal by Subject|3|||
13188898|NCT02129777|26179328|FG003|Double-Blind Period|Withdrawal by Subject|2|||
13188899|NCT02129777|26179329|FG004|Double-Blind Period|Withdrawal by Subject|3|||
13188900|NCT02129777|26179330|FG005|Double-Blind Period|Withdrawal by Subject|0|||
13188901|NCT02129777|26179331|FG006|Double-Blind Period|Withdrawal by Subject|0|||
13188902|NCT02129777|26179325|FG000|Double-Blind Period|Pregnancy|0|||
13188903|NCT02129777|26179326|FG001|Double-Blind Period|Pregnancy|0|||
13188904|NCT02129777|26179327|FG002|Double-Blind Period|Pregnancy|0|||
13188905|NCT02129777|26179328|FG003|Double-Blind Period|Pregnancy|0|||
13188906|NCT02129777|26179329|FG004|Double-Blind Period|Pregnancy|1|||
13188907|NCT02129777|26179330|FG005|Double-Blind Period|Pregnancy|0|||
13188908|NCT02129777|26179331|FG006|Double-Blind Period|Pregnancy|0|||
13188909|NCT02129777|26179325|FG000|Double-Blind Period|Lack of Efficacy|3|||
13188910|NCT02129777|26179326|FG001|Double-Blind Period|Lack of Efficacy|1|||
13188911|NCT02129777|26179327|FG002|Double-Blind Period|Lack of Efficacy|0|||
13223173|NCT01799889|26287997|FG009|Overall Study|Specified Criteria for Withdrawal|0|||
13111069|NCT03197376|25901828|FG000|Immune Persistence Phase|Lost to Follow-up|0|||
13111070|NCT03197376|25901829|FG001|Immune Persistence Phase|Lost to Follow-up|0|||
13111071|NCT03197376|25901830|FG002|Immune Persistence Phase|Lost to Follow-up|2|||
13111072|NCT03197376|25901831|FG003|Immune Persistence Phase|Lost to Follow-up|1|||
13111073|NCT03197376|25901828|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4|||
13111074|NCT03197376|25901829|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4|||
13111075|NCT03197376|25901830|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2|||
13111076|NCT03197376|25901831|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3|||
13111077|NCT03197376|25901828|FG000|Immune Persistence Phase|Not vaccine related|1|||
13111078|NCT03197376|25901829|FG001|Immune Persistence Phase|Not vaccine related|0|||
13111079|NCT03197376|25901830|FG002|Immune Persistence Phase|Not vaccine related|1|||
13111080|NCT03197376|25901831|FG003|Immune Persistence Phase|Not vaccine related|1|||
13188912|NCT02129777|26179328|FG003|Double-Blind Period|Lack of Efficacy|3|||
13188913|NCT02129777|26179329|FG004|Double-Blind Period|Lack of Efficacy|2|||
13188914|NCT02129777|26179330|FG005|Double-Blind Period|Lack of Efficacy|0|||
13188915|NCT02129777|26179331|FG006|Double-Blind Period|Lack of Efficacy|0|||
13111081|NCT03197324|25901850|FG000|Overall Study|Adverse Event|0|||
13111082|NCT03197324|25901851|FG001|Overall Study|Adverse Event|1|||
13111083|NCT03197129|25901864|FG000|Overall Study|did not answer the VPT: shyness|4|||
13111084|NCT03197129|25901865|FG001|Overall Study|did not answer the VPT: shyness|5|||
13111085|NCT03196973|25901886|FG000|Overall Study|Adverse Event|1|||
13111086|NCT03196973|25901887|FG001|Overall Study|Adverse Event|1|||
13188916|NCT02129777|26179325|FG000|Double-Blind Period|Other|1|||
13188917|NCT02129777|26179326|FG001|Double-Blind Period|Other|2|||
13188918|NCT02129777|26179327|FG002|Double-Blind Period|Other|0|||
13188919|NCT02129777|26179328|FG003|Double-Blind Period|Other|0|||
13188920|NCT02129777|26179329|FG004|Double-Blind Period|Other|0|||
13188921|NCT02129777|26179330|FG005|Double-Blind Period|Other|0|||
13188922|NCT02129777|26179331|FG006|Double-Blind Period|Other|0|||
13188923|NCT02129777|26179325|FG000|Open-Label Period|Lack of Efficacy|0|||
13188924|NCT02129777|26179326|FG001|Open-Label Period|Lack of Efficacy|0|||
13188925|NCT02129777|26179327|FG002|Open-Label Period|Lack of Efficacy|0|||
13188926|NCT02129777|26179328|FG003|Open-Label Period|Lack of Efficacy|0|||
13188927|NCT02129777|26179329|FG004|Open-Label Period|Lack of Efficacy|0|||
13188928|NCT02129777|26179330|FG005|Open-Label Period|Lack of Efficacy|0|||
13188929|NCT02129777|26179331|FG006|Open-Label Period|Lack of Efficacy|5|||
13188930|NCT02129777|26179325|FG000|Open-Label Period|Lost to Follow-up|0|||
13188931|NCT02129777|26179326|FG001|Open-Label Period|Lost to Follow-up|0|||
13188932|NCT02129777|26179327|FG002|Open-Label Period|Lost to Follow-up|0|||
13111087|NCT03196973|25901888|FG002|Overall Study|Adverse Event|2|||
13111088|NCT03196973|25901886|FG000|Overall Study|Lack of Efficacy|2|||
13111089|NCT03196973|25901887|FG001|Overall Study|Lack of Efficacy|6|||
13111090|NCT03196973|25901888|FG002|Overall Study|Lack of Efficacy|1|||
13111091|NCT03196973|25901886|FG000|Overall Study|Lost to Follow-up|4|||
13111092|NCT03196973|25901887|FG001|Overall Study|Lost to Follow-up|3|||
13111093|NCT03196973|25901888|FG002|Overall Study|Lost to Follow-up|2|||
13111094|NCT03196973|25901886|FG000|Overall Study|Consent withdrawn|2|||
13111095|NCT03196973|25901887|FG001|Overall Study|Consent withdrawn|1|||
13111096|NCT03196973|25901888|FG002|Overall Study|Consent withdrawn|0|||
13111097|NCT03196973|25901886|FG000|Overall Study|Administration of a wrong kit of study medication|0|||
13111098|NCT03196973|25901887|FG001|Overall Study|Administration of a wrong kit of study medication|1|||
13111099|NCT03196973|25901888|FG002|Overall Study|Administration of a wrong kit of study medication|0|||
13111100|NCT03196791|25901907|FG000|Overall Study|Protocol Violation|7|||
13111101|NCT03196791|25901908|FG001|Overall Study|Protocol Violation|3|||
13111102|NCT03196791|25901907|FG000|Overall Study|Withdrawal by Subject|3|||
13111103|NCT03196791|25901908|FG001|Overall Study|Withdrawal by Subject|2|||
13111104|NCT03196635|25901928|FG000|Overall Study|Withdrawal by Subject|1|||
13111105|NCT03196505|25901943|FG000|Overall Study|Physician Decision|26|||
13111106|NCT03196505|25901944|FG001|Overall Study|Physician Decision|26|||
13111107|NCT03196349|25901980|FG000|Overall Study|Did not receive study drug|0|||
13111108|NCT03196349|25901981|FG001|Overall Study|Did not receive study drug|1|||
13111109|NCT03196349|25901982|FG002|Overall Study|Did not receive study drug|2|||
13111110|NCT03196349|25901980|FG000|Overall Study|No data entered|2|||
13111111|NCT03196349|25901981|FG001|Overall Study|No data entered|4|||
13111112|NCT03196349|25901982|FG002|Overall Study|No data entered|0|||
13111113|NCT03196349|25901980|FG000|Overall Study|Study Terminated early|15|||
13111114|NCT03196349|25901981|FG001|Overall Study|Study Terminated early|9|||
13111115|NCT03196349|25901982|FG002|Overall Study|Study Terminated early|11|||
13111116|NCT03196297|25902078|FG000|Main Period|Withdrawal by Subject|4|||
13111117|NCT03196297|25902078|FG000|Extension Period|Withdrawal by Subject|1|||
13111118|NCT03196297|25902078|FG000|Extension Period|Lack of Efficacy|2|||
13111119|NCT03196284|25902177|FG000|Main Part|Withdrawal by Subject|0|||
13111120|NCT03196284|25902178|FG001|Main Part|Withdrawal by Subject|1|||
13111121|NCT03196284|25902179|FG002|Main Part|Withdrawal by Subject|0|||
13111122|NCT03196284|25902177|FG000|Extension Part|Lack of Efficacy|0|||
13111123|NCT03196284|25902178|FG001|Extension Part|Lack of Efficacy|0|||
13111124|NCT03196284|25902179|FG002|Extension Part|Lack of Efficacy|1|||
13111125|NCT03196284|25902177|FG000|Extension Part|Withdrawal by Subject|0|||
13111126|NCT03196284|25902178|FG001|Extension Part|Withdrawal by Subject|0|||
13111127|NCT03196284|25902179|FG002|Extension Part|Withdrawal by Subject|1|||
13111128|NCT03196284|25902177|FG000|Extension Part|Physician Decision|0|||
13111129|NCT03196284|25902178|FG001|Extension Part|Physician Decision|0|||
13111130|NCT03196284|25902179|FG002|Extension Part|Physician Decision|1|||
13111131|NCT03196193|25902198|FG000|Overall Study|Adverse Event|1|||
13111132|NCT03196193|25902199|FG001|Overall Study|Adverse Event|0|||
13111133|NCT03196193|25902198|FG000|Overall Study|Computed Tomography (CT) data missing|2|||
13111134|NCT03196193|25902199|FG001|Overall Study|Computed Tomography (CT) data missing|0|||
13111135|NCT03195660|25902208|FG000|Overall Study|The study was terminated|2|||
13111136|NCT03194490|25902257|FG000|Overall Study|Lost to Follow-up|1|||
13111137|NCT03194490|25902258|FG001|Overall Study|Lost to Follow-up|3|||
13188933|NCT02129777|26179328|FG003|Open-Label Period|Lost to Follow-up|0|||
13188934|NCT02129777|26179329|FG004|Open-Label Period|Lost to Follow-up|0|||
13188935|NCT02129777|26179330|FG005|Open-Label Period|Lost to Follow-up|1|||
13188936|NCT02129777|26179331|FG006|Open-Label Period|Lost to Follow-up|1|||
13188937|NCT02129777|26179325|FG000|Open-Label Period|Withdrawal by Subject|0|||
13188938|NCT02129777|26179326|FG001|Open-Label Period|Withdrawal by Subject|0|||
13188939|NCT02129777|26179327|FG002|Open-Label Period|Withdrawal by Subject|0|||
13111138|NCT03194490|25902257|FG000|Overall Study|participant developed specific neck pain|1|||
13111139|NCT03194490|25902258|FG001|Overall Study|participant developed specific neck pain|0|||
13111140|NCT03194464|25902267|FG000|Overall Study|data not usable|2|||
13111141|NCT03194217|25902290|FG000|Overall Study|Adverse Event|0|||
13188940|NCT02129777|26179328|FG003|Open-Label Period|Withdrawal by Subject|0|||
13188941|NCT02129777|26179329|FG004|Open-Label Period|Withdrawal by Subject|0|||
13188942|NCT02129777|26179330|FG005|Open-Label Period|Withdrawal by Subject|1|||
13188943|NCT02129777|26179331|FG006|Open-Label Period|Withdrawal by Subject|3|||
13188944|NCT02129777|26179325|FG000|Open-Label Period|Study Termination|0|||
13188945|NCT02129777|26179326|FG001|Open-Label Period|Study Termination|0|||
13188946|NCT02129777|26179327|FG002|Open-Label Period|Study Termination|0|||
13188947|NCT02129777|26179328|FG003|Open-Label Period|Study Termination|0|||
13188948|NCT02129777|26179329|FG004|Open-Label Period|Study Termination|0|||
13188949|NCT02129777|26179330|FG005|Open-Label Period|Study Termination|10|||
13188950|NCT02129777|26179331|FG006|Open-Label Period|Study Termination|39|||
13188951|NCT02129647|26179341|FG000|Overall Study|Adverse Event|2|||
13188952|NCT02129647|26179341|FG000|Overall Study|surgical intervention for clinically progressive disease|1|||
13188953|NCT02129608|26179362|FG000|Overall Study|Lost to Follow-up|0|||
13188954|NCT02129608|26179363|FG001|Overall Study|Lost to Follow-up|1|||
13188955|NCT02129608|26179364|FG002|Overall Study|Lost to Follow-up|1|||
13188956|NCT02129608|26179362|FG000|Overall Study|Withdrawal by Subject|0|||
13188957|NCT02129608|26179363|FG001|Overall Study|Withdrawal by Subject|0|||
13188958|NCT02129608|26179364|FG002|Overall Study|Withdrawal by Subject|2|||
13111142|NCT03194217|25902291|FG001|Overall Study|Adverse Event|2|||
13111143|NCT03194217|25902292|FG002|Overall Study|Adverse Event|3|||
13111144|NCT03194217|25902293|FG003|Overall Study|Adverse Event|3|||
13111145|NCT03194217|25902290|FG000|Overall Study|Failure to meet randomisation criteria|0|||
13111146|NCT03194217|25902291|FG001|Overall Study|Failure to meet randomisation criteria|0|||
13111147|NCT03194217|25902292|FG002|Overall Study|Failure to meet randomisation criteria|0|||
13111148|NCT03194217|25902293|FG003|Overall Study|Failure to meet randomisation criteria|1|||
13111149|NCT03194217|25902290|FG000|Overall Study|Other|0|||
13111150|NCT03194217|25902291|FG001|Overall Study|Other|1|||
13111151|NCT03194217|25902292|FG002|Overall Study|Other|1|||
13111152|NCT03194217|25902293|FG003|Overall Study|Other|0|||
13111153|NCT03193736|25902299|FG000|Overall Study|Death|2|||
13111154|NCT03193736|25902299|FG000|Overall Study|Withdrawal by Subject|1|||
13111155|NCT03193736|25902299|FG000|Overall Study|Lost to Follow-up|1|||
13111156|NCT03193736|25902299|FG000|Overall Study|implant not received|1|||
13111157|NCT03193047|25902324|FG000|Overall Study|Physician Decision|1|||
13111158|NCT03193047|25902325|FG001|Overall Study|Physician Decision|0|||
13111159|NCT03193047|25902324|FG000|Overall Study|Participant Left State|1|||
13111160|NCT03193047|25902325|FG001|Overall Study|Participant Left State|0|||
13111161|NCT03193021|25902355|FG000|Overall Study|Lost to Follow-up|1|||
13111162|NCT03193021|25902356|FG001|Overall Study|Lost to Follow-up|1|||
13111163|NCT03192904|25902397|FG000|Overall Study|Physician Decision|3|||
13111164|NCT03192904|25902398|FG001|Overall Study|Physician Decision|1|||
13111165|NCT03192904|25902397|FG000|Overall Study|Lost to Follow-up|0|||
13111166|NCT03192904|25902398|FG001|Overall Study|Lost to Follow-up|1|||
13111167|NCT03192488|25902419|FG000|First Washout (>6d)|Withdrawal by Subject|0|||
13111168|NCT03192488|25902420|FG001|First Washout (>6d)|Withdrawal by Subject|0|||
13111169|NCT03192488|25902421|FG002|First Washout (>6d)|Withdrawal by Subject|1|||
13111170|NCT03192488|25902422|FG003|First Washout (>6d)|Withdrawal by Subject|0|||
13111171|NCT03192488|25902423|FG004|First Washout (>6d)|Withdrawal by Subject|0|||
13111172|NCT03192488|25902424|FG005|First Washout (>6d)|Withdrawal by Subject|1|||
13111173|NCT03192488|25902419|FG000|Third Intervention (d1)|Adverse Event|0|||
13111174|NCT03192488|25902420|FG001|Third Intervention (d1)|Adverse Event|0|||
13111175|NCT03192488|25902421|FG002|Third Intervention (d1)|Adverse Event|0|||
13111176|NCT03192488|25902422|FG003|Third Intervention (d1)|Adverse Event|0|||
13111177|NCT03192488|25902423|FG004|Third Intervention (d1)|Adverse Event|1|||
13111178|NCT03192488|25902424|FG005|Third Intervention (d1)|Adverse Event|0|||
13111179|NCT03192475|25902465|FG000|Overall Study|Death|0|||
13111180|NCT03192475|25902466|FG001|Overall Study|Death|1|||
13111181|NCT03192475|25902465|FG000|Overall Study|Lost to Follow-up|13|||
13111182|NCT03192475|25902466|FG001|Overall Study|Lost to Follow-up|8|||
13111183|NCT03192306|25902491|FG000|Overall Study|Did not treat cold sore during study|149|||
13111184|NCT03192306|25902492|FG001|Overall Study|Did not treat cold sore during study|143|||
13111185|NCT03192306|25902491|FG000|Overall Study|Withdrawal by Subject|1|||
13111186|NCT03192306|25902492|FG001|Overall Study|Withdrawal by Subject|1|||
13111187|NCT03192306|25902491|FG000|Overall Study|Lost to Follow-up|1|||
13188959|NCT02129205|26179546|FG000|Overall Study|Withdrawal by Subject|0|||
13188960|NCT02129205|26179547|FG001|Overall Study|Withdrawal by Subject|0|||
13188961|NCT02129205|26179548|FG002|Overall Study|Withdrawal by Subject|0|||
13111188|NCT03192306|25902492|FG001|Overall Study|Lost to Follow-up|0|||
13188962|NCT02129205|26179549|FG003|Overall Study|Withdrawal by Subject|0|||
13188963|NCT02129205|26179550|FG004|Overall Study|Withdrawal by Subject|1|||
13188964|NCT02129205|26179551|FG005|Overall Study|Withdrawal by Subject|1|||
13188965|NCT02129205|26179552|FG006|Overall Study|Withdrawal by Subject|1|||
13188966|NCT02129205|26179553|FG007|Overall Study|Withdrawal by Subject|0|||
13188967|NCT02129205|26179554|FG008|Overall Study|Withdrawal by Subject|1|||
13188968|NCT02129205|26179555|FG009|Overall Study|Withdrawal by Subject|0|||
13188969|NCT02129205|26179546|FG000|Overall Study|Other|1|||
13188970|NCT02129205|26179547|FG001|Overall Study|Other|0|||
13188971|NCT02129205|26179548|FG002|Overall Study|Other|0|||
13188972|NCT02129205|26179549|FG003|Overall Study|Other|0|||
13188973|NCT02129205|26179550|FG004|Overall Study|Other|2|||
13188974|NCT02129205|26179551|FG005|Overall Study|Other|3|||
13188975|NCT02129205|26179552|FG006|Overall Study|Other|3|||
13188976|NCT02129205|26179553|FG007|Overall Study|Other|2|||
13188977|NCT02129205|26179554|FG008|Overall Study|Other|1|||
13188978|NCT02129205|26179555|FG009|Overall Study|Other|0|||
13188979|NCT02129192|26179579|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0|||
13188980|NCT02129192|26179580|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1|||
13188981|NCT02129062|26179587|FG000|Overall Study|Death|1|||
13188982|NCT02129062|26179587|FG000|Overall Study|Disease Progression|2|||
13188983|NCT02128997|26179606|FG000|Overall Study|Lost to Follow-up|6|||
13188984|NCT02128997|26179607|FG001|Overall Study|Lost to Follow-up|11|||
13188985|NCT02128932|26179646|FG000|Overall Study|Withdrawal by Subject|11|||
13188986|NCT02128932|26179647|FG001|Overall Study|Withdrawal by Subject|7|||
13188987|NCT02128932|26179648|FG002|Overall Study|Withdrawal by Subject|8|||
13188988|NCT02128932|26179646|FG000|Overall Study|Death|2|||
13188989|NCT02128932|26179647|FG001|Overall Study|Death|0|||
13188990|NCT02128932|26179648|FG002|Overall Study|Death|2|||
13188991|NCT02128932|26179646|FG000|Overall Study|Lost to Follow-up|2|||
13188992|NCT02128932|26179647|FG001|Overall Study|Lost to Follow-up|1|||
13188993|NCT02128932|26179648|FG002|Overall Study|Lost to Follow-up|1|||
13188994|NCT02128932|26179646|FG000|Overall Study|No reason for withdrawal|12|||
13188995|NCT02128932|26179647|FG001|Overall Study|No reason for withdrawal|11|||
13188996|NCT02128932|26179648|FG002|Overall Study|No reason for withdrawal|7|||
13206204|NCT01959243|26233971|FG000|Overall Study|Investigator Decision|3|||
13206205|NCT01959243|26233972|FG001|Overall Study|Investigator Decision|0|||
13206206|NCT01959243|26233971|FG000|Overall Study|Adverse Event|5|||
13206207|NCT01959243|26233972|FG001|Overall Study|Adverse Event|2|||
13206208|NCT01959243|26233971|FG000|Overall Study|Administrative reasons|2|||
13206209|NCT01959243|26233972|FG001|Overall Study|Administrative reasons|1|||
13206210|NCT01959243|26233971|FG000|Overall Study|Lost to Follow-up|3|||
13206211|NCT01959243|26233972|FG001|Overall Study|Lost to Follow-up|1|||
13206212|NCT01959230|26233989|FG000|Overall Study|Failure to follow study procedures|0|||
13206213|NCT01959230|26233990|FG001|Overall Study|Failure to follow study procedures|1|||
13206214|NCT01959230|26233989|FG000|Overall Study|Administrative reasons|2|||
13206215|NCT01959230|26233990|FG001|Overall Study|Administrative reasons|0|||
13206216|NCT01959230|26233989|FG000|Overall Study|Withdrawal by Subject|2|||
13206217|NCT01959230|26233990|FG001|Overall Study|Withdrawal by Subject|0|||
13206218|NCT01959165|26234025|FG000|Overall Study|Adverse Event|0|||
13206219|NCT01959165|26234026|FG001|Overall Study|Adverse Event|0|||
13206220|NCT01959165|26234027|FG002|Overall Study|Adverse Event|0|||
13206221|NCT01959165|26234028|FG003|Overall Study|Adverse Event|1|||
13206222|NCT01959165|26234025|FG000|Overall Study|Lack of Efficacy|1|||
13206223|NCT01959165|26234026|FG001|Overall Study|Lack of Efficacy|0|||
13206224|NCT01959165|26234027|FG002|Overall Study|Lack of Efficacy|0|||
13206225|NCT01959165|26234028|FG003|Overall Study|Lack of Efficacy|0|||
13206226|NCT01959165|26234025|FG000|Overall Study|overdose|0|||
13206227|NCT01959165|26234026|FG001|Overall Study|overdose|0|||
13206228|NCT01959165|26234027|FG002|Overall Study|overdose|0|||
13206229|NCT01959165|26234028|FG003|Overall Study|overdose|1|||
13206230|NCT01959165|26234025|FG000|Overall Study|Welfare recipient|0|||
13206231|NCT01959165|26234026|FG001|Overall Study|Welfare recipient|1|||
13206232|NCT01959165|26234027|FG002|Overall Study|Welfare recipient|0|||
13206233|NCT01959165|26234028|FG003|Overall Study|Welfare recipient|0|||
13206234|NCT01959139|26234060|FG000|Phase II|Disease progression|0|||
13206235|NCT01959139|26234061|FG001|Phase II|Disease progression|0|||
13206236|NCT01959139|26234062|FG002|Phase II|Disease progression|26|||
13206237|NCT01959139|26234063|FG003|Phase II|Disease progression|34|||
13206238|NCT01959139|26234060|FG000|Phase II|Adverse Event|0|||
13206239|NCT01959139|26234061|FG001|Phase II|Adverse Event|0|||
13206240|NCT01959139|26234062|FG002|Phase II|Adverse Event|10|||
13206241|NCT01959139|26234063|FG003|Phase II|Adverse Event|11|||
13206242|NCT01959139|26234060|FG000|Phase II|Patient Refusal|0|||
13206243|NCT01959139|26234061|FG001|Phase II|Patient Refusal|0|||
13206244|NCT01959139|26234062|FG002|Phase II|Patient Refusal|5|||
13206245|NCT01959139|26234063|FG003|Phase II|Patient Refusal|4|||
13206246|NCT01959139|26234060|FG000|Phase II|Death|0|||
13206247|NCT01959139|26234061|FG001|Phase II|Death|0|||
13206248|NCT01959139|26234062|FG002|Phase II|Death|3|||
13206249|NCT01959139|26234063|FG003|Phase II|Death|1|||
13206250|NCT01959139|26234060|FG000|Phase II|Other/Unknown|0|||
13188997|NCT02128724|26179714|FG000|Overall Study|Death|1|||
13188998|NCT02128724|26179715|FG001|Overall Study|Death|0|||
13188999|NCT02128724|26179716|FG002|Overall Study|Death|0|||
13189000|NCT02128724|26179717|FG003|Overall Study|Death|0|||
13189001|NCT02128724|26179714|FG000|Overall Study|Adverse Event|0|||
13189002|NCT02128724|26179715|FG001|Overall Study|Adverse Event|1|||
13189003|NCT02128724|26179716|FG002|Overall Study|Adverse Event|0|||
13189004|NCT02128724|26179717|FG003|Overall Study|Adverse Event|0|||
13189005|NCT02128724|26179714|FG000|Overall Study|Physician Decision|0|||
13189006|NCT02128724|26179715|FG001|Overall Study|Physician Decision|0|||
13189007|NCT02128724|26179716|FG002|Overall Study|Physician Decision|0|||
13189008|NCT02128724|26179717|FG003|Overall Study|Physician Decision|2|||
13189009|NCT02128724|26179714|FG000|Overall Study|Withdrawal by Subject|0|||
13189010|NCT02128724|26179715|FG001|Overall Study|Withdrawal by Subject|0|||
13189011|NCT02128724|26179716|FG002|Overall Study|Withdrawal by Subject|0|||
13189012|NCT02128724|26179717|FG003|Overall Study|Withdrawal by Subject|1|||
13189013|NCT02128542|26179737|FG000|Overall Study|Lost to Follow-up|3|||
13189014|NCT02128542|26179738|FG001|Overall Study|Lost to Follow-up|0|||
13189015|NCT02128542|26179737|FG000|Overall Study|Withdrew Consent|1|||
13189016|NCT02128542|26179738|FG001|Overall Study|Withdrew Consent|0|||
13189017|NCT02128490|26179776|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
13189018|NCT02128490|26179777|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
13189019|NCT02128490|26179778|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
13189020|NCT02128490|26179779|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
13189021|NCT02128490|26179780|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
13189022|NCT02128490|26179776|FG000|Overall Study|Major Protocol Deviation|1|||
13189023|NCT02128490|26179777|FG001|Overall Study|Major Protocol Deviation|2|||
13189024|NCT02128490|26179778|FG002|Overall Study|Major Protocol Deviation|0|||
13189025|NCT02128490|26179779|FG003|Overall Study|Major Protocol Deviation|2|||
13189026|NCT02128490|26179780|FG004|Overall Study|Major Protocol Deviation|2|||
13189027|NCT02128490|26179776|FG000|Overall Study|Lost to Follow-up|0|||
13189028|NCT02128490|26179777|FG001|Overall Study|Lost to Follow-up|0|||
13189029|NCT02128490|26179778|FG002|Overall Study|Lost to Follow-up|1|||
13189030|NCT02128490|26179779|FG003|Overall Study|Lost to Follow-up|1|||
13189031|NCT02128490|26179780|FG004|Overall Study|Lost to Follow-up|1|||
13189032|NCT02128490|26179776|FG000|Overall Study|Voluntary Withdrawal|3|||
13189033|NCT02128490|26179777|FG001|Overall Study|Voluntary Withdrawal|3|||
13189034|NCT02128490|26179778|FG002|Overall Study|Voluntary Withdrawal|1|||
13189035|NCT02128490|26179779|FG003|Overall Study|Voluntary Withdrawal|1|||
13189036|NCT02128490|26179780|FG004|Overall Study|Voluntary Withdrawal|2|||
13189037|NCT02128490|26179776|FG000|Overall Study|Lack of Efficacy|0|||
13189038|NCT02128490|26179777|FG001|Overall Study|Lack of Efficacy|1|||
13189039|NCT02128490|26179778|FG002|Overall Study|Lack of Efficacy|0|||
13189040|NCT02128490|26179779|FG003|Overall Study|Lack of Efficacy|0|||
13189041|NCT02128490|26179780|FG004|Overall Study|Lack of Efficacy|0|||
13189042|NCT02128490|26179776|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
13189043|NCT02128490|26179777|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
13189044|NCT02128490|26179778|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
13189045|NCT02128490|26179779|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
13189046|NCT02128490|26179780|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1|||
13189047|NCT02128490|26179776|FG000|Overall Study|Other Miscellaneous Reasons|0|||
13189048|NCT02128490|26179777|FG001|Overall Study|Other Miscellaneous Reasons|0|||
13189049|NCT02128490|26179778|FG002|Overall Study|Other Miscellaneous Reasons|2|||
13189050|NCT02128490|26179779|FG003|Overall Study|Other Miscellaneous Reasons|1|||
13189051|NCT02128490|26179780|FG004|Overall Study|Other Miscellaneous Reasons|1|||
13189052|NCT02128269|26179786|FG000|Treatment Period|Adverse Event|1|||
13189053|NCT02128269|26179786|FG000|Treatment Period|Physician Decision|1|||
13189054|NCT02128217|26179835|FG000|Overall Study|Lost to Follow-up|0|||
13189055|NCT02128217|26179836|FG001|Overall Study|Lost to Follow-up|1|||
13189056|NCT02127970|26179865|FG000|Overall Study|Adverse Event|2|||
13189057|NCT02127970|26179866|FG001|Overall Study|Adverse Event|1|||
13189058|NCT02127970|26179865|FG000|Overall Study|Death|1|||
13189059|NCT02127970|26179866|FG001|Overall Study|Death|1|||
13189060|NCT02127970|26179865|FG000|Overall Study|Lost to Follow-up|14|||
13189061|NCT02127970|26179866|FG001|Overall Study|Lost to Follow-up|14|||
13189062|NCT02127970|26179865|FG000|Overall Study|Reason not Specified|4|||
13189063|NCT02127970|26179866|FG001|Overall Study|Reason not Specified|7|||
13189064|NCT02127970|26179865|FG000|Overall Study|Pregnancy|0|||
13189065|NCT02127970|26179866|FG001|Overall Study|Pregnancy|1|||
13189066|NCT02127970|26179865|FG000|Overall Study|Subject Withdrew Consent|5|||
13189067|NCT02127970|26179866|FG001|Overall Study|Subject Withdrew Consent|3|||
13189068|NCT02127931|26179874|FG000|Overall Study|Glitch in Game|1|||
13189069|NCT02127372|26179891|FG000|Overall Study|Withdrawal by Subject|1|||
13189070|NCT02127372|26179892|FG001|Overall Study|Withdrawal by Subject|0|||
13189071|NCT02127307|26179898|FG000|Overall Study|Protocol Violation|36|||
13189072|NCT02127307|26179898|FG000|Overall Study|Lost to Follow-up|2|||
13189073|NCT02127307|26179898|FG000|Overall Study|Death|101|||
13189074|NCT02127307|26179898|FG000|Overall Study|Other than specified above|169|||
13189075|NCT02127281|26179931|FG000|Overall Study|Lost to Follow-up|1|||
13189076|NCT02127281|26179932|FG001|Overall Study|Lost to Follow-up|0|||
13189077|NCT02127125|26179998|FG000|Overall Study|Lost to Follow-up|0|||
13189078|NCT02127125|26179999|FG001|Overall Study|Lost to Follow-up|0|||
13189079|NCT02127125|26180000|FG002|Overall Study|Lost to Follow-up|0|||
13189080|NCT02127125|26180001|FG003|Overall Study|Lost to Follow-up|0|||
13189081|NCT02127125|26180002|FG004|Overall Study|Lost to Follow-up|2|||
13189082|NCT02127125|26180003|FG005|Overall Study|Lost to Follow-up|1|||
13189083|NCT02127125|26180004|FG006|Overall Study|Lost to Follow-up|0|||
13189084|NCT02127125|26180005|FG007|Overall Study|Lost to Follow-up|0|||
13189085|NCT02127125|26180006|FG008|Overall Study|Lost to Follow-up|0|||
13189086|NCT02127125|26179998|FG000|Overall Study|Withdrawal by Subject|0|||
13189087|NCT02127125|26179999|FG001|Overall Study|Withdrawal by Subject|0|||
13189088|NCT02127125|26180000|FG002|Overall Study|Withdrawal by Subject|0|||
13189089|NCT02127125|26180001|FG003|Overall Study|Withdrawal by Subject|1|||
13189090|NCT02127125|26180002|FG004|Overall Study|Withdrawal by Subject|0|||
13189091|NCT02127125|26180003|FG005|Overall Study|Withdrawal by Subject|0|||
13189092|NCT02127125|26180004|FG006|Overall Study|Withdrawal by Subject|0|||
13189093|NCT02127125|26180005|FG007|Overall Study|Withdrawal by Subject|0|||
13189094|NCT02127125|26180006|FG008|Overall Study|Withdrawal by Subject|0|||
13189095|NCT02127125|26179998|FG000|Overall Study|Physician Decision|0|||
13189096|NCT02127125|26179999|FG001|Overall Study|Physician Decision|0|||
13189097|NCT02127125|26180000|FG002|Overall Study|Physician Decision|1|||
13189098|NCT02127125|26180001|FG003|Overall Study|Physician Decision|0|||
13189099|NCT02127125|26180002|FG004|Overall Study|Physician Decision|1|||
13189100|NCT02127125|26180003|FG005|Overall Study|Physician Decision|2|||
13189101|NCT02127125|26180004|FG006|Overall Study|Physician Decision|0|||
13189102|NCT02127125|26180005|FG007|Overall Study|Physician Decision|0|||
13189103|NCT02127125|26180006|FG008|Overall Study|Physician Decision|0|||
13189104|NCT02126969|26180023|FG000|Overall Study|Withdrawal by Subject|1|||
13189105|NCT02126969|26180024|FG001|Overall Study|Withdrawal by Subject|2|||
13189106|NCT02126839|26180041|FG000|Overall Study|Adverse Event|0|||
13189107|NCT02126839|26180042|FG001|Overall Study|Adverse Event|1|||
13189108|NCT02126839|26180041|FG000|Overall Study|Withdrawal by Subject|1|||
13189109|NCT02126839|26180042|FG001|Overall Study|Withdrawal by Subject|0|||
13189110|NCT02126839|26180041|FG000|Overall Study|Withdrawal by parent/guardian|1|||
13189111|NCT02126839|26180042|FG001|Overall Study|Withdrawal by parent/guardian|0|||
13189112|NCT02126839|26180041|FG000|Overall Study|Protocol Violation|2|||
13189113|NCT02126839|26180042|FG001|Overall Study|Protocol Violation|3|||
13189114|NCT02126839|26180041|FG000|Overall Study|Sponsor request|0|||
13189115|NCT02126839|26180042|FG001|Overall Study|Sponsor request|1|||
13189116|NCT02126839|26180041|FG000|Overall Study|Lost to Follow-up|1|||
13189117|NCT02126839|26180042|FG001|Overall Study|Lost to Follow-up|4|||
13189118|NCT02126839|26180041|FG000|Overall Study|Other|5|||
13189119|NCT02126839|26180042|FG001|Overall Study|Other|5|||
13189120|NCT02126826|26180115|FG000|Overall Study|Withdrawal by Subject|0|||
13189121|NCT02126826|26180116|FG001|Overall Study|Withdrawal by Subject|0|||
13189122|NCT02126826|26180117|FG002|Overall Study|Withdrawal by Subject|0|||
13189123|NCT02126826|26180118|FG003|Overall Study|Withdrawal by Subject|1|||
13189124|NCT02126826|26180119|FG004|Overall Study|Withdrawal by Subject|0|||
13189125|NCT02126826|26180120|FG005|Overall Study|Withdrawal by Subject|0|||
13189126|NCT02126826|26180121|FG006|Overall Study|Withdrawal by Subject|0|||
13189127|NCT02126670|26180148|FG000|Overall Study|Withdrawal by Subject|1|||
13189128|NCT02126670|26180149|FG001|Overall Study|Withdrawal by Subject|0|||
13189129|NCT02126670|26180150|FG002|Overall Study|Withdrawal by Subject|0|||
13189130|NCT02126670|26180151|FG003|Overall Study|Withdrawal by Subject|1|||
13189131|NCT02125877|26180186|FG000|Overall Study|Physician Decision|1|||
13189132|NCT02125877|26180187|FG001|Overall Study|Physician Decision|0|||
13189133|NCT02125877|26180186|FG000|Overall Study|Death|0|||
13189134|NCT02125877|26180187|FG001|Overall Study|Death|1|||
13189135|NCT02125877|26180186|FG000|Overall Study|Administrative problems|0|||
13189136|NCT02125877|26180187|FG001|Overall Study|Administrative problems|1|||
13189137|NCT02125877|26180186|FG000|Overall Study|Participant/guardian decision|0|||
13189138|NCT02125877|26180187|FG001|Overall Study|Participant/guardian decision|2|||
13189139|NCT02125877|26180186|FG000|Overall Study|Withdrawal by Subject|2|||
13189140|NCT02125877|26180187|FG001|Overall Study|Withdrawal by Subject|1|||
13189141|NCT02125877|26180186|FG000|Overall Study|Protocol deviation|4|||
13189142|NCT02125877|26180187|FG001|Overall Study|Protocol deviation|1|||
13189143|NCT02125877|26180186|FG000|Overall Study|Adverse Event|6|||
13189144|NCT02125877|26180187|FG001|Overall Study|Adverse Event|4|||
13189145|NCT02125838|26180210|FG000|Overall Study|Lost to Follow-up|4|||
13189146|NCT02125838|26180211|FG001|Overall Study|Lost to Follow-up|4|||
13189147|NCT02125734|26180228|FG000|Period 2|Adverse Event|0|||
13189148|NCT02125734|26180229|FG001|Period 2|Adverse Event|1|||
13189149|NCT02125604|26180245|FG000|Overall Study|Other|4|||
13189150|NCT02125604|26180245|FG000|Overall Study|Investigator Decision|1|||
13189151|NCT02125604|26180245|FG000|Overall Study|Lost to Follow-up|2|||
13189152|NCT02125604|26180245|FG000|Overall Study|Consent Withdrawn|4|||
13189153|NCT02125604|26180245|FG000|Overall Study|Adverse Event|20|||
13189162|NCT02125331|26180295|FG000|Overall Study|Protocol Violation|1|||
13189163|NCT02125331|26180296|FG001|Overall Study|Protocol Violation|0|||
13189164|NCT02125331|26180295|FG000|Overall Study|technical problem|2|||
13189165|NCT02125331|26180296|FG001|Overall Study|technical problem|0|||
13189166|NCT02125331|26180295|FG000|Overall Study|screen failure|2|||
13189167|NCT02125331|26180296|FG001|Overall Study|screen failure|0|||
13189168|NCT02125279|26180325|FG000|Overall Study|Lack of Efficacy|2|||
13189169|NCT02125279|26180325|FG000|Overall Study|Withdrawal by Subject|6|||
13189170|NCT02125279|26180325|FG000|Overall Study|Protocol Violation|1|||
13189171|NCT02125279|26180325|FG000|Overall Study|Lost to Follow-up|4|||
13189172|NCT02124811|26180348|FG000|Overall Study|Early termination|2|||
13189173|NCT02124811|26180349|FG001|Overall Study|Early termination|2|||
13189174|NCT02124811|26180348|FG000|Overall Study|Withdrawal by Subject|1|||
13189175|NCT02124811|26180349|FG001|Overall Study|Withdrawal by Subject|0|||
13189176|NCT02124798|26180357|FG000|Overall Study|Adverse Event|3|||
13189177|NCT02124798|26180357|FG000|Overall Study|Lost to Follow-up|1|||
13189178|NCT02124772|26180636|FG000|Overall Study|Lack of Efficacy|2|||
13189179|NCT02124772|26180637|FG001|Overall Study|Lack of Efficacy|0|||
13189180|NCT02124772|26180638|FG002|Overall Study|Lack of Efficacy|0|||
13189181|NCT02124772|26180639|FG003|Overall Study|Lack of Efficacy|1|||
13189182|NCT02124772|26180640|FG004|Overall Study|Lack of Efficacy|2|||
13189183|NCT02124772|26180641|FG005|Overall Study|Lack of Efficacy|3|||
13189184|NCT02124772|26180642|FG006|Overall Study|Lack of Efficacy|0|||
13189185|NCT02124772|26180643|FG007|Overall Study|Lack of Efficacy|2|||
13189186|NCT02124772|26180644|FG008|Overall Study|Lack of Efficacy|0|||
13189187|NCT02124772|26180645|FG009|Overall Study|Lack of Efficacy|1|||
13189188|NCT02124772|26180646|FG010|Overall Study|Lack of Efficacy|0|||
13189189|NCT02124772|26180647|FG011|Overall Study|Lack of Efficacy|0|||
13189190|NCT02124772|26180648|FG012|Overall Study|Lack of Efficacy|1|||
13189191|NCT02124772|26180636|FG000|Overall Study|Adverse Event|1|||
13189192|NCT02124772|26180637|FG001|Overall Study|Adverse Event|4|||
13189193|NCT02124772|26180638|FG002|Overall Study|Adverse Event|1|||
13189194|NCT02124772|26180639|FG003|Overall Study|Adverse Event|5|||
13189195|NCT02124772|26180640|FG004|Overall Study|Adverse Event|2|||
13189196|NCT02124772|26180641|FG005|Overall Study|Adverse Event|1|||
13189197|NCT02124772|26180642|FG006|Overall Study|Adverse Event|1|||
13189198|NCT02124772|26180643|FG007|Overall Study|Adverse Event|5|||
13189199|NCT02124772|26180644|FG008|Overall Study|Adverse Event|0|||
13189200|NCT02124772|26180645|FG009|Overall Study|Adverse Event|3|||
13189201|NCT02124772|26180646|FG010|Overall Study|Adverse Event|1|||
13189202|NCT02124772|26180647|FG011|Overall Study|Adverse Event|3|||
13189203|NCT02124772|26180648|FG012|Overall Study|Adverse Event|1|||
13189204|NCT02124772|26180636|FG000|Overall Study|Withdrawal consent|0|||
13189205|NCT02124772|26180637|FG001|Overall Study|Withdrawal consent|1|||
13189206|NCT02124772|26180638|FG002|Overall Study|Withdrawal consent|1|||
13189207|NCT02124772|26180639|FG003|Overall Study|Withdrawal consent|1|||
13189208|NCT02124772|26180640|FG004|Overall Study|Withdrawal consent|0|||
13189209|NCT02124772|26180641|FG005|Overall Study|Withdrawal consent|1|||
13189210|NCT02124772|26180642|FG006|Overall Study|Withdrawal consent|1|||
13189211|NCT02124772|26180643|FG007|Overall Study|Withdrawal consent|0|||
13189212|NCT02124772|26180644|FG008|Overall Study|Withdrawal consent|0|||
13189213|NCT02124772|26180645|FG009|Overall Study|Withdrawal consent|1|||
13189214|NCT02124772|26180646|FG010|Overall Study|Withdrawal consent|0|||
13189215|NCT02124772|26180647|FG011|Overall Study|Withdrawal consent|1|||
13189216|NCT02124772|26180648|FG012|Overall Study|Withdrawal consent|0|||
13189217|NCT02124772|26180636|FG000|Overall Study|Investigator discretion|0|||
13189218|NCT02124772|26180637|FG001|Overall Study|Investigator discretion|2|||
13189219|NCT02124772|26180638|FG002|Overall Study|Investigator discretion|2|||
13189220|NCT02124772|26180639|FG003|Overall Study|Investigator discretion|1|||
13189221|NCT02124772|26180640|FG004|Overall Study|Investigator discretion|1|||
13189222|NCT02124772|26180641|FG005|Overall Study|Investigator discretion|0|||
13189223|NCT02124772|26180642|FG006|Overall Study|Investigator discretion|1|||
13189224|NCT02124772|26180643|FG007|Overall Study|Investigator discretion|0|||
13189225|NCT02124772|26180644|FG008|Overall Study|Investigator discretion|0|||
13189226|NCT02124772|26180645|FG009|Overall Study|Investigator discretion|1|||
13189227|NCT02124772|26180646|FG010|Overall Study|Investigator discretion|0|||
13189228|NCT02124772|26180647|FG011|Overall Study|Investigator discretion|1|||
13189229|NCT02124772|26180648|FG012|Overall Study|Investigator discretion|0|||
13189230|NCT02124772|26180636|FG000|Overall Study|Progressive disease|0|||
13189231|NCT02124772|26180637|FG001|Overall Study|Progressive disease|0|||
13189232|NCT02124772|26180638|FG002|Overall Study|Progressive disease|0|||
13189233|NCT02124772|26180639|FG003|Overall Study|Progressive disease|0|||
13189234|NCT02124772|26180640|FG004|Overall Study|Progressive disease|0|||
13189235|NCT02124772|26180641|FG005|Overall Study|Progressive disease|0|||
13189236|NCT02124772|26180642|FG006|Overall Study|Progressive disease|1|||
13189237|NCT02124772|26180643|FG007|Overall Study|Progressive disease|1|||
13189238|NCT02124772|26180644|FG008|Overall Study|Progressive disease|0|||
13189239|NCT02124772|26180645|FG009|Overall Study|Progressive disease|0|||
13189240|NCT02124772|26180646|FG010|Overall Study|Progressive disease|0|||
13189241|NCT02124772|26180647|FG011|Overall Study|Progressive disease|0|||
13189242|NCT02124772|26180648|FG012|Overall Study|Progressive disease|0|||
13189243|NCT02124772|26180636|FG000|Overall Study|Other|0|||
13189244|NCT02124772|26180637|FG001|Overall Study|Other|7|||
13189245|NCT02124772|26180638|FG002|Overall Study|Other|2|||
13189246|NCT02124772|26180639|FG003|Overall Study|Other|5|||
13189247|NCT02124772|26180640|FG004|Overall Study|Other|4|||
13189248|NCT02124772|26180641|FG005|Overall Study|Other|3|||
13189249|NCT02124772|26180642|FG006|Overall Study|Other|4|||
13189250|NCT02124772|26180643|FG007|Overall Study|Other|1|||
13189251|NCT02124772|26180644|FG008|Overall Study|Other|1|||
13189252|NCT02124772|26180645|FG009|Overall Study|Other|1|||
13189253|NCT02124772|26180646|FG010|Overall Study|Other|1|||
13189254|NCT02124772|26180647|FG011|Overall Study|Other|1|||
13189255|NCT02124772|26180648|FG012|Overall Study|Other|0|||
13189256|NCT02124759|26180675|FG000|Overall Study|Withdrawal by Subject|3|||
13189257|NCT02124759|26180676|FG001|Overall Study|Withdrawal by Subject|1|||
13189258|NCT02124759|26180677|FG002|Overall Study|Withdrawal by Subject|1|||
13189259|NCT02124759|26180675|FG000|Overall Study|Screen Fail|2|||
13189260|NCT02124759|26180676|FG001|Overall Study|Screen Fail|2|||
13189261|NCT02124759|26180677|FG002|Overall Study|Screen Fail|3|||
13189262|NCT02124746|26180728|FG000|Overall Study|Adverse Event|2|||
13189263|NCT02124746|26180729|FG001|Overall Study|Adverse Event|1|||
13189264|NCT02124746|26180730|FG002|Overall Study|Adverse Event|2|||
13189265|NCT02124746|26180728|FG000|Overall Study|Death|2|||
13189266|NCT02124746|26180729|FG001|Overall Study|Death|1|||
13189267|NCT02124746|26180730|FG002|Overall Study|Death|3|||
13189268|NCT02124746|26180728|FG000|Overall Study|Lack of Efficacy|3|||
13189269|NCT02124746|26180729|FG001|Overall Study|Lack of Efficacy|2|||
13189270|NCT02124746|26180730|FG002|Overall Study|Lack of Efficacy|2|||
13189271|NCT02124746|26180728|FG000|Overall Study|Physician Decision|6|||
13189272|NCT02124746|26180729|FG001|Overall Study|Physician Decision|4|||
13189273|NCT02124746|26180730|FG002|Overall Study|Physician Decision|5|||
13189274|NCT02124746|26180728|FG000|Overall Study|Non-Compliance with Study Drug|0|||
13189275|NCT02124746|26180729|FG001|Overall Study|Non-Compliance with Study Drug|1|||
13189276|NCT02124746|26180730|FG002|Overall Study|Non-Compliance with Study Drug|0|||
13189277|NCT02124746|26180728|FG000|Overall Study|Withdrawal by Subject|3|||
13189278|NCT02124746|26180729|FG001|Overall Study|Withdrawal by Subject|3|||
13189279|NCT02124746|26180730|FG002|Overall Study|Withdrawal by Subject|0|||
13189280|NCT02124746|26180728|FG000|Overall Study|Study Terminated by Sponsor|0|||
13189281|NCT02124746|26180729|FG001|Overall Study|Study Terminated by Sponsor|0|||
13189282|NCT02124746|26180730|FG002|Overall Study|Study Terminated by Sponsor|6|||
13189283|NCT02124746|26180728|FG000|Overall Study|Disease Progression|3|||
13189284|NCT02124746|26180729|FG001|Overall Study|Disease Progression|6|||
13189285|NCT02124746|26180730|FG002|Overall Study|Disease Progression|4|||
13189286|NCT02124707|26180740|FG000|Overall Study|Adverse Event|5|||
13189287|NCT02124707|26180740|FG000|Overall Study|Physician Decision|1|||
13189288|NCT02124707|26180740|FG000|Overall Study|Death|1|||
13189289|NCT02124564|26180752|FG000|Treatment Period|Adverse Event|2|||
13189290|NCT02124564|26180752|FG000|Treatment Period|Lack of Efficacy|3|||
13189291|NCT02124564|26180752|FG000|Treatment Period|Withdrawal by Subject|2|||
13189292|NCT02124265|26180758|FG000|Overall Study|Adverse Event|1|||
13189293|NCT02124161|26180795|FG000|Overall Study|Other unspecified|0|||
13189294|NCT02124161|26180796|FG001|Overall Study|Other unspecified|1|||
13189295|NCT02124161|26180795|FG000|Overall Study|Death|1|||
13189296|NCT02124161|26180796|FG001|Overall Study|Death|0|||
13189297|NCT02124161|26180795|FG000|Overall Study|Protocol Violation|2|||
13189298|NCT02124161|26180796|FG001|Overall Study|Protocol Violation|1|||
13189299|NCT02124161|26180795|FG000|Overall Study|Withdrawal by Subject|1|||
13189300|NCT02124161|26180796|FG001|Overall Study|Withdrawal by Subject|2|||
13189301|NCT02124161|26180795|FG000|Overall Study|Adverse Event|2|||
13189302|NCT02124161|26180796|FG001|Overall Study|Adverse Event|0|||
13189303|NCT02124161|26180795|FG000|Overall Study|Does not meet entrance criteria|2|||
13189304|NCT02124161|26180796|FG001|Overall Study|Does not meet entrance criteria|3|||
13189305|NCT02124161|26180795|FG000|Overall Study|No longer meets eligibility criteria|5|||
13189306|NCT02124161|26180796|FG001|Overall Study|No longer meets eligibility criteria|4|||
13189307|NCT02124161|26180795|FG000|Overall Study|Lost to Follow-up|3|||
13189308|NCT02124161|26180796|FG001|Overall Study|Lost to Follow-up|4|||
13189309|NCT02123966|26180803|FG000|Overall Study|Intercurrent Illness|1|||
13189310|NCT02123797|26180912|FG000|Baseline Intervention|Death|9|||
13189311|NCT02123797|26180913|FG001|Baseline Intervention|Death|16|||
13189312|NCT02123797|26180914|FG002|Baseline Intervention|Death|0|||
13189313|NCT02123797|26180915|FG003|Baseline Intervention|Death|0|||
13189314|NCT02123797|26180916|FG004|Baseline Intervention|Death|0|||
13189315|NCT02123797|26180912|FG000|Baseline Intervention|Withdrawal by Subject|2|||
13189316|NCT02123797|26180913|FG001|Baseline Intervention|Withdrawal by Subject|8|||
13189317|NCT02123797|26180914|FG002|Baseline Intervention|Withdrawal by Subject|0|||
13189318|NCT02123797|26180915|FG003|Baseline Intervention|Withdrawal by Subject|0|||
13189319|NCT02123797|26180916|FG004|Baseline Intervention|Withdrawal by Subject|0|||
13189320|NCT02123797|26180912|FG000|Baseline Intervention|Relocation|2|||
13189321|NCT02123797|26180913|FG001|Baseline Intervention|Relocation|0|||
13189322|NCT02123797|26180914|FG002|Baseline Intervention|Relocation|0|||
13189323|NCT02123797|26180915|FG003|Baseline Intervention|Relocation|0|||
13189324|NCT02123797|26180916|FG004|Baseline Intervention|Relocation|0|||
13189325|NCT02123797|26180912|FG000|Baseline Intervention|Out of window for initial survey|6|||
13189326|NCT02123797|26180913|FG001|Baseline Intervention|Out of window for initial survey|13|||
13189327|NCT02123797|26180914|FG002|Baseline Intervention|Out of window for initial survey|0|||
13189328|NCT02123797|26180915|FG003|Baseline Intervention|Out of window for initial survey|0|||
13189329|NCT02123797|26180916|FG004|Baseline Intervention|Out of window for initial survey|0|||
13189330|NCT02123797|26180912|FG000|Baseline Intervention|Lost to Follow-up|0|||
13189331|NCT02123797|26180913|FG001|Baseline Intervention|Lost to Follow-up|5|||
13189332|NCT02123797|26180914|FG002|Baseline Intervention|Lost to Follow-up|0|||
13189333|NCT02123797|26180915|FG003|Baseline Intervention|Lost to Follow-up|0|||
13189334|NCT02123797|26180916|FG004|Baseline Intervention|Lost to Follow-up|0|||
13189335|NCT02123797|26180912|FG000|Baseline Intervention|Other Disease|3|||
13189336|NCT02123797|26180913|FG001|Baseline Intervention|Other Disease|0|||
13189337|NCT02123797|26180914|FG002|Baseline Intervention|Other Disease|0|||
13189338|NCT02123797|26180915|FG003|Baseline Intervention|Other Disease|0|||
13189339|NCT02123797|26180916|FG004|Baseline Intervention|Other Disease|0|||
13189340|NCT02123797|26180912|FG000|3-month Follow up (Cumulative Counts)|Death|33|||
13189341|NCT02123797|26180913|FG001|3-month Follow up (Cumulative Counts)|Death|57|||
13189342|NCT02123797|26180914|FG002|3-month Follow up (Cumulative Counts)|Death|0|||
13189343|NCT02123797|26180915|FG003|3-month Follow up (Cumulative Counts)|Death|0|||
13189344|NCT02123797|26180916|FG004|3-month Follow up (Cumulative Counts)|Death|0|||
13189345|NCT02123797|26180912|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2|||
13189346|NCT02123797|26180913|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7|||
13189347|NCT02123797|26180914|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50|||
13189348|NCT02123797|26180915|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82|||
13189349|NCT02123797|26180916|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
13189350|NCT02123797|26180912|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6|||
13189351|NCT02123797|26180913|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16|||
13189352|NCT02123797|26180914|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
13189353|NCT02123797|26180915|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
13189354|NCT02123797|26180916|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
13189355|NCT02123797|26180912|FG000|3-month Follow up (Cumulative Counts)|Relocation|0|||
13189356|NCT02123797|26180913|FG001|3-month Follow up (Cumulative Counts)|Relocation|1|||
13189357|NCT02123797|26180914|FG002|3-month Follow up (Cumulative Counts)|Relocation|0|||
13189358|NCT02123797|26180915|FG003|3-month Follow up (Cumulative Counts)|Relocation|0|||
13189359|NCT02123797|26180916|FG004|3-month Follow up (Cumulative Counts)|Relocation|0|||
13189360|NCT02123797|26180912|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16|||
13189361|NCT02123797|26180913|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36|||
13189362|NCT02123797|26180914|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
13189363|NCT02123797|26180915|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
13189364|NCT02123797|26180916|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
13189365|NCT02123797|26180912|FG000|6-month Follow up (Cumulative Counts)|Death|51|||
13189366|NCT02123797|26180913|FG001|6-month Follow up (Cumulative Counts)|Death|97|||
13189367|NCT02123797|26180914|FG002|6-month Follow up (Cumulative Counts)|Death|0|||
13189368|NCT02123797|26180915|FG003|6-month Follow up (Cumulative Counts)|Death|0|||
13189369|NCT02123797|26180916|FG004|6-month Follow up (Cumulative Counts)|Death|0|||
13189370|NCT02123797|26180912|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
13189371|NCT02123797|26180913|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20|||
13189372|NCT02123797|26180914|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66|||
13189373|NCT02123797|26180915|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113|||
13189374|NCT02123797|26180916|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
13189375|NCT02123797|26180912|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1|||
13189376|NCT02123797|26180913|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9|||
13189377|NCT02123797|26180914|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
13189378|NCT02123797|26180915|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
13189379|NCT02123797|26180916|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
13189380|NCT02123797|26180912|FG000|6-month Follow up (Cumulative Counts)|Relocation|0|||
13189381|NCT02123797|26180913|FG001|6-month Follow up (Cumulative Counts)|Relocation|2|||
13189382|NCT02123797|26180914|FG002|6-month Follow up (Cumulative Counts)|Relocation|0|||
13189383|NCT02123797|26180915|FG003|6-month Follow up (Cumulative Counts)|Relocation|0|||
13189384|NCT02123797|26180916|FG004|6-month Follow up (Cumulative Counts)|Relocation|0|||
13189385|NCT02123576|26180939|FG000|Overall Study|Adverse Event|1|||
13189386|NCT02123576|26180940|FG001|Overall Study|Adverse Event|0|||
13189387|NCT02123511|26180971|FG000|Overall Study|Cancelled treatment|1|||
13189388|NCT02123511|26180972|FG001|Overall Study|Cancelled treatment|0|||
13189389|NCT02123511|26180971|FG000|Overall Study|Incomplete data|1|||
13189390|NCT02123511|26180972|FG001|Overall Study|Incomplete data|3|||
13189391|NCT02123511|26180971|FG000|Overall Study|Ineligible|0|||
13189392|NCT02123511|26180972|FG001|Overall Study|Ineligible|1|||
13189393|NCT02123472|26180985|FG000|Period 2 (7 Days)|Withdrawal by Subject|0|||
13189394|NCT02123472|26180986|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
13189395|NCT02123459|26180999|FG000|Washout Period (1 Day)|Adverse Event|1|||
13189396|NCT02123459|26181000|FG001|Washout Period (1 Day)|Adverse Event|0|||
13189397|NCT02123446|26181013|FG000|Washout Period (1 Day)|Physician Decision|1|||
13189398|NCT02123446|26181014|FG001|Washout Period (1 Day)|Physician Decision|0|||
13189399|NCT02123251|26181045|FG000|Overall Study|Death|1|||
13189400|NCT02123251|26181046|FG001|Overall Study|Death|1|||
13189401|NCT02123251|26181045|FG000|Overall Study|Withdrawal by Subject|0|||
13189402|NCT02123251|26181046|FG001|Overall Study|Withdrawal by Subject|3|||
13189403|NCT02123251|26181045|FG000|Overall Study|Lost Medicaid eligibility|29|||
13189404|NCT02123251|26181046|FG001|Overall Study|Lost Medicaid eligibility|22|||
13189405|NCT02123251|26181045|FG000|Overall Study|Switched Managed Care Organization (MCO)|4|||
13189406|NCT02123251|26181046|FG001|Overall Study|Switched Managed Care Organization (MCO)|4|||
13189407|NCT02123134|26181071|FG000|Overall Study|Withdrawal of consent|3|||
13189408|NCT02123134|26181072|FG001|Overall Study|Withdrawal of consent|2|||
13189409|NCT02123134|26181071|FG000|Overall Study|Administrative decision|0|||
13189410|NCT02123134|26181072|FG001|Overall Study|Administrative decision|1|||
13189411|NCT02123108|26181093|FG000|Overall Study|Death|2|||
13189412|NCT02123108|26181094|FG001|Overall Study|Death|3|||
13189413|NCT02122887|26181121|FG000|Overall Study|Withdrawal by Subject|20|||
13189414|NCT02122887|26181122|FG001|Overall Study|Withdrawal by Subject|2|||
13189415|NCT02122783|26181147|FG000|Overall Study|Adverse Event|0|||
13189416|NCT02122783|26181148|FG001|Overall Study|Adverse Event|1|||
13189417|NCT02122770|26181243|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3|||
13189418|NCT02122770|26181244|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0|||
13189419|NCT02122770|26181245|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1|||
13189420|NCT02122770|26181246|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2|||
13189421|NCT02122770|26181247|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0|||
13189422|NCT02122770|26181248|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0|||
13189423|NCT02122770|26181243|FG000|Part A: Drug-drug Interaction 2|Other|0|||
13189424|NCT02122770|26181244|FG001|Part A: Drug-drug Interaction 2|Other|0|||
13189425|NCT02122770|26181245|FG002|Part A: Drug-drug Interaction 2|Other|1|||
13189426|NCT02122770|26181246|FG003|Part A: Drug-drug Interaction 2|Other|0|||
13189427|NCT02122770|26181247|FG004|Part A: Drug-drug Interaction 2|Other|0|||
13189428|NCT02122770|26181248|FG005|Part A: Drug-drug Interaction 2|Other|0|||
13189429|NCT02122770|26181243|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
13189430|NCT02122770|26181244|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1|||
13189431|NCT02122770|26181245|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
13189432|NCT02122770|26181246|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
13189433|NCT02122770|26181247|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
13189434|NCT02122770|26181248|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
13189435|NCT02122770|26181243|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
13189436|NCT02122770|26181244|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5|||
13189437|NCT02122770|26181245|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
13189438|NCT02122770|26181246|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
13189439|NCT02122770|26181247|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
13189440|NCT02122770|26181248|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
13189441|NCT02122770|26181243|FG000|Part B: Standard of Care|Adverse Event|0|||
13189442|NCT02122770|26181244|FG001|Part B: Standard of Care|Adverse Event|0|||
13189443|NCT02122770|26181245|FG002|Part B: Standard of Care|Adverse Event|0|||
13189444|NCT02122770|26181246|FG003|Part B: Standard of Care|Adverse Event|0|||
13189445|NCT02122770|26181247|FG004|Part B: Standard of Care|Adverse Event|4|||
13189446|NCT02122770|26181248|FG005|Part B: Standard of Care|Adverse Event|1|||
13189447|NCT02122770|26181243|FG000|Part B: Standard of Care|Other|0|||
13189448|NCT02122770|26181244|FG001|Part B: Standard of Care|Other|0|||
13189449|NCT02122770|26181245|FG002|Part B: Standard of Care|Other|0|||
13189450|NCT02122770|26181246|FG003|Part B: Standard of Care|Other|0|||
13189451|NCT02122770|26181247|FG004|Part B: Standard of Care|Other|0|||
13189452|NCT02122770|26181248|FG005|Part B: Standard of Care|Other|2|||
13189453|NCT02122770|26181243|FG000|Part B: Standard of Care|Withdrawal by Subject|0|||
13189454|NCT02122770|26181244|FG001|Part B: Standard of Care|Withdrawal by Subject|0|||
13189455|NCT02122770|26181245|FG002|Part B: Standard of Care|Withdrawal by Subject|0|||
13189456|NCT02122770|26181246|FG003|Part B: Standard of Care|Withdrawal by Subject|0|||
13189457|NCT02122770|26181247|FG004|Part B: Standard of Care|Withdrawal by Subject|4|||
13189458|NCT02122770|26181248|FG005|Part B: Standard of Care|Withdrawal by Subject|2|||
13189459|NCT02122770|26181243|FG000|Part B: Standard of Care|Symptomatic Deterioration|0|||
13189460|NCT02122770|26181244|FG001|Part B: Standard of Care|Symptomatic Deterioration|0|||
13189461|NCT02122770|26181245|FG002|Part B: Standard of Care|Symptomatic Deterioration|0|||
13189462|NCT02122770|26181246|FG003|Part B: Standard of Care|Symptomatic Deterioration|0|||
13189463|NCT02122770|26181247|FG004|Part B: Standard of Care|Symptomatic Deterioration|5|||
13189464|NCT02122770|26181248|FG005|Part B: Standard of Care|Symptomatic Deterioration|0|||
13189465|NCT02122770|26181243|FG000|Part B: Standard of Care|Progressive Disease|0|||
13189466|NCT02122770|26181244|FG001|Part B: Standard of Care|Progressive Disease|0|||
13189467|NCT02122770|26181245|FG002|Part B: Standard of Care|Progressive Disease|0|||
13189468|NCT02122770|26181246|FG003|Part B: Standard of Care|Progressive Disease|0|||
13189469|NCT02122770|26181247|FG004|Part B: Standard of Care|Progressive Disease|10|||
13189470|NCT02122770|26181248|FG005|Part B: Standard of Care|Progressive Disease|8|||
13189471|NCT02122380|26181269|FG000|First Intervention (30 Days)|Adverse Event|1|||
13189472|NCT02122380|26181270|FG001|First Intervention (30 Days)|Adverse Event|0|||
13189473|NCT02122380|26181269|FG000|First Intervention (30 Days)|Physician Decision|0|||
13189474|NCT02122380|26181270|FG001|First Intervention (30 Days)|Physician Decision|1|||
13189475|NCT02122380|26181269|FG000|Washout (8 Weeks)|Lost to Follow-up|1|||
13189476|NCT02122380|26181270|FG001|Washout (8 Weeks)|Lost to Follow-up|0|||
13189477|NCT02122380|26181269|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0|||
13189478|NCT02122380|26181270|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2|||
13189479|NCT02122380|26181269|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0|||
13189480|NCT02122380|26181270|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2|||
13189481|NCT02122146|26181530|FG000|Part 1: Dose Escalation|Death|0|||
13189482|NCT02122146|26181531|FG001|Part 1: Dose Escalation|Death|1|||
13189483|NCT02122146|26181532|FG002|Part 1: Dose Escalation|Death|1|||
13189484|NCT02122146|26181533|FG003|Part 1: Dose Escalation|Death|0|||
13189485|NCT02122146|26181534|FG004|Part 1: Dose Escalation|Death|0|||
13189486|NCT02122146|26181535|FG005|Part 1: Dose Escalation|Death|0|||
13189487|NCT02122146|26181536|FG006|Part 1: Dose Escalation|Death|0|||
13189488|NCT02122146|26181537|FG007|Part 1: Dose Escalation|Death|0|||
13189489|NCT02122146|26181530|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
13189490|NCT02122146|26181531|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
13189491|NCT02122146|26181532|FG002|Part 1: Dose Escalation|Lost to Follow-up|1|||
13189492|NCT02122146|26181533|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
13189493|NCT02122146|26181534|FG004|Part 1: Dose Escalation|Lost to Follow-up|1|||
13189494|NCT02122146|26181535|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
13189495|NCT02122146|26181536|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
13189496|NCT02122146|26181537|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
13189497|NCT02122146|26181530|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
13189498|NCT02122146|26181531|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
13189499|NCT02122146|26181532|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
13189500|NCT02122146|26181533|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1|||
13189501|NCT02122146|26181534|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
13189502|NCT02122146|26181535|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
13189503|NCT02122146|26181536|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
13189504|NCT02122146|26181537|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
13189505|NCT02122146|26181530|FG000|Part 1: Dose Escalation|Other|1|||
13189506|NCT02122146|26181531|FG001|Part 1: Dose Escalation|Other|0|||
13189507|NCT02122146|26181532|FG002|Part 1: Dose Escalation|Other|0|||
13189508|NCT02122146|26181533|FG003|Part 1: Dose Escalation|Other|0|||
13189509|NCT02122146|26181534|FG004|Part 1: Dose Escalation|Other|0|||
13189510|NCT02122146|26181535|FG005|Part 1: Dose Escalation|Other|1|||
13189511|NCT02122146|26181536|FG006|Part 1: Dose Escalation|Other|1|||
13189512|NCT02122146|26181537|FG007|Part 1: Dose Escalation|Other|2|||
13189513|NCT02121847|26181558|FG000|Overall Study|Administrative Reasons|1|||
13189514|NCT02121847|26181558|FG000|Overall Study|Adverse Event|2|||
13189515|NCT02121834|26181606|FG000|Overall Study|Protocol Violation|0|||
13189516|NCT02121834|26181607|FG001|Overall Study|Protocol Violation|1|||
13189517|NCT02121834|26181608|FG002|Overall Study|Protocol Violation|0|||
13189518|NCT02121834|26181609|FG003|Overall Study|Protocol Violation|0|||
13189519|NCT02121834|26181610|FG004|Overall Study|Protocol Violation|0|||
13189520|NCT02121834|26181611|FG005|Overall Study|Protocol Violation|0|||
13189521|NCT02121834|26181612|FG006|Overall Study|Protocol Violation|0|||
13189522|NCT02121834|26181606|FG000|Overall Study|Withdrawal by Subject|0|||
13111189|NCT03192306|25902491|FG000|Overall Study|Protocol Violation|1|||
13111190|NCT03192306|25902492|FG001|Overall Study|Protocol Violation|1|||
13111191|NCT03192176|25902815|FG000|Overall Study|Adverse Event|1|||
13111192|NCT03192176|25902816|FG001|Overall Study|Adverse Event|0|||
13111193|NCT03192176|25902817|FG002|Overall Study|Adverse Event|4|||
13111194|NCT03192176|25902818|FG003|Overall Study|Adverse Event|5|||
13111195|NCT03192176|25902819|FG004|Overall Study|Adverse Event|3|||
13111196|NCT03192176|25902820|FG005|Overall Study|Adverse Event|2|||
13189523|NCT02121834|26181607|FG001|Overall Study|Withdrawal by Subject|1|||
13189524|NCT02121834|26181608|FG002|Overall Study|Withdrawal by Subject|1|||
13189525|NCT02121834|26181609|FG003|Overall Study|Withdrawal by Subject|0|||
13189526|NCT02121834|26181610|FG004|Overall Study|Withdrawal by Subject|0|||
13189527|NCT02121834|26181611|FG005|Overall Study|Withdrawal by Subject|0|||
13189528|NCT02121834|26181612|FG006|Overall Study|Withdrawal by Subject|0|||
13189529|NCT02121834|26181606|FG000|Overall Study|Lost to Follow-up|0|||
13189530|NCT02121834|26181607|FG001|Overall Study|Lost to Follow-up|0|||
13189531|NCT02121834|26181608|FG002|Overall Study|Lost to Follow-up|1|||
13189532|NCT02121834|26181609|FG003|Overall Study|Lost to Follow-up|0|||
13111197|NCT03192176|25902821|FG006|Overall Study|Adverse Event|3|||
13111198|NCT03192176|25902822|FG007|Overall Study|Adverse Event|3|||
13111199|NCT03192176|25902815|FG000|Overall Study|Lost to Follow-up|0|||
13189533|NCT02121834|26181610|FG004|Overall Study|Lost to Follow-up|0|||
13189534|NCT02121834|26181611|FG005|Overall Study|Lost to Follow-up|0|||
13189535|NCT02121834|26181612|FG006|Overall Study|Lost to Follow-up|0|||
13189536|NCT02121808|26181623|FG000|Overall Study|Technical problem|3|||
13111200|NCT03192176|25902816|FG001|Overall Study|Lost to Follow-up|0|||
13111201|NCT03192176|25902817|FG002|Overall Study|Lost to Follow-up|1|||
13111202|NCT03192176|25902818|FG003|Overall Study|Lost to Follow-up|2|||
13111203|NCT03192176|25902819|FG004|Overall Study|Lost to Follow-up|3|||
13111204|NCT03192176|25902820|FG005|Overall Study|Lost to Follow-up|1|||
13111205|NCT03192176|25902821|FG006|Overall Study|Lost to Follow-up|1|||
13111206|NCT03192176|25902822|FG007|Overall Study|Lost to Follow-up|1|||
13189537|NCT02121795|26181656|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
13189538|NCT02121795|26181657|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
13189539|NCT02121795|26181656|FG000|Double-Blind Phase|Withdrawal by Subject|19|||
13189540|NCT02121795|26181657|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
13189541|NCT02121795|26181656|FG000|Double-Blind Phase|Lost to Follow-up|7|||
13189542|NCT02121795|26181657|FG001|Double-Blind Phase|Lost to Follow-up|4|||
13189543|NCT02121795|26181656|FG000|Double-Blind Phase|Physician Decision|2|||
13189544|NCT02121795|26181657|FG001|Double-Blind Phase|Physician Decision|5|||
13189545|NCT02121795|26181656|FG000|Double-Blind Phase|Adverse Event|5|||
13189546|NCT02121795|26181657|FG001|Double-Blind Phase|Adverse Event|0|||
13189547|NCT02121795|26181656|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
13189548|NCT02121795|26181657|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
13189549|NCT02121795|26181656|FG000|Double-Blind Phase|Protocol Violation|0|||
13189550|NCT02121795|26181657|FG001|Double-Blind Phase|Protocol Violation|3|||
13189551|NCT02121795|26181656|FG000|Double-Blind Phase|Death|1|||
13189552|NCT02121795|26181657|FG001|Double-Blind Phase|Death|1|||
13189553|NCT02121795|26181656|FG000|Open-Label Phase|Physician Decision|8|||
13189554|NCT02121795|26181657|FG001|Open-Label Phase|Physician Decision|8|||
13189555|NCT02121795|26181656|FG000|Open-Label Phase|Withdrawal by Subject|3|||
13189556|NCT02121795|26181657|FG001|Open-Label Phase|Withdrawal by Subject|2|||
13189557|NCT02121795|26181656|FG000|Open-Label Phase|Lost to Follow-up|1|||
13189558|NCT02121795|26181657|FG001|Open-Label Phase|Lost to Follow-up|0|||
13189559|NCT02121756|26181699|FG000|Overall Study|Adverse Event|3|||
13189560|NCT02121756|26181700|FG001|Overall Study|Adverse Event|0|||
13189561|NCT02121756|26181699|FG000|Overall Study|Protocol Violation|1|||
13189562|NCT02121756|26181700|FG001|Overall Study|Protocol Violation|1|||
13189563|NCT02121756|26181699|FG000|Overall Study|Physician Decision|2|||
13189564|NCT02121756|26181700|FG001|Overall Study|Physician Decision|1|||
13189565|NCT02121535|26181730|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0|||
13189566|NCT02121535|26181731|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1|||
13189567|NCT02121535|26181730|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1|||
13189568|NCT02121535|26181731|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0|||
13189569|NCT02121522|26181738|FG000|Overall Study|Adverse Event|1|||
13189570|NCT02121509|26181777|FG000|Washout Period (35 Days)|Adverse Event|1|||
13189571|NCT02121509|26181778|FG001|Washout Period (35 Days)|Adverse Event|1|||
13189572|NCT02121509|26181779|FG002|Washout Period (35 Days)|Adverse Event|0|||
13189573|NCT02121509|26181780|FG003|Washout Period (35 Days)|Adverse Event|0|||
13189574|NCT02121509|26181777|FG000|Washout Period (35 Days)|Withdrawal by Subject|0|||
13189575|NCT02121509|26181778|FG001|Washout Period (35 Days)|Withdrawal by Subject|3|||
13189576|NCT02121509|26181779|FG002|Washout Period (35 Days)|Withdrawal by Subject|0|||
13189577|NCT02121509|26181780|FG003|Washout Period (35 Days)|Withdrawal by Subject|0|||
13189578|NCT02121509|26181777|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1|||
13189579|NCT02121509|26181778|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0|||
13189580|NCT02121509|26181779|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0|||
13485561|NCT02906020|27032867|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
13111207|NCT03192176|25902815|FG000|Overall Study|Physician Decision|1|||
13111208|NCT03192176|25902816|FG001|Overall Study|Physician Decision|0|||
13189581|NCT02121509|26181780|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0|||
13189582|NCT02121392|26181809|FG000|Prior to Intervention|Protocol Violation|40|||
13189583|NCT02121392|26181810|FG001|Prior to Intervention|Protocol Violation|35|||
13189584|NCT02121392|26181809|FG000|Prior to Intervention|Withdrawal by Subject|8|||
13189585|NCT02121392|26181810|FG001|Prior to Intervention|Withdrawal by Subject|6|||
13189586|NCT02121392|26181809|FG000|After Placement of AC Block vs Sham|Protocol Violation|3|||
13189587|NCT02121392|26181810|FG001|After Placement of AC Block vs Sham|Protocol Violation|2|||
13189588|NCT02121392|26181809|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0|||
13189589|NCT02121392|26181810|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1|||
13189590|NCT02121301|26181831|FG000|Overall Study|Protocol Violation|1|||
13189591|NCT02121301|26181832|FG001|Overall Study|Protocol Violation|4|||
13189592|NCT02121301|26181833|FG002|Overall Study|Protocol Violation|1|||
13189593|NCT02121262|26181852|FG000|Overall Study|Adverse Event|6|||
13189594|NCT02121262|26181853|FG001|Overall Study|Adverse Event|3|||
13189595|NCT02121262|26181852|FG000|Overall Study|Lack of Efficacy|3|||
13189596|NCT02121262|26181853|FG001|Overall Study|Lack of Efficacy|0|||
13189597|NCT02121262|26181852|FG000|Overall Study|Personal Reasons|19|||
13189598|NCT02121262|26181853|FG001|Overall Study|Personal Reasons|5|||
13189599|NCT02121262|26181852|FG000|Overall Study|Protocol Violation|1|||
13189600|NCT02121262|26181853|FG001|Overall Study|Protocol Violation|1|||
13189601|NCT02121262|26181852|FG000|Overall Study|Participant Dropped-out|0|||
13189602|NCT02121262|26181853|FG001|Overall Study|Participant Dropped-out|1|||
13189603|NCT02121262|26181852|FG000|Overall Study|Participant was Deemed Unsuitable|1|||
13189604|NCT02121262|26181853|FG001|Overall Study|Participant was Deemed Unsuitable|0|||
13189605|NCT02121262|26181852|FG000|Overall Study|Consent Withdrawn|1|||
13189606|NCT02121262|26181853|FG001|Overall Study|Consent Withdrawn|0|||
13189607|NCT02121210|26181868|FG000|Overall Study|Adverse Event|5|||
13189608|NCT02121210|26181869|FG001|Overall Study|Adverse Event|7|||
13189609|NCT02121210|26181868|FG000|Overall Study|Lack of Efficacy|2|||
13189610|NCT02121210|26181869|FG001|Overall Study|Lack of Efficacy|0|||
13189611|NCT02121210|26181868|FG000|Overall Study|Other than specified above|0|||
13189612|NCT02121210|26181869|FG001|Overall Study|Other than specified above|2|||
13189613|NCT02121002|26181887|FG000|Overall Study|Physician Decision|2|||
13189614|NCT02121002|26181888|FG001|Overall Study|Physician Decision|0|||
13189615|NCT02121002|26181889|FG002|Overall Study|Physician Decision|0|||
13189616|NCT02121002|26181887|FG000|Overall Study|Withdrawal by Subject|3|||
13189617|NCT02121002|26181888|FG001|Overall Study|Withdrawal by Subject|1|||
13189618|NCT02121002|26181889|FG002|Overall Study|Withdrawal by Subject|4|||
13189619|NCT02121002|26181887|FG000|Overall Study|Protocol Violation|1|||
13189620|NCT02121002|26181888|FG001|Overall Study|Protocol Violation|2|||
13189621|NCT02121002|26181889|FG002|Overall Study|Protocol Violation|4|||
13189622|NCT02121002|26181887|FG000|Overall Study|Concomitant therapy|0|||
13189623|NCT02121002|26181888|FG001|Overall Study|Concomitant therapy|1|||
13189624|NCT02121002|26181889|FG002|Overall Study|Concomitant therapy|1|||
13189625|NCT02121002|26181887|FG000|Overall Study|Others|1|||
13189626|NCT02121002|26181888|FG001|Overall Study|Others|0|||
13189627|NCT02121002|26181889|FG002|Overall Study|Others|1|||
13189628|NCT02120950|26181930|FG000|Overall Study|Adverse Event|5|||
13189629|NCT02120950|26181931|FG001|Overall Study|Adverse Event|4|||
13189630|NCT02120950|26181932|FG002|Overall Study|Adverse Event|3|||
13189631|NCT02120950|26181930|FG000|Overall Study|Death|3|||
13111209|NCT03192176|25902817|FG002|Overall Study|Physician Decision|0|||
13111210|NCT03192176|25902818|FG003|Overall Study|Physician Decision|0|||
13111211|NCT03192176|25902819|FG004|Overall Study|Physician Decision|0|||
13111212|NCT03192176|25902820|FG005|Overall Study|Physician Decision|2|||
13111213|NCT03192176|25902821|FG006|Overall Study|Physician Decision|1|||
13111214|NCT03192176|25902822|FG007|Overall Study|Physician Decision|0|||
13111215|NCT03192176|25902815|FG000|Overall Study|Protocol Deviation|1|||
13189632|NCT02120950|26181931|FG001|Overall Study|Death|0|||
13189633|NCT02120950|26181932|FG002|Overall Study|Death|1|||
13189634|NCT02120950|26181930|FG000|Overall Study|Withdrawal by Subject|6|||
13189635|NCT02120950|26181931|FG001|Overall Study|Withdrawal by Subject|3|||
13189636|NCT02120950|26181932|FG002|Overall Study|Withdrawal by Subject|2|||
13189637|NCT02120950|26181930|FG000|Overall Study|Protocol Violation|1|||
13189638|NCT02120950|26181931|FG001|Overall Study|Protocol Violation|1|||
13189639|NCT02120950|26181932|FG002|Overall Study|Protocol Violation|7|||
13189640|NCT02120950|26181930|FG000|Overall Study|Other reasons|5|||
13189641|NCT02120950|26181931|FG001|Overall Study|Other reasons|4|||
13189642|NCT02120950|26181932|FG002|Overall Study|Other reasons|1|||
13189643|NCT02120950|26181930|FG000|Overall Study|Lost to Follow-up|0|||
13189644|NCT02120950|26181931|FG001|Overall Study|Lost to Follow-up|2|||
13189645|NCT02120950|26181932|FG002|Overall Study|Lost to Follow-up|1|||
13189646|NCT02120924|26181953|FG000|Overall Study|Lack of Efficacy|1|||
13189647|NCT02120924|26181954|FG001|Overall Study|Lack of Efficacy|2|||
13189648|NCT02120924|26181955|FG002|Overall Study|Lack of Efficacy|3|||
13111216|NCT03192176|25902816|FG001|Overall Study|Protocol Deviation|1|||
13111217|NCT03192176|25902817|FG002|Overall Study|Protocol Deviation|0|||
13111218|NCT03192176|25902818|FG003|Overall Study|Protocol Deviation|0|||
13111219|NCT03192176|25902819|FG004|Overall Study|Protocol Deviation|2|||
13189649|NCT02120924|26181953|FG000|Overall Study|Adverse Event|0|||
13189650|NCT02120924|26181954|FG001|Overall Study|Adverse Event|1|||
13111220|NCT03192176|25902820|FG005|Overall Study|Protocol Deviation|0|||
13111221|NCT03192176|25902821|FG006|Overall Study|Protocol Deviation|0|||
13189651|NCT02120924|26181955|FG002|Overall Study|Adverse Event|3|||
13189652|NCT02120924|26181953|FG000|Overall Study|Withdrawal by Subject|16|||
13189653|NCT02120924|26181954|FG001|Overall Study|Withdrawal by Subject|20|||
13189654|NCT02120924|26181955|FG002|Overall Study|Withdrawal by Subject|8|||
13189655|NCT02120924|26181953|FG000|Overall Study|Lost to Follow-up|14|||
13189656|NCT02120924|26181954|FG001|Overall Study|Lost to Follow-up|14|||
13189657|NCT02120924|26181955|FG002|Overall Study|Lost to Follow-up|11|||
13189658|NCT02120924|26181953|FG000|Overall Study|Pregnancy|2|||
13189659|NCT02120924|26181954|FG001|Overall Study|Pregnancy|0|||
13189660|NCT02120924|26181955|FG002|Overall Study|Pregnancy|0|||
13111222|NCT03192176|25902822|FG007|Overall Study|Protocol Deviation|0|||
13111223|NCT03192176|25902815|FG000|Overall Study|Withdrawal by Subject|3|||
13111224|NCT03192176|25902816|FG001|Overall Study|Withdrawal by Subject|4|||
13111225|NCT03192176|25902817|FG002|Overall Study|Withdrawal by Subject|0|||
13111226|NCT03192176|25902818|FG003|Overall Study|Withdrawal by Subject|4|||
13189661|NCT02120924|26181953|FG000|Overall Study|Protocol Violation|3|||
13189662|NCT02120924|26181954|FG001|Overall Study|Protocol Violation|7|||
13189663|NCT02120924|26181955|FG002|Overall Study|Protocol Violation|2|||
13189664|NCT02120924|26181953|FG000|Overall Study|Physician Decision|0|||
13189665|NCT02120924|26181954|FG001|Overall Study|Physician Decision|1|||
13189666|NCT02120924|26181955|FG002|Overall Study|Physician Decision|1|||
13189667|NCT02120924|26181953|FG000|Overall Study|Death|1|||
13111227|NCT03192176|25902819|FG004|Overall Study|Withdrawal by Subject|3|||
13111228|NCT03192176|25902820|FG005|Overall Study|Withdrawal by Subject|4|||
13111229|NCT03192176|25902821|FG006|Overall Study|Withdrawal by Subject|4|||
13189668|NCT02120924|26181954|FG001|Overall Study|Death|0|||
13189669|NCT02120924|26181955|FG002|Overall Study|Death|0|||
13189670|NCT02120924|26181953|FG000|Overall Study|Compliance with IP|5|||
13189671|NCT02120924|26181954|FG001|Overall Study|Compliance with IP|1|||
13189672|NCT02120924|26181955|FG002|Overall Study|Compliance with IP|1|||
13189673|NCT02120898|26181985|FG000|Overall Study|Withdrawal by Subject|4|||
13111230|NCT03192176|25902822|FG007|Overall Study|Withdrawal by Subject|2|||
13111231|NCT03192176|25902815|FG000|Overall Study|Miscellaneous|1|||
13111232|NCT03192176|25902816|FG001|Overall Study|Miscellaneous|0|||
13111233|NCT03192176|25902817|FG002|Overall Study|Miscellaneous|1|||
13111234|NCT03192176|25902818|FG003|Overall Study|Miscellaneous|1|||
13111235|NCT03192176|25902819|FG004|Overall Study|Miscellaneous|1|||
13111236|NCT03192176|25902820|FG005|Overall Study|Miscellaneous|2|||
13111237|NCT03192176|25902821|FG006|Overall Study|Miscellaneous|0|||
13111238|NCT03192176|25902822|FG007|Overall Study|Miscellaneous|1|||
13111239|NCT03192150|25902837|FG000|Overall Study|Adverse Event|14|||
13111240|NCT03192150|25902838|FG001|Overall Study|Adverse Event|12|||
13111241|NCT03192150|25902837|FG000|Overall Study|Lack of Efficacy|23|||
13111242|NCT03192150|25902838|FG001|Overall Study|Lack of Efficacy|30|||
13111243|NCT03192150|25902837|FG000|Overall Study|Lost to Follow-up|1|||
13111244|NCT03192150|25902838|FG001|Overall Study|Lost to Follow-up|1|||
13111245|NCT03192150|25902837|FG000|Overall Study|Withdrawal by Subject|4|||
13111246|NCT03192150|25902838|FG001|Overall Study|Withdrawal by Subject|2|||
13111247|NCT03192150|25902837|FG000|Overall Study|Protocol Violation|5|||
13111248|NCT03192150|25902838|FG001|Overall Study|Protocol Violation|2|||
13111249|NCT03192150|25902837|FG000|Overall Study|Surgery Canceled|6|||
13111250|NCT03192150|25902838|FG001|Overall Study|Surgery Canceled|2|||
13111251|NCT03192150|25902837|FG000|Overall Study|Other-Various Administrative Reasons|2|||
13111252|NCT03192150|25902838|FG001|Overall Study|Other-Various Administrative Reasons|5|||
13111253|NCT03192137|25902853|FG000|Overall Study|Adverse Event|10|||
13111254|NCT03192137|25902854|FG001|Overall Study|Adverse Event|11|||
13111255|NCT03192137|25902853|FG000|Overall Study|Physician Decision|1|||
13189674|NCT02120898|26181986|FG001|Overall Study|Withdrawal by Subject|2|||
13189675|NCT02120898|26181987|FG002|Overall Study|Withdrawal by Subject|2|||
13189676|NCT02120898|26181985|FG000|Overall Study|Non-compliance with study drug|3|||
13189677|NCT02120898|26181986|FG001|Overall Study|Non-compliance with study drug|0|||
13189678|NCT02120898|26181987|FG002|Overall Study|Non-compliance with study drug|0|||
13189679|NCT02120898|26181985|FG000|Overall Study|Adverse Event|1|||
13189680|NCT02120898|26181986|FG001|Overall Study|Adverse Event|2|||
13189681|NCT02120898|26181987|FG002|Overall Study|Adverse Event|1|||
13189682|NCT02120898|26181985|FG000|Overall Study|Protocol Violation|1|||
13189683|NCT02120898|26181986|FG001|Overall Study|Protocol Violation|2|||
13189684|NCT02120898|26181987|FG002|Overall Study|Protocol Violation|0|||
13189685|NCT02120898|26181985|FG000|Overall Study|Lost to Follow-up|0|||
13189686|NCT02120898|26181986|FG001|Overall Study|Lost to Follow-up|0|||
13189687|NCT02120898|26181987|FG002|Overall Study|Lost to Follow-up|1|||
13189688|NCT02120833|26182148|FG000|Overall Study|Adverse Event|1|||
13189689|NCT02120833|26182149|FG001|Overall Study|Adverse Event|0|||
13189690|NCT02120833|26182148|FG000|Overall Study|Withdrawal by Subject|2|||
13189691|NCT02120833|26182149|FG001|Overall Study|Withdrawal by Subject|0|||
13189692|NCT02120833|26182148|FG000|Overall Study|Lost to Follow-up|1|||
13189693|NCT02120833|26182149|FG001|Overall Study|Lost to Follow-up|1|||
13189694|NCT02120794|26182158|FG000|Overall Study|Withdrawal by Subject|43|||
13111256|NCT03192137|25902854|FG001|Overall Study|Physician Decision|0|||
13189695|NCT02120794|26182158|FG000|Overall Study|Adverse Event|10|||
13189696|NCT02120794|26182158|FG000|Overall Study|Physician Decision|4|||
13189697|NCT02120794|26182158|FG000|Overall Study|Due to insurance coverage|1|||
13189698|NCT02120781|26182185|FG000|Overall Study|Physician Decision|2|||
13189699|NCT02120781|26182186|FG001|Overall Study|Physician Decision|0|||
13189700|NCT02120781|26182185|FG000|Overall Study|Completion not documented|2|||
13189701|NCT02120781|26182186|FG001|Overall Study|Completion not documented|1|||
13189702|NCT02120664|26182220|FG000|Overall Study|Withdrawal by Subject|0|||
13189703|NCT02120664|26182221|FG001|Overall Study|Withdrawal by Subject|0|||
13189704|NCT02120664|26182222|FG002|Overall Study|Withdrawal by Subject|0|||
13189705|NCT02120664|26182223|FG003|Overall Study|Withdrawal by Subject|1|||
13189706|NCT02120664|26182224|FG004|Overall Study|Withdrawal by Subject|0|||
13189707|NCT02120625|26182233|FG000|Overall Study|Physician Decision|2|||
13189708|NCT02120469|26182262|FG000|Overall Study|HER-2/neu-amplified|1|||
13189709|NCT02120469|26182263|FG001|Overall Study|HER-2/neu-amplified|0|||
13189710|NCT02120469|26182264|FG002|Overall Study|HER-2/neu-amplified|1|||
13189711|NCT02120456|26182318|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0|||
13189712|NCT02120456|26182319|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0|||
13189713|NCT02120456|26182320|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0|||
13189714|NCT02120456|26182321|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0|||
13189715|NCT02120456|26182322|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0|||
13189716|NCT02120456|26182323|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0|||
13189717|NCT02120456|26182324|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1|||
13189718|NCT02120456|26182325|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0|||
13189719|NCT02120456|26182326|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0|||
13189720|NCT02120456|26182318|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0|||
13189721|NCT02120456|26182319|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0|||
13189722|NCT02120456|26182320|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0|||
13189723|NCT02120456|26182321|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0|||
13189724|NCT02120456|26182322|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0|||
13189725|NCT02120456|26182323|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0|||
13189726|NCT02120456|26182324|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1|||
13189727|NCT02120456|26182325|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0|||
13189728|NCT02120456|26182326|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0|||
13189729|NCT02120456|26182318|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
13189730|NCT02120456|26182319|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
13189731|NCT02120456|26182320|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
13189732|NCT02120456|26182321|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
13189733|NCT02120456|26182322|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
13189734|NCT02120456|26182323|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
13189735|NCT02120456|26182324|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
13189736|NCT02120456|26182325|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
13189737|NCT02120456|26182326|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1|||
13189738|NCT02120417|26182351|FG000|Overall Study|Death|5|||
13189739|NCT02120417|26182352|FG001|Overall Study|Death|1|||
13189740|NCT02120417|26182351|FG000|Overall Study|Adverse Event|3|||
13189741|NCT02120417|26182352|FG001|Overall Study|Adverse Event|9|||
13189742|NCT02120417|26182351|FG000|Overall Study|Participant decision|4|||
13111257|NCT03192137|25902853|FG000|Overall Study|Lack of Efficacy|20|||
13111258|NCT03192137|25902854|FG001|Overall Study|Lack of Efficacy|37|||
13111259|NCT03192137|25902853|FG000|Overall Study|Withdrawal by Subject|3|||
13189743|NCT02120417|26182352|FG001|Overall Study|Participant decision|4|||
13189744|NCT02120417|26182351|FG000|Overall Study|Disease progression|41|||
13189745|NCT02120417|26182352|FG001|Overall Study|Disease progression|45|||
13189746|NCT02120417|26182351|FG000|Overall Study|Noncompliance with study treatment|0|||
13189747|NCT02120417|26182352|FG001|Overall Study|Noncompliance with study treatment|2|||
13189748|NCT02120417|26182351|FG000|Overall Study|Physician Decision|2|||
13189749|NCT02120417|26182352|FG001|Overall Study|Physician Decision|3|||
13189750|NCT02120417|26182351|FG000|Overall Study|Other unspecified|5|||
13189751|NCT02120417|26182352|FG001|Overall Study|Other unspecified|4|||
13189752|NCT02120300|26182401|FG000|Overall Study|Enrolled but Never Treated|2|||
13189753|NCT02120300|26182402|FG001|Overall Study|Enrolled but Never Treated|0|||
13189754|NCT02120300|26182403|FG002|Overall Study|Enrolled but Never Treated|0|||
13189755|NCT02120300|26182404|FG003|Overall Study|Enrolled but Never Treated|0|||
13189756|NCT02120300|26182401|FG000|Overall Study|Lack of Efficacy|0|||
13189757|NCT02120300|26182402|FG001|Overall Study|Lack of Efficacy|0|||
13111260|NCT03192137|25902854|FG001|Overall Study|Withdrawal by Subject|3|||
13111261|NCT03192137|25902853|FG000|Overall Study|Protocol Violation|4|||
13111262|NCT03192137|25902854|FG001|Overall Study|Protocol Violation|3|||
13111263|NCT03192137|25902853|FG000|Overall Study|Surgery Cancelled|4|||
13111264|NCT03192137|25902854|FG001|Overall Study|Surgery Cancelled|1|||
13111265|NCT03192137|25902853|FG000|Overall Study|Other - Various Administrative Reasons|8|||
13133263|NCT02776033|25987079|FG002|Overall Study|Lost to Follow-up|0|||
13189758|NCT02120300|26182403|FG002|Overall Study|Lack of Efficacy|0|||
13189759|NCT02120300|26182404|FG003|Overall Study|Lack of Efficacy|1|||
13189760|NCT02120300|26182401|FG000|Overall Study|Lost to Follow-up|1|||
13111266|NCT03192137|25902854|FG001|Overall Study|Other - Various Administrative Reasons|3|||
13189761|NCT02120300|26182402|FG001|Overall Study|Lost to Follow-up|0|||
13189762|NCT02120300|26182403|FG002|Overall Study|Lost to Follow-up|0|||
13189763|NCT02120300|26182404|FG003|Overall Study|Lost to Follow-up|0|||
13189764|NCT02120157|26182421|FG000|Overall Study|Death|8|||
13189765|NCT02120027|26182442|FG000|Overall Study|Adverse Event|4|||
13189766|NCT02120027|26182443|FG001|Overall Study|Adverse Event|5|||
13189767|NCT02120027|26182442|FG000|Overall Study|Lack of Efficacy|3|||
13189768|NCT02120027|26182443|FG001|Overall Study|Lack of Efficacy|5|||
13189769|NCT02120027|26182442|FG000|Overall Study|Lost to Follow-up|5|||
13189770|NCT02120027|26182443|FG001|Overall Study|Lost to Follow-up|13|||
13189771|NCT02120027|26182442|FG000|Overall Study|Other|4|||
13189772|NCT02120027|26182443|FG001|Overall Study|Other|0|||
13189773|NCT02120027|26182442|FG000|Overall Study|Physician Decision|4|||
13189774|NCT02120027|26182443|FG001|Overall Study|Physician Decision|3|||
13189775|NCT02120027|26182442|FG000|Overall Study|Protocol Violation|18|||
13189776|NCT02120027|26182443|FG001|Overall Study|Protocol Violation|21|||
13189777|NCT02120027|26182442|FG000|Overall Study|Study terminated by Sponsor|45|||
13189778|NCT02120027|26182443|FG001|Overall Study|Study terminated by Sponsor|47|||
13189779|NCT02120027|26182442|FG000|Overall Study|Withdrawal by Subject|33|||
13189780|NCT02120027|26182443|FG001|Overall Study|Withdrawal by Subject|25|||
13189781|NCT02119936|26182454|FG000|Overall Study|Lost to Follow-up|10|||
13189782|NCT02119819|26182567|FG000|Overall Study|Adverse Event|3|||
13189783|NCT02119819|26182568|FG001|Overall Study|Adverse Event|1|||
13189784|NCT02119819|26182569|FG002|Overall Study|Adverse Event|2|||
13189785|NCT02119819|26182570|FG003|Overall Study|Adverse Event|3|||
13189786|NCT02119819|26182571|FG004|Overall Study|Adverse Event|0|||
13189787|NCT02119819|26182572|FG005|Overall Study|Adverse Event|1|||
13189788|NCT02119819|26182567|FG000|Overall Study|Lack of Efficacy|0|||
13189789|NCT02119819|26182568|FG001|Overall Study|Lack of Efficacy|0|||
13189790|NCT02119819|26182569|FG002|Overall Study|Lack of Efficacy|0|||
13189791|NCT02119819|26182570|FG003|Overall Study|Lack of Efficacy|0|||
13189792|NCT02119819|26182571|FG004|Overall Study|Lack of Efficacy|0|||
13189793|NCT02119819|26182572|FG005|Overall Study|Lack of Efficacy|1|||
13189794|NCT02119819|26182567|FG000|Overall Study|Lost to Follow-up|0|||
13189795|NCT02119819|26182568|FG001|Overall Study|Lost to Follow-up|0|||
13189796|NCT02119819|26182569|FG002|Overall Study|Lost to Follow-up|1|||
13189797|NCT02119819|26182570|FG003|Overall Study|Lost to Follow-up|2|||
13189798|NCT02119819|26182571|FG004|Overall Study|Lost to Follow-up|1|||
13189799|NCT02119819|26182572|FG005|Overall Study|Lost to Follow-up|2|||
13189800|NCT02119819|26182567|FG000|Overall Study|Physician Decision|1|||
13189801|NCT02119819|26182568|FG001|Overall Study|Physician Decision|1|||
13189802|NCT02119819|26182569|FG002|Overall Study|Physician Decision|0|||
13189803|NCT02119819|26182570|FG003|Overall Study|Physician Decision|0|||
13189804|NCT02119819|26182571|FG004|Overall Study|Physician Decision|0|||
13189805|NCT02119819|26182572|FG005|Overall Study|Physician Decision|1|||
13189806|NCT02119819|26182567|FG000|Overall Study|Withdrawal by Subject|5|||
13189807|NCT02119819|26182568|FG001|Overall Study|Withdrawal by Subject|3|||
13189808|NCT02119819|26182569|FG002|Overall Study|Withdrawal by Subject|0|||
13189809|NCT02119819|26182570|FG003|Overall Study|Withdrawal by Subject|0|||
13189810|NCT02119819|26182571|FG004|Overall Study|Withdrawal by Subject|6|||
13189811|NCT02119819|26182572|FG005|Overall Study|Withdrawal by Subject|10|||
13189812|NCT02119819|26182567|FG000|Overall Study|Jury Duty|0|||
13189813|NCT02119819|26182568|FG001|Overall Study|Jury Duty|0|||
13189814|NCT02119819|26182569|FG002|Overall Study|Jury Duty|1|||
13189815|NCT02119819|26182570|FG003|Overall Study|Jury Duty|0|||
13189816|NCT02119819|26182571|FG004|Overall Study|Jury Duty|0|||
13189817|NCT02119819|26182572|FG005|Overall Study|Jury Duty|0|||
13111267|NCT03191799|25902907|FG000|Overall Study|Withdrawal by Subject|4|||
13111268|NCT03191799|25902907|FG000|Overall Study|Physician Decision|2|||
13111269|NCT03191799|25902907|FG000|Overall Study|Lost to Follow-up|1|||
13111270|NCT03191799|25902907|FG000|Overall Study|Death|2|||
13111271|NCT03191630|25902934|FG000|Overall Study|Lost to Follow-up|7|||
13189818|NCT02119819|26182567|FG000|Overall Study|Protocol Violation|0|||
13189819|NCT02119819|26182568|FG001|Overall Study|Protocol Violation|0|||
13111272|NCT03191630|25902935|FG001|Overall Study|Lost to Follow-up|7|||
13111273|NCT03191552|25902996|FG000|Overall Study|Lost to Follow-up|1|||
13189820|NCT02119819|26182569|FG002|Overall Study|Protocol Violation|0|||
13189821|NCT02119819|26182570|FG003|Overall Study|Protocol Violation|1|||
13189822|NCT02119819|26182571|FG004|Overall Study|Protocol Violation|0|||
13111274|NCT03191552|25902997|FG001|Overall Study|Lost to Follow-up|0|||
13189823|NCT02119819|26182572|FG005|Overall Study|Protocol Violation|0|||
13189824|NCT02119819|26182567|FG000|Overall Study|Left the city to get a job|0|||
13189825|NCT02119819|26182568|FG001|Overall Study|Left the city to get a job|0|||
13189826|NCT02119819|26182569|FG002|Overall Study|Left the city to get a job|0|||
13189827|NCT02119819|26182570|FG003|Overall Study|Left the city to get a job|1|||
13189828|NCT02119819|26182571|FG004|Overall Study|Left the city to get a job|0|||
13189829|NCT02119819|26182572|FG005|Overall Study|Left the city to get a job|0|||
13189830|NCT02119676|26182615|FG000|Overall Study|Adverse Event|9|||
13189831|NCT02119676|26182616|FG001|Overall Study|Adverse Event|17|||
13111275|NCT03191552|25902998|FG002|Overall Study|Lost to Follow-up|0|||
13111276|NCT03191552|25902996|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
13111277|NCT03191552|25902997|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1|||
13189832|NCT02119676|26182617|FG002|Overall Study|Adverse Event|10|||
13111278|NCT03191552|25902998|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
13111279|NCT03191396|25903091|FG000|Overall Study|Lost to Follow-up|0|||
13111280|NCT03191396|25903092|FG001|Overall Study|Lost to Follow-up|3|||
13111281|NCT03191396|25903091|FG000|Overall Study|Withdrawal by Subject|3|||
13111282|NCT03191396|25903092|FG001|Overall Study|Withdrawal by Subject|2|||
13111283|NCT03189745|25903125|FG000|Overall Study|Conflict in work schedule of participant|1|||
13111284|NCT03189745|25903126|FG001|Overall Study|Conflict in work schedule of participant|1|||
13111285|NCT03189524|25903170|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7|||
13111286|NCT03189524|25903171|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5|||
13111287|NCT03189524|25903172|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11|||
13111288|NCT03189524|25903170|FG000|Overall Study|Death|2|||
13189833|NCT02119676|26182618|FG003|Overall Study|Adverse Event|10|||
13189834|NCT02119676|26182615|FG000|Overall Study|Disease progression|53|||
13189835|NCT02119676|26182616|FG001|Overall Study|Disease progression|55|||
13189836|NCT02119676|26182617|FG002|Overall Study|Disease progression|68|||
13189837|NCT02119676|26182618|FG003|Overall Study|Disease progression|73|||
13189838|NCT02119676|26182615|FG000|Overall Study|Patient decision, inc. consent withdrawn|4|||
13189839|NCT02119676|26182616|FG001|Overall Study|Patient decision, inc. consent withdrawn|5|||
13189840|NCT02119676|26182617|FG002|Overall Study|Patient decision, inc. consent withdrawn|5|||
13189841|NCT02119676|26182618|FG003|Overall Study|Patient decision, inc. consent withdrawn|6|||
13189842|NCT02119676|26182615|FG000|Overall Study|Physician Decision|4|||
13189843|NCT02119676|26182616|FG001|Overall Study|Physician Decision|2|||
13189844|NCT02119676|26182617|FG002|Overall Study|Physician Decision|3|||
13189845|NCT02119676|26182618|FG003|Overall Study|Physician Decision|2|||
13189846|NCT02119676|26182615|FG000|Overall Study|Death|9|||
13189847|NCT02119676|26182616|FG001|Overall Study|Death|3|||
13189848|NCT02119676|26182617|FG002|Overall Study|Death|2|||
13189849|NCT02119676|26182618|FG003|Overall Study|Death|1|||
13189850|NCT02119676|26182615|FG000|Overall Study|Noncompliance|0|||
13189851|NCT02119676|26182616|FG001|Overall Study|Noncompliance|1|||
13189852|NCT02119676|26182617|FG002|Overall Study|Noncompliance|0|||
13189853|NCT02119676|26182618|FG003|Overall Study|Noncompliance|0|||
13189854|NCT02119676|26182615|FG000|Overall Study|Lost to Follow-up|0|||
13189855|NCT02119676|26182616|FG001|Overall Study|Lost to Follow-up|0|||
13189856|NCT02119676|26182617|FG002|Overall Study|Lost to Follow-up|1|||
13189857|NCT02119676|26182618|FG003|Overall Study|Lost to Follow-up|0|||
13189858|NCT02119676|26182615|FG000|Overall Study|Protocol deviation|0|||
13189859|NCT02119676|26182616|FG001|Overall Study|Protocol deviation|0|||
13189860|NCT02119676|26182617|FG002|Overall Study|Protocol deviation|1|||
13189861|NCT02119676|26182618|FG003|Overall Study|Protocol deviation|0|||
13189862|NCT02119676|26182615|FG000|Overall Study|Other, unspecified|2|||
13189863|NCT02119676|26182616|FG001|Overall Study|Other, unspecified|1|||
13189864|NCT02119676|26182617|FG002|Overall Study|Other, unspecified|3|||
13189865|NCT02119676|26182618|FG003|Overall Study|Other, unspecified|4|||
13189866|NCT02119676|26182615|FG000|Overall Study|Did not receive study med|2|||
13189867|NCT02119676|26182616|FG001|Overall Study|Did not receive study med|2|||
13189868|NCT02119676|26182617|FG002|Overall Study|Did not receive study med|4|||
13189869|NCT02119676|26182618|FG003|Overall Study|Did not receive study med|5|||
13189870|NCT02119663|26182641|FG000|Overall Study|Disease progression|26|||
13189871|NCT02119663|26182642|FG001|Overall Study|Disease progression|27|||
13189872|NCT02119663|26182641|FG000|Overall Study|Adverse Event|5|||
13189873|NCT02119663|26182642|FG001|Overall Study|Adverse Event|5|||
13189874|NCT02119663|26182641|FG000|Overall Study|Death|3|||
13189875|NCT02119663|26182642|FG001|Overall Study|Death|2|||
13189876|NCT02119663|26182641|FG000|Overall Study|Physician Decision|1|||
13189877|NCT02119663|26182642|FG001|Overall Study|Physician Decision|2|||
13189878|NCT02119663|26182641|FG000|Overall Study|Other unspecified|2|||
13189879|NCT02119663|26182642|FG001|Overall Study|Other unspecified|0|||
13189880|NCT02119663|26182641|FG000|Overall Study|Subject decision|0|||
13189881|NCT02119663|26182642|FG001|Overall Study|Subject decision|1|||
13189882|NCT02119663|26182641|FG000|Overall Study|Study Terminated by the Sponsor|3|||
13189883|NCT02119663|26182642|FG001|Overall Study|Study Terminated by the Sponsor|4|||
13189884|NCT02119650|26182663|FG000|Overall Study|Adverse Event|3|||
13189885|NCT02119650|26182664|FG001|Overall Study|Adverse Event|4|||
13189886|NCT02119650|26182663|FG000|Overall Study|Subject decision|2|||
13189887|NCT02119650|26182664|FG001|Overall Study|Subject decision|3|||
13189888|NCT02119650|26182663|FG000|Overall Study|Disease progression|11|||
13189889|NCT02119650|26182664|FG001|Overall Study|Disease progression|14|||
13189890|NCT02119650|26182663|FG000|Overall Study|Death|5|||
13189891|NCT02119650|26182664|FG001|Overall Study|Death|1|||
13189892|NCT02119650|26182663|FG000|Overall Study|Noncompliance with study treatment|1|||
13189893|NCT02119650|26182664|FG001|Overall Study|Noncompliance with study treatment|1|||
13189894|NCT02119650|26182663|FG000|Overall Study|Study terminated by the sponsor|1|||
13189895|NCT02119650|26182664|FG001|Overall Study|Study terminated by the sponsor|0|||
13189896|NCT02119650|26182663|FG000|Overall Study|Physician Decision|0|||
13189897|NCT02119650|26182664|FG001|Overall Study|Physician Decision|2|||
13189898|NCT02119650|26182663|FG000|Overall Study|Multiple reasons for termination|2|||
13189899|NCT02119650|26182664|FG001|Overall Study|Multiple reasons for termination|1|||
13189900|NCT02119416|26182685|FG000|Overall Study|Protocol Violation|1|||
13189901|NCT02119416|26182686|FG001|Overall Study|Protocol Violation|1|||
13189902|NCT02119416|26182687|FG002|Overall Study|Protocol Violation|1|||
13189903|NCT02119416|26182685|FG000|Overall Study|wrong pubertal stage|1|||
13189904|NCT02119416|26182686|FG001|Overall Study|wrong pubertal stage|0|||
13189905|NCT02119416|26182687|FG002|Overall Study|wrong pubertal stage|1|||
13189906|NCT02119325|26182734|FG000|Washout Period 1|Adverse Event|0|||
13189907|NCT02119325|26182735|FG001|Washout Period 1|Adverse Event|1|||
13189908|NCT02119299|26182748|FG000|Overall Study|Withdrawal by Subject|7|||
13189909|NCT02119299|26182748|FG000|Overall Study|Lack of Efficacy|1|||
13189910|NCT02119299|26182748|FG000|Overall Study|Pregnancy|1|||
13189911|NCT02119286|26182769|FG000|Overall Study|Adverse Event|9|||
13189912|NCT02119286|26182770|FG001|Overall Study|Adverse Event|7|||
13189913|NCT02119286|26182771|FG002|Overall Study|Adverse Event|2|||
13189914|NCT02119286|26182769|FG000|Overall Study|Lack of Efficacy|11|||
13189915|NCT02119286|26182770|FG001|Overall Study|Lack of Efficacy|3|||
13189916|NCT02119286|26182771|FG002|Overall Study|Lack of Efficacy|4|||
13189917|NCT02119286|26182769|FG000|Overall Study|Lost to Follow-up|2|||
13189918|NCT02119286|26182770|FG001|Overall Study|Lost to Follow-up|0|||
13111289|NCT03189524|25903171|FG001|Overall Study|Death|2|||
13111290|NCT03189524|25903172|FG002|Overall Study|Death|1|||
13189919|NCT02119286|26182771|FG002|Overall Study|Lost to Follow-up|1|||
13189920|NCT02119286|26182769|FG000|Overall Study|Withdrawal by Subject|4|||
13189921|NCT02119286|26182770|FG001|Overall Study|Withdrawal by Subject|1|||
13189922|NCT02119286|26182771|FG002|Overall Study|Withdrawal by Subject|0|||
13189923|NCT02119260|26182863|FG000|Overall Study|Adverse Event|1|||
13189924|NCT02119260|26182864|FG001|Overall Study|Adverse Event|0|||
13189925|NCT02119260|26182865|FG002|Overall Study|Adverse Event|0|||
13189926|NCT02119260|26182866|FG003|Overall Study|Adverse Event|0|||
13189927|NCT02119260|26182867|FG004|Overall Study|Adverse Event|0|||
13189928|NCT02119260|26182868|FG005|Overall Study|Adverse Event|0|||
13189929|NCT02119260|26182869|FG006|Overall Study|Adverse Event|0|||
13189930|NCT02119260|26182863|FG000|Overall Study|Withdrew consent|0|||
13189931|NCT02119260|26182864|FG001|Overall Study|Withdrew consent|1|||
13189932|NCT02119260|26182865|FG002|Overall Study|Withdrew consent|1|||
13189933|NCT02119260|26182866|FG003|Overall Study|Withdrew consent|0|||
13189934|NCT02119260|26182867|FG004|Overall Study|Withdrew consent|0|||
13189935|NCT02119260|26182868|FG005|Overall Study|Withdrew consent|0|||
13189936|NCT02119260|26182869|FG006|Overall Study|Withdrew consent|0|||
13189937|NCT02119156|26182937|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
13189938|NCT02119156|26182938|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
13189939|NCT02119156|26182939|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1|||
13189940|NCT02119156|26182937|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4|||
13189941|NCT02119156|26182938|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
13189942|NCT02119156|26182939|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
13189943|NCT02119156|26182937|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1|||
13189944|NCT02119156|26182938|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2|||
13189945|NCT02119156|26182939|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0|||
13189946|NCT02119156|26182937|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1|||
13189947|NCT02119156|26182938|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
13189948|NCT02119156|26182939|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
13189949|NCT02119156|26182937|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0|||
13189950|NCT02119156|26182938|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10|||
13206251|NCT01959139|26234061|FG001|Phase II|Other/Unknown|0|||
13111291|NCT03189524|25903170|FG000|Overall Study|Lost to Follow-up|1|||
13111292|NCT03189524|25903171|FG001|Overall Study|Lost to Follow-up|0|||
13111293|NCT03189524|25903172|FG002|Overall Study|Lost to Follow-up|8|||
13111294|NCT03189524|25903170|FG000|Overall Study|Withdrawal by Subject|1|||
13111295|NCT03189524|25903171|FG001|Overall Study|Withdrawal by Subject|1|||
13111296|NCT03189524|25903172|FG002|Overall Study|Withdrawal by Subject|3|||
13111297|NCT03189524|25903170|FG000|Overall Study|Progressive Disease|0|||
13111298|NCT03189524|25903171|FG001|Overall Study|Progressive Disease|2|||
13111299|NCT03189524|25903172|FG002|Overall Study|Progressive Disease|0|||
13111300|NCT03189446|25903179|FG000|Overall Study|Adverse Event|2|||
13111301|NCT03189446|25903179|FG000|Overall Study|Withdrawal by Subject|2|||
13111302|NCT03189446|25903179|FG000|Overall Study|Physician Decision|1|||
13111303|NCT03188991|25903206|FG000|Overall Study|Withdrawal by Subject|0|||
13111304|NCT03188991|25903207|FG001|Overall Study|Withdrawal by Subject|0|||
13111305|NCT03188991|25903208|FG002|Overall Study|Withdrawal by Subject|0|||
13111306|NCT03188991|25903209|FG003|Overall Study|Withdrawal by Subject|1|||
13189951|NCT02119156|26182939|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7|||
13189952|NCT02119104|26182945|FG000|Overall Study|Protocol Violation|16|||
13189953|NCT02119026|26182974|FG000|1st-line Treatment|Adverse Event|9|||
13111307|NCT03188718|25903223|FG000|Overall Study|Participant noncompliance|4|||
13111308|NCT03188718|25903223|FG000|Overall Study|Withdrawal by Subject|1|||
13189954|NCT02119026|26182975|FG001|1st-line Treatment|Adverse Event|14|||
13189955|NCT02119026|26182974|FG000|1st-line Treatment|Physician Decision|3|||
13189956|NCT02119026|26182975|FG001|1st-line Treatment|Physician Decision|8|||
13189957|NCT02119026|26182974|FG000|1st-line Treatment|Withdrawal by Subject|4|||
13189958|NCT02119026|26182975|FG001|1st-line Treatment|Withdrawal by Subject|10|||
13189959|NCT02119026|26182974|FG000|1st-line Treatment|Patient condition or compliance|6|||
13189960|NCT02119026|26182975|FG001|1st-line Treatment|Patient condition or compliance|4|||
13189961|NCT02119026|26182974|FG000|1st-line Treatment|Surgery of metastases|2|||
13189962|NCT02119026|26182975|FG001|1st-line Treatment|Surgery of metastases|1|||
13189963|NCT02119026|26182974|FG000|1st-line Treatment|Death|2|||
13189964|NCT02119026|26182975|FG001|1st-line Treatment|Death|1|||
13189965|NCT02119026|26182974|FG000|2nd-line Treatment|Lost to Follow-up|2|||
13111309|NCT03188718|25903223|FG000|Overall Study|Device failure|3|||
13111310|NCT03188536|25903237|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5|||
13189966|NCT02119026|26182975|FG001|2nd-line Treatment|Lost to Follow-up|0|||
13189967|NCT02119026|26182974|FG000|2nd-line Treatment|Withdrawal by Subject|3|||
13189968|NCT02119026|26182975|FG001|2nd-line Treatment|Withdrawal by Subject|1|||
13189969|NCT02119026|26182974|FG000|2nd-line Treatment|Adverse Event|4|||
13189970|NCT02119026|26182975|FG001|2nd-line Treatment|Adverse Event|1|||
13189971|NCT02118961|26183000|FG000|Overall Study|Withdrawal by Subject|1|||
13189972|NCT02118961|26183001|FG001|Overall Study|Withdrawal by Subject|0|||
13189973|NCT02118896|26183104|FG000|Overall Study|Death|4|||
13189974|NCT02118896|26183105|FG001|Overall Study|Death|0|||
13189975|NCT02118896|26183106|FG002|Overall Study|Death|4|||
13189976|NCT02118896|26183107|FG003|Overall Study|Death|6|||
13189977|NCT02118896|26183108|FG004|Overall Study|Death|3|||
13189978|NCT02118896|26183109|FG005|Overall Study|Death|1|||
13189979|NCT02118896|26183110|FG006|Overall Study|Death|0|||
13189980|NCT02118896|26183111|FG007|Overall Study|Death|0|||
13189981|NCT02118896|26183112|FG008|Overall Study|Death|0|||
13189982|NCT02118896|26183113|FG009|Overall Study|Death|0|||
13189983|NCT02118896|26183104|FG000|Overall Study|Adverse Event|5|||
13189984|NCT02118896|26183105|FG001|Overall Study|Adverse Event|4|||
13189985|NCT02118896|26183106|FG002|Overall Study|Adverse Event|4|||
13189986|NCT02118896|26183107|FG003|Overall Study|Adverse Event|5|||
13189987|NCT02118896|26183108|FG004|Overall Study|Adverse Event|5|||
13189988|NCT02118896|26183109|FG005|Overall Study|Adverse Event|9|||
13189989|NCT02118896|26183110|FG006|Overall Study|Adverse Event|1|||
13189990|NCT02118896|26183111|FG007|Overall Study|Adverse Event|1|||
13189991|NCT02118896|26183112|FG008|Overall Study|Adverse Event|4|||
13189992|NCT02118896|26183113|FG009|Overall Study|Adverse Event|0|||
13189993|NCT02118896|26183104|FG000|Overall Study|Consent withdrawn|2|||
13189994|NCT02118896|26183105|FG001|Overall Study|Consent withdrawn|0|||
13189995|NCT02118896|26183106|FG002|Overall Study|Consent withdrawn|3|||
13189996|NCT02118896|26183107|FG003|Overall Study|Consent withdrawn|4|||
13189997|NCT02118896|26183108|FG004|Overall Study|Consent withdrawn|1|||
13189998|NCT02118896|26183109|FG005|Overall Study|Consent withdrawn|4|||
13189999|NCT02118896|26183110|FG006|Overall Study|Consent withdrawn|0|||
13190000|NCT02118896|26183111|FG007|Overall Study|Consent withdrawn|0|||
13190001|NCT02118896|26183112|FG008|Overall Study|Consent withdrawn|0|||
13190002|NCT02118896|26183113|FG009|Overall Study|Consent withdrawn|0|||
13190003|NCT02118896|26183104|FG000|Overall Study|Non-compliance|2|||
13190004|NCT02118896|26183105|FG001|Overall Study|Non-compliance|1|||
13190005|NCT02118896|26183106|FG002|Overall Study|Non-compliance|1|||
13190006|NCT02118896|26183107|FG003|Overall Study|Non-compliance|5|||
13190007|NCT02118896|26183108|FG004|Overall Study|Non-compliance|0|||
13190008|NCT02118896|26183109|FG005|Overall Study|Non-compliance|1|||
13190009|NCT02118896|26183110|FG006|Overall Study|Non-compliance|0|||
13190010|NCT02118896|26183111|FG007|Overall Study|Non-compliance|1|||
13190011|NCT02118896|26183112|FG008|Overall Study|Non-compliance|0|||
13190012|NCT02118896|26183113|FG009|Overall Study|Non-compliance|0|||
13223174|NCT01799889|26287998|FG010|Overall Study|Specified Criteria for Withdrawal|0|||
13111311|NCT03188536|25903237|FG000|Overall Study|Not participated/met inclusion criteria|1|||
13111312|NCT03188263|25903252|FG000|Overall Study|Withdrawal by Subject|3|||
13111313|NCT03188263|25903253|FG001|Overall Study|Withdrawal by Subject|0|||
13111314|NCT03188263|25903252|FG000|Overall Study|Physician Decision|1|||
13111315|NCT03188263|25903253|FG001|Overall Study|Physician Decision|0|||
13111316|NCT03188185|25903280|FG000|Stage 1|Adverse Event|4|||
13190013|NCT02118896|26183104|FG000|Overall Study|Pregnancy|1|||
13190014|NCT02118896|26183105|FG001|Overall Study|Pregnancy|1|||
13190015|NCT02118896|26183106|FG002|Overall Study|Pregnancy|0|||
13223175|NCT01799889|26287999|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
13190016|NCT02118896|26183107|FG003|Overall Study|Pregnancy|0|||
13190017|NCT02118896|26183108|FG004|Overall Study|Pregnancy|1|||
13190018|NCT02118896|26183109|FG005|Overall Study|Pregnancy|3|||
13190019|NCT02118896|26183110|FG006|Overall Study|Pregnancy|1|||
13190020|NCT02118896|26183111|FG007|Overall Study|Pregnancy|0|||
13190021|NCT02118896|26183112|FG008|Overall Study|Pregnancy|0|||
13190022|NCT02118896|26183113|FG009|Overall Study|Pregnancy|0|||
13190023|NCT02118896|26183104|FG000|Overall Study|Lost to Follow-up|1|||
13190024|NCT02118896|26183105|FG001|Overall Study|Lost to Follow-up|2|||
13190025|NCT02118896|26183106|FG002|Overall Study|Lost to Follow-up|1|||
13190026|NCT02118896|26183107|FG003|Overall Study|Lost to Follow-up|0|||
13190027|NCT02118896|26183108|FG004|Overall Study|Lost to Follow-up|2|||
13190028|NCT02118896|26183109|FG005|Overall Study|Lost to Follow-up|1|||
13190029|NCT02118896|26183110|FG006|Overall Study|Lost to Follow-up|0|||
13111317|NCT03188185|25903281|FG001|Stage 1|Adverse Event|12|||
13111318|NCT03188185|25903282|FG002|Stage 1|Adverse Event|0|||
13111319|NCT03188185|25903283|FG003|Stage 1|Adverse Event|0|||
13111320|NCT03188185|25903280|FG000|Stage 1|Lack of Efficacy|0|||
13190030|NCT02118896|26183111|FG007|Overall Study|Lost to Follow-up|0|||
13190031|NCT02118896|26183112|FG008|Overall Study|Lost to Follow-up|0|||
13190032|NCT02118896|26183113|FG009|Overall Study|Lost to Follow-up|0|||
13190033|NCT02118896|26183104|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1|||
13190034|NCT02118896|26183105|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5|||
13190035|NCT02118896|26183106|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1|||
13190036|NCT02118896|26183107|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2|||
13190037|NCT02118896|26183108|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4|||
13190038|NCT02118896|26183109|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2|||
13190039|NCT02118896|26183110|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0|||
13190040|NCT02118896|26183111|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0|||
13190041|NCT02118896|26183112|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0|||
13190042|NCT02118896|26183113|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2|||
13190043|NCT02118896|26183104|FG000|Overall Study|Prohibited medication|0|||
13190044|NCT02118896|26183105|FG001|Overall Study|Prohibited medication|0|||
13190045|NCT02118896|26183106|FG002|Overall Study|Prohibited medication|0|||
13190046|NCT02118896|26183107|FG003|Overall Study|Prohibited medication|0|||
13190047|NCT02118896|26183108|FG004|Overall Study|Prohibited medication|1|||
13190048|NCT02118896|26183109|FG005|Overall Study|Prohibited medication|3|||
13190049|NCT02118896|26183110|FG006|Overall Study|Prohibited medication|0|||
13190050|NCT02118896|26183111|FG007|Overall Study|Prohibited medication|0|||
13190051|NCT02118896|26183112|FG008|Overall Study|Prohibited medication|0|||
13190052|NCT02118896|26183113|FG009|Overall Study|Prohibited medication|0|||
13190053|NCT02118896|26183104|FG000|Overall Study|Miscellaneous|1|||
13190054|NCT02118896|26183105|FG001|Overall Study|Miscellaneous|2|||
13190055|NCT02118896|26183106|FG002|Overall Study|Miscellaneous|0|||
13190056|NCT02118896|26183107|FG003|Overall Study|Miscellaneous|2|||
13190057|NCT02118896|26183108|FG004|Overall Study|Miscellaneous|0|||
13190058|NCT02118896|26183109|FG005|Overall Study|Miscellaneous|4|||
13190059|NCT02118896|26183110|FG006|Overall Study|Miscellaneous|0|||
13190060|NCT02118896|26183111|FG007|Overall Study|Miscellaneous|0|||
13190061|NCT02118896|26183112|FG008|Overall Study|Miscellaneous|0|||
13190062|NCT02118896|26183113|FG009|Overall Study|Miscellaneous|0|||
13190063|NCT02118792|26183160|FG000|Overall Study|Withdrawal by Subject|6|||
13190064|NCT02118792|26183161|FG001|Overall Study|Withdrawal by Subject|3|||
13190065|NCT02118792|26183160|FG000|Overall Study|Lost to Follow-up|4|||
13190066|NCT02118792|26183161|FG001|Overall Study|Lost to Follow-up|4|||
13190067|NCT02118792|26183160|FG000|Overall Study|Adverse Event|5|||
13190068|NCT02118792|26183161|FG001|Overall Study|Adverse Event|4|||
13190069|NCT02118792|26183160|FG000|Overall Study|Withdrawal by parent/guardian|14|||
13206252|NCT01959139|26234062|FG002|Phase II|Other/Unknown|8|||
13111321|NCT03188185|25903281|FG001|Stage 1|Lack of Efficacy|2|||
13111322|NCT03188185|25903282|FG002|Stage 1|Lack of Efficacy|0|||
13111323|NCT03188185|25903283|FG003|Stage 1|Lack of Efficacy|0|||
13111324|NCT03188185|25903280|FG000|Stage 1|Lost to Follow-up|6|||
13111325|NCT03188185|25903281|FG001|Stage 1|Lost to Follow-up|1|||
13111326|NCT03188185|25903282|FG002|Stage 1|Lost to Follow-up|0|||
13111327|NCT03188185|25903283|FG003|Stage 1|Lost to Follow-up|0|||
13111328|NCT03188185|25903280|FG000|Stage 1|Withdrawal by Subject|9|||
13111329|NCT03188185|25903281|FG001|Stage 1|Withdrawal by Subject|0|||
13111330|NCT03188185|25903282|FG002|Stage 1|Withdrawal by Subject|0|||
13111331|NCT03188185|25903283|FG003|Stage 1|Withdrawal by Subject|0|||
13111332|NCT03188185|25903280|FG000|Stage 1|Identified as a professional patient|0|||
13111333|NCT03188185|25903281|FG001|Stage 1|Identified as a professional patient|1|||
13111334|NCT03188185|25903282|FG002|Stage 1|Identified as a professional patient|0|||
13111335|NCT03188185|25903283|FG003|Stage 1|Identified as a professional patient|0|||
13111336|NCT03188185|25903280|FG000|Stage 2|Adverse Event|0|||
13111337|NCT03188185|25903281|FG001|Stage 2|Adverse Event|0|||
13111338|NCT03188185|25903282|FG002|Stage 2|Adverse Event|2|||
13111339|NCT03188185|25903283|FG003|Stage 2|Adverse Event|4|||
13111340|NCT03188185|25903280|FG000|Stage 2|Lack of Efficacy|0|||
13111341|NCT03188185|25903281|FG001|Stage 2|Lack of Efficacy|0|||
13111342|NCT03188185|25903282|FG002|Stage 2|Lack of Efficacy|3|||
13111343|NCT03188185|25903283|FG003|Stage 2|Lack of Efficacy|0|||
13111344|NCT03188185|25903280|FG000|Stage 2|Lost to Follow-up|0|||
13190070|NCT02118792|26183161|FG001|Overall Study|Withdrawal by parent/guardian|20|||
13190071|NCT02118792|26183160|FG000|Overall Study|Other|1|||
13190072|NCT02118792|26183161|FG001|Overall Study|Other|6|||
13190073|NCT02118792|26183160|FG000|Overall Study|Randomised but not treated|1|||
13190074|NCT02118792|26183161|FG001|Overall Study|Randomised but not treated|0|||
13190075|NCT02118766|26183190|FG000|Overall Study|Adverse Event|7|||
13190076|NCT02118766|26183191|FG001|Overall Study|Adverse Event|2|||
13190077|NCT02118766|26183190|FG000|Overall Study|Withdrawal by Subject|3|||
13190078|NCT02118766|26183191|FG001|Overall Study|Withdrawal by Subject|6|||
13190079|NCT02118766|26183190|FG000|Overall Study|Lost to Follow-up|5|||
13190080|NCT02118766|26183191|FG001|Overall Study|Lost to Follow-up|4|||
13190081|NCT02118766|26183190|FG000|Overall Study|Withdrawal by parent/guardian|12|||
13190082|NCT02118766|26183191|FG001|Overall Study|Withdrawal by parent/guardian|18|||
13190083|NCT02118766|26183190|FG000|Overall Study|Other|3|||
13190084|NCT02118766|26183191|FG001|Overall Study|Other|1|||
13190085|NCT02118714|26183207|FG000|Overall Study|Lost to Follow-up|2|||
13190086|NCT02118714|26183207|FG000|Overall Study|Protocol Violation|1|||
13190087|NCT02118597|26183223|FG000|Overall Study|Sponsor terminated the study|14|||
13190088|NCT02118597|26183223|FG000|Overall Study|Serious Adverse Event|1|||
13190089|NCT02118597|26183223|FG000|Overall Study|Investigator's decision|1|||
13190090|NCT02118428|26183269|FG000|Overall Study|Physician Decision|0|||
13190091|NCT02118428|26183270|FG001|Overall Study|Physician Decision|1|||
13190092|NCT02118428|26183271|FG002|Overall Study|Physician Decision|0|||
13190093|NCT02118428|26183269|FG000|Overall Study|Withdrawal by Subject|2|||
13190094|NCT02118428|26183270|FG001|Overall Study|Withdrawal by Subject|2|||
13190095|NCT02118428|26183271|FG002|Overall Study|Withdrawal by Subject|0|||
13190096|NCT02118428|26183269|FG000|Overall Study|Death|7|||
13190097|NCT02118428|26183270|FG001|Overall Study|Death|5|||
13190098|NCT02118428|26183271|FG002|Overall Study|Death|0|||
13190099|NCT02118428|26183269|FG000|Overall Study|Lost to Follow-up|3|||
13190100|NCT02118428|26183270|FG001|Overall Study|Lost to Follow-up|1|||
13190101|NCT02118428|26183271|FG002|Overall Study|Lost to Follow-up|0|||
13190102|NCT02118428|26183269|FG000|Overall Study|Screen Failure or Became Inelegible|1|||
13190103|NCT02118428|26183270|FG001|Overall Study|Screen Failure or Became Inelegible|0|||
13190104|NCT02118428|26183271|FG002|Overall Study|Screen Failure or Became Inelegible|1|||
13190105|NCT02118337|26183454|FG000|Overall Study|Other|1|||
13190106|NCT02118337|26183455|FG001|Overall Study|Other|0|||
13190107|NCT02118337|26183456|FG002|Overall Study|Other|0|||
13190108|NCT02118337|26183457|FG003|Overall Study|Other|0|||
13190109|NCT02118337|26183458|FG004|Overall Study|Other|2|||
13190110|NCT02118337|26183459|FG005|Overall Study|Other|3|||
13190111|NCT02118337|26183460|FG006|Overall Study|Other|1|||
13190112|NCT02118337|26183461|FG007|Overall Study|Other|28|||
13190113|NCT02118337|26183462|FG008|Overall Study|Other|15|||
13190114|NCT02118337|26183454|FG000|Overall Study|Lost to Follow-up|0|||
13190115|NCT02118337|26183455|FG001|Overall Study|Lost to Follow-up|0|||
13190116|NCT02118337|26183456|FG002|Overall Study|Lost to Follow-up|0|||
13190117|NCT02118337|26183457|FG003|Overall Study|Lost to Follow-up|0|||
13190118|NCT02118337|26183458|FG004|Overall Study|Lost to Follow-up|0|||
13190119|NCT02118337|26183459|FG005|Overall Study|Lost to Follow-up|0|||
13190120|NCT02118337|26183460|FG006|Overall Study|Lost to Follow-up|0|||
13190121|NCT02118337|26183461|FG007|Overall Study|Lost to Follow-up|1|||
13190122|NCT02118337|26183462|FG008|Overall Study|Lost to Follow-up|0|||
13190123|NCT02118337|26183454|FG000|Overall Study|Withdrawal by Subject|1|||
13190124|NCT02118337|26183455|FG001|Overall Study|Withdrawal by Subject|3|||
13190125|NCT02118337|26183456|FG002|Overall Study|Withdrawal by Subject|2|||
13190126|NCT02118337|26183457|FG003|Overall Study|Withdrawal by Subject|1|||
13190127|NCT02118337|26183458|FG004|Overall Study|Withdrawal by Subject|2|||
13190128|NCT02118337|26183459|FG005|Overall Study|Withdrawal by Subject|2|||
13190129|NCT02118337|26183460|FG006|Overall Study|Withdrawal by Subject|1|||
13190130|NCT02118337|26183461|FG007|Overall Study|Withdrawal by Subject|4|||
13190131|NCT02118337|26183462|FG008|Overall Study|Withdrawal by Subject|2|||
13190132|NCT02118337|26183454|FG000|Overall Study|Death|2|||
13190133|NCT02118337|26183455|FG001|Overall Study|Death|2|||
13190134|NCT02118337|26183456|FG002|Overall Study|Death|1|||
13190135|NCT02118337|26183457|FG003|Overall Study|Death|2|||
13190136|NCT02118337|26183458|FG004|Overall Study|Death|5|||
13190137|NCT02118337|26183459|FG005|Overall Study|Death|1|||
13190138|NCT02118337|26183460|FG006|Overall Study|Death|2|||
13190139|NCT02118337|26183461|FG007|Overall Study|Death|9|||
13190140|NCT02118337|26183462|FG008|Overall Study|Death|4|||
13190141|NCT02118012|26183481|FG000|Overall Study|Adverse Event|0|||
13190142|NCT02118012|26183482|FG001|Overall Study|Adverse Event|1|||
13190143|NCT02118012|26183481|FG000|Overall Study|Physician Decision|0|||
13190144|NCT02118012|26183482|FG001|Overall Study|Physician Decision|1|||
13190145|NCT02117713|26183509|FG000|Week 48|Adverse Event|4|||
13190146|NCT02117713|26183509|FG000|Week 48|Withdrawal by caregiver|2|||
13190147|NCT02117713|26183509|FG000|Week 48|Did not consent to Protocol Amendment 4|2|||
13190148|NCT02117713|26183509|FG000|Long Term Follow-up Treatment|Adverse Event|3|||
13190149|NCT02117713|26183509|FG000|Long Term Follow-up Treatment|Progressive Disease|2|||
13190150|NCT02117713|26183509|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1|||
13190151|NCT02117687|26183548|FG000|Overall Study|Lost to Follow-up|0|||
13190152|NCT02117687|26183549|FG001|Overall Study|Lost to Follow-up|1|||
13190153|NCT02117687|26183548|FG000|Overall Study|Adverse Event|0|||
13190154|NCT02117687|26183549|FG001|Overall Study|Adverse Event|2|||
13190155|NCT02117687|26183548|FG000|Overall Study|Other Reasons|1|||
13190156|NCT02117687|26183549|FG001|Overall Study|Other Reasons|1|||
13190157|NCT02117648|26183561|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1|||
13190158|NCT02117648|26183561|FG000|Abemaciclib Alone Period 1|Adverse Event|1|||
13190159|NCT02117648|26183561|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1|||
13190160|NCT02117648|26183561|FG000|Abemaciclib + Clarithromycin Period 2|Death|1|||
13190161|NCT02117648|26183561|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1|||
13190162|NCT02117648|26183561|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1|||
13190163|NCT02117648|26183561|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12|||
13190164|NCT02117648|26183561|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1|||
13190165|NCT02117648|26183561|FG000|Abemaciclib Safety-Extension Phase|Death|3|||
13190166|NCT02117648|26183561|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2|||
13190167|NCT02117648|26183561|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2|||
13190168|NCT02117570|26183621|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0|||
13190169|NCT02117570|26183622|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2|||
13190170|NCT02117570|26183623|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1|||
13190171|NCT02117570|26183621|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
13190172|NCT02117570|26183622|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
13190173|NCT02117570|26183623|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0|||
13190174|NCT02117570|26183621|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
13190175|NCT02117570|26183622|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
13190176|NCT02117570|26183623|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2|||
13190177|NCT02117570|26183621|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
13190178|NCT02117570|26183622|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
13190179|NCT02117570|26183623|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1|||
13190180|NCT02117570|26183621|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
13190181|NCT02117570|26183622|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
13190182|NCT02117570|26183623|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1|||
13190183|NCT02117570|26183621|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1|||
13190184|NCT02117570|26183622|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
13190185|NCT02117570|26183623|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
13190186|NCT02117570|26183621|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
13190187|NCT02117570|26183622|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1|||
13190188|NCT02117570|26183623|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
13190189|NCT02117544|26183639|FG000|Period 1|Lost to follow-up (prior to treatment)|2|||
13190190|NCT02117544|26183640|FG001|Period 1|Lost to follow-up (prior to treatment)|0|||
13206253|NCT01959139|26234063|FG003|Phase II|Other/Unknown|5|||
13206254|NCT01959139|26234060|FG000|Phase II|On treatment|0|||
13206255|NCT01959139|26234061|FG001|Phase II|On treatment|0|||
13206256|NCT01959139|26234062|FG002|Phase II|On treatment|4|||
13206257|NCT01959139|26234063|FG003|Phase II|On treatment|0|||
13206258|NCT01959035|26234091|FG000|Overall Study|Adverse Event|5|||
13206259|NCT01959035|26234091|FG000|Overall Study|Withdrawal by Subject|4|||
13206260|NCT01959035|26234091|FG000|Overall Study|Lost to Follow-up|1|||
13206261|NCT01959035|26234091|FG000|Overall Study|Other (no primary reason given)|1|||
13206262|NCT01958918|26234112|FG000|Overall Study|Death|1|||
13206263|NCT01958918|26234113|FG001|Overall Study|Death|3|||
13206264|NCT01958918|26234112|FG000|Overall Study|Lost to Follow-up|4|||
13206265|NCT01958918|26234113|FG001|Overall Study|Lost to Follow-up|7|||
13206266|NCT01958918|26234112|FG000|Overall Study|Withdrawal by Subject|13|||
13206267|NCT01958918|26234113|FG001|Overall Study|Withdrawal by Subject|8|||
13206268|NCT01958918|26234112|FG000|Overall Study|Lack of Efficacy|13|||
13206269|NCT01958918|26234113|FG001|Overall Study|Lack of Efficacy|10|||
13206270|NCT01958918|26234112|FG000|Overall Study|Adverse Event|12|||
13206271|NCT01958918|26234113|FG001|Overall Study|Adverse Event|12|||
13206272|NCT01958918|26234112|FG000|Overall Study|administrative problems|0|||
13206273|NCT01958918|26234113|FG001|Overall Study|administrative problems|2|||
13206274|NCT01958827|26234133|FG000|Overall Study|Adverse Event|3|||
13206275|NCT01958827|26234133|FG000|Overall Study|Lack of Efficacy|6|||
13206276|NCT01958827|26234133|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1|||
13206277|NCT01958671|26234184|FG000|Overall Study|Adverse Event|1|||
13206278|NCT01958671|26234185|FG001|Overall Study|Adverse Event|1|||
13206279|NCT01958671|26234186|FG002|Overall Study|Adverse Event|5|||
13206280|NCT01958671|26234184|FG000|Overall Study|Death|1|||
13206281|NCT01958671|26234185|FG001|Overall Study|Death|0|||
13206282|NCT01958671|26234186|FG002|Overall Study|Death|0|||
13206283|NCT01958671|26234184|FG000|Overall Study|Excluded medication|0|||
13190191|NCT02117479|26183663|FG000|Overall Study|Death|13|||
13190192|NCT02117479|26183664|FG001|Overall Study|Death|8|||
13190193|NCT02117479|26183663|FG000|Overall Study|Adverse Event|8|||
13190194|NCT02117479|26183664|FG001|Overall Study|Adverse Event|16|||
13190195|NCT02117479|26183663|FG000|Overall Study|Subject decision|8|||
13190196|NCT02117479|26183664|FG001|Overall Study|Subject decision|9|||
13190197|NCT02117479|26183663|FG000|Overall Study|Disease progression|104|||
13190198|NCT02117479|26183664|FG001|Overall Study|Disease progression|108|||
13190199|NCT02117479|26183663|FG000|Overall Study|Noncompliance with study treatment|1|||
13190200|NCT02117479|26183664|FG001|Overall Study|Noncompliance with study treatment|0|||
13190201|NCT02117479|26183663|FG000|Overall Study|Study terminated by the sponsor|4|||
13190202|NCT02117479|26183664|FG001|Overall Study|Study terminated by the sponsor|6|||
13190203|NCT02117479|26183663|FG000|Overall Study|Physician Decision|7|||
13190204|NCT02117479|26183664|FG001|Overall Study|Physician Decision|2|||
13190205|NCT02117479|26183663|FG000|Overall Study|Other unspecified|11|||
13190206|NCT02117479|26183664|FG001|Overall Study|Other unspecified|7|||
13190207|NCT02117427|26183682|FG000|Overall Study|Permanent need for exogenous EPO Tx|2|||
13190208|NCT02117427|26183683|FG001|Overall Study|Permanent need for exogenous EPO Tx|0|||
13190209|NCT02117427|26183684|FG002|Overall Study|Permanent need for exogenous EPO Tx|0|||
13190210|NCT02117427|26183682|FG000|Overall Study|Permanent need for exogenous ESA Tx|3|||
13190211|NCT02117427|26183683|FG001|Overall Study|Permanent need for exogenous ESA Tx|1|||
13190212|NCT02117427|26183684|FG002|Overall Study|Permanent need for exogenous ESA Tx|0|||
13190213|NCT02117427|26183682|FG000|Overall Study|Physician Decision|0|||
13190214|NCT02117427|26183683|FG001|Overall Study|Physician Decision|2|||
13190215|NCT02117427|26183684|FG002|Overall Study|Physician Decision|0|||
13190216|NCT02117427|26183682|FG000|Overall Study|No longer meets inclusion criteria|0|||
13190217|NCT02117427|26183683|FG001|Overall Study|No longer meets inclusion criteria|1|||
13190218|NCT02117427|26183684|FG002|Overall Study|No longer meets inclusion criteria|0|||
13190219|NCT02117427|26183682|FG000|Overall Study|Death|0|||
13190220|NCT02117427|26183683|FG001|Overall Study|Death|1|||
13190221|NCT02117427|26183684|FG002|Overall Study|Death|0|||
13190222|NCT02117414|26183709|FG000|Overall Study|Death|5|||
13190223|NCT02117414|26183710|FG001|Overall Study|Death|2|||
13190224|NCT02117414|26183709|FG000|Overall Study|Withdrawal by Subject|10|||
13190225|NCT02117414|26183710|FG001|Overall Study|Withdrawal by Subject|4|||
13190226|NCT02117349|26183727|FG000|Overall Study|Withdrawal by Subject|1|||
13190227|NCT02117349|26183728|FG001|Overall Study|Withdrawal by Subject|0|||
13190228|NCT02117349|26183727|FG000|Overall Study|Lost to Follow-up|1|||
13190229|NCT02117349|26183728|FG001|Overall Study|Lost to Follow-up|1|||
13190230|NCT02117349|26183727|FG000|Overall Study|Death|1|||
13190231|NCT02117349|26183728|FG001|Overall Study|Death|0|||
13190232|NCT02117050|26183742|FG000|Overall Study|Subject Enrolled but not Dosed|1|||
13190233|NCT02117024|26183773|FG000|Overall Study|Progressive Disease|26|||
13190234|NCT02117024|26183774|FG001|Overall Study|Progressive Disease|9|||
13190235|NCT02117024|26183773|FG000|Overall Study|Significant Clinical Progression|7|||
13190236|NCT02117024|26183774|FG001|Overall Study|Significant Clinical Progression|4|||
13190237|NCT02117024|26183773|FG000|Overall Study|Death|5|||
13190238|NCT02117024|26183774|FG001|Overall Study|Death|0|||
13190239|NCT02117024|26183773|FG000|Overall Study|Withdrawal by Subject|3|||
13190240|NCT02117024|26183774|FG001|Overall Study|Withdrawal by Subject|1|||
13190241|NCT02117024|26183773|FG000|Overall Study|Protocol Violation|1|||
13190242|NCT02117024|26183774|FG001|Overall Study|Protocol Violation|0|||
13111345|NCT03188185|25903281|FG001|Stage 2|Lost to Follow-up|0|||
13111346|NCT03188185|25903282|FG002|Stage 2|Lost to Follow-up|1|||
13111347|NCT03188185|25903283|FG003|Stage 2|Lost to Follow-up|0|||
13190243|NCT02117024|26183773|FG000|Overall Study|Adverse Event|1|||
13190244|NCT02117024|26183774|FG001|Overall Study|Adverse Event|2|||
13190245|NCT02117024|26183773|FG000|Overall Study|Randomized in Error|1|||
13190246|NCT02117024|26183774|FG001|Overall Study|Randomized in Error|0|||
13190247|NCT02117024|26183773|FG000|Overall Study|Patient returned to primary oncologist|0|||
13190248|NCT02117024|26183774|FG001|Overall Study|Patient returned to primary oncologist|1|||
13190249|NCT02117024|26183773|FG000|Overall Study|Patient took treatment break|0|||
13190250|NCT02117024|26183774|FG001|Overall Study|Patient took treatment break|1|||
13190251|NCT02117024|26183773|FG000|Overall Study|Physician Decision|0|||
13111348|NCT03188185|25903280|FG000|Stage 2|Physician Decision|0|||
13111349|NCT03188185|25903281|FG001|Stage 2|Physician Decision|0|||
13111350|NCT03188185|25903282|FG002|Stage 2|Physician Decision|0|||
13111351|NCT03188185|25903283|FG003|Stage 2|Physician Decision|1|||
13111352|NCT03188185|25903280|FG000|Stage 2|Withdrawal by Subject|0|||
13111353|NCT03188185|25903281|FG001|Stage 2|Withdrawal by Subject|0|||
13111354|NCT03188185|25903282|FG002|Stage 2|Withdrawal by Subject|3|||
13111355|NCT03188185|25903283|FG003|Stage 2|Withdrawal by Subject|1|||
13111356|NCT03188120|25903290|FG000|Overall Study|Adverse Event|4|||
13111357|NCT03188120|25903290|FG000|Overall Study|Insufficient Effectiveness|8|||
13111358|NCT03188120|25903290|FG000|Overall Study|Improved|12|||
13190252|NCT02117024|26183774|FG001|Overall Study|Physician Decision|2|||
13190253|NCT02116972|26183814|FG000|Overall Study|Adverse Event|4|||
13190254|NCT02116972|26183815|FG001|Overall Study|Adverse Event|4|||
13190255|NCT02116972|26183816|FG002|Overall Study|Adverse Event|1|||
13190256|NCT02116972|26183814|FG000|Overall Study|Withdrawal by Subject|1|||
13190257|NCT02116972|26183815|FG001|Overall Study|Withdrawal by Subject|1|||
13190258|NCT02116972|26183816|FG002|Overall Study|Withdrawal by Subject|5|||
13190259|NCT02116972|26183814|FG000|Overall Study|Protocol Violation|1|||
13190260|NCT02116972|26183815|FG001|Overall Study|Protocol Violation|0|||
13190261|NCT02116972|26183816|FG002|Overall Study|Protocol Violation|1|||
13190262|NCT02116972|26183814|FG000|Overall Study|Lost to Follow-up|4|||
13190263|NCT02116972|26183815|FG001|Overall Study|Lost to Follow-up|3|||
13190264|NCT02116972|26183816|FG002|Overall Study|Lost to Follow-up|1|||
13190265|NCT02116972|26183814|FG000|Overall Study|Lack of Efficacy|6|||
13190266|NCT02116972|26183815|FG001|Overall Study|Lack of Efficacy|6|||
13190267|NCT02116972|26183816|FG002|Overall Study|Lack of Efficacy|5|||
13190268|NCT02116972|26183814|FG000|Overall Study|scheduling conflicts and relocation|3|||
13190269|NCT02116972|26183815|FG001|Overall Study|scheduling conflicts and relocation|3|||
13190270|NCT02116972|26183816|FG002|Overall Study|scheduling conflicts and relocation|6|||
13190271|NCT02116803|26183829|FG000|Overall Study|Adverse Event|2|||
13190272|NCT02116803|26183830|FG001|Overall Study|Adverse Event|1|||
13190273|NCT02116803|26183829|FG000|Overall Study|Physician Decision|1|||
13190274|NCT02116803|26183830|FG001|Overall Study|Physician Decision|0|||
13190275|NCT02116803|26183829|FG000|Overall Study|Progressive disease|4|||
13190276|NCT02116803|26183830|FG001|Overall Study|Progressive disease|0|||
13190277|NCT02116803|26183829|FG000|Overall Study|Study terminated by sponsor|2|||
13190278|NCT02116803|26183830|FG001|Overall Study|Study terminated by sponsor|1|||
13190279|NCT02116803|26183829|FG000|Overall Study|Death|1|||
13190280|NCT02116803|26183830|FG001|Overall Study|Death|0|||
13190281|NCT02116777|26183892|FG000|Overall Study|Adverse Event|0|||
13190282|NCT02116777|26183893|FG001|Overall Study|Adverse Event|0|||
13190283|NCT02116777|26183894|FG002|Overall Study|Adverse Event|0|||
13190284|NCT02116777|26183895|FG003|Overall Study|Adverse Event|0|||
13190285|NCT02116777|26183896|FG004|Overall Study|Adverse Event|2|||
13190286|NCT02116777|26183897|FG005|Overall Study|Adverse Event|2|||
13190287|NCT02116777|26183898|FG006|Overall Study|Adverse Event|0|||
13190288|NCT02116777|26183892|FG000|Overall Study|Death|0|||
13190289|NCT02116777|26183893|FG001|Overall Study|Death|0|||
13190290|NCT02116777|26183894|FG002|Overall Study|Death|0|||
13190291|NCT02116777|26183895|FG003|Overall Study|Death|1|||
13190292|NCT02116777|26183896|FG004|Overall Study|Death|0|||
13190293|NCT02116777|26183897|FG005|Overall Study|Death|0|||
13190294|NCT02116777|26183898|FG006|Overall Study|Death|0|||
13190295|NCT02116777|26183892|FG000|Overall Study|Lack of Efficacy|3|||
13190296|NCT02116777|26183893|FG001|Overall Study|Lack of Efficacy|3|||
13190297|NCT02116777|26183894|FG002|Overall Study|Lack of Efficacy|3|||
13190298|NCT02116777|26183895|FG003|Overall Study|Lack of Efficacy|8|||
13190299|NCT02116777|26183896|FG004|Overall Study|Lack of Efficacy|4|||
13190300|NCT02116777|26183897|FG005|Overall Study|Lack of Efficacy|1|||
13190301|NCT02116777|26183898|FG006|Overall Study|Lack of Efficacy|9|||
13190302|NCT02116777|26183892|FG000|Overall Study|Physician Decision|0|||
13190303|NCT02116777|26183893|FG001|Overall Study|Physician Decision|0|||
13190304|NCT02116777|26183894|FG002|Overall Study|Physician Decision|0|||
13190305|NCT02116777|26183895|FG003|Overall Study|Physician Decision|2|||
13190306|NCT02116777|26183896|FG004|Overall Study|Physician Decision|0|||
13190307|NCT02116777|26183897|FG005|Overall Study|Physician Decision|0|||
13190308|NCT02116777|26183898|FG006|Overall Study|Physician Decision|0|||
13190309|NCT02116777|26183892|FG000|Overall Study|Protocol Violation|0|||
13190310|NCT02116777|26183893|FG001|Overall Study|Protocol Violation|0|||
13190311|NCT02116777|26183894|FG002|Overall Study|Protocol Violation|0|||
13190312|NCT02116777|26183895|FG003|Overall Study|Protocol Violation|1|||
13190313|NCT02116777|26183896|FG004|Overall Study|Protocol Violation|0|||
13190314|NCT02116777|26183897|FG005|Overall Study|Protocol Violation|0|||
13190315|NCT02116777|26183898|FG006|Overall Study|Protocol Violation|0|||
13190316|NCT02116777|26183892|FG000|Overall Study|Withdrawal by Subject|0|||
13190317|NCT02116777|26183893|FG001|Overall Study|Withdrawal by Subject|0|||
13190318|NCT02116777|26183894|FG002|Overall Study|Withdrawal by Subject|0|||
13190319|NCT02116777|26183895|FG003|Overall Study|Withdrawal by Subject|1|||
13190320|NCT02116777|26183896|FG004|Overall Study|Withdrawal by Subject|0|||
13190321|NCT02116777|26183897|FG005|Overall Study|Withdrawal by Subject|0|||
13190322|NCT02116777|26183898|FG006|Overall Study|Withdrawal by Subject|0|||
13190323|NCT02116660|26183947|FG000|Overall Study|Deteriorating renal function|0|||
13190324|NCT02116660|26183948|FG001|Overall Study|Deteriorating renal function|1|||
13190325|NCT02116660|26183947|FG000|Overall Study|Adverse Event|1|||
13190326|NCT02116660|26183948|FG001|Overall Study|Adverse Event|1|||
13190327|NCT02116660|26183947|FG000|Overall Study|Withdrawal by Subject|0|||
13190328|NCT02116660|26183948|FG001|Overall Study|Withdrawal by Subject|2|||
13190329|NCT02116660|26183947|FG000|Overall Study|Organization reason|1|||
13190330|NCT02116660|26183948|FG001|Overall Study|Organization reason|0|||
13190331|NCT02116621|26184043|FG000|Baseline|Withdrawal by Subject|0|||
13190332|NCT02116621|26184044|FG001|Baseline|Withdrawal by Subject|4|||
13190333|NCT02116621|26184043|FG000|Three Month Follow-up|Death|1|||
13190334|NCT02116621|26184044|FG001|Three Month Follow-up|Death|1|||
13190335|NCT02116621|26184043|FG000|Three Month Follow-up|Withdrawal by Subject|4|||
13190336|NCT02116621|26184044|FG001|Three Month Follow-up|Withdrawal by Subject|1|||
13190337|NCT02116621|26184043|FG000|Three Month Follow-up|Lost to Follow-up|0|||
13190338|NCT02116621|26184044|FG001|Three Month Follow-up|Lost to Follow-up|1|||
13190339|NCT02116621|26184043|FG000|Three Month Follow-up|Did not complete follow-up survey|14|||
13190340|NCT02116621|26184044|FG001|Three Month Follow-up|Did not complete follow-up survey|4|||
13190341|NCT02116621|26184043|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
13190342|NCT02116621|26184044|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
13190343|NCT02116621|26184043|FG000|Six Month Follow-up|Lost to Follow-up|2|||
13190344|NCT02116621|26184044|FG001|Six Month Follow-up|Lost to Follow-up|1|||
13190345|NCT02116621|26184043|FG000|Six Month Follow-up|Did not complete follow-up survey|1|||
13111359|NCT03188120|25903290|FG000|Overall Study|Lost to Follow-up|7|||
13190346|NCT02116621|26184044|FG001|Six Month Follow-up|Did not complete follow-up survey|1|||
13190347|NCT02116621|26184043|FG000|Twelve Month Follow-up|Withdrawal by Subject|1|||
13190348|NCT02116621|26184044|FG001|Twelve Month Follow-up|Withdrawal by Subject|0|||
13190349|NCT02116621|26184043|FG000|Twelve Month Follow-up|Lost to Follow-up|0|||
13190350|NCT02116621|26184044|FG001|Twelve Month Follow-up|Lost to Follow-up|1|||
13190351|NCT02116621|26184043|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1|||
13190352|NCT02116621|26184044|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3|||
13190353|NCT02116621|26184043|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14|||
13190354|NCT02116621|26184044|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8|||
13190355|NCT02116608|26184068|FG000|Overall Study|Lost to Follow-up|0|||
13190356|NCT02116608|26184069|FG001|Overall Study|Lost to Follow-up|0|||
13190357|NCT02116608|26184070|FG002|Overall Study|Lost to Follow-up|1|||
13190358|NCT02116608|26184068|FG000|Overall Study|Physician Decision|0|||
13190359|NCT02116608|26184069|FG001|Overall Study|Physician Decision|1|||
13190360|NCT02116608|26184070|FG002|Overall Study|Physician Decision|0|||
13190361|NCT02116608|26184068|FG000|Overall Study|Death|0|||
13190362|NCT02116608|26184069|FG001|Overall Study|Death|1|||
13190363|NCT02116608|26184070|FG002|Overall Study|Death|0|||
13190364|NCT02116582|26184080|FG000|Overall Study|Enrolled but Never Received Study Drug|1|||
13190365|NCT02116582|26184080|FG000|Overall Study|Adverse Event|22|||
13190366|NCT02116582|26184080|FG000|Overall Study|Death|9|||
13190367|NCT02116582|26184080|FG000|Overall Study|Progressive Disease|148|||
13190368|NCT02116582|26184080|FG000|Overall Study|Protocol Violation|3|||
13190369|NCT02116582|26184080|FG000|Overall Study|Withdrawal by Subject|8|||
13190370|NCT02116582|26184080|FG000|Overall Study|Other: Miscellaneous|11|||
13190371|NCT02116582|26184080|FG000|Overall Study|Lost to Follow-up|1|||
13190372|NCT02116582|26184080|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12|||
13190373|NCT02116530|26184101|FG000|Overall Study|Withdrawal by Subject|1|||
13190374|NCT02116530|26184102|FG001|Overall Study|Withdrawal by Subject|2|||
13190375|NCT02116530|26184101|FG000|Overall Study|Adverse Event|4|||
13190376|NCT02116530|26184102|FG001|Overall Study|Adverse Event|0|||
13190377|NCT02116530|26184101|FG000|Overall Study|Physician Decision|1|||
13190378|NCT02116530|26184102|FG001|Overall Study|Physician Decision|0|||
13190379|NCT02116530|26184101|FG000|Overall Study|Lost to Follow-up|1|||
13190380|NCT02116530|26184102|FG001|Overall Study|Lost to Follow-up|0|||
13190381|NCT02116530|26184101|FG000|Overall Study|Other Medical Problems|2|||
13111360|NCT03188120|25903290|FG000|Overall Study|Other than specified|3|||
13111361|NCT03188120|25903290|FG000|Overall Study|No visit after the first visit|13|||
13111362|NCT03188055|25903327|FG000|Overall Study|Unavailable for training|0|||
13111363|NCT03188055|25903328|FG001|Overall Study|Unavailable for training|0|||
13111364|NCT03188055|25903329|FG002|Overall Study|Unavailable for training|19|||
13111365|NCT03188055|25903330|FG003|Overall Study|Unavailable for training|0|||
13111366|NCT03188055|25903331|FG004|Overall Study|Unavailable for training|0|||
13111367|NCT03188055|25903332|FG005|Overall Study|Unavailable for training||||
13111368|NCT03188055|25903327|FG000|Overall Study|Lost to Follow-up|0|||
13111369|NCT03188055|25903328|FG001|Overall Study|Lost to Follow-up|18|||
13111370|NCT03188055|25903329|FG002|Overall Study|Lost to Follow-up|0|||
13111371|NCT03188055|25903330|FG003|Overall Study|Lost to Follow-up|11|||
13111372|NCT03188055|25903331|FG004|Overall Study|Lost to Follow-up|0|||
13111373|NCT03188055|25903332|FG005|Overall Study|Lost to Follow-up||||
13111374|NCT03188055|25903327|FG000|Overall Study|Withdrawal by Subject|0|||
13111375|NCT03188055|25903328|FG001|Overall Study|Withdrawal by Subject|1|||
13111376|NCT03188055|25903329|FG002|Overall Study|Withdrawal by Subject|0|||
13111377|NCT03188055|25903330|FG003|Overall Study|Withdrawal by Subject|1|||
13111378|NCT03188055|25903331|FG004|Overall Study|Withdrawal by Subject|0|||
13111379|NCT03188055|25903332|FG005|Overall Study|Withdrawal by Subject||||
13111380|NCT03187756|25903344|FG000|Overall Study|Termination of study|4|||
13111381|NCT03187301|25903401|FG000|Titration Period|Adverse Event|0|||
13111382|NCT03187301|25903402|FG001|Titration Period|Adverse Event|0|||
13111383|NCT03187301|25903403|FG002|Titration Period|Adverse Event|0|||
13111384|NCT03187301|25903404|FG003|Titration Period|Adverse Event|0|||
13111385|NCT03187301|25903405|FG004|Titration Period|Adverse Event|0|||
13111386|NCT03187301|25903406|FG005|Titration Period|Adverse Event|0|||
13111387|NCT03187301|25903407|FG006|Titration Period|Adverse Event|5|||
13190382|NCT02116530|26184102|FG001|Overall Study|Other Medical Problems|2|||
13190383|NCT02116361|26184145|FG000|Overall Study|Pregnancy|0|||
13190384|NCT02116361|26184146|FG001|Overall Study|Pregnancy|0|||
13190385|NCT02116361|26184147|FG002|Overall Study|Pregnancy|0|||
13190386|NCT02116361|26184148|FG003|Overall Study|Pregnancy|1|||
13190387|NCT02116361|26184145|FG000|Overall Study|Protocol Violation|1|||
13190388|NCT02116361|26184146|FG001|Overall Study|Protocol Violation|0|||
13190389|NCT02116361|26184147|FG002|Overall Study|Protocol Violation|0|||
13190390|NCT02116361|26184148|FG003|Overall Study|Protocol Violation|2|||
13190391|NCT02116361|26184145|FG000|Overall Study|Physician Decision|2|||
13190392|NCT02116361|26184146|FG001|Overall Study|Physician Decision|3|||
13190393|NCT02116361|26184147|FG002|Overall Study|Physician Decision|0|||
13190394|NCT02116361|26184148|FG003|Overall Study|Physician Decision|0|||
13190395|NCT02116361|26184145|FG000|Overall Study|Adverse Event|1|||
13190396|NCT02116361|26184146|FG001|Overall Study|Adverse Event|0|||
13190397|NCT02116361|26184147|FG002|Overall Study|Adverse Event|0|||
13190398|NCT02116361|26184148|FG003|Overall Study|Adverse Event|3|||
13190399|NCT02116361|26184145|FG000|Overall Study|Other Reasons|3|||
13190400|NCT02116361|26184146|FG001|Overall Study|Other Reasons|3|||
13190401|NCT02116361|26184147|FG002|Overall Study|Other Reasons|3|||
13190402|NCT02116361|26184148|FG003|Overall Study|Other Reasons|3|||
13190403|NCT02116361|26184145|FG000|Overall Study|Lack of Efficacy|5|||
13190404|NCT02116361|26184146|FG001|Overall Study|Lack of Efficacy|7|||
13190405|NCT02116361|26184147|FG002|Overall Study|Lack of Efficacy|4|||
13190406|NCT02116361|26184148|FG003|Overall Study|Lack of Efficacy|3|||
13190407|NCT02116361|26184145|FG000|Overall Study|Lost to Follow-up|4|||
13190408|NCT02116361|26184146|FG001|Overall Study|Lost to Follow-up|5|||
13190409|NCT02116361|26184147|FG002|Overall Study|Lost to Follow-up|7|||
13190410|NCT02116361|26184148|FG003|Overall Study|Lost to Follow-up|5|||
13190411|NCT02116361|26184145|FG000|Overall Study|Personal Reasons|6|||
13190412|NCT02116361|26184146|FG001|Overall Study|Personal Reasons|6|||
13190413|NCT02116361|26184147|FG002|Overall Study|Personal Reasons|4|||
13190414|NCT02116361|26184148|FG003|Overall Study|Personal Reasons|9|||
13190415|NCT02116361|26184145|FG000|Overall Study|Investigator Decision - Relapse|9|||
13190416|NCT02116361|26184146|FG001|Overall Study|Investigator Decision - Relapse|7|||
13190417|NCT02116361|26184147|FG002|Overall Study|Investigator Decision - Relapse|8|||
13190418|NCT02116361|26184148|FG003|Overall Study|Investigator Decision - Relapse|5|||
13190419|NCT02116309|26184163|FG000|Overall Study|Lost to Follow-up|0|||
13190420|NCT02116309|26184164|FG001|Overall Study|Lost to Follow-up|1|||
13190421|NCT02116205|26184195|FG000|Overall Study|Withdrawal by Subject|2|||
13190422|NCT02116205|26184196|FG001|Overall Study|Withdrawal by Subject|4|||
13190423|NCT02116205|26184197|FG002|Overall Study|Withdrawal by Subject|1|||
13190424|NCT02116205|26184198|FG003|Overall Study|Withdrawal by Subject|3|||
13190425|NCT02116205|26184195|FG000|Overall Study|Lost to Follow-up|0|||
13190426|NCT02116205|26184196|FG001|Overall Study|Lost to Follow-up|2|||
13190427|NCT02116205|26184197|FG002|Overall Study|Lost to Follow-up|1|||
13190428|NCT02116205|26184198|FG003|Overall Study|Lost to Follow-up|2|||
13190429|NCT02116205|26184195|FG000|Overall Study|Physician Decision|0|||
13190430|NCT02116205|26184196|FG001|Overall Study|Physician Decision|1|||
13190431|NCT02116205|26184197|FG002|Overall Study|Physician Decision|1|||
13190432|NCT02116205|26184198|FG003|Overall Study|Physician Decision|1|||
13190433|NCT02116205|26184195|FG000|Overall Study|Exclusion criteria|0|||
13190434|NCT02116205|26184196|FG001|Overall Study|Exclusion criteria|0|||
13190435|NCT02116205|26184197|FG002|Overall Study|Exclusion criteria|1|||
13190436|NCT02116205|26184198|FG003|Overall Study|Exclusion criteria|0|||
13190437|NCT02115815|26184313|FG000|Overall Study|Withdrawal by Subject|2|||
13190438|NCT02115815|26184314|FG001|Overall Study|Withdrawal by Subject|0|||
13190439|NCT02115815|26184315|FG002|Overall Study|Withdrawal by Subject|0|||
13190440|NCT02115815|26184316|FG003|Overall Study|Withdrawal by Subject|0|||
13190441|NCT02115815|26184317|FG004|Overall Study|Withdrawal by Subject|0|||
13190442|NCT02115815|26184318|FG005|Overall Study|Withdrawal by Subject|0|||
13190443|NCT02115815|26184319|FG006|Overall Study|Withdrawal by Subject|0|||
13190444|NCT02115815|26184313|FG000|Overall Study|Not enough drug to dose participant|0|||
13190445|NCT02115815|26184314|FG001|Overall Study|Not enough drug to dose participant|0|||
13190446|NCT02115815|26184315|FG002|Overall Study|Not enough drug to dose participant|0|||
13190447|NCT02115815|26184316|FG003|Overall Study|Not enough drug to dose participant|0|||
13190448|NCT02115815|26184317|FG004|Overall Study|Not enough drug to dose participant|0|||
13190449|NCT02115815|26184318|FG005|Overall Study|Not enough drug to dose participant|1|||
13190450|NCT02115815|26184319|FG006|Overall Study|Not enough drug to dose participant|0|||
13190451|NCT02115815|26184313|FG000|Overall Study|Missed appointment, randomized in error|0|||
13190452|NCT02115815|26184314|FG001|Overall Study|Missed appointment, randomized in error|0|||
13190453|NCT02115815|26184315|FG002|Overall Study|Missed appointment, randomized in error|0|||
13190454|NCT02115815|26184316|FG003|Overall Study|Missed appointment, randomized in error|0|||
13190455|NCT02115815|26184317|FG004|Overall Study|Missed appointment, randomized in error|0|||
13190456|NCT02115815|26184318|FG005|Overall Study|Missed appointment, randomized in error|1|||
13190457|NCT02115815|26184319|FG006|Overall Study|Missed appointment, randomized in error|0|||
13190458|NCT02115607|26184328|FG000|Overall Study|Withdrawal by Subject|1|||
13190459|NCT02115386|26184340|FG000|Overall Study|Protocol Violation|1|||
13190460|NCT02115386|26184340|FG000|Overall Study|Administrative - trial was terminated|6|||
13190461|NCT02115321|26184367|FG000|Overall Study|Death|1|||
13190462|NCT02115321|26184368|FG001|Overall Study|Death|0|||
13190463|NCT02115308|26184391|FG000|Overall Study|Safety Screening|2|||
13190464|NCT02115308|26184392|FG001|Overall Study|Safety Screening|2|||
13190465|NCT02115282|26184423|FG000|Overall Study|Disease progression during treatment|216|||
13190466|NCT02115282|26184424|FG001|Overall Study|Disease progression during treatment|229|||
13190467|NCT02115282|26184423|FG000|Overall Study|Adverse Event|49|||
13190468|NCT02115282|26184424|FG001|Overall Study|Adverse Event|23|||
13190469|NCT02115282|26184423|FG000|Overall Study|Death|1|||
13190470|NCT02115282|26184424|FG001|Overall Study|Death|3|||
13190471|NCT02115282|26184423|FG000|Overall Study|Alternative therapy|1|||
13190472|NCT02115282|26184424|FG001|Overall Study|Alternative therapy|1|||
13190473|NCT02115282|26184423|FG000|Overall Study|Complicating disease|0|||
13190474|NCT02115282|26184424|FG001|Overall Study|Complicating disease|3|||
13190475|NCT02115282|26184423|FG000|Overall Study|Withdrawal by Subject|12|||
13190476|NCT02115282|26184424|FG001|Overall Study|Withdrawal by Subject|10|||
13190477|NCT02115282|26184423|FG000|Overall Study|Symptomatic progression/deterioration|7|||
13190478|NCT02115282|26184424|FG001|Overall Study|Symptomatic progression/deterioration|18|||
13190479|NCT02115282|26184423|FG000|Overall Study|Non-compliance|5|||
13190480|NCT02115282|26184424|FG001|Overall Study|Non-compliance|1|||
13190481|NCT02115282|26184423|FG000|Overall Study|Protocol Violation|2|||
13190482|NCT02115282|26184424|FG001|Overall Study|Protocol Violation|2|||
13190483|NCT02115282|26184423|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
13190484|NCT02115282|26184424|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
13190485|NCT02115282|26184423|FG000|Overall Study|Not start protocol therapy|9|||
13190486|NCT02115282|26184424|FG001|Overall Study|Not start protocol therapy|10|||
13190487|NCT02115269|26184444|FG000|Overall Study|Lost to Follow-up|43|||
13190488|NCT02115269|26184444|FG000|Overall Study|Did not complete patient diary|3|||
13190489|NCT02115269|26184444|FG000|Overall Study|Moved to another city|7|||
13190490|NCT02115269|26184444|FG000|Overall Study|Withdrawal by Subject|2|||
13190491|NCT02115269|26184444|FG000|Overall Study|Didn't take study drug|2|||
13190492|NCT02115256|26184463|FG000|Overall Study|Withdrawal by Subject|0|||
13190493|NCT02115256|26184464|FG001|Overall Study|Withdrawal by Subject|1|||
13190494|NCT02115113|26184481|FG000|Participants in Run-in Period|Death|0|||
13190495|NCT02115113|26184482|FG001|Participants in Run-in Period|Death|0|||
13190496|NCT02115113|26184483|FG002|Participants in Run-in Period|Death|1|||
13190497|NCT02115113|26184481|FG000|Participants in Run-in Period|Administrative problems|0|||
13190498|NCT02115113|26184482|FG001|Participants in Run-in Period|Administrative problems|0|||
13190499|NCT02115113|26184483|FG002|Participants in Run-in Period|Administrative problems|1|||
13190500|NCT02115113|26184481|FG000|Participants in Run-in Period|Lost to Follow-up|0|||
13190501|NCT02115113|26184482|FG001|Participants in Run-in Period|Lost to Follow-up|0|||
13190502|NCT02115113|26184483|FG002|Participants in Run-in Period|Lost to Follow-up|5|||
13190503|NCT02115113|26184481|FG000|Participants in Run-in Period|Withdrawal by Subject|0|||
13190504|NCT02115113|26184482|FG001|Participants in Run-in Period|Withdrawal by Subject|0|||
13190505|NCT02115113|26184483|FG002|Participants in Run-in Period|Withdrawal by Subject|3|||
13190506|NCT02115113|26184481|FG000|Participants Randomized|Lost to Follow-up|1|||
13190507|NCT02115113|26184482|FG001|Participants Randomized|Lost to Follow-up|0|||
13190508|NCT02115113|26184483|FG002|Participants Randomized|Lost to Follow-up|0|||
13190509|NCT02115113|26184481|FG000|Participants Randomized|Death|1|||
13190510|NCT02115113|26184482|FG001|Participants Randomized|Death|0|||
13190511|NCT02115113|26184483|FG002|Participants Randomized|Death|0|||
13190512|NCT02114931|26184504|FG000|Overall Study|Withdrawal by Subject|15|||
13190513|NCT02114931|26184505|FG001|Overall Study|Withdrawal by Subject|18|||
13190514|NCT02114931|26184504|FG000|Overall Study|Adverse Event|4|||
13190515|NCT02114931|26184505|FG001|Overall Study|Adverse Event|6|||
13190516|NCT02114931|26184504|FG000|Overall Study|Lost to Follow-up|3|||
13190517|NCT02114931|26184505|FG001|Overall Study|Lost to Follow-up|3|||
13190518|NCT02114931|26184504|FG000|Overall Study|Physician Decision|1|||
13190519|NCT02114931|26184505|FG001|Overall Study|Physician Decision|2|||
13190520|NCT02114931|26184504|FG000|Overall Study|Other|2|||
13190521|NCT02114931|26184505|FG001|Overall Study|Other|1|||
13190522|NCT02114892|26184546|FG000|Overall Study|Lost to Follow-up|1|||
13190523|NCT02114892|26184547|FG001|Overall Study|Lost to Follow-up|2|||
13190524|NCT02114879|26184570|FG000|Overall Study|Withdrawal by Subject|9|||
13190525|NCT02114879|26184571|FG001|Overall Study|Withdrawal by Subject|5|||
13190526|NCT02114879|26184570|FG000|Overall Study|Death|6|||
13190527|NCT02114879|26184571|FG001|Overall Study|Death|11|||
13190528|NCT02114879|26184570|FG000|Overall Study|Lost to Follow-up|4|||
13190529|NCT02114879|26184571|FG001|Overall Study|Lost to Follow-up|6|||
13190530|NCT02114879|26184570|FG000|Overall Study|Physician Decision|0|||
13190531|NCT02114879|26184571|FG001|Overall Study|Physician Decision|2|||
13190532|NCT02114684|26184594|FG000|Overall Study|Death|6|||
13190533|NCT02114684|26184595|FG001|Overall Study|Death|4|||
13190534|NCT02114684|26184594|FG000|Overall Study|Lost to Follow-up|1|||
13190535|NCT02114684|26184595|FG001|Overall Study|Lost to Follow-up|2|||
13190536|NCT02114684|26184594|FG000|Overall Study|Withdrawal by Subject|1|||
13190537|NCT02114684|26184595|FG001|Overall Study|Withdrawal by Subject|2|||
13190538|NCT02114684|26184594|FG000|Overall Study|Relocation|3|||
13190539|NCT02114684|26184595|FG001|Overall Study|Relocation|1|||
13190540|NCT02114684|26184594|FG000|Overall Study|Rifampicin resistant on culture|0|||
13190541|NCT02114684|26184595|FG001|Overall Study|Rifampicin resistant on culture|1|||
13190542|NCT02114684|26184594|FG000|Overall Study|Patient Incarcerated|1|||
13190543|NCT02114684|26184595|FG001|Overall Study|Patient Incarcerated|0|||
13190544|NCT02114606|26184605|FG000|Overall Study|Unable to swallow Cytosponge|6|||
13190545|NCT02114515|26184656|FG000|Overall Study|Lost to Follow-up|52|||
13190546|NCT02114515|26184657|FG001|Overall Study|Lost to Follow-up|55|||
13190547|NCT02114515|26184656|FG000|Overall Study|Death|12|||
13190548|NCT02114515|26184657|FG001|Overall Study|Death|12|||
13190549|NCT02114515|26184656|FG000|Overall Study|Withdrawal by Subject|4|||
13190550|NCT02114515|26184657|FG001|Overall Study|Withdrawal by Subject|22|||
13190551|NCT02114515|26184656|FG000|Overall Study|Other|65|||
13190552|NCT02114515|26184657|FG001|Overall Study|Other|61|||
13190553|NCT02114385|26184686|FG000|Overall Study|Withdrawal by Subject|3|||
13190554|NCT02114385|26184687|FG001|Overall Study|Withdrawal by Subject|2|||
13190555|NCT02114385|26184686|FG000|Overall Study|Lost to Follow-up|0|||
13190556|NCT02114385|26184687|FG001|Overall Study|Lost to Follow-up|6|||
13190557|NCT02114268|26184756|FG000|Overall Study|Lost to Follow-up|4|||
13190558|NCT02114268|26184757|FG001|Overall Study|Lost to Follow-up|1|||
13190559|NCT02114268|26184758|FG002|Overall Study|Lost to Follow-up|1|||
13190560|NCT02114268|26184759|FG003|Overall Study|Lost to Follow-up|0|||
13190561|NCT02114268|26184760|FG004|Overall Study|Lost to Follow-up|0|||
13190562|NCT02114268|26184761|FG005|Overall Study|Lost to Follow-up|2|||
13190563|NCT02114268|26184756|FG000|Overall Study|Withdrawal by Subject|1|||
13190564|NCT02114268|26184757|FG001|Overall Study|Withdrawal by Subject|0|||
13190565|NCT02114268|26184758|FG002|Overall Study|Withdrawal by Subject|0|||
13190566|NCT02114268|26184759|FG003|Overall Study|Withdrawal by Subject|0|||
13190567|NCT02114268|26184760|FG004|Overall Study|Withdrawal by Subject|0|||
13190568|NCT02114268|26184761|FG005|Overall Study|Withdrawal by Subject|1|||
13190569|NCT02114268|26184756|FG000|Overall Study|Withdrawn by site due to noncompliance|1|||
13190570|NCT02114268|26184757|FG001|Overall Study|Withdrawn by site due to noncompliance|0|||
13190571|NCT02114268|26184758|FG002|Overall Study|Withdrawn by site due to noncompliance|0|||
13190572|NCT02114268|26184759|FG003|Overall Study|Withdrawn by site due to noncompliance|0|||
13190573|NCT02114268|26184760|FG004|Overall Study|Withdrawn by site due to noncompliance|0|||
13190574|NCT02114268|26184761|FG005|Overall Study|Withdrawn by site due to noncompliance|0|||
13190575|NCT02114203|26184803|FG000|Overall Study|Adverse Event|0|||
13190576|NCT02114203|26184804|FG001|Overall Study|Adverse Event|1|||
13190577|NCT02114203|26184805|FG002|Overall Study|Adverse Event|0|||
13190578|NCT02114203|26184803|FG000|Overall Study|Withdrawal by Subject|0|||
13190579|NCT02114203|26184804|FG001|Overall Study|Withdrawal by Subject|1|||
13190580|NCT02114203|26184805|FG002|Overall Study|Withdrawal by Subject|0|||
13190581|NCT02114177|26184836|FG000|Overall Study|Lost to Follow-up|1|||
13190582|NCT02114177|26184837|FG001|Overall Study|Lost to Follow-up|2|||
13190583|NCT02114177|26184836|FG000|Overall Study|Withdrawal by Subject|6|||
13190584|NCT02114177|26184837|FG001|Overall Study|Withdrawal by Subject|1|||
13190585|NCT02114177|26184836|FG000|Overall Study|Other|2|||
13190586|NCT02114177|26184837|FG001|Overall Study|Other|1|||
13190587|NCT02114151|26184854|FG000|Overall Study|Death|1|||
13190588|NCT02114151|26184854|FG000|Overall Study|Lost to Follow-up|1|||
13190589|NCT02114151|26184854|FG000|Overall Study|Withdrawal by Subject|5|||
13190590|NCT02113956|26184893|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5|||
13190591|NCT02113956|26184894|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1|||
13190592|NCT02113956|26184893|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4|||
13190593|NCT02113956|26184894|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3|||
13190594|NCT02113956|26184893|FG000|3 Month Post-intervention|Lost to Follow-up|4|||
13190595|NCT02113956|26184894|FG001|3 Month Post-intervention|Lost to Follow-up|2|||
13190596|NCT02113579|26184925|FG000|Overall Study|Adverse Event|1|||
13190597|NCT02113579|26184926|FG001|Overall Study|Adverse Event|0|||
13190598|NCT02113579|26184925|FG000|Overall Study|Withdrawal by Subject|3|||
13190599|NCT02113579|26184926|FG001|Overall Study|Withdrawal by Subject|2|||
13190600|NCT02113579|26184925|FG000|Overall Study|Lost to Follow-up|6|||
13190601|NCT02113579|26184926|FG001|Overall Study|Lost to Follow-up|2|||
13190602|NCT02113449|26184942|FG000|Overall Study|Adverse Event|4|||
13190603|NCT02113436|26184972|FG000|Period 1: 8 Weeks|Adverse Event|1|||
13190604|NCT02113436|26184973|FG001|Period 1: 8 Weeks|Adverse Event|0|||
13190605|NCT02113436|26184974|FG002|Period 1: 8 Weeks|Adverse Event|0|||
13190606|NCT02113436|26184975|FG003|Period 1: 8 Weeks|Adverse Event|0|||
13190607|NCT02113436|26184972|FG000|Period 1: 8 Weeks|Protocol Violation|1|||
13190608|NCT02113436|26184973|FG001|Period 1: 8 Weeks|Protocol Violation|0|||
13190609|NCT02113436|26184974|FG002|Period 1: 8 Weeks|Protocol Violation|0|||
13190610|NCT02113436|26184975|FG003|Period 1: 8 Weeks|Protocol Violation|0|||
13190611|NCT02113436|26184972|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5|||
13190612|NCT02113436|26184973|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2|||
13190613|NCT02113436|26184974|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
13190614|NCT02113436|26184975|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
13190615|NCT02113436|26184972|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1|||
13190616|NCT02113436|26184973|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0|||
13190617|NCT02113436|26184974|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0|||
13190618|NCT02113436|26184975|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0|||
13190619|NCT02113436|26184972|FG000|Period 2: 16 Weeks|Adverse Event|0|||
13190620|NCT02113436|26184973|FG001|Period 2: 16 Weeks|Adverse Event|0|||
13190621|NCT02113436|26184974|FG002|Period 2: 16 Weeks|Adverse Event|4|||
13190622|NCT02113436|26184975|FG003|Period 2: 16 Weeks|Adverse Event|5|||
13190623|NCT02113436|26184972|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
13190624|NCT02113436|26184973|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
13190625|NCT02113436|26184974|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2|||
13190626|NCT02113436|26184975|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5|||
13190627|NCT02113436|26184972|FG000|Period 2: 16 Weeks|Physician Decision|0|||
13190628|NCT02113436|26184973|FG001|Period 2: 16 Weeks|Physician Decision|0|||
13190629|NCT02113436|26184974|FG002|Period 2: 16 Weeks|Physician Decision|2|||
13190630|NCT02113436|26184975|FG003|Period 2: 16 Weeks|Physician Decision|0|||
13190631|NCT02113436|26184972|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0|||
13190632|NCT02113436|26184973|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0|||
13190633|NCT02113436|26184974|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1|||
13190634|NCT02113436|26184975|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1|||
13190635|NCT02113189|26184999|FG000|Overall Study|Lost to follow up|2|||
13190636|NCT02113189|26185000|FG001|Overall Study|Lost to follow up|1|||
13190637|NCT02113189|26185001|FG002|Overall Study|Lost to follow up|3|||
13190638|NCT02113124|26185014|FG000|Overall Study|Unable to retrieve blood sample|1|||
13190639|NCT02113124|26185015|FG001|Overall Study|Unable to retrieve blood sample|1|||
13190640|NCT02113007|26185023|FG000|Overall Study|Progressive disease|2|||
13190641|NCT02112994|26185043|FG000|Overall Study|Progressive Disease|0|||
13190642|NCT02112994|26185044|FG001|Overall Study|Progressive Disease|0|||
13190643|NCT02112994|26185045|FG002|Overall Study|Progressive Disease|1|||
13190644|NCT02112994|26185043|FG000|Overall Study|Pregnancy|0|||
13190645|NCT02112994|26185044|FG001|Overall Study|Pregnancy|1|||
13190646|NCT02112994|26185045|FG002|Overall Study|Pregnancy|1|||
13190647|NCT02112994|26185043|FG000|Overall Study|Liver Transplant|0|||
13190648|NCT02112994|26185044|FG001|Overall Study|Liver Transplant|1|||
13190649|NCT02112994|26185045|FG002|Overall Study|Liver Transplant|0|||
13190650|NCT02112994|26185043|FG000|Overall Study|Withdrawal by Subject|0|||
13190651|NCT02112994|26185044|FG001|Overall Study|Withdrawal by Subject|0|||
13190652|NCT02112994|26185045|FG002|Overall Study|Withdrawal by Subject|1|||
13190653|NCT02112877|26185076|FG000|Overall Study|Withdrawal by Subject|1|||
13190654|NCT02112877|26185077|FG001|Overall Study|Withdrawal by Subject|7|||
13190655|NCT02112877|26185076|FG000|Overall Study|Visit Missed|1|||
13190656|NCT02112877|26185077|FG001|Overall Study|Visit Missed|6|||
13190657|NCT02112448|26185092|FG000|Overall Study|lab values precluding use of ketorolac|2|||
13190658|NCT02112448|26185093|FG001|Overall Study|lab values precluding use of ketorolac|2|||
13111388|NCT03187301|25903401|FG000|Titration Period|Withdrawal by Subject|0|||
13111389|NCT03187301|25903402|FG001|Titration Period|Withdrawal by Subject|0|||
13111390|NCT03187301|25903403|FG002|Titration Period|Withdrawal by Subject|0|||
13111391|NCT03187301|25903404|FG003|Titration Period|Withdrawal by Subject|0|||
13111392|NCT03187301|25903405|FG004|Titration Period|Withdrawal by Subject|0|||
13111393|NCT03187301|25903406|FG005|Titration Period|Withdrawal by Subject|0|||
13111394|NCT03187301|25903407|FG006|Titration Period|Withdrawal by Subject|1|||
13111395|NCT03187301|25903401|FG000|Titration Period|Exclusion Criteria Met|0|||
13111396|NCT03187301|25903402|FG001|Titration Period|Exclusion Criteria Met|0|||
13111397|NCT03187301|25903403|FG002|Titration Period|Exclusion Criteria Met|0|||
13111398|NCT03187301|25903404|FG003|Titration Period|Exclusion Criteria Met|0|||
13111399|NCT03187301|25903405|FG004|Titration Period|Exclusion Criteria Met|0|||
13111400|NCT03187301|25903406|FG005|Titration Period|Exclusion Criteria Met|0|||
13111401|NCT03187301|25903407|FG006|Titration Period|Exclusion Criteria Met|1|||
13111402|NCT03187301|25903401|FG000|Pre-Intervention|Withdrawal by Subject|1|||
13111403|NCT03187301|25903402|FG001|Pre-Intervention|Withdrawal by Subject|0|||
13111404|NCT03187301|25903403|FG002|Pre-Intervention|Withdrawal by Subject|0|||
13111405|NCT03187301|25903404|FG003|Pre-Intervention|Withdrawal by Subject|0|||
13111406|NCT03187301|25903405|FG004|Pre-Intervention|Withdrawal by Subject|0|||
13111407|NCT03187301|25903406|FG005|Pre-Intervention|Withdrawal by Subject|0|||
13111408|NCT03187301|25903407|FG006|Pre-Intervention|Withdrawal by Subject|0|||
13111409|NCT03187197|25903428|FG000|Overall Study|Stopped Pradaxa®/VKA|11|||
13111410|NCT03187197|25903429|FG001|Overall Study|Stopped Pradaxa®/VKA|65|||
13111411|NCT03187197|25903430|FG002|Overall Study|Stopped Pradaxa®/VKA|4|||
13111412|NCT03187197|25903428|FG000|Overall Study|Withdrawal by Subject|8|||
13111413|NCT03187197|25903429|FG001|Overall Study|Withdrawal by Subject|63|||
13111414|NCT03187197|25903430|FG002|Overall Study|Withdrawal by Subject|4|||
13111415|NCT03187197|25903428|FG000|Overall Study|Lost to Follow-up|1|||
13111416|NCT03187197|25903429|FG001|Overall Study|Lost to Follow-up|60|||
13190659|NCT02112448|26185092|FG000|Overall Study|Protocol Violation|1|||
13190660|NCT02112448|26185093|FG001|Overall Study|Protocol Violation|2|||
13190661|NCT02112448|26185092|FG000|Overall Study|Physician Decision|4|||
13190662|NCT02112448|26185093|FG001|Overall Study|Physician Decision|6|||
13190663|NCT02112448|26185092|FG000|Overall Study|required heparin so could not use ketoro|1|||
13190664|NCT02112448|26185093|FG001|Overall Study|required heparin so could not use ketoro|0|||
13190665|NCT02112045|26185118|FG000|Overall Study|Withdrawal by Subject|1|||
13190666|NCT02112045|26185119|FG001|Overall Study|Withdrawal by Subject|0|||
13111417|NCT03187197|25903430|FG002|Overall Study|Lost to Follow-up|7|||
13190667|NCT02111993|26185136|FG000|Overall Study|Physician Decision|5|||
13190668|NCT02111993|26185137|FG001|Overall Study|Physician Decision|4|||
13190669|NCT02111850|26185230|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
13190670|NCT02111850|26185231|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
13190671|NCT02111850|26185232|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
13190672|NCT02111850|26185233|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
13190673|NCT02111850|26185234|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1|||
13190674|NCT02111850|26185235|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
13190675|NCT02111850|26185236|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
13190676|NCT02111850|26185237|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
13190677|NCT02111850|26185238|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
13190678|NCT02111850|26185239|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
13190679|NCT02111850|26185240|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
13190680|NCT02111811|26185256|FG000|Treatment Phase|Lost to Follow-up|22|||
13190681|NCT02111811|26185257|FG001|Treatment Phase|Lost to Follow-up|18|||
13190682|NCT02111811|26185256|FG000|Treatment Phase|Death|2|||
13190683|NCT02111811|26185257|FG001|Treatment Phase|Death|0|||
13190684|NCT02111811|26185256|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26|||
13190685|NCT02111811|26185257|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17|||
13190686|NCT02111811|26185256|FG000|Follow up Period (Aim 2)|Death|2|||
13190687|NCT02111811|26185257|FG001|Follow up Period (Aim 2)|Death|0|||
13190688|NCT02111785|26185296|FG000|Overall Study|Death|0|||
13190689|NCT02111785|26185297|FG001|Overall Study|Death|1|||
13190690|NCT02111785|26185298|FG002|Overall Study|Death|0|||
13190691|NCT02111785|26185299|FG003|Overall Study|Death|0|||
13190692|NCT02111603|26185310|FG000|Overall Study|Withdrawal by Subject|1|||
13190693|NCT02111577|26185351|FG000|Overall Study|Protocol Violation|2|||
13190694|NCT02111577|26185352|FG001|Overall Study|Protocol Violation|0|||
13190695|NCT02111577|26185351|FG000|Overall Study|Unable to tolerate leukapheresis|1|||
13190696|NCT02111577|26185352|FG001|Overall Study|Unable to tolerate leukapheresis|0|||
13190697|NCT02111577|26185351|FG000|Overall Study|Failure to produce study treatment|6|||
13190698|NCT02111577|26185352|FG001|Overall Study|Failure to produce study treatment|0|||
13190699|NCT02111577|26185351|FG000|Overall Study|Death|518|||
13190700|NCT02111577|26185352|FG001|Overall Study|Death|254|||
13190701|NCT02111577|26185351|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1|||
13190702|NCT02111577|26185352|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0|||
13190703|NCT02111577|26185351|FG000|Overall Study|Adverse Event|1|||
13190704|NCT02111577|26185352|FG001|Overall Study|Adverse Event|1|||
13190705|NCT02111577|26185351|FG000|Overall Study|Withdrawal by Subject|51|||
13190706|NCT02111577|26185352|FG001|Overall Study|Withdrawal by Subject|23|||
13190707|NCT02111577|26185351|FG000|Overall Study|Disease progression|0|||
13190708|NCT02111577|26185352|FG001|Overall Study|Disease progression|1|||
13190709|NCT02111577|26185351|FG000|Overall Study|Lost to Follow-up|19|||
13190710|NCT02111577|26185352|FG001|Overall Study|Lost to Follow-up|10|||
13190711|NCT02111564|26185377|FG000|Overall Study|Death|109|||
13190712|NCT02111564|26185378|FG001|Overall Study|Death|120|||
13190713|NCT02111564|26185377|FG000|Overall Study|Lost to Follow-up|2|||
13190714|NCT02111564|26185378|FG001|Overall Study|Lost to Follow-up|3|||
13190715|NCT02111564|26185377|FG000|Overall Study|Withdrawal by Subject|20|||
13190716|NCT02111564|26185378|FG001|Overall Study|Withdrawal by Subject|20|||
13190717|NCT02111369|26185388|FG000|Overall Study|Lost to Follow-up|2|||
13111418|NCT03187197|25903428|FG000|Overall Study|Adverse Event|6|||
13111419|NCT03187197|25903429|FG001|Overall Study|Adverse Event|29|||
13111420|NCT03187197|25903430|FG002|Overall Study|Adverse Event|0|||
13111421|NCT03187197|25903428|FG000|Overall Study|Death|0|||
13111422|NCT03187197|25903429|FG001|Overall Study|Death|11|||
13111423|NCT03187197|25903430|FG002|Overall Study|Death|0|||
13111424|NCT03187197|25903428|FG000|Overall Study|Administrative problem|1|||
13111425|NCT03187197|25903429|FG001|Overall Study|Administrative problem|1|||
13111426|NCT03187197|25903430|FG002|Overall Study|Administrative problem|0|||
13111427|NCT03187197|25903428|FG000|Overall Study|Reason not listed|2|||
13111428|NCT03187197|25903429|FG001|Overall Study|Reason not listed|54|||
13190718|NCT02111369|26185388|FG000|Overall Study|Withdrawal by Subject|1|||
13190719|NCT02111213|26185405|FG000|Overall Study|Withdrawal by Subject|3|||
13190720|NCT02111213|26185406|FG001|Overall Study|Withdrawal by Subject|2|||
13190721|NCT02111213|26185405|FG000|Overall Study|Lost to Follow-up|3|||
13190722|NCT02111213|26185406|FG001|Overall Study|Lost to Follow-up|4|||
13190723|NCT02111174|26185439|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1|||
13190724|NCT02111174|26185440|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0|||
13190725|NCT02111174|26185439|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2|||
13190726|NCT02111174|26185440|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2|||
13190727|NCT02111174|26185439|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8|||
13190728|NCT02111174|26185440|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6|||
13190729|NCT02111174|26185439|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0|||
13190730|NCT02111174|26185440|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1|||
13190731|NCT02111096|26185496|FG000|Overall Study|Adverse Event|4|||
13190732|NCT02111096|26185497|FG001|Overall Study|Adverse Event|1|||
13190733|NCT02111096|26185498|FG002|Overall Study|Adverse Event|2|||
13190734|NCT02111096|26185496|FG000|Overall Study|Non-Compliance with Study Drug|1|||
13190735|NCT02111096|26185497|FG001|Overall Study|Non-Compliance with Study Drug|1|||
13190736|NCT02111096|26185498|FG002|Overall Study|Non-Compliance with Study Drug|0|||
13190737|NCT02111096|26185496|FG000|Overall Study|Lost to Follow Up|1|||
13190738|NCT02111096|26185497|FG001|Overall Study|Lost to Follow Up|1|||
13190739|NCT02111096|26185498|FG002|Overall Study|Lost to Follow Up|1|||
13190740|NCT02111096|26185496|FG000|Overall Study|Physician Decision|0|||
13190741|NCT02111096|26185497|FG001|Overall Study|Physician Decision|1|||
13190742|NCT02111096|26185498|FG002|Overall Study|Physician Decision|0|||
13190743|NCT02111096|26185496|FG000|Overall Study|Protocol Violation|1|||
13190744|NCT02111096|26185497|FG001|Overall Study|Protocol Violation|0|||
13190745|NCT02111096|26185498|FG002|Overall Study|Protocol Violation|1|||
13190746|NCT02111096|26185496|FG000|Overall Study|Terminated by Sponsor|53|||
13190747|NCT02111096|26185497|FG001|Overall Study|Terminated by Sponsor|35|||
13190748|NCT02111096|26185498|FG002|Overall Study|Terminated by Sponsor|54|||
13190749|NCT02111096|26185496|FG000|Overall Study|Withdrawal by Subject|4|||
13190750|NCT02111096|26185497|FG001|Overall Study|Withdrawal by Subject|2|||
13190751|NCT02111096|26185498|FG002|Overall Study|Withdrawal by Subject|8|||
13190752|NCT02111083|26185523|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
13190753|NCT02111083|26185524|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
13190754|NCT02110901|26185543|FG000|Overall Study|Death|6|||
13190755|NCT02110901|26185544|FG001|Overall Study|Death|3|||
13190756|NCT02110901|26185543|FG000|Overall Study|Lost to Follow-up|12|||
13190757|NCT02110901|26185544|FG001|Overall Study|Lost to Follow-up|8|||
13190758|NCT02110901|26185543|FG000|Overall Study|Withdrawal by Subject|7|||
13190759|NCT02110901|26185544|FG001|Overall Study|Withdrawal by Subject|3|||
13190760|NCT02110901|26185543|FG000|Overall Study|received a kidney transplant|5|||
13190761|NCT02110901|26185544|FG001|Overall Study|received a kidney transplant|0|||
13190762|NCT02110732|26185561|FG000|Overall Study|Physician Decision|5|||
13190763|NCT02110732|26185562|FG001|Overall Study|Physician Decision|2|||
13190764|NCT02110732|26185561|FG000|Overall Study|Lost to Follow-up|1|||
13190765|NCT02110732|26185562|FG001|Overall Study|Lost to Follow-up|1|||
13190766|NCT02110706|26185581|FG000|Overall Study|Adverse Event|2|||
13190767|NCT02110706|26185582|FG001|Overall Study|Adverse Event|3|||
13190768|NCT02110706|26185581|FG000|Overall Study|Patients who didn't receive 2nd infusion|3|||
13190769|NCT02110706|26185582|FG001|Overall Study|Patients who didn't receive 2nd infusion|1|||
13190770|NCT02110693|26185610|FG000|Overall Study|Withdrawal by Subject|6|||
13190771|NCT02110693|26185611|FG001|Overall Study|Withdrawal by Subject|7|||
13190772|NCT02110693|26185610|FG000|Overall Study|skipped assessment|15|||
13190773|NCT02110693|26185611|FG001|Overall Study|skipped assessment|18|||
13190774|NCT02110693|26185610|FG000|Overall Study|technical difficulties|6|||
13190775|NCT02110693|26185611|FG001|Overall Study|technical difficulties|4|||
13190776|NCT02110693|26185610|FG000|Overall Study|Other|1|||
13190777|NCT02110693|26185611|FG001|Overall Study|Other|0|||
13190778|NCT02110238|26185624|FG000|12 Week Pivotal Phase|Adverse Event|3|||
13190779|NCT02110238|26185625|FG001|12 Week Pivotal Phase|Adverse Event|0|||
13190780|NCT02110238|26185624|FG000|12 Week Pivotal Phase|Lack of Efficacy|2|||
13190781|NCT02110238|26185625|FG001|12 Week Pivotal Phase|Lack of Efficacy|3|||
13190782|NCT02110238|26185624|FG000|12 Week Pivotal Phase|Lost to Follow-up|2|||
13190783|NCT02110238|26185625|FG001|12 Week Pivotal Phase|Lost to Follow-up|0|||
13190784|NCT02110238|26185624|FG000|12 Week Pivotal Phase|Physician Decision|0|||
13190785|NCT02110238|26185625|FG001|12 Week Pivotal Phase|Physician Decision|2|||
13190786|NCT02110238|26185624|FG000|12 Week Pivotal Phase|Protocol Violation|0|||
13190787|NCT02110238|26185625|FG001|12 Week Pivotal Phase|Protocol Violation|1|||
13190788|NCT02110238|26185624|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3|||
13190789|NCT02110238|26185625|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3|||
13190790|NCT02110238|26185624|FG000|14 Week Blinded Extension Phase|Adverse Event|1|||
13190791|NCT02110238|26185625|FG001|14 Week Blinded Extension Phase|Adverse Event|1|||
13190792|NCT02110238|26185624|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2|||
13190793|NCT02110238|26185625|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4|||
13190794|NCT02110238|26185624|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3|||
13190795|NCT02110238|26185625|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1|||
13190796|NCT02110238|26185624|FG000|14 Week Blinded Extension Phase|Protocol Violation|2|||
13190797|NCT02110238|26185625|FG001|14 Week Blinded Extension Phase|Protocol Violation|3|||
13190798|NCT02110238|26185624|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4|||
13190799|NCT02110238|26185625|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3|||
13190800|NCT02110225|26185687|FG000|Overall Study|Lost to Follow-up|0|||
13190801|NCT02110225|26185688|FG001|Overall Study|Lost to Follow-up|1|||
13190802|NCT02110225|26185689|FG002|Overall Study|Lost to Follow-up|0|||
13190803|NCT02109744|26185706|FG000|Overall Study|Death|1|||
13190804|NCT02109744|26185707|FG001|Overall Study|Death|1|||
13190805|NCT02109744|26185706|FG000|Overall Study|no marrow exam|1|||
13190806|NCT02109744|26185707|FG001|Overall Study|no marrow exam|0|||
13190807|NCT02109562|26185731|FG000|Overall Study|Insufficient clinical response|2|||
13190808|NCT02109562|26185732|FG001|Overall Study|Insufficient clinical response|0|||
13190809|NCT02109562|26185733|FG002|Overall Study|Insufficient clinical response|4|||
13190810|NCT02109562|26185731|FG000|Overall Study|Adverse Event|0|||
13190811|NCT02109562|26185732|FG001|Overall Study|Adverse Event|2|||
13190812|NCT02109562|26185733|FG002|Overall Study|Adverse Event|3|||
13190813|NCT02109562|26185731|FG000|Overall Study|Lost to Follow-up|1|||
13190814|NCT02109562|26185732|FG001|Overall Study|Lost to Follow-up|0|||
13190815|NCT02109562|26185733|FG002|Overall Study|Lost to Follow-up|1|||
13190816|NCT02109562|26185731|FG000|Overall Study|Protocol Violation|0|||
13190817|NCT02109562|26185732|FG001|Overall Study|Protocol Violation|3|||
13190818|NCT02109562|26185733|FG002|Overall Study|Protocol Violation|1|||
13190819|NCT02109562|26185731|FG000|Overall Study|Withdrawal by Subject|20|||
13190820|NCT02109562|26185732|FG001|Overall Study|Withdrawal by Subject|25|||
13190821|NCT02109562|26185733|FG002|Overall Study|Withdrawal by Subject|21|||
13190822|NCT02109562|26185731|FG000|Overall Study|Physician Decision|3|||
13190823|NCT02109562|26185732|FG001|Overall Study|Physician Decision|4|||
13190824|NCT02109562|26185733|FG002|Overall Study|Physician Decision|5|||
13190825|NCT02109484|26185807|FG000|Overall Study|Lost to Follow-up|0|||
13190826|NCT02109484|26185808|FG001|Overall Study|Lost to Follow-up|0|||
13190827|NCT02109484|26185809|FG002|Overall Study|Lost to Follow-up|0|||
13190828|NCT02109484|26185810|FG003|Overall Study|Lost to Follow-up|1|||
13190829|NCT02109484|26185811|FG004|Overall Study|Lost to Follow-up|1|||
13190830|NCT02109484|26185812|FG005|Overall Study|Lost to Follow-up|0|||
13190831|NCT02109484|26185813|FG006|Overall Study|Lost to Follow-up|1|||
13190832|NCT02109484|26185814|FG007|Overall Study|Lost to Follow-up|0|||
13190833|NCT02109484|26185807|FG000|Overall Study|Withdrawal by Subject|0|||
13190834|NCT02109484|26185808|FG001|Overall Study|Withdrawal by Subject|0|||
13190835|NCT02109484|26185809|FG002|Overall Study|Withdrawal by Subject|0|||
13190836|NCT02109484|26185810|FG003|Overall Study|Withdrawal by Subject|0|||
13190837|NCT02109484|26185811|FG004|Overall Study|Withdrawal by Subject|1|||
13190838|NCT02109484|26185812|FG005|Overall Study|Withdrawal by Subject|1|||
13190839|NCT02109484|26185813|FG006|Overall Study|Withdrawal by Subject|1|||
13190840|NCT02109484|26185814|FG007|Overall Study|Withdrawal by Subject|0|||
13190841|NCT02109484|26185807|FG000|Overall Study|Physician Decision|0|||
13190842|NCT02109484|26185808|FG001|Overall Study|Physician Decision|0|||
13190843|NCT02109484|26185809|FG002|Overall Study|Physician Decision|0|||
13190844|NCT02109484|26185810|FG003|Overall Study|Physician Decision|0|||
13190845|NCT02109484|26185811|FG004|Overall Study|Physician Decision|2|||
13190846|NCT02109484|26185812|FG005|Overall Study|Physician Decision|0|||
13190847|NCT02109484|26185813|FG006|Overall Study|Physician Decision|0|||
13190848|NCT02109484|26185814|FG007|Overall Study|Physician Decision|0|||
13190849|NCT02109484|26185807|FG000|Overall Study|Death|0|||
13190850|NCT02109484|26185808|FG001|Overall Study|Death|0|||
13190851|NCT02109484|26185809|FG002|Overall Study|Death|0|||
13190852|NCT02109484|26185810|FG003|Overall Study|Death|0|||
13190853|NCT02109484|26185811|FG004|Overall Study|Death|0|||
13190854|NCT02109484|26185812|FG005|Overall Study|Death|0|||
13190855|NCT02109484|26185813|FG006|Overall Study|Death|0|||
13190856|NCT02109484|26185814|FG007|Overall Study|Death|2|||
13190857|NCT02109484|26185807|FG000|Overall Study|Moved away from study area|0|||
13190858|NCT02109484|26185808|FG001|Overall Study|Moved away from study area|0|||
13190859|NCT02109484|26185809|FG002|Overall Study|Moved away from study area|0|||
13190860|NCT02109484|26185810|FG003|Overall Study|Moved away from study area|0|||
13190861|NCT02109484|26185811|FG004|Overall Study|Moved away from study area|0|||
13190862|NCT02109484|26185812|FG005|Overall Study|Moved away from study area|0|||
13190863|NCT02109484|26185813|FG006|Overall Study|Moved away from study area|1|||
13190864|NCT02109484|26185814|FG007|Overall Study|Moved away from study area|1|||
13190865|NCT02109445|26185849|FG000|Overall Study|Symptomatic deterioration|2|||
13190866|NCT02109445|26185849|FG000|Overall Study|Adverse Event|1|||
13190867|NCT02109432|26185855|FG000|Overall Study|Withdrawal by Subject|1|||
13190868|NCT02109133|26185874|FG000|Overall Study|Lost to Follow-up|1|||
13190869|NCT02109133|26185875|FG001|Overall Study|Lost to Follow-up|0|||
13190870|NCT02109107|26185884|FG000|Overall Study|Lost to Follow-up|2|||
13190871|NCT02109042|26185892|FG000|Overall Study|Sponsor Decision|15|||
13190872|NCT02109029|26185917|FG000|Part B|Adverse Event|0|||
13190873|NCT02109029|26185918|FG001|Part B|Adverse Event|0|||
13190874|NCT02109029|26185919|FG002|Part B|Adverse Event|0|||
13190875|NCT02109029|26185920|FG003|Part B|Adverse Event|0|||
13190876|NCT02109029|26185921|FG004|Part B|Adverse Event|1|||
13190877|NCT02109029|26185922|FG005|Part B|Adverse Event|1|||
13190878|NCT02108964|26185966|FG000|Overall Study|Progressive disease|12|||
13190879|NCT02108964|26185967|FG001|Overall Study|Progressive disease|25|||
13190880|NCT02108964|26185968|FG002|Overall Study|Progressive disease|50|||
13190881|NCT02108964|26185969|FG003|Overall Study|Progressive disease|6|||
13190882|NCT02108964|26185970|FG004|Overall Study|Progressive disease|18|||
13190883|NCT02108964|26185971|FG005|Overall Study|Progressive disease|5|||
13190884|NCT02108964|26185972|FG006|Overall Study|Progressive disease|7|||
13190885|NCT02108964|26185973|FG007|Overall Study|Progressive disease|9|||
13190886|NCT02108964|26185966|FG000|Overall Study|Physician Decision|1|||
13190887|NCT02108964|26185967|FG001|Overall Study|Physician Decision|5|||
13190888|NCT02108964|26185968|FG002|Overall Study|Physician Decision|6|||
13190889|NCT02108964|26185969|FG003|Overall Study|Physician Decision|0|||
13190890|NCT02108964|26185970|FG004|Overall Study|Physician Decision|1|||
13190891|NCT02108964|26185971|FG005|Overall Study|Physician Decision|0|||
13190892|NCT02108964|26185972|FG006|Overall Study|Physician Decision|0|||
13190893|NCT02108964|26185973|FG007|Overall Study|Physician Decision|0|||
13190894|NCT02108964|26185966|FG000|Overall Study|Adverse Event|0|||
13190895|NCT02108964|26185967|FG001|Overall Study|Adverse Event|0|||
13190896|NCT02108964|26185968|FG002|Overall Study|Adverse Event|4|||
13190897|NCT02108964|26185969|FG003|Overall Study|Adverse Event|0|||
13190898|NCT02108964|26185970|FG004|Overall Study|Adverse Event|1|||
13190899|NCT02108964|26185971|FG005|Overall Study|Adverse Event|0|||
13190900|NCT02108964|26185972|FG006|Overall Study|Adverse Event|3|||
13190901|NCT02108964|26185973|FG007|Overall Study|Adverse Event|1|||
13190902|NCT02108964|26185966|FG000|Overall Study|Death|1|||
13190903|NCT02108964|26185967|FG001|Overall Study|Death|1|||
13190904|NCT02108964|26185968|FG002|Overall Study|Death|2|||
13190905|NCT02108964|26185969|FG003|Overall Study|Death|0|||
13190906|NCT02108964|26185970|FG004|Overall Study|Death|3|||
13190907|NCT02108964|26185971|FG005|Overall Study|Death|0|||
13190908|NCT02108964|26185972|FG006|Overall Study|Death|0|||
13190909|NCT02108964|26185973|FG007|Overall Study|Death|1|||
13190910|NCT02108964|26185966|FG000|Overall Study|Subject/Guardian decision|0|||
13190911|NCT02108964|26185967|FG001|Overall Study|Subject/Guardian decision|1|||
13190912|NCT02108964|26185968|FG002|Overall Study|Subject/Guardian decision|3|||
13190913|NCT02108964|26185969|FG003|Overall Study|Subject/Guardian decision|0|||
13190914|NCT02108964|26185970|FG004|Overall Study|Subject/Guardian decision|2|||
13190915|NCT02108964|26185971|FG005|Overall Study|Subject/Guardian decision|0|||
13190916|NCT02108964|26185972|FG006|Overall Study|Subject/Guardian decision|1|||
13190917|NCT02108964|26185973|FG007|Overall Study|Subject/Guardian decision|1|||
13190918|NCT02108951|26185992|FG000|Overall Study|Lost to Follow-up|1|||
13190919|NCT02108951|26185992|FG000|Overall Study|Patient's/guardian's decision|1|||
13190920|NCT02108951|26185992|FG000|Overall Study|Study Terminated by Sponsor|14|||
13190921|NCT02108912|26186007|FG000|Overall Study|Lost to Follow-up|1|||
13190922|NCT02108912|26186008|FG001|Overall Study|Lost to Follow-up|1|||
13190923|NCT02108912|26186007|FG000|Overall Study|lack of transportation|1|||
13190924|NCT02108912|26186008|FG001|Overall Study|lack of transportation|0|||
13190925|NCT02108912|26186007|FG000|Overall Study|high blood pressure|1|||
13190926|NCT02108912|26186008|FG001|Overall Study|high blood pressure|0|||
13190927|NCT02108600|26186027|FG000|Overall Study|Withdrawal by Subject|2|||
13190928|NCT02108600|26186028|FG001|Overall Study|Withdrawal by Subject|0|||
13190929|NCT02108600|26186027|FG000|Overall Study|Lost to Follow-up|1|||
13190930|NCT02108600|26186028|FG001|Overall Study|Lost to Follow-up|1|||
13190931|NCT02108262|26186236|FG000|Overall Study|Non-compliance|0|||
13190932|NCT02108262|26186237|FG001|Overall Study|Non-compliance|2|||
13190933|NCT02108262|26186238|FG002|Overall Study|Non-compliance|1|||
13190934|NCT02108262|26186239|FG003|Overall Study|Non-compliance|1|||
13190935|NCT02108262|26186236|FG000|Overall Study|Randomized by error/screen failure|0|||
13190936|NCT02108262|26186237|FG001|Overall Study|Randomized by error/screen failure|0|||
13190937|NCT02108262|26186238|FG002|Overall Study|Randomized by error/screen failure|1|||
13190938|NCT02108262|26186239|FG003|Overall Study|Randomized by error/screen failure|0|||
13190939|NCT02108262|26186236|FG000|Overall Study|Distance to center|0|||
13190940|NCT02108262|26186237|FG001|Overall Study|Distance to center|1|||
13190941|NCT02108262|26186238|FG002|Overall Study|Distance to center|1|||
13190942|NCT02108262|26186239|FG003|Overall Study|Distance to center|0|||
13190943|NCT02108262|26186236|FG000|Overall Study|Adverse Event|0|||
13190944|NCT02108262|26186237|FG001|Overall Study|Adverse Event|11|||
13190945|NCT02108262|26186238|FG002|Overall Study|Adverse Event|6|||
13190946|NCT02108262|26186239|FG003|Overall Study|Adverse Event|12|||
13190947|NCT02108262|26186236|FG000|Overall Study|Death|0|||
13190948|NCT02108262|26186237|FG001|Overall Study|Death|2|||
13190949|NCT02108262|26186238|FG002|Overall Study|Death|2|||
13190950|NCT02108262|26186239|FG003|Overall Study|Death|1|||
13190951|NCT02108262|26186236|FG000|Overall Study|Lost to Follow-up|0|||
13190952|NCT02108262|26186237|FG001|Overall Study|Lost to Follow-up|0|||
13190953|NCT02108262|26186238|FG002|Overall Study|Lost to Follow-up|1|||
13190954|NCT02108262|26186239|FG003|Overall Study|Lost to Follow-up|0|||
13190955|NCT02108262|26186236|FG000|Overall Study|Physician Decision|0|||
13190956|NCT02108262|26186237|FG001|Overall Study|Physician Decision|0|||
13190957|NCT02108262|26186238|FG002|Overall Study|Physician Decision|2|||
13190958|NCT02108262|26186239|FG003|Overall Study|Physician Decision|0|||
13190959|NCT02108262|26186236|FG000|Overall Study|Withdrawal by Subject|0|||
13190960|NCT02108262|26186237|FG001|Overall Study|Withdrawal by Subject|7|||
13190961|NCT02108262|26186238|FG002|Overall Study|Withdrawal by Subject|3|||
13190962|NCT02108262|26186239|FG003|Overall Study|Withdrawal by Subject|4|||
13190963|NCT02108262|26186236|FG000|Overall Study|Due to key hepatic values|0|||
13190964|NCT02108262|26186237|FG001|Overall Study|Due to key hepatic values|1|||
13190965|NCT02108262|26186238|FG002|Overall Study|Due to key hepatic values|0|||
13190966|NCT02108262|26186239|FG003|Overall Study|Due to key hepatic values|0|||
13190967|NCT02108262|26186236|FG000|Overall Study|Unable to contact patient|0|||
13190968|NCT02108262|26186237|FG001|Overall Study|Unable to contact patient|3|||
13190969|NCT02108262|26186238|FG002|Overall Study|Unable to contact patient|1|||
13190970|NCT02108262|26186239|FG003|Overall Study|Unable to contact patient|2|||
13190971|NCT02108262|26186236|FG000|Overall Study|Patient unable to come to site/attend visit|0|||
13190972|NCT02108262|26186237|FG001|Overall Study|Patient unable to come to site/attend visit|6|||
13190973|NCT02108262|26186238|FG002|Overall Study|Patient unable to come to site/attend visit|11|||
13190974|NCT02108262|26186239|FG003|Overall Study|Patient unable to come to site/attend visit|6|||
13190975|NCT02108262|26186236|FG000|Overall Study|Patient did not want another infusion|0|||
13190976|NCT02108262|26186237|FG001|Overall Study|Patient did not want another infusion|3|||
13190977|NCT02108262|26186238|FG002|Overall Study|Patient did not want another infusion|3|||
13190978|NCT02108262|26186239|FG003|Overall Study|Patient did not want another infusion|2|||
13190979|NCT02108262|26186236|FG000|Overall Study|Vacation|0|||
13190980|NCT02108262|26186237|FG001|Overall Study|Vacation|1|||
13190981|NCT02108262|26186238|FG002|Overall Study|Vacation|0|||
13190982|NCT02108262|26186239|FG003|Overall Study|Vacation|0|||
13190983|NCT02108262|26186236|FG000|Overall Study|Patient decision|0|||
13190984|NCT02108262|26186237|FG001|Overall Study|Patient decision|7|||
13190985|NCT02108262|26186238|FG002|Overall Study|Patient decision|9|||
13190986|NCT02108262|26186239|FG003|Overall Study|Patient decision|14|||
13190987|NCT02108262|26186236|FG000|Overall Study|Missed IV due to pharmacy error|0|||
13190988|NCT02108262|26186237|FG001|Overall Study|Missed IV due to pharmacy error|0|||
13190989|NCT02108262|26186238|FG002|Overall Study|Missed IV due to pharmacy error|1|||
13190990|NCT02108262|26186239|FG003|Overall Study|Missed IV due to pharmacy error|0|||
13190991|NCT02107898|26186298|FG000|Overall Study|Adverse Event|4|||
13190992|NCT02107898|26186299|FG001|Overall Study|Adverse Event|7|||
13190993|NCT02107898|26186298|FG000|Overall Study|Poor compliance to protocol|0|||
13190994|NCT02107898|26186299|FG001|Overall Study|Poor compliance to protocol|1|||
13190995|NCT02107898|26186298|FG000|Overall Study|Participant moved|0|||
13190996|NCT02107898|26186299|FG001|Overall Study|Participant moved|2|||
13190997|NCT02107898|26186298|FG000|Overall Study|Consent withdrawn by participant|2|||
13190998|NCT02107898|26186299|FG001|Overall Study|Consent withdrawn by participant|1|||
13190999|NCT02107898|26186298|FG000|Overall Study|Randomized but not treated|0|||
13191000|NCT02107898|26186299|FG001|Overall Study|Randomized but not treated|1|||
13191001|NCT02107859|26186315|FG000|Overall Study|Withdrawal by Subject|14|||
13191002|NCT02107859|26186315|FG000|Overall Study|Adverse Event|3|||
13191003|NCT02107859|26186315|FG000|Overall Study|Study closure|41|||
13191004|NCT02107859|26186315|FG000|Overall Study|Other than specified|3|||
13191005|NCT02107703|26186347|FG000|Overall Study|Withdrawal by Subject|36|||
13191006|NCT02107703|26186348|FG001|Overall Study|Withdrawal by Subject|19|||
13191007|NCT02107703|26186347|FG000|Overall Study|Lost to Follow-up|6|||
13191008|NCT02107703|26186348|FG001|Overall Study|Lost to Follow-up|4|||
13191009|NCT02107703|26186347|FG000|Overall Study|On study treatment/follow up|319|||
13191010|NCT02107703|26186348|FG001|Overall Study|On study treatment/follow up|152|||
13191011|NCT02107482|26186356|FG000|Overall Study|inconveinence|2|||
13191012|NCT02107482|26186356|FG000|Overall Study|Lost to Follow-up|1|||
13191013|NCT02107482|26186356|FG000|Overall Study|Lack of Efficacy|1|||
13191014|NCT02107443|26186377|FG000|Overall Study|Death|42|||
13191015|NCT02107443|26186378|FG001|Overall Study|Death|30|||
13191016|NCT02107443|26186377|FG000|Overall Study|Study Protocol Violation|3|||
13191017|NCT02107443|26186378|FG001|Overall Study|Study Protocol Violation|1|||
13191018|NCT02107443|26186377|FG000|Overall Study|Registered but Not Eligible|0|||
13191019|NCT02107443|26186378|FG001|Overall Study|Registered but Not Eligible|1|||
13191020|NCT02107443|26186377|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
13191021|NCT02107443|26186378|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
13111429|NCT03187197|25903430|FG002|Overall Study|Reason not listed|1|||
13111430|NCT03187197|25903428|FG000|Overall Study|Missing|1|||
13111431|NCT03187197|25903429|FG001|Overall Study|Missing|32|||
13111432|NCT03187197|25903430|FG002|Overall Study|Missing|3|||
13111433|NCT03187197|25903428|FG000|Overall Study|Status missing|2|||
13111434|NCT03187197|25903429|FG001|Overall Study|Status missing|33|||
13111435|NCT03187197|25903430|FG002|Overall Study|Status missing|3|||
13111436|NCT03187197|25903428|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14|||
13111437|NCT03187197|25903429|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45|||
13191022|NCT02107443|26186377|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1|||
13191023|NCT02107443|26186378|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2|||
13191024|NCT02107443|26186377|FG000|Overall Study|Withdrawal: Changed Mind|2|||
13191025|NCT02107443|26186378|FG001|Overall Study|Withdrawal: Changed Mind|0|||
13191026|NCT02107443|26186377|FG000|Overall Study|Withdrawal: Changed MD/Facility|1|||
13191027|NCT02107443|26186378|FG001|Overall Study|Withdrawal: Changed MD/Facility|3|||
13191028|NCT02107443|26186377|FG000|Overall Study|Withdrawal: Too Many Forms|3|||
13191029|NCT02107443|26186378|FG001|Overall Study|Withdrawal: Too Many Forms|1|||
13191030|NCT02107443|26186377|FG000|Overall Study|Withdrawal: Too Time Consuming|3|||
13191031|NCT02107443|26186378|FG001|Overall Study|Withdrawal: Too Time Consuming|6|||
13191032|NCT02107443|26186377|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2|||
13191033|NCT02107443|26186378|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1|||
13191034|NCT02107443|26186377|FG000|Overall Study|Withdrawal: Other Medical|9|||
13191035|NCT02107443|26186378|FG001|Overall Study|Withdrawal: Other Medical|5|||
13191036|NCT02107443|26186377|FG000|Overall Study|Withdrawal: Disease Progression|4|||
13111438|NCT03187197|25903430|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1|||
13111439|NCT03187132|25903451|FG000|Inpatient Trauma Only|Lost to Follow-up|3|||
13111440|NCT03187132|25903452|FG001|Inpatient Trauma Only|Lost to Follow-up|12|||
13111441|NCT03187132|25903451|FG000|Inpatient Trauma Only|socioeconomic burden|1|||
13111442|NCT03187132|25903452|FG001|Inpatient Trauma Only|socioeconomic burden|0|||
13191037|NCT02107443|26186378|FG001|Overall Study|Withdrawal: Disease Progression|2|||
13191038|NCT02107443|26186377|FG000|Overall Study|Withdrawal: Personal Issues|0|||
13191039|NCT02107443|26186378|FG001|Overall Study|Withdrawal: Personal Issues|3|||
13191040|NCT02107313|26186389|FG000|Overall Study|One participant did not do the FED cohor|0|||
13191041|NCT02107313|26186390|FG001|Overall Study|One participant did not do the FED cohor|1|||
13191042|NCT02107274|26186409|FG000|Treatment vs. Placebo|Adverse Event|3|||
13191043|NCT02107274|26186410|FG001|Treatment vs. Placebo|Adverse Event|0|||
13191044|NCT02107274|26186409|FG000|Treatment vs. Placebo|Lost to Follow-up|0|||
13191045|NCT02107274|26186410|FG001|Treatment vs. Placebo|Lost to Follow-up|2|||
13191046|NCT02107274|26186409|FG000|Control Phase|Lost to Follow-up|1|||
13191047|NCT02107274|26186410|FG001|Control Phase|Lost to Follow-up|1|||
13191048|NCT02107274|26186409|FG000|Control Phase|Death|2|||
13191049|NCT02107274|26186410|FG001|Control Phase|Death|0|||
13191050|NCT02107274|26186409|FG000|Control Phase|Adverse Event|0|||
13191051|NCT02107274|26186410|FG001|Control Phase|Adverse Event|1|||
13191052|NCT02107196|26186430|FG000|12-week Treatment Period|Adverse Event|6|||
13191053|NCT02107196|26186431|FG001|12-week Treatment Period|Adverse Event|3|||
13191054|NCT02107196|26186430|FG000|12-week Treatment Period|Lack of Efficacy|2|||
13191055|NCT02107196|26186431|FG001|12-week Treatment Period|Lack of Efficacy|1|||
13191056|NCT02107196|26186430|FG000|12-week Treatment Period|Lost to Follow-up|3|||
13191057|NCT02107196|26186431|FG001|12-week Treatment Period|Lost to Follow-up|6|||
13191058|NCT02107196|26186430|FG000|12-week Treatment Period|Physician Decision|0|||
13191059|NCT02107196|26186431|FG001|12-week Treatment Period|Physician Decision|1|||
13191060|NCT02107196|26186430|FG000|12-week Treatment Period|Withdrawal by Subject|15|||
13191061|NCT02107196|26186431|FG001|12-week Treatment Period|Withdrawal by Subject|12|||
13191062|NCT02107196|26186430|FG000|12-week Treatment Period|Protocol Violation|7|||
13191063|NCT02107196|26186431|FG001|12-week Treatment Period|Protocol Violation|8|||
13191064|NCT02107196|26186430|FG000|12-week Treatment Period|Reason Missing|11|||
13191065|NCT02107196|26186431|FG001|12-week Treatment Period|Reason Missing|8|||
13191066|NCT02107196|26186430|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2|||
13191067|NCT02107196|26186431|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0|||
13191068|NCT02107196|26186430|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
13191069|NCT02107196|26186431|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
13191070|NCT02107196|26186430|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2|||
13191071|NCT02107196|26186431|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0|||
13191072|NCT02107196|26186430|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18|||
13111443|NCT03187132|25903451|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0|||
13111444|NCT03187132|25903452|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5|||
13111445|NCT03187132|25903451|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1|||
13111446|NCT03187132|25903452|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0|||
13111447|NCT03187132|25903451|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2|||
13111448|NCT03187132|25903452|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5|||
13111449|NCT03187132|25903451|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1|||
13111450|NCT03187132|25903452|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0|||
13111451|NCT03187132|25903451|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0|||
13111452|NCT03187132|25903452|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2|||
13111453|NCT03187132|25903451|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27|||
13111454|NCT03187132|25903452|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47|||
13111455|NCT03187132|25903451|FG000|Pain Clinic Only, Fully Remote|Disease burden|6|||
13191073|NCT02107196|26186431|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5|||
13191074|NCT02107131|26186450|FG000|Overall Study|Lost to Follow-up|4|||
13191075|NCT02107131|26186451|FG001|Overall Study|Lost to Follow-up|4|||
13191076|NCT02107131|26186450|FG000|Overall Study|Physician Decision|1|||
13191077|NCT02107131|26186451|FG001|Overall Study|Physician Decision|0|||
13191078|NCT02107131|26186450|FG000|Overall Study|Withdrawal by Subject|2|||
13191079|NCT02107131|26186451|FG001|Overall Study|Withdrawal by Subject|0|||
13191080|NCT02107131|26186450|FG000|Overall Study|mental instability|1|||
13191081|NCT02107131|26186451|FG001|Overall Study|mental instability|0|||
13191082|NCT02107131|26186450|FG000|Overall Study|Death|0|||
13191083|NCT02107131|26186451|FG001|Overall Study|Death|1|||
13191084|NCT02107131|26186450|FG000|Overall Study|Protocol Violation|0|||
13191085|NCT02107131|26186451|FG001|Overall Study|Protocol Violation|4|||
13191086|NCT02107092|26186458|FG000|Overall Study|Miscellaneous|3|||
13111456|NCT03187132|25903452|FG001|Pain Clinic Only, Fully Remote|Disease burden|5|||
13111457|NCT03187132|25903451|FG000|Pain Clinic Only, Fully Remote|Language barrier|0|||
13111458|NCT03187132|25903452|FG001|Pain Clinic Only, Fully Remote|Language barrier|1|||
13111459|NCT03187132|25903451|FG000|Pain Clinic Only, Fully Remote|EMR|0|||
13111460|NCT03187132|25903452|FG001|Pain Clinic Only, Fully Remote|EMR|1|||
13111461|NCT03186781|25903537|FG000|Overall Study|Lost to Follow-up|0|||
13111462|NCT03186781|25903538|FG001|Overall Study|Lost to Follow-up|0|||
13111463|NCT03186781|25903539|FG002|Overall Study|Lost to Follow-up|1|||
13111464|NCT03186781|25903540|FG003|Overall Study|Lost to Follow-up|0|||
13111465|NCT03186781|25903541|FG004|Overall Study|Lost to Follow-up|1|||
13111466|NCT03186781|25903542|FG005|Overall Study|Lost to Follow-up|0|||
13111467|NCT03186781|25903537|FG000|Overall Study|Moved from Area|0|||
13111468|NCT03186781|25903538|FG001|Overall Study|Moved from Area|0|||
13111469|NCT03186781|25903539|FG002|Overall Study|Moved from Area|0|||
13111470|NCT03186781|25903540|FG003|Overall Study|Moved from Area|0|||
13111471|NCT03186781|25903541|FG004|Overall Study|Moved from Area|1|||
13111472|NCT03186781|25903542|FG005|Overall Study|Moved from Area|0|||
13111473|NCT03186781|25903537|FG000|Overall Study|Withdrawal by Subject|0|||
13111474|NCT03186781|25903538|FG001|Overall Study|Withdrawal by Subject|0|||
13111475|NCT03186781|25903539|FG002|Overall Study|Withdrawal by Subject|0|||
13111476|NCT03186781|25903540|FG003|Overall Study|Withdrawal by Subject|0|||
13111477|NCT03186781|25903541|FG004|Overall Study|Withdrawal by Subject|1|||
13111478|NCT03186781|25903542|FG005|Overall Study|Withdrawal by Subject|0|||
13111479|NCT03186378|25903566|FG000|Overall Study|Lost to Follow-up|1|||
13111480|NCT03186378|25903567|FG001|Overall Study|Lost to Follow-up|0|||
13111481|NCT03185949|25903592|FG000|ITT Analysis|Withdrawal by Subject|4|||
13111482|NCT03185949|25903593|FG001|ITT Analysis|Withdrawal by Subject|3|||
13111483|NCT03185949|25903592|FG000|PP Analysis|Protocol Violation|2|||
13111484|NCT03185949|25903593|FG001|PP Analysis|Protocol Violation|2|||
13111485|NCT03185949|25903592|FG000|PP Analysis|Failed/Incomplete LGA embolization|0|||
13111486|NCT03185949|25903593|FG001|PP Analysis|Failed/Incomplete LGA embolization|2|||
13111487|NCT03185481|25903612|FG000|Overall Study|Adverse Event|1|||
13111488|NCT03185481|25903612|FG000|Overall Study|Study Terminated by Sponsor|4|||
13111489|NCT03184987|25903687|FG000|Overall Study|Withdrawal by Subject|0|||
13111490|NCT03184987|25903688|FG001|Overall Study|Withdrawal by Subject|1|||
13111491|NCT03184987|25903689|FG002|Overall Study|Withdrawal by Subject|2|||
13111492|NCT03184987|25903687|FG000|Overall Study|Physician Decision|0|||
13111493|NCT03184987|25903688|FG001|Overall Study|Physician Decision|0|||
13111494|NCT03184987|25903689|FG002|Overall Study|Physician Decision|1|||
13111495|NCT03184987|25903687|FG000|Overall Study|Adverse Event|1|||
13111496|NCT03184987|25903688|FG001|Overall Study|Adverse Event|0|||
13111497|NCT03184987|25903689|FG002|Overall Study|Adverse Event|1|||
13111498|NCT03184701|25903695|FG000|Overall Study|Death|3|||
13111499|NCT03184701|25903695|FG000|Overall Study|Physician Decision|3|||
13111500|NCT03184701|25903695|FG000|Overall Study|Withdrawal by Subject|6|||
13111501|NCT03184701|25903695|FG000|Overall Study|Lost to Follow-up|5|||
13111502|NCT03184558|25903705|FG000|Overall Study|Withdrawal by Subject|2|||
13191087|NCT02107092|26186458|FG000|Overall Study|Subject compliance|3|||
13191088|NCT02107092|26186458|FG000|Overall Study|Hypo-or hyperkalemia|2|||
13191089|NCT02107092|26186458|FG000|Overall Study|Met ECG withdrawal criteria|3|||
13191090|NCT02107092|26186458|FG000|Overall Study|Physician Decision|3|||
13191091|NCT02107092|26186458|FG000|Overall Study|Lost to Follow-up|2|||
13191092|NCT02107092|26186458|FG000|Overall Study|Withdrawal by Subject|9|||
13191093|NCT02107092|26186458|FG000|Overall Study|Adverse Event|7|||
13191094|NCT02107092|26186458|FG000|Overall Study|Expected progression of CKD|12|||
13191095|NCT02107014|26186528|FG000|Overall Study|Withdrew before drug: moving interstate|1|||
13191096|NCT02106975|26186581|FG000|Overall Study|Death|25|||
13191097|NCT02106975|26186582|FG001|Overall Study|Death|39|||
13191098|NCT02106923|26186639|FG000|Overall Study|Protocol Violation|0|||
13191099|NCT02106923|26186640|FG001|Overall Study|Protocol Violation|0|||
13191100|NCT02106923|26186641|FG002|Overall Study|Protocol Violation|0|||
13111503|NCT03184558|25903705|FG000|Overall Study|Death|16|||
13191101|NCT02106923|26186642|FG003|Overall Study|Protocol Violation|0|||
13191102|NCT02106923|26186643|FG004|Overall Study|Protocol Violation|0|||
13191103|NCT02106923|26186644|FG005|Overall Study|Protocol Violation|1|||
13111504|NCT03184558|25903705|FG000|Overall Study|Lost to Follow-up|2|||
13111505|NCT03184558|25903705|FG000|Overall Study|Other|9|||
13191104|NCT02106910|26186665|FG000|Overall Study|Lost to Follow-up|1|||
13191105|NCT02106910|26186666|FG001|Overall Study|Lost to Follow-up|1|||
13191106|NCT02106884|26186693|FG000|Overall Study|Change of diagnosis/exclusion|0|||
13111506|NCT03184519|25903711|FG000|Overall Study|Lost to Follow-up|6|||
13191107|NCT02106884|26186694|FG001|Overall Study|Change of diagnosis/exclusion|1|||
13191108|NCT02106832|26186740|FG000|Overall Study|Adverse Event|1|||
13191109|NCT02106832|26186741|FG001|Overall Study|Adverse Event|2|||
13485562|NCT02906020|27032868|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
13485563|NCT02906020|27032869|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
13191110|NCT02106832|26186742|FG002|Overall Study|Adverse Event|3|||
13191111|NCT02106832|26186743|FG003|Overall Study|Adverse Event|0|||
13191112|NCT02106832|26186740|FG000|Overall Study|Death|4|||
13191113|NCT02106832|26186741|FG001|Overall Study|Death|4|||
13191114|NCT02106832|26186742|FG002|Overall Study|Death|1|||
13191115|NCT02106832|26186743|FG003|Overall Study|Death|4|||
13191116|NCT02106832|26186740|FG000|Overall Study|Deterioration of general conditions|0|||
13191117|NCT02106832|26186741|FG001|Overall Study|Deterioration of general conditions|0|||
13191118|NCT02106832|26186742|FG002|Overall Study|Deterioration of general conditions|1|||
13191119|NCT02106832|26186743|FG003|Overall Study|Deterioration of general conditions|0|||
13191120|NCT02106832|26186740|FG000|Overall Study|Lost to Follow-up|0|||
13191121|NCT02106832|26186741|FG001|Overall Study|Lost to Follow-up|1|||
13191122|NCT02106832|26186742|FG002|Overall Study|Lost to Follow-up|1|||
13191123|NCT02106832|26186743|FG003|Overall Study|Lost to Follow-up|3|||
13191124|NCT02106832|26186740|FG000|Overall Study|Physician Decision|1|||
13191125|NCT02106832|26186741|FG001|Overall Study|Physician Decision|0|||
13191126|NCT02106832|26186742|FG002|Overall Study|Physician Decision|0|||
13191127|NCT02106832|26186743|FG003|Overall Study|Physician Decision|0|||
13191128|NCT02106832|26186740|FG000|Overall Study|Protocol Violation|0|||
13191129|NCT02106832|26186741|FG001|Overall Study|Protocol Violation|0|||
13191130|NCT02106832|26186742|FG002|Overall Study|Protocol Violation|0|||
13191131|NCT02106832|26186743|FG003|Overall Study|Protocol Violation|1|||
13191132|NCT02106832|26186740|FG000|Overall Study|Withdrawal by Subject|17|||
13191133|NCT02106832|26186741|FG001|Overall Study|Withdrawal by Subject|17|||
13191134|NCT02106832|26186742|FG002|Overall Study|Withdrawal by Subject|10|||
13191135|NCT02106832|26186743|FG003|Overall Study|Withdrawal by Subject|7|||
13191136|NCT02106832|26186740|FG000|Overall Study|Technical problems|0|||
13191137|NCT02106832|26186741|FG001|Overall Study|Technical problems|1|||
13191138|NCT02106832|26186742|FG002|Overall Study|Technical problems|0|||
13191139|NCT02106832|26186743|FG003|Overall Study|Technical problems|0|||
13191140|NCT02106455|26186759|FG000|Overall Study|Case Report Form Uncollected|6|||
13191141|NCT02106455|26186759|FG000|Overall Study|Protocol Deviation|2|||
13191142|NCT02106442|26186779|FG000|Overall Study|Case Report Forms Uncollected|7|||
13191143|NCT02106442|26186779|FG000|Overall Study|Protocol Deviation|30|||
13191144|NCT02106403|26186806|FG000|Follow-Up Visit 3|Other Reason|0|||
13191145|NCT02106403|26186807|FG001|Follow-Up Visit 3|Other Reason|0|||
13191146|NCT02106403|26186808|FG002|Follow-Up Visit 3|Other Reason|0|||
13111507|NCT03184519|25903711|FG000|Overall Study|Physician Decision|21|||
13111508|NCT03184441|25903721|FG000|Overall Study|Withdrawal by Subject|1|||
13111509|NCT03184077|25903738|FG000|Overall Study|Lost to Follow-up|21|||
13111510|NCT03184077|25903739|FG001|Overall Study|Lost to Follow-up|21|||
13111511|NCT03183908|25903806|FG000|Overall Study|Missing Symptom Diary Data|0|||
13111512|NCT03183908|25903807|FG001|Overall Study|Missing Symptom Diary Data|2|||
13111513|NCT03183778|25903818|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1|||
13111514|NCT03183518|25903851|FG000|Overall Study|Other (Not specified)|2|||
13111515|NCT03183518|25903851|FG000|Overall Study|Other (Withdrawal of consent)|1|||
13111516|NCT03183063|25903884|FG000|Overall Study|Withdrawal by Subject|2|||
13111517|NCT03183063|25903885|FG001|Overall Study|Withdrawal by Subject|0|||
13111518|NCT03183063|25903886|FG002|Overall Study|Withdrawal by Subject|0|||
13111519|NCT03183063|25903884|FG000|Overall Study|Physician Decision|3|||
13111520|NCT03183063|25903885|FG001|Overall Study|Physician Decision|4|||
13111521|NCT03183063|25903886|FG002|Overall Study|Physician Decision|4|||
13111522|NCT03182829|25903899|FG000|Overall Study|Protocol Violation|12|||
13191147|NCT02106403|26186809|FG003|Follow-Up Visit 3|Other Reason|0|||
13191148|NCT02106403|26186810|FG004|Follow-Up Visit 3|Other Reason|0|||
13191149|NCT02106403|26186811|FG005|Follow-Up Visit 3|Other Reason|1|||
13191150|NCT02106390|26186895|FG000|Overall Study|Withdrawal by Subject|15|||
13191151|NCT02106390|26186896|FG001|Overall Study|Withdrawal by Subject|16|||
13191152|NCT02106390|26186897|FG002|Overall Study|Withdrawal by Subject|15|||
13191153|NCT02106390|26186895|FG000|Overall Study|Lost to Follow-up|25|||
13191154|NCT02106390|26186896|FG001|Overall Study|Lost to Follow-up|20|||
13191155|NCT02106390|26186897|FG002|Overall Study|Lost to Follow-up|13|||
13191156|NCT02106390|26186895|FG000|Overall Study|Other: Administrative Reason|8|||
13191157|NCT02106390|26186896|FG001|Overall Study|Other: Administrative Reason|5|||
13191158|NCT02106390|26186897|FG002|Overall Study|Other: Administrative Reason|12|||
13191159|NCT02106390|26186895|FG000|Overall Study|Other: Unspecified|1|||
13191160|NCT02106390|26186896|FG001|Overall Study|Other: Unspecified|4|||
13191161|NCT02106390|26186897|FG002|Overall Study|Other: Unspecified|2|||
13191162|NCT02106390|26186895|FG000|Overall Study|Adverse Event|0|||
13191163|NCT02106390|26186896|FG001|Overall Study|Adverse Event|2|||
13191164|NCT02106390|26186897|FG002|Overall Study|Adverse Event|1|||
13111523|NCT03182829|25903900|FG001|Overall Study|Protocol Violation|12|||
13191165|NCT02106390|26186895|FG000|Overall Study|Protocol Violation|0|||
13191166|NCT02106390|26186896|FG001|Overall Study|Protocol Violation|1|||
13191167|NCT02106390|26186897|FG002|Overall Study|Protocol Violation|0|||
13206284|NCT01958671|26234185|FG001|Overall Study|Excluded medication|0|||
13206285|NCT01958671|26234186|FG002|Overall Study|Excluded medication|1|||
13206286|NCT01958671|26234184|FG000|Overall Study|Hyperglycemia|0|||
13206287|NCT01958671|26234185|FG001|Overall Study|Hyperglycemia|0|||
13206288|NCT01958671|26234186|FG002|Overall Study|Hyperglycemia|2|||
13206289|NCT01958671|26234184|FG000|Overall Study|Lost to Follow-up|7|||
13206290|NCT01958671|26234185|FG001|Overall Study|Lost to Follow-up|11|||
13206291|NCT01958671|26234186|FG002|Overall Study|Lost to Follow-up|7|||
13206292|NCT01958671|26234184|FG000|Overall Study|Non-compliance with study drug|1|||
13206293|NCT01958671|26234185|FG001|Overall Study|Non-compliance with study drug|1|||
13206294|NCT01958671|26234186|FG002|Overall Study|Non-compliance with study drug|1|||
13206295|NCT01958671|26234184|FG000|Overall Study|Pregnancy|0|||
13206296|NCT01958671|26234185|FG001|Overall Study|Pregnancy|0|||
13206297|NCT01958671|26234186|FG002|Overall Study|Pregnancy|1|||
13206298|NCT01958671|26234184|FG000|Overall Study|Protocol Violation|0|||
13206299|NCT01958671|26234185|FG001|Overall Study|Protocol Violation|1|||
13206300|NCT01958671|26234186|FG002|Overall Study|Protocol Violation|0|||
13206301|NCT01958671|26234184|FG000|Overall Study|Study site terminated by sponsor|1|||
13206302|NCT01958671|26234185|FG001|Overall Study|Study site terminated by sponsor|0|||
13206303|NCT01958671|26234186|FG002|Overall Study|Study site terminated by sponsor|1|||
13206304|NCT01958671|26234184|FG000|Overall Study|Participant moved|0|||
13206305|NCT01958671|26234185|FG001|Overall Study|Participant moved|0|||
13206306|NCT01958671|26234186|FG002|Overall Study|Participant moved|1|||
13206307|NCT01958671|26234184|FG000|Overall Study|Withdrawal by Subject|8|||
13206308|NCT01958671|26234185|FG001|Overall Study|Withdrawal by Subject|10|||
13206309|NCT01958671|26234186|FG002|Overall Study|Withdrawal by Subject|13|||
13206310|NCT01958619|26234219|FG000|Overall Study|Protocol Violation|2|||
13206311|NCT01958619|26234220|FG001|Overall Study|Protocol Violation|0|||
13206312|NCT01958619|26234221|FG002|Overall Study|Protocol Violation|1|||
13206313|NCT01958619|26234222|FG003|Overall Study|Protocol Violation|0|||
13206314|NCT01958489|26234239|FG000|Period 2|Adverse Event|0|||
13206315|NCT01958489|26234240|FG001|Period 2|Adverse Event|1|||
13206316|NCT01958476|26234275|FG000|Overall Study|Parent requested exclusion from analysis|1|||
13206317|NCT01958476|26234276|FG001|Overall Study|Parent requested exclusion from analysis|0|||
13206318|NCT01958437|26234307|FG000|Overall Study|Incidental MRI findings|0|||
13206319|NCT01958437|26234308|FG001|Overall Study|Incidental MRI findings|0|||
13206320|NCT01958437|26234309|FG002|Overall Study|Incidental MRI findings|1|||
13206321|NCT01958437|26234310|FG003|Overall Study|Incidental MRI findings|1|||
13206322|NCT01958294|26234318|FG000|Overall Study|Clinical Circumstances|2|||
13206323|NCT01958281|26234402|FG000|Overall Study|Lack of Efficacy|5|||
13206324|NCT01958281|26234403|FG001|Overall Study|Lack of Efficacy|2|||
13206325|NCT01958281|26234404|FG002|Overall Study|Lack of Efficacy|0|||
13111524|NCT03182829|25903899|FG000|Overall Study|Other|4|||
13111525|NCT03182829|25903900|FG001|Overall Study|Other|3|||
13111526|NCT03182738|25903921|FG000|Overall Study|Lost to Follow-up|9|||
13111527|NCT03182738|25903922|FG001|Overall Study|Lost to Follow-up|3|||
13111528|NCT03182738|25903921|FG000|Overall Study|Pregnancy|0|||
13111529|NCT03182738|25903922|FG001|Overall Study|Pregnancy|1|||
13111530|NCT03182738|25903921|FG000|Overall Study|Withdrawal by Subject|0|||
13111531|NCT03182738|25903922|FG001|Overall Study|Withdrawal by Subject|1|||
13111532|NCT03182686|25903935|FG000|Overall Study|Lost to Follow-up|2|||
13111533|NCT03182686|25903936|FG001|Overall Study|Lost to Follow-up|0|||
13111534|NCT03182686|25903935|FG000|Overall Study|Adverse Event|2|||
13111535|NCT03182686|25903936|FG001|Overall Study|Adverse Event|0|||
13111536|NCT03182686|25903935|FG000|Overall Study|Withdrawal by Subject|3|||
13111537|NCT03182686|25903936|FG001|Overall Study|Withdrawal by Subject|0|||
13111538|NCT03181958|25903990|FG000|Overall Study|Lost to Follow-up|17|||
13111539|NCT03181958|25903991|FG001|Overall Study|Lost to Follow-up|21|||
13111540|NCT03181958|25903992|FG002|Overall Study|Lost to Follow-up|15|||
13111541|NCT03181789|25904059|FG000|Overall Study|Withdrawal by Subject|0|||
13111542|NCT03181789|25904060|FG001|Overall Study|Withdrawal by Subject|1|||
13111543|NCT03181789|25904061|FG002|Overall Study|Withdrawal by Subject|1|||
13111544|NCT03181789|25904062|FG003|Overall Study|Withdrawal by Subject|0|||
13111545|NCT03181789|25904059|FG000|Overall Study|Lost to Follow-up|7|||
13111546|NCT03181789|25904060|FG001|Overall Study|Lost to Follow-up|1|||
13111547|NCT03181789|25904061|FG002|Overall Study|Lost to Follow-up|0|||
13111548|NCT03181789|25904062|FG003|Overall Study|Lost to Follow-up|0|||
13111549|NCT03181789|25904059|FG000|Overall Study|Participant unable to adhere to visit|0|||
13206326|NCT01958281|26234402|FG000|Overall Study|Adverse Event|0|||
13111550|NCT03181789|25904060|FG001|Overall Study|Participant unable to adhere to visit|1|||
13206327|NCT01958281|26234403|FG001|Overall Study|Adverse Event|2|||
13206328|NCT01958281|26234404|FG002|Overall Study|Adverse Event|0|||
13191168|NCT02106351|26186948|FG000|Treatment Cycle 1|Adverse Event|2|||
13191169|NCT02106351|26186949|FG001|Treatment Cycle 1|Adverse Event|0|||
13191170|NCT02106351|26186950|FG002|Treatment Cycle 1|Adverse Event|0|||
13191171|NCT02106351|26186948|FG000|Treatment Cycle 1|Consent withdrawn|1|||
13111551|NCT03181789|25904061|FG002|Overall Study|Participant unable to adhere to visit|0|||
13191172|NCT02106351|26186949|FG001|Treatment Cycle 1|Consent withdrawn|0|||
13191173|NCT02106351|26186950|FG002|Treatment Cycle 1|Consent withdrawn|2|||
13191174|NCT02106351|26186948|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
13191175|NCT02106351|26186949|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
13191176|NCT02106351|26186950|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
13191177|NCT02106351|26186948|FG000|Treatment Cycle 1|Other|0|||
13191178|NCT02106351|26186949|FG001|Treatment Cycle 1|Other|3|||
13191179|NCT02106351|26186950|FG002|Treatment Cycle 1|Other|1|||
13191180|NCT02106351|26186948|FG000|Treatment Cycle 1|Randomised but not treated|1|||
13191181|NCT02106351|26186949|FG001|Treatment Cycle 1|Randomised but not treated|0|||
13191182|NCT02106351|26186950|FG002|Treatment Cycle 1|Randomised but not treated|1|||
13191183|NCT02106351|26186948|FG000|Treatment Cycle 2|Adverse Event|0|||
13191184|NCT02106351|26186949|FG001|Treatment Cycle 2|Adverse Event|2|||
13191185|NCT02106351|26186950|FG002|Treatment Cycle 2|Adverse Event|0|||
13191186|NCT02106351|26186948|FG000|Treatment Cycle 2|Consent withdrawn|0|||
13191187|NCT02106351|26186949|FG001|Treatment Cycle 2|Consent withdrawn|1|||
13191188|NCT02106351|26186950|FG002|Treatment Cycle 2|Consent withdrawn|1|||
13191189|NCT02106351|26186948|FG000|Treatment Cycle 2|Other|0|||
13191190|NCT02106351|26186949|FG001|Treatment Cycle 2|Other|2|||
13191191|NCT02106351|26186950|FG002|Treatment Cycle 2|Other|2|||
13191192|NCT02106351|26186948|FG000|Treatment Cycle 3|Adverse Event|0|||
13191193|NCT02106351|26186949|FG001|Treatment Cycle 3|Adverse Event|1|||
13223176|NCT01799889|26287988|FG000|Overall Study|Study Terminated By Sponsor|1|||
13111552|NCT03181789|25904062|FG003|Overall Study|Participant unable to adhere to visit|0|||
13111553|NCT03181594|25904071|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4|||
13111554|NCT03181594|25904071|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3|||
13111555|NCT03181594|25904071|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1|||
13111556|NCT03181594|25904071|FG000|Initial Study Protocol (12-month FU)|Death|1|||
13111557|NCT03181594|25904071|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3|||
13111558|NCT03181594|25904071|FG000|Long-term Extension (15-24 Month FU)|Death|2|||
13111559|NCT03181503|25904114|FG000|Overall Study|Adverse Event|2|||
13111560|NCT03181503|25904115|FG001|Overall Study|Adverse Event|2|||
13111561|NCT03181503|25904114|FG000|Overall Study|Protocol Violation|1|||
13111562|NCT03181503|25904115|FG001|Overall Study|Protocol Violation|0|||
13111563|NCT03181503|25904114|FG000|Overall Study|Withdrawal by Subject|3|||
13111564|NCT03181503|25904115|FG001|Overall Study|Withdrawal by Subject|0|||
13111565|NCT03181503|25904114|FG000|Overall Study|Lost to Follow-up|1|||
13111566|NCT03181503|25904115|FG001|Overall Study|Lost to Follow-up|1|||
13111567|NCT03181451|25904283|FG000|Overall Study|Adverse Event|0|||
13111568|NCT03181451|25904284|FG001|Overall Study|Adverse Event|1|||
13111569|NCT03181451|25904285|FG002|Overall Study|Adverse Event|0|||
13111570|NCT03181451|25904283|FG000|Overall Study|Withdrawal by Subject|0|||
13111571|NCT03181451|25904284|FG001|Overall Study|Withdrawal by Subject|1|||
13111572|NCT03181451|25904285|FG002|Overall Study|Withdrawal by Subject|0|||
13111573|NCT03180801|25904336|FG000|Overall Study|Physician Decision|3|||
13111574|NCT03180801|25904337|FG001|Overall Study|Physician Decision|3|||
13111575|NCT03180801|25904338|FG002|Overall Study|Physician Decision|1|||
13111576|NCT03180801|25904336|FG000|Overall Study|Non-compliance|1|||
13111577|NCT03180801|25904337|FG001|Overall Study|Non-compliance|4|||
13111578|NCT03180801|25904338|FG002|Overall Study|Non-compliance|0|||
13111579|NCT03180801|25904336|FG000|Overall Study|Inoculation Target Reached|1|||
13191194|NCT02106351|26186950|FG002|Treatment Cycle 3|Adverse Event|0|||
13191195|NCT02106351|26186948|FG000|Treatment Cycle 3|Consent withdrawn|0|||
13191196|NCT02106351|26186949|FG001|Treatment Cycle 3|Consent withdrawn|0|||
13191197|NCT02106351|26186950|FG002|Treatment Cycle 3|Consent withdrawn|2|||
13191198|NCT02106351|26186948|FG000|Treatment Cycle 3|Lost to Follow-up|0|||
13191199|NCT02106351|26186949|FG001|Treatment Cycle 3|Lost to Follow-up|1|||
13191200|NCT02106351|26186950|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
13191201|NCT02106351|26186948|FG000|Treatment Cycle 3|Other|0|||
13191202|NCT02106351|26186949|FG001|Treatment Cycle 3|Other|2|||
13191203|NCT02106351|26186950|FG002|Treatment Cycle 3|Other|3|||
13191204|NCT02106351|26186948|FG000|Treatment Cycle 4|Consent withdrawn|0|||
13191205|NCT02106351|26186949|FG001|Treatment Cycle 4|Consent withdrawn|0|||
13191206|NCT02106351|26186950|FG002|Treatment Cycle 4|Consent withdrawn|2|||
13191207|NCT02106351|26186948|FG000|Treatment Cycle 4|Other|0|||
13191208|NCT02106351|26186949|FG001|Treatment Cycle 4|Other|1|||
13191209|NCT02106351|26186950|FG002|Treatment Cycle 4|Other|0|||
13191210|NCT02106325|26186979|FG000|Phase 1|Lost to Follow-up|2|||
13191211|NCT02106325|26186980|FG001|Phase 1|Lost to Follow-up|2|||
13191212|NCT02106325|26186979|FG000|Phase 2|Lost to Follow-up|2|||
13191213|NCT02106325|26186980|FG001|Phase 2|Lost to Follow-up|3|||
13191214|NCT02106325|26186979|FG000|Phase 3|Lost to Follow-up|2|||
13191215|NCT02106325|26186980|FG001|Phase 3|Lost to Follow-up|1|||
13191216|NCT02106156|26187012|FG000|Overall Study|Patient Died|19|||
13191217|NCT02106156|26187013|FG001|Overall Study|Patient Died|0|||
13191218|NCT02106156|26187014|FG002|Overall Study|Patient Died|0|||
13191219|NCT02106156|26187012|FG000|Overall Study|Lack of Tolerability|305|||
13191220|NCT02106156|26187013|FG001|Overall Study|Lack of Tolerability|3|||
13191221|NCT02106156|26187014|FG002|Overall Study|Lack of Tolerability|0|||
13191222|NCT02106156|26187012|FG000|Overall Study|Lack of Virological Response|1044|||
13191223|NCT02106156|26187013|FG001|Overall Study|Lack of Virological Response|8|||
13191224|NCT02106156|26187014|FG002|Overall Study|Lack of Virological Response|0|||
13191225|NCT02106156|26187012|FG000|Overall Study|Concomitant Disease|74|||
13191226|NCT02106156|26187013|FG001|Overall Study|Concomitant Disease|2|||
13191227|NCT02106156|26187014|FG002|Overall Study|Concomitant Disease|0|||
13191228|NCT02106156|26187012|FG000|Overall Study|Lack of Compliance|211|||
13191229|NCT02106156|26187013|FG001|Overall Study|Lack of Compliance|7|||
13191230|NCT02106156|26187014|FG002|Overall Study|Lack of Compliance|0|||
13191231|NCT02106156|26187012|FG000|Overall Study|Patients Request|307|||
13191232|NCT02106156|26187013|FG001|Overall Study|Patients Request|9|||
13191233|NCT02106156|26187014|FG002|Overall Study|Patients Request|0|||
13191234|NCT02106156|26187012|FG000|Overall Study|Lost to Follow-up|451|||
13191235|NCT02106156|26187013|FG001|Overall Study|Lost to Follow-up|8|||
13191236|NCT02106156|26187014|FG002|Overall Study|Lost to Follow-up|0|||
13191237|NCT02106156|26187012|FG000|Overall Study|Unplanned Event|82|||
13191238|NCT02106156|26187013|FG001|Overall Study|Unplanned Event|2|||
13191239|NCT02106156|26187014|FG002|Overall Study|Unplanned Event|0|||
13191240|NCT02106156|26187012|FG000|Overall Study|Change of Laboratory Parameter|10|||
13191241|NCT02106156|26187013|FG001|Overall Study|Change of Laboratory Parameter|0|||
13191242|NCT02106156|26187014|FG002|Overall Study|Change of Laboratory Parameter|0|||
13191243|NCT02106156|26187012|FG000|Overall Study|Hospitalization/Surgical Intervention|6|||
13191244|NCT02106156|26187013|FG001|Overall Study|Hospitalization/Surgical Intervention|0|||
13191245|NCT02106156|26187014|FG002|Overall Study|Hospitalization/Surgical Intervention|0|||
13191246|NCT02106156|26187012|FG000|Overall Study|Relocation/Change of Physician|40|||
13191247|NCT02106156|26187013|FG001|Overall Study|Relocation/Change of Physician|1|||
13191248|NCT02106156|26187014|FG002|Overall Study|Relocation/Change of Physician|0|||
13191249|NCT02105987|26187077|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10|||
13191250|NCT02105987|26187078|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0|||
13191251|NCT02105987|26187079|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0|||
13191252|NCT02105987|26187080|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0|||
13191253|NCT02105987|26187081|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0|||
13191254|NCT02105987|26187082|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0|||
13191255|NCT02105987|26187077|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15|||
13191256|NCT02105987|26187078|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17|||
13191257|NCT02105987|26187079|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
13191258|NCT02105987|26187080|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
13191259|NCT02105987|26187081|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
13191260|NCT02105987|26187082|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
13191261|NCT02105987|26187077|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4|||
13191262|NCT02105987|26187078|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10|||
13191263|NCT02105987|26187079|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
13191264|NCT02105987|26187080|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
13191265|NCT02105987|26187081|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
13191266|NCT02105987|26187082|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
13191267|NCT02105987|26187077|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
13111580|NCT03180801|25904337|FG001|Overall Study|Inoculation Target Reached|1|||
13111581|NCT03180801|25904338|FG002|Overall Study|Inoculation Target Reached|3|||
13111582|NCT03180801|25904336|FG000|Overall Study|Adverse Event|1|||
13111583|NCT03180801|25904337|FG001|Overall Study|Adverse Event|0|||
13111584|NCT03180801|25904338|FG002|Overall Study|Adverse Event|2|||
13111585|NCT03180801|25904336|FG000|Overall Study|Withdrawal by Subject|2|||
13111586|NCT03180801|25904337|FG001|Overall Study|Withdrawal by Subject|2|||
13111587|NCT03180801|25904338|FG002|Overall Study|Withdrawal by Subject|1|||
13111588|NCT03180801|25904336|FG000|Overall Study|Lost to Follow-up|0|||
13111589|NCT03180801|25904337|FG001|Overall Study|Lost to Follow-up|2|||
13111590|NCT03180801|25904338|FG002|Overall Study|Lost to Follow-up|3|||
13111591|NCT03180736|25904368|FG000|Overall Study|Adverse Event|3|||
13111592|NCT03180736|25904369|FG001|Overall Study|Adverse Event|4|||
13111593|NCT03180736|25904368|FG000|Overall Study|Death|10|||
13191268|NCT02105987|26187078|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
13191269|NCT02105987|26187079|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
13191270|NCT02105987|26187080|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
13191271|NCT02105987|26187081|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
13111594|NCT03180736|25904369|FG001|Overall Study|Death|7|||
13111595|NCT03180736|25904368|FG000|Overall Study|Withdrawal by Subject|5|||
13111596|NCT03180736|25904369|FG001|Overall Study|Withdrawal by Subject|12|||
13111597|NCT03180736|25904368|FG000|Overall Study|Lost to Follow-up|1|||
13191272|NCT02105987|26187082|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
13191273|NCT02105987|26187077|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4|||
13191274|NCT02105987|26187078|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3|||
13191275|NCT02105987|26187079|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0|||
13191276|NCT02105987|26187080|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0|||
13191277|NCT02105987|26187081|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0|||
13191278|NCT02105987|26187082|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0|||
13191279|NCT02105987|26187077|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
13191280|NCT02105987|26187078|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1|||
13191281|NCT02105987|26187079|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
13191282|NCT02105987|26187080|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
13191283|NCT02105987|26187081|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
13191284|NCT02105987|26187082|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
13191285|NCT02105987|26187077|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0|||
13191286|NCT02105987|26187078|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0|||
13191287|NCT02105987|26187079|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10|||
13191288|NCT02105987|26187080|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4|||
13191289|NCT02105987|26187081|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0|||
13191290|NCT02105987|26187082|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0|||
13191291|NCT02105987|26187077|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
13191292|NCT02105987|26187078|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
13191293|NCT02105987|26187079|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15|||
13191294|NCT02105987|26187080|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1|||
13191295|NCT02105987|26187081|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
13191296|NCT02105987|26187082|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
13191297|NCT02105987|26187077|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
13191298|NCT02105987|26187078|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
13191299|NCT02105987|26187079|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6|||
13191300|NCT02105987|26187080|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5|||
13191301|NCT02105987|26187081|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
13191302|NCT02105987|26187082|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
13191303|NCT02105987|26187077|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
13191304|NCT02105987|26187078|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
13191305|NCT02105987|26187079|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8|||
13191306|NCT02105987|26187080|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3|||
13191307|NCT02105987|26187081|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
13191308|NCT02105987|26187082|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
13191309|NCT02105987|26187077|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0|||
13191310|NCT02105987|26187078|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0|||
13191311|NCT02105987|26187079|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5|||
13191312|NCT02105987|26187080|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0|||
13191313|NCT02105987|26187081|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0|||
13191314|NCT02105987|26187082|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0|||
13191315|NCT02105987|26187077|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
13191316|NCT02105987|26187078|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
13191317|NCT02105987|26187079|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
13191318|NCT02105987|26187080|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1|||
13191319|NCT02105987|26187081|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
13191320|NCT02105987|26187082|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
13191321|NCT02105987|26187077|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
13191322|NCT02105987|26187078|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
13191323|NCT02105987|26187079|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1|||
13191324|NCT02105987|26187080|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
13191325|NCT02105987|26187081|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
13191326|NCT02105987|26187082|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
13111598|NCT03180736|25904369|FG001|Overall Study|Lost to Follow-up|0|||
13111599|NCT03180736|25904368|FG000|Overall Study|Lack of Efficacy|66|||
13111600|NCT03180736|25904369|FG001|Overall Study|Lack of Efficacy|87|||
13111601|NCT03180736|25904368|FG000|Overall Study|Physician Decision|4|||
13111602|NCT03180736|25904369|FG001|Overall Study|Physician Decision|7|||
13111603|NCT03180736|25904368|FG000|Overall Study|randomized but not treated|2|||
13111604|NCT03180736|25904369|FG001|Overall Study|randomized but not treated|3|||
13111605|NCT03180645|25904418|FG000|Overall Study|Adverse Event|0|||
13111606|NCT03180645|25904419|FG001|Overall Study|Adverse Event|1|||
13111607|NCT03180645|25904420|FG002|Overall Study|Adverse Event|2|||
13111608|NCT03180619|25904573|FG000|Overall Study|Withdrew Consent|5|||
13111609|NCT03180619|25904574|FG001|Overall Study|Withdrew Consent|0|||
13111610|NCT03180619|25904575|FG002|Overall Study|Withdrew Consent|2|||
13111611|NCT03180619|25904573|FG000|Overall Study|Death|2|||
13111612|NCT03180619|25904574|FG001|Overall Study|Death|1|||
13191327|NCT02105987|26187077|FG000|Continuation Phase|Protocol Violation|0|||
13191328|NCT02105987|26187078|FG001|Continuation Phase|Protocol Violation|0|||
13191329|NCT02105987|26187079|FG002|Continuation Phase|Protocol Violation|0|||
13191330|NCT02105987|26187080|FG003|Continuation Phase|Protocol Violation|0|||
13191331|NCT02105987|26187081|FG004|Continuation Phase|Protocol Violation|1|||
13191332|NCT02105987|26187082|FG005|Continuation Phase|Protocol Violation|0|||
13191333|NCT02105974|26187100|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158|||
13191334|NCT02105974|26187101|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0|||
13191335|NCT02105974|26187102|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0|||
13191336|NCT02105974|26187100|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603|||
13191337|NCT02105974|26187101|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
13191338|NCT02105974|26187102|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
13191339|NCT02105974|26187100|FG000|2 Week Run-in Period|Adverse Event|6|||
13191340|NCT02105974|26187101|FG001|2 Week Run-in Period|Adverse Event|0|||
13191341|NCT02105974|26187102|FG002|2 Week Run-in Period|Adverse Event|0|||
13191342|NCT02105974|26187100|FG000|2 Week Run-in Period|Study closed/terminated|1|||
13191343|NCT02105974|26187101|FG001|2 Week Run-in Period|Study closed/terminated|0|||
13191344|NCT02105974|26187102|FG002|2 Week Run-in Period|Study closed/terminated|0|||
13191345|NCT02105974|26187100|FG000|2 Week Run-in Period|Lost to Follow-up|2|||
13191346|NCT02105974|26187101|FG001|2 Week Run-in Period|Lost to Follow-up|0|||
13191347|NCT02105974|26187102|FG002|2 Week Run-in Period|Lost to Follow-up|0|||
13191348|NCT02105974|26187100|FG000|2 Week Run-in Period|Withdrew consent|23|||
13191349|NCT02105974|26187101|FG001|2 Week Run-in Period|Withdrew consent|0|||
13191350|NCT02105974|26187102|FG002|2 Week Run-in Period|Withdrew consent|0|||
13191351|NCT02105974|26187100|FG000|2 Week Run-in Period|Investigator discretion|8|||
13191352|NCT02105974|26187101|FG001|2 Week Run-in Period|Investigator discretion|0|||
13191353|NCT02105974|26187102|FG002|2 Week Run-in Period|Investigator discretion|0|||
13191354|NCT02105974|26187100|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0|||
13191355|NCT02105974|26187101|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14|||
13191356|NCT02105974|26187102|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18|||
13191357|NCT02105974|26187100|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0|||
13191358|NCT02105974|26187101|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6|||
13191359|NCT02105974|26187102|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9|||
13191360|NCT02105974|26187100|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0|||
13191361|NCT02105974|26187101|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2|||
13191362|NCT02105974|26187102|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6|||
13191363|NCT02105974|26187100|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0|||
13191364|NCT02105974|26187101|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1|||
13191365|NCT02105974|26187102|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2|||
13191366|NCT02105974|26187100|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
13191367|NCT02105974|26187101|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
13191368|NCT02105974|26187102|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1|||
13191369|NCT02105974|26187100|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0|||
13191370|NCT02105974|26187101|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7|||
13191371|NCT02105974|26187102|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4|||
13191372|NCT02105974|26187100|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0|||
13191373|NCT02105974|26187101|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12|||
13191374|NCT02105974|26187102|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18|||
13191375|NCT02105961|26187132|FG000|Overall Study|Adverse Event|18|||
13191376|NCT02105961|26187133|FG001|Overall Study|Adverse Event|7|||
13191377|NCT02105961|26187134|FG002|Overall Study|Adverse Event|13|||
13191378|NCT02105961|26187132|FG000|Overall Study|Lack of Efficacy|3|||
13191379|NCT02105961|26187133|FG001|Overall Study|Lack of Efficacy|0|||
13191380|NCT02105961|26187134|FG002|Overall Study|Lack of Efficacy|3|||
13191381|NCT02105961|26187132|FG000|Overall Study|Lost to Follow-up|2|||
13191382|NCT02105961|26187133|FG001|Overall Study|Lost to Follow-up|0|||
13191383|NCT02105961|26187134|FG002|Overall Study|Lost to Follow-up|1|||
13191384|NCT02105961|26187132|FG000|Overall Study|Physician Decision|3|||
13191385|NCT02105961|26187133|FG001|Overall Study|Physician Decision|3|||
13191386|NCT02105961|26187134|FG002|Overall Study|Physician Decision|2|||
13191387|NCT02105961|26187132|FG000|Overall Study|Withdrawal by Subject|15|||
13191388|NCT02105961|26187133|FG001|Overall Study|Withdrawal by Subject|7|||
13191389|NCT02105961|26187134|FG002|Overall Study|Withdrawal by Subject|11|||
13191390|NCT02105948|26187173|FG000|Overall Study|Adverse Event|10|||
13191391|NCT02105948|26187174|FG001|Overall Study|Adverse Event|7|||
13191392|NCT02105948|26187175|FG002|Overall Study|Adverse Event|11|||
13191393|NCT02105948|26187176|FG003|Overall Study|Adverse Event|11|||
13191394|NCT02105948|26187173|FG000|Overall Study|Lack of Efficacy|0|||
13191395|NCT02105948|26187174|FG001|Overall Study|Lack of Efficacy|1|||
13191396|NCT02105948|26187175|FG002|Overall Study|Lack of Efficacy|3|||
13191397|NCT02105948|26187176|FG003|Overall Study|Lack of Efficacy|2|||
13191398|NCT02105948|26187173|FG000|Overall Study|Lost to Follow-up|0|||
13191399|NCT02105948|26187174|FG001|Overall Study|Lost to Follow-up|0|||
13191400|NCT02105948|26187175|FG002|Overall Study|Lost to Follow-up|2|||
13191401|NCT02105948|26187176|FG003|Overall Study|Lost to Follow-up|1|||
13191402|NCT02105948|26187173|FG000|Overall Study|Physician Decision|2|||
13191403|NCT02105948|26187174|FG001|Overall Study|Physician Decision|2|||
13191404|NCT02105948|26187175|FG002|Overall Study|Physician Decision|2|||
13191405|NCT02105948|26187176|FG003|Overall Study|Physician Decision|2|||
13191406|NCT02105948|26187173|FG000|Overall Study|Withdrawal by Subject|15|||
13191407|NCT02105948|26187174|FG001|Overall Study|Withdrawal by Subject|10|||
13191408|NCT02105948|26187175|FG002|Overall Study|Withdrawal by Subject|10|||
13191409|NCT02105948|26187176|FG003|Overall Study|Withdrawal by Subject|11|||
13191410|NCT02105701|26187211|FG000|Overall Study|Lost to Follow-up|1|||
13191411|NCT02105701|26187212|FG001|Overall Study|Lost to Follow-up|0|||
13191412|NCT02105701|26187213|FG002|Overall Study|Lost to Follow-up|2|||
13191413|NCT02105701|26187214|FG003|Overall Study|Lost to Follow-up|1|||
13191414|NCT02105701|26187211|FG000|Overall Study|Protocol Violation|0|||
13191415|NCT02105701|26187212|FG001|Overall Study|Protocol Violation|0|||
13191416|NCT02105701|26187213|FG002|Overall Study|Protocol Violation|1|||
13191417|NCT02105701|26187214|FG003|Overall Study|Protocol Violation|0|||
13191418|NCT02105701|26187211|FG000|Overall Study|Withdrawal by Subject|2|||
13191419|NCT02105701|26187212|FG001|Overall Study|Withdrawal by Subject|1|||
13191420|NCT02105701|26187213|FG002|Overall Study|Withdrawal by Subject|0|||
13191421|NCT02105701|26187214|FG003|Overall Study|Withdrawal by Subject|1|||
13191422|NCT02105701|26187211|FG000|Overall Study|Death|1|||
13191423|NCT02105701|26187212|FG001|Overall Study|Death|0|||
13191424|NCT02105701|26187213|FG002|Overall Study|Death|0|||
13191425|NCT02105701|26187214|FG003|Overall Study|Death|0|||
13191426|NCT02105688|26187234|FG000|Part A: Double-Blind|Adverse Event|1|||
13191427|NCT02105688|26187235|FG001|Part A: Double-Blind|Adverse Event|0|||
13191428|NCT02105688|26187234|FG000|Part A: Double-Blind|Death|0|||
13191429|NCT02105688|26187235|FG001|Part A: Double-Blind|Death|1|||
13191430|NCT02105688|26187234|FG000|Part A: Double-Blind|Lost to Follow-up|15|||
13191431|NCT02105688|26187235|FG001|Part A: Double-Blind|Lost to Follow-up|11|||
13191432|NCT02105688|26187234|FG000|Part A: Double-Blind|Physician Decision|0|||
13191433|NCT02105688|26187235|FG001|Part A: Double-Blind|Physician Decision|1|||
13191434|NCT02105688|26187234|FG000|Part A: Double-Blind|Status Unknown|0|||
13191435|NCT02105688|26187235|FG001|Part A: Double-Blind|Status Unknown|2|||
13191436|NCT02105688|26187234|FG000|Part A: Double-Blind|Withdrawal by Subject|4|||
13191437|NCT02105688|26187235|FG001|Part A: Double-Blind|Withdrawal by Subject|2|||
13191438|NCT02105688|26187234|FG000|Part B: Observational Follow-up|Death|2|||
13191439|NCT02105688|26187235|FG001|Part B: Observational Follow-up|Death|1|||
13191440|NCT02105688|26187234|FG000|Part B: Observational Follow-up|Lost to Follow-up|23|||
13191441|NCT02105688|26187235|FG001|Part B: Observational Follow-up|Lost to Follow-up|15|||
13191442|NCT02105688|26187234|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9|||
13191443|NCT02105688|26187235|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3|||
13191444|NCT02105688|26187234|FG000|Part B: Observational Follow-up|Physician Decision|3|||
13191445|NCT02105688|26187235|FG001|Part B: Observational Follow-up|Physician Decision|1|||
13191446|NCT02105662|26187244|FG000|Overall Study|Lost to Follow-up|5|||
13191447|NCT02105662|26187244|FG000|Overall Study|Withdrawal by Subject|1|||
13191448|NCT02105636|26187263|FG000|Pre-Treatment|Disease Progression|1|||
13191449|NCT02105636|26187264|FG001|Pre-Treatment|Disease Progression|0|||
13191450|NCT02105636|26187263|FG000|Pre-Treatment|Participant request to discontinue study treatment|1|||
13191451|NCT02105636|26187264|FG001|Pre-Treatment|Participant request to discontinue study treatment|2|||
13191452|NCT02105636|26187263|FG000|Pre-Treatment|Participant withdrew consent|0|||
13191453|NCT02105636|26187264|FG001|Pre-Treatment|Participant withdrew consent|6|||
13191454|NCT02105636|26187263|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
13191455|NCT02105636|26187264|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
13191456|NCT02105636|26187263|FG000|Treatment|Study Drug Toxicity|14|||
13191457|NCT02105636|26187264|FG001|Treatment|Study Drug Toxicity|10|||
13191458|NCT02105636|26187263|FG000|Treatment|Adverse event unrelated to study drug|19|||
13191459|NCT02105636|26187264|FG001|Treatment|Adverse event unrelated to study drug|3|||
13191460|NCT02105636|26187263|FG000|Treatment|Participant request to discontinue study treatment|8|||
13191461|NCT02105636|26187264|FG001|Treatment|Participant request to discontinue study treatment|6|||
13191462|NCT02105636|26187263|FG000|Treatment|Participant withdrew consent|5|||
13191463|NCT02105636|26187264|FG001|Treatment|Participant withdrew consent|1|||
13191464|NCT02105636|26187263|FG000|Treatment|Lost to Follow-up|1|||
13191465|NCT02105636|26187264|FG001|Treatment|Lost to Follow-up|0|||
13191466|NCT02105636|26187263|FG000|Treatment|Maximum Clinical Benefit|1|||
13191467|NCT02105636|26187264|FG001|Treatment|Maximum Clinical Benefit|3|||
13191468|NCT02105636|26187263|FG000|Treatment|Poor/Non-compliance|0|||
13191469|NCT02105636|26187264|FG001|Treatment|Poor/Non-compliance|1|||
13191470|NCT02105636|26187263|FG000|Treatment|Participant no longer meets study criteria|1|||
13191471|NCT02105636|26187264|FG001|Treatment|Participant no longer meets study criteria|0|||
13191472|NCT02105636|26187263|FG000|Treatment|Other reasons|1|||
13191473|NCT02105636|26187264|FG001|Treatment|Other reasons|0|||
13191474|NCT02105636|26187263|FG000|Treatment|Disease Progression|185|||
13191475|NCT02105636|26187264|FG001|Treatment|Disease Progression|87|||
13191476|NCT02105467|26187283|FG000|Period 1|Lost to Follow-up|1|||
13191477|NCT02105467|26187284|FG001|Period 1|Lost to Follow-up|0|||
13191478|NCT02105467|26187283|FG000|Period 1|Death|1|||
13191479|NCT02105467|26187284|FG001|Period 1|Death|0|||
13191480|NCT02105467|26187283|FG000|Period 2|Lost to Follow-up|1|||
13191481|NCT02105467|26187284|FG001|Period 2|Lost to Follow-up|0|||
13191482|NCT02105467|26187283|FG000|Period 2|Death|1|||
13191483|NCT02105467|26187284|FG001|Period 2|Death|0|||
13191484|NCT02105467|26187283|FG000|Period 2|Withdrawal by Subject|0|||
13191485|NCT02105467|26187284|FG001|Period 2|Withdrawal by Subject|2|||
13191486|NCT02105467|26187283|FG000|Period 3|Lost to Follow-up|0|||
13191487|NCT02105467|26187284|FG001|Period 3|Lost to Follow-up|1|||
13191488|NCT02105454|26187293|FG000|Overall Study|Withdrawal by Subject|1|||
13191489|NCT02105285|26187320|FG000|Overall Study|Adverse Event|1|||
13191490|NCT02105285|26187321|FG001|Overall Study|Adverse Event|1|||
13191491|NCT02105285|26187322|FG002|Overall Study|Adverse Event|0|||
13191492|NCT02105285|26187320|FG000|Overall Study|Protocol Violation|0|||
13191493|NCT02105285|26187321|FG001|Overall Study|Protocol Violation|1|||
13191494|NCT02105285|26187322|FG002|Overall Study|Protocol Violation|0|||
13191495|NCT02105285|26187320|FG000|Overall Study|Withdrawal by Subject|1|||
13191496|NCT02105285|26187321|FG001|Overall Study|Withdrawal by Subject|0|||
13191497|NCT02105285|26187322|FG002|Overall Study|Withdrawal by Subject|0|||
13191498|NCT02105272|26187345|FG000|Overall Study|Adverse Event|1|||
13191499|NCT02105272|26187346|FG001|Overall Study|Adverse Event|2|||
13191500|NCT02105272|26187345|FG000|Overall Study|Physician Decision|0|||
13191501|NCT02105272|26187346|FG001|Overall Study|Physician Decision|1|||
13191502|NCT02105272|26187345|FG000|Overall Study|Protocol Violation|2|||
13191503|NCT02105272|26187346|FG001|Overall Study|Protocol Violation|0|||
13191504|NCT02105272|26187345|FG000|Overall Study|Withdrawal by Subject|2|||
13191505|NCT02105272|26187346|FG001|Overall Study|Withdrawal by Subject|0|||
13191506|NCT02105116|26187355|FG000|Overall Study|not eligible for step 2 of trial|5|||
13191507|NCT02105116|26187355|FG000|Overall Study|Death|1|||
13191508|NCT02105012|26187389|FG000|Overall Study|Withdrawal by Subject|11|||
13191509|NCT02105012|26187389|FG000|Overall Study|Protocol Specified Criteria|9|||
13191510|NCT02105012|26187389|FG000|Overall Study|Lost to Follow-up|4|||
13191511|NCT02105012|26187389|FG000|Overall Study|Protocol Violation|4|||
13191512|NCT02105012|26187389|FG000|Overall Study|Physician Decision|3|||
13191513|NCT02105012|26187389|FG000|Overall Study|Adverse Event|1|||
13191514|NCT02105012|26187389|FG000|Overall Study|Lack of Efficacy|1|||
13191515|NCT02104947|26187412|FG000|Overall Study|Withdrawal by Subject|10|||
13191516|NCT02104947|26187413|FG001|Overall Study|Withdrawal by Subject|3|||
13191517|NCT02104947|26187412|FG000|Overall Study|Lost to Follow-up|4|||
13191518|NCT02104947|26187413|FG001|Overall Study|Lost to Follow-up|4|||
13191519|NCT02104947|26187412|FG000|Overall Study|Protocol Violation|6|||
13191520|NCT02104947|26187413|FG001|Overall Study|Protocol Violation|8|||
13191521|NCT02104947|26187412|FG000|Overall Study|Adverse Event|57|||
13191522|NCT02104947|26187413|FG001|Overall Study|Adverse Event|38|||
13191523|NCT02104947|26187412|FG000|Overall Study|Other than stated above|2|||
13191524|NCT02104947|26187413|FG001|Overall Study|Other than stated above|3|||
13191525|NCT02104895|26187430|FG000|Overall Study|Withdrawal by Subject|0|||
13191526|NCT02104895|26187431|FG001|Overall Study|Withdrawal by Subject|14|||
13191527|NCT02104817|26187470|FG000|Overall Study|Death|363|||
13191528|NCT02104817|26187471|FG001|Overall Study|Death|330|||
13191529|NCT02104817|26187470|FG000|Overall Study|Lost to Follow-up|3|||
13191530|NCT02104817|26187471|FG001|Overall Study|Lost to Follow-up|2|||
13191531|NCT02104817|26187470|FG000|Overall Study|Protocol Violation|0|||
13191532|NCT02104817|26187471|FG001|Overall Study|Protocol Violation|1|||
13191533|NCT02104817|26187470|FG000|Overall Study|Study terminated by sponsor|5854|||
13191534|NCT02104817|26187471|FG001|Overall Study|Study terminated by sponsor|5901|||
13191535|NCT02104817|26187470|FG000|Overall Study|Withdrawal by Subject|111|||
13191536|NCT02104817|26187471|FG001|Overall Study|Withdrawal by Subject|78|||
13191537|NCT02104817|26187470|FG000|Overall Study|Other reasons|128|||
13191538|NCT02104817|26187471|FG001|Overall Study|Other reasons|135|||
13191539|NCT02104804|26187494|FG000|Overall Study|Did not take study medication|0|||
13191540|NCT02104804|26187495|FG001|Overall Study|Did not take study medication|1|||
13191541|NCT02104804|26187494|FG000|Overall Study|Study specific discontinuation criteria|6|||
13191542|NCT02104804|26187495|FG001|Overall Study|Study specific discontinuation criteria|1|||
13191543|NCT02104804|26187494|FG000|Overall Study|Other listed|2|||
13191544|NCT02104804|26187495|FG001|Overall Study|Other listed|1|||
13191545|NCT02104804|26187494|FG000|Overall Study|Protocol Violation|0|||
13191546|NCT02104804|26187495|FG001|Overall Study|Protocol Violation|1|||
13191547|NCT02104804|26187494|FG000|Overall Study|Adverse Event|4|||
13191548|NCT02104804|26187495|FG001|Overall Study|Adverse Event|3|||
13191549|NCT02104804|26187494|FG000|Overall Study|Withdrawal by Subject|4|||
13191550|NCT02104804|26187495|FG001|Overall Study|Withdrawal by Subject|12|||
13191551|NCT02104765|26187543|FG000|Overall Study|Lost to Follow-up|0|||
13191552|NCT02104765|26187544|FG001|Overall Study|Lost to Follow-up|0|||
13191553|NCT02104765|26187545|FG002|Overall Study|Lost to Follow-up|1|||
13191554|NCT02104765|26187546|FG003|Overall Study|Lost to Follow-up|0|||
13191555|NCT02104765|26187547|FG004|Overall Study|Lost to Follow-up|0|||
13191556|NCT02104765|26187548|FG005|Overall Study|Lost to Follow-up|0|||
13191557|NCT02104765|26187549|FG006|Overall Study|Lost to Follow-up|0|||
13191558|NCT02104765|26187543|FG000|Overall Study|Withdrawal by Subject|0|||
13191559|NCT02104765|26187544|FG001|Overall Study|Withdrawal by Subject|0|||
13191560|NCT02104765|26187545|FG002|Overall Study|Withdrawal by Subject|0|||
13191561|NCT02104765|26187546|FG003|Overall Study|Withdrawal by Subject|1|||
13191562|NCT02104765|26187547|FG004|Overall Study|Withdrawal by Subject|1|||
13191563|NCT02104765|26187548|FG005|Overall Study|Withdrawal by Subject|0|||
13191564|NCT02104765|26187549|FG006|Overall Study|Withdrawal by Subject|1|||
13191565|NCT02104752|26187570|FG000|Overall Study|Withdrawal by Subject|1|||
13191566|NCT02104752|26187571|FG001|Overall Study|Withdrawal by Subject|0|||
13191567|NCT02104752|26187570|FG000|Overall Study|Weight gain; unrelated anxiety|0|||
13191568|NCT02104752|26187571|FG001|Overall Study|Weight gain; unrelated anxiety|2|||
13191569|NCT02104583|26187648|FG000|Overall Study|New ICD or CRT-D implanted|2|||
13191570|NCT02104583|26187649|FG001|Overall Study|New ICD or CRT-D implanted|0|||
13191571|NCT02104583|26187650|FG002|Overall Study|New ICD or CRT-D implanted|1|||
13191572|NCT02104583|26187651|FG003|Overall Study|New ICD or CRT-D implanted|0|||
13191573|NCT02104583|26187652|FG004|Overall Study|New ICD or CRT-D implanted|0|||
13191574|NCT02104583|26187648|FG000|Overall Study|Death|2|||
13191575|NCT02104583|26187649|FG001|Overall Study|Death|1|||
13191576|NCT02104583|26187650|FG002|Overall Study|Death|3|||
13191577|NCT02104583|26187651|FG003|Overall Study|Death|3|||
13191578|NCT02104583|26187652|FG004|Overall Study|Death|5|||
13191579|NCT02104583|26187648|FG000|Overall Study|Subject required cardiac ablation|6|||
13191580|NCT02104583|26187649|FG001|Overall Study|Subject required cardiac ablation|4|||
13191581|NCT02104583|26187650|FG002|Overall Study|Subject required cardiac ablation|4|||
13191582|NCT02104583|26187651|FG003|Overall Study|Subject required cardiac ablation|5|||
13191583|NCT02104583|26187652|FG004|Overall Study|Subject required cardiac ablation|4|||
13191584|NCT02104583|26187648|FG000|Overall Study|Subject required prohibited medication|0|||
13191585|NCT02104583|26187649|FG001|Overall Study|Subject required prohibited medication|1|||
13191586|NCT02104583|26187650|FG002|Overall Study|Subject required prohibited medication|1|||
13191587|NCT02104583|26187651|FG003|Overall Study|Subject required prohibited medication|0|||
13191588|NCT02104583|26187652|FG004|Overall Study|Subject required prohibited medication|1|||
13191589|NCT02104583|26187648|FG000|Overall Study|Withdrew Consent|3|||
13191590|NCT02104583|26187649|FG001|Overall Study|Withdrew Consent|2|||
13191591|NCT02104583|26187650|FG002|Overall Study|Withdrew Consent|0|||
13191592|NCT02104583|26187651|FG003|Overall Study|Withdrew Consent|2|||
13191593|NCT02104583|26187652|FG004|Overall Study|Withdrew Consent|1|||
13191594|NCT02104583|26187648|FG000|Overall Study|Investigator's Discretion|1|||
13191595|NCT02104583|26187649|FG001|Overall Study|Investigator's Discretion|0|||
13191596|NCT02104583|26187650|FG002|Overall Study|Investigator's Discretion|0|||
13191597|NCT02104583|26187651|FG003|Overall Study|Investigator's Discretion|0|||
13191598|NCT02104583|26187652|FG004|Overall Study|Investigator's Discretion|0|||
13191599|NCT02104583|26187648|FG000|Overall Study|Protocol Violation|0|||
13191600|NCT02104583|26187649|FG001|Overall Study|Protocol Violation|0|||
13191601|NCT02104583|26187650|FG002|Overall Study|Protocol Violation|1|||
13191602|NCT02104583|26187651|FG003|Overall Study|Protocol Violation|0|||
13191603|NCT02104583|26187652|FG004|Overall Study|Protocol Violation|0|||
13111613|NCT03180619|25904575|FG002|Overall Study|Death|2|||
13111614|NCT03180619|25904573|FG000|Overall Study|Adverse Event|2|||
13111615|NCT03180619|25904574|FG001|Overall Study|Adverse Event|0|||
13111616|NCT03180619|25904575|FG002|Overall Study|Adverse Event|1|||
13111617|NCT03180619|25904573|FG000|Overall Study|Investigator's discretion|2|||
13111618|NCT03180619|25904574|FG001|Overall Study|Investigator's discretion|0|||
13111619|NCT03180619|25904575|FG002|Overall Study|Investigator's discretion|1|||
13111620|NCT03180528|25904584|FG000|Overall Study|Adverse Event|1|||
13111621|NCT03180528|25904584|FG000|Overall Study|Withdrawal by Subject|1|||
13111622|NCT03180528|25904584|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1|||
13111623|NCT03180138|25904605|FG000|Overall Study|Mobile-phone could not be verified|2|||
13111624|NCT03180138|25904606|FG001|Overall Study|Mobile-phone could not be verified|13|||
13111625|NCT03180138|25904607|FG002|Overall Study|Mobile-phone could not be verified|15|||
13111626|NCT03180138|25904605|FG000|Overall Study|No prior immunization records|17|||
13111627|NCT03180138|25904606|FG001|Overall Study|No prior immunization records|0|||
13111628|NCT03180138|25904607|FG002|Overall Study|No prior immunization records|6|||
13111629|NCT03180138|25904605|FG000|Overall Study|Found to be >24 mon after randomization|3|||
13191604|NCT02104583|26187648|FG000|Overall Study|Adverse Event|3|||
13191605|NCT02104583|26187649|FG001|Overall Study|Adverse Event|3|||
13191606|NCT02104583|26187650|FG002|Overall Study|Adverse Event|6|||
13191607|NCT02104583|26187651|FG003|Overall Study|Adverse Event|6|||
13191608|NCT02104583|26187652|FG004|Overall Study|Adverse Event|1|||
13191609|NCT02104583|26187648|FG000|Overall Study|Lost to Follow-up|1|||
13191610|NCT02104583|26187649|FG001|Overall Study|Lost to Follow-up|0|||
13191611|NCT02104583|26187650|FG002|Overall Study|Lost to Follow-up|0|||
13191612|NCT02104583|26187651|FG003|Overall Study|Lost to Follow-up|0|||
13111630|NCT03180138|25904606|FG001|Overall Study|Found to be >24 mon after randomization|0|||
13111631|NCT03180138|25904607|FG002|Overall Study|Found to be >24 mon after randomization|3|||
13111632|NCT03179891|25904630|FG000|First Intervention|Withdrawal by Subject|1|||
13111633|NCT03179891|25904631|FG001|First Intervention|Withdrawal by Subject|1|||
13111634|NCT03179891|25904630|FG000|First Intervention|Unspecified reason|1|||
13111635|NCT03179891|25904631|FG001|First Intervention|Unspecified reason|0|||
13111636|NCT03179891|25904630|FG000|First Intervention|Protocol Violation|0|||
13111637|NCT03179891|25904631|FG001|First Intervention|Protocol Violation|1|||
13111638|NCT03179787|25904637|FG000|Overall Study|Lost to Follow-up|15|||
13111639|NCT03179787|25904637|FG000|Overall Study|Case report failures|2|||
13111640|NCT03179787|25904637|FG000|Overall Study|Treatment not administered|1|||
13111641|NCT03179319|25904657|FG000|Overall Study|Lost to Follow-up|6|||
13111642|NCT03179319|25904658|FG001|Overall Study|Lost to Follow-up|0|||
13111643|NCT03179202|25904671|FG000|Overall Study|Screen Failure|67|||
13111644|NCT03179202|25904671|FG000|Overall Study|Subject Lost to Follow Up|12|||
13111645|NCT03179202|25904671|FG000|Overall Study|Withdrawal by Subject|7|||
13111646|NCT03179202|25904671|FG000|Overall Study|Adverse Event|3|||
13111647|NCT03179202|25904671|FG000|Overall Study|Unrelated Death Reported in All-Cause Mortality|1|||
13111648|NCT03179202|25904671|FG000|Overall Study|Other Reason: Incarceration after Enrollment|1|||
13111649|NCT03178942|25904690|FG000|Overall Study|Withdrawal by Subject|2|||
13111650|NCT03178942|25904691|FG001|Overall Study|Withdrawal by Subject|0|||
13111651|NCT03178942|25904690|FG000|Overall Study|Lost to Follow-up|1|||
13111652|NCT03178942|25904691|FG001|Overall Study|Lost to Follow-up|2|||
13111653|NCT03178851|25904736|FG000|Overall Study|Death|48|||
13111654|NCT03178851|25904737|FG001|Overall Study|Death|2|||
13111655|NCT03178851|25904738|FG002|Overall Study|Death|25|||
13111656|NCT03178851|25904736|FG000|Overall Study|Withdrawal by Subject|8|||
13111657|NCT03178851|25904737|FG001|Overall Study|Withdrawal by Subject|0|||
13111658|NCT03178851|25904738|FG002|Overall Study|Withdrawal by Subject|0|||
13111659|NCT03178851|25904736|FG000|Overall Study|Lost to Follow-up|5|||
13111660|NCT03178851|25904737|FG001|Overall Study|Lost to Follow-up|2|||
13111661|NCT03178851|25904738|FG002|Overall Study|Lost to Follow-up|0|||
13111662|NCT03178851|25904736|FG000|Overall Study|Adverse Event|0|||
13111663|NCT03178851|25904737|FG001|Overall Study|Adverse Event|0|||
13111664|NCT03178851|25904738|FG002|Overall Study|Adverse Event|1|||
13111665|NCT03178851|25904736|FG000|Overall Study|Study Termination by Sponsor|31|||
13111666|NCT03178851|25904737|FG001|Overall Study|Study Termination by Sponsor|7|||
13111667|NCT03178851|25904738|FG002|Overall Study|Study Termination by Sponsor|26|||
13111668|NCT03178773|25904852|FG000|Overall Study|Death|0|||
13111669|NCT03178773|25904853|FG001|Overall Study|Death|1|||
13111670|NCT03178773|25904852|FG000|Overall Study|Lost to Follow-up|29|||
13111671|NCT03178773|25904853|FG001|Overall Study|Lost to Follow-up|25|||
13111672|NCT03178773|25904852|FG000|Overall Study|Withdrawal by Subject|10|||
13111673|NCT03178773|25904853|FG001|Overall Study|Withdrawal by Subject|14|||
13133264|NCT02776033|25987077|FG000|Overall Study|Adverse Event|1|||
13133265|NCT02776033|25987078|FG001|Overall Study|Adverse Event|2|||
13133266|NCT02776033|25987079|FG002|Overall Study|Adverse Event|0|||
13133267|NCT02775916|25987104|FG000|Overall Study|Adverse Event|1|||
13133268|NCT02775916|25987105|FG001|Overall Study|Adverse Event|0|||
13133269|NCT02775916|25987104|FG000|Overall Study|Subject/Guardian Decision|2|||
13133270|NCT02775916|25987105|FG001|Overall Study|Subject/Guardian Decision|0|||
13133271|NCT02775903|25987166|FG000|Overall Study|Ongoing|14|||
13133272|NCT02775903|25987167|FG001|Overall Study|Ongoing|15|||
13133273|NCT02775903|25987168|FG002|Overall Study|Ongoing|15|||
13133274|NCT02775903|25987169|FG003|Overall Study|Ongoing|19|||
13133275|NCT02775903|25987166|FG000|Overall Study|Death|19|||
13133276|NCT02775903|25987167|FG001|Overall Study|Death|18|||
13133277|NCT02775903|25987168|FG002|Overall Study|Death|38|||
13133278|NCT02775903|25987169|FG003|Overall Study|Death|35|||
13133279|NCT02775903|25987166|FG000|Overall Study|Withdrawal by Subject|5|||
13133280|NCT02775903|25987167|FG001|Overall Study|Withdrawal by Subject|5|||
13133281|NCT02775903|25987168|FG002|Overall Study|Withdrawal by Subject|5|||
13133282|NCT02775903|25987169|FG003|Overall Study|Withdrawal by Subject|4|||
13133283|NCT02775903|25987166|FG000|Overall Study|Adverse Event|0|||
13133284|NCT02775903|25987167|FG001|Overall Study|Adverse Event|0|||
13191613|NCT02104583|26187652|FG004|Overall Study|Lost to Follow-up|0|||
13191614|NCT02104583|26187648|FG000|Overall Study|Randomized but Never Treated|0|||
13191615|NCT02104583|26187649|FG001|Overall Study|Randomized but Never Treated|0|||
13191616|NCT02104583|26187650|FG002|Overall Study|Randomized but Never Treated|0|||
13191617|NCT02104583|26187651|FG003|Overall Study|Randomized but Never Treated|1|||
13191618|NCT02104583|26187652|FG004|Overall Study|Randomized but Never Treated|0|||
13191619|NCT02104557|26187667|FG000|Overall Study|Adverse Event|24|||
13191620|NCT02104557|26187667|FG000|Overall Study|Lost to Follow-up|34|||
13133285|NCT02775903|25987168|FG002|Overall Study|Adverse Event|1|||
13133286|NCT02775903|25987169|FG003|Overall Study|Adverse Event|1|||
13133287|NCT02775903|25987166|FG000|Overall Study|Lost to Follow-up|0|||
13133288|NCT02775903|25987167|FG001|Overall Study|Lost to Follow-up|0|||
13133289|NCT02775903|25987168|FG002|Overall Study|Lost to Follow-up|1|||
13191621|NCT02104557|26187667|FG000|Overall Study|Violated the usage and dosage|14|||
13191622|NCT02104557|26187667|FG000|Overall Study|No longer met inclusion/exclusion criteria|1|||
13191623|NCT02104557|26187667|FG000|Overall Study|Administered Sayana prior to the contract|1|||
13191624|NCT02104557|26187667|FG000|Overall Study|Other|17|||
13191625|NCT02104557|26187667|FG000|Overall Study|Change to other contraception methods|5|||
13191626|NCT02104557|26187667|FG000|Overall Study|Discontinuation due to no pain|1|||
13191627|NCT02104557|26187667|FG000|Overall Study|Withdrawal consent|2|||
13191628|NCT02104557|26187667|FG000|Overall Study|Refusal of administration due to unknown reasons|69|||
13191629|NCT02104557|26187667|FG000|Overall Study|Discontinuation of contraception|9|||
13191630|NCT02104505|26187686|FG000|First Intervention (14 Days)|Adverse Event|2|||
13191631|NCT02104505|26187687|FG001|First Intervention (14 Days)|Adverse Event|0|||
13191632|NCT02104505|26187686|FG000|First Intervention (14 Days)|Withdrawal by Subject|0|||
13191633|NCT02104505|26187687|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
13191634|NCT02104505|26187686|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
13191635|NCT02104505|26187687|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
13191636|NCT02104505|26187686|FG000|First Intervention (14 Days)|exclusionary condition|0|||
13111674|NCT03178669|25904906|FG000|Overall Study|Adverse Event|4|||
13111675|NCT03178669|25904907|FG001|Overall Study|Adverse Event|1|||
13111676|NCT03178669|25904908|FG002|Overall Study|Adverse Event|4|||
13111677|NCT03178669|25904909|FG003|Overall Study|Adverse Event|2|||
13111678|NCT03178669|25904910|FG004|Overall Study|Adverse Event|2|||
13111679|NCT03178669|25904906|FG000|Overall Study|Lack of Efficacy|0|||
13111680|NCT03178669|25904907|FG001|Overall Study|Lack of Efficacy|0|||
13111681|NCT03178669|25904908|FG002|Overall Study|Lack of Efficacy|2|||
13111682|NCT03178669|25904909|FG003|Overall Study|Lack of Efficacy|0|||
13111683|NCT03178669|25904910|FG004|Overall Study|Lack of Efficacy|1|||
13111684|NCT03178669|25904906|FG000|Overall Study|Physician Decision|0|||
13111685|NCT03178669|25904907|FG001|Overall Study|Physician Decision|0|||
13111686|NCT03178669|25904908|FG002|Overall Study|Physician Decision|0|||
13111687|NCT03178669|25904909|FG003|Overall Study|Physician Decision|0|||
13111688|NCT03178669|25904910|FG004|Overall Study|Physician Decision|1|||
13111689|NCT03178669|25904906|FG000|Overall Study|Withdrawal by Subject|1|||
13111690|NCT03178669|25904907|FG001|Overall Study|Withdrawal by Subject|0|||
13111691|NCT03178669|25904908|FG002|Overall Study|Withdrawal by Subject|1|||
13111692|NCT03178669|25904909|FG003|Overall Study|Withdrawal by Subject|1|||
13111693|NCT03178669|25904910|FG004|Overall Study|Withdrawal by Subject|0|||
13111694|NCT03178669|25904906|FG000|Overall Study|Lost to Follow-up|0|||
13111695|NCT03178669|25904907|FG001|Overall Study|Lost to Follow-up|0|||
13111696|NCT03178669|25904908|FG002|Overall Study|Lost to Follow-up|0|||
13111697|NCT03178669|25904909|FG003|Overall Study|Lost to Follow-up|1|||
13111698|NCT03178669|25904910|FG004|Overall Study|Lost to Follow-up|0|||
13111699|NCT03178266|25904925|FG000|Overall Study|Death|0|||
13111700|NCT03178266|25904926|FG001|Overall Study|Death|1|||
13111701|NCT03178266|25904925|FG000|Overall Study|Disont. Early|0|||
13111702|NCT03178266|25904926|FG001|Overall Study|Disont. Early|1|||
13111703|NCT03178266|25904925|FG000|Overall Study|Withdrawal by Subject|0|||
13111704|NCT03178266|25904926|FG001|Overall Study|Withdrawal by Subject|2|||
13111705|NCT03178201|25904937|FG000|Overall Study|Off study|5|||
13111706|NCT03178045|25904969|FG000|Overall Study|Withdrawal by Subject|5|||
13111707|NCT03178045|25904970|FG001|Overall Study|Withdrawal by Subject|7|||
13111708|NCT03178045|25904969|FG000|Overall Study|Surgery Cancelled/Relocated|34|||
13111709|NCT03178045|25904970|FG001|Overall Study|Surgery Cancelled/Relocated|30|||
13111710|NCT03178045|25904969|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47|||
13111711|NCT03178045|25904970|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46|||
13111712|NCT03176966|25904985|FG000|Baseline to 3 Months (1st Intervention)|Death|2|||
13111713|NCT03176966|25904986|FG001|Baseline to 3 Months (1st Intervention)|Death|1|||
13111714|NCT03176966|25904985|FG000|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|1|||
13111715|NCT03176966|25904986|FG001|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|4|||
13111716|NCT03176966|25904985|FG000|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|1|||
13111717|NCT03176966|25904986|FG001|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|2|||
13111718|NCT03176966|25904985|FG000|3 Month to 6 Months (2nd Intervention)|Death|0|||
13111719|NCT03176966|25904986|FG001|3 Month to 6 Months (2nd Intervention)|Death|1|||
13111720|NCT03176966|25904985|FG000|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|3|||
13111721|NCT03176966|25904986|FG001|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|4|||
13111722|NCT03176966|25904985|FG000|3 Month to 6 Months (2nd Intervention)|Physician Decision|1|||
13111723|NCT03176966|25904986|FG001|3 Month to 6 Months (2nd Intervention)|Physician Decision|0|||
13111724|NCT03176966|25904985|FG000|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|2|||
13111725|NCT03176966|25904986|FG001|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|0|||
13111726|NCT03176459|25905015|FG000|Overall Study|Lost to Follow-up|5|||
13111727|NCT03176459|25905016|FG001|Overall Study|Lost to Follow-up|7|||
13111728|NCT03176407|25905026|FG000|Overall Study|Protocol Violation|1|||
13111729|NCT03176407|25905026|FG000|Overall Study|human failure|1|||
13191637|NCT02104505|26187687|FG001|First Intervention (14 Days)|exclusionary condition|1|||
13206329|NCT01958281|26234402|FG000|Overall Study|Withdrew Consent|1|||
13191638|NCT02104505|26187686|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
13191639|NCT02104505|26187687|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
13191640|NCT02104505|26187686|FG000|Second Intervention (14 Days)|Adverse Event|2|||
13191641|NCT02104505|26187687|FG001|Second Intervention (14 Days)|Adverse Event|0|||
13191642|NCT02103478|26187818|FG000|Overall Study|Adverse Event|0|||
13191643|NCT02103478|26187819|FG001|Overall Study|Adverse Event|0|||
13191644|NCT02103478|26187820|FG002|Overall Study|Adverse Event|1|||
13191645|NCT02103478|26187821|FG003|Overall Study|Adverse Event|1|||
13191646|NCT02103478|26187822|FG004|Overall Study|Adverse Event|2|||
13191647|NCT02103478|26187823|FG005|Overall Study|Adverse Event|1|||
13191648|NCT02103478|26187824|FG006|Overall Study|Adverse Event|0|||
13191649|NCT02103478|26187825|FG007|Overall Study|Adverse Event|0|||
13191650|NCT02103478|26187826|FG008|Overall Study|Adverse Event|0|||
13191651|NCT02103478|26187818|FG000|Overall Study|Death|2|||
13191652|NCT02103478|26187819|FG001|Overall Study|Death|2|||
13191653|NCT02103478|26187820|FG002|Overall Study|Death|1|||
13191654|NCT02103478|26187821|FG003|Overall Study|Death|1|||
13191655|NCT02103478|26187822|FG004|Overall Study|Death|5|||
13191656|NCT02103478|26187823|FG005|Overall Study|Death|15|||
13191657|NCT02103478|26187824|FG006|Overall Study|Death|14|||
13191658|NCT02103478|26187825|FG007|Overall Study|Death|10|||
13191659|NCT02103478|26187826|FG008|Overall Study|Death|11|||
13191660|NCT02103478|26187818|FG000|Overall Study|Progressive Disease|2|||
13191661|NCT02103478|26187819|FG001|Overall Study|Progressive Disease|1|||
13191662|NCT02103478|26187820|FG002|Overall Study|Progressive Disease|2|||
13191663|NCT02103478|26187821|FG003|Overall Study|Progressive Disease|0|||
13191664|NCT02103478|26187822|FG004|Overall Study|Progressive Disease|9|||
13191665|NCT02103478|26187823|FG005|Overall Study|Progressive Disease|1|||
13191666|NCT02103478|26187824|FG006|Overall Study|Progressive Disease|2|||
13191667|NCT02103478|26187825|FG007|Overall Study|Progressive Disease|0|||
13191668|NCT02103478|26187826|FG008|Overall Study|Progressive Disease|1|||
13191669|NCT02103478|26187818|FG000|Overall Study|Withdrawal by Subject|2|||
13191670|NCT02103478|26187819|FG001|Overall Study|Withdrawal by Subject|0|||
13191671|NCT02103478|26187820|FG002|Overall Study|Withdrawal by Subject|0|||
13191672|NCT02103478|26187821|FG003|Overall Study|Withdrawal by Subject|4|||
13191673|NCT02103478|26187822|FG004|Overall Study|Withdrawal by Subject|0|||
13191674|NCT02103478|26187823|FG005|Overall Study|Withdrawal by Subject|0|||
13191675|NCT02103478|26187824|FG006|Overall Study|Withdrawal by Subject|1|||
13191676|NCT02103478|26187825|FG007|Overall Study|Withdrawal by Subject|1|||
13191677|NCT02103478|26187826|FG008|Overall Study|Withdrawal by Subject|0|||
13191678|NCT02103478|26187818|FG000|Overall Study|Lost to Follow-up|0|||
13191679|NCT02103478|26187819|FG001|Overall Study|Lost to Follow-up|0|||
13191680|NCT02103478|26187820|FG002|Overall Study|Lost to Follow-up|0|||
13191681|NCT02103478|26187821|FG003|Overall Study|Lost to Follow-up|0|||
13191682|NCT02103478|26187822|FG004|Overall Study|Lost to Follow-up|0|||
13191683|NCT02103478|26187823|FG005|Overall Study|Lost to Follow-up|0|||
13191684|NCT02103478|26187824|FG006|Overall Study|Lost to Follow-up|0|||
13191685|NCT02103478|26187825|FG007|Overall Study|Lost to Follow-up|1|||
13191686|NCT02103478|26187826|FG008|Overall Study|Lost to Follow-up|0|||
13191687|NCT02103478|26187818|FG000|Overall Study|Other|1|||
13191688|NCT02103478|26187819|FG001|Overall Study|Other|3|||
13191689|NCT02103478|26187820|FG002|Overall Study|Other|2|||
13191690|NCT02103478|26187821|FG003|Overall Study|Other|0|||
13191691|NCT02103478|26187822|FG004|Overall Study|Other|3|||
13191692|NCT02103478|26187823|FG005|Overall Study|Other|8|||
13191693|NCT02103478|26187824|FG006|Overall Study|Other|8|||
13191694|NCT02103478|26187825|FG007|Overall Study|Other|4|||
13191695|NCT02103478|26187826|FG008|Overall Study|Other|2|||
13191696|NCT02103439|26187853|FG000|Overall Study|Adverse Event|0|||
13191697|NCT02103439|26187854|FG001|Overall Study|Adverse Event|2|||
13191698|NCT02103439|26187853|FG000|Overall Study|Withdrawal by Subject|3|||
13191699|NCT02103439|26187854|FG001|Overall Study|Withdrawal by Subject|1|||
13191700|NCT02103062|26187879|FG000|Overall Study|Adverse Event|1|||
13191701|NCT02103062|26187880|FG001|Overall Study|Adverse Event|2|||
13191702|NCT02103062|26187879|FG000|Overall Study|Progressive Disease|17|||
13191703|NCT02103062|26187880|FG001|Overall Study|Progressive Disease|20|||
13191704|NCT02103062|26187879|FG000|Overall Study|Death|0|||
13191705|NCT02103062|26187880|FG001|Overall Study|Death|1|||
13191706|NCT02102724|26187893|FG000|Overall Study|Lost to Follow-up|1|||
13191707|NCT02102724|26187894|FG001|Overall Study|Lost to Follow-up|0|||
13191708|NCT02102724|26187893|FG000|Overall Study|surgery for brain aneurysm|1|||
13191709|NCT02102724|26187894|FG001|Overall Study|surgery for brain aneurysm|1|||
13191710|NCT02102490|26187908|FG000|Overall Study|Death|6|||
13191711|NCT02102490|26187908|FG000|Overall Study|Lost to Follow-up|1|||
13191712|NCT02102464|26187933|FG000|Randomized Study|Withdrawal by Subject|0|||
13191713|NCT02102464|26187934|FG001|Randomized Study|Withdrawal by Subject|1|||
13191714|NCT02102464|26187935|FG002|Randomized Study|Withdrawal by Subject|0|||
13191715|NCT02102399|26187990|FG000|Overall Study|Withdrawal by Subject|6|||
13191716|NCT02102399|26187991|FG001|Overall Study|Withdrawal by Subject|4|||
13191717|NCT02102204|26188002|FG000|Overall Study|Withdrawal by Subject|137|||
13191718|NCT02102204|26188002|FG000|Overall Study|Death|92|||
13191719|NCT02102204|26188002|FG000|Overall Study|Lost to Follow-up|65|||
13191720|NCT02102204|26188002|FG000|Overall Study|Sponsor Decision|5|||
13191721|NCT02102204|26188002|FG000|Overall Study|Ongoing|5|||
13191722|NCT02101983|26188019|FG000|Overall Study|Physician Decision|1|||
13191723|NCT02101983|26188020|FG001|Overall Study|Physician Decision|0|||
13191724|NCT02101554|26188110|FG000|Overall Study|Protocol Violation|0|||
13191725|NCT02101554|26188111|FG001|Overall Study|Protocol Violation|1|||
13191726|NCT02101554|26188112|FG002|Overall Study|Protocol Violation|0|||
13191727|NCT02101554|26188110|FG000|Overall Study|Insufficient Clinical Response|0|||
13191728|NCT02101554|26188111|FG001|Overall Study|Insufficient Clinical Response|2|||
13191729|NCT02101554|26188112|FG002|Overall Study|Insufficient Clinical Response|0|||
13191730|NCT02101554|26188110|FG000|Overall Study|Adverse Event|2|||
13191731|NCT02101554|26188111|FG001|Overall Study|Adverse Event|1|||
13191732|NCT02101554|26188112|FG002|Overall Study|Adverse Event|1|||
13191733|NCT02101554|26188110|FG000|Overall Study|Lost to Follow-up|0|||
13191734|NCT02101554|26188111|FG001|Overall Study|Lost to Follow-up|1|||
13191735|NCT02101554|26188112|FG002|Overall Study|Lost to Follow-up|0|||
13191736|NCT02101554|26188110|FG000|Overall Study|Withdrawl by Parents/Guardians|1|||
13191737|NCT02101554|26188111|FG001|Overall Study|Withdrawl by Parents/Guardians|0|||
13191738|NCT02101554|26188112|FG002|Overall Study|Withdrawl by Parents/Guardians|0|||
13191739|NCT02101359|26188125|FG000|Overall Study|Not included|23|||
13191740|NCT02101359|26188126|FG001|Overall Study|Not included|13|||
13191741|NCT02101359|26188125|FG000|Overall Study|Withdrawal by Subject|5|||
13191742|NCT02101359|26188126|FG001|Overall Study|Withdrawal by Subject|4|||
13191743|NCT02101359|26188125|FG000|Overall Study|Lost to Follow-up|1|||
13191744|NCT02101359|26188126|FG001|Overall Study|Lost to Follow-up|0|||
13191745|NCT02101359|26188125|FG000|Overall Study|Protocol Violation|0|||
13191746|NCT02101359|26188126|FG001|Overall Study|Protocol Violation|2|||
13191747|NCT02101294|26188135|FG000|Overall Study|Withdrawal by Subject|5|||
13191748|NCT02101294|26188135|FG000|Overall Study|Lost to Follow-up|6|||
13191749|NCT02101112|26188167|FG000|Overall Study|Adverse Event|0|||
13191750|NCT02101112|26188168|FG001|Overall Study|Adverse Event|0|||
13191751|NCT02101112|26188169|FG002|Overall Study|Adverse Event|1|||
13191752|NCT02101112|26188170|FG003|Overall Study|Adverse Event|0|||
13191753|NCT02101112|26188171|FG004|Overall Study|Adverse Event|0|||
13191754|NCT02101112|26188172|FG005|Overall Study|Adverse Event|0|||
13191755|NCT02101112|26188167|FG000|Overall Study|Withdrawal by Subject|0|||
13191756|NCT02101112|26188168|FG001|Overall Study|Withdrawal by Subject|0|||
13191757|NCT02101112|26188169|FG002|Overall Study|Withdrawal by Subject|0|||
13191758|NCT02101112|26188170|FG003|Overall Study|Withdrawal by Subject|0|||
13191759|NCT02101112|26188171|FG004|Overall Study|Withdrawal by Subject|1|||
13191760|NCT02101112|26188172|FG005|Overall Study|Withdrawal by Subject|0|||
13191761|NCT02101060|26188189|FG000|Overall Study|Adverse Event|1|||
13191762|NCT02101060|26188190|FG001|Overall Study|Adverse Event|0|||
13191763|NCT02101060|26188189|FG000|Overall Study|Withdrawal by Subject|1|||
13191764|NCT02101060|26188190|FG001|Overall Study|Withdrawal by Subject|1|||
13191765|NCT02101060|26188189|FG000|Overall Study|Lost to Follow-up|3|||
13191766|NCT02101060|26188190|FG001|Overall Study|Lost to Follow-up|3|||
13191767|NCT02101021|26188248|FG000|Overall Study|Death|4|||
13191768|NCT02101021|26188249|FG001|Overall Study|Death|3|||
13191769|NCT02101021|26188250|FG002|Overall Study|Death|6|||
13191770|NCT02101021|26188251|FG003|Overall Study|Death|0|||
13191771|NCT02101021|26188252|FG004|Overall Study|Death|3|||
13191772|NCT02101021|26188248|FG000|Overall Study|Withdrew Consent from study|1|||
13191773|NCT02101021|26188249|FG001|Overall Study|Withdrew Consent from study|1|||
13191774|NCT02101021|26188250|FG002|Overall Study|Withdrew Consent from study|0|||
13191775|NCT02101021|26188251|FG003|Overall Study|Withdrew Consent from study|2|||
13191776|NCT02101021|26188252|FG004|Overall Study|Withdrew Consent from study|0|||
13191777|NCT02101021|26188248|FG000|Overall Study|Lost to Follow-up|1|||
13191778|NCT02101021|26188249|FG001|Overall Study|Lost to Follow-up|0|||
13191779|NCT02101021|26188250|FG002|Overall Study|Lost to Follow-up|0|||
13191780|NCT02101021|26188251|FG003|Overall Study|Lost to Follow-up|0|||
13191781|NCT02101021|26188252|FG004|Overall Study|Lost to Follow-up|0|||
13191782|NCT02101021|26188248|FG000|Overall Study|Study Terminated by Sponsor|1|||
13191783|NCT02101021|26188249|FG001|Overall Study|Study Terminated by Sponsor|0|||
13191784|NCT02101021|26188250|FG002|Overall Study|Study Terminated by Sponsor|1|||
13191785|NCT02101021|26188251|FG003|Overall Study|Study Terminated by Sponsor|1|||
13191786|NCT02101021|26188252|FG004|Overall Study|Study Terminated by Sponsor|1|||
13191787|NCT02100969|26188266|FG000|Overall Study|Did not pass screening phase|1|||
13191788|NCT02100839|26188285|FG000|Multiple Ascending Dose|Adverse Event|2|||
13191789|NCT02100839|26188286|FG001|Multiple Ascending Dose|Adverse Event|0|||
13191790|NCT02100839|26188285|FG000|Multiple Ascending Dose|Withdrawal by Subject|2|||
13191791|NCT02100839|26188286|FG001|Multiple Ascending Dose|Withdrawal by Subject|0|||
13191792|NCT02100813|26188335|FG000|Overall Study|Adverse Event|0|||
13191793|NCT02100813|26188336|FG001|Overall Study|Adverse Event|0|||
13191794|NCT02100813|26188337|FG002|Overall Study|Adverse Event|0|||
13191795|NCT02100813|26188338|FG003|Overall Study|Adverse Event|0|||
13191796|NCT02100813|26188339|FG004|Overall Study|Adverse Event|0|||
13191797|NCT02100813|26188340|FG005|Overall Study|Adverse Event|0|||
13191798|NCT02100813|26188341|FG006|Overall Study|Adverse Event|0|||
13191799|NCT02100813|26188342|FG007|Overall Study|Adverse Event|1|||
13191800|NCT02100696|26188464|FG000|Induction Phase|Adverse Event|0|||
13191801|NCT02100696|26188465|FG001|Induction Phase|Adverse Event|0|||
13191802|NCT02100696|26188466|FG002|Induction Phase|Adverse Event|1|||
13191803|NCT02100696|26188467|FG003|Induction Phase|Adverse Event|0|||
13191804|NCT02100696|26188468|FG004|Induction Phase|Adverse Event|0|||
13191805|NCT02100696|26188469|FG005|Induction Phase|Adverse Event|0|||
13191806|NCT02100696|26188464|FG000|Induction Phase|Lost to Follow-up|1|||
13191807|NCT02100696|26188465|FG001|Induction Phase|Lost to Follow-up|0|||
13191808|NCT02100696|26188466|FG002|Induction Phase|Lost to Follow-up|1|||
13191809|NCT02100696|26188467|FG003|Induction Phase|Lost to Follow-up|0|||
13191810|NCT02100696|26188468|FG004|Induction Phase|Lost to Follow-up|0|||
13191811|NCT02100696|26188469|FG005|Induction Phase|Lost to Follow-up|0|||
13191812|NCT02100696|26188464|FG000|Induction Phase|Protocol Violation|0|||
13191813|NCT02100696|26188465|FG001|Induction Phase|Protocol Violation|1|||
13191814|NCT02100696|26188466|FG002|Induction Phase|Protocol Violation|1|||
13191815|NCT02100696|26188467|FG003|Induction Phase|Protocol Violation|0|||
13191816|NCT02100696|26188468|FG004|Induction Phase|Protocol Violation|0|||
13191817|NCT02100696|26188469|FG005|Induction Phase|Protocol Violation|0|||
13191818|NCT02100696|26188464|FG000|Induction Phase|Withdrawal by Subject|8|||
13191819|NCT02100696|26188465|FG001|Induction Phase|Withdrawal by Subject|2|||
13191820|NCT02100696|26188466|FG002|Induction Phase|Withdrawal by Subject|13|||
13191821|NCT02100696|26188467|FG003|Induction Phase|Withdrawal by Subject|0|||
13191822|NCT02100696|26188468|FG004|Induction Phase|Withdrawal by Subject|0|||
13191823|NCT02100696|26188469|FG005|Induction Phase|Withdrawal by Subject|0|||
13191824|NCT02100696|26188464|FG000|Induction Phase|Physician Decision|1|||
13191825|NCT02100696|26188465|FG001|Induction Phase|Physician Decision|0|||
13191826|NCT02100696|26188466|FG002|Induction Phase|Physician Decision|2|||
13191827|NCT02100696|26188467|FG003|Induction Phase|Physician Decision|0|||
13191828|NCT02100696|26188468|FG004|Induction Phase|Physician Decision|0|||
13191829|NCT02100696|26188469|FG005|Induction Phase|Physician Decision|0|||
13191830|NCT02100696|26188464|FG000|Induction Phase|Multiple Reasons|5|||
13191831|NCT02100696|26188465|FG001|Induction Phase|Multiple Reasons|2|||
13191832|NCT02100696|26188466|FG002|Induction Phase|Multiple Reasons|8|||
13191833|NCT02100696|26188467|FG003|Induction Phase|Multiple Reasons|0|||
13191834|NCT02100696|26188468|FG004|Induction Phase|Multiple Reasons|0|||
13191835|NCT02100696|26188469|FG005|Induction Phase|Multiple Reasons|0|||
13191836|NCT02100696|26188464|FG000|Maintenance Phase|Adverse Event|0|||
13191837|NCT02100696|26188465|FG001|Maintenance Phase|Adverse Event|0|||
13191838|NCT02100696|26188466|FG002|Maintenance Phase|Adverse Event|0|||
13191839|NCT02100696|26188467|FG003|Maintenance Phase|Adverse Event|0|||
13191840|NCT02100696|26188468|FG004|Maintenance Phase|Adverse Event|0|||
13191841|NCT02100696|26188469|FG005|Maintenance Phase|Adverse Event|2|||
13191842|NCT02100696|26188464|FG000|Maintenance Phase|Lost to Follow-up|0|||
13191843|NCT02100696|26188465|FG001|Maintenance Phase|Lost to Follow-up|0|||
13191844|NCT02100696|26188466|FG002|Maintenance Phase|Lost to Follow-up|0|||
13191845|NCT02100696|26188467|FG003|Maintenance Phase|Lost to Follow-up|0|||
13191846|NCT02100696|26188468|FG004|Maintenance Phase|Lost to Follow-up|1|||
13191847|NCT02100696|26188469|FG005|Maintenance Phase|Lost to Follow-up|0|||
13191848|NCT02100696|26188464|FG000|Maintenance Phase|Protocol Violation|0|||
13191849|NCT02100696|26188465|FG001|Maintenance Phase|Protocol Violation|0|||
13191850|NCT02100696|26188466|FG002|Maintenance Phase|Protocol Violation|0|||
13191851|NCT02100696|26188467|FG003|Maintenance Phase|Protocol Violation|0|||
13191852|NCT02100696|26188468|FG004|Maintenance Phase|Protocol Violation|1|||
13191853|NCT02100696|26188469|FG005|Maintenance Phase|Protocol Violation|0|||
13191854|NCT02100696|26188464|FG000|Maintenance Phase|Withdrawal by Subject|0|||
13191855|NCT02100696|26188465|FG001|Maintenance Phase|Withdrawal by Subject|0|||
13191856|NCT02100696|26188466|FG002|Maintenance Phase|Withdrawal by Subject|0|||
13191857|NCT02100696|26188467|FG003|Maintenance Phase|Withdrawal by Subject|1|||
13191858|NCT02100696|26188468|FG004|Maintenance Phase|Withdrawal by Subject|4|||
13191859|NCT02100696|26188469|FG005|Maintenance Phase|Withdrawal by Subject|2|||
13191860|NCT02100696|26188464|FG000|Maintenance Phase|Physician Decision|0|||
13191861|NCT02100696|26188465|FG001|Maintenance Phase|Physician Decision|0|||
13191862|NCT02100696|26188466|FG002|Maintenance Phase|Physician Decision|0|||
13191863|NCT02100696|26188467|FG003|Maintenance Phase|Physician Decision|0|||
13191864|NCT02100696|26188468|FG004|Maintenance Phase|Physician Decision|1|||
13191865|NCT02100696|26188469|FG005|Maintenance Phase|Physician Decision|0|||
13191866|NCT02100696|26188464|FG000|Maintenance Phase|Multiple Reasons|0|||
13191867|NCT02100696|26188465|FG001|Maintenance Phase|Multiple Reasons|0|||
13191868|NCT02100696|26188466|FG002|Maintenance Phase|Multiple Reasons|0|||
13191869|NCT02100696|26188467|FG003|Maintenance Phase|Multiple Reasons|0|||
13191870|NCT02100696|26188468|FG004|Maintenance Phase|Multiple Reasons|2|||
13191871|NCT02100696|26188469|FG005|Maintenance Phase|Multiple Reasons|1|||
13191872|NCT02100670|26188542|FG000|Overall Study|Adverse Event|10|||
13191873|NCT02100670|26188543|FG001|Overall Study|Adverse Event|3|||
13191874|NCT02100670|26188544|FG002|Overall Study|Adverse Event|3|||
13191875|NCT02100670|26188545|FG003|Overall Study|Adverse Event|0|||
13191876|NCT02100670|26188542|FG000|Overall Study|Lost to Follow-up|1|||
13191877|NCT02100670|26188543|FG001|Overall Study|Lost to Follow-up|0|||
13191878|NCT02100670|26188544|FG002|Overall Study|Lost to Follow-up|0|||
13191879|NCT02100670|26188545|FG003|Overall Study|Lost to Follow-up|0|||
13191880|NCT02100670|26188542|FG000|Overall Study|Protocol Violation|0|||
13191881|NCT02100670|26188543|FG001|Overall Study|Protocol Violation|1|||
13191882|NCT02100670|26188544|FG002|Overall Study|Protocol Violation|0|||
13191883|NCT02100670|26188545|FG003|Overall Study|Protocol Violation|1|||
13191884|NCT02100670|26188542|FG000|Overall Study|Withdrawal of Consent|0|||
13191885|NCT02100670|26188543|FG001|Overall Study|Withdrawal of Consent|1|||
13191886|NCT02100670|26188544|FG002|Overall Study|Withdrawal of Consent|1|||
13191887|NCT02100670|26188545|FG003|Overall Study|Withdrawal of Consent|0|||
13191888|NCT02100670|26188542|FG000|Overall Study|No swelling no pain|1|||
13191889|NCT02100670|26188543|FG001|Overall Study|No swelling no pain|0|||
13191890|NCT02100670|26188544|FG002|Overall Study|No swelling no pain|0|||
13191891|NCT02100670|26188545|FG003|Overall Study|No swelling no pain|0|||
13191892|NCT02100670|26188542|FG000|Overall Study|Poor Efficacy|0|||
13191893|NCT02100670|26188543|FG001|Overall Study|Poor Efficacy|1|||
13191894|NCT02100670|26188544|FG002|Overall Study|Poor Efficacy|0|||
13191895|NCT02100670|26188545|FG003|Overall Study|Poor Efficacy|0|||
13191896|NCT02100670|26188542|FG000|Overall Study|Physician Decision|0|||
13191897|NCT02100670|26188543|FG001|Overall Study|Physician Decision|1|||
13191898|NCT02100670|26188544|FG002|Overall Study|Physician Decision|0|||
13191899|NCT02100670|26188545|FG003|Overall Study|Physician Decision|0|||
13191900|NCT02100670|26188542|FG000|Overall Study|Withdrawal by Subject|1|||
13191901|NCT02100670|26188543|FG001|Overall Study|Withdrawal by Subject|0|||
13191902|NCT02100670|26188544|FG002|Overall Study|Withdrawal by Subject|0|||
13191903|NCT02100670|26188545|FG003|Overall Study|Withdrawal by Subject|0|||
13191904|NCT02100657|26188593|FG000|Cohort 1: Dose Level 1|Progressive disease|6|||
13191905|NCT02100657|26188594|FG001|Cohort 1: Dose Level 1|Progressive disease|0|||
13191906|NCT02100657|26188595|FG002|Cohort 1: Dose Level 1|Progressive disease|0|||
13191907|NCT02100657|26188593|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1|||
13191908|NCT02100657|26188594|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
13191909|NCT02100657|26188595|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
13191910|NCT02100657|26188593|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1|||
13191911|NCT02100657|26188594|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
13191912|NCT02100657|26188595|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
13191913|NCT02100657|26188593|FG000|Cohort 2: Dose Level 2|Progressive disease|0|||
13191914|NCT02100657|26188594|FG001|Cohort 2: Dose Level 2|Progressive disease|2|||
13191915|NCT02100657|26188595|FG002|Cohort 2: Dose Level 2|Progressive disease|0|||
13191916|NCT02100657|26188593|FG000|Cohort 2: Dose Level 2|Physician Decision|0|||
13191917|NCT02100657|26188594|FG001|Cohort 2: Dose Level 2|Physician Decision|1|||
13191918|NCT02100657|26188595|FG002|Cohort 2: Dose Level 2|Physician Decision|0|||
13191919|NCT02100657|26188593|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
13191920|NCT02100657|26188594|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1|||
13191921|NCT02100657|26188595|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
13191922|NCT02100657|26188593|FG000|Cohort 3: Dose Level 3|Progressive disease|0|||
13191923|NCT02100657|26188594|FG001|Cohort 3: Dose Level 3|Progressive disease|0|||
13191924|NCT02100657|26188595|FG002|Cohort 3: Dose Level 3|Progressive disease|15|||
13191925|NCT02100657|26188593|FG000|Cohort 3: Dose Level 3|Death|0|||
13191926|NCT02100657|26188594|FG001|Cohort 3: Dose Level 3|Death|0|||
13191927|NCT02100657|26188595|FG002|Cohort 3: Dose Level 3|Death|1|||
13191928|NCT02100657|26188593|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
13191929|NCT02100657|26188594|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
13191930|NCT02100657|26188595|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1|||
13191931|NCT02100657|26188593|FG000|Cohort 3: Dose Level 3|Physician Decision|0|||
13191932|NCT02100657|26188594|FG001|Cohort 3: Dose Level 3|Physician Decision|0|||
13191933|NCT02100657|26188595|FG002|Cohort 3: Dose Level 3|Physician Decision|1|||
13191934|NCT02100657|26188593|FG000|Cohort 3: Dose Level 3|Never were treated|0|||
13191935|NCT02100657|26188594|FG001|Cohort 3: Dose Level 3|Never were treated|0|||
13191936|NCT02100657|26188595|FG002|Cohort 3: Dose Level 3|Never were treated|3|||
13191937|NCT02100657|26188593|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
13191938|NCT02100657|26188594|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
13191939|NCT02100657|26188595|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3|||
13191940|NCT02100657|26188593|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
13191941|NCT02100657|26188594|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
13191942|NCT02100657|26188595|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3|||
13191943|NCT02100644|26188609|FG000|LTG Escalation Phase|Adverse Event|9|||
13191944|NCT02100644|26188610|FG001|LTG Escalation Phase|Adverse Event|0|||
13191945|NCT02100644|26188611|FG002|LTG Escalation Phase|Adverse Event|0|||
13191946|NCT02100644|26188609|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1|||
13191947|NCT02100644|26188610|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
13191948|NCT02100644|26188611|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
13191949|NCT02100644|26188609|FG000|LTG Escalation Phase|Withdrawal by Subject|3|||
13191950|NCT02100644|26188610|FG001|LTG Escalation Phase|Withdrawal by Subject|0|||
13191951|NCT02100644|26188611|FG002|LTG Escalation Phase|Withdrawal by Subject|0|||
13191952|NCT02100631|26188639|FG000|Overall Study|Withdrawal by Subject|1|||
13191953|NCT02100631|26188640|FG001|Overall Study|Withdrawal by Subject|0|||
13191954|NCT02100631|26188641|FG002|Overall Study|Withdrawal by Subject|0|||
13191955|NCT02100631|26188639|FG000|Overall Study|Lost to Follow-up|3|||
13191956|NCT02100631|26188640|FG001|Overall Study|Lost to Follow-up|4|||
13191957|NCT02100631|26188641|FG002|Overall Study|Lost to Follow-up|0|||
13191958|NCT02100631|26188639|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3|||
13191959|NCT02100631|26188640|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
13191960|NCT02100631|26188641|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
13191961|NCT02100514|26188717|FG000|Treatment Period|Adverse Event|0|||
13191962|NCT02100514|26188718|FG001|Treatment Period|Adverse Event|5|||
13191963|NCT02100514|26188719|FG002|Treatment Period|Adverse Event|0|||
13191964|NCT02100514|26188720|FG003|Treatment Period|Adverse Event|0|||
13191965|NCT02100514|26188721|FG004|Treatment Period|Adverse Event|0|||
13191966|NCT02100514|26188717|FG000|Treatment Period|Death|2|||
13191967|NCT02100514|26188718|FG001|Treatment Period|Death|2|||
13191968|NCT02100514|26188719|FG002|Treatment Period|Death|0|||
13191969|NCT02100514|26188720|FG003|Treatment Period|Death|0|||
13191970|NCT02100514|26188721|FG004|Treatment Period|Death|0|||
13191971|NCT02100514|26188717|FG000|Treatment Period|Lost to Follow-up|5|||
13191972|NCT02100514|26188718|FG001|Treatment Period|Lost to Follow-up|17|||
13191973|NCT02100514|26188719|FG002|Treatment Period|Lost to Follow-up|0|||
13191974|NCT02100514|26188720|FG003|Treatment Period|Lost to Follow-up|0|||
13191975|NCT02100514|26188721|FG004|Treatment Period|Lost to Follow-up|0|||
13191976|NCT02100514|26188717|FG000|Treatment Period|Did Not Meet Entrance Criteria|0|||
13191977|NCT02100514|26188718|FG001|Treatment Period|Did Not Meet Entrance Criteria|1|||
13191978|NCT02100514|26188719|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
13191979|NCT02100514|26188720|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
13191980|NCT02100514|26188721|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
13111730|NCT03176407|25905026|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1|||
13111731|NCT03176238|25905052|FG000|Overall Study|Unacceptable AEs|15|||
13111732|NCT03176238|25905053|FG001|Overall Study|Unacceptable AEs|8|||
13111733|NCT03176238|25905052|FG000|Overall Study|Abnormal lab value(s)|2|||
13111734|NCT03176238|25905053|FG001|Overall Study|Abnormal lab value(s)|0|||
13111735|NCT03176238|25905052|FG000|Overall Study|Inter-current illness|0|||
13111736|NCT03176238|25905053|FG001|Overall Study|Inter-current illness|1|||
13111737|NCT03176238|25905052|FG000|Overall Study|Consent withdrawal|14|||
13111738|NCT03176238|25905053|FG001|Overall Study|Consent withdrawal|2|||
13111739|NCT03176238|25905052|FG000|Overall Study|Lost to Follow-up|3|||
13111740|NCT03176238|25905053|FG001|Overall Study|Lost to Follow-up|0|||
13111741|NCT03176238|25905052|FG000|Overall Study|Administrative problems|1|||
13111742|NCT03176238|25905053|FG001|Overall Study|Administrative problems|0|||
13111743|NCT03176238|25905052|FG000|Overall Study|Death|3|||
13111744|NCT03176238|25905053|FG001|Overall Study|Death|0|||
13111745|NCT03176238|25905052|FG000|Overall Study|Disease Progression|133|||
13111746|NCT03176238|25905053|FG001|Overall Study|Disease Progression|22|||
13191981|NCT02100514|26188717|FG000|Treatment Period|Protocol Violation|1|||
13191982|NCT02100514|26188718|FG001|Treatment Period|Protocol Violation|1|||
13191983|NCT02100514|26188719|FG002|Treatment Period|Protocol Violation|0|||
13191984|NCT02100514|26188720|FG003|Treatment Period|Protocol Violation|0|||
13191985|NCT02100514|26188721|FG004|Treatment Period|Protocol Violation|0|||
13191986|NCT02100514|26188717|FG000|Treatment Period|Withdrawal by Subject|12|||
13191987|NCT02100514|26188718|FG001|Treatment Period|Withdrawal by Subject|37|||
13191988|NCT02100514|26188719|FG002|Treatment Period|Withdrawal by Subject|0|||
13191989|NCT02100514|26188720|FG003|Treatment Period|Withdrawal by Subject|0|||
13191990|NCT02100514|26188721|FG004|Treatment Period|Withdrawal by Subject|0|||
13191991|NCT02100514|26188717|FG000|Treatment Period|Other|9|||
13191992|NCT02100514|26188718|FG001|Treatment Period|Other|11|||
13191993|NCT02100514|26188719|FG002|Treatment Period|Other|0|||
13111747|NCT03176238|25905052|FG000|Overall Study|Tx duration completed per EAP|0|||
13111748|NCT03176238|25905053|FG001|Overall Study|Tx duration completed per EAP|1|||
13111749|NCT03176238|25905052|FG000|Overall Study|Patient is switched to commercial drug|16|||
13111750|NCT03176238|25905053|FG001|Overall Study|Patient is switched to commercial drug|1|||
13111751|NCT03176238|25905052|FG000|Overall Study|Protocol Violation|1|||
13191994|NCT02100514|26188720|FG003|Treatment Period|Other|0|||
13191995|NCT02100514|26188721|FG004|Treatment Period|Other|0|||
13191996|NCT02100514|26188717|FG000|Extension Period|Withdrew consent|0|||
13191997|NCT02100514|26188718|FG001|Extension Period|Withdrew consent|0|||
13191998|NCT02100514|26188719|FG002|Extension Period|Withdrew consent|2|||
13191999|NCT02100514|26188720|FG003|Extension Period|Withdrew consent|0|||
13192000|NCT02100514|26188721|FG004|Extension Period|Withdrew consent|0|||
13192001|NCT02100475|26188738|FG000|Overall Study|Unclassified|1|||
13192002|NCT02100475|26188739|FG001|Overall Study|Unclassified|2|||
13192003|NCT02100475|26188738|FG000|Overall Study|Withdrawal criteria|1|||
13192004|NCT02100475|26188739|FG001|Overall Study|Withdrawal criteria|0|||
13192005|NCT02100319|26188750|FG000|Overall Study|Case Report Forms Uncollected|11|||
13192006|NCT02100319|26188750|FG000|Overall Study|Protocol Deviation|5|||
13192007|NCT02100228|26188783|FG000|Overall Study|Other|19|||
13192008|NCT02100228|26188784|FG001|Overall Study|Other|19|||
13192009|NCT02100228|26188783|FG000|Overall Study|Administrative reason|0|||
13192010|NCT02100228|26188784|FG001|Overall Study|Administrative reason|1|||
13192011|NCT02100228|26188783|FG000|Overall Study|Inclusion/Exclusion criteria not met|12|||
13192012|NCT02100228|26188784|FG001|Overall Study|Inclusion/Exclusion criteria not met|16|||
13192013|NCT02100228|26188783|FG000|Overall Study|Non-compliance|0|||
13192014|NCT02100228|26188784|FG001|Overall Study|Non-compliance|3|||
13192015|NCT02100228|26188783|FG000|Overall Study|Lost to Follow-up|0|||
13192016|NCT02100228|26188784|FG001|Overall Study|Lost to Follow-up|1|||
13192017|NCT02100228|26188783|FG000|Overall Study|Withdrawal by Subject|27|||
13192018|NCT02100228|26188784|FG001|Overall Study|Withdrawal by Subject|37|||
13192019|NCT02100228|26188783|FG000|Overall Study|Adverse Event|16|||
13192020|NCT02100228|26188784|FG001|Overall Study|Adverse Event|12|||
13192021|NCT02100228|26188783|FG000|Overall Study|Death|1|||
13192022|NCT02100228|26188784|FG001|Overall Study|Death|1|||
13192023|NCT02100124|26188811|FG000|Overall Study|Lost to Follow-up|5|||
13192024|NCT02100124|26188812|FG001|Overall Study|Lost to Follow-up|11|||
13192025|NCT02100124|26188813|FG002|Overall Study|Lost to Follow-up|3|||
13192026|NCT02100124|26188811|FG000|Overall Study|Withdrawal by Subject|1|||
13192027|NCT02100124|26188812|FG001|Overall Study|Withdrawal by Subject|0|||
13192028|NCT02100124|26188813|FG002|Overall Study|Withdrawal by Subject|0|||
13192029|NCT02099838|26188850|FG000|Overall Study|Death|1|||
13192030|NCT02099838|26188851|FG001|Overall Study|Death|0|||
13192031|NCT02099838|26188850|FG000|Overall Study|Lost to Follow-up|3|||
13192032|NCT02099838|26188851|FG001|Overall Study|Lost to Follow-up|1|||
13192033|NCT02099838|26188850|FG000|Overall Study|Withdrawal by Subject|0|||
13192034|NCT02099838|26188851|FG001|Overall Study|Withdrawal by Subject|1|||
13192035|NCT02099708|26188864|FG000|Overall Study|Data Not Available|30|||
13192036|NCT02099708|26188864|FG000|Overall Study|Lost to Follow-up|141|||
13192037|NCT02099708|26188864|FG000|Overall Study|Other|29|||
13192038|NCT02099682|26188877|FG000|Overall Study|Data Not Available|51|||
13192039|NCT02099682|26188877|FG000|Overall Study|Lost to Follow-up|31|||
13192040|NCT02099682|26188877|FG000|Overall Study|Other|29|||
13192041|NCT02099344|26188892|FG000|Overall Study|Physician Decision|1|||
13192042|NCT02099344|26188893|FG001|Overall Study|Physician Decision|0|||
13192043|NCT02099110|26188956|FG000|Overall Study|Protocol Violation|2|||
13192044|NCT02099110|26188957|FG001|Overall Study|Protocol Violation|1|||
13192045|NCT02099110|26188958|FG002|Overall Study|Protocol Violation|0|||
13192046|NCT02099110|26188959|FG003|Overall Study|Protocol Violation|3|||
13192047|NCT02099110|26188960|FG004|Overall Study|Protocol Violation|1|||
13192048|NCT02099110|26188956|FG000|Overall Study|Participant moved|1|||
13192049|NCT02099110|26188957|FG001|Overall Study|Participant moved|1|||
13192050|NCT02099110|26188958|FG002|Overall Study|Participant moved|1|||
13192051|NCT02099110|26188959|FG003|Overall Study|Participant moved|0|||
13192052|NCT02099110|26188960|FG004|Overall Study|Participant moved|2|||
13192053|NCT02099110|26188956|FG000|Overall Study|Withdrawal by Subject|7|||
13192054|NCT02099110|26188957|FG001|Overall Study|Withdrawal by Subject|11|||
13192055|NCT02099110|26188958|FG002|Overall Study|Withdrawal by Subject|13|||
13192056|NCT02099110|26188959|FG003|Overall Study|Withdrawal by Subject|9|||
13192057|NCT02099110|26188960|FG004|Overall Study|Withdrawal by Subject|13|||
13192058|NCT02099110|26188956|FG000|Overall Study|Adverse Event|3|||
13192059|NCT02099110|26188957|FG001|Overall Study|Adverse Event|5|||
13192060|NCT02099110|26188958|FG002|Overall Study|Adverse Event|2|||
13192061|NCT02099110|26188959|FG003|Overall Study|Adverse Event|3|||
13192062|NCT02099110|26188960|FG004|Overall Study|Adverse Event|2|||
13192063|NCT02099110|26188956|FG000|Overall Study|Lost to Follow-up|6|||
13192064|NCT02099110|26188957|FG001|Overall Study|Lost to Follow-up|12|||
13192065|NCT02099110|26188958|FG002|Overall Study|Lost to Follow-up|11|||
13192066|NCT02099110|26188959|FG003|Overall Study|Lost to Follow-up|5|||
13192067|NCT02099110|26188960|FG004|Overall Study|Lost to Follow-up|6|||
13192068|NCT02099110|26188956|FG000|Overall Study|Death|0|||
13192069|NCT02099110|26188957|FG001|Overall Study|Death|1|||
13192070|NCT02099110|26188958|FG002|Overall Study|Death|0|||
13192071|NCT02099110|26188959|FG003|Overall Study|Death|0|||
13192072|NCT02099110|26188960|FG004|Overall Study|Death|0|||
13192073|NCT02099110|26188956|FG000|Overall Study|Screen failure|0|||
13192074|NCT02099110|26188957|FG001|Overall Study|Screen failure|0|||
13192075|NCT02099110|26188958|FG002|Overall Study|Screen failure|0|||
13192076|NCT02099110|26188959|FG003|Overall Study|Screen failure|0|||
13192077|NCT02099110|26188960|FG004|Overall Study|Screen failure|1|||
13192078|NCT02099110|26188956|FG000|Overall Study|Non-compliance with study drug|2|||
13192079|NCT02099110|26188957|FG001|Overall Study|Non-compliance with study drug|0|||
13192080|NCT02099110|26188958|FG002|Overall Study|Non-compliance with study drug|0|||
13192081|NCT02099110|26188959|FG003|Overall Study|Non-compliance with study drug|0|||
13192082|NCT02099110|26188960|FG004|Overall Study|Non-compliance with study drug|1|||
13192083|NCT02099110|26188956|FG000|Overall Study|Physician Decision|3|||
13192084|NCT02099110|26188957|FG001|Overall Study|Physician Decision|0|||
13192085|NCT02099110|26188958|FG002|Overall Study|Physician Decision|1|||
13192086|NCT02099110|26188959|FG003|Overall Study|Physician Decision|2|||
13192087|NCT02099110|26188960|FG004|Overall Study|Physician Decision|1|||
13192088|NCT02098876|26188987|FG000|Overall Study|Withdrawal by Subject|5|||
13192089|NCT02098876|26188988|FG001|Overall Study|Withdrawal by Subject|5|||
13192090|NCT02098746|26188998|FG000|Overall Study|Changes of Investigator|2|||
13192091|NCT02098746|26188998|FG000|Overall Study|Other Miscellaneous Reasons|1|||
13192092|NCT02098746|26188998|FG000|Overall Study|Enrolled 15 Days After the First Dose|1|||
13192093|NCT02098746|26188998|FG000|Overall Study|Data Not Available After Treatment|1|||
13192094|NCT02098733|26189010|FG000|Overall Study|Data Not Available|5|||
13192095|NCT02098733|26189010|FG000|Overall Study|Lost to Follow-up|5|||
13192096|NCT02098395|26189041|FG000|Overall Study|Protocol Violation|2|||
13192097|NCT02098395|26189042|FG001|Overall Study|Protocol Violation|2|||
13192098|NCT02098395|26189043|FG002|Overall Study|Protocol Violation|0|||
13192099|NCT02098395|26189044|FG003|Overall Study|Protocol Violation|7|||
13192100|NCT02098395|26189041|FG000|Overall Study|Withdrawal by Subject|10|||
13192101|NCT02098395|26189042|FG001|Overall Study|Withdrawal by Subject|10|||
13192102|NCT02098395|26189043|FG002|Overall Study|Withdrawal by Subject|5|||
13192103|NCT02098395|26189044|FG003|Overall Study|Withdrawal by Subject|13|||
13192104|NCT02098395|26189041|FG000|Overall Study|Adverse Event|12|||
13192105|NCT02098395|26189042|FG001|Overall Study|Adverse Event|19|||
13192106|NCT02098395|26189043|FG002|Overall Study|Adverse Event|34|||
13192107|NCT02098395|26189044|FG003|Overall Study|Adverse Event|2|||
13192108|NCT02098395|26189041|FG000|Overall Study|Lost to Follow-up|2|||
13192109|NCT02098395|26189042|FG001|Overall Study|Lost to Follow-up|1|||
13192110|NCT02098395|26189043|FG002|Overall Study|Lost to Follow-up|0|||
13192111|NCT02098395|26189044|FG003|Overall Study|Lost to Follow-up|3|||
13192112|NCT02098395|26189041|FG000|Overall Study|Unclassified|0|||
13192113|NCT02098395|26189042|FG001|Overall Study|Unclassified|0|||
13192114|NCT02098395|26189043|FG002|Overall Study|Unclassified|3|||
13192115|NCT02098395|26189044|FG003|Overall Study|Unclassified|2|||
13192116|NCT02098369|26189083|FG000|Overall Study|Withdrawal by Subject|1|||
13192117|NCT02098369|26189084|FG001|Overall Study|Withdrawal by Subject|5|||
13192118|NCT02098369|26189085|FG002|Overall Study|Withdrawal by Subject|0|||
13192119|NCT02098369|26189083|FG000|Overall Study|Lost to Follow-up|5|||
13192120|NCT02098369|26189084|FG001|Overall Study|Lost to Follow-up|1|||
13192121|NCT02098369|26189085|FG002|Overall Study|Lost to Follow-up|3|||
13192122|NCT02098369|26189083|FG000|Overall Study|Death|1|||
13192123|NCT02098369|26189084|FG001|Overall Study|Death|1|||
13192124|NCT02098369|26189085|FG002|Overall Study|Death|1|||
13192125|NCT02098369|26189083|FG000|Overall Study|Other|0|||
13192126|NCT02098369|26189084|FG001|Overall Study|Other|2|||
13192127|NCT02098369|26189085|FG002|Overall Study|Other|1|||
13192128|NCT02098109|26189114|FG000|Overall Study|Protocol Violation|3|||
13192129|NCT02098109|26189115|FG001|Overall Study|Protocol Violation|0|||
13192130|NCT02097823|26189137|FG000|Overall Study|Withdrawal by Subject|1|||
13192131|NCT02097823|26189138|FG001|Overall Study|Withdrawal by Subject|1|||
13192132|NCT02097745|26189162|FG000|Overall Study|Adverse Event|25|||
13192133|NCT02097745|26189162|FG000|Overall Study|Death|16|||
13192134|NCT02097745|26189162|FG000|Overall Study|Failure to Return|14|||
13192135|NCT02097745|26189162|FG000|Overall Study|Administrative/Other|27|||
13192136|NCT02097745|26189162|FG000|Overall Study|Reason Not Specified|96|||
13192137|NCT02097719|26189175|FG000|Overall Study|Subject Withdrew Consent|1|||
13192138|NCT02097719|26189176|FG001|Overall Study|Subject Withdrew Consent|0|||
13192139|NCT02097719|26189175|FG000|Overall Study|Lost to Follow-up|0|||
13192140|NCT02097719|26189176|FG001|Overall Study|Lost to Follow-up|1|||
13192141|NCT02097719|26189175|FG000|Overall Study|Adverse Event|2|||
13192142|NCT02097719|26189176|FG001|Overall Study|Adverse Event|0|||
13192143|NCT02097472|26189622|FG000|Received Vaccination 2|Adverse Event|0|||
13192144|NCT02097472|26189623|FG001|Received Vaccination 2|Adverse Event|0|||
13192145|NCT02097472|26189624|FG002|Received Vaccination 2|Adverse Event|0|||
13192146|NCT02097472|26189625|FG003|Received Vaccination 2|Adverse Event|0|||
13192147|NCT02097472|26189626|FG004|Received Vaccination 2|Adverse Event|0|||
13192148|NCT02097472|26189627|FG005|Received Vaccination 2|Adverse Event|0|||
13192149|NCT02097472|26189628|FG006|Received Vaccination 2|Adverse Event|1|||
13192150|NCT02097472|26189629|FG007|Received Vaccination 2|Adverse Event|0|||
13192151|NCT02097420|26189644|FG000|Overall Study|Death|4|||
13192152|NCT02097420|26189644|FG000|Overall Study|Device explanted|3|||
13192153|NCT02097420|26189644|FG000|Overall Study|Not reached 12-month visit|7|||
13192154|NCT02097290|26189656|FG000|Overall Study|Death|6|||
13192155|NCT02097290|26189656|FG000|Overall Study|Total Withdrawals|3|||
13192156|NCT02097290|26189656|FG000|Overall Study|Attempt|8|||
13192157|NCT02097277|26189755|FG000|Overall Study|Subject no longer meets study criteria|0|||
13192158|NCT02097277|26189756|FG001|Overall Study|Subject no longer meets study criteria|1|||
13192159|NCT02097277|26189757|FG002|Overall Study|Subject no longer meets study criteria|0|||
13206330|NCT01958281|26234403|FG001|Overall Study|Withdrew Consent|0|||
13192160|NCT02097277|26189758|FG003|Overall Study|Subject no longer meets study criteria|1|||
13192161|NCT02097277|26189759|FG004|Overall Study|Subject no longer meets study criteria|0|||
13192162|NCT02097277|26189755|FG000|Overall Study|Subject request to discontinue treatment|0|||
13192163|NCT02097277|26189756|FG001|Overall Study|Subject request to discontinue treatment|0|||
13192164|NCT02097277|26189757|FG002|Overall Study|Subject request to discontinue treatment|0|||
13192165|NCT02097277|26189758|FG003|Overall Study|Subject request to discontinue treatment|0|||
13192166|NCT02097277|26189759|FG004|Overall Study|Subject request to discontinue treatment|1|||
13192167|NCT02097277|26189755|FG000|Overall Study|Lost to Follow-up|0|||
13192168|NCT02097277|26189756|FG001|Overall Study|Lost to Follow-up|1|||
13192169|NCT02097277|26189757|FG002|Overall Study|Lost to Follow-up|1|||
13192170|NCT02097277|26189758|FG003|Overall Study|Lost to Follow-up|0|||
13192171|NCT02097277|26189759|FG004|Overall Study|Lost to Follow-up|0|||
13192172|NCT02097277|26189755|FG000|Overall Study|Withdrawal by Subject|2|||
13192173|NCT02097277|26189756|FG001|Overall Study|Withdrawal by Subject|1|||
13192174|NCT02097277|26189757|FG002|Overall Study|Withdrawal by Subject|0|||
13192175|NCT02097277|26189758|FG003|Overall Study|Withdrawal by Subject|1|||
13192176|NCT02097277|26189759|FG004|Overall Study|Withdrawal by Subject|0|||
13192177|NCT02097277|26189755|FG000|Overall Study|Adverse Event|0|||
13192178|NCT02097277|26189756|FG001|Overall Study|Adverse Event|0|||
13192179|NCT02097277|26189757|FG002|Overall Study|Adverse Event|1|||
13192180|NCT02097277|26189758|FG003|Overall Study|Adverse Event|2|||
13192181|NCT02097277|26189759|FG004|Overall Study|Adverse Event|0|||
13192182|NCT02097238|26189770|FG000|Overall Study|Death|1|||
13192183|NCT02097238|26189770|FG000|Overall Study|Physician Decision|1|||
13192184|NCT02097238|26189770|FG000|Overall Study|Progressive Disease|17|||
13192185|NCT02097134|26189780|FG000|Overall Study|Physician Decision|4|||
13192186|NCT02097134|26189780|FG000|Overall Study|Non-Protocol Therapy|1|||
13192187|NCT02097134|26189780|FG000|Overall Study|Progressive Disease|3|||
13192188|NCT02097134|26189780|FG000|Overall Study|Refusal of Further Protocol Therapy|1|||
13192189|NCT02097108|26189789|FG000|Overall Study|Adverse Event|1|||
13192190|NCT02097108|26189789|FG000|Overall Study|patient was abroad for 6 months|1|||
13192191|NCT02097056|26189797|FG000|Overall Study|Protocol Violation|2|||
13192192|NCT02097056|26189797|FG000|Overall Study|Withdrawal by Subject|15|||
13192193|NCT02097056|26189797|FG000|Overall Study|Lost to Follow-up|2|||
13192194|NCT02097056|26189797|FG000|Overall Study|Adverse Event|37|||
13192195|NCT02097056|26189797|FG000|Overall Study|Other|2|||
13192196|NCT02097030|26189865|FG000|First Intervention (3 Days)|Lost to Follow-up|1|||
13192197|NCT02097030|26189866|FG001|First Intervention (3 Days)|Lost to Follow-up|0|||
13192198|NCT02097030|26189865|FG000|First Intervention (3 Days)|Visual Acuity|0|||
13192199|NCT02097030|26189866|FG001|First Intervention (3 Days)|Visual Acuity|1|||
13192200|NCT02096952|26189872|FG000|Overall Study|Adverse Event|1|||
13192201|NCT02096900|26189893|FG000|Overall Study|Did not receive medication|3|||
13192202|NCT02096900|26189894|FG001|Overall Study|Did not receive medication|1|||
13192203|NCT02096900|26189893|FG000|Overall Study|Surgery cancelled- medication received|1|||
13192204|NCT02096900|26189894|FG001|Overall Study|Surgery cancelled- medication received|1|||
13192205|NCT02096835|26189921|FG000|Overall Study|Withdrawal by Subject|1|||
13192206|NCT02096835|26189922|FG001|Overall Study|Withdrawal by Subject|0|||
13192207|NCT02096835|26189923|FG002|Overall Study|Withdrawal by Subject|0|||
13192208|NCT02096835|26189921|FG000|Overall Study|converted to open procedures|1|||
13192209|NCT02096835|26189922|FG001|Overall Study|converted to open procedures|0|||
13192210|NCT02096835|26189923|FG002|Overall Study|converted to open procedures|0|||
13192211|NCT02096835|26189921|FG000|Overall Study|Lost to Follow-up|1|||
13192212|NCT02096835|26189922|FG001|Overall Study|Lost to Follow-up|0|||
13192213|NCT02096835|26189923|FG002|Overall Study|Lost to Follow-up|1|||
13192214|NCT02096744|26189939|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0|||
13192215|NCT02096744|26189940|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1|||
13192216|NCT02096744|26189939|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1|||
13192217|NCT02096744|26189940|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0|||
13192218|NCT02096744|26189939|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0|||
13192219|NCT02096744|26189940|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1|||
13192220|NCT02096705|26189959|FG000|Treatment|Adverse Event|6|||
13192221|NCT02096705|26189960|FG001|Treatment|Adverse Event|3|||
13192222|NCT02096705|26189959|FG000|Treatment|Subject request to discontinue treatment|1|||
13192223|NCT02096705|26189960|FG001|Treatment|Subject request to discontinue treatment|1|||
13192224|NCT02096705|26189959|FG000|Treatment|Withdrawal by Subject|1|||
13192225|NCT02096705|26189960|FG001|Treatment|Withdrawal by Subject|0|||
13192226|NCT02096705|26189959|FG000|Treatment|Other|1|||
13192227|NCT02096705|26189960|FG001|Treatment|Other|1|||
13192228|NCT02096705|26189959|FG000|Follow-up|Withdrawal by Subject|1|||
13192229|NCT02096705|26189960|FG001|Follow-up|Withdrawal by Subject|0|||
13192230|NCT02096705|26189959|FG000|Follow-up|Adverse Event|2|||
13192231|NCT02096705|26189960|FG001|Follow-up|Adverse Event|2|||
13192232|NCT02096705|26189959|FG000|Follow-up|Subjects not reporting status|1|||
13192233|NCT02096705|26189960|FG001|Follow-up|Subjects not reporting status|2|||
13192234|NCT02096588|26189975|FG000|Overall Study|Lack of Efficacy|2|||
13192235|NCT02096588|26189976|FG001|Overall Study|Lack of Efficacy|0|||
13192236|NCT02096588|26189975|FG000|Overall Study|Withdrawal by Subject|0|||
13192237|NCT02096588|26189976|FG001|Overall Study|Withdrawal by Subject|1|||
13192238|NCT02096471|26189989|FG000|Overall Study|Adverse Event|1|||
13192239|NCT02096471|26189989|FG000|Overall Study|Lack of Efficacy|7|||
13192240|NCT02096471|26189989|FG000|Overall Study|Withdrawal by Subject|3|||
13192241|NCT02096471|26189989|FG000|Overall Study|Non-Compliant|2|||
13192242|NCT02096263|26190133|FG000|Overall Study|Adverse Event|1|||
13192243|NCT02096263|26190134|FG001|Overall Study|Adverse Event|0|||
13192244|NCT02096263|26190135|FG002|Overall Study|Adverse Event|1|||
13192245|NCT02096263|26190133|FG000|Overall Study|Lost to Follow-up|14|||
13192246|NCT02096263|26190134|FG001|Overall Study|Lost to Follow-up|18|||
13192247|NCT02096263|26190135|FG002|Overall Study|Lost to Follow-up|15|||
13192248|NCT02096263|26190133|FG000|Overall Study|Other|7|||
13192249|NCT02096263|26190134|FG001|Overall Study|Other|9|||
13192250|NCT02096263|26190135|FG002|Overall Study|Other|6|||
13192251|NCT02096263|26190133|FG000|Overall Study|Sponsor study termination|0|||
13192252|NCT02096263|26190134|FG001|Overall Study|Sponsor study termination|0|||
13192253|NCT02096263|26190135|FG002|Overall Study|Sponsor study termination|1|||
13192254|NCT02096263|26190133|FG000|Overall Study|Protocol Violation|7|||
13192255|NCT02096263|26190134|FG001|Overall Study|Protocol Violation|2|||
13192256|NCT02096263|26190135|FG002|Overall Study|Protocol Violation|8|||
13192257|NCT02096263|26190133|FG000|Overall Study|Withdrawal by Subject|5|||
13192258|NCT02096263|26190134|FG001|Overall Study|Withdrawal by Subject|7|||
13192259|NCT02096263|26190135|FG002|Overall Study|Withdrawal by Subject|8|||
13192260|NCT02096042|26190146|FG000|Overall Study|Disease Progression|1|||
13192261|NCT02096042|26190147|FG001|Overall Study|Disease Progression|0|||
13192262|NCT02096042|26190148|FG002|Overall Study|Disease Progression|0|||
13192263|NCT02096003|26190169|FG000|Overall Study|Protocol Violation|0|||
13192264|NCT02096003|26190170|FG001|Overall Study|Protocol Violation|2|||
13192265|NCT02096003|26190169|FG000|Overall Study|additional surgery|2|||
13192266|NCT02096003|26190170|FG001|Overall Study|additional surgery|1|||
13192267|NCT02095951|26190195|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9|||
13192268|NCT02095951|26190196|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6|||
13192269|NCT02095873|26190215|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
13192270|NCT02095873|26190216|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
13192271|NCT02095873|26190215|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
13192272|NCT02095873|26190216|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
13192273|NCT02095873|26190215|FG000|Second Intervention (8 Weeks)|Protocol Violation|1|||
13192274|NCT02095873|26190216|FG001|Second Intervention (8 Weeks)|Protocol Violation|0|||
13192275|NCT02095691|26190235|FG000|Overall Study|Physician Decision|1|||
13192276|NCT02095535|26190241|FG000|Recruitment|Protocol Violation|2|||
13192277|NCT02095223|26190256|FG000|Overall Study|Withdrawal by Subject|1|||
13192278|NCT02095223|26190257|FG001|Overall Study|Withdrawal by Subject|0|||
13192279|NCT02095197|26190276|FG000|Overall Study|Lost to Follow-up|0|||
13192280|NCT02095197|26190277|FG001|Overall Study|Lost to Follow-up|3|||
13192281|NCT02095158|26190284|FG000|Overall Study|Adverse Event|14|||
13192282|NCT02095158|26190284|FG000|Overall Study|Lack of Efficacy|3|||
13192283|NCT02095158|26190284|FG000|Overall Study|Pregnancy|1|||
13192284|NCT02095158|26190284|FG000|Overall Study|Lost to Follow-up|20|||
13192285|NCT02095158|26190284|FG000|Overall Study|Personal Reasons|35|||
13192286|NCT02095158|26190284|FG000|Overall Study|Protocol Violation|1|||
13192287|NCT02095158|26190284|FG000|Overall Study|Other Miscellaneous Reasons|1|||
13192288|NCT02095145|26190335|FG000|Overall Study|Withdrawal by Subject|1|||
13192289|NCT02095145|26190336|FG001|Overall Study|Withdrawal by Subject|0|||
13192290|NCT02095132|26190424|FG000|Overall Study|Adverse Event|0|||
13192291|NCT02095132|26190425|FG001|Overall Study|Adverse Event|0|||
13192292|NCT02095132|26190426|FG002|Overall Study|Adverse Event|0|||
13192293|NCT02095132|26190427|FG003|Overall Study|Adverse Event|0|||
13192294|NCT02095132|26190428|FG004|Overall Study|Adverse Event|1|||
13192295|NCT02095132|26190429|FG005|Overall Study|Adverse Event|0|||
13192296|NCT02095132|26190430|FG006|Overall Study|Adverse Event|1|||
13192297|NCT02095132|26190431|FG007|Overall Study|Adverse Event|0|||
13192298|NCT02095132|26190432|FG008|Overall Study|Adverse Event|0|||
13192299|NCT02095132|26190424|FG000|Overall Study|Death|0|||
13192300|NCT02095132|26190425|FG001|Overall Study|Death|0|||
13192301|NCT02095132|26190426|FG002|Overall Study|Death|0|||
13192302|NCT02095132|26190427|FG003|Overall Study|Death|0|||
13192303|NCT02095132|26190428|FG004|Overall Study|Death|0|||
13192304|NCT02095132|26190429|FG005|Overall Study|Death|0|||
13192305|NCT02095132|26190430|FG006|Overall Study|Death|1|||
13192306|NCT02095132|26190431|FG007|Overall Study|Death|0|||
13192307|NCT02095132|26190432|FG008|Overall Study|Death|0|||
13192308|NCT02095132|26190424|FG000|Overall Study|Lack of Efficacy|3|||
13192309|NCT02095132|26190425|FG001|Overall Study|Lack of Efficacy|5|||
13192310|NCT02095132|26190426|FG002|Overall Study|Lack of Efficacy|2|||
13192311|NCT02095132|26190427|FG003|Overall Study|Lack of Efficacy|8|||
13192312|NCT02095132|26190428|FG004|Overall Study|Lack of Efficacy|3|||
13192313|NCT02095132|26190429|FG005|Overall Study|Lack of Efficacy|6|||
13192314|NCT02095132|26190430|FG006|Overall Study|Lack of Efficacy|10|||
13192315|NCT02095132|26190431|FG007|Overall Study|Lack of Efficacy|9|||
13192316|NCT02095132|26190432|FG008|Overall Study|Lack of Efficacy|8|||
13192317|NCT02095132|26190424|FG000|Overall Study|Physician Decision|1|||
13192318|NCT02095132|26190425|FG001|Overall Study|Physician Decision|0|||
13192319|NCT02095132|26190426|FG002|Overall Study|Physician Decision|0|||
13192320|NCT02095132|26190427|FG003|Overall Study|Physician Decision|0|||
13192321|NCT02095132|26190428|FG004|Overall Study|Physician Decision|0|||
13192322|NCT02095132|26190429|FG005|Overall Study|Physician Decision|0|||
13192323|NCT02095132|26190430|FG006|Overall Study|Physician Decision|1|||
13192324|NCT02095132|26190431|FG007|Overall Study|Physician Decision|0|||
13192325|NCT02095132|26190432|FG008|Overall Study|Physician Decision|2|||
13192326|NCT02095132|26190424|FG000|Overall Study|Withdrawal by Subject|0|||
13192327|NCT02095132|26190425|FG001|Overall Study|Withdrawal by Subject|0|||
13192328|NCT02095132|26190426|FG002|Overall Study|Withdrawal by Subject|2|||
13192329|NCT02095132|26190427|FG003|Overall Study|Withdrawal by Subject|2|||
13192330|NCT02095132|26190428|FG004|Overall Study|Withdrawal by Subject|3|||
13192331|NCT02095132|26190429|FG005|Overall Study|Withdrawal by Subject|0|||
13192332|NCT02095132|26190430|FG006|Overall Study|Withdrawal by Subject|5|||
13192333|NCT02095132|26190431|FG007|Overall Study|Withdrawal by Subject|0|||
13192334|NCT02095132|26190432|FG008|Overall Study|Withdrawal by Subject|0|||
13192335|NCT02095106|26190455|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
13192336|NCT02095106|26190456|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
13192337|NCT02094937|26190491|FG000|8 Weeks in Period 1|Adverse Event|9|||
13192338|NCT02094937|26190492|FG001|8 Weeks in Period 1|Adverse Event|0|||
13192339|NCT02094937|26190493|FG002|8 Weeks in Period 1|Adverse Event|0|||
13192340|NCT02094937|26190494|FG003|8 Weeks in Period 1|Adverse Event|0|||
13192341|NCT02094937|26190491|FG000|8 Weeks in Period 1|Lack of Efficacy|3|||
13192342|NCT02094937|26190492|FG001|8 Weeks in Period 1|Lack of Efficacy|0|||
13192343|NCT02094937|26190493|FG002|8 Weeks in Period 1|Lack of Efficacy|0|||
13192344|NCT02094937|26190494|FG003|8 Weeks in Period 1|Lack of Efficacy|0|||
13192345|NCT02094937|26190491|FG000|8 Weeks in Period 1|Protocol Violation|2|||
13192346|NCT02094937|26190492|FG001|8 Weeks in Period 1|Protocol Violation|0|||
13192347|NCT02094937|26190493|FG002|8 Weeks in Period 1|Protocol Violation|0|||
13192348|NCT02094937|26190494|FG003|8 Weeks in Period 1|Protocol Violation|0|||
13192349|NCT02094937|26190491|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41|||
13192350|NCT02094937|26190492|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
13192351|NCT02094937|26190493|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
13192352|NCT02094937|26190494|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
13192353|NCT02094937|26190491|FG000|8 Weeks in Period 1|Physician Decision|1|||
13192354|NCT02094937|26190492|FG001|8 Weeks in Period 1|Physician Decision|0|||
13192355|NCT02094937|26190493|FG002|8 Weeks in Period 1|Physician Decision|0|||
13192356|NCT02094937|26190494|FG003|8 Weeks in Period 1|Physician Decision|0|||
13192357|NCT02094937|26190491|FG000|8 Weeks in Period 1|Withdrawal by Subject|4|||
13192358|NCT02094937|26190492|FG001|8 Weeks in Period 1|Withdrawal by Subject|0|||
13192359|NCT02094937|26190493|FG002|8 Weeks in Period 1|Withdrawal by Subject|0|||
13192360|NCT02094937|26190494|FG003|8 Weeks in Period 1|Withdrawal by Subject|0|||
13192361|NCT02094937|26190491|FG000|12 Weeks in Period 2|Adverse Event|0|||
13192362|NCT02094937|26190492|FG001|12 Weeks in Period 2|Adverse Event|2|||
13192363|NCT02094937|26190493|FG002|12 Weeks in Period 2|Adverse Event|4|||
13192364|NCT02094937|26190494|FG003|12 Weeks in Period 2|Adverse Event|1|||
13192365|NCT02094937|26190491|FG000|12 Weeks in Period 2|Lack of Efficacy|0|||
13192366|NCT02094937|26190492|FG001|12 Weeks in Period 2|Lack of Efficacy|1|||
13192367|NCT02094937|26190493|FG002|12 Weeks in Period 2|Lack of Efficacy|0|||
13192368|NCT02094937|26190494|FG003|12 Weeks in Period 2|Lack of Efficacy|0|||
13192369|NCT02094937|26190491|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0|||
13192370|NCT02094937|26190492|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5|||
13192371|NCT02094937|26190493|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6|||
13192372|NCT02094937|26190494|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11|||
13192373|NCT02094937|26190491|FG000|12 Weeks in Period 2|Withdrawal by Subject|0|||
13192374|NCT02094937|26190492|FG001|12 Weeks in Period 2|Withdrawal by Subject|2|||
13192375|NCT02094937|26190493|FG002|12 Weeks in Period 2|Withdrawal by Subject|2|||
13192376|NCT02094937|26190494|FG003|12 Weeks in Period 2|Withdrawal by Subject|0|||
13192377|NCT02094937|26190491|FG000|12 Weeks in Period 2|Randomized incorrectly|0|||
13192378|NCT02094937|26190492|FG001|12 Weeks in Period 2|Randomized incorrectly|1|||
13192379|NCT02094937|26190493|FG002|12 Weeks in Period 2|Randomized incorrectly|0|||
13192380|NCT02094937|26190494|FG003|12 Weeks in Period 2|Randomized incorrectly|0|||
13192381|NCT02094898|26190541|FG000|Overall Study|Clinical Worsening|2|||
13192382|NCT02094898|26190541|FG000|Overall Study|Adverse Event|2|||
13192383|NCT02094898|26190541|FG000|Overall Study|Lack of Efficacy|1|||
13192384|NCT02094885|26190560|FG000|Overall Study|Death|1|||
13192385|NCT02094885|26190561|FG001|Overall Study|Death|5|||
13192386|NCT02094885|26190560|FG000|Overall Study|Withdrawn due to age|1|||
13192387|NCT02094885|26190561|FG001|Overall Study|Withdrawn due to age|0|||
13223177|NCT01799889|26287989|FG001|Overall Study|Study Terminated By Sponsor|0|||
13192388|NCT02094677|26190630|FG000|Overall Study|Screening|3|||
13192389|NCT02094677|26190631|FG001|Overall Study|Screening|1|||
13192390|NCT02094612|26190656|FG000|Overall Study|Lost to Follow-up|47|||
13192391|NCT02094612|26190657|FG001|Overall Study|Lost to Follow-up|47|||
13192392|NCT02094612|26190656|FG000|Overall Study|Never started ADHD medication|32|||
13192393|NCT02094612|26190657|FG001|Overall Study|Never started ADHD medication|23|||
13192394|NCT02094573|26190696|FG000|Overall Study|Adverse Event|4|||
13192395|NCT02094573|26190697|FG001|Overall Study|Adverse Event|14|||
13192396|NCT02094573|26190696|FG000|Overall Study|Clinical Progressive Disease|9|||
13192397|NCT02094573|26190697|FG001|Overall Study|Clinical Progressive Disease|13|||
13192398|NCT02094573|26190696|FG000|Overall Study|Death|11|||
13192399|NCT02094573|26190697|FG001|Overall Study|Death|3|||
13192400|NCT02094573|26190696|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63|||
13192401|NCT02094573|26190697|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50|||
13192402|NCT02094573|26190696|FG000|Overall Study|Non-compliance with Study Drug|1|||
13192403|NCT02094573|26190697|FG001|Overall Study|Non-compliance with Study Drug|1|||
13192404|NCT02094573|26190696|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1|||
13192405|NCT02094573|26190697|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0|||
13192406|NCT02094573|26190696|FG000|Overall Study|Physician Decision|4|||
13192407|NCT02094573|26190697|FG001|Overall Study|Physician Decision|4|||
13192408|NCT02094573|26190696|FG000|Overall Study|Site Terminated by Sponsor|10|||
13192409|NCT02094573|26190697|FG001|Overall Study|Site Terminated by Sponsor|17|||
13192410|NCT02094573|26190696|FG000|Overall Study|Withdrawal by Subject|6|||
13192411|NCT02094573|26190697|FG001|Overall Study|Withdrawal by Subject|8|||
13192412|NCT02094573|26190696|FG000|Overall Study|Randomized but not Treated|3|||
13192413|NCT02094573|26190697|FG001|Overall Study|Randomized but not Treated|0|||
13192414|NCT02094417|26190744|FG000|Overall Study|Adverse Event|0|||
13192415|NCT02094417|26190745|FG001|Overall Study|Adverse Event|0|||
13192416|NCT02094417|26190746|FG002|Overall Study|Adverse Event|0|||
13192417|NCT02094417|26190747|FG003|Overall Study|Adverse Event|1|||
13192418|NCT02094417|26190744|FG000|Overall Study|Eligibility criteria|0|||
13192419|NCT02094417|26190745|FG001|Overall Study|Eligibility criteria|1|||
13192420|NCT02094417|26190746|FG002|Overall Study|Eligibility criteria|0|||
13192421|NCT02094417|26190747|FG003|Overall Study|Eligibility criteria|0|||
13192422|NCT02094417|26190744|FG000|Overall Study|No responder|4|||
13192423|NCT02094417|26190745|FG001|Overall Study|No responder|4|||
13192424|NCT02094417|26190746|FG002|Overall Study|No responder|4|||
13192425|NCT02094417|26190747|FG003|Overall Study|No responder|3|||
13192426|NCT02094417|26190744|FG000|Overall Study|Unable to conduct observations or assess|0|||
13192427|NCT02094417|26190745|FG001|Overall Study|Unable to conduct observations or assess|1|||
13192428|NCT02094417|26190746|FG002|Overall Study|Unable to conduct observations or assess|0|||
13192429|NCT02094417|26190747|FG003|Overall Study|Unable to conduct observations or assess|0|||
13192430|NCT02094417|26190744|FG000|Overall Study|Withdrawal by Subject|1|||
13192431|NCT02094417|26190745|FG001|Overall Study|Withdrawal by Subject|2|||
13192432|NCT02094417|26190746|FG002|Overall Study|Withdrawal by Subject|1|||
13192433|NCT02094417|26190747|FG003|Overall Study|Withdrawal by Subject|3|||
13192434|NCT02094300|26190753|FG000|Overall Study|Death|7|||
13192435|NCT02094300|26190753|FG000|Overall Study|Lost to Follow-up|10|||
13192436|NCT02094300|26190753|FG000|Overall Study|Still be eligible for follow-up|3|||
13192437|NCT02093923|26190821|FG000|Overall Study|Lost to Follow-up|0|||
13192438|NCT02093923|26190822|FG001|Overall Study|Lost to Follow-up|0|||
13192439|NCT02093923|26190823|FG002|Overall Study|Lost to Follow-up|0|||
13192440|NCT02093923|26190824|FG003|Overall Study|Lost to Follow-up|1|||
13192441|NCT02093923|26190825|FG004|Overall Study|Lost to Follow-up|0|||
13192442|NCT02093923|26190821|FG000|Overall Study|Screen failure after randomization|0|||
13192443|NCT02093923|26190822|FG001|Overall Study|Screen failure after randomization|0|||
13192444|NCT02093923|26190823|FG002|Overall Study|Screen failure after randomization|0|||
13192445|NCT02093923|26190824|FG003|Overall Study|Screen failure after randomization|1|||
13192446|NCT02093923|26190825|FG004|Overall Study|Screen failure after randomization|0|||
13192447|NCT02093897|26190847|FG000|Overall Study|Physician Decision|1|||
13192448|NCT02093897|26190847|FG000|Overall Study|Planned age group closure - no's reached|17|||
13192449|NCT02093897|26190847|FG000|Overall Study|Adverse event, non-fatal|1|||
13192450|NCT02093689|26190863|FG000|Overall Study|Physician Decision|4|||
13192451|NCT02093689|26190864|FG001|Overall Study|Physician Decision|0|||
13192452|NCT02093689|26190865|FG002|Overall Study|Physician Decision|0|||
13192453|NCT02093663|26190898|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1|||
13192454|NCT02093663|26190899|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
13192455|NCT02093663|26190900|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
13192456|NCT02093663|26190901|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
13192457|NCT02093663|26190902|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
13192458|NCT02093663|26190898|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5|||
13192459|NCT02093663|26190899|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
13192460|NCT02093663|26190900|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
13192461|NCT02093663|26190901|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
13192462|NCT02093663|26190902|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
13192463|NCT02093663|26190898|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2|||
13192464|NCT02093663|26190899|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4|||
13192465|NCT02093663|26190900|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
13192466|NCT02093663|26190901|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
13192467|NCT02093663|26190902|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
13192468|NCT02093663|26190898|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
13192469|NCT02093663|26190899|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
13192470|NCT02093663|26190900|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1|||
13192471|NCT02093663|26190901|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
13192472|NCT02093663|26190902|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
13192473|NCT02093663|26190898|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
13192474|NCT02093663|26190899|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
13192475|NCT02093663|26190900|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5|||
13192476|NCT02093663|26190901|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
13192477|NCT02093663|26190902|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
13192478|NCT02093663|26190898|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
13192479|NCT02093663|26190899|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
13192480|NCT02093663|26190900|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
13192481|NCT02093663|26190901|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3|||
13192482|NCT02093663|26190902|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2|||
13192483|NCT02093663|26190898|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
13192484|NCT02093663|26190899|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
13192485|NCT02093663|26190900|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
13192486|NCT02093663|26190901|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6|||
13192487|NCT02093663|26190902|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7|||
13192488|NCT02093663|26190898|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
13192489|NCT02093663|26190899|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
13192490|NCT02093663|26190900|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
13192491|NCT02093663|26190901|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
13192492|NCT02093663|26190902|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
13192493|NCT02093663|26190898|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
13192494|NCT02093663|26190899|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
13192495|NCT02093663|26190900|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
13192496|NCT02093663|26190901|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
13192497|NCT02093663|26190902|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1|||
13192498|NCT02093520|26190919|FG000|Overall Study|Not treated|6|||
13192499|NCT02093520|26190920|FG001|Overall Study|Not treated|22|||
13192500|NCT02093390|26190963|FG000|Overall Study|Withdrawal by Subject|0|||
13192501|NCT02093390|26190964|FG001|Overall Study|Withdrawal by Subject|1|||
13192502|NCT02093351|26191005|FG000|Part A|Adverse Event|0|||
13192503|NCT02093351|26191006|FG001|Part A|Adverse Event|1|||
13192504|NCT02093351|26191007|FG002|Part A|Adverse Event|1|||
13192505|NCT02093351|26191008|FG003|Part A|Adverse Event|0|||
13192506|NCT02093351|26191005|FG000|Part A|Condition under investigation worsened|2|||
13192507|NCT02093351|26191006|FG001|Part A|Condition under investigation worsened|0|||
13192508|NCT02093351|26191007|FG002|Part A|Condition under investigation worsened|2|||
13192509|NCT02093351|26191008|FG003|Part A|Condition under investigation worsened|0|||
13192510|NCT02093351|26191005|FG000|Part A|Death|0|||
13192511|NCT02093351|26191006|FG001|Part A|Death|1|||
13192512|NCT02093351|26191007|FG002|Part A|Death|0|||
13192513|NCT02093351|26191008|FG003|Part A|Death|0|||
13192514|NCT02093351|26191005|FG000|Part B|Patient decision|0|||
13192515|NCT02093351|26191006|FG001|Part B|Patient decision|0|||
13192516|NCT02093351|26191007|FG002|Part B|Patient decision|0|||
13192517|NCT02093351|26191008|FG003|Part B|Patient decision|3|||
13192518|NCT02093351|26191005|FG000|Part B|Disease progression|0|||
13192519|NCT02093351|26191006|FG001|Part B|Disease progression|0|||
13192520|NCT02093351|26191007|FG002|Part B|Disease progression|0|||
13192521|NCT02093351|26191008|FG003|Part B|Disease progression|4|||
13111752|NCT03176238|25905053|FG001|Overall Study|Protocol Violation|0|||
13111753|NCT03176238|25905052|FG000|Overall Study|Changes in the patient's condition|2|||
13111754|NCT03176238|25905053|FG001|Overall Study|Changes in the patient's condition|1|||
13111755|NCT03176238|25905052|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9|||
13111756|NCT03176238|25905053|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0|||
13111757|NCT03175562|25905080|FG000|Overall Study|Adverse Event|1|||
13111758|NCT03175562|25905080|FG000|Overall Study|Lost to Follow-up|3|||
13111759|NCT03175562|25905080|FG000|Overall Study|Withdrawal by Subject|7|||
13111760|NCT03175562|25905080|FG000|Overall Study|Other (Not Specified)|5|||
13111761|NCT03175549|25905095|FG000|Overall Study|Lost to Follow-up|2|||
13111762|NCT03175549|25905096|FG001|Overall Study|Lost to Follow-up|2|||
13111763|NCT03175549|25905095|FG000|Overall Study|Medication non-compliance|2|||
13111764|NCT03175549|25905096|FG001|Overall Study|Medication non-compliance|2|||
13111765|NCT03175198|25905102|FG000|Overall Study|Adverse Event|480|||
13111766|NCT03175198|25905102|FG000|Overall Study|No actual visit|120|||
13111767|NCT03175198|25905102|FG000|Overall Study|Registration rule not followed|4|||
13111768|NCT03175198|25905102|FG000|Overall Study|Patients received Prazaxa treatment before|5|||
13111769|NCT03175198|25905102|FG000|Overall Study|Other personal reason|509|||
13111770|NCT03175198|25905102|FG000|Overall Study|To take a contraindication/careful administration drug|8|||
13111771|NCT03175198|25905102|FG000|Overall Study|Lost to follow-up (changing hospital)|373|||
13111772|NCT03175198|25905102|FG000|Overall Study|Lost to follow-up (unknown reason)|146|||
13111773|NCT03175198|25905102|FG000|Overall Study|To conduct invasive treatment of operation|53|||
13111774|NCT03175198|25905102|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629|||
13111775|NCT03175172|25905112|FG000|Overall Study|Death|3|||
13111776|NCT03175172|25905112|FG000|Overall Study|Withdrawal by Subject|3|||
13111777|NCT03175172|25905112|FG000|Overall Study|Lost to Follow-up|1|||
13111778|NCT03175172|25905112|FG000|Overall Study|Study Terminated by Sponsor|3|||
13111779|NCT03175120|25905241|FG000|Overall Study|Adverse Event|2|||
13192522|NCT02093351|26191005|FG000|Part B|Complete response|0|||
13192523|NCT02093351|26191006|FG001|Part B|Complete response|0|||
13192524|NCT02093351|26191007|FG002|Part B|Complete response|0|||
13192525|NCT02093351|26191008|FG003|Part B|Complete response|1|||
13192526|NCT02093351|26191005|FG000|Part B|Adverse event + disease progression|0|||
13192527|NCT02093351|26191006|FG001|Part B|Adverse event + disease progression|0|||
13192528|NCT02093351|26191007|FG002|Part B|Adverse event + disease progression|0|||
13192529|NCT02093351|26191008|FG003|Part B|Adverse event + disease progression|1|||
13192530|NCT02093351|26191005|FG000|Part B|Lack of therapeutic response|0|||
13192531|NCT02093351|26191006|FG001|Part B|Lack of therapeutic response|0|||
13192532|NCT02093351|26191007|FG002|Part B|Lack of therapeutic response|0|||
13192533|NCT02093351|26191008|FG003|Part B|Lack of therapeutic response|12|||
13192534|NCT02093351|26191005|FG000|Part B|Condition under investigation worsened|0|||
13192535|NCT02093351|26191006|FG001|Part B|Condition under investigation worsened|0|||
13192536|NCT02093351|26191007|FG002|Part B|Condition under investigation worsened|0|||
13192537|NCT02093351|26191008|FG003|Part B|Condition under investigation worsened|39|||
13192538|NCT02093351|26191005|FG000|Part B|Adverse Event|0|||
13192539|NCT02093351|26191006|FG001|Part B|Adverse Event|0|||
13192540|NCT02093351|26191007|FG002|Part B|Adverse Event|0|||
13192541|NCT02093351|26191008|FG003|Part B|Adverse Event|2|||
13192542|NCT02093351|26191005|FG000|Part B|Death|0|||
13192543|NCT02093351|26191006|FG001|Part B|Death|0|||
13192544|NCT02093351|26191007|FG002|Part B|Death|0|||
13111780|NCT03175120|25905242|FG001|Overall Study|Adverse Event|2|||
13111781|NCT03175120|25905241|FG000|Overall Study|Protocol Violation|5|||
13111782|NCT03175120|25905242|FG001|Overall Study|Protocol Violation|2|||
13111783|NCT03175120|25905241|FG000|Overall Study|Lost to Follow-up|1|||
13111784|NCT03175120|25905242|FG001|Overall Study|Lost to Follow-up|0|||
13111785|NCT03175120|25905241|FG000|Overall Study|Withdrawal by Subject|2|||
13111786|NCT03175120|25905242|FG001|Overall Study|Withdrawal by Subject|5|||
13111787|NCT03175120|25905241|FG000|Overall Study|Other|2|||
13111788|NCT03175120|25905242|FG001|Overall Study|Other|3|||
13111789|NCT03174925|25905248|FG000|Overall Study|Elastographic images not retrievable|2|||
13111790|NCT03174925|25905248|FG000|Overall Study|Elastography image not interpretable|1|||
13111791|NCT03173547|25905263|FG000|Overall Study|Adverse Event|2|||
13111792|NCT03173547|25905264|FG001|Overall Study|Adverse Event|0|||
13111793|NCT03173547|25905263|FG000|Overall Study|Withdrawal by Subject|2|||
13111794|NCT03173547|25905264|FG001|Overall Study|Withdrawal by Subject|2|||
13111795|NCT03173313|25905279|FG000|Overall Study|Lost to Follow-up|2|||
13111796|NCT03173313|25905280|FG001|Overall Study|Lost to Follow-up|3|||
13111797|NCT03173313|25905279|FG000|Overall Study|Withdrawal by Subject|0|||
13111798|NCT03173313|25905280|FG001|Overall Study|Withdrawal by Subject|1|||
13111799|NCT03173313|25905279|FG000|Overall Study|Death|5|||
13111800|NCT03173313|25905280|FG001|Overall Study|Death|0|||
13111801|NCT03173313|25905279|FG000|Overall Study|Physician Decision|1|||
13111802|NCT03173313|25905280|FG001|Overall Study|Physician Decision|0|||
13111803|NCT03173313|25905279|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0|||
13111804|NCT03173313|25905280|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1|||
13111805|NCT03173313|25905279|FG000|Overall Study|Bone Fracture|1|||
13111806|NCT03173313|25905280|FG001|Overall Study|Bone Fracture|0|||
13111807|NCT03172702|25905303|FG000|Overall Study|Adverse Event|9|||
13111808|NCT03172702|25905303|FG000|Overall Study|Death|2|||
13111809|NCT03172702|25905303|FG000|Overall Study|Study-specific Withdrawal Criteria|10|||
13111810|NCT03172702|25905303|FG000|Overall Study|Withdrawal by Subject|5|||
13111811|NCT03172702|25905303|FG000|Overall Study|Other|2|||
13111812|NCT03172481|25905316|FG000|Double-blind|Withdrawal by Subject|1|||
13111813|NCT03172481|25905317|FG001|Double-blind|Withdrawal by Subject|0|||
13111814|NCT03172364|25905340|FG000|Overall Study|Adverse Event|1|||
13192545|NCT02093351|26191008|FG003|Part B|Death|1|||
13192546|NCT02093221|26191061|FG000|Overall Study|Adverse Event|1|||
13192547|NCT02093221|26191062|FG001|Overall Study|Adverse Event|0|||
13192548|NCT02093221|26191063|FG002|Overall Study|Adverse Event|0|||
13192549|NCT02093221|26191064|FG003|Overall Study|Adverse Event|0|||
13192550|NCT02093221|26191065|FG004|Overall Study|Adverse Event|0|||
13192551|NCT02093221|26191061|FG000|Overall Study|Withdrawal by Subject|1|||
13192552|NCT02093221|26191062|FG001|Overall Study|Withdrawal by Subject|1|||
13192553|NCT02093221|26191063|FG002|Overall Study|Withdrawal by Subject|4|||
13192554|NCT02093221|26191064|FG003|Overall Study|Withdrawal by Subject|1|||
13192555|NCT02093221|26191065|FG004|Overall Study|Withdrawal by Subject|1|||
13192556|NCT02093221|26191061|FG000|Overall Study|Lost to Follow-up|2|||
13192557|NCT02093221|26191062|FG001|Overall Study|Lost to Follow-up|0|||
13192558|NCT02093221|26191063|FG002|Overall Study|Lost to Follow-up|1|||
13192559|NCT02093221|26191064|FG003|Overall Study|Lost to Follow-up|1|||
13192560|NCT02093221|26191065|FG004|Overall Study|Lost to Follow-up|0|||
13192561|NCT02093221|26191061|FG000|Overall Study|Death|0|||
13192562|NCT02093221|26191062|FG001|Overall Study|Death|1|||
13192563|NCT02093221|26191063|FG002|Overall Study|Death|0|||
13192564|NCT02093221|26191064|FG003|Overall Study|Death|0|||
13192565|NCT02093221|26191065|FG004|Overall Study|Death|0|||
13192566|NCT02093221|26191061|FG000|Overall Study|Protocol Violation|0|||
13192567|NCT02093221|26191062|FG001|Overall Study|Protocol Violation|1|||
13192568|NCT02093221|26191063|FG002|Overall Study|Protocol Violation|0|||
13192569|NCT02093221|26191064|FG003|Overall Study|Protocol Violation|0|||
13192570|NCT02093221|26191065|FG004|Overall Study|Protocol Violation|0|||
13192571|NCT02093221|26191061|FG000|Overall Study|Study termination|6|||
13192572|NCT02093221|26191062|FG001|Overall Study|Study termination|5|||
13192573|NCT02093221|26191063|FG002|Overall Study|Study termination|4|||
13192574|NCT02093221|26191064|FG003|Overall Study|Study termination|6|||
13192575|NCT02093221|26191065|FG004|Overall Study|Study termination|7|||
13192576|NCT02093026|26191086|FG000|Overall Study|Adverse Event|26|||
13192577|NCT02093026|26191086|FG000|Overall Study|Death|10|||
13192578|NCT02093026|26191086|FG000|Overall Study|Other|157|||
13192579|NCT02092961|26191117|FG000|Overall Study|Not reported|1|||
13192580|NCT02092961|26191118|FG001|Overall Study|Not reported|0|||
13192581|NCT02092961|26191119|FG002|Overall Study|Not reported|1|||
13192582|NCT02092961|26191117|FG000|Overall Study|Study stopped|13|||
13111815|NCT03172364|25905341|FG001|Overall Study|Adverse Event|1|||
13111816|NCT03172364|25905340|FG000|Overall Study|Protocol Violation|1|||
13111817|NCT03172364|25905341|FG001|Overall Study|Protocol Violation|0|||
13111818|NCT03172325|25905362|FG000|Overall Study|Adverse Event|2|||
13111819|NCT03172325|25905363|FG001|Overall Study|Adverse Event|3|||
13111820|NCT03172325|25905362|FG000|Overall Study|Positive PPD|1|||
13111821|NCT03172325|25905363|FG001|Overall Study|Positive PPD|0|||
13111822|NCT03172325|25905362|FG000|Overall Study|Poor Compliance|1|||
13111823|NCT03172325|25905363|FG001|Overall Study|Poor Compliance|1|||
13192583|NCT02092961|26191118|FG001|Overall Study|Study stopped|9|||
13192584|NCT02092961|26191119|FG002|Overall Study|Study stopped|12|||
13192585|NCT02092961|26191117|FG000|Overall Study|Lack of therapeutic response|2|||
13192586|NCT02092961|26191118|FG001|Overall Study|Lack of therapeutic response|1|||
13192587|NCT02092961|26191119|FG002|Overall Study|Lack of therapeutic response|3|||
13192588|NCT02092961|26191117|FG000|Overall Study|Dev. of study specific discont. criteria|3|||
13192589|NCT02092961|26191118|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
13192590|NCT02092961|26191119|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
13192591|NCT02092961|26191117|FG000|Overall Study|Adverse Event|2|||
13192592|NCT02092961|26191118|FG001|Overall Study|Adverse Event|4|||
13192593|NCT02092961|26191119|FG002|Overall Study|Adverse Event|0|||
13192594|NCT02092909|26191158|FG000|Overall Study|Adverse Event|0|||
13192595|NCT02092909|26191159|FG001|Overall Study|Adverse Event|0|||
13192596|NCT02092909|26191160|FG002|Overall Study|Adverse Event|4|||
13192597|NCT02092909|26191161|FG003|Overall Study|Adverse Event|2|||
13192598|NCT02092909|26191158|FG000|Overall Study|Lack of Efficacy|0|||
13192599|NCT02092909|26191159|FG001|Overall Study|Lack of Efficacy|2|||
13192600|NCT02092909|26191160|FG002|Overall Study|Lack of Efficacy|1|||
13192601|NCT02092909|26191161|FG003|Overall Study|Lack of Efficacy|0|||
13192602|NCT02092909|26191158|FG000|Overall Study|Withdrawal by Subject|0|||
13192603|NCT02092909|26191159|FG001|Overall Study|Withdrawal by Subject|0|||
13192604|NCT02092909|26191160|FG002|Overall Study|Withdrawal by Subject|2|||
13192605|NCT02092909|26191161|FG003|Overall Study|Withdrawal by Subject|1|||
13192606|NCT02092909|26191158|FG000|Overall Study|Study terminated by Sponsor|0|||
13192607|NCT02092909|26191159|FG001|Overall Study|Study terminated by Sponsor|0|||
13192608|NCT02092909|26191160|FG002|Overall Study|Study terminated by Sponsor|0|||
13192609|NCT02092909|26191161|FG003|Overall Study|Study terminated by Sponsor|2|||
13111824|NCT03172130|25905390|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3|||
13111825|NCT03172130|25905391|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1|||
13192610|NCT02092909|26191158|FG000|Overall Study|Miscellaneous|1|||
13192611|NCT02092909|26191159|FG001|Overall Study|Miscellaneous|1|||
13192612|NCT02092909|26191160|FG002|Overall Study|Miscellaneous|2|||
13192613|NCT02092909|26191161|FG003|Overall Study|Miscellaneous|1|||
13192614|NCT02092662|26191175|FG000|Overall Study|Lost to Follow-up|13|||
13192615|NCT02092662|26191176|FG001|Overall Study|Lost to Follow-up|0|||
13192616|NCT02092467|26191265|FG000|Overall Study|Death|49|||
13192617|NCT02092467|26191266|FG001|Overall Study|Death|66|||
13192618|NCT02092467|26191267|FG002|Overall Study|Death|38|||
13192619|NCT02092467|26191265|FG000|Overall Study|Lost to Follow-up|38|||
13192620|NCT02092467|26191266|FG001|Overall Study|Lost to Follow-up|35|||
13192621|NCT02092467|26191267|FG002|Overall Study|Lost to Follow-up|40|||
13192622|NCT02092467|26191265|FG000|Overall Study|Global Deterioration of Health Status|1|||
13192623|NCT02092467|26191266|FG001|Overall Study|Global Deterioration of Health Status|0|||
13192624|NCT02092467|26191267|FG002|Overall Study|Global Deterioration of Health Status|0|||
13192625|NCT02092467|26191265|FG000|Overall Study|Other|32|||
13192626|NCT02092467|26191266|FG001|Overall Study|Other|30|||
13192627|NCT02092467|26191267|FG002|Overall Study|Other|24|||
13192628|NCT02092467|26191265|FG000|Overall Study|Withdrawal by Subject|282|||
13192629|NCT02092467|26191266|FG001|Overall Study|Withdrawal by Subject|327|||
13192630|NCT02092467|26191267|FG002|Overall Study|Withdrawal by Subject|289|||
13192631|NCT02092467|26191265|FG000|Overall Study|Randomized but not treated|2|||
13192632|NCT02092467|26191266|FG001|Overall Study|Randomized but not treated|1|||
13192633|NCT02092467|26191267|FG002|Overall Study|Randomized but not treated|7|||
13192634|NCT02092389|26191279|FG000|Overall Study|Adverse Event|1|||
13192635|NCT02092389|26191279|FG000|Overall Study|Other|5|||
13192636|NCT02092350|26191301|FG000|Overall Study|Adverse Event|0|||
13192637|NCT02092350|26191302|FG001|Overall Study|Adverse Event|3|||
13192638|NCT02092350|26191301|FG000|Overall Study|Death|2|||
13192639|NCT02092350|26191302|FG001|Overall Study|Death|5|||
13192640|NCT02092350|26191301|FG000|Overall Study|Lost to Follow-up|3|||
13192641|NCT02092350|26191302|FG001|Overall Study|Lost to Follow-up|1|||
13192642|NCT02092350|26191301|FG000|Overall Study|Protocol Violation|1|||
13192643|NCT02092350|26191302|FG001|Overall Study|Protocol Violation|0|||
13192644|NCT02092350|26191301|FG000|Overall Study|Physician Decision|1|||
13192645|NCT02092350|26191302|FG001|Overall Study|Physician Decision|1|||
13192646|NCT02092350|26191301|FG000|Overall Study|Screen Failure|1|||
13192647|NCT02092350|26191302|FG001|Overall Study|Screen Failure|0|||
13192648|NCT02092350|26191301|FG000|Overall Study|Withdrawal by Subject|2|||
13192649|NCT02092350|26191302|FG001|Overall Study|Withdrawal by Subject|2|||
13192650|NCT02092324|26191326|FG000|Overall Study|Adverse Event|1|||
13192651|NCT02092324|26191326|FG000|Overall Study|Lack of Efficacy|6|||
13192652|NCT02092324|26191326|FG000|Overall Study|Proceed to Transplant|3|||
13192653|NCT02092324|26191326|FG000|Overall Study|Physician Decision|7|||
13192654|NCT02092324|26191326|FG000|Overall Study|Misdiagnosis|2|||
13192655|NCT02092285|26191332|FG000|Induction Phase|Adverse Event|7|||
13192656|NCT02092285|26191332|FG000|Induction Phase|Physician Decision|4|||
13192657|NCT02092285|26191332|FG000|Induction Phase|Pregnancy|1|||
13192658|NCT02092285|26191332|FG000|Induction Phase|Relapse/Recurrence|7|||
13192659|NCT02092285|26191332|FG000|Induction Phase|Withdrawal by Subject|2|||
13192660|NCT02092285|26191332|FG000|Induction Phase|Lack of Efficacy|14|||
13192661|NCT02092285|26191332|FG000|Maintenance Phase & Follow-up|Adverse Event|22|||
13192662|NCT02092285|26191332|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1|||
13192663|NCT02092285|26191332|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2|||
13192664|NCT02092285|26191332|FG000|Maintenance Phase & Follow-up|Physician Decision|10|||
13192665|NCT02092285|26191332|FG000|Maintenance Phase & Follow-up|Pregnancy|1|||
13192666|NCT02092285|26191332|FG000|Maintenance Phase & Follow-up|Protocol Violation|11|||
13192667|NCT02092285|26191332|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29|||
13192668|NCT02092285|26191332|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11|||
13192669|NCT02092285|26191332|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23|||
13192670|NCT02092220|26191393|FG000|Period 1|Unrelated Illness|0|||
13192671|NCT02092220|26191394|FG001|Period 1|Unrelated Illness|2|||
13192672|NCT02092220|26191393|FG000|Period 2|Severe Hypoglycaemia|1|||
13192673|NCT02092220|26191394|FG001|Period 2|Severe Hypoglycaemia|0|||
13192674|NCT02092220|26191393|FG000|Period 2|Nausea, Anxiety, Inconvenience|0|||
13192675|NCT02092220|26191394|FG001|Period 2|Nausea, Anxiety, Inconvenience|1|||
13192676|NCT02092116|26191410|FG000|Overall Study|Withdrawal by Subject|0|||
13192677|NCT02092116|26191411|FG001|Overall Study|Withdrawal by Subject|3|||
13192678|NCT02092116|26191410|FG000|Overall Study|Adverse Event|0|||
13192679|NCT02092116|26191411|FG001|Overall Study|Adverse Event|1|||
13192680|NCT02092025|26191419|FG000|Overall Study|Case Report Forms Uncollected|44|||
13192681|NCT02092025|26191419|FG000|Overall Study|Protocol Deviation|24|||
13192682|NCT02091986|26191476|FG000|Overall Study|7 rand in error 1 patient decision|2|||
13192683|NCT02091986|26191477|FG001|Overall Study|7 rand in error 1 patient decision|3|||
13192684|NCT02091986|26191478|FG002|Overall Study|7 rand in error 1 patient decision|3|||
13192685|NCT02091986|26191476|FG000|Overall Study|Lost to Follow-up|1|||
13192686|NCT02091986|26191477|FG001|Overall Study|Lost to Follow-up|0|||
13192687|NCT02091986|26191478|FG002|Overall Study|Lost to Follow-up|0|||
13192688|NCT02091986|26191476|FG000|Overall Study|Withdrawal by Subject|4|||
13192689|NCT02091986|26191477|FG001|Overall Study|Withdrawal by Subject|8|||
13192690|NCT02091986|26191478|FG002|Overall Study|Withdrawal by Subject|3|||
13192691|NCT02091986|26191476|FG000|Overall Study|Adverse Event|0|||
13192692|NCT02091986|26191477|FG001|Overall Study|Adverse Event|0|||
13192693|NCT02091986|26191478|FG002|Overall Study|Adverse Event|2|||
13192694|NCT02091921|26191487|FG000|Overall Study|Adverse Event|3|||
13192695|NCT02091869|26191506|FG000|Overall Study|Withdrawal by Subject|0|||
13192696|NCT02091869|26191507|FG001|Overall Study|Withdrawal by Subject|3|||
13192697|NCT02091752|26191520|FG000|Overall Study|Study terminated by Sponsor|2|||
13192698|NCT02091752|26191520|FG000|Overall Study|Adverse Event|1|||
13192699|NCT02091739|26191551|FG000|MP: 16 Weeks|Adverse Event|1|||
13192700|NCT02091739|26191552|FG001|MP: 16 Weeks|Adverse Event|1|||
13192701|NCT02091739|26191553|FG002|MP: 16 Weeks|Adverse Event|1|||
13192702|NCT02091739|26191554|FG003|MP: 16 Weeks|Adverse Event|0|||
13192703|NCT02091739|26191555|FG004|MP: 16 Weeks|Adverse Event|0|||
13192704|NCT02091739|26191551|FG000|MP: 16 Weeks|Withdrawal by Subject|3|||
13192705|NCT02091739|26191552|FG001|MP: 16 Weeks|Withdrawal by Subject|4|||
13192706|NCT02091739|26191553|FG002|MP: 16 Weeks|Withdrawal by Subject|0|||
13192707|NCT02091739|26191554|FG003|MP: 16 Weeks|Withdrawal by Subject|0|||
13192708|NCT02091739|26191555|FG004|MP: 16 Weeks|Withdrawal by Subject|0|||
13192709|NCT02091739|26191551|FG000|MP: 16 Weeks|Lost to Follow-up|0|||
13192710|NCT02091739|26191552|FG001|MP: 16 Weeks|Lost to Follow-up|0|||
13192711|NCT02091739|26191553|FG002|MP: 16 Weeks|Lost to Follow-up|1|||
13192712|NCT02091739|26191554|FG003|MP: 16 Weeks|Lost to Follow-up|0|||
13192713|NCT02091739|26191555|FG004|MP: 16 Weeks|Lost to Follow-up|0|||
13192714|NCT02091739|26191551|FG000|EP: 48 Weeks|Other|0|||
13192715|NCT02091739|26191552|FG001|EP: 48 Weeks|Other|0|||
13192716|NCT02091739|26191553|FG002|EP: 48 Weeks|Other|0|||
13192717|NCT02091739|26191554|FG003|EP: 48 Weeks|Other|1|||
13111826|NCT03172026|25905424|FG000|Overall Study|Withdrawal by Subject|1|||
13111827|NCT03172026|25905425|FG001|Overall Study|Withdrawal by Subject|0|||
13111828|NCT03172026|25905424|FG000|Overall Study|COVID restrictions|1|||
13111829|NCT03172026|25905425|FG001|Overall Study|COVID restrictions|0|||
13111830|NCT03171415|25905502|FG000|Overall Study|Lost to Follow-up|0|||
13111831|NCT03171415|25905503|FG001|Overall Study|Lost to Follow-up|0|||
13111832|NCT03171415|25905504|FG002|Overall Study|Lost to Follow-up|0|||
13111833|NCT03171415|25905505|FG003|Overall Study|Lost to Follow-up|0|||
13111834|NCT03171415|25905506|FG004|Overall Study|Lost to Follow-up|2|||
13111835|NCT03170609|25905586|FG000|Overall Study|Death|0|||
13111836|NCT03170609|25905587|FG001|Overall Study|Death|0|||
13111837|NCT03170609|25905588|FG002|Overall Study|Death|1|||
13111838|NCT03170609|25905589|FG003|Overall Study|Death|0|||
13111839|NCT03170609|25905590|FG004|Overall Study|Death|0|||
13111840|NCT03170609|25905591|FG005|Overall Study|Death|0|||
13192718|NCT02091739|26191555|FG004|EP: 48 Weeks|Other|0|||
13192719|NCT02091739|26191551|FG000|EP: 48 Weeks|Death|0|||
13192720|NCT02091739|26191552|FG001|EP: 48 Weeks|Death|0|||
13192721|NCT02091739|26191553|FG002|EP: 48 Weeks|Death|0|||
13192722|NCT02091739|26191554|FG003|EP: 48 Weeks|Death|3|||
13192723|NCT02091739|26191555|FG004|EP: 48 Weeks|Death|2|||
13192724|NCT02091739|26191551|FG000|EP: 48 Weeks|Adverse Event|0|||
13192725|NCT02091739|26191552|FG001|EP: 48 Weeks|Adverse Event|0|||
13192726|NCT02091739|26191553|FG002|EP: 48 Weeks|Adverse Event|0|||
13192727|NCT02091739|26191554|FG003|EP: 48 Weeks|Adverse Event|2|||
13192728|NCT02091739|26191555|FG004|EP: 48 Weeks|Adverse Event|6|||
13192729|NCT02091739|26191551|FG000|EP: 48 Weeks|Withdrawal by Subject|0|||
13192730|NCT02091739|26191552|FG001|EP: 48 Weeks|Withdrawal by Subject|0|||
13192731|NCT02091739|26191553|FG002|EP: 48 Weeks|Withdrawal by Subject|0|||
13192732|NCT02091739|26191554|FG003|EP: 48 Weeks|Withdrawal by Subject|2|||
13192733|NCT02091739|26191555|FG004|EP: 48 Weeks|Withdrawal by Subject|6|||
13192734|NCT02091726|26191565|FG000|Overall Study|Lost to Follow-up|6|||
13192735|NCT02091440|26191577|FG000|Overall Study|Death|2|||
13192736|NCT02091414|26191591|FG000|Overall Study|Withdrawal by Subject|2|||
13192737|NCT02091414|26191591|FG000|Overall Study|Death|2|||
13192738|NCT02091375|26191626|FG000|Overall Study|Adverse Event|8|||
13192739|NCT02091375|26191627|FG001|Overall Study|Adverse Event|1|||
13192740|NCT02091375|26191626|FG000|Overall Study|Lost to Follow-up|0|||
13192741|NCT02091375|26191627|FG001|Overall Study|Lost to Follow-up|1|||
13192742|NCT02091375|26191626|FG000|Overall Study|Withdrawal by Subject|0|||
13192743|NCT02091375|26191627|FG001|Overall Study|Withdrawal by Subject|1|||
13192744|NCT02091375|26191626|FG000|Overall Study|Withdrawn by the investigator|1|||
13192745|NCT02091375|26191627|FG001|Overall Study|Withdrawn by the investigator|0|||
13192746|NCT02091362|26191654|FG000|Period 1|Protocol Violation|1|||
13192747|NCT02091362|26191655|FG001|Period 1|Protocol Violation|0|||
13192748|NCT02091362|26191654|FG000|Period 1|Withdrawal by Subject|2|||
13192749|NCT02091362|26191655|FG001|Period 1|Withdrawal by Subject|3|||
13192750|NCT02091362|26191654|FG000|Period 1|Lost to Follow-up|0|||
13192751|NCT02091362|26191655|FG001|Period 1|Lost to Follow-up|1|||
13192752|NCT02091362|26191654|FG000|Period 1|Adverse Event|2|||
13192753|NCT02091362|26191655|FG001|Period 1|Adverse Event|0|||
13111841|NCT03170609|25905592|FG006|Overall Study|Death|0|||
13192754|NCT02091362|26191654|FG000|Wash-out|Lost to Follow-up|1|||
13192755|NCT02091362|26191655|FG001|Wash-out|Lost to Follow-up|1|||
13192756|NCT02091362|26191654|FG000|Wash-out|Withdrawal by Subject|0|||
13192757|NCT02091362|26191655|FG001|Wash-out|Withdrawal by Subject|2|||
13192758|NCT02091362|26191654|FG000|Period 2|Adverse Event|1|||
13192759|NCT02091362|26191655|FG001|Period 2|Adverse Event|0|||
13192760|NCT02091362|26191654|FG000|Period 2|Lost to Follow-up|0|||
13192761|NCT02091362|26191655|FG001|Period 2|Lost to Follow-up|1|||
13192762|NCT02091362|26191654|FG000|Period 2|Withdrawal by Subject|1|||
13192763|NCT02091362|26191655|FG001|Period 2|Withdrawal by Subject|1|||
13192764|NCT02091284|26191680|FG000|Overall Study|Withdrawal by Subject|2|||
13192765|NCT02091284|26191681|FG001|Overall Study|Withdrawal by Subject|1|||
13192766|NCT02091284|26191680|FG000|Overall Study|unreliable data|1|||
13192767|NCT02091284|26191681|FG001|Overall Study|unreliable data|0|||
13192768|NCT02091206|26191711|FG000|Treatment Period|Adverse Event|0|||
13192769|NCT02091206|26191712|FG001|Treatment Period|Adverse Event|1|||
13192770|NCT02091206|26191713|FG002|Treatment Period|Adverse Event|0|||
13192771|NCT02091206|26191714|FG003|Treatment Period|Adverse Event|0|||
13192772|NCT02091206|26191711|FG000|Treatment Period|Met withdrawal criteria|0|||
13192773|NCT02091206|26191712|FG001|Treatment Period|Met withdrawal criteria|0|||
13192774|NCT02091206|26191713|FG002|Treatment Period|Met withdrawal criteria|1|||
13192775|NCT02091206|26191714|FG003|Treatment Period|Met withdrawal criteria|0|||
13192776|NCT02091206|26191711|FG000|Taper Period|Participant refused study drug|1|||
13192777|NCT02091206|26191712|FG001|Taper Period|Participant refused study drug|0|||
13192778|NCT02091206|26191713|FG002|Taper Period|Participant refused study drug|0|||
13192779|NCT02091206|26191714|FG003|Taper Period|Participant refused study drug|1|||
13192780|NCT02091206|26191711|FG000|Taper Period|Lost to Follow-up|0|||
13192781|NCT02091206|26191712|FG001|Taper Period|Lost to Follow-up|0|||
13192782|NCT02091206|26191713|FG002|Taper Period|Lost to Follow-up|0|||
13192783|NCT02091206|26191714|FG003|Taper Period|Lost to Follow-up|1|||
13192784|NCT02091167|26191729|FG000|Overall Study|Lost to Follow-up|0|||
13192785|NCT02091167|26191730|FG001|Overall Study|Lost to Follow-up|2|||
13192786|NCT02091089|26191740|FG000|Overall Study|Lost to Follow-up|2|||
13192787|NCT02090959|26191764|FG000|Overall Study|Withdrawal by Subject|10|||
13192788|NCT02090959|26191764|FG000|Overall Study|Adverse Event|1|||
13192789|NCT02090959|26191764|FG000|Overall Study|Investigator decision|2|||
13192790|NCT02090959|26191764|FG000|Overall Study|Study termination|6|||
13192791|NCT02090959|26191764|FG000|Overall Study|Enrolled but not treated|1|||
13192792|NCT02090959|26191764|FG000|Overall Study|Transfer for compassionate use medicine|4|||
13192793|NCT02090959|26191764|FG000|Overall Study|Move to medical need program|3|||
13192794|NCT02090959|26191764|FG000|Overall Study|Entered in to other study|34|||
13192795|NCT02090959|26191764|FG000|Overall Study|Switched to commercial supply|88|||
13192796|NCT02090959|26191764|FG000|Overall Study|Other than specified|2|||
13192797|NCT02090855|26191773|FG000|Overall Study|no evaluable Standard of Truth results|2|||
13192798|NCT02090764|26191786|FG000|Overall Study|Adverse Event|1|||
13192799|NCT02090764|26191787|FG001|Overall Study|Adverse Event|3|||
13192800|NCT02090764|26191786|FG000|Overall Study|Lack of Efficacy|0|||
13192801|NCT02090764|26191787|FG001|Overall Study|Lack of Efficacy|13|||
13192802|NCT02090764|26191786|FG000|Overall Study|Withdrawal by Subject|2|||
13192803|NCT02090764|26191787|FG001|Overall Study|Withdrawal by Subject|1|||
13192804|NCT02090764|26191786|FG000|Overall Study|Intercurrent illness and other|1|||
13192805|NCT02090764|26191787|FG001|Overall Study|Intercurrent illness and other|1|||
13192806|NCT02090764|26191786|FG000|Overall Study|Lost to Follow-up|2|||
13192807|NCT02090764|26191787|FG001|Overall Study|Lost to Follow-up|2|||
13192808|NCT02090725|26191793|FG000|Overall Study|Withdrawal by Subject|1|||
13192809|NCT02090725|26191793|FG000|Overall Study|participants moved from area|3|||
13192810|NCT02090634|26191808|FG000|Overall Study|Lost to Follow-up|0|||
13192811|NCT02090634|26191809|FG001|Overall Study|Lost to Follow-up|1|||
13192812|NCT02090634|26191808|FG000|Overall Study|Death|0|||
13192813|NCT02090634|26191809|FG001|Overall Study|Death|1|||
13192814|NCT02090634|26191808|FG000|Overall Study|Protocol Violation|3|||
13192815|NCT02090634|26191809|FG001|Overall Study|Protocol Violation|1|||
13192816|NCT02090634|26191808|FG000|Overall Study|Adverse Event|2|||
13192817|NCT02090634|26191809|FG001|Overall Study|Adverse Event|0|||
13192818|NCT02090426|26191844|FG000|Overall Study|Lost to Follow-up|12|||
13192819|NCT02090426|26191845|FG001|Overall Study|Lost to Follow-up|6|||
13192820|NCT02090413|26191929|FG000|Overall Study|Adverse Event|11|||
13192821|NCT02090413|26191930|FG001|Overall Study|Adverse Event|15|||
13192822|NCT02090413|26191931|FG002|Overall Study|Adverse Event|20|||
13192823|NCT02090413|26191929|FG000|Overall Study|Flushing event|2|||
13192824|NCT02090413|26191930|FG001|Overall Study|Flushing event|0|||
13192825|NCT02090413|26191931|FG002|Overall Study|Flushing event|1|||
13192826|NCT02090413|26191929|FG000|Overall Study|Withdrawal by Subject|2|||
13192827|NCT02090413|26191930|FG001|Overall Study|Withdrawal by Subject|2|||
13192828|NCT02090413|26191931|FG002|Overall Study|Withdrawal by Subject|2|||
13192829|NCT02090413|26191929|FG000|Overall Study|Investigator Decision|1|||
13192830|NCT02090413|26191930|FG001|Overall Study|Investigator Decision|1|||
13192831|NCT02090413|26191931|FG002|Overall Study|Investigator Decision|0|||
13192832|NCT02090413|26191929|FG000|Overall Study|Other|2|||
13192833|NCT02090413|26191930|FG001|Overall Study|Other|1|||
13192834|NCT02090413|26191931|FG002|Overall Study|Other|0|||
13192835|NCT02090413|26191929|FG000|Overall Study|Lost to Follow-up|1|||
13192836|NCT02090413|26191930|FG001|Overall Study|Lost to Follow-up|1|||
13192837|NCT02090413|26191931|FG002|Overall Study|Lost to Follow-up|0|||
13192838|NCT02090283|26191952|FG000|Overall Study|Withdrawal by Subject|6|||
13192839|NCT02090283|26191953|FG001|Overall Study|Withdrawal by Subject|6|||
13192840|NCT02090283|26191954|FG002|Overall Study|Withdrawal by Subject|6|||
13192841|NCT02090283|26191952|FG000|Overall Study|Sponsor Terminated Study|6|||
13192842|NCT02090283|26191953|FG001|Overall Study|Sponsor Terminated Study|6|||
13192843|NCT02090283|26191954|FG002|Overall Study|Sponsor Terminated Study|1|||
13192844|NCT02090283|26191952|FG000|Overall Study|Lost to Follow-up|2|||
13192845|NCT02090283|26191953|FG001|Overall Study|Lost to Follow-up|2|||
13192846|NCT02090283|26191954|FG002|Overall Study|Lost to Follow-up|3|||
13192847|NCT02090283|26191952|FG000|Overall Study|Adverse Event|1|||
13192848|NCT02090283|26191953|FG001|Overall Study|Adverse Event|1|||
13192849|NCT02090283|26191954|FG002|Overall Study|Adverse Event|0|||
13192850|NCT02090283|26191952|FG000|Overall Study|Protocol Violation|2|||
13192851|NCT02090283|26191953|FG001|Overall Study|Protocol Violation|0|||
13192852|NCT02090283|26191954|FG002|Overall Study|Protocol Violation|0|||
13192853|NCT02090114|26192021|FG000|Overall Study|Withdrawal by Subject|3|||
13192854|NCT02090114|26192022|FG001|Overall Study|Withdrawal by Subject|6|||
13192855|NCT02090114|26192023|FG002|Overall Study|Withdrawal by Subject|2|||
13192856|NCT02090114|26192024|FG003|Overall Study|Withdrawal by Subject|1|||
13192857|NCT02090114|26192021|FG000|Overall Study|Physician Decision|5|||
13192858|NCT02090114|26192022|FG001|Overall Study|Physician Decision|0|||
13192859|NCT02090114|26192023|FG002|Overall Study|Physician Decision|1|||
13192860|NCT02090114|26192024|FG003|Overall Study|Physician Decision|1|||
13192861|NCT02090114|26192021|FG000|Overall Study|Adverse Event|1|||
13192862|NCT02090114|26192022|FG001|Overall Study|Adverse Event|2|||
13192863|NCT02090114|26192023|FG002|Overall Study|Adverse Event|2|||
13192864|NCT02090114|26192024|FG003|Overall Study|Adverse Event|0|||
13192865|NCT02090114|26192021|FG000|Overall Study|Progressive Disease|20|||
13192866|NCT02090114|26192022|FG001|Overall Study|Progressive Disease|21|||
13192867|NCT02090114|26192023|FG002|Overall Study|Progressive Disease|23|||
13192868|NCT02090114|26192024|FG003|Overall Study|Progressive Disease|6|||
13192869|NCT02090114|26192021|FG000|Overall Study|Death|1|||
13192870|NCT02090114|26192022|FG001|Overall Study|Death|0|||
13192871|NCT02090114|26192023|FG002|Overall Study|Death|1|||
13192872|NCT02090114|26192024|FG003|Overall Study|Death|0|||
13192873|NCT02089997|26192041|FG000|Overall Study|Case report forms uncollected|99|||
13192874|NCT02089997|26192041|FG000|Overall Study|Protocol Violation|147|||
13192875|NCT02089737|26192050|FG000|Overall Study|Survey form not completed|5|||
13192876|NCT02089737|26192050|FG000|Overall Study|Not treated|1|||
13192877|NCT02089685|26192181|FG000|Overall Study|Adverse Event|1|||
13192878|NCT02089685|26192182|FG001|Overall Study|Adverse Event|0|||
13192879|NCT02089685|26192183|FG002|Overall Study|Adverse Event|0|||
13192880|NCT02089685|26192184|FG003|Overall Study|Adverse Event|0|||
13192881|NCT02089685|26192185|FG004|Overall Study|Adverse Event|1|||
13192882|NCT02089685|26192186|FG005|Overall Study|Adverse Event|0|||
13192883|NCT02089685|26192181|FG000|Overall Study|Clinical Progression|4|||
13192884|NCT02089685|26192182|FG001|Overall Study|Clinical Progression|0|||
13192885|NCT02089685|26192183|FG002|Overall Study|Clinical Progression|0|||
13192886|NCT02089685|26192184|FG003|Overall Study|Clinical Progression|5|||
13192887|NCT02089685|26192185|FG004|Overall Study|Clinical Progression|1|||
13192888|NCT02089685|26192186|FG005|Overall Study|Clinical Progression|2|||
13192889|NCT02089685|26192181|FG000|Overall Study|Excluded Medication|1|||
13192890|NCT02089685|26192182|FG001|Overall Study|Excluded Medication|0|||
13192891|NCT02089685|26192183|FG002|Overall Study|Excluded Medication|0|||
13192892|NCT02089685|26192184|FG003|Overall Study|Excluded Medication|11|||
13192893|NCT02089685|26192185|FG004|Overall Study|Excluded Medication|2|||
13192894|NCT02089685|26192186|FG005|Overall Study|Excluded Medication|1|||
13192895|NCT02089685|26192181|FG000|Overall Study|Progressive disease|13|||
13192896|NCT02089685|26192182|FG001|Overall Study|Progressive disease|10|||
13192897|NCT02089685|26192183|FG002|Overall Study|Progressive disease|3|||
13192898|NCT02089685|26192184|FG003|Overall Study|Progressive disease|51|||
13192899|NCT02089685|26192185|FG004|Overall Study|Progressive disease|17|||
13192900|NCT02089685|26192186|FG005|Overall Study|Progressive disease|12|||
13192901|NCT02089685|26192181|FG000|Overall Study|Follow up ended by sponsor|2|||
13192902|NCT02089685|26192182|FG001|Overall Study|Follow up ended by sponsor|2|||
13192903|NCT02089685|26192183|FG002|Overall Study|Follow up ended by sponsor|0|||
13192904|NCT02089685|26192184|FG003|Overall Study|Follow up ended by sponsor|70|||
13192905|NCT02089685|26192185|FG004|Overall Study|Follow up ended by sponsor|26|||
13192906|NCT02089685|26192186|FG005|Overall Study|Follow up ended by sponsor|26|||
13192907|NCT02089685|26192181|FG000|Overall Study|Withdrawal by Subject|0|||
13192908|NCT02089685|26192182|FG001|Overall Study|Withdrawal by Subject|2|||
13192909|NCT02089685|26192183|FG002|Overall Study|Withdrawal by Subject|0|||
13192910|NCT02089685|26192184|FG003|Overall Study|Withdrawal by Subject|8|||
13192911|NCT02089685|26192185|FG004|Overall Study|Withdrawal by Subject|1|||
13192912|NCT02089685|26192186|FG005|Overall Study|Withdrawal by Subject|1|||
13192913|NCT02089685|26192181|FG000|Overall Study|Status not recorded|1|||
13192914|NCT02089685|26192182|FG001|Overall Study|Status not recorded|0|||
13192915|NCT02089685|26192183|FG002|Overall Study|Status not recorded|0|||
13192916|NCT02089685|26192184|FG003|Overall Study|Status not recorded|0|||
13192917|NCT02089685|26192185|FG004|Overall Study|Status not recorded|1|||
13192918|NCT02089685|26192186|FG005|Overall Study|Status not recorded|0|||
13192919|NCT02089685|26192181|FG000|Overall Study|Death|0|||
13192920|NCT02089685|26192182|FG001|Overall Study|Death|0|||
13192921|NCT02089685|26192183|FG002|Overall Study|Death|0|||
13192922|NCT02089685|26192184|FG003|Overall Study|Death|7|||
13192923|NCT02089685|26192185|FG004|Overall Study|Death|2|||
13192924|NCT02089685|26192186|FG005|Overall Study|Death|5|||
13192925|NCT02089685|26192181|FG000|Overall Study|Lost to Follow-up|0|||
13192926|NCT02089685|26192182|FG001|Overall Study|Lost to Follow-up|0|||
13192927|NCT02089685|26192183|FG002|Overall Study|Lost to Follow-up|0|||
13192928|NCT02089685|26192184|FG003|Overall Study|Lost to Follow-up|1|||
13192929|NCT02089685|26192185|FG004|Overall Study|Lost to Follow-up|0|||
13192930|NCT02089685|26192186|FG005|Overall Study|Lost to Follow-up|0|||
13192931|NCT02089685|26192181|FG000|Overall Study|Physician Decision|0|||
13192932|NCT02089685|26192182|FG001|Overall Study|Physician Decision|0|||
13192933|NCT02089685|26192183|FG002|Overall Study|Physician Decision|0|||
13192934|NCT02089685|26192184|FG003|Overall Study|Physician Decision|0|||
13192935|NCT02089685|26192185|FG004|Overall Study|Physician Decision|0|||
13192936|NCT02089685|26192186|FG005|Overall Study|Physician Decision|4|||
13192937|NCT02089685|26192181|FG000|Overall Study|Screen failure|1|||
13192938|NCT02089685|26192182|FG001|Overall Study|Screen failure|0|||
13192939|NCT02089685|26192183|FG002|Overall Study|Screen failure|0|||
13192940|NCT02089685|26192184|FG003|Overall Study|Screen failure|0|||
13192941|NCT02089685|26192185|FG004|Overall Study|Screen failure|0|||
13192942|NCT02089685|26192186|FG005|Overall Study|Screen failure|0|||
13192943|NCT02089347|26192215|FG000|Overall Study|Protocol Violation|1|||
13192944|NCT02089347|26192216|FG001|Overall Study|Protocol Violation|0|||
13192945|NCT02089334|26192246|FG000|Overall Study|Withdrawal by Subject|0|||
13192946|NCT02089334|26192247|FG001|Overall Study|Withdrawal by Subject|0|||
13192947|NCT02089334|26192248|FG002|Overall Study|Withdrawal by Subject|0|||
13192948|NCT02089334|26192249|FG003|Overall Study|Withdrawal by Subject|2|||
13192949|NCT02089334|26192246|FG000|Overall Study|Adverse Event|0|||
13192950|NCT02089334|26192247|FG001|Overall Study|Adverse Event|0|||
13192951|NCT02089334|26192248|FG002|Overall Study|Adverse Event|0|||
13192952|NCT02089334|26192249|FG003|Overall Study|Adverse Event|2|||
13192953|NCT02089334|26192246|FG000|Overall Study|Progressive disease|0|||
13192954|NCT02089334|26192247|FG001|Overall Study|Progressive disease|0|||
13192955|NCT02089334|26192248|FG002|Overall Study|Progressive disease|0|||
13192956|NCT02089334|26192249|FG003|Overall Study|Progressive disease|2|||
13192957|NCT02089334|26192246|FG000|Overall Study|Physician Decision|0|||
13192958|NCT02089334|26192247|FG001|Overall Study|Physician Decision|0|||
13192959|NCT02089334|26192248|FG002|Overall Study|Physician Decision|1|||
13192960|NCT02089334|26192249|FG003|Overall Study|Physician Decision|1|||
13192961|NCT02089230|26192270|FG000|Overall Study|Death|0|||
13192962|NCT02089230|26192271|FG001|Overall Study|Death|0|||
13192963|NCT02089230|26192272|FG002|Overall Study|Death|2|||
13192964|NCT02089230|26192270|FG000|Overall Study|Seeking Alternative Therapy|0|||
13192965|NCT02089230|26192271|FG001|Overall Study|Seeking Alternative Therapy|0|||
13192966|NCT02089230|26192272|FG002|Overall Study|Seeking Alternative Therapy|4|||
13192967|NCT02088957|26192291|FG000|Overall Study|Lack of Efficacy|1|||
13192968|NCT02088957|26192292|FG001|Overall Study|Lack of Efficacy|0|||
13192969|NCT02088905|26192319|FG000|Overall Study|Withdrawal by Subject|5|||
13192970|NCT02088905|26192320|FG001|Overall Study|Withdrawal by Subject|1|||
13192971|NCT02088697|26192335|FG000|Period I|Physician Decision|1|||
13192972|NCT02088697|26192336|FG001|Period I|Physician Decision|4|||
13192973|NCT02088697|26192335|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1|||
13192974|NCT02088697|26192336|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0|||
13192975|NCT02088177|26192343|FG000|Overall Study|Lost to Follow-up|3|||
13192976|NCT02088073|26192411|FG000|Acute Phase|Withdrawal by Subject|5|||
13192977|NCT02088073|26192412|FG001|Acute Phase|Withdrawal by Subject|0|||
13192978|NCT02088073|26192413|FG002|Acute Phase|Withdrawal by Subject|0|||
13192979|NCT02088073|26192414|FG003|Acute Phase|Withdrawal by Subject|0|||
13192980|NCT02088073|26192415|FG004|Acute Phase|Withdrawal by Subject|0|||
13192981|NCT02088073|26192411|FG000|Acute Phase|Hyperkalemia|2|||
13192982|NCT02088073|26192412|FG001|Acute Phase|Hyperkalemia|0|||
13192983|NCT02088073|26192413|FG002|Acute Phase|Hyperkalemia|0|||
13192984|NCT02088073|26192414|FG003|Acute Phase|Hyperkalemia|0|||
13192985|NCT02088073|26192415|FG004|Acute Phase|Hyperkalemia|0|||
13192986|NCT02088073|26192411|FG000|Maintanance Phase|Withdrawal by Subject|0|||
13192987|NCT02088073|26192412|FG001|Maintanance Phase|Withdrawal by Subject|2|||
13192988|NCT02088073|26192413|FG002|Maintanance Phase|Withdrawal by Subject|0|||
13192989|NCT02088073|26192414|FG003|Maintanance Phase|Withdrawal by Subject|0|||
13192990|NCT02088073|26192415|FG004|Maintanance Phase|Withdrawal by Subject|0|||
13192991|NCT02088073|26192411|FG000|Maintanance Phase|Adverse Event|0|||
13192992|NCT02088073|26192412|FG001|Maintanance Phase|Adverse Event|0|||
13192993|NCT02088073|26192413|FG002|Maintanance Phase|Adverse Event|3|||
13192994|NCT02088073|26192414|FG003|Maintanance Phase|Adverse Event|0|||
13192995|NCT02088073|26192415|FG004|Maintanance Phase|Adverse Event|1|||
13192996|NCT02088073|26192411|FG000|Maintanance Phase|Physician Decision|0|||
13192997|NCT02088073|26192412|FG001|Maintanance Phase|Physician Decision|0|||
13192998|NCT02088073|26192413|FG002|Maintanance Phase|Physician Decision|0|||
13192999|NCT02088073|26192414|FG003|Maintanance Phase|Physician Decision|0|||
13193000|NCT02088073|26192415|FG004|Maintanance Phase|Physician Decision|1|||
13193001|NCT02088073|26192411|FG000|Maintanance Phase|Sponsor's decision|0|||
13193002|NCT02088073|26192412|FG001|Maintanance Phase|Sponsor's decision|2|||
13193003|NCT02088073|26192413|FG002|Maintanance Phase|Sponsor's decision|0|||
13193004|NCT02088073|26192414|FG003|Maintanance Phase|Sponsor's decision|2|||
13193005|NCT02088073|26192415|FG004|Maintanance Phase|Sponsor's decision|1|||
13193006|NCT02088073|26192411|FG000|Maintanance Phase|Hypo- or hyperkalemia|0|||
13193007|NCT02088073|26192412|FG001|Maintanance Phase|Hypo- or hyperkalemia|3|||
13193008|NCT02088073|26192413|FG002|Maintanance Phase|Hypo- or hyperkalemia|0|||
13193009|NCT02088073|26192414|FG003|Maintanance Phase|Hypo- or hyperkalemia|3|||
13193010|NCT02088073|26192415|FG004|Maintanance Phase|Hypo- or hyperkalemia|1|||
13193011|NCT02088073|26192411|FG000|Maintanance Phase|Miscellaneous|0|||
13193012|NCT02088073|26192412|FG001|Maintanance Phase|Miscellaneous|2|||
13193013|NCT02088073|26192413|FG002|Maintanance Phase|Miscellaneous|1|||
13193014|NCT02088073|26192414|FG003|Maintanance Phase|Miscellaneous|2|||
13193015|NCT02088073|26192415|FG004|Maintanance Phase|Miscellaneous|1|||
13193016|NCT02088073|26192411|FG000|Maintanance Phase|Met ECG withdrawal criteria|0|||
13193017|NCT02088073|26192412|FG001|Maintanance Phase|Met ECG withdrawal criteria|0|||
13193018|NCT02088073|26192413|FG002|Maintanance Phase|Met ECG withdrawal criteria|1|||
13193019|NCT02088073|26192414|FG003|Maintanance Phase|Met ECG withdrawal criteria|0|||
13193020|NCT02088073|26192415|FG004|Maintanance Phase|Met ECG withdrawal criteria|2|||
13193021|NCT02088073|26192411|FG000|Maintanance Phase|Subject compliance|0|||
13193022|NCT02088073|26192412|FG001|Maintanance Phase|Subject compliance|1|||
13193023|NCT02088073|26192413|FG002|Maintanance Phase|Subject compliance|0|||
13193024|NCT02088073|26192414|FG003|Maintanance Phase|Subject compliance|0|||
13193025|NCT02088073|26192415|FG004|Maintanance Phase|Subject compliance|0|||
13193026|NCT02088047|26192428|FG000|Overall Study|Withdrawal by Subject|1|||
13193027|NCT02088047|26192429|FG001|Overall Study|Withdrawal by Subject|0|||
13193028|NCT02088034|26192447|FG000|Overall Study|Lost to Follow-up|1|||
13193029|NCT02088034|26192448|FG001|Overall Study|Lost to Follow-up|1|||
13193030|NCT02088034|26192449|FG002|Overall Study|Lost to Follow-up|0|||
13193031|NCT02088034|26192447|FG000|Overall Study|Pregnancy|2|||
13193032|NCT02088034|26192448|FG001|Overall Study|Pregnancy|1|||
13193033|NCT02088034|26192449|FG002|Overall Study|Pregnancy|2|||
13193034|NCT02087943|26192485|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1|||
13193035|NCT02087943|26192486|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2|||
13193036|NCT02087943|26192487|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6|||
13193037|NCT02087943|26192488|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
13193038|NCT02087943|26192489|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
13193039|NCT02087943|26192485|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8|||
13193040|NCT02087943|26192486|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7|||
13193041|NCT02087943|26192487|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4|||
13193042|NCT02087943|26192488|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
13111842|NCT03170609|25905586|FG000|Overall Study|Withdrawal by Subject|1|||
13111843|NCT03170609|25905587|FG001|Overall Study|Withdrawal by Subject|2|||
13193043|NCT02087943|26192489|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
13193044|NCT02087943|26192485|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4|||
13193045|NCT02087943|26192486|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
13193046|NCT02087943|26192487|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
13193047|NCT02087943|26192488|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
13193048|NCT02087943|26192489|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
13193049|NCT02087943|26192485|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
13193050|NCT02087943|26192486|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
13193051|NCT02087943|26192487|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
13193052|NCT02087943|26192488|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
13193053|NCT02087943|26192489|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
13193054|NCT02087943|26192485|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
13193055|NCT02087943|26192486|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1|||
13193056|NCT02087943|26192487|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
13193057|NCT02087943|26192488|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
13111844|NCT03170609|25905588|FG002|Overall Study|Withdrawal by Subject|0|||
13111845|NCT03170609|25905589|FG003|Overall Study|Withdrawal by Subject|0|||
13111846|NCT03170609|25905590|FG004|Overall Study|Withdrawal by Subject|0|||
13111847|NCT03170609|25905591|FG005|Overall Study|Withdrawal by Subject|0|||
13111848|NCT03170609|25905592|FG006|Overall Study|Withdrawal by Subject|1|||
13111849|NCT03170609|25905586|FG000|Overall Study|Lost to Follow-up|1|||
13111850|NCT03170609|25905587|FG001|Overall Study|Lost to Follow-up|0|||
13111851|NCT03170609|25905588|FG002|Overall Study|Lost to Follow-up|5|||
13111852|NCT03170609|25905589|FG003|Overall Study|Lost to Follow-up|2|||
13111853|NCT03170609|25905590|FG004|Overall Study|Lost to Follow-up|1|||
13193058|NCT02087943|26192489|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
13193059|NCT02087943|26192485|FG000|Active Treatment Phase Week 12-24|Adverse Event|0|||
13193060|NCT02087943|26192486|FG001|Active Treatment Phase Week 12-24|Adverse Event|1|||
13193061|NCT02087943|26192487|FG002|Active Treatment Phase Week 12-24|Adverse Event|2|||
13193062|NCT02087943|26192488|FG003|Active Treatment Phase Week 12-24|Adverse Event|0|||
13193063|NCT02087943|26192489|FG004|Active Treatment Phase Week 12-24|Adverse Event|1|||
13193064|NCT02087943|26192485|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
13193065|NCT02087943|26192486|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3|||
13193066|NCT02087943|26192487|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
13193067|NCT02087943|26192488|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
13193068|NCT02087943|26192489|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
13193069|NCT02087943|26192485|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
13193070|NCT02087943|26192486|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
13193071|NCT02087943|26192487|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1|||
13193072|NCT02087943|26192488|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
13193073|NCT02087943|26192489|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
13193074|NCT02087943|26192485|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
13193075|NCT02087943|26192486|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
13193076|NCT02087943|26192487|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
13193077|NCT02087943|26192488|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
13193078|NCT02087943|26192489|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1|||
13193079|NCT02087943|26192485|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
13193080|NCT02087943|26192486|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
13193081|NCT02087943|26192487|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
13193082|NCT02087943|26192488|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
13193083|NCT02087943|26192489|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
13193084|NCT02087904|26192616|FG000|Overall Study|Did Not Receive Study Drug|0|||
13193085|NCT02087904|26192617|FG001|Overall Study|Did Not Receive Study Drug|0|||
13193086|NCT02087904|26192618|FG002|Overall Study|Did Not Receive Study Drug|2|||
13193087|NCT02087904|26192619|FG003|Overall Study|Did Not Receive Study Drug|1|||
13193088|NCT02087904|26192616|FG000|Overall Study|Adverse Event|8|||
13193089|NCT02087904|26192617|FG001|Overall Study|Adverse Event|4|||
13193090|NCT02087904|26192618|FG002|Overall Study|Adverse Event|4|||
13193091|NCT02087904|26192619|FG003|Overall Study|Adverse Event|12|||
13193092|NCT02087904|26192616|FG000|Overall Study|Lack of Efficacy|3|||
13193093|NCT02087904|26192617|FG001|Overall Study|Lack of Efficacy|6|||
13193094|NCT02087904|26192618|FG002|Overall Study|Lack of Efficacy|3|||
13193095|NCT02087904|26192619|FG003|Overall Study|Lack of Efficacy|2|||
13193096|NCT02087904|26192616|FG000|Overall Study|Other|6|||
13193097|NCT02087904|26192617|FG001|Overall Study|Other|2|||
13193098|NCT02087904|26192618|FG002|Overall Study|Other|4|||
13193099|NCT02087904|26192619|FG003|Overall Study|Other|4|||
13193100|NCT02087904|26192616|FG000|Overall Study|Withdrawal by Subject|8|||
13193101|NCT02087904|26192617|FG001|Overall Study|Withdrawal by Subject|3|||
13193102|NCT02087904|26192618|FG002|Overall Study|Withdrawal by Subject|7|||
13193103|NCT02087904|26192619|FG003|Overall Study|Withdrawal by Subject|4|||
13193104|NCT02087904|26192616|FG000|Overall Study|Lost to Follow-up|0|||
13193105|NCT02087904|26192617|FG001|Overall Study|Lost to Follow-up|4|||
13193106|NCT02087904|26192618|FG002|Overall Study|Lost to Follow-up|2|||
13193107|NCT02087904|26192619|FG003|Overall Study|Lost to Follow-up|2|||
13193108|NCT02087774|26192634|FG000|Overall Study|Were absent day of data collection|8|||
13193109|NCT02087774|26192635|FG001|Overall Study|Were absent day of data collection|20|||
13193110|NCT02087670|26192650|FG000|Overall Study|Withdrawal by Subject|3|||
13193111|NCT02087670|26192651|FG001|Overall Study|Withdrawal by Subject|2|||
13193112|NCT02087241|26192690|FG000|Overall Study|Death|2|||
13193113|NCT02087241|26192691|FG001|Overall Study|Death|1|||
13193114|NCT02087241|26192692|FG002|Overall Study|Death|1|||
13193115|NCT02087241|26192693|FG003|Overall Study|Death|1|||
13193116|NCT02087241|26192690|FG000|Overall Study|Withdrawal by Subject|1|||
13193117|NCT02087241|26192691|FG001|Overall Study|Withdrawal by Subject|0|||
13193118|NCT02087241|26192692|FG002|Overall Study|Withdrawal by Subject|0|||
13193119|NCT02087241|26192693|FG003|Overall Study|Withdrawal by Subject|1|||
13193120|NCT02087241|26192690|FG000|Overall Study|Progressive Disease|0|||
13193121|NCT02087241|26192691|FG001|Overall Study|Progressive Disease|0|||
13193122|NCT02087241|26192692|FG002|Overall Study|Progressive Disease|0|||
13193123|NCT02087241|26192693|FG003|Overall Study|Progressive Disease|1|||
13193124|NCT02087241|26192690|FG000|Overall Study|Study Terminated by Sponsor|0|||
13193125|NCT02087241|26192691|FG001|Overall Study|Study Terminated by Sponsor|2|||
13193126|NCT02087241|26192692|FG002|Overall Study|Study Terminated by Sponsor|0|||
13193127|NCT02087241|26192693|FG003|Overall Study|Study Terminated by Sponsor|4|||
13193128|NCT02087176|26192700|FG000|Overall Study|Withdrawal by Subject|1|||
13193129|NCT02087176|26192700|FG000|Overall Study|Death|10|||
13193130|NCT02087176|26192700|FG000|Overall Study|Censored|19|||
13193131|NCT02087176|26192700|FG000|Overall Study|Study Terminated by Sponsor|2|||
13193132|NCT02087150|26192727|FG000|Overall Study|Death|0|||
13193133|NCT02087150|26192728|FG001|Overall Study|Death|1|||
13193134|NCT02087150|26192729|FG002|Overall Study|Death|0|||
13193135|NCT02087150|26192727|FG000|Overall Study|Lost to Follow-up|6|||
13193136|NCT02087150|26192728|FG001|Overall Study|Lost to Follow-up|13|||
13193137|NCT02087150|26192729|FG002|Overall Study|Lost to Follow-up|7|||
13111854|NCT03170609|25905591|FG005|Overall Study|Lost to Follow-up|1|||
13111855|NCT03170609|25905592|FG006|Overall Study|Lost to Follow-up|0|||
13111856|NCT03170609|25905586|FG000|Overall Study|Other|1|||
13111857|NCT03170609|25905587|FG001|Overall Study|Other|0|||
13111858|NCT03170609|25905588|FG002|Overall Study|Other|0|||
13111859|NCT03170609|25905589|FG003|Overall Study|Other|0|||
13111860|NCT03170609|25905590|FG004|Overall Study|Other|0|||
13111861|NCT03170609|25905591|FG005|Overall Study|Other|1|||
13111862|NCT03170609|25905592|FG006|Overall Study|Other|0|||
13111863|NCT03170544|25905791|FG000|Part 1|Lost to Follow-up|1|||
13111864|NCT03170544|25905792|FG001|Part 1|Lost to Follow-up|0|||
13111865|NCT03170544|25905793|FG002|Part 1|Lost to Follow-up|0|||
13111866|NCT03170544|25905794|FG003|Part 1|Lost to Follow-up|0|||
13111867|NCT03170544|25905795|FG004|Part 1|Lost to Follow-up|0|||
13111868|NCT03170544|25905796|FG005|Part 1|Lost to Follow-up|0|||
13111869|NCT03170544|25905797|FG006|Part 1|Lost to Follow-up|0|||
13111870|NCT03170544|25905798|FG007|Part 1|Lost to Follow-up|0|||
13111871|NCT03170544|25905799|FG008|Part 1|Lost to Follow-up|0|||
13111872|NCT03170544|25905800|FG009|Part 1|Lost to Follow-up|0|||
13111873|NCT03170544|25905801|FG010|Part 1|Lost to Follow-up|0|||
13111874|NCT03170544|25905802|FG011|Part 1|Lost to Follow-up|0|||
13111875|NCT03170544|25905791|FG000|Part 1|Not treated|0|||
13111876|NCT03170544|25905792|FG001|Part 1|Not treated|0|||
13193138|NCT02087150|26192727|FG000|Overall Study|Withdrawal by Subject|2|||
13193139|NCT02087150|26192728|FG001|Overall Study|Withdrawal by Subject|5|||
13193140|NCT02087150|26192729|FG002|Overall Study|Withdrawal by Subject|3|||
13193141|NCT02087150|26192727|FG000|Overall Study|Physician Decision|0|||
13193142|NCT02087150|26192728|FG001|Overall Study|Physician Decision|1|||
13193143|NCT02087150|26192729|FG002|Overall Study|Physician Decision|0|||
13193144|NCT02087150|26192727|FG000|Overall Study|Procedure not done|1|||
13193145|NCT02087150|26192728|FG001|Overall Study|Procedure not done|13|||
13193146|NCT02087150|26192729|FG002|Overall Study|Procedure not done|0|||
13111877|NCT03170544|25905793|FG002|Part 1|Not treated|0|||
13111878|NCT03170544|25905794|FG003|Part 1|Not treated|1|||
13111879|NCT03170544|25905795|FG004|Part 1|Not treated|0|||
13193147|NCT02087150|26192727|FG000|Overall Study|F/U not completed w/in study window|0|||
13193148|NCT02087150|26192728|FG001|Overall Study|F/U not completed w/in study window|0|||
13193149|NCT02087150|26192729|FG002|Overall Study|F/U not completed w/in study window|1|||
13193150|NCT02087150|26192727|FG000|Overall Study|Other|1|||
13193151|NCT02087150|26192728|FG001|Overall Study|Other|0|||
13193152|NCT02087150|26192729|FG002|Overall Study|Other|0|||
13193153|NCT02087150|26192727|FG000|Overall Study|Pt moved out of town|0|||
13193154|NCT02087150|26192728|FG001|Overall Study|Pt moved out of town|1|||
13193155|NCT02087150|26192729|FG002|Overall Study|Pt moved out of town|0|||
13193156|NCT02087085|26192746|FG000|Overall Study|Adverse Event|10|||
13193157|NCT02087085|26192747|FG001|Overall Study|Adverse Event|14|||
13193158|NCT02087085|26192746|FG000|Overall Study|Lack of Efficacy|4|||
13193159|NCT02087085|26192747|FG001|Overall Study|Lack of Efficacy|3|||
13193160|NCT02087085|26192746|FG000|Overall Study|Lost to Follow-up|6|||
13193161|NCT02087085|26192747|FG001|Overall Study|Lost to Follow-up|4|||
13193162|NCT02087085|26192746|FG000|Overall Study|Withdrawal by Subject|9|||
13193163|NCT02087085|26192747|FG001|Overall Study|Withdrawal by Subject|11|||
13485564|NCT02906020|27032870|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
13485565|NCT02906020|27032871|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
13193164|NCT02087085|26192746|FG000|Overall Study|Protocol Violation|1|||
13193165|NCT02087085|26192747|FG001|Overall Study|Protocol Violation|0|||
13223178|NCT01799889|26287990|FG002|Overall Study|Study Terminated By Sponsor|0|||
13223179|NCT01799889|26287991|FG003|Overall Study|Study Terminated By Sponsor|0|||
13223180|NCT01799889|26287992|FG004|Overall Study|Study Terminated By Sponsor|2|||
13223181|NCT01799889|26287993|FG005|Overall Study|Study Terminated By Sponsor|1|||
13223182|NCT01799889|26287994|FG006|Overall Study|Study Terminated By Sponsor|0|||
13223183|NCT01799889|26287995|FG007|Overall Study|Study Terminated By Sponsor|2|||
13223184|NCT01799889|26287996|FG008|Overall Study|Study Terminated By Sponsor|1|||
13223185|NCT01799889|26287997|FG009|Overall Study|Study Terminated By Sponsor|1|||
13223186|NCT01799889|26287998|FG010|Overall Study|Study Terminated By Sponsor|0|||
13223187|NCT01799889|26287999|FG011|Overall Study|Study Terminated By Sponsor|0|||
13111880|NCT03170544|25905796|FG005|Part 1|Not treated|0|||
13111881|NCT03170544|25905797|FG006|Part 1|Not treated|0|||
13111882|NCT03170544|25905798|FG007|Part 1|Not treated|0|||
13111883|NCT03170544|25905799|FG008|Part 1|Not treated|0|||
13111884|NCT03170544|25905800|FG009|Part 1|Not treated|0|||
13111885|NCT03170544|25905801|FG010|Part 1|Not treated|0|||
13111886|NCT03170544|25905802|FG011|Part 1|Not treated|0|||
13111887|NCT03170349|25905828|FG000|At 30 Days Follow-up|Death|1|||
13111888|NCT03170349|25905828|FG000|At 6 Months Follow-up|Death|3|||
13223188|NCT01799889|26287988|FG000|Overall Study|Withdrawal by Subject|1|||
13223189|NCT01799889|26287989|FG001|Overall Study|Withdrawal by Subject|6|||
13223190|NCT01799889|26287990|FG002|Overall Study|Withdrawal by Subject|4|||
13111889|NCT03170349|25905828|FG000|At 6 Months Follow-up|Withdrawal by Subject|1|||
13111890|NCT03170349|25905828|FG000|At 6 Months Follow-up|Exited for Other Reasons|5|||
13111891|NCT03170349|25905828|FG000|At 1 Year Follow-up|Death|6|||
13111892|NCT03170349|25905828|FG000|At 1 Year Follow-up|Exited for Other Reasons|2|||
13111893|NCT03170271|25905861|FG000|Overall Study|Adverse Event|7|||
13111894|NCT03170271|25905862|FG001|Overall Study|Adverse Event|2|||
13111895|NCT03170271|25905861|FG000|Overall Study|Lost to Follow-up|0|||
13111896|NCT03170271|25905862|FG001|Overall Study|Lost to Follow-up|1|||
13111897|NCT03170271|25905861|FG000|Overall Study|Physician Decision|1|||
13111898|NCT03170271|25905862|FG001|Overall Study|Physician Decision|0|||
13111899|NCT03170271|25905861|FG000|Overall Study|Protocol-specified withdrawal criterion|2|||
13111900|NCT03170271|25905862|FG001|Overall Study|Protocol-specified withdrawal criterion|1|||
13111901|NCT03170271|25905861|FG000|Overall Study|Withdrawal by Subject|17|||
13111902|NCT03170271|25905862|FG001|Overall Study|Withdrawal by Subject|5|||
13111903|NCT03170271|25905861|FG000|Overall Study|Other|2|||
13111904|NCT03170271|25905862|FG001|Overall Study|Other|2|||
13111905|NCT03170271|25905861|FG000|Overall Study|Randomized in error|4|||
13111906|NCT03170271|25905862|FG001|Overall Study|Randomized in error|0|||
13111907|NCT03170232|25905913|FG000|Overall Study|Adverse Event|0|||
13111908|NCT03170232|25905914|FG001|Overall Study|Adverse Event|1|||
13111909|NCT03170232|25905913|FG000|Overall Study|Protocol Violation|0|||
13111910|NCT03170232|25905914|FG001|Overall Study|Protocol Violation|1|||
13111911|NCT03170232|25905913|FG000|Overall Study|Lack of Efficacy|0|||
13111912|NCT03170232|25905914|FG001|Overall Study|Lack of Efficacy|1|||
13111913|NCT03170232|25905913|FG000|Overall Study|Study closed/terminated|26|||
13111914|NCT03170232|25905914|FG001|Overall Study|Study closed/terminated|23|||
13111915|NCT03170232|25905913|FG000|Overall Study|Lost to Follow-up|1|||
13111916|NCT03170232|25905914|FG001|Overall Study|Lost to Follow-up|0|||
13193166|NCT02087085|26192746|FG000|Overall Study|Study Terminated by Sponsor|87|||
13193167|NCT02087085|26192747|FG001|Overall Study|Study Terminated by Sponsor|80|||
13193168|NCT02087085|26192746|FG000|Overall Study|Other Miscellaneous Reasons|3|||
13193169|NCT02087085|26192747|FG001|Overall Study|Other Miscellaneous Reasons|4|||
13193170|NCT02087059|26192757|FG000|Overall Study|Disease Progression|1|||
13485566|NCT02906020|27032872|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
13485567|NCT02906020|27032873|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
13485568|NCT02906020|27032874|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
13485569|NCT02906020|27032875|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
13193171|NCT02087059|26192757|FG000|Overall Study|Adverse Event|5|||
13193172|NCT02087059|26192757|FG000|Overall Study|Lost to Follow-up|1|||
13193173|NCT02087046|26192829|FG000|Overall Study|Adverse Event|4|||
13193174|NCT02087046|26192829|FG000|Overall Study|Death|1|||
13193175|NCT02087046|26192829|FG000|Overall Study|Lost to Follow-up|3|||
13193176|NCT02087046|26192829|FG000|Overall Study|Withdrawal by Subject|2|||
13193177|NCT02087046|26192829|FG000|Overall Study|Physician Decision|1|||
13193178|NCT02086968|26192842|FG000|Overall Study|Adverse Event|1|||
13193179|NCT02086968|26192843|FG001|Overall Study|Adverse Event|5|||
13193180|NCT02086968|26192842|FG000|Overall Study|Lost to Follow-up|2|||
13193181|NCT02086968|26192843|FG001|Overall Study|Lost to Follow-up|3|||
13193182|NCT02086968|26192842|FG000|Overall Study|Study drug received outside protocol|0|||
13193183|NCT02086968|26192843|FG001|Overall Study|Study drug received outside protocol|1|||
13193184|NCT02086968|26192842|FG000|Overall Study|Physician Decision|4|||
13193185|NCT02086968|26192843|FG001|Overall Study|Physician Decision|0|||
13193186|NCT02086968|26192842|FG000|Overall Study|Withdrawal by Subject|1|||
13193187|NCT02086968|26192843|FG001|Overall Study|Withdrawal by Subject|4|||
13193188|NCT02086591|26192851|FG000|Overall Study|Adverse Event|1|||
13193189|NCT02086591|26192851|FG000|Overall Study|Withdrawal by Subject|1|||
13193190|NCT02086591|26192851|FG000|Overall Study|protocol terminated|3|||
13193191|NCT02086565|26192872|FG000|Overall Study|Lost to Follow-up|9|||
13193192|NCT02086565|26192873|FG001|Overall Study|Lost to Follow-up|7|||
13193193|NCT02086565|26192872|FG000|Overall Study|Withdrawal by Subject|2|||
13193194|NCT02086565|26192873|FG001|Overall Study|Withdrawal by Subject|1|||
13193195|NCT02086565|26192872|FG000|Overall Study|Death|3|||
13193196|NCT02086565|26192873|FG001|Overall Study|Death|2|||
13193197|NCT02086565|26192872|FG000|Overall Study|withdrawn by research team|2|||
13193198|NCT02086565|26192873|FG001|Overall Study|withdrawn by research team|2|||
13193199|NCT02086162|26192890|FG000|Overall Study|Withdrawal by Subject|4|||
13193200|NCT02086162|26192891|FG001|Overall Study|Withdrawal by Subject|4|||
13111917|NCT03170232|25905913|FG000|Overall Study|Withdrawal by Subject|0|||
13111918|NCT03170232|25905914|FG001|Overall Study|Withdrawal by Subject|1|||
13111919|NCT03170193|25906005|FG000|Overall Study|Withdrawal by Subject|0|||
13111920|NCT03170193|25906006|FG001|Overall Study|Withdrawal by Subject|0|||
13111921|NCT03170193|25906007|FG002|Overall Study|Withdrawal by Subject|0|||
13111922|NCT03170193|25906008|FG003|Overall Study|Withdrawal by Subject|1|||
13193201|NCT02086162|26192890|FG000|Overall Study|moved|1|||
13193202|NCT02086162|26192891|FG001|Overall Study|moved|1|||
13193203|NCT02086162|26192890|FG000|Overall Study|Lost to Follow-up|4|||
13193204|NCT02086162|26192891|FG001|Overall Study|Lost to Follow-up|2|||
13193205|NCT02086162|26192890|FG000|Overall Study|Death|1|||
13193206|NCT02086162|26192891|FG001|Overall Study|Death|0|||
13193207|NCT02086110|26192907|FG000|Overall Study|Withdrawal by Subject|1|||
13193208|NCT02086110|26192908|FG001|Overall Study|Withdrawal by Subject|1|||
13193209|NCT02085941|26192925|FG000|Overall Study|Lack of Efficacy|1|||
13193210|NCT02085941|26192926|FG001|Overall Study|Lack of Efficacy|0|||
13193211|NCT02085941|26192925|FG000|Overall Study|Death|6|||
13193212|NCT02085941|26192926|FG001|Overall Study|Death|1|||
13193213|NCT02085941|26192925|FG000|Overall Study|Lost to Follow-up|1|||
13193214|NCT02085941|26192926|FG001|Overall Study|Lost to Follow-up|0|||
13193215|NCT02085941|26192925|FG000|Overall Study|Physician Decision|0|||
13193216|NCT02085941|26192926|FG001|Overall Study|Physician Decision|2|||
13193217|NCT02085785|26192945|FG000|Overall Study|Withdrawal by Subject|2|||
13193218|NCT02085785|26192946|FG001|Overall Study|Withdrawal by Subject|1|||
13193219|NCT02085785|26192945|FG000|Overall Study|Lost to Follow-up|0|||
13193220|NCT02085785|26192946|FG001|Overall Study|Lost to Follow-up|1|||
13193221|NCT02085460|26192967|FG000|Overall Study|Adverse Event|2|||
13193222|NCT02085460|26192968|FG001|Overall Study|Adverse Event|2|||
13193223|NCT02085460|26192969|FG002|Overall Study|Adverse Event|1|||
13193224|NCT02085460|26192967|FG000|Overall Study|Physician Decision|1|||
13193225|NCT02085460|26192968|FG001|Overall Study|Physician Decision|1|||
13193226|NCT02085460|26192969|FG002|Overall Study|Physician Decision|2|||
13193227|NCT02085460|26192967|FG000|Overall Study|Withdrawal by Subject|11|||
13193228|NCT02085460|26192968|FG001|Overall Study|Withdrawal by Subject|5|||
13193229|NCT02085460|26192969|FG002|Overall Study|Withdrawal by Subject|7|||
13193230|NCT02085252|26192996|FG000|Overall Study|Withdrawal of Consent|1|||
13193231|NCT02085252|26192997|FG001|Overall Study|Withdrawal of Consent|0|||
13193232|NCT02085252|26192996|FG000|Overall Study|Adverse Event|0|||
13193233|NCT02085252|26192997|FG001|Overall Study|Adverse Event|1|||
13193234|NCT02085252|26192996|FG000|Overall Study|Discontinuation Due to Patient Decision|0|||
13193235|NCT02085252|26192997|FG001|Overall Study|Discontinuation Due to Patient Decision|1|||
13193236|NCT02085252|26192996|FG000|Overall Study|Reason Not Specified|0|||
13193237|NCT02085252|26192997|FG001|Overall Study|Reason Not Specified|1|||
13193238|NCT02085252|26192996|FG000|Overall Study|Reason Unknown|0|||
13193239|NCT02085252|26192997|FG001|Overall Study|Reason Unknown|1|||
13193240|NCT02085161|26193049|FG000|Overall Study|Not Treated|1|||
13193241|NCT02085161|26193050|FG001|Overall Study|Not Treated|0|||
13193242|NCT02085161|26193051|FG002|Overall Study|Not Treated|0|||
13193243|NCT02085161|26193052|FG003|Overall Study|Not Treated|0|||
13193244|NCT02085161|26193049|FG000|Overall Study|Adverse Event|8|||
13193245|NCT02085161|26193050|FG001|Overall Study|Adverse Event|5|||
13193246|NCT02085161|26193051|FG002|Overall Study|Adverse Event|4|||
13193247|NCT02085161|26193052|FG003|Overall Study|Adverse Event|5|||
13193248|NCT02085161|26193049|FG000|Overall Study|Protocol Violation|0|||
13193249|NCT02085161|26193050|FG001|Overall Study|Protocol Violation|1|||
13193250|NCT02085161|26193051|FG002|Overall Study|Protocol Violation|0|||
13193251|NCT02085161|26193052|FG003|Overall Study|Protocol Violation|1|||
13193252|NCT02085161|26193049|FG000|Overall Study|Withdrawal by Subject|2|||
13193253|NCT02085161|26193050|FG001|Overall Study|Withdrawal by Subject|4|||
13193254|NCT02085161|26193051|FG002|Overall Study|Withdrawal by Subject|0|||
13193255|NCT02085161|26193052|FG003|Overall Study|Withdrawal by Subject|3|||
13193256|NCT02085161|26193049|FG000|Overall Study|Other Reason|1|||
13193257|NCT02085161|26193050|FG001|Overall Study|Other Reason|0|||
13193258|NCT02085161|26193051|FG002|Overall Study|Other Reason|1|||
13193259|NCT02085161|26193052|FG003|Overall Study|Other Reason|1|||
13193260|NCT02085135|26193065|FG000|Overall Study|Adverse Event|4|||
13193261|NCT02085135|26193066|FG001|Overall Study|Adverse Event|7|||
13193262|NCT02085135|26193065|FG000|Overall Study|Lost to Follow-up|2|||
13193263|NCT02085135|26193066|FG001|Overall Study|Lost to Follow-up|2|||
13193264|NCT02085135|26193065|FG000|Overall Study|Withdrawal by Subject|3|||
13193265|NCT02085135|26193066|FG001|Overall Study|Withdrawal by Subject|0|||
13193266|NCT02085135|26193065|FG000|Overall Study|Lack of Efficacy|2|||
13193267|NCT02085135|26193066|FG001|Overall Study|Lack of Efficacy|0|||
13193268|NCT02084238|26193079|FG000|Overall Study|Lost to Follow-up|2|||
13193269|NCT02084134|26193094|FG000|Overall Study|Protocol Violation|4|||
13193270|NCT02084134|26193095|FG001|Overall Study|Protocol Violation|2|||
13193271|NCT02084134|26193094|FG000|Overall Study|Death|0|||
13193272|NCT02084134|26193095|FG001|Overall Study|Death|1|||
13193273|NCT02084082|26193134|FG000|Washout Period 1 (35 Days)|Adverse Event|0|||
13193274|NCT02084082|26193135|FG001|Washout Period 1 (35 Days)|Adverse Event|0|||
13193275|NCT02084082|26193136|FG002|Washout Period 1 (35 Days)|Adverse Event|1|||
13193276|NCT02084082|26193137|FG003|Washout Period 1 (35 Days)|Adverse Event|1|||
13193277|NCT02084082|26193134|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
13193278|NCT02084082|26193135|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
13193279|NCT02084082|26193136|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
13193280|NCT02084082|26193137|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
13193281|NCT02084056|26193176|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
13193282|NCT02084056|26193177|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
13193283|NCT02084056|26193178|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
13193284|NCT02084056|26193179|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
13193285|NCT02084056|26193176|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
13193286|NCT02084056|26193177|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
13193287|NCT02084056|26193178|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
13193288|NCT02084056|26193179|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
13193289|NCT02083965|26193242|FG000|Treatment Period|Other|1|||
13193290|NCT02083965|26193243|FG001|Treatment Period|Other|0|||
13193291|NCT02083926|26193258|FG000|Overall Study|Withdrawal by Subject|1|||
13193292|NCT02083926|26193259|FG001|Overall Study|Withdrawal by Subject|0|||
13193293|NCT02083783|26193274|FG000|Overall Study|Withdrawal by Subject|1|||
13193294|NCT02083783|26193275|FG001|Overall Study|Withdrawal by Subject|0|||
13193295|NCT02083653|26193328|FG000|Overall Study|Randomized but not Treated|0|||
13193296|NCT02083653|26193329|FG001|Overall Study|Randomized but not Treated|2|||
13193297|NCT02083653|26193330|FG002|Overall Study|Randomized but not Treated|7|||
13193298|NCT02083653|26193328|FG000|Overall Study|Adverse Event|12|||
13193299|NCT02083653|26193329|FG001|Overall Study|Adverse Event|5|||
13193300|NCT02083653|26193330|FG002|Overall Study|Adverse Event|4|||
13193301|NCT02083653|26193328|FG000|Overall Study|Lost to Follow-up|1|||
13193302|NCT02083653|26193329|FG001|Overall Study|Lost to Follow-up|0|||
13193303|NCT02083653|26193330|FG002|Overall Study|Lost to Follow-up|0|||
13193304|NCT02083653|26193328|FG000|Overall Study|Death|2|||
13193305|NCT02083653|26193329|FG001|Overall Study|Death|2|||
13193306|NCT02083653|26193330|FG002|Overall Study|Death|2|||
13193307|NCT02083653|26193328|FG000|Overall Study|Progressive Disease|65|||
13193308|NCT02083653|26193329|FG001|Overall Study|Progressive Disease|73|||
13193309|NCT02083653|26193330|FG002|Overall Study|Progressive Disease|63|||
13193310|NCT02083653|26193328|FG000|Overall Study|Withdrawal by Subject|2|||
13193311|NCT02083653|26193329|FG001|Overall Study|Withdrawal by Subject|1|||
13193312|NCT02083653|26193330|FG002|Overall Study|Withdrawal by Subject|2|||
13193313|NCT02083653|26193328|FG000|Overall Study|Other Events|0|||
13193314|NCT02083653|26193329|FG001|Overall Study|Other Events|2|||
13193315|NCT02083653|26193330|FG002|Overall Study|Other Events|2|||
13193316|NCT02083653|26193328|FG000|Overall Study|Reason Missing|0|||
13193317|NCT02083653|26193329|FG001|Overall Study|Reason Missing|0|||
13193318|NCT02083653|26193330|FG002|Overall Study|Reason Missing|4|||
13193319|NCT02083380|26193433|FG000|Overall Study|Lack of Efficacy|68|||
13193320|NCT02083380|26193434|FG001|Overall Study|Lack of Efficacy|79|||
13193321|NCT02083380|26193435|FG002|Overall Study|Lack of Efficacy|64|||
13193322|NCT02083380|26193433|FG000|Overall Study|Withdrawal by Subject|9|||
13193323|NCT02083380|26193434|FG001|Overall Study|Withdrawal by Subject|3|||
13193324|NCT02083380|26193435|FG002|Overall Study|Withdrawal by Subject|7|||
13193325|NCT02083380|26193433|FG000|Overall Study|Physician Decision|1|||
13193326|NCT02083380|26193434|FG001|Overall Study|Physician Decision|6|||
13193327|NCT02083380|26193435|FG002|Overall Study|Physician Decision|3|||
13193328|NCT02083380|26193433|FG000|Overall Study|Adverse Event|0|||
13193329|NCT02083380|26193434|FG001|Overall Study|Adverse Event|0|||
13193330|NCT02083380|26193435|FG002|Overall Study|Adverse Event|1|||
13193331|NCT02083380|26193433|FG000|Overall Study|Lost to Follow-up|5|||
13193332|NCT02083380|26193434|FG001|Overall Study|Lost to Follow-up|3|||
13193333|NCT02083380|26193435|FG002|Overall Study|Lost to Follow-up|3|||
13193334|NCT02083380|26193433|FG000|Overall Study|Other|8|||
13193335|NCT02083380|26193434|FG001|Overall Study|Other|4|||
13193336|NCT02083380|26193435|FG002|Overall Study|Other|6|||
13193337|NCT02083185|26193500|FG000|Overall Study|Lost to Follow-up|0|||
13193338|NCT02083185|26193501|FG001|Overall Study|Lost to Follow-up|3|||
13193339|NCT02083185|26193502|FG002|Overall Study|Lost to Follow-up|0|||
13193340|NCT02083185|26193500|FG000|Overall Study|Withdrawal by Subject|9|||
13193341|NCT02083185|26193501|FG001|Overall Study|Withdrawal by Subject|15|||
13193342|NCT02083185|26193502|FG002|Overall Study|Withdrawal by Subject|1|||
13193343|NCT02083185|26193500|FG000|Overall Study|Death|2|||
13193344|NCT02083185|26193501|FG001|Overall Study|Death|2|||
13193345|NCT02083185|26193502|FG002|Overall Study|Death|1|||
13193346|NCT02083185|26193500|FG000|Overall Study|Reason not Specified|9|||
13193347|NCT02083185|26193501|FG001|Overall Study|Reason not Specified|6|||
13193348|NCT02083185|26193502|FG002|Overall Study|Reason not Specified|5|||
13193349|NCT02083185|26193500|FG000|Overall Study|Study Terminated by Sponsor|0|||
13193350|NCT02083185|26193501|FG001|Overall Study|Study Terminated by Sponsor|1|||
13193351|NCT02083185|26193502|FG002|Overall Study|Study Terminated by Sponsor|0|||
13193352|NCT02083185|26193500|FG000|Overall Study|Did not Receive Study Drug|0|||
13193353|NCT02083185|26193501|FG001|Overall Study|Did not Receive Study Drug|2|||
13193354|NCT02083185|26193502|FG002|Overall Study|Did not Receive Study Drug|0|||
13193355|NCT02083081|26193519|FG000|Overall Study|Lost to Follow-up|31|||
13193356|NCT02083081|26193520|FG001|Overall Study|Lost to Follow-up|9|||
13193357|NCT02082977|26193803|FG000|Part 1 (Up to 3.2 Years)|Death|1|||
13193358|NCT02082977|26193804|FG001|Part 1 (Up to 3.2 Years)|Death|0|||
13193359|NCT02082977|26193805|FG002|Part 1 (Up to 3.2 Years)|Death|0|||
13193360|NCT02082977|26193806|FG003|Part 1 (Up to 3.2 Years)|Death|0|||
13193361|NCT02082977|26193807|FG004|Part 1 (Up to 3.2 Years)|Death|0|||
13193362|NCT02082977|26193808|FG005|Part 1 (Up to 3.2 Years)|Death|1|||
13193363|NCT02082977|26193809|FG006|Part 1 (Up to 3.2 Years)|Death|2|||
13193364|NCT02082977|26193810|FG007|Part 1 (Up to 3.2 Years)|Death|0|||
13193365|NCT02082977|26193811|FG008|Part 1 (Up to 3.2 Years)|Death|1|||
13193366|NCT02082977|26193812|FG009|Part 1 (Up to 3.2 Years)|Death|0|||
13193367|NCT02082977|26193803|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
13193368|NCT02082977|26193804|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
13193369|NCT02082977|26193805|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
13193370|NCT02082977|26193806|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
13193371|NCT02082977|26193807|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
13193372|NCT02082977|26193808|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
13193373|NCT02082977|26193809|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
13193374|NCT02082977|26193810|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2|||
13193375|NCT02082977|26193811|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
13193376|NCT02082977|26193812|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
13193377|NCT02082977|26193803|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
13193378|NCT02082977|26193804|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
13193379|NCT02082977|26193805|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
13193380|NCT02082977|26193806|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
13193381|NCT02082977|26193807|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
13193382|NCT02082977|26193808|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1|||
13193383|NCT02082977|26193809|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
13193384|NCT02082977|26193810|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
13193385|NCT02082977|26193811|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
13193386|NCT02082977|26193812|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
13193387|NCT02082977|26193803|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
13193388|NCT02082977|26193804|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
13193389|NCT02082977|26193805|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
13193390|NCT02082977|26193806|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
13193391|NCT02082977|26193807|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
13193392|NCT02082977|26193808|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
13193393|NCT02082977|26193809|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4|||
13193394|NCT02082977|26193810|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
13193395|NCT02082977|26193811|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2|||
13193396|NCT02082977|26193812|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
13193397|NCT02082977|26193803|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
13193398|NCT02082977|26193804|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
13193399|NCT02082977|26193805|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
13193400|NCT02082977|26193806|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
13193401|NCT02082977|26193807|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
13193402|NCT02082977|26193808|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
13193403|NCT02082977|26193809|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
13193404|NCT02082977|26193810|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2|||
13193405|NCT02082977|26193811|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
13193406|NCT02082977|26193812|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
13193407|NCT02082912|26193833|FG000|Overall Study|Physician Decision|0|||
13193408|NCT02082912|26193834|FG001|Overall Study|Physician Decision|1|||
13193409|NCT02082522|26193889|FG000|Overall Study|Sponsor termination|5|||
13193410|NCT02082522|26193890|FG001|Overall Study|Sponsor termination|3|||
13193411|NCT02082522|26193889|FG000|Overall Study|Withdrawal by Subject|2|||
13193412|NCT02082522|26193890|FG001|Overall Study|Withdrawal by Subject|4|||
13193413|NCT02082522|26193889|FG000|Overall Study|Death|1|||
13193414|NCT02082522|26193890|FG001|Overall Study|Death|0|||
13193415|NCT02082522|26193889|FG000|Overall Study|Lost to Follow-up|1|||
13193416|NCT02082522|26193890|FG001|Overall Study|Lost to Follow-up|0|||
13193417|NCT02082522|26193889|FG000|Overall Study|Physician Decision|3|||
13193418|NCT02082522|26193890|FG001|Overall Study|Physician Decision|1|||
13193419|NCT02082522|26193889|FG000|Overall Study|Disease progression|2|||
13193420|NCT02082522|26193890|FG001|Overall Study|Disease progression|2|||
13193421|NCT02082522|26193889|FG000|Overall Study|Chemotherapy change|1|||
13193422|NCT02082522|26193890|FG001|Overall Study|Chemotherapy change|3|||
13193423|NCT02082483|26193912|FG000|Overall Study|Lost to Follow-up|1|||
13193424|NCT02082483|26193913|FG001|Overall Study|Lost to Follow-up|1|||
13193425|NCT02082483|26193912|FG000|Overall Study|Withdrawal by Subject|2|||
13193426|NCT02082483|26193913|FG001|Overall Study|Withdrawal by Subject|1|||
13193427|NCT02082483|26193912|FG000|Overall Study|Physician Decision|1|||
13193428|NCT02082483|26193913|FG001|Overall Study|Physician Decision|1|||
13193429|NCT02082483|26193912|FG000|Overall Study|Death|2|||
13193430|NCT02082483|26193913|FG001|Overall Study|Death|3|||
13193431|NCT02082340|26193926|FG000|Overall Study|Lost to Follow-up|1|||
13193432|NCT02082340|26193927|FG001|Overall Study|Lost to Follow-up|1|||
13193433|NCT02082262|26193933|FG000|Overall Study|Withdrawal by Subject|3|||
13193434|NCT02082262|26193933|FG000|Overall Study|Adverse Event|48|||
13193435|NCT02082210|26193998|FG000|Overall Study|Death|0|||
13193436|NCT02082210|26193999|FG001|Overall Study|Death|0|||
13193437|NCT02082210|26194000|FG002|Overall Study|Death|1|||
13193438|NCT02082210|26194001|FG003|Overall Study|Death|1|||
13193439|NCT02082210|26194002|FG004|Overall Study|Death|1|||
13193440|NCT02082210|26194003|FG005|Overall Study|Death|0|||
13193441|NCT02082210|26193998|FG000|Overall Study|Withdrawal by Subject|0|||
13193442|NCT02082210|26193999|FG001|Overall Study|Withdrawal by Subject|0|||
13193443|NCT02082210|26194000|FG002|Overall Study|Withdrawal by Subject|0|||
13193444|NCT02082210|26194001|FG003|Overall Study|Withdrawal by Subject|1|||
13193445|NCT02082210|26194002|FG004|Overall Study|Withdrawal by Subject|2|||
13193446|NCT02082210|26194003|FG005|Overall Study|Withdrawal by Subject|2|||
13193447|NCT02082210|26193998|FG000|Overall Study|Clinical Progression|0|||
13193448|NCT02082210|26193999|FG001|Overall Study|Clinical Progression|0|||
13193449|NCT02082210|26194000|FG002|Overall Study|Clinical Progression|0|||
13193450|NCT02082210|26194001|FG003|Overall Study|Clinical Progression|1|||
13193451|NCT02082210|26194002|FG004|Overall Study|Clinical Progression|0|||
13193452|NCT02082210|26194003|FG005|Overall Study|Clinical Progression|0|||
13193453|NCT02082210|26193998|FG000|Overall Study|No Post-Baseline Tumor Assesment|0|||
13193454|NCT02082210|26193999|FG001|Overall Study|No Post-Baseline Tumor Assesment|0|||
13193455|NCT02082210|26194000|FG002|Overall Study|No Post-Baseline Tumor Assesment|1|||
13193456|NCT02082210|26194001|FG003|Overall Study|No Post-Baseline Tumor Assesment|2|||
13193457|NCT02082210|26194002|FG004|Overall Study|No Post-Baseline Tumor Assesment|0|||
13193458|NCT02082210|26194003|FG005|Overall Study|No Post-Baseline Tumor Assesment|0|||
13193459|NCT02082210|26193998|FG000|Overall Study|Physician Decision|0|||
13193460|NCT02082210|26193999|FG001|Overall Study|Physician Decision|0|||
13193461|NCT02082210|26194000|FG002|Overall Study|Physician Decision|1|||
13193462|NCT02082210|26194001|FG003|Overall Study|Physician Decision|1|||
13193463|NCT02082210|26194002|FG004|Overall Study|Physician Decision|0|||
13193464|NCT02082210|26194003|FG005|Overall Study|Physician Decision|0|||
13206331|NCT01958281|26234404|FG002|Overall Study|Withdrew Consent|0|||
13206332|NCT01958164|26234424|FG000|Overall Study|Adverse Event|0|||
13206333|NCT01958164|26234425|FG001|Overall Study|Adverse Event|2|||
13206334|NCT01958164|26234424|FG000|Overall Study|Lost to Follow-up|2|||
13206335|NCT01958164|26234425|FG001|Overall Study|Lost to Follow-up|3|||
13206336|NCT01958125|26234446|FG000|Overall Study|Missing diary data|2|||
13206337|NCT01958125|26234447|FG001|Overall Study|Missing diary data|6|||
13206338|NCT01958125|26234446|FG000|Overall Study|No headache attacks|0|||
13206339|NCT01958125|26234447|FG001|Overall Study|No headache attacks|2|||
13206340|NCT01958060|26234489|FG000|Overall Study|Not treated|2|||
13206341|NCT01958060|26234490|FG001|Overall Study|Not treated|0|||
13206342|NCT01958060|26234491|FG002|Overall Study|Not treated|0|||
13206343|NCT01958060|26234492|FG003|Overall Study|Not treated|0|||
13206344|NCT01958060|26234493|FG004|Overall Study|Not treated|1|||
13206345|NCT01958060|26234494|FG005|Overall Study|Not treated|0|||
13206346|NCT01958008|26234535|FG000|Overall Study|Worsening of disease under study|0|||
13206347|NCT01958008|26234536|FG001|Overall Study|Worsening of disease under study|0|||
13206348|NCT01958008|26234537|FG002|Overall Study|Worsening of disease under study|1|||
13206349|NCT01958008|26234538|FG003|Overall Study|Worsening of disease under study|0|||
13206350|NCT01958008|26234535|FG000|Overall Study|Other adverse event|1|||
13206351|NCT01958008|26234536|FG001|Overall Study|Other adverse event|0|||
13206352|NCT01958008|26234537|FG002|Overall Study|Other adverse event|0|||
13206353|NCT01958008|26234538|FG003|Overall Study|Other adverse event|0|||
13206354|NCT01957865|26234559|FG000|Overall Study|Found HIV negative|0|||
13206355|NCT01957865|26234560|FG001|Overall Study|Found HIV negative|0|||
13206356|NCT01957865|26234561|FG002|Overall Study|Found HIV negative|1|||
13206357|NCT01957865|26234559|FG000|Overall Study|Lost to Follow-up|0|||
13206358|NCT01957865|26234560|FG001|Overall Study|Lost to Follow-up|2|||
13206359|NCT01957865|26234561|FG002|Overall Study|Lost to Follow-up|2|||
13206360|NCT01957787|26234578|FG000|Overall Study|Death|18|||
13206361|NCT01957787|26234578|FG000|Overall Study|Lost to Follow-up|3|||
13206362|NCT01957787|26234578|FG000|Overall Study|Withdrawal by Subject|3|||
13206363|NCT01957787|26234578|FG000|Overall Study|Entered Hospice or Similar Program|2|||
13206364|NCT01957787|26234578|FG000|Overall Study|Index Tumor(s) Resected|2|||
13206365|NCT01957787|26234578|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2|||
13206366|NCT01957787|26234578|FG000|Overall Study|Local therapy, not cryoablation|6|||
13206367|NCT01957709|26234586|FG000|Overall Study|Patient refused to complete post-tx bx|1|||
13206368|NCT01957644|26234622|FG000|Overall Study|Adverse Event|4|||
13206369|NCT01957644|26234623|FG001|Overall Study|Adverse Event|2|||
13206370|NCT01957644|26234624|FG002|Overall Study|Adverse Event|0|||
13206371|NCT01957644|26234625|FG003|Overall Study|Adverse Event|0|||
13206372|NCT01957644|26234626|FG004|Overall Study|Adverse Event|1|||
13206373|NCT01957644|26234622|FG000|Overall Study|Progressive disease / relapse|0|||
13206374|NCT01957644|26234623|FG001|Overall Study|Progressive disease / relapse|1|||
13206375|NCT01957644|26234624|FG002|Overall Study|Progressive disease / relapse|0|||
13206376|NCT01957644|26234625|FG003|Overall Study|Progressive disease / relapse|1|||
13206377|NCT01957644|26234626|FG004|Overall Study|Progressive disease / relapse|0|||
13206378|NCT01957644|26234622|FG000|Overall Study|Other reason|1|||
13193465|NCT02082184|26194029|FG000|Overall Study|Adverse Event|1|||
13193466|NCT02082184|26194030|FG001|Overall Study|Adverse Event|0|||
13193467|NCT02082184|26194029|FG000|Overall Study|Medical diagnosis|1|||
13193468|NCT02082184|26194030|FG001|Overall Study|Medical diagnosis|2|||
13193469|NCT02082184|26194029|FG000|Overall Study|Device associated symptoms|5|||
13193470|NCT02082184|26194030|FG001|Overall Study|Device associated symptoms|0|||
13193471|NCT02082184|26194029|FG000|Overall Study|Withdrawal by Subject|3|||
13193472|NCT02082184|26194030|FG001|Overall Study|Withdrawal by Subject|2|||
13193473|NCT02082184|26194029|FG000|Overall Study|Protocol Violation|0|||
13193474|NCT02082184|26194030|FG001|Overall Study|Protocol Violation|6|||
13193475|NCT02082184|26194029|FG000|Overall Study|Lost to Follow-up|0|||
13193476|NCT02082184|26194030|FG001|Overall Study|Lost to Follow-up|2|||
13193477|NCT02082184|26194029|FG000|Overall Study|Subject non-compliance|0|||
13193478|NCT02082184|26194030|FG001|Overall Study|Subject non-compliance|1|||
13193479|NCT02082158|26194069|FG000|Overall Study|Withdrawal by Subject|0|||
13193480|NCT02082158|26194070|FG001|Overall Study|Withdrawal by Subject|0|||
13193481|NCT02082158|26194071|FG002|Overall Study|Withdrawal by Subject|0|||
13193482|NCT02082158|26194072|FG003|Overall Study|Withdrawal by Subject|0|||
13193483|NCT02082158|26194073|FG004|Overall Study|Withdrawal by Subject|1|||
13193484|NCT02082158|26194074|FG005|Overall Study|Withdrawal by Subject|0|||
13193485|NCT02082158|26194069|FG000|Overall Study|Failed Fit-testing|8|||
13193486|NCT02082158|26194070|FG001|Overall Study|Failed Fit-testing|8|||
13193487|NCT02082158|26194071|FG002|Overall Study|Failed Fit-testing|14|||
13193488|NCT02082158|26194072|FG003|Overall Study|Failed Fit-testing|4|||
13193489|NCT02082158|26194073|FG004|Overall Study|Failed Fit-testing|3|||
13193490|NCT02082158|26194074|FG005|Overall Study|Failed Fit-testing|7|||
13193491|NCT02081859|26194089|FG000|Overall Study|No fertilization|2|||
13193492|NCT02081859|26194090|FG001|Overall Study|No fertilization|2|||
13193493|NCT02081859|26194089|FG000|Overall Study|No sperm|1|||
13193494|NCT02081859|26194090|FG001|Overall Study|No sperm|0|||
13193495|NCT02081859|26194089|FG000|Overall Study|Unanticipated freeze all cycle|2|||
13193496|NCT02081859|26194090|FG001|Overall Study|Unanticipated freeze all cycle|6|||
13193497|NCT02081859|26194089|FG000|Overall Study|< 4 embryos|27|||
13193498|NCT02081859|26194090|FG001|Overall Study|< 4 embryos|23|||
13193499|NCT02081859|26194089|FG000|Overall Study|Other reasons|2|||
13193500|NCT02081859|26194090|FG001|Overall Study|Other reasons|0|||
13193501|NCT02081846|26194115|FG000|Overall Study|Withdrawal by Subject|1|||
13193502|NCT02081846|26194116|FG001|Overall Study|Withdrawal by Subject|0|||
13193503|NCT02081846|26194115|FG000|Overall Study|invalid consent|1|||
13193504|NCT02081846|26194116|FG001|Overall Study|invalid consent|0|||
13193505|NCT02081690|26194125|FG000|Overall Study|Death|3|||
13193506|NCT02081690|26194125|FG000|Overall Study|Physician Decision|3|||
13193507|NCT02081690|26194125|FG000|Overall Study|Withdrawal by Subject|1|||
13193508|NCT02081677|26194228|FG000|Overall Study|Adverse Event|0|||
13193509|NCT02081677|26194229|FG001|Overall Study|Adverse Event|0|||
13193510|NCT02081677|26194230|FG002|Overall Study|Adverse Event|1|||
13193511|NCT02081677|26194231|FG003|Overall Study|Adverse Event|0|||
13193512|NCT02081677|26194228|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
13193513|NCT02081677|26194229|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
13193514|NCT02081677|26194230|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
13193515|NCT02081677|26194231|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
13193516|NCT02081677|26194228|FG000|Overall Study|Not comfortable with lens care system|1|||
13193517|NCT02081677|26194229|FG001|Overall Study|Not comfortable with lens care system|0|||
13193518|NCT02081677|26194230|FG002|Overall Study|Not comfortable with lens care system|0|||
13193519|NCT02081677|26194231|FG003|Overall Study|Not comfortable with lens care system|0|||
13193520|NCT02081677|26194228|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
13193521|NCT02081677|26194229|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
13193522|NCT02081677|26194230|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
13193523|NCT02081677|26194231|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
13193524|NCT02081599|26194252|FG000|Period 1：Double-blind Period|Adverse Event|3|||
13193525|NCT02081599|26194253|FG001|Period 1：Double-blind Period|Adverse Event|0|||
13193526|NCT02081599|26194252|FG000|Period 1：Double-blind Period|Lack of Efficacy|2|||
13193527|NCT02081599|26194253|FG001|Period 1：Double-blind Period|Lack of Efficacy|1|||
13193528|NCT02081599|26194252|FG000|Period 1：Double-blind Period|Physician Decision|1|||
13193529|NCT02081599|26194253|FG001|Period 1：Double-blind Period|Physician Decision|0|||
13193530|NCT02081599|26194252|FG000|Period 1：Double-blind Period|Protocol Violation|0|||
13193531|NCT02081599|26194253|FG001|Period 1：Double-blind Period|Protocol Violation|1|||
13193532|NCT02081599|26194252|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1|||
13193533|NCT02081599|26194253|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0|||
13193534|NCT02081599|26194252|FG000|Period 1：Double-blind Period|stopping criteria|1|||
13193535|NCT02081599|26194253|FG001|Period 1：Double-blind Period|stopping criteria|0|||
13193536|NCT02081599|26194252|FG000|Period 2：Open-label Period|Adverse Event|1|||
13193537|NCT02081599|26194253|FG001|Period 2：Open-label Period|Adverse Event|0|||
13193538|NCT02081599|26194252|FG000|Period 2：Open-label Period|Lack of Efficacy|2|||
13485570|NCT02906020|27032876|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
13193539|NCT02081599|26194253|FG001|Period 2：Open-label Period|Lack of Efficacy|4|||
13193540|NCT02081599|26194252|FG000|Period 2：Open-label Period|Physician Decision|1|||
13193541|NCT02081599|26194253|FG001|Period 2：Open-label Period|Physician Decision|0|||
13193542|NCT02081599|26194252|FG000|Period 2：Open-label Period|Withdrawal by Subject|2|||
13193543|NCT02081599|26194253|FG001|Period 2：Open-label Period|Withdrawal by Subject|0|||
13193544|NCT02081586|26194293|FG000|Overall Study|Lost to Follow-up|0|||
13193545|NCT02081586|26194294|FG001|Overall Study|Lost to Follow-up|1|||
13193546|NCT02081586|26194295|FG002|Overall Study|Lost to Follow-up|0|||
13193547|NCT02081586|26194296|FG003|Overall Study|Lost to Follow-up|1|||
13193548|NCT02081586|26194293|FG000|Overall Study|Head injury not related to study|0|||
13193549|NCT02081586|26194294|FG001|Overall Study|Head injury not related to study|0|||
13193550|NCT02081586|26194295|FG002|Overall Study|Head injury not related to study|1|||
13193551|NCT02081586|26194296|FG003|Overall Study|Head injury not related to study|0|||
13193552|NCT02081534|26194341|FG000|Overall Study|Adverse Event|5|||
13193553|NCT02081534|26194342|FG001|Overall Study|Adverse Event|4|||
13193554|NCT02081534|26194343|FG002|Overall Study|Adverse Event|3|||
13193555|NCT02081534|26194344|FG003|Overall Study|Adverse Event|10|||
13193556|NCT02081534|26194345|FG004|Overall Study|Adverse Event|2|||
13193557|NCT02081534|26194346|FG005|Overall Study|Adverse Event|8|||
13193558|NCT02081534|26194347|FG006|Overall Study|Adverse Event|2|||
13193559|NCT02081534|26194341|FG000|Overall Study|Withdrawal by Subject|0|||
13193560|NCT02081534|26194342|FG001|Overall Study|Withdrawal by Subject|1|||
13193561|NCT02081534|26194343|FG002|Overall Study|Withdrawal by Subject|1|||
13193562|NCT02081534|26194344|FG003|Overall Study|Withdrawal by Subject|1|||
13193563|NCT02081534|26194345|FG004|Overall Study|Withdrawal by Subject|1|||
13193564|NCT02081534|26194346|FG005|Overall Study|Withdrawal by Subject|0|||
13193565|NCT02081534|26194347|FG006|Overall Study|Withdrawal by Subject|1|||
13193566|NCT02081534|26194341|FG000|Overall Study|Protocol Violation|0|||
13193567|NCT02081534|26194342|FG001|Overall Study|Protocol Violation|3|||
13193568|NCT02081534|26194343|FG002|Overall Study|Protocol Violation|0|||
13193569|NCT02081534|26194344|FG003|Overall Study|Protocol Violation|0|||
13193570|NCT02081534|26194345|FG004|Overall Study|Protocol Violation|0|||
13193571|NCT02081534|26194346|FG005|Overall Study|Protocol Violation|0|||
13193572|NCT02081534|26194347|FG006|Overall Study|Protocol Violation|1|||
13193573|NCT02081534|26194341|FG000|Overall Study|Lost to Follow-up|0|||
13193574|NCT02081534|26194342|FG001|Overall Study|Lost to Follow-up|0|||
13193575|NCT02081534|26194343|FG002|Overall Study|Lost to Follow-up|0|||
13193576|NCT02081534|26194344|FG003|Overall Study|Lost to Follow-up|2|||
13193577|NCT02081534|26194345|FG004|Overall Study|Lost to Follow-up|1|||
13193578|NCT02081534|26194346|FG005|Overall Study|Lost to Follow-up|1|||
13193579|NCT02081534|26194347|FG006|Overall Study|Lost to Follow-up|0|||
13193580|NCT02081417|26194370|FG000|Overall Study|Lost to Follow-up|26|||
13193581|NCT02081417|26194371|FG001|Overall Study|Lost to Follow-up|23|||
13193582|NCT02081417|26194370|FG000|Overall Study|Moved Away|1|||
13193583|NCT02081417|26194371|FG001|Overall Study|Moved Away|2|||
13193584|NCT02081417|26194370|FG000|Overall Study|Incarcerated|2|||
13193585|NCT02081417|26194371|FG001|Overall Study|Incarcerated|2|||
13193586|NCT02081417|26194370|FG000|Overall Study|Death|4|||
13193587|NCT02081417|26194371|FG001|Overall Study|Death|3|||
13193588|NCT02081417|26194370|FG000|Overall Study|Withdrawal by Subject|4|||
13193589|NCT02081417|26194371|FG001|Overall Study|Withdrawal by Subject|0|||
13193590|NCT02081417|26194370|FG000|Overall Study|Admitted to Residential Treatment|2|||
13193591|NCT02081417|26194371|FG001|Overall Study|Admitted to Residential Treatment|0|||
13193592|NCT02081417|26194370|FG000|Overall Study|Did not start treatment|17|||
13193593|NCT02081417|26194371|FG001|Overall Study|Did not start treatment|21|||
13193594|NCT02081196|26194382|FG000|Overall Study|Lost to Follow-up|1|||
13193595|NCT02081183|26194401|FG000|Overall Study|Lost to Follow-up|0|||
13193596|NCT02081183|26194402|FG001|Overall Study|Lost to Follow-up|1|||
13193597|NCT02081183|26194401|FG000|Overall Study|Protocol Violation|1|||
13193598|NCT02081183|26194402|FG001|Overall Study|Protocol Violation|0|||
13193599|NCT02081183|26194401|FG000|Overall Study|Other|3|||
13193600|NCT02081183|26194402|FG001|Overall Study|Other|3|||
13193601|NCT02081079|26194435|FG000|Overall Study|Lack of Efficacy|3|||
13193602|NCT02081079|26194436|FG001|Overall Study|Lack of Efficacy|2|||
13193603|NCT02081079|26194435|FG000|Overall Study|Lost to Follow-up|1|||
13193604|NCT02081079|26194436|FG001|Overall Study|Lost to Follow-up|0|||
13193605|NCT02081001|26194517|FG000|Overall Study|Adverse Event|0|||
13193606|NCT02081001|26194518|FG001|Overall Study|Adverse Event|0|||
13193607|NCT02081001|26194519|FG002|Overall Study|Adverse Event|0|||
13193608|NCT02081001|26194520|FG003|Overall Study|Adverse Event|0|||
13193609|NCT02081001|26194521|FG004|Overall Study|Adverse Event|1|||
13193610|NCT02081001|26194522|FG005|Overall Study|Adverse Event|0|||
13193611|NCT02081001|26194523|FG006|Overall Study|Adverse Event|0|||
13193612|NCT02081001|26194524|FG007|Overall Study|Adverse Event|0|||
13193613|NCT02081001|26194525|FG008|Overall Study|Adverse Event|0|||
13193614|NCT02081001|26194526|FG009|Overall Study|Adverse Event|0|||
13193615|NCT02081001|26194527|FG010|Overall Study|Adverse Event|0|||
13193616|NCT02081001|26194528|FG011|Overall Study|Adverse Event|0|||
13193617|NCT02080871|26194611|FG000|Overall Study|Death|1|||
13193618|NCT02080871|26194611|FG000|Overall Study|Lost to Follow-up|1|||
13193619|NCT02080832|26194635|FG000|Overall Study|Excluded from analysis by MRI|9|||
13193620|NCT02080832|26194636|FG001|Overall Study|Excluded from analysis by MRI|10|||
13193621|NCT02080832|26194637|FG002|Overall Study|Excluded from analysis by MRI|14|||
13193622|NCT02080832|26194635|FG000|Overall Study|Lost to Follow-up|0|||
13193623|NCT02080832|26194636|FG001|Overall Study|Lost to Follow-up|2|||
13193624|NCT02080832|26194637|FG002|Overall Study|Lost to Follow-up|2|||
13193625|NCT02080481|26194656|FG000|Overall Study|Never received a block.|1|||
13193626|NCT02080481|26194657|FG001|Overall Study|Never received a block.|0|||
13193627|NCT02080403|26194676|FG000|Overall Study|Adverse Event|5|||
13193628|NCT02080403|26194677|FG001|Overall Study|Adverse Event|1|||
13193629|NCT02080403|26194676|FG000|Overall Study|Death|0|||
13193630|NCT02080403|26194677|FG001|Overall Study|Death|2|||
13193631|NCT02080403|26194676|FG000|Overall Study|Lost to Follow-up|2|||
13193632|NCT02080403|26194677|FG001|Overall Study|Lost to Follow-up|0|||
13193633|NCT02080403|26194676|FG000|Overall Study|Pregnancy|0|||
13193634|NCT02080403|26194677|FG001|Overall Study|Pregnancy|1|||
13193635|NCT02080403|26194676|FG000|Overall Study|Protocol Violation|3|||
13193636|NCT02080403|26194677|FG001|Overall Study|Protocol Violation|7|||
13193637|NCT02080403|26194676|FG000|Overall Study|Withdrawal by Subject|5|||
13193638|NCT02080403|26194677|FG001|Overall Study|Withdrawal by Subject|1|||
13193639|NCT02080364|26194730|FG000|Baseline Period|Protocol Violation|2|||
13193640|NCT02080364|26194731|FG001|Baseline Period|Protocol Violation|1|||
13193641|NCT02080364|26194732|FG002|Baseline Period|Protocol Violation|0|||
13193642|NCT02080364|26194733|FG003|Baseline Period|Protocol Violation|0|||
13193643|NCT02080364|26194730|FG000|Baseline Period|Other|0|||
13193644|NCT02080364|26194731|FG001|Baseline Period|Other|1|||
13193645|NCT02080364|26194732|FG002|Baseline Period|Other|1|||
13193646|NCT02080364|26194733|FG003|Baseline Period|Other|0|||
13193647|NCT02080364|26194730|FG000|Treatment Period|Adverse Event|10|||
13193648|NCT02080364|26194731|FG001|Treatment Period|Adverse Event|15|||
13193649|NCT02080364|26194732|FG002|Treatment Period|Adverse Event|11|||
13193650|NCT02080364|26194733|FG003|Treatment Period|Adverse Event|14|||
13193651|NCT02080364|26194730|FG000|Treatment Period|Lost to Follow-up|2|||
13193652|NCT02080364|26194731|FG001|Treatment Period|Lost to Follow-up|3|||
13193653|NCT02080364|26194732|FG002|Treatment Period|Lost to Follow-up|5|||
13193654|NCT02080364|26194733|FG003|Treatment Period|Lost to Follow-up|0|||
13193655|NCT02080364|26194730|FG000|Treatment Period|Protocol Violation|5|||
13193656|NCT02080364|26194731|FG001|Treatment Period|Protocol Violation|3|||
13193657|NCT02080364|26194732|FG002|Treatment Period|Protocol Violation|5|||
13193658|NCT02080364|26194733|FG003|Treatment Period|Protocol Violation|1|||
13193659|NCT02080364|26194730|FG000|Treatment Period|Withdrawal by Subject|16|||
13193660|NCT02080364|26194731|FG001|Treatment Period|Withdrawal by Subject|16|||
13193661|NCT02080364|26194732|FG002|Treatment Period|Withdrawal by Subject|15|||
13193662|NCT02080364|26194733|FG003|Treatment Period|Withdrawal by Subject|10|||
13193663|NCT02080364|26194730|FG000|Treatment Period|Study Terminated by Sponsor|0|||
13193664|NCT02080364|26194731|FG001|Treatment Period|Study Terminated by Sponsor|0|||
13193665|NCT02080364|26194732|FG002|Treatment Period|Study Terminated by Sponsor|180|||
13193666|NCT02080364|26194733|FG003|Treatment Period|Study Terminated by Sponsor|183|||
13193667|NCT02080364|26194730|FG000|Treatment Period|Other|14|||
13193668|NCT02080364|26194731|FG001|Treatment Period|Other|12|||
13193669|NCT02080364|26194732|FG002|Treatment Period|Other|21|||
13193670|NCT02080364|26194733|FG003|Treatment Period|Other|16|||
13193671|NCT02080260|26194743|FG000|Overall Study|Death|18|||
13193672|NCT02080260|26194743|FG000|Overall Study|Withdrawal by Subject|1|||
13193673|NCT02080221|26194750|FG000|Overall Study|Withdrawal by Subject|1|||
13193674|NCT02080221|26194750|FG000|Overall Study|Clinical Progression of Disease|1|||
13193675|NCT02080091|26194758|FG000|Overall Study|Study Terminated|22|||
13193676|NCT02080091|26194758|FG000|Overall Study|Death|1|||
13193677|NCT02080091|26194758|FG000|Overall Study|Withdrawal by Subject|1|||
13193678|NCT02080091|26194758|FG000|Overall Study|Other|1|||
13193679|NCT02079909|26194782|FG000|Overall Study|Adverse Event|23|||
13193680|NCT02079909|26194783|FG001|Overall Study|Adverse Event|23|||
13193681|NCT02079909|26194784|FG002|Overall Study|Adverse Event|7|||
13193682|NCT02079909|26194782|FG000|Overall Study|Withdrawal by Subject|9|||
13193683|NCT02079909|26194783|FG001|Overall Study|Withdrawal by Subject|17|||
13193684|NCT02079909|26194784|FG002|Overall Study|Withdrawal by Subject|4|||
13193685|NCT02079909|26194782|FG000|Overall Study|Lost to Follow-up|2|||
13193686|NCT02079909|26194783|FG001|Overall Study|Lost to Follow-up|3|||
13193687|NCT02079909|26194784|FG002|Overall Study|Lost to Follow-up|1|||
13193688|NCT02079909|26194782|FG000|Overall Study|Death|2|||
13193689|NCT02079909|26194783|FG001|Overall Study|Death|2|||
13193690|NCT02079909|26194784|FG002|Overall Study|Death|0|||
13193691|NCT02079909|26194782|FG000|Overall Study|Lack of Efficacy|0|||
13193692|NCT02079909|26194783|FG001|Overall Study|Lack of Efficacy|0|||
13193693|NCT02079909|26194784|FG002|Overall Study|Lack of Efficacy|1|||
13193694|NCT02079909|26194782|FG000|Overall Study|Protocol Violation|0|||
13193695|NCT02079909|26194783|FG001|Overall Study|Protocol Violation|1|||
13193696|NCT02079909|26194784|FG002|Overall Study|Protocol Violation|1|||
13193697|NCT02079909|26194782|FG000|Overall Study|Physician Decision|0|||
13193698|NCT02079909|26194783|FG001|Overall Study|Physician Decision|1|||
13193699|NCT02079909|26194784|FG002|Overall Study|Physician Decision|1|||
13193700|NCT02079909|26194782|FG000|Overall Study|Relocation etc.|2|||
13193701|NCT02079909|26194783|FG001|Overall Study|Relocation etc.|2|||
13193702|NCT02079909|26194784|FG002|Overall Study|Relocation etc.|3|||
13193703|NCT02079844|26194850|FG000|Treatment Period 1|Voluntary Withdrawal|0|||
13193704|NCT02079844|26194851|FG001|Treatment Period 1|Voluntary Withdrawal|0|||
13193705|NCT02079844|26194852|FG002|Treatment Period 1|Voluntary Withdrawal|2|||
13193706|NCT02079844|26194850|FG000|Treatment Period 2|Voluntary Withdrawal|0|||
13193707|NCT02079844|26194851|FG001|Treatment Period 2|Voluntary Withdrawal|1|||
13193708|NCT02079844|26194852|FG002|Treatment Period 2|Voluntary Withdrawal|0|||
13193709|NCT02079805|26194877|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
13193710|NCT02079805|26194878|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
13193711|NCT02079805|26194877|FG000|Overall Study|Voluntary Withdrawal|0|||
13193712|NCT02079805|26194878|FG001|Overall Study|Voluntary Withdrawal|1|||
13193713|NCT02079649|26194906|FG000|Overall Study|Lost to Follow-up|0|||
13193714|NCT02079649|26194907|FG001|Overall Study|Lost to Follow-up|0|||
13193715|NCT02079649|26194908|FG002|Overall Study|Lost to Follow-up|0|||
13193716|NCT02079649|26194909|FG003|Overall Study|Lost to Follow-up|1|||
13193717|NCT02079649|26194906|FG000|Overall Study|Withdrawal by Subject|0|||
13193718|NCT02079649|26194907|FG001|Overall Study|Withdrawal by Subject|0|||
13193719|NCT02079649|26194908|FG002|Overall Study|Withdrawal by Subject|0|||
13193720|NCT02079649|26194909|FG003|Overall Study|Withdrawal by Subject|1|||
13193721|NCT02079649|26194906|FG000|Overall Study|Randomization error (prior to treatment)|1|||
13193722|NCT02079649|26194907|FG001|Overall Study|Randomization error (prior to treatment)|0|||
13193723|NCT02079649|26194908|FG002|Overall Study|Randomization error (prior to treatment)|1|||
13193724|NCT02079649|26194909|FG003|Overall Study|Randomization error (prior to treatment)|0|||
13193725|NCT02079636|26195064|FG000|Overall Study|Death|2|||
13111923|NCT03170193|25906009|FG004|Overall Study|Withdrawal by Subject|0|||
13111924|NCT03170193|25906010|FG005|Overall Study|Withdrawal by Subject|0|||
13111925|NCT03170193|25906011|FG006|Overall Study|Withdrawal by Subject|0|||
13111926|NCT03170193|25906005|FG000|Overall Study|Lost to Follow-up|1|||
13111927|NCT03170193|25906006|FG001|Overall Study|Lost to Follow-up|1|||
13193726|NCT02079636|26195065|FG001|Overall Study|Death|1|||
13193727|NCT02079636|26195066|FG002|Overall Study|Death|0|||
13193728|NCT02079636|26195067|FG003|Overall Study|Death|5|||
13193729|NCT02079636|26195068|FG004|Overall Study|Death|1|||
13193730|NCT02079636|26195069|FG005|Overall Study|Death|2|||
13193731|NCT02079636|26195070|FG006|Overall Study|Death|1|||
13193732|NCT02079636|26195071|FG007|Overall Study|Death|0|||
13193733|NCT02079636|26195072|FG008|Overall Study|Death|0|||
13193734|NCT02079636|26195073|FG009|Overall Study|Death|0|||
13193735|NCT02079636|26195074|FG010|Overall Study|Death|0|||
13193736|NCT02079636|26195075|FG011|Overall Study|Death|1|||
13193737|NCT02079636|26195076|FG012|Overall Study|Death|1|||
13193738|NCT02079636|26195077|FG013|Overall Study|Death|0|||
13193739|NCT02079636|26195078|FG014|Overall Study|Death|2|||
13193740|NCT02079636|26195064|FG000|Overall Study|Adverse Event|1|||
13193741|NCT02079636|26195065|FG001|Overall Study|Adverse Event|1|||
13193742|NCT02079636|26195066|FG002|Overall Study|Adverse Event|0|||
13193743|NCT02079636|26195067|FG003|Overall Study|Adverse Event|1|||
13193744|NCT02079636|26195068|FG004|Overall Study|Adverse Event|1|||
13193745|NCT02079636|26195069|FG005|Overall Study|Adverse Event|2|||
13193746|NCT02079636|26195070|FG006|Overall Study|Adverse Event|0|||
13193747|NCT02079636|26195071|FG007|Overall Study|Adverse Event|0|||
13193748|NCT02079636|26195072|FG008|Overall Study|Adverse Event|0|||
13193749|NCT02079636|26195073|FG009|Overall Study|Adverse Event|0|||
13193750|NCT02079636|26195074|FG010|Overall Study|Adverse Event|0|||
13193751|NCT02079636|26195075|FG011|Overall Study|Adverse Event|0|||
13193752|NCT02079636|26195076|FG012|Overall Study|Adverse Event|0|||
13193753|NCT02079636|26195077|FG013|Overall Study|Adverse Event|0|||
13193754|NCT02079636|26195078|FG014|Overall Study|Adverse Event|0|||
13193755|NCT02079636|26195064|FG000|Overall Study|Progressive disease|0|||
13111928|NCT03170193|25906007|FG002|Overall Study|Lost to Follow-up|0|||
13111929|NCT03170193|25906008|FG003|Overall Study|Lost to Follow-up|0|||
13111930|NCT03170193|25906009|FG004|Overall Study|Lost to Follow-up|0|||
13111931|NCT03170193|25906010|FG005|Overall Study|Lost to Follow-up|0|||
13111932|NCT03170193|25906011|FG006|Overall Study|Lost to Follow-up|0|||
13111933|NCT03170154|25906026|FG000|Overall Study|Lost to Follow-up|4|||
13111934|NCT03170154|25906026|FG000|Overall Study|Death|2|||
13111935|NCT03170154|25906026|FG000|Overall Study|Withdrawal by Subject|2|||
13193756|NCT02079636|26195065|FG001|Overall Study|Progressive disease|0|||
13193757|NCT02079636|26195066|FG002|Overall Study|Progressive disease|0|||
13193758|NCT02079636|26195067|FG003|Overall Study|Progressive disease|2|||
13193759|NCT02079636|26195068|FG004|Overall Study|Progressive disease|0|||
13193760|NCT02079636|26195069|FG005|Overall Study|Progressive disease|0|||
13193761|NCT02079636|26195070|FG006|Overall Study|Progressive disease|0|||
13193762|NCT02079636|26195071|FG007|Overall Study|Progressive disease|0|||
13193763|NCT02079636|26195072|FG008|Overall Study|Progressive disease|0|||
13193764|NCT02079636|26195073|FG009|Overall Study|Progressive disease|0|||
13193765|NCT02079636|26195074|FG010|Overall Study|Progressive disease|0|||
13193766|NCT02079636|26195075|FG011|Overall Study|Progressive disease|0|||
13193767|NCT02079636|26195076|FG012|Overall Study|Progressive disease|1|||
13193768|NCT02079636|26195077|FG013|Overall Study|Progressive disease|0|||
13193769|NCT02079636|26195078|FG014|Overall Study|Progressive disease|0|||
13193770|NCT02079636|26195064|FG000|Overall Study|Withdrawal by Subject|0|||
13193771|NCT02079636|26195065|FG001|Overall Study|Withdrawal by Subject|0|||
13193772|NCT02079636|26195066|FG002|Overall Study|Withdrawal by Subject|0|||
13193773|NCT02079636|26195067|FG003|Overall Study|Withdrawal by Subject|4|||
13193774|NCT02079636|26195068|FG004|Overall Study|Withdrawal by Subject|0|||
13193775|NCT02079636|26195069|FG005|Overall Study|Withdrawal by Subject|1|||
13193776|NCT02079636|26195070|FG006|Overall Study|Withdrawal by Subject|0|||
13193777|NCT02079636|26195071|FG007|Overall Study|Withdrawal by Subject|0|||
13193778|NCT02079636|26195072|FG008|Overall Study|Withdrawal by Subject|0|||
13193779|NCT02079636|26195073|FG009|Overall Study|Withdrawal by Subject|2|||
13193780|NCT02079636|26195074|FG010|Overall Study|Withdrawal by Subject|1|||
13193781|NCT02079636|26195075|FG011|Overall Study|Withdrawal by Subject|1|||
13193782|NCT02079636|26195076|FG012|Overall Study|Withdrawal by Subject|1|||
13193783|NCT02079636|26195077|FG013|Overall Study|Withdrawal by Subject|0|||
13193784|NCT02079636|26195078|FG014|Overall Study|Withdrawal by Subject|2|||
13193785|NCT02079636|26195064|FG000|Overall Study|Physician Decision|0|||
13193786|NCT02079636|26195065|FG001|Overall Study|Physician Decision|0|||
13193787|NCT02079636|26195066|FG002|Overall Study|Physician Decision|0|||
13193788|NCT02079636|26195067|FG003|Overall Study|Physician Decision|0|||
13193789|NCT02079636|26195068|FG004|Overall Study|Physician Decision|0|||
13193790|NCT02079636|26195069|FG005|Overall Study|Physician Decision|1|||
13193791|NCT02079636|26195070|FG006|Overall Study|Physician Decision|0|||
13193792|NCT02079636|26195071|FG007|Overall Study|Physician Decision|0|||
13193793|NCT02079636|26195072|FG008|Overall Study|Physician Decision|0|||
13193794|NCT02079636|26195073|FG009|Overall Study|Physician Decision|1|||
13193795|NCT02079636|26195074|FG010|Overall Study|Physician Decision|1|||
13193796|NCT02079636|26195075|FG011|Overall Study|Physician Decision|0|||
13193797|NCT02079636|26195076|FG012|Overall Study|Physician Decision|0|||
13193798|NCT02079636|26195077|FG013|Overall Study|Physician Decision|0|||
13193799|NCT02079636|26195078|FG014|Overall Study|Physician Decision|1|||
13193800|NCT02079636|26195064|FG000|Overall Study|Lost to Follow-up|0|||
13193801|NCT02079636|26195065|FG001|Overall Study|Lost to Follow-up|0|||
13193802|NCT02079636|26195066|FG002|Overall Study|Lost to Follow-up|0|||
13193803|NCT02079636|26195067|FG003|Overall Study|Lost to Follow-up|0|||
13193804|NCT02079636|26195068|FG004|Overall Study|Lost to Follow-up|0|||
13193805|NCT02079636|26195069|FG005|Overall Study|Lost to Follow-up|0|||
13193806|NCT02079636|26195070|FG006|Overall Study|Lost to Follow-up|0|||
13193807|NCT02079636|26195071|FG007|Overall Study|Lost to Follow-up|1|||
13193808|NCT02079636|26195072|FG008|Overall Study|Lost to Follow-up|0|||
13193809|NCT02079636|26195073|FG009|Overall Study|Lost to Follow-up|0|||
13193810|NCT02079636|26195074|FG010|Overall Study|Lost to Follow-up|0|||
13193811|NCT02079636|26195075|FG011|Overall Study|Lost to Follow-up|0|||
13193812|NCT02079636|26195076|FG012|Overall Study|Lost to Follow-up|0|||
13193813|NCT02079636|26195077|FG013|Overall Study|Lost to Follow-up|0|||
13193814|NCT02079636|26195078|FG014|Overall Study|Lost to Follow-up|0|||
13193815|NCT02079610|26195095|FG000|Overall Study|Withdrawal by Subject|1|||
13193816|NCT02079610|26195096|FG001|Overall Study|Withdrawal by Subject|1|||
13111936|NCT03169530|25906051|FG000|Overall Study|Study ended by NIH|15|||
13111937|NCT03169530|25906052|FG001|Overall Study|Study ended by NIH|17|||
13111938|NCT03169244|25906069|FG000|Overall Study|Lost to Follow-up|1|||
13111939|NCT03169244|25906070|FG001|Overall Study|Lost to Follow-up|2|||
13111940|NCT03169244|25906069|FG000|Overall Study|Adverse Event|1|||
13111941|NCT03169244|25906070|FG001|Overall Study|Adverse Event|0|||
13111942|NCT03169244|25906069|FG000|Overall Study|Withdrawal by Subject|2|||
13111943|NCT03169244|25906070|FG001|Overall Study|Withdrawal by Subject|2|||
13111944|NCT03169244|25906069|FG000|Overall Study|Physician Decision|1|||
13111945|NCT03169244|25906070|FG001|Overall Study|Physician Decision|0|||
13111946|NCT03169153|25906079|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
13111947|NCT03169153|25906080|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
13111948|NCT03169153|25906079|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2|||
13111949|NCT03169153|25906080|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3|||
13111950|NCT03169153|25906079|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
13111951|NCT03169153|25906080|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2|||
13111952|NCT03169153|25906079|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1|||
13111953|NCT03169153|25906080|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0|||
13111954|NCT03168919|25906090|FG000|Overall Study|Withdrawal by Subject|2|||
13193817|NCT02079532|26195120|FG000|Overall Study|Adverse Event|7|||
13193818|NCT02079532|26195120|FG000|Overall Study|Additional or changed therapy|2|||
13193819|NCT02079532|26195120|FG000|Overall Study|Lack of Efficacy|9|||
13193820|NCT02079532|26195120|FG000|Overall Study|Protocol Violation|3|||
13193821|NCT02079532|26195120|FG000|Overall Study|Withdrawal by Subject|1|||
13193822|NCT02079532|26195120|FG000|Overall Study|Administrative problems|1|||
13111955|NCT03168906|25906117|FG000|Overall Study|Lack of Efficacy|6|||
13111956|NCT03168906|25906118|FG001|Overall Study|Lack of Efficacy|6|||
13111957|NCT03168711|25906133|FG000|Overall Study|Adverse Event|2|||
13111958|NCT03168711|25906134|FG001|Overall Study|Adverse Event|0|||
13111959|NCT03168711|25906133|FG000|Overall Study|Withdrawal by Subject|0|||
13111960|NCT03168711|25906134|FG001|Overall Study|Withdrawal by Subject|1|||
13111961|NCT03168711|25906133|FG000|Overall Study|Death|0|||
13111962|NCT03168711|25906134|FG001|Overall Study|Death|1|||
13111963|NCT03168555|25906161|FG000|Visit 1 (Pro-operative)|intercurrent disease, drop-out before visit 1|1|||
13111964|NCT03168555|25906161|FG000|Visit 2 (Post-operative)|Lost to Follow-up|1|||
13111965|NCT03168555|25906161|FG000|Visit 2 (Post-operative)|Adverse Event|1|||
13111966|NCT03168555|25906161|FG000|Visit 2 (Post-operative)|Withdrawal by Subject|2|||
13111967|NCT03168425|25906176|FG000|Overall Study|Lost to Follow-up|5|||
13111968|NCT03168425|25906177|FG001|Overall Study|Lost to Follow-up|8|||
13111969|NCT03168425|25906176|FG000|Overall Study|unable to confirm post op opioids|2|||
13111970|NCT03168425|25906177|FG001|Overall Study|unable to confirm post op opioids|3|||
13111971|NCT03167619|25906196|FG000|Overall Study|Death|11|||
13111972|NCT03167619|25906197|FG001|Overall Study|Death|8|||
13111973|NCT03167619|25906196|FG000|Overall Study|Withdrawal by Subject|1|||
13111974|NCT03167619|25906197|FG001|Overall Study|Withdrawal by Subject|2|||
13111975|NCT03167619|25906196|FG000|Overall Study|Physician Decision|0|||
13111976|NCT03167619|25906197|FG001|Overall Study|Physician Decision|1|||
13111977|NCT03167411|25906218|FG000|Overall Study|Adverse Event|0|||
13111978|NCT03167411|25906219|FG001|Overall Study|Adverse Event|1|||
13111979|NCT03167359|25906244|FG000|Overall Study|Physician Decision|1|||
13193823|NCT02079532|26195120|FG000|Overall Study|Inclusion into ReFIRST|3|||
13193824|NCT02079532|26195120|FG000|Overall Study|Other|3|||
13193825|NCT02079519|26195126|FG000|Overall Study|Disease Progression|9|||
13193826|NCT02079519|26195126|FG000|Overall Study|Adverse Event|1|||
13193827|NCT02079246|26195146|FG000|OLEX|Withdrawal before treatment|1|||
13193828|NCT02079246|26195147|FG001|OLEX|Withdrawal before treatment|0|||
13193829|NCT02079246|26195146|FG000|OLEX|Death|11|||
13193830|NCT02079246|26195147|FG001|OLEX|Death|0|||
13193831|NCT02079246|26195146|FG000|OLEX|Adverse Event|66|||
13193832|NCT02079246|26195147|FG001|OLEX|Adverse Event|0|||
13193833|NCT02079246|26195146|FG000|OLEX|Withdrawal by Subject|60|||
13193834|NCT02079246|26195147|FG001|OLEX|Withdrawal by Subject|0|||
13193835|NCT02079246|26195146|FG000|OLEX|Lost to Follow-up|6|||
13193836|NCT02079246|26195147|FG001|OLEX|Lost to Follow-up|0|||
13193837|NCT02079246|26195146|FG000|OLEX|Protocol Violation|6|||
13193838|NCT02079246|26195147|FG001|OLEX|Protocol Violation|0|||
13193839|NCT02079246|26195146|FG000|OLEX|Lack of Efficacy|3|||
13193840|NCT02079246|26195147|FG001|OLEX|Lack of Efficacy|0|||
13193841|NCT02079246|26195146|FG000|OLEX|Results of the lead-in studies|58|||
13193842|NCT02079246|26195147|FG001|OLEX|Results of the lead-in studies|0|||
13193843|NCT02079246|26195146|FG000|OLEX|Other: Disallowed medication|8|||
13193844|NCT02079246|26195147|FG001|OLEX|Other: Disallowed medication|0|||
13193845|NCT02079246|26195146|FG000|OLEX|Other: Insufficient compliance|2|||
13193846|NCT02079246|26195147|FG001|OLEX|Other: Insufficient compliance|0|||
13193847|NCT02079246|26195146|FG000|OLEX|Other: Caregiver unavailable|3|||
13193848|NCT02079246|26195147|FG001|OLEX|Other: Caregiver unavailable|0|||
13193849|NCT02079246|26195146|FG000|OLEX|Other: Coordinator decision|1|||
13193850|NCT02079246|26195147|FG001|OLEX|Other: Coordinator decision|0|||
13193851|NCT02079246|26195146|FG000|OLEX|Other: Worsening of condition|1|||
13193852|NCT02079246|26195147|FG001|OLEX|Other: Worsening of condition|0|||
13193853|NCT02079246|26195146|FG000|OLEX|Other: Moved to nursing home|1|||
13193854|NCT02079246|26195147|FG001|OLEX|Other: Moved to nursing home|0|||
13193855|NCT02079246|26195146|FG000|OLEX|Other: Withdrawal of caregiver consent|1|||
13193856|NCT02079246|26195147|FG001|OLEX|Other: Withdrawal of caregiver consent|0|||
13193857|NCT02079246|26195146|FG000|OLEX-MEM|Adverse Event|0|||
13193858|NCT02079246|26195147|FG001|OLEX-MEM|Adverse Event|6|||
13193859|NCT02079246|26195146|FG000|OLEX-MEM|Withdrawal by Subject|0|||
13193860|NCT02079246|26195147|FG001|OLEX-MEM|Withdrawal by Subject|7|||
13193861|NCT02079246|26195146|FG000|OLEX-MEM|Protocol Violation|0|||
13193862|NCT02079246|26195147|FG001|OLEX-MEM|Protocol Violation|2|||
13193863|NCT02079246|26195146|FG000|OLEX-MEM|Lost to Follow-up|0|||
13193864|NCT02079246|26195147|FG001|OLEX-MEM|Lost to Follow-up|1|||
13193865|NCT02079246|26195146|FG000|OLEX-MEM|Other: Moved to nursing home|0|||
13111980|NCT03167359|25906244|FG000|Overall Study|Lost to Follow-up|1|||
13111981|NCT03167242|25906410|FG000|Overall Study|Patient/Guardian Decision|0|||
13111982|NCT03167242|25906411|FG001|Overall Study|Patient/Guardian Decision|1|||
13111983|NCT03167242|25906412|FG002|Overall Study|Patient/Guardian Decision|2|||
13111984|NCT03167242|25906413|FG003|Overall Study|Patient/Guardian Decision|1|||
13111985|NCT03167242|25906414|FG004|Overall Study|Patient/Guardian Decision|1|||
13193866|NCT02079246|26195147|FG001|OLEX-MEM|Other: Moved to nursing home|3|||
13193867|NCT02079077|26195162|FG000|Overall Study|Lost to Follow-up|5|||
13193868|NCT02079077|26195163|FG001|Overall Study|Lost to Follow-up|7|||
13193869|NCT02079077|26195162|FG000|Overall Study|Became STIs Positive|1|||
13193870|NCT02079077|26195163|FG001|Overall Study|Became STIs Positive|2|||
13206379|NCT01957644|26234623|FG001|Overall Study|Other reason|2|||
13193871|NCT02079038|26195176|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6|||
13193872|NCT02079038|26195177|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5|||
13193873|NCT02079038|26195176|FG000|Modified Intent to Treat Population|Death|1|||
13193874|NCT02079038|26195177|FG001|Modified Intent to Treat Population|Death|0|||
13193875|NCT02079038|26195176|FG000|Completed 6 Months|Lost to Follow-up|2|||
13193876|NCT02079038|26195177|FG001|Completed 6 Months|Lost to Follow-up|1|||
13193877|NCT02078960|26195209|FG000|Treatment Period|Other|0|||
13193878|NCT02078960|26195210|FG001|Treatment Period|Other|0|||
13193879|NCT02078960|26195211|FG002|Treatment Period|Other|1|||
13193880|NCT02078960|26195209|FG000|Treatment Period|Lack of Efficacy|0|||
13193881|NCT02078960|26195210|FG001|Treatment Period|Lack of Efficacy|1|||
13193882|NCT02078960|26195211|FG002|Treatment Period|Lack of Efficacy|0|||
13193883|NCT02078960|26195209|FG000|Treatment Period|Disease progression - accelerated phase|0|||
13193884|NCT02078960|26195210|FG001|Treatment Period|Disease progression - accelerated phase|1|||
13193885|NCT02078960|26195211|FG002|Treatment Period|Disease progression - accelerated phase|0|||
13193886|NCT02078960|26195209|FG000|Treatment Period|Disease progression - blast phase|1|||
13193887|NCT02078960|26195210|FG001|Treatment Period|Disease progression - blast phase|0|||
13193888|NCT02078960|26195211|FG002|Treatment Period|Disease progression - blast phase|0|||
13193889|NCT02078960|26195209|FG000|Treatment Period|Withdrawal by Subject|0|||
13193890|NCT02078960|26195210|FG001|Treatment Period|Withdrawal by Subject|1|||
13193891|NCT02078960|26195211|FG002|Treatment Period|Withdrawal by Subject|1|||
13193892|NCT02078960|26195209|FG000|Treatment Period|Adverse Event|1|||
13193893|NCT02078960|26195210|FG001|Treatment Period|Adverse Event|0|||
13193894|NCT02078960|26195211|FG002|Treatment Period|Adverse Event|0|||
13193895|NCT02078960|26195209|FG000|Treatment Period|Death|0|||
13193896|NCT02078960|26195210|FG001|Treatment Period|Death|0|||
13193897|NCT02078960|26195211|FG002|Treatment Period|Death|1|||
13193898|NCT02078960|26195209|FG000|Follow-up Period|Death|2|||
13193899|NCT02078960|26195210|FG001|Follow-up Period|Death|0|||
13193900|NCT02078960|26195211|FG002|Follow-up Period|Death|0|||
13193901|NCT02078960|26195209|FG000|Follow-up Period|Lost to Follow-up|0|||
13193902|NCT02078960|26195210|FG001|Follow-up Period|Lost to Follow-up|1|||
13193903|NCT02078960|26195211|FG002|Follow-up Period|Lost to Follow-up|0|||
13193904|NCT02078817|26195225|FG000|Overall Study|Withdrawal by Subject|1|||
13193905|NCT02078752|26195528|FG000|Overall Study|Death|0|||
13193906|NCT02078752|26195529|FG001|Overall Study|Death|3|||
13193907|NCT02078752|26195530|FG002|Overall Study|Death|0|||
13193908|NCT02078752|26195531|FG003|Overall Study|Death|0|||
13193909|NCT02078752|26195532|FG004|Overall Study|Death|0|||
13193910|NCT02078752|26195533|FG005|Overall Study|Death|1|||
13193911|NCT02078752|26195534|FG006|Overall Study|Death|0|||
13193912|NCT02078752|26195535|FG007|Overall Study|Death|1|||
13193913|NCT02078752|26195536|FG008|Overall Study|Death|0|||
13193914|NCT02078752|26195537|FG009|Overall Study|Death|4|||
13193915|NCT02078752|26195528|FG000|Overall Study|Lost to Follow-up|1|||
13193916|NCT02078752|26195529|FG001|Overall Study|Lost to Follow-up|0|||
13193917|NCT02078752|26195530|FG002|Overall Study|Lost to Follow-up|0|||
13193918|NCT02078752|26195531|FG003|Overall Study|Lost to Follow-up|1|||
13193919|NCT02078752|26195532|FG004|Overall Study|Lost to Follow-up|0|||
13193920|NCT02078752|26195533|FG005|Overall Study|Lost to Follow-up|0|||
13193921|NCT02078752|26195534|FG006|Overall Study|Lost to Follow-up|0|||
13193922|NCT02078752|26195535|FG007|Overall Study|Lost to Follow-up|0|||
13193923|NCT02078752|26195536|FG008|Overall Study|Lost to Follow-up|0|||
13193924|NCT02078752|26195537|FG009|Overall Study|Lost to Follow-up|0|||
13193925|NCT02078752|26195528|FG000|Overall Study|Withdrawal by Subject|1|||
13193926|NCT02078752|26195529|FG001|Overall Study|Withdrawal by Subject|1|||
13193927|NCT02078752|26195530|FG002|Overall Study|Withdrawal by Subject|1|||
13193928|NCT02078752|26195531|FG003|Overall Study|Withdrawal by Subject|1|||
13193929|NCT02078752|26195532|FG004|Overall Study|Withdrawal by Subject|0|||
13193930|NCT02078752|26195533|FG005|Overall Study|Withdrawal by Subject|3|||
13193931|NCT02078752|26195534|FG006|Overall Study|Withdrawal by Subject|2|||
13193932|NCT02078752|26195535|FG007|Overall Study|Withdrawal by Subject|1|||
13193933|NCT02078752|26195536|FG008|Overall Study|Withdrawal by Subject|0|||
13193934|NCT02078752|26195537|FG009|Overall Study|Withdrawal by Subject|1|||
13193935|NCT02078752|26195528|FG000|Overall Study|Other|0|||
13193936|NCT02078752|26195529|FG001|Overall Study|Other|3|||
13193937|NCT02078752|26195530|FG002|Overall Study|Other|0|||
13193938|NCT02078752|26195531|FG003|Overall Study|Other|0|||
13193939|NCT02078752|26195532|FG004|Overall Study|Other|1|||
13193940|NCT02078752|26195533|FG005|Overall Study|Other|0|||
13193941|NCT02078752|26195534|FG006|Overall Study|Other|0|||
13193942|NCT02078752|26195535|FG007|Overall Study|Other|1|||
13193943|NCT02078752|26195536|FG008|Overall Study|Other|0|||
13193944|NCT02078752|26195537|FG009|Overall Study|Other|0|||
13193945|NCT02078752|26195528|FG000|Overall Study|Study terminated by sponsor|0|||
13193946|NCT02078752|26195529|FG001|Overall Study|Study terminated by sponsor|0|||
13193947|NCT02078752|26195530|FG002|Overall Study|Study terminated by sponsor|0|||
13193948|NCT02078752|26195531|FG003|Overall Study|Study terminated by sponsor|0|||
13193949|NCT02078752|26195532|FG004|Overall Study|Study terminated by sponsor|0|||
13206380|NCT01957644|26234624|FG002|Overall Study|Other reason|1|||
13193950|NCT02078752|26195533|FG005|Overall Study|Study terminated by sponsor|0|||
13193951|NCT02078752|26195534|FG006|Overall Study|Study terminated by sponsor|0|||
13193952|NCT02078752|26195535|FG007|Overall Study|Study terminated by sponsor|0|||
13193953|NCT02078752|26195536|FG008|Overall Study|Study terminated by sponsor|0|||
13193954|NCT02078752|26195537|FG009|Overall Study|Study terminated by sponsor|5|||
13193955|NCT02078713|26195602|FG000|Overall Study|Lost to Follow-up|49|||
13193956|NCT02078713|26195603|FG001|Overall Study|Lost to Follow-up|55|||
13193957|NCT02078713|26195604|FG002|Overall Study|Lost to Follow-up|0|||
13193958|NCT02078713|26195605|FG003|Overall Study|Lost to Follow-up|0|||
13193959|NCT02078713|26195602|FG000|Overall Study|Pregnant at baseline|3|||
13193960|NCT02078713|26195603|FG001|Overall Study|Pregnant at baseline|5|||
13193961|NCT02078713|26195604|FG002|Overall Study|Pregnant at baseline|0|||
13193962|NCT02078713|26195605|FG003|Overall Study|Pregnant at baseline|0|||
13193963|NCT02078713|26195602|FG000|Overall Study|Enrolled twice|0|||
13193964|NCT02078713|26195603|FG001|Overall Study|Enrolled twice|1|||
13193965|NCT02078713|26195604|FG002|Overall Study|Enrolled twice|0|||
13193966|NCT02078713|26195605|FG003|Overall Study|Enrolled twice|0|||
13193967|NCT02078219|26195648|FG000|Overall Study|Other|2|||
13193968|NCT02078219|26195649|FG001|Overall Study|Other|2|||
13193969|NCT02078219|26195650|FG002|Overall Study|Other|3|||
13193970|NCT02078219|26195651|FG003|Overall Study|Other|0|||
13193971|NCT02078219|26195652|FG004|Overall Study|Other|1|||
13193972|NCT02078219|26195648|FG000|Overall Study|Withdrawal by Subject|0|||
13193973|NCT02078219|26195649|FG001|Overall Study|Withdrawal by Subject|1|||
13193974|NCT02078219|26195650|FG002|Overall Study|Withdrawal by Subject|0|||
13193975|NCT02078219|26195651|FG003|Overall Study|Withdrawal by Subject|1|||
13193976|NCT02078219|26195652|FG004|Overall Study|Withdrawal by Subject|1|||
13193977|NCT02078219|26195648|FG000|Overall Study|Protocol Violation|0|||
13193978|NCT02078219|26195649|FG001|Overall Study|Protocol Violation|0|||
13193979|NCT02078219|26195650|FG002|Overall Study|Protocol Violation|0|||
13193980|NCT02078219|26195651|FG003|Overall Study|Protocol Violation|1|||
13193981|NCT02078219|26195652|FG004|Overall Study|Protocol Violation|0|||
13193982|NCT02078219|26195648|FG000|Overall Study|Death|0|||
13193983|NCT02078219|26195649|FG001|Overall Study|Death|0|||
13193984|NCT02078219|26195650|FG002|Overall Study|Death|0|||
13193985|NCT02078219|26195651|FG003|Overall Study|Death|1|||
13193986|NCT02078219|26195652|FG004|Overall Study|Death|0|||
13193987|NCT02078219|26195648|FG000|Overall Study|Adverse Event|1|||
13193988|NCT02078219|26195649|FG001|Overall Study|Adverse Event|1|||
13193989|NCT02078219|26195650|FG002|Overall Study|Adverse Event|3|||
13193990|NCT02078219|26195651|FG003|Overall Study|Adverse Event|1|||
13193991|NCT02078219|26195652|FG004|Overall Study|Adverse Event|0|||
13193992|NCT02078102|26195671|FG000|Overall Study|Adverse Event|1|||
13193993|NCT02078102|26195672|FG001|Overall Study|Adverse Event|0|||
13193994|NCT02078102|26195671|FG000|Overall Study|Withdrawal by Subject|1|||
13193995|NCT02078102|26195672|FG001|Overall Study|Withdrawal by Subject|0|||
13193996|NCT02078102|26195671|FG000|Overall Study|Physician Decision|0|||
13193997|NCT02078102|26195672|FG001|Overall Study|Physician Decision|1|||
13193998|NCT02077465|26195700|FG000|Overall Study|Withdrew Consent|0|||
13193999|NCT02077465|26195701|FG001|Overall Study|Withdrew Consent|1|||
13194000|NCT02077465|26195700|FG000|Overall Study|Lost to Follow-up|1|||
13194001|NCT02077465|26195701|FG001|Overall Study|Lost to Follow-up|0|||
13194002|NCT02077374|26195724|FG000|Overall Study|Withdrawal by Subject|0|||
13194003|NCT02077374|26195725|FG001|Overall Study|Withdrawal by Subject|1|||
13194004|NCT02077374|26195724|FG000|Overall Study|Protocol Violation|0|||
13194005|NCT02077374|26195725|FG001|Overall Study|Protocol Violation|1|||
13194006|NCT02077140|26195828|FG000|Overall Study|Lost to Follow-up|4|||
13194007|NCT02077140|26195829|FG001|Overall Study|Lost to Follow-up|1|||
13194008|NCT02077140|26195830|FG002|Overall Study|Lost to Follow-up|2|||
13194009|NCT02077140|26195831|FG003|Overall Study|Lost to Follow-up|2|||
13194010|NCT02077140|26195832|FG004|Overall Study|Lost to Follow-up|3|||
13194011|NCT02077140|26195828|FG000|Overall Study|Withdrawal by Subject|0|||
13194012|NCT02077140|26195829|FG001|Overall Study|Withdrawal by Subject|1|||
13194013|NCT02077140|26195830|FG002|Overall Study|Withdrawal by Subject|0|||
13194014|NCT02077140|26195831|FG003|Overall Study|Withdrawal by Subject|2|||
13194015|NCT02077140|26195832|FG004|Overall Study|Withdrawal by Subject|2|||
13194016|NCT02076334|26195859|FG000|Overall Study|Protocol Violation|1|||
13194017|NCT02076334|26195860|FG001|Overall Study|Protocol Violation|0|||
13194018|NCT02076334|26195861|FG002|Overall Study|Protocol Violation|0|||
13194019|NCT02076334|26195862|FG003|Overall Study|Protocol Violation|0|||
13194020|NCT02076334|26195859|FG000|Overall Study|Lost to Follow-up|0|||
13194021|NCT02076334|26195860|FG001|Overall Study|Lost to Follow-up|1|||
13194022|NCT02076334|26195861|FG002|Overall Study|Lost to Follow-up|1|||
13194023|NCT02076334|26195862|FG003|Overall Study|Lost to Follow-up|0|||
13194024|NCT02076334|26195859|FG000|Overall Study|muscle soreness|0|||
13194025|NCT02076334|26195860|FG001|Overall Study|muscle soreness|0|||
13194026|NCT02076334|26195861|FG002|Overall Study|muscle soreness|0|||
13194027|NCT02076334|26195862|FG003|Overall Study|muscle soreness|1|||
13194028|NCT02076165|26195893|FG000|Overall Study|Lost to Follow-up|7|||
13194029|NCT02076165|26195894|FG001|Overall Study|Lost to Follow-up|5|||
13194030|NCT02076165|26195893|FG000|Overall Study|Refused follow-up assessment|1|||
13194031|NCT02076165|26195894|FG001|Overall Study|Refused follow-up assessment|1|||
13194032|NCT02076113|26195932|FG000|Overall Study|Lost to Follow-up|4|||
13194033|NCT02076113|26195933|FG001|Overall Study|Lost to Follow-up|1|||
13194034|NCT02076113|26195932|FG000|Overall Study|Withdrawal by Subject|2|||
13194035|NCT02076113|26195933|FG001|Overall Study|Withdrawal by Subject|3|||
13194036|NCT02076113|26195932|FG000|Overall Study|Death|1|||
13194037|NCT02076113|26195933|FG001|Overall Study|Death|3|||
13194038|NCT02076022|26195950|FG000|Overall Study|Withdrawal by Subject|2|||
13194039|NCT02076022|26195951|FG001|Overall Study|Withdrawal by Subject|0|||
13194040|NCT02075658|26195966|FG000|Overall Study|Physician Decision|2|||
13194041|NCT02075658|26195967|FG001|Overall Study|Physician Decision|2|||
13194042|NCT02075632|26195984|FG000|Overall Study|Adverse Event|1|||
13194043|NCT02075632|26195985|FG001|Overall Study|Adverse Event|1|||
13194044|NCT02075632|26195984|FG000|Overall Study|Lost to Follow-up|0|||
13194045|NCT02075632|26195985|FG001|Overall Study|Lost to Follow-up|3|||
13194046|NCT02075632|26195984|FG000|Overall Study|Withdrawal by Subject|0|||
13194047|NCT02075632|26195985|FG001|Overall Study|Withdrawal by Subject|1|||
13194048|NCT02075606|26196009|FG000|Overall Study|Adverse Event|5|||
13194049|NCT02075606|26196009|FG000|Overall Study|Withdrawal by Subject|1|||
13194050|NCT02075606|26196009|FG000|Overall Study|Death|1|||
13194051|NCT02075606|26196009|FG000|Overall Study|Investigator's decision|1|||
13194052|NCT02075606|26196009|FG000|Overall Study|Symptom management|1|||
13194053|NCT02075606|26196009|FG000|Overall Study|Increasing Symptoms|1|||
13194054|NCT02075554|26196018|FG000|Overall Study|Lost to Follow-up|7|||
13194055|NCT02075554|26196018|FG000|Overall Study|Withdrawal by Subject|5|||
13194056|NCT02075554|26196018|FG000|Overall Study|Physician Decision|3|||
13194057|NCT02075541|26196071|FG000|Overall Study|Serious Adverse Event|1|||
13194058|NCT02075541|26196072|FG001|Overall Study|Serious Adverse Event|4|||
13194059|NCT02075541|26196071|FG000|Overall Study|Protocol Violation|1|||
13111986|NCT03167242|25906415|FG005|Overall Study|Patient/Guardian Decision|1|||
13194060|NCT02075541|26196072|FG001|Overall Study|Protocol Violation|0|||
13194061|NCT02075541|26196071|FG000|Overall Study|Withdrawal by Subject|1|||
13194062|NCT02075541|26196072|FG001|Overall Study|Withdrawal by Subject|3|||
13194063|NCT02075541|26196071|FG000|Overall Study|Sponsor study termination|0|||
13194064|NCT02075541|26196072|FG001|Overall Study|Sponsor study termination|1|||
13194065|NCT02075541|26196071|FG000|Overall Study|Other- unable to perform study procedure|1|||
13194066|NCT02075541|26196072|FG001|Overall Study|Other- unable to perform study procedure|0|||
13194067|NCT02075515|26196117|FG000|Overall Study|Serious Adverse Event|1|||
13194068|NCT02075515|26196118|FG001|Overall Study|Serious Adverse Event|1|||
13194069|NCT02075515|26196119|FG002|Overall Study|Serious Adverse Event|1|||
13194070|NCT02075515|26196117|FG000|Overall Study|Non-Serious Adverse Event|0|||
13194071|NCT02075515|26196118|FG001|Overall Study|Non-Serious Adverse Event|1|||
13194072|NCT02075515|26196119|FG002|Overall Study|Non-Serious Adverse Event|0|||
13194073|NCT02075515|26196117|FG000|Overall Study|Withdrawal by Subject|2|||
13194074|NCT02075515|26196118|FG001|Overall Study|Withdrawal by Subject|0|||
13194075|NCT02075515|26196119|FG002|Overall Study|Withdrawal by Subject|1|||
13194076|NCT02075515|26196117|FG000|Overall Study|Lost to Follow-up|1|||
13194077|NCT02075515|26196118|FG001|Overall Study|Lost to Follow-up|3|||
13194078|NCT02075515|26196119|FG002|Overall Study|Lost to Follow-up|6|||
13194079|NCT02075476|26196136|FG000|Overall Study|Death|2|||
13194080|NCT02075476|26196137|FG001|Overall Study|Death|2|||
13194081|NCT02075476|26196136|FG000|Overall Study|Lost to Follow-up|1|||
13194082|NCT02075476|26196137|FG001|Overall Study|Lost to Follow-up|3|||
13194083|NCT02075463|26196164|FG000|Overall Study|Adverse Event|3|||
13194084|NCT02075463|26196164|FG000|Overall Study|Par. reached stopping criteria|4|||
13194085|NCT02075463|26196164|FG000|Overall Study|Withdrawal by Subject|1|||
13111987|NCT03167242|25906416|FG006|Overall Study|Patient/Guardian Decision|0|||
13111988|NCT03167242|25906417|FG007|Overall Study|Patient/Guardian Decision|0|||
13111989|NCT03167242|25906418|FG008|Overall Study|Patient/Guardian Decision|0|||
13111990|NCT03167242|25906419|FG009|Overall Study|Patient/Guardian Decision|0|||
13111991|NCT03167242|25906420|FG010|Overall Study|Patient/Guardian Decision|1|||
13111992|NCT03167242|25906421|FG011|Overall Study|Patient/Guardian Decision|0|||
13111993|NCT03167242|25906410|FG000|Overall Study|Lost to Follow-up|0|||
13111994|NCT03167242|25906411|FG001|Overall Study|Lost to Follow-up|0|||
13111995|NCT03167242|25906412|FG002|Overall Study|Lost to Follow-up|1|||
13111996|NCT03167242|25906413|FG003|Overall Study|Lost to Follow-up|0|||
13111997|NCT03167242|25906414|FG004|Overall Study|Lost to Follow-up|0|||
13194086|NCT02075320|26196173|FG000|Overall Study|Withdrawal by Subject|2|||
13194087|NCT02075255|26196290|FG000|Overall Study|Study specific withdrawal criteria|0|||
13194088|NCT02075255|26196291|FG001|Overall Study|Study specific withdrawal criteria|1|||
13194089|NCT02075255|26196292|FG002|Overall Study|Study specific withdrawal criteria|1|||
13194090|NCT02075255|26196290|FG000|Overall Study|Withdrawal by Subject|4|||
13194091|NCT02075255|26196291|FG001|Overall Study|Withdrawal by Subject|1|||
13194092|NCT02075255|26196292|FG002|Overall Study|Withdrawal by Subject|0|||
13194093|NCT02075255|26196290|FG000|Overall Study|Lost to Follow-up|0|||
13194094|NCT02075255|26196291|FG001|Overall Study|Lost to Follow-up|0|||
13194095|NCT02075255|26196292|FG002|Overall Study|Lost to Follow-up|1|||
13194096|NCT02075255|26196290|FG000|Overall Study|Adverse Event|0|||
13194097|NCT02075255|26196291|FG001|Overall Study|Adverse Event|0|||
13194098|NCT02075255|26196292|FG002|Overall Study|Adverse Event|1|||
13194099|NCT02075255|26196290|FG000|Overall Study|Death|0|||
13194100|NCT02075255|26196291|FG001|Overall Study|Death|2|||
13194101|NCT02075255|26196292|FG002|Overall Study|Death|0|||
13194102|NCT02075203|26196319|FG000|Overall Study|Withdrawal by Subject|1|||
13194103|NCT02075203|26196320|FG001|Overall Study|Withdrawal by Subject|0|||
13194104|NCT02075203|26196321|FG002|Overall Study|Withdrawal by Subject|1|||
13194105|NCT02075203|26196319|FG000|Overall Study|Adverse Event|1|||
13194106|NCT02075203|26196320|FG001|Overall Study|Adverse Event|0|||
13194107|NCT02075203|26196321|FG002|Overall Study|Adverse Event|0|||
13194108|NCT02075203|26196319|FG000|Overall Study|participant refused to use contraception|1|||
13194109|NCT02075203|26196320|FG001|Overall Study|participant refused to use contraception|0|||
13194110|NCT02075203|26196321|FG002|Overall Study|participant refused to use contraception|0|||
13194111|NCT02075073|26196348|FG000|Overall Study|Withdrawal by Subject|0|||
13194112|NCT02075073|26196349|FG001|Overall Study|Withdrawal by Subject|1|||
13194113|NCT02075073|26196350|FG002|Overall Study|Withdrawal by Subject|0|||
13194114|NCT02075047|26196401|FG000|Treatment Phase (4 Weeks)|Adverse Event|14|||
13194115|NCT02075047|26196402|FG001|Treatment Phase (4 Weeks)|Adverse Event|4|||
13194116|NCT02075047|26196401|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
13194117|NCT02075047|26196402|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
13194118|NCT02075047|26196401|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
13194119|NCT02075047|26196402|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
13194120|NCT02075047|26196401|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1|||
13194121|NCT02075047|26196402|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0|||
13194122|NCT02075047|26196401|FG000|Treatment Phase (4 Weeks)|Screen Failure|1|||
13194123|NCT02075047|26196402|FG001|Treatment Phase (4 Weeks)|Screen Failure|0|||
13194124|NCT02075047|26196401|FG000|Treatment Phase (4 Weeks)|Other|1|||
13194125|NCT02075047|26196402|FG001|Treatment Phase (4 Weeks)|Other|1|||
13194126|NCT02075047|26196401|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4|||
13194127|NCT02075047|26196402|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2|||
13194128|NCT02075047|26196401|FG000|Follow up Phase (5 Weeks)|Adverse Event|14|||
13194129|NCT02075047|26196402|FG001|Follow up Phase (5 Weeks)|Adverse Event|4|||
13194130|NCT02075047|26196401|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
13194131|NCT02075047|26196402|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
13194132|NCT02075047|26196401|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0|||
13194133|NCT02075047|26196402|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1|||
13194134|NCT02075047|26196401|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1|||
13194135|NCT02075047|26196402|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0|||
13194136|NCT02075047|26196401|FG000|Follow up Phase (5 Weeks)|Screen Failure|1|||
13194137|NCT02075047|26196402|FG001|Follow up Phase (5 Weeks)|Screen Failure|0|||
13194138|NCT02075047|26196401|FG000|Follow up Phase (5 Weeks)|Other|1|||
13194139|NCT02075047|26196402|FG001|Follow up Phase (5 Weeks)|Other|2|||
13194140|NCT02075047|26196401|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7|||
13194141|NCT02075047|26196402|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4|||
13194142|NCT02075008|26196408|FG000|Overall Study|Technical problems|1|||
13194143|NCT02075008|26196408|FG000|Overall Study|Pregnancy|1|||
13194144|NCT02075008|26196408|FG000|Overall Study|Physician Decision|1|||
13194145|NCT02075008|26196408|FG000|Overall Study|Lost to Follow-up|1|||
13194146|NCT02075008|26196408|FG000|Overall Study|Lack of Efficacy|1|||
13194147|NCT02075008|26196408|FG000|Overall Study|Death|1|||
13194148|NCT02075008|26196408|FG000|Overall Study|Adverse Event|5|||
13194149|NCT02075008|26196408|FG000|Overall Study|Withdrawal by Subject|6|||
13194150|NCT02075008|26196408|FG000|Overall Study|Study terminated by Sponsor|159|||
13194151|NCT02074982|26196425|FG000|Overall Study|Adverse Event|15|||
13194152|NCT02074982|26196426|FG001|Overall Study|Adverse Event|7|||
13194153|NCT02074982|26196425|FG000|Overall Study|Lack of Efficacy|6|||
13194154|NCT02074982|26196426|FG001|Overall Study|Lack of Efficacy|1|||
13194155|NCT02074982|26196425|FG000|Overall Study|Lost to Follow-up|9|||
13194156|NCT02074982|26196426|FG001|Overall Study|Lost to Follow-up|10|||
13194157|NCT02074982|26196425|FG000|Overall Study|Non-compliance with study treatment|0|||
13194158|NCT02074982|26196426|FG001|Overall Study|Non-compliance with study treatment|2|||
13194159|NCT02074982|26196425|FG000|Overall Study|Physician Decision|1|||
13194160|NCT02074982|26196426|FG001|Overall Study|Physician Decision|1|||
13194161|NCT02074982|26196425|FG000|Overall Study|Pregnancy|1|||
13194162|NCT02074982|26196426|FG001|Overall Study|Pregnancy|2|||
13194163|NCT02074982|26196425|FG000|Overall Study|Protocol deviation|4|||
13194164|NCT02074982|26196426|FG001|Overall Study|Protocol deviation|3|||
13194165|NCT02074982|26196425|FG000|Overall Study|Technical problems|0|||
13194166|NCT02074982|26196426|FG001|Overall Study|Technical problems|2|||
13194167|NCT02074982|26196425|FG000|Overall Study|Subject/guardian decision|15|||
13194168|NCT02074982|26196426|FG001|Overall Study|Subject/guardian decision|24|||
13194169|NCT02074982|26196425|FG000|Overall Study|Death|0|||
13194170|NCT02074982|26196426|FG001|Overall Study|Death|2|||
13194171|NCT02074553|26196617|FG000|Intervention Period 1|Family Emergency|0|||
13194172|NCT02074553|26196618|FG001|Intervention Period 1|Family Emergency|0|||
13194173|NCT02074553|26196619|FG002|Intervention Period 1|Family Emergency|0|||
13194174|NCT02074553|26196620|FG003|Intervention Period 1|Family Emergency|1|||
13194175|NCT02074553|26196621|FG004|Intervention Period 1|Family Emergency|0|||
13194176|NCT02074553|26196622|FG005|Intervention Period 1|Family Emergency|0|||
13194177|NCT02074553|26196623|FG006|Intervention Period 1|Family Emergency|0|||
13194178|NCT02074553|26196624|FG007|Intervention Period 1|Family Emergency|0|||
13194179|NCT02074553|26196617|FG000|Washout Period 1|Adverse Event|1|||
13194180|NCT02074553|26196618|FG001|Washout Period 1|Adverse Event|0|||
13194181|NCT02074553|26196619|FG002|Washout Period 1|Adverse Event|0|||
13194182|NCT02074553|26196620|FG003|Washout Period 1|Adverse Event|0|||
13194183|NCT02074553|26196621|FG004|Washout Period 1|Adverse Event|0|||
13194184|NCT02074553|26196622|FG005|Washout Period 1|Adverse Event|0|||
13194185|NCT02074553|26196623|FG006|Washout Period 1|Adverse Event|0|||
13194186|NCT02074553|26196624|FG007|Washout Period 1|Adverse Event|0|||
13194187|NCT02074553|26196617|FG000|Washout Period 1|Physician Decision|0|||
13194188|NCT02074553|26196618|FG001|Washout Period 1|Physician Decision|0|||
13194189|NCT02074553|26196619|FG002|Washout Period 1|Physician Decision|0|||
13194190|NCT02074553|26196620|FG003|Washout Period 1|Physician Decision|1|||
13194191|NCT02074553|26196621|FG004|Washout Period 1|Physician Decision|0|||
13194192|NCT02074553|26196622|FG005|Washout Period 1|Physician Decision|0|||
13194193|NCT02074553|26196623|FG006|Washout Period 1|Physician Decision|0|||
13194194|NCT02074553|26196624|FG007|Washout Period 1|Physician Decision|0|||
13194195|NCT02074553|26196617|FG000|Washout Period 1|Other|0|||
13194196|NCT02074553|26196618|FG001|Washout Period 1|Other|0|||
13194197|NCT02074553|26196619|FG002|Washout Period 1|Other|0|||
13194198|NCT02074553|26196620|FG003|Washout Period 1|Other|0|||
13194199|NCT02074553|26196621|FG004|Washout Period 1|Other|0|||
13194200|NCT02074553|26196622|FG005|Washout Period 1|Other|1|||
13194201|NCT02074553|26196623|FG006|Washout Period 1|Other|0|||
13194202|NCT02074553|26196624|FG007|Washout Period 1|Other|0|||
13194203|NCT02074553|26196617|FG000|Washout Period 2|Adverse Event|0|||
13194204|NCT02074553|26196618|FG001|Washout Period 2|Adverse Event|0|||
13194205|NCT02074553|26196619|FG002|Washout Period 2|Adverse Event|0|||
13194206|NCT02074553|26196620|FG003|Washout Period 2|Adverse Event|0|||
13194207|NCT02074553|26196621|FG004|Washout Period 2|Adverse Event|0|||
13194208|NCT02074553|26196622|FG005|Washout Period 2|Adverse Event|0|||
13194209|NCT02074553|26196623|FG006|Washout Period 2|Adverse Event|1|||
13194210|NCT02074553|26196624|FG007|Washout Period 2|Adverse Event|0|||
13194211|NCT02074553|26196617|FG000|Washout Period 2|Physician Decision|0|||
13194212|NCT02074553|26196618|FG001|Washout Period 2|Physician Decision|0|||
13194213|NCT02074553|26196619|FG002|Washout Period 2|Physician Decision|0|||
13194214|NCT02074553|26196620|FG003|Washout Period 2|Physician Decision|0|||
13194215|NCT02074553|26196621|FG004|Washout Period 2|Physician Decision|0|||
13194216|NCT02074553|26196622|FG005|Washout Period 2|Physician Decision|1|||
13194217|NCT02074553|26196623|FG006|Washout Period 2|Physician Decision|0|||
13194218|NCT02074553|26196624|FG007|Washout Period 2|Physician Decision|0|||
13194219|NCT02074553|26196617|FG000|Washout Period 2|Lost to Follow-up|0|||
13194220|NCT02074553|26196618|FG001|Washout Period 2|Lost to Follow-up|0|||
13194221|NCT02074553|26196619|FG002|Washout Period 2|Lost to Follow-up|1|||
13194222|NCT02074553|26196620|FG003|Washout Period 2|Lost to Follow-up|0|||
13194223|NCT02074553|26196621|FG004|Washout Period 2|Lost to Follow-up|0|||
13194224|NCT02074553|26196622|FG005|Washout Period 2|Lost to Follow-up|0|||
13194225|NCT02074553|26196623|FG006|Washout Period 2|Lost to Follow-up|0|||
13194226|NCT02074553|26196624|FG007|Washout Period 2|Lost to Follow-up|0|||
13194227|NCT02074553|26196617|FG000|Washout Period 3|Physician Decision|0|||
13194228|NCT02074553|26196618|FG001|Washout Period 3|Physician Decision|0|||
13194229|NCT02074553|26196619|FG002|Washout Period 3|Physician Decision|0|||
13194230|NCT02074553|26196620|FG003|Washout Period 3|Physician Decision|0|||
13194231|NCT02074553|26196621|FG004|Washout Period 3|Physician Decision|0|||
13194232|NCT02074553|26196622|FG005|Washout Period 3|Physician Decision|0|||
13194233|NCT02074553|26196623|FG006|Washout Period 3|Physician Decision|0|||
13194234|NCT02074553|26196624|FG007|Washout Period 3|Physician Decision|1|||
13194235|NCT02074514|26196653|FG000|Overall Study|Lack of Efficacy|3|||
13194236|NCT02074514|26196654|FG001|Overall Study|Lack of Efficacy|2|||
13194237|NCT02074514|26196653|FG000|Overall Study|Lost to Follow-up|0|||
13194238|NCT02074514|26196654|FG001|Overall Study|Lost to Follow-up|1|||
13194239|NCT02074514|26196653|FG000|Overall Study|Withdrew Consent|0|||
13194240|NCT02074514|26196654|FG001|Overall Study|Withdrew Consent|1|||
13194241|NCT02074059|26196711|FG000|Overall Study|Death|0|||
13194242|NCT02074059|26196712|FG001|Overall Study|Death|0|||
13194243|NCT02074059|26196713|FG002|Overall Study|Death|0|||
13194244|NCT02074059|26196714|FG003|Overall Study|Death|0|||
13194245|NCT02074059|26196715|FG004|Overall Study|Death|1|||
13194246|NCT02074059|26196716|FG005|Overall Study|Death|1|||
13194247|NCT02073929|26196749|FG000|Overall Study|Lost to Follow-up|2|||
13194248|NCT02073929|26196750|FG001|Overall Study|Lost to Follow-up|1|||
13194249|NCT02073929|26196749|FG000|Overall Study|Adverse Event|2|||
13194250|NCT02073929|26196750|FG001|Overall Study|Adverse Event|1|||
13194251|NCT02073929|26196749|FG000|Overall Study|Withdrawal by Subject|0|||
13194252|NCT02073929|26196750|FG001|Overall Study|Withdrawal by Subject|1|||
13194253|NCT02073682|26196775|FG000|Overall Study|Low Creatinine Clearance|1|||
13194254|NCT02073682|26196776|FG001|Overall Study|Low Creatinine Clearance|2|||
13194255|NCT02073682|26196775|FG000|Overall Study|Death|86|||
13194256|NCT02073682|26196776|FG001|Overall Study|Death|100|||
13194257|NCT02073682|26196775|FG000|Overall Study|Cancer Cured|10|||
13194258|NCT02073682|26196776|FG001|Overall Study|Cancer Cured|15|||
13194259|NCT02073682|26196775|FG000|Overall Study|ID: Patient Noncompliance|1|||
13194260|NCT02073682|26196776|FG001|Overall Study|ID: Patient Noncompliance|2|||
13194261|NCT02073682|26196775|FG000|Overall Study|ID: Palliative Treatment Only|10|||
13194262|NCT02073682|26196776|FG001|Overall Study|ID: Palliative Treatment Only|7|||
13194263|NCT02073682|26196775|FG000|Overall Study|Prohibited Concomitant Medication Use|0|||
13194264|NCT02073682|26196776|FG001|Overall Study|Prohibited Concomitant Medication Use|1|||
13194265|NCT02073682|26196775|FG000|Overall Study|Platelet Count <50,000/mL|1|||
13194266|NCT02073682|26196776|FG001|Overall Study|Platelet Count <50,000/mL|2|||
13194267|NCT02073682|26196775|FG000|Overall Study|Surgery/Medical Procedure|3|||
13194268|NCT02073682|26196776|FG001|Overall Study|Surgery/Medical Procedure|1|||
13194269|NCT02073682|26196775|FG000|Overall Study|Withdrawal by Subject|6|||
13194270|NCT02073682|26196776|FG001|Overall Study|Withdrawal by Subject|8|||
13194271|NCT02073682|26196775|FG000|Overall Study|Start of New Chemotherapy Regimen|6|||
13194272|NCT02073682|26196776|FG001|Overall Study|Start of New Chemotherapy Regimen|3|||
13194273|NCT02073682|26196775|FG000|Overall Study|Cancer Progression|53|||
13194274|NCT02073682|26196776|FG001|Overall Study|Cancer Progression|33|||
13194275|NCT02073682|26196775|FG000|Overall Study|Protocol Violation|1|||
13194276|NCT02073682|26196776|FG001|Overall Study|Protocol Violation|0|||
13194277|NCT02073682|26196775|FG000|Overall Study|Adverse Event|79|||
13194278|NCT02073682|26196776|FG001|Overall Study|Adverse Event|62|||
13194279|NCT02073682|26196775|FG000|Overall Study|No reason provided|11|||
13194280|NCT02073682|26196776|FG001|Overall Study|No reason provided|9|||
13194281|NCT02073682|26196775|FG000|Overall Study|PD: Inconvenience of Dosing|21|||
13194282|NCT02073682|26196776|FG001|Overall Study|PD: Inconvenience of Dosing|78|||
13194283|NCT02073682|26196775|FG000|Overall Study|Lost to Follow-up|1|||
13194284|NCT02073682|26196776|FG001|Overall Study|Lost to Follow-up|1|||
13194285|NCT02073682|26196775|FG000|Overall Study|ID: Benefit/Risk Judgment|32|||
13194286|NCT02073682|26196776|FG001|Overall Study|ID: Benefit/Risk Judgment|46|||
13194287|NCT02073656|26196794|FG000|Primary Study|Lost to Follow-up|6|||
13194288|NCT02073656|26196794|FG000|Primary Study|Death|1|||
13194289|NCT02073656|26196794|FG000|Primary Study|Withdrew Consent|1|||
13194290|NCT02073643|26196805|FG000|Overall Study|Lost to Follow-up|24|||
13194291|NCT02073565|26196824|FG000|Cohort A|Withdrawal by Subject|1|||
13194292|NCT02073565|26196825|FG001|Cohort A|Withdrawal by Subject|0|||
13194293|NCT02073565|26196824|FG000|Cohort B|Withdrawal by Subject|1|||
13194294|NCT02073565|26196825|FG001|Cohort B|Withdrawal by Subject|2|||
13194295|NCT02073565|26196824|FG000|Cohort C|Withdrawal by Subject|0|||
13194296|NCT02073565|26196825|FG001|Cohort C|Withdrawal by Subject|2|||
13194297|NCT02073565|26196824|FG000|Cohort C|Lost to Follow-up|0|||
13194298|NCT02073565|26196825|FG001|Cohort C|Lost to Follow-up|2|||
13194299|NCT02073279|26196904|FG000|Double-blind Period|Adverse Event|1|||
13194300|NCT02073279|26196905|FG001|Double-blind Period|Adverse Event|1|||
13194301|NCT02073279|26196904|FG000|Double-blind Period|Protocol Deviation|0|||
13194302|NCT02073279|26196905|FG001|Double-blind Period|Protocol Deviation|1|||
13194303|NCT02073279|26196904|FG000|Double-blind Period|Withdrawal by Subject|2|||
13194304|NCT02073279|26196905|FG001|Double-blind Period|Withdrawal by Subject|2|||
13194305|NCT02073279|26196904|FG000|Double-blind Period|Reason Not Specified|1|||
13194306|NCT02073279|26196905|FG001|Double-blind Period|Reason Not Specified|2|||
13194307|NCT02073279|26196904|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0|||
13194308|NCT02073279|26196905|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1|||
13194309|NCT02073279|26196904|FG000|Double-blind Period|On-going in Study|11|||
13194310|NCT02073279|26196905|FG001|Double-blind Period|On-going in Study|40|||
13194311|NCT02073279|26196904|FG000|Open-label Extension Period|Lack of Efficacy|1|||
13194312|NCT02073279|26196905|FG001|Open-label Extension Period|Lack of Efficacy|0|||
13194313|NCT02073279|26196904|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
13194314|NCT02073279|26196905|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
13194315|NCT02073279|26196904|FG000|Open-label Extension Period|Withdrawal by Subject|1|||
13194316|NCT02073279|26196905|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
13194317|NCT02073279|26196904|FG000|Open-label Extension Period|Reason Not Specified|1|||
13194318|NCT02073279|26196905|FG001|Open-label Extension Period|Reason Not Specified|1|||
13194319|NCT02073279|26196904|FG000|Open-label Extension Period|On-going in Study|14|||
13194320|NCT02073279|26196905|FG001|Open-label Extension Period|On-going in Study|13|||
13194321|NCT02072980|26196914|FG000|Period 2, Second Wear|Adverse Event|0|||
13194322|NCT02072980|26196915|FG001|Period 2, Second Wear|Adverse Event|1|||
13194323|NCT02072941|26196930|FG000|Overall Study|Withdrawal by Subject|29|||
13194324|NCT02072941|26196931|FG001|Overall Study|Withdrawal by Subject|21|||
13194325|NCT02072941|26196930|FG000|Overall Study|Lost to Follow-up|4|||
13194326|NCT02072941|26196931|FG001|Overall Study|Lost to Follow-up|4|||
13194327|NCT02072941|26196930|FG000|Overall Study|Death|3|||
13194328|NCT02072941|26196931|FG001|Overall Study|Death|2|||
13194329|NCT02072941|26196930|FG000|Overall Study|Removed by Study Staff|2|||
13194330|NCT02072941|26196931|FG001|Overall Study|Removed by Study Staff|2|||
13194331|NCT02072824|26196976|FG000|Overall Study|Insufficient clinical response|1|||
13194332|NCT02072824|26196977|FG001|Overall Study|Insufficient clinical response|0|||
13194333|NCT02072824|26196978|FG002|Overall Study|Insufficient clinical response|1|||
13194334|NCT02072824|26196976|FG000|Overall Study|No longer willing to participate|1|||
13194335|NCT02072824|26196977|FG001|Overall Study|No longer willing to participate|0|||
13194336|NCT02072824|26196978|FG002|Overall Study|No longer willing to participate|1|||
13194337|NCT02072824|26196976|FG000|Overall Study|Medication error|0|||
13194338|NCT02072824|26196977|FG001|Overall Study|Medication error|1|||
13194339|NCT02072824|26196978|FG002|Overall Study|Medication error|0|||
13194340|NCT02072824|26196976|FG000|Overall Study|Adverse Event|0|||
13194341|NCT02072824|26196977|FG001|Overall Study|Adverse Event|0|||
13194342|NCT02072824|26196978|FG002|Overall Study|Adverse Event|1|||
13194343|NCT02072668|26197019|FG000|Second Intervention|Lost to Follow-up|1|||
13194344|NCT02072668|26197020|FG001|Second Intervention|Lost to Follow-up|0|||
13194345|NCT02072434|26197037|FG000|Overall Study|Protocol Violation|10|||
13194346|NCT02072434|26197038|FG001|Overall Study|Protocol Violation|9|||
13194347|NCT02072434|26197037|FG000|Overall Study|Physician Decision|5|||
13194348|NCT02072434|26197038|FG001|Overall Study|Physician Decision|10|||
13194349|NCT02072434|26197037|FG000|Overall Study|Adverse event, serious fatal|1|||
13194350|NCT02072434|26197038|FG001|Overall Study|Adverse event, serious fatal|6|||
13194351|NCT02072434|26197037|FG000|Overall Study|Adverse Event|7|||
13194352|NCT02072434|26197038|FG001|Overall Study|Adverse Event|6|||
13194353|NCT02072434|26197037|FG000|Overall Study|Withdrawal by Subject|17|||
13194354|NCT02072434|26197038|FG001|Overall Study|Withdrawal by Subject|29|||
13194355|NCT02072434|26197037|FG000|Overall Study|Other|14|||
13194356|NCT02072434|26197038|FG001|Overall Study|Other|29|||
13194357|NCT02072434|26197037|FG000|Overall Study|Lost to Follow-up|0|||
13194358|NCT02072434|26197038|FG001|Overall Study|Lost to Follow-up|1|||
13194359|NCT02072226|26197067|FG000|Overall Study|Lost to Follow-up|11|||
13194360|NCT02072226|26197068|FG001|Overall Study|Lost to Follow-up|7|||
13194361|NCT02072226|26197067|FG000|Overall Study|Patient Non-compliance|2|||
13194362|NCT02072226|26197068|FG001|Overall Study|Patient Non-compliance|3|||
13194363|NCT02072226|26197067|FG000|Overall Study|Death|1|||
13194364|NCT02072226|26197068|FG001|Overall Study|Death|0|||
13194365|NCT02072226|26197067|FG000|Overall Study|Patient Withdrawal of Consent|1|||
13194366|NCT02072226|26197068|FG001|Overall Study|Patient Withdrawal of Consent|0|||
13194367|NCT02072174|26197097|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14|||
13194368|NCT02072174|26197098|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15|||
13194369|NCT02072174|26197097|FG000|Overall Study|Protocol Violation|16|||
13194370|NCT02072174|26197098|FG001|Overall Study|Protocol Violation|23|||
13194371|NCT02072174|26197097|FG000|Overall Study|Physician Decision|0|||
13194372|NCT02072174|26197098|FG001|Overall Study|Physician Decision|1|||
13194373|NCT02072174|26197097|FG000|Overall Study|Non-compliance with protocol requirement|2|||
13194374|NCT02072174|26197098|FG001|Overall Study|Non-compliance with protocol requirement|0|||
13194375|NCT02072096|26197127|FG000|Overall Study|Lack of Efficacy|18|||
13194376|NCT02072096|26197128|FG001|Overall Study|Lack of Efficacy|29|||
13194377|NCT02072096|26197127|FG000|Overall Study|Protocol Violation|7|||
13194378|NCT02072096|26197128|FG001|Overall Study|Protocol Violation|7|||
13194379|NCT02072096|26197127|FG000|Overall Study|Withdrawal by Subject|5|||
13194380|NCT02072096|26197128|FG001|Overall Study|Withdrawal by Subject|7|||
13194381|NCT02072096|26197127|FG000|Overall Study|Adverse Event|5|||
13194382|NCT02072096|26197128|FG001|Overall Study|Adverse Event|2|||
13194383|NCT02072096|26197127|FG000|Overall Study|No Reason Provided|4|||
13194384|NCT02072096|26197128|FG001|Overall Study|No Reason Provided|2|||
13194385|NCT02072096|26197127|FG000|Overall Study|Death|2|||
13194386|NCT02072096|26197128|FG001|Overall Study|Death|0|||
13194387|NCT02072096|26197127|FG000|Overall Study|Physician Decision|0|||
13194388|NCT02072096|26197128|FG001|Overall Study|Physician Decision|1|||
13194389|NCT02072096|26197127|FG000|Overall Study|Study Terminated by Sponsor|43|||
13194390|NCT02072096|26197128|FG001|Overall Study|Study Terminated by Sponsor|30|||
13194391|NCT02072096|26197127|FG000|Overall Study|Lost to Follow-up|1|||
13194392|NCT02072096|26197128|FG001|Overall Study|Lost to Follow-up|0|||
13194393|NCT02071849|26197162|FG000|6-month Primary Endpoint|Did not receive device|4|||
13194394|NCT02071849|26197162|FG000|6-month Primary Endpoint|Adverse Event|1|||
13194395|NCT02071849|26197162|FG000|2-year Extended Follow-up|Adverse Event|1|||
13194396|NCT02071771|26197173|FG000|Period 1: First 10 Days|Unacceptable lens fit|1|||
13194397|NCT02071771|26197174|FG001|Period 1: First 10 Days|Unacceptable lens fit|0|||
13194398|NCT02071771|26197173|FG000|Period 1: First 10 Days|Unavailable lens power|1|||
13194399|NCT02071771|26197174|FG001|Period 1: First 10 Days|Unavailable lens power|0|||
13194400|NCT02071706|26197181|FG000|Overall Study|Adverse Event|1|||
13194401|NCT02071706|26197181|FG000|Overall Study|Withdrawal by Subject|2|||
13194402|NCT02071290|26197242|FG000|Overall Study|Death|1|||
13194403|NCT02071290|26197243|FG001|Overall Study|Death|0|||
13194404|NCT02071290|26197242|FG000|Overall Study|Withdrawal by Subject|0|||
13194405|NCT02071290|26197243|FG001|Overall Study|Withdrawal by Subject|1|||
13194406|NCT02071290|26197242|FG000|Overall Study|Protocol Violation|3|||
13194407|NCT02071290|26197243|FG001|Overall Study|Protocol Violation|5|||
13194408|NCT02071290|26197242|FG000|Overall Study|Physician Decision|0|||
13194409|NCT02071290|26197243|FG001|Overall Study|Physician Decision|1|||
13194410|NCT02071225|26197263|FG000|Overall Study|Withdrawal of Consent|2|||
13194411|NCT02071225|26197263|FG000|Overall Study|Protocol Deviation|1|||
13194412|NCT02071225|26197263|FG000|Overall Study|Lost to Follow-up|2|||
13194413|NCT02071225|26197263|FG000|Overall Study|Death|25|||
13194414|NCT02071082|26197298|FG000|Overall Study|Enrolled and Never Treated|1|||
13194415|NCT02071082|26197299|FG001|Overall Study|Enrolled and Never Treated|1|||
13194416|NCT02071082|26197298|FG000|Overall Study|Adverse Event|0|||
13111998|NCT03167242|25906415|FG005|Overall Study|Lost to Follow-up|1|||
13111999|NCT03167242|25906416|FG006|Overall Study|Lost to Follow-up|2|||
13112000|NCT03167242|25906417|FG007|Overall Study|Lost to Follow-up|1|||
13112001|NCT03167242|25906418|FG008|Overall Study|Lost to Follow-up|0|||
13112002|NCT03167242|25906419|FG009|Overall Study|Lost to Follow-up|0|||
13112003|NCT03167242|25906420|FG010|Overall Study|Lost to Follow-up|1|||
13112004|NCT03167242|25906421|FG011|Overall Study|Lost to Follow-up|1|||
13112005|NCT03167242|25906410|FG000|Overall Study|Reason not provided|0|||
13112006|NCT03167242|25906411|FG001|Overall Study|Reason not provided|0|||
13112007|NCT03167242|25906412|FG002|Overall Study|Reason not provided|0|||
13112008|NCT03167242|25906413|FG003|Overall Study|Reason not provided|0|||
13112009|NCT03167242|25906414|FG004|Overall Study|Reason not provided|0|||
13112010|NCT03167242|25906415|FG005|Overall Study|Reason not provided|0|||
13112011|NCT03167242|25906416|FG006|Overall Study|Reason not provided|0|||
13194417|NCT02071082|26197299|FG001|Overall Study|Adverse Event|1|||
13194418|NCT02071082|26197298|FG000|Overall Study|Withdrew Consent|0|||
13194419|NCT02071082|26197299|FG001|Overall Study|Withdrew Consent|4|||
13194420|NCT02071082|26197298|FG000|Overall Study|Lost to Follow-up|1|||
13194421|NCT02071082|26197299|FG001|Overall Study|Lost to Follow-up|1|||
13194422|NCT02070991|26197326|FG000|Overall Study|Death|2|||
13194423|NCT02070991|26197327|FG001|Overall Study|Death|0|||
13194424|NCT02070991|26197326|FG000|Overall Study|Withdrawal by Subject|1|||
13194425|NCT02070991|26197327|FG001|Overall Study|Withdrawal by Subject|0|||
13194426|NCT02070978|26197396|FG000|Overall Study|Adverse Event|6|||
13194427|NCT02070978|26197397|FG001|Overall Study|Adverse Event|2|||
13194428|NCT02070978|26197398|FG002|Overall Study|Adverse Event|0|||
13194429|NCT02070978|26197396|FG000|Overall Study|Lost to Follow-up|1|||
13194430|NCT02070978|26197397|FG001|Overall Study|Lost to Follow-up|3|||
13194431|NCT02070978|26197398|FG002|Overall Study|Lost to Follow-up|4|||
13194432|NCT02070978|26197396|FG000|Overall Study|Withdrawal by Subject|3|||
13194433|NCT02070978|26197397|FG001|Overall Study|Withdrawal by Subject|5|||
13194434|NCT02070978|26197398|FG002|Overall Study|Withdrawal by Subject|3|||
13194435|NCT02070978|26197396|FG000|Overall Study|Protocol Violation|1|||
13194436|NCT02070978|26197397|FG001|Overall Study|Protocol Violation|0|||
13194437|NCT02070978|26197398|FG002|Overall Study|Protocol Violation|3|||
13194438|NCT02070978|26197396|FG000|Overall Study|Lack of Efficacy|0|||
13194439|NCT02070978|26197397|FG001|Overall Study|Lack of Efficacy|1|||
13194440|NCT02070978|26197398|FG002|Overall Study|Lack of Efficacy|0|||
13194441|NCT02070978|26197396|FG000|Overall Study|Death|0|||
13194442|NCT02070978|26197397|FG001|Overall Study|Death|0|||
13194443|NCT02070978|26197398|FG002|Overall Study|Death|2|||
13194444|NCT02070978|26197396|FG000|Overall Study|Un-specified|3|||
13194445|NCT02070978|26197397|FG001|Overall Study|Un-specified|2|||
13194446|NCT02070978|26197398|FG002|Overall Study|Un-specified|2|||
13194447|NCT02070978|26197396|FG000|Overall Study|Terminated by Sponsor|33|||
13194448|NCT02070978|26197397|FG001|Overall Study|Terminated by Sponsor|40|||
13194449|NCT02070978|26197398|FG002|Overall Study|Terminated by Sponsor|39|||
13194450|NCT02070965|26197416|FG000|Overall Study|Lost to Follow-up|0|||
13194451|NCT02070965|26197417|FG001|Overall Study|Lost to Follow-up|1|||
13194452|NCT02070965|26197418|FG002|Overall Study|Lost to Follow-up|0|||
13194453|NCT02070965|26197416|FG000|Overall Study|Withdrawal by Subject|1|||
13194454|NCT02070965|26197417|FG001|Overall Study|Withdrawal by Subject|1|||
13194455|NCT02070965|26197418|FG002|Overall Study|Withdrawal by Subject|1|||
13194456|NCT02070965|26197416|FG000|Overall Study|Subject moved|1|||
13194457|NCT02070965|26197417|FG001|Overall Study|Subject moved|0|||
13194458|NCT02070965|26197418|FG002|Overall Study|Subject moved|0|||
13194459|NCT02070757|26197455|FG000|Overall Study|Adverse Event|107|||
13194460|NCT02070757|26197456|FG001|Overall Study|Adverse Event|99|||
13194461|NCT02070757|26197455|FG000|Overall Study|Lost to Follow-up|7|||
13194462|NCT02070757|26197456|FG001|Overall Study|Lost to Follow-up|4|||
13194463|NCT02070757|26197455|FG000|Overall Study|Protocol Violation|0|||
13194464|NCT02070757|26197456|FG001|Overall Study|Protocol Violation|4|||
13194465|NCT02070757|26197455|FG000|Overall Study|Withdrawal by Subject|1|||
13112012|NCT03167242|25906417|FG007|Overall Study|Reason not provided|0|||
13194466|NCT02070757|26197456|FG001|Overall Study|Withdrawal by Subject|3|||
13194467|NCT02070757|26197455|FG000|Overall Study|Investigator Decision|0|||
13194468|NCT02070757|26197456|FG001|Overall Study|Investigator Decision|2|||
13194469|NCT02070757|26197455|FG000|Overall Study|Discharged from Study Hospital|2|||
13194470|NCT02070757|26197456|FG001|Overall Study|Discharged from Study Hospital|2|||
13194471|NCT02070744|26197520|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0|||
13194472|NCT02070744|26197521|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0|||
13194473|NCT02070744|26197522|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0|||
13194474|NCT02070744|26197523|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1|||
13194475|NCT02070744|26197524|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0|||
13194476|NCT02070744|26197520|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
13194477|NCT02070744|26197521|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
13194478|NCT02070744|26197522|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
13194479|NCT02070744|26197523|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
13194480|NCT02070744|26197524|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2|||
13194481|NCT02070744|26197520|FG000|OLE Phase (48 Weeks)|Other|0|||
13194482|NCT02070744|26197521|FG001|OLE Phase (48 Weeks)|Other|0|||
13194483|NCT02070744|26197522|FG002|OLE Phase (48 Weeks)|Other|0|||
13194484|NCT02070744|26197523|FG003|OLE Phase (48 Weeks)|Other|0|||
13194485|NCT02070744|26197524|FG004|OLE Phase (48 Weeks)|Other|1|||
13194486|NCT02070588|26197548|FG000|Overall Study|Withdrawal by Subject|29|||
13194487|NCT02070588|26197549|FG001|Overall Study|Withdrawal by Subject|1|||
13194488|NCT02070588|26197550|FG002|Overall Study|Withdrawal by Subject|0|||
13194489|NCT02070588|26197548|FG000|Overall Study|Writhdrawal due to early termination|9|||
13194490|NCT02070588|26197549|FG001|Overall Study|Writhdrawal due to early termination|0|||
13194491|NCT02070588|26197550|FG002|Overall Study|Writhdrawal due to early termination|0|||
13194492|NCT02070588|26197548|FG000|Overall Study|Adverse Event|1|||
13194493|NCT02070588|26197549|FG001|Overall Study|Adverse Event|0|||
13194494|NCT02070588|26197550|FG002|Overall Study|Adverse Event|0|||
13194495|NCT02070484|26197575|FG000|Overall Study|Withdrawal by Subject|1|||
13194496|NCT02070484|26197576|FG001|Overall Study|Withdrawal by Subject|0|||
13194497|NCT02070380|26197637|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0|||
13194498|NCT02070380|26197638|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5|||
13194499|NCT02070380|26197639|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2|||
13194500|NCT02070380|26197640|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3|||
13194501|NCT02070380|26197637|FG000|Second Injection|Image sets missing or technically inadeq|0|||
13194502|NCT02070380|26197638|FG001|Second Injection|Image sets missing or technically inadeq|1|||
13194503|NCT02070380|26197639|FG002|Second Injection|Image sets missing or technically inadeq|0|||
13194504|NCT02070380|26197640|FG003|Second Injection|Image sets missing or technically inadeq|0|||
13194505|NCT02070380|26197637|FG000|Second Injection|Protocol Violation|0|||
13194506|NCT02070380|26197638|FG001|Second Injection|Protocol Violation|1|||
13194507|NCT02070380|26197639|FG002|Second Injection|Protocol Violation|1|||
13194508|NCT02070380|26197640|FG003|Second Injection|Protocol Violation|5|||
13194509|NCT02069899|26197673|FG000|Overall Study|Adverse Event|6|||
13194510|NCT02069899|26197674|FG001|Overall Study|Adverse Event|0|||
13194511|NCT02069899|26197675|FG002|Overall Study|Adverse Event|1|||
13194512|NCT02069899|26197673|FG000|Overall Study|Withdrawal by Participant|2|||
13194513|NCT02069899|26197674|FG001|Overall Study|Withdrawal by Participant|0|||
13194514|NCT02069899|26197675|FG002|Overall Study|Withdrawal by Participant|0|||
13194515|NCT02069899|26197673|FG000|Overall Study|Lost to Follow-up|1|||
13194516|NCT02069899|26197674|FG001|Overall Study|Lost to Follow-up|0|||
13194517|NCT02069899|26197675|FG002|Overall Study|Lost to Follow-up|1|||
13194518|NCT02069899|26197673|FG000|Overall Study|Other|4|||
13194519|NCT02069899|26197674|FG001|Overall Study|Other|0|||
13194520|NCT02069899|26197675|FG002|Overall Study|Other|0|||
13194521|NCT02069899|26197673|FG000|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
13194522|NCT02069899|26197674|FG001|Overall Study|Participant could not travel to the study site due to Covid restrictions|1|||
13194523|NCT02069899|26197675|FG002|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
13194524|NCT02069899|26197673|FG000|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
13194525|NCT02069899|26197674|FG001|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
13194526|NCT02069899|26197675|FG002|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|1|||
13194527|NCT02069392|26197704|FG000|Overall Study|Withdrawal by Subject|4|||
13194528|NCT02069392|26197705|FG001|Overall Study|Withdrawal by Subject|2|||
13194529|NCT02069379|26197740|FG000|Baseline Measurements|Lost to Follow-up|1|||
13194530|NCT02069379|26197741|FG001|Baseline Measurements|Lost to Follow-up|0|||
13194531|NCT02069379|26197742|FG002|Baseline Measurements|Lost to Follow-up|0|||
13194532|NCT02069379|26197743|FG003|Baseline Measurements|Lost to Follow-up|0|||
13194533|NCT02069379|26197740|FG000|Baseline Measurements|Ineligible based on initial assessments|2|||
13194534|NCT02069379|26197741|FG001|Baseline Measurements|Ineligible based on initial assessments|0|||
13194535|NCT02069379|26197742|FG002|Baseline Measurements|Ineligible based on initial assessments|0|||
13194536|NCT02069379|26197743|FG003|Baseline Measurements|Ineligible based on initial assessments|2|||
13194537|NCT02069379|26197740|FG000|First Treatment Arm|Lost to Follow-up|0|||
13194538|NCT02069379|26197741|FG001|First Treatment Arm|Lost to Follow-up|1|||
13194539|NCT02069379|26197742|FG002|First Treatment Arm|Lost to Follow-up|1|||
13194540|NCT02069379|26197743|FG003|First Treatment Arm|Lost to Follow-up|0|||
13194541|NCT02069379|26197740|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0|||
13194542|NCT02069379|26197741|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
13194543|NCT02069379|26197742|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0|||
13194544|NCT02069379|26197743|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0|||
13194545|NCT02069379|26197740|FG000|Washout Period (4 Weeks)|Unrelated event|0|||
13194546|NCT02069379|26197741|FG001|Washout Period (4 Weeks)|Unrelated event|1|||
13194547|NCT02069379|26197742|FG002|Washout Period (4 Weeks)|Unrelated event|0|||
13194548|NCT02069379|26197743|FG003|Washout Period (4 Weeks)|Unrelated event|0|||
13194549|NCT02069379|26197740|FG000|Second Treatment Arm|Lost to Follow-up|0|||
13194550|NCT02069379|26197741|FG001|Second Treatment Arm|Lost to Follow-up|0|||
13194551|NCT02069379|26197742|FG002|Second Treatment Arm|Lost to Follow-up|1|||
13194552|NCT02069379|26197743|FG003|Second Treatment Arm|Lost to Follow-up|0|||
13194553|NCT02069366|26197788|FG000|Overall Study|Lost to Follow-up|0|||
13194554|NCT02069366|26197789|FG001|Overall Study|Lost to Follow-up|0|||
13194555|NCT02069366|26197790|FG002|Overall Study|Lost to Follow-up|1|||
13194556|NCT02069366|26197791|FG003|Overall Study|Lost to Follow-up|0|||
13194557|NCT02069366|26197792|FG004|Overall Study|Lost to Follow-up|0|||
13194558|NCT02069366|26197793|FG005|Overall Study|Lost to Follow-up|2|||
13194559|NCT02069366|26197788|FG000|Overall Study|Protocol Violation|0|||
13194560|NCT02069366|26197789|FG001|Overall Study|Protocol Violation|0|||
13194561|NCT02069366|26197790|FG002|Overall Study|Protocol Violation|1|||
13194562|NCT02069366|26197791|FG003|Overall Study|Protocol Violation|0|||
13194563|NCT02069366|26197792|FG004|Overall Study|Protocol Violation|0|||
13194564|NCT02069366|26197793|FG005|Overall Study|Protocol Violation|0|||
13194565|NCT02069366|26197788|FG000|Overall Study|Withdrawal by Subject|1|||
13194566|NCT02069366|26197789|FG001|Overall Study|Withdrawal by Subject|0|||
13194567|NCT02069366|26197790|FG002|Overall Study|Withdrawal by Subject|1|||
13194568|NCT02069366|26197791|FG003|Overall Study|Withdrawal by Subject|2|||
13194569|NCT02069366|26197792|FG004|Overall Study|Withdrawal by Subject|0|||
13194570|NCT02069366|26197793|FG005|Overall Study|Withdrawal by Subject|0|||
13194571|NCT02069093|26197804|FG000|Overall Study|Disease progression|14|||
13194572|NCT02069093|26197804|FG000|Overall Study|New cancer therapy|1|||
13194573|NCT02069093|26197804|FG000|Overall Study|Death|1|||
13194574|NCT02069093|26197804|FG000|Overall Study|Administrative problems|1|||
13194575|NCT02069093|26197804|FG000|Overall Study|Withdrawal by Subject|2|||
13194576|NCT02069093|26197804|FG000|Overall Study|Abnormal laboratory values|1|||
13194577|NCT02069093|26197804|FG000|Overall Study|Adverse Event|10|||
13194578|NCT02069015|26197818|FG000|Overall Study|Lost to Follow-up|39|||
13194579|NCT02069015|26197819|FG001|Overall Study|Lost to Follow-up|32|||
13194580|NCT02069015|26197818|FG000|Overall Study|Withdrawal by Subject|1|||
13194581|NCT02069015|26197819|FG001|Overall Study|Withdrawal by Subject|1|||
13194582|NCT02068885|26197949|FG000|Overall Study|Withdrew|3|||
13194583|NCT02068885|26197950|FG001|Overall Study|Withdrew|5|||
13194584|NCT02068885|26197951|FG002|Overall Study|Withdrew|8|||
13194585|NCT02068768|26197959|FG000|Overall Study|Lost to Follow-up|5|||
13194586|NCT02068768|26197959|FG000|Overall Study|Early Termination by Sponsor|2|||
13206381|NCT01957644|26234625|FG003|Overall Study|Other reason|1|||
13206382|NCT01957644|26234626|FG004|Overall Study|Other reason|0|||
13206383|NCT01957644|26234622|FG000|Overall Study|Withdrawal by Subject|1|||
13206384|NCT01957644|26234623|FG001|Overall Study|Withdrawal by Subject|0|||
13206385|NCT01957644|26234624|FG002|Overall Study|Withdrawal by Subject|0|||
13206386|NCT01957644|26234625|FG003|Overall Study|Withdrawal by Subject|0|||
13206387|NCT01957644|26234626|FG004|Overall Study|Withdrawal by Subject|0|||
13206388|NCT01957644|26234622|FG000|Overall Study|Protocol Violation|0|||
13206389|NCT01957644|26234623|FG001|Overall Study|Protocol Violation|1|||
13206390|NCT01957644|26234624|FG002|Overall Study|Protocol Violation|0|||
13206391|NCT01957644|26234625|FG003|Overall Study|Protocol Violation|0|||
13206392|NCT01957644|26234626|FG004|Overall Study|Protocol Violation|0|||
13206393|NCT01957579|26234706|FG000|Overall Study|Withdrawal of concent|0|||
13206394|NCT01957579|26234707|FG001|Overall Study|Withdrawal of concent|1|||
13206395|NCT01957579|26234708|FG002|Overall Study|Withdrawal of concent|0|||
13206396|NCT01957579|26234709|FG003|Overall Study|Withdrawal of concent|0|||
13206397|NCT01957579|26234706|FG000|Overall Study|Death|0|||
13206398|NCT01957579|26234707|FG001|Overall Study|Death|0|||
13206399|NCT01957579|26234708|FG002|Overall Study|Death|2|||
13206400|NCT01957579|26234709|FG003|Overall Study|Death|0|||
13206401|NCT01957553|26234718|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2|||
13206402|NCT01957553|26234719|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3|||
13206403|NCT01957553|26234718|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2|||
13206404|NCT01957553|26234719|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0|||
13206405|NCT01957553|26234718|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2|||
13206406|NCT01957553|26234719|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0|||
13206407|NCT01957553|26234718|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1|||
13206408|NCT01957553|26234719|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0|||
13194587|NCT02068599|26198007|FG000|Overall Study|Adverse Event|4|||
13194588|NCT02068599|26198008|FG001|Overall Study|Adverse Event|1|||
13194589|NCT02068599|26198009|FG002|Overall Study|Adverse Event|1|||
13194590|NCT02068599|26198007|FG000|Overall Study|Withdrawal by Subject|2|||
13194591|NCT02068599|26198008|FG001|Overall Study|Withdrawal by Subject|7|||
13194592|NCT02068599|26198009|FG002|Overall Study|Withdrawal by Subject|5|||
13194593|NCT02068599|26198007|FG000|Overall Study|Protocol Violation|4|||
13194594|NCT02068599|26198008|FG001|Overall Study|Protocol Violation|2|||
13194595|NCT02068599|26198009|FG002|Overall Study|Protocol Violation|3|||
13194596|NCT02068599|26198007|FG000|Overall Study|Lost to Follow-up|1|||
13194597|NCT02068599|26198008|FG001|Overall Study|Lost to Follow-up|0|||
13194598|NCT02068599|26198009|FG002|Overall Study|Lost to Follow-up|0|||
13194599|NCT02068599|26198007|FG000|Overall Study|Lack of Efficacy|0|||
13194600|NCT02068599|26198008|FG001|Overall Study|Lack of Efficacy|0|||
13194601|NCT02068599|26198009|FG002|Overall Study|Lack of Efficacy|3|||
13194602|NCT02068599|26198007|FG000|Overall Study|Noncompliance|0|||
13194603|NCT02068599|26198008|FG001|Overall Study|Noncompliance|0|||
13194604|NCT02068599|26198009|FG002|Overall Study|Noncompliance|1|||
13194605|NCT02068547|26198026|FG000|Overall Study|Lost to Follow-up|3|||
13194606|NCT02068547|26198027|FG001|Overall Study|Lost to Follow-up|3|||
13194607|NCT02068547|26198026|FG000|Overall Study|Physician Decision|1|||
13194608|NCT02068547|26198027|FG001|Overall Study|Physician Decision|0|||
13194609|NCT02068508|26198039|FG000|Overall Study|Case report forms uncollected|27|||
13194610|NCT02068508|26198039|FG000|Overall Study|Patient did not visit the study site|1|||
13194611|NCT02068508|26198039|FG000|Overall Study|Protocol Violation|4|||
13194612|NCT02068495|26198050|FG000|Overall Study|Case Report Forms Uncollected|60|||
13194613|NCT02068495|26198050|FG000|Overall Study|Protocol Deviation|49|||
13194614|NCT02068443|26198095|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
13194615|NCT02068443|26198096|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
13194616|NCT02068443|26198097|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
13194617|NCT02068443|26198095|FG000|Overall Study|Voluntary Withdrawal|4|||
13194618|NCT02068443|26198096|FG001|Overall Study|Voluntary Withdrawal|0|||
13194619|NCT02068443|26198097|FG002|Overall Study|Voluntary Withdrawal|1|||
13194620|NCT02068443|26198095|FG000|Overall Study|Lack of Efficacy|2|||
13194621|NCT02068443|26198096|FG001|Overall Study|Lack of Efficacy|1|||
13194622|NCT02068443|26198097|FG002|Overall Study|Lack of Efficacy|0|||
13194623|NCT02068443|26198095|FG000|Overall Study|Other Reason Not Specified|1|||
13194624|NCT02068443|26198096|FG001|Overall Study|Other Reason Not Specified|0|||
13194625|NCT02068443|26198097|FG002|Overall Study|Other Reason Not Specified|0|||
13194626|NCT02068352|26198139|FG000|Overall Study|Lost to Follow-up|0|||
13194627|NCT02068352|26198140|FG001|Overall Study|Lost to Follow-up|2|||
13194628|NCT02068352|26198141|FG002|Overall Study|Lost to Follow-up|0|||
13194629|NCT02068352|26198139|FG000|Overall Study|Adverse Event|4|||
13194630|NCT02068352|26198140|FG001|Overall Study|Adverse Event|2|||
13194631|NCT02068352|26198141|FG002|Overall Study|Adverse Event|7|||
13194632|NCT02068352|26198139|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
13194633|NCT02068352|26198140|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1|||
13194634|NCT02068352|26198141|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
13194635|NCT02068352|26198139|FG000|Overall Study|Participant Withdrew Consent to Participate|6|||
13194636|NCT02068352|26198140|FG001|Overall Study|Participant Withdrew Consent to Participate|3|||
13194637|NCT02068352|26198141|FG002|Overall Study|Participant Withdrew Consent to Participate|1|||
13194638|NCT02068352|26198139|FG000|Overall Study|Protocol Deviation|0|||
13194639|NCT02068352|26198140|FG001|Overall Study|Protocol Deviation|0|||
13194640|NCT02068352|26198141|FG002|Overall Study|Protocol Deviation|1|||
13194641|NCT02068222|26198150|FG000|Overall Study|Lost to Follow-up|1|||
13194642|NCT02068118|26198203|FG000|18-month Comparative Study Period|Death|90|||
13194643|NCT02068118|26198204|FG001|18-month Comparative Study Period|Death|97|||
13194644|NCT02068118|26198203|FG000|18-month Comparative Study Period|Withdrawal by Subject|23|||
13194645|NCT02068118|26198204|FG001|18-month Comparative Study Period|Withdrawal by Subject|52|||
13194646|NCT02068118|26198203|FG000|18-month Comparative Study Period|Lost to Follow-up|6|||
13194647|NCT02068118|26198204|FG001|18-month Comparative Study Period|Lost to Follow-up|7|||
13194648|NCT02068118|26198203|FG000|18-month Comparative Study Period|Heart transplant|9|||
13194649|NCT02068118|26198204|FG001|18-month Comparative Study Period|Heart transplant|15|||
13194650|NCT02068118|26198203|FG000|18-month Comparative Study Period|Inclusion in another protocol|0|||
13194651|NCT02068118|26198204|FG001|18-month Comparative Study Period|Inclusion in another protocol|2|||
13194652|NCT02068118|26198203|FG000|18-month Comparative Study Period|Hemiplegia|0|||
13194653|NCT02068118|26198204|FG001|18-month Comparative Study Period|Hemiplegia|1|||
13194654|NCT02068118|26198203|FG000|18-month Comparative Study Period|Alzheimer's disease|0|||
13194655|NCT02068118|26198204|FG001|18-month Comparative Study Period|Alzheimer's disease|1|||
13194656|NCT02068118|26198203|FG000|18-month Comparative Study Period|Move|0|||
13194657|NCT02068118|26198204|FG001|18-month Comparative Study Period|Move|1|||
13194658|NCT02068118|26198203|FG000|18-month Comparative Study Period|Hearing loss|0|||
13194659|NCT02068118|26198204|FG001|18-month Comparative Study Period|Hearing loss|1|||
13194660|NCT02068118|26198203|FG000|Extension Period|Death|0|||
13194661|NCT02068118|26198204|FG001|Extension Period|Death|2|||
13194662|NCT02068118|26198203|FG000|Extension Period|Withdrawal by Subject|1|||
13194663|NCT02068118|26198204|FG001|Extension Period|Withdrawal by Subject|0|||
13194664|NCT02068118|26198203|FG000|Extension Period|Heart transplant|1|||
13194665|NCT02068118|26198204|FG001|Extension Period|Heart transplant|0|||
13194666|NCT02068118|26198203|FG000|Extension Period|Wrong device use|0|||
13194667|NCT02068118|26198204|FG001|Extension Period|Wrong device use|1|||
13194668|NCT02067728|26198239|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7|||
13194669|NCT02067728|26198240|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28|||
13194670|NCT02067728|26198239|FG000|6 Month Follow up Survey|Lost to Follow-up|48|||
13194671|NCT02067728|26198240|FG001|6 Month Follow up Survey|Lost to Follow-up|60|||
13194672|NCT02067728|26198239|FG000|6 Month Measurements|Unable to attend|114|||
13194673|NCT02067728|26198240|FG001|6 Month Measurements|Unable to attend|97|||
13194674|NCT02067676|26198297|FG000|Overall Study|Withdrawal by Subject|1|||
13194675|NCT02067676|26198298|FG001|Overall Study|Withdrawal by Subject|0|||
13194676|NCT02067676|26198299|FG002|Overall Study|Withdrawal by Subject|0|||
13194677|NCT02067676|26198300|FG003|Overall Study|Withdrawal by Subject|0|||
13194678|NCT02067676|26198301|FG004|Overall Study|Withdrawal by Subject|0|||
13194679|NCT02067676|26198302|FG005|Overall Study|Withdrawal by Subject|0|||
13194680|NCT02067663|26198329|FG000|Overall Study|Lost to Follow-up|13|||
13194681|NCT02067663|26198330|FG001|Overall Study|Lost to Follow-up|14|||
13194682|NCT02067533|26198343|FG000|Overall Study|Lost to Follow-up|4|||
13194683|NCT02067533|26198344|FG001|Overall Study|Lost to Follow-up|2|||
13194684|NCT02067104|26198359|FG000|Overall Study|Study termination due to low accrual|4|||
13194685|NCT02067104|26198360|FG001|Overall Study|Study termination due to low accrual|5|||
13194686|NCT02066922|26198370|FG000|Overall Study|Adverse Event|1|||
13194687|NCT02066467|26198378|FG000|Overall Study|Did not undergo implant procedure|24|||
13194688|NCT02066467|26198378|FG000|Overall Study|Attempted to implant withoput success|43|||
13194689|NCT02066467|26198378|FG000|Overall Study|Consent ineligible|1|||
13194690|NCT02066467|26198378|FG000|Overall Study|Death|54|||
13194691|NCT02066467|26198378|FG000|Overall Study|Lost to Follow-up|51|||
13194692|NCT02066467|26198378|FG000|Overall Study|Adverse Event|20|||
13194693|NCT02066467|26198378|FG000|Overall Study|Withdrawal by Subject|16|||
13194694|NCT02066467|26198378|FG000|Overall Study|Physician Decision|2|||
13194695|NCT02066467|26198378|FG000|Overall Study|Not defined|4|||
13194696|NCT02066402|26198411|FG000|Overall Study|Adverse Event|1|||
13194697|NCT02066402|26198412|FG001|Overall Study|Adverse Event|2|||
13194698|NCT02066402|26198411|FG000|Overall Study|Lost to Follow-up|11|||
13194699|NCT02066402|26198412|FG001|Overall Study|Lost to Follow-up|8|||
13194700|NCT02066402|26198411|FG000|Overall Study|Withdrawal by Subject|14|||
13194701|NCT02066402|26198412|FG001|Overall Study|Withdrawal by Subject|11|||
13194702|NCT02066402|26198411|FG000|Overall Study|Progressive disease-clinical progression|0|||
13194703|NCT02066402|26198412|FG001|Overall Study|Progressive disease-clinical progression|1|||
13194704|NCT02066402|26198411|FG000|Overall Study|Protocol driven decision point|0|||
13194705|NCT02066402|26198412|FG001|Overall Study|Protocol driven decision point|1|||
13194706|NCT02066389|26198481|FG000|Overall Study|Adverse Event|1|||
13194707|NCT02066389|26198482|FG001|Overall Study|Adverse Event|1|||
13194708|NCT02066389|26198483|FG002|Overall Study|Adverse Event|1|||
13194709|NCT02066389|26198484|FG003|Overall Study|Adverse Event|1|||
13194710|NCT02066389|26198485|FG004|Overall Study|Adverse Event|5|||
13194711|NCT02066389|26198486|FG005|Overall Study|Adverse Event|1|||
13194712|NCT02066389|26198481|FG000|Overall Study|Withdrawal by Subject|4|||
13194713|NCT02066389|26198482|FG001|Overall Study|Withdrawal by Subject|0|||
13194714|NCT02066389|26198483|FG002|Overall Study|Withdrawal by Subject|5|||
13194715|NCT02066389|26198484|FG003|Overall Study|Withdrawal by Subject|1|||
13194716|NCT02066389|26198485|FG004|Overall Study|Withdrawal by Subject|1|||
13194717|NCT02066389|26198486|FG005|Overall Study|Withdrawal by Subject|2|||
13194718|NCT02066389|26198481|FG000|Overall Study|Lost to Follow-up|0|||
13194719|NCT02066389|26198482|FG001|Overall Study|Lost to Follow-up|0|||
13194720|NCT02066389|26198483|FG002|Overall Study|Lost to Follow-up|0|||
13194721|NCT02066389|26198484|FG003|Overall Study|Lost to Follow-up|1|||
13194722|NCT02066389|26198485|FG004|Overall Study|Lost to Follow-up|1|||
13194723|NCT02066389|26198486|FG005|Overall Study|Lost to Follow-up|1|||
13194724|NCT02066389|26198481|FG000|Overall Study|Randomized in Error|0|||
13194725|NCT02066389|26198482|FG001|Overall Study|Randomized in Error|0|||
13194726|NCT02066389|26198483|FG002|Overall Study|Randomized in Error|0|||
13194727|NCT02066389|26198484|FG003|Overall Study|Randomized in Error|0|||
13194728|NCT02066389|26198485|FG004|Overall Study|Randomized in Error|0|||
13194729|NCT02066389|26198486|FG005|Overall Study|Randomized in Error|1|||
13194730|NCT02066311|26198492|FG000|Overall Study|Adverse Event|4|||
13194731|NCT02066311|26198492|FG000|Overall Study|Withdrawal by Subject|1|||
13194732|NCT02066298|26198533|FG000|Overall Study|Lost to Follow-up|3|||
13194733|NCT02066298|26198534|FG001|Overall Study|Lost to Follow-up|2|||
13194734|NCT02066298|26198535|FG002|Overall Study|Lost to Follow-up|3|||
13194735|NCT02066298|26198536|FG003|Overall Study|Lost to Follow-up|2|||
13194736|NCT02066298|26198537|FG004|Overall Study|Lost to Follow-up|3|||
13194737|NCT02066298|26198538|FG005|Overall Study|Lost to Follow-up|4|||
13194738|NCT02066298|26198533|FG000|Overall Study|Withdrawal by Subject|6|||
13194739|NCT02066298|26198534|FG001|Overall Study|Withdrawal by Subject|6|||
13194740|NCT02066298|26198535|FG002|Overall Study|Withdrawal by Subject|6|||
13194741|NCT02066298|26198536|FG003|Overall Study|Withdrawal by Subject|4|||
13194742|NCT02066298|26198537|FG004|Overall Study|Withdrawal by Subject|5|||
13194743|NCT02066298|26198538|FG005|Overall Study|Withdrawal by Subject|8|||
13194744|NCT02066298|26198533|FG000|Overall Study|Physician Decision|0|||
13194745|NCT02066298|26198534|FG001|Overall Study|Physician Decision|0|||
13194746|NCT02066298|26198535|FG002|Overall Study|Physician Decision|1|||
13194747|NCT02066298|26198536|FG003|Overall Study|Physician Decision|0|||
13194748|NCT02066298|26198537|FG004|Overall Study|Physician Decision|1|||
13194749|NCT02066298|26198538|FG005|Overall Study|Physician Decision|0|||
13194750|NCT02066233|26198553|FG000|EG Scan II (Day 1)|difficulty intubating subject|6|||
13194751|NCT02066233|26198554|FG001|EG Scan II (Day 1)|difficulty intubating subject|6|||
13194754|NCT02066129|26198603|FG000|Overall Study|Lost to Follow-up|13|||
13194755|NCT02066129|26198604|FG001|Overall Study|Lost to Follow-up|12|||
13194756|NCT02066129|26198603|FG000|Overall Study|Withdrawal by Subject|7|||
13194757|NCT02066129|26198604|FG001|Overall Study|Withdrawal by Subject|10|||
13194758|NCT02066129|26198603|FG000|Overall Study|Lack of Efficacy|8|||
13194759|NCT02066129|26198604|FG001|Overall Study|Lack of Efficacy|10|||
13194760|NCT02066129|26198603|FG000|Overall Study|Physician Decision|1|||
13194761|NCT02066129|26198604|FG001|Overall Study|Physician Decision|1|||
13194762|NCT02066051|26198611|FG000|Overall Study|Subject developed active GVHD|1|||
13194763|NCT02065895|26198635|FG000|Overall Study|Protocol Violation|1|||
13194764|NCT02065895|26198636|FG001|Overall Study|Protocol Violation|0|||
13194765|NCT02065895|26198637|FG002|Overall Study|Protocol Violation|0|||
13194766|NCT02065895|26198638|FG003|Overall Study|Protocol Violation|1|||
13194767|NCT02065895|26198639|FG004|Overall Study|Protocol Violation|0|||
13194768|NCT02065895|26198640|FG005|Overall Study|Protocol Violation|0|||
13194769|NCT02065895|26198635|FG000|Overall Study|Scheduling conflicts|0|||
13194770|NCT02065895|26198636|FG001|Overall Study|Scheduling conflicts|1|||
13194771|NCT02065895|26198637|FG002|Overall Study|Scheduling conflicts|0|||
13194772|NCT02065895|26198638|FG003|Overall Study|Scheduling conflicts|0|||
13194773|NCT02065895|26198639|FG004|Overall Study|Scheduling conflicts|0|||
13194774|NCT02065895|26198640|FG005|Overall Study|Scheduling conflicts|0|||
13194775|NCT02065791|26198667|FG000|Overall Study|Closed Site|1|||
13194776|NCT02065791|26198668|FG001|Overall Study|Closed Site|1|||
13194777|NCT02065791|26198667|FG000|Overall Study|Withdrawal by Subject|11|||
13194778|NCT02065791|26198668|FG001|Overall Study|Withdrawal by Subject|5|||
13194779|NCT02065791|26198667|FG000|Overall Study|Lost to Follow-up|13|||
13194780|NCT02065791|26198668|FG001|Overall Study|Lost to Follow-up|9|||
13194781|NCT02065713|26198681|FG000|Overall Study|Adverse Event|0|||
13194782|NCT02065713|26198682|FG001|Overall Study|Adverse Event|1|||
13194783|NCT02065713|26198681|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
13194784|NCT02065713|26198682|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
13194785|NCT02065622|26198791|FG000|Induction Study|Adverse Event|13|||
13194786|NCT02065622|26198792|FG001|Induction Study|Adverse Event|19|||
13194787|NCT02065622|26198793|FG002|Induction Study|Adverse Event|0|||
13194788|NCT02065622|26198794|FG003|Induction Study|Adverse Event|0|||
13194789|NCT02065622|26198795|FG004|Induction Study|Adverse Event|0|||
13194790|NCT02065622|26198791|FG000|Induction Study|Withdrawal by Subject|3|||
13194791|NCT02065622|26198792|FG001|Induction Study|Withdrawal by Subject|5|||
13194792|NCT02065622|26198793|FG002|Induction Study|Withdrawal by Subject|0|||
13194793|NCT02065622|26198794|FG003|Induction Study|Withdrawal by Subject|0|||
13194794|NCT02065622|26198795|FG004|Induction Study|Withdrawal by Subject|0|||
13194795|NCT02065622|26198791|FG000|Induction Study|Lost to Follow-up|1|||
13194796|NCT02065622|26198792|FG001|Induction Study|Lost to Follow-up|0|||
13194797|NCT02065622|26198793|FG002|Induction Study|Lost to Follow-up|0|||
13194798|NCT02065622|26198794|FG003|Induction Study|Lost to Follow-up|0|||
13194799|NCT02065622|26198795|FG004|Induction Study|Lost to Follow-up|0|||
13194800|NCT02065622|26198791|FG000|Induction Study|Lack of Efficacy|22|||
13194801|NCT02065622|26198792|FG001|Induction Study|Lack of Efficacy|27|||
13194802|NCT02065622|26198793|FG002|Induction Study|Lack of Efficacy|0|||
13194803|NCT02065622|26198794|FG003|Induction Study|Lack of Efficacy|0|||
13194804|NCT02065622|26198795|FG004|Induction Study|Lack of Efficacy|0|||
13194805|NCT02065622|26198791|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4|||
13194806|NCT02065622|26198792|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5|||
13194807|NCT02065622|26198793|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0|||
13194808|NCT02065622|26198794|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0|||
13194809|NCT02065622|26198795|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0|||
13194810|NCT02065622|26198791|FG000|Induction Study|Subject Noncompliance|1|||
13194811|NCT02065622|26198792|FG001|Induction Study|Subject Noncompliance|1|||
13194812|NCT02065622|26198793|FG002|Induction Study|Subject Noncompliance|0|||
13194813|NCT02065622|26198794|FG003|Induction Study|Subject Noncompliance|0|||
13194814|NCT02065622|26198795|FG004|Induction Study|Subject Noncompliance|0|||
13194815|NCT02065622|26198791|FG000|Induction Study|Other, Not Specified|3|||
13194816|NCT02065622|26198792|FG001|Induction Study|Other, Not Specified|2|||
13194817|NCT02065622|26198793|FG002|Induction Study|Other, Not Specified|0|||
13194818|NCT02065622|26198794|FG003|Induction Study|Other, Not Specified|0|||
13194819|NCT02065622|26198795|FG004|Induction Study|Other, Not Specified|0|||
13194820|NCT02065622|26198791|FG000|Maintenance Study|Adverse Event|0|||
13194821|NCT02065622|26198792|FG001|Maintenance Study|Adverse Event|0|||
13194822|NCT02065622|26198793|FG002|Maintenance Study|Adverse Event|25|||
13194823|NCT02065622|26198794|FG003|Maintenance Study|Adverse Event|22|||
13194824|NCT02065622|26198795|FG004|Maintenance Study|Adverse Event|11|||
13194825|NCT02065622|26198791|FG000|Maintenance Study|Withdrawal by Subject|0|||
13194826|NCT02065622|26198792|FG001|Maintenance Study|Withdrawal by Subject|0|||
13194827|NCT02065622|26198793|FG002|Maintenance Study|Withdrawal by Subject|11|||
13194828|NCT02065622|26198794|FG003|Maintenance Study|Withdrawal by Subject|5|||
13194829|NCT02065622|26198795|FG004|Maintenance Study|Withdrawal by Subject|7|||
13194830|NCT02065622|26198791|FG000|Maintenance Study|Lost to Follow-up|0|||
13194831|NCT02065622|26198792|FG001|Maintenance Study|Lost to Follow-up|0|||
13194832|NCT02065622|26198793|FG002|Maintenance Study|Lost to Follow-up|4|||
13194833|NCT02065622|26198794|FG003|Maintenance Study|Lost to Follow-up|1|||
13194834|NCT02065622|26198795|FG004|Maintenance Study|Lost to Follow-up|1|||
13194835|NCT02065622|26198791|FG000|Maintenance Study|Lack of Efficacy|0|||
13112013|NCT03167242|25906418|FG008|Overall Study|Reason not provided|1|||
13112014|NCT03167242|25906419|FG009|Overall Study|Reason not provided|0|||
13112015|NCT03167242|25906420|FG010|Overall Study|Reason not provided|0|||
13194836|NCT02065622|26198792|FG001|Maintenance Study|Lack of Efficacy|0|||
13194837|NCT02065622|26198793|FG002|Maintenance Study|Lack of Efficacy|70|||
13194838|NCT02065622|26198794|FG003|Maintenance Study|Lack of Efficacy|55|||
13194839|NCT02065622|26198795|FG004|Maintenance Study|Lack of Efficacy|19|||
13194840|NCT02065622|26198791|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
13194841|NCT02065622|26198792|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
13194842|NCT02065622|26198793|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7|||
13194843|NCT02065622|26198794|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3|||
13194844|NCT02065622|26198795|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4|||
13194845|NCT02065622|26198791|FG000|Maintenance Study|Subject Non-Compliance|0|||
13194846|NCT02065622|26198792|FG001|Maintenance Study|Subject Non-Compliance|0|||
13194847|NCT02065622|26198793|FG002|Maintenance Study|Subject Non-Compliance|1|||
13194848|NCT02065622|26198794|FG003|Maintenance Study|Subject Non-Compliance|3|||
13194849|NCT02065622|26198795|FG004|Maintenance Study|Subject Non-Compliance|2|||
13194850|NCT02065622|26198791|FG000|Maintenance Study|Other, Not Specified|0|||
13194851|NCT02065622|26198792|FG001|Maintenance Study|Other, Not Specified|0|||
13194852|NCT02065622|26198793|FG002|Maintenance Study|Other, Not Specified|6|||
13194853|NCT02065622|26198794|FG003|Maintenance Study|Other, Not Specified|14|||
13194854|NCT02065622|26198795|FG004|Maintenance Study|Other, Not Specified|2|||
13194855|NCT02065622|26198791|FG000|Maintenance Study|Unknown Reason|0|||
13194856|NCT02065622|26198792|FG001|Maintenance Study|Unknown Reason|0|||
13194857|NCT02065622|26198793|FG002|Maintenance Study|Unknown Reason|0|||
13194858|NCT02065622|26198794|FG003|Maintenance Study|Unknown Reason|1|||
13194859|NCT02065622|26198795|FG004|Maintenance Study|Unknown Reason|0|||
13194860|NCT02065570|26198848|FG000|Induction Study|Adverse Event|5|||
13194861|NCT02065570|26198849|FG001|Induction Study|Adverse Event|12|||
13194862|NCT02065570|26198850|FG002|Induction Study|Adverse Event|0|||
13194863|NCT02065570|26198851|FG003|Induction Study|Adverse Event|0|||
13194864|NCT02065570|26198848|FG000|Induction Study|Withdrawal by Subject|2|||
13194865|NCT02065570|26198849|FG001|Induction Study|Withdrawal by Subject|3|||
13194866|NCT02065570|26198850|FG002|Induction Study|Withdrawal by Subject|0|||
13112016|NCT03167242|25906421|FG011|Overall Study|Reason not provided|0|||
13112017|NCT03167151|25906439|FG000|Overall Study|Withdrawal by Subject|1|||
13112018|NCT03167151|25906440|FG001|Overall Study|Withdrawal by Subject|0|||
13112019|NCT03167151|25906441|FG002|Overall Study|Withdrawal by Subject|0|||
13112020|NCT03167151|25906439|FG000|Overall Study|No evidence of tumour at surgery|0|||
13112021|NCT03167151|25906440|FG001|Overall Study|No evidence of tumour at surgery|1|||
13112022|NCT03167151|25906441|FG002|Overall Study|No evidence of tumour at surgery|1|||
13112023|NCT03167073|25906472|FG000|Overall Study|Stillbirth|1|||
13112024|NCT03167073|25906473|FG001|Overall Study|Stillbirth|0|||
13112025|NCT03166735|25906537|FG000|Overall Study|Not Treated|1|||
13112026|NCT03166735|25906538|FG001|Overall Study|Not Treated|0|||
13112027|NCT03166735|25906539|FG002|Overall Study|Not Treated|0|||
13112028|NCT03166735|25906540|FG003|Overall Study|Not Treated|0|||
13112029|NCT03166735|25906541|FG004|Overall Study|Not Treated|0|||
13112030|NCT03166735|25906537|FG000|Overall Study|follow-up not completed as planned|0|||
13112031|NCT03166735|25906538|FG001|Overall Study|follow-up not completed as planned|1|||
13112032|NCT03166735|25906539|FG002|Overall Study|follow-up not completed as planned|1|||
13112033|NCT03166735|25906540|FG003|Overall Study|follow-up not completed as planned|0|||
13112034|NCT03166735|25906541|FG004|Overall Study|follow-up not completed as planned|1|||
13194867|NCT02065570|26198851|FG003|Induction Study|Withdrawal by Subject|0|||
13194868|NCT02065570|26198848|FG000|Induction Study|Lost to Follow-up|1|||
13194869|NCT02065570|26198849|FG001|Induction Study|Lost to Follow-up|1|||
13194870|NCT02065570|26198850|FG002|Induction Study|Lost to Follow-up|0|||
13194871|NCT02065570|26198851|FG003|Induction Study|Lost to Follow-up|0|||
13194872|NCT02065570|26198848|FG000|Induction Study|Other, Not Specified|6|||
13194873|NCT02065570|26198849|FG001|Induction Study|Other, Not Specified|5|||
13194874|NCT02065570|26198850|FG002|Induction Study|Other, Not Specified|0|||
13194875|NCT02065570|26198851|FG003|Induction Study|Other, Not Specified|0|||
13194876|NCT02065570|26198848|FG000|Maintenance Study|Adverse Event|0|||
13194877|NCT02065570|26198849|FG001|Maintenance Study|Adverse Event|0|||
13194878|NCT02065570|26198850|FG002|Maintenance Study|Adverse Event|8|||
13194879|NCT02065570|26198851|FG003|Maintenance Study|Adverse Event|8|||
13194880|NCT02065570|26198848|FG000|Maintenance Study|Withdrawal by Subject|0|||
13194881|NCT02065570|26198849|FG001|Maintenance Study|Withdrawal by Subject|0|||
13194882|NCT02065570|26198850|FG002|Maintenance Study|Withdrawal by Subject|1|||
13194883|NCT02065570|26198851|FG003|Maintenance Study|Withdrawal by Subject|4|||
13194884|NCT02065570|26198848|FG000|Maintenance Study|Lost to Follow-up|0|||
13194885|NCT02065570|26198849|FG001|Maintenance Study|Lost to Follow-up|0|||
13194886|NCT02065570|26198850|FG002|Maintenance Study|Lost to Follow-up|2|||
13194887|NCT02065570|26198851|FG003|Maintenance Study|Lost to Follow-up|2|||
13194888|NCT02065570|26198848|FG000|Maintenance Study|Other, Not Specified|0|||
13194889|NCT02065570|26198849|FG001|Maintenance Study|Other, Not Specified|0|||
13194890|NCT02065570|26198850|FG002|Maintenance Study|Other, Not Specified|11|||
13194891|NCT02065570|26198851|FG003|Maintenance Study|Other, Not Specified|5|||
13194892|NCT02065557|26198921|FG000|Induction Period|Withdrawal by Subject|2|||
13194893|NCT02065557|26198922|FG001|Induction Period|Withdrawal by Subject|1|||
13194894|NCT02065557|26198923|FG002|Induction Period|Withdrawal by Subject|0|||
13194895|NCT02065557|26198924|FG003|Induction Period|Withdrawal by Subject|0|||
13194896|NCT02065557|26198925|FG004|Induction Period|Withdrawal by Subject|0|||
13194897|NCT02065557|26198926|FG005|Induction Period|Withdrawal by Subject|0|||
13194898|NCT02065557|26198921|FG000|Induction Period|Lack of Efficacy|2|||
13194899|NCT02065557|26198922|FG001|Induction Period|Lack of Efficacy|1|||
13194900|NCT02065557|26198923|FG002|Induction Period|Lack of Efficacy|1|||
13194901|NCT02065557|26198924|FG003|Induction Period|Lack of Efficacy|0|||
13194902|NCT02065557|26198925|FG004|Induction Period|Lack of Efficacy|0|||
13194903|NCT02065557|26198926|FG005|Induction Period|Lack of Efficacy|0|||
13194904|NCT02065557|26198921|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1|||
13194905|NCT02065557|26198922|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1|||
13194906|NCT02065557|26198923|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1|||
13194907|NCT02065557|26198924|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0|||
13194908|NCT02065557|26198925|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0|||
13194909|NCT02065557|26198926|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0|||
13194910|NCT02065557|26198921|FG000|Induction Period|Non-Responder at Week 8|4|||
13194911|NCT02065557|26198922|FG001|Induction Period|Non-Responder at Week 8|4|||
13194912|NCT02065557|26198923|FG002|Induction Period|Non-Responder at Week 8|0|||
13194913|NCT02065557|26198924|FG003|Induction Period|Non-Responder at Week 8|0|||
13194914|NCT02065557|26198925|FG004|Induction Period|Non-Responder at Week 8|0|||
13194915|NCT02065557|26198926|FG005|Induction Period|Non-Responder at Week 8|0|||
13194916|NCT02065557|26198921|FG000|Induction Period|Adverse Event|1|||
13194917|NCT02065557|26198922|FG001|Induction Period|Adverse Event|1|||
13194918|NCT02065557|26198923|FG002|Induction Period|Adverse Event|0|||
13194919|NCT02065557|26198924|FG003|Induction Period|Adverse Event|0|||
13194920|NCT02065557|26198925|FG004|Induction Period|Adverse Event|0|||
13194921|NCT02065557|26198926|FG005|Induction Period|Adverse Event|0|||
13194922|NCT02065557|26198921|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
13194923|NCT02065557|26198922|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
13194924|NCT02065557|26198923|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
13194925|NCT02065557|26198924|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
13194926|NCT02065557|26198925|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
13194927|NCT02065557|26198926|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
13194928|NCT02065557|26198921|FG000|Maintenance Period|Withdrawal by Subject|0|||
13194929|NCT02065557|26198922|FG001|Maintenance Period|Withdrawal by Subject|0|||
13194930|NCT02065557|26198923|FG002|Maintenance Period|Withdrawal by Subject|0|||
13194931|NCT02065557|26198924|FG003|Maintenance Period|Withdrawal by Subject|0|||
13194932|NCT02065557|26198925|FG004|Maintenance Period|Withdrawal by Subject|2|||
13194933|NCT02065557|26198926|FG005|Maintenance Period|Withdrawal by Subject|1|||
13194934|NCT02065557|26198921|FG000|Maintenance Period|Lack of Efficacy|0|||
13194935|NCT02065557|26198922|FG001|Maintenance Period|Lack of Efficacy|0|||
13194936|NCT02065557|26198923|FG002|Maintenance Period|Lack of Efficacy|0|||
13194937|NCT02065557|26198924|FG003|Maintenance Period|Lack of Efficacy|0|||
13194938|NCT02065557|26198925|FG004|Maintenance Period|Lack of Efficacy|5|||
13194939|NCT02065557|26198926|FG005|Maintenance Period|Lack of Efficacy|2|||
13194940|NCT02065557|26198921|FG000|Maintenance Period|Subject Non-Compliance|0|||
13194941|NCT02065557|26198922|FG001|Maintenance Period|Subject Non-Compliance|0|||
13194942|NCT02065557|26198923|FG002|Maintenance Period|Subject Non-Compliance|0|||
13194943|NCT02065557|26198924|FG003|Maintenance Period|Subject Non-Compliance|0|||
13194944|NCT02065557|26198925|FG004|Maintenance Period|Subject Non-Compliance|0|||
13194945|NCT02065557|26198926|FG005|Maintenance Period|Subject Non-Compliance|1|||
13194946|NCT02065518|26198989|FG000|Overall Study|Lost to Follow-up|3|||
13194947|NCT02065518|26198990|FG001|Overall Study|Lost to Follow-up|4|||
13194948|NCT02065518|26198991|FG002|Overall Study|Lost to Follow-up|0|||
13194949|NCT02065518|26198992|FG003|Overall Study|Lost to Follow-up|3|||
13194950|NCT02065518|26198989|FG000|Overall Study|Withdrawal by Subject|3|||
13194951|NCT02065518|26198990|FG001|Overall Study|Withdrawal by Subject|4|||
13194952|NCT02065518|26198991|FG002|Overall Study|Withdrawal by Subject|9|||
13194953|NCT02065518|26198992|FG003|Overall Study|Withdrawal by Subject|2|||
13194954|NCT02065336|26199111|FG000|Extension Phase|Study Terminated by Sponsor|0|||
13194955|NCT02065336|26199112|FG001|Extension Phase|Study Terminated by Sponsor|0|||
13194956|NCT02065336|26199113|FG002|Extension Phase|Study Terminated by Sponsor|0|||
13194957|NCT02065336|26199114|FG003|Extension Phase|Study Terminated by Sponsor|0|||
13194958|NCT02065336|26199115|FG004|Extension Phase|Study Terminated by Sponsor|0|||
13194959|NCT02065336|26199116|FG005|Extension Phase|Study Terminated by Sponsor|0|||
13194960|NCT02065336|26199117|FG006|Extension Phase|Study Terminated by Sponsor|0|||
13194961|NCT02065336|26199118|FG007|Extension Phase|Study Terminated by Sponsor|0|||
13194962|NCT02065336|26199119|FG008|Extension Phase|Study Terminated by Sponsor|2|||
13194963|NCT02065336|26199120|FG009|Extension Phase|Study Terminated by Sponsor|8|||
13194964|NCT02065245|26199158|FG000|Infusion 1|Lost to Follow-up|0|||
13194965|NCT02065245|26199159|FG001|Infusion 1|Lost to Follow-up|0|||
13194966|NCT02065245|26199160|FG002|Infusion 1|Lost to Follow-up|0|||
13194967|NCT02065245|26199161|FG003|Infusion 1|Lost to Follow-up|0|||
13194968|NCT02065245|26199162|FG004|Infusion 1|Lost to Follow-up|0|||
13194969|NCT02065245|26199163|FG005|Infusion 1|Lost to Follow-up|0|||
13194970|NCT02065245|26199164|FG006|Infusion 1|Lost to Follow-up|1|||
13194971|NCT02065245|26199158|FG000|Infusion 1|Death|0|||
13194972|NCT02065245|26199159|FG001|Infusion 1|Death|0|||
13194973|NCT02065245|26199160|FG002|Infusion 1|Death|1|||
13194974|NCT02065245|26199161|FG003|Infusion 1|Death|0|||
13194975|NCT02065245|26199162|FG004|Infusion 1|Death|1|||
13194976|NCT02065245|26199163|FG005|Infusion 1|Death|0|||
13194977|NCT02065245|26199164|FG006|Infusion 1|Death|0|||
13194978|NCT02065245|26199158|FG000|Infusion 2|Death|0|||
13194979|NCT02065245|26199159|FG001|Infusion 2|Death|0|||
13194980|NCT02065245|26199160|FG002|Infusion 2|Death|0|||
13194981|NCT02065245|26199161|FG003|Infusion 2|Death|0|||
13194982|NCT02065245|26199162|FG004|Infusion 2|Death|0|||
13194983|NCT02065245|26199163|FG005|Infusion 2|Death|0|||
13194984|NCT02065245|26199164|FG006|Infusion 2|Death|1|||
13194985|NCT02065245|26199158|FG000|Infusion 3|Lost to Follow-up|1|||
13194986|NCT02065245|26199159|FG001|Infusion 3|Lost to Follow-up|1|||
13194987|NCT02065245|26199160|FG002|Infusion 3|Lost to Follow-up|0|||
13194988|NCT02065245|26199161|FG003|Infusion 3|Lost to Follow-up|0|||
13194989|NCT02065245|26199162|FG004|Infusion 3|Lost to Follow-up|0|||
13194990|NCT02065245|26199163|FG005|Infusion 3|Lost to Follow-up|0|||
13194991|NCT02065245|26199164|FG006|Infusion 3|Lost to Follow-up|0|||
13194992|NCT02064920|26199179|FG000|Overall Study|Adverse Event|0|||
13194993|NCT02064920|26199180|FG001|Overall Study|Adverse Event|4|||
13194994|NCT02064920|26199179|FG000|Overall Study|Physician Decision|0|||
13194995|NCT02064920|26199180|FG001|Overall Study|Physician Decision|1|||
13194996|NCT02064920|26199179|FG000|Overall Study|Technical Problems|0|||
13194997|NCT02064920|26199180|FG001|Overall Study|Technical Problems|1|||
13194998|NCT02064920|26199179|FG000|Overall Study|Withdrawal by Subject|1|||
13194999|NCT02064920|26199180|FG001|Overall Study|Withdrawal by Subject|3|||
13195000|NCT02064894|26199201|FG000|Overall Study|Withdrawal by Subject|43|||
13195001|NCT02064894|26199202|FG001|Overall Study|Withdrawal by Subject|102|||
13195002|NCT02064894|26199203|FG002|Overall Study|Withdrawal by Subject|115|||
13195003|NCT02064868|26199228|FG000|Overall Study|Lost to Follow-up|14|||
13195004|NCT02064868|26199229|FG001|Overall Study|Lost to Follow-up|8|||
13195005|NCT02064868|26199228|FG000|Overall Study|Physician Decision|1|||
13195006|NCT02064868|26199229|FG001|Overall Study|Physician Decision|0|||
13195007|NCT02064868|26199228|FG000|Overall Study|Withdrawal by Subject|14|||
13195008|NCT02064868|26199229|FG001|Overall Study|Withdrawal by Subject|3|||
13195009|NCT02064868|26199228|FG000|Overall Study|Technical Problems or Missing|5|||
13195010|NCT02064868|26199229|FG001|Overall Study|Technical Problems or Missing|2|||
13195011|NCT02064816|26199274|FG000|Overall Study|Adverse Event|3|||
13195012|NCT02064816|26199275|FG001|Overall Study|Adverse Event|2|||
13195013|NCT02064816|26199274|FG000|Overall Study|Withdrawal by Subject|2|||
13195014|NCT02064816|26199275|FG001|Overall Study|Withdrawal by Subject|1|||
13195015|NCT02064816|26199274|FG000|Overall Study|Lost to Follow-up|2|||
13195016|NCT02064816|26199275|FG001|Overall Study|Lost to Follow-up|1|||
13195017|NCT02064816|26199274|FG000|Overall Study|Therapeutic failure|0|||
13195018|NCT02064816|26199275|FG001|Overall Study|Therapeutic failure|1|||
13195019|NCT02064816|26199274|FG000|Overall Study|Other|1|||
13195020|NCT02064816|26199275|FG001|Overall Study|Other|3|||
13195021|NCT02064439|26199302|FG000|Overall Study|Adverse Event|51|||
13195022|NCT02064439|26199303|FG001|Overall Study|Adverse Event|47|||
13195023|NCT02064439|26199304|FG002|Overall Study|Adverse Event|46|||
13195024|NCT02064439|26199302|FG000|Overall Study|Death|0|||
13195025|NCT02064439|26199303|FG001|Overall Study|Death|2|||
13195026|NCT02064439|26199304|FG002|Overall Study|Death|3|||
13195027|NCT02064439|26199302|FG000|Overall Study|Withdrawal by Subject|29|||
13195028|NCT02064439|26199303|FG001|Overall Study|Withdrawal by Subject|18|||
13195029|NCT02064439|26199304|FG002|Overall Study|Withdrawal by Subject|26|||
13195030|NCT02064439|26199302|FG000|Overall Study|Protocol Violation|3|||
13195031|NCT02064439|26199303|FG001|Overall Study|Protocol Violation|5|||
13195032|NCT02064439|26199304|FG002|Overall Study|Protocol Violation|3|||
13195033|NCT02064439|26199302|FG000|Overall Study|Lost to Follow-up|1|||
13195034|NCT02064439|26199303|FG001|Overall Study|Lost to Follow-up|3|||
13195035|NCT02064439|26199304|FG002|Overall Study|Lost to Follow-up|4|||
13195036|NCT02064439|26199302|FG000|Overall Study|Non-compliance with study medication|21|||
13195037|NCT02064439|26199303|FG001|Overall Study|Non-compliance with study medication|19|||
13195038|NCT02064439|26199304|FG002|Overall Study|Non-compliance with study medication|23|||
13195039|NCT02064439|26199302|FG000|Overall Study|Physician Decision|0|||
13195040|NCT02064439|26199303|FG001|Overall Study|Physician Decision|1|||
13195041|NCT02064439|26199304|FG002|Overall Study|Physician Decision|1|||
13195042|NCT02064439|26199302|FG000|Overall Study|Logistical difficulties|6|||
13195043|NCT02064439|26199303|FG001|Overall Study|Logistical difficulties|5|||
13195044|NCT02064439|26199304|FG002|Overall Study|Logistical difficulties|2|||
13195045|NCT02064439|26199302|FG000|Overall Study|Efficacy outcome reached|18|||
13195046|NCT02064439|26199303|FG001|Overall Study|Efficacy outcome reached|16|||
13195047|NCT02064439|26199304|FG002|Overall Study|Efficacy outcome reached|57|||
13195048|NCT02064439|26199302|FG000|Overall Study|Safety outcome reached|12|||
13195049|NCT02064439|26199303|FG001|Overall Study|Safety outcome reached|20|||
13195050|NCT02064439|26199304|FG002|Overall Study|Safety outcome reached|10|||
13195051|NCT02064439|26199302|FG000|Overall Study|Other|2|||
13195052|NCT02064439|26199303|FG001|Overall Study|Other|2|||
13195053|NCT02064439|26199304|FG002|Overall Study|Other|7|||
13195054|NCT02064296|26199327|FG000|Eligibility to Baseline Data Collection|Withdrawal by Subject|1|||
13195055|NCT02064296|26199328|FG001|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
13195056|NCT02064296|26199329|FG002|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
13195057|NCT02064296|26199327|FG000|Intervention|Withdrawal by Subject|0|||
13195058|NCT02064296|26199328|FG001|Intervention|Withdrawal by Subject|1|||
13195059|NCT02064296|26199329|FG002|Intervention|Withdrawal by Subject|2|||
13195060|NCT02064231|26199346|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5|||
13195061|NCT02064231|26199347|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3|||
13195062|NCT02064231|26199348|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
13195063|NCT02064231|26199349|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
13195064|NCT02064231|26199346|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
13195065|NCT02064231|26199347|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
13195066|NCT02064231|26199348|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
13195067|NCT02064231|26199349|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
13195068|NCT02064231|26199346|FG000|First Test Period (Test A or Test C)|Adverse Event|1|||
13195069|NCT02064231|26199347|FG001|First Test Period (Test A or Test C)|Adverse Event|0|||
13195070|NCT02064231|26199348|FG002|First Test Period (Test A or Test C)|Adverse Event|1|||
13195071|NCT02064231|26199349|FG003|First Test Period (Test A or Test C)|Adverse Event|0|||
13195072|NCT02064231|26199346|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
13195073|NCT02064231|26199347|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
13195074|NCT02064231|26199348|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
13195075|NCT02064231|26199349|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
13195076|NCT02064205|26199367|FG000|Overall Study|Withdrawal by Subject|1|||
13195077|NCT02064166|26199402|FG000|Overall Study|Adverse Event|1|||
13195078|NCT02064166|26199403|FG001|Overall Study|Adverse Event|0|||
13195079|NCT02063984|26199430|FG000|Overall Study|Lost to Follow-up|6|||
13195080|NCT02063984|26199431|FG001|Overall Study|Lost to Follow-up|5|||
13195081|NCT02063880|26199448|FG000|Overall Study|Death|21|||
13195082|NCT02063880|26199449|FG001|Overall Study|Death|18|||
13195083|NCT02063880|26199448|FG000|Overall Study|Lost to Follow-up|7|||
13195084|NCT02063880|26199449|FG001|Overall Study|Lost to Follow-up|7|||
13195085|NCT02063880|26199448|FG000|Overall Study|Ineligible|0|||
13195086|NCT02063880|26199449|FG001|Overall Study|Ineligible|2|||
13195087|NCT02063854|26199553|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
13195088|NCT02063854|26199554|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
13195089|NCT02063854|26199555|FG002|Overall Study|Pretreatment Event/Adverse Event|13|||
13195090|NCT02063854|26199556|FG003|Overall Study|Pretreatment Event/Adverse Event|8|||
13195091|NCT02063854|26199557|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
13195092|NCT02063854|26199558|FG005|Overall Study|Pretreatment Event/Adverse Event|18|||
13195093|NCT02063854|26199559|FG006|Overall Study|Pretreatment Event/Adverse Event|4|||
13195094|NCT02063854|26199553|FG000|Overall Study|Major Protocol Deviation|0|||
13195095|NCT02063854|26199554|FG001|Overall Study|Major Protocol Deviation|0|||
13195096|NCT02063854|26199555|FG002|Overall Study|Major Protocol Deviation|3|||
13195097|NCT02063854|26199556|FG003|Overall Study|Major Protocol Deviation|0|||
13195098|NCT02063854|26199557|FG004|Overall Study|Major Protocol Deviation|0|||
13195099|NCT02063854|26199558|FG005|Overall Study|Major Protocol Deviation|0|||
13195100|NCT02063854|26199559|FG006|Overall Study|Major Protocol Deviation|0|||
13195101|NCT02063854|26199553|FG000|Overall Study|Voluntary Withdrawal|2|||
13195102|NCT02063854|26199554|FG001|Overall Study|Voluntary Withdrawal|0|||
13195103|NCT02063854|26199555|FG002|Overall Study|Voluntary Withdrawal|8|||
13195104|NCT02063854|26199556|FG003|Overall Study|Voluntary Withdrawal|1|||
13195105|NCT02063854|26199557|FG004|Overall Study|Voluntary Withdrawal|3|||
13195106|NCT02063854|26199558|FG005|Overall Study|Voluntary Withdrawal|6|||
13195107|NCT02063854|26199559|FG006|Overall Study|Voluntary Withdrawal|1|||
13195108|NCT02063854|26199553|FG000|Overall Study|Surgical Dental Work Performed/Planned|5|||
13195109|NCT02063854|26199554|FG001|Overall Study|Surgical Dental Work Performed/Planned|2|||
13195110|NCT02063854|26199555|FG002|Overall Study|Surgical Dental Work Performed/Planned|6|||
13195111|NCT02063854|26199556|FG003|Overall Study|Surgical Dental Work Performed/Planned|1|||
13195112|NCT02063854|26199557|FG004|Overall Study|Surgical Dental Work Performed/Planned|1|||
13195113|NCT02063854|26199558|FG005|Overall Study|Surgical Dental Work Performed/Planned|6|||
13195114|NCT02063854|26199559|FG006|Overall Study|Surgical Dental Work Performed/Planned|1|||
13195115|NCT02063854|26199553|FG000|Overall Study|Reason Not Specified|1|||
13195116|NCT02063854|26199554|FG001|Overall Study|Reason Not Specified|0|||
13195117|NCT02063854|26199555|FG002|Overall Study|Reason Not Specified|0|||
13195118|NCT02063854|26199556|FG003|Overall Study|Reason Not Specified|0|||
13195119|NCT02063854|26199557|FG004|Overall Study|Reason Not Specified|0|||
13195120|NCT02063854|26199558|FG005|Overall Study|Reason Not Specified|0|||
13195121|NCT02063854|26199559|FG006|Overall Study|Reason Not Specified|0|||
13195122|NCT02063854|26199553|FG000|Overall Study|Did Not Receive Study Drug|0|||
13195123|NCT02063854|26199554|FG001|Overall Study|Did Not Receive Study Drug|0|||
13195124|NCT02063854|26199555|FG002|Overall Study|Did Not Receive Study Drug|0|||
13195125|NCT02063854|26199556|FG003|Overall Study|Did Not Receive Study Drug|0|||
13195126|NCT02063854|26199557|FG004|Overall Study|Did Not Receive Study Drug|0|||
13195127|NCT02063854|26199558|FG005|Overall Study|Did Not Receive Study Drug|1|||
13195128|NCT02063854|26199559|FG006|Overall Study|Did Not Receive Study Drug|0|||
13195129|NCT02063828|26199586|FG000|Overall Study|Withdrawal by Subject|4|||
13195130|NCT02063828|26199587|FG001|Overall Study|Withdrawal by Subject|6|||
13195131|NCT02063828|26199588|FG002|Overall Study|Withdrawal by Subject|3|||
13195132|NCT02063828|26199586|FG000|Overall Study|Death|0|||
13195133|NCT02063828|26199587|FG001|Overall Study|Death|0|||
13195134|NCT02063828|26199588|FG002|Overall Study|Death|1|||
13195135|NCT02063737|26199627|FG000|Overall Study|Lost to Follow-up|11|||
13195136|NCT02063737|26199628|FG001|Overall Study|Lost to Follow-up|4|||
13195137|NCT02063698|26199657|FG000|Overall Study|did not complete booklet for days 2-8|1|||
13195138|NCT02063698|26199658|FG001|Overall Study|did not complete booklet for days 2-8|2|||
13195139|NCT02063672|26199709|FG000|Overall Study|Ongoing Follow-up|27|||
13195140|NCT02063672|26199710|FG001|Overall Study|Ongoing Follow-up|14|||
13195141|NCT02063672|26199709|FG000|Overall Study|Death|5|||
13195142|NCT02063672|26199710|FG001|Overall Study|Death|3|||
13195143|NCT02063672|26199709|FG000|Overall Study|Lost to Follow-up|1|||
13195144|NCT02063672|26199710|FG001|Overall Study|Lost to Follow-up|3|||
13195145|NCT02063672|26199709|FG000|Overall Study|Withdrawal by Subject|2|||
13195146|NCT02063672|26199710|FG001|Overall Study|Withdrawal by Subject|2|||
13195147|NCT02063659|26199751|FG000|Double-Blind Treatment Period|Adverse Event|1|||
13485571|NCT02906020|27032877|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
13485572|NCT02906020|27032878|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
13485573|NCT02906020|27032879|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1|||
13485574|NCT02906020|27032880|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4|||
13485575|NCT02906020|27032881|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
13485576|NCT02906020|27032882|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
13485577|NCT02906020|27032867|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
13485578|NCT02906020|27032868|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
13485579|NCT02906020|27032869|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
13485580|NCT02906020|27032870|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
13485581|NCT02906020|27032871|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
13485582|NCT02906020|27032872|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
13485583|NCT02906020|27032873|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
13485584|NCT02906020|27032874|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
13485585|NCT02906020|27032875|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
13195148|NCT02063659|26199752|FG001|Double-Blind Treatment Period|Adverse Event|2|||
13195149|NCT02063659|26199753|FG002|Double-Blind Treatment Period|Adverse Event|0|||
13195150|NCT02063659|26199754|FG003|Double-Blind Treatment Period|Adverse Event|0|||
13195151|NCT02063659|26199751|FG000|Double-Blind Treatment Period|Physician Decision|1|||
13195152|NCT02063659|26199752|FG001|Double-Blind Treatment Period|Physician Decision|0|||
13485586|NCT02906020|27032876|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
13485587|NCT02906020|27032877|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
13485588|NCT02906020|27032878|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
13485589|NCT02906020|27032879|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67|||
13485590|NCT02906020|27032880|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64|||
13485591|NCT02906020|27032881|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7|||
13485592|NCT02906020|27032882|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8|||
13485593|NCT02906020|27032867|FG000|Part 2: Long-term Follow-up Period|Other|0|||
13485594|NCT02906020|27032868|FG001|Part 2: Long-term Follow-up Period|Other|0|||
13485595|NCT02906020|27032869|FG002|Part 2: Long-term Follow-up Period|Other|0|||
13485596|NCT02906020|27032870|FG003|Part 2: Long-term Follow-up Period|Other|0|||
13485597|NCT02906020|27032871|FG004|Part 2: Long-term Follow-up Period|Other|0|||
13485598|NCT02906020|27032872|FG005|Part 2: Long-term Follow-up Period|Other|0|||
13485599|NCT02906020|27032873|FG006|Part 2: Long-term Follow-up Period|Other|0|||
13485600|NCT02906020|27032874|FG007|Part 2: Long-term Follow-up Period|Other|0|||
13485601|NCT02906020|27032875|FG008|Part 2: Long-term Follow-up Period|Other|0|||
13485602|NCT02906020|27032876|FG009|Part 2: Long-term Follow-up Period|Other|0|||
13485603|NCT02906020|27032877|FG010|Part 2: Long-term Follow-up Period|Other|0|||
13485604|NCT02906020|27032878|FG011|Part 2: Long-term Follow-up Period|Other|0|||
13195153|NCT02063659|26199753|FG002|Double-Blind Treatment Period|Physician Decision|0|||
13195154|NCT02063659|26199754|FG003|Double-Blind Treatment Period|Physician Decision|0|||
13195155|NCT02063659|26199751|FG000|Double-Blind Treatment Period|Withdrawal of consent|0|||
13195156|NCT02063659|26199752|FG001|Double-Blind Treatment Period|Withdrawal of consent|1|||
13195157|NCT02063659|26199753|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
13195158|NCT02063659|26199754|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
13195159|NCT02063659|26199751|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
13195160|NCT02063659|26199752|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
13195161|NCT02063659|26199753|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
13195162|NCT02063659|26199754|FG003|Open-Label Extension Period (OLE)|Physician Decision|1|||
13195163|NCT02063659|26199751|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
13195164|NCT02063659|26199752|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
13195165|NCT02063659|26199753|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
13195166|NCT02063659|26199754|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
13195167|NCT02063659|26199751|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
13195168|NCT02063659|26199752|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
13195169|NCT02063659|26199753|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
13195170|NCT02063659|26199754|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1|||
13195171|NCT02063659|26199751|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
13195172|NCT02063659|26199752|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
13195173|NCT02063659|26199753|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
13195174|NCT02063659|26199754|FG003|Open-Label Extension Period (OLE)|Adverse Event|7|||
13195175|NCT02063659|26199751|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
13195176|NCT02063659|26199752|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
13195177|NCT02063659|26199753|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
13195178|NCT02063659|26199754|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
13195179|NCT02063217|26199772|FG000|Overall Study|Withdrawal by Subject|1|||
13195180|NCT02063217|26199773|FG001|Overall Study|Withdrawal by Subject|0|||
13195181|NCT02063217|26199774|FG002|Overall Study|Withdrawal by Subject|0|||
13195182|NCT02062944|26199782|FG000|Overall Study|Lost to Follow-up|1|||
13195183|NCT02062944|26199782|FG000|Overall Study|New hemotological disorder identified|1|||
13195184|NCT02062944|26199782|FG000|Overall Study|Uncontrolled Hypertension|1|||
13195185|NCT02062944|26199782|FG000|Overall Study|underwent pre-weaning biospsy and excluded for mild subclinical ACR|3|||
13195186|NCT02062879|26199799|FG000|Overall Study|Withdrawal by Subject|4|||
13195187|NCT02062879|26199800|FG001|Overall Study|Withdrawal by Subject|1|||
13195188|NCT02062658|26199806|FG000|Overall Study|Withdrawal by Subject|1|||
13195189|NCT02062658|26199806|FG000|Overall Study|Lack of Efficacy|1|||
13195190|NCT02062645|26199816|FG000|Overall Study|Adverse Event|2|||
13195191|NCT02062645|26199816|FG000|Overall Study|Protocol Violation|8|||
13195192|NCT02062645|26199816|FG000|Overall Study|Lost to Follow-up|5|||
13195193|NCT02062632|26199825|FG000|Overall Study|No treatment data|1|||
13195194|NCT02062450|26199845|FG000|Overall Study|No follow-up visit|124|||
13195195|NCT02062437|26199856|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31|||
13195196|NCT02062437|26199856|FG000|Overall Study|Patient not available for the 2y visit|18|||
13195197|NCT02062437|26199856|FG000|Overall Study|Death|2|||
13195198|NCT02062437|26199856|FG000|Overall Study|Pt. couldn't come due to med. condition|1|||
13195199|NCT02062398|26199866|FG000|Overall Study|Implant removal|1|||
13195200|NCT02062385|26199899|FG000|Overall Study|Adverse Event|19|||
13195201|NCT02062385|26199900|FG001|Overall Study|Adverse Event|13|||
13195202|NCT02062385|26199901|FG002|Overall Study|Adverse Event|1|||
13195203|NCT02062385|26199902|FG003|Overall Study|Adverse Event|0|||
13195204|NCT02062385|26199899|FG000|Overall Study|Protocol Violation|1|||
13112035|NCT03166735|25906537|FG000|Overall Study|Withdrawal by Subject|0|||
13112036|NCT03166735|25906538|FG001|Overall Study|Withdrawal by Subject|0|||
13112037|NCT03166735|25906539|FG002|Overall Study|Withdrawal by Subject|1|||
13112038|NCT03166735|25906540|FG003|Overall Study|Withdrawal by Subject|1|||
13112039|NCT03166735|25906541|FG004|Overall Study|Withdrawal by Subject|2|||
13112040|NCT03166735|25906537|FG000|Overall Study|Lost to Follow-up|0|||
13112041|NCT03166735|25906538|FG001|Overall Study|Lost to Follow-up|2|||
13195205|NCT02062385|26199900|FG001|Overall Study|Protocol Violation|0|||
13195206|NCT02062385|26199901|FG002|Overall Study|Protocol Violation|0|||
13195207|NCT02062385|26199902|FG003|Overall Study|Protocol Violation|0|||
13195208|NCT02062385|26199899|FG000|Overall Study|Incomplete EPI by database lock|2|||
13195209|NCT02062385|26199900|FG001|Overall Study|Incomplete EPI by database lock|0|||
13112042|NCT03166735|25906539|FG002|Overall Study|Lost to Follow-up|1|||
13112043|NCT03166735|25906540|FG003|Overall Study|Lost to Follow-up|0|||
13112044|NCT03166735|25906541|FG004|Overall Study|Lost to Follow-up|1|||
13112045|NCT03166618|25906558|FG000|Overall Study|Study was Terminated|0|||
13112046|NCT03166618|25906559|FG001|Overall Study|Study was Terminated|1|||
13112047|NCT03166215|25906605|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
13112048|NCT03166215|25906606|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2|||
13112049|NCT03166215|25906607|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
13112050|NCT03166215|25906605|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
13112051|NCT03166215|25906606|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
13112052|NCT03166215|25906607|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2|||
13112053|NCT03166124|25906630|FG000|Treatment Period 1|Adverse Event|0|||
13112054|NCT03166124|25906631|FG001|Treatment Period 1|Adverse Event|0|||
13112055|NCT03166124|25906632|FG002|Treatment Period 1|Adverse Event|1|||
13112056|NCT03166124|25906633|FG003|Treatment Period 1|Adverse Event|0|||
13112057|NCT03166124|25906630|FG000|Wash-out Period|Withdrawal by Subject|0|||
13112058|NCT03166124|25906631|FG001|Wash-out Period|Withdrawal by Subject|1|||
13112059|NCT03166124|25906632|FG002|Wash-out Period|Withdrawal by Subject|0|||
13112060|NCT03166124|25906633|FG003|Wash-out Period|Withdrawal by Subject|1|||
13112061|NCT03166124|25906630|FG000|Wash-out Period|Adverse Event|0|||
13112062|NCT03166124|25906631|FG001|Wash-out Period|Adverse Event|1|||
13112063|NCT03166124|25906632|FG002|Wash-out Period|Adverse Event|1|||
13112064|NCT03166124|25906633|FG003|Wash-out Period|Adverse Event|0|||
13112065|NCT03165955|25906652|FG000|Treatment|Withdrawal by Subject|3|||
13112066|NCT03165955|25906652|FG000|Treatment|Death|1|||
13112067|NCT03165955|25906652|FG000|Treatment|Adverse Event|1|||
13112068|NCT03165955|25906652|FG000|Treatment|Progressive disease|3|||
13112069|NCT03165721|25906695|FG000|Overall Study|Refused further treatment|3|||
13112070|NCT03165721|25906696|FG001|Overall Study|Refused further treatment|0|||
13112071|NCT03165721|25906697|FG002|Overall Study|Refused further treatment|0|||
13112072|NCT03165721|25906695|FG000|Overall Study|Physician Decision|1|||
13112073|NCT03165721|25906696|FG001|Overall Study|Physician Decision|0|||
13112074|NCT03165721|25906697|FG002|Overall Study|Physician Decision|0|||
13112075|NCT03165110|25906711|FG000|Overall Study|Anroid phone software incompatibility|1|||
13112076|NCT03165045|25906722|FG000|Visit 1|No registration after visit 1|9|||
13112077|NCT03165045|25906722|FG000|Visit 1|No treatment documented|10|||
13112078|NCT03165045|25906722|FG000|Visit 1|No visit 1|10|||
13112079|NCT03165045|25906722|FG000|Visit 2|Available CCQ score at visit 1 only|109|||
13112080|NCT03165045|25906722|FG000|Visit 2|No available total CCQ score at all|29|||
13112081|NCT03165045|25906722|FG000|Visit 2|Available total CCQ score at vist 2 only|44|||
13112082|NCT03164772|25906757|FG000|Overall Study|Death|4|||
13112083|NCT03164772|25906758|FG001|Overall Study|Death|2|||
13112084|NCT03164772|25906757|FG000|Overall Study|Adverse Event|1|||
13112085|NCT03164772|25906758|FG001|Overall Study|Adverse Event|4|||
13112086|NCT03164772|25906757|FG000|Overall Study|Progressive Disease|11|||
13112087|NCT03164772|25906758|FG001|Overall Study|Progressive Disease|21|||
13112088|NCT03164772|25906757|FG000|Overall Study|Physician Decision|2|||
13112089|NCT03164772|25906758|FG001|Overall Study|Physician Decision|0|||
13112090|NCT03164772|25906757|FG000|Overall Study|Withdrawal by Subject|0|||
13112091|NCT03164772|25906758|FG001|Overall Study|Withdrawal by Subject|4|||
13112092|NCT03164551|25906789|FG000|Overall Study|Imaging discontinued prior completion|8|||
13112093|NCT03164551|25906790|FG001|Overall Study|Imaging discontinued prior completion|0|||
13112094|NCT03164551|25906789|FG000|Overall Study|Participant was non-compliant|1|||
13112095|NCT03164551|25906790|FG001|Overall Study|Participant was non-compliant|0|||
13112096|NCT03164551|25906789|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12|||
13112097|NCT03164551|25906790|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14|||
13112098|NCT03164551|25906789|FG000|Overall Study|Other|8|||
13112099|NCT03164551|25906790|FG001|Overall Study|Other|2|||
13112100|NCT03164356|25906851|FG000|Overall Study|Lost to Follow-up|1|||
13112101|NCT03164356|25906852|FG001|Overall Study|Lost to Follow-up|1|||
13195210|NCT02062385|26199901|FG002|Overall Study|Incomplete EPI by database lock|0|||
13112102|NCT03164356|25906853|FG002|Overall Study|Lost to Follow-up|2|||
13112103|NCT03164356|25906854|FG003|Overall Study|Lost to Follow-up|1|||
13112104|NCT03164356|25906851|FG000|Overall Study|Physician Decision|0|||
13195211|NCT02062385|26199902|FG003|Overall Study|Incomplete EPI by database lock|0|||
13195212|NCT02062385|26199899|FG000|Overall Study|Moved|10|||
13195213|NCT02062385|26199900|FG001|Overall Study|Moved|11|||
13195214|NCT02062385|26199901|FG002|Overall Study|Moved|1|||
13195215|NCT02062385|26199902|FG003|Overall Study|Moved|0|||
13195216|NCT02062385|26199899|FG000|Overall Study|Withdrawn by parent/guardian|46|||
13195217|NCT02062385|26199900|FG001|Overall Study|Withdrawn by parent/guardian|41|||
13195218|NCT02062385|26199901|FG002|Overall Study|Withdrawn by parent/guardian|9|||
13195219|NCT02062385|26199902|FG003|Overall Study|Withdrawn by parent/guardian|8|||
13195220|NCT02062385|26199899|FG000|Overall Study|Death|0|||
13195221|NCT02062385|26199900|FG001|Overall Study|Death|0|||
13195222|NCT02062385|26199901|FG002|Overall Study|Death|0|||
13195223|NCT02062385|26199902|FG003|Overall Study|Death|1|||
13195224|NCT02062385|26199899|FG000|Overall Study|Lost to Follow-up|0|||
13195225|NCT02062385|26199900|FG001|Overall Study|Lost to Follow-up|0|||
13195226|NCT02062385|26199901|FG002|Overall Study|Lost to Follow-up|1|||
13195227|NCT02062385|26199902|FG003|Overall Study|Lost to Follow-up|0|||
13195228|NCT02062151|26199909|FG000|Overall Study|screen failure|1|||
13195229|NCT02061813|26199918|FG000|Overall Study|Withdrawal by Subject|1|||
13195230|NCT02061813|26199918|FG000|Overall Study|Protocol Violation|2|||
13195231|NCT02061592|26199937|FG000|Period 1|Withdrawal by Subject|1|||
13195232|NCT02061592|26199938|FG001|Period 1|Withdrawal by Subject|0|||
13195233|NCT02061592|26199937|FG000|Period 1|Protocol Violation|1|||
13195234|NCT02061592|26199938|FG001|Period 1|Protocol Violation|0|||
13195235|NCT02061592|26199937|FG000|Period 2|Lost to Follow-up|0|||
13195236|NCT02061592|26199938|FG001|Period 2|Lost to Follow-up|1|||
13195237|NCT02061540|26199953|FG000|Overall Study|Adverse Event|2|||
13195238|NCT02061540|26199953|FG000|Overall Study|Withdrawal by Subject|2|||
13195239|NCT02061280|26199990|FG000|Overall Study|Protocol Violation|12|||
13195240|NCT02061280|26199991|FG001|Overall Study|Protocol Violation|8|||
13195241|NCT02061280|26199990|FG000|Overall Study|moved out of state|0|||
13195242|NCT02061280|26199991|FG001|Overall Study|moved out of state|1|||
13195243|NCT02061280|26199990|FG000|Overall Study|Withdrawal by Subject|1|||
13195244|NCT02061280|26199991|FG001|Overall Study|Withdrawal by Subject|2|||
13195245|NCT02061280|26199990|FG000|Overall Study|Lost to Follow-up|5|||
13195246|NCT02061280|26199991|FG001|Overall Study|Lost to Follow-up|1|||
13195247|NCT02061202|26200022|FG000|Overall Study|Lost to Follow-up|1|||
13195248|NCT02061202|26200023|FG001|Overall Study|Lost to Follow-up|1|||
13195249|NCT02060903|26200036|FG000|Overall Study|Lost to Follow-up|4|||
13195250|NCT02060903|26200037|FG001|Overall Study|Lost to Follow-up|0|||
13195251|NCT02060903|26200036|FG000|Overall Study|Withdrawal by Subject|0|||
13195252|NCT02060903|26200037|FG001|Overall Study|Withdrawal by Subject|7|||
13195253|NCT02060487|26200064|FG000|Overall Study|Other|1|||
13195254|NCT02060487|26200065|FG001|Overall Study|Other|2|||
13195255|NCT02060487|26200066|FG002|Overall Study|Other|1|||
13195256|NCT02060487|26200064|FG000|Overall Study|Lack of Efficacy|0|||
13195257|NCT02060487|26200065|FG001|Overall Study|Lack of Efficacy|1|||
13195258|NCT02060487|26200066|FG002|Overall Study|Lack of Efficacy|0|||
13195259|NCT02060487|26200064|FG000|Overall Study|Withdrawal by Subject|3|||
13195260|NCT02060487|26200065|FG001|Overall Study|Withdrawal by Subject|10|||
13195261|NCT02060487|26200066|FG002|Overall Study|Withdrawal by Subject|4|||
13195262|NCT02060487|26200064|FG000|Overall Study|Study Terminated By Sponsor|87|||
13195263|NCT02060487|26200065|FG001|Overall Study|Study Terminated By Sponsor|89|||
13195264|NCT02060487|26200066|FG002|Overall Study|Study Terminated By Sponsor|100|||
13195265|NCT02060487|26200064|FG000|Overall Study|Randomized in error|1|||
13195266|NCT02060487|26200065|FG001|Overall Study|Randomized in error|0|||
13195267|NCT02060487|26200066|FG002|Overall Study|Randomized in error|0|||
13195268|NCT02060487|26200064|FG000|Overall Study|Protocol Violation|0|||
13195269|NCT02060487|26200065|FG001|Overall Study|Protocol Violation|1|||
13195270|NCT02060487|26200066|FG002|Overall Study|Protocol Violation|1|||
13195271|NCT02060487|26200064|FG000|Overall Study|Lost to Follow-up|3|||
13195272|NCT02060487|26200065|FG001|Overall Study|Lost to Follow-up|0|||
13195273|NCT02060487|26200066|FG002|Overall Study|Lost to Follow-up|2|||
13195274|NCT02060487|26200064|FG000|Overall Study|Death|34|||
13195275|NCT02060487|26200065|FG001|Overall Study|Death|25|||
13195276|NCT02060487|26200066|FG002|Overall Study|Death|19|||
13195277|NCT02060487|26200064|FG000|Overall Study|Adverse Event|0|||
13195278|NCT02060487|26200065|FG001|Overall Study|Adverse Event|0|||
13195279|NCT02060487|26200066|FG002|Overall Study|Adverse Event|1|||
13195280|NCT02060383|26200108|FG000|Core Phase|Unsatisfactory therapeutic effect|1|||
13195281|NCT02060383|26200109|FG001|Core Phase|Unsatisfactory therapeutic effect|5|||
13195282|NCT02060383|26200110|FG002|Core Phase|Unsatisfactory therapeutic effect|0|||
13195283|NCT02060383|26200111|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
13195284|NCT02060383|26200112|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
13195285|NCT02060383|26200108|FG000|Core Phase|Adverse Event|2|||
13195286|NCT02060383|26200109|FG001|Core Phase|Adverse Event|0|||
13195287|NCT02060383|26200110|FG002|Core Phase|Adverse Event|0|||
13195288|NCT02060383|26200111|FG003|Core Phase|Adverse Event|2|||
13195289|NCT02060383|26200112|FG004|Core Phase|Adverse Event|6|||
13195290|NCT02060383|26200108|FG000|Core Phase|Administrative problems|0|||
13195291|NCT02060383|26200109|FG001|Core Phase|Administrative problems|1|||
13195292|NCT02060383|26200110|FG002|Core Phase|Administrative problems|0|||
13195293|NCT02060383|26200111|FG003|Core Phase|Administrative problems|0|||
13195294|NCT02060383|26200112|FG004|Core Phase|Administrative problems|0|||
13195295|NCT02060383|26200108|FG000|Core Phase|Protocol Violation|0|||
13195296|NCT02060383|26200109|FG001|Core Phase|Protocol Violation|0|||
13195297|NCT02060383|26200110|FG002|Core Phase|Protocol Violation|0|||
13195298|NCT02060383|26200111|FG003|Core Phase|Protocol Violation|1|||
13195299|NCT02060383|26200112|FG004|Core Phase|Protocol Violation|0|||
13195300|NCT02060383|26200108|FG000|Core Phase|Withdrawal by Subject|0|||
13195301|NCT02060383|26200109|FG001|Core Phase|Withdrawal by Subject|0|||
13195302|NCT02060383|26200110|FG002|Core Phase|Withdrawal by Subject|0|||
13195303|NCT02060383|26200111|FG003|Core Phase|Withdrawal by Subject|4|||
13195304|NCT02060383|26200112|FG004|Core Phase|Withdrawal by Subject|2|||
13195305|NCT02060383|26200108|FG000|Extension Phase|Unsatisfactory therapeutic effect|1|||
13195306|NCT02060383|26200109|FG001|Extension Phase|Unsatisfactory therapeutic effect|1|||
13195307|NCT02060383|26200110|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
13195308|NCT02060383|26200111|FG003|Extension Phase|Unsatisfactory therapeutic effect|2|||
13195309|NCT02060383|26200112|FG004|Extension Phase|Unsatisfactory therapeutic effect|2|||
13195310|NCT02060383|26200108|FG000|Extension Phase|Adverse Event|1|||
13195311|NCT02060383|26200109|FG001|Extension Phase|Adverse Event|1|||
13195312|NCT02060383|26200110|FG002|Extension Phase|Adverse Event|2|||
13195313|NCT02060383|26200111|FG003|Extension Phase|Adverse Event|0|||
13195314|NCT02060383|26200112|FG004|Extension Phase|Adverse Event|1|||
13195315|NCT02060383|26200108|FG000|Extension Phase|Withdrawal by Subject|0|||
13195316|NCT02060383|26200109|FG001|Extension Phase|Withdrawal by Subject|1|||
13195317|NCT02060383|26200110|FG002|Extension Phase|Withdrawal by Subject|0|||
13195318|NCT02060383|26200111|FG003|Extension Phase|Withdrawal by Subject|0|||
13195319|NCT02060383|26200112|FG004|Extension Phase|Withdrawal by Subject|2|||
13195320|NCT02060383|26200108|FG000|Extension Phase|Administrative problems|1|||
13195321|NCT02060383|26200109|FG001|Extension Phase|Administrative problems|0|||
13195322|NCT02060383|26200110|FG002|Extension Phase|Administrative problems|0|||
13195323|NCT02060383|26200111|FG003|Extension Phase|Administrative problems|0|||
13195324|NCT02060383|26200112|FG004|Extension Phase|Administrative problems|0|||
13195325|NCT02060383|26200108|FG000|Extension Phase|Death|0|||
13195326|NCT02060383|26200109|FG001|Extension Phase|Death|0|||
13195327|NCT02060383|26200110|FG002|Extension Phase|Death|1|||
13195328|NCT02060383|26200111|FG003|Extension Phase|Death|0|||
13195329|NCT02060383|26200112|FG004|Extension Phase|Death|1|||
13195330|NCT02060383|26200108|FG000|Extension Phase|Protocol Violation|0|||
13195331|NCT02060383|26200109|FG001|Extension Phase|Protocol Violation|0|||
13195332|NCT02060383|26200110|FG002|Extension Phase|Protocol Violation|0|||
13195333|NCT02060383|26200111|FG003|Extension Phase|Protocol Violation|0|||
13195334|NCT02060383|26200112|FG004|Extension Phase|Protocol Violation|1|||
13195335|NCT02060370|26200123|FG000|Overall Study|Physician Decision|1|||
13195336|NCT02059980|26200142|FG000|Overall Study|Lost to Follow-up|2|||
13195337|NCT02059980|26200143|FG001|Overall Study|Lost to Follow-up|1|||
13195338|NCT02059434|26200233|FG000|Washout Between Periods 1 and 2|Physician Decision|0|||
13195339|NCT02059434|26200234|FG001|Washout Between Periods 1 and 2|Physician Decision|0|||
13195340|NCT02059434|26200235|FG002|Washout Between Periods 1 and 2|Physician Decision|0|||
13195341|NCT02059434|26200236|FG003|Washout Between Periods 1 and 2|Physician Decision|0|||
13195342|NCT02059434|26200237|FG004|Washout Between Periods 1 and 2|Physician Decision|0|||
13195343|NCT02059434|26200238|FG005|Washout Between Periods 1 and 2|Physician Decision|0|||
13195344|NCT02059434|26200239|FG006|Washout Between Periods 1 and 2|Physician Decision|0|||
13195345|NCT02059434|26200240|FG007|Washout Between Periods 1 and 2|Physician Decision|1|||
13195346|NCT02059434|26200241|FG008|Washout Between Periods 1 and 2|Physician Decision|0|||
13195347|NCT02059434|26200233|FG000|Washout Between Periods 4 and 5|Adverse Event|0|||
13195348|NCT02059434|26200234|FG001|Washout Between Periods 4 and 5|Adverse Event|0|||
13195349|NCT02059434|26200235|FG002|Washout Between Periods 4 and 5|Adverse Event|0|||
13195350|NCT02059434|26200236|FG003|Washout Between Periods 4 and 5|Adverse Event|0|||
13195351|NCT02059434|26200237|FG004|Washout Between Periods 4 and 5|Adverse Event|0|||
13195352|NCT02059434|26200238|FG005|Washout Between Periods 4 and 5|Adverse Event|0|||
13195353|NCT02059434|26200239|FG006|Washout Between Periods 4 and 5|Adverse Event|0|||
13195354|NCT02059434|26200240|FG007|Washout Between Periods 4 and 5|Adverse Event|0|||
13195355|NCT02059434|26200241|FG008|Washout Between Periods 4 and 5|Adverse Event|1|||
13195356|NCT02059434|26200233|FG000|Washout Between Periods 6 and 7|Physician Decision|0|||
13195357|NCT02059434|26200234|FG001|Washout Between Periods 6 and 7|Physician Decision|0|||
13195358|NCT02059434|26200235|FG002|Washout Between Periods 6 and 7|Physician Decision|0|||
13195359|NCT02059434|26200236|FG003|Washout Between Periods 6 and 7|Physician Decision|0|||
13195360|NCT02059434|26200237|FG004|Washout Between Periods 6 and 7|Physician Decision|0|||
13195361|NCT02059434|26200238|FG005|Washout Between Periods 6 and 7|Physician Decision|0|||
13195362|NCT02059434|26200239|FG006|Washout Between Periods 6 and 7|Physician Decision|0|||
13195363|NCT02059434|26200240|FG007|Washout Between Periods 6 and 7|Physician Decision|0|||
13195364|NCT02059434|26200241|FG008|Washout Between Periods 6 and 7|Physician Decision|1|||
13195365|NCT02059434|26200233|FG000|Washout Between Periods 7 and 8|Adverse Event|0|||
13195366|NCT02059434|26200234|FG001|Washout Between Periods 7 and 8|Adverse Event|0|||
13195367|NCT02059434|26200235|FG002|Washout Between Periods 7 and 8|Adverse Event|0|||
13195368|NCT02059434|26200236|FG003|Washout Between Periods 7 and 8|Adverse Event|0|||
13195369|NCT02059434|26200237|FG004|Washout Between Periods 7 and 8|Adverse Event|0|||
13195370|NCT02059434|26200238|FG005|Washout Between Periods 7 and 8|Adverse Event|0|||
13195371|NCT02059434|26200239|FG006|Washout Between Periods 7 and 8|Adverse Event|0|||
13195372|NCT02059434|26200240|FG007|Washout Between Periods 7 and 8|Adverse Event|0|||
13195373|NCT02059434|26200241|FG008|Washout Between Periods 7 and 8|Adverse Event|1|||
13195374|NCT02059434|26200233|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
13195375|NCT02059434|26200234|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
13195376|NCT02059434|26200235|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
13195377|NCT02059434|26200236|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
13195378|NCT02059434|26200237|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
13195379|NCT02059434|26200238|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
13195380|NCT02059434|26200239|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
13195381|NCT02059434|26200240|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
13195382|NCT02059434|26200241|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1|||
13195383|NCT02059408|26200268|FG000|Overall Study|Did not get tested|0|||
13195384|NCT02059408|26200269|FG001|Overall Study|Did not get tested|330|||
13195385|NCT02059408|26200270|FG002|Overall Study|Did not get tested|358|||
13195386|NCT02059395|26200283|FG000|Overall Study|Lost to Follow-up|2|||
13195387|NCT02059395|26200284|FG001|Overall Study|Lost to Follow-up|4|||
13195388|NCT02059291|26200380|FG000|Epoch 2|Lack of Efficacy|0|||
13195389|NCT02059291|26200381|FG001|Epoch 2|Lack of Efficacy|0|||
13195390|NCT02059291|26200382|FG002|Epoch 2|Lack of Efficacy|0|||
13195391|NCT02059291|26200383|FG003|Epoch 2|Lack of Efficacy|1|||
13195392|NCT02059291|26200384|FG004|Epoch 2|Lack of Efficacy|0|||
13195393|NCT02059291|26200385|FG005|Epoch 2|Lack of Efficacy|1|||
13195394|NCT02059291|26200386|FG006|Epoch 2|Lack of Efficacy|0|||
13195395|NCT02059291|26200387|FG007|Epoch 2|Lack of Efficacy|0|||
13195396|NCT02059291|26200388|FG008|Epoch 2|Lack of Efficacy|0|||
13195397|NCT02059291|26200389|FG009|Epoch 2|Lack of Efficacy|0|||
13195398|NCT02059291|26200390|FG010|Epoch 2|Lack of Efficacy|0|||
13195399|NCT02059291|26200391|FG011|Epoch 2|Lack of Efficacy|0|||
13195400|NCT02059291|26200392|FG012|Epoch 2|Lack of Efficacy|0|||
13195401|NCT02059291|26200393|FG013|Epoch 2|Lack of Efficacy|0|||
13195402|NCT02059291|26200394|FG014|Epoch 2|Lack of Efficacy|0|||
13195403|NCT02059291|26200395|FG015|Epoch 2|Lack of Efficacy|0|||
13195404|NCT02059291|26200396|FG016|Epoch 2|Lack of Efficacy|0|||
13195405|NCT02059291|26200397|FG017|Epoch 2|Lack of Efficacy|0|||
13195406|NCT02059291|26200398|FG018|Epoch 2|Lack of Efficacy|0|||
13195407|NCT02059291|26200399|FG019|Epoch 2|Lack of Efficacy|0|||
13195408|NCT02059291|26200400|FG020|Epoch 2|Lack of Efficacy|0|||
13195409|NCT02059291|26200401|FG021|Epoch 2|Lack of Efficacy|0|||
13195410|NCT02059291|26200402|FG022|Epoch 2|Lack of Efficacy|0|||
13195411|NCT02059291|26200403|FG023|Epoch 2|Lack of Efficacy|0|||
13195412|NCT02059291|26200404|FG024|Epoch 2|Lack of Efficacy|0|||
13195413|NCT02059291|26200380|FG000|Epoch 2|Adverse Event|0|||
13195414|NCT02059291|26200381|FG001|Epoch 2|Adverse Event|0|||
13195415|NCT02059291|26200382|FG002|Epoch 2|Adverse Event|1|||
13195416|NCT02059291|26200383|FG003|Epoch 2|Adverse Event|1|||
13195417|NCT02059291|26200384|FG004|Epoch 2|Adverse Event|0|||
13195418|NCT02059291|26200385|FG005|Epoch 2|Adverse Event|0|||
13195419|NCT02059291|26200386|FG006|Epoch 2|Adverse Event|0|||
13195420|NCT02059291|26200387|FG007|Epoch 2|Adverse Event|1|||
13195421|NCT02059291|26200388|FG008|Epoch 2|Adverse Event|1|||
13195422|NCT02059291|26200389|FG009|Epoch 2|Adverse Event|0|||
13195423|NCT02059291|26200390|FG010|Epoch 2|Adverse Event|0|||
13195424|NCT02059291|26200391|FG011|Epoch 2|Adverse Event|0|||
13195425|NCT02059291|26200392|FG012|Epoch 2|Adverse Event|0|||
13195426|NCT02059291|26200393|FG013|Epoch 2|Adverse Event|0|||
13195427|NCT02059291|26200394|FG014|Epoch 2|Adverse Event|0|||
13195428|NCT02059291|26200395|FG015|Epoch 2|Adverse Event|0|||
13195429|NCT02059291|26200396|FG016|Epoch 2|Adverse Event|0|||
13195430|NCT02059291|26200397|FG017|Epoch 2|Adverse Event|0|||
13195431|NCT02059291|26200398|FG018|Epoch 2|Adverse Event|0|||
13195432|NCT02059291|26200399|FG019|Epoch 2|Adverse Event|0|||
13195433|NCT02059291|26200400|FG020|Epoch 2|Adverse Event|0|||
13195434|NCT02059291|26200401|FG021|Epoch 2|Adverse Event|0|||
13195435|NCT02059291|26200402|FG022|Epoch 2|Adverse Event|0|||
13195436|NCT02059291|26200403|FG023|Epoch 2|Adverse Event|0|||
13195437|NCT02059291|26200404|FG024|Epoch 2|Adverse Event|0|||
13195438|NCT02059291|26200380|FG000|Epoch 2|Withdrawal by Subject|0|||
13195439|NCT02059291|26200381|FG001|Epoch 2|Withdrawal by Subject|1|||
13195440|NCT02059291|26200382|FG002|Epoch 2|Withdrawal by Subject|0|||
13195441|NCT02059291|26200383|FG003|Epoch 2|Withdrawal by Subject|0|||
13195442|NCT02059291|26200384|FG004|Epoch 2|Withdrawal by Subject|0|||
13195443|NCT02059291|26200385|FG005|Epoch 2|Withdrawal by Subject|1|||
13195444|NCT02059291|26200386|FG006|Epoch 2|Withdrawal by Subject|0|||
13195445|NCT02059291|26200387|FG007|Epoch 2|Withdrawal by Subject|0|||
13195446|NCT02059291|26200388|FG008|Epoch 2|Withdrawal by Subject|1|||
13195447|NCT02059291|26200389|FG009|Epoch 2|Withdrawal by Subject|0|||
13195448|NCT02059291|26200390|FG010|Epoch 2|Withdrawal by Subject|0|||
13195449|NCT02059291|26200391|FG011|Epoch 2|Withdrawal by Subject|0|||
13195450|NCT02059291|26200392|FG012|Epoch 2|Withdrawal by Subject|0|||
13195451|NCT02059291|26200393|FG013|Epoch 2|Withdrawal by Subject|0|||
13195452|NCT02059291|26200394|FG014|Epoch 2|Withdrawal by Subject|0|||
13195453|NCT02059291|26200395|FG015|Epoch 2|Withdrawal by Subject|0|||
13195454|NCT02059291|26200396|FG016|Epoch 2|Withdrawal by Subject|0|||
13112105|NCT03164356|25906852|FG001|Overall Study|Physician Decision|0|||
13195455|NCT02059291|26200397|FG017|Epoch 2|Withdrawal by Subject|0|||
13195456|NCT02059291|26200398|FG018|Epoch 2|Withdrawal by Subject|0|||
13195457|NCT02059291|26200399|FG019|Epoch 2|Withdrawal by Subject|0|||
13195458|NCT02059291|26200400|FG020|Epoch 2|Withdrawal by Subject|0|||
13195459|NCT02059291|26200401|FG021|Epoch 2|Withdrawal by Subject|0|||
13195460|NCT02059291|26200402|FG022|Epoch 2|Withdrawal by Subject|0|||
13112106|NCT03164356|25906853|FG002|Overall Study|Physician Decision|3|||
13112107|NCT03164356|25906854|FG003|Overall Study|Physician Decision|0|||
13112108|NCT03164356|25906851|FG000|Overall Study|Protocol Violation|2|||
13112109|NCT03164356|25906852|FG001|Overall Study|Protocol Violation|1|||
13112110|NCT03164356|25906853|FG002|Overall Study|Protocol Violation|0|||
13112111|NCT03164356|25906854|FG003|Overall Study|Protocol Violation|0|||
13195461|NCT02059291|26200403|FG023|Epoch 2|Withdrawal by Subject|0|||
13485605|NCT02906020|27032879|FG012|Part 2: Long-term Follow-up Period|Other|13|||
13195462|NCT02059291|26200404|FG024|Epoch 2|Withdrawal by Subject|0|||
13195463|NCT02059291|26200380|FG000|Epoch 3|Physician Decision|0|||
13195464|NCT02059291|26200381|FG001|Epoch 3|Physician Decision|0|||
13195465|NCT02059291|26200382|FG002|Epoch 3|Physician Decision|0|||
13195466|NCT02059291|26200383|FG003|Epoch 3|Physician Decision|0|||
13195467|NCT02059291|26200384|FG004|Epoch 3|Physician Decision|0|||
13195468|NCT02059291|26200385|FG005|Epoch 3|Physician Decision|0|||
13195469|NCT02059291|26200386|FG006|Epoch 3|Physician Decision|0|||
13195470|NCT02059291|26200387|FG007|Epoch 3|Physician Decision|0|||
13195471|NCT02059291|26200388|FG008|Epoch 3|Physician Decision|0|||
13195472|NCT02059291|26200389|FG009|Epoch 3|Physician Decision|0|||
13195473|NCT02059291|26200390|FG010|Epoch 3|Physician Decision|0|||
13195474|NCT02059291|26200391|FG011|Epoch 3|Physician Decision|0|||
13195475|NCT02059291|26200392|FG012|Epoch 3|Physician Decision|0|||
13195476|NCT02059291|26200393|FG013|Epoch 3|Physician Decision|1|||
13195477|NCT02059291|26200394|FG014|Epoch 3|Physician Decision|0|||
13195478|NCT02059291|26200395|FG015|Epoch 3|Physician Decision|1|||
13195479|NCT02059291|26200396|FG016|Epoch 3|Physician Decision|0|||
13195480|NCT02059291|26200397|FG017|Epoch 3|Physician Decision|0|||
13195481|NCT02059291|26200398|FG018|Epoch 3|Physician Decision|0|||
13195482|NCT02059291|26200399|FG019|Epoch 3|Physician Decision|0|||
13195483|NCT02059291|26200400|FG020|Epoch 3|Physician Decision|0|||
13195484|NCT02059291|26200401|FG021|Epoch 3|Physician Decision|0|||
13195485|NCT02059291|26200402|FG022|Epoch 3|Physician Decision|0|||
13195486|NCT02059291|26200403|FG023|Epoch 3|Physician Decision|0|||
13195487|NCT02059291|26200404|FG024|Epoch 3|Physician Decision|0|||
13195488|NCT02059291|26200380|FG000|Epoch 3|Adverse Event|0|||
13195489|NCT02059291|26200381|FG001|Epoch 3|Adverse Event|0|||
13195490|NCT02059291|26200382|FG002|Epoch 3|Adverse Event|0|||
13195491|NCT02059291|26200383|FG003|Epoch 3|Adverse Event|0|||
13195492|NCT02059291|26200384|FG004|Epoch 3|Adverse Event|0|||
13195493|NCT02059291|26200385|FG005|Epoch 3|Adverse Event|0|||
13195494|NCT02059291|26200386|FG006|Epoch 3|Adverse Event|0|||
13195495|NCT02059291|26200387|FG007|Epoch 3|Adverse Event|0|||
13195496|NCT02059291|26200388|FG008|Epoch 3|Adverse Event|0|||
13195497|NCT02059291|26200389|FG009|Epoch 3|Adverse Event|0|||
13195498|NCT02059291|26200390|FG010|Epoch 3|Adverse Event|0|||
13485606|NCT02906020|27032880|FG013|Part 2: Long-term Follow-up Period|Other|8|||
13485607|NCT02906020|27032881|FG014|Part 2: Long-term Follow-up Period|Other|3|||
13485608|NCT02906020|27032882|FG015|Part 2: Long-term Follow-up Period|Other|2|||
13485609|NCT02323126|27032965|FG000|Overall Study|Patient / guardian decision|0|||
13485610|NCT02323126|27032966|FG001|Overall Study|Patient / guardian decision|1|||
13485611|NCT02323126|27032967|FG002|Overall Study|Patient / guardian decision|2|||
13485612|NCT02323126|27032965|FG000|Overall Study|Progressive disease|14|||
13112112|NCT03164356|25906851|FG000|Overall Study|Withdrawal by Subject|1|||
13112113|NCT03164356|25906852|FG001|Overall Study|Withdrawal by Subject|0|||
13112114|NCT03164356|25906853|FG002|Overall Study|Withdrawal by Subject|0|||
13112115|NCT03164356|25906854|FG003|Overall Study|Withdrawal by Subject|0|||
13112116|NCT03164356|25906851|FG000|Overall Study|Study timeframe interrupted by COVID-19|1|||
13112117|NCT03164356|25906852|FG001|Overall Study|Study timeframe interrupted by COVID-19|0|||
13112118|NCT03164356|25906853|FG002|Overall Study|Study timeframe interrupted by COVID-19|0|||
13195499|NCT02059291|26200391|FG011|Epoch 3|Adverse Event|0|||
13195500|NCT02059291|26200392|FG012|Epoch 3|Adverse Event|0|||
13195501|NCT02059291|26200393|FG013|Epoch 3|Adverse Event|0|||
13195502|NCT02059291|26200394|FG014|Epoch 3|Adverse Event|0|||
13195503|NCT02059291|26200395|FG015|Epoch 3|Adverse Event|1|||
13195504|NCT02059291|26200396|FG016|Epoch 3|Adverse Event|0|||
13195505|NCT02059291|26200397|FG017|Epoch 3|Adverse Event|0|||
13485613|NCT02323126|27032966|FG001|Overall Study|Progressive disease|8|||
13485614|NCT02323126|27032967|FG002|Overall Study|Progressive disease|14|||
13485615|NCT02323126|27032965|FG000|Overall Study|Physician Decision|0|||
13485616|NCT02323126|27032966|FG001|Overall Study|Physician Decision|1|||
13485617|NCT02323126|27032967|FG002|Overall Study|Physician Decision|3|||
13485618|NCT02323126|27032965|FG000|Overall Study|Death|1|||
13195506|NCT02059291|26200398|FG018|Epoch 3|Adverse Event|0|||
13195507|NCT02059291|26200399|FG019|Epoch 3|Adverse Event|0|||
13195508|NCT02059291|26200400|FG020|Epoch 3|Adverse Event|0|||
13195509|NCT02059291|26200401|FG021|Epoch 3|Adverse Event|0|||
13195510|NCT02059291|26200402|FG022|Epoch 3|Adverse Event|0|||
13195511|NCT02059291|26200403|FG023|Epoch 3|Adverse Event|0|||
13195512|NCT02059291|26200404|FG024|Epoch 3|Adverse Event|0|||
13195513|NCT02059291|26200380|FG000|Epoch 3|Lack of Efficacy|0|||
13195514|NCT02059291|26200381|FG001|Epoch 3|Lack of Efficacy|0|||
13195515|NCT02059291|26200382|FG002|Epoch 3|Lack of Efficacy|0|||
13195516|NCT02059291|26200383|FG003|Epoch 3|Lack of Efficacy|0|||
13195517|NCT02059291|26200384|FG004|Epoch 3|Lack of Efficacy|0|||
13195518|NCT02059291|26200385|FG005|Epoch 3|Lack of Efficacy|0|||
13195519|NCT02059291|26200386|FG006|Epoch 3|Lack of Efficacy|0|||
13195520|NCT02059291|26200387|FG007|Epoch 3|Lack of Efficacy|0|||
13195521|NCT02059291|26200388|FG008|Epoch 3|Lack of Efficacy|0|||
13195522|NCT02059291|26200389|FG009|Epoch 3|Lack of Efficacy|0|||
13195523|NCT02059291|26200390|FG010|Epoch 3|Lack of Efficacy|0|||
13195524|NCT02059291|26200391|FG011|Epoch 3|Lack of Efficacy|0|||
13195525|NCT02059291|26200392|FG012|Epoch 3|Lack of Efficacy|0|||
13195526|NCT02059291|26200393|FG013|Epoch 3|Lack of Efficacy|0|||
13195527|NCT02059291|26200394|FG014|Epoch 3|Lack of Efficacy|0|||
13195528|NCT02059291|26200395|FG015|Epoch 3|Lack of Efficacy|3|||
13195529|NCT02059291|26200396|FG016|Epoch 3|Lack of Efficacy|0|||
13195530|NCT02059291|26200397|FG017|Epoch 3|Lack of Efficacy|0|||
13195531|NCT02059291|26200398|FG018|Epoch 3|Lack of Efficacy|0|||
13195532|NCT02059291|26200399|FG019|Epoch 3|Lack of Efficacy|0|||
13195533|NCT02059291|26200400|FG020|Epoch 3|Lack of Efficacy|0|||
13195534|NCT02059291|26200401|FG021|Epoch 3|Lack of Efficacy|0|||
13195535|NCT02059291|26200402|FG022|Epoch 3|Lack of Efficacy|0|||
13195536|NCT02059291|26200403|FG023|Epoch 3|Lack of Efficacy|0|||
13195537|NCT02059291|26200404|FG024|Epoch 3|Lack of Efficacy|0|||
13195538|NCT02059291|26200380|FG000|Epoch 3|Withdrawal by Subject|0|||
13195539|NCT02059291|26200381|FG001|Epoch 3|Withdrawal by Subject|0|||
13195540|NCT02059291|26200382|FG002|Epoch 3|Withdrawal by Subject|0|||
13195541|NCT02059291|26200383|FG003|Epoch 3|Withdrawal by Subject|0|||
13195542|NCT02059291|26200384|FG004|Epoch 3|Withdrawal by Subject|0|||
13195543|NCT02059291|26200385|FG005|Epoch 3|Withdrawal by Subject|0|||
13195544|NCT02059291|26200386|FG006|Epoch 3|Withdrawal by Subject|0|||
13195545|NCT02059291|26200387|FG007|Epoch 3|Withdrawal by Subject|0|||
13195546|NCT02059291|26200388|FG008|Epoch 3|Withdrawal by Subject|0|||
13195547|NCT02059291|26200389|FG009|Epoch 3|Withdrawal by Subject|0|||
13195548|NCT02059291|26200390|FG010|Epoch 3|Withdrawal by Subject|0|||
13195549|NCT02059291|26200391|FG011|Epoch 3|Withdrawal by Subject|0|||
13195550|NCT02059291|26200392|FG012|Epoch 3|Withdrawal by Subject|0|||
13195551|NCT02059291|26200393|FG013|Epoch 3|Withdrawal by Subject|0|||
13195552|NCT02059291|26200394|FG014|Epoch 3|Withdrawal by Subject|0|||
13195553|NCT02059291|26200395|FG015|Epoch 3|Withdrawal by Subject|1|||
13195554|NCT02059291|26200396|FG016|Epoch 3|Withdrawal by Subject|0|||
13195555|NCT02059291|26200397|FG017|Epoch 3|Withdrawal by Subject|0|||
13195556|NCT02059291|26200398|FG018|Epoch 3|Withdrawal by Subject|0|||
13195557|NCT02059291|26200399|FG019|Epoch 3|Withdrawal by Subject|0|||
13195558|NCT02059291|26200400|FG020|Epoch 3|Withdrawal by Subject|0|||
13195559|NCT02059291|26200401|FG021|Epoch 3|Withdrawal by Subject|0|||
13195560|NCT02059291|26200402|FG022|Epoch 3|Withdrawal by Subject|0|||
13195561|NCT02059291|26200403|FG023|Epoch 3|Withdrawal by Subject|0|||
13195562|NCT02059291|26200404|FG024|Epoch 3|Withdrawal by Subject|0|||
13195563|NCT02059291|26200380|FG000|Epoch 4|Adverse Event|0|||
13195564|NCT02059291|26200381|FG001|Epoch 4|Adverse Event|0|||
13195565|NCT02059291|26200382|FG002|Epoch 4|Adverse Event|0|||
13195566|NCT02059291|26200383|FG003|Epoch 4|Adverse Event|0|||
13195567|NCT02059291|26200384|FG004|Epoch 4|Adverse Event|0|||
13195568|NCT02059291|26200385|FG005|Epoch 4|Adverse Event|0|||
13195569|NCT02059291|26200386|FG006|Epoch 4|Adverse Event|0|||
13195570|NCT02059291|26200387|FG007|Epoch 4|Adverse Event|0|||
13195571|NCT02059291|26200388|FG008|Epoch 4|Adverse Event|0|||
13195572|NCT02059291|26200389|FG009|Epoch 4|Adverse Event|0|||
13195573|NCT02059291|26200390|FG010|Epoch 4|Adverse Event|0|||
13195574|NCT02059291|26200391|FG011|Epoch 4|Adverse Event|0|||
13195575|NCT02059291|26200392|FG012|Epoch 4|Adverse Event|0|||
13195576|NCT02059291|26200393|FG013|Epoch 4|Adverse Event|0|||
13195577|NCT02059291|26200394|FG014|Epoch 4|Adverse Event|0|||
13195578|NCT02059291|26200395|FG015|Epoch 4|Adverse Event|0|||
13195579|NCT02059291|26200396|FG016|Epoch 4|Adverse Event|1|||
13195580|NCT02059291|26200397|FG017|Epoch 4|Adverse Event|0|||
13195581|NCT02059291|26200398|FG018|Epoch 4|Adverse Event|0|||
13195582|NCT02059291|26200399|FG019|Epoch 4|Adverse Event|0|||
13195583|NCT02059291|26200400|FG020|Epoch 4|Adverse Event|0|||
13195584|NCT02059291|26200401|FG021|Epoch 4|Adverse Event|0|||
13485619|NCT02323126|27032966|FG001|Overall Study|Death|1|||
13195585|NCT02059291|26200402|FG022|Epoch 4|Adverse Event|1|||
13195586|NCT02059291|26200403|FG023|Epoch 4|Adverse Event|0|||
13195587|NCT02059291|26200404|FG024|Epoch 4|Adverse Event|0|||
13195588|NCT02059291|26200380|FG000|Epoch 4|Pregnancy|0|||
13195589|NCT02059291|26200381|FG001|Epoch 4|Pregnancy|0|||
13195590|NCT02059291|26200382|FG002|Epoch 4|Pregnancy|0|||
13195591|NCT02059291|26200383|FG003|Epoch 4|Pregnancy|0|||
13195592|NCT02059291|26200384|FG004|Epoch 4|Pregnancy|0|||
13195593|NCT02059291|26200385|FG005|Epoch 4|Pregnancy|0|||
13195594|NCT02059291|26200386|FG006|Epoch 4|Pregnancy|0|||
13195595|NCT02059291|26200387|FG007|Epoch 4|Pregnancy|0|||
13195596|NCT02059291|26200388|FG008|Epoch 4|Pregnancy|0|||
13195597|NCT02059291|26200389|FG009|Epoch 4|Pregnancy|0|||
13195598|NCT02059291|26200390|FG010|Epoch 4|Pregnancy|0|||
13195599|NCT02059291|26200391|FG011|Epoch 4|Pregnancy|0|||
13195600|NCT02059291|26200392|FG012|Epoch 4|Pregnancy|0|||
13195601|NCT02059291|26200393|FG013|Epoch 4|Pregnancy|0|||
13195602|NCT02059291|26200394|FG014|Epoch 4|Pregnancy|0|||
13195603|NCT02059291|26200395|FG015|Epoch 4|Pregnancy|0|||
13195604|NCT02059291|26200396|FG016|Epoch 4|Pregnancy|1|||
13195605|NCT02059291|26200397|FG017|Epoch 4|Pregnancy|0|||
13195606|NCT02059291|26200398|FG018|Epoch 4|Pregnancy|0|||
13195607|NCT02059291|26200399|FG019|Epoch 4|Pregnancy|0|||
13195608|NCT02059291|26200400|FG020|Epoch 4|Pregnancy|0|||
13195609|NCT02059291|26200401|FG021|Epoch 4|Pregnancy|0|||
13195610|NCT02059291|26200402|FG022|Epoch 4|Pregnancy|0|||
13195611|NCT02059291|26200403|FG023|Epoch 4|Pregnancy|0|||
13195612|NCT02059291|26200404|FG024|Epoch 4|Pregnancy|0|||
13195613|NCT02059291|26200380|FG000|Epoch 4|Withdrawal by Subject|0|||
13195614|NCT02059291|26200381|FG001|Epoch 4|Withdrawal by Subject|0|||
13195615|NCT02059291|26200382|FG002|Epoch 4|Withdrawal by Subject|0|||
13195616|NCT02059291|26200383|FG003|Epoch 4|Withdrawal by Subject|0|||
13195617|NCT02059291|26200384|FG004|Epoch 4|Withdrawal by Subject|0|||
13195618|NCT02059291|26200385|FG005|Epoch 4|Withdrawal by Subject|0|||
13195619|NCT02059291|26200386|FG006|Epoch 4|Withdrawal by Subject|0|||
13195620|NCT02059291|26200387|FG007|Epoch 4|Withdrawal by Subject|0|||
13195621|NCT02059291|26200388|FG008|Epoch 4|Withdrawal by Subject|0|||
13195622|NCT02059291|26200389|FG009|Epoch 4|Withdrawal by Subject|0|||
13195623|NCT02059291|26200390|FG010|Epoch 4|Withdrawal by Subject|0|||
13195624|NCT02059291|26200391|FG011|Epoch 4|Withdrawal by Subject|0|||
13195625|NCT02059291|26200392|FG012|Epoch 4|Withdrawal by Subject|0|||
13195626|NCT02059291|26200393|FG013|Epoch 4|Withdrawal by Subject|0|||
13195627|NCT02059291|26200394|FG014|Epoch 4|Withdrawal by Subject|0|||
13195628|NCT02059291|26200395|FG015|Epoch 4|Withdrawal by Subject|0|||
13195629|NCT02059291|26200396|FG016|Epoch 4|Withdrawal by Subject|0|||
13195630|NCT02059291|26200397|FG017|Epoch 4|Withdrawal by Subject|0|||
13195631|NCT02059291|26200398|FG018|Epoch 4|Withdrawal by Subject|0|||
13195632|NCT02059291|26200399|FG019|Epoch 4|Withdrawal by Subject|0|||
13195633|NCT02059291|26200400|FG020|Epoch 4|Withdrawal by Subject|1|||
13195634|NCT02059291|26200401|FG021|Epoch 4|Withdrawal by Subject|0|||
13195635|NCT02059291|26200402|FG022|Epoch 4|Withdrawal by Subject|0|||
13195636|NCT02059291|26200403|FG023|Epoch 4|Withdrawal by Subject|0|||
13195637|NCT02059291|26200404|FG024|Epoch 4|Withdrawal by Subject|0|||
13195638|NCT02059291|26200380|FG000|Epoch 4|Lack of Efficacy|0|||
13195639|NCT02059291|26200381|FG001|Epoch 4|Lack of Efficacy|0|||
13195640|NCT02059291|26200382|FG002|Epoch 4|Lack of Efficacy|0|||
13195641|NCT02059291|26200383|FG003|Epoch 4|Lack of Efficacy|0|||
13195642|NCT02059291|26200384|FG004|Epoch 4|Lack of Efficacy|0|||
13195643|NCT02059291|26200385|FG005|Epoch 4|Lack of Efficacy|0|||
13195644|NCT02059291|26200386|FG006|Epoch 4|Lack of Efficacy|0|||
13195645|NCT02059291|26200387|FG007|Epoch 4|Lack of Efficacy|0|||
13195646|NCT02059291|26200388|FG008|Epoch 4|Lack of Efficacy|0|||
13195647|NCT02059291|26200389|FG009|Epoch 4|Lack of Efficacy|0|||
13195648|NCT02059291|26200390|FG010|Epoch 4|Lack of Efficacy|0|||
13195649|NCT02059291|26200391|FG011|Epoch 4|Lack of Efficacy|0|||
13195650|NCT02059291|26200392|FG012|Epoch 4|Lack of Efficacy|0|||
13195651|NCT02059291|26200393|FG013|Epoch 4|Lack of Efficacy|0|||
13195652|NCT02059291|26200394|FG014|Epoch 4|Lack of Efficacy|0|||
13195653|NCT02059291|26200395|FG015|Epoch 4|Lack of Efficacy|0|||
13195654|NCT02059291|26200396|FG016|Epoch 4|Lack of Efficacy|0|||
13195655|NCT02059291|26200397|FG017|Epoch 4|Lack of Efficacy|0|||
13195656|NCT02059291|26200398|FG018|Epoch 4|Lack of Efficacy|0|||
13195657|NCT02059291|26200399|FG019|Epoch 4|Lack of Efficacy|0|||
13195658|NCT02059291|26200400|FG020|Epoch 4|Lack of Efficacy|0|||
13195659|NCT02059291|26200401|FG021|Epoch 4|Lack of Efficacy|0|||
13195660|NCT02059291|26200402|FG022|Epoch 4|Lack of Efficacy|0|||
13195661|NCT02059291|26200403|FG023|Epoch 4|Lack of Efficacy|1|||
13195662|NCT02059291|26200404|FG024|Epoch 4|Lack of Efficacy|0|||
13195663|NCT02059278|26200425|FG000|Overall Study|Adverse Event|1|||
13195664|NCT02059278|26200426|FG001|Overall Study|Adverse Event|1|||
13195665|NCT02059278|26200425|FG000|Overall Study|Lost to Follow-up|1|||
13195666|NCT02059278|26200426|FG001|Overall Study|Lost to Follow-up|0|||
13195667|NCT02059278|26200425|FG000|Overall Study|Withdrawal by Subject|0|||
13195668|NCT02059278|26200426|FG001|Overall Study|Withdrawal by Subject|3|||
13195669|NCT02059278|26200425|FG000|Overall Study|Ran out of IP and decided to discontinue|1|||
13195670|NCT02059278|26200426|FG001|Overall Study|Ran out of IP and decided to discontinue|0|||
13195672|NCT02059239|26200468|FG000|Overall Study|Progressive Disease after Bendamustine|1|||
13195673|NCT02059239|26200469|FG001|Overall Study|Progressive Disease after Bendamustine|3|||
13195674|NCT02059239|26200468|FG000|Overall Study|Physician Decision|1|||
13195675|NCT02059239|26200469|FG001|Overall Study|Physician Decision|0|||
13195676|NCT02059187|26200502|FG000|Overall Study|Adverse Event|0|||
13195677|NCT02059187|26200503|FG001|Overall Study|Adverse Event|3|||
13195678|NCT02059187|26200502|FG000|Overall Study|Death|1|||
13195679|NCT02059187|26200503|FG001|Overall Study|Death|1|||
13195680|NCT02059187|26200502|FG000|Overall Study|Lost to Follow-up|9|||
13195681|NCT02059187|26200503|FG001|Overall Study|Lost to Follow-up|8|||
13195682|NCT02059187|26200502|FG000|Overall Study|Non-compliance with study drug|1|||
13195683|NCT02059187|26200503|FG001|Overall Study|Non-compliance with study drug|0|||
13195684|NCT02059187|26200502|FG000|Overall Study|Physician Decision|1|||
13195685|NCT02059187|26200503|FG001|Overall Study|Physician Decision|2|||
13195686|NCT02059187|26200502|FG000|Overall Study|Protocol Violation|1|||
13195687|NCT02059187|26200503|FG001|Overall Study|Protocol Violation|0|||
13195688|NCT02059187|26200502|FG000|Overall Study|Withdrawal by Subject|12|||
13195689|NCT02059187|26200503|FG001|Overall Study|Withdrawal by Subject|8|||
13195690|NCT02059174|26200528|FG000|Period 1|Withdrawal by Subject|0|||
13195691|NCT02059174|26200529|FG001|Period 1|Withdrawal by Subject|2|||
13195692|NCT02059174|26200528|FG000|Period 2|Withdrawal by Subject|0|||
13195693|NCT02059174|26200529|FG001|Period 2|Withdrawal by Subject|2|||
13195694|NCT02059174|26200528|FG000|Period 2|Protocol Violation|1|||
13195695|NCT02059174|26200529|FG001|Period 2|Protocol Violation|0|||
13195696|NCT02059174|26200528|FG000|Period 3|Physician Decision|1|||
13195697|NCT02059174|26200529|FG001|Period 3|Physician Decision|0|||
13195698|NCT02059161|26200596|FG000|Overall Study|Pregnancy|0|||
13195699|NCT02059161|26200597|FG001|Overall Study|Pregnancy|2|||
13195700|NCT02059161|26200596|FG000|Overall Study|Adverse Event|2|||
13195701|NCT02059161|26200597|FG001|Overall Study|Adverse Event|6|||
13195702|NCT02059161|26200596|FG000|Overall Study|Lost to Follow-up|20|||
13195703|NCT02059161|26200597|FG001|Overall Study|Lost to Follow-up|12|||
13195704|NCT02059161|26200596|FG000|Overall Study|Physician Decision|4|||
13195705|NCT02059161|26200597|FG001|Overall Study|Physician Decision|4|||
13195706|NCT02059161|26200596|FG000|Overall Study|Protocol Violation|1|||
13195707|NCT02059161|26200597|FG001|Overall Study|Protocol Violation|1|||
13195708|NCT02059161|26200596|FG000|Overall Study|Withdrawal by Subject|16|||
13195709|NCT02059161|26200597|FG001|Overall Study|Withdrawal by Subject|13|||
13195710|NCT02059161|26200596|FG000|Overall Study|Randomized in error, no study drug|0|||
13195711|NCT02059161|26200597|FG001|Overall Study|Randomized in error, no study drug|1|||
13195712|NCT02059161|26200596|FG000|Overall Study|Non-compliance with study drug|6|||
13195713|NCT02059161|26200597|FG001|Overall Study|Non-compliance with study drug|2|||
13195714|NCT02059148|26200621|FG000|Treatment 1|Protocol Violation|0|||
13195715|NCT02059148|26200622|FG001|Treatment 1|Protocol Violation|0|||
13195716|NCT02059148|26200623|FG002|Treatment 1|Protocol Violation|0|||
13195717|NCT02059148|26200624|FG003|Treatment 1|Protocol Violation|0|||
13195718|NCT02059148|26200625|FG004|Treatment 1|Protocol Violation|0|||
13195719|NCT02059148|26200626|FG005|Treatment 1|Protocol Violation|1|||
13195720|NCT02059135|26200645|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3|||
13195721|NCT02059135|26200646|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2|||
13195722|NCT02059135|26200645|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0|||
13195723|NCT02059135|26200646|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3|||
13195724|NCT02059135|26200645|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0|||
13195725|NCT02059135|26200646|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1|||
13195726|NCT02059135|26200645|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0|||
13195727|NCT02059135|26200646|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1|||
13195728|NCT02059135|26200645|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1|||
13195729|NCT02059135|26200646|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0|||
13195730|NCT02059135|26200645|FG000|Neonatal Follow-up (Safety Population)|Death|3|||
13195731|NCT02059135|26200646|FG001|Neonatal Follow-up (Safety Population)|Death|2|||
13195732|NCT02059135|26200645|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0|||
13195733|NCT02059135|26200646|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1|||
13195734|NCT02059135|26200645|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0|||
13195735|NCT02059135|26200646|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1|||
13195736|NCT02059005|26200663|FG000|Overall Study|Death|1|||
13195737|NCT02059005|26200664|FG001|Overall Study|Death|3|||
13195738|NCT02059005|26200663|FG000|Overall Study|Lost to Follow-up|19|||
13195739|NCT02059005|26200664|FG001|Overall Study|Lost to Follow-up|19|||
13195740|NCT02059005|26200663|FG000|Overall Study|Incarceration|0|||
13195741|NCT02059005|26200664|FG001|Overall Study|Incarceration|1|||
13195742|NCT02059005|26200663|FG000|Overall Study|Inpatient|0|||
13195743|NCT02059005|26200664|FG001|Overall Study|Inpatient|1|||
13195744|NCT02058992|26200675|FG000|Overall Study|Lost to Follow-up|4|||
13195745|NCT02058992|26200675|FG000|Overall Study|Protocol Violation|92|||
13195746|NCT02058992|26200675|FG000|Overall Study|CRF Uncollected|20|||
13195747|NCT02058966|26200704|FG000|Open-Label Methamphetamine|Adverse Event|1|||
13195748|NCT02058966|26200704|FG000|First Intervention|Withdrawal by Subject|1|||
13195749|NCT02058940|26200728|FG000|Overall Study|Discharged from Critical Care Unit|1|||
13195750|NCT02058849|26200761|FG000|Overall Study|Hospitalization|1|||
13195751|NCT02058849|26200762|FG001|Overall Study|Hospitalization|1|||
13195752|NCT02058849|26200761|FG000|Overall Study|Death|1|||
13195753|NCT02058849|26200762|FG001|Overall Study|Death|0|||
13195754|NCT02058849|26200761|FG000|Overall Study|Lost to Follow-up|1|||
13195755|NCT02058849|26200762|FG001|Overall Study|Lost to Follow-up|0|||
13195756|NCT02058849|26200761|FG000|Overall Study|Withdrawal by Subject|4|||
13195757|NCT02058849|26200762|FG001|Overall Study|Withdrawal by Subject|0|||
13195758|NCT02058836|26200797|FG000|Overall Study|Withdrawal by Subject|1|||
13195759|NCT02058836|26200798|FG001|Overall Study|Withdrawal by Subject|1|||
13195760|NCT02058628|26200835|FG000|Overall Study|Adverse Event|1|||
13195761|NCT02058628|26200836|FG001|Overall Study|Adverse Event|0|||
13195762|NCT02058628|26200835|FG000|Overall Study|Withdrawal by Subject|2|||
13195763|NCT02058628|26200836|FG001|Overall Study|Withdrawal by Subject|2|||
13195764|NCT02058628|26200835|FG000|Overall Study|Lost to Follow-up|2|||
13195765|NCT02058628|26200836|FG001|Overall Study|Lost to Follow-up|4|||
13195766|NCT02058628|26200835|FG000|Overall Study|Not in time schedule|0|||
13195767|NCT02058628|26200836|FG001|Overall Study|Not in time schedule|1|||
13195768|NCT02058628|26200835|FG000|Overall Study|The visit date was not in timeline|0|||
13195769|NCT02058628|26200836|FG001|Overall Study|The visit date was not in timeline|1|||
13195770|NCT02058628|26200835|FG000|Overall Study|A lot of time for study for participant|1|||
13195771|NCT02058628|26200836|FG001|Overall Study|A lot of time for study for participant|0|||
13195772|NCT02058628|26200835|FG000|Overall Study|Non compliance|1|||
13195773|NCT02058628|26200836|FG001|Overall Study|Non compliance|0|||
13195774|NCT02058589|26200883|FG000|Overall Study|Serious Adverse Event|1|||
13195775|NCT02058589|26200884|FG001|Overall Study|Serious Adverse Event|1|||
13195776|NCT02058589|26200883|FG000|Overall Study|Non-Serious Adverse Event|1|||
13195777|NCT02058589|26200884|FG001|Overall Study|Non-Serious Adverse Event|0|||
13195778|NCT02058589|26200883|FG000|Overall Study|Withdrawal by Subject|0|||
13195779|NCT02058589|26200884|FG001|Overall Study|Withdrawal by Subject|1|||
13195780|NCT02058563|26200927|FG000|Overall Study|Lost to Follow-up|26|||
13195781|NCT02058563|26200928|FG001|Overall Study|Lost to Follow-up|22|||
13195782|NCT02058563|26200927|FG000|Overall Study|Other (vaccinated later as new subject)|1|||
13195783|NCT02058563|26200928|FG001|Overall Study|Other (vaccinated later as new subject)|0|||
13195784|NCT02058563|26200927|FG000|Overall Study|Consent Withdrawal|1|||
13195785|NCT02058563|26200928|FG001|Overall Study|Consent Withdrawal|1|||
13195786|NCT02058563|26200927|FG000|Overall Study|Other (patient incarcerated)|0|||
13195787|NCT02058563|26200928|FG001|Overall Study|Other (patient incarcerated)|1|||
13195788|NCT02058537|26200936|FG000|Overall Study|Withdrawal by Subject|1|||
13195789|NCT02058498|26200944|FG000|Overall Study|Withdrawal by Subject|4|||
13195790|NCT02058368|26201001|FG000|Overall Study|Adverse Event|15|||
13195791|NCT02058368|26201002|FG001|Overall Study|Adverse Event|20|||
13195792|NCT02058368|26201001|FG000|Overall Study|Lack of Efficacy|0|||
13195793|NCT02058368|26201002|FG001|Overall Study|Lack of Efficacy|1|||
13195794|NCT02058368|26201001|FG000|Overall Study|Protocol Violation|0|||
13195795|NCT02058368|26201002|FG001|Overall Study|Protocol Violation|4|||
13195796|NCT02058368|26201001|FG000|Overall Study|Lost to Follow-up|2|||
13195797|NCT02058368|26201002|FG001|Overall Study|Lost to Follow-up|0|||
13195798|NCT02058368|26201001|FG000|Overall Study|Physician Decision|2|||
13195799|NCT02058368|26201002|FG001|Overall Study|Physician Decision|3|||
13195800|NCT02058368|26201001|FG000|Overall Study|Withdrawal by Subject|22|||
13195801|NCT02058368|26201002|FG001|Overall Study|Withdrawal by Subject|26|||
13195802|NCT02058290|26201023|FG000|Overall Study|Protocol Violation|2|||
13195803|NCT02058290|26201024|FG001|Overall Study|Protocol Violation|1|||
13195804|NCT02058290|26201023|FG000|Overall Study|Physician Decision|1|||
13112119|NCT03164356|25906854|FG003|Overall Study|Study timeframe interrupted by COVID-19|1|||
13112120|NCT03164356|25906851|FG000|Overall Study|Subject Incarcerated|0|||
13112121|NCT03164356|25906852|FG001|Overall Study|Subject Incarcerated|1|||
13112122|NCT03164356|25906853|FG002|Overall Study|Subject Incarcerated|0|||
13112123|NCT03164356|25906854|FG003|Overall Study|Subject Incarcerated|0|||
13112124|NCT03164356|25906851|FG000|Overall Study|Prosthetist unable to participate|0|||
13112125|NCT03164356|25906852|FG001|Overall Study|Prosthetist unable to participate|2|||
13112126|NCT03164356|25906853|FG002|Overall Study|Prosthetist unable to participate|1|||
13112127|NCT03164356|25906854|FG003|Overall Study|Prosthetist unable to participate|0|||
13112128|NCT03163667|25906869|FG000|Overall Study|Death|15|||
13112129|NCT03163667|25906870|FG001|Overall Study|Death|27|||
13112130|NCT03163667|25906869|FG000|Overall Study|Study terminated by sponsor (after primary endpoint was met)|8|||
13112131|NCT03163667|25906870|FG001|Overall Study|Study terminated by sponsor (after primary endpoint was met)|19|||
13112132|NCT03163446|25906909|FG000|Overall Study|Unable to return for Day 180 visit|2|||
13112133|NCT03163446|25906910|FG001|Overall Study|Unable to return for Day 180 visit|0|||
13195805|NCT02058290|26201024|FG001|Overall Study|Physician Decision|0|||
13195806|NCT02058290|26201023|FG000|Overall Study|Didn't meet intraoperative criteria|8|||
13485620|NCT02323126|27032967|FG002|Overall Study|Death|4|||
13195807|NCT02058290|26201024|FG001|Overall Study|Didn't meet intraoperative criteria|7|||
13195808|NCT02058290|26201023|FG000|Overall Study|Withdrawal by Subject|0|||
13195809|NCT02058290|26201024|FG001|Overall Study|Withdrawal by Subject|1|||
13195810|NCT02058160|26201065|FG000|Overall Study|Randomized but not treated|2|||
13195811|NCT02058160|26201066|FG001|Overall Study|Randomized but not treated|4|||
13195812|NCT02058160|26201065|FG000|Overall Study|Poor compliance to protocol|4|||
13195813|NCT02058160|26201066|FG001|Overall Study|Poor compliance to protocol|1|||
13195814|NCT02058160|26201065|FG000|Overall Study|Adverse Event|12|||
13195815|NCT02058160|26201066|FG001|Overall Study|Adverse Event|3|||
13195816|NCT02058160|26201065|FG000|Overall Study|Lost to Follow-up|1|||
13195817|NCT02058160|26201066|FG001|Overall Study|Lost to Follow-up|0|||
13195818|NCT02058160|26201065|FG000|Overall Study|Other than specified above|12|||
13195819|NCT02058160|26201066|FG001|Overall Study|Other than specified above|6|||
13195820|NCT02058147|26201125|FG000|Overall Study|Randomized but not treated|0|||
13195821|NCT02058147|26201126|FG001|Overall Study|Randomized but not treated|0|||
13195822|NCT02058147|26201127|FG002|Overall Study|Randomized but not treated|1|||
13195823|NCT02058147|26201125|FG000|Overall Study|Adverse Event|12|||
13195824|NCT02058147|26201126|FG001|Overall Study|Adverse Event|9|||
13195825|NCT02058147|26201127|FG002|Overall Study|Adverse Event|21|||
13195826|NCT02058147|26201125|FG000|Overall Study|Lack of Efficacy|1|||
13112134|NCT03163446|25906909|FG000|Overall Study|Withdrawal by Subject|2|||
13195827|NCT02058147|26201126|FG001|Overall Study|Lack of Efficacy|0|||
13195828|NCT02058147|26201127|FG002|Overall Study|Lack of Efficacy|3|||
13195829|NCT02058147|26201125|FG000|Overall Study|Poor compliance to protocol|8|||
13195830|NCT02058147|26201126|FG001|Overall Study|Poor compliance to protocol|9|||
13195831|NCT02058147|26201127|FG002|Overall Study|Poor compliance to protocol|4|||
13195832|NCT02058147|26201125|FG000|Overall Study|Other than specified|8|||
13195833|NCT02058147|26201126|FG001|Overall Study|Other than specified|9|||
13195834|NCT02058147|26201127|FG002|Overall Study|Other than specified|0|||
13195835|NCT02058108|26201158|FG000|Overall Study|Abnormal Laboratory Values|0|||
13195836|NCT02058108|26201159|FG001|Overall Study|Abnormal Laboratory Values|1|||
13195837|NCT02058108|26201158|FG000|Overall Study|Unsatisfactory therapeutic effect|37|||
13195838|NCT02058108|26201159|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
13195839|NCT02058108|26201158|FG000|Overall Study|No longer requires study drug|0|||
13195840|NCT02058108|26201159|FG001|Overall Study|No longer requires study drug|1|||
13195841|NCT02058108|26201158|FG000|Overall Study|Withdrawal by Subject|1|||
13195842|NCT02058108|26201159|FG001|Overall Study|Withdrawal by Subject|0|||
13195843|NCT02058108|26201158|FG000|Overall Study|Administrative problems|3|||
13195844|NCT02058108|26201159|FG001|Overall Study|Administrative problems|3|||
13195845|NCT02058108|26201158|FG000|Overall Study|Protocol Violation|0|||
13195846|NCT02058108|26201159|FG001|Overall Study|Protocol Violation|1|||
13195847|NCT02058095|26201176|FG000|Overall Study|Adverse Event|1|||
13195848|NCT02058095|26201177|FG001|Overall Study|Adverse Event|0|||
13195849|NCT02058069|26201188|FG000|Overall Study|Exclusion due to implant size|5|||
13112135|NCT03163446|25906910|FG001|Overall Study|Withdrawal by Subject|6|||
13112136|NCT03163446|25906909|FG000|Overall Study|Death|16|||
13112137|NCT03163446|25906910|FG001|Overall Study|Death|5|||
13112138|NCT03163446|25906909|FG000|Overall Study|Lost to Follow-up|6|||
13112139|NCT03163446|25906910|FG001|Overall Study|Lost to Follow-up|5|||
13112140|NCT03163446|25906909|FG000|Overall Study|Physician Decision|1|||
13112141|NCT03163446|25906910|FG001|Overall Study|Physician Decision|1|||
13112142|NCT03163446|25906909|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1|||
13112143|NCT03163446|25906910|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0|||
13112144|NCT03162796|25907224|FG000|Placebo Controlled Period: Week 0 - 24|Other|0|||
13112145|NCT03162796|25907225|FG001|Placebo Controlled Period: Week 0 - 24|Other|1|||
13112146|NCT03162796|25907226|FG002|Placebo Controlled Period: Week 0 - 24|Other|1|||
13112147|NCT03162796|25907224|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1|||
13112148|NCT03162796|25907225|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
13112149|NCT03162796|25907226|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
13112150|NCT03162796|25907224|FG000|Placebo Controlled Period: Week 0 - 24|Death|1|||
13112151|NCT03162796|25907225|FG001|Placebo Controlled Period: Week 0 - 24|Death|0|||
13112152|NCT03162796|25907226|FG002|Placebo Controlled Period: Week 0 - 24|Death|0|||
13112153|NCT03162796|25907224|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1|||
13112154|NCT03162796|25907225|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
13112155|NCT03162796|25907226|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
13112156|NCT03162796|25907224|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3|||
13112157|NCT03162796|25907225|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
13112158|NCT03162796|25907226|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
13195850|NCT02058069|26201188|FG000|Overall Study|Withdrawal by Subject|6|||
13206409|NCT01957553|26234718|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1|||
13206410|NCT01957553|26234719|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3|||
13206411|NCT01957553|26234718|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1|||
13206412|NCT01957553|26234719|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2|||
13195851|NCT02057874|26201198|FG000|Overall Study|participant did not return for scan|1|||
13195852|NCT02057835|26201306|FG000|Overall Study|Withdrawal by Subject|0|||
13195853|NCT02057835|26201307|FG001|Overall Study|Withdrawal by Subject|2|||
13195854|NCT02057835|26201308|FG002|Overall Study|Withdrawal by Subject|0|||
13195855|NCT02057835|26201309|FG003|Overall Study|Withdrawal by Subject|0|||
13195856|NCT02057835|26201310|FG004|Overall Study|Withdrawal by Subject|0|||
13195857|NCT02057835|26201311|FG005|Overall Study|Withdrawal by Subject|0|||
13195858|NCT02057835|26201312|FG006|Overall Study|Withdrawal by Subject|0|||
13195859|NCT02057835|26201313|FG007|Overall Study|Withdrawal by Subject|0|||
13195860|NCT02057835|26201314|FG008|Overall Study|Withdrawal by Subject|0|||
13195861|NCT02057835|26201315|FG009|Overall Study|Withdrawal by Subject|0|||
13195862|NCT02057757|26201372|FG000|Overall Study|Withdrawal by Subject|3|||
13195863|NCT02057757|26201373|FG001|Overall Study|Withdrawal by Subject|5|||
13195864|NCT02057757|26201372|FG000|Overall Study|Death|2|||
13195865|NCT02057757|26201373|FG001|Overall Study|Death|0|||
13195866|NCT02057757|26201372|FG000|Overall Study|Lost to Follow-up|8|||
13195867|NCT02057757|26201373|FG001|Overall Study|Lost to Follow-up|3|||
13195868|NCT02057757|26201372|FG000|Overall Study|Non-compliance|1|||
13195869|NCT02057757|26201373|FG001|Overall Study|Non-compliance|0|||
13195870|NCT02057718|26201401|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0|||
13195871|NCT02057718|26201402|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2|||
13195872|NCT02057718|26201401|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1|||
13195873|NCT02057718|26201402|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0|||
13195874|NCT02057718|26201401|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0|||
13195875|NCT02057718|26201402|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1|||
13195876|NCT02057718|26201401|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0|||
13195877|NCT02057718|26201402|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3|||
13195878|NCT02057718|26201401|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
13195879|NCT02057718|26201402|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
13195880|NCT02057718|26201401|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0|||
13195881|NCT02057718|26201402|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1|||
13195882|NCT02057718|26201401|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0|||
13112159|NCT03162796|25907224|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4|||
13195883|NCT02057718|26201402|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1|||
13195884|NCT02057718|26201401|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1|||
13195885|NCT02057718|26201402|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3|||
13195886|NCT02057718|26201401|FG000|Optional Follow-up Treatment Period|Progressive disease|0|||
13195887|NCT02057718|26201402|FG001|Optional Follow-up Treatment Period|Progressive disease|1|||
13195888|NCT02057718|26201401|FG000|Optional Follow-up Treatment Period|Adverse Event|1|||
13195889|NCT02057718|26201402|FG001|Optional Follow-up Treatment Period|Adverse Event|2|||
13195890|NCT02057718|26201401|FG000|Optional Follow-up Treatment Period|Liver Transplant|0|||
13195891|NCT02057718|26201402|FG001|Optional Follow-up Treatment Period|Liver Transplant|2|||
13195892|NCT02057692|26201443|FG000|Overall Study|Adverse Event|1|||
13195893|NCT02057692|26201444|FG001|Overall Study|Adverse Event|0|||
13195894|NCT02057692|26201445|FG002|Overall Study|Adverse Event|0|||
13195895|NCT02057692|26201446|FG003|Overall Study|Adverse Event|0|||
13195896|NCT02057692|26201443|FG000|Overall Study|Lost to Follow-up|0|||
13195897|NCT02057692|26201444|FG001|Overall Study|Lost to Follow-up|0|||
13195898|NCT02057692|26201445|FG002|Overall Study|Lost to Follow-up|0|||
13195899|NCT02057692|26201446|FG003|Overall Study|Lost to Follow-up|1|||
13195900|NCT02057666|26201469|FG000|Double Blind Treatment Period|Withdrawal by Subject|8|||
13195901|NCT02057666|26201470|FG001|Double Blind Treatment Period|Withdrawal by Subject|5|||
13195902|NCT02057666|26201469|FG000|Double Blind Treatment Period|Poor tolerability|7|||
13195903|NCT02057666|26201470|FG001|Double Blind Treatment Period|Poor tolerability|2|||
13195904|NCT02057666|26201469|FG000|Double Blind Treatment Period|Symptomatic disease progression|8|||
13195905|NCT02057666|26201470|FG001|Double Blind Treatment Period|Symptomatic disease progression|3|||
13195906|NCT02057666|26201469|FG000|Double Blind Treatment Period|Physician Decision|1|||
13195907|NCT02057666|26201470|FG001|Double Blind Treatment Period|Physician Decision|0|||
13195908|NCT02057666|26201469|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1|||
13195909|NCT02057666|26201470|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0|||
13195910|NCT02057666|26201469|FG000|Double Blind Treatment Period|Subject planning to withdraw|1|||
13112160|NCT03162796|25907225|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
13112161|NCT03162796|25907226|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
13112162|NCT03162796|25907224|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2|||
13112163|NCT03162796|25907225|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3|||
13112164|NCT03162796|25907226|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1|||
13112165|NCT03162796|25907224|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
13133290|NCT02775903|25987169|FG003|Overall Study|Lost to Follow-up|1|||
13195911|NCT02057666|26201470|FG001|Double Blind Treatment Period|Subject planning to withdraw|0|||
13112166|NCT03162796|25907225|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
13112167|NCT03162796|25907226|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
13112168|NCT03162796|25907224|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
13112169|NCT03162796|25907225|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
13112170|NCT03162796|25907226|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1|||
13112171|NCT03162796|25907224|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
13195912|NCT02057666|26201469|FG000|Double Blind Treatment Period|Sponsor's request|70|||
13195913|NCT02057666|26201470|FG001|Double Blind Treatment Period|Sponsor's request|34|||
13195914|NCT02057666|26201469|FG000|Open-Label Treatment Period|Poor tolerability|0|||
13195915|NCT02057666|26201470|FG001|Open-Label Treatment Period|Poor tolerability|1|||
13195916|NCT02057666|26201469|FG000|Open-Label Treatment Period|Symptomatic disease progression|0|||
13195917|NCT02057666|26201470|FG001|Open-Label Treatment Period|Symptomatic disease progression|1|||
13195918|NCT02057666|26201469|FG000|Open-Label Treatment Period|Sponsor's request|0|||
13195919|NCT02057666|26201470|FG001|Open-Label Treatment Period|Sponsor's request|4|||
13112172|NCT03162796|25907225|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2|||
13112173|NCT03162796|25907226|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
13112174|NCT03162796|25907224|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
13112175|NCT03162796|25907225|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2|||
13112176|NCT03162796|25907226|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
13112177|NCT03162614|25907337|FG000|Overall Study|Lost to Follow-up|2|||
13195920|NCT02057575|26201493|FG000|Overall Study|Adverse Event|0|||
13195921|NCT02057575|26201494|FG001|Overall Study|Adverse Event|2|||
13195922|NCT02057575|26201495|FG002|Overall Study|Adverse Event|0|||
13195923|NCT02057575|26201496|FG003|Overall Study|Adverse Event|1|||
13195924|NCT02057575|26201493|FG000|Overall Study|Withdrawal by Subject|1|||
13195925|NCT02057575|26201494|FG001|Overall Study|Withdrawal by Subject|0|||
13195926|NCT02057575|26201495|FG002|Overall Study|Withdrawal by Subject|0|||
13195927|NCT02057575|26201496|FG003|Overall Study|Withdrawal by Subject|0|||
13195928|NCT02057575|26201493|FG000|Overall Study|Dissallowed Concurrent Medication|0|||
13195929|NCT02057575|26201494|FG001|Overall Study|Dissallowed Concurrent Medication|1|||
13195930|NCT02057575|26201495|FG002|Overall Study|Dissallowed Concurrent Medication|0|||
13195931|NCT02057575|26201496|FG003|Overall Study|Dissallowed Concurrent Medication|0|||
13195932|NCT02057575|26201493|FG000|Overall Study|Protocol Violation|0|||
13195933|NCT02057575|26201494|FG001|Overall Study|Protocol Violation|1|||
13195934|NCT02057575|26201495|FG002|Overall Study|Protocol Violation|0|||
13195935|NCT02057575|26201496|FG003|Overall Study|Protocol Violation|0|||
13195936|NCT02057549|26201523|FG000|Overall Study|Lost to Follow-up|1|||
13195937|NCT02057549|26201524|FG001|Overall Study|Lost to Follow-up|0|||
13195938|NCT02057549|26201523|FG000|Overall Study|Physician Decision|1|||
13195939|NCT02057549|26201524|FG001|Overall Study|Physician Decision|0|||
13195940|NCT02057549|26201523|FG000|Overall Study|Withdrawal by Subject|1|||
13195941|NCT02057549|26201524|FG001|Overall Study|Withdrawal by Subject|0|||
13195942|NCT02057523|26201531|FG000|Overall Study|Withdrawal by Subject|1|||
13195943|NCT02057523|26201531|FG000|Overall Study|Lack of Efficacy|1|||
13195944|NCT02057458|26201570|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0|||
13195945|NCT02057458|26201571|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1|||
13195946|NCT02057458|26201572|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0|||
13195947|NCT02057458|26201570|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2|||
13195948|NCT02057458|26201571|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
13195949|NCT02057458|26201572|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
13195950|NCT02057458|26201570|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1|||
13195951|NCT02057458|26201571|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
13195952|NCT02057458|26201572|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
13195953|NCT02057406|26201593|FG000|Overall Study|Physician Decision|0|||
13195954|NCT02057406|26201594|FG001|Overall Study|Physician Decision|0|||
13195955|NCT02057406|26201595|FG002|Overall Study|Physician Decision|2|||
13195956|NCT02057406|26201593|FG000|Overall Study|Withdrawal by Subject|0|||
13195957|NCT02057406|26201594|FG001|Overall Study|Withdrawal by Subject|2|||
13195958|NCT02057406|26201595|FG002|Overall Study|Withdrawal by Subject|0|||
13195959|NCT02057406|26201593|FG000|Overall Study|Lost to Follow-up|0|||
13195960|NCT02057406|26201594|FG001|Overall Study|Lost to Follow-up|0|||
13195961|NCT02057406|26201595|FG002|Overall Study|Lost to Follow-up|1|||
13195962|NCT02057406|26201593|FG000|Overall Study|Death|1|||
13195963|NCT02057406|26201594|FG001|Overall Study|Death|0|||
13195964|NCT02057406|26201595|FG002|Overall Study|Death|0|||
13195965|NCT02057406|26201593|FG000|Overall Study|Protocol Violation|0|||
13195966|NCT02057406|26201594|FG001|Overall Study|Protocol Violation|1|||
13195967|NCT02057406|26201595|FG002|Overall Study|Protocol Violation|0|||
13195968|NCT02057406|26201593|FG000|Overall Study|Patient transportation issues|0|||
13195969|NCT02057406|26201594|FG001|Overall Study|Patient transportation issues|0|||
13195970|NCT02057406|26201595|FG002|Overall Study|Patient transportation issues|1|||
13195971|NCT02057393|26201601|FG000|Overall Study|Withdrawal by Subject|1|||
13485621|NCT02323126|27032965|FG000|Overall Study|Adverse Event|3|||
13195972|NCT02057393|26201601|FG000|Overall Study|Patient did not meet criteria|1|||
13195973|NCT02057250|26201628|FG000|AID Assessment Phase|Adverse Event|3|||
13195974|NCT02057250|26201629|FG001|AID Assessment Phase|Adverse Event|2|||
13195975|NCT02057250|26201630|FG002|AID Assessment Phase|Adverse Event|6|||
13195976|NCT02057250|26201631|FG003|AID Assessment Phase|Adverse Event|1|||
13195977|NCT02057250|26201632|FG004|AID Assessment Phase|Adverse Event|0|||
13195978|NCT02057250|26201628|FG000|AID Assessment Phase|Other than specified above|1|||
13195979|NCT02057250|26201629|FG001|AID Assessment Phase|Other than specified above|1|||
13195980|NCT02057250|26201630|FG002|AID Assessment Phase|Other than specified above|1|||
13195981|NCT02057250|26201631|FG003|AID Assessment Phase|Other than specified above|1|||
13195982|NCT02057250|26201632|FG004|AID Assessment Phase|Other than specified above|0|||
13195983|NCT02057250|26201628|FG000|Extension Phase|Adverse Event|0|||
13195984|NCT02057250|26201629|FG001|Extension Phase|Adverse Event|0|||
13195985|NCT02057250|26201630|FG002|Extension Phase|Adverse Event|0|||
13195986|NCT02057250|26201631|FG003|Extension Phase|Adverse Event|0|||
13195987|NCT02057250|26201632|FG004|Extension Phase|Adverse Event|15|||
13195988|NCT02057250|26201628|FG000|Extension Phase|Lack of Efficacy|0|||
13195989|NCT02057250|26201629|FG001|Extension Phase|Lack of Efficacy|0|||
13195990|NCT02057250|26201630|FG002|Extension Phase|Lack of Efficacy|0|||
13195991|NCT02057250|26201631|FG003|Extension Phase|Lack of Efficacy|0|||
13112178|NCT03162614|25907338|FG001|Overall Study|Lost to Follow-up|1|||
13195992|NCT02057250|26201632|FG004|Extension Phase|Lack of Efficacy|10|||
13195993|NCT02057250|26201628|FG000|Extension Phase|Entered in this period but not treated|0|||
13195994|NCT02057250|26201629|FG001|Extension Phase|Entered in this period but not treated|0|||
13195995|NCT02057250|26201630|FG002|Extension Phase|Entered in this period but not treated|0|||
13195996|NCT02057250|26201631|FG003|Extension Phase|Entered in this period but not treated|0|||
13195997|NCT02057250|26201632|FG004|Extension Phase|Entered in this period but not treated|4|||
13195998|NCT02057250|26201628|FG000|Extension Phase|Other than specified above|0|||
13195999|NCT02057250|26201629|FG001|Extension Phase|Other than specified above|0|||
13196000|NCT02057250|26201630|FG002|Extension Phase|Other than specified above|0|||
13196001|NCT02057250|26201631|FG003|Extension Phase|Other than specified above|0|||
13196002|NCT02057250|26201632|FG004|Extension Phase|Other than specified above|7|||
13196003|NCT02057198|26201665|FG000|Overall Study|Death|0|||
13196004|NCT02057198|26201666|FG001|Overall Study|Death|0|||
13196005|NCT02057198|26201667|FG002|Overall Study|Death|1|||
13196006|NCT02057198|26201665|FG000|Overall Study|Discharged early; lost to followup|0|||
13196007|NCT02057198|26201666|FG001|Overall Study|Discharged early; lost to followup|1|||
13196008|NCT02057198|26201667|FG002|Overall Study|Discharged early; lost to followup|0|||
13196009|NCT02057068|26201684|FG000|Overall Study|Withdrawal by Subject|2|||
13196010|NCT02057068|26201685|FG001|Overall Study|Withdrawal by Subject|2|||
13196011|NCT02057068|26201684|FG000|Overall Study|Caregiver (CG) Health|0|||
13196012|NCT02057068|26201685|FG001|Overall Study|Caregiver (CG) Health|2|||
13196013|NCT02057068|26201684|FG000|Overall Study|Carepartner (CP) Health|4|||
13196014|NCT02057068|26201685|FG001|Overall Study|Carepartner (CP) Health|2|||
13196015|NCT02057068|26201684|FG000|Overall Study|Lost to Follow-up|2|||
13196016|NCT02057068|26201685|FG001|Overall Study|Lost to Follow-up|2|||
13196017|NCT02056834|26201706|FG000|Overall Study|Lost to Follow-up|7|||
13196018|NCT02056652|26201729|FG000|Overall Study|Withdrawal by Subject|1|||
13196019|NCT02056652|26201730|FG001|Overall Study|Withdrawal by Subject|0|||
13196020|NCT02056652|26201729|FG000|Overall Study|Lost to Follow-up|0|||
13196021|NCT02056652|26201730|FG001|Overall Study|Lost to Follow-up|3|||
13196022|NCT02056626|26201761|FG000|Overall Study|patient did not follow directions|3|||
13196023|NCT02056626|26201762|FG001|Overall Study|patient did not follow directions|1|||
13196024|NCT02056626|26201763|FG002|Overall Study|patient did not follow directions|0|||
13196025|NCT02056626|26201764|FG003|Overall Study|patient did not follow directions|0|||
13196026|NCT02056392|26201818|FG000|Overall Study|Lost to Follow-up|0|||
13196027|NCT02056392|26201819|FG001|Overall Study|Lost to Follow-up|1|||
13196028|NCT02056392|26201820|FG002|Overall Study|Lost to Follow-up|2|||
13196029|NCT02056392|26201821|FG003|Overall Study|Lost to Follow-up|0|||
13196030|NCT02056392|26201822|FG004|Overall Study|Lost to Follow-up|0|||
13196031|NCT02056392|26201823|FG005|Overall Study|Lost to Follow-up|0|||
13196032|NCT02056392|26201818|FG000|Overall Study|Protocol Violation|1|||
13196033|NCT02056392|26201819|FG001|Overall Study|Protocol Violation|0|||
13196034|NCT02056392|26201820|FG002|Overall Study|Protocol Violation|1|||
13112179|NCT03162614|25907339|FG002|Overall Study|Lost to Follow-up|1|||
13112180|NCT03162614|25907340|FG003|Overall Study|Lost to Follow-up|1|||
13112181|NCT03162614|25907341|FG004|Overall Study|Lost to Follow-up|2|||
13112182|NCT03162614|25907342|FG005|Overall Study|Lost to Follow-up|0|||
13112183|NCT03162614|25907337|FG000|Overall Study|Protocol Violation|0|||
13112184|NCT03162614|25907338|FG001|Overall Study|Protocol Violation|1|||
13112185|NCT03162614|25907339|FG002|Overall Study|Protocol Violation|0|||
13112186|NCT03162614|25907340|FG003|Overall Study|Protocol Violation|1|||
13112187|NCT03162614|25907341|FG004|Overall Study|Protocol Violation|0|||
13112188|NCT03162614|25907342|FG005|Overall Study|Protocol Violation|0|||
13112189|NCT03162614|25907337|FG000|Overall Study|Withdrawal by Subject|2|||
13112190|NCT03162614|25907338|FG001|Overall Study|Withdrawal by Subject|1|||
13196035|NCT02056392|26201821|FG003|Overall Study|Protocol Violation|0|||
13196036|NCT02056392|26201822|FG004|Overall Study|Protocol Violation|0|||
13196037|NCT02056392|26201823|FG005|Overall Study|Protocol Violation|0|||
13196038|NCT02056392|26201818|FG000|Overall Study|Withdrawal by Subject|1|||
13196039|NCT02056392|26201819|FG001|Overall Study|Withdrawal by Subject|0|||
13196040|NCT02056392|26201820|FG002|Overall Study|Withdrawal by Subject|0|||
13196041|NCT02056392|26201821|FG003|Overall Study|Withdrawal by Subject|0|||
13196042|NCT02056392|26201822|FG004|Overall Study|Withdrawal by Subject|1|||
13196043|NCT02056392|26201823|FG005|Overall Study|Withdrawal by Subject|0|||
13196044|NCT02056340|26201838|FG000|Overall Study|Lost to Follow-up|5|||
13196045|NCT02056340|26201839|FG001|Overall Study|Lost to Follow-up|5|||
13196046|NCT02056340|26201838|FG000|Overall Study|Withdrawal by Subject|2|||
13196047|NCT02056340|26201839|FG001|Overall Study|Withdrawal by Subject|6|||
13196048|NCT02056301|26201856|FG000|Overall Study|Protocol Violation|1|||
13196049|NCT02056301|26201857|FG001|Overall Study|Protocol Violation|2|||
13196050|NCT02056301|26201856|FG000|Overall Study|Surgical complications req. 2nd surgery|1|||
13196051|NCT02056301|26201857|FG001|Overall Study|Surgical complications req. 2nd surgery|0|||
13196052|NCT02056301|26201856|FG000|Overall Study|Withdrawal by Subject|0|||
13196053|NCT02056301|26201857|FG001|Overall Study|Withdrawal by Subject|1|||
13196054|NCT02056301|26201856|FG000|Overall Study|Issues with epidural|0|||
13196055|NCT02056301|26201857|FG001|Overall Study|Issues with epidural|3|||
13196056|NCT02056288|26201880|FG000|In-Hospital Data|Surgery cancelled|1|||
13196057|NCT02056288|26201881|FG001|In-Hospital Data|Surgery cancelled|0|||
13196058|NCT02056288|26201880|FG000|In-Hospital Data|Protocol Violation|3|||
13196059|NCT02056288|26201881|FG001|In-Hospital Data|Protocol Violation|0|||
13196060|NCT02056288|26201880|FG000|In-Hospital Data|Physician Decision|1|||
13196061|NCT02056288|26201881|FG001|In-Hospital Data|Physician Decision|0|||
13196062|NCT02056288|26201880|FG000|48-Hour Post-Discharge Data|Did not return diary|14|||
13196063|NCT02056288|26201881|FG001|48-Hour Post-Discharge Data|Did not return diary|20|||
13196064|NCT02055976|26202328|FG000|Overall Study|Other|0|||
13196065|NCT02055976|26202329|FG001|Overall Study|Other|0|||
13196066|NCT02055976|26202330|FG002|Overall Study|Other|1|||
13196067|NCT02055976|26202331|FG003|Overall Study|Other|0|||
13196068|NCT02055976|26202332|FG004|Overall Study|Other|0|||
13196069|NCT02055976|26202333|FG005|Overall Study|Other|0|||
13196070|NCT02055976|26202334|FG006|Overall Study|Other|0|||
13196071|NCT02055976|26202335|FG007|Overall Study|Other|0|||
13196072|NCT02055976|26202336|FG008|Overall Study|Other|0|||
13196073|NCT02055976|26202328|FG000|Overall Study|Adverse Event|0|||
13196074|NCT02055976|26202329|FG001|Overall Study|Adverse Event|0|||
13196075|NCT02055976|26202330|FG002|Overall Study|Adverse Event|0|||
13196076|NCT02055976|26202331|FG003|Overall Study|Adverse Event|0|||
13196077|NCT02055976|26202332|FG004|Overall Study|Adverse Event|0|||
13196078|NCT02055976|26202333|FG005|Overall Study|Adverse Event|1|||
13196079|NCT02055976|26202334|FG006|Overall Study|Adverse Event|1|||
13196080|NCT02055976|26202335|FG007|Overall Study|Adverse Event|0|||
13196081|NCT02055976|26202336|FG008|Overall Study|Adverse Event|0|||
13196082|NCT02055976|26202328|FG000|Overall Study|Does not meet entrance criteria|0|||
13196083|NCT02055976|26202329|FG001|Overall Study|Does not meet entrance criteria|0|||
13196084|NCT02055976|26202330|FG002|Overall Study|Does not meet entrance criteria|0|||
13196085|NCT02055976|26202331|FG003|Overall Study|Does not meet entrance criteria|0|||
13196086|NCT02055976|26202332|FG004|Overall Study|Does not meet entrance criteria|0|||
13196087|NCT02055976|26202333|FG005|Overall Study|Does not meet entrance criteria|0|||
13196088|NCT02055976|26202334|FG006|Overall Study|Does not meet entrance criteria|1|||
13196089|NCT02055976|26202335|FG007|Overall Study|Does not meet entrance criteria|0|||
13196090|NCT02055976|26202336|FG008|Overall Study|Does not meet entrance criteria|0|||
13196091|NCT02055976|26202328|FG000|Overall Study|Lost to Follow-up|0|||
13196092|NCT02055976|26202329|FG001|Overall Study|Lost to Follow-up|0|||
13196093|NCT02055976|26202330|FG002|Overall Study|Lost to Follow-up|0|||
13196094|NCT02055976|26202331|FG003|Overall Study|Lost to Follow-up|1|||
13196095|NCT02055976|26202332|FG004|Overall Study|Lost to Follow-up|0|||
13196096|NCT02055976|26202333|FG005|Overall Study|Lost to Follow-up|0|||
13196097|NCT02055976|26202334|FG006|Overall Study|Lost to Follow-up|0|||
13196098|NCT02055976|26202335|FG007|Overall Study|Lost to Follow-up|0|||
13196099|NCT02055976|26202336|FG008|Overall Study|Lost to Follow-up|0|||
13196100|NCT02055898|26202355|FG000|First Intervention (5 Days)|Physician Decision|2|||
13196101|NCT02055898|26202356|FG001|First Intervention (5 Days)|Physician Decision|0|||
13196102|NCT02055898|26202355|FG000|First Intervention (5 Days)|Withdrawal by Subject|0|||
13196103|NCT02055898|26202356|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
13196104|NCT02055820|26202489|FG000|Phase I: Dose-Finding|Death|1|||
13196105|NCT02055820|26202490|FG001|Phase I: Dose-Finding|Death|0|||
13196106|NCT02055820|26202491|FG002|Phase I: Dose-Finding|Death|1|||
13196107|NCT02055820|26202492|FG003|Phase I: Dose-Finding|Death|2|||
13196108|NCT02055820|26202493|FG004|Phase I: Dose-Finding|Death|0|||
13196109|NCT02055820|26202494|FG005|Phase I: Dose-Finding|Death|1|||
13196110|NCT02055820|26202495|FG006|Phase I: Dose-Finding|Death|1|||
13196111|NCT02055820|26202496|FG007|Phase I: Dose-Finding|Death|0|||
13196112|NCT02055820|26202497|FG008|Phase I: Dose-Finding|Death|0|||
13196113|NCT02055820|26202498|FG009|Phase I: Dose-Finding|Death|0|||
13196114|NCT02055820|26202489|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0|||
13196115|NCT02055820|26202490|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0|||
13196116|NCT02055820|26202491|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0|||
13196117|NCT02055820|26202492|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0|||
13196118|NCT02055820|26202493|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0|||
13196119|NCT02055820|26202494|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1|||
13196120|NCT02055820|26202495|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0|||
13196121|NCT02055820|26202496|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0|||
13196122|NCT02055820|26202497|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0|||
13196123|NCT02055820|26202498|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0|||
13196124|NCT02055820|26202489|FG000|Phase I: Dose-Finding|Lost to Follow-up|0|||
13196125|NCT02055820|26202490|FG001|Phase I: Dose-Finding|Lost to Follow-up|0|||
13196126|NCT02055820|26202491|FG002|Phase I: Dose-Finding|Lost to Follow-up|0|||
13196127|NCT02055820|26202492|FG003|Phase I: Dose-Finding|Lost to Follow-up|1|||
13196128|NCT02055820|26202493|FG004|Phase I: Dose-Finding|Lost to Follow-up|0|||
13196129|NCT02055820|26202494|FG005|Phase I: Dose-Finding|Lost to Follow-up|0|||
13196130|NCT02055820|26202495|FG006|Phase I: Dose-Finding|Lost to Follow-up|1|||
13196131|NCT02055820|26202496|FG007|Phase I: Dose-Finding|Lost to Follow-up|0|||
13196132|NCT02055820|26202497|FG008|Phase I: Dose-Finding|Lost to Follow-up|0|||
13196133|NCT02055820|26202498|FG009|Phase I: Dose-Finding|Lost to Follow-up|0|||
13196134|NCT02055820|26202489|FG000|Phase II: Expansion|Death|0|||
13196135|NCT02055820|26202490|FG001|Phase II: Expansion|Death|0|||
13196136|NCT02055820|26202491|FG002|Phase II: Expansion|Death|0|||
13196137|NCT02055820|26202492|FG003|Phase II: Expansion|Death|0|||
13196138|NCT02055820|26202493|FG004|Phase II: Expansion|Death|33|||
13196139|NCT02055820|26202494|FG005|Phase II: Expansion|Death|0|||
13196140|NCT02055820|26202495|FG006|Phase II: Expansion|Death|0|||
13196141|NCT02055820|26202496|FG007|Phase II: Expansion|Death|0|||
13196142|NCT02055820|26202497|FG008|Phase II: Expansion|Death|0|||
13196143|NCT02055820|26202498|FG009|Phase II: Expansion|Death|0|||
13196144|NCT02055820|26202489|FG000|Phase II: Expansion|Lost to Follow-up|0|||
13196145|NCT02055820|26202490|FG001|Phase II: Expansion|Lost to Follow-up|0|||
13196146|NCT02055820|26202491|FG002|Phase II: Expansion|Lost to Follow-up|0|||
13196147|NCT02055820|26202492|FG003|Phase II: Expansion|Lost to Follow-up|0|||
13196148|NCT02055820|26202493|FG004|Phase II: Expansion|Lost to Follow-up|4|||
13196149|NCT02055820|26202494|FG005|Phase II: Expansion|Lost to Follow-up|0|||
13196150|NCT02055820|26202495|FG006|Phase II: Expansion|Lost to Follow-up|0|||
13196151|NCT02055820|26202496|FG007|Phase II: Expansion|Lost to Follow-up|0|||
13196152|NCT02055820|26202497|FG008|Phase II: Expansion|Lost to Follow-up|0|||
13196153|NCT02055820|26202498|FG009|Phase II: Expansion|Lost to Follow-up|0|||
13196154|NCT02055820|26202489|FG000|Phase II: Expansion|Withdrawal by Subject|0|||
13196155|NCT02055820|26202490|FG001|Phase II: Expansion|Withdrawal by Subject|0|||
13196156|NCT02055820|26202491|FG002|Phase II: Expansion|Withdrawal by Subject|0|||
13196157|NCT02055820|26202492|FG003|Phase II: Expansion|Withdrawal by Subject|0|||
13196158|NCT02055820|26202493|FG004|Phase II: Expansion|Withdrawal by Subject|12|||
13196159|NCT02055820|26202494|FG005|Phase II: Expansion|Withdrawal by Subject|0|||
13196160|NCT02055820|26202495|FG006|Phase II: Expansion|Withdrawal by Subject|0|||
13196161|NCT02055820|26202496|FG007|Phase II: Expansion|Withdrawal by Subject|0|||
13196162|NCT02055820|26202497|FG008|Phase II: Expansion|Withdrawal by Subject|0|||
13196163|NCT02055820|26202498|FG009|Phase II: Expansion|Withdrawal by Subject|0|||
13196164|NCT02055365|26202511|FG000|Overall Study|Prematurely Withdrawn|1|||
13196165|NCT02055352|26202532|FG000|Overall Study|Adverse Event|0|||
13196166|NCT02055352|26202533|FG001|Overall Study|Adverse Event|1|||
13196167|NCT02055352|26202532|FG000|Overall Study|Non-eligible|0|||
13196168|NCT02055352|26202533|FG001|Overall Study|Non-eligible|1|||
13196169|NCT02055352|26202532|FG000|Overall Study|Poor compliance|1|||
13196170|NCT02055352|26202533|FG001|Overall Study|Poor compliance|1|||
13196171|NCT02055352|26202532|FG000|Overall Study|Death|1|||
13196172|NCT02055352|26202533|FG001|Overall Study|Death|2|||
13196173|NCT02055352|26202532|FG000|Overall Study|Patient decision|1|||
13196174|NCT02055352|26202533|FG001|Overall Study|Patient decision|1|||
13196175|NCT02055352|26202532|FG000|Overall Study|Use of prohibited treatment|0|||
13196176|NCT02055352|26202533|FG001|Overall Study|Use of prohibited treatment|3|||
13196177|NCT02055352|26202532|FG000|Overall Study|AE, study drug would be detrimental|1|||
13196178|NCT02055352|26202533|FG001|Overall Study|AE, study drug would be detrimental|3|||
13196179|NCT02055352|26202532|FG000|Overall Study|Withdrawal of informed consent|1|||
13196180|NCT02055352|26202533|FG001|Overall Study|Withdrawal of informed consent|0|||
13196181|NCT02055352|26202532|FG000|Overall Study|Reason unknown|1|||
13196182|NCT02055352|26202533|FG001|Overall Study|Reason unknown|5|||
13196183|NCT02055157|26202623|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
13196184|NCT02055157|26202624|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1|||
13196185|NCT02055157|26202625|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
13196186|NCT02055157|26202626|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
13196187|NCT02055157|26202623|FG000|Initial 6 Months|Adverse Event|0|||
13196188|NCT02055157|26202624|FG001|Initial 6 Months|Adverse Event|0|||
13196189|NCT02055157|26202625|FG002|Initial 6 Months|Adverse Event|0|||
13196190|NCT02055157|26202626|FG003|Initial 6 Months|Adverse Event|1|||
13196191|NCT02055157|26202623|FG000|Initial 6 Months|Consent withdrawn by subject|1|||
13196192|NCT02055157|26202624|FG001|Initial 6 Months|Consent withdrawn by subject|0|||
13196193|NCT02055157|26202625|FG002|Initial 6 Months|Consent withdrawn by subject|0|||
13196194|NCT02055157|26202626|FG003|Initial 6 Months|Consent withdrawn by subject|0|||
13196195|NCT02055157|26202623|FG000|18-month Extension|Investigator decision|0|||
13196196|NCT02055157|26202624|FG001|18-month Extension|Investigator decision|1|||
13196197|NCT02055157|26202625|FG002|18-month Extension|Investigator decision|0|||
13196198|NCT02055157|26202626|FG003|18-month Extension|Investigator decision|0|||
13196199|NCT02055157|26202623|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1|||
13196200|NCT02055157|26202624|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
13196201|NCT02055157|26202625|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
13196202|NCT02055157|26202626|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
13196203|NCT02055118|26202693|FG000|Overall Study|Withdrawal by Subject|0|||
13196204|NCT02055118|26202694|FG001|Overall Study|Withdrawal by Subject|2|||
13196205|NCT02055118|26202695|FG002|Overall Study|Withdrawal by Subject|0|||
13196206|NCT02054910|26202718|FG000|Overall Study|Lost to Follow-up|4|||
13196207|NCT02054910|26202719|FG001|Overall Study|Lost to Follow-up|1|||
13196208|NCT02054897|26202752|FG000|Overall Study|Withdrawal by Subject|2|||
13196209|NCT02054897|26202753|FG001|Overall Study|Withdrawal by Subject|0|||
13196210|NCT02054897|26202754|FG002|Overall Study|Withdrawal by Subject|2|||
13196211|NCT02054897|26202752|FG000|Overall Study|Missing follow-up information|3|||
13196212|NCT02054897|26202753|FG001|Overall Study|Missing follow-up information|5|||
13196213|NCT02054897|26202754|FG002|Overall Study|Missing follow-up information|3|||
13196214|NCT02054897|26202752|FG000|Overall Study|Lost to Follow-up|4|||
13196215|NCT02054897|26202753|FG001|Overall Study|Lost to Follow-up|2|||
13196216|NCT02054897|26202754|FG002|Overall Study|Lost to Follow-up|7|||
13196217|NCT02054897|26202752|FG000|Overall Study|Randomized but not exposed|1|||
13196218|NCT02054897|26202753|FG001|Overall Study|Randomized but not exposed|0|||
13196219|NCT02054897|26202754|FG002|Overall Study|Randomized but not exposed|0|||
13196220|NCT02054715|26202773|FG000|Baseline/Follow-up 1|Refused|1|||
13196221|NCT02054715|26202774|FG001|Baseline/Follow-up 1|Refused|3|||
13196222|NCT02054715|26202773|FG000|Baseline/Follow-up 1|Medical|0|||
13196223|NCT02054715|26202774|FG001|Baseline/Follow-up 1|Medical|1|||
13196224|NCT02054715|26202773|FG000|Baseline/Follow-up 1|Changed MD/Facility|0|||
13196225|NCT02054715|26202774|FG001|Baseline/Follow-up 1|Changed MD/Facility|1|||
13196226|NCT02054715|26202773|FG000|Baseline/Follow-up 1|Disliked Procedure|0|||
13196227|NCT02054715|26202774|FG001|Baseline/Follow-up 1|Disliked Procedure|1|||
13196228|NCT02054715|26202773|FG000|Baseline/Follow-up 1|No Reason|0|||
13196229|NCT02054715|26202774|FG001|Baseline/Follow-up 1|No Reason|1|||
13196230|NCT02054715|26202773|FG000|Baseline/Follow-up 1|Overwhelmed|2|||
13196231|NCT02054715|26202774|FG001|Baseline/Follow-up 1|Overwhelmed|0|||
13196232|NCT02054715|26202773|FG000|Baseline/Follow-up 1|Ineligible|3|||
13196233|NCT02054715|26202774|FG001|Baseline/Follow-up 1|Ineligible|0|||
13196234|NCT02054715|26202773|FG000|Baseline/Follow-up 1|Hospitalization|1|||
13196235|NCT02054715|26202774|FG001|Baseline/Follow-up 1|Hospitalization|0|||
13196236|NCT02054715|26202773|FG000|Baseline/Follow-up 1|Changed Mind|1|||
13196237|NCT02054715|26202774|FG001|Baseline/Follow-up 1|Changed Mind|0|||
13196238|NCT02054715|26202773|FG000|Follow-up 2|Lost to Followup|3|||
13196239|NCT02054715|26202774|FG001|Follow-up 2|Lost to Followup|1|||
13196240|NCT02054715|26202773|FG000|Follow-up 2|Refused|3|||
13196241|NCT02054715|26202774|FG001|Follow-up 2|Refused|2|||
13196242|NCT02054715|26202773|FG000|Follow-up 2|Followup Not Completed|3|||
13196243|NCT02054715|26202774|FG001|Follow-up 2|Followup Not Completed|4|||
13196244|NCT02054715|26202773|FG000|Follow-up 2|Ineligible|4|||
13196245|NCT02054715|26202774|FG001|Follow-up 2|Ineligible|5|||
13196246|NCT02054715|26202773|FG000|Follow-up 2|Death|3|||
13196247|NCT02054715|26202774|FG001|Follow-up 2|Death|3|||
13196248|NCT02054715|26202773|FG000|Follow-up 2|Hospitalization|0|||
13196249|NCT02054715|26202774|FG001|Follow-up 2|Hospitalization|2|||
13196250|NCT02054715|26202773|FG000|Follow-up 2|Changed MD/Facility|0|||
13196251|NCT02054715|26202774|FG001|Follow-up 2|Changed MD/Facility|1|||
13196252|NCT02054715|26202773|FG000|Follow-up 2|Changed Mind|0|||
13196253|NCT02054715|26202774|FG001|Follow-up 2|Changed Mind|1|||
13196254|NCT02054715|26202773|FG000|Follow-up 2|No Reason|2|||
13196255|NCT02054715|26202774|FG001|Follow-up 2|No Reason|0|||
13196256|NCT02054715|26202773|FG000|Follow-up 2|Treatment Change or Delay|1|||
13196257|NCT02054715|26202774|FG001|Follow-up 2|Treatment Change or Delay|0|||
13196258|NCT02054702|26202809|FG000|Overall Study|Lost to Follow-up|3|||
13196259|NCT02054702|26202810|FG001|Overall Study|Lost to Follow-up|5|||
13196260|NCT02054702|26202809|FG000|Overall Study|Adverse Event|3|||
13196261|NCT02054702|26202810|FG001|Overall Study|Adverse Event|1|||
13196262|NCT02054702|26202809|FG000|Overall Study|Met Withdrawal Criteria|4|||
13196263|NCT02054702|26202810|FG001|Overall Study|Met Withdrawal Criteria|1|||
13196264|NCT02054702|26202809|FG000|Overall Study|Physician Decision|0|||
13196265|NCT02054702|26202810|FG001|Overall Study|Physician Decision|1|||
13196266|NCT02054702|26202809|FG000|Overall Study|Withdrawal by Subject|14|||
13196267|NCT02054702|26202810|FG001|Overall Study|Withdrawal by Subject|4|||
13196268|NCT02054520|26202849|FG000|Overall Study|Adverse Event|1|||
13196269|NCT02054520|26202850|FG001|Overall Study|Adverse Event|4|||
13196270|NCT02054520|26202851|FG002|Overall Study|Adverse Event|2|||
13196271|NCT02054520|26202852|FG003|Overall Study|Adverse Event|1|||
13196272|NCT02054520|26202853|FG004|Overall Study|Adverse Event|1|||
13196273|NCT02054520|26202854|FG005|Overall Study|Adverse Event|0|||
13196274|NCT02054520|26202849|FG000|Overall Study|Lack of Efficacy|7|||
13196275|NCT02054520|26202850|FG001|Overall Study|Lack of Efficacy|0|||
13196276|NCT02054520|26202851|FG002|Overall Study|Lack of Efficacy|2|||
13196277|NCT02054520|26202852|FG003|Overall Study|Lack of Efficacy|1|||
13196278|NCT02054520|26202853|FG004|Overall Study|Lack of Efficacy|3|||
13196279|NCT02054520|26202854|FG005|Overall Study|Lack of Efficacy|2|||
13196280|NCT02054520|26202849|FG000|Overall Study|Withdrawal by Subject|1|||
13196281|NCT02054520|26202850|FG001|Overall Study|Withdrawal by Subject|0|||
13196282|NCT02054520|26202851|FG002|Overall Study|Withdrawal by Subject|0|||
13196283|NCT02054520|26202852|FG003|Overall Study|Withdrawal by Subject|2|||
13196284|NCT02054520|26202853|FG004|Overall Study|Withdrawal by Subject|1|||
13196285|NCT02054520|26202854|FG005|Overall Study|Withdrawal by Subject|0|||
13196286|NCT02054520|26202849|FG000|Overall Study|Physician Decision|0|||
13196287|NCT02054520|26202850|FG001|Overall Study|Physician Decision|1|||
13196288|NCT02054520|26202851|FG002|Overall Study|Physician Decision|0|||
13196289|NCT02054520|26202852|FG003|Overall Study|Physician Decision|1|||
13196290|NCT02054520|26202853|FG004|Overall Study|Physician Decision|0|||
13196291|NCT02054520|26202854|FG005|Overall Study|Physician Decision|1|||
13196292|NCT02054520|26202849|FG000|Overall Study|Study terminated by Sponsor|0|||
13196293|NCT02054520|26202850|FG001|Overall Study|Study terminated by Sponsor|0|||
13196294|NCT02054520|26202851|FG002|Overall Study|Study terminated by Sponsor|2|||
13196295|NCT02054520|26202852|FG003|Overall Study|Study terminated by Sponsor|1|||
13196296|NCT02054520|26202853|FG004|Overall Study|Study terminated by Sponsor|0|||
13196297|NCT02054520|26202854|FG005|Overall Study|Study terminated by Sponsor|0|||
13196298|NCT02054481|26202913|FG000|Overall Study|Adverse Event|1|||
13196299|NCT02054481|26202914|FG001|Overall Study|Adverse Event|1|||
13196300|NCT02054481|26202915|FG002|Overall Study|Adverse Event|0|||
13196301|NCT02054481|26202916|FG003|Overall Study|Adverse Event|1|||
13196302|NCT02054481|26202913|FG000|Overall Study|Lost to Follow-up|1|||
13196303|NCT02054481|26202914|FG001|Overall Study|Lost to Follow-up|0|||
13196304|NCT02054481|26202915|FG002|Overall Study|Lost to Follow-up|0|||
13196305|NCT02054481|26202916|FG003|Overall Study|Lost to Follow-up|0|||
13196306|NCT02054481|26202913|FG000|Overall Study|Other reason|2|||
13196307|NCT02054481|26202914|FG001|Overall Study|Other reason|1|||
13196308|NCT02054481|26202915|FG002|Overall Study|Other reason|2|||
13196309|NCT02054481|26202916|FG003|Overall Study|Other reason|0|||
13196310|NCT02054325|26202931|FG000|Overall Study|Lost to Follow-up|8|||
13196311|NCT02054325|26202932|FG001|Overall Study|Lost to Follow-up|5|||
13196312|NCT02054130|26203037|FG000|Overall Study|Withdrawal by Subject|4|||
13196313|NCT02054130|26203038|FG001|Overall Study|Withdrawal by Subject|4|||
13196314|NCT02054130|26203039|FG002|Overall Study|Withdrawal by Subject|7|||
13196315|NCT02054130|26203040|FG003|Overall Study|Withdrawal by Subject|10|||
13196316|NCT02054130|26203037|FG000|Overall Study|Death|0|||
13196317|NCT02054130|26203038|FG001|Overall Study|Death|1|||
13196318|NCT02054130|26203039|FG002|Overall Study|Death|0|||
13196319|NCT02054130|26203040|FG003|Overall Study|Death|0|||
13196320|NCT02054130|26203037|FG000|Overall Study|Lost to Follow-up|0|||
13196321|NCT02054130|26203038|FG001|Overall Study|Lost to Follow-up|0|||
13196322|NCT02054130|26203039|FG002|Overall Study|Lost to Follow-up|1|||
13196323|NCT02054130|26203040|FG003|Overall Study|Lost to Follow-up|2|||
13196324|NCT02054130|26203037|FG000|Overall Study|Missed dose|4|||
13196325|NCT02054130|26203038|FG001|Overall Study|Missed dose|6|||
13196326|NCT02054130|26203039|FG002|Overall Study|Missed dose|7|||
13196327|NCT02054130|26203040|FG003|Overall Study|Missed dose|10|||
13196328|NCT02053792|26203077|FG000|Overall Study|Physician Decision|0|||
13196329|NCT02053792|26203078|FG001|Overall Study|Physician Decision|1|||
13196330|NCT02053792|26203077|FG000|Overall Study|Development of High titer FIX inhibitor|0|||
13196331|NCT02053792|26203078|FG001|Overall Study|Development of High titer FIX inhibitor|1|||
13196332|NCT02053792|26203077|FG000|Overall Study|Lack of Efficacy|1|||
13196333|NCT02053792|26203078|FG001|Overall Study|Lack of Efficacy|0|||
13196334|NCT02053792|26203077|FG000|Overall Study|Adverse Event|1|||
13196335|NCT02053792|26203078|FG001|Overall Study|Adverse Event|0|||
13196336|NCT02053792|26203077|FG000|Overall Study|Withdrawal by Subject|2|||
13196337|NCT02053792|26203078|FG001|Overall Study|Withdrawal by Subject|2|||
13196338|NCT02053792|26203077|FG000|Overall Study|The patient was not compliant to the study procedure|1|||
13196339|NCT02053792|26203078|FG001|Overall Study|The patient was not compliant to the study procedure|0|||
13196340|NCT02053792|26203077|FG000|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|1|||
13196341|NCT02053792|26203078|FG001|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|0|||
13196342|NCT02053753|26203107|FG000|Overall Study|Withdrawal by Subject|2|||
13196343|NCT02053753|26203108|FG001|Overall Study|Withdrawal by Subject|4|||
13196344|NCT02053753|26203107|FG000|Overall Study|Decision by Sponsor|1|||
13196345|NCT02053753|26203108|FG001|Overall Study|Decision by Sponsor|1|||
13196346|NCT02053753|26203107|FG000|Overall Study|Lost to Follow-up|4|||
13196347|NCT02053753|26203108|FG001|Overall Study|Lost to Follow-up|3|||
13196348|NCT02053610|26203145|FG000|Overall Study|Adverse Event/Intercurrent Illness|25|||
13196349|NCT02053610|26203146|FG001|Overall Study|Adverse Event/Intercurrent Illness|43|||
13196350|NCT02053610|26203145|FG000|Overall Study|Withdrew Consent|2|||
13196351|NCT02053610|26203146|FG001|Overall Study|Withdrew Consent|9|||
13196352|NCT02053610|26203145|FG000|Overall Study|Death|5|||
13196353|NCT02053610|26203146|FG001|Overall Study|Death|5|||
13196354|NCT02053610|26203145|FG000|Overall Study|Administrative/Other|1|||
13196355|NCT02053610|26203146|FG001|Overall Study|Administrative/Other|1|||
13196356|NCT02053610|26203145|FG000|Overall Study|Disease Progression|2|||
13196357|NCT02053610|26203146|FG001|Overall Study|Disease Progression|3|||
13196358|NCT02053610|26203145|FG000|Overall Study|Refused treatment/Did not cooperate|1|||
13196359|NCT02053610|26203146|FG001|Overall Study|Refused treatment/Did not cooperate|3|||
13196360|NCT02053610|26203145|FG000|Overall Study|Did not Receive Treatment|4|||
13196361|NCT02053610|26203146|FG001|Overall Study|Did not Receive Treatment|2|||
13196362|NCT02053610|26203145|FG000|Overall Study|Insufficient Therapeutic Response|1|||
13196363|NCT02053610|26203146|FG001|Overall Study|Insufficient Therapeutic Response|1|||
13196364|NCT02053610|26203145|FG000|Overall Study|Violation of Selection Criteria|1|||
13196365|NCT02053610|26203146|FG001|Overall Study|Violation of Selection Criteria|0|||
13196366|NCT02053493|26203191|FG000|Overall Study|Withdrawal by Subject|1|||
13196367|NCT02053493|26203192|FG001|Overall Study|Withdrawal by Subject|1|||
13196368|NCT02053350|26203199|FG000|Overall Study|Withdrawal by Subject|1|||
13196369|NCT02053350|26203199|FG000|Overall Study|Adverse Event|4|||
13196370|NCT02053246|26203206|FG000|Overall Study|Withdrawal by Subject|3|||
13196371|NCT02053246|26203206|FG000|Overall Study|Physician Decision|1|||
13196372|NCT02053168|26203222|FG000|Overall Study|Withdrawal by Subject|1|||
13196373|NCT02053168|26203222|FG000|Overall Study|Physician Decision|1|||
13196374|NCT02053168|26203222|FG000|Overall Study|Lost to Follow-up|1|||
13196375|NCT02052960|26203245|FG000|Overall Study|Adverse Event|19|||
13196376|NCT02052960|26203246|FG001|Overall Study|Adverse Event|17|||
13196377|NCT02052960|26203245|FG000|Overall Study|Protocol Violation|4|||
13196378|NCT02052960|26203246|FG001|Overall Study|Protocol Violation|3|||
13196379|NCT02052960|26203245|FG000|Overall Study|Withdrawal by Subject|6|||
13196380|NCT02052960|26203246|FG001|Overall Study|Withdrawal by Subject|11|||
13196381|NCT02052960|26203245|FG000|Overall Study|Other|25|||
13196382|NCT02052960|26203246|FG001|Overall Study|Other|15|||
13196383|NCT02052739|26203379|FG000|Overall Study|Withdrew due to Adverse Event|3|||
13196384|NCT02052739|26203380|FG001|Overall Study|Withdrew due to Adverse Event|0|||
13196385|NCT02052739|26203379|FG000|Overall Study|Participant Died|2|||
13196386|NCT02052739|26203380|FG001|Overall Study|Participant Died|1|||
13196387|NCT02052596|26203412|FG000|Active Phase|Adverse Event|3|||
13196388|NCT02052596|26203413|FG001|Active Phase|Adverse Event|2|||
13196389|NCT02052596|26203412|FG000|Active Phase|Lost to Follow-up|8|||
13196390|NCT02052596|26203413|FG001|Active Phase|Lost to Follow-up|11|||
13196391|NCT02052596|26203412|FG000|Active Phase|Protocol Violation|1|||
13196392|NCT02052596|26203413|FG001|Active Phase|Protocol Violation|2|||
13196393|NCT02052596|26203412|FG000|Active Phase|Withdrawal by Subject|3|||
13196394|NCT02052596|26203413|FG001|Active Phase|Withdrawal by Subject|4|||
13196395|NCT02052596|26203412|FG000|Active Phase|Enrolled in error|1|||
13196396|NCT02052596|26203413|FG001|Active Phase|Enrolled in error|0|||
13196397|NCT02052596|26203412|FG000|Active Phase|Lost due to Crohn's disease|0|||
13196398|NCT02052596|26203413|FG001|Active Phase|Lost due to Crohn's disease|1|||
13196399|NCT02052596|26203412|FG000|Safety Phase|Adverse Event|6|||
13196400|NCT02052596|26203413|FG001|Safety Phase|Adverse Event|3|||
13196401|NCT02052596|26203412|FG000|Safety Phase|Lost to Follow-up|11|||
13196402|NCT02052596|26203413|FG001|Safety Phase|Lost to Follow-up|18|||
13196403|NCT02052596|26203412|FG000|Safety Phase|Protocol Violation|1|||
13196404|NCT02052596|26203413|FG001|Safety Phase|Protocol Violation|2|||
13196405|NCT02052596|26203412|FG000|Safety Phase|Withdrawal by Subject|8|||
13196406|NCT02052596|26203413|FG001|Safety Phase|Withdrawal by Subject|11|||
13196407|NCT02052596|26203412|FG000|Safety Phase|Enrolled in error|1|||
13196408|NCT02052596|26203413|FG001|Safety Phase|Enrolled in error|0|||
13196409|NCT02052596|26203412|FG000|Safety Phase|Lost due to Crohn's disease|0|||
13196410|NCT02052596|26203413|FG001|Safety Phase|Lost due to Crohn's disease|1|||
13196411|NCT02052466|26203430|FG000|Overall Study|Withdrawal by Subject|1|||
13196412|NCT02052466|26203430|FG000|Overall Study|Acromial fracture|1|||
13196413|NCT02052440|26203449|FG000|Overall Study|Withdrawal by Subject|0|||
13196414|NCT02052440|26203450|FG001|Overall Study|Withdrawal by Subject|1|||
13196415|NCT02052414|26203460|FG000|Overall Study|Adverse Event|12|||
13196416|NCT02052414|26203460|FG000|Overall Study|Lack of Efficacy|2|||
13196417|NCT02052414|26203460|FG000|Overall Study|Withdrawal by Subject|3|||
13196418|NCT02052310|26203499|FG000|Overall Study|Death|64|||
13196419|NCT02052310|26203500|FG001|Overall Study|Death|54|||
13196420|NCT02052310|26203499|FG000|Overall Study|Withdrawal by Subject|37|||
13196421|NCT02052310|26203500|FG001|Overall Study|Withdrawal by Subject|49|||
13196422|NCT02052310|26203499|FG000|Overall Study|Other than specified|32|||
13196423|NCT02052310|26203500|FG001|Overall Study|Other than specified|29|||
13196424|NCT02052310|26203499|FG000|Overall Study|Adverse Event|29|||
13196425|NCT02052310|26203500|FG001|Overall Study|Adverse Event|22|||
13196426|NCT02052310|26203499|FG000|Overall Study|Kidney Transplant|23|||
13196427|NCT02052310|26203500|FG001|Overall Study|Kidney Transplant|29|||
13196428|NCT02052310|26203499|FG000|Overall Study|Physician Decision|14|||
13196429|NCT02052310|26203500|FG001|Overall Study|Physician Decision|7|||
13196430|NCT02052310|26203499|FG000|Overall Study|Lack of Efficacy|6|||
13196431|NCT02052310|26203500|FG001|Overall Study|Lack of Efficacy|1|||
13196432|NCT02052310|26203499|FG000|Overall Study|Site Terminated by Sponsor|5|||
13196433|NCT02052310|26203500|FG001|Overall Study|Site Terminated by Sponsor|13|||
13196434|NCT02052310|26203499|FG000|Overall Study|Lost to Follow-up|4|||
13196435|NCT02052310|26203500|FG001|Overall Study|Lost to Follow-up|2|||
13196436|NCT02052310|26203499|FG000|Overall Study|Protocol Violation|1|||
13196437|NCT02052310|26203500|FG001|Overall Study|Protocol Violation|6|||
13196438|NCT02052011|26203513|FG000|Overall Study|Lost to Follow-up|3|||
13196439|NCT02052011|26203514|FG001|Overall Study|Lost to Follow-up|0|||
13196440|NCT02052011|26203513|FG000|Overall Study|Withdrawal by Subject|1|||
13196441|NCT02052011|26203514|FG001|Overall Study|Withdrawal by Subject|2|||
13196442|NCT02051933|26203539|FG000|Overall Study|Physician Decision|0|||
13196443|NCT02051933|26203540|FG001|Overall Study|Physician Decision|1|||
13196444|NCT02051764|26203553|FG000|Overall Study|Study terminated by sponsor|0|||
13196445|NCT02051764|26203554|FG001|Overall Study|Study terminated by sponsor|7|||
13196446|NCT02051296|26203567|FG000|Overall Study|Lost to Follow-up|1|||
13196447|NCT02051296|26203568|FG001|Overall Study|Lost to Follow-up|2|||
13196448|NCT02051296|26203567|FG000|Overall Study|withdraw prior to treatment|7|||
13196449|NCT02051296|26203568|FG001|Overall Study|withdraw prior to treatment|7|||
13196450|NCT02050373|26203583|FG000|Overall Study|Adverse Event|4|||
13196451|NCT02050373|26203584|FG001|Overall Study|Adverse Event|7|||
13196452|NCT02050373|26203583|FG000|Overall Study|Death|3|||
13196453|NCT02050373|26203584|FG001|Overall Study|Death|3|||
13196454|NCT02050321|26203591|FG000|Overall Study|Withdrawal by Subject|1|||
13196455|NCT02050321|26203591|FG000|Overall Study|Adverse Event|1|||
13196456|NCT02050048|26203604|FG000|Overall Study|Lost to Follow-up|0|||
13196457|NCT02050048|26203605|FG001|Overall Study|Lost to Follow-up|1|||
13196458|NCT02050048|26203604|FG000|Overall Study|Death|1|||
13196459|NCT02050048|26203605|FG001|Overall Study|Death|0|||
13196460|NCT02050048|26203604|FG000|Overall Study|Ineligible after ERCP|4|||
13196461|NCT02050048|26203605|FG001|Overall Study|Ineligible after ERCP|1|||
13196462|NCT02049957|26203698|FG000|Overall Study|Progressive Disease|5|||
13196463|NCT02049957|26203699|FG001|Overall Study|Progressive Disease|4|||
13196464|NCT02049957|26203700|FG002|Overall Study|Progressive Disease|2|||
13196465|NCT02049957|26203701|FG003|Overall Study|Progressive Disease|2|||
13196466|NCT02049957|26203702|FG004|Overall Study|Progressive Disease|6|||
13196467|NCT02049957|26203703|FG005|Overall Study|Progressive Disease|35|||
13196468|NCT02049957|26203704|FG006|Overall Study|Progressive Disease|7|||
13196469|NCT02049957|26203705|FG007|Overall Study|Progressive Disease|26|||
13196470|NCT02049957|26203706|FG008|Overall Study|Progressive Disease|6|||
13196471|NCT02049957|26203698|FG000|Overall Study|Adverse Event|1|||
13196472|NCT02049957|26203699|FG001|Overall Study|Adverse Event|1|||
13196473|NCT02049957|26203700|FG002|Overall Study|Adverse Event|1|||
13196474|NCT02049957|26203701|FG003|Overall Study|Adverse Event|0|||
13196475|NCT02049957|26203702|FG004|Overall Study|Adverse Event|0|||
13196476|NCT02049957|26203703|FG005|Overall Study|Adverse Event|5|||
13196477|NCT02049957|26203704|FG006|Overall Study|Adverse Event|0|||
13196478|NCT02049957|26203705|FG007|Overall Study|Adverse Event|6|||
13196479|NCT02049957|26203706|FG008|Overall Study|Adverse Event|1|||
13196480|NCT02049957|26203698|FG000|Overall Study|Study Terminated by Sponsor|0|||
13196481|NCT02049957|26203699|FG001|Overall Study|Study Terminated by Sponsor|1|||
13196482|NCT02049957|26203700|FG002|Overall Study|Study Terminated by Sponsor|0|||
13196483|NCT02049957|26203701|FG003|Overall Study|Study Terminated by Sponsor|0|||
13196484|NCT02049957|26203702|FG004|Overall Study|Study Terminated by Sponsor|0|||
13196485|NCT02049957|26203703|FG005|Overall Study|Study Terminated by Sponsor|0|||
13196486|NCT02049957|26203704|FG006|Overall Study|Study Terminated by Sponsor|1|||
13196487|NCT02049957|26203705|FG007|Overall Study|Study Terminated by Sponsor|0|||
13196488|NCT02049957|26203706|FG008|Overall Study|Study Terminated by Sponsor|0|||
13196489|NCT02049957|26203698|FG000|Overall Study|Withdrawal by Subject|0|||
13196490|NCT02049957|26203699|FG001|Overall Study|Withdrawal by Subject|0|||
13196491|NCT02049957|26203700|FG002|Overall Study|Withdrawal by Subject|0|||
13196492|NCT02049957|26203701|FG003|Overall Study|Withdrawal by Subject|1|||
13196493|NCT02049957|26203702|FG004|Overall Study|Withdrawal by Subject|0|||
13196494|NCT02049957|26203703|FG005|Overall Study|Withdrawal by Subject|2|||
13196495|NCT02049957|26203704|FG006|Overall Study|Withdrawal by Subject|0|||
13196496|NCT02049957|26203705|FG007|Overall Study|Withdrawal by Subject|3|||
13196497|NCT02049957|26203706|FG008|Overall Study|Withdrawal by Subject|1|||
13196498|NCT02049957|26203698|FG000|Overall Study|Physician Decision|0|||
13196499|NCT02049957|26203699|FG001|Overall Study|Physician Decision|0|||
13196500|NCT02049957|26203700|FG002|Overall Study|Physician Decision|0|||
13196501|NCT02049957|26203701|FG003|Overall Study|Physician Decision|0|||
13196502|NCT02049957|26203702|FG004|Overall Study|Physician Decision|0|||
13196503|NCT02049957|26203703|FG005|Overall Study|Physician Decision|1|||
13196504|NCT02049957|26203704|FG006|Overall Study|Physician Decision|0|||
13196505|NCT02049957|26203705|FG007|Overall Study|Physician Decision|0|||
13196506|NCT02049957|26203706|FG008|Overall Study|Physician Decision|0|||
13196507|NCT02049944|26203712|FG000|Overall Study|Protocol Violation|2|||
13196508|NCT02049814|26203745|FG000|Overall Study|Reason not Specified|4|||
13196509|NCT02049814|26203746|FG001|Overall Study|Reason not Specified|3|||
13196510|NCT02049814|26203745|FG000|Overall Study|Pregnancy|1|||
13196511|NCT02049814|26203746|FG001|Overall Study|Pregnancy|0|||
13196512|NCT02049814|26203745|FG000|Overall Study|Lost to Follow-up|2|||
13196513|NCT02049814|26203746|FG001|Overall Study|Lost to Follow-up|3|||
13196514|NCT02049814|26203745|FG000|Overall Study|Serious Protocol Violation|5|||
13196515|NCT02049814|26203746|FG001|Overall Study|Serious Protocol Violation|7|||
13196516|NCT02049814|26203745|FG000|Overall Study|Study Termination|0|||
13196517|NCT02049814|26203746|FG001|Overall Study|Study Termination|1|||
13196518|NCT02049814|26203745|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8|||
13196519|NCT02049814|26203746|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5|||
13196520|NCT02049814|26203745|FG000|Overall Study|Voluntary withdrawal|9|||
13196521|NCT02049814|26203746|FG001|Overall Study|Voluntary withdrawal|8|||
13196522|NCT02049450|26203762|FG000|Overall Study|Adverse Event|2|||
13196523|NCT02049450|26203762|FG000|Overall Study|Withdrawal by Subject|1|||
13196524|NCT02049450|26203762|FG000|Overall Study|Patients/guardian decision|1|||
13196525|NCT02049437|26203779|FG000|Period 1|Adverse Event|1|||
13196526|NCT02049437|26203780|FG001|Period 1|Adverse Event|1|||
13196527|NCT02049437|26203779|FG000|Period 1|Adverse Event|1|||
13196528|NCT02049437|26203780|FG001|Period 1|Adverse Event|0|||
13196529|NCT02049138|26203870|FG000|Overall Study|Adverse Event|46|||
13196530|NCT02049138|26203871|FG001|Overall Study|Adverse Event|25|||
13196531|NCT02049138|26203872|FG002|Overall Study|Adverse Event|1|||
13196532|NCT02049138|26203870|FG000|Overall Study|Withdrawal by Subject|57|||
13196533|NCT02049138|26203871|FG001|Overall Study|Withdrawal by Subject|21|||
13196534|NCT02049138|26203872|FG002|Overall Study|Withdrawal by Subject|5|||
13196535|NCT02049138|26203870|FG000|Overall Study|Lost to Follow-up|18|||
13196536|NCT02049138|26203871|FG001|Overall Study|Lost to Follow-up|5|||
13196537|NCT02049138|26203872|FG002|Overall Study|Lost to Follow-up|1|||
13196538|NCT02049138|26203870|FG000|Overall Study|Lack of Efficacy|10|||
13196539|NCT02049138|26203871|FG001|Overall Study|Lack of Efficacy|26|||
13196540|NCT02049138|26203872|FG002|Overall Study|Lack of Efficacy|1|||
13196541|NCT02049138|26203870|FG000|Overall Study|Non-Compliance|15|||
13196542|NCT02049138|26203871|FG001|Overall Study|Non-Compliance|6|||
13196543|NCT02049138|26203872|FG002|Overall Study|Non-Compliance|0|||
13196544|NCT02049138|26203870|FG000|Overall Study|Required Alternative / Prohibited Therapy|1|||
13196545|NCT02049138|26203871|FG001|Overall Study|Required Alternative / Prohibited Therapy|1|||
13196546|NCT02049138|26203872|FG002|Overall Study|Required Alternative / Prohibited Therapy|0|||
13196547|NCT02049138|26203870|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|1|||
13196548|NCT02049138|26203871|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
13196549|NCT02049138|26203872|FG002|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
13196550|NCT02049138|26203870|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
13196551|NCT02049138|26203871|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
13196552|NCT02049138|26203872|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
13196553|NCT02049138|26203870|FG000|Overall Study|Other|15|||
13196554|NCT02049138|26203871|FG001|Overall Study|Other|13|||
13196555|NCT02049138|26203872|FG002|Overall Study|Other|0|||
13196556|NCT02049138|26203870|FG000|Overall Study|Missing|0|||
13196557|NCT02049138|26203871|FG001|Overall Study|Missing|1|||
13196558|NCT02049138|26203872|FG002|Overall Study|Missing|0|||
13196559|NCT02048904|26203878|FG000|Overall Study|Withdrawal by Subject|7|||
13196560|NCT02048904|26203878|FG000|Overall Study|Physician Decision|70|||
13196561|NCT02048826|26203895|FG000|Overall Study|Withdrawal by Subject|1|||
13196562|NCT02048826|26203896|FG001|Overall Study|Withdrawal by Subject|0|||
13196563|NCT02048722|26203908|FG000|2 Cycles of Treatment|Adverse Event|2|||
13196564|NCT02048722|26203908|FG000|2 Cycles of Treatment|Withdrawal by Subject|4|||
13196565|NCT02048722|26203908|FG000|2 Cycles of Treatment|Progressive Disease|2|||
13196566|NCT02048722|26203908|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10|||
13196567|NCT02048722|26203908|FG000|Follow up 5 Years or Cut of Timepoint|Death|24|||
13196568|NCT02048722|26203908|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3|||
13196569|NCT02048241|26203921|FG000|Overall Study|Withdrawal by Subject|0|||
13196570|NCT02048241|26203922|FG001|Overall Study|Withdrawal by Subject|1|||
13196571|NCT02048072|26203928|FG000|Overall Study|Adverse Event|3|||
13196572|NCT02048072|26203928|FG000|Overall Study|Lost to Follow-up|1|||
13196573|NCT02047903|26203942|FG000|Overall Study|Adverse Event|14|||
13196574|NCT02047903|26203942|FG000|Overall Study|Serious adverse event|10|||
13196575|NCT02047903|26203942|FG000|Overall Study|Withdrawal by Subject|16|||
13196576|NCT02047903|26203942|FG000|Overall Study|Lost to Follow-up|4|||
13196577|NCT02047903|26203942|FG000|Overall Study|Reason not listed|6|||
13196578|NCT02047903|26203942|FG000|Overall Study|Not Treated|9|||
13196579|NCT02047734|26203993|FG000|Overall Study|Adverse Event|18|||
13196580|NCT02047734|26203994|FG001|Overall Study|Adverse Event|13|||
13196581|NCT02047734|26203995|FG002|Overall Study|Adverse Event|13|||
13196582|NCT02047734|26203993|FG000|Overall Study|Lack of Efficacy|4|||
13196583|NCT02047734|26203994|FG001|Overall Study|Lack of Efficacy|5|||
13196584|NCT02047734|26203995|FG002|Overall Study|Lack of Efficacy|1|||
13196585|NCT02047734|26203993|FG000|Overall Study|Protocol Violation|3|||
13196586|NCT02047734|26203994|FG001|Overall Study|Protocol Violation|1|||
13196587|NCT02047734|26203995|FG002|Overall Study|Protocol Violation|1|||
13196588|NCT02047734|26203993|FG000|Overall Study|Lost to Follow-up|1|||
13196589|NCT02047734|26203994|FG001|Overall Study|Lost to Follow-up|4|||
13196590|NCT02047734|26203995|FG002|Overall Study|Lost to Follow-up|0|||
13196591|NCT02047734|26203993|FG000|Overall Study|Death|0|||
13196592|NCT02047734|26203994|FG001|Overall Study|Death|1|||
13196593|NCT02047734|26203995|FG002|Overall Study|Death|0|||
13196594|NCT02047734|26203993|FG000|Overall Study|Withdrawal by Subject|30|||
13196595|NCT02047734|26203994|FG001|Overall Study|Withdrawal by Subject|31|||
13196596|NCT02047734|26203995|FG002|Overall Study|Withdrawal by Subject|19|||
13196597|NCT02047734|26203993|FG000|Overall Study|Physician Decision|7|||
13196598|NCT02047734|26203994|FG001|Overall Study|Physician Decision|6|||
13196599|NCT02047734|26203995|FG002|Overall Study|Physician Decision|5|||
13196600|NCT02047734|26203993|FG000|Overall Study|Miscellaneous|2|||
13196601|NCT02047734|26203994|FG001|Overall Study|Miscellaneous|4|||
13196602|NCT02047734|26203995|FG002|Overall Study|Miscellaneous|6|||
13196603|NCT02047734|26203993|FG000|Overall Study|Did Not Receive Study Drug|2|||
13196604|NCT02047734|26203994|FG001|Overall Study|Did Not Receive Study Drug|4|||
13196605|NCT02047734|26203995|FG002|Overall Study|Did Not Receive Study Drug|1|||
13196606|NCT02047604|26204052|FG000|Overall Study|Withdrawal by Subject|0|||
13196607|NCT02047604|26204053|FG001|Overall Study|Withdrawal by Subject|0|||
13196608|NCT02047604|26204054|FG002|Overall Study|Withdrawal by Subject|0|||
13196609|NCT02047604|26204055|FG003|Overall Study|Withdrawal by Subject|0|||
13196610|NCT02047604|26204056|FG004|Overall Study|Withdrawal by Subject|1|||
13196611|NCT02047604|26204057|FG005|Overall Study|Withdrawal by Subject|1|||
13196612|NCT02047318|26204101|FG000|Core Study Period|Did not consent to 52-week follow- up|8|||
13196613|NCT02047318|26204101|FG000|Core Study Period|Adverse Event|1|||
13196614|NCT02047318|26204101|FG000|Core Study Period|Withdrawal by caregiver|3|||
13196615|NCT02047318|26204101|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1|||
13196616|NCT02047253|26204111|FG000|Overall Study|Lost to Follow-up|8|||
13196617|NCT02047227|26204134|FG000|Overall Study|Adverse Event|2|||
13196618|NCT02047227|26204135|FG001|Overall Study|Adverse Event|4|||
13196619|NCT02047227|26204134|FG000|Overall Study|Lost to Follow-up|0|||
13196620|NCT02047227|26204135|FG001|Overall Study|Lost to Follow-up|3|||
13196621|NCT02047227|26204134|FG000|Overall Study|Protocol Violation|1|||
13196622|NCT02047227|26204135|FG001|Overall Study|Protocol Violation|0|||
13196623|NCT02047227|26204134|FG000|Overall Study|Spontaneous pregnancy|1|||
13196624|NCT02047227|26204135|FG001|Overall Study|Spontaneous pregnancy|0|||
13196625|NCT02047227|26204134|FG000|Overall Study|Lack of ovarian response to stimulation|35|||
13196626|NCT02047227|26204135|FG001|Overall Study|Lack of ovarian response to stimulation|32|||
13196627|NCT02047227|26204134|FG000|Overall Study|No oocytes retrieved|21|||
13196628|NCT02047227|26204135|FG001|Overall Study|No oocytes retrieved|20|||
13196629|NCT02047227|26204134|FG000|Overall Study|No fertilization|61|||
13196630|NCT02047227|26204135|FG001|Overall Study|No fertilization|51|||
13196631|NCT02047227|26204134|FG000|Overall Study|Intention to freeze all embryos|1|||
13196632|NCT02047227|26204135|FG001|Overall Study|Intention to freeze all embryos|0|||
13196633|NCT02047227|26204134|FG000|Overall Study|All embryos discarded|12|||
13196634|NCT02047227|26204135|FG001|Overall Study|All embryos discarded|11|||
13196635|NCT02047227|26204134|FG000|Overall Study|Other|10|||
13196636|NCT02047227|26204135|FG001|Overall Study|Other|9|||
13196637|NCT02047110|26204189|FG000|DB Treatment Period up to Week 24|Adverse Event|1|||
13196638|NCT02047110|26204190|FG001|DB Treatment Period up to Week 24|Adverse Event|0|||
13196639|NCT02047110|26204191|FG002|DB Treatment Period up to Week 24|Adverse Event|0|||
13196640|NCT02047110|26204192|FG003|DB Treatment Period up to Week 24|Adverse Event|0|||
13196641|NCT02047110|26204189|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1|||
13196642|NCT02047110|26204190|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
13196643|NCT02047110|26204191|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
13196644|NCT02047110|26204192|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
13196645|NCT02047110|26204189|FG000|DB Treatment Period up to Week 24|Protocol Violation|1|||
13196646|NCT02047110|26204190|FG001|DB Treatment Period up to Week 24|Protocol Violation|0|||
13196647|NCT02047110|26204191|FG002|DB Treatment Period up to Week 24|Protocol Violation|0|||
13196648|NCT02047110|26204192|FG003|DB Treatment Period up to Week 24|Protocol Violation|0|||
13196649|NCT02047110|26204189|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
13196650|NCT02047110|26204190|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
13196651|NCT02047110|26204191|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
13196652|NCT02047110|26204192|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
13196653|NCT02047110|26204189|FG000|DB Treatment Period up to Week 24|Other than specified|1|||
13196654|NCT02047110|26204190|FG001|DB Treatment Period up to Week 24|Other than specified|2|||
13196655|NCT02047110|26204191|FG002|DB Treatment Period up to Week 24|Other than specified|3|||
13196656|NCT02047110|26204192|FG003|DB Treatment Period up to Week 24|Other than specified|1|||
13196657|NCT02047110|26204189|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
13196658|NCT02047110|26204190|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1|||
13196659|NCT02047110|26204191|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
13196660|NCT02047110|26204192|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
13196661|NCT02047110|26204189|FG000|DB (Week 12 up to Week 24)|Other than specified|0|||
13196662|NCT02047110|26204190|FG001|DB (Week 12 up to Week 24)|Other than specified|1|||
13196663|NCT02047110|26204191|FG002|DB (Week 12 up to Week 24)|Other than specified|1|||
13196664|NCT02047110|26204192|FG003|DB (Week 12 up to Week 24)|Other than specified|0|||
13196665|NCT02047110|26204189|FG000|Escape Treatment Period|Withdrawal by Subject|1|||
13223191|NCT01799889|26287991|FG003|Overall Study|Withdrawal by Subject|0|||
13196666|NCT02047110|26204190|FG001|Escape Treatment Period|Withdrawal by Subject|2|||
13196667|NCT02047110|26204191|FG002|Escape Treatment Period|Withdrawal by Subject|1|||
13196668|NCT02047110|26204192|FG003|Escape Treatment Period|Withdrawal by Subject|1|||
13196669|NCT02047110|26204189|FG000|Escape Treatment Period|Adverse Event|1|||
13196670|NCT02047110|26204190|FG001|Escape Treatment Period|Adverse Event|2|||
13196671|NCT02047110|26204191|FG002|Escape Treatment Period|Adverse Event|2|||
13196672|NCT02047110|26204192|FG003|Escape Treatment Period|Adverse Event|0|||
13196673|NCT02047110|26204189|FG000|Escape Treatment Period|Other than specified|1|||
13196674|NCT02047110|26204190|FG001|Escape Treatment Period|Other than specified|2|||
13196675|NCT02047110|26204191|FG002|Escape Treatment Period|Other than specified|0|||
13196676|NCT02047110|26204192|FG003|Escape Treatment Period|Other than specified|1|||
13196677|NCT02047110|26204189|FG000|OLE Treatment Period|Other than specified|0|||
13196678|NCT02047110|26204190|FG001|OLE Treatment Period|Other than specified|0|||
13196679|NCT02047110|26204191|FG002|OLE Treatment Period|Other than specified|1|||
13196680|NCT02047110|26204192|FG003|OLE Treatment Period|Other than specified|0|||
13196681|NCT02047045|26204231|FG000|Baseline|Withdrawal by Subject|3|||
13196682|NCT02047045|26204232|FG001|Baseline|Withdrawal by Subject|2|||
13196683|NCT02047045|26204231|FG000|Treatment Period (8 Weeks )|Adverse Event|3|||
13196684|NCT02047045|26204232|FG001|Treatment Period (8 Weeks )|Adverse Event|1|||
13196685|NCT02047045|26204231|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1|||
13196686|NCT02047045|26204232|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3|||
13196687|NCT02047045|26204231|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3|||
13196688|NCT02047045|26204232|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5|||
13196689|NCT02047045|26204231|FG000|Treatment Period (8 Weeks )|moved far away out of work|3|||
13196690|NCT02047045|26204232|FG001|Treatment Period (8 Weeks )|moved far away out of work|0|||
13196691|NCT02047045|26204231|FG000|Treatment Period (8 Weeks )|no reason was given|1|||
13196692|NCT02047045|26204232|FG001|Treatment Period (8 Weeks )|no reason was given|0|||
13196693|NCT02047045|26204231|FG000|Treatment Period (8 Weeks )|refused to take drugs|0|||
13196694|NCT02047045|26204232|FG001|Treatment Period (8 Weeks )|refused to take drugs|5|||
13196695|NCT02047045|26204231|FG000|Treatment Period (8 Weeks )|for safety considerations|0|||
13196696|NCT02047045|26204232|FG001|Treatment Period (8 Weeks )|for safety considerations|1|||
13196697|NCT02047045|26204231|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
13196698|NCT02047045|26204232|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
13196699|NCT02046993|26204255|FG000|Overall Study|Withdrawal by Subject|2|||
13196700|NCT02046993|26204256|FG001|Overall Study|Withdrawal by Subject|10|||
13196701|NCT02046993|26204255|FG000|Overall Study|Lost to Follow-up|1|||
13196702|NCT02046993|26204256|FG001|Overall Study|Lost to Follow-up|1|||
13196703|NCT02046616|26204278|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1|||
13196704|NCT02046616|26204278|FG000|24-Week Treatment Period|Any Other Adverse Event|13|||
13196705|NCT02046616|26204278|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1|||
13196706|NCT02046616|26204278|FG000|24-Week Treatment Period|Physician Decision|3|||
13196707|NCT02046616|26204278|FG000|24-Week Treatment Period|Other|1|||
13196708|NCT02046616|26204278|FG000|8-Week FU Period|Lost to Follow-up|1|||
13196709|NCT02046603|26204362|FG000|Overall Study|Other|11|||
13196710|NCT02046603|26204363|FG001|Overall Study|Other|66|||
13196711|NCT02046603|26204362|FG000|Overall Study|Protocol Violation|0|||
13196712|NCT02046603|26204363|FG001|Overall Study|Protocol Violation|1|||
13196713|NCT02046603|26204362|FG000|Overall Study|Participant/legal guardian decision|1|||
13196714|NCT02046603|26204363|FG001|Overall Study|Participant/legal guardian decision|3|||
13196715|NCT02046603|26204362|FG000|Overall Study|Physician Decision|2|||
13196716|NCT02046603|26204363|FG001|Overall Study|Physician Decision|1|||
13196717|NCT02046603|26204362|FG000|Overall Study|Lost to Follow-up|1|||
13196718|NCT02046603|26204363|FG001|Overall Study|Lost to Follow-up|2|||
13196719|NCT02046603|26204362|FG000|Overall Study|Death|0|||
13196720|NCT02046603|26204363|FG001|Overall Study|Death|1|||
13196721|NCT02046603|26204362|FG000|Overall Study|Adverse Event|0|||
13196722|NCT02046603|26204363|FG001|Overall Study|Adverse Event|1|||
13196723|NCT02046564|26204392|FG000|Overall Study|Adverse Event|6|||
13196724|NCT02046564|26204393|FG001|Overall Study|Adverse Event|3|||
13196725|NCT02046564|26204392|FG000|Overall Study|Physician Decision|0|||
13196726|NCT02046564|26204393|FG001|Overall Study|Physician Decision|1|||
13196727|NCT02046564|26204392|FG000|Overall Study|Protocol Violation|3|||
13196728|NCT02046564|26204393|FG001|Overall Study|Protocol Violation|1|||
13112191|NCT03162614|25907339|FG002|Overall Study|Withdrawal by Subject|1|||
13196729|NCT02046564|26204392|FG000|Overall Study|Withdrawal by Subject|4|||
13196730|NCT02046564|26204393|FG001|Overall Study|Withdrawal by Subject|10|||
13196731|NCT02046564|26204392|FG000|Overall Study|Subject met withdrawal criteria|2|||
13196732|NCT02046564|26204393|FG001|Overall Study|Subject met withdrawal criteria|5|||
13196733|NCT02046369|26204416|FG000|Overall Study|Adverse Event|3|||
13196734|NCT02046369|26204417|FG001|Overall Study|Adverse Event|3|||
13196735|NCT02046369|26204416|FG000|Overall Study|Lack of Efficacy|3|||
13112192|NCT03162614|25907340|FG003|Overall Study|Withdrawal by Subject|1|||
13112193|NCT03162614|25907341|FG004|Overall Study|Withdrawal by Subject|0|||
13112194|NCT03162614|25907342|FG005|Overall Study|Withdrawal by Subject|0|||
13112195|NCT03162614|25907337|FG000|Overall Study|Missed vaccination, exclusion criteria|2|||
13112196|NCT03162614|25907338|FG001|Overall Study|Missed vaccination, exclusion criteria|2|||
13112197|NCT03162614|25907339|FG002|Overall Study|Missed vaccination, exclusion criteria|2|||
13112198|NCT03162614|25907340|FG003|Overall Study|Missed vaccination, exclusion criteria|4|||
13112199|NCT03162614|25907341|FG004|Overall Study|Missed vaccination, exclusion criteria|3|||
13112200|NCT03162614|25907342|FG005|Overall Study|Missed vaccination, exclusion criteria|0|||
13112201|NCT03162328|25907373|FG000|Screening Period|Did not meet inclusion/exclusion|21|||
13112202|NCT03162328|25907374|FG001|Screening Period|Did not meet inclusion/exclusion|0|||
13112203|NCT03162328|25907375|FG002|Screening Period|Did not meet inclusion/exclusion|0|||
13112204|NCT03162328|25907373|FG000|Screening Period|Withdrawal by Subject|1|||
13112205|NCT03162328|25907374|FG001|Screening Period|Withdrawal by Subject|0|||
13112206|NCT03162328|25907375|FG002|Screening Period|Withdrawal by Subject|0|||
13112207|NCT03162328|25907373|FG000|Study Period|Withdrawal by Subject|0|||
13112208|NCT03162328|25907374|FG001|Study Period|Withdrawal by Subject|0|||
13112209|NCT03162328|25907375|FG002|Study Period|Withdrawal by Subject|1|||
13112210|NCT03162224|25907438|FG000|Overall Study|Death|4|||
13112211|NCT03162224|25907439|FG001|Overall Study|Death|5|||
13112212|NCT03162224|25907440|FG002|Overall Study|Death|8|||
13112213|NCT03162224|25907438|FG000|Overall Study|Withdrawal by Subject|1|||
13112214|NCT03162224|25907439|FG001|Overall Study|Withdrawal by Subject|0|||
13112215|NCT03162224|25907440|FG002|Overall Study|Withdrawal by Subject|1|||
13112216|NCT03162224|25907438|FG000|Overall Study|Lost to Follow-up|0|||
13112217|NCT03162224|25907439|FG001|Overall Study|Lost to Follow-up|1|||
13112218|NCT03162224|25907440|FG002|Overall Study|Lost to Follow-up|0|||
13112219|NCT03162224|25907438|FG000|Overall Study|Other|6|||
13112220|NCT03162224|25907439|FG001|Overall Study|Other|2|||
13112221|NCT03162224|25907440|FG002|Overall Study|Other|1|||
13112222|NCT03162055|25907471|FG000|Overall Study|Adverse Event|6|||
13112223|NCT03162055|25907472|FG001|Overall Study|Adverse Event|5|||
13112224|NCT03162055|25907471|FG000|Overall Study|Death|3|||
13112225|NCT03162055|25907472|FG001|Overall Study|Death|3|||
13112226|NCT03162055|25907471|FG000|Overall Study|Lost to Follow-up|0|||
13112227|NCT03162055|25907472|FG001|Overall Study|Lost to Follow-up|1|||
13112228|NCT03162055|25907471|FG000|Overall Study|Study-specific withdrawal criteria|22|||
13112229|NCT03162055|25907472|FG001|Overall Study|Study-specific withdrawal criteria|14|||
13112230|NCT03162055|25907471|FG000|Overall Study|Withdrawal by Subject|17|||
13112231|NCT03162055|25907472|FG001|Overall Study|Withdrawal by Subject|2|||
13112232|NCT03162055|25907471|FG000|Overall Study|Did not receive treatment|2|||
13112233|NCT03162055|25907472|FG001|Overall Study|Did not receive treatment|0|||
13112234|NCT03162055|25907471|FG000|Overall Study|Incorrect randomization|4|||
13112235|NCT03162055|25907472|FG001|Overall Study|Incorrect randomization|3|||
13112236|NCT03162055|25907471|FG000|Overall Study|Other|8|||
13112237|NCT03162055|25907472|FG001|Overall Study|Other|15|||
13112238|NCT03161483|25907543|FG000|Overall Study|Death|1|||
13112239|NCT03161483|25907544|FG001|Overall Study|Death|0|||
13112240|NCT03161483|25907545|FG002|Overall Study|Death|0|||
13112241|NCT03161483|25907546|FG003|Overall Study|Death|0|||
13112242|NCT03161483|25907543|FG000|Overall Study|Adverse Event|5|||
13112243|NCT03161483|25907544|FG001|Overall Study|Adverse Event|1|||
13112244|NCT03161483|25907545|FG002|Overall Study|Adverse Event|11|||
13112245|NCT03161483|25907546|FG003|Overall Study|Adverse Event|2|||
13112246|NCT03161483|25907543|FG000|Overall Study|Pregnancy|1|||
13112247|NCT03161483|25907544|FG001|Overall Study|Pregnancy|0|||
13112248|NCT03161483|25907545|FG002|Overall Study|Pregnancy|0|||
13112249|NCT03161483|25907546|FG003|Overall Study|Pregnancy|0|||
13112250|NCT03161483|25907543|FG000|Overall Study|Lack of Efficacy|0|||
13112251|NCT03161483|25907544|FG001|Overall Study|Lack of Efficacy|0|||
13112252|NCT03161483|25907545|FG002|Overall Study|Lack of Efficacy|1|||
13112253|NCT03161483|25907546|FG003|Overall Study|Lack of Efficacy|0|||
13196736|NCT02046369|26204417|FG001|Overall Study|Lack of Efficacy|3|||
13196737|NCT02046369|26204416|FG000|Overall Study|Lost to Follow-up|3|||
13112254|NCT03161483|25907543|FG000|Overall Study|Withdrawal by Subject|2|||
13112255|NCT03161483|25907544|FG001|Overall Study|Withdrawal by Subject|2|||
13112256|NCT03161483|25907545|FG002|Overall Study|Withdrawal by Subject|6|||
13196738|NCT02046369|26204417|FG001|Overall Study|Lost to Follow-up|3|||
13196739|NCT02046369|26204416|FG000|Overall Study|Protocol Violation|1|||
13196740|NCT02046369|26204417|FG001|Overall Study|Protocol Violation|2|||
13196741|NCT02046369|26204416|FG000|Overall Study|Withdrawal by Subject|3|||
13196742|NCT02046369|26204417|FG001|Overall Study|Withdrawal by Subject|6|||
13196743|NCT02046369|26204416|FG000|Overall Study|never received study drug|0|||
13196744|NCT02046369|26204417|FG001|Overall Study|never received study drug|1|||
13196745|NCT02046369|26204416|FG000|Overall Study|non compliance|1|||
13196746|NCT02046369|26204417|FG001|Overall Study|non compliance|0|||
13196747|NCT02046226|26204426|FG000|Overall Study|Lost to Follow-up|7|||
13112257|NCT03161483|25907546|FG003|Overall Study|Withdrawal by Subject|5|||
13112258|NCT03161483|25907543|FG000|Overall Study|Lost to Follow-up|0|||
13112259|NCT03161483|25907544|FG001|Overall Study|Lost to Follow-up|0|||
13112260|NCT03161483|25907545|FG002|Overall Study|Lost to Follow-up|1|||
13196748|NCT02046174|26204514|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1|||
13196749|NCT02046174|26204515|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0|||
13196750|NCT02046148|26204582|FG000|Overall Study|Lost to Follow-up|1|||
13196751|NCT02046148|26204583|FG001|Overall Study|Lost to Follow-up|1|||
13196752|NCT02046148|26204582|FG000|Overall Study|Withdrawal by Subject|0|||
13196753|NCT02046148|26204583|FG001|Overall Study|Withdrawal by Subject|2|||
13196754|NCT02046122|26204596|FG000|Overall Study|Physician Decision|8|||
13196755|NCT02046122|26204596|FG000|Overall Study|Withdrawal by Subject|1|||
13196756|NCT02046070|26204650|FG000|Overall Study|Progressive Disease|18|||
13196757|NCT02046070|26204651|FG001|Overall Study|Progressive Disease|11|||
13196758|NCT02046070|26204652|FG002|Overall Study|Progressive Disease|40|||
13196759|NCT02046070|26204650|FG000|Overall Study|Adverse Event|8|||
13196760|NCT02046070|26204651|FG001|Overall Study|Adverse Event|10|||
13196761|NCT02046070|26204652|FG002|Overall Study|Adverse Event|17|||
13196762|NCT02046070|26204650|FG000|Overall Study|Withdrawal by Subject|1|||
13196763|NCT02046070|26204651|FG001|Overall Study|Withdrawal by Subject|2|||
13196764|NCT02046070|26204652|FG002|Overall Study|Withdrawal by Subject|6|||
13196765|NCT02046070|26204650|FG000|Overall Study|Study Terminated by Sponsor|1|||
13196766|NCT02046070|26204651|FG001|Overall Study|Study Terminated by Sponsor|1|||
13196767|NCT02046070|26204652|FG002|Overall Study|Study Terminated by Sponsor|1|||
13196768|NCT02046070|26204650|FG000|Overall Study|Reason not Specified|4|||
13196769|NCT02046070|26204651|FG001|Overall Study|Reason not Specified|4|||
13196770|NCT02046070|26204652|FG002|Overall Study|Reason not Specified|6|||
13196771|NCT02045979|26204697|FG000|Overall Study|Informed Consent Withdrawn|2|||
13196772|NCT02045979|26204698|FG001|Overall Study|Informed Consent Withdrawn|0|||
13196773|NCT02045979|26204699|FG002|Overall Study|Informed Consent Withdrawn|1|||
13196774|NCT02045979|26204697|FG000|Overall Study|not specified above|0|||
13196775|NCT02045979|26204698|FG001|Overall Study|not specified above|1|||
13196776|NCT02045979|26204699|FG002|Overall Study|not specified above|0|||
13196777|NCT02045875|26204714|FG000|Overall Study|Lost to Follow-up|3|||
13196778|NCT02045875|26204715|FG001|Overall Study|Lost to Follow-up|0|||
13196779|NCT02045875|26204714|FG000|Overall Study|Withdrawal by Subject|4|||
13196780|NCT02045875|26204715|FG001|Overall Study|Withdrawal by Subject|3|||
13196781|NCT02045862|26204904|FG000|Overall Study|Death|0|||
13196782|NCT02045862|26204905|FG001|Overall Study|Death|0|||
13196783|NCT02045862|26204906|FG002|Overall Study|Death|1|||
13196784|NCT02045862|26204904|FG000|Overall Study|Miscellaneous|5|||
13196785|NCT02045862|26204905|FG001|Overall Study|Miscellaneous|0|||
13196786|NCT02045862|26204906|FG002|Overall Study|Miscellaneous|8|||
13196787|NCT02045862|26204904|FG000|Overall Study|Withdrawal by Patient|18|||
13112261|NCT03161483|25907546|FG003|Overall Study|Lost to Follow-up|0|||
13112262|NCT03161483|25907543|FG000|Overall Study|Protocol Violation|0|||
13112263|NCT03161483|25907544|FG001|Overall Study|Protocol Violation|0|||
13112264|NCT03161483|25907545|FG002|Overall Study|Protocol Violation|1|||
13112265|NCT03161483|25907546|FG003|Overall Study|Protocol Violation|0|||
13112266|NCT03161483|25907543|FG000|Overall Study|Other reasons|1|||
13112267|NCT03161483|25907544|FG001|Overall Study|Other reasons|0|||
13112268|NCT03161483|25907545|FG002|Overall Study|Other reasons|0|||
13112269|NCT03161483|25907546|FG003|Overall Study|Other reasons|1|||
13112270|NCT03161405|25907559|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1|||
13112271|NCT03161093|25907716|FG000|Overall Study|Protocol Violation|11|||
13112272|NCT03161093|25907717|FG001|Overall Study|Protocol Violation|14|||
13196788|NCT02045862|26204905|FG001|Overall Study|Withdrawal by Patient|27|||
13196789|NCT02045862|26204906|FG002|Overall Study|Withdrawal by Patient|57|||
13196790|NCT02045862|26204904|FG000|Overall Study|Protocol Violation|0|||
13196791|NCT02045862|26204905|FG001|Overall Study|Protocol Violation|0|||
13196792|NCT02045862|26204906|FG002|Overall Study|Protocol Violation|6|||
13196793|NCT02045862|26204904|FG000|Overall Study|Lack of Efficacy|8|||
13196794|NCT02045862|26204905|FG001|Overall Study|Lack of Efficacy|4|||
13112273|NCT03161093|25907718|FG002|Overall Study|Protocol Violation|6|||
13112274|NCT03161093|25907719|FG003|Overall Study|Protocol Violation|13|||
13112275|NCT03161093|25907720|FG004|Overall Study|Protocol Violation|1|||
13112276|NCT03161093|25907721|FG005|Overall Study|Protocol Violation|0|||
13112277|NCT03161093|25907716|FG000|Overall Study|Adverse Event|5|||
13196795|NCT02045862|26204906|FG002|Overall Study|Lack of Efficacy|13|||
13196796|NCT02045862|26204904|FG000|Overall Study|Randomized but not Received Study Drug|0|||
13196797|NCT02045862|26204905|FG001|Overall Study|Randomized but not Received Study Drug|2|||
13196798|NCT02045862|26204906|FG002|Overall Study|Randomized but not Received Study Drug|8|||
13196799|NCT02045862|26204904|FG000|Overall Study|Adverse Event|7|||
13196800|NCT02045862|26204905|FG001|Overall Study|Adverse Event|5|||
13196801|NCT02045862|26204906|FG002|Overall Study|Adverse Event|27|||
13196802|NCT02045862|26204904|FG000|Overall Study|Lost to Follow-up|1|||
13196803|NCT02045862|26204905|FG001|Overall Study|Lost to Follow-up|2|||
13196804|NCT02045862|26204906|FG002|Overall Study|Lost to Follow-up|6|||
13196805|NCT02045836|26204944|FG000|Overall Study|Adverse Event|4|||
13196806|NCT02045836|26204945|FG001|Overall Study|Adverse Event|4|||
13196807|NCT02045836|26204944|FG000|Overall Study|Withdrawal by Subject|1|||
13196808|NCT02045836|26204945|FG001|Overall Study|Withdrawal by Subject|1|||
13196809|NCT02045836|26204944|FG000|Overall Study|Lost to Follow-up|4|||
13196810|NCT02045836|26204945|FG001|Overall Study|Lost to Follow-up|7|||
13196811|NCT02045836|26204944|FG000|Overall Study|Migrated from study area|0|||
13196812|NCT02045836|26204945|FG001|Overall Study|Migrated from study area|2|||
13196813|NCT02045732|26204970|FG000|Overall Study|At the discretion of the investigator|1|||
13196814|NCT02045732|26204971|FG001|Overall Study|At the discretion of the investigator|1|||
13196815|NCT02045433|26204977|FG000|Overall Study|Withdrawal by Subject|1|||
13196816|NCT02045212|26204996|FG000|Overall Study|Adverse Event|0|||
13196817|NCT02045212|26204997|FG001|Overall Study|Adverse Event|1|||
13196818|NCT02045212|26204996|FG000|Overall Study|Withdrawal by Subject|1|||
13196819|NCT02045212|26204997|FG001|Overall Study|Withdrawal by Subject|0|||
13196820|NCT02045212|26204996|FG000|Overall Study|Finished 13 weeks, chose not to extend|1|||
13196821|NCT02045212|26204997|FG001|Overall Study|Finished 13 weeks, chose not to extend|0|||
13196822|NCT02045095|26205147|FG000|Overall Study|Other|0|||
13196823|NCT02045095|26205148|FG001|Overall Study|Other|0|||
13196824|NCT02045095|26205149|FG002|Overall Study|Other|1|||
13196825|NCT02045095|26205150|FG003|Overall Study|Other|0|||
13196826|NCT02045095|26205151|FG004|Overall Study|Other|0|||
13196827|NCT02045095|26205152|FG005|Overall Study|Other|2|||
13196828|NCT02045095|26205153|FG006|Overall Study|Other|0|||
13196829|NCT02045095|26205147|FG000|Overall Study|Progressive Disease|3|||
13196830|NCT02045095|26205148|FG001|Overall Study|Progressive Disease|3|||
13196831|NCT02045095|26205149|FG002|Overall Study|Progressive Disease|2|||
13196832|NCT02045095|26205150|FG003|Overall Study|Progressive Disease|4|||
13196833|NCT02045095|26205151|FG004|Overall Study|Progressive Disease|2|||
13196834|NCT02045095|26205152|FG005|Overall Study|Progressive Disease|4|||
13196835|NCT02045095|26205153|FG006|Overall Study|Progressive Disease|1|||
13196836|NCT02045095|26205147|FG000|Overall Study|Withdrawal by Subject|0|||
13196837|NCT02045095|26205148|FG001|Overall Study|Withdrawal by Subject|0|||
13196838|NCT02045095|26205149|FG002|Overall Study|Withdrawal by Subject|0|||
13196839|NCT02045095|26205150|FG003|Overall Study|Withdrawal by Subject|0|||
13196840|NCT02045095|26205151|FG004|Overall Study|Withdrawal by Subject|3|||
13196841|NCT02045095|26205152|FG005|Overall Study|Withdrawal by Subject|0|||
13196842|NCT02045095|26205153|FG006|Overall Study|Withdrawal by Subject|0|||
13196843|NCT02045095|26205147|FG000|Overall Study|Adverse Event|0|||
13196844|NCT02045095|26205148|FG001|Overall Study|Adverse Event|1|||
13196845|NCT02045095|26205149|FG002|Overall Study|Adverse Event|1|||
13196846|NCT02045095|26205150|FG003|Overall Study|Adverse Event|0|||
13196847|NCT02045095|26205151|FG004|Overall Study|Adverse Event|0|||
13196848|NCT02045095|26205152|FG005|Overall Study|Adverse Event|2|||
13196849|NCT02045095|26205153|FG006|Overall Study|Adverse Event|0|||
13196850|NCT02044874|26205183|FG000|Overall Study|Adverse Event|5|||
13196851|NCT02044874|26205184|FG001|Overall Study|Adverse Event|6|||
13196852|NCT02044874|26205185|FG002|Overall Study|Adverse Event|6|||
13196853|NCT02044874|26205183|FG000|Overall Study|Withdrawal by Subject|8|||
13196854|NCT02044874|26205184|FG001|Overall Study|Withdrawal by Subject|16|||
13196855|NCT02044874|26205185|FG002|Overall Study|Withdrawal by Subject|23|||
13196856|NCT02044874|26205183|FG000|Overall Study|Physician Decision|0|||
13196857|NCT02044874|26205184|FG001|Overall Study|Physician Decision|2|||
13196858|NCT02044874|26205185|FG002|Overall Study|Physician Decision|1|||
13196859|NCT02044874|26205183|FG000|Overall Study|Lost to Follow-up|10|||
13196860|NCT02044874|26205184|FG001|Overall Study|Lost to Follow-up|27|||
13196861|NCT02044874|26205185|FG002|Overall Study|Lost to Follow-up|21|||
13196862|NCT02044874|26205183|FG000|Overall Study|Sponsor Decision|0|||
13196863|NCT02044874|26205184|FG001|Overall Study|Sponsor Decision|1|||
13196864|NCT02044874|26205185|FG002|Overall Study|Sponsor Decision|1|||
13196865|NCT02044874|26205183|FG000|Overall Study|Other|7|||
13196866|NCT02044874|26205184|FG001|Overall Study|Other|3|||
13196867|NCT02044874|26205185|FG002|Overall Study|Other|8|||
13196868|NCT02044848|26205198|FG000|Overall Study|Administrative Problems|2|||
13196869|NCT02044848|26205199|FG001|Overall Study|Administrative Problems|3|||
13196870|NCT02044822|26205211|FG000|Overall Study|Study Terminated by Sponsor|77|||
13196871|NCT02044822|26205211|FG000|Overall Study|Investigator's Discretion|10|||
13196872|NCT02044822|26205211|FG000|Overall Study|Withdrew Consent|3|||
13485622|NCT02323126|27032966|FG001|Overall Study|Adverse Event|5|||
13196873|NCT02044822|26205211|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2|||
13196874|NCT02044822|26205211|FG000|Overall Study|Lost to Follow-up|1|||
13196875|NCT02044510|26205224|FG000|Overall Study|Adverse Event|1|||
13196876|NCT02044510|26205225|FG001|Overall Study|Adverse Event|2|||
13206413|NCT01957553|26234718|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0|||
13206414|NCT01957553|26234719|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1|||
13206415|NCT01957553|26234718|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0|||
13206416|NCT01957553|26234719|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1|||
13206417|NCT01957553|26234718|FG000|Test Period 2 (21 +- 1 Days)|Other|1|||
13206418|NCT01957553|26234719|FG001|Test Period 2 (21 +- 1 Days)|Other|0|||
13206419|NCT01957488|26234734|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2|||
13206420|NCT01957488|26234735|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
13206421|NCT01957488|26234736|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
13206422|NCT01957488|26234737|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
13206423|NCT01957488|26234738|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
13206424|NCT01957488|26234739|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
13206425|NCT01957488|26234734|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1|||
13206426|NCT01957488|26234735|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2|||
13206427|NCT01957488|26234736|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2|||
13206428|NCT01957488|26234737|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1|||
13206429|NCT01957488|26234738|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0|||
13206430|NCT01957488|26234739|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3|||
13206431|NCT01957488|26234734|FG000|Test Period 1 (2 Weeks)|Adverse Event|0|||
13206432|NCT01957488|26234735|FG001|Test Period 1 (2 Weeks)|Adverse Event|1|||
13206433|NCT01957488|26234736|FG002|Test Period 1 (2 Weeks)|Adverse Event|1|||
13206434|NCT01957488|26234737|FG003|Test Period 1 (2 Weeks)|Adverse Event|0|||
13206435|NCT01957488|26234738|FG004|Test Period 1 (2 Weeks)|Adverse Event|1|||
13206436|NCT01957488|26234739|FG005|Test Period 1 (2 Weeks)|Adverse Event|0|||
13206437|NCT01957488|26234734|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
13206438|NCT01957488|26234735|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
13206439|NCT01957488|26234736|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
13206440|NCT01957488|26234737|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
13206441|NCT01957488|26234738|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
13206442|NCT01957488|26234739|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2|||
13206443|NCT01957488|26234734|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
13206444|NCT01957488|26234735|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
13206445|NCT01957488|26234736|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
13206446|NCT01957488|26234737|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
13206447|NCT01957488|26234738|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1|||
13206448|NCT01957488|26234739|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
13206449|NCT01957488|26234734|FG000|Test Period 1 (2 Weeks)|screen failure|0|||
13206450|NCT01957488|26234735|FG001|Test Period 1 (2 Weeks)|screen failure|0|||
13206451|NCT01957488|26234736|FG002|Test Period 1 (2 Weeks)|screen failure|0|||
13206452|NCT01957488|26234737|FG003|Test Period 1 (2 Weeks)|screen failure|0|||
13206453|NCT01957488|26234738|FG004|Test Period 1 (2 Weeks)|screen failure|0|||
13206454|NCT01957488|26234739|FG005|Test Period 1 (2 Weeks)|screen failure|1|||
13206455|NCT01957488|26234734|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2|||
13206456|NCT01957488|26234735|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0|||
13206457|NCT01957488|26234736|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1|||
13206458|NCT01957488|26234737|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1|||
13206459|NCT01957488|26234738|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0|||
13206460|NCT01957488|26234739|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0|||
13206461|NCT01957488|26234734|FG000|Test Period 2 (2 Weeks)|Other|1|||
13206462|NCT01957488|26234735|FG001|Test Period 2 (2 Weeks)|Other|0|||
13206463|NCT01957488|26234736|FG002|Test Period 2 (2 Weeks)|Other|0|||
13206464|NCT01957488|26234737|FG003|Test Period 2 (2 Weeks)|Other|0|||
13206465|NCT01957488|26234738|FG004|Test Period 2 (2 Weeks)|Other|0|||
13206466|NCT01957488|26234739|FG005|Test Period 2 (2 Weeks)|Other|0|||
13206467|NCT01957488|26234734|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
13206468|NCT01957488|26234735|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1|||
13206469|NCT01957488|26234736|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
13206470|NCT01957488|26234737|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
13206471|NCT01957488|26234738|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
13206472|NCT01957488|26234739|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
13206473|NCT01957488|26234734|FG000|Test Period 2 (2 Weeks)|Adverse Event|0|||
13206474|NCT01957488|26234735|FG001|Test Period 2 (2 Weeks)|Adverse Event|0|||
13206475|NCT01957488|26234736|FG002|Test Period 2 (2 Weeks)|Adverse Event|0|||
13206476|NCT01957488|26234737|FG003|Test Period 2 (2 Weeks)|Adverse Event|0|||
13206477|NCT01957488|26234738|FG004|Test Period 2 (2 Weeks)|Adverse Event|2|||
13206478|NCT01957488|26234739|FG005|Test Period 2 (2 Weeks)|Adverse Event|0|||
13206479|NCT01957488|26234734|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
13206480|NCT01957488|26234735|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
13196877|NCT02044458|26205242|FG000|Overall Study|Protocol Violation|3|||
13196878|NCT02044458|26205243|FG001|Overall Study|Protocol Violation|8|||
13196879|NCT02044302|26205256|FG000|Overall Study|study terminated|2|||
13196880|NCT02044302|26205257|FG001|Overall Study|study terminated|0|||
13196881|NCT02044159|26205277|FG000|Overall Study|Consent declined (deferred consent)|2|||
13196882|NCT02044159|26205278|FG001|Overall Study|Consent declined (deferred consent)|4|||
13196883|NCT02044159|26205277|FG000|Overall Study|No longer eligible, drug not given|1|||
13196884|NCT02044159|26205278|FG001|Overall Study|No longer eligible, drug not given|0|||
13196885|NCT02044159|26205277|FG000|Overall Study|Nurse declined to give study drug|1|||
13196886|NCT02044159|26205278|FG001|Overall Study|Nurse declined to give study drug|0|||
13196887|NCT02044094|26205337|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3|||
13196888|NCT02044094|26205337|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3|||
13196889|NCT02044094|26205337|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3|||
13196890|NCT02044094|26205337|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4|||
13196891|NCT02044094|26205337|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5|||
13196892|NCT02044094|26205337|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2|||
13196893|NCT02044094|26205337|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1|||
13196894|NCT02044094|26205337|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1|||
13196895|NCT02043938|26205349|FG000|Overall Study|Withdrawal by Subject|7|||
13196896|NCT02043938|26205349|FG000|Overall Study|Unable to place EEG sensors on patient|1|||
13196897|NCT02043938|26205349|FG000|Overall Study|No show by subject|1|||
13196898|NCT02043938|26205349|FG000|Overall Study|Investigator decision|1|||
13196899|NCT02043899|26205357|FG000|Overall Study|Adverse Event|3|||
13196900|NCT02043899|26205357|FG000|Overall Study|Physician Decision|1|||
13196901|NCT02043899|26205357|FG000|Overall Study|Withdrawal by Subject|2|||
13196902|NCT02043899|26205357|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5|||
13196903|NCT02043899|26205357|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12|||
13196904|NCT02043899|26205357|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2|||
13196905|NCT02043899|26205357|FG000|Overall Study|Clinical progression necessitating urgent treatment|1|||
13196906|NCT02043899|26205357|FG000|Overall Study|Treatment delayed|1|||
13196907|NCT02043782|26205372|FG000|Period 1|Adverse Event|0|||
13196908|NCT02043782|26205373|FG001|Period 1|Adverse Event|0|||
13196909|NCT02043782|26205374|FG002|Period 1|Adverse Event|1|||
13196910|NCT02043782|26205375|FG003|Period 1|Adverse Event|0|||
13196911|NCT02043782|26205376|FG004|Period 1|Adverse Event|0|||
13196912|NCT02043782|26205377|FG005|Period 1|Adverse Event|0|||
13196913|NCT02043548|26205400|FG000|Overall Study|Lack of Efficacy|1|||
13196914|NCT02043548|26205401|FG001|Overall Study|Lack of Efficacy|0|||
13196915|NCT02043548|26205400|FG000|Overall Study|Adverse Event|0|||
13196916|NCT02043548|26205401|FG001|Overall Study|Adverse Event|1|||
13196917|NCT02043509|26205431|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61|||
13196918|NCT02043509|26205432|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47|||
13196919|NCT02043509|26205431|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4|||
13196920|NCT02043509|26205432|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0|||
13196921|NCT02043509|26205431|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
13196922|NCT02043509|26205432|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
13196923|NCT02043509|26205431|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7|||
13196924|NCT02043509|26205432|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5|||
13196925|NCT02043366|26205471|FG000|Overall Study|Lost to Follow-up|2|||
13196926|NCT02043366|26205472|FG001|Overall Study|Lost to Follow-up|2|||
13196927|NCT02043366|26205473|FG002|Overall Study|Lost to Follow-up|2|||
13196928|NCT02043366|26205474|FG003|Overall Study|Lost to Follow-up|2|||
13196929|NCT02043366|26205475|FG004|Overall Study|Lost to Follow-up|2|||
13196930|NCT02043366|26205476|FG005|Overall Study|Lost to Follow-up|2|||
13112278|NCT03161093|25907717|FG001|Overall Study|Adverse Event|21|||
13112279|NCT03161093|25907718|FG002|Overall Study|Adverse Event|16|||
13112280|NCT03161093|25907719|FG003|Overall Study|Adverse Event|35|||
13112281|NCT03161093|25907720|FG004|Overall Study|Adverse Event|2|||
13112282|NCT03161093|25907721|FG005|Overall Study|Adverse Event|1|||
13112283|NCT03161093|25907716|FG000|Overall Study|Lack of Efficacy|9|||
13112284|NCT03161093|25907717|FG001|Overall Study|Lack of Efficacy|13|||
13112285|NCT03161093|25907718|FG002|Overall Study|Lack of Efficacy|9|||
13112286|NCT03161093|25907719|FG003|Overall Study|Lack of Efficacy|24|||
13196931|NCT02043301|26205544|FG000|Overall Study|Discontinued|0|||
13196932|NCT02043301|26205545|FG001|Overall Study|Discontinued|1|||
13196933|NCT02043301|26205546|FG002|Overall Study|Discontinued|0|||
13196934|NCT02043132|26205573|FG000|Overall Study|Lost to Follow-up|1|||
13196935|NCT02043132|26205574|FG001|Overall Study|Lost to Follow-up|1|||
13196936|NCT02043132|26205573|FG000|Overall Study|screen failures|4|||
13196937|NCT02043132|26205574|FG001|Overall Study|screen failures|8|||
13196938|NCT02043015|26205589|FG000|Overall Study|Lost to Follow-up|4|||
13485623|NCT02323126|27032967|FG002|Overall Study|Adverse Event|7|||
13112287|NCT03161093|25907720|FG004|Overall Study|Lack of Efficacy|4|||
13112288|NCT03161093|25907721|FG005|Overall Study|Lack of Efficacy|1|||
13196939|NCT02043015|26205589|FG000|Overall Study|Withdrawal by Subject|4|||
13196940|NCT02043015|26205589|FG000|Overall Study|Removed once target enrollment reached|15|||
13196941|NCT02043015|26205589|FG000|Overall Study|Participant moved away from study city|4|||
13196942|NCT02043015|26205589|FG000|Overall Study|Incarceration|1|||
13196943|NCT02042950|26205597|FG000|Overall Study|Progressive Disease|4|||
13196944|NCT02042924|26205605|FG000|Overall Study|Early Death|1|||
13196945|NCT02042443|26205624|FG000|Overall Study|Adverse Event|2|||
13196946|NCT02042443|26205625|FG001|Overall Study|Adverse Event|1|||
13196947|NCT02042443|26205624|FG000|Overall Study|Withdrawal by Subject|0|||
13196948|NCT02042443|26205625|FG001|Overall Study|Withdrawal by Subject|1|||
13196949|NCT02042443|26205624|FG000|Overall Study|Progression|21|||
13196950|NCT02042443|26205625|FG001|Overall Study|Progression|17|||
13196951|NCT02042443|26205624|FG000|Overall Study|not protocol specified|1|||
13196952|NCT02042443|26205625|FG001|Overall Study|not protocol specified|1|||
13196953|NCT02042443|26205624|FG000|Overall Study|Not eligible/not analyzable|3|||
13196954|NCT02042443|26205625|FG001|Overall Study|Not eligible/not analyzable|6|||
13196955|NCT02042404|26205639|FG000|Overall Study|Death|1|||
13196956|NCT02042404|26205640|FG001|Overall Study|Death|0|||
13196957|NCT02042404|26205639|FG000|Overall Study|Unrelated Adverse Event|3|||
13196958|NCT02042404|26205640|FG001|Overall Study|Unrelated Adverse Event|0|||
13196959|NCT02042404|26205639|FG000|Overall Study|Inability to meet time requirements|1|||
13196960|NCT02042404|26205640|FG001|Overall Study|Inability to meet time requirements|0|||
13196961|NCT02042183|26205655|FG000|Overall Study|Physician Decision|7|||
13196962|NCT02042183|26205656|FG001|Overall Study|Physician Decision|2|||
13196963|NCT02042183|26205655|FG000|Overall Study|Lack of Efficacy|4|||
13196964|NCT02042183|26205656|FG001|Overall Study|Lack of Efficacy|3|||
13196965|NCT02042183|26205655|FG000|Overall Study|Non-compliance with Study Drug|2|||
13196966|NCT02042183|26205656|FG001|Overall Study|Non-compliance with Study Drug|3|||
13196967|NCT02042183|26205655|FG000|Overall Study|Adverse Event|17|||
13196968|NCT02042183|26205656|FG001|Overall Study|Adverse Event|6|||
13196969|NCT02042183|26205655|FG000|Overall Study|Other|3|||
13196970|NCT02042183|26205656|FG001|Overall Study|Other|3|||
13196971|NCT02042183|26205655|FG000|Overall Study|Withdrawal by Subject|21|||
13196972|NCT02042183|26205656|FG001|Overall Study|Withdrawal by Subject|16|||
13196973|NCT02042183|26205655|FG000|Overall Study|Site Terminated by Sponsor|2|||
13196974|NCT02042183|26205656|FG001|Overall Study|Site Terminated by Sponsor|1|||
13196975|NCT02042183|26205655|FG000|Overall Study|Lost to Follow-up|9|||
13196976|NCT02042183|26205656|FG001|Overall Study|Lost to Follow-up|2|||
13196977|NCT02042014|26205662|FG000|Overall Study|Adverse Event|1|||
13196978|NCT02042014|26205662|FG000|Overall Study|Physician Decision|7|||
13196979|NCT02041962|26205677|FG000|Overall Study|Lost Aetna Coverage|43|||
13196980|NCT02041962|26205678|FG001|Overall Study|Lost Aetna Coverage|40|||
13196981|NCT02041962|26205677|FG000|Overall Study|Death|1|||
13196982|NCT02041962|26205678|FG001|Overall Study|Death|1|||
13196983|NCT02041962|26205677|FG000|Overall Study|Lost to Follow-up|37|||
13196984|NCT02041962|26205678|FG001|Overall Study|Lost to Follow-up|32|||
13196985|NCT02041962|26205677|FG000|Overall Study|Withdrawal by Subject|0|||
13196986|NCT02041962|26205678|FG001|Overall Study|Withdrawal by Subject|11|||
13196987|NCT02041923|26205697|FG000|Overall Study|Lost to Follow-up|26|||
13196988|NCT02041923|26205698|FG001|Overall Study|Lost to Follow-up|30|||
13196989|NCT02041702|26205718|FG000|Overall Study|Lost to Follow-up|1|||
13196990|NCT02041702|26205719|FG001|Overall Study|Lost to Follow-up|6|||
13196991|NCT02041702|26205718|FG000|Overall Study|Death|4|||
13196992|NCT02041702|26205719|FG001|Overall Study|Death|0|||
13196993|NCT02041702|26205718|FG000|Overall Study|Withdrawal by Subject|4|||
13196994|NCT02041702|26205719|FG001|Overall Study|Withdrawal by Subject|3|||
13196995|NCT02041702|26205718|FG000|Overall Study|Patient not confirmed as MRI compatible|1|||
13196996|NCT02041702|26205719|FG001|Overall Study|Patient not confirmed as MRI compatible|0|||
13196997|NCT02041702|26205718|FG000|Overall Study|Cardiac Resynchronization Therapy|1|||
13196998|NCT02041702|26205719|FG001|Overall Study|Cardiac Resynchronization Therapy|0|||
13196999|NCT02041533|26205746|FG000|Overall Study|Disease Progression|168|||
13197000|NCT02041533|26205747|FG001|Overall Study|Disease Progression|142|||
13197001|NCT02041533|26205746|FG000|Overall Study|Study drug toxicity|27|||
13197002|NCT02041533|26205747|FG001|Overall Study|Study drug toxicity|30|||
13197003|NCT02041533|26205746|FG000|Overall Study|Death|1|||
13197004|NCT02041533|26205747|FG001|Overall Study|Death|0|||
13197005|NCT02041533|26205746|FG000|Overall Study|Adverse Event unrelated to study drug|20|||
13197006|NCT02041533|26205747|FG001|Overall Study|Adverse Event unrelated to study drug|21|||
13197007|NCT02041533|26205746|FG000|Overall Study|Subject request to discontinue treatment|5|||
13197008|NCT02041533|26205747|FG001|Overall Study|Subject request to discontinue treatment|9|||
13197009|NCT02041533|26205746|FG000|Overall Study|Withdrawal by Subject|2|||
13197010|NCT02041533|26205747|FG001|Overall Study|Withdrawal by Subject|1|||
13197011|NCT02041533|26205746|FG000|Overall Study|Maximum clinical benefit|0|||
13197012|NCT02041533|26205747|FG001|Overall Study|Maximum clinical benefit|18|||
13197013|NCT02041533|26205746|FG000|Overall Study|Poor/non-compliance|1|||
13197014|NCT02041533|26205747|FG001|Overall Study|Poor/non-compliance|0|||
13197015|NCT02041533|26205746|FG000|Overall Study|Other reasons|0|||
13197016|NCT02041533|26205747|FG001|Overall Study|Other reasons|1|||
13197017|NCT02041533|26205746|FG000|Overall Study|Completed max number of chemo cycles|0|||
13197018|NCT02041533|26205747|FG001|Overall Study|Completed max number of chemo cycles|29|||
13197019|NCT02041533|26205746|FG000|Overall Study|Randomized, not treated|4|||
13197020|NCT02041533|26205747|FG001|Overall Study|Randomized, not treated|7|||
13197021|NCT02041520|26205774|FG000|Overall Study|Adverse Event|2|||
13197022|NCT02041520|26205775|FG001|Overall Study|Adverse Event|1|||
13197023|NCT02041520|26205774|FG000|Overall Study|Withdrawal by Subject|3|||
13197024|NCT02041520|26205775|FG001|Overall Study|Withdrawal by Subject|4|||
13197025|NCT02041520|26205774|FG000|Overall Study|Protocol Violation|1|||
13197026|NCT02041520|26205775|FG001|Overall Study|Protocol Violation|0|||
13197027|NCT02041520|26205774|FG000|Overall Study|Lost to Follow-up|0|||
13197028|NCT02041520|26205775|FG001|Overall Study|Lost to Follow-up|1|||
13197029|NCT02041520|26205774|FG000|Overall Study|Hypothiroidism identified during follow-|0|||
13197030|NCT02041520|26205775|FG001|Overall Study|Hypothiroidism identified during follow-|1|||
13197031|NCT02041494|26205794|FG000|Overall Study|Death|1|||
13197032|NCT02041494|26205795|FG001|Overall Study|Death|3|||
13197033|NCT02041494|26205794|FG000|Overall Study|Lost to Follow-up|2|||
13197034|NCT02041494|26205795|FG001|Overall Study|Lost to Follow-up|6|||
13197035|NCT02041494|26205794|FG000|Overall Study|study terminated|16|||
13197036|NCT02041494|26205795|FG001|Overall Study|study terminated|11|||
13197037|NCT02041429|26205835|FG000|Overall Study|Progressive Disease|2|||
13197038|NCT02041429|26205836|FG001|Overall Study|Progressive Disease|2|||
13197039|NCT02041429|26205837|FG002|Overall Study|Progressive Disease|3|||
13197040|NCT02041429|26205838|FG003|Overall Study|Progressive Disease|2|||
13197041|NCT02041429|26205835|FG000|Overall Study|Toxicity|0|||
13197042|NCT02041429|26205836|FG001|Overall Study|Toxicity|1|||
13197043|NCT02041429|26205837|FG002|Overall Study|Toxicity|4|||
13197044|NCT02041429|26205838|FG003|Overall Study|Toxicity|2|||
13197045|NCT02041429|26205835|FG000|Overall Study|Withdrawal by Subject|0|||
13197046|NCT02041429|26205836|FG001|Overall Study|Withdrawal by Subject|1|||
13197047|NCT02041429|26205837|FG002|Overall Study|Withdrawal by Subject|0|||
13197048|NCT02041429|26205838|FG003|Overall Study|Withdrawal by Subject|0|||
13197049|NCT02041429|26205835|FG000|Overall Study|On Maintenance Therapy|1|||
13197050|NCT02041429|26205836|FG001|Overall Study|On Maintenance Therapy|0|||
13197051|NCT02041429|26205837|FG002|Overall Study|On Maintenance Therapy|0|||
13197052|NCT02041429|26205838|FG003|Overall Study|On Maintenance Therapy|2|||
13197053|NCT02041299|26205857|FG000|Overall Study|Adverse Event|9|||
13197054|NCT02041299|26205858|FG001|Overall Study|Adverse Event|3|||
13197055|NCT02041299|26205857|FG000|Overall Study|Lost to Follow-up|4|||
13197056|NCT02041299|26205858|FG001|Overall Study|Lost to Follow-up|1|||
13197057|NCT02041299|26205857|FG000|Overall Study|Physician Decision|1|||
13197058|NCT02041299|26205858|FG001|Overall Study|Physician Decision|1|||
13197059|NCT02041299|26205857|FG000|Overall Study|Withdrawal by Subject|13|||
13197060|NCT02041299|26205858|FG001|Overall Study|Withdrawal by Subject|7|||
13197061|NCT02041299|26205857|FG000|Overall Study|Protocol Violation|11|||
13197062|NCT02041299|26205858|FG001|Overall Study|Protocol Violation|4|||
13197063|NCT02041299|26205857|FG000|Overall Study|Termination of the study|7|||
13197064|NCT02041299|26205858|FG001|Overall Study|Termination of the study|3|||
13197065|NCT02041299|26205857|FG000|Overall Study|Required bone marrow transplant|0|||
13197066|NCT02041299|26205858|FG001|Overall Study|Required bone marrow transplant|1|||
13197067|NCT02041299|26205857|FG000|Overall Study|Patient stopped dosing on unknown date|1|||
13197068|NCT02041299|26205858|FG001|Overall Study|Patient stopped dosing on unknown date|0|||
13197069|NCT02041286|26205868|FG000|Overall Study|Adverse Event|1|||
13197070|NCT02041104|26205913|FG000|Overall Study|Lost to Follow-up|1|||
13197071|NCT02041104|26205914|FG001|Overall Study|Lost to Follow-up|4|||
13197072|NCT02041104|26205913|FG000|Overall Study|discomfort during OGTT|0|||
13197073|NCT02041104|26205914|FG001|Overall Study|discomfort during OGTT|3|||
13197074|NCT02041091|26205943|FG000|Treatment|Adverse Event|3|||
13197075|NCT02041091|26205944|FG001|Treatment|Adverse Event|3|||
13197076|NCT02041091|26205943|FG000|Treatment|Withdrawal by Subject|2|||
13197077|NCT02041091|26205944|FG001|Treatment|Withdrawal by Subject|4|||
13197078|NCT02041091|26205943|FG000|Treatment|Physician Decision|1|||
13197079|NCT02041091|26205944|FG001|Treatment|Physician Decision|0|||
13197080|NCT02041091|26205943|FG000|Treatment|Sponsor Decision|15|||
13197081|NCT02041091|26205944|FG001|Treatment|Sponsor Decision|16|||
13197082|NCT02041091|26205943|FG000|Treatment|Lost to Follow-up|1|||
13197083|NCT02041091|26205944|FG001|Treatment|Lost to Follow-up|0|||
13197084|NCT02041091|26205943|FG000|Optional Safety Extension Period|Adverse Event|4|||
13197085|NCT02041091|26205944|FG001|Optional Safety Extension Period|Adverse Event|2|||
13197086|NCT02041091|26205943|FG000|Optional Safety Extension Period|Withdrawal by Subject|5|||
13197087|NCT02041091|26205944|FG001|Optional Safety Extension Period|Withdrawal by Subject|2|||
13197088|NCT02041091|26205943|FG000|Optional Safety Extension Period|Protocol Violation|2|||
13197089|NCT02041091|26205944|FG001|Optional Safety Extension Period|Protocol Violation|0|||
13197090|NCT02041091|26205943|FG000|Optional Safety Extension Period|Physician Decision|2|||
13197091|NCT02041091|26205944|FG001|Optional Safety Extension Period|Physician Decision|1|||
13197092|NCT02041091|26205943|FG000|Optional Safety Extension Period|Sponsor Decision|70|||
13197093|NCT02041091|26205944|FG001|Optional Safety Extension Period|Sponsor Decision|74|||
13197094|NCT02041091|26205943|FG000|Optional Safety Extension Period|Lost to Follow-up|2|||
13197095|NCT02041091|26205944|FG001|Optional Safety Extension Period|Lost to Follow-up|3|||
13197096|NCT02040870|26205967|FG000|Overall Study|Completed treatment phase|6|||
13197097|NCT02040870|26205967|FG000|Overall Study|Adverse Event|7|||
13197098|NCT02040870|26205967|FG000|Overall Study|Progressive disease|58|||
13197099|NCT02040870|26205967|FG000|Overall Study|Physician Decision|6|||
13197100|NCT02040870|26205967|FG000|Overall Study|Subject/guardian decision|10|||
13197101|NCT02040870|26205967|FG000|Overall Study|Lost to Follow-up|3|||
13197102|NCT02040870|26205967|FG000|Overall Study|Death|13|||
13197103|NCT02040844|26206000|FG000|Overall Study|Adverse Event|0|||
13197104|NCT02040844|26206001|FG001|Overall Study|Adverse Event|0|||
13197105|NCT02040844|26206002|FG002|Overall Study|Adverse Event|1|||
13197106|NCT02040844|26206000|FG000|Overall Study|Withdrawal by Subject|16|||
13197107|NCT02040844|26206001|FG001|Overall Study|Withdrawal by Subject|22|||
13197108|NCT02040844|26206002|FG002|Overall Study|Withdrawal by Subject|25|||
13197109|NCT02040844|26206000|FG000|Overall Study|Lost to Follow-up|12|||
13197110|NCT02040844|26206001|FG001|Overall Study|Lost to Follow-up|9|||
13197111|NCT02040844|26206002|FG002|Overall Study|Lost to Follow-up|13|||
13197112|NCT02040844|26206000|FG000|Overall Study|Missing|13|||
13197113|NCT02040844|26206001|FG001|Overall Study|Missing|3|||
13197114|NCT02040844|26206002|FG002|Overall Study|Missing|2|||
13197115|NCT02040844|26206000|FG000|Overall Study|Non-specified|8|||
13197116|NCT02040844|26206001|FG001|Overall Study|Non-specified|2|||
13197117|NCT02040844|26206002|FG002|Overall Study|Non-specified|5|||
13197118|NCT02040844|26206000|FG000|Overall Study|Concomitant medication|1|||
13197119|NCT02040844|26206001|FG001|Overall Study|Concomitant medication|3|||
13197120|NCT02040844|26206002|FG002|Overall Study|Concomitant medication|1|||
13197121|NCT02040805|26206021|FG000|Overall Study|Lost to Follow-up|14|||
13197122|NCT02040805|26206022|FG001|Overall Study|Lost to Follow-up|9|||
13197123|NCT02040805|26206021|FG000|Overall Study|Withdrawal by Subject|28|||
13197124|NCT02040805|26206022|FG001|Overall Study|Withdrawal by Subject|41|||
13197125|NCT02040779|26206067|FG000|Overall Study|Adverse Event|1|||
13197126|NCT02040779|26206068|FG001|Overall Study|Adverse Event|0|||
13197127|NCT02040779|26206069|FG002|Overall Study|Adverse Event|0|||
13197128|NCT02040779|26206067|FG000|Overall Study|Withdrawal by Subject|4|||
13197129|NCT02040779|26206068|FG001|Overall Study|Withdrawal by Subject|1|||
13197130|NCT02040779|26206069|FG002|Overall Study|Withdrawal by Subject|3|||
13197131|NCT02040779|26206067|FG000|Overall Study|Non-compliance|0|||
13197132|NCT02040779|26206068|FG001|Overall Study|Non-compliance|1|||
13197133|NCT02040779|26206069|FG002|Overall Study|Non-compliance|0|||
13197134|NCT02040779|26206067|FG000|Overall Study|Protocol Violation|2|||
13197135|NCT02040779|26206068|FG001|Overall Study|Protocol Violation|1|||
13197136|NCT02040779|26206069|FG002|Overall Study|Protocol Violation|0|||
13197137|NCT02040779|26206067|FG000|Overall Study|Lost to Follow-up|1|||
13197138|NCT02040779|26206068|FG001|Overall Study|Lost to Follow-up|2|||
13197139|NCT02040779|26206069|FG002|Overall Study|Lost to Follow-up|1|||
13197140|NCT02040779|26206067|FG000|Overall Study|Lack of Efficacy|4|||
13197141|NCT02040779|26206068|FG001|Overall Study|Lack of Efficacy|2|||
13197142|NCT02040779|26206069|FG002|Overall Study|Lack of Efficacy|0|||
13197143|NCT02040766|26206123|FG000|Overall Study|Adverse Event|1|||
13197144|NCT02040766|26206124|FG001|Overall Study|Adverse Event|1|||
13197145|NCT02040766|26206125|FG002|Overall Study|Adverse Event|1|||
13197146|NCT02040766|26206126|FG003|Overall Study|Adverse Event|0|||
13197147|NCT02040766|26206127|FG004|Overall Study|Adverse Event|2|||
13197148|NCT02040766|26206123|FG000|Overall Study|Withdrawal by Subject|4|||
13197149|NCT02040766|26206124|FG001|Overall Study|Withdrawal by Subject|3|||
13197150|NCT02040766|26206125|FG002|Overall Study|Withdrawal by Subject|2|||
13197151|NCT02040766|26206126|FG003|Overall Study|Withdrawal by Subject|3|||
13197152|NCT02040766|26206127|FG004|Overall Study|Withdrawal by Subject|2|||
13197153|NCT02040766|26206123|FG000|Overall Study|Non-compliance|0|||
13197154|NCT02040766|26206124|FG001|Overall Study|Non-compliance|1|||
13197155|NCT02040766|26206125|FG002|Overall Study|Non-compliance|0|||
13197156|NCT02040766|26206126|FG003|Overall Study|Non-compliance|0|||
13197157|NCT02040766|26206127|FG004|Overall Study|Non-compliance|0|||
13197158|NCT02040766|26206123|FG000|Overall Study|Protocol Violation|2|||
13197159|NCT02040766|26206124|FG001|Overall Study|Protocol Violation|1|||
13197160|NCT02040766|26206125|FG002|Overall Study|Protocol Violation|2|||
13197161|NCT02040766|26206126|FG003|Overall Study|Protocol Violation|3|||
13197162|NCT02040766|26206127|FG004|Overall Study|Protocol Violation|0|||
13197163|NCT02040766|26206123|FG000|Overall Study|Lost to Follow-up|4|||
13197164|NCT02040766|26206124|FG001|Overall Study|Lost to Follow-up|1|||
13197165|NCT02040766|26206125|FG002|Overall Study|Lost to Follow-up|3|||
13197166|NCT02040766|26206126|FG003|Overall Study|Lost to Follow-up|1|||
13197167|NCT02040766|26206127|FG004|Overall Study|Lost to Follow-up|4|||
13197168|NCT02040766|26206123|FG000|Overall Study|Not reported|1|||
13197169|NCT02040766|26206124|FG001|Overall Study|Not reported|0|||
13197170|NCT02040766|26206125|FG002|Overall Study|Not reported|0|||
13197171|NCT02040766|26206126|FG003|Overall Study|Not reported|0|||
13197172|NCT02040766|26206127|FG004|Overall Study|Not reported|0|||
13197173|NCT02040766|26206123|FG000|Overall Study|Lack of Efficacy|6|||
13197174|NCT02040766|26206124|FG001|Overall Study|Lack of Efficacy|3|||
13197175|NCT02040766|26206125|FG002|Overall Study|Lack of Efficacy|4|||
13197176|NCT02040766|26206126|FG003|Overall Study|Lack of Efficacy|6|||
13197177|NCT02040766|26206127|FG004|Overall Study|Lack of Efficacy|5|||
13197178|NCT02040532|26206140|FG000|Overall Study|Lost to Follow-up|1|||
13197179|NCT02040532|26206140|FG000|Overall Study|Physician Decision|4|||
13197180|NCT02040532|26206140|FG000|Overall Study|Adverse Event|4|||
13197181|NCT02040532|26206140|FG000|Overall Study|Withdrawal by Subject|3|||
13197182|NCT02040428|26206159|FG000|Overall Study|Death|4|||
13197183|NCT02040428|26206160|FG001|Overall Study|Death|3|||
13197184|NCT02040428|26206159|FG000|Overall Study|Withdrawal by Subject|1|||
13197185|NCT02040428|26206160|FG001|Overall Study|Withdrawal by Subject|1|||
13197186|NCT02040259|26206170|FG000|Overall Study|Death|280|||
13197187|NCT02040259|26206170|FG000|Overall Study|Lost to Follow-up|76|||
13197188|NCT02040259|26206170|FG000|Overall Study|Assessment not completed|3|||
13197189|NCT02040259|26206170|FG000|Overall Study|Withdrawal by Subject|4|||
13197190|NCT02040090|26206183|FG000|Overall Study|Adverse Event|2|||
13197191|NCT02040090|26206184|FG001|Overall Study|Adverse Event|0|||
13197192|NCT02040090|26206183|FG000|Overall Study|Physician Decision|1|||
13197193|NCT02040090|26206184|FG001|Overall Study|Physician Decision|0|||
13197194|NCT02040090|26206183|FG000|Overall Study|Withdrawal by Subject|0|||
13197195|NCT02040090|26206184|FG001|Overall Study|Withdrawal by Subject|1|||
13197196|NCT02040090|26206183|FG000|Overall Study|Lost to Follow-up|0|||
13197197|NCT02040090|26206184|FG001|Overall Study|Lost to Follow-up|1|||
13197198|NCT02039908|26206201|FG000|Phase 1-Summer|Withdrawal by Subject|7|||
13197199|NCT02039908|26206202|FG001|Phase 1-Summer|Withdrawal by Subject|6|||
13197200|NCT02039908|26206203|FG002|Phase 1-Summer|Withdrawal by Subject|0|||
13197201|NCT02039908|26206204|FG003|Phase 1-Summer|Withdrawal by Subject|0|||
13197202|NCT02039908|26206201|FG000|Phase 1-Summer|Protocol Violation|6|||
13197203|NCT02039908|26206202|FG001|Phase 1-Summer|Protocol Violation|0|||
13197204|NCT02039908|26206203|FG002|Phase 1-Summer|Protocol Violation|0|||
13197205|NCT02039908|26206204|FG003|Phase 1-Summer|Protocol Violation|0|||
13197206|NCT02039908|26206201|FG000|Phase 2-School Year|Lost to Follow-up|0|||
13197207|NCT02039908|26206202|FG001|Phase 2-School Year|Lost to Follow-up|0|||
13197208|NCT02039908|26206203|FG002|Phase 2-School Year|Lost to Follow-up|1|||
13197209|NCT02039908|26206204|FG003|Phase 2-School Year|Lost to Follow-up|3|||
13197210|NCT02039908|26206201|FG000|Phase 2-School Year|Protocol Violation|0|||
13197211|NCT02039908|26206202|FG001|Phase 2-School Year|Protocol Violation|0|||
13197212|NCT02039908|26206203|FG002|Phase 2-School Year|Protocol Violation|3|||
13197213|NCT02039908|26206204|FG003|Phase 2-School Year|Protocol Violation|0|||
13197214|NCT02039908|26206201|FG000|Phase 2-School Year|Withdrawal by Subject|0|||
13197215|NCT02039908|26206202|FG001|Phase 2-School Year|Withdrawal by Subject|0|||
13197216|NCT02039908|26206203|FG002|Phase 2-School Year|Withdrawal by Subject|8|||
13197217|NCT02039908|26206204|FG003|Phase 2-School Year|Withdrawal by Subject|5|||
13197218|NCT02039856|26206231|FG000|Overall Study|Death|5|||
13197219|NCT02039856|26206232|FG001|Overall Study|Death|3|||
13197220|NCT02039856|26206231|FG000|Overall Study|Partial survey completion|61|||
13197221|NCT02039856|26206232|FG001|Overall Study|Partial survey completion|26|||
13197222|NCT02039856|26206231|FG000|Overall Study|Lost to Follow-up|388|||
13197223|NCT02039856|26206232|FG001|Overall Study|Lost to Follow-up|206|||
13197224|NCT02039856|26206231|FG000|Overall Study|Withdrawal by Subject|1573|||
13197225|NCT02039856|26206232|FG001|Overall Study|Withdrawal by Subject|618|||
13197226|NCT02039778|26206242|FG000|Overall Study|Death|2|||
13197227|NCT02039778|26206242|FG000|Overall Study|Withdrawal by Subject|1|||
13197228|NCT02039778|26206242|FG000|Overall Study|Never started the protocol treatment|1|||
13197229|NCT02039687|26206281|FG000|Overall Study|Adverse Event|0|||
13197230|NCT02039687|26206282|FG001|Overall Study|Adverse Event|0|||
13197231|NCT02039687|26206283|FG002|Overall Study|Adverse Event|1|||
13197232|NCT02039687|26206284|FG003|Overall Study|Adverse Event|0|||
13197233|NCT02039687|26206281|FG000|Overall Study|Withdrawal by Subject|0|||
13197234|NCT02039687|26206282|FG001|Overall Study|Withdrawal by Subject|1|||
13197235|NCT02039687|26206283|FG002|Overall Study|Withdrawal by Subject|0|||
13197236|NCT02039687|26206284|FG003|Overall Study|Withdrawal by Subject|0|||
13197237|NCT02039687|26206281|FG000|Overall Study|treatment assignment could not be confir|0|||
13197238|NCT02039687|26206282|FG001|Overall Study|treatment assignment could not be confir|0|||
13197239|NCT02039687|26206283|FG002|Overall Study|treatment assignment could not be confir|2|||
13197240|NCT02039687|26206284|FG003|Overall Study|treatment assignment could not be confir|0|||
13197241|NCT02039505|26206370|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2|||
13197242|NCT02039505|26206371|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8|||
13197243|NCT02039505|26206372|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7|||
13197244|NCT02039505|26206373|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
13197245|NCT02039505|26206374|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
13197246|NCT02039505|26206375|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
13197247|NCT02039505|26206376|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
13197248|NCT02039505|26206370|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
13197249|NCT02039505|26206371|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
13197250|NCT02039505|26206372|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3|||
13197251|NCT02039505|26206373|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
13197252|NCT02039505|26206374|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
13197253|NCT02039505|26206375|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
13197254|NCT02039505|26206376|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
13197255|NCT02039505|26206370|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1|||
13197256|NCT02039505|26206371|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
13197257|NCT02039505|26206372|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
13197258|NCT02039505|26206373|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
13197259|NCT02039505|26206374|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
13197260|NCT02039505|26206375|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
13197261|NCT02039505|26206376|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
13197262|NCT02039505|26206370|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
13197263|NCT02039505|26206371|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
13197264|NCT02039505|26206372|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
13197265|NCT02039505|26206373|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13|||
13197266|NCT02039505|26206374|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8|||
13197267|NCT02039505|26206375|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12|||
13197268|NCT02039505|26206376|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
13197269|NCT02039505|26206370|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
13197270|NCT02039505|26206371|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
13197271|NCT02039505|26206372|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
13197272|NCT02039505|26206373|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6|||
13197273|NCT02039505|26206374|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
13197274|NCT02039505|26206375|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
13197275|NCT02039505|26206376|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
13197276|NCT02039505|26206370|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
13197277|NCT02039505|26206371|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
13197278|NCT02039505|26206372|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
13197279|NCT02039505|26206373|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3|||
13197280|NCT02039505|26206374|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2|||
13197281|NCT02039505|26206375|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1|||
13197282|NCT02039505|26206376|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
13197283|NCT02039505|26206370|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
13197284|NCT02039505|26206371|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
13197285|NCT02039505|26206372|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
13197286|NCT02039505|26206373|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2|||
13197287|NCT02039505|26206374|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
13197288|NCT02039505|26206375|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
13197289|NCT02039505|26206376|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
13197290|NCT02039505|26206370|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
13197291|NCT02039505|26206371|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
13197292|NCT02039505|26206372|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
13197293|NCT02039505|26206373|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
13197294|NCT02039505|26206374|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
13197295|NCT02039505|26206375|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
13197296|NCT02039505|26206376|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44|||
13197297|NCT02039505|26206370|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
13197298|NCT02039505|26206371|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
13197299|NCT02039505|26206372|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
13197300|NCT02039505|26206373|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
13197301|NCT02039505|26206374|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
13197302|NCT02039505|26206375|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
13197303|NCT02039505|26206376|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19|||
13197304|NCT02039505|26206370|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
13197305|NCT02039505|26206371|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
13197306|NCT02039505|26206372|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
13197307|NCT02039505|26206373|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
13197308|NCT02039505|26206374|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
13197309|NCT02039505|26206375|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
13197310|NCT02039505|26206376|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7|||
13197311|NCT02039505|26206370|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
13197312|NCT02039505|26206371|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
13197313|NCT02039505|26206372|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
13197314|NCT02039505|26206373|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
13197315|NCT02039505|26206374|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
13197316|NCT02039505|26206375|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
13112289|NCT03161093|25907716|FG000|Overall Study|Physician Decision|0|||
13112290|NCT03161093|25907717|FG001|Overall Study|Physician Decision|1|||
13112291|NCT03161093|25907718|FG002|Overall Study|Physician Decision|0|||
13112292|NCT03161093|25907719|FG003|Overall Study|Physician Decision|2|||
13112293|NCT03161093|25907720|FG004|Overall Study|Physician Decision|17|||
13112294|NCT03161093|25907721|FG005|Overall Study|Physician Decision|15|||
13197317|NCT02039505|26206376|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1|||
13197318|NCT02039427|26206407|FG000|Overall Study|Duration of surgery > 3h|1|||
13197319|NCT02039427|26206408|FG001|Overall Study|Duration of surgery > 3h|1|||
13197320|NCT02039427|26206409|FG002|Overall Study|Duration of surgery > 3h|0|||
13197321|NCT02039427|26206410|FG003|Overall Study|Duration of surgery > 3h|0|||
13197322|NCT02039427|26206407|FG000|Overall Study|Withdrawal on concent|0|||
13197323|NCT02039427|26206408|FG001|Overall Study|Withdrawal on concent|0|||
13197324|NCT02039427|26206409|FG002|Overall Study|Withdrawal on concent|0|||
13197325|NCT02039427|26206410|FG003|Overall Study|Withdrawal on concent|1|||
13197326|NCT02039427|26206407|FG000|Overall Study|Cancellation of surgery|0|||
13197327|NCT02039427|26206408|FG001|Overall Study|Cancellation of surgery|0|||
13197328|NCT02039427|26206409|FG002|Overall Study|Cancellation of surgery|1|||
13197329|NCT02039427|26206410|FG003|Overall Study|Cancellation of surgery|0|||
13197330|NCT02039427|26206407|FG000|Overall Study|Loss of follow - up|1|||
13197331|NCT02039427|26206408|FG001|Overall Study|Loss of follow - up|0|||
13197332|NCT02039427|26206409|FG002|Overall Study|Loss of follow - up|2|||
13197333|NCT02039427|26206410|FG003|Overall Study|Loss of follow - up|4|||
13197334|NCT02039427|26206407|FG000|Overall Study|Steroid Use|1|||
13197335|NCT02039427|26206408|FG001|Overall Study|Steroid Use|0|||
13197336|NCT02039427|26206409|FG002|Overall Study|Steroid Use|0|||
13197337|NCT02039427|26206410|FG003|Overall Study|Steroid Use|0|||
13197338|NCT02039414|26206429|FG000|Overall Study|Delivered|1|||
13197339|NCT02039414|26206430|FG001|Overall Study|Delivered|1|||
13197340|NCT02039414|26206429|FG000|Overall Study|Lost to Follow-up|2|||
13197341|NCT02039414|26206430|FG001|Overall Study|Lost to Follow-up|0|||
13197342|NCT02039414|26206429|FG000|Overall Study|Protocol Violation|3|||
13197343|NCT02039414|26206430|FG001|Overall Study|Protocol Violation|1|||
13197344|NCT02039375|26206441|FG000|Overall Study|Lost to Follow-up|2|||
13197345|NCT02039219|26206486|FG000|Treatment|Withdrawal by Subject|1|||
13197346|NCT02039219|26206487|FG001|Treatment|Withdrawal by Subject|0|||
13197347|NCT02039219|26206486|FG000|Treatment|Adverse Event|0|||
13197348|NCT02039219|26206487|FG001|Treatment|Adverse Event|1|||
13197349|NCT02039219|26206486|FG000|Treatment|Physician Decision|1|||
13197350|NCT02039219|26206487|FG001|Treatment|Physician Decision|0|||
13197351|NCT02039219|26206486|FG000|Treatment|Lost to Follow-up|0|||
13197352|NCT02039219|26206487|FG001|Treatment|Lost to Follow-up|1|||
13197353|NCT02039219|26206486|FG000|Treatment|Protocol Violation|1|||
13197354|NCT02039219|26206487|FG001|Treatment|Protocol Violation|0|||
13197355|NCT02039219|26206486|FG000|Treatment|Death|1|||
13197356|NCT02039219|26206487|FG001|Treatment|Death|0|||
13197357|NCT02039219|26206486|FG000|Follow up|Adverse Event|0|||
13197358|NCT02039219|26206487|FG001|Follow up|Adverse Event|1|||
13197359|NCT02038959|26206520|FG000|Overall Study|Withdrawal by Subject|6|||
13197360|NCT02038959|26206521|FG001|Overall Study|Withdrawal by Subject|8|||
13197361|NCT02038933|26206546|FG000|Overall Study|Disease progression|104|||
13197362|NCT02038933|26206546|FG000|Overall Study|Study drug toxicity|6|||
13197363|NCT02038933|26206546|FG000|Overall Study|Adverse event unrelated to study drug|6|||
13197364|NCT02038933|26206546|FG000|Overall Study|Participant request to discontinue treatment|2|||
13197365|NCT02038933|26206546|FG000|Overall Study|Lost to Follow-up|1|||
13197366|NCT02038933|26206546|FG000|Overall Study|Other reasons|2|||
13197367|NCT02038920|26206620|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3|||
13197368|NCT02038920|26206621|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11|||
13197369|NCT02038920|26206622|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
13197370|NCT02038920|26206623|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
13197371|NCT02038920|26206624|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
13197372|NCT02038920|26206625|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
13197373|NCT02038920|26206620|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2|||
13197374|NCT02038920|26206621|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
13112295|NCT03161093|25907716|FG000|Overall Study|Withdrawal by Subject|24|||
13112296|NCT03161093|25907717|FG001|Overall Study|Withdrawal by Subject|73|||
13112297|NCT03161093|25907718|FG002|Overall Study|Withdrawal by Subject|44|||
13112298|NCT03161093|25907719|FG003|Overall Study|Withdrawal by Subject|97|||
13112299|NCT03161093|25907720|FG004|Overall Study|Withdrawal by Subject|11|||
13112300|NCT03161093|25907721|FG005|Overall Study|Withdrawal by Subject|10|||
13112301|NCT03161093|25907716|FG000|Overall Study|Lost to Follow-up|3|||
13112302|NCT03161093|25907717|FG001|Overall Study|Lost to Follow-up|12|||
13197375|NCT02038920|26206622|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
13112303|NCT03161093|25907718|FG002|Overall Study|Lost to Follow-up|4|||
13112304|NCT03161093|25907719|FG003|Overall Study|Lost to Follow-up|7|||
13112305|NCT03161093|25907720|FG004|Overall Study|Lost to Follow-up|8|||
13112306|NCT03161093|25907721|FG005|Overall Study|Lost to Follow-up|13|||
13112307|NCT03161093|25907716|FG000|Overall Study|Death|3|||
13112308|NCT03161093|25907717|FG001|Overall Study|Death|9|||
13112309|NCT03161093|25907718|FG002|Overall Study|Death|7|||
13112310|NCT03161093|25907719|FG003|Overall Study|Death|9|||
13112311|NCT03161093|25907720|FG004|Overall Study|Death|0|||
13112312|NCT03161093|25907721|FG005|Overall Study|Death|0|||
13112313|NCT03161093|25907716|FG000|Overall Study|Unknown - Not reported|0|||
13112314|NCT03161093|25907717|FG001|Overall Study|Unknown - Not reported|1|||
13112315|NCT03161093|25907718|FG002|Overall Study|Unknown - Not reported|0|||
13197376|NCT02038920|26206623|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
13197377|NCT02038920|26206624|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
13197378|NCT02038920|26206625|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
13197379|NCT02038920|26206620|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
13197380|NCT02038920|26206621|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
13197381|NCT02038920|26206622|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
13197382|NCT02038920|26206623|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
13197383|NCT02038920|26206624|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
13197384|NCT02038920|26206625|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
13197385|NCT02038920|26206620|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
13197386|NCT02038920|26206621|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
13197387|NCT02038920|26206622|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
13197388|NCT02038920|26206623|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4|||
13197389|NCT02038920|26206624|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
13197390|NCT02038920|26206625|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
13197391|NCT02038920|26206620|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
13197392|NCT02038920|26206621|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
13197393|NCT02038920|26206622|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1|||
13197394|NCT02038920|26206623|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
13197395|NCT02038920|26206624|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
13197396|NCT02038920|26206625|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
13197397|NCT02038920|26206620|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
13197398|NCT02038920|26206621|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
13197399|NCT02038920|26206622|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2|||
13197400|NCT02038920|26206623|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4|||
13197401|NCT02038920|26206624|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10|||
13197402|NCT02038920|26206625|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
13197403|NCT02038920|26206620|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
13197404|NCT02038920|26206621|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
13197405|NCT02038920|26206622|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
13197406|NCT02038920|26206623|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
13197407|NCT02038920|26206624|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
13197408|NCT02038920|26206625|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43|||
13197409|NCT02038920|26206620|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
13112316|NCT03161093|25907719|FG003|Overall Study|Unknown - Not reported|0|||
13112317|NCT03161093|25907720|FG004|Overall Study|Unknown - Not reported|0|||
13112318|NCT03161093|25907721|FG005|Overall Study|Unknown - Not reported|1|||
13112319|NCT03160898|25907755|FG000|Overall Study|Adverse Event|4|||
13112320|NCT03160898|25907756|FG001|Overall Study|Adverse Event|8|||
13112321|NCT03160898|25907757|FG002|Overall Study|Adverse Event|7|||
13112322|NCT03160898|25907758|FG003|Overall Study|Adverse Event|10|||
13112323|NCT03160898|25907755|FG000|Overall Study|Death|1|||
13112324|NCT03160898|25907756|FG001|Overall Study|Death|0|||
13112325|NCT03160898|25907757|FG002|Overall Study|Death|0|||
13112326|NCT03160898|25907758|FG003|Overall Study|Death|1|||
13112327|NCT03160898|25907755|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3|||
13112328|NCT03160898|25907756|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0|||
13112329|NCT03160898|25907757|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0|||
13112330|NCT03160898|25907758|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1|||
13112331|NCT03160898|25907755|FG000|Overall Study|Lost to Follow-up|1|||
13112332|NCT03160898|25907756|FG001|Overall Study|Lost to Follow-up|1|||
13112333|NCT03160898|25907757|FG002|Overall Study|Lost to Follow-up|1|||
13112334|NCT03160898|25907758|FG003|Overall Study|Lost to Follow-up|2|||
13112335|NCT03160898|25907755|FG000|Overall Study|Physician Decision|1|||
13112336|NCT03160898|25907756|FG001|Overall Study|Physician Decision|0|||
13112337|NCT03160898|25907757|FG002|Overall Study|Physician Decision|0|||
13112338|NCT03160898|25907758|FG003|Overall Study|Physician Decision|1|||
13112339|NCT03160898|25907755|FG000|Overall Study|Progressive Disease|4|||
13112340|NCT03160898|25907756|FG001|Overall Study|Progressive Disease|1|||
13112341|NCT03160898|25907757|FG002|Overall Study|Progressive Disease|2|||
13112342|NCT03160898|25907758|FG003|Overall Study|Progressive Disease|1|||
13112343|NCT03160898|25907755|FG000|Overall Study|Protocol Violation|1|||
13112344|NCT03160898|25907756|FG001|Overall Study|Protocol Violation|0|||
13112345|NCT03160898|25907757|FG002|Overall Study|Protocol Violation|2|||
13112346|NCT03160898|25907758|FG003|Overall Study|Protocol Violation|0|||
13112347|NCT03160898|25907755|FG000|Overall Study|Sponsor Discretion|2|||
13112348|NCT03160898|25907756|FG001|Overall Study|Sponsor Discretion|0|||
13112349|NCT03160898|25907757|FG002|Overall Study|Sponsor Discretion|0|||
13112350|NCT03160898|25907758|FG003|Overall Study|Sponsor Discretion|0|||
13112351|NCT03160898|25907755|FG000|Overall Study|Withdrawal by Subject|1|||
13112352|NCT03160898|25907756|FG001|Overall Study|Withdrawal by Subject|3|||
13112353|NCT03160898|25907757|FG002|Overall Study|Withdrawal by Subject|2|||
13112354|NCT03160898|25907758|FG003|Overall Study|Withdrawal by Subject|1|||
13112355|NCT03160898|25907755|FG000|Overall Study|Other|2|||
13112356|NCT03160898|25907756|FG001|Overall Study|Other|0|||
13112357|NCT03160898|25907757|FG002|Overall Study|Other|2|||
13112358|NCT03160898|25907758|FG003|Overall Study|Other|2|||
13112359|NCT03160885|25907816|FG000|Initial Treatment Period|Not dosed|2|||
13112360|NCT03160885|25907817|FG001|Initial Treatment Period|Not dosed|0|||
13112361|NCT03160885|25907818|FG002|Initial Treatment Period|Not dosed|0|||
13112362|NCT03160885|25907819|FG003|Initial Treatment Period|Not dosed|0|||
13112363|NCT03160885|25907820|FG004|Initial Treatment Period|Not dosed|0|||
13112364|NCT03160885|25907821|FG005|Initial Treatment Period|Not dosed|0|||
13112365|NCT03160885|25907822|FG006|Initial Treatment Period|Not dosed|0|||
13112366|NCT03160885|25907816|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33|||
13197410|NCT02038920|26206621|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
13197411|NCT02038920|26206622|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
13197412|NCT02038920|26206623|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
13197413|NCT02038920|26206624|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
13197414|NCT02038920|26206625|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1|||
13197415|NCT02038920|26206620|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
13197416|NCT02038920|26206621|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
13197417|NCT02038920|26206622|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
13197418|NCT02038920|26206623|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
13197419|NCT02038920|26206624|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
13197420|NCT02038920|26206625|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7|||
13197421|NCT02038920|26206620|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
13197422|NCT02038920|26206621|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
13197423|NCT02038920|26206622|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
13197424|NCT02038920|26206623|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
13197425|NCT02038920|26206624|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
13197426|NCT02038920|26206625|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1|||
13197427|NCT02038920|26206620|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
13197428|NCT02038920|26206621|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
13197429|NCT02038920|26206622|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
13197430|NCT02038920|26206623|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
13197431|NCT02038920|26206624|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
13197432|NCT02038920|26206625|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23|||
13197433|NCT02038920|26206620|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
13197434|NCT02038920|26206621|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
13197435|NCT02038920|26206622|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
13197436|NCT02038920|26206623|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
13197437|NCT02038920|26206624|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
13197438|NCT02038920|26206625|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2|||
13197439|NCT02038907|26207196|FG000|Overall Study|Protocol Violation|0|||
13197440|NCT02038907|26207197|FG001|Overall Study|Protocol Violation|0|||
13197441|NCT02038907|26207198|FG002|Overall Study|Protocol Violation|0|||
13197442|NCT02038907|26207199|FG003|Overall Study|Protocol Violation|0|||
13197443|NCT02038907|26207200|FG004|Overall Study|Protocol Violation|0|||
13197444|NCT02038907|26207201|FG005|Overall Study|Protocol Violation|0|||
13197445|NCT02038907|26207202|FG006|Overall Study|Protocol Violation|0|||
13197446|NCT02038907|26207203|FG007|Overall Study|Protocol Violation|0|||
13197447|NCT02038907|26207204|FG008|Overall Study|Protocol Violation|0|||
13197448|NCT02038907|26207205|FG009|Overall Study|Protocol Violation|0|||
13112367|NCT03160885|25907817|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22|||
13112368|NCT03160885|25907818|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
13112369|NCT03160885|25907819|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
13112370|NCT03160885|25907820|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
13112371|NCT03160885|25907821|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
13197449|NCT02038907|26207206|FG010|Overall Study|Protocol Violation|1|||
13197450|NCT02038907|26207207|FG011|Overall Study|Protocol Violation|0|||
13197451|NCT02038907|26207208|FG012|Overall Study|Protocol Violation|0|||
13112372|NCT03160885|25907822|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
13112373|NCT03160885|25907816|FG000|Open-label Treatment|Not dosed|0|||
13112374|NCT03160885|25907817|FG001|Open-label Treatment|Not dosed|0|||
13112375|NCT03160885|25907818|FG002|Open-label Treatment|Not dosed|0|||
13112376|NCT03160885|25907819|FG003|Open-label Treatment|Not dosed|0|||
13197452|NCT02038907|26207209|FG013|Overall Study|Protocol Violation|0|||
13197453|NCT02038907|26207196|FG000|Overall Study|Withdrawal by Subject|0|||
13197454|NCT02038907|26207197|FG001|Overall Study|Withdrawal by Subject|0|||
13197455|NCT02038907|26207198|FG002|Overall Study|Withdrawal by Subject|0|||
13197456|NCT02038907|26207199|FG003|Overall Study|Withdrawal by Subject|0|||
13197457|NCT02038907|26207200|FG004|Overall Study|Withdrawal by Subject|0|||
13197458|NCT02038907|26207201|FG005|Overall Study|Withdrawal by Subject|0|||
13197459|NCT02038907|26207202|FG006|Overall Study|Withdrawal by Subject|0|||
13197460|NCT02038907|26207203|FG007|Overall Study|Withdrawal by Subject|0|||
13197461|NCT02038907|26207204|FG008|Overall Study|Withdrawal by Subject|0|||
13197462|NCT02038907|26207205|FG009|Overall Study|Withdrawal by Subject|0|||
13197463|NCT02038907|26207206|FG010|Overall Study|Withdrawal by Subject|1|||
13197464|NCT02038907|26207207|FG011|Overall Study|Withdrawal by Subject|0|||
13197465|NCT02038907|26207208|FG012|Overall Study|Withdrawal by Subject|0|||
13197466|NCT02038907|26207209|FG013|Overall Study|Withdrawal by Subject|0|||
13197467|NCT02038881|26207292|FG000|Overall Study|Withdrawal by Subject|0|||
13197468|NCT02038881|26207293|FG001|Overall Study|Withdrawal by Subject|0|||
13197469|NCT02038881|26207294|FG002|Overall Study|Withdrawal by Subject|1|||
13197470|NCT02038881|26207292|FG000|Overall Study|Lost to Follow-up|2|||
13197471|NCT02038881|26207293|FG001|Overall Study|Lost to Follow-up|0|||
13197472|NCT02038881|26207294|FG002|Overall Study|Lost to Follow-up|0|||
13197473|NCT02038881|26207292|FG000|Overall Study|incarcerated|1|||
13197474|NCT02038881|26207293|FG001|Overall Study|incarcerated|0|||
13197475|NCT02038881|26207294|FG002|Overall Study|incarcerated|0|||
13197476|NCT02038829|26207341|FG000|Washout Period 1|Death|0|||
13197477|NCT02038829|26207342|FG001|Washout Period 1|Death|0|||
13197478|NCT02038829|26207343|FG002|Washout Period 1|Death|0|||
13197479|NCT02038829|26207344|FG003|Washout Period 1|Death|0|||
13197480|NCT02038829|26207345|FG004|Washout Period 1|Death|1|||
13197481|NCT02038829|26207346|FG005|Washout Period 1|Death|0|||
13197482|NCT02038829|26207347|FG006|Washout Period 1|Death|0|||
13197483|NCT02038829|26207348|FG007|Washout Period 1|Death|0|||
13197484|NCT02038829|26207349|FG008|Washout Period 1|Death|0|||
13197485|NCT02038829|26207350|FG009|Washout Period 1|Death|0|||
13112377|NCT03160885|25907820|FG004|Open-label Treatment|Not dosed|0|||
13112378|NCT03160885|25907821|FG005|Open-label Treatment|Not dosed|0|||
13112379|NCT03160885|25907822|FG006|Open-label Treatment|Not dosed|2|||
13112380|NCT03160885|25907816|FG000|Open-label Treatment|Discontinued IMP|0|||
13112381|NCT03160885|25907817|FG001|Open-label Treatment|Discontinued IMP|0|||
13112382|NCT03160885|25907818|FG002|Open-label Treatment|Discontinued IMP|0|||
13112383|NCT03160885|25907819|FG003|Open-label Treatment|Discontinued IMP|0|||
13112384|NCT03160885|25907820|FG004|Open-label Treatment|Discontinued IMP|0|||
13112385|NCT03160885|25907821|FG005|Open-label Treatment|Discontinued IMP|0|||
13112386|NCT03160885|25907822|FG006|Open-label Treatment|Discontinued IMP|131|||
13112387|NCT03160885|25907816|FG000|Open-label Treatment|Completed Week 50|0|||
13112388|NCT03160885|25907817|FG001|Open-label Treatment|Completed Week 50|0|||
13112389|NCT03160885|25907818|FG002|Open-label Treatment|Completed Week 50|0|||
13112390|NCT03160885|25907819|FG003|Open-label Treatment|Completed Week 50|0|||
13112391|NCT03160885|25907820|FG004|Open-label Treatment|Completed Week 50|0|||
13112392|NCT03160885|25907821|FG005|Open-label Treatment|Completed Week 50|0|||
13112393|NCT03160885|25907822|FG006|Open-label Treatment|Completed Week 50|4|||
13112394|NCT03160885|25907816|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
13112395|NCT03160885|25907817|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
13112396|NCT03160885|25907818|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
13112397|NCT03160885|25907819|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1|||
13112398|NCT03160885|25907820|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
13112399|NCT03160885|25907821|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
13112400|NCT03160885|25907822|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
13112401|NCT03160885|25907816|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
13112402|NCT03160885|25907817|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
13112403|NCT03160885|25907818|FG002|Maintenance Treatment Period|Discontinued IMP|9|||
13112404|NCT03160885|25907819|FG003|Maintenance Treatment Period|Discontinued IMP|13|||
13112405|NCT03160885|25907820|FG004|Maintenance Treatment Period|Discontinued IMP|5|||
13197486|NCT02038829|26207351|FG010|Washout Period 1|Death|0|||
13197487|NCT02038829|26207352|FG011|Washout Period 1|Death|0|||
13197488|NCT02038829|26207341|FG000|Treatment Period 2|Adverse Event|0|||
13197489|NCT02038829|26207342|FG001|Treatment Period 2|Adverse Event|0|||
13197490|NCT02038829|26207343|FG002|Treatment Period 2|Adverse Event|0|||
13197491|NCT02038829|26207344|FG003|Treatment Period 2|Adverse Event|0|||
13197492|NCT02038829|26207345|FG004|Treatment Period 2|Adverse Event|0|||
13197493|NCT02038829|26207346|FG005|Treatment Period 2|Adverse Event|0|||
13197494|NCT02038829|26207347|FG006|Treatment Period 2|Adverse Event|0|||
13197495|NCT02038829|26207348|FG007|Treatment Period 2|Adverse Event|0|||
13197496|NCT02038829|26207349|FG008|Treatment Period 2|Adverse Event|0|||
13197497|NCT02038829|26207350|FG009|Treatment Period 2|Adverse Event|0|||
13197498|NCT02038829|26207351|FG010|Treatment Period 2|Adverse Event|1|||
13197499|NCT02038829|26207352|FG011|Treatment Period 2|Adverse Event|0|||
13197500|NCT02038829|26207341|FG000|Treatment Period 2|Withdrawal by Subject|1|||
13197501|NCT02038829|26207342|FG001|Treatment Period 2|Withdrawal by Subject|0|||
13197502|NCT02038829|26207343|FG002|Treatment Period 2|Withdrawal by Subject|0|||
13197503|NCT02038829|26207344|FG003|Treatment Period 2|Withdrawal by Subject|0|||
13197504|NCT02038829|26207345|FG004|Treatment Period 2|Withdrawal by Subject|0|||
13197505|NCT02038829|26207346|FG005|Treatment Period 2|Withdrawal by Subject|0|||
13197506|NCT02038829|26207347|FG006|Treatment Period 2|Withdrawal by Subject|0|||
13197507|NCT02038829|26207348|FG007|Treatment Period 2|Withdrawal by Subject|0|||
13197508|NCT02038829|26207349|FG008|Treatment Period 2|Withdrawal by Subject|0|||
13197509|NCT02038829|26207350|FG009|Treatment Period 2|Withdrawal by Subject|0|||
13197510|NCT02038829|26207351|FG010|Treatment Period 2|Withdrawal by Subject|0|||
13197511|NCT02038829|26207352|FG011|Treatment Period 2|Withdrawal by Subject|0|||
13197512|NCT02038829|26207341|FG000|Washout Period 2|Adverse Event|0|||
13197513|NCT02038829|26207342|FG001|Washout Period 2|Adverse Event|0|||
13197514|NCT02038829|26207343|FG002|Washout Period 2|Adverse Event|0|||
13197515|NCT02038829|26207344|FG003|Washout Period 2|Adverse Event|0|||
13197516|NCT02038829|26207345|FG004|Washout Period 2|Adverse Event|0|||
13197517|NCT02038829|26207346|FG005|Washout Period 2|Adverse Event|0|||
13197518|NCT02038829|26207347|FG006|Washout Period 2|Adverse Event|0|||
13197519|NCT02038829|26207348|FG007|Washout Period 2|Adverse Event|0|||
13197520|NCT02038829|26207349|FG008|Washout Period 2|Adverse Event|1|||
13197521|NCT02038829|26207350|FG009|Washout Period 2|Adverse Event|0|||
13197522|NCT02038829|26207351|FG010|Washout Period 2|Adverse Event|0|||
13197523|NCT02038829|26207352|FG011|Washout Period 2|Adverse Event|0|||
13197524|NCT02038829|26207341|FG000|Washout Period 2|Withdrawal by Subject|0|||
13197525|NCT02038829|26207342|FG001|Washout Period 2|Withdrawal by Subject|0|||
13197526|NCT02038829|26207343|FG002|Washout Period 2|Withdrawal by Subject|0|||
13197527|NCT02038829|26207344|FG003|Washout Period 2|Withdrawal by Subject|0|||
13197528|NCT02038829|26207345|FG004|Washout Period 2|Withdrawal by Subject|0|||
13197529|NCT02038829|26207346|FG005|Washout Period 2|Withdrawal by Subject|1|||
13197530|NCT02038829|26207347|FG006|Washout Period 2|Withdrawal by Subject|0|||
13197531|NCT02038829|26207348|FG007|Washout Period 2|Withdrawal by Subject|0|||
13197532|NCT02038829|26207349|FG008|Washout Period 2|Withdrawal by Subject|0|||
13197533|NCT02038829|26207350|FG009|Washout Period 2|Withdrawal by Subject|0|||
13197534|NCT02038829|26207351|FG010|Washout Period 2|Withdrawal by Subject|0|||
13197535|NCT02038829|26207352|FG011|Washout Period 2|Withdrawal by Subject|0|||
13197536|NCT02038829|26207341|FG000|Treatment Period 4|Adverse Event|0|||
13197537|NCT02038829|26207342|FG001|Treatment Period 4|Adverse Event|1|||
13197538|NCT02038829|26207343|FG002|Treatment Period 4|Adverse Event|0|||
13197539|NCT02038829|26207344|FG003|Treatment Period 4|Adverse Event|0|||
13197540|NCT02038829|26207345|FG004|Treatment Period 4|Adverse Event|0|||
13197541|NCT02038829|26207346|FG005|Treatment Period 4|Adverse Event|0|||
13197542|NCT02038829|26207347|FG006|Treatment Period 4|Adverse Event|0|||
13197543|NCT02038829|26207348|FG007|Treatment Period 4|Adverse Event|0|||
13197544|NCT02038829|26207349|FG008|Treatment Period 4|Adverse Event|0|||
13197545|NCT02038829|26207350|FG009|Treatment Period 4|Adverse Event|0|||
13197546|NCT02038829|26207351|FG010|Treatment Period 4|Adverse Event|0|||
13197547|NCT02038829|26207352|FG011|Treatment Period 4|Adverse Event|0|||
13197548|NCT02038829|26207341|FG000|Washout Period 4|Adverse Event|0|||
13197549|NCT02038829|26207342|FG001|Washout Period 4|Adverse Event|0|||
13197550|NCT02038829|26207343|FG002|Washout Period 4|Adverse Event|0|||
13197551|NCT02038829|26207344|FG003|Washout Period 4|Adverse Event|0|||
13197552|NCT02038829|26207345|FG004|Washout Period 4|Adverse Event|0|||
13197553|NCT02038829|26207346|FG005|Washout Period 4|Adverse Event|0|||
13197554|NCT02038829|26207347|FG006|Washout Period 4|Adverse Event|1|||
13197555|NCT02038829|26207348|FG007|Washout Period 4|Adverse Event|0|||
13197556|NCT02038829|26207349|FG008|Washout Period 4|Adverse Event|0|||
13197557|NCT02038829|26207350|FG009|Washout Period 4|Adverse Event|0|||
13197558|NCT02038829|26207351|FG010|Washout Period 4|Adverse Event|0|||
13197559|NCT02038829|26207352|FG011|Washout Period 4|Adverse Event|0|||
13197560|NCT02038829|26207341|FG000|Treatment Period 6|Adverse Event|0|||
13197561|NCT02038829|26207342|FG001|Treatment Period 6|Adverse Event|0|||
13197562|NCT02038829|26207343|FG002|Treatment Period 6|Adverse Event|1|||
13197563|NCT02038829|26207344|FG003|Treatment Period 6|Adverse Event|0|||
13197564|NCT02038829|26207345|FG004|Treatment Period 6|Adverse Event|0|||
13197565|NCT02038829|26207346|FG005|Treatment Period 6|Adverse Event|0|||
13197566|NCT02038829|26207347|FG006|Treatment Period 6|Adverse Event|0|||
13197567|NCT02038829|26207348|FG007|Treatment Period 6|Adverse Event|0|||
13197568|NCT02038829|26207349|FG008|Treatment Period 6|Adverse Event|0|||
13197569|NCT02038829|26207350|FG009|Treatment Period 6|Adverse Event|0|||
13197570|NCT02038829|26207351|FG010|Treatment Period 6|Adverse Event|0|||
13197571|NCT02038829|26207352|FG011|Treatment Period 6|Adverse Event|0|||
13197572|NCT02038790|26207386|FG000|Day 0 - First Treatment|Withdrawal by Subject|1|||
13197573|NCT02038790|26207387|FG001|Day 0 - First Treatment|Withdrawal by Subject|1|||
13197574|NCT02038777|26207524|FG000|Overall Study|Death|0|||
13197575|NCT02038777|26207525|FG001|Overall Study|Death|2|||
13197576|NCT02038777|26207526|FG002|Overall Study|Death|0|||
13197577|NCT02038777|26207527|FG003|Overall Study|Death|1|||
13197578|NCT02038777|26207528|FG004|Overall Study|Death|2|||
13197579|NCT02038777|26207529|FG005|Overall Study|Death|4|||
13197580|NCT02038777|26207530|FG006|Overall Study|Death|0|||
13197581|NCT02038777|26207531|FG007|Overall Study|Death|10|||
13112406|NCT03160885|25907821|FG005|Maintenance Treatment Period|Discontinued IMP|7|||
13112407|NCT03160885|25907822|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
13112408|NCT03160885|25907816|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
13112409|NCT03160885|25907817|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
13112410|NCT03160885|25907818|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29|||
13112411|NCT03160885|25907819|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26|||
13112412|NCT03160885|25907820|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26|||
13112413|NCT03160885|25907821|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8|||
13112414|NCT03160885|25907822|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
13112415|NCT03160885|25907816|FG000|Maintenance Treatment Period|Completed Week 50|0|||
13112416|NCT03160885|25907817|FG001|Maintenance Treatment Period|Completed Week 50|0|||
13112417|NCT03160885|25907818|FG002|Maintenance Treatment Period|Completed Week 50|1|||
13112418|NCT03160885|25907819|FG003|Maintenance Treatment Period|Completed Week 50|0|||
13112419|NCT03160885|25907820|FG004|Maintenance Treatment Period|Completed Week 50|0|||
13112420|NCT03160885|25907821|FG005|Maintenance Treatment Period|Completed Week 50|0|||
13112421|NCT03160885|25907822|FG006|Maintenance Treatment Period|Completed Week 50|0|||
13112422|NCT03160716|25907831|FG000|Overall Study|Lost to Follow-up|1|||
13112423|NCT03160703|25907854|FG000|Overall Study|Withdrawal by Subject|0|||
13112424|NCT03160703|25907855|FG001|Overall Study|Withdrawal by Subject|0|||
13112425|NCT03160703|25907856|FG002|Overall Study|Withdrawal by Subject|0|||
13112426|NCT03160703|25907857|FG003|Overall Study|Withdrawal by Subject|1|||
13112427|NCT03160573|25907880|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1|||
13112428|NCT03160573|25907881|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3|||
13112429|NCT03160573|25907882|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
13112430|NCT03160573|25907883|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
13112431|NCT03160560|25907906|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
13112432|NCT03160560|25907907|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
13112433|NCT03160560|25907908|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
13112434|NCT03160560|25907909|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
13112435|NCT03160560|25907906|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
13112436|NCT03160560|25907907|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
13112437|NCT03160560|25907908|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
13112438|NCT03160560|25907909|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
13112439|NCT03159611|25907930|FG000|Overall Study|Did Not Meet Inclusion Criteria|9|||
13112440|NCT03159611|25907931|FG001|Overall Study|Did Not Meet Inclusion Criteria|5|||
13112441|NCT03159611|25907930|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
13112442|NCT03159611|25907931|FG001|Overall Study|Did Not Meet Exclusion Criteria|3|||
13112443|NCT03159611|25907930|FG000|Overall Study|Protocol Violation|7|||
13112444|NCT03159611|25907931|FG001|Overall Study|Protocol Violation|4|||
13112445|NCT03159611|25907930|FG000|Overall Study|Adverse Event|1|||
13112446|NCT03159611|25907931|FG001|Overall Study|Adverse Event|0|||
13112447|NCT03159611|25907930|FG000|Overall Study|Withdrawal by Subject|1|||
13112448|NCT03159611|25907931|FG001|Overall Study|Withdrawal by Subject|1|||
13112449|NCT03159611|25907930|FG000|Overall Study|Non-compliance with protocol requirement|3|||
13112450|NCT03159611|25907931|FG001|Overall Study|Non-compliance with protocol requirement|2|||
13112451|NCT03159611|25907930|FG000|Overall Study|Inability to perform procedures|1|||
13112452|NCT03159611|25907931|FG001|Overall Study|Inability to perform procedures|0|||
13112453|NCT03159468|25907964|FG000|Overall Study|Withdrawal by Subject|0|||
13112454|NCT03159468|25907965|FG001|Overall Study|Withdrawal by Subject|0|||
13112455|NCT03159468|25907966|FG002|Overall Study|Withdrawal by Subject|3|||
13112456|NCT03159468|25907967|FG003|Overall Study|Withdrawal by Subject|0|||
13112457|NCT03159468|25907968|FG004|Overall Study|Withdrawal by Subject|0|||
13112458|NCT03159468|25907969|FG005|Overall Study|Withdrawal by Subject|0|||
13112459|NCT03159455|25908018|FG000|Overall Study|Adverse Event|0|||
13112460|NCT03159455|25908019|FG001|Overall Study|Adverse Event|0|||
13112461|NCT03159455|25908020|FG002|Overall Study|Adverse Event|0|||
13112462|NCT03159455|25908021|FG003|Overall Study|Adverse Event|0|||
13112463|NCT03159455|25908022|FG004|Overall Study|Adverse Event|0|||
13112464|NCT03159455|25908023|FG005|Overall Study|Adverse Event|1|||
13112465|NCT03159091|25908044|FG000|Overall Study|Incorrect inclusion ineligible patient|5|||
13197582|NCT02038777|26207524|FG000|Overall Study|Lost to Follow-up|0|||
13112466|NCT03159091|25908045|FG001|Overall Study|Incorrect inclusion ineligible patient|3|||
13112467|NCT03159091|25908044|FG000|Overall Study|Patient has taken no dose of study drug|0|||
13112468|NCT03159091|25908045|FG001|Overall Study|Patient has taken no dose of study drug|1|||
13112469|NCT03158727|25908124|FG000|Overall Study|Withdrawal by Subject|2|||
13112470|NCT03158727|25908125|FG001|Overall Study|Withdrawal by Subject|6|||
13112471|NCT03158727|25908124|FG000|Overall Study|Death|11|||
13112472|NCT03158727|25908125|FG001|Overall Study|Death|12|||
13197583|NCT02038777|26207525|FG001|Overall Study|Lost to Follow-up|0|||
13197584|NCT02038777|26207526|FG002|Overall Study|Lost to Follow-up|0|||
13197585|NCT02038777|26207527|FG003|Overall Study|Lost to Follow-up|1|||
13197586|NCT02038777|26207528|FG004|Overall Study|Lost to Follow-up|0|||
13197587|NCT02038777|26207529|FG005|Overall Study|Lost to Follow-up|0|||
13197588|NCT02038777|26207530|FG006|Overall Study|Lost to Follow-up|0|||
13197589|NCT02038777|26207531|FG007|Overall Study|Lost to Follow-up|0|||
13112473|NCT03158727|25908124|FG000|Overall Study|Lost to Follow-up|1|||
13112474|NCT03158727|25908125|FG001|Overall Study|Lost to Follow-up|0|||
13112475|NCT03158727|25908124|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2|||
13112476|NCT03158727|25908125|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0|||
13112477|NCT03158727|25908124|FG000|Overall Study|Visit 11 not done by mistake|0|||
13112478|NCT03158727|25908125|FG001|Overall Study|Visit 11 not done by mistake|1|||
13112479|NCT03158727|25908124|FG000|Overall Study|Enrolled, not treated|1|||
13112480|NCT03158727|25908125|FG001|Overall Study|Enrolled, not treated|0|||
13112481|NCT03158688|25908162|FG000|Overall Study|Continuing in study|107|||
13112482|NCT03158688|25908163|FG001|Overall Study|Continuing in study|233|||
13112483|NCT03158688|25908162|FG000|Overall Study|Death|36|||
13112484|NCT03158688|25908163|FG001|Overall Study|Death|59|||
13112485|NCT03158688|25908162|FG000|Overall Study|Withdrawal by Subject|9|||
13112486|NCT03158688|25908163|FG001|Overall Study|Withdrawal by Subject|14|||
13112487|NCT03158688|25908162|FG000|Overall Study|Decision by sponsor|2|||
13112488|NCT03158688|25908163|FG001|Overall Study|Decision by sponsor|3|||
13112489|NCT03158688|25908162|FG000|Overall Study|Lost to Follow-up|0|||
13112490|NCT03158688|25908163|FG001|Overall Study|Lost to Follow-up|3|||
13112491|NCT03158311|25908202|FG000|Overall Study|Subject/Guardian Decision|10|||
13112492|NCT03158311|25908203|FG001|Overall Study|Subject/Guardian Decision|6|||
13112493|NCT03158311|25908204|FG002|Overall Study|Subject/Guardian Decision|11|||
13112494|NCT03158311|25908202|FG000|Overall Study|Adverse Event|5|||
13112495|NCT03158311|25908203|FG001|Overall Study|Adverse Event|3|||
13112496|NCT03158311|25908204|FG002|Overall Study|Adverse Event|3|||
13112497|NCT03158311|25908202|FG000|Overall Study|Techinical Problems|3|||
13112498|NCT03158311|25908203|FG001|Overall Study|Techinical Problems|1|||
13112499|NCT03158311|25908204|FG002|Overall Study|Techinical Problems|5|||
13112500|NCT03158311|25908202|FG000|Overall Study|Physician Decision|2|||
13112501|NCT03158311|25908203|FG001|Overall Study|Physician Decision|3|||
13112502|NCT03158311|25908204|FG002|Overall Study|Physician Decision|7|||
13112503|NCT03158311|25908202|FG000|Overall Study|Lost to Follow-up|1|||
13112504|NCT03158311|25908203|FG001|Overall Study|Lost to Follow-up|1|||
13112505|NCT03158311|25908204|FG002|Overall Study|Lost to Follow-up|1|||
13112506|NCT03158311|25908202|FG000|Overall Study|Sponsor decision|1|||
13112507|NCT03158311|25908203|FG001|Overall Study|Sponsor decision|0|||
13112508|NCT03158311|25908204|FG002|Overall Study|Sponsor decision|0|||
13112509|NCT03158311|25908202|FG000|Overall Study|Pregnancy|0|||
13112510|NCT03158311|25908203|FG001|Overall Study|Pregnancy|2|||
13112511|NCT03158311|25908204|FG002|Overall Study|Pregnancy|0|||
13112512|NCT03158311|25908202|FG000|Overall Study|Randomized in error|0|||
13112513|NCT03158311|25908203|FG001|Overall Study|Randomized in error|0|||
13112514|NCT03158311|25908204|FG002|Overall Study|Randomized in error|1|||
13112515|NCT03158272|25908285|FG000|Overall Study|Disease progression|3|||
13112516|NCT03158272|25908286|FG001|Overall Study|Disease progression|3|||
13112517|NCT03158272|25908287|FG002|Overall Study|Disease progression|4|||
13112518|NCT03158272|25908288|FG003|Overall Study|Disease progression|6|||
13112519|NCT03158272|25908285|FG000|Overall Study|Death|0|||
13112520|NCT03158272|25908286|FG001|Overall Study|Death|0|||
13112521|NCT03158272|25908287|FG002|Overall Study|Death|1|||
13112522|NCT03158272|25908288|FG003|Overall Study|Death|0|||
13112523|NCT03158272|25908285|FG000|Overall Study|Other reasons|0|||
13112524|NCT03158272|25908286|FG001|Overall Study|Other reasons|0|||
13112525|NCT03158272|25908287|FG002|Overall Study|Other reasons|1|||
13112526|NCT03158272|25908288|FG003|Overall Study|Other reasons|0|||
13112527|NCT03158272|25908285|FG000|Overall Study|Adverse event unrelated to the drug|0|||
13112528|NCT03158272|25908286|FG001|Overall Study|Adverse event unrelated to the drug|1|||
13112529|NCT03158272|25908287|FG002|Overall Study|Adverse event unrelated to the drug|0|||
13112530|NCT03158272|25908288|FG003|Overall Study|Adverse event unrelated to the drug|0|||
13112531|NCT03158220|25908313|FG000|Overall Study|Screen Failure|0|||
13112532|NCT03158220|25908314|FG001|Overall Study|Screen Failure|1|||
13112533|NCT03158220|25908313|FG000|Overall Study|Withdrawal by Subject|8|||
13112534|NCT03158220|25908314|FG001|Overall Study|Withdrawal by Subject|9|||
13112535|NCT03158220|25908313|FG000|Overall Study|Status unknown|0|||
13112536|NCT03158220|25908314|FG001|Overall Study|Status unknown|1|||
13197590|NCT02038777|26207524|FG000|Overall Study|Other|0|||
13197591|NCT02038777|26207525|FG001|Overall Study|Other|1|||
13197592|NCT02038777|26207526|FG002|Overall Study|Other|0|||
13197593|NCT02038777|26207527|FG003|Overall Study|Other|2|||
13197594|NCT02038777|26207528|FG004|Overall Study|Other|1|||
13197595|NCT02038777|26207529|FG005|Overall Study|Other|0|||
13197596|NCT02038777|26207530|FG006|Overall Study|Other|0|||
13197597|NCT02038777|26207531|FG007|Overall Study|Other|0|||
13197598|NCT02038777|26207524|FG000|Overall Study|Randomized but not treated|0|||
13197599|NCT02038777|26207525|FG001|Overall Study|Randomized but not treated|1|||
13197600|NCT02038777|26207526|FG002|Overall Study|Randomized but not treated|0|||
13197601|NCT02038777|26207527|FG003|Overall Study|Randomized but not treated|0|||
13197602|NCT02038777|26207528|FG004|Overall Study|Randomized but not treated|0|||
13197603|NCT02038777|26207529|FG005|Overall Study|Randomized but not treated|0|||
13197604|NCT02038777|26207530|FG006|Overall Study|Randomized but not treated|0|||
13197605|NCT02038777|26207531|FG007|Overall Study|Randomized but not treated|0|||
13197606|NCT02038777|26207524|FG000|Overall Study|Started Chemotherapy|1|||
13197607|NCT02038777|26207525|FG001|Overall Study|Started Chemotherapy|0|||
13197608|NCT02038777|26207526|FG002|Overall Study|Started Chemotherapy|3|||
13197609|NCT02038777|26207527|FG003|Overall Study|Started Chemotherapy|0|||
13197610|NCT02038777|26207528|FG004|Overall Study|Started Chemotherapy|0|||
13197611|NCT02038777|26207529|FG005|Overall Study|Started Chemotherapy|0|||
13197612|NCT02038777|26207530|FG006|Overall Study|Started Chemotherapy|0|||
13197613|NCT02038777|26207531|FG007|Overall Study|Started Chemotherapy|0|||
13197614|NCT02038764|26207647|FG000|Overall Study|Adverse Event|0|||
13197615|NCT02038764|26207648|FG001|Overall Study|Adverse Event|0|||
13197616|NCT02038764|26207649|FG002|Overall Study|Adverse Event|1|||
13197617|NCT02038764|26207650|FG003|Overall Study|Adverse Event|0|||
13197618|NCT02038764|26207651|FG004|Overall Study|Adverse Event|0|||
13197619|NCT02038764|26207647|FG000|Overall Study|Lost to Follow-up|0|||
13197620|NCT02038764|26207648|FG001|Overall Study|Lost to Follow-up|1|||
13197621|NCT02038764|26207649|FG002|Overall Study|Lost to Follow-up|0|||
13197622|NCT02038764|26207650|FG003|Overall Study|Lost to Follow-up|0|||
13197623|NCT02038764|26207651|FG004|Overall Study|Lost to Follow-up|0|||
13197624|NCT02038764|26207647|FG000|Overall Study|Withdrawal by Subject|0|||
13197625|NCT02038764|26207648|FG001|Overall Study|Withdrawal by Subject|0|||
13197626|NCT02038764|26207649|FG002|Overall Study|Withdrawal by Subject|0|||
13197627|NCT02038764|26207650|FG003|Overall Study|Withdrawal by Subject|0|||
13197628|NCT02038764|26207651|FG004|Overall Study|Withdrawal by Subject|1|||
13197629|NCT02038764|26207647|FG000|Overall Study|Other|1|||
13197630|NCT02038764|26207648|FG001|Overall Study|Other|0|||
13197631|NCT02038764|26207649|FG002|Overall Study|Other|1|||
13197632|NCT02038764|26207650|FG003|Overall Study|Other|0|||
13197633|NCT02038764|26207651|FG004|Overall Study|Other|0|||
13197634|NCT02038647|26207690|FG000|Overall Study|Progressive Disease|50|||
13197635|NCT02038647|26207691|FG001|Overall Study|Progressive Disease|59|||
13197636|NCT02038647|26207690|FG000|Overall Study|Adverse Event|18|||
13197637|NCT02038647|26207691|FG001|Overall Study|Adverse Event|10|||
13197638|NCT02038647|26207690|FG000|Overall Study|Symptomatic Deterioration|7|||
13197639|NCT02038647|26207691|FG001|Overall Study|Symptomatic Deterioration|7|||
13197640|NCT02038647|26207690|FG000|Overall Study|Withdrawal by Subject|5|||
13197641|NCT02038647|26207691|FG001|Overall Study|Withdrawal by Subject|2|||
13197642|NCT02038647|26207690|FG000|Overall Study|Not Reported|0|||
13197643|NCT02038647|26207691|FG001|Overall Study|Not Reported|1|||
13197644|NCT02038647|26207690|FG000|Overall Study|Ongoing at Datacut|9|||
13197645|NCT02038647|26207691|FG001|Overall Study|Ongoing at Datacut|10|||
13197646|NCT02038543|26207718|FG000|Overall Study|Screen Failure|0|||
13197647|NCT02038543|26207719|FG001|Overall Study|Screen Failure|0|||
13197648|NCT02038543|26207720|FG002|Overall Study|Screen Failure|0|||
13197649|NCT02038543|26207721|FG003|Overall Study|Screen Failure|1|||
13197650|NCT02038543|26207718|FG000|Overall Study|Withdrawal by Subject|0|||
13197651|NCT02038543|26207719|FG001|Overall Study|Withdrawal by Subject|0|||
13197652|NCT02038543|26207720|FG002|Overall Study|Withdrawal by Subject|0|||
13197653|NCT02038543|26207721|FG003|Overall Study|Withdrawal by Subject|1|||
13197654|NCT02038153|26207728|FG000|Overall Study|Withdrawal by Subject|1|||
13197655|NCT02038075|26207741|FG000|Overall Study|Withdrawal by Subject|3|||
13197656|NCT02038075|26207742|FG001|Overall Study|Withdrawal by Subject|0|||
13197657|NCT02038049|26207771|FG000|Overall Study|Lost to Follow-up|1|||
13197658|NCT02038049|26207772|FG001|Overall Study|Lost to Follow-up|0|||
13197659|NCT02038036|26207828|FG000|Core Study|Adverse Event|7|||
13197660|NCT02038036|26207829|FG001|Core Study|Adverse Event|7|||
13112537|NCT03158220|25908313|FG000|Overall Study|Lost to Follow-up|8|||
13197661|NCT02038036|26207828|FG000|Core Study|Death|1|||
13197662|NCT02038036|26207829|FG001|Core Study|Death|1|||
13112538|NCT03158220|25908314|FG001|Overall Study|Lost to Follow-up|5|||
13112539|NCT03158220|25908313|FG000|Overall Study|Physician Decision|1|||
13112540|NCT03158220|25908314|FG001|Overall Study|Physician Decision|0|||
13112541|NCT03158012|25908327|FG000|Overall Study|Withdrawal by Subject|0|||
13112542|NCT03158012|25908328|FG001|Overall Study|Withdrawal by Subject|1|||
13112543|NCT03157583|25908348|FG000|Overall Study|Other (did not meet study criteria)|1|||
13112544|NCT03157531|25908365|FG000|Overall Study|Death|2|||
13197663|NCT02038036|26207828|FG000|Core Study|Disease progression|2|||
13197664|NCT02038036|26207829|FG001|Core Study|Disease progression|2|||
13197665|NCT02038036|26207828|FG000|Core Study|Lost to Follow-up|0|||
13197666|NCT02038036|26207829|FG001|Core Study|Lost to Follow-up|1|||
13197667|NCT02038036|26207828|FG000|Core Study|Physician Decision|2|||
13197668|NCT02038036|26207829|FG001|Core Study|Physician Decision|1|||
13197669|NCT02038036|26207828|FG000|Core Study|Subject/guardian decision|0|||
13197670|NCT02038036|26207829|FG001|Core Study|Subject/guardian decision|1|||
13197671|NCT02038036|26207828|FG000|Core Study|Withdrawal by Subject|3|||
13197672|NCT02038036|26207829|FG001|Core Study|Withdrawal by Subject|1|||
13197673|NCT02038036|26207828|FG000|Crossover Period|Withdrawal by Subject|0|||
13197674|NCT02038036|26207829|FG001|Crossover Period|Withdrawal by Subject|3|||
13197675|NCT02038036|26207828|FG000|Crossover Period|Adverse Event|0|||
13197676|NCT02038036|26207829|FG001|Crossover Period|Adverse Event|9|||
13197677|NCT02038036|26207828|FG000|Crossover Period|Death|0|||
13197678|NCT02038036|26207829|FG001|Crossover Period|Death|2|||
13197679|NCT02038036|26207828|FG000|Crossover Period|Disease progression|0|||
13197680|NCT02038036|26207829|FG001|Crossover Period|Disease progression|3|||
13197681|NCT02038036|26207828|FG000|Crossover Period|Lost to Follow-up|0|||
13197682|NCT02038036|26207829|FG001|Crossover Period|Lost to Follow-up|1|||
13197683|NCT02038036|26207828|FG000|Crossover Period|Physician Decision|0|||
13197684|NCT02038036|26207829|FG001|Crossover Period|Physician Decision|2|||
13197685|NCT02038010|26207853|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
13197686|NCT02038010|26207854|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1|||
13197687|NCT02038010|26207855|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
13197688|NCT02038010|26207856|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
13197689|NCT02038010|26207853|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1|||
13197690|NCT02038010|26207854|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
13197691|NCT02038010|26207855|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
13197692|NCT02038010|26207856|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
13197693|NCT02038010|26207853|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
13197694|NCT02038010|26207854|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1|||
13197695|NCT02038010|26207855|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
13197696|NCT02038010|26207856|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
13197697|NCT02038010|26207853|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
13197698|NCT02038010|26207854|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
13197699|NCT02038010|26207855|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
13197700|NCT02038010|26207856|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
13197701|NCT02038010|26207853|FG000|Follow Up|Death|4|||
13197702|NCT02038010|26207854|FG001|Follow Up|Death|3|||
13197703|NCT02038010|26207855|FG002|Follow Up|Death|0|||
13197704|NCT02038010|26207856|FG003|Follow Up|Death|0|||
13197705|NCT02038010|26207853|FG000|Follow Up|Other|3|||
13197706|NCT02038010|26207854|FG001|Follow Up|Other|0|||
13197707|NCT02038010|26207855|FG002|Follow Up|Other|0|||
13197708|NCT02038010|26207856|FG003|Follow Up|Other|0|||
13197709|NCT02037984|26207944|FG000|Overall Study|Lack of Efficacy|0|||
13197710|NCT02037984|26207945|FG001|Overall Study|Lack of Efficacy|0|||
13197711|NCT02037984|26207946|FG002|Overall Study|Lack of Efficacy|3|||
13197712|NCT02037984|26207947|FG003|Overall Study|Lack of Efficacy|10|||
13197713|NCT02037984|26207948|FG004|Overall Study|Lack of Efficacy|2|||
13197714|NCT02037984|26207949|FG005|Overall Study|Lack of Efficacy|2|||
13197715|NCT02037984|26207950|FG006|Overall Study|Lack of Efficacy|4|||
13197716|NCT02037984|26207951|FG007|Overall Study|Lack of Efficacy|3|||
13197717|NCT02037984|26207944|FG000|Overall Study|Lost to Follow-up|1|||
13197718|NCT02037984|26207945|FG001|Overall Study|Lost to Follow-up|0|||
13197719|NCT02037984|26207946|FG002|Overall Study|Lost to Follow-up|3|||
13197720|NCT02037984|26207947|FG003|Overall Study|Lost to Follow-up|5|||
13197721|NCT02037984|26207948|FG004|Overall Study|Lost to Follow-up|2|||
13197722|NCT02037984|26207949|FG005|Overall Study|Lost to Follow-up|2|||
13197723|NCT02037984|26207950|FG006|Overall Study|Lost to Follow-up|2|||
13197724|NCT02037984|26207951|FG007|Overall Study|Lost to Follow-up|4|||
13197725|NCT02037984|26207944|FG000|Overall Study|Physician Decision|0|||
13197726|NCT02037984|26207945|FG001|Overall Study|Physician Decision|0|||
13197727|NCT02037984|26207946|FG002|Overall Study|Physician Decision|0|||
13197728|NCT02037984|26207947|FG003|Overall Study|Physician Decision|0|||
13197729|NCT02037984|26207948|FG004|Overall Study|Physician Decision|0|||
13197730|NCT02037984|26207949|FG005|Overall Study|Physician Decision|0|||
13197731|NCT02037984|26207950|FG006|Overall Study|Physician Decision|1|||
13197732|NCT02037984|26207951|FG007|Overall Study|Physician Decision|0|||
13197733|NCT02037984|26207944|FG000|Overall Study|Protocol Violation|0|||
13197734|NCT02037984|26207945|FG001|Overall Study|Protocol Violation|0|||
13197735|NCT02037984|26207946|FG002|Overall Study|Protocol Violation|0|||
13197736|NCT02037984|26207947|FG003|Overall Study|Protocol Violation|0|||
13197737|NCT02037984|26207948|FG004|Overall Study|Protocol Violation|0|||
13197738|NCT02037984|26207949|FG005|Overall Study|Protocol Violation|1|||
13197739|NCT02037984|26207950|FG006|Overall Study|Protocol Violation|2|||
13197740|NCT02037984|26207951|FG007|Overall Study|Protocol Violation|0|||
13197741|NCT02037984|26207944|FG000|Overall Study|Technical Problems|0|||
13197742|NCT02037984|26207945|FG001|Overall Study|Technical Problems|0|||
13197743|NCT02037984|26207946|FG002|Overall Study|Technical Problems|3|||
13197744|NCT02037984|26207947|FG003|Overall Study|Technical Problems|3|||
13197745|NCT02037984|26207948|FG004|Overall Study|Technical Problems|2|||
13197746|NCT02037984|26207949|FG005|Overall Study|Technical Problems|3|||
13197747|NCT02037984|26207950|FG006|Overall Study|Technical Problems|4|||
13197748|NCT02037984|26207951|FG007|Overall Study|Technical Problems|2|||
13197749|NCT02037984|26207944|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
13197750|NCT02037984|26207945|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
13197751|NCT02037984|26207946|FG002|Overall Study|Withdrawal by Parent/Guardian|3|||
13197752|NCT02037984|26207947|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
13197753|NCT02037984|26207948|FG004|Overall Study|Withdrawal by Parent/Guardian|5|||
13197754|NCT02037984|26207949|FG005|Overall Study|Withdrawal by Parent/Guardian|1|||
13197755|NCT02037984|26207950|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
13197756|NCT02037984|26207951|FG007|Overall Study|Withdrawal by Parent/Guardian|2|||
13197757|NCT02037984|26207944|FG000|Overall Study|Withdrawal by Subject|0|||
13197758|NCT02037984|26207945|FG001|Overall Study|Withdrawal by Subject|0|||
13197759|NCT02037984|26207946|FG002|Overall Study|Withdrawal by Subject|0|||
13197760|NCT02037984|26207947|FG003|Overall Study|Withdrawal by Subject|1|||
13197761|NCT02037984|26207948|FG004|Overall Study|Withdrawal by Subject|1|||
13197762|NCT02037984|26207949|FG005|Overall Study|Withdrawal by Subject|3|||
13197763|NCT02037984|26207950|FG006|Overall Study|Withdrawal by Subject|0|||
13197764|NCT02037984|26207951|FG007|Overall Study|Withdrawal by Subject|1|||
13197765|NCT02037568|26207980|FG000|Overall Study|Withdrawal by Subject|17|||
13197766|NCT02037568|26207981|FG001|Overall Study|Withdrawal by Subject|24|||
13197767|NCT02037568|26207980|FG000|Overall Study|Lost to Follow-up|16|||
13197768|NCT02037568|26207981|FG001|Overall Study|Lost to Follow-up|13|||
13197769|NCT02037568|26207980|FG000|Overall Study|Screen Failure|3|||
13197770|NCT02037568|26207981|FG001|Overall Study|Screen Failure|1|||
13197771|NCT02037568|26207980|FG000|Overall Study|Patient did not receive transplant|0|||
13197772|NCT02037568|26207981|FG001|Overall Study|Patient did not receive transplant|1|||
13197773|NCT02037477|26208020|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
13197774|NCT02037477|26208021|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
13197775|NCT02037477|26208022|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1|||
13197776|NCT02037477|26208023|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
13197777|NCT02037295|26208056|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
13197778|NCT02037295|26208057|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
13197779|NCT02037295|26208058|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
13197780|NCT02037295|26208059|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
13197781|NCT02037256|26208074|FG000|Overall Study|Protocol Violation|0|||
13197782|NCT02037256|26208075|FG001|Overall Study|Protocol Violation|1|||
13197783|NCT02037256|26208074|FG000|Overall Study|Withdrawn prior to Velcade|0|||
13197784|NCT02037256|26208075|FG001|Overall Study|Withdrawn prior to Velcade|2|||
13197785|NCT02037165|26208134|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
13197786|NCT02037165|26208135|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
13197787|NCT02037165|26208136|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
13197788|NCT02037165|26208137|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
13197789|NCT02037165|26208138|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1|||
13197790|NCT02036853|26208165|FG000|Overall Study|Adverse Event|0|||
13197791|NCT02036853|26208166|FG001|Overall Study|Adverse Event|2|||
13197792|NCT02036853|26208165|FG000|Overall Study|Lack of Efficacy|0|||
13197793|NCT02036853|26208166|FG001|Overall Study|Lack of Efficacy|2|||
13197794|NCT02036853|26208165|FG000|Overall Study|Physician Decision|0|||
13197795|NCT02036853|26208166|FG001|Overall Study|Physician Decision|1|||
13197796|NCT02036853|26208165|FG000|Overall Study|Withdrawal by Subject|0|||
13197797|NCT02036853|26208166|FG001|Overall Study|Withdrawal by Subject|1|||
13197798|NCT02036775|26208211|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
13197799|NCT02036775|26208212|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
13197800|NCT02036775|26208213|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
13112545|NCT03157531|25908365|FG000|Overall Study|Lost to Follow-up|4|||
13112546|NCT03157089|25908389|FG000|Overall Study|Treated only with pembrolizumab|1|||
13112547|NCT03157089|25908390|FG001|Overall Study|Treated only with pembrolizumab|0|||
13112548|NCT03157089|25908389|FG000|Overall Study|Adverse Event|5|||
13112549|NCT03157089|25908390|FG001|Overall Study|Adverse Event|4|||
13112550|NCT03157089|25908389|FG000|Overall Study|Progressive disease|6|||
13112551|NCT03157089|25908390|FG001|Overall Study|Progressive disease|8|||
13112552|NCT03157037|25908425|FG000|Overall Study|Death|1|||
13112553|NCT03156621|25908485|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0|||
13112554|NCT03156621|25908486|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2|||
13112555|NCT03156621|25908485|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
13112556|NCT03156621|25908486|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
13112557|NCT03156543|25908501|FG000|Overall Study|Withdrawal by Subject|1|||
13197801|NCT02036775|26208214|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
13197802|NCT02036775|26208215|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
13197803|NCT02036775|26208216|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1|||
13197804|NCT02036645|26208355|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
13197805|NCT02036645|26208356|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
13197806|NCT02036645|26208357|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
13197807|NCT02036645|26208358|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
13197808|NCT02036645|26208359|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
13197809|NCT02036645|26208360|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
13197810|NCT02036645|26208361|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1|||
13197811|NCT02036645|26208362|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
13197812|NCT02036645|26208363|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
13197813|NCT02036645|26208364|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
13197814|NCT02036645|26208365|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
13197815|NCT02036645|26208366|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
13197816|NCT02036645|26208355|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
13197817|NCT02036645|26208356|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
13197818|NCT02036645|26208357|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
13197819|NCT02036645|26208358|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1|||
13197820|NCT02036645|26208359|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
13197821|NCT02036645|26208360|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
13197822|NCT02036645|26208361|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
13197823|NCT02036645|26208362|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
13197824|NCT02036645|26208363|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
13197825|NCT02036645|26208364|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
13197826|NCT02036645|26208365|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
13197827|NCT02036645|26208366|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
13197828|NCT02036580|26208389|FG000|Overall Study|Withdrawal by Subject|0|||
13197829|NCT02036580|26208390|FG001|Overall Study|Withdrawal by Subject|1|||
13197830|NCT02036580|26208391|FG002|Overall Study|Withdrawal by Subject|0|||
13197831|NCT02036580|26208389|FG000|Overall Study|Adverse Event|1|||
13197832|NCT02036580|26208390|FG001|Overall Study|Adverse Event|0|||
13197833|NCT02036580|26208391|FG002|Overall Study|Adverse Event|0|||
13197834|NCT02036515|26208478|FG000|Overall Study|Adverse Event|1|||
13197835|NCT02036515|26208479|FG001|Overall Study|Adverse Event|1|||
13197836|NCT02036515|26208480|FG002|Overall Study|Adverse Event|2|||
13197837|NCT02036515|26208478|FG000|Overall Study|Lost to Follow-up|0|||
13197838|NCT02036515|26208479|FG001|Overall Study|Lost to Follow-up|2|||
13197839|NCT02036515|26208480|FG002|Overall Study|Lost to Follow-up|0|||
13197840|NCT02036515|26208478|FG000|Overall Study|Non-compliance with study drug|0|||
13197841|NCT02036515|26208479|FG001|Overall Study|Non-compliance with study drug|0|||
13197842|NCT02036515|26208480|FG002|Overall Study|Non-compliance with study drug|2|||
13197843|NCT02036515|26208478|FG000|Overall Study|Screen failure|0|||
13197844|NCT02036515|26208479|FG001|Overall Study|Screen failure|2|||
13197845|NCT02036515|26208480|FG002|Overall Study|Screen failure|0|||
13197846|NCT02036515|26208478|FG000|Overall Study|Withdrawal by Subject|4|||
13197847|NCT02036515|26208479|FG001|Overall Study|Withdrawal by Subject|7|||
13197848|NCT02036515|26208480|FG002|Overall Study|Withdrawal by Subject|9|||
13197849|NCT02036515|26208478|FG000|Overall Study|Hyperglycemia|0|||
13197850|NCT02036515|26208479|FG001|Overall Study|Hyperglycemia|0|||
13197851|NCT02036515|26208480|FG002|Overall Study|Hyperglycemia|1|||
13197852|NCT02036502|26208599|FG000|Part 1:Dose Determination/Escalation|Death|3|||
13197853|NCT02036502|26208600|FG001|Part 1:Dose Determination/Escalation|Death|2|||
13197854|NCT02036502|26208601|FG002|Part 1:Dose Determination/Escalation|Death|0|||
13197855|NCT02036502|26208602|FG003|Part 1:Dose Determination/Escalation|Death|0|||
13197856|NCT02036502|26208603|FG004|Part 1:Dose Determination/Escalation|Death|0|||
13197857|NCT02036502|26208604|FG005|Part 1:Dose Determination/Escalation|Death|0|||
13197858|NCT02036502|26208605|FG006|Part 1:Dose Determination/Escalation|Death|0|||
13197859|NCT02036502|26208606|FG007|Part 1:Dose Determination/Escalation|Death|0|||
13197860|NCT02036502|26208599|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3|||
13197861|NCT02036502|26208600|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
13197862|NCT02036502|26208601|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
13197863|NCT02036502|26208602|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
13197864|NCT02036502|26208603|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
13197865|NCT02036502|26208604|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
13197866|NCT02036502|26208605|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
13197867|NCT02036502|26208606|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
13197868|NCT02036502|26208599|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0|||
13197869|NCT02036502|26208600|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1|||
13197870|NCT02036502|26208601|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0|||
13197871|NCT02036502|26208602|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0|||
13197872|NCT02036502|26208603|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0|||
13197873|NCT02036502|26208604|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0|||
13197874|NCT02036502|26208605|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0|||
13197875|NCT02036502|26208606|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0|||
13197876|NCT02036502|26208599|FG000|Part 1:Dose Determination/Escalation|Not treated|0|||
13197877|NCT02036502|26208600|FG001|Part 1:Dose Determination/Escalation|Not treated|1|||
13197878|NCT02036502|26208601|FG002|Part 1:Dose Determination/Escalation|Not treated|0|||
13197879|NCT02036502|26208602|FG003|Part 1:Dose Determination/Escalation|Not treated|0|||
13197880|NCT02036502|26208603|FG004|Part 1:Dose Determination/Escalation|Not treated|0|||
13197881|NCT02036502|26208604|FG005|Part 1:Dose Determination/Escalation|Not treated|0|||
13197882|NCT02036502|26208605|FG006|Part 1:Dose Determination/Escalation|Not treated|0|||
13197883|NCT02036502|26208606|FG007|Part 1:Dose Determination/Escalation|Not treated|0|||
13197884|NCT02036502|26208599|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
13197885|NCT02036502|26208600|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
13197886|NCT02036502|26208601|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2|||
13197887|NCT02036502|26208602|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
13197888|NCT02036502|26208603|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
13197889|NCT02036502|26208604|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
13197890|NCT02036502|26208605|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
13197891|NCT02036502|26208606|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
13197892|NCT02036502|26208599|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
13197893|NCT02036502|26208600|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
13197894|NCT02036502|26208601|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3|||
13197895|NCT02036502|26208602|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
13197896|NCT02036502|26208603|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
13197897|NCT02036502|26208604|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
13197898|NCT02036502|26208605|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
13197899|NCT02036502|26208606|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
13197900|NCT02036502|26208599|FG000|Part 2:Dose Confirmation|Death|0|||
13197901|NCT02036502|26208600|FG001|Part 2:Dose Confirmation|Death|0|||
13197902|NCT02036502|26208601|FG002|Part 2:Dose Confirmation|Death|1|||
13197903|NCT02036502|26208602|FG003|Part 2:Dose Confirmation|Death|0|||
13197904|NCT02036502|26208603|FG004|Part 2:Dose Confirmation|Death|0|||
13197905|NCT02036502|26208604|FG005|Part 2:Dose Confirmation|Death|0|||
13197906|NCT02036502|26208605|FG006|Part 2:Dose Confirmation|Death|0|||
13197907|NCT02036502|26208606|FG007|Part 2:Dose Confirmation|Death|0|||
13197908|NCT02036502|26208599|FG000|Part 2:Dose Confirmation|Not treated|0|||
13197909|NCT02036502|26208600|FG001|Part 2:Dose Confirmation|Not treated|0|||
13197910|NCT02036502|26208601|FG002|Part 2:Dose Confirmation|Not treated|0|||
13197911|NCT02036502|26208602|FG003|Part 2:Dose Confirmation|Not treated|1|||
13197912|NCT02036502|26208603|FG004|Part 2:Dose Confirmation|Not treated|0|||
13197913|NCT02036502|26208604|FG005|Part 2:Dose Confirmation|Not treated|0|||
13197914|NCT02036502|26208605|FG006|Part 2:Dose Confirmation|Not treated|0|||
13197915|NCT02036502|26208606|FG007|Part 2:Dose Confirmation|Not treated|0|||
13197916|NCT02036502|26208599|FG000|Part 3:Dose Expansion|Adverse Event|0|||
13197917|NCT02036502|26208600|FG001|Part 3:Dose Expansion|Adverse Event|0|||
13197918|NCT02036502|26208601|FG002|Part 3:Dose Expansion|Adverse Event|0|||
13197919|NCT02036502|26208602|FG003|Part 3:Dose Expansion|Adverse Event|0|||
13197920|NCT02036502|26208603|FG004|Part 3:Dose Expansion|Adverse Event|0|||
13197921|NCT02036502|26208604|FG005|Part 3:Dose Expansion|Adverse Event|4|||
13197922|NCT02036502|26208605|FG006|Part 3:Dose Expansion|Adverse Event|0|||
13197923|NCT02036502|26208606|FG007|Part 3:Dose Expansion|Adverse Event|2|||
13197924|NCT02036502|26208599|FG000|Part 3:Dose Expansion|Death|0|||
13197925|NCT02036502|26208600|FG001|Part 3:Dose Expansion|Death|0|||
13197926|NCT02036502|26208601|FG002|Part 3:Dose Expansion|Death|0|||
13197927|NCT02036502|26208602|FG003|Part 3:Dose Expansion|Death|0|||
13197928|NCT02036502|26208603|FG004|Part 3:Dose Expansion|Death|0|||
13197929|NCT02036502|26208604|FG005|Part 3:Dose Expansion|Death|24|||
13197930|NCT02036502|26208605|FG006|Part 3:Dose Expansion|Death|0|||
13197931|NCT02036502|26208606|FG007|Part 3:Dose Expansion|Death|3|||
13197932|NCT02036502|26208599|FG000|Part 3:Dose Expansion|Lost to Follow-up|0|||
13197933|NCT02036502|26208600|FG001|Part 3:Dose Expansion|Lost to Follow-up|0|||
13197934|NCT02036502|26208601|FG002|Part 3:Dose Expansion|Lost to Follow-up|0|||
13197935|NCT02036502|26208602|FG003|Part 3:Dose Expansion|Lost to Follow-up|0|||
13197936|NCT02036502|26208603|FG004|Part 3:Dose Expansion|Lost to Follow-up|0|||
13197937|NCT02036502|26208604|FG005|Part 3:Dose Expansion|Lost to Follow-up|0|||
13197938|NCT02036502|26208605|FG006|Part 3:Dose Expansion|Lost to Follow-up|0|||
13197939|NCT02036502|26208606|FG007|Part 3:Dose Expansion|Lost to Follow-up|1|||
13197940|NCT02036502|26208599|FG000|Part 3:Dose Expansion|Physician Decision|0|||
13197941|NCT02036502|26208600|FG001|Part 3:Dose Expansion|Physician Decision|0|||
13197942|NCT02036502|26208601|FG002|Part 3:Dose Expansion|Physician Decision|0|||
13197943|NCT02036502|26208602|FG003|Part 3:Dose Expansion|Physician Decision|0|||
13197944|NCT02036502|26208603|FG004|Part 3:Dose Expansion|Physician Decision|0|||
13197945|NCT02036502|26208604|FG005|Part 3:Dose Expansion|Physician Decision|1|||
13197946|NCT02036502|26208605|FG006|Part 3:Dose Expansion|Physician Decision|0|||
13197947|NCT02036502|26208606|FG007|Part 3:Dose Expansion|Physician Decision|0|||
13197948|NCT02036502|26208599|FG000|Part 3:Dose Expansion|Progressive Disease|0|||
13197949|NCT02036502|26208600|FG001|Part 3:Dose Expansion|Progressive Disease|0|||
13197950|NCT02036502|26208601|FG002|Part 3:Dose Expansion|Progressive Disease|0|||
13197951|NCT02036502|26208602|FG003|Part 3:Dose Expansion|Progressive Disease|0|||
13197952|NCT02036502|26208603|FG004|Part 3:Dose Expansion|Progressive Disease|0|||
13197953|NCT02036502|26208604|FG005|Part 3:Dose Expansion|Progressive Disease|1|||
13197954|NCT02036502|26208605|FG006|Part 3:Dose Expansion|Progressive Disease|0|||
13197955|NCT02036502|26208606|FG007|Part 3:Dose Expansion|Progressive Disease|0|||
13197956|NCT02036502|26208599|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
13197957|NCT02036502|26208600|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
13197958|NCT02036502|26208601|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
13197959|NCT02036502|26208602|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
13197960|NCT02036502|26208603|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
13197961|NCT02036502|26208604|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11|||
13197962|NCT02036502|26208605|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
13197963|NCT02036502|26208606|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2|||
13197964|NCT02036502|26208599|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0|||
13197965|NCT02036502|26208600|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0|||
13197966|NCT02036502|26208601|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0|||
13197967|NCT02036502|26208602|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0|||
13197968|NCT02036502|26208603|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0|||
13197969|NCT02036502|26208604|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4|||
13197970|NCT02036502|26208605|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1|||
13197971|NCT02036502|26208606|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2|||
13197972|NCT02036502|26208599|FG000|Part 3:Dose Expansion|Not Treated|0|||
13197973|NCT02036502|26208600|FG001|Part 3:Dose Expansion|Not Treated|0|||
13197974|NCT02036502|26208601|FG002|Part 3:Dose Expansion|Not Treated|0|||
13197975|NCT02036502|26208602|FG003|Part 3:Dose Expansion|Not Treated|0|||
13197976|NCT02036502|26208603|FG004|Part 3:Dose Expansion|Not Treated|0|||
13197977|NCT02036502|26208604|FG005|Part 3:Dose Expansion|Not Treated|2|||
13197978|NCT02036502|26208605|FG006|Part 3:Dose Expansion|Not Treated|0|||
13197979|NCT02036502|26208606|FG007|Part 3:Dose Expansion|Not Treated|0|||
13197980|NCT02036294|26208629|FG000|Overall Study|Death|7|||
13197981|NCT02036294|26208630|FG001|Overall Study|Death|8|||
13197982|NCT02036294|26208629|FG000|Overall Study|Withdrawal by Subject|2|||
13197983|NCT02036294|26208630|FG001|Overall Study|Withdrawal by Subject|3|||
13197984|NCT02035748|26208642|FG000|Overall Study|Adverse Event|5|||
13197985|NCT02035748|26208642|FG000|Overall Study|Death|3|||
13197986|NCT02035748|26208642|FG000|Overall Study|Lost to Follow-up|2|||
13197987|NCT02035748|26208642|FG000|Overall Study|Physician Decision|3|||
13197988|NCT02035748|26208642|FG000|Overall Study|Withdrawal by Subject|6|||
13197989|NCT02035748|26208642|FG000|Overall Study|Progressive Disease|1|||
13197990|NCT02035696|26208709|FG000|Overall Study|Lost to Follow-up|0|||
13197991|NCT02035696|26208710|FG001|Overall Study|Lost to Follow-up|3|||
13197992|NCT02035696|26208711|FG002|Overall Study|Lost to Follow-up|1|||
13197993|NCT02035696|26208712|FG003|Overall Study|Lost to Follow-up|2|||
13197994|NCT02035696|26208709|FG000|Overall Study|Withdrawal by Subject|3|||
13197995|NCT02035696|26208710|FG001|Overall Study|Withdrawal by Subject|0|||
13197996|NCT02035696|26208711|FG002|Overall Study|Withdrawal by Subject|2|||
13197997|NCT02035696|26208712|FG003|Overall Study|Withdrawal by Subject|1|||
13197998|NCT02035553|26208725|FG000|Overall Study|Death (See All-Cause Mortality Table)|0|||
13197999|NCT02035553|26208726|FG001|Overall Study|Death (See All-Cause Mortality Table)|1|||
13198000|NCT02035553|26208725|FG000|Overall Study|Adverse Event|10|||
13198001|NCT02035553|26208726|FG001|Overall Study|Adverse Event|6|||
13198002|NCT02035553|26208725|FG000|Overall Study|Physician Decision|3|||
13198003|NCT02035553|26208726|FG001|Overall Study|Physician Decision|2|||
13198004|NCT02035553|26208725|FG000|Overall Study|Lack of Efficacy|1|||
13198005|NCT02035553|26208726|FG001|Overall Study|Lack of Efficacy|1|||
13198006|NCT02035553|26208725|FG000|Overall Study|Withdrawal by Subject|4|||
13198007|NCT02035553|26208726|FG001|Overall Study|Withdrawal by Subject|7|||
13198008|NCT02035553|26208725|FG000|Overall Study|Non-compliance with Study Drug|0|||
13198009|NCT02035553|26208726|FG001|Overall Study|Non-compliance with Study Drug|1|||
13198010|NCT02035553|26208725|FG000|Overall Study|Lost to Follow-up|0|||
13198011|NCT02035553|26208726|FG001|Overall Study|Lost to Follow-up|1|||
13198012|NCT02035553|26208725|FG000|Overall Study|Other Reason|0|||
13485624|NCT01126749|27033000|FG000|Phase 1b|Other|0|||
13198013|NCT02035553|26208726|FG001|Overall Study|Other Reason|4|||
13198014|NCT02035475|26208734|FG000|Overall Study|Withdrawal by Subject|4|||
13198015|NCT02035475|26208734|FG000|Overall Study|Physician Decision|1|||
13198016|NCT02035475|26208734|FG000|Overall Study|Equipment Error|1|||
13198017|NCT02035332|26208742|FG000|Overall Study|Procedure Aborted due to Uterine Width|1|||
13198018|NCT02035267|26208783|FG000|Overall Study|Withdrawal consent-subject convenience|0|||
13198019|NCT02035267|26208784|FG001|Overall Study|Withdrawal consent-subject convenience|0|||
13198020|NCT02035267|26208785|FG002|Overall Study|Withdrawal consent-subject convenience|1|||
13198021|NCT02035267|26208786|FG003|Overall Study|Withdrawal consent-subject convenience|0|||
13198022|NCT02035267|26208783|FG000|Overall Study|Adverse Event|0|||
13198023|NCT02035267|26208784|FG001|Overall Study|Adverse Event|0|||
13198024|NCT02035267|26208785|FG002|Overall Study|Adverse Event|1|||
13198025|NCT02035267|26208786|FG003|Overall Study|Adverse Event|0|||
13198026|NCT02035267|26208783|FG000|Overall Study|Lost to Follow-up|0|||
13198027|NCT02035267|26208784|FG001|Overall Study|Lost to Follow-up|0|||
13198028|NCT02035267|26208785|FG002|Overall Study|Lost to Follow-up|0|||
13198029|NCT02035267|26208786|FG003|Overall Study|Lost to Follow-up|1|||
13198030|NCT02035267|26208783|FG000|Overall Study|Other unspecified|0|||
13198031|NCT02035267|26208784|FG001|Overall Study|Other unspecified|1|||
13198032|NCT02035267|26208785|FG002|Overall Study|Other unspecified|0|||
13198033|NCT02035267|26208786|FG003|Overall Study|Other unspecified|0|||
13198034|NCT02035202|26208810|FG000|Overall Study|Lost to Follow-up|8|||
13198035|NCT02035202|26208811|FG001|Overall Study|Lost to Follow-up|16|||
13198036|NCT02035202|26208812|FG002|Overall Study|Lost to Follow-up|2|||
13198037|NCT02034916|26208854|FG000|Overall Study|Death|39|||
13198038|NCT02034916|26208855|FG001|Overall Study|Death|28|||
13198039|NCT02034916|26208854|FG000|Overall Study|Withdrawal by Subject|2|||
13198040|NCT02034916|26208855|FG001|Overall Study|Withdrawal by Subject|1|||
13198041|NCT02034916|26208854|FG000|Overall Study|Lost to Follow-up|4|||
13198042|NCT02034916|26208855|FG001|Overall Study|Lost to Follow-up|1|||
13198043|NCT02034916|26208854|FG000|Overall Study|Study terminated by sponsor|4|||
13198044|NCT02034916|26208855|FG001|Overall Study|Study terminated by sponsor|5|||
13198045|NCT02034877|26208878|FG000|Overall Study|Lost to Follow-up|0|||
13198046|NCT02034877|26208879|FG001|Overall Study|Lost to Follow-up|3|||
13198047|NCT02034877|26208878|FG000|Overall Study|No Longer Willing to Participate|0|||
13198048|NCT02034877|26208879|FG001|Overall Study|No Longer Willing to Participate|3|||
13198049|NCT02034799|26208898|FG000|Overall Study|Withdrawal by Subject|0|||
13198050|NCT02034799|26208899|FG001|Overall Study|Withdrawal by Subject|2|||
13198051|NCT02034799|26208898|FG000|Overall Study|Lost to Follow-up|0|||
13198052|NCT02034799|26208899|FG001|Overall Study|Lost to Follow-up|1|||
13198053|NCT02034799|26208898|FG000|Overall Study|Death|2|||
13198054|NCT02034799|26208899|FG001|Overall Study|Death|1|||
13198055|NCT02034708|26208917|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2|||
13198056|NCT02034708|26208918|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5|||
13198057|NCT02034708|26208917|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1|||
13198058|NCT02034708|26208918|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0|||
13198059|NCT02034708|26208917|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
13198060|NCT02034708|26208918|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
13198061|NCT02034708|26208917|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3|||
13198062|NCT02034708|26208918|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2|||
13198063|NCT02034591|26208948|FG000|Overall Study|Withdrawal by Subject|0|||
13198064|NCT02034591|26208949|FG001|Overall Study|Withdrawal by Subject|0|||
13198065|NCT02034591|26208950|FG002|Overall Study|Withdrawal by Subject|0|||
13198066|NCT02034591|26208951|FG003|Overall Study|Withdrawal by Subject|0|||
13198067|NCT02034591|26208952|FG004|Overall Study|Withdrawal by Subject|1|||
13198068|NCT02034591|26208953|FG005|Overall Study|Withdrawal by Subject|0|||
13198069|NCT02034565|26208970|FG000|Overall Study|Adverse Event|1|||
13198070|NCT02034565|26208971|FG001|Overall Study|Adverse Event|0|||
13198071|NCT02034552|26209010|FG000|Overall Study|Never treated|3|||
13198072|NCT02034552|26209011|FG001|Overall Study|Never treated|2|||
13198073|NCT02034552|26209012|FG002|Overall Study|Never treated|0|||
13198074|NCT02034552|26209010|FG000|Overall Study|Radiological progression|3|||
13198075|NCT02034552|26209011|FG001|Overall Study|Radiological progression|5|||
13198076|NCT02034552|26209012|FG002|Overall Study|Radiological progression|4|||
13198077|NCT02034552|26209010|FG000|Overall Study|AE not assoc. with disease progression|1|||
13198078|NCT02034552|26209011|FG001|Overall Study|AE not assoc. with disease progression|4|||
13198079|NCT02034552|26209012|FG002|Overall Study|AE not assoc. with disease progression|2|||
13198080|NCT02034552|26209010|FG000|Overall Study|AE associated with disease progression|0|||
13198081|NCT02034552|26209011|FG001|Overall Study|AE associated with disease progression|1|||
13198082|NCT02034552|26209012|FG002|Overall Study|AE associated with disease progression|0|||
13198083|NCT02034552|26209010|FG000|Overall Study|Withdrawal by Subject|2|||
13198084|NCT02034552|26209011|FG001|Overall Study|Withdrawal by Subject|1|||
13198085|NCT02034552|26209012|FG002|Overall Study|Withdrawal by Subject|1|||
13198086|NCT02034552|26209010|FG000|Overall Study|Non-compliance with study drug|0|||
13198087|NCT02034552|26209011|FG001|Overall Study|Non-compliance with study drug|0|||
13198088|NCT02034552|26209012|FG002|Overall Study|Non-compliance with study drug|1|||
13198089|NCT02034552|26209010|FG000|Overall Study|Clinical progression|5|||
13198090|NCT02034552|26209011|FG001|Overall Study|Clinical progression|7|||
13198091|NCT02034552|26209012|FG002|Overall Study|Clinical progression|9|||
13198092|NCT02034513|26209035|FG000|Overall Study|Adverse Event|11|||
13198093|NCT02034513|26209036|FG001|Overall Study|Adverse Event|10|||
13198094|NCT02034513|26209035|FG000|Overall Study|Lack of Efficacy|0|||
13198095|NCT02034513|26209036|FG001|Overall Study|Lack of Efficacy|1|||
13198096|NCT02034513|26209035|FG000|Overall Study|Lost to Follow-up|6|||
13198097|NCT02034513|26209036|FG001|Overall Study|Lost to Follow-up|7|||
13198098|NCT02034513|26209035|FG000|Overall Study|Pregnancy|0|||
13198099|NCT02034513|26209036|FG001|Overall Study|Pregnancy|3|||
13198100|NCT02034513|26209035|FG000|Overall Study|Protocol Violation|7|||
13198101|NCT02034513|26209036|FG001|Overall Study|Protocol Violation|10|||
13198102|NCT02034513|26209035|FG000|Overall Study|Withdrawal by Subject|25|||
13198103|NCT02034513|26209036|FG001|Overall Study|Withdrawal by Subject|25|||
13198104|NCT02034513|26209035|FG000|Overall Study|Unclassified|0|||
13198105|NCT02034513|26209036|FG001|Overall Study|Unclassified|1|||
13198106|NCT02034474|26209053|FG000|Overall Study|Adverse Event|3|||
13198107|NCT02034474|26209054|FG001|Overall Study|Adverse Event|2|||
13198108|NCT02034474|26209053|FG000|Overall Study|Withdrawal by Subject|1|||
13198109|NCT02034474|26209054|FG001|Overall Study|Withdrawal by Subject|2|||
13198110|NCT02034435|26209077|FG000|Overall Study|Withdrawal by Subject|1|||
13198111|NCT02034435|26209078|FG001|Overall Study|Withdrawal by Subject|0|||
13198112|NCT02034435|26209079|FG002|Overall Study|Withdrawal by Subject|0|||
13198113|NCT02034435|26209080|FG003|Overall Study|Withdrawal by Subject|0|||
13198114|NCT02034435|26209077|FG000|Overall Study|Illness|0|||
13198115|NCT02034435|26209078|FG001|Overall Study|Illness|2|||
13198116|NCT02034435|26209079|FG002|Overall Study|Illness|0|||
13198117|NCT02034435|26209080|FG003|Overall Study|Illness|0|||
13198118|NCT02034435|26209077|FG000|Overall Study|Inadequate IV access|1|||
13198119|NCT02034435|26209078|FG001|Overall Study|Inadequate IV access|0|||
13198120|NCT02034435|26209079|FG002|Overall Study|Inadequate IV access|0|||
13198121|NCT02034435|26209080|FG003|Overall Study|Inadequate IV access|1|||
13198122|NCT02034409|26209115|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4|||
13198123|NCT02034409|26209116|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0|||
13198124|NCT02034409|26209115|FG000|Sham-Controlled Treatment Period|Adverse Event|1|||
13198125|NCT02034409|26209116|FG001|Sham-Controlled Treatment Period|Adverse Event|1|||
13198126|NCT02034409|26209115|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0|||
13198127|NCT02034409|26209116|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1|||
13198128|NCT02034409|26209115|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
13198129|NCT02034409|26209116|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
13198130|NCT02034409|26209115|FG000|Sham-Controlled Treatment Period|Physician Decision|1|||
13198131|NCT02034409|26209116|FG001|Sham-Controlled Treatment Period|Physician Decision|3|||
13198132|NCT02034409|26209115|FG000|Sham-Controlled Treatment Period|misrandomized|2|||
13198133|NCT02034409|26209116|FG001|Sham-Controlled Treatment Period|misrandomized|2|||
13198134|NCT02034162|26209152|FG000|Double-blind|Lost to Follow-up|3|||
13198135|NCT02034162|26209153|FG001|Double-blind|Lost to Follow-up|0|||
13198136|NCT02034162|26209154|FG002|Double-blind|Lost to Follow-up|0|||
13198137|NCT02034162|26209152|FG000|Double-blind|Physician Decision|1|||
13198138|NCT02034162|26209153|FG001|Double-blind|Physician Decision|0|||
13198139|NCT02034162|26209154|FG002|Double-blind|Physician Decision|0|||
13198140|NCT02034162|26209152|FG000|Double-blind|Protocol Violation|0|||
13198141|NCT02034162|26209153|FG001|Double-blind|Protocol Violation|1|||
13198142|NCT02034162|26209154|FG002|Double-blind|Protocol Violation|0|||
13198143|NCT02034162|26209152|FG000|Double-blind|Withdrawal by Subject|5|||
13198144|NCT02034162|26209153|FG001|Double-blind|Withdrawal by Subject|7|||
13198145|NCT02034162|26209154|FG002|Double-blind|Withdrawal by Subject|0|||
13198146|NCT02034058|26209164|FG000|Overall Study|Death|3|||
13198147|NCT02034006|26209201|FG000|Overall Study|Withdrawal by Subject|7|||
13198148|NCT02034006|26209201|FG000|Overall Study|Lost to Follow-up|5|||
13198149|NCT02034006|26209201|FG000|Overall Study|Death|1|||
13198150|NCT02034006|26209201|FG000|Overall Study|Pregnancy|1|||
13198151|NCT02033889|26209363|FG000|Overall Study|Adverse Event|3|||
13198152|NCT02033889|26209364|FG001|Overall Study|Adverse Event|1|||
13198153|NCT02033889|26209365|FG002|Overall Study|Adverse Event|3|||
13198154|NCT02033889|26209363|FG000|Overall Study|Death|3|||
13198155|NCT02033889|26209364|FG001|Overall Study|Death|1|||
13198156|NCT02033889|26209365|FG002|Overall Study|Death|2|||
13198157|NCT02033889|26209363|FG000|Overall Study|Excluded Medication|1|||
13198158|NCT02033889|26209364|FG001|Overall Study|Excluded Medication|1|||
13198159|NCT02033889|26209365|FG002|Overall Study|Excluded Medication|0|||
13198160|NCT02033889|26209363|FG000|Overall Study|Lost to Follow-up|8|||
13198161|NCT02033889|26209364|FG001|Overall Study|Lost to Follow-up|5|||
13198162|NCT02033889|26209365|FG002|Overall Study|Lost to Follow-up|6|||
13198163|NCT02033889|26209363|FG000|Overall Study|Non-Compliance With Study Drug|1|||
13198164|NCT02033889|26209364|FG001|Overall Study|Non-Compliance With Study Drug|0|||
13198165|NCT02033889|26209365|FG002|Overall Study|Non-Compliance With Study Drug|0|||
13198166|NCT02033889|26209363|FG000|Overall Study|Physician Decision|0|||
13198167|NCT02033889|26209364|FG001|Overall Study|Physician Decision|1|||
13198168|NCT02033889|26209365|FG002|Overall Study|Physician Decision|1|||
13198169|NCT02033889|26209363|FG000|Overall Study|Participant moved|0|||
13198170|NCT02033889|26209364|FG001|Overall Study|Participant moved|1|||
13198171|NCT02033889|26209365|FG002|Overall Study|Participant moved|0|||
13198172|NCT02033889|26209363|FG000|Overall Study|Withdrawal by Subject|18|||
13198173|NCT02033889|26209364|FG001|Overall Study|Withdrawal by Subject|10|||
13198174|NCT02033889|26209365|FG002|Overall Study|Withdrawal by Subject|13|||
13198175|NCT02033850|26209394|FG000|Overall Study|Death|1|||
13198176|NCT02033850|26209395|FG001|Overall Study|Death|0|||
13198177|NCT02033850|26209394|FG000|Overall Study|unrelated medical reason|1|||
13198178|NCT02033850|26209395|FG001|Overall Study|unrelated medical reason|1|||
13206481|NCT01957488|26234736|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
13206482|NCT01957488|26234737|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
13206483|NCT01957488|26234738|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
13206484|NCT01957488|26234739|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1|||
13206485|NCT01957488|26234734|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1|||
13206486|NCT01957488|26234735|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
13206487|NCT01957488|26234736|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
13206488|NCT01957488|26234737|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
13206489|NCT01957488|26234738|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
13206490|NCT01957488|26234739|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
13206491|NCT01957488|26234734|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
13206492|NCT01957488|26234735|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1|||
13206493|NCT01957488|26234736|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
13206494|NCT01957488|26234737|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
13206495|NCT01957488|26234738|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
13206496|NCT01957488|26234739|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
13206497|NCT01957475|26234748|FG000|Test Period 1|Withdrawal by Subject|1|||
13206498|NCT01957475|26234749|FG001|Test Period 1|Withdrawal by Subject|0|||
13206499|NCT01957475|26234748|FG000|Test Period 1|Other|1|||
13206500|NCT01957475|26234749|FG001|Test Period 1|Other|0|||
13206501|NCT01957475|26234748|FG000|Test Period 1|Lack of Efficacy|0|||
13206502|NCT01957475|26234749|FG001|Test Period 1|Lack of Efficacy|1|||
13206503|NCT01957475|26234748|FG000|Test Period 2|Adverse Event|1|||
13206504|NCT01957475|26234749|FG001|Test Period 2|Adverse Event|0|||
13206505|NCT01957462|26234758|FG000|Test Period 1|Withdrawal by Subject|1|||
13206506|NCT01957462|26234759|FG001|Test Period 1|Withdrawal by Subject|0|||
13206507|NCT01957462|26234758|FG000|Test Period 1|Adverse Event|1|||
13206508|NCT01957462|26234759|FG001|Test Period 1|Adverse Event|0|||
13206509|NCT01957397|26234772|FG000|Test Period 1|sudden leakage/small bag|1|||
13206510|NCT01957397|26234773|FG001|Test Period 1|sudden leakage/small bag|1|||
13206511|NCT01957397|26234772|FG000|Test Period 1|Withdrawal by Subject|1|||
13206512|NCT01957397|26234773|FG001|Test Period 1|Withdrawal by Subject|0|||
13206513|NCT01957397|26234772|FG000|Test Period 2|Adverse Event|0|||
13206514|NCT01957397|26234773|FG001|Test Period 2|Adverse Event|1|||
13206515|NCT01957397|26234772|FG000|Test Period 3|Adverse Event|1|||
13206516|NCT01957397|26234773|FG001|Test Period 3|Adverse Event|2|||
13206517|NCT01957397|26234772|FG000|Test Period 3|the adhesive did not work|1|||
13206518|NCT01957397|26234773|FG001|Test Period 3|the adhesive did not work|0|||
13206519|NCT01957215|26234808|FG000|Overall Study|Adverse Event|2|||
13206520|NCT01957215|26234809|FG001|Overall Study|Adverse Event|2|||
13206521|NCT01957215|26234808|FG000|Overall Study|Lost to Follow-up|3|||
13206522|NCT01957215|26234809|FG001|Overall Study|Lost to Follow-up|3|||
13206523|NCT01957215|26234808|FG000|Overall Study|Protocol Violation|1|||
13206524|NCT01957215|26234809|FG001|Overall Study|Protocol Violation|2|||
13206525|NCT01957215|26234808|FG000|Overall Study|Withdrawal by Subject|7|||
13206526|NCT01957215|26234809|FG001|Overall Study|Withdrawal by Subject|5|||
13206527|NCT01957202|26234850|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
13206528|NCT01957202|26234851|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
13206529|NCT01957202|26234852|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
13206530|NCT01957202|26234853|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
13206531|NCT01957202|26234854|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
13206532|NCT01957202|26234855|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
13206533|NCT01957202|26234856|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
13206534|NCT01957202|26234857|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
13206535|NCT01957202|26234858|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
13206536|NCT01957202|26234859|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
13206537|NCT01957202|26234860|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
13206538|NCT01957202|26234861|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
13206539|NCT01957202|26234862|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
13206540|NCT01957202|26234863|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
13206541|NCT01957202|26234864|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
13206542|NCT01957202|26234865|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
13206543|NCT01957202|26234866|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
13206544|NCT01957202|26234867|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
13206545|NCT01957202|26234850|FG000|Treatment Period 3 (8 Days)|Adverse Event|0|||
13206546|NCT01957202|26234851|FG001|Treatment Period 3 (8 Days)|Adverse Event|0|||
13206547|NCT01957202|26234852|FG002|Treatment Period 3 (8 Days)|Adverse Event|0|||
13198179|NCT02033759|26209412|FG000|Overall Study|Withdrawal by Subject|2|||
13198180|NCT02033759|26209413|FG001|Overall Study|Withdrawal by Subject|1|||
13198181|NCT02033759|26209412|FG000|Overall Study|Protocol Violation|1|||
13198182|NCT02033759|26209413|FG001|Overall Study|Protocol Violation|1|||
13198183|NCT02033369|26209430|FG000|Overall Study|Physician Decision|1|||
13198184|NCT02033369|26209431|FG001|Overall Study|Physician Decision|2|||
13198185|NCT02033369|26209430|FG000|Overall Study|Not a good demographic match|0|||
13198186|NCT02033369|26209431|FG001|Overall Study|Not a good demographic match|2|||
13198187|NCT02033369|26209430|FG000|Overall Study|Withdrawal by Subject|1|||
13198188|NCT02033369|26209431|FG001|Overall Study|Withdrawal by Subject|1|||
13198189|NCT02033369|26209430|FG000|Overall Study|Lost to Follow-up|1|||
13198190|NCT02033369|26209431|FG001|Overall Study|Lost to Follow-up|0|||
13198191|NCT02033369|26209430|FG000|Overall Study|Protocol Violation|2|||
13198192|NCT02033369|26209431|FG001|Overall Study|Protocol Violation|0|||
13198193|NCT02032901|26209459|FG000|Treatment Period (12 Weeks)|Pregnancy|1|||
13198194|NCT02032901|26209460|FG001|Treatment Period (12 Weeks)|Pregnancy|0|||
13198195|NCT02032901|26209459|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0|||
13198196|NCT02032901|26209460|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1|||
13198197|NCT02032888|26209499|FG000|Treatment Period|Poor compliance/noncompliance|1|||
13198198|NCT02032888|26209500|FG001|Treatment Period|Poor compliance/noncompliance|1|||
13198199|NCT02032888|26209501|FG002|Treatment Period|Poor compliance/noncompliance|0|||
13198200|NCT02032888|26209499|FG000|Treatment Period|Other|1|||
13198201|NCT02032888|26209500|FG001|Treatment Period|Other|1|||
13198202|NCT02032888|26209501|FG002|Treatment Period|Other|0|||
13198203|NCT02032888|26209499|FG000|Follow-up Period|Lost to Follow-up|1|||
13198204|NCT02032888|26209500|FG001|Follow-up Period|Lost to Follow-up|1|||
13198205|NCT02032888|26209501|FG002|Follow-up Period|Lost to Follow-up|0|||
13198206|NCT02032888|26209499|FG000|Follow-up Period|Death|1|||
13198207|NCT02032888|26209500|FG001|Follow-up Period|Death|1|||
13198208|NCT02032888|26209501|FG002|Follow-up Period|Death|0|||
13198209|NCT02032888|26209499|FG000|Follow-up Period|Other|1|||
13198210|NCT02032888|26209500|FG001|Follow-up Period|Other|0|||
13198211|NCT02032888|26209501|FG002|Follow-up Period|Other|0|||
13198212|NCT02032875|26209526|FG000|Treatment Period|Adverse Event|1|||
13198213|NCT02032875|26209527|FG001|Treatment Period|Adverse Event|0|||
13198214|NCT02032875|26209526|FG000|Treatment Period|Liver transplant, No extension needed|0|||
13198215|NCT02032875|26209527|FG001|Treatment Period|Liver transplant, No extension needed|1|||
13198216|NCT02032875|26209526|FG000|Treatment Period|Liver transplant, Treatment extension|0|||
13198217|NCT02032875|26209527|FG001|Treatment Period|Liver transplant, Treatment extension|3|||
13198218|NCT02032875|26209526|FG000|Follow-up Period|Death|0|||
13198219|NCT02032875|26209527|FG001|Follow-up Period|Death|1|||
13198220|NCT02032875|26209526|FG000|Follow-up Period|Virologic Relapse|3|||
13198221|NCT02032875|26209527|FG001|Follow-up Period|Virologic Relapse|10|||
13198222|NCT02032706|26209542|FG000|Overall Study|Did not qualify|5|||
13198223|NCT02032706|26209542|FG000|Overall Study|Protocol Violation|1|||
13198224|NCT02032407|26209555|FG000|Overall Study|Lost to Follow-up|2|||
13198225|NCT02032407|26209555|FG000|Overall Study|Pregnancy|1|||
13198226|NCT02032407|26209555|FG000|Overall Study|Other Miscellaneous Reasons|2|||
13198227|NCT02032238|26209568|FG000|Overall Study|Lost to Follow-up|2|||
13198228|NCT02032238|26209569|FG001|Overall Study|Lost to Follow-up|0|||
13198229|NCT02032173|26209584|FG000|Overall Study|Discontinuation due to sponsor decision|31|||
13198230|NCT02031679|26209601|FG000|Overall Study|Protocol Violation|0|||
13198231|NCT02031679|26209602|FG001|Overall Study|Protocol Violation|1|||
13198232|NCT02031679|26209601|FG000|Overall Study|Lack of Efficacy|0|||
13198233|NCT02031679|26209602|FG001|Overall Study|Lack of Efficacy|1|||
13198234|NCT02031640|26209662|FG000|Screening Period|Adverse Event|1|||
13198235|NCT02031640|26209663|FG001|Screening Period|Adverse Event|0|||
13198236|NCT02031640|26209664|FG002|Screening Period|Adverse Event|0|||
13198237|NCT02031640|26209665|FG003|Screening Period|Adverse Event|0|||
13198238|NCT02031640|26209666|FG004|Screening Period|Adverse Event|0|||
13198239|NCT02031640|26209667|FG005|Screening Period|Adverse Event|0|||
13198240|NCT02031640|26209662|FG000|Screening Period|Withdrawal by Subject|29|||
13198241|NCT02031640|26209663|FG001|Screening Period|Withdrawal by Subject|0|||
13198242|NCT02031640|26209664|FG002|Screening Period|Withdrawal by Subject|0|||
13198243|NCT02031640|26209665|FG003|Screening Period|Withdrawal by Subject|0|||
13198244|NCT02031640|26209666|FG004|Screening Period|Withdrawal by Subject|0|||
13198245|NCT02031640|26209667|FG005|Screening Period|Withdrawal by Subject|0|||
13198246|NCT02031640|26209662|FG000|Screening Period|Inclusion criteria not met|312|||
13198247|NCT02031640|26209663|FG001|Screening Period|Inclusion criteria not met|0|||
13198248|NCT02031640|26209664|FG002|Screening Period|Inclusion criteria not met|0|||
13198249|NCT02031640|26209665|FG003|Screening Period|Inclusion criteria not met|0|||
13198250|NCT02031640|26209666|FG004|Screening Period|Inclusion criteria not met|0|||
13198251|NCT02031640|26209667|FG005|Screening Period|Inclusion criteria not met|0|||
13198252|NCT02031640|26209662|FG000|Screening Period|Exclusion criteria met|30|||
13198253|NCT02031640|26209663|FG001|Screening Period|Exclusion criteria met|0|||
13198254|NCT02031640|26209664|FG002|Screening Period|Exclusion criteria met|0|||
13198255|NCT02031640|26209665|FG003|Screening Period|Exclusion criteria met|0|||
13198256|NCT02031640|26209666|FG004|Screening Period|Exclusion criteria met|0|||
13198257|NCT02031640|26209667|FG005|Screening Period|Exclusion criteria met|0|||
13198258|NCT02031640|26209662|FG000|Screening Period|Lost to Follow-up|14|||
13198259|NCT02031640|26209663|FG001|Screening Period|Lost to Follow-up|0|||
13198260|NCT02031640|26209664|FG002|Screening Period|Lost to Follow-up|0|||
13198261|NCT02031640|26209665|FG003|Screening Period|Lost to Follow-up|0|||
13198262|NCT02031640|26209666|FG004|Screening Period|Lost to Follow-up|0|||
13198263|NCT02031640|26209667|FG005|Screening Period|Lost to Follow-up|0|||
13198264|NCT02031640|26209662|FG000|Screening Period|Enrollment closed|26|||
13198265|NCT02031640|26209663|FG001|Screening Period|Enrollment closed|0|||
13198266|NCT02031640|26209664|FG002|Screening Period|Enrollment closed|0|||
13198267|NCT02031640|26209665|FG003|Screening Period|Enrollment closed|0|||
13198268|NCT02031640|26209666|FG004|Screening Period|Enrollment closed|0|||
13198269|NCT02031640|26209667|FG005|Screening Period|Enrollment closed|0|||
13198270|NCT02031640|26209662|FG000|Run-In Period|Adverse Event|4|||
13198271|NCT02031640|26209663|FG001|Run-In Period|Adverse Event|0|||
13198272|NCT02031640|26209664|FG002|Run-In Period|Adverse Event|0|||
13198273|NCT02031640|26209665|FG003|Run-In Period|Adverse Event|0|||
13198274|NCT02031640|26209666|FG004|Run-In Period|Adverse Event|0|||
13198275|NCT02031640|26209667|FG005|Run-In Period|Adverse Event|0|||
13198276|NCT02031640|26209662|FG000|Run-In Period|Withdrawal by Subject|17|||
13198277|NCT02031640|26209663|FG001|Run-In Period|Withdrawal by Subject|0|||
13198278|NCT02031640|26209664|FG002|Run-In Period|Withdrawal by Subject|0|||
13198279|NCT02031640|26209665|FG003|Run-In Period|Withdrawal by Subject|0|||
13198280|NCT02031640|26209666|FG004|Run-In Period|Withdrawal by Subject|0|||
13198281|NCT02031640|26209667|FG005|Run-In Period|Withdrawal by Subject|0|||
13198282|NCT02031640|26209662|FG000|Run-In Period|Inclusion criteria not met|38|||
13198283|NCT02031640|26209663|FG001|Run-In Period|Inclusion criteria not met|0|||
13198284|NCT02031640|26209664|FG002|Run-In Period|Inclusion criteria not met|0|||
13198285|NCT02031640|26209665|FG003|Run-In Period|Inclusion criteria not met|0|||
13198286|NCT02031640|26209666|FG004|Run-In Period|Inclusion criteria not met|0|||
13198287|NCT02031640|26209667|FG005|Run-In Period|Inclusion criteria not met|0|||
13198288|NCT02031640|26209662|FG000|Run-In Period|Exclusion criteria met|8|||
13198289|NCT02031640|26209663|FG001|Run-In Period|Exclusion criteria met|0|||
13198290|NCT02031640|26209664|FG002|Run-In Period|Exclusion criteria met|0|||
13198291|NCT02031640|26209665|FG003|Run-In Period|Exclusion criteria met|0|||
13198292|NCT02031640|26209666|FG004|Run-In Period|Exclusion criteria met|0|||
13198293|NCT02031640|26209667|FG005|Run-In Period|Exclusion criteria met|0|||
13198294|NCT02031640|26209662|FG000|Run-In Period|Randomization criteria not met|85|||
13198295|NCT02031640|26209663|FG001|Run-In Period|Randomization criteria not met|0|||
13198296|NCT02031640|26209664|FG002|Run-In Period|Randomization criteria not met|0|||
13198297|NCT02031640|26209665|FG003|Run-In Period|Randomization criteria not met|0|||
13198298|NCT02031640|26209666|FG004|Run-In Period|Randomization criteria not met|0|||
13198299|NCT02031640|26209667|FG005|Run-In Period|Randomization criteria not met|0|||
13198300|NCT02031640|26209662|FG000|Run-In Period|Various administrative reasons|17|||
13198301|NCT02031640|26209663|FG001|Run-In Period|Various administrative reasons|0|||
13198302|NCT02031640|26209664|FG002|Run-In Period|Various administrative reasons|0|||
13198303|NCT02031640|26209665|FG003|Run-In Period|Various administrative reasons|0|||
13198304|NCT02031640|26209666|FG004|Run-In Period|Various administrative reasons|0|||
13198305|NCT02031640|26209667|FG005|Run-In Period|Various administrative reasons|0|||
13198306|NCT02031640|26209662|FG000|Double-blind Treatment Period|Protocol deviation|0|||
13198307|NCT02031640|26209663|FG001|Double-blind Treatment Period|Protocol deviation|2|||
13198308|NCT02031640|26209664|FG002|Double-blind Treatment Period|Protocol deviation|0|||
13198309|NCT02031640|26209665|FG003|Double-blind Treatment Period|Protocol deviation|1|||
13198310|NCT02031640|26209666|FG004|Double-blind Treatment Period|Protocol deviation|3|||
13198311|NCT02031640|26209667|FG005|Double-blind Treatment Period|Protocol deviation|1|||
13198312|NCT02031640|26209662|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
13198313|NCT02031640|26209663|FG001|Double-blind Treatment Period|Lack of Efficacy|14|||
13198314|NCT02031640|26209664|FG002|Double-blind Treatment Period|Lack of Efficacy|3|||
13198315|NCT02031640|26209665|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
13198316|NCT02031640|26209666|FG004|Double-blind Treatment Period|Lack of Efficacy|5|||
13198317|NCT02031640|26209667|FG005|Double-blind Treatment Period|Lack of Efficacy|1|||
13198318|NCT02031640|26209662|FG000|Double-blind Treatment Period|Non-compliance|0|||
13198319|NCT02031640|26209663|FG001|Double-blind Treatment Period|Non-compliance|1|||
13198320|NCT02031640|26209664|FG002|Double-blind Treatment Period|Non-compliance|0|||
13198321|NCT02031640|26209665|FG003|Double-blind Treatment Period|Non-compliance|1|||
13198322|NCT02031640|26209666|FG004|Double-blind Treatment Period|Non-compliance|1|||
13198323|NCT02031640|26209667|FG005|Double-blind Treatment Period|Non-compliance|0|||
13198324|NCT02031640|26209662|FG000|Double-blind Treatment Period|Adverse Event|0|||
13198325|NCT02031640|26209663|FG001|Double-blind Treatment Period|Adverse Event|0|||
13198326|NCT02031640|26209664|FG002|Double-blind Treatment Period|Adverse Event|0|||
13198327|NCT02031640|26209665|FG003|Double-blind Treatment Period|Adverse Event|2|||
13198328|NCT02031640|26209666|FG004|Double-blind Treatment Period|Adverse Event|0|||
13198329|NCT02031640|26209667|FG005|Double-blind Treatment Period|Adverse Event|0|||
13198330|NCT02031640|26209662|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
13198331|NCT02031640|26209663|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
13198332|NCT02031640|26209664|FG002|Double-blind Treatment Period|Withdrawal by Subject|3|||
13198333|NCT02031640|26209665|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
13198334|NCT02031640|26209666|FG004|Double-blind Treatment Period|Withdrawal by Subject|1|||
13198335|NCT02031640|26209667|FG005|Double-blind Treatment Period|Withdrawal by Subject|1|||
13198336|NCT02031640|26209662|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
13198337|NCT02031640|26209663|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
13198338|NCT02031640|26209664|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
13198339|NCT02031640|26209665|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
13198340|NCT02031640|26209666|FG004|Double-blind Treatment Period|Lost to Follow-up|1|||
13198341|NCT02031640|26209667|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
13198342|NCT02031536|26209682|FG000|Overall Study|ineligible|1|||
13198343|NCT02031536|26209683|FG001|Overall Study|ineligible|0|||
13198344|NCT02031471|26209715|FG000|24 Week Treatment Period|Adverse Event|6|||
13198345|NCT02031471|26209715|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2|||
13198346|NCT02031471|26209715|FG000|24 Week Treatment Period|Protocol Violation|1|||
13198347|NCT02031471|26209715|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1|||
13198348|NCT02031471|26209715|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1|||
13198349|NCT02031471|26209715|FG000|Long Term Extension (LTE) Period|Adverse Event|1|||
13198350|NCT02031471|26209715|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1|||
13198351|NCT02031458|26209819|FG000|May 8, 2015 to January 11, 2019|Death|89|||
13198352|NCT02031458|26209820|FG001|May 8, 2015 to January 11, 2019|Death|193|||
13198353|NCT02031458|26209821|FG002|May 8, 2015 to January 11, 2019|Death|198|||
13198354|NCT02031458|26209819|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2|||
13198355|NCT02031458|26209820|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5|||
13198356|NCT02031458|26209821|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8|||
13198357|NCT02031458|26209819|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1|||
13198358|NCT02031458|26209820|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
13198359|NCT02031458|26209821|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
13198360|NCT02031458|26209819|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2|||
13198361|NCT02031458|26209820|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3|||
13198362|NCT02031458|26209821|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3|||
13198363|NCT02031458|26209819|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7|||
13198364|NCT02031458|26209820|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4|||
13198365|NCT02031458|26209821|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0|||
13198366|NCT02031458|26209819|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24|||
13198367|NCT02031458|26209820|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42|||
13198368|NCT02031458|26209821|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23|||
13198369|NCT02031458|26209819|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13|||
13198370|NCT02031458|26209820|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16|||
13198371|NCT02031458|26209821|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14|||
13198372|NCT02031458|26209819|FG000|Baseline to May 8, 2015|Death|36|||
13198373|NCT02031458|26209820|FG001|Baseline to May 8, 2015|Death|87|||
13198374|NCT02031458|26209821|FG002|Baseline to May 8, 2015|Death|100|||
13198375|NCT02031458|26209819|FG000|Baseline to May 8, 2015|Protocol Violation|7|||
13198376|NCT02031458|26209820|FG001|Baseline to May 8, 2015|Protocol Violation|4|||
13198377|NCT02031458|26209821|FG002|Baseline to May 8, 2015|Protocol Violation|0|||
13198378|NCT02031458|26209819|FG000|Baseline to May 8, 2015|Physician Decision|0|||
13198379|NCT02031458|26209820|FG001|Baseline to May 8, 2015|Physician Decision|1|||
13198380|NCT02031458|26209821|FG002|Baseline to May 8, 2015|Physician Decision|0|||
13198381|NCT02031458|26209819|FG000|Baseline to May 8, 2015|Unknown Reason|0|||
13198382|NCT02031458|26209820|FG001|Baseline to May 8, 2015|Unknown Reason|1|||
13198383|NCT02031458|26209821|FG002|Baseline to May 8, 2015|Unknown Reason|2|||
13198384|NCT02031458|26209819|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6|||
13198385|NCT02031458|26209820|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9|||
13198386|NCT02031458|26209821|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3|||
13198387|NCT02031458|26209819|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46|||
13198388|NCT02031458|26209820|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83|||
13198389|NCT02031458|26209821|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73|||
13133291|NCT02775903|25987166|FG000|Overall Study|Other-Miscellaneous|4|||
13133292|NCT02775903|25987167|FG001|Overall Study|Other-Miscellaneous|3|||
13133293|NCT02775903|25987168|FG002|Overall Study|Other-Miscellaneous|4|||
13133294|NCT02775903|25987169|FG003|Overall Study|Other-Miscellaneous|5|||
13133295|NCT02775864|25987200|FG000|Overall Study|Data ended end of 2010|1764|||
13133296|NCT02775864|25987201|FG001|Overall Study|Data ended end of 2010|2880|||
13133297|NCT02775864|25987202|FG002|Overall Study|Data ended end of 2010|1140|||
13133298|NCT02775864|25987203|FG003|Overall Study|Data ended end of 2010|1194|||
13198390|NCT02031458|26209819|FG000|Baseline to May 8, 2015|On Treatment|43|||
13198391|NCT02031458|26209820|FG001|Baseline to May 8, 2015|On Treatment|81|||
13198392|NCT02031458|26209821|FG002|Baseline to May 8, 2015|On Treatment|73|||
13198393|NCT02031458|26209819|FG000|Baseline to May 8, 2015|Lost to Follow-up|1|||
13198394|NCT02031458|26209820|FG001|Baseline to May 8, 2015|Lost to Follow-up|1|||
13198395|NCT02031458|26209821|FG002|Baseline to May 8, 2015|Lost to Follow-up|2|||
13198396|NCT02031432|26209848|FG000|Overall Study|Protocol Violation|1|||
13198397|NCT02031432|26209848|FG000|Overall Study|Lack of Efficacy|5|||
13198398|NCT02031432|26209848|FG000|Overall Study|Cancer Progression|2|||
13198399|NCT02031432|26209848|FG000|Overall Study|Withdrawn as forbidden meds required|1|||
13198400|NCT02031432|26209848|FG000|Overall Study|Adverse Event|8|||
13198401|NCT02031432|26209848|FG000|Overall Study|Withdrawal by Subject|5|||
13198402|NCT02031432|26209848|FG000|Overall Study|Lost to Follow-up|1|||
13198403|NCT02031432|26209848|FG000|Overall Study|Inclusion/Exclusion criteria not met|5|||
13198404|NCT02031432|26209848|FG000|Overall Study|Death|10|||
13198405|NCT02031302|26209873|FG000|Overall Study|Death|115|||
13198406|NCT02031302|26209874|FG001|Overall Study|Death|0|||
13198407|NCT02031302|26209873|FG000|Overall Study|Not treated with study valve system|18|||
13198408|NCT02031302|26209874|FG001|Overall Study|Not treated with study valve system|0|||
13198409|NCT02031302|26209873|FG000|Overall Study|Missed Follow Up|27|||
13198410|NCT02031302|26209874|FG001|Overall Study|Missed Follow Up|0|||
13198411|NCT02031302|26209873|FG000|Overall Study|Lost to Follow-up|4|||
13198412|NCT02031302|26209874|FG001|Overall Study|Lost to Follow-up|0|||
13198413|NCT02031276|26209916|FG000|Period 1 Double-blind IV|Adverse Event|6|||
13198414|NCT02031276|26209917|FG001|Period 1 Double-blind IV|Adverse Event|5|||
13198415|NCT02031276|26209918|FG002|Period 1 Double-blind IV|Adverse Event|1|||
13198416|NCT02031276|26209916|FG000|Period 1 Double-blind IV|Other|0|||
13198417|NCT02031276|26209917|FG001|Period 1 Double-blind IV|Other|1|||
13198418|NCT02031276|26209918|FG002|Period 1 Double-blind IV|Other|0|||
13198419|NCT02031276|26209916|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1|||
13198420|NCT02031276|26209917|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
13198421|NCT02031276|26209918|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
13198422|NCT02031276|26209916|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3|||
13198423|NCT02031276|26209917|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
13198424|NCT02031276|26209918|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
13198425|NCT02031276|26209916|FG000|Period 2 Open-label Risankizumab IV|Other|0|||
13198426|NCT02031276|26209917|FG001|Period 2 Open-label Risankizumab IV|Other|2|||
13112558|NCT03156543|25908502|FG001|Overall Study|Withdrawal by Subject|0|||
13112559|NCT03156504|25908509|FG000|Overall Study|Withdrawal by Subject|1|||
13112560|NCT03156270|25908518|FG000|Overall Study|Failed pre-treatment screening|1|||
13112561|NCT03156270|25908518|FG000|Overall Study|Lost to Follow-up|1|||
13112562|NCT03155945|25908531|FG000|Overall Study|Lost to Follow-up|0|||
13112563|NCT03155945|25908532|FG001|Overall Study|Lost to Follow-up|1|||
13112564|NCT03155945|25908531|FG000|Overall Study|Withdrawal by Subject|0|||
13112565|NCT03155945|25908532|FG001|Overall Study|Withdrawal by Subject|1|||
13112566|NCT03155945|25908531|FG000|Overall Study|Other Reason|0|||
13112567|NCT03155945|25908532|FG001|Overall Study|Other Reason|1|||
13112568|NCT03155724|25908541|FG000|Overall Study|Death|3|||
13112569|NCT03155724|25908541|FG000|Overall Study|Physician Decision|1|||
13112570|NCT03155724|25908541|FG000|Overall Study|Study closure|7|||
13112571|NCT03155269|25908590|FG000|Overall Study|Withdrawal by Subject|4|||
13112572|NCT03155269|25908591|FG001|Overall Study|Withdrawal by Subject|5|||
13112573|NCT03155269|25908590|FG000|Overall Study|Lost to Follow-up|1|||
13112574|NCT03155269|25908591|FG001|Overall Study|Lost to Follow-up|2|||
13112575|NCT03155178|25908622|FG000|Overall Study|Did not meet treatment day baseline|7|||
13112576|NCT03155178|25908623|FG001|Overall Study|Did not meet treatment day baseline|7|||
13112577|NCT03155178|25908624|FG002|Overall Study|Did not meet treatment day baseline|7|||
13112578|NCT03155178|25908625|FG003|Overall Study|Did not meet treatment day baseline|7|||
13112579|NCT03154476|25908638|FG000|Overall Study|Lost to Follow-up|4|||
13112580|NCT03154476|25908639|FG001|Overall Study|Lost to Follow-up|4|||
13112581|NCT03154086|25909085|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
13112582|NCT03154086|25909086|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
13112583|NCT03154086|25909087|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
13112584|NCT03154086|25909088|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1|||
13112585|NCT03154086|25909089|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
13112586|NCT03154086|25909090|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
13112587|NCT03154086|25909091|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
13112588|NCT03154086|25909092|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
13112589|NCT03154086|25909093|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
13112590|NCT03154086|25909094|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
13112591|NCT03154086|25909095|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
13112592|NCT03154086|25909096|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
13198427|NCT02031276|26209918|FG002|Period 2 Open-label Risankizumab IV|Other|1|||
13112593|NCT03154086|25909097|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
13112594|NCT03154086|25909098|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
13112595|NCT03154086|25909099|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
13112596|NCT03154086|25909085|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
13112597|NCT03154086|25909086|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1|||
13112598|NCT03154086|25909087|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
13112599|NCT03154086|25909088|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
13112600|NCT03154086|25909089|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
13112601|NCT03154086|25909090|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
13198428|NCT02031276|26209916|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
13198429|NCT02031276|26209917|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2|||
13198430|NCT02031276|26209918|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
13198431|NCT02031276|26209916|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2|||
13198432|NCT02031276|26209917|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
13198433|NCT02031276|26209918|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
13198434|NCT02031276|26209916|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
13198435|NCT02031276|26209917|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
13198436|NCT02031276|26209918|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
13198437|NCT02031276|26209916|FG000|Period 3 Open-label Risankizumab SC|Other|0|||
13198438|NCT02031276|26209917|FG001|Period 3 Open-label Risankizumab SC|Other|0|||
13198439|NCT02031276|26209918|FG002|Period 3 Open-label Risankizumab SC|Other|1|||
13198440|NCT02031237|26209933|FG000|Overall Study|Death|1|||
13198441|NCT02031237|26209934|FG001|Overall Study|Death|5|||
13198442|NCT02031237|26209935|FG002|Overall Study|Death|0|||
13198443|NCT02031237|26209933|FG000|Overall Study|Physician Decision|0|||
13198444|NCT02031237|26209934|FG001|Overall Study|Physician Decision|1|||
13198445|NCT02031237|26209935|FG002|Overall Study|Physician Decision|0|||
13198446|NCT02031237|26209933|FG000|Overall Study|Withdrawal by Subject|2|||
13198447|NCT02031237|26209934|FG001|Overall Study|Withdrawal by Subject|2|||
13198448|NCT02031237|26209935|FG002|Overall Study|Withdrawal by Subject|0|||
13198449|NCT02031237|26209933|FG000|Overall Study|Protocol Violation|2|||
13198450|NCT02031237|26209934|FG001|Overall Study|Protocol Violation|6|||
13198451|NCT02031237|26209935|FG002|Overall Study|Protocol Violation|0|||
13198452|NCT02031237|26209933|FG000|Overall Study|Alternate Treatment Given|0|||
13198453|NCT02031237|26209934|FG001|Overall Study|Alternate Treatment Given|0|||
13198454|NCT02031237|26209935|FG002|Overall Study|Alternate Treatment Given|3|||
13198455|NCT02031146|26209957|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
13198456|NCT02031146|26209958|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
13198457|NCT02031146|26209959|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
13198458|NCT02031146|26209960|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100|||
13198459|NCT02031146|26209961|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26|||
13198460|NCT02031146|26209962|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4|||
13198461|NCT02031146|26209963|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5|||
13198462|NCT02030847|26209970|FG000|Overall Study|Death|10|||
13198463|NCT02030847|26209970|FG000|Overall Study|Disease Progression|15|||
13198464|NCT02030847|26209970|FG000|Overall Study|New Cancer Therapy|8|||
13198465|NCT02030847|26209970|FG000|Overall Study|Physician Decision|3|||
13198466|NCT02030847|26209970|FG000|Overall Study|Withdrawal by Subject|1|||
13198467|NCT02030834|26209988|FG000|Overall Study|Death|4|||
13198468|NCT02030834|26209989|FG001|Overall Study|Death|0|||
13198469|NCT02030834|26209990|FG002|Overall Study|Death|0|||
13198470|NCT02030834|26209988|FG000|Overall Study|Manufacturing failure|2|||
13198471|NCT02030834|26209989|FG001|Overall Study|Manufacturing failure|0|||
13198472|NCT02030834|26209990|FG002|Overall Study|Manufacturing failure|1|||
13198473|NCT02030834|26209988|FG000|Overall Study|Disease progression|2|||
13198474|NCT02030834|26209989|FG001|Overall Study|Disease progression|0|||
13198475|NCT02030834|26209990|FG002|Overall Study|Disease progression|2|||
13198476|NCT02030834|26209988|FG000|Overall Study|Lost to Follow-up|1|||
13198477|NCT02030834|26209989|FG001|Overall Study|Lost to Follow-up|0|||
13198478|NCT02030834|26209990|FG002|Overall Study|Lost to Follow-up|0|||
13198479|NCT02030834|26209988|FG000|Overall Study|Withdrawal by Subject|1|||
13198480|NCT02030834|26209989|FG001|Overall Study|Withdrawal by Subject|0|||
13198481|NCT02030834|26209990|FG002|Overall Study|Withdrawal by Subject|0|||
13198482|NCT02030834|26209988|FG000|Overall Study|Lack of funding|1|||
13198483|NCT02030834|26209989|FG001|Overall Study|Lack of funding|0|||
13198484|NCT02030834|26209990|FG002|Overall Study|Lack of funding|0|||
13198485|NCT02030821|26210029|FG000|Overall Study|Physician Decision|2|||
13198486|NCT02030821|26210030|FG001|Overall Study|Physician Decision|2|||
13198487|NCT02030821|26210031|FG002|Overall Study|Physician Decision|5|||
13198488|NCT02030821|26210032|FG003|Overall Study|Physician Decision|2|||
13198489|NCT02030600|26210055|FG000|Treatment Period 1|Adverse Event|5|||
13198490|NCT02030600|26210056|FG001|Treatment Period 1|Adverse Event|7|||
13198491|NCT02030600|26210055|FG000|Treatment Period 1|Lack of Efficacy|0|||
13198492|NCT02030600|26210056|FG001|Treatment Period 1|Lack of Efficacy|1|||
13198493|NCT02030600|26210055|FG000|Treatment Period 1|Lost to Follow-up|11|||
13198494|NCT02030600|26210056|FG001|Treatment Period 1|Lost to Follow-up|3|||
13198495|NCT02030600|26210055|FG000|Treatment Period 1|Protocol Violation|22|||
13198496|NCT02030600|26210056|FG001|Treatment Period 1|Protocol Violation|17|||
13198497|NCT02030600|26210055|FG000|Treatment Period 1|Withdrawal by Subject|13|||
13198498|NCT02030600|26210056|FG001|Treatment Period 1|Withdrawal by Subject|17|||
13198499|NCT02030600|26210055|FG000|Treatment Period 1|Casebook Unsigned|1|||
13198500|NCT02030600|26210056|FG001|Treatment Period 1|Casebook Unsigned|0|||
13198501|NCT02030600|26210055|FG000|Treatment Period 1|Unclassified|1|||
13198502|NCT02030600|26210056|FG001|Treatment Period 1|Unclassified|0|||
13198503|NCT02030600|26210055|FG000|Treatment Period 2|Adverse Event|4|||
13198504|NCT02030600|26210056|FG001|Treatment Period 2|Adverse Event|4|||
13198505|NCT02030600|26210055|FG000|Treatment Period 2|Lack of Efficacy|2|||
13198506|NCT02030600|26210056|FG001|Treatment Period 2|Lack of Efficacy|1|||
13198507|NCT02030600|26210055|FG000|Treatment Period 2|Lost to Follow-up|4|||
13198508|NCT02030600|26210056|FG001|Treatment Period 2|Lost to Follow-up|2|||
13198509|NCT02030600|26210055|FG000|Treatment Period 2|Protocol Violation|1|||
13198510|NCT02030600|26210056|FG001|Treatment Period 2|Protocol Violation|2|||
13198511|NCT02030600|26210055|FG000|Treatment Period 2|Withdrawal by Subject|13|||
13198512|NCT02030600|26210056|FG001|Treatment Period 2|Withdrawal by Subject|9|||
13198513|NCT02030600|26210055|FG000|Treatment Period 2|Unclassified|1|||
13198514|NCT02030600|26210056|FG001|Treatment Period 2|Unclassified|0|||
13198515|NCT02030535|26210126|FG000|Washout Period 1 (21 Days)|Adverse Event|1|||
13198516|NCT02030405|26210135|FG000|Overall Study|Withdrawal by Subject|1|||
13198517|NCT02030405|26210135|FG000|Overall Study|Lost to Follow-up|1|||
13198518|NCT02030119|26210162|FG000|Overall Study|Withdrawal by Subject|3|||
13198519|NCT02030119|26210163|FG001|Overall Study|Withdrawal by Subject|1|||
13198520|NCT02030119|26210164|FG002|Overall Study|Withdrawal by Subject|5|||
13198521|NCT02030119|26210165|FG003|Overall Study|Withdrawal by Subject|3|||
13198522|NCT02030119|26210162|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0|||
13198523|NCT02030119|26210163|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1|||
13198524|NCT02030119|26210164|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1|||
13198525|NCT02030119|26210165|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0|||
13198526|NCT02030041|26210186|FG000|Overall Study|Withdrawal by Subject|2|||
13198527|NCT02030041|26210187|FG001|Overall Study|Withdrawal by Subject|2|||
13198528|NCT02030041|26210188|FG002|Overall Study|Withdrawal by Subject|1|||
13198529|NCT02030015|26210195|FG000|Overall Study|Withdrawal by Subject|3|||
13198530|NCT02030015|26210195|FG000|Overall Study|Death|13|||
13198531|NCT02030002|26210209|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1|||
13198532|NCT02030002|26210209|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4|||
13198533|NCT02030002|26210209|FG000|Follow-up|Lost to Follow-up|2|||
13198534|NCT02029989|26210222|FG000|Overall Study|Withdrawal by Subject|1|||
13198535|NCT02029989|26210223|FG001|Overall Study|Withdrawal by Subject|0|||
13198536|NCT02029989|26210222|FG000|Overall Study|Withdrawal: Fear of needles|1|||
13198537|NCT02029989|26210223|FG001|Overall Study|Withdrawal: Fear of needles|0|||
13198538|NCT02029989|26210222|FG000|Overall Study|Change of location|2|||
13198539|NCT02029989|26210223|FG001|Overall Study|Change of location|3|||
13198540|NCT02029989|26210222|FG000|Overall Study|Physician Decision|2|||
13198541|NCT02029989|26210223|FG001|Overall Study|Physician Decision|0|||
13198542|NCT02029989|26210222|FG000|Overall Study|Lost to Follow-up|9|||
13198543|NCT02029989|26210223|FG001|Overall Study|Lost to Follow-up|7|||
13198544|NCT02029989|26210222|FG000|Overall Study|Death|0|||
13198545|NCT02029989|26210223|FG001|Overall Study|Death|1|||
13198546|NCT02029989|26210222|FG000|Overall Study|Protocol Violation|1|||
13198547|NCT02029989|26210223|FG001|Overall Study|Protocol Violation|0|||
13198548|NCT02029976|26210242|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12|||
13198549|NCT02029976|26210243|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8|||
13198550|NCT02029976|26210242|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8|||
13198551|NCT02029976|26210243|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4|||
13198552|NCT02029976|26210242|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
13198553|NCT02029976|26210243|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
13198554|NCT02029976|26210242|FG000|YR-2 Follow Up vs Baseline|Moved from area|0|||
13198555|NCT02029976|26210243|FG001|YR-2 Follow Up vs Baseline|Moved from area|2|||
13198556|NCT02029846|26210260|FG000|Overall Study|n=1 each arm|1|||
13198557|NCT02029846|26210261|FG001|Overall Study|n=1 each arm|1|||
13112602|NCT03154086|25909091|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
13112603|NCT03154086|25909092|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
13112604|NCT03154086|25909093|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
13112605|NCT03154086|25909094|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
13112606|NCT03154086|25909095|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
13112607|NCT03154086|25909096|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
13112608|NCT03154086|25909097|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
13198558|NCT02029638|26210298|FG000|Overall Study|Death|0|||
13112609|NCT03154086|25909098|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
13112610|NCT03154086|25909099|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
13112611|NCT03154086|25909085|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
13112612|NCT03154086|25909086|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
13112613|NCT03154086|25909087|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1|||
13112614|NCT03154086|25909088|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
13112615|NCT03154086|25909089|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
13112616|NCT03154086|25909090|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
13112617|NCT03154086|25909091|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
13198559|NCT02029638|26210299|FG001|Overall Study|Death|0|||
13198560|NCT02029638|26210300|FG002|Overall Study|Death|1|||
13198561|NCT02029638|26210298|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2|||
13198562|NCT02029638|26210299|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0|||
13198563|NCT02029638|26210300|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0|||
13198564|NCT02029521|26210389|FG000|Overall Study|Protocol Violation|1|||
13198565|NCT02029521|26210390|FG001|Overall Study|Protocol Violation|0|||
13198566|NCT02029521|26210389|FG000|Overall Study|Withdrawal by Subject|1|||
13198567|NCT02029521|26210390|FG001|Overall Study|Withdrawal by Subject|1|||
13198568|NCT02029417|26210397|FG000|Overall Study|Death|1|||
13198569|NCT02029417|26210397|FG000|Overall Study|Adverse Event|1|||
13198570|NCT02029274|26210440|FG000|Overall Study|Adverse Event|1|||
13198571|NCT02029274|26210441|FG001|Overall Study|Adverse Event|0|||
13198572|NCT02029274|26210442|FG002|Overall Study|Adverse Event|2|||
13198573|NCT02029274|26210443|FG003|Overall Study|Adverse Event|2|||
13198574|NCT02029235|26210458|FG000|Overall Study|Non-compliance with study meds or diary|4|||
13198575|NCT02029235|26210459|FG001|Overall Study|Non-compliance with study meds or diary|1|||
13198576|NCT02028884|26210534|FG000|Double-blind Period|Adverse Event|5|||
13198577|NCT02028884|26210535|FG001|Double-blind Period|Adverse Event|3|||
13198578|NCT02028884|26210534|FG000|Double-blind Period|Eligibility Violation|1|||
13112618|NCT03154086|25909092|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
13112619|NCT03154086|25909093|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
13112620|NCT03154086|25909094|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
13112621|NCT03154086|25909095|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
13112622|NCT03154086|25909096|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
13112623|NCT03154086|25909097|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
13112624|NCT03154086|25909098|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
13112625|NCT03154086|25909099|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
13112626|NCT03154086|25909085|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1|||
13112627|NCT03154086|25909086|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
13112628|NCT03154086|25909087|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
13112629|NCT03154086|25909088|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
13112630|NCT03154086|25909089|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
13198579|NCT02028884|26210535|FG001|Double-blind Period|Eligibility Violation|0|||
13198580|NCT02028884|26210534|FG000|Double-blind Period|Non-Compliance With Study Drug|2|||
13198581|NCT02028884|26210535|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
13198582|NCT02028884|26210534|FG000|Double-blind Period|Withdrawal by Subject|2|||
13198583|NCT02028884|26210535|FG001|Double-blind Period|Withdrawal by Subject|0|||
13198584|NCT02028884|26210534|FG000|Double-blind Period|On-going in Study|8|||
13198585|NCT02028884|26210535|FG001|Double-blind Period|On-going in Study|20|||
13198586|NCT02028884|26210534|FG000|Open-label Extension Period|Adverse Event|2|||
13198587|NCT02028884|26210535|FG001|Open-label Extension Period|Adverse Event|1|||
13198588|NCT02028884|26210534|FG000|Open-label Extension Period|Lack of Efficacy|3|||
13198589|NCT02028884|26210535|FG001|Open-label Extension Period|Lack of Efficacy|0|||
13198590|NCT02028884|26210534|FG000|Open-label Extension Period|Non-Compliance With Study Drug|0|||
13198591|NCT02028884|26210535|FG001|Open-label Extension Period|Non-Compliance With Study Drug|1|||
13112631|NCT03154086|25909090|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
13112632|NCT03154086|25909091|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
13112633|NCT03154086|25909092|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
13112634|NCT03154086|25909093|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
13112635|NCT03154086|25909094|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
13112636|NCT03154086|25909095|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
13112637|NCT03154086|25909096|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
13112638|NCT03154086|25909097|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
13198592|NCT02028884|26210534|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
13198593|NCT02028884|26210535|FG001|Open-label Extension Period|Withdrawal by Subject|2|||
13198594|NCT02028884|26210534|FG000|Open-label Extension Period|On-going in Study|19|||
13198595|NCT02028884|26210535|FG001|Open-label Extension Period|On-going in Study|14|||
13198596|NCT02028871|26210551|FG000|Overall Study|Positive urine drug screen|1|||
13198597|NCT02028871|26210552|FG001|Overall Study|Positive urine drug screen|1|||
13198598|NCT02028871|26210551|FG000|Overall Study|Withdrawal by Subject|1|||
13198599|NCT02028871|26210552|FG001|Overall Study|Withdrawal by Subject|2|||
13198600|NCT02028871|26210551|FG000|Overall Study|IV placement difficulty|1|||
13198601|NCT02028871|26210552|FG001|Overall Study|IV placement difficulty|0|||
13198602|NCT02028871|26210551|FG000|Overall Study|Current Illness|1|||
13198603|NCT02028871|26210552|FG001|Overall Study|Current Illness|0|||
13198604|NCT02028767|26210565|FG000|Treatment Period 2|Non compliant with protocol|1|||
13198605|NCT02028767|26210566|FG001|Treatment Period 2|Non compliant with protocol|0|||
13198606|NCT02028767|26210565|FG000|Treatment Period 2|Reason other than those specified above|1|||
13198607|NCT02028767|26210566|FG001|Treatment Period 2|Reason other than those specified above|0|||
13198608|NCT02028715|26210591|FG000|Overall Study|Adverse Event|2|||
13198609|NCT02028715|26210592|FG001|Overall Study|Adverse Event|2|||
13198610|NCT02028715|26210591|FG000|Overall Study|Physician Decision|1|||
13198611|NCT02028715|26210592|FG001|Overall Study|Physician Decision|0|||
13198612|NCT02028715|26210591|FG000|Overall Study|Did not complete satisfaction surveys|2|||
13198613|NCT02028715|26210592|FG001|Overall Study|Did not complete satisfaction surveys|2|||
13198614|NCT02028338|26210611|FG000|Overall Study|Withdrawal by Subject|3|||
13198615|NCT02028338|26210612|FG001|Overall Study|Withdrawal by Subject|1|||
13198616|NCT02028338|26210611|FG000|Overall Study|Unable to contact participant|1|||
13198617|NCT02028338|26210612|FG001|Overall Study|Unable to contact participant|0|||
13198618|NCT02028182|26210620|FG000|Overall Study|Protocol Violation|2|||
13198619|NCT02028169|26210645|FG000|Overall Study|Lost to Follow-up|21|||
13198620|NCT02028169|26210645|FG000|Overall Study|Lack of Efficacy|2|||
13198621|NCT02028169|26210645|FG000|Overall Study|Withdrawal by Subject|2|||
13198622|NCT02028169|26210645|FG000|Overall Study|Adverse Event|1|||
13198623|NCT02028169|26210645|FG000|Overall Study|Cessation of Drug|1|||
13198624|NCT02028169|26210645|FG000|Overall Study|Concomitant Medication Usage|1|||
13198625|NCT02028065|26210666|FG000|Randomization Through Start Treatment|Not treated|1|||
13198626|NCT02028065|26210667|FG001|Randomization Through Start Treatment|Not treated|3|||
13198627|NCT02028065|26210668|FG002|Randomization Through Start Treatment|Not treated|3|||
13198628|NCT02028065|26210666|FG000|Treatment Through Study Completion|Lost to Follow-up|2|||
13198629|NCT02028065|26210667|FG001|Treatment Through Study Completion|Lost to Follow-up|4|||
13198630|NCT02028065|26210668|FG002|Treatment Through Study Completion|Lost to Follow-up|6|||
13198631|NCT02028065|26210666|FG000|Treatment Through Study Completion|Physician Decision|1|||
13198632|NCT02028065|26210667|FG001|Treatment Through Study Completion|Physician Decision|0|||
13198633|NCT02028065|26210668|FG002|Treatment Through Study Completion|Physician Decision|0|||
13198634|NCT02028065|26210666|FG000|Treatment Through Study Completion|Protocol Violation|1|||
13198635|NCT02028065|26210667|FG001|Treatment Through Study Completion|Protocol Violation|4|||
13198636|NCT02028065|26210668|FG002|Treatment Through Study Completion|Protocol Violation|0|||
13198637|NCT02028065|26210666|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
13198638|NCT02028065|26210667|FG001|Treatment Through Study Completion|Withdrawal by Subject|4|||
13198639|NCT02028065|26210668|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
13198640|NCT02028065|26210666|FG000|Treatment Through Study Completion|Adverse Event|3|||
13198641|NCT02028065|26210667|FG001|Treatment Through Study Completion|Adverse Event|3|||
13198642|NCT02028065|26210668|FG002|Treatment Through Study Completion|Adverse Event|5|||
13198643|NCT02027844|26210695|FG000|Overall Study|Withdrawal by Subject|3|||
13198644|NCT02027844|26210696|FG001|Overall Study|Withdrawal by Subject|2|||
13198645|NCT02027844|26210697|FG002|Overall Study|Withdrawal by Subject|1|||
13198646|NCT02027844|26210695|FG000|Overall Study|Lost to Follow-up|0|||
13198647|NCT02027844|26210696|FG001|Overall Study|Lost to Follow-up|2|||
13198648|NCT02027844|26210697|FG002|Overall Study|Lost to Follow-up|1|||
13198649|NCT02027844|26210695|FG000|Overall Study|Protocol Violation|0|||
13198650|NCT02027844|26210696|FG001|Overall Study|Protocol Violation|2|||
13198651|NCT02027844|26210697|FG002|Overall Study|Protocol Violation|0|||
13198652|NCT02027844|26210695|FG000|Overall Study|Incomlete data|2|||
13198653|NCT02027844|26210696|FG001|Overall Study|Incomlete data|0|||
13198654|NCT02027844|26210697|FG002|Overall Study|Incomlete data|0|||
13198655|NCT02027701|26210715|FG000|Overall Study|Adverse Event|3|||
13198656|NCT02027701|26210715|FG000|Overall Study|Lack of Efficacy|8|||
13198657|NCT02027701|26210715|FG000|Overall Study|Physician Decision|2|||
13198658|NCT02027701|26210715|FG000|Overall Study|Withdrawal by Subject|3|||
13198659|NCT02027623|26210816|FG000|Overall Study|Lost to Follow-up|3|||
13198660|NCT02027623|26210817|FG001|Overall Study|Lost to Follow-up|3|||
13223192|NCT01799889|26287992|FG004|Overall Study|Withdrawal by Subject|5|||
13198661|NCT02027623|26210816|FG000|Overall Study|Withdrawal by Subject|6|||
13198662|NCT02027623|26210817|FG001|Overall Study|Withdrawal by Subject|9|||
13198663|NCT02027558|26210840|FG000|Overall Study|Death|0|||
13198664|NCT02027558|26210841|FG001|Overall Study|Death|1|||
13198665|NCT02027558|26210840|FG000|Overall Study|Withdrawal by Subject|2|||
13198666|NCT02027558|26210841|FG001|Overall Study|Withdrawal by Subject|0|||
13198667|NCT02027558|26210840|FG000|Overall Study|Lost to Follow-up|4|||
13198668|NCT02027558|26210841|FG001|Overall Study|Lost to Follow-up|1|||
13198669|NCT02027558|26210840|FG000|Overall Study|Refused assessment|3|||
13198670|NCT02027558|26210841|FG001|Overall Study|Refused assessment|0|||
13198671|NCT02027545|26210858|FG000|Overall Study|Failed to sign HIPAA|0|||
13198672|NCT02027545|26210859|FG001|Overall Study|Failed to sign HIPAA|2|||
13198673|NCT02027545|26210858|FG000|Overall Study|Failed to attend study visit|2|||
13198674|NCT02027545|26210859|FG001|Overall Study|Failed to attend study visit|0|||
13198675|NCT02027428|26210903|FG000|Induction|Never treated|7|||
13198676|NCT02027428|26210904|FG001|Induction|Never treated|0|||
13198677|NCT02027428|26210905|FG002|Induction|Never treated|0|||
13198678|NCT02027428|26210903|FG000|Induction|Progressive disease|77|||
13198679|NCT02027428|26210904|FG001|Induction|Progressive disease|0|||
13198680|NCT02027428|26210905|FG002|Induction|Progressive disease|0|||
13198681|NCT02027428|26210903|FG000|Induction|Adverse Event|51|||
13198682|NCT02027428|26210904|FG001|Induction|Adverse Event|0|||
13198683|NCT02027428|26210905|FG002|Induction|Adverse Event|0|||
13198684|NCT02027428|26210903|FG000|Induction|Withdrawal by Subject|22|||
13198685|NCT02027428|26210904|FG001|Induction|Withdrawal by Subject|0|||
13198686|NCT02027428|26210905|FG002|Induction|Withdrawal by Subject|0|||
13198687|NCT02027428|26210903|FG000|Induction|Death|21|||
13198688|NCT02027428|26210904|FG001|Induction|Death|0|||
13198689|NCT02027428|26210905|FG002|Induction|Death|0|||
13198690|NCT02027428|26210903|FG000|Induction|Symptomatic deterioration|16|||
13198691|NCT02027428|26210904|FG001|Induction|Symptomatic deterioration|0|||
13198692|NCT02027428|26210905|FG002|Induction|Symptomatic deterioration|0|||
13198693|NCT02027428|26210903|FG000|Induction|Study terminated by sponsor|12|||
13198694|NCT02027428|26210904|FG001|Induction|Study terminated by sponsor|0|||
13198695|NCT02027428|26210905|FG002|Induction|Study terminated by sponsor|0|||
13198696|NCT02027428|26210903|FG000|Induction|Protocol Violation|1|||
13198697|NCT02027428|26210904|FG001|Induction|Protocol Violation|0|||
13198698|NCT02027428|26210905|FG002|Induction|Protocol Violation|0|||
13198699|NCT02027428|26210903|FG000|Induction|Miscellaneous|14|||
13198700|NCT02027428|26210904|FG001|Induction|Miscellaneous|0|||
13198701|NCT02027428|26210905|FG002|Induction|Miscellaneous|0|||
13198702|NCT02027428|26210903|FG000|Induction|Induction Treatment Ongoing|4|||
13198703|NCT02027428|26210904|FG001|Induction|Induction Treatment Ongoing|0|||
13198704|NCT02027428|26210905|FG002|Induction|Induction Treatment Ongoing|0|||
13198705|NCT02027428|26210903|FG000|Maintenance|Death|0|||
13198706|NCT02027428|26210904|FG001|Maintenance|Death|3|||
13198707|NCT02027428|26210905|FG002|Maintenance|Death|2|||
13198708|NCT02027428|26210903|FG000|Maintenance|Adverse Event|0|||
13198709|NCT02027428|26210904|FG001|Maintenance|Adverse Event|21|||
13198710|NCT02027428|26210905|FG002|Maintenance|Adverse Event|1|||
13198711|NCT02027428|26210903|FG000|Maintenance|Progressive disease|0|||
13198712|NCT02027428|26210904|FG001|Maintenance|Progressive disease|84|||
13198713|NCT02027428|26210905|FG002|Maintenance|Progressive disease|47|||
13198714|NCT02027428|26210903|FG000|Maintenance|Symptomatic deterioration|0|||
13198715|NCT02027428|26210904|FG001|Maintenance|Symptomatic deterioration|4|||
13198716|NCT02027428|26210905|FG002|Maintenance|Symptomatic deterioration|1|||
13198717|NCT02027428|26210903|FG000|Maintenance|Withdrawal by Subject|0|||
13198718|NCT02027428|26210904|FG001|Maintenance|Withdrawal by Subject|6|||
13198719|NCT02027428|26210905|FG002|Maintenance|Withdrawal by Subject|5|||
13198720|NCT02027428|26210903|FG000|Maintenance|Protocol Violation|0|||
13198721|NCT02027428|26210904|FG001|Maintenance|Protocol Violation|0|||
13198722|NCT02027428|26210905|FG002|Maintenance|Protocol Violation|1|||
13198723|NCT02027428|26210903|FG000|Maintenance|Other|0|||
13198724|NCT02027428|26210904|FG001|Maintenance|Other|6|||
13198725|NCT02027428|26210905|FG002|Maintenance|Other|3|||
13198726|NCT02027428|26210903|FG000|Survival Follow-up|Death|0|||
13198727|NCT02027428|26210904|FG001|Survival Follow-up|Death|78|||
13198728|NCT02027428|26210905|FG002|Survival Follow-up|Death|45|||
13198729|NCT02027428|26210903|FG000|Survival Follow-up|Lost to Follow-up|0|||
13198730|NCT02027428|26210904|FG001|Survival Follow-up|Lost to Follow-up|1|||
13198731|NCT02027428|26210905|FG002|Survival Follow-up|Lost to Follow-up|1|||
13198732|NCT02027402|26210924|FG000|Overall Study|Withdrawal by Subject|4|||
13198733|NCT02027402|26210925|FG001|Overall Study|Withdrawal by Subject|1|||
13198734|NCT02027376|26210953|FG000|Overall Study|Death|1|||
13198735|NCT02027376|26210954|FG001|Overall Study|Death|0|||
13198736|NCT02027376|26210955|FG002|Overall Study|Death|0|||
13198737|NCT02027311|26210970|FG000|Overall Study|Protocol Violation|3|||
13198738|NCT02027311|26210971|FG001|Overall Study|Protocol Violation|2|||
13198739|NCT02027025|26211000|FG000|Overall Study|Adverse Event|0|||
13198740|NCT02027025|26211001|FG001|Overall Study|Adverse Event|1|||
13198741|NCT02027025|26211002|FG002|Overall Study|Adverse Event|1|||
13198742|NCT02027025|26211000|FG000|Overall Study|Protocol Violation|1|||
13198743|NCT02027025|26211001|FG001|Overall Study|Protocol Violation|0|||
13198744|NCT02027025|26211002|FG002|Overall Study|Protocol Violation|0|||
13198745|NCT02027025|26211000|FG000|Overall Study|Lost to Follow-up|0|||
13198746|NCT02027025|26211001|FG001|Overall Study|Lost to Follow-up|2|||
13198747|NCT02027025|26211002|FG002|Overall Study|Lost to Follow-up|0|||
13198748|NCT02027025|26211000|FG000|Overall Study|Withdrawal by Subject|0|||
13198749|NCT02027025|26211001|FG001|Overall Study|Withdrawal by Subject|1|||
13198750|NCT02027025|26211002|FG002|Overall Study|Withdrawal by Subject|0|||
13198751|NCT02027025|26211000|FG000|Overall Study|Sponsor's decision|0|||
13198752|NCT02027025|26211001|FG001|Overall Study|Sponsor's decision|1|||
13198753|NCT02027025|26211002|FG002|Overall Study|Sponsor's decision|0|||
13198754|NCT02026258|26211021|FG000|Randomized|Did not start treatment|2|||
13198755|NCT02026258|26211022|FG001|Randomized|Did not start treatment|1|||
13198756|NCT02026258|26211021|FG000|Randomized|Change in treatment plan|1|||
13198757|NCT02026258|26211022|FG001|Randomized|Change in treatment plan|0|||
13198758|NCT02026258|26211021|FG000|Randomized|Presence of periodontal disease|1|||
13198759|NCT02026258|26211022|FG001|Randomized|Presence of periodontal disease|1|||
13198760|NCT02026258|26211021|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1|||
13198761|NCT02026258|26211022|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1|||
13198762|NCT02026258|26211021|FG000|Recieved Allocated Intervention|Lost to Follow-up|0|||
13198763|NCT02026258|26211022|FG001|Recieved Allocated Intervention|Lost to Follow-up|1|||
13198764|NCT02026141|26211035|FG000|Overall Study|Protocol Violation|0|||
13198765|NCT02026141|26211036|FG001|Overall Study|Protocol Violation|1|||
13198766|NCT02026063|26211053|FG000|Overall Study|Physician Decision|0|||
13198767|NCT02026063|26211054|FG001|Overall Study|Physician Decision|10|||
13198768|NCT02026063|26211053|FG000|Overall Study|Noncompliance with Study Drug|1|||
13198769|NCT02026063|26211054|FG001|Overall Study|Noncompliance with Study Drug|1|||
13198770|NCT02026063|26211053|FG000|Overall Study|Withdrawal of Consent|1|||
13198771|NCT02026063|26211054|FG001|Overall Study|Withdrawal of Consent|6|||
13198772|NCT02026063|26211053|FG000|Overall Study|Adverse Event|5|||
13198773|NCT02026063|26211054|FG001|Overall Study|Adverse Event|20|||
13198774|NCT02026063|26211053|FG000|Overall Study|Lack of Efficacy|0|||
13198775|NCT02026063|26211054|FG001|Overall Study|Lack of Efficacy|4|||
13198776|NCT02026063|26211053|FG000|Overall Study|Lost to Follow-up|0|||
13198777|NCT02026063|26211054|FG001|Overall Study|Lost to Follow-up|1|||
13198778|NCT02026063|26211053|FG000|Overall Study|Reason not Specified|2|||
13198779|NCT02026063|26211054|FG001|Overall Study|Reason not Specified|7|||
13198780|NCT02026011|26211085|FG000|Allocation 1 (First Set of Medication)|Side Effects|6|||
13198781|NCT02026011|26211086|FG001|Allocation 1 (First Set of Medication)|Side Effects|0|||
13198782|NCT02026011|26211085|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1|||
13198783|NCT02026011|26211086|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2|||
13198784|NCT02026011|26211085|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1|||
13198785|NCT02026011|26211086|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0|||
13198786|NCT02026011|26211085|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1|||
13198787|NCT02026011|26211086|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2|||
13198788|NCT02025907|26211107|FG000|Overall Study|Lack of Efficacy|1|||
13198789|NCT02025907|26211108|FG001|Overall Study|Lack of Efficacy|0|||
13223193|NCT01799889|26287993|FG005|Overall Study|Withdrawal by Subject|1|||
13223194|NCT01799889|26287994|FG006|Overall Study|Withdrawal by Subject|3|||
13223195|NCT01799889|26287995|FG007|Overall Study|Withdrawal by Subject|1|||
13223196|NCT01799889|26287996|FG008|Overall Study|Withdrawal by Subject|2|||
13223197|NCT01799889|26287997|FG009|Overall Study|Withdrawal by Subject|1|||
13223198|NCT01799889|26287998|FG010|Overall Study|Withdrawal by Subject|1|||
13223199|NCT01799889|26287999|FG011|Overall Study|Withdrawal by Subject|1|||
13223200|NCT01799889|26287988|FG000|Overall Study|Non-Compliance With Study Drug|0|||
13223201|NCT01799889|26287989|FG001|Overall Study|Non-Compliance With Study Drug|0|||
13223202|NCT01799889|26287990|FG002|Overall Study|Non-Compliance With Study Drug|0|||
13223203|NCT01799889|26287991|FG003|Overall Study|Non-Compliance With Study Drug|0|||
13223204|NCT01799889|26287992|FG004|Overall Study|Non-Compliance With Study Drug|0|||
13223205|NCT01799889|26287993|FG005|Overall Study|Non-Compliance With Study Drug|1|||
13223206|NCT01799889|26287994|FG006|Overall Study|Non-Compliance With Study Drug|0|||
13223207|NCT01799889|26287995|FG007|Overall Study|Non-Compliance With Study Drug|0|||
13223208|NCT01799889|26287996|FG008|Overall Study|Non-Compliance With Study Drug|0|||
13223209|NCT01799889|26287997|FG009|Overall Study|Non-Compliance With Study Drug|0|||
13223210|NCT01799889|26287998|FG010|Overall Study|Non-Compliance With Study Drug|0|||
13223211|NCT01799889|26287999|FG011|Overall Study|Non-Compliance With Study Drug|0|||
13223212|NCT01799720|26288044|FG000|Overall Study|Withdrawal by Subject|3|||
13223213|NCT01799720|26288045|FG001|Overall Study|Withdrawal by Subject|0|||
13223214|NCT01799720|26288046|FG002|Overall Study|Withdrawal by Subject|0|||
13223215|NCT01799720|26288044|FG000|Overall Study|Protocol Violation|0|||
13223216|NCT01799720|26288045|FG001|Overall Study|Protocol Violation|1|||
13223217|NCT01799720|26288046|FG002|Overall Study|Protocol Violation|0|||
13223218|NCT01799720|26288044|FG000|Overall Study|Pregnancy|0|||
13223219|NCT01799720|26288045|FG001|Overall Study|Pregnancy|0|||
13223220|NCT01799720|26288046|FG002|Overall Study|Pregnancy|1|||
13223221|NCT01799590|26288091|FG000|Overall Study|Adverse Event|13|||
13223222|NCT01799590|26288092|FG001|Overall Study|Adverse Event|7|||
13223223|NCT01799590|26288093|FG002|Overall Study|Adverse Event|5|||
13223224|NCT01799590|26288091|FG000|Overall Study|Pregnancy|2|||
13198790|NCT02025907|26211107|FG000|Overall Study|Withdrawal by Subject|15|||
13198791|NCT02025907|26211108|FG001|Overall Study|Withdrawal by Subject|8|||
13198792|NCT02025907|26211107|FG000|Overall Study|Protocol Violation|2|||
13198793|NCT02025907|26211108|FG001|Overall Study|Protocol Violation|0|||
13198794|NCT02025907|26211107|FG000|Overall Study|Physician Decision|2|||
13198795|NCT02025907|26211108|FG001|Overall Study|Physician Decision|0|||
13198796|NCT02025907|26211107|FG000|Overall Study|Lost to Follow-up|2|||
13198797|NCT02025907|26211108|FG001|Overall Study|Lost to Follow-up|2|||
13198798|NCT02025907|26211107|FG000|Overall Study|Adverse Event|3|||
13198799|NCT02025907|26211108|FG001|Overall Study|Adverse Event|1|||
13198800|NCT02025907|26211107|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2|||
13198801|NCT02025907|26211108|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1|||
13198802|NCT02025751|26211121|FG000|Overall Study|Lost to Follow-up|1|||
13198803|NCT02025751|26211122|FG001|Overall Study|Lost to Follow-up|0|||
13198804|NCT02025751|26211121|FG000|Overall Study|Adverse Event|0|||
13198805|NCT02025751|26211122|FG001|Overall Study|Adverse Event|1|||
13198806|NCT02025751|26211121|FG000|Overall Study|Physician Decision|0|||
13198807|NCT02025751|26211122|FG001|Overall Study|Physician Decision|1|||
13198808|NCT02025751|26211121|FG000|Overall Study|Withdrawal by Subject|0|||
13198809|NCT02025751|26211122|FG001|Overall Study|Withdrawal by Subject|1|||
13198810|NCT02025725|26211137|FG000|Overall Study|Adverse Event|5|||
13198811|NCT02025725|26211138|FG001|Overall Study|Adverse Event|0|||
13198812|NCT02025725|26211137|FG000|Overall Study|Lost to Follow-up|2|||
13198813|NCT02025725|26211138|FG001|Overall Study|Lost to Follow-up|0|||
13198814|NCT02025725|26211137|FG000|Overall Study|Protocol Violation|1|||
13198815|NCT02025725|26211138|FG001|Overall Study|Protocol Violation|1|||
13198816|NCT02025725|26211137|FG000|Overall Study|Withdrawal by Subject|3|||
13198817|NCT02025725|26211138|FG001|Overall Study|Withdrawal by Subject|2|||
13198818|NCT02025725|26211137|FG000|Overall Study|Post-dose QTcB > 270 msec|0|||
13198819|NCT02025725|26211138|FG001|Overall Study|Post-dose QTcB > 270 msec|1|||
13198820|NCT02025621|26211163|FG000|Overall Study|Withdrawal by Subject|1|||
13198821|NCT02025621|26211164|FG001|Overall Study|Withdrawal by Subject|0|||
13198822|NCT02025621|26211163|FG000|Overall Study|Death|0|||
13198823|NCT02025621|26211164|FG001|Overall Study|Death|1|||
13198824|NCT02025621|26211163|FG000|Overall Study|No longer eligible|10|||
13198825|NCT02025621|26211164|FG001|Overall Study|No longer eligible|15|||
13198826|NCT02025621|26211163|FG000|Overall Study|Surgery initiated before infusion|3|||
13198827|NCT02025621|26211164|FG001|Overall Study|Surgery initiated before infusion|3|||
13198828|NCT02025530|26211181|FG000|Overall Study|No longer met elligibility criteria|5|||
13198829|NCT02025530|26211182|FG001|Overall Study|No longer met elligibility criteria|1|||
13198830|NCT02025205|26211230|FG000|Overall Study|Withdrawal by Subject|1|||
13198831|NCT02025205|26211231|FG001|Overall Study|Withdrawal by Subject|1|||
13198832|NCT02025205|26211230|FG000|Overall Study|Protocol Violation|2|||
13198833|NCT02025205|26211231|FG001|Overall Study|Protocol Violation|1|||
13198834|NCT02025205|26211230|FG000|Overall Study|Death|0|||
13198835|NCT02025205|26211231|FG001|Overall Study|Death|1|||
13198836|NCT02025179|26211264|FG000|Overall Study|Lost to Follow-up|0|||
13198837|NCT02025179|26211265|FG001|Overall Study|Lost to Follow-up|0|||
13198838|NCT02025179|26211266|FG002|Overall Study|Lost to Follow-up|1|||
13198839|NCT02024971|26211275|FG000|Overall Study|Data Not Available|30|||
13198840|NCT02024971|26211275|FG000|Overall Study|Lost to Follow-up|6|||
13198841|NCT02024932|26211351|FG000|Overall Study|Adverse Event|2|||
13112639|NCT03154086|25909098|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
13112640|NCT03154086|25909099|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
13112641|NCT03154086|25909085|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
13112642|NCT03154086|25909086|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
13198842|NCT02024932|26211352|FG001|Overall Study|Adverse Event|3|||
13198843|NCT02024932|26211353|FG002|Overall Study|Adverse Event|0|||
13198844|NCT02024932|26211354|FG003|Overall Study|Adverse Event|0|||
13198845|NCT02024932|26211355|FG004|Overall Study|Adverse Event|2|||
13198846|NCT02024932|26211356|FG005|Overall Study|Adverse Event|0|||
13198847|NCT02024932|26211351|FG000|Overall Study|Abnormal laboratory value|0|||
13198848|NCT02024932|26211352|FG001|Overall Study|Abnormal laboratory value|0|||
13198849|NCT02024932|26211353|FG002|Overall Study|Abnormal laboratory value|0|||
13198850|NCT02024932|26211354|FG003|Overall Study|Abnormal laboratory value|2|||
13198851|NCT02024932|26211355|FG004|Overall Study|Abnormal laboratory value|0|||
13198852|NCT02024932|26211356|FG005|Overall Study|Abnormal laboratory value|0|||
13198853|NCT02024867|26211379|FG000|Overall Study|Protocol Violation|3|||
13112643|NCT03154086|25909087|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
13112644|NCT03154086|25909088|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
13112645|NCT03154086|25909089|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
13112646|NCT03154086|25909090|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
13112647|NCT03154086|25909091|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
13198854|NCT02024867|26211380|FG001|Overall Study|Protocol Violation|3|||
13198855|NCT02024867|26211379|FG000|Overall Study|Lost to Follow-up|6|||
13198856|NCT02024867|26211380|FG001|Overall Study|Lost to Follow-up|4|||
13198857|NCT02024750|26211399|FG000|Overall Study|Withdrawal by Subject|2|||
13198858|NCT02024750|26211400|FG001|Overall Study|Withdrawal by Subject|1|||
13198859|NCT02024698|26211429|FG000|First Intervention (7 Days)|Withdrawal by Subject|0|||
13198860|NCT02024698|26211430|FG001|First Intervention (7 Days)|Withdrawal by Subject|1|||
13198861|NCT02024529|26211449|FG000|Overall Study|Withdrawal by Subject|11|||
13198862|NCT02024529|26211450|FG001|Overall Study|Withdrawal by Subject|21|||
13198863|NCT02024529|26211449|FG000|Overall Study|Lost to Follow-up|2|||
13198864|NCT02024529|26211450|FG001|Overall Study|Lost to Follow-up|4|||
13198865|NCT02023879|26211549|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
13198866|NCT02023879|26211550|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
13198867|NCT02023879|26211551|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5|||
13198868|NCT02023879|26211549|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0|||
13198869|NCT02023879|26211550|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2|||
13198870|NCT02023879|26211551|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1|||
13198871|NCT02023879|26211549|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
13198872|NCT02023879|26211550|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1|||
13198873|NCT02023879|26211551|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
13198874|NCT02023879|26211549|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
13198875|NCT02023879|26211550|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0|||
13198876|NCT02023879|26211551|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
13198877|NCT02023879|26211549|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0|||
13198878|NCT02023879|26211550|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
13198879|NCT02023879|26211551|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
13198880|NCT02023879|26211549|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
13198881|NCT02023879|26211550|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3|||
13198882|NCT02023879|26211551|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
13198883|NCT02023879|26211549|FG000|Extension Open Label Treatment|Adverse Event|1|||
13198884|NCT02023879|26211550|FG001|Extension Open Label Treatment|Adverse Event|7|||
13198885|NCT02023879|26211551|FG002|Extension Open Label Treatment|Adverse Event|3|||
13198886|NCT02023879|26211549|FG000|Extension Open Label Treatment|Poor compliance to protocol|1|||
13198887|NCT02023879|26211550|FG001|Extension Open Label Treatment|Poor compliance to protocol|1|||
13198888|NCT02023879|26211551|FG002|Extension Open Label Treatment|Poor compliance to protocol|0|||
13198889|NCT02023879|26211549|FG000|Extension Open Label Treatment|Participant moved|1|||
13198890|NCT02023879|26211550|FG001|Extension Open Label Treatment|Participant moved|2|||
13198891|NCT02023879|26211551|FG002|Extension Open Label Treatment|Participant moved|0|||
13198892|NCT02023879|26211549|FG000|Extension Open Label Treatment|Other than specified above|2|||
13198893|NCT02023879|26211550|FG001|Extension Open Label Treatment|Other than specified above|7|||
13198894|NCT02023879|26211551|FG002|Extension Open Label Treatment|Other than specified above|2|||
13112648|NCT03154086|25909092|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
13198895|NCT02023866|26211566|FG000|Overall Study|Non-compliance|2|||
13198896|NCT02023866|26211566|FG000|Overall Study|Adverse Event|3|||
13198897|NCT02023866|26211566|FG000|Overall Study|Withdrawal by Subject|1|||
13198898|NCT02023697|26211676|FG000|Treatment Period|Radiological progression|13|||
13198899|NCT02023697|26211677|FG001|Treatment Period|Radiological progression|17|||
13198900|NCT02023697|26211678|FG002|Treatment Period|Radiological progression|26|||
13198901|NCT02023697|26211676|FG000|Treatment Period|Never Treated|5|||
13198902|NCT02023697|26211677|FG001|Treatment Period|Never Treated|6|||
13198903|NCT02023697|26211678|FG002|Treatment Period|Never Treated|10|||
13198904|NCT02023697|26211676|FG000|Treatment Period|Adverse Event|13|||
13198905|NCT02023697|26211677|FG001|Treatment Period|Adverse Event|25|||
13198906|NCT02023697|26211678|FG002|Treatment Period|Adverse Event|23|||
13198907|NCT02023697|26211676|FG000|Treatment Period|Logistical difficulties|1|||
13198908|NCT02023697|26211677|FG001|Treatment Period|Logistical difficulties|1|||
13198909|NCT02023697|26211678|FG002|Treatment Period|Logistical difficulties|1|||
13198910|NCT02023697|26211676|FG000|Treatment Period|Clinical progression|10|||
13198911|NCT02023697|26211677|FG001|Treatment Period|Clinical progression|8|||
13198912|NCT02023697|26211678|FG002|Treatment Period|Clinical progression|28|||
13112649|NCT03154086|25909093|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1|||
13112650|NCT03154086|25909094|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
13112651|NCT03154086|25909095|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
13112652|NCT03154086|25909096|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
13112653|NCT03154086|25909097|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
13112654|NCT03154086|25909098|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
13112655|NCT03154086|25909099|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
13112656|NCT03154086|25909085|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
13112657|NCT03154086|25909086|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
13112658|NCT03154086|25909087|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
13112659|NCT03154086|25909088|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
13112660|NCT03154086|25909089|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
13112661|NCT03154086|25909090|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
13198913|NCT02023697|26211676|FG000|Treatment Period|Withdrawal by Subject|4|||
13198914|NCT02023697|26211677|FG001|Treatment Period|Withdrawal by Subject|5|||
13223225|NCT01799590|26288092|FG001|Overall Study|Pregnancy|0|||
13198915|NCT02023697|26211678|FG002|Treatment Period|Withdrawal by Subject|13|||
13198916|NCT02023697|26211676|FG000|Treatment Period|Safety outcome reached|0|||
13198917|NCT02023697|26211677|FG001|Treatment Period|Safety outcome reached|1|||
13198918|NCT02023697|26211678|FG002|Treatment Period|Safety outcome reached|0|||
13198919|NCT02023697|26211676|FG000|Treatment Period|Physician Decision|0|||
13198920|NCT02023697|26211677|FG001|Treatment Period|Physician Decision|0|||
13198921|NCT02023697|26211678|FG002|Treatment Period|Physician Decision|1|||
13198922|NCT02023697|26211676|FG000|Active Follow-up Period|Withdrawal by Subject|5|||
13198923|NCT02023697|26211677|FG001|Active Follow-up Period|Withdrawal by Subject|13|||
13198924|NCT02023697|26211678|FG002|Active Follow-up Period|Withdrawal by Subject|7|||
13198925|NCT02023697|26211676|FG000|Active Follow-up Period|Lost to Follow-up|1|||
13198926|NCT02023697|26211677|FG001|Active Follow-up Period|Lost to Follow-up|1|||
13198927|NCT02023697|26211678|FG002|Active Follow-up Period|Lost to Follow-up|1|||
13198928|NCT02023697|26211676|FG000|Active Follow-up Period|Deterioration of general condition|1|||
13198929|NCT02023697|26211677|FG001|Active Follow-up Period|Deterioration of general condition|1|||
13198930|NCT02023697|26211678|FG002|Active Follow-up Period|Deterioration of general condition|1|||
13198931|NCT02023697|26211676|FG000|Active Follow-up Period|Other unspecified|2|||
13198932|NCT02023697|26211677|FG001|Active Follow-up Period|Other unspecified|0|||
13198933|NCT02023697|26211678|FG002|Active Follow-up Period|Other unspecified|1|||
13198934|NCT02023697|26211676|FG000|Active Follow-up Period|Clinical progression|0|||
13198935|NCT02023697|26211677|FG001|Active Follow-up Period|Clinical progression|2|||
13198936|NCT02023697|26211678|FG002|Active Follow-up Period|Clinical progression|1|||
13198937|NCT02023697|26211676|FG000|Active Follow-up Period|Radiological progression|0|||
13198938|NCT02023697|26211677|FG001|Active Follow-up Period|Radiological progression|0|||
13198939|NCT02023697|26211678|FG002|Active Follow-up Period|Radiological progression|1|||
13198940|NCT02023697|26211676|FG000|Active Follow-up Period|Death|83|||
13198941|NCT02023697|26211677|FG001|Active Follow-up Period|Death|82|||
13198942|NCT02023697|26211678|FG002|Active Follow-up Period|Death|87|||
13198943|NCT02023697|26211676|FG000|Long-term Follow-up Period|Death|9|||
13198944|NCT02023697|26211677|FG001|Long-term Follow-up Period|Death|6|||
13198945|NCT02023697|26211678|FG002|Long-term Follow-up Period|Death|4|||
13198946|NCT02023697|26211676|FG000|Long-term Follow-up Period|Withdrawal by Subject|6|||
13198947|NCT02023697|26211677|FG001|Long-term Follow-up Period|Withdrawal by Subject|3|||
13198948|NCT02023697|26211678|FG002|Long-term Follow-up Period|Withdrawal by Subject|0|||
13198949|NCT02023697|26211676|FG000|Long-term Follow-up Period|Lost to Follow-up|1|||
13198950|NCT02023697|26211677|FG001|Long-term Follow-up Period|Lost to Follow-up|0|||
13198951|NCT02023697|26211678|FG002|Long-term Follow-up Period|Lost to Follow-up|1|||
13198952|NCT02023697|26211676|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
13198953|NCT02023697|26211677|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9|||
13198954|NCT02023697|26211678|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
13198955|NCT02023697|26211676|FG000|Long-term Follow-up Period|Technical problems|0|||
13198956|NCT02023697|26211677|FG001|Long-term Follow-up Period|Technical problems|0|||
13198957|NCT02023697|26211678|FG002|Long-term Follow-up Period|Technical problems|1|||
13198958|NCT02023697|26211676|FG000|Long-term Follow-up Period|Other unspecified|6|||
13198959|NCT02023697|26211677|FG001|Long-term Follow-up Period|Other unspecified|3|||
13198960|NCT02023697|26211678|FG002|Long-term Follow-up Period|Other unspecified|5|||
13198961|NCT02023268|26211691|FG000|Overall Study|Lack of Efficacy|0|||
13198962|NCT02023268|26211692|FG001|Overall Study|Lack of Efficacy|1|||
13198963|NCT02023268|26211691|FG000|Overall Study|Adverse Event|0|||
13198964|NCT02023268|26211692|FG001|Overall Study|Adverse Event|2|||
13198965|NCT02023268|26211691|FG000|Overall Study|Withdrawal by Subject|0|||
13198966|NCT02023268|26211692|FG001|Overall Study|Withdrawal by Subject|1|||
13198967|NCT02023242|26211713|FG000|Overall Study|Lost to Follow-up|3|||
13198968|NCT02023242|26211714|FG001|Overall Study|Lost to Follow-up|1|||
13198969|NCT02023242|26211713|FG000|Overall Study|Death|0|||
13198970|NCT02023242|26211714|FG001|Overall Study|Death|1|||
13198971|NCT02023151|26211721|FG000|Overall Study|Lost to Follow-up|4|||
13198972|NCT02023112|26211746|FG000|Overall Study|Withdrawal by Subject|2|||
13198973|NCT02023112|26211747|FG001|Overall Study|Withdrawal by Subject|1|||
13198974|NCT02023099|26211773|FG000|Overall Study|Non-fatal Adverse Event (AE)|0|||
13198975|NCT02023099|26211774|FG001|Overall Study|Non-fatal Adverse Event (AE)|0|||
13198976|NCT02023099|26211775|FG002|Overall Study|Non-fatal Adverse Event (AE)|1|||
13198977|NCT02023099|26211773|FG000|Overall Study|Withdrawn Consent|3|||
13198978|NCT02023099|26211774|FG001|Overall Study|Withdrawn Consent|0|||
13198979|NCT02023099|26211775|FG002|Overall Study|Withdrawn Consent|1|||
13198980|NCT02023099|26211773|FG000|Overall Study|Non-treatment-emergent Fatal AE|0|||
13198981|NCT02023099|26211774|FG001|Overall Study|Non-treatment-emergent Fatal AE|0|||
13198982|NCT02023099|26211775|FG002|Overall Study|Non-treatment-emergent Fatal AE|1|||
13198983|NCT02022748|26211806|FG000|Overall Study|Adverse Event|1|||
13198984|NCT02022748|26211807|FG001|Overall Study|Adverse Event|1|||
13198985|NCT02022748|26211808|FG002|Overall Study|Adverse Event|0|||
13198986|NCT02022748|26211806|FG000|Overall Study|Withdrawal by Subject|0|||
13198987|NCT02022748|26211807|FG001|Overall Study|Withdrawal by Subject|1|||
13198988|NCT02022748|26211808|FG002|Overall Study|Withdrawal by Subject|0|||
13198989|NCT02022670|26211832|FG000|Overall Study|Adverse Event|1|||
13198990|NCT02022670|26211833|FG001|Overall Study|Adverse Event|0|||
13198991|NCT02022670|26211834|FG002|Overall Study|Adverse Event|1|||
13198992|NCT02022657|26211847|FG000|Overall Study|Withdrawal by Subject|2|||
13198993|NCT02022657|26211848|FG001|Overall Study|Withdrawal by Subject|0|||
13198994|NCT02022657|26211849|FG002|Overall Study|Withdrawal by Subject|1|||
13198995|NCT02022657|26211850|FG003|Overall Study|Withdrawal by Subject|0|||
13198996|NCT02022657|26211851|FG004|Overall Study|Withdrawal by Subject|0|||
13198997|NCT02022657|26211852|FG005|Overall Study|Withdrawal by Subject|0|||
13198998|NCT02022657|26211847|FG000|Overall Study|Physician Decision|0|||
13198999|NCT02022657|26211848|FG001|Overall Study|Physician Decision|0|||
13199000|NCT02022657|26211849|FG002|Overall Study|Physician Decision|0|||
13199001|NCT02022657|26211850|FG003|Overall Study|Physician Decision|0|||
13199002|NCT02022657|26211851|FG004|Overall Study|Physician Decision|0|||
13199003|NCT02022657|26211852|FG005|Overall Study|Physician Decision|1|||
13199004|NCT02022007|26211903|FG000|Overall Study|Withdrawal by Subject|1|||
13199005|NCT02022007|26211904|FG001|Overall Study|Withdrawal by Subject|1|||
13199006|NCT02022007|26211905|FG002|Overall Study|Withdrawal by Subject|1|||
13199007|NCT02022007|26211903|FG000|Overall Study|Noncompliant|0|||
13199008|NCT02022007|26211904|FG001|Overall Study|Noncompliant|0|||
13199009|NCT02022007|26211905|FG002|Overall Study|Noncompliant|1|||
13199010|NCT02021812|26211915|FG000|Overall Study|Death|8|||
13199011|NCT02021812|26211915|FG000|Overall Study|Withdrawal by Subject|3|||
13199012|NCT02021812|26211915|FG000|Overall Study|Lost to Follow-up|2|||
13199013|NCT02021812|26211915|FG000|Overall Study|Refuse to return, COVD 19|2|||
13199014|NCT02021656|26211931|FG000|Overall Study|Adverse Event|1|||
13199015|NCT02021656|26211931|FG000|Overall Study|Lack of Efficacy|2|||
13199016|NCT02021656|26211931|FG000|Overall Study|Lost to Follow-up|1|||
13199017|NCT02021656|26211931|FG000|Overall Study|Withdrew Consent|2|||
13199018|NCT02021643|26211988|FG000|Overall Study|Enrolled but Never Treated|1|||
13199019|NCT02021643|26211989|FG001|Overall Study|Enrolled but Never Treated|0|||
13199020|NCT02021643|26211990|FG002|Overall Study|Enrolled but Never Treated|0|||
13199021|NCT02021643|26211991|FG003|Overall Study|Enrolled but Never Treated|0|||
13199022|NCT02021643|26211988|FG000|Overall Study|Adverse Event|0|||
13199023|NCT02021643|26211989|FG001|Overall Study|Adverse Event|1|||
13199024|NCT02021643|26211990|FG002|Overall Study|Adverse Event|0|||
13199025|NCT02021643|26211991|FG003|Overall Study|Adverse Event|0|||
13199026|NCT02021643|26211988|FG000|Overall Study|Death|0|||
13199027|NCT02021643|26211989|FG001|Overall Study|Death|1|||
13199028|NCT02021643|26211990|FG002|Overall Study|Death|0|||
13199029|NCT02021643|26211991|FG003|Overall Study|Death|0|||
13199030|NCT02021643|26211988|FG000|Overall Study|Investigator's Discretion|1|||
13199031|NCT02021643|26211989|FG001|Overall Study|Investigator's Discretion|0|||
13199032|NCT02021643|26211990|FG002|Overall Study|Investigator's Discretion|0|||
13199033|NCT02021643|26211991|FG003|Overall Study|Investigator's Discretion|0|||
13199034|NCT02021643|26211988|FG000|Overall Study|Lack of Efficacy|7|||
13199035|NCT02021643|26211989|FG001|Overall Study|Lack of Efficacy|6|||
13199036|NCT02021643|26211990|FG002|Overall Study|Lack of Efficacy|0|||
13199037|NCT02021643|26211991|FG003|Overall Study|Lack of Efficacy|12|||
13199038|NCT02021643|26211988|FG000|Overall Study|Lost to Follow-up|0|||
13199039|NCT02021643|26211989|FG001|Overall Study|Lost to Follow-up|1|||
13199040|NCT02021643|26211990|FG002|Overall Study|Lost to Follow-up|0|||
13199041|NCT02021643|26211991|FG003|Overall Study|Lost to Follow-up|0|||
13199042|NCT02021643|26211988|FG000|Overall Study|Withdrew Consent|0|||
13199043|NCT02021643|26211989|FG001|Overall Study|Withdrew Consent|1|||
13199044|NCT02021643|26211990|FG002|Overall Study|Withdrew Consent|0|||
13199045|NCT02021643|26211991|FG003|Overall Study|Withdrew Consent|0|||
13199046|NCT02021565|26212010|FG000|Baseline Through Intervention|Death|0|||
13199047|NCT02021565|26212011|FG001|Baseline Through Intervention|Death|1|||
13199048|NCT02021565|26212010|FG000|Baseline Through Intervention|Withdrawal by Subject|8|||
13199049|NCT02021565|26212011|FG001|Baseline Through Intervention|Withdrawal by Subject|8|||
13199050|NCT02021565|26212010|FG000|Baseline Through Intervention|Protocol Violation|0|||
13199051|NCT02021565|26212011|FG001|Baseline Through Intervention|Protocol Violation|7|||
13199052|NCT02021565|26212010|FG000|Baseline Through Intervention|Lost to Follow-up|4|||
13199053|NCT02021565|26212011|FG001|Baseline Through Intervention|Lost to Follow-up|2|||
13199054|NCT02021565|26212010|FG000|3-month Follow-up|Death|3|||
13199055|NCT02021565|26212011|FG001|3-month Follow-up|Death|0|||
13199056|NCT02021565|26212010|FG000|3-month Follow-up|Withdrawal by Subject|4|||
13199057|NCT02021565|26212011|FG001|3-month Follow-up|Withdrawal by Subject|0|||
13199058|NCT02021565|26212010|FG000|3-month Follow-up|Protocol Violation|3|||
13199059|NCT02021565|26212011|FG001|3-month Follow-up|Protocol Violation|2|||
13199060|NCT02021331|26212028|FG000|Overall Study|Adverse Event|0|||
13199061|NCT02021331|26212029|FG001|Overall Study|Adverse Event|2|||
13199062|NCT02021318|26212162|FG000|Overall Study|Adverse Event|2|||
13199063|NCT02021318|26212163|FG001|Overall Study|Adverse Event|1|||
13199064|NCT02021318|26212162|FG000|Overall Study|Death|33|||
13199065|NCT02021318|26212163|FG001|Overall Study|Death|34|||
13199066|NCT02021318|26212162|FG000|Overall Study|Lost to Follow-up|3|||
13199067|NCT02021318|26212163|FG001|Overall Study|Lost to Follow-up|3|||
13199068|NCT02021318|26212162|FG000|Overall Study|Progressive Disease|0|||
13199069|NCT02021318|26212163|FG001|Overall Study|Progressive Disease|1|||
13199070|NCT02021318|26212162|FG000|Overall Study|Withdrawal by Subject|30|||
13199071|NCT02021318|26212163|FG001|Overall Study|Withdrawal by Subject|18|||
13199072|NCT02021318|26212162|FG000|Overall Study|Physician Decision|3|||
13199073|NCT02021318|26212163|FG001|Overall Study|Physician Decision|3|||
13199074|NCT02021318|26212162|FG000|Overall Study|Miscellaneous|2|||
13199075|NCT02021318|26212163|FG001|Overall Study|Miscellaneous|3|||
13199076|NCT02021292|26212190|FG000|Overall Study|Physician Decision|0|||
13199077|NCT02021292|26212191|FG001|Overall Study|Physician Decision|1|||
13199078|NCT02021292|26212190|FG000|Overall Study|Lost to Follow-up|0|||
13199079|NCT02021292|26212191|FG001|Overall Study|Lost to Follow-up|1|||
13199080|NCT02021292|26212190|FG000|Overall Study|Death|0|||
13199081|NCT02021292|26212191|FG001|Overall Study|Death|1|||
13199082|NCT02020967|26212207|FG000|Overall Study|Withdrawal by Subject|51|||
13199083|NCT02020941|26212218|FG000|Overall Study|Adverse Event|1|||
13199084|NCT02020941|26212218|FG000|Overall Study|Physician Decision|2|||
13199085|NCT02020941|26212218|FG000|Overall Study|Withdrawal by Subject|1|||
13199086|NCT02020941|26212218|FG000|Overall Study|Disease Progression|4|||
13199087|NCT02020889|26212279|FG000|Overall Study|Adverse Event|0|||
13199088|NCT02020889|26212280|FG001|Overall Study|Adverse Event|1|||
13199089|NCT02020889|26212279|FG000|Overall Study|Lack of Efficacy|1|||
13199090|NCT02020889|26212280|FG001|Overall Study|Lack of Efficacy|0|||
13199091|NCT02020889|26212279|FG000|Overall Study|Lost to Follow-up|1|||
13199092|NCT02020889|26212280|FG001|Overall Study|Lost to Follow-up|0|||
13199093|NCT02020889|26212279|FG000|Overall Study|Physician Decision|2|||
13199094|NCT02020889|26212280|FG001|Overall Study|Physician Decision|0|||
13199095|NCT02020889|26212279|FG000|Overall Study|Withdrawal by Subject|3|||
13199096|NCT02020889|26212280|FG001|Overall Study|Withdrawal by Subject|2|||
13199097|NCT02020863|26212286|FG000|Overall Study|Discovery of Metastatic disease|4|||
13199098|NCT02020863|26212286|FG000|Overall Study|Team chose not to place an a line|1|||
13199099|NCT02020616|26212399|FG000|Overall Study|Adverse Event|0|||
13199100|NCT02020616|26212400|FG001|Overall Study|Adverse Event|0|||
13199101|NCT02020616|26212401|FG002|Overall Study|Adverse Event|0|||
13199102|NCT02020616|26212402|FG003|Overall Study|Adverse Event|0|||
13199103|NCT02020616|26212403|FG004|Overall Study|Adverse Event|0|||
13199104|NCT02020616|26212404|FG005|Overall Study|Adverse Event|1|||
13199105|NCT02020616|26212405|FG006|Overall Study|Adverse Event|1|||
13199106|NCT02020616|26212399|FG000|Overall Study|Physician Decision|0|||
13199107|NCT02020616|26212400|FG001|Overall Study|Physician Decision|0|||
13199108|NCT02020616|26212401|FG002|Overall Study|Physician Decision|0|||
13199109|NCT02020616|26212402|FG003|Overall Study|Physician Decision|0|||
13199110|NCT02020616|26212403|FG004|Overall Study|Physician Decision|0|||
13199111|NCT02020616|26212404|FG005|Overall Study|Physician Decision|1|||
13199112|NCT02020616|26212405|FG006|Overall Study|Physician Decision|2|||
13199113|NCT02020616|26212399|FG000|Overall Study|Withdrawal by Subject|0|||
13199114|NCT02020616|26212400|FG001|Overall Study|Withdrawal by Subject|0|||
13199115|NCT02020616|26212401|FG002|Overall Study|Withdrawal by Subject|1|||
13199116|NCT02020616|26212402|FG003|Overall Study|Withdrawal by Subject|0|||
13199117|NCT02020616|26212403|FG004|Overall Study|Withdrawal by Subject|0|||
13199118|NCT02020616|26212404|FG005|Overall Study|Withdrawal by Subject|1|||
13199119|NCT02020616|26212405|FG006|Overall Study|Withdrawal by Subject|1|||
13199120|NCT02020616|26212399|FG000|Overall Study|Lost to Follow-up|0|||
13199121|NCT02020616|26212400|FG001|Overall Study|Lost to Follow-up|1|||
13199122|NCT02020616|26212401|FG002|Overall Study|Lost to Follow-up|0|||
13199123|NCT02020616|26212402|FG003|Overall Study|Lost to Follow-up|1|||
13199124|NCT02020616|26212403|FG004|Overall Study|Lost to Follow-up|1|||
13199125|NCT02020616|26212404|FG005|Overall Study|Lost to Follow-up|1|||
13199126|NCT02020616|26212405|FG006|Overall Study|Lost to Follow-up|0|||
13199127|NCT02020616|26212399|FG000|Overall Study|Early Termination Criteria Met|0|||
13199128|NCT02020616|26212400|FG001|Overall Study|Early Termination Criteria Met|0|||
13199129|NCT02020616|26212401|FG002|Overall Study|Early Termination Criteria Met|1|||
13199130|NCT02020616|26212402|FG003|Overall Study|Early Termination Criteria Met|0|||
13199131|NCT02020616|26212403|FG004|Overall Study|Early Termination Criteria Met|0|||
13199132|NCT02020616|26212404|FG005|Overall Study|Early Termination Criteria Met|1|||
13199133|NCT02020616|26212405|FG006|Overall Study|Early Termination Criteria Met|0|||
13199134|NCT02020616|26212399|FG000|Overall Study|Randomized in Error|0|||
13199135|NCT02020616|26212400|FG001|Overall Study|Randomized in Error|0|||
13199136|NCT02020616|26212401|FG002|Overall Study|Randomized in Error|0|||
13199137|NCT02020616|26212402|FG003|Overall Study|Randomized in Error|1|||
13199138|NCT02020616|26212403|FG004|Overall Study|Randomized in Error|0|||
13199139|NCT02020616|26212404|FG005|Overall Study|Randomized in Error|0|||
13199140|NCT02020616|26212405|FG006|Overall Study|Randomized in Error|0|||
13199141|NCT02020616|26212399|FG000|Overall Study|Lack of Efficacy|0|||
13199142|NCT02020616|26212400|FG001|Overall Study|Lack of Efficacy|0|||
13199143|NCT02020616|26212401|FG002|Overall Study|Lack of Efficacy|0|||
13199144|NCT02020616|26212402|FG003|Overall Study|Lack of Efficacy|0|||
13199145|NCT02020616|26212403|FG004|Overall Study|Lack of Efficacy|1|||
13199146|NCT02020616|26212404|FG005|Overall Study|Lack of Efficacy|0|||
13199147|NCT02020616|26212405|FG006|Overall Study|Lack of Efficacy|0|||
13199148|NCT02020577|26212439|FG000|Overall Study|Progressive disease|3|||
13199149|NCT02020577|26212440|FG001|Overall Study|Progressive disease|38|||
13199150|NCT02020577|26212439|FG000|Overall Study|Other AE or clinical progression|0|||
13199151|NCT02020577|26212440|FG001|Overall Study|Other AE or clinical progression|15|||
13199152|NCT02020577|26212439|FG000|Overall Study|Withdrawal by Subject|0|||
13199153|NCT02020577|26212440|FG001|Overall Study|Withdrawal by Subject|1|||
13199154|NCT02020577|26212439|FG000|Overall Study|Other than stated above|0|||
13199155|NCT02020577|26212440|FG001|Overall Study|Other than stated above|1|||
13199156|NCT02020512|26212446|FG000|Overall Study|Adverse Event|1|||
13199157|NCT02020512|26212446|FG000|Overall Study|Lost to Follow-up|3|||
13199158|NCT02020512|26212446|FG000|Overall Study|Protocol Violation|4|||
13199159|NCT02020031|26212461|FG000|Overall Study|Physician Decision|1|||
13199160|NCT02020031|26212462|FG001|Overall Study|Physician Decision|1|||
13199161|NCT02019979|26212470|FG000|Overall Study|study terminated|14|||
13206548|NCT01957202|26234853|FG003|Treatment Period 3 (8 Days)|Adverse Event|0|||
13206549|NCT01957202|26234854|FG004|Treatment Period 3 (8 Days)|Adverse Event|0|||
13206550|NCT01957202|26234855|FG005|Treatment Period 3 (8 Days)|Adverse Event|0|||
13206551|NCT01957202|26234856|FG006|Treatment Period 3 (8 Days)|Adverse Event|0|||
13206552|NCT01957202|26234857|FG007|Treatment Period 3 (8 Days)|Adverse Event|0|||
13206553|NCT01957202|26234858|FG008|Treatment Period 3 (8 Days)|Adverse Event|0|||
13206554|NCT01957202|26234859|FG009|Treatment Period 3 (8 Days)|Adverse Event|0|||
13206555|NCT01957202|26234860|FG010|Treatment Period 3 (8 Days)|Adverse Event|0|||
13206556|NCT01957202|26234861|FG011|Treatment Period 3 (8 Days)|Adverse Event|0|||
13206557|NCT01957202|26234862|FG012|Treatment Period 3 (8 Days)|Adverse Event|0|||
13206558|NCT01957202|26234863|FG013|Treatment Period 3 (8 Days)|Adverse Event|0|||
13206559|NCT01957202|26234864|FG014|Treatment Period 3 (8 Days)|Adverse Event|0|||
13206560|NCT01957202|26234865|FG015|Treatment Period 3 (8 Days)|Adverse Event|0|||
13206561|NCT01957202|26234866|FG016|Treatment Period 3 (8 Days)|Adverse Event|1|||
13206562|NCT01957202|26234867|FG017|Treatment Period 3 (8 Days)|Adverse Event|0|||
13206563|NCT01957163|26234888|FG000|Overall Study|Adverse Event|5|||
13206564|NCT01957163|26234889|FG001|Overall Study|Adverse Event|2|||
13206565|NCT01957163|26234890|FG002|Overall Study|Adverse Event|4|||
13206566|NCT01957163|26234888|FG000|Overall Study|Lack of Efficacy|5|||
13206567|NCT01957163|26234889|FG001|Overall Study|Lack of Efficacy|4|||
13206568|NCT01957163|26234890|FG002|Overall Study|Lack of Efficacy|9|||
13206569|NCT01957163|26234888|FG000|Overall Study|Protocol Violation|1|||
13206570|NCT01957163|26234889|FG001|Overall Study|Protocol Violation|2|||
13206571|NCT01957163|26234890|FG002|Overall Study|Protocol Violation|0|||
13206572|NCT01957163|26234888|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
13206573|NCT01957163|26234889|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
13206574|NCT01957163|26234890|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1|||
13206575|NCT01957163|26234888|FG000|Overall Study|Lost to Follow-up|0|||
13206576|NCT01957163|26234889|FG001|Overall Study|Lost to Follow-up|1|||
13206577|NCT01957163|26234890|FG002|Overall Study|Lost to Follow-up|0|||
13206578|NCT01957163|26234888|FG000|Overall Study|Withdrawal by Subject|4|||
13206579|NCT01957163|26234889|FG001|Overall Study|Withdrawal by Subject|2|||
13206580|NCT01957163|26234890|FG002|Overall Study|Withdrawal by Subject|4|||
13206581|NCT01957150|26234913|FG000|Overall Study|Adverse Event|23|||
13206582|NCT01957150|26234914|FG001|Overall Study|Adverse Event|20|||
13206583|NCT01957150|26234913|FG000|Overall Study|Withdrawal by Subject|13|||
13206584|NCT01957150|26234914|FG001|Overall Study|Withdrawal by Subject|17|||
13206585|NCT01957150|26234913|FG000|Overall Study|Physician Decision|3|||
13206586|NCT01957150|26234914|FG001|Overall Study|Physician Decision|6|||
13206587|NCT01957150|26234913|FG000|Overall Study|Lost to Follow-up|4|||
13206588|NCT01957150|26234914|FG001|Overall Study|Lost to Follow-up|4|||
13206589|NCT01957150|26234913|FG000|Overall Study|Protocol Violation|1|||
13206590|NCT01957150|26234914|FG001|Overall Study|Protocol Violation|0|||
13206591|NCT01957150|26234913|FG000|Overall Study|Lack of Efficacy|11|||
13206592|NCT01957150|26234914|FG001|Overall Study|Lack of Efficacy|11|||
13206593|NCT01957137|26234944|FG000|Randomized Portion|Adverse Event|1|||
13206594|NCT01957137|26234944|FG000|Randomized Portion|Withdrawal by Subject|1|||
13206595|NCT01957111|26234959|FG000|Overall Study|Withdrawal by Subject|1|||
13206596|NCT01957111|26234960|FG001|Overall Study|Withdrawal by Subject|1|||
13206597|NCT01956773|26234978|FG000|Overall Study|Lost to Follow-up|628|||
13206598|NCT01956773|26234979|FG001|Overall Study|Lost to Follow-up|1|||
13206599|NCT01956240|26234994|FG000|Overall Study|Lost to Follow-up|6|||
13206600|NCT01956240|26234995|FG001|Overall Study|Lost to Follow-up|20|||
13206601|NCT01956240|26234994|FG000|Overall Study|Adverse Event|17|||
13206602|NCT01956240|26234995|FG001|Overall Study|Adverse Event|4|||
13206603|NCT01956123|26235054|FG000|COS Cycle 2|Protocol Violation|8|||
13206604|NCT01956123|26235055|FG001|COS Cycle 2|Protocol Violation|3|||
13206605|NCT01956123|26235056|FG002|COS Cycle 2|Protocol Violation|0|||
13206606|NCT01956123|26235057|FG003|COS Cycle 2|Protocol Violation|0|||
13206607|NCT01956123|26235054|FG000|COS Cycle 2|Adverse Event|3|||
13206608|NCT01956123|26235055|FG001|COS Cycle 2|Adverse Event|4|||
13206609|NCT01956123|26235056|FG002|COS Cycle 2|Adverse Event|0|||
13206610|NCT01956123|26235057|FG003|COS Cycle 2|Adverse Event|0|||
13199162|NCT02019927|26212557|FG000|Overall Study|Lost to Follow-up|2|||
13199163|NCT02019927|26212558|FG001|Overall Study|Lost to Follow-up|4|||
13199164|NCT02019927|26212559|FG002|Overall Study|Lost to Follow-up|1|||
13199165|NCT02019927|26212560|FG003|Overall Study|Lost to Follow-up|2|||
13199166|NCT02019927|26212561|FG004|Overall Study|Lost to Follow-up|3|||
13199167|NCT02019927|26212562|FG005|Overall Study|Lost to Follow-up|1|||
13199168|NCT02019719|26212675|FG000|Overall Study|Adverse Event|1|||
13199169|NCT02019719|26212676|FG001|Overall Study|Adverse Event|0|||
13199170|NCT02019719|26212677|FG002|Overall Study|Adverse Event|0|||
13199171|NCT02019719|26212678|FG003|Overall Study|Adverse Event|1|||
13199172|NCT02019719|26212679|FG004|Overall Study|Adverse Event|1|||
13199173|NCT02019719|26212675|FG000|Overall Study|Protocol Violation|1|||
13199174|NCT02019719|26212676|FG001|Overall Study|Protocol Violation|1|||
13199175|NCT02019719|26212677|FG002|Overall Study|Protocol Violation|0|||
13199176|NCT02019719|26212678|FG003|Overall Study|Protocol Violation|0|||
13199177|NCT02019719|26212679|FG004|Overall Study|Protocol Violation|0|||
13199178|NCT02019719|26212675|FG000|Overall Study|Protocol defined stopping criteria|2|||
13199179|NCT02019719|26212676|FG001|Overall Study|Protocol defined stopping criteria|0|||
13199180|NCT02019719|26212677|FG002|Overall Study|Protocol defined stopping criteria|0|||
13199181|NCT02019719|26212678|FG003|Overall Study|Protocol defined stopping criteria|1|||
13199182|NCT02019719|26212679|FG004|Overall Study|Protocol defined stopping criteria|1|||
13199183|NCT02019719|26212675|FG000|Overall Study|Physician Decision|2|||
13199184|NCT02019719|26212676|FG001|Overall Study|Physician Decision|0|||
13199185|NCT02019719|26212677|FG002|Overall Study|Physician Decision|0|||
13199186|NCT02019719|26212678|FG003|Overall Study|Physician Decision|0|||
13199187|NCT02019719|26212679|FG004|Overall Study|Physician Decision|0|||
13199188|NCT02019667|26212700|FG000|First Intervention (6 Months)|Adverse Event|0|||
13199189|NCT02019667|26212701|FG001|First Intervention (6 Months)|Adverse Event|1|||
13199190|NCT02019667|26212700|FG000|2nd Intervention (6 Months)|Adverse Event|0|||
13199191|NCT02019667|26212701|FG001|2nd Intervention (6 Months)|Adverse Event|1|||
13199192|NCT02019667|26212700|FG000|2nd Intervention (6 Months)|Physician Decision|0|||
13199193|NCT02019667|26212701|FG001|2nd Intervention (6 Months)|Physician Decision|1|||
13199194|NCT02019602|26212718|FG000|Screening Period|Ineligibility|4|||
13199195|NCT02019602|26212719|FG001|Screening Period|Ineligibility|0|||
13199196|NCT02019602|26212718|FG000|Screening Period|Adverse Event|1|||
13199197|NCT02019602|26212719|FG001|Screening Period|Adverse Event|0|||
13199198|NCT02019550|26212764|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
13199199|NCT02019550|26212765|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
13199200|NCT02019472|26212796|FG000|Overall Study|Adverse Event|14|||
13199201|NCT02019472|26212797|FG001|Overall Study|Adverse Event|23|||
13199202|NCT02019472|26212798|FG002|Overall Study|Adverse Event|17|||
13199203|NCT02019472|26212796|FG000|Overall Study|Death|0|||
13199204|NCT02019472|26212797|FG001|Overall Study|Death|1|||
13199205|NCT02019472|26212798|FG002|Overall Study|Death|1|||
13199206|NCT02019472|26212796|FG000|Overall Study|Lack of Efficacy|7|||
13199207|NCT02019472|26212797|FG001|Overall Study|Lack of Efficacy|4|||
13199208|NCT02019472|26212798|FG002|Overall Study|Lack of Efficacy|4|||
13199209|NCT02019472|26212796|FG000|Overall Study|Lost to Follow-up|0|||
13199210|NCT02019472|26212797|FG001|Overall Study|Lost to Follow-up|2|||
13199211|NCT02019472|26212798|FG002|Overall Study|Lost to Follow-up|1|||
13199212|NCT02019472|26212796|FG000|Overall Study|Physician Decision|1|||
13199213|NCT02019472|26212797|FG001|Overall Study|Physician Decision|2|||
13199214|NCT02019472|26212798|FG002|Overall Study|Physician Decision|0|||
13199215|NCT02019472|26212796|FG000|Overall Study|Pregnancy|1|||
13199216|NCT02019472|26212797|FG001|Overall Study|Pregnancy|2|||
13199217|NCT02019472|26212798|FG002|Overall Study|Pregnancy|2|||
13199218|NCT02019472|26212796|FG000|Overall Study|Withdrawal by Subject|11|||
13199219|NCT02019472|26212797|FG001|Overall Study|Withdrawal by Subject|10|||
13199220|NCT02019472|26212798|FG002|Overall Study|Withdrawal by Subject|11|||
13199221|NCT02019472|26212796|FG000|Overall Study|Other|3|||
13199222|NCT02019472|26212797|FG001|Overall Study|Other|8|||
13199223|NCT02019472|26212798|FG002|Overall Study|Other|6|||
13199224|NCT02019420|26212833|FG000|Overall Study|Did not receive study drug|2|||
13199225|NCT02019420|26212834|FG001|Overall Study|Did not receive study drug|2|||
13199226|NCT02019420|26212833|FG000|Overall Study|Withdrawal by Subject|1|||
13199227|NCT02019420|26212834|FG001|Overall Study|Withdrawal by Subject|3|||
13199228|NCT02019420|26212833|FG000|Overall Study|At request of sponsor or investigator|0|||
13199229|NCT02019420|26212834|FG001|Overall Study|At request of sponsor or investigator|1|||
13199230|NCT02019420|26212833|FG000|Overall Study|Death|104|||
13199231|NCT02019420|26212834|FG001|Overall Study|Death|99|||
13199232|NCT02019420|26212833|FG000|Overall Study|Transferred to other care facility|1|||
13199233|NCT02019420|26212834|FG001|Overall Study|Transferred to other care facility|1|||
13199234|NCT02019277|26212853|FG000|Overall Study|Withdrawal by Subject|3|||
13199235|NCT02019277|26212853|FG000|Overall Study|Death|7|||
13199236|NCT02019277|26212853|FG000|Overall Study|Did no Cooperate|1|||
13199237|NCT02019277|26212853|FG000|Overall Study|Adverse Event|1|||
13199238|NCT02019264|26212894|FG000|Overall Study|Not treated|6|||
13199239|NCT02019264|26212895|FG001|Overall Study|Not treated|4|||
13199240|NCT02019264|26212894|FG000|Overall Study|Lost to Follow-up|50|||
13199241|NCT02019264|26212895|FG001|Overall Study|Lost to Follow-up|47|||
13199242|NCT02019264|26212894|FG000|Overall Study|Withdrawal by Subject|142|||
13199243|NCT02019264|26212895|FG001|Overall Study|Withdrawal by Subject|117|||
13199244|NCT02019264|26212894|FG000|Overall Study|Administrative reason|36|||
13199245|NCT02019264|26212895|FG001|Overall Study|Administrative reason|28|||
13199246|NCT02019264|26212894|FG000|Overall Study|Missing|14|||
13199247|NCT02019264|26212895|FG001|Overall Study|Missing|11|||
13199248|NCT02019108|26212924|FG000|Overall Study|Lost to Follow-up|5|||
13199249|NCT02019108|26212925|FG001|Overall Study|Lost to Follow-up|7|||
13199250|NCT02018887|26213040|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1|||
13199251|NCT02018887|26213041|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
13199252|NCT02018887|26213042|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
13199253|NCT02018887|26213043|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
13199254|NCT02018887|26213044|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
13199255|NCT02018887|26213045|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
13199256|NCT02018887|26213046|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
13199257|NCT02018887|26213047|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
13199258|NCT02018887|26213048|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
13199259|NCT02018887|26213049|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
13199260|NCT02018887|26213050|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
13199261|NCT02018887|26213040|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
13199262|NCT02018887|26213041|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
13199263|NCT02018887|26213042|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
13199264|NCT02018887|26213043|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
13199265|NCT02018887|26213044|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
13199266|NCT02018887|26213045|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
13199267|NCT02018887|26213046|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
13199268|NCT02018887|26213047|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4|||
13199269|NCT02018887|26213048|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
13199270|NCT02018887|26213049|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
13199271|NCT02018887|26213050|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
13199272|NCT02018887|26213040|FG000|Part C: Cohort 8 Overall|Adverse Event|0|||
13199273|NCT02018887|26213041|FG001|Part C: Cohort 8 Overall|Adverse Event|0|||
13199274|NCT02018887|26213042|FG002|Part C: Cohort 8 Overall|Adverse Event|0|||
13199275|NCT02018887|26213043|FG003|Part C: Cohort 8 Overall|Adverse Event|0|||
13199276|NCT02018887|26213044|FG004|Part C: Cohort 8 Overall|Adverse Event|0|||
13199277|NCT02018887|26213045|FG005|Part C: Cohort 8 Overall|Adverse Event|0|||
13199278|NCT02018887|26213046|FG006|Part C: Cohort 8 Overall|Adverse Event|0|||
13199279|NCT02018887|26213047|FG007|Part C: Cohort 8 Overall|Adverse Event|0|||
13199280|NCT02018887|26213048|FG008|Part C: Cohort 8 Overall|Adverse Event|1|||
13199281|NCT02018887|26213049|FG009|Part C: Cohort 8 Overall|Adverse Event|3|||
13199282|NCT02018887|26213050|FG010|Part C: Cohort 8 Overall|Adverse Event|0|||
13199283|NCT02018887|26213040|FG000|Part C: Cohort 8 Overall|Physician Decision|0|||
13199284|NCT02018887|26213041|FG001|Part C: Cohort 8 Overall|Physician Decision|0|||
13199285|NCT02018887|26213042|FG002|Part C: Cohort 8 Overall|Physician Decision|0|||
13199286|NCT02018887|26213043|FG003|Part C: Cohort 8 Overall|Physician Decision|0|||
13199287|NCT02018887|26213044|FG004|Part C: Cohort 8 Overall|Physician Decision|0|||
13199288|NCT02018887|26213045|FG005|Part C: Cohort 8 Overall|Physician Decision|0|||
13199289|NCT02018887|26213046|FG006|Part C: Cohort 8 Overall|Physician Decision|0|||
13199290|NCT02018887|26213047|FG007|Part C: Cohort 8 Overall|Physician Decision|0|||
13199291|NCT02018887|26213048|FG008|Part C: Cohort 8 Overall|Physician Decision|2|||
13199292|NCT02018887|26213049|FG009|Part C: Cohort 8 Overall|Physician Decision|0|||
13199293|NCT02018887|26213050|FG010|Part C: Cohort 8 Overall|Physician Decision|1|||
13199294|NCT02018861|26213209|FG000|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
13199295|NCT02018861|26213210|FG001|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|2|||
13199296|NCT02018861|26213211|FG002|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
13199297|NCT02018861|26213212|FG003|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|6|||
13199298|NCT02018861|26213213|FG004|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|4|||
13199299|NCT02018861|26213214|FG005|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
13199300|NCT02018861|26213215|FG006|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
13199301|NCT02018861|26213216|FG007|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
13199302|NCT02018861|26213217|FG008|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
13199303|NCT02018861|26213218|FG009|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
13199304|NCT02018861|26213209|FG000|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
13199305|NCT02018861|26213210|FG001|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
13199306|NCT02018861|26213211|FG002|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
13199307|NCT02018861|26213212|FG003|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
13199308|NCT02018861|26213213|FG004|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
13199309|NCT02018861|26213214|FG005|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
13199310|NCT02018861|26213215|FG006|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
13199311|NCT02018861|26213216|FG007|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
13112662|NCT03154086|25909091|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
13199312|NCT02018861|26213217|FG008|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
13199313|NCT02018861|26213218|FG009|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
13199314|NCT02018861|26213209|FG000|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
13199315|NCT02018861|26213210|FG001|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
13199316|NCT02018861|26213211|FG002|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
13199317|NCT02018861|26213212|FG003|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|13|||
13199318|NCT02018861|26213213|FG004|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|18|||
13199319|NCT02018861|26213214|FG005|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
13485625|NCT01126749|27033001|FG001|Phase 1b|Other|1|||
13485626|NCT01126749|27033002|FG002|Phase 1b|Other|0|||
13112663|NCT03154086|25909092|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1|||
13112664|NCT03154086|25909093|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
13112665|NCT03154086|25909094|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
13112666|NCT03154086|25909095|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
13112667|NCT03154086|25909096|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
13112668|NCT03154086|25909097|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
13112669|NCT03154086|25909098|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
13112670|NCT03154086|25909099|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
13112671|NCT03154086|25909085|FG000|Part B (Up to 25 Days)|Adverse Event|0|||
13485627|NCT01126749|27033003|FG003|Phase 1b|Other|0|||
13485628|NCT01126749|27033000|FG000|Phase 1b|Withdrawal by Subject|0|||
13112672|NCT03154086|25909086|FG001|Part B (Up to 25 Days)|Adverse Event|0|||
13112673|NCT03154086|25909087|FG002|Part B (Up to 25 Days)|Adverse Event|0|||
13199320|NCT02018861|26213215|FG006|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
13199321|NCT02018861|26213216|FG007|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
13199322|NCT02018861|26213217|FG008|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
13199323|NCT02018861|26213218|FG009|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
13199324|NCT02018861|26213209|FG000|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
13199325|NCT02018861|26213210|FG001|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
13199326|NCT02018861|26213211|FG002|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
13199327|NCT02018861|26213212|FG003|Parsaclisib Monotherapy: 21-day Cycles|Death|3|||
13199328|NCT02018861|26213213|FG004|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
13199329|NCT02018861|26213214|FG005|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
13199330|NCT02018861|26213215|FG006|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
13199331|NCT02018861|26213216|FG007|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
13199332|NCT02018861|26213217|FG008|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
13112674|NCT03154086|25909088|FG003|Part B (Up to 25 Days)|Adverse Event|0|||
13112675|NCT03154086|25909089|FG004|Part B (Up to 25 Days)|Adverse Event|0|||
13112676|NCT03154086|25909090|FG005|Part B (Up to 25 Days)|Adverse Event|0|||
13112677|NCT03154086|25909091|FG006|Part B (Up to 25 Days)|Adverse Event|0|||
13112678|NCT03154086|25909092|FG007|Part B (Up to 25 Days)|Adverse Event|0|||
13112679|NCT03154086|25909093|FG008|Part B (Up to 25 Days)|Adverse Event|0|||
13112680|NCT03154086|25909094|FG009|Part B (Up to 25 Days)|Adverse Event|0|||
13112681|NCT03154086|25909095|FG010|Part B (Up to 25 Days)|Adverse Event|1|||
13112682|NCT03154086|25909096|FG011|Part B (Up to 25 Days)|Adverse Event|0|||
13112683|NCT03154086|25909097|FG012|Part B (Up to 25 Days)|Adverse Event|0|||
13199333|NCT02018861|26213218|FG009|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
13199334|NCT02018861|26213209|FG000|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
13199335|NCT02018861|26213210|FG001|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
13199336|NCT02018861|26213211|FG002|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
13199337|NCT02018861|26213212|FG003|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
13199338|NCT02018861|26213213|FG004|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
13199339|NCT02018861|26213214|FG005|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
13199340|NCT02018861|26213215|FG006|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
13199341|NCT02018861|26213216|FG007|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
13199342|NCT02018861|26213217|FG008|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
13199343|NCT02018861|26213218|FG009|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
13199344|NCT02018861|26213209|FG000|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
13199345|NCT02018861|26213210|FG001|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
13199346|NCT02018861|26213211|FG002|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
13199347|NCT02018861|26213212|FG003|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
13199348|NCT02018861|26213213|FG004|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|1|||
13199349|NCT02018861|26213214|FG005|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
13199350|NCT02018861|26213215|FG006|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
13485629|NCT01126749|27033001|FG001|Phase 1b|Withdrawal by Subject|1|||
13485630|NCT01126749|27033002|FG002|Phase 1b|Withdrawal by Subject|0|||
13199351|NCT02018861|26213216|FG007|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
13199352|NCT02018861|26213217|FG008|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
13199353|NCT02018861|26213218|FG009|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
13199354|NCT02018861|26213209|FG000|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
13199355|NCT02018861|26213210|FG001|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
13199356|NCT02018861|26213211|FG002|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
13199357|NCT02018861|26213212|FG003|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|4|||
13199358|NCT02018861|26213213|FG004|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|1|||
13199359|NCT02018861|26213214|FG005|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|2|||
13199360|NCT02018861|26213215|FG006|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
13199361|NCT02018861|26213216|FG007|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
13199362|NCT02018861|26213217|FG008|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
13199363|NCT02018861|26213218|FG009|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
13199364|NCT02018861|26213209|FG000|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
13199365|NCT02018861|26213210|FG001|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
13199366|NCT02018861|26213211|FG002|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
13199367|NCT02018861|26213212|FG003|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|2|||
13199368|NCT02018861|26213213|FG004|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|1|||
13199369|NCT02018861|26213214|FG005|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
13199370|NCT02018861|26213215|FG006|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
13199371|NCT02018861|26213216|FG007|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
13199372|NCT02018861|26213217|FG008|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
13199373|NCT02018861|26213218|FG009|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
13199374|NCT02018861|26213209|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
13199375|NCT02018861|26213210|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
13199376|NCT02018861|26213211|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
13199377|NCT02018861|26213212|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
13199378|NCT02018861|26213213|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
13199379|NCT02018861|26213214|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
13199380|NCT02018861|26213215|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|5|||
13199381|NCT02018861|26213216|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|2|||
13199382|NCT02018861|26213217|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
13199383|NCT02018861|26213218|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
13199384|NCT02018861|26213209|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
13199385|NCT02018861|26213210|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
13199386|NCT02018861|26213211|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
13199387|NCT02018861|26213212|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
13199388|NCT02018861|26213213|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
13199389|NCT02018861|26213214|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
13199390|NCT02018861|26213215|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|3|||
13199391|NCT02018861|26213216|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|1|||
13199392|NCT02018861|26213217|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
13199393|NCT02018861|26213218|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
13199394|NCT02018861|26213209|FG000|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
13199395|NCT02018861|26213210|FG001|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
13199396|NCT02018861|26213211|FG002|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
13199397|NCT02018861|26213212|FG003|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
13199398|NCT02018861|26213213|FG004|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
13199399|NCT02018861|26213214|FG005|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
13199400|NCT02018861|26213215|FG006|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
13199401|NCT02018861|26213216|FG007|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
13199402|NCT02018861|26213217|FG008|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|1|||
13199403|NCT02018861|26213218|FG009|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
13199404|NCT02018861|26213209|FG000|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
13199405|NCT02018861|26213210|FG001|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
13199406|NCT02018861|26213211|FG002|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
13199407|NCT02018861|26213212|FG003|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
13199408|NCT02018861|26213213|FG004|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
13199409|NCT02018861|26213214|FG005|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
13199410|NCT02018861|26213215|FG006|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
13199411|NCT02018861|26213216|FG007|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
13199412|NCT02018861|26213217|FG008|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|1|||
13199413|NCT02018861|26213218|FG009|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
13199414|NCT02018861|26213209|FG000|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
13199415|NCT02018861|26213210|FG001|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
13199416|NCT02018861|26213211|FG002|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
13199417|NCT02018861|26213212|FG003|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
13199418|NCT02018861|26213213|FG004|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
13199419|NCT02018861|26213214|FG005|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
13199420|NCT02018861|26213215|FG006|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
13199421|NCT02018861|26213216|FG007|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
13199422|NCT02018861|26213217|FG008|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|1|||
13199423|NCT02018861|26213218|FG009|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
13199424|NCT02018822|26213249|FG000|Overall Study|filling replaced by crown|0|||
13199425|NCT02018822|26213250|FG001|Overall Study|filling replaced by crown|1|||
13199426|NCT02018822|26213251|FG002|Overall Study|filling replaced by crown|0|||
13199427|NCT02018822|26213249|FG000|Overall Study|Physician Decision|0|||
13199428|NCT02018822|26213250|FG001|Overall Study|Physician Decision|1|||
13199429|NCT02018822|26213251|FG002|Overall Study|Physician Decision|1|||
13199430|NCT02018822|26213249|FG000|Overall Study|Lost to Follow-up|6|||
13199431|NCT02018822|26213250|FG001|Overall Study|Lost to Follow-up|6|||
13199432|NCT02018822|26213251|FG002|Overall Study|Lost to Follow-up|5|||
13199433|NCT02018562|26213276|FG000|Overall Study|Withdrawal by Subject|2|||
13199434|NCT02018562|26213277|FG001|Overall Study|Withdrawal by Subject|0|||
13199435|NCT02018562|26213276|FG000|Overall Study|Discharged prior to study completion|1|||
13199436|NCT02018562|26213277|FG001|Overall Study|Discharged prior to study completion|0|||
13199437|NCT02018458|26213285|FG000|Overall Study|Death|4|||
13199438|NCT02018042|26213293|FG000|Overall Study|Withdrawal by Subject|1|||
13199439|NCT02017899|26213386|FG000|Overall Study|Withdrawal by Subject|0|||
13199440|NCT02017899|26213387|FG001|Overall Study|Withdrawal by Subject|0|||
13199441|NCT02017899|26213388|FG002|Overall Study|Withdrawal by Subject|0|||
13199442|NCT02017899|26213389|FG003|Overall Study|Withdrawal by Subject|1|||
13199443|NCT02017899|26213390|FG004|Overall Study|Withdrawal by Subject|1|||
13199444|NCT02017899|26213391|FG005|Overall Study|Withdrawal by Subject|0|||
13199445|NCT02017860|26213397|FG000|Overall Study|Adverse Event|1|||
13199446|NCT02017860|26213397|FG000|Overall Study|Withdrawal by Subject|1|||
13199447|NCT02017535|26213432|FG000|Overall Study|Withdrawal by Subject|1|||
13199448|NCT02017535|26213433|FG001|Overall Study|Withdrawal by Subject|0|||
13199449|NCT02017535|26213434|FG002|Overall Study|Withdrawal by Subject|0|||
13199450|NCT02017535|26213435|FG003|Overall Study|Withdrawal by Subject|0|||
13199451|NCT02017522|26213442|FG000|Overall Study|Withdrawal by Subject|1|||
13199452|NCT02017444|26213483|FG000|Overall Study|Physician Decision|1|||
13199453|NCT02017444|26213484|FG001|Overall Study|Physician Decision|0|||
13199454|NCT02017444|26213483|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1|||
13199455|NCT02017444|26213484|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0|||
13199456|NCT02017223|26213490|FG000|Overall Study|Algorithm problems|2|||
13199457|NCT02017171|26213519|FG000|Overall Study|Death|10|||
13199458|NCT02017171|26213520|FG001|Overall Study|Death|4|||
13199459|NCT02017171|26213519|FG000|Overall Study|Withdrawal by Subject|23|||
13199460|NCT02017171|26213520|FG001|Overall Study|Withdrawal by Subject|17|||
13199461|NCT02017171|26213519|FG000|Overall Study|Lost to Follow-up|21|||
13199462|NCT02017171|26213520|FG001|Overall Study|Lost to Follow-up|20|||
13199463|NCT02017171|26213519|FG000|Overall Study|ESKD|6|||
13199464|NCT02017171|26213520|FG001|Overall Study|ESKD|2|||
13199465|NCT02017171|26213519|FG000|Overall Study|Miscellaneous|2|||
13199466|NCT02017171|26213520|FG001|Overall Study|Miscellaneous|3|||
13199467|NCT02017015|26213529|FG000|Overall Study|Adverse Event|9|||
13199468|NCT02017015|26213529|FG000|Overall Study|Withdrawal by Subject|21|||
13199469|NCT02017015|26213529|FG000|Overall Study|Death|4|||
13199470|NCT02017015|26213529|FG000|Overall Study|Progressive Disease|31|||
13112684|NCT03154086|25909098|FG013|Part B (Up to 25 Days)|Adverse Event|0|||
13112685|NCT03154086|25909099|FG014|Part B (Up to 25 Days)|Adverse Event|0|||
13112686|NCT03154047|25909105|FG000|Overall Study|Death|1|||
13112687|NCT03154047|25909105|FG000|Overall Study|Study terminated by sponsor|76|||
13112688|NCT03154047|25909105|FG000|Overall Study|Withdrawal by Subject|3|||
13112689|NCT03153137|25909170|FG000|Overall Study|Lost to Follow-up|1|||
13112690|NCT03153137|25909171|FG001|Overall Study|Lost to Follow-up|0|||
13112691|NCT03153137|25909170|FG000|Overall Study|Withdrawal by Subject|2|||
13112692|NCT03153137|25909171|FG001|Overall Study|Withdrawal by Subject|1|||
13112693|NCT03153137|25909170|FG000|Overall Study|Physician Decision|0|||
13112694|NCT03153137|25909171|FG001|Overall Study|Physician Decision|3|||
13112695|NCT03152552|25909318|FG000|Treatment Period 1 (12 Weeks)|Death|0|||
13112696|NCT03152552|25909319|FG001|Treatment Period 1 (12 Weeks)|Death|1|||
13112697|NCT03152552|25909320|FG002|Treatment Period 1 (12 Weeks)|Death|0|||
13112698|NCT03152552|25909321|FG003|Treatment Period 1 (12 Weeks)|Death|0|||
13112699|NCT03152552|25909322|FG004|Treatment Period 1 (12 Weeks)|Death|1|||
13112700|NCT03152552|25909318|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
13112701|NCT03152552|25909319|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1|||
13112702|NCT03152552|25909320|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
13112703|NCT03152552|25909321|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
13112704|NCT03152552|25909322|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
13112705|NCT03152552|25909318|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8|||
13112706|NCT03152552|25909319|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9|||
13112707|NCT03152552|25909320|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
13112708|NCT03152552|25909321|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
13112709|NCT03152552|25909322|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20|||
13112710|NCT03152552|25909318|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
13112711|NCT03152552|25909319|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
13112712|NCT03152552|25909320|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
13112713|NCT03152552|25909321|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
13112714|NCT03152552|25909322|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
13112715|NCT03152552|25909318|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0|||
13112716|NCT03152552|25909319|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0|||
13112717|NCT03152552|25909320|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1|||
13112718|NCT03152552|25909321|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0|||
13112719|NCT03152552|25909322|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0|||
13112720|NCT03152552|25909318|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
13199471|NCT02017015|26213529|FG000|Overall Study|Non-compliance with study drug|2|||
13199472|NCT02017015|26213529|FG000|Overall Study|Physician Decision|2|||
13199473|NCT02016898|26213544|FG000|Overall Study|Death|1|||
13199474|NCT02016898|26213545|FG001|Overall Study|Death|1|||
13199475|NCT02016898|26213544|FG000|Overall Study|Lost to Follow-up|4|||
13199476|NCT02016898|26213545|FG001|Overall Study|Lost to Follow-up|4|||
13199477|NCT02016781|26213584|FG000|Interim Look for Primary Analysis|Alive and on study|71|||
13199478|NCT02016781|26213585|FG001|Interim Look for Primary Analysis|Alive and on study|23|||
13199479|NCT02016781|26213584|FG000|Interim Look for Primary Analysis|Withdrawal by Subject|2|||
13199480|NCT02016781|26213585|FG001|Interim Look for Primary Analysis|Withdrawal by Subject|1|||
13199481|NCT02016781|26213584|FG000|Final Database Lock|Withdrawal by Subject|2|||
13199482|NCT02016781|26213585|FG001|Final Database Lock|Withdrawal by Subject|1|||
13199483|NCT02016781|26213584|FG000|Final Database Lock|Lost to Follow-up|11|||
13199484|NCT02016781|26213585|FG001|Final Database Lock|Lost to Follow-up|4|||
13199485|NCT02016781|26213584|FG000|Final Database Lock|Missing data|0|||
13199486|NCT02016781|26213585|FG001|Final Database Lock|Missing data|3|||
13199487|NCT02016755|26213603|FG000|Overall Study|Major amputation of index limb|2|||
13199488|NCT02016755|26213603|FG000|Overall Study|Adverse Event|2|||
13199489|NCT02016755|26213603|FG000|Overall Study|Physician Decision|1|||
13199490|NCT02016755|26213603|FG000|Overall Study|Death|2|||
13199491|NCT02016716|26213634|FG000|Overall Study|Withdrawal by Subject|5|||
13199492|NCT02016716|26213635|FG001|Overall Study|Withdrawal by Subject|5|||
13199493|NCT02016716|26213636|FG002|Overall Study|Withdrawal by Subject|5|||
13199494|NCT02016716|26213634|FG000|Overall Study|Protocol-specified Criteria|0|||
13199495|NCT02016716|26213635|FG001|Overall Study|Protocol-specified Criteria|1|||
13199496|NCT02016716|26213636|FG002|Overall Study|Protocol-specified Criteria|0|||
13199497|NCT02016716|26213634|FG000|Overall Study|Lost to Follow-up|1|||
13199498|NCT02016716|26213635|FG001|Overall Study|Lost to Follow-up|2|||
13199499|NCT02016716|26213636|FG002|Overall Study|Lost to Follow-up|1|||
13199500|NCT02016690|26213649|FG000|Overall Study|Excluded from SAS: Enrollment violation|2|||
13199501|NCT02016690|26213649|FG000|Overall Study|Excluded from SAS: Duplication|2|||
13199502|NCT02016690|26213649|FG000|Overall Study|Excluded from SAS: Early treatment|2|||
13199503|NCT02016690|26213649|FG000|Overall Study|Excluded from SAS: Ineligible for study|2|||
13199504|NCT02016690|26213649|FG000|Overall Study|Did not meet inclusion criteria|13|||
13199505|NCT02016690|26213649|FG000|Overall Study|Hospitalized for RSV at study start|3|||
13199506|NCT02016625|26213688|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0|||
13199507|NCT02016625|26213689|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1|||
13199508|NCT02016625|26213688|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1|||
13199509|NCT02016625|26213689|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0|||
13199510|NCT02016625|26213688|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2|||
13199511|NCT02016625|26213689|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0|||
13199512|NCT02016482|26213784|FG000|Period A|Adverse Event|3|||
13199513|NCT02016482|26213785|FG001|Period A|Adverse Event|5|||
13199514|NCT02016482|26213784|FG000|Period A|Withdrawal by Subject|3|||
13199515|NCT02016482|26213785|FG001|Period A|Withdrawal by Subject|4|||
13199516|NCT02016482|26213784|FG000|Period A|Lost to Follow-up|3|||
13199517|NCT02016482|26213785|FG001|Period A|Lost to Follow-up|3|||
13199518|NCT02016482|26213784|FG000|Period A|Lack of Efficacy|2|||
13199519|NCT02016482|26213785|FG001|Period A|Lack of Efficacy|1|||
13199520|NCT02016482|26213784|FG000|Period A|Other|3|||
13199521|NCT02016482|26213785|FG001|Period A|Other|0|||
13199522|NCT02016482|26213784|FG000|Period A|Protocol Violation|0|||
13199523|NCT02016482|26213785|FG001|Period A|Protocol Violation|1|||
13199524|NCT02016482|26213784|FG000|Period A|Required Alternative/Prohibited Therapy|0|||
13199525|NCT02016482|26213785|FG001|Period A|Required Alternative/Prohibited Therapy|1|||
13199526|NCT02016482|26213784|FG000|Period B|Withdrawal by Subject|1|||
13199527|NCT02016482|26213785|FG001|Period B|Withdrawal by Subject|1|||
13199528|NCT02016482|26213784|FG000|Period B|Lost to Follow-up|2|||
13199529|NCT02016482|26213785|FG001|Period B|Lost to Follow-up|0|||
13199530|NCT02016482|26213784|FG000|Period B|Lack of Efficacy|6|||
13199531|NCT02016482|26213785|FG001|Period B|Lack of Efficacy|4|||
13199532|NCT02016482|26213784|FG000|Period B|Other|4|||
13199533|NCT02016482|26213785|FG001|Period B|Other|0|||
13199534|NCT02016482|26213784|FG000|Period B|Required Alternative/Prohibited Therapy|0|||
13199535|NCT02016482|26213785|FG001|Period B|Required Alternative/Prohibited Therapy|2|||
13199536|NCT02016300|26213810|FG000|Overall Study|Lost to Follow-up|0|||
13199537|NCT02016300|26213811|FG001|Overall Study|Lost to Follow-up|3|||
13199538|NCT02016183|26213820|FG000|Overall Study|Case Report Forms Uncollected|13|||
13199539|NCT02016183|26213820|FG000|Overall Study|Protocol Violation|52|||
13199540|NCT02016170|26213839|FG000|Overall Study|Adverse Event|1|||
13199541|NCT02016170|26213840|FG001|Overall Study|Adverse Event|1|||
13199542|NCT02016170|26213841|FG002|Overall Study|Adverse Event|0|||
13199543|NCT02016170|26213839|FG000|Overall Study|Protocol Violation|1|||
13199544|NCT02016170|26213840|FG001|Overall Study|Protocol Violation|0|||
13199545|NCT02016170|26213841|FG002|Overall Study|Protocol Violation|0|||
13199546|NCT02016105|26213900|FG000|TREATMENT PERIOD 1|Protocol Violation|2|||
13199547|NCT02016105|26213901|FG001|TREATMENT PERIOD 1|Protocol Violation|8|||
13199548|NCT02016105|26213902|FG002|TREATMENT PERIOD 1|Protocol Violation|0|||
13199549|NCT02016105|26213903|FG003|TREATMENT PERIOD 1|Protocol Violation|0|||
13199550|NCT02016105|26213904|FG004|TREATMENT PERIOD 1|Protocol Violation|0|||
13199551|NCT02016105|26213905|FG005|TREATMENT PERIOD 1|Protocol Violation|0|||
13199552|NCT02016105|26213900|FG000|TREATMENT PERIOD 1|Physician Decision|0|||
13199553|NCT02016105|26213901|FG001|TREATMENT PERIOD 1|Physician Decision|2|||
13199554|NCT02016105|26213902|FG002|TREATMENT PERIOD 1|Physician Decision|0|||
13199555|NCT02016105|26213903|FG003|TREATMENT PERIOD 1|Physician Decision|0|||
13199556|NCT02016105|26213904|FG004|TREATMENT PERIOD 1|Physician Decision|0|||
13199557|NCT02016105|26213905|FG005|TREATMENT PERIOD 1|Physician Decision|0|||
13199558|NCT02016105|26213900|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4|||
13199559|NCT02016105|26213901|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2|||
13199560|NCT02016105|26213902|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0|||
13199561|NCT02016105|26213903|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0|||
13199562|NCT02016105|26213904|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0|||
13199563|NCT02016105|26213905|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0|||
13199564|NCT02016105|26213900|FG000|TREATMENT PERIOD 1|Pregnancy|0|||
13199565|NCT02016105|26213901|FG001|TREATMENT PERIOD 1|Pregnancy|1|||
13199566|NCT02016105|26213902|FG002|TREATMENT PERIOD 1|Pregnancy|0|||
13199567|NCT02016105|26213903|FG003|TREATMENT PERIOD 1|Pregnancy|0|||
13199568|NCT02016105|26213904|FG004|TREATMENT PERIOD 1|Pregnancy|0|||
13199569|NCT02016105|26213905|FG005|TREATMENT PERIOD 1|Pregnancy|0|||
13199570|NCT02016105|26213900|FG000|TREATMENT PERIOD 1|Adverse Event|3|||
13199571|NCT02016105|26213901|FG001|TREATMENT PERIOD 1|Adverse Event|5|||
13199572|NCT02016105|26213902|FG002|TREATMENT PERIOD 1|Adverse Event|0|||
13199573|NCT02016105|26213903|FG003|TREATMENT PERIOD 1|Adverse Event|0|||
13199574|NCT02016105|26213904|FG004|TREATMENT PERIOD 1|Adverse Event|0|||
13199575|NCT02016105|26213905|FG005|TREATMENT PERIOD 1|Adverse Event|0|||
13199576|NCT02016105|26213900|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15|||
13199577|NCT02016105|26213901|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11|||
13223226|NCT01799590|26288093|FG002|Overall Study|Pregnancy|0|||
13112721|NCT03152552|25909319|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
13112722|NCT03152552|25909320|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
13112723|NCT03152552|25909321|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1|||
13112724|NCT03152552|25909322|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
13112725|NCT03152552|25909318|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6|||
13112726|NCT03152552|25909319|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5|||
13112727|NCT03152552|25909320|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
13112728|NCT03152552|25909321|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
13112729|NCT03152552|25909322|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11|||
13112730|NCT03152526|25909337|FG000|Overall Study|Withdrawal by Subject|0|||
13199578|NCT02016105|26213902|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
13199579|NCT02016105|26213903|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
13199580|NCT02016105|26213904|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
13199581|NCT02016105|26213905|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
13199582|NCT02016105|26213900|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6|||
13199583|NCT02016105|26213901|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4|||
13199584|NCT02016105|26213902|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0|||
13199585|NCT02016105|26213903|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0|||
13199586|NCT02016105|26213904|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0|||
13199587|NCT02016105|26213905|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0|||
13199588|NCT02016105|26213900|FG000|TREATMENT PERIOD 2|Non compliance study medication|0|||
13112731|NCT03152526|25909338|FG001|Overall Study|Withdrawal by Subject|1|||
13199589|NCT02016105|26213901|FG001|TREATMENT PERIOD 2|Non compliance study medication|0|||
13199590|NCT02016105|26213902|FG002|TREATMENT PERIOD 2|Non compliance study medication|0|||
13199591|NCT02016105|26213903|FG003|TREATMENT PERIOD 2|Non compliance study medication|0|||
13199592|NCT02016105|26213904|FG004|TREATMENT PERIOD 2|Non compliance study medication|0|||
13199593|NCT02016105|26213905|FG005|TREATMENT PERIOD 2|Non compliance study medication|1|||
13199594|NCT02016105|26213900|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0|||
13199595|NCT02016105|26213901|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0|||
13199596|NCT02016105|26213902|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2|||
13199597|NCT02016105|26213903|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6|||
13199598|NCT02016105|26213904|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3|||
13199599|NCT02016105|26213905|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2|||
13199600|NCT02016105|26213900|FG000|TREATMENT PERIOD 2|Pregnancy|0|||
13199601|NCT02016105|26213901|FG001|TREATMENT PERIOD 2|Pregnancy|0|||
13199602|NCT02016105|26213902|FG002|TREATMENT PERIOD 2|Pregnancy|0|||
13199603|NCT02016105|26213903|FG003|TREATMENT PERIOD 2|Pregnancy|0|||
13199604|NCT02016105|26213904|FG004|TREATMENT PERIOD 2|Pregnancy|0|||
13199605|NCT02016105|26213905|FG005|TREATMENT PERIOD 2|Pregnancy|1|||
13112732|NCT03152110|25909353|FG000|Overall Study|Withdrawal by Subject|3|||
13112733|NCT03152019|25909366|FG000|Overall Study|Adverse Event|0|||
13199606|NCT02016105|26213900|FG000|TREATMENT PERIOD 2|Death|0|||
13199607|NCT02016105|26213901|FG001|TREATMENT PERIOD 2|Death|0|||
13112734|NCT03152019|25909367|FG001|Overall Study|Adverse Event|1|||
13112735|NCT03151551|25909438|FG000|Open-Label Treatment Period|Adverse Event|0|||
13112736|NCT03151551|25909439|FG001|Open-Label Treatment Period|Adverse Event|2|||
13112737|NCT03151551|25909438|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
13112738|NCT03151551|25909439|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
13112739|NCT03151551|25909438|FG000|Open-Label Treatment Period|Withdrawal by Subject|12|||
13112740|NCT03151551|25909439|FG001|Open-Label Treatment Period|Withdrawal by Subject|18|||
13112741|NCT03151551|25909438|FG000|Open-Label Treatment Period|Lack of Efficacy|1|||
13112742|NCT03151551|25909439|FG001|Open-Label Treatment Period|Lack of Efficacy|1|||
13112743|NCT03151551|25909438|FG000|Open-Label Treatment Period|Physician Decision|3|||
13112744|NCT03151551|25909439|FG001|Open-Label Treatment Period|Physician Decision|0|||
13112745|NCT03151551|25909438|FG000|Open-Label Treatment Period|Protocol Deviation|1|||
13112746|NCT03151551|25909439|FG001|Open-Label Treatment Period|Protocol Deviation|2|||
13112747|NCT03151551|25909438|FG000|Post-Treatment Follow-Up Period|Adverse Event|1|||
13112748|NCT03151551|25909439|FG001|Post-Treatment Follow-Up Period|Adverse Event|3|||
13112749|NCT03151551|25909438|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
13112750|NCT03151551|25909439|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
13112751|NCT03151551|25909438|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20|||
13112752|NCT03151551|25909439|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22|||
13112753|NCT03151551|25909438|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
13112754|NCT03151551|25909439|FG001|Post-Treatment Follow-Up Period|Physician Decision|1|||
13112755|NCT03151408|25909476|FG000|Overall Study|Adverse Event|24|||
13112756|NCT03151408|25909477|FG001|Overall Study|Adverse Event|23|||
13112757|NCT03151408|25909476|FG000|Overall Study|Death|46|||
13112758|NCT03151408|25909477|FG001|Overall Study|Death|26|||
13112759|NCT03151408|25909476|FG000|Overall Study|Physician Decision|13|||
13112760|NCT03151408|25909477|FG001|Overall Study|Physician Decision|19|||
13112761|NCT03151408|25909476|FG000|Overall Study|Withdrawal by Subject|16|||
13112762|NCT03151408|25909477|FG001|Overall Study|Withdrawal by Subject|20|||
13112763|NCT03151408|25909476|FG000|Overall Study|Progressive disease|45|||
13112764|NCT03151408|25909477|FG001|Overall Study|Progressive disease|61|||
13112765|NCT03151408|25909476|FG000|Overall Study|non-compliance by patient|1|||
13112766|NCT03151408|25909477|FG001|Overall Study|non-compliance by patient|0|||
13112767|NCT03151408|25909476|FG000|Overall Study|other reasons|56|||
13112768|NCT03151408|25909477|FG001|Overall Study|other reasons|52|||
13112769|NCT03151408|25909476|FG000|Overall Study|randomized and not treated|2|||
13112770|NCT03151408|25909477|FG001|Overall Study|randomized and not treated|2|||
13112771|NCT03151395|25909502|FG000|Overall Study|Adverse Event|2|||
13112772|NCT03151395|25909502|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
13112773|NCT03151395|25909502|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3|||
13112774|NCT03151395|25909502|FG000|Overall Study|Unspecified reason|4|||
13112775|NCT03151304|25909520|FG000|Overall Study|Termination of study by Sponsor|23|||
13112776|NCT03151304|25909520|FG000|Overall Study|missing|3|||
13112777|NCT03151304|25909520|FG000|Overall Study|Withdrawal by Subject|8|||
13112778|NCT03151304|25909520|FG000|Overall Study|multiple reasons|30|||
13112779|NCT03151226|25909526|FG000|Overall Study|Withdrawal by Subject|2|||
13112780|NCT03151226|25909526|FG000|Overall Study|not wear device correctly|1|||
13112781|NCT03151148|25909581|FG000|Overall Study|Lost to Follow-up|1|||
13112782|NCT03151148|25909582|FG001|Overall Study|Lost to Follow-up|0|||
13112783|NCT03151148|25909581|FG000|Overall Study|Withdrawal by Subject|1|||
13112784|NCT03151148|25909582|FG001|Overall Study|Withdrawal by Subject|0|||
13112785|NCT03150862|25909696|FG000|Overall Study|Death|2|||
13112786|NCT03150862|25909697|FG001|Overall Study|Death|7|||
13112787|NCT03150862|25909698|FG002|Overall Study|Death|8|||
13112788|NCT03150862|25909699|FG003|Overall Study|Death|27|||
13199608|NCT02016105|26213902|FG002|TREATMENT PERIOD 2|Death|0|||
13199609|NCT02016105|26213903|FG003|TREATMENT PERIOD 2|Death|0|||
13199610|NCT02016105|26213904|FG004|TREATMENT PERIOD 2|Death|0|||
13199611|NCT02016105|26213905|FG005|TREATMENT PERIOD 2|Death|1|||
13199612|NCT02016105|26213900|FG000|TREATMENT PERIOD 2|Adverse Event|0|||
13199613|NCT02016105|26213901|FG001|TREATMENT PERIOD 2|Adverse Event|0|||
13199614|NCT02016105|26213902|FG002|TREATMENT PERIOD 2|Adverse Event|0|||
13199615|NCT02016105|26213903|FG003|TREATMENT PERIOD 2|Adverse Event|4|||
13199616|NCT02016105|26213904|FG004|TREATMENT PERIOD 2|Adverse Event|0|||
13199617|NCT02016105|26213905|FG005|TREATMENT PERIOD 2|Adverse Event|1|||
13199618|NCT02016105|26213900|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
13199619|NCT02016105|26213901|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
13199620|NCT02016105|26213902|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3|||
13199621|NCT02016105|26213903|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
13199622|NCT02016105|26213904|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
13199623|NCT02016105|26213905|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7|||
13199624|NCT02016105|26213900|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0|||
13199625|NCT02016105|26213901|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0|||
13199626|NCT02016105|26213902|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1|||
13199627|NCT02016105|26213903|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0|||
13199628|NCT02016105|26213904|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0|||
13199629|NCT02016105|26213905|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1|||
13199630|NCT02016105|26213900|FG000|EXTENSION PERIOD|New therapy for study indication|0|||
13199631|NCT02016105|26213901|FG001|EXTENSION PERIOD|New therapy for study indication|0|||
13199632|NCT02016105|26213902|FG002|EXTENSION PERIOD|New therapy for study indication|0|||
13199633|NCT02016105|26213903|FG003|EXTENSION PERIOD|New therapy for study indication|0|||
13199634|NCT02016105|26213904|FG004|EXTENSION PERIOD|New therapy for study indication|1|||
13199635|NCT02016105|26213905|FG005|EXTENSION PERIOD|New therapy for study indication|1|||
13199636|NCT02016105|26213900|FG000|EXTENSION PERIOD|Lack of Efficacy|0|||
13199637|NCT02016105|26213901|FG001|EXTENSION PERIOD|Lack of Efficacy|0|||
13199638|NCT02016105|26213902|FG002|EXTENSION PERIOD|Lack of Efficacy|1|||
13199639|NCT02016105|26213903|FG003|EXTENSION PERIOD|Lack of Efficacy|3|||
13199640|NCT02016105|26213904|FG004|EXTENSION PERIOD|Lack of Efficacy|1|||
13199641|NCT02016105|26213905|FG005|EXTENSION PERIOD|Lack of Efficacy|1|||
13199642|NCT02016105|26213900|FG000|EXTENSION PERIOD|Adverse Event|0|||
13199643|NCT02016105|26213901|FG001|EXTENSION PERIOD|Adverse Event|0|||
13199644|NCT02016105|26213902|FG002|EXTENSION PERIOD|Adverse Event|2|||
13199645|NCT02016105|26213903|FG003|EXTENSION PERIOD|Adverse Event|0|||
13199646|NCT02016105|26213904|FG004|EXTENSION PERIOD|Adverse Event|1|||
13199647|NCT02016105|26213905|FG005|EXTENSION PERIOD|Adverse Event|0|||
13199648|NCT02016105|26213900|FG000|EXTENSION PERIOD|Withdrawal by Subject|0|||
13199649|NCT02016105|26213901|FG001|EXTENSION PERIOD|Withdrawal by Subject|0|||
13199650|NCT02016105|26213902|FG002|EXTENSION PERIOD|Withdrawal by Subject|2|||
13199651|NCT02016105|26213903|FG003|EXTENSION PERIOD|Withdrawal by Subject|2|||
13199652|NCT02016105|26213904|FG004|EXTENSION PERIOD|Withdrawal by Subject|2|||
13199653|NCT02016105|26213905|FG005|EXTENSION PERIOD|Withdrawal by Subject|2|||
13199654|NCT02016105|26213900|FG000|EXTENSION PERIOD|Non-compliance with study indication|0|||
13199655|NCT02016105|26213901|FG001|EXTENSION PERIOD|Non-compliance with study indication|0|||
13199656|NCT02016105|26213902|FG002|EXTENSION PERIOD|Non-compliance with study indication|0|||
13199657|NCT02016105|26213903|FG003|EXTENSION PERIOD|Non-compliance with study indication|0|||
13199658|NCT02016105|26213904|FG004|EXTENSION PERIOD|Non-compliance with study indication|1|||
13199659|NCT02016105|26213905|FG005|EXTENSION PERIOD|Non-compliance with study indication|0|||
13199660|NCT02016105|26213900|FG000|EXTENSION PERIOD|Lost to Follow-up|0|||
13199661|NCT02016105|26213901|FG001|EXTENSION PERIOD|Lost to Follow-up|0|||
13199662|NCT02016105|26213902|FG002|EXTENSION PERIOD|Lost to Follow-up|0|||
13199663|NCT02016105|26213903|FG003|EXTENSION PERIOD|Lost to Follow-up|0|||
13199664|NCT02016105|26213904|FG004|EXTENSION PERIOD|Lost to Follow-up|0|||
13199665|NCT02016105|26213905|FG005|EXTENSION PERIOD|Lost to Follow-up|2|||
13199666|NCT02015819|26213943|FG000|Overall Study|Rickham catheter was misaligned|0|||
13199667|NCT02015819|26213944|FG001|Overall Study|Rickham catheter was misaligned|0|||
13199668|NCT02015819|26213945|FG002|Overall Study|Rickham catheter was misaligned|0|||
13199669|NCT02015819|26213946|FG003|Overall Study|Rickham catheter was misaligned|1|||
13199670|NCT02015793|26213983|FG000|Overall Study|Adverse Event|3|||
13199671|NCT02015793|26213984|FG001|Overall Study|Adverse Event|3|||
13199672|NCT02015793|26213983|FG000|Overall Study|Withdrawal by Subject|1|||
13199673|NCT02015793|26213984|FG001|Overall Study|Withdrawal by Subject|1|||
13199674|NCT02015754|26214003|FG000|Overall Study|Disease progression|5|||
13199675|NCT02015754|26214003|FG000|Overall Study|Change in treatment modality|5|||
13199676|NCT02015754|26214003|FG000|Overall Study|Lost to Follow-up|1|||
13199677|NCT02015676|26214027|FG000|Overall Study|Adverse Event|2|||
13199678|NCT02015676|26214028|FG001|Overall Study|Adverse Event|18|||
13199679|NCT02015676|26214029|FG002|Overall Study|Adverse Event|0|||
13199680|NCT02015676|26214027|FG000|Overall Study|Lack of Efficacy|2|||
13199681|NCT02015676|26214028|FG001|Overall Study|Lack of Efficacy|4|||
13199682|NCT02015676|26214029|FG002|Overall Study|Lack of Efficacy|0|||
13199683|NCT02015676|26214027|FG000|Overall Study|Protocol Violation|1|||
13199684|NCT02015676|26214028|FG001|Overall Study|Protocol Violation|0|||
13199685|NCT02015676|26214029|FG002|Overall Study|Protocol Violation|0|||
13199686|NCT02015676|26214027|FG000|Overall Study|Withdrawal by Subject|1|||
13199687|NCT02015676|26214028|FG001|Overall Study|Withdrawal by Subject|7|||
13199688|NCT02015676|26214029|FG002|Overall Study|Withdrawal by Subject|1|||
13199689|NCT02015676|26214027|FG000|Overall Study|Administrative reasons|0|||
13199690|NCT02015676|26214028|FG001|Overall Study|Administrative reasons|3|||
13199691|NCT02015676|26214029|FG002|Overall Study|Administrative reasons|1|||
13199692|NCT02015676|26214027|FG000|Overall Study|Death|0|||
13199693|NCT02015676|26214028|FG001|Overall Study|Death|1|||
13199694|NCT02015676|26214029|FG002|Overall Study|Death|0|||
13199695|NCT02015676|26214027|FG000|Overall Study|Disease progression|3|||
13199696|NCT02015676|26214028|FG001|Overall Study|Disease progression|1|||
13199697|NCT02015676|26214029|FG002|Overall Study|Disease progression|1|||
13199698|NCT02015663|26214065|FG000|Overall Study|unsatisfactory therapeutic effect|1|||
13199699|NCT02015663|26214066|FG001|Overall Study|unsatisfactory therapeutic effect|0|||
13199700|NCT02015663|26214065|FG000|Overall Study|Withdrawal by Subject|1|||
13199701|NCT02015663|26214066|FG001|Overall Study|Withdrawal by Subject|0|||
13199702|NCT02015663|26214065|FG000|Overall Study|Protocol Violation|0|||
13199703|NCT02015663|26214066|FG001|Overall Study|Protocol Violation|1|||
13199704|NCT02015663|26214065|FG000|Overall Study|Adverse Event|3|||
13199705|NCT02015663|26214066|FG001|Overall Study|Adverse Event|0|||
13199706|NCT02015663|26214065|FG000|Overall Study|Administrative problems|10|||
13199707|NCT02015663|26214066|FG001|Overall Study|Administrative problems|11|||
13199708|NCT02015637|26214081|FG000|Overall Study|Lost to Follow-up|3|||
13199709|NCT02015637|26214082|FG001|Overall Study|Lost to Follow-up|5|||
13199710|NCT02015637|26214081|FG000|Overall Study|Adverse Event|3|||
13199711|NCT02015637|26214082|FG001|Overall Study|Adverse Event|0|||
13199712|NCT02015637|26214081|FG000|Overall Study|Did not take study drug|2|||
13199713|NCT02015637|26214082|FG001|Overall Study|Did not take study drug|0|||
13199714|NCT02015546|26214124|FG000|Overall Study|Withdrawal by Subject|1|||
13199715|NCT02015546|26214125|FG001|Overall Study|Withdrawal by Subject|1|||
13199716|NCT02015546|26214126|FG002|Overall Study|Withdrawal by Subject|1|||
13199717|NCT02015546|26214124|FG000|Overall Study|Screem Failure|2|||
13199718|NCT02015546|26214125|FG001|Overall Study|Screem Failure|1|||
13199719|NCT02015546|26214126|FG002|Overall Study|Screem Failure|3|||
13199720|NCT02015520|26214177|FG000|Overall Study|Lack of Efficacy|1|||
13199721|NCT02015520|26214178|FG001|Overall Study|Lack of Efficacy|0|||
13199722|NCT02015520|26214179|FG002|Overall Study|Lack of Efficacy|3|||
13199723|NCT02015520|26214180|FG003|Overall Study|Lack of Efficacy|2|||
13199724|NCT02015520|26214177|FG000|Overall Study|Adverse Event|0|||
13199725|NCT02015520|26214178|FG001|Overall Study|Adverse Event|0|||
13199726|NCT02015520|26214179|FG002|Overall Study|Adverse Event|0|||
13199727|NCT02015520|26214180|FG003|Overall Study|Adverse Event|1|||
13199728|NCT02015520|26214177|FG000|Overall Study|Withdrawal by Subject|2|||
13199729|NCT02015520|26214178|FG001|Overall Study|Withdrawal by Subject|2|||
13199730|NCT02015520|26214179|FG002|Overall Study|Withdrawal by Subject|1|||
13199731|NCT02015520|26214180|FG003|Overall Study|Withdrawal by Subject|0|||
13199732|NCT02015520|26214177|FG000|Overall Study|Death|1|||
13199733|NCT02015520|26214178|FG001|Overall Study|Death|0|||
13199734|NCT02015520|26214179|FG002|Overall Study|Death|0|||
13199735|NCT02015520|26214180|FG003|Overall Study|Death|0|||
13199736|NCT02015520|26214177|FG000|Overall Study|Lost to Follow-up|0|||
13199737|NCT02015520|26214178|FG001|Overall Study|Lost to Follow-up|0|||
13199738|NCT02015520|26214179|FG002|Overall Study|Lost to Follow-up|1|||
13199739|NCT02015520|26214180|FG003|Overall Study|Lost to Follow-up|0|||
13199740|NCT02015520|26214177|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1|||
13199741|NCT02015520|26214178|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1|||
13199742|NCT02015520|26214179|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2|||
13199743|NCT02015520|26214180|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1|||
13199744|NCT02015520|26214177|FG000|Overall Study|Subject no Longer Meets Study Criteria|0|||
13199745|NCT02015520|26214178|FG001|Overall Study|Subject no Longer Meets Study Criteria|1|||
13199746|NCT02015520|26214179|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
13199747|NCT02015520|26214180|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
13199748|NCT02015481|26214189|FG000|Overall Study|Death|1|||
13199749|NCT02015390|26214216|FG000|Overall Study|Lost to Follow-up|1|||
13199750|NCT02015390|26214217|FG001|Overall Study|Lost to Follow-up|0|||
13199751|NCT02015390|26214216|FG000|Overall Study|Adverse Event|0|||
13199752|NCT02015390|26214217|FG001|Overall Study|Adverse Event|3|||
13199753|NCT02015390|26214216|FG000|Overall Study|Physician Decision|0|||
13199754|NCT02015390|26214217|FG001|Overall Study|Physician Decision|1|||
13199755|NCT02015221|26214230|FG000|Overall Study|Withdrawal by Subject|8|||
13199756|NCT02015221|26214231|FG001|Overall Study|Withdrawal by Subject|6|||
13199757|NCT02015221|26214230|FG000|Overall Study|Lost to Follow-up|1|||
13199758|NCT02015221|26214231|FG001|Overall Study|Lost to Follow-up|0|||
13199759|NCT02015195|26214274|FG000|Overall Study|Adverse Event|0|||
13199760|NCT02015195|26214275|FG001|Overall Study|Adverse Event|0|||
13199761|NCT02015195|26214276|FG002|Overall Study|Adverse Event|0|||
13199762|NCT02015195|26214277|FG003|Overall Study|Adverse Event|1|||
13199763|NCT02015195|26214278|FG004|Overall Study|Adverse Event|0|||
13199764|NCT02015195|26214279|FG005|Overall Study|Adverse Event|0|||
13199765|NCT02015195|26214280|FG006|Overall Study|Adverse Event|0|||
13199766|NCT02015104|26214301|FG000|Overall Study|Withdrew consent after first dose drug|1|||
13199767|NCT02015104|26214302|FG001|Overall Study|Withdrew consent after first dose drug|0|||
13199768|NCT02015104|26214301|FG000|Overall Study|Withdrew consent prior to treatment|0|||
13199769|NCT02015104|26214302|FG001|Overall Study|Withdrew consent prior to treatment|1|||
13199770|NCT02015065|26214332|FG000|Overall Study|Death on study|1|||
13199771|NCT02015065|26214333|FG001|Overall Study|Death on study|2|||
13199772|NCT02015065|26214334|FG002|Overall Study|Death on study|1|||
13199773|NCT02015039|26214359|FG000|Overall Study|Not eligible|0|||
13199774|NCT02015039|26214360|FG001|Overall Study|Not eligible|1|||
13199775|NCT02014740|26214373|FG000|Overall Study|Lost to Follow-up|4|||
13199776|NCT02014740|26214374|FG001|Overall Study|Lost to Follow-up|4|||
13199777|NCT02014740|26214373|FG000|Overall Study|Withdrawal by Subject|2|||
13199778|NCT02014740|26214374|FG001|Overall Study|Withdrawal by Subject|1|||
13199779|NCT02014597|26214395|FG000|Overall Study|Unable to record log contrast sensitivity|2|||
13199780|NCT02014597|26214396|FG001|Overall Study|Unable to record log contrast sensitivity|1|||
13199781|NCT02014584|26214524|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
13199782|NCT02014584|26214525|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
13199783|NCT02014584|26214526|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
13199784|NCT02014584|26214527|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
13199785|NCT02014584|26214528|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
13199786|NCT02014584|26214529|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
13199787|NCT02014584|26214524|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2|||
13199788|NCT02014584|26214525|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5|||
13199789|NCT02014584|26214526|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
13199790|NCT02014584|26214527|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
13199791|NCT02014584|26214528|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
13199792|NCT02014584|26214529|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
13199793|NCT02014584|26214524|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
13199794|NCT02014584|26214525|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
13199795|NCT02014584|26214526|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2|||
13199796|NCT02014584|26214527|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
13199797|NCT02014584|26214528|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
13199798|NCT02014584|26214529|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
13199799|NCT02014584|26214524|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
13199800|NCT02014584|26214525|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
13199801|NCT02014584|26214526|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3|||
13199802|NCT02014584|26214527|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1|||
13199803|NCT02014584|26214528|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
13199804|NCT02014584|26214529|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
13199805|NCT02014584|26214524|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
13199806|NCT02014584|26214525|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
13199807|NCT02014584|26214526|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
13199808|NCT02014584|26214527|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
13199809|NCT02014584|26214528|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1|||
13199810|NCT02014584|26214529|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
13199811|NCT02014480|26214553|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
13199812|NCT02014480|26214554|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
13199813|NCT02014480|26214555|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
13199814|NCT02014480|26214556|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
13199815|NCT02014480|26214557|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
13199816|NCT02014480|26214558|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
13199817|NCT02014480|26214553|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
13199818|NCT02014480|26214554|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
13199819|NCT02014480|26214555|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
13199820|NCT02014480|26214556|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
13199821|NCT02014480|26214557|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
13199822|NCT02014480|26214558|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
13199823|NCT02014480|26214553|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
13199824|NCT02014480|26214554|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
13199825|NCT02014480|26214555|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
13199826|NCT02014480|26214556|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
13199827|NCT02014480|26214557|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
13199828|NCT02014480|26214558|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
13199829|NCT02014480|26214553|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1|||
13199830|NCT02014480|26214554|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1|||
13199831|NCT02014480|26214555|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2|||
13199832|NCT02014480|26214556|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
13199833|NCT02014480|26214557|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
13199834|NCT02014480|26214558|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
13199835|NCT02014480|26214553|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
13199836|NCT02014480|26214554|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
13199837|NCT02014480|26214555|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
13199838|NCT02014480|26214556|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
13199839|NCT02014480|26214557|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
13199840|NCT02014480|26214558|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
13199841|NCT02014480|26214553|FG000|Treatment Period 3 (14 Days)|Adverse Event|0|||
13199842|NCT02014480|26214554|FG001|Treatment Period 3 (14 Days)|Adverse Event|0|||
13199843|NCT02014480|26214555|FG002|Treatment Period 3 (14 Days)|Adverse Event|1|||
13199844|NCT02014480|26214556|FG003|Treatment Period 3 (14 Days)|Adverse Event|0|||
13199845|NCT02014480|26214557|FG004|Treatment Period 3 (14 Days)|Adverse Event|0|||
13199846|NCT02014480|26214558|FG005|Treatment Period 3 (14 Days)|Adverse Event|1|||
13199847|NCT02014480|26214553|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
13199848|NCT02014480|26214554|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
13199849|NCT02014480|26214555|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
13199850|NCT02014480|26214556|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
13199851|NCT02014480|26214557|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
13199852|NCT02014480|26214558|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
13199853|NCT02014467|26214625|FG000|Overall Study|Adverse Event|4|||
13199854|NCT02014467|26214626|FG001|Overall Study|Adverse Event|0|||
13199855|NCT02014467|26214625|FG000|Overall Study|Protocol Violation|3|||
13199856|NCT02014467|26214626|FG001|Overall Study|Protocol Violation|0|||
13199857|NCT02014467|26214625|FG000|Overall Study|Physician Decision|2|||
13199858|NCT02014467|26214626|FG001|Overall Study|Physician Decision|3|||
13199859|NCT02014467|26214625|FG000|Overall Study|Withdrawal by Subject|16|||
13199860|NCT02014467|26214626|FG001|Overall Study|Withdrawal by Subject|4|||
13199861|NCT02014441|26214720|FG000|Overall Study|Withdrawal by Subject|12|||
13199862|NCT02014402|26214760|FG000|Overall Study|Adverse Event|1|||
13199863|NCT02014402|26214761|FG001|Overall Study|Adverse Event|0|||
13199864|NCT02014402|26214762|FG002|Overall Study|Adverse Event|0|||
13199865|NCT02014402|26214763|FG003|Overall Study|Adverse Event|0|||
13199866|NCT02014402|26214760|FG000|Overall Study|Withdrawal by Subject|1|||
13199867|NCT02014402|26214761|FG001|Overall Study|Withdrawal by Subject|2|||
13199868|NCT02014402|26214762|FG002|Overall Study|Withdrawal by Subject|2|||
13199869|NCT02014402|26214763|FG003|Overall Study|Withdrawal by Subject|1|||
13199870|NCT02014402|26214760|FG000|Overall Study|Subject did not have transportation|0|||
13199871|NCT02014402|26214761|FG001|Overall Study|Subject did not have transportation|1|||
13199872|NCT02014402|26214762|FG002|Overall Study|Subject did not have transportation|0|||
13199873|NCT02014402|26214763|FG003|Overall Study|Subject did not have transportation|0|||
13199874|NCT02014402|26214760|FG000|Overall Study|Lost to Follow-up|0|||
13199875|NCT02014402|26214761|FG001|Overall Study|Lost to Follow-up|0|||
13199876|NCT02014402|26214762|FG002|Overall Study|Lost to Follow-up|1|||
13199877|NCT02014402|26214763|FG003|Overall Study|Lost to Follow-up|2|||
13199878|NCT02014376|26214796|FG000|Overall Study|Adverse Event|1|||
13199879|NCT02014376|26214797|FG001|Overall Study|Adverse Event|1|||
13199880|NCT02014376|26214798|FG002|Overall Study|Adverse Event|0|||
13199881|NCT02014376|26214796|FG000|Overall Study|Lost to Follow-up|2|||
13199882|NCT02014376|26214797|FG001|Overall Study|Lost to Follow-up|0|||
13199883|NCT02014376|26214798|FG002|Overall Study|Lost to Follow-up|0|||
13199884|NCT02014272|26214819|FG000|Intervention Period 1|Withdrawal by Subject|1|||
13199885|NCT02014272|26214820|FG001|Intervention Period 1|Withdrawal by Subject|0|||
13199886|NCT02014272|26214819|FG000|Intervention Period 1|Adverse Event|0|||
13199887|NCT02014272|26214820|FG001|Intervention Period 1|Adverse Event|1|||
13199888|NCT02014116|26214899|FG000|Overall Study|Progressive Disease|3|||
13199889|NCT02014116|26214900|FG001|Overall Study|Progressive Disease|4|||
13199890|NCT02014116|26214901|FG002|Overall Study|Progressive Disease|2|||
13199891|NCT02014116|26214902|FG003|Overall Study|Progressive Disease|6|||
13199892|NCT02014116|26214903|FG004|Overall Study|Progressive Disease|1|||
13199893|NCT02014116|26214904|FG005|Overall Study|Progressive Disease|13|||
13199894|NCT02014116|26214905|FG006|Overall Study|Progressive Disease|1|||
13112789|NCT03150862|25909700|FG004|Overall Study|Death|4|||
13112790|NCT03150862|25909701|FG005|Overall Study|Death|8|||
13112791|NCT03150862|25909702|FG006|Overall Study|Death|6|||
13112792|NCT03150862|25909703|FG007|Overall Study|Death|21|||
13112793|NCT03150862|25909696|FG000|Overall Study|Withdrawal by Subject|1|||
13112794|NCT03150862|25909697|FG001|Overall Study|Withdrawal by Subject|1|||
13112795|NCT03150862|25909698|FG002|Overall Study|Withdrawal by Subject|0|||
13112796|NCT03150862|25909699|FG003|Overall Study|Withdrawal by Subject|3|||
13112797|NCT03150862|25909700|FG004|Overall Study|Withdrawal by Subject|1|||
13112798|NCT03150862|25909701|FG005|Overall Study|Withdrawal by Subject|1|||
13199895|NCT02014116|26214906|FG007|Overall Study|Progressive Disease|3|||
13199896|NCT02014116|26214907|FG008|Overall Study|Progressive Disease|7|||
13199897|NCT02014116|26214899|FG000|Overall Study|Adverse Event|0|||
13199898|NCT02014116|26214900|FG001|Overall Study|Adverse Event|0|||
13199899|NCT02014116|26214901|FG002|Overall Study|Adverse Event|0|||
13199900|NCT02014116|26214902|FG003|Overall Study|Adverse Event|0|||
13199901|NCT02014116|26214903|FG004|Overall Study|Adverse Event|1|||
13199902|NCT02014116|26214904|FG005|Overall Study|Adverse Event|0|||
13199903|NCT02014116|26214905|FG006|Overall Study|Adverse Event|0|||
13199904|NCT02014116|26214906|FG007|Overall Study|Adverse Event|1|||
13199905|NCT02014116|26214907|FG008|Overall Study|Adverse Event|0|||
13199906|NCT02014116|26214899|FG000|Overall Study|Lost to Follow-up|0|||
13199907|NCT02014116|26214900|FG001|Overall Study|Lost to Follow-up|0|||
13199908|NCT02014116|26214901|FG002|Overall Study|Lost to Follow-up|0|||
13199909|NCT02014116|26214902|FG003|Overall Study|Lost to Follow-up|0|||
13199910|NCT02014116|26214903|FG004|Overall Study|Lost to Follow-up|0|||
13199911|NCT02014116|26214904|FG005|Overall Study|Lost to Follow-up|1|||
13199912|NCT02014116|26214905|FG006|Overall Study|Lost to Follow-up|0|||
13199913|NCT02014116|26214906|FG007|Overall Study|Lost to Follow-up|0|||
13199914|NCT02014116|26214907|FG008|Overall Study|Lost to Follow-up|1|||
13199915|NCT02014116|26214899|FG000|Overall Study|Death|0|||
13199916|NCT02014116|26214900|FG001|Overall Study|Death|0|||
13199917|NCT02014116|26214901|FG002|Overall Study|Death|0|||
13199918|NCT02014116|26214902|FG003|Overall Study|Death|0|||
13199919|NCT02014116|26214903|FG004|Overall Study|Death|0|||
13199920|NCT02014116|26214904|FG005|Overall Study|Death|0|||
13199921|NCT02014116|26214905|FG006|Overall Study|Death|0|||
13199922|NCT02014116|26214906|FG007|Overall Study|Death|1|||
13199923|NCT02014116|26214907|FG008|Overall Study|Death|1|||
13199924|NCT02014116|26214899|FG000|Overall Study|Withdrawal by Subject|0|||
13199925|NCT02014116|26214900|FG001|Overall Study|Withdrawal by Subject|0|||
13199926|NCT02014116|26214901|FG002|Overall Study|Withdrawal by Subject|1|||
13199927|NCT02014116|26214902|FG003|Overall Study|Withdrawal by Subject|1|||
13199928|NCT02014116|26214903|FG004|Overall Study|Withdrawal by Subject|0|||
13199929|NCT02014116|26214904|FG005|Overall Study|Withdrawal by Subject|1|||
13199930|NCT02014116|26214905|FG006|Overall Study|Withdrawal by Subject|0|||
13199931|NCT02014116|26214906|FG007|Overall Study|Withdrawal by Subject|0|||
13199932|NCT02014116|26214907|FG008|Overall Study|Withdrawal by Subject|0|||
13199933|NCT02014116|26214899|FG000|Overall Study|Withdrawal Caregiver Decision|0|||
13199934|NCT02014116|26214900|FG001|Overall Study|Withdrawal Caregiver Decision|0|||
13199935|NCT02014116|26214901|FG002|Overall Study|Withdrawal Caregiver Decision|0|||
13199936|NCT02014116|26214902|FG003|Overall Study|Withdrawal Caregiver Decision|0|||
13199937|NCT02014116|26214903|FG004|Overall Study|Withdrawal Caregiver Decision|0|||
13199938|NCT02014116|26214904|FG005|Overall Study|Withdrawal Caregiver Decision|1|||
13199939|NCT02014116|26214905|FG006|Overall Study|Withdrawal Caregiver Decision|0|||
13199940|NCT02014116|26214906|FG007|Overall Study|Withdrawal Caregiver Decision|0|||
13199941|NCT02014116|26214907|FG008|Overall Study|Withdrawal Caregiver Decision|0|||
13199942|NCT02014116|26214899|FG000|Overall Study|Physician Decision|0|||
13199943|NCT02014116|26214900|FG001|Overall Study|Physician Decision|0|||
13199944|NCT02014116|26214901|FG002|Overall Study|Physician Decision|0|||
13199945|NCT02014116|26214902|FG003|Overall Study|Physician Decision|0|||
13199946|NCT02014116|26214903|FG004|Overall Study|Physician Decision|0|||
13199947|NCT02014116|26214904|FG005|Overall Study|Physician Decision|0|||
13199948|NCT02014116|26214905|FG006|Overall Study|Physician Decision|0|||
13199949|NCT02014116|26214906|FG007|Overall Study|Physician Decision|0|||
13199950|NCT02014116|26214907|FG008|Overall Study|Physician Decision|1|||
13199951|NCT02013830|26214920|FG000|Overall Study|Adverse Event|3|||
13199952|NCT02013830|26214920|FG000|Overall Study|Death|1|||
13199953|NCT02013830|26214920|FG000|Overall Study|Insufficient therapeutic response|25|||
13199954|NCT02013830|26214920|FG000|Overall Study|Refused treatment|1|||
13199955|NCT02013817|26214931|FG000|Overall Study|Adverse Event|12|||
13199956|NCT02013817|26214931|FG000|Overall Study|Withdrawal by Subject|4|||
13199957|NCT02013817|26214931|FG000|Overall Study|Death|2|||
13199958|NCT02013817|26214931|FG000|Overall Study|Other|9|||
13199959|NCT02013791|26214980|FG000|Period 1|Lost to Follow-up|0|||
13199960|NCT02013791|26214981|FG001|Period 1|Lost to Follow-up|0|||
13199961|NCT02013791|26214982|FG002|Period 1|Lost to Follow-up|0|||
13199962|NCT02013791|26214983|FG003|Period 1|Lost to Follow-up|1|||
13199963|NCT02013791|26214984|FG004|Period 1|Lost to Follow-up|0|||
13199964|NCT02013791|26214985|FG005|Period 1|Lost to Follow-up|0|||
13199965|NCT02013791|26214986|FG006|Period 1|Lost to Follow-up|1|||
13199966|NCT02013791|26214987|FG007|Period 1|Lost to Follow-up|1|||
13199967|NCT02013791|26214988|FG008|Period 1|Lost to Follow-up|0|||
13199968|NCT02013791|26214980|FG000|Period 1|Other Miscellaneous Reasons|0|||
13199969|NCT02013791|26214981|FG001|Period 1|Other Miscellaneous Reasons|2|||
13199970|NCT02013791|26214982|FG002|Period 1|Other Miscellaneous Reasons|0|||
13199971|NCT02013791|26214983|FG003|Period 1|Other Miscellaneous Reasons|0|||
13199972|NCT02013791|26214984|FG004|Period 1|Other Miscellaneous Reasons|0|||
13199973|NCT02013791|26214985|FG005|Period 1|Other Miscellaneous Reasons|0|||
13199974|NCT02013791|26214986|FG006|Period 1|Other Miscellaneous Reasons|0|||
13199975|NCT02013791|26214987|FG007|Period 1|Other Miscellaneous Reasons|0|||
13199976|NCT02013791|26214988|FG008|Period 1|Other Miscellaneous Reasons|0|||
13199977|NCT02013778|26214994|FG000|Overall Study|Death|4|||
13199978|NCT02013778|26214994|FG000|Overall Study|Withdrawal by Subject|1|||
13199979|NCT02013778|26214994|FG000|Overall Study|Physician Decision|1|||
13199980|NCT02013778|26214994|FG000|Overall Study|Adverse Event|1|||
13199981|NCT02013765|26215006|FG000|Overall Study|Trial was terminated by sponsor|1|||
13199982|NCT02013687|26215049|FG000|Overall Study|Lost to Follow-up|0|||
13199983|NCT02013687|26215050|FG001|Overall Study|Lost to Follow-up|0|||
13199984|NCT02013687|26215051|FG002|Overall Study|Lost to Follow-up|1|||
13199985|NCT02013687|26215052|FG003|Overall Study|Lost to Follow-up|0|||
13199986|NCT02013687|26215049|FG000|Overall Study|Protocol Violation|0|||
13199987|NCT02013687|26215050|FG001|Overall Study|Protocol Violation|0|||
13199988|NCT02013687|26215051|FG002|Overall Study|Protocol Violation|0|||
13199989|NCT02013687|26215052|FG003|Overall Study|Protocol Violation|1|||
13199990|NCT02013687|26215049|FG000|Overall Study|Withdrawal by Subject|0|||
13199991|NCT02013687|26215050|FG001|Overall Study|Withdrawal by Subject|0|||
13199992|NCT02013687|26215051|FG002|Overall Study|Withdrawal by Subject|0|||
13199993|NCT02013687|26215052|FG003|Overall Study|Withdrawal by Subject|1|||
13199994|NCT02013687|26215049|FG000|Overall Study|Missed visits due to patient travel|0|||
13199995|NCT02013687|26215050|FG001|Overall Study|Missed visits due to patient travel|0|||
13199996|NCT02013687|26215051|FG002|Overall Study|Missed visits due to patient travel|1|||
13199997|NCT02013687|26215052|FG003|Overall Study|Missed visits due to patient travel|0|||
13199998|NCT02013674|26215109|FG000|Overall Study|Death|0|||
13199999|NCT02013674|26215110|FG001|Overall Study|Death|1|||
13200000|NCT02013674|26215109|FG000|Overall Study|Lost to Follow-up|1|||
13200001|NCT02013674|26215110|FG001|Overall Study|Lost to Follow-up|0|||
13200002|NCT02013622|26215132|FG000|Overall Study|Lost to Follow-up|10|||
13200003|NCT02013622|26215132|FG000|Overall Study|Adverse Event|3|||
13200004|NCT02013622|26215132|FG000|Overall Study|Met Withdrawal Criteria|3|||
13200005|NCT02013622|26215132|FG000|Overall Study|Withdrawal by Subject|6|||
13200006|NCT02013622|26215132|FG000|Overall Study|Protocol Deviation|1|||
13200007|NCT02013622|26215132|FG000|Overall Study|Lack of Efficacy|1|||
13200008|NCT02013609|26215157|FG000|Overall Study|Withdrawal by Subject|9|||
13200009|NCT02013609|26215157|FG000|Overall Study|Lost to Follow-up|3|||
13200010|NCT02013609|26215157|FG000|Overall Study|Adverse Event|3|||
13200011|NCT02013609|26215157|FG000|Overall Study|Met Withdrawal Criteria|3|||
13200012|NCT02013544|26215186|FG000|Overall Study|Adverse Event|5|||
13200013|NCT02013544|26215187|FG001|Overall Study|Adverse Event|5|||
13200014|NCT02013544|26215186|FG000|Overall Study|Lost to Follow-up|2|||
13200015|NCT02013544|26215187|FG001|Overall Study|Lost to Follow-up|3|||
13200016|NCT02013544|26215186|FG000|Overall Study|Withdrawal by Subject|2|||
13200017|NCT02013544|26215187|FG001|Overall Study|Withdrawal by Subject|8|||
13200018|NCT02013544|26215186|FG000|Overall Study|Physician Decision|0|||
13200019|NCT02013544|26215187|FG001|Overall Study|Physician Decision|1|||
13200020|NCT02013544|26215186|FG000|Overall Study|Entry criteria not met/non-compliance|2|||
13200021|NCT02013544|26215187|FG001|Overall Study|Entry criteria not met/non-compliance|3|||
13200022|NCT02013531|26215211|FG000|Overall Study|Lost to Follow-up|3|||
13200023|NCT02013531|26215211|FG000|Overall Study|Met Withdrawal Criteria|1|||
13200024|NCT02013531|26215211|FG000|Overall Study|Withdrawal by Subject|1|||
13200025|NCT02013388|26215270|FG000|Overall Study|work emergency|1|||
13200026|NCT02013388|26215271|FG001|Overall Study|work emergency|0|||
13200027|NCT02013388|26215272|FG002|Overall Study|work emergency|0|||
13200028|NCT02013388|26215273|FG003|Overall Study|work emergency|0|||
13200029|NCT02013388|26215274|FG004|Overall Study|work emergency|1|||
13200030|NCT02013388|26215275|FG005|Overall Study|work emergency|0|||
13200031|NCT02013388|26215276|FG006|Overall Study|work emergency|0|||
13200032|NCT02013388|26215277|FG007|Overall Study|work emergency|0|||
13200033|NCT02013375|26215286|FG000|Overall Study|Did not engraft|1|||
13200034|NCT02013375|26215286|FG000|Overall Study|Did not engraft|1|||
13200035|NCT02013206|26215313|FG000|Overall Study|Progressive disease (PD)|14|||
13200036|NCT02013206|26215314|FG001|Overall Study|Progressive disease (PD)|17|||
13200037|NCT02013206|26215313|FG000|Overall Study|Symptomatic deterioration|3|||
13200038|NCT02013206|26215314|FG001|Overall Study|Symptomatic deterioration|1|||
13200039|NCT02013206|26215313|FG000|Overall Study|Adverse Event|1|||
13200040|NCT02013206|26215314|FG001|Overall Study|Adverse Event|0|||
13200041|NCT02013206|26215313|FG000|Overall Study|Patient refusal|2|||
13200042|NCT02013206|26215314|FG001|Overall Study|Patient refusal|0|||
13200043|NCT02013206|26215313|FG000|Overall Study|Patient non-compliance|1|||
13200044|NCT02013206|26215314|FG001|Overall Study|Patient non-compliance|0|||
13200045|NCT02013206|26215313|FG000|Overall Study|Death|1|||
13200046|NCT02013206|26215314|FG001|Overall Study|Death|2|||
13200047|NCT02013206|26215313|FG000|Overall Study|Other reasons off treatment|5|||
13200048|NCT02013206|26215314|FG001|Overall Study|Other reasons off treatment|2|||
13200049|NCT02013037|26215327|FG000|Overall Study|Death|6|||
13200050|NCT02013037|26215327|FG000|Overall Study|Withdrawal by Subject|1|||
13200051|NCT02013037|26215327|FG000|Overall Study|Awaiting Transplantation|7|||
13200052|NCT02013037|26215327|FG000|Overall Study|Transplanted without DSA|2|||
13200053|NCT02012959|26215344|FG000|Treatment Phase A|Adverse Event|2|||
13200054|NCT02012959|26215345|FG001|Treatment Phase A|Adverse Event|0|||
13200055|NCT02012959|26215346|FG002|Treatment Phase A|Adverse Event|0|||
13200056|NCT02012959|26215347|FG003|Treatment Phase A|Adverse Event|0|||
13200057|NCT02012959|26215348|FG004|Treatment Phase A|Adverse Event|0|||
13200058|NCT02012686|26215367|FG000|Overall Study|muscle contraction|0|||
13200059|NCT02012686|26215368|FG001|Overall Study|muscle contraction|1|||
13200060|NCT02012686|26215367|FG000|Overall Study|electrocardiography monitoring noise|0|||
13200061|NCT02012686|26215368|FG001|Overall Study|electrocardiography monitoring noise|1|||
13200062|NCT02012491|26215391|FG000|Overall Study|Lost to Follow-up|1|||
13200063|NCT02012491|26215392|FG001|Overall Study|Lost to Follow-up|0|||
13200064|NCT02012491|26215391|FG000|Overall Study|Protocol Violation|0|||
13200065|NCT02012491|26215392|FG001|Overall Study|Protocol Violation|1|||
13200066|NCT02012491|26215391|FG000|Overall Study|Withdrawal by Subject|1|||
13200067|NCT02012491|26215392|FG001|Overall Study|Withdrawal by Subject|0|||
13200068|NCT02012452|26215407|FG000|Overall Study|Lost to Follow-up|2|||
13200069|NCT02012452|26215408|FG001|Overall Study|Lost to Follow-up|1|||
13200070|NCT02012452|26215407|FG000|Overall Study|Withdrawal by Subject|4|||
13200071|NCT02012452|26215408|FG001|Overall Study|Withdrawal by Subject|0|||
13200072|NCT02012296|26215444|FG000|Overall Study|Lack of Efficacy|0|||
13200073|NCT02012296|26215445|FG001|Overall Study|Lack of Efficacy|0|||
13200074|NCT02012296|26215446|FG002|Overall Study|Lack of Efficacy|15|||
13200075|NCT02012296|26215444|FG000|Overall Study|Adverse Event|0|||
13200076|NCT02012296|26215445|FG001|Overall Study|Adverse Event|0|||
13200077|NCT02012296|26215446|FG002|Overall Study|Adverse Event|2|||
13200078|NCT02012296|26215444|FG000|Overall Study|Early study closure|0|||
13200079|NCT02012296|26215445|FG001|Overall Study|Early study closure|0|||
13200080|NCT02012296|26215446|FG002|Overall Study|Early study closure|5|||
13200081|NCT02012296|26215444|FG000|Overall Study|Protocol Violation|0|||
13200082|NCT02012296|26215445|FG001|Overall Study|Protocol Violation|1|||
13200083|NCT02012296|26215446|FG002|Overall Study|Protocol Violation|0|||
13200084|NCT02012218|26215474|FG000|Overall Study|Withdrawal by Subject|1|||
13200085|NCT02012218|26215475|FG001|Overall Study|Withdrawal by Subject|0|||
13200086|NCT02012218|26215476|FG002|Overall Study|Withdrawal by Subject|1|||
13200087|NCT02012218|26215477|FG003|Overall Study|Withdrawal by Subject|1|||
13200088|NCT02012218|26215478|FG004|Overall Study|Withdrawal by Subject|1|||
13200089|NCT02012218|26215474|FG000|Overall Study|Adverse Event|1|||
13200090|NCT02012218|26215475|FG001|Overall Study|Adverse Event|0|||
13200091|NCT02012218|26215476|FG002|Overall Study|Adverse Event|0|||
13200092|NCT02012218|26215477|FG003|Overall Study|Adverse Event|1|||
13200093|NCT02012218|26215478|FG004|Overall Study|Adverse Event|0|||
13200094|NCT02012218|26215474|FG000|Overall Study|Lost to Follow-up|0|||
13200095|NCT02012218|26215475|FG001|Overall Study|Lost to Follow-up|1|||
13200096|NCT02012218|26215476|FG002|Overall Study|Lost to Follow-up|1|||
13200097|NCT02012218|26215477|FG003|Overall Study|Lost to Follow-up|0|||
13200098|NCT02012218|26215478|FG004|Overall Study|Lost to Follow-up|0|||
13200099|NCT02012218|26215474|FG000|Overall Study|Protocol Specified|1|||
13200100|NCT02012218|26215475|FG001|Overall Study|Protocol Specified|0|||
13200101|NCT02012218|26215476|FG002|Overall Study|Protocol Specified|0|||
13200102|NCT02012218|26215477|FG003|Overall Study|Protocol Specified|0|||
13200103|NCT02012218|26215478|FG004|Overall Study|Protocol Specified|0|||
13200104|NCT02012218|26215474|FG000|Overall Study|Protocol Deviation|1|||
13200105|NCT02012218|26215475|FG001|Overall Study|Protocol Deviation|0|||
13200106|NCT02012218|26215476|FG002|Overall Study|Protocol Deviation|0|||
13200107|NCT02012218|26215477|FG003|Overall Study|Protocol Deviation|0|||
13200108|NCT02012218|26215478|FG004|Overall Study|Protocol Deviation|0|||
13200109|NCT02011945|26215565|FG000|Overall Study|Participant requested to Discontinue|0|||
13200110|NCT02011945|26215566|FG001|Overall Study|Participant requested to Discontinue|1|||
13200111|NCT02011945|26215567|FG002|Overall Study|Participant requested to Discontinue|1|||
13200112|NCT02011945|26215565|FG000|Overall Study|Adverse Event unrelated to Drug|0|||
13200113|NCT02011945|26215566|FG001|Overall Study|Adverse Event unrelated to Drug|2|||
13200114|NCT02011945|26215567|FG002|Overall Study|Adverse Event unrelated to Drug|1|||
13200115|NCT02011945|26215565|FG000|Overall Study|Study Drug Toxicity|0|||
13200116|NCT02011945|26215566|FG001|Overall Study|Study Drug Toxicity|0|||
13200117|NCT02011945|26215567|FG002|Overall Study|Study Drug Toxicity|1|||
13200118|NCT02011945|26215565|FG000|Overall Study|Treatment Failure|0|||
13200119|NCT02011945|26215566|FG001|Overall Study|Treatment Failure|7|||
13200120|NCT02011945|26215567|FG002|Overall Study|Treatment Failure|6|||
13200121|NCT02011945|26215565|FG000|Overall Study|No Longer Meets Study Criteria|1|||
13200122|NCT02011945|26215566|FG001|Overall Study|No Longer Meets Study Criteria|0|||
13200123|NCT02011945|26215567|FG002|Overall Study|No Longer Meets Study Criteria|0|||
13200124|NCT02011945|26215565|FG000|Overall Study|Proceeded to stem cell transplant|0|||
13200125|NCT02011945|26215566|FG001|Overall Study|Proceeded to stem cell transplant|0|||
13200126|NCT02011945|26215567|FG002|Overall Study|Proceeded to stem cell transplant|1|||
13200127|NCT02011945|26215565|FG000|Overall Study|Sub-Optimal Response to dasatinib|1|||
13200128|NCT02011945|26215566|FG001|Overall Study|Sub-Optimal Response to dasatinib|0|||
13200129|NCT02011945|26215567|FG002|Overall Study|Sub-Optimal Response to dasatinib|0|||
13200130|NCT02011893|26215582|FG000|Enrollment to Randomization|Adverse Event|2|||
13200131|NCT02011893|26215583|FG001|Enrollment to Randomization|Adverse Event|0|||
13200132|NCT02011893|26215584|FG002|Enrollment to Randomization|Adverse Event|0|||
13200133|NCT02011893|26215582|FG000|Enrollment to Randomization|Physician Decision|10|||
13200134|NCT02011893|26215583|FG001|Enrollment to Randomization|Physician Decision|0|||
13200135|NCT02011893|26215584|FG002|Enrollment to Randomization|Physician Decision|0|||
13200136|NCT02011893|26215582|FG000|Enrollment to Randomization|Withdrawal by Subject|21|||
13200137|NCT02011893|26215583|FG001|Enrollment to Randomization|Withdrawal by Subject|0|||
13200138|NCT02011893|26215584|FG002|Enrollment to Randomization|Withdrawal by Subject|0|||
13200139|NCT02011893|26215582|FG000|Enrollment to Randomization|Screening Failure|29|||
13200140|NCT02011893|26215583|FG001|Enrollment to Randomization|Screening Failure|0|||
13200141|NCT02011893|26215584|FG002|Enrollment to Randomization|Screening Failure|0|||
13200142|NCT02011893|26215582|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9|||
13200143|NCT02011893|26215583|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
13200144|NCT02011893|26215584|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
13200145|NCT02011893|26215582|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2|||
13200146|NCT02011893|26215583|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0|||
13200147|NCT02011893|26215584|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0|||
13200148|NCT02011893|26215582|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
13200149|NCT02011893|26215583|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
13200150|NCT02011893|26215584|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1|||
13200151|NCT02011893|26215582|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
13200152|NCT02011893|26215583|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
13200153|NCT02011893|26215584|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2|||
13200154|NCT02011893|26215582|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
13200155|NCT02011893|26215583|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
13200156|NCT02011893|26215584|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1|||
13200157|NCT02011542|26215591|FG000|Overall Study|Physician Decision|1|||
13200158|NCT02011386|26215607|FG000|Overall Study|Non-compliance|2|||
13200159|NCT02011386|26215607|FG000|Overall Study|Lack of Efficacy|3|||
13200160|NCT02011113|26215623|FG000|Overall Study|Adverse Event|4|||
13200161|NCT02011113|26215623|FG000|Overall Study|Disease Progression (DP)|16|||
13200162|NCT02011113|26215623|FG000|Overall Study|Death|1|||
13200163|NCT02011113|26215623|FG000|Overall Study|Insufficient effect of Pomalidomide|1|||
13200164|NCT02011113|26215623|FG000|Overall Study|Investigator's judgement- DP|3|||
13200165|NCT02011113|26215623|FG000|Overall Study|Study terminated by sponsor|11|||
13200166|NCT02010775|26215656|FG000|Overall Study|Adverse Event|0|||
13200167|NCT02010775|26215657|FG001|Overall Study|Adverse Event|0|||
13200168|NCT02010775|26215658|FG002|Overall Study|Adverse Event|0|||
13200169|NCT02010775|26215659|FG003|Overall Study|Adverse Event|0|||
13200170|NCT02010775|26215660|FG004|Overall Study|Adverse Event|1|||
13200171|NCT02010775|26215656|FG000|Overall Study|Pregnancy|0|||
13200172|NCT02010775|26215657|FG001|Overall Study|Pregnancy|0|||
13200173|NCT02010775|26215658|FG002|Overall Study|Pregnancy|2|||
13200174|NCT02010775|26215659|FG003|Overall Study|Pregnancy|0|||
13200175|NCT02010775|26215660|FG004|Overall Study|Pregnancy|0|||
13200176|NCT02010775|26215656|FG000|Overall Study|Lost to Follow-up|2|||
13200177|NCT02010775|26215657|FG001|Overall Study|Lost to Follow-up|0|||
13200178|NCT02010775|26215658|FG002|Overall Study|Lost to Follow-up|0|||
13200179|NCT02010775|26215659|FG003|Overall Study|Lost to Follow-up|1|||
13200180|NCT02010775|26215660|FG004|Overall Study|Lost to Follow-up|1|||
13200181|NCT02010775|26215656|FG000|Overall Study|Personal Reasons|3|||
13200182|NCT02010775|26215657|FG001|Overall Study|Personal Reasons|3|||
13200183|NCT02010775|26215658|FG002|Overall Study|Personal Reasons|1|||
13200184|NCT02010775|26215659|FG003|Overall Study|Personal Reasons|2|||
13200185|NCT02010775|26215660|FG004|Overall Study|Personal Reasons|4|||
13200186|NCT02010684|26215685|FG000|Overall Study|Lost to Follow-up|8|||
13200187|NCT02010684|26215686|FG001|Overall Study|Lost to Follow-up|18|||
13200188|NCT02010684|26215685|FG000|Overall Study|Withdrawal by Subject|4|||
13200189|NCT02010684|26215686|FG001|Overall Study|Withdrawal by Subject|5|||
13200190|NCT02010632|26215695|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
13200191|NCT02010632|26215696|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
13200192|NCT02010593|26215715|FG000|Overall Study|Lost to Follow-up|1|||
13200193|NCT02010593|26215716|FG001|Overall Study|Lost to Follow-up|0|||
13200194|NCT02010593|26215715|FG000|Overall Study|Physician Decision|1|||
13200195|NCT02010593|26215716|FG001|Overall Study|Physician Decision|0|||
13200196|NCT02010593|26215715|FG000|Overall Study|Unable to adhere to visit schedule|0|||
13200197|NCT02010593|26215716|FG001|Overall Study|Unable to adhere to visit schedule|2|||
13200198|NCT02010567|26215747|FG000|Overall Study|Adverse Event|0|||
13200199|NCT02010567|26215748|FG001|Overall Study|Adverse Event|0|||
13200200|NCT02010567|26215749|FG002|Overall Study|Adverse Event|1|||
13200201|NCT02010567|26215750|FG003|Overall Study|Adverse Event|0|||
13200202|NCT02010567|26215751|FG004|Overall Study|Adverse Event|1|||
13200203|NCT02010255|26216118|FG000|Overall Study|Death|0|||
13200204|NCT02010255|26216119|FG001|Overall Study|Death|1|||
13200205|NCT02010255|26216120|FG002|Overall Study|Death|4|||
13200206|NCT02010255|26216121|FG003|Overall Study|Death|4|||
13200207|NCT02010255|26216122|FG004|Overall Study|Death|2|||
13200208|NCT02010255|26216123|FG005|Overall Study|Death|0|||
13200209|NCT02010255|26216124|FG006|Overall Study|Death|1|||
13200210|NCT02010255|26216125|FG007|Overall Study|Death|1|||
13200211|NCT02010255|26216126|FG008|Overall Study|Death|1|||
13200212|NCT02010255|26216127|FG009|Overall Study|Death|0|||
13200213|NCT02010255|26216128|FG010|Overall Study|Death|1|||
13200214|NCT02010255|26216129|FG011|Overall Study|Death|1|||
13200215|NCT02010255|26216130|FG012|Overall Study|Death|0|||
13200216|NCT02010255|26216131|FG013|Overall Study|Death|0|||
13200217|NCT02010255|26216118|FG000|Overall Study|Lack of Efficacy|4|||
13200218|NCT02010255|26216119|FG001|Overall Study|Lack of Efficacy|1|||
13200219|NCT02010255|26216120|FG002|Overall Study|Lack of Efficacy|2|||
13200220|NCT02010255|26216121|FG003|Overall Study|Lack of Efficacy|1|||
13200221|NCT02010255|26216122|FG004|Overall Study|Lack of Efficacy|1|||
13200222|NCT02010255|26216123|FG005|Overall Study|Lack of Efficacy|0|||
13200223|NCT02010255|26216124|FG006|Overall Study|Lack of Efficacy|0|||
13200224|NCT02010255|26216125|FG007|Overall Study|Lack of Efficacy|0|||
13200225|NCT02010255|26216126|FG008|Overall Study|Lack of Efficacy|0|||
13200226|NCT02010255|26216127|FG009|Overall Study|Lack of Efficacy|0|||
13200227|NCT02010255|26216128|FG010|Overall Study|Lack of Efficacy|1|||
13200228|NCT02010255|26216129|FG011|Overall Study|Lack of Efficacy|0|||
13200229|NCT02010255|26216130|FG012|Overall Study|Lack of Efficacy|0|||
13200230|NCT02010255|26216131|FG013|Overall Study|Lack of Efficacy|0|||
13200231|NCT02010255|26216118|FG000|Overall Study|Withdrew Consent|1|||
13200232|NCT02010255|26216119|FG001|Overall Study|Withdrew Consent|0|||
13200233|NCT02010255|26216120|FG002|Overall Study|Withdrew Consent|0|||
13200234|NCT02010255|26216121|FG003|Overall Study|Withdrew Consent|1|||
13200235|NCT02010255|26216122|FG004|Overall Study|Withdrew Consent|0|||
13200236|NCT02010255|26216123|FG005|Overall Study|Withdrew Consent|0|||
13200237|NCT02010255|26216124|FG006|Overall Study|Withdrew Consent|0|||
13200238|NCT02010255|26216125|FG007|Overall Study|Withdrew Consent|0|||
13200239|NCT02010255|26216126|FG008|Overall Study|Withdrew Consent|0|||
13200240|NCT02010255|26216127|FG009|Overall Study|Withdrew Consent|0|||
13200241|NCT02010255|26216128|FG010|Overall Study|Withdrew Consent|0|||
13200242|NCT02010255|26216129|FG011|Overall Study|Withdrew Consent|0|||
13200243|NCT02010255|26216130|FG012|Overall Study|Withdrew Consent|0|||
13200244|NCT02010255|26216131|FG013|Overall Study|Withdrew Consent|0|||
13200245|NCT02010255|26216118|FG000|Overall Study|Adverse Event|1|||
13200246|NCT02010255|26216119|FG001|Overall Study|Adverse Event|0|||
13200247|NCT02010255|26216120|FG002|Overall Study|Adverse Event|0|||
13200248|NCT02010255|26216121|FG003|Overall Study|Adverse Event|0|||
13200249|NCT02010255|26216122|FG004|Overall Study|Adverse Event|0|||
13200250|NCT02010255|26216123|FG005|Overall Study|Adverse Event|0|||
13200251|NCT02010255|26216124|FG006|Overall Study|Adverse Event|0|||
13200252|NCT02010255|26216125|FG007|Overall Study|Adverse Event|0|||
13200253|NCT02010255|26216126|FG008|Overall Study|Adverse Event|0|||
13200254|NCT02010255|26216127|FG009|Overall Study|Adverse Event|0|||
13200255|NCT02010255|26216128|FG010|Overall Study|Adverse Event|0|||
13200256|NCT02010255|26216129|FG011|Overall Study|Adverse Event|0|||
13200257|NCT02010255|26216130|FG012|Overall Study|Adverse Event|0|||
13200258|NCT02010255|26216131|FG013|Overall Study|Adverse Event|0|||
13200259|NCT02010255|26216118|FG000|Overall Study|Lost to Follow-up|0|||
13200260|NCT02010255|26216119|FG001|Overall Study|Lost to Follow-up|0|||
13200261|NCT02010255|26216120|FG002|Overall Study|Lost to Follow-up|1|||
13200262|NCT02010255|26216121|FG003|Overall Study|Lost to Follow-up|0|||
13200263|NCT02010255|26216122|FG004|Overall Study|Lost to Follow-up|1|||
13200264|NCT02010255|26216123|FG005|Overall Study|Lost to Follow-up|0|||
13200265|NCT02010255|26216124|FG006|Overall Study|Lost to Follow-up|0|||
13200266|NCT02010255|26216125|FG007|Overall Study|Lost to Follow-up|0|||
13200267|NCT02010255|26216126|FG008|Overall Study|Lost to Follow-up|0|||
13200268|NCT02010255|26216127|FG009|Overall Study|Lost to Follow-up|0|||
13200269|NCT02010255|26216128|FG010|Overall Study|Lost to Follow-up|0|||
13200270|NCT02010255|26216129|FG011|Overall Study|Lost to Follow-up|0|||
13200271|NCT02010255|26216130|FG012|Overall Study|Lost to Follow-up|0|||
13200272|NCT02010255|26216131|FG013|Overall Study|Lost to Follow-up|0|||
13200273|NCT02010255|26216118|FG000|Overall Study|Randomized but Not Treated|0|||
13200274|NCT02010255|26216119|FG001|Overall Study|Randomized but Not Treated|0|||
13200275|NCT02010255|26216120|FG002|Overall Study|Randomized but Not Treated|0|||
13200276|NCT02010255|26216121|FG003|Overall Study|Randomized but Not Treated|0|||
13200277|NCT02010255|26216122|FG004|Overall Study|Randomized but Not Treated|0|||
13200278|NCT02010255|26216123|FG005|Overall Study|Randomized but Not Treated|0|||
13200279|NCT02010255|26216124|FG006|Overall Study|Randomized but Not Treated|0|||
13200280|NCT02010255|26216125|FG007|Overall Study|Randomized but Not Treated|0|||
13200281|NCT02010255|26216126|FG008|Overall Study|Randomized but Not Treated|0|||
13200282|NCT02010255|26216127|FG009|Overall Study|Randomized but Not Treated|0|||
13200283|NCT02010255|26216128|FG010|Overall Study|Randomized but Not Treated|0|||
13200284|NCT02010255|26216129|FG011|Overall Study|Randomized but Not Treated|0|||
13200285|NCT02010255|26216130|FG012|Overall Study|Randomized but Not Treated|0|||
13200286|NCT02010255|26216131|FG013|Overall Study|Randomized but Not Treated|1|||
13200287|NCT02009930|26216155|FG000|Overall Study|withdrawn|5|||
13200288|NCT02009878|26216197|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
13200289|NCT02009878|26216198|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
13200290|NCT02009878|26216199|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
13200291|NCT02009865|26216220|FG000|Overall Study|Adverse Event|0|||
13200292|NCT02009865|26216221|FG001|Overall Study|Adverse Event|2|||
13200293|NCT02009865|26216220|FG000|Overall Study|Protocol Violation|0|||
13200294|NCT02009865|26216221|FG001|Overall Study|Protocol Violation|2|||
13200295|NCT02009865|26216220|FG000|Overall Study|Withdrawal by Subject|1|||
13200296|NCT02009865|26216221|FG001|Overall Study|Withdrawal by Subject|1|||
13200297|NCT02009722|26216252|FG000|Overall Study|Protocol Violation|1|||
13200298|NCT02009722|26216253|FG001|Overall Study|Protocol Violation|2|||
13200299|NCT02009722|26216252|FG000|Overall Study|Did not receive intervention|0|||
13200300|NCT02009722|26216253|FG001|Overall Study|Did not receive intervention|1|||
13200301|NCT02009696|26216263|FG000|Overall Study|Withdrawal by Subject|2|||
13200302|NCT02009397|26216269|FG000|Overall Study|Protocol Violation|6|||
13200303|NCT02009397|26216269|FG000|Overall Study|Death|8|||
13200304|NCT02009397|26216269|FG000|Overall Study|Lost to Follow-up|6|||
13200305|NCT02009384|26216275|FG000|Overall Study|Death|2|||
13200306|NCT02009332|26216313|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
13200307|NCT02009332|26216314|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1|||
13200308|NCT02009332|26216315|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
13200309|NCT02009332|26216316|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
13200310|NCT02009332|26216317|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
13200311|NCT02009332|26216318|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
13200312|NCT02009332|26216313|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
13200313|NCT02009332|26216314|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
13200314|NCT02009332|26216315|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
13200315|NCT02009332|26216316|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
13200316|NCT02009332|26216317|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1|||
13200317|NCT02009332|26216318|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
13200318|NCT02009332|26216313|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
13200319|NCT02009332|26216314|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
13200320|NCT02009332|26216315|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
13200321|NCT02009332|26216316|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
13200322|NCT02009332|26216317|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
13200323|NCT02009332|26216318|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1|||
13206611|NCT01956123|26235054|FG000|COS Cycle 2|Personal Reasons|2|||
13206612|NCT01956123|26235055|FG001|COS Cycle 2|Personal Reasons|0|||
13206613|NCT01956123|26235056|FG002|COS Cycle 2|Personal Reasons|0|||
13206614|NCT01956123|26235057|FG003|COS Cycle 2|Personal Reasons|0|||
13206615|NCT01956123|26235054|FG000|COS Cycle 2|Withdrawal by Subject|1|||
13206616|NCT01956123|26235055|FG001|COS Cycle 2|Withdrawal by Subject|0|||
13206617|NCT01956123|26235056|FG002|COS Cycle 2|Withdrawal by Subject|0|||
13206618|NCT01956123|26235057|FG003|COS Cycle 2|Withdrawal by Subject|0|||
13206619|NCT01956123|26235054|FG000|COS Cycle 3|Protocol Violation|0|||
13206620|NCT01956123|26235055|FG001|COS Cycle 3|Protocol Violation|0|||
13206621|NCT01956123|26235056|FG002|COS Cycle 3|Protocol Violation|2|||
13206622|NCT01956123|26235057|FG003|COS Cycle 3|Protocol Violation|1|||
13206623|NCT01956123|26235054|FG000|COS Cycle 3|Adverse Event|0|||
13206624|NCT01956123|26235055|FG001|COS Cycle 3|Adverse Event|0|||
13206625|NCT01956123|26235056|FG002|COS Cycle 3|Adverse Event|3|||
13206626|NCT01956123|26235057|FG003|COS Cycle 3|Adverse Event|0|||
13206627|NCT01956123|26235054|FG000|COS Cycle 3|Personal Reasons|0|||
13206628|NCT01956123|26235055|FG001|COS Cycle 3|Personal Reasons|0|||
13206629|NCT01956123|26235056|FG002|COS Cycle 3|Personal Reasons|1|||
13206630|NCT01956123|26235057|FG003|COS Cycle 3|Personal Reasons|0|||
13206631|NCT01956123|26235054|FG000|COS Cycle 3|Withdrawal by Subject|0|||
13206632|NCT01956123|26235055|FG001|COS Cycle 3|Withdrawal by Subject|0|||
13206633|NCT01956123|26235056|FG002|COS Cycle 3|Withdrawal by Subject|0|||
13206634|NCT01956123|26235057|FG003|COS Cycle 3|Withdrawal by Subject|1|||
13206635|NCT01955733|26235087|FG000|Period 1|Lost to Follow-up|1|||
13206636|NCT01955733|26235088|FG001|Period 1|Lost to Follow-up|0|||
13206637|NCT01955733|26235089|FG002|Period 1|Lost to Follow-up|0|||
13206638|NCT01955733|26235087|FG000|Period 2|Adverse Event|1|||
13206639|NCT01955733|26235088|FG001|Period 2|Adverse Event|0|||
13206640|NCT01955733|26235089|FG002|Period 2|Adverse Event|0|||
13206641|NCT01955733|26235087|FG000|Period 2|Physician Decision|0|||
13206642|NCT01955733|26235088|FG001|Period 2|Physician Decision|0|||
13206643|NCT01955733|26235089|FG002|Period 2|Physician Decision|1|||
13206644|NCT01955733|26235087|FG000|Period 2|Withdrawal by Subject|1|||
13206645|NCT01955733|26235088|FG001|Period 2|Withdrawal by Subject|3|||
13206646|NCT01955733|26235089|FG002|Period 2|Withdrawal by Subject|2|||
13206647|NCT01955733|26235087|FG000|Period 2|Study terminated by sponsor|8|||
13206648|NCT01955733|26235088|FG001|Period 2|Study terminated by sponsor|14|||
13206649|NCT01955733|26235089|FG002|Period 2|Study terminated by sponsor|16|||
13200324|NCT02009163|26216355|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48|||
13200325|NCT02009163|26216356|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
13200326|NCT02009163|26216357|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
13200327|NCT02009163|26216355|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29|||
13200328|NCT02009163|26216356|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
13200329|NCT02009163|26216357|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
13200330|NCT02009163|26216355|FG000|Open-label Period (Non-randomized)|Adverse Event|22|||
13200331|NCT02009163|26216356|FG001|Open-label Period (Non-randomized)|Adverse Event|0|||
13200332|NCT02009163|26216357|FG002|Open-label Period (Non-randomized)|Adverse Event|0|||
13200333|NCT02009163|26216355|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20|||
13200334|NCT02009163|26216356|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
13200335|NCT02009163|26216357|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
13200336|NCT02009163|26216355|FG000|Open-label Period (Non-randomized)|Protocol Violation|10|||
13200337|NCT02009163|26216356|FG001|Open-label Period (Non-randomized)|Protocol Violation|0|||
13200338|NCT02009163|26216357|FG002|Open-label Period (Non-randomized)|Protocol Violation|0|||
13200339|NCT02009163|26216355|FG000|Open-label Period (Non-randomized)|Pregnancy|1|||
13200340|NCT02009163|26216356|FG001|Open-label Period (Non-randomized)|Pregnancy|0|||
13200341|NCT02009163|26216357|FG002|Open-label Period (Non-randomized)|Pregnancy|0|||
13200342|NCT02009163|26216355|FG000|Open-label Period (Non-randomized)|Other|13|||
13200343|NCT02009163|26216356|FG001|Open-label Period (Non-randomized)|Other|0|||
13200344|NCT02009163|26216357|FG002|Open-label Period (Non-randomized)|Other|0|||
13200345|NCT02009163|26216355|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0|||
13200346|NCT02009163|26216356|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25|||
13200347|NCT02009163|26216357|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9|||
13200348|NCT02009163|26216355|FG000|Randomized-withdrawal Period|Lost to Follow-up|0|||
13200349|NCT02009163|26216356|FG001|Randomized-withdrawal Period|Lost to Follow-up|13|||
13200350|NCT02009163|26216357|FG002|Randomized-withdrawal Period|Lost to Follow-up|6|||
13200351|NCT02009163|26216355|FG000|Randomized-withdrawal Period|Adverse Event|0|||
13200352|NCT02009163|26216356|FG001|Randomized-withdrawal Period|Adverse Event|0|||
13200353|NCT02009163|26216357|FG002|Randomized-withdrawal Period|Adverse Event|6|||
13200354|NCT02009163|26216355|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0|||
13200355|NCT02009163|26216356|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40|||
13200356|NCT02009163|26216357|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5|||
13200357|NCT02009163|26216355|FG000|Randomized-withdrawal Period|Protocol Violation|0|||
13200358|NCT02009163|26216356|FG001|Randomized-withdrawal Period|Protocol Violation|1|||
13200359|NCT02009163|26216357|FG002|Randomized-withdrawal Period|Protocol Violation|2|||
13200360|NCT02009163|26216355|FG000|Randomized-withdrawal Period|Pregnancy|0|||
13200361|NCT02009163|26216356|FG001|Randomized-withdrawal Period|Pregnancy|0|||
13200362|NCT02009163|26216357|FG002|Randomized-withdrawal Period|Pregnancy|2|||
13200363|NCT02009163|26216355|FG000|Randomized-withdrawal Period|Other|0|||
13200364|NCT02009163|26216356|FG001|Randomized-withdrawal Period|Other|9|||
13200365|NCT02009163|26216357|FG002|Randomized-withdrawal Period|Other|5|||
13200366|NCT02009046|26216414|FG000|Overall Study|Lost to Follow-up|256|||
13200367|NCT02009046|26216415|FG001|Overall Study|Lost to Follow-up|206|||
13200368|NCT02008916|26216458|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0|||
13200369|NCT02008916|26216459|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1|||
13200370|NCT02008916|26216460|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3|||
13112799|NCT03150862|25909702|FG006|Overall Study|Withdrawal by Subject|1|||
13112800|NCT03150862|25909703|FG007|Overall Study|Withdrawal by Subject|3|||
13112801|NCT03150862|25909696|FG000|Overall Study|Lost to Follow-up|0|||
13112802|NCT03150862|25909697|FG001|Overall Study|Lost to Follow-up|0|||
13112803|NCT03150862|25909698|FG002|Overall Study|Lost to Follow-up|1|||
13112804|NCT03150862|25909699|FG003|Overall Study|Lost to Follow-up|0|||
13112805|NCT03150862|25909700|FG004|Overall Study|Lost to Follow-up|0|||
13112806|NCT03150862|25909701|FG005|Overall Study|Lost to Follow-up|0|||
13112807|NCT03150862|25909702|FG006|Overall Study|Lost to Follow-up|0|||
13112808|NCT03150862|25909703|FG007|Overall Study|Lost to Follow-up|2|||
13112809|NCT03150862|25909696|FG000|Overall Study|Sponsor's decision|0|||
13112810|NCT03150862|25909697|FG001|Overall Study|Sponsor's decision|0|||
13112811|NCT03150862|25909698|FG002|Overall Study|Sponsor's decision|0|||
13112812|NCT03150862|25909699|FG003|Overall Study|Sponsor's decision|10|||
13112813|NCT03150862|25909700|FG004|Overall Study|Sponsor's decision|3|||
13112814|NCT03150862|25909701|FG005|Overall Study|Sponsor's decision|0|||
13112815|NCT03150862|25909702|FG006|Overall Study|Sponsor's decision|1|||
13112816|NCT03150862|25909703|FG007|Overall Study|Sponsor's decision|1|||
13112817|NCT03150862|25909696|FG000|Overall Study|Change in Methylation status|0|||
13112818|NCT03150862|25909697|FG001|Overall Study|Change in Methylation status|0|||
13112819|NCT03150862|25909698|FG002|Overall Study|Change in Methylation status|0|||
13112820|NCT03150862|25909699|FG003|Overall Study|Change in Methylation status|0|||
13112821|NCT03150862|25909700|FG004|Overall Study|Change in Methylation status|1|||
13112822|NCT03150862|25909701|FG005|Overall Study|Change in Methylation status|0|||
13112823|NCT03150862|25909702|FG006|Overall Study|Change in Methylation status|0|||
13112824|NCT03150862|25909703|FG007|Overall Study|Change in Methylation status|0|||
13112825|NCT03150862|25909696|FG000|Overall Study|Roll over in to Long Term Extension|0|||
13112826|NCT03150862|25909697|FG001|Overall Study|Roll over in to Long Term Extension|0|||
13112827|NCT03150862|25909698|FG002|Overall Study|Roll over in to Long Term Extension|0|||
13112828|NCT03150862|25909699|FG003|Overall Study|Roll over in to Long Term Extension|0|||
13112829|NCT03150862|25909700|FG004|Overall Study|Roll over in to Long Term Extension|0|||
13200371|NCT02008916|26216458|FG000|Week 16 - 156|Adverse Event|4|||
13200372|NCT02008916|26216459|FG001|Week 16 - 156|Adverse Event|2|||
13200373|NCT02008916|26216460|FG002|Week 16 - 156|Adverse Event|3|||
13200374|NCT02008916|26216458|FG000|Week 16 - 156|Withdrawal by Subject|7|||
13200375|NCT02008916|26216459|FG001|Week 16 - 156|Withdrawal by Subject|3|||
13200376|NCT02008916|26216460|FG002|Week 16 - 156|Withdrawal by Subject|5|||
13200377|NCT02008916|26216458|FG000|Week 16 - 156|No longer requires treatment|0|||
13200378|NCT02008916|26216459|FG001|Week 16 - 156|No longer requires treatment|1|||
13200379|NCT02008916|26216460|FG002|Week 16 - 156|No longer requires treatment|0|||
13200380|NCT02008916|26216458|FG000|Week 16 - 156|Lost to Follow-up|5|||
13200381|NCT02008916|26216459|FG001|Week 16 - 156|Lost to Follow-up|0|||
13200382|NCT02008916|26216460|FG002|Week 16 - 156|Lost to Follow-up|0|||
13200383|NCT02008916|26216458|FG000|Week 16 - 156|Lack of Efficacy|3|||
13200384|NCT02008916|26216459|FG001|Week 16 - 156|Lack of Efficacy|5|||
13200385|NCT02008916|26216460|FG002|Week 16 - 156|Lack of Efficacy|2|||
13200386|NCT02008916|26216458|FG000|Week 16 - 156|Pregnancy|0|||
13200387|NCT02008916|26216459|FG001|Week 16 - 156|Pregnancy|1|||
13200388|NCT02008916|26216460|FG002|Week 16 - 156|Pregnancy|0|||
13200389|NCT02008916|26216458|FG000|Week 16 - 156|Physician Decision|0|||
13200390|NCT02008916|26216459|FG001|Week 16 - 156|Physician Decision|1|||
13200391|NCT02008916|26216460|FG002|Week 16 - 156|Physician Decision|0|||
13200392|NCT02008890|26216508|FG000|Period 1|Withdrawal by Subject|7|||
13200393|NCT02008890|26216509|FG001|Period 1|Withdrawal by Subject|7|||
13200394|NCT02008890|26216510|FG002|Period 1|Withdrawal by Subject|5|||
13200395|NCT02008890|26216511|FG003|Period 1|Withdrawal by Subject|0|||
13200396|NCT02008890|26216512|FG004|Period 1|Withdrawal by Subject|0|||
13200397|NCT02008890|26216508|FG000|Period 1|Pregnancy|1|||
13200398|NCT02008890|26216509|FG001|Period 1|Pregnancy|0|||
13200399|NCT02008890|26216510|FG002|Period 1|Pregnancy|0|||
13200400|NCT02008890|26216511|FG003|Period 1|Pregnancy|0|||
13200401|NCT02008890|26216512|FG004|Period 1|Pregnancy|0|||
13200402|NCT02008890|26216508|FG000|Period 1|Physician Decision|1|||
13200403|NCT02008890|26216509|FG001|Period 1|Physician Decision|0|||
13200404|NCT02008890|26216510|FG002|Period 1|Physician Decision|1|||
13200405|NCT02008890|26216511|FG003|Period 1|Physician Decision|0|||
13200406|NCT02008890|26216512|FG004|Period 1|Physician Decision|0|||
13200407|NCT02008890|26216508|FG000|Period 1|Adverse Event|6|||
13200408|NCT02008890|26216509|FG001|Period 1|Adverse Event|8|||
13200409|NCT02008890|26216510|FG002|Period 1|Adverse Event|6|||
13200410|NCT02008890|26216511|FG003|Period 1|Adverse Event|0|||
13200411|NCT02008890|26216512|FG004|Period 1|Adverse Event|0|||
13200412|NCT02008890|26216508|FG000|Period 2|Adverse Event|12|||
13112830|NCT03150862|25909701|FG005|Overall Study|Roll over in to Long Term Extension|0|||
13112831|NCT03150862|25909702|FG006|Overall Study|Roll over in to Long Term Extension|0|||
13112832|NCT03150862|25909703|FG007|Overall Study|Roll over in to Long Term Extension|1|||
13112833|NCT03150862|25909696|FG000|Overall Study|Progressive Disease|0|||
13200413|NCT02008890|26216509|FG001|Period 2|Adverse Event|7|||
13200414|NCT02008890|26216510|FG002|Period 2|Adverse Event|0|||
13200415|NCT02008890|26216511|FG003|Period 2|Adverse Event|5|||
13200416|NCT02008890|26216512|FG004|Period 2|Adverse Event|5|||
13200417|NCT02008890|26216508|FG000|Period 2|Withdrawal by Subject|11|||
13200418|NCT02008890|26216509|FG001|Period 2|Withdrawal by Subject|8|||
13200419|NCT02008890|26216510|FG002|Period 2|Withdrawal by Subject|0|||
13200420|NCT02008890|26216511|FG003|Period 2|Withdrawal by Subject|7|||
13200421|NCT02008890|26216512|FG004|Period 2|Withdrawal by Subject|2|||
13200422|NCT02008890|26216508|FG000|Period 2|Physician Decision|4|||
13200423|NCT02008890|26216509|FG001|Period 2|Physician Decision|0|||
13200424|NCT02008890|26216510|FG002|Period 2|Physician Decision|0|||
13200425|NCT02008890|26216511|FG003|Period 2|Physician Decision|2|||
13200426|NCT02008890|26216512|FG004|Period 2|Physician Decision|1|||
13200427|NCT02008890|26216508|FG000|Period 2|Lost to Follow-up|0|||
13200428|NCT02008890|26216509|FG001|Period 2|Lost to Follow-up|0|||
13200429|NCT02008890|26216510|FG002|Period 2|Lost to Follow-up|1|||
13200430|NCT02008890|26216511|FG003|Period 2|Lost to Follow-up|0|||
13200431|NCT02008890|26216512|FG004|Period 2|Lost to Follow-up|0|||
13200432|NCT02008890|26216508|FG000|Extension Period|Withdrawal by Subject|3|||
13200433|NCT02008890|26216509|FG001|Extension Period|Withdrawal by Subject|2|||
13200434|NCT02008890|26216510|FG002|Extension Period|Withdrawal by Subject|0|||
13200435|NCT02008890|26216511|FG003|Extension Period|Withdrawal by Subject|4|||
13200436|NCT02008890|26216512|FG004|Extension Period|Withdrawal by Subject|2|||
13200437|NCT02008890|26216508|FG000|Extension Period|Lost to Follow-up|1|||
13200438|NCT02008890|26216509|FG001|Extension Period|Lost to Follow-up|0|||
13200439|NCT02008890|26216510|FG002|Extension Period|Lost to Follow-up|0|||
13200440|NCT02008890|26216511|FG003|Extension Period|Lost to Follow-up|0|||
13200441|NCT02008890|26216512|FG004|Extension Period|Lost to Follow-up|0|||
13200442|NCT02008890|26216508|FG000|Extension Period|Adverse Event|1|||
13200443|NCT02008890|26216509|FG001|Extension Period|Adverse Event|3|||
13200444|NCT02008890|26216510|FG002|Extension Period|Adverse Event|0|||
13200445|NCT02008890|26216511|FG003|Extension Period|Adverse Event|0|||
13200446|NCT02008890|26216512|FG004|Extension Period|Adverse Event|2|||
13200447|NCT02008877|26216531|FG000|Overall Study|Inevaluable|0|||
13200448|NCT02008877|26216532|FG001|Overall Study|Inevaluable|1|||
13200449|NCT02008877|26216533|FG002|Overall Study|Inevaluable|0|||
13200450|NCT02008773|26216574|FG000|Overall Study|Adverse Event|3|||
13200451|NCT02008773|26216575|FG001|Overall Study|Adverse Event|3|||
13200452|NCT02008773|26216576|FG002|Overall Study|Adverse Event|1|||
13200453|NCT02008773|26216577|FG003|Overall Study|Adverse Event|2|||
13200454|NCT02008773|26216574|FG000|Overall Study|Medication Non-compliance|2|||
13200455|NCT02008773|26216575|FG001|Overall Study|Medication Non-compliance|1|||
13200456|NCT02008773|26216576|FG002|Overall Study|Medication Non-compliance|3|||
13200457|NCT02008773|26216577|FG003|Overall Study|Medication Non-compliance|2|||
13200458|NCT02008773|26216574|FG000|Overall Study|Withdrawal by Subject|8|||
13200459|NCT02008773|26216575|FG001|Overall Study|Withdrawal by Subject|4|||
13200460|NCT02008773|26216576|FG002|Overall Study|Withdrawal by Subject|7|||
13200461|NCT02008773|26216577|FG003|Overall Study|Withdrawal by Subject|6|||
13200462|NCT02008773|26216574|FG000|Overall Study|Lost to Follow-up|0|||
13200463|NCT02008773|26216575|FG001|Overall Study|Lost to Follow-up|1|||
13200464|NCT02008773|26216576|FG002|Overall Study|Lost to Follow-up|3|||
13200465|NCT02008773|26216577|FG003|Overall Study|Lost to Follow-up|2|||
13200466|NCT02008565|26216648|FG000|Overall Study|Protocol Violation|1|||
13200467|NCT02008565|26216649|FG001|Overall Study|Protocol Violation|1|||
13200468|NCT02008565|26216650|FG002|Overall Study|Protocol Violation|2|||
13112834|NCT03150862|25909697|FG001|Overall Study|Progressive Disease|0|||
13112835|NCT03150862|25909698|FG002|Overall Study|Progressive Disease|0|||
13112836|NCT03150862|25909699|FG003|Overall Study|Progressive Disease|0|||
13112837|NCT03150862|25909700|FG004|Overall Study|Progressive Disease|0|||
13112838|NCT03150862|25909701|FG005|Overall Study|Progressive Disease|0|||
13112839|NCT03150862|25909702|FG006|Overall Study|Progressive Disease|0|||
13112840|NCT03150862|25909703|FG007|Overall Study|Progressive Disease|2|||
13112841|NCT03150719|25909726|FG000|Overall Study|Adverse Event|0|||
13112842|NCT03150719|25909727|FG001|Overall Study|Adverse Event|1|||
13112843|NCT03150719|25909726|FG000|Overall Study|Death|0|||
13112844|NCT03150719|25909727|FG001|Overall Study|Death|1|||
13112845|NCT03150719|25909726|FG000|Overall Study|Other|1|||
13112846|NCT03150719|25909727|FG001|Overall Study|Other|0|||
13112847|NCT03150589|25909742|FG000|Overall Study|Withdrawal by Subject|16|||
13112848|NCT03150589|25909743|FG001|Overall Study|Withdrawal by Subject|9|||
13112849|NCT03150589|25909742|FG000|Overall Study|Adverse Event|7|||
13112850|NCT03150589|25909743|FG001|Overall Study|Adverse Event|6|||
13112851|NCT03150589|25909742|FG000|Overall Study|Protocol Violation|4|||
13112852|NCT03150589|25909743|FG001|Overall Study|Protocol Violation|3|||
13112853|NCT03150589|25909742|FG000|Overall Study|Lost to Follow-up|3|||
13112854|NCT03150589|25909743|FG001|Overall Study|Lost to Follow-up|3|||
13112855|NCT03150589|25909742|FG000|Overall Study|Death|2|||
13112856|NCT03150589|25909743|FG001|Overall Study|Death|3|||
13112857|NCT03150589|25909742|FG000|Overall Study|IP non-compliance and other reasons|12|||
13112858|NCT03150589|25909743|FG001|Overall Study|IP non-compliance and other reasons|3|||
13112859|NCT03150485|25909765|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
13112860|NCT03150485|25909766|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
13112861|NCT03150485|25909767|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
13112862|NCT03150485|25909768|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
13112863|NCT03150485|25909769|FG004|Overall Study|Unsatisfactory Lens Fitting|0|||
13112864|NCT03150485|25909770|FG005|Overall Study|Unsatisfactory Lens Fitting|0|||
13112865|NCT03150082|25909827|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1|||
13112866|NCT03150082|25909828|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
13112867|NCT03150056|25910005|FG000|Overall Study|Withdrawal by Subject|0|||
13112868|NCT03150056|25910006|FG001|Overall Study|Withdrawal by Subject|0|||
13112869|NCT03150056|25910007|FG002|Overall Study|Withdrawal by Subject|0|||
13112870|NCT03150056|25910008|FG003|Overall Study|Withdrawal by Subject|0|||
13112871|NCT03150056|25910009|FG004|Overall Study|Withdrawal by Subject|0|||
13112872|NCT03150056|25910010|FG005|Overall Study|Withdrawal by Subject|2|||
13112873|NCT03150056|25910005|FG000|Overall Study|Study terminated by Sponsor|1|||
13112874|NCT03150056|25910006|FG001|Overall Study|Study terminated by Sponsor|3|||
13200469|NCT02008565|26216651|FG003|Overall Study|Protocol Violation|0|||
13200470|NCT02008526|26216672|FG000|Overall Study|Death|0|||
13200471|NCT02008526|26216673|FG001|Overall Study|Death|2|||
13112875|NCT03150056|25910007|FG002|Overall Study|Study terminated by Sponsor|1|||
13112876|NCT03150056|25910008|FG003|Overall Study|Study terminated by Sponsor|1|||
13112877|NCT03150056|25910009|FG004|Overall Study|Study terminated by Sponsor|5|||
13112878|NCT03150056|25910010|FG005|Overall Study|Study terminated by Sponsor|6|||
13112879|NCT03150056|25910005|FG000|Overall Study|Death|9|||
13112880|NCT03150056|25910006|FG001|Overall Study|Death|2|||
13200472|NCT02008526|26216674|FG002|Overall Study|Death|1|||
13200473|NCT02008526|26216672|FG000|Overall Study|Withdrawal by Subject|3|||
13200474|NCT02008526|26216673|FG001|Overall Study|Withdrawal by Subject|3|||
13200475|NCT02008526|26216674|FG002|Overall Study|Withdrawal by Subject|2|||
13200476|NCT02008526|26216672|FG000|Overall Study|Lost to Follow-up|5|||
13200477|NCT02008526|26216673|FG001|Overall Study|Lost to Follow-up|9|||
13200478|NCT02008526|26216674|FG002|Overall Study|Lost to Follow-up|6|||
13200479|NCT02008396|26216692|FG000|Overall Study|Protocol Violation|0|||
13200480|NCT02008396|26216693|FG001|Overall Study|Protocol Violation|1|||
13200481|NCT02008370|26216701|FG000|Overall Study|Lost to Follow-up|7|||
13200482|NCT02008318|26216727|FG000|Overall Study|Adverse Event|4|||
13200483|NCT02008318|26216728|FG001|Overall Study|Adverse Event|0|||
13200484|NCT02008318|26216727|FG000|Overall Study|Physician Decision|2|||
13200485|NCT02008318|26216728|FG001|Overall Study|Physician Decision|0|||
13200486|NCT02008318|26216727|FG000|Overall Study|Progressive Disease|2|||
13200487|NCT02008318|26216728|FG001|Overall Study|Progressive Disease|0|||
13200488|NCT02008318|26216727|FG000|Overall Study|Protocol Violation|1|||
13200489|NCT02008318|26216728|FG001|Overall Study|Protocol Violation|1|||
13200490|NCT02008318|26216727|FG000|Overall Study|Withdrawal by Subject|3|||
13200491|NCT02008318|26216728|FG001|Overall Study|Withdrawal by Subject|0|||
13200492|NCT02008227|26216810|FG000|Overall Study|Lost to Follow-up|7|||
13200493|NCT02008227|26216811|FG001|Overall Study|Lost to Follow-up|9|||
13200494|NCT02008227|26216810|FG000|Overall Study|Death|494|||
13200495|NCT02008227|26216811|FG001|Overall Study|Death|485|||
13200496|NCT02008227|26216810|FG000|Overall Study|Withdrawal by Subject|67|||
13200497|NCT02008227|26216811|FG001|Overall Study|Withdrawal by Subject|36|||
13200498|NCT02008227|26216810|FG000|Overall Study|Study Terminated By Sponsor|44|||
13200499|NCT02008227|26216811|FG001|Overall Study|Study Terminated By Sponsor|83|||
13200500|NCT02007954|26216826|FG000|Overall Study|Received liver transplant|3|||
13200501|NCT02007954|26216826|FG000|Overall Study|Switch in treatment modality|2|||
13200502|NCT02007954|26216826|FG000|Overall Study|Disease progression and unrelated AE|1|||
13200503|NCT02007954|26216826|FG000|Overall Study|Death|1|||
13200504|NCT02007720|26216866|FG000|Overall Study|Withdrawal by Subject|9|||
13200505|NCT02007720|26216867|FG001|Overall Study|Withdrawal by Subject|11|||
13200506|NCT02007720|26216866|FG000|Overall Study|study terminated by sponsor|58|||
13200507|NCT02007720|26216867|FG001|Overall Study|study terminated by sponsor|54|||
13200508|NCT02007720|26216866|FG000|Overall Study|technical problem|4|||
13112881|NCT03150056|25910007|FG002|Overall Study|Death|2|||
13112882|NCT03150056|25910008|FG003|Overall Study|Death|7|||
13112883|NCT03150056|25910009|FG004|Overall Study|Death|8|||
13112884|NCT03150056|25910010|FG005|Overall Study|Death|10|||
13112885|NCT03149848|25910049|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1|||
13112886|NCT03149848|25910049|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2|||
13112887|NCT03149328|25910072|FG000|Overall Study|Withdrawal by Subject|30|||
13112888|NCT03149328|25910073|FG001|Overall Study|Withdrawal by Subject|26|||
13112889|NCT03149328|25910072|FG000|Overall Study|Changed Dialysis Modality|18|||
13112890|NCT03149328|25910073|FG001|Overall Study|Changed Dialysis Modality|1|||
13112891|NCT03149328|25910072|FG000|Overall Study|Transplant|9|||
13112892|NCT03149328|25910073|FG001|Overall Study|Transplant|1|||
13112893|NCT03149328|25910072|FG000|Overall Study|Lost to Follow-up|25|||
13112894|NCT03149328|25910073|FG001|Overall Study|Lost to Follow-up|16|||
13112895|NCT03149328|25910072|FG000|Overall Study|Left Study Site|1|||
13200509|NCT02007720|26216867|FG001|Overall Study|technical problem|2|||
13200510|NCT02007720|26216866|FG000|Overall Study|patient followd less than 165 days|11|||
13200511|NCT02007720|26216867|FG001|Overall Study|patient followd less than 165 days|5|||
13206650|NCT01955733|26235087|FG000|Period 2|Lost to Follow-up|2|||
13206651|NCT01955733|26235088|FG001|Period 2|Lost to Follow-up|0|||
13206652|NCT01955733|26235089|FG002|Period 2|Lost to Follow-up|0|||
13206653|NCT01955733|26235087|FG000|Period 2|Other not defined above|0|||
13206654|NCT01955733|26235088|FG001|Period 2|Other not defined above|2|||
13206655|NCT01955733|26235089|FG002|Period 2|Other not defined above|2|||
13206656|NCT01955707|26235120|FG000|Overall Study|Adverse Event|1|||
13206657|NCT01955707|26235121|FG001|Overall Study|Adverse Event|2|||
13206658|NCT01955707|26235120|FG000|Overall Study|Lost to Follow-up|2|||
13206659|NCT01955707|26235121|FG001|Overall Study|Lost to Follow-up|1|||
13206660|NCT01955707|26235120|FG000|Overall Study|Withdrawal by Subject|0|||
13206661|NCT01955707|26235121|FG001|Overall Study|Withdrawal by Subject|3|||
13206662|NCT01955707|26235120|FG000|Overall Study|Death|13|||
13206663|NCT01955707|26235121|FG001|Overall Study|Death|14|||
13206664|NCT01955707|26235120|FG000|Overall Study|Other|4|||
13112896|NCT03149328|25910073|FG001|Overall Study|Left Study Site|2|||
13112897|NCT03149328|25910072|FG000|Overall Study|Language Barrier|1|||
13112898|NCT03149328|25910073|FG001|Overall Study|Language Barrier|0|||
13206665|NCT01955707|26235121|FG001|Overall Study|Other|2|||
13206666|NCT01955161|26235169|FG000|Overall Study|Withdrawal before treatment|2|||
13206667|NCT01955161|26235170|FG001|Overall Study|Withdrawal before treatment|0|||
13206668|NCT01955161|26235171|FG002|Overall Study|Withdrawal before treatment|1|||
13206669|NCT01955161|26235169|FG000|Overall Study|Adverse Event|10|||
13206670|NCT01955161|26235170|FG001|Overall Study|Adverse Event|14|||
13200512|NCT02007577|26216882|FG000|Overall Study|Adverse Event|1|||
13200513|NCT02007577|26216883|FG001|Overall Study|Adverse Event|0|||
13200514|NCT02007577|26216882|FG000|Overall Study|Withdrawal by Subject|0|||
13200515|NCT02007577|26216883|FG001|Overall Study|Withdrawal by Subject|1|||
13200516|NCT02007512|26216966|FG000|Double Blind Treatment Period|Adverse Event|4|||
13200517|NCT02007512|26216967|FG001|Double Blind Treatment Period|Adverse Event|2|||
13200518|NCT02007512|26216968|FG002|Double Blind Treatment Period|Adverse Event|6|||
13200519|NCT02007512|26216969|FG003|Double Blind Treatment Period|Adverse Event|2|||
13200520|NCT02007512|26216966|FG000|Double Blind Treatment Period|Death|1|||
13200521|NCT02007512|26216967|FG001|Double Blind Treatment Period|Death|0|||
13200522|NCT02007512|26216968|FG002|Double Blind Treatment Period|Death|0|||
13200523|NCT02007512|26216969|FG003|Double Blind Treatment Period|Death|0|||
13200524|NCT02007512|26216966|FG000|Double Blind Treatment Period|Disease progression|44|||
13200525|NCT02007512|26216967|FG001|Double Blind Treatment Period|Disease progression|49|||
13200526|NCT02007512|26216968|FG002|Double Blind Treatment Period|Disease progression|45|||
13200527|NCT02007512|26216969|FG003|Double Blind Treatment Period|Disease progression|51|||
13200528|NCT02007512|26216966|FG000|Double Blind Treatment Period|Withdrawal by Subject|4|||
13200529|NCT02007512|26216967|FG001|Double Blind Treatment Period|Withdrawal by Subject|2|||
13200530|NCT02007512|26216968|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
13200531|NCT02007512|26216969|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
13200532|NCT02007512|26216966|FG000|Double Blind Treatment Period|Protocol Violation|0|||
13200533|NCT02007512|26216967|FG001|Double Blind Treatment Period|Protocol Violation|0|||
13200534|NCT02007512|26216968|FG002|Double Blind Treatment Period|Protocol Violation|0|||
13200535|NCT02007512|26216969|FG003|Double Blind Treatment Period|Protocol Violation|1|||
13200536|NCT02007512|26216966|FG000|Double Blind Treatment Period|Other|0|||
13200537|NCT02007512|26216967|FG001|Double Blind Treatment Period|Other|0|||
13200538|NCT02007512|26216968|FG002|Double Blind Treatment Period|Other|1|||
13200539|NCT02007512|26216969|FG003|Double Blind Treatment Period|Other|2|||
13200540|NCT02007512|26216966|FG000|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|10|||
13200541|NCT02007512|26216967|FG001|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|11|||
13200542|NCT02007512|26216968|FG002|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|5|||
13200543|NCT02007512|26216969|FG003|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|1|||
13200544|NCT02007512|26216966|FG000|Open Label Treatment Period|Adverse Event|0|||
13200545|NCT02007512|26216967|FG001|Open Label Treatment Period|Adverse Event|1|||
13200546|NCT02007512|26216968|FG002|Open Label Treatment Period|Adverse Event|0|||
13200547|NCT02007512|26216969|FG003|Open Label Treatment Period|Adverse Event|0|||
13200548|NCT02007512|26216966|FG000|Open Label Treatment Period|Other|0|||
13200549|NCT02007512|26216967|FG001|Open Label Treatment Period|Other|0|||
13200550|NCT02007512|26216968|FG002|Open Label Treatment Period|Other|0|||
13200551|NCT02007512|26216969|FG003|Open Label Treatment Period|Other|1|||
13200552|NCT02007512|26216966|FG000|Open Label Treatment Period|Disease progression|0|||
13200553|NCT02007512|26216967|FG001|Open Label Treatment Period|Disease progression|17|||
13200554|NCT02007512|26216968|FG002|Open Label Treatment Period|Disease progression|0|||
13200555|NCT02007512|26216969|FG003|Open Label Treatment Period|Disease progression|11|||
13200556|NCT02007512|26216966|FG000|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
13200557|NCT02007512|26216967|FG001|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|3|||
13200558|NCT02007512|26216968|FG002|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
13200559|NCT02007512|26216969|FG003|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
13200560|NCT02007434|26217092|FG000|Overall Study|Lost to Follow-up|0|||
13200561|NCT02007434|26217093|FG001|Overall Study|Lost to Follow-up|1|||
13200562|NCT02007434|26217094|FG002|Overall Study|Lost to Follow-up|0|||
13200563|NCT02007434|26217095|FG003|Overall Study|Lost to Follow-up|0|||
13200564|NCT02007434|26217096|FG004|Overall Study|Lost to Follow-up|0|||
13200565|NCT02007434|26217097|FG005|Overall Study|Lost to Follow-up|0|||
13200566|NCT02007434|26217098|FG006|Overall Study|Lost to Follow-up|0|||
13200567|NCT02007434|26217099|FG007|Overall Study|Lost to Follow-up|0|||
13200568|NCT02007434|26217092|FG000|Overall Study|Non-compliance|1|||
13200569|NCT02007434|26217093|FG001|Overall Study|Non-compliance|0|||
13200570|NCT02007434|26217094|FG002|Overall Study|Non-compliance|1|||
13200571|NCT02007434|26217095|FG003|Overall Study|Non-compliance|0|||
13200572|NCT02007434|26217096|FG004|Overall Study|Non-compliance|0|||
13200573|NCT02007434|26217097|FG005|Overall Study|Non-compliance|0|||
13200574|NCT02007434|26217098|FG006|Overall Study|Non-compliance|0|||
13200575|NCT02007434|26217099|FG007|Overall Study|Non-compliance|0|||
13200576|NCT02007278|26217126|FG000|Overall Study|Failure to comply with an eligibility|0|||
13200577|NCT02007278|26217127|FG001|Overall Study|Failure to comply with an eligibility|1|||
13200578|NCT02007278|26217126|FG000|Overall Study|Ingestion of drugs not allowed in study|0|||
13200579|NCT02007278|26217127|FG001|Overall Study|Ingestion of drugs not allowed in study|1|||
13485631|NCT01126749|27033003|FG003|Phase 1b|Withdrawal by Subject|0|||
13200580|NCT02007278|26217126|FG000|Overall Study|Incorrect medication administration|1|||
13200581|NCT02007278|26217127|FG001|Overall Study|Incorrect medication administration|0|||
13200582|NCT02007278|26217126|FG000|Overall Study|Mis-randomization|1|||
13200583|NCT02007278|26217127|FG001|Overall Study|Mis-randomization|1|||
13200584|NCT02007252|26217140|FG000|Overall Study|Administrative problems|3|||
13200585|NCT02007252|26217141|FG001|Overall Study|Administrative problems|7|||
13200586|NCT02007252|26217140|FG000|Overall Study|Abnormal laboratory value(s)|1|||
13200587|NCT02007252|26217141|FG001|Overall Study|Abnormal laboratory value(s)|0|||
13200588|NCT02007252|26217140|FG000|Overall Study|Adverse Event|7|||
13200589|NCT02007252|26217141|FG001|Overall Study|Adverse Event|4|||
13200590|NCT02007109|26217150|FG000|Overall Study|Diary not returned or excluded|102|||
13200591|NCT02007109|26217150|FG000|Overall Study|Excluded - Age<7yo|9|||
13200592|NCT02007096|26217169|FG000|Overall Study|medication not available|2|||
13200593|NCT02007096|26217170|FG001|Overall Study|medication not available|0|||
13200594|NCT02007096|26217169|FG000|Overall Study|did not inject saline|0|||
13200595|NCT02007096|26217170|FG001|Overall Study|did not inject saline|3|||
13200596|NCT02007096|26217169|FG000|Overall Study|did not follow postoperative protocol|8|||
13200597|NCT02007096|26217170|FG001|Overall Study|did not follow postoperative protocol|11|||
13200598|NCT02007096|26217169|FG000|Overall Study|converted to open surgery|1|||
13200599|NCT02007096|26217170|FG001|Overall Study|converted to open surgery|1|||
13200600|NCT02007096|26217169|FG000|Overall Study|no mesh placed|0|||
13200601|NCT02007096|26217170|FG001|Overall Study|no mesh placed|1|||
13200602|NCT02007070|26217191|FG000|Overall Study|Adverse Event|4|||
13200603|NCT02007070|26217191|FG000|Overall Study|Clinical Progression|4|||
13200604|NCT02007070|26217191|FG000|Overall Study|Death|1|||
13200605|NCT02007070|26217191|FG000|Overall Study|Protocol Violation|2|||
13200606|NCT02007070|26217191|FG000|Overall Study|Physician Decision|1|||
13200607|NCT02007070|26217191|FG000|Overall Study|Progressive Disease|21|||
13200608|NCT02006979|26217210|FG000|Overall Study|Withdrawal by Subject|1|||
13200609|NCT02006979|26217211|FG001|Overall Study|Withdrawal by Subject|1|||
13200610|NCT02006979|26217210|FG000|Overall Study|Protocol Violation|0|||
13200611|NCT02006979|26217211|FG001|Overall Study|Protocol Violation|1|||
13200612|NCT02006927|26217218|FG000|Overall Study|Adverse Event|2|||
13200613|NCT02006927|26217218|FG000|Overall Study|Withdrawal by Subject|1|||
13200614|NCT02006758|26217247|FG000|Overall Study|Protocol Violation|1|||
13200615|NCT02006758|26217247|FG000|Overall Study|Death|1|||
13200616|NCT02006758|26217247|FG000|Overall Study|Lost to Follow-up|4|||
13200617|NCT02006758|26217247|FG000|Overall Study|Withdrawal by Subject|4|||
13200618|NCT02006758|26217247|FG000|Overall Study|Procedurally excluded|1|||
13200619|NCT02006758|26217247|FG000|Overall Study|Other|2|||
13200620|NCT02006732|26217298|FG000|Overall Study|Adverse Event|10|||
13200621|NCT02006732|26217299|FG001|Overall Study|Adverse Event|7|||
13200622|NCT02006732|26217300|FG002|Overall Study|Adverse Event|4|||
13200623|NCT02006732|26217301|FG003|Overall Study|Adverse Event|2|||
13200624|NCT02006732|26217298|FG000|Overall Study|Lack of Efficacy|6|||
13200625|NCT02006732|26217299|FG001|Overall Study|Lack of Efficacy|3|||
13200626|NCT02006732|26217300|FG002|Overall Study|Lack of Efficacy|1|||
13200627|NCT02006732|26217301|FG003|Overall Study|Lack of Efficacy|1|||
13200628|NCT02006732|26217298|FG000|Overall Study|Protocol Violation|1|||
13200629|NCT02006732|26217299|FG001|Overall Study|Protocol Violation|1|||
13200630|NCT02006732|26217300|FG002|Overall Study|Protocol Violation|0|||
13200631|NCT02006732|26217301|FG003|Overall Study|Protocol Violation|0|||
13200632|NCT02006732|26217298|FG000|Overall Study|Lost to Follow-up|0|||
13200633|NCT02006732|26217299|FG001|Overall Study|Lost to Follow-up|1|||
13200634|NCT02006732|26217300|FG002|Overall Study|Lost to Follow-up|0|||
13200635|NCT02006732|26217301|FG003|Overall Study|Lost to Follow-up|0|||
13200636|NCT02006732|26217298|FG000|Overall Study|Withdrawal by Subject|3|||
13200637|NCT02006732|26217299|FG001|Overall Study|Withdrawal by Subject|0|||
13112899|NCT03149055|25910080|FG000|Overall Study|Not treated|4|||
13112900|NCT03149042|25910094|FG000|Overall Study|Invasive FFR not performed|21|||
13112901|NCT03149042|25910094|FG000|Overall Study|Poor CT Image Quality|1|||
13112902|NCT03149042|25910094|FG000|Overall Study|Invasive FFR Measurement cancelled|1|||
13112903|NCT03148756|25910131|FG000|Overall Study|Study Terminated|0|||
13112904|NCT03148756|25910132|FG001|Overall Study|Study Terminated|1|||
13112905|NCT03148691|25910150|FG000|Overall Study|Protocol Violation|1|||
13200638|NCT02006732|26217300|FG002|Overall Study|Withdrawal by Subject|4|||
13200639|NCT02006732|26217301|FG003|Overall Study|Withdrawal by Subject|1|||
13200640|NCT02006719|26217338|FG000|Overall Study|Withdrawal by Subject|10|||
13200641|NCT02006719|26217339|FG001|Overall Study|Withdrawal by Subject|2|||
13200642|NCT02006719|26217338|FG000|Overall Study|Lost to Follow-up|5|||
13200643|NCT02006719|26217339|FG001|Overall Study|Lost to Follow-up|1|||
13112906|NCT03148691|25910151|FG001|Overall Study|Protocol Violation|2|||
13112907|NCT03148691|25910152|FG002|Overall Study|Protocol Violation|7|||
13112908|NCT03148691|25910150|FG000|Overall Study|Lost to Follow-up|0|||
13112909|NCT03148691|25910151|FG001|Overall Study|Lost to Follow-up|0|||
13112910|NCT03148691|25910152|FG002|Overall Study|Lost to Follow-up|1|||
13112911|NCT03148691|25910150|FG000|Overall Study|Other|1|||
13112912|NCT03148691|25910151|FG001|Overall Study|Other|0|||
13112913|NCT03148691|25910152|FG002|Overall Study|Other|0|||
13112914|NCT03148691|25910150|FG000|Overall Study|Withdrawal by Subject|1|||
13200644|NCT02006719|26217338|FG000|Overall Study|Protocol Violation|2|||
13200645|NCT02006719|26217339|FG001|Overall Study|Protocol Violation|0|||
13200646|NCT02006719|26217338|FG000|Overall Study|Adverse Event|1|||
13200647|NCT02006719|26217339|FG001|Overall Study|Adverse Event|1|||
13200648|NCT02006719|26217338|FG000|Overall Study|Other/Unknown|0|||
13200649|NCT02006719|26217339|FG001|Overall Study|Other/Unknown|1|||
13200650|NCT02006706|26217346|FG000|Overall Study|Lost to Follow-up|1|||
13200651|NCT02006693|26217365|FG000|Overall Study|No Reason Specified|6|||
13200652|NCT02006693|26217366|FG001|Overall Study|No Reason Specified|8|||
13200653|NCT02006693|26217365|FG000|Overall Study|Another Glaucoma-related Surgery|12|||
13200654|NCT02006693|26217366|FG001|Overall Study|Another Glaucoma-related Surgery|1|||
13200655|NCT02006693|26217365|FG000|Overall Study|XEN Implant Explantation|0|||
13200656|NCT02006693|26217366|FG001|Overall Study|XEN Implant Explantation|1|||
13200657|NCT02006693|26217365|FG000|Overall Study|Death|2|||
13200658|NCT02006693|26217366|FG001|Overall Study|Death|2|||
13200659|NCT02006693|26217365|FG000|Overall Study|Lost to Follow-up|4|||
13200660|NCT02006693|26217366|FG001|Overall Study|Lost to Follow-up|1|||
13200661|NCT02006693|26217365|FG000|Overall Study|Patient Decision|4|||
13200662|NCT02006693|26217366|FG001|Overall Study|Patient Decision|0|||
13200663|NCT02006667|26217378|FG000|Overall Study|Adverse Event|3|||
13200664|NCT02006667|26217378|FG000|Overall Study|Death|2|||
13200665|NCT02006667|26217378|FG000|Overall Study|Withdrawal by Subject|1|||
13200666|NCT02006654|26217411|FG000|Overall Study|Withdrawal before treatment|4|||
13200667|NCT02006654|26217412|FG001|Overall Study|Withdrawal before treatment|2|||
13200668|NCT02006654|26217411|FG000|Overall Study|Adverse Event|16|||
13200669|NCT02006654|26217412|FG001|Overall Study|Adverse Event|17|||
13200670|NCT02006654|26217411|FG000|Overall Study|Death|1|||
13200671|NCT02006654|26217412|FG001|Overall Study|Death|0|||
13200672|NCT02006654|26217411|FG000|Overall Study|Withdrawal by Subject|14|||
13200673|NCT02006654|26217412|FG001|Overall Study|Withdrawal by Subject|12|||
13200674|NCT02006654|26217411|FG000|Overall Study|Protocol Violation|5|||
13200675|NCT02006654|26217412|FG001|Overall Study|Protocol Violation|8|||
13200676|NCT02006654|26217411|FG000|Overall Study|Lost to Follow-up|1|||
13200677|NCT02006654|26217412|FG001|Overall Study|Lost to Follow-up|0|||
13200678|NCT02006654|26217411|FG000|Overall Study|patient's will|2|||
13200679|NCT02006654|26217412|FG001|Overall Study|patient's will|1|||
13200680|NCT02006654|26217411|FG000|Overall Study|insufficient compliance|1|||
13200681|NCT02006654|26217412|FG001|Overall Study|insufficient compliance|0|||
13200682|NCT02006654|26217411|FG000|Overall Study|worsening cognitive condition|0|||
13200683|NCT02006654|26217412|FG001|Overall Study|worsening cognitive condition|1|||
13200684|NCT02006654|26217411|FG000|Overall Study|faecal incontinence|0|||
13200685|NCT02006654|26217412|FG001|Overall Study|faecal incontinence|1|||
13200686|NCT02006654|26217411|FG000|Overall Study|mood disorder|0|||
13200687|NCT02006654|26217412|FG001|Overall Study|mood disorder|1|||
13200688|NCT02006654|26217411|FG000|Overall Study|disallowed medication|1|||
13200689|NCT02006654|26217412|FG001|Overall Study|disallowed medication|0|||
13200690|NCT02006654|26217411|FG000|Overall Study|moving out of state|0|||
13200691|NCT02006654|26217412|FG001|Overall Study|moving out of state|1|||
13200692|NCT02006641|26217460|FG000|Overall Study|Withdrawal before treatment|2|||
13200693|NCT02006641|26217461|FG001|Overall Study|Withdrawal before treatment|5|||
13200694|NCT02006641|26217462|FG002|Overall Study|Withdrawal before treatment|3|||
13200695|NCT02006641|26217460|FG000|Overall Study|Adverse Event|15|||
13200696|NCT02006641|26217461|FG001|Overall Study|Adverse Event|11|||
13200697|NCT02006641|26217462|FG002|Overall Study|Adverse Event|15|||
13200698|NCT02006641|26217460|FG000|Overall Study|Protocol Violation|0|||
13200699|NCT02006641|26217461|FG001|Overall Study|Protocol Violation|2|||
13200700|NCT02006641|26217462|FG002|Overall Study|Protocol Violation|2|||
13200701|NCT02006641|26217460|FG000|Overall Study|Lost to Follow-up|0|||
13200702|NCT02006641|26217461|FG001|Overall Study|Lost to Follow-up|1|||
13200703|NCT02006641|26217462|FG002|Overall Study|Lost to Follow-up|0|||
13200704|NCT02006641|26217460|FG000|Overall Study|Withdrawal by Subject|7|||
13200705|NCT02006641|26217461|FG001|Overall Study|Withdrawal by Subject|12|||
13200706|NCT02006641|26217462|FG002|Overall Study|Withdrawal by Subject|11|||
13200707|NCT02006641|26217460|FG000|Overall Study|Other reason: patient didn't show up|1|||
13200708|NCT02006641|26217461|FG001|Overall Study|Other reason: patient didn't show up|0|||
13200709|NCT02006641|26217462|FG002|Overall Study|Other reason: patient didn't show up|0|||
13200710|NCT02006641|26217460|FG000|Overall Study|Other reason:patient didn't want to come|0|||
13200711|NCT02006641|26217461|FG001|Overall Study|Other reason:patient didn't want to come|0|||
13200712|NCT02006641|26217462|FG002|Overall Study|Other reason:patient didn't want to come|1|||
13200713|NCT02006641|26217460|FG000|Overall Study|Other reason: patient has moved|1|||
13200714|NCT02006641|26217461|FG001|Overall Study|Other reason: patient has moved|0|||
13200715|NCT02006641|26217462|FG002|Overall Study|Other reason: patient has moved|1|||
13200716|NCT02006641|26217460|FG000|Overall Study|Other reason: caregiver in hospital|0|||
13200717|NCT02006641|26217461|FG001|Overall Study|Other reason: caregiver in hospital|1|||
13200718|NCT02006641|26217462|FG002|Overall Study|Other reason: caregiver in hospital|0|||
13200719|NCT02006641|26217460|FG000|Overall Study|Other reason: patient's wife has died|0|||
13200720|NCT02006641|26217461|FG001|Overall Study|Other reason: patient's wife has died|0|||
13200721|NCT02006641|26217462|FG002|Overall Study|Other reason: patient's wife has died|1|||
13200722|NCT02006641|26217460|FG000|Overall Study|Other reason: hospitalisation|0|||
13200723|NCT02006641|26217461|FG001|Overall Study|Other reason: hospitalisation|1|||
13200724|NCT02006641|26217462|FG002|Overall Study|Other reason: hospitalisation|0|||
13200725|NCT02006641|26217460|FG000|Overall Study|Other reason: caregiver impossibility|0|||
13200726|NCT02006641|26217461|FG001|Overall Study|Other reason: caregiver impossibility|0|||
13200727|NCT02006641|26217462|FG002|Overall Study|Other reason: caregiver impossibility|1|||
13200728|NCT02006641|26217460|FG000|Overall Study|Other reason: protocol non-compliance|0|||
13200729|NCT02006641|26217461|FG001|Overall Study|Other reason: protocol non-compliance|0|||
13200730|NCT02006641|26217462|FG002|Overall Study|Other reason: protocol non-compliance|1|||
13200731|NCT02006628|26217491|FG000|Overall Study|Adverse Event|1|||
13200732|NCT02006628|26217492|FG001|Overall Study|Adverse Event|1|||
13200733|NCT02006628|26217491|FG000|Overall Study|Withdrawal by Subject|2|||
13200734|NCT02006628|26217492|FG001|Overall Study|Withdrawal by Subject|1|||
13200735|NCT02006576|26217513|FG000|Overall Study|Withdrawal by Subject|4|||
13200736|NCT02006576|26217514|FG001|Overall Study|Withdrawal by Subject|6|||
13200737|NCT02006576|26217515|FG002|Overall Study|Withdrawal by Subject|2|||
13200738|NCT02006576|26217513|FG000|Overall Study|Death|0|||
13200739|NCT02006576|26217514|FG001|Overall Study|Death|0|||
13200740|NCT02006576|26217515|FG002|Overall Study|Death|1|||
13200741|NCT02006576|26217513|FG000|Overall Study|Lost to Follow-up|1|||
13200742|NCT02006576|26217514|FG001|Overall Study|Lost to Follow-up|0|||
13200743|NCT02006576|26217515|FG002|Overall Study|Lost to Follow-up|1|||
13200744|NCT02006576|26217513|FG000|Overall Study|Screen Failure, too sick, other|13|||
13200745|NCT02006576|26217514|FG001|Overall Study|Screen Failure, too sick, other|1|||
13200746|NCT02006576|26217515|FG002|Overall Study|Screen Failure, too sick, other|13|||
13200747|NCT02006472|26217559|FG000|Period 1 (Through Week 26)|Protocol Violation|1|||
13200748|NCT02006472|26217560|FG001|Period 1 (Through Week 26)|Protocol Violation|1|||
13200749|NCT02006472|26217561|FG002|Period 1 (Through Week 26)|Protocol Violation|1|||
13200750|NCT02006472|26217562|FG003|Period 1 (Through Week 26)|Protocol Violation|1|||
13200751|NCT02006472|26217563|FG004|Period 1 (Through Week 26)|Protocol Violation|0|||
13200752|NCT02006472|26217559|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0|||
13200753|NCT02006472|26217560|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0|||
13200754|NCT02006472|26217561|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1|||
13200755|NCT02006472|26217562|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0|||
13200756|NCT02006472|26217563|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0|||
13200757|NCT02006472|26217559|FG000|Period 1 (Through Week 26)|Noncompliance|2|||
13200758|NCT02006472|26217560|FG001|Period 1 (Through Week 26)|Noncompliance|1|||
13200759|NCT02006472|26217561|FG002|Period 1 (Through Week 26)|Noncompliance|1|||
13200760|NCT02006472|26217562|FG003|Period 1 (Through Week 26)|Noncompliance|0|||
13200761|NCT02006472|26217563|FG004|Period 1 (Through Week 26)|Noncompliance|0|||
13200762|NCT02006472|26217559|FG000|Period 1 (Through Week 26)|Other|1|||
13200763|NCT02006472|26217560|FG001|Period 1 (Through Week 26)|Other|5|||
13200764|NCT02006472|26217561|FG002|Period 1 (Through Week 26)|Other|0|||
13200765|NCT02006472|26217562|FG003|Period 1 (Through Week 26)|Other|2|||
13200766|NCT02006472|26217563|FG004|Period 1 (Through Week 26)|Other|3|||
13200767|NCT02006472|26217559|FG000|Period 1 (Through Week 26)|Adverse Event|5|||
13200768|NCT02006472|26217560|FG001|Period 1 (Through Week 26)|Adverse Event|6|||
13200769|NCT02006472|26217561|FG002|Period 1 (Through Week 26)|Adverse Event|11|||
13200770|NCT02006472|26217562|FG003|Period 1 (Through Week 26)|Adverse Event|11|||
13200771|NCT02006472|26217563|FG004|Period 1 (Through Week 26)|Adverse Event|14|||
13200772|NCT02006472|26217559|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
13200773|NCT02006472|26217560|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9|||
13200774|NCT02006472|26217561|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
13200775|NCT02006472|26217562|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0|||
13200776|NCT02006472|26217563|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
13200777|NCT02006472|26217559|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1|||
13200778|NCT02006472|26217560|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0|||
13200779|NCT02006472|26217561|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0|||
13200780|NCT02006472|26217562|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1|||
13200781|NCT02006472|26217563|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1|||
13200782|NCT02006472|26217559|FG000|Period 2 (Through Week 52)|Noncompliance|1|||
13200783|NCT02006472|26217560|FG001|Period 2 (Through Week 52)|Noncompliance|0|||
13200784|NCT02006472|26217561|FG002|Period 2 (Through Week 52)|Noncompliance|0|||
13200785|NCT02006472|26217562|FG003|Period 2 (Through Week 52)|Noncompliance|0|||
13200786|NCT02006472|26217563|FG004|Period 2 (Through Week 52)|Noncompliance|0|||
13200787|NCT02006472|26217559|FG000|Period 2 (Through Week 52)|Adverse Event|1|||
13200788|NCT02006472|26217560|FG001|Period 2 (Through Week 52)|Adverse Event|4|||
13200789|NCT02006472|26217561|FG002|Period 2 (Through Week 52)|Adverse Event|5|||
13485632|NCT01126749|27033000|FG000|Phase 1b|Death|3|||
13200790|NCT02006472|26217562|FG003|Period 2 (Through Week 52)|Adverse Event|1|||
13200791|NCT02006472|26217563|FG004|Period 2 (Through Week 52)|Adverse Event|1|||
13200792|NCT02006472|26217559|FG000|Period 2 (Through Week 52)|Other|0|||
13200793|NCT02006472|26217560|FG001|Period 2 (Through Week 52)|Other|1|||
13200794|NCT02006472|26217561|FG002|Period 2 (Through Week 52)|Other|0|||
13200795|NCT02006472|26217562|FG003|Period 2 (Through Week 52)|Other|1|||
13200796|NCT02006472|26217563|FG004|Period 2 (Through Week 52)|Other|0|||
13200797|NCT02006472|26217559|FG000|Period 2 (Through Week 52)|Not treated|0|||
13200798|NCT02006472|26217560|FG001|Period 2 (Through Week 52)|Not treated|0|||
13200799|NCT02006472|26217561|FG002|Period 2 (Through Week 52)|Not treated|2|||
13200800|NCT02006472|26217562|FG003|Period 2 (Through Week 52)|Not treated|0|||
13200801|NCT02006472|26217563|FG004|Period 2 (Through Week 52)|Not treated|0|||
13200802|NCT02006472|26217559|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
13200803|NCT02006472|26217560|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1|||
13200804|NCT02006472|26217561|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
13200805|NCT02006472|26217562|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
13200806|NCT02006472|26217563|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
13200807|NCT02006472|26217559|FG000|Period 2 (Through Week 52)|Sponsor decision|0|||
13200808|NCT02006472|26217560|FG001|Period 2 (Through Week 52)|Sponsor decision|0|||
13200809|NCT02006472|26217561|FG002|Period 2 (Through Week 52)|Sponsor decision|1|||
13200810|NCT02006472|26217562|FG003|Period 2 (Through Week 52)|Sponsor decision|0|||
13200811|NCT02006472|26217563|FG004|Period 2 (Through Week 52)|Sponsor decision|0|||
13200812|NCT02006121|26217584|FG000|Double Blind Phase|Adverse Event|6|||
13200813|NCT02006121|26217585|FG001|Double Blind Phase|Adverse Event|0|||
13200814|NCT02006121|26217584|FG000|Double Blind Phase|Lack of Efficacy|1|||
13200815|NCT02006121|26217585|FG001|Double Blind Phase|Lack of Efficacy|16|||
13200816|NCT02006121|26217584|FG000|Double Blind Phase|Withdrawal by Subject|3|||
13200817|NCT02006121|26217585|FG001|Double Blind Phase|Withdrawal by Subject|4|||
13200818|NCT02006121|26217584|FG000|Double Blind Phase|Non-compliance with study drug|1|||
13200819|NCT02006121|26217585|FG001|Double Blind Phase|Non-compliance with study drug|3|||
13200820|NCT02006121|26217584|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1|||
13200821|NCT02006121|26217585|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0|||
13200822|NCT02006121|26217584|FG000|Double Blind Phase|Inconvenience of infusion system|0|||
13200823|NCT02006121|26217585|FG001|Double Blind Phase|Inconvenience of infusion system|1|||
13200824|NCT02006121|26217584|FG000|Open Label Phase|Adverse Event|15|||
13200825|NCT02006121|26217585|FG001|Open Label Phase|Adverse Event|0|||
13200826|NCT02006121|26217584|FG000|Open Label Phase|Lack of Efficacy|2|||
13200827|NCT02006121|26217585|FG001|Open Label Phase|Lack of Efficacy|0|||
13200828|NCT02006121|26217584|FG000|Open Label Phase|Protocol Violation|2|||
13200829|NCT02006121|26217585|FG001|Open Label Phase|Protocol Violation|0|||
13200830|NCT02006121|26217584|FG000|Open Label Phase|Withdrawal by Subject|3|||
13200831|NCT02006121|26217585|FG001|Open Label Phase|Withdrawal by Subject|0|||
13200832|NCT02006121|26217584|FG000|Open Label Phase|Non-compliance with study drug|3|||
13200833|NCT02006121|26217585|FG001|Open Label Phase|Non-compliance with study drug|0|||
13200834|NCT02005887|26217610|FG000|Overall Study|Protocol Violation|0|||
13200835|NCT02005887|26217611|FG001|Overall Study|Protocol Violation|2|||
13200836|NCT02005692|26217618|FG000|Overall Study|Protocol Violation|1|||
13200837|NCT02005692|26217618|FG000|Overall Study|Withdrawal by Subject|1|||
13200838|NCT02005692|26217618|FG000|Overall Study|Discharged earlier than anticipated|5|||
13200839|NCT02005627|26217639|FG000|Overall Study|Lost to Follow-up|1|||
13200840|NCT02005627|26217640|FG001|Overall Study|Lost to Follow-up|2|||
13200841|NCT02005627|26217639|FG000|Overall Study|Withdrawal by Subject|1|||
13200842|NCT02005627|26217640|FG001|Overall Study|Withdrawal by Subject|2|||
13200843|NCT02005562|26217675|FG000|Overall Study|Death|2|||
13200844|NCT02005562|26217676|FG001|Overall Study|Death|2|||
13200845|NCT02005562|26217675|FG000|Overall Study|Graft loss|7|||
13200846|NCT02005562|26217676|FG001|Overall Study|Graft loss|6|||
13200847|NCT02005562|26217675|FG000|Overall Study|Withdrawal by Subject|2|||
13200848|NCT02005562|26217676|FG001|Overall Study|Withdrawal by Subject|2|||
13200849|NCT02005562|26217675|FG000|Overall Study|No transplant|1|||
13200850|NCT02005562|26217676|FG001|Overall Study|No transplant|4|||
13200851|NCT02005562|26217675|FG000|Overall Study|Physician Decision|0|||
13200852|NCT02005562|26217676|FG001|Overall Study|Physician Decision|1|||
13200853|NCT02005484|26217688|FG000|Overall Study|Death|1|||
13200854|NCT02005484|26217688|FG000|Overall Study|Disease progression|1|||
13200855|NCT02005484|26217688|FG000|Overall Study|Changed to a Different Study|1|||
13200856|NCT02005484|26217688|FG000|Overall Study|Sponsor decision|1|||
13200857|NCT02005471|26217748|FG000|Overall Study|Ongoing in Study|144|||
13200858|NCT02005471|26217749|FG001|Overall Study|Ongoing in Study|171|||
13200859|NCT02005471|26217748|FG000|Overall Study|Adverse Event|1|||
13200860|NCT02005471|26217749|FG001|Overall Study|Adverse Event|0|||
13200861|NCT02005471|26217748|FG000|Overall Study|Death|26|||
13200862|NCT02005471|26217749|FG001|Overall Study|Death|15|||
13200863|NCT02005471|26217748|FG000|Overall Study|Lost to Follow-up|1|||
13200864|NCT02005471|26217749|FG001|Overall Study|Lost to Follow-up|0|||
13200865|NCT02005471|26217748|FG000|Overall Study|Physician Decision|2|||
13200866|NCT02005471|26217749|FG001|Overall Study|Physician Decision|1|||
13200867|NCT02005471|26217748|FG000|Overall Study|Progressive Disease|3|||
13200868|NCT02005471|26217749|FG001|Overall Study|Progressive Disease|0|||
13200869|NCT02005471|26217748|FG000|Overall Study|Withdrawal by Subject|18|||
13200870|NCT02005471|26217749|FG001|Overall Study|Withdrawal by Subject|7|||
13200871|NCT02005445|26217762|FG000|Overall Study|Dual study enrollment|0|||
13200872|NCT02005445|26217763|FG001|Overall Study|Dual study enrollment|1|||
13200873|NCT02005276|26217790|FG000|Overall Study|No longer interested|5|||
13200874|NCT02005276|26217791|FG001|Overall Study|No longer interested|2|||
13200875|NCT02005276|26217792|FG002|Overall Study|No longer interested|3|||
13200876|NCT02005276|26217793|FG003|Overall Study|No longer interested|3|||
13200877|NCT02005250|26217806|FG000|Overall Study|Lost to Follow-up|15|||
13200878|NCT02005250|26217807|FG001|Overall Study|Lost to Follow-up|5|||
13200879|NCT02005211|26217862|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
13200880|NCT02005211|26217863|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
13200881|NCT02005211|26217864|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
13200882|NCT02005211|26217865|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
13200883|NCT02005211|26217866|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1|||
13200884|NCT02005211|26217867|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
13200885|NCT02005211|26217868|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
13200886|NCT02005029|26217901|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1|||
13200887|NCT02005029|26217902|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0|||
13200888|NCT02004886|26217965|FG000|Overall Study|Adverse Event|0|||
13200889|NCT02004886|26217966|FG001|Overall Study|Adverse Event|1|||
13200890|NCT02004886|26217967|FG002|Overall Study|Adverse Event|0|||
13200891|NCT02004886|26217968|FG003|Overall Study|Adverse Event|0|||
13200892|NCT02004886|26217965|FG000|Overall Study|Unable to attend future visits|1|||
13200893|NCT02004886|26217966|FG001|Overall Study|Unable to attend future visits|0|||
13200894|NCT02004886|26217967|FG002|Overall Study|Unable to attend future visits|0|||
13200895|NCT02004886|26217968|FG003|Overall Study|Unable to attend future visits|0|||
13200896|NCT02004873|26217977|FG000|Overall Study|Implant unsuccessful|6|||
13200897|NCT02004873|26217977|FG000|Overall Study|Awaiting 6-month visit|390|||
13200898|NCT02004873|26217977|FG000|Overall Study|Missed 6-month visit|4|||
13200899|NCT02004873|26217977|FG000|Overall Study|Death|23|||
13200900|NCT02004873|26217977|FG000|Overall Study|Withdrawal by Subject|1|||
13200901|NCT02004847|26218028|FG000|Overall Study|Protocol Violation|1|||
13200902|NCT02004847|26218029|FG001|Overall Study|Protocol Violation|1|||
13200903|NCT02004353|26218044|FG000|Overall Study|Voluntary participation|1334|||
13200904|NCT02004262|26218080|FG000|Overall Study|Death|67|||
13200905|NCT02004262|26218081|FG001|Overall Study|Death|64|||
13200906|NCT02004262|26218082|FG002|Overall Study|Death|66|||
13200907|NCT02004262|26218083|FG003|Overall Study|Death|28|||
13200908|NCT02004262|26218084|FG004|Overall Study|Death|29|||
13200909|NCT02004262|26218085|FG005|Overall Study|Death|22|||
13200910|NCT02004262|26218080|FG000|Overall Study|Withdrawal by Subject|1|||
13200911|NCT02004262|26218081|FG001|Overall Study|Withdrawal by Subject|0|||
13200912|NCT02004262|26218082|FG002|Overall Study|Withdrawal by Subject|4|||
13200913|NCT02004262|26218083|FG003|Overall Study|Withdrawal by Subject|0|||
13200914|NCT02004262|26218084|FG004|Overall Study|Withdrawal by Subject|1|||
13200915|NCT02004262|26218085|FG005|Overall Study|Withdrawal by Subject|3|||
13200916|NCT02004262|26218080|FG000|Overall Study|Lost to Follow-up|1|||
13200917|NCT02004262|26218081|FG001|Overall Study|Lost to Follow-up|1|||
13200918|NCT02004262|26218082|FG002|Overall Study|Lost to Follow-up|0|||
13200919|NCT02004262|26218083|FG003|Overall Study|Lost to Follow-up|0|||
13200920|NCT02004262|26218084|FG004|Overall Study|Lost to Follow-up|0|||
13200921|NCT02004262|26218085|FG005|Overall Study|Lost to Follow-up|0|||
13200922|NCT02004262|26218080|FG000|Overall Study|Study Terminated by Sponsor|4|||
13200923|NCT02004262|26218081|FG001|Overall Study|Study Terminated by Sponsor|3|||
13200924|NCT02004262|26218082|FG002|Overall Study|Study Terminated by Sponsor|2|||
13200925|NCT02004262|26218083|FG003|Overall Study|Study Terminated by Sponsor|1|||
13200926|NCT02004262|26218084|FG004|Overall Study|Study Terminated by Sponsor|1|||
13200927|NCT02004262|26218085|FG005|Overall Study|Study Terminated by Sponsor|5|||
13200928|NCT02004236|26218139|FG000|Overall Study|Lack of Efficacy|0|||
13200929|NCT02004236|26218140|FG001|Overall Study|Lack of Efficacy|0|||
13200930|NCT02004236|26218141|FG002|Overall Study|Lack of Efficacy|16|||
13200931|NCT02004093|26218178|FG000|Overall Study|Death|2|||
13200932|NCT02004093|26218179|FG001|Overall Study|Death|1|||
13200933|NCT02004093|26218178|FG000|Overall Study|Lack of Efficacy|66|||
13200934|NCT02004093|26218179|FG001|Overall Study|Lack of Efficacy|62|||
13200935|NCT02004093|26218178|FG000|Overall Study|Protocol Violation|0|||
13200936|NCT02004093|26218179|FG001|Overall Study|Protocol Violation|1|||
13200937|NCT02004093|26218178|FG000|Overall Study|Lost to Follow-up|0|||
13200938|NCT02004093|26218179|FG001|Overall Study|Lost to Follow-up|1|||
13200939|NCT02004093|26218178|FG000|Overall Study|Withdrawal by Subject|3|||
13200940|NCT02004093|26218179|FG001|Overall Study|Withdrawal by Subject|7|||
13200941|NCT02004093|26218178|FG000|Overall Study|Other|3|||
13200942|NCT02004093|26218179|FG001|Overall Study|Other|1|||
13200943|NCT02003963|26218206|FG000|Overall Study|Lost to Follow-up|2|||
13200944|NCT02003963|26218207|FG001|Overall Study|Lost to Follow-up|1|||
13200945|NCT02003898|26218216|FG000|Overall Study|Death|3|||
13200946|NCT02003898|26218216|FG000|Overall Study|Lost to Follow-up|12|||
13200947|NCT02003898|26218216|FG000|Overall Study|Withdrawal by Subject|52|||
13200948|NCT02003638|26218229|FG000|Overall Study|Withdrawal by Subject|1|||
13200949|NCT02003638|26218230|FG001|Overall Study|Withdrawal by Subject|0|||
13200950|NCT02003573|26218250|FG000|Overall Study|Progressive disease|2|||
13200951|NCT02003573|26218251|FG001|Overall Study|Progressive disease|0|||
13200952|NCT02003573|26218252|FG002|Overall Study|Progressive disease|1|||
13200953|NCT02003573|26218250|FG000|Overall Study|Other Adverse event|0|||
13200954|NCT02003573|26218251|FG001|Overall Study|Other Adverse event|1|||
13200955|NCT02003573|26218252|FG002|Overall Study|Other Adverse event|1|||
13200956|NCT02003573|26218250|FG000|Overall Study|Refuse to take trial medication|0|||
13200957|NCT02003573|26218251|FG001|Overall Study|Refuse to take trial medication|1|||
13200958|NCT02003573|26218252|FG002|Overall Study|Refuse to take trial medication|1|||
13200959|NCT02003573|26218250|FG000|Overall Study|Other than specified|1|||
13200960|NCT02003573|26218251|FG001|Overall Study|Other than specified|2|||
13200961|NCT02003573|26218252|FG002|Overall Study|Other than specified|3|||
13200962|NCT02003534|26218258|FG000|Overall Study|Lost to Follow-up|47|||
13200963|NCT02003391|26218275|FG000|Overall Study|Withdrawal by Subject|2|||
13200964|NCT02003391|26218276|FG001|Overall Study|Withdrawal by Subject|1|||
13200965|NCT02003391|26218275|FG000|Overall Study|Protocol Violation|0|||
13200966|NCT02003391|26218276|FG001|Overall Study|Protocol Violation|1|||
13200967|NCT02003391|26218275|FG000|Overall Study|Adverse Event|1|||
13200968|NCT02003391|26218276|FG001|Overall Study|Adverse Event|0|||
13200969|NCT02003365|26218297|FG000|Overall Study|Lost to Follow-up|0|||
13200970|NCT02003365|26218298|FG001|Overall Study|Lost to Follow-up|0|||
13200971|NCT02003365|26218299|FG002|Overall Study|Lost to Follow-up|1|||
13200972|NCT02003183|26218312|FG000|Overall Study|Lost to Follow-up|0|||
13200973|NCT02003183|26218313|FG001|Overall Study|Lost to Follow-up|2|||
13200974|NCT02003144|26218343|FG000|Open Label Maintenance Phase|Other than specified|2|||
13200975|NCT02003144|26218344|FG001|Open Label Maintenance Phase|Other than specified|4|||
13200976|NCT02003144|26218343|FG000|Open Label Maintenance Phase|Withdrawal by Subject|4|||
13200977|NCT02003144|26218344|FG001|Open Label Maintenance Phase|Withdrawal by Subject|5|||
13200978|NCT02003144|26218343|FG000|Open Label Maintenance Phase|Pregnancy|0|||
13200979|NCT02003144|26218344|FG001|Open Label Maintenance Phase|Pregnancy|2|||
13200980|NCT02003144|26218343|FG000|Open Label Maintenance Phase|Physician Decision|1|||
13200981|NCT02003144|26218344|FG001|Open Label Maintenance Phase|Physician Decision|1|||
13200982|NCT02003144|26218343|FG000|Open Label Maintenance Phase|Lost to Follow-up|0|||
13200983|NCT02003144|26218344|FG001|Open Label Maintenance Phase|Lost to Follow-up|1|||
13200984|NCT02003144|26218343|FG000|Open Label Maintenance Phase|Adverse Event|2|||
13200985|NCT02003144|26218344|FG001|Open Label Maintenance Phase|Adverse Event|1|||
13200986|NCT02003014|26218356|FG000|Overall Study|Case report forms uncollected|9|||
13200987|NCT02003014|26218356|FG000|Overall Study|Treatment started after contract period|1|||
13200988|NCT02003014|26218356|FG000|Overall Study|Patient did not visit the study site|5|||
13200989|NCT02003014|26218356|FG000|Overall Study|Investigator's transfer|4|||
13200990|NCT02002975|26218374|FG000|Overall Study|Case Report Forms Uncollected|135|||
13200991|NCT02002975|26218374|FG000|Overall Study|Protocol Deviation|437|||
13200992|NCT02002884|26218444|FG000|Main Period (MP)|Other|0|||
13200993|NCT02002884|26218445|FG001|Main Period (MP)|Other|3|||
13200994|NCT02002884|26218446|FG002|Main Period (MP)|Other|3|||
13200995|NCT02002884|26218447|FG003|Main Period (MP)|Other|0|||
13200996|NCT02002884|26218444|FG000|Main Period (MP)|Adverse Event|0|||
13200997|NCT02002884|26218445|FG001|Main Period (MP)|Adverse Event|1|||
13200998|NCT02002884|26218446|FG002|Main Period (MP)|Adverse Event|1|||
13200999|NCT02002884|26218447|FG003|Main Period (MP)|Adverse Event|0|||
13201000|NCT02002884|26218444|FG000|Main Period (MP)|Withdrawal by Subject|6|||
13201001|NCT02002884|26218445|FG001|Main Period (MP)|Withdrawal by Subject|2|||
13201002|NCT02002884|26218446|FG002|Main Period (MP)|Withdrawal by Subject|2|||
13201003|NCT02002884|26218447|FG003|Main Period (MP)|Withdrawal by Subject|0|||
13201004|NCT02002884|26218444|FG000|Main Period (MP)|Lost to Follow-up|0|||
13201005|NCT02002884|26218445|FG001|Main Period (MP)|Lost to Follow-up|0|||
13201006|NCT02002884|26218446|FG002|Main Period (MP)|Lost to Follow-up|2|||
13201007|NCT02002884|26218447|FG003|Main Period (MP)|Lost to Follow-up|0|||
13201008|NCT02002884|26218444|FG000|Open-Label Extension Period (OLEX)|Other|0|||
13201009|NCT02002884|26218445|FG001|Open-Label Extension Period (OLEX)|Other|0|||
13201010|NCT02002884|26218446|FG002|Open-Label Extension Period (OLEX)|Other|0|||
13201011|NCT02002884|26218447|FG003|Open-Label Extension Period (OLEX)|Other|24|||
13201012|NCT02002884|26218444|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0|||
13201013|NCT02002884|26218445|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0|||
13201014|NCT02002884|26218446|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0|||
13201015|NCT02002884|26218447|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1|||
13201016|NCT02002884|26218444|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0|||
13201017|NCT02002884|26218445|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0|||
13201018|NCT02002884|26218446|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0|||
13201019|NCT02002884|26218447|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5|||
13201020|NCT02002884|26218444|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
13206671|NCT01955161|26235171|FG002|Overall Study|Adverse Event|15|||
13485633|NCT01126749|27033001|FG001|Phase 1b|Death|4|||
13201021|NCT02002884|26218445|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
13201022|NCT02002884|26218446|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
13201023|NCT02002884|26218447|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10|||
13201024|NCT02002884|26218444|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
13201025|NCT02002884|26218445|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
13201026|NCT02002884|26218446|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
13201027|NCT02002884|26218447|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10|||
13201028|NCT02002689|26218455|FG000|Overall Study|Disease Progression|7|||
13201029|NCT02002689|26218455|FG000|Overall Study|Adverse Event|3|||
13201030|NCT02002533|26218485|FG000|Overall Study|Withdrawal by Subject|6|||
13201031|NCT02002533|26218486|FG001|Overall Study|Withdrawal by Subject|13|||
13201032|NCT02002533|26218485|FG000|Overall Study|Protocol Violation|0|||
13201033|NCT02002533|26218486|FG001|Overall Study|Protocol Violation|1|||
13201034|NCT02002533|26218485|FG000|Overall Study|Adverse Event|0|||
13201035|NCT02002533|26218486|FG001|Overall Study|Adverse Event|3|||
13201036|NCT02002533|26218485|FG000|Overall Study|Lost to Follow-up|0|||
13201037|NCT02002533|26218486|FG001|Overall Study|Lost to Follow-up|1|||
13201038|NCT02002221|26218507|FG000|Overall Study|Adverse Event|2|||
13201039|NCT02002221|26218508|FG001|Overall Study|Adverse Event|1|||
13201040|NCT02002221|26218507|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
13201041|NCT02002221|26218508|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
13201042|NCT02002221|26218507|FG000|Overall Study|Patient withdrew consent|0|||
13201043|NCT02002221|26218508|FG001|Overall Study|Patient withdrew consent|1|||
13201044|NCT02002182|26218525|FG000|Overall Study|Withdraw from study|3|||
13201045|NCT02002182|26218526|FG001|Overall Study|Withdraw from study|1|||
13201046|NCT02002182|26218525|FG000|Overall Study|Health Reasons|1|||
13201047|NCT02002182|26218526|FG001|Overall Study|Health Reasons|0|||
13201048|NCT02002182|26218525|FG000|Overall Study|Death|1|||
13201049|NCT02002182|26218526|FG001|Overall Study|Death|0|||
13201050|NCT02002091|26218568|FG000|Screening|Lost to Follow-up|10|||
13201051|NCT02002091|26218569|FG001|Screening|Lost to Follow-up|12|||
13201052|NCT02002091|26218568|FG000|Screening|Death|3|||
13201053|NCT02002091|26218569|FG001|Screening|Death|2|||
13201054|NCT02001987|26218645|FG000|Core Study Period (24 Weeks)|Adverse Event|9|||
13112915|NCT03148691|25910151|FG001|Overall Study|Withdrawal by Subject|0|||
13112916|NCT03148691|25910152|FG002|Overall Study|Withdrawal by Subject|0|||
13112917|NCT03148067|25910159|FG000|Overall Study|Lost to Follow-up|3|||
13112918|NCT03148067|25910159|FG000|Overall Study|Death|1|||
13112919|NCT03147495|25910182|FG000|Overall Study|Physician Decision|0|||
13112920|NCT03147495|25910183|FG001|Overall Study|Physician Decision|6|||
13112921|NCT03147248|25910224|FG000|Overall Study|Adverse Event|0|||
13112922|NCT03147248|25910225|FG001|Overall Study|Adverse Event|2|||
13112923|NCT03147248|25910226|FG002|Overall Study|Adverse Event|2|||
13112924|NCT03147248|25910227|FG003|Overall Study|Adverse Event|2|||
13112925|NCT03147248|25910228|FG004|Overall Study|Adverse Event|6|||
13112926|NCT03147248|25910229|FG005|Overall Study|Adverse Event|11|||
13112927|NCT03147248|25910224|FG000|Overall Study|Disease progression|1|||
13112928|NCT03147248|25910225|FG001|Overall Study|Disease progression|0|||
13112929|NCT03147248|25910226|FG002|Overall Study|Disease progression|0|||
13112930|NCT03147248|25910227|FG003|Overall Study|Disease progression|0|||
13201055|NCT02001987|26218645|FG000|Core Study Period (24 Weeks)|Death|1|||
13201056|NCT02001987|26218645|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2|||
13112931|NCT03147248|25910228|FG004|Overall Study|Disease progression|0|||
13201057|NCT02001987|26218645|FG000|Core Study Period (24 Weeks)|Physician Decision|1|||
13201058|NCT02001987|26218645|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4|||
13201059|NCT02001987|26218645|FG000|Core Study Period (24 Weeks)|Protocol Violation|3|||
13201060|NCT02001987|26218645|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3|||
13201061|NCT02001987|26218645|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2|||
13201062|NCT02001987|26218645|FG000|LTE Period (52 Weeks)|Physician Decision|2|||
13201063|NCT02001987|26218645|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1|||
13201064|NCT02001987|26218645|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1|||
13201065|NCT02001987|26218645|FG000|LTE Period (52 Weeks)|Other|3|||
13201066|NCT02001688|26218672|FG000|Overall Study|Withdrawal by Subject|0|||
13201067|NCT02001688|26218673|FG001|Overall Study|Withdrawal by Subject|0|||
13201068|NCT02001688|26218674|FG002|Overall Study|Withdrawal by Subject|1|||
13201069|NCT02001688|26218672|FG000|Overall Study|Adverse Event|0|||
13201070|NCT02001688|26218673|FG001|Overall Study|Adverse Event|1|||
13201071|NCT02001688|26218674|FG002|Overall Study|Adverse Event|0|||
13201072|NCT02001558|26218713|FG000|Overall Study|Lost to Follow-up|8|||
13201073|NCT02001558|26218714|FG001|Overall Study|Lost to Follow-up|14|||
13201074|NCT02001194|26218741|FG000|Intervention Period (13 Weeks)|No longer interested|1|||
13201075|NCT02001194|26218742|FG001|Intervention Period (13 Weeks)|No longer interested|0|||
13201076|NCT02001194|26218743|FG002|Intervention Period (13 Weeks)|No longer interested|2|||
13112932|NCT03147248|25910229|FG005|Overall Study|Disease progression|2|||
13201077|NCT02001194|26218744|FG003|Intervention Period (13 Weeks)|No longer interested|2|||
13112933|NCT03147248|25910224|FG000|Overall Study|Withdrawal by Subject|0|||
13201078|NCT02001194|26218741|FG000|Follow-Up Period (13 Weeks)|No longer interested|3|||
13201079|NCT02001194|26218742|FG001|Follow-Up Period (13 Weeks)|No longer interested|2|||
13201080|NCT02001194|26218743|FG002|Follow-Up Period (13 Weeks)|No longer interested|1|||
13201081|NCT02001194|26218744|FG003|Follow-Up Period (13 Weeks)|No longer interested|0|||
13201082|NCT02001181|26218765|FG000|Overall Study|Adverse Event|0|||
13201083|NCT02001181|26218766|FG001|Overall Study|Adverse Event|2|||
13201084|NCT02001181|26218765|FG000|Overall Study|Lost to Follow-up|1|||
13201085|NCT02001181|26218766|FG001|Overall Study|Lost to Follow-up|0|||
13201086|NCT02001181|26218765|FG000|Overall Study|Withdrawal by Subject|0|||
13201087|NCT02001181|26218766|FG001|Overall Study|Withdrawal by Subject|1|||
13201088|NCT02001064|26218783|FG000|Overall Study|Withdrawal by Subject|2|||
13201089|NCT02001064|26218784|FG001|Overall Study|Withdrawal by Subject|1|||
13201090|NCT02001051|26218811|FG000|Overall Study|Deemed not eligible following enrollment|0|||
13201091|NCT02001051|26218812|FG001|Overall Study|Deemed not eligible following enrollment|1|||
13201092|NCT02000921|26218839|FG000|Overall Study|Withdrawal by Subject|3|||
13201093|NCT02000921|26218840|FG001|Overall Study|Withdrawal by Subject|10|||
13201094|NCT02000921|26218841|FG002|Overall Study|Withdrawal by Subject|5|||
13201095|NCT02000921|26218839|FG000|Overall Study|Lost to Follow-up|2|||
13201096|NCT02000921|26218840|FG001|Overall Study|Lost to Follow-up|4|||
13201097|NCT02000921|26218841|FG002|Overall Study|Lost to Follow-up|5|||
13201098|NCT02000921|26218839|FG000|Overall Study|Physician Decision|0|||
13201099|NCT02000921|26218840|FG001|Overall Study|Physician Decision|2|||
13201100|NCT02000921|26218841|FG002|Overall Study|Physician Decision|0|||
13201101|NCT02000882|26218851|FG000|Overall Study|Adverse Event|3|||
13201102|NCT02000882|26218851|FG000|Overall Study|Physician Decision|2|||
13201103|NCT02000882|26218851|FG000|Overall Study|Withdrawal by Subject|1|||
13201104|NCT02000817|26218957|FG000|Overall Study|Withdrawal by Subject|2|||
13201105|NCT02000817|26218958|FG001|Overall Study|Withdrawal by Subject|0|||
13201106|NCT02000817|26218959|FG002|Overall Study|Withdrawal by Subject|0|||
13201107|NCT02000817|26218960|FG003|Overall Study|Withdrawal by Subject|0|||
13201108|NCT02000817|26218957|FG000|Overall Study|Adverse Event|0|||
13201109|NCT02000817|26218958|FG001|Overall Study|Adverse Event|1|||
13201110|NCT02000817|26218959|FG002|Overall Study|Adverse Event|0|||
13201111|NCT02000817|26218960|FG003|Overall Study|Adverse Event|0|||
13201112|NCT02000817|26218957|FG000|Overall Study|Lost to Follow-up|0|||
13201113|NCT02000817|26218958|FG001|Overall Study|Lost to Follow-up|0|||
13201114|NCT02000817|26218959|FG002|Overall Study|Lost to Follow-up|1|||
13201115|NCT02000817|26218960|FG003|Overall Study|Lost to Follow-up|0|||
13201116|NCT02000752|26218979|FG000|Overall Study|Dystocic delivery|19|||
13201117|NCT02000752|26218980|FG001|Overall Study|Dystocic delivery|8|||
13201118|NCT02000752|26218979|FG000|Overall Study|Shift Changes|12|||
13201119|NCT02000752|26218980|FG001|Overall Study|Shift Changes|5|||
13201120|NCT02000622|26219015|FG000|Overall Study|Withdrawal by Subject|5|||
13201121|NCT02000622|26219016|FG001|Overall Study|Withdrawal by Subject|7|||
13201122|NCT02000622|26219015|FG000|Overall Study|Lost to Follow-up|4|||
13201123|NCT02000622|26219016|FG001|Overall Study|Lost to Follow-up|0|||
13201124|NCT02000622|26219015|FG000|Overall Study|Death|159|||
13201125|NCT02000622|26219016|FG001|Overall Study|Death|73|||
13201126|NCT02000622|26219015|FG000|Overall Study|Withdrawn due to site closure|1|||
13201127|NCT02000622|26219016|FG001|Overall Study|Withdrawn due to site closure|0|||
13201128|NCT02000531|26219031|FG000|Overall Study|Lost to Follow-up|1|||
13201129|NCT02000531|26219032|FG001|Overall Study|Lost to Follow-up|0|||
13201130|NCT02000531|26219031|FG000|Overall Study|Discontinued due to data cut-off|3|||
13201131|NCT02000531|26219032|FG001|Overall Study|Discontinued due to data cut-off|8|||
13201132|NCT02000440|26219054|FG000|Overall Study|Adverse Event|3|||
13201133|NCT02000440|26219054|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
13201134|NCT02000427|26219071|FG000|Overall Study|Death|22|||
13201135|NCT02000115|26219100|FG000|Overall Study|Death|56|||
13201136|NCT02000115|26219101|FG001|Overall Study|Death|45|||
13201137|NCT02000115|26219102|FG002|Overall Study|Death|0|||
13201138|NCT02000115|26219103|FG003|Overall Study|Death|0|||
13201139|NCT02000115|26219100|FG000|Overall Study|Missed Visit|6|||
13201140|NCT02000115|26219101|FG001|Overall Study|Missed Visit|8|||
13112934|NCT03147248|25910225|FG001|Overall Study|Withdrawal by Subject|0|||
13112935|NCT03147248|25910226|FG002|Overall Study|Withdrawal by Subject|0|||
13201141|NCT02000115|26219102|FG002|Overall Study|Missed Visit|1|||
13201142|NCT02000115|26219103|FG003|Overall Study|Missed Visit|0|||
13112936|NCT03147248|25910227|FG003|Overall Study|Withdrawal by Subject|0|||
13112937|NCT03147248|25910228|FG004|Overall Study|Withdrawal by Subject|12|||
13112938|NCT03147248|25910229|FG005|Overall Study|Withdrawal by Subject|9|||
13112939|NCT03147248|25910224|FG000|Overall Study|Protocol Violation|0|||
13112940|NCT03147248|25910225|FG001|Overall Study|Protocol Violation|0|||
13112941|NCT03147248|25910226|FG002|Overall Study|Protocol Violation|0|||
13201143|NCT02000115|26219100|FG000|Overall Study|Protocol Violation|2|||
13201144|NCT02000115|26219101|FG001|Overall Study|Protocol Violation|1|||
13201145|NCT02000115|26219102|FG002|Overall Study|Protocol Violation|0|||
13201146|NCT02000115|26219103|FG003|Overall Study|Protocol Violation|0|||
13201147|NCT02000115|26219100|FG000|Overall Study|Physician Decision|2|||
13112942|NCT03147248|25910227|FG003|Overall Study|Protocol Violation|0|||
13112943|NCT03147248|25910228|FG004|Overall Study|Protocol Violation|2|||
13112944|NCT03147248|25910229|FG005|Overall Study|Protocol Violation|0|||
13112945|NCT03147248|25910224|FG000|Overall Study|Lost to Follow-up|0|||
13112946|NCT03147248|25910225|FG001|Overall Study|Lost to Follow-up|0|||
13112947|NCT03147248|25910226|FG002|Overall Study|Lost to Follow-up|0|||
13112948|NCT03147248|25910227|FG003|Overall Study|Lost to Follow-up|0|||
13112949|NCT03147248|25910228|FG004|Overall Study|Lost to Follow-up|2|||
13112950|NCT03147248|25910229|FG005|Overall Study|Lost to Follow-up|0|||
13112951|NCT03147248|25910224|FG000|Overall Study|Pregnancy|0|||
13112952|NCT03147248|25910225|FG001|Overall Study|Pregnancy|0|||
13112953|NCT03147248|25910226|FG002|Overall Study|Pregnancy|0|||
13112954|NCT03147248|25910227|FG003|Overall Study|Pregnancy|0|||
13112955|NCT03147248|25910228|FG004|Overall Study|Pregnancy|1|||
13112956|NCT03147248|25910229|FG005|Overall Study|Pregnancy|0|||
13112957|NCT03147248|25910224|FG000|Overall Study|Death|0|||
13112958|NCT03147248|25910225|FG001|Overall Study|Death|0|||
13112959|NCT03147248|25910226|FG002|Overall Study|Death|0|||
13112960|NCT03147248|25910227|FG003|Overall Study|Death|0|||
13112961|NCT03147248|25910228|FG004|Overall Study|Death|0|||
13112962|NCT03147248|25910229|FG005|Overall Study|Death|4|||
13112963|NCT03147248|25910224|FG000|Overall Study|Physician Decision|0|||
13112964|NCT03147248|25910225|FG001|Overall Study|Physician Decision|0|||
13112965|NCT03147248|25910226|FG002|Overall Study|Physician Decision|0|||
13112966|NCT03147248|25910227|FG003|Overall Study|Physician Decision|0|||
13112967|NCT03147248|25910228|FG004|Overall Study|Physician Decision|2|||
13112968|NCT03147248|25910229|FG005|Overall Study|Physician Decision|4|||
13112969|NCT03147248|25910224|FG000|Overall Study|Prolonged Dosing Interval|0|||
13112970|NCT03147248|25910225|FG001|Overall Study|Prolonged Dosing Interval|0|||
13112971|NCT03147248|25910226|FG002|Overall Study|Prolonged Dosing Interval|0|||
13112972|NCT03147248|25910227|FG003|Overall Study|Prolonged Dosing Interval|0|||
13112973|NCT03147248|25910228|FG004|Overall Study|Prolonged Dosing Interval|1|||
13112974|NCT03147248|25910229|FG005|Overall Study|Prolonged Dosing Interval|1|||
13112975|NCT03146741|25910236|FG000|Overall Study|Txp with non-HCV+ heart|4|||
13112976|NCT03146741|25910236|FG000|Overall Study|Listeted for MOT|2|||
13112977|NCT03146741|25910236|FG000|Overall Study|Physician Decision|2|||
13112978|NCT03146741|25910236|FG000|Overall Study|Awaiting txp|2|||
13112979|NCT03146663|25910251|FG000|Overall Study|Did not receive study treatment|1|||
13112980|NCT03146663|25910252|FG001|Overall Study|Did not receive study treatment|1|||
13112981|NCT03146403|25910273|FG000|Overall Study|Withdrawal by Subject|0|||
13112982|NCT03146403|25910274|FG001|Overall Study|Withdrawal by Subject|3|||
13112983|NCT03146403|25910273|FG000|Overall Study|Lost to Follow-up|2|||
13112984|NCT03146403|25910274|FG001|Overall Study|Lost to Follow-up|0|||
13112985|NCT03145766|25910417|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
13112986|NCT03145766|25910418|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
13112987|NCT03145766|25910419|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0|||
13112988|NCT03145766|25910420|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
13112989|NCT03145766|25910421|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2|||
13112990|NCT03145766|25910417|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
13112991|NCT03145766|25910418|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
13112992|NCT03145766|25910419|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
13112993|NCT03145766|25910420|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2|||
13112994|NCT03145766|25910421|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
13112995|NCT03145766|25910417|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
13112996|NCT03145766|25910418|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
13112997|NCT03145766|25910419|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
13112998|NCT03145766|25910420|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3|||
13112999|NCT03145766|25910421|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
13113000|NCT03145766|25910417|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4|||
13113001|NCT03145766|25910418|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
13113002|NCT03145766|25910419|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
13113003|NCT03145766|25910420|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
13113004|NCT03145766|25910421|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0|||
13113005|NCT03145766|25910417|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2|||
13113006|NCT03145766|25910418|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
13113007|NCT03145766|25910419|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
13113008|NCT03145766|25910420|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1|||
13113009|NCT03145766|25910421|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
13113010|NCT03145766|25910417|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
13113011|NCT03145766|25910418|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1|||
13113012|NCT03145766|25910419|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
13201148|NCT02000115|26219101|FG001|Overall Study|Physician Decision|0|||
13201149|NCT02000115|26219102|FG002|Overall Study|Physician Decision|0|||
13201150|NCT02000115|26219103|FG003|Overall Study|Physician Decision|0|||
13201151|NCT02000115|26219100|FG000|Overall Study|Withdrawal by Subject|11|||
13201152|NCT02000115|26219101|FG001|Overall Study|Withdrawal by Subject|11|||
13201153|NCT02000115|26219102|FG002|Overall Study|Withdrawal by Subject|0|||
13201154|NCT02000115|26219103|FG003|Overall Study|Withdrawal by Subject|0|||
13201155|NCT02000115|26219100|FG000|Overall Study|Lost to Follow-up|0|||
13201156|NCT02000115|26219101|FG001|Overall Study|Lost to Follow-up|1|||
13201157|NCT02000115|26219102|FG002|Overall Study|Lost to Follow-up|0|||
13201158|NCT02000115|26219103|FG003|Overall Study|Lost to Follow-up|0|||
13201159|NCT02000115|26219100|FG000|Overall Study|Non-compliance|2|||
13201160|NCT02000115|26219101|FG001|Overall Study|Non-compliance|1|||
13201161|NCT02000115|26219102|FG002|Overall Study|Non-compliance|0|||
13201162|NCT02000115|26219103|FG003|Overall Study|Non-compliance|0|||
13201163|NCT02000115|26219100|FG000|Overall Study|Withdrawn on day of randomization|0|||
13201164|NCT02000115|26219101|FG001|Overall Study|Withdrawn on day of randomization|1|||
13201165|NCT02000115|26219102|FG002|Overall Study|Withdrawn on day of randomization|0|||
13201166|NCT02000115|26219103|FG003|Overall Study|Withdrawn on day of randomization|0|||
13201167|NCT02000115|26219100|FG000|Overall Study|Still on Study|0|||
13201168|NCT02000115|26219101|FG001|Overall Study|Still on Study|0|||
13201169|NCT02000115|26219102|FG002|Overall Study|Still on Study|0|||
13201170|NCT02000115|26219103|FG003|Overall Study|Still on Study|53|||
13201171|NCT01999972|26219234|FG000|Dose Escalation Part|Participant refused further follow-up|1|||
13201172|NCT01999972|26219235|FG001|Dose Escalation Part|Participant refused further follow-up|0|||
13201173|NCT01999972|26219236|FG002|Dose Escalation Part|Participant refused further follow-up|1|||
13201174|NCT01999972|26219237|FG003|Dose Escalation Part|Participant refused further follow-up|1|||
13201175|NCT01999972|26219238|FG004|Dose Escalation Part|Participant refused further follow-up|0|||
13201176|NCT01999972|26219239|FG005|Dose Escalation Part|Participant refused further follow-up|0|||
13201177|NCT01999972|26219234|FG000|Dose Escalation Part|Death|0|||
13201178|NCT01999972|26219235|FG001|Dose Escalation Part|Death|1|||
13201179|NCT01999972|26219236|FG002|Dose Escalation Part|Death|0|||
13201180|NCT01999972|26219237|FG003|Dose Escalation Part|Death|0|||
13201181|NCT01999972|26219238|FG004|Dose Escalation Part|Death|0|||
13201182|NCT01999972|26219239|FG005|Dose Escalation Part|Death|0|||
13201183|NCT01999972|26219234|FG000|Dose Escalation Part|Enrolled but not treated|0|||
13201184|NCT01999972|26219235|FG001|Dose Escalation Part|Enrolled but not treated|0|||
13201185|NCT01999972|26219236|FG002|Dose Escalation Part|Enrolled but not treated|1|||
13201186|NCT01999972|26219237|FG003|Dose Escalation Part|Enrolled but not treated|1|||
13201187|NCT01999972|26219238|FG004|Dose Escalation Part|Enrolled but not treated|0|||
13201188|NCT01999972|26219239|FG005|Dose Escalation Part|Enrolled but not treated|0|||
13201189|NCT01999972|26219234|FG000|Dose Escalation Part|Disease progression|3|||
13201190|NCT01999972|26219235|FG001|Dose Escalation Part|Disease progression|2|||
13201191|NCT01999972|26219236|FG002|Dose Escalation Part|Disease progression|3|||
13201192|NCT01999972|26219237|FG003|Dose Escalation Part|Disease progression|6|||
13201193|NCT01999972|26219238|FG004|Dose Escalation Part|Disease progression|0|||
13201194|NCT01999972|26219239|FG005|Dose Escalation Part|Disease progression|0|||
13201195|NCT01999972|26219234|FG000|Dose Escalation Part|Adverse Event|0|||
13201196|NCT01999972|26219235|FG001|Dose Escalation Part|Adverse Event|0|||
13201197|NCT01999972|26219236|FG002|Dose Escalation Part|Adverse Event|0|||
13201198|NCT01999972|26219237|FG003|Dose Escalation Part|Adverse Event|2|||
13201199|NCT01999972|26219238|FG004|Dose Escalation Part|Adverse Event|0|||
13201200|NCT01999972|26219239|FG005|Dose Escalation Part|Adverse Event|0|||
13201201|NCT01999972|26219234|FG000|Dose Escalation Part|Global deterioration of health status|1|||
13201202|NCT01999972|26219235|FG001|Dose Escalation Part|Global deterioration of health status|0|||
13201203|NCT01999972|26219236|FG002|Dose Escalation Part|Global deterioration of health status|0|||
13201204|NCT01999972|26219237|FG003|Dose Escalation Part|Global deterioration of health status|1|||
13201205|NCT01999972|26219238|FG004|Dose Escalation Part|Global deterioration of health status|0|||
13201206|NCT01999972|26219239|FG005|Dose Escalation Part|Global deterioration of health status|0|||
13201207|NCT01999972|26219234|FG000|Dose Expansion Part|Death|0|||
13201208|NCT01999972|26219235|FG001|Dose Expansion Part|Death|0|||
13201209|NCT01999972|26219236|FG002|Dose Expansion Part|Death|0|||
13201210|NCT01999972|26219237|FG003|Dose Expansion Part|Death|0|||
13201211|NCT01999972|26219238|FG004|Dose Expansion Part|Death|2|||
13201212|NCT01999972|26219239|FG005|Dose Expansion Part|Death|1|||
13201213|NCT01999972|26219234|FG000|Dose Expansion Part|Disease progression|0|||
13201214|NCT01999972|26219235|FG001|Dose Expansion Part|Disease progression|0|||
13201215|NCT01999972|26219236|FG002|Dose Expansion Part|Disease progression|0|||
13201216|NCT01999972|26219237|FG003|Dose Expansion Part|Disease progression|0|||
13201217|NCT01999972|26219238|FG004|Dose Expansion Part|Disease progression|9|||
13201218|NCT01999972|26219239|FG005|Dose Expansion Part|Disease progression|3|||
13201219|NCT01999972|26219234|FG000|Dose Expansion Part|Sponsor decision|0|||
13201220|NCT01999972|26219235|FG001|Dose Expansion Part|Sponsor decision|0|||
13201221|NCT01999972|26219236|FG002|Dose Expansion Part|Sponsor decision|0|||
13201222|NCT01999972|26219237|FG003|Dose Expansion Part|Sponsor decision|0|||
13201223|NCT01999972|26219238|FG004|Dose Expansion Part|Sponsor decision|1|||
13201224|NCT01999972|26219239|FG005|Dose Expansion Part|Sponsor decision|0|||
13201225|NCT01999972|26219234|FG000|Dose Expansion Part|Adverse Event|0|||
13201226|NCT01999972|26219235|FG001|Dose Expansion Part|Adverse Event|0|||
13201227|NCT01999972|26219236|FG002|Dose Expansion Part|Adverse Event|0|||
13201228|NCT01999972|26219237|FG003|Dose Expansion Part|Adverse Event|0|||
13201229|NCT01999972|26219238|FG004|Dose Expansion Part|Adverse Event|4|||
13201230|NCT01999972|26219239|FG005|Dose Expansion Part|Adverse Event|2|||
13201231|NCT01999972|26219234|FG000|Dose Expansion Part|Participant's non-compliance|0|||
13201232|NCT01999972|26219235|FG001|Dose Expansion Part|Participant's non-compliance|0|||
13201233|NCT01999972|26219236|FG002|Dose Expansion Part|Participant's non-compliance|0|||
13201234|NCT01999972|26219237|FG003|Dose Expansion Part|Participant's non-compliance|0|||
13201235|NCT01999972|26219238|FG004|Dose Expansion Part|Participant's non-compliance|0|||
13201236|NCT01999972|26219239|FG005|Dose Expansion Part|Participant's non-compliance|1|||
13201237|NCT01999972|26219234|FG000|Dose Expansion Part|Participant refused further follow-up|0|||
13201238|NCT01999972|26219235|FG001|Dose Expansion Part|Participant refused further follow-up|0|||
13201239|NCT01999972|26219236|FG002|Dose Expansion Part|Participant refused further follow-up|0|||
13201240|NCT01999972|26219237|FG003|Dose Expansion Part|Participant refused further follow-up|0|||
13201241|NCT01999972|26219238|FG004|Dose Expansion Part|Participant refused further follow-up|4|||
13201242|NCT01999972|26219239|FG005|Dose Expansion Part|Participant refused further follow-up|0|||
13201243|NCT01999972|26219234|FG000|Dose Expansion Part|Changed to standard of care|0|||
13201244|NCT01999972|26219235|FG001|Dose Expansion Part|Changed to standard of care|0|||
13201245|NCT01999972|26219236|FG002|Dose Expansion Part|Changed to standard of care|0|||
13201246|NCT01999972|26219237|FG003|Dose Expansion Part|Changed to standard of care|0|||
13201247|NCT01999972|26219238|FG004|Dose Expansion Part|Changed to standard of care|1|||
13201248|NCT01999972|26219239|FG005|Dose Expansion Part|Changed to standard of care|0|||
13201249|NCT01999946|26219256|FG000|Overall Study|Participant not released from jail|2|||
13201250|NCT01999946|26219257|FG001|Overall Study|Participant not released from jail|2|||
13201251|NCT01999946|26219258|FG002|Overall Study|Participant not released from jail|0|||
13201252|NCT01999946|26219256|FG000|Overall Study|Not included in primary outcome analysis|0|||
13201253|NCT01999946|26219257|FG001|Overall Study|Not included in primary outcome analysis|0|||
13201254|NCT01999946|26219258|FG002|Overall Study|Not included in primary outcome analysis|79|||
13201255|NCT01999894|26219265|FG000|Overall Study|Adverse Event|9|||
13201256|NCT01999894|26219265|FG000|Overall Study|Lack of Efficacy|5|||
13201257|NCT01999894|26219265|FG000|Overall Study|Protocol Violation|1|||
13201258|NCT01999894|26219265|FG000|Overall Study|Withdrawal by Subject|7|||
13201259|NCT01999894|26219265|FG000|Overall Study|Lost to Follow-up|10|||
13201260|NCT01999894|26219265|FG000|Overall Study|Other Reason|3|||
13201261|NCT01999894|26219265|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
13201262|NCT01999868|26219300|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
13201263|NCT01999868|26219301|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
13201264|NCT01999868|26219302|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5|||
13201265|NCT01999868|26219300|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
13201266|NCT01999868|26219301|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
13201267|NCT01999868|26219302|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0|||
13201268|NCT01999868|26219300|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3|||
13201269|NCT01999868|26219301|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4|||
13201270|NCT01999868|26219302|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0|||
13201271|NCT01999868|26219300|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
13201272|NCT01999868|26219301|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1|||
13201273|NCT01999868|26219302|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
13201274|NCT01999868|26219300|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
13201275|NCT01999868|26219301|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2|||
13201276|NCT01999868|26219302|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
13201277|NCT01999868|26219300|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1|||
13201278|NCT01999868|26219301|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2|||
13201279|NCT01999868|26219302|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0|||
13201280|NCT01999868|26219300|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8|||
13201281|NCT01999868|26219301|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1|||
13201282|NCT01999868|26219302|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0|||
13201283|NCT01999868|26219300|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1|||
13201284|NCT01999868|26219301|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
13201285|NCT01999868|26219302|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
13201286|NCT01999868|26219300|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4|||
13201287|NCT01999868|26219301|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
13201288|NCT01999868|26219302|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
13201289|NCT01999868|26219300|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
13201290|NCT01999868|26219301|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1|||
13201291|NCT01999868|26219302|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
13201292|NCT01999868|26219300|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
13201293|NCT01999868|26219301|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1|||
13201294|NCT01999868|26219302|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
13201295|NCT01999868|26219300|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1|||
13201296|NCT01999868|26219301|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2|||
13201297|NCT01999868|26219302|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0|||
13201298|NCT01999868|26219300|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10|||
13201299|NCT01999868|26219301|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19|||
13201300|NCT01999868|26219302|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0|||
13201301|NCT01999868|26219300|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
13201302|NCT01999868|26219301|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2|||
13201303|NCT01999868|26219302|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
13201304|NCT01999868|26219300|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12|||
13201305|NCT01999868|26219301|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4|||
13201306|NCT01999868|26219302|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0|||
13201307|NCT01999465|26219317|FG000|Overall Study|Lost to Follow-up|0|||
13201308|NCT01999465|26219318|FG001|Overall Study|Lost to Follow-up|2|||
13201309|NCT01999465|26219317|FG000|Overall Study|Protocol Violation|0|||
13201310|NCT01999465|26219318|FG001|Overall Study|Protocol Violation|1|||
13201311|NCT01999335|26219378|FG000|Overall Study|Discontinued before receiving treatment|0|||
13201312|NCT01999335|26219379|FG001|Overall Study|Discontinued before receiving treatment|0|||
13201313|NCT01999335|26219380|FG002|Overall Study|Discontinued before receiving treatment|0|||
13201314|NCT01999335|26219381|FG003|Overall Study|Discontinued before receiving treatment|0|||
13201315|NCT01999335|26219382|FG004|Overall Study|Discontinued before receiving treatment|2|||
13201316|NCT01999322|26219401|FG000|Overall Study|Adverse Event|1|||
13201317|NCT01999322|26219402|FG001|Overall Study|Adverse Event|0|||
13201318|NCT01999218|26219435|FG000|Overall Study|Hyperglycemia|18|||
13201319|NCT01999218|26219436|FG001|Overall Study|Hyperglycemia|17|||
13201320|NCT01999218|26219437|FG002|Overall Study|Hyperglycemia|17|||
13201321|NCT01999218|26219435|FG000|Overall Study|Lack of Efficacy|1|||
13201322|NCT01999218|26219436|FG001|Overall Study|Lack of Efficacy|0|||
13201323|NCT01999218|26219437|FG002|Overall Study|Lack of Efficacy|1|||
13201324|NCT01999218|26219435|FG000|Overall Study|Lost to Follow-up|22|||
13201325|NCT01999218|26219436|FG001|Overall Study|Lost to Follow-up|17|||
13201326|NCT01999218|26219437|FG002|Overall Study|Lost to Follow-up|18|||
13201327|NCT01999218|26219435|FG000|Overall Study|Non-Compliance With Study Drug|6|||
13201328|NCT01999218|26219436|FG001|Overall Study|Non-Compliance With Study Drug|4|||
13201329|NCT01999218|26219437|FG002|Overall Study|Non-Compliance With Study Drug|1|||
13201330|NCT01999218|26219435|FG000|Overall Study|Physician Decision|1|||
13201331|NCT01999218|26219436|FG001|Overall Study|Physician Decision|4|||
13201332|NCT01999218|26219437|FG002|Overall Study|Physician Decision|6|||
13201333|NCT01999218|26219435|FG000|Overall Study|Protocol Violation|4|||
13201334|NCT01999218|26219436|FG001|Overall Study|Protocol Violation|5|||
13201335|NCT01999218|26219437|FG002|Overall Study|Protocol Violation|4|||
13201336|NCT01999218|26219435|FG000|Overall Study|Screen failure|0|||
13201337|NCT01999218|26219436|FG001|Overall Study|Screen failure|1|||
13201338|NCT01999218|26219437|FG002|Overall Study|Screen failure|0|||
13201339|NCT01999218|26219435|FG000|Overall Study|Study Terminated By Sponsor|7|||
13201340|NCT01999218|26219436|FG001|Overall Study|Study Terminated By Sponsor|5|||
13201341|NCT01999218|26219437|FG002|Overall Study|Study Terminated By Sponsor|12|||
13201342|NCT01999218|26219435|FG000|Overall Study|Participant moves|2|||
13201343|NCT01999218|26219436|FG001|Overall Study|Participant moves|5|||
13201344|NCT01999218|26219437|FG002|Overall Study|Participant moves|3|||
13201345|NCT01999218|26219435|FG000|Overall Study|Withdrawal by Subject|28|||
13201346|NCT01999218|26219436|FG001|Overall Study|Withdrawal by Subject|29|||
13201347|NCT01999218|26219437|FG002|Overall Study|Withdrawal by Subject|34|||
13201348|NCT01999218|26219435|FG000|Overall Study|Creatinine/eGFR|0|||
13201349|NCT01999218|26219436|FG001|Overall Study|Creatinine/eGFR|0|||
13201350|NCT01999218|26219437|FG002|Overall Study|Creatinine/eGFR|1|||
13201351|NCT01999218|26219435|FG000|Overall Study|Death|7|||
13201352|NCT01999218|26219436|FG001|Overall Study|Death|1|||
13201353|NCT01999218|26219437|FG002|Overall Study|Death|2|||
13201354|NCT01999218|26219435|FG000|Overall Study|Excluded Medication|1|||
13201355|NCT01999218|26219436|FG001|Overall Study|Excluded Medication|1|||
13201356|NCT01999218|26219437|FG002|Overall Study|Excluded Medication|2|||
13201357|NCT01999218|26219435|FG000|Overall Study|Adverse Event|9|||
13201358|NCT01999218|26219436|FG001|Overall Study|Adverse Event|7|||
13201359|NCT01999218|26219437|FG002|Overall Study|Adverse Event|7|||
13201360|NCT01999218|26219435|FG000|Overall Study|Treated but excluded at 1 trial site|3|||
13201361|NCT01999218|26219436|FG001|Overall Study|Treated but excluded at 1 trial site|5|||
13201362|NCT01999218|26219437|FG002|Overall Study|Treated but excluded at 1 trial site|2|||
13201363|NCT01999179|26219447|FG000|Overall Study|Adverse Event|1|||
13201364|NCT01999179|26219447|FG000|Overall Study|Lost to Follow-up|1|||
13201365|NCT01999179|26219447|FG000|Overall Study|Change in Therapy|3|||
13201366|NCT01999179|26219447|FG000|Overall Study|New catheter|2|||
13201367|NCT01999114|26219527|FG000|Overall Study|Adverse Event|8|||
13201368|NCT01999114|26219528|FG001|Overall Study|Adverse Event|7|||
13201369|NCT01999114|26219529|FG002|Overall Study|Adverse Event|2|||
13201370|NCT01999114|26219530|FG003|Overall Study|Adverse Event|2|||
13201371|NCT01999114|26219531|FG004|Overall Study|Adverse Event|1|||
13201372|NCT01999114|26219527|FG000|Overall Study|Withdrawal by Subject|0|||
13201373|NCT01999114|26219528|FG001|Overall Study|Withdrawal by Subject|0|||
13201374|NCT01999114|26219529|FG002|Overall Study|Withdrawal by Subject|1|||
13201375|NCT01999114|26219530|FG003|Overall Study|Withdrawal by Subject|0|||
13201376|NCT01999114|26219531|FG004|Overall Study|Withdrawal by Subject|1|||
13201377|NCT01999114|26219527|FG000|Overall Study|Lost to Follow-up|0|||
13201378|NCT01999114|26219528|FG001|Overall Study|Lost to Follow-up|0|||
13201379|NCT01999114|26219529|FG002|Overall Study|Lost to Follow-up|1|||
13201380|NCT01999114|26219530|FG003|Overall Study|Lost to Follow-up|0|||
13201381|NCT01999114|26219531|FG004|Overall Study|Lost to Follow-up|0|||
13201382|NCT01999114|26219527|FG000|Overall Study|Administrative|0|||
13201383|NCT01999114|26219528|FG001|Overall Study|Administrative|0|||
13201384|NCT01999114|26219529|FG002|Overall Study|Administrative|1|||
13201385|NCT01999114|26219530|FG003|Overall Study|Administrative|1|||
13201386|NCT01999114|26219531|FG004|Overall Study|Administrative|2|||
13201387|NCT01998984|26219562|FG000|Overall Study|Adverse Event|0|||
13201388|NCT01998984|26219563|FG001|Overall Study|Adverse Event|0|||
13201389|NCT01998984|26219564|FG002|Overall Study|Adverse Event|0|||
13201390|NCT01998984|26219565|FG003|Overall Study|Adverse Event|1|||
13201391|NCT01998984|26219562|FG000|Overall Study|Lost to Follow-up|0|||
13201392|NCT01998984|26219563|FG001|Overall Study|Lost to Follow-up|1|||
13201393|NCT01998984|26219564|FG002|Overall Study|Lost to Follow-up|0|||
13201394|NCT01998984|26219565|FG003|Overall Study|Lost to Follow-up|1|||
13201395|NCT01998984|26219562|FG000|Overall Study|Withdrawal by Subject|0|||
13201396|NCT01998984|26219563|FG001|Overall Study|Withdrawal by Subject|0|||
13201397|NCT01998984|26219564|FG002|Overall Study|Withdrawal by Subject|1|||
13201398|NCT01998984|26219565|FG003|Overall Study|Withdrawal by Subject|0|||
13201399|NCT01998984|26219562|FG000|Overall Study|Other|0|||
13201400|NCT01998984|26219563|FG001|Overall Study|Other|0|||
13201401|NCT01998984|26219564|FG002|Overall Study|Other|0|||
13201402|NCT01998984|26219565|FG003|Overall Study|Other|1|||
13201403|NCT01998958|26219749|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
13201404|NCT01998958|26219750|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1|||
13201405|NCT01998958|26219751|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
13201406|NCT01998958|26219752|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
13201407|NCT01998958|26219753|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
13201408|NCT01998958|26219754|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
13201409|NCT01998958|26219755|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
13201410|NCT01998958|26219756|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
13201411|NCT01998958|26219757|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
13201412|NCT01998958|26219758|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
13201413|NCT01998958|26219759|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
13201414|NCT01998958|26219760|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
13201415|NCT01998958|26219761|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
13201416|NCT01998958|26219762|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
13201417|NCT01998958|26219763|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
13201418|NCT01998958|26219764|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
13201419|NCT01998958|26219765|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
13201420|NCT01998958|26219766|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
13201421|NCT01998958|26219767|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
13201422|NCT01998958|26219768|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
13201423|NCT01998958|26219769|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
13201424|NCT01998958|26219770|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
13201425|NCT01998958|26219771|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
13201426|NCT01998958|26219772|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
13201427|NCT01998958|26219773|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
13201428|NCT01998958|26219774|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
13201429|NCT01998958|26219775|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
13201430|NCT01998958|26219776|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
13201431|NCT01998958|26219777|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
13201432|NCT01998958|26219778|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
13201433|NCT01998958|26219779|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
13201434|NCT01998958|26219780|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
13201435|NCT01998958|26219749|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0|||
13201436|NCT01998958|26219750|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1|||
13201437|NCT01998958|26219751|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0|||
13201438|NCT01998958|26219752|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0|||
13201439|NCT01998958|26219753|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0|||
13201440|NCT01998958|26219754|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0|||
13201441|NCT01998958|26219755|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0|||
13201442|NCT01998958|26219756|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0|||
13201443|NCT01998958|26219757|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0|||
13201444|NCT01998958|26219758|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0|||
13201445|NCT01998958|26219759|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0|||
13201446|NCT01998958|26219760|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0|||
13201447|NCT01998958|26219761|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0|||
13201448|NCT01998958|26219762|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0|||
13201449|NCT01998958|26219763|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0|||
13201450|NCT01998958|26219764|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0|||
13201451|NCT01998958|26219765|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0|||
13201452|NCT01998958|26219766|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0|||
13201453|NCT01998958|26219767|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0|||
13201454|NCT01998958|26219768|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0|||
13201455|NCT01998958|26219769|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0|||
13201456|NCT01998958|26219770|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0|||
13201457|NCT01998958|26219771|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0|||
13201458|NCT01998958|26219772|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0|||
13201459|NCT01998958|26219773|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0|||
13201460|NCT01998958|26219774|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0|||
13201461|NCT01998958|26219775|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0|||
13201462|NCT01998958|26219776|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0|||
13201463|NCT01998958|26219777|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0|||
13201464|NCT01998958|26219778|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0|||
13201465|NCT01998958|26219779|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0|||
13201466|NCT01998958|26219780|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0|||
13201467|NCT01998958|26219749|FG000|Period 1 (Panel A and B)|Adverse Event|0|||
13201468|NCT01998958|26219750|FG001|Period 1 (Panel A and B)|Adverse Event|1|||
13201469|NCT01998958|26219751|FG002|Period 1 (Panel A and B)|Adverse Event|0|||
13201470|NCT01998958|26219752|FG003|Period 1 (Panel A and B)|Adverse Event|0|||
13201471|NCT01998958|26219753|FG004|Period 1 (Panel A and B)|Adverse Event|0|||
13201472|NCT01998958|26219754|FG005|Period 1 (Panel A and B)|Adverse Event|0|||
13201473|NCT01998958|26219755|FG006|Period 1 (Panel A and B)|Adverse Event|0|||
13201474|NCT01998958|26219756|FG007|Period 1 (Panel A and B)|Adverse Event|0|||
13201475|NCT01998958|26219757|FG008|Period 1 (Panel A and B)|Adverse Event|0|||
13201476|NCT01998958|26219758|FG009|Period 1 (Panel A and B)|Adverse Event|0|||
13201477|NCT01998958|26219759|FG010|Period 1 (Panel A and B)|Adverse Event|0|||
13201478|NCT01998958|26219760|FG011|Period 1 (Panel A and B)|Adverse Event|0|||
13201479|NCT01998958|26219761|FG012|Period 1 (Panel A and B)|Adverse Event|0|||
13201480|NCT01998958|26219762|FG013|Period 1 (Panel A and B)|Adverse Event|0|||
13201481|NCT01998958|26219763|FG014|Period 1 (Panel A and B)|Adverse Event|0|||
13201482|NCT01998958|26219764|FG015|Period 1 (Panel A and B)|Adverse Event|0|||
13201483|NCT01998958|26219765|FG016|Period 1 (Panel A and B)|Adverse Event|0|||
13201484|NCT01998958|26219766|FG017|Period 1 (Panel A and B)|Adverse Event|0|||
13201485|NCT01998958|26219767|FG018|Period 1 (Panel A and B)|Adverse Event|0|||
13201486|NCT01998958|26219768|FG019|Period 1 (Panel A and B)|Adverse Event|0|||
13201487|NCT01998958|26219769|FG020|Period 1 (Panel A and B)|Adverse Event|0|||
13201488|NCT01998958|26219770|FG021|Period 1 (Panel A and B)|Adverse Event|0|||
13201489|NCT01998958|26219771|FG022|Period 1 (Panel A and B)|Adverse Event|0|||
13201490|NCT01998958|26219772|FG023|Period 1 (Panel A and B)|Adverse Event|0|||
13201491|NCT01998958|26219773|FG024|Period 1 (Panel A and B)|Adverse Event|0|||
13201492|NCT01998958|26219774|FG025|Period 1 (Panel A and B)|Adverse Event|0|||
13201493|NCT01998958|26219775|FG026|Period 1 (Panel A and B)|Adverse Event|0|||
13201494|NCT01998958|26219776|FG027|Period 1 (Panel A and B)|Adverse Event|0|||
13201495|NCT01998958|26219777|FG028|Period 1 (Panel A and B)|Adverse Event|0|||
13201496|NCT01998958|26219778|FG029|Period 1 (Panel A and B)|Adverse Event|0|||
13201497|NCT01998958|26219779|FG030|Period 1 (Panel A and B)|Adverse Event|0|||
13201498|NCT01998958|26219780|FG031|Period 1 (Panel A and B)|Adverse Event|0|||
13201499|NCT01998958|26219749|FG000|Period 1 (Panel A and B)|Other|1|||
13201500|NCT01998958|26219750|FG001|Period 1 (Panel A and B)|Other|0|||
13201501|NCT01998958|26219751|FG002|Period 1 (Panel A and B)|Other|0|||
13201502|NCT01998958|26219752|FG003|Period 1 (Panel A and B)|Other|0|||
13201503|NCT01998958|26219753|FG004|Period 1 (Panel A and B)|Other|0|||
13201504|NCT01998958|26219754|FG005|Period 1 (Panel A and B)|Other|0|||
13201505|NCT01998958|26219755|FG006|Period 1 (Panel A and B)|Other|0|||
13201506|NCT01998958|26219756|FG007|Period 1 (Panel A and B)|Other|0|||
13201507|NCT01998958|26219757|FG008|Period 1 (Panel A and B)|Other|0|||
13201508|NCT01998958|26219758|FG009|Period 1 (Panel A and B)|Other|0|||
13201509|NCT01998958|26219759|FG010|Period 1 (Panel A and B)|Other|0|||
13201510|NCT01998958|26219760|FG011|Period 1 (Panel A and B)|Other|0|||
13201511|NCT01998958|26219761|FG012|Period 1 (Panel A and B)|Other|0|||
13201512|NCT01998958|26219762|FG013|Period 1 (Panel A and B)|Other|0|||
13201513|NCT01998958|26219763|FG014|Period 1 (Panel A and B)|Other|0|||
13201514|NCT01998958|26219764|FG015|Period 1 (Panel A and B)|Other|0|||
13201515|NCT01998958|26219765|FG016|Period 1 (Panel A and B)|Other|0|||
13201516|NCT01998958|26219766|FG017|Period 1 (Panel A and B)|Other|0|||
13201517|NCT01998958|26219767|FG018|Period 1 (Panel A and B)|Other|0|||
13201518|NCT01998958|26219768|FG019|Period 1 (Panel A and B)|Other|0|||
13201519|NCT01998958|26219769|FG020|Period 1 (Panel A and B)|Other|0|||
13201520|NCT01998958|26219770|FG021|Period 1 (Panel A and B)|Other|0|||
13201521|NCT01998958|26219771|FG022|Period 1 (Panel A and B)|Other|0|||
13201522|NCT01998958|26219772|FG023|Period 1 (Panel A and B)|Other|0|||
13201523|NCT01998958|26219773|FG024|Period 1 (Panel A and B)|Other|0|||
13201524|NCT01998958|26219774|FG025|Period 1 (Panel A and B)|Other|0|||
13201525|NCT01998958|26219775|FG026|Period 1 (Panel A and B)|Other|0|||
13201526|NCT01998958|26219776|FG027|Period 1 (Panel A and B)|Other|0|||
13201527|NCT01998958|26219777|FG028|Period 1 (Panel A and B)|Other|0|||
13201528|NCT01998958|26219778|FG029|Period 1 (Panel A and B)|Other|0|||
13201529|NCT01998958|26219779|FG030|Period 1 (Panel A and B)|Other|0|||
13201530|NCT01998958|26219780|FG031|Period 1 (Panel A and B)|Other|0|||
13201531|NCT01998958|26219749|FG000|Period 2 (Panel A and B)|Adverse Event|0|||
13201532|NCT01998958|26219750|FG001|Period 2 (Panel A and B)|Adverse Event|0|||
13201533|NCT01998958|26219751|FG002|Period 2 (Panel A and B)|Adverse Event|0|||
13201534|NCT01998958|26219752|FG003|Period 2 (Panel A and B)|Adverse Event|0|||
13201535|NCT01998958|26219753|FG004|Period 2 (Panel A and B)|Adverse Event|0|||
13201536|NCT01998958|26219754|FG005|Period 2 (Panel A and B)|Adverse Event|0|||
13113013|NCT03145766|25910420|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2|||
13113014|NCT03145766|25910421|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3|||
13113015|NCT03145766|25910417|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
13113016|NCT03145766|25910418|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
13113017|NCT03145766|25910419|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
13113018|NCT03145766|25910420|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
13113019|NCT03145766|25910421|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
13113020|NCT03145207|25910438|FG000|Overall Study|volunteer started taking allergy shots|1|||
13113021|NCT03145207|25910438|FG000|Overall Study|baseline blood pressure high|1|||
13113022|NCT03145064|25910449|FG000|Overall Study|Death|24|||
13113023|NCT03145064|25910449|FG000|Overall Study|Lost to Follow-up|3|||
13113024|NCT03145064|25910449|FG000|Overall Study|Withdrawal by Subject|6|||
13113025|NCT03145064|25910449|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4|||
13113026|NCT03145064|25910449|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4|||
13113027|NCT03144804|25910456|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4|||
13113028|NCT03144674|25910504|FG000|Overall Study|Participants Still Ongoing in the Study|1|||
13113029|NCT03144674|25910505|FG001|Overall Study|Participants Still Ongoing in the Study|4|||
13113030|NCT03144674|25910506|FG002|Overall Study|Participants Still Ongoing in the Study|24|||
13201537|NCT01998958|26219755|FG006|Period 2 (Panel A and B)|Adverse Event|0|||
13201538|NCT01998958|26219756|FG007|Period 2 (Panel A and B)|Adverse Event|0|||
13201539|NCT01998958|26219757|FG008|Period 2 (Panel A and B)|Adverse Event|0|||
13201540|NCT01998958|26219758|FG009|Period 2 (Panel A and B)|Adverse Event|0|||
13201541|NCT01998958|26219759|FG010|Period 2 (Panel A and B)|Adverse Event|1|||
13201542|NCT01998958|26219760|FG011|Period 2 (Panel A and B)|Adverse Event|0|||
13201543|NCT01998958|26219761|FG012|Period 2 (Panel A and B)|Adverse Event|0|||
13201544|NCT01998958|26219762|FG013|Period 2 (Panel A and B)|Adverse Event|0|||
13201545|NCT01998958|26219763|FG014|Period 2 (Panel A and B)|Adverse Event|1|||
13201546|NCT01998958|26219764|FG015|Period 2 (Panel A and B)|Adverse Event|0|||
13201547|NCT01998958|26219765|FG016|Period 2 (Panel A and B)|Adverse Event|0|||
13201548|NCT01998958|26219766|FG017|Period 2 (Panel A and B)|Adverse Event|0|||
13201549|NCT01998958|26219767|FG018|Period 2 (Panel A and B)|Adverse Event|0|||
13201550|NCT01998958|26219768|FG019|Period 2 (Panel A and B)|Adverse Event|0|||
13201551|NCT01998958|26219769|FG020|Period 2 (Panel A and B)|Adverse Event|0|||
13201552|NCT01998958|26219770|FG021|Period 2 (Panel A and B)|Adverse Event|0|||
13201553|NCT01998958|26219771|FG022|Period 2 (Panel A and B)|Adverse Event|0|||
13201554|NCT01998958|26219772|FG023|Period 2 (Panel A and B)|Adverse Event|0|||
13201555|NCT01998958|26219773|FG024|Period 2 (Panel A and B)|Adverse Event|0|||
13201556|NCT01998958|26219774|FG025|Period 2 (Panel A and B)|Adverse Event|0|||
13201557|NCT01998958|26219775|FG026|Period 2 (Panel A and B)|Adverse Event|0|||
13201558|NCT01998958|26219776|FG027|Period 2 (Panel A and B)|Adverse Event|0|||
13201559|NCT01998958|26219777|FG028|Period 2 (Panel A and B)|Adverse Event|0|||
13201560|NCT01998958|26219778|FG029|Period 2 (Panel A and B)|Adverse Event|0|||
13201561|NCT01998958|26219779|FG030|Period 2 (Panel A and B)|Adverse Event|0|||
13201562|NCT01998958|26219780|FG031|Period 2 (Panel A and B)|Adverse Event|0|||
13201563|NCT01998958|26219749|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
13201564|NCT01998958|26219750|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
13201565|NCT01998958|26219751|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
13201566|NCT01998958|26219752|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
13201567|NCT01998958|26219753|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
13201568|NCT01998958|26219754|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
13201569|NCT01998958|26219755|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
13201570|NCT01998958|26219756|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
13201571|NCT01998958|26219757|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
13201572|NCT01998958|26219758|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
13201573|NCT01998958|26219759|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
13201574|NCT01998958|26219760|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
13201575|NCT01998958|26219761|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
13201576|NCT01998958|26219762|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
13201577|NCT01998958|26219763|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
13201578|NCT01998958|26219764|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
13201579|NCT01998958|26219765|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
13201580|NCT01998958|26219766|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
13201581|NCT01998958|26219767|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
13201582|NCT01998958|26219768|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
13201583|NCT01998958|26219769|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
13201584|NCT01998958|26219770|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
13201585|NCT01998958|26219771|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
13201586|NCT01998958|26219772|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
13201587|NCT01998958|26219773|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
13201588|NCT01998958|26219774|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
13201589|NCT01998958|26219775|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
13201590|NCT01998958|26219776|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
13201591|NCT01998958|26219777|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
13201592|NCT01998958|26219778|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
13201593|NCT01998958|26219779|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
13201594|NCT01998958|26219780|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
13201595|NCT01998958|26219749|FG000|Open Label Phase (Optional)|Adverse Event|0|||
13201596|NCT01998958|26219750|FG001|Open Label Phase (Optional)|Adverse Event|0|||
13201597|NCT01998958|26219751|FG002|Open Label Phase (Optional)|Adverse Event|0|||
13201598|NCT01998958|26219752|FG003|Open Label Phase (Optional)|Adverse Event|0|||
13201599|NCT01998958|26219753|FG004|Open Label Phase (Optional)|Adverse Event|0|||
13201600|NCT01998958|26219754|FG005|Open Label Phase (Optional)|Adverse Event|0|||
13201601|NCT01998958|26219755|FG006|Open Label Phase (Optional)|Adverse Event|0|||
13201602|NCT01998958|26219756|FG007|Open Label Phase (Optional)|Adverse Event|0|||
13201603|NCT01998958|26219757|FG008|Open Label Phase (Optional)|Adverse Event|0|||
13201604|NCT01998958|26219758|FG009|Open Label Phase (Optional)|Adverse Event|0|||
13201605|NCT01998958|26219759|FG010|Open Label Phase (Optional)|Adverse Event|0|||
13201606|NCT01998958|26219760|FG011|Open Label Phase (Optional)|Adverse Event|0|||
13201607|NCT01998958|26219761|FG012|Open Label Phase (Optional)|Adverse Event|0|||
13201608|NCT01998958|26219762|FG013|Open Label Phase (Optional)|Adverse Event|0|||
13201609|NCT01998958|26219763|FG014|Open Label Phase (Optional)|Adverse Event|0|||
13201610|NCT01998958|26219764|FG015|Open Label Phase (Optional)|Adverse Event|0|||
13201611|NCT01998958|26219765|FG016|Open Label Phase (Optional)|Adverse Event|0|||
13201612|NCT01998958|26219766|FG017|Open Label Phase (Optional)|Adverse Event|0|||
13201613|NCT01998958|26219767|FG018|Open Label Phase (Optional)|Adverse Event|0|||
13201614|NCT01998958|26219768|FG019|Open Label Phase (Optional)|Adverse Event|0|||
13201615|NCT01998958|26219769|FG020|Open Label Phase (Optional)|Adverse Event|0|||
13201616|NCT01998958|26219770|FG021|Open Label Phase (Optional)|Adverse Event|0|||
13201617|NCT01998958|26219771|FG022|Open Label Phase (Optional)|Adverse Event|0|||
13201618|NCT01998958|26219772|FG023|Open Label Phase (Optional)|Adverse Event|1|||
13201619|NCT01998958|26219773|FG024|Open Label Phase (Optional)|Adverse Event|0|||
13201620|NCT01998958|26219774|FG025|Open Label Phase (Optional)|Adverse Event|0|||
13201621|NCT01998958|26219775|FG026|Open Label Phase (Optional)|Adverse Event|0|||
13201622|NCT01998958|26219776|FG027|Open Label Phase (Optional)|Adverse Event|0|||
13201623|NCT01998958|26219777|FG028|Open Label Phase (Optional)|Adverse Event|0|||
13201624|NCT01998958|26219778|FG029|Open Label Phase (Optional)|Adverse Event|0|||
13201625|NCT01998958|26219779|FG030|Open Label Phase (Optional)|Adverse Event|0|||
13201626|NCT01998958|26219780|FG031|Open Label Phase (Optional)|Adverse Event|0|||
13201627|NCT01998958|26219749|FG000|Open Label Phase (Optional)|Other|0|||
13201628|NCT01998958|26219750|FG001|Open Label Phase (Optional)|Other|0|||
13201629|NCT01998958|26219751|FG002|Open Label Phase (Optional)|Other|0|||
13201630|NCT01998958|26219752|FG003|Open Label Phase (Optional)|Other|0|||
13201631|NCT01998958|26219753|FG004|Open Label Phase (Optional)|Other|0|||
13201632|NCT01998958|26219754|FG005|Open Label Phase (Optional)|Other|0|||
13201633|NCT01998958|26219755|FG006|Open Label Phase (Optional)|Other|0|||
13201634|NCT01998958|26219756|FG007|Open Label Phase (Optional)|Other|0|||
13201635|NCT01998958|26219757|FG008|Open Label Phase (Optional)|Other|0|||
13201636|NCT01998958|26219758|FG009|Open Label Phase (Optional)|Other|0|||
13201637|NCT01998958|26219759|FG010|Open Label Phase (Optional)|Other|0|||
13201638|NCT01998958|26219760|FG011|Open Label Phase (Optional)|Other|0|||
13201639|NCT01998958|26219761|FG012|Open Label Phase (Optional)|Other|0|||
13201640|NCT01998958|26219762|FG013|Open Label Phase (Optional)|Other|0|||
13201641|NCT01998958|26219763|FG014|Open Label Phase (Optional)|Other|0|||
13201642|NCT01998958|26219764|FG015|Open Label Phase (Optional)|Other|0|||
13201643|NCT01998958|26219765|FG016|Open Label Phase (Optional)|Other|0|||
13201644|NCT01998958|26219766|FG017|Open Label Phase (Optional)|Other|0|||
13201645|NCT01998958|26219767|FG018|Open Label Phase (Optional)|Other|0|||
13201646|NCT01998958|26219768|FG019|Open Label Phase (Optional)|Other|0|||
13201647|NCT01998958|26219769|FG020|Open Label Phase (Optional)|Other|0|||
13201648|NCT01998958|26219770|FG021|Open Label Phase (Optional)|Other|0|||
13201649|NCT01998958|26219771|FG022|Open Label Phase (Optional)|Other|5|||
13201650|NCT01998958|26219772|FG023|Open Label Phase (Optional)|Other|1|||
13201651|NCT01998958|26219773|FG024|Open Label Phase (Optional)|Other|0|||
13201652|NCT01998958|26219774|FG025|Open Label Phase (Optional)|Other|0|||
13201653|NCT01998958|26219775|FG026|Open Label Phase (Optional)|Other|0|||
13201654|NCT01998958|26219776|FG027|Open Label Phase (Optional)|Other|0|||
13201655|NCT01998958|26219777|FG028|Open Label Phase (Optional)|Other|0|||
13201656|NCT01998958|26219778|FG029|Open Label Phase (Optional)|Other|0|||
13201657|NCT01998958|26219779|FG030|Open Label Phase (Optional)|Other|0|||
13201658|NCT01998958|26219780|FG031|Open Label Phase (Optional)|Other|0|||
13201659|NCT01998958|26219749|FG000|Open Label Phase (Optional)|Lost to Follow-up|0|||
13201660|NCT01998958|26219750|FG001|Open Label Phase (Optional)|Lost to Follow-up|0|||
13201661|NCT01998958|26219751|FG002|Open Label Phase (Optional)|Lost to Follow-up|0|||
13201662|NCT01998958|26219752|FG003|Open Label Phase (Optional)|Lost to Follow-up|0|||
13201663|NCT01998958|26219753|FG004|Open Label Phase (Optional)|Lost to Follow-up|0|||
13201664|NCT01998958|26219754|FG005|Open Label Phase (Optional)|Lost to Follow-up|0|||
13201665|NCT01998958|26219755|FG006|Open Label Phase (Optional)|Lost to Follow-up|0|||
13201666|NCT01998958|26219756|FG007|Open Label Phase (Optional)|Lost to Follow-up|0|||
13201667|NCT01998958|26219757|FG008|Open Label Phase (Optional)|Lost to Follow-up|0|||
13201668|NCT01998958|26219758|FG009|Open Label Phase (Optional)|Lost to Follow-up|0|||
13201669|NCT01998958|26219759|FG010|Open Label Phase (Optional)|Lost to Follow-up|0|||
13201670|NCT01998958|26219760|FG011|Open Label Phase (Optional)|Lost to Follow-up|0|||
13201671|NCT01998958|26219761|FG012|Open Label Phase (Optional)|Lost to Follow-up|0|||
13113031|NCT03144674|25910507|FG003|Overall Study|Participants Still Ongoing in the Study|54|||
13113032|NCT03144674|25910504|FG000|Overall Study|Death|3|||
13113033|NCT03144674|25910505|FG001|Overall Study|Death|1|||
13113034|NCT03144674|25910506|FG002|Overall Study|Death|1|||
13113035|NCT03144674|25910507|FG003|Overall Study|Death|10|||
13113036|NCT03144674|25910504|FG000|Overall Study|Lost to Follow-up|0|||
13113037|NCT03144674|25910505|FG001|Overall Study|Lost to Follow-up|1|||
13201672|NCT01998958|26219762|FG013|Open Label Phase (Optional)|Lost to Follow-up|0|||
13201673|NCT01998958|26219763|FG014|Open Label Phase (Optional)|Lost to Follow-up|0|||
13201674|NCT01998958|26219764|FG015|Open Label Phase (Optional)|Lost to Follow-up|0|||
13113038|NCT03144674|25910506|FG002|Overall Study|Lost to Follow-up|1|||
13113039|NCT03144674|25910507|FG003|Overall Study|Lost to Follow-up|1|||
13113040|NCT03144674|25910504|FG000|Overall Study|Withdrawal by Participant|0|||
13113041|NCT03144674|25910505|FG001|Overall Study|Withdrawal by Participant|0|||
13113042|NCT03144674|25910506|FG002|Overall Study|Withdrawal by Participant|0|||
13201675|NCT01998958|26219765|FG016|Open Label Phase (Optional)|Lost to Follow-up|0|||
13201676|NCT01998958|26219766|FG017|Open Label Phase (Optional)|Lost to Follow-up|0|||
13201677|NCT01998958|26219767|FG018|Open Label Phase (Optional)|Lost to Follow-up|0|||
13201678|NCT01998958|26219768|FG019|Open Label Phase (Optional)|Lost to Follow-up|0|||
13201679|NCT01998958|26219769|FG020|Open Label Phase (Optional)|Lost to Follow-up|0|||
13201680|NCT01998958|26219770|FG021|Open Label Phase (Optional)|Lost to Follow-up|0|||
13201681|NCT01998958|26219771|FG022|Open Label Phase (Optional)|Lost to Follow-up|1|||
13201682|NCT01998958|26219772|FG023|Open Label Phase (Optional)|Lost to Follow-up|0|||
13201683|NCT01998958|26219773|FG024|Open Label Phase (Optional)|Lost to Follow-up|0|||
13201684|NCT01998958|26219774|FG025|Open Label Phase (Optional)|Lost to Follow-up|0|||
13201685|NCT01998958|26219775|FG026|Open Label Phase (Optional)|Lost to Follow-up|0|||
13201686|NCT01998958|26219776|FG027|Open Label Phase (Optional)|Lost to Follow-up|0|||
13201687|NCT01998958|26219777|FG028|Open Label Phase (Optional)|Lost to Follow-up|0|||
13201688|NCT01998958|26219778|FG029|Open Label Phase (Optional)|Lost to Follow-up|0|||
13201689|NCT01998958|26219779|FG030|Open Label Phase (Optional)|Lost to Follow-up|0|||
13201690|NCT01998958|26219780|FG031|Open Label Phase (Optional)|Lost to Follow-up|0|||
13201691|NCT01998958|26219749|FG000|Open Label Phase (Optional)|Lack of Efficacy|0|||
13201692|NCT01998958|26219750|FG001|Open Label Phase (Optional)|Lack of Efficacy|0|||
13201693|NCT01998958|26219751|FG002|Open Label Phase (Optional)|Lack of Efficacy|0|||
13201694|NCT01998958|26219752|FG003|Open Label Phase (Optional)|Lack of Efficacy|0|||
13201695|NCT01998958|26219753|FG004|Open Label Phase (Optional)|Lack of Efficacy|0|||
13201696|NCT01998958|26219754|FG005|Open Label Phase (Optional)|Lack of Efficacy|0|||
13201697|NCT01998958|26219755|FG006|Open Label Phase (Optional)|Lack of Efficacy|0|||
13201698|NCT01998958|26219756|FG007|Open Label Phase (Optional)|Lack of Efficacy|0|||
13201699|NCT01998958|26219757|FG008|Open Label Phase (Optional)|Lack of Efficacy|0|||
13201700|NCT01998958|26219758|FG009|Open Label Phase (Optional)|Lack of Efficacy|0|||
13201701|NCT01998958|26219759|FG010|Open Label Phase (Optional)|Lack of Efficacy|0|||
13201702|NCT01998958|26219760|FG011|Open Label Phase (Optional)|Lack of Efficacy|0|||
13201703|NCT01998958|26219761|FG012|Open Label Phase (Optional)|Lack of Efficacy|0|||
13113043|NCT03144674|25910507|FG003|Overall Study|Withdrawal by Participant|3|||
13201704|NCT01998958|26219762|FG013|Open Label Phase (Optional)|Lack of Efficacy|0|||
13201705|NCT01998958|26219763|FG014|Open Label Phase (Optional)|Lack of Efficacy|0|||
13201706|NCT01998958|26219764|FG015|Open Label Phase (Optional)|Lack of Efficacy|0|||
13201707|NCT01998958|26219765|FG016|Open Label Phase (Optional)|Lack of Efficacy|0|||
13201708|NCT01998958|26219766|FG017|Open Label Phase (Optional)|Lack of Efficacy|0|||
13201709|NCT01998958|26219767|FG018|Open Label Phase (Optional)|Lack of Efficacy|0|||
13201710|NCT01998958|26219768|FG019|Open Label Phase (Optional)|Lack of Efficacy|0|||
13201711|NCT01998958|26219769|FG020|Open Label Phase (Optional)|Lack of Efficacy|0|||
13201712|NCT01998958|26219770|FG021|Open Label Phase (Optional)|Lack of Efficacy|1|||
13201713|NCT01998958|26219771|FG022|Open Label Phase (Optional)|Lack of Efficacy|2|||
13201714|NCT01998958|26219772|FG023|Open Label Phase (Optional)|Lack of Efficacy|0|||
13201715|NCT01998958|26219773|FG024|Open Label Phase (Optional)|Lack of Efficacy|0|||
13201716|NCT01998958|26219774|FG025|Open Label Phase (Optional)|Lack of Efficacy|0|||
13113044|NCT03144674|25910504|FG000|Overall Study|Reason not Specified|0|||
13113045|NCT03144674|25910505|FG001|Overall Study|Reason not Specified|0|||
13113046|NCT03144674|25910506|FG002|Overall Study|Reason not Specified|2|||
13113047|NCT03144674|25910507|FG003|Overall Study|Reason not Specified|4|||
13113048|NCT03144180|25910524|FG000|Overall Study|STAT Delivery|1|||
13113049|NCT03144180|25910525|FG001|Overall Study|STAT Delivery|1|||
13113050|NCT03144180|25910524|FG000|Overall Study|Provider forgot to fill out forms|1|||
13113051|NCT03144180|25910525|FG001|Overall Study|Provider forgot to fill out forms|3|||
13113052|NCT03144180|25910524|FG000|Overall Study|Provider forgot to use the Q-cup|0|||
13113053|NCT03144180|25910525|FG001|Overall Study|Provider forgot to use the Q-cup|1|||
13113054|NCT03144180|25910524|FG000|Overall Study|Scrub tech removed tube cap|0|||
13113055|NCT03144180|25910525|FG001|Overall Study|Scrub tech removed tube cap|1|||
13113056|NCT03143855|25910538|FG000|Overall Study|Withdrawal by Subject|4|||
13113057|NCT03143855|25910539|FG001|Overall Study|Withdrawal by Subject|3|||
13113058|NCT03143855|25910538|FG000|Overall Study|Protocol Violation|1|||
13113059|NCT03143855|25910539|FG001|Overall Study|Protocol Violation|0|||
13113060|NCT03143855|25910538|FG000|Overall Study|Participant experienced withdrawal|0|||
13201717|NCT01998958|26219775|FG026|Open Label Phase (Optional)|Lack of Efficacy|0|||
13201718|NCT01998958|26219776|FG027|Open Label Phase (Optional)|Lack of Efficacy|0|||
13201719|NCT01998958|26219777|FG028|Open Label Phase (Optional)|Lack of Efficacy|0|||
13201720|NCT01998958|26219778|FG029|Open Label Phase (Optional)|Lack of Efficacy|0|||
13201721|NCT01998958|26219779|FG030|Open Label Phase (Optional)|Lack of Efficacy|0|||
13201722|NCT01998958|26219780|FG031|Open Label Phase (Optional)|Lack of Efficacy|0|||
13201723|NCT01998958|26219749|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0|||
13201724|NCT01998958|26219750|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0|||
13201725|NCT01998958|26219751|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0|||
13201726|NCT01998958|26219752|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0|||
13201727|NCT01998958|26219753|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0|||
13201728|NCT01998958|26219754|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0|||
13201729|NCT01998958|26219755|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0|||
13201730|NCT01998958|26219756|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0|||
13201731|NCT01998958|26219757|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0|||
13201732|NCT01998958|26219758|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0|||
13201733|NCT01998958|26219759|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0|||
13113061|NCT03143855|25910539|FG001|Overall Study|Participant experienced withdrawal|1|||
13201734|NCT01998958|26219760|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0|||
13201735|NCT01998958|26219761|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0|||
13201736|NCT01998958|26219762|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0|||
13201737|NCT01998958|26219763|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0|||
13201738|NCT01998958|26219764|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0|||
13201739|NCT01998958|26219765|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0|||
13201740|NCT01998958|26219766|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0|||
13201741|NCT01998958|26219767|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0|||
13201742|NCT01998958|26219768|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0|||
13201743|NCT01998958|26219769|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0|||
13201744|NCT01998958|26219770|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2|||
13201745|NCT01998958|26219771|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1|||
13201746|NCT01998958|26219772|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2|||
13201747|NCT01998958|26219773|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0|||
13201748|NCT01998958|26219774|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0|||
13201749|NCT01998958|26219775|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0|||
13201750|NCT01998958|26219776|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0|||
13201751|NCT01998958|26219777|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0|||
13201752|NCT01998958|26219778|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0|||
13113062|NCT03143166|25910557|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1|||
13113063|NCT03143101|25910620|FG000|Overall Study|Withdrawal by Subject|0|||
13113064|NCT03143101|25910621|FG001|Overall Study|Withdrawal by Subject|1|||
13113065|NCT03143101|25910622|FG002|Overall Study|Withdrawal by Subject|0|||
13113066|NCT03143101|25910620|FG000|Overall Study|Lost to Follow-up|2|||
13113067|NCT03143101|25910621|FG001|Overall Study|Lost to Follow-up|2|||
13113068|NCT03143101|25910622|FG002|Overall Study|Lost to Follow-up|0|||
13113069|NCT03142932|25910643|FG000|Overall Study|Lost to Follow-up|2|||
13113070|NCT03142932|25910644|FG001|Overall Study|Lost to Follow-up|11|||
13113071|NCT03142750|25910662|FG000|Overall Study|Lost to Follow-up|4|||
13113072|NCT03142750|25910663|FG001|Overall Study|Lost to Follow-up|1|||
13113073|NCT03142451|25910688|FG000|Overall Study|Adverse Event|5|||
13113074|NCT03142451|25910689|FG001|Overall Study|Adverse Event|2|||
13113075|NCT03142451|25910688|FG000|Overall Study|Lost to Follow-up|25|||
13113076|NCT03142451|25910689|FG001|Overall Study|Lost to Follow-up|8|||
13113077|NCT03142451|25910688|FG000|Overall Study|Participant request|24|||
13113078|NCT03142451|25910689|FG001|Overall Study|Participant request|12|||
13113079|NCT03142451|25910688|FG000|Overall Study|Protocol Violation|3|||
13113080|NCT03142451|25910689|FG001|Overall Study|Protocol Violation|1|||
13113081|NCT03142451|25910688|FG000|Overall Study|Other|1|||
13113082|NCT03142451|25910689|FG001|Overall Study|Other|1|||
13113083|NCT03141905|25910709|FG000|Overall Study|Death|3|||
13113084|NCT03141905|25910710|FG001|Overall Study|Death|2|||
13113085|NCT03141905|25910709|FG000|Overall Study|Withdrawal by Subject|1|||
13113086|NCT03141905|25910710|FG001|Overall Study|Withdrawal by Subject|0|||
13113087|NCT03141905|25910709|FG000|Overall Study|Lost to Follow-up|3|||
13113088|NCT03141905|25910710|FG001|Overall Study|Lost to Follow-up|7|||
13113089|NCT03141905|25910709|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17|||
13113090|NCT03141905|25910710|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10|||
13113091|NCT03141788|25910727|FG000|Overall Study|Lost to Follow-up|1|||
13113092|NCT03141788|25910727|FG000|Overall Study|Protocol Violation|3|||
13113093|NCT03141788|25910727|FG000|Overall Study|Withdrawal by Subject|4|||
13113094|NCT03141307|25910750|FG000|In-Hospital|Withdrawal by Subject|0|||
13113095|NCT03141307|25910751|FG001|In-Hospital|Withdrawal by Subject|2|||
13113096|NCT03141307|25910750|FG000|In-Hospital|Protocol Violation|4|||
13113097|NCT03141307|25910751|FG001|In-Hospital|Protocol Violation|0|||
13113098|NCT03141307|25910750|FG000|Follow-Up|Lost to Follow-up|97|||
13113099|NCT03141307|25910751|FG001|Follow-Up|Lost to Follow-up|54|||
13113100|NCT03141151|25910774|FG000|Overall Study|Lost to Follow-up|3|||
13113101|NCT03141151|25910775|FG001|Overall Study|Lost to Follow-up|2|||
13113102|NCT03141151|25910774|FG000|Overall Study|Withdrawal by Subject|3|||
13113103|NCT03141151|25910775|FG001|Overall Study|Withdrawal by Subject|2|||
13113104|NCT03141086|25910809|FG000|Overall Study|Study Terminated By Sponsor|1|||
13113105|NCT03141086|25910810|FG001|Overall Study|Study Terminated By Sponsor|1|||
13113106|NCT03141086|25910809|FG000|Overall Study|Withdrawal by Subject|0|||
13113107|NCT03141086|25910810|FG001|Overall Study|Withdrawal by Subject|1|||
13113108|NCT03141086|25910809|FG000|Overall Study|Protocol Violation|0|||
13113109|NCT03141086|25910810|FG001|Overall Study|Protocol Violation|1|||
13113110|NCT03141086|25910809|FG000|Overall Study|Adverse Event|0|||
13201753|NCT01998958|26219779|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0|||
13201754|NCT01998958|26219780|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0|||
13201755|NCT01998919|26219805|FG000|Overall Study|Death|2|||
13201756|NCT01998919|26219806|FG001|Overall Study|Death|2|||
13201757|NCT01998919|26219805|FG000|Overall Study|Adverse Event|0|||
13201758|NCT01998919|26219806|FG001|Overall Study|Adverse Event|5|||
13201759|NCT01998919|26219805|FG000|Overall Study|Disease progression|31|||
13201760|NCT01998919|26219806|FG001|Overall Study|Disease progression|22|||
13113111|NCT03141086|25910810|FG001|Overall Study|Adverse Event|2|||
13113112|NCT03140280|25910817|FG000|Overall Study|Physician Decision|5|||
13113113|NCT03139604|25910864|FG000|Overall Study|Other|7|||
13113114|NCT03139604|25910865|FG001|Overall Study|Other|3|||
13113115|NCT03139604|25910864|FG000|Overall Study|Withdrawal by Subject|16|||
13113116|NCT03139604|25910865|FG001|Overall Study|Withdrawal by Subject|17|||
13201761|NCT01998919|26219805|FG000|Overall Study|Withdrawal by Subject|2|||
13113117|NCT03139604|25910864|FG000|Overall Study|Physician Decision|1|||
13113118|NCT03139604|25910865|FG001|Overall Study|Physician Decision|2|||
13201762|NCT01998919|26219806|FG001|Overall Study|Withdrawal by Subject|4|||
13201763|NCT01998919|26219805|FG000|Overall Study|Lost to Follow-up|2|||
13201764|NCT01998919|26219806|FG001|Overall Study|Lost to Follow-up|0|||
13201765|NCT01998919|26219805|FG000|Overall Study|Other|5|||
13201766|NCT01998919|26219806|FG001|Overall Study|Other|2|||
13206672|NCT01955161|26235169|FG000|Overall Study|Death|1|||
13206673|NCT01955161|26235170|FG001|Overall Study|Death|1|||
13206674|NCT01955161|26235171|FG002|Overall Study|Death|3|||
13206675|NCT01955161|26235169|FG000|Overall Study|Withdrawal by Subject|9|||
13206676|NCT01955161|26235170|FG001|Overall Study|Withdrawal by Subject|8|||
13206677|NCT01955161|26235171|FG002|Overall Study|Withdrawal by Subject|12|||
13206678|NCT01955161|26235169|FG000|Overall Study|Protocol Violation|2|||
13206679|NCT01955161|26235170|FG001|Overall Study|Protocol Violation|0|||
13113119|NCT03139604|25910864|FG000|Overall Study|Lost to Follow-up|3|||
13113120|NCT03139604|25910865|FG001|Overall Study|Lost to Follow-up|1|||
13113121|NCT03139604|25910864|FG000|Overall Study|Death|65|||
13113122|NCT03139604|25910865|FG001|Overall Study|Death|67|||
13206680|NCT01955161|26235171|FG002|Overall Study|Protocol Violation|0|||
13201767|NCT01998906|26219860|FG000|Overall Study|Participants ongoing in follow-up|77|||
13201768|NCT01998906|26219861|FG001|Overall Study|Participants ongoing in follow-up|60|||
13201769|NCT01998906|26219862|FG002|Overall Study|Participants ongoing in follow-up|58|||
13201770|NCT01998906|26219860|FG000|Overall Study|Death|21|||
13201771|NCT01998906|26219861|FG001|Overall Study|Death|30|||
13201772|NCT01998906|26219862|FG002|Overall Study|Death|17|||
13201773|NCT01998906|26219860|FG000|Overall Study|Lack of Efficacy|10|||
13201774|NCT01998906|26219861|FG001|Overall Study|Lack of Efficacy|9|||
13201775|NCT01998906|26219862|FG002|Overall Study|Lack of Efficacy|8|||
13201776|NCT01998906|26219860|FG000|Overall Study|Failure to return|0|||
13201777|NCT01998906|26219861|FG001|Overall Study|Failure to return|2|||
13201778|NCT01998906|26219862|FG002|Overall Study|Failure to return|4|||
13201779|NCT01998906|26219860|FG000|Overall Study|Violation of Selection Criteria|0|||
13201780|NCT01998906|26219861|FG001|Overall Study|Violation of Selection Criteria|0|||
13201781|NCT01998906|26219862|FG002|Overall Study|Violation of Selection Criteria|1|||
13201782|NCT01998906|26219860|FG000|Overall Study|Withdrawal by Subject|1|||
13201783|NCT01998906|26219861|FG001|Overall Study|Withdrawal by Subject|4|||
13201784|NCT01998906|26219862|FG002|Overall Study|Withdrawal by Subject|3|||
13201785|NCT01998906|26219860|FG000|Overall Study|Administrative/Other|2|||
13201786|NCT01998906|26219861|FG001|Overall Study|Administrative/Other|1|||
13201787|NCT01998906|26219862|FG002|Overall Study|Administrative/Other|3|||
13201788|NCT01998906|26219860|FG000|Overall Study|Other|3|||
13201789|NCT01998906|26219861|FG001|Overall Study|Other|8|||
13201790|NCT01998906|26219862|FG002|Overall Study|Other|4|||
13201791|NCT01998893|26219874|FG000|Overall Study|Adverse Event|2|||
13201792|NCT01998893|26219874|FG000|Overall Study|Death|1|||
13201793|NCT01998893|26219874|FG000|Overall Study|Lost to Follow-up|8|||
13201794|NCT01998893|26219874|FG000|Overall Study|Physician Decision|2|||
13201795|NCT01998893|26219874|FG000|Overall Study|Protocol Violation|2|||
13201796|NCT01998893|26219874|FG000|Overall Study|Withdrawal by Subject|1|||
13201797|NCT01998893|26219874|FG000|Overall Study|Transformation to high-grade lymphoma|1|||
13201798|NCT01998880|26219911|FG000|Overall Study|Adverse Events or Intercurrent Illness|16|||
13201799|NCT01998880|26219912|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
13201800|NCT01998880|26219911|FG000|Overall Study|Disease Progression|1|||
13201801|NCT01998880|26219912|FG001|Overall Study|Disease Progression|8|||
13201802|NCT01998880|26219911|FG000|Overall Study|Withdrew Consent|2|||
13201803|NCT01998880|26219912|FG001|Overall Study|Withdrew Consent|1|||
13201804|NCT01998880|26219911|FG000|Overall Study|Death|3|||
13201805|NCT01998880|26219912|FG001|Overall Study|Death|6|||
13201806|NCT01998880|26219911|FG000|Overall Study|Insufficient Therapeutic Response|1|||
13201807|NCT01998880|26219912|FG001|Overall Study|Insufficient Therapeutic Response|5|||
13201808|NCT01998880|26219911|FG000|Overall Study|Administrative/Other|1|||
13201809|NCT01998880|26219912|FG001|Overall Study|Administrative/Other|1|||
13201810|NCT01998880|26219911|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
13201811|NCT01998880|26219912|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
13201812|NCT01998880|26219911|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
13201813|NCT01998880|26219912|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
13201814|NCT01998880|26219911|FG000|Overall Study|Did Not Receive Treatment|3|||
13201815|NCT01998880|26219912|FG001|Overall Study|Did Not Receive Treatment|2|||
13201816|NCT01998737|26219929|FG000|Overall Study|Corrupted database|23|||
13201817|NCT01998737|26219930|FG001|Overall Study|Corrupted database|0|||
13201818|NCT01998581|26219948|FG000|Overall Study|Refused repeat treatment|20|||
13201819|NCT01998581|26219949|FG001|Overall Study|Refused repeat treatment|4|||
13201820|NCT01998581|26219948|FG000|Overall Study|Protocol Violation|1|||
13201821|NCT01998581|26219949|FG001|Overall Study|Protocol Violation|0|||
13201822|NCT01998581|26219948|FG000|Overall Study|Withdrawal by Subject|8|||
13201823|NCT01998581|26219949|FG001|Overall Study|Withdrawal by Subject|1|||
13201824|NCT01998581|26219948|FG000|Overall Study|Lost to Follow-up|12|||
13201825|NCT01998581|26219949|FG001|Overall Study|Lost to Follow-up|4|||
13201826|NCT01998581|26219948|FG000|Overall Study|Adverse Event|1|||
13201827|NCT01998581|26219949|FG001|Overall Study|Adverse Event|1|||
13201828|NCT01998581|26219948|FG000|Overall Study|Other reasons|3|||
13201829|NCT01998581|26219949|FG001|Overall Study|Other reasons|2|||
13201830|NCT01998581|26219948|FG000|Overall Study|Randomized but withdrew before treatment|1|||
13201831|NCT01998581|26219949|FG001|Overall Study|Randomized but withdrew before treatment|0|||
13201832|NCT01998477|26219987|FG000|Overall Study|Lost to Follow-up|4|||
13201833|NCT01998477|26219988|FG001|Overall Study|Lost to Follow-up|5|||
13201834|NCT01998477|26219987|FG000|Overall Study|Withdrawal by Subject|6|||
13201835|NCT01998477|26219988|FG001|Overall Study|Withdrawal by Subject|0|||
13201836|NCT01998399|26220027|FG000|Overall Study|Lost to Follow-up|1|||
13201837|NCT01998399|26220028|FG001|Overall Study|Lost to Follow-up|3|||
13201838|NCT01998399|26220027|FG000|Overall Study|Death|4|||
13201839|NCT01998399|26220028|FG001|Overall Study|Death|2|||
13201840|NCT01998399|26220027|FG000|Overall Study|Study stopped before dosing completed|3|||
13201841|NCT01998399|26220028|FG001|Overall Study|Study stopped before dosing completed|3|||
13201842|NCT01998399|26220027|FG000|Overall Study|Withdrawal by Subject|0|||
13201843|NCT01998399|26220028|FG001|Overall Study|Withdrawal by Subject|1|||
13201844|NCT01998243|26220049|FG000|Overall Study|Pregnancy|0|||
13201845|NCT01998243|26220050|FG001|Overall Study|Pregnancy|1|||
13201846|NCT01998243|26220049|FG000|Overall Study|Protocol Violation|5|||
13201847|NCT01998243|26220050|FG001|Overall Study|Protocol Violation|2|||
13201848|NCT01998243|26220049|FG000|Overall Study|Withdrawal by Subject|3|||
13201849|NCT01998243|26220050|FG001|Overall Study|Withdrawal by Subject|4|||
13201850|NCT01997892|26220064|FG000|Overall Study|Physician Decision|2|||
13201851|NCT01997892|26220064|FG000|Overall Study|Lost to Follow-up|6|||
13201852|NCT01997892|26220064|FG000|Overall Study|Death|14|||
13201853|NCT01997892|26220064|FG000|Overall Study|Renal transplant|8|||
13201854|NCT01997892|26220064|FG000|Overall Study|Other|3|||
13201855|NCT01997892|26220064|FG000|Overall Study|Study completion data not recorded|35|||
13201856|NCT01997333|26220086|FG000|Randomization and Treatment|Disease Progression|70|||
13201857|NCT01997333|26220087|FG001|Randomization and Treatment|Disease Progression|159|||
13201858|NCT01997333|26220086|FG000|Randomization and Treatment|Adverse Event|10|||
13201859|NCT01997333|26220087|FG001|Randomization and Treatment|Adverse Event|32|||
13201860|NCT01997333|26220086|FG000|Randomization and Treatment|Physician Decision|0|||
13201861|NCT01997333|26220087|FG001|Randomization and Treatment|Physician Decision|4|||
13201862|NCT01997333|26220086|FG000|Randomization and Treatment|Withdrawal by Subject|6|||
13201863|NCT01997333|26220087|FG001|Randomization and Treatment|Withdrawal by Subject|3|||
13201864|NCT01997333|26220086|FG000|Randomization and Treatment|Did not receive treatment|17|||
13201865|NCT01997333|26220087|FG001|Randomization and Treatment|Did not receive treatment|5|||
13201866|NCT01997333|26220086|FG000|Survival Follow up|Withdrawal by Subject|15|||
13201867|NCT01997333|26220087|FG001|Survival Follow up|Withdrawal by Subject|6|||
13201868|NCT01997333|26220086|FG000|Survival Follow up|Lost to Follow-up|0|||
13201869|NCT01997333|26220087|FG001|Survival Follow up|Lost to Follow-up|6|||
13201870|NCT01997333|26220086|FG000|Survival Follow up|Various|1|||
13201871|NCT01997333|26220087|FG001|Survival Follow up|Various|2|||
13201872|NCT01997281|26220100|FG000|Overall Study|Withdrawal by Subject|1|||
13201873|NCT01997281|26220101|FG001|Overall Study|Withdrawal by Subject|0|||
13201874|NCT01996982|26220108|FG000|Overall Study|PI/team left institution|7|||
13201875|NCT01996904|26220121|FG000|Overall Study|Lost to Follow-up|38|||
13201876|NCT01996904|26220122|FG001|Overall Study|Lost to Follow-up|27|||
13201877|NCT01996826|26220139|FG000|Overall Study|Lost to Follow-up|6|||
13201878|NCT01996826|26220140|FG001|Overall Study|Lost to Follow-up|2|||
13201879|NCT01996826|26220139|FG000|Overall Study|Physician Decision|1|||
13201880|NCT01996826|26220140|FG001|Overall Study|Physician Decision|1|||
13201881|NCT01996748|26220159|FG000|Overall Study|Personal reason|1|||
13201882|NCT01996748|26220160|FG001|Overall Study|Personal reason|0|||
13201883|NCT01996748|26220159|FG000|Overall Study|Physician Decision|2|||
13201884|NCT01996748|26220160|FG001|Overall Study|Physician Decision|0|||
13201885|NCT01996748|26220159|FG000|Overall Study|Adverse Event|1|||
13201886|NCT01996748|26220160|FG001|Overall Study|Adverse Event|4|||
13201887|NCT01996748|26220159|FG000|Overall Study|Withdrawal by Subject|0|||
13201888|NCT01996748|26220160|FG001|Overall Study|Withdrawal by Subject|1|||
13201889|NCT01996748|26220159|FG000|Overall Study|Lost to Follow-up|4|||
13201890|NCT01996748|26220160|FG001|Overall Study|Lost to Follow-up|1|||
13201891|NCT01996709|26220181|FG000|Overall Study|Withdrawal by Subject|1|||
13201892|NCT01996709|26220182|FG001|Overall Study|Withdrawal by Subject|0|||
13201893|NCT01996709|26220181|FG000|Overall Study|Lost to Follow-up|3|||
13201894|NCT01996709|26220182|FG001|Overall Study|Lost to Follow-up|0|||
13201895|NCT01996709|26220181|FG000|Overall Study|Subject Non-Compliant|1|||
13201896|NCT01996709|26220182|FG001|Overall Study|Subject Non-Compliant|0|||
13201897|NCT01996709|26220181|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
13201898|NCT01996709|26220182|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
13201899|NCT01996592|26220193|FG000|Overall Study|no response to text/no diary entry|32|||
13201900|NCT01996592|26220193|FG000|Overall Study|change in surgical date|4|||
13201901|NCT01996592|26220193|FG000|Overall Study|Withdrawal by Subject|5|||
13201902|NCT01996592|26220193|FG000|Overall Study|change in mode of delivery|4|||
13201903|NCT01996332|26220201|FG000|Overall Study|Adverse Event|117|||
13201904|NCT01996332|26220201|FG000|Overall Study|Lack of Efficacy|1245|||
13201905|NCT01996332|26220201|FG000|Overall Study|Death|264|||
13201906|NCT01996332|26220201|FG000|Overall Study|Protocol Violation|9|||
13201907|NCT01996332|26220201|FG000|Overall Study|Withdrawal by Subject|71|||
13201908|NCT01996332|26220201|FG000|Overall Study|Other|20|||
13201909|NCT01996332|26220201|FG000|Overall Study|Clinical Deterioration|28|||
13201910|NCT01996332|26220201|FG000|Overall Study|Physician Decision|17|||
13201911|NCT01996332|26220201|FG000|Overall Study|Lost to Follow-up|34|||
13201912|NCT01996319|26220228|FG000|Overall Study|Protocol Violation|1|||
13201913|NCT01996319|26220229|FG001|Overall Study|Protocol Violation|0|||
13201914|NCT01996319|26220228|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5|||
13201915|NCT01996319|26220229|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1|||
13201916|NCT01996319|26220228|FG000|Overall Study|Adverse Event|2|||
13201917|NCT01996319|26220229|FG001|Overall Study|Adverse Event|2|||
13201918|NCT01996254|26220263|FG000|Overall Study|Change in Eligibility|0|||
13201919|NCT01996254|26220264|FG001|Overall Study|Change in Eligibility|2|||
13201920|NCT01996254|26220265|FG002|Overall Study|Change in Eligibility|0|||
13201921|NCT01996254|26220263|FG000|Overall Study|Withdrawal by Subject|0|||
13201922|NCT01996254|26220264|FG001|Overall Study|Withdrawal by Subject|3|||
13201923|NCT01996254|26220265|FG002|Overall Study|Withdrawal by Subject|4|||
13201924|NCT01996254|26220263|FG000|Overall Study|Lost to Follow-up|1|||
13201925|NCT01996254|26220264|FG001|Overall Study|Lost to Follow-up|0|||
13201926|NCT01996254|26220265|FG002|Overall Study|Lost to Follow-up|4|||
13201927|NCT01996241|26220288|FG000|Overall Study|Lost to Follow-up|252|||
13201928|NCT01996241|26220289|FG001|Overall Study|Lost to Follow-up|235|||
13201929|NCT01996033|26220304|FG000|Overall Study|Death|1|||
13201930|NCT01996033|26220304|FG000|Overall Study|Physician Decision|1|||
13201931|NCT01996033|26220304|FG000|Overall Study|Withdrawal by Subject|4|||
13201932|NCT01996033|26220304|FG000|Overall Study|Lost to Follow-up|3|||
13201933|NCT01995838|26220425|FG000|Overall Study|Lost to Follow-up|0|||
13201934|NCT01995838|26220426|FG001|Overall Study|Lost to Follow-up|1|||
13201935|NCT01995838|26220427|FG002|Overall Study|Lost to Follow-up|0|||
13201936|NCT01995838|26220428|FG003|Overall Study|Lost to Follow-up|0|||
13201937|NCT01995838|26220429|FG004|Overall Study|Lost to Follow-up|0|||
13201938|NCT01995838|26220430|FG005|Overall Study|Lost to Follow-up|0|||
13201939|NCT01995838|26220431|FG006|Overall Study|Lost to Follow-up|1|||
13201940|NCT01995838|26220425|FG000|Overall Study|Participant choice|2|||
13201941|NCT01995838|26220426|FG001|Overall Study|Participant choice|0|||
13201942|NCT01995838|26220427|FG002|Overall Study|Participant choice|0|||
13201943|NCT01995838|26220428|FG003|Overall Study|Participant choice|0|||
13201944|NCT01995838|26220429|FG004|Overall Study|Participant choice|0|||
13201945|NCT01995838|26220430|FG005|Overall Study|Participant choice|1|||
13201946|NCT01995838|26220431|FG006|Overall Study|Participant choice|1|||
13201947|NCT01995838|26220425|FG000|Overall Study|Adverse Event|0|||
13201948|NCT01995838|26220426|FG001|Overall Study|Adverse Event|0|||
13201949|NCT01995838|26220427|FG002|Overall Study|Adverse Event|0|||
13201950|NCT01995838|26220428|FG003|Overall Study|Adverse Event|0|||
13201951|NCT01995838|26220429|FG004|Overall Study|Adverse Event|0|||
13201952|NCT01995838|26220430|FG005|Overall Study|Adverse Event|0|||
13201953|NCT01995838|26220431|FG006|Overall Study|Adverse Event|1|||
13201954|NCT01995838|26220425|FG000|Overall Study|Withdrawal by Subject|0|||
13201955|NCT01995838|26220426|FG001|Overall Study|Withdrawal by Subject|0|||
13201956|NCT01995838|26220427|FG002|Overall Study|Withdrawal by Subject|0|||
13201957|NCT01995838|26220428|FG003|Overall Study|Withdrawal by Subject|0|||
13201958|NCT01995838|26220429|FG004|Overall Study|Withdrawal by Subject|1|||
13201959|NCT01995838|26220430|FG005|Overall Study|Withdrawal by Subject|0|||
13201960|NCT01995838|26220431|FG006|Overall Study|Withdrawal by Subject|0|||
13201961|NCT01995838|26220425|FG000|Overall Study|Other|3|||
13201962|NCT01995838|26220426|FG001|Overall Study|Other|1|||
13201963|NCT01995838|26220427|FG002|Overall Study|Other|0|||
13201964|NCT01995838|26220428|FG003|Overall Study|Other|2|||
13201965|NCT01995838|26220429|FG004|Overall Study|Other|1|||
13201966|NCT01995838|26220430|FG005|Overall Study|Other|1|||
13201967|NCT01995838|26220431|FG006|Overall Study|Other|2|||
13201968|NCT01995825|26220446|FG000|Overall Study|Withdrawal by Subject|1|||
13201969|NCT01995825|26220447|FG001|Overall Study|Withdrawal by Subject|0|||
13201970|NCT01995552|26220455|FG000|Overall Study|Protocol Violation|1|||
13201971|NCT01995552|26220455|FG000|Overall Study|Lack of Efficacy|15|||
13201972|NCT01995552|26220455|FG000|Overall Study|Death|1|||
13201973|NCT01995539|26220462|FG000|Overall Study|Screening Failure|1|||
13201974|NCT01995539|26220462|FG000|Overall Study|Withdrawal by Investigator|15|||
13201975|NCT01995539|26220462|FG000|Overall Study|Withdrawal by Subject|11|||
13201976|NCT01995539|26220462|FG000|Overall Study|Lost to Follow-up|5|||
13201977|NCT01995539|26220462|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1|||
13201978|NCT01995526|26220472|FG000|Overall Study|Physician Decision|1|||
13201979|NCT01995461|26220480|FG000|Overall Study|Death|1|||
13201980|NCT01995461|26220480|FG000|Overall Study|Lost to Follow-up|2|||
13201981|NCT01995461|26220480|FG000|Overall Study|Withdrawal by Subject|2|||
13201982|NCT01995357|26220503|FG000|Period 5|Lack of Efficacy|1|||
13201983|NCT01995357|26220504|FG001|Period 5|Lack of Efficacy|0|||
13201984|NCT01995357|26220505|FG002|Period 5|Lack of Efficacy|0|||
13201985|NCT01995357|26220506|FG003|Period 5|Lack of Efficacy|0|||
13201986|NCT01995357|26220507|FG004|Period 5|Lack of Efficacy|0|||
13201987|NCT01995357|26220508|FG005|Period 5|Lack of Efficacy|0|||
13201988|NCT01995357|26220503|FG000|Period 5|Adverse Event|1|||
13201989|NCT01995357|26220504|FG001|Period 5|Adverse Event|0|||
13201990|NCT01995357|26220505|FG002|Period 5|Adverse Event|1|||
13201991|NCT01995357|26220506|FG003|Period 5|Adverse Event|0|||
13201992|NCT01995357|26220507|FG004|Period 5|Adverse Event|0|||
13201993|NCT01995357|26220508|FG005|Period 5|Adverse Event|0|||
13201994|NCT01995266|26220523|FG000|Overall Study|Death|1|||
13201995|NCT01995266|26220523|FG000|Overall Study|Lack of Efficacy|6|||
13201996|NCT01995266|26220523|FG000|Overall Study|Adverse Event|2|||
13201997|NCT01995201|26220644|FG000|From Baseline Until Week 24|Adverse Event|4|||
13201998|NCT01995201|26220645|FG001|From Baseline Until Week 24|Adverse Event|15|||
13201999|NCT01995201|26220646|FG002|From Baseline Until Week 24|Adverse Event|0|||
13202000|NCT01995201|26220647|FG003|From Baseline Until Week 24|Adverse Event|0|||
13202001|NCT01995201|26220648|FG004|From Baseline Until Week 24|Adverse Event|0|||
13202002|NCT01995201|26220649|FG005|From Baseline Until Week 24|Adverse Event|0|||
13202003|NCT01995201|26220650|FG006|From Baseline Until Week 24|Adverse Event|0|||
13202004|NCT01995201|26220644|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
13202005|NCT01995201|26220645|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3|||
13202006|NCT01995201|26220646|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
13202007|NCT01995201|26220647|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
13202008|NCT01995201|26220648|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
13202009|NCT01995201|26220649|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
13202010|NCT01995201|26220650|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
13202011|NCT01995201|26220644|FG000|From Baseline Until Week 24|Death|0|||
13202012|NCT01995201|26220645|FG001|From Baseline Until Week 24|Death|1|||
13202013|NCT01995201|26220646|FG002|From Baseline Until Week 24|Death|0|||
13202014|NCT01995201|26220647|FG003|From Baseline Until Week 24|Death|0|||
13202015|NCT01995201|26220648|FG004|From Baseline Until Week 24|Death|0|||
13202016|NCT01995201|26220649|FG005|From Baseline Until Week 24|Death|0|||
13202017|NCT01995201|26220650|FG006|From Baseline Until Week 24|Death|0|||
13202018|NCT01995201|26220644|FG000|From Baseline Until Week 24|Lack of Efficacy|2|||
13202019|NCT01995201|26220645|FG001|From Baseline Until Week 24|Lack of Efficacy|5|||
13202020|NCT01995201|26220646|FG002|From Baseline Until Week 24|Lack of Efficacy|0|||
13202021|NCT01995201|26220647|FG003|From Baseline Until Week 24|Lack of Efficacy|0|||
13202022|NCT01995201|26220648|FG004|From Baseline Until Week 24|Lack of Efficacy|0|||
13202023|NCT01995201|26220649|FG005|From Baseline Until Week 24|Lack of Efficacy|0|||
13202024|NCT01995201|26220650|FG006|From Baseline Until Week 24|Lack of Efficacy|0|||
13202025|NCT01995201|26220644|FG000|From Baseline Until Week 24|Lost to Follow-up|2|||
13202026|NCT01995201|26220645|FG001|From Baseline Until Week 24|Lost to Follow-up|3|||
13202027|NCT01995201|26220646|FG002|From Baseline Until Week 24|Lost to Follow-up|0|||
13202028|NCT01995201|26220647|FG003|From Baseline Until Week 24|Lost to Follow-up|0|||
13202029|NCT01995201|26220648|FG004|From Baseline Until Week 24|Lost to Follow-up|0|||
13202030|NCT01995201|26220649|FG005|From Baseline Until Week 24|Lost to Follow-up|0|||
13202031|NCT01995201|26220650|FG006|From Baseline Until Week 24|Lost to Follow-up|0|||
13202032|NCT01995201|26220644|FG000|From Baseline Until Week 24|Withdrawal by Subject|2|||
13202033|NCT01995201|26220645|FG001|From Baseline Until Week 24|Withdrawal by Subject|8|||
13202034|NCT01995201|26220646|FG002|From Baseline Until Week 24|Withdrawal by Subject|0|||
13202035|NCT01995201|26220647|FG003|From Baseline Until Week 24|Withdrawal by Subject|0|||
13202036|NCT01995201|26220648|FG004|From Baseline Until Week 24|Withdrawal by Subject|0|||
13202037|NCT01995201|26220649|FG005|From Baseline Until Week 24|Withdrawal by Subject|0|||
13202038|NCT01995201|26220650|FG006|From Baseline Until Week 24|Withdrawal by Subject|0|||
13202039|NCT01995201|26220644|FG000|From Baseline Until Week 24|Physician Decision|0|||
13202040|NCT01995201|26220645|FG001|From Baseline Until Week 24|Physician Decision|2|||
13202041|NCT01995201|26220646|FG002|From Baseline Until Week 24|Physician Decision|0|||
13202042|NCT01995201|26220647|FG003|From Baseline Until Week 24|Physician Decision|0|||
13202043|NCT01995201|26220648|FG004|From Baseline Until Week 24|Physician Decision|0|||
13202044|NCT01995201|26220649|FG005|From Baseline Until Week 24|Physician Decision|0|||
13202045|NCT01995201|26220650|FG006|From Baseline Until Week 24|Physician Decision|0|||
13202046|NCT01995201|26220644|FG000|From Baseline Until Week 24|Protocol Violation|0|||
13202047|NCT01995201|26220645|FG001|From Baseline Until Week 24|Protocol Violation|9|||
13202048|NCT01995201|26220646|FG002|From Baseline Until Week 24|Protocol Violation|0|||
13202049|NCT01995201|26220647|FG003|From Baseline Until Week 24|Protocol Violation|0|||
13202050|NCT01995201|26220648|FG004|From Baseline Until Week 24|Protocol Violation|0|||
13202051|NCT01995201|26220649|FG005|From Baseline Until Week 24|Protocol Violation|0|||
13202052|NCT01995201|26220650|FG006|From Baseline Until Week 24|Protocol Violation|0|||
13202053|NCT01995201|26220644|FG000|From Week 24 Until Week 48|Adverse Event|0|||
13202054|NCT01995201|26220645|FG001|From Week 24 Until Week 48|Adverse Event|0|||
13202055|NCT01995201|26220646|FG002|From Week 24 Until Week 48|Adverse Event|2|||
13202056|NCT01995201|26220647|FG003|From Week 24 Until Week 48|Adverse Event|1|||
13202057|NCT01995201|26220648|FG004|From Week 24 Until Week 48|Adverse Event|1|||
13202058|NCT01995201|26220649|FG005|From Week 24 Until Week 48|Adverse Event|3|||
13202059|NCT01995201|26220650|FG006|From Week 24 Until Week 48|Adverse Event|1|||
13202060|NCT01995201|26220644|FG000|From Week 24 Until Week 48|Death|0|||
13202061|NCT01995201|26220645|FG001|From Week 24 Until Week 48|Death|0|||
13202062|NCT01995201|26220646|FG002|From Week 24 Until Week 48|Death|0|||
13202063|NCT01995201|26220647|FG003|From Week 24 Until Week 48|Death|0|||
13202064|NCT01995201|26220648|FG004|From Week 24 Until Week 48|Death|0|||
13202065|NCT01995201|26220649|FG005|From Week 24 Until Week 48|Death|2|||
13202066|NCT01995201|26220650|FG006|From Week 24 Until Week 48|Death|0|||
13202067|NCT01995201|26220644|FG000|From Week 24 Until Week 48|Lack of Efficacy|0|||
13202068|NCT01995201|26220645|FG001|From Week 24 Until Week 48|Lack of Efficacy|0|||
13202069|NCT01995201|26220646|FG002|From Week 24 Until Week 48|Lack of Efficacy|1|||
13202070|NCT01995201|26220647|FG003|From Week 24 Until Week 48|Lack of Efficacy|0|||
13485634|NCT01126749|27033002|FG002|Phase 1b|Death|0|||
13485635|NCT01126749|27033003|FG003|Phase 1b|Death|0|||
13485636|NCT01126749|27033000|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
13202071|NCT01995201|26220648|FG004|From Week 24 Until Week 48|Lack of Efficacy|0|||
13202072|NCT01995201|26220649|FG005|From Week 24 Until Week 48|Lack of Efficacy|2|||
13202073|NCT01995201|26220650|FG006|From Week 24 Until Week 48|Lack of Efficacy|1|||
13202074|NCT01995201|26220644|FG000|From Week 24 Until Week 48|Lost to Follow-up|0|||
13202075|NCT01995201|26220645|FG001|From Week 24 Until Week 48|Lost to Follow-up|0|||
13202076|NCT01995201|26220646|FG002|From Week 24 Until Week 48|Lost to Follow-up|0|||
13202077|NCT01995201|26220647|FG003|From Week 24 Until Week 48|Lost to Follow-up|0|||
13202078|NCT01995201|26220648|FG004|From Week 24 Until Week 48|Lost to Follow-up|1|||
13202079|NCT01995201|26220649|FG005|From Week 24 Until Week 48|Lost to Follow-up|1|||
13202080|NCT01995201|26220650|FG006|From Week 24 Until Week 48|Lost to Follow-up|0|||
13202081|NCT01995201|26220644|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0|||
13202082|NCT01995201|26220645|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0|||
13202083|NCT01995201|26220646|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1|||
13202084|NCT01995201|26220647|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0|||
13202085|NCT01995201|26220648|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1|||
13202086|NCT01995201|26220649|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0|||
13202087|NCT01995201|26220650|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0|||
13202088|NCT01995201|26220644|FG000|From Week 24 Until Week 48|Physician Decision|0|||
13202089|NCT01995201|26220645|FG001|From Week 24 Until Week 48|Physician Decision|0|||
13202090|NCT01995201|26220646|FG002|From Week 24 Until Week 48|Physician Decision|0|||
13202091|NCT01995201|26220647|FG003|From Week 24 Until Week 48|Physician Decision|0|||
13202092|NCT01995201|26220648|FG004|From Week 24 Until Week 48|Physician Decision|1|||
13202093|NCT01995201|26220649|FG005|From Week 24 Until Week 48|Physician Decision|0|||
13202094|NCT01995201|26220650|FG006|From Week 24 Until Week 48|Physician Decision|0|||
13202095|NCT01995201|26220644|FG000|From Week 24 Until Week 48|Protocol Violation|0|||
13202096|NCT01995201|26220645|FG001|From Week 24 Until Week 48|Protocol Violation|0|||
13202097|NCT01995201|26220646|FG002|From Week 24 Until Week 48|Protocol Violation|1|||
13202098|NCT01995201|26220647|FG003|From Week 24 Until Week 48|Protocol Violation|0|||
13113123|NCT03139604|25910864|FG000|Overall Study|Study Terminated by Sponsor|122|||
13113124|NCT03139604|25910865|FG001|Overall Study|Study Terminated by Sponsor|127|||
13113125|NCT03139604|25910864|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5|||
13113126|NCT03139604|25910865|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3|||
13113127|NCT03139552|25910908|FG000|Overall Study|unable to attend tasting due to schedule|3|||
13113128|NCT03139448|25910937|FG000|Overall Study|Lack of Efficacy|6|||
13113129|NCT03139448|25910938|FG001|Overall Study|Lack of Efficacy|7|||
13113130|NCT03139448|25910937|FG000|Overall Study|Location of procedure changed|2|||
13113131|NCT03139448|25910938|FG001|Overall Study|Location of procedure changed|8|||
13113132|NCT03139448|25910937|FG000|Overall Study|Withdrawal by Subject|3|||
13113133|NCT03139448|25910938|FG001|Overall Study|Withdrawal by Subject|6|||
13113134|NCT03139448|25910937|FG000|Overall Study|Screen fail|1|||
13113135|NCT03139448|25910938|FG001|Overall Study|Screen fail|3|||
13113136|NCT03139448|25910937|FG000|Overall Study|Physician Decision|0|||
13202099|NCT01995201|26220648|FG004|From Week 24 Until Week 48|Protocol Violation|2|||
13113137|NCT03139448|25910938|FG001|Overall Study|Physician Decision|2|||
13113138|NCT03139279|25910959|FG000|Overall Study|Physician Decision|2|||
13113139|NCT03139279|25910960|FG001|Overall Study|Physician Decision|0|||
13113140|NCT03139279|25910959|FG000|Overall Study|Protocol Violation|5|||
13113141|NCT03139279|25910960|FG001|Overall Study|Protocol Violation|4|||
13113142|NCT03139279|25910959|FG000|Overall Study|Withdrawal by Subject|0|||
13202100|NCT01995201|26220649|FG005|From Week 24 Until Week 48|Protocol Violation|0|||
13202101|NCT01995201|26220650|FG006|From Week 24 Until Week 48|Protocol Violation|0|||
13202102|NCT01995136|26220656|FG000|Overall Study|Change in residence|1|||
13202103|NCT01995071|26220752|FG000|Overall Study|Adverse Event|0|||
13202104|NCT01995071|26220753|FG001|Overall Study|Adverse Event|0|||
13202105|NCT01995071|26220754|FG002|Overall Study|Adverse Event|0|||
13202106|NCT01995071|26220755|FG003|Overall Study|Adverse Event|0|||
13202107|NCT01995071|26220756|FG004|Overall Study|Adverse Event|0|||
13202108|NCT01995071|26220757|FG005|Overall Study|Adverse Event|0|||
13202109|NCT01995071|26220758|FG006|Overall Study|Adverse Event|1|||
13202110|NCT01995071|26220759|FG007|Overall Study|Adverse Event|0|||
13202111|NCT01995071|26220760|FG008|Overall Study|Adverse Event|0|||
13202112|NCT01995071|26220761|FG009|Overall Study|Adverse Event|0|||
13202113|NCT01995071|26220762|FG010|Overall Study|Adverse Event|0|||
13202114|NCT01995071|26220763|FG011|Overall Study|Adverse Event|0|||
13202115|NCT01995071|26220752|FG000|Overall Study|Moved|0|||
13202116|NCT01995071|26220753|FG001|Overall Study|Moved|0|||
13202117|NCT01995071|26220754|FG002|Overall Study|Moved|1|||
13202118|NCT01995071|26220755|FG003|Overall Study|Moved|0|||
13202119|NCT01995071|26220756|FG004|Overall Study|Moved|1|||
13202120|NCT01995071|26220757|FG005|Overall Study|Moved|0|||
13202121|NCT01995071|26220758|FG006|Overall Study|Moved|0|||
13202122|NCT01995071|26220759|FG007|Overall Study|Moved|0|||
13202123|NCT01995071|26220760|FG008|Overall Study|Moved|0|||
13202124|NCT01995071|26220761|FG009|Overall Study|Moved|0|||
13202125|NCT01995071|26220762|FG010|Overall Study|Moved|1|||
13202126|NCT01995071|26220763|FG011|Overall Study|Moved|0|||
13202127|NCT01995071|26220752|FG000|Overall Study|Lost to Follow-up|1|||
13202128|NCT01995071|26220753|FG001|Overall Study|Lost to Follow-up|0|||
13202129|NCT01995071|26220754|FG002|Overall Study|Lost to Follow-up|0|||
13202130|NCT01995071|26220755|FG003|Overall Study|Lost to Follow-up|0|||
13202131|NCT01995071|26220756|FG004|Overall Study|Lost to Follow-up|0|||
13202132|NCT01995071|26220757|FG005|Overall Study|Lost to Follow-up|0|||
13202133|NCT01995071|26220758|FG006|Overall Study|Lost to Follow-up|0|||
13202134|NCT01995071|26220759|FG007|Overall Study|Lost to Follow-up|1|||
13202135|NCT01995071|26220760|FG008|Overall Study|Lost to Follow-up|1|||
13202136|NCT01995071|26220761|FG009|Overall Study|Lost to Follow-up|0|||
13202137|NCT01995071|26220762|FG010|Overall Study|Lost to Follow-up|0|||
13202138|NCT01995071|26220763|FG011|Overall Study|Lost to Follow-up|0|||
13202139|NCT01995071|26220752|FG000|Overall Study|Incarcerated|0|||
13202140|NCT01995071|26220753|FG001|Overall Study|Incarcerated|0|||
13202141|NCT01995071|26220754|FG002|Overall Study|Incarcerated|0|||
13202142|NCT01995071|26220755|FG003|Overall Study|Incarcerated|0|||
13202143|NCT01995071|26220756|FG004|Overall Study|Incarcerated|0|||
13202144|NCT01995071|26220757|FG005|Overall Study|Incarcerated|0|||
13202145|NCT01995071|26220758|FG006|Overall Study|Incarcerated|0|||
13202146|NCT01995071|26220759|FG007|Overall Study|Incarcerated|1|||
13202147|NCT01995071|26220760|FG008|Overall Study|Incarcerated|0|||
13202148|NCT01995071|26220761|FG009|Overall Study|Incarcerated|0|||
13202149|NCT01995071|26220762|FG010|Overall Study|Incarcerated|0|||
13202150|NCT01995071|26220763|FG011|Overall Study|Incarcerated|0|||
13202151|NCT01994954|26220788|FG000|Overall Study|Death|1|||
13202152|NCT01994954|26220789|FG001|Overall Study|Death|0|||
13202153|NCT01994954|26220788|FG000|Overall Study|Withdrawal by Subject|9|||
13202154|NCT01994954|26220789|FG001|Overall Study|Withdrawal by Subject|14|||
13202155|NCT01994954|26220788|FG000|Overall Study|Physician Decision|2|||
13202156|NCT01994954|26220789|FG001|Overall Study|Physician Decision|2|||
13202157|NCT01994954|26220788|FG000|Overall Study|Lost to Follow-up|8|||
13202158|NCT01994954|26220789|FG001|Overall Study|Lost to Follow-up|10|||
13202159|NCT01994954|26220788|FG000|Overall Study|6 Month Follow-up Not Complete|5|||
13202160|NCT01994954|26220789|FG001|Overall Study|6 Month Follow-up Not Complete|4|||
13202161|NCT01994902|26220798|FG000|Test Period 1|Withdrawal by Subject|3|||
13202162|NCT01994902|26220799|FG001|Test Period 1|Withdrawal by Subject|0|||
13202163|NCT01994902|26220798|FG000|Test Period 1|device deficiency with adverse event|0|||
13202164|NCT01994902|26220799|FG001|Test Period 1|device deficiency with adverse event|1|||
13202165|NCT01994902|26220798|FG000|Test Period 1|Adverse Event|2|||
13202166|NCT01994902|26220799|FG001|Test Period 1|Adverse Event|1|||
13113143|NCT03139279|25910960|FG001|Overall Study|Withdrawal by Subject|2|||
13113144|NCT03139240|25910983|FG000|Overall Study|Lost to Follow-up|0|||
13113145|NCT03139240|25910984|FG001|Overall Study|Lost to Follow-up|1|||
13202167|NCT01994902|26220798|FG000|Test Period 1|Lack of Efficacy|0|||
13202168|NCT01994902|26220799|FG001|Test Period 1|Lack of Efficacy|1|||
13202169|NCT01994902|26220798|FG000|Test Period 1|bag too small|1|||
13202170|NCT01994902|26220799|FG001|Test Period 1|bag too small|0|||
13202171|NCT01994902|26220798|FG000|Test Period 2|Withdrawal by Subject|0|||
13202172|NCT01994902|26220799|FG001|Test Period 2|Withdrawal by Subject|2|||
13202173|NCT01994902|26220798|FG000|Test Period 2|Lack of Efficacy|0|||
13202174|NCT01994902|26220799|FG001|Test Period 2|Lack of Efficacy|1|||
13202175|NCT01994902|26220798|FG000|Test Period 2|Other|0|||
13202176|NCT01994902|26220799|FG001|Test Period 2|Other|3|||
13202177|NCT01994889|26220828|FG000|Overall Study|Adverse Event|5|||
13202178|NCT01994889|26220829|FG001|Overall Study|Adverse Event|12|||
13202179|NCT01994889|26220830|FG002|Overall Study|Adverse Event|11|||
13202180|NCT01994889|26220828|FG000|Overall Study|Cardiac Device Implantation|0|||
13202181|NCT01994889|26220829|FG001|Overall Study|Cardiac Device Implantation|2|||
13202182|NCT01994889|26220830|FG002|Overall Study|Cardiac Device Implantation|0|||
13202183|NCT01994889|26220828|FG000|Overall Study|Organ Transplantation|1|||
13202184|NCT01994889|26220829|FG001|Overall Study|Organ Transplantation|5|||
13202185|NCT01994889|26220830|FG002|Overall Study|Organ Transplantation|5|||
13202186|NCT01994889|26220828|FG000|Overall Study|No longer willing to participate|8|||
13202187|NCT01994889|26220829|FG001|Overall Study|No longer willing to participate|17|||
13202188|NCT01994889|26220830|FG002|Overall Study|No longer willing to participate|37|||
13113146|NCT03139240|25910985|FG002|Overall Study|Lost to Follow-up|1|||
13113147|NCT03139240|25910986|FG003|Overall Study|Lost to Follow-up|0|||
13113148|NCT03138967|25911003|FG000|Overall Study|Death|0|||
13113149|NCT03138967|25911004|FG001|Overall Study|Death|1|||
13113150|NCT03138967|25911003|FG000|Overall Study|Physician Decision|1|||
13113151|NCT03138967|25911004|FG001|Overall Study|Physician Decision|3|||
13113152|NCT03138655|25911069|FG000|Overall Study|Adverse Event|2|||
13113153|NCT03138655|25911070|FG001|Overall Study|Adverse Event|1|||
13113154|NCT03138655|25911071|FG002|Overall Study|Adverse Event|2|||
13113155|NCT03138655|25911072|FG003|Overall Study|Adverse Event|1|||
13202189|NCT01994889|26220828|FG000|Overall Study|Lost to Follow-up|0|||
13202190|NCT01994889|26220829|FG001|Overall Study|Lost to Follow-up|1|||
13202191|NCT01994889|26220830|FG002|Overall Study|Lost to Follow-up|0|||
13113156|NCT03138655|25911073|FG004|Overall Study|Adverse Event|1|||
13113157|NCT03138655|25911074|FG005|Overall Study|Adverse Event|4|||
13113158|NCT03138655|25911075|FG006|Overall Study|Adverse Event|2|||
13113159|NCT03138655|25911076|FG007|Overall Study|Adverse Event|2|||
13113160|NCT03138655|25911069|FG000|Overall Study|Withdrawal by Subject|0|||
13113161|NCT03138655|25911070|FG001|Overall Study|Withdrawal by Subject|1|||
13113162|NCT03138655|25911071|FG002|Overall Study|Withdrawal by Subject|0|||
13113163|NCT03138655|25911072|FG003|Overall Study|Withdrawal by Subject|0|||
13113164|NCT03138655|25911073|FG004|Overall Study|Withdrawal by Subject|0|||
13113165|NCT03138655|25911074|FG005|Overall Study|Withdrawal by Subject|0|||
13113166|NCT03138655|25911075|FG006|Overall Study|Withdrawal by Subject|1|||
13113167|NCT03138655|25911076|FG007|Overall Study|Withdrawal by Subject|0|||
13113168|NCT03138655|25911069|FG000|Overall Study|Reason not Specified|1|||
13113169|NCT03138655|25911070|FG001|Overall Study|Reason not Specified|0|||
13113170|NCT03138655|25911071|FG002|Overall Study|Reason not Specified|0|||
13113171|NCT03138655|25911072|FG003|Overall Study|Reason not Specified|2|||
13113172|NCT03138655|25911073|FG004|Overall Study|Reason not Specified|1|||
13113173|NCT03138655|25911074|FG005|Overall Study|Reason not Specified|1|||
13113174|NCT03138655|25911075|FG006|Overall Study|Reason not Specified|0|||
13113175|NCT03138655|25911076|FG007|Overall Study|Reason not Specified|0|||
13113176|NCT03137992|25911093|FG000|Washout Period 1|Adverse Event|1|||
13113177|NCT03137992|25911094|FG001|Washout Period 1|Adverse Event|1|||
13113178|NCT03137992|25911095|FG002|Washout Period 1|Adverse Event|0|||
13113179|NCT03137992|25911096|FG003|Washout Period 1|Adverse Event|0|||
13202192|NCT01994889|26220828|FG000|Overall Study|Protocol Violation|0|||
13202193|NCT01994889|26220829|FG001|Overall Study|Protocol Violation|1|||
13202194|NCT01994889|26220830|FG002|Overall Study|Protocol Violation|1|||
13202195|NCT01994889|26220828|FG000|Overall Study|Death|14|||
13202196|NCT01994889|26220829|FG001|Overall Study|Death|25|||
13113180|NCT03137992|25911097|FG004|Washout Period 1|Adverse Event|0|||
13113181|NCT03137992|25911098|FG005|Washout Period 1|Adverse Event|1|||
13113182|NCT03137992|25911093|FG000|Washout Period 1|Withdrawal by Subject|0|||
13113183|NCT03137992|25911094|FG001|Washout Period 1|Withdrawal by Subject|1|||
13113184|NCT03137992|25911095|FG002|Washout Period 1|Withdrawal by Subject|1|||
13113185|NCT03137992|25911096|FG003|Washout Period 1|Withdrawal by Subject|0|||
13113186|NCT03137992|25911097|FG004|Washout Period 1|Withdrawal by Subject|0|||
13113187|NCT03137992|25911098|FG005|Washout Period 1|Withdrawal by Subject|0|||
13113188|NCT03137992|25911093|FG000|Washout Period 1|Principal Investigator Discretion|0|||
13113189|NCT03137992|25911094|FG001|Washout Period 1|Principal Investigator Discretion|1|||
13113190|NCT03137992|25911095|FG002|Washout Period 1|Principal Investigator Discretion|0|||
13202197|NCT01994889|26220830|FG002|Overall Study|Death|38|||
13202198|NCT01994876|26220841|FG000|Test Period 1|Withdrawal by Subject|0|||
13202199|NCT01994876|26220842|FG001|Test Period 1|Withdrawal by Subject|1|||
13202200|NCT01994876|26220841|FG000|Test Period 1|Adverse Event|0|||
13202201|NCT01994876|26220842|FG001|Test Period 1|Adverse Event|1|||
13202202|NCT01994876|26220841|FG000|Test Period 2|Adverse Event|1|||
13202203|NCT01994876|26220842|FG001|Test Period 2|Adverse Event|0|||
13202204|NCT01994876|26220841|FG000|Test Period 2|Protocol Violation|0|||
13202205|NCT01994876|26220842|FG001|Test Period 2|Protocol Violation|1|||
13202206|NCT01994863|26220851|FG000|Period 1|Adverse Event|4|||
13202207|NCT01994863|26220852|FG001|Period 1|Adverse Event|0|||
13202208|NCT01994863|26220851|FG000|Period 1|Withdrawal by Subject|1|||
13202209|NCT01994863|26220852|FG001|Period 1|Withdrawal by Subject|0|||
13202210|NCT01994863|26220851|FG000|Period 1|Trial stopped by sponsor|1|||
13202211|NCT01994863|26220852|FG001|Period 1|Trial stopped by sponsor|3|||
13202212|NCT01994863|26220851|FG000|Period 1|Lack of Efficacy|1|||
13202213|NCT01994863|26220852|FG001|Period 1|Lack of Efficacy|0|||
13202214|NCT01994863|26220851|FG000|Period 2|Adverse Event|0|||
13202215|NCT01994863|26220852|FG001|Period 2|Adverse Event|1|||
13202216|NCT01994863|26220851|FG000|Period 2|Lack of Efficacy|0|||
13202217|NCT01994863|26220852|FG001|Period 2|Lack of Efficacy|2|||
13202218|NCT01994863|26220851|FG000|Period 2|Withdrawal by Subject|1|||
13202219|NCT01994863|26220852|FG001|Period 2|Withdrawal by Subject|1|||
13202220|NCT01994850|26220859|FG000|Overall Study|Physician Decision|1|||
13202221|NCT01994850|26220859|FG000|Overall Study|Withdrawal by Subject|1|||
13202222|NCT01994837|26220874|FG000|Overall Study|Progressive disease per protocol|23|||
13202223|NCT01994837|26220874|FG000|Overall Study|Adv event related to progressive disease|3|||
13202224|NCT01994837|26220874|FG000|Overall Study|Fatal progressive disease|2|||
13202225|NCT01994837|26220874|FG000|Overall Study|Adverse event not related to progression|1|||
13202226|NCT01994837|26220874|FG000|Overall Study|Chose palliative care|1|||
13202227|NCT01994837|26220874|FG000|Overall Study|Proceeded to transplant|1|||
13202228|NCT01994837|26220874|FG000|Overall Study|Removed from study due to no response|1|||
13202229|NCT01994720|26220921|FG000|Overall Study|Withdrawal by Subject|46|||
13202230|NCT01994720|26220922|FG001|Overall Study|Withdrawal by Subject|56|||
13202231|NCT01994629|26220953|FG000|Overall Study|Withdrawal by Subject|1|||
13113191|NCT03137992|25911096|FG003|Washout Period 1|Principal Investigator Discretion|0|||
13113192|NCT03137992|25911097|FG004|Washout Period 1|Principal Investigator Discretion|0|||
13202232|NCT01994629|26220954|FG001|Overall Study|Withdrawal by Subject|0|||
13202233|NCT01994629|26220953|FG000|Overall Study|Lost to Follow-up|0|||
13202234|NCT01994629|26220954|FG001|Overall Study|Lost to Follow-up|3|||
13202235|NCT01994590|26220960|FG000|Overall Study|Adverse Event|1|||
13202236|NCT01994590|26220960|FG000|Overall Study|Trial Terminated|1|||
13202237|NCT01994395|26220989|FG000|Overall Study|Withdrawal by Subject|1|||
13202238|NCT01994395|26220990|FG001|Overall Study|Withdrawal by Subject|2|||
13202239|NCT01994382|26221146|FG000|Overall Study|Informed consent withdrawn|0|||
13202240|NCT01994382|26221147|FG001|Overall Study|Informed consent withdrawn|0|||
13202241|NCT01994382|26221148|FG002|Overall Study|Informed consent withdrawn|0|||
13202242|NCT01994382|26221149|FG003|Overall Study|Informed consent withdrawn|0|||
13202243|NCT01994382|26221150|FG004|Overall Study|Informed consent withdrawn|0|||
13202244|NCT01994382|26221151|FG005|Overall Study|Informed consent withdrawn|0|||
13202245|NCT01994382|26221152|FG006|Overall Study|Informed consent withdrawn|1|||
13202246|NCT01994382|26221153|FG007|Overall Study|Informed consent withdrawn|0|||
13202247|NCT01994382|26221154|FG008|Overall Study|Informed consent withdrawn|0|||
13202248|NCT01994382|26221155|FG009|Overall Study|Informed consent withdrawn|0|||
13202249|NCT01994382|26221156|FG010|Overall Study|Informed consent withdrawn|0|||
13202250|NCT01994382|26221157|FG011|Overall Study|Informed consent withdrawn|0|||
13202251|NCT01994382|26221158|FG012|Overall Study|Informed consent withdrawn|0|||
13202252|NCT01994382|26221159|FG013|Overall Study|Informed consent withdrawn|0|||
13202253|NCT01994382|26221160|FG014|Overall Study|Informed consent withdrawn|0|||
13202254|NCT01994382|26221161|FG015|Overall Study|Informed consent withdrawn|0|||
13202255|NCT01994382|26221162|FG016|Overall Study|Informed consent withdrawn|0|||
13202256|NCT01994382|26221146|FG000|Overall Study|Progressive disease|3|||
13202257|NCT01994382|26221147|FG001|Overall Study|Progressive disease|4|||
13202258|NCT01994382|26221148|FG002|Overall Study|Progressive disease|4|||
13202259|NCT01994382|26221149|FG003|Overall Study|Progressive disease|3|||
13202260|NCT01994382|26221150|FG004|Overall Study|Progressive disease|2|||
13202261|NCT01994382|26221151|FG005|Overall Study|Progressive disease|3|||
13202262|NCT01994382|26221152|FG006|Overall Study|Progressive disease|3|||
13202263|NCT01994382|26221153|FG007|Overall Study|Progressive disease|6|||
13202264|NCT01994382|26221154|FG008|Overall Study|Progressive disease|2|||
13202265|NCT01994382|26221155|FG009|Overall Study|Progressive disease|2|||
13202266|NCT01994382|26221156|FG010|Overall Study|Progressive disease|13|||
13202267|NCT01994382|26221157|FG011|Overall Study|Progressive disease|8|||
13202268|NCT01994382|26221158|FG012|Overall Study|Progressive disease|7|||
13202269|NCT01994382|26221159|FG013|Overall Study|Progressive disease|3|||
13202270|NCT01994382|26221160|FG014|Overall Study|Progressive disease|6|||
13202271|NCT01994382|26221161|FG015|Overall Study|Progressive disease|44|||
13202272|NCT01994382|26221162|FG016|Overall Study|Progressive disease|28|||
13202273|NCT01994382|26221146|FG000|Overall Study|Physician Decision|0|||
13113193|NCT03137992|25911098|FG005|Washout Period 1|Principal Investigator Discretion|0|||
13113194|NCT03137992|25911093|FG000|Washout Period 1|COPD Exacerbation|1|||
13113195|NCT03137992|25911094|FG001|Washout Period 1|COPD Exacerbation|1|||
13113196|NCT03137992|25911095|FG002|Washout Period 1|COPD Exacerbation|1|||
13113197|NCT03137992|25911096|FG003|Washout Period 1|COPD Exacerbation|0|||
13113198|NCT03137992|25911097|FG004|Washout Period 1|COPD Exacerbation|1|||
13113199|NCT03137992|25911098|FG005|Washout Period 1|COPD Exacerbation|1|||
13113200|NCT03137992|25911093|FG000|Washout Period 1|Subject Noncompliance|1|||
13113201|NCT03137992|25911094|FG001|Washout Period 1|Subject Noncompliance|0|||
13113202|NCT03137992|25911095|FG002|Washout Period 1|Subject Noncompliance|0|||
13113203|NCT03137992|25911096|FG003|Washout Period 1|Subject Noncompliance|0|||
13113204|NCT03137992|25911097|FG004|Washout Period 1|Subject Noncompliance|1|||
13113205|NCT03137992|25911098|FG005|Washout Period 1|Subject Noncompliance|0|||
13113206|NCT03137992|25911093|FG000|Period 2 (Visit 3)|COPD Exacerbation|1|||
13113207|NCT03137992|25911094|FG001|Period 2 (Visit 3)|COPD Exacerbation|1|||
13113208|NCT03137992|25911095|FG002|Period 2 (Visit 3)|COPD Exacerbation|0|||
13113209|NCT03137992|25911096|FG003|Period 2 (Visit 3)|COPD Exacerbation|0|||
13113210|NCT03137992|25911097|FG004|Period 2 (Visit 3)|COPD Exacerbation|0|||
13113211|NCT03137992|25911098|FG005|Period 2 (Visit 3)|COPD Exacerbation|1|||
13113212|NCT03137992|25911093|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2|||
13113213|NCT03137992|25911094|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
13113214|NCT03137992|25911095|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
13113215|NCT03137992|25911096|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4|||
13113216|NCT03137992|25911097|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
13113217|NCT03137992|25911098|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7|||
13113218|NCT03137992|25911093|FG000|Period 2 (Visit 3)|Adverse Event|0|||
13113219|NCT03137992|25911094|FG001|Period 2 (Visit 3)|Adverse Event|1|||
13113220|NCT03137992|25911095|FG002|Period 2 (Visit 3)|Adverse Event|0|||
13113221|NCT03137992|25911096|FG003|Period 2 (Visit 3)|Adverse Event|0|||
13113222|NCT03137992|25911097|FG004|Period 2 (Visit 3)|Adverse Event|0|||
13113223|NCT03137992|25911098|FG005|Period 2 (Visit 3)|Adverse Event|0|||
13113224|NCT03137992|25911093|FG000|Period 2 (Visit 3)|Lost to Follow-up|0|||
13113225|NCT03137992|25911094|FG001|Period 2 (Visit 3)|Lost to Follow-up|0|||
13113226|NCT03137992|25911095|FG002|Period 2 (Visit 3)|Lost to Follow-up|0|||
13113227|NCT03137992|25911096|FG003|Period 2 (Visit 3)|Lost to Follow-up|1|||
13113228|NCT03137992|25911097|FG004|Period 2 (Visit 3)|Lost to Follow-up|0|||
13113229|NCT03137992|25911098|FG005|Period 2 (Visit 3)|Lost to Follow-up|0|||
13113230|NCT03137992|25911093|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0|||
13113231|NCT03137992|25911094|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2|||
13113232|NCT03137992|25911095|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0|||
13113233|NCT03137992|25911096|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0|||
13113234|NCT03137992|25911097|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1|||
13113235|NCT03137992|25911098|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0|||
13113236|NCT03137992|25911093|FG000|Washout Period 2|COPD Exacerbation|1|||
13113237|NCT03137992|25911094|FG001|Washout Period 2|COPD Exacerbation|1|||
13113238|NCT03137992|25911095|FG002|Washout Period 2|COPD Exacerbation|0|||
13113239|NCT03137992|25911096|FG003|Washout Period 2|COPD Exacerbation|0|||
13113240|NCT03137992|25911097|FG004|Washout Period 2|COPD Exacerbation|1|||
13202274|NCT01994382|26221147|FG001|Overall Study|Physician Decision|1|||
13202275|NCT01994382|26221148|FG002|Overall Study|Physician Decision|0|||
13202276|NCT01994382|26221149|FG003|Overall Study|Physician Decision|0|||
13202277|NCT01994382|26221150|FG004|Overall Study|Physician Decision|0|||
13202278|NCT01994382|26221151|FG005|Overall Study|Physician Decision|0|||
13202279|NCT01994382|26221152|FG006|Overall Study|Physician Decision|0|||
13202280|NCT01994382|26221153|FG007|Overall Study|Physician Decision|0|||
13202281|NCT01994382|26221154|FG008|Overall Study|Physician Decision|0|||
13202282|NCT01994382|26221155|FG009|Overall Study|Physician Decision|0|||
13202283|NCT01994382|26221156|FG010|Overall Study|Physician Decision|3|||
13202284|NCT01994382|26221157|FG011|Overall Study|Physician Decision|1|||
13202285|NCT01994382|26221158|FG012|Overall Study|Physician Decision|1|||
13202286|NCT01994382|26221159|FG013|Overall Study|Physician Decision|0|||
13202287|NCT01994382|26221160|FG014|Overall Study|Physician Decision|1|||
13202288|NCT01994382|26221161|FG015|Overall Study|Physician Decision|4|||
13202289|NCT01994382|26221162|FG016|Overall Study|Physician Decision|2|||
13202290|NCT01994382|26221146|FG000|Overall Study|Death|0|||
13202291|NCT01994382|26221147|FG001|Overall Study|Death|0|||
13202292|NCT01994382|26221148|FG002|Overall Study|Death|0|||
13202293|NCT01994382|26221149|FG003|Overall Study|Death|0|||
13202294|NCT01994382|26221150|FG004|Overall Study|Death|1|||
13202295|NCT01994382|26221151|FG005|Overall Study|Death|0|||
13202296|NCT01994382|26221152|FG006|Overall Study|Death|0|||
13202297|NCT01994382|26221153|FG007|Overall Study|Death|0|||
13202298|NCT01994382|26221154|FG008|Overall Study|Death|1|||
13202299|NCT01994382|26221155|FG009|Overall Study|Death|1|||
13202300|NCT01994382|26221156|FG010|Overall Study|Death|0|||
13202301|NCT01994382|26221157|FG011|Overall Study|Death|0|||
13202302|NCT01994382|26221158|FG012|Overall Study|Death|0|||
13202303|NCT01994382|26221159|FG013|Overall Study|Death|0|||
13202304|NCT01994382|26221160|FG014|Overall Study|Death|0|||
13202305|NCT01994382|26221161|FG015|Overall Study|Death|1|||
13202306|NCT01994382|26221162|FG016|Overall Study|Death|0|||
13202307|NCT01994382|26221146|FG000|Overall Study|Adverse Event|0|||
13202308|NCT01994382|26221147|FG001|Overall Study|Adverse Event|1|||
13202309|NCT01994382|26221148|FG002|Overall Study|Adverse Event|2|||
13202310|NCT01994382|26221149|FG003|Overall Study|Adverse Event|0|||
13202311|NCT01994382|26221150|FG004|Overall Study|Adverse Event|0|||
13202312|NCT01994382|26221151|FG005|Overall Study|Adverse Event|0|||
13202313|NCT01994382|26221152|FG006|Overall Study|Adverse Event|0|||
13202314|NCT01994382|26221153|FG007|Overall Study|Adverse Event|0|||
13202315|NCT01994382|26221154|FG008|Overall Study|Adverse Event|0|||
13202316|NCT01994382|26221155|FG009|Overall Study|Adverse Event|0|||
13202317|NCT01994382|26221156|FG010|Overall Study|Adverse Event|15|||
13202318|NCT01994382|26221157|FG011|Overall Study|Adverse Event|2|||
13202319|NCT01994382|26221158|FG012|Overall Study|Adverse Event|7|||
13202320|NCT01994382|26221159|FG013|Overall Study|Adverse Event|3|||
13202321|NCT01994382|26221160|FG014|Overall Study|Adverse Event|17|||
13202322|NCT01994382|26221161|FG015|Overall Study|Adverse Event|6|||
13202323|NCT01994382|26221162|FG016|Overall Study|Adverse Event|3|||
13202324|NCT01994382|26221146|FG000|Overall Study|Other than specified|0|||
13202325|NCT01994382|26221147|FG001|Overall Study|Other than specified|0|||
13202326|NCT01994382|26221148|FG002|Overall Study|Other than specified|0|||
13202327|NCT01994382|26221149|FG003|Overall Study|Other than specified|0|||
13202328|NCT01994382|26221150|FG004|Overall Study|Other than specified|0|||
13202329|NCT01994382|26221151|FG005|Overall Study|Other than specified|0|||
13202330|NCT01994382|26221152|FG006|Overall Study|Other than specified|0|||
13202331|NCT01994382|26221153|FG007|Overall Study|Other than specified|0|||
13202332|NCT01994382|26221154|FG008|Overall Study|Other than specified|0|||
13202333|NCT01994382|26221155|FG009|Overall Study|Other than specified|0|||
13113241|NCT03137992|25911098|FG005|Washout Period 2|COPD Exacerbation|0|||
13202334|NCT01994382|26221156|FG010|Overall Study|Other than specified|2|||
13202335|NCT01994382|26221157|FG011|Overall Study|Other than specified|0|||
13202336|NCT01994382|26221158|FG012|Overall Study|Other than specified|2|||
13202337|NCT01994382|26221159|FG013|Overall Study|Other than specified|0|||
13202338|NCT01994382|26221160|FG014|Overall Study|Other than specified|0|||
13202339|NCT01994382|26221161|FG015|Overall Study|Other than specified|4|||
13202340|NCT01994382|26221162|FG016|Overall Study|Other than specified|4|||
13202341|NCT01994382|26221146|FG000|Overall Study|Withdrawal by Subject|0|||
13202342|NCT01994382|26221147|FG001|Overall Study|Withdrawal by Subject|0|||
13202343|NCT01994382|26221148|FG002|Overall Study|Withdrawal by Subject|0|||
13202344|NCT01994382|26221149|FG003|Overall Study|Withdrawal by Subject|0|||
13202345|NCT01994382|26221150|FG004|Overall Study|Withdrawal by Subject|0|||
13202346|NCT01994382|26221151|FG005|Overall Study|Withdrawal by Subject|0|||
13202347|NCT01994382|26221152|FG006|Overall Study|Withdrawal by Subject|0|||
13202348|NCT01994382|26221153|FG007|Overall Study|Withdrawal by Subject|0|||
13202349|NCT01994382|26221154|FG008|Overall Study|Withdrawal by Subject|0|||
13202350|NCT01994382|26221155|FG009|Overall Study|Withdrawal by Subject|0|||
13202351|NCT01994382|26221156|FG010|Overall Study|Withdrawal by Subject|6|||
13202352|NCT01994382|26221157|FG011|Overall Study|Withdrawal by Subject|0|||
13202353|NCT01994382|26221158|FG012|Overall Study|Withdrawal by Subject|2|||
13202354|NCT01994382|26221159|FG013|Overall Study|Withdrawal by Subject|0|||
13202355|NCT01994382|26221160|FG014|Overall Study|Withdrawal by Subject|4|||
13202356|NCT01994382|26221161|FG015|Overall Study|Withdrawal by Subject|3|||
13202357|NCT01994382|26221162|FG016|Overall Study|Withdrawal by Subject|0|||
13202358|NCT01994382|26221146|FG000|Overall Study|Lost to Follow-up|0|||
13202359|NCT01994382|26221147|FG001|Overall Study|Lost to Follow-up|0|||
13202360|NCT01994382|26221148|FG002|Overall Study|Lost to Follow-up|0|||
13202361|NCT01994382|26221149|FG003|Overall Study|Lost to Follow-up|0|||
13202362|NCT01994382|26221150|FG004|Overall Study|Lost to Follow-up|0|||
13202363|NCT01994382|26221151|FG005|Overall Study|Lost to Follow-up|0|||
13202364|NCT01994382|26221152|FG006|Overall Study|Lost to Follow-up|0|||
13202365|NCT01994382|26221153|FG007|Overall Study|Lost to Follow-up|0|||
13202366|NCT01994382|26221154|FG008|Overall Study|Lost to Follow-up|0|||
13202367|NCT01994382|26221155|FG009|Overall Study|Lost to Follow-up|0|||
13202368|NCT01994382|26221156|FG010|Overall Study|Lost to Follow-up|1|||
13202369|NCT01994382|26221157|FG011|Overall Study|Lost to Follow-up|0|||
13202370|NCT01994382|26221158|FG012|Overall Study|Lost to Follow-up|0|||
13202371|NCT01994382|26221159|FG013|Overall Study|Lost to Follow-up|0|||
13202372|NCT01994382|26221160|FG014|Overall Study|Lost to Follow-up|0|||
13113242|NCT03137992|25911093|FG000|Washout Period 2|Subject Non-compliance|0|||
13113243|NCT03137992|25911094|FG001|Washout Period 2|Subject Non-compliance|1|||
13113244|NCT03137992|25911095|FG002|Washout Period 2|Subject Non-compliance|0|||
13113245|NCT03137992|25911096|FG003|Washout Period 2|Subject Non-compliance|0|||
13113246|NCT03137992|25911097|FG004|Washout Period 2|Subject Non-compliance|0|||
13113247|NCT03137992|25911098|FG005|Washout Period 2|Subject Non-compliance|0|||
13113248|NCT03137992|25911093|FG000|Washout Period 2|Adverse Event|0|||
13202373|NCT01994382|26221161|FG015|Overall Study|Lost to Follow-up|0|||
13202374|NCT01994382|26221162|FG016|Overall Study|Lost to Follow-up|0|||
13202375|NCT01994382|26221146|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
13202376|NCT01994382|26221147|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
13202377|NCT01994382|26221148|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
13202378|NCT01994382|26221149|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
13202379|NCT01994382|26221150|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
13202380|NCT01994382|26221151|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
13202381|NCT01994382|26221152|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
13202382|NCT01994382|26221153|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
13202383|NCT01994382|26221154|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
13202384|NCT01994382|26221155|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
13202385|NCT01994382|26221156|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
13202386|NCT01994382|26221157|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
13202387|NCT01994382|26221158|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7|||
13202388|NCT01994382|26221159|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
13202389|NCT01994382|26221160|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
13202390|NCT01994382|26221161|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3|||
13202391|NCT01994382|26221162|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
13202392|NCT01994382|26221146|FG000|Overall Study|Protocol violation/noncompliance|0|||
13202393|NCT01994382|26221147|FG001|Overall Study|Protocol violation/noncompliance|0|||
13202394|NCT01994382|26221148|FG002|Overall Study|Protocol violation/noncompliance|0|||
13202395|NCT01994382|26221149|FG003|Overall Study|Protocol violation/noncompliance|0|||
13202396|NCT01994382|26221150|FG004|Overall Study|Protocol violation/noncompliance|0|||
13202397|NCT01994382|26221151|FG005|Overall Study|Protocol violation/noncompliance|0|||
13202398|NCT01994382|26221152|FG006|Overall Study|Protocol violation/noncompliance|0|||
13223227|NCT01799590|26288091|FG000|Overall Study|Lack of Efficacy|3|||
13113249|NCT03137992|25911094|FG001|Washout Period 2|Adverse Event|0|||
13113250|NCT03137992|25911095|FG002|Washout Period 2|Adverse Event|0|||
13202399|NCT01994382|26221153|FG007|Overall Study|Protocol violation/noncompliance|0|||
13202400|NCT01994382|26221154|FG008|Overall Study|Protocol violation/noncompliance|0|||
13202401|NCT01994382|26221155|FG009|Overall Study|Protocol violation/noncompliance|0|||
13202402|NCT01994382|26221156|FG010|Overall Study|Protocol violation/noncompliance|0|||
13202403|NCT01994382|26221157|FG011|Overall Study|Protocol violation/noncompliance|1|||
13202404|NCT01994382|26221158|FG012|Overall Study|Protocol violation/noncompliance|0|||
13202405|NCT01994382|26221159|FG013|Overall Study|Protocol violation/noncompliance|0|||
13202406|NCT01994382|26221160|FG014|Overall Study|Protocol violation/noncompliance|0|||
13202407|NCT01994382|26221161|FG015|Overall Study|Protocol violation/noncompliance|0|||
13202408|NCT01994382|26221162|FG016|Overall Study|Protocol violation/noncompliance|2|||
13202409|NCT01994382|26221146|FG000|Overall Study|Rolled over to Phase 2a|0|||
13202410|NCT01994382|26221147|FG001|Overall Study|Rolled over to Phase 2a|0|||
13202411|NCT01994382|26221148|FG002|Overall Study|Rolled over to Phase 2a|1|||
13202412|NCT01994382|26221149|FG003|Overall Study|Rolled over to Phase 2a|0|||
13202413|NCT01994382|26221150|FG004|Overall Study|Rolled over to Phase 2a|0|||
13202414|NCT01994382|26221151|FG005|Overall Study|Rolled over to Phase 2a|0|||
13202415|NCT01994382|26221152|FG006|Overall Study|Rolled over to Phase 2a|0|||
13202416|NCT01994382|26221153|FG007|Overall Study|Rolled over to Phase 2a|0|||
13202417|NCT01994382|26221154|FG008|Overall Study|Rolled over to Phase 2a|0|||
13202418|NCT01994382|26221155|FG009|Overall Study|Rolled over to Phase 2a|2|||
13202419|NCT01994382|26221156|FG010|Overall Study|Rolled over to Phase 2a|0|||
13202420|NCT01994382|26221157|FG011|Overall Study|Rolled over to Phase 2a|0|||
13202421|NCT01994382|26221158|FG012|Overall Study|Rolled over to Phase 2a|0|||
13202422|NCT01994382|26221159|FG013|Overall Study|Rolled over to Phase 2a|0|||
13202423|NCT01994382|26221160|FG014|Overall Study|Rolled over to Phase 2a|0|||
13202424|NCT01994382|26221161|FG015|Overall Study|Rolled over to Phase 2a|0|||
13202425|NCT01994382|26221162|FG016|Overall Study|Rolled over to Phase 2a|0|||
13202426|NCT01994291|26221226|FG000|Overall Study|Adverse Event|4|||
13202427|NCT01994291|26221227|FG001|Overall Study|Adverse Event|1|||
13202428|NCT01994291|26221228|FG002|Overall Study|Adverse Event|3|||
13202429|NCT01994291|26221226|FG000|Overall Study|Lost to Follow-up|1|||
13202430|NCT01994291|26221227|FG001|Overall Study|Lost to Follow-up|1|||
13202431|NCT01994291|26221228|FG002|Overall Study|Lost to Follow-up|0|||
13202432|NCT01994291|26221226|FG000|Overall Study|Does not meet entrance criteria|1|||
13202433|NCT01994291|26221227|FG001|Overall Study|Does not meet entrance criteria|0|||
13202434|NCT01994291|26221228|FG002|Overall Study|Does not meet entrance criteria|0|||
13202435|NCT01994291|26221226|FG000|Overall Study|Medication error without associated AE|1|||
13202436|NCT01994291|26221227|FG001|Overall Study|Medication error without associated AE|0|||
13202437|NCT01994291|26221228|FG002|Overall Study|Medication error without associated AE|1|||
13202438|NCT01994291|26221226|FG000|Overall Study|Protocol Violation|1|||
13202439|NCT01994291|26221227|FG001|Overall Study|Protocol Violation|0|||
13202440|NCT01994291|26221228|FG002|Overall Study|Protocol Violation|0|||
13202441|NCT01994291|26221226|FG000|Overall Study|Withdrawal by Subject|6|||
13202442|NCT01994291|26221227|FG001|Overall Study|Withdrawal by Subject|3|||
13202443|NCT01994291|26221228|FG002|Overall Study|Withdrawal by Subject|5|||
13202444|NCT01994291|26221226|FG000|Overall Study|Other|1|||
13202445|NCT01994291|26221227|FG001|Overall Study|Other|2|||
13202446|NCT01994291|26221228|FG002|Overall Study|Other|0|||
13202447|NCT01994226|26221241|FG000|Overall Study|Protocol Violation|13|||
13202448|NCT01994226|26221242|FG001|Overall Study|Protocol Violation|10|||
13202449|NCT01994226|26221241|FG000|Overall Study|Early Cessation of treatment|6|||
13202450|NCT01994226|26221242|FG001|Overall Study|Early Cessation of treatment|11|||
13202451|NCT01993940|26221263|FG000|Overall Study|Adverse Event|16|||
13202452|NCT01993940|26221264|FG001|Overall Study|Adverse Event|11|||
13202453|NCT01993940|26221263|FG000|Overall Study|Withdrawal by Subject|15|||
13202454|NCT01993940|26221264|FG001|Overall Study|Withdrawal by Subject|19|||
13202455|NCT01993940|26221263|FG000|Overall Study|Lost to Follow-up|2|||
13202456|NCT01993940|26221264|FG001|Overall Study|Lost to Follow-up|5|||
13202457|NCT01993940|26221263|FG000|Overall Study|Protocol Violation|5|||
13202458|NCT01993940|26221264|FG001|Overall Study|Protocol Violation|8|||
13202459|NCT01993940|26221263|FG000|Overall Study|Death|1|||
13202460|NCT01993940|26221264|FG001|Overall Study|Death|0|||
13202461|NCT01993940|26221263|FG000|Overall Study|Other - Miscellaneous|1|||
13202462|NCT01993940|26221264|FG001|Overall Study|Other - Miscellaneous|1|||
13202463|NCT01993927|26221272|FG000|Overall Study|Case Report Forms Uncollected|18|||
13202464|NCT01993927|26221272|FG000|Overall Study|Protocol Violation|11|||
13202465|NCT01993888|26221295|FG000|Overall Study|Death|1|||
13202466|NCT01993888|26221296|FG001|Overall Study|Death|1|||
13202467|NCT01993888|26221295|FG000|Overall Study|Lost to Follow-up|1|||
13202468|NCT01993888|26221296|FG001|Overall Study|Lost to Follow-up|1|||
13202469|NCT01993888|26221295|FG000|Overall Study|Withdrawal by Subject|0|||
13202470|NCT01993888|26221296|FG001|Overall Study|Withdrawal by Subject|1|||
13202471|NCT01993836|26221320|FG000|Overall Study|Surgery Cancelled|3|||
13202472|NCT01993836|26221321|FG001|Overall Study|Surgery Cancelled|0|||
13202473|NCT01993836|26221322|FG002|Overall Study|Surgery Cancelled|0|||
13202474|NCT01993836|26221320|FG000|Overall Study|Physician Decision|2|||
13202475|NCT01993836|26221321|FG001|Overall Study|Physician Decision|1|||
13202476|NCT01993836|26221322|FG002|Overall Study|Physician Decision|0|||
13202477|NCT01993836|26221320|FG000|Overall Study|Death|0|||
13202478|NCT01993836|26221321|FG001|Overall Study|Death|2|||
13202479|NCT01993836|26221322|FG002|Overall Study|Death|0|||
13202480|NCT01993836|26221320|FG000|Overall Study|Withdrawal by Subject|12|||
13202481|NCT01993836|26221321|FG001|Overall Study|Withdrawal by Subject|10|||
13202482|NCT01993836|26221322|FG002|Overall Study|Withdrawal by Subject|5|||
13202483|NCT01993823|26221337|FG000|Overall Study|Requested by the patient|6|||
13202484|NCT01993823|26221338|FG001|Overall Study|Requested by the patient|11|||
13202485|NCT01993823|26221337|FG000|Overall Study|Protocol Violation|0|||
13202486|NCT01993823|26221338|FG001|Overall Study|Protocol Violation|1|||
13202487|NCT01993823|26221337|FG000|Overall Study|Lost to Follow-up|1|||
13202488|NCT01993823|26221338|FG001|Overall Study|Lost to Follow-up|4|||
13202489|NCT01993667|26221353|FG000|Overall Study|Insufficient data to analyze|16|||
13202490|NCT01993667|26221354|FG001|Overall Study|Insufficient data to analyze|16|||
13202491|NCT01993667|26221353|FG000|Overall Study|Insufficient altitude reached|3|||
13202492|NCT01993667|26221354|FG001|Overall Study|Insufficient altitude reached|1|||
13202493|NCT01993667|26221353|FG000|Overall Study|Lost to Follow-up|2|||
13202494|NCT01993667|26221354|FG001|Overall Study|Lost to Follow-up|2|||
13202495|NCT01993615|26221373|FG000|Overall Study|Death|1|||
13202496|NCT01993615|26221374|FG001|Overall Study|Death|0|||
13202497|NCT01993329|26221405|FG000|Period 2|Adverse Event|0|||
13202498|NCT01993329|26221406|FG001|Period 2|Adverse Event|0|||
13202499|NCT01993329|26221407|FG002|Period 2|Adverse Event|0|||
13202500|NCT01993329|26221408|FG003|Period 2|Adverse Event|0|||
13202501|NCT01993329|26221409|FG004|Period 2|Adverse Event|0|||
13202502|NCT01993329|26221410|FG005|Period 2|Adverse Event|1|||
13202503|NCT01993329|26221405|FG000|Wash-out|Personal reasons|0|||
13202504|NCT01993329|26221406|FG001|Wash-out|Personal reasons|1|||
13202505|NCT01993329|26221407|FG002|Wash-out|Personal reasons|0|||
13202506|NCT01993329|26221408|FG003|Wash-out|Personal reasons|0|||
13202507|NCT01993329|26221409|FG004|Wash-out|Personal reasons|0|||
13202508|NCT01993329|26221410|FG005|Wash-out|Personal reasons|0|||
13202509|NCT01993186|26221460|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1|||
13202510|NCT01993186|26221461|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
13202511|NCT01993186|26221460|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1|||
13202512|NCT01993186|26221461|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
13202513|NCT01993186|26221460|FG000|Open-Label Extension Period|Other, Not Specified|0|||
13202514|NCT01993186|26221461|FG001|Open-Label Extension Period|Other, Not Specified|1|||
13202515|NCT01993186|26221460|FG000|Open-Label Extension Period|Adverse Event|1|||
13202516|NCT01993186|26221461|FG001|Open-Label Extension Period|Adverse Event|0|||
13485637|NCT01126749|27033001|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
13202517|NCT01993186|26221460|FG000|Open-Label Extension Period|Principal Investigator Decision|1|||
13202518|NCT01993186|26221461|FG001|Open-Label Extension Period|Principal Investigator Decision|0|||
13202519|NCT01993186|26221460|FG000|Open-Label Extension Period|Withdrawal by Subject|4|||
13202520|NCT01993186|26221461|FG001|Open-Label Extension Period|Withdrawal by Subject|5|||
13202521|NCT01993186|26221460|FG000|Open-Label Extension Period|Subject Non-Compliance|1|||
13202522|NCT01993186|26221461|FG001|Open-Label Extension Period|Subject Non-Compliance|0|||
13202523|NCT01993030|26221482|FG000|Overall Study|Adverse Event|0|||
13202524|NCT01993030|26221483|FG001|Overall Study|Adverse Event|4|||
13202525|NCT01993017|26221507|FG000|Overall Study|Death|23|||
13202526|NCT01993017|26221508|FG001|Overall Study|Death|26|||
13202527|NCT01993017|26221509|FG002|Overall Study|Death|18|||
13202528|NCT01993017|26221507|FG000|Overall Study|Could not be contacted|43|||
13202529|NCT01993017|26221508|FG001|Overall Study|Could not be contacted|42|||
13202530|NCT01993017|26221509|FG002|Overall Study|Could not be contacted|38|||
13202531|NCT01993017|26221507|FG000|Overall Study|Dropped out|19|||
13202532|NCT01993017|26221508|FG001|Overall Study|Dropped out|6|||
13202533|NCT01993017|26221509|FG002|Overall Study|Dropped out|11|||
13202534|NCT01993017|26221507|FG000|Overall Study|Other reasons|17|||
13202535|NCT01993017|26221508|FG001|Overall Study|Other reasons|11|||
13202536|NCT01993017|26221509|FG002|Overall Study|Other reasons|7|||
13202537|NCT01993017|26221507|FG000|Overall Study|Ineligible after randomization|4|||
13202538|NCT01993017|26221508|FG001|Overall Study|Ineligible after randomization|5|||
13202539|NCT01993017|26221509|FG002|Overall Study|Ineligible after randomization|5|||
13202540|NCT01992757|26221516|FG000|Overall Study|2 patients excluded due to FFP given.|2|||
13202541|NCT01992549|26221528|FG000|Overall Study|Lost to Follow-up|2|||
13202542|NCT01992549|26221528|FG000|Overall Study|Serious Adverse Event|1|||
13202543|NCT01992549|26221528|FG000|Overall Study|Product Switch to Extend Half Life|1|||
13202544|NCT01992536|26221774|FG000|Overall Study|Administrative Reason|0|||
13202545|NCT01992536|26221775|FG001|Overall Study|Administrative Reason|0|||
13202546|NCT01992536|26221776|FG002|Overall Study|Administrative Reason|0|||
13202547|NCT01992536|26221777|FG003|Overall Study|Administrative Reason|0|||
13202548|NCT01992536|26221778|FG004|Overall Study|Administrative Reason|0|||
13202549|NCT01992536|26221779|FG005|Overall Study|Administrative Reason|0|||
13202550|NCT01992536|26221780|FG006|Overall Study|Administrative Reason|7|||
13202551|NCT01992536|26221781|FG007|Overall Study|Administrative Reason|0|||
13202552|NCT01992536|26221782|FG008|Overall Study|Administrative Reason|0|||
13202553|NCT01992536|26221783|FG009|Overall Study|Administrative Reason|0|||
13202554|NCT01992536|26221774|FG000|Overall Study|Lost to Follow-up|4|||
13202555|NCT01992536|26221775|FG001|Overall Study|Lost to Follow-up|2|||
13202556|NCT01992536|26221776|FG002|Overall Study|Lost to Follow-up|1|||
13202557|NCT01992536|26221777|FG003|Overall Study|Lost to Follow-up|0|||
13202558|NCT01992536|26221778|FG004|Overall Study|Lost to Follow-up|0|||
13202559|NCT01992536|26221779|FG005|Overall Study|Lost to Follow-up|1|||
13202560|NCT01992536|26221780|FG006|Overall Study|Lost to Follow-up|0|||
13202561|NCT01992536|26221781|FG007|Overall Study|Lost to Follow-up|0|||
13202562|NCT01992536|26221782|FG008|Overall Study|Lost to Follow-up|1|||
13202563|NCT01992536|26221783|FG009|Overall Study|Lost to Follow-up|1|||
13202564|NCT01992536|26221774|FG000|Overall Study|Withdrawal by Subject|0|||
13202565|NCT01992536|26221775|FG001|Overall Study|Withdrawal by Subject|1|||
13202566|NCT01992536|26221776|FG002|Overall Study|Withdrawal by Subject|0|||
13202567|NCT01992536|26221777|FG003|Overall Study|Withdrawal by Subject|2|||
13202568|NCT01992536|26221778|FG004|Overall Study|Withdrawal by Subject|0|||
13202569|NCT01992536|26221779|FG005|Overall Study|Withdrawal by Subject|0|||
13202570|NCT01992536|26221780|FG006|Overall Study|Withdrawal by Subject|0|||
13202571|NCT01992536|26221781|FG007|Overall Study|Withdrawal by Subject|0|||
13202572|NCT01992536|26221782|FG008|Overall Study|Withdrawal by Subject|0|||
13202573|NCT01992536|26221783|FG009|Overall Study|Withdrawal by Subject|0|||
13202574|NCT01992159|26221846|FG000|Overall Study|Withdrawal by Subject|4|||
13202575|NCT01992159|26221847|FG001|Overall Study|Withdrawal by Subject|7|||
13202576|NCT01992159|26221848|FG002|Overall Study|Withdrawal by Subject|0|||
13202577|NCT01992159|26221849|FG003|Overall Study|Withdrawal by Subject|3|||
13202578|NCT01992159|26221846|FG000|Overall Study|Adverse Event|0|||
13202579|NCT01992159|26221847|FG001|Overall Study|Adverse Event|1|||
13202580|NCT01992159|26221848|FG002|Overall Study|Adverse Event|0|||
13202581|NCT01992159|26221849|FG003|Overall Study|Adverse Event|1|||
13202582|NCT01992159|26221846|FG000|Overall Study|Death|0|||
13202583|NCT01992159|26221847|FG001|Overall Study|Death|0|||
13202584|NCT01992159|26221848|FG002|Overall Study|Death|1|||
13202585|NCT01992159|26221849|FG003|Overall Study|Death|0|||
13202586|NCT01992107|26221912|FG000|Overall Study|Administrative reasons|2|||
13202587|NCT01992107|26221913|FG001|Overall Study|Administrative reasons|0|||
13202588|NCT01992107|26221914|FG002|Overall Study|Administrative reasons|0|||
13202589|NCT01992107|26221912|FG000|Overall Study|Adverse Event|0|||
13202590|NCT01992107|26221913|FG001|Overall Study|Adverse Event|1|||
13202591|NCT01992107|26221914|FG002|Overall Study|Adverse Event|0|||
13202592|NCT01992107|26221912|FG000|Overall Study|Lost to Follow-up|46|||
13202593|NCT01992107|26221913|FG001|Overall Study|Lost to Follow-up|22|||
13202594|NCT01992107|26221914|FG002|Overall Study|Lost to Follow-up|26|||
13202595|NCT01992107|26221912|FG000|Overall Study|noncompliance and were unavailable|7|||
13202596|NCT01992107|26221913|FG001|Overall Study|noncompliance and were unavailable|3|||
13202597|NCT01992107|26221914|FG002|Overall Study|noncompliance and were unavailable|2|||
13202598|NCT01992107|26221912|FG000|Overall Study|Withdrawal by Subject|13|||
13202599|NCT01992107|26221913|FG001|Overall Study|Withdrawal by Subject|7|||
13202600|NCT01992107|26221914|FG002|Overall Study|Withdrawal by Subject|8|||
13202601|NCT01992094|26221980|FG000|Overall Study|ADMINISTRATIVE REASON|6|||
13202602|NCT01992094|26221981|FG001|Overall Study|ADMINISTRATIVE REASON|7|||
13202603|NCT01992094|26221982|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
13202604|NCT01992094|26221980|FG000|Overall Study|Adverse Event|1|||
13202605|NCT01992094|26221981|FG001|Overall Study|Adverse Event|0|||
13202606|NCT01992094|26221982|FG002|Overall Study|Adverse Event|0|||
13202607|NCT01992094|26221980|FG000|Overall Study|Death|5|||
13202608|NCT01992094|26221981|FG001|Overall Study|Death|5|||
13202609|NCT01992094|26221982|FG002|Overall Study|Death|2|||
13202610|NCT01992094|26221980|FG000|Overall Study|Lost to Follow-up|26|||
13202611|NCT01992094|26221981|FG001|Overall Study|Lost to Follow-up|9|||
13202612|NCT01992094|26221982|FG002|Overall Study|Lost to Follow-up|13|||
13202613|NCT01992094|26221980|FG000|Overall Study|OTHER|4|||
13202614|NCT01992094|26221981|FG001|Overall Study|OTHER|0|||
13202615|NCT01992094|26221982|FG002|Overall Study|OTHER|0|||
13202616|NCT01992094|26221980|FG000|Overall Study|Protocol Violation|1|||
13202617|NCT01992094|26221981|FG001|Overall Study|Protocol Violation|0|||
13202618|NCT01992094|26221982|FG002|Overall Study|Protocol Violation|1|||
13202619|NCT01992094|26221980|FG000|Overall Study|Withdrawal by Subject|7|||
13202620|NCT01992094|26221981|FG001|Overall Study|Withdrawal by Subject|3|||
13202621|NCT01992094|26221982|FG002|Overall Study|Withdrawal by Subject|4|||
13202622|NCT01991795|26222011|FG000|Overall Study|Lost to Follow-up|6|||
13202623|NCT01991795|26222012|FG001|Overall Study|Lost to Follow-up|4|||
13202624|NCT01991795|26222011|FG000|Overall Study|Withdrawal by Subject|117|||
13202625|NCT01991795|26222012|FG001|Overall Study|Withdrawal by Subject|94|||
13202626|NCT01991795|26222011|FG000|Overall Study|Site prematurely closed by sponsor|26|||
13202627|NCT01991795|26222012|FG001|Overall Study|Site prematurely closed by sponsor|25|||
13202628|NCT01991743|26222051|FG000|Overall Study|external cephalic version not performed|0|||
13202629|NCT01991743|26222052|FG001|Overall Study|external cephalic version not performed|0|||
13202630|NCT01991743|26222053|FG002|Overall Study|external cephalic version not performed|1|||
13202631|NCT01991743|26222054|FG003|Overall Study|external cephalic version not performed|0|||
13202632|NCT01991483|26222133|FG000|Dose Level 600 mg|Withdrawal by Subject|0|||
13202633|NCT01991483|26222134|FG001|Dose Level 600 mg|Withdrawal by Subject|0|||
13202634|NCT01991483|26222135|FG002|Dose Level 600 mg|Withdrawal by Subject|1|||
13113251|NCT03137992|25911096|FG003|Washout Period 2|Adverse Event|1|||
13113252|NCT03137992|25911097|FG004|Washout Period 2|Adverse Event|1|||
13113253|NCT03137992|25911098|FG005|Washout Period 2|Adverse Event|0|||
13113254|NCT03137992|25911093|FG000|Washout Period 2|Withdrawal by Subject|1|||
13113255|NCT03137992|25911094|FG001|Washout Period 2|Withdrawal by Subject|0|||
13202635|NCT01991483|26222136|FG003|Dose Level 600 mg|Withdrawal by Subject|0|||
13202636|NCT01991483|26222133|FG000|Dose Level 600 mg|Physician Decision|0|||
13202637|NCT01991483|26222134|FG001|Dose Level 600 mg|Physician Decision|0|||
13202638|NCT01991483|26222135|FG002|Dose Level 600 mg|Physician Decision|1|||
13202639|NCT01991483|26222136|FG003|Dose Level 600 mg|Physician Decision|0|||
13202640|NCT01991483|26222133|FG000|Dose Level 1000 mg|Protocol Violation|0|||
13202641|NCT01991483|26222134|FG001|Dose Level 1000 mg|Protocol Violation|0|||
13202642|NCT01991483|26222135|FG002|Dose Level 1000 mg|Protocol Violation|0|||
13202643|NCT01991483|26222136|FG003|Dose Level 1000 mg|Protocol Violation|1|||
13202644|NCT01991470|26222150|FG000|Enlite 1 Period|Withdrawal by Subject|18|||
13202645|NCT01991470|26222150|FG000|Enlite 1 Period|Adverse Event|1|||
13202646|NCT01991470|26222150|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1|||
13202647|NCT01991470|26222150|FG000|Enlite 3 Period|Lost to Follow-up|1|||
13202648|NCT01991470|26222150|FG000|Enlite 3 Period|Physician Decision|2|||
13202649|NCT01991470|26222150|FG000|Enlite 3 Period|Physician Decision|8|||
13202650|NCT01991470|26222150|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1|||
13202651|NCT01991314|26222175|FG000|Overall Study|Adverse Event|5|||
13202652|NCT01991314|26222176|FG001|Overall Study|Adverse Event|1|||
13202653|NCT01991314|26222175|FG000|Overall Study|Lost to Follow-up|6|||
13202654|NCT01991314|26222176|FG001|Overall Study|Lost to Follow-up|10|||
13202655|NCT01991197|26222219|FG000|Overall Study|Lost to Follow-up|1|||
13202656|NCT01991197|26222220|FG001|Overall Study|Lost to Follow-up|1|||
13202657|NCT01991197|26222219|FG000|Overall Study|Physician Decision|0|||
13202658|NCT01991197|26222220|FG001|Overall Study|Physician Decision|2|||
13202659|NCT01991197|26222219|FG000|Overall Study|Withdrawal by Subject|2|||
13202660|NCT01991197|26222220|FG001|Overall Study|Withdrawal by Subject|0|||
13202661|NCT01990950|26222226|FG000|Overall Study|Death|3|||
13202662|NCT01990950|26222226|FG000|Overall Study|Lost to Follow-up|2|||
13202663|NCT01990950|26222226|FG000|Overall Study|Withdrawal by Subject|6|||
13202664|NCT01990859|26222239|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5|||
13202665|NCT01990859|26222239|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17|||
13223228|NCT01799590|26288092|FG001|Overall Study|Lack of Efficacy|1|||
13202666|NCT01990768|26222312|FG000|Intervention Started|Found to be ineligible|14|||
13202667|NCT01990768|26222313|FG001|Intervention Started|Found to be ineligible|13|||
13202668|NCT01990768|26222314|FG002|Intervention Started|Found to be ineligible|11|||
13202669|NCT01990768|26222312|FG000|Intervention Started|Study drug issue or kit malfunction|9|||
13202670|NCT01990768|26222313|FG001|Intervention Started|Study drug issue or kit malfunction|6|||
13202671|NCT01990768|26222314|FG002|Intervention Started|Study drug issue or kit malfunction|7|||
13202672|NCT01990768|26222312|FG000|Intervention Started|Patient became ineligible due to vitals|5|||
13202673|NCT01990768|26222313|FG001|Intervention Started|Patient became ineligible due to vitals|5|||
13202674|NCT01990768|26222314|FG002|Intervention Started|Patient became ineligible due to vitals|2|||
13202675|NCT01990768|26222312|FG000|Intervention Started|Not enough time for EMS to enroll|4|||
13202676|NCT01990768|26222313|FG001|Intervention Started|Not enough time for EMS to enroll|3|||
13202677|NCT01990768|26222314|FG002|Intervention Started|Not enough time for EMS to enroll|0|||
13202678|NCT01990768|26222312|FG000|Intervention Started|Patient care priority|1|||
13202679|NCT01990768|26222313|FG001|Intervention Started|Patient care priority|2|||
13202680|NCT01990768|26222314|FG002|Intervention Started|Patient care priority|3|||
13202681|NCT01990768|26222312|FG000|Intervention Started|IV lost|2|||
13113256|NCT03137992|25911095|FG002|Washout Period 2|Withdrawal by Subject|0|||
13113257|NCT03137992|25911096|FG003|Washout Period 2|Withdrawal by Subject|0|||
13113258|NCT03137992|25911097|FG004|Washout Period 2|Withdrawal by Subject|1|||
13113259|NCT03137992|25911098|FG005|Washout Period 2|Withdrawal by Subject|0|||
13113260|NCT03137992|25911093|FG000|Washout Period 2|Sponsor Decision|0|||
13113261|NCT03137992|25911094|FG001|Washout Period 2|Sponsor Decision|0|||
13202682|NCT01990768|26222313|FG001|Intervention Started|IV lost|2|||
13202683|NCT01990768|26222314|FG002|Intervention Started|IV lost|2|||
13202684|NCT01990768|26222312|FG000|Intervention Started|Required CPR|1|||
13202685|NCT01990768|26222313|FG001|Intervention Started|Required CPR|1|||
13202686|NCT01990768|26222314|FG002|Intervention Started|Required CPR|0|||
13223229|NCT01799590|26288093|FG002|Overall Study|Lack of Efficacy|3|||
13113262|NCT03137992|25911095|FG002|Washout Period 2|Sponsor Decision|0|||
13113263|NCT03137992|25911096|FG003|Washout Period 2|Sponsor Decision|0|||
13113264|NCT03137992|25911097|FG004|Washout Period 2|Sponsor Decision|0|||
13202687|NCT01990768|26222312|FG000|Intervention Started|Seizure or hx of seizure|0|||
13113265|NCT03137992|25911098|FG005|Washout Period 2|Sponsor Decision|1|||
13113266|NCT03137992|25911093|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6|||
13113267|NCT03137992|25911094|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
13113268|NCT03137992|25911095|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
13113269|NCT03137992|25911096|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
13113270|NCT03137992|25911097|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
13113271|NCT03137992|25911098|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3|||
13113272|NCT03137992|25911093|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0|||
13113273|NCT03137992|25911094|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2|||
13113274|NCT03137992|25911095|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1|||
13113275|NCT03137992|25911096|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0|||
13113276|NCT03137992|25911097|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1|||
13113277|NCT03137992|25911098|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0|||
13113278|NCT03137992|25911093|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
13113279|NCT03137992|25911094|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
13113280|NCT03137992|25911095|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
13113281|NCT03137992|25911096|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
13113282|NCT03137992|25911097|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
13113283|NCT03137992|25911098|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
13113284|NCT03137992|25911093|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0|||
13113285|NCT03137992|25911094|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0|||
13202688|NCT01990768|26222313|FG001|Intervention Started|Seizure or hx of seizure|0|||
13202689|NCT01990768|26222314|FG002|Intervention Started|Seizure or hx of seizure|2|||
13202690|NCT01990768|26222312|FG000|Intervention Started|Discovered to be pregnant|0|||
13202691|NCT01990768|26222313|FG001|Intervention Started|Discovered to be pregnant|1|||
13202692|NCT01990768|26222314|FG002|Intervention Started|Discovered to be pregnant|0|||
13202693|NCT01990768|26222312|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4|||
13202694|NCT01990768|26222313|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11|||
13202695|NCT01990768|26222314|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10|||
13202696|NCT01990768|26222312|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
13202697|NCT01990768|26222313|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3|||
13202698|NCT01990768|26222314|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
13202699|NCT01990768|26222312|FG000|Prehospital Study Drug Infusion|Required CPR|2|||
13202700|NCT01990768|26222313|FG001|Prehospital Study Drug Infusion|Required CPR|6|||
13202701|NCT01990768|26222314|FG002|Prehospital Study Drug Infusion|Required CPR|0|||
13202702|NCT01990768|26222312|FG000|Prehospital Study Drug Infusion|Other safety concern|2|||
13202703|NCT01990768|26222313|FG001|Prehospital Study Drug Infusion|Other safety concern|1|||
13202704|NCT01990768|26222314|FG002|Prehospital Study Drug Infusion|Other safety concern|1|||
13202705|NCT01990768|26222312|FG000|Prehospital Study Drug Infusion|Death|3|||
13202706|NCT01990768|26222313|FG001|Prehospital Study Drug Infusion|Death|1|||
13202707|NCT01990768|26222314|FG002|Prehospital Study Drug Infusion|Death|1|||
13202708|NCT01990768|26222312|FG000|Prehospital Study Drug Infusion|Discharged|2|||
13202709|NCT01990768|26222313|FG001|Prehospital Study Drug Infusion|Discharged|1|||
13202710|NCT01990768|26222314|FG002|Prehospital Study Drug Infusion|Discharged|0|||
13202711|NCT01990768|26222312|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1|||
13202712|NCT01990768|26222313|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
13202713|NCT01990768|26222314|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
13202714|NCT01990768|26222312|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0|||
13202715|NCT01990768|26222313|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0|||
13202716|NCT01990768|26222314|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1|||
13202717|NCT01990768|26222312|FG000|Prehospital Study Drug Infusion|Unknown if completed|1|||
13202718|NCT01990768|26222313|FG001|Prehospital Study Drug Infusion|Unknown if completed|4|||
13202719|NCT01990768|26222314|FG002|Prehospital Study Drug Infusion|Unknown if completed|2|||
13202720|NCT01990768|26222312|FG000|In-Hospital Study Drug Infusion|Discharged|19|||
13202721|NCT01990768|26222313|FG001|In-Hospital Study Drug Infusion|Discharged|18|||
13202722|NCT01990768|26222314|FG002|In-Hospital Study Drug Infusion|Discharged|13|||
13202723|NCT01990768|26222312|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14|||
13202724|NCT01990768|26222313|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17|||
13202725|NCT01990768|26222314|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10|||
13202726|NCT01990768|26222312|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13|||
13202727|NCT01990768|26222313|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7|||
13202728|NCT01990768|26222314|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12|||
13202729|NCT01990768|26222312|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12|||
13202730|NCT01990768|26222313|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11|||
13202731|NCT01990768|26222314|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6|||
13113286|NCT03137992|25911095|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0|||
13202732|NCT01990768|26222312|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11|||
13202733|NCT01990768|26222313|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4|||
13202734|NCT01990768|26222314|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7|||
13202735|NCT01990768|26222312|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8|||
13202736|NCT01990768|26222313|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9|||
13202737|NCT01990768|26222314|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17|||
13202738|NCT01990768|26222312|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
13202739|NCT01990768|26222313|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
13202740|NCT01990768|26222314|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4|||
13202741|NCT01990768|26222312|FG000|In-Hospital Study Drug Infusion|Required CPR|3|||
13202742|NCT01990768|26222313|FG001|In-Hospital Study Drug Infusion|Required CPR|7|||
13202743|NCT01990768|26222314|FG002|In-Hospital Study Drug Infusion|Required CPR|1|||
13202744|NCT01990768|26222312|FG000|In-Hospital Study Drug Infusion|Other safety concern|4|||
13202745|NCT01990768|26222313|FG001|In-Hospital Study Drug Infusion|Other safety concern|2|||
13202746|NCT01990768|26222314|FG002|In-Hospital Study Drug Infusion|Other safety concern|3|||
13202747|NCT01990768|26222312|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4|||
13202748|NCT01990768|26222313|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0|||
13202749|NCT01990768|26222314|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3|||
13202750|NCT01990768|26222312|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1|||
13202751|NCT01990768|26222313|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1|||
13202752|NCT01990768|26222314|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1|||
13202753|NCT01990768|26222312|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
13202754|NCT01990768|26222313|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
13202755|NCT01990768|26222314|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0|||
13202756|NCT01990768|26222312|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0|||
13202757|NCT01990768|26222313|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1|||
13202758|NCT01990768|26222314|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2|||
13202759|NCT01990768|26222312|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0|||
13202760|NCT01990768|26222313|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0|||
13202761|NCT01990768|26222314|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1|||
13202762|NCT01990768|26222312|FG000|6-Month Follow-up|Withdrawal by Subject|25|||
13202763|NCT01990768|26222313|FG001|6-Month Follow-up|Withdrawal by Subject|25|||
13202764|NCT01990768|26222314|FG002|6-Month Follow-up|Withdrawal by Subject|26|||
13202765|NCT01990768|26222312|FG000|6-Month Follow-up|Calls unreturned or refused contact|4|||
13202766|NCT01990768|26222313|FG001|6-Month Follow-up|Calls unreturned or refused contact|15|||
13202767|NCT01990768|26222314|FG002|6-Month Follow-up|Calls unreturned or refused contact|20|||
13202768|NCT01990768|26222312|FG000|6-Month Follow-up|No contact information|5|||
13202769|NCT01990768|26222313|FG001|6-Month Follow-up|No contact information|6|||
13202770|NCT01990768|26222314|FG002|6-Month Follow-up|No contact information|5|||
13202771|NCT01990768|26222312|FG000|6-Month Follow-up|Homeless|4|||
13202772|NCT01990768|26222313|FG001|6-Month Follow-up|Homeless|3|||
13202773|NCT01990768|26222314|FG002|6-Month Follow-up|Homeless|6|||
13202774|NCT01990768|26222312|FG000|6-Month Follow-up|Prisoner at time of enrollment|0|||
13202775|NCT01990768|26222313|FG001|6-Month Follow-up|Prisoner at time of enrollment|0|||
13202776|NCT01990768|26222314|FG002|6-Month Follow-up|Prisoner at time of enrollment|1|||
13202777|NCT01990768|26222312|FG000|6-Month Follow-up|Prisoner at time of follow-up|0|||
13202778|NCT01990768|26222313|FG001|6-Month Follow-up|Prisoner at time of follow-up|2|||
13202779|NCT01990768|26222314|FG002|6-Month Follow-up|Prisoner at time of follow-up|0|||
13202780|NCT01990768|26222312|FG000|6-Month Follow-up|Patient at psychiatric hospital|1|||
13202781|NCT01990768|26222313|FG001|6-Month Follow-up|Patient at psychiatric hospital|0|||
13202782|NCT01990768|26222314|FG002|6-Month Follow-up|Patient at psychiatric hospital|0|||
13202783|NCT01990742|26222331|FG000|Overall Study|Withdrawal by facility|407|||
13202784|NCT01990742|26222332|FG001|Overall Study|Withdrawal by facility|1083|||
13202785|NCT01990742|26222331|FG000|Overall Study|Facility closed|0|||
13202786|NCT01990742|26222332|FG001|Overall Study|Facility closed|270|||
13202787|NCT01990664|26222345|FG000|Overall Study|Lost to Follow-up|2|||
13202788|NCT01990664|26222346|FG001|Overall Study|Lost to Follow-up|6|||
13202789|NCT01990664|26222345|FG000|Overall Study|Withdrawal by Subject|2|||
13202790|NCT01990664|26222346|FG001|Overall Study|Withdrawal by Subject|3|||
13202791|NCT01990664|26222345|FG000|Overall Study|Protocol Violation|1|||
13202792|NCT01990664|26222346|FG001|Overall Study|Protocol Violation|0|||
13202793|NCT01990664|26222345|FG000|Overall Study|Lens Discomfort|1|||
13202794|NCT01990664|26222346|FG001|Overall Study|Lens Discomfort|1|||
13202795|NCT01990664|26222345|FG000|Overall Study|Lens Handling Difficulties|1|||
13202796|NCT01990664|26222346|FG001|Overall Study|Lens Handling Difficulties|0|||
13202797|NCT01990664|26222345|FG000|Overall Study|Unsatisfactory Visual Response|0|||
13202798|NCT01990664|26222346|FG001|Overall Study|Unsatisfactory Visual Response|1|||
13202799|NCT01990612|26222431|FG000|Overall Study|Lost to Follow-up|2|||
13202800|NCT01990612|26222432|FG001|Overall Study|Lost to Follow-up|1|||
13202801|NCT01990612|26222431|FG000|Overall Study|Withdrawal by Subject|5|||
13202802|NCT01990612|26222432|FG001|Overall Study|Withdrawal by Subject|2|||
13202803|NCT01990573|26222455|FG000|Overall Study|Physician Decision|0|||
13202804|NCT01990573|26222456|FG001|Overall Study|Physician Decision|0|||
13202805|NCT01990573|26222457|FG002|Overall Study|Physician Decision|1|||
13202806|NCT01990560|26222473|FG000|Overall Study|Withdrawal by Subject|1|||
13202807|NCT01990534|26222491|FG000|Overall Study|Death|22|||
13202808|NCT01990534|26222491|FG000|Overall Study|Progressive disease|3|||
13202809|NCT01990534|26222491|FG000|Overall Study|Protocol Violation|1|||
13202810|NCT01990534|26222491|FG000|Overall Study|Withdrawal of Informed Consent|2|||
13202811|NCT01990534|26222491|FG000|Overall Study|Symptomatic Deterioration|1|||
13202812|NCT01990534|26222491|FG000|Overall Study|Withdrawal by Subject|3|||
13202813|NCT01990534|26222491|FG000|Overall Study|Reason not Specified|2|||
13202814|NCT01990534|26222491|FG000|Overall Study|Lost to Follow-up|1|||
13113287|NCT03137992|25911096|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1|||
13113288|NCT03137992|25911097|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0|||
13113289|NCT03137992|25911098|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0|||
13113290|NCT03137992|25911093|FG000|Part 2 (Open-label Extension)|Per study team|1|||
13113291|NCT03137992|25911094|FG001|Part 2 (Open-label Extension)|Per study team|0|||
13113292|NCT03137992|25911095|FG002|Part 2 (Open-label Extension)|Per study team|0|||
13113293|NCT03137992|25911096|FG003|Part 2 (Open-label Extension)|Per study team|0|||
13113294|NCT03137992|25911097|FG004|Part 2 (Open-label Extension)|Per study team|0|||
13113295|NCT03137992|25911098|FG005|Part 2 (Open-label Extension)|Per study team|0|||
13113296|NCT03137992|25911093|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0|||
13113297|NCT03137992|25911094|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0|||
13113298|NCT03137992|25911095|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0|||
13113299|NCT03137992|25911096|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0|||
13113300|NCT03137992|25911097|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0|||
13113301|NCT03137992|25911098|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1|||
13113302|NCT03137784|25911140|FG000|Overall Study|Adverse Event|1|||
13113303|NCT03137784|25911141|FG001|Overall Study|Adverse Event|1|||
13113304|NCT03137784|25911142|FG002|Overall Study|Adverse Event|0|||
13113305|NCT03137784|25911143|FG003|Overall Study|Adverse Event|0|||
13113306|NCT03137784|25911144|FG004|Overall Study|Adverse Event|0|||
13113307|NCT03137784|25911145|FG005|Overall Study|Adverse Event|0|||
13113308|NCT03137784|25911140|FG000|Overall Study|Subject/guardian decision|1|||
13113309|NCT03137784|25911141|FG001|Overall Study|Subject/guardian decision|0|||
13113310|NCT03137784|25911142|FG002|Overall Study|Subject/guardian decision|0|||
13113311|NCT03137784|25911143|FG003|Overall Study|Subject/guardian decision|0|||
13113312|NCT03137784|25911144|FG004|Overall Study|Subject/guardian decision|0|||
13113313|NCT03137784|25911145|FG005|Overall Study|Subject/guardian decision|0|||
13113314|NCT03137784|25911140|FG000|Overall Study|Non-compliance with study treatment|0|||
13113315|NCT03137784|25911141|FG001|Overall Study|Non-compliance with study treatment|0|||
13113316|NCT03137784|25911142|FG002|Overall Study|Non-compliance with study treatment|0|||
13113317|NCT03137784|25911143|FG003|Overall Study|Non-compliance with study treatment|0|||
13113318|NCT03137784|25911144|FG004|Overall Study|Non-compliance with study treatment|1|||
13113319|NCT03137784|25911145|FG005|Overall Study|Non-compliance with study treatment|0|||
13113320|NCT03137537|25911160|FG000|Overall Study|Adverse Event|0|||
13113321|NCT03137537|25911161|FG001|Overall Study|Adverse Event|1|||
13113322|NCT03137459|25911180|FG000|2-month Assessment|Withdrawal by Subject|13|||
13113323|NCT03137459|25911181|FG001|2-month Assessment|Withdrawal by Subject|3|||
13113324|NCT03137459|25911180|FG000|2-month Assessment|Unable to reach|42|||
13113325|NCT03137459|25911181|FG001|2-month Assessment|Unable to reach|32|||
13113326|NCT03137459|25911180|FG000|2-month Assessment|Refused assessment|7|||
13113327|NCT03137459|25911181|FG001|2-month Assessment|Refused assessment|5|||
13113328|NCT03137459|25911180|FG000|2-month Assessment|Acutely ill|6|||
13113329|NCT03137459|25911181|FG001|2-month Assessment|Acutely ill|2|||
13113330|NCT03137459|25911180|FG000|4-month Assessment|Death|4|||
13113331|NCT03137459|25911181|FG001|4-month Assessment|Death|2|||
13113332|NCT03137459|25911180|FG000|4-month Assessment|Withdrawal by Subject|4|||
13113333|NCT03137459|25911181|FG001|4-month Assessment|Withdrawal by Subject|2|||
13113334|NCT03137459|25911180|FG000|4-month Assessment|Unable to reach|44|||
13113335|NCT03137459|25911181|FG001|4-month Assessment|Unable to reach|29|||
13113336|NCT03137459|25911180|FG000|4-month Assessment|Refused assessment|24|||
13113337|NCT03137459|25911181|FG001|4-month Assessment|Refused assessment|10|||
13113338|NCT03137459|25911180|FG000|4-month Assessment|Acutely ill|2|||
13113339|NCT03137459|25911181|FG001|4-month Assessment|Acutely ill|3|||
13113340|NCT03137459|25911180|FG000|6-months|Lost to Follow-up|14|||
13113341|NCT03137459|25911181|FG001|6-months|Lost to Follow-up|11|||
13113342|NCT03137459|25911180|FG000|6-months|Death|0|||
13113343|NCT03137459|25911181|FG001|6-months|Death|2|||
13113344|NCT03137459|25911180|FG000|6-months|Refused assessment|6|||
13113345|NCT03137459|25911181|FG001|6-months|Refused assessment|3|||
13113346|NCT03137459|25911180|FG000|6-months|Acutely ill|1|||
13113347|NCT03137459|25911181|FG001|6-months|Acutely ill|1|||
13202815|NCT01990495|26222508|FG000|Overall Study|Physician Decision|5|||
13113348|NCT03137303|25911196|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1|||
13113349|NCT03137303|25911197|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4|||
13113350|NCT03137303|25911196|FG000|T1: 3-month Follow-up|Lost to Follow-up|5|||
13113351|NCT03137303|25911197|FG001|T1: 3-month Follow-up|Lost to Follow-up|6|||
13113352|NCT03137303|25911196|FG000|T2: 6-month Follow-up|Lost to Follow-up|5|||
13113353|NCT03137303|25911197|FG001|T2: 6-month Follow-up|Lost to Follow-up|5|||
13113354|NCT03137303|25911196|FG000|T3: 9-month Follow-up|Death|1|||
13113355|NCT03137303|25911197|FG001|T3: 9-month Follow-up|Death|0|||
13113356|NCT03137303|25911196|FG000|T3: 9-month Follow-up|Lost to Follow-up|4|||
13113357|NCT03137303|25911197|FG001|T3: 9-month Follow-up|Lost to Follow-up|4|||
13113358|NCT03137303|25911196|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0|||
13113359|NCT03137303|25911197|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1|||
13113360|NCT03137303|25911196|FG000|T4: 12-month Follow-up|Lost to Follow-up|7|||
13113361|NCT03137303|25911197|FG001|T4: 12-month Follow-up|Lost to Follow-up|4|||
13113362|NCT03137121|25911214|FG000|Overall Study|Withdrawal by Subject|0|||
13113363|NCT03137121|25911215|FG001|Overall Study|Withdrawal by Subject|1|||
13113364|NCT03137069|25911270|FG000|Overall Study|Withdrawal by Subject|1|||
13113365|NCT03137069|25911271|FG001|Overall Study|Withdrawal by Subject|2|||
13113366|NCT03137069|25911272|FG002|Overall Study|Withdrawal by Subject|2|||
13113367|NCT03137069|25911273|FG003|Overall Study|Withdrawal by Subject|2|||
13113368|NCT03137069|25911274|FG004|Overall Study|Withdrawal by Subject|0|||
13113369|NCT03137069|25911275|FG005|Overall Study|Withdrawal by Subject|0|||
13113370|NCT03137069|25911270|FG000|Overall Study|Adverse Event|0|||
13113371|NCT03137069|25911271|FG001|Overall Study|Adverse Event|3|||
13113372|NCT03137069|25911272|FG002|Overall Study|Adverse Event|1|||
13113373|NCT03137069|25911273|FG003|Overall Study|Adverse Event|1|||
13113374|NCT03137069|25911274|FG004|Overall Study|Adverse Event|0|||
13113375|NCT03137069|25911275|FG005|Overall Study|Adverse Event|1|||
13113376|NCT03137069|25911270|FG000|Overall Study|Protocol Violation|0|||
13113377|NCT03137069|25911271|FG001|Overall Study|Protocol Violation|1|||
13113378|NCT03137069|25911272|FG002|Overall Study|Protocol Violation|0|||
13113379|NCT03137069|25911273|FG003|Overall Study|Protocol Violation|1|||
13113380|NCT03137069|25911274|FG004|Overall Study|Protocol Violation|1|||
13113381|NCT03137069|25911275|FG005|Overall Study|Protocol Violation|1|||
13113382|NCT03137069|25911270|FG000|Overall Study|Physician Decision|0|||
13202816|NCT01990495|26222509|FG001|Overall Study|Physician Decision|4|||
13202817|NCT01990339|26222516|FG000|Overall Study|Data Not Available|49|||
13202818|NCT01990339|26222516|FG000|Overall Study|Voluntary Withdrawal|1402|||
13202819|NCT01990339|26222516|FG000|Overall Study|Lost to Follow-up|861|||
13202820|NCT01990313|26222523|FG000|Overall Study|Lost to Follow-up|1|||
13202821|NCT01990300|26222531|FG000|Overall Study|Case Report Forms Uncollected|89|||
13202822|NCT01990300|26222531|FG000|Overall Study|Protocol Deviation|53|||
13202823|NCT01990261|26222543|FG000|Overall Study|Death Before Treatment Start|2|||
13202824|NCT01990261|26222543|FG000|Overall Study|Death due to Disease Progression (PD)|10|||
13202825|NCT01990261|26222543|FG000|Overall Study|Death From other Causes|1|||
13202826|NCT01990261|26222543|FG000|Overall Study|Disease Progression (PD)|8|||
13202827|NCT01990261|26222543|FG000|Overall Study|PD Before Treatment Start|1|||
13202828|NCT01990261|26222543|FG000|Overall Study|Dossier not Approved|1|||
13202829|NCT01990261|26222543|FG000|Overall Study|Lost to Follow-up|2|||
13202830|NCT01989754|26222560|FG000|Overall Study|Withdrawal by Subject|10|||
13202831|NCT01989754|26222561|FG001|Overall Study|Withdrawal by Subject|14|||
13202832|NCT01989754|26222560|FG000|Overall Study|Lost to Follow-up|28|||
13202833|NCT01989754|26222561|FG001|Overall Study|Lost to Follow-up|20|||
13202834|NCT01989754|26222560|FG000|Overall Study|Closed Site|1|||
13202835|NCT01989754|26222561|FG001|Overall Study|Closed Site|1|||
13202836|NCT01989689|26222578|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0|||
13202837|NCT01989689|26222579|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2|||
13202838|NCT01989689|26222578|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0|||
13202839|NCT01989689|26222579|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1|||
13202840|NCT01989572|26222626|FG000|Overall Study|Lack of Efficacy|35|||
13202841|NCT01989572|26222627|FG001|Overall Study|Lack of Efficacy|48|||
13202842|NCT01989572|26222628|FG002|Overall Study|Lack of Efficacy|48|||
13202843|NCT01989572|26222629|FG003|Overall Study|Lack of Efficacy|43|||
13202844|NCT01989572|26222630|FG004|Overall Study|Lack of Efficacy|71|||
13202845|NCT01989572|26222631|FG005|Overall Study|Lack of Efficacy|79|||
13485638|NCT01126749|27033002|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4|||
13202846|NCT01989572|26222626|FG000|Overall Study|Adverse Event|2|||
13202847|NCT01989572|26222627|FG001|Overall Study|Adverse Event|1|||
13202848|NCT01989572|26222628|FG002|Overall Study|Adverse Event|3|||
13202849|NCT01989572|26222629|FG003|Overall Study|Adverse Event|0|||
13202850|NCT01989572|26222630|FG004|Overall Study|Adverse Event|3|||
13113383|NCT03137069|25911271|FG001|Overall Study|Physician Decision|0|||
13113384|NCT03137069|25911272|FG002|Overall Study|Physician Decision|0|||
13113385|NCT03137069|25911273|FG003|Overall Study|Physician Decision|1|||
13113386|NCT03137069|25911274|FG004|Overall Study|Physician Decision|0|||
13113387|NCT03137069|25911275|FG005|Overall Study|Physician Decision|0|||
13113388|NCT03137069|25911270|FG000|Overall Study|Study Terminated by Sponsor|0|||
13202851|NCT01989572|26222631|FG005|Overall Study|Adverse Event|0|||
13202852|NCT01989572|26222626|FG000|Overall Study|Death|0|||
13202853|NCT01989572|26222627|FG001|Overall Study|Death|0|||
13202854|NCT01989572|26222628|FG002|Overall Study|Death|0|||
13202855|NCT01989572|26222629|FG003|Overall Study|Death|0|||
13202856|NCT01989572|26222630|FG004|Overall Study|Death|1|||
13202857|NCT01989572|26222631|FG005|Overall Study|Death|0|||
13202858|NCT01989572|26222626|FG000|Overall Study|Withdrawal by Subject|4|||
13202859|NCT01989572|26222627|FG001|Overall Study|Withdrawal by Subject|1|||
13202860|NCT01989572|26222628|FG002|Overall Study|Withdrawal by Subject|5|||
13202861|NCT01989572|26222629|FG003|Overall Study|Withdrawal by Subject|1|||
13202862|NCT01989572|26222630|FG004|Overall Study|Withdrawal by Subject|12|||
13113389|NCT03137069|25911271|FG001|Overall Study|Study Terminated by Sponsor|0|||
13113390|NCT03137069|25911272|FG002|Overall Study|Study Terminated by Sponsor|0|||
13113391|NCT03137069|25911273|FG003|Overall Study|Study Terminated by Sponsor|0|||
13113392|NCT03137069|25911274|FG004|Overall Study|Study Terminated by Sponsor|1|||
13113393|NCT03137069|25911275|FG005|Overall Study|Study Terminated by Sponsor|0|||
13113394|NCT03137069|25911270|FG000|Overall Study|Data Entry Error|0|||
13113395|NCT03137069|25911271|FG001|Overall Study|Data Entry Error|0|||
13113396|NCT03137069|25911272|FG002|Overall Study|Data Entry Error|0|||
13113397|NCT03137069|25911273|FG003|Overall Study|Data Entry Error|1|||
13113398|NCT03137069|25911274|FG004|Overall Study|Data Entry Error|0|||
13113399|NCT03137069|25911275|FG005|Overall Study|Data Entry Error|0|||
13113400|NCT03136861|25911310|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3|||
13113401|NCT03136861|25911311|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2|||
13113402|NCT03136861|25911312|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
13113403|NCT03136861|25911313|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
13113404|NCT03136861|25911314|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
13113405|NCT03136861|25911315|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
13113406|NCT03136861|25911316|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
13113407|NCT03136861|25911310|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
13113408|NCT03136861|25911311|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
13113409|NCT03136861|25911312|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
13113410|NCT03136861|25911313|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
13113411|NCT03136861|25911314|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
13113412|NCT03136861|25911315|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
13113413|NCT03136861|25911316|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
13202863|NCT01989572|26222631|FG005|Overall Study|Withdrawal by Subject|4|||
13202864|NCT01989572|26222626|FG000|Overall Study|complicating disease|1|||
13202865|NCT01989572|26222627|FG001|Overall Study|complicating disease|1|||
13202866|NCT01989572|26222628|FG002|Overall Study|complicating disease|2|||
13202867|NCT01989572|26222629|FG003|Overall Study|complicating disease|0|||
13202868|NCT01989572|26222630|FG004|Overall Study|complicating disease|1|||
13202869|NCT01989572|26222631|FG005|Overall Study|complicating disease|0|||
13202870|NCT01989572|26222626|FG000|Overall Study|error|2|||
13202871|NCT01989572|26222627|FG001|Overall Study|error|1|||
13202872|NCT01989572|26222628|FG002|Overall Study|error|1|||
13202873|NCT01989572|26222629|FG003|Overall Study|error|1|||
13202874|NCT01989572|26222630|FG004|Overall Study|error|1|||
13202875|NCT01989572|26222631|FG005|Overall Study|error|1|||
13202876|NCT01989572|26222626|FG000|Overall Study|maximum dose reached|0|||
13202877|NCT01989572|26222627|FG001|Overall Study|maximum dose reached|1|||
13202878|NCT01989572|26222628|FG002|Overall Study|maximum dose reached|0|||
13202879|NCT01989572|26222629|FG003|Overall Study|maximum dose reached|0|||
13202880|NCT01989572|26222630|FG004|Overall Study|maximum dose reached|1|||
13202881|NCT01989572|26222631|FG005|Overall Study|maximum dose reached|0|||
13202882|NCT01989572|26222626|FG000|Overall Study|unknown/not specify|3|||
13202883|NCT01989572|26222627|FG001|Overall Study|unknown/not specify|4|||
13202884|NCT01989572|26222628|FG002|Overall Study|unknown/not specify|1|||
13202885|NCT01989572|26222629|FG003|Overall Study|unknown/not specify|3|||
13202886|NCT01989572|26222630|FG004|Overall Study|unknown/not specify|3|||
13202887|NCT01989572|26222631|FG005|Overall Study|unknown/not specify|5|||
13202888|NCT01989572|26222626|FG000|Overall Study|not start protocol therapy|5|||
13202889|NCT01989572|26222627|FG001|Overall Study|not start protocol therapy|1|||
13202890|NCT01989572|26222628|FG002|Overall Study|not start protocol therapy|2|||
13202891|NCT01989572|26222629|FG003|Overall Study|not start protocol therapy|3|||
13202892|NCT01989572|26222630|FG004|Overall Study|not start protocol therapy|4|||
13202893|NCT01989572|26222631|FG005|Overall Study|not start protocol therapy|18|||
13202894|NCT01989572|26222626|FG000|Overall Study|alternative therapy|3|||
13202895|NCT01989572|26222627|FG001|Overall Study|alternative therapy|0|||
13202896|NCT01989572|26222628|FG002|Overall Study|alternative therapy|0|||
13202897|NCT01989572|26222629|FG003|Overall Study|alternative therapy|0|||
13202898|NCT01989572|26222630|FG004|Overall Study|alternative therapy|1|||
13202899|NCT01989572|26222631|FG005|Overall Study|alternative therapy|3|||
13202900|NCT01989546|26222639|FG000|Overall Study|Clinical Progression|1|||
13202901|NCT01989546|26222639|FG000|Overall Study|Disease progression on study|8|||
13113414|NCT03136861|25911310|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2|||
13113415|NCT03136861|25911311|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1|||
13113416|NCT03136861|25911312|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
13113417|NCT03136861|25911313|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
13113418|NCT03136861|25911314|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
13113419|NCT03136861|25911315|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
13113420|NCT03136861|25911316|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
13113421|NCT03136861|25911310|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
13113422|NCT03136861|25911311|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1|||
13113423|NCT03136861|25911312|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
13113424|NCT03136861|25911313|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
13113425|NCT03136861|25911314|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
13113426|NCT03136861|25911315|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
13113427|NCT03136861|25911316|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
13113428|NCT03136861|25911310|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
13113429|NCT03136861|25911311|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
13113430|NCT03136861|25911312|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
13113431|NCT03136861|25911313|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
13113432|NCT03136861|25911314|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
13113433|NCT03136861|25911315|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
13113434|NCT03136861|25911316|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
13113435|NCT03136861|25911310|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
13113436|NCT03136861|25911311|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
13113437|NCT03136861|25911312|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
13113438|NCT03136861|25911313|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
13113439|NCT03136861|25911314|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2|||
13113440|NCT03136861|25911315|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
13113441|NCT03136861|25911316|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
13113442|NCT03136861|25911310|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
13113443|NCT03136861|25911311|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
13202902|NCT01989468|26222688|FG000|Overall Study|Adverse Event|10|||
13202903|NCT01989468|26222689|FG001|Overall Study|Adverse Event|15|||
13202904|NCT01989468|26222690|FG002|Overall Study|Adverse Event|4|||
13202905|NCT01989468|26222691|FG003|Overall Study|Adverse Event|5|||
13202906|NCT01989468|26222692|FG004|Overall Study|Adverse Event|4|||
13202907|NCT01989468|26222688|FG000|Overall Study|Lack of Efficacy|11|||
13202908|NCT01989468|26222689|FG001|Overall Study|Lack of Efficacy|11|||
13202909|NCT01989468|26222690|FG002|Overall Study|Lack of Efficacy|7|||
13202910|NCT01989468|26222691|FG003|Overall Study|Lack of Efficacy|4|||
13202911|NCT01989468|26222692|FG004|Overall Study|Lack of Efficacy|2|||
13202912|NCT01989468|26222688|FG000|Overall Study|Lost to Follow-up|5|||
13202913|NCT01989468|26222689|FG001|Overall Study|Lost to Follow-up|2|||
13202914|NCT01989468|26222690|FG002|Overall Study|Lost to Follow-up|0|||
13202915|NCT01989468|26222691|FG003|Overall Study|Lost to Follow-up|1|||
13202916|NCT01989468|26222692|FG004|Overall Study|Lost to Follow-up|1|||
13202917|NCT01989468|26222688|FG000|Overall Study|Physician Decision|4|||
13202918|NCT01989468|26222689|FG001|Overall Study|Physician Decision|1|||
13202919|NCT01989468|26222690|FG002|Overall Study|Physician Decision|0|||
13202920|NCT01989468|26222691|FG003|Overall Study|Physician Decision|1|||
13202921|NCT01989468|26222692|FG004|Overall Study|Physician Decision|0|||
13202922|NCT01989468|26222688|FG000|Overall Study|Pregnancy|0|||
13202923|NCT01989468|26222689|FG001|Overall Study|Pregnancy|1|||
13202924|NCT01989468|26222690|FG002|Overall Study|Pregnancy|0|||
13202925|NCT01989468|26222691|FG003|Overall Study|Pregnancy|0|||
13202926|NCT01989468|26222692|FG004|Overall Study|Pregnancy|0|||
13202927|NCT01989468|26222688|FG000|Overall Study|Technical Problems|3|||
13202928|NCT01989468|26222689|FG001|Overall Study|Technical Problems|1|||
13202929|NCT01989468|26222690|FG002|Overall Study|Technical Problems|3|||
13202930|NCT01989468|26222691|FG003|Overall Study|Technical Problems|1|||
13202931|NCT01989468|26222692|FG004|Overall Study|Technical Problems|0|||
13202932|NCT01989468|26222688|FG000|Overall Study|Subject Guardian Decision|11|||
13202933|NCT01989468|26222689|FG001|Overall Study|Subject Guardian Decision|6|||
13202934|NCT01989468|26222690|FG002|Overall Study|Subject Guardian Decision|4|||
13202935|NCT01989468|26222691|FG003|Overall Study|Subject Guardian Decision|4|||
13202936|NCT01989468|26222692|FG004|Overall Study|Subject Guardian Decision|1|||
13202937|NCT01989468|26222688|FG000|Overall Study|Death|3|||
13202938|NCT01989468|26222689|FG001|Overall Study|Death|0|||
13202939|NCT01989468|26222690|FG002|Overall Study|Death|1|||
13202940|NCT01989468|26222691|FG003|Overall Study|Death|0|||
13202941|NCT01989468|26222692|FG004|Overall Study|Death|0|||
13202942|NCT01989455|26222742|FG000|Overall Study|Adverse Event|0|||
13202943|NCT01989455|26222743|FG001|Overall Study|Adverse Event|1|||
13202944|NCT01989455|26222744|FG002|Overall Study|Adverse Event|0|||
13202945|NCT01989455|26222745|FG003|Overall Study|Adverse Event|0|||
13202946|NCT01989455|26222746|FG004|Overall Study|Adverse Event|0|||
13202947|NCT01989455|26222742|FG000|Overall Study|Withdrawal by Subject|0|||
13202948|NCT01989455|26222743|FG001|Overall Study|Withdrawal by Subject|1|||
13202949|NCT01989455|26222744|FG002|Overall Study|Withdrawal by Subject|0|||
13202950|NCT01989455|26222745|FG003|Overall Study|Withdrawal by Subject|0|||
13202951|NCT01989455|26222746|FG004|Overall Study|Withdrawal by Subject|0|||
13202952|NCT01989455|26222742|FG000|Overall Study|Technical problems with infusion|0|||
13202953|NCT01989455|26222743|FG001|Overall Study|Technical problems with infusion|0|||
13202954|NCT01989455|26222744|FG002|Overall Study|Technical problems with infusion|1|||
13202955|NCT01989455|26222745|FG003|Overall Study|Technical problems with infusion|0|||
13202956|NCT01989455|26222746|FG004|Overall Study|Technical problems with infusion|1|||
13202957|NCT01989208|26222771|FG000|200 mg (7 Days)|Protocol Violation|0|||
13202958|NCT01989208|26222772|FG001|200 mg (7 Days)|Protocol Violation|1|||
13202959|NCT01989169|26222789|FG000|Period 2|Adverse Event|0|||
13202960|NCT01989169|26222790|FG001|Period 2|Adverse Event|1|||
13202961|NCT01989156|26222820|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0|||
13202962|NCT01989156|26222821|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
13202963|NCT01989156|26222822|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3|||
13202964|NCT01989156|26222820|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
13202965|NCT01989156|26222821|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
13202966|NCT01989156|26222822|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1|||
13202967|NCT01989156|26222820|FG000|Confinement Period (Population at Day 5)|Adverse Event|0|||
13202968|NCT01989156|26222821|FG001|Confinement Period (Population at Day 5)|Adverse Event|0|||
13202969|NCT01989156|26222822|FG002|Confinement Period (Population at Day 5)|Adverse Event|1|||
13202970|NCT01989156|26222820|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
13202971|NCT01989156|26222821|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
13202972|NCT01989156|26222822|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
13202973|NCT01989156|26222820|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3|||
13202974|NCT01989156|26222821|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2|||
13202975|NCT01989156|26222822|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0|||
13202976|NCT01989156|26222820|FG000|End of Study (Population at Day 90)|Physician Decision|1|||
13202977|NCT01989156|26222821|FG001|End of Study (Population at Day 90)|Physician Decision|0|||
13113444|NCT03136861|25911312|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1|||
13113445|NCT03136861|25911313|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
13113446|NCT03136861|25911314|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
13113447|NCT03136861|25911315|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
13113448|NCT03136861|25911316|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
13113449|NCT03136861|25911310|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
13113450|NCT03136861|25911311|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
13113451|NCT03136861|25911312|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1|||
13113452|NCT03136861|25911313|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
13113453|NCT03136861|25911314|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
13113454|NCT03136861|25911315|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
13113455|NCT03136861|25911316|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
13113456|NCT03136484|25911449|FG000|Overall Study|Withdrawal by Subject|19|||
13113457|NCT03136484|25911450|FG001|Overall Study|Withdrawal by Subject|14|||
13113458|NCT03136484|25911449|FG000|Overall Study|Lost to Follow-up|7|||
13113459|NCT03136484|25911450|FG001|Overall Study|Lost to Follow-up|8|||
13113460|NCT03136484|25911449|FG000|Overall Study|Death|1|||
13113461|NCT03136484|25911450|FG001|Overall Study|Death|0|||
13113462|NCT03136380|25911633|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
13113463|NCT03136380|25911634|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
13113464|NCT03136380|25911635|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
13113465|NCT03136380|25911636|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
13113466|NCT03136380|25911637|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
13113467|NCT03136367|25911684|FG000|T1 Consultation|discontinued mistakenly included|2|||
13113468|NCT03136367|25911685|FG001|T1 Consultation|discontinued mistakenly included|6|||
13113469|NCT03136367|25911686|FG002|T1 Consultation|discontinued mistakenly included|1|||
13113470|NCT03136367|25911684|FG000|T1 Consultation|Discontinued other|0|||
13113471|NCT03136367|25911685|FG001|T1 Consultation|Discontinued other|1|||
13113472|NCT03136367|25911686|FG002|T1 Consultation|Discontinued other|0|||
13113473|NCT03136367|25911684|FG000|T2 Post-consultation|Withdrawal by Subject|1|||
13113474|NCT03136367|25911685|FG001|T2 Post-consultation|Withdrawal by Subject|1|||
13113475|NCT03136367|25911686|FG002|T2 Post-consultation|Withdrawal by Subject|5|||
13113476|NCT03136367|25911684|FG000|T2 Post-consultation|discontinued mistakenly included|2|||
13113477|NCT03136367|25911685|FG001|T2 Post-consultation|discontinued mistakenly included|2|||
13113478|NCT03136367|25911686|FG002|T2 Post-consultation|discontinued mistakenly included|17|||
13113479|NCT03136367|25911684|FG000|T2 Post-consultation|Discontinued other|0|||
13113480|NCT03136367|25911685|FG001|T2 Post-consultation|Discontinued other|2|||
13113481|NCT03136367|25911686|FG002|T2 Post-consultation|Discontinued other|6|||
13113482|NCT03136367|25911684|FG000|T2 Post-consultation|Discontinued transferred care|0|||
13113483|NCT03136367|25911685|FG001|T2 Post-consultation|Discontinued transferred care|0|||
13113484|NCT03136367|25911686|FG002|T2 Post-consultation|Discontinued transferred care|3|||
13113485|NCT03136367|25911684|FG000|T2 Post-consultation|Discontinued lost contact|0|||
13113486|NCT03136367|25911685|FG001|T2 Post-consultation|Discontinued lost contact|1|||
13113487|NCT03136367|25911686|FG002|T2 Post-consultation|Discontinued lost contact|0|||
13113488|NCT03136367|25911684|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5|||
13113489|NCT03136367|25911685|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9|||
13113490|NCT03136367|25911686|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8|||
13113491|NCT03136367|25911684|FG000|T3 1 Week After Surgery|Discontinued transferred care|2|||
13113492|NCT03136367|25911685|FG001|T3 1 Week After Surgery|Discontinued transferred care|11|||
13113493|NCT03136367|25911686|FG002|T3 1 Week After Surgery|Discontinued transferred care|14|||
13113494|NCT03136367|25911684|FG000|T3 1 Week After Surgery|other discontinued|2|||
13113495|NCT03136367|25911685|FG001|T3 1 Week After Surgery|other discontinued|4|||
13113496|NCT03136367|25911686|FG002|T3 1 Week After Surgery|other discontinued|3|||
13113497|NCT03136367|25911684|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0|||
13113498|NCT03136367|25911685|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6|||
13113499|NCT03136367|25911686|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2|||
13113500|NCT03136367|25911684|FG000|T3 1 Week After Surgery|Discontinued lost contact|1|||
13113501|NCT03136367|25911685|FG001|T3 1 Week After Surgery|Discontinued lost contact|2|||
13113502|NCT03136367|25911686|FG002|T3 1 Week After Surgery|Discontinued lost contact|4|||
13113503|NCT03136367|25911684|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1|||
13113504|NCT03136367|25911685|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3|||
13113505|NCT03136367|25911686|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0|||
13113506|NCT03136367|25911684|FG000|T4 12 Weeks After Surgery|Death|0|||
13113507|NCT03136367|25911685|FG001|T4 12 Weeks After Surgery|Death|1|||
13113508|NCT03136367|25911686|FG002|T4 12 Weeks After Surgery|Death|3|||
13113509|NCT03136367|25911684|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1|||
13113510|NCT03136367|25911685|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0|||
13113511|NCT03136367|25911686|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0|||
13113512|NCT03136367|25911684|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0|||
13113513|NCT03136367|25911685|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1|||
13113514|NCT03136367|25911686|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5|||
13113515|NCT03136367|25911684|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
13202978|NCT01989156|26222822|FG002|End of Study (Population at Day 90)|Physician Decision|1|||
13202979|NCT01989156|26222820|FG000|End of Study (Population at Day 90)|Moved out of state|1|||
13202980|NCT01989156|26222821|FG001|End of Study (Population at Day 90)|Moved out of state|0|||
13202981|NCT01989156|26222822|FG002|End of Study (Population at Day 90)|Moved out of state|0|||
13202982|NCT01989156|26222820|FG000|End of Study (Population at Day 90)|Employment Conflict|0|||
13202983|NCT01989156|26222821|FG001|End of Study (Population at Day 90)|Employment Conflict|1|||
13202984|NCT01989156|26222822|FG002|End of Study (Population at Day 90)|Employment Conflict|0|||
13202985|NCT01988779|26222843|FG000|Overall Study|Withdrawal by Subject|2|||
13202986|NCT01988779|26222844|FG001|Overall Study|Withdrawal by Subject|2|||
13202987|NCT01988779|26222843|FG000|Overall Study|Protocol Violation|1|||
13202988|NCT01988779|26222844|FG001|Overall Study|Protocol Violation|0|||
13202989|NCT01988662|26222868|FG000|Overall Study|Subject/guardian decision|1|||
13113516|NCT03136367|25911685|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
13113517|NCT03136367|25911686|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1|||
13113518|NCT03136367|25911684|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1|||
13113519|NCT03136367|25911685|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1|||
13113520|NCT03136367|25911686|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1|||
13113521|NCT03136367|25911684|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1|||
13113522|NCT03136367|25911685|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0|||
13113523|NCT03136367|25911686|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0|||
13113524|NCT03136367|25911684|FG000|T5 1 Year After Surgery|Death|0|||
13113525|NCT03136367|25911685|FG001|T5 1 Year After Surgery|Death|0|||
13113526|NCT03136367|25911686|FG002|T5 1 Year After Surgery|Death|1|||
13113527|NCT03136367|25911684|FG000|T5 1 Year After Surgery|Discontinued lost contact|1|||
13113528|NCT03136367|25911685|FG001|T5 1 Year After Surgery|Discontinued lost contact|6|||
13113529|NCT03136367|25911686|FG002|T5 1 Year After Surgery|Discontinued lost contact|0|||
13113530|NCT03136367|25911684|FG000|T5 1 Year After Surgery|Lost to Follow-up|2|||
13113531|NCT03136367|25911685|FG001|T5 1 Year After Surgery|Lost to Follow-up|22|||
13202990|NCT01988662|26222869|FG001|Overall Study|Subject/guardian decision|1|||
13113532|NCT03136367|25911686|FG002|T5 1 Year After Surgery|Lost to Follow-up|15|||
13113533|NCT03136367|25911684|FG000|T5 1 Year After Surgery|study ended before due|31|||
13113534|NCT03136367|25911685|FG001|T5 1 Year After Surgery|study ended before due|103|||
13113535|NCT03136367|25911686|FG002|T5 1 Year After Surgery|study ended before due|110|||
13202991|NCT01988662|26222868|FG000|Overall Study|Adverse Event|3|||
13202992|NCT01988662|26222869|FG001|Overall Study|Adverse Event|1|||
13202993|NCT01988493|26222954|FG000|Overall Study|Randomized but not treated|0|||
13202994|NCT01988493|26222955|FG001|Overall Study|Randomized but not treated|0|||
13202995|NCT01988493|26222956|FG002|Overall Study|Randomized but not treated|0|||
13202996|NCT01988493|26222957|FG003|Overall Study|Randomized but not treated|0|||
13202997|NCT01988493|26222958|FG004|Overall Study|Randomized but not treated|1|||
13202998|NCT01988402|26222977|FG000|Overall Study|Adverse Event|1|||
13202999|NCT01988402|26222978|FG001|Overall Study|Adverse Event|2|||
13203000|NCT01988402|26222977|FG000|Overall Study|Withdrawal by Subject|1|||
13203001|NCT01988402|26222978|FG001|Overall Study|Withdrawal by Subject|0|||
13203002|NCT01988337|26222990|FG000|Overall Study|Study was terminated due to insufficient recruitment before 36 month follow up could be completed|56|||
13203003|NCT01988233|26223009|FG000|Overall Study|Lost to Follow-up|64|||
13203004|NCT01988233|26223010|FG001|Overall Study|Lost to Follow-up|51|||
13206681|NCT01955161|26235169|FG000|Overall Study|Other reason: physician decision|0|||
13206682|NCT01955161|26235170|FG001|Overall Study|Other reason: physician decision|1|||
13206683|NCT01955161|26235171|FG002|Overall Study|Other reason: physician decision|1|||
13206684|NCT01955161|26235169|FG000|Overall Study|Other reason: disallowed medication|1|||
13206685|NCT01955161|26235170|FG001|Overall Study|Other reason: disallowed medication|0|||
13206686|NCT01955161|26235171|FG002|Overall Study|Other reason: disallowed medication|1|||
13206687|NCT01955161|26235169|FG000|Overall Study|Other reason: caregiver unavailable|1|||
13206688|NCT01955161|26235170|FG001|Overall Study|Other reason: caregiver unavailable|0|||
13206689|NCT01955161|26235171|FG002|Overall Study|Other reason: caregiver unavailable|0|||
13206690|NCT01955161|26235169|FG000|Overall Study|Other reason: moved to nursing home|0|||
13206691|NCT01955161|26235170|FG001|Overall Study|Other reason: moved to nursing home|1|||
13206692|NCT01955161|26235171|FG002|Overall Study|Other reason: moved to nursing home|0|||
13206693|NCT01955161|26235169|FG000|Overall Study|Other reason: insufficient compliance|0|||
13206694|NCT01955161|26235170|FG001|Overall Study|Other reason: insufficient compliance|0|||
13206695|NCT01955161|26235171|FG002|Overall Study|Other reason: insufficient compliance|1|||
13206696|NCT01955161|26235169|FG000|Overall Study|Other reason: primary biliary cirrhosis|1|||
13206697|NCT01955161|26235170|FG001|Overall Study|Other reason: primary biliary cirrhosis|0|||
13206698|NCT01955161|26235171|FG002|Overall Study|Other reason: primary biliary cirrhosis|0|||
13206699|NCT01955161|26235169|FG000|Overall Study|Other reason: patient's will|0|||
13206700|NCT01955161|26235170|FG001|Overall Study|Other reason: patient's will|0|||
13206701|NCT01955161|26235171|FG002|Overall Study|Other reason: patient's will|1|||
13206702|NCT01955122|26235196|FG000|Overall Study|Physician Decision|5|||
13206703|NCT01955122|26235197|FG001|Overall Study|Physician Decision|5|||
13206704|NCT01955083|26235234|FG000|Overall Study|Lost to Follow-up|1|||
13206705|NCT01955083|26235235|FG001|Overall Study|Lost to Follow-up|1|||
13206706|NCT01955044|26235256|FG000|Overall Study|Death|1|||
13206707|NCT01955044|26235257|FG001|Overall Study|Death|1|||
13206708|NCT01955044|26235258|FG002|Overall Study|Death|0|||
13206709|NCT01955005|26235275|FG000|Overall Study|Withdrawal by Subject|3|||
13206710|NCT01955005|26235276|FG001|Overall Study|Withdrawal by Subject|5|||
13206711|NCT01954927|26235301|FG000|Overall Study|Withdrawal by Subject|3|||
13206712|NCT01954927|26235302|FG001|Overall Study|Withdrawal by Subject|1|||
13206713|NCT01954771|26235329|FG000|Overall Study|Missing HbA1c of end-point|1|||
13206714|NCT01954771|26235330|FG001|Overall Study|Missing HbA1c of end-point|1|||
13206715|NCT01954771|26235331|FG002|Overall Study|Missing HbA1c of end-point|0|||
13206716|NCT01954771|26235329|FG000|Overall Study|Missing CGMS of end-point|1|||
13206717|NCT01954771|26235330|FG001|Overall Study|Missing CGMS of end-point|1|||
13206718|NCT01954771|26235331|FG002|Overall Study|Missing CGMS of end-point|0|||
13206719|NCT01954771|26235329|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5|||
13206720|NCT01954771|26235330|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1|||
13206721|NCT01954771|26235331|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3|||
13206722|NCT01954745|26235340|FG000|Overall Study|Radiological Progression|11|||
13206723|NCT01954745|26235340|FG000|Overall Study|Clinical Progression|5|||
13206724|NCT01954745|26235340|FG000|Overall Study|Adverse Event|2|||
13206725|NCT01954745|26235340|FG000|Overall Study|Death|1|||
13206726|NCT01954394|26235397|FG000|Overall Study|Enrolled but not treated|1|||
13206727|NCT01954394|26235398|FG001|Overall Study|Enrolled but not treated|0|||
13206728|NCT01954394|26235397|FG000|Overall Study|Adverse Event|10|||
13206729|NCT01954394|26235398|FG001|Overall Study|Adverse Event|23|||
13206730|NCT01954394|26235397|FG000|Overall Study|Poor compliance to protocol|7|||
13206731|NCT01954394|26235398|FG001|Overall Study|Poor compliance to protocol|7|||
13206732|NCT01954394|26235397|FG000|Overall Study|Participant Moved|0|||
13206733|NCT01954394|26235398|FG001|Overall Study|Participant Moved|4|||
13206734|NCT01954394|26235397|FG000|Overall Study|Related to Study Drug administration|2|||
13206735|NCT01954394|26235398|FG001|Overall Study|Related to Study Drug administration|2|||
13206736|NCT01954394|26235397|FG000|Overall Study|Other than specified above|10|||
13206737|NCT01954394|26235398|FG001|Overall Study|Other than specified above|21|||
13206738|NCT01954342|26235461|FG000|Overall Study|Missing data from 13-16week study visit|0|||
13206739|NCT01954342|26235462|FG001|Overall Study|Missing data from 13-16week study visit|0|||
13203005|NCT01988103|26223067|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3|||
13203006|NCT01988103|26223068|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10|||
13203007|NCT01988103|26223069|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6|||
13203008|NCT01988103|26223070|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
13203009|NCT01988103|26223071|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
13203010|NCT01988103|26223067|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1|||
13203011|NCT01988103|26223068|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
13203012|NCT01988103|26223069|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
13203013|NCT01988103|26223070|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
13203014|NCT01988103|26223071|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
13203015|NCT01988103|26223067|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8|||
13203016|NCT01988103|26223068|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4|||
13203017|NCT01988103|26223069|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1|||
13203018|NCT01988103|26223070|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
13203019|NCT01988103|26223071|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
13203020|NCT01988103|26223067|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0|||
13203021|NCT01988103|26223068|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6|||
13203022|NCT01988103|26223069|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
13203023|NCT01988103|26223070|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
13203024|NCT01988103|26223071|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2|||
13203025|NCT01988103|26223067|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
13203026|NCT01988103|26223068|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1|||
13203027|NCT01988103|26223069|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2|||
13223230|NCT01799590|26288091|FG000|Overall Study|Participants convenience|4|||
13223231|NCT01799590|26288092|FG001|Overall Study|Participants convenience|4|||
13223232|NCT01799590|26288093|FG002|Overall Study|Participants convenience|2|||
13223233|NCT01799590|26288091|FG000|Overall Study|Aggravation of complications|0|||
13223234|NCT01799590|26288092|FG001|Overall Study|Aggravation of complications|1|||
13223235|NCT01799590|26288093|FG002|Overall Study|Aggravation of complications|1|||
13223236|NCT01799590|26288091|FG000|Overall Study|Using drugs with restricted days of use|0|||
13223237|NCT01799590|26288092|FG001|Overall Study|Using drugs with restricted days of use|3|||
13223238|NCT01799590|26288093|FG002|Overall Study|Using drugs with restricted days of use|2|||
13223239|NCT01799590|26288091|FG000|Overall Study|Use of prohibited concomitant drugs|1|||
13223240|NCT01799590|26288092|FG001|Overall Study|Use of prohibited concomitant drugs|0|||
13223241|NCT01799590|26288093|FG002|Overall Study|Use of prohibited concomitant drugs|0|||
13223242|NCT01799590|26288091|FG000|Overall Study|Other|3|||
13223243|NCT01799590|26288092|FG001|Overall Study|Other|0|||
13223244|NCT01799590|26288093|FG002|Overall Study|Other|1|||
13223245|NCT01799239|26288102|FG000|Period 1 (7 Days)|Lack of Efficacy|1|||
13223246|NCT01799239|26288103|FG001|Period 1 (7 Days)|Lack of Efficacy|0|||
13223247|NCT01799239|26288102|FG000|Period 1 (7 Days)|Withdrawal by Subject|2|||
13223248|NCT01799239|26288103|FG001|Period 1 (7 Days)|Withdrawal by Subject|0|||
13223249|NCT01799239|26288102|FG000|Period 1 (7 Days)|Protocol Violation|0|||
13223250|NCT01799239|26288103|FG001|Period 1 (7 Days)|Protocol Violation|1|||
13223251|NCT01799239|26288102|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
13223252|NCT01799239|26288103|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
13223253|NCT01799239|26288102|FG000|Period 2 (7 Days)|Protocol Violation|1|||
13223254|NCT01799239|26288103|FG001|Period 2 (7 Days)|Protocol Violation|0|||
13223255|NCT01799226|26288118|FG000|Overall Study|Withdrawal by Subject|1|||
13223256|NCT01799226|26288119|FG001|Overall Study|Withdrawal by Subject|0|||
13223257|NCT01799226|26288118|FG000|Overall Study|Disqualified at Day 14|1|||
13223258|NCT01799226|26288119|FG001|Overall Study|Disqualified at Day 14|0|||
13223259|NCT01798992|26288146|FG000|Overall Study|Administrative withdrawal|0|||
13223260|NCT01798992|26288147|FG001|Overall Study|Administrative withdrawal|1|||
13223261|NCT01798992|26288148|FG002|Overall Study|Administrative withdrawal|0|||
13223262|NCT01798992|26288149|FG003|Overall Study|Administrative withdrawal|1|||
13223263|NCT01798992|26288146|FG000|Overall Study|Lost to Follow-up|0|||
13223264|NCT01798992|26288147|FG001|Overall Study|Lost to Follow-up|1|||
13223265|NCT01798992|26288148|FG002|Overall Study|Lost to Follow-up|1|||
13223266|NCT01798992|26288149|FG003|Overall Study|Lost to Follow-up|0|||
13223267|NCT01798992|26288146|FG000|Overall Study|Insufficient biopsy tissue|0|||
13223268|NCT01798992|26288147|FG001|Overall Study|Insufficient biopsy tissue|0|||
13223269|NCT01798992|26288148|FG002|Overall Study|Insufficient biopsy tissue|1|||
13223270|NCT01798992|26288149|FG003|Overall Study|Insufficient biopsy tissue|0|||
13223271|NCT01798927|26288157|FG000|Overall Study|Withdrawal by Subject|1|||
13223272|NCT01798849|26288355|FG000|Overall Study|Physician Decision|0|||
13223273|NCT01798849|26288356|FG001|Overall Study|Physician Decision|0|||
13223274|NCT01798849|26288357|FG002|Overall Study|Physician Decision|1|||
13223275|NCT01798706|26288390|FG000|Overall Study|Adverse Event|15|||
13223276|NCT01798706|26288391|FG001|Overall Study|Adverse Event|10|||
13223277|NCT01798706|26288390|FG000|Overall Study|Lack of Efficacy|0|||
13223278|NCT01798706|26288391|FG001|Overall Study|Lack of Efficacy|2|||
13223279|NCT01798706|26288390|FG000|Overall Study|Poor compliance to protocol|1|||
13223280|NCT01798706|26288391|FG001|Overall Study|Poor compliance to protocol|0|||
13223281|NCT01798706|26288390|FG000|Overall Study|Other than specified above|5|||
13223282|NCT01798706|26288391|FG001|Overall Study|Other than specified above|9|||
13223283|NCT01798485|26288432|FG000|Overall Study|Adverse Event|32|||
13223284|NCT01798485|26288433|FG001|Overall Study|Adverse Event|40|||
13223285|NCT01798485|26288432|FG000|Overall Study|Withdrawal by Subject|27|||
13223286|NCT01798485|26288433|FG001|Overall Study|Withdrawal by Subject|31|||
13223287|NCT01798485|26288432|FG000|Overall Study|Lost to Follow-up|0|||
13223288|NCT01798485|26288433|FG001|Overall Study|Lost to Follow-up|3|||
13223289|NCT01798485|26288432|FG000|Overall Study|Physician Decision|14|||
13223290|NCT01798485|26288433|FG001|Overall Study|Physician Decision|10|||
13223291|NCT01798485|26288432|FG000|Overall Study|Objective Disease Progression|152|||
13223292|NCT01798485|26288433|FG001|Overall Study|Objective Disease Progression|106|||
13223293|NCT01798485|26288432|FG000|Overall Study|Death|25|||
13223294|NCT01798485|26288433|FG001|Overall Study|Death|22|||
13223295|NCT01798485|26288432|FG000|Overall Study|Sponsor Decision|61|||
13223296|NCT01798485|26288433|FG001|Overall Study|Sponsor Decision|54|||
13223297|NCT01798485|26288432|FG000|Overall Study|Clinical Progression|35|||
13223298|NCT01798485|26288433|FG001|Overall Study|Clinical Progression|24|||
13223299|NCT01798134|26288442|FG000|Overall Study|Lost to Follow-up|1|||
13223300|NCT01798134|26288442|FG000|Overall Study|Withdrawal by Subject|3|||
13223301|NCT01798134|26288442|FG000|Overall Study|Death|2|||
13223302|NCT01798134|26288442|FG000|Overall Study|Adverse Event|3|||
13223303|NCT01798134|26288442|FG000|Overall Study|Physician Decision|3|||
13223304|NCT01798134|26288442|FG000|Overall Study|Liver transplant/surgery|4|||
13223305|NCT01798056|26288483|FG000|Overall Study|Serious Adverse Event|13|||
13223306|NCT01798056|26288484|FG001|Overall Study|Serious Adverse Event|12|||
13223307|NCT01798056|26288483|FG000|Overall Study|Withdrawal by Subject|12|||
13223308|NCT01798056|26288484|FG001|Overall Study|Withdrawal by Subject|9|||
13223309|NCT01798056|26288483|FG000|Overall Study|Migrated/moved from study area|1|||
13223310|NCT01798056|26288484|FG001|Overall Study|Migrated/moved from study area|1|||
13223311|NCT01798056|26288483|FG000|Overall Study|Lost to Follow-up|1|||
13223312|NCT01798056|26288484|FG001|Overall Study|Lost to Follow-up|1|||
13223313|NCT01798056|26288483|FG000|Overall Study|Other|0|||
13223314|NCT01798056|26288484|FG001|Overall Study|Other|2|||
13223315|NCT01797965|26288629|FG000|Overall Study|Adverse Event|104|||
13223316|NCT01797965|26288630|FG001|Overall Study|Adverse Event|129|||
13223317|NCT01797965|26288631|FG002|Overall Study|Adverse Event|4|||
13223318|NCT01797965|26288632|FG003|Overall Study|Adverse Event|21|||
13223319|NCT01797965|26288629|FG000|Overall Study|Lost to Follow-up|9|||
13223320|NCT01797965|26288630|FG001|Overall Study|Lost to Follow-up|8|||
13223321|NCT01797965|26288631|FG002|Overall Study|Lost to Follow-up|1|||
13223322|NCT01797965|26288632|FG003|Overall Study|Lost to Follow-up|2|||
13223323|NCT01797965|26288629|FG000|Overall Study|Consent withdrawn|130|||
13223324|NCT01797965|26288630|FG001|Overall Study|Consent withdrawn|117|||
13223325|NCT01797965|26288631|FG002|Overall Study|Consent withdrawn|3|||
13223326|NCT01797965|26288632|FG003|Overall Study|Consent withdrawn|35|||
13223327|NCT01797965|26288629|FG000|Overall Study|Investigator decision|21|||
13223328|NCT01797965|26288630|FG001|Overall Study|Investigator decision|15|||
13223329|NCT01797965|26288631|FG002|Overall Study|Investigator decision|0|||
13223330|NCT01797965|26288632|FG003|Overall Study|Investigator decision|0|||
13223331|NCT01797965|26288629|FG000|Overall Study|Death|2|||
13223332|NCT01797965|26288630|FG001|Overall Study|Death|4|||
13223333|NCT01797965|26288631|FG002|Overall Study|Death|0|||
13223334|NCT01797965|26288632|FG003|Overall Study|Death|0|||
13223335|NCT01797965|26288629|FG000|Overall Study|Disease progression, defined by protocol|3|||
13223336|NCT01797965|26288630|FG001|Overall Study|Disease progression, defined by protocol|1|||
13223337|NCT01797965|26288631|FG002|Overall Study|Disease progression, defined by protocol|0|||
13223338|NCT01797965|26288632|FG003|Overall Study|Disease progression, defined by protocol|0|||
13223339|NCT01797965|26288629|FG000|Overall Study|Reason Not Specified|280|||
13223340|NCT01797965|26288630|FG001|Overall Study|Reason Not Specified|295|||
13223341|NCT01797965|26288631|FG002|Overall Study|Reason Not Specified|0|||
13223342|NCT01797965|26288632|FG003|Overall Study|Reason Not Specified|15|||
13223343|NCT01797835|26288647|FG000|Overall Study|Lost to Follow-up|31|||
13223344|NCT01797835|26288648|FG001|Overall Study|Lost to Follow-up|27|||
13223345|NCT01797783|26288677|FG000|Overall Study|Adverse Event|1|||
13223346|NCT01797783|26288678|FG001|Overall Study|Adverse Event|1|||
13223347|NCT01797783|26288677|FG000|Overall Study|Withdrawal by Subject|1|||
13223348|NCT01797783|26288678|FG001|Overall Study|Withdrawal by Subject|0|||
13223349|NCT01797731|26288693|FG000|Overall Study|Didn't have proper radiographs required|3|||
13223350|NCT01797731|26288694|FG001|Overall Study|Didn't have proper radiographs required|3|||
13223351|NCT01797705|26288700|FG000|Overall Study|Equipment anomalies during sleep studies|4|||
13223352|NCT01797705|26288700|FG000|Overall Study|Withdrawal by Subject|1|||
13223353|NCT01797562|26288707|FG000|Overall Study|Protocol Violation|5|||
13223354|NCT01797536|26288750|FG000|Overall Study|Adverse Event|0|||
13223355|NCT01797536|26288751|FG001|Overall Study|Adverse Event|1|||
13223356|NCT01797536|26288752|FG002|Overall Study|Adverse Event|0|||
13223357|NCT01797536|26288753|FG003|Overall Study|Adverse Event|0|||
13223358|NCT01797445|26288800|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
13223359|NCT01797445|26288801|FG001|Double-Blind Phase|Randomized but Not Treated|2|||
13223360|NCT01797445|26288800|FG000|Double-Blind Phase|Adverse Event|3|||
13223361|NCT01797445|26288801|FG001|Double-Blind Phase|Adverse Event|0|||
13223362|NCT01797445|26288800|FG000|Double-Blind Phase|Death|5|||
13223363|NCT01797445|26288801|FG001|Double-Blind Phase|Death|4|||
13223364|NCT01797445|26288800|FG000|Double-Blind Phase|Pregnancy|0|||
13223365|NCT01797445|26288801|FG001|Double-Blind Phase|Pregnancy|1|||
13223366|NCT01797445|26288800|FG000|Double-Blind Phase|Lack of Efficacy|1|||
13223367|NCT01797445|26288801|FG001|Double-Blind Phase|Lack of Efficacy|2|||
13223368|NCT01797445|26288800|FG000|Double-Blind Phase|Investigator's Discretion|15|||
13223369|NCT01797445|26288801|FG001|Double-Blind Phase|Investigator's Discretion|17|||
13223370|NCT01797445|26288800|FG000|Double-Blind Phase|Noncompliance with Study Drug|5|||
13223371|NCT01797445|26288801|FG001|Double-Blind Phase|Noncompliance with Study Drug|1|||
13223372|NCT01797445|26288800|FG000|Double-Blind Phase|Protocol Violation|0|||
13223373|NCT01797445|26288801|FG001|Double-Blind Phase|Protocol Violation|1|||
13223374|NCT01797445|26288800|FG000|Double-Blind Phase|Withdrew Consent|20|||
13223375|NCT01797445|26288801|FG001|Double-Blind Phase|Withdrew Consent|35|||
13223376|NCT01797445|26288800|FG000|Double-Blind Phase|Lost to Follow-up|34|||
13223377|NCT01797445|26288801|FG001|Double-Blind Phase|Lost to Follow-up|26|||
13223378|NCT01797445|26288800|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
13223379|NCT01797445|26288801|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
13289421|NCT01589523|26479118|FG000|Overall Study|Withdrawal by Subject|1|||
13289422|NCT01585103|26479125|FG000|Overall Study|Unable to swallow Cytosponge|6|||
13289423|NCT01564537|26479152|FG000|Overall Study|Withdrawal by Participant|4|||
13289424|NCT01564537|26479153|FG001|Overall Study|Withdrawal by Participant|4|||
13289425|NCT01564537|26479152|FG000|Overall Study|Lost to Follow-up|1|||
13289426|NCT01564537|26479153|FG001|Overall Study|Lost to Follow-up|0|||
13289427|NCT01564537|26479152|FG000|Overall Study|Other Miscellaneous Reasons|1|||
13289428|NCT01564537|26479153|FG001|Overall Study|Other Miscellaneous Reasons|2|||
13289429|NCT01561430|26479204|FG000|Overall Study|Adverse Event|0|||
13289430|NCT01561430|26479205|FG001|Overall Study|Adverse Event|0|||
13289431|NCT01561430|26479206|FG002|Overall Study|Adverse Event|3|||
13289432|NCT01561430|26479207|FG003|Overall Study|Adverse Event|1|||
13289433|NCT01561430|26479204|FG000|Overall Study|Withdrawal by Subject|0|||
13289434|NCT01561430|26479205|FG001|Overall Study|Withdrawal by Subject|0|||
13289435|NCT01561430|26479206|FG002|Overall Study|Withdrawal by Subject|1|||
13289436|NCT01561430|26479207|FG003|Overall Study|Withdrawal by Subject|0|||
13289437|NCT01561430|26479204|FG000|Overall Study|Physician Decision|0|||
13289438|NCT01561430|26479205|FG001|Overall Study|Physician Decision|1|||
13289439|NCT01561430|26479206|FG002|Overall Study|Physician Decision|0|||
13289440|NCT01561430|26479207|FG003|Overall Study|Physician Decision|0|||
13289441|NCT01561430|26479204|FG000|Overall Study|Sponsor Decision|1|||
13289442|NCT01561430|26479205|FG001|Overall Study|Sponsor Decision|14|||
13289443|NCT01561430|26479206|FG002|Overall Study|Sponsor Decision|13|||
13289444|NCT01561430|26479207|FG003|Overall Study|Sponsor Decision|12|||
13289445|NCT01560637|26479217|FG000|Overall Study|Adverse Event|63|||
13289446|NCT01560637|26479217|FG000|Overall Study|Death|69|||
13289447|NCT01560637|26479217|FG000|Overall Study|Lost to Follow-up|8|||
13289448|NCT01560637|26479217|FG000|Overall Study|Protocol Violation|8|||
13289449|NCT01560637|26479217|FG000|Overall Study|Withdrawal by Subject|24|||
13289450|NCT01560637|26479217|FG000|Overall Study|Progressive Disease|20|||
13289451|NCT01560637|26479217|FG000|Overall Study|Other Reason Not Specified|6|||
13289452|NCT01563107|26479296|FG000|Overall Study|Physician Decision|0|||
13289453|NCT01563107|26479297|FG001|Overall Study|Physician Decision|1|||
13289454|NCT01563107|26479298|FG002|Overall Study|Physician Decision|1|||
13289455|NCT01563107|26479299|FG003|Overall Study|Physician Decision|3|||
13289456|NCT01563107|26479296|FG000|Overall Study|Withdrawal by Subject|1|||
13289457|NCT01563107|26479297|FG001|Overall Study|Withdrawal by Subject|2|||
13289458|NCT01563107|26479298|FG002|Overall Study|Withdrawal by Subject|1|||
13289459|NCT01563107|26479299|FG003|Overall Study|Withdrawal by Subject|2|||
13289460|NCT00109967|26479320|FG000|Overall Study|Cancel Prior to Treatment|2|||
13289461|NCT00109967|26479321|FG001|Overall Study|Cancel Prior to Treatment|0|||
13289462|NCT00109967|26479320|FG000|Overall Study|Adverse Event|12|||
13289463|NCT00109967|26479321|FG001|Overall Study|Adverse Event|1|||
13289464|NCT00109967|26479320|FG000|Overall Study|Withdrawal by Subject|5|||
13289465|NCT00109967|26479321|FG001|Overall Study|Withdrawal by Subject|0|||
13289466|NCT00109967|26479320|FG000|Overall Study|Physician Decision|1|||
13289467|NCT00109967|26479321|FG001|Overall Study|Physician Decision|3|||
13289468|NCT00109967|26479320|FG000|Overall Study|Death|0|||
13289469|NCT00109967|26479321|FG001|Overall Study|Death|2|||
13289470|NCT00109928|26479330|FG000|Overall Study|Adverse Event|2|||
13289471|NCT00109928|26479330|FG000|Overall Study|Progression|6|||
13289472|NCT00109928|26479330|FG000|Overall Study|Death|2|||
13289473|NCT00109928|26479330|FG000|Overall Study|not protocol specified|2|||
13289474|NCT00109928|26479330|FG000|Overall Study|not eligible|1|||
13223380|NCT01797432|26288808|FG000|Overall Study|Lost to Follow-up|1|||
13223381|NCT01797432|26288808|FG000|Overall Study|Adverse Event|1|||
13223382|NCT01797432|26288808|FG000|Overall Study|Withdrawal by Subject|1|||
13223383|NCT01797432|26288808|FG000|Overall Study|lived too far from study site|1|||
13223384|NCT01797302|26288853|FG000|Overall Study|Lost to Follow-up|16|||
13223385|NCT01797302|26288854|FG001|Overall Study|Lost to Follow-up|23|||
13223386|NCT01797302|26288855|FG002|Overall Study|Lost to Follow-up|22|||
13223387|NCT01797302|26288853|FG000|Overall Study|Withdrawal by Subject|1|||
13223388|NCT01797302|26288854|FG001|Overall Study|Withdrawal by Subject|3|||
13223389|NCT01797302|26288855|FG002|Overall Study|Withdrawal by Subject|4|||
13223390|NCT01797263|26288894|FG000|Overall Study|Withdrawal by Subject|21|||
13223391|NCT01797263|26288895|FG001|Overall Study|Withdrawal by Subject|25|||
13223392|NCT01797263|26288894|FG000|Overall Study|Death|1|||
13223393|NCT01797263|26288895|FG001|Overall Study|Death|0|||
13223394|NCT01797263|26288894|FG000|Overall Study|Lost to Follow-up|15|||
13223395|NCT01797263|26288895|FG001|Overall Study|Lost to Follow-up|15|||
13223396|NCT01797185|26288913|FG000|Overall Study|Adverse Event|5|||
13223397|NCT01797185|26288914|FG001|Overall Study|Adverse Event|15|||
13223398|NCT01797185|26288915|FG002|Overall Study|Adverse Event|6|||
13223399|NCT01797185|26288913|FG000|Overall Study|Withdrawal by Subject|6|||
13223400|NCT01797185|26288914|FG001|Overall Study|Withdrawal by Subject|9|||
13223401|NCT01797185|26288915|FG002|Overall Study|Withdrawal by Subject|5|||
13223402|NCT01797185|26288913|FG000|Overall Study|Site terminated|8|||
13223403|NCT01797185|26288914|FG001|Overall Study|Site terminated|4|||
13223404|NCT01797185|26288915|FG002|Overall Study|Site terminated|0|||
13223405|NCT01797185|26288913|FG000|Overall Study|Lost to Follow-up|2|||
13223406|NCT01797185|26288914|FG001|Overall Study|Lost to Follow-up|6|||
13223407|NCT01797185|26288915|FG002|Overall Study|Lost to Follow-up|1|||
13223408|NCT01797185|26288913|FG000|Overall Study|Withdrawn per sponsor|5|||
13223409|NCT01797185|26288914|FG001|Overall Study|Withdrawn per sponsor|0|||
13223410|NCT01797185|26288915|FG002|Overall Study|Withdrawn per sponsor|0|||
13223411|NCT01797185|26288913|FG000|Overall Study|Physician Decision|1|||
13223412|NCT01797185|26288914|FG001|Overall Study|Physician Decision|3|||
13223413|NCT01797185|26288915|FG002|Overall Study|Physician Decision|0|||
13223414|NCT01797185|26288913|FG000|Overall Study|Protocol Violation|1|||
13223415|NCT01797185|26288914|FG001|Overall Study|Protocol Violation|1|||
13223416|NCT01797185|26288915|FG002|Overall Study|Protocol Violation|0|||
13223417|NCT01797120|26288934|FG000|Overall Study|Disesae progression|37|||
13223418|NCT01797120|26288935|FG001|Overall Study|Disesae progression|49|||
13223419|NCT01797120|26288934|FG000|Overall Study|Adverse Event|13|||
13223420|NCT01797120|26288935|FG001|Overall Study|Adverse Event|5|||
13223421|NCT01797120|26288934|FG000|Overall Study|Withdrawal by Subject|6|||
13223422|NCT01797120|26288935|FG001|Overall Study|Withdrawal by Subject|6|||
13223423|NCT01797120|26288934|FG000|Overall Study|Symptomatic progression|2|||
13223424|NCT01797120|26288935|FG001|Overall Study|Symptomatic progression|1|||
13223425|NCT01797120|26288934|FG000|Overall Study|Non-compliance|1|||
13223426|NCT01797120|26288935|FG001|Overall Study|Non-compliance|0|||
13223427|NCT01797120|26288934|FG000|Overall Study|Physician Decision|3|||
13223428|NCT01797120|26288935|FG001|Overall Study|Physician Decision|0|||
13223429|NCT01797120|26288934|FG000|Overall Study|still on treatment|2|||
13223430|NCT01797120|26288935|FG001|Overall Study|still on treatment|4|||
13223431|NCT01797120|26288934|FG000|Overall Study|never start protocol therapy|2|||
13223432|NCT01797120|26288935|FG001|Overall Study|never start protocol therapy|0|||
13223433|NCT01797094|26288960|FG000|Overall Study|Adverse Event|1|||
13223434|NCT01797094|26288961|FG001|Overall Study|Adverse Event|1|||
13223435|NCT01797094|26288960|FG000|Overall Study|Personal Reasons|4|||
13223436|NCT01797094|26288961|FG001|Overall Study|Personal Reasons|0|||
13223437|NCT01797094|26288960|FG000|Overall Study|Protocol Violation|0|||
13223438|NCT01797094|26288961|FG001|Overall Study|Protocol Violation|1|||
13223439|NCT01797094|26288960|FG000|Overall Study|Other Miscellaneous Reasons|1|||
13223440|NCT01797094|26288961|FG001|Overall Study|Other Miscellaneous Reasons|0|||
13223441|NCT01797081|26288991|FG000|Overall Study|Adverse Event|1|||
13223442|NCT01797081|26288992|FG001|Overall Study|Adverse Event|0|||
13223443|NCT01797081|26288993|FG002|Overall Study|Adverse Event|1|||
13223444|NCT01797081|26288994|FG003|Overall Study|Adverse Event|0|||
13223445|NCT01797081|26288991|FG000|Overall Study|Pregnancy|1|||
13223446|NCT01797081|26288992|FG001|Overall Study|Pregnancy|0|||
13223447|NCT01797081|26288993|FG002|Overall Study|Pregnancy|0|||
13223448|NCT01797081|26288994|FG003|Overall Study|Pregnancy|0|||
13223449|NCT01797081|26288991|FG000|Overall Study|Personal Reasons|12|||
13223450|NCT01797081|26288992|FG001|Overall Study|Personal Reasons|4|||
13223451|NCT01797081|26288993|FG002|Overall Study|Personal Reasons|4|||
13223452|NCT01797081|26288994|FG003|Overall Study|Personal Reasons|8|||
13223453|NCT01797081|26288991|FG000|Overall Study|Protocol Violation|0|||
13223454|NCT01797081|26288992|FG001|Overall Study|Protocol Violation|0|||
13223455|NCT01797081|26288993|FG002|Overall Study|Protocol Violation|0|||
13223456|NCT01797081|26288994|FG003|Overall Study|Protocol Violation|1|||
13223457|NCT01796964|26289023|FG000|Overall Study|Adverse Event|1|||
13223458|NCT01796964|26289024|FG001|Overall Study|Adverse Event|1|||
13223459|NCT01796964|26289023|FG000|Overall Study|Death|1|||
13223460|NCT01796964|26289024|FG001|Overall Study|Death|0|||
13223461|NCT01796964|26289023|FG000|Overall Study|Protocol Violation|0|||
13223462|NCT01796964|26289024|FG001|Overall Study|Protocol Violation|1|||
13223463|NCT01796964|26289023|FG000|Overall Study|Withdrawal by Subject|1|||
13223464|NCT01796964|26289024|FG001|Overall Study|Withdrawal by Subject|1|||
13223465|NCT01796860|26289032|FG000|Overall Study|Withdrawal by Subject|3|||
13223466|NCT01796548|26289046|FG000|Overall Study|Lost to Follow-up|1|||
13223467|NCT01796548|26289046|FG000|Overall Study|Other|2|||
13223468|NCT01796470|26289104|FG000|Overall Study|Adverse Event|4|||
13223469|NCT01796470|26289105|FG001|Overall Study|Adverse Event|2|||
13223470|NCT01796470|26289106|FG002|Overall Study|Adverse Event|2|||
13223471|NCT01796470|26289107|FG003|Overall Study|Adverse Event|1|||
13223472|NCT01796470|26289108|FG004|Overall Study|Adverse Event|3|||
13223473|NCT01796470|26289104|FG000|Overall Study|Death|2|||
13223474|NCT01796470|26289105|FG001|Overall Study|Death|0|||
13223475|NCT01796470|26289106|FG002|Overall Study|Death|0|||
13223476|NCT01796470|26289107|FG003|Overall Study|Death|0|||
13223477|NCT01796470|26289108|FG004|Overall Study|Death|1|||
13223478|NCT01796470|26289104|FG000|Overall Study|Initiated New Therapy|9|||
13223479|NCT01796470|26289105|FG001|Overall Study|Initiated New Therapy|0|||
13223480|NCT01796470|26289106|FG002|Overall Study|Initiated New Therapy|0|||
13223481|NCT01796470|26289107|FG003|Overall Study|Initiated New Therapy|0|||
13223482|NCT01796470|26289108|FG004|Overall Study|Initiated New Therapy|2|||
13223483|NCT01796470|26289104|FG000|Overall Study|Lost to Follow-up|0|||
13223484|NCT01796470|26289105|FG001|Overall Study|Lost to Follow-up|1|||
13223485|NCT01796470|26289106|FG002|Overall Study|Lost to Follow-up|0|||
13223486|NCT01796470|26289107|FG003|Overall Study|Lost to Follow-up|0|||
13223487|NCT01796470|26289108|FG004|Overall Study|Lost to Follow-up|0|||
13223488|NCT01796470|26289104|FG000|Overall Study|Physician Decision|5|||
13223489|NCT01796470|26289105|FG001|Overall Study|Physician Decision|4|||
13223490|NCT01796470|26289106|FG002|Overall Study|Physician Decision|1|||
13223491|NCT01796470|26289107|FG003|Overall Study|Physician Decision|0|||
13223492|NCT01796470|26289108|FG004|Overall Study|Physician Decision|1|||
13223493|NCT01796470|26289104|FG000|Overall Study|Progressive Disease|7|||
13223494|NCT01796470|26289105|FG001|Overall Study|Progressive Disease|7|||
13223495|NCT01796470|26289106|FG002|Overall Study|Progressive Disease|3|||
13223496|NCT01796470|26289107|FG003|Overall Study|Progressive Disease|2|||
13223497|NCT01796470|26289108|FG004|Overall Study|Progressive Disease|0|||
13223498|NCT01796470|26289104|FG000|Overall Study|Protocol Criteria for Withdrawal|1|||
13223499|NCT01796470|26289105|FG001|Overall Study|Protocol Criteria for Withdrawal|0|||
13223500|NCT01796470|26289106|FG002|Overall Study|Protocol Criteria for Withdrawal|0|||
13223501|NCT01796470|26289107|FG003|Overall Study|Protocol Criteria for Withdrawal|0|||
13223502|NCT01796470|26289108|FG004|Overall Study|Protocol Criteria for Withdrawal|0|||
13223503|NCT01796470|26289104|FG000|Overall Study|Withdrawal by Subject|7|||
13223504|NCT01796470|26289105|FG001|Overall Study|Withdrawal by Subject|0|||
13223505|NCT01796470|26289106|FG002|Overall Study|Withdrawal by Subject|0|||
13223506|NCT01796470|26289107|FG003|Overall Study|Withdrawal by Subject|0|||
13223507|NCT01796470|26289108|FG004|Overall Study|Withdrawal by Subject|1|||
13223508|NCT01796392|26289127|FG000|Overall Study|Withdrawal by Subject|2|||
13223509|NCT01796392|26289128|FG001|Overall Study|Withdrawal by Subject|0|||
13223510|NCT01796392|26289127|FG000|Overall Study|Death|5|||
13223511|NCT01796392|26289128|FG001|Overall Study|Death|1|||
13223512|NCT01796392|26289127|FG000|Overall Study|Excluded for medical reasons|1|||
13223513|NCT01796392|26289128|FG001|Overall Study|Excluded for medical reasons|2|||
13223514|NCT01796392|26289127|FG000|Overall Study|Lost to Follow-up|1|||
13113536|NCT03136367|25911684|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0|||
13113537|NCT03136367|25911685|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4|||
13113538|NCT03136367|25911686|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2|||
13113539|NCT03136198|25911699|FG000|Overall Study|Withdrawal by Subject|0|||
13223515|NCT01796392|26289128|FG001|Overall Study|Lost to Follow-up|0|||
13223516|NCT01796197|26289143|FG000|Overall Study|Lost to Follow-up|1|||
13223517|NCT01796197|26289143|FG000|Overall Study|Lack of Efficacy|1|||
13223518|NCT01795937|26289182|FG000|Overall Study|Withdrawal by Subject|1|||
13223519|NCT01795937|26289183|FG001|Overall Study|Withdrawal by Subject|0|||
13223520|NCT01795937|26289184|FG002|Overall Study|Withdrawal by Subject|0|||
13223521|NCT01795937|26289182|FG000|Overall Study|Physician Decision|0|||
13223522|NCT01795937|26289183|FG001|Overall Study|Physician Decision|1|||
13223523|NCT01795937|26289184|FG002|Overall Study|Physician Decision|0|||
13223524|NCT01795898|26289194|FG000|Overall Study|Adverse Event|27|||
13223525|NCT01795898|26289194|FG000|Overall Study|Lost to Follow-up|20|||
13223526|NCT01795898|26289194|FG000|Overall Study|Withdrawal of consent|6|||
13223527|NCT01795898|26289194|FG000|Overall Study|Diagnosed with metastasis|1|||
13223528|NCT01795898|26289194|FG000|Overall Study|No pain|1|||
13223529|NCT01795898|26289194|FG000|Overall Study|Death|1|||
13223530|NCT01795898|26289194|FG000|Overall Study|Withdrew consent & had adverse events|3|||
13223531|NCT01795898|26289194|FG000|Overall Study|Physician Decision|1|||
13223532|NCT01795638|26289225|FG000|Overall Study|Death|0|||
13223533|NCT01795638|26289226|FG001|Overall Study|Death|3|||
13223534|NCT01795638|26289225|FG000|Overall Study|transferred to quaternary hospital|2|||
13223535|NCT01795638|26289226|FG001|Overall Study|transferred to quaternary hospital|3|||
13223536|NCT01795638|26289225|FG000|Overall Study|Protocol Violation|3|||
13223537|NCT01795638|26289226|FG001|Overall Study|Protocol Violation|0|||
13223538|NCT01795638|26289225|FG000|Overall Study|discharged from hospital|7|||
13223539|NCT01795638|26289226|FG001|Overall Study|discharged from hospital|5|||
13223540|NCT01795638|26289225|FG000|Overall Study|Withdrawal by Subject|1|||
13223541|NCT01795638|26289226|FG001|Overall Study|Withdrawal by Subject|0|||
13223542|NCT01795547|26289255|FG000|Overall Study|Adverse Event|16|||
13223543|NCT01795547|26289256|FG001|Overall Study|Adverse Event|27|||
13223544|NCT01795547|26289255|FG000|Overall Study|Lack of Efficacy|8|||
13223545|NCT01795547|26289256|FG001|Overall Study|Lack of Efficacy|3|||
13223546|NCT01795547|26289255|FG000|Overall Study|Protocol Violation|6|||
13223547|NCT01795547|26289256|FG001|Overall Study|Protocol Violation|4|||
13223548|NCT01795547|26289255|FG000|Overall Study|Lost to Follow-up|2|||
13223549|NCT01795547|26289256|FG001|Overall Study|Lost to Follow-up|5|||
13223550|NCT01795547|26289255|FG000|Overall Study|Withdrawal of consent|7|||
13223551|NCT01795547|26289256|FG001|Overall Study|Withdrawal of consent|12|||
13223552|NCT01795547|26289255|FG000|Overall Study|Not Treated|4|||
13223553|NCT01795547|26289256|FG001|Overall Study|Not Treated|10|||
13223554|NCT01795547|26289255|FG000|Overall Study|Non-compliance with IMP|1|||
13223555|NCT01795547|26289256|FG001|Overall Study|Non-compliance with IMP|1|||
13223556|NCT01795547|26289255|FG000|Overall Study|Others|4|||
13223557|NCT01795547|26289256|FG001|Overall Study|Others|1|||
13223558|NCT01795547|26289255|FG000|Overall Study|Not stated|0|||
13223559|NCT01795547|26289256|FG001|Overall Study|Not stated|1|||
13223560|NCT01795495|26289277|FG000|Overall Study|Protocol Violation|1|||
13223561|NCT01795495|26289278|FG001|Overall Study|Protocol Violation|0|||
13223562|NCT01795495|26289279|FG002|Overall Study|Protocol Violation|1|||
13223563|NCT01795495|26289277|FG000|Overall Study|Physician Decision|0|||
13223564|NCT01795495|26289278|FG001|Overall Study|Physician Decision|0|||
13223565|NCT01795495|26289279|FG002|Overall Study|Physician Decision|1|||
13223566|NCT01794949|26289292|FG000|Overall Study|Lost to Follow-up|1|||
13223567|NCT01794949|26289293|FG001|Overall Study|Lost to Follow-up|0|||
13223568|NCT01794923|26289344|FG000|Overall Study|Adverse Event|0|||
13223569|NCT01794923|26289345|FG001|Overall Study|Adverse Event|0|||
13223570|NCT01794923|26289346|FG002|Overall Study|Adverse Event|1|||
13223571|NCT01794845|26289355|FG000|Overall Study|Withdrawal by Subject|1|||
13223572|NCT01794780|26289428|FG000|Overall Study|Adverse Event|0|||
13223573|NCT01794780|26289429|FG001|Overall Study|Adverse Event|1|||
13223574|NCT01794780|26289430|FG002|Overall Study|Adverse Event|2|||
13223575|NCT01794780|26289431|FG003|Overall Study|Adverse Event|0|||
13223576|NCT01794780|26289432|FG004|Overall Study|Adverse Event|0|||
13223577|NCT01794780|26289433|FG005|Overall Study|Adverse Event|0|||
13223578|NCT01794780|26289434|FG006|Overall Study|Adverse Event|0|||
13223579|NCT01794780|26289435|FG007|Overall Study|Adverse Event|0|||
13223580|NCT01794780|26289428|FG000|Overall Study|Death|0|||
13223581|NCT01794780|26289429|FG001|Overall Study|Death|2|||
13223582|NCT01794780|26289430|FG002|Overall Study|Death|14|||
13223583|NCT01794780|26289431|FG003|Overall Study|Death|1|||
13223584|NCT01794780|26289432|FG004|Overall Study|Death|0|||
13223585|NCT01794780|26289433|FG005|Overall Study|Death|9|||
13223586|NCT01794780|26289434|FG006|Overall Study|Death|4|||
13223587|NCT01794780|26289435|FG007|Overall Study|Death|0|||
13223588|NCT01794780|26289428|FG000|Overall Study|Lost to Follow-up|10|||
13223589|NCT01794780|26289429|FG001|Overall Study|Lost to Follow-up|64|||
13223590|NCT01794780|26289430|FG002|Overall Study|Lost to Follow-up|165|||
13223591|NCT01794780|26289431|FG003|Overall Study|Lost to Follow-up|53|||
13223592|NCT01794780|26289432|FG004|Overall Study|Lost to Follow-up|2|||
13223593|NCT01794780|26289433|FG005|Overall Study|Lost to Follow-up|99|||
13223594|NCT01794780|26289434|FG006|Overall Study|Lost to Follow-up|30|||
13223595|NCT01794780|26289435|FG007|Overall Study|Lost to Follow-up|5|||
13223596|NCT01794780|26289428|FG000|Overall Study|Withdrew informed consent|7|||
13223597|NCT01794780|26289429|FG001|Overall Study|Withdrew informed consent|17|||
13223598|NCT01794780|26289430|FG002|Overall Study|Withdrew informed consent|36|||
13223599|NCT01794780|26289431|FG003|Overall Study|Withdrew informed consent|9|||
13223600|NCT01794780|26289432|FG004|Overall Study|Withdrew informed consent|0|||
13223601|NCT01794780|26289433|FG005|Overall Study|Withdrew informed consent|48|||
13223602|NCT01794780|26289434|FG006|Overall Study|Withdrew informed consent|4|||
13223603|NCT01794780|26289435|FG007|Overall Study|Withdrew informed consent|3|||
13223604|NCT01794780|26289428|FG000|Overall Study|Other|0|||
13223605|NCT01794780|26289429|FG001|Overall Study|Other|12|||
13223606|NCT01794780|26289430|FG002|Overall Study|Other|25|||
13223607|NCT01794780|26289431|FG003|Overall Study|Other|20|||
13223608|NCT01794780|26289432|FG004|Overall Study|Other|1|||
13223609|NCT01794780|26289433|FG005|Overall Study|Other|24|||
13223610|NCT01794780|26289434|FG006|Overall Study|Other|4|||
13223611|NCT01794780|26289435|FG007|Overall Study|Other|1|||
13223612|NCT01794689|26289470|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3|||
13223613|NCT01794689|26289471|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0|||
13223614|NCT01794689|26289472|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2|||
13223615|NCT01794689|26289473|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4|||
13223616|NCT01794689|26289470|FG000|Intervention 1 (2 Nights)|Protocol Violation|1|||
13223617|NCT01794689|26289471|FG001|Intervention 1 (2 Nights)|Protocol Violation|0|||
13223618|NCT01794689|26289472|FG002|Intervention 1 (2 Nights)|Protocol Violation|1|||
13223619|NCT01794689|26289473|FG003|Intervention 1 (2 Nights)|Protocol Violation|0|||
13223620|NCT01794689|26289470|FG000|Intervention 1 (2 Nights)|Physician Decision|1|||
13223621|NCT01794689|26289471|FG001|Intervention 1 (2 Nights)|Physician Decision|1|||
13223622|NCT01794689|26289472|FG002|Intervention 1 (2 Nights)|Physician Decision|0|||
13223623|NCT01794689|26289473|FG003|Intervention 1 (2 Nights)|Physician Decision|0|||
13223624|NCT01794689|26289470|FG000|Intervention 1 (2 Nights)|Adverse Event|0|||
13223625|NCT01794689|26289471|FG001|Intervention 1 (2 Nights)|Adverse Event|1|||
13223626|NCT01794689|26289472|FG002|Intervention 1 (2 Nights)|Adverse Event|0|||
13223627|NCT01794689|26289473|FG003|Intervention 1 (2 Nights)|Adverse Event|0|||
13223628|NCT01794338|26289486|FG000|Overall Study|Death|2|||
13223629|NCT01794338|26289487|FG001|Overall Study|Death|0|||
13223630|NCT01794338|26289486|FG000|Overall Study|Lost to Follow-up|6|||
13223631|NCT01794338|26289487|FG001|Overall Study|Lost to Follow-up|9|||
13223632|NCT01794299|26289499|FG000|Overall Study|ATIR manufacturing not possible|1|||
13223633|NCT01794299|26289499|FG000|Overall Study|Death|14|||
13223634|NCT01794299|26289499|FG000|Overall Study|Graft failure|1|||
13223635|NCT01794299|26289499|FG000|Overall Study|ATIR batch rejected|2|||
13223636|NCT01794299|26289499|FG000|Overall Study|Relapse|2|||
13223637|NCT01794299|26289499|FG000|Overall Study|Discontinued from active follow-up|1|||
13223638|NCT01794299|26289499|FG000|Overall Study|Relapse and rejection of ATIR batch|1|||
13223639|NCT01794117|26289524|FG000|Overall Study|Adverse Event|1|||
13223640|NCT01794117|26289525|FG001|Overall Study|Adverse Event|0|||
13223641|NCT01794117|26289526|FG002|Overall Study|Adverse Event|0|||
13223642|NCT01794117|26289527|FG003|Overall Study|Adverse Event|0|||
13223643|NCT01794117|26289524|FG000|Overall Study|Participant noncompliance|0|||
13223644|NCT01794117|26289525|FG001|Overall Study|Participant noncompliance|1|||
13223645|NCT01794117|26289526|FG002|Overall Study|Participant noncompliance|0|||
13223646|NCT01794117|26289527|FG003|Overall Study|Participant noncompliance|0|||
13223647|NCT01794117|26289524|FG000|Overall Study|Refused further treatment|0|||
13223648|NCT01794117|26289525|FG001|Overall Study|Refused further treatment|2|||
13223649|NCT01794117|26289526|FG002|Overall Study|Refused further treatment|0|||
13223650|NCT01794117|26289527|FG003|Overall Study|Refused further treatment|0|||
13223651|NCT01794000|26289565|FG000|Double-Blind Phase (DBP)|Adverse Event|5|||
13223652|NCT01794000|26289566|FG001|Double-Blind Phase (DBP)|Adverse Event|2|||
13223653|NCT01794000|26289565|FG000|Double-Blind Phase (DBP)|Death|1|||
13223654|NCT01794000|26289566|FG001|Double-Blind Phase (DBP)|Death|2|||
13223655|NCT01794000|26289565|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2|||
13223656|NCT01794000|26289566|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0|||
13223657|NCT01794000|26289565|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5|||
13223658|NCT01794000|26289566|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2|||
13223659|NCT01794000|26289565|FG000|Double-Blind Phase (DBP)|Physician Decision|2|||
13223660|NCT01794000|26289566|FG001|Double-Blind Phase (DBP)|Physician Decision|0|||
13223661|NCT01794000|26289565|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148|||
13223662|NCT01794000|26289566|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149|||
13223663|NCT01794000|26289565|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6|||
13223664|NCT01794000|26289566|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11|||
13223665|NCT01794000|26289565|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3|||
13223666|NCT01794000|26289566|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
13223667|NCT01793935|26289607|FG000|Overall Study|Pregnancy|1|||
13223668|NCT01793935|26289608|FG001|Overall Study|Pregnancy|0|||
13223669|NCT01793935|26289607|FG000|Overall Study|Protocol Violation|2|||
13223670|NCT01793935|26289608|FG001|Overall Study|Protocol Violation|1|||
13223671|NCT01793935|26289607|FG000|Overall Study|Adverse Event|2|||
13223672|NCT01793935|26289608|FG001|Overall Study|Adverse Event|0|||
13223673|NCT01793935|26289607|FG000|Overall Study|Patient did not take study medication|1|||
13223674|NCT01793935|26289608|FG001|Overall Study|Patient did not take study medication|1|||
13223675|NCT01793935|26289607|FG000|Overall Study|Lost to Follow-up|0|||
13223676|NCT01793935|26289608|FG001|Overall Study|Lost to Follow-up|1|||
13223677|NCT01793883|26289626|FG000|Overall Study|Withdrawal by Subject|3|||
13223678|NCT01793883|26289627|FG001|Overall Study|Withdrawal by Subject|7|||
13223679|NCT01793883|26289628|FG002|Overall Study|Withdrawal by Subject|3|||
13223680|NCT01793883|26289626|FG000|Overall Study|Subject noncompliance|0|||
13223681|NCT01793883|26289627|FG001|Overall Study|Subject noncompliance|1|||
13223682|NCT01793883|26289628|FG002|Overall Study|Subject noncompliance|1|||
13223683|NCT01793883|26289626|FG000|Overall Study|Lost to Follow-up|5|||
13223684|NCT01793883|26289627|FG001|Overall Study|Lost to Follow-up|1|||
13223685|NCT01793883|26289628|FG002|Overall Study|Lost to Follow-up|3|||
13223686|NCT01793883|26289626|FG000|Overall Study|Randomized in error|1|||
13223687|NCT01793883|26289627|FG001|Overall Study|Randomized in error|0|||
13223688|NCT01793883|26289628|FG002|Overall Study|Randomized in error|0|||
13223689|NCT01793883|26289626|FG000|Overall Study|Unable to complete spriometry|1|||
13289475|NCT00109850|26479339|FG000|Overall Study|Adverse Event|1|||
13223690|NCT01793883|26289627|FG001|Overall Study|Unable to complete spriometry|0|||
13223691|NCT01793883|26289628|FG002|Overall Study|Unable to complete spriometry|0|||
13223692|NCT01793883|26289626|FG000|Overall Study|Unable to complete measurements|1|||
13223693|NCT01793883|26289627|FG001|Overall Study|Unable to complete measurements|0|||
13223694|NCT01793883|26289628|FG002|Overall Study|Unable to complete measurements|0|||
13223695|NCT01793883|26289626|FG000|Overall Study|Met exclusion criteria|1|||
13223696|NCT01793883|26289627|FG001|Overall Study|Met exclusion criteria|0|||
13223697|NCT01793883|26289628|FG002|Overall Study|Met exclusion criteria|0|||
13223698|NCT01793883|26289626|FG000|Overall Study|Dosing error|0|||
13223699|NCT01793883|26289627|FG001|Overall Study|Dosing error|1|||
13223700|NCT01793883|26289628|FG002|Overall Study|Dosing error|0|||
13223701|NCT01793883|26289626|FG000|Overall Study|Respiratory distress during spirometry|0|||
13223702|NCT01793883|26289627|FG001|Overall Study|Respiratory distress during spirometry|0|||
13223703|NCT01793883|26289628|FG002|Overall Study|Respiratory distress during spirometry|1|||
13223704|NCT01793792|26289635|FG000|Overall Study|Death|5|||
13223705|NCT01793792|26289635|FG000|Overall Study|Lost to Follow-up|5|||
13223706|NCT01793792|26289635|FG000|Overall Study|Withdrawal by Subject|1|||
13223707|NCT01793792|26289635|FG000|Overall Study|Device Not Implanted|1|||
13223708|NCT01793688|26289644|FG000|Overall Study|Protocol Violation|2|||
13223709|NCT01793610|26289681|FG000|Overall Study|Withdrawal by Subject|1|||
13223710|NCT01793610|26289682|FG001|Overall Study|Withdrawal by Subject|0|||
13223711|NCT01793610|26289683|FG002|Overall Study|Withdrawal by Subject|1|||
13113540|NCT03136198|25911700|FG001|Overall Study|Withdrawal by Subject|1|||
13113541|NCT03136159|25911713|FG000|Overall Study|chorioamnionitis|2|||
13113542|NCT03136159|25911714|FG001|Overall Study|chorioamnionitis|0|||
13113543|NCT03136159|25911713|FG000|Overall Study|vertical skin incision|1|||
13113544|NCT03136159|25911714|FG001|Overall Study|vertical skin incision|0|||
13113545|NCT03136159|25911713|FG000|Overall Study|additional dressing|1|||
13113546|NCT03136159|25911714|FG001|Overall Study|additional dressing|0|||
13113547|NCT03136159|25911713|FG000|Overall Study|never got dressing placed|1|||
13113548|NCT03136159|25911714|FG001|Overall Study|never got dressing placed|0|||
13223712|NCT01793142|26289696|FG000|Overall Study|Randomized not treated|7|||
13223713|NCT01793051|26289709|FG000|Overall Study|Withdrawal by Subject|6|||
13223714|NCT01793051|26289710|FG001|Overall Study|Withdrawal by Subject|4|||
13113549|NCT03136107|25911724|FG000|Overall Study|Other (Not specified)|1|||
13113550|NCT03136068|25911745|FG000|Overall Study|Lost to Follow-up|1|||
13113551|NCT03136068|25911746|FG001|Overall Study|Lost to Follow-up|1|||
13113552|NCT03136068|25911745|FG000|Overall Study|Protocol Violation|1|||
13223715|NCT01793051|26289709|FG000|Overall Study|Adverse Event|0|||
13223716|NCT01793051|26289710|FG001|Overall Study|Adverse Event|2|||
13223717|NCT01793051|26289709|FG000|Overall Study|Too ill to continue|1|||
13223718|NCT01793051|26289710|FG001|Overall Study|Too ill to continue|0|||
13223719|NCT01793051|26289709|FG000|Overall Study|Switched chemo|1|||
13223720|NCT01793051|26289710|FG001|Overall Study|Switched chemo|1|||
13223721|NCT01793051|26289709|FG000|Overall Study|Lack of compliance|1|||
13223722|NCT01793051|26289710|FG001|Overall Study|Lack of compliance|0|||
13223723|NCT01793051|26289709|FG000|Overall Study|Requested to be removed from the study|1|||
13223724|NCT01793051|26289710|FG001|Overall Study|Requested to be removed from the study|1|||
13223725|NCT01792830|26289811|FG000|Overall Study|Withdrawal by Subject|22|||
13223726|NCT01792830|26289812|FG001|Overall Study|Withdrawal by Subject|0|||
13223727|NCT01792830|26289813|FG002|Overall Study|Withdrawal by Subject|0|||
13223728|NCT01792830|26289814|FG003|Overall Study|Withdrawal by Subject|2|||
13223729|NCT01792830|26289815|FG004|Overall Study|Withdrawal by Subject|1|||
13223730|NCT01792830|26289816|FG005|Overall Study|Withdrawal by Subject|1|||
13223731|NCT01792830|26289817|FG006|Overall Study|Withdrawal by Subject|1|||
13223732|NCT01792830|26289818|FG007|Overall Study|Withdrawal by Subject|1|||
13223733|NCT01792830|26289819|FG008|Overall Study|Withdrawal by Subject|7|||
13223734|NCT01792830|26289820|FG009|Overall Study|Withdrawal by Subject|0|||
13223735|NCT01792830|26289821|FG010|Overall Study|Withdrawal by Subject|2|||
13223736|NCT01792830|26289811|FG000|Overall Study|Death|3|||
13223737|NCT01792830|26289812|FG001|Overall Study|Death|0|||
13223738|NCT01792830|26289813|FG002|Overall Study|Death|0|||
13223739|NCT01792830|26289814|FG003|Overall Study|Death|1|||
13223740|NCT01792830|26289815|FG004|Overall Study|Death|0|||
13223741|NCT01792830|26289816|FG005|Overall Study|Death|0|||
13113553|NCT03136068|25911746|FG001|Overall Study|Protocol Violation|0|||
13113554|NCT03135899|25911801|FG000|Overall Study|Failed spirometry,unable to repeat visit|0|||
13113555|NCT03135899|25911802|FG001|Overall Study|Failed spirometry,unable to repeat visit|0|||
13113556|NCT03135899|25911803|FG002|Overall Study|Failed spirometry,unable to repeat visit|0|||
13113557|NCT03135899|25911804|FG003|Overall Study|Failed spirometry,unable to repeat visit|0|||
13113558|NCT03135899|25911805|FG004|Overall Study|Failed spirometry,unable to repeat visit|0|||
13223742|NCT01792830|26289817|FG006|Overall Study|Death|1|||
13223743|NCT01792830|26289818|FG007|Overall Study|Death|0|||
13223744|NCT01792830|26289819|FG008|Overall Study|Death|1|||
13113559|NCT03135899|25911806|FG005|Overall Study|Failed spirometry,unable to repeat visit|0|||
13113560|NCT03135899|25911807|FG006|Overall Study|Failed spirometry,unable to repeat visit|1|||
13113561|NCT03135899|25911808|FG007|Overall Study|Failed spirometry,unable to repeat visit|0|||
13113562|NCT03135899|25911801|FG000|Overall Study|Withdrawal by Subject|0|||
13113563|NCT03135899|25911802|FG001|Overall Study|Withdrawal by Subject|0|||
13113564|NCT03135899|25911803|FG002|Overall Study|Withdrawal by Subject|0|||
13113565|NCT03135899|25911804|FG003|Overall Study|Withdrawal by Subject|0|||
13113566|NCT03135899|25911805|FG004|Overall Study|Withdrawal by Subject|0|||
13223745|NCT01792830|26289820|FG009|Overall Study|Death|0|||
13223746|NCT01792830|26289821|FG010|Overall Study|Death|1|||
13223747|NCT01792830|26289811|FG000|Overall Study|Adverse Event|0|||
13223748|NCT01792830|26289812|FG001|Overall Study|Adverse Event|0|||
13223749|NCT01792830|26289813|FG002|Overall Study|Adverse Event|0|||
13223750|NCT01792830|26289814|FG003|Overall Study|Adverse Event|0|||
13223751|NCT01792830|26289815|FG004|Overall Study|Adverse Event|0|||
13223752|NCT01792830|26289816|FG005|Overall Study|Adverse Event|0|||
13223753|NCT01792830|26289817|FG006|Overall Study|Adverse Event|0|||
13223754|NCT01792830|26289818|FG007|Overall Study|Adverse Event|0|||
13223755|NCT01792830|26289819|FG008|Overall Study|Adverse Event|1|||
13223756|NCT01792830|26289820|FG009|Overall Study|Adverse Event|0|||
13223757|NCT01792830|26289821|FG010|Overall Study|Adverse Event|0|||
13223758|NCT01792635|26289857|FG000|Part B|Adverse Event|0|||
13223759|NCT01792635|26289858|FG001|Part B|Adverse Event|0|||
13223760|NCT01792635|26289859|FG002|Part B|Adverse Event|1|||
13223761|NCT01792635|26289857|FG000|Part B|Study terminated|0|||
13223762|NCT01792635|26289858|FG001|Part B|Study terminated|4|||
13223763|NCT01792635|26289859|FG002|Part B|Study terminated|3|||
13223764|NCT01792518|26289876|FG000|Overall Study|Adverse Event|3|||
13223765|NCT01792518|26289877|FG001|Overall Study|Adverse Event|4|||
13223766|NCT01792518|26289876|FG000|Overall Study|Protocol Violation|0|||
13223767|NCT01792518|26289877|FG001|Overall Study|Protocol Violation|1|||
13223768|NCT01792518|26289876|FG000|Overall Study|Lost to Follow-up|3|||
13223769|NCT01792518|26289877|FG001|Overall Study|Lost to Follow-up|1|||
13223770|NCT01792518|26289876|FG000|Overall Study|Withdrawal by Subject|2|||
13223771|NCT01792518|26289877|FG001|Overall Study|Withdrawal by Subject|0|||
13223772|NCT01792518|26289876|FG000|Overall Study|Other Reason|0|||
13223773|NCT01792518|26289877|FG001|Overall Study|Other Reason|1|||
13223774|NCT01792284|26289919|FG000|Lead-in Period|Adverse Event|15|||
13223775|NCT01792284|26289920|FG001|Lead-in Period|Adverse Event|0|||
13223776|NCT01792284|26289921|FG002|Lead-in Period|Adverse Event|0|||
13223777|NCT01792284|26289919|FG000|Lead-in Period|Lost to Follow-up|2|||
13223778|NCT01792284|26289920|FG001|Lead-in Period|Lost to Follow-up|0|||
13223779|NCT01792284|26289921|FG002|Lead-in Period|Lost to Follow-up|0|||
13223780|NCT01792284|26289919|FG000|Lead-in Period|Protocol Violation|1|||
13223781|NCT01792284|26289920|FG001|Lead-in Period|Protocol Violation|0|||
13223782|NCT01792284|26289921|FG002|Lead-in Period|Protocol Violation|0|||
13113567|NCT03135899|25911806|FG005|Overall Study|Withdrawal by Subject|2|||
13223783|NCT01792284|26289919|FG000|Lead-in Period|Withdrawal by Subject|10|||
13223784|NCT01792284|26289920|FG001|Lead-in Period|Withdrawal by Subject|0|||
13223785|NCT01792284|26289921|FG002|Lead-in Period|Withdrawal by Subject|0|||
13223786|NCT01792284|26289919|FG000|Lead-in Period|Physician Decision|1|||
13223787|NCT01792284|26289920|FG001|Lead-in Period|Physician Decision|0|||
13223788|NCT01792284|26289921|FG002|Lead-in Period|Physician Decision|0|||
13223789|NCT01792284|26289919|FG000|Lead-in Period|Protocol Required Discontinuation|1|||
13223790|NCT01792284|26289920|FG001|Lead-in Period|Protocol Required Discontinuation|0|||
13223791|NCT01792284|26289921|FG002|Lead-in Period|Protocol Required Discontinuation|0|||
13223792|NCT01792284|26289919|FG000|Randomization Period 1|Withdrawal by Subject|0|||
13223793|NCT01792284|26289920|FG001|Randomization Period 1|Withdrawal by Subject|1|||
13223794|NCT01792284|26289921|FG002|Randomization Period 1|Withdrawal by Subject|1|||
13223795|NCT01792284|26289919|FG000|Randomization Period 1|Physician Decision|0|||
13223796|NCT01792284|26289920|FG001|Randomization Period 1|Physician Decision|1|||
13223797|NCT01792284|26289921|FG002|Randomization Period 1|Physician Decision|1|||
13223798|NCT01792284|26289919|FG000|Randomization Period 1|Adverse Event|0|||
13223799|NCT01792284|26289920|FG001|Randomization Period 1|Adverse Event|0|||
13223800|NCT01792284|26289921|FG002|Randomization Period 1|Adverse Event|2|||
13223801|NCT01792284|26289919|FG000|Randomization Period 1|Lost to Follow-up|0|||
13223802|NCT01792284|26289920|FG001|Randomization Period 1|Lost to Follow-up|0|||
13223803|NCT01792284|26289921|FG002|Randomization Period 1|Lost to Follow-up|1|||
13223804|NCT01792284|26289919|FG000|Randomization Period 2|Protocol Violation|0|||
13223805|NCT01792284|26289920|FG001|Randomization Period 2|Protocol Violation|1|||
13223806|NCT01792284|26289921|FG002|Randomization Period 2|Protocol Violation|0|||
13223807|NCT01792284|26289919|FG000|Randomization Period 2|Withdrawal by Subject|0|||
13223808|NCT01792284|26289920|FG001|Randomization Period 2|Withdrawal by Subject|2|||
13113568|NCT03135899|25911807|FG006|Overall Study|Withdrawal by Subject|0|||
13223809|NCT01792284|26289921|FG002|Randomization Period 2|Withdrawal by Subject|0|||
13223810|NCT01792115|26289960|FG000|Overall Study|Lost to Follow-up|0|||
13223811|NCT01792115|26289961|FG001|Overall Study|Lost to Follow-up|1|||
13223812|NCT01792115|26289962|FG002|Overall Study|Lost to Follow-up|0|||
13223813|NCT01791985|26289973|FG000|Overall Study|Adverse Event|7|||
13113569|NCT03135899|25911808|FG007|Overall Study|Withdrawal by Subject|0|||
13113570|NCT03135548|25911838|FG000|Overall Study|Lost to Follow-up|3|||
13113571|NCT03135548|25911839|FG001|Overall Study|Lost to Follow-up|0|||
13113572|NCT03135548|25911840|FG002|Overall Study|Lost to Follow-up|0|||
13113573|NCT03135548|25911838|FG000|Overall Study|Withdrawal by Subject|2|||
13113574|NCT03135548|25911839|FG001|Overall Study|Withdrawal by Subject|2|||
13113575|NCT03135548|25911840|FG002|Overall Study|Withdrawal by Subject|1|||
13113576|NCT03135548|25911838|FG000|Overall Study|Other than listed|0|||
13113577|NCT03135548|25911839|FG001|Overall Study|Other than listed|2|||
13113578|NCT03135548|25911840|FG002|Overall Study|Other than listed|2|||
13113579|NCT03135522|25911859|FG000|Overall Study|Adverse Event|1|||
13113580|NCT03135522|25911860|FG001|Overall Study|Adverse Event|0|||
13113581|NCT03135431|25911877|FG000|Overall Study|Study Surgeon not available|2|||
13113582|NCT03135431|25911878|FG001|Overall Study|Study Surgeon not available|0|||
13113583|NCT03135210|25911891|FG000|Overall Study|Death|0|||
13113584|NCT03135210|25911892|FG001|Overall Study|Death|1|||
13113585|NCT03135119|25911911|FG000|Overall Study|Lost to Follow-up|2|||
13113586|NCT03135119|25911912|FG001|Overall Study|Lost to Follow-up|0|||
13113587|NCT03135119|25911911|FG000|Overall Study|Physician Decision|1|||
13113588|NCT03135119|25911912|FG001|Overall Study|Physician Decision|1|||
13113589|NCT03135119|25911911|FG000|Overall Study|COVID-19 Shutdown|2|||
13113590|NCT03135119|25911912|FG001|Overall Study|COVID-19 Shutdown|2|||
13113591|NCT03135028|25911920|FG000|Overall Study|Death|6|||
13113592|NCT03135028|25911920|FG000|Overall Study|Study Terminated by Sponsor|2|||
13113593|NCT03135028|25911920|FG000|Overall Study|Withdrew Consent|1|||
13113594|NCT03134911|25911953|FG000|Overall Study|Screen failure|31|||
13113595|NCT03134911|25911953|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3|||
13113596|NCT03134599|25911968|FG000|Week 1|Lost to Follow-up|0|||
13113597|NCT03134599|25911969|FG001|Week 1|Lost to Follow-up|0|||
13113598|NCT03134599|25911970|FG002|Week 1|Lost to Follow-up|0|||
13113599|NCT03134599|25911971|FG003|Week 1|Lost to Follow-up|0|||
13113600|NCT03134599|25911972|FG004|Week 1|Lost to Follow-up|1|||
13113601|NCT03134599|25911973|FG005|Week 1|Lost to Follow-up|0|||
13203028|NCT01988103|26223070|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
13113602|NCT03134599|25911968|FG000|Week 2|Lost to Follow-up|1|||
13113603|NCT03134599|25911969|FG001|Week 2|Lost to Follow-up|0|||
13113604|NCT03134599|25911970|FG002|Week 2|Lost to Follow-up|0|||
13113605|NCT03134599|25911971|FG003|Week 2|Lost to Follow-up|1|||
13113606|NCT03134599|25911972|FG004|Week 2|Lost to Follow-up|1|||
13113607|NCT03134599|25911973|FG005|Week 2|Lost to Follow-up|0|||
13113608|NCT03134599|25911968|FG000|Week 3|Lost to Follow-up|0|||
13113609|NCT03134599|25911969|FG001|Week 3|Lost to Follow-up|0|||
13113610|NCT03134599|25911970|FG002|Week 3|Lost to Follow-up|0|||
13113611|NCT03134599|25911971|FG003|Week 3|Lost to Follow-up|1|||
13113612|NCT03134599|25911972|FG004|Week 3|Lost to Follow-up|0|||
13113613|NCT03134599|25911973|FG005|Week 3|Lost to Follow-up|1|||
13113614|NCT03134222|25912005|FG000|Treatment Period (Up to Week 12)|Adverse Event|4|||
13113615|NCT03134222|25912006|FG001|Treatment Period (Up to Week 12)|Adverse Event|1|||
13113616|NCT03134222|25912007|FG002|Treatment Period (Up to Week 12)|Adverse Event|0|||
13113617|NCT03134222|25912008|FG003|Treatment Period (Up to Week 12)|Adverse Event|0|||
13113618|NCT03134222|25912009|FG004|Treatment Period (Up to Week 12)|Adverse Event|0|||
13113619|NCT03134222|25912005|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
13113620|NCT03134222|25912006|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
13203029|NCT01988103|26223071|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
13203030|NCT01988103|26223067|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
13203031|NCT01988103|26223068|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5|||
13203032|NCT01988103|26223069|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4|||
13203033|NCT01988103|26223070|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
13203034|NCT01988103|26223071|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1|||
13203035|NCT01988103|26223067|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
13203036|NCT01988103|26223068|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1|||
13203037|NCT01988103|26223069|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
13203038|NCT01988103|26223070|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
13203039|NCT01988103|26223071|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
13203040|NCT01988090|26223088|FG000|Start Treament After Randomization|Withdrawal by Subject|2|||
13203041|NCT01988090|26223089|FG001|Start Treament After Randomization|Withdrawal by Subject|3|||
13203042|NCT01988090|26223088|FG000|Start Treament After Randomization|Protocol Violation|0|||
13203043|NCT01988090|26223089|FG001|Start Treament After Randomization|Protocol Violation|1|||
13203044|NCT01988090|26223088|FG000|Complete Study After Start|Withdrawal by Subject|2|||
13203045|NCT01988090|26223089|FG001|Complete Study After Start|Withdrawal by Subject|0|||
13203046|NCT01988090|26223088|FG000|Complete Study After Start|Protocol Violation|1|||
13203047|NCT01988090|26223089|FG001|Complete Study After Start|Protocol Violation|1|||
13113621|NCT03134222|25912007|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
13113622|NCT03134222|25912008|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
13113623|NCT03134222|25912009|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
13113624|NCT03134222|25912005|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
13113625|NCT03134222|25912006|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1|||
13203048|NCT01988012|26223113|FG000|Overall Study|Adverse Event|5|||
13203049|NCT01988012|26223113|FG000|Overall Study|Insufficient Therapeutic Response|3|||
13203050|NCT01988012|26223113|FG000|Overall Study|Patient Withdrawal of Consent|4|||
13203051|NCT01988012|26223113|FG000|Overall Study|Lost to Follow-up|1|||
13203052|NCT01988012|26223113|FG000|Overall Study|Physician Decision|1|||
13203053|NCT01988012|26223113|FG000|Overall Study|Protocol Violation|1|||
13203054|NCT01987986|26223164|FG000|Overall Study|Lost to Follow-up|1|||
13203055|NCT01987986|26223165|FG001|Overall Study|Lost to Follow-up|0|||
13203056|NCT01987986|26223166|FG002|Overall Study|Lost to Follow-up|0|||
13203057|NCT01987986|26223167|FG003|Overall Study|Lost to Follow-up|0|||
13203058|NCT01987986|26223164|FG000|Overall Study|Adverse Event|1|||
13203059|NCT01987986|26223165|FG001|Overall Study|Adverse Event|0|||
13203060|NCT01987986|26223166|FG002|Overall Study|Adverse Event|2|||
13203061|NCT01987986|26223167|FG003|Overall Study|Adverse Event|0|||
13203062|NCT01987960|26223188|FG000|Period 1|Adverse Event|24|||
13203063|NCT01987960|26223189|FG001|Period 1|Adverse Event|0|||
13203064|NCT01987960|26223190|FG002|Period 1|Adverse Event|0|||
13203065|NCT01987960|26223191|FG003|Period 1|Adverse Event|0|||
13203066|NCT01987960|26223188|FG000|Period 1|Lack of Efficacy|4|||
13203067|NCT01987960|26223189|FG001|Period 1|Lack of Efficacy|0|||
13203068|NCT01987960|26223190|FG002|Period 1|Lack of Efficacy|0|||
13203069|NCT01987960|26223191|FG003|Period 1|Lack of Efficacy|0|||
13203070|NCT01987960|26223188|FG000|Period 1|Non-compliance with IMP|6|||
13203071|NCT01987960|26223189|FG001|Period 1|Non-compliance with IMP|0|||
13203072|NCT01987960|26223190|FG002|Period 1|Non-compliance with IMP|0|||
13203073|NCT01987960|26223191|FG003|Period 1|Non-compliance with IMP|0|||
13113626|NCT03134222|25912007|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
13113627|NCT03134222|25912008|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
13113628|NCT03134222|25912009|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
13113629|NCT03134222|25912005|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
13113630|NCT03134222|25912006|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
13113631|NCT03134222|25912007|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
13113632|NCT03134222|25912008|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
13113633|NCT03134222|25912009|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
13203074|NCT01987960|26223188|FG000|Period 1|Protocol Violation|12|||
13203075|NCT01987960|26223189|FG001|Period 1|Protocol Violation|0|||
13203076|NCT01987960|26223190|FG002|Period 1|Protocol Violation|0|||
13223814|NCT01791985|26289973|FG000|Overall Study|Withdrawal by Subject|1|||
13223815|NCT01791894|26289982|FG000|Overall Study|Adverse Event|1|||
13223816|NCT01791803|26290010|FG000|Overall Study|Withdrawal by Subject|0|||
13223817|NCT01791803|26290011|FG001|Overall Study|Withdrawal by Subject|0|||
13223818|NCT01791803|26290012|FG002|Overall Study|Withdrawal by Subject|0|||
13223819|NCT01791803|26290013|FG003|Overall Study|Withdrawal by Subject|2|||
13223820|NCT01791803|26290010|FG000|Overall Study|Physician Decision|0|||
13223821|NCT01791803|26290011|FG001|Overall Study|Physician Decision|2|||
13223822|NCT01791803|26290012|FG002|Overall Study|Physician Decision|0|||
13223823|NCT01791803|26290013|FG003|Overall Study|Physician Decision|1|||
13223824|NCT01791803|26290010|FG000|Overall Study|Death|0|||
13223825|NCT01791803|26290011|FG001|Overall Study|Death|0|||
13223826|NCT01791803|26290012|FG002|Overall Study|Death|2|||
13223827|NCT01791803|26290013|FG003|Overall Study|Death|2|||
13223828|NCT01791725|26290043|FG000|Overall Study|Withdrawal by Subject|0|||
13223829|NCT01791725|26290044|FG001|Overall Study|Withdrawal by Subject|1|||
13223830|NCT01791725|26290045|FG002|Overall Study|Withdrawal by Subject|0|||
13223831|NCT01791517|26290090|FG000|Phase I: Period 1|Withdrawal by Subject|0|||
13223832|NCT01791517|26290091|FG001|Phase I: Period 1|Withdrawal by Subject|1|||
13223833|NCT01791517|26290092|FG002|Phase I: Period 1|Withdrawal by Subject|1|||
13223834|NCT01791517|26290093|FG003|Phase I: Period 1|Withdrawal by Subject|0|||
13223835|NCT01791517|26290094|FG004|Phase I: Period 1|Withdrawal by Subject|1|||
13223836|NCT01791517|26290095|FG005|Phase I: Period 1|Withdrawal by Subject|1|||
13223837|NCT01791517|26290096|FG006|Phase I: Period 1|Withdrawal by Subject|0|||
13223838|NCT01791517|26290097|FG007|Phase I: Period 1|Withdrawal by Subject|0|||
13223839|NCT01791517|26290098|FG008|Phase I: Period 1|Withdrawal by Subject|0|||
13223840|NCT01791517|26290099|FG009|Phase I: Period 1|Withdrawal by Subject|0|||
13223841|NCT01791517|26290100|FG010|Phase I: Period 1|Withdrawal by Subject|0|||
13223842|NCT01791517|26290101|FG011|Phase I: Period 1|Withdrawal by Subject|0|||
13223843|NCT01791517|26290090|FG000|Phase I: Period 1|Adverse Event|0|||
13223844|NCT01791517|26290091|FG001|Phase I: Period 1|Adverse Event|0|||
13223845|NCT01791517|26290092|FG002|Phase I: Period 1|Adverse Event|1|||
13223846|NCT01791517|26290093|FG003|Phase I: Period 1|Adverse Event|1|||
13223847|NCT01791517|26290094|FG004|Phase I: Period 1|Adverse Event|0|||
13203077|NCT01987960|26223191|FG003|Period 1|Protocol Violation|0|||
13203078|NCT01987960|26223188|FG000|Period 1|Withdrawal by Subject|21|||
13203079|NCT01987960|26223189|FG001|Period 1|Withdrawal by Subject|0|||
13203080|NCT01987960|26223190|FG002|Period 1|Withdrawal by Subject|0|||
13223848|NCT01791517|26290095|FG005|Phase I: Period 1|Adverse Event|0|||
13223849|NCT01791517|26290096|FG006|Phase I: Period 1|Adverse Event|0|||
13223850|NCT01791517|26290097|FG007|Phase I: Period 1|Adverse Event|0|||
13223851|NCT01791517|26290098|FG008|Phase I: Period 1|Adverse Event|0|||
13223852|NCT01791517|26290099|FG009|Phase I: Period 1|Adverse Event|0|||
13223853|NCT01791517|26290100|FG010|Phase I: Period 1|Adverse Event|0|||
13223854|NCT01791517|26290101|FG011|Phase I: Period 1|Adverse Event|0|||
13223855|NCT01791517|26290090|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1|||
13223856|NCT01791517|26290091|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
13223857|NCT01791517|26290092|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
13223858|NCT01791517|26290093|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
13223859|NCT01791517|26290094|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
13223860|NCT01791517|26290095|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
13223861|NCT01791517|26290096|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
13223862|NCT01791517|26290097|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
13223863|NCT01791517|26290098|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
13223864|NCT01791517|26290099|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
13223865|NCT01791517|26290100|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
13223866|NCT01791517|26290101|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
13223867|NCT01791517|26290090|FG000|Phase I: Period 1|Protocol Violation|0|||
13223868|NCT01791517|26290091|FG001|Phase I: Period 1|Protocol Violation|1|||
13223869|NCT01791517|26290092|FG002|Phase I: Period 1|Protocol Violation|0|||
13223870|NCT01791517|26290093|FG003|Phase I: Period 1|Protocol Violation|0|||
13223871|NCT01791517|26290094|FG004|Phase I: Period 1|Protocol Violation|0|||
13223872|NCT01791517|26290095|FG005|Phase I: Period 1|Protocol Violation|0|||
13223873|NCT01791517|26290096|FG006|Phase I: Period 1|Protocol Violation|0|||
13223874|NCT01791517|26290097|FG007|Phase I: Period 1|Protocol Violation|0|||
13223875|NCT01791517|26290098|FG008|Phase I: Period 1|Protocol Violation|0|||
13223876|NCT01791517|26290099|FG009|Phase I: Period 1|Protocol Violation|0|||
13113634|NCT03134222|25912005|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
13113635|NCT03134222|25912006|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2|||
13223877|NCT01791517|26290100|FG010|Phase I: Period 1|Protocol Violation|0|||
13223878|NCT01791517|26290101|FG011|Phase I: Period 1|Protocol Violation|0|||
13223879|NCT01791517|26290090|FG000|Phase I: Period 1|Lost to Follow-up|0|||
13223880|NCT01791517|26290091|FG001|Phase I: Period 1|Lost to Follow-up|0|||
13223881|NCT01791517|26290092|FG002|Phase I: Period 1|Lost to Follow-up|0|||
13223882|NCT01791517|26290093|FG003|Phase I: Period 1|Lost to Follow-up|1|||
13223883|NCT01791517|26290094|FG004|Phase I: Period 1|Lost to Follow-up|0|||
13223884|NCT01791517|26290095|FG005|Phase I: Period 1|Lost to Follow-up|0|||
13223885|NCT01791517|26290096|FG006|Phase I: Period 1|Lost to Follow-up|1|||
13223886|NCT01791517|26290097|FG007|Phase I: Period 1|Lost to Follow-up|0|||
13223887|NCT01791517|26290098|FG008|Phase I: Period 1|Lost to Follow-up|1|||
13223888|NCT01791517|26290099|FG009|Phase I: Period 1|Lost to Follow-up|1|||
13223889|NCT01791517|26290100|FG010|Phase I: Period 1|Lost to Follow-up|0|||
13223890|NCT01791517|26290101|FG011|Phase I: Period 1|Lost to Follow-up|0|||
13223891|NCT01791517|26290090|FG000|Phase I: Period 1|Lens Handling DIfficulties|0|||
13223892|NCT01791517|26290091|FG001|Phase I: Period 1|Lens Handling DIfficulties|0|||
13223893|NCT01791517|26290092|FG002|Phase I: Period 1|Lens Handling DIfficulties|0|||
13223894|NCT01791517|26290093|FG003|Phase I: Period 1|Lens Handling DIfficulties|0|||
13223895|NCT01791517|26290094|FG004|Phase I: Period 1|Lens Handling DIfficulties|0|||
13223896|NCT01791517|26290095|FG005|Phase I: Period 1|Lens Handling DIfficulties|0|||
13223897|NCT01791517|26290096|FG006|Phase I: Period 1|Lens Handling DIfficulties|0|||
13223898|NCT01791517|26290097|FG007|Phase I: Period 1|Lens Handling DIfficulties|0|||
13223899|NCT01791517|26290098|FG008|Phase I: Period 1|Lens Handling DIfficulties|0|||
13223900|NCT01791517|26290099|FG009|Phase I: Period 1|Lens Handling DIfficulties|0|||
13223901|NCT01791517|26290100|FG010|Phase I: Period 1|Lens Handling DIfficulties|0|||
13223902|NCT01791517|26290101|FG011|Phase I: Period 1|Lens Handling DIfficulties|1|||
13223903|NCT01791517|26290090|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1|||
13223904|NCT01791517|26290091|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
13223905|NCT01791517|26290092|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
13223906|NCT01791517|26290093|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
13223907|NCT01791517|26290094|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
13223908|NCT01791517|26290095|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
13223909|NCT01791517|26290096|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
13223910|NCT01791517|26290097|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
13223911|NCT01791517|26290098|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
13223912|NCT01791517|26290099|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
13223913|NCT01791517|26290100|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
13223914|NCT01791517|26290101|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
13223915|NCT01791517|26290090|FG000|Phase I: Period 2|Protocol Violation|0|||
13223916|NCT01791517|26290091|FG001|Phase I: Period 2|Protocol Violation|0|||
13223917|NCT01791517|26290092|FG002|Phase I: Period 2|Protocol Violation|0|||
13223918|NCT01791517|26290093|FG003|Phase I: Period 2|Protocol Violation|1|||
13223919|NCT01791517|26290094|FG004|Phase I: Period 2|Protocol Violation|0|||
13223920|NCT01791517|26290095|FG005|Phase I: Period 2|Protocol Violation|0|||
13223921|NCT01791517|26290096|FG006|Phase I: Period 2|Protocol Violation|0|||
13223922|NCT01791517|26290097|FG007|Phase I: Period 2|Protocol Violation|0|||
13223923|NCT01791517|26290098|FG008|Phase I: Period 2|Protocol Violation|0|||
13223924|NCT01791517|26290099|FG009|Phase I: Period 2|Protocol Violation|0|||
13223925|NCT01791517|26290100|FG010|Phase I: Period 2|Protocol Violation|0|||
13223926|NCT01791517|26290101|FG011|Phase I: Period 2|Protocol Violation|0|||
13223927|NCT01791517|26290090|FG000|Phase I: Period 2|Withdrawal by Subject|0|||
13223928|NCT01791517|26290091|FG001|Phase I: Period 2|Withdrawal by Subject|0|||
13223929|NCT01791517|26290092|FG002|Phase I: Period 2|Withdrawal by Subject|0|||
13223930|NCT01791517|26290093|FG003|Phase I: Period 2|Withdrawal by Subject|0|||
13223931|NCT01791517|26290094|FG004|Phase I: Period 2|Withdrawal by Subject|0|||
13223932|NCT01791517|26290095|FG005|Phase I: Period 2|Withdrawal by Subject|0|||
13223933|NCT01791517|26290096|FG006|Phase I: Period 2|Withdrawal by Subject|0|||
13223934|NCT01791517|26290097|FG007|Phase I: Period 2|Withdrawal by Subject|0|||
13223935|NCT01791517|26290098|FG008|Phase I: Period 2|Withdrawal by Subject|0|||
13223936|NCT01791517|26290099|FG009|Phase I: Period 2|Withdrawal by Subject|1|||
13223937|NCT01791517|26290100|FG010|Phase I: Period 2|Withdrawal by Subject|1|||
13223938|NCT01791517|26290101|FG011|Phase I: Period 2|Withdrawal by Subject|0|||
13223939|NCT01791517|26290090|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0|||
13223940|NCT01791517|26290091|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0|||
13223941|NCT01791517|26290092|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0|||
13223942|NCT01791517|26290093|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0|||
13223943|NCT01791517|26290094|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0|||
13223944|NCT01791517|26290095|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0|||
13223945|NCT01791517|26290096|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0|||
13223946|NCT01791517|26290097|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0|||
13223947|NCT01791517|26290098|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0|||
13223948|NCT01791517|26290099|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0|||
13223949|NCT01791517|26290100|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1|||
13223950|NCT01791517|26290101|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0|||
13223951|NCT01791517|26290090|FG000|Phase I: Period 2|Lens Discomfort|0|||
13223952|NCT01791517|26290091|FG001|Phase I: Period 2|Lens Discomfort|0|||
13223953|NCT01791517|26290092|FG002|Phase I: Period 2|Lens Discomfort|0|||
13223954|NCT01791517|26290093|FG003|Phase I: Period 2|Lens Discomfort|0|||
13223955|NCT01791517|26290094|FG004|Phase I: Period 2|Lens Discomfort|0|||
13223956|NCT01791517|26290095|FG005|Phase I: Period 2|Lens Discomfort|1|||
13223957|NCT01791517|26290096|FG006|Phase I: Period 2|Lens Discomfort|0|||
13223958|NCT01791517|26290097|FG007|Phase I: Period 2|Lens Discomfort|0|||
13223959|NCT01791517|26290098|FG008|Phase I: Period 2|Lens Discomfort|0|||
13223960|NCT01791517|26290099|FG009|Phase I: Period 2|Lens Discomfort|0|||
13223961|NCT01791517|26290100|FG010|Phase I: Period 2|Lens Discomfort|0|||
13223962|NCT01791517|26290101|FG011|Phase I: Period 2|Lens Discomfort|0|||
13223963|NCT01791517|26290090|FG000|Phase I: Period 2|Lost to Follow-up|0|||
13223964|NCT01791517|26290091|FG001|Phase I: Period 2|Lost to Follow-up|3|||
13223965|NCT01791517|26290092|FG002|Phase I: Period 2|Lost to Follow-up|2|||
13223966|NCT01791517|26290093|FG003|Phase I: Period 2|Lost to Follow-up|0|||
13223967|NCT01791517|26290094|FG004|Phase I: Period 2|Lost to Follow-up|0|||
13223968|NCT01791517|26290095|FG005|Phase I: Period 2|Lost to Follow-up|0|||
13223969|NCT01791517|26290096|FG006|Phase I: Period 2|Lost to Follow-up|0|||
13223970|NCT01791517|26290097|FG007|Phase I: Period 2|Lost to Follow-up|0|||
13223971|NCT01791517|26290098|FG008|Phase I: Period 2|Lost to Follow-up|0|||
13223972|NCT01791517|26290099|FG009|Phase I: Period 2|Lost to Follow-up|0|||
13223973|NCT01791517|26290100|FG010|Phase I: Period 2|Lost to Follow-up|0|||
13223974|NCT01791517|26290101|FG011|Phase I: Period 2|Lost to Follow-up|0|||
13223975|NCT01791517|26290090|FG000|Phase I: Period 3|Lens Discomfort|0|||
13223976|NCT01791517|26290091|FG001|Phase I: Period 3|Lens Discomfort|0|||
13223977|NCT01791517|26290092|FG002|Phase I: Period 3|Lens Discomfort|0|||
13223978|NCT01791517|26290093|FG003|Phase I: Period 3|Lens Discomfort|0|||
13223979|NCT01791517|26290094|FG004|Phase I: Period 3|Lens Discomfort|0|||
13223980|NCT01791517|26290095|FG005|Phase I: Period 3|Lens Discomfort|0|||
13223981|NCT01791517|26290096|FG006|Phase I: Period 3|Lens Discomfort|0|||
13223982|NCT01791517|26290097|FG007|Phase I: Period 3|Lens Discomfort|0|||
13223983|NCT01791517|26290098|FG008|Phase I: Period 3|Lens Discomfort|0|||
13223984|NCT01791517|26290099|FG009|Phase I: Period 3|Lens Discomfort|0|||
13223985|NCT01791517|26290100|FG010|Phase I: Period 3|Lens Discomfort|0|||
13223986|NCT01791517|26290101|FG011|Phase I: Period 3|Lens Discomfort|1|||
13223987|NCT01791517|26290090|FG000|Phase I: Period 3|Lost to Follow-up|0|||
13223988|NCT01791517|26290091|FG001|Phase I: Period 3|Lost to Follow-up|1|||
13223989|NCT01791517|26290092|FG002|Phase I: Period 3|Lost to Follow-up|0|||
13223990|NCT01791517|26290093|FG003|Phase I: Period 3|Lost to Follow-up|0|||
13223991|NCT01791517|26290094|FG004|Phase I: Period 3|Lost to Follow-up|1|||
13223992|NCT01791517|26290095|FG005|Phase I: Period 3|Lost to Follow-up|0|||
13223993|NCT01791517|26290096|FG006|Phase I: Period 3|Lost to Follow-up|0|||
13223994|NCT01791517|26290097|FG007|Phase I: Period 3|Lost to Follow-up|0|||
13223995|NCT01791517|26290098|FG008|Phase I: Period 3|Lost to Follow-up|0|||
13223996|NCT01791517|26290099|FG009|Phase I: Period 3|Lost to Follow-up|0|||
13223997|NCT01791517|26290100|FG010|Phase I: Period 3|Lost to Follow-up|0|||
13223998|NCT01791517|26290101|FG011|Phase I: Period 3|Lost to Follow-up|0|||
13223999|NCT01791517|26290090|FG000|Phase I: Period 3|Adverse Event|0|||
13224000|NCT01791517|26290091|FG001|Phase I: Period 3|Adverse Event|0|||
13224001|NCT01791517|26290092|FG002|Phase I: Period 3|Adverse Event|0|||
13224002|NCT01791517|26290093|FG003|Phase I: Period 3|Adverse Event|1|||
13224003|NCT01791517|26290094|FG004|Phase I: Period 3|Adverse Event|0|||
13224004|NCT01791517|26290095|FG005|Phase I: Period 3|Adverse Event|0|||
13224005|NCT01791517|26290096|FG006|Phase I: Period 3|Adverse Event|0|||
13224006|NCT01791517|26290097|FG007|Phase I: Period 3|Adverse Event|0|||
13224007|NCT01791517|26290098|FG008|Phase I: Period 3|Adverse Event|0|||
13224008|NCT01791517|26290099|FG009|Phase I: Period 3|Adverse Event|0|||
13224009|NCT01791517|26290100|FG010|Phase I: Period 3|Adverse Event|0|||
13224010|NCT01791517|26290101|FG011|Phase I: Period 3|Adverse Event|0|||
13224011|NCT01791517|26290090|FG000|Phase II|Lost to Follow-up|1|||
13224012|NCT01791517|26290091|FG001|Phase II|Lost to Follow-up|0|||
13224013|NCT01791517|26290092|FG002|Phase II|Lost to Follow-up|1|||
13224014|NCT01791517|26290093|FG003|Phase II|Lost to Follow-up|0|||
13224015|NCT01791517|26290094|FG004|Phase II|Lost to Follow-up|1|||
13224016|NCT01791517|26290095|FG005|Phase II|Lost to Follow-up|2|||
13224017|NCT01791517|26290096|FG006|Phase II|Lost to Follow-up|0|||
13224018|NCT01791517|26290097|FG007|Phase II|Lost to Follow-up|1|||
13224019|NCT01791517|26290098|FG008|Phase II|Lost to Follow-up|1|||
13224020|NCT01791517|26290099|FG009|Phase II|Lost to Follow-up|1|||
13224021|NCT01791517|26290100|FG010|Phase II|Lost to Follow-up|0|||
13224022|NCT01791517|26290101|FG011|Phase II|Lost to Follow-up|0|||
13224023|NCT01791517|26290090|FG000|Phase II|Withdrawal by Subject|1|||
13224024|NCT01791517|26290091|FG001|Phase II|Withdrawal by Subject|0|||
13224025|NCT01791517|26290092|FG002|Phase II|Withdrawal by Subject|0|||
13224026|NCT01791517|26290093|FG003|Phase II|Withdrawal by Subject|0|||
13224027|NCT01791517|26290094|FG004|Phase II|Withdrawal by Subject|0|||
13224028|NCT01791517|26290095|FG005|Phase II|Withdrawal by Subject|2|||
13224029|NCT01791517|26290096|FG006|Phase II|Withdrawal by Subject|0|||
13224030|NCT01791517|26290097|FG007|Phase II|Withdrawal by Subject|1|||
13224031|NCT01791517|26290098|FG008|Phase II|Withdrawal by Subject|0|||
13224032|NCT01791517|26290099|FG009|Phase II|Withdrawal by Subject|0|||
13224033|NCT01791517|26290100|FG010|Phase II|Withdrawal by Subject|1|||
13224034|NCT01791517|26290101|FG011|Phase II|Withdrawal by Subject|0|||
13224035|NCT01791517|26290090|FG000|Phase II|Lack of Efficacy|0|||
13224036|NCT01791517|26290091|FG001|Phase II|Lack of Efficacy|0|||
13224037|NCT01791517|26290092|FG002|Phase II|Lack of Efficacy|0|||
13224038|NCT01791517|26290093|FG003|Phase II|Lack of Efficacy|0|||
13224039|NCT01791517|26290094|FG004|Phase II|Lack of Efficacy|1|||
13224040|NCT01791517|26290095|FG005|Phase II|Lack of Efficacy|0|||
13224041|NCT01791517|26290096|FG006|Phase II|Lack of Efficacy|0|||
13224042|NCT01791517|26290097|FG007|Phase II|Lack of Efficacy|0|||
13224043|NCT01791517|26290098|FG008|Phase II|Lack of Efficacy|0|||
13224044|NCT01791517|26290099|FG009|Phase II|Lack of Efficacy|0|||
13224045|NCT01791517|26290100|FG010|Phase II|Lack of Efficacy|0|||
13224046|NCT01791517|26290101|FG011|Phase II|Lack of Efficacy|0|||
13224047|NCT01791517|26290090|FG000|Phase II|Adverse Event|0|||
13224048|NCT01791517|26290091|FG001|Phase II|Adverse Event|0|||
13224049|NCT01791517|26290092|FG002|Phase II|Adverse Event|0|||
13224050|NCT01791517|26290093|FG003|Phase II|Adverse Event|0|||
13224051|NCT01791517|26290094|FG004|Phase II|Adverse Event|0|||
13224052|NCT01791517|26290095|FG005|Phase II|Adverse Event|0|||
13224053|NCT01791517|26290096|FG006|Phase II|Adverse Event|2|||
13224054|NCT01791517|26290097|FG007|Phase II|Adverse Event|1|||
13224055|NCT01791517|26290098|FG008|Phase II|Adverse Event|0|||
13224056|NCT01791517|26290099|FG009|Phase II|Adverse Event|1|||
13224057|NCT01791517|26290100|FG010|Phase II|Adverse Event|0|||
13224058|NCT01791517|26290101|FG011|Phase II|Adverse Event|0|||
13224059|NCT01791517|26290090|FG000|Phase II|Lens Handling Difficulties|0|||
13224060|NCT01791517|26290091|FG001|Phase II|Lens Handling Difficulties|0|||
13224061|NCT01791517|26290092|FG002|Phase II|Lens Handling Difficulties|0|||
13224062|NCT01791517|26290093|FG003|Phase II|Lens Handling Difficulties|0|||
13485639|NCT01126749|27033003|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7|||
13485640|NCT01126749|27033000|FG000|Phase 2|Study Termination by Sponsor|0|||
13224063|NCT01791517|26290094|FG004|Phase II|Lens Handling Difficulties|0|||
13224064|NCT01791517|26290095|FG005|Phase II|Lens Handling Difficulties|0|||
13224065|NCT01791517|26290096|FG006|Phase II|Lens Handling Difficulties|0|||
13224066|NCT01791517|26290097|FG007|Phase II|Lens Handling Difficulties|0|||
13224067|NCT01791517|26290098|FG008|Phase II|Lens Handling Difficulties|1|||
13224068|NCT01791517|26290099|FG009|Phase II|Lens Handling Difficulties|0|||
13224069|NCT01791517|26290100|FG010|Phase II|Lens Handling Difficulties|0|||
13224070|NCT01791517|26290101|FG011|Phase II|Lens Handling Difficulties|0|||
13224071|NCT01791517|26290090|FG000|Phase II|Unsatisfactory Lens Fitting|0|||
13224072|NCT01791517|26290091|FG001|Phase II|Unsatisfactory Lens Fitting|0|||
13224073|NCT01791517|26290092|FG002|Phase II|Unsatisfactory Lens Fitting|0|||
13224074|NCT01791517|26290093|FG003|Phase II|Unsatisfactory Lens Fitting|0|||
13289476|NCT00109850|26479339|FG000|Overall Study|Death|2|||
13224075|NCT01791517|26290094|FG004|Phase II|Unsatisfactory Lens Fitting|0|||
13224076|NCT01791517|26290095|FG005|Phase II|Unsatisfactory Lens Fitting|0|||
13224077|NCT01791517|26290096|FG006|Phase II|Unsatisfactory Lens Fitting|0|||
13224078|NCT01791517|26290097|FG007|Phase II|Unsatisfactory Lens Fitting|0|||
13224079|NCT01791517|26290098|FG008|Phase II|Unsatisfactory Lens Fitting|0|||
13224080|NCT01791517|26290099|FG009|Phase II|Unsatisfactory Lens Fitting|1|||
13224081|NCT01791517|26290100|FG010|Phase II|Unsatisfactory Lens Fitting|0|||
13224082|NCT01791517|26290101|FG011|Phase II|Unsatisfactory Lens Fitting|0|||
13224083|NCT01791517|26290090|FG000|Phase II|Pre-Existing Ocular Issue|0|||
13224084|NCT01791517|26290091|FG001|Phase II|Pre-Existing Ocular Issue|0|||
13224085|NCT01791517|26290092|FG002|Phase II|Pre-Existing Ocular Issue|0|||
13224086|NCT01791517|26290093|FG003|Phase II|Pre-Existing Ocular Issue|0|||
13224087|NCT01791517|26290094|FG004|Phase II|Pre-Existing Ocular Issue|0|||
13224088|NCT01791517|26290095|FG005|Phase II|Pre-Existing Ocular Issue|0|||
13224089|NCT01791517|26290096|FG006|Phase II|Pre-Existing Ocular Issue|0|||
13224090|NCT01791517|26290097|FG007|Phase II|Pre-Existing Ocular Issue|0|||
13224091|NCT01791517|26290098|FG008|Phase II|Pre-Existing Ocular Issue|0|||
13224092|NCT01791517|26290099|FG009|Phase II|Pre-Existing Ocular Issue|0|||
13224093|NCT01791517|26290100|FG010|Phase II|Pre-Existing Ocular Issue|0|||
13224094|NCT01791517|26290101|FG011|Phase II|Pre-Existing Ocular Issue|1|||
13224095|NCT01791413|26290115|FG000|Overall Study|Lost to Follow-up|5|||
13224096|NCT01791413|26290116|FG001|Overall Study|Lost to Follow-up|1|||
13224097|NCT01791244|26290157|FG000|Overall Study|Adverse Event|5|||
13224098|NCT01791244|26290158|FG001|Overall Study|Adverse Event|7|||
13224099|NCT01791244|26290157|FG000|Overall Study|Insufficient clinical response|10|||
13224100|NCT01791244|26290158|FG001|Overall Study|Insufficient clinical response|10|||
13224101|NCT01791244|26290157|FG000|Overall Study|Laboratory Abnormality|0|||
13224102|NCT01791244|26290158|FG001|Overall Study|Laboratory Abnormality|1|||
13224103|NCT01791205|26290245|FG000|Phase II|Lack of Efficacy|6|||
13224104|NCT01791205|26290246|FG001|Phase II|Lack of Efficacy|0|||
13224105|NCT01791205|26290245|FG000|Phase II|Adverse Event|2|||
13224106|NCT01791205|26290246|FG001|Phase II|Adverse Event|0|||
13224107|NCT01791205|26290245|FG000|Phase II|Safety|1|||
13224108|NCT01791205|26290246|FG001|Phase II|Safety|0|||
13224109|NCT01791205|26290245|FG000|Phase II|Lost to Follow-up|1|||
13224110|NCT01791205|26290246|FG001|Phase II|Lost to Follow-up|0|||
13224111|NCT01791205|26290245|FG000|Phase II|Remission of disease|1|||
13224112|NCT01791205|26290246|FG001|Phase II|Remission of disease|0|||
13224113|NCT01791205|26290245|FG000|Phase II|Physician's decision|1|||
13224114|NCT01791205|26290246|FG001|Phase II|Physician's decision|0|||
13224115|NCT01791153|26290323|FG000|Part 1: Blinded Period|Adverse Event|7|||
13224116|NCT01791153|26290324|FG001|Part 1: Blinded Period|Adverse Event|3|||
13224117|NCT01791153|26290325|FG002|Part 1: Blinded Period|Adverse Event|2|||
13224118|NCT01791153|26290326|FG003|Part 1: Blinded Period|Adverse Event|0|||
13224119|NCT01791153|26290327|FG004|Part 1: Blinded Period|Adverse Event|0|||
13224120|NCT01791153|26290328|FG005|Part 1: Blinded Period|Adverse Event|0|||
13224121|NCT01791153|26290329|FG006|Part 1: Blinded Period|Adverse Event|0|||
13224122|NCT01791153|26290330|FG007|Part 1: Blinded Period|Adverse Event|0|||
13224123|NCT01791153|26290323|FG000|Part 1: Blinded Period|Lack of Efficacy|1|||
13224124|NCT01791153|26290324|FG001|Part 1: Blinded Period|Lack of Efficacy|3|||
13224125|NCT01791153|26290325|FG002|Part 1: Blinded Period|Lack of Efficacy|2|||
13224126|NCT01791153|26290326|FG003|Part 1: Blinded Period|Lack of Efficacy|2|||
13224127|NCT01791153|26290327|FG004|Part 1: Blinded Period|Lack of Efficacy|0|||
13224128|NCT01791153|26290328|FG005|Part 1: Blinded Period|Lack of Efficacy|0|||
13224129|NCT01791153|26290329|FG006|Part 1: Blinded Period|Lack of Efficacy|0|||
13224130|NCT01791153|26290330|FG007|Part 1: Blinded Period|Lack of Efficacy|0|||
13224131|NCT01791153|26290323|FG000|Part 1: Blinded Period|Non-Compliance|1|||
13224132|NCT01791153|26290324|FG001|Part 1: Blinded Period|Non-Compliance|0|||
13224133|NCT01791153|26290325|FG002|Part 1: Blinded Period|Non-Compliance|0|||
13224134|NCT01791153|26290326|FG003|Part 1: Blinded Period|Non-Compliance|0|||
13224135|NCT01791153|26290327|FG004|Part 1: Blinded Period|Non-Compliance|0|||
13224136|NCT01791153|26290328|FG005|Part 1: Blinded Period|Non-Compliance|0|||
13224137|NCT01791153|26290329|FG006|Part 1: Blinded Period|Non-Compliance|0|||
13224138|NCT01791153|26290330|FG007|Part 1: Blinded Period|Non-Compliance|0|||
13224139|NCT01791153|26290323|FG000|Part 1: Blinded Period|Physician Decision|0|||
13224140|NCT01791153|26290324|FG001|Part 1: Blinded Period|Physician Decision|0|||
13224141|NCT01791153|26290325|FG002|Part 1: Blinded Period|Physician Decision|0|||
13224142|NCT01791153|26290326|FG003|Part 1: Blinded Period|Physician Decision|1|||
13224143|NCT01791153|26290327|FG004|Part 1: Blinded Period|Physician Decision|0|||
13224144|NCT01791153|26290328|FG005|Part 1: Blinded Period|Physician Decision|0|||
13224145|NCT01791153|26290329|FG006|Part 1: Blinded Period|Physician Decision|0|||
13224146|NCT01791153|26290330|FG007|Part 1: Blinded Period|Physician Decision|0|||
13224147|NCT01791153|26290323|FG000|Part 1: Blinded Period|Protocol Violation|0|||
13224148|NCT01791153|26290324|FG001|Part 1: Blinded Period|Protocol Violation|0|||
13113636|NCT03134222|25912007|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
13224149|NCT01791153|26290325|FG002|Part 1: Blinded Period|Protocol Violation|0|||
13224150|NCT01791153|26290326|FG003|Part 1: Blinded Period|Protocol Violation|1|||
13224151|NCT01791153|26290327|FG004|Part 1: Blinded Period|Protocol Violation|0|||
13224152|NCT01791153|26290328|FG005|Part 1: Blinded Period|Protocol Violation|0|||
13224153|NCT01791153|26290329|FG006|Part 1: Blinded Period|Protocol Violation|0|||
13224154|NCT01791153|26290330|FG007|Part 1: Blinded Period|Protocol Violation|0|||
13224155|NCT01791153|26290323|FG000|Part 1: Blinded Period|Withdrawal by Subject|6|||
13224156|NCT01791153|26290324|FG001|Part 1: Blinded Period|Withdrawal by Subject|2|||
13224157|NCT01791153|26290325|FG002|Part 1: Blinded Period|Withdrawal by Subject|2|||
13224158|NCT01791153|26290326|FG003|Part 1: Blinded Period|Withdrawal by Subject|1|||
13224159|NCT01791153|26290327|FG004|Part 1: Blinded Period|Withdrawal by Subject|0|||
13224160|NCT01791153|26290328|FG005|Part 1: Blinded Period|Withdrawal by Subject|0|||
13224161|NCT01791153|26290329|FG006|Part 1: Blinded Period|Withdrawal by Subject|0|||
13224162|NCT01791153|26290330|FG007|Part 1: Blinded Period|Withdrawal by Subject|0|||
13224163|NCT01791153|26290323|FG000|Part 2: Open-label Period|Adverse Event|0|||
13224164|NCT01791153|26290324|FG001|Part 2: Open-label Period|Adverse Event|0|||
13224165|NCT01791153|26290325|FG002|Part 2: Open-label Period|Adverse Event|0|||
13224166|NCT01791153|26290326|FG003|Part 2: Open-label Period|Adverse Event|0|||
13224167|NCT01791153|26290327|FG004|Part 2: Open-label Period|Adverse Event|0|||
13224168|NCT01791153|26290328|FG005|Part 2: Open-label Period|Adverse Event|1|||
13224169|NCT01791153|26290329|FG006|Part 2: Open-label Period|Adverse Event|1|||
13224170|NCT01791153|26290330|FG007|Part 2: Open-label Period|Adverse Event|2|||
13224171|NCT01791153|26290323|FG000|Part 2: Open-label Period|Death|0|||
13224172|NCT01791153|26290324|FG001|Part 2: Open-label Period|Death|0|||
13224173|NCT01791153|26290325|FG002|Part 2: Open-label Period|Death|0|||
13224174|NCT01791153|26290326|FG003|Part 2: Open-label Period|Death|0|||
13224175|NCT01791153|26290327|FG004|Part 2: Open-label Period|Death|0|||
13224176|NCT01791153|26290328|FG005|Part 2: Open-label Period|Death|1|||
13224177|NCT01791153|26290329|FG006|Part 2: Open-label Period|Death|1|||
13224178|NCT01791153|26290330|FG007|Part 2: Open-label Period|Death|1|||
13224179|NCT01791153|26290323|FG000|Part 2: Open-label Period|Lost to Follow-up|0|||
13224180|NCT01791153|26290324|FG001|Part 2: Open-label Period|Lost to Follow-up|0|||
13224181|NCT01791153|26290325|FG002|Part 2: Open-label Period|Lost to Follow-up|0|||
13224182|NCT01791153|26290326|FG003|Part 2: Open-label Period|Lost to Follow-up|0|||
13224183|NCT01791153|26290327|FG004|Part 2: Open-label Period|Lost to Follow-up|0|||
13224184|NCT01791153|26290328|FG005|Part 2: Open-label Period|Lost to Follow-up|0|||
13224185|NCT01791153|26290329|FG006|Part 2: Open-label Period|Lost to Follow-up|1|||
13224186|NCT01791153|26290330|FG007|Part 2: Open-label Period|Lost to Follow-up|0|||
13224187|NCT01791153|26290323|FG000|Part 2: Open-label Period|Lack of Efficacy|0|||
13224188|NCT01791153|26290324|FG001|Part 2: Open-label Period|Lack of Efficacy|0|||
13224189|NCT01791153|26290325|FG002|Part 2: Open-label Period|Lack of Efficacy|0|||
13224190|NCT01791153|26290326|FG003|Part 2: Open-label Period|Lack of Efficacy|0|||
13224191|NCT01791153|26290327|FG004|Part 2: Open-label Period|Lack of Efficacy|0|||
13224192|NCT01791153|26290328|FG005|Part 2: Open-label Period|Lack of Efficacy|0|||
13224193|NCT01791153|26290329|FG006|Part 2: Open-label Period|Lack of Efficacy|0|||
13224194|NCT01791153|26290330|FG007|Part 2: Open-label Period|Lack of Efficacy|1|||
13224195|NCT01791153|26290323|FG000|Part 2: Open-label Period|Withdrawal by Subject|0|||
13224196|NCT01791153|26290324|FG001|Part 2: Open-label Period|Withdrawal by Subject|0|||
13224197|NCT01791153|26290325|FG002|Part 2: Open-label Period|Withdrawal by Subject|0|||
13224198|NCT01791153|26290326|FG003|Part 2: Open-label Period|Withdrawal by Subject|0|||
13224199|NCT01791153|26290327|FG004|Part 2: Open-label Period|Withdrawal by Subject|1|||
13224200|NCT01791153|26290328|FG005|Part 2: Open-label Period|Withdrawal by Subject|1|||
13224201|NCT01791153|26290329|FG006|Part 2: Open-label Period|Withdrawal by Subject|3|||
13224202|NCT01791153|26290330|FG007|Part 2: Open-label Period|Withdrawal by Subject|2|||
13224203|NCT01791153|26290323|FG000|Part 2: Open-label Period|Physician Decision|0|||
13224204|NCT01791153|26290324|FG001|Part 2: Open-label Period|Physician Decision|0|||
13224205|NCT01791153|26290325|FG002|Part 2: Open-label Period|Physician Decision|0|||
13224206|NCT01791153|26290326|FG003|Part 2: Open-label Period|Physician Decision|0|||
13224207|NCT01791153|26290327|FG004|Part 2: Open-label Period|Physician Decision|1|||
13224208|NCT01791153|26290328|FG005|Part 2: Open-label Period|Physician Decision|1|||
13224209|NCT01791153|26290329|FG006|Part 2: Open-label Period|Physician Decision|0|||
13224210|NCT01791153|26290330|FG007|Part 2: Open-label Period|Physician Decision|0|||
13224211|NCT01791127|26290356|FG000|Overall Study|Death|356|||
13224212|NCT01791127|26290356|FG000|Overall Study|Patient has withdrawn from study|293|||
13224213|NCT01791127|26290356|FG000|Overall Study|Lost to Follow-up|42|||
13224214|NCT01791127|26290356|FG000|Overall Study|All Siello leads are explanted|31|||
13224215|NCT01791127|26290356|FG000|Overall Study|Completion of 30 day safety registry|1|||
13224216|NCT01791127|26290356|FG000|Overall Study|Study terminated for EP Passion|749|||
13224217|NCT01790984|26290395|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
13224218|NCT01790984|26290396|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
13224219|NCT01790984|26290397|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
13224220|NCT01790984|26290398|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
13224221|NCT01790932|26290406|FG000|Overall Study|Disease Progression|41|||
13224222|NCT01790932|26290406|FG000|Overall Study|Adverse Event|7|||
13224223|NCT01790932|26290406|FG000|Overall Study|Physician Decision|1|||
13224224|NCT01790932|26290406|FG000|Overall Study|Withdrawal by Subject|1|||
13224225|NCT01790828|26290431|FG000|Overall Study|Other|34|||
13224226|NCT01790633|26290449|FG000|Overall Study|Protocol Violation|1|||
13224227|NCT01790633|26290450|FG001|Overall Study|Protocol Violation|2|||
13224228|NCT01790633|26290449|FG000|Overall Study|Did not have serology performed|47|||
13224229|NCT01790633|26290450|FG001|Overall Study|Did not have serology performed|0|||
13224230|NCT01790633|26290449|FG000|Overall Study|RT failure and no follow-up ELISA|0|||
13224231|NCT01790633|26290450|FG001|Overall Study|RT failure and no follow-up ELISA|3|||
13224232|NCT01790594|26290524|FG000|Overall Study|Death|1|||
13224233|NCT01790594|26290525|FG001|Overall Study|Death|0|||
13224234|NCT01790594|26290526|FG002|Overall Study|Death|0|||
13224235|NCT01790594|26290524|FG000|Overall Study|Physician Decision|2|||
13224236|NCT01790594|26290525|FG001|Overall Study|Physician Decision|1|||
13224237|NCT01790594|26290526|FG002|Overall Study|Physician Decision|0|||
13224238|NCT01790594|26290524|FG000|Overall Study|Withdrawal by Subject|2|||
13224239|NCT01790594|26290525|FG001|Overall Study|Withdrawal by Subject|0|||
13224240|NCT01790594|26290526|FG002|Overall Study|Withdrawal by Subject|0|||
13224241|NCT01790594|26290524|FG000|Overall Study|Transplant was not done|0|||
13224242|NCT01790594|26290525|FG001|Overall Study|Transplant was not done|0|||
13224243|NCT01790594|26290526|FG002|Overall Study|Transplant was not done|3|||
13224244|NCT01790594|26290524|FG000|Overall Study|Terminated prior to week 76|0|||
13224245|NCT01790594|26290525|FG001|Overall Study|Terminated prior to week 76|2|||
13224246|NCT01790594|26290526|FG002|Overall Study|Terminated prior to week 76|0|||
13224247|NCT01790568|26290535|FG000|Overall Study|Progression prior to transplant|0|||
13224248|NCT01790568|26290536|FG001|Overall Study|Progression prior to transplant|1|||
13224249|NCT01790516|26290549|FG000|Overall Study|Physician Decision|1|||
13224250|NCT01790516|26290550|FG001|Overall Study|Physician Decision|0|||
13224251|NCT01790503|26290636|FG000|Overall Study|Adverse Event|1|||
13224252|NCT01790503|26290637|FG001|Overall Study|Adverse Event|0|||
13224253|NCT01790503|26290638|FG002|Overall Study|Adverse Event|0|||
13224254|NCT01790503|26290639|FG003|Overall Study|Adverse Event|0|||
13224255|NCT01790503|26290640|FG004|Overall Study|Adverse Event|0|||
13224256|NCT01790503|26290641|FG005|Overall Study|Adverse Event|2|||
13224257|NCT01790503|26290642|FG006|Overall Study|Adverse Event|0|||
13224258|NCT01790503|26290643|FG007|Overall Study|Adverse Event|0|||
13224259|NCT01790503|26290644|FG008|Overall Study|Adverse Event|2|||
13224260|NCT01790503|26290645|FG009|Overall Study|Adverse Event|4|||
13224261|NCT01790503|26290646|FG010|Overall Study|Adverse Event|7|||
13224262|NCT01790503|26290636|FG000|Overall Study|Withdrawal by Subject|0|||
13224263|NCT01790503|26290637|FG001|Overall Study|Withdrawal by Subject|0|||
13224264|NCT01790503|26290638|FG002|Overall Study|Withdrawal by Subject|1|||
13224265|NCT01790503|26290639|FG003|Overall Study|Withdrawal by Subject|1|||
13224266|NCT01790503|26290640|FG004|Overall Study|Withdrawal by Subject|1|||
13224267|NCT01790503|26290641|FG005|Overall Study|Withdrawal by Subject|2|||
13224268|NCT01790503|26290642|FG006|Overall Study|Withdrawal by Subject|1|||
13224269|NCT01790503|26290643|FG007|Overall Study|Withdrawal by Subject|0|||
13224270|NCT01790503|26290644|FG008|Overall Study|Withdrawal by Subject|0|||
13224271|NCT01790503|26290645|FG009|Overall Study|Withdrawal by Subject|0|||
13113637|NCT03134222|25912008|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
13113638|NCT03134222|25912009|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1|||
13113639|NCT03134222|25912005|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2|||
13113640|NCT03134222|25912006|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
13113641|NCT03134222|25912007|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
13113642|NCT03134222|25912008|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
13224272|NCT01790503|26290646|FG010|Overall Study|Withdrawal by Subject|1|||
13224273|NCT01790503|26290636|FG000|Overall Study|Disease progression|2|||
13224274|NCT01790503|26290637|FG001|Overall Study|Disease progression|1|||
13224275|NCT01790503|26290638|FG002|Overall Study|Disease progression|0|||
13224276|NCT01790503|26290639|FG003|Overall Study|Disease progression|1|||
13224277|NCT01790503|26290640|FG004|Overall Study|Disease progression|2|||
13224278|NCT01790503|26290641|FG005|Overall Study|Disease progression|1|||
13224279|NCT01790503|26290642|FG006|Overall Study|Disease progression|0|||
13224280|NCT01790503|26290643|FG007|Overall Study|Disease progression|1|||
13224281|NCT01790503|26290644|FG008|Overall Study|Disease progression|0|||
13224282|NCT01790503|26290645|FG009|Overall Study|Disease progression|17|||
13224283|NCT01790503|26290646|FG010|Overall Study|Disease progression|7|||
13224284|NCT01790503|26290636|FG000|Overall Study|Protocol Violation|0|||
13224285|NCT01790503|26290637|FG001|Overall Study|Protocol Violation|0|||
13224286|NCT01790503|26290638|FG002|Overall Study|Protocol Violation|0|||
13224287|NCT01790503|26290639|FG003|Overall Study|Protocol Violation|0|||
13224288|NCT01790503|26290640|FG004|Overall Study|Protocol Violation|0|||
13224289|NCT01790503|26290641|FG005|Overall Study|Protocol Violation|0|||
13224290|NCT01790503|26290642|FG006|Overall Study|Protocol Violation|0|||
13224291|NCT01790503|26290643|FG007|Overall Study|Protocol Violation|0|||
13224292|NCT01790503|26290644|FG008|Overall Study|Protocol Violation|0|||
13224293|NCT01790503|26290645|FG009|Overall Study|Protocol Violation|1|||
13224294|NCT01790503|26290646|FG010|Overall Study|Protocol Violation|0|||
13224295|NCT01790503|26290636|FG000|Overall Study|Physician Decision|0|||
13224296|NCT01790503|26290637|FG001|Overall Study|Physician Decision|0|||
13224297|NCT01790503|26290638|FG002|Overall Study|Physician Decision|0|||
13224298|NCT01790503|26290639|FG003|Overall Study|Physician Decision|0|||
13224299|NCT01790503|26290640|FG004|Overall Study|Physician Decision|0|||
13224300|NCT01790503|26290641|FG005|Overall Study|Physician Decision|0|||
13224301|NCT01790503|26290642|FG006|Overall Study|Physician Decision|0|||
13224302|NCT01790503|26290643|FG007|Overall Study|Physician Decision|0|||
13224303|NCT01790503|26290644|FG008|Overall Study|Physician Decision|0|||
13224304|NCT01790503|26290645|FG009|Overall Study|Physician Decision|1|||
13224305|NCT01790503|26290646|FG010|Overall Study|Physician Decision|1|||
13224306|NCT01790503|26290636|FG000|Overall Study|Death|0|||
13224307|NCT01790503|26290637|FG001|Overall Study|Death|0|||
13224308|NCT01790503|26290638|FG002|Overall Study|Death|0|||
13224309|NCT01790503|26290639|FG003|Overall Study|Death|0|||
13224310|NCT01790503|26290640|FG004|Overall Study|Death|0|||
13224311|NCT01790503|26290641|FG005|Overall Study|Death|0|||
13224312|NCT01790503|26290642|FG006|Overall Study|Death|0|||
13224313|NCT01790503|26290643|FG007|Overall Study|Death|0|||
13224314|NCT01790503|26290644|FG008|Overall Study|Death|0|||
13224315|NCT01790503|26290645|FG009|Overall Study|Death|1|||
13224316|NCT01790503|26290646|FG010|Overall Study|Death|0|||
13224317|NCT01790503|26290636|FG000|Overall Study|Non Compliance|0|||
13224318|NCT01790503|26290637|FG001|Overall Study|Non Compliance|0|||
13224319|NCT01790503|26290638|FG002|Overall Study|Non Compliance|0|||
13224320|NCT01790503|26290639|FG003|Overall Study|Non Compliance|0|||
13224321|NCT01790503|26290640|FG004|Overall Study|Non Compliance|1|||
13224322|NCT01790503|26290641|FG005|Overall Study|Non Compliance|0|||
13224323|NCT01790503|26290642|FG006|Overall Study|Non Compliance|0|||
13224324|NCT01790503|26290643|FG007|Overall Study|Non Compliance|0|||
13224325|NCT01790503|26290644|FG008|Overall Study|Non Compliance|0|||
13224326|NCT01790503|26290645|FG009|Overall Study|Non Compliance|0|||
13224327|NCT01790503|26290646|FG010|Overall Study|Non Compliance|0|||
13224328|NCT01790503|26290636|FG000|Overall Study|Other|0|||
13224329|NCT01790503|26290637|FG001|Overall Study|Other|0|||
13224330|NCT01790503|26290638|FG002|Overall Study|Other|0|||
13224331|NCT01790503|26290639|FG003|Overall Study|Other|0|||
13224332|NCT01790503|26290640|FG004|Overall Study|Other|1|||
13224333|NCT01790503|26290641|FG005|Overall Study|Other|0|||
13224334|NCT01790503|26290642|FG006|Overall Study|Other|0|||
13224335|NCT01790503|26290643|FG007|Overall Study|Other|0|||
13224336|NCT01790503|26290644|FG008|Overall Study|Other|1|||
13224337|NCT01790503|26290645|FG009|Overall Study|Other|2|||
13224338|NCT01790503|26290646|FG010|Overall Study|Other|0|||
13224339|NCT01790438|26290703|FG000|Overall Study|Adverse Event|3|||
13224340|NCT01790438|26290704|FG001|Overall Study|Adverse Event|2|||
13224341|NCT01790438|26290703|FG000|Overall Study|Death|4|||
13224342|NCT01790438|26290704|FG001|Overall Study|Death|0|||
13224343|NCT01790438|26290703|FG000|Overall Study|Lost to Follow-up|5|||
13224344|NCT01790438|26290704|FG001|Overall Study|Lost to Follow-up|2|||
13224345|NCT01790438|26290703|FG000|Overall Study|Withdrawal by Subject|13|||
13224346|NCT01790438|26290704|FG001|Overall Study|Withdrawal by Subject|2|||
13224347|NCT01790438|26290703|FG000|Overall Study|Physician Decision|3|||
13224348|NCT01790438|26290704|FG001|Overall Study|Physician Decision|1|||
13224349|NCT01790438|26290703|FG000|Overall Study|Sponsor Decision|0|||
13224350|NCT01790438|26290704|FG001|Overall Study|Sponsor Decision|3|||
13224351|NCT01790438|26290703|FG000|Overall Study|Protocol Required Discontinuation|7|||
13224352|NCT01790438|26290704|FG001|Overall Study|Protocol Required Discontinuation|1|||
13224353|NCT01790295|26290729|FG000|Overall Study|Adverse Event|1|||
13224354|NCT01790295|26290729|FG000|Overall Study|Death|4|||
13224355|NCT01790295|26290729|FG000|Overall Study|Lack of Efficacy|2|||
13224356|NCT01790295|26290729|FG000|Overall Study|Study closure|4|||
13224357|NCT01790126|26290794|FG000|Overall Study|PSA Progression|12|||
13224358|NCT01790126|26290795|FG001|Overall Study|PSA Progression|16|||
13224359|NCT01790126|26290796|FG002|Overall Study|PSA Progression|16|||
13224360|NCT01790126|26290794|FG000|Overall Study|Other|5|||
13224361|NCT01790126|26290795|FG001|Overall Study|Other|4|||
13224362|NCT01790126|26290796|FG002|Overall Study|Other|8|||
13224363|NCT01790126|26290794|FG000|Overall Study|Initiation of Non-Protocol Therapy|3|||
13224364|NCT01790126|26290795|FG001|Overall Study|Initiation of Non-Protocol Therapy|4|||
13224365|NCT01790126|26290796|FG002|Overall Study|Initiation of Non-Protocol Therapy|2|||
13224366|NCT01790126|26290794|FG000|Overall Study|Withdrawal by Physician|1|||
13224367|NCT01790126|26290795|FG001|Overall Study|Withdrawal by Physician|1|||
13224368|NCT01790126|26290796|FG002|Overall Study|Withdrawal by Physician|2|||
13224369|NCT01790126|26290794|FG000|Overall Study|Withdrawal by Subject|3|||
13224370|NCT01790126|26290795|FG001|Overall Study|Withdrawal by Subject|1|||
13224371|NCT01790126|26290796|FG002|Overall Study|Withdrawal by Subject|2|||
13224372|NCT01790126|26290794|FG000|Overall Study|Lost to Follow-up|1|||
13224373|NCT01790126|26290795|FG001|Overall Study|Lost to Follow-up|0|||
13224374|NCT01790126|26290796|FG002|Overall Study|Lost to Follow-up|1|||
13224375|NCT01790126|26290794|FG000|Overall Study|Adverse Event|0|||
13224376|NCT01790126|26290795|FG001|Overall Study|Adverse Event|2|||
13224377|NCT01790126|26290796|FG002|Overall Study|Adverse Event|0|||
13224378|NCT01790126|26290794|FG000|Overall Study|Death|2|||
13224379|NCT01790126|26290795|FG001|Overall Study|Death|0|||
13224380|NCT01790126|26290796|FG002|Overall Study|Death|0|||
13224381|NCT01790126|26290794|FG000|Overall Study|Radiographic Progression|3|||
13224382|NCT01790126|26290795|FG001|Overall Study|Radiographic Progression|1|||
13224383|NCT01790126|26290796|FG002|Overall Study|Radiographic Progression|0|||
13224384|NCT01790113|26290809|FG000|Overall Study|Adverse Event|2|||
13224385|NCT01790113|26290810|FG001|Overall Study|Adverse Event|7|||
13224386|NCT01790113|26290809|FG000|Overall Study|Study ended due to FDA clearance|1|||
13224387|NCT01790113|26290810|FG001|Overall Study|Study ended due to FDA clearance|68|||
13224388|NCT01790048|26290833|FG000|Overall Study|Incorrect Age|9|||
13224389|NCT01790048|26290834|FG001|Overall Study|Incorrect Age|14|||
13224390|NCT01790048|26290833|FG000|Overall Study|data entry error|0|||
13224391|NCT01790048|26290834|FG001|Overall Study|data entry error|1|||
13224392|NCT01790048|26290833|FG000|Overall Study|Other|0|||
13224393|NCT01790048|26290834|FG001|Overall Study|Other|2|||
13224394|NCT01790048|26290833|FG000|Overall Study|SAM at Enrollment|2|||
13224395|NCT01790048|26290834|FG001|Overall Study|SAM at Enrollment|0|||
13224396|NCT01790048|26290833|FG000|Overall Study|Measurement error|1|||
13224397|NCT01790048|26290834|FG001|Overall Study|Measurement error|0|||
13224398|NCT01789970|26290874|FG000|Open-label Titration Period|Adverse Event|68|||
13224399|NCT01789970|26290875|FG001|Open-label Titration Period|Adverse Event|0|||
13224400|NCT01789970|26290876|FG002|Open-label Titration Period|Adverse Event|0|||
13224401|NCT01789970|26290874|FG000|Open-label Titration Period|Lack of Efficacy|31|||
13224402|NCT01789970|26290875|FG001|Open-label Titration Period|Lack of Efficacy|0|||
13224403|NCT01789970|26290876|FG002|Open-label Titration Period|Lack of Efficacy|0|||
13224404|NCT01789970|26290874|FG000|Open-label Titration Period|Withdrawal by Subject|31|||
13224405|NCT01789970|26290875|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
13224406|NCT01789970|26290876|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
13224407|NCT01789970|26290874|FG000|Open-label Titration Period|Protocol Violation|18|||
13224408|NCT01789970|26290875|FG001|Open-label Titration Period|Protocol Violation|0|||
13224409|NCT01789970|26290876|FG002|Open-label Titration Period|Protocol Violation|0|||
13224410|NCT01789970|26290874|FG000|Open-label Titration Period|Lost to Follow-up|5|||
13224411|NCT01789970|26290875|FG001|Open-label Titration Period|Lost to Follow-up|0|||
13224412|NCT01789970|26290876|FG002|Open-label Titration Period|Lost to Follow-up|0|||
13224413|NCT01789970|26290874|FG000|Open-label Titration Period|Noncompliance to study drug admin|11|||
13224414|NCT01789970|26290875|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
13224415|NCT01789970|26290876|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
13224416|NCT01789970|26290874|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2|||
13224417|NCT01789970|26290875|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0|||
13224418|NCT01789970|26290876|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0|||
13224419|NCT01789970|26290874|FG000|Open-label Titration Period|Noncompliance with study procedures|8|||
13224420|NCT01789970|26290875|FG001|Open-label Titration Period|Noncompliance with study procedures|0|||
13224421|NCT01789970|26290876|FG002|Open-label Titration Period|Noncompliance with study procedures|0|||
13113643|NCT03134222|25912009|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
13113644|NCT03134222|25912005|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
13113645|NCT03134222|25912006|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
13113646|NCT03134222|25912007|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
13113647|NCT03134222|25912008|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1|||
13113648|NCT03134222|25912009|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
13113649|NCT03134222|25912005|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
13113650|NCT03134222|25912006|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1|||
13113651|NCT03134222|25912007|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
13113652|NCT03134222|25912008|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
13113653|NCT03134222|25912009|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
13113654|NCT03134183|25912024|FG000|Overall Study|Withdrawal by Subject|1|||
13113655|NCT03134183|25912025|FG001|Overall Study|Withdrawal by Subject|1|||
13113656|NCT03133793|25912076|FG000|Overall Study|Withdrawal by Subject|0|||
13113657|NCT03133793|25912077|FG001|Overall Study|Withdrawal by Subject|4|||
13113658|NCT03133793|25912078|FG002|Overall Study|Withdrawal by Subject|2|||
13113659|NCT03133793|25912079|FG003|Overall Study|Withdrawal by Subject|4|||
13113660|NCT03133793|25912076|FG000|Overall Study|Lost to Follow-up|1|||
13113661|NCT03133793|25912077|FG001|Overall Study|Lost to Follow-up|0|||
13113662|NCT03133793|25912078|FG002|Overall Study|Lost to Follow-up|2|||
13113663|NCT03133793|25912079|FG003|Overall Study|Lost to Follow-up|0|||
13113664|NCT03133793|25912076|FG000|Overall Study|Death|0|||
13113665|NCT03133793|25912077|FG001|Overall Study|Death|0|||
13113666|NCT03133793|25912078|FG002|Overall Study|Death|0|||
13224422|NCT01789970|26290874|FG000|Open-label Titration Period|Pregnancy|2|||
13224423|NCT01789970|26290875|FG001|Open-label Titration Period|Pregnancy|0|||
13224424|NCT01789970|26290876|FG002|Open-label Titration Period|Pregnancy|0|||
13113667|NCT03133793|25912079|FG003|Overall Study|Death|1|||
13224425|NCT01789970|26290874|FG000|Open-label Titration Period|Other|76|||
13224426|NCT01789970|26290875|FG001|Open-label Titration Period|Other|0|||
13224427|NCT01789970|26290876|FG002|Open-label Titration Period|Other|0|||
13224428|NCT01789970|26290874|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
13224429|NCT01789970|26290875|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
13224430|NCT01789970|26290876|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
13224431|NCT01789970|26290874|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
13224432|NCT01789970|26290875|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9|||
13224433|NCT01789970|26290876|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15|||
13224434|NCT01789970|26290874|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
13224435|NCT01789970|26290875|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
13224436|NCT01789970|26290876|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
13224437|NCT01789970|26290874|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
13224438|NCT01789970|26290875|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
13224439|NCT01789970|26290876|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
13224440|NCT01789970|26290874|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
13224441|NCT01789970|26290875|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
13224442|NCT01789970|26290876|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7|||
13224443|NCT01789970|26290874|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
13224444|NCT01789970|26290875|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
13224445|NCT01789970|26290876|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
13224446|NCT01789970|26290874|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0|||
13224447|NCT01789970|26290875|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2|||
13113668|NCT03133767|25912100|FG000|Overall Study|Lost to Follow-up|38|||
13113669|NCT03133767|25912101|FG001|Overall Study|Lost to Follow-up|24|||
13113670|NCT03133767|25912100|FG000|Overall Study|Protocol Violation|0|||
13113671|NCT03133767|25912101|FG001|Overall Study|Protocol Violation|1|||
13224448|NCT01789970|26290876|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1|||
13224449|NCT01789970|26290874|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
13224450|NCT01789970|26290875|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
13224451|NCT01789970|26290876|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2|||
13224452|NCT01789970|26290874|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
13224453|NCT01789970|26290875|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1|||
13224454|NCT01789970|26290876|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
13224455|NCT01789970|26290874|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
13113672|NCT03133481|25912136|FG000|Overall Study|FC Catheter fell out post operative day1|0|||
13113673|NCT03133481|25912137|FG001|Overall Study|FC Catheter fell out post operative day1|4|||
13224456|NCT01789970|26290875|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
13224457|NCT01789970|26290876|FG002|Double-blind Treatment Period (12 Weeks)|Other|3|||
13224458|NCT01789970|26290874|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
13224459|NCT01789970|26290875|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1|||
13224460|NCT01789970|26290876|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
13224461|NCT01789606|26290901|FG000|Overall Study|Participant not Purchased the Product|0|||
13224462|NCT01789606|26290902|FG001|Overall Study|Participant not Purchased the Product|20|||
13224463|NCT01789606|26290901|FG000|Overall Study|Withdrawal by Subject|0|||
13224464|NCT01789606|26290902|FG001|Overall Study|Withdrawal by Subject|1|||
13224465|NCT01789606|26290901|FG000|Overall Study|Ineligible|6|||
13224466|NCT01789606|26290902|FG001|Overall Study|Ineligible|2|||
13224467|NCT01789606|26290901|FG000|Overall Study|Administrative Reasons|17|||
13224468|NCT01789606|26290902|FG001|Overall Study|Administrative Reasons|6|||
13224469|NCT01789606|26290901|FG000|Overall Study|No Study Medication Taken|0|||
13224470|NCT01789606|26290902|FG001|Overall Study|No Study Medication Taken|1|||
13224471|NCT01789606|26290901|FG000|Overall Study|Protocol Violation|0|||
13224472|NCT01789606|26290902|FG001|Overall Study|Protocol Violation|55|||
13224473|NCT01789606|26290901|FG000|Overall Study|Adverse Event|0|||
13224474|NCT01789606|26290902|FG001|Overall Study|Adverse Event|3|||
13224475|NCT01789606|26290901|FG000|Overall Study|Lost to Follow-up|0|||
13224476|NCT01789606|26290902|FG001|Overall Study|Lost to Follow-up|14|||
13224477|NCT01789606|26290901|FG000|Overall Study|Ineligible or not Willing to Continue|0|||
13224478|NCT01789606|26290902|FG001|Overall Study|Ineligible or not Willing to Continue|348|||
13224479|NCT01789567|26290911|FG000|Overall Study|Death|6|||
13224480|NCT01789476|26290928|FG000|Overall Study|Lack of Efficacy|6|||
13224481|NCT01789476|26290929|FG001|Overall Study|Lack of Efficacy|2|||
13224482|NCT01789476|26290928|FG000|Overall Study|Adverse Event|1|||
13224483|NCT01789476|26290929|FG001|Overall Study|Adverse Event|0|||
13224484|NCT01789476|26290928|FG000|Overall Study|Unable to get IV access|1|||
13224485|NCT01789476|26290929|FG001|Overall Study|Unable to get IV access|0|||
13224486|NCT01789320|26290938|FG000|Overall Study|Re-enrolled into study|1|||
13113674|NCT03132805|25912170|FG000|Overall Study|Lost to Follow-up|142|||
13224487|NCT01789320|26290938|FG000|Overall Study|Lost to Follow-up|1|||
13224488|NCT01789281|26290954|FG000|Overall Study|Disease progression|15|||
13224489|NCT01789281|26290955|FG001|Overall Study|Disease progression|4|||
13224490|NCT01789281|26290954|FG000|Overall Study|Adverse Event|5|||
13224491|NCT01789281|26290955|FG001|Overall Study|Adverse Event|5|||
13224492|NCT01789281|26290954|FG000|Overall Study|Withdrawal by Subject|1|||
13224493|NCT01789281|26290955|FG001|Overall Study|Withdrawal by Subject|0|||
13224494|NCT01789281|26290954|FG000|Overall Study|Lost to Follow-up|1|||
13224495|NCT01789281|26290955|FG001|Overall Study|Lost to Follow-up|0|||
13224496|NCT01789281|26290954|FG000|Overall Study|Administrative problems|0|||
13224497|NCT01789281|26290955|FG001|Overall Study|Administrative problems|1|||
13224498|NCT01789203|26290990|FG000|Overall Study|Adverse Event|2|||
13224499|NCT01789203|26290991|FG001|Overall Study|Adverse Event|2|||
13224500|NCT01789203|26290990|FG000|Overall Study|Withdrawal by Subject|1|||
13224501|NCT01789203|26290991|FG001|Overall Study|Withdrawal by Subject|0|||
13224502|NCT01789203|26290990|FG000|Overall Study|Death|1|||
13224503|NCT01789203|26290991|FG001|Overall Study|Death|0|||
13224504|NCT01789203|26290990|FG000|Overall Study|Protocol Violation|2|||
13224505|NCT01789203|26290991|FG001|Overall Study|Protocol Violation|1|||
13224506|NCT01789203|26290990|FG000|Overall Study|Other|1|||
13224507|NCT01789203|26290991|FG001|Overall Study|Other|1|||
13113675|NCT03132805|25912171|FG001|Overall Study|Lost to Follow-up|141|||
13113676|NCT03132805|25912172|FG002|Overall Study|Lost to Follow-up|113|||
13113677|NCT03132636|25912209|FG000|Overall Study|Adverse Event|1|||
13113678|NCT03132636|25912210|FG001|Overall Study|Adverse Event|2|||
13113679|NCT03132636|25912209|FG000|Overall Study|Death|4|||
13113680|NCT03132636|25912210|FG001|Overall Study|Death|7|||
13113681|NCT03132636|25912209|FG000|Overall Study|Lost to Follow-up|2|||
13113682|NCT03132636|25912210|FG001|Overall Study|Lost to Follow-up|2|||
13113683|NCT03132636|25912209|FG000|Overall Study|Protocol Violation|1|||
13113684|NCT03132636|25912210|FG001|Overall Study|Protocol Violation|1|||
13224508|NCT01789203|26290990|FG000|Overall Study|patient non-adherent|2|||
13224509|NCT01789203|26290991|FG001|Overall Study|patient non-adherent|0|||
13224510|NCT01789047|26291004|FG000|Overall Study|Adverse Event|3|||
13224511|NCT01789047|26291005|FG001|Overall Study|Adverse Event|2|||
13224512|NCT01789047|26291004|FG000|Overall Study|Withdrawal by Subject|1|||
13224513|NCT01789047|26291005|FG001|Overall Study|Withdrawal by Subject|2|||
13224514|NCT01788943|26291020|FG000|Overall Study|Withdrawal by Subject|1|||
13224515|NCT01788943|26291021|FG001|Overall Study|Withdrawal by Subject|0|||
13224516|NCT01788566|26291033|FG000|Overall Study|Death|4|||
13224517|NCT01788566|26291033|FG000|Overall Study|Adverse Event|1|||
13224518|NCT01788566|26291033|FG000|Overall Study|Clinical Progressive Disease|3|||
13224519|NCT01788423|26291054|FG000|Overall Study|See Comments in Completed (above)|0|||
13224520|NCT01788423|26291055|FG001|Overall Study|See Comments in Completed (above)|4|||
13224521|NCT01788423|26291056|FG002|Overall Study|See Comments in Completed (above)|5|||
13224522|NCT01788358|26291070|FG000|Overall Study|Other|11|||
13224523|NCT01788358|26291070|FG000|Overall Study|Logistical difficulties|1|||
13224524|NCT01788358|26291070|FG000|Overall Study|Lost to Follow-up|5|||
13224525|NCT01788358|26291070|FG000|Overall Study|Protocol Violation|3|||
13224526|NCT01788358|26291070|FG000|Overall Study|Withdrawal by Subject|26|||
13224527|NCT01788358|26291070|FG000|Overall Study|Lack of Efficacy|1|||
13224528|NCT01788358|26291070|FG000|Overall Study|Adverse Event|51|||
13224529|NCT01788228|26291108|FG000|Overall Study|Migrated/moved from study area|1|||
13224530|NCT01788228|26291109|FG001|Overall Study|Migrated/moved from study area|0|||
13224531|NCT01788215|26291136|FG000|Overall Study|Withdrawal by Subject|0|||
13224532|NCT01788215|26291137|FG001|Overall Study|Withdrawal by Subject|1|||
13224533|NCT01788215|26291136|FG000|Overall Study|Lost to Follow-up|2|||
13224534|NCT01788215|26291137|FG001|Overall Study|Lost to Follow-up|0|||
13224535|NCT01788163|26291326|FG000|Overall Study|Other|53|||
13224536|NCT01788163|26291327|FG001|Overall Study|Other|0|||
13224537|NCT01788163|26291328|FG002|Overall Study|Other|0|||
13224538|NCT01788163|26291329|FG003|Overall Study|Other|0|||
13224539|NCT01788163|26291330|FG004|Overall Study|Other|0|||
13224540|NCT01788163|26291331|FG005|Overall Study|Other|7|||
13224541|NCT01788163|26291332|FG006|Overall Study|Other|1|||
13224542|NCT01788163|26291333|FG007|Overall Study|Other|48|||
13224543|NCT01788163|26291334|FG008|Overall Study|Other|15|||
13224544|NCT01788163|26291326|FG000|Overall Study|Withdrawal by Subject|2|||
13224545|NCT01788163|26291327|FG001|Overall Study|Withdrawal by Subject|0|||
13224546|NCT01788163|26291328|FG002|Overall Study|Withdrawal by Subject|0|||
13224547|NCT01788163|26291329|FG003|Overall Study|Withdrawal by Subject|0|||
13224548|NCT01788163|26291330|FG004|Overall Study|Withdrawal by Subject|0|||
13224549|NCT01788163|26291331|FG005|Overall Study|Withdrawal by Subject|0|||
13224550|NCT01788163|26291332|FG006|Overall Study|Withdrawal by Subject|0|||
13224551|NCT01788163|26291333|FG007|Overall Study|Withdrawal by Subject|0|||
13224552|NCT01788163|26291334|FG008|Overall Study|Withdrawal by Subject|1|||
13224553|NCT01788046|26291357|FG000|Overall Study|Withdrawal by Subject|12|||
13113685|NCT03132636|25912209|FG000|Overall Study|Participant Decision|1|||
13224554|NCT01788046|26291358|FG001|Overall Study|Withdrawal by Subject|12|||
13224555|NCT01788046|26291357|FG000|Overall Study|Lost to Follow-up|12|||
13224556|NCT01788046|26291358|FG001|Overall Study|Lost to Follow-up|19|||
13224557|NCT01788046|26291357|FG000|Overall Study|Death|7|||
13224558|NCT01788046|26291358|FG001|Overall Study|Death|5|||
13224559|NCT01788046|26291357|FG000|Overall Study|Protocol Specified Criteria|25|||
13224560|NCT01788046|26291358|FG001|Overall Study|Protocol Specified Criteria|1|||
13224561|NCT01787838|26291364|FG000|Overall Study|refused|1413|||
13224562|NCT01787825|26291378|FG000|Overall Study|Subject Did Not Ingest Capsules|1|||
13224563|NCT01787825|26291379|FG001|Overall Study|Subject Did Not Ingest Capsules|0|||
13224564|NCT01787825|26291378|FG000|Overall Study|Data Not Analyzable|5|||
13224565|NCT01787825|26291379|FG001|Overall Study|Data Not Analyzable|1|||
13224566|NCT01787760|26291401|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1|||
13224567|NCT01787760|26291402|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
13224568|NCT01787760|26291403|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
13224569|NCT01787760|26291401|FG000|Overall Study|Decompensated on left exotropia|0|||
13224570|NCT01787760|26291402|FG001|Overall Study|Decompensated on left exotropia|0|||
13224571|NCT01787760|26291403|FG002|Overall Study|Decompensated on left exotropia|1|||
13224572|NCT01787760|26291401|FG000|Overall Study|Dryness|0|||
13224573|NCT01787760|26291402|FG001|Overall Study|Dryness|1|||
13224574|NCT01787760|26291403|FG002|Overall Study|Dryness|0|||
13224575|NCT01787760|26291401|FG000|Overall Study|Relocation|1|||
13224576|NCT01787760|26291402|FG001|Overall Study|Relocation|1|||
13224577|NCT01787760|26291403|FG002|Overall Study|Relocation|0|||
13224578|NCT01787760|26291401|FG000|Overall Study|Lens discomfort|3|||
13224579|NCT01787760|26291402|FG001|Overall Study|Lens discomfort|0|||
13224580|NCT01787760|26291403|FG002|Overall Study|Lens discomfort|0|||
13203081|NCT01987960|26223191|FG003|Period 1|Withdrawal by Subject|0|||
13224581|NCT01787760|26291401|FG000|Overall Study|Lens handling difficulty|1|||
13224582|NCT01787760|26291402|FG001|Overall Study|Lens handling difficulty|2|||
13224583|NCT01787760|26291403|FG002|Overall Study|Lens handling difficulty|0|||
13224584|NCT01787760|26291401|FG000|Overall Study|Protocol Violation|6|||
13224585|NCT01787760|26291402|FG001|Overall Study|Protocol Violation|0|||
13224586|NCT01787760|26291403|FG002|Overall Study|Protocol Violation|1|||
13224587|NCT01787760|26291401|FG000|Overall Study|Withdrawal by Subject|5|||
13224588|NCT01787760|26291402|FG001|Overall Study|Withdrawal by Subject|1|||
13224589|NCT01787760|26291403|FG002|Overall Study|Withdrawal by Subject|2|||
13224590|NCT01787760|26291401|FG000|Overall Study|Lost to Follow-up|1|||
13224591|NCT01787760|26291402|FG001|Overall Study|Lost to Follow-up|0|||
13224592|NCT01787760|26291403|FG002|Overall Study|Lost to Follow-up|1|||
13224593|NCT01787760|26291401|FG000|Overall Study|Stroke|1|||
13224594|NCT01787760|26291402|FG001|Overall Study|Stroke|0|||
13224595|NCT01787760|26291403|FG002|Overall Study|Stroke|0|||
13224596|NCT01787760|26291401|FG000|Overall Study|Unsatisfactory lens fitting performance|3|||
13224597|NCT01787760|26291402|FG001|Overall Study|Unsatisfactory lens fitting performance|6|||
13224598|NCT01787760|26291403|FG002|Overall Study|Unsatisfactory lens fitting performance|0|||
13224599|NCT01787760|26291401|FG000|Overall Study|Unsatisfactory physiological response|2|||
13224600|NCT01787760|26291402|FG001|Overall Study|Unsatisfactory physiological response|4|||
13224601|NCT01787760|26291403|FG002|Overall Study|Unsatisfactory physiological response|0|||
13224602|NCT01787760|26291401|FG000|Overall Study|Unsatisfactory visual response|1|||
13224603|NCT01787760|26291402|FG001|Overall Study|Unsatisfactory visual response|1|||
13224604|NCT01787760|26291403|FG002|Overall Study|Unsatisfactory visual response|0|||
13224605|NCT01787760|26291401|FG000|Overall Study|Near vision blur|1|||
13224606|NCT01787760|26291402|FG001|Overall Study|Near vision blur|0|||
13224607|NCT01787760|26291403|FG002|Overall Study|Near vision blur|0|||
13203082|NCT01987960|26223188|FG000|Period 1|Lost to Follow-up|40|||
13203083|NCT01987960|26223189|FG001|Period 1|Lost to Follow-up|0|||
13203084|NCT01987960|26223190|FG002|Period 1|Lost to Follow-up|0|||
13203085|NCT01987960|26223191|FG003|Period 1|Lost to Follow-up|0|||
13203086|NCT01987960|26223188|FG000|Period 1|administrative or other reason|75|||
13203087|NCT01987960|26223189|FG001|Period 1|administrative or other reason|0|||
13203088|NCT01987960|26223190|FG002|Period 1|administrative or other reason|0|||
13203089|NCT01987960|26223191|FG003|Period 1|administrative or other reason|0|||
13203090|NCT01987960|26223188|FG000|Period 1|Withdrawal of consent before treatment|4|||
13203091|NCT01987960|26223189|FG001|Period 1|Withdrawal of consent before treatment|0|||
13203092|NCT01987960|26223190|FG002|Period 1|Withdrawal of consent before treatment|0|||
13203093|NCT01987960|26223191|FG003|Period 1|Withdrawal of consent before treatment|0|||
13203094|NCT01987960|26223188|FG000|Period 2|Adverse Event|0|||
13203095|NCT01987960|26223189|FG001|Period 2|Adverse Event|0|||
13203096|NCT01987960|26223190|FG002|Period 2|Adverse Event|1|||
13203097|NCT01987960|26223191|FG003|Period 2|Adverse Event|0|||
13203098|NCT01987960|26223188|FG000|Period 2|Withdrawal by Subject|0|||
13224608|NCT01787591|26291438|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
13224609|NCT01787591|26291439|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
13224610|NCT01787591|26291440|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
13224611|NCT01787591|26291441|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1|||
13224612|NCT01787461|26291474|FG000|Overall Study|Adverse Event|4|||
13224613|NCT01787461|26291475|FG001|Overall Study|Adverse Event|3|||
13224614|NCT01787461|26291474|FG000|Overall Study|Lost to Follow-up|3|||
13224615|NCT01787461|26291475|FG001|Overall Study|Lost to Follow-up|2|||
13224616|NCT01787461|26291474|FG000|Overall Study|No longer met eligibility criteria|1|||
13224617|NCT01787461|26291475|FG001|Overall Study|No longer met eligibility criteria|0|||
13224618|NCT01787461|26291474|FG000|Overall Study|Withdrawal by Subject|3|||
13224619|NCT01787461|26291475|FG001|Overall Study|Withdrawal by Subject|4|||
13224620|NCT01787461|26291474|FG000|Overall Study|Protocol Violation|3|||
13224621|NCT01787461|26291475|FG001|Overall Study|Protocol Violation|0|||
13224622|NCT01787331|26291489|FG000|Overall Study|Physician Decision|1|||
13224623|NCT01787331|26291489|FG000|Overall Study|Withdrawal by Subject|1|||
13224624|NCT01787292|26291509|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2|||
13224625|NCT01787292|26291510|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2|||
13224626|NCT01787292|26291509|FG000|Home Based Exercise Program|Withdrawal by Subject|3|||
13224627|NCT01787292|26291510|FG001|Home Based Exercise Program|Withdrawal by Subject|1|||
13224628|NCT01787279|26291521|FG000|Overall Study|Lost to Follow-up|2|||
13224629|NCT01787279|26291521|FG000|Overall Study|Lack of Efficacy|1|||
13224630|NCT01787188|26291584|FG000|Overall Study|Adverse Event|2|||
13224631|NCT01787188|26291585|FG001|Overall Study|Adverse Event|4|||
13224632|NCT01787188|26291586|FG002|Overall Study|Adverse Event|6|||
13224633|NCT01787188|26291584|FG000|Overall Study|Lack of Efficacy|7|||
13224634|NCT01787188|26291585|FG001|Overall Study|Lack of Efficacy|3|||
13224635|NCT01787188|26291586|FG002|Overall Study|Lack of Efficacy|5|||
13224636|NCT01787188|26291584|FG000|Overall Study|Non-compliance with Study Drug|0|||
13224637|NCT01787188|26291585|FG001|Overall Study|Non-compliance with Study Drug|1|||
13224638|NCT01787188|26291586|FG002|Overall Study|Non-compliance with Study Drug|0|||
13224639|NCT01787188|26291584|FG000|Overall Study|Withdrawal by Subject|4|||
13224640|NCT01787188|26291585|FG001|Overall Study|Withdrawal by Subject|3|||
13224641|NCT01787188|26291586|FG002|Overall Study|Withdrawal by Subject|2|||
13224642|NCT01787188|26291584|FG000|Overall Study|Protocol Violation|3|||
13224643|NCT01787188|26291585|FG001|Overall Study|Protocol Violation|2|||
13224644|NCT01787188|26291586|FG002|Overall Study|Protocol Violation|3|||
13113686|NCT03132636|25912210|FG001|Overall Study|Participant Decision|9|||
13224645|NCT01787188|26291584|FG000|Overall Study|Lost to Follow-up|1|||
13224646|NCT01787188|26291585|FG001|Overall Study|Lost to Follow-up|2|||
13224647|NCT01787188|26291586|FG002|Overall Study|Lost to Follow-up|2|||
13224648|NCT01787188|26291584|FG000|Overall Study|Other, including patient moved|0|||
13224649|NCT01787188|26291585|FG001|Overall Study|Other, including patient moved|3|||
13224650|NCT01787188|26291586|FG002|Overall Study|Other, including patient moved|0|||
13224651|NCT01787097|26291617|FG000|Overall Study|Withdrawal by Subject|1|||
13224652|NCT01787097|26291618|FG001|Overall Study|Withdrawal by Subject|0|||
13224653|NCT01787097|26291619|FG002|Overall Study|Withdrawal by Subject|0|||
13224654|NCT01787097|26291620|FG003|Overall Study|Withdrawal by Subject|0|||
13224655|NCT01787032|26291661|FG000|Overall Study|Protocol Violation|0|||
13224656|NCT01787032|26291662|FG001|Overall Study|Protocol Violation|0|||
13224657|NCT01787032|26291663|FG002|Overall Study|Protocol Violation|0|||
13224658|NCT01787032|26291664|FG003|Overall Study|Protocol Violation|0|||
13224659|NCT01787032|26291665|FG004|Overall Study|Protocol Violation|1|||
13224660|NCT01787032|26291666|FG005|Overall Study|Protocol Violation|1|||
13224661|NCT01786993|26291680|FG000|Overall Study|Death|6|||
13224662|NCT01786993|26291681|FG001|Overall Study|Death|7|||
13224663|NCT01786993|26291680|FG000|Overall Study|Withdrawal by Subject|3|||
13224664|NCT01786993|26291681|FG001|Overall Study|Withdrawal by Subject|2|||
13224665|NCT01786993|26291680|FG000|Overall Study|Lost to Follow-up|0|||
13224666|NCT01786993|26291681|FG001|Overall Study|Lost to Follow-up|1|||
13224667|NCT01786993|26291680|FG000|Overall Study|Subject Non-Compliance|1|||
13224668|NCT01786993|26291681|FG001|Overall Study|Subject Non-Compliance|0|||
13224669|NCT01786993|26291680|FG000|Overall Study|System Explant|1|||
13224670|NCT01786993|26291681|FG001|Overall Study|System Explant|0|||
13224671|NCT01786993|26291680|FG000|Overall Study|Hospice Admission|1|||
13224672|NCT01786993|26291681|FG001|Overall Study|Hospice Admission|0|||
13224673|NCT01786707|26291696|FG000|Overall Study|Lost to Follow-up|1|||
13224674|NCT01786707|26291697|FG001|Overall Study|Lost to Follow-up|1|||
13224675|NCT01786668|26291808|FG000|Overall Study|Adverse Event|0|||
13224676|NCT01786668|26291809|FG001|Overall Study|Adverse Event|1|||
13224677|NCT01786668|26291810|FG002|Overall Study|Adverse Event|1|||
13224678|NCT01786668|26291811|FG003|Overall Study|Adverse Event|2|||
13224679|NCT01786668|26291808|FG000|Overall Study|Withdrawal by Subject|0|||
13224680|NCT01786668|26291809|FG001|Overall Study|Withdrawal by Subject|0|||
13224681|NCT01786668|26291810|FG002|Overall Study|Withdrawal by Subject|3|||
13224682|NCT01786668|26291811|FG003|Overall Study|Withdrawal by Subject|1|||
13224683|NCT01786668|26291808|FG000|Overall Study|Pregnancy|0|||
13224684|NCT01786668|26291809|FG001|Overall Study|Pregnancy|0|||
13224685|NCT01786668|26291810|FG002|Overall Study|Pregnancy|0|||
13224686|NCT01786668|26291811|FG003|Overall Study|Pregnancy|1|||
13224687|NCT01786668|26291808|FG000|Overall Study|Lost to Follow-up|1|||
13224688|NCT01786668|26291809|FG001|Overall Study|Lost to Follow-up|0|||
13224689|NCT01786668|26291810|FG002|Overall Study|Lost to Follow-up|1|||
13224690|NCT01786668|26291811|FG003|Overall Study|Lost to Follow-up|0|||
13224691|NCT01786629|26291824|FG000|Overall Study|Lack of Efficacy|0|||
13224692|NCT01786629|26291825|FG001|Overall Study|Lack of Efficacy|4|||
13224693|NCT01786629|26291824|FG000|Overall Study|Adverse Event|0|||
13224694|NCT01786629|26291825|FG001|Overall Study|Adverse Event|1|||
13224695|NCT01786603|26291850|FG000|Overall Study|Death|5|||
13224696|NCT01786603|26291851|FG001|Overall Study|Death|1|||
13224697|NCT01786603|26291850|FG000|Overall Study|Adverse Event|6|||
13224698|NCT01786603|26291851|FG001|Overall Study|Adverse Event|2|||
13224699|NCT01786603|26291850|FG000|Overall Study|Physician decision to withdraw|6|||
13224700|NCT01786603|26291851|FG001|Overall Study|Physician decision to withdraw|7|||
13224701|NCT01786603|26291850|FG000|Overall Study|Lost to Follow-up|1|||
13224702|NCT01786603|26291851|FG001|Overall Study|Lost to Follow-up|2|||
13224703|NCT01786564|26291857|FG000|Overall Study|Lost to Follow-up|47|||
13224704|NCT01786564|26291857|FG000|Overall Study|Ineligible|17|||
13224705|NCT01786551|26291865|FG000|Overall Study|Participant withdrew consent|2|||
13224706|NCT01786512|26291969|FG000|Overall Study|Lost to Follow-up|0|||
13224707|NCT01786512|26291970|FG001|Overall Study|Lost to Follow-up|0|||
13224708|NCT01786512|26291971|FG002|Overall Study|Lost to Follow-up|0|||
13224709|NCT01786512|26291972|FG003|Overall Study|Lost to Follow-up|0|||
13224710|NCT01786512|26291973|FG004|Overall Study|Lost to Follow-up|0|||
13224711|NCT01786512|26291974|FG005|Overall Study|Lost to Follow-up|0|||
13224712|NCT01786512|26291975|FG006|Overall Study|Lost to Follow-up|0|||
13224713|NCT01786512|26291976|FG007|Overall Study|Lost to Follow-up|0|||
13224714|NCT01786512|26291977|FG008|Overall Study|Lost to Follow-up|0|||
13224715|NCT01786512|26291978|FG009|Overall Study|Lost to Follow-up|1|||
13224716|NCT01786512|26291979|FG010|Overall Study|Lost to Follow-up|0|||
13224717|NCT01786512|26291969|FG000|Overall Study|Decision by sponsor|0|||
13224718|NCT01786512|26291970|FG001|Overall Study|Decision by sponsor|0|||
13224719|NCT01786512|26291971|FG002|Overall Study|Decision by sponsor|0|||
13224720|NCT01786512|26291972|FG003|Overall Study|Decision by sponsor|0|||
13224721|NCT01786512|26291973|FG004|Overall Study|Decision by sponsor|0|||
13224722|NCT01786512|26291974|FG005|Overall Study|Decision by sponsor|0|||
13224723|NCT01786512|26291975|FG006|Overall Study|Decision by sponsor|0|||
13224724|NCT01786512|26291976|FG007|Overall Study|Decision by sponsor|0|||
13224725|NCT01786512|26291977|FG008|Overall Study|Decision by sponsor|0|||
13224726|NCT01786512|26291978|FG009|Overall Study|Decision by sponsor|0|||
13224727|NCT01786512|26291979|FG010|Overall Study|Decision by sponsor|2|||
13224728|NCT01786512|26291969|FG000|Overall Study|Withdrawal by Subject|0|||
13224729|NCT01786512|26291970|FG001|Overall Study|Withdrawal by Subject|1|||
13224730|NCT01786512|26291971|FG002|Overall Study|Withdrawal by Subject|0|||
13224731|NCT01786512|26291972|FG003|Overall Study|Withdrawal by Subject|0|||
13224732|NCT01786512|26291973|FG004|Overall Study|Withdrawal by Subject|0|||
13224733|NCT01786512|26291974|FG005|Overall Study|Withdrawal by Subject|0|||
13224734|NCT01786512|26291975|FG006|Overall Study|Withdrawal by Subject|1|||
13224735|NCT01786512|26291976|FG007|Overall Study|Withdrawal by Subject|0|||
13224736|NCT01786512|26291977|FG008|Overall Study|Withdrawal by Subject|0|||
13224737|NCT01786512|26291978|FG009|Overall Study|Withdrawal by Subject|3|||
13224738|NCT01786512|26291979|FG010|Overall Study|Withdrawal by Subject|7|||
13224739|NCT01786512|26291969|FG000|Overall Study|Death|0|||
13224740|NCT01786512|26291970|FG001|Overall Study|Death|0|||
13224741|NCT01786512|26291971|FG002|Overall Study|Death|0|||
13224742|NCT01786512|26291972|FG003|Overall Study|Death|0|||
13224743|NCT01786512|26291973|FG004|Overall Study|Death|0|||
13224744|NCT01786512|26291974|FG005|Overall Study|Death|0|||
13224745|NCT01786512|26291975|FG006|Overall Study|Death|0|||
13224746|NCT01786512|26291976|FG007|Overall Study|Death|0|||
13224747|NCT01786512|26291977|FG008|Overall Study|Death|4|||
13224748|NCT01786512|26291978|FG009|Overall Study|Death|1|||
13224749|NCT01786512|26291979|FG010|Overall Study|Death|3|||
13224750|NCT01786330|26291998|FG000|Overall Study|Withdrawal by Subject|0|||
13224751|NCT01786330|26291999|FG001|Overall Study|Withdrawal by Subject|1|||
13224752|NCT01786330|26291998|FG000|Overall Study|Lost to Follow-up|0|||
13224753|NCT01786330|26291999|FG001|Overall Study|Lost to Follow-up|1|||
13224754|NCT01786330|26291998|FG000|Overall Study|Excluded intraoperatively|0|||
13224755|NCT01786330|26291999|FG001|Overall Study|Excluded intraoperatively|1|||
13224756|NCT01786330|26291998|FG000|Overall Study|Protocol Violation|1|||
13224757|NCT01786330|26291999|FG001|Overall Study|Protocol Violation|0|||
13224758|NCT01786174|26292020|FG000|Overall Study|Discontinued Study Drug|2|||
13224759|NCT01786174|26292021|FG001|Overall Study|Discontinued Study Drug|0|||
13224760|NCT01786148|26292040|FG000|Overall Study|Lost to Follow-up|21|||
13224761|NCT01786148|26292041|FG001|Overall Study|Lost to Follow-up|13|||
13224762|NCT01786148|26292040|FG000|Overall Study|Death|0|||
13224763|NCT01786148|26292041|FG001|Overall Study|Death|1|||
13224764|NCT01786148|26292040|FG000|Overall Study|Withdrawal by Subject|0|||
13224765|NCT01786148|26292041|FG001|Overall Study|Withdrawal by Subject|7|||
13224766|NCT01786148|26292040|FG000|Overall Study|Incarceration|1|||
13224767|NCT01786148|26292041|FG001|Overall Study|Incarceration|1|||
13289477|NCT00109850|26479339|FG000|Overall Study|Ineligible|1|||
13289478|NCT00109837|26479349|FG000|Overall Study|Adverse Event|2|||
13289479|NCT00109837|26479349|FG000|Overall Study|Refusal unrelated to adverse effects|1|||
13224768|NCT01786109|26292080|FG000|Overall Study|fail manometry barostat tube placement|1|||
13224769|NCT01786109|26292081|FG001|Overall Study|fail manometry barostat tube placement|0|||
13224770|NCT01786109|26292082|FG002|Overall Study|fail manometry barostat tube placement|0|||
13224771|NCT01786109|26292080|FG000|Overall Study|unrelated illness|0|||
13224772|NCT01786109|26292081|FG001|Overall Study|unrelated illness|0|||
13224773|NCT01786109|26292082|FG002|Overall Study|unrelated illness|1|||
13224774|NCT01786109|26292080|FG000|Overall Study|adverse effects colon preparation|0|||
13224775|NCT01786109|26292081|FG001|Overall Study|adverse effects colon preparation|0|||
13224776|NCT01786109|26292082|FG002|Overall Study|adverse effects colon preparation|1|||
13224777|NCT01785875|26292153|FG000|Overall Study|Withdrawal by Subject|41|||
13224778|NCT01785875|26292154|FG001|Overall Study|Withdrawal by Subject|34|||
13224779|NCT01785875|26292155|FG002|Overall Study|Withdrawal by Subject|36|||
13224780|NCT01785875|26292153|FG000|Overall Study|Lost to Follow-up|19|||
13224781|NCT01785875|26292154|FG001|Overall Study|Lost to Follow-up|22|||
13224782|NCT01785875|26292155|FG002|Overall Study|Lost to Follow-up|6|||
13224783|NCT01785875|26292153|FG000|Overall Study|Death|27|||
13224784|NCT01785875|26292154|FG001|Overall Study|Death|16|||
13224785|NCT01785875|26292155|FG002|Overall Study|Death|7|||
13224786|NCT01785875|26292153|FG000|Overall Study|Sponsor Decision|0|||
13224787|NCT01785875|26292154|FG001|Overall Study|Sponsor Decision|2|||
13224788|NCT01785875|26292155|FG002|Overall Study|Sponsor Decision|0|||
13224789|NCT01785875|26292153|FG000|Overall Study|Protocol Specified Criteria|207|||
13224790|NCT01785875|26292154|FG001|Overall Study|Protocol Specified Criteria|214|||
13224791|NCT01785875|26292155|FG002|Overall Study|Protocol Specified Criteria|55|||
13224792|NCT01785875|26292153|FG000|Overall Study|Missing|0|||
13224793|NCT01785875|26292154|FG001|Overall Study|Missing|1|||
13224794|NCT01785875|26292155|FG002|Overall Study|Missing|3|||
13224795|NCT01785849|26292178|FG000|Overall Study|Death|7|||
13224796|NCT01785849|26292179|FG001|Overall Study|Death|9|||
13224797|NCT01785849|26292178|FG000|Overall Study|Protocol Specified Criteria|29|||
13224798|NCT01785849|26292179|FG001|Overall Study|Protocol Specified Criteria|1|||
13224799|NCT01785849|26292178|FG000|Overall Study|Withdrawal by Subject|15|||
13224800|NCT01785849|26292179|FG001|Overall Study|Withdrawal by Subject|12|||
13224801|NCT01785849|26292178|FG000|Overall Study|Sponsor Decision|0|||
13224802|NCT01785849|26292179|FG001|Overall Study|Sponsor Decision|1|||
13224803|NCT01785849|26292178|FG000|Overall Study|Lost to Follow-up|10|||
13224804|NCT01785849|26292179|FG001|Overall Study|Lost to Follow-up|11|||
13224805|NCT01785628|26292206|FG000|Overall Study|Lost to Follow-up|2|||
13224806|NCT01785628|26292207|FG001|Overall Study|Lost to Follow-up|3|||
13224807|NCT01785615|26292288|FG000|Dietary Phase|Lost to Follow-up|0|||
13224808|NCT01785615|26292289|FG001|Dietary Phase|Lost to Follow-up|0|||
13224809|NCT01785615|26292290|FG002|Dietary Phase|Lost to Follow-up|0|||
13224810|NCT01785615|26292291|FG003|Dietary Phase|Lost to Follow-up|24|||
13224811|NCT01785602|26292306|FG000|Overall Study|Withdrawal by Subject|2|||
13224812|NCT01785602|26292307|FG001|Overall Study|Withdrawal by Subject|0|||
13224813|NCT01785602|26292306|FG000|Overall Study|Lost to Follow-up|1|||
13224814|NCT01785602|26292307|FG001|Overall Study|Lost to Follow-up|1|||
13224815|NCT01785602|26292306|FG000|Overall Study|Adverse Event|3|||
13224816|NCT01785602|26292307|FG001|Overall Study|Adverse Event|5|||
13224817|NCT01785602|26292306|FG000|Overall Study|Administrative problems|7|||
13224818|NCT01785602|26292307|FG001|Overall Study|Administrative problems|3|||
13224819|NCT01785524|26292330|FG000|Overall Study|Withdrawal by Subject|2|||
13224820|NCT01785524|26292331|FG001|Overall Study|Withdrawal by Subject|2|||
13224821|NCT01785472|26292383|FG000|Overall Study|Adverse Event|5|||
13224822|NCT01785472|26292384|FG001|Overall Study|Adverse Event|4|||
13224823|NCT01785472|26292385|FG002|Overall Study|Adverse Event|6|||
13224824|NCT01785472|26292383|FG000|Overall Study|Lack of Efficacy|2|||
13224825|NCT01785472|26292384|FG001|Overall Study|Lack of Efficacy|0|||
13224826|NCT01785472|26292385|FG002|Overall Study|Lack of Efficacy|1|||
13224827|NCT01785472|26292383|FG000|Overall Study|Lost to Follow-up|1|||
13224828|NCT01785472|26292384|FG001|Overall Study|Lost to Follow-up|2|||
13224829|NCT01785472|26292385|FG002|Overall Study|Lost to Follow-up|0|||
13224830|NCT01785472|26292383|FG000|Overall Study|Physician Decision|1|||
13113687|NCT03132636|25912209|FG000|Overall Study|Sponsor Decision|0|||
13224831|NCT01785472|26292384|FG001|Overall Study|Physician Decision|1|||
13224832|NCT01785472|26292385|FG002|Overall Study|Physician Decision|1|||
13224833|NCT01785472|26292383|FG000|Overall Study|Protocol deviation|0|||
13224834|NCT01785472|26292384|FG001|Overall Study|Protocol deviation|2|||
13224835|NCT01785472|26292385|FG002|Overall Study|Protocol deviation|2|||
13224836|NCT01785472|26292383|FG000|Overall Study|Subject/guardian decision|15|||
13224837|NCT01785472|26292384|FG001|Overall Study|Subject/guardian decision|10|||
13224838|NCT01785472|26292385|FG002|Overall Study|Subject/guardian decision|11|||
13224839|NCT01785472|26292383|FG000|Overall Study|Technical problems|0|||
13224840|NCT01785472|26292384|FG001|Overall Study|Technical problems|0|||
13224841|NCT01785472|26292385|FG002|Overall Study|Technical problems|1|||
13224842|NCT01785160|26292395|FG000|Treatment Period 1: Raltegravir|Not treated|1|||
13224843|NCT01785160|26292395|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1|||
13224844|NCT01785069|26292434|FG000|Overall Study|Implanted with nonstudy device|1|||
13289480|NCT00109837|26479349|FG000|Overall Study|Death|1|||
13224845|NCT01785069|26292435|FG001|Overall Study|Implanted with nonstudy device|2|||
13224846|NCT01785069|26292436|FG002|Overall Study|Implanted with nonstudy device|1|||
13224847|NCT01785069|26292437|FG003|Overall Study|Implanted with nonstudy device|0|||
13224848|NCT01785069|26292434|FG000|Overall Study|Death|0|||
13224849|NCT01785069|26292435|FG001|Overall Study|Death|0|||
13224850|NCT01785069|26292436|FG002|Overall Study|Death|2|||
13224851|NCT01785069|26292437|FG003|Overall Study|Death|0|||
13224852|NCT01785069|26292434|FG000|Overall Study|Subject choice|2|||
13224853|NCT01785069|26292435|FG001|Overall Study|Subject choice|2|||
13224854|NCT01785069|26292436|FG002|Overall Study|Subject choice|0|||
13224855|NCT01785069|26292437|FG003|Overall Study|Subject choice|1|||
13224856|NCT01785069|26292434|FG000|Overall Study|Lost to Follow-up|1|||
13224857|NCT01785069|26292435|FG001|Overall Study|Lost to Follow-up|2|||
13224858|NCT01785069|26292436|FG002|Overall Study|Lost to Follow-up|4|||
13224859|NCT01785069|26292437|FG003|Overall Study|Lost to Follow-up|1|||
13224860|NCT01785069|26292434|FG000|Overall Study|Reason not Specified|1|||
13224861|NCT01785069|26292435|FG001|Overall Study|Reason not Specified|2|||
13224862|NCT01785069|26292436|FG002|Overall Study|Reason not Specified|1|||
13224863|NCT01785069|26292437|FG003|Overall Study|Reason not Specified|4|||
13224864|NCT01785069|26292434|FG000|Overall Study|Not evaluable|7|||
13224865|NCT01785069|26292435|FG001|Overall Study|Not evaluable|4|||
13224866|NCT01785069|26292436|FG002|Overall Study|Not evaluable|5|||
13224867|NCT01785069|26292437|FG003|Overall Study|Not evaluable|8|||
13224868|NCT01784965|26292454|FG000|Overall Study|Withdrawal by Subject|6|||
13224869|NCT01784965|26292455|FG001|Overall Study|Withdrawal by Subject|3|||
13224870|NCT01784965|26292454|FG000|Overall Study|Adverse Event|0|||
13224871|NCT01784965|26292455|FG001|Overall Study|Adverse Event|8|||
13224872|NCT01784861|26292526|FG000|Overall Study|Adverse Event|0|||
13224873|NCT01784861|26292527|FG001|Overall Study|Adverse Event|0|||
13224874|NCT01784861|26292528|FG002|Overall Study|Adverse Event|1|||
13224875|NCT01784861|26292529|FG003|Overall Study|Adverse Event|2|||
13224876|NCT01784861|26292530|FG004|Overall Study|Adverse Event|1|||
13224877|NCT01784861|26292531|FG005|Overall Study|Adverse Event|0|||
13224878|NCT01784861|26292526|FG000|Overall Study|Withdrawal by Subject|0|||
13224879|NCT01784861|26292527|FG001|Overall Study|Withdrawal by Subject|0|||
13224880|NCT01784861|26292528|FG002|Overall Study|Withdrawal by Subject|0|||
13224881|NCT01784861|26292529|FG003|Overall Study|Withdrawal by Subject|1|||
13224882|NCT01784861|26292530|FG004|Overall Study|Withdrawal by Subject|0|||
13224883|NCT01784861|26292531|FG005|Overall Study|Withdrawal by Subject|0|||
13224884|NCT01784861|26292526|FG000|Overall Study|Physician Decision|0|||
13224885|NCT01784861|26292527|FG001|Overall Study|Physician Decision|0|||
13224886|NCT01784861|26292528|FG002|Overall Study|Physician Decision|0|||
13224887|NCT01784861|26292529|FG003|Overall Study|Physician Decision|2|||
13224888|NCT01784861|26292530|FG004|Overall Study|Physician Decision|0|||
13224889|NCT01784861|26292531|FG005|Overall Study|Physician Decision|1|||
13224890|NCT01784523|26292544|FG000|Overall Study|Study closed early|7|||
13224891|NCT01784523|26292545|FG001|Overall Study|Study closed early|4|||
13224892|NCT01784419|26292553|FG000|Overall Study|Adverse Event|3|||
13224893|NCT01784211|26292582|FG000|Part A (Days 1-15)|Adverse Event|1|||
13224894|NCT01784211|26292583|FG001|Part A (Days 1-15)|Adverse Event|1|||
13224895|NCT01784211|26292584|FG002|Part A (Days 1-15)|Adverse Event|0|||
13224896|NCT01784211|26292585|FG003|Part A (Days 1-15)|Adverse Event|0|||
13224897|NCT01784211|26292586|FG004|Part A (Days 1-15)|Adverse Event|0|||
13224898|NCT01784211|26292587|FG005|Part A (Days 1-15)|Adverse Event|0|||
13224899|NCT01784211|26292582|FG000|Part A (Days 1-15)|Withdrawal by Subject|2|||
13224900|NCT01784211|26292583|FG001|Part A (Days 1-15)|Withdrawal by Subject|1|||
13224901|NCT01784211|26292584|FG002|Part A (Days 1-15)|Withdrawal by Subject|0|||
13224902|NCT01784211|26292585|FG003|Part A (Days 1-15)|Withdrawal by Subject|0|||
13224903|NCT01784211|26292586|FG004|Part A (Days 1-15)|Withdrawal by Subject|0|||
13224904|NCT01784211|26292587|FG005|Part A (Days 1-15)|Withdrawal by Subject|0|||
13224905|NCT01784068|26292601|FG000|NTCS Phase|Adverse Event|5|||
13224906|NCT01784068|26292602|FG001|NTCS Phase|Adverse Event|0|||
13224907|NCT01784068|26292601|FG000|NTCS Phase|Physician Decision|2|||
13224908|NCT01784068|26292602|FG001|NTCS Phase|Physician Decision|0|||
13224909|NCT01784068|26292601|FG000|NTCS Phase|Patient/guardian decision|3|||
13224910|NCT01784068|26292602|FG001|NTCS Phase|Patient/guardian decision|0|||
13224911|NCT01784068|26292601|FG000|NTCS Phase|Death|2|||
13224912|NCT01784068|26292602|FG001|NTCS Phase|Death|0|||
13224913|NCT01784068|26292601|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203|||
13224914|NCT01784068|26292602|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0|||
13224915|NCT01784068|26292601|FG000|TFR Phase|Physician Decision|0|||
13224916|NCT01784068|26292602|FG001|TFR Phase|Physician Decision|1|||
13224917|NCT01784068|26292601|FG000|TFR Phase|Patient/guardian decision|0|||
13224918|NCT01784068|26292602|FG001|TFR Phase|Patient/guardian decision|3|||
13224919|NCT01784068|26292601|FG000|TFR Phase|Death|0|||
13224920|NCT01784068|26292602|FG001|TFR Phase|Death|1|||
13224921|NCT01784068|26292601|FG000|TFR Phase|Lack of Efficacy|0|||
13224922|NCT01784068|26292602|FG001|TFR Phase|Lack of Efficacy|88|||
13224923|NCT01784029|26292620|FG000|Overall Study|Lost to Follow-up|19|||
13224924|NCT01784029|26292621|FG001|Overall Study|Lost to Follow-up|20|||
13224925|NCT01784029|26292622|FG002|Overall Study|Lost to Follow-up|22|||
13224926|NCT01783938|26292641|FG000|Overall Study|Disease Progression|18|||
13224927|NCT01783938|26292642|FG001|Overall Study|Disease Progression|41|||
13224928|NCT01783938|26292641|FG000|Overall Study|Study Drug Toxicity|27|||
13224929|NCT01783938|26292642|FG001|Overall Study|Study Drug Toxicity|14|||
13224930|NCT01783938|26292641|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4|||
13224931|NCT01783938|26292642|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
13224932|NCT01783938|26292641|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2|||
13224933|NCT01783938|26292642|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3|||
13224934|NCT01783938|26292641|FG000|Overall Study|Participant Withdrew Consent|2|||
13224935|NCT01783938|26292642|FG001|Overall Study|Participant Withdrew Consent|0|||
13224936|NCT01783938|26292641|FG000|Overall Study|Maximum Clinical Benefit|1|||
13224937|NCT01783938|26292642|FG001|Overall Study|Maximum Clinical Benefit|0|||
13224938|NCT01783938|26292641|FG000|Overall Study|Other Reasons|3|||
13224939|NCT01783938|26292642|FG001|Overall Study|Other Reasons|1|||
13224940|NCT01783886|26292678|FG000|Overall Study|Lost to Follow-up|0|||
13224941|NCT01783886|26292679|FG001|Overall Study|Lost to Follow-up|3|||
13224942|NCT01783886|26292680|FG002|Overall Study|Lost to Follow-up|0|||
13224943|NCT01783886|26292678|FG000|Overall Study|Protocol deviation|0|||
13224944|NCT01783886|26292679|FG001|Overall Study|Protocol deviation|0|||
13224945|NCT01783886|26292680|FG002|Overall Study|Protocol deviation|2|||
13224946|NCT01783886|26292678|FG000|Overall Study|Withdrawal of consent by participant|1|||
13224947|NCT01783886|26292679|FG001|Overall Study|Withdrawal of consent by participant|3|||
13224948|NCT01783886|26292680|FG002|Overall Study|Withdrawal of consent by participant|4|||
13224949|NCT01783886|26292678|FG000|Overall Study|Adverse Event|4|||
13224950|NCT01783886|26292679|FG001|Overall Study|Adverse Event|5|||
13224951|NCT01783886|26292680|FG002|Overall Study|Adverse Event|4|||
13224952|NCT01783821|26292703|FG000|Overall Study|Screen Failure|1|||
13224953|NCT01783821|26292704|FG001|Overall Study|Screen Failure|1|||
13224954|NCT01783743|26292725|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427|||
13224955|NCT01783743|26292726|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439|||
13224956|NCT01783743|26292725|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591|||
13224957|NCT01783743|26292726|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684|||
13224958|NCT01783743|26292725|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305|||
13224959|NCT01783743|26292726|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236|||
13224960|NCT01783730|26292747|FG000|Overall Study|Failed to meet inclusion criteria|6|||
13224961|NCT01783678|26292838|FG000|Overall Study|Randomized but Not Treated|0|||
13224962|NCT01783678|26292839|FG001|Overall Study|Randomized but Not Treated|0|||
13224963|NCT01783678|26292840|FG002|Overall Study|Randomized but Not Treated|0|||
13224964|NCT01783678|26292841|FG003|Overall Study|Randomized but Not Treated|1|||
13224965|NCT01783678|26292842|FG004|Overall Study|Randomized but Not Treated|0|||
13224966|NCT01783678|26292843|FG005|Overall Study|Randomized but Not Treated|0|||
13224967|NCT01783678|26292838|FG000|Overall Study|Lack of Efficacy|1|||
13224968|NCT01783678|26292839|FG001|Overall Study|Lack of Efficacy|13|||
13224969|NCT01783678|26292840|FG002|Overall Study|Lack of Efficacy|1|||
13224970|NCT01783678|26292841|FG003|Overall Study|Lack of Efficacy|3|||
13224971|NCT01783678|26292842|FG004|Overall Study|Lack of Efficacy|6|||
13224972|NCT01783678|26292843|FG005|Overall Study|Lack of Efficacy|5|||
13224973|NCT01783678|26292838|FG000|Overall Study|Lost to Follow-up|0|||
13224974|NCT01783678|26292839|FG001|Overall Study|Lost to Follow-up|4|||
13224975|NCT01783678|26292840|FG002|Overall Study|Lost to Follow-up|0|||
13224976|NCT01783678|26292841|FG003|Overall Study|Lost to Follow-up|2|||
13224977|NCT01783678|26292842|FG004|Overall Study|Lost to Follow-up|1|||
13224978|NCT01783678|26292843|FG005|Overall Study|Lost to Follow-up|0|||
13224979|NCT01783678|26292838|FG000|Overall Study|Withdrew Consent|1|||
13224980|NCT01783678|26292839|FG001|Overall Study|Withdrew Consent|1|||
13224981|NCT01783678|26292840|FG002|Overall Study|Withdrew Consent|0|||
13224982|NCT01783678|26292841|FG003|Overall Study|Withdrew Consent|2|||
13224983|NCT01783678|26292842|FG004|Overall Study|Withdrew Consent|0|||
13224984|NCT01783678|26292843|FG005|Overall Study|Withdrew Consent|0|||
13224985|NCT01783548|26292862|FG000|Overall Study|Adverse Event|8|||
13224986|NCT01783548|26292863|FG001|Overall Study|Adverse Event|4|||
13224987|NCT01783548|26292862|FG000|Overall Study|Withdrawal by Subject|11|||
13224988|NCT01783548|26292863|FG001|Overall Study|Withdrawal by Subject|8|||
13224989|NCT01783548|26292862|FG000|Overall Study|Non-compliance|4|||
13224990|NCT01783548|26292863|FG001|Overall Study|Non-compliance|0|||
13224991|NCT01783548|26292862|FG000|Overall Study|Protocol Violation|2|||
13224992|NCT01783548|26292863|FG001|Overall Study|Protocol Violation|2|||
13224993|NCT01783548|26292862|FG000|Overall Study|Lost to Follow-up|8|||
13224994|NCT01783548|26292863|FG001|Overall Study|Lost to Follow-up|3|||
13224995|NCT01783548|26292862|FG000|Overall Study|Lack of Efficacy|1|||
13224996|NCT01783548|26292863|FG001|Overall Study|Lack of Efficacy|1|||
13224997|NCT01783496|26292908|FG000|Overall Study|Lost to Follow-up|0|||
13224998|NCT01783496|26292909|FG001|Overall Study|Lost to Follow-up|0|||
13224999|NCT01783496|26292910|FG002|Overall Study|Lost to Follow-up|0|||
13225000|NCT01783496|26292911|FG003|Overall Study|Lost to Follow-up|2|||
13225001|NCT01783496|26292912|FG004|Overall Study|Lost to Follow-up|0|||
13225002|NCT01783496|26292913|FG005|Overall Study|Lost to Follow-up|1|||
13225003|NCT01783496|26292908|FG000|Overall Study|Withdrawal by Subject|1|||
13225004|NCT01783496|26292909|FG001|Overall Study|Withdrawal by Subject|0|||
13225005|NCT01783496|26292910|FG002|Overall Study|Withdrawal by Subject|0|||
13225006|NCT01783496|26292911|FG003|Overall Study|Withdrawal by Subject|0|||
13225007|NCT01783496|26292912|FG004|Overall Study|Withdrawal by Subject|0|||
13225008|NCT01783496|26292913|FG005|Overall Study|Withdrawal by Subject|0|||
13225009|NCT01783483|26292948|FG000|Overall Study|Death|3|||
13225010|NCT01783483|26292949|FG001|Overall Study|Death|3|||
13225011|NCT01783483|26292948|FG000|Overall Study|Lost to Follow-up|14|||
13225012|NCT01783483|26292949|FG001|Overall Study|Lost to Follow-up|10|||
13225013|NCT01783483|26292948|FG000|Overall Study|Withdrawal by Subject|2|||
13225014|NCT01783483|26292949|FG001|Overall Study|Withdrawal by Subject|1|||
13225015|NCT01783483|26292948|FG000|Overall Study|Physician Decision|1|||
13225016|NCT01783483|26292949|FG001|Overall Study|Physician Decision|1|||
13225017|NCT01783444|26292989|FG000|Treatment Phase|Adverse Event|9|||
13225018|NCT01783444|26292990|FG001|Treatment Phase|Adverse Event|20|||
13225019|NCT01783444|26292991|FG002|Treatment Phase|Adverse Event|19|||
13225020|NCT01783444|26292989|FG000|Treatment Phase|Disease Progression|76|||
13225021|NCT01783444|26292990|FG001|Treatment Phase|Disease Progression|66|||
13225022|NCT01783444|26292991|FG002|Treatment Phase|Disease Progression|64|||
13225023|NCT01783444|26292989|FG000|Treatment Phase|Death|2|||
13225024|NCT01783444|26292990|FG001|Treatment Phase|Death|2|||
13225025|NCT01783444|26292991|FG002|Treatment Phase|Death|2|||
13225026|NCT01783444|26292989|FG000|Treatment Phase|Protocol Violation|1|||
13225027|NCT01783444|26292990|FG001|Treatment Phase|Protocol Violation|1|||
13225028|NCT01783444|26292991|FG002|Treatment Phase|Protocol Violation|2|||
13225029|NCT01783444|26292989|FG000|Treatment Phase|Withdrawal by Subject|6|||
13225030|NCT01783444|26292990|FG001|Treatment Phase|Withdrawal by Subject|8|||
13225031|NCT01783444|26292991|FG002|Treatment Phase|Withdrawal by Subject|9|||
13113688|NCT03132636|25912210|FG001|Overall Study|Sponsor Decision|1|||
13225032|NCT01783444|26292989|FG000|Treatment Phase|Administrative problems|2|||
13225033|NCT01783444|26292990|FG001|Treatment Phase|Administrative problems|0|||
13225034|NCT01783444|26292991|FG002|Treatment Phase|Administrative problems|1|||
13225035|NCT01783444|26292989|FG000|Treatment Phase|Physician Decision|8|||
13225036|NCT01783444|26292990|FG001|Treatment Phase|Physician Decision|6|||
13225037|NCT01783444|26292991|FG002|Treatment Phase|Physician Decision|5|||
13225038|NCT01783444|26292989|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7|||
13225039|NCT01783444|26292990|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8|||
13225040|NCT01783444|26292991|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11|||
13225041|NCT01783444|26292989|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9|||
13225042|NCT01783444|26292990|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7|||
13225043|NCT01783444|26292991|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5|||
13225044|NCT01783444|26292989|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4|||
13225045|NCT01783444|26292990|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
13225046|NCT01783444|26292991|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
13225047|NCT01783444|26292989|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
13225048|NCT01783444|26292990|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1|||
13225049|NCT01783444|26292991|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
13225050|NCT01783444|26292989|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7|||
13225051|NCT01783444|26292990|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16|||
13225052|NCT01783444|26292991|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15|||
13225053|NCT01783444|26292989|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69|||
13225054|NCT01783444|26292990|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53|||
13225055|NCT01783444|26292991|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52|||
13225056|NCT01783418|26293016|FG000|Overall Study|Withdrawal by Subject|1|||
13225057|NCT01783418|26293017|FG001|Overall Study|Withdrawal by Subject|0|||
13225058|NCT01783015|26293110|FG000|Blinded Treatment|Adverse Event|0|||
13225059|NCT01783015|26293111|FG001|Blinded Treatment|Adverse Event|1|||
13225060|NCT01783015|26293112|FG002|Blinded Treatment|Adverse Event|0|||
13225061|NCT01783015|26293110|FG000|Blinded Treatment|Protocol Violation|0|||
13225062|NCT01783015|26293111|FG001|Blinded Treatment|Protocol Violation|1|||
13225063|NCT01783015|26293112|FG002|Blinded Treatment|Protocol Violation|0|||
13225064|NCT01783015|26293110|FG000|Blinded Treatment|Withdrawal by Subject|0|||
13225065|NCT01783015|26293111|FG001|Blinded Treatment|Withdrawal by Subject|1|||
13225066|NCT01783015|26293112|FG002|Blinded Treatment|Withdrawal by Subject|0|||
13225067|NCT01783015|26293110|FG000|Blinded Treatment|Study Terminated by Sponsor|2|||
13225068|NCT01783015|26293111|FG001|Blinded Treatment|Study Terminated by Sponsor|0|||
13225069|NCT01783015|26293112|FG002|Blinded Treatment|Study Terminated by Sponsor|0|||
13225070|NCT01783015|26293110|FG000|Open Label Treatment|Study Terminated by Sponsor|0|||
13225071|NCT01783015|26293111|FG001|Open Label Treatment|Study Terminated by Sponsor|0|||
13225072|NCT01783015|26293112|FG002|Open Label Treatment|Study Terminated by Sponsor|6|||
13225073|NCT01782885|26293141|FG000|Overall Study|Lost to Follow-up|4|||
13225074|NCT01782885|26293142|FG001|Overall Study|Lost to Follow-up|6|||
13225075|NCT01782872|26293177|FG000|Overall Study|Protocol Violation|0|||
13225076|NCT01782872|26293178|FG001|Overall Study|Protocol Violation|0|||
13225077|NCT01782872|26293179|FG002|Overall Study|Protocol Violation|0|||
13225078|NCT01782872|26293180|FG003|Overall Study|Protocol Violation|1|||
13225079|NCT01782872|26293177|FG000|Overall Study|Withdrawal by Subject|0|||
13225080|NCT01782872|26293178|FG001|Overall Study|Withdrawal by Subject|1|||
13225081|NCT01782872|26293179|FG002|Overall Study|Withdrawal by Subject|0|||
13225082|NCT01782872|26293180|FG003|Overall Study|Withdrawal by Subject|0|||
13113689|NCT03132636|25912209|FG000|Overall Study|Progressive disease|32|||
13113690|NCT03132636|25912210|FG001|Overall Study|Progressive disease|36|||
13113691|NCT03132636|25912209|FG000|Overall Study|Withdrawal of consent|2|||
13113692|NCT03132636|25912210|FG001|Overall Study|Withdrawal of consent|5|||
13113693|NCT03132636|25912209|FG000|Overall Study|Study ongoing|9|||
13113694|NCT03132636|25912210|FG001|Overall Study|Study ongoing|10|||
13113695|NCT03132636|25912209|FG000|Overall Study|Other|1|||
13113696|NCT03132636|25912210|FG001|Overall Study|Other|2|||
13113697|NCT03132467|25912217|FG000|Overall Study|Adverse Event|2|||
13113698|NCT03132467|25912217|FG000|Overall Study|Withdrawal by Subject|2|||
13113699|NCT03132220|25912250|FG000|Overall Study|Lost to Follow-up|17|||
13225083|NCT01782859|26293201|FG000|Overall Study|Protocol Violation|6|||
13225084|NCT01782859|26293202|FG001|Overall Study|Protocol Violation|6|||
13225085|NCT01782859|26293201|FG000|Overall Study|Withdrawal by Subject|0|||
13225086|NCT01782859|26293202|FG001|Overall Study|Withdrawal by Subject|1|||
13225087|NCT01782742|26293242|FG000|Double-blind Treatment Phase|Adverse Event|1|||
13225088|NCT01782742|26293243|FG001|Double-blind Treatment Phase|Adverse Event|0|||
13225089|NCT01782690|26293261|FG000|Overall Study|Not reported|7|||
13225090|NCT01782690|26293261|FG000|Overall Study|Toxicity of gemcitabine|1|||
13225091|NCT01782690|26293261|FG000|Overall Study|Toxicity of erlotinib|1|||
13225092|NCT01782690|26293261|FG000|Overall Study|Lost to Follow-up|31|||
13225093|NCT01782690|26293261|FG000|Overall Study|Withdrawal of informed consent|2|||
13225094|NCT01782690|26293261|FG000|Overall Study|Absent rash|9|||
13225095|NCT01782690|26293261|FG000|Overall Study|Physician Decision|13|||
13225096|NCT01782690|26293261|FG000|Overall Study|Patient's wish|21|||
13225097|NCT01782690|26293261|FG000|Overall Study|Tumor progression|74|||
13225098|NCT01782690|26293261|FG000|Overall Study|Death|133|||
13225099|NCT01782690|26293261|FG000|Overall Study|Study completion unknown|7|||
13225100|NCT01782664|26293426|FG000|Overall Study|Adverse Event|2|||
13225101|NCT01782664|26293427|FG001|Overall Study|Adverse Event|2|||
13225102|NCT01782664|26293428|FG002|Overall Study|Adverse Event|2|||
13225103|NCT01782664|26293429|FG003|Overall Study|Adverse Event|2|||
13225104|NCT01782664|26293430|FG004|Overall Study|Adverse Event|0|||
13225105|NCT01782664|26293431|FG005|Overall Study|Adverse Event|0|||
13225106|NCT01782664|26293426|FG000|Overall Study|Lack of Efficacy|2|||
13225107|NCT01782664|26293427|FG001|Overall Study|Lack of Efficacy|0|||
13225108|NCT01782664|26293428|FG002|Overall Study|Lack of Efficacy|2|||
13225109|NCT01782664|26293429|FG003|Overall Study|Lack of Efficacy|2|||
13225110|NCT01782664|26293430|FG004|Overall Study|Lack of Efficacy|0|||
13225111|NCT01782664|26293431|FG005|Overall Study|Lack of Efficacy|0|||
13225112|NCT01782664|26293426|FG000|Overall Study|Protocol Violation|0|||
13225113|NCT01782664|26293427|FG001|Overall Study|Protocol Violation|1|||
13225114|NCT01782664|26293428|FG002|Overall Study|Protocol Violation|0|||
13225115|NCT01782664|26293429|FG003|Overall Study|Protocol Violation|1|||
13225116|NCT01782664|26293430|FG004|Overall Study|Protocol Violation|0|||
13225117|NCT01782664|26293431|FG005|Overall Study|Protocol Violation|0|||
13225118|NCT01782664|26293426|FG000|Overall Study|Withdrawal by Subject|2|||
13225119|NCT01782664|26293427|FG001|Overall Study|Withdrawal by Subject|2|||
13225120|NCT01782664|26293428|FG002|Overall Study|Withdrawal by Subject|0|||
13225121|NCT01782664|26293429|FG003|Overall Study|Withdrawal by Subject|0|||
13225122|NCT01782664|26293430|FG004|Overall Study|Withdrawal by Subject|0|||
13225123|NCT01782664|26293431|FG005|Overall Study|Withdrawal by Subject|0|||
13225124|NCT01782495|26293522|FG000|Overall Study|Adverse Event|0|||
13225125|NCT01782495|26293523|FG001|Overall Study|Adverse Event|0|||
13225126|NCT01782495|26293524|FG002|Overall Study|Adverse Event|0|||
13225127|NCT01782495|26293525|FG003|Overall Study|Adverse Event|0|||
13225128|NCT01782495|26293526|FG004|Overall Study|Adverse Event|0|||
13225129|NCT01782495|26293527|FG005|Overall Study|Adverse Event|0|||
13225130|NCT01782495|26293528|FG006|Overall Study|Adverse Event|0|||
13225131|NCT01782495|26293529|FG007|Overall Study|Adverse Event|2|||
13225132|NCT01782495|26293530|FG008|Overall Study|Adverse Event|0|||
13225133|NCT01782495|26293531|FG009|Overall Study|Adverse Event|0|||
13113700|NCT03132220|25912251|FG001|Overall Study|Lost to Follow-up|8|||
13225134|NCT01782495|26293532|FG010|Overall Study|Adverse Event|0|||
13225135|NCT01782495|26293522|FG000|Overall Study|Withdrew Consent|0|||
13225136|NCT01782495|26293523|FG001|Overall Study|Withdrew Consent|1|||
13225137|NCT01782495|26293524|FG002|Overall Study|Withdrew Consent|0|||
13225138|NCT01782495|26293525|FG003|Overall Study|Withdrew Consent|0|||
13225139|NCT01782495|26293526|FG004|Overall Study|Withdrew Consent|0|||
13225140|NCT01782495|26293527|FG005|Overall Study|Withdrew Consent|0|||
13225141|NCT01782495|26293528|FG006|Overall Study|Withdrew Consent|0|||
13225142|NCT01782495|26293529|FG007|Overall Study|Withdrew Consent|1|||
13225143|NCT01782495|26293530|FG008|Overall Study|Withdrew Consent|0|||
13225144|NCT01782495|26293531|FG009|Overall Study|Withdrew Consent|0|||
13225145|NCT01782495|26293532|FG010|Overall Study|Withdrew Consent|0|||
13225146|NCT01782482|26293547|FG000|Overall Study|Adverse Event|2|||
13225147|NCT01782482|26293548|FG001|Overall Study|Adverse Event|1|||
13225148|NCT01782482|26293547|FG000|Overall Study|Lost to Follow-up|2|||
13225149|NCT01782482|26293548|FG001|Overall Study|Lost to Follow-up|3|||
13225150|NCT01782482|26293547|FG000|Overall Study|Physician Decision|1|||
13225151|NCT01782482|26293548|FG001|Overall Study|Physician Decision|0|||
13225152|NCT01782482|26293547|FG000|Overall Study|Protocol Violation|1|||
13225153|NCT01782482|26293548|FG001|Overall Study|Protocol Violation|0|||
13225154|NCT01782482|26293547|FG000|Overall Study|Withdrawal by Subject|2|||
13225155|NCT01782482|26293548|FG001|Overall Study|Withdrawal by Subject|3|||
13225156|NCT01782482|26293547|FG000|Overall Study|Randomized in Error|2|||
13225157|NCT01782482|26293548|FG001|Overall Study|Randomized in Error|2|||
13225158|NCT01782482|26293547|FG000|Overall Study|Habitually wearing toric lens OS|0|||
13225159|NCT01782482|26293548|FG001|Overall Study|Habitually wearing toric lens OS|1|||
13225160|NCT01782469|26293558|FG000|Overall Study|Lost to Follow-up|1|||
13225161|NCT01782378|26293629|FG000|First Series|Lost to Follow-up|7|||
13225162|NCT01782378|26293630|FG001|First Series|Lost to Follow-up|8|||
13225163|NCT01782378|26293629|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0|||
13225164|NCT01782378|26293630|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25|||
13225165|NCT01782378|26293629|FG000|Second Series|Lost to Follow-up|8|||
13225166|NCT01782378|26293630|FG001|Second Series|Lost to Follow-up|7|||
13225167|NCT01782378|26293629|FG000|Second Series|Did not choose to complete S2 Optional|18|||
13225168|NCT01782378|26293630|FG001|Second Series|Did not choose to complete S2 Optional|0|||
13225169|NCT01782326|26293697|FG000|Planned Treatment Epoch|Subject/guardian decision|149|||
13225170|NCT01782326|26293698|FG001|Planned Treatment Epoch|Subject/guardian decision|151|||
13225171|NCT01782326|26293697|FG000|Planned Treatment Epoch|Death|29|||
13225172|NCT01782326|26293698|FG001|Planned Treatment Epoch|Death|30|||
13225173|NCT01782326|26293697|FG000|Planned Treatment Epoch|Physician Decision|18|||
13225174|NCT01782326|26293698|FG001|Planned Treatment Epoch|Physician Decision|16|||
13225175|NCT01782326|26293697|FG000|Planned Treatment Epoch|Protocol deviation|2|||
13225176|NCT01782326|26293698|FG001|Planned Treatment Epoch|Protocol deviation|3|||
13225177|NCT01782326|26293697|FG000|Planned Treatment Epoch|Lost to Follow-up|4|||
13225178|NCT01782326|26293698|FG001|Planned Treatment Epoch|Lost to Follow-up|4|||
13225179|NCT01782326|26293697|FG000|Planned Treatment Epoch|Technical problems|0|||
13225180|NCT01782326|26293698|FG001|Planned Treatment Epoch|Technical problems|4|||
13225181|NCT01782326|26293697|FG000|Double-blind Treatment|Adverse Event|129|||
13225182|NCT01782326|26293698|FG001|Double-blind Treatment|Adverse Event|145|||
13225183|NCT01782326|26293697|FG000|Double-blind Treatment|Subject/guardian decision|111|||
13225184|NCT01782326|26293698|FG001|Double-blind Treatment|Subject/guardian decision|125|||
13225185|NCT01782326|26293697|FG000|Double-blind Treatment|Lack of Efficacy|17|||
13225186|NCT01782326|26293698|FG001|Double-blind Treatment|Lack of Efficacy|22|||
13225187|NCT01782326|26293697|FG000|Double-blind Treatment|Physician Decision|13|||
13225188|NCT01782326|26293698|FG001|Double-blind Treatment|Physician Decision|16|||
13225189|NCT01782326|26293697|FG000|Double-blind Treatment|Protocol deviation|8|||
13225190|NCT01782326|26293698|FG001|Double-blind Treatment|Protocol deviation|7|||
13225191|NCT01782326|26293697|FG000|Double-blind Treatment|Technical problems|0|||
13225192|NCT01782326|26293698|FG001|Double-blind Treatment|Technical problems|5|||
13225193|NCT01782313|26293711|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3|||
13225194|NCT01782313|26293711|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3|||
13225195|NCT01782313|26293711|FG000|Treated Cycle 3|Progressive Disease|21|||
13225196|NCT01782313|26293711|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5|||
13225197|NCT01782313|26293711|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1|||
13225198|NCT01782313|26293711|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6|||
13225199|NCT01782313|26293711|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1|||
13225200|NCT01782313|26293711|FG000|Survival Follow up|Lost to Follow-up|1|||
13225201|NCT01782222|26293753|FG000|Overall Study|Adverse Event|4|||
13225202|NCT01782222|26293754|FG001|Overall Study|Adverse Event|5|||
13225203|NCT01782222|26293755|FG002|Overall Study|Adverse Event|3|||
13225204|NCT01782222|26293753|FG000|Overall Study|Lack of Efficacy|2|||
13225205|NCT01782222|26293754|FG001|Overall Study|Lack of Efficacy|1|||
13225206|NCT01782222|26293755|FG002|Overall Study|Lack of Efficacy|0|||
13225207|NCT01782222|26293753|FG000|Overall Study|Protocol Violation|1|||
13225208|NCT01782222|26293754|FG001|Overall Study|Protocol Violation|0|||
13225209|NCT01782222|26293755|FG002|Overall Study|Protocol Violation|0|||
13225210|NCT01782222|26293753|FG000|Overall Study|Withdrawal by Subject|1|||
13225211|NCT01782222|26293754|FG001|Overall Study|Withdrawal by Subject|4|||
13225212|NCT01782222|26293755|FG002|Overall Study|Withdrawal by Subject|1|||
13225213|NCT01782222|26293753|FG000|Overall Study|Moved to other state|0|||
13225214|NCT01782222|26293754|FG001|Overall Study|Moved to other state|1|||
13225215|NCT01782222|26293755|FG002|Overall Study|Moved to other state|0|||
13225216|NCT01782131|26293797|FG000|Overall Study|Death|93|||
13225217|NCT01782131|26293798|FG001|Overall Study|Death|96|||
13225218|NCT01782131|26293797|FG000|Overall Study|Lost to Follow-up|1|||
13225219|NCT01782131|26293798|FG001|Overall Study|Lost to Follow-up|3|||
13225220|NCT01782131|26293797|FG000|Overall Study|Withdrawal by Subject|10|||
13225221|NCT01782131|26293798|FG001|Overall Study|Withdrawal by Subject|10|||
13225222|NCT01782131|26293797|FG000|Overall Study|Randomized but not treated|5|||
13225223|NCT01782131|26293798|FG001|Overall Study|Randomized but not treated|5|||
13225224|NCT01782131|26293797|FG000|Overall Study|Reason not provided|0|||
13225225|NCT01782131|26293798|FG001|Overall Study|Reason not provided|1|||
13225226|NCT01781975|26293821|FG000|Overall Study|Death|1|||
13225227|NCT01781975|26293822|FG001|Overall Study|Death|0|||
13225228|NCT01781975|26293821|FG000|Overall Study|Withdrawal by Subject|1|||
13225229|NCT01781975|26293822|FG001|Overall Study|Withdrawal by Subject|1|||
13225230|NCT01781962|26293830|FG000|Overall Study|Other Miscellaneous Reasons|5|||
13225231|NCT01781832|26293837|FG000|Overall Study|Withdrawal by Subject|1|||
13225232|NCT01781611|26293854|FG000|Overall Study|Adverse Event|4|||
13225233|NCT01781611|26293855|FG001|Overall Study|Adverse Event|0|||
13225234|NCT01781572|26294123|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7|||
13225235|NCT01781572|26294124|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0|||
13225236|NCT01781572|26294125|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11|||
13225237|NCT01781572|26294123|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8|||
13225238|NCT01781572|26294124|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6|||
13225239|NCT01781572|26294125|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23|||
13225240|NCT01781572|26294123|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1|||
13225241|NCT01781572|26294124|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0|||
13225242|NCT01781572|26294125|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2|||
13225243|NCT01781572|26294123|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
13225244|NCT01781572|26294124|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
13225245|NCT01781572|26294125|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4|||
13225246|NCT01781572|26294123|FG000|MEK162 45mg BID+LEE011 200mg|Death|0|||
13225247|NCT01781572|26294124|FG001|MEK162 45mg BID+LEE011 200mg|Death|0|||
13225248|NCT01781572|26294125|FG002|MEK162 45mg BID+LEE011 200mg|Death|1|||
13225249|NCT01781572|26294123|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2|||
13225250|NCT01781572|26294124|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
13225251|NCT01781572|26294125|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
13225252|NCT01781572|26294123|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1|||
13225253|NCT01781572|26294124|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
13225254|NCT01781572|26294125|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
13225255|NCT01781572|26294123|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1|||
13225256|NCT01781572|26294124|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
13225257|NCT01781572|26294125|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
13225258|NCT01781572|26294123|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3|||
13225259|NCT01781572|26294124|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2|||
13225260|NCT01781572|26294125|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0|||
13225261|NCT01781572|26294123|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
13225262|NCT01781572|26294124|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
13225263|NCT01781572|26294125|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0|||
13225264|NCT01781572|26294123|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4|||
13225265|NCT01781572|26294124|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3|||
13225266|NCT01781572|26294125|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0|||
13225267|NCT01781572|26294123|FG000|MEK162 45mg BID+LEE011 300mg|Death|1|||
13225268|NCT01781572|26294124|FG001|MEK162 45mg BID+LEE011 300mg|Death|0|||
13225269|NCT01781572|26294125|FG002|MEK162 45mg BID+LEE011 300mg|Death|0|||
13225270|NCT01781572|26294123|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
13225271|NCT01781572|26294124|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5|||
13225272|NCT01781572|26294125|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
13225273|NCT01781572|26294123|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0|||
13225274|NCT01781572|26294124|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1|||
13225275|NCT01781572|26294125|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0|||
13225276|NCT01781572|26294123|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0|||
13225277|NCT01781572|26294124|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2|||
13225278|NCT01781572|26294125|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0|||
13225279|NCT01781572|26294123|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
13225280|NCT01781572|26294124|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6|||
13225281|NCT01781572|26294125|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
13225282|NCT01781572|26294123|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0|||
13225283|NCT01781572|26294124|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1|||
13225284|NCT01781572|26294125|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0|||
13225285|NCT01781572|26294123|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
13225286|NCT01781572|26294124|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5|||
13225287|NCT01781572|26294125|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
13225288|NCT01781429|26294229|FG000|Overall Study|Death|0|||
13225289|NCT01781429|26294230|FG001|Overall Study|Death|0|||
13225290|NCT01781429|26294231|FG002|Overall Study|Death|0|||
13225291|NCT01781429|26294232|FG003|Overall Study|Death|0|||
13225292|NCT01781429|26294233|FG004|Overall Study|Death|0|||
13225293|NCT01781429|26294234|FG005|Overall Study|Death|0|||
13225294|NCT01781429|26294235|FG006|Overall Study|Death|0|||
13225295|NCT01781429|26294236|FG007|Overall Study|Death|0|||
13225296|NCT01781429|26294237|FG008|Overall Study|Death|0|||
13225297|NCT01781429|26294238|FG009|Overall Study|Death|1|||
13225298|NCT01781429|26294239|FG010|Overall Study|Death|0|||
13225299|NCT01781429|26294240|FG011|Overall Study|Death|0|||
13225300|NCT01781429|26294241|FG012|Overall Study|Death|1|||
13225301|NCT01781429|26294242|FG013|Overall Study|Death|0|||
13225302|NCT01781429|26294243|FG014|Overall Study|Death|1|||
13225303|NCT01781429|26294244|FG015|Overall Study|Death|0|||
13225304|NCT01781429|26294229|FG000|Overall Study|Withdrawal by Subject|0|||
13225305|NCT01781429|26294230|FG001|Overall Study|Withdrawal by Subject|0|||
13225306|NCT01781429|26294231|FG002|Overall Study|Withdrawal by Subject|0|||
13225307|NCT01781429|26294232|FG003|Overall Study|Withdrawal by Subject|0|||
13225308|NCT01781429|26294233|FG004|Overall Study|Withdrawal by Subject|0|||
13225309|NCT01781429|26294234|FG005|Overall Study|Withdrawal by Subject|0|||
13225310|NCT01781429|26294235|FG006|Overall Study|Withdrawal by Subject|0|||
13225311|NCT01781429|26294236|FG007|Overall Study|Withdrawal by Subject|0|||
13225312|NCT01781429|26294237|FG008|Overall Study|Withdrawal by Subject|1|||
13225313|NCT01781429|26294238|FG009|Overall Study|Withdrawal by Subject|3|||
13225314|NCT01781429|26294239|FG010|Overall Study|Withdrawal by Subject|1|||
13225315|NCT01781429|26294240|FG011|Overall Study|Withdrawal by Subject|1|||
13225316|NCT01781429|26294241|FG012|Overall Study|Withdrawal by Subject|5|||
13225317|NCT01781429|26294242|FG013|Overall Study|Withdrawal by Subject|2|||
13225318|NCT01781429|26294243|FG014|Overall Study|Withdrawal by Subject|3|||
13225319|NCT01781429|26294244|FG015|Overall Study|Withdrawal by Subject|0|||
13225320|NCT01781429|26294229|FG000|Overall Study|Disease Progression|1|||
13225321|NCT01781429|26294230|FG001|Overall Study|Disease Progression|0|||
13225322|NCT01781429|26294231|FG002|Overall Study|Disease Progression|1|||
13225323|NCT01781429|26294232|FG003|Overall Study|Disease Progression|1|||
13225324|NCT01781429|26294233|FG004|Overall Study|Disease Progression|1|||
13225325|NCT01781429|26294234|FG005|Overall Study|Disease Progression|4|||
13225326|NCT01781429|26294235|FG006|Overall Study|Disease Progression|7|||
13225327|NCT01781429|26294236|FG007|Overall Study|Disease Progression|4|||
13225328|NCT01781429|26294237|FG008|Overall Study|Disease Progression|6|||
13225329|NCT01781429|26294238|FG009|Overall Study|Disease Progression|15|||
13225330|NCT01781429|26294239|FG010|Overall Study|Disease Progression|15|||
13225331|NCT01781429|26294240|FG011|Overall Study|Disease Progression|15|||
13225332|NCT01781429|26294241|FG012|Overall Study|Disease Progression|15|||
13225333|NCT01781429|26294242|FG013|Overall Study|Disease Progression|4|||
13225334|NCT01781429|26294243|FG014|Overall Study|Disease Progression|11|||
13225335|NCT01781429|26294244|FG015|Overall Study|Disease Progression|0|||
13225336|NCT01781429|26294229|FG000|Overall Study|Unacceptable Toxicity|0|||
13225337|NCT01781429|26294230|FG001|Overall Study|Unacceptable Toxicity|0|||
13225338|NCT01781429|26294231|FG002|Overall Study|Unacceptable Toxicity|0|||
13225339|NCT01781429|26294232|FG003|Overall Study|Unacceptable Toxicity|0|||
13225340|NCT01781429|26294233|FG004|Overall Study|Unacceptable Toxicity|0|||
13225341|NCT01781429|26294234|FG005|Overall Study|Unacceptable Toxicity|0|||
13225342|NCT01781429|26294235|FG006|Overall Study|Unacceptable Toxicity|0|||
13225343|NCT01781429|26294236|FG007|Overall Study|Unacceptable Toxicity|0|||
13225344|NCT01781429|26294237|FG008|Overall Study|Unacceptable Toxicity|0|||
13225345|NCT01781429|26294238|FG009|Overall Study|Unacceptable Toxicity|0|||
13225346|NCT01781429|26294239|FG010|Overall Study|Unacceptable Toxicity|0|||
13225347|NCT01781429|26294240|FG011|Overall Study|Unacceptable Toxicity|2|||
13225348|NCT01781429|26294241|FG012|Overall Study|Unacceptable Toxicity|0|||
13225349|NCT01781429|26294242|FG013|Overall Study|Unacceptable Toxicity|0|||
13225350|NCT01781429|26294243|FG014|Overall Study|Unacceptable Toxicity|0|||
13225351|NCT01781429|26294244|FG015|Overall Study|Unacceptable Toxicity|0|||
13225352|NCT01781429|26294229|FG000|Overall Study|Patient Condition Changed|0|||
13225353|NCT01781429|26294230|FG001|Overall Study|Patient Condition Changed|0|||
13225354|NCT01781429|26294231|FG002|Overall Study|Patient Condition Changed|0|||
13225355|NCT01781429|26294232|FG003|Overall Study|Patient Condition Changed|0|||
13225356|NCT01781429|26294233|FG004|Overall Study|Patient Condition Changed|0|||
13225357|NCT01781429|26294234|FG005|Overall Study|Patient Condition Changed|0|||
13225358|NCT01781429|26294235|FG006|Overall Study|Patient Condition Changed|0|||
13225359|NCT01781429|26294236|FG007|Overall Study|Patient Condition Changed|0|||
13225360|NCT01781429|26294237|FG008|Overall Study|Patient Condition Changed|0|||
13225361|NCT01781429|26294238|FG009|Overall Study|Patient Condition Changed|4|||
13225362|NCT01781429|26294239|FG010|Overall Study|Patient Condition Changed|0|||
13225363|NCT01781429|26294240|FG011|Overall Study|Patient Condition Changed|1|||
13225364|NCT01781429|26294241|FG012|Overall Study|Patient Condition Changed|0|||
13225365|NCT01781429|26294242|FG013|Overall Study|Patient Condition Changed|1|||
13225366|NCT01781429|26294243|FG014|Overall Study|Patient Condition Changed|0|||
13225367|NCT01781429|26294244|FG015|Overall Study|Patient Condition Changed|0|||
13113701|NCT03132220|25912250|FG000|Overall Study|Withdrawal by Subject|1|||
13113702|NCT03132220|25912251|FG001|Overall Study|Withdrawal by Subject|4|||
13113703|NCT03131999|25912266|FG000|Overall Study|Withdrawal by Subject|0|||
13113704|NCT03131999|25912267|FG001|Overall Study|Withdrawal by Subject|1|||
13113705|NCT03131960|25912286|FG000|Overall Study|Adverse Event|0|||
13113706|NCT03131960|25912287|FG001|Overall Study|Adverse Event|1|||
13113707|NCT03131895|25912318|FG000|Washout Period (at Least 5 Days)|Adverse Event|1|||
13113708|NCT03131895|25912319|FG001|Washout Period (at Least 5 Days)|Adverse Event|0|||
13113709|NCT03131895|25912320|FG002|Washout Period (at Least 5 Days)|Adverse Event|0|||
13113710|NCT03131895|25912321|FG003|Washout Period (at Least 5 Days)|Adverse Event|1|||
13113711|NCT03131895|25912318|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
13113712|NCT03131895|25912319|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
13113713|NCT03131895|25912320|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2|||
13113714|NCT03131895|25912321|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
13113715|NCT03131895|25912318|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
13113716|NCT03131895|25912319|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2|||
13113717|NCT03131895|25912320|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
13225368|NCT01781429|26294229|FG000|Overall Study|Other - as entered by PI in eCRF|0|||
13225369|NCT01781429|26294230|FG001|Overall Study|Other - as entered by PI in eCRF|1|||
13225370|NCT01781429|26294231|FG002|Overall Study|Other - as entered by PI in eCRF|0|||
13225371|NCT01781429|26294232|FG003|Overall Study|Other - as entered by PI in eCRF|0|||
13225372|NCT01781429|26294233|FG004|Overall Study|Other - as entered by PI in eCRF|0|||
13225373|NCT01781429|26294234|FG005|Overall Study|Other - as entered by PI in eCRF|0|||
13225374|NCT01781429|26294235|FG006|Overall Study|Other - as entered by PI in eCRF|0|||
13225375|NCT01781429|26294236|FG007|Overall Study|Other - as entered by PI in eCRF|0|||
13225376|NCT01781429|26294237|FG008|Overall Study|Other - as entered by PI in eCRF|0|||
13225377|NCT01781429|26294238|FG009|Overall Study|Other - as entered by PI in eCRF|1|||
13225378|NCT01781429|26294239|FG010|Overall Study|Other - as entered by PI in eCRF|1|||
13225379|NCT01781429|26294240|FG011|Overall Study|Other - as entered by PI in eCRF|2|||
13225380|NCT01781429|26294241|FG012|Overall Study|Other - as entered by PI in eCRF|1|||
13225381|NCT01781429|26294242|FG013|Overall Study|Other - as entered by PI in eCRF|1|||
13225382|NCT01781429|26294243|FG014|Overall Study|Other - as entered by PI in eCRF|1|||
13225383|NCT01781429|26294244|FG015|Overall Study|Other - as entered by PI in eCRF|0|||
13225384|NCT01781429|26294229|FG000|Overall Study|Enrolled, but not treated|0|||
13225385|NCT01781429|26294230|FG001|Overall Study|Enrolled, but not treated|0|||
13225386|NCT01781429|26294231|FG002|Overall Study|Enrolled, but not treated|0|||
13225387|NCT01781429|26294232|FG003|Overall Study|Enrolled, but not treated|0|||
13225388|NCT01781429|26294233|FG004|Overall Study|Enrolled, but not treated|0|||
13225389|NCT01781429|26294234|FG005|Overall Study|Enrolled, but not treated|0|||
13225390|NCT01781429|26294235|FG006|Overall Study|Enrolled, but not treated|0|||
13225391|NCT01781429|26294236|FG007|Overall Study|Enrolled, but not treated|0|||
13225392|NCT01781429|26294237|FG008|Overall Study|Enrolled, but not treated|0|||
13225393|NCT01781429|26294238|FG009|Overall Study|Enrolled, but not treated|0|||
13225394|NCT01781429|26294239|FG010|Overall Study|Enrolled, but not treated|1|||
13225395|NCT01781429|26294240|FG011|Overall Study|Enrolled, but not treated|0|||
13225396|NCT01781429|26294241|FG012|Overall Study|Enrolled, but not treated|0|||
13225397|NCT01781429|26294242|FG013|Overall Study|Enrolled, but not treated|0|||
13225398|NCT01781429|26294243|FG014|Overall Study|Enrolled, but not treated|0|||
13225399|NCT01781429|26294244|FG015|Overall Study|Enrolled, but not treated|0|||
13225400|NCT01781390|26294262|FG000|Overall Study|Withdrawal of Consent|0|||
13225401|NCT01781390|26294263|FG001|Overall Study|Withdrawal of Consent|3|||
13225402|NCT01781390|26294264|FG002|Overall Study|Withdrawal of Consent|1|||
13225403|NCT01781390|26294262|FG000|Overall Study|Lost to Follow-up|1|||
13225404|NCT01781390|26294263|FG001|Overall Study|Lost to Follow-up|1|||
13225405|NCT01781390|26294264|FG002|Overall Study|Lost to Follow-up|1|||
13485641|NCT01126749|27033001|FG001|Phase 2|Study Termination by Sponsor|0|||
13485642|NCT01126749|27033002|FG002|Phase 2|Study Termination by Sponsor|12|||
13225406|NCT01781390|26294262|FG000|Overall Study|Adverse Event|1|||
13225407|NCT01781390|26294263|FG001|Overall Study|Adverse Event|2|||
13225408|NCT01781390|26294264|FG002|Overall Study|Adverse Event|1|||
13485643|NCT01126749|27033003|FG003|Phase 2|Study Termination by Sponsor|6|||
13113718|NCT03131895|25912321|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
13225409|NCT01781390|26294262|FG000|Overall Study|Participants who were Randomized and Not Treated|1|||
13225410|NCT01781390|26294263|FG001|Overall Study|Participants who were Randomized and Not Treated|1|||
13225411|NCT01781390|26294264|FG002|Overall Study|Participants who were Randomized and Not Treated|1|||
13225412|NCT01781299|26294279|FG000|Overall Study|Withdrawal by Subject|0|||
13225413|NCT01781299|26294280|FG001|Overall Study|Withdrawal by Subject|1|||
13225414|NCT01781286|26294310|FG000|Overall Study|Lost to Follow-up|0|||
13225415|NCT01781286|26294311|FG001|Overall Study|Lost to Follow-up|0|||
13225416|NCT01781286|26294312|FG002|Overall Study|Lost to Follow-up|0|||
13225417|NCT01781286|26294313|FG003|Overall Study|Lost to Follow-up|0|||
13225418|NCT01781286|26294314|FG004|Overall Study|Lost to Follow-up|0|||
13225419|NCT01781286|26294315|FG005|Overall Study|Lost to Follow-up|1|||
13225420|NCT01781286|26294310|FG000|Overall Study|Time Constraints|2|||
13225421|NCT01781286|26294311|FG001|Overall Study|Time Constraints|0|||
13225422|NCT01781286|26294312|FG002|Overall Study|Time Constraints|2|||
13225423|NCT01781286|26294313|FG003|Overall Study|Time Constraints|0|||
13225424|NCT01781286|26294314|FG004|Overall Study|Time Constraints|0|||
13225425|NCT01781286|26294315|FG005|Overall Study|Time Constraints|0|||
13225426|NCT01781286|26294310|FG000|Overall Study|Noncompliance|0|||
13225427|NCT01781286|26294311|FG001|Overall Study|Noncompliance|0|||
13225428|NCT01781286|26294312|FG002|Overall Study|Noncompliance|0|||
13225429|NCT01781286|26294313|FG003|Overall Study|Noncompliance|1|||
13225430|NCT01781286|26294314|FG004|Overall Study|Noncompliance|0|||
13225431|NCT01781286|26294315|FG005|Overall Study|Noncompliance|0|||
13225432|NCT01781234|26294332|FG000|Overall Study|Adverse Event|2|||
13225433|NCT01781234|26294333|FG001|Overall Study|Adverse Event|0|||
13225434|NCT01781234|26294332|FG000|Overall Study|Protocol Violation|3|||
13225435|NCT01781234|26294333|FG001|Overall Study|Protocol Violation|0|||
13225436|NCT01781234|26294332|FG000|Overall Study|Withdrawal by Subject|4|||
13225437|NCT01781234|26294333|FG001|Overall Study|Withdrawal by Subject|3|||
13225438|NCT01781026|26294339|FG000|Overall Study|Lack of Efficacy|2|||
13225439|NCT01780987|26294362|FG000|Overall Study|Adverse Event|0|||
13225440|NCT01780987|26294363|FG001|Overall Study|Adverse Event|4|||
13225441|NCT01780987|26294362|FG000|Overall Study|Withdrawal by Subject|2|||
13225442|NCT01780987|26294363|FG001|Overall Study|Withdrawal by Subject|0|||
13225443|NCT01780987|26294362|FG000|Overall Study|Request of Changing Hospital|0|||
13225444|NCT01780987|26294363|FG001|Overall Study|Request of Changing Hospital|1|||
13225445|NCT01780987|26294362|FG000|Overall Study|Changing Residence|1|||
13225446|NCT01780987|26294363|FG001|Overall Study|Changing Residence|0|||
13225447|NCT01780987|26294362|FG000|Overall Study|Not Receiving any Study Medication|0|||
13225448|NCT01780987|26294363|FG001|Overall Study|Not Receiving any Study Medication|1|||
13225449|NCT01780974|26294378|FG000|Overall Study|Death|1|||
13225450|NCT01780974|26294379|FG001|Overall Study|Death|0|||
13225451|NCT01780974|26294378|FG000|Overall Study|Adverse Event|1|||
13225452|NCT01780974|26294379|FG001|Overall Study|Adverse Event|3|||
13225453|NCT01780935|26294416|FG000|Overall Study|Admin problems due to early termination|321|||
13225454|NCT01780935|26294417|FG001|Overall Study|Admin problems due to early termination|309|||
13225455|NCT01780935|26294416|FG000|Overall Study|Adverse Event|2|||
13225456|NCT01780935|26294417|FG001|Overall Study|Adverse Event|4|||
13225457|NCT01780935|26294416|FG000|Overall Study|Death|1|||
13225458|NCT01780935|26294417|FG001|Overall Study|Death|6|||
13225459|NCT01780935|26294416|FG000|Overall Study|Lost to Follow-up|2|||
13225460|NCT01780935|26294417|FG001|Overall Study|Lost to Follow-up|6|||
13225461|NCT01780935|26294416|FG000|Overall Study|Physician Decision|1|||
13225462|NCT01780935|26294417|FG001|Overall Study|Physician Decision|1|||
13225463|NCT01780935|26294416|FG000|Overall Study|Protocol deviation|0|||
13225464|NCT01780935|26294417|FG001|Overall Study|Protocol deviation|1|||
13225465|NCT01780935|26294416|FG000|Overall Study|Patient withdrew consent|8|||
13225466|NCT01780935|26294417|FG001|Overall Study|Patient withdrew consent|9|||
13225467|NCT01780831|26294495|FG000|Overall Study|Withdrawal by Subject|0|||
13225468|NCT01780831|26294496|FG001|Overall Study|Withdrawal by Subject|0|||
13225469|NCT01780831|26294497|FG002|Overall Study|Withdrawal by Subject|4|||
13225470|NCT01780831|26294498|FG003|Overall Study|Withdrawal by Subject|0|||
13225471|NCT01780831|26294495|FG000|Overall Study|Lost to Follow-up|0|||
13225472|NCT01780831|26294496|FG001|Overall Study|Lost to Follow-up|0|||
13225473|NCT01780831|26294497|FG002|Overall Study|Lost to Follow-up|0|||
13225474|NCT01780831|26294498|FG003|Overall Study|Lost to Follow-up|1|||
13225475|NCT01780662|26294522|FG000|Overall Study|Adverse Event|1|||
13225476|NCT01780662|26294523|FG001|Overall Study|Adverse Event|0|||
13225477|NCT01780662|26294524|FG002|Overall Study|Adverse Event|2|||
13225478|NCT01780662|26294522|FG000|Overall Study|Physician Decision|0|||
13225479|NCT01780662|26294523|FG001|Overall Study|Physician Decision|5|||
13225480|NCT01780662|26294524|FG002|Overall Study|Physician Decision|7|||
13225481|NCT01780662|26294522|FG000|Overall Study|Protocol Violation|0|||
13225482|NCT01780662|26294523|FG001|Overall Study|Protocol Violation|1|||
13225483|NCT01780662|26294524|FG002|Overall Study|Protocol Violation|0|||
13225484|NCT01780662|26294522|FG000|Overall Study|Ineligible|0|||
13225485|NCT01780662|26294523|FG001|Overall Study|Ineligible|0|||
13225486|NCT01780662|26294524|FG002|Overall Study|Ineligible|1|||
13225487|NCT01780584|26294554|FG000|Overall Study|Death|1|||
13225488|NCT01780584|26294555|FG001|Overall Study|Death|0|||
13225489|NCT01780584|26294556|FG002|Overall Study|Death|1|||
13225490|NCT01780584|26294554|FG000|Overall Study|Adverse Event|0|||
13225491|NCT01780584|26294555|FG001|Overall Study|Adverse Event|1|||
13225492|NCT01780584|26294556|FG002|Overall Study|Adverse Event|0|||
13225493|NCT01780584|26294554|FG000|Overall Study|Protocol Violation|0|||
13225494|NCT01780584|26294555|FG001|Overall Study|Protocol Violation|0|||
13225495|NCT01780584|26294556|FG002|Overall Study|Protocol Violation|1|||
13225496|NCT01780545|26294579|FG000|Overall Study|Withdrawal by Subject|3|||
13225497|NCT01780545|26294580|FG001|Overall Study|Withdrawal by Subject|1|||
13225498|NCT01780545|26294579|FG000|Overall Study|Lost to Follow-up|1|||
13225499|NCT01780545|26294580|FG001|Overall Study|Lost to Follow-up|1|||
13225500|NCT01780506|26294641|FG000|Double-Blind Phase|Randomized but not Treated|3|||
13225501|NCT01780506|26294642|FG001|Double-Blind Phase|Randomized but not Treated|2|||
13225502|NCT01780506|26294641|FG000|Double-Blind Phase|Adverse Event|4|||
13225503|NCT01780506|26294642|FG001|Double-Blind Phase|Adverse Event|14|||
13225504|NCT01780506|26294641|FG000|Double-Blind Phase|Death|1|||
13225505|NCT01780506|26294642|FG001|Double-Blind Phase|Death|2|||
13225506|NCT01780506|26294641|FG000|Double-Blind Phase|Pregnancy|2|||
13225507|NCT01780506|26294642|FG001|Double-Blind Phase|Pregnancy|1|||
13225508|NCT01780506|26294641|FG000|Double-Blind Phase|Lack of Efficacy|1|||
13225509|NCT01780506|26294642|FG001|Double-Blind Phase|Lack of Efficacy|1|||
13225510|NCT01780506|26294641|FG000|Double-Blind Phase|Investigator's Discretion|5|||
13225511|NCT01780506|26294642|FG001|Double-Blind Phase|Investigator's Discretion|2|||
13225512|NCT01780506|26294641|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
13225513|NCT01780506|26294642|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3|||
13225514|NCT01780506|26294641|FG000|Double-Blind Phase|Protocol Violation|4|||
13225515|NCT01780506|26294642|FG001|Double-Blind Phase|Protocol Violation|3|||
13225516|NCT01780506|26294641|FG000|Double-Blind Phase|Withdrew Consent|23|||
13225517|NCT01780506|26294642|FG001|Double-Blind Phase|Withdrew Consent|24|||
13225518|NCT01780506|26294641|FG000|Double-Blind Phase|Lost to Follow-up|23|||
13225519|NCT01780506|26294642|FG001|Double-Blind Phase|Lost to Follow-up|26|||
13485644|NCT01126749|27033000|FG000|Phase 2|Other|0|||
13203099|NCT01987960|26223189|FG001|Period 2|Withdrawal by Subject|0|||
13203100|NCT01987960|26223190|FG002|Period 2|Withdrawal by Subject|1|||
13203101|NCT01987960|26223191|FG003|Period 2|Withdrawal by Subject|0|||
13203102|NCT01987960|26223188|FG000|Period 2|Administrative or other reason|0|||
13203103|NCT01987960|26223189|FG001|Period 2|Administrative or other reason|5|||
13203104|NCT01987960|26223190|FG002|Period 2|Administrative or other reason|7|||
13203105|NCT01987960|26223191|FG003|Period 2|Administrative or other reason|0|||
13203106|NCT01987960|26223188|FG000|Period 3|Adverse Event|0|||
13203107|NCT01987960|26223189|FG001|Period 3|Adverse Event|0|||
13203108|NCT01987960|26223190|FG002|Period 3|Adverse Event|0|||
13203109|NCT01987960|26223191|FG003|Period 3|Adverse Event|7|||
13203110|NCT01987960|26223188|FG000|Period 3|Non-compliance with IMP|0|||
13203111|NCT01987960|26223189|FG001|Period 3|Non-compliance with IMP|0|||
13203112|NCT01987960|26223190|FG002|Period 3|Non-compliance with IMP|0|||
13203113|NCT01987960|26223191|FG003|Period 3|Non-compliance with IMP|1|||
13203114|NCT01987960|26223188|FG000|Period 3|Protocol Violation|0|||
13203115|NCT01987960|26223189|FG001|Period 3|Protocol Violation|0|||
13203116|NCT01987960|26223190|FG002|Period 3|Protocol Violation|0|||
13203117|NCT01987960|26223191|FG003|Period 3|Protocol Violation|6|||
13203118|NCT01987960|26223188|FG000|Period 3|Withdrawal by Subject|0|||
13203119|NCT01987960|26223189|FG001|Period 3|Withdrawal by Subject|0|||
13203120|NCT01987960|26223190|FG002|Period 3|Withdrawal by Subject|0|||
13203121|NCT01987960|26223191|FG003|Period 3|Withdrawal by Subject|9|||
13203122|NCT01987960|26223188|FG000|Period 3|Lost to Follow-up|0|||
13203123|NCT01987960|26223189|FG001|Period 3|Lost to Follow-up|0|||
13203124|NCT01987960|26223190|FG002|Period 3|Lost to Follow-up|0|||
13203125|NCT01987960|26223191|FG003|Period 3|Lost to Follow-up|5|||
13203126|NCT01987960|26223188|FG000|Period 3|Administrative or other reason|0|||
13203127|NCT01987960|26223189|FG001|Period 3|Administrative or other reason|0|||
13203128|NCT01987960|26223190|FG002|Period 3|Administrative or other reason|0|||
13203129|NCT01987960|26223191|FG003|Period 3|Administrative or other reason|43|||
13203130|NCT01987908|26223276|FG000|Placebo Lead-in Period|Adverse Event|2|||
13203131|NCT01987908|26223277|FG001|Placebo Lead-in Period|Adverse Event|0|||
13203132|NCT01987908|26223278|FG002|Placebo Lead-in Period|Adverse Event|0|||
13203133|NCT01987908|26223276|FG000|Placebo Lead-in Period|Physician Decision|2|||
13203134|NCT01987908|26223277|FG001|Placebo Lead-in Period|Physician Decision|0|||
13203135|NCT01987908|26223278|FG002|Placebo Lead-in Period|Physician Decision|0|||
13203136|NCT01987908|26223276|FG000|Placebo Lead-in Period|Withdrawal by Subject|1|||
13203137|NCT01987908|26223277|FG001|Placebo Lead-in Period|Withdrawal by Subject|0|||
13203138|NCT01987908|26223278|FG002|Placebo Lead-in Period|Withdrawal by Subject|0|||
13203139|NCT01987908|26223276|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4|||
13203140|NCT01987908|26223277|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
13203141|NCT01987908|26223278|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
13203142|NCT01987908|26223276|FG000|Treatment Period|Adverse Event|0|||
13203143|NCT01987908|26223277|FG001|Treatment Period|Adverse Event|1|||
13203144|NCT01987908|26223278|FG002|Treatment Period|Adverse Event|1|||
13203145|NCT01987908|26223276|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
13203146|NCT01987908|26223277|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2|||
13203147|NCT01987908|26223278|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
13203148|NCT01987908|26223276|FG000|Post-Treatment Observation Period|Other: Bad Veins|0|||
13203149|NCT01987908|26223277|FG001|Post-Treatment Observation Period|Other: Bad Veins|1|||
13225520|NCT01780506|26294641|FG000|Open-Label Extension Phase|Enrolled but not Treated|0|||
13225521|NCT01780506|26294642|FG001|Open-Label Extension Phase|Enrolled but not Treated|1|||
13225522|NCT01780389|26294655|FG000|Overall Study|Adverse Event|1|||
13225523|NCT01779869|26294661|FG000|Overall Study|Physician Decision|2|||
13225524|NCT01779856|26294675|FG000|Overall Study|Withdrawal by Subject|15|||
13225525|NCT01779856|26294675|FG000|Overall Study|Death|3|||
13225526|NCT01779856|26294675|FG000|Overall Study|Physician Decision|1|||
13225527|NCT01779856|26294675|FG000|Overall Study|Inclusion/Exclusion Not Met|2|||
13225528|NCT01779856|26294675|FG000|Overall Study|Delays in scheduling implant|1|||
13225529|NCT01779856|26294675|FG000|Overall Study|Subject ineligible for Implant|2|||
13225530|NCT01779700|26294720|FG000|Overall Study|Adverse Event|4|||
13225531|NCT01779700|26294721|FG001|Overall Study|Adverse Event|3|||
13225532|NCT01779700|26294720|FG000|Overall Study|Withdrawal by Subject|0|||
13225533|NCT01779700|26294721|FG001|Overall Study|Withdrawal by Subject|2|||
13225534|NCT01779648|26294756|FG000|Overall Study|Protocol Violation|1|||
13225535|NCT01779648|26294757|FG001|Overall Study|Protocol Violation|0|||
13225536|NCT01779440|26294772|FG000|Overall Study|Withdrawal by Subject|3|||
13225537|NCT01779440|26294773|FG001|Overall Study|Withdrawal by Subject|5|||
13225538|NCT01778985|26294824|FG000|Overall Study|Lost to Follow-up|1|||
13225539|NCT01778985|26294825|FG001|Overall Study|Lost to Follow-up|0|||
13225540|NCT01778985|26294824|FG000|Overall Study|Physician Decision|2|||
13225541|NCT01778985|26294825|FG001|Overall Study|Physician Decision|2|||
13225542|NCT01778985|26294824|FG000|Overall Study|Protocol Violation|4|||
13225543|NCT01778985|26294825|FG001|Overall Study|Protocol Violation|1|||
13225544|NCT01778855|26294838|FG000|Overall Study|Death|0|||
13225545|NCT01778855|26294839|FG001|Overall Study|Death|1|||
13225546|NCT01778751|26294858|FG000|Overall Study|Lost to Follow-up|1|||
13225547|NCT01778751|26294859|FG001|Overall Study|Lost to Follow-up|0|||
13225548|NCT01778751|26294858|FG000|Overall Study|Withdrawal by Subject|0|||
13225549|NCT01778751|26294859|FG001|Overall Study|Withdrawal by Subject|2|||
13225550|NCT01778751|26294858|FG000|Overall Study|Transfered care|1|||
13225551|NCT01778751|26294859|FG001|Overall Study|Transfered care|0|||
13225552|NCT01778556|26294879|FG000|Intervention 1 (5 Days)|Protocol Violation|0|||
13225553|NCT01778556|26294880|FG001|Intervention 1 (5 Days)|Protocol Violation|1|||
13225554|NCT01778556|26294879|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
13225555|NCT01778556|26294880|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1|||
13225556|NCT01778556|26294879|FG000|Intervention 2 (14 Days)|Protocol Violation|1|||
13225557|NCT01778556|26294880|FG001|Intervention 2 (14 Days)|Protocol Violation|0|||
13225558|NCT01778556|26294879|FG000|Long-term Follow-up|noncompliance with metreleptin|1|||
13225559|NCT01778556|26294880|FG001|Long-term Follow-up|noncompliance with metreleptin|0|||
13225560|NCT01778530|26294887|FG000|Overall Study|Progression on study|1|||
13225561|NCT01778530|26294887|FG000|Overall Study|Adverse event/side effect|1|||
13225562|NCT01778127|26294938|FG000|Overall Study|Lost to Follow-up|5|||
13225563|NCT01778127|26294939|FG001|Overall Study|Lost to Follow-up|1|||
13225564|NCT01778127|26294940|FG002|Overall Study|Lost to Follow-up|2|||
13225565|NCT01778127|26294938|FG000|Overall Study|Withdrawal by Subject|3|||
13225566|NCT01778127|26294939|FG001|Overall Study|Withdrawal by Subject|1|||
13225567|NCT01778127|26294940|FG002|Overall Study|Withdrawal by Subject|4|||
13225568|NCT01778062|26294959|FG000|Overall Study|Adverse Event|1|||
13225569|NCT01778062|26294960|FG001|Overall Study|Adverse Event|3|||
13225570|NCT01778062|26294959|FG000|Overall Study|Consent Withdrawal|1|||
13225571|NCT01778062|26294960|FG001|Overall Study|Consent Withdrawal|5|||
13225572|NCT01778062|26294959|FG000|Overall Study|major protocol deviation|4|||
13225573|NCT01778062|26294960|FG001|Overall Study|major protocol deviation|3|||
13225574|NCT01778049|26294987|FG000|Open Label Treatment Period|Adverse Event|5|||
13225575|NCT01778049|26294988|FG001|Open Label Treatment Period|Adverse Event|15|||
13225576|NCT01778049|26294989|FG002|Open Label Treatment Period|Adverse Event|0|||
13225577|NCT01778049|26294990|FG003|Open Label Treatment Period|Adverse Event|0|||
13225578|NCT01778049|26294991|FG004|Open Label Treatment Period|Adverse Event|0|||
13225579|NCT01778049|26294992|FG005|Open Label Treatment Period|Adverse Event|0|||
13225580|NCT01778049|26294987|FG000|Open Label Treatment Period|Lack of Efficacy|1|||
13225581|NCT01778049|26294988|FG001|Open Label Treatment Period|Lack of Efficacy|1|||
13225582|NCT01778049|26294989|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
13225583|NCT01778049|26294990|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
13225584|NCT01778049|26294991|FG004|Open Label Treatment Period|Lack of Efficacy|0|||
13485645|NCT01126749|27033001|FG001|Phase 2|Other|0|||
13225585|NCT01778049|26294992|FG005|Open Label Treatment Period|Lack of Efficacy|0|||
13225586|NCT01778049|26294987|FG000|Open Label Treatment Period|Protocol Violation|5|||
13225587|NCT01778049|26294988|FG001|Open Label Treatment Period|Protocol Violation|5|||
13225588|NCT01778049|26294989|FG002|Open Label Treatment Period|Protocol Violation|0|||
13225589|NCT01778049|26294990|FG003|Open Label Treatment Period|Protocol Violation|0|||
13225590|NCT01778049|26294991|FG004|Open Label Treatment Period|Protocol Violation|0|||
13225591|NCT01778049|26294992|FG005|Open Label Treatment Period|Protocol Violation|0|||
13225592|NCT01778049|26294987|FG000|Open Label Treatment Period|Lost to Follow-up|4|||
13225593|NCT01778049|26294988|FG001|Open Label Treatment Period|Lost to Follow-up|3|||
13485646|NCT01126749|27033002|FG002|Phase 2|Other|4|||
13225594|NCT01778049|26294989|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
13225595|NCT01778049|26294990|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
13225596|NCT01778049|26294991|FG004|Open Label Treatment Period|Lost to Follow-up|0|||
13225597|NCT01778049|26294992|FG005|Open Label Treatment Period|Lost to Follow-up|0|||
13225598|NCT01778049|26294987|FG000|Open Label Treatment Period|Withdrawal by Subject|4|||
13225599|NCT01778049|26294988|FG001|Open Label Treatment Period|Withdrawal by Subject|10|||
13225600|NCT01778049|26294989|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
13225601|NCT01778049|26294990|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
13225602|NCT01778049|26294991|FG004|Open Label Treatment Period|Withdrawal by Subject|0|||
13225603|NCT01778049|26294992|FG005|Open Label Treatment Period|Withdrawal by Subject|0|||
13225604|NCT01778049|26294987|FG000|Open Label Treatment Period|Not treated|2|||
13225605|NCT01778049|26294988|FG001|Open Label Treatment Period|Not treated|1|||
13225606|NCT01778049|26294989|FG002|Open Label Treatment Period|Not treated|0|||
13225607|NCT01778049|26294990|FG003|Open Label Treatment Period|Not treated|0|||
13225608|NCT01778049|26294991|FG004|Open Label Treatment Period|Not treated|0|||
13225609|NCT01778049|26294992|FG005|Open Label Treatment Period|Not treated|0|||
13225610|NCT01778049|26294987|FG000|Open Label Treatment Period|Other reason not defined above|77|||
13225611|NCT01778049|26294988|FG001|Open Label Treatment Period|Other reason not defined above|94|||
13225612|NCT01778049|26294989|FG002|Open Label Treatment Period|Other reason not defined above|0|||
13225613|NCT01778049|26294990|FG003|Open Label Treatment Period|Other reason not defined above|0|||
13225614|NCT01778049|26294991|FG004|Open Label Treatment Period|Other reason not defined above|0|||
13225615|NCT01778049|26294992|FG005|Open Label Treatment Period|Other reason not defined above|0|||
13225616|NCT01778049|26294987|FG000|Double Blind Treatment Period|Adverse Event|0|||
13225617|NCT01778049|26294988|FG001|Double Blind Treatment Period|Adverse Event|0|||
13225618|NCT01778049|26294989|FG002|Double Blind Treatment Period|Adverse Event|4|||
13225619|NCT01778049|26294990|FG003|Double Blind Treatment Period|Adverse Event|5|||
13225620|NCT01778049|26294991|FG004|Double Blind Treatment Period|Adverse Event|3|||
13225621|NCT01778049|26294992|FG005|Double Blind Treatment Period|Adverse Event|2|||
13225622|NCT01778049|26294987|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
13225623|NCT01778049|26294988|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
13225624|NCT01778049|26294989|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
13225625|NCT01778049|26294990|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
13225626|NCT01778049|26294991|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
13225627|NCT01778049|26294992|FG005|Double Blind Treatment Period|Lack of Efficacy|1|||
13225628|NCT01778049|26294987|FG000|Double Blind Treatment Period|Protocol Violation|0|||
13225629|NCT01778049|26294988|FG001|Double Blind Treatment Period|Protocol Violation|0|||
13225630|NCT01778049|26294989|FG002|Double Blind Treatment Period|Protocol Violation|2|||
13225631|NCT01778049|26294990|FG003|Double Blind Treatment Period|Protocol Violation|0|||
13225632|NCT01778049|26294991|FG004|Double Blind Treatment Period|Protocol Violation|0|||
13225633|NCT01778049|26294992|FG005|Double Blind Treatment Period|Protocol Violation|0|||
13225634|NCT01778049|26294987|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
13225635|NCT01778049|26294988|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
13225636|NCT01778049|26294989|FG002|Double Blind Treatment Period|Lost to Follow-up|4|||
13225637|NCT01778049|26294990|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
13225638|NCT01778049|26294991|FG004|Double Blind Treatment Period|Lost to Follow-up|5|||
13225639|NCT01778049|26294992|FG005|Double Blind Treatment Period|Lost to Follow-up|2|||
13225640|NCT01778049|26294987|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
13225641|NCT01778049|26294988|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
13225642|NCT01778049|26294989|FG002|Double Blind Treatment Period|Withdrawal by Subject|1|||
13225643|NCT01778049|26294990|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
13225644|NCT01778049|26294991|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
13225645|NCT01778049|26294992|FG005|Double Blind Treatment Period|Withdrawal by Subject|1|||
13225646|NCT01778049|26294987|FG000|Double Blind Treatment Period|Not treated|0|||
13225647|NCT01778049|26294988|FG001|Double Blind Treatment Period|Not treated|0|||
13225648|NCT01778049|26294989|FG002|Double Blind Treatment Period|Not treated|0|||
13225649|NCT01778049|26294990|FG003|Double Blind Treatment Period|Not treated|2|||
13225650|NCT01778049|26294991|FG004|Double Blind Treatment Period|Not treated|2|||
13225651|NCT01778049|26294992|FG005|Double Blind Treatment Period|Not treated|0|||
13225652|NCT01778049|26294987|FG000|Double Blind Treatment Period|Other reason not defined above|0|||
13225653|NCT01778049|26294988|FG001|Double Blind Treatment Period|Other reason not defined above|0|||
13225654|NCT01778049|26294989|FG002|Double Blind Treatment Period|Other reason not defined above|4|||
13225655|NCT01778049|26294990|FG003|Double Blind Treatment Period|Other reason not defined above|2|||
13225656|NCT01778049|26294991|FG004|Double Blind Treatment Period|Other reason not defined above|2|||
13225657|NCT01778049|26294992|FG005|Double Blind Treatment Period|Other reason not defined above|1|||
13225658|NCT01778023|26295016|FG000|Overall Study|Withdrawal by Subject|0|||
13225659|NCT01778023|26295017|FG001|Overall Study|Withdrawal by Subject|3|||
13225660|NCT01778010|26295060|FG000|Overall Study|Withdrawal by Subject|2|||
13225661|NCT01778010|26295060|FG000|Overall Study|abnormal ECG before meds|1|||
13225662|NCT01778010|26295060|FG000|Overall Study|Arrested|1|||
13113719|NCT03131895|25912318|FG000|Washout Period (at Least 5 Days)|Other|0|||
13113720|NCT03131895|25912319|FG001|Washout Period (at Least 5 Days)|Other|0|||
13113721|NCT03131895|25912320|FG002|Washout Period (at Least 5 Days)|Other|2|||
13113722|NCT03131895|25912321|FG003|Washout Period (at Least 5 Days)|Other|0|||
13113723|NCT03131895|25912318|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
13113724|NCT03131895|25912319|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1|||
13113725|NCT03131895|25912320|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
13113726|NCT03131895|25912321|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
13225663|NCT01778010|26295060|FG000|Overall Study|rash while on placebo|1|||
13225664|NCT01777997|26295074|FG000|12 Week lead-in of no ART|Severe debilitation|2|||
13225665|NCT01777997|26295074|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1|||
13225666|NCT01777997|26295074|FG000|Weeks 48 to 72/96 on ART|Death|1|||
13225667|NCT01777997|26295074|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1|||
13225668|NCT01777932|26295090|FG000|Overall Study|Disease progression|136|||
13113727|NCT03131895|25912318|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1|||
13225669|NCT01777932|26295090|FG000|Overall Study|Death|3|||
13225670|NCT01777932|26295090|FG000|Overall Study|Adverse Event|34|||
13225671|NCT01777932|26295090|FG000|Overall Study|Lost to Follow-up|3|||
13225672|NCT01777932|26295090|FG000|Overall Study|Investigator decision|10|||
13225673|NCT01777932|26295090|FG000|Overall Study|Reimbursement limit|9|||
13225674|NCT01777932|26295090|FG000|Overall Study|Patient refused further treatment|10|||
13225675|NCT01777854|26295097|FG000|Overall Study|Physician Decision|3|||
13225676|NCT01777854|26295098|FG001|Overall Study|Physician Decision|3|||
13225677|NCT01777776|26295168|FG000|Overall Study|Adverse Event|2|||
13225678|NCT01777776|26295169|FG001|Overall Study|Adverse Event|4|||
13225679|NCT01777776|26295170|FG002|Overall Study|Adverse Event|0|||
13225680|NCT01777776|26295171|FG003|Overall Study|Adverse Event|0|||
13225681|NCT01777776|26295168|FG000|Overall Study|Disease Progression|4|||
13225682|NCT01777776|26295169|FG001|Overall Study|Disease Progression|8|||
13225683|NCT01777776|26295170|FG002|Overall Study|Disease Progression|6|||
13225684|NCT01777776|26295171|FG003|Overall Study|Disease Progression|3|||
13225685|NCT01777776|26295168|FG000|Overall Study|Withdrawal by Subject|0|||
13225686|NCT01777776|26295169|FG001|Overall Study|Withdrawal by Subject|0|||
13225687|NCT01777776|26295170|FG002|Overall Study|Withdrawal by Subject|0|||
13225688|NCT01777776|26295171|FG003|Overall Study|Withdrawal by Subject|1|||
13225689|NCT01777763|26295200|FG000|Overall Study|Adverse Event|2|||
13225690|NCT01777763|26295201|FG001|Overall Study|Adverse Event|32|||
13225691|NCT01777763|26295200|FG000|Overall Study|Protocol Violation|1|||
13225692|NCT01777763|26295201|FG001|Overall Study|Protocol Violation|7|||
13225693|NCT01777763|26295200|FG000|Overall Study|Withdrawal by Subject|0|||
13225694|NCT01777763|26295201|FG001|Overall Study|Withdrawal by Subject|2|||
13225695|NCT01777763|26295200|FG000|Overall Study|Treatment Failure|1|||
13225696|NCT01777763|26295201|FG001|Overall Study|Treatment Failure|6|||
13225697|NCT01777620|26295232|FG000|Overall Study|Subject Withdrawal|1|||
13225698|NCT01777620|26295233|FG001|Overall Study|Subject Withdrawal|0|||
13225699|NCT01777581|26295258|FG000|Overall Study|Lost to Follow-up|1|||
13225700|NCT01777581|26295259|FG001|Overall Study|Lost to Follow-up|1|||
13225701|NCT01777581|26295258|FG000|Overall Study|Adverse Event|2|||
13225702|NCT01777581|26295259|FG001|Overall Study|Adverse Event|0|||
13225703|NCT01777581|26295258|FG000|Overall Study|Lack of Efficacy|0|||
13225704|NCT01777581|26295259|FG001|Overall Study|Lack of Efficacy|1|||
13225705|NCT01777542|26295301|FG000|Second Intervention (20 Weeks)|Adverse Event|0|||
13225706|NCT01777542|26295302|FG001|Second Intervention (20 Weeks)|Adverse Event|1|||
13225707|NCT01777490|26295331|FG000|Overall Study|Dyad withdrew with data use prohibition|0|||
13225708|NCT01777490|26295332|FG001|Overall Study|Dyad withdrew with data use prohibition|0|||
13225709|NCT01777490|26295333|FG002|Overall Study|Dyad withdrew with data use prohibition|1|||
13225710|NCT01777490|26295334|FG003|Overall Study|Dyad withdrew with data use prohibition|1|||
13225711|NCT01777334|26295349|FG000|Overall Study|Adverse Event|18|||
13225712|NCT01777334|26295350|FG001|Overall Study|Adverse Event|14|||
13225713|NCT01777334|26295349|FG000|Overall Study|Lack of Efficacy|15|||
13225714|NCT01777334|26295350|FG001|Overall Study|Lack of Efficacy|29|||
13225715|NCT01777334|26295349|FG000|Overall Study|Protocol Violation|3|||
13225716|NCT01777334|26295350|FG001|Overall Study|Protocol Violation|7|||
13225717|NCT01777334|26295349|FG000|Overall Study|Lost to Follow-up|3|||
13225718|NCT01777334|26295350|FG001|Overall Study|Lost to Follow-up|2|||
13225719|NCT01777334|26295349|FG000|Overall Study|Withdrawal by Subject|14|||
13225720|NCT01777334|26295350|FG001|Overall Study|Withdrawal by Subject|11|||
13225721|NCT01777321|26295393|FG000|Overall Study|Withdrawal by Subject|0|||
13225722|NCT01777321|26295394|FG001|Overall Study|Withdrawal by Subject|1|||
13225723|NCT01777308|26295431|FG000|Overall Study|Withdrawal by Subject|5|||
13225724|NCT01777308|26295432|FG001|Overall Study|Withdrawal by Subject|1|||
13225725|NCT01777308|26295431|FG000|Overall Study|Migrated/moved from study area|1|||
13225726|NCT01777308|26295432|FG001|Overall Study|Migrated/moved from study area|0|||
13225727|NCT01777308|26295431|FG000|Overall Study|Lost to Follow-up|7|||
13225728|NCT01777308|26295432|FG001|Overall Study|Lost to Follow-up|2|||
13113728|NCT03131895|25912319|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
13225729|NCT01777308|26295431|FG000|Overall Study|Blood draw refusal at Visit 3|1|||
13225730|NCT01777308|26295432|FG001|Overall Study|Blood draw refusal at Visit 3|0|||
13225731|NCT01777282|26295490|FG000|Overall Study|Persistent Hyperglycemia|0|||
13225732|NCT01777282|26295491|FG001|Overall Study|Persistent Hyperglycemia|0|||
13225733|NCT01777282|26295492|FG002|Overall Study|Persistent Hyperglycemia|1|||
13225734|NCT01777282|26295493|FG003|Overall Study|Persistent Hyperglycemia|0|||
13225735|NCT01777282|26295494|FG004|Overall Study|Persistent Hyperglycemia|0|||
13225736|NCT01777282|26295490|FG000|Overall Study|New Antidiabetic Medication|0|||
13225737|NCT01777282|26295491|FG001|Overall Study|New Antidiabetic Medication|0|||
13113729|NCT03131895|25912320|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
13225738|NCT01777282|26295492|FG002|Overall Study|New Antidiabetic Medication|1|||
13225739|NCT01777282|26295493|FG003|Overall Study|New Antidiabetic Medication|0|||
13225740|NCT01777282|26295494|FG004|Overall Study|New Antidiabetic Medication|0|||
13225741|NCT01777282|26295490|FG000|Overall Study|Adverse Event|4|||
13225742|NCT01777282|26295491|FG001|Overall Study|Adverse Event|4|||
13225743|NCT01777282|26295492|FG002|Overall Study|Adverse Event|2|||
13225744|NCT01777282|26295493|FG003|Overall Study|Adverse Event|1|||
13225745|NCT01777282|26295494|FG004|Overall Study|Adverse Event|3|||
13225746|NCT01777282|26295490|FG000|Overall Study|Withdrawal by Subject|4|||
13225747|NCT01777282|26295491|FG001|Overall Study|Withdrawal by Subject|0|||
13225748|NCT01777282|26295492|FG002|Overall Study|Withdrawal by Subject|0|||
13225749|NCT01777282|26295493|FG003|Overall Study|Withdrawal by Subject|1|||
13225750|NCT01777282|26295494|FG004|Overall Study|Withdrawal by Subject|2|||
13225751|NCT01777282|26295490|FG000|Overall Study|Protocol Violation|2|||
13225752|NCT01777282|26295491|FG001|Overall Study|Protocol Violation|0|||
13225753|NCT01777282|26295492|FG002|Overall Study|Protocol Violation|1|||
13225754|NCT01777282|26295493|FG003|Overall Study|Protocol Violation|0|||
13225755|NCT01777282|26295494|FG004|Overall Study|Protocol Violation|2|||
13225756|NCT01777282|26295490|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1|||
13225757|NCT01777282|26295491|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0|||
13225758|NCT01777282|26295492|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1|||
13225759|NCT01777282|26295493|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0|||
13225760|NCT01777282|26295494|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0|||
13225761|NCT01777269|26295527|FG000|Overall Study|Adverse Event|24|||
13225762|NCT01777269|26295528|FG001|Overall Study|Adverse Event|33|||
13225763|NCT01777269|26295527|FG000|Overall Study|Lack of Efficacy|8|||
13225764|NCT01777269|26295528|FG001|Overall Study|Lack of Efficacy|10|||
13225765|NCT01777269|26295527|FG000|Overall Study|Protocol Violation|4|||
13225766|NCT01777269|26295528|FG001|Overall Study|Protocol Violation|4|||
13225767|NCT01777269|26295527|FG000|Overall Study|Participants reached stopping criteria|1|||
13225768|NCT01777269|26295528|FG001|Overall Study|Participants reached stopping criteria|1|||
13225769|NCT01777269|26295527|FG000|Overall Study|Lost to Follow-up|4|||
13225770|NCT01777269|26295528|FG001|Overall Study|Lost to Follow-up|0|||
13225771|NCT01777269|26295527|FG000|Overall Study|Physician Decision|5|||
13225772|NCT01777269|26295528|FG001|Overall Study|Physician Decision|2|||
13225773|NCT01777269|26295527|FG000|Overall Study|Withdrawal by Subject|9|||
13225774|NCT01777269|26295528|FG001|Overall Study|Withdrawal by Subject|9|||
13225775|NCT01777191|26295563|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2|||
13225776|NCT01777191|26295564|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1|||
13225777|NCT01777191|26295563|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
13225778|NCT01777191|26295564|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
13225779|NCT01777191|26295563|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1|||
13225780|NCT01777191|26295564|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2|||
13225781|NCT01777191|26295563|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0|||
13225782|NCT01777191|26295564|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3|||
13225783|NCT01777191|26295563|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
13225784|NCT01777191|26295564|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
13225785|NCT01777191|26295563|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1|||
13225786|NCT01777191|26295564|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0|||
13225787|NCT01777191|26295563|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
13225788|NCT01777191|26295564|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
13225789|NCT01777191|26295563|FG000|Safety Extension Per (Week 12-Week 48)|Death|0|||
13225790|NCT01777191|26295564|FG001|Safety Extension Per (Week 12-Week 48)|Death|1|||
13225791|NCT01777191|26295563|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
13225792|NCT01777191|26295564|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
13225793|NCT01777191|26295563|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1|||
13225794|NCT01777191|26295564|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2|||
13225795|NCT01777191|26295563|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1|||
13225796|NCT01777191|26295564|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3|||
13225797|NCT01777152|26295590|FG000|Overall Study|Withdrawal by Subject|22|||
13225798|NCT01777152|26295591|FG001|Overall Study|Withdrawal by Subject|16|||
13225799|NCT01777152|26295590|FG000|Overall Study|Lost to Follow-up|3|||
13225800|NCT01777152|26295591|FG001|Overall Study|Lost to Follow-up|5|||
13225801|NCT01777152|26295590|FG000|Overall Study|Death|68|||
13225802|NCT01777152|26295591|FG001|Overall Study|Death|89|||
13225803|NCT01777152|26295590|FG000|Overall Study|Not eligible, no study drug received|1|||
13225804|NCT01777152|26295591|FG001|Overall Study|Not eligible, no study drug received|0|||
13225805|NCT01777152|26295590|FG000|Overall Study|Change of diagnosis|1|||
13225806|NCT01777152|26295591|FG001|Overall Study|Change of diagnosis|0|||
13225807|NCT01777139|26295633|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7|||
13225808|NCT01777139|26295634|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0|||
13225809|NCT01777139|26295633|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6|||
13225810|NCT01777139|26295634|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0|||
13225811|NCT01777139|26295633|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8|||
13225812|NCT01777139|26295634|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0|||
13225813|NCT01777139|26295633|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3|||
13225814|NCT01777139|26295634|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0|||
13225815|NCT01777139|26295633|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2|||
13225816|NCT01777139|26295634|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0|||
13225817|NCT01777139|26295633|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4|||
13225818|NCT01777139|26295634|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0|||
13225819|NCT01777139|26295633|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0|||
13225820|NCT01777139|26295634|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1|||
13225821|NCT01777139|26295633|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0|||
13225822|NCT01777139|26295634|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3|||
13225823|NCT01776554|26295682|FG000|Overall Study|Adverse Event|1|||
13225824|NCT01776554|26295683|FG001|Overall Study|Adverse Event|0|||
13225825|NCT01776554|26295682|FG000|Overall Study|Withdrawal by Subject|3|||
13225826|NCT01776554|26295683|FG001|Overall Study|Withdrawal by Subject|8|||
13225827|NCT01776554|26295682|FG000|Overall Study|Lost to Follow-up|6|||
13225828|NCT01776554|26295683|FG001|Overall Study|Lost to Follow-up|9|||
13225829|NCT01776554|26295682|FG000|Overall Study|Administrative Reason|2|||
13225830|NCT01776554|26295683|FG001|Overall Study|Administrative Reason|5|||
13225831|NCT01776554|26295682|FG000|Overall Study|Protocol Violation|1|||
13225832|NCT01776554|26295683|FG001|Overall Study|Protocol Violation|0|||
13225833|NCT01776554|26295682|FG000|Overall Study|Unclassified|4|||
13225834|NCT01776554|26295683|FG001|Overall Study|Unclassified|1|||
13225835|NCT01776541|26295709|FG000|Overall Study|Administrative Reason|6|||
13225836|NCT01776541|26295710|FG001|Overall Study|Administrative Reason|2|||
13225837|NCT01776541|26295709|FG000|Overall Study|Death|4|||
13225838|NCT01776541|26295710|FG001|Overall Study|Death|0|||
13225839|NCT01776541|26295709|FG000|Overall Study|Lost to Follow-up|27|||
13225840|NCT01776541|26295710|FG001|Overall Study|Lost to Follow-up|48|||
13225841|NCT01776541|26295709|FG000|Overall Study|Unclassified|5|||
13225842|NCT01776541|26295710|FG001|Overall Study|Unclassified|4|||
13225843|NCT01776541|26295709|FG000|Overall Study|Protocol Violation|2|||
13225844|NCT01776541|26295710|FG001|Overall Study|Protocol Violation|1|||
13225845|NCT01776541|26295709|FG000|Overall Study|Withdrawal by Subject|12|||
13225846|NCT01776541|26295710|FG001|Overall Study|Withdrawal by Subject|20|||
13225847|NCT01776307|26295770|FG000|Overall Study|Not dosed|0|||
13225848|NCT01776307|26295771|FG001|Overall Study|Not dosed|0|||
13225849|NCT01776307|26295772|FG002|Overall Study|Not dosed|1|||
13225850|NCT01776008|26295786|FG000|Overall Study|ineligible|2|||
13225851|NCT01775995|26295853|FG000|Overall Study|Lost to Follow-up|1|||
13225852|NCT01775995|26295854|FG001|Overall Study|Lost to Follow-up|1|||
13289481|NCT00109837|26479349|FG000|Overall Study|BCR/ABL+ or Ph+|17|||
13289482|NCT00109837|26479349|FG000|Overall Study|Not treated|1|||
13289483|NCT00109837|26479349|FG000|Overall Study|Ineligible|1|||
13289484|NCT00109772|26479394|FG000|Double-blind Treatment|Adverse Event|14|||
13289485|NCT00109772|26479395|FG001|Double-blind Treatment|Adverse Event|5|||
13289486|NCT00109772|26479394|FG000|Double-blind Treatment|Lack of Efficacy|1|||
13289487|NCT00109772|26479395|FG001|Double-blind Treatment|Lack of Efficacy|0|||
13289488|NCT00109772|26479394|FG000|Double-blind Treatment|Withdrawal by Subject|2|||
13289489|NCT00109772|26479395|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
13289490|NCT00109772|26479394|FG000|Double-blind Treatment|Lost to Follow-up|2|||
13289491|NCT00109772|26479395|FG001|Double-blind Treatment|Lost to Follow-up|3|||
13289492|NCT00109772|26479394|FG000|Double-blind Treatment|Protocol Violation|0|||
13289493|NCT00109772|26479395|FG001|Double-blind Treatment|Protocol Violation|1|||
13289494|NCT00109772|26479394|FG000|Double-blind Treatment|Other|0|||
13289495|NCT00109772|26479395|FG001|Double-blind Treatment|Other|4|||
13289496|NCT00109772|26479394|FG000|Double-blind Treatment|Withdrew prior to treatment|3|||
13289497|NCT00109772|26479395|FG001|Double-blind Treatment|Withdrew prior to treatment|1|||
13289498|NCT00109772|26479394|FG000|Open-label Extension|Adverse Event|10|||
13289499|NCT00109772|26479395|FG001|Open-label Extension|Adverse Event|19|||
13289500|NCT00109772|26479394|FG000|Open-label Extension|Lack of Efficacy|19|||
13289501|NCT00109772|26479395|FG001|Open-label Extension|Lack of Efficacy|11|||
13225853|NCT01775930|26295864|FG000|Overall Study|Futility stopping boundary met|1|||
13225854|NCT01775904|26295888|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1|||
13225855|NCT01775904|26295888|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1|||
13225856|NCT01775787|26295899|FG000|First 7-10 Days|Adverse Event|0|||
13225857|NCT01775787|26295900|FG001|First 7-10 Days|Adverse Event|1|||
13225858|NCT01775787|26295899|FG000|First 7-10 Days|family emergency|0|||
13225859|NCT01775787|26295900|FG001|First 7-10 Days|family emergency|1|||
13225860|NCT01775787|26295899|FG000|First 7-10 Days|time commitment|0|||
13225861|NCT01775787|26295900|FG001|First 7-10 Days|time commitment|2|||
13225862|NCT01775787|26295899|FG000|First 7-10 Days|concerns with using IV|1|||
13225863|NCT01775787|26295900|FG001|First 7-10 Days|concerns with using IV|2|||
13225864|NCT01775787|26295899|FG000|Second 7-10 Days|time commitment|0|||
13225865|NCT01775787|26295900|FG001|Second 7-10 Days|time commitment|1|||
13225866|NCT01775787|26295899|FG000|Second 7-10 Days|concerns with using IV|0|||
13225867|NCT01775787|26295900|FG001|Second 7-10 Days|concerns with using IV|1|||
13225868|NCT01775670|26295933|FG000|Overall Study|Lost to Follow-up|1|||
13225869|NCT01775670|26295934|FG001|Overall Study|Lost to Follow-up|1|||
13225870|NCT01775553|26295944|FG000|Overall Study|Adverse Event|1|||
13225871|NCT01775553|26295944|FG000|Overall Study|Disease Progression|12|||
13225872|NCT01775501|26295955|FG000|Overall Study|Discontinued prior to treatment|1|||
13225873|NCT01775475|26295982|FG000|Overall Study|Death|3|||
13225874|NCT01775475|26295983|FG001|Overall Study|Death|3|||
13225875|NCT01775189|26296210|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
13225876|NCT01775189|26296211|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
13225877|NCT01775189|26296212|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
13225878|NCT01775189|26296213|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
13225879|NCT01775189|26296214|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
13225880|NCT01775189|26296215|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
13225881|NCT01775189|26296216|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
13225882|NCT01775189|26296210|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
13225883|NCT01775189|26296211|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1|||
13225884|NCT01775189|26296212|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
13225885|NCT01775189|26296213|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
13225886|NCT01775189|26296214|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
13225887|NCT01775189|26296215|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
13225888|NCT01775189|26296216|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
13225889|NCT01775189|26296210|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
13225890|NCT01775189|26296211|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2|||
13225891|NCT01775189|26296212|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7|||
13225892|NCT01775189|26296213|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
13225893|NCT01775189|26296214|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
13225894|NCT01775189|26296215|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
13225895|NCT01775189|26296216|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
13225896|NCT01775189|26296210|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0|||
13225897|NCT01775189|26296211|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0|||
13225898|NCT01775189|26296212|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0|||
13225899|NCT01775189|26296213|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0|||
13225900|NCT01775189|26296214|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0|||
13225901|NCT01775189|26296215|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1|||
13225902|NCT01775189|26296216|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0|||
13225903|NCT01775189|26296210|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0|||
13225904|NCT01775189|26296211|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0|||
13225905|NCT01775189|26296212|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0|||
13225906|NCT01775189|26296213|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1|||
13225907|NCT01775189|26296214|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0|||
13225908|NCT01775189|26296215|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0|||
13225909|NCT01775189|26296216|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0|||
13225910|NCT01775189|26296210|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0|||
13225911|NCT01775189|26296211|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0|||
13225912|NCT01775189|26296212|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0|||
13225913|NCT01775189|26296213|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1|||
13225914|NCT01775189|26296214|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0|||
13225915|NCT01775189|26296215|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0|||
13225916|NCT01775189|26296216|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1|||
13225917|NCT01775137|26296243|FG000|Overall Study|Death|1|||
13225918|NCT01775137|26296243|FG000|Overall Study|Protocol deviation|2|||
13225919|NCT01775137|26296243|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
13225920|NCT01775137|26296243|FG000|Overall Study|Adverse Event|1|||
13225921|NCT01775137|26296243|FG000|Overall Study|Withdrawal by participants|5|||
13225922|NCT01775124|26296277|FG000|Core Period|Disease Progression|0|||
13225923|NCT01775124|26296278|FG001|Core Period|Disease Progression|1|||
13225924|NCT01775124|26296277|FG000|Core Period|Physician Decision|1|||
13225925|NCT01775124|26296278|FG001|Core Period|Physician Decision|1|||
13225926|NCT01775124|26296277|FG000|Core Period|Death|0|||
13225927|NCT01775124|26296278|FG001|Core Period|Death|1|||
13225928|NCT01775124|26296277|FG000|Core Period|Administrative problems|1|||
13225929|NCT01775124|26296278|FG001|Core Period|Administrative problems|0|||
13225930|NCT01775124|26296277|FG000|Core Period|Withdrawal by Subject|4|||
13225931|NCT01775124|26296278|FG001|Core Period|Withdrawal by Subject|2|||
13225932|NCT01775124|26296277|FG000|Core Period|Adverse Event|5|||
13225933|NCT01775124|26296278|FG001|Core Period|Adverse Event|5|||
13225934|NCT01775124|26296277|FG000|Extension Period|Adverse Event|3|||
13225935|NCT01775124|26296278|FG001|Extension Period|Adverse Event|2|||
13225936|NCT01775124|26296277|FG000|Extension Period|Physician Decision|0|||
13225937|NCT01775124|26296278|FG001|Extension Period|Physician Decision|2|||
13225938|NCT01775124|26296277|FG000|Extension Period|Administrative problems|0|||
13225939|NCT01775124|26296278|FG001|Extension Period|Administrative problems|1|||
13225940|NCT01775124|26296277|FG000|Extension Period|Lost to Follow-up|0|||
13225941|NCT01775124|26296278|FG001|Extension Period|Lost to Follow-up|1|||
13225942|NCT01775124|26296277|FG000|Extension Period|Withdrawal by Subject|9|||
13225943|NCT01775124|26296278|FG001|Extension Period|Withdrawal by Subject|12|||
13225944|NCT01774981|26296333|FG000|Overall Study|Adverse Event|0|||
13225945|NCT01774981|26296334|FG001|Overall Study|Adverse Event|0|||
13225946|NCT01774981|26296335|FG002|Overall Study|Adverse Event|0|||
13225947|NCT01774981|26296336|FG003|Overall Study|Adverse Event|0|||
13225948|NCT01774981|26296337|FG004|Overall Study|Adverse Event|0|||
13225949|NCT01774981|26296338|FG005|Overall Study|Adverse Event|1|||
13225950|NCT01774981|26296339|FG006|Overall Study|Adverse Event|0|||
13225951|NCT01774981|26296340|FG007|Overall Study|Adverse Event|0|||
13225952|NCT01774981|26296333|FG000|Overall Study|Withdrawal by Subject|0|||
13225953|NCT01774981|26296334|FG001|Overall Study|Withdrawal by Subject|0|||
13225954|NCT01774981|26296335|FG002|Overall Study|Withdrawal by Subject|0|||
13225955|NCT01774981|26296336|FG003|Overall Study|Withdrawal by Subject|0|||
13225956|NCT01774981|26296337|FG004|Overall Study|Withdrawal by Subject|0|||
13225957|NCT01774981|26296338|FG005|Overall Study|Withdrawal by Subject|0|||
13225958|NCT01774981|26296339|FG006|Overall Study|Withdrawal by Subject|0|||
13225959|NCT01774981|26296340|FG007|Overall Study|Withdrawal by Subject|1|||
13225960|NCT01774981|26296333|FG000|Overall Study|Death|0|||
13225961|NCT01774981|26296334|FG001|Overall Study|Death|0|||
13225962|NCT01774981|26296335|FG002|Overall Study|Death|0|||
13225963|NCT01774981|26296336|FG003|Overall Study|Death|0|||
13225964|NCT01774981|26296337|FG004|Overall Study|Death|1|||
13225965|NCT01774981|26296338|FG005|Overall Study|Death|0|||
13225966|NCT01774981|26296339|FG006|Overall Study|Death|0|||
13225967|NCT01774981|26296340|FG007|Overall Study|Death|0|||
13225968|NCT01774968|26296381|FG000|Overall Study|Adverse Event|4|||
13225969|NCT01774968|26296382|FG001|Overall Study|Adverse Event|4|||
13225970|NCT01774968|26296381|FG000|Overall Study|Death|0|||
13225971|NCT01774968|26296382|FG001|Overall Study|Death|1|||
13225972|NCT01774968|26296381|FG000|Overall Study|Lost to Follow-up|1|||
13225973|NCT01774968|26296382|FG001|Overall Study|Lost to Follow-up|3|||
13225974|NCT01774968|26296381|FG000|Overall Study|Physician Decision|5|||
13225975|NCT01774968|26296382|FG001|Overall Study|Physician Decision|1|||
13225976|NCT01774968|26296381|FG000|Overall Study|Protocol Violation|14|||
13225977|NCT01774968|26296382|FG001|Overall Study|Protocol Violation|13|||
13225978|NCT01774968|26296381|FG000|Overall Study|Sponsor Decision|0|||
13225979|NCT01774968|26296382|FG001|Overall Study|Sponsor Decision|2|||
13225980|NCT01774968|26296381|FG000|Overall Study|Withdrawal by Subject|6|||
13225981|NCT01774968|26296382|FG001|Overall Study|Withdrawal by Subject|11|||
13225982|NCT01774929|26296390|FG000|Overall Study|Adverse Event|3|||
13225983|NCT01774903|26296399|FG000|Overall Study|Adverse Event|7|||
13485647|NCT01126749|27033003|FG003|Phase 2|Other|2|||
13225984|NCT01774903|26296399|FG000|Overall Study|Withdrawal by Subject|2|||
13225985|NCT01774903|26296399|FG000|Overall Study|Lack of Efficacy|1|||
13225986|NCT01774903|26296399|FG000|Overall Study|Ineligible to continue the trial|1|||
13225987|NCT01774799|26296426|FG000|Overall Study|Lost to Follow-up|1|||
13225988|NCT01774799|26296427|FG001|Overall Study|Lost to Follow-up|1|||
13225989|NCT01774799|26296428|FG002|Overall Study|Lost to Follow-up|0|||
13225990|NCT01774799|26296429|FG003|Overall Study|Lost to Follow-up|0|||
13225991|NCT01774786|26296466|FG000|Overall Study|Death|300|||
13225992|NCT01774786|26296467|FG001|Overall Study|Death|319|||
13225993|NCT01774786|26296466|FG000|Overall Study|Lost to Follow-up|6|||
13225994|NCT01774786|26296467|FG001|Overall Study|Lost to Follow-up|7|||
13225995|NCT01774786|26296466|FG000|Overall Study|Withdrawal by Subject|18|||
13225996|NCT01774786|26296467|FG001|Overall Study|Withdrawal by Subject|14|||
13225997|NCT01774786|26296466|FG000|Overall Study|Physician Decision|2|||
13225998|NCT01774786|26296467|FG001|Overall Study|Physician Decision|0|||
13225999|NCT01774786|26296466|FG000|Overall Study|Non-compliance|0|||
13226000|NCT01774786|26296467|FG001|Overall Study|Non-compliance|1|||
13226001|NCT01774786|26296466|FG000|Overall Study|Reason Not Specified|2|||
13485648|NCT01126749|27033000|FG000|Phase 2|Withdrawal by Subject|0|||
13226002|NCT01774786|26296467|FG001|Overall Study|Reason Not Specified|5|||
13226003|NCT01774591|26296484|FG000|Overall Study|Physician Decision|1|||
13226004|NCT01774591|26296485|FG001|Overall Study|Physician Decision|1|||
13226005|NCT01774591|26296484|FG000|Overall Study|Withdrawal by Subject|0|||
13226006|NCT01774591|26296485|FG001|Overall Study|Withdrawal by Subject|1|||
13226007|NCT01774591|26296484|FG000|Overall Study|Adverse Event|0|||
13226008|NCT01774591|26296485|FG001|Overall Study|Adverse Event|2|||
13226009|NCT01774344|26296508|FG000|Overall Study|Withdrawal by Subject|3|||
13226010|NCT01774344|26296509|FG001|Overall Study|Withdrawal by Subject|10|||
13226011|NCT01774344|26296508|FG000|Overall Study|Protocol Violation|0|||
13226012|NCT01774344|26296509|FG001|Overall Study|Protocol Violation|1|||
13226013|NCT01774344|26296508|FG000|Overall Study|Lost to Follow-up|4|||
13226014|NCT01774344|26296509|FG001|Overall Study|Lost to Follow-up|10|||
13226015|NCT01774344|26296508|FG000|Overall Study|End of survival follow-up not available|2|||
13226016|NCT01774344|26296509|FG001|Overall Study|End of survival follow-up not available|2|||
13226017|NCT01774344|26296508|FG000|Overall Study|Data collection finished|4|||
13226018|NCT01774344|26296509|FG001|Overall Study|Data collection finished|14|||
13226019|NCT01774344|26296508|FG000|Overall Study|Other|0|||
13226020|NCT01774344|26296509|FG001|Overall Study|Other|1|||
13226021|NCT01774344|26296508|FG000|Overall Study|Did not enter Survival Follow up|49|||
13226022|NCT01774344|26296509|FG001|Overall Study|Did not enter Survival Follow up|83|||
13226023|NCT01774305|26296524|FG000|Overall Study|Physician Decision|1|||
13226024|NCT01774305|26296525|FG001|Overall Study|Physician Decision|0|||
13226025|NCT01774253|26296535|FG000|Overall Study|Lack of Efficacy|4|||
13226026|NCT01774253|26296535|FG000|Overall Study|Physician Decision|2|||
13226027|NCT01774253|26296535|FG000|Overall Study|Withdrawal by Subject|2|||
13226028|NCT01774253|26296535|FG000|Overall Study|Death|1|||
13226029|NCT01774110|26296543|FG000|Overall Study|Lost to Follow-up|7|||
13226030|NCT01774097|26296578|FG000|Overall Study|Withdrawal by Subject|1|||
13226031|NCT01774097|26296579|FG001|Overall Study|Withdrawal by Subject|1|||
13226032|NCT01774097|26296578|FG000|Overall Study|Adverse Event|1|||
13226033|NCT01774097|26296579|FG001|Overall Study|Adverse Event|1|||
13226034|NCT01774084|26296594|FG000|Overall Study|Personal reasons|1|||
13226035|NCT01774084|26296595|FG001|Overall Study|Personal reasons|0|||
13226036|NCT01773993|26296614|FG000|Overall Study|No Visit After Treatment|35|||
13226037|NCT01773967|26296631|FG000|Overall Study|Lost to Follow-up|15|||
13226038|NCT01773967|26296632|FG001|Overall Study|Lost to Follow-up|13|||
13226039|NCT01773889|26296638|FG000|Overall Study|lack of funding|2|||
13226040|NCT01773473|26296663|FG000|Overall Study|Adverse Event|3|||
13226041|NCT01773473|26296664|FG001|Overall Study|Adverse Event|2|||
13226042|NCT01773473|26296663|FG000|Overall Study|Protocol Violation|0|||
13226043|NCT01773473|26296664|FG001|Overall Study|Protocol Violation|4|||
13226044|NCT01773473|26296663|FG000|Overall Study|Physician Decision|3|||
13226045|NCT01773473|26296664|FG001|Overall Study|Physician Decision|5|||
13226046|NCT01773473|26296663|FG000|Overall Study|Sponsor Decision|2|||
13226047|NCT01773473|26296664|FG001|Overall Study|Sponsor Decision|0|||
13226048|NCT01773473|26296663|FG000|Overall Study|Lack of Efficacy|0|||
13226049|NCT01773473|26296664|FG001|Overall Study|Lack of Efficacy|1|||
13226050|NCT01773473|26296663|FG000|Overall Study|Non-Compliance with study drug|1|||
13226051|NCT01773473|26296664|FG001|Overall Study|Non-Compliance with study drug|4|||
13226052|NCT01773473|26296663|FG000|Overall Study|Withdrawal by Subject|5|||
13226053|NCT01773473|26296664|FG001|Overall Study|Withdrawal by Subject|3|||
13226054|NCT01773473|26296663|FG000|Overall Study|Lost to Follow-up|2|||
13226055|NCT01773473|26296664|FG001|Overall Study|Lost to Follow-up|0|||
13226056|NCT01773421|26296708|FG000|Treatment Phase|Other|0|||
13226057|NCT01773421|26296709|FG001|Treatment Phase|Other|0|||
13226058|NCT01773421|26296710|FG002|Treatment Phase|Other|2|||
13226059|NCT01773421|26296711|FG003|Treatment Phase|Other|0|||
13226060|NCT01773421|26296712|FG004|Treatment Phase|Other|0|||
13226061|NCT01773421|26296713|FG005|Treatment Phase|Other|0|||
13226062|NCT01773421|26296714|FG006|Treatment Phase|Other|0|||
13226063|NCT01773421|26296708|FG000|Treatment Phase|Adverse Event|0|||
13226064|NCT01773421|26296709|FG001|Treatment Phase|Adverse Event|0|||
13226065|NCT01773421|26296710|FG002|Treatment Phase|Adverse Event|3|||
13226066|NCT01773421|26296711|FG003|Treatment Phase|Adverse Event|1|||
13226067|NCT01773421|26296712|FG004|Treatment Phase|Adverse Event|0|||
13226068|NCT01773421|26296713|FG005|Treatment Phase|Adverse Event|0|||
13226069|NCT01773421|26296714|FG006|Treatment Phase|Adverse Event|0|||
13226070|NCT01773421|26296708|FG000|Treatment Phase|Withdrawal by Subject|0|||
13226071|NCT01773421|26296709|FG001|Treatment Phase|Withdrawal by Subject|0|||
13226072|NCT01773421|26296710|FG002|Treatment Phase|Withdrawal by Subject|1|||
13226073|NCT01773421|26296711|FG003|Treatment Phase|Withdrawal by Subject|1|||
13226074|NCT01773421|26296712|FG004|Treatment Phase|Withdrawal by Subject|0|||
13226075|NCT01773421|26296713|FG005|Treatment Phase|Withdrawal by Subject|0|||
13226076|NCT01773421|26296714|FG006|Treatment Phase|Withdrawal by Subject|0|||
13226077|NCT01773421|26296708|FG000|Extension Phase|Other|0|||
13226078|NCT01773421|26296709|FG001|Extension Phase|Other|0|||
13226079|NCT01773421|26296710|FG002|Extension Phase|Other|0|||
13226080|NCT01773421|26296711|FG003|Extension Phase|Other|0|||
13226081|NCT01773421|26296712|FG004|Extension Phase|Other|1|||
13226082|NCT01773421|26296713|FG005|Extension Phase|Other|2|||
13226083|NCT01773421|26296714|FG006|Extension Phase|Other|0|||
13226084|NCT01773421|26296708|FG000|Extension Phase|Adverse Event|0|||
13226085|NCT01773421|26296709|FG001|Extension Phase|Adverse Event|0|||
13226086|NCT01773421|26296710|FG002|Extension Phase|Adverse Event|0|||
13226087|NCT01773421|26296711|FG003|Extension Phase|Adverse Event|0|||
13226088|NCT01773421|26296712|FG004|Extension Phase|Adverse Event|2|||
13226089|NCT01773421|26296713|FG005|Extension Phase|Adverse Event|0|||
13226090|NCT01773421|26296714|FG006|Extension Phase|Adverse Event|0|||
13226091|NCT01773291|26296735|FG000|Overall Study|Protocol Violation|1|||
13226092|NCT01773291|26296736|FG001|Overall Study|Protocol Violation|0|||
13226093|NCT01773291|26296737|FG002|Overall Study|Protocol Violation|0|||
13226094|NCT01773291|26296735|FG000|Overall Study|Withdrawal by Subject|0|||
13226095|NCT01773291|26296736|FG001|Overall Study|Withdrawal by Subject|0|||
13226096|NCT01773291|26296737|FG002|Overall Study|Withdrawal by Subject|1|||
13226097|NCT01773226|26296747|FG000|Overall Study|Withdrawal by Subject|1|||
13226098|NCT01773122|26296774|FG000|Overall Study|Due to amended age eligibility criteria|3|||
13226099|NCT01773122|26296775|FG001|Overall Study|Due to amended age eligibility criteria|1|||
13226100|NCT01773122|26296776|FG002|Overall Study|Due to amended age eligibility criteria|0|||
13226101|NCT01773122|26296777|FG003|Overall Study|Due to amended age eligibility criteria|1|||
13226102|NCT01773109|26296783|FG000|Overall Study|Symptomatic Progression|2|||
13226103|NCT01773109|26296783|FG000|Overall Study|Death|1|||
13226104|NCT01773070|26296793|FG000|Overall Study|Withdrawal by Subject|24|||
13226105|NCT01773070|26296793|FG000|Overall Study|Lost to Follow-up|39|||
13226106|NCT01773070|26296793|FG000|Overall Study|Other|15|||
13226107|NCT01773070|26296793|FG000|Overall Study|Death (unrelated to study procedures)|3|||
13226108|NCT01772823|26296896|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1|||
13226109|NCT01772823|26296897|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0|||
13226110|NCT01772823|26296896|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
13226111|NCT01772823|26296897|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
13226112|NCT01772823|26296896|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1|||
13226113|NCT01772823|26296897|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0|||
13226114|NCT01772823|26296896|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2|||
13226115|NCT01772823|26296897|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1|||
13226116|NCT01772823|26296896|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6|||
13226117|NCT01772823|26296897|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0|||
13226118|NCT01772823|26296896|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1|||
13226119|NCT01772823|26296897|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0|||
13226120|NCT01772823|26296896|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15|||
13226121|NCT01772823|26296897|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13|||
13226122|NCT01772823|26296896|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6|||
13226123|NCT01772823|26296897|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1|||
13226124|NCT01772823|26296896|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4|||
13226125|NCT01772823|26296897|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3|||
13226126|NCT01772823|26296896|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1|||
13226127|NCT01772823|26296897|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0|||
13226128|NCT01772823|26296896|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1|||
13226129|NCT01772823|26296897|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0|||
13226130|NCT01772823|26296896|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
13226131|NCT01772823|26296897|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
13226132|NCT01772823|26296896|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6|||
13226133|NCT01772823|26296897|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5|||
13226134|NCT01772823|26296896|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1|||
13226135|NCT01772823|26296897|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2|||
13226136|NCT01772823|26296896|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
13226137|NCT01772823|26296897|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
13226138|NCT01772823|26296896|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1|||
13226139|NCT01772823|26296897|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0|||
13226140|NCT01772719|26296910|FG000|Overall Study|Withdrawal by Subject|3|||
13226141|NCT01772719|26296910|FG000|Overall Study|Adverse Event|2|||
13226142|NCT01772719|26296910|FG000|Overall Study|Protocol Violation|1|||
13226143|NCT01772719|26296910|FG000|Overall Study|Lost to Follow-up|1|||
13226144|NCT01772693|26296929|FG000|Overall Study|Health Concerns Unrelated to Study|2|||
13226145|NCT01772693|26296930|FG001|Overall Study|Health Concerns Unrelated to Study|1|||
13226146|NCT01772693|26296929|FG000|Overall Study|Withdrawal by Subject|2|||
13226147|NCT01772693|26296930|FG001|Overall Study|Withdrawal by Subject|0|||
13226148|NCT01772693|26296929|FG000|Overall Study|Alternative Treatment|2|||
13226149|NCT01772693|26296930|FG001|Overall Study|Alternative Treatment|0|||
13226150|NCT01772576|26296941|FG000|Overall Study|Death|15|||
13226151|NCT01772576|26296941|FG000|Overall Study|Protocol Violation|1|||
13226152|NCT01772576|26296941|FG000|Overall Study|Lost to Follow-up|3|||
13226153|NCT01772576|26296941|FG000|Overall Study|Study device not used|3|||
13226154|NCT01772576|26296941|FG000|Overall Study|Adverse Event|6|||
13226155|NCT01772576|26296941|FG000|Overall Study|Withdrawal by Subject|6|||
13226156|NCT01772550|26296989|FG000|Overall Study|Unable to insert IV in antecubital vein|1|||
13226157|NCT01772550|26296990|FG001|Overall Study|Unable to insert IV in antecubital vein|1|||
13226158|NCT01772550|26296991|FG002|Overall Study|Unable to insert IV in antecubital vein|5|||
13226159|NCT01772550|26296989|FG000|Overall Study|Adverse Event|0|||
13226160|NCT01772550|26296990|FG001|Overall Study|Adverse Event|0|||
13226161|NCT01772550|26296991|FG002|Overall Study|Adverse Event|1|||
13226162|NCT01772537|26297015|FG000|Overall Study|unsuccessful lumbar drain placement|1|||
13226163|NCT01772537|26297016|FG001|Overall Study|unsuccessful lumbar drain placement|0|||
13226164|NCT01772537|26297017|FG002|Overall Study|unsuccessful lumbar drain placement|0|||
13226165|NCT01772368|26297065|FG000|Overall Study|Adverse Event|1|||
13226166|NCT01772368|26297065|FG000|Overall Study|Withdrawal by Subject|3|||
13226167|NCT01772368|26297065|FG000|Overall Study|Protocol Violation|2|||
13226168|NCT01772368|26297065|FG000|Overall Study|Other|1|||
13226169|NCT01772316|26297085|FG000|Overall Study|Serious adverse event|1|||
13226170|NCT01772316|26297085|FG000|Overall Study|Inform consent withdrawn|1|||
13226171|NCT01772316|26297085|FG000|Overall Study|Withdrawn by sponsor decision|5|||
13226172|NCT01772160|26297107|FG000|Overall Study|Death|3|||
13226173|NCT01772160|26297107|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
13226174|NCT01772160|26297107|FG000|Overall Study|Consent withdrawal|3|||
13226175|NCT01772160|26297107|FG000|Overall Study|Migrated / moved from the study area|4|||
13226176|NCT01772160|26297107|FG000|Overall Study|Lost to Follow-up|30|||
13226177|NCT01772160|26297107|FG000|Overall Study|Other|5|||
13226178|NCT01772147|26297134|FG000|Overall Study|Adverse Event|13|||
13226179|NCT01772147|26297135|FG001|Overall Study|Adverse Event|10|||
13226180|NCT01772147|26297136|FG002|Overall Study|Adverse Event|6|||
13226181|NCT01772147|26297134|FG000|Overall Study|Withdrew Consent|7|||
13226182|NCT01772147|26297135|FG001|Overall Study|Withdrew Consent|8|||
13226183|NCT01772147|26297136|FG002|Overall Study|Withdrew Consent|4|||
13226184|NCT01772147|26297134|FG000|Overall Study|Lost to Follow-up|1|||
13226185|NCT01772147|26297135|FG001|Overall Study|Lost to Follow-up|0|||
13226186|NCT01772147|26297136|FG002|Overall Study|Lost to Follow-up|1|||
13226187|NCT01772147|26297134|FG000|Overall Study|Protocol Deviation|2|||
13226188|NCT01772147|26297135|FG001|Overall Study|Protocol Deviation|1|||
13226189|NCT01772147|26297136|FG002|Overall Study|Protocol Deviation|1|||
13226190|NCT01772147|26297134|FG000|Overall Study|Lack of Efficacy|8|||
13226191|NCT01772147|26297135|FG001|Overall Study|Lack of Efficacy|6|||
13226192|NCT01772147|26297136|FG002|Overall Study|Lack of Efficacy|6|||
13226193|NCT01772134|26297163|FG000|Overall Study|Adverse Event|6|||
13226194|NCT01772134|26297164|FG001|Overall Study|Adverse Event|5|||
13226195|NCT01772134|26297165|FG002|Overall Study|Adverse Event|10|||
13226196|NCT01772134|26297163|FG000|Overall Study|Withdrew Consent|3|||
13226197|NCT01772134|26297164|FG001|Overall Study|Withdrew Consent|1|||
13226198|NCT01772134|26297165|FG002|Overall Study|Withdrew Consent|5|||
13226199|NCT01772134|26297163|FG000|Overall Study|Lost to Follow-up|2|||
13226200|NCT01772134|26297164|FG001|Overall Study|Lost to Follow-up|0|||
13226201|NCT01772134|26297165|FG002|Overall Study|Lost to Follow-up|0|||
13226202|NCT01772134|26297163|FG000|Overall Study|Protocol Deviation|4|||
13226203|NCT01772134|26297164|FG001|Overall Study|Protocol Deviation|3|||
13226204|NCT01772134|26297165|FG002|Overall Study|Protocol Deviation|3|||
13226205|NCT01772134|26297163|FG000|Overall Study|Lack of Efficacy|11|||
13226206|NCT01772134|26297164|FG001|Overall Study|Lack of Efficacy|5|||
13226207|NCT01772134|26297165|FG002|Overall Study|Lack of Efficacy|3|||
13226208|NCT01772134|26297163|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
13226209|NCT01772134|26297164|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
13226210|NCT01772134|26297165|FG002|Overall Study|Protocol-defined Stopping Criteria|0|||
13226211|NCT01772134|26297163|FG000|Overall Study|Randomized Study Medication Not Received|2|||
13226212|NCT01772134|26297164|FG001|Overall Study|Randomized Study Medication Not Received|0|||
13226213|NCT01772134|26297165|FG002|Overall Study|Randomized Study Medication Not Received|1|||
13226214|NCT01771913|26297182|FG000|Overall Study|Withdrawal by Subject|1|||
13226215|NCT01771913|26297183|FG001|Overall Study|Withdrawal by Subject|0|||
13226216|NCT01771809|26297204|FG000|Overall Study|Adverse Event|4|||
13226217|NCT01771809|26297205|FG001|Overall Study|Adverse Event|12|||
13226218|NCT01771809|26297204|FG000|Overall Study|Protocol Violation|0|||
13226219|NCT01771809|26297205|FG001|Overall Study|Protocol Violation|1|||
13226220|NCT01771809|26297204|FG000|Overall Study|Withdrawal by Subject|34|||
13226221|NCT01771809|26297205|FG001|Overall Study|Withdrawal by Subject|42|||
13226222|NCT01771809|26297204|FG000|Overall Study|Lost to Follow-up|1|||
13226223|NCT01771809|26297205|FG001|Overall Study|Lost to Follow-up|3|||
13226224|NCT01771809|26297204|FG000|Overall Study|Other (Insufficient clinical response)|22|||
13226225|NCT01771809|26297205|FG001|Overall Study|Other (Insufficient clinical response)|20|||
13226226|NCT01771809|26297204|FG000|Overall Study|Death|1|||
13226227|NCT01771809|26297205|FG001|Overall Study|Death|0|||
13226228|NCT01771809|26297204|FG000|Overall Study|Other (other)|9|||
13226229|NCT01771809|26297205|FG001|Overall Study|Other (other)|5|||
13226230|NCT01771731|26297218|FG000|Overall Study|Physician Decision|1|||
13226231|NCT01771731|26297219|FG001|Overall Study|Physician Decision|0|||
13226232|NCT01771731|26297218|FG000|Overall Study|Protocol Violation|0|||
13226233|NCT01771731|26297219|FG001|Overall Study|Protocol Violation|1|||
13226234|NCT01771731|26297218|FG000|Overall Study|Adverse event: Pain Crisis|1|||
13226235|NCT01771731|26297219|FG001|Overall Study|Adverse event: Pain Crisis|1|||
13226236|NCT01771250|26297234|FG000|Period 1|Met exclusion criteria|1|||
13226237|NCT01771250|26297235|FG001|Period 1|Met exclusion criteria|0|||
13226238|NCT01770912|26297276|FG000|Overall Study|Lost to Follow-up|2|||
13226239|NCT01770912|26297277|FG001|Overall Study|Lost to Follow-up|0|||
13226240|NCT01770860|26297322|FG000|Overall Study|Withdrawal by Subject|4|||
13226241|NCT01770860|26297322|FG000|Overall Study|Lost to Follow-up|1|||
13226242|NCT01770860|26297322|FG000|Overall Study|Administrative decision made by the PI|1|||
13226243|NCT01770743|26297390|FG000|Overall Study|Adverse Event|1|||
13226244|NCT01770743|26297391|FG001|Overall Study|Adverse Event|0|||
13226245|NCT01770743|26297392|FG002|Overall Study|Adverse Event|0|||
13226246|NCT01770743|26297393|FG003|Overall Study|Adverse Event|0|||
13226247|NCT01770743|26297394|FG004|Overall Study|Adverse Event|0|||
13226248|NCT01770743|26297390|FG000|Overall Study|Withdrawal by Subject|0|||
13226249|NCT01770743|26297391|FG001|Overall Study|Withdrawal by Subject|0|||
13226250|NCT01770743|26297392|FG002|Overall Study|Withdrawal by Subject|1|||
13226251|NCT01770743|26297393|FG003|Overall Study|Withdrawal by Subject|1|||
13226252|NCT01770743|26297394|FG004|Overall Study|Withdrawal by Subject|1|||
13226253|NCT01770743|26297390|FG000|Overall Study|Lost to Follow-up|0|||
13226254|NCT01770743|26297391|FG001|Overall Study|Lost to Follow-up|2|||
13226255|NCT01770743|26297392|FG002|Overall Study|Lost to Follow-up|0|||
13226256|NCT01770743|26297393|FG003|Overall Study|Lost to Follow-up|0|||
13226257|NCT01770743|26297394|FG004|Overall Study|Lost to Follow-up|1|||
13226258|NCT01770743|26297390|FG000|Overall Study|Sponsor Terminated Subject|1|||
13226259|NCT01770743|26297391|FG001|Overall Study|Sponsor Terminated Subject|0|||
13226260|NCT01770743|26297392|FG002|Overall Study|Sponsor Terminated Subject|0|||
13226261|NCT01770743|26297393|FG003|Overall Study|Sponsor Terminated Subject|1|||
13226262|NCT01770743|26297394|FG004|Overall Study|Sponsor Terminated Subject|0|||
13226263|NCT01770743|26297390|FG000|Overall Study|Moving Out of State|0|||
13226264|NCT01770743|26297391|FG001|Overall Study|Moving Out of State|1|||
13226265|NCT01770743|26297392|FG002|Overall Study|Moving Out of State|0|||
13226266|NCT01770743|26297393|FG003|Overall Study|Moving Out of State|0|||
13226267|NCT01770743|26297394|FG004|Overall Study|Moving Out of State|0|||
13226268|NCT01770509|26297415|FG000|Overall Study|Injury|0|||
13226269|NCT01770509|26297416|FG001|Overall Study|Injury|1|||
13226270|NCT01770509|26297415|FG000|Overall Study|Lost to Follow-up|1|||
13226271|NCT01770509|26297416|FG001|Overall Study|Lost to Follow-up|2|||
13226272|NCT01770392|26297430|FG000|Washout Period of at Least 14 Days|Adverse Event|1|||
13226273|NCT01770379|26297457|FG000|Overall Study|Technical issues|1|||
13226274|NCT01770379|26297458|FG001|Overall Study|Technical issues|0|||
13226275|NCT01770379|26297459|FG002|Overall Study|Technical issues|0|||
13226276|NCT01770379|26297457|FG000|Overall Study|Withdrawal by Subject|7|||
13226277|NCT01770379|26297458|FG001|Overall Study|Withdrawal by Subject|10|||
13226278|NCT01770379|26297459|FG002|Overall Study|Withdrawal by Subject|7|||
13226279|NCT01770379|26297457|FG000|Overall Study|study terminated by sponsor|22|||
13226280|NCT01770379|26297458|FG001|Overall Study|study terminated by sponsor|23|||
13226281|NCT01770379|26297459|FG002|Overall Study|study terminated by sponsor|22|||
13226282|NCT01770379|26297457|FG000|Overall Study|Protocol Violation|0|||
13226283|NCT01770379|26297458|FG001|Overall Study|Protocol Violation|1|||
13226284|NCT01770379|26297459|FG002|Overall Study|Protocol Violation|1|||
13226285|NCT01770379|26297457|FG000|Overall Study|Physician Decision|0|||
13226286|NCT01770379|26297458|FG001|Overall Study|Physician Decision|1|||
13226287|NCT01770379|26297459|FG002|Overall Study|Physician Decision|2|||
13226288|NCT01770379|26297457|FG000|Overall Study|Lost to Follow-up|0|||
13226289|NCT01770379|26297458|FG001|Overall Study|Lost to Follow-up|0|||
13226290|NCT01770379|26297459|FG002|Overall Study|Lost to Follow-up|2|||
13226291|NCT01770379|26297457|FG000|Overall Study|Lack of Efficacy|8|||
13226292|NCT01770379|26297458|FG001|Overall Study|Lack of Efficacy|6|||
13226293|NCT01770379|26297459|FG002|Overall Study|Lack of Efficacy|6|||
13226294|NCT01770379|26297457|FG000|Overall Study|Adverse Event|1|||
13226295|NCT01770379|26297458|FG001|Overall Study|Adverse Event|3|||
13226296|NCT01770379|26297459|FG002|Overall Study|Adverse Event|2|||
13226297|NCT01770353|26297514|FG000|Overall Study|Progressive disease|2|||
13226298|NCT01770353|26297515|FG001|Overall Study|Progressive disease|1|||
13226299|NCT01770353|26297514|FG000|Overall Study|Adverse Event|0|||
13226300|NCT01770353|26297515|FG001|Overall Study|Adverse Event|1|||
13226301|NCT01770353|26297514|FG000|Overall Study|Protocol Violation|1|||
13226302|NCT01770353|26297515|FG001|Overall Study|Protocol Violation|0|||
13226303|NCT01770353|26297514|FG000|Overall Study|Physician Decision|0|||
13226304|NCT01770353|26297515|FG001|Overall Study|Physician Decision|3|||
13226305|NCT01770353|26297514|FG000|Overall Study|Clinical deterioration|3|||
13226306|NCT01770353|26297515|FG001|Overall Study|Clinical deterioration|6|||
13226307|NCT01770353|26297514|FG000|Overall Study|Toxicity related diarrhoea + progression|0|||
13226308|NCT01770353|26297515|FG001|Overall Study|Toxicity related diarrhoea + progression|1|||
13226309|NCT01770145|26297522|FG000|Baseline|Adverse Event|20|||
13226310|NCT01770145|26297522|FG000|Baseline|Withdrawal by Subject|1|||
13226311|NCT01770145|26297522|FG000|Baseline|Lost to Follow-up|1|||
13226312|NCT01770145|26297522|FG000|Baseline|Unable to define optimal dose|4|||
13226313|NCT01770145|26297522|FG000|Treatment|Adverse Event|3|||
13226314|NCT01770145|26297522|FG000|Treatment|Withdrawal by Subject|1|||
13226315|NCT01769508|26297533|FG000|Overall Study|Death|3|||
13226316|NCT01769508|26297533|FG000|Overall Study|Withdrawal by Subject|1|||
13226317|NCT01769508|26297533|FG000|Overall Study|Adverse Event|1|||
13226318|NCT01769508|26297533|FG000|Overall Study|Lost to Follow-up|1|||
13226319|NCT01769469|26297695|FG000|Overall Study|Consent Withdrawn|5|||
13226320|NCT01769469|26297695|FG000|Overall Study|Moved Out Of Area|3|||
13226321|NCT01769469|26297695|FG000|Overall Study|Lost to Follow-up|17|||
13226322|NCT01769469|26297695|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7|||
13226323|NCT01769469|26297695|FG000|Overall Study|Subject Confirmed HIV Positive|3|||
13226324|NCT01769456|26297716|FG000|Overall Study|Lost to Follow-up|19|||
13226325|NCT01769456|26297716|FG000|Overall Study|Withdrawal by Subject|3|||
13226326|NCT01769456|26297716|FG000|Overall Study|Did not receive PCC intervention|6|||
13226327|NCT01769456|26297716|FG000|Overall Study|Moved out of the area|3|||
13226328|NCT01769456|26297716|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5|||
13226329|NCT01769456|26297716|FG000|Overall Study|Parental request to youth to withdraw|1|||
13226330|NCT01769443|26297765|FG000|Overall Study|Study closure|1|||
13226331|NCT01769443|26297766|FG001|Overall Study|Study closure|0|||
13226332|NCT01769404|26297789|FG000|Treatment Period 1|Did not meet eligibility criteria|1|||
13226333|NCT01769404|26297790|FG001|Treatment Period 1|Did not meet eligibility criteria|0|||
13226334|NCT01769404|26297789|FG000|Treatment Period 1|Withdrawal by Subject|3|||
13226335|NCT01769404|26297790|FG001|Treatment Period 1|Withdrawal by Subject|0|||
13226336|NCT01769404|26297789|FG000|Treatment Period 1|Sponsor decision|1|||
13226337|NCT01769404|26297790|FG001|Treatment Period 1|Sponsor decision|0|||
13226338|NCT01769404|26297789|FG000|Treatment Period 2|Sponsor decision|7|||
13226339|NCT01769404|26297790|FG001|Treatment Period 2|Sponsor decision|0|||
13226340|NCT01769391|26297814|FG000|Overall Study|Death|10|||
13226341|NCT01769391|26297815|FG001|Overall Study|Death|1|||
13226342|NCT01769391|26297814|FG000|Overall Study|Adverse Event|0|||
13226343|NCT01769391|26297815|FG001|Overall Study|Adverse Event|3|||
13226344|NCT01769391|26297814|FG000|Overall Study|Progressive Disease|1|||
13226345|NCT01769391|26297815|FG001|Overall Study|Progressive Disease|2|||
13226346|NCT01769391|26297814|FG000|Overall Study|Withdrawal by Subject|4|||
13226347|NCT01769391|26297815|FG001|Overall Study|Withdrawal by Subject|3|||
13226348|NCT01769391|26297814|FG000|Overall Study|Investigator Decision|2|||
13226349|NCT01769391|26297815|FG001|Overall Study|Investigator Decision|0|||
13226350|NCT01769378|26297857|FG000|Overall Study|Adverse Event|10|||
13226351|NCT01769378|26297858|FG001|Overall Study|Adverse Event|0|||
13226352|NCT01769378|26297857|FG000|Overall Study|Entry criteria not met|1|||
13226353|NCT01769378|26297858|FG001|Overall Study|Entry criteria not met|0|||
13226354|NCT01769378|26297857|FG000|Overall Study|Protocol Violation|1|||
13226355|NCT01769378|26297858|FG001|Overall Study|Protocol Violation|1|||
13226356|NCT01769378|26297857|FG000|Overall Study|Withdrawal by Subject|10|||
13226357|NCT01769378|26297858|FG001|Overall Study|Withdrawal by Subject|3|||
13226358|NCT01769378|26297857|FG000|Overall Study|Sponsor Decision|1|||
13226359|NCT01769378|26297858|FG001|Overall Study|Sponsor Decision|0|||
13226360|NCT01769378|26297857|FG000|Overall Study|Lost to Follow-up|2|||
13226361|NCT01769378|26297858|FG001|Overall Study|Lost to Follow-up|0|||
13226362|NCT01769339|26297867|FG000|Overall Study|Lost to Follow-up|42|||
13226363|NCT01769339|26297867|FG000|Overall Study|Adverse Event|1|||
13226364|NCT01769326|26297890|FG000|Overall Study|Lost to Follow-up|1|||
13226365|NCT01769326|26297891|FG001|Overall Study|Lost to Follow-up|2|||
13226366|NCT01769326|26297892|FG002|Overall Study|Lost to Follow-up|0|||
13226367|NCT01769326|26297893|FG003|Overall Study|Lost to Follow-up|0|||
13226368|NCT01769326|26297890|FG000|Overall Study|unrelated injry|1|||
13226369|NCT01769326|26297891|FG001|Overall Study|unrelated injry|1|||
13226370|NCT01769326|26297892|FG002|Overall Study|unrelated injry|0|||
13226371|NCT01769326|26297893|FG003|Overall Study|unrelated injry|0|||
13226372|NCT01769326|26297890|FG000|Overall Study|got a job|0|||
13226373|NCT01769326|26297891|FG001|Overall Study|got a job|1|||
13226374|NCT01769326|26297892|FG002|Overall Study|got a job|0|||
13226375|NCT01769326|26297893|FG003|Overall Study|got a job|0|||
13113730|NCT03131895|25912321|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
13226376|NCT01769326|26297890|FG000|Overall Study|Got sick and could not complete study|0|||
13226377|NCT01769326|26297891|FG001|Overall Study|Got sick and could not complete study|0|||
13226378|NCT01769326|26297892|FG002|Overall Study|Got sick and could not complete study|1|||
13226379|NCT01769326|26297893|FG003|Overall Study|Got sick and could not complete study|0|||
13226380|NCT01769196|26297928|FG000|Overall Study|Adverse Event|24|||
13226381|NCT01769196|26297929|FG001|Overall Study|Adverse Event|20|||
13226382|NCT01769196|26297928|FG000|Overall Study|Death|21|||
13226383|NCT01769196|26297929|FG001|Overall Study|Death|26|||
13226384|NCT01769196|26297928|FG000|Overall Study|Investigator Discretion|7|||
13113731|NCT03131713|25912346|FG000|Overall Study|Lost to Follow-up|5|||
13226385|NCT01769196|26297929|FG001|Overall Study|Investigator Discretion|3|||
13226386|NCT01769196|26297928|FG000|Overall Study|Lack of Efficacy|3|||
13226387|NCT01769196|26297929|FG001|Overall Study|Lack of Efficacy|2|||
13226388|NCT01769196|26297928|FG000|Overall Study|Progressive disease|11|||
13226389|NCT01769196|26297929|FG001|Overall Study|Progressive disease|6|||
13226390|NCT01769196|26297928|FG000|Overall Study|Protocol defined criteria for withdrawal|9|||
13226391|NCT01769196|26297929|FG001|Overall Study|Protocol defined criteria for withdrawal|11|||
13226392|NCT01769196|26297928|FG000|Overall Study|Protocol Violation|0|||
13226393|NCT01769196|26297929|FG001|Overall Study|Protocol Violation|3|||
13226394|NCT01769196|26297928|FG000|Overall Study|Study terminated by sponsor|160|||
13226395|NCT01769196|26297929|FG001|Overall Study|Study terminated by sponsor|161|||
13226396|NCT01769196|26297928|FG000|Overall Study|Participant never dosed with study drug|1|||
13226397|NCT01769196|26297929|FG001|Overall Study|Participant never dosed with study drug|0|||
13226398|NCT01769196|26297928|FG000|Overall Study|Withdrew consent|36|||
13226399|NCT01769196|26297929|FG001|Overall Study|Withdrew consent|40|||
13226400|NCT01769105|26297955|FG000|First Intervention|Protocol Violation|2|||
13226401|NCT01769105|26297956|FG001|First Intervention|Protocol Violation|2|||
13226402|NCT01769105|26297955|FG000|Cross-over|Lost to Follow-up|5|||
13226403|NCT01769105|26297956|FG001|Cross-over|Lost to Follow-up|0|||
13226404|NCT01768858|26297970|FG000|Overall Study|Lost to Follow-up|9|||
13226405|NCT01768858|26297970|FG000|Overall Study|Lack of Efficacy|8|||
13226406|NCT01768858|26297970|FG000|Overall Study|Serious Adverse Event|1|||
13226407|NCT01768858|26297970|FG000|Overall Study|Participant moved to Germany|1|||
13226408|NCT01768858|26297970|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1|||
13226409|NCT01768858|26297970|FG000|Overall Study|Exanthema|1|||
13226410|NCT01768858|26297970|FG000|Overall Study|Withdrawal by Subject|1|||
13226411|NCT01768676|26297991|FG000|Overall Study|Adverse Event|3|||
13226412|NCT01768676|26297992|FG001|Overall Study|Adverse Event|3|||
13226413|NCT01768676|26297991|FG000|Overall Study|Lost to Follow-up|13|||
13226414|NCT01768676|26297992|FG001|Overall Study|Lost to Follow-up|16|||
13226415|NCT01768676|26297991|FG000|Overall Study|Protocol Violation|1|||
13226416|NCT01768676|26297992|FG001|Overall Study|Protocol Violation|1|||
13226417|NCT01768676|26297991|FG000|Overall Study|Physician Decision|4|||
13226418|NCT01768676|26297992|FG001|Overall Study|Physician Decision|1|||
13226419|NCT01768676|26297991|FG000|Overall Study|Withdrawal by Subject|3|||
13226420|NCT01768676|26297992|FG001|Overall Study|Withdrawal by Subject|10|||
13226421|NCT01768637|26298009|FG000|Overall Study|Lost to Follow-up|2|||
13226422|NCT01768637|26298010|FG001|Overall Study|Lost to Follow-up|7|||
13226423|NCT01768637|26298009|FG000|Overall Study|Difficult blood draw|1|||
13226424|NCT01768637|26298010|FG001|Overall Study|Difficult blood draw|0|||
13226425|NCT01768572|26298028|FG000|Overall Study|Adverse Event|7|||
13226426|NCT01768572|26298029|FG001|Overall Study|Adverse Event|8|||
13226427|NCT01768572|26298030|FG002|Overall Study|Adverse Event|4|||
13226428|NCT01768572|26298028|FG000|Overall Study|Lack of Efficacy|1|||
13226429|NCT01768572|26298029|FG001|Overall Study|Lack of Efficacy|3|||
13226430|NCT01768572|26298030|FG002|Overall Study|Lack of Efficacy|1|||
13226431|NCT01768572|26298028|FG000|Overall Study|Other, Not due to an adverse event|1|||
13226432|NCT01768572|26298029|FG001|Overall Study|Other, Not due to an adverse event|1|||
13226433|NCT01768572|26298030|FG002|Overall Study|Other, Not due to an adverse event|1|||
13226434|NCT01768559|26298088|FG000|Overall Study|Randomized but not treated|0|||
13226435|NCT01768559|26298089|FG001|Overall Study|Randomized but not treated|0|||
13226436|NCT01768559|26298090|FG002|Overall Study|Randomized but not treated|1|||
13226437|NCT01768559|26298088|FG000|Overall Study|Adverse Event|15|||
13226438|NCT01768559|26298089|FG001|Overall Study|Adverse Event|2|||
13226439|NCT01768559|26298090|FG002|Overall Study|Adverse Event|5|||
13226440|NCT01768559|26298088|FG000|Overall Study|Lack of Efficacy|6|||
13226441|NCT01768559|26298089|FG001|Overall Study|Lack of Efficacy|4|||
13226442|NCT01768559|26298090|FG002|Overall Study|Lack of Efficacy|0|||
13226443|NCT01768559|26298088|FG000|Overall Study|Poor compliance to protocol|0|||
13226444|NCT01768559|26298089|FG001|Overall Study|Poor compliance to protocol|3|||
13226445|NCT01768559|26298090|FG002|Overall Study|Poor compliance to protocol|2|||
13226446|NCT01768559|26298088|FG000|Overall Study|Other than specified|9|||
13226447|NCT01768559|26298089|FG001|Overall Study|Other than specified|8|||
13226448|NCT01768559|26298090|FG002|Overall Study|Other than specified|5|||
13226449|NCT01768286|26298165|FG000|Overall Study|Randomized But Not Treated|0|||
13226450|NCT01768286|26298166|FG001|Overall Study|Randomized But Not Treated|0|||
13226451|NCT01768286|26298167|FG002|Overall Study|Randomized But Not Treated|1|||
13226452|NCT01768286|26298168|FG003|Overall Study|Randomized But Not Treated|0|||
13226453|NCT01768286|26298165|FG000|Overall Study|Lack of Efficacy|7|||
13226454|NCT01768286|26298166|FG001|Overall Study|Lack of Efficacy|4|||
13226455|NCT01768286|26298167|FG002|Overall Study|Lack of Efficacy|0|||
13226456|NCT01768286|26298168|FG003|Overall Study|Lack of Efficacy|1|||
13226457|NCT01768286|26298165|FG000|Overall Study|Withdrew Consent|0|||
13113732|NCT03131713|25912347|FG001|Overall Study|Lost to Follow-up|0|||
13226458|NCT01768286|26298166|FG001|Overall Study|Withdrew Consent|0|||
13226459|NCT01768286|26298167|FG002|Overall Study|Withdrew Consent|1|||
13226460|NCT01768286|26298168|FG003|Overall Study|Withdrew Consent|0|||
13226461|NCT01768117|26298178|FG000|Overall Study|Lost to Follow-up|1|||
13226462|NCT01768117|26298178|FG000|Overall Study|Withdrawal by Subject|2|||
13226463|NCT01768117|26298178|FG000|Overall Study|Protocol Violation|3|||
13226464|NCT01767987|26298207|FG000|Overall Study|Physician Decision|4|||
13226465|NCT01767987|26298208|FG001|Overall Study|Physician Decision|1|||
13226466|NCT01767909|26298231|FG000|Overall Study|Withdrawal by Subject|4|||
13226467|NCT01767909|26298232|FG001|Overall Study|Withdrawal by Subject|7|||
13226468|NCT01767909|26298231|FG000|Overall Study|Adverse Event|3|||
13226469|NCT01767909|26298232|FG001|Overall Study|Adverse Event|1|||
13226470|NCT01767909|26298231|FG000|Overall Study|Withdrawal by Study Partner|3|||
13226471|NCT01767909|26298232|FG001|Overall Study|Withdrawal by Study Partner|1|||
13226472|NCT01767909|26298231|FG000|Overall Study|Non-Compliance|2|||
13226473|NCT01767909|26298232|FG001|Overall Study|Non-Compliance|0|||
13226474|NCT01767909|26298231|FG000|Overall Study|Perceived Lack of Efficacy|1|||
13226475|NCT01767909|26298232|FG001|Overall Study|Perceived Lack of Efficacy|0|||
13226476|NCT01767909|26298231|FG000|Overall Study|Investigator Recommendation|0|||
13226477|NCT01767909|26298232|FG001|Overall Study|Investigator Recommendation|1|||
13226478|NCT01767909|26298231|FG000|Overall Study|Lost to Follow-up|0|||
13226479|NCT01767909|26298232|FG001|Overall Study|Lost to Follow-up|1|||
13226480|NCT01767909|26298231|FG000|Overall Study|LP uncessessful|0|||
13226481|NCT01767909|26298232|FG001|Overall Study|LP uncessessful|1|||
13226482|NCT01767857|26298257|FG000|Overall Study|Adverse Event|27|||
13226483|NCT01767857|26298258|FG001|Overall Study|Adverse Event|7|||
13226484|NCT01767857|26298257|FG000|Overall Study|Death|28|||
13226485|NCT01767857|26298258|FG001|Overall Study|Death|13|||
13485649|NCT01126749|27033001|FG001|Phase 2|Withdrawal by Subject|0|||
13485650|NCT01126749|27033002|FG002|Phase 2|Withdrawal by Subject|0|||
13485651|NCT01126749|27033003|FG003|Phase 2|Withdrawal by Subject|2|||
13113733|NCT03131687|25912474|FG000|Overall Study|Adverse Event|0|||
13113734|NCT03131687|25912475|FG001|Overall Study|Adverse Event|1|||
13113735|NCT03131687|25912476|FG002|Overall Study|Adverse Event|0|||
13113736|NCT03131687|25912477|FG003|Overall Study|Adverse Event|1|||
13113737|NCT03131687|25912478|FG004|Overall Study|Adverse Event|2|||
13113738|NCT03131687|25912479|FG005|Overall Study|Adverse Event|2|||
13113739|NCT03131687|25912474|FG000|Overall Study|Death|1|||
13113740|NCT03131687|25912475|FG001|Overall Study|Death|0|||
13113741|NCT03131687|25912476|FG002|Overall Study|Death|0|||
13113742|NCT03131687|25912477|FG003|Overall Study|Death|0|||
13113743|NCT03131687|25912478|FG004|Overall Study|Death|0|||
13113744|NCT03131687|25912479|FG005|Overall Study|Death|0|||
13113745|NCT03131687|25912474|FG000|Overall Study|Withdrawal by Subject|3|||
13113746|NCT03131687|25912475|FG001|Overall Study|Withdrawal by Subject|3|||
13113747|NCT03131687|25912476|FG002|Overall Study|Withdrawal by Subject|3|||
13113748|NCT03131687|25912477|FG003|Overall Study|Withdrawal by Subject|1|||
13113749|NCT03131687|25912478|FG004|Overall Study|Withdrawal by Subject|2|||
13113750|NCT03131687|25912479|FG005|Overall Study|Withdrawal by Subject|1|||
13113751|NCT03131687|25912474|FG000|Overall Study|Lost to Follow-up|1|||
13113752|NCT03131687|25912475|FG001|Overall Study|Lost to Follow-up|4|||
13113753|NCT03131687|25912476|FG002|Overall Study|Lost to Follow-up|0|||
13113754|NCT03131687|25912477|FG003|Overall Study|Lost to Follow-up|1|||
13113755|NCT03131687|25912478|FG004|Overall Study|Lost to Follow-up|4|||
13113756|NCT03131687|25912479|FG005|Overall Study|Lost to Follow-up|2|||
13113757|NCT03131687|25912474|FG000|Overall Study|Participant Started New Diabetic Drug|1|||
13113758|NCT03131687|25912475|FG001|Overall Study|Participant Started New Diabetic Drug|0|||
13113759|NCT03131687|25912476|FG002|Overall Study|Participant Started New Diabetic Drug|0|||
13113760|NCT03131687|25912477|FG003|Overall Study|Participant Started New Diabetic Drug|0|||
13113761|NCT03131687|25912478|FG004|Overall Study|Participant Started New Diabetic Drug|0|||
13113762|NCT03131687|25912479|FG005|Overall Study|Participant Started New Diabetic Drug|0|||
13113763|NCT03131687|25912474|FG000|Overall Study|Principle Investigator Decision|0|||
13485652|NCT01126749|27033000|FG000|Phase 2|Lost to Follow-up|0|||
13485653|NCT01126749|27033001|FG001|Phase 2|Lost to Follow-up|0|||
13485654|NCT01126749|27033002|FG002|Phase 2|Lost to Follow-up|0|||
13485655|NCT01126749|27033003|FG003|Phase 2|Lost to Follow-up|1|||
13485656|NCT01126749|27033000|FG000|Phase 2|Death|0|||
13485657|NCT01126749|27033001|FG001|Phase 2|Death|0|||
13485658|NCT01126749|27033002|FG002|Phase 2|Death|22|||
13485659|NCT01126749|27033003|FG003|Phase 2|Death|22|||
13485660|NCT01126749|27033000|FG000|Phase 2|Adverse Event|0|||
13113764|NCT03131687|25912475|FG001|Overall Study|Principle Investigator Decision|1|||
13113765|NCT03131687|25912476|FG002|Overall Study|Principle Investigator Decision|0|||
13113766|NCT03131687|25912477|FG003|Overall Study|Principle Investigator Decision|0|||
13113767|NCT03131687|25912478|FG004|Overall Study|Principle Investigator Decision|0|||
13113768|NCT03131687|25912479|FG005|Overall Study|Principle Investigator Decision|0|||
13226486|NCT01767857|26298257|FG000|Overall Study|Lack of Efficacy|299|||
13226487|NCT01767857|26298258|FG001|Overall Study|Lack of Efficacy|151|||
13485661|NCT01126749|27033001|FG001|Phase 2|Adverse Event|0|||
13113769|NCT03131687|25912474|FG000|Overall Study|Inadvertent Enrollment|0|||
13113770|NCT03131687|25912475|FG001|Overall Study|Inadvertent Enrollment|0|||
13113771|NCT03131687|25912476|FG002|Overall Study|Inadvertent Enrollment|0|||
13113772|NCT03131687|25912477|FG003|Overall Study|Inadvertent Enrollment|1|||
13113773|NCT03131687|25912478|FG004|Overall Study|Inadvertent Enrollment|0|||
13113774|NCT03131687|25912479|FG005|Overall Study|Inadvertent Enrollment|0|||
13113775|NCT03131648|25912538|FG000|Initial Treatment Period|Not dosed|2|||
13226488|NCT01767857|26298257|FG000|Overall Study|Lost to Follow-up|1|||
13226489|NCT01767857|26298258|FG001|Overall Study|Lost to Follow-up|1|||
13226490|NCT01767857|26298257|FG000|Overall Study|Withdrawal by Subject|38|||
13226491|NCT01767857|26298258|FG001|Overall Study|Withdrawal by Subject|18|||
13226492|NCT01767857|26298257|FG000|Overall Study|Physician Decision|17|||
13226493|NCT01767857|26298258|FG001|Overall Study|Physician Decision|10|||
13226494|NCT01767857|26298257|FG000|Overall Study|Protocol Terminated|1|||
13226495|NCT01767857|26298258|FG001|Overall Study|Protocol Terminated|0|||
13226496|NCT01767857|26298257|FG000|Overall Study|Randomized But Never Treated|19|||
13226497|NCT01767857|26298258|FG001|Overall Study|Randomized But Never Treated|13|||
13226498|NCT01767597|26298271|FG000|Overall Study|Incomplete intervention|3|||
13226499|NCT01767597|26298272|FG001|Overall Study|Incomplete intervention|1|||
13226500|NCT01767597|26298271|FG000|Overall Study|Withdrawal by Subject|1|||
13226501|NCT01767597|26298272|FG001|Overall Study|Withdrawal by Subject|0|||
13226502|NCT01767519|26298308|FG000|Overall Study|Other Reasons|4|||
13226503|NCT01767519|26298309|FG001|Overall Study|Other Reasons|4|||
13226504|NCT01767519|26298310|FG002|Overall Study|Other Reasons|2|||
13226505|NCT01767519|26298308|FG000|Overall Study|Protocol Violation|0|||
13226506|NCT01767519|26298309|FG001|Overall Study|Protocol Violation|3|||
13226507|NCT01767519|26298310|FG002|Overall Study|Protocol Violation|0|||
13226508|NCT01767519|26298308|FG000|Overall Study|Personal Reasons|1|||
13226509|NCT01767519|26298309|FG001|Overall Study|Personal Reasons|0|||
13226510|NCT01767519|26298310|FG002|Overall Study|Personal Reasons|0|||
13226511|NCT01767519|26298308|FG000|Overall Study|Lost to Follow-up|3|||
13226512|NCT01767519|26298309|FG001|Overall Study|Lost to Follow-up|1|||
13226513|NCT01767519|26298310|FG002|Overall Study|Lost to Follow-up|2|||
13226514|NCT01767519|26298308|FG000|Overall Study|Lack of Efficacy|1|||
13226515|NCT01767519|26298309|FG001|Overall Study|Lack of Efficacy|0|||
13226516|NCT01767519|26298310|FG002|Overall Study|Lack of Efficacy|0|||
13226517|NCT01767519|26298308|FG000|Overall Study|Adverse Event|5|||
13226518|NCT01767519|26298309|FG001|Overall Study|Adverse Event|5|||
13226519|NCT01767519|26298310|FG002|Overall Study|Adverse Event|1|||
13226520|NCT01767493|26298316|FG000|Overall Study|screen failures|3|||
13226521|NCT01767467|26298371|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8|||
13226522|NCT01767467|26298372|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8|||
13226523|NCT01767467|26298371|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1|||
13226524|NCT01767467|26298372|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0|||
13226525|NCT01767467|26298371|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7|||
13226526|NCT01767467|26298372|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10|||
13226527|NCT01767467|26298371|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0|||
13226528|NCT01767467|26298372|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1|||
13226529|NCT01767467|26298371|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1|||
13113776|NCT03131648|25912539|FG001|Initial Treatment Period|Not dosed|2|||
13113777|NCT03131648|25912540|FG002|Initial Treatment Period|Not dosed|0|||
13113778|NCT03131648|25912541|FG003|Initial Treatment Period|Not dosed|0|||
13113779|NCT03131648|25912542|FG004|Initial Treatment Period|Not dosed|0|||
13113780|NCT03131648|25912543|FG005|Initial Treatment Period|Not dosed|0|||
13113781|NCT03131648|25912544|FG006|Initial Treatment Period|Not dosed|0|||
13113782|NCT03131648|25912545|FG007|Initial Treatment Period|Not dosed|0|||
13113783|NCT03131648|25912538|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51|||
13113784|NCT03131648|25912539|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18|||
13113785|NCT03131648|25912540|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
13113786|NCT03131648|25912541|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
13113787|NCT03131648|25912542|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
13113788|NCT03131648|25912543|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
13113789|NCT03131648|25912544|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
13113790|NCT03131648|25912545|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0|||
13113791|NCT03131648|25912538|FG000|Open-label Treatment|Discontinued IMP|0|||
13226530|NCT01767467|26298372|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0|||
13226531|NCT01767467|26298371|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0|||
13226532|NCT01767467|26298372|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1|||
13226533|NCT01767467|26298371|FG000|End of Study Phase (up to Month 13)|Adverse Event|29|||
13226534|NCT01767467|26298372|FG001|End of Study Phase (up to Month 13)|Adverse Event|39|||
13226535|NCT01767467|26298371|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2|||
13485662|NCT01126749|27033002|FG002|Phase 2|Adverse Event|0|||
13113792|NCT03131648|25912539|FG001|Open-label Treatment|Discontinued IMP|0|||
13113793|NCT03131648|25912540|FG002|Open-label Treatment|Discontinued IMP|0|||
13226536|NCT01767467|26298372|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0|||
13226537|NCT01767467|26298371|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9|||
13226538|NCT01767467|26298372|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14|||
13226539|NCT01767467|26298371|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0|||
13226540|NCT01767467|26298372|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3|||
13226541|NCT01767467|26298371|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6|||
13226542|NCT01767467|26298372|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4|||
13226543|NCT01767467|26298371|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0|||
13226544|NCT01767467|26298372|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1|||
13226545|NCT01767467|26298371|FG000|End of Study Phase (up to Month 13)|Physician Decision|1|||
13226546|NCT01767467|26298372|FG001|End of Study Phase (up to Month 13)|Physician Decision|0|||
13226547|NCT01767467|26298371|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0|||
13226548|NCT01767467|26298372|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2|||
13226549|NCT01767376|26298427|FG000|Overall Study|Lost to Follow-up|3|||
13226550|NCT01767376|26298428|FG001|Overall Study|Lost to Follow-up|2|||
13226551|NCT01767376|26298429|FG002|Overall Study|Lost to Follow-up|0|||
13226552|NCT01767376|26298427|FG000|Overall Study|Withdrawal by Subject|1|||
13226553|NCT01767376|26298428|FG001|Overall Study|Withdrawal by Subject|1|||
13226554|NCT01767376|26298429|FG002|Overall Study|Withdrawal by Subject|0|||
13226555|NCT01767194|26298443|FG000|Overall Study|Adverse Event|1|||
13226556|NCT01767194|26298444|FG001|Overall Study|Adverse Event|1|||
13226557|NCT01767194|26298443|FG000|Overall Study|Death|0|||
13226558|NCT01767194|26298444|FG001|Overall Study|Death|1|||
13226559|NCT01767194|26298443|FG000|Overall Study|Lack of Efficacy|12|||
13226560|NCT01767194|26298444|FG001|Overall Study|Lack of Efficacy|11|||
13226561|NCT01767194|26298443|FG000|Overall Study|Physician Decision|2|||
13226562|NCT01767194|26298444|FG001|Overall Study|Physician Decision|23|||
13226563|NCT01767194|26298443|FG000|Overall Study|Withdrawal by Subject|0|||
13226564|NCT01767194|26298444|FG001|Overall Study|Withdrawal by Subject|1|||
13226565|NCT01767194|26298443|FG000|Overall Study|Ineligible|1|||
13226566|NCT01767194|26298444|FG001|Overall Study|Ineligible|1|||
13226567|NCT01767194|26298443|FG000|Overall Study|Refusal by patient/parent|2|||
13226568|NCT01767194|26298444|FG001|Overall Study|Refusal by patient/parent|4|||
13226569|NCT01767194|26298443|FG000|Overall Study|Criteria not met on time for next cycle|0|||
13226570|NCT01767194|26298444|FG001|Overall Study|Criteria not met on time for next cycle|1|||
13226571|NCT01767142|26298453|FG000|Overall Study|Lost to Follow-up|3|||
13226572|NCT01767116|26298476|FG000|Overall Study|Lost to Follow-up|2|||
13226573|NCT01767116|26298477|FG001|Overall Study|Lost to Follow-up|2|||
13226574|NCT01766921|26298503|FG000|Overall Study|Administrative Reason|5|||
13226575|NCT01766921|26298504|FG001|Overall Study|Administrative Reason|5|||
13226576|NCT01766921|26298503|FG000|Overall Study|Death|1|||
13226577|NCT01766921|26298504|FG001|Overall Study|Death|1|||
13226578|NCT01766921|26298503|FG000|Overall Study|Lost to Follow-up|1|||
13226579|NCT01766921|26298504|FG001|Overall Study|Lost to Follow-up|3|||
13226580|NCT01766921|26298503|FG000|Overall Study|Unclassified|2|||
13226581|NCT01766921|26298504|FG001|Overall Study|Unclassified|2|||
13226582|NCT01766921|26298503|FG000|Overall Study|Protocol Violation|1|||
13226583|NCT01766921|26298504|FG001|Overall Study|Protocol Violation|1|||
13226584|NCT01766921|26298503|FG000|Overall Study|Withdrawal by Subject|14|||
13226585|NCT01766921|26298504|FG001|Overall Study|Withdrawal by Subject|5|||
13226586|NCT01766817|26298563|FG000|Overall Study|Drug-related adverse event|1|||
13226587|NCT01766817|26298564|FG001|Overall Study|Drug-related adverse event|2|||
13226588|NCT01766817|26298565|FG002|Overall Study|Drug-related adverse event|1|||
13226589|NCT01766817|26298563|FG000|Overall Study|Drug-unrelated adverse event|3|||
13226590|NCT01766817|26298564|FG001|Overall Study|Drug-unrelated adverse event|3|||
13226591|NCT01766817|26298565|FG002|Overall Study|Drug-unrelated adverse event|3|||
13226592|NCT01766817|26298563|FG000|Overall Study|Death|1|||
13226593|NCT01766817|26298564|FG001|Overall Study|Death|1|||
13226594|NCT01766817|26298565|FG002|Overall Study|Death|0|||
13226595|NCT01766817|26298563|FG000|Overall Study|Unable to take study drug|0|||
13226596|NCT01766817|26298564|FG001|Overall Study|Unable to take study drug|1|||
13226597|NCT01766817|26298565|FG002|Overall Study|Unable to take study drug|0|||
13226598|NCT01766817|26298563|FG000|Overall Study|Withdrawal by Subject|2|||
13226599|NCT01766817|26298564|FG001|Overall Study|Withdrawal by Subject|0|||
13226600|NCT01766817|26298565|FG002|Overall Study|Withdrawal by Subject|3|||
13226601|NCT01766817|26298563|FG000|Overall Study|Subject non-compliance|0|||
13226602|NCT01766817|26298564|FG001|Overall Study|Subject non-compliance|1|||
13226603|NCT01766817|26298565|FG002|Overall Study|Subject non-compliance|2|||
13226604|NCT01766817|26298563|FG000|Overall Study|Physician Decision|3|||
13226605|NCT01766817|26298564|FG001|Overall Study|Physician Decision|3|||
13226606|NCT01766817|26298565|FG002|Overall Study|Physician Decision|4|||
13226607|NCT01766817|26298563|FG000|Overall Study|Other|1|||
13226608|NCT01766817|26298564|FG001|Overall Study|Other|0|||
13226609|NCT01766817|26298565|FG002|Overall Study|Other|0|||
13226610|NCT01766778|26298588|FG000|Overall Study|Adverse Event|4|||
13226611|NCT01766778|26298589|FG001|Overall Study|Adverse Event|4|||
13226612|NCT01766778|26298588|FG000|Overall Study|Withdrawal by Subject|1|||
13226613|NCT01766778|26298589|FG001|Overall Study|Withdrawal by Subject|0|||
13226614|NCT01766401|26298604|FG000|Overall Study|Adverse Event|7|||
13226615|NCT01766401|26298605|FG001|Overall Study|Adverse Event|22|||
13226616|NCT01766401|26298604|FG000|Overall Study|Lack of Efficacy|1|||
13226617|NCT01766401|26298605|FG001|Overall Study|Lack of Efficacy|2|||
13226618|NCT01766401|26298604|FG000|Overall Study|Protocol Violation|3|||
13226619|NCT01766401|26298605|FG001|Overall Study|Protocol Violation|8|||
13226620|NCT01766401|26298604|FG000|Overall Study|Withdrawal by Subject|15|||
13226621|NCT01766401|26298605|FG001|Overall Study|Withdrawal by Subject|12|||
13226622|NCT01766401|26298604|FG000|Overall Study|Lost to Follow-up|10|||
13226623|NCT01766401|26298605|FG001|Overall Study|Lost to Follow-up|11|||
13226624|NCT01766401|26298604|FG000|Overall Study|Pregnancy|1|||
13226625|NCT01766401|26298605|FG001|Overall Study|Pregnancy|1|||
13226626|NCT01766336|26298618|FG000|Overall Study|Adverse Event|11|||
13226627|NCT01766336|26298619|FG001|Overall Study|Adverse Event|8|||
13226628|NCT01766336|26298618|FG000|Overall Study|Death|4|||
13226629|NCT01766336|26298619|FG001|Overall Study|Death|3|||
13226630|NCT01766336|26298618|FG000|Overall Study|Lost to Follow-up|1|||
13226631|NCT01766336|26298619|FG001|Overall Study|Lost to Follow-up|3|||
13226632|NCT01766336|26298618|FG000|Overall Study|Physician Decision|4|||
13226633|NCT01766336|26298619|FG001|Overall Study|Physician Decision|2|||
13226634|NCT01766336|26298618|FG000|Overall Study|Protocol Violation|0|||
13226635|NCT01766336|26298619|FG001|Overall Study|Protocol Violation|1|||
13226636|NCT01766336|26298618|FG000|Overall Study|Sponsor Decision|52|||
13226637|NCT01766336|26298619|FG001|Overall Study|Sponsor Decision|43|||
13226638|NCT01766336|26298618|FG000|Overall Study|Withdrawal by Subject|18|||
13226639|NCT01766336|26298619|FG001|Overall Study|Withdrawal by Subject|15|||
13226640|NCT01766310|26298634|FG000|Overall Study|Lost to Follow-up|1|||
13226641|NCT01766310|26298635|FG001|Overall Study|Lost to Follow-up|3|||
13226642|NCT01766206|26298644|FG000|Overall Study|Withdrawal by Subject|22|||
13226643|NCT01766206|26298644|FG000|Overall Study|Lost to Follow-up|10|||
13226644|NCT01766206|26298644|FG000|Overall Study|Inappropriate enrollment|18|||
13226645|NCT01766206|26298644|FG000|Overall Study|Withdrawal and inappropriate enrollment|1|||
13226646|NCT01766050|26298779|FG000|Overall Study|Adverse Event|1|||
13226647|NCT01766050|26298779|FG000|Overall Study|Lost to Follow-up|1|||
13226648|NCT01766050|26298779|FG000|Overall Study|Withdrawal by Subject|2|||
13226649|NCT01766037|26298821|FG000|Overall Study|Adverse Event|1|||
13226650|NCT01766037|26298822|FG001|Overall Study|Adverse Event|0|||
13226651|NCT01766037|26298821|FG000|Overall Study|Lack of Efficacy|1|||
13226652|NCT01766037|26298822|FG001|Overall Study|Lack of Efficacy|0|||
13226653|NCT01766037|26298821|FG000|Overall Study|Lost to Follow-up|0|||
13226654|NCT01766037|26298822|FG001|Overall Study|Lost to Follow-up|10|||
13226655|NCT01766037|26298821|FG000|Overall Study|Physician Decision|0|||
13226656|NCT01766037|26298822|FG001|Overall Study|Physician Decision|1|||
13226657|NCT01766037|26298821|FG000|Overall Study|Withdrawal by Subject|18|||
13226658|NCT01766037|26298822|FG001|Overall Study|Withdrawal by Subject|16|||
13226659|NCT01766037|26298821|FG000|Overall Study|Moved from area|5|||
13226660|NCT01766037|26298822|FG001|Overall Study|Moved from area|0|||
13226661|NCT01766037|26298821|FG000|Overall Study|medical - unrelated|1|||
13226662|NCT01766037|26298822|FG001|Overall Study|medical - unrelated|2|||
13226663|NCT01766037|26298821|FG000|Overall Study|nausea / discomfort|3|||
13226664|NCT01766037|26298822|FG001|Overall Study|nausea / discomfort|0|||
13226665|NCT01765920|26298843|FG000|Overall Study|Incorrect inclusion ineligible patient|2|||
13226666|NCT01765920|26298844|FG001|Overall Study|Incorrect inclusion ineligible patient|5|||
13226667|NCT01765920|26298843|FG000|Overall Study|Patient code disclosure|0|||
13226668|NCT01765920|26298844|FG001|Overall Study|Patient code disclosure|1|||
13226669|NCT01765764|26298871|FG000|Treatment Period|Adverse Event|1|||
13226670|NCT01765764|26298872|FG001|Treatment Period|Adverse Event|2|||
13226671|NCT01765764|26298873|FG002|Treatment Period|Adverse Event|1|||
13226672|NCT01765764|26298871|FG000|Treatment Period|Lost to Follow-up|0|||
13226673|NCT01765764|26298872|FG001|Treatment Period|Lost to Follow-up|3|||
13226674|NCT01765764|26298873|FG002|Treatment Period|Lost to Follow-up|2|||
13226675|NCT01765764|26298871|FG000|Treatment Period|Personal Reasons|1|||
13226676|NCT01765764|26298872|FG001|Treatment Period|Personal Reasons|2|||
13226677|NCT01765764|26298873|FG002|Treatment Period|Personal Reasons|1|||
13226678|NCT01765764|26298871|FG000|Treatment Period|Other Miscellaneous Reasons|1|||
13226679|NCT01765764|26298872|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
13226680|NCT01765764|26298873|FG002|Treatment Period|Other Miscellaneous Reasons|2|||
13226681|NCT01765751|26298915|FG000|Overall Study|Lost to Follow-up|0|||
13226682|NCT01765751|26298916|FG001|Overall Study|Lost to Follow-up|2|||
13226683|NCT01765751|26298917|FG002|Overall Study|Lost to Follow-up|1|||
13226684|NCT01765673|26298942|FG000|Overall Study|No transportation for 2nd/3rd visits|1|||
13226685|NCT01765582|26298985|FG000|Overall Study|Other|3|||
13226686|NCT01765582|26298986|FG001|Overall Study|Other|6|||
13226687|NCT01765582|26298987|FG002|Overall Study|Other|9|||
13226688|NCT01765582|26298985|FG000|Overall Study|Lost to Follow-up|2|||
13226689|NCT01765582|26298986|FG001|Overall Study|Lost to Follow-up|2|||
13226690|NCT01765582|26298987|FG002|Overall Study|Lost to Follow-up|1|||
13226691|NCT01765582|26298985|FG000|Overall Study|Death|31|||
13226692|NCT01765582|26298986|FG001|Overall Study|Death|36|||
13226693|NCT01765582|26298987|FG002|Overall Study|Death|33|||
13226694|NCT01765582|26298985|FG000|Overall Study|Sponsor Decision|46|||
13226695|NCT01765582|26298986|FG001|Overall Study|Sponsor Decision|42|||
13226696|NCT01765582|26298987|FG002|Overall Study|Sponsor Decision|42|||
13226697|NCT01765582|26298985|FG000|Overall Study|Withdrawal of Consent|11|||
13226698|NCT01765582|26298986|FG001|Overall Study|Withdrawal of Consent|6|||
13226699|NCT01765582|26298987|FG002|Overall Study|Withdrawal of Consent|10|||
13226700|NCT01765569|26299010|FG000|Period B|Withdrawal by Subject|1|||
13226701|NCT01765569|26299010|FG000|Period C|Death|1|||
13289502|NCT00109772|26479394|FG000|Open-label Extension|Withdrawal by Subject|9|||
13289503|NCT00109772|26479395|FG001|Open-label Extension|Withdrawal by Subject|6|||
13289504|NCT00109772|26479394|FG000|Open-label Extension|Lost to Follow-up|1|||
13289505|NCT00109772|26479395|FG001|Open-label Extension|Lost to Follow-up|0|||
13289506|NCT00109772|26479394|FG000|Open-label Extension|Death|0|||
13289507|NCT00109772|26479395|FG001|Open-label Extension|Death|1|||
13289508|NCT00109772|26479394|FG000|Open-label Extension|Protocol Violation|2|||
13289509|NCT00109772|26479395|FG001|Open-label Extension|Protocol Violation|2|||
13289510|NCT00109772|26479394|FG000|Open-label Extension|Other|4|||
13289511|NCT00109772|26479395|FG001|Open-label Extension|Other|10|||
13289512|NCT00109733|26479416|FG000|Overall Study|Protocol Violation|0|||
13289513|NCT00109733|26479417|FG001|Overall Study|Protocol Violation|1|||
13289514|NCT00109733|26479416|FG000|Overall Study|Stopped taking study drug|1|||
13289515|NCT00109733|26479417|FG001|Overall Study|Stopped taking study drug|1|||
13289516|NCT00109733|26479416|FG000|Overall Study|Non-compliant|0|||
13289517|NCT00109733|26479417|FG001|Overall Study|Non-compliant|1|||
13289518|NCT00109733|26479416|FG000|Overall Study|Could not commit time for study|1|||
13289519|NCT00109733|26479417|FG001|Overall Study|Could not commit time for study|1|||
13289520|NCT00109590|26479467|FG000|Overall Study|Lost to Follow-up|1|||
13289521|NCT00109590|26479468|FG001|Overall Study|Lost to Follow-up|0|||
13289522|NCT00109590|26479469|FG002|Overall Study|Lost to Follow-up|1|||
13289523|NCT00109590|26479467|FG000|Overall Study|Never Started Treatment|1|||
13289524|NCT00109590|26479468|FG001|Overall Study|Never Started Treatment|2|||
13289525|NCT00109590|26479469|FG002|Overall Study|Never Started Treatment|3|||
13289526|NCT00109031|26479516|FG000|Overall Study|Adverse Event|0|||
13289527|NCT00109031|26479517|FG001|Overall Study|Adverse Event|0|||
13289528|NCT00109031|26479518|FG002|Overall Study|Adverse Event|1|||
13289529|NCT00109031|26479519|FG003|Overall Study|Adverse Event|0|||
13289530|NCT00109031|26479516|FG000|Overall Study|Withdrawal by Subject|0|||
13289531|NCT00109031|26479517|FG001|Overall Study|Withdrawal by Subject|1|||
13289532|NCT00109031|26479518|FG002|Overall Study|Withdrawal by Subject|0|||
13289533|NCT00109031|26479519|FG003|Overall Study|Withdrawal by Subject|0|||
13289534|NCT00109031|26479516|FG000|Overall Study|Physician Decision|0|||
13289535|NCT00109031|26479517|FG001|Overall Study|Physician Decision|1|||
13289536|NCT00109031|26479518|FG002|Overall Study|Physician Decision|0|||
13289537|NCT00109031|26479519|FG003|Overall Study|Physician Decision|0|||
13289538|NCT00109031|26479516|FG000|Overall Study|Protocol Violation|0|||
13289539|NCT00109031|26479517|FG001|Overall Study|Protocol Violation|0|||
13289540|NCT00109031|26479518|FG002|Overall Study|Protocol Violation|1|||
13289541|NCT00109031|26479519|FG003|Overall Study|Protocol Violation|0|||
13289542|NCT00108953|26479546|FG000|Follow-up|Death|18|||
13289543|NCT00108953|26479547|FG001|Follow-up|Death|26|||
13289544|NCT00108953|26479546|FG000|Follow-up|Lost to Follow-up|1|||
13289545|NCT00108953|26479547|FG001|Follow-up|Lost to Follow-up|1|||
13289546|NCT00108953|26479546|FG000|Follow-up|Study terminated by sponsor|10|||
13289547|NCT00108953|26479547|FG001|Follow-up|Study terminated by sponsor|6|||
13289548|NCT00108862|26479582|FG000|Overall Study|Death|31|||
13289549|NCT00108862|26479583|FG001|Overall Study|Death|37|||
13289550|NCT00108862|26479582|FG000|Overall Study|Withdrawal by Subject|10|||
13289551|NCT00108862|26479583|FG001|Overall Study|Withdrawal by Subject|6|||
13289552|NCT00108862|26479582|FG000|Overall Study|Lost to Follow-up|27|||
13289553|NCT00108862|26479583|FG001|Overall Study|Lost to Follow-up|19|||
13289554|NCT00108732|26479592|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1|||
13289555|NCT00108732|26479592|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2|||
13289556|NCT00108732|26479592|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10|||
13289557|NCT00108732|26479592|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1|||
13289558|NCT00108732|26479592|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3|||
13289559|NCT00108732|26479592|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1|||
13289560|NCT00108732|26479592|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1|||
13289561|NCT00108628|26479623|FG000|Overall Study|Withdrawal by Subject|17|||
13289562|NCT00108628|26479624|FG001|Overall Study|Withdrawal by Subject|9|||
13289563|NCT00108628|26479623|FG000|Overall Study|Lack of Efficacy|2|||
13289564|NCT00108628|26479624|FG001|Overall Study|Lack of Efficacy|1|||
13289565|NCT00108628|26479623|FG000|Overall Study|Death|1|||
13289566|NCT00108628|26479624|FG001|Overall Study|Death|0|||
13289567|NCT00108160|26479641|FG000|Overall Study|Lost to Follow-up|25|||
13289568|NCT00108160|26479642|FG001|Overall Study|Lost to Follow-up|12|||
13226702|NCT01765543|26299034|FG000|Overall Study|Death|1|||
13226703|NCT01765543|26299034|FG000|Overall Study|Withdrawal by Subject|2|||
13226704|NCT01765426|26299101|FG000|Overall Study|Lost to Follow-up|0|||
13226705|NCT01765426|26299102|FG001|Overall Study|Lost to Follow-up|1|||
13226706|NCT01765426|26299103|FG002|Overall Study|Lost to Follow-up|0|||
13226707|NCT01765426|26299104|FG003|Overall Study|Lost to Follow-up|0|||
13226708|NCT01765270|26299131|FG000|Overall Study|Physician Decision|1|||
13226709|NCT01765270|26299132|FG001|Overall Study|Physician Decision|0|||
13226710|NCT01765270|26299131|FG000|Overall Study|Withdrawal by Subject|0|||
13226711|NCT01765270|26299132|FG001|Overall Study|Withdrawal by Subject|1|||
13226712|NCT01765192|26299157|FG000|Treatment Period 1|Adverse Event|0|||
13226713|NCT01765192|26299158|FG001|Treatment Period 1|Adverse Event|1|||
13226714|NCT01765192|26299157|FG000|Washout Period|Voluntary Withdrawal|1|||
13226715|NCT01765192|26299158|FG001|Washout Period|Voluntary Withdrawal|1|||
13226716|NCT01765192|26299157|FG000|Washout Period|Reason not specified|1|||
13226717|NCT01765192|26299158|FG001|Washout Period|Reason not specified|0|||
13226718|NCT01765192|26299157|FG000|Treatment Period 2|Reason not specified|0|||
13226719|NCT01765192|26299158|FG001|Treatment Period 2|Reason not specified|2|||
13226720|NCT01765192|26299157|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0|||
13226721|NCT01765192|26299158|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1|||
13226722|NCT01765179|26299165|FG000|Overall Study|Adverse Event|3|||
13226723|NCT01765179|26299165|FG000|Overall Study|Lost to Follow-up|5|||
13226724|NCT01765179|26299165|FG000|Overall Study|Non-compliance with study drug|2|||
13226725|NCT01765179|26299165|FG000|Overall Study|Protocol Violation|1|||
13226726|NCT01765179|26299165|FG000|Overall Study|Withdrawal by Subject|8|||
13226727|NCT01765179|26299165|FG000|Overall Study|Hematocrit >54%|3|||
13226728|NCT01765179|26299165|FG000|Overall Study|prohibited med|1|||
13226729|NCT01765179|26299165|FG000|Overall Study|Out of country unable to finish study|1|||
13226730|NCT01765179|26299165|FG000|Overall Study|lack of venous access|1|||
13226731|NCT01765179|26299165|FG000|Overall Study|work conflict|1|||
13226732|NCT01765179|26299165|FG000|Overall Study|Ca elevated 10.6|1|||
13226733|NCT01765153|26299274|FG000|Training Phase 1|Format of intervention differed|1|||
13226734|NCT01765153|26299275|FG001|Training Phase 1|Format of intervention differed|0|||
13226735|NCT01765153|26299274|FG000|Training Phase 1|Poor participation in intervention|0|||
13226736|NCT01765153|26299275|FG001|Training Phase 1|Poor participation in intervention|1|||
13226737|NCT01765153|26299274|FG000|Rest Phase 1|Withdrawal by Subject|0|||
13226738|NCT01765153|26299275|FG001|Rest Phase 1|Withdrawal by Subject|1|||
13226739|NCT01765153|26299274|FG000|Training Phase 2|Withdrawal by Subject|0|||
13226740|NCT01765153|26299275|FG001|Training Phase 2|Withdrawal by Subject|1|||
13226741|NCT01765153|26299274|FG000|Rest Phase 2|Lost to Follow-up|2|||
13226742|NCT01765153|26299275|FG001|Rest Phase 2|Lost to Follow-up|1|||
13226743|NCT01764997|26299310|FG000|Run-in Period|Adverse Event|15|||
13226744|NCT01764997|26299311|FG001|Run-in Period|Adverse Event|0|||
13226745|NCT01764997|26299312|FG002|Run-in Period|Adverse Event|0|||
13226746|NCT01764997|26299313|FG003|Run-in Period|Adverse Event|0|||
13226747|NCT01764997|26299314|FG004|Run-in Period|Adverse Event|0|||
13226748|NCT01764997|26299310|FG000|Run-in Period|Lack of Efficacy|5|||
13226749|NCT01764997|26299311|FG001|Run-in Period|Lack of Efficacy|0|||
13226750|NCT01764997|26299312|FG002|Run-in Period|Lack of Efficacy|0|||
13226751|NCT01764997|26299313|FG003|Run-in Period|Lack of Efficacy|0|||
13226752|NCT01764997|26299314|FG004|Run-in Period|Lack of Efficacy|0|||
13226753|NCT01764997|26299310|FG000|Run-in Period|Poor compliance to protocol|1|||
13226754|NCT01764997|26299311|FG001|Run-in Period|Poor compliance to protocol|0|||
13226755|NCT01764997|26299312|FG002|Run-in Period|Poor compliance to protocol|0|||
13226756|NCT01764997|26299313|FG003|Run-in Period|Poor compliance to protocol|0|||
13226757|NCT01764997|26299314|FG004|Run-in Period|Poor compliance to protocol|0|||
13226758|NCT01764997|26299310|FG000|Run-in Period|Other than specified above|17|||
13226759|NCT01764997|26299311|FG001|Run-in Period|Other than specified above|0|||
13226760|NCT01764997|26299312|FG002|Run-in Period|Other than specified above|0|||
13226761|NCT01764997|26299313|FG003|Run-in Period|Other than specified above|0|||
13226762|NCT01764997|26299314|FG004|Run-in Period|Other than specified above|0|||
13226763|NCT01764997|26299310|FG000|Study Drug Treatment Period|Adverse Event|0|||
13226764|NCT01764997|26299311|FG001|Study Drug Treatment Period|Adverse Event|1|||
13226765|NCT01764997|26299312|FG002|Study Drug Treatment Period|Adverse Event|0|||
13226766|NCT01764997|26299313|FG003|Study Drug Treatment Period|Adverse Event|0|||
13226767|NCT01764997|26299314|FG004|Study Drug Treatment Period|Adverse Event|24|||
13226768|NCT01764997|26299310|FG000|Study Drug Treatment Period|Lack of Efficacy|0|||
13226769|NCT01764997|26299311|FG001|Study Drug Treatment Period|Lack of Efficacy|0|||
13226770|NCT01764997|26299312|FG002|Study Drug Treatment Period|Lack of Efficacy|0|||
13226771|NCT01764997|26299313|FG003|Study Drug Treatment Period|Lack of Efficacy|0|||
13113794|NCT03131648|25912541|FG003|Open-label Treatment|Discontinued IMP|0|||
13226772|NCT01764997|26299314|FG004|Study Drug Treatment Period|Lack of Efficacy|2|||
13226773|NCT01764997|26299310|FG000|Study Drug Treatment Period|Other than specified above|0|||
13226774|NCT01764997|26299311|FG001|Study Drug Treatment Period|Other than specified above|0|||
13226775|NCT01764997|26299312|FG002|Study Drug Treatment Period|Other than specified above|0|||
13289569|NCT00108160|26479641|FG000|Overall Study|Death|1|||
13226776|NCT01764997|26299313|FG003|Study Drug Treatment Period|Other than specified above|0|||
13226777|NCT01764997|26299314|FG004|Study Drug Treatment Period|Other than specified above|10|||
13226778|NCT01764945|26299373|FG000|Overall Study|Adverse Event|0|||
13226779|NCT01764945|26299374|FG001|Overall Study|Adverse Event|1|||
13226780|NCT01764945|26299375|FG002|Overall Study|Adverse Event|0|||
13226781|NCT01764945|26299376|FG003|Overall Study|Adverse Event|0|||
13226782|NCT01764945|26299377|FG004|Overall Study|Adverse Event|0|||
13226783|NCT01764945|26299378|FG005|Overall Study|Adverse Event|0|||
13226784|NCT01764945|26299379|FG006|Overall Study|Adverse Event|1|||
13226785|NCT01764945|26299380|FG007|Overall Study|Adverse Event|0|||
13226786|NCT01764854|26299403|FG000|Overall Study|Adverse Event|0|||
13226787|NCT01764854|26299404|FG001|Overall Study|Adverse Event|0|||
13226788|NCT01764854|26299405|FG002|Overall Study|Adverse Event|2|||
13226789|NCT01764854|26299406|FG003|Overall Study|Adverse Event|0|||
13226790|NCT01764854|26299403|FG000|Overall Study|Withdrawal by Subject|0|||
13226791|NCT01764854|26299404|FG001|Overall Study|Withdrawal by Subject|0|||
13226792|NCT01764854|26299405|FG002|Overall Study|Withdrawal by Subject|1|||
13226793|NCT01764854|26299406|FG003|Overall Study|Withdrawal by Subject|0|||
13226794|NCT01764854|26299403|FG000|Overall Study|relocation|0|||
13226795|NCT01764854|26299404|FG001|Overall Study|relocation|0|||
13226796|NCT01764854|26299405|FG002|Overall Study|relocation|2|||
13226797|NCT01764854|26299406|FG003|Overall Study|relocation|0|||
13226798|NCT01764854|26299403|FG000|Overall Study|Protocol Violation|0|||
13226799|NCT01764854|26299404|FG001|Overall Study|Protocol Violation|0|||
13226800|NCT01764854|26299405|FG002|Overall Study|Protocol Violation|1|||
13226801|NCT01764854|26299406|FG003|Overall Study|Protocol Violation|2|||
13226802|NCT01764841|26299451|FG000|Overall Study|Logistical Difficulties|0|||
13226803|NCT01764841|26299452|FG001|Overall Study|Logistical Difficulties|1|||
13226804|NCT01764841|26299453|FG002|Overall Study|Logistical Difficulties|0|||
13226805|NCT01764841|26299454|FG003|Overall Study|Logistical Difficulties|0|||
13226806|NCT01764841|26299451|FG000|Overall Study|Death|3|||
13226807|NCT01764841|26299452|FG001|Overall Study|Death|0|||
13226808|NCT01764841|26299453|FG002|Overall Study|Death|1|||
13226809|NCT01764841|26299454|FG003|Overall Study|Death|4|||
13226810|NCT01764841|26299451|FG000|Overall Study|No Follow Up|1|||
13226811|NCT01764841|26299452|FG001|Overall Study|No Follow Up|0|||
13226812|NCT01764841|26299453|FG002|Overall Study|No Follow Up|1|||
13226813|NCT01764841|26299454|FG003|Overall Study|No Follow Up|0|||
13226814|NCT01764841|26299451|FG000|Overall Study|Protocol Violation|0|||
13226815|NCT01764841|26299452|FG001|Overall Study|Protocol Violation|1|||
13226816|NCT01764841|26299453|FG002|Overall Study|Protocol Violation|0|||
13226817|NCT01764841|26299454|FG003|Overall Study|Protocol Violation|0|||
13226818|NCT01764841|26299451|FG000|Overall Study|Withdrawal by Subject|16|||
13226819|NCT01764841|26299452|FG001|Overall Study|Withdrawal by Subject|24|||
13226820|NCT01764841|26299453|FG002|Overall Study|Withdrawal by Subject|11|||
13226821|NCT01764841|26299454|FG003|Overall Study|Withdrawal by Subject|15|||
13226822|NCT01764841|26299451|FG000|Overall Study|Lost to Follow-up|3|||
13226823|NCT01764841|26299452|FG001|Overall Study|Lost to Follow-up|0|||
13226824|NCT01764841|26299453|FG002|Overall Study|Lost to Follow-up|1|||
13226825|NCT01764841|26299454|FG003|Overall Study|Lost to Follow-up|0|||
13226826|NCT01764659|26299468|FG000|Overall Study|Death|1|||
13226827|NCT01764659|26299468|FG000|Overall Study|Physician Decision|1|||
13226828|NCT01764633|26299497|FG000|Overall Study|Withdrawal by Subject|105|||
13226829|NCT01764633|26299498|FG001|Overall Study|Withdrawal by Subject|88|||
13226830|NCT01764633|26299497|FG000|Overall Study|Lost to Follow-up|13|||
13226831|NCT01764633|26299498|FG001|Overall Study|Lost to Follow-up|5|||
13226832|NCT01764464|26299521|FG000|First Intervention|Withdrawal by Subject|1|||
13226833|NCT01764464|26299522|FG001|First Intervention|Withdrawal by Subject|0|||
13226834|NCT01764464|26299521|FG000|First Intervention|Lost to Follow-up|1|||
13226835|NCT01764464|26299522|FG001|First Intervention|Lost to Follow-up|0|||
13113795|NCT03131648|25912542|FG004|Open-label Treatment|Discontinued IMP|0|||
13113796|NCT03131648|25912543|FG005|Open-label Treatment|Discontinued IMP|0|||
13226836|NCT01764464|26299521|FG000|First Intervention|Adverse Event|0|||
13226837|NCT01764464|26299522|FG001|First Intervention|Adverse Event|2|||
13226838|NCT01764464|26299521|FG000|First Intervention|did not receive study drug|0|||
13226839|NCT01764464|26299522|FG001|First Intervention|did not receive study drug|1|||
13226840|NCT01764464|26299521|FG000|Second Intervention (Cross-over)|Adverse Event|2|||
13226841|NCT01764464|26299522|FG001|Second Intervention (Cross-over)|Adverse Event|0|||
13226842|NCT01764386|26299570|FG000|Controlled Treatment Period (CTP)|Adverse Event|35|||
13226843|NCT01764386|26299571|FG001|Controlled Treatment Period (CTP)|Adverse Event|0|||
13226844|NCT01764386|26299570|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32|||
13226845|NCT01764386|26299571|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0|||
13226846|NCT01764386|26299570|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9|||
13226847|NCT01764386|26299571|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5|||
13226848|NCT01764386|26299570|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6|||
13226849|NCT01764386|26299571|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2|||
13226850|NCT01764386|26299570|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2|||
13226851|NCT01764386|26299571|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13|||
13226852|NCT01764386|26299570|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0|||
13226853|NCT01764386|26299571|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26|||
13226854|NCT01764386|26299570|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
13226855|NCT01764386|26299571|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
13226856|NCT01764386|26299570|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
13226857|NCT01764386|26299571|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
13226858|NCT01764256|26299625|FG000|Received All Vaccinations|Adverse Event|1|||
13226859|NCT01764256|26299626|FG001|Received All Vaccinations|Adverse Event|1|||
13226860|NCT01764256|26299627|FG002|Received All Vaccinations|Adverse Event|0|||
13226861|NCT01764256|26299628|FG003|Received All Vaccinations|Adverse Event|0|||
13226862|NCT01764256|26299625|FG000|Received All Vaccinations|Did not meet inclusion criteria|0|||
13226863|NCT01764256|26299626|FG001|Received All Vaccinations|Did not meet inclusion criteria|0|||
13226864|NCT01764256|26299627|FG002|Received All Vaccinations|Did not meet inclusion criteria|1|||
13226865|NCT01764256|26299628|FG003|Received All Vaccinations|Did not meet inclusion criteria|0|||
13226866|NCT01764256|26299625|FG000|Received All Vaccinations|Lost to Follow-up|1|||
13226867|NCT01764256|26299626|FG001|Received All Vaccinations|Lost to Follow-up|0|||
13226868|NCT01764256|26299627|FG002|Received All Vaccinations|Lost to Follow-up|0|||
13226869|NCT01764256|26299628|FG003|Received All Vaccinations|Lost to Follow-up|0|||
13226870|NCT01764256|26299625|FG000|Completed Study|Lost to Follow-up|0|||
13226871|NCT01764256|26299626|FG001|Completed Study|Lost to Follow-up|0|||
13226872|NCT01764256|26299627|FG002|Completed Study|Lost to Follow-up|0|||
13226873|NCT01764256|26299628|FG003|Completed Study|Lost to Follow-up|1|||
13226874|NCT01764022|26299667|FG000|Overall Study|Death|3|||
13226875|NCT01764022|26299668|FG001|Overall Study|Death|5|||
13226876|NCT01764022|26299667|FG000|Overall Study|Withdrawal by Subject|2|||
13226877|NCT01764022|26299668|FG001|Overall Study|Withdrawal by Subject|6|||
13226878|NCT01764022|26299667|FG000|Overall Study|Lack of Efficacy|0|||
13226879|NCT01764022|26299668|FG001|Overall Study|Lack of Efficacy|1|||
13226880|NCT01764022|26299667|FG000|Overall Study|Physician Decision|0|||
13226881|NCT01764022|26299668|FG001|Overall Study|Physician Decision|2|||
13226882|NCT01764022|26299667|FG000|Overall Study|Lost to Follow-up|2|||
13226883|NCT01764022|26299668|FG001|Overall Study|Lost to Follow-up|0|||
13226884|NCT01764022|26299667|FG000|Overall Study|Protocol Violation|1|||
13226885|NCT01764022|26299668|FG001|Overall Study|Protocol Violation|0|||
13226886|NCT01763996|26299697|FG000|Treatment Period 2|Adverse Event|0|||
13226887|NCT01763996|26299698|FG001|Treatment Period 2|Adverse Event|1|||
13226888|NCT01763918|26299805|FG000|Overall Study|Withdrawal by Subject|2|||
13226889|NCT01763918|26299806|FG001|Overall Study|Withdrawal by Subject|1|||
13226890|NCT01763918|26299807|FG002|Overall Study|Withdrawal by Subject|1|||
13226891|NCT01763918|26299808|FG003|Overall Study|Withdrawal by Subject|2|||
13226892|NCT01763918|26299805|FG000|Overall Study|Sponsor Decision|4|||
13226893|NCT01763918|26299806|FG001|Overall Study|Sponsor Decision|0|||
13226894|NCT01763918|26299807|FG002|Overall Study|Sponsor Decision|9|||
13226895|NCT01763918|26299808|FG003|Overall Study|Sponsor Decision|0|||
13226896|NCT01763905|26299915|FG000|Overall Study|Withdrawal by Subject|1|||
13226897|NCT01763905|26299916|FG001|Overall Study|Withdrawal by Subject|1|||
13226898|NCT01763905|26299917|FG002|Overall Study|Withdrawal by Subject|0|||
13226899|NCT01763905|26299918|FG003|Overall Study|Withdrawal by Subject|1|||
13226900|NCT01763905|26299915|FG000|Overall Study|Decision by sponsor|5|||
13226901|NCT01763905|26299916|FG001|Overall Study|Decision by sponsor|0|||
13226902|NCT01763905|26299917|FG002|Overall Study|Decision by sponsor|8|||
13226903|NCT01763905|26299918|FG003|Overall Study|Decision by sponsor|0|||
13226904|NCT01763905|26299915|FG000|Overall Study|Lost to Follow-up|0|||
13226905|NCT01763905|26299916|FG001|Overall Study|Lost to Follow-up|0|||
13226906|NCT01763905|26299917|FG002|Overall Study|Lost to Follow-up|1|||
13226907|NCT01763905|26299918|FG003|Overall Study|Lost to Follow-up|0|||
13226908|NCT01763684|26299951|FG000|Overall Study|Study terminated early due to low enrollment|126|||
13226909|NCT01763684|26299952|FG001|Overall Study|Study terminated early due to low enrollment|127|||
13226910|NCT01763684|26299951|FG000|Overall Study|Study surgery not performed|7|||
13226911|NCT01763684|26299952|FG001|Overall Study|Study surgery not performed|6|||
13226912|NCT01763203|26300003|FG000|Overall Study|Death|4|||
13226913|NCT01763203|26300004|FG001|Overall Study|Death|7|||
13226914|NCT01763203|26300003|FG000|Overall Study|Lost to Follow-up|12|||
13226915|NCT01763203|26300004|FG001|Overall Study|Lost to Follow-up|12|||
13226916|NCT01763203|26300003|FG000|Overall Study|Withdrawal by Subject|8|||
13226917|NCT01763203|26300004|FG001|Overall Study|Withdrawal by Subject|12|||
13226918|NCT01763203|26300003|FG000|Overall Study|Moved out of study region|7|||
13226919|NCT01763203|26300004|FG001|Overall Study|Moved out of study region|10|||
13226920|NCT01763203|26300003|FG000|Overall Study|Physician Decision|2|||
13226921|NCT01763203|26300004|FG001|Overall Study|Physician Decision|1|||
13226922|NCT01763164|26300056|FG000|Treatment Phase|Participant/Guardian decision|26|||
13226923|NCT01763164|26300057|FG001|Treatment Phase|Participant/Guardian decision|14|||
13226924|NCT01763164|26300056|FG000|Treatment Phase|Protocol Violation|1|||
13226925|NCT01763164|26300057|FG001|Treatment Phase|Protocol Violation|1|||
13226926|NCT01763164|26300056|FG000|Treatment Phase|Progressive Disease|142|||
13226927|NCT01763164|26300057|FG001|Treatment Phase|Progressive Disease|76|||
13226928|NCT01763164|26300056|FG000|Treatment Phase|Physician Decision|24|||
13226929|NCT01763164|26300057|FG001|Treatment Phase|Physician Decision|13|||
13226930|NCT01763164|26300056|FG000|Treatment Phase|Death|10|||
13226931|NCT01763164|26300057|FG001|Treatment Phase|Death|1|||
13226932|NCT01763164|26300056|FG000|Treatment Phase|Adverse Event|66|||
13226933|NCT01763164|26300057|FG001|Treatment Phase|Adverse Event|8|||
13226934|NCT01763164|26300056|FG000|Treatment Phase|Randomized but not Treated|0|||
13226935|NCT01763164|26300057|FG001|Treatment Phase|Randomized but not Treated|19|||
13226936|NCT01763164|26300056|FG000|Treatment Phase|Other|0|||
13226937|NCT01763164|26300057|FG001|Treatment Phase|Other|1|||
13226938|NCT01763164|26300056|FG000|Follow up Phase|New therapy for study indication|12|||
13226939|NCT01763164|26300057|FG001|Follow up Phase|New therapy for study indication|3|||
13226940|NCT01763164|26300056|FG000|Follow up Phase|Death|21|||
13226941|NCT01763164|26300057|FG001|Follow up Phase|Death|4|||
13226942|NCT01763164|26300056|FG000|Follow up Phase|Subject/guardian decision|9|||
13226943|NCT01763164|26300057|FG001|Follow up Phase|Subject/guardian decision|2|||
13226944|NCT01763164|26300056|FG000|Follow up Phase|Progressive disease|127|||
13226945|NCT01763164|26300057|FG001|Follow up Phase|Progressive disease|62|||
13226946|NCT01763164|26300056|FG000|Follow up Phase|Physician Decision|10|||
13226947|NCT01763164|26300057|FG001|Follow up Phase|Physician Decision|3|||
13226948|NCT01763164|26300056|FG000|Follow up Phase|Lost to Follow-up|1|||
13226949|NCT01763164|26300057|FG001|Follow up Phase|Lost to Follow-up|0|||
13226950|NCT01763164|26300056|FG000|Follow up Phase|Adverse Event|17|||
13226951|NCT01763164|26300057|FG001|Follow up Phase|Adverse Event|1|||
13226952|NCT01763047|26300080|FG000|Period 1|Test Article Not Available|4|||
13113797|NCT03131648|25912544|FG006|Open-label Treatment|Discontinued IMP|112|||
13113798|NCT03131648|25912545|FG007|Open-label Treatment|Discontinued IMP|0|||
13113799|NCT03131648|25912538|FG000|Open-label Treatment|Completed Week 50|0|||
13113800|NCT03131648|25912539|FG001|Open-label Treatment|Completed Week 50|0|||
13113801|NCT03131648|25912540|FG002|Open-label Treatment|Completed Week 50|0|||
13113802|NCT03131648|25912541|FG003|Open-label Treatment|Completed Week 50|0|||
13113803|NCT03131648|25912542|FG004|Open-label Treatment|Completed Week 50|0|||
13113804|NCT03131648|25912543|FG005|Open-label Treatment|Completed Week 50|0|||
13113805|NCT03131648|25912544|FG006|Open-label Treatment|Completed Week 50|6|||
13113806|NCT03131648|25912545|FG007|Open-label Treatment|Completed Week 50|0|||
13113807|NCT03131648|25912538|FG000|Maintenance Treatment Period|Not dosed|0|||
13113808|NCT03131648|25912539|FG001|Maintenance Treatment Period|Not dosed|0|||
13113809|NCT03131648|25912540|FG002|Maintenance Treatment Period|Not dosed|3|||
13113810|NCT03131648|25912541|FG003|Maintenance Treatment Period|Not dosed|2|||
13113811|NCT03131648|25912542|FG004|Maintenance Treatment Period|Not dosed|1|||
13113812|NCT03131648|25912543|FG005|Maintenance Treatment Period|Not dosed|0|||
13113813|NCT03131648|25912544|FG006|Maintenance Treatment Period|Not dosed|0|||
13113814|NCT03131648|25912545|FG007|Maintenance Treatment Period|Not dosed|0|||
13113815|NCT03131648|25912538|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
13113816|NCT03131648|25912539|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
13113817|NCT03131648|25912540|FG002|Maintenance Treatment Period|Discontinued IMP|3|||
13113818|NCT03131648|25912541|FG003|Maintenance Treatment Period|Discontinued IMP|5|||
13113819|NCT03131648|25912542|FG004|Maintenance Treatment Period|Discontinued IMP|4|||
13113820|NCT03131648|25912543|FG005|Maintenance Treatment Period|Discontinued IMP|4|||
13113821|NCT03131648|25912544|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
13113822|NCT03131648|25912545|FG007|Maintenance Treatment Period|Discontinued IMP|0|||
13113823|NCT03131648|25912538|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
13113824|NCT03131648|25912539|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
13113825|NCT03131648|25912540|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21|||
13113826|NCT03131648|25912541|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18|||
13113827|NCT03131648|25912542|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9|||
13113828|NCT03131648|25912543|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10|||
13113829|NCT03131648|25912544|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
13113830|NCT03131648|25912545|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0|||
13113831|NCT03131648|25912538|FG000|Maintenance Treatment Period|Completed Week 50|0|||
13113832|NCT03131648|25912539|FG001|Maintenance Treatment Period|Completed Week 50|0|||
13113833|NCT03131648|25912540|FG002|Maintenance Treatment Period|Completed Week 50|0|||
13113834|NCT03131648|25912541|FG003|Maintenance Treatment Period|Completed Week 50|0|||
13113835|NCT03131648|25912542|FG004|Maintenance Treatment Period|Completed Week 50|1|||
13226953|NCT01763047|26300081|FG001|Period 1|Test Article Not Available|1|||
13226954|NCT01763047|26300080|FG000|Period 1|Protocol Violation|4|||
13226955|NCT01763047|26300081|FG001|Period 1|Protocol Violation|4|||
13226956|NCT01763047|26300080|FG000|Period 1|No Longer Meets Eligibility criteria|1|||
13226957|NCT01763047|26300081|FG001|Period 1|No Longer Meets Eligibility criteria|0|||
13113836|NCT03131648|25912543|FG005|Maintenance Treatment Period|Completed Week 50|0|||
13113837|NCT03131648|25912544|FG006|Maintenance Treatment Period|Completed Week 50|0|||
13113838|NCT03131648|25912545|FG007|Maintenance Treatment Period|Completed Week 50|0|||
13113839|NCT03131648|25912538|FG000|Open-label (Short Term Extension)|Discontinued IMP|0|||
13113840|NCT03131648|25912539|FG001|Open-label (Short Term Extension)|Discontinued IMP|0|||
13113841|NCT03131648|25912540|FG002|Open-label (Short Term Extension)|Discontinued IMP|0|||
13113842|NCT03131648|25912541|FG003|Open-label (Short Term Extension)|Discontinued IMP|0|||
13113843|NCT03131648|25912542|FG004|Open-label (Short Term Extension)|Discontinued IMP|0|||
13113844|NCT03131648|25912543|FG005|Open-label (Short Term Extension)|Discontinued IMP|0|||
13113845|NCT03131648|25912544|FG006|Open-label (Short Term Extension)|Discontinued IMP|0|||
13113846|NCT03131648|25912545|FG007|Open-label (Short Term Extension)|Discontinued IMP|3|||
13113847|NCT03131596|25912564|FG000|Overall Study|Protocol Violation|3|||
13113848|NCT03131596|25912565|FG001|Overall Study|Protocol Violation|3|||
13113849|NCT03131596|25912564|FG000|Overall Study|Lost to Follow-up|3|||
13113850|NCT03131596|25912565|FG001|Overall Study|Lost to Follow-up|0|||
13113851|NCT03131570|25912596|FG000|Overall Study|Adverse Event|1|||
13113852|NCT03131570|25912597|FG001|Overall Study|Adverse Event|0|||
13113853|NCT03131479|25912670|FG000|Overall Study|Adverse Event|0|||
13113854|NCT03131479|25912671|FG001|Overall Study|Adverse Event|0|||
13113855|NCT03131479|25912672|FG002|Overall Study|Adverse Event|1|||
13113856|NCT03131479|25912673|FG003|Overall Study|Adverse Event|1|||
13113857|NCT03131479|25912674|FG004|Overall Study|Adverse Event|0|||
13113858|NCT03131479|25912670|FG000|Overall Study|Subject/Guardian Decision|0|||
13113859|NCT03131479|25912671|FG001|Overall Study|Subject/Guardian Decision|0|||
13113860|NCT03131479|25912672|FG002|Overall Study|Subject/Guardian Decision|0|||
13113861|NCT03131479|25912673|FG003|Overall Study|Subject/Guardian Decision|1|||
13113862|NCT03131479|25912674|FG004|Overall Study|Subject/Guardian Decision|0|||
13113863|NCT03131453|25912734|FG000|Overall Study|Study terminated by Sponsor|424|||
13113864|NCT03131453|25912735|FG001|Overall Study|Study terminated by Sponsor|222|||
13113865|NCT03131453|25912736|FG002|Overall Study|Study terminated by Sponsor|438|||
13113866|NCT03131453|25912734|FG000|Overall Study|Withdrawal by Subject|18|||
13113867|NCT03131453|25912735|FG001|Overall Study|Withdrawal by Subject|7|||
13113868|NCT03131453|25912736|FG002|Overall Study|Withdrawal by Subject|13|||
13113869|NCT03131453|25912734|FG000|Overall Study|Adverse Event|10|||
13113870|NCT03131453|25912735|FG001|Overall Study|Adverse Event|3|||
13113871|NCT03131453|25912736|FG002|Overall Study|Adverse Event|3|||
13113872|NCT03131453|25912734|FG000|Overall Study|Lost to Follow-up|1|||
13113873|NCT03131453|25912735|FG001|Overall Study|Lost to Follow-up|0|||
13113874|NCT03131453|25912736|FG002|Overall Study|Lost to Follow-up|1|||
13113875|NCT03131453|25912734|FG000|Overall Study|Physician Decision|1|||
13113876|NCT03131453|25912735|FG001|Overall Study|Physician Decision|0|||
13113877|NCT03131453|25912736|FG002|Overall Study|Physician Decision|1|||
13113878|NCT03131453|25912734|FG000|Overall Study|Non-compliance with study treatment|1|||
13113879|NCT03131453|25912735|FG001|Overall Study|Non-compliance with study treatment|0|||
13113880|NCT03131453|25912736|FG002|Overall Study|Non-compliance with study treatment|0|||
13113881|NCT03131453|25912734|FG000|Overall Study|Technical problems|1|||
13113882|NCT03131453|25912735|FG001|Overall Study|Technical problems|0|||
13113883|NCT03131453|25912736|FG002|Overall Study|Technical problems|0|||
13113884|NCT03131453|25912734|FG000|Overall Study|Protocol deviation|0|||
13113885|NCT03131453|25912735|FG001|Overall Study|Protocol deviation|1|||
13113886|NCT03131453|25912736|FG002|Overall Study|Protocol deviation|0|||
13113887|NCT03131219|25912765|FG000|Initial Evaluation Period|Adverse Event|1|||
13113888|NCT03131219|25912766|FG001|Initial Evaluation Period|Adverse Event|0|||
13113889|NCT03131219|25912765|FG000|Initial Evaluation Period|Protocol Violation|1|||
13113890|NCT03131219|25912766|FG001|Initial Evaluation Period|Protocol Violation|0|||
13113891|NCT03131219|25912765|FG000|Initial Evaluation Period|Deemed ineligible post treatment|2|||
13113892|NCT03131219|25912766|FG001|Initial Evaluation Period|Deemed ineligible post treatment|0|||
13113893|NCT03131167|25912847|FG000|Overall Study|Other (Unspecified)|0|||
13113894|NCT03131167|25912848|FG001|Overall Study|Other (Unspecified)|0|||
13113895|NCT03131167|25912849|FG002|Overall Study|Other (Unspecified)|0|||
13113896|NCT03131167|25912850|FG003|Overall Study|Other (Unspecified)|0|||
13113897|NCT03131167|25912851|FG004|Overall Study|Other (Unspecified)|0|||
13113898|NCT03131167|25912852|FG005|Overall Study|Other (Unspecified)|1|||
13113899|NCT03131167|25912853|FG006|Overall Study|Other (Unspecified)|0|||
13113900|NCT03131167|25912854|FG007|Overall Study|Other (Unspecified)|0|||
13113901|NCT03131167|25912855|FG008|Overall Study|Other (Unspecified)|0|||
13203150|NCT01987908|26223278|FG002|Post-Treatment Observation Period|Other: Bad Veins|0|||
13203151|NCT01987895|26223309|FG000|Overall Study|Withdrawal by Subject|12|||
13203152|NCT01987895|26223310|FG001|Overall Study|Withdrawal by Subject|7|||
13203153|NCT01987895|26223309|FG000|Overall Study|Physician Decision|8|||
13203154|NCT01987895|26223310|FG001|Overall Study|Physician Decision|10|||
13203155|NCT01987895|26223309|FG000|Overall Study|Death|7|||
13113902|NCT03131167|25912856|FG009|Overall Study|Other (Unspecified)|0|||
13113903|NCT03131167|25912857|FG010|Overall Study|Other (Unspecified)|0|||
13113904|NCT03131167|25912858|FG011|Overall Study|Other (Unspecified)|0|||
13113905|NCT03131167|25912859|FG012|Overall Study|Other (Unspecified)|0|||
13113906|NCT03130959|25913027|FG000|Overall Study|Disease progression|19|||
13113907|NCT03130959|25913028|FG001|Overall Study|Disease progression|7|||
13113908|NCT03130959|25913029|FG002|Overall Study|Disease progression|12|||
13113909|NCT03130959|25913030|FG003|Overall Study|Disease progression|7|||
13113910|NCT03130959|25913031|FG004|Overall Study|Disease progression|12|||
13113911|NCT03130959|25913032|FG005|Overall Study|Disease progression|3|||
13113912|NCT03130959|25913033|FG006|Overall Study|Disease progression|6|||
13113913|NCT03130959|25913034|FG007|Overall Study|Disease progression|3|||
13113914|NCT03130959|25913035|FG008|Overall Study|Disease progression|15|||
13113915|NCT03130959|25913036|FG009|Overall Study|Disease progression|8|||
13113916|NCT03130959|25913027|FG000|Overall Study|Study drug toxicity|2|||
13113917|NCT03130959|25913028|FG001|Overall Study|Study drug toxicity|2|||
13113918|NCT03130959|25913029|FG002|Overall Study|Study drug toxicity|1|||
13113919|NCT03130959|25913030|FG003|Overall Study|Study drug toxicity|2|||
13113920|NCT03130959|25913031|FG004|Overall Study|Study drug toxicity|1|||
13113921|NCT03130959|25913032|FG005|Overall Study|Study drug toxicity|1|||
13113922|NCT03130959|25913033|FG006|Overall Study|Study drug toxicity|3|||
13113923|NCT03130959|25913034|FG007|Overall Study|Study drug toxicity|0|||
13113924|NCT03130959|25913035|FG008|Overall Study|Study drug toxicity|3|||
13113925|NCT03130959|25913036|FG009|Overall Study|Study drug toxicity|3|||
13113926|NCT03130959|25913027|FG000|Overall Study|Other reasons|0|||
13113927|NCT03130959|25913028|FG001|Overall Study|Other reasons|0|||
13113928|NCT03130959|25913029|FG002|Overall Study|Other reasons|0|||
13113929|NCT03130959|25913030|FG003|Overall Study|Other reasons|0|||
13113930|NCT03130959|25913031|FG004|Overall Study|Other reasons|0|||
13113931|NCT03130959|25913032|FG005|Overall Study|Other reasons|1|||
13113932|NCT03130959|25913033|FG006|Overall Study|Other reasons|1|||
13113933|NCT03130959|25913034|FG007|Overall Study|Other reasons|0|||
13113934|NCT03130959|25913035|FG008|Overall Study|Other reasons|0|||
13113935|NCT03130959|25913036|FG009|Overall Study|Other reasons|0|||
13113936|NCT03130959|25913027|FG000|Overall Study|Subject request to discontinue therapy|0|||
13113937|NCT03130959|25913028|FG001|Overall Study|Subject request to discontinue therapy|0|||
13113938|NCT03130959|25913029|FG002|Overall Study|Subject request to discontinue therapy|1|||
13113939|NCT03130959|25913030|FG003|Overall Study|Subject request to discontinue therapy|1|||
13113940|NCT03130959|25913031|FG004|Overall Study|Subject request to discontinue therapy|0|||
13113941|NCT03130959|25913032|FG005|Overall Study|Subject request to discontinue therapy|0|||
13113942|NCT03130959|25913033|FG006|Overall Study|Subject request to discontinue therapy|1|||
13113943|NCT03130959|25913034|FG007|Overall Study|Subject request to discontinue therapy|1|||
13113944|NCT03130959|25913035|FG008|Overall Study|Subject request to discontinue therapy|0|||
13113945|NCT03130959|25913036|FG009|Overall Study|Subject request to discontinue therapy|0|||
13113946|NCT03130959|25913027|FG000|Overall Study|Not reported|0|||
13113947|NCT03130959|25913028|FG001|Overall Study|Not reported|0|||
13113948|NCT03130959|25913029|FG002|Overall Study|Not reported|0|||
13113949|NCT03130959|25913030|FG003|Overall Study|Not reported|1|||
13113950|NCT03130959|25913031|FG004|Overall Study|Not reported|0|||
13113951|NCT03130959|25913032|FG005|Overall Study|Not reported|1|||
13113952|NCT03130959|25913033|FG006|Overall Study|Not reported|0|||
13113953|NCT03130959|25913034|FG007|Overall Study|Not reported|0|||
13113954|NCT03130959|25913035|FG008|Overall Study|Not reported|0|||
13113955|NCT03130959|25913036|FG009|Overall Study|Not reported|1|||
13113956|NCT03130959|25913027|FG000|Overall Study|Adverse Event unrelated to drug|0|||
13113957|NCT03130959|25913028|FG001|Overall Study|Adverse Event unrelated to drug|0|||
13113958|NCT03130959|25913029|FG002|Overall Study|Adverse Event unrelated to drug|1|||
13113959|NCT03130959|25913030|FG003|Overall Study|Adverse Event unrelated to drug|1|||
13113960|NCT03130959|25913031|FG004|Overall Study|Adverse Event unrelated to drug|1|||
13113961|NCT03130959|25913032|FG005|Overall Study|Adverse Event unrelated to drug|0|||
13113962|NCT03130959|25913033|FG006|Overall Study|Adverse Event unrelated to drug|1|||
13113963|NCT03130959|25913034|FG007|Overall Study|Adverse Event unrelated to drug|0|||
13113964|NCT03130959|25913035|FG008|Overall Study|Adverse Event unrelated to drug|1|||
13113965|NCT03130959|25913036|FG009|Overall Study|Adverse Event unrelated to drug|1|||
13113966|NCT03130959|25913027|FG000|Overall Study|Participant withdrew consent|0|||
13113967|NCT03130959|25913028|FG001|Overall Study|Participant withdrew consent|1|||
13113968|NCT03130959|25913029|FG002|Overall Study|Participant withdrew consent|0|||
13113969|NCT03130959|25913030|FG003|Overall Study|Participant withdrew consent|2|||
13113970|NCT03130959|25913031|FG004|Overall Study|Participant withdrew consent|1|||
13113971|NCT03130959|25913032|FG005|Overall Study|Participant withdrew consent|0|||
13113972|NCT03130959|25913033|FG006|Overall Study|Participant withdrew consent|0|||
13113973|NCT03130959|25913034|FG007|Overall Study|Participant withdrew consent|0|||
13113974|NCT03130959|25913035|FG008|Overall Study|Participant withdrew consent|0|||
13113975|NCT03130959|25913036|FG009|Overall Study|Participant withdrew consent|2|||
13113976|NCT03130959|25913027|FG000|Overall Study|Administrative reason by sponsor|1|||
13113977|NCT03130959|25913028|FG001|Overall Study|Administrative reason by sponsor|0|||
13113978|NCT03130959|25913029|FG002|Overall Study|Administrative reason by sponsor|1|||
13113979|NCT03130959|25913030|FG003|Overall Study|Administrative reason by sponsor|0|||
13113980|NCT03130959|25913031|FG004|Overall Study|Administrative reason by sponsor|0|||
13113981|NCT03130959|25913032|FG005|Overall Study|Administrative reason by sponsor|0|||
13203156|NCT01987895|26223310|FG001|Overall Study|Death|7|||
13113982|NCT03130959|25913033|FG006|Overall Study|Administrative reason by sponsor|0|||
13113983|NCT03130959|25913034|FG007|Overall Study|Administrative reason by sponsor|0|||
13226958|NCT01763047|26300080|FG000|Period 1|Adverse Event|0|||
13226959|NCT01763047|26300081|FG001|Period 1|Adverse Event|1|||
13226960|NCT01763047|26300080|FG000|Period 1|Unsatisfactory Visual Response|0|||
13226961|NCT01763047|26300081|FG001|Period 1|Unsatisfactory Visual Response|3|||
13226962|NCT01763047|26300080|FG000|Period 1|Lens Power Not Available|0|||
13226963|NCT01763047|26300081|FG001|Period 1|Lens Power Not Available|1|||
13226964|NCT01763047|26300080|FG000|Period 1|Study Site office Closed|0|||
13226965|NCT01763047|26300081|FG001|Period 1|Study Site office Closed|1|||
13226966|NCT01763047|26300080|FG000|Period 2|Lens Discomfort|1|||
13226967|NCT01763047|26300081|FG001|Period 2|Lens Discomfort|0|||
13226968|NCT01763047|26300080|FG000|Period 2|No longer meets Eligibility Criteria|1|||
13226969|NCT01763047|26300081|FG001|Period 2|No longer meets Eligibility Criteria|0|||
13226970|NCT01763047|26300080|FG000|Period 2|Study Site office Closed|1|||
13226971|NCT01763047|26300081|FG001|Period 2|Study Site office Closed|1|||
13226972|NCT01763047|26300080|FG000|Period 2|Unsatisfactory Visual Response|1|||
13226973|NCT01763047|26300081|FG001|Period 2|Unsatisfactory Visual Response|1|||
13226974|NCT01763047|26300080|FG000|Period 2|Protocol Violation|0|||
13226975|NCT01763047|26300081|FG001|Period 2|Protocol Violation|2|||
13226976|NCT01763047|26300080|FG000|Period 2|Unsatisfactory lens Fitting|0|||
13226977|NCT01763047|26300081|FG001|Period 2|Unsatisfactory lens Fitting|1|||
13226978|NCT01762943|26300096|FG000|Overall Study|Physician Decision|1|||
13226979|NCT01762943|26300097|FG001|Overall Study|Physician Decision|1|||
13226980|NCT01762943|26300096|FG000|Overall Study|Protocol Violation|1|||
13226981|NCT01762943|26300097|FG001|Overall Study|Protocol Violation|0|||
13226982|NCT01762943|26300096|FG000|Overall Study|Withdrawal by Subject|2|||
13226983|NCT01762943|26300097|FG001|Overall Study|Withdrawal by Subject|1|||
13226984|NCT01762800|26300176|FG000|Overall Study|Adverse Event|8|||
13226985|NCT01762800|26300177|FG001|Overall Study|Adverse Event|13|||
13226986|NCT01762800|26300176|FG000|Overall Study|Lack of Efficacy|3|||
13226987|NCT01762800|26300177|FG001|Overall Study|Lack of Efficacy|2|||
13226988|NCT01762800|26300176|FG000|Overall Study|Study Closed/Terminated|0|||
13226989|NCT01762800|26300177|FG001|Overall Study|Study Closed/Terminated|1|||
13226990|NCT01762800|26300176|FG000|Overall Study|Physician Decision|1|||
13226991|NCT01762800|26300177|FG001|Overall Study|Physician Decision|1|||
13226992|NCT01762800|26300176|FG000|Overall Study|Withdrawal by Subject|7|||
13226993|NCT01762800|26300177|FG001|Overall Study|Withdrawal by Subject|4|||
13226994|NCT01762345|26300189|FG000|Overall Study|Adverse Event|5|||
13226995|NCT01762345|26300189|FG000|Overall Study|Protocol Violation|2|||
13226996|NCT01761565|26300200|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1|||
13226997|NCT01761292|26300227|FG000|Part 1|Adverse Event|1|||
13226998|NCT01761292|26300227|FG000|Part 1|not receiving treatment in Part 1|1|||
13226999|NCT01761292|26300227|FG000|Extension 1|Withdrawal by Subject|1|||
13227000|NCT01761266|26300260|FG000|Overall Study|Death|415|||
13113984|NCT03130959|25913035|FG008|Overall Study|Administrative reason by sponsor|0|||
13113985|NCT03130959|25913036|FG009|Overall Study|Administrative reason by sponsor|0|||
13113986|NCT03130959|25913027|FG000|Overall Study|Lost to Follow-up|1|||
13113987|NCT03130959|25913028|FG001|Overall Study|Lost to Follow-up|0|||
13113988|NCT03130959|25913029|FG002|Overall Study|Lost to Follow-up|0|||
13113989|NCT03130959|25913030|FG003|Overall Study|Lost to Follow-up|0|||
13113990|NCT03130959|25913031|FG004|Overall Study|Lost to Follow-up|0|||
13113991|NCT03130959|25913032|FG005|Overall Study|Lost to Follow-up|0|||
13113992|NCT03130959|25913033|FG006|Overall Study|Lost to Follow-up|0|||
13113993|NCT03130959|25913034|FG007|Overall Study|Lost to Follow-up|0|||
13113994|NCT03130959|25913035|FG008|Overall Study|Lost to Follow-up|0|||
13113995|NCT03130959|25913036|FG009|Overall Study|Lost to Follow-up|0|||
13113996|NCT03130257|25913054|FG000|Overall Study|Withdrawal by Subject|1|||
13113997|NCT03130257|25913055|FG001|Overall Study|Withdrawal by Subject|0|||
13113998|NCT03130257|25913056|FG002|Overall Study|Withdrawal by Subject|2|||
13113999|NCT03129360|25913074|FG000|Overall Study|Did not meet entry criteria|0|||
13114000|NCT03129360|25913075|FG001|Overall Study|Did not meet entry criteria|2|||
13114001|NCT03129360|25913076|FG002|Overall Study|Did not meet entry criteria|1|||
13114002|NCT03129360|25913074|FG000|Overall Study|Excluded due to motion in scanner|1|||
13114003|NCT03129360|25913075|FG001|Overall Study|Excluded due to motion in scanner|0|||
13203157|NCT01987895|26223309|FG000|Overall Study|Lost to Follow-up|3|||
13203158|NCT01987895|26223310|FG001|Overall Study|Lost to Follow-up|5|||
13203159|NCT01987895|26223309|FG000|Overall Study|randomized before giving IC|0|||
13203160|NCT01987895|26223310|FG001|Overall Study|randomized before giving IC|1|||
13203161|NCT01987830|26223316|FG000|Overall Study|Never received baseline scan|1|||
13203162|NCT01987817|26223339|FG000|Overall Study|Adverse Event|4|||
13203163|NCT01987817|26223340|FG001|Overall Study|Adverse Event|0|||
13203164|NCT01987817|26223339|FG000|Overall Study|Withdrawal by Subject|1|||
13203165|NCT01987817|26223340|FG001|Overall Study|Withdrawal by Subject|1|||
13203166|NCT01987817|26223339|FG000|Overall Study|Physician Decision|1|||
13203167|NCT01987817|26223340|FG001|Overall Study|Physician Decision|0|||
13203168|NCT01987765|26223347|FG000|Overall Study|Protocol Violation|65|||
13203169|NCT01987765|26223347|FG000|Overall Study|Lost to Follow-up|37|||
13114004|NCT03129360|25913076|FG002|Overall Study|Excluded due to motion in scanner|0|||
13114005|NCT03128931|25913082|FG000|Overall Study|Physician Decision|1|||
13114006|NCT03128931|25913082|FG000|Overall Study|Equipment Issues|3|||
13133299|NCT02775864|25987200|FG000|Overall Study|Medicaid eligibility discontinued|1478|||
13133300|NCT02775864|25987201|FG001|Overall Study|Medicaid eligibility discontinued|2019|||
13133301|NCT02775864|25987202|FG002|Overall Study|Medicaid eligibility discontinued|720|||
13133302|NCT02775864|25987203|FG003|Overall Study|Medicaid eligibility discontinued|890|||
13133303|NCT02775344|25987228|FG000|Overall Study|No ovarian cyst identified|3|||
13133304|NCT02775344|25987229|FG001|Overall Study|No ovarian cyst identified|2|||
13133305|NCT02774681|25987240|FG000|Treatment on Study|Progressive Disease|7|||
13133306|NCT02774681|25987240|FG000|Follow-Up for 3 Years|Death|11|||
13133307|NCT02774681|25987240|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1|||
13133308|NCT02774278|25987250|FG000|Overall Study|Lack of Efficacy|199|||
13133309|NCT02774278|25987250|FG000|Overall Study|Death|29|||
13133310|NCT02774278|25987250|FG000|Overall Study|Adverse event/intercurrent illness|16|||
13133311|NCT02774278|25987250|FG000|Overall Study|Refused treatment/did not cooperate|9|||
13133312|NCT02774278|25987250|FG000|Overall Study|Administrative reasons|6|||
13133313|NCT02774278|25987250|FG000|Overall Study|Withdrawal by Subject|3|||
13133314|NCT02774278|25987250|FG000|Overall Study|Protocol Violation|2|||
13133315|NCT02773537|25987289|FG000|Overall Study|Lost to Follow-up|0|||
13133316|NCT02773537|25987290|FG001|Overall Study|Lost to Follow-up|1|||
13133317|NCT02773537|25987291|FG002|Overall Study|Lost to Follow-up|4|||
13133318|NCT02773446|25987349|FG000|First Admission|Withdrawal by Subject|0|||
13133319|NCT02773446|25987350|FG001|First Admission|Withdrawal by Subject|0|||
13133320|NCT02773446|25987351|FG002|First Admission|Withdrawal by Subject|0|||
13133321|NCT02773446|25987352|FG003|First Admission|Withdrawal by Subject|1|||
13133322|NCT02773446|25987353|FG004|First Admission|Withdrawal by Subject|0|||
13133323|NCT02773446|25987354|FG005|First Admission|Withdrawal by Subject|0|||
13133324|NCT02773446|25987349|FG000|First Admission|Lost to Follow-up|1|||
13133325|NCT02773446|25987350|FG001|First Admission|Lost to Follow-up|0|||
13133326|NCT02773446|25987351|FG002|First Admission|Lost to Follow-up|0|||
13133327|NCT02773446|25987352|FG003|First Admission|Lost to Follow-up|0|||
13133328|NCT02773446|25987353|FG004|First Admission|Lost to Follow-up|0|||
13133329|NCT02773446|25987354|FG005|First Admission|Lost to Follow-up|0|||
13133330|NCT02773368|25987431|FG000|Overall Study|Lost to Follow-up|4|||
13133331|NCT02773368|25987432|FG001|Overall Study|Lost to Follow-up|1|||
13133332|NCT02773368|25987431|FG000|Overall Study|Withdrawal by Subject|5|||
13133333|NCT02773368|25987432|FG001|Overall Study|Withdrawal by Subject|1|||
13133334|NCT02773368|25987431|FG000|Overall Study|Unclassified|1|||
13133335|NCT02773368|25987432|FG001|Overall Study|Unclassified|1|||
13133336|NCT02773368|25987431|FG000|Overall Study|Missing|0|||
13133337|NCT02773368|25987432|FG001|Overall Study|Missing|1|||
13133338|NCT02772978|25987441|FG000|Overall Study|Withdrawal by Subject|1|||
13133339|NCT02772978|25987442|FG001|Overall Study|Withdrawal by Subject|1|||
13133340|NCT02772809|25987453|FG000|Overall Study|not completed some tasks|6|||
13133341|NCT02772757|25987480|FG000|Overall Study|Withdrawal by Subject|1|||
13133342|NCT02772757|25987481|FG001|Overall Study|Withdrawal by Subject|0|||
13133343|NCT02772757|25987482|FG002|Overall Study|Withdrawal by Subject|1|||
13133344|NCT02772757|25987480|FG000|Overall Study|Protocol Violation|0|||
13133345|NCT02772757|25987481|FG001|Overall Study|Protocol Violation|0|||
13133346|NCT02772757|25987482|FG002|Overall Study|Protocol Violation|1|||
13133347|NCT02772757|25987480|FG000|Overall Study|Physician Decision|0|||
13133348|NCT02772757|25987481|FG001|Overall Study|Physician Decision|3|||
13133349|NCT02772757|25987482|FG002|Overall Study|Physician Decision|3|||
13227001|NCT01761266|26300261|FG001|Overall Study|Death|402|||
13227002|NCT01761266|26300260|FG000|Overall Study|Lost to Follow-up|8|||
13227003|NCT01761266|26300261|FG001|Overall Study|Lost to Follow-up|12|||
13227004|NCT01761266|26300260|FG000|Overall Study|Withdrawal by Subject|14|||
13227005|NCT01761266|26300261|FG001|Overall Study|Withdrawal by Subject|10|||
13227006|NCT01761266|26300260|FG000|Overall Study|Sponsor Decision|41|||
13227007|NCT01761266|26300261|FG001|Overall Study|Sponsor Decision|52|||
13227008|NCT01761162|26300271|FG000|Overall Study|Withdrawal by Subject|3|||
13227009|NCT01760954|26300362|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8|||
13227010|NCT01760954|26300363|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8|||
13227011|NCT01760954|26300364|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4|||
13227012|NCT01760954|26300365|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5|||
13227013|NCT01760954|26300362|FG000|Treatment Period (6 Months)|Adverse Event|5|||
13133350|NCT02771522|25987493|FG000|Overall Study|Lost to Follow-up|3|||
13133351|NCT02771522|25987493|FG000|Overall Study|Withdrawal by Subject|2|||
13133352|NCT02771522|25987493|FG000|Overall Study|No white spot lesions|3|||
13133353|NCT02771366|25987507|FG000|Period 1|Withdrawal by Subject|0|||
13133354|NCT02771366|25987508|FG001|Period 1|Withdrawal by Subject|2|||
13133355|NCT02771366|25987507|FG000|Period 2 (Crossover)|Withdrawal by Subject|2|||
13133356|NCT02771366|25987508|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
13133357|NCT02771275|25987518|FG000|Overall Study|Reoperation|2|||
13133358|NCT02771275|25987518|FG000|Overall Study|On Study|11|||
13133359|NCT02771210|25987551|FG000|Period 1|Adverse Event|5|||
13114007|NCT03128892|25913090|FG000|Overall Study|Withdrawal by Subject|2|||
13114008|NCT03128892|25913090|FG000|Overall Study|Physician Decision|1|||
13114009|NCT03128723|25913107|FG000|Overall Study|Withdrawal by Subject|2|||
13114010|NCT03128411|25913149|FG000|Treatment Phase|Adverse Event|21|||
13114011|NCT03128411|25913149|FG000|Treatment Phase|Physician Decision|1|||
13114012|NCT03128411|25913149|FG000|Treatment Phase|Other|2|||
13114013|NCT03128411|25913149|FG000|Long Term Follow-up Phase|Death|2|||
13114014|NCT03128307|25913156|FG000|Overall Study|Lost to Follow-up|29|||
13114015|NCT03128307|25913156|FG000|Overall Study|Withdrawal by Subject|5|||
13114016|NCT03128099|25913172|FG000|Overall Study|High dose task was too long|0|||
13114017|NCT03128099|25913173|FG001|Overall Study|High dose task was too long|4|||
13114018|NCT03128099|25913174|FG002|Overall Study|High dose task was too long|0|||
13114019|NCT03128099|25913172|FG000|Overall Study|Participant got a full time job.|1|||
13114020|NCT03128099|25913173|FG001|Overall Study|Participant got a full time job.|0|||
13114021|NCT03128099|25913174|FG002|Overall Study|Participant got a full time job.|0|||
13114022|NCT03128099|25913172|FG000|Overall Study|Became homeless and lost contact|1|||
13114023|NCT03128099|25913173|FG001|Overall Study|Became homeless and lost contact|0|||
13114024|NCT03128099|25913174|FG002|Overall Study|Became homeless and lost contact|0|||
13114025|NCT03128099|25913172|FG000|Overall Study|Did not complete all the assessments|0|||
13114026|NCT03128099|25913173|FG001|Overall Study|Did not complete all the assessments|0|||
13114027|NCT03128099|25913174|FG002|Overall Study|Did not complete all the assessments|1|||
13114028|NCT03127644|25913216|FG000|Overall Study|Study-specific withdrawal criteria|0|||
13114029|NCT03127644|25913217|FG001|Overall Study|Study-specific withdrawal criteria|0|||
13114030|NCT03127644|25913218|FG002|Overall Study|Study-specific withdrawal criteria|2|||
13114031|NCT03127384|25913226|FG000|Overall Study|Lost to Follow-up|4|||
13114032|NCT03127384|25913226|FG000|Overall Study|Subject request|2|||
13114033|NCT03126786|25913241|FG000|Overall Study|Adverse Event|3|||
13114034|NCT03126786|25913242|FG001|Overall Study|Adverse Event|0|||
13114035|NCT03126786|25913241|FG000|Overall Study|Lost to Follow-up|0|||
13114036|NCT03126786|25913242|FG001|Overall Study|Lost to Follow-up|1|||
13114037|NCT03126786|25913241|FG000|Overall Study|Withdrawal by Subject|3|||
13114038|NCT03126786|25913242|FG001|Overall Study|Withdrawal by Subject|1|||
13114039|NCT03126344|25913266|FG000|Overall Study|Lost to Follow-up|0|||
13114040|NCT03126344|25913267|FG001|Overall Study|Lost to Follow-up|0|||
13114041|NCT03126344|25913268|FG002|Overall Study|Lost to Follow-up|5|||
13114042|NCT03126227|25913301|FG000|Overall Study|Adverse Event|43|||
13114043|NCT03126227|25913302|FG001|Overall Study|Adverse Event|4|||
13114044|NCT03126227|25913301|FG000|Overall Study|Death|0|||
13114045|NCT03126227|25913302|FG001|Overall Study|Death|1|||
13114046|NCT03126227|25913301|FG000|Overall Study|Lost to Follow-up|0|||
13114047|NCT03126227|25913302|FG001|Overall Study|Lost to Follow-up|1|||
13114048|NCT03126227|25913301|FG000|Overall Study|Physician Decision|2|||
13114049|NCT03126227|25913302|FG001|Overall Study|Physician Decision|0|||
13114050|NCT03126227|25913301|FG000|Overall Study|Protocol Violation|1|||
13114051|NCT03126227|25913302|FG001|Overall Study|Protocol Violation|0|||
13114052|NCT03126227|25913301|FG000|Overall Study|Withdrawal by Subject|19|||
13114053|NCT03126227|25913302|FG001|Overall Study|Withdrawal by Subject|3|||
13114054|NCT03126227|25913301|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8|||
13114055|NCT03126227|25913302|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1|||
13114056|NCT03126227|25913301|FG000|Overall Study|Lack of dosing compliance|2|||
13114057|NCT03126227|25913302|FG001|Overall Study|Lack of dosing compliance|0|||
13114058|NCT03126227|25913301|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2|||
13114059|NCT03126227|25913302|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0|||
13114060|NCT03126227|25913301|FG000|Overall Study|Scheduling conflict|1|||
13114061|NCT03126227|25913302|FG001|Overall Study|Scheduling conflict|0|||
13114062|NCT03126019|25913328|FG000|Overall Study|Participants Still Ongoing in the Study|17|||
13114063|NCT03126019|25913329|FG001|Overall Study|Participants Still Ongoing in the Study|87|||
13114064|NCT03126019|25913328|FG000|Overall Study|Death|2|||
13114065|NCT03126019|25913329|FG001|Overall Study|Death|7|||
13114066|NCT03126019|25913328|FG000|Overall Study|Lost to Follow-up|2|||
13114067|NCT03126019|25913329|FG001|Overall Study|Lost to Follow-up|3|||
13114068|NCT03126019|25913328|FG000|Overall Study|Withdrawal by Participant|1|||
13114069|NCT03126019|25913329|FG001|Overall Study|Withdrawal by Participant|3|||
13114070|NCT03126019|25913328|FG000|Overall Study|Reason not Specified|1|||
13114071|NCT03126019|25913329|FG001|Overall Study|Reason not Specified|3|||
13114072|NCT03125941|25913368|FG000|Overall Study|did not receive intervention|1|||
13114073|NCT03125941|25913369|FG001|Overall Study|did not receive intervention|2|||
13114074|NCT03125915|25913400|FG000|1 Month Follow up|Lost to Follow-up|3|||
13114075|NCT03125915|25913401|FG001|1 Month Follow up|Lost to Follow-up|3|||
13114076|NCT03125915|25913402|FG002|1 Month Follow up|Lost to Follow-up|2|||
13114077|NCT03125915|25913403|FG003|1 Month Follow up|Lost to Follow-up|3|||
13114078|NCT03125915|25913400|FG000|3 Month Follow-up|Lost to Follow-up|6|||
13114079|NCT03125915|25913401|FG001|3 Month Follow-up|Lost to Follow-up|4|||
13114080|NCT03125915|25913402|FG002|3 Month Follow-up|Lost to Follow-up|4|||
13114081|NCT03125915|25913403|FG003|3 Month Follow-up|Lost to Follow-up|2|||
13114082|NCT03125915|25913400|FG000|6 Month Follow-up|Lost to Follow-up|7|||
13114083|NCT03125915|25913401|FG001|6 Month Follow-up|Lost to Follow-up|3|||
13114084|NCT03125915|25913402|FG002|6 Month Follow-up|Lost to Follow-up|6|||
13114085|NCT03125915|25913403|FG003|6 Month Follow-up|Lost to Follow-up|3|||
13114086|NCT03125629|25913417|FG000|Overall Study|Withdrawal by Subject|2|||
13114087|NCT03125629|25913417|FG000|Overall Study|Equipment malfunction|1|||
13114088|NCT03125395|25913438|FG000|Overall Study|Adverse Event|2|||
13114089|NCT03125395|25913438|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
13114090|NCT03125395|25913438|FG000|Overall Study|Physician Decision|2|||
13114091|NCT03125395|25913438|FG000|Overall Study|Commercial drug is available|5|||
13114092|NCT03125200|25913658|FG000|Overall Study|Study Termination|0|||
13114093|NCT03125200|25913659|FG001|Overall Study|Study Termination|0|||
13114094|NCT03125200|25913660|FG002|Overall Study|Study Termination|0|||
13485663|NCT01126749|27033003|FG003|Phase 2|Adverse Event|1|||
13485664|NCT00821587|27033034|FG000|Overall Study|Physician Decision|0|||
13485665|NCT00821587|27033035|FG001|Overall Study|Physician Decision|1|||
13485666|NCT00585195|27033410|FG000|Overall Study|Adverse Event|0|||
13485667|NCT00585195|27033411|FG001|Overall Study|Adverse Event|0|||
13485668|NCT00585195|27033412|FG002|Overall Study|Adverse Event|0|||
13485669|NCT00585195|27033413|FG003|Overall Study|Adverse Event|0|||
13485670|NCT00585195|27033414|FG004|Overall Study|Adverse Event|2|||
13485671|NCT00585195|27033415|FG005|Overall Study|Adverse Event|1|||
13485672|NCT00585195|27033416|FG006|Overall Study|Adverse Event|0|||
13485673|NCT00585195|27033417|FG007|Overall Study|Adverse Event|1|||
13485674|NCT00585195|27033418|FG008|Overall Study|Adverse Event|0|||
13227014|NCT01760954|26300363|FG001|Treatment Period (6 Months)|Adverse Event|3|||
13227015|NCT01760954|26300364|FG002|Treatment Period (6 Months)|Adverse Event|4|||
13227016|NCT01760954|26300365|FG003|Treatment Period (6 Months)|Adverse Event|10|||
13227017|NCT01760954|26300362|FG000|Treatment Period (6 Months)|Lost to Follow-up|9|||
13227018|NCT01760954|26300363|FG001|Treatment Period (6 Months)|Lost to Follow-up|1|||
13227019|NCT01760954|26300364|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
13227020|NCT01760954|26300365|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
13227021|NCT01760954|26300362|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
13227022|NCT01760954|26300363|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
13227023|NCT01760954|26300364|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
13227024|NCT01760954|26300365|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2|||
13227025|NCT01760954|26300362|FG000|Treatment Period (6 Months)|Pregnancy|5|||
13227026|NCT01760954|26300363|FG001|Treatment Period (6 Months)|Pregnancy|0|||
13227027|NCT01760954|26300364|FG002|Treatment Period (6 Months)|Pregnancy|3|||
13227028|NCT01760954|26300365|FG003|Treatment Period (6 Months)|Pregnancy|2|||
13227029|NCT01760954|26300362|FG000|Treatment Period (6 Months)|Non-compliance|1|||
13227030|NCT01760954|26300363|FG001|Treatment Period (6 Months)|Non-compliance|4|||
13227031|NCT01760954|26300364|FG002|Treatment Period (6 Months)|Non-compliance|0|||
13227032|NCT01760954|26300365|FG003|Treatment Period (6 Months)|Non-compliance|3|||
13227033|NCT01760954|26300362|FG000|Treatment Period (6 Months)|Other|0|||
13227034|NCT01760954|26300363|FG001|Treatment Period (6 Months)|Other|3|||
13227035|NCT01760954|26300364|FG002|Treatment Period (6 Months)|Other|3|||
13227036|NCT01760954|26300365|FG003|Treatment Period (6 Months)|Other|1|||
13227037|NCT01760954|26300362|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1|||
13227038|NCT01760954|26300363|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6|||
13227039|NCT01760954|26300364|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
13227040|NCT01760954|26300365|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
13227041|NCT01760954|26300362|FG000|Treatment Period (6 Months)|Exclusionary Medication|1|||
13227042|NCT01760954|26300363|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
13227043|NCT01760954|26300364|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
13227044|NCT01760954|26300365|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
13227045|NCT01760954|26300362|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
13227046|NCT01760954|26300363|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
13227047|NCT01760954|26300364|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
13485675|NCT00585195|27033419|FG009|Overall Study|Adverse Event|0|||
13485676|NCT00585195|27033420|FG010|Overall Study|Adverse Event|3|||
13485677|NCT00585195|27033421|FG011|Overall Study|Adverse Event|0|||
13485678|NCT00585195|27033422|FG012|Overall Study|Adverse Event|8|||
13485679|NCT00585195|27033423|FG013|Overall Study|Adverse Event|6|||
13485680|NCT00585195|27033424|FG014|Overall Study|Adverse Event|4|||
13485681|NCT00585195|27033425|FG015|Overall Study|Adverse Event|1|||
13485682|NCT00585195|27033426|FG016|Overall Study|Adverse Event|14|||
13485683|NCT00585195|27033427|FG017|Overall Study|Adverse Event|9|||
13485684|NCT00585195|27033428|FG018|Overall Study|Adverse Event|2|||
13227048|NCT01760954|26300365|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9|||
13289570|NCT00108160|26479642|FG001|Overall Study|Death|2|||
13485685|NCT00585195|27033429|FG019|Overall Study|Adverse Event|3|||
13485686|NCT00585195|27033430|FG020|Overall Study|Adverse Event|1|||
13485687|NCT00585195|27033410|FG000|Overall Study|Progressive Disease|2|||
13485688|NCT00585195|27033411|FG001|Overall Study|Progressive Disease|2|||
13485689|NCT00585195|27033412|FG002|Overall Study|Progressive Disease|5|||
13485690|NCT00585195|27033413|FG003|Overall Study|Progressive Disease|4|||
13485691|NCT00585195|27033414|FG004|Overall Study|Progressive Disease|6|||
13485692|NCT00585195|27033415|FG005|Overall Study|Progressive Disease|4|||
13485693|NCT00585195|27033416|FG006|Overall Study|Progressive Disease|6|||
13485694|NCT00585195|27033417|FG007|Overall Study|Progressive Disease|3|||
13485695|NCT00585195|27033418|FG008|Overall Study|Progressive Disease|0|||
13485696|NCT00585195|27033419|FG009|Overall Study|Progressive Disease|5|||
13485697|NCT00585195|27033420|FG010|Overall Study|Progressive Disease|2|||
13485698|NCT00585195|27033421|FG011|Overall Study|Progressive Disease|25|||
13485699|NCT00585195|27033422|FG012|Overall Study|Progressive Disease|29|||
13485700|NCT00585195|27033423|FG013|Overall Study|Progressive Disease|26|||
13485701|NCT00585195|27033424|FG014|Overall Study|Progressive Disease|21|||
13485702|NCT00585195|27033425|FG015|Overall Study|Progressive Disease|12|||
13485703|NCT00585195|27033426|FG016|Overall Study|Progressive Disease|94|||
13485704|NCT00585195|27033427|FG017|Overall Study|Progressive Disease|42|||
13485705|NCT00585195|27033428|FG018|Overall Study|Progressive Disease|4|||
13485706|NCT00585195|27033429|FG019|Overall Study|Progressive Disease|9|||
13485707|NCT00585195|27033430|FG020|Overall Study|Progressive Disease|8|||
13485708|NCT00585195|27033410|FG000|Overall Study|Withdrawal by Subject|1|||
13485709|NCT00585195|27033411|FG001|Overall Study|Withdrawal by Subject|1|||
13485710|NCT00585195|27033412|FG002|Overall Study|Withdrawal by Subject|2|||
13485711|NCT00585195|27033413|FG003|Overall Study|Withdrawal by Subject|2|||
13485712|NCT00585195|27033414|FG004|Overall Study|Withdrawal by Subject|0|||
13485713|NCT00585195|27033415|FG005|Overall Study|Withdrawal by Subject|0|||
13485714|NCT00585195|27033416|FG006|Overall Study|Withdrawal by Subject|0|||
13485715|NCT00585195|27033417|FG007|Overall Study|Withdrawal by Subject|1|||
13485716|NCT00585195|27033418|FG008|Overall Study|Withdrawal by Subject|0|||
13485717|NCT00585195|27033419|FG009|Overall Study|Withdrawal by Subject|0|||
13485718|NCT00585195|27033420|FG010|Overall Study|Withdrawal by Subject|3|||
13114095|NCT03125200|25913661|FG003|Overall Study|Study Termination|1|||
13114096|NCT03125200|25913662|FG004|Overall Study|Study Termination|1|||
13114097|NCT03125200|25913663|FG005|Overall Study|Study Termination|2|||
13114098|NCT03125200|25913664|FG006|Overall Study|Study Termination|1|||
13114099|NCT03125200|25913658|FG000|Overall Study|Clinical Progression|0|||
13114100|NCT03125200|25913659|FG001|Overall Study|Clinical Progression|0|||
13114101|NCT03125200|25913660|FG002|Overall Study|Clinical Progression|0|||
13114102|NCT03125200|25913661|FG003|Overall Study|Clinical Progression|1|||
13114103|NCT03125200|25913662|FG004|Overall Study|Clinical Progression|0|||
13114104|NCT03125200|25913663|FG005|Overall Study|Clinical Progression|1|||
13114105|NCT03125200|25913664|FG006|Overall Study|Clinical Progression|0|||
13114106|NCT03125200|25913658|FG000|Overall Study|Progressive Disease|2|||
13114107|NCT03125200|25913659|FG001|Overall Study|Progressive Disease|1|||
13114108|NCT03125200|25913660|FG002|Overall Study|Progressive Disease|2|||
13114109|NCT03125200|25913661|FG003|Overall Study|Progressive Disease|1|||
13114110|NCT03125200|25913662|FG004|Overall Study|Progressive Disease|2|||
13114111|NCT03125200|25913663|FG005|Overall Study|Progressive Disease|0|||
13114112|NCT03125200|25913664|FG006|Overall Study|Progressive Disease|1|||
13114113|NCT03125200|25913658|FG000|Overall Study|Lack of Efficacy|0|||
13114114|NCT03125200|25913659|FG001|Overall Study|Lack of Efficacy|0|||
13114115|NCT03125200|25913660|FG002|Overall Study|Lack of Efficacy|0|||
13114116|NCT03125200|25913661|FG003|Overall Study|Lack of Efficacy|1|||
13114117|NCT03125200|25913662|FG004|Overall Study|Lack of Efficacy|0|||
13114118|NCT03125200|25913663|FG005|Overall Study|Lack of Efficacy|0|||
13114119|NCT03125200|25913664|FG006|Overall Study|Lack of Efficacy|0|||
13114120|NCT03125200|25913658|FG000|Overall Study|Toxicity|0|||
13114121|NCT03125200|25913659|FG001|Overall Study|Toxicity|0|||
13114122|NCT03125200|25913660|FG002|Overall Study|Toxicity|0|||
13114123|NCT03125200|25913661|FG003|Overall Study|Toxicity|1|||
13114124|NCT03125200|25913662|FG004|Overall Study|Toxicity|0|||
13114125|NCT03125200|25913663|FG005|Overall Study|Toxicity|0|||
13114126|NCT03125200|25913664|FG006|Overall Study|Toxicity|0|||
13114127|NCT03125200|25913658|FG000|Overall Study|Consent Withdrawn by Subject|0|||
13114128|NCT03125200|25913659|FG001|Overall Study|Consent Withdrawn by Subject|1|||
13114129|NCT03125200|25913660|FG002|Overall Study|Consent Withdrawn by Subject|0|||
13114130|NCT03125200|25913661|FG003|Overall Study|Consent Withdrawn by Subject|0|||
13114131|NCT03125200|25913662|FG004|Overall Study|Consent Withdrawn by Subject|1|||
13114132|NCT03125200|25913663|FG005|Overall Study|Consent Withdrawn by Subject|0|||
13114133|NCT03125200|25913664|FG006|Overall Study|Consent Withdrawn by Subject|1|||
13114134|NCT03124784|25913670|FG000|Overall Study|Adverse Event|1|||
13114135|NCT03124784|25913670|FG000|Overall Study|Computer/Equip Malfunction|1|||
13114136|NCT03124563|25913693|FG000|Overall Study|Lost to Follow-up|1|||
13114137|NCT03124563|25913694|FG001|Overall Study|Lost to Follow-up|1|||
13114138|NCT03124563|25913693|FG000|Overall Study|Withdrawal by Subject|1|||
13114139|NCT03124563|25913694|FG001|Overall Study|Withdrawal by Subject|1|||
13114140|NCT03124537|25913721|FG000|Overall Study|Lost to Follow-up|3|||
13114141|NCT03124537|25913722|FG001|Overall Study|Lost to Follow-up|5|||
13114142|NCT03124537|25913721|FG000|Overall Study|App Crash, Incomplete Data|7|||
13114143|NCT03124537|25913722|FG001|Overall Study|App Crash, Incomplete Data|8|||
13114144|NCT03124459|25913772|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
13114145|NCT03124459|25913773|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
13114146|NCT03124459|25913774|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
13114147|NCT03124459|25913775|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
13114148|NCT03124459|25913776|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2|||
13114149|NCT03124459|25913777|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
13114150|NCT03124459|25913772|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
13114151|NCT03124459|25913773|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
13114152|NCT03124459|25913774|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
13114153|NCT03124459|25913775|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
13114154|NCT03124459|25913776|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1|||
13114155|NCT03124459|25913777|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
13114156|NCT03124459|25913772|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
13114157|NCT03124459|25913773|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
13114158|NCT03124459|25913774|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
13114159|NCT03124459|25913775|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11|||
13114160|NCT03124459|25913776|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12|||
13114161|NCT03124459|25913777|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
13114162|NCT03124459|25913772|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
13114163|NCT03124459|25913773|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
13114164|NCT03124459|25913774|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
13114165|NCT03124459|25913775|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1|||
13114166|NCT03124459|25913776|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4|||
13114167|NCT03124459|25913777|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
13114168|NCT03124459|25913772|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
13114169|NCT03124459|25913773|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
13114170|NCT03124459|25913774|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
13114171|NCT03124459|25913775|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
13114172|NCT03124459|25913776|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
13114173|NCT03124459|25913777|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22|||
13114174|NCT03124459|25913772|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
13114175|NCT03124459|25913773|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
13114176|NCT03124459|25913774|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
13114177|NCT03124459|25913775|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
13114178|NCT03124459|25913776|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
13114179|NCT03124459|25913777|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1|||
13114180|NCT03124407|25913808|FG000|Overall Study|Lost to Follow-up|1|||
13114181|NCT03124407|25913809|FG001|Overall Study|Lost to Follow-up|0|||
13114182|NCT03124407|25913810|FG002|Overall Study|Lost to Follow-up|0|||
13114183|NCT03124407|25913811|FG003|Overall Study|Lost to Follow-up|0|||
13114184|NCT03124407|25913808|FG000|Overall Study|Adverse Event|0|||
13114185|NCT03124407|25913809|FG001|Overall Study|Adverse Event|0|||
13114186|NCT03124407|25913810|FG002|Overall Study|Adverse Event|1|||
13114187|NCT03124407|25913811|FG003|Overall Study|Adverse Event|0|||
13114188|NCT03124381|25913908|FG000|Overall Study|Lost to Follow-up|1|||
13114189|NCT03124381|25913909|FG001|Overall Study|Lost to Follow-up|1|||
13114190|NCT03124381|25913908|FG000|Overall Study|Withdrawal by Subject|6|||
13114191|NCT03124381|25913909|FG001|Overall Study|Withdrawal by Subject|3|||
13114192|NCT03124381|25913908|FG000|Overall Study|Protocol Violation|0|||
13114193|NCT03124381|25913909|FG001|Overall Study|Protocol Violation|1|||
13114194|NCT03124381|25913908|FG000|Overall Study|Adverse Event|1|||
13114195|NCT03124381|25913909|FG001|Overall Study|Adverse Event|1|||
13114196|NCT03124381|25913908|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
13114197|NCT03124381|25913909|FG001|Overall Study|Non-Compliance with Study Treatment|0|||
13114198|NCT03124199|25913917|FG000|Overall Study|Lost to Follow-up|4|||
13114199|NCT03124108|25914058|FG000|Overall Study|Adverse Event|0|||
13114200|NCT03124108|25914059|FG001|Overall Study|Adverse Event|1|||
13227049|NCT01760954|26300362|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4|||
13227050|NCT01760954|26300363|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7|||
13114201|NCT03124108|25914060|FG002|Overall Study|Adverse Event|0|||
13114202|NCT03123939|25914089|FG000|Overall Study|Lack of Efficacy|6|||
13114203|NCT03123939|25914089|FG000|Overall Study|Death|5|||
13114204|NCT03123939|25914089|FG000|Overall Study|Physician Decision|2|||
13114205|NCT03123939|25914089|FG000|Overall Study|Subject/guardian decision|2|||
13114206|NCT03123939|25914089|FG000|Overall Study|Lost to Follow-up|1|||
13114207|NCT03123939|25914089|FG000|Overall Study|New therapy for study indication|1|||
13114208|NCT03123939|25914089|FG000|Overall Study|Protocol deviation|1|||
13114209|NCT03123939|25914089|FG000|Overall Study|Progressive disease|18|||
13133360|NCT02771210|25987552|FG001|Period 1|Adverse Event|3|||
13114210|NCT03123939|25914089|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4|||
13114211|NCT03123939|25914089|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1|||
13114212|NCT03123861|25914108|FG000|Overall Study|Protocol Violation|1|||
13114213|NCT03123861|25914109|FG001|Overall Study|Protocol Violation|1|||
13114214|NCT03123861|25914108|FG000|Overall Study|Withdrawal by Subject|2|||
13114215|NCT03123861|25914109|FG001|Overall Study|Withdrawal by Subject|2|||
13227051|NCT01760954|26300364|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2|||
13227052|NCT01760954|26300365|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0|||
13227053|NCT01760954|26300362|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6|||
13227054|NCT01760954|26300363|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10|||
13227055|NCT01760954|26300364|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
13227056|NCT01760954|26300365|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
13227057|NCT01760954|26300362|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1|||
13227058|NCT01760954|26300363|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4|||
13227059|NCT01760954|26300364|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
13227060|NCT01760954|26300365|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
13227061|NCT01760954|26300362|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
13227062|NCT01760954|26300363|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
13227063|NCT01760954|26300364|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1|||
13227064|NCT01760954|26300365|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
13227065|NCT01760954|26300362|FG000|Post-treatment Follow-up (12 Months)|Other|13|||
13227066|NCT01760954|26300363|FG001|Post-treatment Follow-up (12 Months)|Other|8|||
13227067|NCT01760954|26300364|FG002|Post-treatment Follow-up (12 Months)|Other|9|||
13227068|NCT01760954|26300365|FG003|Post-treatment Follow-up (12 Months)|Other|6|||
13227069|NCT01760876|26300371|FG000|Overall Study|Non-cardiac death (head injury)|1|||
13227070|NCT01760876|26300371|FG000|Overall Study|Carcinoma of prostate|1|||
13227071|NCT01760876|26300371|FG000|Overall Study|Impaired renal function|1|||
13227072|NCT01760876|26300371|FG000|Overall Study|Major depression|1|||
13227073|NCT01760876|26300371|FG000|Overall Study|Very poor baseline OCT quality|2|||
13227074|NCT01760733|26300378|FG000|Waiting List|Death|18|||
13227075|NCT01760733|26300378|FG000|Waiting List|Removed from waiting list|41|||
13227076|NCT01760733|26300378|FG000|Waiting List|Not received a transplant yet|13|||
13227077|NCT01760733|26300378|FG000|Transplanted|Not reached 10 years post transplant|184|||
13227078|NCT01760733|26300378|FG000|Transplanted|Death|26|||
13227079|NCT01760733|26300378|FG000|Transplanted|Graft loss|7|||
13227080|NCT01760447|26300449|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
13227081|NCT01760447|26300450|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
13227082|NCT01760447|26300451|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1|||
13227083|NCT01760447|26300452|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3|||
13227084|NCT01760447|26300449|FG000|Weeks 0-20|Withdrawal by Subject|2|||
13227085|NCT01760447|26300450|FG001|Weeks 0-20|Withdrawal by Subject|0|||
13227086|NCT01760447|26300451|FG002|Weeks 0-20|Withdrawal by Subject|1|||
13227087|NCT01760447|26300452|FG003|Weeks 0-20|Withdrawal by Subject|0|||
13227088|NCT01760447|26300449|FG000|Weeks 0-20|Lost to Follow-up|1|||
13227089|NCT01760447|26300450|FG001|Weeks 0-20|Lost to Follow-up|0|||
13227090|NCT01760447|26300451|FG002|Weeks 0-20|Lost to Follow-up|1|||
13227091|NCT01760447|26300452|FG003|Weeks 0-20|Lost to Follow-up|1|||
13227092|NCT01760447|26300449|FG000|Weeks 0-20|Randomized but not treated|0|||
13227093|NCT01760447|26300450|FG001|Weeks 0-20|Randomized but not treated|0|||
13227094|NCT01760447|26300451|FG002|Weeks 0-20|Randomized but not treated|2|||
13227095|NCT01760447|26300452|FG003|Weeks 0-20|Randomized but not treated|0|||
13227096|NCT01760447|26300449|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
13227097|NCT01760447|26300450|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
13227098|NCT01760447|26300451|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
13227099|NCT01760447|26300452|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0|||
13227100|NCT01760447|26300449|FG000|Weeks 20-54|Withdrawal by Subject|2|||
13227101|NCT01760447|26300450|FG001|Weeks 20-54|Withdrawal by Subject|1|||
13227102|NCT01760447|26300451|FG002|Weeks 20-54|Withdrawal by Subject|1|||
13227103|NCT01760447|26300452|FG003|Weeks 20-54|Withdrawal by Subject|2|||
13227104|NCT01760447|26300449|FG000|Weeks 20-54|Lost to Follow-up|0|||
13227105|NCT01760447|26300450|FG001|Weeks 20-54|Lost to Follow-up|0|||
13227106|NCT01760447|26300451|FG002|Weeks 20-54|Lost to Follow-up|1|||
13227107|NCT01760447|26300452|FG003|Weeks 20-54|Lost to Follow-up|2|||
13227108|NCT01759862|26300469|FG000|Overall Study|Physician Decision|3|||
13227109|NCT01759862|26300470|FG001|Overall Study|Physician Decision|1|||
13227110|NCT01759862|26300469|FG000|Overall Study|Adverse Event|0|||
13227111|NCT01759862|26300470|FG001|Overall Study|Adverse Event|1|||
13227112|NCT01759511|26300480|FG000|Overall Study|Adverse Event|4|||
13227113|NCT01759511|26300480|FG000|Overall Study|Death|2|||
13227114|NCT01759511|26300480|FG000|Overall Study|Lack of Efficacy|2|||
13227115|NCT01759511|26300480|FG000|Overall Study|Physician Decision|1|||
13114216|NCT03123588|25914134|FG000|Overall Study|Study Terminated by Sponsor|2|||
13227116|NCT01759511|26300480|FG000|Overall Study|Progressive Disease|5|||
13227117|NCT01759511|26300480|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4|||
13227118|NCT01759511|26300480|FG000|Overall Study|Study Terminated by Sponsor|13|||
13227119|NCT01759511|26300480|FG000|Overall Study|Withdrawal by Subject|3|||
13227120|NCT01759446|26300508|FG000|Overall Study|Protocol Violation|1|||
13227121|NCT01759446|26300509|FG001|Overall Study|Protocol Violation|0|||
13227122|NCT01759446|26300510|FG002|Overall Study|Protocol Violation|1|||
13227123|NCT01759446|26300511|FG003|Overall Study|Protocol Violation|0|||
13227124|NCT01759446|26300512|FG004|Overall Study|Protocol Violation|0|||
13227125|NCT01759446|26300508|FG000|Overall Study|Withdrawal by Subject|0|||
13227126|NCT01759446|26300509|FG001|Overall Study|Withdrawal by Subject|1|||
13227127|NCT01759446|26300510|FG002|Overall Study|Withdrawal by Subject|0|||
13227128|NCT01759446|26300511|FG003|Overall Study|Withdrawal by Subject|1|||
13114217|NCT03123588|25914135|FG001|Overall Study|Study Terminated by Sponsor|5|||
13114218|NCT03123588|25914134|FG000|Overall Study|Withdrawal by Subject|1|||
13114219|NCT03123588|25914135|FG001|Overall Study|Withdrawal by Subject|0|||
13114220|NCT03123588|25914134|FG000|Overall Study|Adverse Event|1|||
13114221|NCT03123588|25914135|FG001|Overall Study|Adverse Event|0|||
13114222|NCT03123588|25914134|FG000|Overall Study|Physician Decision|2|||
13114223|NCT03123588|25914135|FG001|Overall Study|Physician Decision|1|||
13114224|NCT03123471|25914167|FG000|Placebo-controlled Phase|Adverse Event|3|||
13114225|NCT03123471|25914168|FG001|Placebo-controlled Phase|Adverse Event|8|||
13114226|NCT03123471|25914167|FG000|Placebo-controlled Phase|Lack of Efficacy|3|||
13114227|NCT03123471|25914168|FG001|Placebo-controlled Phase|Lack of Efficacy|4|||
13114228|NCT03123471|25914167|FG000|Placebo-controlled Phase|Withdrawal by Subject|6|||
13114229|NCT03123471|25914168|FG001|Placebo-controlled Phase|Withdrawal by Subject|16|||
13114230|NCT03123471|25914167|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3|||
13227129|NCT01759446|26300512|FG004|Overall Study|Withdrawal by Subject|0|||
13114231|NCT03123471|25914168|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0|||
13227130|NCT01759420|26300519|FG000|Overall Study|Screen failure|5|||
13227131|NCT01759420|26300519|FG000|Overall Study|Inaccurate EKG machine readings|1|||
13227132|NCT01759407|26300536|FG000|Overall Study|Protocol Violation|0|||
13227133|NCT01759407|26300537|FG001|Overall Study|Protocol Violation|2|||
13227134|NCT01759381|26300550|FG000|Overall Study|Death|1|||
13227135|NCT01759381|26300551|FG001|Overall Study|Death|0|||
13227136|NCT01759368|26300576|FG000|Overall Study|Lost to Follow-up|1|||
13227137|NCT01759368|26300577|FG001|Overall Study|Lost to Follow-up|0|||
13227138|NCT01759290|26300639|FG000|Overall Study|Subjects withdrawn consent|5|||
13227139|NCT01759290|26300639|FG000|Overall Study|Physician Decision|2|||
13227140|NCT01759290|26300639|FG000|Overall Study|Death|17|||
13227141|NCT01759290|26300639|FG000|Overall Study|Lost to Follow-up|53|||
13227142|NCT01759290|26300639|FG000|Overall Study|Unknown reason|4|||
13227143|NCT01759264|26300654|FG000|Overall Study|Serious Adverse Events (SAEs)|1|||
13227144|NCT01759264|26300654|FG000|Overall Study|Adverse Event|1|||
13227145|NCT01759264|26300654|FG000|Overall Study|Other|2|||
13227146|NCT01759264|26300654|FG000|Overall Study|Lost to Follow-up|2|||
13227147|NCT01759264|26300654|FG000|Overall Study|Withdrawal by Subject|3|||
13227148|NCT01759264|26300654|FG000|Overall Study|Discontinued Humira Due to Business Trip|1|||
13227149|NCT01758900|26300679|FG000|Overall Study|difficulty for further intubation|7|||
13227150|NCT01758900|26300680|FG001|Overall Study|difficulty for further intubation|8|||
13227151|NCT01758731|26300686|FG000|Overall Study|Physician Decision|1|||
13227152|NCT01758523|26300711|FG000|Overall Study|Adverse Event|2|||
13227153|NCT01758523|26300712|FG001|Overall Study|Adverse Event|1|||
13114232|NCT03123471|25914167|FG000|Placebo-controlled Phase|Lost to Follow-up|1|||
13227154|NCT01758523|26300711|FG000|Overall Study|Lack of Efficacy|4|||
13227155|NCT01758523|26300712|FG001|Overall Study|Lack of Efficacy|2|||
13227156|NCT01758523|26300711|FG000|Overall Study|Lost to Follow-up|3|||
13227157|NCT01758523|26300712|FG001|Overall Study|Lost to Follow-up|4|||
13227158|NCT01758523|26300711|FG000|Overall Study|Withdrawal by Subject|12|||
13227159|NCT01758523|26300712|FG001|Overall Study|Withdrawal by Subject|7|||
13227160|NCT01758289|26300731|FG000|Overall Study|Premature Study Termination|44|||
13227161|NCT01758289|26300731|FG000|Overall Study|Adverse Event|9|||
13227162|NCT01757847|26300746|FG000|Overall Study|Withdrawal by Subject|3|||
13227163|NCT01757847|26300747|FG001|Overall Study|Withdrawal by Subject|4|||
13227164|NCT01757821|26300757|FG000|Overall Study|Adverse Event|1|||
13227165|NCT01757704|26300782|FG000|Overall Study|Protocol Violation|1|||
13227166|NCT01757704|26300783|FG001|Overall Study|Protocol Violation|3|||
13114233|NCT03123471|25914168|FG001|Placebo-controlled Phase|Lost to Follow-up|3|||
13114234|NCT03123471|25914167|FG000|Placebo-controlled Phase|Protocol Deviation|2|||
13114235|NCT03123471|25914168|FG001|Placebo-controlled Phase|Protocol Deviation|1|||
13227167|NCT01757691|26300799|FG000|Overall Study|Administrative problems|2|||
13227168|NCT01757691|26300800|FG001|Overall Study|Administrative problems|0|||
13227169|NCT01757405|26300823|FG000|Overall Study|Lost to Follow-up|1|||
13227170|NCT01757405|26300824|FG001|Overall Study|Lost to Follow-up|1|||
13227171|NCT01757405|26300823|FG000|Overall Study|Withdrawal by Subject|0|||
13227172|NCT01757405|26300824|FG001|Overall Study|Withdrawal by Subject|1|||
13227173|NCT01757392|26300834|FG000|Overall Study|Withdrawal by Subject|1|||
13227174|NCT01757392|26300834|FG000|Overall Study|Screen Fail|3|||
13114236|NCT03123471|25914167|FG000|Placebo-controlled Phase|Miscellaneous|0|||
13114237|NCT03123471|25914168|FG001|Placebo-controlled Phase|Miscellaneous|1|||
13114238|NCT03123471|25914167|FG000|Apremilast Extension Phase|Lost to Follow-up|2|||
13114239|NCT03123471|25914168|FG001|Apremilast Extension Phase|Lost to Follow-up|5|||
13114240|NCT03123471|25914167|FG000|Apremilast Extension Phase|Adverse Event|1|||
13114241|NCT03123471|25914168|FG001|Apremilast Extension Phase|Adverse Event|5|||
13114242|NCT03123471|25914167|FG000|Apremilast Extension Phase|Lack of Efficacy|2|||
13114243|NCT03123471|25914168|FG001|Apremilast Extension Phase|Lack of Efficacy|8|||
13114244|NCT03123471|25914167|FG000|Apremilast Extension Phase|Withdrawal by Subject|3|||
13114245|NCT03123471|25914168|FG001|Apremilast Extension Phase|Withdrawal by Subject|7|||
13114246|NCT03123393|25914203|FG000|Overall Study|Study Terminated by Sponsor|6|||
13114247|NCT03123393|25914204|FG001|Overall Study|Study Terminated by Sponsor|9|||
13114248|NCT03123393|25914203|FG000|Overall Study|Withdrawal by Subject|2|||
13114249|NCT03123393|25914204|FG001|Overall Study|Withdrawal by Subject|1|||
13114250|NCT03123393|25914203|FG000|Overall Study|Reason not Specified|13|||
13114251|NCT03123393|25914204|FG001|Overall Study|Reason not Specified|13|||
13114252|NCT03123354|25914210|FG000|Overall Study|Physician Decision|6|||
13114253|NCT03123185|25914315|FG000|Overall Study|Withdrawal by Subject|0|||
13114254|NCT03123185|25914316|FG001|Overall Study|Withdrawal by Subject|0|||
13114255|NCT03123185|25914317|FG002|Overall Study|Withdrawal by Subject|0|||
13114256|NCT03123185|25914318|FG003|Overall Study|Withdrawal by Subject|0|||
13114257|NCT03123185|25914319|FG004|Overall Study|Withdrawal by Subject|0|||
13114258|NCT03123185|25914320|FG005|Overall Study|Withdrawal by Subject|0|||
13114259|NCT03123185|25914321|FG006|Overall Study|Withdrawal by Subject|0|||
13114260|NCT03123185|25914322|FG007|Overall Study|Withdrawal by Subject|0|||
13114261|NCT03123185|25914323|FG008|Overall Study|Withdrawal by Subject|0|||
13114262|NCT03123185|25914324|FG009|Overall Study|Withdrawal by Subject|0|||
13114263|NCT03123185|25914325|FG010|Overall Study|Withdrawal by Subject|0|||
13114264|NCT03123185|25914326|FG011|Overall Study|Withdrawal by Subject|0|||
13114265|NCT03123185|25914327|FG012|Overall Study|Withdrawal by Subject|1|||
13114266|NCT03123185|25914328|FG013|Overall Study|Withdrawal by Subject|0|||
13114267|NCT03123120|25914349|FG000|Overall Study|Lost to Follow-up|0|||
13114268|NCT03123120|25914350|FG001|Overall Study|Lost to Follow-up|1|||
13114269|NCT03123120|25914349|FG000|Overall Study|Withdrawal by Subject|0|||
13114270|NCT03123120|25914350|FG001|Overall Study|Withdrawal by Subject|1|||
13114271|NCT03122886|25914363|FG000|Overall Study|Withdrawal by Subject|1|||
13114272|NCT03122886|25914364|FG001|Overall Study|Withdrawal by Subject|2|||
13114273|NCT03122860|25914446|FG000|Overall Study|Discontinued Before Treatment|1|||
13114274|NCT03122860|25914447|FG001|Overall Study|Discontinued Before Treatment|1|||
13114275|NCT03122860|25914448|FG002|Overall Study|Discontinued Before Treatment|2|||
13114276|NCT03122860|25914449|FG003|Overall Study|Discontinued Before Treatment|0|||
13114277|NCT03122860|25914450|FG004|Overall Study|Discontinued Before Treatment|1|||
13114278|NCT03122860|25914451|FG005|Overall Study|Discontinued Before Treatment|0|||
13114279|NCT03122860|25914446|FG000|Overall Study|Adverse Event|1|||
13114280|NCT03122860|25914447|FG001|Overall Study|Adverse Event|0|||
13114281|NCT03122860|25914448|FG002|Overall Study|Adverse Event|1|||
13114282|NCT03122860|25914449|FG003|Overall Study|Adverse Event|1|||
13114283|NCT03122860|25914450|FG004|Overall Study|Adverse Event|0|||
13114284|NCT03122860|25914451|FG005|Overall Study|Adverse Event|0|||
13114285|NCT03122860|25914446|FG000|Overall Study|Lost to Follow-up|5|||
13114286|NCT03122860|25914447|FG001|Overall Study|Lost to Follow-up|2|||
13114287|NCT03122860|25914448|FG002|Overall Study|Lost to Follow-up|3|||
13227175|NCT01757288|26300882|FG000|Overall Study|Consent withdrawal|0|||
13227176|NCT01757288|26300883|FG001|Overall Study|Consent withdrawal|4|||
13227177|NCT01757288|26300884|FG002|Overall Study|Consent withdrawal|4|||
13227178|NCT01757288|26300882|FG000|Overall Study|Patient off study, IRB hold.|0|||
13227179|NCT01757288|26300883|FG001|Overall Study|Patient off study, IRB hold.|0|||
13227180|NCT01757288|26300884|FG002|Overall Study|Patient off study, IRB hold.|1|||
13227181|NCT01757288|26300882|FG000|Overall Study|Patient death prior to starting treatment|0|||
13227182|NCT01757288|26300883|FG001|Overall Study|Patient death prior to starting treatment|0|||
13227183|NCT01757288|26300884|FG002|Overall Study|Patient death prior to starting treatment|1|||
13114288|NCT03122860|25914449|FG003|Overall Study|Lost to Follow-up|3|||
13114289|NCT03122860|25914450|FG004|Overall Study|Lost to Follow-up|5|||
13114290|NCT03122860|25914451|FG005|Overall Study|Lost to Follow-up|4|||
13114291|NCT03122860|25914446|FG000|Overall Study|Subject Non-Compliance|0|||
13114292|NCT03122860|25914447|FG001|Overall Study|Subject Non-Compliance|0|||
13114293|NCT03122860|25914448|FG002|Overall Study|Subject Non-Compliance|1|||
13114294|NCT03122860|25914449|FG003|Overall Study|Subject Non-Compliance|0|||
13114295|NCT03122860|25914450|FG004|Overall Study|Subject Non-Compliance|0|||
13114296|NCT03122860|25914451|FG005|Overall Study|Subject Non-Compliance|0|||
13114297|NCT03122860|25914446|FG000|Overall Study|Withdrawal by Subject|3|||
13114298|NCT03122860|25914447|FG001|Overall Study|Withdrawal by Subject|2|||
13114299|NCT03122860|25914448|FG002|Overall Study|Withdrawal by Subject|5|||
13227184|NCT01757288|26300882|FG000|Overall Study|Wrong medication administered|0|||
13227185|NCT01757288|26300883|FG001|Overall Study|Wrong medication administered|1|||
13227186|NCT01757288|26300884|FG002|Overall Study|Wrong medication administered|0|||
13227187|NCT01757288|26300882|FG000|Overall Study|Liver metastasis identified at CT simulation|0|||
13114300|NCT03122860|25914449|FG003|Overall Study|Withdrawal by Subject|7|||
13114301|NCT03122860|25914450|FG004|Overall Study|Withdrawal by Subject|9|||
13114302|NCT03122860|25914451|FG005|Overall Study|Withdrawal by Subject|8|||
13114303|NCT03122548|25914461|FG000|Overall Study|Death|2|||
13114304|NCT03122548|25914461|FG000|Overall Study|Progression - subject went into hospice|1|||
13114305|NCT03122548|25914461|FG000|Overall Study|Study Terminated by Sponsor|2|||
13114306|NCT03122535|25914472|FG000|Overall Study|Lost to Follow-up|68|||
13114307|NCT03122535|25914473|FG001|Overall Study|Lost to Follow-up|68|||
13227188|NCT01757288|26300883|FG001|Overall Study|Liver metastasis identified at CT simulation|1|||
13227189|NCT01757288|26300884|FG002|Overall Study|Liver metastasis identified at CT simulation|0|||
13227190|NCT01757288|26300882|FG000|Overall Study|Not meeting protocol constraints|0|||
13227191|NCT01757288|26300883|FG001|Overall Study|Not meeting protocol constraints|1|||
13227192|NCT01757288|26300884|FG002|Overall Study|Not meeting protocol constraints|1|||
13227193|NCT01757288|26300882|FG000|Overall Study|Multiple missed appointments|0|||
13227194|NCT01757288|26300883|FG001|Overall Study|Multiple missed appointments|1|||
13227195|NCT01757288|26300884|FG002|Overall Study|Multiple missed appointments|0|||
13227196|NCT01757288|26300882|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
13227197|NCT01757288|26300883|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
13227198|NCT01757288|26300884|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1|||
13227199|NCT01757288|26300882|FG000|Overall Study|>2 weeks treatment break|0|||
13227200|NCT01757288|26300883|FG001|Overall Study|>2 weeks treatment break|0|||
13227201|NCT01757288|26300884|FG002|Overall Study|>2 weeks treatment break|1|||
13227202|NCT01757275|26300913|FG000|Overall Study|Lost to Follow-up|1|||
13227203|NCT01757275|26300914|FG001|Overall Study|Lost to Follow-up|2|||
13227204|NCT01757275|26300913|FG000|Overall Study|Adverse Event|3|||
13227205|NCT01757275|26300914|FG001|Overall Study|Adverse Event|3|||
13227206|NCT01757275|26300913|FG000|Overall Study|Withdrawal by Subject|2|||
13227207|NCT01757275|26300914|FG001|Overall Study|Withdrawal by Subject|4|||
13227208|NCT01757275|26300913|FG000|Overall Study|Not treated|3|||
13227209|NCT01757275|26300914|FG001|Overall Study|Not treated|4|||
13227210|NCT01757197|26300923|FG000|Overall Study|Death|2|||
13227211|NCT01757184|26300974|FG000|Double-blind Period|Adverse Event|1|||
13227212|NCT01757184|26300975|FG001|Double-blind Period|Adverse Event|0|||
13227213|NCT01757184|26300976|FG002|Double-blind Period|Adverse Event|0|||
13227214|NCT01757184|26300977|FG003|Double-blind Period|Adverse Event|0|||
13227215|NCT01757184|26300974|FG000|Open-label Period|Lost to Follow-up|0|||
13227216|NCT01757184|26300975|FG001|Open-label Period|Lost to Follow-up|0|||
13227217|NCT01757184|26300976|FG002|Open-label Period|Lost to Follow-up|2|||
13227218|NCT01757184|26300977|FG003|Open-label Period|Lost to Follow-up|0|||
13227219|NCT01757184|26300974|FG000|Open-label Period|Withdrawal by Subject|0|||
13227220|NCT01757184|26300975|FG001|Open-label Period|Withdrawal by Subject|0|||
13227221|NCT01757184|26300976|FG002|Open-label Period|Withdrawal by Subject|1|||
13227222|NCT01757184|26300977|FG003|Open-label Period|Withdrawal by Subject|1|||
13227223|NCT01757184|26300974|FG000|Open-label Period|Discontinued by Sponsor|0|||
13227224|NCT01757184|26300975|FG001|Open-label Period|Discontinued by Sponsor|0|||
13227225|NCT01757184|26300976|FG002|Open-label Period|Discontinued by Sponsor|1|||
13227226|NCT01757184|26300977|FG003|Open-label Period|Discontinued by Sponsor|2|||
13227227|NCT01757171|26300996|FG000|Overall Study|Adverse Event|5|||
13227228|NCT01757171|26300997|FG001|Overall Study|Adverse Event|1|||
13227229|NCT01757171|26300996|FG000|Overall Study|Disease Progression|1|||
13227230|NCT01757171|26300997|FG001|Overall Study|Disease Progression|0|||
13227231|NCT01757171|26300996|FG000|Overall Study|Hospitalization|1|||
13227232|NCT01757171|26300997|FG001|Overall Study|Hospitalization|0|||
13227233|NCT01757171|26300996|FG000|Overall Study|ECOG decline|1|||
13227234|NCT01757171|26300997|FG001|Overall Study|ECOG decline|0|||
13227235|NCT01756898|26301056|FG000|Overall Study|Adverse Event|7|||
13227236|NCT01756898|26301057|FG001|Overall Study|Adverse Event|1|||
13227237|NCT01756898|26301058|FG002|Overall Study|Adverse Event|0|||
13227238|NCT01756898|26301059|FG003|Overall Study|Adverse Event|0|||
13227239|NCT01756898|26301056|FG000|Overall Study|Lack of Efficacy|4|||
13227240|NCT01756898|26301057|FG001|Overall Study|Lack of Efficacy|7|||
13227241|NCT01756898|26301058|FG002|Overall Study|Lack of Efficacy|6|||
13227242|NCT01756898|26301059|FG003|Overall Study|Lack of Efficacy|6|||
13227243|NCT01756898|26301056|FG000|Overall Study|Lost to Follow-up|2|||
13227244|NCT01756898|26301057|FG001|Overall Study|Lost to Follow-up|4|||
13227245|NCT01756898|26301058|FG002|Overall Study|Lost to Follow-up|2|||
13227246|NCT01756898|26301059|FG003|Overall Study|Lost to Follow-up|3|||
13227247|NCT01756898|26301056|FG000|Overall Study|Protocol Violation|1|||
13227248|NCT01756898|26301057|FG001|Overall Study|Protocol Violation|2|||
13227249|NCT01756898|26301058|FG002|Overall Study|Protocol Violation|2|||
13227250|NCT01756898|26301059|FG003|Overall Study|Protocol Violation|1|||
13227251|NCT01756898|26301056|FG000|Overall Study|Withdrew Consent|5|||
13227252|NCT01756898|26301057|FG001|Overall Study|Withdrew Consent|3|||
13114308|NCT03122535|25914472|FG000|Overall Study|Physician Decision|3|||
13114309|NCT03122535|25914473|FG001|Overall Study|Physician Decision|3|||
13114310|NCT03122535|25914472|FG000|Overall Study|Withdrawal by Subject|2|||
13114311|NCT03122535|25914473|FG001|Overall Study|Withdrawal by Subject|2|||
13114312|NCT03122457|25914480|FG000|Overall Study|Withdrawal by Subject|6|||
13114313|NCT03122223|25914547|FG000|Overall Study|Withdrawal by Subject|2|||
13114314|NCT03122223|25914548|FG001|Overall Study|Withdrawal by Subject|2|||
13114315|NCT03122223|25914549|FG002|Overall Study|Withdrawal by Subject|1|||
13114316|NCT03122223|25914550|FG003|Overall Study|Withdrawal by Subject|0|||
13114317|NCT03122223|25914547|FG000|Overall Study|Lost to Follow-up|0|||
13114318|NCT03122223|25914548|FG001|Overall Study|Lost to Follow-up|2|||
13114319|NCT03122223|25914549|FG002|Overall Study|Lost to Follow-up|2|||
13114320|NCT03122223|25914550|FG003|Overall Study|Lost to Follow-up|0|||
13114321|NCT03122223|25914547|FG000|Overall Study|Participant unable to adhere|1|||
13114322|NCT03122223|25914548|FG001|Overall Study|Participant unable to adhere|1|||
13114323|NCT03122223|25914549|FG002|Overall Study|Participant unable to adhere|1|||
13114324|NCT03122223|25914550|FG003|Overall Study|Participant unable to adhere|0|||
13114325|NCT03122184|25914594|FG000|Overall Study|Lost to Follow-up|4|||
13114326|NCT03122184|25914595|FG001|Overall Study|Lost to Follow-up|6|||
13114327|NCT03122184|25914594|FG000|Overall Study|Withdrawal by Subject|3|||
13114328|NCT03122184|25914595|FG001|Overall Study|Withdrawal by Subject|0|||
13114329|NCT03122184|25914594|FG000|Overall Study|Terminated due to cognitive problem|1|||
13227253|NCT01756898|26301058|FG002|Overall Study|Withdrew Consent|5|||
13227254|NCT01756898|26301059|FG003|Overall Study|Withdrew Consent|6|||
13227255|NCT01756898|26301056|FG000|Overall Study|Other|0|||
13227256|NCT01756898|26301057|FG001|Overall Study|Other|2|||
13114330|NCT03122184|25914595|FG001|Overall Study|Terminated due to cognitive problem|0|||
13114331|NCT03122171|25914604|FG000|Overall Study|Withdrawal by Subject|1|||
13114332|NCT03122145|25914619|FG000|Overall Study|Concurrent respiratory disease|3|||
13114333|NCT03122145|25914620|FG001|Overall Study|Concurrent respiratory disease|0|||
13114334|NCT03122106|25914626|FG000|Overall Study|Not enough tissue|1|||
13114335|NCT03122106|25914626|FG000|Overall Study|Disease progression during screening|2|||
13114336|NCT03122106|25914626|FG000|Overall Study|Poor RNA quality for vaccine|1|||
13114337|NCT03121950|25914643|FG000|Overall Study|Withdrawal by Subject|11|||
13114338|NCT03121950|25914644|FG001|Overall Study|Withdrawal by Subject|2|||
13114339|NCT03120949|25914697|FG000|Overall Study|randomized in error|1|||
13114340|NCT03120949|25914698|FG001|Overall Study|randomized in error|0|||
13114341|NCT03120949|25914697|FG000|Overall Study|Death|13|||
13227257|NCT01756898|26301058|FG002|Overall Study|Other|2|||
13227258|NCT01756898|26301059|FG003|Overall Study|Other|0|||
13227259|NCT01756846|26301074|FG000|Overall Study|Lost to Follow-up|5|||
13227260|NCT01756846|26301075|FG001|Overall Study|Lost to Follow-up|10|||
13227261|NCT01756846|26301074|FG000|Overall Study|Withdrawal by Subject|1|||
13227262|NCT01756846|26301075|FG001|Overall Study|Withdrawal by Subject|2|||
13227263|NCT01756833|26301102|FG000|Overall Study|Withdrawal by Subject|4|||
13227264|NCT01756833|26301103|FG001|Overall Study|Withdrawal by Subject|3|||
13227265|NCT01756456|26301220|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
13227266|NCT01756456|26301221|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
13227267|NCT01756456|26301222|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
13227268|NCT01756456|26301223|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
13114342|NCT03120949|25914698|FG001|Overall Study|Death|13|||
13114343|NCT03120949|25914697|FG000|Overall Study|Lost to Follow-up|23|||
13114344|NCT03120949|25914698|FG001|Overall Study|Lost to Follow-up|13|||
13227269|NCT01756456|26301224|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
13227270|NCT01756456|26301225|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
13227271|NCT01756456|26301220|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0|||
13227272|NCT01756456|26301221|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0|||
13227273|NCT01756456|26301222|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0|||
13227274|NCT01756456|26301223|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2|||
13227275|NCT01756456|26301224|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1|||
13227276|NCT01756456|26301225|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0|||
13227277|NCT01756456|26301220|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
13227278|NCT01756456|26301221|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1|||
13227279|NCT01756456|26301222|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
13227280|NCT01756456|26301223|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
13227281|NCT01756456|26301224|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
13227282|NCT01756456|26301225|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
13227283|NCT01756456|26301220|FG000|Treatment Period: Phase I/II|Adverse Event|1|||
13227284|NCT01756456|26301221|FG001|Treatment Period: Phase I/II|Adverse Event|0|||
13227285|NCT01756456|26301222|FG002|Treatment Period: Phase I/II|Adverse Event|2|||
13485719|NCT00585195|27033421|FG011|Overall Study|Withdrawal by Subject|8|||
13485720|NCT00585195|27033422|FG012|Overall Study|Withdrawal by Subject|15|||
13114345|NCT03120949|25914697|FG000|Overall Study|Withdrawal by Subject|139|||
13114346|NCT03120949|25914698|FG001|Overall Study|Withdrawal by Subject|124|||
13114347|NCT03120949|25914697|FG000|Overall Study|Covid-19|43|||
13114348|NCT03120949|25914698|FG001|Overall Study|Covid-19|34|||
13114349|NCT03120949|25914697|FG000|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|1|||
13114350|NCT03120949|25914698|FG001|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|3|||
13114351|NCT03120949|25914697|FG000|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|1|||
13114352|NCT03120949|25914698|FG001|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|0|||
13114353|NCT03120949|25914697|FG000|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|1|||
13114354|NCT03120949|25914698|FG001|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|0|||
13114355|NCT03120949|25914697|FG000|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|1|||
13114356|NCT03120949|25914698|FG001|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|0|||
13114357|NCT03120949|25914697|FG000|Overall Study|Site was closed|2|||
13114358|NCT03120949|25914698|FG001|Overall Study|Site was closed|3|||
13114359|NCT03120949|25914697|FG000|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|1|||
13114360|NCT03120949|25914698|FG001|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|0|||
13114361|NCT03120949|25914697|FG000|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|0|||
13114362|NCT03120949|25914698|FG001|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|1|||
13114363|NCT03120949|25914697|FG000|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|1|||
13114364|NCT03120949|25914698|FG001|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|0|||
13114365|NCT03120949|25914697|FG000|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|1|||
13114366|NCT03120949|25914698|FG001|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|0|||
13114367|NCT03120949|25914697|FG000|Overall Study|Other: Adverse Event|0|||
13114368|NCT03120949|25914698|FG001|Overall Study|Other: Adverse Event|1|||
13114369|NCT03120949|25914697|FG000|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|0|||
13114370|NCT03120949|25914698|FG001|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|1|||
13114371|NCT03120949|25914697|FG000|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|0|||
13114372|NCT03120949|25914698|FG001|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|2|||
13114373|NCT03120949|25914697|FG000|Overall Study|Subject Refusal To Attend Visit|0|||
13227286|NCT01756456|26301223|FG003|Treatment Period: Phase I/II|Adverse Event|3|||
13227287|NCT01756456|26301224|FG004|Treatment Period: Phase I/II|Adverse Event|9|||
13227288|NCT01756456|26301225|FG005|Treatment Period: Phase I/II|Adverse Event|1|||
13227289|NCT01756456|26301220|FG000|Treatment Period: Phase I/II|Other causes|0|||
13227290|NCT01756456|26301221|FG001|Treatment Period: Phase I/II|Other causes|0|||
13227291|NCT01756456|26301222|FG002|Treatment Period: Phase I/II|Other causes|0|||
13227292|NCT01756456|26301223|FG003|Treatment Period: Phase I/II|Other causes|1|||
13227293|NCT01756456|26301224|FG004|Treatment Period: Phase I/II|Other causes|2|||
13227294|NCT01756456|26301225|FG005|Treatment Period: Phase I/II|Other causes|2|||
13227295|NCT01756456|26301220|FG000|Follow Up Period Phase I/II|still in study after week 20|0|||
13227296|NCT01756456|26301221|FG001|Follow Up Period Phase I/II|still in study after week 20|0|||
13227297|NCT01756456|26301222|FG002|Follow Up Period Phase I/II|still in study after week 20|0|||
13227298|NCT01756456|26301223|FG003|Follow Up Period Phase I/II|still in study after week 20|25|||
13227299|NCT01756456|26301224|FG004|Follow Up Period Phase I/II|still in study after week 20|23|||
13227300|NCT01756456|26301225|FG005|Follow Up Period Phase I/II|still in study after week 20|25|||
13227301|NCT01756456|26301220|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
13227302|NCT01756456|26301221|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1|||
13227303|NCT01756456|26301222|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
13227304|NCT01756456|26301223|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
13227305|NCT01756456|26301224|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
13227306|NCT01756456|26301225|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
13227307|NCT01756456|26301220|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0|||
13227308|NCT01756456|26301221|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0|||
13227309|NCT01756456|26301222|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0|||
13227310|NCT01756456|26301223|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0|||
13227311|NCT01756456|26301224|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0|||
13227312|NCT01756456|26301225|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1|||
13227313|NCT01756456|26301220|FG000|Follow Up Period Phase I/II|Adverse Event|1|||
13227314|NCT01756456|26301221|FG001|Follow Up Period Phase I/II|Adverse Event|0|||
13227315|NCT01756456|26301222|FG002|Follow Up Period Phase I/II|Adverse Event|0|||
13227316|NCT01756456|26301223|FG003|Follow Up Period Phase I/II|Adverse Event|5|||
13227317|NCT01756456|26301224|FG004|Follow Up Period Phase I/II|Adverse Event|0|||
13227318|NCT01756456|26301225|FG005|Follow Up Period Phase I/II|Adverse Event|1|||
13227319|NCT01756456|26301220|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0|||
13114374|NCT03120949|25914698|FG001|Overall Study|Subject Refusal To Attend Visit|1|||
13114375|NCT03120949|25914697|FG000|Overall Study|Personal Reasons|0|||
13114376|NCT03120949|25914698|FG001|Overall Study|Personal Reasons|1|||
13114377|NCT03120949|25914697|FG000|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|0|||
13114378|NCT03120949|25914698|FG001|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|1|||
13114379|NCT03120949|25914697|FG000|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|0|||
13114380|NCT03120949|25914698|FG001|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|1|||
13114381|NCT03120949|25914697|FG000|Overall Study|Compliance With Medication|0|||
13114382|NCT03120949|25914698|FG001|Overall Study|Compliance With Medication|1|||
13114383|NCT03120949|25914697|FG000|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|0|||
13114384|NCT03120949|25914698|FG001|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|1|||
13227320|NCT01756456|26301221|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0|||
13227321|NCT01756456|26301222|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1|||
13227322|NCT01756456|26301223|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2|||
13227323|NCT01756456|26301224|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0|||
13227324|NCT01756456|26301225|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1|||
13227325|NCT01756456|26301220|FG000|Follow Up Period Phase I/II|Other causes|0|||
13227326|NCT01756456|26301221|FG001|Follow Up Period Phase I/II|Other causes|0|||
13227327|NCT01756456|26301222|FG002|Follow Up Period Phase I/II|Other causes|0|||
13227328|NCT01756456|26301223|FG003|Follow Up Period Phase I/II|Other causes|1|||
13227329|NCT01756456|26301224|FG004|Follow Up Period Phase I/II|Other causes|3|||
13227330|NCT01756456|26301225|FG005|Follow Up Period Phase I/II|Other causes|5|||
13227331|NCT01756352|26301232|FG000|Overall Study|moved away and lost to followup|1|||
13227332|NCT01756300|26301256|FG000|Overall Study|Death|1|||
13227333|NCT01756300|26301256|FG000|Overall Study|Withdrawal by Subject|1|||
13227334|NCT01756274|26301265|FG000|Overall Study|Protocol Violation|2|||
13227335|NCT01756274|26301265|FG000|Overall Study|Laboratory error|1|||
13227336|NCT01756235|26301288|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
13227337|NCT01756157|26301305|FG000|First Intervention Period|Withdrawal by Subject|1|||
13227338|NCT01756157|26301306|FG001|First Intervention Period|Withdrawal by Subject|0|||
13227339|NCT01756157|26301305|FG000|First Intervention Period|Lost to Follow-up|0|||
13227340|NCT01756157|26301306|FG001|First Intervention Period|Lost to Follow-up|2|||
13227341|NCT01756079|26301314|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4|||
13227342|NCT01756079|26301314|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5|||
13227343|NCT01756079|26301314|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2|||
13227344|NCT01756079|26301314|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20|||
13227345|NCT01756079|26301314|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4|||
13227346|NCT01756053|26301337|FG000|Period 1 (10 Days)|Protocol Violation|1|||
13227347|NCT01756053|26301338|FG001|Period 1 (10 Days)|Protocol Violation|1|||
13227348|NCT01756053|26301337|FG000|Period 2 (10 Days)|Protocol Violation|0|||
13227349|NCT01756053|26301338|FG001|Period 2 (10 Days)|Protocol Violation|2|||
13227350|NCT01755858|26301367|FG000|Overall Study|Adverse Event|1|||
13227351|NCT01755858|26301368|FG001|Overall Study|Adverse Event|1|||
13227352|NCT01755767|26301397|FG000|Overall Study|Progressive Disease|8|||
13227353|NCT01755767|26301398|FG001|Overall Study|Progressive Disease|7|||
13227354|NCT01755767|26301399|FG002|Overall Study|Progressive Disease|91|||
13114385|NCT03120949|25914697|FG000|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|0|||
13114386|NCT03120949|25914698|FG001|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|1|||
13114387|NCT03120949|25914697|FG000|Overall Study|Study Terminated By Principal Investigator|0|||
13114388|NCT03120949|25914698|FG001|Overall Study|Study Terminated By Principal Investigator|1|||
13114389|NCT03120676|25914704|FG000|Overall Study|Not treated|1|||
13114390|NCT03120520|25914739|FG000|Overall Study|Lost to Follow-up|1|||
13114391|NCT03120520|25914740|FG001|Overall Study|Lost to Follow-up|1|||
13114392|NCT03120520|25914741|FG002|Overall Study|Lost to Follow-up|1|||
13114393|NCT03120520|25914742|FG003|Overall Study|Lost to Follow-up|1|||
13114394|NCT03120520|25914739|FG000|Overall Study|Withdrawal by Subject|3|||
13114395|NCT03120520|25914740|FG001|Overall Study|Withdrawal by Subject|2|||
13114396|NCT03120520|25914741|FG002|Overall Study|Withdrawal by Subject|3|||
13114397|NCT03120520|25914742|FG003|Overall Study|Withdrawal by Subject|2|||
13114398|NCT03120520|25914739|FG000|Overall Study|Other|0|||
13114399|NCT03120520|25914740|FG001|Overall Study|Other|1|||
13114400|NCT03120520|25914741|FG002|Overall Study|Other|0|||
13114401|NCT03120520|25914742|FG003|Overall Study|Other|0|||
13114402|NCT03120351|25914755|FG000|Overall Study|Physician Decision|1|||
13114403|NCT03120351|25914756|FG001|Overall Study|Physician Decision|1|||
13114404|NCT03120013|25914779|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
13114405|NCT03120013|25914780|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
13227355|NCT01755767|26301400|FG003|Overall Study|Progressive Disease|43|||
13227356|NCT01755767|26301397|FG000|Overall Study|Clinical Disease Progression|4|||
13227357|NCT01755767|26301398|FG001|Overall Study|Clinical Disease Progression|2|||
13227358|NCT01755767|26301399|FG002|Overall Study|Clinical Disease Progression|29|||
13114406|NCT03119701|25914819|FG000|6-day Dosing|Death|4|||
13114407|NCT03119701|25914820|FG001|6-day Dosing|Death|1|||
13114408|NCT03119701|25914819|FG000|6-day Dosing|Adverse Event|3|||
13114409|NCT03119701|25914820|FG001|6-day Dosing|Adverse Event|0|||
13114410|NCT03119701|25914819|FG000|6-day Dosing|Physician Decision|0|||
13114411|NCT03119701|25914820|FG001|6-day Dosing|Physician Decision|1|||
13114412|NCT03119701|25914819|FG000|6-day Dosing|Withdrawal by Subject|0|||
13114413|NCT03119701|25914820|FG001|6-day Dosing|Withdrawal by Subject|1|||
13114414|NCT03119701|25914819|FG000|Mid-term (Final) Follow-up at D90|Death|3|||
13114415|NCT03119701|25914820|FG001|Mid-term (Final) Follow-up at D90|Death|1|||
13114416|NCT03119688|25914853|FG000|Overall Study|Adverse Event|4|||
13114417|NCT03119662|25914876|FG000|Overall Study|Withdrawal by Subject|0|||
13114418|NCT03119662|25914877|FG001|Overall Study|Withdrawal by Subject|1|||
13114419|NCT03119610|25914914|FG000|Overall Study|Adverse Event|1|||
13114420|NCT03119610|25914915|FG001|Overall Study|Adverse Event|0|||
13114421|NCT03119610|25914914|FG000|Overall Study|Lost to Follow-up|0|||
13114422|NCT03119610|25914915|FG001|Overall Study|Lost to Follow-up|1|||
13227359|NCT01755767|26301400|FG003|Overall Study|Clinical Disease Progression|20|||
13227360|NCT01755767|26301397|FG000|Overall Study|Radiographic Disease Progression|9|||
13227361|NCT01755767|26301398|FG001|Overall Study|Radiographic Disease Progression|4|||
13227362|NCT01755767|26301399|FG002|Overall Study|Radiographic Disease Progression|44|||
13227363|NCT01755767|26301400|FG003|Overall Study|Radiographic Disease Progression|27|||
13227364|NCT01755767|26301397|FG000|Overall Study|Adverse Event|6|||
13227365|NCT01755767|26301398|FG001|Overall Study|Adverse Event|0|||
13227366|NCT01755767|26301399|FG002|Overall Study|Adverse Event|28|||
13227367|NCT01755767|26301400|FG003|Overall Study|Adverse Event|11|||
13227368|NCT01755767|26301397|FG000|Overall Study|Death|1|||
13227369|NCT01755767|26301398|FG001|Overall Study|Death|2|||
13227370|NCT01755767|26301399|FG002|Overall Study|Death|15|||
13227371|NCT01755767|26301400|FG003|Overall Study|Death|4|||
13227372|NCT01755767|26301397|FG000|Overall Study|Subject Decision|0|||
13227373|NCT01755767|26301398|FG001|Overall Study|Subject Decision|0|||
13227374|NCT01755767|26301399|FG002|Overall Study|Subject Decision|10|||
13227375|NCT01755767|26301400|FG003|Overall Study|Subject Decision|3|||
13227376|NCT01755767|26301397|FG000|Overall Study|Withdrawal by Subject|0|||
13227377|NCT01755767|26301398|FG001|Overall Study|Withdrawal by Subject|0|||
13227378|NCT01755767|26301399|FG002|Overall Study|Withdrawal by Subject|2|||
13227379|NCT01755767|26301400|FG003|Overall Study|Withdrawal by Subject|1|||
13227380|NCT01755767|26301397|FG000|Overall Study|Other|0|||
13227381|NCT01755767|26301398|FG001|Overall Study|Other|0|||
13227382|NCT01755767|26301399|FG002|Overall Study|Other|2|||
13227383|NCT01755767|26301400|FG003|Overall Study|Other|3|||
13227384|NCT01755767|26301397|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
13227385|NCT01755767|26301398|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
13227386|NCT01755767|26301399|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5|||
13227387|NCT01755767|26301400|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2|||
13227388|NCT01755702|26301444|FG000|Wash Out Period I|Other Reason|3|||
13227389|NCT01755702|26301444|FG000|Washout Period II|Other Reason|5|||
13227390|NCT01755637|26301465|FG000|Period 1|Adverse Event|0|||
13227391|NCT01755637|26301466|FG001|Period 1|Adverse Event|1|||
13114423|NCT03118947|25914921|FG000|Overall Study|Adverse Event|7|||
13114424|NCT03118947|25914921|FG000|Overall Study|Death|3|||
13114425|NCT03118947|25914921|FG000|Overall Study|Lack of Efficacy|4|||
13114426|NCT03118947|25914921|FG000|Overall Study|Non-compliance with study drug|1|||
13114427|NCT03118947|25914921|FG000|Overall Study|Protocol Violation|2|||
13114428|NCT03118947|25914921|FG000|Overall Study|Withdrawal by Subject|3|||
13114429|NCT03118947|25914921|FG000|Overall Study|Withdrawal by caregiver|3|||
13227392|NCT01755598|26301507|FG000|Overall Study|Other|109|||
13227393|NCT01755598|26301508|FG001|Overall Study|Other|109|||
13227394|NCT01755598|26301507|FG000|Overall Study|Lost to Follow-up|32|||
13227395|NCT01755598|26301508|FG001|Overall Study|Lost to Follow-up|43|||
13227396|NCT01755598|26301507|FG000|Overall Study|Migrated/moved from study area|76|||
13227397|NCT01755598|26301508|FG001|Overall Study|Migrated/moved from study area|65|||
13227398|NCT01755598|26301507|FG000|Overall Study|Withdrawal by Subject|22|||
13227399|NCT01755598|26301508|FG001|Overall Study|Withdrawal by Subject|31|||
13227400|NCT01755598|26301507|FG000|Overall Study|Protocol Violation|7|||
13227401|NCT01755598|26301508|FG001|Overall Study|Protocol Violation|7|||
13114430|NCT03118947|25914921|FG000|Overall Study|Change in patient's living situation|4|||
13114431|NCT03118947|25914921|FG000|Overall Study|Lost to Follow-up|2|||
13114432|NCT03118934|25914944|FG000|Overall Study|Adverse Event|0|||
13114433|NCT03118934|25914945|FG001|Overall Study|Adverse Event|0|||
13114434|NCT03118934|25914946|FG002|Overall Study|Adverse Event|0|||
13227402|NCT01755598|26301507|FG000|Overall Study|Adverse Event|19|||
13227403|NCT01755598|26301508|FG001|Overall Study|Adverse Event|28|||
13227404|NCT01755546|26301514|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1|||
13227405|NCT01755546|26301514|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3|||
13114435|NCT03118934|25914947|FG003|Overall Study|Adverse Event|0|||
13227406|NCT01755546|26301514|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1|||
13227407|NCT01755546|26301514|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5|||
13227408|NCT01755546|26301514|FG000|Titration Phase|Adverse Event|11|||
13227409|NCT01755546|26301514|FG000|Titration Phase|Lack of Efficacy|18|||
13227410|NCT01755546|26301514|FG000|Titration Phase|Protocol Violation|9|||
13227411|NCT01755546|26301514|FG000|Titration Phase|Lost to Follow-up|2|||
13227412|NCT01755546|26301514|FG000|Titration Phase|Other and Continuing|22|||
13227413|NCT01755546|26301514|FG000|Titration Phase|Withdrawal by Subject|8|||
13114436|NCT03118934|25914948|FG004|Overall Study|Adverse Event|0|||
13114437|NCT03118934|25914949|FG005|Overall Study|Adverse Event|1|||
13114438|NCT03118934|25914944|FG000|Overall Study|Physician Decision|0|||
13227414|NCT01755546|26301514|FG000|Long Term Treatment|Adverse Event|12|||
13227415|NCT01755546|26301514|FG000|Long Term Treatment|Lack of Efficacy|6|||
13227416|NCT01755546|26301514|FG000|Long Term Treatment|Protocol Violation|10|||
13227417|NCT01755546|26301514|FG000|Long Term Treatment|Withdrawal by Subject|35|||
13227418|NCT01755546|26301514|FG000|Long Term Treatment|Lost to Follow-up|17|||
13227419|NCT01755546|26301514|FG000|Long Term Treatment|other and ongoing|41|||
13227420|NCT01755416|26301523|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1|||
13227421|NCT01755416|26301524|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2|||
13227422|NCT01755234|26301543|FG000|Overall Study|Lost to Follow-up|11|||
13227423|NCT01755234|26301544|FG001|Overall Study|Lost to Follow-up|6|||
13227424|NCT01755234|26301543|FG000|Overall Study|Change in surgical case|2|||
13227425|NCT01755234|26301544|FG001|Overall Study|Change in surgical case|1|||
13227426|NCT01755234|26301543|FG000|Overall Study|case cancelled|1|||
13227427|NCT01755234|26301544|FG001|Overall Study|case cancelled|0|||
13227428|NCT01755234|26301543|FG000|Overall Study|Withdrawal by Subject|0|||
13227429|NCT01755234|26301544|FG001|Overall Study|Withdrawal by Subject|1|||
13227430|NCT01755234|26301543|FG000|Overall Study|unblinded|1|||
13227431|NCT01755234|26301544|FG001|Overall Study|unblinded|0|||
13227432|NCT01755156|26301595|FG000|Phase A (Weeks 0-24)|Adverse Event|2|||
13227433|NCT01755156|26301596|FG001|Phase A (Weeks 0-24)|Adverse Event|3|||
13227434|NCT01755156|26301595|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1|||
13227435|NCT01755156|26301596|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0|||
13227436|NCT01755156|26301595|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
13227437|NCT01755156|26301596|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3|||
13227438|NCT01755156|26301595|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1|||
13227439|NCT01755156|26301596|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0|||
13114439|NCT03118934|25914945|FG001|Overall Study|Physician Decision|0|||
13114440|NCT03118934|25914946|FG002|Overall Study|Physician Decision|0|||
13114441|NCT03118934|25914947|FG003|Overall Study|Physician Decision|0|||
13114442|NCT03118934|25914948|FG004|Overall Study|Physician Decision|0|||
13114443|NCT03118934|25914949|FG005|Overall Study|Physician Decision|1|||
13114444|NCT03118934|25914944|FG000|Overall Study|Discontinued prior to exposure|0|||
13114445|NCT03118934|25914945|FG001|Overall Study|Discontinued prior to exposure|1|||
13114446|NCT03118934|25914946|FG002|Overall Study|Discontinued prior to exposure|1|||
13114447|NCT03118934|25914947|FG003|Overall Study|Discontinued prior to exposure|1|||
13114448|NCT03118934|25914948|FG004|Overall Study|Discontinued prior to exposure|2|||
13114449|NCT03118934|25914949|FG005|Overall Study|Discontinued prior to exposure|0|||
13114450|NCT03118765|25915059|FG000|Overall Study|Withdrawal by Subject|0|||
13114451|NCT03118765|25915060|FG001|Overall Study|Withdrawal by Subject|0|||
13114452|NCT03118765|25915061|FG002|Overall Study|Withdrawal by Subject|1|||
13114453|NCT03118765|25915062|FG003|Overall Study|Withdrawal by Subject|0|||
13114454|NCT03118765|25915063|FG004|Overall Study|Withdrawal by Subject|0|||
13114455|NCT03118765|25915059|FG000|Overall Study|Adverse Event|1|||
13114456|NCT03118765|25915060|FG001|Overall Study|Adverse Event|1|||
13114457|NCT03118765|25915061|FG002|Overall Study|Adverse Event|1|||
13114458|NCT03118765|25915062|FG003|Overall Study|Adverse Event|1|||
13227440|NCT01755156|26301595|FG000|Phase A (Weeks 0-24)|Physician Decision|0|||
13227441|NCT01755156|26301596|FG001|Phase A (Weeks 0-24)|Physician Decision|1|||
13227442|NCT01755156|26301595|FG000|Phase A (Weeks 0-24)|Protocol Violation|1|||
13227443|NCT01755156|26301596|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
13227444|NCT01755156|26301595|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6|||
13227445|NCT01755156|26301596|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13|||
13114459|NCT03118765|25915063|FG004|Overall Study|Adverse Event|1|||
13114460|NCT03118765|25915059|FG000|Overall Study|Non compliance with Study Procedures|0|||
13114461|NCT03118765|25915060|FG001|Overall Study|Non compliance with Study Procedures|0|||
13114462|NCT03118765|25915061|FG002|Overall Study|Non compliance with Study Procedures|0|||
13114463|NCT03118765|25915062|FG003|Overall Study|Non compliance with Study Procedures|1|||
13114464|NCT03118765|25915063|FG004|Overall Study|Non compliance with Study Procedures|0|||
13227446|NCT01755156|26301595|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0|||
13227447|NCT01755156|26301596|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2|||
13227448|NCT01755156|26301595|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
13227449|NCT01755156|26301596|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
13227450|NCT01755156|26301595|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12|||
13227451|NCT01755156|26301596|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5|||
13227452|NCT01755156|26301595|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27|||
13227453|NCT01755156|26301596|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31|||
13227454|NCT01755091|26301629|FG000|Overall Study|Withdrawal by Subject|6|||
13227455|NCT01755091|26301630|FG001|Overall Study|Withdrawal by Subject|1|||
13227456|NCT01755091|26301631|FG002|Overall Study|Withdrawal by Subject|3|||
13227457|NCT01755091|26301629|FG000|Overall Study|Adverse Event|1|||
13227458|NCT01755091|26301630|FG001|Overall Study|Adverse Event|1|||
13227459|NCT01755091|26301631|FG002|Overall Study|Adverse Event|1|||
13227460|NCT01755091|26301629|FG000|Overall Study|Lost to Follow-up|1|||
13227461|NCT01755091|26301630|FG001|Overall Study|Lost to Follow-up|0|||
13227462|NCT01755091|26301631|FG002|Overall Study|Lost to Follow-up|1|||
13227463|NCT01755091|26301629|FG000|Overall Study|Physician Decision|1|||
13227464|NCT01755091|26301630|FG001|Overall Study|Physician Decision|1|||
13227465|NCT01755091|26301631|FG002|Overall Study|Physician Decision|2|||
13227466|NCT01755026|26301644|FG000|Overall Study|Adverse Event|1|||
13227467|NCT01755026|26301645|FG001|Overall Study|Adverse Event|0|||
13227468|NCT01755026|26301644|FG000|Overall Study|Withdrawal by Subject|1|||
13227469|NCT01755026|26301645|FG001|Overall Study|Withdrawal by Subject|1|||
13227470|NCT01754922|26301662|FG000|Overall Study|Adverse Event|0|||
13227471|NCT01754922|26301663|FG001|Overall Study|Adverse Event|1|||
13227472|NCT01754766|26301687|FG000|Overall Study|Personal reasons|1|||
13227473|NCT01754766|26301688|FG001|Overall Study|Personal reasons|1|||
13227474|NCT01754766|26301689|FG002|Overall Study|Personal reasons|0|||
13227475|NCT01754753|26301714|FG000|Overall Study|Study close|43|||
13227476|NCT01754753|26301715|FG001|Overall Study|Study close|44|||
13227477|NCT01754753|26301714|FG000|Overall Study|Lost to Follow-up|9|||
13114465|NCT03118765|25915059|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
13114466|NCT03118765|25915060|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
13114467|NCT03118765|25915061|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
13114468|NCT03118765|25915062|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
13114469|NCT03118765|25915063|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
13227478|NCT01754753|26301715|FG001|Overall Study|Lost to Follow-up|5|||
13227479|NCT01754727|26301731|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
13114470|NCT03118765|25915059|FG000|Overall Study|COPD Exacerbation|1|||
13114471|NCT03118765|25915060|FG001|Overall Study|COPD Exacerbation|0|||
13114472|NCT03118765|25915061|FG002|Overall Study|COPD Exacerbation|0|||
13114473|NCT03118765|25915062|FG003|Overall Study|COPD Exacerbation|1|||
13227480|NCT01754493|26301741|FG000|Overall Study|Adverse Event|1|||
13227481|NCT01754493|26301741|FG000|Overall Study|Lost to Follow-up|3|||
13227482|NCT01754493|26301741|FG000|Overall Study|Withdrawal by Subject|1|||
13227483|NCT01754493|26301741|FG000|Overall Study|Moved out of town|1|||
13227484|NCT01754493|26301741|FG000|Overall Study|Scheduling conflict|1|||
13227485|NCT01754467|26301750|FG000|Overall Study|Lost to Follow-up|1|||
13227486|NCT01754402|26301769|FG000|Overall Study|Death|0|||
13227487|NCT01754402|26301770|FG001|Overall Study|Death|0|||
13227488|NCT01754402|26301771|FG002|Overall Study|Death|1|||
13227489|NCT01754402|26301769|FG000|Overall Study|Adverse Event|2|||
13227490|NCT01754402|26301770|FG001|Overall Study|Adverse Event|2|||
13227491|NCT01754402|26301771|FG002|Overall Study|Adverse Event|1|||
13227492|NCT01754402|26301769|FG000|Overall Study|Withdrawal by Subject|0|||
13227493|NCT01754402|26301770|FG001|Overall Study|Withdrawal by Subject|0|||
13227494|NCT01754402|26301771|FG002|Overall Study|Withdrawal by Subject|1|||
13227495|NCT01754402|26301769|FG000|Overall Study|Lack of Efficacy|0|||
13227496|NCT01754402|26301770|FG001|Overall Study|Lack of Efficacy|0|||
13227497|NCT01754402|26301771|FG002|Overall Study|Lack of Efficacy|1|||
13227498|NCT01754376|26301782|FG000|Overall Study|Adverse Event|1|||
13227499|NCT01754376|26301782|FG000|Overall Study|Lack of Efficacy|2|||
13227500|NCT01754259|26301797|FG000|Overall Study|Withdrawal by Subject|2|||
13227501|NCT01754259|26301798|FG001|Overall Study|Withdrawal by Subject|4|||
13227502|NCT01754259|26301797|FG000|Overall Study|Adverse Event|3|||
13227503|NCT01754259|26301798|FG001|Overall Study|Adverse Event|1|||
13227504|NCT01754259|26301797|FG000|Overall Study|Lost to Follow-up|0|||
13227505|NCT01754259|26301798|FG001|Overall Study|Lost to Follow-up|1|||
13227506|NCT01754194|26301825|FG000|Overall Study|Lost to Follow-up|39|||
13227507|NCT01754194|26301826|FG001|Overall Study|Lost to Follow-up|14|||
13227508|NCT01754194|26301825|FG000|Overall Study|Withdrawal by Subject|4|||
13227509|NCT01754194|26301826|FG001|Overall Study|Withdrawal by Subject|5|||
13227510|NCT01754194|26301825|FG000|Overall Study|Other|9|||
13227511|NCT01754194|26301826|FG001|Overall Study|Other|8|||
13227512|NCT01754129|26301851|FG000|Overall Study|Death|13|||
13227513|NCT01754129|26301851|FG000|Overall Study|Duodopa discontinuation|9|||
13114474|NCT03118765|25915063|FG004|Overall Study|COPD Exacerbation|0|||
13114475|NCT03118765|25915059|FG000|Overall Study|Lost to Follow-up|1|||
13114476|NCT03118765|25915060|FG001|Overall Study|Lost to Follow-up|0|||
13114477|NCT03118765|25915061|FG002|Overall Study|Lost to Follow-up|1|||
13227514|NCT01754129|26301851|FG000|Overall Study|Lost to Follow-up|7|||
13227515|NCT01754129|26301851|FG000|Overall Study|Withdrew consent|1|||
13227516|NCT01754129|26301851|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
13227517|NCT01753999|26301870|FG000|Period 1 - Initial Assignment|Physician Decision|2|||
13114478|NCT03118765|25915062|FG003|Overall Study|Lost to Follow-up|0|||
13114479|NCT03118765|25915063|FG004|Overall Study|Lost to Follow-up|0|||
13114480|NCT03118765|25915059|FG000|Overall Study|Sponsor Decision|1|||
13114481|NCT03118765|25915060|FG001|Overall Study|Sponsor Decision|0|||
13114482|NCT03118765|25915061|FG002|Overall Study|Sponsor Decision|1|||
13114483|NCT03118765|25915062|FG003|Overall Study|Sponsor Decision|0|||
13114484|NCT03118765|25915063|FG004|Overall Study|Sponsor Decision|1|||
13114485|NCT03118739|25915160|FG000|Overall Study|Physician Decision|0|||
13114486|NCT03118739|25915161|FG001|Overall Study|Physician Decision|1|||
13114487|NCT03118739|25915160|FG000|Overall Study|Withdrawal by Subject|5|||
13114488|NCT03118739|25915161|FG001|Overall Study|Withdrawal by Subject|3|||
13114489|NCT03118739|25915160|FG000|Overall Study|Lost to Follow-up|2|||
13227518|NCT01753999|26301871|FG001|Period 1 - Initial Assignment|Physician Decision|3|||
13227519|NCT01753999|26301870|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19|||
13227520|NCT01753999|26301871|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20|||
13227521|NCT01753999|26301870|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18|||
13227522|NCT01753999|26301871|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27|||
13227523|NCT01753999|26301870|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13|||
13227524|NCT01753999|26301871|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17|||
13227525|NCT01753999|26301870|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3|||
13227526|NCT01753999|26301871|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5|||
13227527|NCT01753999|26301870|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
13227528|NCT01753999|26301871|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
13227529|NCT01753856|26301928|FG000|Overall Study|Adverse Event|1|||
13227530|NCT01753856|26301929|FG001|Overall Study|Adverse Event|0|||
13227531|NCT01753856|26301928|FG000|Overall Study|Withdrawal by Subject|0|||
13227532|NCT01753856|26301929|FG001|Overall Study|Withdrawal by Subject|2|||
13227533|NCT01753856|26301928|FG000|Overall Study|Sponsor Decision|2|||
13227534|NCT01753856|26301929|FG001|Overall Study|Sponsor Decision|0|||
13227535|NCT01753570|26301961|FG000|Overall Study|Adverse Event|1|||
13227536|NCT01753570|26301962|FG001|Overall Study|Adverse Event|0|||
13227537|NCT01753570|26301963|FG002|Overall Study|Adverse Event|1|||
13227538|NCT01753570|26301961|FG000|Overall Study|Physician Decision|0|||
13227539|NCT01753570|26301962|FG001|Overall Study|Physician Decision|1|||
13227540|NCT01753570|26301963|FG002|Overall Study|Physician Decision|0|||
13227541|NCT01753570|26301961|FG000|Overall Study|Withdrawal by Subject|1|||
13227542|NCT01753570|26301962|FG001|Overall Study|Withdrawal by Subject|4|||
13227543|NCT01753570|26301963|FG002|Overall Study|Withdrawal by Subject|0|||
13227544|NCT01753518|26301992|FG000|Intention-to-Treat Analysis|Missing consent form|5|||
13227545|NCT01753518|26301993|FG001|Intention-to-Treat Analysis|Missing consent form|3|||
13227546|NCT01753518|26301992|FG000|Intention-to-Treat Analysis|Multifetal gestation|2|||
13227547|NCT01753518|26301993|FG001|Intention-to-Treat Analysis|Multifetal gestation|3|||
13227548|NCT01753518|26301992|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0|||
13227549|NCT01753518|26301993|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1|||
13227550|NCT01753518|26301992|FG000|Postpartum Follow-up|Lost to Follow-up|22|||
13227551|NCT01753518|26301993|FG001|Postpartum Follow-up|Lost to Follow-up|15|||
13227552|NCT01753401|26302050|FG000|Double-blind Period (8 Weeks)|Adverse Event|0|||
13227553|NCT01753401|26302051|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
13227554|NCT01753401|26302052|FG002|Double-blind Period (8 Weeks)|Adverse Event|0|||
13227555|NCT01753401|26302053|FG003|Double-blind Period (8 Weeks)|Adverse Event|0|||
13227556|NCT01753401|26302050|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
13227557|NCT01753401|26302051|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
13227558|NCT01753401|26302052|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
13227559|NCT01753401|26302053|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
13227560|NCT01753401|26302050|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0|||
13227561|NCT01753401|26302051|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1|||
13227562|NCT01753401|26302052|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0|||
13227563|NCT01753401|26302053|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0|||
13227564|NCT01753401|26302050|FG000|Open Label Period (44 Weeks)|Adverse Event|0|||
13227565|NCT01753401|26302051|FG001|Open Label Period (44 Weeks)|Adverse Event|0|||
13227566|NCT01753401|26302052|FG002|Open Label Period (44 Weeks)|Adverse Event|3|||
13227567|NCT01753401|26302053|FG003|Open Label Period (44 Weeks)|Adverse Event|4|||
13227568|NCT01753401|26302050|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
13227569|NCT01753401|26302051|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
13227570|NCT01753401|26302052|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
13227571|NCT01753401|26302053|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2|||
13227572|NCT01753401|26302050|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
13227573|NCT01753401|26302051|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
13114490|NCT03118739|25915161|FG001|Overall Study|Lost to Follow-up|0|||
13114491|NCT03118518|25915178|FG000|Overall Study|Early Exit after treatment|2|||
13114492|NCT03118518|25915179|FG001|Overall Study|Early Exit after treatment|8|||
13114493|NCT03118518|25915178|FG000|Overall Study|Early Exit after randomization but prior to treatment|4|||
13114494|NCT03118518|25915179|FG001|Overall Study|Early Exit after randomization but prior to treatment|3|||
13114495|NCT03118297|25915200|FG000|Overall Study|Lost to Follow-up|0|||
13114496|NCT03118297|25915201|FG001|Overall Study|Lost to Follow-up|2|||
13114497|NCT03117738|25915228|FG000|Overall Study|Withdrawal by Subject|3|||
13114498|NCT03117738|25915229|FG001|Overall Study|Withdrawal by Subject|1|||
13114499|NCT03117738|25915228|FG000|Overall Study|Lost to Follow-up|1|||
13114500|NCT03117738|25915229|FG001|Overall Study|Lost to Follow-up|4|||
13114501|NCT03117361|25915254|FG000|Overall Study|Progressive disease|5|||
13114502|NCT03117361|25915254|FG000|Overall Study|Death|1|||
13114503|NCT03117361|25915254|FG000|Overall Study|Physician Decision|2|||
13114504|NCT03117361|25915254|FG000|Overall Study|On study treatment at the end of study|1|||
13114505|NCT03117361|25915254|FG000|Overall Study|Treatment-related adverse event|1|||
13114506|NCT03116828|25915267|FG000|Overall Study|Adverse Event|1|||
13114507|NCT03116828|25915268|FG001|Overall Study|Adverse Event|10|||
13114508|NCT03116828|25915267|FG000|Overall Study|Withdrawal by Subject|4|||
13114509|NCT03116828|25915268|FG001|Overall Study|Withdrawal by Subject|8|||
13114510|NCT03116828|25915267|FG000|Overall Study|OTHER|3|||
13114511|NCT03116828|25915268|FG001|Overall Study|OTHER|3|||
13114512|NCT03116698|25915295|FG000|Overall Study|Adverse Event|1|||
13114513|NCT03116698|25915296|FG001|Overall Study|Adverse Event|1|||
13114514|NCT03116698|25915297|FG002|Overall Study|Adverse Event|1|||
13114515|NCT03116698|25915298|FG003|Overall Study|Adverse Event|0|||
13114516|NCT03116698|25915295|FG000|Overall Study|Withdrawal by Subject|1|||
13114517|NCT03116698|25915296|FG001|Overall Study|Withdrawal by Subject|4|||
13114518|NCT03116698|25915297|FG002|Overall Study|Withdrawal by Subject|5|||
13114519|NCT03116698|25915298|FG003|Overall Study|Withdrawal by Subject|2|||
13114520|NCT03116698|25915295|FG000|Overall Study|Lost to Follow-up|2|||
13114521|NCT03116698|25915296|FG001|Overall Study|Lost to Follow-up|0|||
13114522|NCT03116698|25915297|FG002|Overall Study|Lost to Follow-up|0|||
13114523|NCT03116698|25915298|FG003|Overall Study|Lost to Follow-up|0|||
13114524|NCT03116698|25915295|FG000|Overall Study|Physician Decision|1|||
13114525|NCT03116698|25915296|FG001|Overall Study|Physician Decision|1|||
13114526|NCT03116698|25915297|FG002|Overall Study|Physician Decision|0|||
13114527|NCT03116698|25915298|FG003|Overall Study|Physician Decision|0|||
13114528|NCT03116698|25915295|FG000|Overall Study|Protocol Violation|1|||
13114529|NCT03116698|25915296|FG001|Overall Study|Protocol Violation|0|||
13114530|NCT03116698|25915297|FG002|Overall Study|Protocol Violation|0|||
13114531|NCT03116698|25915298|FG003|Overall Study|Protocol Violation|0|||
13114532|NCT03116698|25915295|FG000|Overall Study|Death|0|||
13114533|NCT03116698|25915296|FG001|Overall Study|Death|0|||
13114534|NCT03116698|25915297|FG002|Overall Study|Death|2|||
13114535|NCT03116698|25915298|FG003|Overall Study|Death|0|||
13114536|NCT03116399|25915313|FG000|Overall Study|Death|8|||
13114537|NCT03116399|25915314|FG001|Overall Study|Death|3|||
13114538|NCT03116399|25915313|FG000|Overall Study|Lost to Follow-up|7|||
13114539|NCT03116399|25915314|FG001|Overall Study|Lost to Follow-up|11|||
13114540|NCT03116399|25915313|FG000|Overall Study|Investigator Decision|1|||
13114541|NCT03116399|25915314|FG001|Overall Study|Investigator Decision|1|||
13114542|NCT03116399|25915313|FG000|Overall Study|Withdrawal by Subject|24|||
13227574|NCT01753401|26302052|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
13227575|NCT01753401|26302053|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
13227576|NCT01753401|26302050|FG000|Open Label Period (44 Weeks)|Reason not provided|0|||
13227577|NCT01753401|26302051|FG001|Open Label Period (44 Weeks)|Reason not provided|0|||
13227578|NCT01753401|26302052|FG002|Open Label Period (44 Weeks)|Reason not provided|0|||
13227579|NCT01753401|26302053|FG003|Open Label Period (44 Weeks)|Reason not provided|2|||
13227580|NCT01753336|26302064|FG000|Overall Study|Patient decision|12|||
13227581|NCT01753336|26302064|FG000|Overall Study|Lost to Follow-up|3|||
13227582|NCT01753336|26302064|FG000|Overall Study|Physician Decision|2|||
13227583|NCT01753336|26302064|FG000|Overall Study|Sponsor's decision|2|||
13227584|NCT01753336|26302064|FG000|Overall Study|Withdrawal by Subject|1|||
13227585|NCT01753323|26302110|FG000|Overall Study|Lack of Efficacy|0|||
13227586|NCT01753323|26302111|FG001|Overall Study|Lack of Efficacy|0|||
13227587|NCT01753323|26302112|FG002|Overall Study|Lack of Efficacy|8|||
13227588|NCT01753323|26302110|FG000|Overall Study|Protocol deviation|1|||
13227589|NCT01753323|26302111|FG001|Overall Study|Protocol deviation|0|||
13227590|NCT01753323|26302112|FG002|Overall Study|Protocol deviation|0|||
13227591|NCT01753323|26302110|FG000|Overall Study|Adverse Event|0|||
13227592|NCT01753323|26302111|FG001|Overall Study|Adverse Event|0|||
13227593|NCT01753323|26302112|FG002|Overall Study|Adverse Event|1|||
13227594|NCT01753310|26302139|FG000|Overall Study|Entered into open label extension study|25|||
13227595|NCT01753310|26302140|FG001|Overall Study|Entered into open label extension study|22|||
13227596|NCT01753310|26302139|FG000|Overall Study|Adverse Event|1|||
13227597|NCT01753310|26302140|FG001|Overall Study|Adverse Event|0|||
13227598|NCT01753310|26302139|FG000|Overall Study|Lost to Follow-up|2|||
13227599|NCT01753310|26302140|FG001|Overall Study|Lost to Follow-up|0|||
13114543|NCT03116399|25915314|FG001|Overall Study|Withdrawal by Subject|9|||
13114544|NCT03116152|25915333|FG000|Overall Study|Disease Progression|49|||
13114545|NCT03116152|25915334|FG001|Overall Study|Disease Progression|47|||
13227600|NCT01753310|26302139|FG000|Overall Study|Subject decision|2|||
13227601|NCT01753310|26302140|FG001|Overall Study|Subject decision|2|||
13227602|NCT01753310|26302139|FG000|Overall Study|Sponsor decision|1|||
13227603|NCT01753310|26302140|FG001|Overall Study|Sponsor decision|0|||
13227604|NCT01753310|26302139|FG000|Overall Study|Withdrawal by Subject|1|||
13227605|NCT01753310|26302140|FG001|Overall Study|Withdrawal by Subject|0|||
13227606|NCT01753297|26302179|FG000|Overall Study|Lost to Follow-up|7|||
13227607|NCT01753297|26302180|FG001|Overall Study|Lost to Follow-up|2|||
13227608|NCT01753297|26302179|FG000|Overall Study|Withdrawal by Subject|26|||
13227609|NCT01753297|26302180|FG001|Overall Study|Withdrawal by Subject|23|||
13227610|NCT01753297|26302179|FG000|Overall Study|Adverse Event (up to Month 36)|1|||
13227611|NCT01753297|26302180|FG001|Overall Study|Adverse Event (up to Month 36)|1|||
13227612|NCT01753297|26302179|FG000|Overall Study|Death|0|||
13227613|NCT01753297|26302180|FG001|Overall Study|Death|2|||
13227614|NCT01753297|26302179|FG000|Overall Study|Did not attend end of study visit|7|||
13227615|NCT01753297|26302180|FG001|Overall Study|Did not attend end of study visit|8|||
13289571|NCT00108160|26479641|FG000|Overall Study|Withdrawal by Subject|4|||
13289572|NCT00108160|26479642|FG001|Overall Study|Withdrawal by Subject|2|||
13289573|NCT00108160|26479641|FG000|Overall Study|Protocol Violation|9|||
13289574|NCT00108160|26479642|FG001|Overall Study|Protocol Violation|5|||
13289575|NCT00108082|26479699|FG000|Overall Study|Adverse Event|14|||
13289576|NCT00108082|26479700|FG001|Overall Study|Adverse Event|12|||
13114546|NCT03116152|25915333|FG000|Overall Study|Death|5|||
13114547|NCT03116152|25915334|FG001|Overall Study|Death|2|||
13114548|NCT03116152|25915333|FG000|Overall Study|Adverse Event|21|||
13114549|NCT03116152|25915334|FG001|Overall Study|Adverse Event|7|||
13114550|NCT03116152|25915333|FG000|Overall Study|Protocol Violation|2|||
13114551|NCT03116152|25915334|FG001|Overall Study|Protocol Violation|2|||
13114552|NCT03116152|25915333|FG000|Overall Study|Withdrawal by Subject|0|||
13114553|NCT03116152|25915334|FG001|Overall Study|Withdrawal by Subject|1|||
13114554|NCT03116152|25915333|FG000|Overall Study|Physician Decision|3|||
13114555|NCT03116152|25915334|FG001|Overall Study|Physician Decision|2|||
13114556|NCT03116152|25915333|FG000|Overall Study|other|11|||
13114557|NCT03116152|25915334|FG001|Overall Study|other|34|||
13114558|NCT03115476|25915355|FG000|LP0084-1369|Death|1|||
13114559|NCT03115476|25915356|FG001|LP0084-1369|Death|0|||
13114560|NCT03115476|25915357|FG002|LP0084-1369|Death|2|||
13114561|NCT03115476|25915355|FG000|LP0084-1369|Trial terminated by Sponsor|190|||
13114562|NCT03115476|25915356|FG001|LP0084-1369|Trial terminated by Sponsor|210|||
13114563|NCT03115476|25915357|FG002|LP0084-1369|Trial terminated by Sponsor|160|||
13114564|NCT03115112|25915376|FG000|Overall Study|Adverse Event|5|||
13114565|NCT03115112|25915377|FG001|Overall Study|Adverse Event|1|||
13114566|NCT03115112|25915376|FG000|Overall Study|Withdrawal by Subject|4|||
13114567|NCT03115112|25915377|FG001|Overall Study|Withdrawal by Subject|2|||
13114568|NCT03115112|25915376|FG000|Overall Study|Lost to Follow-up|0|||
13114569|NCT03115112|25915377|FG001|Overall Study|Lost to Follow-up|1|||
13114570|NCT03115112|25915376|FG000|Overall Study|Death|1|||
13114571|NCT03115112|25915377|FG001|Overall Study|Death|0|||
13114572|NCT03115112|25915376|FG000|Overall Study|Pregnancy|1|||
13114573|NCT03115112|25915377|FG001|Overall Study|Pregnancy|0|||
13114574|NCT03115112|25915376|FG000|Overall Study|Site closure|1|||
13114575|NCT03115112|25915377|FG001|Overall Study|Site closure|1|||
13114576|NCT03114969|25915500|FG000|Overall Study|Lost to Follow-up|0|||
13114577|NCT03114969|25915501|FG001|Overall Study|Lost to Follow-up|0|||
13114578|NCT03114969|25915502|FG002|Overall Study|Lost to Follow-up|3|||
13114579|NCT03114969|25915503|FG003|Overall Study|Lost to Follow-up|2|||
13114580|NCT03114969|25915504|FG004|Overall Study|Lost to Follow-up|0|||
13114581|NCT03114969|25915505|FG005|Overall Study|Lost to Follow-up|0|||
13114582|NCT03114969|25915506|FG006|Overall Study|Lost to Follow-up|0|||
13114583|NCT03114969|25915507|FG007|Overall Study|Lost to Follow-up|0|||
13114584|NCT03114969|25915508|FG008|Overall Study|Lost to Follow-up|0|||
13114585|NCT03114969|25915500|FG000|Overall Study|Adverse Event|0|||
13114586|NCT03114969|25915501|FG001|Overall Study|Adverse Event|0|||
13114587|NCT03114969|25915502|FG002|Overall Study|Adverse Event|1|||
13114588|NCT03114969|25915503|FG003|Overall Study|Adverse Event|0|||
13114589|NCT03114969|25915504|FG004|Overall Study|Adverse Event|0|||
13114590|NCT03114969|25915505|FG005|Overall Study|Adverse Event|1|||
13114591|NCT03114969|25915506|FG006|Overall Study|Adverse Event|1|||
13114592|NCT03114969|25915507|FG007|Overall Study|Adverse Event|0|||
13114593|NCT03114969|25915508|FG008|Overall Study|Adverse Event|2|||
13289577|NCT00108082|26479701|FG002|Overall Study|Adverse Event|17|||
13289578|NCT00108082|26479699|FG000|Overall Study|Lost to Follow-up|6|||
13289579|NCT00108082|26479700|FG001|Overall Study|Lost to Follow-up|3|||
13289580|NCT00108082|26479701|FG002|Overall Study|Lost to Follow-up|7|||
13114594|NCT03114657|25915560|FG000|Overall Study|Adverse Event|9|||
13114595|NCT03114657|25915561|FG001|Overall Study|Adverse Event|6|||
13114596|NCT03114657|25915560|FG000|Overall Study|Death|4|||
13114597|NCT03114657|25915561|FG001|Overall Study|Death|0|||
13114598|NCT03114657|25915560|FG000|Overall Study|Multiple Reasons|1|||
13114599|NCT03114657|25915561|FG001|Overall Study|Multiple Reasons|2|||
13114600|NCT03114657|25915560|FG000|Overall Study|Physician Decision|2|||
13114601|NCT03114657|25915561|FG001|Overall Study|Physician Decision|2|||
13114602|NCT03114657|25915560|FG000|Overall Study|Study Terminated By Sponsor|355|||
13114603|NCT03114657|25915561|FG001|Overall Study|Study Terminated By Sponsor|374|||
13114604|NCT03114657|25915560|FG000|Overall Study|Symptomatic Deterioration|0|||
13114605|NCT03114657|25915561|FG001|Overall Study|Symptomatic Deterioration|1|||
13114606|NCT03114657|25915560|FG000|Overall Study|Withdrawal by Subject|28|||
13114607|NCT03114657|25915561|FG001|Overall Study|Withdrawal by Subject|22|||
13114608|NCT03114488|25915574|FG000|Time Period 2|Withdrawal by Subject|1|||
13114609|NCT03114488|25915575|FG001|Time Period 2|Withdrawal by Subject|3|||
13114610|NCT03113916|25915611|FG000|Overall Study|Withdrawal by Subject|9|||
13114611|NCT03113916|25915612|FG001|Overall Study|Withdrawal by Subject|7|||
13114612|NCT03113916|25915611|FG000|Overall Study|Pregnancy|1|||
13114613|NCT03113916|25915612|FG001|Overall Study|Pregnancy|3|||
13114614|NCT03113916|25915611|FG000|Overall Study|Lost to Follow-up|1|||
13114615|NCT03113916|25915612|FG001|Overall Study|Lost to Follow-up|2|||
13114616|NCT03113409|25915620|FG000|Overall Study|Withdrawal by Subject|5|||
13114617|NCT03113409|25915621|FG001|Overall Study|Withdrawal by Subject|0|||
13114618|NCT03113409|25915622|FG002|Overall Study|Withdrawal by Subject|0|||
13114619|NCT03113071|25915641|FG000|Overall Study|Withdrawal by Subject|1|||
13114620|NCT03113071|25915642|FG001|Overall Study|Withdrawal by Subject|0|||
13114621|NCT03112590|25915661|FG000|Overall Study|Adverse Event|0|||
13114622|NCT03112590|25915662|FG001|Overall Study|Adverse Event|1|||
13114623|NCT03112590|25915663|FG002|Overall Study|Adverse Event|0|||
13114624|NCT03111108|25915686|FG000|Overall Study|Death|0|||
13114625|NCT03111108|25915687|FG001|Overall Study|Death|1|||
13114626|NCT03111108|25915686|FG000|Overall Study|Withdrawal by Subject|1|||
13114627|NCT03111108|25915687|FG001|Overall Study|Withdrawal by Subject|0|||
13114628|NCT03110900|25915700|FG000|Overall Study|Sponsor withdrew|1|||
13114629|NCT03110900|25915701|FG001|Overall Study|Sponsor withdrew|1|||
13114630|NCT03110770|25915764|FG000|Overall Study|Death|1|||
13114631|NCT03110770|25915765|FG001|Overall Study|Death|0|||
13114632|NCT03110770|25915766|FG002|Overall Study|Death|0|||
13114633|NCT03110770|25915767|FG003|Overall Study|Death|1|||
13114634|NCT03110770|25915768|FG004|Overall Study|Death|0|||
13114635|NCT03110770|25915764|FG000|Overall Study|Enrolled but did not receive product|0|||
13114636|NCT03110770|25915765|FG001|Overall Study|Enrolled but did not receive product|0|||
13114637|NCT03110770|25915766|FG002|Overall Study|Enrolled but did not receive product|0|||
13114638|NCT03110770|25915767|FG003|Overall Study|Enrolled but did not receive product|8|||
13114639|NCT03110770|25915768|FG004|Overall Study|Enrolled but did not receive product|7|||
13114640|NCT03110770|25915764|FG000|Overall Study|Lost to Follow-up|0|||
13114641|NCT03110770|25915765|FG001|Overall Study|Lost to Follow-up|0|||
13114642|NCT03110770|25915766|FG002|Overall Study|Lost to Follow-up|0|||
13114643|NCT03110770|25915767|FG003|Overall Study|Lost to Follow-up|53|||
13114644|NCT03110770|25915768|FG004|Overall Study|Lost to Follow-up|45|||
13114645|NCT03110770|25915764|FG000|Overall Study|Investigator Decision|0|||
13114646|NCT03110770|25915765|FG001|Overall Study|Investigator Decision|0|||
13114647|NCT03110770|25915766|FG002|Overall Study|Investigator Decision|0|||
13114648|NCT03110770|25915767|FG003|Overall Study|Investigator Decision|5|||
13114649|NCT03110770|25915768|FG004|Overall Study|Investigator Decision|3|||
13114650|NCT03110770|25915764|FG000|Overall Study|Withdrawal by Subject|0|||
13114651|NCT03110770|25915765|FG001|Overall Study|Withdrawal by Subject|0|||
13114652|NCT03110770|25915766|FG002|Overall Study|Withdrawal by Subject|0|||
13114653|NCT03110770|25915767|FG003|Overall Study|Withdrawal by Subject|24|||
13114654|NCT03110770|25915768|FG004|Overall Study|Withdrawal by Subject|24|||
13114655|NCT03110770|25915764|FG000|Overall Study|Moved from area|5|||
13114656|NCT03110770|25915765|FG001|Overall Study|Moved from area|0|||
13114657|NCT03110770|25915766|FG002|Overall Study|Moved from area|2|||
13114658|NCT03110770|25915767|FG003|Overall Study|Moved from area|42|||
13114659|NCT03110770|25915768|FG004|Overall Study|Moved from area|43|||
13114660|NCT03110770|25915764|FG000|Overall Study|Illness/Injury unrelated to product|0|||
13114661|NCT03110770|25915765|FG001|Overall Study|Illness/Injury unrelated to product|0|||
13114662|NCT03110770|25915766|FG002|Overall Study|Illness/Injury unrelated to product|0|||
13114663|NCT03110770|25915767|FG003|Overall Study|Illness/Injury unrelated to product|0|||
13114664|NCT03110770|25915768|FG004|Overall Study|Illness/Injury unrelated to product|1|||
13114665|NCT03110185|25915785|FG000|Overall Study|Death|0|||
13114666|NCT03110185|25915786|FG001|Overall Study|Death|1|||
13114667|NCT03110185|25915785|FG000|Overall Study|Withdrawal by Subject|2|||
13114668|NCT03110185|25915786|FG001|Overall Study|Withdrawal by Subject|7|||
13114669|NCT03110185|25915785|FG000|Overall Study|Time Constraints|0|||
13114670|NCT03110185|25915786|FG001|Overall Study|Time Constraints|6|||
13114671|NCT03110185|25915785|FG000|Overall Study|Conflict with care|5|||
13114672|NCT03110185|25915786|FG001|Overall Study|Conflict with care|12|||
13114673|NCT03110185|25915785|FG000|Overall Study|Protocol Violation|1|||
13114674|NCT03110185|25915786|FG001|Overall Study|Protocol Violation|4|||
13114675|NCT03110185|25915785|FG000|Overall Study|MRI Incompatible|2|||
13114676|NCT03110185|25915786|FG001|Overall Study|MRI Incompatible|0|||
13114677|NCT03110185|25915785|FG000|Overall Study|Patient Refusal|0|||
13114678|NCT03110185|25915786|FG001|Overall Study|Patient Refusal|1|||
13114679|NCT03110029|25915801|FG000|Overall Study|Withdrawal by Subject|1|||
13114680|NCT03110029|25915802|FG001|Overall Study|Withdrawal by Subject|1|||
13114681|NCT03109184|25915827|FG000|Overall Study|Lost to Follow-up|6|||
13114682|NCT03109184|25915828|FG001|Overall Study|Lost to Follow-up|6|||
13114683|NCT03109184|25915827|FG000|Overall Study|Withdrawal by Subject|1|||
13114684|NCT03109184|25915828|FG001|Overall Study|Withdrawal by Subject|1|||
13114685|NCT03108521|25915845|FG000|Overall Study|Lost to Follow-up|3|||
13114686|NCT03108521|25915846|FG001|Overall Study|Lost to Follow-up|0|||
13114687|NCT03108521|25915845|FG000|Overall Study|Lack of Efficacy|2|||
13114688|NCT03108521|25915846|FG001|Overall Study|Lack of Efficacy|0|||
13114689|NCT03108521|25915845|FG000|Overall Study|Physician Decision|4|||
13114690|NCT03108521|25915846|FG001|Overall Study|Physician Decision|0|||
13114691|NCT03108521|25915845|FG000|Overall Study|Adverse Event|3|||
13114692|NCT03108521|25915846|FG001|Overall Study|Adverse Event|0|||
13114693|NCT03108157|25915863|FG000|Overall Study|Protocol Violation|15|||
13114694|NCT03108157|25915864|FG001|Overall Study|Protocol Violation|4|||
13114695|NCT03108027|25915885|FG000|Period 1|Subject/Guardian Decision|0|||
13114696|NCT03108027|25915886|FG001|Period 1|Subject/Guardian Decision|0|||
13114697|NCT03108027|25915887|FG002|Period 1|Subject/Guardian Decision|0|||
13114698|NCT03108027|25915888|FG003|Period 1|Subject/Guardian Decision|2|||
13114699|NCT03108027|25915889|FG004|Period 1|Subject/Guardian Decision|0|||
13114700|NCT03108027|25915890|FG005|Period 1|Subject/Guardian Decision|0|||
13114701|NCT03108027|25915885|FG000|Period 3|Adverse Event|0|||
13114702|NCT03108027|25915886|FG001|Period 3|Adverse Event|1|||
13114703|NCT03108027|25915887|FG002|Period 3|Adverse Event|0|||
13114704|NCT03108027|25915888|FG003|Period 3|Adverse Event|0|||
13114705|NCT03108027|25915889|FG004|Period 3|Adverse Event|0|||
13114706|NCT03108027|25915890|FG005|Period 3|Adverse Event|0|||
13114707|NCT03107715|25915909|FG000|Overall Study|did not deliver at the home hospital|4|||
13114708|NCT03107715|25915910|FG001|Overall Study|did not deliver at the home hospital|6|||
13114709|NCT03107715|25915909|FG000|Overall Study|infant stillborn|0|||
13114710|NCT03107715|25915910|FG001|Overall Study|infant stillborn|1|||
13114711|NCT03107377|25915939|FG000|Overall Study|Adverse Event|3|||
13114712|NCT03107377|25915940|FG001|Overall Study|Adverse Event|3|||
13114713|NCT03107377|25915939|FG000|Overall Study|Protocol Violation|9|||
13114714|NCT03107377|25915940|FG001|Overall Study|Protocol Violation|12|||
13114715|NCT03107377|25915939|FG000|Overall Study|Physician Decision|3|||
13114716|NCT03107377|25915940|FG001|Overall Study|Physician Decision|6|||
13114717|NCT03107377|25915939|FG000|Overall Study|Pregnancy|7|||
13114718|NCT03107377|25915940|FG001|Overall Study|Pregnancy|7|||
13114719|NCT03107377|25915939|FG000|Overall Study|Withdrawal by Subject|16|||
13114720|NCT03107377|25915940|FG001|Overall Study|Withdrawal by Subject|22|||
13114721|NCT03107377|25915939|FG000|Overall Study|Lost to Follow-up|37|||
13114722|NCT03107377|25915940|FG001|Overall Study|Lost to Follow-up|34|||
13114723|NCT03107377|25915939|FG000|Overall Study|Other reason not specified|16|||
13114724|NCT03107377|25915940|FG001|Overall Study|Other reason not specified|15|||
13114725|NCT03107091|25915948|FG000|Overall Study|Physician Decision|1|||
13114726|NCT03107052|25915999|FG000|Overall Study|Adverse Event|6|||
13114727|NCT03107052|25916000|FG001|Overall Study|Adverse Event|1|||
13114728|NCT03107052|25916001|FG002|Overall Study|Adverse Event|2|||
13114729|NCT03107052|25915999|FG000|Overall Study|Withdrawal by Subject|9|||
13114730|NCT03107052|25916000|FG001|Overall Study|Withdrawal by Subject|5|||
13114731|NCT03107052|25916001|FG002|Overall Study|Withdrawal by Subject|8|||
13114732|NCT03107052|25915999|FG000|Overall Study|Protocol Violation|6|||
13114733|NCT03107052|25916000|FG001|Overall Study|Protocol Violation|0|||
13114734|NCT03107052|25916001|FG002|Overall Study|Protocol Violation|3|||
13114735|NCT03107052|25915999|FG000|Overall Study|Lost to Follow-up|4|||
13114736|NCT03107052|25916000|FG001|Overall Study|Lost to Follow-up|0|||
13114737|NCT03107052|25916001|FG002|Overall Study|Lost to Follow-up|1|||
13227616|NCT01753193|26302194|FG000|Overall Study|Withdrawal by Subject|23|||
13227617|NCT01753193|26302194|FG000|Overall Study|Lost to Follow-up|6|||
13227618|NCT01753193|26302194|FG000|Overall Study|Death|1|||
13227619|NCT01753193|26302194|FG000|Overall Study|Other|16|||
13227620|NCT01753115|26302212|FG000|Overall Study|Lost to Follow-up|3|||
13227621|NCT01753115|26302213|FG001|Overall Study|Lost to Follow-up|6|||
13227622|NCT01753115|26302214|FG002|Overall Study|Lost to Follow-up|8|||
13227623|NCT01753115|26302212|FG000|Overall Study|Withdrawal by Subject|6|||
13114738|NCT03107052|25915999|FG000|Overall Study|Lack of Efficacy|23|||
13114739|NCT03107052|25916000|FG001|Overall Study|Lack of Efficacy|7|||
13114740|NCT03107052|25916001|FG002|Overall Study|Lack of Efficacy|4|||
13114741|NCT03107052|25915999|FG000|Overall Study|Other than specified|4|||
13114742|NCT03107052|25916000|FG001|Overall Study|Other than specified|2|||
13114743|NCT03107052|25916001|FG002|Overall Study|Other than specified|0|||
13114744|NCT03107052|25915999|FG000|Overall Study|Study terminated due to futility|67|||
13114745|NCT03107052|25916000|FG001|Overall Study|Study terminated due to futility|31|||
13114746|NCT03107052|25916001|FG002|Overall Study|Study terminated due to futility|23|||
13227624|NCT01753115|26302213|FG001|Overall Study|Withdrawal by Subject|5|||
13114747|NCT03107026|25916058|FG000|Overall Study|Adverse Event|2|||
13114748|NCT03107026|25916059|FG001|Overall Study|Adverse Event|14|||
13114749|NCT03107026|25916060|FG002|Overall Study|Adverse Event|23|||
13227625|NCT01753115|26302214|FG002|Overall Study|Withdrawal by Subject|6|||
13227626|NCT01753115|26302212|FG000|Overall Study|Subject non-compliant|3|||
13227627|NCT01753115|26302213|FG001|Overall Study|Subject non-compliant|3|||
13227628|NCT01753115|26302214|FG002|Overall Study|Subject non-compliant|0|||
13227629|NCT01753115|26302212|FG000|Overall Study|Used excluded drug|0|||
13227630|NCT01753115|26302213|FG001|Overall Study|Used excluded drug|1|||
13227631|NCT01753115|26302214|FG002|Overall Study|Used excluded drug|0|||
13227632|NCT01753076|26302245|FG000|Overall Study|Adverse Event|17|||
13227633|NCT01753076|26302246|FG001|Overall Study|Adverse Event|18|||
13114750|NCT03107026|25916058|FG000|Overall Study|Lost to Follow-up|12|||
13114751|NCT03107026|25916059|FG001|Overall Study|Lost to Follow-up|12|||
13227634|NCT01753076|26302245|FG000|Overall Study|Lack of Efficacy|3|||
13227635|NCT01753076|26302246|FG001|Overall Study|Lack of Efficacy|1|||
13227636|NCT01753076|26302245|FG000|Overall Study|Lost to Follow-up|2|||
13227637|NCT01753076|26302246|FG001|Overall Study|Lost to Follow-up|1|||
13114752|NCT03107026|25916060|FG002|Overall Study|Lost to Follow-up|13|||
13114753|NCT03107026|25916058|FG000|Overall Study|Protocol Violation|1|||
13227638|NCT01753076|26302245|FG000|Overall Study|Physician Decision|4|||
13227639|NCT01753076|26302246|FG001|Overall Study|Physician Decision|2|||
13114754|NCT03107026|25916059|FG001|Overall Study|Protocol Violation|2|||
13114755|NCT03107026|25916060|FG002|Overall Study|Protocol Violation|0|||
13227640|NCT01753076|26302245|FG000|Overall Study|Withdrawal by Subject|14|||
13227641|NCT01753076|26302246|FG001|Overall Study|Withdrawal by Subject|24|||
13227642|NCT01753076|26302245|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1|||
13227643|NCT01753076|26302246|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0|||
13227644|NCT01752985|26302282|FG000|Treatment Period|Subject request to discontinue treatment|1|||
13114756|NCT03107026|25916058|FG000|Overall Study|Pregnancy|1|||
13114757|NCT03107026|25916059|FG001|Overall Study|Pregnancy|0|||
13114758|NCT03107026|25916060|FG002|Overall Study|Pregnancy|0|||
13114759|NCT03107026|25916058|FG000|Overall Study|Withdrawal by Subject|13|||
13114760|NCT03107026|25916059|FG001|Overall Study|Withdrawal by Subject|5|||
13114761|NCT03107026|25916060|FG002|Overall Study|Withdrawal by Subject|17|||
13114762|NCT03107026|25916058|FG000|Overall Study|non compliance with study visits|1|||
13114763|NCT03107026|25916059|FG001|Overall Study|non compliance with study visits|2|||
13227645|NCT01752985|26302283|FG001|Treatment Period|Subject request to discontinue treatment|0|||
13227646|NCT01752985|26302284|FG002|Treatment Period|Subject request to discontinue treatment|1|||
13227647|NCT01752985|26302282|FG000|Treatment Period|Subject no longer meets study criteria|0|||
13227648|NCT01752985|26302283|FG001|Treatment Period|Subject no longer meets study criteria|1|||
13227649|NCT01752985|26302284|FG002|Treatment Period|Subject no longer meets study criteria|1|||
13227650|NCT01752985|26302282|FG000|Treatment Period|Adverse Event|2|||
13227651|NCT01752985|26302283|FG001|Treatment Period|Adverse Event|1|||
13227652|NCT01752985|26302284|FG002|Treatment Period|Adverse Event|2|||
13227653|NCT01752985|26302282|FG000|Treatment Period|Withdrawal by Subject|1|||
13227654|NCT01752985|26302283|FG001|Treatment Period|Withdrawal by Subject|1|||
13227655|NCT01752985|26302284|FG002|Treatment Period|Withdrawal by Subject|0|||
13227656|NCT01752985|26302282|FG000|Treatment Period|Lost to Follow-up|0|||
13227657|NCT01752985|26302283|FG001|Treatment Period|Lost to Follow-up|0|||
13227658|NCT01752985|26302284|FG002|Treatment Period|Lost to Follow-up|1|||
13227659|NCT01752933|26302307|FG000|Treatment|Disease Progression|3|||
13227660|NCT01752933|26302308|FG001|Treatment|Disease Progression|29|||
13227661|NCT01752933|26302307|FG000|Treatment|Withdrawal by Subject|0|||
13227662|NCT01752933|26302308|FG001|Treatment|Withdrawal by Subject|5|||
13227663|NCT01752933|26302307|FG000|Treatment|Adverse Event|1|||
13227664|NCT01752933|26302308|FG001|Treatment|Adverse Event|4|||
13227665|NCT01752933|26302307|FG000|Treatment|Physician Decision|0|||
13227666|NCT01752933|26302308|FG001|Treatment|Physician Decision|3|||
13227667|NCT01752933|26302307|FG000|Treatment|Death|0|||
13227668|NCT01752933|26302308|FG001|Treatment|Death|2|||
13227669|NCT01752933|26302307|FG000|Treatment|Hepatocellular carcinoma not confirmed|0|||
13227670|NCT01752933|26302308|FG001|Treatment|Hepatocellular carcinoma not confirmed|1|||
13227671|NCT01752933|26302307|FG000|Treatment|Patient noncompliant|0|||
13227672|NCT01752933|26302308|FG001|Treatment|Patient noncompliant|1|||
13227673|NCT01752933|26302307|FG000|Treatment|Patient unable to travel to appointments|0|||
13227674|NCT01752933|26302308|FG001|Treatment|Patient unable to travel to appointments|1|||
13227675|NCT01752933|26302307|FG000|Overall Study and Follow-up|Death|4|||
13227676|NCT01752933|26302308|FG001|Overall Study and Follow-up|Death|34|||
13227677|NCT01752933|26302307|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0|||
13227678|NCT01752933|26302308|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7|||
13227679|NCT01752933|26302307|FG000|Overall Study and Follow-up|Withdrawal by Subject|0|||
13227680|NCT01752933|26302308|FG001|Overall Study and Follow-up|Withdrawal by Subject|3|||
13114764|NCT03107026|25916060|FG002|Overall Study|non compliance with study visits|0|||
13114765|NCT03107026|25916058|FG000|Overall Study|non-compliance with study drug|2|||
13114766|NCT03107026|25916059|FG001|Overall Study|non-compliance with study drug|2|||
13227681|NCT01752933|26302307|FG000|Overall Study and Follow-up|Lost to Follow-up|0|||
13227682|NCT01752933|26302308|FG001|Overall Study and Follow-up|Lost to Follow-up|2|||
13227683|NCT01752855|26302329|FG000|Overall Study|Adverse Event|1|||
13227684|NCT01752855|26302330|FG001|Overall Study|Adverse Event|0|||
13227685|NCT01752855|26302329|FG000|Overall Study|Withdrew Consent|0|||
13227686|NCT01752855|26302330|FG001|Overall Study|Withdrew Consent|2|||
13227687|NCT01752855|26302329|FG000|Overall Study|Lack of Efficacy|0|||
13227688|NCT01752855|26302330|FG001|Overall Study|Lack of Efficacy|2|||
13227689|NCT01752842|26302347|FG000|Overall Study|Adverse Event|3|||
13227690|NCT01752842|26302348|FG001|Overall Study|Adverse Event|0|||
13227691|NCT01752842|26302347|FG000|Overall Study|Withdrawal by Subject|0|||
13227692|NCT01752842|26302348|FG001|Overall Study|Withdrawal by Subject|2|||
13227693|NCT01752634|26302409|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
13227694|NCT01752634|26302410|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
13227695|NCT01752634|26302411|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
13227696|NCT01752634|26302412|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
13227697|NCT01752634|26302413|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
13227698|NCT01752634|26302414|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3|||
13227699|NCT01752634|26302409|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
13227700|NCT01752634|26302410|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1|||
13227701|NCT01752634|26302411|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
13227702|NCT01752634|26302412|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
13227703|NCT01752634|26302413|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
13227704|NCT01752634|26302414|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
13227705|NCT01752634|26302409|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2|||
13227706|NCT01752634|26302410|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
13227707|NCT01752634|26302411|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
13227708|NCT01752634|26302412|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
13227709|NCT01752634|26302413|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
13227710|NCT01752634|26302414|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
13114767|NCT03107026|25916060|FG002|Overall Study|non-compliance with study drug|3|||
13114768|NCT03107026|25916058|FG000|Overall Study|Physician Decision|0|||
13114769|NCT03107026|25916059|FG001|Overall Study|Physician Decision|1|||
13114770|NCT03107026|25916060|FG002|Overall Study|Physician Decision|0|||
13114771|NCT03106753|25916089|FG000|Overall Study|Withdrawal by Subject|0|||
13114772|NCT03106753|25916090|FG001|Overall Study|Withdrawal by Subject|1|||
13114773|NCT03106077|25916103|FG000|Overall Study|Screen Failure|94|||
13114774|NCT03106077|25916104|FG001|Overall Study|Screen Failure|0|||
13114775|NCT03105362|25916113|FG000|Overall Study|Withdrawal by Subject|1|||
13114776|NCT03105362|25916113|FG000|Overall Study|Lost to Follow-up|1|||
13114777|NCT03105297|25916147|FG000|Baseline Phase (Day 1)|Other|21|||
13114778|NCT03105297|25916147|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1|||
13114779|NCT03105297|25916147|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7|||
13114780|NCT03104816|25916165|FG000|Overall Study|Lack of Efficacy|0|||
13114781|NCT03104816|25916166|FG001|Overall Study|Lack of Efficacy|2|||
13114782|NCT03104816|25916167|FG002|Overall Study|Lack of Efficacy|0|||
13114783|NCT03104816|25916165|FG000|Overall Study|Protocol Violation|2|||
13114784|NCT03104816|25916166|FG001|Overall Study|Protocol Violation|0|||
13114785|NCT03104816|25916167|FG002|Overall Study|Protocol Violation|2|||
13114786|NCT03103919|25916208|FG000|Overall Study|Adverse Event|2|||
13114787|NCT03103919|25916209|FG001|Overall Study|Adverse Event|2|||
13114788|NCT03103906|25916236|FG000|Overall Study|Adverse Event|2|||
13114789|NCT03103906|25916237|FG001|Overall Study|Adverse Event|3|||
13114790|NCT03103906|25916236|FG000|Overall Study|Other|2|||
13114791|NCT03103906|25916237|FG001|Overall Study|Other|0|||
13114792|NCT03103763|25916276|FG000|Overall Study|Death|15|||
13114793|NCT03103763|25916277|FG001|Overall Study|Death|5|||
13114794|NCT03103763|25916278|FG002|Overall Study|Death|5|||
13114795|NCT03103763|25916276|FG000|Overall Study|Withdrawal by Subject|0|||
13114796|NCT03103763|25916277|FG001|Overall Study|Withdrawal by Subject|3|||
13114797|NCT03103763|25916278|FG002|Overall Study|Withdrawal by Subject|2|||
13114798|NCT03103542|25916297|FG000|Overall Study|Physician Decision|2|||
13114799|NCT03103542|25916297|FG000|Overall Study|Adverse Event|2|||
13114800|NCT03103542|25916297|FG000|Overall Study|Other|2|||
13114801|NCT03103542|25916297|FG000|Overall Study|Withdrawal by Subject|1|||
13114802|NCT03103503|25916309|FG000|Overall Study|Death|64|||
13114803|NCT03103503|25916309|FG000|Overall Study|Physician Decision|57|||
13114804|NCT03103503|25916309|FG000|Overall Study|Withdrawal by Subject|10|||
13114805|NCT03103503|25916309|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10|||
13114806|NCT03103503|25916309|FG000|Overall Study|Lost to Follow-up|3|||
13114807|NCT03103503|25916309|FG000|Overall Study|Study Closure|757|||
13114808|NCT03103100|25916336|FG000|Overall Study|Adverse Event|1|||
13114809|NCT03103100|25916337|FG001|Overall Study|Adverse Event|0|||
13114810|NCT03103100|25916338|FG002|Overall Study|Adverse Event|0|||
13114811|NCT03103100|25916336|FG000|Overall Study|Physician Decision|1|||
13114812|NCT03103100|25916337|FG001|Overall Study|Physician Decision|0|||
13114813|NCT03103100|25916338|FG002|Overall Study|Physician Decision|2|||
13133361|NCT02771210|25987551|FG000|Period 1|Lack of Efficacy|3|||
13227711|NCT01752634|26302409|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3|||
13227712|NCT01752634|26302410|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
13227713|NCT01752634|26302411|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2|||
13227714|NCT01752634|26302412|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
13227715|NCT01752634|26302413|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
13227716|NCT01752634|26302414|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4|||
13227717|NCT01752634|26302409|FG000|Week 24 to Week 260|Lack of Efficacy|15|||
13227718|NCT01752634|26302410|FG001|Week 24 to Week 260|Lack of Efficacy|7|||
13227719|NCT01752634|26302411|FG002|Week 24 to Week 260|Lack of Efficacy|7|||
13227720|NCT01752634|26302412|FG003|Week 24 to Week 260|Lack of Efficacy|3|||
13227721|NCT01752634|26302413|FG004|Week 24 to Week 260|Lack of Efficacy|4|||
13227722|NCT01752634|26302414|FG005|Week 24 to Week 260|Lack of Efficacy|0|||
13227723|NCT01752634|26302409|FG000|Week 24 to Week 260|Subject/guardian decision|12|||
13227724|NCT01752634|26302410|FG001|Week 24 to Week 260|Subject/guardian decision|10|||
13227725|NCT01752634|26302411|FG002|Week 24 to Week 260|Subject/guardian decision|9|||
13227726|NCT01752634|26302412|FG003|Week 24 to Week 260|Subject/guardian decision|5|||
13227727|NCT01752634|26302413|FG004|Week 24 to Week 260|Subject/guardian decision|5|||
13227728|NCT01752634|26302414|FG005|Week 24 to Week 260|Subject/guardian decision|0|||
13227729|NCT01752634|26302409|FG000|Week 24 to Week 260|Physician Decision|1|||
13227730|NCT01752634|26302410|FG001|Week 24 to Week 260|Physician Decision|2|||
13227731|NCT01752634|26302411|FG002|Week 24 to Week 260|Physician Decision|4|||
13227732|NCT01752634|26302412|FG003|Week 24 to Week 260|Physician Decision|2|||
13227733|NCT01752634|26302413|FG004|Week 24 to Week 260|Physician Decision|1|||
13227734|NCT01752634|26302414|FG005|Week 24 to Week 260|Physician Decision|0|||
13227735|NCT01752634|26302409|FG000|Week 24 to Week 260|Death|0|||
13227736|NCT01752634|26302410|FG001|Week 24 to Week 260|Death|1|||
13227737|NCT01752634|26302411|FG002|Week 24 to Week 260|Death|0|||
13227738|NCT01752634|26302412|FG003|Week 24 to Week 260|Death|0|||
13227739|NCT01752634|26302413|FG004|Week 24 to Week 260|Death|0|||
13227740|NCT01752634|26302414|FG005|Week 24 to Week 260|Death|0|||
13227741|NCT01752634|26302409|FG000|Week 24 to Week 260|Pregnancy|0|||
13227742|NCT01752634|26302410|FG001|Week 24 to Week 260|Pregnancy|0|||
13227743|NCT01752634|26302411|FG002|Week 24 to Week 260|Pregnancy|1|||
13227744|NCT01752634|26302412|FG003|Week 24 to Week 260|Pregnancy|0|||
13227745|NCT01752634|26302413|FG004|Week 24 to Week 260|Pregnancy|0|||
13227746|NCT01752634|26302414|FG005|Week 24 to Week 260|Pregnancy|0|||
13227747|NCT01752634|26302409|FG000|Week 24 to Week 260|Noncompliance with study treatment|0|||
13227748|NCT01752634|26302410|FG001|Week 24 to Week 260|Noncompliance with study treatment|0|||
13227749|NCT01752634|26302411|FG002|Week 24 to Week 260|Noncompliance with study treatment|1|||
13227750|NCT01752634|26302412|FG003|Week 24 to Week 260|Noncompliance with study treatment|0|||
13227751|NCT01752634|26302413|FG004|Week 24 to Week 260|Noncompliance with study treatment|0|||
13227752|NCT01752634|26302414|FG005|Week 24 to Week 260|Noncompliance with study treatment|0|||
13227753|NCT01752634|26302409|FG000|Week 24 to Week 260|Lost to Follow-up|2|||
13227754|NCT01752634|26302410|FG001|Week 24 to Week 260|Lost to Follow-up|2|||
13227755|NCT01752634|26302411|FG002|Week 24 to Week 260|Lost to Follow-up|3|||
13227756|NCT01752634|26302412|FG003|Week 24 to Week 260|Lost to Follow-up|0|||
13227757|NCT01752634|26302413|FG004|Week 24 to Week 260|Lost to Follow-up|2|||
13227758|NCT01752634|26302414|FG005|Week 24 to Week 260|Lost to Follow-up|0|||
13227759|NCT01752634|26302409|FG000|Week 24 to Week 260|Adverse Event|4|||
13227760|NCT01752634|26302410|FG001|Week 24 to Week 260|Adverse Event|8|||
13227761|NCT01752634|26302411|FG002|Week 24 to Week 260|Adverse Event|8|||
13227762|NCT01752634|26302412|FG003|Week 24 to Week 260|Adverse Event|4|||
13227763|NCT01752634|26302413|FG004|Week 24 to Week 260|Adverse Event|2|||
13227764|NCT01752634|26302414|FG005|Week 24 to Week 260|Adverse Event|0|||
13227765|NCT01752036|26302427|FG000|Overall Study|Death|2|||
13227766|NCT01752023|26302450|FG000|Overall Study|Physician Decision|2|||
13227767|NCT01752023|26302451|FG001|Overall Study|Physician Decision|1|||
13227768|NCT01751906|26302566|FG000|Overall Study|Lost to Follow-up|151|||
13227769|NCT01751906|26302567|FG001|Overall Study|Lost to Follow-up|68|||
13227770|NCT01751906|26302566|FG000|Overall Study|Withdrawal by Subject|22|||
13227771|NCT01751906|26302567|FG001|Overall Study|Withdrawal by Subject|18|||
13227772|NCT01751906|26302566|FG000|Overall Study|Physician Decision|5|||
13227773|NCT01751906|26302567|FG001|Overall Study|Physician Decision|2|||
13227774|NCT01751906|26302566|FG000|Overall Study|Death|84|||
13227775|NCT01751906|26302567|FG001|Overall Study|Death|43|||
13227776|NCT01751906|26302566|FG000|Overall Study|Denied on premises for follow-up by law|1|||
13227777|NCT01751906|26302567|FG001|Overall Study|Denied on premises for follow-up by law|0|||
13227778|NCT01751867|26302592|FG000|Overall Study|Completed treatment,dropped in follow-up|4|||
13227779|NCT01751867|26302593|FG001|Overall Study|Completed treatment,dropped in follow-up|8|||
13114814|NCT03103087|25916438|FG000|Overall Study|Did not receive any study drug|1|||
13227780|NCT01751867|26302592|FG000|Overall Study|Diease Progression|4|||
13227781|NCT01751867|26302593|FG001|Overall Study|Diease Progression|18|||
13227782|NCT01751867|26302592|FG000|Overall Study|Adverse Event|8|||
13114815|NCT03103087|25916439|FG001|Overall Study|Did not receive any study drug|0|||
13227783|NCT01751867|26302593|FG001|Overall Study|Adverse Event|15|||
13227784|NCT01751867|26302592|FG000|Overall Study|Poor Compliance|0|||
13227785|NCT01751867|26302593|FG001|Overall Study|Poor Compliance|5|||
13227786|NCT01751867|26302592|FG000|Overall Study|Withdrawal by Subject|3|||
13227787|NCT01751867|26302593|FG001|Overall Study|Withdrawal by Subject|1|||
13227788|NCT01751867|26302592|FG000|Overall Study|Physician Decision|4|||
13227789|NCT01751867|26302593|FG001|Overall Study|Physician Decision|7|||
13227790|NCT01751867|26302592|FG000|Overall Study|Protocol Violation|0|||
13227791|NCT01751867|26302593|FG001|Overall Study|Protocol Violation|2|||
13227792|NCT01751867|26302592|FG000|Overall Study|Death|0|||
13227793|NCT01751867|26302593|FG001|Overall Study|Death|5|||
13227794|NCT01751867|26302592|FG000|Overall Study|Other|11|||
13227795|NCT01751867|26302593|FG001|Overall Study|Other|37|||
13227796|NCT01751867|26302592|FG000|Overall Study|Randomized but not treated.|2|||
13114816|NCT03103087|25916440|FG002|Overall Study|Did not receive any study drug|0|||
13227797|NCT01751867|26302593|FG001|Overall Study|Randomized but not treated.|1|||
13227798|NCT01751802|26302612|FG000|Overall Study|Adverse Event|4|||
13227799|NCT01751802|26302613|FG001|Overall Study|Adverse Event|2|||
13227800|NCT01751724|26302646|FG000|Overall Study|extubated bef.start assigned treatment|1|||
13227801|NCT01751724|26302647|FG001|Overall Study|extubated bef.start assigned treatment|0|||
13114817|NCT03103087|25916438|FG000|Overall Study|Protocol Violation|1|||
13114818|NCT03103087|25916439|FG001|Overall Study|Protocol Violation|2|||
13114819|NCT03103087|25916440|FG002|Overall Study|Protocol Violation|1|||
13114820|NCT03103087|25916438|FG000|Overall Study|Lack of Efficacy|2|||
13114821|NCT03103087|25916439|FG001|Overall Study|Lack of Efficacy|1|||
13114822|NCT03103087|25916440|FG002|Overall Study|Lack of Efficacy|1|||
13114823|NCT03103087|25916438|FG000|Overall Study|Pregnancy|0|||
13114824|NCT03103087|25916439|FG001|Overall Study|Pregnancy|0|||
13114825|NCT03103087|25916440|FG002|Overall Study|Pregnancy|1|||
13114826|NCT03103087|25916438|FG000|Overall Study|Adverse Event|2|||
13114827|NCT03103087|25916439|FG001|Overall Study|Adverse Event|15|||
13114828|NCT03103087|25916440|FG002|Overall Study|Adverse Event|6|||
13114829|NCT03103087|25916438|FG000|Overall Study|Withdrawal by Subject|13|||
13114830|NCT03103087|25916439|FG001|Overall Study|Withdrawal by Subject|6|||
13114831|NCT03103087|25916440|FG002|Overall Study|Withdrawal by Subject|6|||
13114832|NCT03103087|25916438|FG000|Overall Study|Lost to Follow-up|4|||
13114833|NCT03103087|25916439|FG001|Overall Study|Lost to Follow-up|2|||
13114834|NCT03103087|25916440|FG002|Overall Study|Lost to Follow-up|7|||
13114835|NCT03103087|25916438|FG000|Overall Study|Other reason not reported|1|||
13114836|NCT03103087|25916439|FG001|Overall Study|Other reason not reported|3|||
13114837|NCT03103087|25916440|FG002|Overall Study|Other reason not reported|5|||
13114838|NCT03102918|25916453|FG000|Overall Study|Protocol Violation|1|||
13114839|NCT03102918|25916454|FG001|Overall Study|Protocol Violation|0|||
13114840|NCT03102762|25916487|FG000|Overall Study|Lost to Follow-up|1|||
13114841|NCT03102762|25916488|FG001|Overall Study|Lost to Follow-up|0|||
13114842|NCT03102710|25916512|FG000|Overall Study|Dental metal affected MRI scan quality|1|||
13114843|NCT03102710|25916513|FG001|Overall Study|Dental metal affected MRI scan quality|0|||
13114844|NCT03102710|25916514|FG002|Overall Study|Dental metal affected MRI scan quality|0|||
13114845|NCT03102710|25916512|FG000|Overall Study|Technical issues during final MRI scan|0|||
13114846|NCT03102710|25916513|FG001|Overall Study|Technical issues during final MRI scan|1|||
13114847|NCT03102710|25916514|FG002|Overall Study|Technical issues during final MRI scan|0|||
13114848|NCT03102710|25916512|FG000|Overall Study|Nausea during MRI scan|0|||
13114849|NCT03102710|25916513|FG001|Overall Study|Nausea during MRI scan|1|||
13114850|NCT03102710|25916514|FG002|Overall Study|Nausea during MRI scan|0|||
13114851|NCT03102710|25916512|FG000|Overall Study|Subject unable to attend final session|0|||
13114852|NCT03102710|25916513|FG001|Overall Study|Subject unable to attend final session|1|||
13114853|NCT03102710|25916514|FG002|Overall Study|Subject unable to attend final session|0|||
13227802|NCT01751724|26302646|FG000|Overall Study|withdrawn by parent|0|||
13227803|NCT01751724|26302647|FG001|Overall Study|withdrawn by parent|2|||
13227804|NCT01751646|26302802|FG000|Overall Study|Lost to Follow-up|5|||
13227805|NCT01751646|26302803|FG001|Overall Study|Lost to Follow-up|1|||
13227806|NCT01751646|26302802|FG000|Overall Study|Withdrawal by Subject|0|||
13227807|NCT01751646|26302803|FG001|Overall Study|Withdrawal by Subject|4|||
13227808|NCT01751646|26302802|FG000|Overall Study|Starting hormone therapy|1|||
13114854|NCT03102034|25916547|FG000|Overall Study|Withdrawal by Subject|1|||
13114855|NCT03102034|25916548|FG001|Overall Study|Withdrawal by Subject|0|||
13114856|NCT03101930|25916587|FG000|Overall Study|Withdrawal by Subject|2|||
13114857|NCT03101930|25916588|FG001|Overall Study|Withdrawal by Subject|1|||
13114858|NCT03101930|25916589|FG002|Overall Study|Withdrawal by Subject|2|||
13114859|NCT03101592|25916616|FG000|Overall Study|participant files could not be located|111|||
13114860|NCT03101592|25916617|FG001|Overall Study|participant files could not be located|170|||
13114861|NCT03101592|25916618|FG002|Overall Study|participant files could not be located|118|||
13227809|NCT01751646|26302803|FG001|Overall Study|Starting hormone therapy|0|||
13227810|NCT01751646|26302802|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2|||
13227811|NCT01751646|26302803|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3|||
13227812|NCT01751646|26302802|FG000|Overall Study|Inadvertent enrollment|1|||
13227813|NCT01751646|26302803|FG001|Overall Study|Inadvertent enrollment|1|||
13227814|NCT01751646|26302802|FG000|Overall Study|Moved out of the area|1|||
13227815|NCT01751646|26302803|FG001|Overall Study|Moved out of the area|5|||
13114862|NCT03101514|25916629|FG000|Overall Study|Withdrawal by Subject|4|||
13114863|NCT03101514|25916629|FG000|Overall Study|Protocol Violation|2|||
13227816|NCT01751646|26302802|FG000|Overall Study|Inability to attend required visits|0|||
13227817|NCT01751646|26302803|FG001|Overall Study|Inability to attend required visits|1|||
13227818|NCT01751646|26302802|FG000|Overall Study|Off study due to multiple obligations|0|||
13227819|NCT01751646|26302803|FG001|Overall Study|Off study due to multiple obligations|1|||
13227820|NCT01751646|26302802|FG000|Overall Study|Fails to comply with study requirements|0|||
13114864|NCT03101514|25916629|FG000|Overall Study|patient's information was incomplete|1|||
13227821|NCT01751646|26302803|FG001|Overall Study|Fails to comply with study requirements|1|||
13227822|NCT01751646|26302802|FG000|Overall Study|Childcare issues|1|||
13227823|NCT01751646|26302803|FG001|Overall Study|Childcare issues|1|||
13227824|NCT01751568|26302842|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1|||
13227825|NCT01751568|26302843|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
13227826|NCT01751568|26302844|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
13227827|NCT01751412|26302856|FG000|Overall Study|Disease Progression Before Treatment|1|||
13227828|NCT01751178|26302883|FG000|Overall Study|Adverse Event|2|||
13227829|NCT01751178|26302884|FG001|Overall Study|Adverse Event|0|||
13227830|NCT01751178|26302885|FG002|Overall Study|Adverse Event|0|||
13227831|NCT01751178|26302883|FG000|Overall Study|Other Reason (unknown)|1|||
13227832|NCT01751178|26302884|FG001|Overall Study|Other Reason (unknown)|0|||
13227833|NCT01751178|26302885|FG002|Overall Study|Other Reason (unknown)|2|||
13227834|NCT01751165|26302935|FG000|Overall Study|Adverse event, serious fatal|1|||
13114865|NCT03101462|25916650|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1|||
13227835|NCT01751165|26302936|FG001|Overall Study|Adverse event, serious fatal|0|||
13227836|NCT01751165|26302937|FG002|Overall Study|Adverse event, serious fatal|1|||
13227837|NCT01751165|26302935|FG000|Overall Study|Withdrawal by Subject|0|||
13227838|NCT01751165|26302936|FG001|Overall Study|Withdrawal by Subject|0|||
13227839|NCT01751165|26302937|FG002|Overall Study|Withdrawal by Subject|1|||
13227840|NCT01751165|26302935|FG000|Overall Study|Serious adverse event|0|||
13227841|NCT01751165|26302936|FG001|Overall Study|Serious adverse event|2|||
13227842|NCT01751165|26302937|FG002|Overall Study|Serious adverse event|0|||
13227843|NCT01751165|26302935|FG000|Overall Study|Lost to Follow-up|1|||
13227844|NCT01751165|26302936|FG001|Overall Study|Lost to Follow-up|1|||
13227845|NCT01751165|26302937|FG002|Overall Study|Lost to Follow-up|1|||
13227846|NCT01751139|26302957|FG000|Overall Study|Other|135|||
13227847|NCT01751139|26302957|FG000|Overall Study|Sponsor study termination|1609|||
13227848|NCT01751139|26302957|FG000|Overall Study|Lost to Follow-up|240|||
13227849|NCT01751139|26302957|FG000|Overall Study|Withdrawal by Subject|251|||
13227850|NCT01751139|26302957|FG000|Overall Study|Adverse Event|1|||
13227851|NCT01751139|26302957|FG000|Overall Study|Death|31|||
13227852|NCT01751113|26303002|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
13227853|NCT01751113|26303003|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
13227854|NCT01751113|26303004|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
13227855|NCT01751113|26303005|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
13227856|NCT01751113|26303006|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
13227857|NCT01751113|26303007|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
13227858|NCT01751113|26303002|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
13227859|NCT01751113|26303003|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
13227860|NCT01751113|26303004|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
13227861|NCT01751113|26303005|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
13227862|NCT01751113|26303006|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
13227863|NCT01751113|26303007|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1|||
13227864|NCT01751087|26303049|FG000|Overall Study|Withdrawal by Subject|1|||
13227865|NCT01751087|26303050|FG001|Overall Study|Withdrawal by Subject|0|||
13227866|NCT01751087|26303051|FG002|Overall Study|Withdrawal by Subject|0|||
13227867|NCT01751087|26303049|FG000|Overall Study|Physician Decision|0|||
13227868|NCT01751087|26303050|FG001|Overall Study|Physician Decision|0|||
13227869|NCT01751087|26303051|FG002|Overall Study|Physician Decision|1|||
13227870|NCT01751061|26303076|FG000|Overall Study|Death|1|||
13227871|NCT01751061|26303077|FG001|Overall Study|Death|0|||
13227872|NCT01751061|26303076|FG000|Overall Study|patient death|5|||
13227873|NCT01751061|26303077|FG001|Overall Study|patient death|0|||
13227874|NCT01751061|26303076|FG000|Overall Study|Lost to Follow-up|40|||
13227875|NCT01751061|26303077|FG001|Overall Study|Lost to Follow-up|25|||
13227876|NCT01751061|26303076|FG000|Overall Study|patient regained decisional capacity|4|||
13227877|NCT01751061|26303077|FG001|Overall Study|patient regained decisional capacity|8|||
13133362|NCT02771210|25987552|FG001|Period 1|Lack of Efficacy|6|||
13227878|NCT01751061|26303076|FG000|Overall Study|Withdrawal by Subject|4|||
13227879|NCT01751061|26303077|FG001|Overall Study|Withdrawal by Subject|1|||
13227880|NCT01751061|26303076|FG000|Overall Study|Physician Decision|2|||
13227881|NCT01751061|26303077|FG001|Overall Study|Physician Decision|0|||
13227882|NCT01750918|26303303|FG000|Overall Study|Last patient transitioned to a rollover protocol|0|||
13227883|NCT01750918|26303304|FG001|Overall Study|Last patient transitioned to a rollover protocol|0|||
13227884|NCT01750918|26303305|FG002|Overall Study|Last patient transitioned to a rollover protocol|5|||
13227885|NCT01750918|26303306|FG003|Overall Study|Last patient transitioned to a rollover protocol|2|||
13227886|NCT01750918|26303307|FG004|Overall Study|Last patient transitioned to a rollover protocol|0|||
13227887|NCT01750918|26303308|FG005|Overall Study|Last patient transitioned to a rollover protocol|2|||
13227888|NCT01750918|26303309|FG006|Overall Study|Last patient transitioned to a rollover protocol|1|||
13227889|NCT01750918|26303310|FG007|Overall Study|Last patient transitioned to a rollover protocol|1|||
13227890|NCT01750918|26303303|FG000|Overall Study|Lost to Follow-up|0|||
13227891|NCT01750918|26303304|FG001|Overall Study|Lost to Follow-up|0|||
13227892|NCT01750918|26303305|FG002|Overall Study|Lost to Follow-up|2|||
13227893|NCT01750918|26303306|FG003|Overall Study|Lost to Follow-up|2|||
13227894|NCT01750918|26303307|FG004|Overall Study|Lost to Follow-up|0|||
13227895|NCT01750918|26303308|FG005|Overall Study|Lost to Follow-up|0|||
13227896|NCT01750918|26303309|FG006|Overall Study|Lost to Follow-up|0|||
13227897|NCT01750918|26303310|FG007|Overall Study|Lost to Follow-up|1|||
13227898|NCT01750918|26303303|FG000|Overall Study|Withdrawal by Subject|0|||
13227899|NCT01750918|26303304|FG001|Overall Study|Withdrawal by Subject|0|||
13227900|NCT01750918|26303305|FG002|Overall Study|Withdrawal by Subject|1|||
13227901|NCT01750918|26303306|FG003|Overall Study|Withdrawal by Subject|2|||
13227902|NCT01750918|26303307|FG004|Overall Study|Withdrawal by Subject|1|||
13227903|NCT01750918|26303308|FG005|Overall Study|Withdrawal by Subject|1|||
13227904|NCT01750918|26303309|FG006|Overall Study|Withdrawal by Subject|2|||
13227905|NCT01750918|26303310|FG007|Overall Study|Withdrawal by Subject|2|||
13227906|NCT01750879|26303343|FG000|Overall Study|Adverse Event|8|||
13227907|NCT01750879|26303344|FG001|Overall Study|Adverse Event|0|||
13227908|NCT01750879|26303343|FG000|Overall Study|Lack of Efficacy|1|||
13227909|NCT01750879|26303344|FG001|Overall Study|Lack of Efficacy|0|||
13227910|NCT01750879|26303343|FG000|Overall Study|Withdrawal by Subject|1|||
13227911|NCT01750879|26303344|FG001|Overall Study|Withdrawal by Subject|0|||
13227912|NCT01750879|26303343|FG000|Overall Study|Did not complete per protocol|0|||
13227913|NCT01750879|26303344|FG001|Overall Study|Did not complete per protocol|3|||
13227914|NCT01750840|26303351|FG000|Overall Study|Lost to Follow-up|4|||
13227915|NCT01750697|26303363|FG000|Overall Study|Transferred Back to Local Hospital|1|||
13227916|NCT01750697|26303363|FG000|Overall Study|Physician and Family Decision|1|||
13227917|NCT01750697|26303363|FG000|Overall Study|Transferred to Adult Services|5|||
13227918|NCT01750697|26303363|FG000|Overall Study|Physician Decision|1|||
13227919|NCT01750697|26303363|FG000|Overall Study|Withdrawal by Subject|1|||
13227920|NCT01750684|26303378|FG000|Overall Study|Death|1|||
13227921|NCT01750684|26303379|FG001|Overall Study|Death|0|||
13227922|NCT01750684|26303378|FG000|Overall Study|Non-compliance with Study Drug|0|||
13227923|NCT01750684|26303379|FG001|Overall Study|Non-compliance with Study Drug|1|||
13227924|NCT01750684|26303378|FG000|Overall Study|Withdrawn by Sponsor|0|||
13227925|NCT01750684|26303379|FG001|Overall Study|Withdrawn by Sponsor|1|||
13227926|NCT01750684|26303378|FG000|Overall Study|Protocol Violation|1|||
13227927|NCT01750684|26303379|FG001|Overall Study|Protocol Violation|0|||
13227928|NCT01750346|26303415|FG000|Overall Study|Adverse Event|1|||
13227929|NCT01750346|26303416|FG001|Overall Study|Adverse Event|0|||
13227930|NCT01750346|26303417|FG002|Overall Study|Adverse Event|0|||
13227931|NCT01750294|26303423|FG000|Overall Study|Withdrawal by Subject|1|||
13227932|NCT01750294|26303423|FG000|Overall Study|Safety Endpoint|1|||
13227933|NCT01750268|26303438|FG000|Overall Study|Lost to Follow-up|0|||
13227934|NCT01750268|26303439|FG001|Overall Study|Lost to Follow-up|2|||
13227935|NCT01750268|26303438|FG000|Overall Study|Physician Decision|0|||
13227936|NCT01750268|26303439|FG001|Overall Study|Physician Decision|3|||
13114866|NCT03101462|25916651|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1|||
13227937|NCT01750268|26303438|FG000|Overall Study|Withdrawal by Subject|2|||
13227938|NCT01750268|26303439|FG001|Overall Study|Withdrawal by Subject|0|||
13227939|NCT01750242|26303446|FG000|Overall Study|Unreadable Images|3|||
13227940|NCT01750229|26303458|FG000|Randomized Crossover Phase|Adverse Event|1|||
13227941|NCT01750229|26303458|FG000|Randomized Crossover Phase|Withdrawal by Subject|1|||
13227942|NCT01750229|26303458|FG000|Long-term Follow-up Phase|Adverse Event|2|||
13227943|NCT01750229|26303458|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1|||
13227944|NCT01750190|26303493|FG000|Overall Study|Adverse Event|47|||
13227945|NCT01750190|26303494|FG001|Overall Study|Adverse Event|19|||
13227946|NCT01750190|26303493|FG000|Overall Study|Death|38|||
13227947|NCT01750190|26303494|FG001|Overall Study|Death|11|||
13227948|NCT01750190|26303493|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2|||
13227949|NCT01750190|26303494|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43|||
13227950|NCT01750190|26303493|FG000|Overall Study|Lost to Follow-up|28|||
13227951|NCT01750190|26303494|FG001|Overall Study|Lost to Follow-up|7|||
13227952|NCT01750190|26303493|FG000|Overall Study|Physician Decision|16|||
13227953|NCT01750190|26303494|FG001|Overall Study|Physician Decision|17|||
13227954|NCT01750190|26303493|FG000|Overall Study|Protocol Violation|6|||
13227955|NCT01750190|26303494|FG001|Overall Study|Protocol Violation|5|||
13227956|NCT01750190|26303493|FG000|Overall Study|Study/Site Terminated by Sponsor|4|||
13227957|NCT01750190|26303494|FG001|Overall Study|Study/Site Terminated by Sponsor|1|||
13227958|NCT01750190|26303493|FG000|Overall Study|Withdrawal by Subject|83|||
13227959|NCT01750190|26303494|FG001|Overall Study|Withdrawal by Subject|89|||
13227960|NCT01750190|26303493|FG000|Overall Study|Kidney Transplant|8|||
13227961|NCT01750190|26303494|FG001|Overall Study|Kidney Transplant|4|||
13227962|NCT01750190|26303493|FG000|Overall Study|Dialysis|22|||
13227963|NCT01750190|26303494|FG001|Overall Study|Dialysis|8|||
13227964|NCT01750190|26303493|FG000|Overall Study|Other than Specified|13|||
13114867|NCT03101371|25916676|FG000|Overall Study|Physician Decision|0|||
13227965|NCT01750190|26303494|FG001|Overall Study|Other than Specified|4|||
13227966|NCT01749982|26303525|FG000|Overall Study|Physician Decision|0|||
13227967|NCT01749982|26303526|FG001|Overall Study|Physician Decision|0|||
13227968|NCT01749982|26303527|FG002|Overall Study|Physician Decision|0|||
13227969|NCT01749982|26303528|FG003|Overall Study|Physician Decision|1|||
13227970|NCT01749982|26303525|FG000|Overall Study|Lost to Follow-up|0|||
13114868|NCT03101371|25916677|FG001|Overall Study|Physician Decision|1|||
13114869|NCT03101371|25916676|FG000|Overall Study|Lost to Follow-up|1|||
13114870|NCT03101371|25916677|FG001|Overall Study|Lost to Follow-up|4|||
13114871|NCT03101371|25916676|FG000|Overall Study|Did not meet eligibility criteria|2|||
13114872|NCT03101371|25916677|FG001|Overall Study|Did not meet eligibility criteria|1|||
13114873|NCT03101358|25916711|FG000|Overall Study|Non-compliance with study schedule|1|||
13114874|NCT03101358|25916712|FG001|Overall Study|Non-compliance with study schedule|0|||
13114875|NCT03101358|25916713|FG002|Overall Study|Non-compliance with study schedule|0|||
13114876|NCT03101358|25916714|FG003|Overall Study|Non-compliance with study schedule|1|||
13114877|NCT03101358|25916711|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
13114878|NCT03101358|25916712|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
13114879|NCT03101358|25916713|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1|||
13114880|NCT03101358|25916714|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
13114881|NCT03101358|25916711|FG000|Overall Study|Physician Decision|1|||
13114882|NCT03101358|25916712|FG001|Overall Study|Physician Decision|0|||
13114883|NCT03101358|25916713|FG002|Overall Study|Physician Decision|0|||
13227971|NCT01749982|26303526|FG001|Overall Study|Lost to Follow-up|0|||
13227972|NCT01749982|26303527|FG002|Overall Study|Lost to Follow-up|0|||
13227973|NCT01749982|26303528|FG003|Overall Study|Lost to Follow-up|1|||
13227974|NCT01749982|26303525|FG000|Overall Study|Withdrawal by Subject|0|||
13227975|NCT01749982|26303526|FG001|Overall Study|Withdrawal by Subject|0|||
13227976|NCT01749982|26303527|FG002|Overall Study|Withdrawal by Subject|0|||
13227977|NCT01749982|26303528|FG003|Overall Study|Withdrawal by Subject|1|||
13227978|NCT01749826|26303547|FG000|Overall Study|Study Terminated|20|||
13227979|NCT01749826|26303548|FG001|Overall Study|Study Terminated|0|||
13227980|NCT01749800|26303566|FG000|Overall Study|not meeting inclusion criteria|3|||
13227981|NCT01749800|26303567|FG001|Overall Study|not meeting inclusion criteria|0|||
13227982|NCT01749800|26303568|FG002|Overall Study|not meeting inclusion criteria|0|||
13227983|NCT01749800|26303566|FG000|Overall Study|Withdrawal by Subject|0|||
13227984|NCT01749800|26303567|FG001|Overall Study|Withdrawal by Subject|1|||
13227985|NCT01749800|26303568|FG002|Overall Study|Withdrawal by Subject|0|||
13227986|NCT01749735|26303583|FG000|Overall Study|Withdrawal by Subject|1|||
13227987|NCT01749735|26303584|FG001|Overall Study|Withdrawal by Subject|0|||
13227988|NCT01749033|26303617|FG000|Overall Study|Did not receive allocated intervention|3|||
13227989|NCT01749033|26303618|FG001|Overall Study|Did not receive allocated intervention|3|||
13227990|NCT01749033|26303619|FG002|Overall Study|Did not receive allocated intervention|0|||
13227991|NCT01749033|26303617|FG000|Overall Study|Lost to Follow-up|0|||
13227992|NCT01749033|26303618|FG001|Overall Study|Lost to Follow-up|2|||
13227993|NCT01749033|26303619|FG002|Overall Study|Lost to Follow-up|1|||
13227994|NCT01748994|26303638|FG000|Overall Study|Lost to Follow-up|8|||
13227995|NCT01748994|26303639|FG001|Overall Study|Lost to Follow-up|6|||
13227996|NCT01748890|26303645|FG000|Overall Study|Insufficient recruitment for analysis|4|||
13227997|NCT01748825|26303733|FG000|Dose Escalation|Refused further treatment|2|||
13227998|NCT01748825|26303734|FG001|Dose Escalation|Refused further treatment|2|||
13227999|NCT01748825|26303735|FG002|Dose Escalation|Refused further treatment|0|||
13228000|NCT01748825|26303736|FG003|Dose Escalation|Refused further treatment|0|||
13228001|NCT01748825|26303737|FG004|Dose Escalation|Refused further treatment|1|||
13228002|NCT01748825|26303738|FG005|Dose Escalation|Refused further treatment|2|||
13228003|NCT01748825|26303739|FG006|Dose Escalation|Refused further treatment|0|||
13228004|NCT01748825|26303740|FG007|Dose Escalation|Refused further treatment|0|||
13228005|NCT01748825|26303741|FG008|Dose Escalation|Refused further treatment|0|||
13228006|NCT01748825|26303742|FG009|Dose Escalation|Refused further treatment|0|||
13228007|NCT01748825|26303733|FG000|Dose Escalation|Switched to alternative treatment|0|||
13228008|NCT01748825|26303734|FG001|Dose Escalation|Switched to alternative treatment|0|||
13228009|NCT01748825|26303735|FG002|Dose Escalation|Switched to alternative treatment|0|||
13228010|NCT01748825|26303736|FG003|Dose Escalation|Switched to alternative treatment|1|||
13228011|NCT01748825|26303737|FG004|Dose Escalation|Switched to alternative treatment|0|||
13228012|NCT01748825|26303738|FG005|Dose Escalation|Switched to alternative treatment|0|||
13228013|NCT01748825|26303739|FG006|Dose Escalation|Switched to alternative treatment|0|||
13228014|NCT01748825|26303740|FG007|Dose Escalation|Switched to alternative treatment|0|||
13228015|NCT01748825|26303741|FG008|Dose Escalation|Switched to alternative treatment|0|||
13228016|NCT01748825|26303742|FG009|Dose Escalation|Switched to alternative treatment|0|||
13228017|NCT01748825|26303733|FG000|Dose Escalation|Adverse Event|0|||
13114884|NCT03101358|25916714|FG003|Overall Study|Physician Decision|3|||
13228018|NCT01748825|26303734|FG001|Dose Escalation|Adverse Event|0|||
13114885|NCT03101358|25916711|FG000|Overall Study|Adverse Event|0|||
13228019|NCT01748825|26303735|FG002|Dose Escalation|Adverse Event|0|||
13228020|NCT01748825|26303736|FG003|Dose Escalation|Adverse Event|0|||
13228021|NCT01748825|26303737|FG004|Dose Escalation|Adverse Event|0|||
13114886|NCT03101358|25916712|FG001|Overall Study|Adverse Event|0|||
13114887|NCT03101358|25916713|FG002|Overall Study|Adverse Event|1|||
13228022|NCT01748825|26303738|FG005|Dose Escalation|Adverse Event|0|||
13114888|NCT03101358|25916714|FG003|Overall Study|Adverse Event|0|||
13114889|NCT03101358|25916711|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
13114890|NCT03101358|25916712|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
13114891|NCT03101358|25916713|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
13114892|NCT03101358|25916714|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1|||
13228023|NCT01748825|26303739|FG006|Dose Escalation|Adverse Event|1|||
13228024|NCT01748825|26303740|FG007|Dose Escalation|Adverse Event|0|||
13228025|NCT01748825|26303741|FG008|Dose Escalation|Adverse Event|0|||
13228026|NCT01748825|26303742|FG009|Dose Escalation|Adverse Event|0|||
13228027|NCT01748825|26303733|FG000|Dose Expansion|Refused further treatment|0|||
13228028|NCT01748825|26303734|FG001|Dose Expansion|Refused further treatment|0|||
13228029|NCT01748825|26303735|FG002|Dose Expansion|Refused further treatment|0|||
13228030|NCT01748825|26303736|FG003|Dose Expansion|Refused further treatment|0|||
13228031|NCT01748825|26303737|FG004|Dose Expansion|Refused further treatment|0|||
13228032|NCT01748825|26303738|FG005|Dose Expansion|Refused further treatment|0|||
13228033|NCT01748825|26303739|FG006|Dose Expansion|Refused further treatment|0|||
13228034|NCT01748825|26303740|FG007|Dose Expansion|Refused further treatment|0|||
13228035|NCT01748825|26303741|FG008|Dose Expansion|Refused further treatment|1|||
13228036|NCT01748825|26303742|FG009|Dose Expansion|Refused further treatment|1|||
13228037|NCT01748825|26303733|FG000|Dose Expansion|Switched to alternative treatment|0|||
13228038|NCT01748825|26303734|FG001|Dose Expansion|Switched to alternative treatment|0|||
13228039|NCT01748825|26303735|FG002|Dose Expansion|Switched to alternative treatment|0|||
13485721|NCT00585195|27033423|FG013|Overall Study|Withdrawal by Subject|0|||
13485722|NCT00585195|27033424|FG014|Overall Study|Withdrawal by Subject|3|||
13485723|NCT00585195|27033425|FG015|Overall Study|Withdrawal by Subject|0|||
13485724|NCT00585195|27033426|FG016|Overall Study|Withdrawal by Subject|7|||
13485725|NCT00585195|27033427|FG017|Overall Study|Withdrawal by Subject|1|||
13485726|NCT00585195|27033428|FG018|Overall Study|Withdrawal by Subject|2|||
13228040|NCT01748825|26303736|FG003|Dose Expansion|Switched to alternative treatment|0|||
13228041|NCT01748825|26303737|FG004|Dose Expansion|Switched to alternative treatment|0|||
13228042|NCT01748825|26303738|FG005|Dose Expansion|Switched to alternative treatment|0|||
13228043|NCT01748825|26303739|FG006|Dose Expansion|Switched to alternative treatment|0|||
13228044|NCT01748825|26303740|FG007|Dose Expansion|Switched to alternative treatment|0|||
13228045|NCT01748825|26303741|FG008|Dose Expansion|Switched to alternative treatment|0|||
13228046|NCT01748825|26303742|FG009|Dose Expansion|Switched to alternative treatment|1|||
13228047|NCT01748825|26303733|FG000|Dose Expansion|Adverse Event|0|||
13228048|NCT01748825|26303734|FG001|Dose Expansion|Adverse Event|0|||
13228049|NCT01748825|26303735|FG002|Dose Expansion|Adverse Event|0|||
13228050|NCT01748825|26303736|FG003|Dose Expansion|Adverse Event|0|||
13228051|NCT01748825|26303737|FG004|Dose Expansion|Adverse Event|0|||
13114893|NCT03101358|25916711|FG000|Overall Study|Lost to Follow-up|1|||
13114894|NCT03101358|25916712|FG001|Overall Study|Lost to Follow-up|0|||
13114895|NCT03101358|25916713|FG002|Overall Study|Lost to Follow-up|0|||
13114896|NCT03101358|25916714|FG003|Overall Study|Lost to Follow-up|1|||
13114897|NCT03101293|25916733|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1|||
13114898|NCT03101293|25916734|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0|||
13114899|NCT03101267|25916797|FG000|Primary Study Period|Withdrawal by Subject|1|||
13114900|NCT03101267|25916798|FG001|Primary Study Period|Withdrawal by Subject|2|||
13114901|NCT03101267|25916799|FG002|Primary Study Period|Withdrawal by Subject|3|||
13114902|NCT03101267|25916797|FG000|Primary Study Period|Miscellaneous|2|||
13114903|NCT03101267|25916798|FG001|Primary Study Period|Miscellaneous|0|||
13114904|NCT03101267|25916799|FG002|Primary Study Period|Miscellaneous|0|||
13114905|NCT03101241|25916822|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4|||
13114906|NCT03101241|25916823|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2|||
13114907|NCT03101241|25916822|FG000|Overall Study|Participant withdrew consent|3|||
13114908|NCT03101241|25916823|FG001|Overall Study|Participant withdrew consent|1|||
13114909|NCT03101241|25916822|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2|||
13228052|NCT01748825|26303738|FG005|Dose Expansion|Adverse Event|0|||
13228053|NCT01748825|26303739|FG006|Dose Expansion|Adverse Event|0|||
13114910|NCT03101241|25916823|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0|||
13114911|NCT03101241|25916822|FG000|Overall Study|Lost to Follow-up|2|||
13114912|NCT03101241|25916823|FG001|Overall Study|Lost to Follow-up|0|||
13114913|NCT03101241|25916822|FG000|Overall Study|Lack of Efficacy|0|||
13114914|NCT03101241|25916823|FG001|Overall Study|Lack of Efficacy|1|||
13114915|NCT03101241|25916822|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0|||
13114916|NCT03101241|25916823|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1|||
13114917|NCT03101150|25916840|FG000|Overall Study|Lost to Follow-up|2|||
13114918|NCT03101150|25916841|FG001|Overall Study|Lost to Follow-up|4|||
13114919|NCT03101150|25916840|FG000|Overall Study|Miscarriage|3|||
13114920|NCT03101150|25916841|FG001|Overall Study|Miscarriage|6|||
13114921|NCT03101020|25916860|FG000|Overall Study|Lack of time to participate|1|||
13114922|NCT03101020|25916861|FG001|Overall Study|Lack of time to participate|0|||
13114923|NCT03101020|25916860|FG000|Overall Study|Ran over by a car|0|||
13114924|NCT03101020|25916861|FG001|Overall Study|Ran over by a car|1|||
13114925|NCT03101020|25916860|FG000|Overall Study|Withdrawal by Subject|0|||
13114926|NCT03101020|25916861|FG001|Overall Study|Withdrawal by Subject|2|||
13114927|NCT03100942|25916906|FG000|Randomized Treatment Period|Withdrew Consent|4|||
13114928|NCT03100942|25916907|FG001|Randomized Treatment Period|Withdrew Consent|5|||
13114929|NCT03100942|25916908|FG002|Randomized Treatment Period|Withdrew Consent|3|||
13114930|NCT03100942|25916909|FG003|Randomized Treatment Period|Withdrew Consent|3|||
13114931|NCT03100942|25916910|FG004|Randomized Treatment Period|Withdrew Consent|0|||
13114932|NCT03100942|25916911|FG005|Randomized Treatment Period|Withdrew Consent|0|||
13114933|NCT03100942|25916912|FG006|Randomized Treatment Period|Withdrew Consent|0|||
13114934|NCT03100942|25916906|FG000|Randomized Treatment Period|Adverse Event|5|||
13114935|NCT03100942|25916907|FG001|Randomized Treatment Period|Adverse Event|2|||
13114936|NCT03100942|25916908|FG002|Randomized Treatment Period|Adverse Event|1|||
13114937|NCT03100942|25916909|FG003|Randomized Treatment Period|Adverse Event|0|||
13114938|NCT03100942|25916910|FG004|Randomized Treatment Period|Adverse Event|0|||
13114939|NCT03100942|25916911|FG005|Randomized Treatment Period|Adverse Event|0|||
13114940|NCT03100942|25916912|FG006|Randomized Treatment Period|Adverse Event|0|||
13114941|NCT03100942|25916906|FG000|Randomized Treatment Period|Investigator's Discretion|2|||
13114942|NCT03100942|25916907|FG001|Randomized Treatment Period|Investigator's Discretion|1|||
13114943|NCT03100942|25916908|FG002|Randomized Treatment Period|Investigator's Discretion|0|||
13114944|NCT03100942|25916909|FG003|Randomized Treatment Period|Investigator's Discretion|0|||
13114945|NCT03100942|25916910|FG004|Randomized Treatment Period|Investigator's Discretion|0|||
13114946|NCT03100942|25916911|FG005|Randomized Treatment Period|Investigator's Discretion|0|||
13114947|NCT03100942|25916912|FG006|Randomized Treatment Period|Investigator's Discretion|0|||
13114948|NCT03100942|25916906|FG000|Randomized Treatment Period|Protocol Violation|0|||
13114949|NCT03100942|25916907|FG001|Randomized Treatment Period|Protocol Violation|1|||
13114950|NCT03100942|25916908|FG002|Randomized Treatment Period|Protocol Violation|1|||
13114951|NCT03100942|25916909|FG003|Randomized Treatment Period|Protocol Violation|1|||
13114952|NCT03100942|25916910|FG004|Randomized Treatment Period|Protocol Violation|0|||
13114953|NCT03100942|25916911|FG005|Randomized Treatment Period|Protocol Violation|0|||
13114954|NCT03100942|25916912|FG006|Randomized Treatment Period|Protocol Violation|0|||
13114955|NCT03100942|25916906|FG000|Randomized Treatment Period|Lost to Follow-up|0|||
13114956|NCT03100942|25916907|FG001|Randomized Treatment Period|Lost to Follow-up|0|||
13114957|NCT03100942|25916908|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
13114958|NCT03100942|25916909|FG003|Randomized Treatment Period|Lost to Follow-up|0|||
13114959|NCT03100942|25916910|FG004|Randomized Treatment Period|Lost to Follow-up|0|||
13114960|NCT03100942|25916911|FG005|Randomized Treatment Period|Lost to Follow-up|0|||
13114961|NCT03100942|25916912|FG006|Randomized Treatment Period|Lost to Follow-up|0|||
13114962|NCT03100942|25916906|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
13228054|NCT01748825|26303740|FG007|Dose Expansion|Adverse Event|0|||
13228055|NCT01748825|26303741|FG008|Dose Expansion|Adverse Event|0|||
13228056|NCT01748825|26303742|FG009|Dose Expansion|Adverse Event|3|||
13228057|NCT01748825|26303733|FG000|Dose Expansion|Physician Decision|0|||
13228058|NCT01748825|26303734|FG001|Dose Expansion|Physician Decision|0|||
13228059|NCT01748825|26303735|FG002|Dose Expansion|Physician Decision|0|||
13228060|NCT01748825|26303736|FG003|Dose Expansion|Physician Decision|0|||
13228061|NCT01748825|26303737|FG004|Dose Expansion|Physician Decision|0|||
13228062|NCT01748825|26303738|FG005|Dose Expansion|Physician Decision|0|||
13228063|NCT01748825|26303739|FG006|Dose Expansion|Physician Decision|0|||
13228064|NCT01748825|26303740|FG007|Dose Expansion|Physician Decision|0|||
13228065|NCT01748825|26303741|FG008|Dose Expansion|Physician Decision|1|||
13228066|NCT01748825|26303742|FG009|Dose Expansion|Physician Decision|0|||
13228067|NCT01748760|26303755|FG000|Overall Study|Withdrawal by Subject|1|||
13228068|NCT01748760|26303756|FG001|Overall Study|Withdrawal by Subject|1|||
13228069|NCT01748760|26303755|FG000|Overall Study|Lost to Follow-up|5|||
13228070|NCT01748760|26303756|FG001|Overall Study|Lost to Follow-up|1|||
13228071|NCT01748552|26303861|FG000|Intervention Period 2 and Washout|Physician Decision|0|||
13114963|NCT03100942|25916907|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
13114964|NCT03100942|25916908|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
13228072|NCT01748552|26303862|FG001|Intervention Period 2 and Washout|Physician Decision|0|||
13114965|NCT03100942|25916909|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
13114966|NCT03100942|25916910|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
13114967|NCT03100942|25916911|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
13114968|NCT03100942|25916912|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
13114969|NCT03100942|25916906|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0|||
13114970|NCT03100942|25916907|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0|||
13114971|NCT03100942|25916908|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0|||
13114972|NCT03100942|25916909|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0|||
13114973|NCT03100942|25916910|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0|||
13114974|NCT03100942|25916911|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0|||
13114975|NCT03100942|25916912|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1|||
13114976|NCT03100838|25916943|FG000|Overall Study|Adverse Event|1|||
13228073|NCT01748552|26303863|FG002|Intervention Period 2 and Washout|Physician Decision|1|||
13228074|NCT01748552|26303864|FG003|Intervention Period 2 and Washout|Physician Decision|0|||
13228075|NCT01748552|26303865|FG004|Intervention Period 2 and Washout|Physician Decision|0|||
13228076|NCT01748552|26303866|FG005|Intervention Period 2 and Washout|Physician Decision|0|||
13228077|NCT01748552|26303867|FG006|Intervention Period 2 and Washout|Physician Decision|0|||
13228078|NCT01748552|26303868|FG007|Intervention Period 2 and Washout|Physician Decision|0|||
13228079|NCT01748552|26303869|FG008|Intervention Period 2 and Washout|Physician Decision|0|||
13228080|NCT01748552|26303870|FG009|Intervention Period 2 and Washout|Physician Decision|0|||
13228081|NCT01748552|26303871|FG010|Intervention Period 2 and Washout|Physician Decision|0|||
13228082|NCT01748552|26303872|FG011|Intervention Period 2 and Washout|Physician Decision|0|||
13228083|NCT01748552|26303861|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0|||
13228084|NCT01748552|26303862|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0|||
13228085|NCT01748552|26303863|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0|||
13228086|NCT01748552|26303864|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0|||
13228087|NCT01748552|26303865|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0|||
13228088|NCT01748552|26303866|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0|||
13228089|NCT01748552|26303867|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3|||
13228090|NCT01748552|26303868|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3|||
13228091|NCT01748552|26303869|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3|||
13228092|NCT01748552|26303870|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0|||
13228093|NCT01748552|26303871|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0|||
13228094|NCT01748552|26303872|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0|||
13228095|NCT01748292|26303899|FG000|Overall Study|Adverse Event|2|||
13228096|NCT01748292|26303900|FG001|Overall Study|Adverse Event|4|||
13228097|NCT01748292|26303899|FG000|Overall Study|Lost to Follow-up|0|||
13228098|NCT01748292|26303900|FG001|Overall Study|Lost to Follow-up|3|||
13228099|NCT01748292|26303899|FG000|Overall Study|Death|0|||
13228100|NCT01748292|26303900|FG001|Overall Study|Death|3|||
13228101|NCT01748292|26303899|FG000|Overall Study|Withdrawal by Subject|0|||
13228102|NCT01748292|26303900|FG001|Overall Study|Withdrawal by Subject|2|||
13228103|NCT01748162|26303915|FG000|Overall Study|no additional croup episodes to evaluate|2|||
13228104|NCT01748162|26303916|FG001|Overall Study|no additional croup episodes to evaluate|2|||
13228105|NCT01748162|26303915|FG000|Overall Study|participant consented but did not begin|0|||
13228106|NCT01748162|26303916|FG001|Overall Study|participant consented but did not begin|1|||
13228107|NCT01748162|26303915|FG000|Overall Study|reasons not available|3|||
13228108|NCT01748162|26303916|FG001|Overall Study|reasons not available|2|||
13228109|NCT01748071|26303946|FG000|Overall Study|Adverse Event|2|||
13228110|NCT01748071|26303947|FG001|Overall Study|Adverse Event|2|||
13228111|NCT01748071|26303948|FG002|Overall Study|Adverse Event|0|||
13228112|NCT01747915|26303969|FG000|Overall Study|Other|1|||
13228113|NCT01747915|26303970|FG001|Overall Study|Other|1|||
13228114|NCT01747915|26303971|FG002|Overall Study|Other|1|||
13228115|NCT01747915|26303969|FG000|Overall Study|Adverse Event|8|||
13228116|NCT01747915|26303970|FG001|Overall Study|Adverse Event|5|||
13228117|NCT01747915|26303971|FG002|Overall Study|Adverse Event|2|||
13228118|NCT01747915|26303969|FG000|Overall Study|Death|0|||
13228119|NCT01747915|26303970|FG001|Overall Study|Death|0|||
13228120|NCT01747915|26303971|FG002|Overall Study|Death|1|||
13228121|NCT01747915|26303969|FG000|Overall Study|Lack of Efficacy|0|||
13228122|NCT01747915|26303970|FG001|Overall Study|Lack of Efficacy|1|||
13228123|NCT01747915|26303971|FG002|Overall Study|Lack of Efficacy|0|||
13228124|NCT01747915|26303969|FG000|Overall Study|Lost to Follow-up|1|||
13228125|NCT01747915|26303970|FG001|Overall Study|Lost to Follow-up|0|||
13228126|NCT01747915|26303971|FG002|Overall Study|Lost to Follow-up|0|||
13228127|NCT01747915|26303969|FG000|Overall Study|Withdrawal by Subject|4|||
13228128|NCT01747915|26303970|FG001|Overall Study|Withdrawal by Subject|4|||
13228129|NCT01747915|26303971|FG002|Overall Study|Withdrawal by Subject|1|||
13228130|NCT01747915|26303969|FG000|Overall Study|Protocol Violation|1|||
13228131|NCT01747915|26303970|FG001|Overall Study|Protocol Violation|0|||
13228132|NCT01747915|26303971|FG002|Overall Study|Protocol Violation|0|||
13228133|NCT01747915|26303969|FG000|Overall Study|Pregnancy|0|||
13228134|NCT01747915|26303970|FG001|Overall Study|Pregnancy|0|||
13228135|NCT01747915|26303971|FG002|Overall Study|Pregnancy|1|||
13228136|NCT01747876|26304007|FG000|Overall Study|Adverse Event|1|||
13228137|NCT01747876|26304008|FG001|Overall Study|Adverse Event|0|||
13114977|NCT03100838|25916944|FG001|Overall Study|Adverse Event|0|||
13114978|NCT03100838|25916945|FG002|Overall Study|Adverse Event|0|||
13114979|NCT03100838|25916946|FG003|Overall Study|Adverse Event|0|||
13114980|NCT03100838|25916943|FG000|Overall Study|Physician Decision|1|||
13114981|NCT03100838|25916944|FG001|Overall Study|Physician Decision|1|||
13114982|NCT03100838|25916945|FG002|Overall Study|Physician Decision|1|||
13114983|NCT03100838|25916946|FG003|Overall Study|Physician Decision|1|||
13114984|NCT03100838|25916943|FG000|Overall Study|Pregnancy|0|||
13114985|NCT03100838|25916944|FG001|Overall Study|Pregnancy|1|||
13114986|NCT03100838|25916945|FG002|Overall Study|Pregnancy|0|||
13228138|NCT01747876|26304009|FG002|Overall Study|Adverse Event|2|||
13228139|NCT01747876|26304007|FG000|Overall Study|Withdrawal by Subject|0|||
13228140|NCT01747876|26304008|FG001|Overall Study|Withdrawal by Subject|1|||
13228141|NCT01747876|26304009|FG002|Overall Study|Withdrawal by Subject|1|||
13228142|NCT01747876|26304007|FG000|Overall Study|Disease progression|4|||
13228143|NCT01747876|26304008|FG001|Overall Study|Disease progression|13|||
13228144|NCT01747876|26304009|FG002|Overall Study|Disease progression|8|||
13228145|NCT01747876|26304007|FG000|Overall Study|Trtment duration compl. as per protocol|0|||
13228146|NCT01747876|26304008|FG001|Overall Study|Trtment duration compl. as per protocol|1|||
13228147|NCT01747876|26304009|FG002|Overall Study|Trtment duration compl. as per protocol|1|||
13228148|NCT01747837|26304044|FG000|Overall Study|Lost to Follow-up|5|||
13228149|NCT01747837|26304045|FG001|Overall Study|Lost to Follow-up|2|||
13228150|NCT01747837|26304044|FG000|Overall Study|Death|4|||
13228151|NCT01747837|26304045|FG001|Overall Study|Death|4|||
13228152|NCT01747811|26304068|FG000|Overall Study|Lack of Efficacy|2|||
13228153|NCT01747811|26304069|FG001|Overall Study|Lack of Efficacy|4|||
13228154|NCT01747772|26304079|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9|||
13228155|NCT01747655|26304110|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5|||
13228156|NCT01747655|26304111|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0|||
13228157|NCT01747655|26304110|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8|||
13228158|NCT01747655|26304111|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0|||
13228159|NCT01747655|26304110|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1|||
13228160|NCT01747655|26304111|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0|||
13228161|NCT01747629|26304150|FG000|Overall Study|Adverse Event|1|||
13228162|NCT01747629|26304151|FG001|Overall Study|Adverse Event|2|||
13228163|NCT01747629|26304150|FG000|Overall Study|Withdrawal by Subject|2|||
13228164|NCT01747629|26304151|FG001|Overall Study|Withdrawal by Subject|2|||
13228165|NCT01747629|26304150|FG000|Overall Study|Noncompliance|1|||
13228166|NCT01747629|26304151|FG001|Overall Study|Noncompliance|1|||
13228167|NCT01747629|26304150|FG000|Overall Study|Inclusion criteria not met|1|||
13228168|NCT01747629|26304151|FG001|Overall Study|Inclusion criteria not met|0|||
13114987|NCT03100838|25916946|FG003|Overall Study|Pregnancy|0|||
13114988|NCT03100838|25916943|FG000|Overall Study|Lost to Follow-up|0|||
13114989|NCT03100838|25916944|FG001|Overall Study|Lost to Follow-up|0|||
13114990|NCT03100838|25916945|FG002|Overall Study|Lost to Follow-up|1|||
13114991|NCT03100838|25916946|FG003|Overall Study|Lost to Follow-up|0|||
13228169|NCT01747629|26304150|FG000|Overall Study|Not treated|1|||
13228170|NCT01747629|26304151|FG001|Overall Study|Not treated|0|||
13228171|NCT01747629|26304150|FG000|Overall Study|Other|2|||
13228172|NCT01747629|26304151|FG001|Overall Study|Other|1|||
13228173|NCT01747551|26304170|FG000|Overall Study|Progressive Disease|24|||
13228174|NCT01747551|26304171|FG001|Overall Study|Progressive Disease|17|||
13228175|NCT01747551|26304170|FG000|Overall Study|Death|3|||
13228176|NCT01747551|26304171|FG001|Overall Study|Death|1|||
13228177|NCT01747551|26304170|FG000|Overall Study|Adverse Event|7|||
13228178|NCT01747551|26304171|FG001|Overall Study|Adverse Event|1|||
13228179|NCT01747551|26304170|FG000|Overall Study|Prolonged Treatment Delay|2|||
13228180|NCT01747551|26304171|FG001|Overall Study|Prolonged Treatment Delay|0|||
13228181|NCT01747551|26304170|FG000|Overall Study|Withdrawal by Subject|3|||
13228182|NCT01747551|26304171|FG001|Overall Study|Withdrawal by Subject|1|||
13228183|NCT01747551|26304170|FG000|Overall Study|Physician Decision|2|||
13228184|NCT01747551|26304171|FG001|Overall Study|Physician Decision|1|||
13228185|NCT01747551|26304170|FG000|Overall Study|Other|2|||
13228186|NCT01747551|26304171|FG001|Overall Study|Other|0|||
13228187|NCT01747499|26304221|FG000|Overall Study|Steroid refractory aGvHD|1|||
13114992|NCT03100825|25916958|FG000|Overall Study|Participant/Guardian Decision|7|||
13228188|NCT01747499|26304222|FG001|Overall Study|Steroid refractory aGvHD|0|||
13228189|NCT01747499|26304223|FG002|Overall Study|Steroid refractory aGvHD|0|||
13228190|NCT01747499|26304224|FG003|Overall Study|Steroid refractory aGvHD|1|||
13289581|NCT00108082|26479699|FG000|Overall Study|Consent Withdrawn|3|||
13114993|NCT03100825|25916958|FG000|Overall Study|Physician Decision|1|||
13114994|NCT03100344|25917049|FG000|Overall Study|Adverse Event|0|||
13228191|NCT01747499|26304225|FG004|Overall Study|Steroid refractory aGvHD|4|||
13228192|NCT01747499|26304221|FG000|Overall Study|Physician Decision|0|||
13228193|NCT01747499|26304222|FG001|Overall Study|Physician Decision|1|||
13228194|NCT01747499|26304223|FG002|Overall Study|Physician Decision|0|||
13114995|NCT03100344|25917050|FG001|Overall Study|Adverse Event|3|||
13114996|NCT03100344|25917051|FG002|Overall Study|Adverse Event|2|||
13228195|NCT01747499|26304224|FG003|Overall Study|Physician Decision|0|||
13114997|NCT03100344|25917052|FG003|Overall Study|Adverse Event|3|||
13114998|NCT03100344|25917049|FG000|Overall Study|Lack of Efficacy|2|||
13114999|NCT03100344|25917050|FG001|Overall Study|Lack of Efficacy|0|||
13115000|NCT03100344|25917051|FG002|Overall Study|Lack of Efficacy|0|||
13115001|NCT03100344|25917052|FG003|Overall Study|Lack of Efficacy|0|||
13228196|NCT01747499|26304225|FG004|Overall Study|Physician Decision|2|||
13228197|NCT01747499|26304221|FG000|Overall Study|Death|0|||
13228198|NCT01747499|26304222|FG001|Overall Study|Death|0|||
13228199|NCT01747499|26304223|FG002|Overall Study|Death|0|||
13228200|NCT01747499|26304224|FG003|Overall Study|Death|1|||
13228201|NCT01747499|26304225|FG004|Overall Study|Death|1|||
13228202|NCT01747499|26304221|FG000|Overall Study|Withdrawal by Subject|0|||
13228203|NCT01747499|26304222|FG001|Overall Study|Withdrawal by Subject|0|||
13228204|NCT01747499|26304223|FG002|Overall Study|Withdrawal by Subject|0|||
13228205|NCT01747499|26304224|FG003|Overall Study|Withdrawal by Subject|0|||
13228206|NCT01747499|26304225|FG004|Overall Study|Withdrawal by Subject|6|||
13228207|NCT01747499|26304221|FG000|Overall Study|Developed AML and death|0|||
13228208|NCT01747499|26304222|FG001|Overall Study|Developed AML and death|0|||
13228209|NCT01747499|26304223|FG002|Overall Study|Developed AML and death|0|||
13228210|NCT01747499|26304224|FG003|Overall Study|Developed AML and death|0|||
13228211|NCT01747499|26304225|FG004|Overall Study|Developed AML and death|1|||
13228212|NCT01747499|26304221|FG000|Overall Study|Determined not to be eligible|0|||
13228213|NCT01747499|26304222|FG001|Overall Study|Determined not to be eligible|0|||
13228214|NCT01747499|26304223|FG002|Overall Study|Determined not to be eligible|0|||
13228215|NCT01747499|26304224|FG003|Overall Study|Determined not to be eligible|0|||
13228216|NCT01747499|26304225|FG004|Overall Study|Determined not to be eligible|1|||
13228217|NCT01747486|26304238|FG000|Stage 1|Physician Decision|3|||
13228218|NCT01747486|26304239|FG001|Stage 1|Physician Decision|0|||
13228219|NCT01747486|26304238|FG000|Stage 1|Withdrawal by Subject|4|||
13228220|NCT01747486|26304239|FG001|Stage 1|Withdrawal by Subject|3|||
13228221|NCT01747486|26304238|FG000|Stage 1|Disease progression|4|||
13228222|NCT01747486|26304239|FG001|Stage 1|Disease progression|9|||
13228223|NCT01747486|26304238|FG000|Stage 1|Death|1|||
13228224|NCT01747486|26304239|FG001|Stage 1|Death|1|||
13228225|NCT01747486|26304238|FG000|Stage 2|Physician Decision|2|||
13228226|NCT01747486|26304239|FG001|Stage 2|Physician Decision|0|||
13228227|NCT01747486|26304238|FG000|Stage 2|Withdrawal by Subject|1|||
13228228|NCT01747486|26304239|FG001|Stage 2|Withdrawal by Subject|0|||
13228229|NCT01747486|26304238|FG000|Stage 2|New Cancer Therapy|3|||
13228230|NCT01747486|26304239|FG001|Stage 2|New Cancer Therapy|0|||
13115002|NCT03100344|25917049|FG000|Overall Study|Protocol Violation|1|||
13115003|NCT03100344|25917050|FG001|Overall Study|Protocol Violation|0|||
13115004|NCT03100344|25917051|FG002|Overall Study|Protocol Violation|0|||
13228231|NCT01747486|26304238|FG000|Stage 2|Disease Progression|3|||
13228232|NCT01747486|26304239|FG001|Stage 2|Disease Progression|0|||
13228233|NCT01746901|26304570|FG000|Naloxone Challenge Phase|Adverse Event|2|||
13228234|NCT01746901|26304571|FG001|Naloxone Challenge Phase|Adverse Event|0|||
13228235|NCT01746901|26304572|FG002|Naloxone Challenge Phase|Adverse Event|0|||
13228236|NCT01746901|26304573|FG003|Naloxone Challenge Phase|Adverse Event|0|||
13228237|NCT01746901|26304574|FG004|Naloxone Challenge Phase|Adverse Event|0|||
13228238|NCT01746901|26304575|FG005|Naloxone Challenge Phase|Adverse Event|0|||
13228239|NCT01746901|26304576|FG006|Naloxone Challenge Phase|Adverse Event|0|||
13228240|NCT01746901|26304577|FG007|Naloxone Challenge Phase|Adverse Event|0|||
13228241|NCT01746901|26304578|FG008|Naloxone Challenge Phase|Adverse Event|0|||
13228242|NCT01746901|26304570|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1|||
13228243|NCT01746901|26304571|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
13228244|NCT01746901|26304572|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
13228245|NCT01746901|26304573|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
13228246|NCT01746901|26304574|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
13228247|NCT01746901|26304575|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
13228248|NCT01746901|26304576|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
13228249|NCT01746901|26304577|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
13115005|NCT03100344|25917052|FG003|Overall Study|Protocol Violation|0|||
13115006|NCT03100344|25917049|FG000|Overall Study|Withdrawal by Subject|10|||
13228250|NCT01746901|26304578|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
13228251|NCT01746901|26304570|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
13228252|NCT01746901|26304571|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
13228253|NCT01746901|26304572|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
13289582|NCT00108082|26479700|FG001|Overall Study|Consent Withdrawn|3|||
13115007|NCT03100344|25917050|FG001|Overall Study|Withdrawal by Subject|7|||
13228254|NCT01746901|26304573|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
13115008|NCT03100344|25917051|FG002|Overall Study|Withdrawal by Subject|4|||
13228255|NCT01746901|26304574|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
13115009|NCT03100344|25917052|FG003|Overall Study|Withdrawal by Subject|8|||
13115010|NCT03100344|25917049|FG000|Overall Study|Lost to Follow-up|1|||
13115011|NCT03100344|25917050|FG001|Overall Study|Lost to Follow-up|1|||
13115012|NCT03100344|25917051|FG002|Overall Study|Lost to Follow-up|1|||
13115013|NCT03100344|25917052|FG003|Overall Study|Lost to Follow-up|1|||
13115014|NCT03100149|25917097|FG000|Overall Study|Adverse Event|0|||
13115015|NCT03100149|25917098|FG001|Overall Study|Adverse Event|1|||
13115016|NCT03100149|25917099|FG002|Overall Study|Adverse Event|0|||
13115017|NCT03100149|25917097|FG000|Overall Study|Participant Moved out of Country|0|||
13115018|NCT03100149|25917098|FG001|Overall Study|Participant Moved out of Country|0|||
13115019|NCT03100149|25917099|FG002|Overall Study|Participant Moved out of Country|1|||
13115020|NCT03100149|25917097|FG000|Overall Study|Withdrawal by Subject|0|||
13115021|NCT03100149|25917098|FG001|Overall Study|Withdrawal by Subject|3|||
13115022|NCT03100149|25917099|FG002|Overall Study|Withdrawal by Subject|1|||
13133363|NCT02771210|25987551|FG000|Period 1|Lost to Follow-up|2|||
13133364|NCT02771210|25987552|FG001|Period 1|Lost to Follow-up|0|||
13133365|NCT02771210|25987551|FG000|Period 1|Physician Decision|0|||
13133366|NCT02771210|25987552|FG001|Period 1|Physician Decision|1|||
13133367|NCT02771210|25987551|FG000|Period 1|Withdrawal by Subject|0|||
13133368|NCT02771210|25987552|FG001|Period 1|Withdrawal by Subject|3|||
13133369|NCT02771210|25987551|FG000|Period 1|Withdrawal of informed consent|1|||
13228256|NCT01746901|26304575|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
13228257|NCT01746901|26304576|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
13228258|NCT01746901|26304577|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0|||
13228259|NCT01746901|26304578|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0|||
13228260|NCT01746901|26304570|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0|||
13228261|NCT01746901|26304571|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2|||
13228262|NCT01746901|26304572|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1|||
13228263|NCT01746901|26304573|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0|||
13228264|NCT01746901|26304574|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0|||
13228265|NCT01746901|26304575|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0|||
13228266|NCT01746901|26304576|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0|||
13228267|NCT01746901|26304577|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0|||
13228268|NCT01746901|26304578|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0|||
13228269|NCT01746901|26304570|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
13228270|NCT01746901|26304571|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9|||
13228271|NCT01746901|26304572|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10|||
13228272|NCT01746901|26304573|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
13228273|NCT01746901|26304574|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
13228274|NCT01746901|26304575|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
13228275|NCT01746901|26304576|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
13228276|NCT01746901|26304577|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
13228277|NCT01746901|26304578|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
13228278|NCT01746901|26304570|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
13228279|NCT01746901|26304571|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
13228280|NCT01746901|26304572|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
13228281|NCT01746901|26304573|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
13228282|NCT01746901|26304574|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
13228283|NCT01746901|26304575|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
13228284|NCT01746901|26304576|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
13228285|NCT01746901|26304577|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
13228286|NCT01746901|26304578|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
13228287|NCT01746901|26304570|FG000|Treatment Phase: First Intervention|Protocol Violation|0|||
13228288|NCT01746901|26304571|FG001|Treatment Phase: First Intervention|Protocol Violation|0|||
13228289|NCT01746901|26304572|FG002|Treatment Phase: First Intervention|Protocol Violation|0|||
13228290|NCT01746901|26304573|FG003|Treatment Phase: First Intervention|Protocol Violation|0|||
13228291|NCT01746901|26304574|FG004|Treatment Phase: First Intervention|Protocol Violation|0|||
13228292|NCT01746901|26304575|FG005|Treatment Phase: First Intervention|Protocol Violation|0|||
13228293|NCT01746901|26304576|FG006|Treatment Phase: First Intervention|Protocol Violation|1|||
13228294|NCT01746901|26304577|FG007|Treatment Phase: First Intervention|Protocol Violation|0|||
13228295|NCT01746901|26304578|FG008|Treatment Phase: First Intervention|Protocol Violation|0|||
13228296|NCT01746901|26304570|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
13228297|NCT01746901|26304571|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
13228298|NCT01746901|26304572|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
13228299|NCT01746901|26304573|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
13133370|NCT02771210|25987552|FG001|Period 1|Withdrawal of informed consent|5|||
13228300|NCT01746901|26304574|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
13228301|NCT01746901|26304575|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
13228302|NCT01746901|26304576|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
13228303|NCT01746901|26304577|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1|||
13228304|NCT01746901|26304578|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
13228305|NCT01746901|26304570|FG000|Treatment Phase: Third Intervention|Protocol Violation|0|||
13228306|NCT01746901|26304571|FG001|Treatment Phase: Third Intervention|Protocol Violation|0|||
13228307|NCT01746901|26304572|FG002|Treatment Phase: Third Intervention|Protocol Violation|0|||
13228308|NCT01746901|26304573|FG003|Treatment Phase: Third Intervention|Protocol Violation|0|||
13228309|NCT01746901|26304574|FG004|Treatment Phase: Third Intervention|Protocol Violation|0|||
13228310|NCT01746901|26304575|FG005|Treatment Phase: Third Intervention|Protocol Violation|1|||
13228311|NCT01746901|26304576|FG006|Treatment Phase: Third Intervention|Protocol Violation|1|||
13228312|NCT01746901|26304577|FG007|Treatment Phase: Third Intervention|Protocol Violation|0|||
13228313|NCT01746901|26304578|FG008|Treatment Phase: Third Intervention|Protocol Violation|0|||
13228314|NCT01746901|26304570|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
13228315|NCT01746901|26304571|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
13228316|NCT01746901|26304572|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
13228317|NCT01746901|26304573|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1|||
13228318|NCT01746901|26304574|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
13228319|NCT01746901|26304575|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
13228320|NCT01746901|26304576|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
13228321|NCT01746901|26304577|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
13228322|NCT01746901|26304578|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
13228323|NCT01746901|26304570|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0|||
13228324|NCT01746901|26304571|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0|||
13228325|NCT01746901|26304572|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0|||
13228326|NCT01746901|26304573|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0|||
13228327|NCT01746901|26304574|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0|||
13228328|NCT01746901|26304575|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1|||
13228329|NCT01746901|26304576|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0|||
13228330|NCT01746901|26304577|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0|||
13228331|NCT01746901|26304578|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1|||
13228332|NCT01746901|26304570|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
13228333|NCT01746901|26304571|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
13228334|NCT01746901|26304572|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
13228335|NCT01746901|26304573|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
13228336|NCT01746901|26304574|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
13228337|NCT01746901|26304575|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
13228338|NCT01746901|26304576|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
13228339|NCT01746901|26304577|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
13228340|NCT01746901|26304578|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
13228341|NCT01746862|26304605|FG000|Overall Study|Withdrawal by Subject|1|||
13228342|NCT01746862|26304606|FG001|Overall Study|Withdrawal by Subject|1|||
13228343|NCT01746862|26304605|FG000|Overall Study|Protocol Violation|1|||
13228344|NCT01746862|26304606|FG001|Overall Study|Protocol Violation|0|||
13228345|NCT01746862|26304605|FG000|Overall Study|Consent withdrawal by parent's guardian|5|||
13228346|NCT01746862|26304606|FG001|Overall Study|Consent withdrawal by parent's guardian|2|||
13228347|NCT01746862|26304605|FG000|Overall Study|Entered puberty during the study|1|||
13228348|NCT01746862|26304606|FG001|Overall Study|Entered puberty during the study|0|||
13228349|NCT01746732|26304631|FG000|Lead-In Period|Withdrawal by Subject|1|||
13228350|NCT01746732|26304632|FG001|Lead-In Period|Withdrawal by Subject|0|||
13228351|NCT01746732|26304633|FG002|Lead-In Period|Withdrawal by Subject|0|||
13228352|NCT01746732|26304631|FG000|Period 1|Physician Decision|0|||
13228353|NCT01746732|26304632|FG001|Period 1|Physician Decision|1|||
13228354|NCT01746732|26304633|FG002|Period 1|Physician Decision|0|||
13228355|NCT01746732|26304631|FG000|Period 2|Withdrawal by Subject|0|||
13228356|NCT01746732|26304632|FG001|Period 2|Withdrawal by Subject|0|||
13228357|NCT01746732|26304633|FG002|Period 2|Withdrawal by Subject|2|||
13228358|NCT01746732|26304631|FG000|Period 2|Adverse Event|0|||
13228359|NCT01746732|26304632|FG001|Period 2|Adverse Event|0|||
13228360|NCT01746732|26304633|FG002|Period 2|Adverse Event|1|||
13228361|NCT01746732|26304631|FG000|Period 2|Lost to Follow-up|0|||
13228362|NCT01746732|26304632|FG001|Period 2|Lost to Follow-up|0|||
13228363|NCT01746732|26304633|FG002|Period 2|Lost to Follow-up|1|||
13228364|NCT01746368|26304648|FG000|Overall Study|Lost to Follow-up|2|||
13228365|NCT01746368|26304649|FG001|Overall Study|Lost to Follow-up|0|||
13228366|NCT01746368|26304648|FG000|Overall Study|Withdrawal by Subject|0|||
13228367|NCT01746368|26304649|FG001|Overall Study|Withdrawal by Subject|1|||
13228368|NCT01746225|26304682|FG000|Overall Study|Death|1|||
13228369|NCT01746225|26304683|FG001|Overall Study|Death|0|||
13228370|NCT01746225|26304684|FG002|Overall Study|Death|1|||
13228371|NCT01746225|26304682|FG000|Overall Study|Withdrawal by Subject|5|||
13228372|NCT01746225|26304683|FG001|Overall Study|Withdrawal by Subject|15|||
13228373|NCT01746225|26304684|FG002|Overall Study|Withdrawal by Subject|19|||
13228374|NCT01746225|26304682|FG000|Overall Study|Physician Decision|14|||
13228375|NCT01746225|26304683|FG001|Overall Study|Physician Decision|11|||
13228376|NCT01746225|26304684|FG002|Overall Study|Physician Decision|3|||
13228377|NCT01746225|26304682|FG000|Overall Study|Adverse Event|15|||
13228378|NCT01746225|26304683|FG001|Overall Study|Adverse Event|12|||
13228379|NCT01746225|26304684|FG002|Overall Study|Adverse Event|17|||
13228380|NCT01746225|26304682|FG000|Overall Study|Continuing Treatment|5|||
13228381|NCT01746225|26304683|FG001|Overall Study|Continuing Treatment|8|||
13228382|NCT01746225|26304684|FG002|Overall Study|Continuing Treatment|3|||
13228383|NCT01746108|26304730|FG000|Overall Study|Migrated /moved from study area|0|||
13228384|NCT01746108|26304731|FG001|Overall Study|Migrated /moved from study area|1|||
13228385|NCT01746108|26304732|FG002|Overall Study|Migrated /moved from study area|0|||
13228386|NCT01746108|26304730|FG000|Overall Study|Adverse event, non-fatal|0|||
13228387|NCT01746108|26304731|FG001|Overall Study|Adverse event, non-fatal|1|||
13228388|NCT01746108|26304732|FG002|Overall Study|Adverse event, non-fatal|0|||
13228389|NCT01746108|26304730|FG000|Overall Study|Withdrawal by Subject|0|||
13228390|NCT01746108|26304731|FG001|Overall Study|Withdrawal by Subject|1|||
13228391|NCT01746108|26304732|FG002|Overall Study|Withdrawal by Subject|0|||
13228392|NCT01746108|26304730|FG000|Overall Study|Lost to Follow-up|0|||
13228393|NCT01746108|26304731|FG001|Overall Study|Lost to Follow-up|1|||
13228394|NCT01746108|26304732|FG002|Overall Study|Lost to Follow-up|0|||
13228395|NCT01746017|26304842|FG000|Period 1|Withdrawal by Subject|0|||
13228396|NCT01746017|26304843|FG001|Period 1|Withdrawal by Subject|0|||
13228397|NCT01746017|26304844|FG002|Period 1|Withdrawal by Subject|0|||
13228398|NCT01746017|26304845|FG003|Period 1|Withdrawal by Subject|0|||
13228399|NCT01746017|26304846|FG004|Period 1|Withdrawal by Subject|0|||
13228400|NCT01746017|26304847|FG005|Period 1|Withdrawal by Subject|0|||
13228401|NCT01746017|26304848|FG006|Period 1|Withdrawal by Subject|1|||
13228402|NCT01746017|26304849|FG007|Period 1|Withdrawal by Subject|0|||
13228403|NCT01746017|26304850|FG008|Period 1|Withdrawal by Subject|0|||
13228404|NCT01746017|26304851|FG009|Period 1|Withdrawal by Subject|0|||
13228405|NCT01746017|26304852|FG010|Period 1|Withdrawal by Subject|0|||
13228406|NCT01746017|26304842|FG000|Period 3|Withdrawal by Subject|0|||
13228407|NCT01746017|26304843|FG001|Period 3|Withdrawal by Subject|0|||
13228408|NCT01746017|26304844|FG002|Period 3|Withdrawal by Subject|0|||
13228409|NCT01746017|26304845|FG003|Period 3|Withdrawal by Subject|0|||
13228410|NCT01746017|26304846|FG004|Period 3|Withdrawal by Subject|0|||
13228411|NCT01746017|26304847|FG005|Period 3|Withdrawal by Subject|1|||
13228412|NCT01746017|26304848|FG006|Period 3|Withdrawal by Subject|0|||
13228413|NCT01746017|26304849|FG007|Period 3|Withdrawal by Subject|0|||
13228414|NCT01746017|26304850|FG008|Period 3|Withdrawal by Subject|0|||
13228415|NCT01746017|26304851|FG009|Period 3|Withdrawal by Subject|0|||
13228416|NCT01746017|26304852|FG010|Period 3|Withdrawal by Subject|0|||
13228417|NCT01745848|26304859|FG000|Overall Study|Adverse Event|6|||
13228418|NCT01745393|26304876|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20|||
13228419|NCT01745393|26304877|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8|||
13228420|NCT01745393|26304876|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1|||
13228421|NCT01745393|26304877|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0|||
13228422|NCT01745393|26304876|FG000|12-month Follow-up|Lost to Follow-up|6|||
13228423|NCT01745393|26304877|FG001|12-month Follow-up|Lost to Follow-up|5|||
13228424|NCT01745380|26304920|FG000|Overall Study|Lost to Follow-up|1|||
13228425|NCT01745380|26304921|FG001|Overall Study|Lost to Follow-up|0|||
13228426|NCT01745380|26304920|FG000|Overall Study|Lack of Efficacy|0|||
13228427|NCT01745380|26304921|FG001|Overall Study|Lack of Efficacy|1|||
13228428|NCT01745367|26304946|FG000|Overall Study|Death|1|||
13228429|NCT01745367|26304947|FG001|Overall Study|Death|0|||
13228430|NCT01745367|26304946|FG000|Overall Study|Withdrawal by Subject|1|||
13228431|NCT01745367|26304947|FG001|Overall Study|Withdrawal by Subject|2|||
13228432|NCT01745367|26304946|FG000|Overall Study|Termination of The Study by The Sponsor|6|||
13228433|NCT01745367|26304947|FG001|Overall Study|Termination of The Study by The Sponsor|18|||
13228434|NCT01745367|26304946|FG000|Overall Study|Other Reasons Unspecified|0|||
13228435|NCT01745367|26304947|FG001|Overall Study|Other Reasons Unspecified|2|||
13228436|NCT01745146|26304961|FG000|Overall Study|Withdrawal by Subject|1|||
13228437|NCT01745146|26304962|FG001|Overall Study|Withdrawal by Subject|3|||
13228438|NCT01745146|26304961|FG000|Overall Study|Lost to Follow-up|2|||
13228439|NCT01745146|26304962|FG001|Overall Study|Lost to Follow-up|0|||
13228440|NCT01745120|26305023|FG000|Overall Study|Investigator decision|1|||
13228441|NCT01745120|26305024|FG001|Overall Study|Investigator decision|0|||
13228442|NCT01745094|26305103|FG000|Overall Study|Not Meeting the Eligibility Criteria|1|||
13228443|NCT01745094|26305104|FG001|Overall Study|Not Meeting the Eligibility Criteria|0|||
13228444|NCT01745094|26305105|FG002|Overall Study|Not Meeting the Eligibility Criteria|3|||
13228445|NCT01745094|26305106|FG003|Overall Study|Not Meeting the Eligibility Criteria|0|||
13228446|NCT01745094|26305103|FG000|Overall Study|Adverse Event|0|||
13228447|NCT01745094|26305104|FG001|Overall Study|Adverse Event|0|||
13228448|NCT01745094|26305105|FG002|Overall Study|Adverse Event|3|||
13228449|NCT01745094|26305106|FG003|Overall Study|Adverse Event|0|||
13228450|NCT01745094|26305103|FG000|Overall Study|Withdrawal by Subject|2|||
13228451|NCT01745094|26305104|FG001|Overall Study|Withdrawal by Subject|0|||
13228452|NCT01745094|26305105|FG002|Overall Study|Withdrawal by Subject|1|||
13228453|NCT01745094|26305106|FG003|Overall Study|Withdrawal by Subject|2|||
13228454|NCT01745094|26305103|FG000|Overall Study|Protocol Violation|1|||
13228455|NCT01745094|26305104|FG001|Overall Study|Protocol Violation|0|||
13228456|NCT01745094|26305105|FG002|Overall Study|Protocol Violation|3|||
13228457|NCT01745094|26305106|FG003|Overall Study|Protocol Violation|1|||
13228458|NCT01745094|26305103|FG000|Overall Study|Need Further Examinations Due to Biopsy|0|||
13228459|NCT01745094|26305104|FG001|Overall Study|Need Further Examinations Due to Biopsy|0|||
13228460|NCT01745094|26305105|FG002|Overall Study|Need Further Examinations Due to Biopsy|1|||
13228461|NCT01745094|26305106|FG003|Overall Study|Need Further Examinations Due to Biopsy|0|||
13228462|NCT01745094|26305103|FG000|Overall Study|Show no Stable Solifenacin Intake|0|||
13228463|NCT01745094|26305104|FG001|Overall Study|Show no Stable Solifenacin Intake|0|||
13228464|NCT01745094|26305105|FG002|Overall Study|Show no Stable Solifenacin Intake|1|||
13228465|NCT01745094|26305106|FG003|Overall Study|Show no Stable Solifenacin Intake|0|||
13228466|NCT01745094|26305103|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1|||
13228467|NCT01745094|26305104|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0|||
13228468|NCT01745094|26305105|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0|||
13228469|NCT01745094|26305106|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0|||
13228470|NCT01744977|26305121|FG000|Overall Study|Withdrawal by Subject|1|||
13228471|NCT01744977|26305122|FG001|Overall Study|Withdrawal by Subject|2|||
13228472|NCT01744977|26305121|FG000|Overall Study|Death|2|||
13228473|NCT01744977|26305122|FG001|Overall Study|Death|3|||
13228474|NCT01744977|26305121|FG000|Overall Study|Lost to Follow-up|2|||
13228475|NCT01744977|26305122|FG001|Overall Study|Lost to Follow-up|0|||
13228476|NCT01744977|26305121|FG000|Overall Study|No longer meets inclusion|6|||
13228477|NCT01744977|26305122|FG001|Overall Study|No longer meets inclusion|0|||
13228478|NCT01744782|26305132|FG000|Overall Study|Death|1|||
13228479|NCT01744691|26305139|FG000|Overall Study|Progressive Disease|18|||
13228480|NCT01744691|26305139|FG000|Overall Study|Unacceptable toxicity, AE or death|18|||
13228481|NCT01744691|26305139|FG000|Overall Study|Withdrawal of consent for treatment|3|||
13228482|NCT01744691|26305139|FG000|Overall Study|Physician Decision|4|||
13228483|NCT01744665|26305168|FG000|Monitoring Phase|Adverse Event|4|||
13228484|NCT01744665|26305168|FG000|Monitoring Phase|Abnormal laboratory value(s)|1|||
13228485|NCT01744665|26305168|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7|||
13228486|NCT01744665|26305168|FG000|Monitoring Phase|Withdrawal by Subject|5|||
13228487|NCT01744665|26305168|FG000|Monitoring Phase|Did not achieve MR4.5|1|||
13228488|NCT01744665|26305168|FG000|Consolidation Phase|Adverse Event|2|||
13228489|NCT01744665|26305168|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4|||
13228490|NCT01744665|26305168|FG000|Consolidation Phase|Withdrawal by Subject|4|||
13228491|NCT01744665|26305168|FG000|Consolidation Phase|Administrative problems|9|||
13228492|NCT01744665|26305168|FG000|Re-initiation Phase|Administrative problems|10|||
13228493|NCT01744665|26305168|FG000|Re-initiation Phase|Adverse Event|1|||
13228494|NCT01744665|26305168|FG000|Re-initiation Phase|No longer required treatment|1|||
13228495|NCT01744665|26305168|FG000|Re-initiation Phase|Withdrawal by Subject|1|||
13228496|NCT01744496|26305193|FG000|Titration Period|Adverse Event|2|||
13228497|NCT01744496|26305194|FG001|Titration Period|Adverse Event|1|||
13228498|NCT01744496|26305193|FG000|Titration Period|Personal reasons|0|||
13228499|NCT01744496|26305194|FG001|Titration Period|Personal reasons|1|||
13228500|NCT01744496|26305193|FG000|Maintenance Period|Adverse Event|1|||
13228501|NCT01744496|26305194|FG001|Maintenance Period|Adverse Event|3|||
13228502|NCT01744496|26305193|FG000|Maintenance Period|Protocol Violation|1|||
13228503|NCT01744496|26305194|FG001|Maintenance Period|Protocol Violation|0|||
13228504|NCT01744496|26305193|FG000|Maintenance Period|Withdrawal by Subject|1|||
13228505|NCT01744496|26305194|FG001|Maintenance Period|Withdrawal by Subject|1|||
13228506|NCT01744496|26305193|FG000|Maintenance Period|Subject left town|1|||
13228507|NCT01744496|26305194|FG001|Maintenance Period|Subject left town|0|||
13228508|NCT01744483|26305212|FG000|Overall Study|Death|9|||
13228509|NCT01744483|26305213|FG001|Overall Study|Death|4|||
13228510|NCT01744483|26305214|FG002|Overall Study|Death|11|||
13228511|NCT01744483|26305212|FG000|Overall Study|Lost to Follow-up|8|||
13228512|NCT01744483|26305213|FG001|Overall Study|Lost to Follow-up|9|||
13228513|NCT01744483|26305214|FG002|Overall Study|Lost to Follow-up|11|||
13228514|NCT01744483|26305212|FG000|Overall Study|Protocol Violation|1|||
13228515|NCT01744483|26305213|FG001|Overall Study|Protocol Violation|2|||
13228516|NCT01744483|26305214|FG002|Overall Study|Protocol Violation|1|||
13228517|NCT01744483|26305212|FG000|Overall Study|Withdrawal by Subject|4|||
13228518|NCT01744483|26305213|FG001|Overall Study|Withdrawal by Subject|6|||
13228519|NCT01744483|26305214|FG002|Overall Study|Withdrawal by Subject|2|||
13228520|NCT01744483|26305212|FG000|Overall Study|No ICU Admit|5|||
13228521|NCT01744483|26305213|FG001|Overall Study|No ICU Admit|1|||
13228522|NCT01744483|26305214|FG002|Overall Study|No ICU Admit|2|||
13228523|NCT01744483|26305212|FG000|Overall Study|Routed to OSH|2|||
13228524|NCT01744483|26305213|FG001|Overall Study|Routed to OSH|0|||
13228525|NCT01744483|26305214|FG002|Overall Study|Routed to OSH|1|||
13228526|NCT01744392|26305229|FG000|Overall Study|Physician Decision|1|||
13228527|NCT01744197|26305246|FG000|Overall Study|Received 1 patch|2|||
13228528|NCT01744197|26305247|FG001|Overall Study|Received 1 patch|1|||
13228529|NCT01744197|26305246|FG000|Overall Study|No patch received|2|||
13228530|NCT01744197|26305247|FG001|Overall Study|No patch received|2|||
13228531|NCT01744093|26305270|FG000|Overall Study|Withdrawal by Subject|6|||
13228532|NCT01744093|26305271|FG001|Overall Study|Withdrawal by Subject|1|||
13228533|NCT01743989|26305335|FG000|Treatment Phase|Unstable MR4.0|0|||
13228534|NCT01743989|26305336|FG001|Treatment Phase|Unstable MR4.0|6|||
13228535|NCT01743989|26305337|FG002|Treatment Phase|Unstable MR4.0|263|||
13228536|NCT01743989|26305335|FG000|Treatment Phase|Adverse Event|0|||
13228537|NCT01743989|26305336|FG001|Treatment Phase|Adverse Event|4|||
13228538|NCT01743989|26305337|FG002|Treatment Phase|Adverse Event|67|||
13228539|NCT01743989|26305335|FG000|Treatment Phase|Withdrawal by Subject|1|||
13228540|NCT01743989|26305336|FG001|Treatment Phase|Withdrawal by Subject|3|||
13228541|NCT01743989|26305337|FG002|Treatment Phase|Withdrawal by Subject|28|||
13228542|NCT01743989|26305335|FG000|Treatment Phase|Death|0|||
13228543|NCT01743989|26305336|FG001|Treatment Phase|Death|1|||
13228544|NCT01743989|26305337|FG002|Treatment Phase|Death|3|||
13228545|NCT01743989|26305335|FG000|Treatment Phase|Abnormal laboratory value(s)|0|||
13228546|NCT01743989|26305336|FG001|Treatment Phase|Abnormal laboratory value(s)|0|||
13228547|NCT01743989|26305337|FG002|Treatment Phase|Abnormal laboratory value(s)|3|||
13228548|NCT01743989|26305335|FG000|Treatment Phase|Protocol deviation|0|||
13228549|NCT01743989|26305336|FG001|Treatment Phase|Protocol deviation|0|||
13228550|NCT01743989|26305337|FG002|Treatment Phase|Protocol deviation|3|||
13228551|NCT01743989|26305335|FG000|Treatment Phase|Pregnancy|0|||
13228552|NCT01743989|26305336|FG001|Treatment Phase|Pregnancy|0|||
13228553|NCT01743989|26305337|FG002|Treatment Phase|Pregnancy|2|||
13228554|NCT01743989|26305335|FG000|Treatment Phase|Lost to Follow-up|0|||
13228555|NCT01743989|26305336|FG001|Treatment Phase|Lost to Follow-up|0|||
13228556|NCT01743989|26305337|FG002|Treatment Phase|Lost to Follow-up|2|||
13228557|NCT01743989|26305335|FG000|Treatment Phase|Abnormal test procedure result(s)|0|||
13228558|NCT01743989|26305336|FG001|Treatment Phase|Abnormal test procedure result(s)|0|||
13228559|NCT01743989|26305337|FG002|Treatment Phase|Abnormal test procedure result(s)|1|||
13228560|NCT01743989|26305335|FG000|Treatment Phase|Administrative problems|0|||
13228561|NCT01743989|26305336|FG001|Treatment Phase|Administrative problems|0|||
13228562|NCT01743989|26305337|FG002|Treatment Phase|Administrative problems|1|||
13228563|NCT01743989|26305335|FG000|Treatment Phase|New cancer (CML) therapy|0|||
13228564|NCT01743989|26305336|FG001|Treatment Phase|New cancer (CML) therapy|1|||
13228565|NCT01743989|26305337|FG002|Treatment Phase|New cancer (CML) therapy|0|||
13228566|NCT01743989|26305335|FG000|Treatment Phase|Physician Decision|0|||
13228567|NCT01743989|26305336|FG001|Treatment Phase|Physician Decision|0|||
13228568|NCT01743989|26305337|FG002|Treatment Phase|Physician Decision|3|||
13228569|NCT01743989|26305335|FG000|Treatment Phase|Patient non-compliance to treatment|0|||
13228570|NCT01743989|26305336|FG001|Treatment Phase|Patient non-compliance to treatment|0|||
13228571|NCT01743989|26305337|FG002|Treatment Phase|Patient non-compliance to treatment|3|||
13228572|NCT01743989|26305335|FG000|Treatment Phase|Not randomized by mistake|0|||
13228573|NCT01743989|26305336|FG001|Treatment Phase|Not randomized by mistake|0|||
13228574|NCT01743989|26305337|FG002|Treatment Phase|Not randomized by mistake|1|||
13228575|NCT01743989|26305335|FG000|Treatment Phase|Included by mistake|0|||
13228576|NCT01743989|26305336|FG001|Treatment Phase|Included by mistake|0|||
13228577|NCT01743989|26305337|FG002|Treatment Phase|Included by mistake|1|||
13228578|NCT01743989|26305335|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82|||
13228579|NCT01743989|26305336|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59|||
13228580|NCT01743989|26305337|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0|||
13228581|NCT01743989|26305335|FG000|TFR Phase|Adverse Event|0|||
13228582|NCT01743989|26305336|FG001|TFR Phase|Adverse Event|1|||
13228583|NCT01743989|26305337|FG002|TFR Phase|Adverse Event|0|||
13228584|NCT01743989|26305335|FG000|TFR Phase|Lost to Follow-up|0|||
13228585|NCT01743989|26305336|FG001|TFR Phase|Lost to Follow-up|2|||
13228586|NCT01743989|26305337|FG002|TFR Phase|Lost to Follow-up|0|||
13228587|NCT01743989|26305335|FG000|TFR Phase|Physician Decision|0|||
13228588|NCT01743989|26305336|FG001|TFR Phase|Physician Decision|1|||
13228589|NCT01743989|26305337|FG002|TFR Phase|Physician Decision|0|||
13228590|NCT01743989|26305335|FG000|TFR Phase|Logistical problems|0|||
13228591|NCT01743989|26305336|FG001|TFR Phase|Logistical problems|2|||
13228592|NCT01743989|26305337|FG002|TFR Phase|Logistical problems|0|||
13228593|NCT01743989|26305335|FG000|TFR Phase|Protocol deviation|0|||
13228594|NCT01743989|26305336|FG001|TFR Phase|Protocol deviation|1|||
13228595|NCT01743989|26305337|FG002|TFR Phase|Protocol deviation|0|||
13228596|NCT01743989|26305335|FG000|TFR Phase|Withdrawal by Subject|0|||
13228597|NCT01743989|26305336|FG001|TFR Phase|Withdrawal by Subject|2|||
13228598|NCT01743989|26305337|FG002|TFR Phase|Withdrawal by Subject|0|||
13228599|NCT01743989|26305335|FG000|Re-treatment Phase|Adverse Event|8|||
13228600|NCT01743989|26305336|FG001|Re-treatment Phase|Adverse Event|4|||
13228601|NCT01743989|26305337|FG002|Re-treatment Phase|Adverse Event|0|||
13228602|NCT01743989|26305335|FG000|Re-treatment Phase|Death|1|||
13228603|NCT01743989|26305336|FG001|Re-treatment Phase|Death|1|||
13228604|NCT01743989|26305337|FG002|Re-treatment Phase|Death|0|||
13228605|NCT01743989|26305335|FG000|Re-treatment Phase|Administrative problems|1|||
13228606|NCT01743989|26305336|FG001|Re-treatment Phase|Administrative problems|1|||
13228607|NCT01743989|26305337|FG002|Re-treatment Phase|Administrative problems|0|||
13228608|NCT01743989|26305335|FG000|Re-treatment Phase|Withdrawal by Subject|5|||
13228609|NCT01743989|26305336|FG001|Re-treatment Phase|Withdrawal by Subject|1|||
13228610|NCT01743989|26305337|FG002|Re-treatment Phase|Withdrawal by Subject|0|||
13228611|NCT01743989|26305335|FG000|Re-treatment Phase|Unstable MR|1|||
13228612|NCT01743989|26305336|FG001|Re-treatment Phase|Unstable MR|0|||
13228613|NCT01743989|26305337|FG002|Re-treatment Phase|Unstable MR|0|||
13228614|NCT01743989|26305335|FG000|Re-treatment Phase|Physician Decision|0|||
13228615|NCT01743989|26305336|FG001|Re-treatment Phase|Physician Decision|1|||
13228616|NCT01743989|26305337|FG002|Re-treatment Phase|Physician Decision|0|||
13228617|NCT01743989|26305335|FG000|Re-treatment Phase|Lost to Follow-up|0|||
13228618|NCT01743989|26305336|FG001|Re-treatment Phase|Lost to Follow-up|1|||
13228619|NCT01743989|26305337|FG002|Re-treatment Phase|Lost to Follow-up|0|||
13228620|NCT01743560|26305362|FG000|Overall Study|Disease progression|26|||
13228621|NCT01743560|26305362|FG000|Overall Study|Adverse Event|8|||
13228622|NCT01743560|26305362|FG000|Overall Study|Death|3|||
13228623|NCT01743560|26305362|FG000|Overall Study|Withdrawal by Subject|2|||
13228624|NCT01743560|26305362|FG000|Overall Study|Protocol Violation|1|||
13228625|NCT01743560|26305362|FG000|Overall Study|>1 dose of study drug|3|||
13228626|NCT01743469|26305413|FG000|Active Treatment Phase|Adverse Event|10|||
13228627|NCT01743469|26305414|FG001|Active Treatment Phase|Adverse Event|5|||
13228628|NCT01743469|26305415|FG002|Active Treatment Phase|Adverse Event|8|||
13228629|NCT01743469|26305416|FG003|Active Treatment Phase|Adverse Event|1|||
13228630|NCT01743469|26305413|FG000|Active Treatment Phase|Disease Progression|40|||
13228631|NCT01743469|26305414|FG001|Active Treatment Phase|Disease Progression|47|||
13228632|NCT01743469|26305415|FG002|Active Treatment Phase|Disease Progression|30|||
13228633|NCT01743469|26305416|FG003|Active Treatment Phase|Disease Progression|20|||
13228634|NCT01743469|26305413|FG000|Active Treatment Phase|Withdrawal by Subject|2|||
13228635|NCT01743469|26305414|FG001|Active Treatment Phase|Withdrawal by Subject|3|||
13228636|NCT01743469|26305415|FG002|Active Treatment Phase|Withdrawal by Subject|0|||
13228637|NCT01743469|26305416|FG003|Active Treatment Phase|Withdrawal by Subject|0|||
13228638|NCT01743469|26305413|FG000|Active Treatment Phase|Missing|1|||
13228639|NCT01743469|26305414|FG001|Active Treatment Phase|Missing|0|||
13228640|NCT01743469|26305415|FG002|Active Treatment Phase|Missing|0|||
13228641|NCT01743469|26305416|FG003|Active Treatment Phase|Missing|0|||
13228642|NCT01743469|26305413|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
13228643|NCT01743469|26305414|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
13228644|NCT01743469|26305415|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
13228645|NCT01743469|26305416|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
13228646|NCT01743469|26305413|FG000|Follow-up Period - Post-Treatment|Death|43|||
13228647|NCT01743469|26305414|FG001|Follow-up Period - Post-Treatment|Death|47|||
13228648|NCT01743469|26305415|FG002|Follow-up Period - Post-Treatment|Death|22|||
13228649|NCT01743469|26305416|FG003|Follow-up Period - Post-Treatment|Death|16|||
13228650|NCT01743469|26305413|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
13228651|NCT01743469|26305414|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
13228652|NCT01743469|26305415|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
13228653|NCT01743469|26305416|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
13228654|NCT01743092|26305431|FG000|Overall Study|Lost to Follow-up|14|||
13228655|NCT01743092|26305432|FG001|Overall Study|Lost to Follow-up|15|||
13228656|NCT01743040|26305438|FG000|Overall Study|Death|1|||
13228657|NCT01743040|26305438|FG000|Overall Study|Lost to Follow-up|66|||
13228658|NCT01743040|26305438|FG000|Overall Study|Physician Decision|40|||
13228659|NCT01743040|26305438|FG000|Overall Study|Protocol Violation|1|||
13228660|NCT01743040|26305438|FG000|Overall Study|Withdrawal by Subject|121|||
13228661|NCT01743027|26305489|FG000|Overall Study|Adverse Event|2|||
13228662|NCT01743027|26305490|FG001|Overall Study|Adverse Event|0|||
13228663|NCT01743027|26305491|FG002|Overall Study|Adverse Event|0|||
13228664|NCT01743027|26305492|FG003|Overall Study|Adverse Event|0|||
13228665|NCT01743027|26305489|FG000|Overall Study|Lost to Follow-up|0|||
13228666|NCT01743027|26305490|FG001|Overall Study|Lost to Follow-up|0|||
13228667|NCT01743027|26305491|FG002|Overall Study|Lost to Follow-up|2|||
13228668|NCT01743027|26305492|FG003|Overall Study|Lost to Follow-up|0|||
13228669|NCT01743027|26305489|FG000|Overall Study|Progressive Disease|1|||
13228670|NCT01743027|26305490|FG001|Overall Study|Progressive Disease|4|||
13228671|NCT01743027|26305491|FG002|Overall Study|Progressive Disease|3|||
13228672|NCT01743027|26305492|FG003|Overall Study|Progressive Disease|0|||
13228673|NCT01743027|26305489|FG000|Overall Study|Protocol Violation|1|||
13228674|NCT01743027|26305490|FG001|Overall Study|Protocol Violation|1|||
13133371|NCT02771210|25987551|FG000|Period 2|Adverse Event|1|||
13228675|NCT01743027|26305491|FG002|Overall Study|Protocol Violation|1|||
13228676|NCT01743027|26305492|FG003|Overall Study|Protocol Violation|0|||
13228677|NCT01743027|26305489|FG000|Overall Study|Withdrawal by Subject|1|||
13228678|NCT01743027|26305490|FG001|Overall Study|Withdrawal by Subject|0|||
13228679|NCT01743027|26305491|FG002|Overall Study|Withdrawal by Subject|3|||
13228680|NCT01743027|26305492|FG003|Overall Study|Withdrawal by Subject|1|||
13228681|NCT01743001|26305511|FG000|Overall Study|Physician Decision|1|||
13228682|NCT01743001|26305512|FG001|Overall Study|Physician Decision|0|||
13228683|NCT01743001|26305511|FG000|Overall Study|Pregnancy|1|||
13228684|NCT01743001|26305512|FG001|Overall Study|Pregnancy|0|||
13228685|NCT01743001|26305511|FG000|Overall Study|Death|1|||
13228686|NCT01743001|26305512|FG001|Overall Study|Death|0|||
13228687|NCT01742897|26305518|FG000|Overall Study|Adverse Event|3|||
13228688|NCT01742897|26305518|FG000|Overall Study|Withdrawal by Subject|1|||
13228689|NCT01742897|26305518|FG000|Overall Study|Other|1|||
13228690|NCT01742286|26305638|FG000|Escalation Phase|Administrative problems|1|||
13228691|NCT01742286|26305639|FG001|Escalation Phase|Administrative problems|1|||
13228692|NCT01742286|26305640|FG002|Escalation Phase|Administrative problems|0|||
13228693|NCT01742286|26305641|FG003|Escalation Phase|Administrative problems|0|||
13228694|NCT01742286|26305642|FG004|Escalation Phase|Administrative problems|0|||
13228695|NCT01742286|26305643|FG005|Escalation Phase|Administrative problems|0|||
13228696|NCT01742286|26305644|FG006|Escalation Phase|Administrative problems|2|||
13228697|NCT01742286|26305638|FG000|Escalation Phase|Adverse Event|0|||
13228698|NCT01742286|26305639|FG001|Escalation Phase|Adverse Event|1|||
13228699|NCT01742286|26305640|FG002|Escalation Phase|Adverse Event|2|||
13228700|NCT01742286|26305641|FG003|Escalation Phase|Adverse Event|0|||
13228701|NCT01742286|26305642|FG004|Escalation Phase|Adverse Event|0|||
13228702|NCT01742286|26305643|FG005|Escalation Phase|Adverse Event|1|||
13228703|NCT01742286|26305644|FG006|Escalation Phase|Adverse Event|0|||
13228704|NCT01742286|26305638|FG000|Escalation Phase|Disease progression|3|||
13228705|NCT01742286|26305639|FG001|Escalation Phase|Disease progression|7|||
13228706|NCT01742286|26305640|FG002|Escalation Phase|Disease progression|4|||
13228707|NCT01742286|26305641|FG003|Escalation Phase|Disease progression|1|||
13228708|NCT01742286|26305642|FG004|Escalation Phase|Disease progression|4|||
13228709|NCT01742286|26305643|FG005|Escalation Phase|Disease progression|3|||
13228710|NCT01742286|26305644|FG006|Escalation Phase|Disease progression|2|||
13228711|NCT01742286|26305638|FG000|Escalation Phase|Death|0|||
13228712|NCT01742286|26305639|FG001|Escalation Phase|Death|0|||
13228713|NCT01742286|26305640|FG002|Escalation Phase|Death|0|||
13228714|NCT01742286|26305641|FG003|Escalation Phase|Death|0|||
13228715|NCT01742286|26305642|FG004|Escalation Phase|Death|0|||
13228716|NCT01742286|26305643|FG005|Escalation Phase|Death|1|||
13228717|NCT01742286|26305644|FG006|Escalation Phase|Death|0|||
13228718|NCT01742286|26305638|FG000|Escalation Phase|Physician Decision|0|||
13228719|NCT01742286|26305639|FG001|Escalation Phase|Physician Decision|3|||
13228720|NCT01742286|26305640|FG002|Escalation Phase|Physician Decision|0|||
13228721|NCT01742286|26305641|FG003|Escalation Phase|Physician Decision|1|||
13228722|NCT01742286|26305642|FG004|Escalation Phase|Physician Decision|0|||
13228723|NCT01742286|26305643|FG005|Escalation Phase|Physician Decision|0|||
13228724|NCT01742286|26305644|FG006|Escalation Phase|Physician Decision|2|||
13228725|NCT01742286|26305638|FG000|Escalation Phase|Subject/guardian decision|1|||
13228726|NCT01742286|26305639|FG001|Escalation Phase|Subject/guardian decision|0|||
13228727|NCT01742286|26305640|FG002|Escalation Phase|Subject/guardian decision|0|||
13228728|NCT01742286|26305641|FG003|Escalation Phase|Subject/guardian decision|0|||
13228729|NCT01742286|26305642|FG004|Escalation Phase|Subject/guardian decision|0|||
13228730|NCT01742286|26305643|FG005|Escalation Phase|Subject/guardian decision|0|||
13228731|NCT01742286|26305644|FG006|Escalation Phase|Subject/guardian decision|0|||
13228732|NCT01742286|26305638|FG000|Expansion Phase|Administrative problems|0|||
13228733|NCT01742286|26305639|FG001|Expansion Phase|Administrative problems|0|||
13228734|NCT01742286|26305640|FG002|Expansion Phase|Administrative problems|0|||
13228735|NCT01742286|26305641|FG003|Expansion Phase|Administrative problems|0|||
13228736|NCT01742286|26305642|FG004|Expansion Phase|Administrative problems|0|||
13228737|NCT01742286|26305643|FG005|Expansion Phase|Administrative problems|0|||
13228738|NCT01742286|26305644|FG006|Expansion Phase|Administrative problems|5|||
13228739|NCT01742286|26305638|FG000|Expansion Phase|Physician Decision|0|||
13228740|NCT01742286|26305639|FG001|Expansion Phase|Physician Decision|0|||
13228741|NCT01742286|26305640|FG002|Expansion Phase|Physician Decision|4|||
13228742|NCT01742286|26305641|FG003|Expansion Phase|Physician Decision|0|||
13228743|NCT01742286|26305642|FG004|Expansion Phase|Physician Decision|0|||
13228744|NCT01742286|26305643|FG005|Expansion Phase|Physician Decision|0|||
13228745|NCT01742286|26305644|FG006|Expansion Phase|Physician Decision|9|||
13228746|NCT01742286|26305638|FG000|Expansion Phase|Adverse Event|0|||
13228747|NCT01742286|26305639|FG001|Expansion Phase|Adverse Event|0|||
13228748|NCT01742286|26305640|FG002|Expansion Phase|Adverse Event|0|||
13228749|NCT01742286|26305641|FG003|Expansion Phase|Adverse Event|0|||
13228750|NCT01742286|26305642|FG004|Expansion Phase|Adverse Event|0|||
13228751|NCT01742286|26305643|FG005|Expansion Phase|Adverse Event|0|||
13228752|NCT01742286|26305644|FG006|Expansion Phase|Adverse Event|6|||
13228753|NCT01742286|26305638|FG000|Expansion Phase|Disease progression|0|||
13228754|NCT01742286|26305639|FG001|Expansion Phase|Disease progression|0|||
13228755|NCT01742286|26305640|FG002|Expansion Phase|Disease progression|3|||
13228756|NCT01742286|26305641|FG003|Expansion Phase|Disease progression|0|||
13228757|NCT01742286|26305642|FG004|Expansion Phase|Disease progression|0|||
13228758|NCT01742286|26305643|FG005|Expansion Phase|Disease progression|0|||
13228759|NCT01742286|26305644|FG006|Expansion Phase|Disease progression|15|||
13228760|NCT01742286|26305638|FG000|Expansion Phase|Withdrawal by Subject|0|||
13228761|NCT01742286|26305639|FG001|Expansion Phase|Withdrawal by Subject|0|||
13228762|NCT01742286|26305640|FG002|Expansion Phase|Withdrawal by Subject|0|||
13228763|NCT01742286|26305641|FG003|Expansion Phase|Withdrawal by Subject|0|||
13228764|NCT01742286|26305642|FG004|Expansion Phase|Withdrawal by Subject|0|||
13228765|NCT01742286|26305643|FG005|Expansion Phase|Withdrawal by Subject|0|||
13228766|NCT01742286|26305644|FG006|Expansion Phase|Withdrawal by Subject|1|||
13228767|NCT01742091|26305700|FG000|Overall Study|Adverse Event|0|||
13228768|NCT01742091|26305701|FG001|Overall Study|Adverse Event|0|||
13228769|NCT01742091|26305702|FG002|Overall Study|Adverse Event|0|||
13228770|NCT01742091|26305703|FG003|Overall Study|Adverse Event|0|||
13228771|NCT01742091|26305704|FG004|Overall Study|Adverse Event|1|||
13228772|NCT01742091|26305705|FG005|Overall Study|Adverse Event|0|||
13228773|NCT01742091|26305700|FG000|Overall Study|Physician Decision|0|||
13228774|NCT01742091|26305701|FG001|Overall Study|Physician Decision|0|||
13228775|NCT01742091|26305702|FG002|Overall Study|Physician Decision|0|||
13228776|NCT01742091|26305703|FG003|Overall Study|Physician Decision|0|||
13228777|NCT01742091|26305704|FG004|Overall Study|Physician Decision|0|||
13228778|NCT01742091|26305705|FG005|Overall Study|Physician Decision|1|||
13228779|NCT01742091|26305700|FG000|Overall Study|Withdrawal by Subject|0|||
13228780|NCT01742091|26305701|FG001|Overall Study|Withdrawal by Subject|0|||
13228781|NCT01742091|26305702|FG002|Overall Study|Withdrawal by Subject|0|||
13228782|NCT01742091|26305703|FG003|Overall Study|Withdrawal by Subject|1|||
13228783|NCT01742091|26305704|FG004|Overall Study|Withdrawal by Subject|0|||
13228784|NCT01742091|26305705|FG005|Overall Study|Withdrawal by Subject|0|||
13228785|NCT01742091|26305700|FG000|Overall Study|Lost to Follow-up|0|||
13228786|NCT01742091|26305701|FG001|Overall Study|Lost to Follow-up|0|||
13228787|NCT01742091|26305702|FG002|Overall Study|Lost to Follow-up|0|||
13228788|NCT01742091|26305703|FG003|Overall Study|Lost to Follow-up|0|||
13228789|NCT01742091|26305704|FG004|Overall Study|Lost to Follow-up|0|||
13228790|NCT01742091|26305705|FG005|Overall Study|Lost to Follow-up|1|||
13228791|NCT01742078|26305788|FG000|Overall Study|Withdrawal by Subject|0|||
13228792|NCT01742078|26305789|FG001|Overall Study|Withdrawal by Subject|0|||
13228793|NCT01742078|26305790|FG002|Overall Study|Withdrawal by Subject|0|||
13228794|NCT01742078|26305791|FG003|Overall Study|Withdrawal by Subject|1|||
13228795|NCT01742078|26305792|FG004|Overall Study|Withdrawal by Subject|0|||
13228796|NCT01742078|26305793|FG005|Overall Study|Withdrawal by Subject|0|||
13228797|NCT01742078|26305794|FG006|Overall Study|Withdrawal by Subject|0|||
13228798|NCT01742078|26305795|FG007|Overall Study|Withdrawal by Subject|0|||
13228799|NCT01742078|26305796|FG008|Overall Study|Withdrawal by Subject|0|||
13228800|NCT01741792|26305871|FG000|Overall Study|Death|6|||
13228801|NCT01741792|26305872|FG001|Overall Study|Death|1|||
13228802|NCT01741792|26305873|FG002|Overall Study|Death|12|||
13228803|NCT01741701|26305896|FG000|Overall Study|Adverse Event|5|||
13228804|NCT01741701|26305897|FG001|Overall Study|Adverse Event|1|||
13228805|NCT01741701|26305896|FG000|Overall Study|Withdrawal by Subject|0|||
13228806|NCT01741701|26305897|FG001|Overall Study|Withdrawal by Subject|1|||
13228807|NCT01741688|26305916|FG000|Overall Study|Lack of insurance coverage|2|||
13228808|NCT01741688|26305916|FG000|Overall Study|Withdrawal by Subject|1|||
13228809|NCT01741545|26305945|FG000|Treatment Period|Lack of Efficacy|0|||
13228810|NCT01741545|26305946|FG001|Treatment Period|Lack of Efficacy|1|||
13228811|NCT01741545|26305945|FG000|Treatment Period|Adverse event, non-fatal|1|||
13228812|NCT01741545|26305946|FG001|Treatment Period|Adverse event, non-fatal|3|||
13228813|NCT01741545|26305945|FG000|Follow-up Period (24 Weeks)|Other than specified|0|||
13228814|NCT01741545|26305946|FG001|Follow-up Period (24 Weeks)|Other than specified|1|||
13228815|NCT01741545|26305945|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
13228816|NCT01741545|26305946|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
13228817|NCT01741532|26305973|FG000|Overall Study|Adverse Event|4|||
13228818|NCT01741532|26305974|FG001|Overall Study|Adverse Event|0|||
13228819|NCT01741532|26305973|FG000|Overall Study|Withdrawal by Subject|1|||
13228820|NCT01741532|26305974|FG001|Overall Study|Withdrawal by Subject|1|||
13228821|NCT01741532|26305973|FG000|Overall Study|Protocol Violation|0|||
13228822|NCT01741532|26305974|FG001|Overall Study|Protocol Violation|1|||
13228823|NCT01741532|26305973|FG000|Overall Study|Worsening of the disease|3|||
13228824|NCT01741532|26305974|FG001|Overall Study|Worsening of the disease|1|||
13228825|NCT01741532|26305973|FG000|Overall Study|Sponsor decision|1|||
13228826|NCT01741532|26305974|FG001|Overall Study|Sponsor decision|0|||
13228827|NCT01741532|26305973|FG000|Overall Study|Medical event|1|||
13228828|NCT01741532|26305974|FG001|Overall Study|Medical event|0|||
13228829|NCT01741259|26306035|FG000|Overall Study|Protocol Violation|6|||
13228830|NCT01741259|26306036|FG001|Overall Study|Protocol Violation|4|||
13228831|NCT01741259|26306035|FG000|Overall Study|Withdrawal by Subject|0|||
13228832|NCT01741259|26306036|FG001|Overall Study|Withdrawal by Subject|2|||
13228833|NCT01741012|26306045|FG000|Overall Study|Lost to Follow-up|1|||
13228834|NCT01741012|26306045|FG000|Overall Study|Withdrawal by Subject|2|||
13228835|NCT01740791|26306193|FG000|Overall Study|Randomized but never treated|5|||
13228836|NCT01740791|26306194|FG001|Overall Study|Randomized but never treated|3|||
13228837|NCT01740791|26306195|FG002|Overall Study|Randomized but never treated|2|||
13228838|NCT01740791|26306196|FG003|Overall Study|Randomized but never treated|2|||
13228839|NCT01740791|26306197|FG004|Overall Study|Randomized but never treated|1|||
13228840|NCT01740791|26306198|FG005|Overall Study|Randomized but never treated|3|||
13228841|NCT01740791|26306193|FG000|Overall Study|Lost to Follow-up|2|||
13228842|NCT01740791|26306194|FG001|Overall Study|Lost to Follow-up|0|||
13228843|NCT01740791|26306195|FG002|Overall Study|Lost to Follow-up|2|||
13228844|NCT01740791|26306196|FG003|Overall Study|Lost to Follow-up|3|||
13228845|NCT01740791|26306197|FG004|Overall Study|Lost to Follow-up|2|||
13228846|NCT01740791|26306198|FG005|Overall Study|Lost to Follow-up|3|||
13228847|NCT01740791|26306193|FG000|Overall Study|Withdrew Consent|4|||
13228848|NCT01740791|26306194|FG001|Overall Study|Withdrew Consent|0|||
13228849|NCT01740791|26306195|FG002|Overall Study|Withdrew Consent|1|||
13228850|NCT01740791|26306196|FG003|Overall Study|Withdrew Consent|2|||
13228851|NCT01740791|26306197|FG004|Overall Study|Withdrew Consent|0|||
13228852|NCT01740791|26306198|FG005|Overall Study|Withdrew Consent|3|||
13228853|NCT01740791|26306193|FG000|Overall Study|Investigator's discretion|1|||
13228854|NCT01740791|26306194|FG001|Overall Study|Investigator's discretion|0|||
13228855|NCT01740791|26306195|FG002|Overall Study|Investigator's discretion|1|||
13228856|NCT01740791|26306196|FG003|Overall Study|Investigator's discretion|0|||
13228857|NCT01740791|26306197|FG004|Overall Study|Investigator's discretion|0|||
13228858|NCT01740791|26306198|FG005|Overall Study|Investigator's discretion|1|||
13228859|NCT01740791|26306193|FG000|Overall Study|Adverse Event|0|||
13228860|NCT01740791|26306194|FG001|Overall Study|Adverse Event|0|||
13228861|NCT01740791|26306195|FG002|Overall Study|Adverse Event|0|||
13228862|NCT01740791|26306196|FG003|Overall Study|Adverse Event|0|||
13228863|NCT01740791|26306197|FG004|Overall Study|Adverse Event|0|||
13228864|NCT01740791|26306198|FG005|Overall Study|Adverse Event|1|||
13228865|NCT01740440|26306206|FG000|Overall Study|Lost to Follow-up|3|||
13289583|NCT00108082|26479701|FG002|Overall Study|Consent Withdrawn|5|||
13289584|NCT00108082|26479699|FG000|Overall Study|Protocol Violation|1|||
13289585|NCT00108082|26479700|FG001|Overall Study|Protocol Violation|2|||
13289586|NCT00108082|26479701|FG002|Overall Study|Protocol Violation|0|||
13289587|NCT00108082|26479699|FG000|Overall Study|Lack of Efficacy|3|||
13289588|NCT00108082|26479700|FG001|Overall Study|Lack of Efficacy|1|||
13289589|NCT00108082|26479701|FG002|Overall Study|Lack of Efficacy|2|||
13289590|NCT00108082|26479699|FG000|Overall Study|Amendment 4: > Month 12|5|||
13289591|NCT00108082|26479700|FG001|Overall Study|Amendment 4: > Month 12|7|||
13289592|NCT00108082|26479701|FG002|Overall Study|Amendment 4: > Month 12|5|||
13289593|NCT00108082|26479699|FG000|Overall Study|Woman of Child-bearing Potential|2|||
13289594|NCT00108082|26479700|FG001|Overall Study|Woman of Child-bearing Potential|0|||
13289595|NCT00108082|26479701|FG002|Overall Study|Woman of Child-bearing Potential|2|||
13289596|NCT00108082|26479699|FG000|Overall Study|Incorrectly Randomized|0|||
13289597|NCT00108082|26479700|FG001|Overall Study|Incorrectly Randomized|0|||
13289598|NCT00108082|26479701|FG002|Overall Study|Incorrectly Randomized|2|||
13289599|NCT00108082|26479699|FG000|Overall Study|Non-compliance|1|||
13289600|NCT00108082|26479700|FG001|Overall Study|Non-compliance|0|||
13289601|NCT00108082|26479701|FG002|Overall Study|Non-compliance|2|||
13289602|NCT00108082|26479699|FG000|Overall Study|Stopped Study Medication|0|||
13289603|NCT00108082|26479700|FG001|Overall Study|Stopped Study Medication|0|||
13289604|NCT00108082|26479701|FG002|Overall Study|Stopped Study Medication|1|||
13289605|NCT00108082|26479699|FG000|Overall Study|Site Closed Study|0|||
13289606|NCT00108082|26479700|FG001|Overall Study|Site Closed Study|2|||
13289607|NCT00108082|26479701|FG002|Overall Study|Site Closed Study|0|||
13289608|NCT00108082|26479699|FG000|Overall Study|Protocol Amendment|0|||
13289609|NCT00108082|26479700|FG001|Overall Study|Protocol Amendment|1|||
13289610|NCT00108082|26479701|FG002|Overall Study|Protocol Amendment|0|||
13289611|NCT00108082|26479699|FG000|Overall Study|Study Medication Not Tapered|0|||
13289612|NCT00108082|26479700|FG001|Overall Study|Study Medication Not Tapered|1|||
13289613|NCT00108082|26479701|FG002|Overall Study|Study Medication Not Tapered|0|||
13289614|NCT00108082|26479699|FG000|Overall Study|Subject Left Site Location|1|||
13289615|NCT00108082|26479700|FG001|Overall Study|Subject Left Site Location|0|||
13289616|NCT00108082|26479701|FG002|Overall Study|Subject Left Site Location|0|||
13289617|NCT00108082|26479699|FG000|Overall Study|Investigator Not at Site|1|||
13289618|NCT00108082|26479700|FG001|Overall Study|Investigator Not at Site|0|||
13289619|NCT00108082|26479701|FG002|Overall Study|Investigator Not at Site|0|||
13289620|NCT00108082|26479699|FG000|Overall Study|Blood Pressure Not Controlled|1|||
13289621|NCT00108082|26479700|FG001|Overall Study|Blood Pressure Not Controlled|0|||
13289622|NCT00108082|26479701|FG002|Overall Study|Blood Pressure Not Controlled|0|||
13289623|NCT00107991|26479711|FG000|Eligibility Assessment|Disease not severe enough|7|||
13289624|NCT00107991|26479711|FG000|Eligibility Assessment|Unwilling to participate|7|||
13228866|NCT01740401|26306215|FG000|Overall Study|Progression of disease|6|||
13228867|NCT01740401|26306215|FG000|Overall Study|Adverse Event|2|||
13228868|NCT01740401|26306215|FG000|Overall Study|Did not reach primary endpoint|2|||
13228869|NCT01740388|26306238|FG000|Overall Study|Withdrawal by Subject|1|||
13228870|NCT01740388|26306239|FG001|Overall Study|Withdrawal by Subject|2|||
13228871|NCT01740388|26306238|FG000|Overall Study|Lost to Follow-up|2|||
13228872|NCT01740388|26306239|FG001|Overall Study|Lost to Follow-up|0|||
13228873|NCT01740388|26306238|FG000|Overall Study|Physician Decision|2|||
13228874|NCT01740388|26306239|FG001|Overall Study|Physician Decision|6|||
13228875|NCT01740388|26306238|FG000|Overall Study|Subjects missing data, completed|41|||
13228876|NCT01740388|26306239|FG001|Overall Study|Subjects missing data, completed|36|||
13228877|NCT01740323|26306264|FG000|Overall Study|Adverse Event|1|||
13228878|NCT01740323|26306265|FG001|Overall Study|Adverse Event|0|||
13228879|NCT01740323|26306264|FG000|Overall Study|Randomized but did not take study drug|1|||
13228880|NCT01740323|26306265|FG001|Overall Study|Randomized but did not take study drug|0|||
13228881|NCT01740154|26306273|FG000|Overall Study|Adverse Event|1|||
13228882|NCT01740128|26306306|FG000|Overall Study|Pregnancy|0|||
13228883|NCT01740128|26306307|FG001|Overall Study|Pregnancy|1|||
13228884|NCT01740128|26306306|FG000|Overall Study|Protocol Violation|1|||
13228885|NCT01740128|26306307|FG001|Overall Study|Protocol Violation|2|||
13228886|NCT01740128|26306306|FG000|Overall Study|Lost to Follow-up|2|||
13228887|NCT01740128|26306307|FG001|Overall Study|Lost to Follow-up|2|||
13228888|NCT01740128|26306306|FG000|Overall Study|Withdrawal by Subject|1|||
13228889|NCT01740128|26306307|FG001|Overall Study|Withdrawal by Subject|0|||
13228890|NCT01740128|26306306|FG000|Overall Study|Insufficient protocol compliance|2|||
13228891|NCT01740128|26306307|FG001|Overall Study|Insufficient protocol compliance|2|||
13228892|NCT01740089|26306333|FG000|First 12 Weeks of Treatment|Adverse Event|0|||
13228893|NCT01740089|26306334|FG001|First 12 Weeks of Treatment|Adverse Event|1|||
13228894|NCT01740089|26306335|FG002|First 12 Weeks of Treatment|Adverse Event|2|||
13228895|NCT01740089|26306333|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
13228896|NCT01740089|26306334|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1|||
13228897|NCT01740089|26306335|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
13228898|NCT01740089|26306333|FG000|After 12 Weeks|Lack of Efficacy|3|||
13228899|NCT01740089|26306334|FG001|After 12 Weeks|Lack of Efficacy|1|||
13228900|NCT01740089|26306335|FG002|After 12 Weeks|Lack of Efficacy|4|||
13228901|NCT01740089|26306333|FG000|After 12 Weeks|Adverse Event|2|||
13228902|NCT01740089|26306334|FG001|After 12 Weeks|Adverse Event|0|||
13228903|NCT01740089|26306335|FG002|After 12 Weeks|Adverse Event|5|||
13228904|NCT01740089|26306333|FG000|After 12 Weeks|Protocol Violation|1|||
13228905|NCT01740089|26306334|FG001|After 12 Weeks|Protocol Violation|1|||
13228906|NCT01740089|26306335|FG002|After 12 Weeks|Protocol Violation|1|||
13228907|NCT01740089|26306333|FG000|After 12 Weeks|Withdrawal by Subject|1|||
13228908|NCT01740089|26306334|FG001|After 12 Weeks|Withdrawal by Subject|1|||
13228909|NCT01740089|26306335|FG002|After 12 Weeks|Withdrawal by Subject|1|||
13228910|NCT01739933|26306354|FG000|Overall Study|Death|89|||
13228911|NCT01739933|26306355|FG001|Overall Study|Death|86|||
13228912|NCT01739933|26306354|FG000|Overall Study|Withdrawal by Subject|10|||
13228913|NCT01739933|26306355|FG001|Overall Study|Withdrawal by Subject|8|||
13228914|NCT01739933|26306354|FG000|Overall Study|Lost to Follow-up|3|||
13228915|NCT01739933|26306355|FG001|Overall Study|Lost to Follow-up|10|||
13228916|NCT01739933|26306354|FG000|Overall Study|Did not speak English required for neurospychological testing|4|||
13228917|NCT01739933|26306355|FG001|Overall Study|Did not speak English required for neurospychological testing|3|||
13228918|NCT01739803|26306372|FG000|Overall Study|Lost to Follow-up|9|||
13228919|NCT01739803|26306373|FG001|Overall Study|Lost to Follow-up|6|||
13228920|NCT01739790|26306386|FG000|Overall Study|Early Trial Termination|2|||
13228921|NCT01739790|26306387|FG001|Overall Study|Early Trial Termination|4|||
13228922|NCT01739764|26306408|FG000|Overall Study|Adverse Event|0|||
13228923|NCT01739764|26306409|FG001|Overall Study|Adverse Event|3|||
13228924|NCT01739764|26306410|FG002|Overall Study|Adverse Event|4|||
13228925|NCT01739764|26306408|FG000|Overall Study|Death|4|||
13228926|NCT01739764|26306409|FG001|Overall Study|Death|6|||
13228927|NCT01739764|26306410|FG002|Overall Study|Death|38|||
13228928|NCT01739764|26306408|FG000|Overall Study|Lost to Follow-up|0|||
13228929|NCT01739764|26306409|FG001|Overall Study|Lost to Follow-up|0|||
13228930|NCT01739764|26306410|FG002|Overall Study|Lost to Follow-up|5|||
13228931|NCT01739764|26306408|FG000|Overall Study|Non-Compliance|0|||
13228932|NCT01739764|26306409|FG001|Overall Study|Non-Compliance|0|||
13228933|NCT01739764|26306410|FG002|Overall Study|Non-Compliance|1|||
13228934|NCT01739764|26306408|FG000|Overall Study|Multiple Reasons|3|||
13228935|NCT01739764|26306409|FG001|Overall Study|Multiple Reasons|2|||
13228936|NCT01739764|26306410|FG002|Overall Study|Multiple Reasons|3|||
13228937|NCT01739764|26306408|FG000|Overall Study|Physician Decision|2|||
13228938|NCT01739764|26306409|FG001|Overall Study|Physician Decision|2|||
13228939|NCT01739764|26306410|FG002|Overall Study|Physician Decision|4|||
13228940|NCT01739764|26306408|FG000|Overall Study|Progressive Disease|3|||
13228941|NCT01739764|26306409|FG001|Overall Study|Progressive Disease|5|||
13228942|NCT01739764|26306410|FG002|Overall Study|Progressive Disease|16|||
13228943|NCT01739764|26306408|FG000|Overall Study|Protocol Violation|0|||
13228944|NCT01739764|26306409|FG001|Overall Study|Protocol Violation|0|||
13228945|NCT01739764|26306410|FG002|Overall Study|Protocol Violation|2|||
13228946|NCT01739764|26306408|FG000|Overall Study|Study Terminated by Sponsor|8|||
13228947|NCT01739764|26306409|FG001|Overall Study|Study Terminated by Sponsor|13|||
13228948|NCT01739764|26306410|FG002|Overall Study|Study Terminated by Sponsor|26|||
13228949|NCT01739764|26306408|FG000|Overall Study|Withdrawal by Subject|6|||
13228950|NCT01739764|26306409|FG001|Overall Study|Withdrawal by Subject|5|||
13228951|NCT01739764|26306410|FG002|Overall Study|Withdrawal by Subject|27|||
13228952|NCT01739595|26306428|FG000|Overall Study|Adverse Event|3|||
13228953|NCT01739595|26306429|FG001|Overall Study|Adverse Event|0|||
13228954|NCT01739595|26306430|FG002|Overall Study|Adverse Event|0|||
13228955|NCT01739595|26306428|FG000|Overall Study|Lost to Follow-up|2|||
13228956|NCT01739595|26306429|FG001|Overall Study|Lost to Follow-up|0|||
13228957|NCT01739595|26306430|FG002|Overall Study|Lost to Follow-up|0|||
13228958|NCT01739595|26306428|FG000|Overall Study|Withdrawal by Subject|2|||
13115023|NCT03100058|25917336|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
13115024|NCT03100058|25917337|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
13115025|NCT03100058|25917338|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4|||
13115026|NCT03100058|25917339|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8|||
13115027|NCT03100058|25917340|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1|||
13115028|NCT03100058|25917341|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
13115029|NCT03100058|25917342|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3|||
13115030|NCT03100058|25917343|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11|||
13115031|NCT03100058|25917344|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2|||
13115032|NCT03100058|25917345|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
13115033|NCT03100058|25917346|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
13115034|NCT03100058|25917347|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
13228959|NCT01739595|26306429|FG001|Overall Study|Withdrawal by Subject|1|||
13228960|NCT01739595|26306430|FG002|Overall Study|Withdrawal by Subject|2|||
13228961|NCT01739595|26306428|FG000|Overall Study|Eligibility issue|3|||
13228962|NCT01739595|26306429|FG001|Overall Study|Eligibility issue|0|||
13228963|NCT01739595|26306430|FG002|Overall Study|Eligibility issue|0|||
13228964|NCT01739595|26306428|FG000|Overall Study|Protocol Violation|1|||
13228965|NCT01739595|26306429|FG001|Overall Study|Protocol Violation|0|||
13228966|NCT01739595|26306430|FG002|Overall Study|Protocol Violation|0|||
13228967|NCT01739595|26306428|FG000|Overall Study|Lab assessment|1|||
13228968|NCT01739595|26306429|FG001|Overall Study|Lab assessment|0|||
13228969|NCT01739595|26306430|FG002|Overall Study|Lab assessment|0|||
13228970|NCT01739595|26306428|FG000|Overall Study|Drug discrepancy|1|||
13228971|NCT01739595|26306429|FG001|Overall Study|Drug discrepancy|0|||
13228972|NCT01739595|26306430|FG002|Overall Study|Drug discrepancy|0|||
13228973|NCT01739400|26306448|FG000|Overall Study|Physician Decision|3|||
13228974|NCT01739400|26306449|FG001|Overall Study|Physician Decision|0|||
13228975|NCT01739400|26306448|FG000|Overall Study|Lost to Follow-up|2|||
13228976|NCT01739400|26306449|FG001|Overall Study|Lost to Follow-up|0|||
13228977|NCT01739400|26306448|FG000|Overall Study|Death|5|||
13228978|NCT01739400|26306449|FG001|Overall Study|Death|2|||
13133372|NCT02771210|25987552|FG001|Period 2|Adverse Event|0|||
13228979|NCT01739400|26306448|FG000|Overall Study|Withdrawal by Subject|7|||
13228980|NCT01739400|26306449|FG001|Overall Study|Withdrawal by Subject|7|||
13228981|NCT01739348|26306532|FG000|Part I (Base Study)|Adverse Event|41|||
13228982|NCT01739348|26306533|FG001|Part I (Base Study)|Adverse Event|52|||
13228983|NCT01739348|26306534|FG002|Part I (Base Study)|Adverse Event|8|||
13228984|NCT01739348|26306535|FG003|Part I (Base Study)|Adverse Event|33|||
13228985|NCT01739348|26306532|FG000|Part I (Base Study)|Death|10|||
13228986|NCT01739348|26306533|FG001|Part I (Base Study)|Death|7|||
13228987|NCT01739348|26306534|FG002|Part I (Base Study)|Death|2|||
13228988|NCT01739348|26306535|FG003|Part I (Base Study)|Death|8|||
13228989|NCT01739348|26306532|FG000|Part I (Base Study)|Lack of Efficacy|3|||
13228990|NCT01739348|26306533|FG001|Part I (Base Study)|Lack of Efficacy|8|||
13228991|NCT01739348|26306534|FG002|Part I (Base Study)|Lack of Efficacy|0|||
13228992|NCT01739348|26306535|FG003|Part I (Base Study)|Lack of Efficacy|7|||
13228993|NCT01739348|26306532|FG000|Part I (Base Study)|Lost to Follow-up|4|||
13228994|NCT01739348|26306533|FG001|Part I (Base Study)|Lost to Follow-up|2|||
13228995|NCT01739348|26306534|FG002|Part I (Base Study)|Lost to Follow-up|4|||
13228996|NCT01739348|26306535|FG003|Part I (Base Study)|Lost to Follow-up|4|||
13228997|NCT01739348|26306532|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3|||
13228998|NCT01739348|26306533|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2|||
13228999|NCT01739348|26306534|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0|||
13229000|NCT01739348|26306535|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0|||
13229001|NCT01739348|26306532|FG000|Part I (Base Study)|Physician Decision|10|||
13229002|NCT01739348|26306533|FG001|Part I (Base Study)|Physician Decision|7|||
13229003|NCT01739348|26306534|FG002|Part I (Base Study)|Physician Decision|1|||
13229004|NCT01739348|26306535|FG003|Part I (Base Study)|Physician Decision|4|||
13229005|NCT01739348|26306532|FG000|Part I (Base Study)|Protocol Violation|2|||
13229006|NCT01739348|26306533|FG001|Part I (Base Study)|Protocol Violation|0|||
13229007|NCT01739348|26306534|FG002|Part I (Base Study)|Protocol Violation|1|||
13229008|NCT01739348|26306535|FG003|Part I (Base Study)|Protocol Violation|2|||
13229009|NCT01739348|26306532|FG000|Part I (Base Study)|Screen Failure|2|||
13229010|NCT01739348|26306533|FG001|Part I (Base Study)|Screen Failure|0|||
13229011|NCT01739348|26306534|FG002|Part I (Base Study)|Screen Failure|0|||
13229012|NCT01739348|26306535|FG003|Part I (Base Study)|Screen Failure|0|||
13229013|NCT01739348|26306532|FG000|Part I (Base Study)|Site Discontinued Study Participation|1|||
13229014|NCT01739348|26306533|FG001|Part I (Base Study)|Site Discontinued Study Participation|3|||
13229015|NCT01739348|26306534|FG002|Part I (Base Study)|Site Discontinued Study Participation|0|||
13229016|NCT01739348|26306535|FG003|Part I (Base Study)|Site Discontinued Study Participation|0|||
13229017|NCT01739348|26306532|FG000|Part I (Base Study)|Study Terminated by Sponsor|72|||
13229018|NCT01739348|26306533|FG001|Part I (Base Study)|Study Terminated by Sponsor|73|||
13229019|NCT01739348|26306534|FG002|Part I (Base Study)|Study Terminated by Sponsor|0|||
13229020|NCT01739348|26306535|FG003|Part I (Base Study)|Study Terminated by Sponsor|86|||
13229021|NCT01739348|26306532|FG000|Part I (Base Study)|Participant Moved|4|||
13229022|NCT01739348|26306533|FG001|Part I (Base Study)|Participant Moved|3|||
13229023|NCT01739348|26306534|FG002|Part I (Base Study)|Participant Moved|1|||
13229024|NCT01739348|26306535|FG003|Part I (Base Study)|Participant Moved|7|||
13229025|NCT01739348|26306532|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27|||
13229026|NCT01739348|26306533|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25|||
13229027|NCT01739348|26306534|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2|||
13229028|NCT01739348|26306535|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18|||
13229029|NCT01739348|26306532|FG000|Part I (Base Study)|Withdrawal by Subject|23|||
13229030|NCT01739348|26306533|FG001|Part I (Base Study)|Withdrawal by Subject|21|||
13229031|NCT01739348|26306534|FG002|Part I (Base Study)|Withdrawal by Subject|7|||
13115035|NCT03100058|25917348|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
13229032|NCT01739348|26306535|FG003|Part I (Base Study)|Withdrawal by Subject|20|||
13229033|NCT01739348|26306532|FG000|Part II (Extension Study)|Adverse Event|10|||
13229034|NCT01739348|26306533|FG001|Part II (Extension Study)|Adverse Event|11|||
13115036|NCT03100058|25917336|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
13115037|NCT03100058|25917337|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
13115038|NCT03100058|25917338|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3|||
13115039|NCT03100058|25917339|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
13115040|NCT03100058|25917340|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
13115041|NCT03100058|25917341|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
13115042|NCT03100058|25917342|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
13115043|NCT03100058|25917343|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
13115044|NCT03100058|25917344|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
13115045|NCT03100058|25917345|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
13115046|NCT03100058|25917346|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
13229035|NCT01739348|26306534|FG002|Part II (Extension Study)|Adverse Event|7|||
13229036|NCT01739348|26306535|FG003|Part II (Extension Study)|Adverse Event|26|||
13229037|NCT01739348|26306532|FG000|Part II (Extension Study)|Death|3|||
13229038|NCT01739348|26306533|FG001|Part II (Extension Study)|Death|3|||
13229039|NCT01739348|26306534|FG002|Part II (Extension Study)|Death|2|||
13229040|NCT01739348|26306535|FG003|Part II (Extension Study)|Death|6|||
13229041|NCT01739348|26306532|FG000|Part II (Extension Study)|Lack of Efficacy|1|||
13229042|NCT01739348|26306533|FG001|Part II (Extension Study)|Lack of Efficacy|5|||
13229043|NCT01739348|26306534|FG002|Part II (Extension Study)|Lack of Efficacy|0|||
13229044|NCT01739348|26306535|FG003|Part II (Extension Study)|Lack of Efficacy|1|||
13229045|NCT01739348|26306532|FG000|Part II (Extension Study)|Lost to Follow-up|3|||
13229046|NCT01739348|26306533|FG001|Part II (Extension Study)|Lost to Follow-up|4|||
13229047|NCT01739348|26306534|FG002|Part II (Extension Study)|Lost to Follow-up|0|||
13229048|NCT01739348|26306535|FG003|Part II (Extension Study)|Lost to Follow-up|1|||
13229049|NCT01739348|26306532|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
13229050|NCT01739348|26306533|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
13229051|NCT01739348|26306534|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
13229052|NCT01739348|26306535|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1|||
13229053|NCT01739348|26306532|FG000|Part II (Extension Study)|Physician Decision|7|||
13229054|NCT01739348|26306533|FG001|Part II (Extension Study)|Physician Decision|11|||
13229055|NCT01739348|26306534|FG002|Part II (Extension Study)|Physician Decision|6|||
13229056|NCT01739348|26306535|FG003|Part II (Extension Study)|Physician Decision|12|||
13229057|NCT01739348|26306532|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329|||
13229058|NCT01739348|26306533|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315|||
13229059|NCT01739348|26306534|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34|||
13229060|NCT01739348|26306535|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323|||
13229061|NCT01739348|26306532|FG000|Part II (Extension Study)|Participant Moved|3|||
13229062|NCT01739348|26306533|FG001|Part II (Extension Study)|Participant Moved|3|||
13229063|NCT01739348|26306534|FG002|Part II (Extension Study)|Participant Moved|0|||
13229064|NCT01739348|26306535|FG003|Part II (Extension Study)|Participant Moved|3|||
13229065|NCT01739348|26306532|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18|||
13229066|NCT01739348|26306533|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12|||
13229067|NCT01739348|26306534|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8|||
13229068|NCT01739348|26306535|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16|||
13229069|NCT01739348|26306532|FG000|Part II (Extension Study)|Withdrawal by Subject|5|||
13229070|NCT01739348|26306533|FG001|Part II (Extension Study)|Withdrawal by Subject|2|||
13229071|NCT01739348|26306534|FG002|Part II (Extension Study)|Withdrawal by Subject|4|||
13229072|NCT01739348|26306535|FG003|Part II (Extension Study)|Withdrawal by Subject|7|||
13229073|NCT01739335|26306574|FG000|Overall Study|Lost to Follow-up|7|||
13229074|NCT01739335|26306575|FG001|Overall Study|Lost to Follow-up|4|||
13229075|NCT01739335|26306574|FG000|Overall Study|Ineligible patient randomized|0|||
13229076|NCT01739335|26306575|FG001|Overall Study|Ineligible patient randomized|1|||
13229077|NCT01739309|26306594|FG000|Overall Study|On study treatment|3|||
13229078|NCT01738984|26306611|FG000|Overall Study|Pregnancy|4|||
13229079|NCT01738984|26306612|FG001|Overall Study|Pregnancy|0|||
13229080|NCT01738984|26306611|FG000|Overall Study|Withdrawal by Subject|1|||
13229081|NCT01738984|26306612|FG001|Overall Study|Withdrawal by Subject|0|||
13229082|NCT01738984|26306611|FG000|Overall Study|Lost to Follow-up|59|||
13229083|NCT01738984|26306612|FG001|Overall Study|Lost to Follow-up|39|||
13229084|NCT01738971|26306636|FG000|Overall Study|Lost to Follow-up|19|||
13229085|NCT01738971|26306637|FG001|Overall Study|Lost to Follow-up|30|||
13229086|NCT01738971|26306638|FG002|Overall Study|Lost to Follow-up|17|||
13229087|NCT01738919|26306661|FG000|Overall Study|Lost to Follow-up|1|||
13229088|NCT01738919|26306662|FG001|Overall Study|Lost to Follow-up|0|||
13229089|NCT01738919|26306661|FG000|Overall Study|Immigrated|0|||
13229090|NCT01738919|26306662|FG001|Overall Study|Immigrated|1|||
13229091|NCT01738919|26306661|FG000|Overall Study|Withdrawal by Subject|0|||
13229092|NCT01738919|26306662|FG001|Overall Study|Withdrawal by Subject|1|||
13229093|NCT01738919|26306661|FG000|Overall Study|Not treated in accordance to guidelines|0|||
13229094|NCT01738919|26306662|FG001|Overall Study|Not treated in accordance to guidelines|1|||
13229095|NCT01738646|26306672|FG000|Overall Study|Still Receiving Treatment|2|||
13229096|NCT01738594|26306703|FG000|Registration and Treatment Start|Adverse Event|0|||
13229097|NCT01738594|26306704|FG001|Registration and Treatment Start|Adverse Event|1|||
13229098|NCT01738594|26306705|FG002|Registration and Treatment Start|Adverse Event|0|||
13229099|NCT01738594|26306706|FG003|Registration and Treatment Start|Adverse Event|0|||
13229100|NCT01738594|26306707|FG004|Registration and Treatment Start|Adverse Event|0|||
13229101|NCT01738594|26306708|FG005|Registration and Treatment Start|Adverse Event|0|||
13229102|NCT01738594|26306709|FG006|Registration and Treatment Start|Adverse Event|0|||
13229103|NCT01738594|26306710|FG007|Registration and Treatment Start|Adverse Event|0|||
13229104|NCT01738594|26306703|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
13229105|NCT01738594|26306704|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
13229106|NCT01738594|26306705|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
13229107|NCT01738594|26306706|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
13229108|NCT01738594|26306707|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
13229109|NCT01738594|26306708|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1|||
13229110|NCT01738594|26306709|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
13229111|NCT01738594|26306710|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
13229112|NCT01738594|26306703|FG000|Completed 4 Cycles of Treatment|Progressive disease|0|||
13229113|NCT01738594|26306704|FG001|Completed 4 Cycles of Treatment|Progressive disease|2|||
13229114|NCT01738594|26306705|FG002|Completed 4 Cycles of Treatment|Progressive disease|0|||
13229115|NCT01738594|26306706|FG003|Completed 4 Cycles of Treatment|Progressive disease|0|||
13229116|NCT01738594|26306707|FG004|Completed 4 Cycles of Treatment|Progressive disease|0|||
13229117|NCT01738594|26306708|FG005|Completed 4 Cycles of Treatment|Progressive disease|0|||
13229118|NCT01738594|26306709|FG006|Completed 4 Cycles of Treatment|Progressive disease|0|||
13229119|NCT01738594|26306710|FG007|Completed 4 Cycles of Treatment|Progressive disease|0|||
13229120|NCT01738594|26306703|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
13229121|NCT01738594|26306704|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
13229122|NCT01738594|26306705|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
13229123|NCT01738594|26306706|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
13229124|NCT01738594|26306707|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
13229125|NCT01738594|26306708|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1|||
13229126|NCT01738594|26306709|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
13229127|NCT01738594|26306710|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
13229128|NCT01738594|26306703|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
13229129|NCT01738594|26306704|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
13229130|NCT01738594|26306705|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
13229131|NCT01738594|26306706|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
13229132|NCT01738594|26306707|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
13229133|NCT01738594|26306708|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1|||
13229134|NCT01738594|26306709|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
13229135|NCT01738594|26306710|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
13229136|NCT01738594|26306703|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
13229137|NCT01738594|26306704|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
13229138|NCT01738594|26306705|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
13229139|NCT01738594|26306706|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
13229140|NCT01738594|26306707|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1|||
13229141|NCT01738594|26306708|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
13229142|NCT01738594|26306709|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
13229143|NCT01738594|26306710|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
13229144|NCT01738594|26306703|FG000|Follow up for 1 Year|Death|0|||
13229145|NCT01738594|26306704|FG001|Follow up for 1 Year|Death|0|||
13229146|NCT01738594|26306705|FG002|Follow up for 1 Year|Death|0|||
13229147|NCT01738594|26306706|FG003|Follow up for 1 Year|Death|0|||
13229148|NCT01738594|26306707|FG004|Follow up for 1 Year|Death|0|||
13229149|NCT01738594|26306708|FG005|Follow up for 1 Year|Death|1|||
13229150|NCT01738594|26306709|FG006|Follow up for 1 Year|Death|0|||
13229151|NCT01738594|26306710|FG007|Follow up for 1 Year|Death|0|||
13229152|NCT01738594|26306703|FG000|Follow up for 1 Year|Other|0|||
13229153|NCT01738594|26306704|FG001|Follow up for 1 Year|Other|0|||
13229154|NCT01738594|26306705|FG002|Follow up for 1 Year|Other|0|||
13229155|NCT01738594|26306706|FG003|Follow up for 1 Year|Other|0|||
13229156|NCT01738594|26306707|FG004|Follow up for 1 Year|Other|0|||
13229157|NCT01738594|26306708|FG005|Follow up for 1 Year|Other|2|||
13229158|NCT01738594|26306709|FG006|Follow up for 1 Year|Other|0|||
13229159|NCT01738594|26306710|FG007|Follow up for 1 Year|Other|0|||
13229160|NCT01738581|26306735|FG000|Overall Study|Lost to Follow-up|1|||
13229161|NCT01738581|26306736|FG001|Overall Study|Lost to Follow-up|0|||
13229162|NCT01738503|26306952|FG000|Induction/Stabilization (Days -14 to -1)|Other|35|||
13229163|NCT01738503|26306953|FG001|Induction/Stabilization (Days -14 to -1)|Other|0|||
13229164|NCT01738503|26306954|FG002|Induction/Stabilization (Days -14 to -1)|Other|0|||
13229165|NCT01738503|26306955|FG003|Induction/Stabilization (Days -14 to -1)|Other|0|||
13229166|NCT01738503|26306956|FG004|Induction/Stabilization (Days -14 to -1)|Other|0|||
13229167|NCT01738503|26306957|FG005|Induction/Stabilization (Days -14 to -1)|Other|0|||
13229168|NCT01738503|26306958|FG006|Induction/Stabilization (Days -14 to -1)|Other|0|||
13229169|NCT01738503|26306952|FG000|Treatment Period|Adverse Event|0|||
13229170|NCT01738503|26306953|FG001|Treatment Period|Adverse Event|1|||
13229171|NCT01738503|26306954|FG002|Treatment Period|Adverse Event|0|||
13229172|NCT01738503|26306955|FG003|Treatment Period|Adverse Event|1|||
13229173|NCT01738503|26306956|FG004|Treatment Period|Adverse Event|2|||
13229174|NCT01738503|26306957|FG005|Treatment Period|Adverse Event|2|||
13229175|NCT01738503|26306958|FG006|Treatment Period|Adverse Event|2|||
13229176|NCT01738503|26306952|FG000|Treatment Period|Lost to Follow-up|0|||
13229177|NCT01738503|26306953|FG001|Treatment Period|Lost to Follow-up|0|||
13229178|NCT01738503|26306954|FG002|Treatment Period|Lost to Follow-up|3|||
13229179|NCT01738503|26306955|FG003|Treatment Period|Lost to Follow-up|4|||
13229180|NCT01738503|26306956|FG004|Treatment Period|Lost to Follow-up|1|||
13229181|NCT01738503|26306957|FG005|Treatment Period|Lost to Follow-up|1|||
13229182|NCT01738503|26306958|FG006|Treatment Period|Lost to Follow-up|5|||
13229183|NCT01738503|26306952|FG000|Treatment Period|Withdrawal by Subject|0|||
13229184|NCT01738503|26306953|FG001|Treatment Period|Withdrawal by Subject|1|||
13229185|NCT01738503|26306954|FG002|Treatment Period|Withdrawal by Subject|0|||
13229186|NCT01738503|26306955|FG003|Treatment Period|Withdrawal by Subject|1|||
13229187|NCT01738503|26306956|FG004|Treatment Period|Withdrawal by Subject|1|||
13229188|NCT01738503|26306957|FG005|Treatment Period|Withdrawal by Subject|1|||
13229189|NCT01738503|26306958|FG006|Treatment Period|Withdrawal by Subject|1|||
13229190|NCT01738503|26306952|FG000|Treatment Period|Protocol Violation|0|||
13229191|NCT01738503|26306953|FG001|Treatment Period|Protocol Violation|3|||
13229192|NCT01738503|26306954|FG002|Treatment Period|Protocol Violation|1|||
13229193|NCT01738503|26306955|FG003|Treatment Period|Protocol Violation|0|||
13229194|NCT01738503|26306956|FG004|Treatment Period|Protocol Violation|4|||
13229195|NCT01738503|26306957|FG005|Treatment Period|Protocol Violation|2|||
13229196|NCT01738503|26306958|FG006|Treatment Period|Protocol Violation|0|||
13229197|NCT01738503|26306952|FG000|Treatment Period|Other|0|||
13229198|NCT01738503|26306953|FG001|Treatment Period|Other|0|||
13229199|NCT01738503|26306954|FG002|Treatment Period|Other|1|||
13229200|NCT01738503|26306955|FG003|Treatment Period|Other|0|||
13229201|NCT01738503|26306956|FG004|Treatment Period|Other|0|||
13229202|NCT01738503|26306957|FG005|Treatment Period|Other|0|||
13229203|NCT01738503|26306958|FG006|Treatment Period|Other|0|||
13229204|NCT01738503|26306952|FG000|PET Imaging Sub-study|Adverse Event|0|||
13229205|NCT01738503|26306953|FG001|PET Imaging Sub-study|Adverse Event|0|||
13229206|NCT01738503|26306954|FG002|PET Imaging Sub-study|Adverse Event|0|||
13229207|NCT01738503|26306955|FG003|PET Imaging Sub-study|Adverse Event|0|||
13229208|NCT01738503|26306956|FG004|PET Imaging Sub-study|Adverse Event|0|||
13229209|NCT01738503|26306957|FG005|PET Imaging Sub-study|Adverse Event|1|||
13229210|NCT01738503|26306958|FG006|PET Imaging Sub-study|Adverse Event|0|||
13229211|NCT01738503|26306952|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
13229212|NCT01738503|26306953|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
13229213|NCT01738503|26306954|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
13229214|NCT01738503|26306955|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
13229215|NCT01738503|26306956|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
13229216|NCT01738503|26306957|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
13229217|NCT01738503|26306958|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
13229218|NCT01738477|26306993|FG000|Overall Study|Lost to Follow-up|1|||
13229219|NCT01738477|26306994|FG001|Overall Study|Lost to Follow-up|4|||
13229220|NCT01738438|26307002|FG000|Overall Study|Disease Progression|32|||
13229221|NCT01738438|26307002|FG000|Overall Study|Adverse Event|3|||
13229222|NCT01738191|26307029|FG000|Overall Study|Withdrawal by Subject|4|||
13229223|NCT01738191|26307030|FG001|Overall Study|Withdrawal by Subject|1|||
13229224|NCT01737996|26307077|FG000|Overall Study|Adverse Event|0|||
13229225|NCT01737996|26307078|FG001|Overall Study|Adverse Event|1|||
13229226|NCT01737996|26307079|FG002|Overall Study|Adverse Event|1|||
13229227|NCT01737996|26307077|FG000|Overall Study|Withdrawal by Subject|0|||
13229228|NCT01737996|26307078|FG001|Overall Study|Withdrawal by Subject|0|||
13229229|NCT01737996|26307079|FG002|Overall Study|Withdrawal by Subject|1|||
13229230|NCT01737931|26307104|FG000|Overall Study|Withdrawal by Subject|0|||
13229231|NCT01737931|26307105|FG001|Overall Study|Withdrawal by Subject|1|||
13229232|NCT01737931|26307106|FG002|Overall Study|Withdrawal by Subject|1|||
13229233|NCT01737931|26307104|FG000|Overall Study|Physician Decision|0|||
13229234|NCT01737931|26307105|FG001|Overall Study|Physician Decision|1|||
13229235|NCT01737931|26307106|FG002|Overall Study|Physician Decision|0|||
13229236|NCT01737879|26307115|FG000|Overall Study|Death|1|||
13229237|NCT01737879|26307115|FG000|Overall Study|Sponsor decision|40|||
13229238|NCT01737840|26307130|FG000|Overall Study|Diagnosed with an other pathology|2|||
13229239|NCT01737840|26307131|FG001|Overall Study|Diagnosed with an other pathology|2|||
13229240|NCT01737762|26307146|FG000|Overall Study|Adverse Event|2|||
13229241|NCT01737762|26307147|FG001|Overall Study|Adverse Event|2|||
13229242|NCT01737762|26307146|FG000|Overall Study|Lost to Follow-up|1|||
13229243|NCT01737762|26307147|FG001|Overall Study|Lost to Follow-up|0|||
13229244|NCT01737762|26307146|FG000|Overall Study|Withdrawal by Subject|2|||
13229245|NCT01737762|26307147|FG001|Overall Study|Withdrawal by Subject|2|||
13229246|NCT01737762|26307146|FG000|Overall Study|Progressive disease|1|||
13229247|NCT01737762|26307147|FG001|Overall Study|Progressive disease|2|||
13229248|NCT01737762|26307146|FG000|Overall Study|Physician Decision|1|||
13229249|NCT01737762|26307147|FG001|Overall Study|Physician Decision|1|||
13229250|NCT01737762|26307146|FG000|Overall Study|Moved from area|2|||
13229251|NCT01737762|26307147|FG001|Overall Study|Moved from area|1|||
13229252|NCT01737762|26307146|FG000|Overall Study|Trial termination|11|||
13229253|NCT01737762|26307147|FG001|Overall Study|Trial termination|9|||
13229254|NCT01737710|26307200|FG000|Overall Study|Lost to Follow-up|0|||
13229255|NCT01737710|26307201|FG001|Overall Study|Lost to Follow-up|2|||
13229256|NCT01737710|26307202|FG002|Overall Study|Lost to Follow-up|2|||
13229257|NCT01737710|26307203|FG003|Overall Study|Lost to Follow-up|0|||
13229258|NCT01737710|26307204|FG004|Overall Study|Lost to Follow-up|0|||
13229259|NCT01737710|26307200|FG000|Overall Study|Withdrawal by Subject|1|||
13229260|NCT01737710|26307201|FG001|Overall Study|Withdrawal by Subject|1|||
13229261|NCT01737710|26307202|FG002|Overall Study|Withdrawal by Subject|1|||
13229262|NCT01737710|26307203|FG003|Overall Study|Withdrawal by Subject|0|||
13229263|NCT01737710|26307204|FG004|Overall Study|Withdrawal by Subject|0|||
13229264|NCT01737710|26307200|FG000|Overall Study|Vaccinated in Error/Ineligible|1|||
13229265|NCT01737710|26307201|FG001|Overall Study|Vaccinated in Error/Ineligible|1|||
13229266|NCT01737710|26307202|FG002|Overall Study|Vaccinated in Error/Ineligible|0|||
13229267|NCT01737710|26307203|FG003|Overall Study|Vaccinated in Error/Ineligible|0|||
13229268|NCT01737710|26307204|FG004|Overall Study|Vaccinated in Error/Ineligible|0|||
13229269|NCT01737697|26307317|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0|||
13229270|NCT01737697|26307318|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1|||
13229271|NCT01737697|26307319|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0|||
13229272|NCT01737697|26307320|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1|||
13229273|NCT01737697|26307321|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1|||
13229274|NCT01737697|26307322|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0|||
13229275|NCT01737697|26307323|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0|||
13229276|NCT01737697|26307324|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0|||
13229277|NCT01737697|26307325|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0|||
13229278|NCT01737697|26307326|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0|||
13229279|NCT01737697|26307327|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0|||
13229280|NCT01737697|26307328|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0|||
13229281|NCT01737697|26307329|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0|||
13229282|NCT01737697|26307330|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0|||
13229283|NCT01737697|26307331|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0|||
13229284|NCT01737697|26307317|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
13229285|NCT01737697|26307318|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
13229286|NCT01737697|26307319|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3|||
13229287|NCT01737697|26307320|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
13229288|NCT01737697|26307321|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
13229289|NCT01737697|26307322|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
13229290|NCT01737697|26307323|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
13229291|NCT01737697|26307324|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
13229292|NCT01737697|26307325|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
13229293|NCT01737697|26307326|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
13229294|NCT01737697|26307327|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
13229295|NCT01737697|26307328|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
13229296|NCT01737697|26307329|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
13229297|NCT01737697|26307330|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
13229298|NCT01737697|26307331|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
13229299|NCT01737697|26307317|FG000|Acute Phase-Initial 48 Hours|Family emergency|0|||
13229300|NCT01737697|26307318|FG001|Acute Phase-Initial 48 Hours|Family emergency|0|||
13229301|NCT01737697|26307319|FG002|Acute Phase-Initial 48 Hours|Family emergency|0|||
13229302|NCT01737697|26307320|FG003|Acute Phase-Initial 48 Hours|Family emergency|1|||
13229303|NCT01737697|26307321|FG004|Acute Phase-Initial 48 Hours|Family emergency|0|||
13229304|NCT01737697|26307322|FG005|Acute Phase-Initial 48 Hours|Family emergency|0|||
13229305|NCT01737697|26307323|FG006|Acute Phase-Initial 48 Hours|Family emergency|0|||
13229306|NCT01737697|26307324|FG007|Acute Phase-Initial 48 Hours|Family emergency|0|||
13229307|NCT01737697|26307325|FG008|Acute Phase-Initial 48 Hours|Family emergency|0|||
13229308|NCT01737697|26307326|FG009|Acute Phase-Initial 48 Hours|Family emergency|0|||
13229309|NCT01737697|26307327|FG010|Acute Phase-Initial 48 Hours|Family emergency|0|||
13229310|NCT01737697|26307328|FG011|Acute Phase-Initial 48 Hours|Family emergency|0|||
13229311|NCT01737697|26307329|FG012|Acute Phase-Initial 48 Hours|Family emergency|0|||
13229312|NCT01737697|26307330|FG013|Acute Phase-Initial 48 Hours|Family emergency|0|||
13229313|NCT01737697|26307331|FG014|Acute Phase-Initial 48 Hours|Family emergency|0|||
13229314|NCT01737697|26307317|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
13229315|NCT01737697|26307318|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1|||
13229316|NCT01737697|26307319|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
13229317|NCT01737697|26307320|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
13229318|NCT01737697|26307321|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
13229319|NCT01737697|26307322|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
13229320|NCT01737697|26307323|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
13229321|NCT01737697|26307324|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
13229322|NCT01737697|26307325|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
13229323|NCT01737697|26307326|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
13229324|NCT01737697|26307327|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
13115047|NCT03100058|25917347|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
13115048|NCT03100058|25917348|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
13115049|NCT03100058|25917336|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
13115050|NCT03100058|25917337|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
13115051|NCT03100058|25917338|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
13115052|NCT03100058|25917339|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
13115053|NCT03100058|25917340|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
13115054|NCT03100058|25917341|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
13229325|NCT01737697|26307328|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
13229326|NCT01737697|26307329|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
13229327|NCT01737697|26307330|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
13229328|NCT01737697|26307331|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
13229329|NCT01737697|26307317|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
13229330|NCT01737697|26307318|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
13229331|NCT01737697|26307319|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
13229332|NCT01737697|26307320|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
13229333|NCT01737697|26307321|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1|||
13229334|NCT01737697|26307322|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
13229335|NCT01737697|26307323|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
13229336|NCT01737697|26307324|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
13229337|NCT01737697|26307325|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
13229338|NCT01737697|26307326|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
13229339|NCT01737697|26307327|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
13229340|NCT01737697|26307328|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
13229341|NCT01737697|26307329|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
13229342|NCT01737697|26307330|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
13229343|NCT01737697|26307331|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
13229344|NCT01737697|26307317|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
13229345|NCT01737697|26307318|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
13229346|NCT01737697|26307319|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
13229347|NCT01737697|26307320|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4|||
13229348|NCT01737697|26307321|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
13229349|NCT01737697|26307322|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
13229350|NCT01737697|26307323|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
13229351|NCT01737697|26307324|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
13229352|NCT01737697|26307325|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
13229353|NCT01737697|26307326|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
13229354|NCT01737697|26307327|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
13229355|NCT01737697|26307328|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
13229356|NCT01737697|26307329|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
13229357|NCT01737697|26307330|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
13229358|NCT01737697|26307331|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
13229359|NCT01737697|26307317|FG000|Subacute Phase|Adverse Event|0|||
13229360|NCT01737697|26307318|FG001|Subacute Phase|Adverse Event|0|||
13229361|NCT01737697|26307319|FG002|Subacute Phase|Adverse Event|0|||
13229362|NCT01737697|26307320|FG003|Subacute Phase|Adverse Event|0|||
13229363|NCT01737697|26307321|FG004|Subacute Phase|Adverse Event|0|||
13229364|NCT01737697|26307322|FG005|Subacute Phase|Adverse Event|1|||
13229365|NCT01737697|26307323|FG006|Subacute Phase|Adverse Event|1|||
13229366|NCT01737697|26307324|FG007|Subacute Phase|Adverse Event|1|||
13229367|NCT01737697|26307325|FG008|Subacute Phase|Adverse Event|1|||
13229368|NCT01737697|26307326|FG009|Subacute Phase|Adverse Event|1|||
13229369|NCT01737697|26307327|FG010|Subacute Phase|Adverse Event|4|||
13229370|NCT01737697|26307328|FG011|Subacute Phase|Adverse Event|1|||
13229371|NCT01737697|26307329|FG012|Subacute Phase|Adverse Event|1|||
13229372|NCT01737697|26307330|FG013|Subacute Phase|Adverse Event|0|||
13229373|NCT01737697|26307331|FG014|Subacute Phase|Adverse Event|0|||
13229374|NCT01737697|26307317|FG000|Subacute Phase|Withdrawal by Subject|0|||
13229375|NCT01737697|26307318|FG001|Subacute Phase|Withdrawal by Subject|0|||
13229376|NCT01737697|26307319|FG002|Subacute Phase|Withdrawal by Subject|0|||
13229377|NCT01737697|26307320|FG003|Subacute Phase|Withdrawal by Subject|0|||
13229378|NCT01737697|26307321|FG004|Subacute Phase|Withdrawal by Subject|0|||
13229379|NCT01737697|26307322|FG005|Subacute Phase|Withdrawal by Subject|1|||
13229380|NCT01737697|26307323|FG006|Subacute Phase|Withdrawal by Subject|0|||
13229381|NCT01737697|26307324|FG007|Subacute Phase|Withdrawal by Subject|2|||
13229382|NCT01737697|26307325|FG008|Subacute Phase|Withdrawal by Subject|0|||
13229383|NCT01737697|26307326|FG009|Subacute Phase|Withdrawal by Subject|1|||
13229384|NCT01737697|26307327|FG010|Subacute Phase|Withdrawal by Subject|0|||
13229385|NCT01737697|26307328|FG011|Subacute Phase|Withdrawal by Subject|1|||
13229386|NCT01737697|26307329|FG012|Subacute Phase|Withdrawal by Subject|1|||
13229387|NCT01737697|26307330|FG013|Subacute Phase|Withdrawal by Subject|1|||
13229388|NCT01737697|26307331|FG014|Subacute Phase|Withdrawal by Subject|0|||
13229389|NCT01737697|26307317|FG000|Subacute Phase|Lost to Follow-up|0|||
13229390|NCT01737697|26307318|FG001|Subacute Phase|Lost to Follow-up|0|||
13229391|NCT01737697|26307319|FG002|Subacute Phase|Lost to Follow-up|0|||
13229392|NCT01737697|26307320|FG003|Subacute Phase|Lost to Follow-up|0|||
13229393|NCT01737697|26307321|FG004|Subacute Phase|Lost to Follow-up|0|||
13229394|NCT01737697|26307322|FG005|Subacute Phase|Lost to Follow-up|0|||
13229395|NCT01737697|26307323|FG006|Subacute Phase|Lost to Follow-up|0|||
13229396|NCT01737697|26307324|FG007|Subacute Phase|Lost to Follow-up|0|||
13229397|NCT01737697|26307325|FG008|Subacute Phase|Lost to Follow-up|0|||
13229398|NCT01737697|26307326|FG009|Subacute Phase|Lost to Follow-up|0|||
13229399|NCT01737697|26307327|FG010|Subacute Phase|Lost to Follow-up|0|||
13229400|NCT01737697|26307328|FG011|Subacute Phase|Lost to Follow-up|0|||
13229401|NCT01737697|26307329|FG012|Subacute Phase|Lost to Follow-up|0|||
13229402|NCT01737697|26307330|FG013|Subacute Phase|Lost to Follow-up|0|||
13229403|NCT01737697|26307331|FG014|Subacute Phase|Lost to Follow-up|1|||
13229404|NCT01737697|26307317|FG000|Subacute Phase|Hypo-or hyperkalemia|0|||
13229405|NCT01737697|26307318|FG001|Subacute Phase|Hypo-or hyperkalemia|0|||
13229406|NCT01737697|26307319|FG002|Subacute Phase|Hypo-or hyperkalemia|0|||
13229407|NCT01737697|26307320|FG003|Subacute Phase|Hypo-or hyperkalemia|0|||
13229408|NCT01737697|26307321|FG004|Subacute Phase|Hypo-or hyperkalemia|0|||
13229409|NCT01737697|26307322|FG005|Subacute Phase|Hypo-or hyperkalemia|0|||
13229410|NCT01737697|26307323|FG006|Subacute Phase|Hypo-or hyperkalemia|0|||
13229411|NCT01737697|26307324|FG007|Subacute Phase|Hypo-or hyperkalemia|0|||
13229412|NCT01737697|26307325|FG008|Subacute Phase|Hypo-or hyperkalemia|0|||
13229413|NCT01737697|26307326|FG009|Subacute Phase|Hypo-or hyperkalemia|0|||
13229414|NCT01737697|26307327|FG010|Subacute Phase|Hypo-or hyperkalemia|0|||
13229415|NCT01737697|26307328|FG011|Subacute Phase|Hypo-or hyperkalemia|1|||
13229416|NCT01737697|26307329|FG012|Subacute Phase|Hypo-or hyperkalemia|0|||
13229417|NCT01737697|26307330|FG013|Subacute Phase|Hypo-or hyperkalemia|1|||
13229418|NCT01737697|26307331|FG014|Subacute Phase|Hypo-or hyperkalemia|0|||
13229419|NCT01737697|26307317|FG000|Subacute Phase|Protocol Violation|0|||
13229420|NCT01737697|26307318|FG001|Subacute Phase|Protocol Violation|0|||
13229421|NCT01737697|26307319|FG002|Subacute Phase|Protocol Violation|0|||
13229422|NCT01737697|26307320|FG003|Subacute Phase|Protocol Violation|0|||
13229423|NCT01737697|26307321|FG004|Subacute Phase|Protocol Violation|0|||
13229424|NCT01737697|26307322|FG005|Subacute Phase|Protocol Violation|1|||
13229425|NCT01737697|26307323|FG006|Subacute Phase|Protocol Violation|0|||
13229426|NCT01737697|26307324|FG007|Subacute Phase|Protocol Violation|0|||
13229427|NCT01737697|26307325|FG008|Subacute Phase|Protocol Violation|0|||
13229428|NCT01737697|26307326|FG009|Subacute Phase|Protocol Violation|0|||
13229429|NCT01737697|26307327|FG010|Subacute Phase|Protocol Violation|1|||
13229430|NCT01737697|26307328|FG011|Subacute Phase|Protocol Violation|0|||
13229431|NCT01737697|26307329|FG012|Subacute Phase|Protocol Violation|0|||
13229432|NCT01737697|26307330|FG013|Subacute Phase|Protocol Violation|0|||
13229433|NCT01737697|26307331|FG014|Subacute Phase|Protocol Violation|0|||
13229434|NCT01737697|26307317|FG000|Subacute Phase|Physician Decision|0|||
13229435|NCT01737697|26307318|FG001|Subacute Phase|Physician Decision|0|||
13229436|NCT01737697|26307319|FG002|Subacute Phase|Physician Decision|0|||
13229437|NCT01737697|26307320|FG003|Subacute Phase|Physician Decision|0|||
13229438|NCT01737697|26307321|FG004|Subacute Phase|Physician Decision|0|||
13229439|NCT01737697|26307322|FG005|Subacute Phase|Physician Decision|0|||
13229440|NCT01737697|26307323|FG006|Subacute Phase|Physician Decision|0|||
13229441|NCT01737697|26307324|FG007|Subacute Phase|Physician Decision|0|||
13229442|NCT01737697|26307325|FG008|Subacute Phase|Physician Decision|1|||
13229443|NCT01737697|26307326|FG009|Subacute Phase|Physician Decision|0|||
13229444|NCT01737697|26307327|FG010|Subacute Phase|Physician Decision|0|||
13229445|NCT01737697|26307328|FG011|Subacute Phase|Physician Decision|0|||
13229446|NCT01737697|26307329|FG012|Subacute Phase|Physician Decision|0|||
13229447|NCT01737697|26307330|FG013|Subacute Phase|Physician Decision|0|||
13229448|NCT01737697|26307331|FG014|Subacute Phase|Physician Decision|0|||
13229449|NCT01737697|26307317|FG000|Subacute Phase|Death|0|||
13229450|NCT01737697|26307318|FG001|Subacute Phase|Death|0|||
13229451|NCT01737697|26307319|FG002|Subacute Phase|Death|0|||
13229452|NCT01737697|26307320|FG003|Subacute Phase|Death|0|||
13229453|NCT01737697|26307321|FG004|Subacute Phase|Death|0|||
13229454|NCT01737697|26307322|FG005|Subacute Phase|Death|0|||
13229455|NCT01737697|26307323|FG006|Subacute Phase|Death|0|||
13229456|NCT01737697|26307324|FG007|Subacute Phase|Death|0|||
13229457|NCT01737697|26307325|FG008|Subacute Phase|Death|0|||
13229458|NCT01737697|26307326|FG009|Subacute Phase|Death|0|||
13229459|NCT01737697|26307327|FG010|Subacute Phase|Death|1|||
13229460|NCT01737697|26307328|FG011|Subacute Phase|Death|0|||
13229461|NCT01737697|26307329|FG012|Subacute Phase|Death|0|||
13229462|NCT01737697|26307330|FG013|Subacute Phase|Death|0|||
13229463|NCT01737697|26307331|FG014|Subacute Phase|Death|0|||
13229464|NCT01737398|26307380|FG000|Overall Study|Adverse event or SAE|16|||
13229465|NCT01737398|26307381|FG001|Overall Study|Adverse event or SAE|1|||
13229466|NCT01737398|26307380|FG000|Overall Study|Stopping rule met|2|||
13229467|NCT01737398|26307381|FG001|Overall Study|Stopping rule met|1|||
13229468|NCT01737398|26307380|FG000|Overall Study|Voluntary withdrawal|2|||
13229469|NCT01737398|26307381|FG001|Overall Study|Voluntary withdrawal|3|||
13229470|NCT01737398|26307380|FG000|Overall Study|Ineligibility|1|||
13229471|NCT01737398|26307381|FG001|Overall Study|Ineligibility|0|||
13229472|NCT01737398|26307380|FG000|Overall Study|Liver transplant|1|||
13229473|NCT01737398|26307381|FG001|Overall Study|Liver transplant|0|||
13229474|NCT01737398|26307380|FG000|Overall Study|Disease progression|2|||
13229475|NCT01737398|26307381|FG001|Overall Study|Disease progression|3|||
13229476|NCT01737398|26307380|FG000|Overall Study|Sponsor's decision|2|||
13229477|NCT01737398|26307381|FG001|Overall Study|Sponsor's decision|0|||
13229478|NCT01737268|26307395|FG000|Overall Study|Adverse Event|6|||
13229479|NCT01737268|26307395|FG000|Overall Study|Worsening of Target Disease|2|||
13229480|NCT01737268|26307395|FG000|Overall Study|In consideration of the patient's safety|1|||
13229481|NCT01737021|26307408|FG000|Overall Study|Lost to Follow-up|5|||
13485727|NCT00585195|27033429|FG019|Overall Study|Withdrawal by Subject|2|||
13485728|NCT00585195|27033430|FG020|Overall Study|Withdrawal by Subject|0|||
13485729|NCT00585195|27033410|FG000|Overall Study|Other|0|||
13485730|NCT00585195|27033411|FG001|Overall Study|Other|1|||
13115055|NCT03100058|25917342|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
13115056|NCT03100058|25917343|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
13115057|NCT03100058|25917344|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
13229482|NCT01737021|26307409|FG001|Overall Study|Lost to Follow-up|3|||
13229483|NCT01736917|26307418|FG000|Overall Study|Adverse Event|1|||
13229484|NCT01736917|26307418|FG000|Overall Study|Protocol Violation|10|||
13229485|NCT01736696|26307757|FG000|Overall Study|Withdrawal by Subject|0|||
13229486|NCT01736696|26307758|FG001|Overall Study|Withdrawal by Subject|0|||
13229487|NCT01736696|26307759|FG002|Overall Study|Withdrawal by Subject|1|||
13229488|NCT01736696|26307760|FG003|Overall Study|Withdrawal by Subject|0|||
13229489|NCT01736696|26307761|FG004|Overall Study|Withdrawal by Subject|0|||
13229490|NCT01736696|26307762|FG005|Overall Study|Withdrawal by Subject|0|||
13485731|NCT00585195|27033412|FG002|Overall Study|Other|1|||
13485732|NCT00585195|27033413|FG003|Overall Study|Other|1|||
13485733|NCT00585195|27033414|FG004|Overall Study|Other|0|||
13115058|NCT03100058|25917345|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
13115059|NCT03100058|25917346|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
13115060|NCT03100058|25917347|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
13115061|NCT03100058|25917348|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
13115062|NCT03100058|25917336|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
13115063|NCT03100058|25917337|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
13485734|NCT00585195|27033415|FG005|Overall Study|Other|1|||
13485735|NCT00585195|27033416|FG006|Overall Study|Other|0|||
13485736|NCT00585195|27033417|FG007|Overall Study|Other|0|||
13485737|NCT00585195|27033418|FG008|Overall Study|Other|2|||
13485738|NCT00585195|27033419|FG009|Overall Study|Other|1|||
13485739|NCT00585195|27033420|FG010|Overall Study|Other|0|||
13485740|NCT00585195|27033421|FG011|Overall Study|Other|19|||
13485741|NCT00585195|27033422|FG012|Overall Study|Other|23|||
13485742|NCT00585195|27033423|FG013|Overall Study|Other|7|||
13485743|NCT00585195|27033424|FG014|Overall Study|Other|11|||
13485744|NCT00585195|27033425|FG015|Overall Study|Other|3|||
13485745|NCT00585195|27033426|FG016|Overall Study|Other|28|||
13485746|NCT00585195|27033427|FG017|Overall Study|Other|12|||
13485747|NCT00585195|27033428|FG018|Overall Study|Other|10|||
13485748|NCT00585195|27033429|FG019|Overall Study|Other|4|||
13485749|NCT00585195|27033430|FG020|Overall Study|Other|2|||
13485750|NCT00585195|27033410|FG000|Overall Study|Randomized not treated|0|||
13115064|NCT03100058|25917338|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
13115065|NCT03100058|25917339|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
13115066|NCT03100058|25917340|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
13115067|NCT03100058|25917341|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
13115068|NCT03100058|25917342|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
13115069|NCT03100058|25917343|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
13115070|NCT03100058|25917344|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
13115071|NCT03100058|25917345|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
13115072|NCT03100058|25917346|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
13115073|NCT03100058|25917347|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
13115074|NCT03100058|25917348|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
13229491|NCT01736696|26307763|FG006|Overall Study|Withdrawal by Subject|0|||
13229492|NCT01736683|26307841|FG000|Overall Study|Disease Relapse|0|||
13229493|NCT01736683|26307842|FG001|Overall Study|Disease Relapse|0|||
13485751|NCT00585195|27033411|FG001|Overall Study|Randomized not treated|0|||
13485752|NCT00585195|27033412|FG002|Overall Study|Randomized not treated|1|||
13485753|NCT00585195|27033413|FG003|Overall Study|Randomized not treated|0|||
13485754|NCT00585195|27033414|FG004|Overall Study|Randomized not treated|1|||
13485755|NCT00585195|27033415|FG005|Overall Study|Randomized not treated|0|||
13485756|NCT00585195|27033416|FG006|Overall Study|Randomized not treated|1|||
13485757|NCT00585195|27033417|FG007|Overall Study|Randomized not treated|0|||
13485758|NCT00585195|27033418|FG008|Overall Study|Randomized not treated|0|||
13485759|NCT00585195|27033419|FG009|Overall Study|Randomized not treated|0|||
13485760|NCT00585195|27033420|FG010|Overall Study|Randomized not treated|2|||
13485761|NCT00585195|27033421|FG011|Overall Study|Randomized not treated|0|||
13485762|NCT00585195|27033422|FG012|Overall Study|Randomized not treated|0|||
13485763|NCT00585195|27033423|FG013|Overall Study|Randomized not treated|0|||
13485764|NCT00585195|27033424|FG014|Overall Study|Randomized not treated|0|||
13485765|NCT00585195|27033425|FG015|Overall Study|Randomized not treated|1|||
13485766|NCT00585195|27033426|FG016|Overall Study|Randomized not treated|0|||
13485767|NCT00585195|27033427|FG017|Overall Study|Randomized not treated|1|||
13485768|NCT00585195|27033428|FG018|Overall Study|Randomized not treated|3|||
13485769|NCT00585195|27033429|FG019|Overall Study|Randomized not treated|0|||
13485770|NCT00585195|27033430|FG020|Overall Study|Randomized not treated|2|||
13485771|NCT00585195|27033410|FG000|Overall Study|Death|0|||
13485772|NCT00585195|27033411|FG001|Overall Study|Death|0|||
13485773|NCT00585195|27033412|FG002|Overall Study|Death|0|||
13485774|NCT00585195|27033413|FG003|Overall Study|Death|0|||
13485775|NCT00585195|27033414|FG004|Overall Study|Death|0|||
13485776|NCT00585195|27033415|FG005|Overall Study|Death|0|||
13485777|NCT00585195|27033416|FG006|Overall Study|Death|0|||
13485778|NCT00585195|27033417|FG007|Overall Study|Death|0|||
13485779|NCT00585195|27033418|FG008|Overall Study|Death|1|||
13485780|NCT00585195|27033419|FG009|Overall Study|Death|0|||
13485781|NCT00585195|27033420|FG010|Overall Study|Death|1|||
13229494|NCT01736683|26307843|FG002|Overall Study|Disease Relapse|2|||
13229495|NCT01736683|26307844|FG003|Overall Study|Disease Relapse|1|||
13229496|NCT01736683|26307845|FG004|Overall Study|Disease Relapse|0|||
13485782|NCT00585195|27033421|FG011|Overall Study|Death|1|||
13485783|NCT00585195|27033422|FG012|Overall Study|Death|7|||
13485784|NCT00585195|27033423|FG013|Overall Study|Death|2|||
13485785|NCT00585195|27033424|FG014|Overall Study|Death|8|||
13485786|NCT00585195|27033425|FG015|Overall Study|Death|2|||
13229497|NCT01736683|26307841|FG000|Overall Study|Adverse Event|0|||
13229498|NCT01736683|26307842|FG001|Overall Study|Adverse Event|2|||
13229499|NCT01736683|26307843|FG002|Overall Study|Adverse Event|2|||
13229500|NCT01736683|26307844|FG003|Overall Study|Adverse Event|3|||
13229501|NCT01736683|26307845|FG004|Overall Study|Adverse Event|2|||
13229502|NCT01736683|26307841|FG000|Overall Study|Withdrawal by Subject|0|||
13229503|NCT01736683|26307842|FG001|Overall Study|Withdrawal by Subject|0|||
13229504|NCT01736683|26307843|FG002|Overall Study|Withdrawal by Subject|3|||
13229505|NCT01736683|26307844|FG003|Overall Study|Withdrawal by Subject|1|||
13229506|NCT01736683|26307845|FG004|Overall Study|Withdrawal by Subject|1|||
13229507|NCT01736683|26307841|FG000|Overall Study|Lack of Therapeutic Effect|7|||
13229508|NCT01736683|26307842|FG001|Overall Study|Lack of Therapeutic Effect|4|||
13229509|NCT01736683|26307843|FG002|Overall Study|Lack of Therapeutic Effect|13|||
13229510|NCT01736683|26307844|FG003|Overall Study|Lack of Therapeutic Effect|20|||
13229511|NCT01736683|26307845|FG004|Overall Study|Lack of Therapeutic Effect|1|||
13229512|NCT01736683|26307841|FG000|Overall Study|Progressive Disease|0|||
13229513|NCT01736683|26307842|FG001|Overall Study|Progressive Disease|0|||
13229514|NCT01736683|26307843|FG002|Overall Study|Progressive Disease|0|||
13229515|NCT01736683|26307844|FG003|Overall Study|Progressive Disease|1|||
13229516|NCT01736683|26307845|FG004|Overall Study|Progressive Disease|0|||
13229517|NCT01736683|26307841|FG000|Overall Study|Other|0|||
13229518|NCT01736683|26307842|FG001|Overall Study|Other|0|||
13229519|NCT01736683|26307843|FG002|Overall Study|Other|1|||
13229520|NCT01736683|26307844|FG003|Overall Study|Other|9|||
13229521|NCT01736683|26307845|FG004|Overall Study|Other|1|||
13229522|NCT01736657|26307854|FG000|Overall Study|insufficient vascular access|1|||
13229523|NCT01736579|26307895|FG000|Overall Study|Termination of Study by Sponsor|2|||
13229524|NCT01736579|26307896|FG001|Overall Study|Termination of Study by Sponsor|2|||
13229525|NCT01736566|26307995|FG000|Long Term Follow-up|Still collecting data|42|||
13229526|NCT01736566|26307996|FG001|Long Term Follow-up|Still collecting data|0|||
13229527|NCT01736566|26307997|FG002|Long Term Follow-up|Still collecting data|49|||
13229528|NCT01736566|26307998|FG003|Long Term Follow-up|Still collecting data|0|||
13229529|NCT01736566|26307999|FG004|Long Term Follow-up|Still collecting data|1|||
13229530|NCT01736553|26308057|FG000|Overall Study|Death|12|||
13229531|NCT01736553|26308058|FG001|Overall Study|Death|0|||
13229532|NCT01736553|26308057|FG000|Overall Study|Withdrawal by Subject|5|||
13229533|NCT01736553|26308058|FG001|Overall Study|Withdrawal by Subject|2|||
13229534|NCT01736553|26308057|FG000|Overall Study|Lost to Follow-up|2|||
13229535|NCT01736553|26308058|FG001|Overall Study|Lost to Follow-up|2|||
13229536|NCT01736540|26308117|FG000|Overall Study|Did not complete scan within 45 days|2|||
13229537|NCT01736540|26308117|FG000|Overall Study|Death|1|||
13229538|NCT01736540|26308117|FG000|Overall Study|Abnormal test procedure|1|||
13229539|NCT01736540|26308117|FG000|Overall Study|Withdrawal by Subject|5|||
13229540|NCT01736540|26308117|FG000|Overall Study|Protocol Violation|1|||
13229541|NCT01736540|26308117|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1|||
13229542|NCT01736540|26308117|FG000|Overall Study|No show for MRI appointment|1|||
13229543|NCT01736540|26308117|FG000|Overall Study|Unable to make MRI appointment|3|||
13229544|NCT01736475|26308177|FG000|Overall Study|Adverse Event|4|||
13229545|NCT01736475|26308178|FG001|Overall Study|Adverse Event|0|||
13229546|NCT01736475|26308177|FG000|Overall Study|Withdrawal by Subject|2|||
13229547|NCT01736475|26308178|FG001|Overall Study|Withdrawal by Subject|0|||
13229548|NCT01736475|26308177|FG000|Overall Study|Protocol Violation|4|||
13229549|NCT01736475|26308178|FG001|Overall Study|Protocol Violation|0|||
13229550|NCT01736475|26308177|FG000|Overall Study|Other - Screen failure|1|||
13229551|NCT01736475|26308178|FG001|Overall Study|Other - Screen failure|0|||
13229552|NCT01736475|26308177|FG000|Overall Study|Other - Surgical procedure|1|||
13229553|NCT01736475|26308178|FG001|Overall Study|Other - Surgical procedure|0|||
13229554|NCT01736397|26308197|FG000|Overall Study|Lack of Efficacy|1|||
13229555|NCT01736397|26308198|FG001|Overall Study|Lack of Efficacy|11|||
13229556|NCT01736397|26308197|FG000|Overall Study|Withdrawal by Subject|6|||
13229557|NCT01736397|26308198|FG001|Overall Study|Withdrawal by Subject|5|||
13229558|NCT01736397|26308197|FG000|Overall Study|Lost to Follow-up|0|||
13229559|NCT01736397|26308198|FG001|Overall Study|Lost to Follow-up|1|||
13229560|NCT01736397|26308197|FG000|Overall Study|Adverse Event|6|||
13229561|NCT01736397|26308198|FG001|Overall Study|Adverse Event|3|||
13229562|NCT01736397|26308197|FG000|Overall Study|Not stated|1|||
13229563|NCT01736397|26308198|FG001|Overall Study|Not stated|4|||
13229564|NCT01736254|26308217|FG000|Period 2 (Days 2 to 12)|Adverse Event|3|||
13229565|NCT01736254|26308217|FG000|Period 3 (Days 13 to 23)|Adverse Event|1|||
13229566|NCT01736215|26308231|FG000|Overall Study|Early termination of erythropoietin use|1|||
13229567|NCT01736215|26308231|FG000|Overall Study|Adverse Event|4|||
13229568|NCT01736215|26308231|FG000|Overall Study|Progressive disease stop chemotherapy|1|||
13229569|NCT01736215|26308231|FG000|Overall Study|Insufficient data to perform analysis|8|||
13229570|NCT01736189|26308242|FG000|Overall Study|Violation of registration criteria|41|||
13229571|NCT01736189|26308242|FG000|Overall Study|Protocol Violation|4|||
13229572|NCT01736189|26308242|FG000|Overall Study|Criteria and protocol violations|1|||
13229573|NCT01736176|26308288|FG000|Overall Study|Adverse Event|3|||
13229574|NCT01736176|26308288|FG000|Overall Study|Withdrawal by Subject|4|||
13229575|NCT01736176|26308288|FG000|Overall Study|Lack of Efficacy|3|||
13229576|NCT01736176|26308288|FG000|Overall Study|Unable to Complete PEG Placement|1|||
13229577|NCT01736124|26308315|FG000|Post-intervention Assessment|Death|2|||
13229578|NCT01736124|26308316|FG001|Post-intervention Assessment|Death|2|||
13229579|NCT01736124|26308315|FG000|Post-intervention Assessment|lost computer access|1|||
13229580|NCT01736124|26308316|FG001|Post-intervention Assessment|lost computer access|1|||
13229581|NCT01736124|26308315|FG000|Post-intervention Assessment|Moved away|3|||
13229582|NCT01736124|26308316|FG001|Post-intervention Assessment|Moved away|1|||
13229583|NCT01736124|26308315|FG000|Post-intervention Assessment|Withdrawal by Subject|11|||
13229584|NCT01736124|26308316|FG001|Post-intervention Assessment|Withdrawal by Subject|9|||
13229585|NCT01736124|26308315|FG000|Post-intervention Assessment|Illness|3|||
13229586|NCT01736124|26308316|FG001|Post-intervention Assessment|Illness|2|||
13229587|NCT01736124|26308315|FG000|Post-intervention Assessment|Lost to Follow-up|8|||
13229588|NCT01736124|26308316|FG001|Post-intervention Assessment|Lost to Follow-up|5|||
13229589|NCT01736124|26308315|FG000|Post-intervention Assessment|Temporarily away|3|||
13229590|NCT01736124|26308316|FG001|Post-intervention Assessment|Temporarily away|1|||
13229591|NCT01736124|26308315|FG000|6 Mo. Post-Intervention Assessment|Death|0|||
13229592|NCT01736124|26308316|FG001|6 Mo. Post-Intervention Assessment|Death|1|||
13229593|NCT01736124|26308315|FG000|6 Mo. Post-Intervention Assessment|Moved away|0|||
13229594|NCT01736124|26308316|FG001|6 Mo. Post-Intervention Assessment|Moved away|2|||
13229595|NCT01736124|26308315|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
13229596|NCT01736124|26308316|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
13229597|NCT01736124|26308315|FG000|6 Mo. Post-Intervention Assessment|Illness|1|||
13229598|NCT01736124|26308316|FG001|6 Mo. Post-Intervention Assessment|Illness|2|||
13115075|NCT03100058|25917336|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
13115076|NCT03100058|25917337|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
13115077|NCT03100058|25917338|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
13115078|NCT03100058|25917339|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
13115079|NCT03100058|25917340|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
13115080|NCT03100058|25917341|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
13115081|NCT03100058|25917342|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
13115082|NCT03100058|25917343|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
13229599|NCT01736124|26308315|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1|||
13229600|NCT01736124|26308316|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4|||
13229601|NCT01736124|26308315|FG000|12 Mo. Post-Intervention Assessment|Death|1|||
13229602|NCT01736124|26308316|FG001|12 Mo. Post-Intervention Assessment|Death|0|||
13229603|NCT01736124|26308315|FG000|12 Mo. Post-Intervention Assessment|Moved away|1|||
13229604|NCT01736124|26308316|FG001|12 Mo. Post-Intervention Assessment|Moved away|0|||
13229605|NCT01736124|26308315|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0|||
13229606|NCT01736124|26308316|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2|||
13229607|NCT01736124|26308315|FG000|12 Mo. Post-Intervention Assessment|End of study|10|||
13229608|NCT01736124|26308316|FG001|12 Mo. Post-Intervention Assessment|End of study|10|||
13229609|NCT01735994|26308335|FG000|Overall Study|Withdrawal by Subject|6|||
13229610|NCT01735994|26308336|FG001|Overall Study|Withdrawal by Subject|4|||
13229611|NCT01735994|26308335|FG000|Overall Study|Injury|2|||
13229612|NCT01735994|26308336|FG001|Overall Study|Injury|0|||
13229613|NCT01735994|26308335|FG000|Overall Study|Kicked off team|5|||
13229614|NCT01735994|26308336|FG001|Overall Study|Kicked off team|0|||
13229615|NCT01735994|26308335|FG000|Overall Study|Lost to Follow-up|50|||
13229616|NCT01735994|26308336|FG001|Overall Study|Lost to Follow-up|62|||
13229617|NCT01735916|26308365|FG000|Overall Study|Subject not eligible to be randomized|11|||
13229618|NCT01735916|26308366|FG001|Overall Study|Subject not eligible to be randomized|0|||
13229619|NCT01735916|26308367|FG002|Overall Study|Subject not eligible to be randomized|0|||
13229620|NCT01735916|26308365|FG000|Overall Study|Early termination of study by sponsor|4|||
13229621|NCT01735916|26308366|FG001|Overall Study|Early termination of study by sponsor|19|||
13229622|NCT01735916|26308367|FG002|Overall Study|Early termination of study by sponsor|7|||
13229623|NCT01735916|26308365|FG000|Overall Study|Withdrawal by Subject|3|||
13229624|NCT01735916|26308366|FG001|Overall Study|Withdrawal by Subject|0|||
13229625|NCT01735916|26308367|FG002|Overall Study|Withdrawal by Subject|0|||
13229626|NCT01735630|26308388|FG000|Overall Study|Adverse Event|8|||
13229627|NCT01735630|26308389|FG001|Overall Study|Adverse Event|7|||
13229628|NCT01735630|26308388|FG000|Overall Study|Lost to Follow-up|1|||
13229629|NCT01735630|26308389|FG001|Overall Study|Lost to Follow-up|0|||
13229630|NCT01735630|26308388|FG000|Overall Study|Physician Decision|0|||
13229631|NCT01735630|26308389|FG001|Overall Study|Physician Decision|1|||
13229632|NCT01735630|26308388|FG000|Overall Study|Sponsor Decision|2|||
13229633|NCT01735630|26308389|FG001|Overall Study|Sponsor Decision|1|||
13229634|NCT01735630|26308388|FG000|Overall Study|Withdrawal by Subject|7|||
13229635|NCT01735630|26308389|FG001|Overall Study|Withdrawal by Subject|9|||
13229636|NCT01735396|26308400|FG000|Overall Study|not evaluable|1|||
13229637|NCT01735279|26308419|FG000|Overall Study|Lost to Follow-up|11|||
13229638|NCT01735279|26308420|FG001|Overall Study|Lost to Follow-up|8|||
13229639|NCT01735201|26308479|FG000|Overall Study|Adverse Event|1|||
13229640|NCT01735201|26308480|FG001|Overall Study|Adverse Event|1|||
13115083|NCT03100058|25917344|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
13229641|NCT01735201|26308481|FG002|Overall Study|Adverse Event|0|||
13229642|NCT01735201|26308482|FG003|Overall Study|Adverse Event|1|||
13115084|NCT03100058|25917345|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
13229643|NCT01735201|26308483|FG004|Overall Study|Adverse Event|1|||
13229644|NCT01735201|26308484|FG005|Overall Study|Adverse Event|3|||
13229645|NCT01735201|26308485|FG006|Overall Study|Adverse Event|2|||
13229646|NCT01735201|26308486|FG007|Overall Study|Adverse Event|1|||
13229647|NCT01735201|26308479|FG000|Overall Study|Personal Reasons|1|||
13229648|NCT01735201|26308480|FG001|Overall Study|Personal Reasons|0|||
13229649|NCT01735201|26308481|FG002|Overall Study|Personal Reasons|0|||
13229650|NCT01735201|26308482|FG003|Overall Study|Personal Reasons|0|||
13229651|NCT01735201|26308483|FG004|Overall Study|Personal Reasons|0|||
13229652|NCT01735201|26308484|FG005|Overall Study|Personal Reasons|0|||
13229653|NCT01735201|26308485|FG006|Overall Study|Personal Reasons|0|||
13229654|NCT01735201|26308486|FG007|Overall Study|Personal Reasons|0|||
13229655|NCT01735201|26308479|FG000|Overall Study|Protocol Violation|1|||
13229656|NCT01735201|26308480|FG001|Overall Study|Protocol Violation|0|||
13229657|NCT01735201|26308481|FG002|Overall Study|Protocol Violation|0|||
13229658|NCT01735201|26308482|FG003|Overall Study|Protocol Violation|0|||
13229659|NCT01735201|26308483|FG004|Overall Study|Protocol Violation|0|||
13115085|NCT03100058|25917346|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
13115086|NCT03100058|25917347|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
13115087|NCT03100058|25917348|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
13115088|NCT03100058|25917336|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
13115089|NCT03100058|25917337|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
13115090|NCT03100058|25917338|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
13115091|NCT03100058|25917339|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
13115092|NCT03100058|25917340|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
13115093|NCT03100058|25917341|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
13115094|NCT03100058|25917342|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
13115095|NCT03100058|25917343|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
13115096|NCT03100058|25917344|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
13133373|NCT02771210|25987551|FG000|Period 2|Lack of Efficacy|0|||
13229660|NCT01735201|26308484|FG005|Overall Study|Protocol Violation|0|||
13229661|NCT01735201|26308485|FG006|Overall Study|Protocol Violation|0|||
13229662|NCT01735201|26308486|FG007|Overall Study|Protocol Violation|0|||
13229663|NCT01735201|26308479|FG000|Overall Study|Other Miscellaneous Reasons|0|||
13229664|NCT01735201|26308480|FG001|Overall Study|Other Miscellaneous Reasons|0|||
13229665|NCT01735201|26308481|FG002|Overall Study|Other Miscellaneous Reasons|0|||
13229666|NCT01735201|26308482|FG003|Overall Study|Other Miscellaneous Reasons|1|||
13229667|NCT01735201|26308483|FG004|Overall Study|Other Miscellaneous Reasons|0|||
13229668|NCT01735201|26308484|FG005|Overall Study|Other Miscellaneous Reasons|2|||
13229669|NCT01735201|26308485|FG006|Overall Study|Other Miscellaneous Reasons|1|||
13229670|NCT01735201|26308486|FG007|Overall Study|Other Miscellaneous Reasons|1|||
13229671|NCT01735175|26308513|FG000|Overall Study|Withdrawal by Subject|9|||
13229672|NCT01735175|26308514|FG001|Overall Study|Withdrawal by Subject|2|||
13229673|NCT01735175|26308513|FG000|Overall Study|Lost to Follow-up|4|||
13229674|NCT01735175|26308514|FG001|Overall Study|Lost to Follow-up|2|||
13229675|NCT01735175|26308513|FG000|Overall Study|Death|3|||
13229676|NCT01735175|26308514|FG001|Overall Study|Death|2|||
13229677|NCT01735175|26308513|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13|||
13229678|NCT01735175|26308514|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7|||
13229679|NCT01734993|26308542|FG000|Overall Study|Adverse Event|1|||
13229680|NCT01734993|26308542|FG000|Overall Study|Lack of Efficacy|1|||
13229681|NCT01734902|26308559|FG000|Overall Study|Other than listed|0|||
13229682|NCT01734902|26308560|FG001|Overall Study|Other than listed|2|||
13229683|NCT01734850|26308625|FG000|Overall Study|Continued to Week 48 but recommenced ART|3|||
13229684|NCT01734850|26308626|FG001|Overall Study|Continued to Week 48 but recommenced ART|2|||
13229685|NCT01734850|26308627|FG002|Overall Study|Continued to Week 48 but recommenced ART|3|||
13229686|NCT01734850|26308625|FG000|Overall Study|Not infused due to manufacturing failure|0|||
13229687|NCT01734850|26308626|FG001|Overall Study|Not infused due to manufacturing failure|0|||
13229688|NCT01734850|26308627|FG002|Overall Study|Not infused due to manufacturing failure|1|||
13229689|NCT01734811|26308658|FG000|Overall Study|Lost to Follow-up|2|||
13229690|NCT01734811|26308659|FG001|Overall Study|Lost to Follow-up|3|||
13229691|NCT01734811|26308658|FG000|Overall Study|Withdrawal by Subject|2|||
13229692|NCT01734811|26308659|FG001|Overall Study|Withdrawal by Subject|0|||
13229693|NCT01734785|26308685|FG000|Open-Label Period|Adverse Event|0|||
13229694|NCT01734785|26308686|FG001|Open-Label Period|Adverse Event|0|||
13229695|NCT01734785|26308687|FG002|Open-Label Period|Adverse Event|0|||
13229696|NCT01734785|26308688|FG003|Open-Label Period|Adverse Event|9|||
13229697|NCT01734785|26308685|FG000|Open-Label Period|Lack of Efficacy|0|||
13229698|NCT01734785|26308686|FG001|Open-Label Period|Lack of Efficacy|0|||
13229699|NCT01734785|26308687|FG002|Open-Label Period|Lack of Efficacy|0|||
13229700|NCT01734785|26308688|FG003|Open-Label Period|Lack of Efficacy|1|||
13229701|NCT01734785|26308685|FG000|Open-Label Period|Protocol Violation|0|||
13229702|NCT01734785|26308686|FG001|Open-Label Period|Protocol Violation|0|||
13229703|NCT01734785|26308687|FG002|Open-Label Period|Protocol Violation|0|||
13229704|NCT01734785|26308688|FG003|Open-Label Period|Protocol Violation|13|||
13229705|NCT01734785|26308685|FG000|Open-Label Period|Lost to Follow-up|0|||
13229706|NCT01734785|26308686|FG001|Open-Label Period|Lost to Follow-up|0|||
13229707|NCT01734785|26308687|FG002|Open-Label Period|Lost to Follow-up|0|||
13229708|NCT01734785|26308688|FG003|Open-Label Period|Lost to Follow-up|14|||
13229709|NCT01734785|26308685|FG000|Open-Label Period|Withdrawal by Subject|0|||
13229710|NCT01734785|26308686|FG001|Open-Label Period|Withdrawal by Subject|0|||
13229711|NCT01734785|26308687|FG002|Open-Label Period|Withdrawal by Subject|0|||
13229712|NCT01734785|26308688|FG003|Open-Label Period|Withdrawal by Subject|12|||
13229713|NCT01734785|26308685|FG000|Open-Label Period|Other Reasons|0|||
13229714|NCT01734785|26308686|FG001|Open-Label Period|Other Reasons|0|||
13229715|NCT01734785|26308687|FG002|Open-Label Period|Other Reasons|0|||
13229716|NCT01734785|26308688|FG003|Open-Label Period|Other Reasons|224|||
13229717|NCT01734785|26308685|FG000|Double-Blind Period|Adverse Event|0|||
13229718|NCT01734785|26308686|FG001|Double-Blind Period|Adverse Event|3|||
13229719|NCT01734785|26308687|FG002|Double-Blind Period|Adverse Event|2|||
13229720|NCT01734785|26308688|FG003|Double-Blind Period|Adverse Event|0|||
13229721|NCT01734785|26308685|FG000|Double-Blind Period|Lack of Efficacy|0|||
13229722|NCT01734785|26308686|FG001|Double-Blind Period|Lack of Efficacy|1|||
13229723|NCT01734785|26308687|FG002|Double-Blind Period|Lack of Efficacy|0|||
13229724|NCT01734785|26308688|FG003|Double-Blind Period|Lack of Efficacy|0|||
13229725|NCT01734785|26308685|FG000|Double-Blind Period|Protocol Violation|0|||
13229726|NCT01734785|26308686|FG001|Double-Blind Period|Protocol Violation|1|||
13229727|NCT01734785|26308687|FG002|Double-Blind Period|Protocol Violation|1|||
13229728|NCT01734785|26308688|FG003|Double-Blind Period|Protocol Violation|0|||
13229729|NCT01734785|26308685|FG000|Double-Blind Period|Lost to Follow-up|2|||
13229730|NCT01734785|26308686|FG001|Double-Blind Period|Lost to Follow-up|4|||
13229731|NCT01734785|26308687|FG002|Double-Blind Period|Lost to Follow-up|2|||
13229732|NCT01734785|26308688|FG003|Double-Blind Period|Lost to Follow-up|0|||
13229733|NCT01734785|26308685|FG000|Double-Blind Period|Withdrawal by Subject|2|||
13229734|NCT01734785|26308686|FG001|Double-Blind Period|Withdrawal by Subject|0|||
13229735|NCT01734785|26308687|FG002|Double-Blind Period|Withdrawal by Subject|0|||
13229736|NCT01734785|26308688|FG003|Double-Blind Period|Withdrawal by Subject|0|||
13229737|NCT01734785|26308685|FG000|Double-Blind Period|Not treated|1|||
13229738|NCT01734785|26308686|FG001|Double-Blind Period|Not treated|0|||
13229739|NCT01734785|26308687|FG002|Double-Blind Period|Not treated|0|||
13229740|NCT01734785|26308688|FG003|Double-Blind Period|Not treated|0|||
13229741|NCT01734772|26308712|FG000|Overall Study|Adverse Event|1|||
13229742|NCT01734772|26308713|FG001|Overall Study|Adverse Event|2|||
13229743|NCT01734772|26308712|FG000|Overall Study|Withdrawal by Subject|0|||
13229744|NCT01734772|26308713|FG001|Overall Study|Withdrawal by Subject|1|||
13229745|NCT01734434|26308748|FG000|Overall Study|Death Infant|3|||
13229746|NCT01734434|26308749|FG001|Overall Study|Death Infant|1|||
13115097|NCT03100058|25917345|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
13115098|NCT03100058|25917346|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
13115099|NCT03100058|25917347|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
13115100|NCT03100058|25917348|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
13115101|NCT03100058|25917336|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0|||
13115102|NCT03100058|25917337|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1|||
13115103|NCT03100058|25917338|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0|||
13115104|NCT03100058|25917339|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0|||
13115105|NCT03100058|25917340|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0|||
13115106|NCT03100058|25917341|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0|||
13115107|NCT03100058|25917342|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0|||
13115108|NCT03100058|25917343|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0|||
13115109|NCT03100058|25917344|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0|||
13115110|NCT03100058|25917345|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0|||
13115111|NCT03100058|25917346|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0|||
13115112|NCT03100058|25917347|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0|||
13115113|NCT03100058|25917348|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0|||
13115114|NCT03100058|25917336|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1|||
13115115|NCT03100058|25917337|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
13115116|NCT03100058|25917338|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
13115117|NCT03100058|25917339|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
13115118|NCT03100058|25917340|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
13115119|NCT03100058|25917341|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
13115120|NCT03100058|25917342|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
13115121|NCT03100058|25917343|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
13229747|NCT01734434|26308750|FG002|Overall Study|Death Infant|17|||
13229748|NCT01734434|26308751|FG003|Overall Study|Death Infant|5|||
13115122|NCT03100058|25917344|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
13115123|NCT03100058|25917345|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
13115124|NCT03100058|25917346|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
13115125|NCT03100058|25917347|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
13115126|NCT03100058|25917348|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
13115127|NCT03100058|25917336|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
13115128|NCT03100058|25917337|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
13115129|NCT03100058|25917338|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
13115130|NCT03100058|25917339|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
13115131|NCT03100058|25917340|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
13115132|NCT03100058|25917341|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
13115133|NCT03100058|25917342|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1|||
13115134|NCT03100058|25917343|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
13115135|NCT03100058|25917344|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
13115136|NCT03100058|25917345|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
13115137|NCT03100058|25917346|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
13115138|NCT03100058|25917347|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
13115139|NCT03100058|25917348|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
13115140|NCT03100058|25917336|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
13115141|NCT03100058|25917337|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
13115142|NCT03100058|25917338|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
13115143|NCT03100058|25917339|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
13115144|NCT03100058|25917340|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
13115145|NCT03100058|25917341|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
13115146|NCT03100058|25917342|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
13115147|NCT03100058|25917343|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
13115148|NCT03100058|25917344|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
13115149|NCT03100058|25917345|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
13115150|NCT03100058|25917346|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4|||
13115151|NCT03100058|25917347|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2|||
13115152|NCT03100058|25917348|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1|||
13229749|NCT01734434|26308748|FG000|Overall Study|Lost to Follow-up|2|||
13115153|NCT03100058|25917336|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
13115154|NCT03100058|25917337|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
13115155|NCT03100058|25917338|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
13115156|NCT03100058|25917339|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
13115157|NCT03100058|25917340|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
13115158|NCT03100058|25917341|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
13115159|NCT03100058|25917342|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
13115160|NCT03100058|25917343|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
13229750|NCT01734434|26308749|FG001|Overall Study|Lost to Follow-up|9|||
13229751|NCT01734434|26308750|FG002|Overall Study|Lost to Follow-up|67|||
13229752|NCT01734434|26308751|FG003|Overall Study|Lost to Follow-up|11|||
13229753|NCT01734434|26308748|FG000|Overall Study|No Live Birth|1|||
13229754|NCT01734434|26308749|FG001|Overall Study|No Live Birth|2|||
13229755|NCT01734434|26308750|FG002|Overall Study|No Live Birth|32|||
13229756|NCT01734434|26308751|FG003|Overall Study|No Live Birth|6|||
13229757|NCT01734434|26308748|FG000|Overall Study|Withdrawal by Subject|4|||
13229758|NCT01734434|26308749|FG001|Overall Study|Withdrawal by Subject|0|||
13229759|NCT01734434|26308750|FG002|Overall Study|Withdrawal by Subject|8|||
13229760|NCT01734434|26308751|FG003|Overall Study|Withdrawal by Subject|1|||
13229761|NCT01734434|26308748|FG000|Overall Study|Signed Adult Version of Consent Form|0|||
13115161|NCT03100058|25917344|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
13115162|NCT03100058|25917345|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
13115163|NCT03100058|25917346|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3|||
13115164|NCT03100058|25917347|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1|||
13229762|NCT01734434|26308749|FG001|Overall Study|Signed Adult Version of Consent Form|0|||
13229763|NCT01734434|26308750|FG002|Overall Study|Signed Adult Version of Consent Form|1|||
13229764|NCT01734434|26308751|FG003|Overall Study|Signed Adult Version of Consent Form|0|||
13229765|NCT01734434|26308748|FG000|Overall Study|Subject Not Reachable|0|||
13229766|NCT01734434|26308749|FG001|Overall Study|Subject Not Reachable|0|||
13229767|NCT01734434|26308750|FG002|Overall Study|Subject Not Reachable|1|||
13229768|NCT01734434|26308751|FG003|Overall Study|Subject Not Reachable|0|||
13229769|NCT01734434|26308748|FG000|Overall Study|Treatment Defaulter|0|||
13229770|NCT01734434|26308749|FG001|Overall Study|Treatment Defaulter|0|||
13229771|NCT01734434|26308750|FG002|Overall Study|Treatment Defaulter|1|||
13229772|NCT01734434|26308751|FG003|Overall Study|Treatment Defaulter|0|||
13229773|NCT01734434|26308748|FG000|Overall Study|Wrong Version of Consent Form Signed|0|||
13229774|NCT01734434|26308749|FG001|Overall Study|Wrong Version of Consent Form Signed|0|||
13485787|NCT00585195|27033426|FG016|Overall Study|Death|11|||
13229775|NCT01734434|26308750|FG002|Overall Study|Wrong Version of Consent Form Signed|1|||
13229776|NCT01734434|26308751|FG003|Overall Study|Wrong Version of Consent Form Signed|0|||
13229777|NCT01734434|26308748|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0|||
13229778|NCT01734434|26308749|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0|||
13229779|NCT01734434|26308750|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1|||
13229780|NCT01734434|26308751|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0|||
13229781|NCT01734395|26308759|FG000|Overall Study|Other|65|||
13229782|NCT01734395|26308759|FG000|Overall Study|Lost to Follow-up|287|||
13229783|NCT01734395|26308759|FG000|Overall Study|Lack of Efficacy|5|||
13229784|NCT01734395|26308759|FG000|Overall Study|Adverse Event|40|||
13229785|NCT01734395|26308759|FG000|Overall Study|Withdrawal by Subject|10|||
13229786|NCT01734395|26308759|FG000|Overall Study|Missing the reasons for not completed|3|||
13229787|NCT01734382|26308829|FG000|Part 1|Adverse Event|2|||
13229788|NCT01734382|26308830|FG001|Part 1|Adverse Event|0|||
13229789|NCT01734382|26308831|FG002|Part 1|Adverse Event|0|||
13229790|NCT01734382|26308829|FG000|Part 2|Adverse Event|0|||
13229791|NCT01734382|26308830|FG001|Part 2|Adverse Event|0|||
13229792|NCT01734382|26308831|FG002|Part 2|Adverse Event|1|||
13229793|NCT01734382|26308829|FG000|Part 2|Lack of Efficacy|0|||
13229794|NCT01734382|26308830|FG001|Part 2|Lack of Efficacy|1|||
13229795|NCT01734382|26308831|FG002|Part 2|Lack of Efficacy|1|||
13229796|NCT01734382|26308829|FG000|Part 2|Other|0|||
13229797|NCT01734382|26308830|FG001|Part 2|Other|0|||
13229798|NCT01734382|26308831|FG002|Part 2|Other|1|||
13229799|NCT01734382|26308829|FG000|Part 2|Physician Decision|0|||
13229800|NCT01734382|26308830|FG001|Part 2|Physician Decision|0|||
13229801|NCT01734382|26308831|FG002|Part 2|Physician Decision|3|||
13229802|NCT01734382|26308829|FG000|Part 2|Protocol Violation|0|||
13229803|NCT01734382|26308830|FG001|Part 2|Protocol Violation|1|||
13229804|NCT01734382|26308831|FG002|Part 2|Protocol Violation|0|||
13229805|NCT01734382|26308829|FG000|Part 2|Withdrawal by Subject|0|||
13229806|NCT01734382|26308830|FG001|Part 2|Withdrawal by Subject|0|||
13229807|NCT01734382|26308831|FG002|Part 2|Withdrawal by Subject|1|||
13229808|NCT01733758|26308895|FG000|Overall Study|Adverse Event|5|||
13229809|NCT01733758|26308896|FG001|Overall Study|Adverse Event|7|||
13229810|NCT01733758|26308897|FG002|Overall Study|Adverse Event|8|||
13229811|NCT01733758|26308898|FG003|Overall Study|Adverse Event|1|||
13229812|NCT01733758|26308895|FG000|Overall Study|Withdrawal by Subject|1|||
13229813|NCT01733758|26308896|FG001|Overall Study|Withdrawal by Subject|1|||
13229814|NCT01733758|26308897|FG002|Overall Study|Withdrawal by Subject|5|||
13229815|NCT01733758|26308898|FG003|Overall Study|Withdrawal by Subject|3|||
13229816|NCT01733758|26308895|FG000|Overall Study|Persistent Hyperglycemia|3|||
13229817|NCT01733758|26308896|FG001|Overall Study|Persistent Hyperglycemia|2|||
13229818|NCT01733758|26308897|FG002|Overall Study|Persistent Hyperglycemia|0|||
13229819|NCT01733758|26308898|FG003|Overall Study|Persistent Hyperglycemia|0|||
13229820|NCT01733758|26308895|FG000|Overall Study|Protocol Violation|0|||
13229821|NCT01733758|26308896|FG001|Overall Study|Protocol Violation|1|||
13229822|NCT01733758|26308897|FG002|Overall Study|Protocol Violation|2|||
13229823|NCT01733758|26308898|FG003|Overall Study|Protocol Violation|2|||
13229824|NCT01733758|26308895|FG000|Overall Study|Non-compliance|1|||
13229825|NCT01733758|26308896|FG001|Overall Study|Non-compliance|0|||
13229826|NCT01733758|26308897|FG002|Overall Study|Non-compliance|0|||
13229827|NCT01733758|26308898|FG003|Overall Study|Non-compliance|0|||
13229828|NCT01733758|26308895|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4|||
13229829|NCT01733758|26308896|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0|||
13229830|NCT01733758|26308897|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0|||
13229831|NCT01733758|26308898|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1|||
13229832|NCT01733758|26308895|FG000|Overall Study|Inv Decision, HbA1c not controlled|1|||
13229833|NCT01733758|26308896|FG001|Overall Study|Inv Decision, HbA1c not controlled|1|||
13229834|NCT01733758|26308897|FG002|Overall Study|Inv Decision, HbA1c not controlled|0|||
13229835|NCT01733758|26308898|FG003|Overall Study|Inv Decision, HbA1c not controlled|1|||
13229836|NCT01733732|26308939|FG000|Overall Study|Adverse Event|1|||
13229837|NCT01733732|26308940|FG001|Overall Study|Adverse Event|0|||
13229838|NCT01733732|26308939|FG000|Overall Study|Did not attend all study visits|1|||
13229839|NCT01733732|26308940|FG001|Overall Study|Did not attend all study visits|0|||
13229840|NCT01733680|26308957|FG000|Overall Study|Withdrawal by Subject|0|||
13229841|NCT01733680|26308958|FG001|Overall Study|Withdrawal by Subject|1|||
13229842|NCT01733329|26308977|FG000|Overall Study|Protocol Violation|1|||
13229843|NCT01733329|26308978|FG001|Overall Study|Protocol Violation|1|||
13229844|NCT01733329|26308977|FG000|Overall Study|Uterine artery injury|1|||
13229845|NCT01733329|26308978|FG001|Overall Study|Uterine artery injury|0|||
13229846|NCT01733316|26308994|FG000|RP103 Phase|Non-compliance|1|||
13229847|NCT01733316|26308994|FG000|Long Term Extension Phase|Adverse Event|1|||
13229848|NCT01733316|26308994|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2|||
13229849|NCT01733316|26308994|FG000|Long Term Extension Phase|Sponsor Decision|2|||
13229850|NCT01733121|26309013|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2|||
13229851|NCT01733121|26309014|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
13485788|NCT00585195|27033427|FG017|Overall Study|Death|0|||
13229852|NCT01733121|26309013|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
13229853|NCT01733121|26309014|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
13229854|NCT01733121|26309013|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
13229855|NCT01733121|26309014|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3|||
13229856|NCT01733121|26309013|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
13229857|NCT01733121|26309014|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
13229858|NCT01732926|26309035|FG000|Overall Study|Study Terminated by Sponsor|168|||
13229859|NCT01732926|26309036|FG001|Overall Study|Study Terminated by Sponsor|80|||
13229860|NCT01732926|26309035|FG000|Overall Study|Withdrawal by Subject|46|||
13229861|NCT01732926|26309036|FG001|Overall Study|Withdrawal by Subject|8|||
13229862|NCT01732926|26309035|FG000|Overall Study|Physician Decision|24|||
13229863|NCT01732926|26309036|FG001|Overall Study|Physician Decision|11|||
13229864|NCT01732926|26309035|FG000|Overall Study|Other Reason|21|||
13229865|NCT01732926|26309036|FG001|Overall Study|Other Reason|4|||
13229866|NCT01732926|26309035|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7|||
13229867|NCT01732926|26309036|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6|||
13229868|NCT01732926|26309035|FG000|Overall Study|Blind Broken by Subject or Study Site|1|||
13229869|NCT01732926|26309036|FG001|Overall Study|Blind Broken by Subject or Study Site|1|||
13229870|NCT01732913|26309057|FG000|Overall Study|Study Terminated by Sponsor|105|||
13229871|NCT01732913|26309058|FG001|Overall Study|Study Terminated by Sponsor|55|||
13229872|NCT01732913|26309057|FG000|Overall Study|Withdrawal by Subject|27|||
13229873|NCT01732913|26309058|FG001|Overall Study|Withdrawal by Subject|4|||
13229874|NCT01732913|26309057|FG000|Overall Study|Physician Decision|14|||
13229875|NCT01732913|26309058|FG001|Overall Study|Physician Decision|7|||
13229876|NCT01732913|26309057|FG000|Overall Study|Other|7|||
13229877|NCT01732913|26309058|FG001|Overall Study|Other|1|||
13229878|NCT01732913|26309057|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3|||
13229879|NCT01732913|26309058|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2|||
13229880|NCT01732874|26309071|FG000|Overall Study|Withdrawal by Subject|5|||
13229881|NCT01732874|26309072|FG001|Overall Study|Withdrawal by Subject|1|||
13229882|NCT01732874|26309071|FG000|Overall Study|Death of Infant|3|||
13229883|NCT01732874|26309072|FG001|Overall Study|Death of Infant|2|||
13229884|NCT01732835|26309105|FG000|6-month Primary Endpoint|Did not receive device|19|||
13229885|NCT01732835|26309105|FG000|6-month Primary Endpoint|Withdrawal by Subject|2|||
13229886|NCT01732835|26309105|FG000|6-month Primary Endpoint|Adverse Event|3|||
13229887|NCT01732835|26309105|FG000|2-year Extended Follow-up|Withdrawal by Subject|1|||
13229888|NCT01732835|26309105|FG000|2-year Extended Follow-up|Adverse Event|3|||
13229889|NCT01732835|26309105|FG000|2-year Extended Follow-up|Death|1|||
13229890|NCT01732822|26309182|FG000|Overall Study|Withdrawal by Subject|123|||
13229891|NCT01732822|26309183|FG001|Overall Study|Withdrawal by Subject|113|||
13229892|NCT01732796|26309209|FG000|Overall Study|Adverse Event|16|||
13229893|NCT01732796|26309210|FG001|Overall Study|Adverse Event|16|||
13229894|NCT01732796|26309211|FG002|Overall Study|Adverse Event|4|||
13229895|NCT01732796|26309209|FG000|Overall Study|Lack of Efficacy|21|||
13229896|NCT01732796|26309210|FG001|Overall Study|Lack of Efficacy|18|||
13229897|NCT01732796|26309211|FG002|Overall Study|Lack of Efficacy|5|||
13229898|NCT01732796|26309209|FG000|Overall Study|Lost to Follow-up|2|||
13229899|NCT01732796|26309210|FG001|Overall Study|Lost to Follow-up|0|||
13229900|NCT01732796|26309211|FG002|Overall Study|Lost to Follow-up|0|||
13229901|NCT01732796|26309209|FG000|Overall Study|Withdrawal by Subject|6|||
13229902|NCT01732796|26309210|FG001|Overall Study|Withdrawal by Subject|8|||
13229903|NCT01732796|26309211|FG002|Overall Study|Withdrawal by Subject|2|||
13229904|NCT01732796|26309209|FG000|Overall Study|Other reason not defined above|1|||
13229905|NCT01732796|26309210|FG001|Overall Study|Other reason not defined above|0|||
13229906|NCT01732796|26309211|FG002|Overall Study|Other reason not defined above|2|||
13229907|NCT01732770|26309230|FG000|Overall Study|Lost to Follow-up|2|||
13229908|NCT01732770|26309231|FG001|Overall Study|Lost to Follow-up|3|||
13229909|NCT01732770|26309230|FG000|Overall Study|Withdrawal by Subject|5|||
13229910|NCT01732770|26309231|FG001|Overall Study|Withdrawal by Subject|3|||
13229911|NCT01732770|26309230|FG000|Overall Study|Decision by Sponsor|2|||
13229912|NCT01732770|26309231|FG001|Overall Study|Decision by Sponsor|2|||
13229913|NCT01732770|26309230|FG000|Overall Study|Death|1|||
13229914|NCT01732770|26309231|FG001|Overall Study|Death|0|||
13229915|NCT01732757|26309279|FG000|Overall Study|Lost to Follow-up|1|||
13229916|NCT01732757|26309280|FG001|Overall Study|Lost to Follow-up|0|||
13229917|NCT01732757|26309281|FG002|Overall Study|Lost to Follow-up|0|||
13229918|NCT01732692|26309302|FG000|Overall Study|Adverse Event|0|||
13229919|NCT01732692|26309303|FG001|Overall Study|Adverse Event|1|||
13229920|NCT01732640|26309321|FG000|Overall Study|Adverse Event|0|||
13229921|NCT01732640|26309322|FG001|Overall Study|Adverse Event|1|||
13229922|NCT01732640|26309321|FG000|Overall Study|Death|0|||
13229923|NCT01732640|26309322|FG001|Overall Study|Death|1|||
13229924|NCT01732588|26309346|FG000|First Intervention (7 Days)|Adverse Event|0|||
13229925|NCT01732588|26309347|FG001|First Intervention (7 Days)|Adverse Event|1|||
13229926|NCT01732588|26309348|FG002|First Intervention (7 Days)|Adverse Event|0|||
13229927|NCT01732549|26309375|FG000|Overall Study|Adverse Event|13|||
13229928|NCT01732549|26309376|FG001|Overall Study|Adverse Event|3|||
13229929|NCT01732549|26309375|FG000|Overall Study|Consent withdrawn|13|||
13229930|NCT01732549|26309376|FG001|Overall Study|Consent withdrawn|6|||
13229931|NCT01732549|26309375|FG000|Overall Study|Disease progression|37|||
13229932|NCT01732549|26309376|FG001|Overall Study|Disease progression|50|||
13229933|NCT01732549|26309375|FG000|Overall Study|Other|8|||
13229934|NCT01732549|26309376|FG001|Overall Study|Other|14|||
13229935|NCT01732536|26309399|FG000|Overall Study|Withdrawal by Subject|1|||
13229936|NCT01732536|26309400|FG001|Overall Study|Withdrawal by Subject|1|||
13229937|NCT01732510|26309501|FG000|Overall Study|Adverse Event|0|||
13229938|NCT01732510|26309502|FG001|Overall Study|Adverse Event|1|||
13229939|NCT01732510|26309503|FG002|Overall Study|Adverse Event|1|||
13229940|NCT01732510|26309504|FG003|Overall Study|Adverse Event|0|||
13229941|NCT01732510|26309505|FG004|Overall Study|Adverse Event|0|||
13229942|NCT01732510|26309506|FG005|Overall Study|Adverse Event|0|||
13229943|NCT01732510|26309507|FG006|Overall Study|Adverse Event|1|||
13229944|NCT01732510|26309501|FG000|Overall Study|Protocol Violation|0|||
13229945|NCT01732510|26309502|FG001|Overall Study|Protocol Violation|0|||
13229946|NCT01732510|26309503|FG002|Overall Study|Protocol Violation|0|||
13229947|NCT01732510|26309504|FG003|Overall Study|Protocol Violation|1|||
13229948|NCT01732510|26309505|FG004|Overall Study|Protocol Violation|0|||
13229949|NCT01732510|26309506|FG005|Overall Study|Protocol Violation|0|||
13229950|NCT01732510|26309507|FG006|Overall Study|Protocol Violation|0|||
13229951|NCT01732510|26309501|FG000|Overall Study|Withdrawal by Subject|1|||
13229952|NCT01732510|26309502|FG001|Overall Study|Withdrawal by Subject|3|||
13229953|NCT01732510|26309503|FG002|Overall Study|Withdrawal by Subject|2|||
13229954|NCT01732510|26309504|FG003|Overall Study|Withdrawal by Subject|1|||
13229955|NCT01732510|26309505|FG004|Overall Study|Withdrawal by Subject|5|||
13229956|NCT01732510|26309506|FG005|Overall Study|Withdrawal by Subject|0|||
13229957|NCT01732510|26309507|FG006|Overall Study|Withdrawal by Subject|1|||
13229958|NCT01732510|26309501|FG000|Overall Study|Lost to Follow-up|0|||
13229959|NCT01732510|26309502|FG001|Overall Study|Lost to Follow-up|0|||
13229960|NCT01732510|26309503|FG002|Overall Study|Lost to Follow-up|1|||
13229961|NCT01732510|26309504|FG003|Overall Study|Lost to Follow-up|1|||
13229962|NCT01732510|26309505|FG004|Overall Study|Lost to Follow-up|0|||
13229963|NCT01732510|26309506|FG005|Overall Study|Lost to Follow-up|1|||
13229964|NCT01732510|26309507|FG006|Overall Study|Lost to Follow-up|0|||
13229965|NCT01732510|26309501|FG000|Overall Study|Physician Decision|0|||
13229966|NCT01732510|26309502|FG001|Overall Study|Physician Decision|1|||
13229967|NCT01732510|26309503|FG002|Overall Study|Physician Decision|0|||
13229968|NCT01732510|26309504|FG003|Overall Study|Physician Decision|0|||
13229969|NCT01732510|26309505|FG004|Overall Study|Physician Decision|0|||
13229970|NCT01732510|26309506|FG005|Overall Study|Physician Decision|0|||
13229971|NCT01732510|26309507|FG006|Overall Study|Physician Decision|0|||
13229972|NCT01732510|26309501|FG000|Overall Study|Pregnancy|0|||
13229973|NCT01732510|26309502|FG001|Overall Study|Pregnancy|0|||
13229974|NCT01732510|26309503|FG002|Overall Study|Pregnancy|0|||
13229975|NCT01732510|26309504|FG003|Overall Study|Pregnancy|1|||
13229976|NCT01732510|26309505|FG004|Overall Study|Pregnancy|0|||
13229977|NCT01732510|26309506|FG005|Overall Study|Pregnancy|0|||
13229978|NCT01732510|26309507|FG006|Overall Study|Pregnancy|0|||
13229979|NCT01732510|26309501|FG000|Overall Study|Study Terminated By Sponsor|0|||
13229980|NCT01732510|26309502|FG001|Overall Study|Study Terminated By Sponsor|0|||
13229981|NCT01732510|26309503|FG002|Overall Study|Study Terminated By Sponsor|0|||
13229982|NCT01732510|26309504|FG003|Overall Study|Study Terminated By Sponsor|1|||
13229983|NCT01732510|26309505|FG004|Overall Study|Study Terminated By Sponsor|0|||
13229984|NCT01732510|26309506|FG005|Overall Study|Study Terminated By Sponsor|12|||
13229985|NCT01732510|26309507|FG006|Overall Study|Study Terminated By Sponsor|6|||
13229986|NCT01732484|26309517|FG000|Overall Study|Death|7|||
13229987|NCT01732484|26309517|FG000|Overall Study|Lost to Follow-up|14|||
13229988|NCT01732484|26309517|FG000|Overall Study|chronical illness|5|||
13229989|NCT01732471|26309526|FG000|Overall Study|Withdrawal by Subject|1|||
13229990|NCT01732458|26309601|FG000|Overall Study|Lost to Follow-up|0|||
13229991|NCT01732458|26309602|FG001|Overall Study|Lost to Follow-up|2|||
13229992|NCT01732458|26309603|FG002|Overall Study|Lost to Follow-up|0|||
13229993|NCT01732458|26309604|FG003|Overall Study|Lost to Follow-up|0|||
13229994|NCT01732458|26309601|FG000|Overall Study|Non-Compliance With Study Drug|0|||
13229995|NCT01732458|26309602|FG001|Overall Study|Non-Compliance With Study Drug|0|||
13229996|NCT01732458|26309603|FG002|Overall Study|Non-Compliance With Study Drug|1|||
13229997|NCT01732458|26309604|FG003|Overall Study|Non-Compliance With Study Drug|0|||
13229998|NCT01732458|26309601|FG000|Overall Study|Physician Decision|1|||
13229999|NCT01732458|26309602|FG001|Overall Study|Physician Decision|2|||
13230000|NCT01732458|26309603|FG002|Overall Study|Physician Decision|2|||
13230001|NCT01732458|26309604|FG003|Overall Study|Physician Decision|0|||
13230002|NCT01732458|26309601|FG000|Overall Study|Protocol Violation|2|||
13230003|NCT01732458|26309602|FG001|Overall Study|Protocol Violation|0|||
13230004|NCT01732458|26309603|FG002|Overall Study|Protocol Violation|0|||
13230005|NCT01732458|26309604|FG003|Overall Study|Protocol Violation|2|||
13230006|NCT01732458|26309601|FG000|Overall Study|Screen Failure|0|||
13230007|NCT01732458|26309602|FG001|Overall Study|Screen Failure|1|||
13230008|NCT01732458|26309603|FG002|Overall Study|Screen Failure|0|||
13230009|NCT01732458|26309604|FG003|Overall Study|Screen Failure|0|||
13230010|NCT01732107|26309621|FG000|Overall Study|Adverse Event|2|||
13230011|NCT01732107|26309621|FG000|Overall Study|Disease Progression|8|||
13230012|NCT01732107|26309621|FG000|Overall Study|Physician Decision|1|||
13230013|NCT01732107|26309621|FG000|Overall Study|Withdrawal by Subject|2|||
13230014|NCT01731990|26309640|FG000|Overall Study|Adverse Event|1|||
13230015|NCT01731990|26309641|FG001|Overall Study|Adverse Event|5|||
13230016|NCT01731990|26309640|FG000|Overall Study|Withdrawal by Subject|1|||
13230017|NCT01731990|26309641|FG001|Overall Study|Withdrawal by Subject|1|||
13230018|NCT01731990|26309640|FG000|Overall Study|Protocol deviation|1|||
13230019|NCT01731990|26309641|FG001|Overall Study|Protocol deviation|2|||
13230020|NCT01731990|26309640|FG000|Overall Study|Death|1|||
13230021|NCT01731990|26309641|FG001|Overall Study|Death|0|||
13230022|NCT01731951|26309709|FG000|Overall Study|Documented Disease Progression|1|||
13230023|NCT01731951|26309710|FG001|Overall Study|Documented Disease Progression|0|||
13230024|NCT01731951|26309711|FG002|Overall Study|Documented Disease Progression|0|||
13230025|NCT01731951|26309712|FG003|Overall Study|Documented Disease Progression|0|||
13230026|NCT01731951|26309713|FG004|Overall Study|Documented Disease Progression|0|||
13230027|NCT01731951|26309714|FG005|Overall Study|Documented Disease Progression|0|||
13230028|NCT01731951|26309709|FG000|Overall Study|Lost to Follow-up|2|||
13230029|NCT01731951|26309710|FG001|Overall Study|Lost to Follow-up|0|||
13230030|NCT01731951|26309711|FG002|Overall Study|Lost to Follow-up|0|||
13230031|NCT01731951|26309712|FG003|Overall Study|Lost to Follow-up|1|||
13230032|NCT01731951|26309713|FG004|Overall Study|Lost to Follow-up|3|||
13230033|NCT01731951|26309714|FG005|Overall Study|Lost to Follow-up|1|||
13230034|NCT01731951|26309709|FG000|Overall Study|Withdrawal of Consent|1|||
13230035|NCT01731951|26309710|FG001|Overall Study|Withdrawal of Consent|0|||
13230036|NCT01731951|26309711|FG002|Overall Study|Withdrawal of Consent|0|||
13230037|NCT01731951|26309712|FG003|Overall Study|Withdrawal of Consent|0|||
13230038|NCT01731951|26309713|FG004|Overall Study|Withdrawal of Consent|0|||
13230039|NCT01731951|26309714|FG005|Overall Study|Withdrawal of Consent|2|||
13230040|NCT01731951|26309709|FG000|Overall Study|Death|13|||
13230041|NCT01731951|26309710|FG001|Overall Study|Death|15|||
13230042|NCT01731951|26309711|FG002|Overall Study|Death|9|||
13230043|NCT01731951|26309712|FG003|Overall Study|Death|8|||
13230044|NCT01731951|26309713|FG004|Overall Study|Death|9|||
13230045|NCT01731951|26309714|FG005|Overall Study|Death|6|||
13230046|NCT01731938|26309737|FG000|Preliminary Part I|Withdrawal by Subject|2|||
13230047|NCT01731938|26309738|FG001|Preliminary Part I|Withdrawal by Subject|2|||
13230048|NCT01731938|26309737|FG000|Preliminary Part I|Physician Decision|1|||
13230049|NCT01731938|26309738|FG001|Preliminary Part I|Physician Decision|0|||
13230050|NCT01731938|26309737|FG000|Preliminary Part I|Lost to Follow-up|0|||
13230051|NCT01731938|26309738|FG001|Preliminary Part I|Lost to Follow-up|3|||
13230052|NCT01731938|26309737|FG000|Preliminary Part I|Missed Week 6 visit|0|||
13230053|NCT01731938|26309738|FG001|Preliminary Part I|Missed Week 6 visit|3|||
13230054|NCT01731938|26309737|FG000|Primary Part II|Withdrawal by Subject|5|||
13230055|NCT01731938|26309738|FG001|Primary Part II|Withdrawal by Subject|4|||
13230056|NCT01731938|26309737|FG000|Primary Part II|Lost to Follow-up|4|||
13230057|NCT01731938|26309738|FG001|Primary Part II|Lost to Follow-up|5|||
13230058|NCT01731938|26309737|FG000|Primary Part II|Death|2|||
13230059|NCT01731938|26309738|FG001|Primary Part II|Death|1|||
13230060|NCT01731938|26309737|FG000|Primary Part II|Missed Week 6 visit|2|||
13230061|NCT01731938|26309738|FG001|Primary Part II|Missed Week 6 visit|3|||
13230062|NCT01731912|26309745|FG000|Overall Study|noncompliance|2|||
13230063|NCT01731886|26309766|FG000|Overall Study|Death|1|||
13230064|NCT01731886|26309767|FG001|Overall Study|Death|0|||
13230065|NCT01731886|26309766|FG000|Overall Study|Never started treatment|0|||
13230066|NCT01731886|26309767|FG001|Overall Study|Never started treatment|1|||
13230067|NCT01731886|26309766|FG000|Overall Study|Non-compliant|1|||
13230068|NCT01731886|26309767|FG001|Overall Study|Non-compliant|0|||
13230069|NCT01731678|26309773|FG000|Overall Study|Withdrawal by Subject|3|||
13230070|NCT01731678|26309773|FG000|Overall Study|Did not meet inclusion criteria|1|||
13230071|NCT01731678|26309773|FG000|Overall Study|RMT too high, making TMS difficult|3|||
13230072|NCT01731600|26309834|FG000|Overall Study|Adverse Event|2|||
13230073|NCT01731600|26309835|FG001|Overall Study|Adverse Event|0|||
13230074|NCT01731600|26309834|FG000|Overall Study|Withdrawal criteria|1|||
13230075|NCT01731600|26309835|FG001|Overall Study|Withdrawal criteria|0|||
13230076|NCT01731600|26309834|FG000|Overall Study|Other reasons|3|||
13230077|NCT01731600|26309835|FG001|Overall Study|Other reasons|0|||
13230078|NCT01731470|26309842|FG000|Overall Study|Withdrawal by Subject|1|||
13230079|NCT01731470|26309842|FG000|Overall Study|Did not meet study criteria|1|||
13230080|NCT01731171|26309861|FG000|Overall Study|Withdrawal by Subject|4|||
13230081|NCT01731171|26309862|FG001|Overall Study|Withdrawal by Subject|1|||
13230082|NCT01731171|26309861|FG000|Overall Study|Lost to Follow-up|3|||
13230083|NCT01731171|26309862|FG001|Overall Study|Lost to Follow-up|2|||
13230084|NCT01731171|26309861|FG000|Overall Study|Moved out of Area|0|||
13230085|NCT01731171|26309862|FG001|Overall Study|Moved out of Area|2|||
13485789|NCT00585195|27033428|FG018|Overall Study|Death|0|||
13230086|NCT01731171|26309861|FG000|Overall Study|Terminated for Lack of Adherence|0|||
13230087|NCT01731171|26309862|FG001|Overall Study|Terminated for Lack of Adherence|1|||
13230088|NCT01731171|26309861|FG000|Overall Study|Terminated for Safety Reasons|0|||
13230089|NCT01731171|26309862|FG001|Overall Study|Terminated for Safety Reasons|1|||
13230090|NCT01731002|26309883|FG000|Overall Study|Adverse Event|0|||
13230091|NCT01731002|26309884|FG001|Overall Study|Adverse Event|2|||
13230092|NCT01731002|26309885|FG002|Overall Study|Adverse Event|2|||
13230093|NCT01731002|26309883|FG000|Overall Study|Non-Compliant|0|||
13230094|NCT01731002|26309884|FG001|Overall Study|Non-Compliant|1|||
13230095|NCT01731002|26309885|FG002|Overall Study|Non-Compliant|0|||
13230096|NCT01731002|26309883|FG000|Overall Study|Lost to Follow-up|1|||
13230097|NCT01731002|26309884|FG001|Overall Study|Lost to Follow-up|0|||
13230098|NCT01731002|26309885|FG002|Overall Study|Lost to Follow-up|0|||
13230099|NCT01731002|26309883|FG000|Overall Study|Test Agent Discontinuation|0|||
13230100|NCT01731002|26309884|FG001|Overall Study|Test Agent Discontinuation|1|||
13230101|NCT01731002|26309885|FG002|Overall Study|Test Agent Discontinuation|0|||
13230102|NCT01731002|26309883|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2|||
13230103|NCT01731002|26309884|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
13230104|NCT01731002|26309885|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
13230105|NCT01731002|26309883|FG000|Overall Study|Elevated IOP|1|||
13230106|NCT01731002|26309884|FG001|Overall Study|Elevated IOP|0|||
13230107|NCT01731002|26309885|FG002|Overall Study|Elevated IOP|0|||
13230108|NCT01731002|26309883|FG000|Overall Study|Inappropriate use of study medications|0|||
13230109|NCT01731002|26309884|FG001|Overall Study|Inappropriate use of study medications|0|||
13115165|NCT03100058|25917348|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
13115166|NCT03100058|25917336|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
13115167|NCT03100058|25917337|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
13115168|NCT03100058|25917338|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
13115169|NCT03100058|25917339|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
13115170|NCT03100058|25917340|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
13115171|NCT03100058|25917341|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
13230110|NCT01731002|26309885|FG002|Overall Study|Inappropriate use of study medications|1|||
13289625|NCT00107991|26479711|FG000|Eligibility Assessment|Positive purified protein derivative|4|||
13289626|NCT00107991|26479711|FG000|Eligibility Assessment|Abnormal labs|2|||
13289627|NCT00107991|26479711|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1|||
13289628|NCT00107991|26479711|FG000|Eligibility Assessment|chronic uncontrolled asthma|1|||
13289629|NCT00107991|26479711|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1|||
13289630|NCT00107991|26479711|FG000|12 Week Treatment Period|Lack of Efficacy|2|||
13289631|NCT00107991|26479711|FG000|12 Week Treatment Period|Adverse Event|1|||
13289632|NCT00107991|26479711|FG000|12 Week Treatment Period|Protocol Violation|1|||
13289633|NCT00107991|26479711|FG000|12 Week Treatment Period|Incarcerated|1|||
13289634|NCT00107991|26479711|FG000|18-Week Post Treatment Assessment|Adverse Event|2|||
13289635|NCT00107978|26479724|FG000|Overall Study|Adverse Event|1|||
13289636|NCT00107978|26479725|FG001|Overall Study|Adverse Event|5|||
13289637|NCT00107978|26479724|FG000|Overall Study|Death|3|||
13289638|NCT00107978|26479725|FG001|Overall Study|Death|3|||
13289639|NCT00107978|26479724|FG000|Overall Study|Lost to Follow-up|20|||
13289640|NCT00107978|26479725|FG001|Overall Study|Lost to Follow-up|28|||
13289641|NCT00107978|26479724|FG000|Overall Study|Withdrawal by Subject|4|||
13289642|NCT00107978|26479725|FG001|Overall Study|Withdrawal by Subject|9|||
13289643|NCT00107978|26479724|FG000|Overall Study|Protocol Violation|0|||
13289644|NCT00107978|26479725|FG001|Overall Study|Protocol Violation|1|||
13289645|NCT00107978|26479724|FG000|Overall Study|Other|5|||
13289646|NCT00107978|26479725|FG001|Overall Study|Other|4|||
13289647|NCT00107952|26479738|FG000|Overall Study|Death|75|||
13289648|NCT00107952|26479739|FG001|Overall Study|Death|61|||
13289649|NCT00107952|26479738|FG000|Overall Study|Lost to Follow-up|0|||
13289650|NCT00107952|26479739|FG001|Overall Study|Lost to Follow-up|3|||
13289651|NCT00107952|26479738|FG000|Overall Study|Withdrawal by Subject|9|||
13289652|NCT00107952|26479739|FG001|Overall Study|Withdrawal by Subject|6|||
13289653|NCT00107952|26479738|FG000|Overall Study|Other|2|||
13289654|NCT00107952|26479739|FG001|Overall Study|Other|5|||
13289655|NCT00107952|26479738|FG000|Overall Study|Never received study treatment|9|||
13289656|NCT00107952|26479739|FG001|Overall Study|Never received study treatment|6|||
13289657|NCT00107900|26479790|FG000|Overall Study|Adverse Event|3|||
13289658|NCT00107900|26479791|FG001|Overall Study|Adverse Event|2|||
13289659|NCT00107900|26479792|FG002|Overall Study|Adverse Event|10|||
13289660|NCT00107900|26479793|FG003|Overall Study|Adverse Event|3|||
13289661|NCT00107900|26479794|FG004|Overall Study|Adverse Event|5|||
13289662|NCT00107900|26479795|FG005|Overall Study|Adverse Event|3|||
13289663|NCT00107900|26479790|FG000|Overall Study|Death|0|||
13289664|NCT00107900|26479791|FG001|Overall Study|Death|0|||
13289665|NCT00107900|26479792|FG002|Overall Study|Death|0|||
13289666|NCT00107900|26479793|FG003|Overall Study|Death|0|||
13289667|NCT00107900|26479794|FG004|Overall Study|Death|1|||
13289668|NCT00107900|26479795|FG005|Overall Study|Death|0|||
13230111|NCT01730729|26309901|FG000|Overall Study|Adverse Event|1|||
13230112|NCT01730729|26309901|FG000|Overall Study|Death|1|||
13230113|NCT01730729|26309901|FG000|Overall Study|Progressive Disease|12|||
13230114|NCT01730586|26309910|FG000|Overall Study|Progressive Disease|2|||
13230115|NCT01730586|26309910|FG000|Overall Study|Inadequate Trial|8|||
13230116|NCT01730586|26309910|FG000|Overall Study|Adverse Event|2|||
13230117|NCT01730586|26309910|FG000|Overall Study|Hospice|1|||
13230118|NCT01730534|26309929|FG000|Overall Study|Withdrawal by Subject|97|||
13230119|NCT01730534|26309930|FG001|Overall Study|Withdrawal by Subject|127|||
13230120|NCT01730534|26309929|FG000|Overall Study|Lost to Follow-up|12|||
13230121|NCT01730534|26309930|FG001|Overall Study|Lost to Follow-up|18|||
13230122|NCT01730378|26309966|FG000|Overall Study|Lost to Follow-up|1|||
13230123|NCT01730378|26309967|FG001|Overall Study|Lost to Follow-up|0|||
13230124|NCT01730339|26310008|FG000|Overall Study|Withdrawal by Subject|3|||
13230125|NCT01730339|26310009|FG001|Overall Study|Withdrawal by Subject|2|||
13230126|NCT01730339|26310008|FG000|Overall Study|Lost to Follow-up|1|||
13230127|NCT01730339|26310009|FG001|Overall Study|Lost to Follow-up|1|||
13230128|NCT01730339|26310008|FG000|Overall Study|Un-specified|1|||
13230129|NCT01730339|26310009|FG001|Overall Study|Un-specified|0|||
13230130|NCT01730118|26310065|FG000|Dose Escalation|Death on study|5|||
13230131|NCT01730118|26310066|FG001|Dose Escalation|Death on study|7|||
13230132|NCT01730118|26310067|FG002|Dose Escalation|Death on study|2|||
13230133|NCT01730118|26310068|FG003|Dose Escalation|Death on study|6|||
13230134|NCT01730118|26310069|FG004|Dose Escalation|Death on study|0|||
13230135|NCT01730118|26310070|FG005|Dose Escalation|Death on study|0|||
13230136|NCT01730118|26310071|FG006|Dose Escalation|Death on study|0|||
13230137|NCT01730118|26310065|FG000|Dose Escalation|Died before treatment|0|||
13230138|NCT01730118|26310066|FG001|Dose Escalation|Died before treatment|0|||
13230139|NCT01730118|26310067|FG002|Dose Escalation|Died before treatment|0|||
13230140|NCT01730118|26310068|FG003|Dose Escalation|Died before treatment|0|||
13230141|NCT01730118|26310069|FG004|Dose Escalation|Died before treatment|0|||
13230142|NCT01730118|26310070|FG005|Dose Escalation|Died before treatment|0|||
13230143|NCT01730118|26310071|FG006|Dose Escalation|Died before treatment|1|||
13230144|NCT01730118|26310065|FG000|Dose Escalation|Chose to start a different treatment|1|||
13230145|NCT01730118|26310066|FG001|Dose Escalation|Chose to start a different treatment|0|||
13230146|NCT01730118|26310067|FG002|Dose Escalation|Chose to start a different treatment|0|||
13230147|NCT01730118|26310068|FG003|Dose Escalation|Chose to start a different treatment|0|||
13230148|NCT01730118|26310069|FG004|Dose Escalation|Chose to start a different treatment|0|||
13230149|NCT01730118|26310070|FG005|Dose Escalation|Chose to start a different treatment|0|||
13230150|NCT01730118|26310071|FG006|Dose Escalation|Chose to start a different treatment|0|||
13230151|NCT01730118|26310065|FG000|Dose Escalation|Withdrawal by Subject|0|||
13230152|NCT01730118|26310066|FG001|Dose Escalation|Withdrawal by Subject|0|||
13230153|NCT01730118|26310067|FG002|Dose Escalation|Withdrawal by Subject|1|||
13230154|NCT01730118|26310068|FG003|Dose Escalation|Withdrawal by Subject|0|||
13230155|NCT01730118|26310069|FG004|Dose Escalation|Withdrawal by Subject|0|||
13230156|NCT01730118|26310070|FG005|Dose Escalation|Withdrawal by Subject|0|||
13230157|NCT01730118|26310071|FG006|Dose Escalation|Withdrawal by Subject|0|||
13230158|NCT01730118|26310065|FG000|Dose Escalation|Disease progression prior to treatment|0|||
13230159|NCT01730118|26310066|FG001|Dose Escalation|Disease progression prior to treatment|0|||
13230160|NCT01730118|26310067|FG002|Dose Escalation|Disease progression prior to treatment|0|||
13230161|NCT01730118|26310068|FG003|Dose Escalation|Disease progression prior to treatment|0|||
13230162|NCT01730118|26310069|FG004|Dose Escalation|Disease progression prior to treatment|0|||
13230163|NCT01730118|26310070|FG005|Dose Escalation|Disease progression prior to treatment|0|||
13230164|NCT01730118|26310071|FG006|Dose Escalation|Disease progression prior to treatment|1|||
13230165|NCT01730118|26310065|FG000|Dose Expansion|Death|0|||
13230166|NCT01730118|26310066|FG001|Dose Expansion|Death|0|||
13230167|NCT01730118|26310067|FG002|Dose Expansion|Death|0|||
13230168|NCT01730118|26310068|FG003|Dose Expansion|Death|0|||
13230169|NCT01730118|26310069|FG004|Dose Expansion|Death|1|||
13230170|NCT01730118|26310070|FG005|Dose Expansion|Death|0|||
13230171|NCT01730118|26310071|FG006|Dose Expansion|Death|0|||
13230172|NCT01730118|26310065|FG000|Dose Expansion|Other medical condition|0|||
13230173|NCT01730118|26310066|FG001|Dose Expansion|Other medical condition|0|||
13230174|NCT01730118|26310067|FG002|Dose Expansion|Other medical condition|0|||
13230175|NCT01730118|26310068|FG003|Dose Expansion|Other medical condition|0|||
13230176|NCT01730118|26310069|FG004|Dose Expansion|Other medical condition|1|||
13230177|NCT01730118|26310070|FG005|Dose Expansion|Other medical condition|0|||
13230178|NCT01730118|26310071|FG006|Dose Expansion|Other medical condition|0|||
13230179|NCT01730118|26310065|FG000|Dose Expansion|Withdrawal by Subject|0|||
13230180|NCT01730118|26310066|FG001|Dose Expansion|Withdrawal by Subject|0|||
13230181|NCT01730118|26310067|FG002|Dose Expansion|Withdrawal by Subject|0|||
13230182|NCT01730118|26310068|FG003|Dose Expansion|Withdrawal by Subject|0|||
13230183|NCT01730118|26310069|FG004|Dose Expansion|Withdrawal by Subject|1|||
13230184|NCT01730118|26310070|FG005|Dose Expansion|Withdrawal by Subject|0|||
13230185|NCT01730118|26310071|FG006|Dose Expansion|Withdrawal by Subject|0|||
13230186|NCT01730118|26310065|FG000|Dose Expansion|Disease progression|0|||
13230187|NCT01730118|26310066|FG001|Dose Expansion|Disease progression|0|||
13230188|NCT01730118|26310067|FG002|Dose Expansion|Disease progression|0|||
13230189|NCT01730118|26310068|FG003|Dose Expansion|Disease progression|0|||
13230190|NCT01730118|26310069|FG004|Dose Expansion|Disease progression|0|||
13230191|NCT01730118|26310070|FG005|Dose Expansion|Disease progression|1|||
13230192|NCT01730118|26310071|FG006|Dose Expansion|Disease progression|0|||
13230193|NCT01730118|26310065|FG000|Dose Expansion|Inability to return|0|||
13230194|NCT01730118|26310066|FG001|Dose Expansion|Inability to return|0|||
13230195|NCT01730118|26310067|FG002|Dose Expansion|Inability to return|0|||
13230196|NCT01730118|26310068|FG003|Dose Expansion|Inability to return|0|||
13230197|NCT01730118|26310069|FG004|Dose Expansion|Inability to return|0|||
13230198|NCT01730118|26310070|FG005|Dose Expansion|Inability to return|1|||
13230199|NCT01730118|26310071|FG006|Dose Expansion|Inability to return|0|||
13230200|NCT01730118|26310065|FG000|Dose Expansion|Physician Decision|0|||
13230201|NCT01730118|26310066|FG001|Dose Expansion|Physician Decision|0|||
13230202|NCT01730118|26310067|FG002|Dose Expansion|Physician Decision|0|||
13230203|NCT01730118|26310068|FG003|Dose Expansion|Physician Decision|0|||
13230204|NCT01730118|26310069|FG004|Dose Expansion|Physician Decision|0|||
13230205|NCT01730118|26310070|FG005|Dose Expansion|Physician Decision|1|||
13230206|NCT01730118|26310071|FG006|Dose Expansion|Physician Decision|0|||
13230207|NCT01730053|26310242|FG000|Overall Study|Participant moved|0|||
13230208|NCT01730053|26310243|FG001|Overall Study|Participant moved|0|||
13230209|NCT01730053|26310244|FG002|Overall Study|Participant moved|1|||
13230210|NCT01730053|26310245|FG003|Overall Study|Participant moved|0|||
13230211|NCT01730053|26310246|FG004|Overall Study|Participant moved|0|||
13230212|NCT01730053|26310247|FG005|Overall Study|Participant moved|0|||
13230213|NCT01730053|26310242|FG000|Overall Study|Physician Decision|0|||
13230214|NCT01730053|26310243|FG001|Overall Study|Physician Decision|0|||
13230215|NCT01730053|26310244|FG002|Overall Study|Physician Decision|0|||
13230216|NCT01730053|26310245|FG003|Overall Study|Physician Decision|1|||
13230217|NCT01730053|26310246|FG004|Overall Study|Physician Decision|0|||
13230218|NCT01730053|26310247|FG005|Overall Study|Physician Decision|0|||
13230219|NCT01730053|26310242|FG000|Overall Study|Adverse Event|2|||
13230220|NCT01730053|26310243|FG001|Overall Study|Adverse Event|6|||
13230221|NCT01730053|26310244|FG002|Overall Study|Adverse Event|3|||
13230222|NCT01730053|26310245|FG003|Overall Study|Adverse Event|3|||
13230223|NCT01730053|26310246|FG004|Overall Study|Adverse Event|2|||
13230224|NCT01730053|26310247|FG005|Overall Study|Adverse Event|2|||
13230225|NCT01730053|26310242|FG000|Overall Study|Poor compliance to protocol|1|||
13230226|NCT01730053|26310243|FG001|Overall Study|Poor compliance to protocol|2|||
13230227|NCT01730053|26310244|FG002|Overall Study|Poor compliance to protocol|2|||
13230228|NCT01730053|26310245|FG003|Overall Study|Poor compliance to protocol|0|||
13230229|NCT01730053|26310246|FG004|Overall Study|Poor compliance to protocol|0|||
13230230|NCT01730053|26310247|FG005|Overall Study|Poor compliance to protocol|2|||
13230231|NCT01730053|26310242|FG000|Overall Study|Other than specified|2|||
13230232|NCT01730053|26310243|FG001|Overall Study|Other than specified|6|||
13230233|NCT01730053|26310244|FG002|Overall Study|Other than specified|5|||
13230234|NCT01730053|26310245|FG003|Overall Study|Other than specified|4|||
13230235|NCT01730053|26310246|FG004|Overall Study|Other than specified|7|||
13230236|NCT01730053|26310247|FG005|Overall Study|Other than specified|9|||
13230237|NCT01730040|26310446|FG000|Overall Study|Randomized but not treated|0|||
13230238|NCT01730040|26310447|FG001|Overall Study|Randomized but not treated|0|||
13230239|NCT01730040|26310448|FG002|Overall Study|Randomized but not treated|0|||
13230240|NCT01730040|26310449|FG003|Overall Study|Randomized but not treated|0|||
13230241|NCT01730040|26310450|FG004|Overall Study|Randomized but not treated|0|||
13230242|NCT01730040|26310451|FG005|Overall Study|Randomized but not treated|1|||
13230243|NCT01730040|26310452|FG006|Overall Study|Randomized but not treated|0|||
13230244|NCT01730040|26310446|FG000|Overall Study|Subject moved|0|||
13230245|NCT01730040|26310447|FG001|Overall Study|Subject moved|0|||
13230246|NCT01730040|26310448|FG002|Overall Study|Subject moved|1|||
13230247|NCT01730040|26310449|FG003|Overall Study|Subject moved|0|||
13230248|NCT01730040|26310450|FG004|Overall Study|Subject moved|0|||
13230249|NCT01730040|26310451|FG005|Overall Study|Subject moved|0|||
13230250|NCT01730040|26310452|FG006|Overall Study|Subject moved|1|||
13230251|NCT01730040|26310446|FG000|Overall Study|Physician Decision|0|||
13230252|NCT01730040|26310447|FG001|Overall Study|Physician Decision|0|||
13230253|NCT01730040|26310448|FG002|Overall Study|Physician Decision|0|||
13230254|NCT01730040|26310449|FG003|Overall Study|Physician Decision|0|||
13230255|NCT01730040|26310450|FG004|Overall Study|Physician Decision|0|||
13230256|NCT01730040|26310451|FG005|Overall Study|Physician Decision|1|||
13230257|NCT01730040|26310452|FG006|Overall Study|Physician Decision|1|||
13230258|NCT01730040|26310446|FG000|Overall Study|Other than specified|7|||
13230259|NCT01730040|26310447|FG001|Overall Study|Other than specified|8|||
13230260|NCT01730040|26310448|FG002|Overall Study|Other than specified|5|||
13230261|NCT01730040|26310449|FG003|Overall Study|Other than specified|5|||
13230262|NCT01730040|26310450|FG004|Overall Study|Other than specified|5|||
13230263|NCT01730040|26310451|FG005|Overall Study|Other than specified|4|||
13230264|NCT01730040|26310452|FG006|Overall Study|Other than specified|4|||
13230265|NCT01730040|26310446|FG000|Overall Study|Adverse Event|4|||
13230266|NCT01730040|26310447|FG001|Overall Study|Adverse Event|3|||
13230267|NCT01730040|26310448|FG002|Overall Study|Adverse Event|5|||
13230268|NCT01730040|26310449|FG003|Overall Study|Adverse Event|3|||
13230269|NCT01730040|26310450|FG004|Overall Study|Adverse Event|1|||
13230270|NCT01730040|26310451|FG005|Overall Study|Adverse Event|1|||
13230271|NCT01730040|26310452|FG006|Overall Study|Adverse Event|2|||
13230272|NCT01730040|26310446|FG000|Overall Study|Poor compliance to protocol|2|||
13230273|NCT01730040|26310447|FG001|Overall Study|Poor compliance to protocol|4|||
13230274|NCT01730040|26310448|FG002|Overall Study|Poor compliance to protocol|0|||
13230275|NCT01730040|26310449|FG003|Overall Study|Poor compliance to protocol|0|||
13230276|NCT01730040|26310450|FG004|Overall Study|Poor compliance to protocol|0|||
13230277|NCT01730040|26310451|FG005|Overall Study|Poor compliance to protocol|0|||
13230278|NCT01730040|26310452|FG006|Overall Study|Poor compliance to protocol|1|||
13230279|NCT01729871|26310475|FG000|Overall Study|Adverse Event|7|||
13230280|NCT01729871|26310476|FG001|Overall Study|Adverse Event|7|||
13230281|NCT01729871|26310475|FG000|Overall Study|Death|0|||
13230282|NCT01729871|26310476|FG001|Overall Study|Death|1|||
13230283|NCT01729871|26310475|FG000|Overall Study|Lack of Efficacy|0|||
13230284|NCT01729871|26310476|FG001|Overall Study|Lack of Efficacy|1|||
13230285|NCT01729871|26310475|FG000|Overall Study|Physician Decision|0|||
13230286|NCT01729871|26310476|FG001|Overall Study|Physician Decision|2|||
13230287|NCT01729871|26310475|FG000|Overall Study|Protocol Violation|1|||
13230288|NCT01729871|26310476|FG001|Overall Study|Protocol Violation|0|||
13230289|NCT01729871|26310475|FG000|Overall Study|Withdrawal by Subject|0|||
13230290|NCT01729871|26310476|FG001|Overall Study|Withdrawal by Subject|3|||
13230291|NCT01729871|26310475|FG000|Overall Study|Other|4|||
13230292|NCT01729871|26310476|FG001|Overall Study|Other|9|||
13230293|NCT01729819|26310498|FG000|Overall Study|Adverse Event|2|||
13230294|NCT01729819|26310499|FG001|Overall Study|Adverse Event|4|||
13230295|NCT01729819|26310498|FG000|Overall Study|Lack of Efficacy|1|||
13230296|NCT01729819|26310499|FG001|Overall Study|Lack of Efficacy|0|||
13230297|NCT01729819|26310498|FG000|Overall Study|Lost to Follow-up|2|||
13230298|NCT01729819|26310499|FG001|Overall Study|Lost to Follow-up|0|||
13230299|NCT01729819|26310498|FG000|Overall Study|Other reason|1|||
13230300|NCT01729819|26310499|FG001|Overall Study|Other reason|0|||
13230301|NCT01729819|26310498|FG000|Overall Study|Protocol Violation|0|||
13230302|NCT01729819|26310499|FG001|Overall Study|Protocol Violation|1|||
13230303|NCT01729819|26310498|FG000|Overall Study|Withdrawal by Subject|0|||
13230304|NCT01729819|26310499|FG001|Overall Study|Withdrawal by Subject|2|||
13230305|NCT01729728|26310640|FG000|Overall Study|Adverse Event|0|||
13230306|NCT01729728|26310641|FG001|Overall Study|Adverse Event|6|||
13230307|NCT01729728|26310642|FG002|Overall Study|Adverse Event|0|||
13230308|NCT01729728|26310640|FG000|Overall Study|Protocol Violation|1|||
13230309|NCT01729728|26310641|FG001|Overall Study|Protocol Violation|0|||
13230310|NCT01729728|26310642|FG002|Overall Study|Protocol Violation|1|||
13230311|NCT01729559|26310661|FG000|Overall Study|Protocol Violation|31|||
13230312|NCT01729559|26310662|FG001|Overall Study|Protocol Violation|28|||
13230313|NCT01729208|26310699|FG000|Baseline|Physician Decision|5|||
13230314|NCT01729208|26310700|FG001|Baseline|Physician Decision|4|||
13230315|NCT01729208|26310699|FG000|12 Months Follow-up|Withdrawal by Subject|4|||
13230316|NCT01729208|26310700|FG001|12 Months Follow-up|Withdrawal by Subject|7|||
13230317|NCT01729208|26310699|FG000|12 Months Follow-up|Lost to Follow-up|3|||
13230318|NCT01729208|26310700|FG001|12 Months Follow-up|Lost to Follow-up|3|||
13230319|NCT01729208|26310699|FG000|24 Months Follow-up|Lost to Follow-up|3|||
13230320|NCT01729208|26310700|FG001|24 Months Follow-up|Lost to Follow-up|0|||
13230321|NCT01729208|26310699|FG000|36 Months Follow-up|Physician Decision|1|||
13230322|NCT01729208|26310700|FG001|36 Months Follow-up|Physician Decision|0|||
13230323|NCT01729208|26310699|FG000|36 Months Follow-up|Withdrawal by Subject|2|||
13230324|NCT01729208|26310700|FG001|36 Months Follow-up|Withdrawal by Subject|4|||
13230325|NCT01729156|26310736|FG000|Overall Study|Withdrawal by Subject|1|||
13230326|NCT01729156|26310737|FG001|Overall Study|Withdrawal by Subject|0|||
13230327|NCT01729156|26310738|FG002|Overall Study|Withdrawal by Subject|0|||
13230328|NCT01729039|26310759|FG000|Overall Study|disqualified|2|||
13230329|NCT01729039|26310760|FG001|Overall Study|disqualified|5|||
13230330|NCT01729039|26310759|FG000|Overall Study|Withdrawal by Subject|8|||
13230331|NCT01729039|26310760|FG001|Overall Study|Withdrawal by Subject|7|||
13230332|NCT01729026|26310795|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
13230333|NCT01729026|26310796|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
13230334|NCT01729026|26310795|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1|||
13230335|NCT01729026|26310796|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2|||
13115172|NCT03100058|25917342|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
13115173|NCT03100058|25917343|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
13230336|NCT01728792|26310859|FG000|Overall Study|Withdrawal of Consent|1|||
13230337|NCT01728792|26310860|FG001|Overall Study|Withdrawal of Consent|1|||
13230338|NCT01728792|26310861|FG002|Overall Study|Withdrawal of Consent|0|||
13230339|NCT01728792|26310862|FG003|Overall Study|Withdrawal of Consent|1|||
13230340|NCT01728792|26310863|FG004|Overall Study|Withdrawal of Consent|0|||
13115174|NCT03100058|25917344|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
13115175|NCT03100058|25917345|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4|||
13115176|NCT03100058|25917346|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7|||
13115177|NCT03100058|25917347|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
13115178|NCT03100058|25917348|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2|||
13230341|NCT01728792|26310859|FG000|Overall Study|Lost to Follow-up|2|||
13230342|NCT01728792|26310860|FG001|Overall Study|Lost to Follow-up|1|||
13230343|NCT01728792|26310861|FG002|Overall Study|Lost to Follow-up|4|||
13230344|NCT01728792|26310862|FG003|Overall Study|Lost to Follow-up|2|||
13230345|NCT01728792|26310863|FG004|Overall Study|Lost to Follow-up|0|||
13230346|NCT01728779|26310874|FG000|Overall Study|Withdrawal by Subject|1|||
13230347|NCT01728623|26310904|FG000|Overall Study|Disease progression|26|||
13230348|NCT01728623|26310904|FG000|Overall Study|Adverse Event|1|||
13230349|NCT01728623|26310904|FG000|Overall Study|Withdrawal by Subject|1|||
13230350|NCT01728584|26310969|FG000|Overall Study|Adverse Event|1|||
13230351|NCT01728584|26310970|FG001|Overall Study|Adverse Event|0|||
13230352|NCT01728584|26310971|FG002|Overall Study|Adverse Event|0|||
13230353|NCT01728584|26310972|FG003|Overall Study|Adverse Event|0|||
13230354|NCT01728584|26310969|FG000|Overall Study|Physician Decision|4|||
13230355|NCT01728584|26310970|FG001|Overall Study|Physician Decision|0|||
13230356|NCT01728584|26310971|FG002|Overall Study|Physician Decision|1|||
13230357|NCT01728584|26310972|FG003|Overall Study|Physician Decision|0|||
13230358|NCT01728584|26310969|FG000|Overall Study|Withdrawal by Subject|1|||
13230359|NCT01728584|26310970|FG001|Overall Study|Withdrawal by Subject|0|||
13230360|NCT01728584|26310971|FG002|Overall Study|Withdrawal by Subject|0|||
13230361|NCT01728584|26310972|FG003|Overall Study|Withdrawal by Subject|0|||
13230362|NCT01728584|26310969|FG000|Overall Study|Screen failure|1|||
13230363|NCT01728584|26310970|FG001|Overall Study|Screen failure|0|||
13230364|NCT01728584|26310971|FG002|Overall Study|Screen failure|0|||
13230365|NCT01728584|26310972|FG003|Overall Study|Screen failure|0|||
13230366|NCT01728584|26310969|FG000|Overall Study|Other reason (not specified)|1|||
13230367|NCT01728584|26310970|FG001|Overall Study|Other reason (not specified)|0|||
13230368|NCT01728584|26310971|FG002|Overall Study|Other reason (not specified)|0|||
13230369|NCT01728584|26310972|FG003|Overall Study|Other reason (not specified)|1|||
13230370|NCT01728454|26311026|FG000|Stage 1 and 2|Pregnancy|1|||
13230371|NCT01728454|26311027|FG001|Stage 1 and 2|Pregnancy|0|||
13230372|NCT01728454|26311028|FG002|Stage 1 and 2|Pregnancy|0|||
13230373|NCT01728454|26311026|FG000|Stage 1 and 2|Non-compliance with Protocol|0|||
13230374|NCT01728454|26311027|FG001|Stage 1 and 2|Non-compliance with Protocol|0|||
13230375|NCT01728454|26311028|FG002|Stage 1 and 2|Non-compliance with Protocol|1|||
13230376|NCT01728454|26311026|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1|||
13230377|NCT01728454|26311027|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
13230378|NCT01728454|26311028|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
13230379|NCT01728454|26311026|FG000|Stage 1 and 2|Lost to Follow-up|1|||
13230380|NCT01728454|26311027|FG001|Stage 1 and 2|Lost to Follow-up|1|||
13230381|NCT01728454|26311028|FG002|Stage 1 and 2|Lost to Follow-up|0|||
13230382|NCT01728454|26311026|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2|||
13230383|NCT01728454|26311027|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
13230384|NCT01728454|26311028|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
13230385|NCT01728454|26311026|FG000|Stage 3|Reason Missing|0|||
13230386|NCT01728454|26311027|FG001|Stage 3|Reason Missing|0|||
13230387|NCT01728454|26311028|FG002|Stage 3|Reason Missing|1|||
13230388|NCT01728454|26311026|FG000|Stage 3|Subject Required Other Treatment|0|||
13230389|NCT01728454|26311027|FG001|Stage 3|Subject Required Other Treatment|1|||
13230390|NCT01728454|26311028|FG002|Stage 3|Subject Required Other Treatment|0|||
13230391|NCT01728454|26311026|FG000|Stage 3|Pregnancy|1|||
13230392|NCT01728454|26311027|FG001|Stage 3|Pregnancy|0|||
13230393|NCT01728454|26311028|FG002|Stage 3|Pregnancy|0|||
13230394|NCT01728454|26311026|FG000|Stage 3|Withdrew Consent|1|||
13230395|NCT01728454|26311027|FG001|Stage 3|Withdrew Consent|0|||
13230396|NCT01728454|26311028|FG002|Stage 3|Withdrew Consent|1|||
13230397|NCT01728454|26311026|FG000|Stage 3|Non-compliance with Protocol|0|||
13230398|NCT01728454|26311027|FG001|Stage 3|Non-compliance with Protocol|0|||
13230399|NCT01728454|26311028|FG002|Stage 3|Non-compliance with Protocol|1|||
13230400|NCT01728454|26311026|FG000|Stage 3|Lost to Follow-up|0|||
13230401|NCT01728454|26311027|FG001|Stage 3|Lost to Follow-up|3|||
13230402|NCT01728454|26311028|FG002|Stage 3|Lost to Follow-up|1|||
13230403|NCT01728454|26311026|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1|||
13230404|NCT01728454|26311027|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
13230405|NCT01728454|26311028|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
13230406|NCT01728376|26311109|FG000|Overall Study|Adverse Event|1|||
13230407|NCT01728376|26311110|FG001|Overall Study|Adverse Event|1|||
13230408|NCT01728376|26311111|FG002|Overall Study|Adverse Event|1|||
13230409|NCT01728376|26311112|FG003|Overall Study|Adverse Event|1|||
13230410|NCT01728376|26311113|FG004|Overall Study|Adverse Event|1|||
13230411|NCT01728376|26311114|FG005|Overall Study|Adverse Event|0|||
13230412|NCT01728376|26311109|FG000|Overall Study|Persistent Positive Blood Cultures|1|||
13230413|NCT01728376|26311110|FG001|Overall Study|Persistent Positive Blood Cultures|0|||
13230414|NCT01728376|26311111|FG002|Overall Study|Persistent Positive Blood Cultures|1|||
13230415|NCT01728376|26311112|FG003|Overall Study|Persistent Positive Blood Cultures|0|||
13230416|NCT01728376|26311113|FG004|Overall Study|Persistent Positive Blood Cultures|0|||
13230417|NCT01728376|26311114|FG005|Overall Study|Persistent Positive Blood Cultures|0|||
13230418|NCT01728376|26311109|FG000|Overall Study|No relevant bacteria|2|||
13230419|NCT01728376|26311110|FG001|Overall Study|No relevant bacteria|0|||
13230420|NCT01728376|26311111|FG002|Overall Study|No relevant bacteria|0|||
13230421|NCT01728376|26311112|FG003|Overall Study|No relevant bacteria|0|||
13230422|NCT01728376|26311113|FG004|Overall Study|No relevant bacteria|1|||
13230423|NCT01728376|26311114|FG005|Overall Study|No relevant bacteria|1|||
13230424|NCT01728376|26311109|FG000|Overall Study|Did not receive treatment|0|||
13230425|NCT01728376|26311110|FG001|Overall Study|Did not receive treatment|1|||
13230426|NCT01728376|26311111|FG002|Overall Study|Did not receive treatment|0|||
13230427|NCT01728376|26311112|FG003|Overall Study|Did not receive treatment|0|||
13230428|NCT01728376|26311113|FG004|Overall Study|Did not receive treatment|0|||
13230429|NCT01728376|26311114|FG005|Overall Study|Did not receive treatment|0|||
13230430|NCT01728376|26311109|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
13230431|NCT01728376|26311110|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
13230432|NCT01728376|26311111|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
13230433|NCT01728376|26311112|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
13230434|NCT01728376|26311113|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
13230435|NCT01728376|26311114|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
13230436|NCT01728324|26311143|FG000|Termination of DBV|Adverse Event|14|||
13230437|NCT01728324|26311144|FG001|Termination of DBV|Adverse Event|13|||
13230438|NCT01728324|26311145|FG002|Termination of DBV|Adverse Event|4|||
13230439|NCT01728324|26311143|FG000|Termination of DBV|Lack of Efficacy|14|||
13230440|NCT01728324|26311144|FG001|Termination of DBV|Lack of Efficacy|12|||
13230441|NCT01728324|26311145|FG002|Termination of DBV|Lack of Efficacy|8|||
13230442|NCT01728324|26311143|FG000|Termination of DBV|Withdrawal by Subject|9|||
13230443|NCT01728324|26311144|FG001|Termination of DBV|Withdrawal by Subject|6|||
13230444|NCT01728324|26311145|FG002|Termination of DBV|Withdrawal by Subject|2|||
13230445|NCT01728324|26311143|FG000|Termination of DBV|Other than stated|1|||
13230446|NCT01728324|26311144|FG001|Termination of DBV|Other than stated|3|||
13230447|NCT01728324|26311145|FG002|Termination of DBV|Other than stated|0|||
13230448|NCT01728324|26311143|FG000|Termination of DBV|Adverse Event (Placebo Period)|0|||
13230449|NCT01728324|26311144|FG001|Termination of DBV|Adverse Event (Placebo Period)|1|||
13230450|NCT01728324|26311145|FG002|Termination of DBV|Adverse Event (Placebo Period)|0|||
13230451|NCT01728324|26311143|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0|||
13230452|NCT01728324|26311144|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1|||
13230453|NCT01728324|26311145|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0|||
13230454|NCT01728324|26311143|FG000|Termination of FDV|Adverse Event|14|||
13230455|NCT01728324|26311144|FG001|Termination of FDV|Adverse Event|13|||
13230456|NCT01728324|26311145|FG002|Termination of FDV|Adverse Event|4|||
13230457|NCT01728324|26311143|FG000|Termination of FDV|Lack of Efficacy|14|||
13230458|NCT01728324|26311144|FG001|Termination of FDV|Lack of Efficacy|12|||
13230459|NCT01728324|26311145|FG002|Termination of FDV|Lack of Efficacy|8|||
13230460|NCT01728324|26311143|FG000|Termination of FDV|Withdrawal by Subject|9|||
13230461|NCT01728324|26311144|FG001|Termination of FDV|Withdrawal by Subject|6|||
13230462|NCT01728324|26311145|FG002|Termination of FDV|Withdrawal by Subject|2|||
13230463|NCT01728324|26311143|FG000|Termination of FDV|Other than stated|1|||
13230464|NCT01728324|26311144|FG001|Termination of FDV|Other than stated|3|||
13230465|NCT01728324|26311145|FG002|Termination of FDV|Other than stated|0|||
13230466|NCT01728324|26311143|FG000|Termination of FDV|Adverse Event (Placebo Period)|0|||
13230467|NCT01728324|26311144|FG001|Termination of FDV|Adverse Event (Placebo Period)|1|||
13230468|NCT01728324|26311145|FG002|Termination of FDV|Adverse Event (Placebo Period)|0|||
13230469|NCT01728324|26311143|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0|||
13230470|NCT01728324|26311144|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1|||
13230471|NCT01728324|26311145|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0|||
13230472|NCT01728324|26311143|FG000|Termination of RBV|Adverse Event|15|||
13230473|NCT01728324|26311144|FG001|Termination of RBV|Adverse Event|16|||
13230474|NCT01728324|26311145|FG002|Termination of RBV|Adverse Event|5|||
13230475|NCT01728324|26311143|FG000|Termination of RBV|Lack of Efficacy|14|||
13230476|NCT01728324|26311144|FG001|Termination of RBV|Lack of Efficacy|11|||
13230477|NCT01728324|26311145|FG002|Termination of RBV|Lack of Efficacy|7|||
13230478|NCT01728324|26311143|FG000|Termination of RBV|Withdrawal by Subject|9|||
13230479|NCT01728324|26311144|FG001|Termination of RBV|Withdrawal by Subject|5|||
13230480|NCT01728324|26311145|FG002|Termination of RBV|Withdrawal by Subject|2|||
13230481|NCT01728324|26311143|FG000|Termination of RBV|Other than stated|1|||
13230482|NCT01728324|26311144|FG001|Termination of RBV|Other than stated|3|||
13133374|NCT02771210|25987552|FG001|Period 2|Lack of Efficacy|1|||
13230483|NCT01728324|26311145|FG002|Termination of RBV|Other than stated|1|||
13230484|NCT01728324|26311143|FG000|Termination of RBV|Adverse Event (Placebo Period)|0|||
13230485|NCT01728324|26311144|FG001|Termination of RBV|Adverse Event (Placebo Period)|1|||
13230486|NCT01728324|26311145|FG002|Termination of RBV|Adverse Event (Placebo Period)|0|||
13230487|NCT01728324|26311143|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0|||
13230488|NCT01728324|26311144|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1|||
13230489|NCT01728324|26311145|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0|||
13230490|NCT01728246|26311168|FG000|Overall Study|Participant needed rescue medication|1|||
13230491|NCT01728246|26311169|FG001|Overall Study|Participant needed rescue medication|5|||
13230492|NCT01728246|26311168|FG000|Overall Study|Protocol Violation|1|||
13230493|NCT01728246|26311169|FG001|Overall Study|Protocol Violation|0|||
13230494|NCT01728246|26311168|FG000|Overall Study|Withdrawal by Subject|2|||
13230495|NCT01728246|26311169|FG001|Overall Study|Withdrawal by Subject|3|||
13230496|NCT01728246|26311168|FG000|Overall Study|Lost to Follow-up|23|||
13230497|NCT01728246|26311169|FG001|Overall Study|Lost to Follow-up|22|||
13230498|NCT01728246|26311168|FG000|Overall Study|Lack of Efficacy|1|||
13230499|NCT01728246|26311169|FG001|Overall Study|Lack of Efficacy|1|||
13230500|NCT01728246|26311168|FG000|Overall Study|Adverse Event|8|||
13230501|NCT01728246|26311169|FG001|Overall Study|Adverse Event|5|||
13230502|NCT01728194|26311184|FG000|Overall Study|Lost to Follow-up|4|||
13230503|NCT01728194|26311185|FG001|Overall Study|Lost to Follow-up|3|||
13230504|NCT01728194|26311184|FG000|Overall Study|Physician Decision|4|||
13230505|NCT01728194|26311185|FG001|Overall Study|Physician Decision|0|||
13230506|NCT01728194|26311184|FG000|Overall Study|Withdrawal by Subject|7|||
13230507|NCT01728194|26311185|FG001|Overall Study|Withdrawal by Subject|3|||
13230508|NCT01728194|26311184|FG000|Overall Study|Perceived Medication Side Effects|4|||
13230509|NCT01728194|26311185|FG001|Overall Study|Perceived Medication Side Effects|0|||
13230510|NCT01728194|26311184|FG000|Overall Study|Family Member Request|1|||
13230511|NCT01728194|26311185|FG001|Overall Study|Family Member Request|0|||
13230512|NCT01728116|26311215|FG000|Overall Study|Sponsor Terminated Study|106|||
13230513|NCT01728116|26311216|FG001|Overall Study|Sponsor Terminated Study|35|||
13230514|NCT01728116|26311215|FG000|Overall Study|Withdrawal by Subject|16|||
13230515|NCT01728116|26311216|FG001|Overall Study|Withdrawal by Subject|9|||
13230516|NCT01728116|26311215|FG000|Overall Study|Adverse Event|13|||
13230517|NCT01728116|26311216|FG001|Overall Study|Adverse Event|0|||
13230518|NCT01728116|26311215|FG000|Overall Study|Procedure/device failure|7|||
13230519|NCT01728116|26311216|FG001|Overall Study|Procedure/device failure|0|||
13230520|NCT01728116|26311215|FG000|Overall Study|Lost to Follow-up|9|||
13230521|NCT01728116|26311216|FG001|Overall Study|Lost to Follow-up|2|||
13230522|NCT01728116|26311215|FG000|Overall Study|Physician Decision|2|||
13230523|NCT01728116|26311216|FG001|Overall Study|Physician Decision|0|||
13230524|NCT01728116|26311215|FG000|Overall Study|Subject Non-Compliance|2|||
13230525|NCT01728116|26311216|FG001|Overall Study|Subject Non-Compliance|0|||
13230526|NCT01728116|26311215|FG000|Overall Study|Inter-current finding at procedure|1|||
13230527|NCT01728116|26311216|FG001|Overall Study|Inter-current finding at procedure|0|||
13230528|NCT01728116|26311215|FG000|Overall Study|Incorrectly enrolled in Study|0|||
13230529|NCT01728116|26311216|FG001|Overall Study|Incorrectly enrolled in Study|1|||
13230530|NCT01728116|26311215|FG000|Overall Study|various not noted previously|5|||
13230531|NCT01728116|26311216|FG001|Overall Study|various not noted previously|0|||
13230532|NCT01728077|26311236|FG000|Overall Study|Lack of Efficacy|3|||
13230533|NCT01728077|26311237|FG001|Overall Study|Lack of Efficacy|1|||
13230534|NCT01728077|26311236|FG000|Overall Study|Lost to Follow-up|1|||
13230535|NCT01728077|26311237|FG001|Overall Study|Lost to Follow-up|0|||
13230536|NCT01728077|26311236|FG000|Overall Study|Subject choice|2|||
13230537|NCT01728077|26311237|FG001|Overall Study|Subject choice|3|||
13230538|NCT01728077|26311236|FG000|Overall Study|Death|0|||
13230539|NCT01728077|26311237|FG001|Overall Study|Death|1|||
13230540|NCT01728077|26311236|FG000|Overall Study|Patient moving|1|||
13230541|NCT01728077|26311237|FG001|Overall Study|Patient moving|0|||
13230542|NCT01728077|26311236|FG000|Overall Study|Non compliance|1|||
13230543|NCT01728077|26311237|FG001|Overall Study|Non compliance|0|||
13230544|NCT01727713|26311263|FG000|Overall Study|Lost to Follow-up|5|||
13230545|NCT01727713|26311263|FG000|Overall Study|Adverse Event|10|||
13230546|NCT01727713|26311263|FG000|Overall Study|Participant Met Withdrawal Criteria|5|||
13230547|NCT01727713|26311263|FG000|Overall Study|Withdrawal by Subject|13|||
13230548|NCT01727713|26311263|FG000|Overall Study|Protocol Deviation|2|||
13230549|NCT01727700|26311296|FG000|Overall Study|Adverse Event|0|||
13230550|NCT01727700|26311297|FG001|Overall Study|Adverse Event|7|||
13230551|NCT01727700|26311298|FG002|Overall Study|Adverse Event|1|||
13230552|NCT01727700|26311296|FG000|Overall Study|Particpant withdrew consent|0|||
13230553|NCT01727700|26311297|FG001|Overall Study|Particpant withdrew consent|3|||
13230554|NCT01727700|26311298|FG002|Overall Study|Particpant withdrew consent|1|||
13230555|NCT01727700|26311296|FG000|Overall Study|Protocol Violation|2|||
13230556|NCT01727700|26311297|FG001|Overall Study|Protocol Violation|0|||
13230557|NCT01727700|26311298|FG002|Overall Study|Protocol Violation|0|||
13133375|NCT02771210|25987551|FG000|Period 2|Withdrawal by Subject|1|||
13230558|NCT01727505|26311317|FG000|First 24 Hours|Adverse Event|0|||
13230559|NCT01727505|26311318|FG001|First 24 Hours|Adverse Event|1|||
13230560|NCT01727505|26311317|FG000|Second 24 Hours|Missing data|0|||
13230561|NCT01727505|26311318|FG001|Second 24 Hours|Missing data|1|||
13230562|NCT01727297|26311334|FG000|Overall Study|Death|13|||
13230563|NCT01727297|26311335|FG001|Overall Study|Death|0|||
13230564|NCT01727297|26311334|FG000|Overall Study|Protocol Violation|1|||
13230565|NCT01727297|26311335|FG001|Overall Study|Protocol Violation|10|||
13230566|NCT01727297|26311334|FG000|Overall Study|Adverse Event|3|||
13230567|NCT01727297|26311335|FG001|Overall Study|Adverse Event|1|||
13230568|NCT01727297|26311334|FG000|Overall Study|Lost to Follow-up|11|||
13230569|NCT01727297|26311335|FG001|Overall Study|Lost to Follow-up|0|||
13230570|NCT01727297|26311334|FG000|Overall Study|Withdrawal by Subject|26|||
13230571|NCT01727297|26311335|FG001|Overall Study|Withdrawal by Subject|27|||
13230572|NCT01727297|26311334|FG000|Overall Study|Physician Decision|19|||
13230573|NCT01727297|26311335|FG001|Overall Study|Physician Decision|5|||
13230574|NCT01727297|26311334|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29|||
13230575|NCT01727297|26311335|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8|||
13230576|NCT01727258|26311368|FG000|Overall Study|Adverse Event|0|||
13230577|NCT01727258|26311369|FG001|Overall Study|Adverse Event|2|||
13230578|NCT01727258|26311370|FG002|Overall Study|Adverse Event|0|||
13230579|NCT01727258|26311368|FG000|Overall Study|Noncompliance with Study Drug|0|||
13230580|NCT01727258|26311369|FG001|Overall Study|Noncompliance with Study Drug|0|||
13230581|NCT01727258|26311370|FG002|Overall Study|Noncompliance with Study Drug|1|||
13230582|NCT01727258|26311368|FG000|Overall Study|Withdrawal by Subject|1|||
13230583|NCT01727258|26311369|FG001|Overall Study|Withdrawal by Subject|1|||
13230584|NCT01727258|26311370|FG002|Overall Study|Withdrawal by Subject|0|||
13230585|NCT01727258|26311368|FG000|Overall Study|Lost to Follow-up|1|||
13230586|NCT01727258|26311369|FG001|Overall Study|Lost to Follow-up|0|||
13230587|NCT01727258|26311370|FG002|Overall Study|Lost to Follow-up|0|||
13230588|NCT01727154|26311376|FG000|Overall Study|Death|17|||
13230589|NCT01727154|26311376|FG000|Overall Study|Withdrawal by Subject|14|||
13230590|NCT01727154|26311376|FG000|Overall Study|Subject Withdrew Consent|18|||
13230591|NCT01727154|26311376|FG000|Overall Study|Study Terminated|6|||
13230592|NCT01727154|26311376|FG000|Overall Study|No Discontinuation Documentation|4|||
13230593|NCT01727141|26311439|FG000|Overall Study|Physician Decision|0|||
13230594|NCT01727141|26311440|FG001|Overall Study|Physician Decision|1|||
13230595|NCT01727141|26311441|FG002|Overall Study|Physician Decision|0|||
13230596|NCT01727141|26311442|FG003|Overall Study|Physician Decision|2|||
13230597|NCT01727141|26311439|FG000|Overall Study|Lost to Follow-up|0|||
13230598|NCT01727141|26311440|FG001|Overall Study|Lost to Follow-up|2|||
13230599|NCT01727141|26311441|FG002|Overall Study|Lost to Follow-up|0|||
13230600|NCT01727141|26311442|FG003|Overall Study|Lost to Follow-up|0|||
13230601|NCT01727141|26311439|FG000|Overall Study|Death|0|||
13230602|NCT01727141|26311440|FG001|Overall Study|Death|1|||
13230603|NCT01727141|26311441|FG002|Overall Study|Death|1|||
13230604|NCT01727141|26311442|FG003|Overall Study|Death|1|||
13230605|NCT01727141|26311439|FG000|Overall Study|Protocol deviation|1|||
13230606|NCT01727141|26311440|FG001|Overall Study|Protocol deviation|1|||
13230607|NCT01727141|26311441|FG002|Overall Study|Protocol deviation|0|||
13230608|NCT01727141|26311442|FG003|Overall Study|Protocol deviation|1|||
13230609|NCT01727141|26311439|FG000|Overall Study|Withdrawal by Subject|4|||
13230610|NCT01727141|26311440|FG001|Overall Study|Withdrawal by Subject|4|||
13230611|NCT01727141|26311441|FG002|Overall Study|Withdrawal by Subject|2|||
13230612|NCT01727141|26311442|FG003|Overall Study|Withdrawal by Subject|11|||
13230613|NCT01727024|26311458|FG000|Period 1|Lost to Follow-up|1|||
13230614|NCT01727024|26311459|FG001|Period 1|Lost to Follow-up|1|||
13230615|NCT01727024|26311458|FG000|Period 1|Withdrawal by Subject|2|||
13230616|NCT01727024|26311459|FG001|Period 1|Withdrawal by Subject|3|||
13230617|NCT01726803|26311486|FG000|Overall Study|Lost to Follow-up|6|||
13230618|NCT01726803|26311487|FG001|Overall Study|Lost to Follow-up|1|||
13230619|NCT01726803|26311486|FG000|Overall Study|Withdrawal by Subject|1|||
13230620|NCT01726803|26311487|FG001|Overall Study|Withdrawal by Subject|0|||
13230621|NCT01726517|26311530|FG000|Overall Study|Withdrawal by Subject|0|||
13230622|NCT01726517|26311531|FG001|Overall Study|Withdrawal by Subject|0|||
13230623|NCT01726517|26311532|FG002|Overall Study|Withdrawal by Subject|1|||
13115179|NCT03100058|25917336|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
13230624|NCT01726517|26311533|FG003|Overall Study|Withdrawal by Subject|0|||
13230625|NCT01726517|26311534|FG004|Overall Study|Withdrawal by Subject|0|||
13230626|NCT01726335|26311552|FG000|Overall Study|Lost to Follow-up|2|||
13230627|NCT01726335|26311552|FG000|Overall Study|Withdrawal by Subject|15|||
13230628|NCT01726335|26311552|FG000|Overall Study|Adverse Event|4|||
13230629|NCT01726335|26311552|FG000|Overall Study|Lost to Follow-up|2|||
13230630|NCT01726335|26311552|FG000|Overall Study|Exacerbation of psychotic symptoms|1|||
13230631|NCT01726270|26311565|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10|||
13230632|NCT01726270|26311565|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20|||
13230633|NCT01726270|26311565|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21|||
13230634|NCT01726270|26311565|FG000|Part 2, Actual-Use Phase|Adverse Event|6|||
13230635|NCT01726270|26311565|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5|||
13230636|NCT01726270|26311565|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7|||
13230637|NCT01726049|26311584|FG000|Overall Study|Death|1|||
13230638|NCT01726049|26311585|FG001|Overall Study|Death|1|||
13230639|NCT01726049|26311584|FG000|Overall Study|Adverse Event|4|||
13230640|NCT01726049|26311585|FG001|Overall Study|Adverse Event|1|||
13230641|NCT01726049|26311584|FG000|Overall Study|refused second HC|0|||
13230642|NCT01726049|26311585|FG001|Overall Study|refused second HC|2|||
13230643|NCT01726023|26311682|FG000|Overall Study|Death|1|||
13230644|NCT01726023|26311683|FG001|Overall Study|Death|1|||
13230645|NCT01726023|26311682|FG000|Overall Study|Lost to Follow-up|5|||
13230646|NCT01726023|26311683|FG001|Overall Study|Lost to Follow-up|10|||
13230647|NCT01726023|26311682|FG000|Overall Study|Other Eligibility criteria|7|||
13230648|NCT01726023|26311683|FG001|Overall Study|Other Eligibility criteria|7|||
13230649|NCT01726023|26311682|FG000|Overall Study|Withdrawal by Subject|16|||
13230650|NCT01726023|26311683|FG001|Overall Study|Withdrawal by Subject|8|||
13230651|NCT01725750|26311720|FG000|Overall Study|Adverse Event|1|||
13230652|NCT01725750|26311721|FG001|Overall Study|Adverse Event|0|||
13230653|NCT01725750|26311720|FG000|Overall Study|Lost to Follow-up|1|||
13230654|NCT01725750|26311721|FG001|Overall Study|Lost to Follow-up|1|||
13230655|NCT01725750|26311720|FG000|Overall Study|Withdrawal by Subject|0|||
13230656|NCT01725750|26311721|FG001|Overall Study|Withdrawal by Subject|9|||
13230657|NCT01725529|26311757|FG000|Overall Study|Adverse Event|1|||
13230658|NCT01725529|26311758|FG001|Overall Study|Adverse Event|0|||
13230659|NCT01725529|26311759|FG002|Overall Study|Adverse Event|0|||
13230660|NCT01725529|26311757|FG000|Overall Study|Lost to Follow-up|2|||
13230661|NCT01725529|26311758|FG001|Overall Study|Lost to Follow-up|1|||
13230662|NCT01725529|26311759|FG002|Overall Study|Lost to Follow-up|1|||
13230663|NCT01725529|26311757|FG000|Overall Study|Protocol Violation|0|||
13230664|NCT01725529|26311758|FG001|Overall Study|Protocol Violation|1|||
13230665|NCT01725529|26311759|FG002|Overall Study|Protocol Violation|1|||
13230666|NCT01725529|26311757|FG000|Overall Study|Withdrawal by Subject|12|||
13230667|NCT01725529|26311758|FG001|Overall Study|Withdrawal by Subject|14|||
13230668|NCT01725529|26311759|FG002|Overall Study|Withdrawal by Subject|8|||
13230669|NCT01725451|26311784|FG000|Period 1|Withdrawal by Subject|1|||
13230670|NCT01725451|26311785|FG001|Period 1|Withdrawal by Subject|0|||
13230671|NCT01725451|26311786|FG002|Period 1|Withdrawal by Subject|0|||
13230672|NCT01725451|26311787|FG003|Period 1|Withdrawal by Subject|0|||
13230673|NCT01725451|26311784|FG000|Washout From Period 3|Protocol Violation|0|||
13230674|NCT01725451|26311785|FG001|Washout From Period 3|Protocol Violation|0|||
13230675|NCT01725451|26311786|FG002|Washout From Period 3|Protocol Violation|1|||
13230676|NCT01725451|26311787|FG003|Washout From Period 3|Protocol Violation|0|||
13230677|NCT01725451|26311784|FG000|Washout From Period 3|Adverse Event|0|||
13230678|NCT01725451|26311785|FG001|Washout From Period 3|Adverse Event|1|||
13230679|NCT01725451|26311786|FG002|Washout From Period 3|Adverse Event|0|||
13230680|NCT01725451|26311787|FG003|Washout From Period 3|Adverse Event|0|||
13230681|NCT01725451|26311784|FG000|Period 4|Adverse Event|0|||
13230682|NCT01725451|26311785|FG001|Period 4|Adverse Event|0|||
13230683|NCT01725451|26311786|FG002|Period 4|Adverse Event|1|||
13230684|NCT01725451|26311787|FG003|Period 4|Adverse Event|0|||
13230685|NCT01725386|26311810|FG000|Overall Study|Death|84|||
13230686|NCT01725386|26311811|FG001|Overall Study|Death|40|||
13230687|NCT01725386|26311810|FG000|Overall Study|Lost to Follow-up|81|||
13230688|NCT01725386|26311811|FG001|Overall Study|Lost to Follow-up|6|||
13230689|NCT01725386|26311810|FG000|Overall Study|Withdrawal by Subject|10|||
13230690|NCT01725386|26311811|FG001|Overall Study|Withdrawal by Subject|0|||
13230691|NCT01725308|26311964|FG000|Treatment Period I|Did Not Receive Drug|1|||
13230692|NCT01725308|26311965|FG001|Treatment Period I|Did Not Receive Drug|0|||
13230693|NCT01725308|26311966|FG002|Treatment Period I|Did Not Receive Drug|0|||
13230694|NCT01725308|26311964|FG000|Treatment Period I|Adverse Event|5|||
13230695|NCT01725308|26311965|FG001|Treatment Period I|Adverse Event|4|||
13230696|NCT01725308|26311966|FG002|Treatment Period I|Adverse Event|21|||
13230697|NCT01725308|26311964|FG000|Treatment Period I|Insufficient Response|7|||
13230698|NCT01725308|26311965|FG001|Treatment Period I|Insufficient Response|0|||
13230699|NCT01725308|26311966|FG002|Treatment Period I|Insufficient Response|5|||
13230700|NCT01725308|26311964|FG000|Treatment Period I|Worsening of the Target Disease|8|||
13230701|NCT01725308|26311965|FG001|Treatment Period I|Worsening of the Target Disease|0|||
13230702|NCT01725308|26311966|FG002|Treatment Period I|Worsening of the Target Disease|2|||
13230703|NCT01725308|26311964|FG000|Treatment Period I|Changes in the Episodes|3|||
13230704|NCT01725308|26311965|FG001|Treatment Period I|Changes in the Episodes|0|||
13230705|NCT01725308|26311966|FG002|Treatment Period I|Changes in the Episodes|2|||
13230706|NCT01725308|26311964|FG000|Treatment Period I|Withdrawal of Consent|12|||
13230707|NCT01725308|26311965|FG001|Treatment Period I|Withdrawal of Consent|7|||
13230708|NCT01725308|26311966|FG002|Treatment Period I|Withdrawal of Consent|5|||
13230709|NCT01725308|26311964|FG000|Treatment Period I|Lost to Follow-up|3|||
13230710|NCT01725308|26311965|FG001|Treatment Period I|Lost to Follow-up|2|||
13230711|NCT01725308|26311966|FG002|Treatment Period I|Lost to Follow-up|2|||
13230712|NCT01725308|26311964|FG000|Treatment Period I|Protocol Deviations|3|||
13230713|NCT01725308|26311965|FG001|Treatment Period I|Protocol Deviations|1|||
13230714|NCT01725308|26311966|FG002|Treatment Period I|Protocol Deviations|1|||
13230715|NCT01725308|26311964|FG000|Treatment Period I|Miscellaneous|2|||
13230716|NCT01725308|26311965|FG001|Treatment Period I|Miscellaneous|0|||
13230717|NCT01725308|26311966|FG002|Treatment Period I|Miscellaneous|3|||
13230718|NCT01725308|26311964|FG000|Treatment Period II|Did Not Meet Transition Criteria|0|||
13230719|NCT01725308|26311965|FG001|Treatment Period II|Did Not Meet Transition Criteria|3|||
13230720|NCT01725308|26311966|FG002|Treatment Period II|Did Not Meet Transition Criteria|4|||
13230721|NCT01725308|26311964|FG000|Treatment Period II|Did Not Receive Drug|4|||
13230722|NCT01725308|26311965|FG001|Treatment Period II|Did Not Receive Drug|0|||
13230723|NCT01725308|26311966|FG002|Treatment Period II|Did Not Receive Drug|0|||
13230724|NCT01725308|26311964|FG000|Treatment Period II|Adverse Event|13|||
13230725|NCT01725308|26311965|FG001|Treatment Period II|Adverse Event|8|||
13230726|NCT01725308|26311966|FG002|Treatment Period II|Adverse Event|20|||
13230727|NCT01725308|26311964|FG000|Treatment Period II|Insufficient Response|2|||
13230728|NCT01725308|26311965|FG001|Treatment Period II|Insufficient Response|4|||
13230729|NCT01725308|26311966|FG002|Treatment Period II|Insufficient Response|6|||
13230730|NCT01725308|26311964|FG000|Treatment Period II|Worsening of the Target Disease|1|||
13230731|NCT01725308|26311965|FG001|Treatment Period II|Worsening of the Target Disease|4|||
13230732|NCT01725308|26311966|FG002|Treatment Period II|Worsening of the Target Disease|2|||
13230733|NCT01725308|26311964|FG000|Treatment Period II|Changes in the Episodes|1|||
13230734|NCT01725308|26311965|FG001|Treatment Period II|Changes in the Episodes|0|||
13230735|NCT01725308|26311966|FG002|Treatment Period II|Changes in the Episodes|5|||
13230736|NCT01725308|26311964|FG000|Treatment Period II|Withdrawal of Consent|28|||
13230737|NCT01725308|26311965|FG001|Treatment Period II|Withdrawal of Consent|2|||
13230738|NCT01725308|26311966|FG002|Treatment Period II|Withdrawal of Consent|16|||
13230739|NCT01725308|26311964|FG000|Treatment Period II|Lost to Follow-up|1|||
13230740|NCT01725308|26311965|FG001|Treatment Period II|Lost to Follow-up|5|||
13230741|NCT01725308|26311966|FG002|Treatment Period II|Lost to Follow-up|3|||
13230742|NCT01725308|26311964|FG000|Treatment Period II|Protocol Deviations|0|||
13230743|NCT01725308|26311965|FG001|Treatment Period II|Protocol Deviations|0|||
13230744|NCT01725308|26311966|FG002|Treatment Period II|Protocol Deviations|1|||
13230745|NCT01725308|26311964|FG000|Treatment Period II|Miscellaneous|5|||
13230746|NCT01725308|26311965|FG001|Treatment Period II|Miscellaneous|3|||
13230747|NCT01725308|26311966|FG002|Treatment Period II|Miscellaneous|7|||
13230748|NCT01725282|26312009|FG000|Overall Study|Adverse Event|1|||
13230749|NCT01725282|26312010|FG001|Overall Study|Adverse Event|3|||
13230750|NCT01725282|26312011|FG002|Overall Study|Adverse Event|6|||
13230751|NCT01725282|26312012|FG003|Overall Study|Adverse Event|4|||
13230752|NCT01725282|26312009|FG000|Overall Study|Exacerbation of Target Disease|1|||
13230753|NCT01725282|26312010|FG001|Overall Study|Exacerbation of Target Disease|0|||
13230754|NCT01725282|26312011|FG002|Overall Study|Exacerbation of Target Disease|0|||
13230755|NCT01725282|26312012|FG003|Overall Study|Exacerbation of Target Disease|1|||
13230756|NCT01725282|26312009|FG000|Overall Study|Met Exclusion Criteria|0|||
13230757|NCT01725282|26312010|FG001|Overall Study|Met Exclusion Criteria|0|||
13230758|NCT01725282|26312011|FG002|Overall Study|Met Exclusion Criteria|1|||
13230759|NCT01725282|26312012|FG003|Overall Study|Met Exclusion Criteria|0|||
13230760|NCT01725282|26312009|FG000|Overall Study|Study Site Withdrawal|0|||
13230761|NCT01725282|26312010|FG001|Overall Study|Study Site Withdrawal|1|||
13230762|NCT01725282|26312011|FG002|Overall Study|Study Site Withdrawal|0|||
13230763|NCT01725282|26312012|FG003|Overall Study|Study Site Withdrawal|0|||
13230764|NCT01725282|26312009|FG000|Overall Study|Withdrawal by Subject|0|||
13230765|NCT01725282|26312010|FG001|Overall Study|Withdrawal by Subject|0|||
13230766|NCT01725282|26312011|FG002|Overall Study|Withdrawal by Subject|1|||
13230767|NCT01725282|26312012|FG003|Overall Study|Withdrawal by Subject|1|||
13230768|NCT01725282|26312009|FG000|Overall Study|Lack of Efficacy|0|||
13230769|NCT01725282|26312010|FG001|Overall Study|Lack of Efficacy|1|||
13230770|NCT01725282|26312011|FG002|Overall Study|Lack of Efficacy|0|||
13230771|NCT01725282|26312012|FG003|Overall Study|Lack of Efficacy|1|||
13230772|NCT01725217|26312050|FG000|Overall Study|Withdrawal by Subject|1|||
13230773|NCT01725217|26312051|FG001|Overall Study|Withdrawal by Subject|0|||
13230774|NCT01725217|26312052|FG002|Overall Study|Withdrawal by Subject|0|||
13230775|NCT01725126|26312267|FG000|Overall Study|Protocol Violation|0|||
13230776|NCT01725126|26312268|FG001|Overall Study|Protocol Violation|1|||
13230777|NCT01725126|26312269|FG002|Overall Study|Protocol Violation|0|||
13230778|NCT01725126|26312270|FG003|Overall Study|Protocol Violation|0|||
13230779|NCT01725126|26312271|FG004|Overall Study|Protocol Violation|0|||
13230780|NCT01725126|26312272|FG005|Overall Study|Protocol Violation|0|||
13230781|NCT01725126|26312267|FG000|Overall Study|Withdrawal by Subject|0|||
13230782|NCT01725126|26312268|FG001|Overall Study|Withdrawal by Subject|0|||
13230783|NCT01725126|26312269|FG002|Overall Study|Withdrawal by Subject|0|||
13230784|NCT01725126|26312270|FG003|Overall Study|Withdrawal by Subject|1|||
13230785|NCT01725126|26312271|FG004|Overall Study|Withdrawal by Subject|0|||
13230786|NCT01725126|26312272|FG005|Overall Study|Withdrawal by Subject|0|||
13230787|NCT01724866|26312398|FG000|Overall Study|Adverse Event|0|||
13230788|NCT01724866|26312399|FG001|Overall Study|Adverse Event|0|||
13230789|NCT01724866|26312400|FG002|Overall Study|Adverse Event|1|||
13230790|NCT01724866|26312401|FG003|Overall Study|Adverse Event|1|||
13289669|NCT00107900|26479790|FG000|Overall Study|Lost to Follow-up|4|||
13230791|NCT01724866|26312398|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
13230792|NCT01724866|26312399|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2|||
13230793|NCT01724866|26312400|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
13230794|NCT01724866|26312401|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
13230795|NCT01724866|26312398|FG000|Overall Study|Investigator's Discretion|0|||
13230796|NCT01724866|26312399|FG001|Overall Study|Investigator's Discretion|1|||
13230797|NCT01724866|26312400|FG002|Overall Study|Investigator's Discretion|1|||
13230798|NCT01724866|26312401|FG003|Overall Study|Investigator's Discretion|0|||
13230799|NCT01724866|26312398|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1|||
13230800|NCT01724866|26312399|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
13230801|NCT01724866|26312400|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
13230802|NCT01724866|26312401|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
13230803|NCT01724866|26312398|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
13230804|NCT01724866|26312399|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2|||
13230805|NCT01724866|26312400|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1|||
13230806|NCT01724866|26312401|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
13230807|NCT01724528|26312422|FG000|Overall Study|Death|3|||
13230808|NCT01724528|26312423|FG001|Overall Study|Death|0|||
13230809|NCT01724528|26312422|FG000|Overall Study|Withdrawal by Subject|0|||
13230810|NCT01724528|26312423|FG001|Overall Study|Withdrawal by Subject|2|||
13230811|NCT01724528|26312422|FG000|Overall Study|Protocol Violation|0|||
13230812|NCT01724528|26312423|FG001|Overall Study|Protocol Violation|1|||
13230813|NCT01724528|26312422|FG000|Overall Study|Patient refused to attend last visit|1|||
13230814|NCT01724528|26312423|FG001|Overall Study|Patient refused to attend last visit|0|||
13230815|NCT01724489|26312436|FG000|Overall Study|Adverse Event|8|||
13230816|NCT01724489|26312437|FG001|Overall Study|Adverse Event|3|||
13230817|NCT01724489|26312436|FG000|Overall Study|Surgery, medication|1|||
13230818|NCT01724489|26312437|FG001|Overall Study|Surgery, medication|1|||
13230819|NCT01724489|26312436|FG000|Overall Study|Lost to Follow-up|1|||
13230820|NCT01724489|26312437|FG001|Overall Study|Lost to Follow-up|2|||
13230821|NCT01724489|26312436|FG000|Overall Study|Withdrawal by Subject|6|||
13230822|NCT01724489|26312437|FG001|Overall Study|Withdrawal by Subject|6|||
13230823|NCT01724359|26312452|FG000|Overall Study|Adverse Event|10|||
13230824|NCT01724359|26312452|FG000|Overall Study|Death|1|||
13230825|NCT01724359|26312452|FG000|Overall Study|Other|20|||
13230826|NCT01724216|26312458|FG000|Overall Study|Scan was not completed|1|||
13230827|NCT01724177|26312471|FG000|Overall Study|Adverse Event|8|||
13230828|NCT01724177|26312471|FG000|Overall Study|Progressive disease or Relapsed Disease|16|||
13230829|NCT01724177|26312471|FG000|Overall Study|Nervous participant|1|||
13230830|NCT01724177|26312471|FG000|Overall Study|Serious Adverse Event Related|1|||
13230831|NCT01724021|26312510|FG000|Overall Study|Adverse Event|11|||
13230832|NCT01724021|26312511|FG001|Overall Study|Adverse Event|6|||
13230833|NCT01724021|26312510|FG000|Overall Study|Death|46|||
13230834|NCT01724021|26312511|FG001|Overall Study|Death|58|||
13230835|NCT01724021|26312510|FG000|Overall Study|Participant request/ Withdrew consent|18|||
13230836|NCT01724021|26312511|FG001|Overall Study|Participant request/ Withdrew consent|14|||
13230837|NCT01724021|26312510|FG000|Overall Study|Lost to Follow-up|15|||
13230838|NCT01724021|26312511|FG001|Overall Study|Lost to Follow-up|15|||
13230839|NCT01724021|26312510|FG000|Overall Study|Reason Not Specified|36|||
13230840|NCT01724021|26312511|FG001|Overall Study|Reason Not Specified|39|||
13230841|NCT01724021|26312510|FG000|Overall Study|Missing|1|||
13230842|NCT01724021|26312511|FG001|Overall Study|Missing|1|||
13230843|NCT01723904|26312523|FG000|Overall Study|Noncompliant|3|||
13230844|NCT01723904|26312523|FG000|Overall Study|Adverse Event|5|||
13230845|NCT01723904|26312523|FG000|Overall Study|Unable to follow protocol/ judged by inv|3|||
13230846|NCT01723826|26312566|FG000|Overall Study|Adverse Event|4|||
13230847|NCT01723826|26312567|FG001|Overall Study|Adverse Event|1|||
13230848|NCT01723826|26312568|FG002|Overall Study|Adverse Event|4|||
13230849|NCT01723826|26312569|FG003|Overall Study|Adverse Event|5|||
13230850|NCT01723826|26312566|FG000|Overall Study|Death according to AE eCRF|2|||
13230851|NCT01723826|26312567|FG001|Overall Study|Death according to AE eCRF|3|||
13230852|NCT01723826|26312568|FG002|Overall Study|Death according to AE eCRF|3|||
13230853|NCT01723826|26312569|FG003|Overall Study|Death according to AE eCRF|7|||
13230854|NCT01723826|26312566|FG000|Overall Study|Lost to Follow-up|1|||
13230855|NCT01723826|26312567|FG001|Overall Study|Lost to Follow-up|3|||
13230856|NCT01723826|26312568|FG002|Overall Study|Lost to Follow-up|1|||
13230857|NCT01723826|26312569|FG003|Overall Study|Lost to Follow-up|1|||
13230858|NCT01723826|26312566|FG000|Overall Study|Non-compliance|0|||
13230859|NCT01723826|26312567|FG001|Overall Study|Non-compliance|1|||
13230860|NCT01723826|26312568|FG002|Overall Study|Non-compliance|3|||
13230861|NCT01723826|26312569|FG003|Overall Study|Non-compliance|3|||
13230862|NCT01723826|26312566|FG000|Overall Study|Non-compliance With Study Drug|0|||
13230863|NCT01723826|26312567|FG001|Overall Study|Non-compliance With Study Drug|1|||
13230864|NCT01723826|26312568|FG002|Overall Study|Non-compliance With Study Drug|0|||
13230865|NCT01723826|26312569|FG003|Overall Study|Non-compliance With Study Drug|0|||
13230866|NCT01723826|26312566|FG000|Overall Study|Other Reason|8|||
13230867|NCT01723826|26312567|FG001|Overall Study|Other Reason|6|||
13230868|NCT01723826|26312568|FG002|Overall Study|Other Reason|12|||
13230869|NCT01723826|26312569|FG003|Overall Study|Other Reason|14|||
13230870|NCT01723826|26312566|FG000|Overall Study|Physician Decision|1|||
13230871|NCT01723826|26312567|FG001|Overall Study|Physician Decision|3|||
13230872|NCT01723826|26312568|FG002|Overall Study|Physician Decision|4|||
13230873|NCT01723826|26312569|FG003|Overall Study|Physician Decision|11|||
13230874|NCT01723826|26312566|FG000|Overall Study|Protocol Violation|1|||
13230875|NCT01723826|26312567|FG001|Overall Study|Protocol Violation|1|||
13230876|NCT01723826|26312568|FG002|Overall Study|Protocol Violation|3|||
13230877|NCT01723826|26312569|FG003|Overall Study|Protocol Violation|1|||
13230878|NCT01723826|26312566|FG000|Overall Study|Withdrawal by Subject|10|||
13230879|NCT01723826|26312567|FG001|Overall Study|Withdrawal by Subject|17|||
13230880|NCT01723826|26312568|FG002|Overall Study|Withdrawal by Subject|27|||
13230881|NCT01723826|26312569|FG003|Overall Study|Withdrawal by Subject|48|||
13230882|NCT01723397|26312582|FG000|Study Period 1|Protocol Violation|0|||
13230883|NCT01723397|26312583|FG001|Study Period 1|Protocol Violation|1|||
13230884|NCT01723397|26312582|FG000|Study Period 2|Protocol Violation|0|||
13230885|NCT01723397|26312583|FG001|Study Period 2|Protocol Violation|1|||
13230886|NCT01723254|26312658|FG000|Overall Study|Conflict with work schedule|0|||
13230887|NCT01723254|26312659|FG001|Overall Study|Conflict with work schedule|0|||
13230888|NCT01723254|26312660|FG002|Overall Study|Conflict with work schedule|0|||
13230889|NCT01723254|26312661|FG003|Overall Study|Conflict with work schedule|0|||
13230890|NCT01723254|26312662|FG004|Overall Study|Conflict with work schedule|0|||
13230891|NCT01723254|26312663|FG005|Overall Study|Conflict with work schedule|0|||
13230892|NCT01723254|26312664|FG006|Overall Study|Conflict with work schedule|0|||
13230893|NCT01723254|26312665|FG007|Overall Study|Conflict with work schedule|1|||
13230894|NCT01723254|26312658|FG000|Overall Study|Personal issues|0|||
13230895|NCT01723254|26312659|FG001|Overall Study|Personal issues|0|||
13230896|NCT01723254|26312660|FG002|Overall Study|Personal issues|0|||
13230897|NCT01723254|26312661|FG003|Overall Study|Personal issues|0|||
13230898|NCT01723254|26312662|FG004|Overall Study|Personal issues|0|||
13230899|NCT01723254|26312663|FG005|Overall Study|Personal issues|1|||
13230900|NCT01723254|26312664|FG006|Overall Study|Personal issues|0|||
13230901|NCT01723254|26312665|FG007|Overall Study|Personal issues|0|||
13230902|NCT01723254|26312658|FG000|Overall Study|No longer have time to participate|0|||
13230903|NCT01723254|26312659|FG001|Overall Study|No longer have time to participate|0|||
13230904|NCT01723254|26312660|FG002|Overall Study|No longer have time to participate|0|||
13230905|NCT01723254|26312661|FG003|Overall Study|No longer have time to participate|1|||
13230906|NCT01723254|26312662|FG004|Overall Study|No longer have time to participate|0|||
13230907|NCT01723254|26312663|FG005|Overall Study|No longer have time to participate|0|||
13230908|NCT01723254|26312664|FG006|Overall Study|No longer have time to participate|0|||
13230909|NCT01723254|26312665|FG007|Overall Study|No longer have time to participate|0|||
13230910|NCT01723254|26312658|FG000|Overall Study|Move/Left to another country/city|0|||
13230911|NCT01723254|26312659|FG001|Overall Study|Move/Left to another country/city|0|||
13230912|NCT01723254|26312660|FG002|Overall Study|Move/Left to another country/city|2|||
13230913|NCT01723254|26312661|FG003|Overall Study|Move/Left to another country/city|1|||
13230914|NCT01723254|26312662|FG004|Overall Study|Move/Left to another country/city|1|||
13230915|NCT01723254|26312663|FG005|Overall Study|Move/Left to another country/city|0|||
13230916|NCT01723254|26312664|FG006|Overall Study|Move/Left to another country/city|0|||
13230917|NCT01723254|26312665|FG007|Overall Study|Move/Left to another country/city|0|||
13230918|NCT01723254|26312658|FG000|Overall Study|Protocol Violation|0|||
13230919|NCT01723254|26312659|FG001|Overall Study|Protocol Violation|1|||
13230920|NCT01723254|26312660|FG002|Overall Study|Protocol Violation|0|||
13230921|NCT01723254|26312661|FG003|Overall Study|Protocol Violation|0|||
13230922|NCT01723254|26312662|FG004|Overall Study|Protocol Violation|0|||
13230923|NCT01723254|26312663|FG005|Overall Study|Protocol Violation|0|||
13230924|NCT01723254|26312664|FG006|Overall Study|Protocol Violation|0|||
13230925|NCT01723254|26312665|FG007|Overall Study|Protocol Violation|0|||
13230926|NCT01723254|26312658|FG000|Overall Study|Withdrawal by Subject|1|||
13230927|NCT01723254|26312659|FG001|Overall Study|Withdrawal by Subject|2|||
13230928|NCT01723254|26312660|FG002|Overall Study|Withdrawal by Subject|1|||
13230929|NCT01723254|26312661|FG003|Overall Study|Withdrawal by Subject|0|||
13230930|NCT01723254|26312662|FG004|Overall Study|Withdrawal by Subject|1|||
13230931|NCT01723254|26312663|FG005|Overall Study|Withdrawal by Subject|1|||
13230932|NCT01723254|26312664|FG006|Overall Study|Withdrawal by Subject|1|||
13230933|NCT01723254|26312665|FG007|Overall Study|Withdrawal by Subject|2|||
13230934|NCT01723228|26312688|FG000|Overall Study|Adverse Event|2|||
13230935|NCT01723228|26312689|FG001|Overall Study|Adverse Event|6|||
13230936|NCT01723228|26312688|FG000|Overall Study|Withdrawal by Subject|2|||
13230937|NCT01723228|26312689|FG001|Overall Study|Withdrawal by Subject|1|||
13230938|NCT01723228|26312688|FG000|Overall Study|Protocol Violation|0|||
13485790|NCT00585195|27033429|FG019|Overall Study|Death|0|||
13485791|NCT00585195|27033430|FG020|Overall Study|Death|1|||
13485792|NCT00585195|27033410|FG000|Overall Study|Lost to Follow-up|0|||
13485793|NCT00585195|27033411|FG001|Overall Study|Lost to Follow-up|0|||
13485794|NCT00585195|27033412|FG002|Overall Study|Lost to Follow-up|0|||
13485795|NCT00585195|27033413|FG003|Overall Study|Lost to Follow-up|0|||
13485796|NCT00585195|27033414|FG004|Overall Study|Lost to Follow-up|0|||
13485797|NCT00585195|27033415|FG005|Overall Study|Lost to Follow-up|0|||
13485798|NCT00585195|27033416|FG006|Overall Study|Lost to Follow-up|0|||
13485799|NCT00585195|27033417|FG007|Overall Study|Lost to Follow-up|0|||
13485800|NCT00585195|27033418|FG008|Overall Study|Lost to Follow-up|0|||
13115180|NCT03100058|25917337|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
13230939|NCT01723228|26312689|FG001|Overall Study|Protocol Violation|2|||
13230940|NCT01723228|26312688|FG000|Overall Study|Lost to Follow-up|2|||
13230941|NCT01723228|26312689|FG001|Overall Study|Lost to Follow-up|1|||
13230942|NCT01723228|26312688|FG000|Overall Study|Other|2|||
13230943|NCT01723228|26312689|FG001|Overall Study|Other|1|||
13230944|NCT01723163|26312702|FG000|Treatment Phase|Withdrawal by Subject|14|||
13230945|NCT01723163|26312703|FG001|Treatment Phase|Withdrawal by Subject|6|||
13230946|NCT01723163|26312702|FG000|Treatment Phase|Withdrawal by PI|5|||
13230947|NCT01723163|26312703|FG001|Treatment Phase|Withdrawal by PI|1|||
13230948|NCT01723163|26312702|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
13230949|NCT01723163|26312703|FG001|3-Month Follow-up|Withdrawal by Subject|0|||
13230950|NCT01723163|26312702|FG000|3-Month Follow-up|Unable to Contact|12|||
13230951|NCT01723163|26312703|FG001|3-Month Follow-up|Unable to Contact|19|||
13230952|NCT01723163|26312702|FG000|6-Month Follow-up|Death|1|||
13230953|NCT01723163|26312703|FG001|6-Month Follow-up|Death|0|||
13230954|NCT01723163|26312702|FG000|6-Month Follow-up|Unable to Contact|17|||
13230955|NCT01723163|26312703|FG001|6-Month Follow-up|Unable to Contact|15|||
13230956|NCT01723163|26312702|FG000|12-Month Follow-up|Death|1|||
13230957|NCT01723163|26312703|FG001|12-Month Follow-up|Death|0|||
13230958|NCT01723163|26312702|FG000|12-Month Follow-up|Unable to Contact|23|||
13230959|NCT01723163|26312703|FG001|12-Month Follow-up|Unable to Contact|28|||
13230960|NCT01723072|26312746|FG000|Overall Study|Withdrawal by Subject|7|||
13230961|NCT01723072|26312747|FG001|Overall Study|Withdrawal by Subject|13|||
13230962|NCT01723072|26312746|FG000|Overall Study|Discon for rescue medication after wk 24|0|||
13115181|NCT03100058|25917338|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
13115182|NCT03100058|25917339|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
13115183|NCT03100058|25917340|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
13115184|NCT03100058|25917341|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
13115185|NCT03100058|25917342|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
13115186|NCT03100058|25917343|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
13115187|NCT03100058|25917344|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
13115188|NCT03100058|25917345|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
13115189|NCT03100058|25917346|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1|||
13115190|NCT03100058|25917347|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
13115191|NCT03100058|25917348|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
13115192|NCT03100058|25917336|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
13115193|NCT03100058|25917337|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
13115194|NCT03100058|25917338|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
13115195|NCT03100058|25917339|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
13115196|NCT03100058|25917340|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
13115197|NCT03100058|25917341|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
13115198|NCT03100058|25917342|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
13115199|NCT03100058|25917343|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
13115200|NCT03100058|25917344|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
13115201|NCT03100058|25917345|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
13115202|NCT03100058|25917346|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
13115203|NCT03100058|25917347|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
13115204|NCT03100058|25917348|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1|||
13115205|NCT03100058|25917336|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
13115206|NCT03100058|25917337|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
13115207|NCT03100058|25917338|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
13115208|NCT03100058|25917339|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
13115209|NCT03100058|25917340|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
13115210|NCT03100058|25917341|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
13115211|NCT03100058|25917342|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
13133376|NCT02771210|25987552|FG001|Period 2|Withdrawal by Subject|0|||
13230963|NCT01723072|26312747|FG001|Overall Study|Discon for rescue medication after wk 24|5|||
13230964|NCT01723072|26312746|FG000|Overall Study|Other|4|||
13230965|NCT01723072|26312747|FG001|Overall Study|Other|3|||
13485801|NCT00585195|27033419|FG009|Overall Study|Lost to Follow-up|0|||
13485802|NCT00585195|27033420|FG010|Overall Study|Lost to Follow-up|0|||
13115212|NCT03100058|25917343|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
13115213|NCT03100058|25917344|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
13115214|NCT03100058|25917345|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1|||
13115215|NCT03100058|25917346|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
13115216|NCT03100058|25917347|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
13115217|NCT03100058|25917348|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
13115218|NCT03099694|25917383|FG000|Overall Study|Withdrawal by Subject|11|||
13115219|NCT03099694|25917384|FG001|Overall Study|Withdrawal by Subject|13|||
13115220|NCT03099694|25917383|FG000|Overall Study|Lost to Follow-up|9|||
13115221|NCT03099694|25917384|FG001|Overall Study|Lost to Follow-up|5|||
13115222|NCT03099538|25917396|FG000|Overall Study|Lack of Efficacy|3|||
13115223|NCT03099304|25917710|FG000|DB Period: Day 1 to Week 24|Adverse Event|1|||
13115224|NCT03099304|25917711|FG001|DB Period: Day 1 to Week 24|Adverse Event|1|||
13115225|NCT03099304|25917712|FG002|DB Period: Day 1 to Week 24|Adverse Event|0|||
13115226|NCT03099304|25917713|FG003|DB Period: Day 1 to Week 24|Adverse Event|0|||
13115227|NCT03099304|25917714|FG004|DB Period: Day 1 to Week 24|Adverse Event|1|||
13115228|NCT03099304|25917715|FG005|DB Period: Day 1 to Week 24|Adverse Event|0|||
13115229|NCT03099304|25917710|FG000|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
13115230|NCT03099304|25917711|FG001|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
13115231|NCT03099304|25917712|FG002|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
13115232|NCT03099304|25917713|FG003|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
13115233|NCT03099304|25917714|FG004|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
13115234|NCT03099304|25917715|FG005|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
13230966|NCT01722994|26312768|FG000|Overall Study|Missing data|25|||
13230967|NCT01722994|26312769|FG001|Overall Study|Missing data|17|||
13230968|NCT01722877|26312778|FG000|Overall Study|Death|1|||
13230969|NCT01722877|26312778|FG000|Overall Study|Lost to Follow-up|1|||
13230970|NCT01722669|26312817|FG000|Overall Study|Withdrawal by Subject|0|||
13230971|NCT01722669|26312818|FG001|Overall Study|Withdrawal by Subject|0|||
13230972|NCT01722669|26312819|FG002|Overall Study|Withdrawal by Subject|0|||
13230973|NCT01722669|26312820|FG003|Overall Study|Withdrawal by Subject|0|||
13230974|NCT01722669|26312821|FG004|Overall Study|Withdrawal by Subject|0|||
13230975|NCT01722669|26312822|FG005|Overall Study|Withdrawal by Subject|2|||
13230976|NCT01722162|26312837|FG000|Overall Study|Withdrawal by Subject|1|||
13230977|NCT01722162|26312838|FG001|Overall Study|Withdrawal by Subject|1|||
13230978|NCT01722162|26312837|FG000|Overall Study|Found ineligible|1|||
13230979|NCT01722162|26312838|FG001|Overall Study|Found ineligible|0|||
13230980|NCT01722162|26312837|FG000|Overall Study|Unrelated to study adverse event|2|||
13230981|NCT01722162|26312838|FG001|Overall Study|Unrelated to study adverse event|2|||
13230982|NCT01722162|26312837|FG000|Overall Study|Adverse Event|1|||
13230983|NCT01722162|26312838|FG001|Overall Study|Adverse Event|1|||
13230984|NCT01722162|26312837|FG000|Overall Study|Insurance denial post enrollment|0|||
13230985|NCT01722162|26312838|FG001|Overall Study|Insurance denial post enrollment|1|||
13230986|NCT01722162|26312837|FG000|Overall Study|Noncompliance|0|||
13230987|NCT01722162|26312838|FG001|Overall Study|Noncompliance|1|||
13230988|NCT01722097|26312853|FG000|Overall Study|Patient sheets not returned|6|||
13230989|NCT01722097|26312854|FG001|Overall Study|Patient sheets not returned|5|||
13230990|NCT01722071|26312863|FG000|Overall Study|Protocol Violation|1|||
13230991|NCT01722071|26312864|FG001|Overall Study|Protocol Violation|0|||
13230992|NCT01722045|26312876|FG000|Overall Study|Adverse Event|8|||
13230993|NCT01722045|26312876|FG000|Overall Study|Death|3|||
13230994|NCT01722045|26312876|FG000|Overall Study|Withdrawal by Subject|8|||
13230995|NCT01722045|26312876|FG000|Overall Study|Lost to Follow-up|4|||
13230996|NCT01722045|26312876|FG000|Overall Study|Protocol Deviation|1|||
13230997|NCT01722045|26312876|FG000|Overall Study|Physician Decision|3|||
13230998|NCT01722045|26312876|FG000|Overall Study|Relocation (did not wish to transfer)|1|||
13230999|NCT01721954|26312891|FG000|Overall Study|Death|58|||
13231000|NCT01721954|26312892|FG001|Overall Study|Death|64|||
13231001|NCT01721954|26312891|FG000|Overall Study|Withdrawal by Subject|8|||
13231002|NCT01721954|26312892|FG001|Overall Study|Withdrawal by Subject|4|||
13231003|NCT01721954|26312891|FG000|Overall Study|Adverse Event|2|||
13231004|NCT01721954|26312892|FG001|Overall Study|Adverse Event|0|||
13231005|NCT01721954|26312891|FG000|Overall Study|Lost to Follow-up|2|||
13231006|NCT01721954|26312892|FG001|Overall Study|Lost to Follow-up|1|||
13231007|NCT01721876|26312911|FG000|Overall Study|Not treated|1|||
13231008|NCT01721876|26312912|FG001|Overall Study|Not treated|4|||
13231009|NCT01721876|26312911|FG000|Overall Study|Disease progression / relapse|123|||
13231010|NCT01721876|26312912|FG001|Overall Study|Disease progression / relapse|156|||
13231011|NCT01721876|26312911|FG000|Overall Study|Death|6|||
13231012|NCT01721876|26312912|FG001|Overall Study|Death|13|||
13231013|NCT01721876|26312911|FG000|Overall Study|Adverse Event|41|||
13231014|NCT01721876|26312912|FG001|Overall Study|Adverse Event|165|||
13231015|NCT01721876|26312911|FG000|Overall Study|Protocol Violation|2|||
13231016|NCT01721876|26312912|FG001|Overall Study|Protocol Violation|1|||
13231017|NCT01721876|26312911|FG000|Overall Study|Withdrawal by Subject|15|||
13289670|NCT00107900|26479791|FG001|Overall Study|Lost to Follow-up|1|||
13231018|NCT01721876|26312912|FG001|Overall Study|Withdrawal by Subject|38|||
13231019|NCT01721876|26312911|FG000|Overall Study|Reason not listed|34|||
13231020|NCT01721876|26312912|FG001|Overall Study|Reason not listed|63|||
13231021|NCT01721876|26312911|FG000|Overall Study|Sponsor terminated trial|0|||
13231022|NCT01721876|26312912|FG001|Overall Study|Sponsor terminated trial|4|||
13231023|NCT01721772|26312941|FG000|Pre-Treatment|Participant no longer meets study criteria|3|||
13231024|NCT01721772|26312942|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
13231025|NCT01721772|26312941|FG000|Pre-Treatment|Poor/non-compliance|0|||
13231026|NCT01721772|26312942|FG001|Pre-Treatment|Poor/non-compliance|1|||
13231027|NCT01721772|26312941|FG000|Pre-Treatment|Participant withdrew consent|0|||
13231028|NCT01721772|26312942|FG001|Pre-Treatment|Participant withdrew consent|1|||
13231029|NCT01721772|26312941|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
13231030|NCT01721772|26312942|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
13231031|NCT01721772|26312941|FG000|Treatment|Disease progression|119|||
13231032|NCT01721772|26312942|FG001|Treatment|Disease progression|168|||
13231033|NCT01721772|26312941|FG000|Treatment|Study drug toxicity|19|||
13231034|NCT01721772|26312942|FG001|Treatment|Study drug toxicity|10|||
13231035|NCT01721772|26312941|FG000|Treatment|Adverse event unrelated to study drug|7|||
13231036|NCT01721772|26312942|FG001|Treatment|Adverse event unrelated to study drug|7|||
13231037|NCT01721772|26312941|FG000|Treatment|Maximum clinical benefit|16|||
13231038|NCT01721772|26312942|FG001|Treatment|Maximum clinical benefit|4|||
13231039|NCT01721772|26312941|FG000|Treatment|Other|19|||
13231040|NCT01721772|26312942|FG001|Treatment|Other|2|||
13231041|NCT01721772|26312941|FG000|Treatment|Participant withdrew consent|2|||
13231042|NCT01721772|26312942|FG001|Treatment|Participant withdrew consent|5|||
13231043|NCT01721772|26312941|FG000|Treatment|Participant request to discontinue study treatment|21|||
13231044|NCT01721772|26312942|FG001|Treatment|Participant request to discontinue study treatment|8|||
13231045|NCT01721772|26312941|FG000|Treatment|Death|1|||
13231046|NCT01721772|26312942|FG001|Treatment|Death|0|||
13231047|NCT01721772|26312941|FG000|Treatment|Not reported|1|||
13231048|NCT01721772|26312942|FG001|Treatment|Not reported|0|||
13231049|NCT01721772|26312941|FG000|Treatment|Poor/non-compliance|1|||
13231050|NCT01721772|26312942|FG001|Treatment|Poor/non-compliance|0|||
13231051|NCT01721772|26312941|FG000|Treatment|Lost to Follow-up|0|||
13231052|NCT01721772|26312942|FG001|Treatment|Lost to Follow-up|1|||
13231053|NCT01721759|26312952|FG000|Treatment Period|Disease Progression|85|||
13231054|NCT01721759|26312952|FG000|Treatment Period|Study drug toxicity|14|||
13231055|NCT01721759|26312952|FG000|Treatment Period|Death|1|||
13231056|NCT01721759|26312952|FG000|Treatment Period|Adverse event unrelated to study drug|11|||
13231057|NCT01721759|26312952|FG000|Treatment Period|Participant request to withdraw|3|||
13231058|NCT01721759|26312952|FG000|Treatment Period|Other Reasons|3|||
13231059|NCT01721759|26312952|FG000|End of Study Period|Participant Withdrew Consent|5|||
13231060|NCT01721759|26312952|FG000|End of Study Period|Death|101|||
13231061|NCT01721759|26312952|FG000|End of Study Period|Lost to Follow-up|1|||
13231062|NCT01721759|26312952|FG000|End of Study Period|Other Reasons|10|||
13231063|NCT01721746|26312977|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0|||
13231064|NCT01721746|26312978|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13|||
13231065|NCT01721746|26312977|FG000|Pre-Treatment|Withdrawal by Subject|1|||
13231066|NCT01721746|26312978|FG001|Pre-Treatment|Withdrawal by Subject|16|||
13231067|NCT01721746|26312977|FG000|Pre-Treatment|Poor/Non-compliance|1|||
13231068|NCT01721746|26312978|FG001|Pre-Treatment|Poor/Non-compliance|0|||
13231069|NCT01721746|26312977|FG000|Pre-Treatment|Participant no longer met study criteria|2|||
13231070|NCT01721746|26312978|FG001|Pre-Treatment|Participant no longer met study criteria|2|||
13231071|NCT01721746|26312977|FG000|Treatment|Disease Progression|192|||
13231072|NCT01721746|26312978|FG001|Treatment|Disease Progression|74|||
13231073|NCT01721746|26312977|FG000|Treatment|Study Drug Toxicity|19|||
13231074|NCT01721746|26312978|FG001|Treatment|Study Drug Toxicity|11|||
13231075|NCT01721746|26312977|FG000|Treatment|Adverse Event unrelated to Study Drug|6|||
13231076|NCT01721746|26312978|FG001|Treatment|Adverse Event unrelated to Study Drug|3|||
13231077|NCT01721746|26312977|FG000|Treatment|Participant request to discontinue Study treatment|26|||
13231078|NCT01721746|26312978|FG001|Treatment|Participant request to discontinue Study treatment|7|||
13231079|NCT01721746|26312977|FG000|Treatment|Participant withdrew consent|4|||
13231080|NCT01721746|26312978|FG001|Treatment|Participant withdrew consent|2|||
13231081|NCT01721746|26312977|FG000|Treatment|Maximum Clinical Benefit|9|||
13231082|NCT01721746|26312978|FG001|Treatment|Maximum Clinical Benefit|3|||
13231083|NCT01721746|26312977|FG000|Treatment|Poor/Non-compliance|2|||
13231084|NCT01721746|26312978|FG001|Treatment|Poor/Non-compliance|0|||
13231085|NCT01721746|26312977|FG000|Treatment|Participant no longer met Study criteria|4|||
13231086|NCT01721746|26312978|FG001|Treatment|Participant no longer met Study criteria|0|||
13231087|NCT01721746|26312977|FG000|Treatment|Other reasons|6|||
13231088|NCT01721746|26312978|FG001|Treatment|Other reasons|2|||
13231089|NCT01721486|26312997|FG000|Overall Study|Protocol Violation|1|||
13231090|NCT01721486|26312998|FG001|Overall Study|Protocol Violation|0|||
13231091|NCT01721486|26312997|FG000|Overall Study|Physician Decision|0|||
13231092|NCT01721486|26312998|FG001|Overall Study|Physician Decision|1|||
13231093|NCT01721408|26313019|FG000|Overall Study|Adverse Event|6|||
13231094|NCT01721408|26313020|FG001|Overall Study|Adverse Event|1|||
13231095|NCT01721408|26313019|FG000|Overall Study|Death|1|||
13231096|NCT01721408|26313020|FG001|Overall Study|Death|0|||
13231097|NCT01721408|26313019|FG000|Overall Study|Insufficient clinical response|15|||
13231098|NCT01721408|26313020|FG001|Overall Study|Insufficient clinical response|6|||
13231099|NCT01721408|26313019|FG000|Overall Study|No longer willing to participate study|9|||
13231100|NCT01721408|26313020|FG001|Overall Study|No longer willing to participate study|10|||
13231101|NCT01721408|26313019|FG000|Overall Study|Protocol Violation|0|||
13231102|NCT01721408|26313020|FG001|Overall Study|Protocol Violation|2|||
13231103|NCT01721408|26313019|FG000|Overall Study|Other|3|||
13231104|NCT01721408|26313020|FG001|Overall Study|Other|3|||
13231105|NCT01721408|26313019|FG000|Overall Study|Lost to Follow-up|1|||
13231106|NCT01721408|26313020|FG001|Overall Study|Lost to Follow-up|2|||
13231107|NCT01721408|26313019|FG000|Overall Study|Does not meet entrance criteria|1|||
13231108|NCT01721408|26313020|FG001|Overall Study|Does not meet entrance criteria|0|||
13231109|NCT01721369|26313026|FG000|Overall Study|Not initial etiological diagnosis|12|||
13231110|NCT01721330|26313039|FG000|Overall Study|Withdrawal by Subject|0|||
13231111|NCT01721330|26313040|FG001|Overall Study|Withdrawal by Subject|1|||
13231112|NCT01721317|26313113|FG000|Overall Study|Study Closed / Terminated|2|||
13231113|NCT01721317|26313114|FG001|Overall Study|Study Closed / Terminated|2|||
13231114|NCT01721317|26313113|FG000|Overall Study|Physician Decision|0|||
13231115|NCT01721317|26313114|FG001|Overall Study|Physician Decision|1|||
13231116|NCT01721317|26313113|FG000|Overall Study|Withdrawal by Subject|0|||
13231117|NCT01721317|26313114|FG001|Overall Study|Withdrawal by Subject|1|||
13231118|NCT01721200|26313144|FG000|Overall Study|Lost to Follow-up|3|||
13231119|NCT01721200|26313145|FG001|Overall Study|Lost to Follow-up|5|||
13231120|NCT01721161|26313175|FG000|Overall Study|Adverse Event|2|||
13231121|NCT01721161|26313176|FG001|Overall Study|Adverse Event|3|||
13231122|NCT01721161|26313175|FG000|Overall Study|Lost to Follow-up|1|||
13231123|NCT01721161|26313176|FG001|Overall Study|Lost to Follow-up|2|||
13231124|NCT01721161|26313175|FG000|Overall Study|Withdrawal by Subject|1|||
13231125|NCT01721161|26313176|FG001|Overall Study|Withdrawal by Subject|1|||
13231126|NCT01721161|26313175|FG000|Overall Study|Other|0|||
13231127|NCT01721161|26313176|FG001|Overall Study|Other|1|||
13231128|NCT01721109|26313191|FG000|Overall Study|Lack of Efficacy|1|||
13231129|NCT01721109|26313191|FG000|Overall Study|Non- Compliance with Study Drug|3|||
13231130|NCT01721109|26313191|FG000|Overall Study|Withdrew Consent|1|||
13231131|NCT01721109|26313191|FG000|Overall Study|Lost to Follow-up|2|||
13231132|NCT01721070|26313201|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1|||
13231133|NCT01721057|26313285|FG000|Treatment Period|Withdrawal by Subject|11|||
13231134|NCT01721057|26313286|FG001|Treatment Period|Withdrawal by Subject|5|||
13231135|NCT01721057|26313287|FG002|Treatment Period|Withdrawal by Subject|8|||
13231136|NCT01721057|26313288|FG003|Treatment Period|Withdrawal by Subject|0|||
13231137|NCT01721057|26313289|FG004|Treatment Period|Withdrawal by Subject|0|||
13231138|NCT01721057|26313290|FG005|Treatment Period|Withdrawal by Subject|0|||
13231139|NCT01721057|26313291|FG006|Treatment Period|Withdrawal by Subject|0|||
13231140|NCT01721057|26313285|FG000|Treatment Period|Adverse Event|7|||
13231141|NCT01721057|26313286|FG001|Treatment Period|Adverse Event|10|||
13231142|NCT01721057|26313287|FG002|Treatment Period|Adverse Event|12|||
13231143|NCT01721057|26313288|FG003|Treatment Period|Adverse Event|0|||
13231144|NCT01721057|26313289|FG004|Treatment Period|Adverse Event|0|||
13231145|NCT01721057|26313290|FG005|Treatment Period|Adverse Event|0|||
13231146|NCT01721057|26313291|FG006|Treatment Period|Adverse Event|0|||
13231147|NCT01721057|26313285|FG000|Treatment Period|Lack of Efficacy|7|||
13231148|NCT01721057|26313286|FG001|Treatment Period|Lack of Efficacy|3|||
13231149|NCT01721057|26313287|FG002|Treatment Period|Lack of Efficacy|0|||
13231150|NCT01721057|26313288|FG003|Treatment Period|Lack of Efficacy|0|||
13231151|NCT01721057|26313289|FG004|Treatment Period|Lack of Efficacy|0|||
13231152|NCT01721057|26313290|FG005|Treatment Period|Lack of Efficacy|0|||
13231153|NCT01721057|26313291|FG006|Treatment Period|Lack of Efficacy|0|||
13231154|NCT01721057|26313285|FG000|Treatment Period|Lost to Follow-up|1|||
13231155|NCT01721057|26313286|FG001|Treatment Period|Lost to Follow-up|0|||
13231156|NCT01721057|26313287|FG002|Treatment Period|Lost to Follow-up|0|||
13231157|NCT01721057|26313288|FG003|Treatment Period|Lost to Follow-up|0|||
13231158|NCT01721057|26313289|FG004|Treatment Period|Lost to Follow-up|0|||
13231159|NCT01721057|26313290|FG005|Treatment Period|Lost to Follow-up|0|||
13231160|NCT01721057|26313291|FG006|Treatment Period|Lost to Follow-up|0|||
13231161|NCT01721057|26313285|FG000|Treatment Period|Physician Decision|0|||
13231162|NCT01721057|26313286|FG001|Treatment Period|Physician Decision|1|||
13231163|NCT01721057|26313287|FG002|Treatment Period|Physician Decision|3|||
13231164|NCT01721057|26313288|FG003|Treatment Period|Physician Decision|0|||
13231165|NCT01721057|26313289|FG004|Treatment Period|Physician Decision|0|||
13231166|NCT01721057|26313290|FG005|Treatment Period|Physician Decision|0|||
13231167|NCT01721057|26313291|FG006|Treatment Period|Physician Decision|0|||
13231168|NCT01721057|26313285|FG000|Treatment Period|Death|2|||
13231169|NCT01721057|26313286|FG001|Treatment Period|Death|0|||
13231170|NCT01721057|26313287|FG002|Treatment Period|Death|0|||
13231171|NCT01721057|26313288|FG003|Treatment Period|Death|0|||
13231172|NCT01721057|26313289|FG004|Treatment Period|Death|0|||
13231173|NCT01721057|26313290|FG005|Treatment Period|Death|0|||
13231174|NCT01721057|26313291|FG006|Treatment Period|Death|0|||
13231175|NCT01721057|26313285|FG000|Rescue Period|Adverse Event|0|||
13231176|NCT01721057|26313286|FG001|Rescue Period|Adverse Event|0|||
13231177|NCT01721057|26313287|FG002|Rescue Period|Adverse Event|0|||
13231178|NCT01721057|26313288|FG003|Rescue Period|Adverse Event|1|||
13231179|NCT01721057|26313289|FG004|Rescue Period|Adverse Event|0|||
13231180|NCT01721057|26313290|FG005|Rescue Period|Adverse Event|0|||
13231181|NCT01721057|26313291|FG006|Rescue Period|Adverse Event|0|||
13231182|NCT01721057|26313285|FG000|Rescue Period|Lack of Efficacy|0|||
13231183|NCT01721057|26313286|FG001|Rescue Period|Lack of Efficacy|0|||
13231184|NCT01721057|26313287|FG002|Rescue Period|Lack of Efficacy|0|||
13231185|NCT01721057|26313288|FG003|Rescue Period|Lack of Efficacy|2|||
13231186|NCT01721057|26313289|FG004|Rescue Period|Lack of Efficacy|0|||
13231187|NCT01721057|26313290|FG005|Rescue Period|Lack of Efficacy|0|||
13231188|NCT01721057|26313291|FG006|Rescue Period|Lack of Efficacy|0|||
13231189|NCT01721044|26313372|FG000|Treatment Period|Adverse Event|7|||
13231190|NCT01721044|26313373|FG001|Treatment Period|Adverse Event|7|||
13231191|NCT01721044|26313374|FG002|Treatment Period|Adverse Event|10|||
13231192|NCT01721044|26313372|FG000|Treatment Period|Death|0|||
13231193|NCT01721044|26313373|FG001|Treatment Period|Death|0|||
13231194|NCT01721044|26313374|FG002|Treatment Period|Death|1|||
13231195|NCT01721044|26313372|FG000|Treatment Period|Lack of Efficacy|16|||
13231196|NCT01721044|26313373|FG001|Treatment Period|Lack of Efficacy|4|||
13231197|NCT01721044|26313374|FG002|Treatment Period|Lack of Efficacy|4|||
13231198|NCT01721044|26313372|FG000|Treatment Period|Lost to Follow-up|0|||
13231199|NCT01721044|26313373|FG001|Treatment Period|Lost to Follow-up|0|||
13231200|NCT01721044|26313374|FG002|Treatment Period|Lost to Follow-up|1|||
13231201|NCT01721044|26313372|FG000|Treatment Period|Physician Decision|1|||
13231202|NCT01721044|26313373|FG001|Treatment Period|Physician Decision|0|||
13231203|NCT01721044|26313374|FG002|Treatment Period|Physician Decision|2|||
13231204|NCT01721044|26313372|FG000|Treatment Period|Protocol Violation|1|||
13231205|NCT01721044|26313373|FG001|Treatment Period|Protocol Violation|0|||
13231206|NCT01721044|26313374|FG002|Treatment Period|Protocol Violation|0|||
13231207|NCT01721044|26313372|FG000|Treatment Period|Withdrawal by Subject|7|||
13231208|NCT01721044|26313373|FG001|Treatment Period|Withdrawal by Subject|6|||
13231209|NCT01721044|26313374|FG002|Treatment Period|Withdrawal by Subject|1|||
13231210|NCT01720797|26313387|FG000|Overall Study|Withdrawal by Subject|3|||
13231211|NCT01720797|26313388|FG001|Overall Study|Withdrawal by Subject|0|||
13231212|NCT01720667|26313409|FG000|Overall Study|Adverse Event|1|||
13231213|NCT01720667|26313410|FG001|Overall Study|Adverse Event|1|||
13231214|NCT01720667|26313409|FG000|Overall Study|Withdrawal by Subject|3|||
13231215|NCT01720667|26313410|FG001|Overall Study|Withdrawal by Subject|0|||
13231216|NCT01720602|26313420|FG000|Overall Study|Adverse Event|3|||
13231217|NCT01720602|26313420|FG000|Overall Study|Progressive disease on therapy|2|||
13231218|NCT01720524|26313494|FG000|Part A|Insufficient Clinical Response|2|||
13231219|NCT01720524|26313495|FG001|Part A|Insufficient Clinical Response|4|||
13231220|NCT01720524|26313494|FG000|Part A|Adverse Event|2|||
13231221|NCT01720524|26313495|FG001|Part A|Adverse Event|2|||
13231222|NCT01720524|26313494|FG000|Part A|Death|2|||
13231223|NCT01720524|26313495|FG001|Part A|Death|1|||
13231224|NCT01720524|26313494|FG000|Part A|Lost to Follow-up|0|||
13231225|NCT01720524|26313495|FG001|Part A|Lost to Follow-up|1|||
13231226|NCT01720524|26313494|FG000|Part A|Missed 28 day follow-up visit|1|||
13231227|NCT01720524|26313495|FG001|Part A|Missed 28 day follow-up visit|1|||
13231228|NCT01720524|26313494|FG000|Part A|Withdrawal by Subject|0|||
13231229|NCT01720524|26313495|FG001|Part A|Withdrawal by Subject|1|||
13231230|NCT01720524|26313494|FG000|Part A|Other|0|||
13231231|NCT01720524|26313495|FG001|Part A|Other|1|||
13231232|NCT01720524|26313494|FG000|Part A|Lost to Follow-up|0|||
13231233|NCT01720524|26313495|FG001|Part A|Lost to Follow-up|1|||
13231234|NCT01720524|26313494|FG000|Part B|No longer willing to participate in study|1|||
13231235|NCT01720524|26313495|FG001|Part B|No longer willing to participate in study|4|||
13231236|NCT01720524|26313494|FG000|Part B|Other|2|||
13231237|NCT01720524|26313495|FG001|Part B|Other|0|||
13231238|NCT01720524|26313494|FG000|Part B|Lost to Follow-up|2|||
13231239|NCT01720524|26313495|FG001|Part B|Lost to Follow-up|3|||
13231240|NCT01720524|26313494|FG000|Part B|Death|0|||
13231241|NCT01720524|26313495|FG001|Part B|Death|2|||
13231242|NCT01720446|26313567|FG000|Overall Study|Lost to Follow-up|12|||
13231243|NCT01720446|26313568|FG001|Overall Study|Lost to Follow-up|6|||
13231244|NCT01720446|26313569|FG002|Overall Study|Lost to Follow-up|16|||
13231245|NCT01720446|26313570|FG003|Overall Study|Lost to Follow-up|16|||
13231246|NCT01720446|26313567|FG000|Overall Study|Withdrawal by Subject|2|||
13231247|NCT01720446|26313568|FG001|Overall Study|Withdrawal by Subject|5|||
13231248|NCT01720446|26313569|FG002|Overall Study|Withdrawal by Subject|4|||
13231249|NCT01720446|26313570|FG003|Overall Study|Withdrawal by Subject|4|||
13231250|NCT01720264|26313579|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1|||
13231251|NCT01720264|26313579|FG000|Post-transplant (Day 16) to 1 Year|Death|8|||
13231252|NCT01720264|26313579|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4|||
13231253|NCT01720225|26313594|FG000|Overall Study|Withdrawal by Subject|0|||
13231254|NCT01720225|26313595|FG001|Overall Study|Withdrawal by Subject|1|||
13231255|NCT01720225|26313594|FG000|Overall Study|Did not complete 2 cycles of therapy|3|||
13231256|NCT01720225|26313595|FG001|Overall Study|Did not complete 2 cycles of therapy|0|||
13231257|NCT01720069|26313631|FG000|Overall Study|Could not use e-diary correctly|0|||
13231258|NCT01720069|26313632|FG001|Overall Study|Could not use e-diary correctly|1|||
13231259|NCT01720069|26313633|FG002|Overall Study|Could not use e-diary correctly|1|||
13231260|NCT01720069|26313631|FG000|Overall Study|Randomised without baseline values|0|||
13231261|NCT01720069|26313632|FG001|Overall Study|Randomised without baseline values|0|||
13231262|NCT01720069|26313633|FG002|Overall Study|Randomised without baseline values|1|||
13231263|NCT01720069|26313631|FG000|Overall Study|Adverse Event|0|||
13231264|NCT01720069|26313632|FG001|Overall Study|Adverse Event|0|||
13231265|NCT01720069|26313633|FG002|Overall Study|Adverse Event|1|||
13115235|NCT03099304|25917710|FG000|DB Period: Day 1 to Week 24|Reason not specified|0|||
13115236|NCT03099304|25917711|FG001|DB Period: Day 1 to Week 24|Reason not specified|0|||
13115237|NCT03099304|25917712|FG002|DB Period: Day 1 to Week 24|Reason not specified|0|||
13115238|NCT03099304|25917713|FG003|DB Period: Day 1 to Week 24|Reason not specified|1|||
13115239|NCT03099304|25917714|FG004|DB Period: Day 1 to Week 24|Reason not specified|0|||
13115240|NCT03099304|25917715|FG005|DB Period: Day 1 to Week 24|Reason not specified|0|||
13115241|NCT03099304|25917710|FG000|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
13115242|NCT03099304|25917711|FG001|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
13115243|NCT03099304|25917712|FG002|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
13115244|NCT03099304|25917713|FG003|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
13115245|NCT03099304|25917714|FG004|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
13115246|NCT03099304|25917715|FG005|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
13115247|NCT03099304|25917710|FG000|DB Period: Day 1 to Week 24|Protocol Violation|0|||
13115248|NCT03099304|25917711|FG001|DB Period: Day 1 to Week 24|Protocol Violation|0|||
13115249|NCT03099304|25917712|FG002|DB Period: Day 1 to Week 24|Protocol Violation|1|||
13115250|NCT03099304|25917713|FG003|DB Period: Day 1 to Week 24|Protocol Violation|1|||
13115251|NCT03099304|25917714|FG004|DB Period: Day 1 to Week 24|Protocol Violation|0|||
13115252|NCT03099304|25917715|FG005|DB Period: Day 1 to Week 24|Protocol Violation|0|||
13115253|NCT03099304|25917710|FG000|DB Period: Weeks 24 to 52|Protocol Violation|0|||
13115254|NCT03099304|25917711|FG001|DB Period: Weeks 24 to 52|Protocol Violation|0|||
13115255|NCT03099304|25917712|FG002|DB Period: Weeks 24 to 52|Protocol Violation|1|||
13115256|NCT03099304|25917713|FG003|DB Period: Weeks 24 to 52|Protocol Violation|0|||
13115257|NCT03099304|25917714|FG004|DB Period: Weeks 24 to 52|Protocol Violation|0|||
13115258|NCT03099304|25917715|FG005|DB Period: Weeks 24 to 52|Protocol Violation|0|||
13115259|NCT03099304|25917710|FG000|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
13115260|NCT03099304|25917711|FG001|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
13115261|NCT03099304|25917712|FG002|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
13115262|NCT03099304|25917713|FG003|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
13115263|NCT03099304|25917714|FG004|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
13115264|NCT03099304|25917715|FG005|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
13115265|NCT03099304|25917710|FG000|DB Period: Weeks 24 to 52|Adverse Event|0|||
13115266|NCT03099304|25917711|FG001|DB Period: Weeks 24 to 52|Adverse Event|0|||
13115267|NCT03099304|25917712|FG002|DB Period: Weeks 24 to 52|Adverse Event|0|||
13115268|NCT03099304|25917713|FG003|DB Period: Weeks 24 to 52|Adverse Event|1|||
13231266|NCT01720069|26313631|FG000|Overall Study|Lack of Efficacy|0|||
13231267|NCT01720069|26313632|FG001|Overall Study|Lack of Efficacy|4|||
13231268|NCT01720069|26313633|FG002|Overall Study|Lack of Efficacy|0|||
13231269|NCT01720069|26313631|FG000|Overall Study|Treatment period withdrawal criteria met|4|||
13231270|NCT01720069|26313632|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
13231271|NCT01720069|26313633|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
13231272|NCT01720069|26313631|FG000|Overall Study|Withdrawal by Subject|0|||
13231273|NCT01720069|26313632|FG001|Overall Study|Withdrawal by Subject|2|||
13231274|NCT01720069|26313633|FG002|Overall Study|Withdrawal by Subject|1|||
13231275|NCT01720069|26313631|FG000|Overall Study|OCS bursts occured, discontinued in line|1|||
13231276|NCT01720069|26313632|FG001|Overall Study|OCS bursts occured, discontinued in line|0|||
13231277|NCT01720069|26313633|FG002|Overall Study|OCS bursts occured, discontinued in line|0|||
13231278|NCT01720069|26313631|FG000|Overall Study|Non-compliance on using e-diary|0|||
13231279|NCT01720069|26313632|FG001|Overall Study|Non-compliance on using e-diary|0|||
13231280|NCT01720069|26313633|FG002|Overall Study|Non-compliance on using e-diary|1|||
13231281|NCT01720069|26313631|FG000|Overall Study|Lost to Follow-up|0|||
13231282|NCT01720069|26313632|FG001|Overall Study|Lost to Follow-up|0|||
13231283|NCT01720069|26313633|FG002|Overall Study|Lost to Follow-up|1|||
13231284|NCT01720043|26313639|FG000|Overall Study|Withdrawal by Subject|1|||
13115269|NCT03099304|25917714|FG004|DB Period: Weeks 24 to 52|Adverse Event|1|||
13231285|NCT01719861|26313649|FG000|Cycle 1|Death|4|||
13231286|NCT01719861|26313649|FG000|Cycle 2|Death|1|||
13231287|NCT01719783|26313742|FG000|Dose 2|Physician Decision|1|||
13231288|NCT01719783|26313743|FG001|Dose 2|Physician Decision|0|||
13231289|NCT01719757|26313753|FG000|Overall Study|Adverse Event|38|||
13231290|NCT01719757|26313753|FG000|Overall Study|Withdrawal by Subject|15|||
13231291|NCT01719757|26313753|FG000|Overall Study|Lost to Follow-up|20|||
13231292|NCT01719757|26313753|FG000|Overall Study|Protocol Violation|1|||
13231293|NCT01719757|26313753|FG000|Overall Study|well controlled pain|27|||
13231294|NCT01719380|26314001|FG000|Overall Study|Adverse Event|0|||
13231295|NCT01719380|26314002|FG001|Overall Study|Adverse Event|0|||
13231296|NCT01719380|26314003|FG002|Overall Study|Adverse Event|1|||
13231297|NCT01719380|26314004|FG003|Overall Study|Adverse Event|2|||
13231298|NCT01719380|26314005|FG004|Overall Study|Adverse Event|0|||
13231299|NCT01719380|26314006|FG005|Overall Study|Adverse Event|1|||
13231300|NCT01719380|26314007|FG006|Overall Study|Adverse Event|0|||
13231301|NCT01719380|26314008|FG007|Overall Study|Adverse Event|1|||
13231302|NCT01719380|26314009|FG008|Overall Study|Adverse Event|4|||
13231303|NCT01719380|26314010|FG009|Overall Study|Adverse Event|3|||
13231304|NCT01719380|26314001|FG000|Overall Study|Death|0|||
13231305|NCT01719380|26314002|FG001|Overall Study|Death|1|||
13115270|NCT03099304|25917715|FG005|DB Period: Weeks 24 to 52|Adverse Event|0|||
13115271|NCT03099304|25917710|FG000|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
13115272|NCT03099304|25917711|FG001|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
13115273|NCT03099304|25917712|FG002|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
13231306|NCT01719380|26314003|FG002|Overall Study|Death|0|||
13231307|NCT01719380|26314004|FG003|Overall Study|Death|0|||
13231308|NCT01719380|26314005|FG004|Overall Study|Death|0|||
13231309|NCT01719380|26314006|FG005|Overall Study|Death|0|||
13231310|NCT01719380|26314007|FG006|Overall Study|Death|0|||
13231311|NCT01719380|26314008|FG007|Overall Study|Death|0|||
13231312|NCT01719380|26314009|FG008|Overall Study|Death|3|||
13231313|NCT01719380|26314010|FG009|Overall Study|Death|3|||
13231314|NCT01719380|26314001|FG000|Overall Study|Participant/Guardian Decision|0|||
13231315|NCT01719380|26314002|FG001|Overall Study|Participant/Guardian Decision|0|||
13231316|NCT01719380|26314003|FG002|Overall Study|Participant/Guardian Decision|1|||
13231317|NCT01719380|26314004|FG003|Overall Study|Participant/Guardian Decision|0|||
13231318|NCT01719380|26314005|FG004|Overall Study|Participant/Guardian Decision|0|||
13231319|NCT01719380|26314006|FG005|Overall Study|Participant/Guardian Decision|0|||
13231320|NCT01719380|26314007|FG006|Overall Study|Participant/Guardian Decision|0|||
13231321|NCT01719380|26314008|FG007|Overall Study|Participant/Guardian Decision|0|||
13231322|NCT01719380|26314009|FG008|Overall Study|Participant/Guardian Decision|2|||
13231323|NCT01719380|26314010|FG009|Overall Study|Participant/Guardian Decision|2|||
13231324|NCT01719380|26314001|FG000|Overall Study|Physician Decision|0|||
13231325|NCT01719380|26314002|FG001|Overall Study|Physician Decision|0|||
13231326|NCT01719380|26314003|FG002|Overall Study|Physician Decision|2|||
13231327|NCT01719380|26314004|FG003|Overall Study|Physician Decision|0|||
13231328|NCT01719380|26314005|FG004|Overall Study|Physician Decision|0|||
13231329|NCT01719380|26314006|FG005|Overall Study|Physician Decision|0|||
13231330|NCT01719380|26314007|FG006|Overall Study|Physician Decision|0|||
13231331|NCT01719380|26314008|FG007|Overall Study|Physician Decision|0|||
13231332|NCT01719380|26314009|FG008|Overall Study|Physician Decision|1|||
13231333|NCT01719380|26314010|FG009|Overall Study|Physician Decision|1|||
13231334|NCT01719380|26314001|FG000|Overall Study|Lack of Efficacy|2|||
13231335|NCT01719380|26314002|FG001|Overall Study|Lack of Efficacy|6|||
13231336|NCT01719380|26314003|FG002|Overall Study|Lack of Efficacy|5|||
13231337|NCT01719380|26314004|FG003|Overall Study|Lack of Efficacy|6|||
13231338|NCT01719380|26314005|FG004|Overall Study|Lack of Efficacy|3|||
13231339|NCT01719380|26314006|FG005|Overall Study|Lack of Efficacy|7|||
13231340|NCT01719380|26314007|FG006|Overall Study|Lack of Efficacy|10|||
13231341|NCT01719380|26314008|FG007|Overall Study|Lack of Efficacy|6|||
13231342|NCT01719380|26314009|FG008|Overall Study|Lack of Efficacy|39|||
13231343|NCT01719380|26314010|FG009|Overall Study|Lack of Efficacy|42|||
13231344|NCT01719380|26314001|FG000|Overall Study|Progressive Disease|0|||
13231345|NCT01719380|26314002|FG001|Overall Study|Progressive Disease|0|||
13231346|NCT01719380|26314003|FG002|Overall Study|Progressive Disease|0|||
13231347|NCT01719380|26314004|FG003|Overall Study|Progressive Disease|0|||
13231348|NCT01719380|26314005|FG004|Overall Study|Progressive Disease|0|||
13231349|NCT01719380|26314006|FG005|Overall Study|Progressive Disease|0|||
13231350|NCT01719380|26314007|FG006|Overall Study|Progressive Disease|0|||
13231351|NCT01719380|26314008|FG007|Overall Study|Progressive Disease|0|||
13231352|NCT01719380|26314009|FG008|Overall Study|Progressive Disease|1|||
13231353|NCT01719380|26314010|FG009|Overall Study|Progressive Disease|0|||
13231354|NCT01719237|26314025|FG000|Overall Study|Physician Decision|0|||
13231355|NCT01719237|26314026|FG001|Overall Study|Physician Decision|1|||
13289671|NCT00107900|26479792|FG002|Overall Study|Lost to Follow-up|3|||
13289672|NCT00107900|26479793|FG003|Overall Study|Lost to Follow-up|2|||
13289673|NCT00107900|26479794|FG004|Overall Study|Lost to Follow-up|5|||
13289674|NCT00107900|26479795|FG005|Overall Study|Lost to Follow-up|5|||
13289675|NCT00107900|26479790|FG000|Overall Study|Protocol Violation|1|||
13289676|NCT00107900|26479791|FG001|Overall Study|Protocol Violation|0|||
13289677|NCT00107900|26479792|FG002|Overall Study|Protocol Violation|5|||
13289678|NCT00107900|26479793|FG003|Overall Study|Protocol Violation|5|||
13289679|NCT00107900|26479794|FG004|Overall Study|Protocol Violation|7|||
13289680|NCT00107900|26479795|FG005|Overall Study|Protocol Violation|0|||
13289681|NCT00107900|26479790|FG000|Overall Study|Withdrawal by Subject|1|||
13231356|NCT01719224|26314038|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4|||
13231357|NCT01719224|26314039|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2|||
13231358|NCT01719172|26314047|FG000|Overall Study|Lost to Follow-up|1|||
13231359|NCT01719172|26314047|FG000|Overall Study|Death|1|||
13231360|NCT01719003|26314108|FG000|Overall Study|Non compliant with protocol|1|||
13231361|NCT01719003|26314109|FG001|Overall Study|Non compliant with protocol|1|||
13231362|NCT01719003|26314110|FG002|Overall Study|Non compliant with protocol|0|||
13231363|NCT01719003|26314111|FG003|Overall Study|Non compliant with protocol|1|||
13231364|NCT01719003|26314112|FG004|Overall Study|Non compliant with protocol|2|||
13231365|NCT01719003|26314113|FG005|Overall Study|Non compliant with protocol|1|||
13231366|NCT01719003|26314114|FG006|Overall Study|Non compliant with protocol|2|||
13231367|NCT01719003|26314115|FG007|Overall Study|Non compliant with protocol|3|||
13231368|NCT01719003|26314116|FG008|Overall Study|Non compliant with protocol|0|||
13231369|NCT01719003|26314108|FG000|Overall Study|Adverse Event|6|||
13231370|NCT01719003|26314109|FG001|Overall Study|Adverse Event|5|||
13231371|NCT01719003|26314110|FG002|Overall Study|Adverse Event|4|||
13231372|NCT01719003|26314111|FG003|Overall Study|Adverse Event|3|||
13231373|NCT01719003|26314112|FG004|Overall Study|Adverse Event|4|||
13231374|NCT01719003|26314113|FG005|Overall Study|Adverse Event|3|||
13231375|NCT01719003|26314114|FG006|Overall Study|Adverse Event|6|||
13231376|NCT01719003|26314115|FG007|Overall Study|Adverse Event|5|||
13231377|NCT01719003|26314116|FG008|Overall Study|Adverse Event|0|||
13231378|NCT01719003|26314108|FG000|Overall Study|Lost to Follow-up|0|||
13231379|NCT01719003|26314109|FG001|Overall Study|Lost to Follow-up|6|||
13231380|NCT01719003|26314110|FG002|Overall Study|Lost to Follow-up|7|||
13231381|NCT01719003|26314111|FG003|Overall Study|Lost to Follow-up|2|||
13231382|NCT01719003|26314112|FG004|Overall Study|Lost to Follow-up|3|||
13231383|NCT01719003|26314113|FG005|Overall Study|Lost to Follow-up|4|||
13231384|NCT01719003|26314114|FG006|Overall Study|Lost to Follow-up|3|||
13231385|NCT01719003|26314115|FG007|Overall Study|Lost to Follow-up|2|||
13231386|NCT01719003|26314116|FG008|Overall Study|Lost to Follow-up|2|||
13231387|NCT01719003|26314108|FG000|Overall Study|Refusal to continue, not due to AE|2|||
13231388|NCT01719003|26314109|FG001|Overall Study|Refusal to continue, not due to AE|5|||
13231389|NCT01719003|26314110|FG002|Overall Study|Refusal to continue, not due to AE|4|||
13231390|NCT01719003|26314111|FG003|Overall Study|Refusal to continue, not due to AE|4|||
13231391|NCT01719003|26314112|FG004|Overall Study|Refusal to continue, not due to AE|4|||
13231392|NCT01719003|26314113|FG005|Overall Study|Refusal to continue, not due to AE|3|||
13231393|NCT01719003|26314114|FG006|Overall Study|Refusal to continue, not due to AE|8|||
13231394|NCT01719003|26314115|FG007|Overall Study|Refusal to continue, not due to AE|7|||
13231395|NCT01719003|26314116|FG008|Overall Study|Refusal to continue, not due to AE|1|||
13231396|NCT01719003|26314108|FG000|Overall Study|Reason other than those specified|0|||
13231397|NCT01719003|26314109|FG001|Overall Study|Reason other than those specified|0|||
13231398|NCT01719003|26314110|FG002|Overall Study|Reason other than those specified|2|||
13231399|NCT01719003|26314111|FG003|Overall Study|Reason other than those specified|3|||
13231400|NCT01719003|26314112|FG004|Overall Study|Reason other than those specified|4|||
13115274|NCT03099304|25917713|FG003|DB Period: Weeks 24 to 52|Withdrawal by Subject|4|||
13231401|NCT01719003|26314113|FG005|Overall Study|Reason other than those specified|1|||
13231402|NCT01719003|26314114|FG006|Overall Study|Reason other than those specified|0|||
13231403|NCT01719003|26314115|FG007|Overall Study|Reason other than those specified|3|||
13231404|NCT01719003|26314116|FG008|Overall Study|Reason other than those specified|1|||
13231405|NCT01719003|26314108|FG000|Overall Study|Lack of Efficacy|0|||
13231406|NCT01719003|26314109|FG001|Overall Study|Lack of Efficacy|0|||
13231407|NCT01719003|26314110|FG002|Overall Study|Lack of Efficacy|0|||
13231408|NCT01719003|26314111|FG003|Overall Study|Lack of Efficacy|0|||
13231409|NCT01719003|26314112|FG004|Overall Study|Lack of Efficacy|0|||
13231410|NCT01719003|26314113|FG005|Overall Study|Lack of Efficacy|0|||
13231411|NCT01719003|26314114|FG006|Overall Study|Lack of Efficacy|1|||
13231412|NCT01719003|26314115|FG007|Overall Study|Lack of Efficacy|0|||
13231413|NCT01719003|26314116|FG008|Overall Study|Lack of Efficacy|0|||
13231414|NCT01718535|26314169|FG000|Overall Study|Bidirectional Sequencing not possible|1|||
13231415|NCT01718535|26314170|FG001|Overall Study|Bidirectional Sequencing not possible|0|||
13231416|NCT01718535|26314171|FG002|Overall Study|Bidirectional Sequencing not possible|0|||
13231417|NCT01718535|26314172|FG003|Overall Study|Bidirectional Sequencing not possible|1|||
13231418|NCT01718535|26314173|FG004|Overall Study|Bidirectional Sequencing not possible|0|||
13231419|NCT01718535|26314174|FG005|Overall Study|Bidirectional Sequencing not possible|0|||
13231420|NCT01718535|26314175|FG006|Overall Study|Bidirectional Sequencing not possible|0|||
13231421|NCT01718535|26314176|FG007|Overall Study|Bidirectional Sequencing not possible|0|||
13231422|NCT01718535|26314177|FG008|Overall Study|Bidirectional Sequencing not possible|0|||
13231423|NCT01718535|26314178|FG009|Overall Study|Bidirectional Sequencing not possible|0|||
13231424|NCT01718509|26314229|FG000|Overall Study|Lost to Follow-up|18|||
13231425|NCT01718509|26314230|FG001|Overall Study|Lost to Follow-up|15|||
13231426|NCT01718509|26314229|FG000|Overall Study|Withdrawal by Subject|7|||
13231427|NCT01718509|26314230|FG001|Overall Study|Withdrawal by Subject|13|||
13231428|NCT01718509|26314229|FG000|Overall Study|Adverse Event|5|||
13231429|NCT01718509|26314230|FG001|Overall Study|Adverse Event|7|||
13231430|NCT01718509|26314229|FG000|Overall Study|Other|13|||
13231431|NCT01718509|26314230|FG001|Overall Study|Other|11|||
13231432|NCT01718509|26314229|FG000|Overall Study|Protocol Violation|4|||
13231433|NCT01718509|26314230|FG001|Overall Study|Protocol Violation|2|||
13115275|NCT03099304|25917714|FG004|DB Period: Weeks 24 to 52|Withdrawal by Subject|1|||
13115276|NCT03099304|25917715|FG005|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
13115277|NCT03099304|25917710|FG000|DB Period: Weeks 24 to 52|Reason not specified|0|||
13115278|NCT03099304|25917711|FG001|DB Period: Weeks 24 to 52|Reason not specified|0|||
13115279|NCT03099304|25917712|FG002|DB Period: Weeks 24 to 52|Reason not specified|0|||
13115280|NCT03099304|25917713|FG003|DB Period: Weeks 24 to 52|Reason not specified|1|||
13115281|NCT03099304|25917714|FG004|DB Period: Weeks 24 to 52|Reason not specified|0|||
13115282|NCT03099304|25917715|FG005|DB Period: Weeks 24 to 52|Reason not specified|0|||
13115283|NCT03099304|25917710|FG000|104-week Open-Label Extension Period|Adverse Event|0|||
13231434|NCT01718509|26314229|FG000|Overall Study|Lack of Efficacy|1|||
13231435|NCT01718509|26314230|FG001|Overall Study|Lack of Efficacy|0|||
13115284|NCT03099304|25917711|FG001|104-week Open-Label Extension Period|Adverse Event|0|||
13115285|NCT03099304|25917712|FG002|104-week Open-Label Extension Period|Adverse Event|1|||
13231436|NCT01718483|26314281|FG000|Overall Study|Withdrawal by Subject|14|||
13231437|NCT01718483|26314282|FG001|Overall Study|Withdrawal by Subject|12|||
13231438|NCT01718483|26314281|FG000|Overall Study|Adverse Event|5|||
13231439|NCT01718483|26314282|FG001|Overall Study|Adverse Event|12|||
13231440|NCT01718483|26314281|FG000|Overall Study|Lost to Follow-up|8|||
13231441|NCT01718483|26314282|FG001|Overall Study|Lost to Follow-up|3|||
13231442|NCT01718483|26314281|FG000|Overall Study|Protocol Violation|4|||
13231443|NCT01718483|26314282|FG001|Overall Study|Protocol Violation|2|||
13231444|NCT01718483|26314281|FG000|Overall Study|Other|1|||
13231445|NCT01718483|26314282|FG001|Overall Study|Other|4|||
13231446|NCT01718483|26314281|FG000|Overall Study|Pregnancy|1|||
13231447|NCT01718483|26314282|FG001|Overall Study|Pregnancy|1|||
13231448|NCT01718483|26314281|FG000|Overall Study|Lack of Efficacy|1|||
13231449|NCT01718483|26314282|FG001|Overall Study|Lack of Efficacy|0|||
13231450|NCT01718353|26314305|FG000|Overall Study|Lost to Follow-up|0|||
13231451|NCT01718353|26314306|FG001|Overall Study|Lost to Follow-up|1|||
13231452|NCT01718353|26314305|FG000|Overall Study|Principal Investigator's Decision|10|||
13231453|NCT01718353|26314306|FG001|Overall Study|Principal Investigator's Decision|4|||
13231454|NCT01718353|26314305|FG000|Overall Study|Randomized but not treated|2|||
13231455|NCT01718353|26314306|FG001|Overall Study|Randomized but not treated|0|||
13231456|NCT01717989|26314374|FG000|Overall Study|Ineligibility determined|6|||
13231457|NCT01717989|26314374|FG000|Overall Study|Protocol deviation|6|||
13231458|NCT01717989|26314374|FG000|Overall Study|Withdrawal by Subject|11|||
13231459|NCT01717989|26314374|FG000|Overall Study|Physician Decision|2|||
13231460|NCT01717989|26314374|FG000|Overall Study|Lost to Follow-up|11|||
13231461|NCT01717989|26314374|FG000|Overall Study|Death|439|||
13231462|NCT01717989|26314374|FG000|Overall Study|Protocol-specified criteria|551|||
13231463|NCT01717989|26314374|FG000|Overall Study|Other|40|||
13231464|NCT01717976|26314395|FG000|Overall Study|Protocol Violation|0|||
13231465|NCT01717976|26314396|FG001|Overall Study|Protocol Violation|1|||
13231466|NCT01717859|26314409|FG000|Overall Study|Adverse Event|5|||
13231467|NCT01717859|26314409|FG000|Overall Study|Moved out of state|1|||
13231468|NCT01717859|26314409|FG000|Overall Study|Patient concerned about mental health|1|||
13231469|NCT01717859|26314409|FG000|Overall Study|Lost to Follow-up|1|||
13231470|NCT01717859|26314409|FG000|Overall Study|Withdrawal by Subject|2|||
13231471|NCT01717768|26314480|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
13231472|NCT01717768|26314481|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1|||
13231473|NCT01717768|26314482|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
13231474|NCT01717768|26314483|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
13231475|NCT01717768|26314484|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
13231476|NCT01717768|26314485|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
13231477|NCT01717768|26314486|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
13231478|NCT01717768|26314487|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
13231479|NCT01717768|26314488|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
13231480|NCT01717768|26314489|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
13231481|NCT01717768|26314490|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
13231482|NCT01717768|26314491|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
13231483|NCT01717768|26314480|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
13231484|NCT01717768|26314481|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
13231485|NCT01717768|26314482|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
13231486|NCT01717768|26314483|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
13231487|NCT01717768|26314484|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
13231488|NCT01717768|26314485|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
13231489|NCT01717768|26314486|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
13231490|NCT01717768|26314487|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
13231491|NCT01717768|26314488|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
13231492|NCT01717768|26314489|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
13231493|NCT01717768|26314490|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
13231494|NCT01717768|26314491|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1|||
13231495|NCT01717768|26314480|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
13231496|NCT01717768|26314481|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
13231497|NCT01717768|26314482|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
13231498|NCT01717768|26314483|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
13231499|NCT01717768|26314484|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
13231500|NCT01717768|26314485|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
13231501|NCT01717768|26314486|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
13231502|NCT01717768|26314487|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2|||
13231503|NCT01717768|26314488|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
13231504|NCT01717768|26314489|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
13231505|NCT01717768|26314490|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
13231506|NCT01717768|26314491|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
13231507|NCT01717768|26314480|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
13231508|NCT01717768|26314481|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
13231509|NCT01717768|26314482|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
13231510|NCT01717768|26314483|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
13231511|NCT01717768|26314484|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
13231512|NCT01717768|26314485|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
13231513|NCT01717768|26314486|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
13231514|NCT01717768|26314487|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
13231515|NCT01717768|26314488|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
13231516|NCT01717768|26314489|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1|||
13231517|NCT01717768|26314490|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
13231518|NCT01717768|26314491|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
13231519|NCT01717638|26314673|FG000|Overall Study|Lost to Follow-up|0|||
13231520|NCT01717638|26314674|FG001|Overall Study|Lost to Follow-up|0|||
13231521|NCT01717638|26314675|FG002|Overall Study|Lost to Follow-up|0|||
13231522|NCT01717638|26314676|FG003|Overall Study|Lost to Follow-up|0|||
13231523|NCT01717638|26314677|FG004|Overall Study|Lost to Follow-up|0|||
13231524|NCT01717638|26314678|FG005|Overall Study|Lost to Follow-up|1|||
13231525|NCT01717638|26314679|FG006|Overall Study|Lost to Follow-up|0|||
13231526|NCT01717638|26314680|FG007|Overall Study|Lost to Follow-up|0|||
13231527|NCT01717638|26314681|FG008|Overall Study|Lost to Follow-up|0|||
13231528|NCT01717638|26314682|FG009|Overall Study|Lost to Follow-up|0|||
13231529|NCT01717638|26314683|FG010|Overall Study|Lost to Follow-up|0|||
13231530|NCT01717638|26314684|FG011|Overall Study|Lost to Follow-up|0|||
13231531|NCT01717638|26314685|FG012|Overall Study|Lost to Follow-up|0|||
13231532|NCT01717638|26314673|FG000|Overall Study|Father in hospital|0|||
13231533|NCT01717638|26314674|FG001|Overall Study|Father in hospital|0|||
13231534|NCT01717638|26314675|FG002|Overall Study|Father in hospital|0|||
13231535|NCT01717638|26314676|FG003|Overall Study|Father in hospital|0|||
13231536|NCT01717638|26314677|FG004|Overall Study|Father in hospital|0|||
13231537|NCT01717638|26314678|FG005|Overall Study|Father in hospital|0|||
13231538|NCT01717638|26314679|FG006|Overall Study|Father in hospital|0|||
13231539|NCT01717638|26314680|FG007|Overall Study|Father in hospital|0|||
13231540|NCT01717638|26314681|FG008|Overall Study|Father in hospital|0|||
13231541|NCT01717638|26314682|FG009|Overall Study|Father in hospital|0|||
13231542|NCT01717638|26314683|FG010|Overall Study|Father in hospital|0|||
13231543|NCT01717638|26314684|FG011|Overall Study|Father in hospital|0|||
13231544|NCT01717638|26314685|FG012|Overall Study|Father in hospital|1|||
13231545|NCT01717638|26314673|FG000|Overall Study|Withdrawal by Subject|0|||
13231546|NCT01717638|26314674|FG001|Overall Study|Withdrawal by Subject|1|||
13231547|NCT01717638|26314675|FG002|Overall Study|Withdrawal by Subject|1|||
13231548|NCT01717638|26314676|FG003|Overall Study|Withdrawal by Subject|0|||
13231549|NCT01717638|26314677|FG004|Overall Study|Withdrawal by Subject|1|||
13231550|NCT01717638|26314678|FG005|Overall Study|Withdrawal by Subject|0|||
13231551|NCT01717638|26314679|FG006|Overall Study|Withdrawal by Subject|2|||
13231552|NCT01717638|26314680|FG007|Overall Study|Withdrawal by Subject|1|||
13231553|NCT01717638|26314681|FG008|Overall Study|Withdrawal by Subject|2|||
13231554|NCT01717638|26314682|FG009|Overall Study|Withdrawal by Subject|1|||
13231555|NCT01717638|26314683|FG010|Overall Study|Withdrawal by Subject|0|||
13231556|NCT01717638|26314684|FG011|Overall Study|Withdrawal by Subject|0|||
13231557|NCT01717638|26314685|FG012|Overall Study|Withdrawal by Subject|18|||
13231558|NCT01717456|26314760|FG000|End of Treatment|Physician Decision|0|||
13231559|NCT01717456|26314761|FG001|End of Treatment|Physician Decision|1|||
13231560|NCT01717456|26314760|FG000|End of Treatment|Lost to Follow-up|0|||
13231561|NCT01717456|26314761|FG001|End of Treatment|Lost to Follow-up|1|||
13231562|NCT01717456|26314760|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
13231563|NCT01717456|26314761|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
13231564|NCT01717391|26314772|FG000|Overall Study|Withdrawal by Subject|5|||
13231565|NCT01717391|26314772|FG000|Overall Study|Physician Decision|1|||
13231566|NCT01717391|26314772|FG000|Overall Study|FLT technical failure|3|||
13231567|NCT01717326|26315095|FG000|Overall Study|Death|0|||
13231568|NCT01717326|26315096|FG001|Overall Study|Death|0|||
13231569|NCT01717326|26315097|FG002|Overall Study|Death|0|||
13231570|NCT01717326|26315098|FG003|Overall Study|Death|0|||
13231571|NCT01717326|26315099|FG004|Overall Study|Death|0|||
13231572|NCT01717326|26315100|FG005|Overall Study|Death|0|||
13231573|NCT01717326|26315101|FG006|Overall Study|Death|0|||
13231574|NCT01717326|26315102|FG007|Overall Study|Death|0|||
13231575|NCT01717326|26315103|FG008|Overall Study|Death|0|||
13231576|NCT01717326|26315104|FG009|Overall Study|Death|0|||
13231577|NCT01717326|26315105|FG010|Overall Study|Death|1|||
13231578|NCT01717326|26315106|FG011|Overall Study|Death|0|||
13231579|NCT01717326|26315107|FG012|Overall Study|Death|0|||
13231580|NCT01717326|26315108|FG013|Overall Study|Death|0|||
13231581|NCT01717326|26315109|FG014|Overall Study|Death|0|||
13231582|NCT01717326|26315110|FG015|Overall Study|Death|0|||
13231583|NCT01717326|26315111|FG016|Overall Study|Death|0|||
13231584|NCT01717326|26315112|FG017|Overall Study|Death|0|||
13231585|NCT01717326|26315113|FG018|Overall Study|Death|0|||
13231586|NCT01717326|26315114|FG019|Overall Study|Death|0|||
13231587|NCT01717326|26315095|FG000|Overall Study|Lost to Follow-up|3|||
13231588|NCT01717326|26315096|FG001|Overall Study|Lost to Follow-up|0|||
13231589|NCT01717326|26315097|FG002|Overall Study|Lost to Follow-up|0|||
13231590|NCT01717326|26315098|FG003|Overall Study|Lost to Follow-up|2|||
13231591|NCT01717326|26315099|FG004|Overall Study|Lost to Follow-up|1|||
13231592|NCT01717326|26315100|FG005|Overall Study|Lost to Follow-up|0|||
13231593|NCT01717326|26315101|FG006|Overall Study|Lost to Follow-up|1|||
13231594|NCT01717326|26315102|FG007|Overall Study|Lost to Follow-up|0|||
13231595|NCT01717326|26315103|FG008|Overall Study|Lost to Follow-up|0|||
13231596|NCT01717326|26315104|FG009|Overall Study|Lost to Follow-up|0|||
13231597|NCT01717326|26315105|FG010|Overall Study|Lost to Follow-up|1|||
13485803|NCT00585195|27033421|FG011|Overall Study|Lost to Follow-up|0|||
13485804|NCT00585195|27033422|FG012|Overall Study|Lost to Follow-up|1|||
13231598|NCT01717326|26315106|FG011|Overall Study|Lost to Follow-up|0|||
13115286|NCT03099304|25917713|FG003|104-week Open-Label Extension Period|Adverse Event|0|||
13231599|NCT01717326|26315107|FG012|Overall Study|Lost to Follow-up|0|||
13231600|NCT01717326|26315108|FG013|Overall Study|Lost to Follow-up|0|||
13231601|NCT01717326|26315109|FG014|Overall Study|Lost to Follow-up|0|||
13231602|NCT01717326|26315110|FG015|Overall Study|Lost to Follow-up|2|||
13231603|NCT01717326|26315111|FG016|Overall Study|Lost to Follow-up|1|||
13231604|NCT01717326|26315112|FG017|Overall Study|Lost to Follow-up|0|||
13231605|NCT01717326|26315113|FG018|Overall Study|Lost to Follow-up|2|||
13231606|NCT01717326|26315114|FG019|Overall Study|Lost to Follow-up|3|||
13231607|NCT01717326|26315095|FG000|Overall Study|Physician Decision|0|||
13231608|NCT01717326|26315096|FG001|Overall Study|Physician Decision|0|||
13231609|NCT01717326|26315097|FG002|Overall Study|Physician Decision|0|||
13115287|NCT03099304|25917714|FG004|104-week Open-Label Extension Period|Adverse Event|0|||
13231610|NCT01717326|26315098|FG003|Overall Study|Physician Decision|0|||
13231611|NCT01717326|26315099|FG004|Overall Study|Physician Decision|0|||
13115288|NCT03099304|25917715|FG005|104-week Open-Label Extension Period|Adverse Event|0|||
13115289|NCT03099304|25917710|FG000|104-week Open-Label Extension Period|Lost to Follow-up|0|||
13115290|NCT03099304|25917711|FG001|104-week Open-Label Extension Period|Lost to Follow-up|0|||
13115291|NCT03099304|25917712|FG002|104-week Open-Label Extension Period|Lost to Follow-up|3|||
13115292|NCT03099304|25917713|FG003|104-week Open-Label Extension Period|Lost to Follow-up|2|||
13115293|NCT03099304|25917714|FG004|104-week Open-Label Extension Period|Lost to Follow-up|1|||
13115294|NCT03099304|25917715|FG005|104-week Open-Label Extension Period|Lost to Follow-up|6|||
13115295|NCT03099304|25917710|FG000|104-week Open-Label Extension Period|Physician Decision|0|||
13115296|NCT03099304|25917711|FG001|104-week Open-Label Extension Period|Physician Decision|0|||
13115297|NCT03099304|25917712|FG002|104-week Open-Label Extension Period|Physician Decision|0|||
13115298|NCT03099304|25917713|FG003|104-week Open-Label Extension Period|Physician Decision|0|||
13115299|NCT03099304|25917714|FG004|104-week Open-Label Extension Period|Physician Decision|1|||
13115300|NCT03099304|25917715|FG005|104-week Open-Label Extension Period|Physician Decision|0|||
13115301|NCT03099304|25917710|FG000|104-week Open-Label Extension Period|Pregnancy|0|||
13115302|NCT03099304|25917711|FG001|104-week Open-Label Extension Period|Pregnancy|0|||
13115303|NCT03099304|25917712|FG002|104-week Open-Label Extension Period|Pregnancy|0|||
13115304|NCT03099304|25917713|FG003|104-week Open-Label Extension Period|Pregnancy|0|||
13115305|NCT03099304|25917714|FG004|104-week Open-Label Extension Period|Pregnancy|0|||
13115306|NCT03099304|25917715|FG005|104-week Open-Label Extension Period|Pregnancy|1|||
13231612|NCT01717326|26315100|FG005|Overall Study|Physician Decision|0|||
13231613|NCT01717326|26315101|FG006|Overall Study|Physician Decision|0|||
13231614|NCT01717326|26315102|FG007|Overall Study|Physician Decision|0|||
13231615|NCT01717326|26315103|FG008|Overall Study|Physician Decision|0|||
13231616|NCT01717326|26315104|FG009|Overall Study|Physician Decision|1|||
13231617|NCT01717326|26315105|FG010|Overall Study|Physician Decision|0|||
13115307|NCT03099304|25917710|FG000|104-week Open-Label Extension Period|Protocol Violation|0|||
13115308|NCT03099304|25917711|FG001|104-week Open-Label Extension Period|Protocol Violation|0|||
13115309|NCT03099304|25917712|FG002|104-week Open-Label Extension Period|Protocol Violation|0|||
13115310|NCT03099304|25917713|FG003|104-week Open-Label Extension Period|Protocol Violation|0|||
13115311|NCT03099304|25917714|FG004|104-week Open-Label Extension Period|Protocol Violation|0|||
13115312|NCT03099304|25917715|FG005|104-week Open-Label Extension Period|Protocol Violation|1|||
13115313|NCT03099304|25917710|FG000|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
13115314|NCT03099304|25917711|FG001|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
13115315|NCT03099304|25917712|FG002|104-week Open-Label Extension Period|Withdrawal by Subject|9|||
13115316|NCT03099304|25917713|FG003|104-week Open-Label Extension Period|Withdrawal by Subject|10|||
13115317|NCT03099304|25917714|FG004|104-week Open-Label Extension Period|Withdrawal by Subject|13|||
13231618|NCT01717326|26315106|FG011|Overall Study|Physician Decision|0|||
13115318|NCT03099304|25917715|FG005|104-week Open-Label Extension Period|Withdrawal by Subject|15|||
13115319|NCT03099304|25917710|FG000|104-week Open-Label Extension Period|Other Reason not specified|0|||
13231619|NCT01717326|26315107|FG012|Overall Study|Physician Decision|0|||
13231620|NCT01717326|26315108|FG013|Overall Study|Physician Decision|0|||
13231621|NCT01717326|26315109|FG014|Overall Study|Physician Decision|0|||
13231622|NCT01717326|26315110|FG015|Overall Study|Physician Decision|0|||
13231623|NCT01717326|26315111|FG016|Overall Study|Physician Decision|0|||
13231624|NCT01717326|26315112|FG017|Overall Study|Physician Decision|0|||
13231625|NCT01717326|26315113|FG018|Overall Study|Physician Decision|0|||
13231626|NCT01717326|26315114|FG019|Overall Study|Physician Decision|0|||
13231627|NCT01717326|26315095|FG000|Overall Study|Protocol Violation|0|||
13231628|NCT01717326|26315096|FG001|Overall Study|Protocol Violation|0|||
13231629|NCT01717326|26315097|FG002|Overall Study|Protocol Violation|0|||
13231630|NCT01717326|26315098|FG003|Overall Study|Protocol Violation|0|||
13231631|NCT01717326|26315099|FG004|Overall Study|Protocol Violation|1|||
13231632|NCT01717326|26315100|FG005|Overall Study|Protocol Violation|0|||
13231633|NCT01717326|26315101|FG006|Overall Study|Protocol Violation|0|||
13231634|NCT01717326|26315102|FG007|Overall Study|Protocol Violation|0|||
13231635|NCT01717326|26315103|FG008|Overall Study|Protocol Violation|0|||
13231636|NCT01717326|26315104|FG009|Overall Study|Protocol Violation|0|||
13231637|NCT01717326|26315105|FG010|Overall Study|Protocol Violation|0|||
13231638|NCT01717326|26315106|FG011|Overall Study|Protocol Violation|0|||
13231639|NCT01717326|26315107|FG012|Overall Study|Protocol Violation|0|||
13231640|NCT01717326|26315108|FG013|Overall Study|Protocol Violation|0|||
13231641|NCT01717326|26315109|FG014|Overall Study|Protocol Violation|0|||
13231642|NCT01717326|26315110|FG015|Overall Study|Protocol Violation|0|||
13231643|NCT01717326|26315111|FG016|Overall Study|Protocol Violation|0|||
13231644|NCT01717326|26315112|FG017|Overall Study|Protocol Violation|0|||
13231645|NCT01717326|26315113|FG018|Overall Study|Protocol Violation|0|||
13231646|NCT01717326|26315114|FG019|Overall Study|Protocol Violation|0|||
13231647|NCT01717326|26315095|FG000|Overall Study|Withdrawal by Subject|0|||
13231648|NCT01717326|26315096|FG001|Overall Study|Withdrawal by Subject|1|||
13231649|NCT01717326|26315097|FG002|Overall Study|Withdrawal by Subject|0|||
13231650|NCT01717326|26315098|FG003|Overall Study|Withdrawal by Subject|0|||
13231651|NCT01717326|26315099|FG004|Overall Study|Withdrawal by Subject|0|||
13231652|NCT01717326|26315100|FG005|Overall Study|Withdrawal by Subject|0|||
13231653|NCT01717326|26315101|FG006|Overall Study|Withdrawal by Subject|0|||
13231654|NCT01717326|26315102|FG007|Overall Study|Withdrawal by Subject|0|||
13231655|NCT01717326|26315103|FG008|Overall Study|Withdrawal by Subject|0|||
13231656|NCT01717326|26315104|FG009|Overall Study|Withdrawal by Subject|1|||
13231657|NCT01717326|26315105|FG010|Overall Study|Withdrawal by Subject|0|||
13231658|NCT01717326|26315106|FG011|Overall Study|Withdrawal by Subject|0|||
13231659|NCT01717326|26315107|FG012|Overall Study|Withdrawal by Subject|1|||
13231660|NCT01717326|26315108|FG013|Overall Study|Withdrawal by Subject|0|||
13231661|NCT01717326|26315109|FG014|Overall Study|Withdrawal by Subject|0|||
13231662|NCT01717326|26315110|FG015|Overall Study|Withdrawal by Subject|1|||
13231663|NCT01717326|26315111|FG016|Overall Study|Withdrawal by Subject|0|||
13231664|NCT01717326|26315112|FG017|Overall Study|Withdrawal by Subject|0|||
13231665|NCT01717326|26315113|FG018|Overall Study|Withdrawal by Subject|2|||
13231666|NCT01717326|26315114|FG019|Overall Study|Withdrawal by Subject|3|||
13231667|NCT01717313|26315157|FG000|Phase A (Weeks 0 to 24)|Death|0|||
13231668|NCT01717313|26315158|FG001|Phase A (Weeks 0 to 24)|Death|1|||
13231669|NCT01717313|26315157|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1|||
13231670|NCT01717313|26315158|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3|||
13231671|NCT01717313|26315157|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12|||
13231672|NCT01717313|26315158|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6|||
13231673|NCT01717313|26315157|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4|||
13231674|NCT01717313|26315158|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2|||
13231675|NCT01717313|26315157|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
13231676|NCT01717313|26315158|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
13231677|NCT01717313|26315157|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1|||
13231678|NCT01717313|26315158|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0|||
13231679|NCT01717313|26315157|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
13231680|NCT01717313|26315158|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
13231681|NCT01717313|26315157|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7|||
13231682|NCT01717313|26315158|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9|||
13231683|NCT01717313|26315157|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1|||
13231684|NCT01717313|26315158|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3|||
13231685|NCT01717287|26315187|FG000|Overall Study|Lost to Follow-up|0|||
13231686|NCT01717287|26315188|FG001|Overall Study|Lost to Follow-up|2|||
13231687|NCT01717287|26315187|FG000|Overall Study|Protocol Violation|0|||
13231688|NCT01717287|26315188|FG001|Overall Study|Protocol Violation|1|||
13231689|NCT01717040|26315201|FG000|Overall Study|Lost to Follow-up|2|||
13231690|NCT01717040|26315202|FG001|Overall Study|Lost to Follow-up|3|||
13231691|NCT01717040|26315201|FG000|Overall Study|Lack of Efficacy|1|||
13231692|NCT01717040|26315202|FG001|Overall Study|Lack of Efficacy|1|||
13231693|NCT01717040|26315201|FG000|Overall Study|Adverse Event|1|||
13231694|NCT01717040|26315202|FG001|Overall Study|Adverse Event|0|||
13231695|NCT01717040|26315201|FG000|Overall Study|Required Medication Change|0|||
13231696|NCT01717040|26315202|FG001|Overall Study|Required Medication Change|1|||
13231697|NCT01717040|26315201|FG000|Overall Study|New Substance Use Disorder|1|||
13231698|NCT01717040|26315202|FG001|Overall Study|New Substance Use Disorder|0|||
13231699|NCT01716754|26315236|FG000|Overall Study|Death|0|||
13231700|NCT01716754|26315237|FG001|Overall Study|Death|0|||
13231701|NCT01716754|26315238|FG002|Overall Study|Death|0|||
13231702|NCT01716754|26315239|FG003|Overall Study|Death|1|||
13231703|NCT01716754|26315236|FG000|Overall Study|Protocol deviation|0|||
13231704|NCT01716754|26315237|FG001|Overall Study|Protocol deviation|2|||
13231705|NCT01716754|26315238|FG002|Overall Study|Protocol deviation|7|||
13231706|NCT01716754|26315239|FG003|Overall Study|Protocol deviation|2|||
13231707|NCT01716754|26315236|FG000|Overall Study|Non-compliance with study treatment|0|||
13231708|NCT01716754|26315237|FG001|Overall Study|Non-compliance with study treatment|0|||
13231709|NCT01716754|26315238|FG002|Overall Study|Non-compliance with study treatment|1|||
13231710|NCT01716754|26315239|FG003|Overall Study|Non-compliance with study treatment|0|||
13231711|NCT01716754|26315236|FG000|Overall Study|Physician Decision|1|||
13231712|NCT01716754|26315237|FG001|Overall Study|Physician Decision|0|||
13231713|NCT01716754|26315238|FG002|Overall Study|Physician Decision|0|||
13231714|NCT01716754|26315239|FG003|Overall Study|Physician Decision|0|||
13231715|NCT01716754|26315236|FG000|Overall Study|Lost to Follow-up|1|||
13231716|NCT01716754|26315237|FG001|Overall Study|Lost to Follow-up|0|||
13231717|NCT01716754|26315238|FG002|Overall Study|Lost to Follow-up|0|||
13231718|NCT01716754|26315239|FG003|Overall Study|Lost to Follow-up|1|||
13231719|NCT01716754|26315236|FG000|Overall Study|Adverse Event|4|||
13231720|NCT01716754|26315237|FG001|Overall Study|Adverse Event|2|||
13231721|NCT01716754|26315238|FG002|Overall Study|Adverse Event|2|||
13231722|NCT01716754|26315239|FG003|Overall Study|Adverse Event|1|||
13231723|NCT01716754|26315236|FG000|Overall Study|Withdrawal by Subject|5|||
13231724|NCT01716754|26315237|FG001|Overall Study|Withdrawal by Subject|0|||
13231725|NCT01716754|26315238|FG002|Overall Study|Withdrawal by Subject|4|||
13231726|NCT01716754|26315239|FG003|Overall Study|Withdrawal by Subject|3|||
13231727|NCT01716715|26315262|FG000|Overall Study|Never Treated|2|||
13231728|NCT01716715|26315263|FG001|Overall Study|Never Treated|4|||
13231729|NCT01716663|26315273|FG000|Overall Study|Withdrawn prior to procedure|4|||
13231730|NCT01716663|26315273|FG000|Overall Study|Treated with non-study catheter|2|||
13231731|NCT01716585|26315292|FG000|Double-blind Treatment|Did Not Receive Study Drug|4|||
13231732|NCT01716585|26315293|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
13231733|NCT01716585|26315292|FG000|Double-blind Treatment|Adverse Event|2|||
13231734|NCT01716585|26315293|FG001|Double-blind Treatment|Adverse Event|1|||
13231735|NCT01716585|26315292|FG000|Double-blind Treatment|Withdrawal by Subject|3|||
13231736|NCT01716585|26315293|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
13231737|NCT01716585|26315292|FG000|Double-blind Treatment|Lost to Follow-up|2|||
13231738|NCT01716585|26315293|FG001|Double-blind Treatment|Lost to Follow-up|0|||
13231739|NCT01716585|26315292|FG000|Double-blind Treatment|Subject Noncompliant|1|||
13231740|NCT01716585|26315293|FG001|Double-blind Treatment|Subject Noncompliant|0|||
13231741|NCT01716585|26315292|FG000|Double-blind Treatment|Other|1|||
13231742|NCT01716585|26315293|FG001|Double-blind Treatment|Other|0|||
13231743|NCT01716585|26315292|FG000|Open-label Treatment|Adverse Event|0|||
13231744|NCT01716585|26315293|FG001|Open-label Treatment|Adverse Event|2|||
13231745|NCT01716585|26315292|FG000|Open-label Treatment|Virologic Failure|0|||
13231746|NCT01716585|26315293|FG001|Open-label Treatment|Virologic Failure|2|||
13231747|NCT01716585|26315292|FG000|Open-label Treatment|Withdrawal by Subject|0|||
13231748|NCT01716585|26315293|FG001|Open-label Treatment|Withdrawal by Subject|3|||
13231749|NCT01716559|26315303|FG000|Overall Study|Adverse Event|11|||
13231750|NCT01716559|26315303|FG000|Overall Study|Death|21|||
13231751|NCT01716559|26315303|FG000|Overall Study|Withdrawal by Subject|4|||
13231752|NCT01716559|26315303|FG000|Overall Study|Other withdrawal reason|75|||
13231753|NCT01716533|26315370|FG000|Overall Study|Failure of antibiotic treatment to treat|0|||
13231754|NCT01716533|26315371|FG001|Overall Study|Failure of antibiotic treatment to treat|0|||
13231755|NCT01716533|26315372|FG002|Overall Study|Failure of antibiotic treatment to treat|5|||
13231756|NCT01716533|26315373|FG003|Overall Study|Failure of antibiotic treatment to treat|0|||
13231757|NCT01716533|26315370|FG000|Overall Study|Withdrawal by Subject|0|||
13231758|NCT01716533|26315371|FG001|Overall Study|Withdrawal by Subject|0|||
13231759|NCT01716533|26315372|FG002|Overall Study|Withdrawal by Subject|0|||
13231760|NCT01716533|26315373|FG003|Overall Study|Withdrawal by Subject|5|||
13231761|NCT01716533|26315370|FG000|Overall Study|Death|0|||
13231762|NCT01716533|26315371|FG001|Overall Study|Death|0|||
13231763|NCT01716533|26315372|FG002|Overall Study|Death|0|||
13231764|NCT01716533|26315373|FG003|Overall Study|Death|2|||
13231765|NCT01716533|26315370|FG000|Overall Study|Immunosuppressants>14days past 6months|0|||
13231766|NCT01716533|26315371|FG001|Overall Study|Immunosuppressants>14days past 6months|0|||
13231767|NCT01716533|26315372|FG002|Overall Study|Immunosuppressants>14days past 6months|0|||
13231768|NCT01716533|26315373|FG003|Overall Study|Immunosuppressants>14days past 6months|1|||
13231769|NCT01716520|26315396|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
13231770|NCT01716520|26315397|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
13231771|NCT01716520|26315398|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
13231772|NCT01716520|26315399|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
13231773|NCT01716520|26315400|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
13231774|NCT01716520|26315401|FG005|Treatment Period 1 (14 Days)|Adverse Event|0|||
13231775|NCT01716520|26315396|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
13231776|NCT01716520|26315397|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
13231777|NCT01716520|26315398|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2|||
13231778|NCT01716520|26315399|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
13231779|NCT01716520|26315400|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
13231780|NCT01716520|26315401|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
13231781|NCT01716520|26315396|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
13231782|NCT01716520|26315397|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
13231783|NCT01716520|26315398|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
13231784|NCT01716520|26315399|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
13231785|NCT01716520|26315400|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
13231786|NCT01716520|26315401|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
13231787|NCT01716520|26315396|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
13231788|NCT01716520|26315397|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1|||
13231789|NCT01716520|26315398|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
13231790|NCT01716520|26315399|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
13231791|NCT01716520|26315400|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
13231792|NCT01716520|26315401|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
13231793|NCT01716520|26315396|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
13231794|NCT01716520|26315397|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
13231795|NCT01716520|26315398|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
13231796|NCT01716520|26315399|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
13231797|NCT01716520|26315400|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
13231798|NCT01716520|26315401|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
13231799|NCT01716520|26315396|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
13231800|NCT01716520|26315397|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
13231801|NCT01716520|26315398|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
13231802|NCT01716520|26315399|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
13231803|NCT01716520|26315400|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
13231804|NCT01716520|26315401|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
13231805|NCT01716520|26315396|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
13231806|NCT01716520|26315397|FG001|Treatment Period 2 (14 Days)|Adverse Event|0|||
13231807|NCT01716520|26315398|FG002|Treatment Period 2 (14 Days)|Adverse Event|0|||
13231808|NCT01716520|26315399|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
13231809|NCT01716520|26315400|FG004|Treatment Period 2 (14 Days)|Adverse Event|1|||
13231810|NCT01716520|26315401|FG005|Treatment Period 2 (14 Days)|Adverse Event|0|||
13231811|NCT01716520|26315396|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
13231812|NCT01716520|26315397|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
13231813|NCT01716520|26315398|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
13231814|NCT01716520|26315399|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0|||
13231815|NCT01716520|26315400|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1|||
13231816|NCT01716520|26315401|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
13231817|NCT01716520|26315396|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
13231818|NCT01716520|26315397|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
13231819|NCT01716520|26315398|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
13231820|NCT01716520|26315399|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1|||
13231821|NCT01716520|26315400|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
13231822|NCT01716520|26315401|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
13231823|NCT01716520|26315396|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
13231824|NCT01716520|26315397|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
13231825|NCT01716520|26315398|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
13231826|NCT01716520|26315399|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
13231827|NCT01716520|26315400|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
13231828|NCT01716520|26315401|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
13231829|NCT01716520|26315396|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1|||
13231830|NCT01716520|26315397|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
13231831|NCT01716520|26315398|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
13231832|NCT01716520|26315399|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
13231833|NCT01716520|26315400|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
13231834|NCT01716520|26315401|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
13231835|NCT01716520|26315396|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
13231836|NCT01716520|26315397|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
13231837|NCT01716520|26315398|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
13231838|NCT01716520|26315399|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
13231839|NCT01716520|26315400|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
13231840|NCT01716520|26315401|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1|||
13231841|NCT01716520|26315396|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
13231842|NCT01716520|26315397|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1|||
13231843|NCT01716520|26315398|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
13231844|NCT01716520|26315399|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
13231845|NCT01716520|26315400|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
13231846|NCT01716520|26315401|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
13231847|NCT01716520|26315396|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
13231848|NCT01716520|26315397|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
13231849|NCT01716520|26315398|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
13231850|NCT01716520|26315399|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
13231851|NCT01716520|26315400|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
13231852|NCT01716520|26315401|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
13231853|NCT01716520|26315396|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
13231854|NCT01716520|26315397|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
13231855|NCT01716520|26315398|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
13231856|NCT01716520|26315399|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
13231857|NCT01716520|26315400|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
13231858|NCT01716520|26315401|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
13231859|NCT01716234|26315460|FG000|Overall Study|Protocol Violation|0|||
13231860|NCT01716234|26315461|FG001|Overall Study|Protocol Violation|0|||
13231861|NCT01716234|26315462|FG002|Overall Study|Protocol Violation|0|||
13231862|NCT01716234|26315463|FG003|Overall Study|Protocol Violation|1|||
13231863|NCT01716234|26315464|FG004|Overall Study|Protocol Violation|1|||
13231864|NCT01716234|26315465|FG005|Overall Study|Protocol Violation|1|||
13231865|NCT01716234|26315466|FG006|Overall Study|Protocol Violation|0|||
13231866|NCT01716234|26315460|FG000|Overall Study|Lack of Efficacy|0|||
13231867|NCT01716234|26315461|FG001|Overall Study|Lack of Efficacy|0|||
13231868|NCT01716234|26315462|FG002|Overall Study|Lack of Efficacy|0|||
13231869|NCT01716234|26315463|FG003|Overall Study|Lack of Efficacy|1|||
13231870|NCT01716234|26315464|FG004|Overall Study|Lack of Efficacy|0|||
13231871|NCT01716234|26315465|FG005|Overall Study|Lack of Efficacy|0|||
13231872|NCT01716234|26315466|FG006|Overall Study|Lack of Efficacy|0|||
13231873|NCT01716234|26315460|FG000|Overall Study|Did not meet protocol eligibility|0|||
13231874|NCT01716234|26315461|FG001|Overall Study|Did not meet protocol eligibility|0|||
13231875|NCT01716234|26315462|FG002|Overall Study|Did not meet protocol eligibility|1|||
13231876|NCT01716234|26315463|FG003|Overall Study|Did not meet protocol eligibility|0|||
13231877|NCT01716234|26315464|FG004|Overall Study|Did not meet protocol eligibility|0|||
13231878|NCT01716234|26315465|FG005|Overall Study|Did not meet protocol eligibility|4|||
13231879|NCT01716234|26315466|FG006|Overall Study|Did not meet protocol eligibility|0|||
13231880|NCT01716234|26315460|FG000|Overall Study|Adverse Event|7|||
13231881|NCT01716234|26315461|FG001|Overall Study|Adverse Event|10|||
13231882|NCT01716234|26315462|FG002|Overall Study|Adverse Event|2|||
13231883|NCT01716234|26315463|FG003|Overall Study|Adverse Event|8|||
13231884|NCT01716234|26315464|FG004|Overall Study|Adverse Event|3|||
13231885|NCT01716234|26315465|FG005|Overall Study|Adverse Event|6|||
13231886|NCT01716234|26315466|FG006|Overall Study|Adverse Event|0|||
13231887|NCT01716234|26315460|FG000|Overall Study|Withdrawal by Subject|3|||
13231888|NCT01716234|26315461|FG001|Overall Study|Withdrawal by Subject|0|||
13231889|NCT01716234|26315462|FG002|Overall Study|Withdrawal by Subject|2|||
13231890|NCT01716234|26315463|FG003|Overall Study|Withdrawal by Subject|2|||
13231891|NCT01716234|26315464|FG004|Overall Study|Withdrawal by Subject|1|||
13231892|NCT01716234|26315465|FG005|Overall Study|Withdrawal by Subject|3|||
13231893|NCT01716234|26315466|FG006|Overall Study|Withdrawal by Subject|0|||
13231894|NCT01716169|26315474|FG000|Overall Study|Adverse Event|1|||
13231895|NCT01716169|26315474|FG000|Overall Study|Lost to Follow-up|1|||
13231896|NCT01716169|26315474|FG000|Overall Study|Withdrawal by Subject|1|||
13231897|NCT01716169|26315474|FG000|Overall Study|inconsistent dressing application|1|||
13231898|NCT01716156|26315508|FG000|Overall Study|Protocol Violation|1|||
13231899|NCT01716156|26315509|FG001|Overall Study|Protocol Violation|0|||
13231900|NCT01716156|26315510|FG002|Overall Study|Protocol Violation|0|||
13231901|NCT01716156|26315508|FG000|Overall Study|Withdrawal by Subject|0|||
13231902|NCT01716156|26315509|FG001|Overall Study|Withdrawal by Subject|1|||
13231903|NCT01716156|26315510|FG002|Overall Study|Withdrawal by Subject|2|||
13231904|NCT01716156|26315508|FG000|Overall Study|Lost to Follow-up|1|||
13231905|NCT01716156|26315509|FG001|Overall Study|Lost to Follow-up|0|||
13231906|NCT01716156|26315510|FG002|Overall Study|Lost to Follow-up|0|||
13231907|NCT01716104|26315541|FG000|Overall Study|Do not meet inclusion criteria|6|||
13231908|NCT01716104|26315542|FG001|Overall Study|Do not meet inclusion criteria|7|||
13231909|NCT01716052|26315555|FG000|Overall Study|Withdrawal of funding|1|||
13231910|NCT01716052|26315556|FG001|Overall Study|Withdrawal of funding|1|||
13231911|NCT01715896|26315626|FG000|Overall Study|Lost to Follow-up|0|||
13231912|NCT01715896|26315627|FG001|Overall Study|Lost to Follow-up|2|||
13231913|NCT01715896|26315626|FG000|Overall Study|Withdrawal by Subject|1|||
13231914|NCT01715896|26315627|FG001|Overall Study|Withdrawal by Subject|4|||
13231915|NCT01715896|26315626|FG000|Overall Study|Other|2|||
13231916|NCT01715896|26315627|FG001|Overall Study|Other|5|||
13231917|NCT01715857|26315639|FG000|Overall Study|Did Not Meet Eligibility Criteria|96|||
13231918|NCT01715831|26315657|FG000|Overall Study|Adverse Event|1|||
13231919|NCT01715805|26315674|FG000|Placebo + ADT Lead-in Period|Adverse Event|41|||
13231920|NCT01715805|26315675|FG001|Placebo + ADT Lead-in Period|Adverse Event|0|||
13231921|NCT01715805|26315676|FG002|Placebo + ADT Lead-in Period|Adverse Event|0|||
13231922|NCT01715805|26315677|FG003|Placebo + ADT Lead-in Period|Adverse Event|0|||
13231923|NCT01715805|26315674|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6|||
13231924|NCT01715805|26315675|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
13231925|NCT01715805|26315676|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
13231926|NCT01715805|26315677|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
13231927|NCT01715805|26315674|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74|||
13231928|NCT01715805|26315675|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0|||
13231929|NCT01715805|26315676|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0|||
13231930|NCT01715805|26315677|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0|||
13231931|NCT01715805|26315674|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49|||
13231932|NCT01715805|26315675|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
13231933|NCT01715805|26315676|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
13231934|NCT01715805|26315677|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
13231935|NCT01715805|26315674|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34|||
13231936|NCT01715805|26315675|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
13231937|NCT01715805|26315676|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
13231938|NCT01715805|26315677|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
13231939|NCT01715805|26315674|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1|||
13231940|NCT01715805|26315675|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
13231941|NCT01715805|26315676|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
13231942|NCT01715805|26315677|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
13231943|NCT01715805|26315674|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10|||
13231944|NCT01715805|26315675|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
13231945|NCT01715805|26315676|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
13231946|NCT01715805|26315677|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
13231947|NCT01715805|26315674|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
13231948|NCT01715805|26315675|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
13231949|NCT01715805|26315676|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
13231950|NCT01715805|26315677|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1|||
13231951|NCT01715805|26315674|FG000|Double-Blind or Continued Treatment|Adverse Event|0|||
13231952|NCT01715805|26315675|FG001|Double-Blind or Continued Treatment|Adverse Event|3|||
13231953|NCT01715805|26315676|FG002|Double-Blind or Continued Treatment|Adverse Event|23|||
13231954|NCT01715805|26315677|FG003|Double-Blind or Continued Treatment|Adverse Event|2|||
13231955|NCT01715805|26315674|FG000|Double-Blind or Continued Treatment|Protocol Violation|0|||
13231956|NCT01715805|26315675|FG001|Double-Blind or Continued Treatment|Protocol Violation|14|||
13231957|NCT01715805|26315676|FG002|Double-Blind or Continued Treatment|Protocol Violation|12|||
13231958|NCT01715805|26315677|FG003|Double-Blind or Continued Treatment|Protocol Violation|19|||
13231959|NCT01715805|26315674|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0|||
13231960|NCT01715805|26315675|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
13231961|NCT01715805|26315676|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
13231962|NCT01715805|26315677|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13|||
13231963|NCT01715805|26315674|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0|||
13231964|NCT01715805|26315675|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7|||
13231965|NCT01715805|26315676|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
13231966|NCT01715805|26315677|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
13231967|NCT01715805|26315674|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
13231968|NCT01715805|26315675|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1|||
13231969|NCT01715805|26315676|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
13231970|NCT01715805|26315677|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3|||
13231971|NCT01715805|26315674|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
13231972|NCT01715805|26315675|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3|||
13231973|NCT01715805|26315676|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
13231974|NCT01715805|26315677|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
13231975|NCT01715571|26315690|FG000|Overall Study|Lost to Follow-up|8|||
13231976|NCT01715415|26315709|FG000|Double-blind Treatment|Did Not Receive Study Drug|0|||
13231977|NCT01715415|26315710|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
13231978|NCT01715415|26315709|FG000|Double-blind Treatment|Adverse Event|3|||
13231979|NCT01715415|26315710|FG001|Double-blind Treatment|Adverse Event|0|||
13231980|NCT01715415|26315709|FG000|Double-blind Treatment|Withdrawal by Subject|1|||
13231981|NCT01715415|26315710|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
13231982|NCT01715415|26315709|FG000|Double-blind Treatment|Other|1|||
13231983|NCT01715415|26315710|FG001|Double-blind Treatment|Other|0|||
13231984|NCT01715415|26315709|FG000|Open-label Treatment|Adverse Event|0|||
13231985|NCT01715415|26315710|FG001|Open-label Treatment|Adverse Event|1|||
13231986|NCT01715415|26315709|FG000|Open-label Treatment|Subject Noncompliant|0|||
13231987|NCT01715415|26315710|FG001|Open-label Treatment|Subject Noncompliant|1|||
13231988|NCT01715298|26315753|FG000|Overall Study|Lost to Follow-up|0|||
13231989|NCT01715298|26315754|FG001|Overall Study|Lost to Follow-up|2|||
13231990|NCT01715298|26315753|FG000|Overall Study|Patient/guardian decision|7|||
13231991|NCT01715298|26315754|FG001|Overall Study|Patient/guardian decision|9|||
13231992|NCT01715129|26315773|FG000|Overall Study|Adverse Event, fatal|1|||
13231993|NCT01715129|26315773|FG000|Overall Study|Lack of Efficacy|3|||
13231994|NCT01715129|26315773|FG000|Overall Study|Protocol Violation|1|||
13231995|NCT01715129|26315773|FG000|Overall Study|Consent Withdrawn|2|||
13231996|NCT01715129|26315773|FG000|Overall Study|Lost to Follow-up|1|||
13231997|NCT01715129|26315773|FG000|Overall Study|Other|1|||
13231998|NCT01714947|26315804|FG000|Part B|Progressive Disease|3|||
13231999|NCT01714726|26315891|FG000|Double-Blinded Induction Period|Subject not in open label period|3|||
13232000|NCT01714726|26315892|FG001|Double-Blinded Induction Period|Subject not in open label period|1|||
13232001|NCT01714726|26315893|FG002|Double-Blinded Induction Period|Subject not in open label period|0|||
13232002|NCT01714726|26315894|FG003|Double-Blinded Induction Period|Subject not in open label period|0|||
13232003|NCT01714726|26315891|FG000|Double-Blinded Induction Period|Adverse Event|0|||
13232004|NCT01714726|26315892|FG001|Double-Blinded Induction Period|Adverse Event|1|||
13232005|NCT01714726|26315893|FG002|Double-Blinded Induction Period|Adverse Event|0|||
13232006|NCT01714726|26315894|FG003|Double-Blinded Induction Period|Adverse Event|0|||
13232007|NCT01714726|26315891|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5|||
13232008|NCT01714726|26315892|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3|||
13232009|NCT01714726|26315893|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0|||
13232010|NCT01714726|26315894|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0|||
13232011|NCT01714726|26315891|FG000|Double-Blinded Induction Period|Lost to Follow-up|0|||
13232012|NCT01714726|26315892|FG001|Double-Blinded Induction Period|Lost to Follow-up|2|||
13232013|NCT01714726|26315893|FG002|Double-Blinded Induction Period|Lost to Follow-up|0|||
13232014|NCT01714726|26315894|FG003|Double-Blinded Induction Period|Lost to Follow-up|0|||
13232015|NCT01714726|26315891|FG000|Open-Label Period|Other|0|||
13232016|NCT01714726|26315892|FG001|Open-Label Period|Other|0|||
13232017|NCT01714726|26315893|FG002|Open-Label Period|Other|1|||
13232018|NCT01714726|26315894|FG003|Open-Label Period|Other|3|||
13232019|NCT01714726|26315891|FG000|Open-Label Period|Adverse Event|0|||
13232020|NCT01714726|26315892|FG001|Open-Label Period|Adverse Event|0|||
13232021|NCT01714726|26315893|FG002|Open-Label Period|Adverse Event|1|||
13232022|NCT01714726|26315894|FG003|Open-Label Period|Adverse Event|0|||
13232023|NCT01714726|26315891|FG000|Open-Label Period|Withdrawal by Subject|0|||
13232024|NCT01714726|26315892|FG001|Open-Label Period|Withdrawal by Subject|0|||
13232025|NCT01714726|26315893|FG002|Open-Label Period|Withdrawal by Subject|9|||
13232026|NCT01714726|26315894|FG003|Open-Label Period|Withdrawal by Subject|19|||
13232027|NCT01714726|26315891|FG000|Open-Label Period|Developed specific withdrawal criteria|0|||
13232028|NCT01714726|26315892|FG001|Open-Label Period|Developed specific withdrawal criteria|0|||
13232029|NCT01714726|26315893|FG002|Open-Label Period|Developed specific withdrawal criteria|5|||
13232030|NCT01714726|26315894|FG003|Open-Label Period|Developed specific withdrawal criteria|2|||
13232031|NCT01714726|26315891|FG000|Open-Label Period|Lost to Follow-up|0|||
13232032|NCT01714726|26315892|FG001|Open-Label Period|Lost to Follow-up|0|||
13232033|NCT01714726|26315893|FG002|Open-Label Period|Lost to Follow-up|3|||
13232034|NCT01714726|26315894|FG003|Open-Label Period|Lost to Follow-up|4|||
13485805|NCT00585195|27033423|FG013|Overall Study|Lost to Follow-up|0|||
13232035|NCT01714687|26315922|FG000|Overall Study|Withdrawal by Subject|1|||
13232036|NCT01714687|26315923|FG001|Overall Study|Withdrawal by Subject|0|||
13232037|NCT01714687|26315922|FG000|Overall Study|Lost to Follow-up|2|||
13232038|NCT01714687|26315923|FG001|Overall Study|Lost to Follow-up|4|||
13232039|NCT01714635|26315947|FG000|Overall Study|Discontinued|1|||
13232040|NCT01714635|26315948|FG001|Overall Study|Discontinued|0|||
13232041|NCT01714635|26315949|FG002|Overall Study|Discontinued|2|||
13232042|NCT01714635|26315947|FG000|Overall Study|Missed 6-month exam|1|||
13232043|NCT01714635|26315948|FG001|Overall Study|Missed 6-month exam|0|||
13232044|NCT01714635|26315949|FG002|Overall Study|Missed 6-month exam|0|||
13232045|NCT01714609|26315962|FG000|Overall Study|Protocol Violation|1|||
13232046|NCT01714609|26315963|FG001|Overall Study|Protocol Violation|0|||
13232047|NCT01714544|26315969|FG000|Overall Study|Lost to Follow-up|1|||
13232048|NCT01714544|26315969|FG000|Overall Study|Physician Decision|1|||
13232049|NCT01714544|26315969|FG000|Overall Study|Withdrawal by Subject|1|||
13232050|NCT01714310|26316026|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0|||
13232051|NCT01714310|26316027|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0|||
13232052|NCT01714310|26316028|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1|||
13232053|NCT01714310|26316026|FG000|Open Lisdexamfetamine Titration|Adverse Event|0|||
13232054|NCT01714310|26316027|FG001|Open Lisdexamfetamine Titration|Adverse Event|0|||
13232055|NCT01714310|26316028|FG002|Open Lisdexamfetamine Titration|Adverse Event|3|||
13232056|NCT01714310|26316026|FG000|Double Blind Adjunctive Treatment|Adverse Event|1|||
13232057|NCT01714310|26316027|FG001|Double Blind Adjunctive Treatment|Adverse Event|1|||
13232058|NCT01714310|26316028|FG002|Double Blind Adjunctive Treatment|Adverse Event|0|||
13232059|NCT01714310|26316026|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1|||
13232060|NCT01714310|26316027|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2|||
13232061|NCT01714310|26316028|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0|||
13232062|NCT01714063|26316042|FG000|Overall Study|Equipment malfunction|2|||
13232063|NCT01713998|26316070|FG000|Overall Study|Lost to Follow-up|2|||
13232064|NCT01713998|26316071|FG001|Overall Study|Lost to Follow-up|0|||
13232065|NCT01713998|26316072|FG002|Overall Study|Lost to Follow-up|2|||
13232066|NCT01713998|26316070|FG000|Overall Study|Withdrawal by Subject|1|||
13232067|NCT01713998|26316071|FG001|Overall Study|Withdrawal by Subject|0|||
13232068|NCT01713998|26316072|FG002|Overall Study|Withdrawal by Subject|0|||
13232069|NCT01713946|26316173|FG000|Overall Study|Death|0|||
13232070|NCT01713946|26316174|FG001|Overall Study|Death|2|||
13232071|NCT01713946|26316175|FG002|Overall Study|Death|2|||
13232072|NCT01713946|26316173|FG000|Overall Study|Adverse Event|19|||
13232073|NCT01713946|26316174|FG001|Overall Study|Adverse Event|14|||
13232074|NCT01713946|26316175|FG002|Overall Study|Adverse Event|13|||
13232075|NCT01713946|26316173|FG000|Overall Study|Withdrawal by Subject|12|||
13232076|NCT01713946|26316174|FG001|Overall Study|Withdrawal by Subject|12|||
13232077|NCT01713946|26316175|FG002|Overall Study|Withdrawal by Subject|8|||
13232078|NCT01713946|26316173|FG000|Overall Study|Lack of Efficacy|8|||
13232079|NCT01713946|26316174|FG001|Overall Study|Lack of Efficacy|8|||
13232080|NCT01713946|26316175|FG002|Overall Study|Lack of Efficacy|14|||
13232081|NCT01713946|26316173|FG000|Overall Study|Protocol Violation|2|||
13232082|NCT01713946|26316174|FG001|Overall Study|Protocol Violation|4|||
13232083|NCT01713946|26316175|FG002|Overall Study|Protocol Violation|1|||
13232084|NCT01713946|26316173|FG000|Overall Study|Lost to Follow-up|0|||
13232085|NCT01713946|26316174|FG001|Overall Study|Lost to Follow-up|0|||
13232086|NCT01713946|26316175|FG002|Overall Study|Lost to Follow-up|1|||
13232087|NCT01713946|26316173|FG000|Overall Study|Administrative problems|1|||
13232088|NCT01713946|26316174|FG001|Overall Study|Administrative problems|0|||
13232089|NCT01713946|26316175|FG002|Overall Study|Administrative problems|0|||
13232090|NCT01713946|26316173|FG000|Overall Study|Did not continue in Ext|0|||
13232091|NCT01713946|26316174|FG001|Overall Study|Did not continue in Ext|3|||
13232092|NCT01713946|26316175|FG002|Overall Study|Did not continue in Ext|0|||
13232093|NCT01713946|26316173|FG000|Overall Study|Did not continue in Post-Ext. Phase|1|||
13232094|NCT01713946|26316174|FG001|Overall Study|Did not continue in Post-Ext. Phase|2|||
13232095|NCT01713946|26316175|FG002|Overall Study|Did not continue in Post-Ext. Phase|0|||
13232096|NCT01713946|26316173|FG000|Overall Study|Patients never switched to everolimus|0|||
13232097|NCT01713946|26316174|FG001|Overall Study|Patients never switched to everolimus|0|||
13232098|NCT01713946|26316175|FG002|Overall Study|Patients never switched to everolimus|5|||
13232099|NCT01713933|26316189|FG000|Overall Study|Lost to Follow-up|2|||
13232100|NCT01713933|26316189|FG000|Overall Study|Withdrawal by Subject|3|||
13232101|NCT01713933|26316189|FG000|Overall Study|Excluded from analysis as a BMI outlier|1|||
13232102|NCT01713686|26316200|FG000|Overall Study|Lost to Follow-up|9|||
13232103|NCT01713686|26316200|FG000|Overall Study|Withdrawal by Subject|6|||
13232104|NCT01713582|26316425|FG000|Overall Study|Disease progression|3|||
13232105|NCT01713582|26316426|FG001|Overall Study|Disease progression|3|||
13232106|NCT01713582|26316427|FG002|Overall Study|Disease progression|3|||
13232107|NCT01713582|26316428|FG003|Overall Study|Disease progression|2|||
13232108|NCT01713582|26316429|FG004|Overall Study|Disease progression|3|||
13232109|NCT01713582|26316430|FG005|Overall Study|Disease progression|3|||
13232110|NCT01713582|26316431|FG006|Overall Study|Disease progression|3|||
13232111|NCT01713582|26316432|FG007|Overall Study|Disease progression|3|||
13232112|NCT01713582|26316433|FG008|Overall Study|Disease progression|3|||
13232113|NCT01713582|26316434|FG009|Overall Study|Disease progression|11|||
13232114|NCT01713582|26316435|FG010|Overall Study|Disease progression|10|||
13232115|NCT01713582|26316436|FG011|Overall Study|Disease progression|5|||
13232116|NCT01713582|26316437|FG012|Overall Study|Disease progression|3|||
13232117|NCT01713582|26316438|FG013|Overall Study|Disease progression|3|||
13232118|NCT01713582|26316439|FG014|Overall Study|Disease progression|6|||
13232119|NCT01713582|26316440|FG015|Overall Study|Disease progression|6|||
13232120|NCT01713582|26316441|FG016|Overall Study|Disease progression|5|||
13232121|NCT01713582|26316442|FG017|Overall Study|Disease progression|2|||
13232122|NCT01713582|26316443|FG018|Overall Study|Disease progression|3|||
13232123|NCT01713582|26316444|FG019|Overall Study|Disease progression|5|||
13232124|NCT01713582|26316445|FG020|Overall Study|Disease progression|15|||
13232125|NCT01713582|26316425|FG000|Overall Study|Death|0|||
13232126|NCT01713582|26316426|FG001|Overall Study|Death|0|||
13232127|NCT01713582|26316427|FG002|Overall Study|Death|0|||
13232128|NCT01713582|26316428|FG003|Overall Study|Death|1|||
13232129|NCT01713582|26316429|FG004|Overall Study|Death|1|||
13232130|NCT01713582|26316430|FG005|Overall Study|Death|3|||
13232131|NCT01713582|26316431|FG006|Overall Study|Death|3|||
13232132|NCT01713582|26316432|FG007|Overall Study|Death|2|||
13232133|NCT01713582|26316433|FG008|Overall Study|Death|3|||
13232134|NCT01713582|26316434|FG009|Overall Study|Death|4|||
13232135|NCT01713582|26316435|FG010|Overall Study|Death|3|||
13232136|NCT01713582|26316436|FG011|Overall Study|Death|0|||
13232137|NCT01713582|26316437|FG012|Overall Study|Death|0|||
13232138|NCT01713582|26316438|FG013|Overall Study|Death|0|||
13232139|NCT01713582|26316439|FG014|Overall Study|Death|0|||
13232140|NCT01713582|26316440|FG015|Overall Study|Death|0|||
13232141|NCT01713582|26316441|FG016|Overall Study|Death|0|||
13232142|NCT01713582|26316442|FG017|Overall Study|Death|0|||
13232143|NCT01713582|26316443|FG018|Overall Study|Death|0|||
13232144|NCT01713582|26316444|FG019|Overall Study|Death|0|||
13232145|NCT01713582|26316445|FG020|Overall Study|Death|0|||
13232146|NCT01713582|26316425|FG000|Overall Study|Adverse event-related|0|||
13232147|NCT01713582|26316426|FG001|Overall Study|Adverse event-related|0|||
13232148|NCT01713582|26316427|FG002|Overall Study|Adverse event-related|0|||
13232149|NCT01713582|26316428|FG003|Overall Study|Adverse event-related|0|||
13232150|NCT01713582|26316429|FG004|Overall Study|Adverse event-related|0|||
13232151|NCT01713582|26316430|FG005|Overall Study|Adverse event-related|0|||
13232152|NCT01713582|26316431|FG006|Overall Study|Adverse event-related|0|||
13232153|NCT01713582|26316432|FG007|Overall Study|Adverse event-related|0|||
13232154|NCT01713582|26316433|FG008|Overall Study|Adverse event-related|0|||
13232155|NCT01713582|26316434|FG009|Overall Study|Adverse event-related|1|||
13232156|NCT01713582|26316435|FG010|Overall Study|Adverse event-related|1|||
13232157|NCT01713582|26316436|FG011|Overall Study|Adverse event-related|0|||
13232158|NCT01713582|26316437|FG012|Overall Study|Adverse event-related|0|||
13232159|NCT01713582|26316438|FG013|Overall Study|Adverse event-related|0|||
13232160|NCT01713582|26316439|FG014|Overall Study|Adverse event-related|0|||
13232161|NCT01713582|26316440|FG015|Overall Study|Adverse event-related|0|||
13232162|NCT01713582|26316441|FG016|Overall Study|Adverse event-related|0|||
13232163|NCT01713582|26316442|FG017|Overall Study|Adverse event-related|0|||
13232164|NCT01713582|26316443|FG018|Overall Study|Adverse event-related|1|||
13232165|NCT01713582|26316444|FG019|Overall Study|Adverse event-related|0|||
13232166|NCT01713582|26316445|FG020|Overall Study|Adverse event-related|0|||
13232167|NCT01713582|26316425|FG000|Overall Study|Adverse event-unrelated|0|||
13232168|NCT01713582|26316426|FG001|Overall Study|Adverse event-unrelated|0|||
13232169|NCT01713582|26316427|FG002|Overall Study|Adverse event-unrelated|0|||
13232170|NCT01713582|26316428|FG003|Overall Study|Adverse event-unrelated|0|||
13232171|NCT01713582|26316429|FG004|Overall Study|Adverse event-unrelated|0|||
13232172|NCT01713582|26316430|FG005|Overall Study|Adverse event-unrelated|1|||
13232173|NCT01713582|26316431|FG006|Overall Study|Adverse event-unrelated|1|||
13232174|NCT01713582|26316432|FG007|Overall Study|Adverse event-unrelated|1|||
13232175|NCT01713582|26316433|FG008|Overall Study|Adverse event-unrelated|0|||
13232176|NCT01713582|26316434|FG009|Overall Study|Adverse event-unrelated|0|||
13232177|NCT01713582|26316435|FG010|Overall Study|Adverse event-unrelated|0|||
13232178|NCT01713582|26316436|FG011|Overall Study|Adverse event-unrelated|0|||
13232179|NCT01713582|26316437|FG012|Overall Study|Adverse event-unrelated|0|||
13232180|NCT01713582|26316438|FG013|Overall Study|Adverse event-unrelated|1|||
13232181|NCT01713582|26316439|FG014|Overall Study|Adverse event-unrelated|1|||
13232182|NCT01713582|26316440|FG015|Overall Study|Adverse event-unrelated|0|||
13232183|NCT01713582|26316441|FG016|Overall Study|Adverse event-unrelated|0|||
13232184|NCT01713582|26316442|FG017|Overall Study|Adverse event-unrelated|0|||
13232185|NCT01713582|26316443|FG018|Overall Study|Adverse event-unrelated|0|||
13232186|NCT01713582|26316444|FG019|Overall Study|Adverse event-unrelated|0|||
13232187|NCT01713582|26316445|FG020|Overall Study|Adverse event-unrelated|0|||
13232188|NCT01713582|26316425|FG000|Overall Study|Withdrawal of consent|0|||
13232189|NCT01713582|26316426|FG001|Overall Study|Withdrawal of consent|0|||
13232190|NCT01713582|26316427|FG002|Overall Study|Withdrawal of consent|1|||
13232191|NCT01713582|26316428|FG003|Overall Study|Withdrawal of consent|0|||
13232192|NCT01713582|26316429|FG004|Overall Study|Withdrawal of consent|0|||
13232193|NCT01713582|26316430|FG005|Overall Study|Withdrawal of consent|1|||
13232194|NCT01713582|26316431|FG006|Overall Study|Withdrawal of consent|0|||
13232195|NCT01713582|26316432|FG007|Overall Study|Withdrawal of consent|0|||
13232196|NCT01713582|26316433|FG008|Overall Study|Withdrawal of consent|0|||
13232197|NCT01713582|26316434|FG009|Overall Study|Withdrawal of consent|1|||
13232198|NCT01713582|26316435|FG010|Overall Study|Withdrawal of consent|0|||
13232199|NCT01713582|26316436|FG011|Overall Study|Withdrawal of consent|0|||
13232200|NCT01713582|26316437|FG012|Overall Study|Withdrawal of consent|0|||
13232201|NCT01713582|26316438|FG013|Overall Study|Withdrawal of consent|0|||
13232202|NCT01713582|26316439|FG014|Overall Study|Withdrawal of consent|0|||
13232203|NCT01713582|26316440|FG015|Overall Study|Withdrawal of consent|0|||
13232204|NCT01713582|26316441|FG016|Overall Study|Withdrawal of consent|0|||
13232205|NCT01713582|26316442|FG017|Overall Study|Withdrawal of consent|0|||
13232206|NCT01713582|26316443|FG018|Overall Study|Withdrawal of consent|1|||
13232207|NCT01713582|26316444|FG019|Overall Study|Withdrawal of consent|0|||
13232208|NCT01713582|26316445|FG020|Overall Study|Withdrawal of consent|0|||
13232209|NCT01713582|26316425|FG000|Overall Study|Lack of Efficacy|0|||
13232210|NCT01713582|26316426|FG001|Overall Study|Lack of Efficacy|0|||
13232211|NCT01713582|26316427|FG002|Overall Study|Lack of Efficacy|0|||
13232212|NCT01713582|26316428|FG003|Overall Study|Lack of Efficacy|0|||
13232213|NCT01713582|26316429|FG004|Overall Study|Lack of Efficacy|0|||
13232214|NCT01713582|26316430|FG005|Overall Study|Lack of Efficacy|0|||
13232215|NCT01713582|26316431|FG006|Overall Study|Lack of Efficacy|0|||
13232216|NCT01713582|26316432|FG007|Overall Study|Lack of Efficacy|0|||
13232217|NCT01713582|26316433|FG008|Overall Study|Lack of Efficacy|0|||
13232218|NCT01713582|26316434|FG009|Overall Study|Lack of Efficacy|1|||
13232219|NCT01713582|26316435|FG010|Overall Study|Lack of Efficacy|2|||
13232220|NCT01713582|26316436|FG011|Overall Study|Lack of Efficacy|0|||
13232221|NCT01713582|26316437|FG012|Overall Study|Lack of Efficacy|0|||
13232222|NCT01713582|26316438|FG013|Overall Study|Lack of Efficacy|0|||
13232223|NCT01713582|26316439|FG014|Overall Study|Lack of Efficacy|0|||
13232224|NCT01713582|26316440|FG015|Overall Study|Lack of Efficacy|0|||
13232225|NCT01713582|26316441|FG016|Overall Study|Lack of Efficacy|0|||
13232226|NCT01713582|26316442|FG017|Overall Study|Lack of Efficacy|0|||
13232227|NCT01713582|26316443|FG018|Overall Study|Lack of Efficacy|0|||
13232228|NCT01713582|26316444|FG019|Overall Study|Lack of Efficacy|0|||
13232229|NCT01713582|26316445|FG020|Overall Study|Lack of Efficacy|0|||
13232230|NCT01713582|26316425|FG000|Overall Study|Withdrawal by Subject|0|||
13232231|NCT01713582|26316426|FG001|Overall Study|Withdrawal by Subject|0|||
13232232|NCT01713582|26316427|FG002|Overall Study|Withdrawal by Subject|0|||
13232233|NCT01713582|26316428|FG003|Overall Study|Withdrawal by Subject|0|||
13232234|NCT01713582|26316429|FG004|Overall Study|Withdrawal by Subject|0|||
13232235|NCT01713582|26316430|FG005|Overall Study|Withdrawal by Subject|0|||
13232236|NCT01713582|26316431|FG006|Overall Study|Withdrawal by Subject|0|||
13232237|NCT01713582|26316432|FG007|Overall Study|Withdrawal by Subject|0|||
13232238|NCT01713582|26316433|FG008|Overall Study|Withdrawal by Subject|0|||
13232239|NCT01713582|26316434|FG009|Overall Study|Withdrawal by Subject|0|||
13232240|NCT01713582|26316435|FG010|Overall Study|Withdrawal by Subject|0|||
13232241|NCT01713582|26316436|FG011|Overall Study|Withdrawal by Subject|0|||
13232242|NCT01713582|26316437|FG012|Overall Study|Withdrawal by Subject|0|||
13232243|NCT01713582|26316438|FG013|Overall Study|Withdrawal by Subject|0|||
13232244|NCT01713582|26316439|FG014|Overall Study|Withdrawal by Subject|0|||
13232245|NCT01713582|26316440|FG015|Overall Study|Withdrawal by Subject|0|||
13232246|NCT01713582|26316441|FG016|Overall Study|Withdrawal by Subject|0|||
13232247|NCT01713582|26316442|FG017|Overall Study|Withdrawal by Subject|1|||
13232248|NCT01713582|26316443|FG018|Overall Study|Withdrawal by Subject|0|||
13232249|NCT01713582|26316444|FG019|Overall Study|Withdrawal by Subject|0|||
13232250|NCT01713582|26316445|FG020|Overall Study|Withdrawal by Subject|0|||
13232251|NCT01713582|26316425|FG000|Overall Study|Stopped to receive bone marrow graft|0|||
13232252|NCT01713582|26316426|FG001|Overall Study|Stopped to receive bone marrow graft|0|||
13232253|NCT01713582|26316427|FG002|Overall Study|Stopped to receive bone marrow graft|0|||
13232254|NCT01713582|26316428|FG003|Overall Study|Stopped to receive bone marrow graft|0|||
13232255|NCT01713582|26316429|FG004|Overall Study|Stopped to receive bone marrow graft|0|||
13232256|NCT01713582|26316430|FG005|Overall Study|Stopped to receive bone marrow graft|0|||
13232257|NCT01713582|26316431|FG006|Overall Study|Stopped to receive bone marrow graft|0|||
13232258|NCT01713582|26316432|FG007|Overall Study|Stopped to receive bone marrow graft|0|||
13232259|NCT01713582|26316433|FG008|Overall Study|Stopped to receive bone marrow graft|0|||
13232260|NCT01713582|26316434|FG009|Overall Study|Stopped to receive bone marrow graft|0|||
13232261|NCT01713582|26316435|FG010|Overall Study|Stopped to receive bone marrow graft|0|||
13232262|NCT01713582|26316436|FG011|Overall Study|Stopped to receive bone marrow graft|0|||
13232263|NCT01713582|26316437|FG012|Overall Study|Stopped to receive bone marrow graft|0|||
13232264|NCT01713582|26316438|FG013|Overall Study|Stopped to receive bone marrow graft|0|||
13232265|NCT01713582|26316439|FG014|Overall Study|Stopped to receive bone marrow graft|0|||
13232266|NCT01713582|26316440|FG015|Overall Study|Stopped to receive bone marrow graft|0|||
13232267|NCT01713582|26316441|FG016|Overall Study|Stopped to receive bone marrow graft|1|||
13232268|NCT01713582|26316442|FG017|Overall Study|Stopped to receive bone marrow graft|0|||
13232269|NCT01713582|26316443|FG018|Overall Study|Stopped to receive bone marrow graft|0|||
13232270|NCT01713582|26316444|FG019|Overall Study|Stopped to receive bone marrow graft|0|||
13232271|NCT01713582|26316445|FG020|Overall Study|Stopped to receive bone marrow graft|0|||
13232272|NCT01713582|26316425|FG000|Overall Study|Disease progression and adverse event|0|||
13232273|NCT01713582|26316426|FG001|Overall Study|Disease progression and adverse event|0|||
13232274|NCT01713582|26316427|FG002|Overall Study|Disease progression and adverse event|0|||
13232275|NCT01713582|26316428|FG003|Overall Study|Disease progression and adverse event|0|||
13232276|NCT01713582|26316429|FG004|Overall Study|Disease progression and adverse event|0|||
13232277|NCT01713582|26316430|FG005|Overall Study|Disease progression and adverse event|0|||
13232278|NCT01713582|26316431|FG006|Overall Study|Disease progression and adverse event|0|||
13232279|NCT01713582|26316432|FG007|Overall Study|Disease progression and adverse event|0|||
13232280|NCT01713582|26316433|FG008|Overall Study|Disease progression and adverse event|0|||
13232281|NCT01713582|26316434|FG009|Overall Study|Disease progression and adverse event|0|||
13232282|NCT01713582|26316435|FG010|Overall Study|Disease progression and adverse event|0|||
13232283|NCT01713582|26316436|FG011|Overall Study|Disease progression and adverse event|0|||
13232284|NCT01713582|26316437|FG012|Overall Study|Disease progression and adverse event|0|||
13232285|NCT01713582|26316438|FG013|Overall Study|Disease progression and adverse event|0|||
13232286|NCT01713582|26316439|FG014|Overall Study|Disease progression and adverse event|0|||
13232287|NCT01713582|26316440|FG015|Overall Study|Disease progression and adverse event|0|||
13232288|NCT01713582|26316441|FG016|Overall Study|Disease progression and adverse event|1|||
13232289|NCT01713582|26316442|FG017|Overall Study|Disease progression and adverse event|0|||
13232290|NCT01713582|26316443|FG018|Overall Study|Disease progression and adverse event|0|||
13232291|NCT01713582|26316444|FG019|Overall Study|Disease progression and adverse event|0|||
13232292|NCT01713582|26316445|FG020|Overall Study|Disease progression and adverse event|0|||
13232293|NCT01713530|26316468|FG000|Overall Study|Adverse Event|0|||
13232294|NCT01713530|26316469|FG001|Overall Study|Adverse Event|5|||
13232295|NCT01713530|26316468|FG000|Overall Study|Withdrawal criteria|21|||
13232296|NCT01713530|26316469|FG001|Overall Study|Withdrawal criteria|12|||
13232297|NCT01713530|26316468|FG000|Overall Study|Unclassified|4|||
13232298|NCT01713530|26316469|FG001|Overall Study|Unclassified|2|||
13232299|NCT01713348|26316508|FG000|Overall Study|Withdrawal by Subject|3|||
13232300|NCT01713348|26316509|FG001|Overall Study|Withdrawal by Subject|2|||
13232301|NCT01713348|26316510|FG002|Overall Study|Withdrawal by Subject|2|||
13232302|NCT01713348|26316511|FG003|Overall Study|Withdrawal by Subject|0|||
13232303|NCT01713348|26316508|FG000|Overall Study|Lost to Follow-up|1|||
13232304|NCT01713348|26316509|FG001|Overall Study|Lost to Follow-up|0|||
13232305|NCT01713348|26316510|FG002|Overall Study|Lost to Follow-up|0|||
13232306|NCT01713348|26316511|FG003|Overall Study|Lost to Follow-up|0|||
13232307|NCT01713283|26316544|FG000|Overall Study|Lack of Efficacy|10|||
13232308|NCT01713283|26316545|FG001|Overall Study|Lack of Efficacy|2|||
13232309|NCT01713283|26316544|FG000|Overall Study|Lost to Follow-up|1|||
13232310|NCT01713283|26316545|FG001|Overall Study|Lost to Follow-up|1|||
13232311|NCT01713036|26316584|FG000|Overall Study|Death|1|||
13232312|NCT01712984|26316614|FG000|Overall Study|Adverse Event|0|||
13232313|NCT01712984|26316615|FG001|Overall Study|Adverse Event|0|||
13232314|NCT01712984|26316616|FG002|Overall Study|Adverse Event|1|||
13232315|NCT01712984|26316614|FG000|Overall Study|Protocol Violation|2|||
13232316|NCT01712984|26316615|FG001|Overall Study|Protocol Violation|0|||
13232317|NCT01712984|26316616|FG002|Overall Study|Protocol Violation|1|||
13232318|NCT01712984|26316614|FG000|Overall Study|Lost to Follow-up|8|||
13232319|NCT01712984|26316615|FG001|Overall Study|Lost to Follow-up|10|||
13232320|NCT01712984|26316616|FG002|Overall Study|Lost to Follow-up|1|||
13232321|NCT01712984|26316614|FG000|Overall Study|Withdrawal by Subject|6|||
13232322|NCT01712984|26316615|FG001|Overall Study|Withdrawal by Subject|6|||
13232323|NCT01712984|26316616|FG002|Overall Study|Withdrawal by Subject|7|||
13232324|NCT01712854|26316623|FG000|Overall Study|Physician Decision|1|||
13232325|NCT01712685|26316637|FG000|Overall Study|pt declined to participate before trmt|1|||
13232326|NCT01712516|26316700|FG000|Overall Study|Technical problems|0|||
13232327|NCT01712516|26316701|FG001|Overall Study|Technical problems|0|||
13232328|NCT01712516|26316702|FG002|Overall Study|Technical problems|0|||
13232329|NCT01712516|26316703|FG003|Overall Study|Technical problems|2|||
13232330|NCT01712516|26316700|FG000|Overall Study|Lost to Follow-up|0|||
13232331|NCT01712516|26316701|FG001|Overall Study|Lost to Follow-up|0|||
13232332|NCT01712516|26316702|FG002|Overall Study|Lost to Follow-up|2|||
13232333|NCT01712516|26316703|FG003|Overall Study|Lost to Follow-up|1|||
13232334|NCT01712516|26316700|FG000|Overall Study|Death|0|||
13232335|NCT01712516|26316701|FG001|Overall Study|Death|1|||
13232336|NCT01712516|26316702|FG002|Overall Study|Death|0|||
13232337|NCT01712516|26316703|FG003|Overall Study|Death|0|||
13232338|NCT01712516|26316700|FG000|Overall Study|Protocol deviation|1|||
13232339|NCT01712516|26316701|FG001|Overall Study|Protocol deviation|0|||
13232340|NCT01712516|26316702|FG002|Overall Study|Protocol deviation|1|||
13232341|NCT01712516|26316703|FG003|Overall Study|Protocol deviation|0|||
13232342|NCT01712516|26316700|FG000|Overall Study|Physician Decision|2|||
13232343|NCT01712516|26316701|FG001|Overall Study|Physician Decision|0|||
13232344|NCT01712516|26316702|FG002|Overall Study|Physician Decision|0|||
13232345|NCT01712516|26316703|FG003|Overall Study|Physician Decision|1|||
13232346|NCT01712516|26316700|FG000|Overall Study|Withdrawal by Subject|3|||
13232347|NCT01712516|26316701|FG001|Overall Study|Withdrawal by Subject|9|||
13232348|NCT01712516|26316702|FG002|Overall Study|Withdrawal by Subject|3|||
13232349|NCT01712516|26316703|FG003|Overall Study|Withdrawal by Subject|9|||
13232350|NCT01712490|26316747|FG000|Overall Study|Ongoing|601|||
13232351|NCT01712490|26316748|FG001|Overall Study|Ongoing|586|||
13232352|NCT01712490|26316747|FG000|Overall Study|Other|11|||
13232353|NCT01712490|26316748|FG001|Overall Study|Other|11|||
13232354|NCT01712490|26316747|FG000|Overall Study|Withdrawal by Subject|36|||
13232355|NCT01712490|26316748|FG001|Overall Study|Withdrawal by Subject|44|||
13232356|NCT01712490|26316747|FG000|Overall Study|Lost to Follow-up|16|||
13232357|NCT01712490|26316748|FG001|Overall Study|Lost to Follow-up|29|||
13232358|NCT01712438|26316760|FG000|Overall Study|Not treated with Human-cl rhFVIII|2|||
13232359|NCT01712438|26316760|FG000|Overall Study|Ongoing ITI treatment|6|||
13232360|NCT01712438|26316760|FG000|Overall Study|Violated inclusion & exclusion criteria|4|||
13232361|NCT01712438|26316760|FG000|Overall Study|Prematurely Discontinued|25|||
13232362|NCT01712399|26316775|FG000|Overall Study|Lost to Follow-up|1|||
13232363|NCT01712399|26316775|FG000|Overall Study|Withdrawal by Subject|39|||
13232364|NCT01712399|26316775|FG000|Overall Study|Death|1|||
13232365|NCT01712399|26316775|FG000|Overall Study|Adverse Event|11|||
13232366|NCT01712399|26316775|FG000|Overall Study|Study closure|345|||
13232367|NCT01712334|26316786|FG000|Treatment Period 1|Randomized in Error|0|||
13232368|NCT01712334|26316787|FG001|Treatment Period 1|Randomized in Error|2|||
13232369|NCT01712256|26316798|FG000|Overall Study|Lost to Follow-up|1|||
13232370|NCT01712204|26316811|FG000|Overall Study|Adverse Event|3|||
13232371|NCT01712204|26316812|FG001|Overall Study|Adverse Event|1|||
13232372|NCT01712204|26316811|FG000|Overall Study|Withdrawal by Subject|3|||
13232373|NCT01712204|26316812|FG001|Overall Study|Withdrawal by Subject|3|||
13232374|NCT01712204|26316811|FG000|Overall Study|Lost to Follow-up|1|||
13232375|NCT01712204|26316812|FG001|Overall Study|Lost to Follow-up|0|||
13232376|NCT01712204|26316811|FG000|Overall Study|Protocol Violation|1|||
13232377|NCT01712204|26316812|FG001|Overall Study|Protocol Violation|1|||
13232378|NCT01712178|26316841|FG000|Overall Study|Withdrew consent due to an adverse event|1|||
13232379|NCT01712178|26316842|FG001|Overall Study|Withdrew consent due to an adverse event|1|||
13232380|NCT01712178|26316841|FG000|Overall Study|Serious adverse event/withdrew consent|0|||
13232381|NCT01712178|26316842|FG001|Overall Study|Serious adverse event/withdrew consent|1|||
13232382|NCT01712178|26316841|FG000|Overall Study|Lost to Follow-up|0|||
13232383|NCT01712178|26316842|FG001|Overall Study|Lost to Follow-up|1|||
13232384|NCT01712074|26316906|FG000|Placebo Run-in Period|Adverse Event|2|||
13232385|NCT01712074|26316907|FG001|Placebo Run-in Period|Adverse Event|0|||
13232386|NCT01712074|26316908|FG002|Placebo Run-in Period|Adverse Event|0|||
13232387|NCT01712074|26316906|FG000|Placebo Run-in Period|Lost to Follow-up|1|||
13232388|NCT01712074|26316907|FG001|Placebo Run-in Period|Lost to Follow-up|0|||
13232389|NCT01712074|26316908|FG002|Placebo Run-in Period|Lost to Follow-up|0|||
13232390|NCT01712074|26316906|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5|||
13232391|NCT01712074|26316907|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0|||
13232392|NCT01712074|26316908|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0|||
13232393|NCT01712074|26316906|FG000|Placebo Run-in Period|Other|1|||
13232394|NCT01712074|26316907|FG001|Placebo Run-in Period|Other|0|||
13232395|NCT01712074|26316908|FG002|Placebo Run-in Period|Other|0|||
13232396|NCT01712074|26316906|FG000|Placebo Run-in Period|No longer willing to participate|1|||
13232397|NCT01712074|26316907|FG001|Placebo Run-in Period|No longer willing to participate|0|||
13232398|NCT01712074|26316908|FG002|Placebo Run-in Period|No longer willing to participate|0|||
13232399|NCT01712074|26316906|FG000|Double Blind Period|Adverse Event|0|||
13232400|NCT01712074|26316907|FG001|Double Blind Period|Adverse Event|2|||
13232401|NCT01712074|26316908|FG002|Double Blind Period|Adverse Event|1|||
13232402|NCT01712074|26316906|FG000|Double Blind Period|No longer willing to participate|0|||
13232403|NCT01712074|26316907|FG001|Double Blind Period|No longer willing to participate|2|||
13232404|NCT01712074|26316908|FG002|Double Blind Period|No longer willing to participate|4|||
13232405|NCT01712074|26316906|FG000|Double Blind Period|Death|0|||
13232406|NCT01712074|26316907|FG001|Double Blind Period|Death|1|||
13232407|NCT01712074|26316908|FG002|Double Blind Period|Death|0|||
13232408|NCT01712074|26316906|FG000|Double Blind Period|Lost to Follow-up|0|||
13232409|NCT01712074|26316907|FG001|Double Blind Period|Lost to Follow-up|2|||
13232410|NCT01712074|26316908|FG002|Double Blind Period|Lost to Follow-up|1|||
13232411|NCT01712074|26316906|FG000|Double Blind Period|Other|0|||
13232412|NCT01712074|26316907|FG001|Double Blind Period|Other|4|||
13232413|NCT01712074|26316908|FG002|Double Blind Period|Other|1|||
13232414|NCT01712074|26316906|FG000|Double Blind Period|Protocol Violation|0|||
13232415|NCT01712074|26316907|FG001|Double Blind Period|Protocol Violation|0|||
13232416|NCT01712074|26316908|FG002|Double Blind Period|Protocol Violation|1|||
13232417|NCT01712074|26316906|FG000|Double Blind Period|No longer met eligibility criteria|0|||
13232418|NCT01712074|26316907|FG001|Double Blind Period|No longer met eligibility criteria|3|||
13232419|NCT01712074|26316908|FG002|Double Blind Period|No longer met eligibility criteria|0|||
13232420|NCT01712061|26316953|FG000|Overall Study|Adverse Event|4|||
13232421|NCT01712061|26316954|FG001|Overall Study|Adverse Event|9|||
13232422|NCT01712061|26316955|FG002|Overall Study|Adverse Event|5|||
13232423|NCT01712061|26316953|FG000|Overall Study|Death|0|||
13232424|NCT01712061|26316954|FG001|Overall Study|Death|0|||
13232425|NCT01712061|26316955|FG002|Overall Study|Death|1|||
13232426|NCT01712061|26316953|FG000|Overall Study|Lost to Follow-up|1|||
13232427|NCT01712061|26316954|FG001|Overall Study|Lost to Follow-up|0|||
13232428|NCT01712061|26316955|FG002|Overall Study|Lost to Follow-up|1|||
13232429|NCT01712061|26316953|FG000|Overall Study|Did Not Meet Entrance Criteria|4|||
13232430|NCT01712061|26316954|FG001|Overall Study|Did Not Meet Entrance Criteria|6|||
13232431|NCT01712061|26316955|FG002|Overall Study|Did Not Meet Entrance Criteria|3|||
13232432|NCT01712061|26316953|FG000|Overall Study|Medication Error Without Associated AE|0|||
13232433|NCT01712061|26316954|FG001|Overall Study|Medication Error Without Associated AE|1|||
13232434|NCT01712061|26316955|FG002|Overall Study|Medication Error Without Associated AE|0|||
13232435|NCT01712061|26316953|FG000|Overall Study|Withdrawal by Subject|1|||
13232436|NCT01712061|26316954|FG001|Overall Study|Withdrawal by Subject|7|||
13232437|NCT01712061|26316955|FG002|Overall Study|Withdrawal by Subject|1|||
13232438|NCT01712061|26316953|FG000|Overall Study|Other|0|||
13232439|NCT01712061|26316954|FG001|Overall Study|Other|3|||
13232440|NCT01712061|26316955|FG002|Overall Study|Other|0|||
13232441|NCT01712009|26316991|FG000|Overall Study|Withdrawal by Subject|24|||
13232442|NCT01712009|26316992|FG001|Overall Study|Withdrawal by Subject|15|||
13232443|NCT01712009|26316993|FG002|Overall Study|Withdrawal by Subject|8|||
13232444|NCT01712009|26316991|FG000|Overall Study|Lost to Follow-up|2|||
13232445|NCT01712009|26316992|FG001|Overall Study|Lost to Follow-up|0|||
13232446|NCT01712009|26316993|FG002|Overall Study|Lost to Follow-up|1|||
13232447|NCT01712009|26316991|FG000|Overall Study|Decision by Sponsor|12|||
13232448|NCT01712009|26316992|FG001|Overall Study|Decision by Sponsor|14|||
13232449|NCT01712009|26316993|FG002|Overall Study|Decision by Sponsor|12|||
13232450|NCT01711983|26317005|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32|||
13232451|NCT01711983|26317005|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26|||
13232452|NCT01711983|26317005|FG000|36-Month Closure Evaluation|Test Device Removal|2|||
13232453|NCT01711983|26317005|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62|||
13232454|NCT01711879|26317046|FG000|Overall Study|Death|1|||
13232455|NCT01711879|26317047|FG001|Overall Study|Death|0|||
13232456|NCT01711866|26317054|FG000|Overall Study|Noncompliant|3|||
13232457|NCT01711866|26317054|FG000|Overall Study|Withdrawal by Subject|3|||
13232458|NCT01711866|26317054|FG000|Overall Study|Adverse Event|2|||
13232459|NCT01711853|26317061|FG000|Overall Study|Not treated|3|||
13232460|NCT01711736|26317096|FG000|Overall Study|Lost to Follow-up|4|||
13232461|NCT01711736|26317097|FG001|Overall Study|Lost to Follow-up|1|||
13232462|NCT01711736|26317096|FG000|Overall Study|Withdrawal by Subject|6|||
13232463|NCT01711736|26317097|FG001|Overall Study|Withdrawal by Subject|6|||
13232464|NCT01711736|26317096|FG000|Overall Study|Migrated/moved from study area|2|||
13232465|NCT01711736|26317097|FG001|Overall Study|Migrated/moved from study area|1|||
13232466|NCT01711645|26317134|FG000|Overall Study|Withdrawal by Subject|8|||
13232467|NCT01711645|26317134|FG000|Overall Study|Lost to Follow-up|6|||
13232468|NCT01711645|26317134|FG000|Overall Study|Physician Decision|5|||
13232469|NCT01711619|26317153|FG000|Overall Study|Early study termination|10|||
13115320|NCT03099304|25917711|FG001|104-week Open-Label Extension Period|Other Reason not specified|0|||
13115321|NCT03099304|25917712|FG002|104-week Open-Label Extension Period|Other Reason not specified|4|||
13115322|NCT03099304|25917713|FG003|104-week Open-Label Extension Period|Other Reason not specified|1|||
13115323|NCT03099304|25917714|FG004|104-week Open-Label Extension Period|Other Reason not specified|1|||
13115324|NCT03099304|25917715|FG005|104-week Open-Label Extension Period|Other Reason not specified|0|||
13115325|NCT03099187|25917776|FG000|Double-blind Treatment|Adverse Event|19|||
13232470|NCT01711619|26317154|FG001|Overall Study|Early study termination|14|||
13232471|NCT01711619|26317153|FG000|Overall Study|Withdrawal by Subject|3|||
13232472|NCT01711619|26317154|FG001|Overall Study|Withdrawal by Subject|7|||
13232473|NCT01711619|26317153|FG000|Overall Study|Protocol Violation|2|||
13232474|NCT01711619|26317154|FG001|Overall Study|Protocol Violation|3|||
13232475|NCT01711619|26317153|FG000|Overall Study|Adverse Event|2|||
13232476|NCT01711619|26317154|FG001|Overall Study|Adverse Event|0|||
13232477|NCT01711619|26317153|FG000|Overall Study|Lost to Follow-up|1|||
13232478|NCT01711619|26317154|FG001|Overall Study|Lost to Follow-up|0|||
13232479|NCT01711359|26317235|FG000|Treatment Period|Withdrawal by Subject|18|||
13232480|NCT01711359|26317236|FG001|Treatment Period|Withdrawal by Subject|7|||
13115326|NCT03099187|25917777|FG001|Double-blind Treatment|Adverse Event|1|||
13232481|NCT01711359|26317237|FG002|Treatment Period|Withdrawal by Subject|13|||
13232482|NCT01711359|26317235|FG000|Treatment Period|Lack of Efficacy|13|||
13232483|NCT01711359|26317236|FG001|Treatment Period|Lack of Efficacy|2|||
13232484|NCT01711359|26317237|FG002|Treatment Period|Lack of Efficacy|2|||
13232485|NCT01711359|26317235|FG000|Treatment Period|Adverse Event|8|||
13232486|NCT01711359|26317236|FG001|Treatment Period|Adverse Event|10|||
13232487|NCT01711359|26317237|FG002|Treatment Period|Adverse Event|24|||
13232488|NCT01711359|26317235|FG000|Treatment Period|Physician Decision|4|||
13232489|NCT01711359|26317236|FG001|Treatment Period|Physician Decision|3|||
13232490|NCT01711359|26317237|FG002|Treatment Period|Physician Decision|2|||
13232491|NCT01711359|26317235|FG000|Treatment Period|Death|3|||
13232492|NCT01711359|26317236|FG001|Treatment Period|Death|0|||
13232493|NCT01711359|26317237|FG002|Treatment Period|Death|0|||
13232494|NCT01711359|26317235|FG000|Treatment Period|Entry Criteria Not Met|1|||
13232495|NCT01711359|26317236|FG001|Treatment Period|Entry Criteria Not Met|0|||
13232496|NCT01711359|26317237|FG002|Treatment Period|Entry Criteria Not Met|0|||
13232497|NCT01711359|26317235|FG000|Treatment Period|Sponsor Decision|1|||
13232498|NCT01711359|26317236|FG001|Treatment Period|Sponsor Decision|0|||
13232499|NCT01711359|26317237|FG002|Treatment Period|Sponsor Decision|0|||
13232500|NCT01711359|26317235|FG000|Treatment Period|Lost to Follow-up|1|||
13232501|NCT01711359|26317236|FG001|Treatment Period|Lost to Follow-up|1|||
13232502|NCT01711359|26317237|FG002|Treatment Period|Lost to Follow-up|1|||
13232503|NCT01711359|26317235|FG000|Treatment Period|Randomized, Not Treated|3|||
13232504|NCT01711359|26317236|FG001|Treatment Period|Randomized, Not Treated|1|||
13232505|NCT01711359|26317237|FG002|Treatment Period|Randomized, Not Treated|0|||
13232506|NCT01711216|26317260|FG000|Overall Study|Adverse Event|4|||
13232507|NCT01711216|26317260|FG000|Overall Study|Pregnancy|56|||
13232508|NCT01711216|26317260|FG000|Overall Study|Withdrawal by Subject|6|||
13232509|NCT01711216|26317260|FG000|Overall Study|Lost to Follow-up|46|||
13232510|NCT01711216|26317260|FG000|Overall Study|variety of other minor reasons|83|||
13232511|NCT01711216|26317260|FG000|Overall Study|no reason specified|22|||
13232512|NCT01710800|26317268|FG000|Overall Study|Withdrawal by Subject|21|||
13232513|NCT01710800|26317268|FG000|Overall Study|Protocol Violation|1|||
13232514|NCT01710709|26317282|FG000|Overall Study|Lost to Follow-up|29|||
13232515|NCT01710709|26317282|FG000|Overall Study|Adverse Event|48|||
13232516|NCT01710709|26317282|FG000|Overall Study|Participant met withdrawal criteria|33|||
13232517|NCT01710709|26317282|FG000|Overall Study|Participant withdrawn by investigator|2|||
13232518|NCT01710709|26317282|FG000|Overall Study|Withdrawal by Subject|53|||
13232519|NCT01710709|26317282|FG000|Overall Study|Protocol Violation|5|||
13232520|NCT01710709|26317282|FG000|Overall Study|Lack of Efficacy|3|||
13232521|NCT01710657|26317309|FG000|Overall Study|Lost to Follow-up|2|||
13232522|NCT01710657|26317310|FG001|Overall Study|Lost to Follow-up|0|||
13232523|NCT01710657|26317311|FG002|Overall Study|Lost to Follow-up|1|||
13232524|NCT01710657|26317309|FG000|Overall Study|Protocol Violation|2|||
13232525|NCT01710657|26317310|FG001|Overall Study|Protocol Violation|2|||
13232526|NCT01710657|26317311|FG002|Overall Study|Protocol Violation|0|||
13232527|NCT01710657|26317309|FG000|Overall Study|Adverse Event|14|||
13232528|NCT01710657|26317310|FG001|Overall Study|Adverse Event|8|||
13232529|NCT01710657|26317311|FG002|Overall Study|Adverse Event|28|||
13232530|NCT01710657|26317309|FG000|Overall Study|Withdrawal by Subject|0|||
13232531|NCT01710657|26317310|FG001|Overall Study|Withdrawal by Subject|1|||
13232532|NCT01710657|26317311|FG002|Overall Study|Withdrawal by Subject|2|||
13232533|NCT01710657|26317309|FG000|Overall Study|Lack of Efficacy|0|||
13232534|NCT01710657|26317310|FG001|Overall Study|Lack of Efficacy|1|||
13232535|NCT01710657|26317311|FG002|Overall Study|Lack of Efficacy|1|||
13232536|NCT01710527|26317338|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0|||
13232537|NCT01710527|26317339|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1|||
13232538|NCT01710514|26317364|FG000|Overall Study|Adverse Event|6|||
13232539|NCT01710514|26317365|FG001|Overall Study|Adverse Event|7|||
13232540|NCT01710514|26317364|FG000|Overall Study|Withdrawal by Subject|1|||
13232541|NCT01710514|26317365|FG001|Overall Study|Withdrawal by Subject|0|||
13232542|NCT01710501|26317404|FG000|Overall Study|Lost to Follow-up|2|||
13232543|NCT01710501|26317405|FG001|Overall Study|Lost to Follow-up|0|||
13232544|NCT01710501|26317406|FG002|Overall Study|Lost to Follow-up|0|||
13232545|NCT01710358|26317484|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15|||
13232546|NCT01710358|26317485|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18|||
13232547|NCT01710358|26317486|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7|||
13232548|NCT01710358|26317484|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
13232549|NCT01710358|26317485|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2|||
13232550|NCT01710358|26317486|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
13232551|NCT01710358|26317484|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0|||
13232552|NCT01710358|26317485|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
13232553|NCT01710358|26317486|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
13232554|NCT01710358|26317484|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15|||
13232555|NCT01710358|26317485|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1|||
13232556|NCT01710358|26317486|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3|||
13232557|NCT01710358|26317484|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
13232558|NCT01710358|26317485|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1|||
13232559|NCT01710358|26317486|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
13232560|NCT01710358|26317484|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1|||
13232561|NCT01710358|26317485|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
13232562|NCT01710358|26317486|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
13232563|NCT01710358|26317484|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4|||
13232564|NCT01710358|26317485|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
13232565|NCT01710358|26317486|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
13232566|NCT01710358|26317484|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15|||
13232567|NCT01710358|26317485|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5|||
13232568|NCT01710358|26317486|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12|||
13232569|NCT01710358|26317484|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
13232570|NCT01710358|26317485|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
13232571|NCT01710358|26317486|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0|||
13232572|NCT01710358|26317484|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10|||
13232573|NCT01710358|26317485|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16|||
13232574|NCT01710358|26317486|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5|||
13232575|NCT01710358|26317484|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
13232576|NCT01710358|26317485|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0|||
13232577|NCT01710358|26317486|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
13232578|NCT01710358|26317484|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
13232579|NCT01710358|26317485|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
13232580|NCT01710358|26317486|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1|||
13232581|NCT01710358|26317484|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
13232582|NCT01710358|26317485|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
13232583|NCT01710358|26317486|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1|||
13232584|NCT01710358|26317484|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
13232585|NCT01710358|26317485|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1|||
13232586|NCT01710358|26317486|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
13232587|NCT01710358|26317484|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1|||
13232588|NCT01710358|26317485|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2|||
13232589|NCT01710358|26317486|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0|||
13232590|NCT01710358|26317484|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4|||
13232591|NCT01710358|26317485|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3|||
13232592|NCT01710358|26317486|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7|||
13232593|NCT01710358|26317484|FG000|Rescue Period|Adverse Event|0|||
13232594|NCT01710358|26317485|FG001|Rescue Period|Adverse Event|15|||
13232595|NCT01710358|26317486|FG002|Rescue Period|Adverse Event|0|||
13232596|NCT01710358|26317484|FG000|Rescue Period|Death|0|||
13232597|NCT01710358|26317485|FG001|Rescue Period|Death|1|||
13232598|NCT01710358|26317486|FG002|Rescue Period|Death|0|||
13232599|NCT01710358|26317484|FG000|Rescue Period|Lack of Efficacy|0|||
13232600|NCT01710358|26317485|FG001|Rescue Period|Lack of Efficacy|7|||
13232601|NCT01710358|26317486|FG002|Rescue Period|Lack of Efficacy|0|||
13232602|NCT01710358|26317484|FG000|Rescue Period|Withdrawal by Subject|0|||
13232603|NCT01710358|26317485|FG001|Rescue Period|Withdrawal by Subject|8|||
13232604|NCT01710358|26317486|FG002|Rescue Period|Withdrawal by Subject|0|||
13232605|NCT01710345|26317504|FG000|Overall Study|Adverse Event|0|||
13232606|NCT01710345|26317505|FG001|Overall Study|Adverse Event|2|||
13232607|NCT01710345|26317506|FG002|Overall Study|Adverse Event|0|||
13232608|NCT01710345|26317504|FG000|Overall Study|Lack of Efficacy|2|||
13232609|NCT01710345|26317505|FG001|Overall Study|Lack of Efficacy|3|||
13232610|NCT01710345|26317506|FG002|Overall Study|Lack of Efficacy|1|||
13232611|NCT01710345|26317504|FG000|Overall Study|Drug Dosing Error|1|||
13232612|NCT01710345|26317505|FG001|Overall Study|Drug Dosing Error|0|||
13115327|NCT03099187|25917778|FG002|Double-blind Treatment|Adverse Event|0|||
13115328|NCT03099187|25917779|FG003|Double-blind Treatment|Adverse Event|0|||
13115329|NCT03099187|25917776|FG000|Double-blind Treatment|Death|1|||
13115330|NCT03099187|25917777|FG001|Double-blind Treatment|Death|3|||
13115331|NCT03099187|25917778|FG002|Double-blind Treatment|Death|0|||
13115332|NCT03099187|25917779|FG003|Double-blind Treatment|Death|0|||
13115333|NCT03099187|25917776|FG000|Double-blind Treatment|Lack of Efficacy|1|||
13115334|NCT03099187|25917777|FG001|Double-blind Treatment|Lack of Efficacy|0|||
13115335|NCT03099187|25917778|FG002|Double-blind Treatment|Lack of Efficacy|0|||
13115336|NCT03099187|25917779|FG003|Double-blind Treatment|Lack of Efficacy|0|||
13115337|NCT03099187|25917776|FG000|Double-blind Treatment|Physician Decision|2|||
13115338|NCT03099187|25917777|FG001|Double-blind Treatment|Physician Decision|1|||
13115339|NCT03099187|25917778|FG002|Double-blind Treatment|Physician Decision|0|||
13115340|NCT03099187|25917779|FG003|Double-blind Treatment|Physician Decision|0|||
13115341|NCT03099187|25917776|FG000|Double-blind Treatment|Withdrawal by Subject|9|||
13115342|NCT03099187|25917777|FG001|Double-blind Treatment|Withdrawal by Subject|4|||
13232613|NCT01710345|26317506|FG002|Overall Study|Drug Dosing Error|0|||
13232614|NCT01710046|26317549|FG000|Overall Study|Lost to Follow-up|1|||
13232615|NCT01710046|26317550|FG001|Overall Study|Lost to Follow-up|0|||
13115343|NCT03099187|25917778|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
13232616|NCT01710033|26317645|FG000|Stage 2|Adverse Event|0|||
13232617|NCT01710033|26317646|FG001|Stage 2|Adverse Event|0|||
13232618|NCT01710033|26317647|FG002|Stage 2|Adverse Event|0|||
13232619|NCT01710033|26317648|FG003|Stage 2|Adverse Event|0|||
13232620|NCT01710033|26317649|FG004|Stage 2|Adverse Event|1|||
13232621|NCT01710020|26317668|FG000|Period 1|Protocol Violation|1|||
13232622|NCT01709903|26317697|FG000|Overall Study|administrative problems|2|||
13232623|NCT01709903|26317698|FG001|Overall Study|administrative problems|6|||
13232624|NCT01709903|26317697|FG000|Overall Study|Abnormal test procedure results|1|||
13232625|NCT01709903|26317698|FG001|Overall Study|Abnormal test procedure results|0|||
13232626|NCT01709903|26317697|FG000|Overall Study|In ability to use device|1|||
13232627|NCT01709903|26317698|FG001|Overall Study|In ability to use device|1|||
13232628|NCT01709903|26317697|FG000|Overall Study|no longer needed study drug|0|||
13232629|NCT01709903|26317698|FG001|Overall Study|no longer needed study drug|1|||
13232630|NCT01709903|26317697|FG000|Overall Study|Lost to Follow-up|0|||
13232631|NCT01709903|26317698|FG001|Overall Study|Lost to Follow-up|2|||
13232632|NCT01709903|26317697|FG000|Overall Study|Death|2|||
13232633|NCT01709903|26317698|FG001|Overall Study|Death|0|||
13232634|NCT01709903|26317697|FG000|Overall Study|Protocol Violation|3|||
13232635|NCT01709903|26317698|FG001|Overall Study|Protocol Violation|2|||
13232636|NCT01709903|26317697|FG000|Overall Study|Lack of Efficacy|3|||
13232637|NCT01709903|26317698|FG001|Overall Study|Lack of Efficacy|3|||
13232638|NCT01709903|26317697|FG000|Overall Study|Withdrawal by Subject|6|||
13232639|NCT01709903|26317698|FG001|Overall Study|Withdrawal by Subject|6|||
13232640|NCT01709903|26317697|FG000|Overall Study|Adverse Event|11|||
13232641|NCT01709903|26317698|FG001|Overall Study|Adverse Event|18|||
13232642|NCT01709864|26317739|FG000|Overall Study|Physician Decision|0|||
13232643|NCT01709864|26317740|FG001|Overall Study|Physician Decision|1|||
13232644|NCT01709864|26317739|FG000|Overall Study|subject/guardian decision|5|||
13232645|NCT01709864|26317740|FG001|Overall Study|subject/guardian decision|6|||
13232646|NCT01709864|26317739|FG000|Overall Study|Lost to Follow-up|1|||
13115344|NCT03099187|25917779|FG003|Double-blind Treatment|Withdrawal by Subject|0|||
13115345|NCT03099187|25917776|FG000|Double-blind Treatment|Lung transplantation|0|||
13115346|NCT03099187|25917777|FG001|Double-blind Treatment|Lung transplantation|1|||
13115347|NCT03099187|25917778|FG002|Double-blind Treatment|Lung transplantation|0|||
13115348|NCT03099187|25917779|FG003|Double-blind Treatment|Lung transplantation|0|||
13115349|NCT03099187|25917776|FG000|Double-blind Treatment|Non-compliance with study drug|0|||
13115350|NCT03099187|25917777|FG001|Double-blind Treatment|Non-compliance with study drug|2|||
13115351|NCT03099187|25917778|FG002|Double-blind Treatment|Non-compliance with study drug|0|||
13115352|NCT03099187|25917779|FG003|Double-blind Treatment|Non-compliance with study drug|0|||
13115353|NCT03099187|25917776|FG000|Double-blind Treatment|Disease progression|0|||
13232647|NCT01709864|26317740|FG001|Overall Study|Lost to Follow-up|0|||
13232648|NCT01709864|26317739|FG000|Overall Study|non-compliance with study treatment|1|||
13232649|NCT01709864|26317740|FG001|Overall Study|non-compliance with study treatment|1|||
13232650|NCT01709864|26317739|FG000|Overall Study|Adverse Event|0|||
13232651|NCT01709864|26317740|FG001|Overall Study|Adverse Event|2|||
13232652|NCT01709864|26317739|FG000|Overall Study|Death|0|||
13232653|NCT01709864|26317740|FG001|Overall Study|Death|1|||
13232654|NCT01709838|26317762|FG000|Overall Study|Withdrawal by Subject|21|||
13232655|NCT01709838|26317762|FG000|Overall Study|Lost to Follow-up|16|||
13232656|NCT01709838|26317762|FG000|Overall Study|Pregnancy|10|||
13232657|NCT01709838|26317762|FG000|Overall Study|Subject/guardian decision|8|||
13232658|NCT01709838|26317762|FG000|Overall Study|Adverse Event|4|||
13232659|NCT01709838|26317762|FG000|Overall Study|Physician Decision|4|||
13232660|NCT01709838|26317762|FG000|Overall Study|Death|3|||
13232661|NCT01709838|26317762|FG000|Overall Study|Protocol Violation|1|||
13232662|NCT01709721|26317798|FG000|Open Label Phase|Withdrawal by Subject|0|||
13232663|NCT01709721|26317799|FG001|Open Label Phase|Withdrawal by Subject|0|||
13232664|NCT01709721|26317800|FG002|Open Label Phase|Withdrawal by Subject|5|||
13232665|NCT01709721|26317798|FG000|Open Label Phase|Adverse Event|0|||
13232666|NCT01709721|26317799|FG001|Open Label Phase|Adverse Event|0|||
13232667|NCT01709721|26317800|FG002|Open Label Phase|Adverse Event|8|||
13232668|NCT01709721|26317798|FG000|Open Label Phase|Non-compliance With Study Drug|0|||
13232669|NCT01709721|26317799|FG001|Open Label Phase|Non-compliance With Study Drug|0|||
13232670|NCT01709721|26317800|FG002|Open Label Phase|Non-compliance With Study Drug|3|||
13232671|NCT01709721|26317798|FG000|Open Label Phase|Investigator Decision|0|||
13232672|NCT01709721|26317799|FG001|Open Label Phase|Investigator Decision|0|||
13232673|NCT01709721|26317800|FG002|Open Label Phase|Investigator Decision|1|||
13232674|NCT01709721|26317798|FG000|Open Label Phase|Sponsor Decision|0|||
13232675|NCT01709721|26317799|FG001|Open Label Phase|Sponsor Decision|0|||
13232676|NCT01709721|26317800|FG002|Open Label Phase|Sponsor Decision|2|||
13232677|NCT01709721|26317798|FG000|Open Label Phase|Protocol Violation|0|||
13232678|NCT01709721|26317799|FG001|Open Label Phase|Protocol Violation|0|||
13232679|NCT01709721|26317800|FG002|Open Label Phase|Protocol Violation|1|||
13232680|NCT01709721|26317798|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
13232681|NCT01709721|26317799|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
13232682|NCT01709721|26317800|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1|||
13232683|NCT01709721|26317798|FG000|Open Label Phase|Inadequate Pain Control|0|||
13232684|NCT01709721|26317799|FG001|Open Label Phase|Inadequate Pain Control|0|||
13232685|NCT01709721|26317800|FG002|Open Label Phase|Inadequate Pain Control|37|||
13232686|NCT01709721|26317798|FG000|Open Label Phase|Other, Specify in text field in database|0|||
13232687|NCT01709721|26317799|FG001|Open Label Phase|Other, Specify in text field in database|0|||
13232688|NCT01709721|26317800|FG002|Open Label Phase|Other, Specify in text field in database|14|||
13232689|NCT01709721|26317798|FG000|Randomized Phase|Adverse Event|0|||
13232690|NCT01709721|26317799|FG001|Randomized Phase|Adverse Event|1|||
13232691|NCT01709721|26317800|FG002|Randomized Phase|Adverse Event|0|||
13232692|NCT01709721|26317798|FG000|Randomized Phase|Lost to Follow-up|1|||
13232693|NCT01709721|26317799|FG001|Randomized Phase|Lost to Follow-up|0|||
13232694|NCT01709721|26317800|FG002|Randomized Phase|Lost to Follow-up|0|||
13232695|NCT01709721|26317798|FG000|Randomized Phase|Inadequate Pain Control|1|||
13232696|NCT01709721|26317799|FG001|Randomized Phase|Inadequate Pain Control|2|||
13232697|NCT01709721|26317800|FG002|Randomized Phase|Inadequate Pain Control|0|||
13232698|NCT01709721|26317798|FG000|Randomized Phase|Other, Specify text field in database|1|||
13232699|NCT01709721|26317799|FG001|Randomized Phase|Other, Specify text field in database|3|||
13232700|NCT01709721|26317800|FG002|Randomized Phase|Other, Specify text field in database|0|||
13115354|NCT03099187|25917777|FG001|Double-blind Treatment|Disease progression|1|||
13115355|NCT03099187|25917778|FG002|Double-blind Treatment|Disease progression|0|||
13115356|NCT03099187|25917779|FG003|Double-blind Treatment|Disease progression|0|||
13115357|NCT03099187|25917776|FG000|Double-blind Treatment|Randomization error|0|||
13115358|NCT03099187|25917777|FG001|Double-blind Treatment|Randomization error|2|||
13115359|NCT03099187|25917778|FG002|Double-blind Treatment|Randomization error|0|||
13115360|NCT03099187|25917779|FG003|Double-blind Treatment|Randomization error|0|||
13115361|NCT03099187|25917776|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
13115362|NCT03099187|25917777|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
13115363|NCT03099187|25917778|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
13115364|NCT03099187|25917779|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
13115365|NCT03099187|25917776|FG000|12-month Safety Follow-up|Adverse Event|0|||
13115366|NCT03099187|25917777|FG001|12-month Safety Follow-up|Adverse Event|0|||
13115367|NCT03099187|25917778|FG002|12-month Safety Follow-up|Adverse Event|5|||
13115368|NCT03099187|25917779|FG003|12-month Safety Follow-up|Adverse Event|12|||
13115369|NCT03099187|25917776|FG000|12-month Safety Follow-up|Death|0|||
13115370|NCT03099187|25917777|FG001|12-month Safety Follow-up|Death|0|||
13115371|NCT03099187|25917778|FG002|12-month Safety Follow-up|Death|7|||
13115372|NCT03099187|25917779|FG003|12-month Safety Follow-up|Death|9|||
13115373|NCT03099187|25917776|FG000|12-month Safety Follow-up|Lung transplantation|0|||
13115374|NCT03099187|25917777|FG001|12-month Safety Follow-up|Lung transplantation|0|||
13115375|NCT03099187|25917778|FG002|12-month Safety Follow-up|Lung transplantation|2|||
13115376|NCT03099187|25917779|FG003|12-month Safety Follow-up|Lung transplantation|1|||
13115377|NCT03099187|25917776|FG000|12-month Safety Follow-up|Lost to Follow-up|0|||
13115378|NCT03099187|25917777|FG001|12-month Safety Follow-up|Lost to Follow-up|0|||
13115379|NCT03099187|25917778|FG002|12-month Safety Follow-up|Lost to Follow-up|1|||
13232701|NCT01709708|26317829|FG000|Overall Study|Protocol Violation|1|||
13232702|NCT01709708|26317830|FG001|Overall Study|Protocol Violation|2|||
13232703|NCT01709695|26317859|FG000|Overall Study|Withdrawal by Subject|1|||
13232704|NCT01709695|26317860|FG001|Overall Study|Withdrawal by Subject|1|||
13232705|NCT01709578|26317998|FG000|Overall Study|Rescued and entered in long term safety|63|||
13232706|NCT01709578|26317999|FG001|Overall Study|Rescued and entered in long term safety|25|||
13232707|NCT01709578|26318000|FG002|Overall Study|Rescued and entered in long term safety|26|||
13115380|NCT03099187|25917779|FG003|12-month Safety Follow-up|Lost to Follow-up|0|||
13115381|NCT03099187|25917776|FG000|12-month Safety Follow-up|Symptomatic deterioration|0|||
13115382|NCT03099187|25917777|FG001|12-month Safety Follow-up|Symptomatic deterioration|0|||
13115383|NCT03099187|25917778|FG002|12-month Safety Follow-up|Symptomatic deterioration|1|||
13115384|NCT03099187|25917779|FG003|12-month Safety Follow-up|Symptomatic deterioration|1|||
13115385|NCT03099187|25917776|FG000|12-month Safety Follow-up|Withdrawal by Subject|0|||
13115386|NCT03099187|25917777|FG001|12-month Safety Follow-up|Withdrawal by Subject|0|||
13115387|NCT03099187|25917778|FG002|12-month Safety Follow-up|Withdrawal by Subject|3|||
13115388|NCT03099187|25917779|FG003|12-month Safety Follow-up|Withdrawal by Subject|2|||
13115389|NCT03099187|25917776|FG000|12-month Safety Follow-up|Due to hospitalization|0|||
13115390|NCT03099187|25917777|FG001|12-month Safety Follow-up|Due to hospitalization|0|||
13115391|NCT03099187|25917778|FG002|12-month Safety Follow-up|Due to hospitalization|0|||
13232708|NCT01709578|26317998|FG000|Overall Study|Adverse Event|9|||
13232709|NCT01709578|26317999|FG001|Overall Study|Adverse Event|18|||
13232710|NCT01709578|26318000|FG002|Overall Study|Adverse Event|17|||
13232711|NCT01709578|26317998|FG000|Overall Study|Lack of Efficacy|5|||
13232712|NCT01709578|26317999|FG001|Overall Study|Lack of Efficacy|4|||
13232713|NCT01709578|26318000|FG002|Overall Study|Lack of Efficacy|2|||
13232714|NCT01709578|26317998|FG000|Overall Study|Poor compliance to protocol|1|||
13232715|NCT01709578|26317999|FG001|Overall Study|Poor compliance to protocol|2|||
13232716|NCT01709578|26318000|FG002|Overall Study|Poor compliance to protocol|1|||
13232717|NCT01709578|26317998|FG000|Overall Study|Other, not related to safety or efficacy|2|||
13232718|NCT01709578|26317999|FG001|Overall Study|Other, not related to safety or efficacy|7|||
13232719|NCT01709578|26318000|FG002|Overall Study|Other, not related to safety or efficacy|5|||
13232720|NCT01709513|26318069|FG000|Overall Study|Randomized but not treated|0|||
13232721|NCT01709513|26318070|FG001|Overall Study|Randomized but not treated|1|||
13232722|NCT01709513|26318071|FG002|Overall Study|Randomized but not treated|0|||
13232723|NCT01709513|26318069|FG000|Overall Study|Adverse Event|16|||
13232724|NCT01709513|26318070|FG001|Overall Study|Adverse Event|31|||
13232725|NCT01709513|26318071|FG002|Overall Study|Adverse Event|23|||
13232726|NCT01709513|26318069|FG000|Overall Study|Poor compliance to protocol|2|||
13232727|NCT01709513|26318070|FG001|Overall Study|Poor compliance to protocol|0|||
13232728|NCT01709513|26318071|FG002|Overall Study|Poor compliance to protocol|0|||
13232729|NCT01709513|26318069|FG000|Overall Study|Other|3|||
13232730|NCT01709513|26318070|FG001|Overall Study|Other|11|||
13232731|NCT01709513|26318071|FG002|Overall Study|Other|7|||
13232732|NCT01709500|26318132|FG000|Overall Study|Randomized but not treated|0|||
13232733|NCT01709500|26318133|FG001|Overall Study|Randomized but not treated|1|||
13232734|NCT01709500|26318132|FG000|Overall Study|Adverse Event|5|||
13232735|NCT01709500|26318133|FG001|Overall Study|Adverse Event|1|||
13232736|NCT01709500|26318132|FG000|Overall Study|Poor compliance to protocol|2|||
13232737|NCT01709500|26318133|FG001|Overall Study|Poor compliance to protocol|1|||
13232738|NCT01709500|26318132|FG000|Overall Study|Other|3|||
13232739|NCT01709500|26318133|FG001|Overall Study|Other|1|||
13232740|NCT01709500|26318132|FG000|Overall Study|Related to IMP administration|1|||
13232741|NCT01709500|26318133|FG001|Overall Study|Related to IMP administration|0|||
13232742|NCT01709500|26318132|FG000|Overall Study|Treatment ongoing|156|||
13232743|NCT01709500|26318133|FG001|Overall Study|Treatment ongoing|78|||
13232744|NCT01709409|26318146|FG000|Overall Study|Protocol Violation|1|||
13232745|NCT01709409|26318147|FG001|Overall Study|Protocol Violation|0|||
13232746|NCT01709383|26318172|FG000|Overall Study|Lost to Follow-up|1|||
13232747|NCT01709383|26318173|FG001|Overall Study|Lost to Follow-up|0|||
13289682|NCT00107900|26479791|FG001|Overall Study|Withdrawal by Subject|0|||
13289683|NCT00107900|26479792|FG002|Overall Study|Withdrawal by Subject|5|||
13289684|NCT00107900|26479793|FG003|Overall Study|Withdrawal by Subject|0|||
13289685|NCT00107900|26479794|FG004|Overall Study|Withdrawal by Subject|1|||
13289686|NCT00107900|26479795|FG005|Overall Study|Withdrawal by Subject|1|||
13289687|NCT00107900|26479790|FG000|Overall Study|Administrative Reasons|1|||
13289688|NCT00107900|26479791|FG001|Overall Study|Administrative Reasons|0|||
13289689|NCT00107900|26479792|FG002|Overall Study|Administrative Reasons|2|||
13289690|NCT00107900|26479793|FG003|Overall Study|Administrative Reasons|2|||
13289691|NCT00107900|26479794|FG004|Overall Study|Administrative Reasons|2|||
13289692|NCT00107900|26479795|FG005|Overall Study|Administrative Reasons|0|||
13289693|NCT00107614|26479801|FG000|Overall Study|Physician Decision|10|||
13289694|NCT00107614|26479801|FG000|Overall Study|Death|2|||
13289695|NCT00107380|26479809|FG000|Overall Study|Adverse Event|7|||
13289696|NCT00107380|26479809|FG000|Overall Study|Refusal Unrelated to Adverse Event|7|||
13289697|NCT00107380|26479809|FG000|Overall Study|Progression/relapse|4|||
13289698|NCT00107380|26479809|FG000|Overall Study|Death|3|||
13289699|NCT00107380|26479809|FG000|Overall Study|Other - not protocol specified|7|||
13289700|NCT00107380|26479809|FG000|Overall Study|Ineligible|2|||
13289701|NCT00107315|26479818|FG000|Overall Study|Disease Progression|9|||
13289702|NCT00107315|26479818|FG000|Overall Study|Adverse Event|4|||
13289703|NCT00107315|26479818|FG000|Overall Study|Withdrawal by Subject|2|||
13289704|NCT00107276|26479826|FG000|Overall Study|Progression|46|||
13289705|NCT00107276|26479826|FG000|Overall Study|Adverse Event|6|||
13289706|NCT00107276|26479826|FG000|Overall Study|M.D. decision|2|||
13289707|NCT00107276|26479826|FG000|Overall Study|Patient refusal|1|||
13289708|NCT00107276|26479826|FG000|Overall Study|Death|1|||
13289709|NCT00107276|26479826|FG000|Overall Study|Ineligible|16|||
13289710|NCT00107198|26479836|FG000|Overall Study|Lack of Efficacy|28|||
13289711|NCT00107198|26479836|FG000|Overall Study|Lost to Follow-up|12|||
13289712|NCT00107198|26479836|FG000|Overall Study|Protocol Violation|1|||
13289713|NCT00107198|26479836|FG000|Overall Study|Withdrawal by Subject|6|||
13289714|NCT00107198|26479836|FG000|Overall Study|Ineligible|5|||
13289715|NCT00107172|26479871|FG000|Overall Study|Withdrawal by Subject|1|||
13289716|NCT00107172|26479872|FG001|Overall Study|Withdrawal by Subject|0|||
13289717|NCT00107172|26479871|FG000|Overall Study|Death|0|||
13289718|NCT00107172|26479872|FG001|Overall Study|Death|2|||
13289719|NCT00107172|26479871|FG000|Overall Study|Other Reason|4|||
13289720|NCT00107172|26479872|FG001|Overall Study|Other Reason|3|||
13289721|NCT00107120|26479889|FG000|Overall Study|Adverse Event|4|||
13289722|NCT00107120|26479890|FG001|Overall Study|Adverse Event|1|||
13289723|NCT00107120|26479889|FG000|Overall Study|Lack of Efficacy|5|||
13232748|NCT01709318|26318288|FG000|Overall Study|Adverse Event|3|||
13232749|NCT01709318|26318289|FG001|Overall Study|Adverse Event|4|||
13232750|NCT01709318|26318290|FG002|Overall Study|Adverse Event|2|||
13232751|NCT01709318|26318291|FG003|Overall Study|Adverse Event|2|||
13232752|NCT01709318|26318292|FG004|Overall Study|Adverse Event|0|||
13232753|NCT01709318|26318293|FG005|Overall Study|Adverse Event|1|||
13232754|NCT01709318|26318294|FG006|Overall Study|Adverse Event|2|||
13232755|NCT01709318|26318288|FG000|Overall Study|Lost to Follow-up|2|||
13232756|NCT01709318|26318289|FG001|Overall Study|Lost to Follow-up|0|||
13232757|NCT01709318|26318290|FG002|Overall Study|Lost to Follow-up|0|||
13232758|NCT01709318|26318291|FG003|Overall Study|Lost to Follow-up|0|||
13232759|NCT01709318|26318292|FG004|Overall Study|Lost to Follow-up|1|||
13232760|NCT01709318|26318293|FG005|Overall Study|Lost to Follow-up|1|||
13232761|NCT01709318|26318294|FG006|Overall Study|Lost to Follow-up|1|||
13232762|NCT01709318|26318288|FG000|Overall Study|Non-compliance with Study Drug|0|||
13232763|NCT01709318|26318289|FG001|Overall Study|Non-compliance with Study Drug|2|||
13232764|NCT01709318|26318290|FG002|Overall Study|Non-compliance with Study Drug|1|||
13232765|NCT01709318|26318291|FG003|Overall Study|Non-compliance with Study Drug|1|||
13232766|NCT01709318|26318292|FG004|Overall Study|Non-compliance with Study Drug|0|||
13232767|NCT01709318|26318293|FG005|Overall Study|Non-compliance with Study Drug|0|||
13232768|NCT01709318|26318294|FG006|Overall Study|Non-compliance with Study Drug|2|||
13232769|NCT01709318|26318288|FG000|Overall Study|Physician Decision|0|||
13232770|NCT01709318|26318289|FG001|Overall Study|Physician Decision|0|||
13232771|NCT01709318|26318290|FG002|Overall Study|Physician Decision|0|||
13232772|NCT01709318|26318291|FG003|Overall Study|Physician Decision|0|||
13232773|NCT01709318|26318292|FG004|Overall Study|Physician Decision|0|||
13232774|NCT01709318|26318293|FG005|Overall Study|Physician Decision|0|||
13232775|NCT01709318|26318294|FG006|Overall Study|Physician Decision|1|||
13232776|NCT01709318|26318288|FG000|Overall Study|Pregnancy|0|||
13232777|NCT01709318|26318289|FG001|Overall Study|Pregnancy|0|||
13232778|NCT01709318|26318290|FG002|Overall Study|Pregnancy|0|||
13232779|NCT01709318|26318291|FG003|Overall Study|Pregnancy|0|||
13232780|NCT01709318|26318292|FG004|Overall Study|Pregnancy|1|||
13232781|NCT01709318|26318293|FG005|Overall Study|Pregnancy|0|||
13232782|NCT01709318|26318294|FG006|Overall Study|Pregnancy|0|||
13232783|NCT01709318|26318288|FG000|Overall Study|Protocol Violation|0|||
13232784|NCT01709318|26318289|FG001|Overall Study|Protocol Violation|0|||
13232785|NCT01709318|26318290|FG002|Overall Study|Protocol Violation|0|||
13232786|NCT01709318|26318291|FG003|Overall Study|Protocol Violation|0|||
13232787|NCT01709318|26318292|FG004|Overall Study|Protocol Violation|2|||
13232788|NCT01709318|26318293|FG005|Overall Study|Protocol Violation|0|||
13232789|NCT01709318|26318294|FG006|Overall Study|Protocol Violation|1|||
13232790|NCT01709318|26318288|FG000|Overall Study|Technical Problems|1|||
13232791|NCT01709318|26318289|FG001|Overall Study|Technical Problems|0|||
13232792|NCT01709318|26318290|FG002|Overall Study|Technical Problems|0|||
13232793|NCT01709318|26318291|FG003|Overall Study|Technical Problems|0|||
13232794|NCT01709318|26318292|FG004|Overall Study|Technical Problems|0|||
13232795|NCT01709318|26318293|FG005|Overall Study|Technical Problems|0|||
13232796|NCT01709318|26318294|FG006|Overall Study|Technical Problems|0|||
13232797|NCT01709318|26318288|FG000|Overall Study|Withdrawal by Subject|3|||
13232798|NCT01709318|26318289|FG001|Overall Study|Withdrawal by Subject|0|||
13232799|NCT01709318|26318290|FG002|Overall Study|Withdrawal by Subject|3|||
13232800|NCT01709318|26318291|FG003|Overall Study|Withdrawal by Subject|3|||
13232801|NCT01709318|26318292|FG004|Overall Study|Withdrawal by Subject|0|||
13232802|NCT01709318|26318293|FG005|Overall Study|Withdrawal by Subject|2|||
13232803|NCT01709318|26318294|FG006|Overall Study|Withdrawal by Subject|4|||
13232804|NCT01709318|26318288|FG000|Overall Study|Other Protocol Specified Criteria|0|||
13232805|NCT01709318|26318289|FG001|Overall Study|Other Protocol Specified Criteria|1|||
13232806|NCT01709318|26318290|FG002|Overall Study|Other Protocol Specified Criteria|0|||
13232807|NCT01709318|26318291|FG003|Overall Study|Other Protocol Specified Criteria|0|||
13232808|NCT01709318|26318292|FG004|Overall Study|Other Protocol Specified Criteria|0|||
13232809|NCT01709318|26318293|FG005|Overall Study|Other Protocol Specified Criteria|0|||
13232810|NCT01709318|26318294|FG006|Overall Study|Other Protocol Specified Criteria|0|||
13232811|NCT01709305|26318335|FG000|Phase 1|Clinical Adverse Event|80|||
13232812|NCT01709305|26318336|FG001|Phase 1|Clinical Adverse Event|0|||
13232813|NCT01709305|26318337|FG002|Phase 1|Clinical Adverse Event|0|||
13232814|NCT01709305|26318338|FG003|Phase 1|Clinical Adverse Event|0|||
13232815|NCT01709305|26318339|FG004|Phase 1|Clinical Adverse Event|0|||
13232816|NCT01709305|26318335|FG000|Phase 1|Death|2|||
13232817|NCT01709305|26318336|FG001|Phase 1|Death|0|||
13232818|NCT01709305|26318337|FG002|Phase 1|Death|0|||
13232819|NCT01709305|26318338|FG003|Phase 1|Death|0|||
13232820|NCT01709305|26318339|FG004|Phase 1|Death|0|||
13232821|NCT01709305|26318335|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13|||
13232822|NCT01709305|26318336|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0|||
13232823|NCT01709305|26318337|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0|||
13232824|NCT01709305|26318338|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0|||
13232825|NCT01709305|26318339|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0|||
13232826|NCT01709305|26318335|FG000|Phase 1|Laboratory Adverse Event|16|||
13232827|NCT01709305|26318336|FG001|Phase 1|Laboratory Adverse Event|0|||
13232828|NCT01709305|26318337|FG002|Phase 1|Laboratory Adverse Event|0|||
13232829|NCT01709305|26318338|FG003|Phase 1|Laboratory Adverse Event|0|||
13232830|NCT01709305|26318339|FG004|Phase 1|Laboratory Adverse Event|0|||
13232831|NCT01709305|26318335|FG000|Phase 1|Lost to Follow-up|147|||
13232832|NCT01709305|26318336|FG001|Phase 1|Lost to Follow-up|0|||
13232833|NCT01709305|26318337|FG002|Phase 1|Lost to Follow-up|0|||
13232834|NCT01709305|26318338|FG003|Phase 1|Lost to Follow-up|0|||
13232835|NCT01709305|26318339|FG004|Phase 1|Lost to Follow-up|0|||
13232836|NCT01709305|26318335|FG000|Phase 1|Travel, moving, etc.|30|||
13232837|NCT01709305|26318336|FG001|Phase 1|Travel, moving, etc.|0|||
13232838|NCT01709305|26318337|FG002|Phase 1|Travel, moving, etc.|0|||
13232839|NCT01709305|26318338|FG003|Phase 1|Travel, moving, etc.|0|||
13232840|NCT01709305|26318339|FG004|Phase 1|Travel, moving, etc.|0|||
13232841|NCT01709305|26318335|FG000|Phase 1|Physician Decision|13|||
13232842|NCT01709305|26318336|FG001|Phase 1|Physician Decision|0|||
13232843|NCT01709305|26318337|FG002|Phase 1|Physician Decision|0|||
13232844|NCT01709305|26318338|FG003|Phase 1|Physician Decision|0|||
13232845|NCT01709305|26318339|FG004|Phase 1|Physician Decision|0|||
13232846|NCT01709305|26318335|FG000|Phase 1|Protocol Violation|118|||
13232847|NCT01709305|26318336|FG001|Phase 1|Protocol Violation|0|||
13232848|NCT01709305|26318337|FG002|Phase 1|Protocol Violation|0|||
13232849|NCT01709305|26318338|FG003|Phase 1|Protocol Violation|0|||
13232850|NCT01709305|26318339|FG004|Phase 1|Protocol Violation|0|||
13232851|NCT01709305|26318335|FG000|Phase 1|Withdrawal by Subject|218|||
13232852|NCT01709305|26318336|FG001|Phase 1|Withdrawal by Subject|0|||
13232853|NCT01709305|26318337|FG002|Phase 1|Withdrawal by Subject|0|||
13232854|NCT01709305|26318338|FG003|Phase 1|Withdrawal by Subject|0|||
13232855|NCT01709305|26318339|FG004|Phase 1|Withdrawal by Subject|0|||
13232856|NCT01709305|26318335|FG000|Phase 2|Clinical Adverse Event|0|||
13232857|NCT01709305|26318336|FG001|Phase 2|Clinical Adverse Event|10|||
13232858|NCT01709305|26318337|FG002|Phase 2|Clinical Adverse Event|10|||
13232859|NCT01709305|26318338|FG003|Phase 2|Clinical Adverse Event|6|||
13232860|NCT01709305|26318339|FG004|Phase 2|Clinical Adverse Event|11|||
13232861|NCT01709305|26318335|FG000|Phase 2|Death|0|||
13232862|NCT01709305|26318336|FG001|Phase 2|Death|0|||
13232863|NCT01709305|26318337|FG002|Phase 2|Death|1|||
13232864|NCT01709305|26318338|FG003|Phase 2|Death|0|||
13232865|NCT01709305|26318339|FG004|Phase 2|Death|0|||
13232866|NCT01709305|26318335|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0|||
13232867|NCT01709305|26318336|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0|||
13232868|NCT01709305|26318337|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0|||
13232869|NCT01709305|26318338|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0|||
13232870|NCT01709305|26318339|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2|||
13232871|NCT01709305|26318335|FG000|Phase 2|Laboratory Adverse Event|0|||
13232872|NCT01709305|26318336|FG001|Phase 2|Laboratory Adverse Event|1|||
13232873|NCT01709305|26318337|FG002|Phase 2|Laboratory Adverse Event|0|||
13232874|NCT01709305|26318338|FG003|Phase 2|Laboratory Adverse Event|1|||
13232875|NCT01709305|26318339|FG004|Phase 2|Laboratory Adverse Event|1|||
13232876|NCT01709305|26318335|FG000|Phase 2|Lost to Follow-up|0|||
13232877|NCT01709305|26318336|FG001|Phase 2|Lost to Follow-up|10|||
13232878|NCT01709305|26318337|FG002|Phase 2|Lost to Follow-up|6|||
13232879|NCT01709305|26318338|FG003|Phase 2|Lost to Follow-up|9|||
13232880|NCT01709305|26318339|FG004|Phase 2|Lost to Follow-up|5|||
13232881|NCT01709305|26318335|FG000|Phase 2|Travel, moving, etc.|0|||
13232882|NCT01709305|26318336|FG001|Phase 2|Travel, moving, etc.|2|||
13232883|NCT01709305|26318337|FG002|Phase 2|Travel, moving, etc.|3|||
13232884|NCT01709305|26318338|FG003|Phase 2|Travel, moving, etc.|3|||
13232885|NCT01709305|26318339|FG004|Phase 2|Travel, moving, etc.|5|||
13232886|NCT01709305|26318335|FG000|Phase 2|Physician Decision|0|||
13232887|NCT01709305|26318336|FG001|Phase 2|Physician Decision|2|||
13232888|NCT01709305|26318337|FG002|Phase 2|Physician Decision|0|||
13232889|NCT01709305|26318338|FG003|Phase 2|Physician Decision|1|||
13232890|NCT01709305|26318339|FG004|Phase 2|Physician Decision|2|||
13232891|NCT01709305|26318335|FG000|Phase 2|Protocol Violation|0|||
13232892|NCT01709305|26318336|FG001|Phase 2|Protocol Violation|19|||
13232893|NCT01709305|26318337|FG002|Phase 2|Protocol Violation|19|||
13232894|NCT01709305|26318338|FG003|Phase 2|Protocol Violation|13|||
13232895|NCT01709305|26318339|FG004|Phase 2|Protocol Violation|9|||
13232896|NCT01709305|26318335|FG000|Phase 2|Withdrawal by Subject|0|||
13232897|NCT01709305|26318336|FG001|Phase 2|Withdrawal by Subject|8|||
13232898|NCT01709305|26318337|FG002|Phase 2|Withdrawal by Subject|6|||
13232899|NCT01709305|26318338|FG003|Phase 2|Withdrawal by Subject|15|||
13232900|NCT01709305|26318339|FG004|Phase 2|Withdrawal by Subject|12|||
13232901|NCT01709227|26318370|FG000|Overall Study|Physician Decision|1|||
13232902|NCT01709227|26318371|FG001|Overall Study|Physician Decision|0|||
13232903|NCT01709227|26318370|FG000|Overall Study|Pleural Peritoneal communication|0|||
13232904|NCT01709227|26318371|FG001|Overall Study|Pleural Peritoneal communication|9|||
13232905|NCT01709162|26318390|FG000|Overall Study|Disease progression|3|||
13232906|NCT01709162|26318391|FG001|Overall Study|Disease progression|3|||
13232907|NCT01709162|26318390|FG000|Overall Study|Study drug toxicity|2|||
13232908|NCT01709162|26318391|FG001|Overall Study|Study drug toxicity|0|||
13232909|NCT01709162|26318390|FG000|Overall Study|Administrative reason by sponsor|0|||
13232910|NCT01709162|26318391|FG001|Overall Study|Administrative reason by sponsor|1|||
13232911|NCT01709162|26318390|FG000|Overall Study|Other|1|||
13232912|NCT01709162|26318391|FG001|Overall Study|Other|0|||
13232913|NCT01709162|26318390|FG000|Overall Study|Withdrawal by Subject|0|||
13232914|NCT01709162|26318391|FG001|Overall Study|Withdrawal by Subject|1|||
13232915|NCT01709149|26318420|FG000|Open-label Lead-in Phase|Adverse Event|109|||
13232916|NCT01709149|26318421|FG001|Open-label Lead-in Phase|Adverse Event|0|||
13232917|NCT01709149|26318422|FG002|Open-label Lead-in Phase|Adverse Event|0|||
13232918|NCT01709149|26318420|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2|||
13232919|NCT01709149|26318421|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0|||
13232920|NCT01709149|26318422|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0|||
13232921|NCT01709149|26318420|FG000|Open-label Lead-in Phase|Death|1|||
13232922|NCT01709149|26318421|FG001|Open-label Lead-in Phase|Death|0|||
13232923|NCT01709149|26318422|FG002|Open-label Lead-in Phase|Death|0|||
13232924|NCT01709149|26318420|FG000|Open-label Lead-in Phase|Protocol Violation|3|||
13232925|NCT01709149|26318421|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
13232926|NCT01709149|26318422|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
13232927|NCT01709149|26318420|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
13232928|NCT01709149|26318421|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12|||
13232929|NCT01709149|26318422|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78|||
13232930|NCT01709149|26318420|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
13232931|NCT01709149|26318421|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7|||
13232932|NCT01709149|26318422|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12|||
13232933|NCT01709149|26318420|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
13232934|NCT01709149|26318421|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2|||
13232935|NCT01709149|26318422|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5|||
13232936|NCT01709149|26318420|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
13232937|NCT01709149|26318421|FG001|Double-blind, Placebo-controlled Phase|Death|2|||
13232938|NCT01709149|26318422|FG002|Double-blind, Placebo-controlled Phase|Death|0|||
13232939|NCT01709149|26318420|FG000|Double-blind, Placebo-controlled Phase|not defined|0|||
13232940|NCT01709149|26318421|FG001|Double-blind, Placebo-controlled Phase|not defined|1|||
13232941|NCT01709149|26318422|FG002|Double-blind, Placebo-controlled Phase|not defined|2|||
13232942|NCT01709149|26318420|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
13232943|NCT01709149|26318421|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
13232944|NCT01709149|26318422|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
13232945|NCT01709110|26318457|FG000|Overall Study|Adverse Event|56|||
13232946|NCT01709110|26318458|FG001|Overall Study|Adverse Event|48|||
13232947|NCT01709110|26318457|FG000|Overall Study|Death|14|||
13232948|NCT01709110|26318458|FG001|Overall Study|Death|6|||
13232949|NCT01709110|26318457|FG000|Overall Study|Lost to Follow-up|7|||
13232950|NCT01709110|26318458|FG001|Overall Study|Lost to Follow-up|5|||
13232951|NCT01709110|26318457|FG000|Overall Study|Protocol Violation|4|||
13232952|NCT01709110|26318458|FG001|Overall Study|Protocol Violation|6|||
13232953|NCT01709110|26318457|FG000|Overall Study|Withdrawal by Subject|96|||
13232954|NCT01709110|26318458|FG001|Overall Study|Withdrawal by Subject|89|||
13232955|NCT01709110|26318457|FG000|Overall Study|Physician Decision|4|||
13232956|NCT01709110|26318458|FG001|Overall Study|Physician Decision|10|||
13232957|NCT01709110|26318457|FG000|Overall Study|Sponsor Decision|2|||
13232958|NCT01709110|26318458|FG001|Overall Study|Sponsor Decision|2|||
13232959|NCT01709110|26318457|FG000|Overall Study|Lack of Efficacy|1|||
13232960|NCT01709110|26318458|FG001|Overall Study|Lack of Efficacy|1|||
13232961|NCT01709110|26318457|FG000|Overall Study|Caregiver Decision|1|||
13232962|NCT01709110|26318458|FG001|Overall Study|Caregiver Decision|1|||
13232963|NCT01709084|26318481|FG000|Overall Study|Lost to Follow-up|4|||
13232964|NCT01709084|26318482|FG001|Overall Study|Lost to Follow-up|7|||
13232965|NCT01709084|26318481|FG000|Overall Study|Withdrawal by Subject|2|||
13232966|NCT01709084|26318482|FG001|Overall Study|Withdrawal by Subject|2|||
13232967|NCT01709084|26318481|FG000|Overall Study|Adverse Event|5|||
13232968|NCT01709084|26318482|FG001|Overall Study|Adverse Event|0|||
13232969|NCT01709084|26318481|FG000|Overall Study|Other|5|||
13232970|NCT01709084|26318482|FG001|Overall Study|Other|3|||
13232971|NCT01709084|26318481|FG000|Overall Study|Participant Reached a Virologic Endpoint|0|||
13232972|NCT01709084|26318482|FG001|Overall Study|Participant Reached a Virologic Endpoint|1|||
13232973|NCT01709084|26318481|FG000|Overall Study|Not Treated|0|||
13232974|NCT01709084|26318482|FG001|Overall Study|Not Treated|2|||
13232975|NCT01708954|26318513|FG000|Step 1|Disease progression|26|||
13232976|NCT01708954|26318514|FG001|Step 1|Disease progression|17|||
13232977|NCT01708954|26318515|FG002|Step 1|Disease progression|14|||
13232978|NCT01708954|26318513|FG000|Step 1|Adverse Event|3|||
13232979|NCT01708954|26318514|FG001|Step 1|Adverse Event|11|||
13232980|NCT01708954|26318515|FG002|Step 1|Adverse Event|13|||
13232981|NCT01708954|26318513|FG000|Step 1|Death|3|||
13232982|NCT01708954|26318514|FG001|Step 1|Death|2|||
13232983|NCT01708954|26318515|FG002|Step 1|Death|3|||
13485806|NCT00585195|27033424|FG014|Overall Study|Lost to Follow-up|0|||
13232984|NCT01708954|26318513|FG000|Step 1|Withdrawal by Subject|2|||
13232985|NCT01708954|26318514|FG001|Step 1|Withdrawal by Subject|5|||
13232986|NCT01708954|26318515|FG002|Step 1|Withdrawal by Subject|3|||
13232987|NCT01708954|26318513|FG000|Step 1|Other complicating disease|0|||
13232988|NCT01708954|26318514|FG001|Step 1|Other complicating disease|2|||
13232989|NCT01708954|26318515|FG002|Step 1|Other complicating disease|0|||
13232990|NCT01708954|26318513|FG000|Step 1|Crossed over to Step 2|2|||
13232991|NCT01708954|26318514|FG001|Step 1|Crossed over to Step 2|0|||
13232992|NCT01708954|26318515|FG002|Step 1|Crossed over to Step 2|0|||
13232993|NCT01708954|26318513|FG000|Step 1|Symptomatic deterioration|1|||
13232994|NCT01708954|26318514|FG001|Step 1|Symptomatic deterioration|0|||
13232995|NCT01708954|26318515|FG002|Step 1|Symptomatic deterioration|1|||
13232996|NCT01708954|26318513|FG000|Step 1|Off-treatment reason not submitted|1|||
13232997|NCT01708954|26318514|FG001|Step 1|Off-treatment reason not submitted|1|||
13232998|NCT01708954|26318515|FG002|Step 1|Off-treatment reason not submitted|1|||
13232999|NCT01708954|26318513|FG000|Step 1|Ineligible or never received treatment|4|||
13233000|NCT01708954|26318514|FG001|Step 1|Ineligible or never received treatment|2|||
13233001|NCT01708954|26318515|FG002|Step 1|Ineligible or never received treatment|8|||
13233002|NCT01708954|26318513|FG000|Step 2|Disease progression|9|||
13233003|NCT01708954|26318514|FG001|Step 2|Disease progression|4|||
13233004|NCT01708954|26318515|FG002|Step 2|Disease progression|0|||
13233005|NCT01708954|26318513|FG000|Step 2|Adverse Event|3|||
13233006|NCT01708954|26318514|FG001|Step 2|Adverse Event|2|||
13233007|NCT01708954|26318515|FG002|Step 2|Adverse Event|0|||
13233008|NCT01708954|26318513|FG000|Step 2|Withdrawal by Subject|1|||
13233009|NCT01708954|26318514|FG001|Step 2|Withdrawal by Subject|1|||
13233010|NCT01708954|26318515|FG002|Step 2|Withdrawal by Subject|0|||
13233011|NCT01708941|26318542|FG000|Overall Study|Adverse Event|4|||
13233012|NCT01708941|26318543|FG001|Overall Study|Adverse Event|6|||
13233013|NCT01708941|26318544|FG002|Overall Study|Adverse Event|1|||
13233014|NCT01708941|26318545|FG003|Overall Study|Adverse Event|0|||
13233015|NCT01708941|26318542|FG000|Overall Study|Death|1|||
13233016|NCT01708941|26318543|FG001|Overall Study|Death|1|||
13233017|NCT01708941|26318544|FG002|Overall Study|Death|2|||
13233018|NCT01708941|26318545|FG003|Overall Study|Death|14|||
13233019|NCT01708941|26318542|FG000|Overall Study|Withdrawal by Subject|1|||
13233020|NCT01708941|26318543|FG001|Overall Study|Withdrawal by Subject|0|||
13233021|NCT01708941|26318544|FG002|Overall Study|Withdrawal by Subject|3|||
13233022|NCT01708941|26318545|FG003|Overall Study|Withdrawal by Subject|4|||
13233023|NCT01708941|26318542|FG000|Overall Study|Disease progression|9|||
13233024|NCT01708941|26318543|FG001|Overall Study|Disease progression|10|||
13233025|NCT01708941|26318544|FG002|Overall Study|Disease progression|8|||
13233026|NCT01708941|26318545|FG003|Overall Study|Disease progression|0|||
13233027|NCT01708941|26318542|FG000|Overall Study|Alternative therapy|0|||
13233028|NCT01708941|26318543|FG001|Overall Study|Alternative therapy|0|||
13233029|NCT01708941|26318544|FG002|Overall Study|Alternative therapy|2|||
13233030|NCT01708941|26318545|FG003|Overall Study|Alternative therapy|0|||
13233031|NCT01708941|26318542|FG000|Overall Study|Ineligible and never started treatment|1|||
13233032|NCT01708941|26318543|FG001|Overall Study|Ineligible and never started treatment|0|||
13233033|NCT01708941|26318544|FG002|Overall Study|Ineligible and never started treatment|1|||
13233034|NCT01708941|26318545|FG003|Overall Study|Ineligible and never started treatment|0|||
13233035|NCT01708941|26318542|FG000|Overall Study|Never started treatment|2|||
13233036|NCT01708941|26318543|FG001|Overall Study|Never started treatment|1|||
13233037|NCT01708941|26318544|FG002|Overall Study|Never started treatment|0|||
13233038|NCT01708941|26318545|FG003|Overall Study|Never started treatment|0|||
13233039|NCT01708941|26318542|FG000|Overall Study|Ineligible|0|||
13233040|NCT01708941|26318543|FG001|Overall Study|Ineligible|0|||
13233041|NCT01708941|26318544|FG002|Overall Study|Ineligible|2|||
13233042|NCT01708941|26318545|FG003|Overall Study|Ineligible|0|||
13233043|NCT01708915|26318580|FG000|Overall Study|Adverse Event|1|||
13233044|NCT01708915|26318581|FG001|Overall Study|Adverse Event|0|||
13233045|NCT01708915|26318582|FG002|Overall Study|Adverse Event|9|||
13233046|NCT01708915|26318583|FG003|Overall Study|Adverse Event|13|||
13233047|NCT01708915|26318580|FG000|Overall Study|Lack of Efficacy|84|||
13233048|NCT01708915|26318581|FG001|Overall Study|Lack of Efficacy|60|||
13233049|NCT01708915|26318582|FG002|Overall Study|Lack of Efficacy|35|||
13233050|NCT01708915|26318583|FG003|Overall Study|Lack of Efficacy|15|||
13233051|NCT01708915|26318580|FG000|Overall Study|Protocol Violation|0|||
13233052|NCT01708915|26318581|FG001|Overall Study|Protocol Violation|0|||
13233053|NCT01708915|26318582|FG002|Overall Study|Protocol Violation|0|||
13233054|NCT01708915|26318583|FG003|Overall Study|Protocol Violation|1|||
13233055|NCT01708915|26318580|FG000|Overall Study|Withdrawal by Subject|0|||
13233056|NCT01708915|26318581|FG001|Overall Study|Withdrawal by Subject|1|||
13233057|NCT01708915|26318582|FG002|Overall Study|Withdrawal by Subject|2|||
13233058|NCT01708915|26318583|FG003|Overall Study|Withdrawal by Subject|2|||
13233059|NCT01708915|26318580|FG000|Overall Study|Other reasons than stated above|1|||
13233060|NCT01708915|26318581|FG001|Overall Study|Other reasons than stated above|1|||
13233061|NCT01708915|26318582|FG002|Overall Study|Other reasons than stated above|0|||
13233062|NCT01708915|26318583|FG003|Overall Study|Other reasons than stated above|2|||
13233063|NCT01708902|26318664|FG000|Overall Study|Adverse Event|3|||
13233064|NCT01708902|26318665|FG001|Overall Study|Adverse Event|4|||
13233065|NCT01708902|26318666|FG002|Overall Study|Adverse Event|9|||
13233066|NCT01708902|26318667|FG003|Overall Study|Adverse Event|2|||
13233067|NCT01708902|26318668|FG004|Overall Study|Adverse Event|7|||
13233068|NCT01708902|26318669|FG005|Overall Study|Adverse Event|3|||
13233069|NCT01708902|26318670|FG006|Overall Study|Adverse Event|5|||
13233070|NCT01708902|26318664|FG000|Overall Study|Lack of Efficacy|3|||
13233071|NCT01708902|26318665|FG001|Overall Study|Lack of Efficacy|1|||
13233072|NCT01708902|26318666|FG002|Overall Study|Lack of Efficacy|0|||
13233073|NCT01708902|26318667|FG003|Overall Study|Lack of Efficacy|0|||
13233074|NCT01708902|26318668|FG004|Overall Study|Lack of Efficacy|0|||
13233075|NCT01708902|26318669|FG005|Overall Study|Lack of Efficacy|1|||
13233076|NCT01708902|26318670|FG006|Overall Study|Lack of Efficacy|0|||
13233077|NCT01708902|26318664|FG000|Overall Study|Non compliance with protocol|0|||
13233078|NCT01708902|26318665|FG001|Overall Study|Non compliance with protocol|2|||
13233079|NCT01708902|26318666|FG002|Overall Study|Non compliance with protocol|1|||
13233080|NCT01708902|26318667|FG003|Overall Study|Non compliance with protocol|3|||
13233081|NCT01708902|26318668|FG004|Overall Study|Non compliance with protocol|0|||
13233082|NCT01708902|26318669|FG005|Overall Study|Non compliance with protocol|0|||
13233083|NCT01708902|26318670|FG006|Overall Study|Non compliance with protocol|0|||
13233084|NCT01708902|26318664|FG000|Overall Study|Lost to Follow-up|2|||
13233085|NCT01708902|26318665|FG001|Overall Study|Lost to Follow-up|1|||
13233086|NCT01708902|26318666|FG002|Overall Study|Lost to Follow-up|2|||
13233087|NCT01708902|26318667|FG003|Overall Study|Lost to Follow-up|2|||
13233088|NCT01708902|26318668|FG004|Overall Study|Lost to Follow-up|0|||
13233089|NCT01708902|26318669|FG005|Overall Study|Lost to Follow-up|0|||
13233090|NCT01708902|26318670|FG006|Overall Study|Lost to Follow-up|1|||
13233091|NCT01708902|26318664|FG000|Overall Study|Refused to continue trial medication|8|||
13233092|NCT01708902|26318665|FG001|Overall Study|Refused to continue trial medication|0|||
13233093|NCT01708902|26318666|FG002|Overall Study|Refused to continue trial medication|4|||
13233094|NCT01708902|26318667|FG003|Overall Study|Refused to continue trial medication|2|||
13233095|NCT01708902|26318668|FG004|Overall Study|Refused to continue trial medication|8|||
13233096|NCT01708902|26318669|FG005|Overall Study|Refused to continue trial medication|1|||
13233097|NCT01708902|26318670|FG006|Overall Study|Refused to continue trial medication|1|||
13233098|NCT01708902|26318664|FG000|Overall Study|Other Reason|1|||
13233099|NCT01708902|26318665|FG001|Overall Study|Other Reason|0|||
13233100|NCT01708902|26318666|FG002|Overall Study|Other Reason|1|||
13233101|NCT01708902|26318667|FG003|Overall Study|Other Reason|1|||
13233102|NCT01708902|26318668|FG004|Overall Study|Other Reason|1|||
13233103|NCT01708902|26318669|FG005|Overall Study|Other Reason|2|||
13233104|NCT01708902|26318670|FG006|Overall Study|Other Reason|0|||
13233105|NCT01708291|26318683|FG000|Overall Study|fighting|2|||
13233106|NCT01708291|26318684|FG001|Overall Study|fighting|1|||
13233107|NCT01708187|26318697|FG000|Overall Study|Lost to Follow-up|0|||
13233108|NCT01708187|26318698|FG001|Overall Study|Lost to Follow-up|1|||
13233109|NCT01708174|26318734|FG000|Treatment Period|Withdrawal by Subject|1|||
13233110|NCT01708174|26318735|FG001|Treatment Period|Withdrawal by Subject|0|||
13233111|NCT01708174|26318736|FG002|Treatment Period|Withdrawal by Subject|0|||
13233112|NCT01708174|26318734|FG000|Treatment Period|Progressive disease|0|||
13233113|NCT01708174|26318735|FG001|Treatment Period|Progressive disease|1|||
13233114|NCT01708174|26318736|FG002|Treatment Period|Progressive disease|0|||
13233115|NCT01708174|26318734|FG000|Treatment Period|Death|0|||
13233116|NCT01708174|26318735|FG001|Treatment Period|Death|0|||
13233117|NCT01708174|26318736|FG002|Treatment Period|Death|1|||
13233118|NCT01708174|26318734|FG000|Treatment Period|Adverse Event|0|||
13233119|NCT01708174|26318735|FG001|Treatment Period|Adverse Event|1|||
13233120|NCT01708174|26318736|FG002|Treatment Period|Adverse Event|0|||
13233121|NCT01708161|26318795|FG000|Overall Study|Adverse Event|1|||
13233122|NCT01708161|26318796|FG001|Overall Study|Adverse Event|3|||
13233123|NCT01708161|26318797|FG002|Overall Study|Adverse Event|4|||
13233124|NCT01708161|26318798|FG003|Overall Study|Adverse Event|2|||
13233125|NCT01708161|26318799|FG004|Overall Study|Adverse Event|3|||
13233126|NCT01708161|26318800|FG005|Overall Study|Adverse Event|0|||
13233127|NCT01708161|26318795|FG000|Overall Study|Death|0|||
13233128|NCT01708161|26318796|FG001|Overall Study|Death|0|||
13233129|NCT01708161|26318797|FG002|Overall Study|Death|0|||
13233130|NCT01708161|26318798|FG003|Overall Study|Death|1|||
13233131|NCT01708161|26318799|FG004|Overall Study|Death|0|||
13233132|NCT01708161|26318800|FG005|Overall Study|Death|1|||
13233133|NCT01708161|26318795|FG000|Overall Study|Withdrawal by Subject|0|||
13233134|NCT01708161|26318796|FG001|Overall Study|Withdrawal by Subject|1|||
13233135|NCT01708161|26318797|FG002|Overall Study|Withdrawal by Subject|1|||
13233136|NCT01708161|26318798|FG003|Overall Study|Withdrawal by Subject|0|||
13233137|NCT01708161|26318799|FG004|Overall Study|Withdrawal by Subject|0|||
13233138|NCT01708161|26318800|FG005|Overall Study|Withdrawal by Subject|0|||
13233139|NCT01708161|26318795|FG000|Overall Study|Administrative problems|0|||
13233140|NCT01708161|26318796|FG001|Overall Study|Administrative problems|1|||
13233141|NCT01708161|26318797|FG002|Overall Study|Administrative problems|0|||
13233142|NCT01708161|26318798|FG003|Overall Study|Administrative problems|0|||
13233143|NCT01708161|26318799|FG004|Overall Study|Administrative problems|0|||
13233144|NCT01708161|26318800|FG005|Overall Study|Administrative problems|0|||
13233145|NCT01708161|26318795|FG000|Overall Study|Disease progression|3|||
13233146|NCT01708161|26318796|FG001|Overall Study|Disease progression|5|||
13233147|NCT01708161|26318797|FG002|Overall Study|Disease progression|5|||
13233148|NCT01708161|26318798|FG003|Overall Study|Disease progression|13|||
13233149|NCT01708161|26318799|FG004|Overall Study|Disease progression|3|||
13233150|NCT01708161|26318800|FG005|Overall Study|Disease progression|0|||
13233151|NCT01708057|26318860|FG000|Overall Study|Withdrawal due to study termination.|1|||
13233152|NCT01708057|26318861|FG001|Overall Study|Withdrawal due to study termination.|1|||
13233153|NCT01708057|26318862|FG002|Overall Study|Withdrawal due to study termination.|1|||
13233154|NCT01707992|26318925|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8|||
13233155|NCT01707992|26318926|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13|||
13233156|NCT01707992|26318927|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9|||
13233157|NCT01707992|26318928|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
13233158|NCT01707992|26318929|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
13233159|NCT01707992|26318930|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
13233160|NCT01707992|26318925|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10|||
13233161|NCT01707992|26318926|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3|||
13233162|NCT01707992|26318927|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2|||
13233163|NCT01707992|26318928|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
13233164|NCT01707992|26318929|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
13233165|NCT01707992|26318930|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
13233166|NCT01707992|26318925|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88|||
13233167|NCT01707992|26318926|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68|||
13233168|NCT01707992|26318927|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154|||
13233169|NCT01707992|26318928|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
13233170|NCT01707992|26318929|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
13233171|NCT01707992|26318930|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
13233172|NCT01707992|26318925|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1|||
13233173|NCT01707992|26318926|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
13233174|NCT01707992|26318927|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
13233175|NCT01707992|26318928|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
13233176|NCT01707992|26318929|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
13233177|NCT01707992|26318930|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
13233178|NCT01707992|26318925|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12|||
13233179|NCT01707992|26318926|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5|||
13233180|NCT01707992|26318927|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9|||
13233181|NCT01707992|26318928|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
13233182|NCT01707992|26318929|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
13233183|NCT01707992|26318930|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
13233184|NCT01707992|26318925|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10|||
13233185|NCT01707992|26318926|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4|||
13233186|NCT01707992|26318927|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9|||
13233187|NCT01707992|26318928|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
13233188|NCT01707992|26318929|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
13233189|NCT01707992|26318930|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
13233190|NCT01707992|26318925|FG000|Placebo-Controlled Phase (24 Months)|Death|2|||
13233191|NCT01707992|26318926|FG001|Placebo-Controlled Phase (24 Months)|Death|1|||
13233192|NCT01707992|26318927|FG002|Placebo-Controlled Phase (24 Months)|Death|1|||
13233193|NCT01707992|26318928|FG003|Placebo-Controlled Phase (24 Months)|Death|0|||
13233194|NCT01707992|26318929|FG004|Placebo-Controlled Phase (24 Months)|Death|0|||
13233195|NCT01707992|26318930|FG005|Placebo-Controlled Phase (24 Months)|Death|0|||
13233196|NCT01707992|26318925|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2|||
13233197|NCT01707992|26318926|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1|||
13233198|NCT01707992|26318927|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6|||
13233199|NCT01707992|26318928|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
13233200|NCT01707992|26318929|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
13233201|NCT01707992|26318930|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
13233202|NCT01707992|26318925|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11|||
13233203|NCT01707992|26318926|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9|||
13233204|NCT01707992|26318927|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10|||
13115392|NCT03099187|25917779|FG003|12-month Safety Follow-up|Due to hospitalization|1|||
13115393|NCT03099161|25917806|FG000|Overall Study|Adverse Event|0|||
13233205|NCT01707992|26318928|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
13233206|NCT01707992|26318929|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
13233207|NCT01707992|26318930|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
13233208|NCT01707992|26318925|FG000|Active Treatment Phase (24 Months)|Adverse Event|0|||
13233209|NCT01707992|26318926|FG001|Active Treatment Phase (24 Months)|Adverse Event|0|||
13233210|NCT01707992|26318927|FG002|Active Treatment Phase (24 Months)|Adverse Event|0|||
13233211|NCT01707992|26318928|FG003|Active Treatment Phase (24 Months)|Adverse Event|4|||
13233212|NCT01707992|26318929|FG004|Active Treatment Phase (24 Months)|Adverse Event|1|||
13233213|NCT01707992|26318930|FG005|Active Treatment Phase (24 Months)|Adverse Event|0|||
13233214|NCT01707992|26318925|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
13233215|NCT01707992|26318926|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
13233216|NCT01707992|26318927|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
13233217|NCT01707992|26318928|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3|||
13233218|NCT01707992|26318929|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1|||
13233219|NCT01707992|26318930|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2|||
13233220|NCT01707992|26318925|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
13233221|NCT01707992|26318926|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
13233222|NCT01707992|26318927|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
13233223|NCT01707992|26318928|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58|||
13233224|NCT01707992|26318929|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220|||
13233225|NCT01707992|26318930|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32|||
13233226|NCT01707992|26318925|FG000|Active Treatment Phase (24 Months)|Pregnancy|0|||
13233227|NCT01707992|26318926|FG001|Active Treatment Phase (24 Months)|Pregnancy|0|||
13233228|NCT01707992|26318927|FG002|Active Treatment Phase (24 Months)|Pregnancy|0|||
13233229|NCT01707992|26318928|FG003|Active Treatment Phase (24 Months)|Pregnancy|2|||
13233230|NCT01707992|26318929|FG004|Active Treatment Phase (24 Months)|Pregnancy|5|||
13233231|NCT01707992|26318930|FG005|Active Treatment Phase (24 Months)|Pregnancy|2|||
13233232|NCT01707992|26318925|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
13233233|NCT01707992|26318926|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
13233234|NCT01707992|26318927|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
13233235|NCT01707992|26318928|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5|||
13233236|NCT01707992|26318929|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11|||
13233237|NCT01707992|26318930|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1|||
13233238|NCT01707992|26318925|FG000|Active Treatment Phase (24 Months)|Death|0|||
13233239|NCT01707992|26318926|FG001|Active Treatment Phase (24 Months)|Death|0|||
13233240|NCT01707992|26318927|FG002|Active Treatment Phase (24 Months)|Death|0|||
13233241|NCT01707992|26318928|FG003|Active Treatment Phase (24 Months)|Death|2|||
13233242|NCT01707992|26318929|FG004|Active Treatment Phase (24 Months)|Death|0|||
13233243|NCT01707992|26318930|FG005|Active Treatment Phase (24 Months)|Death|0|||
13233244|NCT01707992|26318925|FG000|Active Treatment Phase (24 Months)|Other than specified|0|||
13233245|NCT01707992|26318926|FG001|Active Treatment Phase (24 Months)|Other than specified|0|||
13233246|NCT01707992|26318927|FG002|Active Treatment Phase (24 Months)|Other than specified|0|||
13233247|NCT01707992|26318928|FG003|Active Treatment Phase (24 Months)|Other than specified|1|||
13233248|NCT01707992|26318929|FG004|Active Treatment Phase (24 Months)|Other than specified|5|||
13233249|NCT01707992|26318930|FG005|Active Treatment Phase (24 Months)|Other than specified|2|||
13233250|NCT01707992|26318925|FG000|Active Treatment Phase (24 Months)|Noncompliance|0|||
13233251|NCT01707992|26318926|FG001|Active Treatment Phase (24 Months)|Noncompliance|0|||
13233252|NCT01707992|26318927|FG002|Active Treatment Phase (24 Months)|Noncompliance|0|||
13233253|NCT01707992|26318928|FG003|Active Treatment Phase (24 Months)|Noncompliance|0|||
13233254|NCT01707992|26318929|FG004|Active Treatment Phase (24 Months)|Noncompliance|4|||
13233255|NCT01707992|26318930|FG005|Active Treatment Phase (24 Months)|Noncompliance|2|||
13233256|NCT01707992|26318925|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
13233257|NCT01707992|26318926|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
13233258|NCT01707992|26318927|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
13233259|NCT01707992|26318928|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809|||
13233260|NCT01707992|26318929|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243|||
13233261|NCT01707992|26318930|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174|||
13233262|NCT01707992|26318925|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
13233263|NCT01707992|26318926|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
13233264|NCT01707992|26318927|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
13233265|NCT01707992|26318928|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
13233266|NCT01707992|26318929|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4|||
13233267|NCT01707992|26318930|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
13233268|NCT01707693|26318949|FG000|Overall Study Allocation|Withdrawal by Subject|9|||
13233269|NCT01707693|26318950|FG001|Overall Study Allocation|Withdrawal by Subject|5|||
13233270|NCT01707693|26318949|FG000|Overall Study Allocation|Protocol Violation|4|||
13233271|NCT01707693|26318950|FG001|Overall Study Allocation|Protocol Violation|3|||
13233272|NCT01707693|26318949|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0|||
13233273|NCT01707693|26318950|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3|||
13233274|NCT01707693|26318949|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0|||
13233275|NCT01707693|26318950|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2|||
13233276|NCT01707667|26318975|FG000|Period 1|expulsion of colonic sensor catheter|1|||
13233277|NCT01707667|26318976|FG001|Period 1|expulsion of colonic sensor catheter|0|||
13233278|NCT01707290|26319004|FG000|Overall Study|Adverse event (AE)|1|||
13233279|NCT01707290|26319005|FG001|Overall Study|Adverse event (AE)|0|||
13233280|NCT01707290|26319004|FG000|Overall Study|Physician Decision|1|||
13233281|NCT01707290|26319005|FG001|Overall Study|Physician Decision|0|||
13233282|NCT01707290|26319004|FG000|Overall Study|Lost to Follow-up|3|||
13233283|NCT01707290|26319005|FG001|Overall Study|Lost to Follow-up|0|||
13233284|NCT01707290|26319004|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4|||
13233285|NCT01707290|26319005|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0|||
13233286|NCT01707290|26319004|FG000|Overall Study|Commercial drug available|60|||
13233287|NCT01707290|26319005|FG001|Overall Study|Commercial drug available|1|||
13233288|NCT01707290|26319004|FG000|Overall Study|Other unspecified|17|||
13233289|NCT01707290|26319005|FG001|Overall Study|Other unspecified|0|||
13233290|NCT01707147|26319015|FG000|Overall Study|Administered Trajenta prior to contract|5|||
13233291|NCT01707147|26319015|FG000|Overall Study|Patients who have not taken Trajenta|1|||
13233292|NCT01707147|26319015|FG000|Overall Study|Follow-up failure|17|||
13233293|NCT01707147|26319015|FG000|Overall Study|Violated inclusion/exclusion criteria|77|||
13233294|NCT01707030|26319040|FG000|Overall Study|Death|1|||
13233295|NCT01707030|26319041|FG001|Overall Study|Death|1|||
13233296|NCT01707030|26319040|FG000|Overall Study|Withdrawal by Subject|2|||
13233297|NCT01707030|26319041|FG001|Overall Study|Withdrawal by Subject|3|||
13233298|NCT01707030|26319040|FG000|Overall Study|Lost to Follow-up|8|||
13233299|NCT01707030|26319041|FG001|Overall Study|Lost to Follow-up|13|||
13233300|NCT01707004|26319055|FG000|Overall Study|Physician Decision|3|||
13233301|NCT01706939|26319086|FG000|Pre Randomization|Screen Failure|1|||
13233302|NCT01706939|26319087|FG001|Pre Randomization|Screen Failure|0|||
13233303|NCT01706939|26319088|FG002|Pre Randomization|Screen Failure|0|||
13233304|NCT01706939|26319086|FG000|Pre Randomization|Ineligible for Randomization|1|||
13233305|NCT01706939|26319087|FG001|Pre Randomization|Ineligible for Randomization|0|||
13233306|NCT01706939|26319088|FG002|Pre Randomization|Ineligible for Randomization|0|||
13233307|NCT01706939|26319086|FG000|Pre Randomization|Withdrawal by Subject|1|||
13233308|NCT01706939|26319087|FG001|Pre Randomization|Withdrawal by Subject|0|||
13233309|NCT01706939|26319088|FG002|Pre Randomization|Withdrawal by Subject|0|||
13233310|NCT01706939|26319086|FG000|Randomization|Insufficient QoL survey compliance|0|||
13233311|NCT01706939|26319087|FG001|Randomization|Insufficient QoL survey compliance|1|||
13233312|NCT01706939|26319088|FG002|Randomization|Insufficient QoL survey compliance|1|||
13233313|NCT01706939|26319086|FG000|Randomization|Progression of disease|0|||
13233314|NCT01706939|26319087|FG001|Randomization|Progression of disease|2|||
13233315|NCT01706939|26319088|FG002|Randomization|Progression of disease|1|||
13233316|NCT01706926|26319210|FG000|Overall Study|Lost to Follow-up|0|||
13233317|NCT01706926|26319211|FG001|Overall Study|Lost to Follow-up|0|||
13233318|NCT01706926|26319212|FG002|Overall Study|Lost to Follow-up|1|||
13233319|NCT01706926|26319213|FG003|Overall Study|Lost to Follow-up|0|||
13233320|NCT01706926|26319210|FG000|Overall Study|Withdrawal by Subject|2|||
13233321|NCT01706926|26319211|FG001|Overall Study|Withdrawal by Subject|0|||
13233322|NCT01706926|26319212|FG002|Overall Study|Withdrawal by Subject|1|||
13233323|NCT01706926|26319213|FG003|Overall Study|Withdrawal by Subject|2|||
13233324|NCT01706926|26319210|FG000|Overall Study|Other|4|||
13233325|NCT01706926|26319211|FG001|Overall Study|Other|4|||
13233326|NCT01706926|26319212|FG002|Overall Study|Other|4|||
13233327|NCT01706926|26319213|FG003|Overall Study|Other|3|||
13233328|NCT01706770|26319228|FG000|Overall Study|Lost to Follow-up|1|||
13233329|NCT01706770|26319229|FG001|Overall Study|Lost to Follow-up|0|||
13233330|NCT01706770|26319228|FG000|Overall Study|Physician Decision|1|||
13233331|NCT01706770|26319229|FG001|Overall Study|Physician Decision|0|||
13233332|NCT01706575|26319242|FG000|Overall Study|Participant Withdrew Consent|4|||
13233333|NCT01706575|26319242|FG000|Overall Study|Lost to Follow-up|2|||
13233334|NCT01706575|26319242|FG000|Overall Study|Started but not Treated|6|||
13233335|NCT01706536|26319315|FG000|Overall Study|Withdrawal by Subject|1|||
13233336|NCT01706536|26319316|FG001|Overall Study|Withdrawal by Subject|0|||
13233337|NCT01706536|26319317|FG002|Overall Study|Withdrawal by Subject|1|||
13233338|NCT01706536|26319318|FG003|Overall Study|Withdrawal by Subject|0|||
13233339|NCT01706536|26319319|FG004|Overall Study|Withdrawal by Subject|0|||
13233340|NCT01706536|26319315|FG000|Overall Study|Adverse Event|2|||
13233341|NCT01706536|26319316|FG001|Overall Study|Adverse Event|3|||
13233342|NCT01706536|26319317|FG002|Overall Study|Adverse Event|4|||
13233343|NCT01706536|26319318|FG003|Overall Study|Adverse Event|3|||
13233344|NCT01706536|26319319|FG004|Overall Study|Adverse Event|2|||
13233345|NCT01706536|26319315|FG000|Overall Study|Lack of Efficacy|1|||
13233346|NCT01706536|26319316|FG001|Overall Study|Lack of Efficacy|0|||
13233347|NCT01706536|26319317|FG002|Overall Study|Lack of Efficacy|0|||
13233348|NCT01706536|26319318|FG003|Overall Study|Lack of Efficacy|1|||
13233349|NCT01706536|26319319|FG004|Overall Study|Lack of Efficacy|0|||
13233350|NCT01706536|26319315|FG000|Overall Study|non compliance|0|||
13233351|NCT01706536|26319316|FG001|Overall Study|non compliance|1|||
13233352|NCT01706536|26319317|FG002|Overall Study|non compliance|0|||
13233353|NCT01706536|26319318|FG003|Overall Study|non compliance|0|||
13233354|NCT01706536|26319319|FG004|Overall Study|non compliance|0|||
13233355|NCT01706458|26319350|FG000|Overall Study|Physician Decision|3|||
13233356|NCT01706458|26319351|FG001|Overall Study|Physician Decision|4|||
13233357|NCT01706328|26319369|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140|||
13233358|NCT01706328|26319370|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
13233359|NCT01706328|26319371|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
13233360|NCT01706328|26319369|FG000|2-week Run-in Period|Withdrawal by Subject|15|||
13233361|NCT01706328|26319370|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
13233362|NCT01706328|26319371|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
13233363|NCT01706328|26319369|FG000|2-week Run-in Period|Physician Decision|4|||
13233364|NCT01706328|26319370|FG001|2-week Run-in Period|Physician Decision|0|||
13233365|NCT01706328|26319371|FG002|2-week Run-in Period|Physician Decision|0|||
13233366|NCT01706328|26319369|FG000|2-week Run-in Period|Adverse Event|4|||
13233367|NCT01706328|26319370|FG001|2-week Run-in Period|Adverse Event|0|||
13233368|NCT01706328|26319371|FG002|2-week Run-in Period|Adverse Event|0|||
13233369|NCT01706328|26319369|FG000|2-week Run-in Period|Lost to Follow-up|2|||
13233370|NCT01706328|26319370|FG001|2-week Run-in Period|Lost to Follow-up|0|||
13233371|NCT01706328|26319371|FG002|2-week Run-in Period|Lost to Follow-up|0|||
13233372|NCT01706328|26319369|FG000|12-week Double-blind Treatment Period|Adverse Event|0|||
13233373|NCT01706328|26319370|FG001|12-week Double-blind Treatment Period|Adverse Event|14|||
13233374|NCT01706328|26319371|FG002|12-week Double-blind Treatment Period|Adverse Event|16|||
13233375|NCT01706328|26319369|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0|||
13233376|NCT01706328|26319370|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
13233377|NCT01706328|26319371|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
13233378|NCT01706328|26319369|FG000|12-week Double-blind Treatment Period|Protocol Violation|0|||
13233379|NCT01706328|26319370|FG001|12-week Double-blind Treatment Period|Protocol Violation|4|||
13233380|NCT01706328|26319371|FG002|12-week Double-blind Treatment Period|Protocol Violation|2|||
13233381|NCT01706328|26319369|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0|||
13233382|NCT01706328|26319370|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11|||
13233383|NCT01706328|26319371|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9|||
13233384|NCT01706328|26319369|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0|||
13233385|NCT01706328|26319370|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3|||
13233386|NCT01706328|26319371|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1|||
13233387|NCT01706328|26319369|FG000|12-week Double-blind Treatment Period|Physician Decision|0|||
13233388|NCT01706328|26319370|FG001|12-week Double-blind Treatment Period|Physician Decision|2|||
13233389|NCT01706328|26319371|FG002|12-week Double-blind Treatment Period|Physician Decision|2|||
13233390|NCT01706328|26319369|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0|||
13233391|NCT01706328|26319370|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8|||
13233392|NCT01706328|26319371|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11|||
13233393|NCT01706250|26319402|FG000|Overall Study|Lost to Follow-up|2|||
13233394|NCT01706198|26319459|FG000|Overall Study|Adverse Event|12|||
13233395|NCT01706198|26319460|FG001|Overall Study|Adverse Event|15|||
13233396|NCT01706198|26319459|FG000|Overall Study|Protocol Violation|7|||
13233397|NCT01706198|26319460|FG001|Overall Study|Protocol Violation|5|||
13233398|NCT01706198|26319459|FG000|Overall Study|Other: Subject reached stopping criteria|11|||
13233399|NCT01706198|26319460|FG001|Overall Study|Other: Subject reached stopping criteria|13|||
13233400|NCT01706198|26319459|FG000|Overall Study|Lost to Follow-up|97|||
13233401|NCT01706198|26319460|FG001|Overall Study|Lost to Follow-up|93|||
13233402|NCT01706198|26319459|FG000|Overall Study|Physician Decision|23|||
13233403|NCT01706198|26319460|FG001|Overall Study|Physician Decision|37|||
13233404|NCT01706198|26319459|FG000|Overall Study|Withdrawal by Subject|23|||
13233405|NCT01706198|26319460|FG001|Overall Study|Withdrawal by Subject|31|||
13233406|NCT01706159|26319481|FG000|Overall Study|Withdrawal Criteria|2|||
13233407|NCT01706159|26319482|FG001|Overall Study|Withdrawal Criteria|1|||
13233408|NCT01706159|26319481|FG000|Overall Study|Unclassified|6|||
13233409|NCT01706159|26319482|FG001|Overall Study|Unclassified|1|||
13233410|NCT01706146|26319489|FG000|Overall Study|Withdrawal by Subject|1|||
13233411|NCT01706146|26319489|FG000|Overall Study|Adverse Event|3|||
13233412|NCT01706146|26319489|FG000|Overall Study|Developed AF and need for antiplatelets|2|||
13233413|NCT01706003|26319502|FG000|Overall Study|Withdrawal by Subject|2|||
13233414|NCT01706003|26319503|FG001|Overall Study|Withdrawal by Subject|0|||
13233415|NCT01706003|26319502|FG000|Overall Study|Not scheduled|3|||
13233416|NCT01706003|26319503|FG001|Overall Study|Not scheduled|0|||
13233417|NCT01706003|26319502|FG000|Overall Study|Lost to Follow-up|6|||
13233418|NCT01706003|26319503|FG001|Overall Study|Lost to Follow-up|4|||
13233419|NCT01705730|26319543|FG000|Overall Study|Lack of Efficacy|1|||
13233420|NCT01705730|26319543|FG000|Overall Study|Adverse Event|3|||
13233421|NCT01705730|26319543|FG000|Overall Study|Lost to Follow-up|1|||
13233422|NCT01705730|26319543|FG000|Overall Study|Reason not Specified|4|||
13233423|NCT01705717|26319565|FG000|Overall Study|Adverse Event|2|||
13233424|NCT01705717|26319566|FG001|Overall Study|Adverse Event|2|||
13233425|NCT01705717|26319565|FG000|Overall Study|Lack of Efficacy|0|||
13233426|NCT01705717|26319566|FG001|Overall Study|Lack of Efficacy|1|||
13115394|NCT03099161|25917807|FG001|Overall Study|Adverse Event|0|||
13233427|NCT01705717|26319565|FG000|Overall Study|Other|0|||
13233428|NCT01705717|26319566|FG001|Overall Study|Other|2|||
13233429|NCT01705691|26319591|FG000|Overall Study|Death|1|||
13233430|NCT01705691|26319592|FG001|Overall Study|Death|2|||
13233431|NCT01705691|26319591|FG000|Overall Study|Withdrawal by Subject|1|||
13233432|NCT01705691|26319592|FG001|Overall Study|Withdrawal by Subject|2|||
13233433|NCT01705691|26319591|FG000|Overall Study|Lost to Follow-up|1|||
13233434|NCT01705691|26319592|FG001|Overall Study|Lost to Follow-up|1|||
13233435|NCT01705691|26319591|FG000|Overall Study|Other|0|||
13233436|NCT01705691|26319592|FG001|Overall Study|Other|1|||
13233437|NCT01705652|26319605|FG000|Overall Study|Adverse Event|1|||
13233438|NCT01705652|26319606|FG001|Overall Study|Adverse Event|0|||
13233439|NCT01705652|26319605|FG000|Overall Study|Withdrawal by Subject|1|||
13233440|NCT01705652|26319606|FG001|Overall Study|Withdrawal by Subject|2|||
13233441|NCT01705652|26319605|FG000|Overall Study|non-compliance|1|||
13233442|NCT01705652|26319606|FG001|Overall Study|non-compliance|1|||
13233443|NCT01705587|26319629|FG000|Overall Study|Withdrawal by Subject|0|||
13233444|NCT01705587|26319630|FG001|Overall Study|Withdrawal by Subject|1|||
13233445|NCT01705574|26319656|FG000|Double-Blind Phase|Lost to Follow-up|12|||
13233446|NCT01705574|26319657|FG001|Double-Blind Phase|Lost to Follow-up|16|||
13233447|NCT01705574|26319658|FG002|Double-Blind Phase|Lost to Follow-up|0|||
13233448|NCT01705574|26319659|FG003|Double-Blind Phase|Lost to Follow-up|0|||
13233449|NCT01705574|26319656|FG000|Double-Blind Phase|Adverse Event|3|||
13233450|NCT01705574|26319657|FG001|Double-Blind Phase|Adverse Event|10|||
13233451|NCT01705574|26319658|FG002|Double-Blind Phase|Adverse Event|0|||
13233452|NCT01705574|26319659|FG003|Double-Blind Phase|Adverse Event|0|||
13233453|NCT01705574|26319656|FG000|Double-Blind Phase|Withdrew Consent|8|||
13233454|NCT01705574|26319657|FG001|Double-Blind Phase|Withdrew Consent|5|||
13233455|NCT01705574|26319658|FG002|Double-Blind Phase|Withdrew Consent|0|||
13233456|NCT01705574|26319659|FG003|Double-Blind Phase|Withdrew Consent|0|||
13233457|NCT01705574|26319656|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
13233458|NCT01705574|26319657|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5|||
13233459|NCT01705574|26319658|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0|||
13233460|NCT01705574|26319659|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0|||
13233461|NCT01705574|26319656|FG000|Double-Blind Phase|Pregnancy|1|||
13233462|NCT01705574|26319657|FG001|Double-Blind Phase|Pregnancy|1|||
13233463|NCT01705574|26319658|FG002|Double-Blind Phase|Pregnancy|0|||
13233464|NCT01705574|26319659|FG003|Double-Blind Phase|Pregnancy|0|||
13233465|NCT01705574|26319656|FG000|Double-Blind Phase|Protocol Violation|1|||
13233466|NCT01705574|26319657|FG001|Double-Blind Phase|Protocol Violation|0|||
13233467|NCT01705574|26319658|FG002|Double-Blind Phase|Protocol Violation|0|||
13115395|NCT03099161|25917808|FG002|Overall Study|Adverse Event|2|||
13115396|NCT03099161|25917806|FG000|Overall Study|Physician Decision|2|||
13115397|NCT03099161|25917807|FG001|Overall Study|Physician Decision|0|||
13115398|NCT03099161|25917808|FG002|Overall Study|Physician Decision|0|||
13115399|NCT03099161|25917806|FG000|Overall Study|Progressive Disease|1|||
13115400|NCT03099161|25917807|FG001|Overall Study|Progressive Disease|4|||
13115401|NCT03099161|25917808|FG002|Overall Study|Progressive Disease|1|||
13233468|NCT01705574|26319659|FG003|Double-Blind Phase|Protocol Violation|0|||
13233469|NCT01705574|26319656|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
13233470|NCT01705574|26319657|FG001|Double-Blind Phase|Randomized but Not Treated|4|||
13233471|NCT01705574|26319658|FG002|Double-Blind Phase|Randomized but Not Treated|0|||
13233472|NCT01705574|26319659|FG003|Double-Blind Phase|Randomized but Not Treated|0|||
13233473|NCT01705574|26319656|FG000|Open-Label Extension Phase|Lost to Follow-up|6|||
13233474|NCT01705574|26319657|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
13233475|NCT01705574|26319658|FG002|Open-Label Extension Phase|Lost to Follow-up|2|||
13233476|NCT01705574|26319659|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
13233477|NCT01705574|26319656|FG000|Open-Label Extension Phase|Withdrew Consent|4|||
13233478|NCT01705574|26319657|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
13233479|NCT01705574|26319658|FG002|Open-Label Extension Phase|Withdrew Consent|4|||
13233480|NCT01705574|26319659|FG003|Open-Label Extension Phase|Withdrew Consent|1|||
13233481|NCT01705574|26319656|FG000|Open-Label Extension Phase|Adverse Event|3|||
13115402|NCT03099096|25917817|FG000|Overall Study|Adverse Event|1|||
13233482|NCT01705574|26319657|FG001|Open-Label Extension Phase|Adverse Event|0|||
13233483|NCT01705574|26319658|FG002|Open-Label Extension Phase|Adverse Event|0|||
13233484|NCT01705574|26319659|FG003|Open-Label Extension Phase|Adverse Event|1|||
13233485|NCT01705574|26319656|FG000|Open-Label Extension Phase|Death|2|||
13115403|NCT03099096|25917817|FG000|Overall Study|Physician Decision|1|||
13233486|NCT01705574|26319657|FG001|Open-Label Extension Phase|Death|0|||
13233487|NCT01705574|26319658|FG002|Open-Label Extension Phase|Death|1|||
13233488|NCT01705574|26319659|FG003|Open-Label Extension Phase|Death|0|||
13233489|NCT01705574|26319656|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
13233490|NCT01705574|26319657|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
13233491|NCT01705574|26319658|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1|||
13233492|NCT01705574|26319659|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
13233493|NCT01705574|26319656|FG000|Open-Label Extension Phase|Physician Decision|0|||
13233494|NCT01705574|26319657|FG001|Open-Label Extension Phase|Physician Decision|0|||
13233495|NCT01705574|26319658|FG002|Open-Label Extension Phase|Physician Decision|2|||
13233496|NCT01705574|26319659|FG003|Open-Label Extension Phase|Physician Decision|0|||
13233497|NCT01705574|26319656|FG000|Open-Label Extension Phase|Pregnancy|0|||
13233498|NCT01705574|26319657|FG001|Open-Label Extension Phase|Pregnancy|0|||
13233499|NCT01705574|26319658|FG002|Open-Label Extension Phase|Pregnancy|1|||
13233500|NCT01705574|26319659|FG003|Open-Label Extension Phase|Pregnancy|1|||
13233501|NCT01705509|26319665|FG000|Inclusion CPET|Screen Failure|5|||
13233502|NCT01705509|26319665|FG000|Inclusion CPET|Withdrawal by Subject|2|||
13233503|NCT01705509|26319665|FG000|CPET w/ Ranexa|Screen Failure|2|||
13233504|NCT01705236|26319676|FG000|Overall Study|Lost to Follow-up|1|||
13233505|NCT01705236|26319676|FG000|Overall Study|Administrative problems|2|||
13233506|NCT01705236|26319676|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
13233507|NCT01705236|26319676|FG000|Overall Study|Protocol Violation|3|||
13233508|NCT01705236|26319676|FG000|Overall Study|Abnormal test procedure result(s)|4|||
13233509|NCT01705236|26319676|FG000|Overall Study|Abnormal laboratory value(s)|4|||
13233510|NCT01705236|26319676|FG000|Overall Study|Withdrawal by Subject|5|||
13233511|NCT01705236|26319676|FG000|Overall Study|Adverse Event|5|||
13233512|NCT01705145|26319706|FG000|Part B|Adverse Event|1|||
13233513|NCT01705080|26319817|FG000|Overall Study|Missed visit|10|||
13233514|NCT01705080|26319818|FG001|Overall Study|Missed visit|4|||
13233515|NCT01705080|26319819|FG002|Overall Study|Missed visit|1|||
13233516|NCT01705080|26319817|FG000|Overall Study|Death|4|||
13233517|NCT01705080|26319818|FG001|Overall Study|Death|4|||
13233518|NCT01705080|26319819|FG002|Overall Study|Death|6|||
13233519|NCT01705080|26319817|FG000|Overall Study|Withdrawal by Subject|61|||
13233520|NCT01705080|26319818|FG001|Overall Study|Withdrawal by Subject|44|||
13233521|NCT01705080|26319819|FG002|Overall Study|Withdrawal by Subject|9|||
13233522|NCT01704846|26319844|FG000|Treatment Period 2|Withdrawal by Subject|0|||
13233523|NCT01704846|26319845|FG001|Treatment Period 2|Withdrawal by Subject|1|||
13233524|NCT01704755|26319864|FG000|Overall Study|Adverse Event|4|||
13233525|NCT01704755|26319865|FG001|Overall Study|Adverse Event|1|||
13233526|NCT01704755|26319864|FG000|Overall Study|Lost to Follow-up|3|||
13233527|NCT01704755|26319865|FG001|Overall Study|Lost to Follow-up|4|||
13233528|NCT01704755|26319864|FG000|Overall Study|Withdrew consent|1|||
13233529|NCT01704755|26319865|FG001|Overall Study|Withdrew consent|1|||
13233530|NCT01704755|26319864|FG000|Overall Study|Other (not specified)|3|||
13233531|NCT01704755|26319865|FG001|Overall Study|Other (not specified)|1|||
13233532|NCT01704755|26319864|FG000|Overall Study|Withdrew consent and personal issues|1|||
13233533|NCT01704755|26319865|FG001|Overall Study|Withdrew consent and personal issues|0|||
13233534|NCT01704651|26319880|FG000|Overall Study|Pre-op withdrawal by subject|1|||
13233535|NCT01704651|26319881|FG001|Overall Study|Pre-op withdrawal by subject|1|||
13233536|NCT01704651|26319880|FG000|Overall Study|Pre-op change in treatment plan|1|||
13233537|NCT01704651|26319881|FG001|Overall Study|Pre-op change in treatment plan|4|||
13233538|NCT01704651|26319880|FG000|Overall Study|Nasogastric tube placement in surgery|1|||
13233539|NCT01704651|26319881|FG001|Overall Study|Nasogastric tube placement in surgery|1|||
13233540|NCT01704651|26319880|FG000|Overall Study|Post-op did not have laparotomy|2|||
13233541|NCT01704651|26319881|FG001|Overall Study|Post-op did not have laparotomy|1|||
13233542|NCT01704599|26319910|FG000|Overall Study|Adverse Event|1|||
13233543|NCT01704495|26320097|FG000|Subjects Randomized|Other Reason|3|||
13233544|NCT01704495|26320098|FG001|Subjects Randomized|Other Reason|2|||
13233545|NCT01704495|26320099|FG002|Subjects Randomized|Other Reason|3|||
13233546|NCT01704495|26320100|FG003|Subjects Randomized|Other Reason|2|||
13233547|NCT01704495|26320097|FG000|Subjects Randomized|Discontinuation criteria met|4|||
13233548|NCT01704495|26320098|FG001|Subjects Randomized|Discontinuation criteria met|2|||
13233549|NCT01704495|26320099|FG002|Subjects Randomized|Discontinuation criteria met|2|||
13233550|NCT01704495|26320100|FG003|Subjects Randomized|Discontinuation criteria met|0|||
13233551|NCT01704495|26320097|FG000|Subjects Randomized|Adverse Event|8|||
13233552|NCT01704495|26320098|FG001|Subjects Randomized|Adverse Event|2|||
13233553|NCT01704495|26320099|FG002|Subjects Randomized|Adverse Event|0|||
13233554|NCT01704495|26320100|FG003|Subjects Randomized|Adverse Event|7|||
13233555|NCT01704495|26320097|FG000|Subjects Randomized|Withdrawal by Subject|5|||
13233556|NCT01704495|26320098|FG001|Subjects Randomized|Withdrawal by Subject|5|||
13233557|NCT01704495|26320099|FG002|Subjects Randomized|Withdrawal by Subject|5|||
13233558|NCT01704495|26320100|FG003|Subjects Randomized|Withdrawal by Subject|5|||
13233559|NCT01704495|26320097|FG000|Subjects Randomized|Protocol Violation|1|||
13233560|NCT01704495|26320098|FG001|Subjects Randomized|Protocol Violation|1|||
13233561|NCT01704495|26320099|FG002|Subjects Randomized|Protocol Violation|2|||
13233562|NCT01704495|26320100|FG003|Subjects Randomized|Protocol Violation|0|||
13233563|NCT01704495|26320097|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1|||
13233564|NCT01704495|26320098|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3|||
13233565|NCT01704495|26320099|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4|||
13233566|NCT01704495|26320100|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3|||
13233567|NCT01704495|26320097|FG000|Optional Safety Extension|Adverse Event|0|||
13233568|NCT01704495|26320098|FG001|Optional Safety Extension|Adverse Event|4|||
13233569|NCT01704495|26320099|FG002|Optional Safety Extension|Adverse Event|0|||
13233570|NCT01704495|26320100|FG003|Optional Safety Extension|Adverse Event|1|||
13233571|NCT01704495|26320097|FG000|Optional Safety Extension|Other reason|27|||
13233572|NCT01704495|26320098|FG001|Optional Safety Extension|Other reason|29|||
13233573|NCT01704495|26320099|FG002|Optional Safety Extension|Other reason|30|||
13233574|NCT01704495|26320100|FG003|Optional Safety Extension|Other reason|28|||
13233575|NCT01704495|26320097|FG000|Optional Safety Extension|Withdrawal by Subject|2|||
13233576|NCT01704495|26320098|FG001|Optional Safety Extension|Withdrawal by Subject|0|||
13233577|NCT01704495|26320099|FG002|Optional Safety Extension|Withdrawal by Subject|1|||
13233578|NCT01704495|26320100|FG003|Optional Safety Extension|Withdrawal by Subject|2|||
13233579|NCT01704456|26320127|FG000|Overall Study|Lost to Follow-up|8|||
13233580|NCT01704456|26320128|FG001|Overall Study|Lost to Follow-up|14|||
13233581|NCT01704287|26320186|FG000|Initial Treatment Period|Death|139|||
13233582|NCT01704287|26320187|FG001|Initial Treatment Period|Death|129|||
13233583|NCT01704287|26320188|FG002|Initial Treatment Period|Death|71|||
13233584|NCT01704287|26320189|FG003|Initial Treatment Period|Death|0|||
13233585|NCT01704287|26320190|FG004|Initial Treatment Period|Death|0|||
13233586|NCT01704287|26320186|FG000|Initial Treatment Period|Withdrawal by Subject|3|||
13233587|NCT01704287|26320187|FG001|Initial Treatment Period|Withdrawal by Subject|2|||
13233588|NCT01704287|26320188|FG002|Initial Treatment Period|Withdrawal by Subject|4|||
13233589|NCT01704287|26320189|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
13233590|NCT01704287|26320190|FG004|Initial Treatment Period|Withdrawal by Subject|0|||
13233591|NCT01704287|26320186|FG000|Initial Treatment Period|Lost to Follow-up|5|||
13233592|NCT01704287|26320187|FG001|Initial Treatment Period|Lost to Follow-up|3|||
13233593|NCT01704287|26320188|FG002|Initial Treatment Period|Lost to Follow-up|0|||
13233594|NCT01704287|26320189|FG003|Initial Treatment Period|Lost to Follow-up|0|||
13233595|NCT01704287|26320190|FG004|Initial Treatment Period|Lost to Follow-up|0|||
13233596|NCT01704287|26320186|FG000|Initial Treatment Period|Switched to Pembrolizumab|0|||
13233597|NCT01704287|26320187|FG001|Initial Treatment Period|Switched to Pembrolizumab|0|||
13233598|NCT01704287|26320188|FG002|Initial Treatment Period|Switched to Pembrolizumab|98|||
13233599|NCT01704287|26320189|FG003|Initial Treatment Period|Switched to Pembrolizumab|0|||
13233600|NCT01704287|26320190|FG004|Initial Treatment Period|Switched to Pembrolizumab|0|||
13233601|NCT01704287|26320186|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
13233602|NCT01704287|26320187|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
13233603|NCT01704287|26320188|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
13233604|NCT01704287|26320189|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2|||
13233605|NCT01704287|26320190|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1|||
13233606|NCT01704287|26320186|FG000|Switch to Pembrolizumab Treatment Period|Death|0|||
13233607|NCT01704287|26320187|FG001|Switch to Pembrolizumab Treatment Period|Death|0|||
13233608|NCT01704287|26320188|FG002|Switch to Pembrolizumab Treatment Period|Death|0|||
13233609|NCT01704287|26320189|FG003|Switch to Pembrolizumab Treatment Period|Death|35|||
13233610|NCT01704287|26320190|FG004|Switch to Pembrolizumab Treatment Period|Death|37|||
13233611|NCT01704287|26320186|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
13233612|NCT01704287|26320187|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
13233613|NCT01704287|26320188|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
13233614|NCT01704287|26320189|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1|||
13233615|NCT01704287|26320190|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
13233616|NCT01704261|26320211|FG000|Overall Study|Withdrawal by Subject|12|||
13233617|NCT01704261|26320212|FG001|Overall Study|Withdrawal by Subject|15|||
13233618|NCT01704261|26320211|FG000|Overall Study|Lost to Follow-up|1|||
13233619|NCT01704261|26320212|FG001|Overall Study|Lost to Follow-up|0|||
13233620|NCT01704079|26320231|FG000|Overall Study|Withdrawal by Subject|5|||
13233621|NCT01704079|26320232|FG001|Overall Study|Withdrawal by Subject|7|||
13233622|NCT01704079|26320231|FG000|Overall Study|Lost to Follow-up|2|||
13115404|NCT03098979|25917874|FG000|Overall Study|Adverse Event|1|||
13115405|NCT03098979|25917875|FG001|Overall Study|Adverse Event|0|||
13115406|NCT03098979|25917876|FG002|Overall Study|Adverse Event|1|||
13115407|NCT03098979|25917877|FG003|Overall Study|Adverse Event|4|||
13233623|NCT01704079|26320232|FG001|Overall Study|Lost to Follow-up|5|||
13233624|NCT01704079|26320231|FG000|Overall Study|Adverse Event|4|||
13233625|NCT01704079|26320232|FG001|Overall Study|Adverse Event|7|||
13233626|NCT01704079|26320231|FG000|Overall Study|Protocol Violation|1|||
13115408|NCT03098979|25917878|FG004|Overall Study|Adverse Event|6|||
13115409|NCT03098979|25917879|FG005|Overall Study|Adverse Event|1|||
13115410|NCT03098979|25917874|FG000|Overall Study|Withdrawal by Subject|2|||
13115411|NCT03098979|25917875|FG001|Overall Study|Withdrawal by Subject|1|||
13115412|NCT03098979|25917876|FG002|Overall Study|Withdrawal by Subject|1|||
13115413|NCT03098979|25917877|FG003|Overall Study|Withdrawal by Subject|1|||
13115414|NCT03098979|25917878|FG004|Overall Study|Withdrawal by Subject|2|||
13115415|NCT03098979|25917879|FG005|Overall Study|Withdrawal by Subject|1|||
13115416|NCT03098979|25917874|FG000|Overall Study|Death|1|||
13115417|NCT03098979|25917875|FG001|Overall Study|Death|0|||
13115418|NCT03098979|25917876|FG002|Overall Study|Death|2|||
13115419|NCT03098979|25917877|FG003|Overall Study|Death|0|||
13115420|NCT03098979|25917878|FG004|Overall Study|Death|1|||
13115421|NCT03098979|25917879|FG005|Overall Study|Death|0|||
13115422|NCT03098979|25917874|FG000|Overall Study|Physician Decision|2|||
13115423|NCT03098979|25917875|FG001|Overall Study|Physician Decision|1|||
13115424|NCT03098979|25917876|FG002|Overall Study|Physician Decision|0|||
13115425|NCT03098979|25917877|FG003|Overall Study|Physician Decision|0|||
13115426|NCT03098979|25917878|FG004|Overall Study|Physician Decision|0|||
13115427|NCT03098979|25917879|FG005|Overall Study|Physician Decision|0|||
13115428|NCT03098979|25917874|FG000|Overall Study|Non-compliance|0|||
13115429|NCT03098979|25917875|FG001|Overall Study|Non-compliance|0|||
13115430|NCT03098979|25917876|FG002|Overall Study|Non-compliance|0|||
13115431|NCT03098979|25917877|FG003|Overall Study|Non-compliance|0|||
13115432|NCT03098979|25917878|FG004|Overall Study|Non-compliance|0|||
13115433|NCT03098979|25917879|FG005|Overall Study|Non-compliance|1|||
13115434|NCT03098979|25917874|FG000|Overall Study|Protocol Violation|0|||
13115435|NCT03098979|25917875|FG001|Overall Study|Protocol Violation|0|||
13233627|NCT01704079|26320232|FG001|Overall Study|Protocol Violation|0|||
13233628|NCT01704079|26320231|FG000|Overall Study|Subject noncompliance|2|||
13233629|NCT01704079|26320232|FG001|Overall Study|Subject noncompliance|3|||
13233630|NCT01704079|26320231|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0|||
13233631|NCT01704079|26320232|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1|||
13233632|NCT01703988|26320272|FG000|Overall Study|Investigator Judgment|0|||
13233633|NCT01703988|26320273|FG001|Overall Study|Investigator Judgment|0|||
13233634|NCT01703988|26320274|FG002|Overall Study|Investigator Judgment|0|||
13233635|NCT01703988|26320275|FG003|Overall Study|Investigator Judgment|1|||
13233636|NCT01703858|26320308|FG000|Overall Study|Withdrawal by Subject|0|||
13233637|NCT01703858|26320309|FG001|Overall Study|Withdrawal by Subject|1|||
13233638|NCT01703858|26320310|FG002|Overall Study|Withdrawal by Subject|0|||
13233639|NCT01703845|26320352|FG000|Overall Study|Adverse Event|1|||
13233640|NCT01703845|26320353|FG001|Overall Study|Adverse Event|0|||
13233641|NCT01703845|26320352|FG000|Overall Study|Protocol Violation|1|||
13233642|NCT01703845|26320353|FG001|Overall Study|Protocol Violation|0|||
13233643|NCT01703845|26320352|FG000|Overall Study|other than stated above|1|||
13233644|NCT01703845|26320353|FG001|Overall Study|other than stated above|0|||
13233645|NCT01703832|26320390|FG000|Overall Study|Withdrawal by Subject|1|||
13233646|NCT01703832|26320391|FG001|Overall Study|Withdrawal by Subject|0|||
13233647|NCT01703819|26320428|FG000|Overall Study|Adverse Event|0|||
13233648|NCT01703819|26320429|FG001|Overall Study|Adverse Event|1|||
13233649|NCT01703819|26320428|FG000|Overall Study|Withdrawal by Subject|0|||
13233650|NCT01703819|26320429|FG001|Overall Study|Withdrawal by Subject|1|||
13233651|NCT01703741|26320447|FG000|Overall Study|Withdrawal by Subject|6|||
13233652|NCT01703741|26320447|FG000|Overall Study|Adverse Event|2|||
13233653|NCT01703741|26320447|FG000|Overall Study|Physician Decision|2|||
13233654|NCT01703741|26320447|FG000|Overall Study|Protocol Violation|1|||
13233655|NCT01703741|26320447|FG000|Overall Study|Lost to Follow-up|3|||
13233656|NCT01703741|26320447|FG000|Overall Study|Subject did not want to continue|2|||
13233657|NCT01703741|26320447|FG000|Overall Study|Subject cannot comply with study visits|1|||
13233658|NCT01703741|26320447|FG000|Overall Study|Subject started testosterone injections|1|||
13233659|NCT01703286|26320474|FG000|Period 1 Including Washout|Withdrawal by Subject|0|||
13233660|NCT01703286|26320475|FG001|Period 1 Including Washout|Withdrawal by Subject|0|||
13233661|NCT01703286|26320476|FG002|Period 1 Including Washout|Withdrawal by Subject|0|||
13233662|NCT01703286|26320477|FG003|Period 1 Including Washout|Withdrawal by Subject|1|||
13233663|NCT01703286|26320478|FG004|Period 1 Including Washout|Withdrawal by Subject|0|||
13233664|NCT01703286|26320479|FG005|Period 1 Including Washout|Withdrawal by Subject|1|||
13233665|NCT01703286|26320474|FG000|Period 2 Including Washout|Adverse Event|0|||
13233666|NCT01703286|26320475|FG001|Period 2 Including Washout|Adverse Event|0|||
13233667|NCT01703286|26320476|FG002|Period 2 Including Washout|Adverse Event|0|||
13233668|NCT01703286|26320477|FG003|Period 2 Including Washout|Adverse Event|1|||
13233669|NCT01703286|26320478|FG004|Period 2 Including Washout|Adverse Event|0|||
13233670|NCT01703286|26320479|FG005|Period 2 Including Washout|Adverse Event|0|||
13233671|NCT01703260|26320512|FG000|Overall Study|Adverse Event|1|||
13115436|NCT03098979|25917876|FG002|Overall Study|Protocol Violation|0|||
13115437|NCT03098979|25917877|FG003|Overall Study|Protocol Violation|0|||
13115438|NCT03098979|25917878|FG004|Overall Study|Protocol Violation|0|||
13115439|NCT03098979|25917879|FG005|Overall Study|Protocol Violation|1|||
13115440|NCT03098550|25917930|FG000|Overall Study|Disease Progression|30|||
13233672|NCT01703260|26320513|FG001|Overall Study|Adverse Event|2|||
13233673|NCT01703260|26320514|FG002|Overall Study|Adverse Event|2|||
13233674|NCT01703260|26320512|FG000|Overall Study|Lost to Follow-up|1|||
13233675|NCT01703260|26320513|FG001|Overall Study|Lost to Follow-up|0|||
13233676|NCT01703260|26320514|FG002|Overall Study|Lost to Follow-up|0|||
13233677|NCT01703260|26320512|FG000|Overall Study|Withdrawal by Subject|0|||
13233678|NCT01703260|26320513|FG001|Overall Study|Withdrawal by Subject|0|||
13233679|NCT01703260|26320514|FG002|Overall Study|Withdrawal by Subject|1|||
13233680|NCT01703260|26320512|FG000|Overall Study|Study Termination|1|||
13233681|NCT01703260|26320513|FG001|Overall Study|Study Termination|2|||
13233682|NCT01703260|26320514|FG002|Overall Study|Study Termination|0|||
13233683|NCT01703221|26320553|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2|||
13233684|NCT01703221|26320554|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4|||
13233685|NCT01703221|26320555|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0|||
13233686|NCT01703221|26320553|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2|||
13233687|NCT01703221|26320554|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0|||
13233688|NCT01703221|26320555|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1|||
13233689|NCT01703221|26320553|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1|||
13233690|NCT01703221|26320554|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
13233691|NCT01703221|26320555|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
13233692|NCT01703221|26320553|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2|||
13233693|NCT01703221|26320554|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
13233694|NCT01703221|26320555|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
13233695|NCT01703221|26320553|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
13233696|NCT01703221|26320554|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
13233697|NCT01703221|26320555|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
13233698|NCT01703221|26320553|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2|||
13233699|NCT01703221|26320554|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1|||
13233700|NCT01703221|26320555|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0|||
13233701|NCT01703221|26320553|FG000|Phase B - (Week 25 to 52)|Adverse Event|2|||
13233702|NCT01703221|26320554|FG001|Phase B - (Week 25 to 52)|Adverse Event|3|||
13233703|NCT01703221|26320555|FG002|Phase B - (Week 25 to 52)|Adverse Event|2|||
13233704|NCT01703221|26320553|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12|||
13233705|NCT01703221|26320554|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10|||
13233706|NCT01703221|26320555|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3|||
13233707|NCT01703208|26320616|FG000|Overall Study|Death|61|||
13233708|NCT01703208|26320617|FG001|Overall Study|Death|48|||
13233709|NCT01703208|26320616|FG000|Overall Study|Lack of Efficacy|1|||
13233710|NCT01703208|26320617|FG001|Overall Study|Lack of Efficacy|2|||
13233711|NCT01703208|26320616|FG000|Overall Study|Lost to Follow-up|68|||
13233712|NCT01703208|26320617|FG001|Overall Study|Lost to Follow-up|62|||
13233713|NCT01703208|26320616|FG000|Overall Study|Non-Compliance with Study Drug|1|||
13233714|NCT01703208|26320617|FG001|Overall Study|Non-Compliance with Study Drug|0|||
13233715|NCT01703208|26320616|FG000|Overall Study|Excluded Medication|1|||
13233716|NCT01703208|26320617|FG001|Overall Study|Excluded Medication|2|||
13233717|NCT01703208|26320616|FG000|Overall Study|Site Discontinued Study Participation|23|||
13233718|NCT01703208|26320617|FG001|Overall Study|Site Discontinued Study Participation|27|||
13233719|NCT01703208|26320616|FG000|Overall Study|Physician Decision|11|||
13233720|NCT01703208|26320617|FG001|Overall Study|Physician Decision|13|||
13233721|NCT01703208|26320616|FG000|Overall Study|Progressive disease|2|||
13233722|NCT01703208|26320617|FG001|Overall Study|Progressive disease|2|||
13233723|NCT01703208|26320616|FG000|Overall Study|Protocol Violation|1|||
13233724|NCT01703208|26320617|FG001|Overall Study|Protocol Violation|1|||
13233725|NCT01703208|26320616|FG000|Overall Study|Study Terminated by Sponsor|1710|||
13233726|NCT01703208|26320617|FG001|Overall Study|Study Terminated by Sponsor|1716|||
13233727|NCT01703208|26320616|FG000|Overall Study|Withdrawal by Subject|205|||
13233728|NCT01703208|26320617|FG001|Overall Study|Withdrawal by Subject|209|||
13233729|NCT01703208|26320616|FG000|Overall Study|Adverse Event|14|||
13233730|NCT01703208|26320617|FG001|Overall Study|Adverse Event|19|||
13233731|NCT01703208|26320616|FG000|Overall Study|Technical Problems|0|||
13233732|NCT01703208|26320617|FG001|Overall Study|Technical Problems|1|||
13233733|NCT01703208|26320616|FG000|Overall Study|Protocol Deviation|2|||
13233734|NCT01703208|26320617|FG001|Overall Study|Protocol Deviation|0|||
13233735|NCT01703117|26320640|FG000|Overall Study|Adverse Event|4|||
13233736|NCT01703117|26320641|FG001|Overall Study|Adverse Event|3|||
13233737|NCT01703117|26320640|FG000|Overall Study|Withdrawal by Subject|0|||
13233738|NCT01703117|26320641|FG001|Overall Study|Withdrawal by Subject|1|||
13233739|NCT01703091|26320664|FG000|Overall Study|Adverse Event|5|||
13233740|NCT01703091|26320665|FG001|Overall Study|Adverse Event|3|||
13233741|NCT01703091|26320664|FG000|Overall Study|Physician Decision|2|||
13233742|NCT01703091|26320665|FG001|Overall Study|Physician Decision|1|||
13233743|NCT01703091|26320664|FG000|Overall Study|Withdrawal by Subject|1|||
13233744|NCT01703091|26320665|FG001|Overall Study|Withdrawal by Subject|0|||
13233745|NCT01703091|26320664|FG000|Overall Study|Sponsor Decision|1|||
13233746|NCT01703091|26320665|FG001|Overall Study|Sponsor Decision|0|||
13233747|NCT01703065|26320685|FG000|Overall Study|Lack of Efficacy|1|||
13233748|NCT01703065|26320686|FG001|Overall Study|Lack of Efficacy|0|||
13233749|NCT01703000|26320719|FG000|Overall Study|Death|1|||
13233750|NCT01702987|26320732|FG000|Overall Study|Withdrawal by Subject|1|||
13233751|NCT01702987|26320733|FG001|Overall Study|Withdrawal by Subject|0|||
13233752|NCT01702961|26320741|FG000|Overall Study|Additional treatment|3|||
13233753|NCT01702961|26320741|FG000|Overall Study|Progressive disease|5|||
13233754|NCT01702961|26320741|FG000|Overall Study|Relapse|20|||
13233755|NCT01702961|26320741|FG000|Overall Study|Death|6|||
13233756|NCT01702961|26320741|FG000|Overall Study|Lost to Follow-up|2|||
13233757|NCT01702961|26320741|FG000|Overall Study|Ongoing|11|||
13233758|NCT01702844|26320750|FG000|Overall Study|Adverse Event|9|||
13233759|NCT01702844|26320750|FG000|Overall Study|Death|1|||
13233760|NCT01702844|26320750|FG000|Overall Study|Withdrawal by Subject|3|||
13233761|NCT01702844|26320750|FG000|Overall Study|Physician Decision|6|||
13233762|NCT01702805|26320821|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
13233763|NCT01702805|26320822|FG001|Overall Study|Data withdrawn prior to hospital discharge|7|||
13233764|NCT01702805|26320821|FG000|Overall Study|Incomplete Follow-up|18|||
13233765|NCT01702805|26320822|FG001|Overall Study|Incomplete Follow-up|15|||
13233766|NCT01702805|26320821|FG000|Overall Study|Vital Status Assessment Only|40|||
13233767|NCT01702805|26320822|FG001|Overall Study|Vital Status Assessment Only|39|||
13233768|NCT01702805|26320821|FG000|Overall Study|Lost to Follow-up|5|||
13233769|NCT01702805|26320822|FG001|Overall Study|Lost to Follow-up|5|||
13233770|NCT01702558|26320901|FG000|Overall Study|Withdrawal by Subject|0|||
13233771|NCT01702558|26320902|FG001|Overall Study|Withdrawal by Subject|0|||
13233772|NCT01702558|26320903|FG002|Overall Study|Withdrawal by Subject|0|||
13233773|NCT01702558|26320904|FG003|Overall Study|Withdrawal by Subject|12|||
13233774|NCT01702558|26320905|FG004|Overall Study|Withdrawal by Subject|4|||
13233775|NCT01702558|26320901|FG000|Overall Study|Lost to Follow-up|0|||
13233776|NCT01702558|26320902|FG001|Overall Study|Lost to Follow-up|0|||
13233777|NCT01702558|26320903|FG002|Overall Study|Lost to Follow-up|0|||
13233778|NCT01702558|26320904|FG003|Overall Study|Lost to Follow-up|3|||
13233779|NCT01702558|26320905|FG004|Overall Study|Lost to Follow-up|0|||
13233780|NCT01702558|26320901|FG000|Overall Study|Death|4|||
13233781|NCT01702558|26320902|FG001|Overall Study|Death|3|||
13233782|NCT01702558|26320903|FG002|Overall Study|Death|3|||
13233783|NCT01702558|26320904|FG003|Overall Study|Death|16|||
13233784|NCT01702558|26320905|FG004|Overall Study|Death|20|||
13233785|NCT01702558|26320901|FG000|Overall Study|Safety Follow-Up less than 3 Months|0|||
13233786|NCT01702558|26320902|FG001|Overall Study|Safety Follow-Up less than 3 Months|0|||
13233787|NCT01702558|26320903|FG002|Overall Study|Safety Follow-Up less than 3 Months|2|||
13233788|NCT01702558|26320904|FG003|Overall Study|Safety Follow-Up less than 3 Months|0|||
13233789|NCT01702558|26320905|FG004|Overall Study|Safety Follow-Up less than 3 Months|0|||
13233790|NCT01702558|26320901|FG000|Overall Study|Study Terminated by Sponsor|0|||
13233791|NCT01702558|26320902|FG001|Overall Study|Study Terminated by Sponsor|1|||
13233792|NCT01702558|26320903|FG002|Overall Study|Study Terminated by Sponsor|0|||
13233793|NCT01702558|26320904|FG003|Overall Study|Study Terminated by Sponsor|0|||
13233794|NCT01702558|26320905|FG004|Overall Study|Study Terminated by Sponsor|1|||
13233795|NCT01702558|26320901|FG000|Overall Study|Other|0|||
13233796|NCT01702558|26320902|FG001|Overall Study|Other|0|||
13233797|NCT01702558|26320903|FG002|Overall Study|Other|0|||
13233798|NCT01702558|26320904|FG003|Overall Study|Other|16|||
13233799|NCT01702558|26320905|FG004|Overall Study|Other|17|||
13233800|NCT01702532|26320920|FG000|Overall Study|Adverse Event|0|||
13233801|NCT01702532|26320921|FG001|Overall Study|Adverse Event|1|||
13233802|NCT01702519|26320944|FG000|Washout Period|Lost to Follow-up|1|||
13233803|NCT01702519|26320945|FG001|Washout Period|Lost to Follow-up|0|||
13233804|NCT01702519|26320944|FG000|Washout Period|Withdrawal by Subject|0|||
13233805|NCT01702519|26320945|FG001|Washout Period|Withdrawal by Subject|2|||
13233806|NCT01702454|26321030|FG000|Overall Study|Consent withdrawal|0|||
13233807|NCT01702454|26321031|FG001|Overall Study|Consent withdrawal|1|||
13233808|NCT01702454|26321030|FG000|Overall Study|Migrated/moved from study area|0|||
13233809|NCT01702454|26321031|FG001|Overall Study|Migrated/moved from study area|1|||
13233810|NCT01702454|26321030|FG000|Overall Study|Lost to Follow-up|3|||
13233811|NCT01702454|26321031|FG001|Overall Study|Lost to Follow-up|6|||
13233812|NCT01702428|26321131|FG000|Overall Study|Adverse Event|2|||
13233813|NCT01702428|26321132|FG001|Overall Study|Adverse Event|0|||
13233814|NCT01702428|26321133|FG002|Overall Study|Adverse Event|0|||
13233815|NCT01702428|26321134|FG003|Overall Study|Adverse Event|0|||
13233816|NCT01702428|26321131|FG000|Overall Study|Lost to Follow-up|33|||
13233817|NCT01702428|26321132|FG001|Overall Study|Lost to Follow-up|41|||
13233818|NCT01702428|26321133|FG002|Overall Study|Lost to Follow-up|37|||
13233819|NCT01702428|26321134|FG003|Overall Study|Lost to Follow-up|44|||
13233820|NCT01702428|26321131|FG000|Overall Study|Parents cannot assist to site|1|||
13233821|NCT01702428|26321132|FG001|Overall Study|Parents cannot assist to site|0|||
13233822|NCT01702428|26321133|FG002|Overall Study|Parents cannot assist to site|1|||
13233823|NCT01702428|26321134|FG003|Overall Study|Parents cannot assist to site|0|||
13233824|NCT01702428|26321131|FG000|Overall Study|Lost Coverage|0|||
13233825|NCT01702428|26321132|FG001|Overall Study|Lost Coverage|0|||
13233826|NCT01702428|26321133|FG002|Overall Study|Lost Coverage|0|||
13233827|NCT01702428|26321134|FG003|Overall Study|Lost Coverage|1|||
13233828|NCT01702428|26321131|FG000|Overall Study|Lost Health Plan|3|||
13233829|NCT01702428|26321132|FG001|Overall Study|Lost Health Plan|5|||
13233830|NCT01702428|26321133|FG002|Overall Study|Lost Health Plan|0|||
13233831|NCT01702428|26321134|FG003|Overall Study|Lost Health Plan|2|||
13233832|NCT01702428|26321131|FG000|Overall Study|Mother transferred care|0|||
13233833|NCT01702428|26321132|FG001|Overall Study|Mother transferred care|1|||
13233834|NCT01702428|26321133|FG002|Overall Study|Mother transferred care|0|||
13233835|NCT01702428|26321134|FG003|Overall Study|Mother transferred care|0|||
13233836|NCT01702428|26321131|FG000|Overall Study|Parents too busy|1|||
13233837|NCT01702428|26321132|FG001|Overall Study|Parents too busy|0|||
13233838|NCT01702428|26321133|FG002|Overall Study|Parents too busy|0|||
13233839|NCT01702428|26321134|FG003|Overall Study|Parents too busy|0|||
13233840|NCT01702428|26321131|FG000|Overall Study|Protocol Violation|3|||
13233841|NCT01702428|26321132|FG001|Overall Study|Protocol Violation|0|||
13233842|NCT01702428|26321133|FG002|Overall Study|Protocol Violation|1|||
13233843|NCT01702428|26321134|FG003|Overall Study|Protocol Violation|0|||
13233844|NCT01702428|26321131|FG000|Overall Study|Withdrawal by Subject|21|||
13233845|NCT01702428|26321132|FG001|Overall Study|Withdrawal by Subject|23|||
13233846|NCT01702428|26321133|FG002|Overall Study|Withdrawal by Subject|14|||
13233847|NCT01702428|26321134|FG003|Overall Study|Withdrawal by Subject|10|||
13233848|NCT01702363|26321151|FG000|Overall Study|Adverse Event|14|||
13233849|NCT01702363|26321151|FG000|Overall Study|Lack of Efficacy|4|||
13233850|NCT01702363|26321151|FG000|Overall Study|Withdrawal by Subject|2|||
13233851|NCT01702311|26321188|FG000|Overall Study|Withdrawal by Subject|3|||
13233852|NCT01702311|26321189|FG001|Overall Study|Withdrawal by Subject|2|||
13233853|NCT01702311|26321188|FG000|Overall Study|Discharge less than 24 hours|10|||
13233854|NCT01702311|26321189|FG001|Overall Study|Discharge less than 24 hours|7|||
13233855|NCT01702311|26321188|FG000|Overall Study|Physician Decision|3|||
13233856|NCT01702311|26321189|FG001|Overall Study|Physician Decision|4|||
13233857|NCT01702298|26321202|FG000|Overall Study|Withdrawal by Subject|1|||
13233858|NCT01702246|26321213|FG000|Overall Study|Lost to Follow-up|2|||
13233859|NCT01702246|26321213|FG000|Overall Study|Withdrawal by Subject|2|||
13233860|NCT01702246|26321213|FG000|Overall Study|Physician Decision|1|||
13233861|NCT01702025|26321240|FG000|Overall Study|Equipment failure|1|||
13233862|NCT01702025|26321241|FG001|Overall Study|Equipment failure|0|||
13233863|NCT01702025|26321242|FG002|Overall Study|Equipment failure|0|||
13233864|NCT01702025|26321243|FG003|Overall Study|Equipment failure|0|||
13233865|NCT01702025|26321240|FG000|Overall Study|Adverse Event|1|||
13233866|NCT01702025|26321241|FG001|Overall Study|Adverse Event|1|||
13233867|NCT01702025|26321242|FG002|Overall Study|Adverse Event|1|||
13233868|NCT01702025|26321243|FG003|Overall Study|Adverse Event|0|||
13233869|NCT01701973|26321299|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
13233870|NCT01701973|26321300|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1|||
13233871|NCT01701973|26321301|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
13233872|NCT01701973|26321302|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
13233873|NCT01701973|26321303|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
13233874|NCT01701973|26321304|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
13233875|NCT01701973|26321305|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
13233876|NCT01701973|26321306|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
13233877|NCT01701674|26321315|FG000|Overall Study|Unable to safely complete treatment|1|||
13233878|NCT01701401|26321374|FG000|Overall Study|Randomized But Not Treated|3|||
13233879|NCT01701401|26321375|FG001|Overall Study|Randomized But Not Treated|1|||
13233880|NCT01701401|26321376|FG002|Overall Study|Randomized But Not Treated|0|||
13233881|NCT01701401|26321377|FG003|Overall Study|Randomized But Not Treated|1|||
13233882|NCT01701401|26321374|FG000|Overall Study|Lost to Follow-up|5|||
13233883|NCT01701401|26321375|FG001|Overall Study|Lost to Follow-up|5|||
13233884|NCT01701401|26321376|FG002|Overall Study|Lost to Follow-up|1|||
13233885|NCT01701401|26321377|FG003|Overall Study|Lost to Follow-up|3|||
13233886|NCT01701401|26321374|FG000|Overall Study|Withdrew Consent|0|||
13233887|NCT01701401|26321375|FG001|Overall Study|Withdrew Consent|3|||
13233888|NCT01701401|26321376|FG002|Overall Study|Withdrew Consent|1|||
13233889|NCT01701401|26321377|FG003|Overall Study|Withdrew Consent|2|||
13233890|NCT01701401|26321374|FG000|Overall Study|Lack of Efficacy|1|||
13233891|NCT01701401|26321375|FG001|Overall Study|Lack of Efficacy|0|||
13233892|NCT01701401|26321376|FG002|Overall Study|Lack of Efficacy|2|||
13233893|NCT01701401|26321377|FG003|Overall Study|Lack of Efficacy|0|||
13233894|NCT01701401|26321374|FG000|Overall Study|Adverse Event|1|||
13233895|NCT01701401|26321375|FG001|Overall Study|Adverse Event|0|||
13233896|NCT01701401|26321376|FG002|Overall Study|Adverse Event|0|||
13233897|NCT01701401|26321377|FG003|Overall Study|Adverse Event|0|||
13233898|NCT01701401|26321374|FG000|Overall Study|Protocol Violation|0|||
13233899|NCT01701401|26321375|FG001|Overall Study|Protocol Violation|0|||
13233900|NCT01701401|26321376|FG002|Overall Study|Protocol Violation|1|||
13233901|NCT01701401|26321377|FG003|Overall Study|Protocol Violation|0|||
13233902|NCT01701362|26321412|FG000|Overall Study|Adverse events not related to study drug|1|||
13233903|NCT01701362|26321413|FG001|Overall Study|Adverse events not related to study drug|6|||
13233904|NCT01701362|26321412|FG000|Overall Study|Adverse events related to study drug|12|||
13233905|NCT01701362|26321413|FG001|Overall Study|Adverse events related to study drug|10|||
13233906|NCT01701362|26321412|FG000|Overall Study|Protocol Violation|5|||
13233907|NCT01701362|26321413|FG001|Overall Study|Protocol Violation|3|||
13233908|NCT01701362|26321412|FG000|Overall Study|No longer willing to participate|8|||
13233909|NCT01701362|26321413|FG001|Overall Study|No longer willing to participate|14|||
13233910|NCT01701362|26321412|FG000|Overall Study|Lost to Follow-up|6|||
13233911|NCT01701362|26321413|FG001|Overall Study|Lost to Follow-up|9|||
13233912|NCT01701362|26321412|FG000|Overall Study|Insufficient clinical response|6|||
13233913|NCT01701362|26321413|FG001|Overall Study|Insufficient clinical response|6|||
13233914|NCT01701362|26321412|FG000|Overall Study|Death|0|||
13233915|NCT01701362|26321413|FG001|Overall Study|Death|1|||
13233916|NCT01701362|26321412|FG000|Overall Study|Randomized but not treated|1|||
13233917|NCT01701362|26321413|FG001|Overall Study|Randomized but not treated|2|||
13233918|NCT01701362|26321412|FG000|Overall Study|Reasons other than those mentioned above|3|||
13233919|NCT01701362|26321413|FG001|Overall Study|Reasons other than those mentioned above|5|||
13233920|NCT01701258|26321487|FG000|Assessment and Scheduling|Found to be Ineligible|57|||
13233921|NCT01701258|26321488|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
13233922|NCT01701258|26321489|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
13233923|NCT01701258|26321490|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
13233924|NCT01701258|26321491|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
13233925|NCT01701258|26321492|FG005|Assessment and Scheduling|Found to be Ineligible|0|||
13233926|NCT01701258|26321493|FG006|Assessment and Scheduling|Found to be Ineligible|0|||
13233927|NCT01701258|26321494|FG007|Assessment and Scheduling|Found to be Ineligible|0|||
13233928|NCT01701258|26321495|FG008|Assessment and Scheduling|Found to be Ineligible|0|||
13233929|NCT01701258|26321496|FG009|Assessment and Scheduling|Found to be Ineligible|0|||
13233930|NCT01701258|26321497|FG010|Assessment and Scheduling|Found to be Ineligible|0|||
13233931|NCT01701258|26321498|FG011|Assessment and Scheduling|Found to be Ineligible|0|||
13233932|NCT01701258|26321499|FG012|Assessment and Scheduling|Found to be Ineligible|0|||
13233933|NCT01701258|26321487|FG000|Assessment and Scheduling|Lost to Follow-up|10|||
13233934|NCT01701258|26321488|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
13233935|NCT01701258|26321489|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
13233936|NCT01701258|26321490|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
13233937|NCT01701258|26321491|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
13233938|NCT01701258|26321492|FG005|Assessment and Scheduling|Lost to Follow-up|0|||
13233939|NCT01701258|26321493|FG006|Assessment and Scheduling|Lost to Follow-up|0|||
13233940|NCT01701258|26321494|FG007|Assessment and Scheduling|Lost to Follow-up|0|||
13233941|NCT01701258|26321495|FG008|Assessment and Scheduling|Lost to Follow-up|0|||
13233942|NCT01701258|26321496|FG009|Assessment and Scheduling|Lost to Follow-up|0|||
13233943|NCT01701258|26321497|FG010|Assessment and Scheduling|Lost to Follow-up|0|||
13233944|NCT01701258|26321498|FG011|Assessment and Scheduling|Lost to Follow-up|0|||
13233945|NCT01701258|26321499|FG012|Assessment and Scheduling|Lost to Follow-up|0|||
13233946|NCT01701258|26321487|FG000|Assessment and Scheduling|Withdrawal by Subject|14|||
13233947|NCT01701258|26321488|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
13233948|NCT01701258|26321489|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
13233949|NCT01701258|26321490|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
13233950|NCT01701258|26321491|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
13233951|NCT01701258|26321492|FG005|Assessment and Scheduling|Withdrawal by Subject|0|||
13233952|NCT01701258|26321493|FG006|Assessment and Scheduling|Withdrawal by Subject|0|||
13233953|NCT01701258|26321494|FG007|Assessment and Scheduling|Withdrawal by Subject|0|||
13233954|NCT01701258|26321495|FG008|Assessment and Scheduling|Withdrawal by Subject|0|||
13233955|NCT01701258|26321496|FG009|Assessment and Scheduling|Withdrawal by Subject|0|||
13233956|NCT01701258|26321497|FG010|Assessment and Scheduling|Withdrawal by Subject|0|||
13233957|NCT01701258|26321498|FG011|Assessment and Scheduling|Withdrawal by Subject|0|||
13233958|NCT01701258|26321499|FG012|Assessment and Scheduling|Withdrawal by Subject|0|||
13233959|NCT01701258|26321487|FG000|Assessment and Scheduling|Investigator Terminated|2|||
13233960|NCT01701258|26321488|FG001|Assessment and Scheduling|Investigator Terminated|0|||
13233961|NCT01701258|26321489|FG002|Assessment and Scheduling|Investigator Terminated|0|||
13233962|NCT01701258|26321490|FG003|Assessment and Scheduling|Investigator Terminated|0|||
13233963|NCT01701258|26321491|FG004|Assessment and Scheduling|Investigator Terminated|0|||
13233964|NCT01701258|26321492|FG005|Assessment and Scheduling|Investigator Terminated|0|||
13233965|NCT01701258|26321493|FG006|Assessment and Scheduling|Investigator Terminated|0|||
13233966|NCT01701258|26321494|FG007|Assessment and Scheduling|Investigator Terminated|0|||
13233967|NCT01701258|26321495|FG008|Assessment and Scheduling|Investigator Terminated|0|||
13233968|NCT01701258|26321496|FG009|Assessment and Scheduling|Investigator Terminated|0|||
13233969|NCT01701258|26321497|FG010|Assessment and Scheduling|Investigator Terminated|0|||
13233970|NCT01701258|26321498|FG011|Assessment and Scheduling|Investigator Terminated|0|||
13233971|NCT01701258|26321499|FG012|Assessment and Scheduling|Investigator Terminated|0|||
13233972|NCT01701245|26321518|FG000|Overall Study|Protocol Violation|1|||
13233973|NCT01701245|26321519|FG001|Overall Study|Protocol Violation|3|||
13233974|NCT01701245|26321518|FG000|Overall Study|Did not complete the open label period|11|||
13233975|NCT01701245|26321519|FG001|Overall Study|Did not complete the open label period|12|||
13485807|NCT00585195|27033425|FG015|Overall Study|Lost to Follow-up|0|||
13233976|NCT01701193|26321546|FG000|Overall Study|Withdrawal by Subject|2|||
13233977|NCT01701193|26321547|FG001|Overall Study|Withdrawal by Subject|2|||
13233978|NCT01701193|26321548|FG002|Overall Study|Withdrawal by Subject|1|||
13233979|NCT01701193|26321549|FG003|Overall Study|Withdrawal by Subject|2|||
13233980|NCT01701193|26321546|FG000|Overall Study|Adverse Event|1|||
13233981|NCT01701193|26321547|FG001|Overall Study|Adverse Event|0|||
13233982|NCT01701193|26321548|FG002|Overall Study|Adverse Event|0|||
13233983|NCT01701193|26321549|FG003|Overall Study|Adverse Event|0|||
13233984|NCT01701063|26321601|FG000|Overall Study|Lost to Follow-up|0|||
13233985|NCT01701063|26321602|FG001|Overall Study|Lost to Follow-up|1|||
13233986|NCT01701063|26321603|FG002|Overall Study|Lost to Follow-up|0|||
13233987|NCT01701063|26321601|FG000|Overall Study|Withdrawal by Subject|0|||
13233988|NCT01701063|26321602|FG001|Overall Study|Withdrawal by Subject|0|||
13233989|NCT01701063|26321603|FG002|Overall Study|Withdrawal by Subject|1|||
13233990|NCT01701063|26321601|FG000|Overall Study|Other|0|||
13233991|NCT01701063|26321602|FG001|Overall Study|Other|0|||
13233992|NCT01701063|26321603|FG002|Overall Study|Other|1|||
13233993|NCT01700985|26321626|FG000|Overall Study|Incarcerated|0|||
13233994|NCT01700985|26321627|FG001|Overall Study|Incarcerated|1|||
13233995|NCT01700959|26321668|FG000|Overall Study|Adverse Event|0|||
13233996|NCT01700959|26321669|FG001|Overall Study|Adverse Event|1|||
13233997|NCT01700959|26321670|FG002|Overall Study|Adverse Event|1|||
13233998|NCT01700959|26321671|FG003|Overall Study|Adverse Event|2|||
13233999|NCT01700959|26321672|FG004|Overall Study|Adverse Event|0|||
13234000|NCT01700959|26321673|FG005|Overall Study|Adverse Event|2|||
13234001|NCT01700959|26321668|FG000|Overall Study|Withdrawal by Subject|15|||
13234002|NCT01700959|26321669|FG001|Overall Study|Withdrawal by Subject|9|||
13234003|NCT01700959|26321670|FG002|Overall Study|Withdrawal by Subject|12|||
13234004|NCT01700959|26321671|FG003|Overall Study|Withdrawal by Subject|11|||
13234005|NCT01700959|26321672|FG004|Overall Study|Withdrawal by Subject|8|||
13234006|NCT01700959|26321673|FG005|Overall Study|Withdrawal by Subject|12|||
13234007|NCT01700959|26321668|FG000|Overall Study|Ineligible|2|||
13234008|NCT01700959|26321669|FG001|Overall Study|Ineligible|1|||
13234009|NCT01700959|26321670|FG002|Overall Study|Ineligible|2|||
13234010|NCT01700959|26321671|FG003|Overall Study|Ineligible|0|||
13234011|NCT01700959|26321672|FG004|Overall Study|Ineligible|0|||
13234012|NCT01700959|26321673|FG005|Overall Study|Ineligible|1|||
13234013|NCT01700959|26321668|FG000|Overall Study|Noncompliant|9|||
13234014|NCT01700959|26321669|FG001|Overall Study|Noncompliant|9|||
13234015|NCT01700959|26321670|FG002|Overall Study|Noncompliant|17|||
13234016|NCT01700959|26321671|FG003|Overall Study|Noncompliant|18|||
13115441|NCT03098550|25917931|FG001|Overall Study|Disease Progression|19|||
13115442|NCT03098550|25917932|FG002|Overall Study|Disease Progression|41|||
13115443|NCT03098550|25917930|FG000|Overall Study|Study Drug Toxicity|2|||
13115444|NCT03098550|25917931|FG001|Overall Study|Study Drug Toxicity|1|||
13115445|NCT03098550|25917932|FG002|Overall Study|Study Drug Toxicity|0|||
13115446|NCT03098550|25917930|FG000|Overall Study|Death|1|||
13115447|NCT03098550|25917931|FG001|Overall Study|Death|0|||
13115448|NCT03098550|25917932|FG002|Overall Study|Death|0|||
13115449|NCT03098550|25917930|FG000|Overall Study|Adverse Event unrelated to Study Drug|6|||
13115450|NCT03098550|25917931|FG001|Overall Study|Adverse Event unrelated to Study Drug|0|||
13115451|NCT03098550|25917932|FG002|Overall Study|Adverse Event unrelated to Study Drug|1|||
13115452|NCT03098550|25917930|FG000|Overall Study|Administrative reason by sponsor|0|||
13115453|NCT03098550|25917931|FG001|Overall Study|Administrative reason by sponsor|0|||
13115454|NCT03098550|25917932|FG002|Overall Study|Administrative reason by sponsor|1|||
13115455|NCT03098550|25917930|FG000|Overall Study|Other reasons|2|||
13115456|NCT03098550|25917931|FG001|Overall Study|Other reasons|0|||
13115457|NCT03098550|25917932|FG002|Overall Study|Other reasons|0|||
13115458|NCT03098433|25917939|FG000|Overall Study|Withdrawal by Subject|10|||
13115459|NCT03098030|25917970|FG000|Overall Study|Death|10|||
13115460|NCT03098030|25917971|FG001|Overall Study|Death|156|||
13115461|NCT03098030|25917972|FG002|Overall Study|Death|156|||
13115462|NCT03098030|25917973|FG003|Overall Study|Death|82|||
13115463|NCT03098030|25917970|FG000|Overall Study|Withdrawal by Subject|0|||
13115464|NCT03098030|25917971|FG001|Overall Study|Withdrawal by Subject|7|||
13115465|NCT03098030|25917972|FG002|Overall Study|Withdrawal by Subject|8|||
13115466|NCT03098030|25917973|FG003|Overall Study|Withdrawal by Subject|2|||
13115467|NCT03098030|25917970|FG000|Overall Study|Lost to Follow-up|0|||
13115468|NCT03098030|25917971|FG001|Overall Study|Lost to Follow-up|0|||
13115469|NCT03098030|25917972|FG002|Overall Study|Lost to Follow-up|2|||
13115470|NCT03098030|25917973|FG003|Overall Study|Lost to Follow-up|1|||
13115471|NCT03097861|25918000|FG000|Overall Study|Adverse Event|3|||
13115472|NCT03097861|25918001|FG001|Overall Study|Adverse Event|8|||
13115473|NCT03097861|25918002|FG002|Overall Study|Adverse Event|4|||
13234017|NCT01700959|26321672|FG004|Overall Study|Noncompliant|15|||
13234018|NCT01700959|26321673|FG005|Overall Study|Noncompliant|9|||
13234019|NCT01700959|26321668|FG000|Overall Study|Side effects|1|||
13234020|NCT01700959|26321669|FG001|Overall Study|Side effects|4|||
13234021|NCT01700959|26321670|FG002|Overall Study|Side effects|8|||
13234022|NCT01700959|26321671|FG003|Overall Study|Side effects|4|||
13115474|NCT03097861|25918000|FG000|Overall Study|Investigator Decision|0|||
13115475|NCT03097861|25918001|FG001|Overall Study|Investigator Decision|1|||
13115476|NCT03097861|25918002|FG002|Overall Study|Investigator Decision|0|||
13115477|NCT03097861|25918000|FG000|Overall Study|Lost to Follow-up|0|||
13115478|NCT03097861|25918001|FG001|Overall Study|Lost to Follow-up|7|||
13115479|NCT03097861|25918002|FG002|Overall Study|Lost to Follow-up|1|||
13115480|NCT03097861|25918000|FG000|Overall Study|Withdrawal by Subject|1|||
13115481|NCT03097861|25918001|FG001|Overall Study|Withdrawal by Subject|5|||
13234023|NCT01700959|26321672|FG004|Overall Study|Side effects|4|||
13234024|NCT01700959|26321673|FG005|Overall Study|Side effects|1|||
13234025|NCT01700946|26321701|FG000|Overall Study|Lost to Follow-up|1|||
13234026|NCT01700946|26321702|FG001|Overall Study|Lost to Follow-up|0|||
13234027|NCT01700946|26321701|FG000|Overall Study|Physician Decision|7|||
13234028|NCT01700946|26321702|FG001|Overall Study|Physician Decision|12|||
13234029|NCT01700946|26321701|FG000|Overall Study|Withdrawal by Subject|0|||
13234030|NCT01700946|26321702|FG001|Overall Study|Withdrawal by Subject|2|||
13234031|NCT01700946|26321701|FG000|Overall Study|Failed to achieve Complete Remission after Induction Block III|0|||
13234032|NCT01700946|26321702|FG001|Overall Study|Failed to achieve Complete Remission after Induction Block III|2|||
13234033|NCT01700946|26321701|FG000|Overall Study|Relapse|2|||
13234034|NCT01700946|26321702|FG001|Overall Study|Relapse|1|||
13234035|NCT01700946|26321701|FG000|Overall Study|Unacceptable toxicity|1|||
13234036|NCT01700946|26321702|FG001|Overall Study|Unacceptable toxicity|0|||
13234037|NCT01700829|26321719|FG000|Overall Study|Withdrawal by Subject|1|||
13234038|NCT01700829|26321720|FG001|Overall Study|Withdrawal by Subject|1|||
13234039|NCT01700621|26321762|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7|||
13234040|NCT01700621|26321763|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4|||
13234041|NCT01700621|26321762|FG000|Analyzed for Immunogenicity|Protocol Violation|5|||
13234042|NCT01700621|26321763|FG001|Analyzed for Immunogenicity|Protocol Violation|1|||
13234043|NCT01700621|26321762|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1|||
13234044|NCT01700621|26321763|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2|||
13234045|NCT01700530|26321784|FG000|Overall Study|Withdrawal by Subject|0|||
13234046|NCT01700530|26321785|FG001|Overall Study|Withdrawal by Subject|3|||
13234047|NCT01700530|26321786|FG002|Overall Study|Withdrawal by Subject|1|||
13234048|NCT01700387|26321823|FG000|Overall Study|Withdrawal by Subject|1|||
13234049|NCT01700387|26321824|FG001|Overall Study|Withdrawal by Subject|2|||
13234050|NCT01700387|26321823|FG000|Overall Study|Adverse Event|1|||
13234051|NCT01700387|26321824|FG001|Overall Study|Adverse Event|1|||
13234052|NCT01700387|26321823|FG000|Overall Study|Lost to Follow-up|2|||
13234053|NCT01700387|26321824|FG001|Overall Study|Lost to Follow-up|1|||
13234054|NCT01700348|26321835|FG000|Overall Study|Withdrawal by Subject|22|||
13234055|NCT01700348|26321835|FG000|Overall Study|Lost to Follow-up|1|||
13234056|NCT01700205|26321862|FG000|Overall Study|Withdrawal by Subject|13|||
13234057|NCT01700205|26321863|FG001|Overall Study|Withdrawal by Subject|13|||
13234058|NCT01700205|26321862|FG000|Overall Study|Protocol Violation|2|||
13234059|NCT01700205|26321863|FG001|Overall Study|Protocol Violation|2|||
13234060|NCT01700192|26321888|FG000|Overall Study|Adverse Event|73|||
13234061|NCT01700192|26321889|FG001|Overall Study|Adverse Event|18|||
13234062|NCT01700192|26321888|FG000|Overall Study|Lack of Efficacy|1|||
13234063|NCT01700192|26321889|FG001|Overall Study|Lack of Efficacy|0|||
13234064|NCT01700192|26321888|FG000|Overall Study|Lost to Follow-up|42|||
13234065|NCT01700192|26321889|FG001|Overall Study|Lost to Follow-up|29|||
13234066|NCT01700192|26321888|FG000|Overall Study|Noncompliance with study drug|0|||
13234067|NCT01700192|26321889|FG001|Overall Study|Noncompliance with study drug|5|||
13234068|NCT01700192|26321888|FG000|Overall Study|Physician Decision|2|||
13234069|NCT01700192|26321889|FG001|Overall Study|Physician Decision|3|||
13234070|NCT01700192|26321888|FG000|Overall Study|Pregnancy|1|||
13234071|NCT01700192|26321889|FG001|Overall Study|Pregnancy|4|||
13234072|NCT01700192|26321888|FG000|Overall Study|Progressive disease|1|||
13234073|NCT01700192|26321889|FG001|Overall Study|Progressive disease|0|||
13234074|NCT01700192|26321888|FG000|Overall Study|Protocol Violation|3|||
13234075|NCT01700192|26321889|FG001|Overall Study|Protocol Violation|4|||
13234076|NCT01700192|26321888|FG000|Overall Study|Technical problems|0|||
13234077|NCT01700192|26321889|FG001|Overall Study|Technical problems|1|||
13234078|NCT01700192|26321888|FG000|Overall Study|Withdrawal by Subject|56|||
13234079|NCT01700192|26321889|FG001|Overall Study|Withdrawal by Subject|64|||
13234080|NCT01700192|26321888|FG000|Overall Study|Never received study drug|1|||
13234081|NCT01700192|26321889|FG001|Overall Study|Never received study drug|0|||
13289724|NCT00107120|26479890|FG001|Overall Study|Lack of Efficacy|5|||
13289725|NCT00107120|26479889|FG000|Overall Study|Protocol Violation|3|||
13289726|NCT00107120|26479890|FG001|Overall Study|Protocol Violation|0|||
13289727|NCT00107120|26479889|FG000|Overall Study|Withdrawal by Subject|8|||
13289728|NCT00107120|26479890|FG001|Overall Study|Withdrawal by Subject|9|||
13289729|NCT00107120|26479889|FG000|Overall Study|Lost to Follow-up|8|||
13289730|NCT00107120|26479890|FG001|Overall Study|Lost to Follow-up|6|||
13289731|NCT00107120|26479889|FG000|Overall Study|Pregnancy|0|||
13289732|NCT00107120|26479890|FG001|Overall Study|Pregnancy|1|||
13289733|NCT00107120|26479889|FG000|Overall Study|moving away from site|1|||
13234082|NCT01700179|26321895|FG000|Overall Study|Physician Decision|2|||
13234083|NCT01700140|26321937|FG000|Overall Study|Use of rescue drugs|3|||
13234084|NCT01700140|26321938|FG001|Overall Study|Use of rescue drugs|3|||
13234085|NCT01700140|26321939|FG002|Overall Study|Use of rescue drugs|1|||
13234086|NCT01700140|26321937|FG000|Overall Study|Discontinuation of radiotherapy|1|||
13234087|NCT01700140|26321938|FG001|Overall Study|Discontinuation of radiotherapy|0|||
13234088|NCT01700140|26321939|FG002|Overall Study|Discontinuation of radiotherapy|0|||
13234089|NCT01700140|26321937|FG000|Overall Study|Use of chemotherapy or surgical therapy|0|||
13234090|NCT01700140|26321938|FG001|Overall Study|Use of chemotherapy or surgical therapy|1|||
13234091|NCT01700140|26321939|FG002|Overall Study|Use of chemotherapy or surgical therapy|0|||
13234092|NCT01700140|26321937|FG000|Overall Study|Aggravation of symptoms|1|||
13234093|NCT01700140|26321938|FG001|Overall Study|Aggravation of symptoms|0|||
13234094|NCT01700140|26321939|FG002|Overall Study|Aggravation of symptoms|0|||
13234095|NCT01700140|26321937|FG000|Overall Study|Adverse Event|0|||
13234096|NCT01700140|26321938|FG001|Overall Study|Adverse Event|1|||
13234097|NCT01700140|26321939|FG002|Overall Study|Adverse Event|0|||
13234098|NCT01700140|26321937|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
13234099|NCT01700140|26321938|FG001|Overall Study|Inclusion/exclusion criteria deviation|4|||
13234100|NCT01700140|26321939|FG002|Overall Study|Inclusion/exclusion criteria deviation|0|||
13234101|NCT01700049|26321947|FG000|Overall Study|Withdrawal by Subject|1|||
13234102|NCT01699867|26321954|FG000|Overall Study|Screening Failure|3|||
13234103|NCT01699815|26321971|FG000|Overall Study|Protocol Violation|4|||
13234104|NCT01699815|26321972|FG001|Overall Study|Protocol Violation|7|||
13234105|NCT01699815|26321971|FG000|Overall Study|record could not be located|1|||
13234106|NCT01699815|26321972|FG001|Overall Study|record could not be located|0|||
13234107|NCT01699815|26321971|FG000|Overall Study|Adverse Event|0|||
13234108|NCT01699815|26321972|FG001|Overall Study|Adverse Event|1|||
13234109|NCT01699789|26322087|FG000|Overall Study|Withdrawal by Subject|18|||
13234110|NCT01699789|26322088|FG001|Overall Study|Withdrawal by Subject|23|||
13234111|NCT01699789|26322087|FG000|Overall Study|Death|1|||
13234112|NCT01699789|26322088|FG001|Overall Study|Death|2|||
13234113|NCT01699789|26322087|FG000|Overall Study|Lost to Follow-up|83|||
13234114|NCT01699789|26322088|FG001|Overall Study|Lost to Follow-up|101|||
13234115|NCT01699750|26322117|FG000|Overall Study|Withdrew Consent|0|||
13234116|NCT01699750|26322118|FG001|Overall Study|Withdrew Consent|1|||
13234117|NCT01699750|26322117|FG000|Overall Study|Other|0|||
13234118|NCT01699750|26322118|FG001|Overall Study|Other|2|||
13234119|NCT01699685|26322141|FG000|Period 1|Adverse Event|1|||
13234120|NCT01699685|26322142|FG001|Period 1|Adverse Event|1|||
13234121|NCT01699685|26322141|FG000|Period 1|Medical or ethical, noncompliance|2|||
13234122|NCT01699685|26322142|FG001|Period 1|Medical or ethical, noncompliance|0|||
13234123|NCT01699685|26322141|FG000|Period 1|Other|0|||
13234124|NCT01699685|26322142|FG001|Period 1|Other|1|||
13234125|NCT01699685|26322141|FG000|Period 1|Patient request|0|||
13234126|NCT01699685|26322142|FG001|Period 1|Patient request|1|||
13234127|NCT01699685|26322141|FG000|Period 2|Lost to Follow-up|1|||
13234128|NCT01699685|26322142|FG001|Period 2|Lost to Follow-up|0|||
13234129|NCT01699503|26322163|FG000|Overall Study|Death|31|||
13234130|NCT01699503|26322164|FG001|Overall Study|Death|40|||
13234131|NCT01699503|26322163|FG000|Overall Study|Withdrawal by Subject|65|||
13234132|NCT01699503|26322164|FG001|Overall Study|Withdrawal by Subject|57|||
13234133|NCT01699503|26322163|FG000|Overall Study|Lost to Follow-up|121|||
13234134|NCT01699503|26322164|FG001|Overall Study|Lost to Follow-up|117|||
13234135|NCT01699503|26322163|FG000|Overall Study|Excluded due to quality|783|||
13234136|NCT01699503|26322164|FG001|Overall Study|Excluded due to quality|791|||
13234137|NCT01699178|26322187|FG000|Overall Study|Adverse Event|1|||
13234138|NCT01699178|26322188|FG001|Overall Study|Adverse Event|5|||
13234139|NCT01699178|26322187|FG000|Overall Study|Lost to Follow-up|1|||
13234140|NCT01699178|26322188|FG001|Overall Study|Lost to Follow-up|6|||
13234141|NCT01699178|26322187|FG000|Overall Study|Non-compliance with Study Drug|3|||
13234142|NCT01699178|26322188|FG001|Overall Study|Non-compliance with Study Drug|1|||
13234143|NCT01699178|26322187|FG000|Overall Study|Physician Decision|1|||
13234144|NCT01699178|26322188|FG001|Overall Study|Physician Decision|0|||
13234145|NCT01699178|26322187|FG000|Overall Study|Withdrawal by Subject|4|||
13234146|NCT01699178|26322188|FG001|Overall Study|Withdrawal by Subject|12|||
13234147|NCT01699178|26322187|FG000|Overall Study|Hematocrit >54%|1|||
13234148|NCT01699178|26322188|FG001|Overall Study|Hematocrit >54%|1|||
13234149|NCT01699178|26322187|FG000|Overall Study|PSA increase of >1.4 ng/mL|4|||
13234150|NCT01699178|26322188|FG001|Overall Study|PSA increase of >1.4 ng/mL|3|||
13234151|NCT01699178|26322187|FG000|Overall Study|ineligible/noncompliant/ subject reason|4|||
13234152|NCT01699178|26322188|FG001|Overall Study|ineligible/noncompliant/ subject reason|4|||
13234153|NCT01699087|26322204|FG000|Overall Study|Lost to Follow-up|7|||
13234154|NCT01699087|26322204|FG000|Overall Study|Screen failure (prior to treatment)|15|||
13234155|NCT01699087|26322204|FG000|Overall Study|Unable to make future visits|2|||
13234156|NCT01699022|26322219|FG000|Overall Study|Early discontinuation from the study|3|||
13234157|NCT01698918|26322249|FG000|First Line Treatment (Core+Extension)|Adverse Event|33|||
13234158|NCT01698918|26322249|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11|||
13234159|NCT01698918|26322249|FG000|First Line Treatment (Core+Extension)|Death|2|||
13234160|NCT01698918|26322249|FG000|First Line Treatment (Core+Extension)|Disease progression|120|||
13234161|NCT01698918|26322249|FG000|First Line Treatment (Core+Extension)|Physician Decision|7|||
13234162|NCT01698918|26322249|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3|||
13234163|NCT01698918|26322249|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1|||
13234164|NCT01698918|26322249|FG000|Second Line Treatment (Core+Extension)|Death|1|||
13234165|NCT01698918|26322249|FG000|Second Line Treatment (Core+Extension)|Disease progression|38|||
13234166|NCT01698918|26322249|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3|||
13234167|NCT01698879|26322280|FG000|Overall Study|Withdrawal by Subject|1|||
13234168|NCT01698879|26322281|FG001|Overall Study|Withdrawal by Subject|0|||
13234169|NCT01698879|26322282|FG002|Overall Study|Withdrawal by Subject|0|||
13234170|NCT01698814|26322295|FG000|Overall Study|Adverse Event|0|||
13234171|NCT01698814|26322296|FG001|Overall Study|Adverse Event|2|||
13234172|NCT01698814|26322295|FG000|Overall Study|Lost to Follow-up|0|||
13234173|NCT01698814|26322296|FG001|Overall Study|Lost to Follow-up|1|||
13234174|NCT01698814|26322295|FG000|Overall Study|Pregnancy|1|||
13234175|NCT01698814|26322296|FG001|Overall Study|Pregnancy|0|||
13234176|NCT01698814|26322295|FG000|Overall Study|Randomized in error|1|||
13234177|NCT01698814|26322296|FG001|Overall Study|Randomized in error|0|||
13234178|NCT01698801|26322307|FG000|Treatment Phase|Adverse Event|4|||
13234179|NCT01698801|26322307|FG000|Treatment Phase|Protocol Violation|1|||
13234180|NCT01698801|26322307|FG000|Treatment Phase|Other|4|||
13234181|NCT01698801|26322307|FG000|Treatment Phase|Withdrawal by Subject|1|||
13234182|NCT01698801|26322307|FG000|Treatment Phase|Disease progression|1|||
13234183|NCT01698801|26322307|FG000|Follow Up Phase|Withdrawal by Subject|1|||
13234184|NCT01698801|26322307|FG000|Follow Up Phase|Death|4|||
13234185|NCT01698775|26322340|FG000|Phase A|Adverse Event|2|||
13234186|NCT01698775|26322341|FG001|Phase A|Adverse Event|1|||
13234187|NCT01698775|26322340|FG000|Phase A|Death|1|||
13234188|NCT01698775|26322341|FG001|Phase A|Death|1|||
13234189|NCT01698775|26322340|FG000|Phase A|Lack of Efficacy|1|||
13234190|NCT01698775|26322341|FG001|Phase A|Lack of Efficacy|0|||
13234191|NCT01698775|26322340|FG000|Phase A|Lost to Follow-up|1|||
13234192|NCT01698775|26322341|FG001|Phase A|Lost to Follow-up|2|||
13234193|NCT01698775|26322340|FG000|Phase A|Protocol Violation|1|||
13234194|NCT01698775|26322341|FG001|Phase A|Protocol Violation|0|||
13234195|NCT01698775|26322340|FG000|Phase A|Withdrawal by Subject|3|||
13234196|NCT01698775|26322341|FG001|Phase A|Withdrawal by Subject|4|||
13234197|NCT01698775|26322340|FG000|Phase A|Kidney [transplant]|0|||
13234198|NCT01698775|26322341|FG001|Phase A|Kidney [transplant]|1|||
13234199|NCT01698775|26322340|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0|||
13234200|NCT01698775|26322341|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1|||
13234201|NCT01698775|26322340|FG000|Phase B|Adverse Event|6|||
13234202|NCT01698775|26322341|FG001|Phase B|Adverse Event|3|||
13234203|NCT01698775|26322340|FG000|Phase B|Death|0|||
13234204|NCT01698775|26322341|FG001|Phase B|Death|1|||
13234205|NCT01698775|26322340|FG000|Phase B|Lack of Efficacy|0|||
13234206|NCT01698775|26322341|FG001|Phase B|Lack of Efficacy|1|||
13234207|NCT01698775|26322340|FG000|Phase B|Lost to Follow-up|0|||
13234208|NCT01698775|26322341|FG001|Phase B|Lost to Follow-up|1|||
13234209|NCT01698775|26322340|FG000|Phase B|Physician Decision|1|||
13234210|NCT01698775|26322341|FG001|Phase B|Physician Decision|1|||
13234211|NCT01698775|26322340|FG000|Phase B|Protocol Violation|1|||
13234212|NCT01698775|26322341|FG001|Phase B|Protocol Violation|1|||
13234213|NCT01698775|26322340|FG000|Phase B|Withdrawal by Subject|6|||
13234214|NCT01698775|26322341|FG001|Phase B|Withdrawal by Subject|2|||
13234215|NCT01698554|26322380|FG000|Overall Study|Adverse Event|2|||
13234216|NCT01698554|26322381|FG001|Overall Study|Adverse Event|5|||
13234217|NCT01698554|26322382|FG002|Overall Study|Adverse Event|0|||
13234218|NCT01698554|26322383|FG003|Overall Study|Adverse Event|1|||
13234219|NCT01698554|26322380|FG000|Overall Study|Lost to Follow-up|1|||
13234220|NCT01698554|26322381|FG001|Overall Study|Lost to Follow-up|0|||
13234221|NCT01698554|26322382|FG002|Overall Study|Lost to Follow-up|0|||
13234222|NCT01698554|26322383|FG003|Overall Study|Lost to Follow-up|0|||
13234223|NCT01698554|26322380|FG000|Overall Study|Personal Reasons|0|||
13234224|NCT01698554|26322381|FG001|Overall Study|Personal Reasons|5|||
13234225|NCT01698554|26322382|FG002|Overall Study|Personal Reasons|1|||
13234226|NCT01698554|26322383|FG003|Overall Study|Personal Reasons|1|||
13234227|NCT01698554|26322380|FG000|Overall Study|Protocol Violation|2|||
13234228|NCT01698554|26322381|FG001|Overall Study|Protocol Violation|0|||
13234229|NCT01698554|26322382|FG002|Overall Study|Protocol Violation|1|||
13234230|NCT01698554|26322383|FG003|Overall Study|Protocol Violation|0|||
13234231|NCT01698554|26322380|FG000|Overall Study|Other Miscellaneous Reasons|1|||
13234232|NCT01698554|26322381|FG001|Overall Study|Other Miscellaneous Reasons|0|||
13234233|NCT01698554|26322382|FG002|Overall Study|Other Miscellaneous Reasons|0|||
13234234|NCT01698554|26322383|FG003|Overall Study|Other Miscellaneous Reasons|0|||
13234235|NCT01698320|26322409|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24|||
13234236|NCT01698320|26322410|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
13234237|NCT01698320|26322411|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
13234238|NCT01698320|26322409|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1|||
13234239|NCT01698320|26322410|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
13234240|NCT01698320|26322411|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
13234241|NCT01698320|26322409|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1|||
13234242|NCT01698320|26322410|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
13234243|NCT01698320|26322411|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
13234244|NCT01698320|26322409|FG000|Run-In Period (Week -1 to Day 0)|Other|1|||
13234245|NCT01698320|26322410|FG001|Run-In Period (Week -1 to Day 0)|Other|0|||
13234246|NCT01698320|26322411|FG002|Run-In Period (Week -1 to Day 0)|Other|0|||
13234247|NCT01698320|26322409|FG000|12-Week Double-Blind Period|Adverse Event|0|||
13234248|NCT01698320|26322410|FG001|12-Week Double-Blind Period|Adverse Event|1|||
13234249|NCT01698320|26322411|FG002|12-Week Double-Blind Period|Adverse Event|1|||
13234250|NCT01698320|26322409|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0|||
13234251|NCT01698320|26322410|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2|||
13234252|NCT01698320|26322411|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2|||
13234253|NCT01698320|26322409|FG000|12-Week Double-Blind Period|Protocol Violation|0|||
13234254|NCT01698320|26322410|FG001|12-Week Double-Blind Period|Protocol Violation|0|||
13234255|NCT01698320|26322411|FG002|12-Week Double-Blind Period|Protocol Violation|2|||
13234256|NCT01698320|26322409|FG000|12-Week Double-Blind Period|Pregnancy|0|||
13234257|NCT01698320|26322410|FG001|12-Week Double-Blind Period|Pregnancy|1|||
13234258|NCT01698320|26322411|FG002|12-Week Double-Blind Period|Pregnancy|1|||
13234259|NCT01698320|26322409|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
13234260|NCT01698320|26322410|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
13234261|NCT01698320|26322411|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2|||
13234262|NCT01698320|26322409|FG000|12-Week Double-Blind Period|Lost to Follow-up|0|||
13234263|NCT01698320|26322410|FG001|12-Week Double-Blind Period|Lost to Follow-up|0|||
13234264|NCT01698320|26322411|FG002|12-Week Double-Blind Period|Lost to Follow-up|4|||
13234265|NCT01698320|26322409|FG000|40-Week Open-Label Period|Adverse Event|0|||
13234266|NCT01698320|26322410|FG001|40-Week Open-Label Period|Adverse Event|3|||
13234267|NCT01698320|26322411|FG002|40-Week Open-Label Period|Adverse Event|2|||
13234268|NCT01698320|26322409|FG000|40-Week Open-Label Period|Withdrawal by Subject|0|||
13234269|NCT01698320|26322410|FG001|40-Week Open-Label Period|Withdrawal by Subject|11|||
13234270|NCT01698320|26322411|FG002|40-Week Open-Label Period|Withdrawal by Subject|7|||
13234271|NCT01698320|26322409|FG000|40-Week Open-Label Period|Pregnancy|0|||
13234272|NCT01698320|26322410|FG001|40-Week Open-Label Period|Pregnancy|2|||
13234273|NCT01698320|26322411|FG002|40-Week Open-Label Period|Pregnancy|1|||
13234274|NCT01698320|26322409|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
13234275|NCT01698320|26322410|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1|||
13234276|NCT01698320|26322411|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
13234277|NCT01698320|26322409|FG000|40-Week Open-Label Period|Lost to Follow-up|0|||
13234278|NCT01698320|26322410|FG001|40-Week Open-Label Period|Lost to Follow-up|2|||
13234279|NCT01698320|26322411|FG002|40-Week Open-Label Period|Lost to Follow-up|0|||
13234280|NCT01698268|26322424|FG000|Overall Study|Physician Decision|2|||
13234281|NCT01698268|26322425|FG001|Overall Study|Physician Decision|1|||
13234282|NCT01698008|26322438|FG000|Overall Study|Withdrawal by Subject|1|||
13234283|NCT01698008|26322439|FG001|Overall Study|Withdrawal by Subject|2|||
13234284|NCT01697969|26322446|FG000|Overall Study|Did not meet inc/exc criteria|3|||
13234285|NCT01697956|26322481|FG000|Overall Study|Protocol Violation|1|||
13234286|NCT01697956|26322482|FG001|Overall Study|Protocol Violation|1|||
13234287|NCT01697800|26322495|FG000|Overall Study|Death|0|||
13234288|NCT01697800|26322496|FG001|Overall Study|Death|1|||
13234289|NCT01697748|26322519|FG000|Overall Study|ineligible skin incision|1|||
13234290|NCT01697748|26322520|FG001|Overall Study|ineligible skin incision|2|||
13234291|NCT01697748|26322519|FG000|Overall Study|ineligible uterine incision|4|||
13234292|NCT01697748|26322520|FG001|Overall Study|ineligible uterine incision|1|||
13234293|NCT01697748|26322519|FG000|Overall Study|Lost to Follow-up|53|||
13234294|NCT01697748|26322520|FG001|Overall Study|Lost to Follow-up|65|||
13234295|NCT01697696|26322549|FG000|Overall Study|Study terminated by sponsor|0|||
13234296|NCT01697696|26322550|FG001|Overall Study|Study terminated by sponsor|3|||
13234297|NCT01697696|26322549|FG000|Overall Study|Protocol deviation|1|||
13234298|NCT01697696|26322550|FG001|Overall Study|Protocol deviation|0|||
13234299|NCT01697696|26322549|FG000|Overall Study|Physician Decision|1|||
13234300|NCT01697696|26322550|FG001|Overall Study|Physician Decision|0|||
13234301|NCT01697696|26322549|FG000|Overall Study|Death|4|||
13234302|NCT01697696|26322550|FG001|Overall Study|Death|2|||
13234303|NCT01697696|26322549|FG000|Overall Study|Lost to Follow-up|10|||
13234304|NCT01697696|26322550|FG001|Overall Study|Lost to Follow-up|7|||
13234305|NCT01697696|26322549|FG000|Overall Study|Subject/guardian decision|31|||
13234306|NCT01697696|26322550|FG001|Overall Study|Subject/guardian decision|35|||
13234307|NCT01697592|26322645|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1|||
13234308|NCT01697592|26322646|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
13234309|NCT01697592|26322647|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
13485808|NCT00585195|27033426|FG016|Overall Study|Lost to Follow-up|0|||
13234310|NCT01697592|26322648|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
13234311|NCT01697592|26322649|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
13234312|NCT01697592|26322650|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
13234313|NCT01697592|26322651|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
13234314|NCT01697592|26322652|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
13234315|NCT01697592|26322653|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
13234316|NCT01697592|26322654|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
13234317|NCT01697592|26322645|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0|||
13234318|NCT01697592|26322646|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
13234319|NCT01697592|26322647|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
13234320|NCT01697592|26322648|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0|||
13234321|NCT01697592|26322649|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0|||
13234322|NCT01697592|26322650|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1|||
13234323|NCT01697592|26322651|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0|||
13234324|NCT01697592|26322652|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0|||
13234325|NCT01697592|26322653|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0|||
13234326|NCT01697592|26322654|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0|||
13234327|NCT01697592|26322645|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
13234328|NCT01697592|26322646|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
13115482|NCT03097861|25918002|FG002|Overall Study|Withdrawal by Subject|3|||
13234329|NCT01697592|26322647|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
13234330|NCT01697592|26322648|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
13234331|NCT01697592|26322649|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
13234332|NCT01697592|26322650|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
13234333|NCT01697592|26322651|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
13234334|NCT01697592|26322652|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
13234335|NCT01697592|26322653|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
13234336|NCT01697592|26322654|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
13234337|NCT01697592|26322645|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
13234338|NCT01697592|26322646|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
13234339|NCT01697592|26322647|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
13234340|NCT01697592|26322648|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
13234341|NCT01697592|26322649|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
13234342|NCT01697592|26322650|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
13234343|NCT01697592|26322651|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
13234344|NCT01697592|26322652|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
13234345|NCT01697592|26322653|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
13234346|NCT01697592|26322654|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
13234347|NCT01697592|26322645|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0|||
13234348|NCT01697592|26322646|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2|||
13234349|NCT01697592|26322647|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1|||
13234350|NCT01697592|26322648|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2|||
13234351|NCT01697592|26322649|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0|||
13234352|NCT01697592|26322650|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0|||
13234353|NCT01697592|26322651|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1|||
13234354|NCT01697592|26322652|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0|||
13234355|NCT01697592|26322653|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0|||
13234356|NCT01697592|26322654|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1|||
13234357|NCT01697592|26322645|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1|||
13234358|NCT01697592|26322646|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0|||
13234359|NCT01697592|26322647|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0|||
13234360|NCT01697592|26322648|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1|||
13234361|NCT01697592|26322649|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0|||
13234362|NCT01697592|26322650|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0|||
13234363|NCT01697592|26322651|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0|||
13234364|NCT01697592|26322652|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0|||
13234365|NCT01697592|26322653|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0|||
13234366|NCT01697592|26322654|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0|||
13234367|NCT01697592|26322645|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2|||
13234368|NCT01697592|26322646|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
13234369|NCT01697592|26322647|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
13234370|NCT01697592|26322648|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
13234371|NCT01697592|26322649|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
13115483|NCT03097861|25918000|FG000|Overall Study|Reason not provided|3|||
13234372|NCT01697592|26322650|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
13234373|NCT01697592|26322651|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
13234374|NCT01697592|26322652|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
13234375|NCT01697592|26322653|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
13234376|NCT01697592|26322654|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
13234377|NCT01697592|26322645|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2|||
13234378|NCT01697592|26322646|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1|||
13234379|NCT01697592|26322647|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1|||
13234380|NCT01697592|26322648|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2|||
13234381|NCT01697592|26322649|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0|||
13234382|NCT01697592|26322650|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1|||
13234383|NCT01697592|26322651|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1|||
13234384|NCT01697592|26322652|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0|||
13234385|NCT01697592|26322653|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2|||
13234386|NCT01697592|26322654|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0|||
13234387|NCT01697579|26322784|FG000|Base Study-Cycle 1|Adverse Event|1|||
13234388|NCT01697579|26322785|FG001|Base Study-Cycle 1|Adverse Event|0|||
13234389|NCT01697579|26322786|FG002|Base Study-Cycle 1|Adverse Event|0|||
13234390|NCT01697579|26322787|FG003|Base Study-Cycle 1|Adverse Event|0|||
13234391|NCT01697579|26322788|FG004|Base Study-Cycle 1|Adverse Event|0|||
13234392|NCT01697579|26322789|FG005|Base Study-Cycle 1|Adverse Event|0|||
13234393|NCT01697579|26322790|FG006|Base Study-Cycle 1|Adverse Event|0|||
13234394|NCT01697579|26322784|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1|||
13234395|NCT01697579|26322785|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
13234396|NCT01697579|26322786|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
13234397|NCT01697579|26322787|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
13234398|NCT01697579|26322788|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
13234399|NCT01697579|26322789|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
13234400|NCT01697579|26322790|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
13234401|NCT01697579|26322784|FG000|Base Study-Cycle 1|Protocol Violation|0|||
13234402|NCT01697579|26322785|FG001|Base Study-Cycle 1|Protocol Violation|0|||
13234403|NCT01697579|26322786|FG002|Base Study-Cycle 1|Protocol Violation|0|||
13234404|NCT01697579|26322787|FG003|Base Study-Cycle 1|Protocol Violation|0|||
13234405|NCT01697579|26322788|FG004|Base Study-Cycle 1|Protocol Violation|3|||
13234406|NCT01697579|26322789|FG005|Base Study-Cycle 1|Protocol Violation|0|||
13234407|NCT01697579|26322790|FG006|Base Study-Cycle 1|Protocol Violation|0|||
13234408|NCT01697579|26322784|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
13234409|NCT01697579|26322785|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1|||
13234410|NCT01697579|26322786|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
13234411|NCT01697579|26322787|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
13234412|NCT01697579|26322788|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
13234413|NCT01697579|26322789|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
13234414|NCT01697579|26322790|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
13234415|NCT01697579|26322784|FG000|Base Study-Cycle 1|Technical Problems|0|||
13234416|NCT01697579|26322785|FG001|Base Study-Cycle 1|Technical Problems|0|||
13234417|NCT01697579|26322786|FG002|Base Study-Cycle 1|Technical Problems|1|||
13234418|NCT01697579|26322787|FG003|Base Study-Cycle 1|Technical Problems|1|||
13234419|NCT01697579|26322788|FG004|Base Study-Cycle 1|Technical Problems|0|||
13234420|NCT01697579|26322789|FG005|Base Study-Cycle 1|Technical Problems|0|||
13234421|NCT01697579|26322790|FG006|Base Study-Cycle 1|Technical Problems|0|||
13234422|NCT01697579|26322784|FG000|Optional Extension-Cycles 2-6|Death|0|||
13234423|NCT01697579|26322785|FG001|Optional Extension-Cycles 2-6|Death|0|||
13234424|NCT01697579|26322786|FG002|Optional Extension-Cycles 2-6|Death|0|||
13234425|NCT01697579|26322787|FG003|Optional Extension-Cycles 2-6|Death|0|||
13234426|NCT01697579|26322788|FG004|Optional Extension-Cycles 2-6|Death|0|||
13234427|NCT01697579|26322789|FG005|Optional Extension-Cycles 2-6|Death|0|||
13234428|NCT01697579|26322790|FG006|Optional Extension-Cycles 2-6|Death|2|||
13234429|NCT01697579|26322784|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
13234430|NCT01697579|26322785|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
13234431|NCT01697579|26322786|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
13234432|NCT01697579|26322787|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
13115484|NCT03097861|25918001|FG001|Overall Study|Reason not provided|1|||
13234433|NCT01697579|26322788|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
13234434|NCT01697579|26322789|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1|||
13234435|NCT01697579|26322790|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5|||
13234436|NCT01697579|26322784|FG000|Optional Extension-Cycles 2-6|Physician Decision|0|||
13234437|NCT01697579|26322785|FG001|Optional Extension-Cycles 2-6|Physician Decision|0|||
13234438|NCT01697579|26322786|FG002|Optional Extension-Cycles 2-6|Physician Decision|0|||
13234439|NCT01697579|26322787|FG003|Optional Extension-Cycles 2-6|Physician Decision|0|||
13234440|NCT01697579|26322788|FG004|Optional Extension-Cycles 2-6|Physician Decision|0|||
13234441|NCT01697579|26322789|FG005|Optional Extension-Cycles 2-6|Physician Decision|7|||
13234442|NCT01697579|26322790|FG006|Optional Extension-Cycles 2-6|Physician Decision|11|||
13234443|NCT01697579|26322784|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0|||
13234444|NCT01697579|26322785|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0|||
13234445|NCT01697579|26322786|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0|||
13234446|NCT01697579|26322787|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0|||
13234447|NCT01697579|26322788|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0|||
13234448|NCT01697579|26322789|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0|||
13234449|NCT01697579|26322790|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4|||
13234450|NCT01697579|26322784|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0|||
13234451|NCT01697579|26322785|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0|||
13234452|NCT01697579|26322786|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0|||
13234453|NCT01697579|26322787|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0|||
13234454|NCT01697579|26322788|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0|||
13234455|NCT01697579|26322789|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1|||
13234456|NCT01697579|26322790|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2|||
13234457|NCT01697579|26322784|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
13115485|NCT03097861|25918002|FG002|Overall Study|Reason not provided|1|||
13115486|NCT03097614|25918008|FG000|Overall Study|Adverse Event|3|||
13115487|NCT03097588|25918024|FG000|Overall Study|Adverse Event|1|||
13115488|NCT03097328|25918033|FG000|Overall Study|Still on Therapy|2|||
13234458|NCT01697579|26322785|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
13234459|NCT01697579|26322786|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
13234460|NCT01697579|26322787|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
13234461|NCT01697579|26322788|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
13234462|NCT01697579|26322789|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1|||
13234463|NCT01697579|26322790|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
13234464|NCT01697579|26322784|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
13234465|NCT01697579|26322785|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
13234466|NCT01697579|26322786|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
13234467|NCT01697579|26322787|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
13234468|NCT01697579|26322788|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
13234469|NCT01697579|26322789|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15|||
13234470|NCT01697579|26322790|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24|||
13234471|NCT01697579|26322784|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
13234472|NCT01697579|26322785|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
13234473|NCT01697579|26322786|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
13234474|NCT01697579|26322787|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
13234475|NCT01697579|26322788|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
13234476|NCT01697579|26322789|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4|||
13234477|NCT01697579|26322790|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11|||
13234478|NCT01697579|26322784|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
13234479|NCT01697579|26322785|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
13234480|NCT01697579|26322786|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
13234481|NCT01697579|26322787|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
13234482|NCT01697579|26322788|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
13234483|NCT01697579|26322789|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
13234484|NCT01697579|26322790|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2|||
13234485|NCT01697579|26322784|FG000|Optional Extension-Cycles 2-6|Technical Problems|0|||
13234486|NCT01697579|26322785|FG001|Optional Extension-Cycles 2-6|Technical Problems|0|||
13234487|NCT01697579|26322786|FG002|Optional Extension-Cycles 2-6|Technical Problems|0|||
13234488|NCT01697579|26322787|FG003|Optional Extension-Cycles 2-6|Technical Problems|0|||
13234489|NCT01697579|26322788|FG004|Optional Extension-Cycles 2-6|Technical Problems|0|||
13234490|NCT01697579|26322789|FG005|Optional Extension-Cycles 2-6|Technical Problems|0|||
13234491|NCT01697579|26322790|FG006|Optional Extension-Cycles 2-6|Technical Problems|1|||
13234492|NCT01697579|26322784|FG000|Optional Extension-Cycles 2-6|Participant Moved|0|||
13234493|NCT01697579|26322785|FG001|Optional Extension-Cycles 2-6|Participant Moved|0|||
13234494|NCT01697579|26322786|FG002|Optional Extension-Cycles 2-6|Participant Moved|0|||
13234495|NCT01697579|26322787|FG003|Optional Extension-Cycles 2-6|Participant Moved|0|||
13234496|NCT01697579|26322788|FG004|Optional Extension-Cycles 2-6|Participant Moved|0|||
13234497|NCT01697579|26322789|FG005|Optional Extension-Cycles 2-6|Participant Moved|0|||
13234498|NCT01697579|26322790|FG006|Optional Extension-Cycles 2-6|Participant Moved|2|||
13234499|NCT01697579|26322784|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
13234500|NCT01697579|26322785|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
13234501|NCT01697579|26322786|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
13234502|NCT01697579|26322787|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
13234503|NCT01697579|26322788|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
13234504|NCT01697579|26322789|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6|||
13234505|NCT01697579|26322790|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4|||
13485809|NCT00585195|27033427|FG017|Overall Study|Lost to Follow-up|2|||
13115489|NCT03097328|25918033|FG000|Overall Study|Progressive Disease|29|||
13115490|NCT03097328|25918033|FG000|Overall Study|Adverse Event|4|||
13234506|NCT01697579|26322784|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
13234507|NCT01697579|26322785|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
13234508|NCT01697579|26322786|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
13234509|NCT01697579|26322787|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
13234510|NCT01697579|26322788|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
13234511|NCT01697579|26322789|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
13234512|NCT01697579|26322790|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1|||
13234513|NCT01697501|26322835|FG000|Overall Study|Protocol Violation|2|||
13234514|NCT01697462|26322844|FG000|Overall Study|Disease Progression|1|||
13234515|NCT01697462|26322844|FG000|Overall Study|Adverse Event|6|||
13234516|NCT01697462|26322844|FG000|Overall Study|Lost to Follow-up|21|||
13234517|NCT01697462|26322844|FG000|Overall Study|Withdrawal by Subject|12|||
13234518|NCT01697462|26322844|FG000|Overall Study|Investigator Decision|21|||
13234519|NCT01697462|26322844|FG000|Overall Study|Death|1|||
13234520|NCT01697462|26322844|FG000|Overall Study|Other|10|||
13234521|NCT01697462|26322844|FG000|Overall Study|Missing|5|||
13234522|NCT01697449|26322855|FG000|Overall Study|Disease progression|47|||
13234523|NCT01697449|26322855|FG000|Overall Study|Adverse Event|7|||
13234524|NCT01697449|26322855|FG000|Overall Study|Lost to Follow-up|5|||
13234525|NCT01697449|26322855|FG000|Overall Study|Withdrawal by Subject|2|||
13234526|NCT01697449|26322855|FG000|Overall Study|Physician Decision|1|||
13234527|NCT01697449|26322855|FG000|Overall Study|Death|2|||
13234528|NCT01697449|26322855|FG000|Overall Study|Other|1|||
13234529|NCT01697449|26322855|FG000|Overall Study|Missing|25|||
13234530|NCT01697358|26322878|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6|||
13234531|NCT01697358|26322879|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0|||
13234532|NCT01697358|26322878|FG000|Period I: Randomization to 6 Months|Physician Decision|4|||
13234533|NCT01697358|26322879|FG001|Period I: Randomization to 6 Months|Physician Decision|0|||
13234534|NCT01697358|26322878|FG000|Period I: Randomization to 6 Months|Adverse Event|1|||
13234535|NCT01697358|26322879|FG001|Period I: Randomization to 6 Months|Adverse Event|1|||
13234536|NCT01697358|26322878|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2|||
13234537|NCT01697358|26322879|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0|||
13234538|NCT01697358|26322878|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3|||
13234539|NCT01697358|26322879|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12|||
13234540|NCT01697358|26322878|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8|||
13234541|NCT01697358|26322879|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10|||
13234542|NCT01697358|26322878|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
13234543|NCT01697358|26322879|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
13234544|NCT01697358|26322878|FG000|Period II: 6-24M Long-term Follow-up|Death|1|||
13234545|NCT01697358|26322879|FG001|Period II: 6-24M Long-term Follow-up|Death|1|||
13234546|NCT01697358|26322878|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0|||
13234547|NCT01697358|26322879|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3|||
13234548|NCT01697358|26322878|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34|||
13234549|NCT01697358|26322879|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26|||
13234550|NCT01697345|26322900|FG000|Overall Study|Withdrawal by Subject|1|||
13234551|NCT01697319|26322909|FG000|Primary Phase|Withdrawal by Subject|1|||
13234552|NCT01697319|26322909|FG000|Extension Phase|Terminated by Sponsor|15|||
13234553|NCT01697267|26322952|FG000|Overall Study|Death|3|||
13234554|NCT01697267|26322953|FG001|Overall Study|Death|1|||
13234555|NCT01697267|26322952|FG000|Overall Study|Withdrawal by Subject|5|||
13234556|NCT01697267|26322953|FG001|Overall Study|Withdrawal by Subject|5|||
13234557|NCT01697267|26322952|FG000|Overall Study|Adverse Event|2|||
13234558|NCT01697267|26322953|FG001|Overall Study|Adverse Event|1|||
13234559|NCT01697267|26322952|FG000|Overall Study|Lost to Follow-up|2|||
13234560|NCT01697267|26322953|FG001|Overall Study|Lost to Follow-up|4|||
13234561|NCT01697267|26322952|FG000|Overall Study|Physician Decision|2|||
13234562|NCT01697267|26322953|FG001|Overall Study|Physician Decision|4|||
13234563|NCT01696994|26322986|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0|||
13234564|NCT01696994|26322987|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2|||
13234565|NCT01696994|26322986|FG000|Overall Study|Died Before Randomization|1|||
13234566|NCT01696994|26322987|FG001|Overall Study|Died Before Randomization|2|||
13234567|NCT01696994|26322986|FG000|Overall Study|Died Before ASU (Control)|73|||
13234568|NCT01696994|26322987|FG001|Overall Study|Died Before ASU (Control)|0|||
13234569|NCT01696994|26322986|FG000|Overall Study|No Ovaries at Baseline|4807|||
13234570|NCT01696994|26322987|FG001|Overall Study|No Ovaries at Baseline|4851|||
13234571|NCT01696994|26322986|FG000|Overall Study|Refused ASU (Control)|311|||
13234572|NCT01696994|26322987|FG001|Overall Study|Refused ASU (Control)|0|||
13234573|NCT01696994|26322986|FG000|Overall Study|Refused Screen (Ovarian Screening)|0|||
13234574|NCT01696994|26322987|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582|||
13234575|NCT01696981|26323012|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0|||
13234576|NCT01696981|26323013|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20|||
13234577|NCT01696981|26323012|FG000|Overall Study|Died Before Randomization|3|||
13234578|NCT01696981|26323013|FG001|Overall Study|Died Before Randomization|8|||
13234579|NCT01696981|26323012|FG000|Overall Study|Died Before ASU (Control)|278|||
13234580|NCT01696981|26323013|FG001|Overall Study|Died Before ASU (Control)|0|||
13234581|NCT01696981|26323012|FG000|Overall Study|Refused ASU (Control)|920|||
13234582|NCT01696981|26323013|FG001|Overall Study|Refused ASU (Control)|0|||
13234583|NCT01696981|26323012|FG000|Overall Study|Refused Screen (Colorectal Screening)|0|||
13234584|NCT01696981|26323013|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346|||
13234585|NCT01696955|26323043|FG000|Main Study|Protocol Violation|1|||
13234586|NCT01696955|26323044|FG001|Main Study|Protocol Violation|0|||
13234587|NCT01696955|26323043|FG000|Main Study|Withdrawal by Subject|1|||
13234588|NCT01696955|26323044|FG001|Main Study|Withdrawal by Subject|1|||
13234589|NCT01696942|26323059|FG000|Overall Study|Withdrawal by Subject|1|||
13234590|NCT01696942|26323060|FG001|Overall Study|Withdrawal by Subject|0|||
13234591|NCT01696942|26323059|FG000|Overall Study|Protocol Violation|1|||
13234592|NCT01696942|26323060|FG001|Overall Study|Protocol Violation|2|||
13234593|NCT01696942|26323059|FG000|Overall Study|screen failure|0|||
13234594|NCT01696942|26323060|FG001|Overall Study|screen failure|1|||
13234595|NCT01696929|26323067|FG000|Overall Study|Physician Decision|1|||
13234596|NCT01696877|26323094|FG000|Overall Study|Adverse Event|0|||
13234597|NCT01696877|26323095|FG001|Overall Study|Adverse Event|1|||
13234598|NCT01696773|26323108|FG000|Days 15-27, Washout|Adverse Event|1|||
13234599|NCT01696773|26323109|FG001|Days 15-27, Washout|Adverse Event|0|||
13234600|NCT01696695|26323121|FG000|Overall Study|Disease progression|373|||
13234601|NCT01696695|26323121|FG000|Overall Study|Death|29|||
13234602|NCT01696695|26323121|FG000|Overall Study|Adverse Event|74|||
13234603|NCT01696695|26323121|FG000|Overall Study|Withdrawal by Subject|92|||
13234604|NCT01696695|26323121|FG000|Overall Study|Lost to Follow-up|48|||
13234605|NCT01696695|26323121|FG000|Overall Study|Other|74|||
13234606|NCT01696695|26323121|FG000|Overall Study|Major Protocol Violation|192|||
13234607|NCT01696643|26323143|FG000|Overall Study|Adverse Event|15|||
13234608|NCT01696643|26323144|FG001|Overall Study|Adverse Event|7|||
13234609|NCT01696643|26323143|FG000|Overall Study|Death|1|||
13234610|NCT01696643|26323144|FG001|Overall Study|Death|2|||
13234611|NCT01696643|26323143|FG000|Overall Study|Lack of Efficacy|3|||
13234612|NCT01696643|26323144|FG001|Overall Study|Lack of Efficacy|0|||
13234613|NCT01696643|26323143|FG000|Overall Study|Lost to Follow-up|67|||
13234614|NCT01696643|26323144|FG001|Overall Study|Lost to Follow-up|67|||
13234615|NCT01696643|26323143|FG000|Overall Study|Physician Decision|3|||
13234616|NCT01696643|26323144|FG001|Overall Study|Physician Decision|2|||
13234617|NCT01696643|26323143|FG000|Overall Study|Pregnancy|0|||
13234618|NCT01696643|26323144|FG001|Overall Study|Pregnancy|1|||
13234619|NCT01696643|26323143|FG000|Overall Study|Protocol Violation|7|||
13234620|NCT01696643|26323144|FG001|Overall Study|Protocol Violation|7|||
13234621|NCT01696643|26323143|FG000|Overall Study|Study Terminated by Sponsor|286|||
13234622|NCT01696643|26323144|FG001|Overall Study|Study Terminated by Sponsor|294|||
13234623|NCT01696643|26323143|FG000|Overall Study|Withdrawal by Subject|142|||
13234624|NCT01696643|26323144|FG001|Overall Study|Withdrawal by Subject|149|||
13234625|NCT01696643|26323143|FG000|Overall Study|Participant on Restricted Bed Rest|1|||
13234626|NCT01696643|26323144|FG001|Overall Study|Participant on Restricted Bed Rest|0|||
13234627|NCT01696643|26323143|FG000|Overall Study|Site Error|2|||
13234628|NCT01696643|26323144|FG001|Overall Study|Site Error|1|||
13234629|NCT01696643|26323143|FG000|Overall Study|Participant Incarcerated|0|||
13234630|NCT01696643|26323144|FG001|Overall Study|Participant Incarcerated|1|||
13234631|NCT01696643|26323143|FG000|Overall Study|Medical Monitor Decision|0|||
13234632|NCT01696643|26323144|FG001|Overall Study|Medical Monitor Decision|2|||
13234633|NCT01696643|26323143|FG000|Overall Study|Participant Did Not Receive Study Drug|2|||
13234634|NCT01696643|26323144|FG001|Overall Study|Participant Did Not Receive Study Drug|2|||
13234635|NCT01696396|26323199|FG000|Overall Study|Withdrawal by Subject|19|||
13234636|NCT01696396|26323200|FG001|Overall Study|Withdrawal by Subject|5|||
13234637|NCT01696396|26323201|FG002|Overall Study|Withdrawal by Subject|19|||
13234638|NCT01696396|26323202|FG003|Overall Study|Withdrawal by Subject|11|||
13234639|NCT01696396|26323199|FG000|Overall Study|Decision by Sponsor|3|||
13234640|NCT01696396|26323200|FG001|Overall Study|Decision by Sponsor|1|||
13234641|NCT01696396|26323201|FG002|Overall Study|Decision by Sponsor|2|||
13234642|NCT01696396|26323202|FG003|Overall Study|Decision by Sponsor|2|||
13234643|NCT01696396|26323199|FG000|Overall Study|Lost to Follow-up|9|||
13234644|NCT01696396|26323200|FG001|Overall Study|Lost to Follow-up|1|||
13234645|NCT01696396|26323201|FG002|Overall Study|Lost to Follow-up|4|||
13234646|NCT01696396|26323202|FG003|Overall Study|Lost to Follow-up|1|||
13234647|NCT01696396|26323199|FG000|Overall Study|Death|0|||
13234648|NCT01696396|26323200|FG001|Overall Study|Death|0|||
13234649|NCT01696396|26323201|FG002|Overall Study|Death|1|||
13234650|NCT01696396|26323202|FG003|Overall Study|Death|0|||
13234651|NCT01696279|26323241|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1|||
13234652|NCT01696279|26323242|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
13234653|NCT01696279|26323243|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
13234654|NCT01696279|26323244|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
13234655|NCT01696279|26323241|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
13234656|NCT01696279|26323242|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5|||
13234657|NCT01696279|26323243|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
13234658|NCT01696279|26323244|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
13234659|NCT01696279|26323241|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
13115491|NCT03097328|25918033|FG000|Overall Study|Withdrawal by Subject|1|||
13234660|NCT01696279|26323242|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1|||
13234661|NCT01696279|26323243|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
13234662|NCT01696279|26323244|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
13234663|NCT01696279|26323241|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
13234664|NCT01696279|26323242|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1|||
13234665|NCT01696279|26323243|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
13234666|NCT01696279|26323244|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
13234667|NCT01696279|26323241|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
13234668|NCT01696279|26323242|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3|||
13234669|NCT01696279|26323243|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
13234670|NCT01696279|26323244|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
13234671|NCT01696279|26323241|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
13234672|NCT01696279|26323242|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7|||
13234673|NCT01696279|26323243|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
13234674|NCT01696279|26323244|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
13234675|NCT01696279|26323241|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
13234676|NCT01696279|26323242|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2|||
13234677|NCT01696279|26323243|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
13234678|NCT01696279|26323244|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
13234679|NCT01696279|26323241|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
13234680|NCT01696279|26323242|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
13234681|NCT01696279|26323243|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1|||
13234682|NCT01696279|26323244|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
13234683|NCT01696279|26323241|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
13234684|NCT01696279|26323242|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
13234685|NCT01696279|26323243|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
13234686|NCT01696279|26323244|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6|||
13234687|NCT01696279|26323241|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
13234688|NCT01696279|26323242|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
13234689|NCT01696279|26323243|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
13234690|NCT01696279|26323244|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1|||
13234691|NCT01696279|26323241|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
13234692|NCT01696279|26323242|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
13234693|NCT01696279|26323243|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
13234694|NCT01696279|26323244|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1|||
13234695|NCT01696214|26323275|FG000|Overall Study|Lost to Follow-up|1|||
13234696|NCT01696214|26323276|FG001|Overall Study|Lost to Follow-up|0|||
13234697|NCT01696214|26323277|FG002|Overall Study|Lost to Follow-up|0|||
13234698|NCT01696214|26323278|FG003|Overall Study|Lost to Follow-up|0|||
13234699|NCT01696188|26323297|FG000|Overall Study|Protocol Violation|1|||
13234700|NCT01696188|26323298|FG001|Overall Study|Protocol Violation|1|||
13234701|NCT01696071|26323327|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1|||
13234702|NCT01696071|26323328|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0|||
13234703|NCT01696058|26323361|FG000|Overall Study|Adverse Event|21|||
13234704|NCT01696058|26323362|FG001|Overall Study|Adverse Event|11|||
13234705|NCT01696058|26323361|FG000|Overall Study|Lack of Efficacy|2|||
13234706|NCT01696058|26323362|FG001|Overall Study|Lack of Efficacy|3|||
13234707|NCT01696058|26323361|FG000|Overall Study|Protocol Violation|9|||
13234708|NCT01696058|26323362|FG001|Overall Study|Protocol Violation|3|||
13234709|NCT01696058|26323361|FG000|Overall Study|Lost to Follow-up|2|||
13234710|NCT01696058|26323362|FG001|Overall Study|Lost to Follow-up|5|||
13234711|NCT01696058|26323361|FG000|Overall Study|Withdrawal by Subject|4|||
13234712|NCT01696058|26323362|FG001|Overall Study|Withdrawal by Subject|6|||
13234713|NCT01696058|26323361|FG000|Overall Study|Other reason prematurely discontinued|5|||
13234714|NCT01696058|26323362|FG001|Overall Study|Other reason prematurely discontinued|3|||
13234715|NCT01696045|26323385|FG000|Overall Study|Study drug toxicity|1|||
13234716|NCT01696045|26323386|FG001|Overall Study|Study drug toxicity|5|||
13234717|NCT01696045|26323385|FG000|Overall Study|Disease progression|2|||
13234718|NCT01696045|26323386|FG001|Overall Study|Disease progression|2|||
13234719|NCT01696032|26323446|FG000|Overall Study|Withdrawal by Subject|0|||
13234720|NCT01696032|26323447|FG001|Overall Study|Withdrawal by Subject|0|||
13234721|NCT01696032|26323448|FG002|Overall Study|Withdrawal by Subject|1|||
13234722|NCT01696032|26323449|FG003|Overall Study|Withdrawal by Subject|2|||
13234723|NCT01696032|26323446|FG000|Overall Study|Death|14|||
13234724|NCT01696032|26323447|FG001|Overall Study|Death|4|||
13234725|NCT01696032|26323448|FG002|Overall Study|Death|43|||
13234726|NCT01696032|26323449|FG003|Overall Study|Death|18|||
13234727|NCT01696032|26323446|FG000|Overall Study|Lost to Follow-up|0|||
13234728|NCT01696032|26323447|FG001|Overall Study|Lost to Follow-up|1|||
13234729|NCT01696032|26323448|FG002|Overall Study|Lost to Follow-up|0|||
13234730|NCT01696032|26323449|FG003|Overall Study|Lost to Follow-up|0|||
13234731|NCT01696032|26323446|FG000|Overall Study|Database lock|0|||
13234732|NCT01696032|26323447|FG001|Overall Study|Database lock|1|||
13234733|NCT01696032|26323448|FG002|Overall Study|Database lock|7|||
13234734|NCT01696032|26323449|FG003|Overall Study|Database lock|2|||
13234735|NCT01695993|26323467|FG000|Overall Study|Lost to Follow-up|2|||
13234736|NCT01695993|26323468|FG001|Overall Study|Lost to Follow-up|1|||
13234737|NCT01695993|26323469|FG002|Overall Study|Lost to Follow-up|3|||
13234738|NCT01695993|26323467|FG000|Overall Study|Withdrawal by Subject|2|||
13234739|NCT01695993|26323468|FG001|Overall Study|Withdrawal by Subject|2|||
13234740|NCT01695993|26323469|FG002|Overall Study|Withdrawal by Subject|2|||
13234741|NCT01695993|26323467|FG000|Overall Study|To ill to continue|1|||
13234742|NCT01695993|26323468|FG001|Overall Study|To ill to continue|2|||
13234743|NCT01695993|26323469|FG002|Overall Study|To ill to continue|0|||
13234744|NCT01695993|26323467|FG000|Overall Study|Changed Medical Facility|0|||
13234745|NCT01695993|26323468|FG001|Overall Study|Changed Medical Facility|0|||
13234746|NCT01695993|26323469|FG002|Overall Study|Changed Medical Facility|1|||
13234747|NCT01695954|26323486|FG000|Overall Study|Withdrawal by Subject|4|||
13234748|NCT01695954|26323487|FG001|Overall Study|Withdrawal by Subject|0|||
13234749|NCT01695954|26323486|FG000|Overall Study|Adverse Event|0|||
13234750|NCT01695954|26323487|FG001|Overall Study|Adverse Event|2|||
13234751|NCT01695772|26323501|FG000|Overall Study|Withdrawal by Subject|18|||
13234752|NCT01695772|26323501|FG000|Overall Study|Progressive Disease|8|||
13234753|NCT01695772|26323501|FG000|Overall Study|Investigator Decision|5|||
13234754|NCT01695772|26323501|FG000|Overall Study|Lost to Follow-up|4|||
13234755|NCT01695772|26323501|FG000|Overall Study|Protocol Violation|2|||
13234756|NCT01695772|26323501|FG000|Overall Study|Unspecified Reason|1|||
13234757|NCT01695746|26323517|FG000|Overall Study|Adverse Event|1|||
13234758|NCT01695746|26323517|FG000|Overall Study|Non-compliance by the participant|3|||
13234759|NCT01695746|26323517|FG000|Overall Study|Protocol Violation|5|||
13234760|NCT01695746|26323517|FG000|Overall Study|Participant not willing to participate|3|||
13234761|NCT01695317|26323532|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2|||
13234762|NCT01695317|26323533|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1|||
13234763|NCT01695317|26323532|FG000|Cross-over to Period 2|Withdrawal by Subject|4|||
13234764|NCT01695317|26323533|FG001|Cross-over to Period 2|Withdrawal by Subject|34|||
13234765|NCT01695239|26323695|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
13234766|NCT01695239|26323696|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
13234767|NCT01695239|26323697|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3|||
13234768|NCT01695239|26323698|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4|||
13234769|NCT01695239|26323699|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
13234770|NCT01695239|26323700|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
13234771|NCT01695239|26323701|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
13234772|NCT01695239|26323702|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
13234773|NCT01695239|26323703|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
13234774|NCT01695239|26323704|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
13234775|NCT01695239|26323705|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
13234776|NCT01695239|26323706|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
13234777|NCT01695239|26323707|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
13234778|NCT01695239|26323708|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
13234779|NCT01695239|26323695|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2|||
13234780|NCT01695239|26323696|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2|||
13234781|NCT01695239|26323697|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2|||
13234782|NCT01695239|26323698|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3|||
13234783|NCT01695239|26323699|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0|||
13234784|NCT01695239|26323700|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0|||
13234785|NCT01695239|26323701|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0|||
13234786|NCT01695239|26323702|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0|||
13234787|NCT01695239|26323703|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0|||
13234788|NCT01695239|26323704|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0|||
13234789|NCT01695239|26323705|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0|||
13234790|NCT01695239|26323706|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0|||
13115492|NCT03097328|25918033|FG000|Overall Study|Physician Decision|1|||
13115493|NCT03097328|25918033|FG000|Overall Study|Patient Decision|1|||
13234791|NCT01695239|26323707|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0|||
13234792|NCT01695239|26323708|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0|||
13234793|NCT01695239|26323695|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4|||
13234794|NCT01695239|26323696|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
13234795|NCT01695239|26323697|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
13234796|NCT01695239|26323698|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
13234797|NCT01695239|26323699|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
13234798|NCT01695239|26323700|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
13234799|NCT01695239|26323701|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
13234800|NCT01695239|26323702|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
13234801|NCT01695239|26323703|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
13234802|NCT01695239|26323704|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
13234803|NCT01695239|26323705|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
13234804|NCT01695239|26323706|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
13234805|NCT01695239|26323707|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
13234806|NCT01695239|26323708|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
13234807|NCT01695239|26323695|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
13234808|NCT01695239|26323696|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
13234809|NCT01695239|26323697|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
13234810|NCT01695239|26323698|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
13234811|NCT01695239|26323699|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
13234812|NCT01695239|26323700|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
13234813|NCT01695239|26323701|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
13234814|NCT01695239|26323702|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
13234815|NCT01695239|26323703|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
13234816|NCT01695239|26323704|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
13234817|NCT01695239|26323705|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
13234818|NCT01695239|26323706|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
13234819|NCT01695239|26323707|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
13234820|NCT01695239|26323708|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
13234821|NCT01695239|26323695|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3|||
13234822|NCT01695239|26323696|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
13234823|NCT01695239|26323697|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1|||
13234824|NCT01695239|26323698|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
13234825|NCT01695239|26323699|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
13234826|NCT01695239|26323700|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
13234827|NCT01695239|26323701|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
13234828|NCT01695239|26323702|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
13234829|NCT01695239|26323703|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
13234830|NCT01695239|26323704|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
13234831|NCT01695239|26323705|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
13234832|NCT01695239|26323706|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
13234833|NCT01695239|26323707|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
13234834|NCT01695239|26323708|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
13234835|NCT01695239|26323695|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
13234836|NCT01695239|26323696|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
13234837|NCT01695239|26323697|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
13234838|NCT01695239|26323698|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
13234839|NCT01695239|26323699|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
13234840|NCT01695239|26323700|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
13234841|NCT01695239|26323701|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
13234842|NCT01695239|26323702|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
13234843|NCT01695239|26323703|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
13234844|NCT01695239|26323704|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
13234845|NCT01695239|26323705|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
13234846|NCT01695239|26323706|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
13234847|NCT01695239|26323707|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
13234848|NCT01695239|26323708|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
13234849|NCT01695239|26323695|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1|||
13234850|NCT01695239|26323696|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
13234851|NCT01695239|26323697|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
13234852|NCT01695239|26323698|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
13234853|NCT01695239|26323699|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
13234854|NCT01695239|26323700|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
13234855|NCT01695239|26323701|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
13234856|NCT01695239|26323702|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
13234857|NCT01695239|26323703|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
13234858|NCT01695239|26323704|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
13234859|NCT01695239|26323705|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
13234860|NCT01695239|26323706|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
13234861|NCT01695239|26323707|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
13485810|NCT00585195|27033428|FG018|Overall Study|Lost to Follow-up|0|||
13234862|NCT01695239|26323708|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
13234863|NCT01695239|26323695|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
13234864|NCT01695239|26323696|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
13234865|NCT01695239|26323697|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
13234866|NCT01695239|26323698|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
13234867|NCT01695239|26323699|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
13234868|NCT01695239|26323700|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
13234869|NCT01695239|26323701|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
13234870|NCT01695239|26323702|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9|||
13234871|NCT01695239|26323703|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
13234872|NCT01695239|26323704|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
13234873|NCT01695239|26323705|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
13234874|NCT01695239|26323706|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
13234875|NCT01695239|26323707|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
13234876|NCT01695239|26323708|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
13234877|NCT01695239|26323695|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
13234878|NCT01695239|26323696|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
13234879|NCT01695239|26323697|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
13234880|NCT01695239|26323698|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
13234881|NCT01695239|26323699|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
13234882|NCT01695239|26323700|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
13234883|NCT01695239|26323701|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
13234884|NCT01695239|26323702|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1|||
13234885|NCT01695239|26323703|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
13234886|NCT01695239|26323704|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
13234887|NCT01695239|26323705|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
13234888|NCT01695239|26323706|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
13234889|NCT01695239|26323707|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
13234890|NCT01695239|26323708|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
13234891|NCT01695239|26323695|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
13234892|NCT01695239|26323696|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
13234893|NCT01695239|26323697|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
13234894|NCT01695239|26323698|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
13234895|NCT01695239|26323699|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
13234896|NCT01695239|26323700|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
13234897|NCT01695239|26323701|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
13234898|NCT01695239|26323702|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1|||
13234899|NCT01695239|26323703|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
13234900|NCT01695239|26323704|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
13234901|NCT01695239|26323705|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
13234902|NCT01695239|26323706|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
13234903|NCT01695239|26323707|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
13234904|NCT01695239|26323708|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
13234905|NCT01695239|26323695|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
13234906|NCT01695239|26323696|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
13234907|NCT01695239|26323697|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
13234908|NCT01695239|26323698|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
13234909|NCT01695239|26323699|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
13234910|NCT01695239|26323700|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
13234911|NCT01695239|26323701|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
13234912|NCT01695239|26323702|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
13234913|NCT01695239|26323703|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37|||
13234914|NCT01695239|26323704|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31|||
13234915|NCT01695239|26323705|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
13234916|NCT01695239|26323706|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
13234917|NCT01695239|26323707|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
13234918|NCT01695239|26323708|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
13234919|NCT01695239|26323695|FG000|Extension Long-Term Extension Periods|Adverse Event|0|||
13234920|NCT01695239|26323696|FG001|Extension Long-Term Extension Periods|Adverse Event|0|||
13234921|NCT01695239|26323697|FG002|Extension Long-Term Extension Periods|Adverse Event|0|||
13234922|NCT01695239|26323698|FG003|Extension Long-Term Extension Periods|Adverse Event|0|||
13234923|NCT01695239|26323699|FG004|Extension Long-Term Extension Periods|Adverse Event|0|||
13234924|NCT01695239|26323700|FG005|Extension Long-Term Extension Periods|Adverse Event|0|||
13234925|NCT01695239|26323701|FG006|Extension Long-Term Extension Periods|Adverse Event|0|||
13485811|NCT00585195|27033429|FG019|Overall Study|Lost to Follow-up|0|||
13234926|NCT01695239|26323702|FG007|Extension Long-Term Extension Periods|Adverse Event|0|||
13234927|NCT01695239|26323703|FG008|Extension Long-Term Extension Periods|Adverse Event|15|||
13234928|NCT01695239|26323704|FG009|Extension Long-Term Extension Periods|Adverse Event|21|||
13234929|NCT01695239|26323705|FG010|Extension Long-Term Extension Periods|Adverse Event|0|||
13234930|NCT01695239|26323706|FG011|Extension Long-Term Extension Periods|Adverse Event|0|||
13234931|NCT01695239|26323707|FG012|Extension Long-Term Extension Periods|Adverse Event|0|||
13234932|NCT01695239|26323708|FG013|Extension Long-Term Extension Periods|Adverse Event|0|||
13234933|NCT01695239|26323695|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
13234934|NCT01695239|26323696|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
13234935|NCT01695239|26323697|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
13234936|NCT01695239|26323698|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
13234937|NCT01695239|26323699|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
13234938|NCT01695239|26323700|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
13234939|NCT01695239|26323701|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
13234940|NCT01695239|26323702|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
13234941|NCT01695239|26323703|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6|||
13234942|NCT01695239|26323704|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7|||
13234943|NCT01695239|26323705|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
13234944|NCT01695239|26323706|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
13234945|NCT01695239|26323707|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
13234946|NCT01695239|26323708|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
13234947|NCT01695239|26323695|FG000|Extension Long-Term Extension Periods|Physician Decision|0|||
13234948|NCT01695239|26323696|FG001|Extension Long-Term Extension Periods|Physician Decision|0|||
13234949|NCT01695239|26323697|FG002|Extension Long-Term Extension Periods|Physician Decision|0|||
13234950|NCT01695239|26323698|FG003|Extension Long-Term Extension Periods|Physician Decision|0|||
13234951|NCT01695239|26323699|FG004|Extension Long-Term Extension Periods|Physician Decision|0|||
13234952|NCT01695239|26323700|FG005|Extension Long-Term Extension Periods|Physician Decision|0|||
13234953|NCT01695239|26323701|FG006|Extension Long-Term Extension Periods|Physician Decision|0|||
13234954|NCT01695239|26323702|FG007|Extension Long-Term Extension Periods|Physician Decision|0|||
13234955|NCT01695239|26323703|FG008|Extension Long-Term Extension Periods|Physician Decision|3|||
13234956|NCT01695239|26323704|FG009|Extension Long-Term Extension Periods|Physician Decision|0|||
13234957|NCT01695239|26323705|FG010|Extension Long-Term Extension Periods|Physician Decision|0|||
13234958|NCT01695239|26323706|FG011|Extension Long-Term Extension Periods|Physician Decision|0|||
13234959|NCT01695239|26323707|FG012|Extension Long-Term Extension Periods|Physician Decision|0|||
13234960|NCT01695239|26323708|FG013|Extension Long-Term Extension Periods|Physician Decision|0|||
13234961|NCT01695239|26323695|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
13234962|NCT01695239|26323696|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
13234963|NCT01695239|26323697|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
13234964|NCT01695239|26323698|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
13234965|NCT01695239|26323699|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
13234966|NCT01695239|26323700|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
13234967|NCT01695239|26323701|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
13234968|NCT01695239|26323702|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
13234969|NCT01695239|26323703|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2|||
13234970|NCT01695239|26323704|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1|||
13234971|NCT01695239|26323705|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
13234972|NCT01695239|26323706|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
13234973|NCT01695239|26323707|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
13234974|NCT01695239|26323708|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
13234975|NCT01695239|26323695|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0|||
13234976|NCT01695239|26323696|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0|||
13234977|NCT01695239|26323697|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0|||
13234978|NCT01695239|26323698|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0|||
13234979|NCT01695239|26323699|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0|||
13234980|NCT01695239|26323700|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0|||
13234981|NCT01695239|26323701|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0|||
13234982|NCT01695239|26323702|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0|||
13234983|NCT01695239|26323703|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2|||
13234984|NCT01695239|26323704|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1|||
13234985|NCT01695239|26323705|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0|||
13234986|NCT01695239|26323706|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0|||
13234987|NCT01695239|26323707|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0|||
13234988|NCT01695239|26323708|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0|||
13234989|NCT01695239|26323695|FG000|Extension Long-Term Extension Periods|Death|0|||
13234990|NCT01695239|26323696|FG001|Extension Long-Term Extension Periods|Death|0|||
13234991|NCT01695239|26323697|FG002|Extension Long-Term Extension Periods|Death|0|||
13234992|NCT01695239|26323698|FG003|Extension Long-Term Extension Periods|Death|0|||
13234993|NCT01695239|26323699|FG004|Extension Long-Term Extension Periods|Death|0|||
13234994|NCT01695239|26323700|FG005|Extension Long-Term Extension Periods|Death|0|||
13234995|NCT01695239|26323701|FG006|Extension Long-Term Extension Periods|Death|0|||
13234996|NCT01695239|26323702|FG007|Extension Long-Term Extension Periods|Death|0|||
13234997|NCT01695239|26323703|FG008|Extension Long-Term Extension Periods|Death|1|||
13234998|NCT01695239|26323704|FG009|Extension Long-Term Extension Periods|Death|0|||
13234999|NCT01695239|26323705|FG010|Extension Long-Term Extension Periods|Death|0|||
13235000|NCT01695239|26323706|FG011|Extension Long-Term Extension Periods|Death|0|||
13235001|NCT01695239|26323707|FG012|Extension Long-Term Extension Periods|Death|0|||
13235002|NCT01695239|26323708|FG013|Extension Long-Term Extension Periods|Death|0|||
13235003|NCT01695239|26323695|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
13235004|NCT01695239|26323696|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
13235005|NCT01695239|26323697|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
13235006|NCT01695239|26323698|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
13235007|NCT01695239|26323699|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
13235008|NCT01695239|26323700|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
13235009|NCT01695239|26323701|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
13235010|NCT01695239|26323702|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
13235011|NCT01695239|26323703|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
13235012|NCT01695239|26323704|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
13235013|NCT01695239|26323705|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
13235014|NCT01695239|26323706|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
13235015|NCT01695239|26323707|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
13235016|NCT01695239|26323708|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
13235017|NCT01695239|26323695|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
13235018|NCT01695239|26323696|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
13235019|NCT01695239|26323697|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
13235020|NCT01695239|26323698|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
13235021|NCT01695239|26323699|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
13235022|NCT01695239|26323700|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
13235023|NCT01695239|26323701|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
13235024|NCT01695239|26323702|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
13235025|NCT01695239|26323703|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
13235026|NCT01695239|26323704|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
13235027|NCT01695239|26323705|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
13235028|NCT01695239|26323706|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
13235029|NCT01695239|26323707|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
13235030|NCT01695239|26323708|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
13235031|NCT01695239|26323695|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
13235032|NCT01695239|26323696|FG001|Post-Treatment Follow-Up Period|Physician Decision|0|||
13235033|NCT01695239|26323697|FG002|Post-Treatment Follow-Up Period|Physician Decision|0|||
13235034|NCT01695239|26323698|FG003|Post-Treatment Follow-Up Period|Physician Decision|0|||
13235035|NCT01695239|26323699|FG004|Post-Treatment Follow-Up Period|Physician Decision|0|||
13235036|NCT01695239|26323700|FG005|Post-Treatment Follow-Up Period|Physician Decision|0|||
13235037|NCT01695239|26323701|FG006|Post-Treatment Follow-Up Period|Physician Decision|0|||
13235038|NCT01695239|26323702|FG007|Post-Treatment Follow-Up Period|Physician Decision|0|||
13235039|NCT01695239|26323703|FG008|Post-Treatment Follow-Up Period|Physician Decision|0|||
13235040|NCT01695239|26323704|FG009|Post-Treatment Follow-Up Period|Physician Decision|0|||
13235041|NCT01695239|26323705|FG010|Post-Treatment Follow-Up Period|Physician Decision|0|||
13235042|NCT01695239|26323706|FG011|Post-Treatment Follow-Up Period|Physician Decision|0|||
13235043|NCT01695239|26323707|FG012|Post-Treatment Follow-Up Period|Physician Decision|2|||
13235044|NCT01695239|26323708|FG013|Post-Treatment Follow-Up Period|Physician Decision|0|||
13235045|NCT01695239|26323695|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
13235046|NCT01695239|26323696|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
13235047|NCT01695239|26323697|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
13235048|NCT01695239|26323698|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
13235049|NCT01695239|26323699|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
13235050|NCT01695239|26323700|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
13235051|NCT01695239|26323701|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
13235052|NCT01695239|26323702|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
13235053|NCT01695239|26323703|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
13235054|NCT01695239|26323704|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
13235055|NCT01695239|26323705|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
13235056|NCT01695239|26323706|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
13235057|NCT01695239|26323707|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
13235058|NCT01695239|26323708|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
13235059|NCT01695135|26323739|FG000|Double-blind Treatment Phase|Progressive disease|50|||
13235060|NCT01695135|26323740|FG001|Double-blind Treatment Phase|Progressive disease|110|||
13235061|NCT01695135|26323741|FG002|Double-blind Treatment Phase|Progressive disease|0|||
13235062|NCT01695135|26323742|FG003|Double-blind Treatment Phase|Progressive disease|0|||
13235063|NCT01695135|26323739|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6|||
13235064|NCT01695135|26323740|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14|||
13235065|NCT01695135|26323741|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
13235066|NCT01695135|26323742|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0|||
13235067|NCT01695135|26323739|FG000|Double-blind Treatment Phase|Adverse Event|7|||
13235068|NCT01695135|26323740|FG001|Double-blind Treatment Phase|Adverse Event|7|||
13235069|NCT01695135|26323741|FG002|Double-blind Treatment Phase|Adverse Event|0|||
13235070|NCT01695135|26323742|FG003|Double-blind Treatment Phase|Adverse Event|0|||
13235071|NCT01695135|26323739|FG000|Double-blind Treatment Phase|Other|1|||
13235072|NCT01695135|26323740|FG001|Double-blind Treatment Phase|Other|3|||
13235073|NCT01695135|26323741|FG002|Double-blind Treatment Phase|Other|0|||
13235074|NCT01695135|26323742|FG003|Double-blind Treatment Phase|Other|0|||
13235075|NCT01695135|26323739|FG000|Double-blind Treatment Phase|Physician Decision|6|||
13235076|NCT01695135|26323740|FG001|Double-blind Treatment Phase|Physician Decision|3|||
13235077|NCT01695135|26323741|FG002|Double-blind Treatment Phase|Physician Decision|0|||
13235078|NCT01695135|26323742|FG003|Double-blind Treatment Phase|Physician Decision|0|||
13235079|NCT01695135|26323739|FG000|Double-blind Treatment Phase|Death|1|||
13235080|NCT01695135|26323740|FG001|Double-blind Treatment Phase|Death|1|||
13235081|NCT01695135|26323741|FG002|Double-blind Treatment Phase|Death|0|||
13235082|NCT01695135|26323742|FG003|Double-blind Treatment Phase|Death|0|||
13235083|NCT01695135|26323739|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0|||
13235084|NCT01695135|26323740|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1|||
13235085|NCT01695135|26323741|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0|||
13235086|NCT01695135|26323742|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0|||
13235087|NCT01695135|26323739|FG000|Open Label Extension Treatment Phase|Progressive disease|0|||
13235088|NCT01695135|26323740|FG001|Open Label Extension Treatment Phase|Progressive disease|0|||
13235089|NCT01695135|26323741|FG002|Open Label Extension Treatment Phase|Progressive disease|13|||
13235090|NCT01695135|26323742|FG003|Open Label Extension Treatment Phase|Progressive disease|22|||
13235091|NCT01695135|26323739|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
13235092|NCT01695135|26323740|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
13235093|NCT01695135|26323741|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6|||
13235094|NCT01695135|26323742|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16|||
13235095|NCT01695135|26323739|FG000|Open Label Extension Treatment Phase|Adverse Event|0|||
13235096|NCT01695135|26323740|FG001|Open Label Extension Treatment Phase|Adverse Event|0|||
13235097|NCT01695135|26323741|FG002|Open Label Extension Treatment Phase|Adverse Event|11|||
13235098|NCT01695135|26323742|FG003|Open Label Extension Treatment Phase|Adverse Event|16|||
13235099|NCT01695135|26323739|FG000|Open Label Extension Treatment Phase|Other|0|||
13235100|NCT01695135|26323740|FG001|Open Label Extension Treatment Phase|Other|0|||
13235101|NCT01695135|26323741|FG002|Open Label Extension Treatment Phase|Other|4|||
13235102|NCT01695135|26323742|FG003|Open Label Extension Treatment Phase|Other|7|||
13235103|NCT01695135|26323739|FG000|Open Label Extension Treatment Phase|Physician Decision|0|||
13235104|NCT01695135|26323740|FG001|Open Label Extension Treatment Phase|Physician Decision|0|||
13235105|NCT01695135|26323741|FG002|Open Label Extension Treatment Phase|Physician Decision|4|||
13235106|NCT01695135|26323742|FG003|Open Label Extension Treatment Phase|Physician Decision|1|||
13235107|NCT01695135|26323739|FG000|Open Label Extension Treatment Phase|Death|0|||
13235108|NCT01695135|26323740|FG001|Open Label Extension Treatment Phase|Death|0|||
13235109|NCT01695135|26323741|FG002|Open Label Extension Treatment Phase|Death|2|||
13235110|NCT01695135|26323742|FG003|Open Label Extension Treatment Phase|Death|7|||
13235111|NCT01695135|26323739|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
13235112|NCT01695135|26323740|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
13235113|NCT01695135|26323741|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
13235114|NCT01695135|26323742|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1|||
13235115|NCT01694849|26323901|FG000|Treatment Period (Visit 2 to Visit 8)|Adverse Event|6|||
13235116|NCT01694849|26323902|FG001|Treatment Period (Visit 2 to Visit 8)|Adverse Event|7|||
13235117|NCT01694849|26323903|FG002|Treatment Period (Visit 2 to Visit 8)|Adverse Event|4|||
13235118|NCT01694849|26323901|FG000|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|1|||
13235119|NCT01694849|26323902|FG001|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|3|||
13235120|NCT01694849|26323903|FG002|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|7|||
13235121|NCT01694849|26323901|FG000|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
13235122|NCT01694849|26323902|FG001|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
13235123|NCT01694849|26323903|FG002|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|1|||
13485812|NCT00585195|27033430|FG020|Overall Study|Lost to Follow-up|0|||
13235124|NCT01694849|26323901|FG000|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
13235125|NCT01694849|26323902|FG001|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|0|||
13235126|NCT01694849|26323903|FG002|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
13235127|NCT01694849|26323901|FG000|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
13235128|NCT01694849|26323902|FG001|Treatment Period (Visit 2 to Visit 8)|Non-compliance|0|||
13235129|NCT01694849|26323903|FG002|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
13235130|NCT01694849|26323901|FG000|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
13235131|NCT01694849|26323902|FG001|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|1|||
13235132|NCT01694849|26323903|FG002|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
13235133|NCT01694849|26323901|FG000|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
13235134|NCT01694849|26323902|FG001|Follow-up Period (to Visit 9)|Withdrawal by Subject|1|||
13235135|NCT01694849|26323903|FG002|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
13235136|NCT01694849|26323901|FG000|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
13235137|NCT01694849|26323902|FG001|Follow-up Period (to Visit 9)|Lost to Follow-up|2|||
13235138|NCT01694849|26323903|FG002|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
13235139|NCT01694771|26323934|FG000|Overall Study|Adverse Event|18|||
13235140|NCT01694771|26323935|FG001|Overall Study|Adverse Event|16|||
13235141|NCT01694771|26323934|FG000|Overall Study|Lack of Efficacy|1|||
13235142|NCT01694771|26323935|FG001|Overall Study|Lack of Efficacy|0|||
13235143|NCT01694771|26323934|FG000|Overall Study|Non compliance protocol|7|||
13235144|NCT01694771|26323935|FG001|Overall Study|Non compliance protocol|6|||
13235145|NCT01694771|26323934|FG000|Overall Study|Lost to Follow-up|2|||
13235146|NCT01694771|26323935|FG001|Overall Study|Lost to Follow-up|3|||
13235147|NCT01694771|26323934|FG000|Overall Study|Consent withdrawn|7|||
13235148|NCT01694771|26323935|FG001|Overall Study|Consent withdrawn|9|||
13235149|NCT01694771|26323934|FG000|Overall Study|Other reasons|5|||
13235150|NCT01694771|26323935|FG001|Overall Study|Other reasons|6|||
13235151|NCT01694706|26323954|FG000|Overall Study|Adverse Event|0|||
13235152|NCT01694706|26323955|FG001|Overall Study|Adverse Event|1|||
13235153|NCT01694706|26323956|FG002|Overall Study|Adverse Event|0|||
13235154|NCT01694706|26323954|FG000|Overall Study|other reason not defined above|1|||
13235155|NCT01694706|26323955|FG001|Overall Study|other reason not defined above|0|||
13235156|NCT01694706|26323956|FG002|Overall Study|other reason not defined above|0|||
13235157|NCT01694485|26324004|FG000|Overall Study|Withdrawal by Subject|20|||
13235158|NCT01694485|26324005|FG001|Overall Study|Withdrawal by Subject|6|||
13235159|NCT01694485|26324006|FG002|Overall Study|Withdrawal by Subject|7|||
13235160|NCT01694485|26324007|FG003|Overall Study|Withdrawal by Subject|25|||
13235161|NCT01694485|26324008|FG004|Overall Study|Withdrawal by Subject|18|||
13235162|NCT01694485|26324004|FG000|Overall Study|Sponsor Decision|3|||
13235163|NCT01694485|26324005|FG001|Overall Study|Sponsor Decision|0|||
13235164|NCT01694485|26324006|FG002|Overall Study|Sponsor Decision|0|||
13235165|NCT01694485|26324007|FG003|Overall Study|Sponsor Decision|2|||
13235166|NCT01694485|26324008|FG004|Overall Study|Sponsor Decision|0|||
13235167|NCT01694485|26324004|FG000|Overall Study|Lost to Follow-up|9|||
13235168|NCT01694485|26324005|FG001|Overall Study|Lost to Follow-up|1|||
13235169|NCT01694485|26324006|FG002|Overall Study|Lost to Follow-up|6|||
13235170|NCT01694485|26324007|FG003|Overall Study|Lost to Follow-up|10|||
13235171|NCT01694485|26324008|FG004|Overall Study|Lost to Follow-up|7|||
13235172|NCT01694485|26324004|FG000|Overall Study|Death|1|||
13235173|NCT01694485|26324005|FG001|Overall Study|Death|0|||
13235174|NCT01694485|26324006|FG002|Overall Study|Death|0|||
13235175|NCT01694485|26324007|FG003|Overall Study|Death|1|||
13235176|NCT01694485|26324008|FG004|Overall Study|Death|0|||
13235177|NCT01694433|26324023|FG000|Overall Study|Adverse Event|7|||
13235178|NCT01694433|26324024|FG001|Overall Study|Adverse Event|0|||
13235179|NCT01694433|26324023|FG000|Overall Study|Physician Decision|1|||
13235180|NCT01694433|26324024|FG001|Overall Study|Physician Decision|0|||
13235181|NCT01694433|26324023|FG000|Overall Study|Withdrawal by Subject|3|||
13235182|NCT01694433|26324024|FG001|Overall Study|Withdrawal by Subject|4|||
13235183|NCT01694420|26324035|FG000|Overall Study|Lost to Follow-up|3|||
13235184|NCT01694121|26324054|FG000|Overall Study|Participant used false ID, was withdrawn|1|||
13235185|NCT01694121|26324055|FG001|Overall Study|Participant used false ID, was withdrawn|0|||
13235186|NCT01693692|26324079|FG000|Overall Study|Withdrawal by Subject|12|||
13235187|NCT01693692|26324080|FG001|Overall Study|Withdrawal by Subject|10|||
13235188|NCT01693692|26324081|FG002|Overall Study|Withdrawal by Subject|11|||
13235189|NCT01693692|26324079|FG000|Overall Study|Adverse Event|7|||
13235190|NCT01693692|26324080|FG001|Overall Study|Adverse Event|14|||
13235191|NCT01693692|26324081|FG002|Overall Study|Adverse Event|9|||
13235192|NCT01693692|26324079|FG000|Overall Study|Physician Decision|0|||
13235193|NCT01693692|26324080|FG001|Overall Study|Physician Decision|0|||
13235194|NCT01693692|26324081|FG002|Overall Study|Physician Decision|1|||
13235195|NCT01693692|26324079|FG000|Overall Study|Protocol Violation|5|||
13235196|NCT01693692|26324080|FG001|Overall Study|Protocol Violation|4|||
13235197|NCT01693692|26324081|FG002|Overall Study|Protocol Violation|6|||
13235198|NCT01693692|26324079|FG000|Overall Study|Lost to Follow-up|2|||
13485813|NCT00585195|27033410|FG000|Overall Study|Ongoing|0|||
13235199|NCT01693692|26324080|FG001|Overall Study|Lost to Follow-up|2|||
13235200|NCT01693692|26324081|FG002|Overall Study|Lost to Follow-up|3|||
13235201|NCT01693692|26324079|FG000|Overall Study|Other|4|||
13235202|NCT01693692|26324080|FG001|Overall Study|Other|4|||
13235203|NCT01693692|26324081|FG002|Overall Study|Other|6|||
13235204|NCT01693614|26324113|FG000|Overall Study|Adverse Event|7|||
13235205|NCT01693614|26324114|FG001|Overall Study|Adverse Event|11|||
13235206|NCT01693614|26324115|FG002|Overall Study|Adverse Event|5|||
13235207|NCT01693614|26324113|FG000|Overall Study|Disease progression|11|||
13235208|NCT01693614|26324114|FG001|Overall Study|Disease progression|8|||
13235209|NCT01693614|26324115|FG002|Overall Study|Disease progression|7|||
13235210|NCT01693614|26324113|FG000|Overall Study|Protocol Violation|5|||
13235211|NCT01693614|26324114|FG001|Overall Study|Protocol Violation|2|||
13235212|NCT01693614|26324115|FG002|Overall Study|Protocol Violation|1|||
13235213|NCT01693614|26324113|FG000|Overall Study|Death|1|||
13235214|NCT01693614|26324114|FG001|Overall Study|Death|0|||
13235215|NCT01693614|26324115|FG002|Overall Study|Death|0|||
13235216|NCT01693614|26324113|FG000|Overall Study|Physician Decision|1|||
13235217|NCT01693614|26324114|FG001|Overall Study|Physician Decision|1|||
13235218|NCT01693614|26324115|FG002|Overall Study|Physician Decision|4|||
13235219|NCT01693614|26324113|FG000|Overall Study|Withdrawal by subject/guardian|0|||
13235220|NCT01693614|26324114|FG001|Overall Study|Withdrawal by subject/guardian|0|||
13235221|NCT01693614|26324115|FG002|Overall Study|Withdrawal by subject/guardian|2|||
13235222|NCT01693614|26324113|FG000|Overall Study|Withdrawal by Subject|1|||
13235223|NCT01693614|26324114|FG001|Overall Study|Withdrawal by Subject|0|||
13235224|NCT01693614|26324115|FG002|Overall Study|Withdrawal by Subject|5|||
13235225|NCT01693562|26324399|FG000|Escalation Phase|Withdrawal by Subject|0|||
13235226|NCT01693562|26324400|FG001|Escalation Phase|Withdrawal by Subject|1|||
13235227|NCT01693562|26324401|FG002|Escalation Phase|Withdrawal by Subject|0|||
13235228|NCT01693562|26324402|FG003|Escalation Phase|Withdrawal by Subject|0|||
13235229|NCT01693562|26324403|FG004|Escalation Phase|Withdrawal by Subject|0|||
13235230|NCT01693562|26324404|FG005|Escalation Phase|Withdrawal by Subject|2|||
13235231|NCT01693562|26324405|FG006|Escalation Phase|Withdrawal by Subject|0|||
13235232|NCT01693562|26324406|FG007|Escalation Phase|Withdrawal by Subject|0|||
13235233|NCT01693562|26324407|FG008|Escalation Phase|Withdrawal by Subject|0|||
13235234|NCT01693562|26324408|FG009|Escalation Phase|Withdrawal by Subject|0|||
13235235|NCT01693562|26324409|FG010|Escalation Phase|Withdrawal by Subject|0|||
13235236|NCT01693562|26324410|FG011|Escalation Phase|Withdrawal by Subject|0|||
13235237|NCT01693562|26324411|FG012|Escalation Phase|Withdrawal by Subject|0|||
13235238|NCT01693562|26324412|FG013|Escalation Phase|Withdrawal by Subject|0|||
13235239|NCT01693562|26324413|FG014|Escalation Phase|Withdrawal by Subject|0|||
13235240|NCT01693562|26324414|FG015|Escalation Phase|Withdrawal by Subject|0|||
13235241|NCT01693562|26324415|FG016|Escalation Phase|Withdrawal by Subject|0|||
13235242|NCT01693562|26324416|FG017|Escalation Phase|Withdrawal by Subject|0|||
13235243|NCT01693562|26324417|FG018|Escalation Phase|Withdrawal by Subject|0|||
13235244|NCT01693562|26324418|FG019|Escalation Phase|Withdrawal by Subject|0|||
13235245|NCT01693562|26324419|FG020|Escalation Phase|Withdrawal by Subject|0|||
13235246|NCT01693562|26324420|FG021|Escalation Phase|Withdrawal by Subject|0|||
13235247|NCT01693562|26324421|FG022|Escalation Phase|Withdrawal by Subject|0|||
13235248|NCT01693562|26324399|FG000|Escalation Phase|Death|4|||
13235249|NCT01693562|26324400|FG001|Escalation Phase|Death|2|||
13235250|NCT01693562|26324401|FG002|Escalation Phase|Death|0|||
13235251|NCT01693562|26324402|FG003|Escalation Phase|Death|3|||
13235252|NCT01693562|26324403|FG004|Escalation Phase|Death|6|||
13235253|NCT01693562|26324404|FG005|Escalation Phase|Death|4|||
13235254|NCT01693562|26324405|FG006|Escalation Phase|Death|0|||
13235255|NCT01693562|26324406|FG007|Escalation Phase|Death|0|||
13235256|NCT01693562|26324407|FG008|Escalation Phase|Death|0|||
13235257|NCT01693562|26324408|FG009|Escalation Phase|Death|0|||
13235258|NCT01693562|26324409|FG010|Escalation Phase|Death|0|||
13235259|NCT01693562|26324410|FG011|Escalation Phase|Death|0|||
13235260|NCT01693562|26324411|FG012|Escalation Phase|Death|0|||
13235261|NCT01693562|26324412|FG013|Escalation Phase|Death|0|||
13235262|NCT01693562|26324413|FG014|Escalation Phase|Death|0|||
13235263|NCT01693562|26324414|FG015|Escalation Phase|Death|0|||
13235264|NCT01693562|26324415|FG016|Escalation Phase|Death|0|||
13235265|NCT01693562|26324416|FG017|Escalation Phase|Death|0|||
13235266|NCT01693562|26324417|FG018|Escalation Phase|Death|0|||
13235267|NCT01693562|26324418|FG019|Escalation Phase|Death|0|||
13235268|NCT01693562|26324419|FG020|Escalation Phase|Death|0|||
13235269|NCT01693562|26324420|FG021|Escalation Phase|Death|0|||
13235270|NCT01693562|26324421|FG022|Escalation Phase|Death|0|||
13235271|NCT01693562|26324399|FG000|Escalation Phase|Lost to Follow-up|0|||
13235272|NCT01693562|26324400|FG001|Escalation Phase|Lost to Follow-up|1|||
13235273|NCT01693562|26324401|FG002|Escalation Phase|Lost to Follow-up|1|||
13235274|NCT01693562|26324402|FG003|Escalation Phase|Lost to Follow-up|0|||
13235275|NCT01693562|26324403|FG004|Escalation Phase|Lost to Follow-up|0|||
13235276|NCT01693562|26324404|FG005|Escalation Phase|Lost to Follow-up|0|||
13235277|NCT01693562|26324405|FG006|Escalation Phase|Lost to Follow-up|0|||
13235278|NCT01693562|26324406|FG007|Escalation Phase|Lost to Follow-up|0|||
13235279|NCT01693562|26324407|FG008|Escalation Phase|Lost to Follow-up|0|||
13235280|NCT01693562|26324408|FG009|Escalation Phase|Lost to Follow-up|0|||
13235281|NCT01693562|26324409|FG010|Escalation Phase|Lost to Follow-up|0|||
13235282|NCT01693562|26324410|FG011|Escalation Phase|Lost to Follow-up|0|||
13235283|NCT01693562|26324411|FG012|Escalation Phase|Lost to Follow-up|0|||
13235284|NCT01693562|26324412|FG013|Escalation Phase|Lost to Follow-up|0|||
13235285|NCT01693562|26324413|FG014|Escalation Phase|Lost to Follow-up|0|||
13235286|NCT01693562|26324414|FG015|Escalation Phase|Lost to Follow-up|0|||
13235287|NCT01693562|26324415|FG016|Escalation Phase|Lost to Follow-up|0|||
13235288|NCT01693562|26324416|FG017|Escalation Phase|Lost to Follow-up|0|||
13235289|NCT01693562|26324417|FG018|Escalation Phase|Lost to Follow-up|0|||
13235290|NCT01693562|26324418|FG019|Escalation Phase|Lost to Follow-up|0|||
13235291|NCT01693562|26324419|FG020|Escalation Phase|Lost to Follow-up|0|||
13235292|NCT01693562|26324420|FG021|Escalation Phase|Lost to Follow-up|0|||
13235293|NCT01693562|26324421|FG022|Escalation Phase|Lost to Follow-up|0|||
13235294|NCT01693562|26324399|FG000|Escalation Phase|Other|0|||
13235295|NCT01693562|26324400|FG001|Escalation Phase|Other|0|||
13235296|NCT01693562|26324401|FG002|Escalation Phase|Other|2|||
13235297|NCT01693562|26324402|FG003|Escalation Phase|Other|0|||
13235298|NCT01693562|26324403|FG004|Escalation Phase|Other|0|||
13235299|NCT01693562|26324404|FG005|Escalation Phase|Other|1|||
13235300|NCT01693562|26324405|FG006|Escalation Phase|Other|0|||
13235301|NCT01693562|26324406|FG007|Escalation Phase|Other|0|||
13235302|NCT01693562|26324407|FG008|Escalation Phase|Other|0|||
13235303|NCT01693562|26324408|FG009|Escalation Phase|Other|0|||
13235304|NCT01693562|26324409|FG010|Escalation Phase|Other|0|||
13235305|NCT01693562|26324410|FG011|Escalation Phase|Other|0|||
13235306|NCT01693562|26324411|FG012|Escalation Phase|Other|0|||
13235307|NCT01693562|26324412|FG013|Escalation Phase|Other|0|||
13235308|NCT01693562|26324413|FG014|Escalation Phase|Other|0|||
13235309|NCT01693562|26324414|FG015|Escalation Phase|Other|0|||
13235310|NCT01693562|26324415|FG016|Escalation Phase|Other|0|||
13235311|NCT01693562|26324416|FG017|Escalation Phase|Other|0|||
13235312|NCT01693562|26324417|FG018|Escalation Phase|Other|0|||
13235313|NCT01693562|26324418|FG019|Escalation Phase|Other|0|||
13235314|NCT01693562|26324419|FG020|Escalation Phase|Other|0|||
13235315|NCT01693562|26324420|FG021|Escalation Phase|Other|0|||
13235316|NCT01693562|26324421|FG022|Escalation Phase|Other|0|||
13235317|NCT01693562|26324399|FG000|Exploration Phase|Withdrawal by Subject|0|||
13235318|NCT01693562|26324400|FG001|Exploration Phase|Withdrawal by Subject|0|||
13235319|NCT01693562|26324401|FG002|Exploration Phase|Withdrawal by Subject|0|||
13235320|NCT01693562|26324402|FG003|Exploration Phase|Withdrawal by Subject|0|||
13235321|NCT01693562|26324403|FG004|Exploration Phase|Withdrawal by Subject|0|||
13235322|NCT01693562|26324404|FG005|Exploration Phase|Withdrawal by Subject|0|||
13235323|NCT01693562|26324405|FG006|Exploration Phase|Withdrawal by Subject|2|||
13235324|NCT01693562|26324406|FG007|Exploration Phase|Withdrawal by Subject|0|||
13235325|NCT01693562|26324407|FG008|Exploration Phase|Withdrawal by Subject|0|||
13235326|NCT01693562|26324408|FG009|Exploration Phase|Withdrawal by Subject|0|||
13235327|NCT01693562|26324409|FG010|Exploration Phase|Withdrawal by Subject|0|||
13235328|NCT01693562|26324410|FG011|Exploration Phase|Withdrawal by Subject|0|||
13235329|NCT01693562|26324411|FG012|Exploration Phase|Withdrawal by Subject|0|||
13235330|NCT01693562|26324412|FG013|Exploration Phase|Withdrawal by Subject|0|||
13235331|NCT01693562|26324413|FG014|Exploration Phase|Withdrawal by Subject|0|||
13235332|NCT01693562|26324414|FG015|Exploration Phase|Withdrawal by Subject|0|||
13235333|NCT01693562|26324415|FG016|Exploration Phase|Withdrawal by Subject|0|||
13235334|NCT01693562|26324416|FG017|Exploration Phase|Withdrawal by Subject|0|||
13235335|NCT01693562|26324417|FG018|Exploration Phase|Withdrawal by Subject|0|||
13235336|NCT01693562|26324418|FG019|Exploration Phase|Withdrawal by Subject|0|||
13235337|NCT01693562|26324419|FG020|Exploration Phase|Withdrawal by Subject|0|||
13235338|NCT01693562|26324420|FG021|Exploration Phase|Withdrawal by Subject|0|||
13235339|NCT01693562|26324421|FG022|Exploration Phase|Withdrawal by Subject|0|||
13235340|NCT01693562|26324399|FG000|Exploration Phase|Death|0|||
13235341|NCT01693562|26324400|FG001|Exploration Phase|Death|0|||
13235342|NCT01693562|26324401|FG002|Exploration Phase|Death|0|||
13235343|NCT01693562|26324402|FG003|Exploration Phase|Death|0|||
13235344|NCT01693562|26324403|FG004|Exploration Phase|Death|0|||
13235345|NCT01693562|26324404|FG005|Exploration Phase|Death|0|||
13235346|NCT01693562|26324405|FG006|Exploration Phase|Death|17|||
13235347|NCT01693562|26324406|FG007|Exploration Phase|Death|0|||
13235348|NCT01693562|26324407|FG008|Exploration Phase|Death|0|||
13235349|NCT01693562|26324408|FG009|Exploration Phase|Death|0|||
13235350|NCT01693562|26324409|FG010|Exploration Phase|Death|0|||
13235351|NCT01693562|26324410|FG011|Exploration Phase|Death|0|||
13235352|NCT01693562|26324411|FG012|Exploration Phase|Death|0|||
13235353|NCT01693562|26324412|FG013|Exploration Phase|Death|0|||
13235354|NCT01693562|26324413|FG014|Exploration Phase|Death|0|||
13235355|NCT01693562|26324414|FG015|Exploration Phase|Death|0|||
13235356|NCT01693562|26324415|FG016|Exploration Phase|Death|0|||
13235357|NCT01693562|26324416|FG017|Exploration Phase|Death|0|||
13235358|NCT01693562|26324417|FG018|Exploration Phase|Death|0|||
13235359|NCT01693562|26324418|FG019|Exploration Phase|Death|0|||
13235360|NCT01693562|26324419|FG020|Exploration Phase|Death|0|||
13235361|NCT01693562|26324420|FG021|Exploration Phase|Death|0|||
13235362|NCT01693562|26324421|FG022|Exploration Phase|Death|0|||
13235363|NCT01693562|26324399|FG000|Exploration Phase|Other|0|||
13235364|NCT01693562|26324400|FG001|Exploration Phase|Other|0|||
13235365|NCT01693562|26324401|FG002|Exploration Phase|Other|0|||
13235366|NCT01693562|26324402|FG003|Exploration Phase|Other|0|||
13235367|NCT01693562|26324403|FG004|Exploration Phase|Other|0|||
13235368|NCT01693562|26324404|FG005|Exploration Phase|Other|0|||
13235369|NCT01693562|26324405|FG006|Exploration Phase|Other|2|||
13235370|NCT01693562|26324406|FG007|Exploration Phase|Other|0|||
13235371|NCT01693562|26324407|FG008|Exploration Phase|Other|0|||
13235372|NCT01693562|26324408|FG009|Exploration Phase|Other|0|||
13235373|NCT01693562|26324409|FG010|Exploration Phase|Other|0|||
13235374|NCT01693562|26324410|FG011|Exploration Phase|Other|0|||
13235375|NCT01693562|26324411|FG012|Exploration Phase|Other|0|||
13235376|NCT01693562|26324412|FG013|Exploration Phase|Other|0|||
13235377|NCT01693562|26324413|FG014|Exploration Phase|Other|0|||
13235378|NCT01693562|26324414|FG015|Exploration Phase|Other|0|||
13235379|NCT01693562|26324415|FG016|Exploration Phase|Other|0|||
13235380|NCT01693562|26324416|FG017|Exploration Phase|Other|0|||
13235381|NCT01693562|26324417|FG018|Exploration Phase|Other|0|||
13235382|NCT01693562|26324418|FG019|Exploration Phase|Other|0|||
13235383|NCT01693562|26324419|FG020|Exploration Phase|Other|0|||
13235384|NCT01693562|26324420|FG021|Exploration Phase|Other|0|||
13235385|NCT01693562|26324421|FG022|Exploration Phase|Other|0|||
13235386|NCT01693562|26324399|FG000|Expansion Phase|Withdrawal by Subject|0|||
13235387|NCT01693562|26324400|FG001|Expansion Phase|Withdrawal by Subject|0|||
13235388|NCT01693562|26324401|FG002|Expansion Phase|Withdrawal by Subject|0|||
13235389|NCT01693562|26324402|FG003|Expansion Phase|Withdrawal by Subject|0|||
13235390|NCT01693562|26324403|FG004|Expansion Phase|Withdrawal by Subject|0|||
13235391|NCT01693562|26324404|FG005|Expansion Phase|Withdrawal by Subject|0|||
13235392|NCT01693562|26324405|FG006|Expansion Phase|Withdrawal by Subject|0|||
13235393|NCT01693562|26324406|FG007|Expansion Phase|Withdrawal by Subject|16|||
13235394|NCT01693562|26324407|FG008|Expansion Phase|Withdrawal by Subject|2|||
13235395|NCT01693562|26324408|FG009|Expansion Phase|Withdrawal by Subject|54|||
13235396|NCT01693562|26324409|FG010|Expansion Phase|Withdrawal by Subject|2|||
13235397|NCT01693562|26324410|FG011|Expansion Phase|Withdrawal by Subject|2|||
13235398|NCT01693562|26324411|FG012|Expansion Phase|Withdrawal by Subject|3|||
13235399|NCT01693562|26324412|FG013|Expansion Phase|Withdrawal by Subject|5|||
13235400|NCT01693562|26324413|FG014|Expansion Phase|Withdrawal by Subject|16|||
13235401|NCT01693562|26324414|FG015|Expansion Phase|Withdrawal by Subject|7|||
13235402|NCT01693562|26324415|FG016|Expansion Phase|Withdrawal by Subject|40|||
13235403|NCT01693562|26324416|FG017|Expansion Phase|Withdrawal by Subject|4|||
13235404|NCT01693562|26324417|FG018|Expansion Phase|Withdrawal by Subject|8|||
13235405|NCT01693562|26324418|FG019|Expansion Phase|Withdrawal by Subject|3|||
13235406|NCT01693562|26324419|FG020|Expansion Phase|Withdrawal by Subject|1|||
13235407|NCT01693562|26324420|FG021|Expansion Phase|Withdrawal by Subject|8|||
13235408|NCT01693562|26324421|FG022|Expansion Phase|Withdrawal by Subject|1|||
13235409|NCT01693562|26324399|FG000|Expansion Phase|Death|0|||
13235410|NCT01693562|26324400|FG001|Expansion Phase|Death|0|||
13235411|NCT01693562|26324401|FG002|Expansion Phase|Death|0|||
13235412|NCT01693562|26324402|FG003|Expansion Phase|Death|0|||
13235413|NCT01693562|26324403|FG004|Expansion Phase|Death|0|||
13235414|NCT01693562|26324404|FG005|Expansion Phase|Death|0|||
13235415|NCT01693562|26324405|FG006|Expansion Phase|Death|0|||
13235416|NCT01693562|26324406|FG007|Expansion Phase|Death|42|||
13235417|NCT01693562|26324407|FG008|Expansion Phase|Death|17|||
13235418|NCT01693562|26324408|FG009|Expansion Phase|Death|208|||
13235419|NCT01693562|26324409|FG010|Expansion Phase|Death|30|||
13235420|NCT01693562|26324410|FG011|Expansion Phase|Death|8|||
13235421|NCT01693562|26324411|FG012|Expansion Phase|Death|19|||
13235422|NCT01693562|26324412|FG013|Expansion Phase|Death|42|||
13235423|NCT01693562|26324413|FG014|Expansion Phase|Death|23|||
13235424|NCT01693562|26324414|FG015|Expansion Phase|Death|23|||
13235425|NCT01693562|26324415|FG016|Expansion Phase|Death|128|||
13235426|NCT01693562|26324416|FG017|Expansion Phase|Death|16|||
13235427|NCT01693562|26324417|FG018|Expansion Phase|Death|36|||
13235428|NCT01693562|26324418|FG019|Expansion Phase|Death|16|||
13235429|NCT01693562|26324419|FG020|Expansion Phase|Death|17|||
13235430|NCT01693562|26324420|FG021|Expansion Phase|Death|35|||
13235431|NCT01693562|26324421|FG022|Expansion Phase|Death|7|||
13235432|NCT01693562|26324399|FG000|Expansion Phase|Lost to Follow-up|0|||
13235433|NCT01693562|26324400|FG001|Expansion Phase|Lost to Follow-up|0|||
13235434|NCT01693562|26324401|FG002|Expansion Phase|Lost to Follow-up|0|||
13235435|NCT01693562|26324402|FG003|Expansion Phase|Lost to Follow-up|0|||
13235436|NCT01693562|26324403|FG004|Expansion Phase|Lost to Follow-up|0|||
13235437|NCT01693562|26324404|FG005|Expansion Phase|Lost to Follow-up|0|||
13235438|NCT01693562|26324405|FG006|Expansion Phase|Lost to Follow-up|0|||
13235439|NCT01693562|26324406|FG007|Expansion Phase|Lost to Follow-up|1|||
13235440|NCT01693562|26324407|FG008|Expansion Phase|Lost to Follow-up|2|||
13235441|NCT01693562|26324408|FG009|Expansion Phase|Lost to Follow-up|10|||
13235442|NCT01693562|26324409|FG010|Expansion Phase|Lost to Follow-up|4|||
13235443|NCT01693562|26324410|FG011|Expansion Phase|Lost to Follow-up|4|||
13235444|NCT01693562|26324411|FG012|Expansion Phase|Lost to Follow-up|1|||
13235445|NCT01693562|26324412|FG013|Expansion Phase|Lost to Follow-up|3|||
13235446|NCT01693562|26324413|FG014|Expansion Phase|Lost to Follow-up|0|||
13235447|NCT01693562|26324414|FG015|Expansion Phase|Lost to Follow-up|1|||
13235448|NCT01693562|26324415|FG016|Expansion Phase|Lost to Follow-up|1|||
13235449|NCT01693562|26324416|FG017|Expansion Phase|Lost to Follow-up|0|||
13235450|NCT01693562|26324417|FG018|Expansion Phase|Lost to Follow-up|2|||
13235451|NCT01693562|26324418|FG019|Expansion Phase|Lost to Follow-up|1|||
13235452|NCT01693562|26324419|FG020|Expansion Phase|Lost to Follow-up|2|||
13235453|NCT01693562|26324420|FG021|Expansion Phase|Lost to Follow-up|2|||
13235454|NCT01693562|26324421|FG022|Expansion Phase|Lost to Follow-up|1|||
13235455|NCT01693562|26324399|FG000|Expansion Phase|Other|0|||
13235456|NCT01693562|26324400|FG001|Expansion Phase|Other|0|||
13235457|NCT01693562|26324401|FG002|Expansion Phase|Other|0|||
13235458|NCT01693562|26324402|FG003|Expansion Phase|Other|0|||
13235459|NCT01693562|26324403|FG004|Expansion Phase|Other|0|||
13235460|NCT01693562|26324404|FG005|Expansion Phase|Other|0|||
13235461|NCT01693562|26324405|FG006|Expansion Phase|Other|0|||
13235462|NCT01693562|26324406|FG007|Expansion Phase|Other|3|||
13235463|NCT01693562|26324407|FG008|Expansion Phase|Other|1|||
13235464|NCT01693562|26324408|FG009|Expansion Phase|Other|28|||
13235465|NCT01693562|26324409|FG010|Expansion Phase|Other|4|||
13235466|NCT01693562|26324410|FG011|Expansion Phase|Other|7|||
13235467|NCT01693562|26324411|FG012|Expansion Phase|Other|0|||
13235468|NCT01693562|26324412|FG013|Expansion Phase|Other|1|||
13235469|NCT01693562|26324413|FG014|Expansion Phase|Other|1|||
13235470|NCT01693562|26324414|FG015|Expansion Phase|Other|0|||
13235471|NCT01693562|26324415|FG016|Expansion Phase|Other|28|||
13235472|NCT01693562|26324416|FG017|Expansion Phase|Other|0|||
13235473|NCT01693562|26324417|FG018|Expansion Phase|Other|1|||
13235474|NCT01693562|26324418|FG019|Expansion Phase|Other|0|||
13235475|NCT01693562|26324419|FG020|Expansion Phase|Other|1|||
13235476|NCT01693562|26324420|FG021|Expansion Phase|Other|17|||
13235477|NCT01693562|26324421|FG022|Expansion Phase|Other|1|||
13235478|NCT01693523|26324441|FG000|Overall Study|Adverse Event|2|||
13235479|NCT01693523|26324442|FG001|Overall Study|Adverse Event|1|||
13235480|NCT01693523|26324443|FG002|Overall Study|Adverse Event|0|||
13235481|NCT01693523|26324441|FG000|Overall Study|Death|0|||
13235482|NCT01693523|26324442|FG001|Overall Study|Death|1|||
13235483|NCT01693523|26324443|FG002|Overall Study|Death|1|||
13235484|NCT01693523|26324441|FG000|Overall Study|Lost to Follow-up|0|||
13235485|NCT01693523|26324442|FG001|Overall Study|Lost to Follow-up|0|||
13235486|NCT01693523|26324443|FG002|Overall Study|Lost to Follow-up|4|||
13235487|NCT01693523|26324441|FG000|Overall Study|Physician Decision|0|||
13235488|NCT01693523|26324442|FG001|Overall Study|Physician Decision|0|||
13235489|NCT01693523|26324443|FG002|Overall Study|Physician Decision|1|||
13235490|NCT01693523|26324441|FG000|Overall Study|Withdrawal by Subject|1|||
13235491|NCT01693523|26324442|FG001|Overall Study|Withdrawal by Subject|2|||
13235492|NCT01693523|26324443|FG002|Overall Study|Withdrawal by Subject|2|||
13235493|NCT01693523|26324441|FG000|Overall Study|Lack of compliance study medication|1|||
13235494|NCT01693523|26324442|FG001|Overall Study|Lack of compliance study medication|2|||
13235495|NCT01693523|26324443|FG002|Overall Study|Lack of compliance study medication|0|||
13235496|NCT01693523|26324441|FG000|Overall Study|Chemotherapy was held|1|||
13235497|NCT01693523|26324442|FG001|Overall Study|Chemotherapy was held|2|||
13235498|NCT01693523|26324443|FG002|Overall Study|Chemotherapy was held|0|||
13235499|NCT01693367|26324466|FG000|Overall Study|Withdrawal by Subject|1|||
13235500|NCT01693367|26324467|FG001|Overall Study|Withdrawal by Subject|1|||
13235501|NCT01693367|26324466|FG000|Overall Study|Physician Decision|0|||
13235502|NCT01693367|26324467|FG001|Overall Study|Physician Decision|1|||
13235503|NCT01693250|26324482|FG000|Overall Study|Lost to Follow-up|2|||
13235504|NCT01693250|26324483|FG001|Overall Study|Lost to Follow-up|2|||
13235505|NCT01693185|26324506|FG000|Overall Study|diagnostic procedure after colonoscopy|0|||
13235506|NCT01693185|26324507|FG001|Overall Study|diagnostic procedure after colonoscopy|6|||
13235507|NCT01693120|26324516|FG000|Enrollment|Lost to Follow-up|1|||
13235508|NCT01693120|26324516|FG000|Enrollment|Withdrawal by Subject|10|||
13235509|NCT01693120|26324516|FG000|Enrollment|Protocol Violation|46|||
13235510|NCT01693120|26324516|FG000|Enrollment|Physician Decision|3|||
13235511|NCT01693120|26324516|FG000|Enrollment|Adverse Event|1|||
13235512|NCT01693120|26324516|FG000|Enrollment|Study closed|8|||
13235513|NCT01693120|26324516|FG000|Enrollment|Other|1|||
13235514|NCT01693120|26324516|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1|||
13235515|NCT01693120|26324516|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5|||
13235516|NCT01693120|26324516|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3|||
13235517|NCT01693120|26324516|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1|||
13235518|NCT01693120|26324516|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7|||
13235519|NCT01693068|26324554|FG000|Randomization Period|On-study|2|||
13235520|NCT01693068|26324555|FG001|Randomization Period|On-study|5|||
13235521|NCT01693068|26324556|FG002|Randomization Period|On-study|0|||
13235522|NCT01693068|26324554|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
13235523|NCT01693068|26324555|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
13235524|NCT01693068|26324556|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1|||
13235525|NCT01693029|26324575|FG000|Overall Study|Withdrawal by Subject|15|||
13235526|NCT01693029|26324576|FG001|Overall Study|Withdrawal by Subject|22|||
13235527|NCT01693029|26324575|FG000|Overall Study|Kidney transplantation|7|||
13235528|NCT01693029|26324576|FG001|Overall Study|Kidney transplantation|7|||
13235529|NCT01693029|26324575|FG000|Overall Study|Bindinging anti-EPO antibodies|6|||
13235530|NCT01693029|26324576|FG001|Overall Study|Bindinging anti-EPO antibodies|2|||
13235531|NCT01693029|26324575|FG000|Overall Study|Protocol Violation|6|||
13235532|NCT01693029|26324576|FG001|Overall Study|Protocol Violation|7|||
13235533|NCT01693029|26324575|FG000|Overall Study|Change in dialysis modality|2|||
13235534|NCT01693029|26324576|FG001|Overall Study|Change in dialysis modality|1|||
13235535|NCT01693029|26324575|FG000|Overall Study|Physician Decision|0|||
13235536|NCT01693029|26324576|FG001|Overall Study|Physician Decision|2|||
13235537|NCT01693029|26324575|FG000|Overall Study|Lost to Follow-up|0|||
13235538|NCT01693029|26324576|FG001|Overall Study|Lost to Follow-up|1|||
13235539|NCT01693029|26324575|FG000|Overall Study|Adverse Event|1|||
13235540|NCT01693029|26324576|FG001|Overall Study|Adverse Event|6|||
13235541|NCT01693029|26324575|FG000|Overall Study|Death|5|||
13235542|NCT01693029|26324576|FG001|Overall Study|Death|8|||
13235543|NCT01693029|26324575|FG000|Overall Study|Non-compliance|2|||
13235544|NCT01693029|26324576|FG001|Overall Study|Non-compliance|1|||
13235545|NCT01692938|26324591|FG000|Overall Study|Protocol Deviation|1|||
13235546|NCT01692938|26324592|FG001|Overall Study|Protocol Deviation|1|||
13235547|NCT01692938|26324591|FG000|Overall Study|Study completed prior to site completion|3|||
13235548|NCT01692938|26324592|FG001|Overall Study|Study completed prior to site completion|3|||
13235549|NCT01692782|26324625|FG000|Overall Study|Adverse Event|12|||
13235550|NCT01692782|26324626|FG001|Overall Study|Adverse Event|32|||
13235551|NCT01692782|26324627|FG002|Overall Study|Adverse Event|2|||
13235552|NCT01692782|26324625|FG000|Overall Study|Lack of Efficacy|1|||
13235553|NCT01692782|26324626|FG001|Overall Study|Lack of Efficacy|2|||
13235554|NCT01692782|26324627|FG002|Overall Study|Lack of Efficacy|0|||
13235555|NCT01692782|26324625|FG000|Overall Study|Lost to Follow-up|2|||
13235556|NCT01692782|26324626|FG001|Overall Study|Lost to Follow-up|7|||
13235557|NCT01692782|26324627|FG002|Overall Study|Lost to Follow-up|1|||
13235558|NCT01692782|26324625|FG000|Overall Study|Pregnancy|1|||
13235559|NCT01692782|26324626|FG001|Overall Study|Pregnancy|0|||
13235560|NCT01692782|26324627|FG002|Overall Study|Pregnancy|0|||
13235561|NCT01692782|26324625|FG000|Overall Study|Protocol Violation|1|||
13235562|NCT01692782|26324626|FG001|Overall Study|Protocol Violation|0|||
13235563|NCT01692782|26324627|FG002|Overall Study|Protocol Violation|2|||
13235564|NCT01692782|26324625|FG000|Overall Study|Non-complance with study drug|0|||
13235565|NCT01692782|26324626|FG001|Overall Study|Non-complance with study drug|4|||
13235566|NCT01692782|26324627|FG002|Overall Study|Non-complance with study drug|1|||
13235567|NCT01692782|26324625|FG000|Overall Study|Non-compliant with study visits|0|||
13235568|NCT01692782|26324626|FG001|Overall Study|Non-compliant with study visits|0|||
13235569|NCT01692782|26324627|FG002|Overall Study|Non-compliant with study visits|1|||
13235570|NCT01692782|26324625|FG000|Overall Study|SAE not related to study drug|0|||
13235571|NCT01692782|26324626|FG001|Overall Study|SAE not related to study drug|1|||
13235572|NCT01692782|26324627|FG002|Overall Study|SAE not related to study drug|0|||
13235573|NCT01692782|26324625|FG000|Overall Study|Withdrawal by Subject|3|||
13235574|NCT01692782|26324626|FG001|Overall Study|Withdrawal by Subject|10|||
13235575|NCT01692782|26324627|FG002|Overall Study|Withdrawal by Subject|3|||
13235576|NCT01692730|26324642|FG000|Overall Study|Lost to Follow-up|225|||
13235577|NCT01692730|26324643|FG001|Overall Study|Lost to Follow-up|227|||
13235578|NCT01692626|26324651|FG000|Overall Study|Death|0|||
13235579|NCT01692626|26324652|FG001|Overall Study|Death|1|||
13235580|NCT01692626|26324651|FG000|Overall Study|Adverse Event|2|||
13235581|NCT01692626|26324652|FG001|Overall Study|Adverse Event|3|||
13235582|NCT01692626|26324651|FG000|Overall Study|Protocol Violation|1|||
13235583|NCT01692626|26324652|FG001|Overall Study|Protocol Violation|2|||
13235584|NCT01692626|26324651|FG000|Overall Study|Withdrawal by Subject|1|||
13235585|NCT01692626|26324652|FG001|Overall Study|Withdrawal by Subject|0|||
13235586|NCT01692301|26324685|FG000|Overall Study|Adverse Event|15|||
13235587|NCT01692301|26324686|FG001|Overall Study|Adverse Event|12|||
13235588|NCT01692301|26324685|FG000|Overall Study|Death|1|||
13235589|NCT01692301|26324686|FG001|Overall Study|Death|2|||
13235590|NCT01692301|26324685|FG000|Overall Study|Lack of Efficacy|0|||
13235591|NCT01692301|26324686|FG001|Overall Study|Lack of Efficacy|5|||
13235592|NCT01692301|26324685|FG000|Overall Study|Non-compliance with study treatment|1|||
13235593|NCT01692301|26324686|FG001|Overall Study|Non-compliance with study treatment|2|||
13235594|NCT01692301|26324685|FG000|Overall Study|Protocol deviation|9|||
13235595|NCT01692301|26324686|FG001|Overall Study|Protocol deviation|2|||
13235596|NCT01692301|26324685|FG000|Overall Study|Patient/guardian decision|16|||
13235597|NCT01692301|26324686|FG001|Overall Study|Patient/guardian decision|15|||
13235598|NCT01692301|26324685|FG000|Overall Study|Technical problems|0|||
13235599|NCT01692301|26324686|FG001|Overall Study|Technical problems|1|||
13235600|NCT01692301|26324685|FG000|Overall Study|Physician Decision|2|||
13235601|NCT01692301|26324686|FG001|Overall Study|Physician Decision|2|||
13235602|NCT01692301|26324685|FG000|Overall Study|Lost to Follow-up|1|||
13235603|NCT01692301|26324686|FG001|Overall Study|Lost to Follow-up|1|||
13235604|NCT01692275|26324761|FG000|Overall Study|Lost to Follow-up|57|||
13235605|NCT01692275|26324762|FG001|Overall Study|Lost to Follow-up|48|||
13235606|NCT01692275|26324761|FG000|Overall Study|Withdrawal by Subject|9|||
13235607|NCT01692275|26324762|FG001|Overall Study|Withdrawal by Subject|11|||
13235608|NCT01692197|26324771|FG000|Overall Study|Failed Screening|3|||
13235609|NCT01692119|26324786|FG000|Overall Study|Protocol Violation|3|||
13235610|NCT01692119|26324787|FG001|Overall Study|Protocol Violation|1|||
13235611|NCT01692119|26324786|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17|||
13235612|NCT01692119|26324787|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0|||
13235613|NCT01691898|26324960|FG000|Overall Study|Death|34|||
13235614|NCT01691898|26324961|FG001|Overall Study|Death|32|||
13235615|NCT01691898|26324962|FG002|Overall Study|Death|6|||
13235616|NCT01691898|26324963|FG003|Overall Study|Death|3|||
13235617|NCT01691898|26324964|FG004|Overall Study|Death|8|||
13235618|NCT01691898|26324965|FG005|Overall Study|Death|31|||
13235619|NCT01691898|26324960|FG000|Overall Study|Adverse Event|0|||
13235620|NCT01691898|26324961|FG001|Overall Study|Adverse Event|1|||
13235621|NCT01691898|26324962|FG002|Overall Study|Adverse Event|0|||
13235622|NCT01691898|26324963|FG003|Overall Study|Adverse Event|1|||
13235623|NCT01691898|26324964|FG004|Overall Study|Adverse Event|1|||
13235624|NCT01691898|26324965|FG005|Overall Study|Adverse Event|0|||
13235625|NCT01691898|26324960|FG000|Overall Study|Progression of Disease|1|||
13235626|NCT01691898|26324961|FG001|Overall Study|Progression of Disease|2|||
13235627|NCT01691898|26324962|FG002|Overall Study|Progression of Disease|1|||
13235628|NCT01691898|26324963|FG003|Overall Study|Progression of Disease|0|||
13235629|NCT01691898|26324964|FG004|Overall Study|Progression of Disease|0|||
13235630|NCT01691898|26324965|FG005|Overall Study|Progression of Disease|1|||
13235631|NCT01691898|26324960|FG000|Overall Study|Lost to Follow-up|3|||
13235632|NCT01691898|26324961|FG001|Overall Study|Lost to Follow-up|1|||
13235633|NCT01691898|26324962|FG002|Overall Study|Lost to Follow-up|0|||
13235634|NCT01691898|26324963|FG003|Overall Study|Lost to Follow-up|0|||
13235635|NCT01691898|26324964|FG004|Overall Study|Lost to Follow-up|1|||
13235636|NCT01691898|26324965|FG005|Overall Study|Lost to Follow-up|0|||
13235637|NCT01691898|26324960|FG000|Overall Study|Withdrawal by Subject|9|||
13235638|NCT01691898|26324961|FG001|Overall Study|Withdrawal by Subject|8|||
13235639|NCT01691898|26324962|FG002|Overall Study|Withdrawal by Subject|2|||
13235640|NCT01691898|26324963|FG003|Overall Study|Withdrawal by Subject|1|||
13235641|NCT01691898|26324964|FG004|Overall Study|Withdrawal by Subject|3|||
13235642|NCT01691898|26324965|FG005|Overall Study|Withdrawal by Subject|3|||
13235643|NCT01691898|26324960|FG000|Overall Study|Non-Compliance|0|||
13235644|NCT01691898|26324961|FG001|Overall Study|Non-Compliance|0|||
13235645|NCT01691898|26324962|FG002|Overall Study|Non-Compliance|0|||
13235646|NCT01691898|26324963|FG003|Overall Study|Non-Compliance|0|||
13235647|NCT01691898|26324964|FG004|Overall Study|Non-Compliance|1|||
13235648|NCT01691898|26324965|FG005|Overall Study|Non-Compliance|0|||
13235649|NCT01691885|26324974|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1|||
13235650|NCT01691885|26324975|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1|||
13235651|NCT01691885|26324974|FG000|Washout Period (7-9 Days)|Adverse Event|0|||
13235652|NCT01691885|26324975|FG001|Washout Period (7-9 Days)|Adverse Event|1|||
13235653|NCT01691859|26324996|FG000|Overall Study|Adverse Event|19|||
13235654|NCT01691859|26324996|FG000|Overall Study|Lack of Efficacy|11|||
13235655|NCT01691859|26324996|FG000|Overall Study|Protocol Violation|4|||
13235656|NCT01691859|26324996|FG000|Overall Study|Product commercially available|221|||
13235657|NCT01691859|26324996|FG000|Overall Study|Study closed/terminated|50|||
13235658|NCT01691859|26324996|FG000|Overall Study|Lost to Follow-up|5|||
13235659|NCT01691859|26324996|FG000|Overall Study|Physician Decision|6|||
13235660|NCT01691859|26324996|FG000|Overall Study|Withdrawal by Subject|31|||
13235661|NCT01691820|26325037|FG000|Overall Study|Consent withdrawal (not due to an AE)|9|||
13235662|NCT01691820|26325038|FG001|Overall Study|Consent withdrawal (not due to an AE)|15|||
13235663|NCT01691820|26325037|FG000|Overall Study|Migrated/moved from study area|7|||
13235664|NCT01691820|26325038|FG001|Overall Study|Migrated/moved from study area|4|||
13235665|NCT01691820|26325037|FG000|Overall Study|Lost to Follow-up|6|||
13235666|NCT01691820|26325038|FG001|Overall Study|Lost to Follow-up|17|||
13235667|NCT01691820|26325037|FG000|Overall Study|Other (unspecified)|4|||
13235668|NCT01691820|26325038|FG001|Overall Study|Other (unspecified)|1|||
13235669|NCT01691794|26325062|FG000|Overall Study|Poor/Non-Compliance|1|||
13235670|NCT01691794|26325063|FG001|Overall Study|Poor/Non-Compliance|4|||
13235671|NCT01691794|26325064|FG002|Overall Study|Poor/Non-Compliance|1|||
13235672|NCT01691794|26325062|FG000|Overall Study|Death|0|||
13235673|NCT01691794|26325063|FG001|Overall Study|Death|0|||
13235674|NCT01691794|26325064|FG002|Overall Study|Death|1|||
13235675|NCT01691794|26325062|FG000|Overall Study|Lack of Efficacy|0|||
13235676|NCT01691794|26325063|FG001|Overall Study|Lack of Efficacy|7|||
13235677|NCT01691794|26325064|FG002|Overall Study|Lack of Efficacy|1|||
13235678|NCT01691794|26325062|FG000|Overall Study|Participant request to discontinue|0|||
13235679|NCT01691794|26325063|FG001|Overall Study|Participant request to discontinue|1|||
13235680|NCT01691794|26325064|FG002|Overall Study|Participant request to discontinue|0|||
13235681|NCT01691794|26325062|FG000|Overall Study|Adverse Event|0|||
13235682|NCT01691794|26325063|FG001|Overall Study|Adverse Event|1|||
13235683|NCT01691794|26325064|FG002|Overall Study|Adverse Event|1|||
13235684|NCT01691794|26325062|FG000|Overall Study|Completed Only first 24 weeks of study|0|||
13235685|NCT01691794|26325063|FG001|Overall Study|Completed Only first 24 weeks of study|2|||
13235686|NCT01691794|26325064|FG002|Overall Study|Completed Only first 24 weeks of study|3|||
13235687|NCT01691794|26325062|FG000|Overall Study|Did not complete first 24 weeks of study|0|||
13235688|NCT01691794|26325063|FG001|Overall Study|Did not complete first 24 weeks of study|3|||
13235689|NCT01691794|26325064|FG002|Overall Study|Did not complete first 24 weeks of study|3|||
13235690|NCT01691781|26325081|FG000|Overall Study|Withdrawal by Subject|4|||
13235691|NCT01691781|26325082|FG001|Overall Study|Withdrawal by Subject|3|||
13235692|NCT01691781|26325081|FG000|Overall Study|Physician Decision|1|||
13235693|NCT01691781|26325082|FG001|Overall Study|Physician Decision|1|||
13115494|NCT03097328|25918033|FG000|Overall Study|Ineligible for Study Drug|1|||
13115495|NCT03097315|25918043|FG000|Overall Study|Withdrawal by Subject|1|||
13115496|NCT03097289|25918052|FG000|Overall Study|Adverse Event|1|||
13115497|NCT03097289|25918052|FG000|Overall Study|Equipment failure|2|||
13115498|NCT03097289|25918052|FG000|Overall Study|Collected platelet product unusable|3|||
13115499|NCT03097133|25918109|FG000|Overall Study|Lost to Follow-up|3|||
13115500|NCT03097133|25918110|FG001|Overall Study|Lost to Follow-up|2|||
13115501|NCT03097133|25918109|FG000|Overall Study|Withdrawal by Subject|2|||
13115502|NCT03097133|25918110|FG001|Overall Study|Withdrawal by Subject|5|||
13115503|NCT03097133|25918109|FG000|Overall Study|Discontinued DB, not entered FU Phase|21|||
13235694|NCT01691781|26325081|FG000|Overall Study|Protocol Violation|2|||
13235695|NCT01691781|26325082|FG001|Overall Study|Protocol Violation|2|||
13235696|NCT01691781|26325081|FG000|Overall Study|Adverse Event|0|||
13235697|NCT01691781|26325082|FG001|Overall Study|Adverse Event|1|||
13235698|NCT01691768|26325111|FG000|Overall Study|Death|0|||
13235699|NCT01691768|26325112|FG001|Overall Study|Death|2|||
13235700|NCT01691768|26325111|FG000|Overall Study|Lost to Follow-up|4|||
13235701|NCT01691768|26325112|FG001|Overall Study|Lost to Follow-up|3|||
13235702|NCT01691768|26325111|FG000|Overall Study|Withdrawal by Subject|10|||
13235703|NCT01691768|26325112|FG001|Overall Study|Withdrawal by Subject|9|||
13235704|NCT01691768|26325111|FG000|Overall Study|Relocated|0|||
13235705|NCT01691768|26325112|FG001|Overall Study|Relocated|1|||
13235706|NCT01691768|26325111|FG000|Overall Study|Investigator decision|1|||
13235707|NCT01691768|26325112|FG001|Overall Study|Investigator decision|1|||
13235708|NCT01691612|26325121|FG000|Overall Study|deemed ineligible after 1st visit|6|||
13235709|NCT01691612|26325121|FG000|Overall Study|Adverse Event|1|||
13235710|NCT01691521|26325151|FG000|Overall Study|Adverse Event|4|||
13235711|NCT01691521|26325152|FG001|Overall Study|Adverse Event|0|||
13235712|NCT01691521|26325153|FG002|Overall Study|Adverse Event|1|||
13235713|NCT01691521|26325151|FG000|Overall Study|Lack of Efficacy|1|||
13235714|NCT01691521|26325152|FG001|Overall Study|Lack of Efficacy|1|||
13235715|NCT01691521|26325153|FG002|Overall Study|Lack of Efficacy|2|||
13235716|NCT01691521|26325151|FG000|Overall Study|Protocol Violation|0|||
13235717|NCT01691521|26325152|FG001|Overall Study|Protocol Violation|3|||
13235718|NCT01691521|26325153|FG002|Overall Study|Protocol Violation|0|||
13235719|NCT01691521|26325151|FG000|Overall Study|Lost to Follow-up|0|||
13235720|NCT01691521|26325152|FG001|Overall Study|Lost to Follow-up|2|||
13235721|NCT01691521|26325153|FG002|Overall Study|Lost to Follow-up|2|||
13235722|NCT01691521|26325151|FG000|Overall Study|Physician Decision|2|||
13235723|NCT01691521|26325152|FG001|Overall Study|Physician Decision|1|||
13235724|NCT01691521|26325153|FG002|Overall Study|Physician Decision|0|||
13485814|NCT00585195|27033411|FG001|Overall Study|Ongoing|0|||
13115504|NCT03097133|25918110|FG001|Overall Study|Discontinued DB, not entered FU Phase|25|||
13115505|NCT03097133|25918109|FG000|Overall Study|Other|3|||
13115506|NCT03097133|25918110|FG001|Overall Study|Other|2|||
13115507|NCT03097133|25918109|FG000|Overall Study|Adverse Event|1|||
13115508|NCT03097133|25918110|FG001|Overall Study|Adverse Event|0|||
13115509|NCT03097029|25918117|FG000|Overall Study|Withdrawal by Subject|1|||
13115510|NCT03096847|25918175|FG000|Overall Study|Other|2|||
13115511|NCT03096847|25918176|FG001|Overall Study|Other|1|||
13115512|NCT03096847|25918177|FG002|Overall Study|Other|2|||
13115513|NCT03096847|25918175|FG000|Overall Study|Lost to Follow-up|1|||
13115514|NCT03096847|25918176|FG001|Overall Study|Lost to Follow-up|0|||
13115515|NCT03096847|25918177|FG002|Overall Study|Lost to Follow-up|1|||
13115516|NCT03096847|25918175|FG000|Overall Study|Death|6|||
13115517|NCT03096847|25918176|FG001|Overall Study|Death|0|||
13235725|NCT01691521|26325151|FG000|Overall Study|Withdrawal by Subject|5|||
13235726|NCT01691521|26325152|FG001|Overall Study|Withdrawal by Subject|9|||
13235727|NCT01691521|26325153|FG002|Overall Study|Withdrawal by Subject|4|||
13235728|NCT01691508|26325174|FG000|Overall Study|Adverse Event|3|||
13235729|NCT01691508|26325175|FG001|Overall Study|Adverse Event|3|||
13235730|NCT01691508|26325174|FG000|Overall Study|Withdrawal by Subject|1|||
13235731|NCT01691508|26325175|FG001|Overall Study|Withdrawal by Subject|0|||
13235732|NCT01691482|26325194|FG000|Treatment Period 2|Adverse Event|0|||
13485815|NCT00585195|27033412|FG002|Overall Study|Ongoing|0|||
13235733|NCT01691482|26325195|FG001|Treatment Period 2|Adverse Event|1|||
13235734|NCT01691482|26325194|FG000|Treatment Period 2|Protocol Violation|1|||
13235735|NCT01691482|26325195|FG001|Treatment Period 2|Protocol Violation|1|||
13235736|NCT01691430|26325226|FG000|Overall Study|Death|17|||
13235737|NCT01691430|26325227|FG001|Overall Study|Death|16|||
13235738|NCT01691430|26325226|FG000|Overall Study|Withdrawal by Subject|5|||
13235739|NCT01691430|26325227|FG001|Overall Study|Withdrawal by Subject|1|||
13235740|NCT01691430|26325226|FG000|Overall Study|Lost to Follow-up|0|||
13235741|NCT01691430|26325227|FG001|Overall Study|Lost to Follow-up|3|||
13235742|NCT01691378|26325244|FG000|Overall Study|Withdrawal by Subject|2|||
13235743|NCT01691378|26325245|FG001|Overall Study|Withdrawal by Subject|0|||
13235744|NCT01691378|26325244|FG000|Overall Study|Lost to Follow-up|5|||
13235745|NCT01691378|26325245|FG001|Overall Study|Lost to Follow-up|2|||
13235746|NCT01691248|26325262|FG000|Overall Study|Protocol Violation|43|||
13235747|NCT01691248|26325263|FG001|Overall Study|Protocol Violation|27|||
13235748|NCT01691248|26325262|FG000|Overall Study|Adverse Event|24|||
13235749|NCT01691248|26325263|FG001|Overall Study|Adverse Event|22|||
13235750|NCT01691248|26325262|FG000|Overall Study|Withdrawal by Subject|20|||
13235751|NCT01691248|26325263|FG001|Overall Study|Withdrawal by Subject|18|||
13235752|NCT01691248|26325262|FG000|Overall Study|Confirmed CDAD|14|||
13235753|NCT01691248|26325263|FG001|Overall Study|Confirmed CDAD|31|||
13235754|NCT01691248|26325262|FG000|Overall Study|Lost to Follow-up|2|||
13235755|NCT01691248|26325263|FG001|Overall Study|Lost to Follow-up|5|||
13235756|NCT01691248|26325262|FG000|Overall Study|Reason not provided|4|||
13235757|NCT01691248|26325263|FG001|Overall Study|Reason not provided|4|||
13235758|NCT01691248|26325262|FG000|Overall Study|Not Treated|4|||
13235759|NCT01691248|26325263|FG001|Overall Study|Not Treated|7|||
13235760|NCT01691105|26325290|FG000|1 Month Follow-up|Lost to Follow-up|41|||
13235761|NCT01691105|26325291|FG001|1 Month Follow-up|Lost to Follow-up|38|||
13235762|NCT01691105|26325290|FG000|1 Month Follow-up|Death|2|||
13235763|NCT01691105|26325291|FG001|1 Month Follow-up|Death|3|||
13235764|NCT01691105|26325290|FG000|6 Month Follow-up|Lost to Follow-up|39|||
13235765|NCT01691105|26325291|FG001|6 Month Follow-up|Lost to Follow-up|58|||
13235766|NCT01691105|26325290|FG000|6 Month Follow-up|Death|13|||
13235767|NCT01691105|26325291|FG001|6 Month Follow-up|Death|13|||
13235768|NCT01691105|26325290|FG000|12 Month Follow-up|Lost to Follow-up|50|||
13235769|NCT01691105|26325291|FG001|12 Month Follow-up|Lost to Follow-up|71|||
13235770|NCT01691105|26325290|FG000|12 Month Follow-up|Death|22|||
13235771|NCT01691105|26325291|FG001|12 Month Follow-up|Death|30|||
13235772|NCT01691105|26325290|FG000|12 Month Biochemical Verification|Death|22|||
13235773|NCT01691105|26325291|FG001|12 Month Biochemical Verification|Death|30|||
13235774|NCT01691105|26325290|FG000|12 Month Biochemical Verification|Lost to Follow-up|50|||
13235775|NCT01691105|26325291|FG001|12 Month Biochemical Verification|Lost to Follow-up|71|||
13235776|NCT01691105|26325290|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352|||
13235777|NCT01691105|26325291|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401|||
13235778|NCT01691092|26325297|FG000|Overall Study|Lost to Follow-up|10|||
13235779|NCT01691092|26325297|FG000|Overall Study|Physician Decision|4|||
13235780|NCT01691092|26325297|FG000|Overall Study|Withdrawal by Subject|3|||
13235781|NCT01691092|26325297|FG000|Overall Study|non-compliance|3|||
13235782|NCT01691092|26325297|FG000|Overall Study|used for different study|2|||
13235783|NCT01691092|26325297|FG000|Overall Study|screen fail|19|||
13289734|NCT00107120|26479890|FG001|Overall Study|moving away from site|1|||
13289735|NCT00107120|26479889|FG000|Overall Study|death of parent|0|||
13289736|NCT00107120|26479890|FG001|Overall Study|death of parent|1|||
13289737|NCT00107042|26479960|FG000|Overall Study|Lost to Follow-up|9|||
13289738|NCT00107042|26479961|FG001|Overall Study|Lost to Follow-up|7|||
13289739|NCT00107042|26479960|FG000|Overall Study|Withdrawal by Subject|6|||
13289740|NCT00107042|26479961|FG001|Overall Study|Withdrawal by Subject|1|||
13289741|NCT00107042|26479960|FG000|Overall Study|Moved out of area|5|||
13289742|NCT00107042|26479961|FG001|Overall Study|Moved out of area|3|||
13289743|NCT00107042|26479960|FG000|Overall Study|Pregnancy|1|||
13289744|NCT00107042|26479961|FG001|Overall Study|Pregnancy|1|||
13289745|NCT00107042|26479960|FG000|Overall Study|Inadvertent enrollment|0|||
13289746|NCT00107042|26479961|FG001|Overall Study|Inadvertent enrollment|1|||
13289747|NCT00107042|26479960|FG000|Overall Study|vaccinated outside window|1|||
13289748|NCT00107042|26479961|FG001|Overall Study|vaccinated outside window|1|||
13289749|NCT00107042|26479960|FG000|Overall Study|Disallowed medications|0|||
13289750|NCT00107042|26479961|FG001|Overall Study|Disallowed medications|2|||
13289751|NCT00106964|26479994|FG000|Overall Study|Lost to Follow-up|8|||
13289752|NCT00106964|26479995|FG001|Overall Study|Lost to Follow-up|6|||
13289753|NCT00106964|26479996|FG002|Overall Study|Lost to Follow-up|2|||
13289754|NCT00106964|26479994|FG000|Overall Study|Pregnancy|2|||
13289755|NCT00106964|26479995|FG001|Overall Study|Pregnancy|3|||
13289756|NCT00106964|26479996|FG002|Overall Study|Pregnancy|2|||
13289757|NCT00106964|26479994|FG000|Overall Study|Death|1|||
13289758|NCT00106964|26479995|FG001|Overall Study|Death|1|||
13289759|NCT00106964|26479996|FG002|Overall Study|Death|0|||
13289760|NCT00106964|26479994|FG000|Overall Study|Incarceration|0|||
13289761|NCT00106964|26479995|FG001|Overall Study|Incarceration|1|||
13235784|NCT01691014|26325352|FG000|Overall Study|Premature Termination|1|||
13235785|NCT01691014|26325353|FG001|Overall Study|Premature Termination|6|||
13235786|NCT01691014|26325354|FG002|Overall Study|Premature Termination|0|||
13235787|NCT01691014|26325355|FG003|Overall Study|Premature Termination|3|||
13235788|NCT01691014|26325352|FG000|Overall Study|Other|0|||
13235789|NCT01691014|26325353|FG001|Overall Study|Other|0|||
13235790|NCT01691014|26325354|FG002|Overall Study|Other|2|||
13235791|NCT01691014|26325355|FG003|Overall Study|Other|0|||
13235792|NCT01691014|26325352|FG000|Overall Study|Withdrawal by Subject|0|||
13235793|NCT01691014|26325353|FG001|Overall Study|Withdrawal by Subject|1|||
13235794|NCT01691014|26325354|FG002|Overall Study|Withdrawal by Subject|1|||
13235795|NCT01691014|26325355|FG003|Overall Study|Withdrawal by Subject|1|||
13235796|NCT01691014|26325352|FG000|Overall Study|Adverse Event|0|||
13235797|NCT01691014|26325353|FG001|Overall Study|Adverse Event|5|||
13235798|NCT01691014|26325354|FG002|Overall Study|Adverse Event|1|||
13235799|NCT01691014|26325355|FG003|Overall Study|Adverse Event|1|||
13235800|NCT01691014|26325352|FG000|Overall Study|Lack of Efficacy|2|||
13235801|NCT01691014|26325353|FG001|Overall Study|Lack of Efficacy|3|||
13235802|NCT01691014|26325354|FG002|Overall Study|Lack of Efficacy|7|||
13235803|NCT01691014|26325355|FG003|Overall Study|Lack of Efficacy|0|||
13235804|NCT01690988|26325390|FG000|Overall Study|Withdrawal by Subject|2|||
13235805|NCT01690988|26325391|FG001|Overall Study|Withdrawal by Subject|2|||
13235806|NCT01690988|26325392|FG002|Overall Study|Withdrawal by Subject|3|||
13235807|NCT01690988|26325390|FG000|Overall Study|Physician Decision|0|||
13235808|NCT01690988|26325391|FG001|Overall Study|Physician Decision|0|||
13235809|NCT01690988|26325392|FG002|Overall Study|Physician Decision|1|||
13235810|NCT01690988|26325390|FG000|Overall Study|Operation Cancelled|1|||
13235811|NCT01690988|26325391|FG001|Overall Study|Operation Cancelled|1|||
13235812|NCT01690988|26325392|FG002|Overall Study|Operation Cancelled|0|||
13235813|NCT01690988|26325390|FG000|Overall Study|Determined ineligible|1|||
13235814|NCT01690988|26325391|FG001|Overall Study|Determined ineligible|0|||
13235815|NCT01690988|26325392|FG002|Overall Study|Determined ineligible|0|||
13235816|NCT01690988|26325390|FG000|Overall Study|Death|1|||
13235817|NCT01690988|26325391|FG001|Overall Study|Death|1|||
13235818|NCT01690988|26325392|FG002|Overall Study|Death|1|||
13235819|NCT01690988|26325390|FG000|Overall Study|Sedated|1|||
13235820|NCT01690988|26325391|FG001|Overall Study|Sedated|1|||
13235821|NCT01690988|26325392|FG002|Overall Study|Sedated|2|||
13235822|NCT01690520|26325415|FG000|Overall Study|Death|25|||
13235823|NCT01690520|26325416|FG001|Overall Study|Death|21|||
13235824|NCT01690520|26325415|FG000|Overall Study|Lost to Follow-up|2|||
13235825|NCT01690520|26325416|FG001|Overall Study|Lost to Follow-up|3|||
13235826|NCT01690520|26325415|FG000|Overall Study|Withdrawal by Subject|2|||
13235827|NCT01690520|26325416|FG001|Overall Study|Withdrawal by Subject|0|||
13235828|NCT01690520|26325415|FG000|Overall Study|Relapse|0|||
13235829|NCT01690520|26325416|FG001|Overall Study|Relapse|1|||
13235830|NCT01690520|26325415|FG000|Overall Study|Other|0|||
13235831|NCT01690520|26325416|FG001|Overall Study|Other|1|||
13235832|NCT01690520|26325415|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22|||
13235833|NCT01690520|26325416|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21|||
13235834|NCT01690299|26325471|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
13235835|NCT01690299|26325472|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
13235836|NCT01690299|26325473|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1|||
13235837|NCT01690299|26325474|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
13235838|NCT01690299|26325475|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
13235839|NCT01690299|26325476|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
13235840|NCT01690299|26325471|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4|||
13235841|NCT01690299|26325472|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
13235842|NCT01690299|26325473|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
13235843|NCT01690299|26325474|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
13235844|NCT01690299|26325475|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
13235845|NCT01690299|26325476|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
13235846|NCT01690299|26325471|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1|||
13235847|NCT01690299|26325472|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3|||
13235848|NCT01690299|26325473|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
13235849|NCT01690299|26325474|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
13235850|NCT01690299|26325475|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
13235851|NCT01690299|26325476|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
13235852|NCT01690299|26325471|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2|||
13235853|NCT01690299|26325472|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
13235854|NCT01690299|26325473|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
13235855|NCT01690299|26325474|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
13235856|NCT01690299|26325475|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
13235857|NCT01690299|26325476|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
13235858|NCT01690299|26325471|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
13235859|NCT01690299|26325472|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
13235860|NCT01690299|26325473|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
13235861|NCT01690299|26325474|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
13235862|NCT01690299|26325475|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4|||
13235863|NCT01690299|26325476|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
13235864|NCT01690299|26325471|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
13235865|NCT01690299|26325472|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
13235866|NCT01690299|26325473|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
13235867|NCT01690299|26325474|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9|||
13235868|NCT01690299|26325475|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10|||
13235869|NCT01690299|26325476|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8|||
13235870|NCT01690299|26325471|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
13235871|NCT01690299|26325472|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
13235872|NCT01690299|26325473|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
13235873|NCT01690299|26325474|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
13235874|NCT01690299|26325475|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
13235875|NCT01690299|26325476|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
13235876|NCT01690299|26325471|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
13235877|NCT01690299|26325472|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
13235878|NCT01690299|26325473|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
13235879|NCT01690299|26325474|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8|||
13235880|NCT01690299|26325475|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5|||
13235881|NCT01690299|26325476|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11|||
13235882|NCT01690299|26325471|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
13235883|NCT01690299|26325472|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
13235884|NCT01690299|26325473|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
13235885|NCT01690299|26325474|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
13235886|NCT01690299|26325475|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13|||
13235887|NCT01690299|26325476|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
13235888|NCT01690299|26325471|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
13235889|NCT01690299|26325472|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
13235890|NCT01690299|26325473|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
13235891|NCT01690299|26325474|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
13235892|NCT01690299|26325475|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
13235893|NCT01690299|26325476|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1|||
13235894|NCT01690143|26325486|FG000|Overall Study|Withdrawal by Subject|1|||
13235895|NCT01690130|26325501|FG000|Overall Study|Subject have cancelled visit.|1|||
13235896|NCT01690130|26325502|FG001|Overall Study|Subject have cancelled visit.|0|||
13235897|NCT01690052|26325511|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1|||
13235898|NCT01690052|26325512|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2|||
13235899|NCT01689974|26325525|FG000|Overall Study|Termination of Study|5|||
13235900|NCT01689974|26325526|FG001|Overall Study|Termination of Study|5|||
13235901|NCT01689857|26325539|FG000|Overall Study|Lost to Follow-up|5|||
13235902|NCT01689857|26325540|FG001|Overall Study|Lost to Follow-up|2|||
13235903|NCT01689649|26325552|FG000|Overall Study|Lack of Efficacy|3|||
13235904|NCT01689649|26325552|FG000|Overall Study|Non-compliance|11|||
13235905|NCT01689649|26325552|FG000|Overall Study|Protocol Violation|3|||
13235906|NCT01689649|26325552|FG000|Overall Study|Lost to Follow-up|5|||
13235907|NCT01689532|26325621|FG000|Overall Study|Adverse Event|9|||
13235908|NCT01689532|26325622|FG001|Overall Study|Adverse Event|5|||
13235909|NCT01689532|26325621|FG000|Overall Study|Lack of Efficacy|2|||
13235910|NCT01689532|26325622|FG001|Overall Study|Lack of Efficacy|2|||
13235911|NCT01689532|26325621|FG000|Overall Study|Withdrawal by Subject|1|||
13235912|NCT01689532|26325622|FG001|Overall Study|Withdrawal by Subject|2|||
13235913|NCT01689532|26325621|FG000|Overall Study|Physician Decision|2|||
13235914|NCT01689532|26325622|FG001|Overall Study|Physician Decision|0|||
13235915|NCT01689519|26325641|FG000|Intent to Treat|Death|157|||
13235916|NCT01689519|26325642|FG001|Intent to Treat|Death|167|||
13235917|NCT01689519|26325641|FG000|Intent to Treat|Lost to Follow-up|4|||
13235918|NCT01689519|26325642|FG001|Intent to Treat|Lost to Follow-up|8|||
13235919|NCT01689519|26325641|FG000|Intent to Treat|Other|2|||
13235920|NCT01689519|26325642|FG001|Intent to Treat|Other|4|||
13235921|NCT01689519|26325641|FG000|Intent to Treat|Physician Decision|4|||
13235922|NCT01689519|26325642|FG001|Intent to Treat|Physician Decision|1|||
13235923|NCT01689519|26325641|FG000|Intent to Treat|Study terminated by Spon6sor|59|||
13235924|NCT01689519|26325642|FG001|Intent to Treat|Study terminated by Spon6sor|48|||
13235925|NCT01689519|26325641|FG000|Intent to Treat|Withdrawal by Subject|21|||
13235926|NCT01689519|26325642|FG001|Intent to Treat|Withdrawal by Subject|20|||
13235927|NCT01689519|26325641|FG000|Safety Population|Death|158|||
13235928|NCT01689519|26325642|FG001|Safety Population|Death|165|||
13235929|NCT01689519|26325641|FG000|Safety Population|Lost to Follow-up|4|||
13235930|NCT01689519|26325642|FG001|Safety Population|Lost to Follow-up|8|||
13235931|NCT01689519|26325641|FG000|Safety Population|Other|2|||
13235932|NCT01689519|26325642|FG001|Safety Population|Other|4|||
13235933|NCT01689519|26325641|FG000|Safety Population|Physician Decision|4|||
13235934|NCT01689519|26325642|FG001|Safety Population|Physician Decision|1|||
13235935|NCT01689519|26325641|FG000|Safety Population|Study Terminated By Sponsor|60|||
13235936|NCT01689519|26325642|FG001|Safety Population|Study Terminated By Sponsor|47|||
13235937|NCT01689519|26325641|FG000|Safety Population|Withdrawal by Subject|20|||
13235938|NCT01689519|26325642|FG001|Safety Population|Withdrawal by Subject|20|||
13235939|NCT01689363|26325695|FG000|Overall Study|Protocol Violation|0|||
13235940|NCT01689363|26325696|FG001|Overall Study|Protocol Violation|1|||
13235941|NCT01689363|26325697|FG002|Overall Study|Protocol Violation|0|||
13235942|NCT01689363|26325698|FG003|Overall Study|Protocol Violation|0|||
13235943|NCT01689363|26325699|FG004|Overall Study|Protocol Violation|0|||
13235944|NCT01689363|26325700|FG005|Overall Study|Protocol Violation|0|||
13235945|NCT01689363|26325701|FG006|Overall Study|Protocol Violation|0|||
13235946|NCT01689363|26325702|FG007|Overall Study|Protocol Violation|0|||
13235947|NCT01689337|26325719|FG000|Overall Study|Study Discontinuation|1|||
13235948|NCT01689207|26325849|FG000|Overall Study|Adverse Event|0|||
13235949|NCT01689207|26325850|FG001|Overall Study|Adverse Event|1|||
13235950|NCT01689207|26325851|FG002|Overall Study|Adverse Event|0|||
13235951|NCT01689207|26325852|FG003|Overall Study|Adverse Event|0|||
13235952|NCT01689207|26325853|FG004|Overall Study|Adverse Event|2|||
13235953|NCT01689207|26325854|FG005|Overall Study|Adverse Event|1|||
13235954|NCT01689207|26325855|FG006|Overall Study|Adverse Event|0|||
13235955|NCT01689207|26325856|FG007|Overall Study|Adverse Event|0|||
13235956|NCT01689207|26325857|FG008|Overall Study|Adverse Event|1|||
13235957|NCT01689207|26325858|FG009|Overall Study|Adverse Event|0|||
13235958|NCT01689207|26325859|FG010|Overall Study|Adverse Event|0|||
13235959|NCT01688999|26325883|FG000|Overall Study|Withdrawal by Subject|5|||
13235960|NCT01688999|26325884|FG001|Overall Study|Withdrawal by Subject|1|||
13235961|NCT01688999|26325885|FG002|Overall Study|Withdrawal by Subject|1|||
13235962|NCT01688999|26325883|FG000|Overall Study|Adverse Event|2|||
13235963|NCT01688999|26325884|FG001|Overall Study|Adverse Event|0|||
13235964|NCT01688999|26325885|FG002|Overall Study|Adverse Event|2|||
13235965|NCT01688999|26325883|FG000|Overall Study|Ineligible/Not treated|1|||
13235966|NCT01688999|26325884|FG001|Overall Study|Ineligible/Not treated|0|||
13235967|NCT01688999|26325885|FG002|Overall Study|Ineligible/Not treated|0|||
13235968|NCT01688973|26325904|FG000|Overall Study|Ineligible|2|||
13235969|NCT01688973|26325905|FG001|Overall Study|Ineligible|3|||
13235970|NCT01688921|26325935|FG000|Overall Study|Lost to Follow-up|7|||
13235971|NCT01688921|26325936|FG001|Overall Study|Lost to Follow-up|13|||
13235972|NCT01688921|26325935|FG000|Overall Study|Physician Decision|6|||
13235973|NCT01688921|26325936|FG001|Overall Study|Physician Decision|1|||
13235974|NCT01688921|26325935|FG000|Overall Study|Protocol Violation|0|||
13235975|NCT01688921|26325936|FG001|Overall Study|Protocol Violation|1|||
13235976|NCT01688921|26325935|FG000|Overall Study|informed consent|3|||
13235977|NCT01688921|26325936|FG001|Overall Study|informed consent|0|||
13235978|NCT01688882|26325957|FG000|Overall Study|Adverse Event|1|||
13235979|NCT01688882|26325958|FG001|Overall Study|Adverse Event|0|||
13235980|NCT01688882|26325957|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
13235981|NCT01688882|26325958|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
13235982|NCT01688882|26325957|FG000|Overall Study|Administrative problems|1|||
13235983|NCT01688882|26325958|FG001|Overall Study|Administrative problems|0|||
13235984|NCT01688830|26326166|FG000|Overall Study|Lost to Follow-up|0|||
13235985|NCT01688830|26326167|FG001|Overall Study|Lost to Follow-up|0|||
13235986|NCT01688830|26326168|FG002|Overall Study|Lost to Follow-up|0|||
13235987|NCT01688830|26326169|FG003|Overall Study|Lost to Follow-up|0|||
13235988|NCT01688830|26326170|FG004|Overall Study|Lost to Follow-up|0|||
13235989|NCT01688830|26326171|FG005|Overall Study|Lost to Follow-up|0|||
13235990|NCT01688830|26326172|FG006|Overall Study|Lost to Follow-up|0|||
13235991|NCT01688830|26326173|FG007|Overall Study|Lost to Follow-up|0|||
13235992|NCT01688830|26326174|FG008|Overall Study|Lost to Follow-up|0|||
13235993|NCT01688830|26326175|FG009|Overall Study|Lost to Follow-up|0|||
13235994|NCT01688830|26326176|FG010|Overall Study|Lost to Follow-up|1|||
13235995|NCT01688830|26326177|FG011|Overall Study|Lost to Follow-up|0|||
13235996|NCT01688830|26326178|FG012|Overall Study|Lost to Follow-up|0|||
13235997|NCT01688830|26326179|FG013|Overall Study|Lost to Follow-up|0|||
13235998|NCT01688830|26326180|FG014|Overall Study|Lost to Follow-up|0|||
13235999|NCT01688830|26326181|FG015|Overall Study|Lost to Follow-up|0|||
13236000|NCT01688830|26326182|FG016|Overall Study|Lost to Follow-up|0|||
13236001|NCT01688830|26326183|FG017|Overall Study|Lost to Follow-up|0|||
13236002|NCT01688830|26326184|FG018|Overall Study|Lost to Follow-up|0|||
13236003|NCT01688830|26326185|FG019|Overall Study|Lost to Follow-up|0|||
13236004|NCT01688830|26326186|FG020|Overall Study|Lost to Follow-up|0|||
13236005|NCT01688739|26326291|FG000|Overall Study|Administrative Decision|1|||
13236006|NCT01688739|26326292|FG001|Overall Study|Administrative Decision|0|||
13236007|NCT01688739|26326293|FG002|Overall Study|Administrative Decision|0|||
13236008|NCT01688739|26326294|FG003|Overall Study|Administrative Decision|0|||
13236009|NCT01688739|26326295|FG004|Overall Study|Administrative Decision|0|||
13236010|NCT01688739|26326296|FG005|Overall Study|Administrative Decision|0|||
13236011|NCT01688739|26326297|FG006|Overall Study|Administrative Decision|0|||
13236012|NCT01688739|26326298|FG007|Overall Study|Administrative Decision|0|||
13236013|NCT01688739|26326299|FG008|Overall Study|Administrative Decision|0|||
13236014|NCT01688739|26326300|FG009|Overall Study|Administrative Decision|0|||
13236015|NCT01688726|26326319|FG000|Overall Study|Adverse Event|1|||
13236016|NCT01688726|26326320|FG001|Overall Study|Adverse Event|0|||
13236017|NCT01688726|26326319|FG000|Overall Study|Relocated abroad|0|||
13236018|NCT01688726|26326320|FG001|Overall Study|Relocated abroad|1|||
13236019|NCT01688635|26326335|FG000|Washout 1|Withdrawal by Subject|1|||
13236020|NCT01688635|26326336|FG001|Washout 1|Withdrawal by Subject|0|||
13236021|NCT01688635|26326335|FG000|Washout 1|Adverse Event|0|||
13236022|NCT01688635|26326336|FG001|Washout 1|Adverse Event|1|||
13236023|NCT01688635|26326335|FG000|Washout 1|Physician Decision|0|||
13236024|NCT01688635|26326336|FG001|Washout 1|Physician Decision|1|||
13236025|NCT01688635|26326335|FG000|Washout 2|Physician Decision|1|||
13236026|NCT01688635|26326336|FG001|Washout 2|Physician Decision|0|||
13236027|NCT01688635|26326335|FG000|Washout 2|Withdrawal by Subject|1|||
13236028|NCT01688635|26326336|FG001|Washout 2|Withdrawal by Subject|0|||
13236029|NCT01688635|26326335|FG000|Washout 2|Sponsor Decision|1|||
13236030|NCT01688635|26326336|FG001|Washout 2|Sponsor Decision|2|||
13236031|NCT01688635|26326335|FG000|Washout 3|Withdrawal by Subject|1|||
13236032|NCT01688635|26326336|FG001|Washout 3|Withdrawal by Subject|0|||
13236033|NCT01688466|26326351|FG000|Overall Study|Withdrawal by Subject|2|||
13236034|NCT01688466|26326352|FG001|Overall Study|Withdrawal by Subject|1|||
13236035|NCT01688466|26326351|FG000|Overall Study|Death|0|||
13236036|NCT01688466|26326352|FG001|Overall Study|Death|1|||
13236037|NCT01688466|26326351|FG000|Overall Study|Adverse Event|0|||
13236038|NCT01688466|26326352|FG001|Overall Study|Adverse Event|4|||
13236039|NCT01688466|26326351|FG000|Overall Study|Not evaluable|0|||
13236040|NCT01688466|26326352|FG001|Overall Study|Not evaluable|1|||
13236041|NCT01688050|26326360|FG000|Overall Study|Death|7|||
13236042|NCT01688050|26326360|FG000|Overall Study|Conversion to open repair|1|||
13236043|NCT01688050|26326360|FG000|Overall Study|Lost to Follow-up|13|||
13236044|NCT01688050|26326360|FG000|Overall Study|Withdrawal by Subject|10|||
13236045|NCT01688037|26326384|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
13236046|NCT01688037|26326385|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
13236047|NCT01688037|26326386|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
13236048|NCT01688037|26326384|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1|||
13236049|NCT01688037|26326385|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
13236050|NCT01688037|26326386|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
13236051|NCT01688037|26326384|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4|||
13236052|NCT01688037|26326385|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0|||
13236053|NCT01688037|26326386|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
13236054|NCT01688037|26326384|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
13236055|NCT01688037|26326385|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
13236056|NCT01688037|26326386|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
13236057|NCT01688037|26326384|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
13236058|NCT01688037|26326385|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1|||
13236059|NCT01688037|26326386|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
13236060|NCT01688037|26326384|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4|||
13236061|NCT01688037|26326385|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
13236062|NCT01688037|26326386|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
13236063|NCT01688037|26326384|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
13236064|NCT01688037|26326385|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
13236065|NCT01688037|26326386|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2|||
13236066|NCT01688037|26326384|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1|||
13236067|NCT01688037|26326385|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2|||
13236068|NCT01688037|26326386|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0|||
13236069|NCT01688037|26326384|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
13236070|NCT01688037|26326385|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
13236071|NCT01688037|26326386|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1|||
13236072|NCT01688037|26326384|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
13236073|NCT01688037|26326385|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1|||
13236074|NCT01688037|26326386|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
13236075|NCT01687998|26326409|FG000|Overall Study|Withdrawal by Subject|49|||
13236076|NCT01687998|26326410|FG001|Overall Study|Withdrawal by Subject|51|||
13236077|NCT01687998|26326409|FG000|Overall Study|Known to be Alive at Study End|54|||
13236078|NCT01687998|26326410|FG001|Overall Study|Known to be Alive at Study End|62|||
13236079|NCT01687998|26326409|FG000|Overall Study|Lost to Follow-up|9|||
13236080|NCT01687998|26326410|FG001|Overall Study|Lost to Follow-up|7|||
13236081|NCT01687712|26326455|FG000|Cycle 1|Not Biochemically Pregnant|386|||
13236082|NCT01687712|26326456|FG001|Cycle 1|Not Biochemically Pregnant|348|||
13236083|NCT01687712|26326455|FG000|Cycle 1|Early Pregnancy Loss|43|||
13236084|NCT01687712|26326456|FG001|Cycle 1|Early Pregnancy Loss|60|||
13236085|NCT01687712|26326455|FG000|Cycle 1|Ectopic Pregnancy|5|||
13236086|NCT01687712|26326456|FG001|Cycle 1|Ectopic Pregnancy|5|||
13236087|NCT01687712|26326455|FG000|Cycle 1|Heterotropic Pregnancy|1|||
13236088|NCT01687712|26326456|FG001|Cycle 1|Heterotropic Pregnancy|0|||
13236089|NCT01687712|26326455|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9|||
13236090|NCT01687712|26326456|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14|||
13236091|NCT01687712|26326455|FG000|Cycle 1|Abortion|3|||
13236092|NCT01687712|26326456|FG001|Cycle 1|Abortion|0|||
13236093|NCT01687712|26326455|FG000|Cycle 1|Intrauterine Fetal Death|0|||
13236094|NCT01687712|26326456|FG001|Cycle 1|Intrauterine Fetal Death|1|||
13236095|NCT01687712|26326455|FG000|Cycle 1|Lost to Follow-up|1|||
13236096|NCT01687712|26326456|FG001|Cycle 1|Lost to Follow-up|1|||
13236097|NCT01687712|26326455|FG000|Cycle 2|Not Biochemically Pregnant|74|||
13236098|NCT01687712|26326456|FG001|Cycle 2|Not Biochemically Pregnant|77|||
13236099|NCT01687712|26326455|FG000|Cycle 2|Early Pregnancy Loss|18|||
13236100|NCT01687712|26326456|FG001|Cycle 2|Early Pregnancy Loss|16|||
13236101|NCT01687712|26326455|FG000|Cycle 2|Ectopic Pregnancy|0|||
13236102|NCT01687712|26326456|FG001|Cycle 2|Ectopic Pregnancy|1|||
13236103|NCT01687712|26326455|FG000|Cycle 2|Still Birth|1|||
13236104|NCT01687712|26326456|FG001|Cycle 2|Still Birth|0|||
13236105|NCT01687712|26326455|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0|||
13236106|NCT01687712|26326456|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1|||
13236107|NCT01687712|26326455|FG000|Cycle 3|Not Biochemically Pregnant|21|||
13236108|NCT01687712|26326456|FG001|Cycle 3|Not Biochemically Pregnant|22|||
13236109|NCT01687712|26326455|FG000|Cycle 3|Early Pregnancy Loss|1|||
13236110|NCT01687712|26326456|FG001|Cycle 3|Early Pregnancy Loss|2|||
13236111|NCT01687712|26326455|FG000|Cycle 3|Ectopic Pregnancy|1|||
13236112|NCT01687712|26326456|FG001|Cycle 3|Ectopic Pregnancy|0|||
13236113|NCT01687712|26326455|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1|||
13236114|NCT01687712|26326456|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0|||
13236115|NCT01687673|26326470|FG000|Overall Study|Physician Decision|1|||
13236116|NCT01687595|26326487|FG000|Overall Study|Withdrawal by Subject|8|||
13236117|NCT01687595|26326488|FG001|Overall Study|Withdrawal by Subject|0|||
13236118|NCT01687595|26326487|FG000|Overall Study|Lost to Follow-up|3|||
13236119|NCT01687595|26326488|FG001|Overall Study|Lost to Follow-up|1|||
13236120|NCT01687595|26326487|FG000|Overall Study|Investigator's decision|1|||
13236121|NCT01687595|26326488|FG001|Overall Study|Investigator's decision|0|||
13236122|NCT01687595|26326487|FG000|Overall Study|Sponsor's decision|1|||
13236123|NCT01687595|26326488|FG001|Overall Study|Sponsor's decision|0|||
13236124|NCT01687595|26326487|FG000|Overall Study|Noncompliance|1|||
13236125|NCT01687595|26326488|FG001|Overall Study|Noncompliance|2|||
13236126|NCT01687595|26326487|FG000|Overall Study|Other than specified|56|||
13236127|NCT01687595|26326488|FG001|Overall Study|Other than specified|7|||
13236128|NCT01687478|26326517|FG000|Overall Study|Adverse Event|3|||
13115518|NCT03096847|25918177|FG002|Overall Study|Death|2|||
13236129|NCT01687478|26326518|FG001|Overall Study|Adverse Event|10|||
13236130|NCT01687478|26326517|FG000|Overall Study|Lost to Follow-up|1|||
13236131|NCT01687478|26326518|FG001|Overall Study|Lost to Follow-up|3|||
13236132|NCT01687478|26326517|FG000|Overall Study|Protocol Violation|0|||
13236133|NCT01687478|26326518|FG001|Overall Study|Protocol Violation|2|||
13236134|NCT01687478|26326517|FG000|Overall Study|Withdrawal by Subject|21|||
13236135|NCT01687478|26326518|FG001|Overall Study|Withdrawal by Subject|19|||
13236136|NCT01687478|26326517|FG000|Overall Study|Physician Decision|1|||
13236137|NCT01687478|26326518|FG001|Overall Study|Physician Decision|3|||
13236138|NCT01687478|26326517|FG000|Overall Study|Entry Criteria Not Met|6|||
13236139|NCT01687478|26326518|FG001|Overall Study|Entry Criteria Not Met|2|||
13236140|NCT01687413|26326601|FG000|Overall Study|Withdrawal by Subject|0|||
13236141|NCT01687413|26326602|FG001|Overall Study|Withdrawal by Subject|2|||
13236142|NCT01687413|26326601|FG000|Overall Study|Not eligible|0|||
13236143|NCT01687413|26326602|FG001|Overall Study|Not eligible|2|||
13236144|NCT01687413|26326601|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1|||
13236145|NCT01687413|26326602|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0|||
13236146|NCT01687296|26326629|FG000|Overall Study|Lack of Efficacy|1|||
13236147|NCT01687296|26326630|FG001|Overall Study|Lack of Efficacy|1|||
13236148|NCT01687296|26326629|FG000|Overall Study|Protocol Violation|0|||
13236149|NCT01687296|26326630|FG001|Overall Study|Protocol Violation|1|||
13236150|NCT01687296|26326629|FG000|Overall Study|Withdrawal by Subject|6|||
13236151|NCT01687296|26326630|FG001|Overall Study|Withdrawal by Subject|3|||
13236152|NCT01687283|26326660|FG000|Overall Study|Adverse Event|11|||
13236153|NCT01687283|26326661|FG001|Overall Study|Adverse Event|4|||
13236154|NCT01687283|26326660|FG000|Overall Study|Lack of Efficacy|3|||
13236155|NCT01687283|26326661|FG001|Overall Study|Lack of Efficacy|1|||
13236156|NCT01687283|26326660|FG000|Overall Study|Protocol Violation|1|||
13236157|NCT01687283|26326661|FG001|Overall Study|Protocol Violation|3|||
13236158|NCT01687283|26326660|FG000|Overall Study|protocol defined stopping criteria|8|||
13236159|NCT01687283|26326661|FG001|Overall Study|protocol defined stopping criteria|10|||
13236160|NCT01687283|26326660|FG000|Overall Study|Lost to Follow-up|1|||
13236161|NCT01687283|26326661|FG001|Overall Study|Lost to Follow-up|1|||
13236162|NCT01687283|26326660|FG000|Overall Study|Investigator discretion|2|||
13236163|NCT01687283|26326661|FG001|Overall Study|Investigator discretion|0|||
13236164|NCT01687283|26326660|FG000|Overall Study|Withdrawal by Subject|9|||
13236165|NCT01687283|26326661|FG001|Overall Study|Withdrawal by Subject|8|||
13236166|NCT01687270|26326672|FG000|Overall Study|Lack of Efficacy|11|||
13236167|NCT01687270|26326672|FG000|Overall Study|Lost to Follow-up|1|||
13236168|NCT01687257|26326706|FG000|Overall Study|Efficacy Failure|6|||
13236169|NCT01687257|26326707|FG001|Overall Study|Efficacy Failure|0|||
13236170|NCT01687257|26326708|FG002|Overall Study|Efficacy Failure|5|||
13236171|NCT01687257|26326706|FG000|Overall Study|Subject Withdrew Consent|1|||
13236172|NCT01687257|26326707|FG001|Overall Study|Subject Withdrew Consent|1|||
13236173|NCT01687257|26326708|FG002|Overall Study|Subject Withdrew Consent|1|||
13236174|NCT01687257|26326706|FG000|Overall Study|Adverse Event|1|||
13236175|NCT01687257|26326707|FG001|Overall Study|Adverse Event|0|||
13236176|NCT01687257|26326708|FG002|Overall Study|Adverse Event|0|||
13236177|NCT01687257|26326706|FG000|Overall Study|Investigator's Discretion|0|||
13236178|NCT01687257|26326707|FG001|Overall Study|Investigator's Discretion|3|||
13236179|NCT01687257|26326708|FG002|Overall Study|Investigator's Discretion|0|||
13236180|NCT01687218|26326768|FG000|Overall Study|Withdrawal by Subject|2|||
13236181|NCT01687218|26326769|FG001|Overall Study|Withdrawal by Subject|3|||
13236182|NCT01687218|26326770|FG002|Overall Study|Withdrawal by Subject|0|||
13236183|NCT01687218|26326771|FG003|Overall Study|Withdrawal by Subject|1|||
13236184|NCT01687218|26326772|FG004|Overall Study|Withdrawal by Subject|1|||
13236185|NCT01687218|26326773|FG005|Overall Study|Withdrawal by Subject|0|||
13236186|NCT01687218|26326768|FG000|Overall Study|Relocated, no follow-up planned|1|||
13236187|NCT01687218|26326769|FG001|Overall Study|Relocated, no follow-up planned|0|||
13236188|NCT01687218|26326770|FG002|Overall Study|Relocated, no follow-up planned|1|||
13236189|NCT01687218|26326771|FG003|Overall Study|Relocated, no follow-up planned|1|||
13236190|NCT01687218|26326772|FG004|Overall Study|Relocated, no follow-up planned|0|||
13236191|NCT01687218|26326773|FG005|Overall Study|Relocated, no follow-up planned|0|||
13236192|NCT01687166|26326798|FG000|Overall Study|Attempt subject|2|||
13236193|NCT01687166|26326799|FG001|Overall Study|Attempt subject|3|||
13236194|NCT01687166|26326800|FG002|Overall Study|Attempt subject|2|||
13236195|NCT01687166|26326801|FG003|Overall Study|Attempt subject|0|||
13236196|NCT01687166|26326798|FG000|Overall Study|Did not meet eligibility criteria|4|||
13236197|NCT01687166|26326799|FG001|Overall Study|Did not meet eligibility criteria|6|||
13236198|NCT01687166|26326800|FG002|Overall Study|Did not meet eligibility criteria|1|||
13236199|NCT01687166|26326801|FG003|Overall Study|Did not meet eligibility criteria|1|||
13236200|NCT01687166|26326798|FG000|Overall Study|Adverse Event|2|||
13236201|NCT01687166|26326799|FG001|Overall Study|Adverse Event|1|||
13236202|NCT01687166|26326800|FG002|Overall Study|Adverse Event|0|||
13236203|NCT01687166|26326801|FG003|Overall Study|Adverse Event|0|||
13236204|NCT01687166|26326798|FG000|Overall Study|Physician Decision|3|||
13236205|NCT01687166|26326799|FG001|Overall Study|Physician Decision|2|||
13236206|NCT01687166|26326800|FG002|Overall Study|Physician Decision|1|||
13236207|NCT01687166|26326801|FG003|Overall Study|Physician Decision|0|||
13236208|NCT01687166|26326798|FG000|Overall Study|Withdrawal by Subject|11|||
13236209|NCT01687166|26326799|FG001|Overall Study|Withdrawal by Subject|4|||
13236210|NCT01687166|26326800|FG002|Overall Study|Withdrawal by Subject|3|||
13236211|NCT01687166|26326801|FG003|Overall Study|Withdrawal by Subject|0|||
13236212|NCT01687166|26326798|FG000|Overall Study|Lost to Follow-up|2|||
13236213|NCT01687166|26326799|FG001|Overall Study|Lost to Follow-up|5|||
13236214|NCT01687166|26326800|FG002|Overall Study|Lost to Follow-up|1|||
13236215|NCT01687166|26326801|FG003|Overall Study|Lost to Follow-up|0|||
13236216|NCT01687166|26326798|FG000|Overall Study|Equipment/Device Availability|0|||
13236217|NCT01687166|26326799|FG001|Overall Study|Equipment/Device Availability|1|||
13236218|NCT01687166|26326800|FG002|Overall Study|Equipment/Device Availability|0|||
13236219|NCT01687166|26326801|FG003|Overall Study|Equipment/Device Availability|0|||
13236220|NCT01687166|26326798|FG000|Overall Study|Death|1|||
13236221|NCT01687166|26326799|FG001|Overall Study|Death|1|||
13236222|NCT01687166|26326800|FG002|Overall Study|Death|0|||
13236223|NCT01687166|26326801|FG003|Overall Study|Death|0|||
13236224|NCT01687166|26326798|FG000|Overall Study|Protocol Violation|1|||
13236225|NCT01687166|26326799|FG001|Overall Study|Protocol Violation|1|||
13115519|NCT03096847|25918175|FG000|Overall Study|Protocol Violation|3|||
13236226|NCT01687166|26326800|FG002|Overall Study|Protocol Violation|1|||
13236227|NCT01687166|26326801|FG003|Overall Study|Protocol Violation|0|||
13236228|NCT01687166|26326798|FG000|Overall Study|Subject moved out of state|0|||
13236229|NCT01687166|26326799|FG001|Overall Study|Subject moved out of state|1|||
13236230|NCT01687166|26326800|FG002|Overall Study|Subject moved out of state|0|||
13236231|NCT01687166|26326801|FG003|Overall Study|Subject moved out of state|0|||
13236232|NCT01687166|26326798|FG000|Overall Study|Patient unable to be compliant|1|||
13236233|NCT01687166|26326799|FG001|Overall Study|Patient unable to be compliant|0|||
13236234|NCT01687166|26326800|FG002|Overall Study|Patient unable to be compliant|0|||
13236235|NCT01687166|26326801|FG003|Overall Study|Patient unable to be compliant|0|||
13236236|NCT01687166|26326798|FG000|Overall Study|Physician choice to use different device|1|||
13236237|NCT01687166|26326799|FG001|Overall Study|Physician choice to use different device|2|||
13236238|NCT01687166|26326800|FG002|Overall Study|Physician choice to use different device|4|||
13236239|NCT01687166|26326801|FG003|Overall Study|Physician choice to use different device|0|||
13236240|NCT01687166|26326798|FG000|Overall Study|Insurance|0|||
13236241|NCT01687166|26326799|FG001|Overall Study|Insurance|0|||
13236242|NCT01687166|26326800|FG002|Overall Study|Insurance|1|||
13236243|NCT01687166|26326801|FG003|Overall Study|Insurance|1|||
13236244|NCT01687101|26326807|FG000|Overall Study|Lost to Follow-up|7|||
13236245|NCT01686958|26326820|FG000|Overall Study|Withdrawal by Subject|1|||
13236246|NCT01686932|26326853|FG000|Period 1|Adverse Event|1|||
13236247|NCT01686932|26326854|FG001|Period 1|Adverse Event|1|||
13236248|NCT01686828|26326885|FG000|Overall Study|Physician Decision|1|||
13236249|NCT01686828|26326886|FG001|Overall Study|Physician Decision|0|||
13236250|NCT01686828|26326887|FG002|Overall Study|Physician Decision|0|||
13236251|NCT01686828|26326888|FG003|Overall Study|Physician Decision|0|||
13236252|NCT01686828|26326885|FG000|Overall Study|New Job|0|||
13236253|NCT01686828|26326886|FG001|Overall Study|New Job|1|||
13236254|NCT01686828|26326887|FG002|Overall Study|New Job|0|||
13236255|NCT01686828|26326888|FG003|Overall Study|New Job|0|||
13236256|NCT01686828|26326885|FG000|Overall Study|Weight Loss|0|||
13236257|NCT01686828|26326886|FG001|Overall Study|Weight Loss|0|||
13236258|NCT01686828|26326887|FG002|Overall Study|Weight Loss|1|||
13236259|NCT01686828|26326888|FG003|Overall Study|Weight Loss|0|||
13236260|NCT01686633|26326921|FG000|Overall Study|Lack of Efficacy|33|||
13236261|NCT01686633|26326922|FG001|Overall Study|Lack of Efficacy|13|||
13236262|NCT01686633|26326923|FG002|Overall Study|Lack of Efficacy|11|||
13236263|NCT01686633|26326921|FG000|Overall Study|Withdrawal by Subject|8|||
13236264|NCT01686633|26326922|FG001|Overall Study|Withdrawal by Subject|8|||
13236265|NCT01686633|26326923|FG002|Overall Study|Withdrawal by Subject|5|||
13236266|NCT01686633|26326921|FG000|Overall Study|Physician Decision|3|||
13236267|NCT01686633|26326922|FG001|Overall Study|Physician Decision|4|||
13236268|NCT01686633|26326923|FG002|Overall Study|Physician Decision|4|||
13236269|NCT01686633|26326921|FG000|Overall Study|Adverse Event|4|||
13236270|NCT01686633|26326922|FG001|Overall Study|Adverse Event|3|||
13236271|NCT01686633|26326923|FG002|Overall Study|Adverse Event|3|||
13236272|NCT01686633|26326921|FG000|Overall Study|Protocol Violation|2|||
13236273|NCT01686633|26326922|FG001|Overall Study|Protocol Violation|3|||
13236274|NCT01686633|26326923|FG002|Overall Study|Protocol Violation|0|||
13236275|NCT01686633|26326921|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
13236276|NCT01686633|26326922|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
13236277|NCT01686633|26326923|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
13236278|NCT01686633|26326921|FG000|Overall Study|Lost to Follow-up|0|||
13236279|NCT01686633|26326922|FG001|Overall Study|Lost to Follow-up|1|||
13236280|NCT01686633|26326923|FG002|Overall Study|Lost to Follow-up|1|||
13236281|NCT01686581|26326936|FG000|Overall Study|Side-effects or Health Problems|15|||
13236282|NCT01686581|26326936|FG000|Overall Study|Lack of Efficacy|90|||
13236283|NCT01686581|26326936|FG000|Overall Study|Participant Concerned about Risks|6|||
13236284|NCT01686581|26326936|FG000|Overall Study|Thinks Injections Too Painful|8|||
13236285|NCT01686581|26326936|FG000|Overall Study|Thinks Injections Take Too Much Time|2|||
13236286|NCT01686581|26326936|FG000|Overall Study|Trying to get Pregnant or Nursing|2|||
13236287|NCT01686581|26326936|FG000|Overall Study|Thinks it is Inconvenient|17|||
13236288|NCT01686581|26326936|FG000|Overall Study|Other Miscellaneous Reasons|36|||
13236289|NCT01686581|26326936|FG000|Overall Study|Reason Missing|1|||
13236290|NCT01686568|26326965|FG000|Main Study|Withdrawal by Subject|1|||
13236291|NCT01686568|26326966|FG001|Main Study|Withdrawal by Subject|3|||
13236292|NCT01686568|26326965|FG000|Main Study|Noncompliance with protocol|0|||
13236293|NCT01686568|26326966|FG001|Main Study|Noncompliance with protocol|1|||
13236294|NCT01686568|26326965|FG000|Main Study|Liver enzymes above range of exclusion|1|||
13236295|NCT01686568|26326966|FG001|Main Study|Liver enzymes above range of exclusion|0|||
13236296|NCT01686568|26326965|FG000|Sub-Study|Not consented for sub-study|2|||
13236297|NCT01686568|26326966|FG001|Sub-Study|Not consented for sub-study|2|||
13236298|NCT01686438|26327022|FG000|Overall Study|Lost to Follow-up|8|||
13236299|NCT01686438|26327023|FG001|Overall Study|Lost to Follow-up|9|||
13236300|NCT01686438|26327024|FG002|Overall Study|Lost to Follow-up|10|||
13236301|NCT01686438|26327022|FG000|Overall Study|Adverse Event|0|||
13236302|NCT01686438|26327023|FG001|Overall Study|Adverse Event|0|||
13236303|NCT01686438|26327024|FG002|Overall Study|Adverse Event|1|||
13236304|NCT01686438|26327022|FG000|Overall Study|Protocol Violation|0|||
13236305|NCT01686438|26327023|FG001|Overall Study|Protocol Violation|0|||
13236306|NCT01686438|26327024|FG002|Overall Study|Protocol Violation|1|||
13236307|NCT01686438|26327022|FG000|Overall Study|Withdrawal by Subject|0|||
13236308|NCT01686438|26327023|FG001|Overall Study|Withdrawal by Subject|0|||
13236309|NCT01686438|26327024|FG002|Overall Study|Withdrawal by Subject|1|||
13236310|NCT01686373|26327037|FG000|Overall Study|Lost to Follow-up|3|||
13236311|NCT01686373|26327038|FG001|Overall Study|Lost to Follow-up|0|||
13236312|NCT01686373|26327037|FG000|Overall Study|Withdrawal by Subject|0|||
13236313|NCT01686373|26327038|FG001|Overall Study|Withdrawal by Subject|1|||
13236314|NCT01686373|26327037|FG000|Overall Study|Adverse Event|0|||
13236315|NCT01686373|26327038|FG001|Overall Study|Adverse Event|1|||
13236316|NCT01686152|26327056|FG000|Overall Study|Withdrawal by Subject|11|||
13236317|NCT01686152|26327057|FG001|Overall Study|Withdrawal by Subject|11|||
13236318|NCT01686152|26327058|FG002|Overall Study|Withdrawal by Subject|3|||
13236319|NCT01686152|26327056|FG000|Overall Study|Drug Code Unblinded|0|||
13236320|NCT01686152|26327057|FG001|Overall Study|Drug Code Unblinded|1|||
13236321|NCT01686152|26327058|FG002|Overall Study|Drug Code Unblinded|0|||
13236322|NCT01686152|26327056|FG000|Overall Study|Protocol Violation|6|||
13236323|NCT01686152|26327057|FG001|Overall Study|Protocol Violation|1|||
13236324|NCT01686152|26327058|FG002|Overall Study|Protocol Violation|0|||
13236325|NCT01686152|26327056|FG000|Overall Study|Adverse Event|12|||
13236326|NCT01686152|26327057|FG001|Overall Study|Adverse Event|11|||
13236327|NCT01686152|26327058|FG002|Overall Study|Adverse Event|0|||
13236328|NCT01686152|26327056|FG000|Overall Study|Lack of Efficacy|0|||
13236329|NCT01686152|26327057|FG001|Overall Study|Lack of Efficacy|0|||
13236330|NCT01686152|26327058|FG002|Overall Study|Lack of Efficacy|1|||
13236331|NCT01686152|26327056|FG000|Overall Study|IP Non-compliance|5|||
13236332|NCT01686152|26327057|FG001|Overall Study|IP Non-compliance|5|||
13236333|NCT01686152|26327058|FG002|Overall Study|IP Non-compliance|0|||
13236334|NCT01686152|26327056|FG000|Overall Study|Lost to Follow-up|7|||
13236335|NCT01686152|26327057|FG001|Overall Study|Lost to Follow-up|6|||
13236336|NCT01686152|26327058|FG002|Overall Study|Lost to Follow-up|5|||
13236337|NCT01685983|26327070|FG000|Overall Study|Adverse Event|7|||
13236338|NCT01685983|26327070|FG000|Overall Study|Death|1|||
13236339|NCT01685983|26327070|FG000|Overall Study|Withdrawal by Subject|19|||
13236340|NCT01685983|26327070|FG000|Overall Study|Protocol Violation|2|||
13236341|NCT01685983|26327070|FG000|Overall Study|Physician Decision|13|||
13236342|NCT01685983|26327070|FG000|Overall Study|Other|7|||
13236343|NCT01685983|26327070|FG000|Overall Study|Progressive Disease|32|||
13236344|NCT01685983|26327070|FG000|Overall Study|Noncompliance with Study Drug|1|||
13236345|NCT01685840|26327117|FG000|Overall Study|Death|77|||
13236346|NCT01685840|26327118|FG001|Overall Study|Death|66|||
13236347|NCT01685840|26327117|FG000|Overall Study|Lost to Follow-up|27|||
13236348|NCT01685840|26327118|FG001|Overall Study|Lost to Follow-up|25|||
13236349|NCT01685840|26327117|FG000|Overall Study|Physician Decision|3|||
13236350|NCT01685840|26327118|FG001|Overall Study|Physician Decision|7|||
13236351|NCT01685840|26327117|FG000|Overall Study|Withdrawal by Subject|14|||
13236352|NCT01685840|26327118|FG001|Overall Study|Withdrawal by Subject|17|||
13236353|NCT01685840|26327117|FG000|Overall Study|Futility|197|||
13236354|NCT01685840|26327118|FG001|Overall Study|Futility|200|||
13236355|NCT01685840|26327117|FG000|Overall Study|Had VAD, Dialysis or Transplant|11|||
13236356|NCT01685840|26327118|FG001|Overall Study|Had VAD, Dialysis or Transplant|17|||
13236357|NCT01685801|26327151|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
13236358|NCT01685801|26327152|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
13236359|NCT01685801|26327153|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
13236360|NCT01685801|26327154|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1|||
13236361|NCT01685801|26327151|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
13236362|NCT01685801|26327152|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
13236363|NCT01685801|26327153|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
13236364|NCT01685801|26327154|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
13236365|NCT01685697|26327167|FG000|Overall Study|Protocol Violation|3|||
13236366|NCT01685697|26327168|FG001|Overall Study|Protocol Violation|3|||
13236367|NCT01685606|26327175|FG000|Overall Study|Withdrawal by Subject|1|||
13236368|NCT01685437|26327189|FG000|Overall Study|Withdrawal by Subject|22|||
13236369|NCT01685437|26327189|FG000|Overall Study|Lost to Follow-up|3|||
13236370|NCT01685437|26327189|FG000|Overall Study|Adverse Event|1|||
13236371|NCT01685437|26327189|FG000|Overall Study|Protocol Violation|4|||
13236372|NCT01685437|26327189|FG000|Overall Study|Unable to make visits due to work|1|||
13236373|NCT01685372|26327216|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3|||
13236374|NCT01685372|26327217|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4|||
13236375|NCT01685229|26327250|FG000|Overall Study|Subjects missing Study Exit form|3|||
13236376|NCT01685229|26327251|FG001|Overall Study|Subjects missing Study Exit form|1|||
13236377|NCT01685229|26327250|FG000|Overall Study|Lost to Follow-up|16|||
13236378|NCT01685229|26327251|FG001|Overall Study|Lost to Follow-up|10|||
13236379|NCT01685229|26327250|FG000|Overall Study|Withdrawal by Subject|6|||
13236380|NCT01685229|26327251|FG001|Overall Study|Withdrawal by Subject|5|||
13236381|NCT01685229|26327250|FG000|Overall Study|Death|1|||
13236382|NCT01685229|26327251|FG001|Overall Study|Death|0|||
13236383|NCT01685216|26327263|FG000|Overall Study|Did not receive study drug|1|||
13236384|NCT01685203|26327329|FG000|Overall Study|Lost to Follow-up|3|||
13236385|NCT01685203|26327330|FG001|Overall Study|Lost to Follow-up|3|||
13236386|NCT01685203|26327331|FG002|Overall Study|Lost to Follow-up|0|||
13236387|NCT01685203|26327332|FG003|Overall Study|Lost to Follow-up|1|||
13236388|NCT01685203|26327333|FG004|Overall Study|Lost to Follow-up|0|||
13236389|NCT01685203|26327334|FG005|Overall Study|Lost to Follow-up|0|||
13236390|NCT01685203|26327335|FG006|Overall Study|Lost to Follow-up|0|||
13236391|NCT01685203|26327329|FG000|Overall Study|Adverse Event|0|||
13236392|NCT01685203|26327330|FG001|Overall Study|Adverse Event|0|||
13236393|NCT01685203|26327331|FG002|Overall Study|Adverse Event|0|||
13236394|NCT01685203|26327332|FG003|Overall Study|Adverse Event|0|||
13236395|NCT01685203|26327333|FG004|Overall Study|Adverse Event|0|||
13236396|NCT01685203|26327334|FG005|Overall Study|Adverse Event|2|||
13236397|NCT01685203|26327335|FG006|Overall Study|Adverse Event|0|||
13236398|NCT01685203|26327329|FG000|Overall Study|Adverse event and withdrew consent|1|||
13236399|NCT01685203|26327330|FG001|Overall Study|Adverse event and withdrew consent|0|||
13236400|NCT01685203|26327331|FG002|Overall Study|Adverse event and withdrew consent|0|||
13236401|NCT01685203|26327332|FG003|Overall Study|Adverse event and withdrew consent|0|||
13236402|NCT01685203|26327333|FG004|Overall Study|Adverse event and withdrew consent|0|||
13236403|NCT01685203|26327334|FG005|Overall Study|Adverse event and withdrew consent|0|||
13236404|NCT01685203|26327335|FG006|Overall Study|Adverse event and withdrew consent|0|||
13236405|NCT01685203|26327329|FG000|Overall Study|Patient's decision|0|||
13236406|NCT01685203|26327330|FG001|Overall Study|Patient's decision|0|||
13236407|NCT01685203|26327331|FG002|Overall Study|Patient's decision|0|||
13236408|NCT01685203|26327332|FG003|Overall Study|Patient's decision|0|||
13236409|NCT01685203|26327333|FG004|Overall Study|Patient's decision|0|||
13236410|NCT01685203|26327334|FG005|Overall Study|Patient's decision|1|||
13236411|NCT01685203|26327335|FG006|Overall Study|Patient's decision|0|||
13236412|NCT01685138|26327351|FG000|Overall Study|Lost to Follow-up|1|||
13236413|NCT01685138|26327351|FG000|Overall Study|Protocol Violation|1|||
13236414|NCT01685138|26327351|FG000|Overall Study|No longer requires treatment|1|||
13236415|NCT01685138|26327351|FG000|Overall Study|Subject/guardian decision|2|||
13236416|NCT01685138|26327351|FG000|Overall Study|Physician Decision|6|||
13236417|NCT01685138|26327351|FG000|Overall Study|Death|10|||
13236418|NCT01685138|26327351|FG000|Overall Study|Adverse Event|18|||
13236419|NCT01685138|26327351|FG000|Overall Study|Progressive disease|53|||
13236420|NCT01685073|26327366|FG000|Overall Study|Lost to Follow-up|6|||
13236421|NCT01685073|26327367|FG001|Overall Study|Lost to Follow-up|8|||
13236422|NCT01685073|26327366|FG000|Overall Study|Withdrawal by Subject|24|||
13236423|NCT01685073|26327367|FG001|Overall Study|Withdrawal by Subject|24|||
13236424|NCT01685060|26327384|FG000|Overall Study|Rollover patients|16|||
13236425|NCT01685060|26327384|FG000|Overall Study|Adverse Event|12|||
13236426|NCT01685060|26327384|FG000|Overall Study|Progressive disease|69|||
13236427|NCT01685060|26327384|FG000|Overall Study|Physician Decision|14|||
13236428|NCT01685060|26327384|FG000|Overall Study|Subject/guardian decision|20|||
13236429|NCT01685060|26327384|FG000|Overall Study|Lost to Follow-up|1|||
13236430|NCT01685060|26327384|FG000|Overall Study|Death|8|||
13236431|NCT01685047|26327390|FG000|Overall Study|Withdrawal by Subject|20|||
13236432|NCT01685047|26327390|FG000|Overall Study|Death|26|||
13236433|NCT01685047|26327390|FG000|Overall Study|Lost to Follow-up|8|||
13236434|NCT01685047|26327390|FG000|Overall Study|Physician Decision|25|||
13236435|NCT01685047|26327390|FG000|Overall Study|Adverse Event|5|||
13236436|NCT01685047|26327390|FG000|Overall Study|patient withdrawn by sponsor|1|||
13236437|NCT01684943|26327417|FG000|Overall Study|Inadequate Venous Access|3|||
13236438|NCT01684943|26327418|FG001|Overall Study|Inadequate Venous Access|0|||
13236439|NCT01684943|26327419|FG002|Overall Study|Inadequate Venous Access|0|||
13236440|NCT01684943|26327417|FG000|Overall Study|Principal Investigator Determination|1|||
13236441|NCT01684943|26327418|FG001|Overall Study|Principal Investigator Determination|0|||
13236442|NCT01684943|26327419|FG002|Overall Study|Principal Investigator Determination|0|||
13236443|NCT01684943|26327417|FG000|Overall Study|Excluded from Analysis|1|||
13236444|NCT01684943|26327418|FG001|Overall Study|Excluded from Analysis|1|||
13236445|NCT01684943|26327419|FG002|Overall Study|Excluded from Analysis|1|||
13236446|NCT01684943|26327417|FG000|Overall Study|Lost to Follow-up|3|||
13236447|NCT01684943|26327418|FG001|Overall Study|Lost to Follow-up|0|||
13236448|NCT01684943|26327419|FG002|Overall Study|Lost to Follow-up|0|||
13236449|NCT01684943|26327417|FG000|Overall Study|Planning Pregnancy|1|||
13236450|NCT01684943|26327418|FG001|Overall Study|Planning Pregnancy|0|||
13236451|NCT01684943|26327419|FG002|Overall Study|Planning Pregnancy|0|||
13236452|NCT01684930|26327442|FG000|Overall Study|Withdrawal by Subject|3|||
13236453|NCT01684930|26327443|FG001|Overall Study|Withdrawal by Subject|1|||
13236454|NCT01684878|26327480|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
13236455|NCT01684878|26327481|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
13236456|NCT01684878|26327482|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
13236457|NCT01684878|26327483|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
13236458|NCT01684878|26327480|FG000|Part 1: Safety Run in Phase|Death|15|||
13236459|NCT01684878|26327481|FG001|Part 1: Safety Run in Phase|Death|20|||
13236460|NCT01684878|26327482|FG002|Part 1: Safety Run in Phase|Death|0|||
13236461|NCT01684878|26327483|FG003|Part 1: Safety Run in Phase|Death|0|||
13236462|NCT01684878|26327480|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
13236463|NCT01684878|26327481|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2|||
13236464|NCT01684878|26327482|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
13236465|NCT01684878|26327483|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
13236466|NCT01684878|26327480|FG000|Part 2: Randomized Phase|Participant withdrew consent|0|||
13236467|NCT01684878|26327481|FG001|Part 2: Randomized Phase|Participant withdrew consent|0|||
13236468|NCT01684878|26327482|FG002|Part 2: Randomized Phase|Participant withdrew consent|1|||
13236469|NCT01684878|26327483|FG003|Part 2: Randomized Phase|Participant withdrew consent|2|||
13236470|NCT01684878|26327480|FG000|Part 2: Randomized Phase|Lost to Follow-up|0|||
13236471|NCT01684878|26327481|FG001|Part 2: Randomized Phase|Lost to Follow-up|0|||
13236472|NCT01684878|26327482|FG002|Part 2: Randomized Phase|Lost to Follow-up|2|||
13236473|NCT01684878|26327483|FG003|Part 2: Randomized Phase|Lost to Follow-up|0|||
13236474|NCT01684878|26327480|FG000|Part 2: Randomized Phase|Death|0|||
13236475|NCT01684878|26327481|FG001|Part 2: Randomized Phase|Death|0|||
13236476|NCT01684878|26327482|FG002|Part 2: Randomized Phase|Death|62|||
13236477|NCT01684878|26327483|FG003|Part 2: Randomized Phase|Death|68|||
13236478|NCT01684878|26327480|FG000|Part 2: Randomized Phase|Alive at data-cut|0|||
13236479|NCT01684878|26327481|FG001|Part 2: Randomized Phase|Alive at data-cut|0|||
13236480|NCT01684878|26327482|FG002|Part 2: Randomized Phase|Alive at data-cut|13|||
13236481|NCT01684878|26327483|FG003|Part 2: Randomized Phase|Alive at data-cut|7|||
13236482|NCT01684878|26327480|FG000|Part 2: Randomized Phase|Participant noncompliance|0|||
13236483|NCT01684878|26327481|FG001|Part 2: Randomized Phase|Participant noncompliance|0|||
13236484|NCT01684878|26327482|FG002|Part 2: Randomized Phase|Participant noncompliance|0|||
13236485|NCT01684878|26327483|FG003|Part 2: Randomized Phase|Participant noncompliance|1|||
13236486|NCT01684722|26327522|FG000|Overall Study|Lost to Follow-up|78|||
13236487|NCT01684722|26327523|FG001|Overall Study|Lost to Follow-up|56|||
13236488|NCT01684722|26327524|FG002|Overall Study|Lost to Follow-up|75|||
13236489|NCT01684722|26327525|FG003|Overall Study|Lost to Follow-up|89|||
13236490|NCT01684722|26327522|FG000|Overall Study|Death|19|||
13236491|NCT01684722|26327523|FG001|Overall Study|Death|21|||
13236492|NCT01684722|26327524|FG002|Overall Study|Death|19|||
13236493|NCT01684722|26327525|FG003|Overall Study|Death|21|||
13236494|NCT01684423|26327575|FG000|Overall Study|Withdrawal by Subject|0|||
13236495|NCT01684423|26327576|FG001|Overall Study|Withdrawal by Subject|0|||
13236496|NCT01684423|26327577|FG002|Overall Study|Withdrawal by Subject|1|||
13236497|NCT01684423|26327578|FG003|Overall Study|Withdrawal by Subject|0|||
13236498|NCT01684423|26327579|FG004|Overall Study|Withdrawal by Subject|0|||
13236499|NCT01684215|26327666|FG000|Phase 1, Part 1|Adverse Event|1|||
13236500|NCT01684215|26327667|FG001|Phase 1, Part 1|Adverse Event|0|||
13236501|NCT01684215|26327668|FG002|Phase 1, Part 1|Adverse Event|0|||
13236502|NCT01684215|26327669|FG003|Phase 1, Part 1|Adverse Event|0|||
13236503|NCT01684215|26327666|FG000|Phase 1, Part 1|Objective progression or relapse|5|||
13236504|NCT01684215|26327667|FG001|Phase 1, Part 1|Objective progression or relapse|6|||
13236505|NCT01684215|26327668|FG002|Phase 1, Part 1|Objective progression or relapse|0|||
13236506|NCT01684215|26327669|FG003|Phase 1, Part 1|Objective progression or relapse|0|||
13236507|NCT01684215|26327666|FG000|Phase 1, Part 2|Adverse Event|0|||
13236508|NCT01684215|26327667|FG001|Phase 1, Part 2|Adverse Event|0|||
13236509|NCT01684215|26327668|FG002|Phase 1, Part 2|Adverse Event|1|||
13236510|NCT01684215|26327669|FG003|Phase 1, Part 2|Adverse Event|0|||
13236511|NCT01684215|26327666|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
13236512|NCT01684215|26327667|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
13236513|NCT01684215|26327668|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4|||
13236514|NCT01684215|26327669|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
13236515|NCT01684215|26327666|FG000|Phase 1, Part 2|Withdrawal by Subject|0|||
13236516|NCT01684215|26327667|FG001|Phase 1, Part 2|Withdrawal by Subject|0|||
13236517|NCT01684215|26327668|FG002|Phase 1, Part 2|Withdrawal by Subject|1|||
13236518|NCT01684215|26327669|FG003|Phase 1, Part 2|Withdrawal by Subject|0|||
13236519|NCT01684215|26327666|FG000|Phase 2|Death|0|||
13236520|NCT01684215|26327667|FG001|Phase 2|Death|0|||
13236521|NCT01684215|26327668|FG002|Phase 2|Death|0|||
13236522|NCT01684215|26327669|FG003|Phase 2|Death|8|||
13236523|NCT01684215|26327666|FG000|Phase 2|Study terminated by sponsor|0|||
13115520|NCT03096847|25918176|FG001|Overall Study|Protocol Violation|0|||
13236524|NCT01684215|26327667|FG001|Phase 2|Study terminated by sponsor|0|||
13236525|NCT01684215|26327668|FG002|Phase 2|Study terminated by sponsor|0|||
13236526|NCT01684215|26327669|FG003|Phase 2|Study terminated by sponsor|30|||
13236527|NCT01684215|26327666|FG000|Phase 2|Enrolled but not treated|0|||
13236528|NCT01684215|26327667|FG001|Phase 2|Enrolled but not treated|0|||
13236529|NCT01684215|26327668|FG002|Phase 2|Enrolled but not treated|0|||
13236530|NCT01684215|26327669|FG003|Phase 2|Enrolled but not treated|1|||
13236531|NCT01684215|26327666|FG000|Phase 2|Lost to Follow-up|0|||
13236532|NCT01684215|26327667|FG001|Phase 2|Lost to Follow-up|0|||
13236533|NCT01684215|26327668|FG002|Phase 2|Lost to Follow-up|0|||
13236534|NCT01684215|26327669|FG003|Phase 2|Lost to Follow-up|4|||
13236535|NCT01684202|26327696|FG000|Dose-escalation Period|Adverse Event|0|||
13236536|NCT01684202|26327697|FG001|Dose-escalation Period|Adverse Event|1|||
13236537|NCT01684202|26327698|FG002|Dose-escalation Period|Adverse Event|0|||
13236538|NCT01684202|26327699|FG003|Dose-escalation Period|Adverse Event|0|||
13236539|NCT01684202|26327696|FG000|Dose-escalation Period|Withdrawal by Subject|1|||
13236540|NCT01684202|26327697|FG001|Dose-escalation Period|Withdrawal by Subject|0|||
13236541|NCT01684202|26327698|FG002|Dose-escalation Period|Withdrawal by Subject|0|||
13236542|NCT01684202|26327699|FG003|Dose-escalation Period|Withdrawal by Subject|0|||
13236543|NCT01684202|26327696|FG000|Maintenance Period|Adverse Event|1|||
13236544|NCT01684202|26327697|FG001|Maintenance Period|Adverse Event|1|||
13236545|NCT01684202|26327698|FG002|Maintenance Period|Adverse Event|1|||
13236546|NCT01684202|26327699|FG003|Maintenance Period|Adverse Event|1|||
13236547|NCT01684202|26327696|FG000|Maintenance Period|Physician Decision|0|||
13236548|NCT01684202|26327697|FG001|Maintenance Period|Physician Decision|1|||
13236549|NCT01684202|26327698|FG002|Maintenance Period|Physician Decision|0|||
13236550|NCT01684202|26327699|FG003|Maintenance Period|Physician Decision|0|||
13236551|NCT01684202|26327696|FG000|Maintenance Period|Withdrawal by Subject|0|||
13236552|NCT01684202|26327697|FG001|Maintenance Period|Withdrawal by Subject|1|||
13236553|NCT01684202|26327698|FG002|Maintenance Period|Withdrawal by Subject|0|||
13236554|NCT01684202|26327699|FG003|Maintenance Period|Withdrawal by Subject|0|||
13236555|NCT01684046|26327708|FG000|Period 1, First 30 Days|Adverse Event|0|||
13236556|NCT01684046|26327709|FG001|Period 1, First 30 Days|Adverse Event|2|||
13236557|NCT01684033|26327720|FG000|Period 1, First 30 Days|Adverse Event|1|||
13236558|NCT01684033|26327721|FG001|Period 1, First 30 Days|Adverse Event|1|||
13236559|NCT01684033|26327720|FG000|Period 1, First 30 Days|Noncompliance|1|||
13236560|NCT01684033|26327721|FG001|Period 1, First 30 Days|Noncompliance|0|||
13236561|NCT01684033|26327720|FG000|Period 1, First 30 Days|Withdrawal by Subject|1|||
13236562|NCT01684033|26327721|FG001|Period 1, First 30 Days|Withdrawal by Subject|0|||
13236563|NCT01684033|26327720|FG000|Period 1, First 30 Days|Lost to Follow-up|1|||
13236564|NCT01684033|26327721|FG001|Period 1, First 30 Days|Lost to Follow-up|0|||
13236565|NCT01684033|26327720|FG000|Period 2, Second 30 Days|Adverse Event|1|||
13236566|NCT01684033|26327721|FG001|Period 2, Second 30 Days|Adverse Event|0|||
13236567|NCT01683994|26327763|FG000|Overall Study|Withdrawal by Subject|1|||
13236568|NCT01683994|26327764|FG001|Overall Study|Withdrawal by Subject|0|||
13236569|NCT01683994|26327765|FG002|Overall Study|Withdrawal by Subject|0|||
13236570|NCT01683994|26327766|FG003|Overall Study|Withdrawal by Subject|1|||
13236571|NCT01683994|26327767|FG004|Overall Study|Withdrawal by Subject|0|||
13236572|NCT01683994|26327763|FG000|Overall Study|Intercurrent illness|0|||
13236573|NCT01683994|26327764|FG001|Overall Study|Intercurrent illness|0|||
13236574|NCT01683994|26327765|FG002|Overall Study|Intercurrent illness|0|||
13236575|NCT01683994|26327766|FG003|Overall Study|Intercurrent illness|2|||
13236576|NCT01683994|26327767|FG004|Overall Study|Intercurrent illness|1|||
13236577|NCT01683838|26327796|FG000|Overall Study|Adverse Event|12|||
13236578|NCT01683838|26327797|FG001|Overall Study|Adverse Event|2|||
13236579|NCT01683838|26327796|FG000|Overall Study|Protocol Violation|3|||
13236580|NCT01683838|26327797|FG001|Overall Study|Protocol Violation|1|||
13236581|NCT01683838|26327796|FG000|Overall Study|Withdrawal by Subject|6|||
13236582|NCT01683838|26327797|FG001|Overall Study|Withdrawal by Subject|5|||
13236583|NCT01683838|26327796|FG000|Overall Study|Lost to Follow-up|1|||
13236584|NCT01683838|26327797|FG001|Overall Study|Lost to Follow-up|1|||
13236585|NCT01683838|26327796|FG000|Overall Study|Other|4|||
13236586|NCT01683838|26327797|FG001|Overall Study|Other|3|||
13236587|NCT01683604|26327962|FG000|Overall Study|Adverse Event|2|||
13236588|NCT01683604|26327962|FG000|Overall Study|Lack of Efficacy|1|||
13236589|NCT01683604|26327962|FG000|Overall Study|Other|2|||
13236590|NCT01683565|26327981|FG000|Overall Study|Lost to Follow-up|2|||
13236591|NCT01683565|26327982|FG001|Overall Study|Lost to Follow-up|0|||
13236592|NCT01683565|26327981|FG000|Overall Study|Discontinued Intervention|1|||
13236593|NCT01683565|26327982|FG001|Overall Study|Discontinued Intervention|1|||
13236594|NCT01683409|26328039|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
13236595|NCT01683409|26328040|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
13236596|NCT01683409|26328041|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1|||
13236597|NCT01683409|26328042|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
13236598|NCT01683409|26328043|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
13236599|NCT01683409|26328039|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0|||
13236600|NCT01683409|26328040|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3|||
13236601|NCT01683409|26328041|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0|||
13236602|NCT01683409|26328042|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1|||
13236603|NCT01683409|26328043|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1|||
13236604|NCT01683409|26328039|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
13236605|NCT01683409|26328040|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1|||
13236606|NCT01683409|26328041|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
13236607|NCT01683409|26328042|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
13236608|NCT01683409|26328043|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
13236609|NCT01683409|26328039|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
13236610|NCT01683409|26328040|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
13236611|NCT01683409|26328041|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
13236612|NCT01683409|26328042|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
13236613|NCT01683409|26328043|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
13236614|NCT01683409|26328039|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
13236615|NCT01683409|26328040|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
13236616|NCT01683409|26328041|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1|||
13236617|NCT01683409|26328042|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
13236618|NCT01683409|26328043|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
13236619|NCT01683409|26328039|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
13236620|NCT01683409|26328040|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
13236621|NCT01683409|26328041|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
13236622|NCT01683409|26328042|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
13236623|NCT01683409|26328043|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
13236624|NCT01683409|26328039|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
13236625|NCT01683409|26328040|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
13236626|NCT01683409|26328041|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
13236627|NCT01683409|26328042|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
13236628|NCT01683409|26328043|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
13236629|NCT01683409|26328039|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1|||
13236630|NCT01683409|26328040|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
13236631|NCT01683409|26328041|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
13236632|NCT01683409|26328042|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
13236633|NCT01683409|26328043|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
13236634|NCT01683409|26328039|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
13236635|NCT01683409|26328040|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4|||
13236636|NCT01683409|26328041|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
13236637|NCT01683409|26328042|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1|||
13236638|NCT01683409|26328043|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2|||
13236639|NCT01683409|26328039|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
13236640|NCT01683409|26328040|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
13236641|NCT01683409|26328041|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
13236642|NCT01683409|26328042|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
13236643|NCT01683409|26328043|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3|||
13236644|NCT01683409|26328039|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
13236645|NCT01683409|26328040|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
13236646|NCT01683409|26328041|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1|||
13236647|NCT01683409|26328042|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
13236648|NCT01683409|26328043|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
13236649|NCT01683383|26328064|FG000|Overall Study|Infant was not transported|1|||
13236650|NCT01683383|26328065|FG001|Overall Study|Infant was not transported|0|||
13236651|NCT01683266|26328100|FG000|Overall Study|Adverse Event|5|||
13236652|NCT01683266|26328101|FG001|Overall Study|Adverse Event|4|||
13236653|NCT01683266|26328100|FG000|Overall Study|Lack of Efficacy|5|||
13236654|NCT01683266|26328101|FG001|Overall Study|Lack of Efficacy|2|||
13236655|NCT01683266|26328100|FG000|Overall Study|Protocol Violation|13|||
13236656|NCT01683266|26328101|FG001|Overall Study|Protocol Violation|6|||
13236657|NCT01683266|26328100|FG000|Overall Study|Personal Reason|17|||
13236658|NCT01683266|26328101|FG001|Overall Study|Personal Reason|25|||
13236659|NCT01683266|26328100|FG000|Overall Study|Selection Criterion / Protocol Violation|7|||
13236660|NCT01683266|26328101|FG001|Overall Study|Selection Criterion / Protocol Violation|5|||
13236661|NCT01683266|26328100|FG000|Overall Study|Lost to Follow-up|5|||
13236662|NCT01683266|26328101|FG001|Overall Study|Lost to Follow-up|0|||
13236663|NCT01683266|26328100|FG000|Overall Study|Site Closure / Site Withdrawal|1|||
13236664|NCT01683266|26328101|FG001|Overall Study|Site Closure / Site Withdrawal|3|||
13236665|NCT01683266|26328100|FG000|Overall Study|Nonserious Hypoglycemia|0|||
13236666|NCT01683266|26328101|FG001|Overall Study|Nonserious Hypoglycemia|3|||
13236667|NCT01683266|26328100|FG000|Overall Study|Perceived Lack of Efficacy|1|||
13236668|NCT01683266|26328101|FG001|Overall Study|Perceived Lack of Efficacy|1|||
13236669|NCT01683266|26328100|FG000|Overall Study|Possibly Hypoglycemia|1|||
13236670|NCT01683266|26328101|FG001|Overall Study|Possibly Hypoglycemia|0|||
13236671|NCT01683266|26328100|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0|||
13236672|NCT01683266|26328101|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1|||
13236673|NCT01683071|26328146|FG000|Part 1|Lack of Efficacy|1|||
13236674|NCT01683071|26328147|FG001|Part 1|Lack of Efficacy|0|||
13236675|NCT01683071|26328148|FG002|Part 1|Lack of Efficacy|0|||
13236676|NCT01683071|26328149|FG003|Part 1|Lack of Efficacy|3|||
13236677|NCT01683071|26328150|FG004|Part 1|Lack of Efficacy|0|||
13236678|NCT01683071|26328151|FG005|Part 1|Lack of Efficacy|0|||
13236679|NCT01683071|26328146|FG000|Part 1|Withdrawal by Subject|1|||
13236680|NCT01683071|26328147|FG001|Part 1|Withdrawal by Subject|2|||
13236681|NCT01683071|26328148|FG002|Part 1|Withdrawal by Subject|2|||
13236682|NCT01683071|26328149|FG003|Part 1|Withdrawal by Subject|1|||
13236683|NCT01683071|26328150|FG004|Part 1|Withdrawal by Subject|0|||
13236684|NCT01683071|26328151|FG005|Part 1|Withdrawal by Subject|0|||
13236685|NCT01683071|26328146|FG000|Part 1|Surgery Cancelled|1|||
13236686|NCT01683071|26328147|FG001|Part 1|Surgery Cancelled|0|||
13236687|NCT01683071|26328148|FG002|Part 1|Surgery Cancelled|0|||
13236688|NCT01683071|26328149|FG003|Part 1|Surgery Cancelled|0|||
13236689|NCT01683071|26328150|FG004|Part 1|Surgery Cancelled|0|||
13236690|NCT01683071|26328151|FG005|Part 1|Surgery Cancelled|0|||
13236691|NCT01683071|26328146|FG000|Part 1|Did not receive study drug|1|||
13236692|NCT01683071|26328147|FG001|Part 1|Did not receive study drug|0|||
13236693|NCT01683071|26328148|FG002|Part 1|Did not receive study drug|0|||
13236694|NCT01683071|26328149|FG003|Part 1|Did not receive study drug|1|||
13236695|NCT01683071|26328150|FG004|Part 1|Did not receive study drug|0|||
13236696|NCT01683071|26328151|FG005|Part 1|Did not receive study drug|0|||
13236697|NCT01683071|26328146|FG000|Part 1|Early termination; met exclusion criteria|0|||
13236698|NCT01683071|26328147|FG001|Part 1|Early termination; met exclusion criteria|2|||
13236699|NCT01683071|26328148|FG002|Part 1|Early termination; met exclusion criteria|1|||
13236700|NCT01683071|26328149|FG003|Part 1|Early termination; met exclusion criteria|0|||
13236701|NCT01683071|26328150|FG004|Part 1|Early termination; met exclusion criteria|0|||
13236702|NCT01683071|26328151|FG005|Part 1|Early termination; met exclusion criteria|0|||
13236703|NCT01683071|26328146|FG000|Part 2|Lack of Efficacy|0|||
13236704|NCT01683071|26328147|FG001|Part 2|Lack of Efficacy|0|||
13236705|NCT01683071|26328148|FG002|Part 2|Lack of Efficacy|0|||
13236706|NCT01683071|26328149|FG003|Part 2|Lack of Efficacy|0|||
13236707|NCT01683071|26328150|FG004|Part 2|Lack of Efficacy|3|||
13236708|NCT01683071|26328151|FG005|Part 2|Lack of Efficacy|4|||
13236709|NCT01683071|26328146|FG000|Part 2|Lost to Follow-up|0|||
13236710|NCT01683071|26328147|FG001|Part 2|Lost to Follow-up|0|||
13236711|NCT01683071|26328148|FG002|Part 2|Lost to Follow-up|0|||
13236712|NCT01683071|26328149|FG003|Part 2|Lost to Follow-up|0|||
13236713|NCT01683071|26328150|FG004|Part 2|Lost to Follow-up|2|||
13236714|NCT01683071|26328151|FG005|Part 2|Lost to Follow-up|0|||
13236715|NCT01683071|26328146|FG000|Part 2|Withdrawal by Subject|0|||
13236716|NCT01683071|26328147|FG001|Part 2|Withdrawal by Subject|0|||
13236717|NCT01683071|26328148|FG002|Part 2|Withdrawal by Subject|0|||
13236718|NCT01683071|26328149|FG003|Part 2|Withdrawal by Subject|0|||
13236719|NCT01683071|26328150|FG004|Part 2|Withdrawal by Subject|3|||
13236720|NCT01683071|26328151|FG005|Part 2|Withdrawal by Subject|3|||
13236721|NCT01683071|26328146|FG000|Part 2|Surgery cancelled|0|||
13236722|NCT01683071|26328147|FG001|Part 2|Surgery cancelled|0|||
13236723|NCT01683071|26328148|FG002|Part 2|Surgery cancelled|0|||
13236724|NCT01683071|26328149|FG003|Part 2|Surgery cancelled|0|||
13236725|NCT01683071|26328150|FG004|Part 2|Surgery cancelled|4|||
13236726|NCT01683071|26328151|FG005|Part 2|Surgery cancelled|2|||
13236727|NCT01683071|26328146|FG000|Part 2|Did not receive study drug|0|||
13236728|NCT01683071|26328147|FG001|Part 2|Did not receive study drug|0|||
13236729|NCT01683071|26328148|FG002|Part 2|Did not receive study drug|0|||
13236730|NCT01683071|26328149|FG003|Part 2|Did not receive study drug|0|||
13236731|NCT01683071|26328150|FG004|Part 2|Did not receive study drug|2|||
13236732|NCT01683071|26328151|FG005|Part 2|Did not receive study drug|1|||
13236733|NCT01683071|26328146|FG000|Part 2|Met exclusion criterion|0|||
13236734|NCT01683071|26328147|FG001|Part 2|Met exclusion criterion|0|||
13236735|NCT01683071|26328148|FG002|Part 2|Met exclusion criterion|0|||
13236736|NCT01683071|26328149|FG003|Part 2|Met exclusion criterion|0|||
13236737|NCT01683071|26328150|FG004|Part 2|Met exclusion criterion|1|||
13236738|NCT01683071|26328151|FG005|Part 2|Met exclusion criterion|1|||
13236739|NCT01683071|26328146|FG000|Part 2|Protocol deviation|0|||
13236740|NCT01683071|26328147|FG001|Part 2|Protocol deviation|0|||
13236741|NCT01683071|26328148|FG002|Part 2|Protocol deviation|0|||
13236742|NCT01683071|26328149|FG003|Part 2|Protocol deviation|0|||
13236743|NCT01683071|26328150|FG004|Part 2|Protocol deviation|1|||
13236744|NCT01683071|26328151|FG005|Part 2|Protocol deviation|2|||
13236745|NCT01683071|26328146|FG000|Part 2|Withdrawal by investigator decision|0|||
13236746|NCT01683071|26328147|FG001|Part 2|Withdrawal by investigator decision|0|||
13236747|NCT01683071|26328148|FG002|Part 2|Withdrawal by investigator decision|0|||
13236748|NCT01683071|26328149|FG003|Part 2|Withdrawal by investigator decision|0|||
13236749|NCT01683071|26328150|FG004|Part 2|Withdrawal by investigator decision|1|||
13236750|NCT01683071|26328151|FG005|Part 2|Withdrawal by investigator decision|2|||
13236751|NCT01683058|26328181|FG000|Overall Study|Lost to Follow-up|9|||
13236752|NCT01683058|26328181|FG000|Overall Study|Adverse Event|6|||
13236753|NCT01683058|26328181|FG000|Overall Study|Subject Met Withdrawal Criteria|5|||
13236754|NCT01683058|26328181|FG000|Overall Study|Withdrawal by Subject|7|||
13236755|NCT01683058|26328181|FG000|Overall Study|Lack of Efficacy|2|||
13236756|NCT01683019|26328199|FG000|Overall Study|Withdrawal by Subject|2|||
13236757|NCT01683019|26328200|FG001|Overall Study|Withdrawal by Subject|1|||
13236758|NCT01683019|26328201|FG002|Overall Study|Withdrawal by Subject|4|||
13236759|NCT01682876|26328257|FG000|Overall Study|Administrative reason|4|||
13236760|NCT01682876|26328258|FG001|Overall Study|Administrative reason|4|||
13236761|NCT01682876|26328259|FG002|Overall Study|Administrative reason|0|||
13236762|NCT01682876|26328260|FG003|Overall Study|Administrative reason|3|||
13236763|NCT01682876|26328257|FG000|Overall Study|Adverse Event|0|||
13236764|NCT01682876|26328258|FG001|Overall Study|Adverse Event|0|||
13236765|NCT01682876|26328259|FG002|Overall Study|Adverse Event|0|||
13236766|NCT01682876|26328260|FG003|Overall Study|Adverse Event|1|||
13236767|NCT01682876|26328257|FG000|Overall Study|Lost to Follow-up|11|||
13236768|NCT01682876|26328258|FG001|Overall Study|Lost to Follow-up|15|||
13236769|NCT01682876|26328259|FG002|Overall Study|Lost to Follow-up|9|||
13236770|NCT01682876|26328260|FG003|Overall Study|Lost to Follow-up|11|||
13236771|NCT01682876|26328257|FG000|Overall Study|Protocol Violation|1|||
13236772|NCT01682876|26328258|FG001|Overall Study|Protocol Violation|1|||
13236773|NCT01682876|26328259|FG002|Overall Study|Protocol Violation|1|||
13236774|NCT01682876|26328260|FG003|Overall Study|Protocol Violation|1|||
13236775|NCT01682876|26328257|FG000|Overall Study|Withdrawal by Subject|4|||
13236776|NCT01682876|26328258|FG001|Overall Study|Withdrawal by Subject|0|||
13236777|NCT01682876|26328259|FG002|Overall Study|Withdrawal by Subject|0|||
13236778|NCT01682876|26328260|FG003|Overall Study|Withdrawal by Subject|2|||
13236779|NCT01682876|26328257|FG000|Overall Study|Other|1|||
13236780|NCT01682876|26328258|FG001|Overall Study|Other|0|||
13236781|NCT01682876|26328259|FG002|Overall Study|Other|1|||
13236782|NCT01682876|26328260|FG003|Overall Study|Other|1|||
13236783|NCT01682863|26328299|FG000|Overall Study|Subject/guardian decision|19|||
13236784|NCT01682863|26328300|FG001|Overall Study|Subject/guardian decision|12|||
13236785|NCT01682863|26328301|FG002|Overall Study|Subject/guardian decision|10|||
13236786|NCT01682863|26328299|FG000|Overall Study|Lost to Follow-up|5|||
13236787|NCT01682863|26328300|FG001|Overall Study|Lost to Follow-up|1|||
13236788|NCT01682863|26328301|FG002|Overall Study|Lost to Follow-up|6|||
13236789|NCT01682863|26328299|FG000|Overall Study|Death|1|||
13236790|NCT01682863|26328300|FG001|Overall Study|Death|3|||
13236791|NCT01682863|26328301|FG002|Overall Study|Death|4|||
13236792|NCT01682863|26328299|FG000|Overall Study|Protocol deviation|1|||
13236793|NCT01682863|26328300|FG001|Overall Study|Protocol deviation|0|||
13236794|NCT01682863|26328301|FG002|Overall Study|Protocol deviation|1|||
13236795|NCT01682863|26328299|FG000|Overall Study|Technical problems|1|||
13236796|NCT01682863|26328300|FG001|Overall Study|Technical problems|0|||
13236797|NCT01682863|26328301|FG002|Overall Study|Technical problems|0|||
13236798|NCT01682863|26328299|FG000|Overall Study|Adverse Event|0|||
13236799|NCT01682863|26328300|FG001|Overall Study|Adverse Event|1|||
13115521|NCT03096847|25918177|FG002|Overall Study|Protocol Violation|6|||
13115522|NCT03096847|25918175|FG000|Overall Study|Physician Decision|12|||
13115523|NCT03096847|25918176|FG001|Overall Study|Physician Decision|2|||
13115524|NCT03096847|25918177|FG002|Overall Study|Physician Decision|8|||
13115525|NCT03096847|25918175|FG000|Overall Study|Withdrawal by Subject|24|||
13115526|NCT03096847|25918176|FG001|Overall Study|Withdrawal by Subject|1|||
13115527|NCT03096847|25918177|FG002|Overall Study|Withdrawal by Subject|12|||
13115528|NCT03096847|25918175|FG000|Overall Study|Adverse Event|72|||
13115529|NCT03096847|25918176|FG001|Overall Study|Adverse Event|6|||
13115530|NCT03096847|25918177|FG002|Overall Study|Adverse Event|28|||
13115531|NCT03096847|25918175|FG000|Overall Study|Progressive disease|97|||
13236800|NCT01682863|26328301|FG002|Overall Study|Adverse Event|2|||
13236801|NCT01682863|26328299|FG000|Overall Study|Physician Decision|0|||
13236802|NCT01682863|26328300|FG001|Overall Study|Physician Decision|0|||
13236803|NCT01682863|26328301|FG002|Overall Study|Physician Decision|1|||
13236804|NCT01682837|26328345|FG000|Baseline|Withdrawal by Subject|5|||
13236805|NCT01682811|26328395|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0|||
13236806|NCT01682811|26328396|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0|||
13236807|NCT01682811|26328397|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0|||
13236808|NCT01682811|26328398|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0|||
13236809|NCT01682811|26328399|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1|||
13236810|NCT01682811|26328400|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0|||
13236811|NCT01682811|26328401|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0|||
13236812|NCT01682811|26328395|FG000|Part 2 Dose Level 1|Protocol Violation|0|||
13236813|NCT01682811|26328396|FG001|Part 2 Dose Level 1|Protocol Violation|0|||
13236814|NCT01682811|26328397|FG002|Part 2 Dose Level 1|Protocol Violation|0|||
13236815|NCT01682811|26328398|FG003|Part 2 Dose Level 1|Protocol Violation|0|||
13236816|NCT01682811|26328399|FG004|Part 2 Dose Level 1|Protocol Violation|4|||
13236817|NCT01682811|26328400|FG005|Part 2 Dose Level 1|Protocol Violation|0|||
13236818|NCT01682811|26328401|FG006|Part 2 Dose Level 1|Protocol Violation|0|||
13236819|NCT01682811|26328395|FG000|Part 2 Dose Level 1|Lost to Follow-up|0|||
13236820|NCT01682811|26328396|FG001|Part 2 Dose Level 1|Lost to Follow-up|0|||
13236821|NCT01682811|26328397|FG002|Part 2 Dose Level 1|Lost to Follow-up|0|||
13485816|NCT00585195|27033413|FG003|Overall Study|Ongoing|0|||
13485817|NCT00585195|27033414|FG004|Overall Study|Ongoing|0|||
13485818|NCT00585195|27033415|FG005|Overall Study|Ongoing|0|||
13485819|NCT00585195|27033416|FG006|Overall Study|Ongoing|0|||
13485820|NCT00585195|27033417|FG007|Overall Study|Ongoing|0|||
13485821|NCT00585195|27033418|FG008|Overall Study|Ongoing|0|||
13485822|NCT00585195|27033419|FG009|Overall Study|Ongoing|0|||
13485823|NCT00585195|27033420|FG010|Overall Study|Ongoing|0|||
13485824|NCT00585195|27033421|FG011|Overall Study|Ongoing|0|||
13485825|NCT00585195|27033422|FG012|Overall Study|Ongoing|2|||
13485826|NCT00585195|27033423|FG013|Overall Study|Ongoing|0|||
13485827|NCT00585195|27033424|FG014|Overall Study|Ongoing|0|||
13485828|NCT00585195|27033425|FG015|Overall Study|Ongoing|0|||
13485829|NCT00585195|27033426|FG016|Overall Study|Ongoing|0|||
13115532|NCT03096847|25918176|FG001|Overall Study|Progressive disease|10|||
13236822|NCT01682811|26328398|FG003|Part 2 Dose Level 1|Lost to Follow-up|0|||
13236823|NCT01682811|26328399|FG004|Part 2 Dose Level 1|Lost to Follow-up|6|||
13236824|NCT01682811|26328400|FG005|Part 2 Dose Level 1|Lost to Follow-up|0|||
13485830|NCT00585195|27033427|FG017|Overall Study|Ongoing|0|||
13485831|NCT00585195|27033428|FG018|Overall Study|Ongoing|0|||
13485832|NCT00585195|27033429|FG019|Overall Study|Ongoing|0|||
13485833|NCT00585195|27033430|FG020|Overall Study|Ongoing|0|||
13485834|NCT00585195|27033410|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
13485835|NCT00585195|27033411|FG001|Overall Study|Withdrawn Due to Pregnancy|0|||
13485836|NCT00585195|27033412|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
13485837|NCT00585195|27033413|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
13485838|NCT00585195|27033414|FG004|Overall Study|Withdrawn Due to Pregnancy|0|||
13485839|NCT00585195|27033415|FG005|Overall Study|Withdrawn Due to Pregnancy|0|||
13236825|NCT01682811|26328401|FG006|Part 2 Dose Level 1|Lost to Follow-up|0|||
13236826|NCT01682811|26328395|FG000|Part 2 Dose Level 2|Lost to Follow-up|0|||
13236827|NCT01682811|26328396|FG001|Part 2 Dose Level 2|Lost to Follow-up|0|||
13236828|NCT01682811|26328397|FG002|Part 2 Dose Level 2|Lost to Follow-up|0|||
13236829|NCT01682811|26328398|FG003|Part 2 Dose Level 2|Lost to Follow-up|0|||
13236830|NCT01682811|26328399|FG004|Part 2 Dose Level 2|Lost to Follow-up|0|||
13236831|NCT01682811|26328400|FG005|Part 2 Dose Level 2|Lost to Follow-up|3|||
13236832|NCT01682811|26328401|FG006|Part 2 Dose Level 2|Lost to Follow-up|0|||
13236833|NCT01682759|26328428|FG000|Overall Study|Death|2|||
13236834|NCT01682759|26328429|FG001|Overall Study|Death|1|||
13236835|NCT01682759|26328428|FG000|Overall Study|Lost to Follow-up|10|||
13236836|NCT01682759|26328429|FG001|Overall Study|Lost to Follow-up|13|||
13236837|NCT01682759|26328428|FG000|Overall Study|Physician Decision|1|||
13236838|NCT01682759|26328429|FG001|Overall Study|Physician Decision|1|||
13236839|NCT01682759|26328428|FG000|Overall Study|Withdrawal by Subject|56|||
13236840|NCT01682759|26328429|FG001|Overall Study|Withdrawal by Subject|55|||
13236841|NCT01682720|26328459|FG000|Overall Study|Randomized but Not Treated|0|||
13236842|NCT01682720|26328460|FG001|Overall Study|Randomized but Not Treated|1|||
13236843|NCT01682720|26328461|FG002|Overall Study|Randomized but Not Treated|1|||
13236844|NCT01682720|26328462|FG003|Overall Study|Randomized but Not Treated|0|||
13236845|NCT01682720|26328459|FG000|Overall Study|Terminated by Sponsor|83|||
13236846|NCT01682720|26328460|FG001|Overall Study|Terminated by Sponsor|0|||
13236847|NCT01682720|26328461|FG002|Overall Study|Terminated by Sponsor|0|||
13236848|NCT01682720|26328462|FG003|Overall Study|Terminated by Sponsor|0|||
13236849|NCT01682720|26328459|FG000|Overall Study|Efficacy Failure|0|||
13236850|NCT01682720|26328460|FG001|Overall Study|Efficacy Failure|3|||
13236851|NCT01682720|26328461|FG002|Overall Study|Efficacy Failure|3|||
13236852|NCT01682720|26328462|FG003|Overall Study|Efficacy Failure|30|||
13236853|NCT01682720|26328459|FG000|Overall Study|Lost to Follow-up|1|||
13236854|NCT01682720|26328460|FG001|Overall Study|Lost to Follow-up|1|||
13236855|NCT01682720|26328461|FG002|Overall Study|Lost to Follow-up|0|||
13236856|NCT01682720|26328462|FG003|Overall Study|Lost to Follow-up|6|||
13236857|NCT01682720|26328459|FG000|Overall Study|Subject Withdrew Consent|0|||
13236858|NCT01682720|26328460|FG001|Overall Study|Subject Withdrew Consent|0|||
13236859|NCT01682720|26328461|FG002|Overall Study|Subject Withdrew Consent|2|||
13236860|NCT01682720|26328462|FG003|Overall Study|Subject Withdrew Consent|2|||
13236861|NCT01682720|26328459|FG000|Overall Study|Adverse Event|1|||
13236862|NCT01682720|26328460|FG001|Overall Study|Adverse Event|0|||
13236863|NCT01682720|26328461|FG002|Overall Study|Adverse Event|1|||
13236864|NCT01682720|26328462|FG003|Overall Study|Adverse Event|1|||
13236865|NCT01682681|26328472|FG000|Overall Study|Lack of Efficacy|62|||
13236866|NCT01682681|26328472|FG000|Overall Study|Withdrawal by Subject|1|||
13236867|NCT01682681|26328472|FG000|Overall Study|Moved to other hospital|10|||
13236868|NCT01682681|26328472|FG000|Overall Study|Lost to Follow-up|174|||
13236869|NCT01682681|26328472|FG000|Overall Study|Adverse Event|46|||
13236870|NCT01682681|26328472|FG000|Overall Study|tapering of topiramate|5|||
13236871|NCT01682681|26328472|FG000|Overall Study|Other|21|||
13236872|NCT01682681|26328472|FG000|Overall Study|Low compliance|13|||
13236873|NCT01682603|26328488|FG000|Overall Study|Lost to Follow-up|3|||
13236874|NCT01682512|26328523|FG000|Overall Study|Adverse Event|6|||
13236875|NCT01682512|26328524|FG001|Overall Study|Adverse Event|5|||
13236876|NCT01682512|26328525|FG002|Overall Study|Adverse Event|2|||
13236877|NCT01682512|26328523|FG000|Overall Study|Withdrawal by Subject|2|||
13236878|NCT01682512|26328524|FG001|Overall Study|Withdrawal by Subject|6|||
13236879|NCT01682512|26328525|FG002|Overall Study|Withdrawal by Subject|3|||
13236880|NCT01682512|26328523|FG000|Overall Study|Physician Decision|0|||
13236881|NCT01682512|26328524|FG001|Overall Study|Physician Decision|2|||
13236882|NCT01682512|26328525|FG002|Overall Study|Physician Decision|0|||
13236883|NCT01682512|26328523|FG000|Overall Study|Study terminated by sponsor|46|||
13236884|NCT01682512|26328524|FG001|Overall Study|Study terminated by sponsor|43|||
13236885|NCT01682512|26328525|FG002|Overall Study|Study terminated by sponsor|0|||
13236886|NCT01682512|26328523|FG000|Overall Study|Lost to Follow-up|3|||
13236887|NCT01682512|26328524|FG001|Overall Study|Lost to Follow-up|0|||
13236888|NCT01682512|26328525|FG002|Overall Study|Lost to Follow-up|2|||
13236889|NCT01682512|26328523|FG000|Overall Study|Protocol Violation|2|||
13236890|NCT01682512|26328524|FG001|Overall Study|Protocol Violation|3|||
13236891|NCT01682512|26328525|FG002|Overall Study|Protocol Violation|2|||
13236892|NCT01682512|26328523|FG000|Overall Study|Primary lack of efficacy|10|||
13236893|NCT01682512|26328524|FG001|Overall Study|Primary lack of efficacy|7|||
13236894|NCT01682512|26328525|FG002|Overall Study|Primary lack of efficacy|7|||
13236895|NCT01682512|26328523|FG000|Overall Study|Secondary lack of efficacy|1|||
13236896|NCT01682512|26328524|FG001|Overall Study|Secondary lack of efficacy|1|||
13236897|NCT01682512|26328525|FG002|Overall Study|Secondary lack of efficacy|0|||
13236898|NCT01682512|26328523|FG000|Overall Study|Other than stated above|2|||
13236899|NCT01682512|26328524|FG001|Overall Study|Other than stated above|4|||
13236900|NCT01682512|26328525|FG002|Overall Study|Other than stated above|2|||
13236901|NCT01682460|26328542|FG000|Overall Study|Withdrawal by Subject|2|||
13236902|NCT01682460|26328542|FG000|Overall Study|Did not meet inclusion criteria|2|||
13236903|NCT01682226|26328549|FG000|Overall Study|Participants were pediatric subjects and not adults subjects|3|||
13236904|NCT01682226|26328549|FG000|Overall Study|Participants did not receive treatment|2|||
13236905|NCT01682226|26328549|FG000|Overall Study|Participants received a transplant under a different protocol|1|||
13236906|NCT01682213|26328557|FG000|Overall Study|Withdrawal by Subject|2|||
13236907|NCT01682148|26328585|FG000|Overall Study|Withdrawal by Subject|2|||
13236908|NCT01682148|26328586|FG001|Overall Study|Withdrawal by Subject|0|||
13236909|NCT01682148|26328585|FG000|Overall Study|Lost to Follow-up|1|||
13236910|NCT01682148|26328586|FG001|Overall Study|Lost to Follow-up|2|||
13236911|NCT01682148|26328585|FG000|Overall Study|Protocol Violation|1|||
13236912|NCT01682148|26328586|FG001|Overall Study|Protocol Violation|1|||
13236913|NCT01682044|26328598|FG000|Overall Study|Death|1|||
13236914|NCT01682044|26328598|FG000|Overall Study|Progression|3|||
13236915|NCT01682031|26328625|FG000|Overall Study|Withdrawal by Subject|0|||
13236916|NCT01682031|26328626|FG001|Overall Study|Withdrawal by Subject|1|||
13236917|NCT01682031|26328625|FG000|Overall Study|Adverse Event|0|||
13236918|NCT01682031|26328626|FG001|Overall Study|Adverse Event|2|||
13236919|NCT01682031|26328625|FG000|Overall Study|MRI results indicate increased nodul|0|||
13236920|NCT01682031|26328626|FG001|Overall Study|MRI results indicate increased nodul|1|||
13236921|NCT01682031|26328625|FG000|Overall Study|Patient could not swallow tablets|1|||
13236922|NCT01682031|26328626|FG001|Overall Study|Patient could not swallow tablets|0|||
13236923|NCT01682031|26328625|FG000|Overall Study|Patient stopped selenium on his own|0|||
13236924|NCT01682031|26328626|FG001|Overall Study|Patient stopped selenium on his own|1|||
13236925|NCT01681992|26328722|FG000|Overall Study|Adverse Event|3|||
13236926|NCT01681992|26328723|FG001|Overall Study|Adverse Event|2|||
13236927|NCT01681992|26328724|FG002|Overall Study|Adverse Event|3|||
13236928|NCT01681992|26328722|FG000|Overall Study|Lost to Follow-up|36|||
13236929|NCT01681992|26328723|FG001|Overall Study|Lost to Follow-up|38|||
13236930|NCT01681992|26328724|FG002|Overall Study|Lost to Follow-up|53|||
13236931|NCT01681992|26328722|FG000|Overall Study|As Per Sponsor Decision|0|||
13236932|NCT01681992|26328723|FG001|Overall Study|As Per Sponsor Decision|0|||
13236933|NCT01681992|26328724|FG002|Overall Study|As Per Sponsor Decision|1|||
13236934|NCT01681992|26328722|FG000|Overall Study|Protocol Violation|0|||
13236935|NCT01681992|26328723|FG001|Overall Study|Protocol Violation|0|||
13236936|NCT01681992|26328724|FG002|Overall Study|Protocol Violation|1|||
13236937|NCT01681992|26328722|FG000|Overall Study|Withdrawal by Subject|27|||
13236938|NCT01681992|26328723|FG001|Overall Study|Withdrawal by Subject|30|||
13236939|NCT01681992|26328724|FG002|Overall Study|Withdrawal by Subject|25|||
13236940|NCT01681849|26328743|FG000|Overall Study|Protocol Violation|2|||
13236941|NCT01681849|26328744|FG001|Overall Study|Protocol Violation|0|||
13236942|NCT01681849|26328745|FG002|Overall Study|Protocol Violation|0|||
13236943|NCT01681849|26328743|FG000|Overall Study|Withdrawal by Subject|3|||
13236944|NCT01681849|26328744|FG001|Overall Study|Withdrawal by Subject|5|||
13236945|NCT01681849|26328745|FG002|Overall Study|Withdrawal by Subject|33|||
13236946|NCT01681849|26328743|FG000|Overall Study|Lost to Follow-up|3|||
13236947|NCT01681849|26328744|FG001|Overall Study|Lost to Follow-up|2|||
13236948|NCT01681849|26328745|FG002|Overall Study|Lost to Follow-up|6|||
13236949|NCT01681836|26328772|FG000|Second Intervention|Withdrawal by Subject|0|||
13236950|NCT01681836|26328773|FG001|Second Intervention|Withdrawal by Subject|1|||
13236951|NCT01681771|26328786|FG000|Overall Study|Lost to Follow-up|4|||
13236952|NCT01681771|26328787|FG001|Overall Study|Lost to Follow-up|2|||
13289762|NCT00106964|26479996|FG002|Overall Study|Incarceration|0|||
13289763|NCT00106964|26479994|FG000|Overall Study|Site Funding Terminated|0|||
13289764|NCT00106964|26479995|FG001|Overall Study|Site Funding Terminated|1|||
13289765|NCT00106964|26479996|FG002|Overall Study|Site Funding Terminated|1|||
13289766|NCT00106964|26479994|FG000|Overall Study|Failure to adhere|2|||
13289767|NCT00106964|26479995|FG001|Overall Study|Failure to adhere|0|||
13289768|NCT00106964|26479996|FG002|Overall Study|Failure to adhere|0|||
13289769|NCT00106964|26479994|FG000|Overall Study|Did not meet eligibility criteria|0|||
13289770|NCT00106964|26479995|FG001|Overall Study|Did not meet eligibility criteria|2|||
13289771|NCT00106964|26479996|FG002|Overall Study|Did not meet eligibility criteria|2|||
13289772|NCT00106964|26479994|FG000|Overall Study|Required disallowed medication|0|||
13289773|NCT00106964|26479995|FG001|Overall Study|Required disallowed medication|1|||
13289774|NCT00106964|26479996|FG002|Overall Study|Required disallowed medication|0|||
13289775|NCT00106184|26480013|FG000|Overall Study|Withdrawal by Subject|3|||
13289776|NCT00106184|26480014|FG001|Overall Study|Withdrawal by Subject|2|||
13289777|NCT00106028|26480115|FG000|Overall Study|Adverse Event|3|||
13289778|NCT00106028|26480116|FG001|Overall Study|Adverse Event|2|||
13289779|NCT00106028|26480115|FG000|Overall Study|Protocol Violation|1|||
13236953|NCT01681628|26328805|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14|||
13236954|NCT01681628|26328806|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6|||
13236955|NCT01681628|26328805|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0|||
13236956|NCT01681628|26328806|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15|||
13236957|NCT01681628|26328805|FG000|19 Months Follow-up|Death|1|||
13236958|NCT01681628|26328806|FG001|19 Months Follow-up|Death|0|||
13236959|NCT01681628|26328805|FG000|19 Months Follow-up|Lost to Follow-up|61|||
13236960|NCT01681628|26328806|FG001|19 Months Follow-up|Lost to Follow-up|43|||
13236961|NCT01681576|26328827|FG000|Period 1|Adverse Event|1|||
13236962|NCT01681576|26328828|FG001|Period 1|Adverse Event|0|||
13236963|NCT01681576|26328827|FG000|Period 1|Protocol Deviation|1|||
13236964|NCT01681576|26328828|FG001|Period 1|Protocol Deviation|0|||
13236965|NCT01681576|26328827|FG000|Period 2|subject/guardian decision|3|||
13236966|NCT01681576|26328828|FG001|Period 2|subject/guardian decision|1|||
13236967|NCT01681576|26328827|FG000|Period 2|Non-compliance with study treatment|1|||
13236968|NCT01681576|26328828|FG001|Period 2|Non-compliance with study treatment|0|||
13236969|NCT01681511|26328849|FG000|Overall Study|No Treatment Received|1|||
13236970|NCT01681511|26328850|FG001|Overall Study|No Treatment Received|3|||
13236971|NCT01681511|26328849|FG000|Overall Study|Failed Inclusion/Exclusion|3|||
13236972|NCT01681511|26328850|FG001|Overall Study|Failed Inclusion/Exclusion|0|||
13236973|NCT01681511|26328849|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3|||
13236974|NCT01681511|26328850|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6|||
13236975|NCT01681511|26328849|FG000|Overall Study|No Daily Urine Sample Collected|0|||
13236976|NCT01681511|26328850|FG001|Overall Study|No Daily Urine Sample Collected|1|||
13236977|NCT01681511|26328849|FG000|Overall Study|No post-catheter sample collected|11|||
13236978|NCT01681511|26328850|FG001|Overall Study|No post-catheter sample collected|4|||
13236979|NCT01681472|26329041|FG000|Overall Study|Adverse Event|0|||
13236980|NCT01681472|26329042|FG001|Overall Study|Adverse Event|1|||
13236981|NCT01681472|26329043|FG002|Overall Study|Adverse Event|0|||
13236982|NCT01681472|26329044|FG003|Overall Study|Adverse Event|0|||
13236983|NCT01681433|26329069|FG000|Overall Study|Lack of Efficacy|23|||
13236984|NCT01681433|26329070|FG001|Overall Study|Lack of Efficacy|23|||
13236985|NCT01681433|26329069|FG000|Overall Study|Withdrawal by Subject|5|||
13236986|NCT01681433|26329070|FG001|Overall Study|Withdrawal by Subject|5|||
13236987|NCT01681433|26329069|FG000|Overall Study|Protocol Violation|2|||
13236988|NCT01681433|26329070|FG001|Overall Study|Protocol Violation|0|||
13236989|NCT01681433|26329069|FG000|Overall Study|Adverse Event|2|||
13236990|NCT01681433|26329070|FG001|Overall Study|Adverse Event|4|||
13236991|NCT01681433|26329069|FG000|Overall Study|Lost to Follow-up|0|||
13236992|NCT01681433|26329070|FG001|Overall Study|Lost to Follow-up|1|||
13236993|NCT01681368|26329084|FG000|Overall Study|Refused further treatment|1|||
13236994|NCT01681368|26329084|FG000|Overall Study|Refused further follow up|1|||
13236995|NCT01681277|26329141|FG000|Overall Study|Adverse Event|1|||
13236996|NCT01681277|26329142|FG001|Overall Study|Adverse Event|0|||
13236997|NCT01681277|26329143|FG002|Overall Study|Adverse Event|0|||
13236998|NCT01681277|26329144|FG003|Overall Study|Adverse Event|0|||
13236999|NCT01681277|26329145|FG004|Overall Study|Adverse Event|0|||
13237000|NCT01681212|26329153|FG000|Overall Study|No longer met study criteria|5|||
13237001|NCT01681212|26329153|FG000|Overall Study|Administrative reason by sponsor|1|||
13237002|NCT01681186|26329229|FG000|Washout Period From Second Intervention|Adverse Event|0|||
13237003|NCT01681186|26329230|FG001|Washout Period From Second Intervention|Adverse Event|0|||
13237004|NCT01681186|26329231|FG002|Washout Period From Second Intervention|Adverse Event|0|||
13237005|NCT01681186|26329232|FG003|Washout Period From Second Intervention|Adverse Event|0|||
13237006|NCT01681186|26329233|FG004|Washout Period From Second Intervention|Adverse Event|0|||
13237007|NCT01681186|26329234|FG005|Washout Period From Second Intervention|Adverse Event|0|||
13237008|NCT01681186|26329235|FG006|Washout Period From Second Intervention|Adverse Event|1|||
13237009|NCT01681186|26329236|FG007|Washout Period From Second Intervention|Adverse Event|0|||
13237010|NCT01681186|26329229|FG000|Washout Period From Second Intervention|Protocol Violation|0|||
13237011|NCT01681186|26329230|FG001|Washout Period From Second Intervention|Protocol Violation|0|||
13237012|NCT01681186|26329231|FG002|Washout Period From Second Intervention|Protocol Violation|0|||
13237013|NCT01681186|26329232|FG003|Washout Period From Second Intervention|Protocol Violation|0|||
13237014|NCT01681186|26329233|FG004|Washout Period From Second Intervention|Protocol Violation|0|||
13237015|NCT01681186|26329234|FG005|Washout Period From Second Intervention|Protocol Violation|0|||
13237016|NCT01681186|26329235|FG006|Washout Period From Second Intervention|Protocol Violation|0|||
13237017|NCT01681186|26329236|FG007|Washout Period From Second Intervention|Protocol Violation|1|||
13237018|NCT01681186|26329229|FG000|Washout Period From Third Intervention|Lost to Follow-up|0|||
13237019|NCT01681186|26329230|FG001|Washout Period From Third Intervention|Lost to Follow-up|0|||
13237020|NCT01681186|26329231|FG002|Washout Period From Third Intervention|Lost to Follow-up|0|||
13237021|NCT01681186|26329232|FG003|Washout Period From Third Intervention|Lost to Follow-up|0|||
13237022|NCT01681186|26329233|FG004|Washout Period From Third Intervention|Lost to Follow-up|0|||
13237023|NCT01681186|26329234|FG005|Washout Period From Third Intervention|Lost to Follow-up|0|||
13237024|NCT01681186|26329235|FG006|Washout Period From Third Intervention|Lost to Follow-up|1|||
13237025|NCT01681186|26329236|FG007|Washout Period From Third Intervention|Lost to Follow-up|0|||
13237026|NCT01681186|26329229|FG000|Fourth Intervention|Protocol Violation|0|||
13237027|NCT01681186|26329230|FG001|Fourth Intervention|Protocol Violation|0|||
13237028|NCT01681186|26329231|FG002|Fourth Intervention|Protocol Violation|0|||
13237029|NCT01681186|26329232|FG003|Fourth Intervention|Protocol Violation|0|||
13237030|NCT01681186|26329233|FG004|Fourth Intervention|Protocol Violation|0|||
13237031|NCT01681186|26329234|FG005|Fourth Intervention|Protocol Violation|0|||
13237032|NCT01681186|26329235|FG006|Fourth Intervention|Protocol Violation|0|||
13237033|NCT01681186|26329236|FG007|Fourth Intervention|Protocol Violation|1|||
13237034|NCT01681069|26329253|FG000|Overall Study|Withdrawal by Subject|4|||
13237035|NCT01681069|26329254|FG001|Overall Study|Withdrawal by Subject|5|||
13237036|NCT01681069|26329253|FG000|Overall Study|Protocol Violation|1|||
13237037|NCT01681069|26329254|FG001|Overall Study|Protocol Violation|1|||
13237038|NCT01681069|26329253|FG000|Overall Study|Adverse Event|0|||
13237039|NCT01681069|26329254|FG001|Overall Study|Adverse Event|1|||
13237040|NCT01681004|26329315|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1|||
13237041|NCT01681004|26329316|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2|||
13237042|NCT01681004|26329315|FG000|Study Completion|Lost to Follow-up|8|||
13237043|NCT01681004|26329316|FG001|Study Completion|Lost to Follow-up|3|||
13237044|NCT01681004|26329315|FG000|Study Completion|Physician Decision|1|||
13237045|NCT01681004|26329316|FG001|Study Completion|Physician Decision|3|||
13237046|NCT01681004|26329315|FG000|Study Completion|Site Termination|2|||
13237047|NCT01681004|26329316|FG001|Study Completion|Site Termination|1|||
13237048|NCT01681004|26329315|FG000|Study Completion|Death|1|||
13237049|NCT01681004|26329316|FG001|Study Completion|Death|1|||
13237050|NCT01680991|26329385|FG000|Overall Study|Adverse Event|1|||
13237051|NCT01680991|26329386|FG001|Overall Study|Adverse Event|0|||
13237052|NCT01680991|26329387|FG002|Overall Study|Adverse Event|0|||
13237053|NCT01680991|26329385|FG000|Overall Study|Death|1|||
13237054|NCT01680991|26329386|FG001|Overall Study|Death|0|||
13237055|NCT01680991|26329387|FG002|Overall Study|Death|1|||
13237056|NCT01680991|26329385|FG000|Overall Study|Protocol Violation|0|||
13237057|NCT01680991|26329386|FG001|Overall Study|Protocol Violation|1|||
13237058|NCT01680991|26329387|FG002|Overall Study|Protocol Violation|0|||
13237059|NCT01680991|26329385|FG000|Overall Study|Withdrawal by Subject|5|||
13237060|NCT01680991|26329386|FG001|Overall Study|Withdrawal by Subject|1|||
13237061|NCT01680991|26329387|FG002|Overall Study|Withdrawal by Subject|0|||
13237062|NCT01680991|26329385|FG000|Overall Study|Progressive disease (PD)|0|||
13237063|NCT01680991|26329386|FG001|Overall Study|Progressive disease (PD)|10|||
13237064|NCT01680991|26329387|FG002|Overall Study|Progressive disease (PD)|0|||
13237065|NCT01680991|26329385|FG000|Overall Study|Physician Decision|0|||
13237066|NCT01680991|26329386|FG001|Overall Study|Physician Decision|7|||
13237067|NCT01680991|26329387|FG002|Overall Study|Physician Decision|2|||
13237068|NCT01680991|26329385|FG000|Overall Study|Bad physical condition|0|||
13237069|NCT01680991|26329386|FG001|Overall Study|Bad physical condition|0|||
13237070|NCT01680991|26329387|FG002|Overall Study|Bad physical condition|1|||
13237071|NCT01680991|26329385|FG000|Overall Study|PD confirmed in other hospital|1|||
13237072|NCT01680991|26329386|FG001|Overall Study|PD confirmed in other hospital|0|||
13237073|NCT01680991|26329387|FG002|Overall Study|PD confirmed in other hospital|0|||
13237074|NCT01680861|26329412|FG000|Early Post-transplant Period|Protocol Violation|1|||
13237075|NCT01680861|26329413|FG001|Early Post-transplant Period|Protocol Violation|1|||
13237076|NCT01680497|26329425|FG000|Overall Study|Lost to Follow-up|2|||
13237077|NCT01680458|26329436|FG000|Overall Study|Protocol Violation|3|||
13237078|NCT01680341|26329463|FG000|Overall Study|Adverse Event|3|||
13237079|NCT01680341|26329464|FG001|Overall Study|Adverse Event|2|||
13237080|NCT01680341|26329463|FG000|Overall Study|Unclassified|18|||
13237081|NCT01680341|26329464|FG001|Overall Study|Unclassified|15|||
13237082|NCT01680159|26329499|FG000|Screening Period|Not meet criteria for dose-up period|7|||
13237083|NCT01680159|26329499|FG000|Increased Dose Period|Adverse Event|6|||
13237084|NCT01680159|26329499|FG000|Increased Dose Period|Withdrawal by Subject|2|||
13237085|NCT01680016|26329570|FG000|Overall Study|Adverse Event|0|||
13237086|NCT01680016|26329571|FG001|Overall Study|Adverse Event|0|||
13237087|NCT01680016|26329572|FG002|Overall Study|Adverse Event|1|||
13237088|NCT01680016|26329573|FG003|Overall Study|Adverse Event|4|||
13237089|NCT01680016|26329570|FG000|Overall Study|The Subject went out of The Trial|1|||
13237090|NCT01680016|26329571|FG001|Overall Study|The Subject went out of The Trial|0|||
13237091|NCT01680016|26329572|FG002|Overall Study|The Subject went out of The Trial|3|||
13237092|NCT01680016|26329573|FG003|Overall Study|The Subject went out of The Trial|0|||
13237093|NCT01680016|26329570|FG000|Overall Study|Protocol Violation|0|||
13237094|NCT01680016|26329571|FG001|Overall Study|Protocol Violation|1|||
13237095|NCT01680016|26329572|FG002|Overall Study|Protocol Violation|0|||
13237096|NCT01680016|26329573|FG003|Overall Study|Protocol Violation|0|||
13237097|NCT01680016|26329570|FG000|Overall Study|Withdrawal by Subject|5|||
13237098|NCT01680016|26329571|FG001|Overall Study|Withdrawal by Subject|7|||
13237099|NCT01680016|26329572|FG002|Overall Study|Withdrawal by Subject|1|||
13237100|NCT01680016|26329573|FG003|Overall Study|Withdrawal by Subject|1|||
13237101|NCT01679613|26329589|FG000|Overall Study|other than stated above|0|||
13237102|NCT01679613|26329590|FG001|Overall Study|other than stated above|1|||
13237103|NCT01679613|26329591|FG002|Overall Study|other than stated above|2|||
13237104|NCT01679613|26329592|FG003|Overall Study|other than stated above|2|||
13237105|NCT01679405|26329613|FG000|Overall Study|Death|2|||
13237106|NCT01679405|26329614|FG001|Overall Study|Death|5|||
13237107|NCT01679301|26329624|FG000|Screening Period|screen failure|3|||
13237108|NCT01679301|26329625|FG001|Screening Period|screen failure|0|||
13237109|NCT01679301|26329626|FG002|Screening Period|screen failure|0|||
13237110|NCT01679236|26329639|FG000|Overall Study|Lost to Follow-up|15|||
13237111|NCT01679236|26329640|FG001|Overall Study|Lost to Follow-up|15|||
13237112|NCT01679002|26329664|FG000|Overall Study|Adverse Event|1|||
13237113|NCT01679002|26329665|FG001|Overall Study|Adverse Event|1|||
13237114|NCT01679002|26329666|FG002|Overall Study|Adverse Event|0|||
13237115|NCT01678924|26329810|FG000|Overall Study|Adverse Event|1|||
13237116|NCT01678924|26329811|FG001|Overall Study|Adverse Event|1|||
13237117|NCT01678924|26329812|FG002|Overall Study|Adverse Event|0|||
13237118|NCT01678924|26329813|FG003|Overall Study|Adverse Event|1|||
13237119|NCT01678924|26329810|FG000|Overall Study|Lack of Efficacy|7|||
13237120|NCT01678924|26329811|FG001|Overall Study|Lack of Efficacy|2|||
13237121|NCT01678924|26329812|FG002|Overall Study|Lack of Efficacy|0|||
13237122|NCT01678924|26329813|FG003|Overall Study|Lack of Efficacy|5|||
13237123|NCT01678924|26329810|FG000|Overall Study|Lost to Follow-up|0|||
13237124|NCT01678924|26329811|FG001|Overall Study|Lost to Follow-up|4|||
13237125|NCT01678924|26329812|FG002|Overall Study|Lost to Follow-up|0|||
13237126|NCT01678924|26329813|FG003|Overall Study|Lost to Follow-up|2|||
13237127|NCT01678924|26329810|FG000|Overall Study|Personal Reasons|2|||
13237128|NCT01678924|26329811|FG001|Overall Study|Personal Reasons|2|||
13237129|NCT01678924|26329812|FG002|Overall Study|Personal Reasons|2|||
13237130|NCT01678924|26329813|FG003|Overall Study|Personal Reasons|7|||
13237131|NCT01678924|26329810|FG000|Overall Study|Withdrawal by Subject|0|||
13237132|NCT01678924|26329811|FG001|Overall Study|Withdrawal by Subject|3|||
13237133|NCT01678924|26329812|FG002|Overall Study|Withdrawal by Subject|0|||
13237134|NCT01678924|26329813|FG003|Overall Study|Withdrawal by Subject|2|||
13237135|NCT01678924|26329810|FG000|Overall Study|Unable to attend scheduled visits|0|||
13237136|NCT01678924|26329811|FG001|Overall Study|Unable to attend scheduled visits|0|||
13237137|NCT01678924|26329812|FG002|Overall Study|Unable to attend scheduled visits|0|||
13237138|NCT01678924|26329813|FG003|Overall Study|Unable to attend scheduled visits|1|||
13237139|NCT01678911|26329830|FG000|Second Intervention|Lost to Follow-up|2|||
13237140|NCT01678911|26329831|FG001|Second Intervention|Lost to Follow-up|0|||
13237141|NCT01678898|26329919|FG000|PB-102-F01|Adverse Event|0|||
13237142|NCT01678898|26329920|FG001|PB-102-F01|Adverse Event|1|||
13237143|NCT01678898|26329921|FG002|PB-102-F01|Adverse Event|0|||
13237144|NCT01678898|26329919|FG000|PB-102-F01|Physician Decision|0|||
13237145|NCT01678898|26329920|FG001|PB-102-F01|Physician Decision|1|||
13237146|NCT01678898|26329921|FG002|PB-102-F01|Physician Decision|0|||
13237147|NCT01678820|26329973|FG000|Overall Study|Study Terminated by Sponsor|45|||
13237148|NCT01678820|26329974|FG001|Overall Study|Study Terminated by Sponsor|43|||
13237149|NCT01678820|26329975|FG002|Overall Study|Study Terminated by Sponsor|43|||
13237150|NCT01678820|26329973|FG000|Overall Study|Withdrawal by Subject|2|||
13237151|NCT01678820|26329974|FG001|Overall Study|Withdrawal by Subject|5|||
13237152|NCT01678820|26329975|FG002|Overall Study|Withdrawal by Subject|2|||
13237153|NCT01678820|26329973|FG000|Overall Study|Protocol Specified Criteria|2|||
13237154|NCT01678820|26329974|FG001|Overall Study|Protocol Specified Criteria|3|||
13237155|NCT01678820|26329975|FG002|Overall Study|Protocol Specified Criteria|1|||
13237156|NCT01678820|26329973|FG000|Overall Study|Adverse Event|2|||
13237157|NCT01678820|26329974|FG001|Overall Study|Adverse Event|2|||
13237158|NCT01678820|26329975|FG002|Overall Study|Adverse Event|2|||
13237159|NCT01678820|26329973|FG000|Overall Study|Lost to Follow-up|7|||
13237160|NCT01678820|26329974|FG001|Overall Study|Lost to Follow-up|2|||
13237161|NCT01678820|26329975|FG002|Overall Study|Lost to Follow-up|2|||
13237162|NCT01678820|26329973|FG000|Overall Study|Non-compliance with study drug|0|||
13237163|NCT01678820|26329974|FG001|Overall Study|Non-compliance with study drug|1|||
13237164|NCT01678820|26329975|FG002|Overall Study|Non-compliance with study drug|0|||
13237165|NCT01678820|26329973|FG000|Overall Study|Physician Decision|0|||
13237166|NCT01678820|26329974|FG001|Overall Study|Physician Decision|0|||
13237167|NCT01678820|26329975|FG002|Overall Study|Physician Decision|1|||
13237168|NCT01678820|26329973|FG000|Overall Study|Protocol Violation|4|||
13237169|NCT01678820|26329974|FG001|Overall Study|Protocol Violation|5|||
13237170|NCT01678820|26329975|FG002|Overall Study|Protocol Violation|4|||
13237171|NCT01678820|26329973|FG000|Overall Study|Not treated with double-blind study drug|0|||
13237172|NCT01678820|26329974|FG001|Overall Study|Not treated with double-blind study drug|2|||
13237173|NCT01678820|26329975|FG002|Overall Study|Not treated with double-blind study drug|2|||
13237174|NCT01678807|26329996|FG000|Overall Study|Adverse Event|4|||
13237175|NCT01678807|26329997|FG001|Overall Study|Adverse Event|4|||
13237176|NCT01678807|26329998|FG002|Overall Study|Adverse Event|0|||
13237177|NCT01678807|26329996|FG000|Overall Study|Withdrawn by Parent/Guardian|0|||
13237178|NCT01678807|26329997|FG001|Overall Study|Withdrawn by Parent/Guardian|1|||
13237179|NCT01678807|26329998|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
13237180|NCT01678560|26330019|FG000|Overall Study|Physician Decision|4|||
13237181|NCT01678560|26330020|FG001|Overall Study|Physician Decision|4|||
13237182|NCT01678560|26330019|FG000|Overall Study|Death|0|||
13237183|NCT01678560|26330020|FG001|Overall Study|Death|1|||
13237184|NCT01678560|26330019|FG000|Overall Study|Withdrawal by Subject|0|||
13237185|NCT01678560|26330020|FG001|Overall Study|Withdrawal by Subject|1|||
13237186|NCT01678313|26330043|FG000|Completed the 3-month Therapy|Lost to Follow-up|3|||
13237187|NCT01678313|26330044|FG001|Completed the 3-month Therapy|Lost to Follow-up|8|||
13237188|NCT01678313|26330043|FG000|Completed the 3-month Therapy|Physician Decision|3|||
13237189|NCT01678313|26330044|FG001|Completed the 3-month Therapy|Physician Decision|4|||
13237190|NCT01678313|26330043|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8|||
13237191|NCT01678313|26330044|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9|||
13237192|NCT01678313|26330043|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11|||
13237193|NCT01678313|26330044|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12|||
13237194|NCT01678209|26330080|FG000|Overall Study|could not scan twice|1|||
13237195|NCT01678209|26330081|FG001|Overall Study|could not scan twice|1|||
13237196|NCT01678209|26330082|FG002|Overall Study|could not scan twice|1|||
13237197|NCT01678209|26330080|FG000|Overall Study|scheduling conflicts|0|||
13237198|NCT01678209|26330081|FG001|Overall Study|scheduling conflicts|0|||
13237199|NCT01678209|26330082|FG002|Overall Study|scheduling conflicts|1|||
13237200|NCT01678209|26330080|FG000|Overall Study|screen fail|16|||
13237201|NCT01678209|26330081|FG001|Overall Study|screen fail|17|||
13237202|NCT01678209|26330082|FG002|Overall Study|screen fail|16|||
13237203|NCT01678144|26330100|FG000|Stage 1: MAR Classic|Adverse Event|1|||
13237204|NCT01678131|26330118|FG000|Overall Study|Adverse Event|0|||
13237205|NCT01678131|26330119|FG001|Overall Study|Adverse Event|1|||
13237206|NCT01678131|26330120|FG002|Overall Study|Adverse Event|0|||
13237207|NCT01678131|26330118|FG000|Overall Study|Withdrawal by Subject|0|||
13237208|NCT01678131|26330119|FG001|Overall Study|Withdrawal by Subject|0|||
13237209|NCT01678131|26330120|FG002|Overall Study|Withdrawal by Subject|2|||
13237210|NCT01677988|26330133|FG000|Overall Study|Lack of Efficacy|2|||
13237211|NCT01677936|26330148|FG000|Overall Study|Lost to Follow-up|4|||
13237212|NCT01677936|26330149|FG001|Overall Study|Lost to Follow-up|1|||
13237213|NCT01677936|26330148|FG000|Overall Study|Protocol Violation|3|||
13237214|NCT01677936|26330149|FG001|Overall Study|Protocol Violation|0|||
13237215|NCT01677936|26330148|FG000|Overall Study|Adverse Event|1|||
13237216|NCT01677936|26330149|FG001|Overall Study|Adverse Event|0|||
13237217|NCT01677936|26330148|FG000|Overall Study|Lost to Follow-up|1|||
13237218|NCT01677936|26330149|FG001|Overall Study|Lost to Follow-up|0|||
13237219|NCT01677936|26330148|FG000|Overall Study|Protocol Violation|0|||
13237220|NCT01677936|26330149|FG001|Overall Study|Protocol Violation|4|||
13237221|NCT01677910|26330182|FG000|Double-Blind Treatment Period|Adverse Event|6|||
13237222|NCT01677910|26330183|FG001|Double-Blind Treatment Period|Adverse Event|2|||
13237223|NCT01677910|26330184|FG002|Double-Blind Treatment Period|Adverse Event|3|||
13237224|NCT01677910|26330185|FG003|Double-Blind Treatment Period|Adverse Event|0|||
13237225|NCT01677910|26330182|FG000|Double-Blind Treatment Period|Physician Decision|0|||
13237226|NCT01677910|26330183|FG001|Double-Blind Treatment Period|Physician Decision|0|||
13237227|NCT01677910|26330184|FG002|Double-Blind Treatment Period|Physician Decision|1|||
13237228|NCT01677910|26330185|FG003|Double-Blind Treatment Period|Physician Decision|0|||
13237229|NCT01677910|26330182|FG000|Double-Blind Treatment Period|Withdrawal of consent|1|||
13237230|NCT01677910|26330183|FG001|Double-Blind Treatment Period|Withdrawal of consent|0|||
13237231|NCT01677910|26330184|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
13237232|NCT01677910|26330185|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
13237233|NCT01677910|26330182|FG000|Double-Blind Treatment Period|Reason Not Specified|0|||
13237234|NCT01677910|26330183|FG001|Double-Blind Treatment Period|Reason Not Specified|1|||
13237235|NCT01677910|26330184|FG002|Double-Blind Treatment Period|Reason Not Specified|0|||
13237236|NCT01677910|26330185|FG003|Double-Blind Treatment Period|Reason Not Specified|0|||
13237237|NCT01677910|26330182|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
13237238|NCT01677910|26330183|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
13237239|NCT01677910|26330184|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
13237240|NCT01677910|26330185|FG003|Open-Label Extension Period (OLE)|Physician Decision|4|||
13237241|NCT01677910|26330182|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
13237242|NCT01677910|26330183|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
13237243|NCT01677910|26330184|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
13237244|NCT01677910|26330185|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
13237245|NCT01677910|26330182|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
13237246|NCT01677910|26330183|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
13237247|NCT01677910|26330184|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
13237248|NCT01677910|26330185|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
13237249|NCT01677910|26330182|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
13237250|NCT01677910|26330183|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
13237251|NCT01677910|26330184|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
13289780|NCT00106028|26480116|FG001|Overall Study|Protocol Violation|1|||
13237252|NCT01677910|26330185|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5|||
13237253|NCT01677910|26330182|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
13237254|NCT01677910|26330183|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
13237255|NCT01677910|26330184|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
13237256|NCT01677910|26330185|FG003|Open-Label Extension Period (OLE)|Adverse Event|15|||
13237257|NCT01677910|26330182|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
13237258|NCT01677910|26330183|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
13237259|NCT01677910|26330184|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
13237260|NCT01677910|26330185|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1|||
13237261|NCT01677858|26330274|FG000|Overall Study|Adverse Event|0|||
13237262|NCT01677858|26330275|FG001|Overall Study|Adverse Event|0|||
13237263|NCT01677858|26330276|FG002|Overall Study|Adverse Event|2|||
13237264|NCT01677858|26330277|FG003|Overall Study|Adverse Event|3|||
13237265|NCT01677858|26330278|FG004|Overall Study|Adverse Event|13|||
13237266|NCT01677858|26330274|FG000|Overall Study|Death|0|||
13237267|NCT01677858|26330275|FG001|Overall Study|Death|0|||
13237268|NCT01677858|26330276|FG002|Overall Study|Death|0|||
13237269|NCT01677858|26330277|FG003|Overall Study|Death|0|||
13237270|NCT01677858|26330278|FG004|Overall Study|Death|1|||
13237271|NCT01677858|26330274|FG000|Overall Study|Physician Decision|1|||
13237272|NCT01677858|26330275|FG001|Overall Study|Physician Decision|0|||
13237273|NCT01677858|26330276|FG002|Overall Study|Physician Decision|2|||
13237274|NCT01677858|26330277|FG003|Overall Study|Physician Decision|0|||
13237275|NCT01677858|26330278|FG004|Overall Study|Physician Decision|12|||
13237276|NCT01677858|26330274|FG000|Overall Study|Progressive Disease|2|||
13237277|NCT01677858|26330275|FG001|Overall Study|Progressive Disease|1|||
13237278|NCT01677858|26330276|FG002|Overall Study|Progressive Disease|9|||
13237279|NCT01677858|26330277|FG003|Overall Study|Progressive Disease|3|||
13237280|NCT01677858|26330278|FG004|Overall Study|Progressive Disease|43|||
13237281|NCT01677858|26330274|FG000|Overall Study|Withdrawal by Subject|0|||
13237282|NCT01677858|26330275|FG001|Overall Study|Withdrawal by Subject|1|||
13237283|NCT01677858|26330276|FG002|Overall Study|Withdrawal by Subject|1|||
13237284|NCT01677858|26330277|FG003|Overall Study|Withdrawal by Subject|0|||
13237285|NCT01677858|26330278|FG004|Overall Study|Withdrawal by Subject|15|||
13237286|NCT01677858|26330274|FG000|Overall Study|Lost to Follow-up|0|||
13237287|NCT01677858|26330275|FG001|Overall Study|Lost to Follow-up|0|||
13237288|NCT01677858|26330276|FG002|Overall Study|Lost to Follow-up|0|||
13237289|NCT01677858|26330277|FG003|Overall Study|Lost to Follow-up|0|||
13237290|NCT01677858|26330278|FG004|Overall Study|Lost to Follow-up|1|||
13237291|NCT01677767|26330294|FG000|Overall Study|Adverse Event|1|||
13237292|NCT01677767|26330294|FG000|Overall Study|Death|4|||
13237293|NCT01677767|26330294|FG000|Overall Study|Protocol Violation|4|||
13237294|NCT01677767|26330294|FG000|Overall Study|Withdrawal by Subject|10|||
13237295|NCT01677767|26330294|FG000|Overall Study|Non-compliance by the participants|3|||
13237296|NCT01677741|26330414|FG000|Overall Study|Death|0|||
13237297|NCT01677741|26330415|FG001|Overall Study|Death|0|||
13237298|NCT01677741|26330416|FG002|Overall Study|Death|0|||
13237299|NCT01677741|26330417|FG003|Overall Study|Death|1|||
13237300|NCT01677741|26330418|FG004|Overall Study|Death|0|||
13237301|NCT01677741|26330419|FG005|Overall Study|Death|1|||
13237302|NCT01677741|26330420|FG006|Overall Study|Death|0|||
13237303|NCT01677741|26330421|FG007|Overall Study|Death|0|||
13237304|NCT01677741|26330414|FG000|Overall Study|Withdrawal by Subject|2|||
13237305|NCT01677741|26330415|FG001|Overall Study|Withdrawal by Subject|7|||
13237306|NCT01677741|26330416|FG002|Overall Study|Withdrawal by Subject|5|||
13237307|NCT01677741|26330417|FG003|Overall Study|Withdrawal by Subject|4|||
13237308|NCT01677741|26330418|FG004|Overall Study|Withdrawal by Subject|11|||
13237309|NCT01677741|26330419|FG005|Overall Study|Withdrawal by Subject|20|||
13237310|NCT01677741|26330420|FG006|Overall Study|Withdrawal by Subject|4|||
13237311|NCT01677741|26330421|FG007|Overall Study|Withdrawal by Subject|2|||
13237312|NCT01677741|26330414|FG000|Overall Study|Enrolled in a rollover study|0|||
13237313|NCT01677741|26330415|FG001|Overall Study|Enrolled in a rollover study|3|||
13237314|NCT01677741|26330416|FG002|Overall Study|Enrolled in a rollover study|2|||
13237315|NCT01677741|26330417|FG003|Overall Study|Enrolled in a rollover study|1|||
13237316|NCT01677741|26330418|FG004|Overall Study|Enrolled in a rollover study|6|||
13237317|NCT01677741|26330419|FG005|Overall Study|Enrolled in a rollover study|6|||
13237318|NCT01677741|26330420|FG006|Overall Study|Enrolled in a rollover study|7|||
13237319|NCT01677741|26330421|FG007|Overall Study|Enrolled in a rollover study|0|||
13237320|NCT01677741|26330414|FG000|Overall Study|Progressive disease|1|||
13237321|NCT01677741|26330415|FG001|Overall Study|Progressive disease|0|||
13237322|NCT01677741|26330416|FG002|Overall Study|Progressive disease|1|||
13237323|NCT01677741|26330417|FG003|Overall Study|Progressive disease|0|||
13237324|NCT01677741|26330418|FG004|Overall Study|Progressive disease|0|||
13237325|NCT01677741|26330419|FG005|Overall Study|Progressive disease|1|||
13237326|NCT01677741|26330420|FG006|Overall Study|Progressive disease|0|||
13237327|NCT01677741|26330421|FG007|Overall Study|Progressive disease|0|||
13237328|NCT01677624|26330428|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1|||
13237329|NCT01677507|26330441|FG000|Initial Assignment|Adverse Event|0|||
13237330|NCT01677507|26330442|FG001|Initial Assignment|Adverse Event|1|||
13237331|NCT01677507|26330441|FG000|Initial Assignment|Protocol Violation|0|||
13237332|NCT01677507|26330442|FG001|Initial Assignment|Protocol Violation|1|||
13237333|NCT01677507|26330441|FG000|Second Assigment|Withdrawal by Subject|2|||
13237334|NCT01677507|26330442|FG001|Second Assigment|Withdrawal by Subject|2|||
13237335|NCT01677507|26330441|FG000|Second Assigment|Adverse Event|1|||
13237336|NCT01677507|26330442|FG001|Second Assigment|Adverse Event|3|||
13237337|NCT01677377|26330649|FG000|Overall Study|Protocol Violation|1|||
13237338|NCT01677377|26330650|FG001|Overall Study|Protocol Violation|0|||
13237339|NCT01677377|26330651|FG002|Overall Study|Protocol Violation|0|||
13237340|NCT01677377|26330649|FG000|Overall Study|Lost to Follow-up|0|||
13237341|NCT01677377|26330650|FG001|Overall Study|Lost to Follow-up|1|||
13237342|NCT01677377|26330651|FG002|Overall Study|Lost to Follow-up|1|||
13237343|NCT01677377|26330649|FG000|Overall Study|Withdrawal by Subject|0|||
13237344|NCT01677377|26330650|FG001|Overall Study|Withdrawal by Subject|0|||
13237345|NCT01677377|26330651|FG002|Overall Study|Withdrawal by Subject|3|||
13237346|NCT01677377|26330649|FG000|Overall Study|Lack of Efficacy|0|||
13237347|NCT01677377|26330650|FG001|Overall Study|Lack of Efficacy|0|||
13237348|NCT01677377|26330651|FG002|Overall Study|Lack of Efficacy|1|||
13237349|NCT01677377|26330649|FG000|Overall Study|Pregnancy|0|||
13237350|NCT01677377|26330650|FG001|Overall Study|Pregnancy|0|||
13237351|NCT01677377|26330651|FG002|Overall Study|Pregnancy|1|||
13237352|NCT01677299|26330686|FG000|Overall Study|Adverse Event|0|||
13237353|NCT01677299|26330687|FG001|Overall Study|Adverse Event|2|||
13237354|NCT01677299|26330688|FG002|Overall Study|Adverse Event|1|||
13237355|NCT01677299|26330689|FG003|Overall Study|Adverse Event|0|||
13237356|NCT01677299|26330686|FG000|Overall Study|Withdrawal by Subject|0|||
13237357|NCT01677299|26330687|FG001|Overall Study|Withdrawal by Subject|1|||
13237358|NCT01677299|26330688|FG002|Overall Study|Withdrawal by Subject|0|||
13237359|NCT01677299|26330689|FG003|Overall Study|Withdrawal by Subject|1|||
13237360|NCT01677195|26330707|FG000|Overall Study|Lost to Follow-up|14|||
13237361|NCT01677195|26330708|FG001|Overall Study|Lost to Follow-up|22|||
13237362|NCT01677195|26330709|FG002|Overall Study|Lost to Follow-up|22|||
13237363|NCT01677195|26330707|FG000|Overall Study|Withdrawal by Subject|1|||
13237364|NCT01677195|26330708|FG001|Overall Study|Withdrawal by Subject|0|||
13237365|NCT01677195|26330709|FG002|Overall Study|Withdrawal by Subject|1|||
13237366|NCT01677195|26330707|FG000|Overall Study|Adverse Event|6|||
13237367|NCT01677195|26330708|FG001|Overall Study|Adverse Event|4|||
13237368|NCT01677195|26330709|FG002|Overall Study|Adverse Event|1|||
13237369|NCT01677195|26330707|FG000|Overall Study|Physician Decision|1|||
13237370|NCT01677195|26330708|FG001|Overall Study|Physician Decision|2|||
13237371|NCT01677195|26330709|FG002|Overall Study|Physician Decision|2|||
13237372|NCT01677195|26330707|FG000|Overall Study|Pregnancy|0|||
13237373|NCT01677195|26330708|FG001|Overall Study|Pregnancy|1|||
13237374|NCT01677195|26330709|FG002|Overall Study|Pregnancy|0|||
13237375|NCT01677195|26330707|FG000|Overall Study|Protocol Violation|7|||
13237376|NCT01677195|26330708|FG001|Overall Study|Protocol Violation|3|||
13237377|NCT01677195|26330709|FG002|Overall Study|Protocol Violation|4|||
13237378|NCT01677182|26330751|FG000|Overall Study|Adverse Event|2|||
13237379|NCT01677182|26330752|FG001|Overall Study|Adverse Event|1|||
13237380|NCT01677182|26330753|FG002|Overall Study|Adverse Event|8|||
13237381|NCT01677182|26330751|FG000|Overall Study|Protocol Violation|5|||
13237382|NCT01677182|26330752|FG001|Overall Study|Protocol Violation|1|||
13237383|NCT01677182|26330753|FG002|Overall Study|Protocol Violation|4|||
13237384|NCT01677182|26330751|FG000|Overall Study|Lost to Follow-up|4|||
13237385|NCT01677182|26330752|FG001|Overall Study|Lost to Follow-up|0|||
13237386|NCT01677182|26330753|FG002|Overall Study|Lost to Follow-up|3|||
13237387|NCT01677182|26330751|FG000|Overall Study|Withdrawal by Subject|7|||
13237388|NCT01677182|26330752|FG001|Overall Study|Withdrawal by Subject|12|||
13237389|NCT01677182|26330753|FG002|Overall Study|Withdrawal by Subject|10|||
13237390|NCT01677182|26330751|FG000|Overall Study|Study termination|12|||
13237391|NCT01677182|26330752|FG001|Overall Study|Study termination|9|||
13237392|NCT01677182|26330753|FG002|Overall Study|Study termination|11|||
13237393|NCT01677182|26330751|FG000|Overall Study|Lack of Efficacy|3|||
13237394|NCT01677182|26330752|FG001|Overall Study|Lack of Efficacy|0|||
13237395|NCT01677182|26330753|FG002|Overall Study|Lack of Efficacy|1|||
13237396|NCT01677182|26330751|FG000|Overall Study|Other reasons|1|||
13237397|NCT01677182|26330752|FG001|Overall Study|Other reasons|5|||
13237398|NCT01677182|26330753|FG002|Overall Study|Other reasons|2|||
13237399|NCT01676961|26330760|FG000|Overall Study|Death|3|||
13237400|NCT01676961|26330760|FG000|Overall Study|Lost to Follow-up|1|||
13237401|NCT01676961|26330760|FG000|Overall Study|Withdrawal by Subject|1|||
13237402|NCT01676909|26330829|FG000|Overall Study|Withdrawal by Subject|3|||
13237403|NCT01676909|26330830|FG001|Overall Study|Withdrawal by Subject|5|||
13237404|NCT01676909|26330829|FG000|Overall Study|Lost to Follow-up|15|||
13237405|NCT01676909|26330830|FG001|Overall Study|Lost to Follow-up|9|||
13237406|NCT01676896|26330935|FG000|Overall Study|Withdrawal by Subject|12|||
13237407|NCT01676896|26330936|FG001|Overall Study|Withdrawal by Subject|7|||
13237408|NCT01676896|26330937|FG002|Overall Study|Withdrawal by Subject|19|||
13237409|NCT01676727|26330944|FG000|Overall Study|Death|18|||
13237410|NCT01676727|26330944|FG000|Overall Study|Withdrawal by Subject|6|||
13237411|NCT01676727|26330944|FG000|Overall Study|Screening failure|5|||
13237412|NCT01676727|26330944|FG000|Overall Study|Not willing to attend 1-year visit|2|||
13237413|NCT01676727|26330944|FG000|Overall Study|Valve explanted|1|||
13237414|NCT01676701|26330977|FG000|Overall Study|Protocol Violation|1|||
13237415|NCT01676701|26330978|FG001|Overall Study|Protocol Violation|0|||
13237416|NCT01676701|26330977|FG000|Overall Study|Sponsor Decision|3|||
13237417|NCT01676701|26330978|FG001|Overall Study|Sponsor Decision|4|||
13237418|NCT01676220|26331015|FG000|Overall Study|Randomized But Not Treated|4|||
13237419|NCT01676220|26331016|FG001|Overall Study|Randomized But Not Treated|1|||
13237420|NCT01676220|26331015|FG000|Overall Study|Adverse Event|10|||
13237421|NCT01676220|26331016|FG001|Overall Study|Adverse Event|8|||
13237422|NCT01676220|26331015|FG000|Overall Study|Lack of Efficacy|2|||
13237423|NCT01676220|26331016|FG001|Overall Study|Lack of Efficacy|5|||
13237424|NCT01676220|26331015|FG000|Overall Study|Protocol Violation|11|||
13237425|NCT01676220|26331016|FG001|Overall Study|Protocol Violation|12|||
13237426|NCT01676220|26331015|FG000|Overall Study|Received Rescue Therapy|14|||
13237427|NCT01676220|26331016|FG001|Overall Study|Received Rescue Therapy|22|||
13237428|NCT01676220|26331015|FG000|Overall Study|Personal Reason|34|||
13237429|NCT01676220|26331016|FG001|Overall Study|Personal Reason|45|||
13237430|NCT01676220|26331015|FG000|Overall Study|Lost to Follow-up|11|||
13237431|NCT01676220|26331016|FG001|Overall Study|Lost to Follow-up|18|||
13237432|NCT01676220|26331015|FG000|Overall Study|Selection Criterion/Protocol Violation|9|||
13237433|NCT01676220|26331016|FG001|Overall Study|Selection Criterion/Protocol Violation|9|||
13237434|NCT01676220|26331015|FG000|Overall Study|Site Closure/Site Withdrawal|1|||
13237435|NCT01676220|26331016|FG001|Overall Study|Site Closure/Site Withdrawal|4|||
13237436|NCT01676220|26331015|FG000|Overall Study|Perceived Lack of Efficacy|3|||
13237437|NCT01676220|26331016|FG001|Overall Study|Perceived Lack of Efficacy|1|||
13237438|NCT01676220|26331015|FG000|Overall Study|Non Serious Hypoglycemia|2|||
13237439|NCT01676220|26331016|FG001|Overall Study|Non Serious Hypoglycemia|0|||
13237440|NCT01676220|26331015|FG000|Overall Study|No More Need of Insulin|1|||
13237441|NCT01676220|26331016|FG001|Overall Study|No More Need of Insulin|0|||
13237442|NCT01676116|26331045|FG000|Overall Study|Withdrawal criteria|2|||
13237443|NCT01676116|26331046|FG001|Overall Study|Withdrawal criteria|14|||
13237444|NCT01676116|26331045|FG000|Overall Study|Adverse Event|1|||
13237445|NCT01676116|26331046|FG001|Overall Study|Adverse Event|2|||
13237446|NCT01676116|26331045|FG000|Overall Study|Unclassified|4|||
13237447|NCT01676116|26331046|FG001|Overall Study|Unclassified|10|||
13237448|NCT01676116|26331045|FG000|Overall Study|Protocol Violation|9|||
13237449|NCT01676116|26331046|FG001|Overall Study|Protocol Violation|3|||
13237450|NCT01676012|26331052|FG000|Overall Study|Adverse Event|2|||
13237451|NCT01676012|26331052|FG000|Overall Study|incomplete set of videos|1|||
13237452|NCT01675882|26331147|FG000|Overall Study|Adverse Event|0|||
13237453|NCT01675882|26331148|FG001|Overall Study|Adverse Event|2|||
13237454|NCT01675882|26331149|FG002|Overall Study|Adverse Event|1|||
13237455|NCT01675882|26331150|FG003|Overall Study|Adverse Event|0|||
13237456|NCT01675882|26331147|FG000|Overall Study|Participant unwilling to continue|2|||
13237457|NCT01675882|26331148|FG001|Overall Study|Participant unwilling to continue|4|||
13237458|NCT01675882|26331149|FG002|Overall Study|Participant unwilling to continue|2|||
13237459|NCT01675882|26331150|FG003|Overall Study|Participant unwilling to continue|1|||
13237460|NCT01675882|26331147|FG000|Overall Study|Lost to Follow-up|0|||
13237461|NCT01675882|26331148|FG001|Overall Study|Lost to Follow-up|1|||
13237462|NCT01675882|26331149|FG002|Overall Study|Lost to Follow-up|0|||
13237463|NCT01675882|26331150|FG003|Overall Study|Lost to Follow-up|0|||
13237464|NCT01675882|26331147|FG000|Overall Study|Non-compliance|0|||
13237465|NCT01675882|26331148|FG001|Overall Study|Non-compliance|0|||
13237466|NCT01675882|26331149|FG002|Overall Study|Non-compliance|0|||
13237467|NCT01675882|26331150|FG003|Overall Study|Non-compliance|1|||
13237468|NCT01675765|26331171|FG000|Overall Study|Progressive disease|4|||
13237469|NCT01675765|26331172|FG001|Overall Study|Progressive disease|4|||
13237470|NCT01675765|26331171|FG000|Overall Study|Adverse Event|1|||
13237471|NCT01675765|26331172|FG001|Overall Study|Adverse Event|2|||
13237472|NCT01675765|26331171|FG000|Overall Study|Withdrawal by Subject|2|||
13237473|NCT01675765|26331172|FG001|Overall Study|Withdrawal by Subject|0|||
13237474|NCT01675765|26331171|FG000|Overall Study|Death|1|||
13237475|NCT01675765|26331172|FG001|Overall Study|Death|0|||
13237476|NCT01675765|26331171|FG000|Overall Study|Clinical progression|3|||
13237477|NCT01675765|26331172|FG001|Overall Study|Clinical progression|2|||
13237478|NCT01675661|26331185|FG000|Overall Study|Lost to Follow-up|22|||
13237479|NCT01675661|26331186|FG001|Overall Study|Lost to Follow-up|23|||
13237480|NCT01675661|26331185|FG000|Overall Study|Practical problems|9|||
13237481|NCT01675661|26331186|FG001|Overall Study|Practical problems|5|||
13237482|NCT01675661|26331185|FG000|Overall Study|Moved away|5|||
13237483|NCT01675661|26331186|FG001|Overall Study|Moved away|6|||
13237484|NCT01675661|26331185|FG000|Overall Study|Withdrawal by Subject|3|||
13237485|NCT01675661|26331186|FG001|Overall Study|Withdrawal by Subject|7|||
13237486|NCT01675661|26331185|FG000|Overall Study|Physician Decision|0|||
13237487|NCT01675661|26331186|FG001|Overall Study|Physician Decision|2|||
13237488|NCT01675661|26331185|FG000|Overall Study|Death|0|||
13237489|NCT01675661|26331186|FG001|Overall Study|Death|1|||
13237490|NCT01675661|26331185|FG000|Overall Study|Other reason|1|||
13237491|NCT01675661|26331186|FG001|Overall Study|Other reason|2|||
13237492|NCT01675622|26331217|FG000|Overall Study|Withdrawal by Subject|2|||
13237493|NCT01675622|26331218|FG001|Overall Study|Withdrawal by Subject|2|||
13237494|NCT01675622|26331217|FG000|Overall Study|Adverse Event|12|||
13237495|NCT01675622|26331218|FG001|Overall Study|Adverse Event|10|||
13237496|NCT01675622|26331217|FG000|Overall Study|Protocol Violation|4|||
13237497|NCT01675622|26331218|FG001|Overall Study|Protocol Violation|1|||
13237498|NCT01675622|26331217|FG000|Overall Study|Lack of Efficacy|2|||
13237499|NCT01675622|26331218|FG001|Overall Study|Lack of Efficacy|4|||
13237500|NCT01675622|26331217|FG000|Overall Study|Lost to Follow-up|1|||
13237501|NCT01675622|26331218|FG001|Overall Study|Lost to Follow-up|3|||
13237502|NCT01675622|26331217|FG000|Overall Study|Other|5|||
13237503|NCT01675622|26331218|FG001|Overall Study|Other|4|||
13237504|NCT01675596|26331226|FG000|Overall Study|Death|6|||
13237505|NCT01675596|26331226|FG000|Overall Study|Exit with other reason|1|||
13237506|NCT01675596|26331226|FG000|Overall Study|Missed Visit|1|||
13237507|NCT01675544|26331233|FG000|Overall Study|Withdrawal by Subject|2|||
13237508|NCT01675531|26331242|FG000|Overall Study|Adverse Event|9|||
13237509|NCT01675531|26331242|FG000|Overall Study|Withdrawal by Subject|7|||
13237510|NCT01675531|26331242|FG000|Overall Study|Lack of Efficacy|1|||
13237511|NCT01675531|26331242|FG000|Overall Study|Protocol Violation|8|||
13237512|NCT01675492|26331249|FG000|Overall Study|study completed early - product approval|42|||
13237513|NCT01675427|26331536|FG000|Overall Study|Withdrawal by Subject|7|||
13237514|NCT01675427|26331536|FG000|Overall Study|Participant Refused Sample Collection|18|||
13237515|NCT01675427|26331536|FG000|Overall Study|Sample not Collected by Mistake|2|||
13237516|NCT01675427|26331536|FG000|Overall Study|Lost to Follow-up|5|||
13237517|NCT01675427|26331536|FG000|Overall Study|Other|2|||
13237518|NCT01675167|26331566|FG000|Open-label Titration Phase|Adverse Event|81|||
13237519|NCT01675167|26331567|FG001|Open-label Titration Phase|Adverse Event|0|||
13237520|NCT01675167|26331568|FG002|Open-label Titration Phase|Adverse Event|0|||
13237521|NCT01675167|26331566|FG000|Open-label Titration Phase|Lack of Efficacy|63|||
13237522|NCT01675167|26331567|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
13237523|NCT01675167|26331568|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
13237524|NCT01675167|26331566|FG000|Open-label Titration Phase|Withdrawal by Subject|46|||
13237525|NCT01675167|26331567|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
13237526|NCT01675167|26331568|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
13115533|NCT03096847|25918177|FG002|Overall Study|Progressive disease|78|||
13237527|NCT01675167|26331566|FG000|Open-label Titration Phase|Protocol Violation|43|||
13237528|NCT01675167|26331567|FG001|Open-label Titration Phase|Protocol Violation|0|||
13237529|NCT01675167|26331568|FG002|Open-label Titration Phase|Protocol Violation|0|||
13237530|NCT01675167|26331566|FG000|Open-label Titration Phase|Lost to Follow-up|15|||
13237531|NCT01675167|26331567|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
13237532|NCT01675167|26331568|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
13237533|NCT01675167|26331566|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1|||
13237534|NCT01675167|26331567|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
13115534|NCT03096847|25918175|FG000|Overall Study|Non-compliance with study medication|1|||
13115535|NCT03096847|25918176|FG001|Overall Study|Non-compliance with study medication|0|||
13115536|NCT03096847|25918177|FG002|Overall Study|Non-compliance with study medication|0|||
13237535|NCT01675167|26331568|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
13237536|NCT01675167|26331566|FG000|Open-label Titration Phase|Other|55|||
13237537|NCT01675167|26331567|FG001|Open-label Titration Phase|Other|0|||
13237538|NCT01675167|26331568|FG002|Open-label Titration Phase|Other|0|||
13237539|NCT01675167|26331566|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
13237540|NCT01675167|26331567|FG001|Double-blind Treatment Phase|Lack of Efficacy|19|||
13237541|NCT01675167|26331568|FG002|Double-blind Treatment Phase|Lack of Efficacy|61|||
13237542|NCT01675167|26331566|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
13237543|NCT01675167|26331567|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
13237544|NCT01675167|26331568|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6|||
13237545|NCT01675167|26331566|FG000|Double-blind Treatment Phase|Adverse Event|0|||
13237546|NCT01675167|26331567|FG001|Double-blind Treatment Phase|Adverse Event|5|||
13237547|NCT01675167|26331568|FG002|Double-blind Treatment Phase|Adverse Event|13|||
13237548|NCT01675167|26331566|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
13237549|NCT01675167|26331567|FG001|Double-blind Treatment Phase|Protocol Violation|4|||
13237550|NCT01675167|26331568|FG002|Double-blind Treatment Phase|Protocol Violation|11|||
13237551|NCT01675167|26331566|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
13237552|NCT01675167|26331567|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
13237553|NCT01675167|26331568|FG002|Double-blind Treatment Phase|Lost to Follow-up|5|||
13237554|NCT01675167|26331566|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
13237555|NCT01675167|26331567|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
13237556|NCT01675167|26331568|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9|||
13237557|NCT01675167|26331566|FG000|Double-blind Treatment Phase|Other|0|||
13237558|NCT01675167|26331567|FG001|Double-blind Treatment Phase|Other|7|||
13237559|NCT01675167|26331568|FG002|Double-blind Treatment Phase|Other|5|||
13237560|NCT01675154|26331615|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
13237561|NCT01675154|26331616|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1|||
13237562|NCT01675154|26331617|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
13237563|NCT01675154|26331618|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
13237564|NCT01675141|26331630|FG000|Overall Study|Lenalidomide outside NIH|3|||
13237565|NCT01675141|26331630|FG000|Overall Study|Withdrawal by Subject|3|||
13237566|NCT01675141|26331630|FG000|Overall Study|Physician Decision|4|||
13237567|NCT01675141|26331630|FG000|Overall Study|No treatment, per protocol|1|||
13237568|NCT01675128|26331662|FG000|Overall Study|Disease progression on study|1|||
13237569|NCT01675128|26331663|FG001|Overall Study|Disease progression on study|1|||
13237570|NCT01675128|26331664|FG002|Overall Study|Disease progression on study|1|||
13237571|NCT01675128|26331662|FG000|Overall Study|Refused further treatment|1|||
13237572|NCT01675128|26331663|FG001|Overall Study|Refused further treatment|0|||
13237573|NCT01675128|26331664|FG002|Overall Study|Refused further treatment|0|||
13237574|NCT01675128|26331662|FG000|Overall Study|Pulmonary complication; off study|0|||
13237575|NCT01675128|26331663|FG001|Overall Study|Pulmonary complication; off study|1|||
13237576|NCT01675128|26331664|FG002|Overall Study|Pulmonary complication; off study|0|||
13237577|NCT01675050|26331679|FG000|Period One Treatment|Withdrawal by Subject|1|||
13237578|NCT01675050|26331680|FG001|Period One Treatment|Withdrawal by Subject|0|||
13237579|NCT01675011|26331693|FG000|Overall Study|Trial terminated by Sponsor|3|||
13237580|NCT01675011|26331694|FG001|Overall Study|Trial terminated by Sponsor|1|||
13237581|NCT01674725|26331715|FG000|Overall Study|Adverse Event|1|||
13237582|NCT01674725|26331716|FG001|Overall Study|Adverse Event|0|||
13237583|NCT01674725|26331715|FG000|Overall Study|Did not receive study drug|1|||
13237584|NCT01674725|26331716|FG001|Overall Study|Did not receive study drug|0|||
13237585|NCT01674725|26331715|FG000|Overall Study|Withdrawal by Subject|1|||
13237586|NCT01674725|26331716|FG001|Overall Study|Withdrawal by Subject|0|||
13237587|NCT01674725|26331715|FG000|Overall Study|Lost to Follow-up|0|||
13237588|NCT01674725|26331716|FG001|Overall Study|Lost to Follow-up|1|||
13237589|NCT01674712|26331754|FG000|Overall Study|Adverse Event|5|||
13237590|NCT01674712|26331755|FG001|Overall Study|Adverse Event|6|||
13237591|NCT01674712|26331756|FG002|Overall Study|Adverse Event|3|||
13237592|NCT01674712|26331757|FG003|Overall Study|Adverse Event|4|||
13237593|NCT01674712|26331758|FG004|Overall Study|Adverse Event|6|||
13237594|NCT01674712|26331754|FG000|Overall Study|Lost to Follow-up|1|||
13237595|NCT01674712|26331755|FG001|Overall Study|Lost to Follow-up|0|||
13237596|NCT01674712|26331756|FG002|Overall Study|Lost to Follow-up|0|||
13237597|NCT01674712|26331757|FG003|Overall Study|Lost to Follow-up|0|||
13237598|NCT01674712|26331758|FG004|Overall Study|Lost to Follow-up|0|||
13237599|NCT01674712|26331754|FG000|Overall Study|Protocol Violation|2|||
13237600|NCT01674712|26331755|FG001|Overall Study|Protocol Violation|0|||
13237601|NCT01674712|26331756|FG002|Overall Study|Protocol Violation|0|||
13237602|NCT01674712|26331757|FG003|Overall Study|Protocol Violation|0|||
13237603|NCT01674712|26331758|FG004|Overall Study|Protocol Violation|0|||
13237604|NCT01674712|26331754|FG000|Overall Study|Withdrawal by Subject|2|||
13237605|NCT01674712|26331755|FG001|Overall Study|Withdrawal by Subject|2|||
13237606|NCT01674712|26331756|FG002|Overall Study|Withdrawal by Subject|5|||
13237607|NCT01674712|26331757|FG003|Overall Study|Withdrawal by Subject|4|||
13237608|NCT01674712|26331758|FG004|Overall Study|Withdrawal by Subject|3|||
13237609|NCT01674712|26331754|FG000|Overall Study|Administrative|0|||
13237610|NCT01674712|26331755|FG001|Overall Study|Administrative|1|||
13237611|NCT01674712|26331756|FG002|Overall Study|Administrative|0|||
13237612|NCT01674712|26331757|FG003|Overall Study|Administrative|0|||
13237613|NCT01674712|26331758|FG004|Overall Study|Administrative|1|||
13237614|NCT01674712|26331754|FG000|Overall Study|Lack of Efficacy|0|||
13237615|NCT01674712|26331755|FG001|Overall Study|Lack of Efficacy|0|||
13237616|NCT01674712|26331756|FG002|Overall Study|Lack of Efficacy|1|||
13237617|NCT01674712|26331757|FG003|Overall Study|Lack of Efficacy|0|||
13237618|NCT01674712|26331758|FG004|Overall Study|Lack of Efficacy|1|||
13237619|NCT01674647|26331791|FG000|Treatment Period|Death|4|||
13237620|NCT01674647|26331792|FG001|Treatment Period|Death|1|||
13237621|NCT01674647|26331791|FG000|Treatment Period|Efficacy outcome reached|0|||
13237622|NCT01674647|26331792|FG001|Treatment Period|Efficacy outcome reached|1|||
13237623|NCT01674647|26331791|FG000|Treatment Period|Physician Decision|3|||
13237624|NCT01674647|26331792|FG001|Treatment Period|Physician Decision|1|||
13237625|NCT01674647|26331791|FG000|Treatment Period|Adverse Event|60|||
13237626|NCT01674647|26331792|FG001|Treatment Period|Adverse Event|22|||
13237627|NCT01674647|26331791|FG000|Treatment Period|Non-compliance with study drug|3|||
13237628|NCT01674647|26331792|FG001|Treatment Period|Non-compliance with study drug|0|||
13237629|NCT01674647|26331791|FG000|Treatment Period|Lost to Follow-up|1|||
13237630|NCT01674647|26331792|FG001|Treatment Period|Lost to Follow-up|1|||
13237631|NCT01674647|26331791|FG000|Treatment Period|Withdrawal by Subject|19|||
13237632|NCT01674647|26331792|FG001|Treatment Period|Withdrawal by Subject|16|||
13237633|NCT01674647|26331791|FG000|Treatment Period|Switching to other therapy|5|||
13237634|NCT01674647|26331792|FG001|Treatment Period|Switching to other therapy|2|||
13237635|NCT01674647|26331791|FG000|Treatment Period|Logistical difficulties|5|||
13237636|NCT01674647|26331792|FG001|Treatment Period|Logistical difficulties|8|||
13237637|NCT01674647|26331791|FG000|Treatment Period|Treatment failure|0|||
13237638|NCT01674647|26331792|FG001|Treatment Period|Treatment failure|14|||
13237639|NCT01674647|26331791|FG000|Treatment Period|Protocol Violation|56|||
13237640|NCT01674647|26331792|FG001|Treatment Period|Protocol Violation|36|||
13237641|NCT01674647|26331791|FG000|30-day Safety Follow-up Period|Death|3|||
13237642|NCT01674647|26331792|FG001|30-day Safety Follow-up Period|Death|2|||
13237643|NCT01674647|26331791|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0|||
13237644|NCT01674647|26331792|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1|||
13237645|NCT01674647|26331791|FG000|30-day Safety Follow-up Period|Protocol Violation|39|||
13237646|NCT01674647|26331792|FG001|30-day Safety Follow-up Period|Protocol Violation|22|||
13237647|NCT01674647|26331791|FG000|30-day Safety Follow-up Period|Logistical difficulties|1|||
13237648|NCT01674647|26331792|FG001|30-day Safety Follow-up Period|Logistical difficulties|3|||
13237649|NCT01674647|26331791|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7|||
13237650|NCT01674647|26331792|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8|||
13237651|NCT01674647|26331791|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8|||
13237652|NCT01674647|26331792|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5|||
13237653|NCT01674634|26331809|FG000|Overall Study|Withdrawal by Subject|3|||
13237654|NCT01674634|26331809|FG000|Overall Study|Lost to Follow-up|3|||
13237655|NCT01674621|26331902|FG000|Overall Study|Adverse Event|3|||
13237656|NCT01674621|26331903|FG001|Overall Study|Adverse Event|2|||
13237657|NCT01674621|26331904|FG002|Overall Study|Adverse Event|5|||
13237658|NCT01674621|26331905|FG003|Overall Study|Adverse Event|5|||
13237659|NCT01674621|26331906|FG004|Overall Study|Adverse Event|1|||
13237660|NCT01674621|26331902|FG000|Overall Study|Inability to Complete Study Procedures|0|||
13237661|NCT01674621|26331903|FG001|Overall Study|Inability to Complete Study Procedures|0|||
13237662|NCT01674621|26331904|FG002|Overall Study|Inability to Complete Study Procedures|0|||
13237663|NCT01674621|26331905|FG003|Overall Study|Inability to Complete Study Procedures|0|||
13237664|NCT01674621|26331906|FG004|Overall Study|Inability to Complete Study Procedures|2|||
13237665|NCT01674621|26331902|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
13237666|NCT01674621|26331903|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
13237667|NCT01674621|26331904|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
13237668|NCT01674621|26331905|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1|||
13237669|NCT01674621|26331906|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
13237670|NCT01674621|26331902|FG000|Overall Study|Withdrawal by Subject|2|||
13237671|NCT01674621|26331903|FG001|Overall Study|Withdrawal by Subject|5|||
13237672|NCT01674621|26331904|FG002|Overall Study|Withdrawal by Subject|2|||
13237673|NCT01674621|26331905|FG003|Overall Study|Withdrawal by Subject|0|||
13237674|NCT01674621|26331906|FG004|Overall Study|Withdrawal by Subject|1|||
13237675|NCT01674621|26331902|FG000|Overall Study|Other than specified|0|||
13237676|NCT01674621|26331903|FG001|Overall Study|Other than specified|1|||
13237677|NCT01674621|26331904|FG002|Overall Study|Other than specified|0|||
13237678|NCT01674621|26331905|FG003|Overall Study|Other than specified|0|||
13237679|NCT01674621|26331906|FG004|Overall Study|Other than specified|2|||
13237680|NCT01674569|26331917|FG000|Overall Study|Adverse Event|0|||
13237681|NCT01674569|26331918|FG001|Overall Study|Adverse Event|2|||
13237682|NCT01674569|26331919|FG002|Overall Study|Adverse Event|0|||
13237683|NCT01674569|26331920|FG003|Overall Study|Adverse Event|1|||
13237684|NCT01674569|26331921|FG004|Overall Study|Adverse Event|2|||
13237685|NCT01674569|26331922|FG005|Overall Study|Adverse Event|2|||
13237686|NCT01674569|26331917|FG000|Overall Study|Protocol Violation|0|||
13237687|NCT01674569|26331918|FG001|Overall Study|Protocol Violation|1|||
13237688|NCT01674569|26331919|FG002|Overall Study|Protocol Violation|1|||
13237689|NCT01674569|26331920|FG003|Overall Study|Protocol Violation|0|||
13237690|NCT01674569|26331921|FG004|Overall Study|Protocol Violation|0|||
13237691|NCT01674569|26331922|FG005|Overall Study|Protocol Violation|0|||
13237692|NCT01674569|26331917|FG000|Overall Study|Withdrawal by Subject|0|||
13237693|NCT01674569|26331918|FG001|Overall Study|Withdrawal by Subject|0|||
13237694|NCT01674569|26331919|FG002|Overall Study|Withdrawal by Subject|1|||
13237695|NCT01674569|26331920|FG003|Overall Study|Withdrawal by Subject|0|||
13237696|NCT01674569|26331921|FG004|Overall Study|Withdrawal by Subject|0|||
13237697|NCT01674569|26331922|FG005|Overall Study|Withdrawal by Subject|0|||
13237698|NCT01674062|26331944|FG000|Overall Study|Insufficient Therapeutic Response|56|||
13237699|NCT01674062|26331945|FG001|Overall Study|Insufficient Therapeutic Response|26|||
13237700|NCT01674062|26331944|FG000|Overall Study|Other|8|||
13237701|NCT01674062|26331945|FG001|Overall Study|Other|1|||
13237702|NCT01674062|26331944|FG000|Overall Study|Adverse Event|1|||
13237703|NCT01674062|26331945|FG001|Overall Study|Adverse Event|1|||
13237704|NCT01674062|26331944|FG000|Overall Study|Death|0|||
13237705|NCT01674062|26331945|FG001|Overall Study|Death|1|||
13237706|NCT01674062|26331944|FG000|Overall Study|Programming Error|1|||
13237707|NCT01674062|26331945|FG001|Overall Study|Programming Error|0|||
13237708|NCT01674010|26331966|FG000|Open Treatment Phase 1|Adverse Event|10|||
13237709|NCT01674010|26331967|FG001|Open Treatment Phase 1|Adverse Event|0|||
13237710|NCT01674010|26331968|FG002|Open Treatment Phase 1|Adverse Event|0|||
13237711|NCT01674010|26331966|FG000|Open Treatment Phase 1|Death|1|||
13237712|NCT01674010|26331967|FG001|Open Treatment Phase 1|Death|0|||
13237713|NCT01674010|26331968|FG002|Open Treatment Phase 1|Death|0|||
13237714|NCT01674010|26331966|FG000|Open Treatment Phase 1|Lost to Follow-up|19|||
13237715|NCT01674010|26331967|FG001|Open Treatment Phase 1|Lost to Follow-up|0|||
13237716|NCT01674010|26331968|FG002|Open Treatment Phase 1|Lost to Follow-up|0|||
13237717|NCT01674010|26331966|FG000|Open Treatment Phase 1|Physician Decision|9|||
13237718|NCT01674010|26331967|FG001|Open Treatment Phase 1|Physician Decision|0|||
13237719|NCT01674010|26331968|FG002|Open Treatment Phase 1|Physician Decision|0|||
13237720|NCT01674010|26331966|FG000|Open Treatment Phase 1|Protocol Violation|7|||
13237721|NCT01674010|26331967|FG001|Open Treatment Phase 1|Protocol Violation|0|||
13237722|NCT01674010|26331968|FG002|Open Treatment Phase 1|Protocol Violation|0|||
13237723|NCT01674010|26331966|FG000|Open Treatment Phase 1|Sponsor Decision|79|||
13237724|NCT01674010|26331967|FG001|Open Treatment Phase 1|Sponsor Decision|0|||
13237725|NCT01674010|26331968|FG002|Open Treatment Phase 1|Sponsor Decision|0|||
13237726|NCT01674010|26331966|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30|||
13237727|NCT01674010|26331967|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0|||
13237728|NCT01674010|26331968|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0|||
13237729|NCT01674010|26331966|FG000|Open Treatment Phase 1|Withdrawal by Subject|25|||
13237730|NCT01674010|26331967|FG001|Open Treatment Phase 1|Withdrawal by Subject|0|||
13237731|NCT01674010|26331968|FG002|Open Treatment Phase 1|Withdrawal by Subject|0|||
13237732|NCT01674010|26331966|FG000|Randomization Phase 2|Adverse Event|0|||
13237733|NCT01674010|26331967|FG001|Randomization Phase 2|Adverse Event|1|||
13237734|NCT01674010|26331968|FG002|Randomization Phase 2|Adverse Event|1|||
13237735|NCT01674010|26331966|FG000|Randomization Phase 2|Lost to Follow-up|0|||
13237736|NCT01674010|26331967|FG001|Randomization Phase 2|Lost to Follow-up|1|||
13237737|NCT01674010|26331968|FG002|Randomization Phase 2|Lost to Follow-up|2|||
13237738|NCT01674010|26331966|FG000|Randomization Phase 2|Mood episode recurrence|0|||
13237739|NCT01674010|26331967|FG001|Randomization Phase 2|Mood episode recurrence|8|||
13237740|NCT01674010|26331968|FG002|Randomization Phase 2|Mood episode recurrence|2|||
13237741|NCT01674010|26331966|FG000|Randomization Phase 2|Physician Decision|0|||
13237742|NCT01674010|26331967|FG001|Randomization Phase 2|Physician Decision|0|||
13237743|NCT01674010|26331968|FG002|Randomization Phase 2|Physician Decision|2|||
13237744|NCT01674010|26331966|FG000|Randomization Phase 2|Pregnancy|0|||
13237745|NCT01674010|26331967|FG001|Randomization Phase 2|Pregnancy|1|||
13237746|NCT01674010|26331968|FG002|Randomization Phase 2|Pregnancy|1|||
13237747|NCT01674010|26331966|FG000|Randomization Phase 2|Protocol Violation|0|||
13237748|NCT01674010|26331967|FG001|Randomization Phase 2|Protocol Violation|1|||
13237749|NCT01674010|26331968|FG002|Randomization Phase 2|Protocol Violation|1|||
13237750|NCT01674010|26331966|FG000|Randomization Phase 2|Sponsor Decision|0|||
13237751|NCT01674010|26331967|FG001|Randomization Phase 2|Sponsor Decision|42|||
13237752|NCT01674010|26331968|FG002|Randomization Phase 2|Sponsor Decision|45|||
13237753|NCT01674010|26331966|FG000|Randomization Phase 2|Withdrawal by Subject|0|||
13237754|NCT01674010|26331967|FG001|Randomization Phase 2|Withdrawal by Subject|8|||
13237755|NCT01674010|26331968|FG002|Randomization Phase 2|Withdrawal by Subject|7|||
13237756|NCT01673984|26331993|FG000|Overall Study|Adverse Event|1|||
13237757|NCT01673984|26331994|FG001|Overall Study|Adverse Event|0|||
13237758|NCT01673984|26331993|FG000|Overall Study|Study termination|9|||
13237759|NCT01673984|26331994|FG001|Overall Study|Study termination|6|||
13237760|NCT01673854|26332004|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7|||
13237761|NCT01673854|26332004|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6|||
13237762|NCT01673854|26332004|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2|||
13237763|NCT01673854|26332004|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1|||
13237764|NCT01673854|26332004|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1|||
13237765|NCT01673854|26332004|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1|||
13237766|NCT01673854|26332004|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2|||
13237767|NCT01673854|26332004|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7|||
13237768|NCT01673854|26332004|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12|||
13237769|NCT01673854|26332004|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5|||
13237770|NCT01673854|26332004|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1|||
13237771|NCT01673854|26332004|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1|||
13237772|NCT01673698|26332019|FG000|Overall Study|Lost to Follow-up|51|||
13115537|NCT03096847|25918175|FG000|Overall Study|New therapy for study indication|1|||
13115538|NCT03096847|25918176|FG001|Overall Study|New therapy for study indication|0|||
13115539|NCT03096847|25918177|FG002|Overall Study|New therapy for study indication|1|||
13115540|NCT03096483|25918184|FG000|Overall Study|Withdrawal by site|1|||
13115541|NCT03096314|25918239|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9|||
13115542|NCT03096314|25918240|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12|||
13115543|NCT03096288|25918263|FG000|Overall Study|Withdrawal by Subject|0|||
13237773|NCT01673698|26332020|FG001|Overall Study|Lost to Follow-up|13|||
13237774|NCT01673646|26332067|FG000|Overall Study|Adverse Event|2|||
13237775|NCT01673646|26332068|FG001|Overall Study|Adverse Event|1|||
13237776|NCT01673646|26332069|FG002|Overall Study|Adverse Event|1|||
13237777|NCT01673646|26332067|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
13237778|NCT01673646|26332068|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
13237779|NCT01673646|26332069|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
13237780|NCT01673646|26332067|FG000|Overall Study|Condition no longer requires study drug|0|||
13237781|NCT01673646|26332068|FG001|Overall Study|Condition no longer requires study drug|1|||
13237782|NCT01673646|26332069|FG002|Overall Study|Condition no longer requires study drug|0|||
13237783|NCT01673646|26332067|FG000|Overall Study|Withdrawal by Subject|0|||
13237784|NCT01673646|26332068|FG001|Overall Study|Withdrawal by Subject|2|||
13237785|NCT01673646|26332069|FG002|Overall Study|Withdrawal by Subject|2|||
13237786|NCT01673646|26332067|FG000|Overall Study|Completed Core/did not enter Ext.|2|||
13237787|NCT01673646|26332068|FG001|Overall Study|Completed Core/did not enter Ext.|1|||
13237788|NCT01673646|26332069|FG002|Overall Study|Completed Core/did not enter Ext.|1|||
13237789|NCT01673620|26332084|FG000|Overall Study|Adverse Event|1|||
13237790|NCT01673620|26332085|FG001|Overall Study|Adverse Event|0|||
13237791|NCT01673594|26332100|FG000|Overall Study|Adverse Event|3|||
13237792|NCT01673594|26332101|FG001|Overall Study|Adverse Event|1|||
13237793|NCT01673594|26332100|FG000|Overall Study|Lost to Follow-up|1|||
13237794|NCT01673594|26332101|FG001|Overall Study|Lost to Follow-up|0|||
13237795|NCT01673594|26332100|FG000|Overall Study|Physician Decision|2|||
13115544|NCT03096288|25918264|FG001|Overall Study|Withdrawal by Subject|1|||
13237796|NCT01673594|26332101|FG001|Overall Study|Physician Decision|4|||
13237797|NCT01673594|26332100|FG000|Overall Study|Withdrawal by Subject|0|||
13237798|NCT01673594|26332101|FG001|Overall Study|Withdrawal by Subject|1|||
13237799|NCT01673490|26332116|FG000|Overall Study|Lost to Follow-up|1|||
13237800|NCT01673490|26332116|FG000|Overall Study|Adverse Event|3|||
13237801|NCT01673490|26332116|FG000|Overall Study|Withdrawal by Subject|3|||
13237802|NCT01673386|26332149|FG000|Overall Study|Study terminated by sponsor|16|||
13237803|NCT01673386|26332150|FG001|Overall Study|Study terminated by sponsor|22|||
13237804|NCT01673386|26332149|FG000|Overall Study|Adverse Event|5|||
13237805|NCT01673386|26332150|FG001|Overall Study|Adverse Event|2|||
13237806|NCT01673386|26332149|FG000|Overall Study|Progressive disease|4|||
13237807|NCT01673386|26332150|FG001|Overall Study|Progressive disease|1|||
13237808|NCT01673386|26332149|FG000|Overall Study|Withdrawal by Subject|0|||
13237809|NCT01673386|26332150|FG001|Overall Study|Withdrawal by Subject|2|||
13237810|NCT01673373|26332168|FG000|Overall Study|Death|2|||
13237811|NCT01673347|26332177|FG000|Overall Study|failure of allograft|7|||
13237812|NCT01673282|26332190|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9|||
13237813|NCT01673282|26332191|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5|||
13237814|NCT01673282|26332190|FG000|Overall Study|Lack of Efficacy|9|||
13237815|NCT01673282|26332191|FG001|Overall Study|Lack of Efficacy|2|||
13237816|NCT01673282|26332190|FG000|Overall Study|Lost to Follow-up|11|||
13237817|NCT01673282|26332191|FG001|Overall Study|Lost to Follow-up|10|||
13237818|NCT01673282|26332190|FG000|Overall Study|Withdrawal by Subject|3|||
13237819|NCT01673282|26332191|FG001|Overall Study|Withdrawal by Subject|3|||
13237820|NCT01673282|26332190|FG000|Overall Study|Other|1|||
13237821|NCT01673282|26332191|FG001|Overall Study|Other|6|||
13237822|NCT01673178|26332444|FG000|Overall Study|Lost to Follow-up|0|||
13237823|NCT01673178|26332445|FG001|Overall Study|Lost to Follow-up|1|||
13237824|NCT01673178|26332446|FG002|Overall Study|Lost to Follow-up|0|||
13237825|NCT01673178|26332447|FG003|Overall Study|Lost to Follow-up|0|||
13237826|NCT01673178|26332448|FG004|Overall Study|Lost to Follow-up|0|||
13237827|NCT01673178|26332444|FG000|Overall Study|Withdrawal by Subject|0|||
13237828|NCT01673178|26332445|FG001|Overall Study|Withdrawal by Subject|0|||
13237829|NCT01673178|26332446|FG002|Overall Study|Withdrawal by Subject|1|||
13237830|NCT01673178|26332447|FG003|Overall Study|Withdrawal by Subject|4|||
13237831|NCT01673178|26332448|FG004|Overall Study|Withdrawal by Subject|2|||
13237832|NCT01673178|26332444|FG000|Overall Study|Protocol Violation|1|||
13237833|NCT01673178|26332445|FG001|Overall Study|Protocol Violation|1|||
13237834|NCT01673178|26332446|FG002|Overall Study|Protocol Violation|0|||
13237835|NCT01673178|26332447|FG003|Overall Study|Protocol Violation|1|||
13237836|NCT01673178|26332448|FG004|Overall Study|Protocol Violation|0|||
13237837|NCT01673178|26332444|FG000|Overall Study|Adverse Event|1|||
13237838|NCT01673178|26332445|FG001|Overall Study|Adverse Event|0|||
13115545|NCT03096288|25918265|FG002|Overall Study|Withdrawal by Subject|0|||
13115546|NCT03096288|25918266|FG003|Overall Study|Withdrawal by Subject|1|||
13237839|NCT01673178|26332446|FG002|Overall Study|Adverse Event|0|||
13237840|NCT01673178|26332447|FG003|Overall Study|Adverse Event|2|||
13237841|NCT01673178|26332448|FG004|Overall Study|Adverse Event|0|||
13237842|NCT01673178|26332444|FG000|Overall Study|Other|1|||
13237843|NCT01673178|26332445|FG001|Overall Study|Other|0|||
13237844|NCT01673178|26332446|FG002|Overall Study|Other|2|||
13237845|NCT01673178|26332447|FG003|Overall Study|Other|1|||
13237846|NCT01673178|26332448|FG004|Overall Study|Other|0|||
13237847|NCT01673126|26332461|FG000|Overall Study|change of diagnosis|4|||
13115547|NCT03095651|25918413|FG000|Overall Study|Lost to Follow-up|1|||
13115548|NCT03095651|25918414|FG001|Overall Study|Lost to Follow-up|1|||
13115549|NCT03095651|25918415|FG002|Overall Study|Lost to Follow-up|0|||
13237848|NCT01673126|26332462|FG001|Overall Study|change of diagnosis|3|||
13237849|NCT01673009|26332469|FG000|Overall Study|Physician Decision|5|||
13237850|NCT01673009|26332469|FG000|Overall Study|Withdrawal by Subject|8|||
13237851|NCT01672970|26332507|FG000|Overall Study|Lack of Efficacy|12|||
13115550|NCT03095651|25918416|FG003|Overall Study|Lost to Follow-up|1|||
13115551|NCT03095651|25918417|FG004|Overall Study|Lost to Follow-up|0|||
13115552|NCT03095651|25918418|FG005|Overall Study|Lost to Follow-up|0|||
13115553|NCT03095651|25918419|FG006|Overall Study|Lost to Follow-up|0|||
13115554|NCT03095651|25918420|FG007|Overall Study|Lost to Follow-up|0|||
13115555|NCT03095651|25918413|FG000|Overall Study|Withdrawal by Subject|0|||
13115556|NCT03095651|25918414|FG001|Overall Study|Withdrawal by Subject|0|||
13237852|NCT01672970|26332507|FG000|Overall Study|Adverse Event|18|||
13237853|NCT01672970|26332507|FG000|Overall Study|Withdrawal by Subject|2|||
13237854|NCT01672970|26332507|FG000|Overall Study|Lost to Follow-up|5|||
13237855|NCT01672970|26332507|FG000|Overall Study|Other|9|||
13237856|NCT01672970|26332507|FG000|Overall Study|Enrolled but not treated|1|||
13115557|NCT03095651|25918415|FG002|Overall Study|Withdrawal by Subject|0|||
13115558|NCT03095651|25918416|FG003|Overall Study|Withdrawal by Subject|0|||
13115559|NCT03095651|25918417|FG004|Overall Study|Withdrawal by Subject|0|||
13115560|NCT03095651|25918418|FG005|Overall Study|Withdrawal by Subject|1|||
13115561|NCT03095651|25918419|FG006|Overall Study|Withdrawal by Subject|0|||
13115562|NCT03095651|25918420|FG007|Overall Study|Withdrawal by Subject|0|||
13115563|NCT03095599|25918461|FG000|Overall Study|Withdrawal by Subject|1|||
13115564|NCT03095599|25918462|FG001|Overall Study|Withdrawal by Subject|0|||
13115565|NCT03095599|25918461|FG000|Overall Study|Lost to Follow-up|1|||
13115566|NCT03095599|25918462|FG001|Overall Study|Lost to Follow-up|0|||
13115567|NCT03095599|25918461|FG000|Overall Study|Withdrawal prior to vaccination|1|||
13115568|NCT03095599|25918462|FG001|Overall Study|Withdrawal prior to vaccination|0|||
13115569|NCT03095521|25918485|FG000|Overall Study|Withdrawal by Subject|0|||
13115570|NCT03095521|25918486|FG001|Overall Study|Withdrawal by Subject|1|||
13115571|NCT03095521|25918485|FG000|Overall Study|Lost to Follow-up|0|||
13115572|NCT03095521|25918486|FG001|Overall Study|Lost to Follow-up|1|||
13115573|NCT03095508|25918509|FG000|Overall Study|Adverse Event|0|||
13115574|NCT03095508|25918510|FG001|Overall Study|Adverse Event|1|||
13237857|NCT01672957|26332522|FG000|Overall Study|Protocol Violation|48|||
13237858|NCT01672957|26332522|FG000|Overall Study|Death|2|||
13237859|NCT01672957|26332522|FG000|Overall Study|ICF Signed After Transplantation|5|||
13237860|NCT01672879|26332544|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43|||
13115575|NCT03095287|25918519|FG000|Overall Study|Treatment Failure|1|||
13115576|NCT03095287|25918519|FG000|Overall Study|Adverse Event|1|||
13115577|NCT03095118|25918533|FG000|Overall Study|Adverse Event|1|||
13115578|NCT03095118|25918533|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1|||
13115579|NCT03095027|25918542|FG000|Period 2, Second Week of Wear|Adverse Event|1|||
13115580|NCT03095027|25918543|FG001|Period 2, Second Week of Wear|Adverse Event|0|||
13115581|NCT03094611|25918553|FG000|Overall Study|Lack of Efficacy|1|||
13115582|NCT03094611|25918553|FG000|Overall Study|Stem Cell Transplant|1|||
13115583|NCT03094195|25918614|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12|||
13115584|NCT03094195|25918615|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10|||
13115585|NCT03094195|25918616|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11|||
13115586|NCT03094195|25918617|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
13115587|NCT03094195|25918618|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
13115588|NCT03094195|25918619|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
13115589|NCT03094195|25918620|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
13115590|NCT03094195|25918621|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
13115591|NCT03094195|25918614|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
13115592|NCT03094195|25918615|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2|||
13115593|NCT03094195|25918616|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1|||
13115594|NCT03094195|25918617|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
13115595|NCT03094195|25918618|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
13115596|NCT03094195|25918619|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0|||
13115597|NCT03094195|25918620|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0|||
13115598|NCT03094195|25918621|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0|||
13115599|NCT03094195|25918614|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0|||
13115600|NCT03094195|25918615|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0|||
13115601|NCT03094195|25918616|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1|||
13115602|NCT03094195|25918617|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
13115603|NCT03094195|25918618|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
13115604|NCT03094195|25918619|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0|||
13115605|NCT03094195|25918620|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0|||
13237861|NCT01672879|26332545|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55|||
13237862|NCT01672879|26332546|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61|||
13237863|NCT01672879|26332544|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14|||
13237864|NCT01672879|26332545|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7|||
13237865|NCT01672879|26332546|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6|||
13237866|NCT01672879|26332544|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5|||
13237867|NCT01672879|26332545|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2|||
13237868|NCT01672879|26332546|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7|||
13237869|NCT01672879|26332544|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4|||
13237870|NCT01672879|26332545|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3|||
13237871|NCT01672879|26332546|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1|||
13237872|NCT01672879|26332544|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5|||
13237873|NCT01672879|26332545|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
13237874|NCT01672879|26332546|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2|||
13237875|NCT01672879|26332544|FG000|Blinded Phase (Up to 240 Weeks)|Death|0|||
13237876|NCT01672879|26332545|FG001|Blinded Phase (Up to 240 Weeks)|Death|2|||
13237877|NCT01672879|26332546|FG002|Blinded Phase (Up to 240 Weeks)|Death|0|||
13237878|NCT01672879|26332544|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1|||
13237879|NCT01672879|26332545|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0|||
13237880|NCT01672879|26332546|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0|||
13237881|NCT01672879|26332544|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
13237882|NCT01672879|26332545|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
13237883|NCT01672879|26332546|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1|||
13237884|NCT01672879|26332544|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15|||
13237885|NCT01672879|26332545|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17|||
13237886|NCT01672879|26332546|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8|||
13237887|NCT01672879|26332544|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8|||
13237888|NCT01672879|26332545|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16|||
13237889|NCT01672879|26332546|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6|||
13237890|NCT01672879|26332544|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5|||
13237891|NCT01672879|26332545|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
13237892|NCT01672879|26332546|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
13237893|NCT01672879|26332544|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
13237894|NCT01672879|26332545|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
13237895|NCT01672879|26332546|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
13237896|NCT01672879|26332544|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1|||
13237897|NCT01672879|26332545|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
13237898|NCT01672879|26332546|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
13237899|NCT01672866|26332568|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40|||
13237900|NCT01672866|26332569|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42|||
13237901|NCT01672866|26332570|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35|||
13237902|NCT01672866|26332568|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9|||
13237903|NCT01672866|26332569|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8|||
13237904|NCT01672866|26332570|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12|||
13237905|NCT01672866|26332568|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
13237906|NCT01672866|26332569|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
13237907|NCT01672866|26332570|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5|||
13237908|NCT01672866|26332568|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
13237909|NCT01672866|26332569|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
13237910|NCT01672866|26332570|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
13237911|NCT01672866|26332568|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
13237912|NCT01672866|26332569|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
13237913|NCT01672866|26332570|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2|||
13237914|NCT01672866|26332568|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2|||
13237915|NCT01672866|26332569|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
13237916|NCT01672866|26332570|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
13237917|NCT01672866|26332568|FG000|Blinded Phase (up to 240 Weeks)|Death|0|||
13237918|NCT01672866|26332569|FG001|Blinded Phase (up to 240 Weeks)|Death|0|||
13237919|NCT01672866|26332570|FG002|Blinded Phase (up to 240 Weeks)|Death|1|||
13237920|NCT01672866|26332568|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3|||
13237921|NCT01672866|26332569|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
13237922|NCT01672866|26332570|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
13237923|NCT01672866|26332568|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11|||
13237924|NCT01672866|26332569|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15|||
13237925|NCT01672866|26332570|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16|||
13237926|NCT01672866|26332568|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8|||
13237927|NCT01672866|26332569|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
13237928|NCT01672866|26332570|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
13237929|NCT01672866|26332568|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
13237930|NCT01672866|26332569|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0|||
13237931|NCT01672866|26332570|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
13237932|NCT01672866|26332568|FG000|Open-Label Phase (up to 240 Weeks)|Death|1|||
13237933|NCT01672866|26332569|FG001|Open-Label Phase (up to 240 Weeks)|Death|0|||
13237934|NCT01672866|26332570|FG002|Open-Label Phase (up to 240 Weeks)|Death|0|||
13237935|NCT01672866|26332568|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1|||
13237936|NCT01672866|26332569|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
13237937|NCT01672866|26332570|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
13237938|NCT01672853|26332597|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0|||
13237939|NCT01672853|26332598|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4|||
13237940|NCT01672853|26332599|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0|||
13237941|NCT01672853|26332597|FG000|Overall Study|Pregnancy|0|||
13237942|NCT01672853|26332598|FG001|Overall Study|Pregnancy|1|||
13237943|NCT01672853|26332599|FG002|Overall Study|Pregnancy|0|||
13237944|NCT01672853|26332597|FG000|Overall Study|Investigator's Discretion|1|||
13237945|NCT01672853|26332598|FG001|Overall Study|Investigator's Discretion|0|||
13237946|NCT01672853|26332599|FG002|Overall Study|Investigator's Discretion|0|||
13237947|NCT01672853|26332597|FG000|Overall Study|Withdrew Consent|5|||
13237948|NCT01672853|26332598|FG001|Overall Study|Withdrew Consent|5|||
13237949|NCT01672853|26332599|FG002|Overall Study|Withdrew Consent|5|||
13237950|NCT01672853|26332597|FG000|Overall Study|Adverse Event|4|||
13237951|NCT01672853|26332598|FG001|Overall Study|Adverse Event|6|||
13237952|NCT01672853|26332599|FG002|Overall Study|Adverse Event|8|||
13237953|NCT01672853|26332597|FG000|Overall Study|Lost to Follow-up|0|||
13237954|NCT01672853|26332598|FG001|Overall Study|Lost to Follow-up|1|||
13237955|NCT01672853|26332599|FG002|Overall Study|Lost to Follow-up|0|||
13237956|NCT01672853|26332597|FG000|Overall Study|Randomized but Never Treated|0|||
13237957|NCT01672853|26332598|FG001|Overall Study|Randomized but Never Treated|0|||
13237958|NCT01672853|26332599|FG002|Overall Study|Randomized but Never Treated|1|||
13237959|NCT01672801|26332614|FG000|Overall Study|Screen Failure|0|||
13237960|NCT01672801|26332615|FG001|Overall Study|Screen Failure|1|||
13237961|NCT01672788|26332650|FG000|Washout Period 2 (7 Days)|Adverse Event|0|||
13237962|NCT01672788|26332651|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
13237963|NCT01672788|26332652|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
13237964|NCT01672788|26332653|FG003|Washout Period 2 (7 Days)|Adverse Event|1|||
13237965|NCT01672736|26332659|FG000|Overall Study|Available drug expired on 31 May 16|3|||
13237966|NCT01672723|26332672|FG000|First Intervention|Adverse Event|3|||
13237967|NCT01672723|26332673|FG001|First Intervention|Adverse Event|0|||
13237968|NCT01672710|26332688|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0|||
13237969|NCT01672710|26332689|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1|||
13237970|NCT01672710|26332688|FG000|3 Month Follow up|Lost to Follow-up|2|||
13237971|NCT01672710|26332689|FG001|3 Month Follow up|Lost to Follow-up|3|||
13237972|NCT01672710|26332688|FG000|3 Month Follow up|follow up due after termination date|4|||
13237973|NCT01672710|26332689|FG001|3 Month Follow up|follow up due after termination date|1|||
13289781|NCT00106028|26480115|FG000|Overall Study|Withdrawal by Subject|2|||
13289782|NCT00106028|26480116|FG001|Overall Study|Withdrawal by Subject|8|||
13289783|NCT00106028|26480115|FG000|Overall Study|Lost to Follow-up|0|||
13289784|NCT00106028|26480116|FG001|Overall Study|Lost to Follow-up|1|||
13289785|NCT00106002|26480126|FG000|Overall Study|Did not take any study drug|1|||
13289786|NCT00106002|26480126|FG000|Overall Study|Ineligible after Registration|1|||
13289787|NCT00105989|26480243|FG000|Acute - Open Label: Week 0-10|Adverse Event|33|||
13289788|NCT00105989|26480244|FG001|Acute - Open Label: Week 0-10|Adverse Event|0|||
13289789|NCT00105989|26480243|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24|||
13289790|NCT00105989|26480244|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0|||
13289791|NCT00105989|26480243|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17|||
13289792|NCT00105989|26480244|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0|||
13289793|NCT00105989|26480243|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14|||
13289794|NCT00105989|26480244|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0|||
13289795|NCT00105989|26480243|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8|||
13289796|NCT00105989|26480244|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0|||
13289797|NCT00105989|26480243|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4|||
13289798|NCT00105989|26480244|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0|||
13289799|NCT00105989|26480243|FG000|Acute - Open Label: Week 0-10|Physician Decision|0|||
13289800|NCT00105989|26480244|FG001|Acute - Open Label: Week 0-10|Physician Decision|0|||
13289801|NCT00105989|26480243|FG000|Acute - Open Label: Week 0-10|Death|1|||
13289802|NCT00105989|26480244|FG001|Acute - Open Label: Week 0-10|Death|0|||
13289803|NCT00105989|26480243|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
13289804|NCT00105989|26480244|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
13289805|NCT00105989|26480243|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
13289806|NCT00105989|26480244|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
13237974|NCT01672294|26332724|FG000|Overall Study|Withdrawal by Subject|4|||
13237975|NCT01672294|26332725|FG001|Overall Study|Withdrawal by Subject|4|||
13237976|NCT01672294|26332726|FG002|Overall Study|Withdrawal by Subject|4|||
13237977|NCT01672294|26332727|FG003|Overall Study|Withdrawal by Subject|4|||
13237978|NCT01672294|26332724|FG000|Overall Study|Excluded by study|1|||
13237979|NCT01672294|26332725|FG001|Overall Study|Excluded by study|1|||
13237980|NCT01672294|26332726|FG002|Overall Study|Excluded by study|0|||
13237981|NCT01672294|26332727|FG003|Overall Study|Excluded by study|0|||
13237982|NCT01672294|26332724|FG000|Overall Study|Lost to Follow-up|1|||
13237983|NCT01672294|26332725|FG001|Overall Study|Lost to Follow-up|16|||
13237984|NCT01672294|26332726|FG002|Overall Study|Lost to Follow-up|7|||
13237985|NCT01672294|26332727|FG003|Overall Study|Lost to Follow-up|9|||
13237986|NCT01671748|26332752|FG000|4 Week run-in Phase|Withdrawal by Subject|1|||
13237987|NCT01671748|26332753|FG001|4 Week run-in Phase|Withdrawal by Subject|0|||
13237988|NCT01671748|26332752|FG000|4 Week run-in Phase|Adverse Event|1|||
13237989|NCT01671748|26332753|FG001|4 Week run-in Phase|Adverse Event|0|||
13237990|NCT01671748|26332752|FG000|4 Week run-in Phase|Not eligible|9|||
13237991|NCT01671748|26332753|FG001|4 Week run-in Phase|Not eligible|0|||
13237992|NCT01671488|26332761|FG000|Overall Study|Withdrawal by Subject|1|||
13237993|NCT01671345|26332780|FG000|Overall Study|Lost to Follow-up|10|||
13237994|NCT01671345|26332781|FG001|Overall Study|Lost to Follow-up|6|||
13237995|NCT01671345|26332780|FG000|Overall Study|visit with non-participating physician|3|||
13237996|NCT01671345|26332781|FG001|Overall Study|visit with non-participating physician|3|||
13237997|NCT01671332|26332802|FG000|Overall Study|Withdrawal by Subject|1|||
13237998|NCT01671332|26332803|FG001|Overall Study|Withdrawal by Subject|1|||
13237999|NCT01671319|26332811|FG000|Overall Study|Withdrawal by Subject|1|||
13238000|NCT01671280|26332819|FG000|Overall Study|Withdrawal by Subject|2|||
13238001|NCT01671111|26332831|FG000|Overall Study|Adverse Event|2|||
13238002|NCT01671111|26332831|FG000|Overall Study|Lack of Efficacy|1|||
13238003|NCT01671111|26332831|FG000|Overall Study|Withdrawal by Subject|2|||
13238004|NCT01671111|26332831|FG000|Overall Study|Physician Decision|1|||
13238005|NCT01671111|26332831|FG000|Overall Study|Other|24|||
13238006|NCT01671085|26332849|FG000|Overall Study|Withdrawal by Subject|1|||
13238007|NCT01671085|26332850|FG001|Overall Study|Withdrawal by Subject|0|||
13238008|NCT01671059|26332875|FG000|Overall Study|Adverse Event|4|||
13238009|NCT01671059|26332875|FG000|Overall Study|Lack of Efficacy|1|||
13238010|NCT01671007|26332936|FG000|Overall Study|Other reasons than listed|166|||
13238011|NCT01671007|26332937|FG001|Overall Study|Other reasons than listed|373|||
13238012|NCT01671007|26332938|FG002|Overall Study|Other reasons than listed|197|||
13203170|NCT01987609|26223380|FG000|Overall Study|Adverse Event|1|||
13238013|NCT01671007|26332939|FG003|Overall Study|Other reasons than listed|228|||
13238014|NCT01671007|26332940|FG004|Overall Study|Other reasons than listed|14|||
13238015|NCT01671007|26332941|FG005|Overall Study|Other reasons than listed|71|||
13238016|NCT01671007|26332942|FG006|Overall Study|Other reasons than listed|17|||
13238017|NCT01671007|26332943|FG007|Overall Study|Other reasons than listed|66|||
13238018|NCT01671007|26332944|FG008|Overall Study|Other reasons than listed|0|||
13238019|NCT01671007|26332936|FG000|Overall Study|Withdrawal by Subject|36|||
13238020|NCT01671007|26332937|FG001|Overall Study|Withdrawal by Subject|59|||
13238021|NCT01671007|26332938|FG002|Overall Study|Withdrawal by Subject|53|||
13238022|NCT01671007|26332939|FG003|Overall Study|Withdrawal by Subject|58|||
13238023|NCT01671007|26332940|FG004|Overall Study|Withdrawal by Subject|4|||
13238024|NCT01671007|26332941|FG005|Overall Study|Withdrawal by Subject|15|||
13238025|NCT01671007|26332942|FG006|Overall Study|Withdrawal by Subject|1|||
13238026|NCT01671007|26332943|FG007|Overall Study|Withdrawal by Subject|19|||
13238027|NCT01671007|26332944|FG008|Overall Study|Withdrawal by Subject|0|||
13238028|NCT01671007|26332936|FG000|Overall Study|Lost to Follow-up|93|||
13238029|NCT01671007|26332937|FG001|Overall Study|Lost to Follow-up|142|||
13238030|NCT01671007|26332938|FG002|Overall Study|Lost to Follow-up|91|||
13238031|NCT01671007|26332939|FG003|Overall Study|Lost to Follow-up|63|||
13238032|NCT01671007|26332940|FG004|Overall Study|Lost to Follow-up|7|||
13238033|NCT01671007|26332941|FG005|Overall Study|Lost to Follow-up|20|||
13238034|NCT01671007|26332942|FG006|Overall Study|Lost to Follow-up|2|||
13238035|NCT01671007|26332943|FG007|Overall Study|Lost to Follow-up|28|||
13238036|NCT01671007|26332944|FG008|Overall Study|Lost to Follow-up|0|||
13238037|NCT01671007|26332936|FG000|Overall Study|No end of study case report form|3|||
13238038|NCT01671007|26332937|FG001|Overall Study|No end of study case report form|1|||
13238039|NCT01671007|26332938|FG002|Overall Study|No end of study case report form|0|||
13238040|NCT01671007|26332939|FG003|Overall Study|No end of study case report form|2|||
13203171|NCT01987596|26223399|FG000|Overall Study|Physician Decision|1|||
13203172|NCT01987596|26223400|FG001|Overall Study|Physician Decision|0|||
13203173|NCT01987596|26223399|FG000|Overall Study|Progressive Disease; missing all period|0|||
13203174|NCT01987596|26223400|FG001|Overall Study|Progressive Disease; missing all period|1|||
13203175|NCT01987557|26223418|FG000|Overall Study|Protocol Violation|1|||
13203176|NCT01987557|26223419|FG001|Overall Study|Protocol Violation|0|||
13203177|NCT01987557|26223420|FG002|Overall Study|Protocol Violation|1|||
13203178|NCT01987557|26223418|FG000|Overall Study|Withdrawal by Subject|2|||
13203179|NCT01987557|26223419|FG001|Overall Study|Withdrawal by Subject|1|||
13238041|NCT01671007|26332940|FG004|Overall Study|No end of study case report form|0|||
13238042|NCT01671007|26332941|FG005|Overall Study|No end of study case report form|0|||
13238043|NCT01671007|26332942|FG006|Overall Study|No end of study case report form|0|||
13238044|NCT01671007|26332943|FG007|Overall Study|No end of study case report form|0|||
13238045|NCT01671007|26332944|FG008|Overall Study|No end of study case report form|0|||
13238046|NCT01671007|26332936|FG000|Overall Study|Not eligible|23|||
13238047|NCT01671007|26332937|FG001|Overall Study|Not eligible|76|||
13238048|NCT01671007|26332938|FG002|Overall Study|Not eligible|25|||
13238049|NCT01671007|26332939|FG003|Overall Study|Not eligible|17|||
13238050|NCT01671007|26332940|FG004|Overall Study|Not eligible|0|||
13238051|NCT01671007|26332941|FG005|Overall Study|Not eligible|6|||
13238052|NCT01671007|26332942|FG006|Overall Study|Not eligible|1|||
13238053|NCT01671007|26332943|FG007|Overall Study|Not eligible|19|||
13238054|NCT01671007|26332944|FG008|Overall Study|Not eligible|0|||
13238055|NCT01670877|26333049|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
13238056|NCT01670877|26333050|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1|||
13238057|NCT01670877|26333051|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
13238058|NCT01670877|26333052|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
13238059|NCT01670877|26333053|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
13238060|NCT01670877|26333054|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
13238061|NCT01670877|26333049|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
13238062|NCT01670877|26333050|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
13238063|NCT01670877|26333051|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1|||
13238064|NCT01670877|26333052|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
13238065|NCT01670877|26333053|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
13238066|NCT01670877|26333054|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
13238067|NCT01670877|26333049|FG000|Part I and Part 2|Grade 2 vomiting|0|||
13238068|NCT01670877|26333050|FG001|Part I and Part 2|Grade 2 vomiting|0|||
13238069|NCT01670877|26333051|FG002|Part I and Part 2|Grade 2 vomiting|0|||
13238070|NCT01670877|26333052|FG003|Part I and Part 2|Grade 2 vomiting|1|||
13238071|NCT01670877|26333053|FG004|Part I and Part 2|Grade 2 vomiting|0|||
13238072|NCT01670877|26333054|FG005|Part I and Part 2|Grade 2 vomiting|0|||
13238073|NCT01670877|26333049|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
13238074|NCT01670877|26333050|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
13238075|NCT01670877|26333051|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
13238076|NCT01670877|26333052|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1|||
13238077|NCT01670877|26333053|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
13238078|NCT01670877|26333054|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
13238079|NCT01670877|26333049|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
13238080|NCT01670877|26333050|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
13238081|NCT01670877|26333051|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
13238082|NCT01670877|26333052|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1|||
13238083|NCT01670877|26333053|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
13238084|NCT01670877|26333054|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
13238085|NCT01670721|26333063|FG000|Overall Study|Participant's decision|15|||
13238086|NCT01670721|26333063|FG000|Overall Study|Other than specified above|38|||
13238087|NCT01670539|26333081|FG000|Overall Study|Death|3|||
13238088|NCT01670539|26333082|FG001|Overall Study|Death|5|||
13238089|NCT01670539|26333081|FG000|Overall Study|Withdrawal by Subject|3|||
13238090|NCT01670539|26333082|FG001|Overall Study|Withdrawal by Subject|0|||
13238091|NCT01670526|26333101|FG000|Overall Study|Withdrawal by Subject|3|||
13238092|NCT01670526|26333102|FG001|Overall Study|Withdrawal by Subject|1|||
13238093|NCT01670526|26333101|FG000|Overall Study|Lost to Follow-up|9|||
13238094|NCT01670526|26333102|FG001|Overall Study|Lost to Follow-up|5|||
13238095|NCT01670292|26333142|FG000|Overall Study|Lost to Follow-up|14|||
13238096|NCT01670279|26333188|FG000|Overall Study|Adverse Event|0|||
13238097|NCT01670279|26333189|FG001|Overall Study|Adverse Event|1|||
13238098|NCT01670279|26333190|FG002|Overall Study|Adverse Event|0|||
13238099|NCT01670279|26333191|FG003|Overall Study|Adverse Event|0|||
13238100|NCT01670279|26333188|FG000|Overall Study|Physician Decision|0|||
13238101|NCT01670279|26333189|FG001|Overall Study|Physician Decision|1|||
13238102|NCT01670279|26333190|FG002|Overall Study|Physician Decision|0|||
13238103|NCT01670279|26333191|FG003|Overall Study|Physician Decision|0|||
13238104|NCT01670279|26333188|FG000|Overall Study|Participant met withdrawal criteria|0|||
13238105|NCT01670279|26333189|FG001|Overall Study|Participant met withdrawal criteria|0|||
13238106|NCT01670279|26333190|FG002|Overall Study|Participant met withdrawal criteria|0|||
13238107|NCT01670279|26333191|FG003|Overall Study|Participant met withdrawal criteria|1|||
13238108|NCT01670188|26333204|FG000|Overall Study|Death|0|||
13238109|NCT01670188|26333205|FG001|Overall Study|Death|1|||
13238110|NCT01670097|26333224|FG000|Overall Study|Started Phase 1 cancer treatment|1|||
13238111|NCT01670097|26333225|FG001|Overall Study|Started Phase 1 cancer treatment|0|||
13238112|NCT01670097|26333224|FG000|Overall Study|Study burden|1|||
13238113|NCT01670097|26333225|FG001|Overall Study|Study burden|0|||
13238114|NCT01670097|26333224|FG000|Overall Study|COPD exacerbation|0|||
13238115|NCT01670097|26333225|FG001|Overall Study|COPD exacerbation|1|||
13238116|NCT01670097|26333224|FG000|Overall Study|Neutropenia|0|||
13238117|NCT01670097|26333225|FG001|Overall Study|Neutropenia|1|||
13238118|NCT01670097|26333224|FG000|Overall Study|Clinical deterioration|0|||
13238119|NCT01670097|26333225|FG001|Overall Study|Clinical deterioration|1|||
13238120|NCT01670097|26333224|FG000|Overall Study|Disease progression|0|||
13238121|NCT01670097|26333225|FG001|Overall Study|Disease progression|1|||
13238122|NCT01670045|26333243|FG000|Overall Study|Withdrawal by Subject|3|||
13238123|NCT01670045|26333243|FG000|Overall Study|Adverse Event|1|||
13238124|NCT01670045|26333243|FG000|Overall Study|Death|1|||
13238125|NCT01670045|26333243|FG000|Overall Study|Lost to Follow-up|11|||
13238126|NCT01670019|26333264|FG000|Overall Study|Adverse Event|3|||
13238127|NCT01670019|26333265|FG001|Overall Study|Adverse Event|0|||
13238128|NCT01670019|26333264|FG000|Overall Study|Withdrawal by Subject|6|||
13238129|NCT01670019|26333265|FG001|Overall Study|Withdrawal by Subject|0|||
13238130|NCT01669928|26333294|FG000|First Intervention|Withdrawal by Subject|3|||
13238131|NCT01669928|26333295|FG001|First Intervention|Withdrawal by Subject|5|||
13238132|NCT01669902|26333324|FG000|Overall Study|Adverse Event|11|||
13238133|NCT01669902|26333324|FG000|Overall Study|Lack of Efficacy|10|||
13238134|NCT01669902|26333324|FG000|Overall Study|Other|8|||
13238135|NCT01669811|26333349|FG000|Overall Study|Investigator decision|0|||
13238136|NCT01669811|26333350|FG001|Overall Study|Investigator decision|1|||
13238137|NCT01669811|26333349|FG000|Overall Study|Withdrawal by Subject|1|||
13238138|NCT01669811|26333350|FG001|Overall Study|Withdrawal by Subject|2|||
13238139|NCT01669811|26333349|FG000|Overall Study|Adverse Event|2|||
13238140|NCT01669811|26333350|FG001|Overall Study|Adverse Event|6|||
13238141|NCT01669811|26333349|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
13238142|NCT01669811|26333350|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2|||
13238143|NCT01669798|26333365|FG000|Overall Study|Physician Decision|5|||
13238144|NCT01669629|26333382|FG000|Period 1|protocol deviation|1|||
13238145|NCT01669629|26333383|FG001|Period 1|protocol deviation|2|||
13238146|NCT01669577|26333389|FG000|Overall Study|Death|22|||
13238147|NCT01669577|26333389|FG000|Overall Study|Lost to Follow-up|78|||
13238148|NCT01669577|26333389|FG000|Overall Study|Physician Decision|34|||
13238149|NCT01669421|26333408|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1|||
13238150|NCT01669421|26333408|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1|||
13238151|NCT01669343|26333421|FG000|Part A: All Patients|Withdrawal by Subject|7|||
13238152|NCT01669343|26333421|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2|||
13238153|NCT01669343|26333421|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13|||
13238154|NCT01669343|26333421|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3|||
13238155|NCT01669343|26333421|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1|||
13238156|NCT01669174|26333439|FG000|Overall Study|Subject withdrew consent|2|||
13238157|NCT01669174|26333440|FG001|Overall Study|Subject withdrew consent|2|||
13238158|NCT01669174|26333439|FG000|Overall Study|Lost to Follow-up|1|||
13238159|NCT01669174|26333440|FG001|Overall Study|Lost to Follow-up|0|||
13238160|NCT01669174|26333439|FG000|Overall Study|Adverse Event|2|||
13238161|NCT01669174|26333440|FG001|Overall Study|Adverse Event|2|||
13238162|NCT01669174|26333439|FG000|Overall Study|Administrative problems|1|||
13238163|NCT01669174|26333440|FG001|Overall Study|Administrative problems|2|||
13238164|NCT01669122|26333472|FG000|Period I|Lost to Follow-up|1|||
13238165|NCT01669122|26333472|FG000|Washout Period II|Protocol Violation|2|||
13238166|NCT01668966|26333490|FG000|Overall Study|Withdrawal by Subject|1|||
13238167|NCT01668966|26333490|FG000|Overall Study|Death|1|||
13238168|NCT01668966|26333490|FG000|Overall Study|Not treated|2|||
13238169|NCT01668797|26333562|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3|||
13238170|NCT01668797|26333563|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0|||
13238171|NCT01668797|26333564|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0|||
13238172|NCT01668797|26333565|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0|||
13238173|NCT01668797|26333562|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3|||
13238174|NCT01668797|26333563|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
13238175|NCT01668797|26333564|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
13238176|NCT01668797|26333565|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
13238177|NCT01668797|26333562|FG000|Phase A (Conversion Phase)|Physician Decision|2|||
13238178|NCT01668797|26333563|FG001|Phase A (Conversion Phase)|Physician Decision|0|||
13238179|NCT01668797|26333564|FG002|Phase A (Conversion Phase)|Physician Decision|0|||
13238180|NCT01668797|26333565|FG003|Phase A (Conversion Phase)|Physician Decision|0|||
13238181|NCT01668797|26333562|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16|||
13238182|NCT01668797|26333563|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
13238183|NCT01668797|26333564|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
13238184|NCT01668797|26333565|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
13238185|NCT01668797|26333562|FG000|Phase A (Conversion Phase)|Protocol Violation|2|||
13238186|NCT01668797|26333563|FG001|Phase A (Conversion Phase)|Protocol Violation|0|||
13238187|NCT01668797|26333564|FG002|Phase A (Conversion Phase)|Protocol Violation|0|||
13238188|NCT01668797|26333565|FG003|Phase A (Conversion Phase)|Protocol Violation|0|||
13238189|NCT01668797|26333562|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7|||
13238190|NCT01668797|26333563|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0|||
13238191|NCT01668797|26333564|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0|||
13238192|NCT01668797|26333565|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0|||
13238193|NCT01668797|26333562|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8|||
13238194|NCT01668797|26333563|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
13238195|NCT01668797|26333564|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
13238196|NCT01668797|26333565|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
13238197|NCT01668797|26333562|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19|||
13238198|NCT01668797|26333563|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
13238199|NCT01668797|26333564|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
13238200|NCT01668797|26333565|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
13238201|NCT01668797|26333562|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
13238202|NCT01668797|26333563|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16|||
13238203|NCT01668797|26333564|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
13238204|NCT01668797|26333565|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
13238205|NCT01668797|26333562|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
13238206|NCT01668797|26333563|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22|||
13238207|NCT01668797|26333564|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
13238208|NCT01668797|26333565|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
13238209|NCT01668797|26333562|FG000|Phase B (Stabilization Phase)|Physician Decision|0|||
13238210|NCT01668797|26333563|FG001|Phase B (Stabilization Phase)|Physician Decision|11|||
13238211|NCT01668797|26333564|FG002|Phase B (Stabilization Phase)|Physician Decision|0|||
13238212|NCT01668797|26333565|FG003|Phase B (Stabilization Phase)|Physician Decision|0|||
13238213|NCT01668797|26333562|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
13238214|NCT01668797|26333563|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60|||
13238215|NCT01668797|26333564|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
13238216|NCT01668797|26333565|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
13238217|NCT01668797|26333562|FG000|Phase B (Stabilization Phase)|Protocol Violation|0|||
13238218|NCT01668797|26333563|FG001|Phase B (Stabilization Phase)|Protocol Violation|3|||
13238219|NCT01668797|26333564|FG002|Phase B (Stabilization Phase)|Protocol Violation|0|||
13238220|NCT01668797|26333565|FG003|Phase B (Stabilization Phase)|Protocol Violation|0|||
13238221|NCT01668797|26333562|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
13238222|NCT01668797|26333563|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21|||
13238223|NCT01668797|26333564|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
13238224|NCT01668797|26333565|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
13238225|NCT01668797|26333562|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
13238226|NCT01668797|26333563|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43|||
13238227|NCT01668797|26333564|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
13238228|NCT01668797|26333565|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
13238229|NCT01668797|26333562|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
13238230|NCT01668797|26333563|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86|||
13238231|NCT01668797|26333564|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
13238232|NCT01668797|26333565|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
13238233|NCT01668797|26333562|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
13238234|NCT01668797|26333563|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
13238235|NCT01668797|26333564|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4|||
13238236|NCT01668797|26333565|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6|||
13238237|NCT01668797|26333562|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
13238238|NCT01668797|26333563|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
13238239|NCT01668797|26333564|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
13238240|NCT01668797|26333565|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
13238241|NCT01668797|26333562|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
13238242|NCT01668797|26333563|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
13238243|NCT01668797|26333564|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5|||
13238244|NCT01668797|26333565|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2|||
13238245|NCT01668797|26333562|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
13238246|NCT01668797|26333563|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
13238247|NCT01668797|26333564|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3|||
13238248|NCT01668797|26333565|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5|||
13238249|NCT01668797|26333562|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
13238250|NCT01668797|26333563|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
13238251|NCT01668797|26333564|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2|||
13238252|NCT01668797|26333565|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
13238253|NCT01668797|26333562|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
13238254|NCT01668797|26333563|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
13238255|NCT01668797|26333564|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2|||
13238256|NCT01668797|26333565|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10|||
13238257|NCT01668797|26333562|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
13238258|NCT01668797|26333563|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
13238259|NCT01668797|26333564|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11|||
13238260|NCT01668797|26333565|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30|||
13238261|NCT01668797|26333562|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
13238262|NCT01668797|26333563|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
13238263|NCT01668797|26333564|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4|||
13238264|NCT01668797|26333565|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2|||
13238265|NCT01668797|26333562|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
13238266|NCT01668797|26333563|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
13238267|NCT01668797|26333564|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49|||
13238268|NCT01668797|26333565|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38|||
13238269|NCT01668784|26333598|FG000|Randomized (Pre-treatment)|Disease Progression|0|||
13238270|NCT01668784|26333599|FG001|Randomized (Pre-treatment)|Disease Progression|1|||
13238271|NCT01668784|26333598|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0|||
13238272|NCT01668784|26333599|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3|||
13238273|NCT01668784|26333598|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1|||
13238274|NCT01668784|26333599|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8|||
13238275|NCT01668784|26333598|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1|||
13238276|NCT01668784|26333599|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0|||
13238277|NCT01668784|26333598|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2|||
13238278|NCT01668784|26333599|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1|||
13238279|NCT01668784|26333598|FG000|Randomized (Pre-treatment)|participant requested to be treated a local facility|0|||
13238280|NCT01668784|26333599|FG001|Randomized (Pre-treatment)|participant requested to be treated a local facility|1|||
13238281|NCT01668784|26333598|FG000|Treatment Period|Disease Progression|316|||
13238282|NCT01668784|26333599|FG001|Treatment Period|Disease Progression|293|||
13238283|NCT01668784|26333598|FG000|Treatment Period|Study Drug Toxicity|46|||
13238284|NCT01668784|26333599|FG001|Treatment Period|Study Drug Toxicity|53|||
13238285|NCT01668784|26333598|FG000|Treatment Period|Death|1|||
13238286|NCT01668784|26333599|FG001|Treatment Period|Death|1|||
13238287|NCT01668784|26333598|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
13238288|NCT01668784|26333599|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
13238289|NCT01668784|26333598|FG000|Treatment Period|Request to Discontinue Study Treatment|14|||
13238290|NCT01668784|26333599|FG001|Treatment Period|Request to Discontinue Study Treatment|21|||
13238291|NCT01668784|26333598|FG000|Treatment Period|Withdrawal by Subject|5|||
13238292|NCT01668784|26333599|FG001|Treatment Period|Withdrawal by Subject|3|||
13238293|NCT01668784|26333598|FG000|Treatment Period|Maximal Clinical Benefit|3|||
13238294|NCT01668784|26333599|FG001|Treatment Period|Maximal Clinical Benefit|3|||
13238295|NCT01668784|26333598|FG000|Treatment Period|Other|2|||
13238296|NCT01668784|26333599|FG001|Treatment Period|Other|8|||
13238297|NCT01668784|26333598|FG000|Treatment Period|Administrative Reason by Sponsor|5|||
13238298|NCT01668784|26333599|FG001|Treatment Period|Administrative Reason by Sponsor|1|||
13238299|NCT01668667|26333634|FG000|Overall Study|Adverse Event|3|||
13238300|NCT01668667|26333635|FG001|Overall Study|Adverse Event|6|||
13238301|NCT01668667|26333636|FG002|Overall Study|Adverse Event|4|||
13238302|NCT01668667|26333637|FG003|Overall Study|Adverse Event|4|||
13238303|NCT01668667|26333634|FG000|Overall Study|Lack of Efficacy|3|||
13238304|NCT01668667|26333635|FG001|Overall Study|Lack of Efficacy|2|||
13238305|NCT01668667|26333636|FG002|Overall Study|Lack of Efficacy|2|||
13238306|NCT01668667|26333637|FG003|Overall Study|Lack of Efficacy|3|||
13238307|NCT01668667|26333634|FG000|Overall Study|Protocol Violation|6|||
13238308|NCT01668667|26333635|FG001|Overall Study|Protocol Violation|10|||
13238309|NCT01668667|26333636|FG002|Overall Study|Protocol Violation|12|||
13238310|NCT01668667|26333637|FG003|Overall Study|Protocol Violation|5|||
13238311|NCT01668667|26333634|FG000|Overall Study|Lost to Follow-up|9|||
13238312|NCT01668667|26333635|FG001|Overall Study|Lost to Follow-up|4|||
13238313|NCT01668667|26333636|FG002|Overall Study|Lost to Follow-up|7|||
13238314|NCT01668667|26333637|FG003|Overall Study|Lost to Follow-up|6|||
13238315|NCT01668667|26333634|FG000|Overall Study|Physician Decision|3|||
13238316|NCT01668667|26333635|FG001|Overall Study|Physician Decision|0|||
13238317|NCT01668667|26333636|FG002|Overall Study|Physician Decision|1|||
13238318|NCT01668667|26333637|FG003|Overall Study|Physician Decision|0|||
13238319|NCT01668667|26333634|FG000|Overall Study|Withdrawal by Subject|7|||
13238320|NCT01668667|26333635|FG001|Overall Study|Withdrawal by Subject|4|||
13238321|NCT01668667|26333636|FG002|Overall Study|Withdrawal by Subject|5|||
13238322|NCT01668667|26333637|FG003|Overall Study|Withdrawal by Subject|5|||
13238323|NCT01668654|26333679|FG000|Overall Study|Study Closed/Terminated|3|||
13238324|NCT01668654|26333679|FG000|Overall Study|Withdrawal by Subject|1|||
13238325|NCT01668589|26333730|FG000|Overall Study|Lost to Follow-up|29|||
13238326|NCT01668589|26333731|FG001|Overall Study|Lost to Follow-up|37|||
13238327|NCT01668589|26333732|FG002|Overall Study|Lost to Follow-up|15|||
13238328|NCT01668589|26333733|FG003|Overall Study|Lost to Follow-up|5|||
13238329|NCT01668589|26333730|FG000|Overall Study|Full Consent/Agreement Withdrawn|54|||
13238330|NCT01668589|26333731|FG001|Overall Study|Full Consent/Agreement Withdrawn|8|||
13238331|NCT01668589|26333732|FG002|Overall Study|Full Consent/Agreement Withdrawn|11|||
13238332|NCT01668589|26333733|FG003|Overall Study|Full Consent/Agreement Withdrawn|4|||
13238333|NCT01668589|26333730|FG000|Overall Study|Death|12|||
13238334|NCT01668589|26333731|FG001|Overall Study|Death|3|||
13238335|NCT01668589|26333732|FG002|Overall Study|Death|2|||
13238336|NCT01668589|26333733|FG003|Overall Study|Death|11|||
13238337|NCT01668589|26333730|FG000|Overall Study|Other|44|||
13238338|NCT01668589|26333731|FG001|Overall Study|Other|10|||
13238339|NCT01668589|26333732|FG002|Overall Study|Other|7|||
13238340|NCT01668589|26333733|FG003|Overall Study|Other|15|||
13238341|NCT01668537|26333780|FG000|Overall Study|Request to Discontinue Prematurely|1|||
13238342|NCT01668537|26333781|FG001|Overall Study|Request to Discontinue Prematurely|1|||
13238343|NCT01668537|26333780|FG000|Overall Study|Subject unwilling/unable to comply|5|||
13238344|NCT01668537|26333781|FG001|Overall Study|Subject unwilling/unable to comply|0|||
13238345|NCT01668537|26333780|FG000|Overall Study|Reason Precludes Participation|1|||
13238346|NCT01668537|26333781|FG001|Overall Study|Reason Precludes Participation|0|||
13238347|NCT01668537|26333780|FG000|Overall Study|Lost to Follow-up|13|||
13238348|NCT01668537|26333781|FG001|Overall Study|Lost to Follow-up|6|||
13238349|NCT01668537|26333780|FG000|Overall Study|Other|2|||
13238350|NCT01668537|26333781|FG001|Overall Study|Other|3|||
13238351|NCT01668355|26333808|FG000|Overall Study|Death|3|||
13238352|NCT01668355|26333809|FG001|Overall Study|Death|1|||
13238353|NCT01668355|26333808|FG000|Overall Study|Withdrawal by Subject|6|||
13238354|NCT01668355|26333809|FG001|Overall Study|Withdrawal by Subject|1|||
13238355|NCT01668173|26333815|FG000|Overall Study|Adverse Event|3|||
13238356|NCT01668173|26333815|FG000|Overall Study|Trial suspension|4|||
13238357|NCT01668147|26333825|FG000|Overall Study|Withdrawal by Subject|6|||
13238358|NCT01668004|26333838|FG000|Overall Study|Adverse Event|7|||
13238359|NCT01668004|26333838|FG000|Overall Study|Withdrawal by Subject|2|||
13238360|NCT01668004|26333838|FG000|Overall Study|Lost to Follow-up|5|||
13238361|NCT01668004|26333838|FG000|Overall Study|Lack of Efficacy|9|||
13238362|NCT01668004|26333838|FG000|Overall Study|Non-compliance with treatment|2|||
13238363|NCT01667926|26333854|FG000|Overall Study|Withdrawal by Subject|1|||
13238364|NCT01667926|26333855|FG001|Overall Study|Withdrawal by Subject|2|||
13238365|NCT01667926|26333856|FG002|Overall Study|Withdrawal by Subject|2|||
13238366|NCT01667926|26333854|FG000|Overall Study|Physician Decision|0|||
13238367|NCT01667926|26333855|FG001|Overall Study|Physician Decision|0|||
13238368|NCT01667926|26333856|FG002|Overall Study|Physician Decision|1|||
13238369|NCT01667926|26333854|FG000|Overall Study|Time committment|0|||
13238370|NCT01667926|26333855|FG001|Overall Study|Time committment|0|||
13238371|NCT01667926|26333856|FG002|Overall Study|Time committment|2|||
13238372|NCT01667926|26333854|FG000|Overall Study|Inclusion/Exclusion Criteria|0|||
13238373|NCT01667926|26333855|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
13238374|NCT01667926|26333856|FG002|Overall Study|Inclusion/Exclusion Criteria|5|||
13238375|NCT01667926|26333854|FG000|Overall Study|Lost to Follow-up|1|||
13238376|NCT01667926|26333855|FG001|Overall Study|Lost to Follow-up|2|||
13238377|NCT01667926|26333856|FG002|Overall Study|Lost to Follow-up|1|||
13238378|NCT01667926|26333854|FG000|Overall Study|Side effects|3|||
13238379|NCT01667926|26333855|FG001|Overall Study|Side effects|0|||
13238380|NCT01667926|26333856|FG002|Overall Study|Side effects|0|||
13238381|NCT01667900|26333925|FG000|Part B|Death|0|||
13238382|NCT01667900|26333926|FG001|Part B|Death|0|||
13238383|NCT01667900|26333927|FG002|Part B|Death|0|||
13238384|NCT01667900|26333928|FG003|Part B|Death|0|||
13238385|NCT01667900|26333929|FG004|Part B|Death|0|||
13238386|NCT01667900|26333930|FG005|Part B|Death|0|||
13238387|NCT01667900|26333931|FG006|Part B|Death|0|||
13238388|NCT01667900|26333932|FG007|Part B|Death|0|||
13238389|NCT01667900|26333933|FG008|Part B|Death|0|||
13238390|NCT01667900|26333934|FG009|Part B|Death|0|||
13238391|NCT01667900|26333935|FG010|Part B|Death|0|||
13238392|NCT01667900|26333936|FG011|Part B|Death|0|||
13238393|NCT01667900|26333937|FG012|Part B|Death|0|||
13238394|NCT01667900|26333938|FG013|Part B|Death|0|||
13238395|NCT01667900|26333939|FG014|Part B|Death|0|||
13238396|NCT01667900|26333940|FG015|Part B|Death|0|||
13238397|NCT01667900|26333941|FG016|Part B|Death|1|||
13238398|NCT01667900|26333942|FG017|Part B|Death|0|||
13238399|NCT01667900|26333943|FG018|Part B|Death|0|||
13238400|NCT01667900|26333944|FG019|Part B|Death|0|||
13238401|NCT01667731|26334013|FG000|Overall Study|Enrolled but not treated|0|||
13238402|NCT01667731|26334014|FG001|Overall Study|Enrolled but not treated|0|||
13238403|NCT01667731|26334015|FG002|Overall Study|Enrolled but not treated|0|||
13238404|NCT01667731|26334016|FG003|Overall Study|Enrolled but not treated|0|||
13238405|NCT01667731|26334017|FG004|Overall Study|Enrolled but not treated|1|||
13238406|NCT01667731|26334013|FG000|Overall Study|Efficacy Failure|1|||
13238407|NCT01667731|26334014|FG001|Overall Study|Efficacy Failure|12|||
13238408|NCT01667731|26334015|FG002|Overall Study|Efficacy Failure|0|||
13238409|NCT01667731|26334016|FG003|Overall Study|Efficacy Failure|1|||
13238410|NCT01667731|26334017|FG004|Overall Study|Efficacy Failure|24|||
13238411|NCT01667731|26334013|FG000|Overall Study|Lost to Follow-up|2|||
13238412|NCT01667731|26334014|FG001|Overall Study|Lost to Follow-up|3|||
13238413|NCT01667731|26334015|FG002|Overall Study|Lost to Follow-up|1|||
13238414|NCT01667731|26334016|FG003|Overall Study|Lost to Follow-up|1|||
13238415|NCT01667731|26334017|FG004|Overall Study|Lost to Follow-up|2|||
13238416|NCT01667731|26334013|FG000|Overall Study|Subject Withdrew Consent|2|||
13238417|NCT01667731|26334014|FG001|Overall Study|Subject Withdrew Consent|0|||
13238418|NCT01667731|26334015|FG002|Overall Study|Subject Withdrew Consent|1|||
13238419|NCT01667731|26334016|FG003|Overall Study|Subject Withdrew Consent|0|||
13238420|NCT01667731|26334017|FG004|Overall Study|Subject Withdrew Consent|1|||
13238421|NCT01667731|26334013|FG000|Overall Study|Death|0|||
13238422|NCT01667731|26334014|FG001|Overall Study|Death|1|||
13238423|NCT01667731|26334015|FG002|Overall Study|Death|0|||
13238424|NCT01667731|26334016|FG003|Overall Study|Death|0|||
13238425|NCT01667731|26334017|FG004|Overall Study|Death|0|||
13238426|NCT01667679|26334082|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2|||
13238427|NCT01667679|26334083|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6|||
13238428|NCT01667679|26334082|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2|||
13238429|NCT01667679|26334083|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0|||
13238430|NCT01667679|26334082|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2|||
13238431|NCT01667679|26334083|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0|||
13238432|NCT01667679|26334082|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1|||
13238433|NCT01667679|26334083|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0|||
13238434|NCT01667679|26334082|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6|||
13238435|NCT01667679|26334083|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13|||
13238436|NCT01667679|26334082|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
13238437|NCT01667679|26334083|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
13238438|NCT01667679|26334082|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0|||
13238439|NCT01667679|26334083|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2|||
13238440|NCT01667679|26334082|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0|||
13238441|NCT01667679|26334083|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2|||
13238442|NCT01667679|26334082|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0|||
13238443|NCT01667679|26334083|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3|||
13238444|NCT01667679|26334082|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0|||
13238445|NCT01667679|26334083|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1|||
13238446|NCT01667679|26334082|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6|||
13238447|NCT01667679|26334083|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4|||
13238448|NCT01667679|26334082|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2|||
13238449|NCT01667679|26334083|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0|||
13238450|NCT01667679|26334082|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8|||
13238451|NCT01667679|26334083|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10|||
13238452|NCT01667679|26334082|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3|||
13238453|NCT01667679|26334083|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4|||
13238454|NCT01667679|26334082|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1|||
13238455|NCT01667679|26334083|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0|||
13238456|NCT01667679|26334082|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1|||
13238457|NCT01667679|26334083|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0|||
13238458|NCT01667679|26334082|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1|||
13238459|NCT01667679|26334083|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0|||
13238460|NCT01667679|26334082|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0|||
13238461|NCT01667679|26334083|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1|||
13238462|NCT01667679|26334082|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0|||
13238463|NCT01667679|26334083|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1|||
13238464|NCT01667679|26334082|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0|||
13238465|NCT01667679|26334083|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1|||
13238466|NCT01667679|26334082|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0|||
13238467|NCT01667679|26334083|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1|||
13238468|NCT01667562|26334095|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30|||
13238469|NCT01667562|26334096|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0|||
13238470|NCT01667562|26334095|FG000|Erlotinib Phase|Lost to Follow-up|0|||
13238471|NCT01667562|26334096|FG001|Erlotinib Phase|Lost to Follow-up|1|||
13238472|NCT01667562|26334095|FG000|Erlotinib Phase|Adverse Event|0|||
13238473|NCT01667562|26334096|FG001|Erlotinib Phase|Adverse Event|1|||
13238474|NCT01667562|26334095|FG000|Erlotinib Phase|Switch to Commercial Drug|0|||
13238475|NCT01667562|26334096|FG001|Erlotinib Phase|Switch to Commercial Drug|1|||
13238476|NCT01667549|26334144|FG000|Overall Study|Withdrawal by Subject|3|||
13238477|NCT01667549|26334145|FG001|Overall Study|Withdrawal by Subject|5|||
13238478|NCT01667549|26334146|FG002|Overall Study|Withdrawal by Subject|7|||
13238479|NCT01667549|26334147|FG003|Overall Study|Withdrawal by Subject|6|||
13238480|NCT01667549|26334148|FG004|Overall Study|Withdrawal by Subject|1|||
13238481|NCT01667432|26334155|FG000|Overall Study|Premature Study Termination|26|||
13238482|NCT01667432|26334155|FG000|Overall Study|Failure to Return|10|||
13238483|NCT01667432|26334155|FG000|Overall Study|Moved to Another Center|3|||
13238484|NCT01667432|26334155|FG000|Overall Study|Lost to Follow-up|3|||
13238485|NCT01667432|26334155|FG000|Overall Study|Refused Treatment/Withdrew Consent|1|||
13238486|NCT01667432|26334155|FG000|Overall Study|Insufficient Therapeutic Response|4|||
13238487|NCT01667432|26334155|FG000|Overall Study|Adverse Event|1|||
13238488|NCT01667432|26334155|FG000|Overall Study|Protocol Deviation|2|||
13238489|NCT01667432|26334155|FG000|Overall Study|Principal Investigator Decision|1|||
13238490|NCT01667432|26334155|FG000|Overall Study|Reason Not Specified|2|||
13238491|NCT01667432|26334155|FG000|Overall Study|Missing Information|4|||
13238492|NCT01667419|26334196|FG000|Overall Study|Reason Not Specified|1|||
13238493|NCT01667419|26334197|FG001|Overall Study|Reason Not Specified|0|||
13238494|NCT01667419|26334198|FG002|Overall Study|Reason Not Specified|0|||
13238495|NCT01667419|26334199|FG003|Overall Study|Reason Not Specified|0|||
13238496|NCT01667419|26334196|FG000|Overall Study|Withdrawal by Subject|16|||
13238497|NCT01667419|26334197|FG001|Overall Study|Withdrawal by Subject|8|||
13238498|NCT01667419|26334198|FG002|Overall Study|Withdrawal by Subject|9|||
13238499|NCT01667419|26334199|FG003|Overall Study|Withdrawal by Subject|8|||
13238500|NCT01667419|26334196|FG000|Overall Study|Non-compliance|0|||
13238501|NCT01667419|26334197|FG001|Overall Study|Non-compliance|0|||
13238502|NCT01667419|26334198|FG002|Overall Study|Non-compliance|0|||
13238503|NCT01667419|26334199|FG003|Overall Study|Non-compliance|1|||
13238504|NCT01667419|26334196|FG000|Overall Study|Protocol Violation|1|||
13238505|NCT01667419|26334197|FG001|Overall Study|Protocol Violation|0|||
13238506|NCT01667419|26334198|FG002|Overall Study|Protocol Violation|0|||
13238507|NCT01667419|26334199|FG003|Overall Study|Protocol Violation|0|||
13238508|NCT01667419|26334196|FG000|Overall Study|Lost to Follow-up|7|||
13238509|NCT01667419|26334197|FG001|Overall Study|Lost to Follow-up|6|||
13238510|NCT01667419|26334198|FG002|Overall Study|Lost to Follow-up|2|||
13238511|NCT01667419|26334199|FG003|Overall Study|Lost to Follow-up|4|||
13238512|NCT01667419|26334196|FG000|Overall Study|Death|18|||
13238513|NCT01667419|26334197|FG001|Overall Study|Death|33|||
13238514|NCT01667419|26334198|FG002|Overall Study|Death|25|||
13238515|NCT01667419|26334199|FG003|Overall Study|Death|26|||
13238516|NCT01667224|26334218|FG000|Overall Study|Withdrawal by Subject|3|||
13238517|NCT01667224|26334219|FG001|Overall Study|Withdrawal by Subject|1|||
13238518|NCT01667224|26334218|FG000|Overall Study|Protocol Violation|1|||
13238519|NCT01667224|26334219|FG001|Overall Study|Protocol Violation|1|||
13238520|NCT01667107|26334242|FG000|Overall Study|Adverse Event|4|||
13238521|NCT01667107|26334243|FG001|Overall Study|Adverse Event|3|||
13238522|NCT01667107|26334242|FG000|Overall Study|Tolerability issues|0|||
13238523|NCT01667107|26334243|FG001|Overall Study|Tolerability issues|2|||
13238524|NCT01667107|26334242|FG000|Overall Study|Protocol Violation|0|||
13238525|NCT01667107|26334243|FG001|Overall Study|Protocol Violation|1|||
13238526|NCT01667107|26334242|FG000|Overall Study|Lack of Efficacy|0|||
13238527|NCT01667107|26334243|FG001|Overall Study|Lack of Efficacy|1|||
13238528|NCT01667081|26334274|FG000|Overall Study|Death|43|||
13238529|NCT01667081|26334275|FG001|Overall Study|Death|3|||
13238530|NCT01667081|26334274|FG000|Overall Study|Lost to Follow-up|99|||
13115606|NCT03094195|25918621|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0|||
13238531|NCT01667081|26334275|FG001|Overall Study|Lost to Follow-up|48|||
13238532|NCT01667081|26334274|FG000|Overall Study|Physician Decision|16|||
13238533|NCT01667081|26334275|FG001|Overall Study|Physician Decision|2|||
13238534|NCT01667081|26334274|FG000|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|1529|||
13238535|NCT01667081|26334275|FG001|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|269|||
13238536|NCT01667081|26334274|FG000|Overall Study|Withdrawal by Subject|90|||
13238537|NCT01667081|26334275|FG001|Overall Study|Withdrawal by Subject|35|||
13238538|NCT01666951|26334318|FG000|Overall Study|Not dosed|1|||
13238539|NCT01666951|26334319|FG001|Overall Study|Not dosed|1|||
13238540|NCT01666782|26334342|FG000|Overall Study|Received 2 doses of vaccine|0|||
13238541|NCT01666782|26334343|FG001|Overall Study|Received 2 doses of vaccine|1|||
13238542|NCT01666782|26334342|FG000|Overall Study|Enrolled both years; year 1 data used|4|||
13238543|NCT01666782|26334343|FG001|Overall Study|Enrolled both years; year 1 data used|0|||
13238544|NCT01666730|26334353|FG000|Overall Study|Adverse Event|16|||
13238545|NCT01666730|26334353|FG000|Overall Study|Death|2|||
13238546|NCT01666730|26334353|FG000|Overall Study|Physician Decision|5|||
13238547|NCT01666730|26334353|FG000|Overall Study|Withdrawal by Subject|9|||
13238548|NCT01666730|26334353|FG000|Overall Study|Disease progression/relapse|18|||
13238549|NCT01666652|26334416|FG000|Overall Study|Serious Adverse Event|0|||
13238550|NCT01666652|26334417|FG001|Overall Study|Serious Adverse Event|0|||
13238551|NCT01666652|26334418|FG002|Overall Study|Serious Adverse Event|0|||
13238552|NCT01666652|26334419|FG003|Overall Study|Serious Adverse Event|1|||
13238553|NCT01666652|26334420|FG004|Overall Study|Serious Adverse Event|0|||
13238554|NCT01666652|26334416|FG000|Overall Study|Withdrawal by Subject|0|||
13238555|NCT01666652|26334417|FG001|Overall Study|Withdrawal by Subject|0|||
13238556|NCT01666652|26334418|FG002|Overall Study|Withdrawal by Subject|0|||
13238557|NCT01666652|26334419|FG003|Overall Study|Withdrawal by Subject|0|||
13238558|NCT01666652|26334420|FG004|Overall Study|Withdrawal by Subject|1|||
13238559|NCT01666652|26334416|FG000|Overall Study|Moved from study area|1|||
13238560|NCT01666652|26334417|FG001|Overall Study|Moved from study area|0|||
13238561|NCT01666652|26334418|FG002|Overall Study|Moved from study area|0|||
13238562|NCT01666652|26334419|FG003|Overall Study|Moved from study area|2|||
13238563|NCT01666652|26334420|FG004|Overall Study|Moved from study area|0|||
13238564|NCT01666652|26334416|FG000|Overall Study|Lost to Follow-up|1|||
13238565|NCT01666652|26334417|FG001|Overall Study|Lost to Follow-up|1|||
13238566|NCT01666652|26334418|FG002|Overall Study|Lost to Follow-up|1|||
13238567|NCT01666652|26334419|FG003|Overall Study|Lost to Follow-up|1|||
13238568|NCT01666652|26334420|FG004|Overall Study|Lost to Follow-up|0|||
13238569|NCT01666444|26334437|FG000|Overall Study|Did not initiate treatment|2|||
13238570|NCT01666444|26334438|FG001|Overall Study|Did not initiate treatment|1|||
13238571|NCT01666314|26334568|FG000|Overall Study|Adverse Event|3|||
13238572|NCT01666314|26334569|FG001|Overall Study|Adverse Event|13|||
13238573|NCT01666314|26334570|FG002|Overall Study|Adverse Event|7|||
13238574|NCT01666314|26334571|FG003|Overall Study|Adverse Event|7|||
13238575|NCT01666314|26334568|FG000|Overall Study|Progressive Disease|11|||
13238576|NCT01666314|26334569|FG001|Overall Study|Progressive Disease|9|||
13238577|NCT01666314|26334570|FG002|Overall Study|Progressive Disease|19|||
13238578|NCT01666314|26334571|FG003|Overall Study|Progressive Disease|20|||
13238579|NCT01666314|26334568|FG000|Overall Study|Symptomatic Deterioration|1|||
13238580|NCT01666314|26334569|FG001|Overall Study|Symptomatic Deterioration|0|||
13238581|NCT01666314|26334570|FG002|Overall Study|Symptomatic Deterioration|2|||
13238582|NCT01666314|26334571|FG003|Overall Study|Symptomatic Deterioration|0|||
13238583|NCT01666314|26334568|FG000|Overall Study|Unsatisfactory Therapeutic Response|7|||
13238584|NCT01666314|26334569|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
13238585|NCT01666314|26334570|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
13238586|NCT01666314|26334571|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
13238587|NCT01666314|26334568|FG000|Overall Study|Withdrawal by Subject|1|||
13238588|NCT01666314|26334569|FG001|Overall Study|Withdrawal by Subject|1|||
13238589|NCT01666314|26334570|FG002|Overall Study|Withdrawal by Subject|2|||
13238590|NCT01666314|26334571|FG003|Overall Study|Withdrawal by Subject|3|||
13238591|NCT01666314|26334568|FG000|Overall Study|Reason not Specified|10|||
13238592|NCT01666314|26334569|FG001|Overall Study|Reason not Specified|7|||
13238593|NCT01666314|26334570|FG002|Overall Study|Reason not Specified|5|||
13238594|NCT01666314|26334571|FG003|Overall Study|Reason not Specified|5|||
13115607|NCT03094195|25918614|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
13115608|NCT03094195|25918615|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
13115609|NCT03094195|25918616|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
13115610|NCT03094195|25918617|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
13115611|NCT03094195|25918618|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
13115612|NCT03094195|25918619|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
13115613|NCT03094195|25918620|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
13115614|NCT03094195|25918621|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
13238595|NCT01666119|26334578|FG000|Overall Study|Adverse Event|6|||
13238596|NCT01666119|26334578|FG000|Overall Study|Withdrawal by Subject|16|||
13238597|NCT01666119|26334578|FG000|Overall Study|Lost to Follow-up|7|||
13238598|NCT01666119|26334578|FG000|Overall Study|non compliance with study medication, pa|18|||
13238599|NCT01666119|26334578|FG000|Overall Study|Subject experiencing withdrawal symptoms|5|||
13238600|NCT01666002|26334593|FG000|Overall Study|Lost to Follow-up|5|||
13238601|NCT01666002|26334594|FG001|Overall Study|Lost to Follow-up|0|||
13238602|NCT01665911|26334602|FG000|Overall Study|Protocol Violation|4|||
13238603|NCT01665911|26334602|FG000|Overall Study|Withdrawal by Subject|1|||
13238604|NCT01665911|26334602|FG000|Overall Study|Adverse Event|1|||
13238605|NCT01665807|26334623|FG000|Overall Study|Withdrawal by Subject|2|||
13238606|NCT01665807|26334624|FG001|Overall Study|Withdrawal by Subject|0|||
13238607|NCT01665807|26334625|FG002|Overall Study|Withdrawal by Subject|1|||
13238608|NCT01665768|26334634|FG000|Overall Study|Adverse Event|3|||
13238609|NCT01665768|26334634|FG000|Overall Study|Lack of Efficacy|19|||
13238610|NCT01665768|26334634|FG000|Overall Study|Withdrawal by Subject|1|||
13238611|NCT01665599|26334656|FG000|Overall Study|Adverse Event|1|||
13238612|NCT01665599|26334656|FG000|Overall Study|Consent Withdrawn|1|||
13238613|NCT01665599|26334656|FG000|Overall Study|Investigator/Sponsor decision|1|||
13238614|NCT01665599|26334656|FG000|Overall Study|Death|1|||
13238615|NCT01665599|26334656|FG000|Overall Study|Lost to Follow-up|2|||
13238616|NCT01665599|26334656|FG000|Overall Study|Participant Left for More Than 3 Months|1|||
13238617|NCT01665599|26334656|FG000|Overall Study|Could Not Continue Due to Time Constrain|1|||
13238618|NCT01665430|26334672|FG000|Overall Study|Adverse Event|1|||
13238619|NCT01665430|26334672|FG000|Overall Study|Withdrawal by Subject|6|||
13238620|NCT01665430|26334672|FG000|Overall Study|Other Unspecified|2|||
13238621|NCT01665144|26334685|FG000|Overall Study|New therapy for study indication|2|||
13238622|NCT01665144|26334686|FG001|Overall Study|New therapy for study indication|1|||
13238623|NCT01665144|26334685|FG000|Overall Study|Technical problems|2|||
13238624|NCT01665144|26334686|FG001|Overall Study|Technical problems|0|||
13238625|NCT01665144|26334685|FG000|Overall Study|Death|3|||
13238626|NCT01665144|26334686|FG001|Overall Study|Death|1|||
13238627|NCT01665144|26334685|FG000|Overall Study|Protocol deviation|3|||
13238628|NCT01665144|26334686|FG001|Overall Study|Protocol deviation|1|||
13238629|NCT01665144|26334685|FG000|Overall Study|Non-compliance w/study treatment|5|||
13238630|NCT01665144|26334686|FG001|Overall Study|Non-compliance w/study treatment|0|||
13238631|NCT01665144|26334685|FG000|Overall Study|Progressive disease|8|||
13238632|NCT01665144|26334686|FG001|Overall Study|Progressive disease|4|||
13238633|NCT01665144|26334685|FG000|Overall Study|Lost to Follow-up|9|||
13238634|NCT01665144|26334686|FG001|Overall Study|Lost to Follow-up|8|||
13238635|NCT01665144|26334685|FG000|Overall Study|Physician Decision|13|||
13238636|NCT01665144|26334686|FG001|Overall Study|Physician Decision|1|||
13238637|NCT01665144|26334685|FG000|Overall Study|Lack of Efficacy|16|||
13238638|NCT01665144|26334686|FG001|Overall Study|Lack of Efficacy|11|||
13238639|NCT01665144|26334685|FG000|Overall Study|Adverse Event|45|||
13238640|NCT01665144|26334686|FG001|Overall Study|Adverse Event|18|||
13238641|NCT01665144|26334685|FG000|Overall Study|Withdrawal by Subject|96|||
13238642|NCT01665144|26334686|FG001|Overall Study|Withdrawal by Subject|77|||
13238643|NCT01664949|26334707|FG000|Overall Study|Adverse Event|11|||
13238644|NCT01664949|26334708|FG001|Overall Study|Adverse Event|12|||
13238645|NCT01664949|26334707|FG000|Overall Study|Lack of Efficacy|1|||
13238646|NCT01664949|26334708|FG001|Overall Study|Lack of Efficacy|1|||
13238647|NCT01664949|26334707|FG000|Overall Study|Lost to Follow-up|1|||
13238648|NCT01664949|26334708|FG001|Overall Study|Lost to Follow-up|2|||
13238649|NCT01664949|26334707|FG000|Overall Study|Personal Reasons|3|||
13238650|NCT01664949|26334708|FG001|Overall Study|Personal Reasons|4|||
13238651|NCT01664949|26334707|FG000|Overall Study|Protocol Violation|5|||
13238652|NCT01664949|26334708|FG001|Overall Study|Protocol Violation|5|||
13238653|NCT01664949|26334707|FG000|Overall Study|Other Miscellaneous Reasons|3|||
13238654|NCT01664949|26334708|FG001|Overall Study|Other Miscellaneous Reasons|1|||
13238655|NCT01664923|26334735|FG000|Period1:Double Blind Phase-29 Months|Death|8|||
13238656|NCT01664923|26334736|FG001|Period1:Double Blind Phase-29 Months|Death|6|||
13238657|NCT01664923|26334735|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0|||
13238658|NCT01664923|26334736|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1|||
13238659|NCT01664923|26334735|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2|||
13238660|NCT01664923|26334736|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0|||
13238661|NCT01664923|26334735|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12|||
13238662|NCT01664923|26334736|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8|||
13238663|NCT01664923|26334735|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65|||
13238664|NCT01664923|26334736|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132|||
13238665|NCT01664923|26334735|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14|||
13238666|NCT01664923|26334736|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9|||
13238667|NCT01664923|26334735|FG000|Period1:Double Blind Phase-29 Months|Other|3|||
13238668|NCT01664923|26334736|FG001|Period1:Double Blind Phase-29 Months|Other|4|||
13238669|NCT01664923|26334735|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1|||
13238670|NCT01664923|26334736|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0|||
13238671|NCT01664923|26334735|FG000|Period 2: Open-label Phase-36 Months|Death|3|||
13238672|NCT01664923|26334736|FG001|Period 2: Open-label Phase-36 Months|Death|1|||
13238673|NCT01664923|26334735|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1|||
13238674|NCT01664923|26334736|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1|||
13238675|NCT01664923|26334735|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28|||
13238676|NCT01664923|26334736|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9|||
13238677|NCT01664923|26334735|FG000|Period 2: Open-label Phase-36 Months|Other|3|||
13238678|NCT01664923|26334736|FG001|Period 2: Open-label Phase-36 Months|Other|1|||
13238679|NCT01664923|26334735|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4|||
13238680|NCT01664923|26334736|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7|||
13238681|NCT01664923|26334735|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2|||
13238682|NCT01664923|26334736|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4|||
13238683|NCT01664624|26334779|FG000|Overall Study|Adverse Event|0|||
13238684|NCT01664624|26334780|FG001|Overall Study|Adverse Event|1|||
13238685|NCT01664624|26334781|FG002|Overall Study|Adverse Event|0|||
13238686|NCT01664624|26334782|FG003|Overall Study|Adverse Event|0|||
13238687|NCT01664533|26334792|FG000|Overall Study|Death|42|||
13238688|NCT01664533|26334792|FG000|Overall Study|Lost to Follow-up|3|||
13238689|NCT01664533|26334792|FG000|Overall Study|Study termination|9|||
13238690|NCT01664533|26334792|FG000|Overall Study|Protocol Violation|3|||
13238691|NCT01664494|26334799|FG000|Overall Study|Withdrawal by Subject|27|||
13238692|NCT01664494|26334799|FG000|Overall Study|Death|18|||
13238693|NCT01664494|26334799|FG000|Overall Study|Other|49|||
13238694|NCT01664494|26334799|FG000|Overall Study|Lost to Follow-up|99|||
13238695|NCT01664247|26334828|FG000|Overall Study|Adverse Event|5|||
13238696|NCT01664247|26334829|FG001|Overall Study|Adverse Event|3|||
13238697|NCT01664247|26334828|FG000|Overall Study|Protocol Violation|3|||
13238698|NCT01664247|26334829|FG001|Overall Study|Protocol Violation|5|||
13238699|NCT01664247|26334828|FG000|Overall Study|Withdrawal Criteria|1|||
13238700|NCT01664247|26334829|FG001|Overall Study|Withdrawal Criteria|4|||
13238701|NCT01664247|26334828|FG000|Overall Study|Unclassified|5|||
13238702|NCT01664247|26334829|FG001|Overall Study|Unclassified|29|||
13238703|NCT01664130|26334854|FG000|Overall Study|competing secondary disease|2|||
13238704|NCT01664104|26334923|FG000|Overall Study|Adverse Event|6|||
13238705|NCT01664104|26334923|FG000|Overall Study|Lack of Efficacy|2|||
13238706|NCT01664104|26334923|FG000|Overall Study|Withdrawal by Subject|1|||
13238707|NCT01664104|26334923|FG000|Overall Study|Lost to Follow-up|4|||
13238708|NCT01664104|26334923|FG000|Overall Study|Other|1|||
13238709|NCT01664104|26334923|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2|||
13238710|NCT01664091|26334933|FG000|Overall Study|Death|1|||
13238711|NCT01664091|26334933|FG000|Overall Study|Disease Progression|2|||
13238712|NCT01664091|26334933|FG000|Overall Study|Lost to Follow-up|2|||
13238713|NCT01664091|26334933|FG000|Overall Study|Withdrawal by Subject|1|||
13238714|NCT01664078|26334986|FG000|Overall Study|Death|9|||
13238715|NCT01664078|26334986|FG000|Overall Study|Withdrawal by Subject|4|||
13238716|NCT01664078|26334986|FG000|Overall Study|Lost to Follow-up|2|||
13238717|NCT01664078|26334986|FG000|Overall Study|missed 5 year visit|1|||
13238718|NCT01664078|26334986|FG000|Overall Study|Other|53|||
13238719|NCT01664052|26335009|FG000|Phase 1|No device placement|6|||
13238720|NCT01664052|26335010|FG001|Phase 1|No device placement|0|||
13238721|NCT01664052|26335009|FG000|Phase 1|No HSG 1 hr post placement|1|||
13238722|NCT01664052|26335010|FG001|Phase 1|No HSG 1 hr post placement|0|||
13238723|NCT01664052|26335009|FG000|Phase 2|No device placement|0|||
13238724|NCT01664052|26335010|FG001|Phase 2|No device placement|4|||
13238725|NCT01664039|26335037|FG000|Overall Study|Adverse Event|3|||
13238726|NCT01664039|26335038|FG001|Overall Study|Adverse Event|4|||
13238727|NCT01664039|26335037|FG000|Overall Study|Lost to Follow-up|1|||
13238728|NCT01664039|26335038|FG001|Overall Study|Lost to Follow-up|1|||
13238729|NCT01664039|26335037|FG000|Overall Study|Withdrawal by Subject|1|||
13238730|NCT01664039|26335038|FG001|Overall Study|Withdrawal by Subject|3|||
13238731|NCT01664039|26335037|FG000|Overall Study|Noncompliance|1|||
13238732|NCT01664039|26335038|FG001|Overall Study|Noncompliance|1|||
13238733|NCT01663987|26335073|FG000|Overall Study|Adverse Event|7|||
13238734|NCT01663987|26335074|FG001|Overall Study|Adverse Event|2|||
13238735|NCT01663987|26335073|FG000|Overall Study|Lost to Follow-up|1|||
13238736|NCT01663987|26335074|FG001|Overall Study|Lost to Follow-up|1|||
13238737|NCT01663987|26335073|FG000|Overall Study|Withdrawal by Subject|2|||
13238738|NCT01663987|26335074|FG001|Overall Study|Withdrawal by Subject|3|||
13238739|NCT01663987|26335073|FG000|Overall Study|Other reason not defined above|3|||
13238740|NCT01663987|26335074|FG001|Overall Study|Other reason not defined above|0|||
13238741|NCT01663896|26335083|FG000|Overall Study|Various reasons|43|||
13238742|NCT01663857|26335113|FG000|Overall Study|Withdrew Consent to Study Participation|0|||
13238743|NCT01663857|26335114|FG001|Overall Study|Withdrew Consent to Study Participation|1|||
13238744|NCT01663857|26335115|FG002|Overall Study|Withdrew Consent to Study Participation|7|||
13238745|NCT01663857|26335116|FG003|Overall Study|Withdrew Consent to Study Participation|3|||
13238746|NCT01663857|26335113|FG000|Overall Study|Lost to Follow-up|0|||
13238747|NCT01663857|26335114|FG001|Overall Study|Lost to Follow-up|0|||
13238748|NCT01663857|26335115|FG002|Overall Study|Lost to Follow-up|3|||
13238749|NCT01663857|26335116|FG003|Overall Study|Lost to Follow-up|1|||
13238750|NCT01663740|26335181|FG000|Overall Study|Lost to Follow-up|1|||
13238751|NCT01663740|26335182|FG001|Overall Study|Lost to Follow-up|4|||
13238752|NCT01663740|26335181|FG000|Overall Study|Other|9|||
13238753|NCT01663740|26335182|FG001|Overall Study|Other|2|||
13238754|NCT01663740|26335181|FG000|Overall Study|Inclusion/Exclusion not met|1|||
13238755|NCT01663740|26335182|FG001|Overall Study|Inclusion/Exclusion not met|0|||
13238756|NCT01663740|26335181|FG000|Overall Study|Death|0|||
13238757|NCT01663740|26335182|FG001|Overall Study|Death|1|||
13238758|NCT01663740|26335181|FG000|Overall Study|Withdrawal by Subject|2|||
13238759|NCT01663740|26335182|FG001|Overall Study|Withdrawal by Subject|1|||
13238760|NCT01663740|26335181|FG000|Overall Study|No end of study status|3|||
13238761|NCT01663740|26335182|FG001|Overall Study|No end of study status|0|||
13238762|NCT01663727|26335221|FG000|Overall Study|Death|161|||
13238763|NCT01663727|26335222|FG001|Overall Study|Death|155|||
13238764|NCT01663727|26335221|FG000|Overall Study|Lost to Follow-up|10|||
13238765|NCT01663727|26335222|FG001|Overall Study|Lost to Follow-up|8|||
13238766|NCT01663727|26335221|FG000|Overall Study|Withdrawal by Subject|18|||
13238767|NCT01663727|26335222|FG001|Overall Study|Withdrawal by Subject|25|||
13238768|NCT01663727|26335221|FG000|Overall Study|Study Terminated|51|||
13238769|NCT01663727|26335222|FG001|Overall Study|Study Terminated|50|||
13238770|NCT01663727|26335221|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1|||
13238771|NCT01663727|26335222|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0|||
13238772|NCT01663727|26335221|FG000|Overall Study|Withdrawal prior to dosing.|1|||
13238773|NCT01663727|26335222|FG001|Overall Study|Withdrawal prior to dosing.|0|||
13238774|NCT01663714|26335251|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
13238775|NCT01663714|26335251|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11|||
13238776|NCT01663714|26335251|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16|||
13238777|NCT01663714|26335251|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
13238778|NCT01663714|26335251|FG000|Long-Term Follow-Up|Death|4|||
13238779|NCT01663714|26335251|FG000|Long-Term Follow-Up|Non-compliance|1|||
13238780|NCT01663636|26335264|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25|||
13238781|NCT01663636|26335265|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31|||
13238782|NCT01663623|26335280|FG000|Overall Study|Adverse Event|3|||
13238783|NCT01663623|26335281|FG001|Overall Study|Adverse Event|7|||
13238784|NCT01663623|26335280|FG000|Overall Study|Lack of Efficacy|5|||
13238785|NCT01663623|26335281|FG001|Overall Study|Lack of Efficacy|6|||
13238786|NCT01663623|26335280|FG000|Overall Study|Protocol Violation|0|||
13238787|NCT01663623|26335281|FG001|Overall Study|Protocol Violation|1|||
13238788|NCT01663623|26335280|FG000|Overall Study|Other-Study closed/terminated|1|||
13238789|NCT01663623|26335281|FG001|Overall Study|Other-Study closed/terminated|1|||
13238790|NCT01663623|26335280|FG000|Overall Study|Physician Decision|1|||
13238791|NCT01663623|26335281|FG001|Overall Study|Physician Decision|4|||
13238792|NCT01663623|26335280|FG000|Overall Study|Withdrawal by Subject|2|||
13238793|NCT01663623|26335281|FG001|Overall Study|Withdrawal by Subject|1|||
13238794|NCT01663532|26335306|FG000|Overall Study|Lost to Follow-up|9|||
13238795|NCT01663532|26335307|FG001|Overall Study|Lost to Follow-up|10|||
13238796|NCT01663532|26335306|FG000|Overall Study|Adverse Event|7|||
13238797|NCT01663532|26335307|FG001|Overall Study|Adverse Event|13|||
13238798|NCT01663532|26335306|FG000|Overall Study|Met Withdrawal Criteria|7|||
13238799|NCT01663532|26335307|FG001|Overall Study|Met Withdrawal Criteria|6|||
13238800|NCT01663532|26335306|FG000|Overall Study|Physician Decision|1|||
13238801|NCT01663532|26335307|FG001|Overall Study|Physician Decision|1|||
13238802|NCT01663532|26335306|FG000|Overall Study|Withdrawal by Subject|35|||
13238803|NCT01663532|26335307|FG001|Overall Study|Withdrawal by Subject|17|||
13238804|NCT01663532|26335306|FG000|Overall Study|Lack of Efficacy|15|||
13238805|NCT01663532|26335307|FG001|Overall Study|Lack of Efficacy|60|||
13238806|NCT01663506|26335338|FG000|Overall Study|Lack of Efficacy|3|||
13238807|NCT01663506|26335338|FG000|Overall Study|Consent Withdrawal by Subject|1|||
13238808|NCT01663506|26335338|FG000|Overall Study|Lost to Follow-up|1|||
13238809|NCT01663506|26335338|FG000|Overall Study|Adverse Event|1|||
13238810|NCT01663506|26335338|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2|||
13238811|NCT01663402|26335379|FG000|Overall Study|Randomized but not treated|19|||
13238812|NCT01663402|26335380|FG001|Overall Study|Randomized but not treated|11|||
13238813|NCT01663402|26335379|FG000|Overall Study|Adverse Event|347|||
13238814|NCT01663402|26335380|FG001|Overall Study|Adverse Event|362|||
13238815|NCT01663402|26335379|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0|||
13238816|NCT01663402|26335380|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730|||
13238817|NCT01663402|26335379|FG000|Overall Study|Poor compliance to protocol|529|||
13238818|NCT01663402|26335380|FG001|Overall Study|Poor compliance to protocol|454|||
13238819|NCT01663402|26335379|FG000|Overall Study|Physician Decision|77|||
13238820|NCT01663402|26335380|FG001|Overall Study|Physician Decision|62|||
13238821|NCT01663402|26335379|FG000|Overall Study|Site terminated by sponsor|1|||
13238822|NCT01663402|26335380|FG001|Overall Study|Site terminated by sponsor|3|||
13238823|NCT01663402|26335379|FG000|Overall Study|Participant moved|139|||
13238824|NCT01663402|26335380|FG001|Overall Study|Participant moved|104|||
13238825|NCT01663402|26335379|FG000|Overall Study|Withdrawal by Subject|118|||
13238826|NCT01663402|26335380|FG001|Overall Study|Withdrawal by Subject|91|||
13238827|NCT01663402|26335379|FG000|Overall Study|Related to study drug administration|96|||
13238828|NCT01663402|26335380|FG001|Overall Study|Related to study drug administration|105|||
13238829|NCT01663402|26335379|FG000|Overall Study|Lost to Follow-up|17|||
13238830|NCT01663402|26335380|FG001|Overall Study|Lost to Follow-up|15|||
13238831|NCT01663402|26335379|FG000|Overall Study|Other than specified above|172|||
13238832|NCT01663402|26335380|FG001|Overall Study|Other than specified above|147|||
13238833|NCT01663233|26335409|FG000|Overall Study|Withdrawal by Subject|3|||
13238834|NCT01663233|26335410|FG001|Overall Study|Withdrawal by Subject|2|||
13238835|NCT01663233|26335409|FG000|Overall Study|Protocol Deviation|1|||
13238836|NCT01663233|26335410|FG001|Overall Study|Protocol Deviation|4|||
13238837|NCT01663233|26335409|FG000|Overall Study|Lost to Follow-up|0|||
13238838|NCT01663233|26335410|FG001|Overall Study|Lost to Follow-up|1|||
13238839|NCT01663103|26335433|FG000|Overall Study|Withdrawal by Subject|1|||
13238840|NCT01663103|26335434|FG001|Overall Study|Withdrawal by Subject|2|||
13238841|NCT01663103|26335433|FG000|Overall Study|Adverse Event|1|||
13238842|NCT01663103|26335434|FG001|Overall Study|Adverse Event|0|||
13238843|NCT01663103|26335433|FG000|Overall Study|dog bite|1|||
13238844|NCT01663103|26335434|FG001|Overall Study|dog bite|0|||
13238845|NCT01662999|26335522|FG000|Period 3|Withdrawal by Subject|0|||
13238846|NCT01662999|26335523|FG001|Period 3|Withdrawal by Subject|1|||
13238847|NCT01662999|26335524|FG002|Period 3|Withdrawal by Subject|0|||
13238848|NCT01662999|26335525|FG003|Period 3|Withdrawal by Subject|0|||
13238849|NCT01662999|26335526|FG004|Period 3|Withdrawal by Subject|0|||
13238850|NCT01662999|26335527|FG005|Period 3|Withdrawal by Subject|0|||
13238851|NCT01662986|26335566|FG000|Overall Study|Adverse Event|5|||
13238852|NCT01662986|26335567|FG001|Overall Study|Adverse Event|4|||
13238853|NCT01662986|26335566|FG000|Overall Study|Protocol Violation|2|||
13238854|NCT01662986|26335567|FG001|Overall Study|Protocol Violation|3|||
13238855|NCT01662986|26335566|FG000|Overall Study|Lost to Follow-up|5|||
13115615|NCT03093870|25918661|FG000|Overall Study|Withdrawal by Subject|2|||
13238856|NCT01662986|26335567|FG001|Overall Study|Lost to Follow-up|4|||
13238857|NCT01662986|26335566|FG000|Overall Study|Withdrawal by Subject|2|||
13238858|NCT01662986|26335567|FG001|Overall Study|Withdrawal by Subject|2|||
13238859|NCT01662986|26335566|FG000|Overall Study|Not Treated|1|||
13238860|NCT01662986|26335567|FG001|Overall Study|Not Treated|0|||
13238861|NCT01662986|26335566|FG000|Overall Study|Other than stated above|3|||
13238862|NCT01662986|26335567|FG001|Overall Study|Other than stated above|0|||
13238863|NCT01662895|26335594|FG000|Overall Study|Lost to Follow-up|0|||
13238864|NCT01662895|26335595|FG001|Overall Study|Lost to Follow-up|1|||
13238865|NCT01662648|26335624|FG000|Overall Study|Death|1|||
13115616|NCT03093870|25918662|FG001|Overall Study|Withdrawal by Subject|6|||
13115617|NCT03093870|25918663|FG002|Overall Study|Withdrawal by Subject|5|||
13115618|NCT03093870|25918661|FG000|Overall Study|Death|1|||
13115619|NCT03093870|25918662|FG001|Overall Study|Death|35|||
13115620|NCT03093870|25918663|FG002|Overall Study|Death|35|||
13115621|NCT03093870|25918661|FG000|Overall Study|Radiographic disease progression|10|||
13115622|NCT03093870|25918662|FG001|Overall Study|Radiographic disease progression|0|||
13115623|NCT03093870|25918663|FG002|Overall Study|Radiographic disease progression|0|||
13238866|NCT01662648|26335625|FG001|Overall Study|Death|3|||
13238867|NCT01662648|26335624|FG000|Overall Study|Adverse Event|40|||
13238868|NCT01662648|26335625|FG001|Overall Study|Adverse Event|37|||
13238869|NCT01662648|26335624|FG000|Overall Study|Lack of Efficacy|17|||
13238870|NCT01662648|26335625|FG001|Overall Study|Lack of Efficacy|16|||
13238871|NCT01662648|26335624|FG000|Overall Study|Participant ineligible to continue trial|1|||
13238872|NCT01662648|26335625|FG001|Overall Study|Participant ineligible to continue trial|1|||
13238873|NCT01662648|26335624|FG000|Overall Study|Lost to Follow-up|24|||
13238874|NCT01662648|26335625|FG001|Overall Study|Lost to Follow-up|36|||
13238875|NCT01662648|26335624|FG000|Overall Study|Withdrawal by Subject|36|||
13238876|NCT01662648|26335625|FG001|Overall Study|Withdrawal by Subject|53|||
13238877|NCT01662648|26335624|FG000|Overall Study|Participant non-compliant|16|||
13238878|NCT01662648|26335625|FG001|Overall Study|Participant non-compliant|20|||
13238879|NCT01662648|26335624|FG000|Overall Study|Other|8|||
13238880|NCT01662648|26335625|FG001|Overall Study|Other|11|||
13238881|NCT01662648|26335624|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3|||
13238882|NCT01662648|26335625|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0|||
13238883|NCT01662648|26335624|FG000|Overall Study|LOE and other reason unspecified|1|||
13238884|NCT01662648|26335625|FG001|Overall Study|LOE and other reason unspecified|0|||
13238885|NCT01662648|26335624|FG000|Overall Study|LOE and Participant non-compliant|0|||
13238886|NCT01662648|26335625|FG001|Overall Study|LOE and Participant non-compliant|1|||
13238887|NCT01662635|26335633|FG000|Overall Study|scarce samples for evaluation|30|||
13238888|NCT01662505|26335664|FG000|Overall Study|Progressive disease|6|||
13238889|NCT01662505|26335665|FG001|Overall Study|Progressive disease|1|||
13238890|NCT01662505|26335666|FG002|Overall Study|Progressive disease|5|||
13238891|NCT01662505|26335664|FG000|Overall Study|Refused cont. medication|0|||
13238892|NCT01662505|26335665|FG001|Overall Study|Refused cont. medication|0|||
13238893|NCT01662505|26335666|FG002|Overall Study|Refused cont. medication|1|||
13238894|NCT01662505|26335664|FG000|Overall Study|Not specified above|1|||
13238895|NCT01662505|26335665|FG001|Overall Study|Not specified above|3|||
13238896|NCT01662505|26335666|FG002|Overall Study|Not specified above|2|||
13238897|NCT01662492|26335696|FG000|Overall Study|Other miscellaneous reasons.|1|||
13238898|NCT01662492|26335697|FG001|Overall Study|Other miscellaneous reasons.|0|||
13238899|NCT01662492|26335698|FG002|Overall Study|Other miscellaneous reasons.|1|||
13238900|NCT01662492|26335696|FG000|Overall Study|Withdrawal by Subject|0|||
13238901|NCT01662492|26335697|FG001|Overall Study|Withdrawal by Subject|0|||
13238902|NCT01662492|26335698|FG002|Overall Study|Withdrawal by Subject|1|||
13238903|NCT01662492|26335696|FG000|Overall Study|Protocol Violation|1|||
13238904|NCT01662492|26335697|FG001|Overall Study|Protocol Violation|0|||
13238905|NCT01662492|26335698|FG002|Overall Study|Protocol Violation|0|||
13238906|NCT01662492|26335696|FG000|Overall Study|Lost to Follow-up|0|||
13238907|NCT01662492|26335697|FG001|Overall Study|Lost to Follow-up|0|||
13238908|NCT01662492|26335698|FG002|Overall Study|Lost to Follow-up|2|||
13238909|NCT01662492|26335696|FG000|Overall Study|Lack of Efficacy|1|||
13238910|NCT01662492|26335697|FG001|Overall Study|Lack of Efficacy|1|||
13238911|NCT01662492|26335698|FG002|Overall Study|Lack of Efficacy|2|||
13238912|NCT01662440|26335759|FG000|Overall Study|Adverse Event|1|||
13238913|NCT01662440|26335760|FG001|Overall Study|Adverse Event|0|||
13238914|NCT01662440|26335761|FG002|Overall Study|Adverse Event|0|||
13238915|NCT01662440|26335762|FG003|Overall Study|Adverse Event|1|||
13238916|NCT01662440|26335759|FG000|Overall Study|Death|0|||
13238917|NCT01662440|26335760|FG001|Overall Study|Death|1|||
13238918|NCT01662440|26335761|FG002|Overall Study|Death|0|||
13238919|NCT01662440|26335762|FG003|Overall Study|Death|0|||
13238920|NCT01662440|26335759|FG000|Overall Study|Lost to Follow-up|2|||
13238921|NCT01662440|26335760|FG001|Overall Study|Lost to Follow-up|2|||
13238922|NCT01662440|26335761|FG002|Overall Study|Lost to Follow-up|4|||
13238923|NCT01662440|26335762|FG003|Overall Study|Lost to Follow-up|1|||
13238924|NCT01662440|26335759|FG000|Overall Study|Subject moved to another country.|0|||
13238925|NCT01662440|26335760|FG001|Overall Study|Subject moved to another country.|1|||
13238926|NCT01662440|26335761|FG002|Overall Study|Subject moved to another country.|0|||
13238927|NCT01662440|26335762|FG003|Overall Study|Subject moved to another country.|0|||
13238928|NCT01662440|26335759|FG000|Overall Study|Protocol Violation|1|||
13238929|NCT01662440|26335760|FG001|Overall Study|Protocol Violation|0|||
13238930|NCT01662440|26335761|FG002|Overall Study|Protocol Violation|0|||
13238931|NCT01662440|26335762|FG003|Overall Study|Protocol Violation|0|||
13238932|NCT01662440|26335759|FG000|Overall Study|Withdrawal by Subject|5|||
13238933|NCT01662440|26335760|FG001|Overall Study|Withdrawal by Subject|2|||
13238934|NCT01662440|26335761|FG002|Overall Study|Withdrawal by Subject|2|||
13238935|NCT01662440|26335762|FG003|Overall Study|Withdrawal by Subject|2|||
13289807|NCT00105989|26480243|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25|||
13289808|NCT00105989|26480244|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0|||
13289809|NCT00105989|26480243|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50|||
13289810|NCT00105989|26480244|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0|||
13289811|NCT00105989|26480243|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15|||
13289812|NCT00105989|26480244|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0|||
13289813|NCT00105989|26480243|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16|||
13289814|NCT00105989|26480244|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0|||
13289815|NCT00105989|26480243|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5|||
13289816|NCT00105989|26480244|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0|||
13289817|NCT00105989|26480243|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9|||
13289818|NCT00105989|26480244|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0|||
13289819|NCT00105989|26480243|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3|||
13289820|NCT00105989|26480244|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0|||
13289821|NCT00105989|26480243|FG000|Continuation - Open Label:Week 10-34|Death|0|||
13289822|NCT00105989|26480244|FG001|Continuation - Open Label:Week 10-34|Death|0|||
13289823|NCT00105989|26480243|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2|||
13289824|NCT00105989|26480244|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0|||
13289825|NCT00105989|26480243|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
13289826|NCT00105989|26480244|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
13289827|NCT00105989|26480243|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6|||
13289828|NCT00105989|26480244|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3|||
13289829|NCT00105989|26480243|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17|||
13289830|NCT00105989|26480244|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18|||
13289831|NCT00105989|26480243|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
13289832|NCT00105989|26480244|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
13289833|NCT00105989|26480243|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
13289834|NCT00105989|26480244|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
13289835|NCT00105989|26480243|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5|||
13289836|NCT00105989|26480244|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4|||
13289837|NCT00105989|26480243|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4|||
13289838|NCT00105989|26480244|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0|||
13289839|NCT00105989|26480243|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4|||
13289840|NCT00105989|26480244|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1|||
13289841|NCT00105989|26480243|FG000|Maintenance - Double-Blind:Week 34-86|Death|0|||
13289842|NCT00105989|26480244|FG001|Maintenance - Double-Blind:Week 34-86|Death|0|||
13289843|NCT00105989|26480243|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14|||
13289844|NCT00105989|26480244|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43|||
13289845|NCT00105989|26480243|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
13289846|NCT00105989|26480244|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
13289847|NCT00105586|26480259|FG000|Overall Study|Adverse Event|4|||
13289848|NCT00105586|26480260|FG001|Overall Study|Adverse Event|3|||
13289849|NCT00105586|26480259|FG000|Overall Study|Physician Decision|13|||
13289850|NCT00105586|26480260|FG001|Overall Study|Physician Decision|13|||
13289851|NCT00105534|26480275|FG000|Overall Study|Adverse Event|2|||
13289852|NCT00105534|26480276|FG001|Overall Study|Adverse Event|5|||
13289853|NCT00105534|26480275|FG000|Overall Study|Protocol Violation|1|||
13289854|NCT00105534|26480276|FG001|Overall Study|Protocol Violation|4|||
13289855|NCT00105534|26480275|FG000|Overall Study|Withdrawal by Subject|6|||
13238936|NCT01662362|26335769|FG000|Overall Study|Lost to Follow-up|38|||
13238937|NCT01662336|26335797|FG000|Overall Study|Adverse Event|1|||
13238938|NCT01662336|26335797|FG000|Overall Study|No longer on LPV/r|30|||
13238939|NCT01662336|26335797|FG000|Overall Study|Other|29|||
13238940|NCT01662336|26335797|FG000|Overall Study|Withdrawal by Subject|6|||
13238941|NCT01662310|26335835|FG000|Run-In or Stabilization Phase|Adverse Event|11|||
13238942|NCT01662310|26335836|FG001|Run-In or Stabilization Phase|Adverse Event|0|||
13238943|NCT01662310|26335837|FG002|Run-In or Stabilization Phase|Adverse Event|0|||
13238944|NCT01662310|26335838|FG003|Run-In or Stabilization Phase|Adverse Event|0|||
13238945|NCT01662310|26335839|FG004|Run-In or Stabilization Phase|Adverse Event|0|||
13238946|NCT01662310|26335835|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9|||
13238947|NCT01662310|26335836|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0|||
13238948|NCT01662310|26335837|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0|||
13238949|NCT01662310|26335838|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0|||
13238950|NCT01662310|26335839|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0|||
13238951|NCT01662310|26335835|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4|||
13238952|NCT01662310|26335836|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0|||
13238953|NCT01662310|26335837|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0|||
13238954|NCT01662310|26335838|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0|||
13238955|NCT01662310|26335839|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0|||
13238956|NCT01662310|26335835|FG000|Run-In or Stabilization Phase|Protocol Violation|15|||
13238957|NCT01662310|26335836|FG001|Run-In or Stabilization Phase|Protocol Violation|0|||
13238958|NCT01662310|26335837|FG002|Run-In or Stabilization Phase|Protocol Violation|0|||
13238959|NCT01662310|26335838|FG003|Run-In or Stabilization Phase|Protocol Violation|0|||
13238960|NCT01662310|26335839|FG004|Run-In or Stabilization Phase|Protocol Violation|0|||
13238961|NCT01662310|26335835|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25|||
13238962|NCT01662310|26335836|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
13238963|NCT01662310|26335837|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
13238964|NCT01662310|26335838|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
13238965|NCT01662310|26335839|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
13238966|NCT01662310|26335835|FG000|Run-In or Stabilization Phase|Other|1|||
13238967|NCT01662310|26335836|FG001|Run-In or Stabilization Phase|Other|0|||
13238968|NCT01662310|26335837|FG002|Run-In or Stabilization Phase|Other|0|||
13238969|NCT01662310|26335838|FG003|Run-In or Stabilization Phase|Other|0|||
13238970|NCT01662310|26335839|FG004|Run-In or Stabilization Phase|Other|0|||
13238971|NCT01662310|26335835|FG000|Double-Blind Phase|Adverse Event|0|||
13238972|NCT01662310|26335836|FG001|Double-Blind Phase|Adverse Event|0|||
13238973|NCT01662310|26335837|FG002|Double-Blind Phase|Adverse Event|1|||
13238974|NCT01662310|26335838|FG003|Double-Blind Phase|Adverse Event|0|||
13238975|NCT01662310|26335839|FG004|Double-Blind Phase|Adverse Event|0|||
13238976|NCT01662310|26335835|FG000|Double-Blind Phase|Lost to Follow-up|0|||
13238977|NCT01662310|26335836|FG001|Double-Blind Phase|Lost to Follow-up|3|||
13238978|NCT01662310|26335837|FG002|Double-Blind Phase|Lost to Follow-up|0|||
13238979|NCT01662310|26335838|FG003|Double-Blind Phase|Lost to Follow-up|0|||
13238980|NCT01662310|26335839|FG004|Double-Blind Phase|Lost to Follow-up|0|||
13238981|NCT01662310|26335835|FG000|Double-Blind Phase|Pregnancy|0|||
13238982|NCT01662310|26335836|FG001|Double-Blind Phase|Pregnancy|2|||
13238983|NCT01662310|26335837|FG002|Double-Blind Phase|Pregnancy|0|||
13238984|NCT01662310|26335838|FG003|Double-Blind Phase|Pregnancy|0|||
13238985|NCT01662310|26335839|FG004|Double-Blind Phase|Pregnancy|0|||
13238986|NCT01662310|26335835|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
13238987|NCT01662310|26335836|FG001|Double-Blind Phase|Withdrawal by Subject|9|||
13238988|NCT01662310|26335837|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
13238989|NCT01662310|26335838|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
13238990|NCT01662310|26335839|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
13115624|NCT03093870|25918661|FG000|Overall Study|Clinical disease progression|1|||
13238991|NCT01662310|26335835|FG000|Double-Blind Phase|Other|0|||
13238992|NCT01662310|26335836|FG001|Double-Blind Phase|Other|0|||
13238993|NCT01662310|26335837|FG002|Double-Blind Phase|Other|1|||
13238994|NCT01662310|26335838|FG003|Double-Blind Phase|Other|0|||
13238995|NCT01662310|26335839|FG004|Double-Blind Phase|Other|0|||
13238996|NCT01662310|26335835|FG000|Double-Blind Phase|Randomized but not treated|0|||
13238997|NCT01662310|26335836|FG001|Double-Blind Phase|Randomized but not treated|1|||
13238998|NCT01662310|26335837|FG002|Double-Blind Phase|Randomized but not treated|0|||
13238999|NCT01662310|26335838|FG003|Double-Blind Phase|Randomized but not treated|0|||
13239000|NCT01662310|26335839|FG004|Double-Blind Phase|Randomized but not treated|0|||
13239001|NCT01662310|26335835|FG000|Open-Label Extension Phase|Adverse Event|0|||
13239002|NCT01662310|26335836|FG001|Open-Label Extension Phase|Adverse Event|0|||
13239003|NCT01662310|26335837|FG002|Open-Label Extension Phase|Adverse Event|0|||
13239004|NCT01662310|26335838|FG003|Open-Label Extension Phase|Adverse Event|3|||
13239005|NCT01662310|26335839|FG004|Open-Label Extension Phase|Adverse Event|0|||
13239006|NCT01662310|26335835|FG000|Open-Label Extension Phase|Death|0|||
13239007|NCT01662310|26335836|FG001|Open-Label Extension Phase|Death|0|||
13239008|NCT01662310|26335837|FG002|Open-Label Extension Phase|Death|0|||
13239009|NCT01662310|26335838|FG003|Open-Label Extension Phase|Death|1|||
13239010|NCT01662310|26335839|FG004|Open-Label Extension Phase|Death|0|||
13239011|NCT01662310|26335835|FG000|Open-Label Extension Phase|Lack of Efficacy|0|||
13239012|NCT01662310|26335836|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
13239013|NCT01662310|26335837|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
13239014|NCT01662310|26335838|FG003|Open-Label Extension Phase|Lack of Efficacy|2|||
13239015|NCT01662310|26335839|FG004|Open-Label Extension Phase|Lack of Efficacy|2|||
13239016|NCT01662310|26335835|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
13239017|NCT01662310|26335836|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
13239018|NCT01662310|26335837|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
13239019|NCT01662310|26335838|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
13239020|NCT01662310|26335839|FG004|Open-Label Extension Phase|Lost to Follow-up|1|||
13239021|NCT01662310|26335835|FG000|Open-Label Extension Phase|Pregnancy|0|||
13239022|NCT01662310|26335836|FG001|Open-Label Extension Phase|Pregnancy|0|||
13239023|NCT01662310|26335837|FG002|Open-Label Extension Phase|Pregnancy|0|||
13239024|NCT01662310|26335838|FG003|Open-Label Extension Phase|Pregnancy|1|||
13239025|NCT01662310|26335839|FG004|Open-Label Extension Phase|Pregnancy|0|||
13239026|NCT01662310|26335835|FG000|Open-Label Extension Phase|Withdrawal by Subject|0|||
13239027|NCT01662310|26335836|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
13239028|NCT01662310|26335837|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
13239029|NCT01662310|26335838|FG003|Open-Label Extension Phase|Withdrawal by Subject|2|||
13239030|NCT01662310|26335839|FG004|Open-Label Extension Phase|Withdrawal by Subject|7|||
13239031|NCT01662102|26335878|FG000|Overall Study|Sponsor's decision|1|||
13239032|NCT01662102|26335879|FG001|Overall Study|Sponsor's decision|0|||
13239033|NCT01662063|26335966|FG000|Overall Study|Adverse Event or Intercurrent Illness|1|||
13239034|NCT01662063|26335967|FG001|Overall Study|Adverse Event or Intercurrent Illness|12|||
13239035|NCT01662063|26335968|FG002|Overall Study|Adverse Event or Intercurrent Illness|0|||
13239036|NCT01662063|26335966|FG000|Overall Study|Lack of Efficacy|1|||
13239037|NCT01662063|26335967|FG001|Overall Study|Lack of Efficacy|6|||
13239038|NCT01662063|26335968|FG002|Overall Study|Lack of Efficacy|0|||
13239039|NCT01662063|26335966|FG000|Overall Study|Lost to Follow-up|0|||
13239040|NCT01662063|26335967|FG001|Overall Study|Lost to Follow-up|4|||
13239041|NCT01662063|26335968|FG002|Overall Study|Lost to Follow-up|0|||
13239042|NCT01662063|26335966|FG000|Overall Study|Protocol Violation|1|||
13239043|NCT01662063|26335967|FG001|Overall Study|Protocol Violation|0|||
13239044|NCT01662063|26335968|FG002|Overall Study|Protocol Violation|0|||
13239045|NCT01662063|26335966|FG000|Overall Study|Withdrawal by Subject|2|||
13239046|NCT01662063|26335967|FG001|Overall Study|Withdrawal by Subject|4|||
13239047|NCT01662063|26335968|FG002|Overall Study|Withdrawal by Subject|1|||
13239048|NCT01662063|26335966|FG000|Overall Study|Physician Decision|0|||
13239049|NCT01662063|26335967|FG001|Overall Study|Physician Decision|2|||
13239050|NCT01662063|26335968|FG002|Overall Study|Physician Decision|0|||
13239051|NCT01662063|26335966|FG000|Overall Study|Other|0|||
13239052|NCT01662063|26335967|FG001|Overall Study|Other|1|||
13239053|NCT01662063|26335968|FG002|Overall Study|Other|0|||
13239054|NCT01662024|26335980|FG000|Overall Study|Pregnancy|2|||
13239055|NCT01662024|26335980|FG000|Overall Study|Withdrawal by Subject|3|||
13239056|NCT01661972|26335997|FG000|Overall Study|Adverse Event|1|||
13239057|NCT01661972|26335998|FG001|Overall Study|Adverse Event|2|||
13239058|NCT01661972|26335997|FG000|Overall Study|Death during Treatment period|1|||
13239059|NCT01661972|26335998|FG001|Overall Study|Death during Treatment period|1|||
13239060|NCT01661972|26335997|FG000|Overall Study|Withdrawal by Subject|0|||
13239061|NCT01661972|26335998|FG001|Overall Study|Withdrawal by Subject|1|||
13239062|NCT01661933|26336007|FG000|Low-dose Gluten Challenge|Physician Decision|2|||
13239063|NCT01661933|26336007|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2|||
13239064|NCT01661790|26336020|FG000|Overall Study|Lost to Follow-up|0|||
13239065|NCT01661790|26336021|FG001|Overall Study|Lost to Follow-up|2|||
13239066|NCT01661686|26336042|FG000|Overall Study|Lost to Follow-up|2|||
13239067|NCT01661686|26336043|FG001|Overall Study|Lost to Follow-up|1|||
13239068|NCT01661686|26336042|FG000|Overall Study|did not receive allocated intervention|0|||
13239069|NCT01661686|26336043|FG001|Overall Study|did not receive allocated intervention|1|||
13239070|NCT01661595|26336161|FG000|Phase 1: Week 0-4|Adverse Event|1|||
13239071|NCT01661595|26336162|FG001|Phase 1: Week 0-4|Adverse Event|0|||
13239072|NCT01661595|26336163|FG002|Phase 1: Week 0-4|Adverse Event|0|||
13239073|NCT01661595|26336164|FG003|Phase 1: Week 0-4|Adverse Event|0|||
13239074|NCT01661595|26336161|FG000|Phase 2: Week 5-8.|Protocol Violation|0|||
13239075|NCT01661595|26336162|FG001|Phase 2: Week 5-8.|Protocol Violation|0|||
13239076|NCT01661595|26336163|FG002|Phase 2: Week 5-8.|Protocol Violation|1|||
13239077|NCT01661595|26336164|FG003|Phase 2: Week 5-8.|Protocol Violation|0|||
13239078|NCT01661205|26336177|FG000|Overall Study|Physician Decision|2|||
13239079|NCT01661179|26336183|FG000|Overall Study|Death|1|||
13239080|NCT01661179|26336183|FG000|Overall Study|Withdrawal by Subject|1|||
13239081|NCT01661179|26336183|FG000|Overall Study|Other Eligibility criteria|4|||
13239082|NCT01661140|26336228|FG000|Open-Label Period|Adverse Event|44|||
13239083|NCT01661140|26336229|FG001|Open-Label Period|Adverse Event|0|||
13239084|NCT01661140|26336230|FG002|Open-Label Period|Adverse Event|0|||
13239085|NCT01661140|26336228|FG000|Open-Label Period|Protocol Violation|3|||
13239086|NCT01661140|26336229|FG001|Open-Label Period|Protocol Violation|0|||
13239087|NCT01661140|26336230|FG002|Open-Label Period|Protocol Violation|0|||
13239088|NCT01661140|26336228|FG000|Open-Label Period|Withdrawal by Subject|5|||
13239089|NCT01661140|26336229|FG001|Open-Label Period|Withdrawal by Subject|0|||
13239090|NCT01661140|26336230|FG002|Open-Label Period|Withdrawal by Subject|0|||
13239091|NCT01661140|26336228|FG000|Open-Label Period|Investigator Decision|3|||
13239092|NCT01661140|26336229|FG001|Open-Label Period|Investigator Decision|0|||
13239093|NCT01661140|26336230|FG002|Open-Label Period|Investigator Decision|0|||
13239094|NCT01661140|26336228|FG000|Open-Label Period|Death|1|||
13239095|NCT01661140|26336229|FG001|Open-Label Period|Death|0|||
13239096|NCT01661140|26336230|FG002|Open-Label Period|Death|0|||
13239097|NCT01661140|26336228|FG000|Open-Label Period|Administrative/Other|1|||
13239098|NCT01661140|26336229|FG001|Open-Label Period|Administrative/Other|0|||
13115625|NCT03093870|25918662|FG001|Overall Study|Clinical disease progression|0|||
13115626|NCT03093870|25918663|FG002|Overall Study|Clinical disease progression|0|||
13115627|NCT03093870|25918661|FG000|Overall Study|Physician Decision|2|||
13115628|NCT03093870|25918662|FG001|Overall Study|Physician Decision|0|||
13115629|NCT03093870|25918663|FG002|Overall Study|Physician Decision|0|||
13115630|NCT03093870|25918661|FG000|Overall Study|Adverse Event|7|||
13115631|NCT03093870|25918662|FG001|Overall Study|Adverse Event|0|||
13115632|NCT03093870|25918663|FG002|Overall Study|Adverse Event|0|||
13115633|NCT03093870|25918661|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1|||
13115634|NCT03093870|25918662|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
13115635|NCT03093870|25918663|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
13115636|NCT03093870|25918661|FG000|Overall Study|Lost to Follow-up|0|||
13115637|NCT03093870|25918662|FG001|Overall Study|Lost to Follow-up|0|||
13115638|NCT03093870|25918663|FG002|Overall Study|Lost to Follow-up|1|||
13115639|NCT03093454|25918680|FG000|Overall Study|Withdrawal by Subject|1|||
13115640|NCT03093454|25918681|FG001|Overall Study|Withdrawal by Subject|1|||
13115641|NCT03093454|25918680|FG000|Overall Study|Scheduling conflict|3|||
13115642|NCT03093454|25918681|FG001|Overall Study|Scheduling conflict|1|||
13115643|NCT03093454|25918680|FG000|Overall Study|Physician Decision|2|||
13115644|NCT03093454|25918681|FG001|Overall Study|Physician Decision|1|||
13115645|NCT03093428|25918700|FG000|Overall Study|Not eligible for treatment|2|||
13115646|NCT03093428|25918701|FG001|Overall Study|Not eligible for treatment|1|||
13115647|NCT03093428|25918700|FG000|Overall Study|Progression|14|||
13115648|NCT03093428|25918701|FG001|Overall Study|Progression|4|||
13115649|NCT03093428|25918700|FG000|Overall Study|Death|1|||
13115650|NCT03093428|25918701|FG001|Overall Study|Death|0|||
13239099|NCT01661140|26336230|FG002|Open-Label Period|Administrative/Other|0|||
13239100|NCT01661140|26336228|FG000|Open-Label Period|Sponsor termination|16|||
13239101|NCT01661140|26336229|FG001|Open-Label Period|Sponsor termination|0|||
13239102|NCT01661140|26336230|FG002|Open-Label Period|Sponsor termination|0|||
13239103|NCT01661140|26336228|FG000|Open-Label Period|Did not meet EULAR criteria|1|||
13239104|NCT01661140|26336229|FG001|Open-Label Period|Did not meet EULAR criteria|0|||
13239105|NCT01661140|26336230|FG002|Open-Label Period|Did not meet EULAR criteria|0|||
13239106|NCT01661140|26336228|FG000|Open-Label Period|Lost to Follow-up|2|||
13239107|NCT01661140|26336229|FG001|Open-Label Period|Lost to Follow-up|0|||
13239108|NCT01661140|26336230|FG002|Open-Label Period|Lost to Follow-up|0|||
13239109|NCT01661140|26336228|FG000|Double-Blind Period|Refused Treatment|0|||
13239110|NCT01661140|26336229|FG001|Double-Blind Period|Refused Treatment|0|||
13239111|NCT01661140|26336230|FG002|Double-Blind Period|Refused Treatment|1|||
13239112|NCT01661140|26336228|FG000|Double-Blind Period|Adverse Event|0|||
13239113|NCT01661140|26336229|FG001|Double-Blind Period|Adverse Event|16|||
13239114|NCT01661140|26336230|FG002|Double-Blind Period|Adverse Event|18|||
13239115|NCT01661140|26336228|FG000|Double-Blind Period|Protocol Violation|0|||
13239116|NCT01661140|26336229|FG001|Double-Blind Period|Protocol Violation|2|||
13239117|NCT01661140|26336230|FG002|Double-Blind Period|Protocol Violation|3|||
13239118|NCT01661140|26336228|FG000|Double-Blind Period|Withdrawal by Subject|0|||
13239119|NCT01661140|26336229|FG001|Double-Blind Period|Withdrawal by Subject|1|||
13239120|NCT01661140|26336230|FG002|Double-Blind Period|Withdrawal by Subject|3|||
13239121|NCT01661140|26336228|FG000|Double-Blind Period|Investigator's Decision|0|||
13239122|NCT01661140|26336229|FG001|Double-Blind Period|Investigator's Decision|1|||
13239123|NCT01661140|26336230|FG002|Double-Blind Period|Investigator's Decision|2|||
13239124|NCT01661140|26336228|FG000|Double-Blind Period|Sponsor Termination|0|||
13239125|NCT01661140|26336229|FG001|Double-Blind Period|Sponsor Termination|14|||
13239126|NCT01661140|26336230|FG002|Double-Blind Period|Sponsor Termination|17|||
13239127|NCT01661140|26336228|FG000|Double-Blind Period|Administrative/Other|0|||
13239128|NCT01661140|26336229|FG001|Double-Blind Period|Administrative/Other|7|||
13115651|NCT03093428|25918700|FG000|Overall Study|Adverse Event|1|||
13115652|NCT03093428|25918701|FG001|Overall Study|Adverse Event|0|||
13239129|NCT01661140|26336230|FG002|Double-Blind Period|Administrative/Other|6|||
13239130|NCT01661062|26336237|FG000|Overall Study|Completed Treatment Off Study|3|||
13239131|NCT01661062|26336237|FG000|Overall Study|Withdrawal by Subject|2|||
13239132|NCT01660906|26336248|FG000|Overall Study|Discontinued due to study drug toxicity|3|||
13239133|NCT01660763|26336261|FG000|Overall Study|Lack of Efficacy|45|||
13239134|NCT01660763|26336262|FG001|Overall Study|Lack of Efficacy|50|||
13239135|NCT01660763|26336261|FG000|Overall Study|Adverse Event|22|||
13239136|NCT01660763|26336262|FG001|Overall Study|Adverse Event|7|||
13239137|NCT01660763|26336261|FG000|Overall Study|Protocol Violation|1|||
13239138|NCT01660763|26336262|FG001|Overall Study|Protocol Violation|0|||
13239139|NCT01660763|26336261|FG000|Overall Study|Withdrawal by Subject|4|||
13239140|NCT01660763|26336262|FG001|Overall Study|Withdrawal by Subject|0|||
13239141|NCT01660763|26336261|FG000|Overall Study|Patient ready for early discharge|28|||
13239142|NCT01660763|26336262|FG001|Overall Study|Patient ready for early discharge|4|||
13239143|NCT01660711|26336269|FG000|Overall Study|Adverse Event|7|||
13239144|NCT01660711|26336269|FG000|Overall Study|Withdrawal by Subject|1|||
13239145|NCT01660412|26336278|FG000|Overall Study|Protocol Violation|0|||
13239146|NCT01660412|26336279|FG001|Overall Study|Protocol Violation|3|||
13239147|NCT01660334|26336286|FG000|Overall Study|Lost to Follow-up|1|||
13239148|NCT01660256|26336307|FG000|Overall Study|Adverse Event|4|||
13239149|NCT01660256|26336308|FG001|Overall Study|Adverse Event|0|||
13239150|NCT01660256|26336309|FG002|Overall Study|Adverse Event|2|||
13239151|NCT01660256|26336307|FG000|Overall Study|Withdrawal by Subject|1|||
13239152|NCT01660256|26336308|FG001|Overall Study|Withdrawal by Subject|0|||
13239153|NCT01660256|26336309|FG002|Overall Study|Withdrawal by Subject|2|||
13239154|NCT01660243|26336364|FG000|Overall Study|Adverse Event|1|||
13239155|NCT01660243|26336365|FG001|Overall Study|Adverse Event|0|||
13239156|NCT01660243|26336366|FG002|Overall Study|Adverse Event|1|||
13239157|NCT01660243|26336367|FG003|Overall Study|Adverse Event|0|||
13239158|NCT01660243|26336364|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1|||
13239159|NCT01660243|26336365|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
13239160|NCT01660243|26336366|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
13239161|NCT01660243|26336367|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
13239162|NCT01660243|26336364|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
13239163|NCT01660243|26336365|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
13239164|NCT01660243|26336366|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1|||
13239165|NCT01660243|26336367|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
13239166|NCT01660243|26336364|FG000|Overall Study|Randomization error|0|||
13239167|NCT01660243|26336365|FG001|Overall Study|Randomization error|0|||
13239168|NCT01660243|26336366|FG002|Overall Study|Randomization error|0|||
13239169|NCT01660243|26336367|FG003|Overall Study|Randomization error|1|||
13239170|NCT01660022|26336442|FG000|First Sequence (7 Days)|Withdrawal by Subject|0|||
13239171|NCT01660022|26336443|FG001|First Sequence (7 Days)|Withdrawal by Subject|1|||
13239172|NCT01660022|26336444|FG002|First Sequence (7 Days)|Withdrawal by Subject|0|||
13239173|NCT01660022|26336445|FG003|First Sequence (7 Days)|Withdrawal by Subject|1|||
13239174|NCT01660022|26336446|FG004|First Sequence (7 Days)|Withdrawal by Subject|0|||
13239175|NCT01660022|26336447|FG005|First Sequence (7 Days)|Withdrawal by Subject|0|||
13239176|NCT01660022|26336442|FG000|First Sequence (7 Days)|Adverse Event|0|||
13239177|NCT01660022|26336443|FG001|First Sequence (7 Days)|Adverse Event|0|||
13239178|NCT01660022|26336444|FG002|First Sequence (7 Days)|Adverse Event|0|||
13239179|NCT01660022|26336445|FG003|First Sequence (7 Days)|Adverse Event|0|||
13239180|NCT01660022|26336446|FG004|First Sequence (7 Days)|Adverse Event|1|||
13239181|NCT01660022|26336447|FG005|First Sequence (7 Days)|Adverse Event|3|||
13239182|NCT01660022|26336442|FG000|First Sequence (7 Days)|Protocol Violation|0|||
13239183|NCT01660022|26336443|FG001|First Sequence (7 Days)|Protocol Violation|0|||
13239184|NCT01660022|26336444|FG002|First Sequence (7 Days)|Protocol Violation|0|||
13239185|NCT01660022|26336445|FG003|First Sequence (7 Days)|Protocol Violation|0|||
13239186|NCT01660022|26336446|FG004|First Sequence (7 Days)|Protocol Violation|0|||
13239187|NCT01660022|26336447|FG005|First Sequence (7 Days)|Protocol Violation|1|||
13239188|NCT01659996|26336489|FG000|Overall Study|Protocol Violation|3|||
13239189|NCT01659996|26336490|FG001|Overall Study|Protocol Violation|3|||
13239190|NCT01659996|26336491|FG002|Overall Study|Protocol Violation|3|||
13239191|NCT01659996|26336489|FG000|Overall Study|Lost to Follow-up|1|||
13239192|NCT01659996|26336490|FG001|Overall Study|Lost to Follow-up|3|||
13239193|NCT01659996|26336491|FG002|Overall Study|Lost to Follow-up|2|||
13239194|NCT01659996|26336489|FG000|Overall Study|Adverse Event|0|||
13239195|NCT01659996|26336490|FG001|Overall Study|Adverse Event|0|||
13239196|NCT01659996|26336491|FG002|Overall Study|Adverse Event|1|||
13239197|NCT01659996|26336489|FG000|Overall Study|Withdrawal by Subject|4|||
13239198|NCT01659996|26336490|FG001|Overall Study|Withdrawal by Subject|1|||
13239199|NCT01659996|26336491|FG002|Overall Study|Withdrawal by Subject|5|||
13239200|NCT01659853|26336502|FG000|Washout , 3 to 7 Days|Adverse Event|1|||
13239201|NCT01659853|26336503|FG001|Washout , 3 to 7 Days|Adverse Event|0|||
13239202|NCT01659853|26336502|FG000|Washout , 3 to 7 Days|Protocol Violation|1|||
13239203|NCT01659853|26336503|FG001|Washout , 3 to 7 Days|Protocol Violation|0|||
13239204|NCT01659736|26336524|FG000|Treatment Period|Adverse Event|1|||
13239205|NCT01659736|26336525|FG001|Treatment Period|Adverse Event|1|||
13239206|NCT01659736|26336524|FG000|Treatment Period|Protocol Violation|3|||
13239207|NCT01659736|26336525|FG001|Treatment Period|Protocol Violation|1|||
13239208|NCT01659736|26336524|FG000|Treatment Period|Withdrawal by Subject|1|||
13239209|NCT01659736|26336525|FG001|Treatment Period|Withdrawal by Subject|0|||
13239210|NCT01659736|26336524|FG000|3-month Follow-up|Lost to Follow-up|0|||
13239211|NCT01659736|26336525|FG001|3-month Follow-up|Lost to Follow-up|1|||
13239212|NCT01659567|26336544|FG000|Overall Study|Lack of Efficacy|22|||
13239213|NCT01659567|26336544|FG000|Overall Study|Switched to Pegferon|6|||
13239214|NCT01659567|26336544|FG000|Overall Study|Adverse Event|12|||
13239215|NCT01659567|26336544|FG000|Overall Study|Good result at early stage of treatment|5|||
13239216|NCT01659567|26336544|FG000|Overall Study|Withdrawal by Subject|64|||
13239217|NCT01659567|26336544|FG000|Overall Study|Progression of the main disease|1|||
13239218|NCT01659567|26336544|FG000|Overall Study|Other|13|||
13239219|NCT01659554|26336553|FG000|Overall Study|Study Termination|4|||
13239220|NCT01659320|26336559|FG000|Overall Study|Withdrawal by Subject|2|||
13239221|NCT01659320|26336559|FG000|Overall Study|Physician Decision|1|||
13239222|NCT01659255|26336661|FG000|Overall Study|Adverse Event|0|||
13239223|NCT01659255|26336662|FG001|Overall Study|Adverse Event|0|||
13239224|NCT01659255|26336663|FG002|Overall Study|Adverse Event|0|||
13239225|NCT01659255|26336664|FG003|Overall Study|Adverse Event|0|||
13239226|NCT01659255|26336665|FG004|Overall Study|Adverse Event|0|||
13239227|NCT01659255|26336666|FG005|Overall Study|Adverse Event|1|||
13239228|NCT01659255|26336667|FG006|Overall Study|Adverse Event|1|||
13239229|NCT01659255|26336668|FG007|Overall Study|Adverse Event|0|||
13239230|NCT01659255|26336669|FG008|Overall Study|Adverse Event|0|||
13239231|NCT01659255|26336670|FG009|Overall Study|Adverse Event|1|||
13239232|NCT01659255|26336671|FG010|Overall Study|Adverse Event|0|||
13239233|NCT01659255|26336672|FG011|Overall Study|Adverse Event|1|||
13239234|NCT01659255|26336673|FG012|Overall Study|Adverse Event|0|||
13239235|NCT01659255|26336674|FG013|Overall Study|Adverse Event|2|||
13239236|NCT01659255|26336675|FG014|Overall Study|Adverse Event|0|||
13239237|NCT01659255|26336676|FG015|Overall Study|Adverse Event|1|||
13239238|NCT01659255|26336677|FG016|Overall Study|Adverse Event|0|||
13239239|NCT01659255|26336661|FG000|Overall Study|Death|0|||
13239240|NCT01659255|26336662|FG001|Overall Study|Death|1|||
13239241|NCT01659255|26336663|FG002|Overall Study|Death|0|||
13239242|NCT01659255|26336664|FG003|Overall Study|Death|0|||
13239243|NCT01659255|26336665|FG004|Overall Study|Death|0|||
13239244|NCT01659255|26336666|FG005|Overall Study|Death|0|||
13239245|NCT01659255|26336667|FG006|Overall Study|Death|0|||
13239246|NCT01659255|26336668|FG007|Overall Study|Death|1|||
13239247|NCT01659255|26336669|FG008|Overall Study|Death|1|||
13239248|NCT01659255|26336670|FG009|Overall Study|Death|0|||
13239249|NCT01659255|26336671|FG010|Overall Study|Death|0|||
13239250|NCT01659255|26336672|FG011|Overall Study|Death|0|||
13239251|NCT01659255|26336673|FG012|Overall Study|Death|1|||
13239252|NCT01659255|26336674|FG013|Overall Study|Death|1|||
13239253|NCT01659255|26336675|FG014|Overall Study|Death|2|||
13239254|NCT01659255|26336676|FG015|Overall Study|Death|1|||
13239255|NCT01659255|26336677|FG016|Overall Study|Death|0|||
13239256|NCT01659255|26336661|FG000|Overall Study|Progressive Disease|2|||
13239257|NCT01659255|26336662|FG001|Overall Study|Progressive Disease|0|||
13239258|NCT01659255|26336663|FG002|Overall Study|Progressive Disease|0|||
13239259|NCT01659255|26336664|FG003|Overall Study|Progressive Disease|0|||
13239260|NCT01659255|26336665|FG004|Overall Study|Progressive Disease|0|||
13239261|NCT01659255|26336666|FG005|Overall Study|Progressive Disease|0|||
13239262|NCT01659255|26336667|FG006|Overall Study|Progressive Disease|0|||
13239263|NCT01659255|26336668|FG007|Overall Study|Progressive Disease|1|||
13239264|NCT01659255|26336669|FG008|Overall Study|Progressive Disease|0|||
13239265|NCT01659255|26336670|FG009|Overall Study|Progressive Disease|2|||
13239266|NCT01659255|26336671|FG010|Overall Study|Progressive Disease|2|||
13239267|NCT01659255|26336672|FG011|Overall Study|Progressive Disease|3|||
13239268|NCT01659255|26336673|FG012|Overall Study|Progressive Disease|5|||
13239269|NCT01659255|26336674|FG013|Overall Study|Progressive Disease|13|||
13239270|NCT01659255|26336675|FG014|Overall Study|Progressive Disease|6|||
13239271|NCT01659255|26336676|FG015|Overall Study|Progressive Disease|2|||
13239272|NCT01659255|26336677|FG016|Overall Study|Progressive Disease|3|||
13239273|NCT01659255|26336661|FG000|Overall Study|Withdrew Consent|0|||
13239274|NCT01659255|26336662|FG001|Overall Study|Withdrew Consent|0|||
13239275|NCT01659255|26336663|FG002|Overall Study|Withdrew Consent|0|||
13239276|NCT01659255|26336664|FG003|Overall Study|Withdrew Consent|0|||
13239277|NCT01659255|26336665|FG004|Overall Study|Withdrew Consent|0|||
13239278|NCT01659255|26336666|FG005|Overall Study|Withdrew Consent|0|||
13239279|NCT01659255|26336667|FG006|Overall Study|Withdrew Consent|0|||
13239280|NCT01659255|26336668|FG007|Overall Study|Withdrew Consent|0|||
13239281|NCT01659255|26336669|FG008|Overall Study|Withdrew Consent|0|||
13239282|NCT01659255|26336670|FG009|Overall Study|Withdrew Consent|0|||
13239283|NCT01659255|26336671|FG010|Overall Study|Withdrew Consent|1|||
13239284|NCT01659255|26336672|FG011|Overall Study|Withdrew Consent|0|||
13239285|NCT01659255|26336673|FG012|Overall Study|Withdrew Consent|0|||
13239286|NCT01659255|26336674|FG013|Overall Study|Withdrew Consent|1|||
13239287|NCT01659255|26336675|FG014|Overall Study|Withdrew Consent|0|||
13239288|NCT01659255|26336676|FG015|Overall Study|Withdrew Consent|0|||
13239289|NCT01659255|26336677|FG016|Overall Study|Withdrew Consent|0|||
13239290|NCT01659255|26336661|FG000|Overall Study|Investigator Decision|0|||
13239291|NCT01659255|26336662|FG001|Overall Study|Investigator Decision|0|||
13239292|NCT01659255|26336663|FG002|Overall Study|Investigator Decision|0|||
13239293|NCT01659255|26336664|FG003|Overall Study|Investigator Decision|0|||
13239294|NCT01659255|26336665|FG004|Overall Study|Investigator Decision|0|||
13239295|NCT01659255|26336666|FG005|Overall Study|Investigator Decision|0|||
13239296|NCT01659255|26336667|FG006|Overall Study|Investigator Decision|0|||
13239297|NCT01659255|26336668|FG007|Overall Study|Investigator Decision|0|||
13239298|NCT01659255|26336669|FG008|Overall Study|Investigator Decision|0|||
13239299|NCT01659255|26336670|FG009|Overall Study|Investigator Decision|0|||
13239300|NCT01659255|26336671|FG010|Overall Study|Investigator Decision|0|||
13239301|NCT01659255|26336672|FG011|Overall Study|Investigator Decision|0|||
13239302|NCT01659255|26336673|FG012|Overall Study|Investigator Decision|1|||
13239303|NCT01659255|26336674|FG013|Overall Study|Investigator Decision|1|||
13239304|NCT01659255|26336675|FG014|Overall Study|Investigator Decision|0|||
13239305|NCT01659255|26336676|FG015|Overall Study|Investigator Decision|0|||
13239306|NCT01659255|26336677|FG016|Overall Study|Investigator Decision|0|||
13239307|NCT01659255|26336661|FG000|Overall Study|Sponsor's Decision|0|||
13239308|NCT01659255|26336662|FG001|Overall Study|Sponsor's Decision|0|||
13239309|NCT01659255|26336663|FG002|Overall Study|Sponsor's Decision|0|||
13239310|NCT01659255|26336664|FG003|Overall Study|Sponsor's Decision|0|||
13239311|NCT01659255|26336665|FG004|Overall Study|Sponsor's Decision|0|||
13239312|NCT01659255|26336666|FG005|Overall Study|Sponsor's Decision|0|||
13239313|NCT01659255|26336667|FG006|Overall Study|Sponsor's Decision|1|||
13239314|NCT01659255|26336668|FG007|Overall Study|Sponsor's Decision|0|||
13239315|NCT01659255|26336669|FG008|Overall Study|Sponsor's Decision|0|||
13239316|NCT01659255|26336670|FG009|Overall Study|Sponsor's Decision|0|||
13239317|NCT01659255|26336671|FG010|Overall Study|Sponsor's Decision|0|||
13239318|NCT01659255|26336672|FG011|Overall Study|Sponsor's Decision|0|||
13239319|NCT01659255|26336673|FG012|Overall Study|Sponsor's Decision|0|||
13239320|NCT01659255|26336674|FG013|Overall Study|Sponsor's Decision|0|||
13239321|NCT01659255|26336675|FG014|Overall Study|Sponsor's Decision|0|||
13239322|NCT01659255|26336676|FG015|Overall Study|Sponsor's Decision|0|||
13239323|NCT01659255|26336677|FG016|Overall Study|Sponsor's Decision|0|||
13239324|NCT01659255|26336661|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0|||
13239325|NCT01659255|26336662|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0|||
13239326|NCT01659255|26336663|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0|||
13239327|NCT01659255|26336664|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0|||
13239328|NCT01659255|26336665|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0|||
13239329|NCT01659255|26336666|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0|||
13239330|NCT01659255|26336667|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0|||
13239331|NCT01659255|26336668|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0|||
13239332|NCT01659255|26336669|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0|||
13239333|NCT01659255|26336670|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0|||
13239334|NCT01659255|26336671|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0|||
13239335|NCT01659255|26336672|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0|||
13239336|NCT01659255|26336673|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0|||
13239337|NCT01659255|26336674|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0|||
13239338|NCT01659255|26336675|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0|||
13239339|NCT01659255|26336676|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1|||
13239340|NCT01659255|26336677|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0|||
13239341|NCT01659255|26336661|FG000|Overall Study|Participant Went on to Have an Allograft|0|||
13239342|NCT01659255|26336662|FG001|Overall Study|Participant Went on to Have an Allograft|0|||
13239343|NCT01659255|26336663|FG002|Overall Study|Participant Went on to Have an Allograft|0|||
13239344|NCT01659255|26336664|FG003|Overall Study|Participant Went on to Have an Allograft|0|||
13239345|NCT01659255|26336665|FG004|Overall Study|Participant Went on to Have an Allograft|0|||
13239346|NCT01659255|26336666|FG005|Overall Study|Participant Went on to Have an Allograft|0|||
13239347|NCT01659255|26336667|FG006|Overall Study|Participant Went on to Have an Allograft|0|||
13239348|NCT01659255|26336668|FG007|Overall Study|Participant Went on to Have an Allograft|0|||
13239349|NCT01659255|26336669|FG008|Overall Study|Participant Went on to Have an Allograft|0|||
13239350|NCT01659255|26336670|FG009|Overall Study|Participant Went on to Have an Allograft|0|||
13239351|NCT01659255|26336671|FG010|Overall Study|Participant Went on to Have an Allograft|0|||
13239352|NCT01659255|26336672|FG011|Overall Study|Participant Went on to Have an Allograft|0|||
13239353|NCT01659255|26336673|FG012|Overall Study|Participant Went on to Have an Allograft|1|||
13239354|NCT01659255|26336674|FG013|Overall Study|Participant Went on to Have an Allograft|0|||
13239355|NCT01659255|26336675|FG014|Overall Study|Participant Went on to Have an Allograft|0|||
13239356|NCT01659255|26336676|FG015|Overall Study|Participant Went on to Have an Allograft|0|||
13239357|NCT01659255|26336677|FG016|Overall Study|Participant Went on to Have an Allograft|0|||
13239358|NCT01659151|26336685|FG000|Overall Study|Inadequate TIL growth|1|||
13239359|NCT01659125|26336692|FG000|Overall Study|Withdrawal by Subject|2|||
13239360|NCT01659125|26336692|FG000|Overall Study|Lost to Follow-up|7|||
13239361|NCT01659125|26336692|FG000|Overall Study|Technical Problem|1|||
13239362|NCT01659125|26336692|FG000|Overall Study|Time Constraints|2|||
13239363|NCT01659125|26336692|FG000|Overall Study|Failed to Start Treatment|2|||
13239364|NCT01659021|26336715|FG000|Main Study|Adverse Event|2|||
13239365|NCT01659021|26336716|FG001|Main Study|Adverse Event|3|||
13239366|NCT01659021|26336715|FG000|Main Study|Lost to Follow-up|1|||
13239367|NCT01659021|26336716|FG001|Main Study|Lost to Follow-up|0|||
13239368|NCT01659021|26336715|FG000|Main Study|Unknown Reasons|2|||
13239369|NCT01659021|26336716|FG001|Main Study|Unknown Reasons|1|||
13239370|NCT01659021|26336715|FG000|Main Study|Physician Decision|34|||
13239371|NCT01659021|26336716|FG001|Main Study|Physician Decision|16|||
13239372|NCT01659021|26336715|FG000|Main Study|Withdrawal by Subject|19|||
13239373|NCT01659021|26336716|FG001|Main Study|Withdrawal by Subject|16|||
13239374|NCT01659021|26336715|FG000|Main Study|Study Terminated by Sponsor|16|||
13239375|NCT01659021|26336716|FG001|Main Study|Study Terminated by Sponsor|1|||
13239376|NCT01659021|26336715|FG000|Long-Term Follow Up|Lost to Follow-up|3|||
13239377|NCT01659021|26336716|FG001|Long-Term Follow Up|Lost to Follow-up|3|||
13239378|NCT01659021|26336715|FG000|Long-Term Follow Up|Withdrawal by Subject|2|||
13239379|NCT01659021|26336716|FG001|Long-Term Follow Up|Withdrawal by Subject|1|||
13239380|NCT01658943|26336735|FG000|Overall Study|Adverse Event|6|||
13239381|NCT01658943|26336736|FG001|Overall Study|Adverse Event|13|||
13239382|NCT01658943|26336735|FG000|Overall Study|Withdrawal by Subject|9|||
13239383|NCT01658943|26336736|FG001|Overall Study|Withdrawal by Subject|2|||
13239384|NCT01658943|26336735|FG000|Overall Study|Progression/Relapse|39|||
13239385|NCT01658943|26336736|FG001|Overall Study|Progression/Relapse|40|||
13239386|NCT01658943|26336735|FG000|Overall Study|Death|4|||
13239387|NCT01658943|26336736|FG001|Overall Study|Death|2|||
13239388|NCT01658943|26336735|FG000|Overall Study|not protocol specified|4|||
13239389|NCT01658943|26336736|FG001|Overall Study|not protocol specified|1|||
13239390|NCT01658943|26336735|FG000|Overall Study|Not eligible|7|||
13239391|NCT01658943|26336736|FG001|Overall Study|Not eligible|9|||
13239392|NCT01658943|26336735|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1|||
13239393|NCT01658943|26336736|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0|||
13239394|NCT01658904|26336763|FG000|Overall Study|Principal Investigator discretion|2|||
13239395|NCT01658904|26336764|FG001|Overall Study|Principal Investigator discretion|0|||
13239396|NCT01658904|26336765|FG002|Overall Study|Principal Investigator discretion|0|||
13239397|NCT01658813|26336775|FG000|Overall Study|Disease progression|3|||
13239398|NCT01658735|26336814|FG000|Overall Study|Lack of Efficacy|1|||
13239399|NCT01658735|26336815|FG001|Overall Study|Lack of Efficacy|0|||
13239400|NCT01658735|26336816|FG002|Overall Study|Lack of Efficacy|1|||
13239401|NCT01658735|26336814|FG000|Overall Study|Lost to Follow-up|1|||
13239402|NCT01658735|26336815|FG001|Overall Study|Lost to Follow-up|1|||
13239403|NCT01658735|26336816|FG002|Overall Study|Lost to Follow-up|0|||
13239404|NCT01658735|26336814|FG000|Overall Study|Protocol Violation|0|||
13239405|NCT01658735|26336815|FG001|Overall Study|Protocol Violation|1|||
13239406|NCT01658735|26336816|FG002|Overall Study|Protocol Violation|0|||
13239407|NCT01658735|26336814|FG000|Overall Study|Withdrawal by Subject|3|||
13239408|NCT01658735|26336815|FG001|Overall Study|Withdrawal by Subject|5|||
13239409|NCT01658735|26336816|FG002|Overall Study|Withdrawal by Subject|3|||
13239410|NCT01658579|26336853|FG000|Treatment Period A|Other|0|||
13239411|NCT01658579|26336854|FG001|Treatment Period A|Other|0|||
13239412|NCT01658579|26336855|FG002|Treatment Period A|Other|1|||
13239413|NCT01658579|26336856|FG003|Treatment Period A|Other|1|||
13239414|NCT01658579|26336853|FG000|Treatment Period A|Adverse Event|1|||
13239415|NCT01658579|26336854|FG001|Treatment Period A|Adverse Event|0|||
13239416|NCT01658579|26336855|FG002|Treatment Period A|Adverse Event|0|||
13239417|NCT01658579|26336856|FG003|Treatment Period A|Adverse Event|0|||
13239418|NCT01658579|26336853|FG000|Treatment Period B|Other|0|||
13239419|NCT01658579|26336854|FG001|Treatment Period B|Other|0|||
13239420|NCT01658579|26336855|FG002|Treatment Period B|Other|0|||
13239421|NCT01658579|26336856|FG003|Treatment Period B|Other|1|||
13239422|NCT01658514|26336879|FG000|Overall Study|Protocol Violation|1|||
13239423|NCT01658514|26336880|FG001|Overall Study|Protocol Violation|0|||
13239424|NCT01658514|26336881|FG002|Overall Study|Protocol Violation|2|||
13239425|NCT01658436|26336891|FG000|Overall Study|Adverse Event|6|||
13239426|NCT01658436|26336892|FG001|Overall Study|Adverse Event|5|||
13239427|NCT01658436|26336891|FG000|Overall Study|Physician Decision|1|||
13239428|NCT01658436|26336892|FG001|Overall Study|Physician Decision|0|||
13239429|NCT01658436|26336891|FG000|Overall Study|Progressive disease|12|||
13239430|NCT01658436|26336892|FG001|Overall Study|Progressive disease|4|||
13239431|NCT01658436|26336891|FG000|Overall Study|Study terminated by sponsor|0|||
13239432|NCT01658436|26336892|FG001|Overall Study|Study terminated by sponsor|1|||
13239433|NCT01658436|26336891|FG000|Overall Study|Subject/guardian decision|0|||
13239434|NCT01658436|26336892|FG001|Overall Study|Subject/guardian decision|1|||
13239435|NCT01658436|26336891|FG000|Overall Study|Death|1|||
13239436|NCT01658436|26336892|FG001|Overall Study|Death|0|||
13239437|NCT01658150|26336914|FG000|Overall Study|Withdrawal by Subject|1|||
13239438|NCT01658072|26336927|FG000|Overall Study|Protocol Violation|4|||
13239439|NCT01658072|26336928|FG001|Overall Study|Protocol Violation|2|||
13239440|NCT01658020|26336951|FG000|Overall Study|Adverse Event|3|||
13239441|NCT01658020|26336952|FG001|Overall Study|Adverse Event|3|||
13239442|NCT01658020|26336951|FG000|Overall Study|Lost to Follow-up|1|||
13239443|NCT01658020|26336952|FG001|Overall Study|Lost to Follow-up|0|||
13239444|NCT01658020|26336951|FG000|Overall Study|Withdrawal by Subject|4|||
13239445|NCT01658020|26336952|FG001|Overall Study|Withdrawal by Subject|5|||
13239446|NCT01658020|26336951|FG000|Overall Study|Protocol Violation|0|||
13239447|NCT01658020|26336952|FG001|Overall Study|Protocol Violation|1|||
13239448|NCT01657903|26336976|FG000|Overall Study|Lost to Follow-up|1|||
13239449|NCT01657903|26336976|FG000|Overall Study|Withdrawal by Subject|1|||
13239450|NCT01657877|26336995|FG000|Overall Study|Withdrawal by Subject|4|||
13239451|NCT01657877|26336995|FG000|Overall Study|Protocol Violation|6|||
13239452|NCT01657877|26336995|FG000|Overall Study|Adverse Event|2|||
13239453|NCT01657877|26336995|FG000|Overall Study|Other Reason|2|||
13239454|NCT01657799|26337022|FG000|Overall Study|Adverse Event Related to progression|6|||
13239455|NCT01657799|26337023|FG001|Overall Study|Adverse Event Related to progression|8|||
13239456|NCT01657799|26337024|FG002|Overall Study|Adverse Event Related to progression|12|||
13239457|NCT01657799|26337022|FG000|Overall Study|Adverse Event Not Related to Progression|5|||
13239458|NCT01657799|26337023|FG001|Overall Study|Adverse Event Not Related to Progression|4|||
13239459|NCT01657799|26337024|FG002|Overall Study|Adverse Event Not Related to Progression|4|||
13239460|NCT01657799|26337022|FG000|Overall Study|Withdrawal by Subject|13|||
13239461|NCT01657799|26337023|FG001|Overall Study|Withdrawal by Subject|10|||
13239462|NCT01657799|26337024|FG002|Overall Study|Withdrawal by Subject|10|||
13239463|NCT01657799|26337022|FG000|Overall Study|Lost to Follow-up|1|||
13239464|NCT01657799|26337023|FG001|Overall Study|Lost to Follow-up|0|||
13239465|NCT01657799|26337024|FG002|Overall Study|Lost to Follow-up|1|||
13239466|NCT01657799|26337022|FG000|Overall Study|Disease Progression|2|||
13239467|NCT01657799|26337023|FG001|Overall Study|Disease Progression|4|||
13239468|NCT01657799|26337024|FG002|Overall Study|Disease Progression|4|||
13239469|NCT01657799|26337022|FG000|Overall Study|Progressive Disease Clinical|7|||
13239470|NCT01657799|26337023|FG001|Overall Study|Progressive Disease Clinical|4|||
13239471|NCT01657799|26337024|FG002|Overall Study|Progressive Disease Clinical|7|||
13239472|NCT01657799|26337022|FG000|Overall Study|Radiographic & Clinical Progression|16|||
13239473|NCT01657799|26337023|FG001|Overall Study|Radiographic & Clinical Progression|11|||
13239474|NCT01657799|26337024|FG002|Overall Study|Radiographic & Clinical Progression|15|||
13239475|NCT01657799|26337022|FG000|Overall Study|Other|52|||
13239476|NCT01657799|26337023|FG001|Overall Study|Other|62|||
13239477|NCT01657799|26337024|FG002|Overall Study|Other|49|||
13239478|NCT01657760|26337045|FG000|Overall Study|Withdrawal by Subject|0|||
13239479|NCT01657760|26337046|FG001|Overall Study|Withdrawal by Subject|0|||
13239480|NCT01657760|26337047|FG002|Overall Study|Withdrawal by Subject|0|||
13239481|NCT01657760|26337048|FG003|Overall Study|Withdrawal by Subject|1|||
13239482|NCT01657760|26337045|FG000|Overall Study|Physician Decision|1|||
13239483|NCT01657760|26337046|FG001|Overall Study|Physician Decision|1|||
13239484|NCT01657760|26337047|FG002|Overall Study|Physician Decision|1|||
13239485|NCT01657760|26337048|FG003|Overall Study|Physician Decision|2|||
13239486|NCT01657500|26337061|FG000|Overall Study|set impropperly matched|3|||
13239487|NCT01657500|26337062|FG001|Overall Study|set impropperly matched|3|||
13239488|NCT01657500|26337061|FG000|Overall Study|Lost to Follow-up|2|||
13239489|NCT01657500|26337062|FG001|Overall Study|Lost to Follow-up|2|||
13239490|NCT01657461|26337093|FG000|Overall Study|Death|9|||
13239491|NCT01657461|26337094|FG001|Overall Study|Death|12|||
13239492|NCT01657461|26337093|FG000|Overall Study|Lost to Follow-up|0|||
13239493|NCT01657461|26337094|FG001|Overall Study|Lost to Follow-up|3|||
13239494|NCT01657461|26337093|FG000|Overall Study|Physician Decision|0|||
13239495|NCT01657461|26337094|FG001|Overall Study|Physician Decision|2|||
13239496|NCT01657461|26337093|FG000|Overall Study|Withdrawal by Subject|1|||
13239497|NCT01657461|26337094|FG001|Overall Study|Withdrawal by Subject|3|||
13239498|NCT01657370|26337195|FG000|Overall Study|Withdrawal by Subject|0|||
13239499|NCT01657370|26337196|FG001|Overall Study|Withdrawal by Subject|0|||
13239500|NCT01657370|26337197|FG002|Overall Study|Withdrawal by Subject|1|||
13239501|NCT01657370|26337198|FG003|Overall Study|Withdrawal by Subject|0|||
13239502|NCT01657370|26337199|FG004|Overall Study|Withdrawal by Subject|0|||
13239503|NCT01657370|26337200|FG005|Overall Study|Withdrawal by Subject|1|||
13239504|NCT01657370|26337195|FG000|Overall Study|Physician Decision|2|||
13239505|NCT01657370|26337196|FG001|Overall Study|Physician Decision|3|||
13239506|NCT01657370|26337197|FG002|Overall Study|Physician Decision|1|||
13239507|NCT01657370|26337198|FG003|Overall Study|Physician Decision|2|||
13239508|NCT01657370|26337199|FG004|Overall Study|Physician Decision|5|||
13239509|NCT01657370|26337200|FG005|Overall Study|Physician Decision|0|||
13239510|NCT01657370|26337195|FG000|Overall Study|Lack of Qualifying Event|1|||
13239511|NCT01657370|26337196|FG001|Overall Study|Lack of Qualifying Event|0|||
13239512|NCT01657370|26337197|FG002|Overall Study|Lack of Qualifying Event|3|||
13239513|NCT01657370|26337198|FG003|Overall Study|Lack of Qualifying Event|2|||
13239514|NCT01657370|26337199|FG004|Overall Study|Lack of Qualifying Event|1|||
13239515|NCT01657370|26337200|FG005|Overall Study|Lack of Qualifying Event|2|||
13239516|NCT01657370|26337195|FG000|Overall Study|Adverse Event|0|||
13239517|NCT01657370|26337196|FG001|Overall Study|Adverse Event|0|||
13239518|NCT01657370|26337197|FG002|Overall Study|Adverse Event|0|||
13239519|NCT01657370|26337198|FG003|Overall Study|Adverse Event|0|||
13239520|NCT01657370|26337199|FG004|Overall Study|Adverse Event|1|||
13239521|NCT01657370|26337200|FG005|Overall Study|Adverse Event|0|||
13239522|NCT01657370|26337195|FG000|Overall Study|Protocol Violation|1|||
13239523|NCT01657370|26337196|FG001|Overall Study|Protocol Violation|1|||
13239524|NCT01657370|26337197|FG002|Overall Study|Protocol Violation|1|||
13239525|NCT01657370|26337198|FG003|Overall Study|Protocol Violation|1|||
13239526|NCT01657370|26337199|FG004|Overall Study|Protocol Violation|0|||
13239527|NCT01657370|26337200|FG005|Overall Study|Protocol Violation|0|||
13239528|NCT01657370|26337195|FG000|Overall Study|Lost to Follow-up|2|||
13239529|NCT01657370|26337196|FG001|Overall Study|Lost to Follow-up|0|||
13239530|NCT01657370|26337197|FG002|Overall Study|Lost to Follow-up|1|||
13239531|NCT01657370|26337198|FG003|Overall Study|Lost to Follow-up|0|||
13239532|NCT01657370|26337199|FG004|Overall Study|Lost to Follow-up|0|||
13239533|NCT01657370|26337200|FG005|Overall Study|Lost to Follow-up|1|||
13239534|NCT01657305|26337252|FG000|Overall Study|Lack of Wound Closure at Day 28|15|||
13239535|NCT01657305|26337252|FG000|Overall Study|Withdrawal by Subject|4|||
13239536|NCT01657305|26337252|FG000|Overall Study|Adverse Event|1|||
13239537|NCT01657305|26337252|FG000|Overall Study|Lost to Follow-up|1|||
13239538|NCT01657305|26337252|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4|||
13239539|NCT01657292|26337261|FG000|Overall Study|Adverse Event|6|||
13239540|NCT01657292|26337261|FG000|Overall Study|Withdrawal by Subject|2|||
13239541|NCT01657292|26337261|FG000|Overall Study|Violation of eligibility criteria|1|||
13239542|NCT01657292|26337261|FG000|Overall Study|Change of therapy|1|||
13115653|NCT03093428|25918700|FG000|Overall Study|Withdrawal by Subject|1|||
13115654|NCT03093428|25918701|FG001|Overall Study|Withdrawal by Subject|1|||
13115655|NCT03093415|25918734|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17|||
13115656|NCT03093415|25918735|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36|||
13115657|NCT03093415|25918736|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0|||
13115658|NCT03093415|25918734|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40|||
13115659|NCT03093415|25918735|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
13115660|NCT03093415|25918736|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
13115661|NCT03093415|25918734|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28|||
13115662|NCT03093415|25918735|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6|||
13115663|NCT03093415|25918736|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0|||
13115664|NCT03093415|25918734|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
13115665|NCT03093415|25918735|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12|||
13115666|NCT03093415|25918736|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
13115667|NCT03093415|25918734|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18|||
13115668|NCT03093415|25918735|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12|||
13115669|NCT03093415|25918736|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0|||
13115670|NCT03093415|25918734|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
13115671|NCT03093415|25918735|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
13115672|NCT03093415|25918736|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0|||
13115673|NCT03093415|25918734|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15|||
13115674|NCT03093415|25918735|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32|||
13115675|NCT03093415|25918736|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0|||
13115676|NCT03093415|25918734|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5|||
13115677|NCT03093415|25918735|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3|||
13115678|NCT03093415|25918736|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0|||
13115679|NCT03093415|25918734|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4|||
13115680|NCT03093415|25918735|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2|||
13115681|NCT03093415|25918736|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0|||
13115682|NCT03093415|25918734|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9|||
13115683|NCT03093415|25918735|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3|||
13239543|NCT01657266|26337288|FG000|Overall Study|Lost to Follow-up|2|||
13239544|NCT01657266|26337289|FG001|Overall Study|Lost to Follow-up|2|||
13239545|NCT01657266|26337288|FG000|Overall Study|Adverse Event|2|||
13239546|NCT01657266|26337289|FG001|Overall Study|Adverse Event|3|||
13239547|NCT01657253|26337306|FG000|Overall Study|Lost to Follow-up|6|||
13239548|NCT01657253|26337307|FG001|Overall Study|Lost to Follow-up|5|||
13239549|NCT01657253|26337306|FG000|Overall Study|Withdrawal by Subject|11|||
13239550|NCT01657253|26337307|FG001|Overall Study|Withdrawal by Subject|12|||
13239551|NCT01657253|26337306|FG000|Overall Study|Adverse Event|0|||
13239552|NCT01657253|26337307|FG001|Overall Study|Adverse Event|1|||
13239553|NCT01657162|26337340|FG000|Overall Study|Adverse Event|26|||
13239554|NCT01657162|26337341|FG001|Overall Study|Adverse Event|36|||
13239555|NCT01657162|26337340|FG000|Overall Study|Withdrawal by Subject|13|||
13239556|NCT01657162|26337341|FG001|Overall Study|Withdrawal by Subject|13|||
13239557|NCT01657162|26337340|FG000|Overall Study|Continuing Significant Deterioration|9|||
13239558|NCT01657162|26337341|FG001|Overall Study|Continuing Significant Deterioration|3|||
13239559|NCT01657162|26337340|FG000|Overall Study|Refusal of Treatment|4|||
13239560|NCT01657162|26337341|FG001|Overall Study|Refusal of Treatment|6|||
13239561|NCT01657162|26337340|FG000|Overall Study|Lost to Follow-up|3|||
13239562|NCT01657162|26337341|FG001|Overall Study|Lost to Follow-up|4|||
13239563|NCT01657162|26337340|FG000|Overall Study|Death|2|||
13239564|NCT01657162|26337341|FG001|Overall Study|Death|3|||
13239565|NCT01657162|26337340|FG000|Overall Study|Inability to Complete Study Procedures|1|||
13239566|NCT01657162|26337341|FG001|Overall Study|Inability to Complete Study Procedures|7|||
13239567|NCT01657162|26337340|FG000|Overall Study|Protocol Violation|1|||
13239568|NCT01657162|26337341|FG001|Overall Study|Protocol Violation|0|||
13239569|NCT01657162|26337340|FG000|Overall Study|Hypersensitivity to Alendronate|0|||
13239570|NCT01657162|26337341|FG001|Overall Study|Hypersensitivity to Alendronate|1|||
13239571|NCT01657162|26337340|FG000|Overall Study|Other than Specified|0|||
13239572|NCT01657162|26337341|FG001|Overall Study|Other than Specified|2|||
13239573|NCT01657032|26337374|FG000|Overall Study|Lost to Follow-up|0|||
13239574|NCT01657032|26337375|FG001|Overall Study|Lost to Follow-up|7|||
13239575|NCT01657019|26337389|FG000|Overall Study|Withdrawal by Subject|65|||
13239576|NCT01657019|26337389|FG000|Overall Study|Adverse Event|55|||
13239577|NCT01657019|26337389|FG000|Overall Study|Lost to Follow-up|48|||
13239578|NCT01657019|26337389|FG000|Overall Study|Protocol Violation|6|||
13239579|NCT01657019|26337389|FG000|Overall Study|Lack of Efficacy|3|||
13115684|NCT03093415|25918736|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0|||
13239580|NCT01657019|26337389|FG000|Overall Study|Other|58|||
13239581|NCT01656967|26337420|FG000|Overall Study|faulty monitor|1|||
13239582|NCT01656967|26337421|FG001|Overall Study|faulty monitor|0|||
13239583|NCT01656967|26337420|FG000|Overall Study|unsuccessful ETT insertion|3|||
13239584|NCT01656967|26337421|FG001|Overall Study|unsuccessful ETT insertion|2|||
13239585|NCT01656889|26337446|FG000|Treatment Period, 12 Weeks|Adverse Event|10|||
13115685|NCT03093415|25918734|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1|||
13239586|NCT01656889|26337447|FG001|Treatment Period, 12 Weeks|Adverse Event|4|||
13239587|NCT01656889|26337446|FG000|Treatment Period, 12 Weeks|Death|0|||
13239588|NCT01656889|26337447|FG001|Treatment Period, 12 Weeks|Death|1|||
13239589|NCT01656889|26337446|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
13239590|NCT01656889|26337447|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
13239591|NCT01656889|26337446|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1|||
13239592|NCT01656889|26337447|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2|||
13239593|NCT01656889|26337446|FG000|Treatment Period, 12 Weeks|Protocol Violation|0|||
13239594|NCT01656889|26337447|FG001|Treatment Period, 12 Weeks|Protocol Violation|1|||
13239595|NCT01656889|26337446|FG000|Treatment Period, 12 Weeks|Moved out of the area|0|||
13239596|NCT01656889|26337447|FG001|Treatment Period, 12 Weeks|Moved out of the area|2|||
13239597|NCT01656889|26337446|FG000|Post Treatment Follow-Up, 3 Months|Death|1|||
13239598|NCT01656889|26337447|FG001|Post Treatment Follow-Up, 3 Months|Death|5|||
13239599|NCT01656889|26337446|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1|||
13239600|NCT01656889|26337447|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2|||
13239601|NCT01656889|26337446|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2|||
13239602|NCT01656889|26337447|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1|||
13239603|NCT01656889|26337446|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0|||
13239604|NCT01656889|26337447|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1|||
13239605|NCT01656850|26337532|FG000|First Intervention (3 Months)|Withdrawal by Subject|3|||
13239606|NCT01656850|26337533|FG001|First Intervention (3 Months)|Withdrawal by Subject|4|||
13239607|NCT01656759|26337552|FG000|Overall Study|Protocol Violation|2|||
13239608|NCT01656759|26337553|FG001|Overall Study|Protocol Violation|3|||
13239609|NCT01656733|26337572|FG000|Overall Study|No permission to collect birth outcomes|0|||
13239610|NCT01656733|26337573|FG001|Overall Study|No permission to collect birth outcomes|1|||
13239611|NCT01656733|26337572|FG000|Overall Study|Delivery at another hospital|0|||
13239612|NCT01656733|26337573|FG001|Overall Study|Delivery at another hospital|2|||
13239613|NCT01656733|26337572|FG000|Overall Study|Spontaneous abortion|0|||
13239614|NCT01656733|26337573|FG001|Overall Study|Spontaneous abortion|1|||
13239615|NCT01656408|26337793|FG000|Overall Study|Adverse Event|0|||
13239616|NCT01656408|26337794|FG001|Overall Study|Adverse Event|0|||
13239617|NCT01656408|26337795|FG002|Overall Study|Adverse Event|1|||
13239618|NCT01656408|26337796|FG003|Overall Study|Adverse Event|0|||
13239619|NCT01656408|26337797|FG004|Overall Study|Adverse Event|0|||
13239620|NCT01656408|26337798|FG005|Overall Study|Adverse Event|1|||
13239621|NCT01656408|26337799|FG006|Overall Study|Adverse Event|1|||
13239622|NCT01656408|26337800|FG007|Overall Study|Adverse Event|0|||
13239623|NCT01656408|26337801|FG008|Overall Study|Adverse Event|1|||
13239624|NCT01656408|26337802|FG009|Overall Study|Adverse Event|0|||
13239625|NCT01656408|26337793|FG000|Overall Study|Physician Decision|1|||
13239626|NCT01656408|26337794|FG001|Overall Study|Physician Decision|0|||
13239627|NCT01656408|26337795|FG002|Overall Study|Physician Decision|1|||
13239628|NCT01656408|26337796|FG003|Overall Study|Physician Decision|0|||
13239629|NCT01656408|26337797|FG004|Overall Study|Physician Decision|1|||
13239630|NCT01656408|26337798|FG005|Overall Study|Physician Decision|1|||
13239631|NCT01656408|26337799|FG006|Overall Study|Physician Decision|0|||
13239632|NCT01656408|26337800|FG007|Overall Study|Physician Decision|1|||
13239633|NCT01656408|26337801|FG008|Overall Study|Physician Decision|1|||
13239634|NCT01656408|26337802|FG009|Overall Study|Physician Decision|3|||
13239635|NCT01656395|26337909|FG000|Overall Study|Adverse Event|1|||
13239636|NCT01656395|26337910|FG001|Overall Study|Adverse Event|14|||
13239637|NCT01656395|26337911|FG002|Overall Study|Adverse Event|5|||
13239638|NCT01656395|26337912|FG003|Overall Study|Adverse Event|4|||
13239639|NCT01656395|26337913|FG004|Overall Study|Adverse Event|5|||
13239640|NCT01656395|26337914|FG005|Overall Study|Adverse Event|7|||
13239641|NCT01656395|26337915|FG006|Overall Study|Adverse Event|0|||
13239642|NCT01656395|26337916|FG007|Overall Study|Adverse Event|0|||
13239643|NCT01656395|26337909|FG000|Overall Study|Lack of Efficacy|1|||
13239644|NCT01656395|26337910|FG001|Overall Study|Lack of Efficacy|8|||
13239645|NCT01656395|26337911|FG002|Overall Study|Lack of Efficacy|6|||
13239646|NCT01656395|26337912|FG003|Overall Study|Lack of Efficacy|1|||
13239647|NCT01656395|26337913|FG004|Overall Study|Lack of Efficacy|1|||
13239648|NCT01656395|26337914|FG005|Overall Study|Lack of Efficacy|6|||
13239649|NCT01656395|26337915|FG006|Overall Study|Lack of Efficacy|0|||
13115686|NCT03093415|25918735|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8|||
13239650|NCT01656395|26337916|FG007|Overall Study|Lack of Efficacy|0|||
13239651|NCT01656395|26337909|FG000|Overall Study|Lost to Follow-up|1|||
13239652|NCT01656395|26337910|FG001|Overall Study|Lost to Follow-up|0|||
13239653|NCT01656395|26337911|FG002|Overall Study|Lost to Follow-up|0|||
13239654|NCT01656395|26337912|FG003|Overall Study|Lost to Follow-up|0|||
13239655|NCT01656395|26337913|FG004|Overall Study|Lost to Follow-up|0|||
13239656|NCT01656395|26337914|FG005|Overall Study|Lost to Follow-up|0|||
13239657|NCT01656395|26337915|FG006|Overall Study|Lost to Follow-up|0|||
13239658|NCT01656395|26337916|FG007|Overall Study|Lost to Follow-up|0|||
13239659|NCT01656395|26337909|FG000|Overall Study|Non-Compliance with Study Drug|1|||
13239660|NCT01656395|26337910|FG001|Overall Study|Non-Compliance with Study Drug|1|||
13239661|NCT01656395|26337911|FG002|Overall Study|Non-Compliance with Study Drug|0|||
13239662|NCT01656395|26337912|FG003|Overall Study|Non-Compliance with Study Drug|0|||
13239663|NCT01656395|26337913|FG004|Overall Study|Non-Compliance with Study Drug|1|||
13239664|NCT01656395|26337914|FG005|Overall Study|Non-Compliance with Study Drug|1|||
13239665|NCT01656395|26337915|FG006|Overall Study|Non-Compliance with Study Drug|0|||
13239666|NCT01656395|26337916|FG007|Overall Study|Non-Compliance with Study Drug|0|||
13239667|NCT01656395|26337909|FG000|Overall Study|Other|0|||
13239668|NCT01656395|26337910|FG001|Overall Study|Other|0|||
13239669|NCT01656395|26337911|FG002|Overall Study|Other|1|||
13239670|NCT01656395|26337912|FG003|Overall Study|Other|0|||
13239671|NCT01656395|26337913|FG004|Overall Study|Other|0|||
13239672|NCT01656395|26337914|FG005|Overall Study|Other|1|||
13239673|NCT01656395|26337915|FG006|Overall Study|Other|0|||
13239674|NCT01656395|26337916|FG007|Overall Study|Other|0|||
13239675|NCT01656395|26337909|FG000|Overall Study|Physician Decision|2|||
13239676|NCT01656395|26337910|FG001|Overall Study|Physician Decision|3|||
13239677|NCT01656395|26337911|FG002|Overall Study|Physician Decision|3|||
13239678|NCT01656395|26337912|FG003|Overall Study|Physician Decision|2|||
13239679|NCT01656395|26337913|FG004|Overall Study|Physician Decision|3|||
13239680|NCT01656395|26337914|FG005|Overall Study|Physician Decision|3|||
13239681|NCT01656395|26337915|FG006|Overall Study|Physician Decision|0|||
13239682|NCT01656395|26337916|FG007|Overall Study|Physician Decision|0|||
13239683|NCT01656395|26337909|FG000|Overall Study|Pregnancy|0|||
13239684|NCT01656395|26337910|FG001|Overall Study|Pregnancy|0|||
13239685|NCT01656395|26337911|FG002|Overall Study|Pregnancy|1|||
13239686|NCT01656395|26337912|FG003|Overall Study|Pregnancy|0|||
13239687|NCT01656395|26337913|FG004|Overall Study|Pregnancy|0|||
13239688|NCT01656395|26337914|FG005|Overall Study|Pregnancy|0|||
13239689|NCT01656395|26337915|FG006|Overall Study|Pregnancy|0|||
13239690|NCT01656395|26337916|FG007|Overall Study|Pregnancy|0|||
13239691|NCT01656395|26337909|FG000|Overall Study|Progressive Disease|0|||
13239692|NCT01656395|26337910|FG001|Overall Study|Progressive Disease|0|||
13239693|NCT01656395|26337911|FG002|Overall Study|Progressive Disease|0|||
13239694|NCT01656395|26337912|FG003|Overall Study|Progressive Disease|0|||
13239695|NCT01656395|26337913|FG004|Overall Study|Progressive Disease|0|||
13239696|NCT01656395|26337914|FG005|Overall Study|Progressive Disease|1|||
13239697|NCT01656395|26337915|FG006|Overall Study|Progressive Disease|0|||
13239698|NCT01656395|26337916|FG007|Overall Study|Progressive Disease|0|||
13239699|NCT01656395|26337909|FG000|Overall Study|Protocol Violation|6|||
13239700|NCT01656395|26337910|FG001|Overall Study|Protocol Violation|6|||
13239701|NCT01656395|26337911|FG002|Overall Study|Protocol Violation|9|||
13239702|NCT01656395|26337912|FG003|Overall Study|Protocol Violation|2|||
13239703|NCT01656395|26337913|FG004|Overall Study|Protocol Violation|4|||
13239704|NCT01656395|26337914|FG005|Overall Study|Protocol Violation|10|||
13239705|NCT01656395|26337915|FG006|Overall Study|Protocol Violation|0|||
13239706|NCT01656395|26337916|FG007|Overall Study|Protocol Violation|0|||
13239707|NCT01656395|26337909|FG000|Overall Study|Screen Failure|2|||
13239708|NCT01656395|26337910|FG001|Overall Study|Screen Failure|1|||
13239709|NCT01656395|26337911|FG002|Overall Study|Screen Failure|7|||
13239710|NCT01656395|26337912|FG003|Overall Study|Screen Failure|1|||
13239711|NCT01656395|26337913|FG004|Overall Study|Screen Failure|0|||
13239712|NCT01656395|26337914|FG005|Overall Study|Screen Failure|8|||
13239713|NCT01656395|26337915|FG006|Overall Study|Screen Failure|0|||
13239714|NCT01656395|26337916|FG007|Overall Study|Screen Failure|0|||
13239715|NCT01656395|26337909|FG000|Overall Study|Withdrawal by Subject|3|||
13239716|NCT01656395|26337910|FG001|Overall Study|Withdrawal by Subject|1|||
13239717|NCT01656395|26337911|FG002|Overall Study|Withdrawal by Subject|4|||
13239718|NCT01656395|26337912|FG003|Overall Study|Withdrawal by Subject|2|||
13239719|NCT01656395|26337913|FG004|Overall Study|Withdrawal by Subject|0|||
13239720|NCT01656395|26337914|FG005|Overall Study|Withdrawal by Subject|3|||
13239721|NCT01656395|26337915|FG006|Overall Study|Withdrawal by Subject|0|||
13239722|NCT01656395|26337916|FG007|Overall Study|Withdrawal by Subject|0|||
13239723|NCT01656304|26337927|FG000|Overall Study|Ineligible, uncontrolled hypertension|1|||
13239724|NCT01656200|26337935|FG000|Overall Study|Withdrawal by Subject|1|||
13239725|NCT01656161|26337951|FG000|Overall Study|Death|3|||
13239726|NCT01656161|26337951|FG000|Overall Study|Adverse Event|2|||
13239727|NCT01656161|26337951|FG000|Overall Study|Protocol Violation|1|||
13239728|NCT01656161|26337951|FG000|Overall Study|Withdrawal by Subject|1|||
13239729|NCT01655901|26337967|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1|||
13239730|NCT01655901|26337968|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1|||
13239731|NCT01655901|26337969|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1|||
13239732|NCT01655901|26337970|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0|||
13239733|NCT01655901|26337971|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1|||
13239734|NCT01655901|26337972|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0|||
13239735|NCT01655823|26338000|FG000|Overall Study|Lost to Follow-up|0|||
13239736|NCT01655823|26338001|FG001|Overall Study|Lost to Follow-up|1|||
13239737|NCT01655823|26338002|FG002|Overall Study|Lost to Follow-up|0|||
13239738|NCT01655823|26338003|FG003|Overall Study|Lost to Follow-up|0|||
13239739|NCT01655823|26338004|FG004|Overall Study|Lost to Follow-up|1|||
13239740|NCT01655823|26338000|FG000|Overall Study|Withdrawal by Subject|0|||
13239741|NCT01655823|26338001|FG001|Overall Study|Withdrawal by Subject|1|||
13239742|NCT01655823|26338002|FG002|Overall Study|Withdrawal by Subject|0|||
13239743|NCT01655823|26338003|FG003|Overall Study|Withdrawal by Subject|1|||
13239744|NCT01655823|26338004|FG004|Overall Study|Withdrawal by Subject|0|||
13239745|NCT01655693|26338048|FG000|Overall Study|Progression of Disease|92|||
13239746|NCT01655693|26338049|FG001|Overall Study|Progression of Disease|76|||
13239747|NCT01655693|26338050|FG002|Overall Study|Progression of Disease|58|||
13239748|NCT01655693|26338048|FG000|Overall Study|Death|8|||
13239749|NCT01655693|26338049|FG001|Overall Study|Death|9|||
13239750|NCT01655693|26338050|FG002|Overall Study|Death|12|||
13239751|NCT01655693|26338048|FG000|Overall Study|Serious Adverse Event|3|||
13239752|NCT01655693|26338049|FG001|Overall Study|Serious Adverse Event|15|||
13239753|NCT01655693|26338050|FG002|Overall Study|Serious Adverse Event|11|||
13239754|NCT01655693|26338048|FG000|Overall Study|Withdrawal by Subject|3|||
13239755|NCT01655693|26338049|FG001|Overall Study|Withdrawal by Subject|2|||
13239756|NCT01655693|26338050|FG002|Overall Study|Withdrawal by Subject|20|||
13239757|NCT01655693|26338048|FG000|Overall Study|Adverse Event|3|||
13239758|NCT01655693|26338049|FG001|Overall Study|Adverse Event|11|||
13239759|NCT01655693|26338050|FG002|Overall Study|Adverse Event|3|||
13239760|NCT01655693|26338048|FG000|Overall Study|Aggravation of Liver Dysfunction|5|||
13239761|NCT01655693|26338049|FG001|Overall Study|Aggravation of Liver Dysfunction|4|||
13239762|NCT01655693|26338050|FG002|Overall Study|Aggravation of Liver Dysfunction|0|||
13239763|NCT01655693|26338048|FG000|Overall Study|Non-Compliance|0|||
13239764|NCT01655693|26338049|FG001|Overall Study|Non-Compliance|0|||
13239765|NCT01655693|26338050|FG002|Overall Study|Non-Compliance|7|||
13239766|NCT01655693|26338048|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1|||
13239767|NCT01655693|26338049|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3|||
13239768|NCT01655693|26338050|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0|||
13239769|NCT01655693|26338048|FG000|Overall Study|Protocol Violation|1|||
13239770|NCT01655693|26338049|FG001|Overall Study|Protocol Violation|0|||
13239771|NCT01655693|26338050|FG002|Overall Study|Protocol Violation|3|||
13239772|NCT01655693|26338048|FG000|Overall Study|Lost to Follow-up|1|||
13239773|NCT01655693|26338049|FG001|Overall Study|Lost to Follow-up|0|||
13239774|NCT01655693|26338050|FG002|Overall Study|Lost to Follow-up|1|||
13239775|NCT01655693|26338048|FG000|Overall Study|Screening Failure|1|||
13239776|NCT01655693|26338049|FG001|Overall Study|Screening Failure|0|||
13239777|NCT01655693|26338050|FG002|Overall Study|Screening Failure|0|||
13239778|NCT01655693|26338048|FG000|Overall Study|Other|8|||
13239779|NCT01655693|26338049|FG001|Overall Study|Other|6|||
13239780|NCT01655693|26338050|FG002|Overall Study|Other|15|||
13239781|NCT01655498|26338059|FG000|Overall Study|Unrelated health issue|2|||
13239782|NCT01655498|26338059|FG000|Overall Study|Protocol Violation|2|||
13239783|NCT01655498|26338059|FG000|Overall Study|Withdrawal by Subject|1|||
13239784|NCT01655381|26338081|FG000|Overall Study|Investigator Decision|1|||
13239785|NCT01655381|26338081|FG000|Overall Study|Moved to Another City|1|||
13239786|NCT01655381|26338081|FG000|Overall Study|Insufficient Treatment Response|1|||
13239787|NCT01655069|26338109|FG000|Overall Study|Physician Decision|0|||
13239788|NCT01655069|26338110|FG001|Overall Study|Physician Decision|0|||
13239789|NCT01655069|26338111|FG002|Overall Study|Physician Decision|0|||
13239790|NCT01655069|26338112|FG003|Overall Study|Physician Decision|1|||
13239791|NCT01655069|26338109|FG000|Overall Study|Adverse Event|6|||
13239792|NCT01655069|26338110|FG001|Overall Study|Adverse Event|7|||
13239793|NCT01655069|26338111|FG002|Overall Study|Adverse Event|2|||
13239794|NCT01655069|26338112|FG003|Overall Study|Adverse Event|3|||
13239795|NCT01655069|26338109|FG000|Overall Study|Lack of Efficacy|0|||
13239796|NCT01655069|26338110|FG001|Overall Study|Lack of Efficacy|1|||
13239797|NCT01655069|26338111|FG002|Overall Study|Lack of Efficacy|0|||
13239798|NCT01655069|26338112|FG003|Overall Study|Lack of Efficacy|0|||
13239799|NCT01655069|26338109|FG000|Overall Study|No Treatment Needed|0|||
13239800|NCT01655069|26338110|FG001|Overall Study|No Treatment Needed|1|||
13239801|NCT01655069|26338111|FG002|Overall Study|No Treatment Needed|0|||
13239802|NCT01655069|26338112|FG003|Overall Study|No Treatment Needed|0|||
13239803|NCT01655069|26338109|FG000|Overall Study|Withdrawal by Subject|2|||
13239804|NCT01655069|26338110|FG001|Overall Study|Withdrawal by Subject|3|||
13239805|NCT01655069|26338111|FG002|Overall Study|Withdrawal by Subject|0|||
13239806|NCT01655069|26338112|FG003|Overall Study|Withdrawal by Subject|0|||
13239807|NCT01654666|26338145|FG000|Overall Study|Protocol Violation|7|||
13239808|NCT01654666|26338146|FG001|Overall Study|Protocol Violation|4|||
13239809|NCT01654666|26338147|FG002|Overall Study|Protocol Violation|8|||
13239810|NCT01654666|26338145|FG000|Overall Study|Lost to Follow-up|4|||
13239811|NCT01654666|26338146|FG001|Overall Study|Lost to Follow-up|5|||
13239812|NCT01654666|26338147|FG002|Overall Study|Lost to Follow-up|5|||
13239813|NCT01654666|26338145|FG000|Overall Study|Withdrawal by Subject|4|||
13239814|NCT01654666|26338146|FG001|Overall Study|Withdrawal by Subject|4|||
13239815|NCT01654666|26338147|FG002|Overall Study|Withdrawal by Subject|1|||
13239816|NCT01654601|26338166|FG000|1st Administration|Withdrawal by Subject|2|||
13239817|NCT01654601|26338167|FG001|1st Administration|Withdrawal by Subject|0|||
13239818|NCT01654601|26338166|FG000|1st Administration|Protocol Violation|0|||
13115687|NCT03093415|25918736|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3|||
13115688|NCT03093402|25918943|FG000|Overall Study|Lost to Follow-up|1|||
13115689|NCT03093402|25918944|FG001|Overall Study|Lost to Follow-up|0|||
13115690|NCT03093402|25918945|FG002|Overall Study|Lost to Follow-up|0|||
13115691|NCT03093402|25918946|FG003|Overall Study|Lost to Follow-up|0|||
13115692|NCT03093402|25918943|FG000|Overall Study|Withdrawal by Subject|3|||
13115693|NCT03093402|25918944|FG001|Overall Study|Withdrawal by Subject|3|||
13115694|NCT03093402|25918945|FG002|Overall Study|Withdrawal by Subject|0|||
13239819|NCT01654601|26338167|FG001|1st Administration|Protocol Violation|2|||
13239820|NCT01654601|26338166|FG000|2nd Administration|Adverse Event|1|||
13239821|NCT01654601|26338167|FG001|2nd Administration|Adverse Event|0|||
13239822|NCT01654601|26338166|FG000|2nd Administration|Protocol Violation|0|||
13239823|NCT01654601|26338167|FG001|2nd Administration|Protocol Violation|1|||
13239824|NCT01654549|26338184|FG000|Overall Study|H.pylori eradication not successful|0|||
13239825|NCT01654549|26338185|FG001|Overall Study|H.pylori eradication not successful|1|||
13239826|NCT01654536|26338228|FG000|Overall Study|Lost to Follow-up|5|||
13239827|NCT01654536|26338229|FG001|Overall Study|Lost to Follow-up|5|||
13239828|NCT01654536|26338228|FG000|Overall Study|Physician Decision|12|||
13239829|NCT01654536|26338229|FG001|Overall Study|Physician Decision|8|||
13239830|NCT01654536|26338228|FG000|Overall Study|Withdrawal by Subject|27|||
13239831|NCT01654536|26338229|FG001|Overall Study|Withdrawal by Subject|25|||
13239832|NCT01654523|26338235|FG000|Overall Study|Withdrawal by Subject|1|||
13239833|NCT01654380|26338269|FG000|Part B, Period 1|Physician Decision|0|||
13239834|NCT01654380|26338270|FG001|Part B, Period 1|Physician Decision|0|||
13239835|NCT01654380|26338271|FG002|Part B, Period 1|Physician Decision|1|||
13239836|NCT01654380|26338272|FG003|Part B, Period 1|Physician Decision|0|||
13239837|NCT01654302|26338285|FG000|Second Intervention (Day 7)|Lost to Follow-up|1|||
13239838|NCT01654302|26338286|FG001|Second Intervention (Day 7)|Lost to Follow-up|1|||
13239839|NCT01654289|26338334|FG000|Overall Study|Withdrawal by Subject|10|||
13239840|NCT01654289|26338335|FG001|Overall Study|Withdrawal by Subject|8|||
13239841|NCT01654289|26338336|FG002|Overall Study|Withdrawal by Subject|5|||
13115695|NCT03093402|25918946|FG003|Overall Study|Withdrawal by Subject|1|||
13239842|NCT01654289|26338334|FG000|Overall Study|Withdrew from intervention only|17|||
13239843|NCT01654289|26338335|FG001|Overall Study|Withdrew from intervention only|20|||
13239844|NCT01654289|26338336|FG002|Overall Study|Withdrew from intervention only|0|||
13239845|NCT01654276|26338356|FG000|Overall Study|Lack of Efficacy|1|||
13239846|NCT01654276|26338356|FG000|Overall Study|Lost to Follow-up|4|||
13239847|NCT01654276|26338356|FG000|Overall Study|Withdrawal by Subject|1|||
13239848|NCT01654250|26338378|FG000|Overall Study|Lost to Follow-up|1|||
13239849|NCT01654250|26338379|FG001|Overall Study|Lost to Follow-up|0|||
13239850|NCT01654224|26338396|FG000|Overall Study|Lost to Follow-up|2|||
13239851|NCT01654224|26338397|FG001|Overall Study|Lost to Follow-up|2|||
13239852|NCT01654224|26338396|FG000|Overall Study|Did not receive allocation|1|||
13239853|NCT01654224|26338397|FG001|Overall Study|Did not receive allocation|8|||
13239854|NCT01654224|26338396|FG000|Overall Study|Insufficient blood sample|3|||
13239855|NCT01654224|26338397|FG001|Overall Study|Insufficient blood sample|2|||
13239856|NCT01653912|26338423|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
13239857|NCT01653912|26338424|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1|||
13239858|NCT01653912|26338425|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
13239859|NCT01653912|26338426|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
13239860|NCT01653912|26338427|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
13239861|NCT01653912|26338428|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
13239862|NCT01653912|26338423|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
13115696|NCT03093402|25918943|FG000|Overall Study|Withdrew prior to dosing|2|||
13115697|NCT03093402|25918944|FG001|Overall Study|Withdrew prior to dosing|1|||
13239863|NCT01653912|26338424|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
13239864|NCT01653912|26338425|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2|||
13239865|NCT01653912|26338426|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
13239866|NCT01653912|26338427|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
13239867|NCT01653912|26338428|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
13239868|NCT01653912|26338423|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
13115698|NCT03093402|25918945|FG002|Overall Study|Withdrew prior to dosing|2|||
13239869|NCT01653912|26338424|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
13239870|NCT01653912|26338425|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
13239871|NCT01653912|26338426|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1|||
13239872|NCT01653912|26338427|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
13239873|NCT01653912|26338428|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
13239874|NCT01653912|26338423|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
13239875|NCT01653912|26338424|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
13239876|NCT01653912|26338425|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
13239877|NCT01653912|26338426|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1|||
13239878|NCT01653912|26338427|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
13239879|NCT01653912|26338428|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
13239880|NCT01653912|26338423|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
13239881|NCT01653912|26338424|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
13239882|NCT01653912|26338425|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
13239883|NCT01653912|26338426|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
13239884|NCT01653912|26338427|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
13239885|NCT01653912|26338428|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1|||
13239886|NCT01653912|26338423|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
13239887|NCT01653912|26338424|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
13239888|NCT01653912|26338425|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
13239889|NCT01653912|26338426|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
13239890|NCT01653912|26338427|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
13239891|NCT01653912|26338428|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6|||
13239892|NCT01653912|26338423|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
13239893|NCT01653912|26338424|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
13239894|NCT01653912|26338425|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
13239895|NCT01653912|26338426|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
13239896|NCT01653912|26338427|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
13239897|NCT01653912|26338428|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1|||
13239898|NCT01653847|26338449|FG000|Overall Study|Withdrawal by Subject|1|||
13239899|NCT01653847|26338450|FG001|Overall Study|Withdrawal by Subject|0|||
13239900|NCT01653782|26338468|FG000|Overall Study|Withdrawal by Subject|9|||
13239901|NCT01653782|26338469|FG001|Overall Study|Withdrawal by Subject|15|||
13239902|NCT01653782|26338470|FG002|Overall Study|Withdrawal by Subject|4|||
13239903|NCT01653782|26338468|FG000|Overall Study|Lost to Follow-up|7|||
13239904|NCT01653782|26338469|FG001|Overall Study|Lost to Follow-up|3|||
13239905|NCT01653782|26338470|FG002|Overall Study|Lost to Follow-up|2|||
13239906|NCT01653743|26338491|FG000|Overall Study|Withdrawal by Subject|1|||
13239907|NCT01653743|26338492|FG001|Overall Study|Withdrawal by Subject|0|||
13239908|NCT01653743|26338491|FG000|Overall Study|Investigator discretion|3|||
13239909|NCT01653743|26338492|FG001|Overall Study|Investigator discretion|0|||
13239910|NCT01653704|26338505|FG000|Overall Study|Technical failure during recording|1|||
13239911|NCT01653704|26338506|FG001|Overall Study|Technical failure during recording|1|||
13239912|NCT01653704|26338505|FG000|Overall Study|Performance not reflective of training|1|||
13239913|NCT01653704|26338506|FG001|Overall Study|Performance not reflective of training|0|||
13239914|NCT01653327|26338516|FG000|Overall Study|Withdrawal by Subject|1|||
13239915|NCT01653262|26338531|FG000|Overall Study|Lack of Efficacy|1|||
13239916|NCT01653262|26338531|FG000|Overall Study|SAE, non-fatal|1|||
13239917|NCT01653262|26338531|FG000|Overall Study|AE, non-serious non-fatal|1|||
13239918|NCT01653158|26338812|FG000|Overall Study|Death|0|||
13239919|NCT01653158|26338813|FG001|Overall Study|Death|0|||
13239920|NCT01653158|26338814|FG002|Overall Study|Death|0|||
13239921|NCT01653158|26338815|FG003|Overall Study|Death|1|||
13239922|NCT01653158|26338816|FG004|Overall Study|Death|0|||
13239923|NCT01653158|26338817|FG005|Overall Study|Death|0|||
13239924|NCT01653158|26338818|FG006|Overall Study|Death|0|||
13239925|NCT01653158|26338819|FG007|Overall Study|Death|2|||
13239926|NCT01653158|26338812|FG000|Overall Study|Adverse Event|0|||
13239927|NCT01653158|26338813|FG001|Overall Study|Adverse Event|0|||
13239928|NCT01653158|26338814|FG002|Overall Study|Adverse Event|0|||
13239929|NCT01653158|26338815|FG003|Overall Study|Adverse Event|1|||
13239930|NCT01653158|26338816|FG004|Overall Study|Adverse Event|0|||
13239931|NCT01653158|26338817|FG005|Overall Study|Adverse Event|0|||
13239932|NCT01653158|26338818|FG006|Overall Study|Adverse Event|0|||
13239933|NCT01653158|26338819|FG007|Overall Study|Adverse Event|3|||
13239934|NCT01653158|26338812|FG000|Overall Study|Other|0|||
13115699|NCT03093402|25918946|FG003|Overall Study|Withdrew prior to dosing|3|||
13115700|NCT03093402|25918943|FG000|Overall Study|Ineligible for study|1|||
13239935|NCT01653158|26338813|FG001|Overall Study|Other|0|||
13239936|NCT01653158|26338814|FG002|Overall Study|Other|0|||
13115701|NCT03093402|25918944|FG001|Overall Study|Ineligible for study|0|||
13239937|NCT01653158|26338815|FG003|Overall Study|Other|0|||
13239938|NCT01653158|26338816|FG004|Overall Study|Other|0|||
13239939|NCT01653158|26338817|FG005|Overall Study|Other|0|||
13239940|NCT01653158|26338818|FG006|Overall Study|Other|0|||
13239941|NCT01653158|26338819|FG007|Overall Study|Other|1|||
13239942|NCT01653158|26338812|FG000|Overall Study|Progressive disease|0|||
13239943|NCT01653158|26338813|FG001|Overall Study|Progressive disease|0|||
13239944|NCT01653158|26338814|FG002|Overall Study|Progressive disease|0|||
13239945|NCT01653158|26338815|FG003|Overall Study|Progressive disease|0|||
13239946|NCT01653158|26338816|FG004|Overall Study|Progressive disease|1|||
13239947|NCT01653158|26338817|FG005|Overall Study|Progressive disease|1|||
13239948|NCT01653158|26338818|FG006|Overall Study|Progressive disease|2|||
13239949|NCT01653158|26338819|FG007|Overall Study|Progressive disease|9|||
13239950|NCT01653158|26338812|FG000|Overall Study|Withdrawal by Subject|1|||
13239951|NCT01653158|26338813|FG001|Overall Study|Withdrawal by Subject|0|||
13239952|NCT01653158|26338814|FG002|Overall Study|Withdrawal by Subject|0|||
13239953|NCT01653158|26338815|FG003|Overall Study|Withdrawal by Subject|0|||
13239954|NCT01653158|26338816|FG004|Overall Study|Withdrawal by Subject|0|||
13239955|NCT01653158|26338817|FG005|Overall Study|Withdrawal by Subject|0|||
13239956|NCT01653158|26338818|FG006|Overall Study|Withdrawal by Subject|0|||
13239957|NCT01653158|26338819|FG007|Overall Study|Withdrawal by Subject|0|||
13239958|NCT01653132|26338836|FG000|First Intervention|Protocol Violation|1|||
13239959|NCT01653132|26338837|FG001|First Intervention|Protocol Violation|0|||
13239960|NCT01652885|26338864|FG000|Overall Study|Adverse Event|1|||
13239961|NCT01652872|26338885|FG000|Overall Study|Death|36|||
13239962|NCT01652872|26338886|FG001|Overall Study|Death|39|||
13239963|NCT01652872|26338885|FG000|Overall Study|Lost to Follow-up|28|||
13239964|NCT01652872|26338886|FG001|Overall Study|Lost to Follow-up|23|||
13239965|NCT01652872|26338885|FG000|Overall Study|Decision by sponsor|5|||
13239966|NCT01652872|26338886|FG001|Overall Study|Decision by sponsor|7|||
13239967|NCT01652872|26338885|FG000|Overall Study|Withdrawal by Subject|76|||
13239968|NCT01652872|26338886|FG001|Overall Study|Withdrawal by Subject|84|||
13239969|NCT01652729|26338916|FG000|Overall Study|Withdrawal by Subject|14|||
13239970|NCT01652729|26338917|FG001|Overall Study|Withdrawal by Subject|7|||
13239971|NCT01652729|26338918|FG002|Overall Study|Withdrawal by Subject|7|||
13239972|NCT01652729|26338916|FG000|Overall Study|Adverse Event|4|||
13239973|NCT01652729|26338917|FG001|Overall Study|Adverse Event|0|||
13239974|NCT01652729|26338918|FG002|Overall Study|Adverse Event|3|||
13239975|NCT01652729|26338916|FG000|Overall Study|Physician Decision|1|||
13239976|NCT01652729|26338917|FG001|Overall Study|Physician Decision|0|||
13239977|NCT01652729|26338918|FG002|Overall Study|Physician Decision|1|||
13239978|NCT01652729|26338916|FG000|Overall Study|Protocol Violation|1|||
13239979|NCT01652729|26338917|FG001|Overall Study|Protocol Violation|0|||
13239980|NCT01652729|26338918|FG002|Overall Study|Protocol Violation|0|||
13239981|NCT01652729|26338916|FG000|Overall Study|Lost to Follow-up|6|||
13239982|NCT01652729|26338917|FG001|Overall Study|Lost to Follow-up|6|||
13239983|NCT01652729|26338918|FG002|Overall Study|Lost to Follow-up|3|||
13239984|NCT01652729|26338916|FG000|Overall Study|Administrative|1|||
13239985|NCT01652729|26338917|FG001|Overall Study|Administrative|0|||
13239986|NCT01652729|26338918|FG002|Overall Study|Administrative|0|||
13239987|NCT01652716|26338939|FG000|Overall Study|Loss of glucose control|1|||
13239988|NCT01652716|26338940|FG001|Overall Study|Loss of glucose control|0|||
13239989|NCT01652716|26338939|FG000|Overall Study|Administrative|0|||
13239990|NCT01652716|26338940|FG001|Overall Study|Administrative|2|||
13239991|NCT01652716|26338939|FG000|Overall Study|Investigator decision|1|||
13239992|NCT01652716|26338940|FG001|Overall Study|Investigator decision|4|||
13239993|NCT01652716|26338939|FG000|Overall Study|Lost to Follow-up|12|||
13239994|NCT01652716|26338940|FG001|Overall Study|Lost to Follow-up|11|||
13239995|NCT01652716|26338939|FG000|Overall Study|Protocol Violation|2|||
13239996|NCT01652716|26338940|FG001|Overall Study|Protocol Violation|1|||
13239997|NCT01652716|26338939|FG000|Overall Study|Adverse Event|7|||
13239998|NCT01652716|26338940|FG001|Overall Study|Adverse Event|10|||
13239999|NCT01652716|26338939|FG000|Overall Study|Withdrawal by Subject|33|||
13240000|NCT01652716|26338940|FG001|Overall Study|Withdrawal by Subject|18|||
13240001|NCT01652703|26339015|FG000|Overall Study|Withdrawal by Subject|0|||
13240002|NCT01652703|26339016|FG001|Overall Study|Withdrawal by Subject|1|||
13115702|NCT03093402|25918945|FG002|Overall Study|Ineligible for study|0|||
13115703|NCT03093402|25918946|FG003|Overall Study|Ineligible for study|0|||
13115704|NCT03093402|25918943|FG000|Overall Study|Prescribed a prohibited concomitant medication|0|||
13115705|NCT03093402|25918944|FG001|Overall Study|Prescribed a prohibited concomitant medication|1|||
13115706|NCT03093402|25918945|FG002|Overall Study|Prescribed a prohibited concomitant medication|0|||
13115707|NCT03093402|25918946|FG003|Overall Study|Prescribed a prohibited concomitant medication|0|||
13240003|NCT01652703|26339017|FG002|Overall Study|Withdrawal by Subject|3|||
13240004|NCT01652703|26339018|FG003|Overall Study|Withdrawal by Subject|1|||
13240005|NCT01652703|26339019|FG004|Overall Study|Withdrawal by Subject|0|||
13240006|NCT01652703|26339020|FG005|Overall Study|Withdrawal by Subject|1|||
13240007|NCT01652703|26339015|FG000|Overall Study|Other|0|||
13240008|NCT01652703|26339016|FG001|Overall Study|Other|0|||
13240009|NCT01652703|26339017|FG002|Overall Study|Other|0|||
13240010|NCT01652703|26339018|FG003|Overall Study|Other|1|||
13240011|NCT01652703|26339019|FG004|Overall Study|Other|1|||
13240012|NCT01652703|26339020|FG005|Overall Study|Other|1|||
13240013|NCT01652690|26339059|FG000|Overall Study|Withdrawal by Subject|16|||
13240014|NCT01652690|26339060|FG001|Overall Study|Withdrawal by Subject|4|||
13240015|NCT01652690|26339059|FG000|Overall Study|Other|8|||
13240016|NCT01652690|26339060|FG001|Overall Study|Other|9|||
13240017|NCT01652690|26339059|FG000|Overall Study|Lost to Follow-up|6|||
13240018|NCT01652690|26339060|FG001|Overall Study|Lost to Follow-up|6|||
13240019|NCT01652690|26339059|FG000|Overall Study|Death|5|||
13240020|NCT01652690|26339060|FG001|Overall Study|Death|2|||
13240021|NCT01652664|26339074|FG000|Overall Study|Treatment Failure|5|||
13240022|NCT01652664|26339075|FG001|Overall Study|Treatment Failure|1|||
13240023|NCT01652664|26339074|FG000|Overall Study|Inadequate IOP control|1|||
13240024|NCT01652664|26339075|FG001|Overall Study|Inadequate IOP control|0|||
13289856|NCT00105534|26480276|FG001|Overall Study|Withdrawal by Subject|6|||
13289857|NCT00105534|26480275|FG000|Overall Study|Lost to Follow-up|5|||
13289858|NCT00105534|26480276|FG001|Overall Study|Lost to Follow-up|1|||
13289859|NCT00105534|26480275|FG000|Overall Study|Lack of Efficacy|7|||
13289860|NCT00105534|26480276|FG001|Overall Study|Lack of Efficacy|15|||
13289861|NCT00105534|26480275|FG000|Overall Study|Treatment unmasked|1|||
13289862|NCT00105534|26480276|FG001|Overall Study|Treatment unmasked|0|||
13289863|NCT00105534|26480275|FG000|Overall Study|Other Reason|0|||
13289864|NCT00105534|26480276|FG001|Overall Study|Other Reason|2|||
13289865|NCT00105482|26480297|FG000|Overall Study|Adverse Event|1|||
13289866|NCT00105482|26480298|FG001|Overall Study|Adverse Event|1|||
13289867|NCT00105482|26480297|FG000|Overall Study|Lost to Follow-up|26|||
13289868|NCT00105482|26480298|FG001|Overall Study|Lost to Follow-up|17|||
13289869|NCT00105482|26480297|FG000|Overall Study|Withdrawal by Subject|0|||
13289870|NCT00105482|26480298|FG001|Overall Study|Withdrawal by Subject|1|||
13289871|NCT00105482|26480297|FG000|Overall Study|Lost Interest|29|||
13289872|NCT00105482|26480298|FG001|Overall Study|Lost Interest|32|||
13289873|NCT00105482|26480297|FG000|Overall Study|Scheduling Conflict|2|||
13289874|NCT00105482|26480298|FG001|Overall Study|Scheduling Conflict|3|||
13289875|NCT00105482|26480297|FG000|Overall Study|Withdrawn by PI|1|||
13289876|NCT00105482|26480298|FG001|Overall Study|Withdrawn by PI|1|||
13289877|NCT00105443|26480334|FG000|Double-Blind Treatment|Adverse Event|1|||
13289878|NCT00105443|26480335|FG001|Double-Blind Treatment|Adverse Event|0|||
13289879|NCT00105443|26480336|FG002|Double-Blind Treatment|Adverse Event|0|||
13289880|NCT00105443|26480337|FG003|Double-Blind Treatment|Adverse Event|0|||
13289881|NCT00105443|26480334|FG000|Double-Blind Treatment|Lost to Follow-up|0|||
13289882|NCT00105443|26480335|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
13289883|NCT00105443|26480336|FG002|Double-Blind Treatment|Lost to Follow-up|1|||
13289884|NCT00105443|26480337|FG003|Double-Blind Treatment|Lost to Follow-up|0|||
13289885|NCT00105443|26480334|FG000|Double-Blind Treatment|Withdrawal by Subject|8|||
13289886|NCT00105443|26480335|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
13289887|NCT00105443|26480336|FG002|Double-Blind Treatment|Withdrawal by Subject|7|||
13289888|NCT00105443|26480337|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
13289889|NCT00105443|26480334|FG000|Double-Blind Treatment|Physician Decision|1|||
13289890|NCT00105443|26480335|FG001|Double-Blind Treatment|Physician Decision|0|||
13289891|NCT00105443|26480336|FG002|Double-Blind Treatment|Physician Decision|2|||
13289892|NCT00105443|26480337|FG003|Double-Blind Treatment|Physician Decision|0|||
13289893|NCT00105443|26480334|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4|||
13289894|NCT00105443|26480335|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0|||
13289895|NCT00105443|26480336|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1|||
13240025|NCT01652573|26339122|FG000|Overall Study|Adverse Event|0|||
13240026|NCT01652573|26339123|FG001|Overall Study|Adverse Event|1|||
13240027|NCT01652469|26339144|FG000|Overall Study|Withdrawal by Subject|1|||
13240028|NCT01652469|26339145|FG001|Overall Study|Withdrawal by Subject|4|||
13240029|NCT01652469|26339144|FG000|Overall Study|Lost to Follow-up|0|||
13240030|NCT01652469|26339145|FG001|Overall Study|Lost to Follow-up|2|||
13240031|NCT01652287|26339158|FG000|Overall Study|Withdrawal by Subject|2|||
13240032|NCT01652287|26339159|FG001|Overall Study|Withdrawal by Subject|0|||
13240033|NCT01651949|26339187|FG000|Overall Study|Unknown status|4|||
13240034|NCT01651949|26339188|FG001|Overall Study|Unknown status|4|||
13240035|NCT01651949|26339189|FG002|Overall Study|Unknown status|0|||
13240036|NCT01651949|26339187|FG000|Overall Study|Lost to Follow-up|30|||
13240037|NCT01651949|26339188|FG001|Overall Study|Lost to Follow-up|56|||
13240038|NCT01651949|26339189|FG002|Overall Study|Lost to Follow-up|20|||
13240039|NCT01651949|26339187|FG000|Overall Study|Protocol Violation|0|||
13240040|NCT01651949|26339188|FG001|Overall Study|Protocol Violation|2|||
13240041|NCT01651949|26339189|FG002|Overall Study|Protocol Violation|1|||
13240042|NCT01651949|26339187|FG000|Overall Study|Physician Decision|0|||
13240043|NCT01651949|26339188|FG001|Overall Study|Physician Decision|2|||
13240044|NCT01651949|26339189|FG002|Overall Study|Physician Decision|0|||
13240045|NCT01651949|26339187|FG000|Overall Study|Adverse Event|0|||
13240046|NCT01651949|26339188|FG001|Overall Study|Adverse Event|2|||
13240047|NCT01651949|26339189|FG002|Overall Study|Adverse Event|1|||
13240048|NCT01651949|26339187|FG000|Overall Study|Screen failure|2|||
13240049|NCT01651949|26339188|FG001|Overall Study|Screen failure|2|||
13240050|NCT01651949|26339189|FG002|Overall Study|Screen failure|0|||
13240051|NCT01651949|26339187|FG000|Overall Study|Withdrawal by Subject|17|||
13240052|NCT01651949|26339188|FG001|Overall Study|Withdrawal by Subject|18|||
13240053|NCT01651949|26339189|FG002|Overall Study|Withdrawal by Subject|9|||
13240054|NCT01651936|26339218|FG000|Base Study|Adverse Event|3|||
13240055|NCT01651936|26339219|FG001|Base Study|Adverse Event|0|||
13240056|NCT01651936|26339220|FG002|Base Study|Adverse Event|0|||
13240057|NCT01651936|26339218|FG000|Base Study|Withdrawal by Subject|1|||
13240058|NCT01651936|26339219|FG001|Base Study|Withdrawal by Subject|1|||
13240059|NCT01651936|26339220|FG002|Base Study|Withdrawal by Subject|0|||
13240060|NCT01651936|26339218|FG000|Base Study|Early Escape|2|||
13240061|NCT01651936|26339219|FG001|Base Study|Early Escape|8|||
13240062|NCT01651936|26339220|FG002|Base Study|Early Escape|0|||
13240063|NCT01651936|26339218|FG000|Base Study|Study terminated by sponsor|21|||
13240064|NCT01651936|26339219|FG001|Base Study|Study terminated by sponsor|16|||
13240065|NCT01651936|26339220|FG002|Base Study|Study terminated by sponsor|0|||
13240066|NCT01651936|26339218|FG000|Extension Study|Lack of Efficacy|0|||
13240067|NCT01651936|26339219|FG001|Extension Study|Lack of Efficacy|0|||
13115708|NCT03093324|25918975|FG000|Overall Study|Adverse Event|4|||
13115709|NCT03093324|25918976|FG001|Overall Study|Adverse Event|15|||
13115710|NCT03093324|25918975|FG000|Overall Study|Lost to Follow-up|1|||
13240068|NCT01651936|26339220|FG002|Extension Study|Lack of Efficacy|1|||
13240069|NCT01651936|26339218|FG000|Extension Study|Study terminated by sponsor|0|||
13240070|NCT01651936|26339219|FG001|Extension Study|Study terminated by sponsor|0|||
13240071|NCT01651936|26339220|FG002|Extension Study|Study terminated by sponsor|13|||
13240072|NCT01651780|26339257|FG000|Overall Study|Physician decision: No 30-day visit|2|||
13240073|NCT01651780|26339258|FG001|Overall Study|Physician decision: No 30-day visit|1|||
13240074|NCT01651780|26339257|FG000|Overall Study|Reason Not Specified: No 30-day visit|2|||
13240075|NCT01651780|26339258|FG001|Overall Study|Reason Not Specified: No 30-day visit|2|||
13240076|NCT01651780|26339257|FG000|Overall Study|Withdrawal by Subject|2|||
13240077|NCT01651780|26339258|FG001|Overall Study|Withdrawal by Subject|0|||
13240078|NCT01651780|26339257|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
13240079|NCT01651780|26339258|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
13240080|NCT01651780|26339257|FG000|Overall Study|Lost to Follow-up|1|||
13240081|NCT01651780|26339258|FG001|Overall Study|Lost to Follow-up|2|||
13240082|NCT01651780|26339257|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1|||
13240083|NCT01651780|26339258|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5|||
13240084|NCT01651403|26339329|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
13240085|NCT01651403|26339330|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
13240086|NCT01651403|26339329|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
13115711|NCT03093324|25918976|FG001|Overall Study|Lost to Follow-up|0|||
13115712|NCT03093324|25918975|FG000|Overall Study|Protocol Deviation|2|||
13240087|NCT01651403|26339330|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
13240088|NCT01651403|26339329|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0|||
13240089|NCT01651403|26339330|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1|||
13240090|NCT01651403|26339329|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13|||
13240091|NCT01651403|26339330|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9|||
13240092|NCT01651403|26339329|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2|||
13240093|NCT01651403|26339330|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1|||
13240094|NCT01651403|26339329|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6|||
13240095|NCT01651403|26339330|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4|||
13240096|NCT01651260|26339337|FG000|Overall Study|unable to apply product|3|||
13240097|NCT01651208|26339352|FG000|Overall Study|Lost to Follow-up|14|||
13240098|NCT01651208|26339353|FG001|Overall Study|Lost to Follow-up|16|||
13240099|NCT01651117|26339432|FG000|Overall Study|Death|2|||
13240100|NCT01651117|26339433|FG001|Overall Study|Death|3|||
13240101|NCT01651117|26339434|FG002|Overall Study|Death|2|||
13240102|NCT01651117|26339435|FG003|Overall Study|Death|2|||
13240103|NCT01651052|26339457|FG000|Overall Study|Death|21|||
13240104|NCT01651052|26339457|FG000|Overall Study|Explant|1|||
13240105|NCT01651052|26339457|FG000|Overall Study|Withdrawal by Subject|1|||
13240106|NCT01651052|26339457|FG000|Overall Study|Lost to Follow-up|3|||
13240107|NCT01651039|26339470|FG000|Overall Study|Non-evaluables|5|||
13240108|NCT01651039|26339470|FG000|Overall Study|Physician Decision|2|||
13240109|NCT01651039|26339470|FG000|Overall Study|Withdrawal by Subject|1|||
13240110|NCT01651039|26339470|FG000|Overall Study|Progressive Disease|22|||
13240111|NCT01651000|26339489|FG000|Overall Study|Adverse Event|2|||
13240112|NCT01651000|26339490|FG001|Overall Study|Adverse Event|8|||
13240113|NCT01651000|26339489|FG000|Overall Study|Lost to Follow-up|3|||
13240114|NCT01651000|26339490|FG001|Overall Study|Lost to Follow-up|2|||
13240115|NCT01651000|26339489|FG000|Overall Study|Protocol Violation|0|||
13240116|NCT01651000|26339490|FG001|Overall Study|Protocol Violation|3|||
13240117|NCT01651000|26339489|FG000|Overall Study|Withdrawal by Subject|2|||
13240118|NCT01651000|26339490|FG001|Overall Study|Withdrawal by Subject|10|||
13240119|NCT01651000|26339489|FG000|Overall Study|Subject noncompliance|0|||
13240120|NCT01651000|26339490|FG001|Overall Study|Subject noncompliance|3|||
13240121|NCT01651000|26339489|FG000|Overall Study|Lack of Efficacy|1|||
13240122|NCT01651000|26339490|FG001|Overall Study|Lack of Efficacy|1|||
13240123|NCT01651000|26339489|FG000|Overall Study|Physician Decision|1|||
13240124|NCT01651000|26339490|FG001|Overall Study|Physician Decision|0|||
13240125|NCT01651000|26339489|FG000|Overall Study|Administrative reason|1|||
13240126|NCT01651000|26339490|FG001|Overall Study|Administrative reason|0|||
13240127|NCT01651000|26339489|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0|||
13240128|NCT01651000|26339490|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1|||
13240129|NCT01650805|26339507|FG000|Overall Study|Withdrawal by Subject|1|||
13240130|NCT01650805|26339508|FG001|Overall Study|Withdrawal by Subject|0|||
13240131|NCT01650779|26339517|FG000|Overall Study|Withdrawal by Subject|1|||
13240132|NCT01650636|26339542|FG000|Washout up to 5 Months|Withdrawal by Subject|4|||
13240133|NCT01650636|26339543|FG001|Washout up to 5 Months|Withdrawal by Subject|8|||
13240134|NCT01650636|26339542|FG000|Washout up to 5 Months|Physician Decision|2|||
13240135|NCT01650636|26339543|FG001|Washout up to 5 Months|Physician Decision|2|||
13240136|NCT01650636|26339542|FG000|Washout up to 5 Months|Death|1|||
13240137|NCT01650636|26339543|FG001|Washout up to 5 Months|Death|0|||
13240138|NCT01650636|26339542|FG000|Washout up to 5 Months|Lost to Follow-up|2|||
13240139|NCT01650636|26339543|FG001|Washout up to 5 Months|Lost to Follow-up|8|||
13240140|NCT01650636|26339542|FG000|Washout up to 9 Months|Withdrawal by Subject|4|||
13240141|NCT01650636|26339543|FG001|Washout up to 9 Months|Withdrawal by Subject|2|||
13240142|NCT01650636|26339542|FG000|Washout up to 9 Months|Lost to Follow-up|2|||
13115713|NCT03093324|25918976|FG001|Overall Study|Protocol Deviation|2|||
13115714|NCT03093324|25918975|FG000|Overall Study|Withdrawal by Subject|2|||
13115715|NCT03093324|25918976|FG001|Overall Study|Withdrawal by Subject|2|||
13115716|NCT03093181|25919012|FG000|Overall Study|Withdrawal by Subject|2|||
13115717|NCT03093181|25919013|FG001|Overall Study|Withdrawal by Subject|1|||
13115718|NCT03093181|25919014|FG002|Overall Study|Withdrawal by Subject|2|||
13115719|NCT03093181|25919012|FG000|Overall Study|Other (Not specified)|1|||
13115720|NCT03093181|25919013|FG001|Overall Study|Other (Not specified)|0|||
13115721|NCT03093181|25919014|FG002|Overall Study|Other (Not specified)|0|||
13115722|NCT03093181|25919012|FG000|Overall Study|Adverse Event|0|||
13115723|NCT03093181|25919013|FG001|Overall Study|Adverse Event|1|||
13115724|NCT03093181|25919014|FG002|Overall Study|Adverse Event|0|||
13115725|NCT03093181|25919012|FG000|Overall Study|Other (Protocol violation)|0|||
13115726|NCT03093181|25919013|FG001|Overall Study|Other (Protocol violation)|0|||
13115727|NCT03093181|25919014|FG002|Overall Study|Other (Protocol violation)|1|||
13115728|NCT03092791|25919154|FG000|Overall Study|Lost to Follow-up|0|||
13115729|NCT03092791|25919155|FG001|Overall Study|Lost to Follow-up|0|||
13115730|NCT03092791|25919156|FG002|Overall Study|Lost to Follow-up|0|||
13115731|NCT03092791|25919157|FG003|Overall Study|Lost to Follow-up|0|||
13115732|NCT03092791|25919158|FG004|Overall Study|Lost to Follow-up|0|||
13115733|NCT03092791|25919159|FG005|Overall Study|Lost to Follow-up|0|||
13115734|NCT03092791|25919160|FG006|Overall Study|Lost to Follow-up|1|||
13115735|NCT03092791|25919161|FG007|Overall Study|Lost to Follow-up|0|||
13115736|NCT03092791|25919154|FG000|Overall Study|Withdrawal of Consent|0|||
13115737|NCT03092791|25919155|FG001|Overall Study|Withdrawal of Consent|0|||
13240143|NCT01650636|26339543|FG001|Washout up to 9 Months|Lost to Follow-up|1|||
13240144|NCT01650558|26339576|FG000|Overall Study|Migration out of study area|61|||
13240145|NCT01650558|26339577|FG001|Overall Study|Migration out of study area|71|||
13240146|NCT01650558|26339578|FG002|Overall Study|Migration out of study area|56|||
13240147|NCT01650558|26339576|FG000|Overall Study|Lost to Follow-up|10|||
13240148|NCT01650558|26339577|FG001|Overall Study|Lost to Follow-up|13|||
13240149|NCT01650558|26339578|FG002|Overall Study|Lost to Follow-up|6|||
13240150|NCT01650558|26339576|FG000|Overall Study|Death|10|||
13240151|NCT01650558|26339577|FG001|Overall Study|Death|6|||
13240152|NCT01650558|26339578|FG002|Overall Study|Death|8|||
13240153|NCT01650558|26339576|FG000|Overall Study|Withdrawal by Subject|1|||
13240154|NCT01650558|26339577|FG001|Overall Study|Withdrawal by Subject|1|||
13240155|NCT01650558|26339578|FG002|Overall Study|Withdrawal by Subject|3|||
13240156|NCT01650558|26339576|FG000|Overall Study|Non-compliant participant|1|||
13240157|NCT01650558|26339577|FG001|Overall Study|Non-compliant participant|0|||
13240158|NCT01650558|26339578|FG002|Overall Study|Non-compliant participant|2|||
13240159|NCT01650558|26339576|FG000|Overall Study|Physician Decision|0|||
13115738|NCT03092791|25919156|FG002|Overall Study|Withdrawal of Consent|0|||
13115739|NCT03092791|25919157|FG003|Overall Study|Withdrawal of Consent|0|||
13115740|NCT03092791|25919158|FG004|Overall Study|Withdrawal of Consent|4|||
13115741|NCT03092791|25919159|FG005|Overall Study|Withdrawal of Consent|12|||
13240160|NCT01650558|26339577|FG001|Overall Study|Physician Decision|1|||
13240161|NCT01650558|26339578|FG002|Overall Study|Physician Decision|0|||
13240162|NCT01650519|26339603|FG000|Overall Study|Withdrawal by Subject|1|||
13240163|NCT01650519|26339604|FG001|Overall Study|Withdrawal by Subject|0|||
13240164|NCT01650285|26339611|FG000|Overall Study|Adverse Event|1|||
13240165|NCT01650259|26339623|FG000|Overall Study|Improvement|105|||
13240166|NCT01650259|26339624|FG001|Overall Study|Improvement|0|||
13240167|NCT01650259|26339623|FG000|Overall Study|Adverse Event|127|||
13240168|NCT01650259|26339624|FG001|Overall Study|Adverse Event|0|||
13240169|NCT01650259|26339623|FG000|Overall Study|Lack of Efficacy|143|||
13240170|NCT01650259|26339624|FG001|Overall Study|Lack of Efficacy|0|||
13240171|NCT01650259|26339623|FG000|Overall Study|Lost to Follow-up|435|||
13240172|NCT01650259|26339624|FG001|Overall Study|Lost to Follow-up|0|||
13240173|NCT01650259|26339623|FG000|Overall Study|Patients had no visit after entry|70|||
13240174|NCT01650259|26339624|FG001|Overall Study|Patients had no visit after entry|0|||
13240175|NCT01650259|26339623|FG000|Overall Study|CRF not collected|98|||
13240176|NCT01650259|26339624|FG001|Overall Study|CRF not collected|82|||
13240177|NCT01650259|26339623|FG000|Overall Study|Not treated|1|||
13240178|NCT01650259|26339624|FG001|Overall Study|Not treated|7|||
13240179|NCT01650259|26339623|FG000|Overall Study|Other than listed|64|||
13240180|NCT01650259|26339624|FG001|Overall Study|Other than listed|146|||
13240181|NCT01650246|26339631|FG000|Overall Study|Adverse Event|23|||
13240182|NCT01650246|26339631|FG000|Overall Study|Protocol Violation|5|||
13240183|NCT01650246|26339631|FG000|Overall Study|Sponsor terminated study|53|||
13240184|NCT01650246|26339631|FG000|Overall Study|Lost to Follow-up|5|||
13240185|NCT01650246|26339631|FG000|Overall Study|Withdrawal by Subject|26|||
13240186|NCT01650246|26339631|FG000|Overall Study|Death|1|||
13240187|NCT01650246|26339631|FG000|Overall Study|Lack of Efficacy|30|||
13240188|NCT01650194|26339656|FG000|Overall Study|Progressive Disease (PD)|35|||
13240189|NCT01650194|26339656|FG000|Overall Study|Withdrawal by Subject|2|||
13240190|NCT01650194|26339656|FG000|Overall Study|Miscellaneous|10|||
13240191|NCT01649869|26339709|FG000|Overall Study|Family member illness|1|||
13240192|NCT01649869|26339710|FG001|Overall Study|Family member illness|0|||
13240193|NCT01649869|26339709|FG000|Overall Study|Required treatment outside protocol|1|||
13240194|NCT01649869|26339710|FG001|Overall Study|Required treatment outside protocol|0|||
13240195|NCT01649869|26339709|FG000|Overall Study|Severe hearing loss borderline eligible|0|||
13240196|NCT01649869|26339710|FG001|Overall Study|Severe hearing loss borderline eligible|1|||
13240197|NCT01649856|26339749|FG000|Overall Study|Withdrawal by Subject|14|||
13240198|NCT01649856|26339750|FG001|Overall Study|Withdrawal by Subject|14|||
13240199|NCT01649856|26339749|FG000|Overall Study|Protocol Violation|4|||
13240200|NCT01649856|26339750|FG001|Overall Study|Protocol Violation|4|||
13240201|NCT01649856|26339749|FG000|Overall Study|Treatment Failure|1|||
13240202|NCT01649856|26339750|FG001|Overall Study|Treatment Failure|1|||
13240203|NCT01649856|26339749|FG000|Overall Study|Death|69|||
13240204|NCT01649856|26339750|FG001|Overall Study|Death|34|||
13240205|NCT01649856|26339749|FG000|Overall Study|Stable or Progressed Disease|5|||
13240206|NCT01649856|26339750|FG001|Overall Study|Stable or Progressed Disease|3|||
13240207|NCT01649856|26339749|FG000|Overall Study|Lost to Follow-up|20|||
13240208|NCT01649856|26339750|FG001|Overall Study|Lost to Follow-up|16|||
13240209|NCT01649856|26339749|FG000|Overall Study|Lack of Compliance|6|||
13240210|NCT01649856|26339750|FG001|Overall Study|Lack of Compliance|1|||
13240211|NCT01649856|26339749|FG000|Overall Study|Other|20|||
13240212|NCT01649856|26339750|FG001|Overall Study|Other|5|||
13240213|NCT01649804|26339764|FG000|Overall Study|Administrative/Other|8|||
13240214|NCT01649791|26339773|FG000|Overall Study|Disease Progression|2|||
13240215|NCT01649791|26339773|FG000|Overall Study|Adverse Event|1|||
13240216|NCT01649765|26339806|FG000|Overall Study|Adverse Event|5|||
13240217|NCT01649765|26339807|FG001|Overall Study|Adverse Event|3|||
13240218|NCT01649765|26339806|FG000|Overall Study|Lack of Efficacy|1|||
13115742|NCT03092791|25919160|FG006|Overall Study|Withdrawal of Consent|6|||
13240219|NCT01649765|26339807|FG001|Overall Study|Lack of Efficacy|1|||
13240220|NCT01649765|26339806|FG000|Overall Study|Physician Decision|0|||
13240221|NCT01649765|26339807|FG001|Overall Study|Physician Decision|3|||
13240222|NCT01649765|26339806|FG000|Overall Study|Protocol Violation|1|||
13240223|NCT01649765|26339807|FG001|Overall Study|Protocol Violation|0|||
13240224|NCT01649765|26339806|FG000|Overall Study|Withdrawal by Subject|2|||
13240225|NCT01649765|26339807|FG001|Overall Study|Withdrawal by Subject|1|||
13240226|NCT01649557|26339852|FG000|Overall Study|Lost to Follow-up|5|||
13240227|NCT01649557|26339853|FG001|Overall Study|Lost to Follow-up|0|||
13240228|NCT01649557|26339854|FG002|Overall Study|Lost to Follow-up|3|||
13240229|NCT01649557|26339852|FG000|Overall Study|Adverse Event|7|||
13240230|NCT01649557|26339853|FG001|Overall Study|Adverse Event|5|||
13240231|NCT01649557|26339854|FG002|Overall Study|Adverse Event|1|||
13240232|NCT01649557|26339852|FG000|Overall Study|Met withdrawal criteria|4|||
13240233|NCT01649557|26339853|FG001|Overall Study|Met withdrawal criteria|0|||
13240234|NCT01649557|26339854|FG002|Overall Study|Met withdrawal criteria|0|||
13240235|NCT01649557|26339852|FG000|Overall Study|Physician Decision|8|||
13240236|NCT01649557|26339853|FG001|Overall Study|Physician Decision|2|||
13240237|NCT01649557|26339854|FG002|Overall Study|Physician Decision|1|||
13240238|NCT01649557|26339852|FG000|Overall Study|Withdrawal by Subject|15|||
13240239|NCT01649557|26339853|FG001|Overall Study|Withdrawal by Subject|5|||
13240240|NCT01649557|26339854|FG002|Overall Study|Withdrawal by Subject|4|||
13240241|NCT01649557|26339852|FG000|Overall Study|Protocol deviation|0|||
13240242|NCT01649557|26339853|FG001|Overall Study|Protocol deviation|2|||
13240243|NCT01649557|26339854|FG002|Overall Study|Protocol deviation|0|||
13240244|NCT01649557|26339852|FG000|Overall Study|Lack of Efficacy|5|||
13240245|NCT01649557|26339853|FG001|Overall Study|Lack of Efficacy|0|||
13240246|NCT01649557|26339854|FG002|Overall Study|Lack of Efficacy|0|||
13240247|NCT01649427|26339877|FG000|Overall Study|Adverse Event|1|||
13240248|NCT01649427|26339878|FG001|Overall Study|Adverse Event|1|||
13240249|NCT01649427|26339877|FG000|Overall Study|Withdrawal by Subject|8|||
13240250|NCT01649427|26339878|FG001|Overall Study|Withdrawal by Subject|7|||
13240251|NCT01649427|26339877|FG000|Overall Study|Lost to Follow-up|0|||
13240252|NCT01649427|26339878|FG001|Overall Study|Lost to Follow-up|1|||
13240253|NCT01649427|26339877|FG000|Overall Study|Graft loss|0|||
13240254|NCT01649427|26339878|FG001|Overall Study|Graft loss|1|||
13240255|NCT01649427|26339877|FG000|Overall Study|Surgical problems during nephrectomy|2|||
13240256|NCT01649427|26339878|FG001|Overall Study|Surgical problems during nephrectomy|2|||
13240257|NCT01649375|26339919|FG000|Up to Week 16|Adverse Event|2|||
13240258|NCT01649375|26339920|FG001|Up to Week 16|Adverse Event|5|||
13240259|NCT01649375|26339921|FG002|Up to Week 16|Adverse Event|4|||
13240260|NCT01649375|26339922|FG003|Up to Week 16|Adverse Event|0|||
13240261|NCT01649375|26339923|FG004|Up to Week 16|Adverse Event|0|||
13240262|NCT01649375|26339919|FG000|Up to Week 16|Lack of Efficacy|0|||
13240263|NCT01649375|26339920|FG001|Up to Week 16|Lack of Efficacy|0|||
13240264|NCT01649375|26339921|FG002|Up to Week 16|Lack of Efficacy|1|||
13240265|NCT01649375|26339922|FG003|Up to Week 16|Lack of Efficacy|0|||
13240266|NCT01649375|26339923|FG004|Up to Week 16|Lack of Efficacy|0|||
13240267|NCT01649375|26339919|FG000|Up to Week 16|Physician Decision|0|||
13240268|NCT01649375|26339920|FG001|Up to Week 16|Physician Decision|0|||
13240269|NCT01649375|26339921|FG002|Up to Week 16|Physician Decision|1|||
13240270|NCT01649375|26339922|FG003|Up to Week 16|Physician Decision|0|||
13240271|NCT01649375|26339923|FG004|Up to Week 16|Physician Decision|0|||
13240272|NCT01649375|26339919|FG000|Up to Week 16|Withdrawal by Subject|2|||
13240273|NCT01649375|26339920|FG001|Up to Week 16|Withdrawal by Subject|1|||
13240274|NCT01649375|26339921|FG002|Up to Week 16|Withdrawal by Subject|2|||
13240275|NCT01649375|26339922|FG003|Up to Week 16|Withdrawal by Subject|0|||
13240276|NCT01649375|26339923|FG004|Up to Week 16|Withdrawal by Subject|0|||
13240277|NCT01649375|26339919|FG000|Up to Week 16|Death|1|||
13240278|NCT01649375|26339920|FG001|Up to Week 16|Death|0|||
13240279|NCT01649375|26339921|FG002|Up to Week 16|Death|0|||
13240280|NCT01649375|26339922|FG003|Up to Week 16|Death|0|||
13240281|NCT01649375|26339923|FG004|Up to Week 16|Death|0|||
13240282|NCT01649375|26339919|FG000|Week 16 up to Week 260|Lack of Efficacy|7|||
13240283|NCT01649375|26339920|FG001|Week 16 up to Week 260|Lack of Efficacy|4|||
13240284|NCT01649375|26339921|FG002|Week 16 up to Week 260|Lack of Efficacy|0|||
13240285|NCT01649375|26339922|FG003|Week 16 up to Week 260|Lack of Efficacy|4|||
13240286|NCT01649375|26339923|FG004|Week 16 up to Week 260|Lack of Efficacy|2|||
13240287|NCT01649375|26339919|FG000|Week 16 up to Week 260|Non-compliance|0|||
13240288|NCT01649375|26339920|FG001|Week 16 up to Week 260|Non-compliance|1|||
13240289|NCT01649375|26339921|FG002|Week 16 up to Week 260|Non-compliance|0|||
13240290|NCT01649375|26339922|FG003|Week 16 up to Week 260|Non-compliance|1|||
13240291|NCT01649375|26339923|FG004|Week 16 up to Week 260|Non-compliance|0|||
13240292|NCT01649375|26339919|FG000|Week 16 up to Week 260|Physician Decision|0|||
13240293|NCT01649375|26339920|FG001|Week 16 up to Week 260|Physician Decision|2|||
13240294|NCT01649375|26339921|FG002|Week 16 up to Week 260|Physician Decision|0|||
13240295|NCT01649375|26339922|FG003|Week 16 up to Week 260|Physician Decision|0|||
13240296|NCT01649375|26339923|FG004|Week 16 up to Week 260|Physician Decision|0|||
13240297|NCT01649375|26339919|FG000|Week 16 up to Week 260|Technical issues|0|||
13240298|NCT01649375|26339920|FG001|Week 16 up to Week 260|Technical issues|1|||
13240299|NCT01649375|26339921|FG002|Week 16 up to Week 260|Technical issues|0|||
13240300|NCT01649375|26339922|FG003|Week 16 up to Week 260|Technical issues|1|||
13240301|NCT01649375|26339923|FG004|Week 16 up to Week 260|Technical issues|0|||
13240302|NCT01649375|26339919|FG000|Week 16 up to Week 260|Withdrawal by Subject|7|||
13240303|NCT01649375|26339920|FG001|Week 16 up to Week 260|Withdrawal by Subject|2|||
13240304|NCT01649375|26339921|FG002|Week 16 up to Week 260|Withdrawal by Subject|0|||
13240305|NCT01649375|26339922|FG003|Week 16 up to Week 260|Withdrawal by Subject|3|||
13240306|NCT01649375|26339923|FG004|Week 16 up to Week 260|Withdrawal by Subject|1|||
13240307|NCT01649375|26339919|FG000|Week 16 up to Week 260|Death|1|||
13240308|NCT01649375|26339920|FG001|Week 16 up to Week 260|Death|1|||
13240309|NCT01649375|26339921|FG002|Week 16 up to Week 260|Death|0|||
13240310|NCT01649375|26339922|FG003|Week 16 up to Week 260|Death|0|||
13240311|NCT01649375|26339923|FG004|Week 16 up to Week 260|Death|0|||
13240312|NCT01649375|26339919|FG000|Week 16 up to Week 260|Adverse Event|5|||
13240313|NCT01649375|26339920|FG001|Week 16 up to Week 260|Adverse Event|2|||
13240314|NCT01649375|26339921|FG002|Week 16 up to Week 260|Adverse Event|0|||
13240315|NCT01649375|26339922|FG003|Week 16 up to Week 260|Adverse Event|3|||
13240316|NCT01649375|26339923|FG004|Week 16 up to Week 260|Adverse Event|2|||
13240317|NCT01649297|26339956|FG000|Overall Study|Adverse Event|5|||
13240318|NCT01649297|26339957|FG001|Overall Study|Adverse Event|5|||
13240319|NCT01649297|26339958|FG002|Overall Study|Adverse Event|4|||
13240320|NCT01649297|26339959|FG003|Overall Study|Adverse Event|13|||
13240321|NCT01649297|26339960|FG004|Overall Study|Adverse Event|1|||
13240322|NCT01649297|26339956|FG000|Overall Study|Lack of Efficacy|0|||
13240323|NCT01649297|26339957|FG001|Overall Study|Lack of Efficacy|0|||
13240324|NCT01649297|26339958|FG002|Overall Study|Lack of Efficacy|0|||
13240325|NCT01649297|26339959|FG003|Overall Study|Lack of Efficacy|0|||
13240326|NCT01649297|26339960|FG004|Overall Study|Lack of Efficacy|1|||
13240327|NCT01649297|26339956|FG000|Overall Study|Non compliant with Protocol|1|||
13240328|NCT01649297|26339957|FG001|Overall Study|Non compliant with Protocol|0|||
13240329|NCT01649297|26339958|FG002|Overall Study|Non compliant with Protocol|3|||
13240330|NCT01649297|26339959|FG003|Overall Study|Non compliant with Protocol|2|||
13240331|NCT01649297|26339960|FG004|Overall Study|Non compliant with Protocol|1|||
13240332|NCT01649297|26339956|FG000|Overall Study|Lost to Follow-up|1|||
13240333|NCT01649297|26339957|FG001|Overall Study|Lost to Follow-up|1|||
13240334|NCT01649297|26339958|FG002|Overall Study|Lost to Follow-up|4|||
13240335|NCT01649297|26339959|FG003|Overall Study|Lost to Follow-up|3|||
13240336|NCT01649297|26339960|FG004|Overall Study|Lost to Follow-up|0|||
13240337|NCT01649297|26339956|FG000|Overall Study|Patient withdrawal (not due to AE)|3|||
13240338|NCT01649297|26339957|FG001|Overall Study|Patient withdrawal (not due to AE)|6|||
13240339|NCT01649297|26339958|FG002|Overall Study|Patient withdrawal (not due to AE)|4|||
13240340|NCT01649297|26339959|FG003|Overall Study|Patient withdrawal (not due to AE)|1|||
13240341|NCT01649297|26339960|FG004|Overall Study|Patient withdrawal (not due to AE)|1|||
13240342|NCT01649297|26339956|FG000|Overall Study|For other reason|4|||
13240343|NCT01649297|26339957|FG001|Overall Study|For other reason|1|||
13240344|NCT01649297|26339958|FG002|Overall Study|For other reason|2|||
13240345|NCT01649297|26339959|FG003|Overall Study|For other reason|0|||
13240346|NCT01649297|26339960|FG004|Overall Study|For other reason|0|||
13240347|NCT01649271|26339980|FG000|Overall Study|Progressive disease|4|||
13240348|NCT01649271|26339981|FG001|Overall Study|Progressive disease|5|||
13240349|NCT01649271|26339980|FG000|Overall Study|Other Adverse Event|0|||
13240350|NCT01649271|26339981|FG001|Overall Study|Other Adverse Event|2|||
13240351|NCT01649271|26339980|FG000|Overall Study|Withdrawal by Subject|1|||
13240352|NCT01649271|26339981|FG001|Overall Study|Withdrawal by Subject|0|||
13240353|NCT01649271|26339980|FG000|Overall Study|Other than stated above|1|||
13240354|NCT01649271|26339981|FG001|Overall Study|Other than stated above|0|||
13240355|NCT01649232|26340008|FG000|Overall Study|Physician Decision|2|||
13240356|NCT01649232|26340009|FG001|Overall Study|Physician Decision|0|||
13240357|NCT01648790|26340036|FG000|Treatment 3|Withdrawal by Subject|0|||
13240358|NCT01648790|26340037|FG001|Treatment 3|Withdrawal by Subject|0|||
13240359|NCT01648790|26340038|FG002|Treatment 3|Withdrawal by Subject|0|||
13240360|NCT01648790|26340039|FG003|Treatment 3|Withdrawal by Subject|1|||
13240361|NCT01648790|26340040|FG004|Treatment 3|Withdrawal by Subject|0|||
13240362|NCT01648764|26340235|FG000|Overall Study|Progressive Disease|0|||
13240363|NCT01648764|26340236|FG001|Overall Study|Progressive Disease|1|||
13240364|NCT01648764|26340237|FG002|Overall Study|Progressive Disease|0|||
13240365|NCT01648764|26340238|FG003|Overall Study|Progressive Disease|0|||
13240366|NCT01648764|26340239|FG004|Overall Study|Progressive Disease|0|||
13240367|NCT01648764|26340240|FG005|Overall Study|Progressive Disease|1|||
13240368|NCT01648764|26340241|FG006|Overall Study|Progressive Disease|1|||
13240369|NCT01648764|26340242|FG007|Overall Study|Progressive Disease|0|||
13240370|NCT01648764|26340243|FG008|Overall Study|Progressive Disease|0|||
13240371|NCT01648764|26340244|FG009|Overall Study|Progressive Disease|2|||
13240372|NCT01648764|26340245|FG010|Overall Study|Progressive Disease|0|||
13240373|NCT01648764|26340246|FG011|Overall Study|Progressive Disease|1|||
13240374|NCT01648764|26340247|FG012|Overall Study|Progressive Disease|2|||
13240375|NCT01648764|26340248|FG013|Overall Study|Progressive Disease|1|||
13240376|NCT01648764|26340235|FG000|Overall Study|Adverse Event|0|||
13240377|NCT01648764|26340236|FG001|Overall Study|Adverse Event|0|||
13240378|NCT01648764|26340237|FG002|Overall Study|Adverse Event|0|||
13240379|NCT01648764|26340238|FG003|Overall Study|Adverse Event|0|||
13240380|NCT01648764|26340239|FG004|Overall Study|Adverse Event|0|||
13240381|NCT01648764|26340240|FG005|Overall Study|Adverse Event|1|||
13240382|NCT01648764|26340241|FG006|Overall Study|Adverse Event|0|||
13240383|NCT01648764|26340242|FG007|Overall Study|Adverse Event|0|||
13240384|NCT01648764|26340243|FG008|Overall Study|Adverse Event|0|||
13240385|NCT01648764|26340244|FG009|Overall Study|Adverse Event|1|||
13240386|NCT01648764|26340245|FG010|Overall Study|Adverse Event|0|||
13240387|NCT01648764|26340246|FG011|Overall Study|Adverse Event|3|||
13240388|NCT01648764|26340247|FG012|Overall Study|Adverse Event|1|||
13240389|NCT01648764|26340248|FG013|Overall Study|Adverse Event|1|||
13240390|NCT01648764|26340235|FG000|Overall Study|Death|0|||
13240391|NCT01648764|26340236|FG001|Overall Study|Death|0|||
13240392|NCT01648764|26340237|FG002|Overall Study|Death|0|||
13240393|NCT01648764|26340238|FG003|Overall Study|Death|0|||
13240394|NCT01648764|26340239|FG004|Overall Study|Death|0|||
13240395|NCT01648764|26340240|FG005|Overall Study|Death|0|||
13240396|NCT01648764|26340241|FG006|Overall Study|Death|1|||
13240397|NCT01648764|26340242|FG007|Overall Study|Death|0|||
13240398|NCT01648764|26340243|FG008|Overall Study|Death|0|||
13240399|NCT01648764|26340244|FG009|Overall Study|Death|0|||
13240400|NCT01648764|26340245|FG010|Overall Study|Death|0|||
13240401|NCT01648764|26340246|FG011|Overall Study|Death|0|||
13240402|NCT01648764|26340247|FG012|Overall Study|Death|0|||
13240403|NCT01648764|26340248|FG013|Overall Study|Death|1|||
13240404|NCT01648764|26340235|FG000|Overall Study|Withdrawal by Subject|0|||
13240405|NCT01648764|26340236|FG001|Overall Study|Withdrawal by Subject|0|||
13240406|NCT01648764|26340237|FG002|Overall Study|Withdrawal by Subject|0|||
13240407|NCT01648764|26340238|FG003|Overall Study|Withdrawal by Subject|0|||
13240408|NCT01648764|26340239|FG004|Overall Study|Withdrawal by Subject|0|||
13240409|NCT01648764|26340240|FG005|Overall Study|Withdrawal by Subject|0|||
13240410|NCT01648764|26340241|FG006|Overall Study|Withdrawal by Subject|2|||
13240411|NCT01648764|26340242|FG007|Overall Study|Withdrawal by Subject|0|||
13240412|NCT01648764|26340243|FG008|Overall Study|Withdrawal by Subject|0|||
13240413|NCT01648764|26340244|FG009|Overall Study|Withdrawal by Subject|0|||
13240414|NCT01648764|26340245|FG010|Overall Study|Withdrawal by Subject|0|||
13240415|NCT01648764|26340246|FG011|Overall Study|Withdrawal by Subject|0|||
13240416|NCT01648764|26340247|FG012|Overall Study|Withdrawal by Subject|1|||
13240417|NCT01648764|26340248|FG013|Overall Study|Withdrawal by Subject|0|||
13115743|NCT03092791|25919161|FG007|Overall Study|Withdrawal of Consent|4|||
13240418|NCT01648764|26340235|FG000|Overall Study|Investigator Decision|0|||
13240419|NCT01648764|26340236|FG001|Overall Study|Investigator Decision|0|||
13240420|NCT01648764|26340237|FG002|Overall Study|Investigator Decision|0|||
13240421|NCT01648764|26340238|FG003|Overall Study|Investigator Decision|0|||
13240422|NCT01648764|26340239|FG004|Overall Study|Investigator Decision|0|||
13240423|NCT01648764|26340240|FG005|Overall Study|Investigator Decision|0|||
13240424|NCT01648764|26340241|FG006|Overall Study|Investigator Decision|1|||
13240425|NCT01648764|26340242|FG007|Overall Study|Investigator Decision|0|||
13240426|NCT01648764|26340243|FG008|Overall Study|Investigator Decision|0|||
13240427|NCT01648764|26340244|FG009|Overall Study|Investigator Decision|0|||
13240428|NCT01648764|26340245|FG010|Overall Study|Investigator Decision|0|||
13240429|NCT01648764|26340246|FG011|Overall Study|Investigator Decision|1|||
13240430|NCT01648764|26340247|FG012|Overall Study|Investigator Decision|0|||
13240431|NCT01648764|26340248|FG013|Overall Study|Investigator Decision|0|||
13240432|NCT01648699|26340276|FG000|Overall Study|Death|1|||
13240433|NCT01648699|26340276|FG000|Overall Study|Lost to Follow-up|2|||
13240434|NCT01648699|26340276|FG000|Overall Study|Unspecified/unable to complete 4 visits|2|||
13240435|NCT01648582|26340355|FG000|Overall Study|Adverse Event|6|||
13240436|NCT01648582|26340356|FG001|Overall Study|Adverse Event|11|||
13240437|NCT01648582|26340357|FG002|Overall Study|Adverse Event|2|||
13240438|NCT01648582|26340355|FG000|Overall Study|Lost to Follow-up|9|||
13240439|NCT01648582|26340356|FG001|Overall Study|Lost to Follow-up|6|||
13240440|NCT01648582|26340357|FG002|Overall Study|Lost to Follow-up|8|||
13240441|NCT01648582|26340355|FG000|Overall Study|Protocol Violation|1|||
13240442|NCT01648582|26340356|FG001|Overall Study|Protocol Violation|2|||
13240443|NCT01648582|26340357|FG002|Overall Study|Protocol Violation|1|||
13240444|NCT01648582|26340355|FG000|Overall Study|Withdrawal by Subject|15|||
13240445|NCT01648582|26340356|FG001|Overall Study|Withdrawal by Subject|17|||
13240446|NCT01648582|26340357|FG002|Overall Study|Withdrawal by Subject|17|||
13240447|NCT01648582|26340355|FG000|Overall Study|Physician Decision|0|||
13240448|NCT01648582|26340356|FG001|Overall Study|Physician Decision|1|||
13240449|NCT01648582|26340357|FG002|Overall Study|Physician Decision|3|||
13240450|NCT01648582|26340355|FG000|Overall Study|Death|1|||
13240451|NCT01648582|26340356|FG001|Overall Study|Death|0|||
13240452|NCT01648582|26340357|FG002|Overall Study|Death|0|||
13240453|NCT01648582|26340355|FG000|Overall Study|Sponsor Decision|0|||
13240454|NCT01648582|26340356|FG001|Overall Study|Sponsor Decision|1|||
13240455|NCT01648582|26340357|FG002|Overall Study|Sponsor Decision|1|||
13240456|NCT01648348|26340395|FG000|Overall Study|Cancel|1|||
13240457|NCT01648348|26340396|FG001|Overall Study|Cancel|0|||
13240458|NCT01648348|26340397|FG002|Overall Study|Cancel|0|||
13240459|NCT01648348|26340398|FG003|Overall Study|Cancel|0|||
13240460|NCT01648348|26340399|FG004|Overall Study|Cancel|3|||
13240461|NCT01648348|26340400|FG005|Overall Study|Cancel|6|||
13240462|NCT01648348|26340395|FG000|Overall Study|Replaced for MTD analysis|1|||
13240463|NCT01648348|26340396|FG001|Overall Study|Replaced for MTD analysis|0|||
13240464|NCT01648348|26340397|FG002|Overall Study|Replaced for MTD analysis|1|||
13240465|NCT01648348|26340398|FG003|Overall Study|Replaced for MTD analysis|0|||
13240466|NCT01648348|26340399|FG004|Overall Study|Replaced for MTD analysis|0|||
13240467|NCT01648348|26340400|FG005|Overall Study|Replaced for MTD analysis|0|||
13240468|NCT01648283|26340408|FG000|Overall Study|Withdrawal by Subject|14|||
13240469|NCT01648270|26340420|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12|||
13240470|NCT01648205|26340430|FG000|Placebo|Pregnancy|1|||
13240471|NCT01648205|26340430|FG000|Placebo|Withdrawal by Subject|1|||
13240472|NCT01648205|26340430|FG000|Placebo|Protocol Violation|2|||
13240473|NCT01648205|26340430|FG000|Ranolazine|Death|1|||
13115744|NCT03092791|25919154|FG000|Overall Study|Study Termination|0|||
13240474|NCT01648205|26340430|FG000|Ranolazine|Withdrawal by Subject|1|||
13115745|NCT03092791|25919155|FG001|Overall Study|Study Termination|0|||
13240475|NCT01648205|26340430|FG000|Ranolazine|Protocol Violation|3|||
13240476|NCT01648166|26340443|FG000|Overall Study|inadequate toenail samples|53|||
13240477|NCT01648166|26340444|FG001|Overall Study|inadequate toenail samples|100|||
13240478|NCT01648140|26340619|FG000|Overall Study|Physician Decision|1|||
13240479|NCT01648140|26340620|FG001|Overall Study|Physician Decision|0|||
13240480|NCT01648140|26340621|FG002|Overall Study|Physician Decision|0|||
13240481|NCT01648140|26340622|FG003|Overall Study|Physician Decision|0|||
13240482|NCT01648140|26340619|FG000|Overall Study|Lack of Efficacy|4|||
13240483|NCT01648140|26340620|FG001|Overall Study|Lack of Efficacy|7|||
13240484|NCT01648140|26340621|FG002|Overall Study|Lack of Efficacy|1|||
13240485|NCT01648140|26340622|FG003|Overall Study|Lack of Efficacy|0|||
13240486|NCT01648140|26340619|FG000|Overall Study|Adverse Event|3|||
13240487|NCT01648140|26340620|FG001|Overall Study|Adverse Event|1|||
13240488|NCT01648140|26340621|FG002|Overall Study|Adverse Event|2|||
13240489|NCT01648140|26340622|FG003|Overall Study|Adverse Event|0|||
13240490|NCT01648140|26340619|FG000|Overall Study|Withdrawal by Subject|2|||
13240491|NCT01648140|26340620|FG001|Overall Study|Withdrawal by Subject|3|||
13240492|NCT01648140|26340621|FG002|Overall Study|Withdrawal by Subject|3|||
13240493|NCT01648140|26340622|FG003|Overall Study|Withdrawal by Subject|2|||
13240494|NCT01648140|26340619|FG000|Overall Study|Lost to Follow-up|2|||
13240495|NCT01648140|26340620|FG001|Overall Study|Lost to Follow-up|1|||
13240496|NCT01648140|26340621|FG002|Overall Study|Lost to Follow-up|2|||
13240497|NCT01648140|26340622|FG003|Overall Study|Lost to Follow-up|0|||
13240498|NCT01648101|26340680|FG000|Titration Phase (4 Weeks)|Protocol Violation|2|||
13240499|NCT01648101|26340681|FG001|Titration Phase (4 Weeks)|Protocol Violation|1|||
13240500|NCT01648101|26340682|FG002|Titration Phase (4 Weeks)|Protocol Violation|2|||
13240501|NCT01648101|26340680|FG000|Titration Phase (4 Weeks)|Adverse Event|0|||
13240502|NCT01648101|26340681|FG001|Titration Phase (4 Weeks)|Adverse Event|2|||
13240503|NCT01648101|26340682|FG002|Titration Phase (4 Weeks)|Adverse Event|3|||
13240504|NCT01648101|26340680|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
13240505|NCT01648101|26340681|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
13240506|NCT01648101|26340682|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1|||
13240507|NCT01648101|26340680|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
13240508|NCT01648101|26340681|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0|||
13240509|NCT01648101|26340682|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
13240510|NCT01648101|26340680|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
13240511|NCT01648101|26340681|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0|||
13240512|NCT01648101|26340682|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
13240513|NCT01648101|26340680|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1|||
13240514|NCT01648101|26340681|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3|||
13240515|NCT01648101|26340682|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4|||
13240516|NCT01648101|26340680|FG000|Transition Phase (4 Weeks)|Adverse Event|4|||
13240517|NCT01648101|26340681|FG001|Transition Phase (4 Weeks)|Adverse Event|3|||
13240518|NCT01648101|26340682|FG002|Transition Phase (4 Weeks)|Adverse Event|2|||
13240519|NCT01648101|26340680|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
13240520|NCT01648101|26340681|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2|||
13240521|NCT01648101|26340682|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
13240522|NCT01648101|26340680|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
13240523|NCT01648101|26340681|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
13240524|NCT01648101|26340682|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2|||
13240525|NCT01648101|26340680|FG000|Transition Phase (4 Weeks)|Study Terminated|1|||
13240526|NCT01648101|26340681|FG001|Transition Phase (4 Weeks)|Study Terminated|0|||
13240527|NCT01648101|26340682|FG002|Transition Phase (4 Weeks)|Study Terminated|0|||
13240528|NCT01648101|26340680|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
13240529|NCT01648101|26340681|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1|||
13240530|NCT01648101|26340682|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
13240531|NCT01647958|26340737|FG000|Initial Study|Lost to Follow-up|2|||
13240532|NCT01647958|26340738|FG001|Initial Study|Lost to Follow-up|3|||
13240533|NCT01647958|26340737|FG000|Continuation Phase|treatment received during Overall Study|39|||
13240534|NCT01647958|26340738|FG001|Continuation Phase|treatment received during Overall Study|0|||
13240535|NCT01647958|26340737|FG000|Extended Follow-up Phase|Lost to Follow-up|8|||
13240536|NCT01647958|26340738|FG001|Extended Follow-up Phase|Lost to Follow-up|0|||
13240537|NCT01647711|26340779|FG000|Overall Study|Progressive disease|6|||
13240538|NCT01647711|26340780|FG001|Overall Study|Progressive disease|2|||
13240539|NCT01647711|26340781|FG002|Overall Study|Progressive disease|6|||
13240540|NCT01647711|26340782|FG003|Overall Study|Progressive disease|8|||
13240541|NCT01647711|26340783|FG004|Overall Study|Progressive disease|2|||
13240542|NCT01647711|26340779|FG000|Overall Study|Other adverse event|0|||
13240543|NCT01647711|26340780|FG001|Overall Study|Other adverse event|0|||
13240544|NCT01647711|26340781|FG002|Overall Study|Other adverse event|2|||
13240545|NCT01647711|26340782|FG003|Overall Study|Other adverse event|0|||
13240546|NCT01647711|26340783|FG004|Overall Study|Other adverse event|2|||
13240547|NCT01647711|26340779|FG000|Overall Study|Protocol Violation|0|||
13240548|NCT01647711|26340780|FG001|Overall Study|Protocol Violation|0|||
13240549|NCT01647711|26340781|FG002|Overall Study|Protocol Violation|0|||
13240550|NCT01647711|26340782|FG003|Overall Study|Protocol Violation|0|||
13240551|NCT01647711|26340783|FG004|Overall Study|Protocol Violation|1|||
13240552|NCT01647711|26340779|FG000|Overall Study|Refused to continue taking medication|0|||
13115746|NCT03092791|25919156|FG002|Overall Study|Study Termination|0|||
13240553|NCT01647711|26340780|FG001|Overall Study|Refused to continue taking medication|0|||
13240554|NCT01647711|26340781|FG002|Overall Study|Refused to continue taking medication|0|||
13240555|NCT01647711|26340782|FG003|Overall Study|Refused to continue taking medication|2|||
13240556|NCT01647711|26340783|FG004|Overall Study|Refused to continue taking medication|1|||
13240557|NCT01647711|26340779|FG000|Overall Study|Other reason not defined|0|||
13240558|NCT01647711|26340780|FG001|Overall Study|Other reason not defined|1|||
13240559|NCT01647711|26340781|FG002|Overall Study|Other reason not defined|1|||
13240560|NCT01647711|26340782|FG003|Overall Study|Other reason not defined|1|||
13240561|NCT01647711|26340783|FG004|Overall Study|Other reason not defined|0|||
13240562|NCT01647542|26340810|FG000|Overall Study|Major Protocol Deviation|1|||
13240563|NCT01647542|26340811|FG001|Overall Study|Major Protocol Deviation|0|||
13240564|NCT01647542|26340812|FG002|Overall Study|Major Protocol Deviation|0|||
13240565|NCT01647542|26340810|FG000|Overall Study|Adverse Event|4|||
13240566|NCT01647542|26340811|FG001|Overall Study|Adverse Event|5|||
13240567|NCT01647542|26340812|FG002|Overall Study|Adverse Event|4|||
13240568|NCT01647542|26340810|FG000|Overall Study|Lost to Follow-up|0|||
13240569|NCT01647542|26340811|FG001|Overall Study|Lost to Follow-up|2|||
13240570|NCT01647542|26340812|FG002|Overall Study|Lost to Follow-up|2|||
13240571|NCT01647542|26340810|FG000|Overall Study|Withdrawal by Subject|6|||
13240572|NCT01647542|26340811|FG001|Overall Study|Withdrawal by Subject|4|||
13240573|NCT01647542|26340812|FG002|Overall Study|Withdrawal by Subject|0|||
13240574|NCT01647542|26340810|FG000|Overall Study|Study Termination|64|||
13240575|NCT01647542|26340811|FG001|Overall Study|Study Termination|61|||
13240576|NCT01647542|26340812|FG002|Overall Study|Study Termination|65|||
13240577|NCT01647542|26340810|FG000|Overall Study|Lack of Efficacy|1|||
13240578|NCT01647542|26340811|FG001|Overall Study|Lack of Efficacy|1|||
13240579|NCT01647542|26340812|FG002|Overall Study|Lack of Efficacy|0|||
13240580|NCT01647542|26340810|FG000|Overall Study|Death|0|||
13240581|NCT01647542|26340811|FG001|Overall Study|Death|0|||
13240582|NCT01647542|26340812|FG002|Overall Study|Death|1|||
13240583|NCT01647516|26340864|FG000|Induction Period (IP)|Physician Decision|2|||
13240584|NCT01647516|26340865|FG001|Induction Period (IP)|Physician Decision|0|||
13240585|NCT01647516|26340866|FG002|Induction Period (IP)|Physician Decision|0|||
13240586|NCT01647516|26340867|FG003|Induction Period (IP)|Physician Decision|0|||
13240587|NCT01647516|26340868|FG004|Induction Period (IP)|Physician Decision|0|||
13240588|NCT01647516|26340869|FG005|Induction Period (IP)|Physician Decision|0|||
13240589|NCT01647516|26340864|FG000|Induction Period (IP)|Adverse Event|1|||
13240590|NCT01647516|26340865|FG001|Induction Period (IP)|Adverse Event|2|||
13240591|NCT01647516|26340866|FG002|Induction Period (IP)|Adverse Event|0|||
13240592|NCT01647516|26340867|FG003|Induction Period (IP)|Adverse Event|0|||
13240593|NCT01647516|26340868|FG004|Induction Period (IP)|Adverse Event|0|||
13240594|NCT01647516|26340869|FG005|Induction Period (IP)|Adverse Event|0|||
13240595|NCT01647516|26340864|FG000|Induction Period (IP)|Withdrawal by Subject|1|||
13240596|NCT01647516|26340865|FG001|Induction Period (IP)|Withdrawal by Subject|0|||
13240597|NCT01647516|26340866|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
13240598|NCT01647516|26340867|FG003|Induction Period (IP)|Withdrawal by Subject|0|||
13240599|NCT01647516|26340868|FG004|Induction Period (IP)|Withdrawal by Subject|0|||
13240600|NCT01647516|26340869|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
13240601|NCT01647516|26340864|FG000|Induction Period (IP)|Participant Choice|0|||
13240602|NCT01647516|26340865|FG001|Induction Period (IP)|Participant Choice|0|||
13240603|NCT01647516|26340866|FG002|Induction Period (IP)|Participant Choice|1|||
13240604|NCT01647516|26340867|FG003|Induction Period (IP)|Participant Choice|0|||
13240605|NCT01647516|26340868|FG004|Induction Period (IP)|Participant Choice|0|||
13240606|NCT01647516|26340869|FG005|Induction Period (IP)|Participant Choice|0|||
13240607|NCT01647516|26340864|FG000|Induction Period (IP)|Lack of Efficacy|1|||
13240608|NCT01647516|26340865|FG001|Induction Period (IP)|Lack of Efficacy|0|||
13240609|NCT01647516|26340866|FG002|Induction Period (IP)|Lack of Efficacy|0|||
13240610|NCT01647516|26340867|FG003|Induction Period (IP)|Lack of Efficacy|0|||
13240611|NCT01647516|26340868|FG004|Induction Period (IP)|Lack of Efficacy|0|||
13240612|NCT01647516|26340869|FG005|Induction Period (IP)|Lack of Efficacy|0|||
13240613|NCT01647516|26340864|FG000|Induction Period (IP)|No study drug received|1|||
13240614|NCT01647516|26340865|FG001|Induction Period (IP)|No study drug received|1|||
13240615|NCT01647516|26340866|FG002|Induction Period (IP)|No study drug received|0|||
13240616|NCT01647516|26340867|FG003|Induction Period (IP)|No study drug received|0|||
13240617|NCT01647516|26340868|FG004|Induction Period (IP)|No study drug received|0|||
13240618|NCT01647516|26340869|FG005|Induction Period (IP)|No study drug received|0|||
13240619|NCT01647516|26340864|FG000|Maintenance Period (MP)|Adverse Event|2|||
13240620|NCT01647516|26340865|FG001|Maintenance Period (MP)|Adverse Event|1|||
13240621|NCT01647516|26340866|FG002|Maintenance Period (MP)|Adverse Event|0|||
13240622|NCT01647516|26340867|FG003|Maintenance Period (MP)|Adverse Event|0|||
13240623|NCT01647516|26340868|FG004|Maintenance Period (MP)|Adverse Event|0|||
13115747|NCT03092791|25919157|FG003|Overall Study|Study Termination|0|||
13240624|NCT01647516|26340869|FG005|Maintenance Period (MP)|Adverse Event|0|||
13240625|NCT01647516|26340864|FG000|Maintenance Period (MP)|Non-compliance|1|||
13240626|NCT01647516|26340865|FG001|Maintenance Period (MP)|Non-compliance|0|||
13240627|NCT01647516|26340866|FG002|Maintenance Period (MP)|Non-compliance|0|||
13240628|NCT01647516|26340867|FG003|Maintenance Period (MP)|Non-compliance|0|||
13240629|NCT01647516|26340868|FG004|Maintenance Period (MP)|Non-compliance|0|||
13240630|NCT01647516|26340869|FG005|Maintenance Period (MP)|Non-compliance|0|||
13240631|NCT01647516|26340864|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
13240632|NCT01647516|26340865|FG001|Maintenance Period (MP)|Withdrawal by Subject|1|||
13240633|NCT01647516|26340866|FG002|Maintenance Period (MP)|Withdrawal by Subject|1|||
13240634|NCT01647516|26340867|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
13240635|NCT01647516|26340868|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
13240636|NCT01647516|26340869|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
13240637|NCT01647516|26340864|FG000|Maintenance Period (MP)|Lack of Efficacy|1|||
13240638|NCT01647516|26340865|FG001|Maintenance Period (MP)|Lack of Efficacy|4|||
13240639|NCT01647516|26340866|FG002|Maintenance Period (MP)|Lack of Efficacy|1|||
13240640|NCT01647516|26340867|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
13240641|NCT01647516|26340868|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
13240642|NCT01647516|26340869|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
13240643|NCT01647516|26340864|FG000|Open-Label Period|Adverse Event|0|||
13240644|NCT01647516|26340865|FG001|Open-Label Period|Adverse Event|0|||
13240645|NCT01647516|26340866|FG002|Open-Label Period|Adverse Event|0|||
13240646|NCT01647516|26340867|FG003|Open-Label Period|Adverse Event|5|||
13240647|NCT01647516|26340868|FG004|Open-Label Period|Adverse Event|6|||
13240648|NCT01647516|26340869|FG005|Open-Label Period|Adverse Event|3|||
13240649|NCT01647516|26340864|FG000|Open-Label Period|Pregnancy|0|||
13240650|NCT01647516|26340865|FG001|Open-Label Period|Pregnancy|0|||
13240651|NCT01647516|26340866|FG002|Open-Label Period|Pregnancy|0|||
13240652|NCT01647516|26340867|FG003|Open-Label Period|Pregnancy|0|||
13240653|NCT01647516|26340868|FG004|Open-Label Period|Pregnancy|0|||
13240654|NCT01647516|26340869|FG005|Open-Label Period|Pregnancy|1|||
13240655|NCT01647516|26340864|FG000|Open-Label Period|Non-compliance|0|||
13240656|NCT01647516|26340865|FG001|Open-Label Period|Non-compliance|0|||
13240657|NCT01647516|26340866|FG002|Open-Label Period|Non-compliance|0|||
13240658|NCT01647516|26340867|FG003|Open-Label Period|Non-compliance|1|||
13240659|NCT01647516|26340868|FG004|Open-Label Period|Non-compliance|0|||
13240660|NCT01647516|26340869|FG005|Open-Label Period|Non-compliance|1|||
13240661|NCT01647516|26340864|FG000|Open-Label Period|Physician Decision|0|||
13240662|NCT01647516|26340865|FG001|Open-Label Period|Physician Decision|0|||
13240663|NCT01647516|26340866|FG002|Open-Label Period|Physician Decision|0|||
13240664|NCT01647516|26340867|FG003|Open-Label Period|Physician Decision|1|||
13240665|NCT01647516|26340868|FG004|Open-Label Period|Physician Decision|1|||
13240666|NCT01647516|26340869|FG005|Open-Label Period|Physician Decision|0|||
13240667|NCT01647516|26340864|FG000|Open-Label Period|Withdrawal by Subject|0|||
13240668|NCT01647516|26340865|FG001|Open-Label Period|Withdrawal by Subject|0|||
13240669|NCT01647516|26340866|FG002|Open-Label Period|Withdrawal by Subject|0|||
13240670|NCT01647516|26340867|FG003|Open-Label Period|Withdrawal by Subject|9|||
13240671|NCT01647516|26340868|FG004|Open-Label Period|Withdrawal by Subject|11|||
13240672|NCT01647516|26340869|FG005|Open-Label Period|Withdrawal by Subject|6|||
13240673|NCT01647516|26340864|FG000|Open-Label Period|Lost to Follow-up|0|||
13240674|NCT01647516|26340865|FG001|Open-Label Period|Lost to Follow-up|0|||
13240675|NCT01647516|26340866|FG002|Open-Label Period|Lost to Follow-up|0|||
13240676|NCT01647516|26340867|FG003|Open-Label Period|Lost to Follow-up|1|||
13240677|NCT01647516|26340868|FG004|Open-Label Period|Lost to Follow-up|0|||
13240678|NCT01647516|26340869|FG005|Open-Label Period|Lost to Follow-up|1|||
13240679|NCT01647516|26340864|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
13240680|NCT01647516|26340865|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
13240681|NCT01647516|26340866|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
13240682|NCT01647516|26340867|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18|||
13240683|NCT01647516|26340868|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13|||
13240684|NCT01647516|26340869|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23|||
13240685|NCT01647516|26340864|FG000|Open-Label Period|Lack of Efficacy|0|||
13240686|NCT01647516|26340865|FG001|Open-Label Period|Lack of Efficacy|0|||
13240687|NCT01647516|26340866|FG002|Open-Label Period|Lack of Efficacy|0|||
13240688|NCT01647516|26340867|FG003|Open-Label Period|Lack of Efficacy|7|||
13240689|NCT01647516|26340868|FG004|Open-Label Period|Lack of Efficacy|9|||
13240690|NCT01647516|26340869|FG005|Open-Label Period|Lack of Efficacy|10|||
13240691|NCT01647516|26340864|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0|||
13240692|NCT01647516|26340865|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0|||
13240693|NCT01647516|26340866|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0|||
13240694|NCT01647516|26340867|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7|||
13240695|NCT01647516|26340868|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9|||
13240696|NCT01647516|26340869|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10|||
13240697|NCT01647516|26340864|FG000|Open-Label Period|No completion / discontinuation visit|0|||
13240698|NCT01647516|26340865|FG001|Open-Label Period|No completion / discontinuation visit|0|||
13240699|NCT01647516|26340866|FG002|Open-Label Period|No completion / discontinuation visit|0|||
13240700|NCT01647516|26340867|FG003|Open-Label Period|No completion / discontinuation visit|0|||
13240701|NCT01647516|26340868|FG004|Open-Label Period|No completion / discontinuation visit|2|||
13240702|NCT01647516|26340869|FG005|Open-Label Period|No completion / discontinuation visit|1|||
13240703|NCT01647282|26340884|FG000|Overall Study|Physician Decision|7|||
13240704|NCT01647282|26340885|FG001|Overall Study|Physician Decision|5|||
13240705|NCT01646827|26340920|FG000|Overall Study|Lost to Follow-up|0|||
13240706|NCT01646827|26340921|FG001|Overall Study|Lost to Follow-up|3|||
13240707|NCT01646827|26340920|FG000|Overall Study|Physician Decision|1|||
13240708|NCT01646827|26340921|FG001|Overall Study|Physician Decision|2|||
13240709|NCT01646827|26340920|FG000|Overall Study|Withdrawal by Subject|1|||
13240710|NCT01646827|26340921|FG001|Overall Study|Withdrawal by Subject|0|||
13240711|NCT01646645|26340928|FG000|Overall Study|No Treated|1|||
13240712|NCT01646645|26340928|FG000|Overall Study|Inevaluable Donor|29|||
13240713|NCT01646398|26340949|FG000|Overall Study|Withdrawal by Subject|1|||
13240714|NCT01646398|26340950|FG001|Overall Study|Withdrawal by Subject|0|||
13240715|NCT01646385|26340988|FG000|Overall Study|Death|202|||
13240716|NCT01646385|26340989|FG001|Overall Study|Death|222|||
13240717|NCT01646385|26340988|FG000|Overall Study|Switched to alternate biologic|636|||
13240718|NCT01646385|26340989|FG001|Overall Study|Switched to alternate biologic|649|||
13240719|NCT01646320|26341010|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3|||
13240720|NCT01646320|26341011|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0|||
13240721|NCT01646320|26341010|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
13240722|NCT01646320|26341011|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1|||
13240723|NCT01646320|26341010|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2|||
13240724|NCT01646320|26341011|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2|||
13240725|NCT01646320|26341010|FG000|Short-term Period (Day 1 to Week 24)|Other|1|||
13240726|NCT01646320|26341011|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
13240727|NCT01646320|26341010|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
13240728|NCT01646320|26341011|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
13240729|NCT01646320|26341010|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2|||
13240730|NCT01646320|26341011|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
13240731|NCT01646320|26341010|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2|||
13240732|NCT01646320|26341011|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0|||
13240733|NCT01646320|26341010|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0|||
13240734|NCT01646320|26341011|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2|||
13240735|NCT01646320|26341010|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4|||
13240736|NCT01646320|26341011|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2|||
13240737|NCT01646320|26341010|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0|||
13240738|NCT01646320|26341011|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1|||
13240739|NCT01646320|26341010|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0|||
13240740|NCT01646320|26341011|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2|||
13240741|NCT01646268|26341030|FG000|Overall Study|Adverse Event|6|||
13240742|NCT01646268|26341031|FG001|Overall Study|Adverse Event|7|||
13240743|NCT01646268|26341030|FG000|Overall Study|Lack of Efficacy|1|||
13240744|NCT01646268|26341031|FG001|Overall Study|Lack of Efficacy|3|||
13240745|NCT01646268|26341030|FG000|Overall Study|Protocol Violation|0|||
13240746|NCT01646268|26341031|FG001|Overall Study|Protocol Violation|1|||
13240747|NCT01646268|26341030|FG000|Overall Study|Withdrawal by Subject|2|||
13240748|NCT01646268|26341031|FG001|Overall Study|Withdrawal by Subject|5|||
13240749|NCT01646268|26341030|FG000|Overall Study|Other|2|||
13240750|NCT01646268|26341031|FG001|Overall Study|Other|0|||
13240751|NCT01646255|26341068|FG000|Overall Study|Adverse Event|7|||
13240752|NCT01646255|26341069|FG001|Overall Study|Adverse Event|8|||
13240753|NCT01646255|26341068|FG000|Overall Study|Lack of Efficacy|2|||
13240754|NCT01646255|26341069|FG001|Overall Study|Lack of Efficacy|0|||
13240755|NCT01646255|26341068|FG000|Overall Study|Withdrawal by Subject|10|||
13240756|NCT01646255|26341069|FG001|Overall Study|Withdrawal by Subject|6|||
13240757|NCT01646255|26341068|FG000|Overall Study|Compliance is not well|1|||
13240758|NCT01646255|26341069|FG001|Overall Study|Compliance is not well|0|||
13240759|NCT01646255|26341068|FG000|Overall Study|Inclusion Criteria Deviation|1|||
13240760|NCT01646255|26341069|FG001|Overall Study|Inclusion Criteria Deviation|0|||
13240761|NCT01646216|26341095|FG000|Overall Study|Baseline step length difference (<5cm)|10|||
13240762|NCT01646216|26341096|FG001|Overall Study|Baseline step length difference (<5cm)|10|||
13240763|NCT01646216|26341095|FG000|Overall Study|Did not complete training|0|||
13240764|NCT01646216|26341096|FG001|Overall Study|Did not complete training|2|||
13240765|NCT01646216|26341095|FG000|Overall Study|Investigator decision|1|||
13240766|NCT01646216|26341096|FG001|Overall Study|Investigator decision|1|||
13240767|NCT01646203|26341131|FG000|Overall Study|Adverse Event|2|||
13240768|NCT01646203|26341132|FG001|Overall Study|Adverse Event|0|||
13240769|NCT01646203|26341133|FG002|Overall Study|Adverse Event|1|||
13240770|NCT01646203|26341131|FG000|Overall Study|Withdrawal by Subject|0|||
13240771|NCT01646203|26341132|FG001|Overall Study|Withdrawal by Subject|1|||
13240772|NCT01646203|26341133|FG002|Overall Study|Withdrawal by Subject|0|||
13240773|NCT01646203|26341131|FG000|Overall Study|Physician's Decision|0|||
13240774|NCT01646203|26341132|FG001|Overall Study|Physician's Decision|1|||
13240775|NCT01646203|26341133|FG002|Overall Study|Physician's Decision|0|||
13240776|NCT01646177|26341240|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2|||
13240777|NCT01646177|26341241|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4|||
13240778|NCT01646177|26341242|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9|||
13240779|NCT01646177|26341243|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8|||
13240780|NCT01646177|26341244|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
13240781|NCT01646177|26341245|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
13240782|NCT01646177|26341246|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
13240783|NCT01646177|26341247|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
13240784|NCT01646177|26341248|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
13240785|NCT01646177|26341249|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
13240786|NCT01646177|26341250|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
13240787|NCT01646177|26341251|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
13240788|NCT01646177|26341240|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1|||
13240789|NCT01646177|26341241|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3|||
13240790|NCT01646177|26341242|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8|||
13240791|NCT01646177|26341243|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7|||
13240792|NCT01646177|26341244|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
13240793|NCT01646177|26341245|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
13240794|NCT01646177|26341246|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
13240795|NCT01646177|26341247|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
13240796|NCT01646177|26341248|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
13240797|NCT01646177|26341249|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
13240798|NCT01646177|26341250|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
13240799|NCT01646177|26341251|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
13240800|NCT01646177|26341240|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3|||
13240801|NCT01646177|26341241|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2|||
13240802|NCT01646177|26341242|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
13240803|NCT01646177|26341243|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
13240804|NCT01646177|26341244|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
13240805|NCT01646177|26341245|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
13240806|NCT01646177|26341246|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
13240807|NCT01646177|26341247|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
13240808|NCT01646177|26341248|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
13240809|NCT01646177|26341249|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
13240810|NCT01646177|26341250|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
13240811|NCT01646177|26341251|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
13240812|NCT01646177|26341240|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
13240813|NCT01646177|26341241|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
13240814|NCT01646177|26341242|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
13240815|NCT01646177|26341243|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
13240816|NCT01646177|26341244|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
13240817|NCT01646177|26341245|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
13240818|NCT01646177|26341246|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
13240819|NCT01646177|26341247|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
13240820|NCT01646177|26341248|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
13240821|NCT01646177|26341249|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
13240822|NCT01646177|26341250|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
13240823|NCT01646177|26341251|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
13240824|NCT01646177|26341240|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
13240825|NCT01646177|26341241|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
13240826|NCT01646177|26341242|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2|||
13240827|NCT01646177|26341243|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1|||
13240828|NCT01646177|26341244|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
13240829|NCT01646177|26341245|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
13240830|NCT01646177|26341246|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
13240831|NCT01646177|26341247|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
13240832|NCT01646177|26341248|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
13240833|NCT01646177|26341249|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
13240834|NCT01646177|26341250|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
13240835|NCT01646177|26341251|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
13240836|NCT01646177|26341240|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3|||
13240837|NCT01646177|26341241|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
13240838|NCT01646177|26341242|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
13240839|NCT01646177|26341243|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
13240840|NCT01646177|26341244|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
13240841|NCT01646177|26341245|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
13240842|NCT01646177|26341246|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
13240843|NCT01646177|26341247|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
13240844|NCT01646177|26341248|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
13240845|NCT01646177|26341249|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
13240846|NCT01646177|26341250|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
13240847|NCT01646177|26341251|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
13240848|NCT01646177|26341240|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
13240849|NCT01646177|26341241|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
13240850|NCT01646177|26341242|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
13240851|NCT01646177|26341243|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
13240852|NCT01646177|26341244|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16|||
13240853|NCT01646177|26341245|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34|||
13240854|NCT01646177|26341246|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43|||
13240855|NCT01646177|26341247|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30|||
13240856|NCT01646177|26341248|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
13240857|NCT01646177|26341249|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
13240858|NCT01646177|26341250|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
13240859|NCT01646177|26341251|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
13240860|NCT01646177|26341240|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
13240861|NCT01646177|26341241|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
13240862|NCT01646177|26341242|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
13240863|NCT01646177|26341243|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
13240864|NCT01646177|26341244|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11|||
13240865|NCT01646177|26341245|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30|||
13240866|NCT01646177|26341246|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29|||
13240867|NCT01646177|26341247|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27|||
13240868|NCT01646177|26341248|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
13240869|NCT01646177|26341249|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
13240870|NCT01646177|26341250|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
13240871|NCT01646177|26341251|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
13240872|NCT01646177|26341240|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
13240873|NCT01646177|26341241|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
13240874|NCT01646177|26341242|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
13240875|NCT01646177|26341243|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
13240876|NCT01646177|26341244|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6|||
13240877|NCT01646177|26341245|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17|||
13240878|NCT01646177|26341246|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23|||
13240879|NCT01646177|26341247|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18|||
13240880|NCT01646177|26341248|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
13240881|NCT01646177|26341249|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
13240882|NCT01646177|26341250|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
13240883|NCT01646177|26341251|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
13115748|NCT03092791|25919158|FG004|Overall Study|Study Termination|55|||
13115749|NCT03092791|25919159|FG005|Overall Study|Study Termination|46|||
13115750|NCT03092791|25919160|FG006|Overall Study|Study Termination|53|||
13115751|NCT03092791|25919161|FG007|Overall Study|Study Termination|55|||
13240884|NCT01646177|26341240|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
13240885|NCT01646177|26341241|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
13240886|NCT01646177|26341242|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
13240887|NCT01646177|26341243|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
13240888|NCT01646177|26341244|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6|||
13240889|NCT01646177|26341245|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14|||
13240890|NCT01646177|26341246|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10|||
13240891|NCT01646177|26341247|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11|||
13115752|NCT03092791|25919154|FG000|Overall Study|Death|0|||
13115753|NCT03092791|25919155|FG001|Overall Study|Death|0|||
13115754|NCT03092791|25919156|FG002|Overall Study|Death|0|||
13115755|NCT03092791|25919157|FG003|Overall Study|Death|0|||
13115756|NCT03092791|25919158|FG004|Overall Study|Death|0|||
13115757|NCT03092791|25919159|FG005|Overall Study|Death|1|||
13115758|NCT03092791|25919160|FG006|Overall Study|Death|0|||
13115759|NCT03092791|25919161|FG007|Overall Study|Death|1|||
13115760|NCT03092791|25919154|FG000|Overall Study|Reason Not Specified|0|||
13115761|NCT03092791|25919155|FG001|Overall Study|Reason Not Specified|0|||
13115762|NCT03092791|25919156|FG002|Overall Study|Reason Not Specified|0|||
13115763|NCT03092791|25919157|FG003|Overall Study|Reason Not Specified|0|||
13115764|NCT03092791|25919158|FG004|Overall Study|Reason Not Specified|1|||
13115765|NCT03092791|25919159|FG005|Overall Study|Reason Not Specified|1|||
13115766|NCT03092791|25919160|FG006|Overall Study|Reason Not Specified|0|||
13115767|NCT03092791|25919161|FG007|Overall Study|Reason Not Specified|0|||
13115768|NCT03092752|25919226|FG000|Overall Study|Aged <40 years|14209|||
13115769|NCT03092752|25919226|FG000|Overall Study|At least one claim with T2DM|61299|||
13115770|NCT03092752|25919226|FG000|Overall Study|Having no claim of study drugs|29282|||
13115771|NCT03092752|25919226|FG000|Overall Study|Average hospital visit interval >92 days|10779|||
13115772|NCT03092752|25919226|FG000|Overall Study|<6 month history|245900|||
13240892|NCT01646177|26341248|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
13240893|NCT01646177|26341249|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
13240894|NCT01646177|26341250|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
13240895|NCT01646177|26341251|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
13240896|NCT01646177|26341240|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
13240897|NCT01646177|26341241|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
13240898|NCT01646177|26341242|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
13240899|NCT01646177|26341243|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
13240900|NCT01646177|26341244|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3|||
13240901|NCT01646177|26341245|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
13240902|NCT01646177|26341246|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
13240903|NCT01646177|26341247|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
13240904|NCT01646177|26341248|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
13240905|NCT01646177|26341249|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
13240906|NCT01646177|26341250|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
13115773|NCT03092726|25919257|FG000|Overall Study|Adverse Event|3|||
13115774|NCT03092726|25919258|FG001|Overall Study|Adverse Event|10|||
13115775|NCT03092726|25919257|FG000|Overall Study|Lack of Efficacy|0|||
13115776|NCT03092726|25919258|FG001|Overall Study|Lack of Efficacy|1|||
13115777|NCT03092726|25919257|FG000|Overall Study|Lost to Follow-up|1|||
13115778|NCT03092726|25919258|FG001|Overall Study|Lost to Follow-up|0|||
13115779|NCT03092726|25919257|FG000|Overall Study|Withdrawal by Subject|5|||
13115780|NCT03092726|25919258|FG001|Overall Study|Withdrawal by Subject|3|||
13115781|NCT03092479|25919283|FG000|Overall Study|Lost to Follow-up|3|||
13115782|NCT03092479|25919284|FG001|Overall Study|Lost to Follow-up|2|||
13115783|NCT03092479|25919283|FG000|Overall Study|Withdrawal by Subject|4|||
13240907|NCT01646177|26341251|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
13115784|NCT03092479|25919284|FG001|Overall Study|Withdrawal by Subject|0|||
13115785|NCT03092375|25919323|FG000|Overall Study|Lack of Efficacy|0|||
13115786|NCT03092375|25919324|FG001|Overall Study|Lack of Efficacy|1|||
13115787|NCT03092375|25919325|FG002|Overall Study|Lack of Efficacy|1|||
13115788|NCT03092375|25919326|FG003|Overall Study|Lack of Efficacy|0|||
13115789|NCT03091920|25919480|FG000|Overall Study|Adverse Event|0|||
13115790|NCT03091920|25919481|FG001|Overall Study|Adverse Event|1|||
13115791|NCT03091920|25919482|FG002|Overall Study|Adverse Event|0|||
13115792|NCT03091777|25919500|FG000|Overall Study|Pregnancy|2|||
13115793|NCT03091777|25919501|FG001|Overall Study|Pregnancy|1|||
13115794|NCT03091777|25919502|FG002|Overall Study|Pregnancy|0|||
13240908|NCT01646177|26341240|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
13240909|NCT01646177|26341241|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
13240910|NCT01646177|26341242|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
13240911|NCT01646177|26341243|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
13240912|NCT01646177|26341244|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1|||
13240913|NCT01646177|26341245|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4|||
13240914|NCT01646177|26341246|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
13240915|NCT01646177|26341247|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5|||
13240916|NCT01646177|26341248|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
13240917|NCT01646177|26341249|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
13240918|NCT01646177|26341250|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
13240919|NCT01646177|26341251|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
13240920|NCT01646177|26341240|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
13240921|NCT01646177|26341241|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
13240922|NCT01646177|26341242|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
13240923|NCT01646177|26341243|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
13240924|NCT01646177|26341244|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3|||
13240925|NCT01646177|26341245|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
13240926|NCT01646177|26341246|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
13240927|NCT01646177|26341247|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
13240928|NCT01646177|26341248|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
13240929|NCT01646177|26341249|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
13240930|NCT01646177|26341250|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
13240931|NCT01646177|26341251|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
13240932|NCT01646177|26341240|FG000|Long-Term Extension Period (Week 12-264)|Death|0|||
13115795|NCT03091777|25919500|FG000|Overall Study|Adverse Event|2|||
13115796|NCT03091777|25919501|FG001|Overall Study|Adverse Event|1|||
13115797|NCT03091777|25919502|FG002|Overall Study|Adverse Event|4|||
13240933|NCT01646177|26341241|FG001|Long-Term Extension Period (Week 12-264)|Death|0|||
13240934|NCT01646177|26341242|FG002|Long-Term Extension Period (Week 12-264)|Death|0|||
13240935|NCT01646177|26341243|FG003|Long-Term Extension Period (Week 12-264)|Death|0|||
13240936|NCT01646177|26341244|FG004|Long-Term Extension Period (Week 12-264)|Death|1|||
13240937|NCT01646177|26341245|FG005|Long-Term Extension Period (Week 12-264)|Death|3|||
13240938|NCT01646177|26341246|FG006|Long-Term Extension Period (Week 12-264)|Death|1|||
13240939|NCT01646177|26341247|FG007|Long-Term Extension Period (Week 12-264)|Death|3|||
13240940|NCT01646177|26341248|FG008|Long-Term Extension Period (Week 12-264)|Death|0|||
13240941|NCT01646177|26341249|FG009|Long-Term Extension Period (Week 12-264)|Death|0|||
13240942|NCT01646177|26341250|FG010|Long-Term Extension Period (Week 12-264)|Death|0|||
13240943|NCT01646177|26341251|FG011|Long-Term Extension Period (Week 12-264)|Death|0|||
13240944|NCT01646177|26341240|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
13240945|NCT01646177|26341241|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
13240946|NCT01646177|26341242|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
13240947|NCT01646177|26341243|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
13240948|NCT01646177|26341244|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
13240949|NCT01646177|26341245|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
13240950|NCT01646177|26341246|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
13240951|NCT01646177|26341247|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4|||
13240952|NCT01646177|26341248|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
13240953|NCT01646177|26341249|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
13240954|NCT01646177|26341250|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
13240955|NCT01646177|26341251|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
13240956|NCT01646177|26341240|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
13240957|NCT01646177|26341241|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
13240958|NCT01646177|26341242|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
13240959|NCT01646177|26341243|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
13240960|NCT01646177|26341244|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
13240961|NCT01646177|26341245|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
13240962|NCT01646177|26341246|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
13240963|NCT01646177|26341247|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1|||
13240964|NCT01646177|26341248|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
13240965|NCT01646177|26341249|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
13240966|NCT01646177|26341250|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
13240967|NCT01646177|26341251|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
13240968|NCT01646177|26341240|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
13240969|NCT01646177|26341241|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
13240970|NCT01646177|26341242|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
13240971|NCT01646177|26341243|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
13240972|NCT01646177|26341244|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
13240973|NCT01646177|26341245|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3|||
13240974|NCT01646177|26341246|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2|||
13240975|NCT01646177|26341247|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1|||
13240976|NCT01646177|26341248|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
13240977|NCT01646177|26341249|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
13240978|NCT01646177|26341250|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
13240979|NCT01646177|26341251|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
13240980|NCT01646177|26341240|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
13240981|NCT01646177|26341241|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
13240982|NCT01646177|26341242|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
13240983|NCT01646177|26341243|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
13240984|NCT01646177|26341244|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
13240985|NCT01646177|26341245|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
13240986|NCT01646177|26341246|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
13240987|NCT01646177|26341247|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
13240988|NCT01646177|26341248|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13|||
13240989|NCT01646177|26341249|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28|||
13240990|NCT01646177|26341250|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34|||
13240991|NCT01646177|26341251|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30|||
13240992|NCT01646177|26341240|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
13240993|NCT01646177|26341241|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
13240994|NCT01646177|26341242|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
13240995|NCT01646177|26341243|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
13240996|NCT01646177|26341244|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
13240997|NCT01646177|26341245|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
13240998|NCT01646177|26341246|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
13240999|NCT01646177|26341247|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
13241000|NCT01646177|26341248|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7|||
13241001|NCT01646177|26341249|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21|||
13241002|NCT01646177|26341250|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
13241003|NCT01646177|26341251|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
13241004|NCT01646177|26341240|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
13241005|NCT01646177|26341241|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
13241006|NCT01646177|26341242|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
13241007|NCT01646177|26341243|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
13241008|NCT01646177|26341244|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
13241009|NCT01646177|26341245|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
13241010|NCT01646177|26341246|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
13241011|NCT01646177|26341247|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
13241012|NCT01646177|26341248|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4|||
13241013|NCT01646177|26341249|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8|||
13241014|NCT01646177|26341250|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
13241015|NCT01646177|26341251|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
13241016|NCT01646177|26341240|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
13241017|NCT01646177|26341241|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
13241018|NCT01646177|26341242|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
13241019|NCT01646177|26341243|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
13241020|NCT01646177|26341244|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
13241021|NCT01646177|26341245|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
13241022|NCT01646177|26341246|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
13241023|NCT01646177|26341247|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
13241024|NCT01646177|26341248|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4|||
13241025|NCT01646177|26341249|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
13241026|NCT01646177|26341250|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8|||
13241027|NCT01646177|26341251|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
13241028|NCT01646177|26341240|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
13241029|NCT01646177|26341241|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
13241030|NCT01646177|26341242|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
13241031|NCT01646177|26341243|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
13241032|NCT01646177|26341244|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
13241033|NCT01646177|26341245|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
13241034|NCT01646177|26341246|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
13241035|NCT01646177|26341247|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
13241036|NCT01646177|26341248|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1|||
13241037|NCT01646177|26341249|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6|||
13241038|NCT01646177|26341250|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4|||
13241039|NCT01646177|26341251|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7|||
13241040|NCT01646177|26341240|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
13241041|NCT01646177|26341241|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
13241042|NCT01646177|26341242|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
13241043|NCT01646177|26341243|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
13241044|NCT01646177|26341244|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
13241045|NCT01646177|26341245|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
13241046|NCT01646177|26341246|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
13241047|NCT01646177|26341247|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
13241048|NCT01646177|26341248|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1|||
13241049|NCT01646177|26341249|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
13241050|NCT01646177|26341250|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
13241051|NCT01646177|26341251|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3|||
13241052|NCT01646177|26341240|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
13241053|NCT01646177|26341241|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
13241054|NCT01646177|26341242|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
13241055|NCT01646177|26341243|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
13241056|NCT01646177|26341244|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
13241057|NCT01646177|26341245|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
13241058|NCT01646177|26341246|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
13241059|NCT01646177|26341247|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
13241060|NCT01646177|26341248|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
13241061|NCT01646177|26341249|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
13241062|NCT01646177|26341250|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
13241063|NCT01646177|26341251|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3|||
13241064|NCT01646177|26341240|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
13241065|NCT01646177|26341241|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
13241066|NCT01646177|26341242|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
13241067|NCT01646177|26341243|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
13241068|NCT01646177|26341244|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
13241069|NCT01646177|26341245|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
13241070|NCT01646177|26341246|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
13241071|NCT01646177|26341247|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
13241072|NCT01646177|26341248|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
13241073|NCT01646177|26341249|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
13241074|NCT01646177|26341250|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
13241075|NCT01646177|26341251|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
13241076|NCT01646177|26341240|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
13241077|NCT01646177|26341241|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
13241078|NCT01646177|26341242|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
13241079|NCT01646177|26341243|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
13241080|NCT01646177|26341244|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
13241081|NCT01646177|26341245|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
13241082|NCT01646177|26341246|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
13241083|NCT01646177|26341247|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
13241084|NCT01646177|26341248|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
13241085|NCT01646177|26341249|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
13241086|NCT01646177|26341250|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
13241087|NCT01646177|26341251|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
13241088|NCT01646177|26341240|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
13241089|NCT01646177|26341241|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
13241090|NCT01646177|26341242|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
13241091|NCT01646177|26341243|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
13241092|NCT01646177|26341244|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
13241093|NCT01646177|26341245|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
13241094|NCT01646177|26341246|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
13241095|NCT01646177|26341247|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
13241096|NCT01646177|26341248|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
13241097|NCT01646177|26341249|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
13241098|NCT01646177|26341250|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
13241099|NCT01646177|26341251|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
13241100|NCT01646138|26341279|FG000|Overall Study|Lost to Follow-up|0|||
13241101|NCT01646138|26341280|FG001|Overall Study|Lost to Follow-up|0|||
13241102|NCT01646138|26341281|FG002|Overall Study|Lost to Follow-up|0|||
13241103|NCT01646138|26341282|FG003|Overall Study|Lost to Follow-up|0|||
13241104|NCT01646138|26341283|FG004|Overall Study|Lost to Follow-up|2|||
13241105|NCT01646125|26341313|FG000|Overall Study|Untreated|2|||
13241106|NCT01646125|26341314|FG001|Overall Study|Untreated|5|||
13241107|NCT01646125|26341313|FG000|Overall Study|Adverse Event|2|||
13241108|NCT01646125|26341314|FG001|Overall Study|Adverse Event|1|||
13241109|NCT01646125|26341313|FG000|Overall Study|Death|1|||
13241110|NCT01646125|26341314|FG001|Overall Study|Death|1|||
13241111|NCT01646125|26341313|FG000|Overall Study|Physician Decision|1|||
13241112|NCT01646125|26341314|FG001|Overall Study|Physician Decision|3|||
13241113|NCT01646125|26341313|FG000|Overall Study|Progressive disease|22|||
13241114|NCT01646125|26341314|FG001|Overall Study|Progressive disease|16|||
13241115|NCT01646125|26341313|FG000|Overall Study|Study terminated by sponsor|2|||
13241116|NCT01646125|26341314|FG001|Overall Study|Study terminated by sponsor|1|||
13241117|NCT01646125|26341313|FG000|Overall Study|Subject/Guardian decision|1|||
13241118|NCT01646125|26341314|FG001|Overall Study|Subject/Guardian decision|1|||
13241119|NCT01646073|26341360|FG000|Period A (12 Weeks)|Adverse Event|0|||
13241120|NCT01646073|26341361|FG001|Period A (12 Weeks)|Adverse Event|2|||
13241121|NCT01646073|26341360|FG000|Period A (12 Weeks)|Withdrawal by Subject|1|||
13241122|NCT01646073|26341361|FG001|Period A (12 Weeks)|Withdrawal by Subject|1|||
13241123|NCT01646073|26341360|FG000|Period A (12 Weeks)|Lack of Efficacy|1|||
13241124|NCT01646073|26341361|FG001|Period A (12 Weeks)|Lack of Efficacy|0|||
13241125|NCT01646073|26341360|FG000|Period A (12 Weeks)|Protocol Violation|0|||
13241126|NCT01646073|26341361|FG001|Period A (12 Weeks)|Protocol Violation|1|||
13241127|NCT01646073|26341360|FG000|Period A (12 Weeks)|Other|0|||
13241128|NCT01646073|26341361|FG001|Period A (12 Weeks)|Other|1|||
13241129|NCT01646073|26341360|FG000|Period B (12 Weeks)|Adverse Event|0|||
13241130|NCT01646073|26341361|FG001|Period B (12 Weeks)|Adverse Event|7|||
13241131|NCT01646073|26341360|FG000|Period B (12 Weeks)|Withdrawal by Subject|1|||
13241132|NCT01646073|26341361|FG001|Period B (12 Weeks)|Withdrawal by Subject|5|||
13241133|NCT01646073|26341360|FG000|Period B (12 Weeks)|Lost to Follow-up|0|||
13241134|NCT01646073|26341361|FG001|Period B (12 Weeks)|Lost to Follow-up|1|||
13241135|NCT01646021|26341405|FG000|Overall Study|Death|77|||
13241136|NCT01646021|26341406|FG001|Overall Study|Death|83|||
13241137|NCT01646021|26341405|FG000|Overall Study|Study Terminated by Sponsor|50|||
13241138|NCT01646021|26341406|FG001|Overall Study|Study Terminated by Sponsor|41|||
13241139|NCT01646021|26341405|FG000|Overall Study|Lost to Follow-up|2|||
13241140|NCT01646021|26341406|FG001|Overall Study|Lost to Follow-up|2|||
13241141|NCT01646021|26341405|FG000|Overall Study|Withdrawal by Subject|10|||
13241142|NCT01646021|26341406|FG001|Overall Study|Withdrawal by Subject|15|||
13241143|NCT01645930|26341423|FG000|Overall Study|Participants Ongoing on Study Treatment|22|||
13241144|NCT01645930|26341423|FG000|Overall Study|Progressive Disease|12|||
13241145|NCT01645930|26341423|FG000|Overall Study|Adverse Event|4|||
13241146|NCT01645930|26341423|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
13241147|NCT01645930|26341423|FG000|Overall Study|Withdrawal by Participant|2|||
13241148|NCT01645930|26341423|FG000|Overall Study|Reason not Defined|1|||
13241149|NCT01645735|26341442|FG000|Overall Study|Physician Decision|2|||
13241150|NCT01645735|26341443|FG001|Overall Study|Physician Decision|0|||
13241151|NCT01645735|26341442|FG000|Overall Study|Withdrawal by Subject|1|||
13241152|NCT01645735|26341443|FG001|Overall Study|Withdrawal by Subject|0|||
13241153|NCT01645735|26341442|FG000|Overall Study|Protocol Violation|1|||
13241154|NCT01645735|26341443|FG001|Overall Study|Protocol Violation|0|||
13241155|NCT01645735|26341442|FG000|Overall Study|Adverse Event|0|||
13241156|NCT01645735|26341443|FG001|Overall Study|Adverse Event|1|||
13241157|NCT01645280|26341487|FG000|Overall Study|Death|0|||
13241158|NCT01645280|26341488|FG001|Overall Study|Death|1|||
13241159|NCT01645280|26341489|FG002|Overall Study|Death|0|||
13241160|NCT01645280|26341490|FG003|Overall Study|Death|0|||
13241161|NCT01645280|26341491|FG004|Overall Study|Death|0|||
13241162|NCT01645280|26341487|FG000|Overall Study|Withdrawal by Subject|4|||
13241163|NCT01645280|26341488|FG001|Overall Study|Withdrawal by Subject|0|||
13241164|NCT01645280|26341489|FG002|Overall Study|Withdrawal by Subject|2|||
13241165|NCT01645280|26341490|FG003|Overall Study|Withdrawal by Subject|4|||
13241166|NCT01645280|26341491|FG004|Overall Study|Withdrawal by Subject|5|||
13241167|NCT01645280|26341487|FG000|Overall Study|Lost to Follow-up|0|||
13241168|NCT01645280|26341488|FG001|Overall Study|Lost to Follow-up|0|||
13241169|NCT01645280|26341489|FG002|Overall Study|Lost to Follow-up|0|||
13241170|NCT01645280|26341490|FG003|Overall Study|Lost to Follow-up|2|||
13241171|NCT01645280|26341491|FG004|Overall Study|Lost to Follow-up|1|||
13241172|NCT01645280|26341487|FG000|Overall Study|Other|1|||
13241173|NCT01645280|26341488|FG001|Overall Study|Other|1|||
13241174|NCT01645280|26341489|FG002|Overall Study|Other|2|||
13241175|NCT01645280|26341490|FG003|Overall Study|Other|0|||
13241176|NCT01645280|26341491|FG004|Overall Study|Other|0|||
13241177|NCT01645280|26341487|FG000|Overall Study|Treatment not completed/Completed f/u|1|||
13241178|NCT01645280|26341488|FG001|Overall Study|Treatment not completed/Completed f/u|1|||
13241179|NCT01645280|26341489|FG002|Overall Study|Treatment not completed/Completed f/u|2|||
13241180|NCT01645280|26341490|FG003|Overall Study|Treatment not completed/Completed f/u|0|||
13241181|NCT01645280|26341491|FG004|Overall Study|Treatment not completed/Completed f/u|2|||
13241182|NCT01645176|26341497|FG000|Overall Study|Lack of Efficacy|4|||
13241183|NCT01645176|26341497|FG000|Overall Study|did not complete final MRI|1|||
13241184|NCT01645111|26341503|FG000|Overall Study|Did not require Clevidipine|15|||
13241185|NCT01644890|26341520|FG000|Overall Study|Adverse Event|7|||
13241186|NCT01644890|26341521|FG001|Overall Study|Adverse Event|20|||
13241187|NCT01644890|26341520|FG000|Overall Study|Death|1|||
13115798|NCT03091777|25919500|FG000|Overall Study|Withdrawal by Subject|4|||
13241188|NCT01644890|26341521|FG001|Overall Study|Death|3|||
13241189|NCT01644890|26341520|FG000|Overall Study|Physician Decision|3|||
13241190|NCT01644890|26341521|FG001|Overall Study|Physician Decision|9|||
13241191|NCT01644890|26341520|FG000|Overall Study|Protocol Violation|6|||
13241192|NCT01644890|26341521|FG001|Overall Study|Protocol Violation|7|||
13115799|NCT03091777|25919501|FG001|Overall Study|Withdrawal by Subject|2|||
13115800|NCT03091777|25919502|FG002|Overall Study|Withdrawal by Subject|6|||
13241193|NCT01644890|26341520|FG000|Overall Study|Withdrawal by Subject|19|||
13241194|NCT01644890|26341521|FG001|Overall Study|Withdrawal by Subject|27|||
13241195|NCT01644890|26341520|FG000|Overall Study|Progression Disease|160|||
13241196|NCT01644890|26341521|FG001|Overall Study|Progression Disease|131|||
13241197|NCT01644890|26341520|FG000|Overall Study|Clinical Progression|6|||
13241198|NCT01644890|26341521|FG001|Overall Study|Clinical Progression|6|||
13241199|NCT01644890|26341520|FG000|Overall Study|> 28 days since last dose of study drug|6|||
13241200|NCT01644890|26341521|FG001|Overall Study|> 28 days since last dose of study drug|3|||
13241201|NCT01644890|26341520|FG000|Overall Study|Other|8|||
13241202|NCT01644890|26341521|FG001|Overall Study|Other|9|||
13241203|NCT01644734|26341528|FG000|Overall Study|Adverse Event|4|||
13241204|NCT01644734|26341528|FG000|Overall Study|Lost to Follow-up|17|||
13241205|NCT01644734|26341528|FG000|Overall Study|Reasons other than stated above|7|||
13241206|NCT01644734|26341528|FG000|Overall Study|Missing documentation|238|||
13241207|NCT01644643|26341703|FG000|Overall Study|Death|1|||
13241208|NCT01644643|26341704|FG001|Overall Study|Death|0|||
13241209|NCT01644643|26341705|FG002|Overall Study|Death|3|||
13241210|NCT01644643|26341706|FG003|Overall Study|Death|3|||
13241211|NCT01644643|26341703|FG000|Overall Study|Lost to Follow-up|0|||
13241212|NCT01644643|26341704|FG001|Overall Study|Lost to Follow-up|0|||
13241213|NCT01644643|26341705|FG002|Overall Study|Lost to Follow-up|0|||
13241214|NCT01644643|26341706|FG003|Overall Study|Lost to Follow-up|4|||
13241215|NCT01644643|26341703|FG000|Overall Study|Withdrawal by Subject|1|||
13241216|NCT01644643|26341704|FG001|Overall Study|Withdrawal by Subject|0|||
13241217|NCT01644643|26341705|FG002|Overall Study|Withdrawal by Subject|2|||
13241218|NCT01644643|26341706|FG003|Overall Study|Withdrawal by Subject|1|||
13241219|NCT01644643|26341703|FG000|Overall Study|Other Eligibility criteria|0|||
13241220|NCT01644643|26341704|FG001|Overall Study|Other Eligibility criteria|0|||
13241221|NCT01644643|26341705|FG002|Overall Study|Other Eligibility criteria|0|||
13241222|NCT01644643|26341706|FG003|Overall Study|Other Eligibility criteria|2|||
13241223|NCT01644617|26341766|FG000|Overall Study|Withdrawal by Subject|3|||
13241224|NCT01644617|26341767|FG001|Overall Study|Withdrawal by Subject|4|||
13241225|NCT01644617|26341768|FG002|Overall Study|Withdrawal by Subject|1|||
13241226|NCT01644617|26341766|FG000|Overall Study|Lost to Follow-up|0|||
13241227|NCT01644617|26341767|FG001|Overall Study|Lost to Follow-up|1|||
13241228|NCT01644617|26341768|FG002|Overall Study|Lost to Follow-up|0|||
13241229|NCT01644617|26341766|FG000|Overall Study|Adverse Event|3|||
13241230|NCT01644617|26341767|FG001|Overall Study|Adverse Event|0|||
13241231|NCT01644617|26341768|FG002|Overall Study|Adverse Event|6|||
13241232|NCT01644565|26341816|FG000|Overall Study|Undisclosed Medical History|1|||
13241233|NCT01644565|26341817|FG001|Overall Study|Undisclosed Medical History|0|||
13241234|NCT01644565|26341818|FG002|Overall Study|Undisclosed Medical History|0|||
13241235|NCT01644565|26341819|FG003|Overall Study|Undisclosed Medical History|0|||
13241236|NCT01644565|26341820|FG004|Overall Study|Undisclosed Medical History|0|||
13241237|NCT01644565|26341821|FG005|Overall Study|Undisclosed Medical History|0|||
13241238|NCT01644565|26341822|FG006|Overall Study|Undisclosed Medical History|0|||
13115801|NCT03091777|25919500|FG000|Overall Study|Protocol Violation|2|||
13241239|NCT01644565|26341823|FG007|Overall Study|Undisclosed Medical History|0|||
13241240|NCT01644565|26341824|FG008|Overall Study|Undisclosed Medical History|0|||
13241241|NCT01644565|26341816|FG000|Overall Study|Lost to Follow-up|0|||
13241242|NCT01644565|26341817|FG001|Overall Study|Lost to Follow-up|0|||
13241243|NCT01644565|26341818|FG002|Overall Study|Lost to Follow-up|0|||
13241244|NCT01644565|26341819|FG003|Overall Study|Lost to Follow-up|1|||
13241245|NCT01644565|26341820|FG004|Overall Study|Lost to Follow-up|0|||
13115802|NCT03091777|25919501|FG001|Overall Study|Protocol Violation|1|||
13241246|NCT01644565|26341821|FG005|Overall Study|Lost to Follow-up|0|||
13241247|NCT01644565|26341822|FG006|Overall Study|Lost to Follow-up|0|||
13241248|NCT01644565|26341823|FG007|Overall Study|Lost to Follow-up|2|||
13241249|NCT01644565|26341824|FG008|Overall Study|Lost to Follow-up|0|||
13241250|NCT01644565|26341816|FG000|Overall Study|Family emergency|0|||
13241251|NCT01644565|26341817|FG001|Overall Study|Family emergency|0|||
13241252|NCT01644565|26341818|FG002|Overall Study|Family emergency|0|||
13241253|NCT01644565|26341819|FG003|Overall Study|Family emergency|0|||
13241254|NCT01644565|26341820|FG004|Overall Study|Family emergency|1|||
13241255|NCT01644565|26341821|FG005|Overall Study|Family emergency|0|||
13241256|NCT01644565|26341822|FG006|Overall Study|Family emergency|0|||
13241257|NCT01644565|26341823|FG007|Overall Study|Family emergency|0|||
13241258|NCT01644565|26341824|FG008|Overall Study|Family emergency|0|||
13115803|NCT03091777|25919502|FG002|Overall Study|Protocol Violation|1|||
13115804|NCT03091777|25919500|FG000|Overall Study|Lost to Follow-up|12|||
13241259|NCT01644565|26341816|FG000|Overall Study|Relocation|0|||
13241260|NCT01644565|26341817|FG001|Overall Study|Relocation|0|||
13241261|NCT01644565|26341818|FG002|Overall Study|Relocation|0|||
13241262|NCT01644565|26341819|FG003|Overall Study|Relocation|0|||
13241263|NCT01644565|26341820|FG004|Overall Study|Relocation|0|||
13241264|NCT01644565|26341821|FG005|Overall Study|Relocation|0|||
13241265|NCT01644565|26341822|FG006|Overall Study|Relocation|0|||
13241266|NCT01644565|26341823|FG007|Overall Study|Relocation|0|||
13241267|NCT01644565|26341824|FG008|Overall Study|Relocation|1|||
13241268|NCT01644500|26341902|FG000|Overall Study|Adverse Event|6|||
13241269|NCT01644500|26341903|FG001|Overall Study|Adverse Event|1|||
13241270|NCT01644500|26341904|FG002|Overall Study|Adverse Event|2|||
13241271|NCT01644500|26341902|FG000|Overall Study|Death|0|||
13241272|NCT01644500|26341903|FG001|Overall Study|Death|1|||
13241273|NCT01644500|26341904|FG002|Overall Study|Death|0|||
13241274|NCT01644500|26341902|FG000|Overall Study|Lost to Follow-up|3|||
13241275|NCT01644500|26341903|FG001|Overall Study|Lost to Follow-up|8|||
13241276|NCT01644500|26341904|FG002|Overall Study|Lost to Follow-up|0|||
13241277|NCT01644500|26341902|FG000|Overall Study|Protocol Violation|1|||
13241278|NCT01644500|26341903|FG001|Overall Study|Protocol Violation|1|||
13241279|NCT01644500|26341904|FG002|Overall Study|Protocol Violation|0|||
13241280|NCT01644500|26341902|FG000|Overall Study|Withdrawal by Subject|11|||
13241281|NCT01644500|26341903|FG001|Overall Study|Withdrawal by Subject|12|||
13241282|NCT01644500|26341904|FG002|Overall Study|Withdrawal by Subject|12|||
13241283|NCT01644500|26341902|FG000|Overall Study|Physician Decision|1|||
13241284|NCT01644500|26341903|FG001|Overall Study|Physician Decision|1|||
13241285|NCT01644500|26341904|FG002|Overall Study|Physician Decision|1|||
13241286|NCT01644474|26341951|FG000|Overall Study|Poor compliance to protocol|1|||
13241287|NCT01644474|26341952|FG001|Overall Study|Poor compliance to protocol|0|||
13241288|NCT01644474|26341951|FG000|Overall Study|Consent withdrawn by participant|0|||
13241289|NCT01644474|26341952|FG001|Overall Study|Consent withdrawn by participant|1|||
13241290|NCT01644474|26341951|FG000|Overall Study|Participant moved|0|||
13241291|NCT01644474|26341952|FG001|Overall Study|Participant moved|1|||
13241292|NCT01644474|26341951|FG000|Overall Study|Adverse Event|4|||
13241293|NCT01644474|26341952|FG001|Overall Study|Adverse Event|5|||
13241294|NCT01644474|26341951|FG000|Overall Study|Site scheduling error|1|||
13241295|NCT01644474|26341952|FG001|Overall Study|Site scheduling error|1|||
13241296|NCT01644474|26341951|FG000|Overall Study|Protocol Violation|1|||
13241297|NCT01644474|26341952|FG001|Overall Study|Protocol Violation|0|||
13241298|NCT01644188|26342015|FG000|Overall Study|Adverse Event|44|||
13241299|NCT01644188|26342016|FG001|Overall Study|Adverse Event|20|||
13241300|NCT01644188|26342015|FG000|Overall Study|Poor compliance to protocol|26|||
13241301|NCT01644188|26342016|FG001|Overall Study|Poor compliance to protocol|14|||
13241302|NCT01644188|26342015|FG000|Overall Study|Physician Decision|1|||
13241303|NCT01644188|26342016|FG001|Overall Study|Physician Decision|3|||
13241304|NCT01644188|26342015|FG000|Overall Study|Participant moved|7|||
13241305|NCT01644188|26342016|FG001|Overall Study|Participant moved|2|||
13241306|NCT01644188|26342015|FG000|Overall Study|Related to auto-injector administration|2|||
13241307|NCT01644188|26342016|FG001|Overall Study|Related to auto-injector administration|2|||
13241308|NCT01644188|26342015|FG000|Overall Study|Consent withdrawn by participant|14|||
13241309|NCT01644188|26342016|FG001|Overall Study|Consent withdrawn by participant|7|||
13241310|NCT01644188|26342015|FG000|Overall Study|Selection criteria finally not met|2|||
13241311|NCT01644188|26342016|FG001|Overall Study|Selection criteria finally not met|0|||
13241312|NCT01644188|26342015|FG000|Overall Study|Lost to Follow-up|1|||
13241313|NCT01644188|26342016|FG001|Overall Study|Lost to Follow-up|0|||
13241314|NCT01644188|26342015|FG000|Overall Study|Death|4|||
13241315|NCT01644188|26342016|FG001|Overall Study|Death|3|||
13241316|NCT01644188|26342015|FG000|Overall Study|Last visit outside protocol visit window|14|||
13241317|NCT01644188|26342016|FG001|Overall Study|Last visit outside protocol visit window|16|||
13241318|NCT01644188|26342015|FG000|Overall Study|Site closure|1|||
13241319|NCT01644188|26342016|FG001|Overall Study|Site closure|1|||
13241320|NCT01644188|26342015|FG000|Overall Study|Other than specified above|6|||
13241321|NCT01644188|26342016|FG001|Overall Study|Other than specified above|7|||
13485840|NCT00585195|27033416|FG006|Overall Study|Withdrawn Due to Pregnancy|0|||
13241322|NCT01644175|26342073|FG000|Overall Study|Randomized But Not Treated|0|||
13241323|NCT01644175|26342074|FG001|Overall Study|Randomized But Not Treated|2|||
13241324|NCT01644175|26342073|FG000|Overall Study|Adverse Event|8|||
13241325|NCT01644175|26342074|FG001|Overall Study|Adverse Event|13|||
13241326|NCT01644175|26342073|FG000|Overall Study|Death|1|||
13241327|NCT01644175|26342074|FG001|Overall Study|Death|2|||
13241328|NCT01644175|26342073|FG000|Overall Study|Poor compliance to protocol|9|||
13241329|NCT01644175|26342074|FG001|Overall Study|Poor compliance to protocol|10|||
13241330|NCT01644175|26342073|FG000|Overall Study|Physician Decision|1|||
13241331|NCT01644175|26342074|FG001|Overall Study|Physician Decision|2|||
13241332|NCT01644175|26342073|FG000|Overall Study|Participant Moved|1|||
13241333|NCT01644175|26342074|FG001|Overall Study|Participant Moved|2|||
13241334|NCT01644175|26342073|FG000|Overall Study|Consent withdrawn by participant|3|||
13241335|NCT01644175|26342074|FG001|Overall Study|Consent withdrawn by participant|4|||
13241336|NCT01644175|26342073|FG000|Overall Study|Related to Autoinjector Administration|2|||
13241337|NCT01644175|26342074|FG001|Overall Study|Related to Autoinjector Administration|1|||
13241338|NCT01644175|26342073|FG000|Overall Study|Last visit outside protocol visit window|4|||
13241339|NCT01644175|26342074|FG001|Overall Study|Last visit outside protocol visit window|11|||
13241340|NCT01644175|26342073|FG000|Overall Study|Selection criteria finally not met|0|||
13241341|NCT01644175|26342074|FG001|Overall Study|Selection criteria finally not met|1|||
13241342|NCT01644175|26342073|FG000|Overall Study|Site closure|2|||
13241343|NCT01644175|26342074|FG001|Overall Study|Site closure|2|||
13241344|NCT01644175|26342073|FG000|Overall Study|Lost to Follow-up|1|||
13241345|NCT01644175|26342074|FG001|Overall Study|Lost to Follow-up|0|||
13241346|NCT01644175|26342073|FG000|Overall Study|Other than specified above|0|||
13241347|NCT01644175|26342074|FG001|Overall Study|Other than specified above|3|||
13241348|NCT01644149|26342091|FG000|Overall Study|Withdrawal by Subject|1|||
13241349|NCT01644149|26342092|FG001|Overall Study|Withdrawal by Subject|0|||
13241350|NCT01644149|26342091|FG000|Overall Study|Lost to Follow-up|3|||
13241351|NCT01644149|26342092|FG001|Overall Study|Lost to Follow-up|1|||
13241352|NCT01643928|26342393|FG000|Overall Study|Lost to Follow-up|1|||
13241353|NCT01643928|26342394|FG001|Overall Study|Lost to Follow-up|0|||
13241354|NCT01643928|26342395|FG002|Overall Study|Lost to Follow-up|2|||
13241355|NCT01643928|26342396|FG003|Overall Study|Lost to Follow-up|0|||
13241356|NCT01643928|26342397|FG004|Overall Study|Lost to Follow-up|0|||
13241357|NCT01643928|26342393|FG000|Overall Study|Withdrawal by Subject|2|||
13241358|NCT01643928|26342394|FG001|Overall Study|Withdrawal by Subject|0|||
13241359|NCT01643928|26342395|FG002|Overall Study|Withdrawal by Subject|0|||
13241360|NCT01643928|26342396|FG003|Overall Study|Withdrawal by Subject|1|||
13241361|NCT01643928|26342397|FG004|Overall Study|Withdrawal by Subject|0|||
13241362|NCT01643928|26342393|FG000|Overall Study|Pregnancy|0|||
13241363|NCT01643928|26342394|FG001|Overall Study|Pregnancy|0|||
13241364|NCT01643928|26342395|FG002|Overall Study|Pregnancy|0|||
13241365|NCT01643928|26342396|FG003|Overall Study|Pregnancy|1|||
13241366|NCT01643928|26342397|FG004|Overall Study|Pregnancy|0|||
13241367|NCT01643928|26342393|FG000|Overall Study|Other|5|||
13241368|NCT01643928|26342394|FG001|Overall Study|Other|1|||
13241369|NCT01643928|26342395|FG002|Overall Study|Other|1|||
13241370|NCT01643928|26342396|FG003|Overall Study|Other|0|||
13241371|NCT01643928|26342397|FG004|Overall Study|Other|0|||
13241372|NCT01643928|26342393|FG000|Overall Study|Adverse Event|2|||
13241373|NCT01643928|26342394|FG001|Overall Study|Adverse Event|1|||
13241374|NCT01643928|26342395|FG002|Overall Study|Adverse Event|0|||
13241375|NCT01643928|26342396|FG003|Overall Study|Adverse Event|1|||
13241376|NCT01643928|26342397|FG004|Overall Study|Adverse Event|2|||
13241377|NCT01643850|26342564|FG000|Overall Study|Withdrawal by Subject|0|||
13241378|NCT01643850|26342565|FG001|Overall Study|Withdrawal by Subject|0|||
13241379|NCT01643850|26342566|FG002|Overall Study|Withdrawal by Subject|0|||
13241380|NCT01643850|26342567|FG003|Overall Study|Withdrawal by Subject|0|||
13241381|NCT01643850|26342568|FG004|Overall Study|Withdrawal by Subject|1|||
13241382|NCT01643850|26342569|FG005|Overall Study|Withdrawal by Subject|0|||
13241383|NCT01643850|26342570|FG006|Overall Study|Withdrawal by Subject|0|||
13241384|NCT01643850|26342571|FG007|Overall Study|Withdrawal by Subject|0|||
13241385|NCT01643850|26342572|FG008|Overall Study|Withdrawal by Subject|0|||
13241386|NCT01643850|26342564|FG000|Overall Study|Lost to Follow-up|0|||
13241387|NCT01643850|26342565|FG001|Overall Study|Lost to Follow-up|0|||
13241388|NCT01643850|26342566|FG002|Overall Study|Lost to Follow-up|0|||
13241389|NCT01643850|26342567|FG003|Overall Study|Lost to Follow-up|0|||
13241390|NCT01643850|26342568|FG004|Overall Study|Lost to Follow-up|0|||
13485841|NCT00585195|27033417|FG007|Overall Study|Withdrawn Due to Pregnancy|0|||
13241391|NCT01643850|26342569|FG005|Overall Study|Lost to Follow-up|0|||
13241392|NCT01643850|26342570|FG006|Overall Study|Lost to Follow-up|1|||
13241393|NCT01643850|26342571|FG007|Overall Study|Lost to Follow-up|0|||
13241394|NCT01643850|26342572|FG008|Overall Study|Lost to Follow-up|1|||
13241395|NCT01643850|26342564|FG000|Overall Study|Adverse Event|0|||
13241396|NCT01643850|26342565|FG001|Overall Study|Adverse Event|0|||
13241397|NCT01643850|26342566|FG002|Overall Study|Adverse Event|0|||
13241398|NCT01643850|26342567|FG003|Overall Study|Adverse Event|0|||
13241399|NCT01643850|26342568|FG004|Overall Study|Adverse Event|1|||
13241400|NCT01643850|26342569|FG005|Overall Study|Adverse Event|0|||
13241401|NCT01643850|26342570|FG006|Overall Study|Adverse Event|0|||
13241402|NCT01643850|26342571|FG007|Overall Study|Adverse Event|0|||
13241403|NCT01643850|26342572|FG008|Overall Study|Adverse Event|0|||
13241404|NCT01643850|26342564|FG000|Overall Study|Administrative Problems|0|||
13241405|NCT01643850|26342565|FG001|Overall Study|Administrative Problems|0|||
13241406|NCT01643850|26342566|FG002|Overall Study|Administrative Problems|1|||
13241407|NCT01643850|26342567|FG003|Overall Study|Administrative Problems|0|||
13241408|NCT01643850|26342568|FG004|Overall Study|Administrative Problems|1|||
13241409|NCT01643850|26342569|FG005|Overall Study|Administrative Problems|0|||
13241410|NCT01643850|26342570|FG006|Overall Study|Administrative Problems|0|||
13241411|NCT01643850|26342571|FG007|Overall Study|Administrative Problems|0|||
13241412|NCT01643850|26342572|FG008|Overall Study|Administrative Problems|0|||
13241413|NCT01643798|26342586|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1|||
13241414|NCT01643798|26342587|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0|||
13241415|NCT01643772|26342640|FG000|Overall Study|Protocol Violation|0|||
13241416|NCT01643772|26342641|FG001|Overall Study|Protocol Violation|0|||
13241417|NCT01643772|26342642|FG002|Overall Study|Protocol Violation|0|||
13241418|NCT01643772|26342643|FG003|Overall Study|Protocol Violation|1|||
13241419|NCT01643772|26342640|FG000|Overall Study|Adverse Event|0|||
13241420|NCT01643772|26342641|FG001|Overall Study|Adverse Event|0|||
13241421|NCT01643772|26342642|FG002|Overall Study|Adverse Event|0|||
13241422|NCT01643772|26342643|FG003|Overall Study|Adverse Event|1|||
13241423|NCT01643668|26342657|FG000|Overall Study|Death|1|||
13241424|NCT01643473|26342676|FG000|Overall Study|Lost to Follow-up|1|||
13241425|NCT01643473|26342677|FG001|Overall Study|Lost to Follow-up|0|||
13241426|NCT01643408|26342687|FG000|Overall Study|Adverse Event|12|||
13241427|NCT01643408|26342687|FG000|Overall Study|Other|2|||
13241428|NCT01643044|26342700|FG000|Overall Study|Lost to Follow-up|1|||
13241429|NCT01643044|26342701|FG001|Overall Study|Lost to Follow-up|1|||
13241430|NCT01643044|26342700|FG000|Overall Study|Miscarried baby|2|||
13241431|NCT01643044|26342701|FG001|Overall Study|Miscarried baby|2|||
13241432|NCT01643044|26342700|FG000|Overall Study|Delivered outside of hospital|1|||
13241433|NCT01643044|26342701|FG001|Overall Study|Delivered outside of hospital|2|||
13241434|NCT01642914|26342786|FG000|Overall Study|Adverse Event|11|||
13241435|NCT01642914|26342787|FG001|Overall Study|Adverse Event|7|||
13241436|NCT01642914|26342788|FG002|Overall Study|Adverse Event|15|||
13241437|NCT01642914|26342786|FG000|Overall Study|Lack of Efficacy|9|||
13241438|NCT01642914|26342787|FG001|Overall Study|Lack of Efficacy|4|||
13241439|NCT01642914|26342788|FG002|Overall Study|Lack of Efficacy|2|||
13241440|NCT01642914|26342786|FG000|Overall Study|Protocol Violation|15|||
13241441|NCT01642914|26342787|FG001|Overall Study|Protocol Violation|13|||
13241442|NCT01642914|26342788|FG002|Overall Study|Protocol Violation|6|||
13241443|NCT01642914|26342786|FG000|Overall Study|Withdrawal by Subject|5|||
13241444|NCT01642914|26342787|FG001|Overall Study|Withdrawal by Subject|5|||
13241445|NCT01642914|26342788|FG002|Overall Study|Withdrawal by Subject|10|||
13241446|NCT01642914|26342786|FG000|Overall Study|Lost to Follow-up|5|||
13241447|NCT01642914|26342787|FG001|Overall Study|Lost to Follow-up|3|||
13241448|NCT01642914|26342788|FG002|Overall Study|Lost to Follow-up|7|||
13241449|NCT01642914|26342786|FG000|Overall Study|Other Reason|1|||
13241450|NCT01642914|26342787|FG001|Overall Study|Other Reason|0|||
13241451|NCT01642914|26342788|FG002|Overall Study|Other Reason|0|||
13241452|NCT01642732|26342795|FG000|Overall Study|Withdrawal by Subject|1|||
13241453|NCT01642615|26342813|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1|||
13241454|NCT01642615|26342814|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
13241455|NCT01642615|26342815|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
13241456|NCT01642615|26342813|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1|||
13241457|NCT01642615|26342814|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0|||
13241458|NCT01642615|26342815|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0|||
13241459|NCT01642615|26342813|FG000|Open Label Maintenance Phase|Lost to Follow-up|1|||
13241460|NCT01642615|26342814|FG001|Open Label Maintenance Phase|Lost to Follow-up|0|||
13241461|NCT01642615|26342815|FG002|Open Label Maintenance Phase|Lost to Follow-up|0|||
13241462|NCT01642615|26342813|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1|||
13241463|NCT01642615|26342814|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
13241464|NCT01642615|26342815|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
13241465|NCT01642615|26342813|FG000|Open Label Maintenance Phase|Did not receive treatment|1|||
13241466|NCT01642615|26342814|FG001|Open Label Maintenance Phase|Did not receive treatment|0|||
13241467|NCT01642615|26342815|FG002|Open Label Maintenance Phase|Did not receive treatment|0|||
13241468|NCT01642615|26342813|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0|||
13241469|NCT01642615|26342814|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1|||
13241470|NCT01642615|26342815|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3|||
13241471|NCT01642615|26342813|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0|||
13241472|NCT01642615|26342814|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5|||
13241473|NCT01642615|26342815|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2|||
13241474|NCT01642615|26342813|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
13241475|NCT01642615|26342814|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1|||
13241476|NCT01642615|26342815|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
13241477|NCT01642615|26342813|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
13241478|NCT01642615|26342814|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
13241479|NCT01642615|26342815|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1|||
13241480|NCT01642602|26342822|FG000|Overall Study|Adverse Event|2|||
13241481|NCT01642589|26342843|FG000|Overall Study|Withdrawal by Subject|1|||
13241482|NCT01642589|26342844|FG001|Overall Study|Withdrawal by Subject|1|||
13241483|NCT01642407|26342891|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3|||
13241484|NCT01642407|26342891|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1|||
13241485|NCT01642407|26342891|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1|||
13241486|NCT01642277|26342907|FG000|Overall Study|Adverse Event|10|||
13241487|NCT01642277|26342908|FG001|Overall Study|Adverse Event|0|||
13241488|NCT01642277|26342907|FG000|Overall Study|Physician Decision|2|||
13241489|NCT01642277|26342908|FG001|Overall Study|Physician Decision|0|||
13241490|NCT01642277|26342907|FG000|Overall Study|Protocol Violation|1|||
13241491|NCT01642277|26342908|FG001|Overall Study|Protocol Violation|0|||
13241492|NCT01642277|26342907|FG000|Overall Study|Withdrawal by Subject|11|||
13241493|NCT01642277|26342908|FG001|Overall Study|Withdrawal by Subject|0|||
13241494|NCT01642251|26342934|FG000|Overall Study|Progressive disease|0|||
13241495|NCT01642251|26342935|FG001|Overall Study|Progressive disease|0|||
13241496|NCT01642251|26342936|FG002|Overall Study|Progressive disease|3|||
13241497|NCT01642251|26342937|FG003|Overall Study|Progressive disease|3|||
13241498|NCT01642251|26342934|FG000|Overall Study|Adverse Event|0|||
13241499|NCT01642251|26342935|FG001|Overall Study|Adverse Event|0|||
13241500|NCT01642251|26342936|FG002|Overall Study|Adverse Event|5|||
13241501|NCT01642251|26342937|FG003|Overall Study|Adverse Event|4|||
13241502|NCT01642251|26342934|FG000|Overall Study|Death|0|||
13241503|NCT01642251|26342935|FG001|Overall Study|Death|0|||
13241504|NCT01642251|26342936|FG002|Overall Study|Death|1|||
13241505|NCT01642251|26342937|FG003|Overall Study|Death|3|||
13241506|NCT01642251|26342934|FG000|Overall Study|Withdrawal by Subject|0|||
13241507|NCT01642251|26342935|FG001|Overall Study|Withdrawal by Subject|0|||
13241508|NCT01642251|26342936|FG002|Overall Study|Withdrawal by Subject|1|||
13241509|NCT01642251|26342937|FG003|Overall Study|Withdrawal by Subject|3|||
13241510|NCT01642251|26342934|FG000|Overall Study|Alternative therapy|0|||
13241511|NCT01642251|26342935|FG001|Overall Study|Alternative therapy|0|||
13241512|NCT01642251|26342936|FG002|Overall Study|Alternative therapy|0|||
13241513|NCT01642251|26342937|FG003|Overall Study|Alternative therapy|2|||
13241514|NCT01642251|26342934|FG000|Overall Study|Other complicating disease|0|||
13241515|NCT01642251|26342935|FG001|Overall Study|Other complicating disease|0|||
13241516|NCT01642251|26342936|FG002|Overall Study|Other complicating disease|1|||
13241517|NCT01642251|26342937|FG003|Overall Study|Other complicating disease|0|||
13241518|NCT01642251|26342934|FG000|Overall Study|Ineligible/never start protocol therapy|0|||
13241519|NCT01642251|26342935|FG001|Overall Study|Ineligible/never start protocol therapy|0|||
13241520|NCT01642251|26342936|FG002|Overall Study|Ineligible/never start protocol therapy|11|||
13241521|NCT01642251|26342937|FG003|Overall Study|Ineligible/never start protocol therapy|8|||
13241522|NCT01642212|26342995|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26|||
13241523|NCT01642212|26342996|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
13241524|NCT01642212|26342997|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
13241525|NCT01642212|26342998|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
13241526|NCT01642212|26342999|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
13241527|NCT01642212|26342995|FG000|Double-blind Treatment|Other|0|||
13241528|NCT01642212|26342996|FG001|Double-blind Treatment|Other|2|||
13241529|NCT01642212|26342997|FG002|Double-blind Treatment|Other|1|||
13241530|NCT01642212|26342998|FG003|Double-blind Treatment|Other|0|||
13241531|NCT01642212|26342999|FG004|Double-blind Treatment|Other|0|||
13241532|NCT01642212|26342995|FG000|Double-blind Treatment|Non-compliance|0|||
13241533|NCT01642212|26342996|FG001|Double-blind Treatment|Non-compliance|1|||
13241534|NCT01642212|26342997|FG002|Double-blind Treatment|Non-compliance|0|||
13241535|NCT01642212|26342998|FG003|Double-blind Treatment|Non-compliance|0|||
13241536|NCT01642212|26342999|FG004|Double-blind Treatment|Non-compliance|0|||
13241537|NCT01642212|26342995|FG000|Double-blind Treatment|Adverse Event|0|||
13241538|NCT01642212|26342996|FG001|Double-blind Treatment|Adverse Event|0|||
13241539|NCT01642212|26342997|FG002|Double-blind Treatment|Adverse Event|1|||
13241540|NCT01642212|26342998|FG003|Double-blind Treatment|Adverse Event|0|||
13241541|NCT01642212|26342999|FG004|Double-blind Treatment|Adverse Event|0|||
13241542|NCT01642212|26342995|FG000|Open-label Extension|Adverse Event|0|||
13241543|NCT01642212|26342996|FG001|Open-label Extension|Adverse Event|0|||
13241544|NCT01642212|26342997|FG002|Open-label Extension|Adverse Event|0|||
13241545|NCT01642212|26342998|FG003|Open-label Extension|Adverse Event|3|||
13241546|NCT01642212|26342999|FG004|Open-label Extension|Adverse Event|0|||
13241547|NCT01642212|26342995|FG000|Open-label Extension|Sponsor Decision|0|||
13241548|NCT01642212|26342996|FG001|Open-label Extension|Sponsor Decision|0|||
13241549|NCT01642212|26342997|FG002|Open-label Extension|Sponsor Decision|0|||
13241550|NCT01642212|26342998|FG003|Open-label Extension|Sponsor Decision|7|||
13241551|NCT01642212|26342999|FG004|Open-label Extension|Sponsor Decision|4|||
13241552|NCT01642212|26342995|FG000|Open-label Extension|Consent Withdrawn|0|||
13241553|NCT01642212|26342996|FG001|Open-label Extension|Consent Withdrawn|0|||
13241554|NCT01642212|26342997|FG002|Open-label Extension|Consent Withdrawn|0|||
13241555|NCT01642212|26342998|FG003|Open-label Extension|Consent Withdrawn|0|||
13241556|NCT01642212|26342999|FG004|Open-label Extension|Consent Withdrawn|2|||
13241557|NCT01642212|26342995|FG000|Open-label Extension|Lost to Follow-up|0|||
13241558|NCT01642212|26342996|FG001|Open-label Extension|Lost to Follow-up|0|||
13241559|NCT01642212|26342997|FG002|Open-label Extension|Lost to Follow-up|0|||
13241560|NCT01642212|26342998|FG003|Open-label Extension|Lost to Follow-up|0|||
13241561|NCT01642212|26342999|FG004|Open-label Extension|Lost to Follow-up|1|||
13241562|NCT01642212|26342995|FG000|Open-label Extension|Other|0|||
13241563|NCT01642212|26342996|FG001|Open-label Extension|Other|0|||
13241564|NCT01642212|26342997|FG002|Open-label Extension|Other|0|||
13241565|NCT01642212|26342998|FG003|Open-label Extension|Other|0|||
13241566|NCT01642212|26342999|FG004|Open-label Extension|Other|1|||
13241567|NCT01641991|26343088|FG000|Overall Study|Physician Decision|0|||
13241568|NCT01641991|26343089|FG001|Overall Study|Physician Decision|1|||
13241569|NCT01641991|26343090|FG002|Overall Study|Physician Decision|7|||
13241570|NCT01641991|26343091|FG003|Overall Study|Physician Decision|5|||
13241571|NCT01641991|26343088|FG000|Overall Study|Withdrawal by Subject|4|||
13241572|NCT01641991|26343089|FG001|Overall Study|Withdrawal by Subject|2|||
13241573|NCT01641991|26343090|FG002|Overall Study|Withdrawal by Subject|1|||
13241574|NCT01641991|26343091|FG003|Overall Study|Withdrawal by Subject|5|||
13241575|NCT01641991|26343088|FG000|Overall Study|Adverse Event|2|||
13241576|NCT01641991|26343089|FG001|Overall Study|Adverse Event|1|||
13241577|NCT01641991|26343090|FG002|Overall Study|Adverse Event|2|||
13241578|NCT01641991|26343091|FG003|Overall Study|Adverse Event|1|||
13241579|NCT01641991|26343088|FG000|Overall Study|Lost to Follow-up|0|||
13241580|NCT01641991|26343089|FG001|Overall Study|Lost to Follow-up|2|||
13241581|NCT01641991|26343090|FG002|Overall Study|Lost to Follow-up|3|||
13241582|NCT01641991|26343091|FG003|Overall Study|Lost to Follow-up|1|||
13241583|NCT01641991|26343088|FG000|Overall Study|Protocol Violation|1|||
13241584|NCT01641991|26343089|FG001|Overall Study|Protocol Violation|1|||
13241585|NCT01641991|26343090|FG002|Overall Study|Protocol Violation|3|||
13241586|NCT01641991|26343091|FG003|Overall Study|Protocol Violation|0|||
13241587|NCT01641991|26343088|FG000|Overall Study|Pregnancy|0|||
13241588|NCT01641991|26343089|FG001|Overall Study|Pregnancy|0|||
13241589|NCT01641991|26343090|FG002|Overall Study|Pregnancy|1|||
13241590|NCT01641991|26343091|FG003|Overall Study|Pregnancy|0|||
13241591|NCT01641991|26343088|FG000|Overall Study|no longer eligible|2|||
13241592|NCT01641991|26343089|FG001|Overall Study|no longer eligible|1|||
13241593|NCT01641991|26343090|FG002|Overall Study|no longer eligible|0|||
13241594|NCT01641991|26343091|FG003|Overall Study|no longer eligible|4|||
13241595|NCT01641952|26343106|FG000|Overall Study|Lost to Follow-up|28|||
13241596|NCT01641952|26343106|FG000|Overall Study|Adverse Event|6|||
13241597|NCT01641939|26343155|FG000|Overall Study|Death|90|||
13241598|NCT01641939|26343156|FG001|Overall Study|Death|187|||
13241599|NCT01641939|26343157|FG002|Overall Study|Death|61|||
13241600|NCT01641939|26343155|FG000|Overall Study|Lost to Follow-up|3|||
13241601|NCT01641939|26343156|FG001|Overall Study|Lost to Follow-up|2|||
13241602|NCT01641939|26343157|FG002|Overall Study|Lost to Follow-up|1|||
13241603|NCT01641939|26343155|FG000|Overall Study|Withdrawal by Subject|14|||
13241604|NCT01641939|26343156|FG001|Overall Study|Withdrawal by Subject|11|||
13241605|NCT01641939|26343157|FG002|Overall Study|Withdrawal by Subject|5|||
13241606|NCT01641939|26343155|FG000|Overall Study|Study Terminated by Sponsor|10|||
13241607|NCT01641939|26343156|FG001|Overall Study|Study Terminated by Sponsor|28|||
13241608|NCT01641939|26343157|FG002|Overall Study|Study Terminated by Sponsor|3|||
13241609|NCT01641926|26343196|FG000|Overall Study|Adverse Event|5|||
13241610|NCT01641926|26343197|FG001|Overall Study|Adverse Event|2|||
13241611|NCT01641926|26343198|FG002|Overall Study|Adverse Event|3|||
13241612|NCT01641926|26343199|FG003|Overall Study|Adverse Event|1|||
13241613|NCT01641926|26343196|FG000|Overall Study|Lost to Follow-up|2|||
13241614|NCT01641926|26343197|FG001|Overall Study|Lost to Follow-up|2|||
13241615|NCT01641926|26343198|FG002|Overall Study|Lost to Follow-up|1|||
13241616|NCT01641926|26343199|FG003|Overall Study|Lost to Follow-up|0|||
13241617|NCT01641926|26343196|FG000|Overall Study|Physician Decision|6|||
13241618|NCT01641926|26343197|FG001|Overall Study|Physician Decision|5|||
13241619|NCT01641926|26343198|FG002|Overall Study|Physician Decision|0|||
13241620|NCT01641926|26343199|FG003|Overall Study|Physician Decision|1|||
13241621|NCT01641926|26343196|FG000|Overall Study|Protocol Violation|1|||
13241622|NCT01641926|26343197|FG001|Overall Study|Protocol Violation|0|||
13241623|NCT01641926|26343198|FG002|Overall Study|Protocol Violation|0|||
13241624|NCT01641926|26343199|FG003|Overall Study|Protocol Violation|1|||
13241625|NCT01641926|26343196|FG000|Overall Study|Withdrawal by Subject|13|||
13241626|NCT01641926|26343197|FG001|Overall Study|Withdrawal by Subject|5|||
13241627|NCT01641926|26343198|FG002|Overall Study|Withdrawal by Subject|6|||
13241628|NCT01641926|26343199|FG003|Overall Study|Withdrawal by Subject|1|||
13241629|NCT01641926|26343196|FG000|Overall Study|Not Treated|1|||
13241630|NCT01641926|26343197|FG001|Overall Study|Not Treated|1|||
13241631|NCT01641926|26343198|FG002|Overall Study|Not Treated|1|||
13241632|NCT01641926|26343199|FG003|Overall Study|Not Treated|0|||
13241633|NCT01641900|26343216|FG000|Overall Study|Withdrawal by Subject|2|||
13241634|NCT01641900|26343217|FG001|Overall Study|Withdrawal by Subject|2|||
13289896|NCT00105443|26480337|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0|||
13289897|NCT00105443|26480334|FG000|Follow-up and/or Open Label Nexavar|Death|180|||
13289898|NCT00105443|26480335|FG001|Follow-up and/or Open Label Nexavar|Death|7|||
13289899|NCT00105443|26480336|FG002|Follow-up and/or Open Label Nexavar|Death|219|||
13289900|NCT00105443|26480337|FG003|Follow-up and/or Open Label Nexavar|Death|4|||
13289901|NCT00105443|26480334|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14|||
13289902|NCT00105443|26480335|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
13289903|NCT00105443|26480336|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10|||
13289904|NCT00105443|26480337|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
13289905|NCT00105443|26480334|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24|||
13289906|NCT00105443|26480335|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3|||
13289907|NCT00105443|26480336|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13|||
13289908|NCT00105443|26480337|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4|||
13289909|NCT00105443|26480334|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
13289910|NCT00105443|26480335|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14|||
13289911|NCT00105443|26480336|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
13289912|NCT00105443|26480337|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16|||
13289913|NCT00105443|26480334|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
13289914|NCT00105443|26480335|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
13289915|NCT00105443|26480336|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
13289916|NCT00105443|26480337|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
13289917|NCT00105443|26480334|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
13289918|NCT00105443|26480335|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2|||
13289919|NCT00105443|26480336|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
13289920|NCT00105443|26480337|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
13289921|NCT00105443|26480334|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
13289922|NCT00105443|26480335|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2|||
13289923|NCT00105443|26480336|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
13289924|NCT00105443|26480337|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5|||
13289925|NCT00105443|26480334|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
13289926|NCT00105443|26480335|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
13289927|NCT00105443|26480336|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
13289928|NCT00105443|26480337|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
13289929|NCT00105443|26480334|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6|||
13289930|NCT00105443|26480335|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
13289931|NCT00105443|26480336|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1|||
13289932|NCT00105443|26480337|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
13289933|NCT00105443|26480334|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
13289934|NCT00105443|26480335|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
13289935|NCT00105443|26480336|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1|||
13289936|NCT00105443|26480337|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
13289937|NCT00105443|26480334|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1|||
13289938|NCT00105443|26480335|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
13289939|NCT00105443|26480336|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
13289940|NCT00105443|26480337|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
13289941|NCT00105443|26480334|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
13289942|NCT00105443|26480335|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
13289943|NCT00105443|26480336|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
13289944|NCT00105443|26480337|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1|||
13289945|NCT00105443|26480334|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
13289946|NCT00105443|26480335|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
13289947|NCT00105443|26480336|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
13289948|NCT00105443|26480337|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
13289949|NCT00105443|26480334|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
13289950|NCT00105443|26480335|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23|||
13289951|NCT00105443|26480336|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
13289952|NCT00105443|26480337|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11|||
13289953|NCT00105183|26480379|FG000|Overall Study|Death|19|||
13289954|NCT00105183|26480380|FG001|Overall Study|Death|13|||
13289955|NCT00105183|26480381|FG002|Overall Study|Death|15|||
13289956|NCT00105183|26480379|FG000|Overall Study|Withdrawal by Subject|1|||
13289957|NCT00105183|26480380|FG001|Overall Study|Withdrawal by Subject|1|||
13241635|NCT01641861|26343238|FG000|Overall Study|Lost to Follow-up|21|||
13241636|NCT01641861|26343239|FG001|Overall Study|Lost to Follow-up|16|||
13241637|NCT01641861|26343238|FG000|Overall Study|Lost the tooth due to normal exfoliation|14|||
13241638|NCT01641861|26343239|FG001|Overall Study|Lost the tooth due to normal exfoliation|8|||
13241639|NCT01641861|26343238|FG000|Overall Study|Died due to drowning|0|||
13241640|NCT01641861|26343239|FG001|Overall Study|Died due to drowning|1|||
13241641|NCT01641822|26343264|FG000|Run-in Phase|Noncompliance with study drug|1|||
13241642|NCT01641822|26343265|FG001|Run-in Phase|Noncompliance with study drug|0|||
13241643|NCT01641822|26343266|FG002|Run-in Phase|Noncompliance with study drug|0|||
13241644|NCT01641822|26343264|FG000|Run-in Phase|Adverse Event|3|||
13241645|NCT01641822|26343265|FG001|Run-in Phase|Adverse Event|0|||
13241646|NCT01641822|26343266|FG002|Run-in Phase|Adverse Event|0|||
13241647|NCT01641822|26343264|FG000|Run-in Phase|Withdrew consent|1|||
13241648|NCT01641822|26343265|FG001|Run-in Phase|Withdrew consent|0|||
13241649|NCT01641822|26343266|FG002|Run-in Phase|Withdrew consent|0|||
13241650|NCT01641822|26343264|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9|||
13241651|NCT01641822|26343265|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0|||
13241652|NCT01641822|26343266|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0|||
13241653|NCT01641822|26343264|FG000|Comparative Phase|Noncompliance with study drug|0|||
13241654|NCT01641822|26343265|FG001|Comparative Phase|Noncompliance with study drug|1|||
13241655|NCT01641822|26343266|FG002|Comparative Phase|Noncompliance with study drug|0|||
13241656|NCT01641822|26343264|FG000|Comparative Phase|Investigator's discretion|0|||
13241657|NCT01641822|26343265|FG001|Comparative Phase|Investigator's discretion|0|||
13241658|NCT01641822|26343266|FG002|Comparative Phase|Investigator's discretion|1|||
13241659|NCT01641822|26343264|FG000|Comparative Phase|Pregnancy|0|||
13241660|NCT01641822|26343265|FG001|Comparative Phase|Pregnancy|0|||
13241661|NCT01641822|26343266|FG002|Comparative Phase|Pregnancy|1|||
13241662|NCT01641822|26343264|FG000|Comparative Phase|Adverse event, serious fatal|0|||
13241663|NCT01641822|26343265|FG001|Comparative Phase|Adverse event, serious fatal|1|||
13241664|NCT01641822|26343266|FG002|Comparative Phase|Adverse event, serious fatal|0|||
13241665|NCT01641822|26343264|FG000|Comparative Phase|Withdrew consent|0|||
13241666|NCT01641822|26343265|FG001|Comparative Phase|Withdrew consent|3|||
13241667|NCT01641822|26343266|FG002|Comparative Phase|Withdrew consent|7|||
13241668|NCT01641822|26343264|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0|||
13241669|NCT01641822|26343265|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1|||
13241670|NCT01641822|26343266|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1|||
13241671|NCT01641809|26343463|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
13241672|NCT01641809|26343464|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
13241673|NCT01641809|26343465|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0|||
13115805|NCT03091777|25919501|FG001|Overall Study|Lost to Follow-up|14|||
13115806|NCT03091777|25919502|FG002|Overall Study|Lost to Follow-up|7|||
13115807|NCT03091777|25919500|FG000|Overall Study|Lack of Efficacy|0|||
13115808|NCT03091777|25919501|FG001|Overall Study|Lack of Efficacy|0|||
13115809|NCT03091777|25919502|FG002|Overall Study|Lack of Efficacy|5|||
13115810|NCT03091777|25919500|FG000|Overall Study|Noncompliance with study drug|2|||
13115811|NCT03091777|25919501|FG001|Overall Study|Noncompliance with study drug|3|||
13115812|NCT03091777|25919502|FG002|Overall Study|Noncompliance with study drug|1|||
13115813|NCT03091777|25919500|FG000|Overall Study|Physician Decision|1|||
13115814|NCT03091777|25919501|FG001|Overall Study|Physician Decision|0|||
13115815|NCT03091777|25919502|FG002|Overall Study|Physician Decision|1|||
13115816|NCT03091777|25919500|FG000|Overall Study|Abnormal Laboratory Value|7|||
13115817|NCT03091777|25919501|FG001|Overall Study|Abnormal Laboratory Value|11|||
13115818|NCT03091777|25919502|FG002|Overall Study|Abnormal Laboratory Value|12|||
13115819|NCT03091738|25919510|FG000|Overall Study|Adverse Event|1|||
13115820|NCT03091738|25919510|FG000|Overall Study|Lost to Follow-up|1|||
13115821|NCT03091439|25919539|FG000|Overall Study|Study Terminated by the Sponsor|1|||
13115822|NCT03091439|25919540|FG001|Overall Study|Study Terminated by the Sponsor|0|||
13115823|NCT03091400|25919563|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
13115824|NCT03091400|25919564|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
13115825|NCT03091348|25919595|FG000|Overall Study|Lost to Follow-up|2|||
13115826|NCT03091348|25919596|FG001|Overall Study|Lost to Follow-up|1|||
13115827|NCT03090152|25919647|FG000|Overall Study|Withdrawal by Subject|0|||
13115828|NCT03090152|25919648|FG001|Overall Study|Withdrawal by Subject|2|||
13115829|NCT03090152|25919649|FG002|Overall Study|Withdrawal by Subject|1|||
13115830|NCT03090152|25919647|FG000|Overall Study|Surgery Canceled|1|||
13115831|NCT03090152|25919648|FG001|Overall Study|Surgery Canceled|0|||
13115832|NCT03090152|25919649|FG002|Overall Study|Surgery Canceled|0|||
13115833|NCT03090152|25919647|FG000|Overall Study|Epidural catheter could not be placed|0|||
13115834|NCT03090152|25919648|FG001|Overall Study|Epidural catheter could not be placed|2|||
13115835|NCT03090152|25919649|FG002|Overall Study|Epidural catheter could not be placed|0|||
13115836|NCT03090100|25919696|FG000|Overall Study|Adverse Event|9|||
13115837|NCT03090100|25919697|FG001|Overall Study|Adverse Event|11|||
13115838|NCT03090100|25919696|FG000|Overall Study|Pregnancy|1|||
13115839|NCT03090100|25919697|FG001|Overall Study|Pregnancy|1|||
13241674|NCT01641809|26343466|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
13241675|NCT01641809|26343463|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
13241676|NCT01641809|26343464|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
13115840|NCT03090100|25919696|FG000|Overall Study|Lack of Efficacy|2|||
13241677|NCT01641809|26343465|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
13241678|NCT01641809|26343466|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
13241679|NCT01641809|26343463|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1|||
13241680|NCT01641809|26343464|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2|||
13241681|NCT01641809|26343465|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0|||
13241682|NCT01641809|26343466|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3|||
13241683|NCT01641809|26343463|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2|||
13241684|NCT01641809|26343464|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
13241685|NCT01641809|26343465|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
13241686|NCT01641809|26343466|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0|||
13241687|NCT01641809|26343463|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4|||
13241688|NCT01641809|26343464|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1|||
13241689|NCT01641809|26343465|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2|||
13241690|NCT01641809|26343466|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3|||
13241691|NCT01641809|26343463|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0|||
13241692|NCT01641809|26343464|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1|||
13241693|NCT01641809|26343465|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3|||
13241694|NCT01641809|26343466|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7|||
13241695|NCT01641809|26343463|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2|||
13241696|NCT01641809|26343464|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3|||
13241697|NCT01641809|26343465|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1|||
13241698|NCT01641809|26343466|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0|||
13241699|NCT01641809|26343463|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
13241700|NCT01641809|26343464|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1|||
13241701|NCT01641809|26343465|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
13241702|NCT01641809|26343466|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
13241703|NCT01641809|26343463|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
13241704|NCT01641809|26343464|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0|||
13241705|NCT01641809|26343465|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1|||
13241706|NCT01641809|26343466|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
13241707|NCT01641809|26343463|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
13241708|NCT01641809|26343464|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
13241709|NCT01641809|26343465|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0|||
13241710|NCT01641809|26343466|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2|||
13241711|NCT01641809|26343463|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
13241712|NCT01641809|26343464|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0|||
13241713|NCT01641809|26343465|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
13241714|NCT01641809|26343466|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2|||
13241715|NCT01641809|26343463|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2|||
13241716|NCT01641809|26343464|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3|||
13241717|NCT01641809|26343465|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1|||
13241718|NCT01641809|26343466|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0|||
13241719|NCT01641809|26343463|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0|||
13241720|NCT01641809|26343464|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1|||
13241721|NCT01641809|26343465|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1|||
13241722|NCT01641809|26343466|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0|||
13241723|NCT01641809|26343463|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
13241724|NCT01641809|26343464|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4|||
13241725|NCT01641809|26343465|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
13241726|NCT01641809|26343466|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0|||
13241727|NCT01641809|26343463|FG000|Open-label (Week 96 to Week 324)|Site closed|1|||
13241728|NCT01641809|26343464|FG001|Open-label (Week 96 to Week 324)|Site closed|0|||
13241729|NCT01641809|26343465|FG002|Open-label (Week 96 to Week 324)|Site closed|0|||
13241730|NCT01641809|26343466|FG003|Open-label (Week 96 to Week 324)|Site closed|0|||
13241731|NCT01641809|26343463|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
13241732|NCT01641809|26343464|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
13241733|NCT01641809|26343465|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
13241734|NCT01641809|26343466|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
13241735|NCT01641809|26343463|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4|||
13241736|NCT01641809|26343464|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1|||
13241737|NCT01641809|26343465|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
13115841|NCT03090100|25919697|FG001|Overall Study|Lack of Efficacy|7|||
13241738|NCT01641809|26343466|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
13241739|NCT01641809|26343463|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3|||
13241740|NCT01641809|26343464|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2|||
13241741|NCT01641809|26343465|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1|||
13241742|NCT01641809|26343466|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0|||
13241743|NCT01641692|26343662|FG000|Treatment Period 1|Adverse Event|1|||
13241744|NCT01641692|26343663|FG001|Treatment Period 1|Adverse Event|0|||
13241745|NCT01641692|26343664|FG002|Treatment Period 1|Adverse Event|0|||
13241746|NCT01641692|26343665|FG003|Treatment Period 1|Adverse Event|0|||
13241747|NCT01641692|26343666|FG004|Treatment Period 1|Adverse Event|0|||
13241748|NCT01641692|26343667|FG005|Treatment Period 1|Adverse Event|0|||
13241749|NCT01641692|26343668|FG006|Treatment Period 1|Adverse Event|0|||
13241750|NCT01641692|26343669|FG007|Treatment Period 1|Adverse Event|0|||
13241751|NCT01641692|26343662|FG000|Treatment Period 1|Lack of Efficacy|0|||
13241752|NCT01641692|26343663|FG001|Treatment Period 1|Lack of Efficacy|0|||
13241753|NCT01641692|26343664|FG002|Treatment Period 1|Lack of Efficacy|0|||
13241754|NCT01641692|26343665|FG003|Treatment Period 1|Lack of Efficacy|0|||
13241755|NCT01641692|26343666|FG004|Treatment Period 1|Lack of Efficacy|0|||
13241756|NCT01641692|26343667|FG005|Treatment Period 1|Lack of Efficacy|0|||
13241757|NCT01641692|26343668|FG006|Treatment Period 1|Lack of Efficacy|0|||
13241758|NCT01641692|26343669|FG007|Treatment Period 1|Lack of Efficacy|1|||
13241759|NCT01641692|26343662|FG000|Treatment Period 1|Protocol Violation|1|||
13241760|NCT01641692|26343663|FG001|Treatment Period 1|Protocol Violation|0|||
13241761|NCT01641692|26343664|FG002|Treatment Period 1|Protocol Violation|0|||
13241762|NCT01641692|26343665|FG003|Treatment Period 1|Protocol Violation|0|||
13241763|NCT01641692|26343666|FG004|Treatment Period 1|Protocol Violation|2|||
13241764|NCT01641692|26343667|FG005|Treatment Period 1|Protocol Violation|0|||
13241765|NCT01641692|26343668|FG006|Treatment Period 1|Protocol Violation|0|||
13241766|NCT01641692|26343669|FG007|Treatment Period 1|Protocol Violation|0|||
13241767|NCT01641692|26343662|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
13241768|NCT01641692|26343663|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
13241769|NCT01641692|26343664|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
13241770|NCT01641692|26343665|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
13241771|NCT01641692|26343666|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
13241772|NCT01641692|26343667|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
13241773|NCT01641692|26343668|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
13241774|NCT01641692|26343669|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
13241775|NCT01641692|26343662|FG000|Treatment Period 1|Lost to Follow-up|0|||
13241776|NCT01641692|26343663|FG001|Treatment Period 1|Lost to Follow-up|0|||
13241777|NCT01641692|26343664|FG002|Treatment Period 1|Lost to Follow-up|1|||
13241778|NCT01641692|26343665|FG003|Treatment Period 1|Lost to Follow-up|0|||
13241779|NCT01641692|26343666|FG004|Treatment Period 1|Lost to Follow-up|0|||
13241780|NCT01641692|26343667|FG005|Treatment Period 1|Lost to Follow-up|0|||
13241781|NCT01641692|26343668|FG006|Treatment Period 1|Lost to Follow-up|0|||
13241782|NCT01641692|26343669|FG007|Treatment Period 1|Lost to Follow-up|0|||
13241783|NCT01641692|26343662|FG000|Treatment Period 1|Physician Decision|0|||
13241784|NCT01641692|26343663|FG001|Treatment Period 1|Physician Decision|0|||
13241785|NCT01641692|26343664|FG002|Treatment Period 1|Physician Decision|0|||
13241786|NCT01641692|26343665|FG003|Treatment Period 1|Physician Decision|0|||
13241787|NCT01641692|26343666|FG004|Treatment Period 1|Physician Decision|1|||
13241788|NCT01641692|26343667|FG005|Treatment Period 1|Physician Decision|0|||
13241789|NCT01641692|26343668|FG006|Treatment Period 1|Physician Decision|0|||
13241790|NCT01641692|26343669|FG007|Treatment Period 1|Physician Decision|0|||
13241791|NCT01641692|26343662|FG000|Treatment Period 1|Withdrawal by Subject|0|||
13241792|NCT01641692|26343663|FG001|Treatment Period 1|Withdrawal by Subject|0|||
13241793|NCT01641692|26343664|FG002|Treatment Period 1|Withdrawal by Subject|0|||
13241794|NCT01641692|26343665|FG003|Treatment Period 1|Withdrawal by Subject|0|||
13241795|NCT01641692|26343666|FG004|Treatment Period 1|Withdrawal by Subject|0|||
13241796|NCT01641692|26343667|FG005|Treatment Period 1|Withdrawal by Subject|2|||
13241797|NCT01641692|26343668|FG006|Treatment Period 1|Withdrawal by Subject|0|||
13241798|NCT01641692|26343669|FG007|Treatment Period 1|Withdrawal by Subject|1|||
13241799|NCT01641692|26343662|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2|||
13241800|NCT01641692|26343663|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0|||
13241801|NCT01641692|26343664|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0|||
13241802|NCT01641692|26343665|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0|||
13241803|NCT01641692|26343666|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0|||
13241804|NCT01641692|26343667|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0|||
13241805|NCT01641692|26343668|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0|||
13241806|NCT01641692|26343669|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0|||
13241807|NCT01641692|26343662|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
13241808|NCT01641692|26343663|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
13241809|NCT01641692|26343664|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
13241810|NCT01641692|26343665|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
13241811|NCT01641692|26343666|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
13241812|NCT01641692|26343667|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
13241813|NCT01641692|26343668|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1|||
13241814|NCT01641692|26343669|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
13241815|NCT01641692|26343662|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
13241816|NCT01641692|26343663|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
13241817|NCT01641692|26343664|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
13241818|NCT01641692|26343665|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
13241819|NCT01641692|26343666|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
13241820|NCT01641692|26343667|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
13241821|NCT01641692|26343668|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
13241822|NCT01641692|26343669|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
13241823|NCT01641692|26343662|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
13241824|NCT01641692|26343663|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
13241825|NCT01641692|26343664|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
13241826|NCT01641692|26343665|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
13241827|NCT01641692|26343666|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
13241828|NCT01641692|26343667|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
13241829|NCT01641692|26343668|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
13241830|NCT01641692|26343669|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
13241831|NCT01641692|26343662|FG000|Treatment Period 2|Lack of Efficacy|1|||
13241832|NCT01641692|26343663|FG001|Treatment Period 2|Lack of Efficacy|0|||
13241833|NCT01641692|26343664|FG002|Treatment Period 2|Lack of Efficacy|0|||
13241834|NCT01641692|26343665|FG003|Treatment Period 2|Lack of Efficacy|0|||
13241835|NCT01641692|26343666|FG004|Treatment Period 2|Lack of Efficacy|0|||
13241836|NCT01641692|26343667|FG005|Treatment Period 2|Lack of Efficacy|0|||
13241837|NCT01641692|26343668|FG006|Treatment Period 2|Lack of Efficacy|0|||
13241838|NCT01641692|26343669|FG007|Treatment Period 2|Lack of Efficacy|0|||
13241839|NCT01641692|26343662|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
13241840|NCT01641692|26343663|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
13241841|NCT01641692|26343664|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
13241842|NCT01641692|26343665|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
13241843|NCT01641692|26343666|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
13241844|NCT01641692|26343667|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
13241845|NCT01641692|26343668|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
13241846|NCT01641692|26343669|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
13241847|NCT01641692|26343662|FG000|Treatment Period 2|Lost to Follow-up|0|||
13241848|NCT01641692|26343663|FG001|Treatment Period 2|Lost to Follow-up|0|||
13241849|NCT01641692|26343664|FG002|Treatment Period 2|Lost to Follow-up|0|||
13241850|NCT01641692|26343665|FG003|Treatment Period 2|Lost to Follow-up|0|||
13241851|NCT01641692|26343666|FG004|Treatment Period 2|Lost to Follow-up|0|||
13241852|NCT01641692|26343667|FG005|Treatment Period 2|Lost to Follow-up|1|||
13241853|NCT01641692|26343668|FG006|Treatment Period 2|Lost to Follow-up|0|||
13241854|NCT01641692|26343669|FG007|Treatment Period 2|Lost to Follow-up|0|||
13241855|NCT01641692|26343662|FG000|Treatment Period 2|Withdrawal by Subject|1|||
13241856|NCT01641692|26343663|FG001|Treatment Period 2|Withdrawal by Subject|0|||
13241857|NCT01641692|26343664|FG002|Treatment Period 2|Withdrawal by Subject|0|||
13241858|NCT01641692|26343665|FG003|Treatment Period 2|Withdrawal by Subject|0|||
13241859|NCT01641692|26343666|FG004|Treatment Period 2|Withdrawal by Subject|0|||
13241860|NCT01641692|26343667|FG005|Treatment Period 2|Withdrawal by Subject|1|||
13241861|NCT01641692|26343668|FG006|Treatment Period 2|Withdrawal by Subject|0|||
13241862|NCT01641692|26343669|FG007|Treatment Period 2|Withdrawal by Subject|1|||
13241863|NCT01641692|26343662|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
13241864|NCT01641692|26343663|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
13241865|NCT01641692|26343664|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
13241866|NCT01641692|26343665|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
13241867|NCT01641692|26343666|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
13241868|NCT01641692|26343667|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
13241869|NCT01641692|26343668|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
13241870|NCT01641692|26343669|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
13241871|NCT01641692|26343662|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
13241872|NCT01641692|26343663|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
13241873|NCT01641692|26343664|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
13241874|NCT01641692|26343665|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
13241875|NCT01641692|26343666|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
13485842|NCT00585195|27033418|FG008|Overall Study|Withdrawn Due to Pregnancy|0|||
13115842|NCT03090100|25919696|FG000|Overall Study|Lost to Follow-up|2|||
13115843|NCT03090100|25919697|FG001|Overall Study|Lost to Follow-up|2|||
13115844|NCT03090100|25919696|FG000|Overall Study|Withdrawal by Subject|7|||
13241876|NCT01641692|26343667|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
13241877|NCT01641692|26343668|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
13241878|NCT01641692|26343669|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
13241879|NCT01641692|26343662|FG000|Treatment Period 3|Adverse Event|0|||
13241880|NCT01641692|26343663|FG001|Treatment Period 3|Adverse Event|0|||
13241881|NCT01641692|26343664|FG002|Treatment Period 3|Adverse Event|0|||
13241882|NCT01641692|26343665|FG003|Treatment Period 3|Adverse Event|0|||
13241883|NCT01641692|26343666|FG004|Treatment Period 3|Adverse Event|0|||
13241884|NCT01641692|26343667|FG005|Treatment Period 3|Adverse Event|0|||
13241885|NCT01641692|26343668|FG006|Treatment Period 3|Adverse Event|1|||
13241886|NCT01641692|26343669|FG007|Treatment Period 3|Adverse Event|0|||
13241887|NCT01641692|26343662|FG000|Treatment Period 3|Protocol Violation|0|||
13241888|NCT01641692|26343663|FG001|Treatment Period 3|Protocol Violation|0|||
13241889|NCT01641692|26343664|FG002|Treatment Period 3|Protocol Violation|1|||
13241890|NCT01641692|26343665|FG003|Treatment Period 3|Protocol Violation|0|||
13241891|NCT01641692|26343666|FG004|Treatment Period 3|Protocol Violation|0|||
13241892|NCT01641692|26343667|FG005|Treatment Period 3|Protocol Violation|0|||
13241893|NCT01641692|26343668|FG006|Treatment Period 3|Protocol Violation|0|||
13241894|NCT01641692|26343669|FG007|Treatment Period 3|Protocol Violation|0|||
13241895|NCT01641692|26343662|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
13241896|NCT01641692|26343663|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
13241897|NCT01641692|26343664|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
13241898|NCT01641692|26343665|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
13241899|NCT01641692|26343666|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
13241900|NCT01641692|26343667|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
13241901|NCT01641692|26343668|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
13241902|NCT01641692|26343669|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
13241903|NCT01641692|26343662|FG000|Treatment Period 3|Lost to Follow-up|0|||
13241904|NCT01641692|26343663|FG001|Treatment Period 3|Lost to Follow-up|1|||
13241905|NCT01641692|26343664|FG002|Treatment Period 3|Lost to Follow-up|0|||
13241906|NCT01641692|26343665|FG003|Treatment Period 3|Lost to Follow-up|0|||
13241907|NCT01641692|26343666|FG004|Treatment Period 3|Lost to Follow-up|0|||
13241908|NCT01641692|26343667|FG005|Treatment Period 3|Lost to Follow-up|0|||
13241909|NCT01641692|26343668|FG006|Treatment Period 3|Lost to Follow-up|0|||
13241910|NCT01641692|26343669|FG007|Treatment Period 3|Lost to Follow-up|0|||
13241911|NCT01641692|26343662|FG000|Washout Period 3 or Follow-up|Protocol Violation|0|||
13241912|NCT01641692|26343663|FG001|Washout Period 3 or Follow-up|Protocol Violation|0|||
13241913|NCT01641692|26343664|FG002|Washout Period 3 or Follow-up|Protocol Violation|0|||
13241914|NCT01641692|26343665|FG003|Washout Period 3 or Follow-up|Protocol Violation|0|||
13241915|NCT01641692|26343666|FG004|Washout Period 3 or Follow-up|Protocol Violation|0|||
13241916|NCT01641692|26343667|FG005|Washout Period 3 or Follow-up|Protocol Violation|1|||
13241917|NCT01641692|26343668|FG006|Washout Period 3 or Follow-up|Protocol Violation|0|||
13241918|NCT01641692|26343669|FG007|Washout Period 3 or Follow-up|Protocol Violation|0|||
13241919|NCT01641692|26343662|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
13241920|NCT01641692|26343663|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
13241921|NCT01641692|26343664|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
13241922|NCT01641692|26343665|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
13241923|NCT01641692|26343666|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
13241924|NCT01641692|26343667|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
13241925|NCT01641692|26343668|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
13241926|NCT01641692|26343669|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
13241927|NCT01641640|26343680|FG000|Overall Study|Enrolled but not treated|1|||
13241928|NCT01641640|26343680|FG000|Overall Study|Efficacy failure|29|||
13241929|NCT01641640|26343680|FG000|Overall Study|Lost to Follow-up|3|||
13241930|NCT01641640|26343680|FG000|Overall Study|Withdrawal by Subject|2|||
13241931|NCT01641640|26343680|FG000|Overall Study|Adverse Event|1|||
13241932|NCT01641601|26343695|FG000|Overall Study|Study discontinued.|3|||
13241933|NCT01641601|26343696|FG001|Overall Study|Study discontinued.|5|||
13241934|NCT01641471|26343715|FG000|Overall Study|Withdrawal by Subject|19|||
13241935|NCT01641471|26343716|FG001|Overall Study|Withdrawal by Subject|19|||
13241936|NCT01641471|26343715|FG000|Overall Study|Lost to Follow-up|2|||
13241937|NCT01641471|26343716|FG001|Overall Study|Lost to Follow-up|4|||
13241938|NCT01641471|26343715|FG000|Overall Study|Protocol Violation|2|||
13241939|NCT01641471|26343716|FG001|Overall Study|Protocol Violation|4|||
13241940|NCT01641367|26343988|FG000|Cohorts|Death|18|||
13241941|NCT01641367|26343989|FG001|Cohorts|Death|1|||
13241942|NCT01641367|26343990|FG002|Cohorts|Death|2|||
13241943|NCT01641367|26343991|FG003|Cohorts|Death|0|||
13241944|NCT01641367|26343992|FG004|Cohorts|Death|1|||
13241945|NCT01641367|26343993|FG005|Cohorts|Death|1|||
13241946|NCT01641367|26343994|FG006|Cohorts|Death|0|||
13241947|NCT01641367|26343995|FG007|Cohorts|Death|0|||
13241948|NCT01641367|26343988|FG000|Cohorts|Lost to Follow-up|16|||
13241949|NCT01641367|26343989|FG001|Cohorts|Lost to Follow-up|0|||
13241950|NCT01641367|26343990|FG002|Cohorts|Lost to Follow-up|2|||
13241951|NCT01641367|26343991|FG003|Cohorts|Lost to Follow-up|0|||
13241952|NCT01641367|26343992|FG004|Cohorts|Lost to Follow-up|2|||
13241953|NCT01641367|26343993|FG005|Cohorts|Lost to Follow-up|0|||
13241954|NCT01641367|26343994|FG006|Cohorts|Lost to Follow-up|0|||
13241955|NCT01641367|26343995|FG007|Cohorts|Lost to Follow-up|0|||
13241956|NCT01641367|26343988|FG000|Randomized Adherence Intervention|Death|0|||
13241957|NCT01641367|26343989|FG001|Randomized Adherence Intervention|Death|0|||
13241958|NCT01641367|26343990|FG002|Randomized Adherence Intervention|Death|0|||
13241959|NCT01641367|26343991|FG003|Randomized Adherence Intervention|Death|0|||
13241960|NCT01641367|26343992|FG004|Randomized Adherence Intervention|Death|0|||
13241961|NCT01641367|26343993|FG005|Randomized Adherence Intervention|Death|0|||
13241962|NCT01641367|26343994|FG006|Randomized Adherence Intervention|Death|11|||
13241963|NCT01641367|26343995|FG007|Randomized Adherence Intervention|Death|12|||
13241964|NCT01641367|26343988|FG000|Randomized Adherence Intervention|Lost to Follow-up|0|||
13241965|NCT01641367|26343989|FG001|Randomized Adherence Intervention|Lost to Follow-up|0|||
13241966|NCT01641367|26343990|FG002|Randomized Adherence Intervention|Lost to Follow-up|0|||
13241967|NCT01641367|26343991|FG003|Randomized Adherence Intervention|Lost to Follow-up|0|||
13241968|NCT01641367|26343992|FG004|Randomized Adherence Intervention|Lost to Follow-up|0|||
13241969|NCT01641367|26343993|FG005|Randomized Adherence Intervention|Lost to Follow-up|0|||
13241970|NCT01641367|26343994|FG006|Randomized Adherence Intervention|Lost to Follow-up|8|||
13241971|NCT01641367|26343995|FG007|Randomized Adherence Intervention|Lost to Follow-up|12|||
13241972|NCT01641237|26344022|FG000|Period II|Withdrawal by Subject|1|||
13241973|NCT01641237|26344023|FG001|Period II|Withdrawal by Subject|0|||
13241974|NCT01641237|26344024|FG002|Period II|Withdrawal by Subject|0|||
13241975|NCT01641237|26344025|FG003|Period II|Withdrawal by Subject|0|||
13241976|NCT01641237|26344022|FG000|Period III|Lost to Follow-up|1|||
13241977|NCT01641237|26344023|FG001|Period III|Lost to Follow-up|0|||
13241978|NCT01641237|26344024|FG002|Period III|Lost to Follow-up|0|||
13241979|NCT01641237|26344025|FG003|Period III|Lost to Follow-up|0|||
13241980|NCT01641198|26344049|FG000|After 12 Months of Function|Lost to Follow-up|3|||
13241981|NCT01641198|26344050|FG001|After 12 Months of Function|Lost to Follow-up|2|||
13241982|NCT01641198|26344051|FG002|After 12 Months of Function|Lost to Follow-up|2|||
13241983|NCT01641198|26344049|FG000|After 12 Months of Function|Protocol Violation|1|||
13241984|NCT01641198|26344050|FG001|After 12 Months of Function|Protocol Violation|0|||
13241985|NCT01641198|26344051|FG002|After 12 Months of Function|Protocol Violation|0|||
13241986|NCT01641198|26344049|FG000|After 12 Months of Function|Adverse Event|0|||
13241987|NCT01641198|26344050|FG001|After 12 Months of Function|Adverse Event|1|||
13241988|NCT01641198|26344051|FG002|After 12 Months of Function|Adverse Event|0|||
13241989|NCT01641198|26344049|FG000|After 24 Months of Function|Lost to Follow-up|4|||
13241990|NCT01641198|26344050|FG001|After 24 Months of Function|Lost to Follow-up|9|||
13241991|NCT01641198|26344051|FG002|After 24 Months of Function|Lost to Follow-up|6|||
13241992|NCT01641198|26344049|FG000|At 15-20 Years of Function|Lost to Follow-up|5|||
13241993|NCT01641198|26344050|FG001|At 15-20 Years of Function|Lost to Follow-up|1|||
13241994|NCT01641198|26344051|FG002|At 15-20 Years of Function|Lost to Follow-up|1|||
13241995|NCT01641198|26344049|FG000|At 15-20 Years of Function|Death|1|||
13241996|NCT01641198|26344050|FG001|At 15-20 Years of Function|Death|0|||
13241997|NCT01641198|26344051|FG002|At 15-20 Years of Function|Death|1|||
13241998|NCT01641159|26344066|FG000|Overall Study|Lost to Follow-up|2|||
13241999|NCT01641159|26344067|FG001|Overall Study|Lost to Follow-up|1|||
13242000|NCT01641159|26344066|FG000|Overall Study|Withdrawal by Subject|0|||
13242001|NCT01641159|26344067|FG001|Overall Study|Withdrawal by Subject|1|||
13242002|NCT01641133|26344118|FG000|Overall Study|Protocol Violation|0|||
13242003|NCT01641133|26344119|FG001|Overall Study|Protocol Violation|1|||
13242004|NCT01641133|26344120|FG002|Overall Study|Protocol Violation|1|||
13242005|NCT01641133|26344118|FG000|Overall Study|Migrated/moved from study area|5|||
13242006|NCT01641133|26344119|FG001|Overall Study|Migrated/moved from study area|3|||
13242007|NCT01641133|26344120|FG002|Overall Study|Migrated/moved from study area|1|||
13242008|NCT01641133|26344118|FG000|Overall Study|Adverse Event|0|||
13242009|NCT01641133|26344119|FG001|Overall Study|Adverse Event|0|||
13242010|NCT01641133|26344120|FG002|Overall Study|Adverse Event|1|||
13242011|NCT01641133|26344118|FG000|Overall Study|Withdrawal by Subject|5|||
13242012|NCT01641133|26344119|FG001|Overall Study|Withdrawal by Subject|3|||
13242013|NCT01641133|26344120|FG002|Overall Study|Withdrawal by Subject|3|||
13242014|NCT01641133|26344118|FG000|Overall Study|Lost to Follow-up|0|||
13242015|NCT01641133|26344119|FG001|Overall Study|Lost to Follow-up|2|||
13242016|NCT01641133|26344120|FG002|Overall Study|Lost to Follow-up|2|||
13242017|NCT01641081|26344148|FG000|Period 1|Sponsor request (potential unblinding)|0|||
13242018|NCT01641081|26344149|FG001|Period 1|Sponsor request (potential unblinding)|0|||
13242019|NCT01641081|26344150|FG002|Period 1|Sponsor request (potential unblinding)|0|||
13242020|NCT01641081|26344151|FG003|Period 1|Sponsor request (potential unblinding)|0|||
13242021|NCT01641081|26344152|FG004|Period 1|Sponsor request (potential unblinding)|0|||
13242022|NCT01641081|26344153|FG005|Period 1|Sponsor request (potential unblinding)|0|||
13242023|NCT01641081|26344154|FG006|Period 1|Sponsor request (potential unblinding)|1|||
13242024|NCT01641081|26344155|FG007|Period 1|Sponsor request (potential unblinding)|0|||
13242025|NCT01641081|26344156|FG008|Period 1|Sponsor request (potential unblinding)|0|||
13242026|NCT01641081|26344157|FG009|Period 1|Sponsor request (potential unblinding)|0|||
13242027|NCT01641081|26344148|FG000|Period 1|Protocol Violation|0|||
13242028|NCT01641081|26344149|FG001|Period 1|Protocol Violation|0|||
13242029|NCT01641081|26344150|FG002|Period 1|Protocol Violation|0|||
13242030|NCT01641081|26344151|FG003|Period 1|Protocol Violation|0|||
13242031|NCT01641081|26344152|FG004|Period 1|Protocol Violation|1|||
13242032|NCT01641081|26344153|FG005|Period 1|Protocol Violation|0|||
13242033|NCT01641081|26344154|FG006|Period 1|Protocol Violation|0|||
13242034|NCT01641081|26344155|FG007|Period 1|Protocol Violation|1|||
13242035|NCT01641081|26344156|FG008|Period 1|Protocol Violation|0|||
13242036|NCT01641081|26344157|FG009|Period 1|Protocol Violation|0|||
13242037|NCT01641081|26344148|FG000|Period 1|Adverse Event|1|||
13242038|NCT01641081|26344149|FG001|Period 1|Adverse Event|0|||
13242039|NCT01641081|26344150|FG002|Period 1|Adverse Event|0|||
13242040|NCT01641081|26344151|FG003|Period 1|Adverse Event|0|||
13242041|NCT01641081|26344152|FG004|Period 1|Adverse Event|0|||
13242042|NCT01641081|26344153|FG005|Period 1|Adverse Event|0|||
13242043|NCT01641081|26344154|FG006|Period 1|Adverse Event|0|||
13242044|NCT01641081|26344155|FG007|Period 1|Adverse Event|2|||
13242045|NCT01641081|26344156|FG008|Period 1|Adverse Event|0|||
13242046|NCT01641081|26344157|FG009|Period 1|Adverse Event|0|||
13242047|NCT01641081|26344148|FG000|Period 2|Adverse Event|0|||
13242048|NCT01641081|26344149|FG001|Period 2|Adverse Event|0|||
13242049|NCT01641081|26344150|FG002|Period 2|Adverse Event|0|||
13242050|NCT01641081|26344151|FG003|Period 2|Adverse Event|0|||
13242051|NCT01641081|26344152|FG004|Period 2|Adverse Event|0|||
13242052|NCT01641081|26344153|FG005|Period 2|Adverse Event|1|||
13242053|NCT01641081|26344154|FG006|Period 2|Adverse Event|0|||
13242054|NCT01641081|26344155|FG007|Period 2|Adverse Event|0|||
13242055|NCT01641081|26344156|FG008|Period 2|Adverse Event|0|||
13242056|NCT01641081|26344157|FG009|Period 2|Adverse Event|0|||
13242057|NCT01641081|26344148|FG000|Period 2|Withdrawal by Subject|0|||
13242058|NCT01641081|26344149|FG001|Period 2|Withdrawal by Subject|0|||
13242059|NCT01641081|26344150|FG002|Period 2|Withdrawal by Subject|0|||
13242060|NCT01641081|26344151|FG003|Period 2|Withdrawal by Subject|1|||
13242061|NCT01641081|26344152|FG004|Period 2|Withdrawal by Subject|0|||
13242062|NCT01641081|26344153|FG005|Period 2|Withdrawal by Subject|0|||
13242063|NCT01641081|26344154|FG006|Period 2|Withdrawal by Subject|2|||
13242064|NCT01641081|26344155|FG007|Period 2|Withdrawal by Subject|0|||
13242065|NCT01641081|26344156|FG008|Period 2|Withdrawal by Subject|0|||
13242066|NCT01641081|26344157|FG009|Period 2|Withdrawal by Subject|0|||
13242067|NCT01641081|26344148|FG000|Period 2|Protocol Violation|1|||
13242068|NCT01641081|26344149|FG001|Period 2|Protocol Violation|0|||
13242069|NCT01641081|26344150|FG002|Period 2|Protocol Violation|0|||
13242070|NCT01641081|26344151|FG003|Period 2|Protocol Violation|0|||
13242071|NCT01641081|26344152|FG004|Period 2|Protocol Violation|0|||
13242072|NCT01641081|26344153|FG005|Period 2|Protocol Violation|0|||
13242073|NCT01641081|26344154|FG006|Period 2|Protocol Violation|0|||
13242074|NCT01641081|26344155|FG007|Period 2|Protocol Violation|0|||
13242075|NCT01641081|26344156|FG008|Period 2|Protocol Violation|0|||
13242076|NCT01641081|26344157|FG009|Period 2|Protocol Violation|0|||
13242077|NCT01641081|26344148|FG000|Period 3|Adverse Event|0|||
13242078|NCT01641081|26344149|FG001|Period 3|Adverse Event|0|||
13242079|NCT01641081|26344150|FG002|Period 3|Adverse Event|1|||
13242080|NCT01641081|26344151|FG003|Period 3|Adverse Event|0|||
13242081|NCT01641081|26344152|FG004|Period 3|Adverse Event|0|||
13242082|NCT01641081|26344153|FG005|Period 3|Adverse Event|0|||
13242083|NCT01641081|26344154|FG006|Period 3|Adverse Event|0|||
13242084|NCT01641081|26344155|FG007|Period 3|Adverse Event|0|||
13242085|NCT01641081|26344156|FG008|Period 3|Adverse Event|0|||
13242086|NCT01641081|26344157|FG009|Period 3|Adverse Event|0|||
13242087|NCT01641081|26344148|FG000|Period 3|Withdrawal by Subject|0|||
13242088|NCT01641081|26344149|FG001|Period 3|Withdrawal by Subject|0|||
13242089|NCT01641081|26344150|FG002|Period 3|Withdrawal by Subject|0|||
13242090|NCT01641081|26344151|FG003|Period 3|Withdrawal by Subject|0|||
13242091|NCT01641081|26344152|FG004|Period 3|Withdrawal by Subject|0|||
13242092|NCT01641081|26344153|FG005|Period 3|Withdrawal by Subject|0|||
13242093|NCT01641081|26344154|FG006|Period 3|Withdrawal by Subject|0|||
13242094|NCT01641081|26344155|FG007|Period 3|Withdrawal by Subject|0|||
13242095|NCT01641081|26344156|FG008|Period 3|Withdrawal by Subject|1|||
13242096|NCT01641081|26344157|FG009|Period 3|Withdrawal by Subject|0|||
13242097|NCT01641081|26344148|FG000|Period 4|Adverse Event|0|||
13242098|NCT01641081|26344149|FG001|Period 4|Adverse Event|1|||
13242099|NCT01641081|26344150|FG002|Period 4|Adverse Event|0|||
13242100|NCT01641081|26344151|FG003|Period 4|Adverse Event|1|||
13242101|NCT01641081|26344152|FG004|Period 4|Adverse Event|0|||
13242102|NCT01641081|26344153|FG005|Period 4|Adverse Event|0|||
13242103|NCT01641081|26344154|FG006|Period 4|Adverse Event|0|||
13242104|NCT01641081|26344155|FG007|Period 4|Adverse Event|0|||
13242105|NCT01641081|26344156|FG008|Period 4|Adverse Event|0|||
13242106|NCT01641081|26344157|FG009|Period 4|Adverse Event|0|||
13242107|NCT01641081|26344148|FG000|Period 5|Adverse Event|0|||
13242108|NCT01641081|26344149|FG001|Period 5|Adverse Event|0|||
13242109|NCT01641081|26344150|FG002|Period 5|Adverse Event|2|||
13242110|NCT01641081|26344151|FG003|Period 5|Adverse Event|0|||
13242111|NCT01641081|26344152|FG004|Period 5|Adverse Event|0|||
13242112|NCT01641081|26344153|FG005|Period 5|Adverse Event|0|||
13242113|NCT01641081|26344154|FG006|Period 5|Adverse Event|0|||
13242114|NCT01641081|26344155|FG007|Period 5|Adverse Event|0|||
13242115|NCT01641081|26344156|FG008|Period 5|Adverse Event|0|||
13242116|NCT01641081|26344157|FG009|Period 5|Adverse Event|0|||
13242117|NCT01640964|26344182|FG000|Overall Study|Lost to Follow-up|0|||
13242118|NCT01640964|26344183|FG001|Overall Study|Lost to Follow-up|0|||
13242119|NCT01640964|26344184|FG002|Overall Study|Lost to Follow-up|1|||
13242120|NCT01640964|26344182|FG000|Overall Study|Protocol Deviation|1|||
13242121|NCT01640964|26344183|FG001|Overall Study|Protocol Deviation|1|||
13242122|NCT01640964|26344184|FG002|Overall Study|Protocol Deviation|2|||
13242123|NCT01640951|26344309|FG000|Overall Study|Adverse Event|8|||
13242124|NCT01640951|26344310|FG001|Overall Study|Adverse Event|3|||
13242125|NCT01640951|26344311|FG002|Overall Study|Adverse Event|10|||
13242126|NCT01640951|26344312|FG003|Overall Study|Adverse Event|6|||
13242127|NCT01640951|26344313|FG004|Overall Study|Adverse Event|1|||
13242128|NCT01640951|26344314|FG005|Overall Study|Adverse Event|11|||
13242129|NCT01640951|26344315|FG006|Overall Study|Adverse Event|1|||
13242130|NCT01640951|26344316|FG007|Overall Study|Adverse Event|3|||
13242131|NCT01640951|26344309|FG000|Overall Study|Lack of Efficacy|20|||
13242132|NCT01640951|26344310|FG001|Overall Study|Lack of Efficacy|1|||
13242133|NCT01640951|26344311|FG002|Overall Study|Lack of Efficacy|7|||
13242134|NCT01640951|26344312|FG003|Overall Study|Lack of Efficacy|14|||
13242135|NCT01640951|26344313|FG004|Overall Study|Lack of Efficacy|0|||
13242136|NCT01640951|26344314|FG005|Overall Study|Lack of Efficacy|6|||
13242137|NCT01640951|26344315|FG006|Overall Study|Lack of Efficacy|5|||
13242138|NCT01640951|26344316|FG007|Overall Study|Lack of Efficacy|6|||
13242139|NCT01640951|26344309|FG000|Overall Study|Lost to Follow-up|1|||
13242140|NCT01640951|26344310|FG001|Overall Study|Lost to Follow-up|0|||
13242141|NCT01640951|26344311|FG002|Overall Study|Lost to Follow-up|6|||
13242142|NCT01640951|26344312|FG003|Overall Study|Lost to Follow-up|2|||
13242143|NCT01640951|26344313|FG004|Overall Study|Lost to Follow-up|2|||
13242144|NCT01640951|26344314|FG005|Overall Study|Lost to Follow-up|3|||
13242145|NCT01640951|26344315|FG006|Overall Study|Lost to Follow-up|1|||
13242146|NCT01640951|26344316|FG007|Overall Study|Lost to Follow-up|1|||
13242147|NCT01640951|26344309|FG000|Overall Study|Non-compliance with study treatment|0|||
13242148|NCT01640951|26344310|FG001|Overall Study|Non-compliance with study treatment|0|||
13242149|NCT01640951|26344311|FG002|Overall Study|Non-compliance with study treatment|1|||
13242150|NCT01640951|26344312|FG003|Overall Study|Non-compliance with study treatment|1|||
13242151|NCT01640951|26344313|FG004|Overall Study|Non-compliance with study treatment|1|||
13242152|NCT01640951|26344314|FG005|Overall Study|Non-compliance with study treatment|4|||
13242153|NCT01640951|26344315|FG006|Overall Study|Non-compliance with study treatment|1|||
13242154|NCT01640951|26344316|FG007|Overall Study|Non-compliance with study treatment|0|||
13242155|NCT01640951|26344309|FG000|Overall Study|Physician Decision|2|||
13242156|NCT01640951|26344310|FG001|Overall Study|Physician Decision|5|||
13242157|NCT01640951|26344311|FG002|Overall Study|Physician Decision|2|||
13242158|NCT01640951|26344312|FG003|Overall Study|Physician Decision|2|||
13242159|NCT01640951|26344313|FG004|Overall Study|Physician Decision|2|||
13242160|NCT01640951|26344314|FG005|Overall Study|Physician Decision|3|||
13242161|NCT01640951|26344315|FG006|Overall Study|Physician Decision|3|||
13242162|NCT01640951|26344316|FG007|Overall Study|Physician Decision|0|||
13242163|NCT01640951|26344309|FG000|Overall Study|Pregnancy|3|||
13242164|NCT01640951|26344310|FG001|Overall Study|Pregnancy|0|||
13242165|NCT01640951|26344311|FG002|Overall Study|Pregnancy|0|||
13242166|NCT01640951|26344312|FG003|Overall Study|Pregnancy|4|||
13242167|NCT01640951|26344313|FG004|Overall Study|Pregnancy|0|||
13242168|NCT01640951|26344314|FG005|Overall Study|Pregnancy|0|||
13242169|NCT01640951|26344315|FG006|Overall Study|Pregnancy|2|||
13242170|NCT01640951|26344316|FG007|Overall Study|Pregnancy|0|||
13242171|NCT01640951|26344309|FG000|Overall Study|Protocol Deviation|0|||
13242172|NCT01640951|26344310|FG001|Overall Study|Protocol Deviation|1|||
13242173|NCT01640951|26344311|FG002|Overall Study|Protocol Deviation|2|||
13242174|NCT01640951|26344312|FG003|Overall Study|Protocol Deviation|1|||
13242175|NCT01640951|26344313|FG004|Overall Study|Protocol Deviation|0|||
13242176|NCT01640951|26344314|FG005|Overall Study|Protocol Deviation|1|||
13242177|NCT01640951|26344315|FG006|Overall Study|Protocol Deviation|0|||
13242178|NCT01640951|26344316|FG007|Overall Study|Protocol Deviation|0|||
13242179|NCT01640951|26344309|FG000|Overall Study|Subject/Guardian decision|12|||
13242180|NCT01640951|26344310|FG001|Overall Study|Subject/Guardian decision|4|||
13242181|NCT01640951|26344311|FG002|Overall Study|Subject/Guardian decision|13|||
13242182|NCT01640951|26344312|FG003|Overall Study|Subject/Guardian decision|15|||
13242183|NCT01640951|26344313|FG004|Overall Study|Subject/Guardian decision|7|||
13242184|NCT01640951|26344314|FG005|Overall Study|Subject/Guardian decision|19|||
13242185|NCT01640951|26344315|FG006|Overall Study|Subject/Guardian decision|5|||
13242186|NCT01640951|26344316|FG007|Overall Study|Subject/Guardian decision|4|||
13242187|NCT01640951|26344309|FG000|Overall Study|Death|0|||
13242188|NCT01640951|26344310|FG001|Overall Study|Death|1|||
13242189|NCT01640951|26344311|FG002|Overall Study|Death|1|||
13242190|NCT01640951|26344312|FG003|Overall Study|Death|0|||
13115845|NCT03090100|25919697|FG001|Overall Study|Withdrawal by Subject|19|||
13242191|NCT01640951|26344313|FG004|Overall Study|Death|0|||
13242192|NCT01640951|26344314|FG005|Overall Study|Death|0|||
13242193|NCT01640951|26344315|FG006|Overall Study|Death|0|||
13242194|NCT01640951|26344316|FG007|Overall Study|Death|2|||
13242195|NCT01640925|26344335|FG000|Overall Study|Withdrawal by Subject|1|||
13242196|NCT01640925|26344336|FG001|Overall Study|Withdrawal by Subject|0|||
13242197|NCT01640925|26344335|FG000|Overall Study|Previously enrolled in this trial|13|||
13242198|NCT01640925|26344336|FG001|Overall Study|Previously enrolled in this trial|11|||
13242199|NCT01640873|26344359|FG000|Overall Study|Protocol Violation|2|||
13242200|NCT01640873|26344360|FG001|Overall Study|Protocol Violation|1|||
13242201|NCT01640808|26344377|FG000|Overall Study|Unable to continue dynamic CT|14|||
13242202|NCT01640808|26344378|FG001|Overall Study|Unable to continue dynamic CT|4|||
13242203|NCT01640808|26344377|FG000|Overall Study|Withdrawal by Subject|12|||
13242204|NCT01640808|26344378|FG001|Overall Study|Withdrawal by Subject|4|||
13242205|NCT01640808|26344377|FG000|Overall Study|Lost to Follow-up|4|||
13242206|NCT01640808|26344378|FG001|Overall Study|Lost to Follow-up|0|||
13242207|NCT01640808|26344377|FG000|Overall Study|Start an antiviral therapy using IFN|3|||
13242208|NCT01640808|26344378|FG001|Overall Study|Start an antiviral therapy using IFN|0|||
13242209|NCT01640808|26344377|FG000|Overall Study|Administration of anticancer drugs|2|||
13242210|NCT01640808|26344378|FG001|Overall Study|Administration of anticancer drugs|1|||
13242211|NCT01640808|26344377|FG000|Overall Study|Physician Decision|19|||
13242212|NCT01640808|26344378|FG001|Overall Study|Physician Decision|5|||
13242213|NCT01640808|26344377|FG000|Overall Study|Randomized but not treated|4|||
13242214|NCT01640808|26344378|FG001|Overall Study|Randomized but not treated|2|||
13242215|NCT01640366|26344393|FG000|Overall Study|Withdrawal by Subject|1|||
13242216|NCT01640366|26344393|FG000|Overall Study|Protocol Violation|16|||
13242217|NCT01640366|26344393|FG000|Overall Study|Lost to Follow-up|5|||
13242218|NCT01640353|26344405|FG000|Overall Study|Withdrew prior to treatment|10|||
13242219|NCT01640353|26344405|FG000|Overall Study|Withdrawn from analysis at term site|12|||
13242220|NCT01640353|26344405|FG000|Overall Study|Withdrawal by Subject|5|||
13242221|NCT01640353|26344405|FG000|Overall Study|Death|2|||
13242222|NCT01640353|26344405|FG000|Overall Study|Early site termination|3|||
13242223|NCT01640353|26344405|FG000|Overall Study|Lost to Follow-up|12|||
13242224|NCT01640353|26344405|FG000|Overall Study|Physician Decision|1|||
13242225|NCT01640314|26344426|FG000|Overall Study|Protocol Violation|0|||
13242226|NCT01640314|26344427|FG001|Overall Study|Protocol Violation|1|||
13242227|NCT01640301|26344452|FG000|Overall Study|Death|0|||
13242228|NCT01640301|26344453|FG001|Overall Study|Death|8|||
13242229|NCT01640288|26344470|FG000|Overall Study|Equipment Failure or Poor Image Quality|4|||
13242230|NCT01640288|26344471|FG001|Overall Study|Equipment Failure or Poor Image Quality|5|||
13242231|NCT01640288|26344470|FG000|Overall Study|Screen Failure|20|||
13242232|NCT01640288|26344471|FG001|Overall Study|Screen Failure|18|||
13242233|NCT01640288|26344470|FG000|Overall Study|Withdrawn by PI|5|||
13242234|NCT01640288|26344471|FG001|Overall Study|Withdrawn by PI|0|||
13242235|NCT01640288|26344470|FG000|Overall Study|Withdrawal by Subject|1|||
13242236|NCT01640288|26344471|FG001|Overall Study|Withdrawal by Subject|0|||
13242237|NCT01640249|26344517|FG000|Period 1|Withdrawal by Subject|1|||
13242238|NCT01640249|26344518|FG001|Period 1|Withdrawal by Subject|0|||
13242239|NCT01640249|26344519|FG002|Period 1|Withdrawal by Subject|0|||
13242240|NCT01640249|26344520|FG003|Period 1|Withdrawal by Subject|0|||
13242241|NCT01640249|26344521|FG004|Period 1|Withdrawal by Subject|0|||
13242242|NCT01640249|26344522|FG005|Period 1|Withdrawal by Subject|1|||
13242243|NCT01640249|26344523|FG006|Period 1|Withdrawal by Subject|0|||
13242244|NCT01640184|26344555|FG000|Overall Study|Death|1|||
13242245|NCT01640184|26344556|FG001|Overall Study|Death|0|||
13242246|NCT01640184|26344557|FG002|Overall Study|Death|0|||
13242247|NCT01640184|26344555|FG000|Overall Study|Lost to Follow-up|4|||
13242248|NCT01640184|26344556|FG001|Overall Study|Lost to Follow-up|1|||
13242249|NCT01640184|26344557|FG002|Overall Study|Lost to Follow-up|0|||
13242250|NCT01640184|26344555|FG000|Overall Study|Physician Decision|3|||
13242251|NCT01640184|26344556|FG001|Overall Study|Physician Decision|0|||
13242252|NCT01640184|26344557|FG002|Overall Study|Physician Decision|0|||
13242253|NCT01640184|26344555|FG000|Overall Study|Withdrawal by Subject|0|||
13242254|NCT01640184|26344556|FG001|Overall Study|Withdrawal by Subject|1|||
13242255|NCT01640184|26344557|FG002|Overall Study|Withdrawal by Subject|1|||
13242256|NCT01640184|26344555|FG000|Overall Study|Protocol Violation|0|||
13242257|NCT01640184|26344556|FG001|Overall Study|Protocol Violation|0|||
13242258|NCT01640184|26344557|FG002|Overall Study|Protocol Violation|1|||
13242259|NCT01640054|26344567|FG000|Overall Study|Study-specific disc criteria|1|||
13242260|NCT01640054|26344567|FG000|Overall Study|Lack of Efficacy|3|||
13242261|NCT01640054|26344567|FG000|Overall Study|Adverse Event|2|||
13242262|NCT01639833|26344582|FG000|Overall Study|Death|4|||
13242263|NCT01639833|26344583|FG001|Overall Study|Death|2|||
13242264|NCT01639833|26344582|FG000|Overall Study|Withdrawal by Subject|2|||
13242265|NCT01639833|26344583|FG001|Overall Study|Withdrawal by Subject|2|||
13242266|NCT01639755|26344593|FG000|Overall Study|Study Ongoing|15|||
13242267|NCT01639755|26344593|FG000|Overall Study|Patient had device explantation|4|||
13242268|NCT01639742|26344603|FG000|Overall Study|Study Ongoing|17|||
13242269|NCT01639742|26344603|FG000|Overall Study|Lost to Follow-up|1|||
13242270|NCT01639729|26344632|FG000|Overall Study|Withdrawal by Subject|1|||
13242271|NCT01639729|26344633|FG001|Overall Study|Withdrawal by Subject|0|||
13242272|NCT01639729|26344634|FG002|Overall Study|Withdrawal by Subject|1|||
13242273|NCT01639729|26344635|FG003|Overall Study|Withdrawal by Subject|1|||
13242274|NCT01639729|26344636|FG004|Overall Study|Withdrawal by Subject|0|||
13242275|NCT01639729|26344637|FG005|Overall Study|Withdrawal by Subject|0|||
13242276|NCT01639703|26344680|FG000|Overall Study|Withdrawal by Subject|5|||
13242277|NCT01639703|26344680|FG000|Overall Study|Other reason|7|||
13242278|NCT01639560|26344699|FG000|Overall Study|Withdrawal by Subject|9|||
13242279|NCT01639560|26344700|FG001|Overall Study|Withdrawal by Subject|14|||
13242280|NCT01639560|26344699|FG000|Overall Study|Lack of Efficacy|1|||
13242281|NCT01639560|26344700|FG001|Overall Study|Lack of Efficacy|2|||
13242282|NCT01639560|26344699|FG000|Overall Study|Lost to Follow-up|9|||
13242283|NCT01639560|26344700|FG001|Overall Study|Lost to Follow-up|11|||
13242284|NCT01639560|26344699|FG000|Overall Study|Adverse Event|0|||
13242285|NCT01639560|26344700|FG001|Overall Study|Adverse Event|2|||
13242286|NCT01639495|26344710|FG000|Overall Study|Lost to Follow-up|6|||
13242287|NCT01639495|26344710|FG000|Overall Study|Consented but didn't have study catheter|4|||
13242288|NCT01639495|26344710|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4|||
13242289|NCT01639495|26344710|FG000|Overall Study|No radiofrequency energy applied|2|||
13242290|NCT01639469|26344723|FG000|Overall Study|Death|4|||
13242291|NCT01639469|26344724|FG001|Overall Study|Death|2|||
13242292|NCT01639469|26344723|FG000|Overall Study|Lost to Follow-up|1|||
13242293|NCT01639469|26344724|FG001|Overall Study|Lost to Follow-up|1|||
13242294|NCT01639339|26344755|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26|||
13242295|NCT01639339|26344756|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19|||
13242296|NCT01639339|26344755|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11|||
13242297|NCT01639339|26344756|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5|||
13242298|NCT01639339|26344755|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5|||
13242299|NCT01639339|26344756|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4|||
13242300|NCT01639339|26344755|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0|||
13242301|NCT01639339|26344756|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2|||
13242302|NCT01639339|26344755|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2|||
13242303|NCT01639339|26344756|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1|||
13242304|NCT01639339|26344755|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10|||
13242305|NCT01639339|26344756|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7|||
13242306|NCT01639339|26344755|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0|||
13242307|NCT01639339|26344756|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2|||
13242308|NCT01639339|26344755|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0|||
13242309|NCT01639339|26344756|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1|||
13242310|NCT01639339|26344755|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0|||
13242311|NCT01639339|26344756|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1|||
13242312|NCT01639339|26344755|FG000|Open-label Period (Up to Week 28)|Adverse Event|1|||
13242313|NCT01639339|26344756|FG001|Open-label Period (Up to Week 28)|Adverse Event|4|||
13242314|NCT01639144|26344769|FG000|Overall Study|Withdrawal by Subject|4|||
13242315|NCT01639144|26344770|FG001|Overall Study|Withdrawal by Subject|2|||
13242316|NCT01639144|26344769|FG000|Overall Study|Physician Decision|2|||
13242317|NCT01639144|26344770|FG001|Overall Study|Physician Decision|0|||
13242318|NCT01639144|26344769|FG000|Overall Study|Met postoperative exclusion criteria|4|||
13242319|NCT01639144|26344770|FG001|Overall Study|Met postoperative exclusion criteria|3|||
13242320|NCT01639131|26344778|FG000|Overall Study|Disease Progression|6|||
13242321|NCT01639040|26344801|FG000|Overall Study|Adverse Event|1|||
13242322|NCT01639040|26344802|FG001|Overall Study|Adverse Event|0|||
13242323|NCT01639001|26344853|FG000|Overall Study|Refused further follow-up|9|||
13115846|NCT03090100|25919696|FG000|Overall Study|Protocol Violation|2|||
13242324|NCT01639001|26344854|FG001|Overall Study|Refused further follow-up|12|||
13242325|NCT01639001|26344853|FG000|Overall Study|Lost to Follow-up|3|||
13242326|NCT01639001|26344854|FG001|Overall Study|Lost to Follow-up|0|||
13242327|NCT01639001|26344853|FG000|Overall Study|Death|62|||
13242328|NCT01639001|26344854|FG001|Overall Study|Death|61|||
13242329|NCT01639001|26344853|FG000|Overall Study|Randomized but not treated|0|||
13242330|NCT01639001|26344854|FG001|Overall Study|Randomized but not treated|2|||
13242331|NCT01639001|26344853|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1|||
13242332|NCT01639001|26344854|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2|||
13242333|NCT01638819|26344870|FG000|Overall Study|Lost to Follow-up|1|||
13242334|NCT01638819|26344871|FG001|Overall Study|Lost to Follow-up|0|||
13242335|NCT01638559|26344889|FG000|Overall Study|Lost to Follow-up|1|||
13242336|NCT01638559|26344889|FG000|Overall Study|Withdrawal by Subject|1|||
13242337|NCT01638559|26344889|FG000|Overall Study|Subject declined to travel for biopsy|1|||
13242338|NCT01638546|26344908|FG000|Overall Study|Adverse Event|1|||
13242339|NCT01638546|26344909|FG001|Overall Study|Adverse Event|3|||
13242340|NCT01638429|26344939|FG000|Overall Study|Withdrawal by Subject|1|||
13242341|NCT01638390|26344953|FG000|Overall Study|screening failures|21|||
13242342|NCT01638013|26345094|FG000|Overall Study|Adverse Event|36|||
13242343|NCT01638013|26345095|FG001|Overall Study|Adverse Event|29|||
13242344|NCT01638013|26345096|FG002|Overall Study|Adverse Event|48|||
13242345|NCT01638013|26345094|FG000|Overall Study|Lack of Efficacy|39|||
13242346|NCT01638013|26345095|FG001|Overall Study|Lack of Efficacy|11|||
13242347|NCT01638013|26345096|FG002|Overall Study|Lack of Efficacy|14|||
13242348|NCT01638013|26345094|FG000|Overall Study|Protocol Violation|10|||
13242349|NCT01638013|26345095|FG001|Overall Study|Protocol Violation|7|||
13242350|NCT01638013|26345096|FG002|Overall Study|Protocol Violation|11|||
13242351|NCT01638013|26345094|FG000|Overall Study|Met discontinuation criteria|4|||
13242352|NCT01638013|26345095|FG001|Overall Study|Met discontinuation criteria|0|||
13242353|NCT01638013|26345096|FG002|Overall Study|Met discontinuation criteria|7|||
13242354|NCT01638013|26345094|FG000|Overall Study|Subject Lost to Follow up|1|||
13242355|NCT01638013|26345095|FG001|Overall Study|Subject Lost to Follow up|0|||
13242356|NCT01638013|26345096|FG002|Overall Study|Subject Lost to Follow up|1|||
13242357|NCT01638013|26345094|FG000|Overall Study|Miscellaneous|25|||
13242358|NCT01638013|26345095|FG001|Overall Study|Miscellaneous|19|||
13242359|NCT01638013|26345096|FG002|Overall Study|Miscellaneous|23|||
13242360|NCT01638013|26345094|FG000|Overall Study|Withdrawal of Consent|16|||
13242361|NCT01638013|26345095|FG001|Overall Study|Withdrawal of Consent|12|||
13242362|NCT01638013|26345096|FG002|Overall Study|Withdrawal of Consent|16|||
13242363|NCT01638013|26345094|FG000|Overall Study|Not met inclusion or exclusion criteria|0|||
13242364|NCT01638013|26345095|FG001|Overall Study|Not met inclusion or exclusion criteria|0|||
13242365|NCT01638013|26345096|FG002|Overall Study|Not met inclusion or exclusion criteria|1|||
13242366|NCT01638000|26345201|FG000|Overall Study|Randomized but Never Received Drug|7|||
13242367|NCT01638000|26345202|FG001|Overall Study|Randomized but Never Received Drug|10|||
13242368|NCT01638000|26345201|FG000|Overall Study|Adverse Event|14|||
13242369|NCT01638000|26345202|FG001|Overall Study|Adverse Event|16|||
13242370|NCT01638000|26345201|FG000|Overall Study|Lack of Efficacy|5|||
13115847|NCT03090100|25919697|FG001|Overall Study|Protocol Violation|6|||
13115848|NCT03090100|25919696|FG000|Overall Study|Non-compliance|2|||
13115849|NCT03090100|25919697|FG001|Overall Study|Non-compliance|0|||
13115850|NCT03090100|25919696|FG000|Overall Study|Other|2|||
13115851|NCT03090100|25919697|FG001|Overall Study|Other|2|||
13115852|NCT03089944|25919710|FG000|Overall Study|Lost to Follow-up|8|||
13115853|NCT03089944|25919710|FG000|Overall Study|Withdrew Consent|2|||
13115854|NCT03089944|25919710|FG000|Overall Study|Adverse Event|1|||
13115855|NCT03089944|25919710|FG000|Overall Study|Other|1|||
13115856|NCT03089697|25919729|FG000|Overall Study|Adverse Event|1|||
13115857|NCT03089697|25919730|FG001|Overall Study|Adverse Event|2|||
13115858|NCT03089697|25919729|FG000|Overall Study|Withdrawal by Subject|1|||
13115859|NCT03089697|25919730|FG001|Overall Study|Withdrawal by Subject|0|||
13115860|NCT03089580|25919739|FG000|Overall Study|Lost to Follow-up|2|||
13115861|NCT03089216|25919766|FG000|Overall Study|Adverse Event|0|||
13115862|NCT03089216|25919767|FG001|Overall Study|Adverse Event|0|||
13115863|NCT03089216|25919768|FG002|Overall Study|Adverse Event|0|||
13242371|NCT01638000|26345202|FG001|Overall Study|Lack of Efficacy|6|||
13242372|NCT01638000|26345201|FG000|Overall Study|Protocol Violation|11|||
13242373|NCT01638000|26345202|FG001|Overall Study|Protocol Violation|13|||
13242374|NCT01638000|26345201|FG000|Overall Study|Withdrawal by Subject|21|||
13242375|NCT01638000|26345202|FG001|Overall Study|Withdrawal by Subject|24|||
13242376|NCT01638000|26345201|FG000|Overall Study|Miscellaneous|2|||
13242377|NCT01638000|26345202|FG001|Overall Study|Miscellaneous|2|||
13242378|NCT01637961|26345217|FG000|Overall Study|Ineligible: wrong primary|1|||
13242379|NCT01637961|26345217|FG000|Overall Study|Ineligible: inadequate pathology|1|||
13242380|NCT01637922|26345247|FG000|Overall Study|Adverse Event|0|||
13242381|NCT01637922|26345248|FG001|Overall Study|Adverse Event|1|||
13242382|NCT01637922|26345247|FG000|Overall Study|Protocol Violation|0|||
13242383|NCT01637922|26345248|FG001|Overall Study|Protocol Violation|1|||
13242384|NCT01637922|26345247|FG000|Overall Study|Withdrawal by Subject|0|||
13242385|NCT01637922|26345248|FG001|Overall Study|Withdrawal by Subject|3|||
13242386|NCT01637922|26345247|FG000|Overall Study|Lost to Follow-up|2|||
13242387|NCT01637922|26345248|FG001|Overall Study|Lost to Follow-up|0|||
13242388|NCT01637623|26345296|FG000|Overall Study|Lost to Follow-up|0|||
13242389|NCT01637623|26345297|FG001|Overall Study|Lost to Follow-up|0|||
13242390|NCT01637623|26345298|FG002|Overall Study|Lost to Follow-up|2|||
13242391|NCT01637623|26345296|FG000|Overall Study|Physician Decision|1|||
13485843|NCT00585195|27033419|FG009|Overall Study|Withdrawn Due to Pregnancy|0|||
13115864|NCT03089216|25919769|FG003|Overall Study|Adverse Event|1|||
13115865|NCT03089047|25919786|FG000|Overall Study|Lost to Follow-up|1|||
13242392|NCT01637623|26345297|FG001|Overall Study|Physician Decision|0|||
13242393|NCT01637623|26345298|FG002|Overall Study|Physician Decision|1|||
13242394|NCT01637584|26345312|FG000|Overall Study|Withdrawal by Subject|1|||
13242395|NCT01637584|26345313|FG001|Overall Study|Withdrawal by Subject|3|||
13115866|NCT03089047|25919787|FG001|Overall Study|Lost to Follow-up|0|||
13242396|NCT01637402|26345347|FG000|Standard Dose Regimen|Lack of Efficacy|2|||
13242397|NCT01637402|26345348|FG001|Standard Dose Regimen|Lack of Efficacy|0|||
13242398|NCT01637402|26345347|FG000|Standard Dose Regimen|Adverse Event|1|||
13242399|NCT01637402|26345348|FG001|Standard Dose Regimen|Adverse Event|0|||
13242400|NCT01637402|26345347|FG000|Week 12 Evaluation|Lack of Efficacy|6|||
13242401|NCT01637402|26345348|FG001|Week 12 Evaluation|Lack of Efficacy|0|||
13242402|NCT01637402|26345347|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0|||
13242403|NCT01637402|26345348|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4|||
13242404|NCT01637402|26345347|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4|||
13242405|NCT01637402|26345348|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
13242406|NCT01637402|26345347|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5|||
13242407|NCT01637402|26345348|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0|||
13242408|NCT01637272|26345412|FG000|Overall Study|Adverse Event|6|||
13242409|NCT01637272|26345412|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
13242410|NCT01637272|26345412|FG000|Overall Study|Withdrawal by Subject|3|||
13242411|NCT01637272|26345412|FG000|Overall Study|Lost to Follow-up|2|||
13242412|NCT01637272|26345412|FG000|Overall Study|completed core, did not enter ext. phase|4|||
13242413|NCT01637272|26345412|FG000|Overall Study|Administrative problems|1|||
13242414|NCT01637272|26345412|FG000|Overall Study|Protocol Violation|2|||
13242415|NCT01637142|26345420|FG000|Washout Period (at Least 3 Days)|Physician Decision|1|||
13242416|NCT01637077|26345453|FG000|Overall Study|Cancel|1|||
13242417|NCT01637077|26345454|FG001|Overall Study|Cancel|1|||
13242418|NCT01637077|26345453|FG000|Overall Study|Withdrawal by Subject|1|||
13242419|NCT01637077|26345454|FG001|Overall Study|Withdrawal by Subject|0|||
13242420|NCT01637077|26345453|FG000|Overall Study|No cycle 1 questionnaire data|2|||
13242421|NCT01637077|26345454|FG001|Overall Study|No cycle 1 questionnaire data|0|||
13242422|NCT01636986|26345467|FG000|Overall Study|Withdrawal by Subject|0|||
13242423|NCT01636986|26345468|FG001|Overall Study|Withdrawal by Subject|1|||
13242424|NCT01636986|26345467|FG000|Overall Study|Corneal Staining|0|||
13242425|NCT01636986|26345468|FG001|Overall Study|Corneal Staining|1|||
13242426|NCT01636960|26345476|FG000|Induction Phase|Adverse Event|2|||
13242427|NCT01636960|26345476|FG000|Maintenance Phase|Continued drug after regulatory approval|3|||
13242428|NCT01636960|26345476|FG000|Maintenance Phase|Adverse Event|3|||
13242429|NCT01636960|26345476|FG000|Maintenance Phase|Progressive disease|1|||
13242430|NCT01636947|26345503|FG000|Overall Study|Not Treated|2|||
13242431|NCT01636947|26345504|FG001|Overall Study|Not Treated|2|||
13242432|NCT01636947|26345503|FG000|Overall Study|Lost to Follow-up|4|||
13242433|NCT01636947|26345504|FG001|Overall Study|Lost to Follow-up|0|||
13242434|NCT01636947|26345503|FG000|Overall Study|Protocol Violation|1|||
13242435|NCT01636947|26345504|FG001|Overall Study|Protocol Violation|1|||
13242436|NCT01636947|26345503|FG000|Overall Study|Withdrawal by Subject|3|||
13242437|NCT01636947|26345504|FG001|Overall Study|Withdrawal by Subject|3|||
13242438|NCT01636947|26345503|FG000|Overall Study|Adverse Event|1|||
13242439|NCT01636947|26345504|FG001|Overall Study|Adverse Event|1|||
13242440|NCT01636947|26345503|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
13242441|NCT01636947|26345504|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
13242442|NCT01636934|26345519|FG000|Overall Study|Withdrawal by Subject|3|||
13242443|NCT01636934|26345520|FG001|Overall Study|Withdrawal by Subject|2|||
13242444|NCT01636934|26345519|FG000|Overall Study|Chemo cancel|1|||
13242445|NCT01636934|26345520|FG001|Overall Study|Chemo cancel|0|||
13242446|NCT01636934|26345519|FG000|Overall Study|Too ill to continue|1|||
13242447|NCT01636934|26345520|FG001|Overall Study|Too ill to continue|0|||
13242448|NCT01636934|26345519|FG000|Overall Study|Never started study medication|1|||
13242449|NCT01636934|26345520|FG001|Overall Study|Never started study medication|1|||
13242450|NCT01636778|26345587|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3|||
13242451|NCT01636778|26345588|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
13242452|NCT01636778|26345589|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
13242453|NCT01636778|26345587|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1|||
13242454|NCT01636778|26345588|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
13242455|NCT01636778|26345589|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
13242456|NCT01636778|26345587|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
13242457|NCT01636778|26345588|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7|||
13242458|NCT01636778|26345589|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
13242459|NCT01636778|26345587|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
13242460|NCT01636778|26345588|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1|||
13242461|NCT01636778|26345589|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
13242462|NCT01636778|26345587|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
13242463|NCT01636778|26345588|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2|||
13242464|NCT01636778|26345589|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
13242465|NCT01636778|26345587|FG000|Follow-up Period After Part 2|Other|0|||
13242466|NCT01636778|26345588|FG001|Follow-up Period After Part 2|Other|0|||
13242467|NCT01636778|26345589|FG002|Follow-up Period After Part 2|Other|1|||
13242468|NCT01636778|26345587|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
13242469|NCT01636778|26345588|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
13242470|NCT01636778|26345589|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1|||
13242471|NCT01636778|26345587|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0|||
13242472|NCT01636778|26345588|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0|||
13242473|NCT01636778|26345589|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2|||
13242474|NCT01636713|26345613|FG000|Overall Study|Adverse Event|16|||
13242475|NCT01636713|26345614|FG001|Overall Study|Adverse Event|16|||
13242476|NCT01636713|26345615|FG002|Overall Study|Adverse Event|7|||
13242477|NCT01636713|26345613|FG000|Overall Study|Lack of Efficacy|6|||
13242478|NCT01636713|26345614|FG001|Overall Study|Lack of Efficacy|6|||
13242479|NCT01636713|26345615|FG002|Overall Study|Lack of Efficacy|2|||
13242480|NCT01636713|26345613|FG000|Overall Study|Protocol Violation|3|||
13242481|NCT01636713|26345614|FG001|Overall Study|Protocol Violation|0|||
13242482|NCT01636713|26345615|FG002|Overall Study|Protocol Violation|1|||
13242483|NCT01636713|26345613|FG000|Overall Study|Lost to Follow-up|0|||
13242484|NCT01636713|26345614|FG001|Overall Study|Lost to Follow-up|0|||
13242485|NCT01636713|26345615|FG002|Overall Study|Lost to Follow-up|1|||
13242486|NCT01636713|26345613|FG000|Overall Study|Withdrawal by Subject|5|||
13242487|NCT01636713|26345614|FG001|Overall Study|Withdrawal by Subject|4|||
13242488|NCT01636713|26345615|FG002|Overall Study|Withdrawal by Subject|8|||
13242489|NCT01636713|26345613|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2|||
13242490|NCT01636713|26345614|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2|||
13242491|NCT01636713|26345615|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4|||
13242492|NCT01636687|26345714|FG000|Induction Period|Withdrawal by Subject|1|||
13242493|NCT01636687|26345715|FG001|Induction Period|Withdrawal by Subject|0|||
13242494|NCT01636687|26345716|FG002|Induction Period|Withdrawal by Subject|0|||
13242495|NCT01636687|26345717|FG003|Induction Period|Withdrawal by Subject|0|||
13242496|NCT01636687|26345718|FG004|Induction Period|Withdrawal by Subject|0|||
13242497|NCT01636687|26345714|FG000|Induction Period|Adverse Event|1|||
13242498|NCT01636687|26345715|FG001|Induction Period|Adverse Event|0|||
13242499|NCT01636687|26345716|FG002|Induction Period|Adverse Event|0|||
13242500|NCT01636687|26345717|FG003|Induction Period|Adverse Event|0|||
13242501|NCT01636687|26345718|FG004|Induction Period|Adverse Event|1|||
13242502|NCT01636687|26345714|FG000|Induction Period|Lack of Efficacy|0|||
13242503|NCT01636687|26345715|FG001|Induction Period|Lack of Efficacy|0|||
13242504|NCT01636687|26345716|FG002|Induction Period|Lack of Efficacy|0|||
13242505|NCT01636687|26345717|FG003|Induction Period|Lack of Efficacy|0|||
13242506|NCT01636687|26345718|FG004|Induction Period|Lack of Efficacy|1|||
13242507|NCT01636687|26345714|FG000|Induction Period|Physician Decision|1|||
13242508|NCT01636687|26345715|FG001|Induction Period|Physician Decision|0|||
13242509|NCT01636687|26345716|FG002|Induction Period|Physician Decision|0|||
13242510|NCT01636687|26345717|FG003|Induction Period|Physician Decision|0|||
13242511|NCT01636687|26345718|FG004|Induction Period|Physician Decision|0|||
13115867|NCT03088917|25919797|FG000|Overall Study|In care/cured elsewhere|15|||
13115868|NCT03088917|25919797|FG000|Overall Study|Refuse re-evaluation|13|||
13115869|NCT03088917|25919797|FG000|Overall Study|Contact not established|13|||
13115870|NCT03088917|25919797|FG000|Overall Study|Severe comorbidity/short life expectancy|5|||
13115871|NCT03088917|25919797|FG000|Overall Study|Moved outside study region|50|||
13115872|NCT03087851|25919836|FG000|Overall Study|Withdraw on medical grounds|0|||
13115873|NCT03087851|25919837|FG001|Overall Study|Withdraw on medical grounds|1|||
13115874|NCT03087851|25919838|FG002|Overall Study|Withdraw on medical grounds|2|||
13115875|NCT03087786|25919879|FG000|Overall Study|Withdrawal by Subject|2|||
13115876|NCT03087786|25919880|FG001|Overall Study|Withdrawal by Subject|0|||
13115877|NCT03087643|25919901|FG000|Overall Study|Withdrawal by Subject|2|||
13242512|NCT01636687|26345714|FG000|Maintenance Period|Withdrawal by Subject|2|||
13242513|NCT01636687|26345715|FG001|Maintenance Period|Withdrawal by Subject|0|||
13242514|NCT01636687|26345716|FG002|Maintenance Period|Withdrawal by Subject|2|||
13242515|NCT01636687|26345717|FG003|Maintenance Period|Withdrawal by Subject|0|||
13242516|NCT01636687|26345718|FG004|Maintenance Period|Withdrawal by Subject|0|||
13242517|NCT01636687|26345714|FG000|Maintenance Period|Adverse Event|1|||
13242518|NCT01636687|26345715|FG001|Maintenance Period|Adverse Event|0|||
13242519|NCT01636687|26345716|FG002|Maintenance Period|Adverse Event|0|||
13242520|NCT01636687|26345717|FG003|Maintenance Period|Adverse Event|0|||
13242521|NCT01636687|26345718|FG004|Maintenance Period|Adverse Event|0|||
13242522|NCT01636687|26345714|FG000|Maintenance Period|Lack of Efficacy|4|||
13242523|NCT01636687|26345715|FG001|Maintenance Period|Lack of Efficacy|1|||
13242524|NCT01636687|26345716|FG002|Maintenance Period|Lack of Efficacy|0|||
13242525|NCT01636687|26345717|FG003|Maintenance Period|Lack of Efficacy|0|||
13242526|NCT01636687|26345718|FG004|Maintenance Period|Lack of Efficacy|0|||
13242527|NCT01636687|26345714|FG000|Maintenance Period|Lost to Follow-up|1|||
13242528|NCT01636687|26345715|FG001|Maintenance Period|Lost to Follow-up|1|||
13242529|NCT01636687|26345716|FG002|Maintenance Period|Lost to Follow-up|0|||
13242530|NCT01636687|26345717|FG003|Maintenance Period|Lost to Follow-up|0|||
13242531|NCT01636687|26345718|FG004|Maintenance Period|Lost to Follow-up|1|||
13242532|NCT01636687|26345714|FG000|Maintenance Period|Physician Decision|0|||
13242533|NCT01636687|26345715|FG001|Maintenance Period|Physician Decision|0|||
13242534|NCT01636687|26345716|FG002|Maintenance Period|Physician Decision|0|||
13242535|NCT01636687|26345717|FG003|Maintenance Period|Physician Decision|0|||
13242536|NCT01636687|26345718|FG004|Maintenance Period|Physician Decision|1|||
13242537|NCT01636687|26345714|FG000|Extension Period|technical problems|0|||
13242538|NCT01636687|26345715|FG001|Extension Period|technical problems|1|||
13242539|NCT01636687|26345716|FG002|Extension Period|technical problems|2|||
13242540|NCT01636687|26345717|FG003|Extension Period|technical problems|1|||
13242541|NCT01636687|26345718|FG004|Extension Period|technical problems|0|||
13242542|NCT01636687|26345714|FG000|Extension Period|Adverse Event|4|||
13242543|NCT01636687|26345715|FG001|Extension Period|Adverse Event|3|||
13242544|NCT01636687|26345716|FG002|Extension Period|Adverse Event|2|||
13242545|NCT01636687|26345717|FG003|Extension Period|Adverse Event|1|||
13242546|NCT01636687|26345718|FG004|Extension Period|Adverse Event|0|||
13242547|NCT01636687|26345714|FG000|Extension Period|Lack of Efficacy|7|||
13242548|NCT01636687|26345715|FG001|Extension Period|Lack of Efficacy|0|||
13242549|NCT01636687|26345716|FG002|Extension Period|Lack of Efficacy|2|||
13242550|NCT01636687|26345717|FG003|Extension Period|Lack of Efficacy|1|||
13242551|NCT01636687|26345718|FG004|Extension Period|Lack of Efficacy|0|||
13242552|NCT01636687|26345714|FG000|Extension Period|Lost to Follow-up|1|||
13242553|NCT01636687|26345715|FG001|Extension Period|Lost to Follow-up|0|||
13242554|NCT01636687|26345716|FG002|Extension Period|Lost to Follow-up|1|||
13242555|NCT01636687|26345717|FG003|Extension Period|Lost to Follow-up|0|||
13242556|NCT01636687|26345718|FG004|Extension Period|Lost to Follow-up|0|||
13242557|NCT01636687|26345714|FG000|Extension Period|Physician Decision|1|||
13242558|NCT01636687|26345715|FG001|Extension Period|Physician Decision|0|||
13242559|NCT01636687|26345716|FG002|Extension Period|Physician Decision|0|||
13242560|NCT01636687|26345717|FG003|Extension Period|Physician Decision|1|||
13242561|NCT01636687|26345718|FG004|Extension Period|Physician Decision|0|||
13242562|NCT01636687|26345714|FG000|Extension Period|study terminated by sponsor|33|||
13242563|NCT01636687|26345715|FG001|Extension Period|study terminated by sponsor|50|||
13242564|NCT01636687|26345716|FG002|Extension Period|study terminated by sponsor|17|||
13242565|NCT01636687|26345717|FG003|Extension Period|study terminated by sponsor|23|||
13242566|NCT01636687|26345718|FG004|Extension Period|study terminated by sponsor|0|||
13242567|NCT01636687|26345714|FG000|Extension Period|Withdrawal by Subject|1|||
13242568|NCT01636687|26345715|FG001|Extension Period|Withdrawal by Subject|0|||
13242569|NCT01636687|26345716|FG002|Extension Period|Withdrawal by Subject|1|||
13242570|NCT01636687|26345717|FG003|Extension Period|Withdrawal by Subject|1|||
13242571|NCT01636687|26345718|FG004|Extension Period|Withdrawal by Subject|0|||
13242572|NCT01636687|26345714|FG000|Follow-up Period|Withdrawal by Subject|1|||
13242573|NCT01636687|26345715|FG001|Follow-up Period|Withdrawal by Subject|0|||
13242574|NCT01636687|26345716|FG002|Follow-up Period|Withdrawal by Subject|0|||
13242575|NCT01636687|26345717|FG003|Follow-up Period|Withdrawal by Subject|0|||
13242576|NCT01636687|26345718|FG004|Follow-up Period|Withdrawal by Subject|1|||
13242577|NCT01636362|26345726|FG000|Overall Study|Physician Decision|6|||
13242578|NCT01636362|26345726|FG000|Overall Study|Subject healed, not returning|1|||
13242579|NCT01636362|26345726|FG000|Overall Study|Withdrawal by Subject|1|||
13242580|NCT01636258|26345747|FG000|Overall Study|Lost to Follow-up|1|||
13242581|NCT01636258|26345748|FG001|Overall Study|Lost to Follow-up|0|||
13242582|NCT01636076|26345815|FG000|Overall Study|Terminated by sponsor|1|||
13242583|NCT01636076|26345816|FG001|Overall Study|Terminated by sponsor|1|||
13242584|NCT01636076|26345815|FG000|Overall Study|Lack of Efficacy|0|||
13242585|NCT01636076|26345816|FG001|Overall Study|Lack of Efficacy|1|||
13242586|NCT01636076|26345815|FG000|Overall Study|Lost to Follow-up|1|||
13242587|NCT01636076|26345816|FG001|Overall Study|Lost to Follow-up|0|||
13242588|NCT01636076|26345815|FG000|Overall Study|Physician Decision|1|||
13242589|NCT01636076|26345816|FG001|Overall Study|Physician Decision|1|||
13242590|NCT01636076|26345815|FG000|Overall Study|Non-compliance with study treatment|1|||
13242591|NCT01636076|26345816|FG001|Overall Study|Non-compliance with study treatment|1|||
13242592|NCT01636076|26345815|FG000|Overall Study|Adverse Event|6|||
13242593|NCT01636076|26345816|FG001|Overall Study|Adverse Event|11|||
13242594|NCT01636076|26345815|FG000|Overall Study|Withdrawal by Subject|7|||
13242595|NCT01636076|26345816|FG001|Overall Study|Withdrawal by Subject|10|||
13242596|NCT01635998|26345849|FG000|Overall Study|Death|1|||
13242597|NCT01635998|26345850|FG001|Overall Study|Death|1|||
13242598|NCT01635998|26345849|FG000|Overall Study|Lost to Follow-up|2|||
13242599|NCT01635998|26345850|FG001|Overall Study|Lost to Follow-up|1|||
13242600|NCT01635998|26345849|FG000|Overall Study|Withdrawal by Subject|1|||
13242601|NCT01635998|26345850|FG001|Overall Study|Withdrawal by Subject|5|||
13242602|NCT01635933|26345867|FG000|Overall Study|Adverse Event|1|||
13242603|NCT01635933|26345868|FG001|Overall Study|Adverse Event|0|||
13242604|NCT01635933|26345867|FG000|Overall Study|Lost to Follow-up|0|||
13242605|NCT01635933|26345868|FG001|Overall Study|Lost to Follow-up|5|||
13242606|NCT01635933|26345867|FG000|Overall Study|Subject decision|1|||
13242607|NCT01635933|26345868|FG001|Overall Study|Subject decision|1|||
13242608|NCT01635933|26345867|FG000|Overall Study|Noncompliance|0|||
13242609|NCT01635933|26345868|FG001|Overall Study|Noncompliance|1|||
13242610|NCT01635933|26345867|FG000|Overall Study|No longer had transportation|0|||
13242611|NCT01635933|26345868|FG001|Overall Study|No longer had transportation|1|||
13242612|NCT01635920|26345883|FG000|Overall Study|Adverse Event|1|||
13242613|NCT01635920|26345884|FG001|Overall Study|Adverse Event|0|||
13242614|NCT01635920|26345883|FG000|Overall Study|Lost to Follow-up|0|||
13242615|NCT01635920|26345884|FG001|Overall Study|Lost to Follow-up|1|||
13242616|NCT01635920|26345883|FG000|Overall Study|Subject decision|2|||
13242617|NCT01635920|26345884|FG001|Overall Study|Subject decision|0|||
13242618|NCT01635855|26345890|FG000|Overall Study|Withdrawal by Subject|4|||
13242619|NCT01635764|26345930|FG000|Overall Study|Adverse Event|46|||
13242620|NCT01635764|26345930|FG000|Overall Study|Lack of Efficacy|76|||
13242621|NCT01635764|26345930|FG000|Overall Study|Exceed Protocol-specified Interventions|2|||
13242622|NCT01635764|26345930|FG000|Overall Study|Protocol Deviation|1|||
13242623|NCT01635764|26345930|FG000|Overall Study|Withdrew Consent|67|||
13242624|NCT01635764|26345930|FG000|Overall Study|Lost to Follow-up|53|||
13242625|NCT01635764|26345930|FG000|Overall Study|Other|28|||
13242626|NCT01635283|26345940|FG000|Overall Study|Tumor Progression|3|||
13242627|NCT01635283|26345940|FG000|Overall Study|Lost to Follow-up|1|||
13242628|NCT01635218|26345970|FG000|Overall Study|Lost to Follow-up|3|||
13242629|NCT01635218|26345971|FG001|Overall Study|Lost to Follow-up|7|||
13242630|NCT01635218|26345972|FG002|Overall Study|Lost to Follow-up|6|||
13242631|NCT01635153|26345989|FG000|Overall Study|Lost to Follow-up|40|||
13242632|NCT01635153|26345990|FG001|Overall Study|Lost to Follow-up|43|||
13242633|NCT01634854|26346015|FG000|Overall Study|Cesarean delivery|2|||
13242634|NCT01634854|26346016|FG001|Overall Study|Cesarean delivery|7|||
13242635|NCT01634659|26346033|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2|||
13242636|NCT01634659|26346034|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0|||
13242637|NCT01634659|26346033|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1|||
13242638|NCT01634659|26346034|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0|||
13242639|NCT01634555|26346045|FG000|Overall Study|Adverse Event|3|||
13242640|NCT01634555|26346045|FG000|Overall Study|Physician Decision|1|||
13242641|NCT01634360|26346062|FG000|Overall Study|Adverse Event|10|||
13242642|NCT01634360|26346063|FG001|Overall Study|Adverse Event|34|||
13242643|NCT01634360|26346062|FG000|Overall Study|subject withdrew consent|13|||
13242644|NCT01634360|26346063|FG001|Overall Study|subject withdrew consent|23|||
13242645|NCT01634360|26346062|FG000|Overall Study|Protocol Violation|1|||
13242646|NCT01634360|26346063|FG001|Overall Study|Protocol Violation|1|||
13242647|NCT01634360|26346062|FG000|Overall Study|Lack of Efficacy|4|||
13242648|NCT01634360|26346063|FG001|Overall Study|Lack of Efficacy|14|||
13242649|NCT01634360|26346062|FG000|Overall Study|Other|3|||
13242650|NCT01634360|26346063|FG001|Overall Study|Other|20|||
13242651|NCT01634360|26346062|FG000|Overall Study|Study termination by sponsor|18|||
13242652|NCT01634360|26346063|FG001|Overall Study|Study termination by sponsor|44|||
13242653|NCT01634243|26346096|FG000|Overall Study|Adverse Event|5|||
13242654|NCT01634243|26346097|FG001|Overall Study|Adverse Event|5|||
13242655|NCT01634243|26346096|FG000|Overall Study|Lack of Efficacy|1|||
13242656|NCT01634243|26346097|FG001|Overall Study|Lack of Efficacy|0|||
13242657|NCT01634178|26346121|FG000|Treatment Period 1|Adverse Event|0|||
13242658|NCT01634178|26346122|FG001|Treatment Period 1|Adverse Event|1|||
13242659|NCT01634178|26346121|FG000|Treatment Period 2|Adverse Event|1|||
13242660|NCT01634178|26346122|FG001|Treatment Period 2|Adverse Event|0|||
13242661|NCT01634165|26346157|FG000|Period 2|Adverse Event|0|||
13242662|NCT01634165|26346158|FG001|Period 2|Adverse Event|1|||
13242663|NCT01634165|26346159|FG002|Period 2|Adverse Event|0|||
13242664|NCT01634165|26346160|FG003|Period 2|Adverse Event|0|||
13242665|NCT01634152|26346250|FG000|Overall Study|Adverse Event|2|||
13242666|NCT01634152|26346251|FG001|Overall Study|Adverse Event|0|||
13242667|NCT01634152|26346252|FG002|Overall Study|Adverse Event|2|||
13242668|NCT01634152|26346250|FG000|Overall Study|Consent withdrawn not due to AE|1|||
13242669|NCT01634152|26346251|FG001|Overall Study|Consent withdrawn not due to AE|0|||
13242670|NCT01634152|26346252|FG002|Overall Study|Consent withdrawn not due to AE|1|||
13242671|NCT01634152|26346250|FG000|Overall Study|Not treated|0|||
13242672|NCT01634152|26346251|FG001|Overall Study|Not treated|1|||
13242673|NCT01634152|26346252|FG002|Overall Study|Not treated|0|||
13242674|NCT01634152|26346250|FG000|Overall Study|Other reason not defined above|1|||
13242675|NCT01634152|26346251|FG001|Overall Study|Other reason not defined above|0|||
13242676|NCT01634152|26346252|FG002|Overall Study|Other reason not defined above|1|||
13242677|NCT01634139|26346360|FG000|Overall Study|Non compliant with protocol|1|||
13242678|NCT01634139|26346361|FG001|Overall Study|Non compliant with protocol|0|||
13242679|NCT01634139|26346362|FG002|Overall Study|Non compliant with protocol|0|||
13242680|NCT01634139|26346360|FG000|Overall Study|Consent withdrawn not due to AE|4|||
13242681|NCT01634139|26346361|FG001|Overall Study|Consent withdrawn not due to AE|3|||
13242682|NCT01634139|26346362|FG002|Overall Study|Consent withdrawn not due to AE|2|||
13242683|NCT01634139|26346360|FG000|Overall Study|Other|4|||
13242684|NCT01634139|26346361|FG001|Overall Study|Other|0|||
13242685|NCT01634139|26346362|FG002|Overall Study|Other|3|||
13242686|NCT01634139|26346360|FG000|Overall Study|Lost to Follow-up|0|||
13242687|NCT01634139|26346361|FG001|Overall Study|Lost to Follow-up|2|||
13242688|NCT01634139|26346362|FG002|Overall Study|Lost to Follow-up|0|||
13242689|NCT01634139|26346360|FG000|Overall Study|Not treated|1|||
13242690|NCT01634139|26346361|FG001|Overall Study|Not treated|1|||
13242691|NCT01634139|26346362|FG002|Overall Study|Not treated|0|||
13242692|NCT01634113|26346416|FG000|Overall Study|Not treated|0|||
13242693|NCT01634113|26346417|FG001|Overall Study|Not treated|0|||
13242694|NCT01634113|26346418|FG002|Overall Study|Not treated|1|||
13242695|NCT01634100|26346439|FG000|Overall Study|Withdrawal by Subject|1|||
13242696|NCT01634100|26346440|FG001|Overall Study|Withdrawal by Subject|0|||
13242697|NCT01634100|26346441|FG002|Overall Study|Withdrawal by Subject|1|||
13242698|NCT01634100|26346442|FG003|Overall Study|Withdrawal by Subject|0|||
13242699|NCT01634100|26346443|FG004|Overall Study|Withdrawal by Subject|0|||
13242700|NCT01634100|26346444|FG005|Overall Study|Withdrawal by Subject|0|||
13242701|NCT01633944|26346472|FG000|Open-label Titration Phase|Adverse Event|109|||
13242702|NCT01633944|26346473|FG001|Open-label Titration Phase|Adverse Event|0|||
13242703|NCT01633944|26346474|FG002|Open-label Titration Phase|Adverse Event|0|||
13242704|NCT01633944|26346472|FG000|Open-label Titration Phase|Lack of Efficacy|33|||
13242705|NCT01633944|26346473|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
13242706|NCT01633944|26346474|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
13242707|NCT01633944|26346472|FG000|Open-label Titration Phase|Withdrawal by Subject|34|||
13242708|NCT01633944|26346473|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
13242709|NCT01633944|26346474|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
13242710|NCT01633944|26346472|FG000|Open-label Titration Phase|Protocol Violation|24|||
13242711|NCT01633944|26346473|FG001|Open-label Titration Phase|Protocol Violation|0|||
13242712|NCT01633944|26346474|FG002|Open-label Titration Phase|Protocol Violation|0|||
13242713|NCT01633944|26346472|FG000|Open-label Titration Phase|Lost to Follow-up|22|||
13242714|NCT01633944|26346473|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
13242715|NCT01633944|26346474|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
13242716|NCT01633944|26346472|FG000|Open-label Titration Phase|Other|68|||
13242717|NCT01633944|26346473|FG001|Open-label Titration Phase|Other|0|||
13242718|NCT01633944|26346474|FG002|Open-label Titration Phase|Other|0|||
13242719|NCT01633944|26346472|FG000|Double-blind Treatment Phase|Adverse Event|0|||
13242720|NCT01633944|26346473|FG001|Double-blind Treatment Phase|Adverse Event|13|||
13242721|NCT01633944|26346474|FG002|Double-blind Treatment Phase|Adverse Event|7|||
13242722|NCT01633944|26346472|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
13242723|NCT01633944|26346473|FG001|Double-blind Treatment Phase|Lack of Efficacy|8|||
13242724|NCT01633944|26346474|FG002|Double-blind Treatment Phase|Lack of Efficacy|23|||
13242725|NCT01633944|26346472|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
13242726|NCT01633944|26346473|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
13242727|NCT01633944|26346474|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8|||
13242728|NCT01633944|26346472|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
13242729|NCT01633944|26346473|FG001|Double-blind Treatment Phase|Protocol Violation|7|||
13242730|NCT01633944|26346474|FG002|Double-blind Treatment Phase|Protocol Violation|10|||
13242731|NCT01633944|26346472|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
13242732|NCT01633944|26346473|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
13242733|NCT01633944|26346474|FG002|Double-blind Treatment Phase|Lost to Follow-up|9|||
13242734|NCT01633944|26346472|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
13242735|NCT01633944|26346473|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3|||
13242736|NCT01633944|26346474|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
13242737|NCT01633944|26346472|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
13242738|NCT01633944|26346473|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1|||
13242739|NCT01633944|26346474|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
13242740|NCT01633944|26346472|FG000|Double-blind Treatment Phase|Other|0|||
13242741|NCT01633944|26346473|FG001|Double-blind Treatment Phase|Other|7|||
13242742|NCT01633944|26346474|FG002|Double-blind Treatment Phase|Other|0|||
13242743|NCT01633788|26346505|FG000|Overall Study|Adverse Event|1|||
13242744|NCT01633788|26346506|FG001|Overall Study|Adverse Event|3|||
13242745|NCT01633788|26346507|FG002|Overall Study|Adverse Event|3|||
13242746|NCT01633788|26346508|FG003|Overall Study|Adverse Event|3|||
13242747|NCT01633788|26346505|FG000|Overall Study|Lost to Follow-up|2|||
13242748|NCT01633788|26346506|FG001|Overall Study|Lost to Follow-up|2|||
13242749|NCT01633788|26346507|FG002|Overall Study|Lost to Follow-up|2|||
13242750|NCT01633788|26346508|FG003|Overall Study|Lost to Follow-up|0|||
13242751|NCT01633788|26346505|FG000|Overall Study|Personal Reasons|3|||
13242752|NCT01633788|26346506|FG001|Overall Study|Personal Reasons|1|||
13242753|NCT01633788|26346507|FG002|Overall Study|Personal Reasons|1|||
13242754|NCT01633788|26346508|FG003|Overall Study|Personal Reasons|3|||
13242755|NCT01633788|26346505|FG000|Overall Study|Protocol Violation|1|||
13242756|NCT01633788|26346506|FG001|Overall Study|Protocol Violation|0|||
13242757|NCT01633788|26346507|FG002|Overall Study|Protocol Violation|1|||
13242758|NCT01633788|26346508|FG003|Overall Study|Protocol Violation|0|||
13242759|NCT01633788|26346505|FG000|Overall Study|Other Reasons|0|||
13242760|NCT01633788|26346506|FG001|Overall Study|Other Reasons|2|||
13242761|NCT01633788|26346507|FG002|Overall Study|Other Reasons|3|||
13242762|NCT01633788|26346508|FG003|Overall Study|Other Reasons|7|||
13242763|NCT01633112|26346551|FG000|Overall Study|Lack of Efficacy|1|||
13242764|NCT01633112|26346552|FG001|Overall Study|Lack of Efficacy|6|||
13242765|NCT01633112|26346553|FG002|Overall Study|Lack of Efficacy|13|||
13242766|NCT01633112|26346551|FG000|Overall Study|Abnormal laboratory value(s)|3|||
13242767|NCT01633112|26346552|FG001|Overall Study|Abnormal laboratory value(s)|1|||
13242768|NCT01633112|26346553|FG002|Overall Study|Abnormal laboratory value(s)|0|||
13242769|NCT01633112|26346551|FG000|Overall Study|Abnormal test procedure result(s)|0|||
13242770|NCT01633112|26346552|FG001|Overall Study|Abnormal test procedure result(s)|1|||
13242771|NCT01633112|26346553|FG002|Overall Study|Abnormal test procedure result(s)|0|||
13242772|NCT01633112|26346551|FG000|Overall Study|Administrative problems|1|||
13242773|NCT01633112|26346552|FG001|Overall Study|Administrative problems|2|||
13242774|NCT01633112|26346553|FG002|Overall Study|Administrative problems|5|||
13242775|NCT01633112|26346551|FG000|Overall Study|Adverse Event|16|||
13242776|NCT01633112|26346552|FG001|Overall Study|Adverse Event|18|||
13242777|NCT01633112|26346553|FG002|Overall Study|Adverse Event|20|||
13242778|NCT01633112|26346551|FG000|Overall Study|Lost to Follow-up|7|||
13242779|NCT01633112|26346552|FG001|Overall Study|Lost to Follow-up|19|||
13242780|NCT01633112|26346553|FG002|Overall Study|Lost to Follow-up|6|||
13242781|NCT01633112|26346551|FG000|Overall Study|Protocol Violation|4|||
13242782|NCT01633112|26346552|FG001|Overall Study|Protocol Violation|0|||
13242783|NCT01633112|26346553|FG002|Overall Study|Protocol Violation|2|||
13242784|NCT01633112|26346551|FG000|Overall Study|Subject no longer requires study drug|0|||
13242785|NCT01633112|26346552|FG001|Overall Study|Subject no longer requires study drug|0|||
13242786|NCT01633112|26346553|FG002|Overall Study|Subject no longer requires study drug|1|||
13242787|NCT01633112|26346551|FG000|Overall Study|Withdrawal by Subject|20|||
13242788|NCT01633112|26346552|FG001|Overall Study|Withdrawal by Subject|12|||
13242789|NCT01633112|26346553|FG002|Overall Study|Withdrawal by Subject|41|||
13242790|NCT01633112|26346551|FG000|Overall Study|missing Study Completion CRF|1|||
13242791|NCT01633112|26346552|FG001|Overall Study|missing Study Completion CRF|1|||
13242792|NCT01633112|26346553|FG002|Overall Study|missing Study Completion CRF|4|||
13242793|NCT01633060|26346585|FG000|Randomization Phase|Protocol deviation|1|||
13242794|NCT01633060|26346586|FG001|Randomization Phase|Protocol deviation|2|||
13242795|NCT01633060|26346585|FG000|Randomization Phase|Technical problem|0|||
13242796|NCT01633060|26346586|FG001|Randomization Phase|Technical problem|1|||
13242797|NCT01633060|26346585|FG000|Treatment Phase|Adverse Event|24|||
13242798|NCT01633060|26346586|FG001|Treatment Phase|Adverse Event|3|||
13242799|NCT01633060|26346585|FG000|Treatment Phase|Lost to Follow-up|1|||
13242800|NCT01633060|26346586|FG001|Treatment Phase|Lost to Follow-up|0|||
13242801|NCT01633060|26346585|FG000|Treatment Phase|Physician Decision|16|||
13242802|NCT01633060|26346586|FG001|Treatment Phase|Physician Decision|7|||
13242803|NCT01633060|26346585|FG000|Treatment Phase|Progressive Disease|210|||
13242804|NCT01633060|26346586|FG001|Treatment Phase|Progressive Disease|120|||
13242805|NCT01633060|26346585|FG000|Treatment Phase|Protocol Deviation|1|||
13242806|NCT01633060|26346586|FG001|Treatment Phase|Protocol Deviation|0|||
13242807|NCT01633060|26346585|FG000|Treatment Phase|Study Terminated by sponsor|7|||
13242808|NCT01633060|26346586|FG001|Treatment Phase|Study Terminated by sponsor|3|||
13242809|NCT01633060|26346585|FG000|Treatment Phase|Subject/guardian decision|25|||
13242810|NCT01633060|26346586|FG001|Treatment Phase|Subject/guardian decision|4|||
13242811|NCT01633060|26346585|FG000|Treatment Phase|Death|4|||
13242812|NCT01633060|26346586|FG001|Treatment Phase|Death|3|||
13242813|NCT01633060|26346585|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
13242814|NCT01633060|26346586|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
13242815|NCT01633060|26346585|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1|||
13242816|NCT01633060|26346586|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0|||
13242817|NCT01633060|26346585|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10|||
13242818|NCT01633060|26346586|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1|||
13242819|NCT01633060|26346585|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1|||
13242820|NCT01633060|26346586|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0|||
13242821|NCT01633060|26346585|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
13242822|NCT01633060|26346586|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
13242823|NCT01633060|26346585|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1|||
13242824|NCT01633060|26346586|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0|||
13242825|NCT01632904|26346602|FG000|Overall Study|Adverse Event|4|||
13242826|NCT01632904|26346603|FG001|Overall Study|Adverse Event|1|||
13242827|NCT01632904|26346602|FG000|Overall Study|Physician Decision|0|||
13242828|NCT01632904|26346603|FG001|Overall Study|Physician Decision|1|||
13242829|NCT01632904|26346602|FG000|Overall Study|Subject decision|3|||
13242830|NCT01632904|26346603|FG001|Overall Study|Subject decision|2|||
13242831|NCT01632904|26346602|FG000|Overall Study|Disease Progression|0|||
13242832|NCT01632904|26346603|FG001|Overall Study|Disease Progression|1|||
13242833|NCT01632904|26346602|FG000|Overall Study|Reason for discontinuation not available|0|||
13242834|NCT01632904|26346603|FG001|Overall Study|Reason for discontinuation not available|1|||
13242835|NCT01632891|26346632|FG000|Overall Study|Lost to Follow-up|0|||
13242836|NCT01632891|26346633|FG001|Overall Study|Lost to Follow-up|1|||
13242837|NCT01632891|26346632|FG000|Overall Study|Withdrawal by Subject|1|||
13242838|NCT01632891|26346633|FG001|Overall Study|Withdrawal by Subject|0|||
13242839|NCT01632878|26346643|FG000|Screening|Physician Decision|268|||
13242840|NCT01632878|26346643|FG000|Treatment|Lost to Follow-up|41|||
13242841|NCT01632878|26346643|FG000|Treatment|Withdrawal by Subject|36|||
13242842|NCT01632878|26346643|FG000|Treatment|Physician Decision|34|||
13242843|NCT01632878|26346643|FG000|Treatment|missing information|4|||
13242844|NCT01632878|26346643|FG000|Treatment|no information on study completion|43|||
13242845|NCT01632800|26346649|FG000|Overall Study|Subject did not fit in apparatus|1|||
13242846|NCT01632579|26346721|FG000|Washout Period|Adverse Event|1|||
13242847|NCT01632579|26346722|FG001|Washout Period|Adverse Event|0|||
13242848|NCT01632579|26346723|FG002|Washout Period|Adverse Event|0|||
13242849|NCT01632579|26346724|FG003|Washout Period|Adverse Event|0|||
13242850|NCT01632579|26346725|FG004|Washout Period|Adverse Event|0|||
13242851|NCT01632579|26346726|FG005|Washout Period|Adverse Event|0|||
13242852|NCT01632579|26346727|FG006|Washout Period|Adverse Event|0|||
13242853|NCT01632579|26346728|FG007|Washout Period|Adverse Event|0|||
13242854|NCT01632579|26346729|FG008|Washout Period|Adverse Event|0|||
13242855|NCT01632579|26346721|FG000|Period 2 (Second Intervention)|Adverse Event|1|||
13242856|NCT01632579|26346722|FG001|Period 2 (Second Intervention)|Adverse Event|0|||
13242857|NCT01632579|26346723|FG002|Period 2 (Second Intervention)|Adverse Event|0|||
13242858|NCT01632579|26346724|FG003|Period 2 (Second Intervention)|Adverse Event|0|||
13242859|NCT01632579|26346725|FG004|Period 2 (Second Intervention)|Adverse Event|0|||
13242860|NCT01632579|26346726|FG005|Period 2 (Second Intervention)|Adverse Event|0|||
13242861|NCT01632579|26346727|FG006|Period 2 (Second Intervention)|Adverse Event|0|||
13242862|NCT01632579|26346728|FG007|Period 2 (Second Intervention)|Adverse Event|0|||
13242863|NCT01632579|26346729|FG008|Period 2 (Second Intervention)|Adverse Event|0|||
13242864|NCT01632566|26346783|FG000|Overall Study|Withdrawal by Subject|0|||
13242865|NCT01632566|26346784|FG001|Overall Study|Withdrawal by Subject|1|||
13242866|NCT01632566|26346785|FG002|Overall Study|Withdrawal by Subject|0|||
13242867|NCT01632566|26346786|FG003|Overall Study|Withdrawal by Subject|0|||
13242868|NCT01632566|26346787|FG004|Overall Study|Withdrawal by Subject|0|||
13242869|NCT01632566|26346783|FG000|Overall Study|Sponsor Decision|0|||
13242870|NCT01632566|26346784|FG001|Overall Study|Sponsor Decision|2|||
13242871|NCT01632566|26346785|FG002|Overall Study|Sponsor Decision|9|||
13242872|NCT01632566|26346786|FG003|Overall Study|Sponsor Decision|2|||
13242873|NCT01632566|26346787|FG004|Overall Study|Sponsor Decision|2|||
13242874|NCT01632345|26346865|FG000|Treatment: Part I|Adverse Event|1|||
13242875|NCT01632345|26346866|FG001|Treatment: Part I|Adverse Event|4|||
13242876|NCT01632345|26346867|FG002|Treatment: Part I|Adverse Event|2|||
13242877|NCT01632345|26346868|FG003|Treatment: Part I|Adverse Event|1|||
13242878|NCT01632345|26346869|FG004|Treatment: Part I|Adverse Event|3|||
13242879|NCT01632345|26346870|FG005|Treatment: Part I|Adverse Event|0|||
13242880|NCT01632345|26346871|FG006|Treatment: Part I|Adverse Event|0|||
13242881|NCT01632345|26346865|FG000|Treatment: Part I|Lack of Efficacy|0|||
13242882|NCT01632345|26346866|FG001|Treatment: Part I|Lack of Efficacy|1|||
13242883|NCT01632345|26346867|FG002|Treatment: Part I|Lack of Efficacy|0|||
13242884|NCT01632345|26346868|FG003|Treatment: Part I|Lack of Efficacy|1|||
13242885|NCT01632345|26346869|FG004|Treatment: Part I|Lack of Efficacy|1|||
13242886|NCT01632345|26346870|FG005|Treatment: Part I|Lack of Efficacy|0|||
13242887|NCT01632345|26346871|FG006|Treatment: Part I|Lack of Efficacy|0|||
13242888|NCT01632345|26346865|FG000|Treatment: Part I|Lost to Follow-up|3|||
13242889|NCT01632345|26346866|FG001|Treatment: Part I|Lost to Follow-up|2|||
13242890|NCT01632345|26346867|FG002|Treatment: Part I|Lost to Follow-up|1|||
13242891|NCT01632345|26346868|FG003|Treatment: Part I|Lost to Follow-up|3|||
13242892|NCT01632345|26346869|FG004|Treatment: Part I|Lost to Follow-up|4|||
13242893|NCT01632345|26346870|FG005|Treatment: Part I|Lost to Follow-up|0|||
13242894|NCT01632345|26346871|FG006|Treatment: Part I|Lost to Follow-up|0|||
13242895|NCT01632345|26346865|FG000|Treatment: Part I|Non-Compliance with Study Drug|3|||
13242896|NCT01632345|26346866|FG001|Treatment: Part I|Non-Compliance with Study Drug|2|||
13242897|NCT01632345|26346867|FG002|Treatment: Part I|Non-Compliance with Study Drug|2|||
13242898|NCT01632345|26346868|FG003|Treatment: Part I|Non-Compliance with Study Drug|1|||
13242899|NCT01632345|26346869|FG004|Treatment: Part I|Non-Compliance with Study Drug|0|||
13242900|NCT01632345|26346870|FG005|Treatment: Part I|Non-Compliance with Study Drug|0|||
13242901|NCT01632345|26346871|FG006|Treatment: Part I|Non-Compliance with Study Drug|0|||
13242902|NCT01632345|26346865|FG000|Treatment: Part I|Physician Decision|2|||
13242903|NCT01632345|26346866|FG001|Treatment: Part I|Physician Decision|1|||
13242904|NCT01632345|26346867|FG002|Treatment: Part I|Physician Decision|0|||
13242905|NCT01632345|26346868|FG003|Treatment: Part I|Physician Decision|0|||
13242906|NCT01632345|26346869|FG004|Treatment: Part I|Physician Decision|1|||
13242907|NCT01632345|26346870|FG005|Treatment: Part I|Physician Decision|0|||
13242908|NCT01632345|26346871|FG006|Treatment: Part I|Physician Decision|0|||
13242909|NCT01632345|26346865|FG000|Treatment: Part I|Pregnancy|0|||
13242910|NCT01632345|26346866|FG001|Treatment: Part I|Pregnancy|1|||
13242911|NCT01632345|26346867|FG002|Treatment: Part I|Pregnancy|0|||
13242912|NCT01632345|26346868|FG003|Treatment: Part I|Pregnancy|0|||
13242913|NCT01632345|26346869|FG004|Treatment: Part I|Pregnancy|0|||
13242914|NCT01632345|26346870|FG005|Treatment: Part I|Pregnancy|0|||
13242915|NCT01632345|26346871|FG006|Treatment: Part I|Pregnancy|0|||
13242916|NCT01632345|26346865|FG000|Treatment: Part I|Protocol Deviation|0|||
13242917|NCT01632345|26346866|FG001|Treatment: Part I|Protocol Deviation|0|||
13242918|NCT01632345|26346867|FG002|Treatment: Part I|Protocol Deviation|1|||
13242919|NCT01632345|26346868|FG003|Treatment: Part I|Protocol Deviation|1|||
13242920|NCT01632345|26346869|FG004|Treatment: Part I|Protocol Deviation|0|||
13242921|NCT01632345|26346870|FG005|Treatment: Part I|Protocol Deviation|0|||
13242922|NCT01632345|26346871|FG006|Treatment: Part I|Protocol Deviation|0|||
13242923|NCT01632345|26346865|FG000|Treatment: Part I|Withdrawal by Subject|3|||
13242924|NCT01632345|26346866|FG001|Treatment: Part I|Withdrawal by Subject|4|||
13242925|NCT01632345|26346867|FG002|Treatment: Part I|Withdrawal by Subject|4|||
13242926|NCT01632345|26346868|FG003|Treatment: Part I|Withdrawal by Subject|1|||
13242927|NCT01632345|26346869|FG004|Treatment: Part I|Withdrawal by Subject|4|||
13242928|NCT01632345|26346870|FG005|Treatment: Part I|Withdrawal by Subject|0|||
13242929|NCT01632345|26346871|FG006|Treatment: Part I|Withdrawal by Subject|0|||
13242930|NCT01632345|26346865|FG000|Treatment: Part II|Adverse Event|0|||
13242931|NCT01632345|26346866|FG001|Treatment: Part II|Adverse Event|0|||
13242932|NCT01632345|26346867|FG002|Treatment: Part II|Adverse Event|0|||
13242933|NCT01632345|26346868|FG003|Treatment: Part II|Adverse Event|0|||
13242934|NCT01632345|26346869|FG004|Treatment: Part II|Adverse Event|0|||
13242935|NCT01632345|26346870|FG005|Treatment: Part II|Adverse Event|3|||
13242936|NCT01632345|26346871|FG006|Treatment: Part II|Adverse Event|8|||
13242937|NCT01632345|26346865|FG000|Treatment: Part II|Lost to Follow-up|0|||
13242938|NCT01632345|26346866|FG001|Treatment: Part II|Lost to Follow-up|0|||
13242939|NCT01632345|26346867|FG002|Treatment: Part II|Lost to Follow-up|0|||
13242940|NCT01632345|26346868|FG003|Treatment: Part II|Lost to Follow-up|0|||
13242941|NCT01632345|26346869|FG004|Treatment: Part II|Lost to Follow-up|0|||
13242942|NCT01632345|26346870|FG005|Treatment: Part II|Lost to Follow-up|3|||
13242943|NCT01632345|26346871|FG006|Treatment: Part II|Lost to Follow-up|1|||
13242944|NCT01632345|26346865|FG000|Treatment: Part II|Non-Compliance with Study Drug|0|||
13242945|NCT01632345|26346866|FG001|Treatment: Part II|Non-Compliance with Study Drug|0|||
13242946|NCT01632345|26346867|FG002|Treatment: Part II|Non-Compliance with Study Drug|0|||
13242947|NCT01632345|26346868|FG003|Treatment: Part II|Non-Compliance with Study Drug|0|||
13242948|NCT01632345|26346869|FG004|Treatment: Part II|Non-Compliance with Study Drug|0|||
13242949|NCT01632345|26346870|FG005|Treatment: Part II|Non-Compliance with Study Drug|3|||
13242950|NCT01632345|26346871|FG006|Treatment: Part II|Non-Compliance with Study Drug|0|||
13242951|NCT01632345|26346865|FG000|Treatment: Part II|Withdrawal by Subject|0|||
13242952|NCT01632345|26346866|FG001|Treatment: Part II|Withdrawal by Subject|0|||
13242953|NCT01632345|26346867|FG002|Treatment: Part II|Withdrawal by Subject|0|||
13242954|NCT01632345|26346868|FG003|Treatment: Part II|Withdrawal by Subject|0|||
13242955|NCT01632345|26346869|FG004|Treatment: Part II|Withdrawal by Subject|0|||
13242956|NCT01632345|26346870|FG005|Treatment: Part II|Withdrawal by Subject|2|||
13242957|NCT01632345|26346871|FG006|Treatment: Part II|Withdrawal by Subject|2|||
13242958|NCT01632306|26346893|FG000|Overall Study|Protocol Violation|1|||
13242959|NCT01632306|26346894|FG001|Overall Study|Protocol Violation|0|||
13242960|NCT01632306|26346895|FG002|Overall Study|Protocol Violation|0|||
13242961|NCT01632280|26346912|FG000|Overall Study|Withdrawal by Subject|1|||
13242962|NCT01632280|26346913|FG001|Overall Study|Withdrawal by Subject|0|||
13242963|NCT01632241|26346968|FG000|Double-blinded (Up to Week 52)|Site Closed|3|||
13242964|NCT01632241|26346969|FG001|Double-blinded (Up to Week 52)|Site Closed|5|||
13242965|NCT01632241|26346968|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2|||
13242966|NCT01632241|26346969|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6|||
13242967|NCT01632241|26346968|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1|||
13242968|NCT01632241|26346969|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8|||
13242969|NCT01632241|26346968|FG000|Double-blinded (Up to Week 52)|Physician Decision|9|||
13242970|NCT01632241|26346969|FG001|Double-blinded (Up to Week 52)|Physician Decision|12|||
13242971|NCT01632241|26346968|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9|||
13242972|NCT01632241|26346969|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15|||
13242973|NCT01632241|26346968|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10|||
13242974|NCT01632241|26346969|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14|||
13242975|NCT01632241|26346968|FG000|Double-blinded (Up to Week 52)|Adverse Event|10|||
13242976|NCT01632241|26346969|FG001|Double-blinded (Up to Week 52)|Adverse Event|19|||
13242977|NCT01632241|26346968|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5|||
13242978|NCT01632241|26346969|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2|||
13242979|NCT01632241|26346968|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1|||
13242980|NCT01632241|26346969|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4|||
13242981|NCT01632241|26346968|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1|||
13242982|NCT01632241|26346969|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4|||
13242983|NCT01632241|26346968|FG000|Open-label (Week 52 to Week 76)|Site Closed|2|||
13242984|NCT01632241|26346969|FG001|Open-label (Week 52 to Week 76)|Site Closed|8|||
13242985|NCT01632241|26346968|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0|||
13242986|NCT01632241|26346969|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2|||
13242987|NCT01632241|26346968|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0|||
13242988|NCT01632241|26346969|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2|||
13242989|NCT01632241|26346968|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1|||
13242990|NCT01632241|26346969|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0|||
13242991|NCT01632150|26346978|FG000|Overall Study|Disease progression|27|||
13242992|NCT01632150|26346978|FG000|Overall Study|Study drug toxicity|1|||
13242993|NCT01632150|26346978|FG000|Overall Study|Unrelated adverse event|7|||
13242994|NCT01632150|26346978|FG000|Overall Study|Withdrawal by Subject|2|||
13242995|NCT01632150|26346978|FG000|Overall Study|Patient underwent autologous transplant|1|||
13115878|NCT03087643|25919902|FG001|Overall Study|Withdrawal by Subject|4|||
13115879|NCT03087643|25919901|FG000|Overall Study|Death|2|||
13115880|NCT03087643|25919902|FG001|Overall Study|Death|2|||
13115881|NCT03087617|25919945|FG000|Overall Study|Lost to Follow-up|32|||
13115882|NCT03087617|25919946|FG001|Overall Study|Lost to Follow-up|30|||
13115883|NCT03087617|25919947|FG002|Overall Study|Lost to Follow-up|30|||
13115884|NCT03087617|25919948|FG003|Overall Study|Lost to Follow-up|39|||
13115885|NCT03087513|25919964|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2|||
13115886|NCT03087058|25919980|FG000|Overall Study|Withdrawal by Subject|2|||
13115887|NCT03087058|25919981|FG001|Overall Study|Withdrawal by Subject|0|||
13115888|NCT03087058|25919982|FG002|Overall Study|Withdrawal by Subject|0|||
13115889|NCT03086551|25920003|FG000|First Intervention|Failure to meet inclusion criterion|1|||
13115890|NCT03086551|25920004|FG001|First Intervention|Failure to meet inclusion criterion|0|||
13115891|NCT03086551|25920003|FG000|First Intervention|Lost to Follow-up|0|||
13115892|NCT03086551|25920004|FG001|First Intervention|Lost to Follow-up|1|||
13115893|NCT03086551|25920003|FG000|Washout|Lost to Follow-up|1|||
13115894|NCT03086551|25920004|FG001|Washout|Lost to Follow-up|2|||
13115895|NCT03086551|25920003|FG000|Washout|Withdrawal by Subject|2|||
13115896|NCT03086551|25920004|FG001|Washout|Withdrawal by Subject|1|||
13115897|NCT03086460|25920158|FG000|Study Participants|Lost to Follow-up|2|||
13115898|NCT03086460|25920158|FG000|Study Participants|Protocol Violation|1|||
13115899|NCT03086460|25920158|FG000|Study Participants|Withdrawal by Subject|6|||
13115900|NCT03086460|25920158|FG000|Treatment A|Lost to Follow-up|1|||
13115901|NCT03086460|25920158|FG000|Treatment A|Protocol Violation|1|||
13115902|NCT03086460|25920158|FG000|Treatment A|Withdrawal by Subject|2|||
13115903|NCT03086460|25920158|FG000|Treatment C|Withdrawal by Subject|2|||
13115904|NCT03086460|25920158|FG000|Treatment E|Lost to Follow-up|1|||
13115905|NCT03086460|25920158|FG000|Treatment E|Withdrawal by Subject|3|||
13115906|NCT03086447|25920185|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
13115907|NCT03086447|25920186|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
13115908|NCT03086447|25920185|FG000|Overall Study|Lost Lens|2|||
13115909|NCT03086447|25920186|FG001|Overall Study|Lost Lens|5|||
13115910|NCT03086447|25920185|FG000|Overall Study|Product quality complaint|0|||
13115911|NCT03086447|25920186|FG001|Overall Study|Product quality complaint|1|||
13115912|NCT03086447|25920185|FG000|Overall Study|Lens Damage|1|||
13115913|NCT03086447|25920186|FG001|Overall Study|Lens Damage|6|||
13115914|NCT03086447|25920185|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
13115915|NCT03086447|25920186|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
13115916|NCT03086447|25920185|FG000|Overall Study|Test Article No Longer Available|1|||
13115917|NCT03086447|25920186|FG001|Overall Study|Test Article No Longer Available|0|||
13115918|NCT03086447|25920185|FG000|Overall Study|Protocol Violation|2|||
13115919|NCT03086447|25920186|FG001|Overall Study|Protocol Violation|4|||
13115920|NCT03086447|25920185|FG000|Overall Study|Lost to Follow-up|0|||
13115921|NCT03086447|25920186|FG001|Overall Study|Lost to Follow-up|1|||
13115922|NCT03086447|25920185|FG000|Overall Study|Adverse Event|3|||
13115923|NCT03086447|25920186|FG001|Overall Study|Adverse Event|0|||
13115924|NCT03086447|25920185|FG000|Overall Study|Lens Discomfort|2|||
13115925|NCT03086447|25920186|FG001|Overall Study|Lens Discomfort|1|||
13115926|NCT03086369|25920240|FG000|Overall Study|Lost to Follow-up|1|||
13115927|NCT03086369|25920241|FG001|Overall Study|Lost to Follow-up|0|||
13115928|NCT03086369|25920242|FG002|Overall Study|Lost to Follow-up|0|||
13115929|NCT03086369|25920243|FG003|Overall Study|Lost to Follow-up|2|||
13115930|NCT03086369|25920244|FG004|Overall Study|Lost to Follow-up|1|||
13115931|NCT03086369|25920240|FG000|Overall Study|Physician Decision|0|||
13115932|NCT03086369|25920241|FG001|Overall Study|Physician Decision|0|||
13115933|NCT03086369|25920242|FG002|Overall Study|Physician Decision|0|||
13115934|NCT03086369|25920243|FG003|Overall Study|Physician Decision|1|||
13115935|NCT03086369|25920244|FG004|Overall Study|Physician Decision|2|||
13115936|NCT03086369|25920240|FG000|Overall Study|Withdrawal by Subject|0|||
13115937|NCT03086369|25920241|FG001|Overall Study|Withdrawal by Subject|0|||
13115938|NCT03086369|25920242|FG002|Overall Study|Withdrawal by Subject|0|||
13115939|NCT03086369|25920243|FG003|Overall Study|Withdrawal by Subject|5|||
13115940|NCT03086369|25920244|FG004|Overall Study|Withdrawal by Subject|3|||
13115941|NCT03086369|25920240|FG000|Overall Study|Progressive Disease|0|||
13115942|NCT03086369|25920241|FG001|Overall Study|Progressive Disease|0|||
13242996|NCT01632150|26346978|FG000|Overall Study|Moved to compassionate program|2|||
13242997|NCT01632020|26346993|FG000|Overall Study|Withdrawal by Subject|1|||
13242998|NCT01632020|26346994|FG001|Overall Study|Withdrawal by Subject|0|||
13242999|NCT01632020|26346993|FG000|Overall Study|Adverse Event|1|||
13243000|NCT01632020|26346994|FG001|Overall Study|Adverse Event|0|||
13243001|NCT01631864|26347013|FG000|Overall Study|Withdrawal by Subject|0|||
13243002|NCT01631864|26347014|FG001|Overall Study|Withdrawal by Subject|1|||
13243003|NCT01631864|26347013|FG000|Overall Study|Adverse Event|2|||
13243004|NCT01631864|26347014|FG001|Overall Study|Adverse Event|3|||
13289958|NCT00105183|26480381|FG002|Overall Study|Withdrawal by Subject|4|||
13289959|NCT00105183|26480379|FG000|Overall Study|Physician Decision|1|||
13289960|NCT00105183|26480380|FG001|Overall Study|Physician Decision|2|||
13289961|NCT00105183|26480381|FG002|Overall Study|Physician Decision|3|||
13289962|NCT00105183|26480379|FG000|Overall Study|Lost to Follow-up|0|||
13289963|NCT00105183|26480380|FG001|Overall Study|Lost to Follow-up|1|||
13289964|NCT00105183|26480381|FG002|Overall Study|Lost to Follow-up|1|||
13289965|NCT00105183|26480379|FG000|Overall Study|Other reason|1|||
13289966|NCT00105183|26480380|FG001|Overall Study|Other reason|2|||
13289967|NCT00105183|26480381|FG002|Overall Study|Other reason|0|||
13289968|NCT00105157|26480586|FG000|Double-Blind (DB)|Never Treated|1|||
13289969|NCT00105157|26480587|FG001|Double-Blind (DB)|Never Treated|0|||
13289970|NCT00105157|26480588|FG002|Double-Blind (DB)|Never Treated|0|||
13289971|NCT00105157|26480589|FG003|Double-Blind (DB)|Never Treated|0|||
13289972|NCT00105157|26480586|FG000|Double-Blind (DB)|Adverse Event|2|||
13289973|NCT00105157|26480587|FG001|Double-Blind (DB)|Adverse Event|0|||
13289974|NCT00105157|26480588|FG002|Double-Blind (DB)|Adverse Event|1|||
13289975|NCT00105157|26480589|FG003|Double-Blind (DB)|Adverse Event|1|||
13289976|NCT00105157|26480586|FG000|Double-Blind (DB)|Lack of Efficacy|11|||
13289977|NCT00105157|26480587|FG001|Double-Blind (DB)|Lack of Efficacy|14|||
13289978|NCT00105157|26480588|FG002|Double-Blind (DB)|Lack of Efficacy|11|||
13289979|NCT00105157|26480589|FG003|Double-Blind (DB)|Lack of Efficacy|38|||
13289980|NCT00105157|26480586|FG000|Open-Label Continuation of DB|Adverse Event|3|||
13289981|NCT00105157|26480587|FG001|Open-Label Continuation of DB|Adverse Event|1|||
13289982|NCT00105157|26480588|FG002|Open-Label Continuation of DB|Adverse Event|0|||
13289983|NCT00105157|26480589|FG003|Open-Label Continuation of DB|Adverse Event|0|||
13289984|NCT00105157|26480586|FG000|Open-Label Continuation of DB|Lack of Efficacy|1|||
13289985|NCT00105157|26480587|FG001|Open-Label Continuation of DB|Lack of Efficacy|4|||
13289986|NCT00105157|26480588|FG002|Open-Label Continuation of DB|Lack of Efficacy|3|||
13289987|NCT00105157|26480589|FG003|Open-Label Continuation of DB|Lack of Efficacy|1|||
13289988|NCT00105157|26480586|FG000|Open-Label Continuation of DB|Lost to Follow-up|1|||
13289989|NCT00105157|26480587|FG001|Open-Label Continuation of DB|Lost to Follow-up|1|||
13289990|NCT00105157|26480588|FG002|Open-Label Continuation of DB|Lost to Follow-up|1|||
13289991|NCT00105157|26480589|FG003|Open-Label Continuation of DB|Lost to Follow-up|0|||
13289992|NCT00105157|26480586|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0|||
13289993|NCT00105157|26480587|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1|||
13289994|NCT00105157|26480588|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3|||
13289995|NCT00105157|26480589|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0|||
13289996|NCT00105157|26480586|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1|||
13289997|NCT00105157|26480587|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0|||
13289998|NCT00105157|26480588|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0|||
13289999|NCT00105157|26480589|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0|||
13290000|NCT00105157|26480586|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1|||
13290001|NCT00105157|26480587|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3|||
13290002|NCT00105157|26480588|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2|||
13290003|NCT00105157|26480589|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0|||
13290004|NCT00105157|26480586|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
13290005|NCT00105157|26480587|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
13290006|NCT00105157|26480588|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
13290007|NCT00105157|26480589|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1|||
13290008|NCT00105157|26480586|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7|||
13290009|NCT00105157|26480587|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6|||
13290010|NCT00105157|26480588|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5|||
13290011|NCT00105157|26480589|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10|||
13290012|NCT00105157|26480586|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
13290013|NCT00105157|26480587|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
13290014|NCT00105157|26480588|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
13290015|NCT00105157|26480589|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
13290016|NCT00105157|26480586|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
13290017|NCT00105157|26480587|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
13290018|NCT00105157|26480588|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
13243005|NCT01631825|26347036|FG000|Overall Study|Adverse Event|42|||
13243006|NCT01631825|26347036|FG000|Overall Study|Lack of Efficacy|7|||
13243007|NCT01631825|26347036|FG000|Overall Study|Withdrawal by Subject|9|||
13243008|NCT01631825|26347036|FG000|Overall Study|Protocol Violation|4|||
13243009|NCT01631825|26347036|FG000|Overall Study|Discontinuation criteria|1|||
13243010|NCT01631825|26347036|FG000|Overall Study|Physician Decision|2|||
13243011|NCT01631812|26347046|FG000|Overall Study|Adverse Event|25|||
13243012|NCT01631812|26347046|FG000|Overall Study|Lack of Efficacy|5|||
13243013|NCT01631812|26347046|FG000|Overall Study|Withdrawal by Subject|4|||
13243014|NCT01631812|26347046|FG000|Overall Study|Physician Decision|3|||
13243015|NCT01631747|26347091|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1|||
13243016|NCT01631747|26347092|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0|||
13243017|NCT01631747|26347091|FG000|Live Birth|Pregnancy Termination|1|||
13243018|NCT01631747|26347092|FG001|Live Birth|Pregnancy Termination|0|||
13243019|NCT01631747|26347091|FG000|Live Birth|MIscarriage|2|||
13243020|NCT01631747|26347092|FG001|Live Birth|MIscarriage|0|||
13243021|NCT01631747|26347091|FG000|Live Birth|Stillbirth|1|||
13243022|NCT01631747|26347092|FG001|Live Birth|Stillbirth|1|||
13243023|NCT01631747|26347091|FG000|One Year Infant Outcomes|Patient Refused|13|||
13243024|NCT01631747|26347092|FG001|One Year Infant Outcomes|Patient Refused|9|||
13243025|NCT01631474|26347145|FG000|Overall Study|Lost to Follow-up|8|||
13243026|NCT01631474|26347146|FG001|Overall Study|Lost to Follow-up|5|||
13243027|NCT01631474|26347147|FG002|Overall Study|Lost to Follow-up|7|||
13243028|NCT01631474|26347148|FG003|Overall Study|Lost to Follow-up|5|||
13243029|NCT01631474|26347149|FG004|Overall Study|Lost to Follow-up|5|||
13243030|NCT01631474|26347145|FG000|Overall Study|Withdrawal by Subject|4|||
13243031|NCT01631474|26347146|FG001|Overall Study|Withdrawal by Subject|4|||
13243032|NCT01631474|26347147|FG002|Overall Study|Withdrawal by Subject|2|||
13243033|NCT01631474|26347148|FG003|Overall Study|Withdrawal by Subject|6|||
13243034|NCT01631474|26347149|FG004|Overall Study|Withdrawal by Subject|5|||
13243035|NCT01631474|26347145|FG000|Overall Study|Lack of Efficacy|2|||
13243036|NCT01631474|26347146|FG001|Overall Study|Lack of Efficacy|2|||
13243037|NCT01631474|26347147|FG002|Overall Study|Lack of Efficacy|0|||
13243038|NCT01631474|26347148|FG003|Overall Study|Lack of Efficacy|0|||
13243039|NCT01631474|26347149|FG004|Overall Study|Lack of Efficacy|2|||
13243040|NCT01631474|26347145|FG000|Overall Study|Noncompliance with Study Drug|0|||
13243041|NCT01631474|26347146|FG001|Overall Study|Noncompliance with Study Drug|0|||
13243042|NCT01631474|26347147|FG002|Overall Study|Noncompliance with Study Drug|0|||
13243043|NCT01631474|26347148|FG003|Overall Study|Noncompliance with Study Drug|0|||
13243044|NCT01631474|26347149|FG004|Overall Study|Noncompliance with Study Drug|1|||
13243045|NCT01631474|26347145|FG000|Overall Study|Adverse Event|0|||
13243046|NCT01631474|26347146|FG001|Overall Study|Adverse Event|1|||
13243047|NCT01631474|26347147|FG002|Overall Study|Adverse Event|0|||
13243048|NCT01631474|26347148|FG003|Overall Study|Adverse Event|0|||
13243049|NCT01631474|26347149|FG004|Overall Study|Adverse Event|0|||
13243050|NCT01631435|26347156|FG000|Overall Study|Adverse Event|2|||
13243051|NCT01631435|26347156|FG000|Overall Study|Withdrawal by Subject|2|||
13243052|NCT01631435|26347156|FG000|Overall Study|incomplete study procedure|5|||
13243053|NCT01631227|26347169|FG000|Overall Study|withdrawn consent|27|||
13243054|NCT01631227|26347170|FG001|Overall Study|withdrawn consent|21|||
13243055|NCT01631227|26347169|FG000|Overall Study|Adverse Event|1|||
13243056|NCT01631227|26347170|FG001|Overall Study|Adverse Event|0|||
13243057|NCT01631227|26347169|FG000|Overall Study|administrative|2|||
13243058|NCT01631227|26347170|FG001|Overall Study|administrative|1|||
13243059|NCT01631188|26347178|FG000|Overall Study|Physician Decision|75|||
13243060|NCT01630889|26347189|FG000|Overall Study|Death|2|||
13243061|NCT01630889|26347189|FG000|Overall Study|Withdrawal by Subject|1|||
13243062|NCT01630889|26347189|FG000|Overall Study|Other than Specified|2|||
13243063|NCT01630889|26347189|FG000|Overall Study|Lost to Follow-up|4|||
13243064|NCT01630889|26347189|FG000|Overall Study|Other|1|||
13243065|NCT01630811|26347202|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
13243066|NCT01630811|26347203|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
13243067|NCT01630616|26347295|FG000|Overall Study|Adverse Event|0|||
13243068|NCT01630616|26347296|FG001|Overall Study|Adverse Event|0|||
13243069|NCT01630616|26347297|FG002|Overall Study|Adverse Event|0|||
13243070|NCT01630616|26347298|FG003|Overall Study|Adverse Event|1|||
13243071|NCT01630616|26347299|FG004|Overall Study|Adverse Event|0|||
13243072|NCT01630616|26347300|FG005|Overall Study|Adverse Event|0|||
13243073|NCT01630616|26347295|FG000|Overall Study|Withdrawal by Subject|0|||
13243074|NCT01630616|26347296|FG001|Overall Study|Withdrawal by Subject|0|||
13243075|NCT01630616|26347297|FG002|Overall Study|Withdrawal by Subject|0|||
13243076|NCT01630616|26347298|FG003|Overall Study|Withdrawal by Subject|2|||
13243077|NCT01630616|26347299|FG004|Overall Study|Withdrawal by Subject|0|||
13243078|NCT01630616|26347300|FG005|Overall Study|Withdrawal by Subject|0|||
13243079|NCT01630434|26347333|FG000|Overall Study|Donor lungs turned down|1|||
13243080|NCT01630434|26347334|FG001|Overall Study|Donor lungs turned down|0|||
13243081|NCT01630434|26347333|FG000|Overall Study|Protocol Violation|9|||
13485844|NCT00585195|27033420|FG010|Overall Study|Withdrawn Due to Pregnancy|0|||
13243082|NCT01630434|26347334|FG001|Overall Study|Protocol Violation|4|||
13243083|NCT01630434|26347333|FG000|Overall Study|Death|20|||
13243084|NCT01630434|26347334|FG001|Overall Study|Death|26|||
13243085|NCT01630135|26347377|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0|||
13243086|NCT01630135|26347378|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2|||
13243087|NCT01629966|26347399|FG000|Overall Study|Pregnancy|0|||
13243088|NCT01629966|26347400|FG001|Overall Study|Pregnancy|1|||
13243089|NCT01629966|26347401|FG002|Overall Study|Pregnancy|0|||
13243090|NCT01629966|26347399|FG000|Overall Study|Lost to Follow-up|10|||
13243091|NCT01629966|26347400|FG001|Overall Study|Lost to Follow-up|13|||
13243092|NCT01629966|26347401|FG002|Overall Study|Lost to Follow-up|9|||
13243093|NCT01629966|26347399|FG000|Overall Study|Withdrawal by Subject|8|||
13243094|NCT01629966|26347400|FG001|Overall Study|Withdrawal by Subject|9|||
13243095|NCT01629966|26347401|FG002|Overall Study|Withdrawal by Subject|16|||
13243096|NCT01629966|26347399|FG000|Overall Study|Protocol Violation|7|||
13243097|NCT01629966|26347400|FG001|Overall Study|Protocol Violation|9|||
13243098|NCT01629966|26347401|FG002|Overall Study|Protocol Violation|7|||
13243099|NCT01629966|26347399|FG000|Overall Study|Lack of Efficacy|5|||
13243100|NCT01629966|26347400|FG001|Overall Study|Lack of Efficacy|2|||
13243101|NCT01629966|26347401|FG002|Overall Study|Lack of Efficacy|4|||
13243102|NCT01629966|26347399|FG000|Overall Study|Adverse Event|11|||
13243103|NCT01629966|26347400|FG001|Overall Study|Adverse Event|18|||
13243104|NCT01629966|26347401|FG002|Overall Study|Adverse Event|30|||
13243105|NCT01629953|26347416|FG000|Overall Study|Death|3|||
13243106|NCT01629953|26347417|FG001|Overall Study|Death|1|||
13243107|NCT01629953|26347416|FG000|Overall Study|Lost to Follow-up|10|||
13243108|NCT01629953|26347417|FG001|Overall Study|Lost to Follow-up|14|||
13290019|NCT00105157|26480589|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5|||
13290020|NCT00105157|26480586|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
13290021|NCT00105157|26480587|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0|||
13290022|NCT00105157|26480588|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
13290023|NCT00105157|26480589|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
13290024|NCT00105079|26480612|FG000|Overall Study|Adverse Event|5|||
13290025|NCT00105079|26480613|FG001|Overall Study|Adverse Event|12|||
13290026|NCT00105079|26480612|FG000|Overall Study|Death|3|||
13290027|NCT00105079|26480613|FG001|Overall Study|Death|1|||
13290028|NCT00105079|26480612|FG000|Overall Study|Lost to Follow-up|12|||
13290029|NCT00105079|26480613|FG001|Overall Study|Lost to Follow-up|12|||
13290030|NCT00105079|26480612|FG000|Overall Study|Lack of Efficacy|9|||
13290031|NCT00105079|26480613|FG001|Overall Study|Lack of Efficacy|3|||
13290032|NCT00105079|26480612|FG000|Overall Study|Refused treatment|6|||
13290033|NCT00105079|26480613|FG001|Overall Study|Refused treatment|4|||
13290034|NCT00105079|26480612|FG000|Overall Study|Violation of selection criteria at entry|0|||
13290035|NCT00105079|26480613|FG001|Overall Study|Violation of selection criteria at entry|2|||
13290036|NCT00105079|26480612|FG000|Overall Study|Protocol Violation|1|||
13290037|NCT00105079|26480613|FG001|Overall Study|Protocol Violation|0|||
13290038|NCT00105079|26480612|FG000|Overall Study|Other|3|||
13290039|NCT00105079|26480613|FG001|Overall Study|Other|1|||
13290040|NCT00104884|26480619|FG000|Overall Study|Disease progression|4|||
13290041|NCT00104871|26480627|FG000|Overall Study|Not evaluable|1|||
13290042|NCT00104728|26480634|FG000|Overall Study|screen failures|19|||
13290043|NCT00104676|26480649|FG000|Overall Study|Death|3|||
13290044|NCT00104676|26480650|FG001|Overall Study|Death|2|||
13290045|NCT00104676|26480649|FG000|Overall Study|Withdrawal by Subject|0|||
13290046|NCT00104676|26480650|FG001|Overall Study|Withdrawal by Subject|2|||
13290047|NCT00104676|26480649|FG000|Overall Study|treatment interruption|4|||
13290048|NCT00104676|26480650|FG001|Overall Study|treatment interruption|10|||
13292325|NCT00706654|26485248|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9|||
13292326|NCT00706654|26485249|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
13292327|NCT00706654|26485250|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
13292328|NCT00706654|26485251|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
13292329|NCT00706654|26485248|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2|||
13292330|NCT00706654|26485249|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
13292331|NCT00706654|26485250|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
13292332|NCT00706654|26485251|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
13292333|NCT00706654|26485248|FG000|Oral Stabilization Phase|Lost to Follow-up|17|||
13292334|NCT00706654|26485249|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
13292335|NCT00706654|26485250|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
13292336|NCT00706654|26485251|FG003|Oral Stabilization Phase|Lost to Follow-up|0|||
13292337|NCT00706654|26485248|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19|||
13292338|NCT00706654|26485249|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
13292339|NCT00706654|26485250|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
13292340|NCT00706654|26485251|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
13292341|NCT00706654|26485248|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15|||
13292342|NCT00706654|26485249|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
13243109|NCT01629823|26347435|FG000|Trial Period|Missed visit|11|||
13243110|NCT01629823|26347436|FG001|Trial Period|Missed visit|9|||
13243111|NCT01629823|26347437|FG002|Trial Period|Missed visit|8|||
13243112|NCT01629823|26347435|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
13243113|NCT01629823|26347436|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
13243114|NCT01629823|26347437|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
13243115|NCT01629823|26347435|FG000|Trial Period|Pregnancy|1|||
13243116|NCT01629823|26347436|FG001|Trial Period|Pregnancy|0|||
13243117|NCT01629823|26347437|FG002|Trial Period|Pregnancy|0|||
13243118|NCT01629823|26347435|FG000|Trial Period|Adverse Event|0|||
13243119|NCT01629823|26347436|FG001|Trial Period|Adverse Event|1|||
13243120|NCT01629823|26347437|FG002|Trial Period|Adverse Event|0|||
13243121|NCT01629823|26347435|FG000|Trial Period|Out-of-window visit|0|||
13243122|NCT01629823|26347436|FG001|Trial Period|Out-of-window visit|2|||
13243123|NCT01629823|26347437|FG002|Trial Period|Out-of-window visit|0|||
13243124|NCT01629823|26347435|FG000|Trial Period|Failed to hold medication|0|||
13243125|NCT01629823|26347436|FG001|Trial Period|Failed to hold medication|0|||
13243126|NCT01629823|26347437|FG002|Trial Period|Failed to hold medication|1|||
13243127|NCT01629823|26347435|FG000|Washout Period|Safety|2|||
13243128|NCT01629823|26347436|FG001|Washout Period|Safety|5|||
13243129|NCT01629823|26347437|FG002|Washout Period|Safety|0|||
13243130|NCT01629823|26347435|FG000|Washout Period|Pregnancy|1|||
13243131|NCT01629823|26347436|FG001|Washout Period|Pregnancy|0|||
13243132|NCT01629823|26347437|FG002|Washout Period|Pregnancy|0|||
13243133|NCT01629823|26347435|FG000|Washout Period|Protocol Violation|0|||
13243134|NCT01629823|26347436|FG001|Washout Period|Protocol Violation|1|||
13243135|NCT01629823|26347437|FG002|Washout Period|Protocol Violation|0|||
13243136|NCT01629706|26347465|FG000|Phase 1 PureVision|Screen Failure|4|||
13243137|NCT01629706|26347465|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1|||
13243138|NCT01629706|26347465|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1|||
13243139|NCT01629706|26347465|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3|||
13243140|NCT01629706|26347465|FG000|Phase 2 Habitual|Screen Failure|6|||
13243141|NCT01629706|26347465|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1|||
13243142|NCT01629706|26347465|FG000|Phase 2 Habitual|Relocation prior to Dispense|1|||
13243143|NCT01629706|26347465|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1|||
13243144|NCT01629706|26347465|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1|||
13243145|NCT01629693|26347478|FG000|Overall Study|Lost to Follow-up|2|||
13243146|NCT01629693|26347479|FG001|Overall Study|Lost to Follow-up|4|||
13243147|NCT01629693|26347478|FG000|Overall Study|Withdrawal by Subject|2|||
13243148|NCT01629693|26347479|FG001|Overall Study|Withdrawal by Subject|2|||
13243149|NCT01629693|26347478|FG000|Overall Study|Adverse Event|1|||
13243150|NCT01629693|26347479|FG001|Overall Study|Adverse Event|0|||
13243151|NCT01629693|26347478|FG000|Overall Study|Investigator decision|0|||
13243152|NCT01629693|26347479|FG001|Overall Study|Investigator decision|1|||
13243153|NCT01629693|26347478|FG000|Overall Study|Poor comfort of study lenses|0|||
13243154|NCT01629693|26347479|FG001|Overall Study|Poor comfort of study lenses|2|||
13243155|NCT01629693|26347478|FG000|Overall Study|Subject decision unrelated to AE|0|||
13243156|NCT01629693|26347479|FG001|Overall Study|Subject decision unrelated to AE|1|||
13243157|NCT01629667|26347571|FG000|Overall Study|Lost to Follow-up|0|||
13243158|NCT01629667|26347572|FG001|Overall Study|Lost to Follow-up|1|||
13243159|NCT01629667|26347573|FG002|Overall Study|Lost to Follow-up|1|||
13243160|NCT01629667|26347571|FG000|Overall Study|Withdrawal by Subject|31|||
13243161|NCT01629667|26347572|FG001|Overall Study|Withdrawal by Subject|20|||
13243162|NCT01629667|26347573|FG002|Overall Study|Withdrawal by Subject|28|||
13243163|NCT01629667|26347571|FG000|Overall Study|Death|1|||
13243164|NCT01629667|26347572|FG001|Overall Study|Death|5|||
13243165|NCT01629667|26347573|FG002|Overall Study|Death|3|||
13243166|NCT01629667|26347571|FG000|Overall Study|Randomized, not treated|2|||
13243167|NCT01629667|26347572|FG001|Overall Study|Randomized, not treated|1|||
13243168|NCT01629667|26347573|FG002|Overall Study|Randomized, not treated|0|||
13243169|NCT01629667|26347571|FG000|Overall Study|Ongoing AE worsening right heart failure|0|||
13243170|NCT01629667|26347572|FG001|Overall Study|Ongoing AE worsening right heart failure|1|||
13243171|NCT01629667|26347573|FG002|Overall Study|Ongoing AE worsening right heart failure|0|||
13243172|NCT01629667|26347571|FG000|Overall Study|Requiring lung transplant|2|||
13243173|NCT01629667|26347572|FG001|Overall Study|Requiring lung transplant|1|||
13243174|NCT01629667|26347573|FG002|Overall Study|Requiring lung transplant|3|||
13243175|NCT01629667|26347571|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9|||
13243176|NCT01629667|26347572|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11|||
13243177|NCT01629667|26347573|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8|||
13243178|NCT01629667|26347571|FG000|Overall Study|Started other medicine|1|||
13243179|NCT01629667|26347572|FG001|Overall Study|Started other medicine|0|||
13243180|NCT01629667|26347573|FG002|Overall Study|Started other medicine|1|||
13243181|NCT01629667|26347571|FG000|Overall Study|Site error in safety follow-up|0|||
13243182|NCT01629667|26347572|FG001|Overall Study|Site error in safety follow-up|0|||
13243183|NCT01629667|26347573|FG002|Overall Study|Site error in safety follow-up|1|||
13243184|NCT01629667|26347571|FG000|Overall Study|Enrolled in another clinical study|0|||
13243185|NCT01629667|26347572|FG001|Overall Study|Enrolled in another clinical study|1|||
13243186|NCT01629667|26347573|FG002|Overall Study|Enrolled in another clinical study|0|||
13243187|NCT01629667|26347571|FG000|Overall Study|Code break|1|||
13115943|NCT03086369|25920242|FG002|Overall Study|Progressive Disease|0|||
13115944|NCT03086369|25920243|FG003|Overall Study|Progressive Disease|1|||
13115945|NCT03086369|25920244|FG004|Overall Study|Progressive Disease|1|||
13115946|NCT03086330|25920371|FG000|Overall Study|Withdrawal by Subject|3|||
13115947|NCT03086330|25920372|FG001|Overall Study|Withdrawal by Subject|2|||
13243188|NCT01629667|26347572|FG001|Overall Study|Code break|0|||
13243189|NCT01629667|26347573|FG002|Overall Study|Code break|0|||
13243190|NCT01629589|26347596|FG000|Overall Study|Protocol Violation|4|||
13243191|NCT01629589|26347597|FG001|Overall Study|Protocol Violation|2|||
13243192|NCT01629589|26347596|FG000|Overall Study|Lost to Follow-up|2|||
13243193|NCT01629589|26347597|FG001|Overall Study|Lost to Follow-up|1|||
13243194|NCT01629589|26347596|FG000|Overall Study|Withdrawal by Subject|2|||
13243195|NCT01629589|26347597|FG001|Overall Study|Withdrawal by Subject|3|||
13243196|NCT01629589|26347596|FG000|Overall Study|Did not receive study vaccine|0|||
13243197|NCT01629589|26347597|FG001|Overall Study|Did not receive study vaccine|1|||
13243198|NCT01629563|26347622|FG000|Overall Study|Adverse Event|16|||
13243199|NCT01629563|26347623|FG001|Overall Study|Adverse Event|16|||
13243200|NCT01629563|26347622|FG000|Overall Study|Death|2|||
13243201|NCT01629563|26347623|FG001|Overall Study|Death|0|||
13243202|NCT01629563|26347622|FG000|Overall Study|Lack of Efficacy|2|||
13243203|NCT01629563|26347623|FG001|Overall Study|Lack of Efficacy|3|||
13243204|NCT01629563|26347622|FG000|Overall Study|Lost to Follow-up|1|||
13243205|NCT01629563|26347623|FG001|Overall Study|Lost to Follow-up|0|||
13243206|NCT01629563|26347622|FG000|Overall Study|Pregnancy|1|||
13243207|NCT01629563|26347623|FG001|Overall Study|Pregnancy|2|||
13243208|NCT01629563|26347622|FG000|Overall Study|Protocol Violation|0|||
13243209|NCT01629563|26347623|FG001|Overall Study|Protocol Violation|1|||
13243210|NCT01629563|26347622|FG000|Overall Study|Withdrawal by Subject|27|||
13243211|NCT01629563|26347623|FG001|Overall Study|Withdrawal by Subject|20|||
13243212|NCT01629563|26347622|FG000|Overall Study|surgery|0|||
13243213|NCT01629563|26347623|FG001|Overall Study|surgery|3|||
13243214|NCT01629563|26347622|FG000|Overall Study|Lack of return of menses|12|||
13243215|NCT01629563|26347623|FG001|Overall Study|Lack of return of menses|7|||
13243216|NCT01629563|26347622|FG000|Overall Study|Protocol Violation|0|||
13243217|NCT01629563|26347623|FG001|Overall Study|Protocol Violation|1|||
13243218|NCT01629381|26347642|FG000|Overall Study|Withdrawal by Subject|2|||
13243219|NCT01629381|26347643|FG001|Overall Study|Withdrawal by Subject|5|||
13243220|NCT01628965|26347651|FG000|Overall Study|Adverse Event|30|||
13243221|NCT01628965|26347651|FG000|Overall Study|Lack of Efficacy|7|||
13243222|NCT01628965|26347651|FG000|Overall Study|Withdrawal by Subject|3|||
13243223|NCT01628965|26347651|FG000|Overall Study|Lost to Follow-up|1|||
13243224|NCT01628965|26347651|FG000|Overall Study|Discontinuation criteria|8|||
13243225|NCT01628926|26347708|FG000|Overall Study|Adverse Event|13|||
13243226|NCT01628926|26347709|FG001|Overall Study|Adverse Event|11|||
13243227|NCT01628926|26347710|FG002|Overall Study|Adverse Event|9|||
13243228|NCT01628926|26347708|FG000|Overall Study|Lack of Efficacy|2|||
13243229|NCT01628926|26347709|FG001|Overall Study|Lack of Efficacy|1|||
13243230|NCT01628926|26347710|FG002|Overall Study|Lack of Efficacy|5|||
13243231|NCT01628926|26347708|FG000|Overall Study|Withdrawal by Subject|6|||
13243232|NCT01628926|26347709|FG001|Overall Study|Withdrawal by Subject|4|||
13243233|NCT01628926|26347710|FG002|Overall Study|Withdrawal by Subject|2|||
13243234|NCT01628926|26347708|FG000|Overall Study|Protocol Violation|0|||
13243235|NCT01628926|26347709|FG001|Overall Study|Protocol Violation|1|||
13243236|NCT01628926|26347710|FG002|Overall Study|Protocol Violation|0|||
13243237|NCT01628926|26347708|FG000|Overall Study|Discontinuation criteria|3|||
13243238|NCT01628926|26347709|FG001|Overall Study|Discontinuation criteria|4|||
13243239|NCT01628926|26347710|FG002|Overall Study|Discontinuation criteria|0|||
13243240|NCT01628926|26347708|FG000|Overall Study|Physician Decision|2|||
13243241|NCT01628926|26347709|FG001|Overall Study|Physician Decision|2|||
13243242|NCT01628926|26347710|FG002|Overall Study|Physician Decision|1|||
13243243|NCT01628913|26347729|FG000|Overall Study|Adverse Event|12|||
13243244|NCT01628913|26347730|FG001|Overall Study|Adverse Event|5|||
13243245|NCT01628913|26347729|FG000|Overall Study|Disease Progression|11|||
13243246|NCT01628913|26347730|FG001|Overall Study|Disease Progression|14|||
13243247|NCT01628913|26347729|FG000|Overall Study|Protocol Violation|1|||
13243248|NCT01628913|26347730|FG001|Overall Study|Protocol Violation|0|||
13243249|NCT01628913|26347729|FG000|Overall Study|Death|1|||
13243250|NCT01628913|26347730|FG001|Overall Study|Death|0|||
13243251|NCT01628913|26347729|FG000|Overall Study|study terminated by Sponsor|4|||
13115948|NCT03086330|25920371|FG000|Overall Study|Lost to Follow-up|1|||
13243252|NCT01628913|26347730|FG001|Overall Study|study terminated by Sponsor|9|||
13243253|NCT01628913|26347729|FG000|Overall Study|Withdrawal by Subject|1|||
13243254|NCT01628913|26347730|FG001|Overall Study|Withdrawal by Subject|0|||
13243255|NCT01628913|26347729|FG000|Overall Study|Physician Decision|1|||
13243256|NCT01628913|26347730|FG001|Overall Study|Physician Decision|3|||
13243257|NCT01628874|26347751|FG000|Overall Study|Physician Decision|1|||
13243258|NCT01628874|26347752|FG001|Overall Study|Physician Decision|1|||
13243259|NCT01628874|26347751|FG000|Overall Study|Age >4 months|4|||
13243260|NCT01628874|26347752|FG001|Overall Study|Age >4 months|2|||
13243261|NCT01628848|26347787|FG000|Overall Study|Adverse Event|9|||
13243262|NCT01628848|26347788|FG001|Overall Study|Adverse Event|7|||
13243263|NCT01628848|26347787|FG000|Overall Study|Lack of Efficacy|0|||
13243264|NCT01628848|26347788|FG001|Overall Study|Lack of Efficacy|4|||
13243265|NCT01628848|26347787|FG000|Overall Study|Withdrawal by Subject|0|||
13243266|NCT01628848|26347788|FG001|Overall Study|Withdrawal by Subject|2|||
13243267|NCT01628848|26347787|FG000|Overall Study|Physician Decision|3|||
13243268|NCT01628848|26347788|FG001|Overall Study|Physician Decision|1|||
13243269|NCT01628692|26347851|FG000|Overall Study|Lack of Efficacy|4|||
13243270|NCT01628692|26347852|FG001|Overall Study|Lack of Efficacy|4|||
13243271|NCT01628692|26347853|FG002|Overall Study|Lack of Efficacy|5|||
13243272|NCT01628692|26347854|FG003|Overall Study|Lack of Efficacy|1|||
13243273|NCT01628692|26347855|FG004|Overall Study|Lack of Efficacy|4|||
13243274|NCT01628692|26347856|FG005|Overall Study|Lack of Efficacy|7|||
13243275|NCT01628692|26347851|FG000|Overall Study|Adverse Event|2|||
13243276|NCT01628692|26347852|FG001|Overall Study|Adverse Event|0|||
13243277|NCT01628692|26347853|FG002|Overall Study|Adverse Event|2|||
13243278|NCT01628692|26347854|FG003|Overall Study|Adverse Event|0|||
13243279|NCT01628692|26347855|FG004|Overall Study|Adverse Event|0|||
13243280|NCT01628692|26347856|FG005|Overall Study|Adverse Event|0|||
13243281|NCT01628692|26347851|FG000|Overall Study|Withdrawal by Subject|0|||
13243282|NCT01628692|26347852|FG001|Overall Study|Withdrawal by Subject|1|||
13243283|NCT01628692|26347853|FG002|Overall Study|Withdrawal by Subject|1|||
13243284|NCT01628692|26347854|FG003|Overall Study|Withdrawal by Subject|0|||
13243285|NCT01628692|26347855|FG004|Overall Study|Withdrawal by Subject|0|||
13243286|NCT01628692|26347856|FG005|Overall Study|Withdrawal by Subject|0|||
13243287|NCT01628692|26347851|FG000|Overall Study|Death|0|||
13243288|NCT01628692|26347852|FG001|Overall Study|Death|1|||
13243289|NCT01628692|26347853|FG002|Overall Study|Death|0|||
13243290|NCT01628692|26347854|FG003|Overall Study|Death|0|||
13243291|NCT01628692|26347855|FG004|Overall Study|Death|0|||
13243292|NCT01628692|26347856|FG005|Overall Study|Death|0|||
13243293|NCT01628692|26347851|FG000|Overall Study|Poor compliance/noncompliance|1|||
13243294|NCT01628692|26347852|FG001|Overall Study|Poor compliance/noncompliance|0|||
13243295|NCT01628692|26347853|FG002|Overall Study|Poor compliance/noncompliance|0|||
13243296|NCT01628692|26347854|FG003|Overall Study|Poor compliance/noncompliance|0|||
13243297|NCT01628692|26347855|FG004|Overall Study|Poor compliance/noncompliance|0|||
13243298|NCT01628692|26347856|FG005|Overall Study|Poor compliance/noncompliance|0|||
13243299|NCT01628692|26347851|FG000|Overall Study|Administrative reason by sponsor|0|||
13243300|NCT01628692|26347852|FG001|Overall Study|Administrative reason by sponsor|0|||
13243301|NCT01628692|26347853|FG002|Overall Study|Administrative reason by sponsor|0|||
13243302|NCT01628692|26347854|FG003|Overall Study|Administrative reason by sponsor|0|||
13243303|NCT01628692|26347855|FG004|Overall Study|Administrative reason by sponsor|0|||
13243304|NCT01628692|26347856|FG005|Overall Study|Administrative reason by sponsor|1|||
13243305|NCT01628692|26347851|FG000|Overall Study|Completed 12 Week only|0|||
13243306|NCT01628692|26347852|FG001|Overall Study|Completed 12 Week only|0|||
13243307|NCT01628692|26347853|FG002|Overall Study|Completed 12 Week only|0|||
13243308|NCT01628692|26347854|FG003|Overall Study|Completed 12 Week only|0|||
13243309|NCT01628692|26347855|FG004|Overall Study|Completed 12 Week only|0|||
13243310|NCT01628692|26347856|FG005|Overall Study|Completed 12 Week only|1|||
13243311|NCT01628549|26347903|FG000|Overall Study|Adverse Event|1|||
13243312|NCT01628549|26347904|FG001|Overall Study|Adverse Event|1|||
13243313|NCT01628549|26347905|FG002|Overall Study|Adverse Event|0|||
13243314|NCT01628549|26347906|FG003|Overall Study|Adverse Event|4|||
13243315|NCT01628549|26347903|FG000|Overall Study|Lost to Follow-up|3|||
13243316|NCT01628549|26347904|FG001|Overall Study|Lost to Follow-up|4|||
13243317|NCT01628549|26347905|FG002|Overall Study|Lost to Follow-up|3|||
13243318|NCT01628549|26347906|FG003|Overall Study|Lost to Follow-up|3|||
13243319|NCT01628549|26347903|FG000|Overall Study|Withdrawal by Subject|3|||
13243320|NCT01628549|26347904|FG001|Overall Study|Withdrawal by Subject|4|||
13243321|NCT01628549|26347905|FG002|Overall Study|Withdrawal by Subject|4|||
13243322|NCT01628549|26347906|FG003|Overall Study|Withdrawal by Subject|1|||
13243323|NCT01628549|26347903|FG000|Overall Study|Protocol Violation|2|||
13243324|NCT01628549|26347904|FG001|Overall Study|Protocol Violation|1|||
13243325|NCT01628549|26347905|FG002|Overall Study|Protocol Violation|1|||
13243326|NCT01628549|26347906|FG003|Overall Study|Protocol Violation|0|||
13243327|NCT01628549|26347903|FG000|Overall Study|withdrawn for noncompliance|0|||
13243328|NCT01628549|26347904|FG001|Overall Study|withdrawn for noncompliance|2|||
13243329|NCT01628549|26347905|FG002|Overall Study|withdrawn for noncompliance|1|||
13115949|NCT03086330|25920372|FG001|Overall Study|Lost to Follow-up|2|||
13243330|NCT01628549|26347906|FG003|Overall Study|withdrawn for noncompliance|0|||
13243331|NCT01628549|26347903|FG000|Overall Study|abnormal laboratory test results|0|||
13243332|NCT01628549|26347904|FG001|Overall Study|abnormal laboratory test results|0|||
13243333|NCT01628549|26347905|FG002|Overall Study|abnormal laboratory test results|1|||
13243334|NCT01628549|26347906|FG003|Overall Study|abnormal laboratory test results|0|||
13243335|NCT01628549|26347903|FG000|Overall Study|positive pregnancy test|0|||
13243336|NCT01628549|26347904|FG001|Overall Study|positive pregnancy test|0|||
13243337|NCT01628549|26347905|FG002|Overall Study|positive pregnancy test|0|||
13243338|NCT01628549|26347906|FG003|Overall Study|positive pregnancy test|1|||
13243339|NCT01628510|26347921|FG000|Overall Study|Withdrawal by Subject|0|||
13243340|NCT01628510|26347922|FG001|Overall Study|Withdrawal by Subject|4|||
13243341|NCT01628510|26347921|FG000|Overall Study|Death|3|||
13243342|NCT01628510|26347922|FG001|Overall Study|Death|1|||
13203180|NCT01987557|26223420|FG002|Overall Study|Withdrawal by Subject|2|||
13203181|NCT01987557|26223418|FG000|Overall Study|Adverse Event|0|||
13203182|NCT01987557|26223419|FG001|Overall Study|Adverse Event|2|||
13203183|NCT01987557|26223420|FG002|Overall Study|Adverse Event|0|||
13243343|NCT01628393|26347968|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1|||
13243344|NCT01628393|26347969|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
13243345|NCT01628393|26347970|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
13115950|NCT03086135|25920401|FG000|Overall Study|Adverse Event|1|||
13115951|NCT03086135|25920401|FG000|Overall Study|Lost to Follow-up|2|||
13115952|NCT03086057|25920426|FG000|Stage 1: PrEP Uptake|Incarcerated|3|||
13115953|NCT03086057|25920427|FG001|Stage 1: PrEP Uptake|Incarcerated|1|||
13115954|NCT03086057|25920428|FG002|Stage 1: PrEP Uptake|Incarcerated|0|||
13115955|NCT03086057|25920429|FG003|Stage 1: PrEP Uptake|Incarcerated|0|||
13115956|NCT03086057|25920426|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1|||
13115957|NCT03086057|25920427|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4|||
13115958|NCT03086057|25920428|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
13115959|NCT03086057|25920429|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
13115960|NCT03086057|25920426|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6|||
13243346|NCT01628393|26347971|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
13243347|NCT01628393|26347972|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
13243348|NCT01628393|26347968|FG000|Placebo-controlled Treatment Period|Protocol Violation|0|||
13243349|NCT01628393|26347969|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
13243350|NCT01628393|26347970|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
13243351|NCT01628393|26347971|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
13243352|NCT01628393|26347972|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
13243353|NCT01628393|26347968|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
13243354|NCT01628393|26347969|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
13243355|NCT01628393|26347970|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
13243356|NCT01628393|26347971|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
13243357|NCT01628393|26347972|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
13243358|NCT01628393|26347968|FG000|Blinded Active Extension Period|Adverse Event|0|||
13243359|NCT01628393|26347969|FG001|Blinded Active Extension Period|Adverse Event|1|||
13243360|NCT01628393|26347970|FG002|Blinded Active Extension Period|Adverse Event|0|||
13243361|NCT01628393|26347971|FG003|Blinded Active Extension Period|Adverse Event|2|||
13243362|NCT01628393|26347972|FG004|Blinded Active Extension Period|Adverse Event|2|||
13243363|NCT01628393|26347968|FG000|Blinded Active Extension Period|Lack of Efficacy|0|||
13243364|NCT01628393|26347969|FG001|Blinded Active Extension Period|Lack of Efficacy|0|||
13243365|NCT01628393|26347970|FG002|Blinded Active Extension Period|Lack of Efficacy|2|||
13243366|NCT01628393|26347971|FG003|Blinded Active Extension Period|Lack of Efficacy|0|||
13243367|NCT01628393|26347972|FG004|Blinded Active Extension Period|Lack of Efficacy|2|||
13243368|NCT01628393|26347968|FG000|Blinded Active Extension Period|Physician Decision|0|||
13243369|NCT01628393|26347969|FG001|Blinded Active Extension Period|Physician Decision|3|||
13243370|NCT01628393|26347970|FG002|Blinded Active Extension Period|Physician Decision|0|||
13243371|NCT01628393|26347971|FG003|Blinded Active Extension Period|Physician Decision|1|||
13243372|NCT01628393|26347972|FG004|Blinded Active Extension Period|Physician Decision|0|||
13243373|NCT01628393|26347968|FG000|Blinded Active Extension Period|Protocol Violation|0|||
13243374|NCT01628393|26347969|FG001|Blinded Active Extension Period|Protocol Violation|0|||
13243375|NCT01628393|26347970|FG002|Blinded Active Extension Period|Protocol Violation|2|||
13243376|NCT01628393|26347971|FG003|Blinded Active Extension Period|Protocol Violation|1|||
13243377|NCT01628393|26347972|FG004|Blinded Active Extension Period|Protocol Violation|0|||
13243378|NCT01628393|26347968|FG000|Blinded Active Extension Period|Withdrawal by Subject|0|||
13243379|NCT01628393|26347969|FG001|Blinded Active Extension Period|Withdrawal by Subject|6|||
13243380|NCT01628393|26347970|FG002|Blinded Active Extension Period|Withdrawal by Subject|2|||
13115961|NCT03086057|25920427|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5|||
13115962|NCT03086057|25920428|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
13203184|NCT01987505|26223456|FG000|Overall Study|Other|9|||
13203185|NCT01987505|26223456|FG000|Overall Study|Withdrawal by Subject|2|||
13203186|NCT01987505|26223456|FG000|Overall Study|Other Reason|2|||
13203187|NCT01987505|26223456|FG000|Overall Study|Lost to Follow-up|15|||
13203188|NCT01987505|26223456|FG000|Overall Study|Investigator Decision|2|||
13203189|NCT01987505|26223456|FG000|Overall Study|Death|4|||
13203190|NCT01987479|26223483|FG000|Overall Study|Protocol Violation|1|||
13203191|NCT01987479|26223483|FG000|Overall Study|Physician Decision|2|||
13115963|NCT03086057|25920429|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
13115964|NCT03086057|25920426|FG000|Stage 1: PrEP Uptake|Death|1|||
13243381|NCT01628393|26347971|FG003|Blinded Active Extension Period|Withdrawal by Subject|0|||
13243382|NCT01628393|26347972|FG004|Blinded Active Extension Period|Withdrawal by Subject|2|||
13243383|NCT01628367|26347989|FG000|Overall Study|Adverse Event|1|||
13243384|NCT01628367|26347990|FG001|Overall Study|Adverse Event|0|||
13243385|NCT01628198|26348005|FG000|Overall Study|Lost to Follow-up|7|||
13243386|NCT01628198|26348005|FG000|Overall Study|Withdrawal by Subject|10|||
13243387|NCT01628198|26348005|FG000|Overall Study|Screen failure|1|||
13243388|NCT01628120|26348032|FG000|Overall Study|Withdrawal by Subject|7|||
13243389|NCT01628120|26348032|FG000|Overall Study|Adverse Event|12|||
13243390|NCT01628120|26348032|FG000|Overall Study|Lost to Follow-up|1|||
13243391|NCT01628120|26348032|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2|||
13243392|NCT01628120|26348032|FG000|Overall Study|Non-compliant with Study Procedures|1|||
13243393|NCT01628120|26348032|FG000|Overall Study|Not Treated|3|||
13243394|NCT01628120|26348032|FG000|Overall Study|Sponsor Decision|5|||
13243395|NCT01628120|26348032|FG000|Overall Study|Switched Dialysis Method|2|||
13243396|NCT01628120|26348032|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3|||
13243397|NCT01628120|26348032|FG000|Overall Study|Moved or Relocated|5|||
13243398|NCT01628120|26348032|FG000|Overall Study|Kidney Transplant|2|||
13243399|NCT01628120|26348032|FG000|Overall Study|Use of Standard of Care|1|||
13243400|NCT01628107|26348059|FG000|Overall Study|Withdrawal by Subject|17|||
13243401|NCT01628107|26348059|FG000|Overall Study|Lost to Follow-up|4|||
13243402|NCT01628107|26348059|FG000|Overall Study|Adverse Event|33|||
13243403|NCT01628107|26348059|FG000|Overall Study|Physician Decision|2|||
13243404|NCT01628107|26348059|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1|||
13243405|NCT01628107|26348059|FG000|Overall Study|Non-compliant with Study Procedures|10|||
13243406|NCT01628107|26348059|FG000|Overall Study|Not Treated|8|||
13243407|NCT01628107|26348059|FG000|Overall Study|Sponsor Decision|11|||
13243408|NCT01628107|26348059|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7|||
13243409|NCT01628107|26348059|FG000|Overall Study|Relocated|8|||
13243410|NCT01628107|26348059|FG000|Overall Study|Kidney Transplant|9|||
13243411|NCT01628107|26348059|FG000|Overall Study|Use of Standard of Care|9|||
13243412|NCT01627899|26348069|FG000|Overall Study|Study terminated early by sponsor.|5|||
13243413|NCT01627860|26348086|FG000|Overall Study|Adverse Event|9|||
13243414|NCT01627860|26348087|FG001|Overall Study|Adverse Event|4|||
13243415|NCT01627860|26348086|FG000|Overall Study|Withdrawal by Subject|2|||
13243416|NCT01627860|26348087|FG001|Overall Study|Withdrawal by Subject|1|||
13243417|NCT01627860|26348086|FG000|Overall Study|Seizure frequency doubled|0|||
13243418|NCT01627860|26348087|FG001|Overall Study|Seizure frequency doubled|1|||
13243419|NCT01627860|26348086|FG000|Overall Study|Protocol Violation|1|||
13243420|NCT01627860|26348087|FG001|Overall Study|Protocol Violation|0|||
13243421|NCT01627782|26348156|FG000|Overall Study|Adverse Event|1|||
13243422|NCT01627782|26348157|FG001|Overall Study|Adverse Event|2|||
13243423|NCT01627782|26348158|FG002|Overall Study|Adverse Event|0|||
13243424|NCT01627782|26348159|FG003|Overall Study|Adverse Event|1|||
13243425|NCT01627782|26348156|FG000|Overall Study|Lack of Efficacy|11|||
13243426|NCT01627782|26348157|FG001|Overall Study|Lack of Efficacy|1|||
13243427|NCT01627782|26348158|FG002|Overall Study|Lack of Efficacy|15|||
13243428|NCT01627782|26348159|FG003|Overall Study|Lack of Efficacy|2|||
13243429|NCT01627782|26348156|FG000|Overall Study|Protocol Violation|1|||
13243430|NCT01627782|26348157|FG001|Overall Study|Protocol Violation|0|||
13243431|NCT01627782|26348158|FG002|Overall Study|Protocol Violation|0|||
13243432|NCT01627782|26348159|FG003|Overall Study|Protocol Violation|0|||
13243433|NCT01627782|26348156|FG000|Overall Study|Withdrawal by Subject|2|||
13243434|NCT01627782|26348157|FG001|Overall Study|Withdrawal by Subject|1|||
13243435|NCT01627782|26348158|FG002|Overall Study|Withdrawal by Subject|0|||
13243436|NCT01627782|26348159|FG003|Overall Study|Withdrawal by Subject|0|||
13243437|NCT01627782|26348156|FG000|Overall Study|Other|0|||
13243438|NCT01627782|26348157|FG001|Overall Study|Other|2|||
13243439|NCT01627782|26348158|FG002|Overall Study|Other|0|||
13243440|NCT01627782|26348159|FG003|Overall Study|Other|3|||
13243441|NCT01627782|26348156|FG000|Overall Study|Randomized But Not Treated|1|||
13243442|NCT01627782|26348157|FG001|Overall Study|Randomized But Not Treated|0|||
13243443|NCT01627782|26348158|FG002|Overall Study|Randomized But Not Treated|0|||
13243444|NCT01627782|26348159|FG003|Overall Study|Randomized But Not Treated|0|||
13243445|NCT01627691|26348172|FG000|Overall Study|Death|11|||
13243446|NCT01627691|26348172|FG000|Overall Study|Lost to Follow-up|3|||
13243447|NCT01627691|26348172|FG000|Overall Study|Withdrawal by Subject|1|||
13243448|NCT01627691|26348172|FG000|Overall Study|Missed the visit|3|||
13243449|NCT01627340|26348195|FG000|Overall Study|Adverse Event|1|||
13243450|NCT01627340|26348196|FG001|Overall Study|Adverse Event|0|||
13243451|NCT01627340|26348195|FG000|Overall Study|Lost to Follow-up|8|||
13243452|NCT01627340|26348196|FG001|Overall Study|Lost to Follow-up|4|||
13243453|NCT01627340|26348195|FG000|Overall Study|Pregnancy|1|||
13243454|NCT01627340|26348196|FG001|Overall Study|Pregnancy|0|||
13243455|NCT01627340|26348195|FG000|Overall Study|Withdrawal by Subject|2|||
13243456|NCT01627340|26348196|FG001|Overall Study|Withdrawal by Subject|0|||
13243457|NCT01627327|26348213|FG000|Overall Study|Adverse Event|6|||
13243458|NCT01627327|26348214|FG001|Overall Study|Adverse Event|12|||
13243459|NCT01627327|26348213|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0|||
13243460|NCT01627327|26348214|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2|||
13243461|NCT01627327|26348213|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4|||
13243462|NCT01627327|26348214|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9|||
13243463|NCT01627327|26348213|FG000|Overall Study|Protocol Violation|4|||
13243464|NCT01627327|26348214|FG001|Overall Study|Protocol Violation|10|||
13243465|NCT01627327|26348213|FG000|Overall Study|Lost to Follow-up|1|||
13243466|NCT01627327|26348214|FG001|Overall Study|Lost to Follow-up|3|||
13243467|NCT01627327|26348213|FG000|Overall Study|Physician Decision|1|||
13243468|NCT01627327|26348214|FG001|Overall Study|Physician Decision|0|||
13243469|NCT01627327|26348213|FG000|Overall Study|Withdrawal by Subject|3|||
13243470|NCT01627327|26348214|FG001|Overall Study|Withdrawal by Subject|3|||
13243471|NCT01627249|26348259|FG000|Overall Study|Death|3|||
13243472|NCT01627249|26348260|FG001|Overall Study|Death|5|||
13243473|NCT01627249|26348261|FG002|Overall Study|Death|3|||
13243474|NCT01627249|26348259|FG000|Overall Study|Withdrawal by Subject|12|||
13243475|NCT01627249|26348260|FG001|Overall Study|Withdrawal by Subject|6|||
13243476|NCT01627249|26348261|FG002|Overall Study|Withdrawal by Subject|9|||
13243477|NCT01627249|26348259|FG000|Overall Study|Missed Visit|1|||
13243478|NCT01627249|26348260|FG001|Overall Study|Missed Visit|1|||
13243479|NCT01627249|26348261|FG002|Overall Study|Missed Visit|0|||
13243480|NCT01627067|26348271|FG000|Overall Study|Screen Failure|1|||
13243481|NCT01626989|26348322|FG000|Screening Period|Screen Failure|15|||
13243482|NCT01626989|26348323|FG001|Screening Period|Screen Failure|0|||
13243483|NCT01626989|26348324|FG002|Screening Period|Screen Failure|0|||
13243484|NCT01626989|26348322|FG000|Screening Period|Withdrawal by Subject|2|||
13243485|NCT01626989|26348323|FG001|Screening Period|Withdrawal by Subject|0|||
13243486|NCT01626989|26348324|FG002|Screening Period|Withdrawal by Subject|0|||
13243487|NCT01626885|26348330|FG000|Overall Study|Adverse Event|8|||
13243488|NCT01626885|26348330|FG000|Overall Study|Withdrawal by Subject|4|||
13243489|NCT01626872|26348348|FG000|Overall Study|Physician Decision|13|||
13243490|NCT01626872|26348349|FG001|Overall Study|Physician Decision|9|||
13243491|NCT01626872|26348350|FG002|Overall Study|Physician Decision|6|||
13243492|NCT01626872|26348348|FG000|Overall Study|Withdrawal by Subject|19|||
13243493|NCT01626872|26348349|FG001|Overall Study|Withdrawal by Subject|27|||
13243494|NCT01626872|26348350|FG002|Overall Study|Withdrawal by Subject|8|||
13243495|NCT01626872|26348348|FG000|Overall Study|Adverse Event (including Death)|20|||
13243496|NCT01626872|26348349|FG001|Overall Study|Adverse Event (including Death)|28|||
13243497|NCT01626872|26348350|FG002|Overall Study|Adverse Event (including Death)|8|||
13243498|NCT01626872|26348348|FG000|Overall Study|Protocol Violation (including Pregnancy)|0|||
13243499|NCT01626872|26348349|FG001|Overall Study|Protocol Violation (including Pregnancy)|2|||
13243500|NCT01626872|26348350|FG002|Overall Study|Protocol Violation (including Pregnancy)|2|||
13243501|NCT01626859|26348377|FG000|Overall Study|Adverse Event|1|||
13243502|NCT01626859|26348378|FG001|Overall Study|Adverse Event|3|||
13243503|NCT01626859|26348379|FG002|Overall Study|Adverse Event|2|||
13243504|NCT01626859|26348377|FG000|Overall Study|Physician Decision|0|||
13243505|NCT01626859|26348378|FG001|Overall Study|Physician Decision|1|||
13243506|NCT01626859|26348379|FG002|Overall Study|Physician Decision|0|||
13243507|NCT01626859|26348377|FG000|Overall Study|Withdrawal by Subject|1|||
13243508|NCT01626859|26348378|FG001|Overall Study|Withdrawal by Subject|4|||
13243509|NCT01626859|26348379|FG002|Overall Study|Withdrawal by Subject|2|||
13243510|NCT01626690|26348406|FG000|Overall Study|Protocol Violation|1|||
13243511|NCT01626690|26348407|FG001|Overall Study|Protocol Violation|0|||
13243512|NCT01626690|26348406|FG000|Overall Study|Adverse Event|1|||
13243513|NCT01626690|26348407|FG001|Overall Study|Adverse Event|0|||
13243514|NCT01626495|26348416|FG000|Overall Study|Adverse Event|3|||
13243515|NCT01626495|26348416|FG000|Overall Study|Disease progression|27|||
13243516|NCT01626495|26348416|FG000|Overall Study|Withdrawal by Subject|1|||
13243517|NCT01626495|26348416|FG000|Overall Study|Administrative problem|1|||
13243518|NCT01626495|26348416|FG000|Overall Study|Death|2|||
13243519|NCT01626495|26348416|FG000|Overall Study|Physician Decision|1|||
13243520|NCT01626495|26348416|FG000|Overall Study|New cancer therapy|16|||
13243521|NCT01626495|26348416|FG000|Overall Study|Manufacturing failure|1|||
13243522|NCT01626456|26348451|FG000|Overall Study|Withdrawal by Subject|21|||
13243523|NCT01626456|26348452|FG001|Overall Study|Withdrawal by Subject|46|||
13243524|NCT01626456|26348451|FG000|Overall Study|Adverse Event|2|||
13243525|NCT01626456|26348452|FG001|Overall Study|Adverse Event|27|||
13243526|NCT01626456|26348451|FG000|Overall Study|Lost to Follow-up|2|||
13243527|NCT01626456|26348452|FG001|Overall Study|Lost to Follow-up|27|||
13243528|NCT01626456|26348451|FG000|Overall Study|Lack of Efficacy|6|||
13243529|NCT01626456|26348452|FG001|Overall Study|Lack of Efficacy|7|||
13243530|NCT01626456|26348451|FG000|Overall Study|Physician Decision|1|||
13243531|NCT01626456|26348452|FG001|Overall Study|Physician Decision|4|||
13243532|NCT01626456|26348451|FG000|Overall Study|Protocol Violation|1|||
13243533|NCT01626456|26348452|FG001|Overall Study|Protocol Violation|1|||
13243534|NCT01626456|26348451|FG000|Overall Study|Site Closure|2|||
13243535|NCT01626456|26348452|FG001|Overall Study|Site Closure|3|||
13243536|NCT01626456|26348451|FG000|Overall Study|Incarceration|0|||
13243537|NCT01626456|26348452|FG001|Overall Study|Incarceration|2|||
13243538|NCT01626391|26348465|FG000|Overall Study|Physician Decision|1|||
13243539|NCT01626391|26348466|FG001|Overall Study|Physician Decision|0|||
13243540|NCT01626391|26348465|FG000|Overall Study|Withdrawal by Subject|1|||
13243541|NCT01626391|26348466|FG001|Overall Study|Withdrawal by Subject|0|||
13243542|NCT01626352|26348478|FG000|Overall Study|Disease Progression|3|||
13243543|NCT01626352|26348478|FG000|Overall Study|Intercurrent Illness|2|||
13243544|NCT01626352|26348478|FG000|Overall Study|Death|2|||
13243545|NCT01626352|26348478|FG000|Overall Study|Withdrawal by Subject|1|||
13243546|NCT01626352|26348478|FG000|Overall Study|Non-Compliance|1|||
13243547|NCT01626352|26348478|FG000|Overall Study|Never Treated|1|||
13243548|NCT01626118|26348529|FG000|Overall Study|Lack of Efficacy|1|||
13243549|NCT01626118|26348530|FG001|Overall Study|Lack of Efficacy|0|||
13243550|NCT01626118|26348531|FG002|Overall Study|Lack of Efficacy|1|||
13243551|NCT01626118|26348532|FG003|Overall Study|Lack of Efficacy|3|||
13243552|NCT01626118|26348529|FG000|Overall Study|Lost to Follow-up|1|||
13243553|NCT01626118|26348530|FG001|Overall Study|Lost to Follow-up|0|||
13243554|NCT01626118|26348531|FG002|Overall Study|Lost to Follow-up|0|||
13243555|NCT01626118|26348532|FG003|Overall Study|Lost to Follow-up|0|||
13243556|NCT01626118|26348529|FG000|Overall Study|Adverse Event|0|||
13243557|NCT01626118|26348530|FG001|Overall Study|Adverse Event|1|||
13243558|NCT01626118|26348531|FG002|Overall Study|Adverse Event|1|||
13243559|NCT01626118|26348532|FG003|Overall Study|Adverse Event|0|||
13243560|NCT01626118|26348529|FG000|Overall Study|Investigator Decision|0|||
13243561|NCT01626118|26348530|FG001|Overall Study|Investigator Decision|1|||
13243562|NCT01626118|26348531|FG002|Overall Study|Investigator Decision|0|||
13243563|NCT01626118|26348532|FG003|Overall Study|Investigator Decision|0|||
13243564|NCT01626079|26349001|FG000|Overall Study|Death|117|||
13243565|NCT01626079|26349002|FG001|Overall Study|Death|153|||
13243566|NCT01626079|26349003|FG002|Overall Study|Death|39|||
13243567|NCT01626079|26349001|FG000|Overall Study|Withdrawal by Subject|15|||
13243568|NCT01626079|26349002|FG001|Overall Study|Withdrawal by Subject|39|||
13243569|NCT01626079|26349003|FG002|Overall Study|Withdrawal by Subject|5|||
13243570|NCT01626079|26349001|FG000|Overall Study|Lost to Follow-up|5|||
13243571|NCT01626079|26349002|FG001|Overall Study|Lost to Follow-up|4|||
13243572|NCT01626079|26349003|FG002|Overall Study|Lost to Follow-up|2|||
13243573|NCT01626079|26349001|FG000|Overall Study|Missed Visits|13|||
13243574|NCT01626079|26349002|FG001|Overall Study|Missed Visits|5|||
13243575|NCT01626079|26349003|FG002|Overall Study|Missed Visits|6|||
13243576|NCT01625988|26349024|FG000|Overall Study|Lost to Follow-up|5|||
13243577|NCT01625988|26349025|FG001|Overall Study|Lost to Follow-up|6|||
13243578|NCT01625988|26349024|FG000|Overall Study|Withdrawal by Subject|8|||
13243579|NCT01625988|26349025|FG001|Overall Study|Withdrawal by Subject|3|||
13243580|NCT01625988|26349024|FG000|Overall Study|Adverse Event|0|||
13243581|NCT01625988|26349025|FG001|Overall Study|Adverse Event|1|||
13243582|NCT01625988|26349024|FG000|Overall Study|Lack of Efficacy|0|||
13243583|NCT01625988|26349025|FG001|Overall Study|Lack of Efficacy|1|||
13243584|NCT01625988|26349024|FG000|Overall Study|Randomized Inappropriately|1|||
13243585|NCT01625988|26349025|FG001|Overall Study|Randomized Inappropriately|0|||
13243586|NCT01625988|26349024|FG000|Overall Study|Protocol Violation|0|||
13243587|NCT01625988|26349025|FG001|Overall Study|Protocol Violation|2|||
13243588|NCT01625910|26349040|FG000|Overall Study|Lost to Follow-up|3|||
13243589|NCT01625910|26349041|FG001|Overall Study|Lost to Follow-up|4|||
13243590|NCT01625897|26349054|FG000|Overall Study|Adverse Event|27|||
13243591|NCT01625897|26349055|FG001|Overall Study|Adverse Event|10|||
13243592|NCT01625897|26349054|FG000|Overall Study|Physician Decision|0|||
13243593|NCT01625897|26349055|FG001|Overall Study|Physician Decision|1|||
13243594|NCT01625897|26349054|FG000|Overall Study|Withdrawal by Subject|25|||
13243595|NCT01625897|26349055|FG001|Overall Study|Withdrawal by Subject|3|||
13243596|NCT01625845|26349080|FG000|Overall Study|Adverse Event|1|||
13243597|NCT01625845|26349081|FG001|Overall Study|Adverse Event|2|||
13243598|NCT01625845|26349080|FG000|Overall Study|Lost to Follow-up|2|||
13243599|NCT01625845|26349081|FG001|Overall Study|Lost to Follow-up|1|||
13243600|NCT01625845|26349080|FG000|Overall Study|Withdrawal by Subject|2|||
13243601|NCT01625845|26349081|FG001|Overall Study|Withdrawal by Subject|0|||
13243602|NCT01625689|26349098|FG000|Overall Study|Migration|2|||
13243603|NCT01625689|26349099|FG001|Overall Study|Migration|1|||
13243604|NCT01625611|26349114|FG000|Overall Study|No adlib drinks Lab 1|3|||
13243605|NCT01625611|26349115|FG001|Overall Study|No adlib drinks Lab 1|0|||
13243606|NCT01625611|26349114|FG000|Overall Study|Technical issues with PET|1|||
13243607|NCT01625611|26349115|FG001|Overall Study|Technical issues with PET|0|||
13243608|NCT01625611|26349114|FG000|Overall Study|Unable to complete study procedures|1|||
13243609|NCT01625611|26349115|FG001|Overall Study|Unable to complete study procedures|0|||
13243610|NCT01625611|26349114|FG000|Overall Study|Withdrawal by Subject|3|||
13243611|NCT01625611|26349115|FG001|Overall Study|Withdrawal by Subject|0|||
13243612|NCT01625377|26349152|FG000|Overall Study|Death|1|||
13243613|NCT01625377|26349153|FG001|Overall Study|Death|1|||
13243614|NCT01625377|26349152|FG000|Overall Study|Administrative Problem|1|||
13243615|NCT01625377|26349153|FG001|Overall Study|Administrative Problem|1|||
13243616|NCT01625377|26349152|FG000|Overall Study|Protocol Violation|0|||
13243617|NCT01625377|26349153|FG001|Overall Study|Protocol Violation|3|||
13243618|NCT01625377|26349152|FG000|Overall Study|Adverse Event|3|||
13243619|NCT01625377|26349153|FG001|Overall Study|Adverse Event|16|||
13243620|NCT01625377|26349152|FG000|Overall Study|Graft loss|1|||
13243621|NCT01625377|26349153|FG001|Overall Study|Graft loss|0|||
13243622|NCT01625377|26349152|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
13243623|NCT01625377|26349153|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
13243624|NCT01625377|26349152|FG000|Overall Study|Abnormal laboratory values|1|||
13243625|NCT01625377|26349153|FG001|Overall Study|Abnormal laboratory values|0|||
13243626|NCT01625338|26349183|FG000|Overall Study|Enrolled but not Treated|0|||
13243627|NCT01625338|26349184|FG001|Overall Study|Enrolled but not Treated|0|||
13243628|NCT01625338|26349185|FG002|Overall Study|Enrolled but not Treated|1|||
13243629|NCT01625338|26349183|FG000|Overall Study|Efficacy Failure|27|||
13243630|NCT01625338|26349184|FG001|Overall Study|Efficacy Failure|39|||
13243631|NCT01625338|26349185|FG002|Overall Study|Efficacy Failure|31|||
13243632|NCT01625338|26349183|FG000|Overall Study|Lost to Follow-up|3|||
13243633|NCT01625338|26349184|FG001|Overall Study|Lost to Follow-up|3|||
13243634|NCT01625338|26349185|FG002|Overall Study|Lost to Follow-up|2|||
13243635|NCT01625338|26349183|FG000|Overall Study|Investigator Decision|0|||
13243636|NCT01625338|26349184|FG001|Overall Study|Investigator Decision|2|||
13243637|NCT01625338|26349185|FG002|Overall Study|Investigator Decision|1|||
13243638|NCT01625338|26349183|FG000|Overall Study|Subject Withdrew Consent|1|||
13243639|NCT01625338|26349184|FG001|Overall Study|Subject Withdrew Consent|0|||
13243640|NCT01625338|26349185|FG002|Overall Study|Subject Withdrew Consent|2|||
13243641|NCT01625338|26349183|FG000|Overall Study|Adverse Event|1|||
13243642|NCT01625338|26349184|FG001|Overall Study|Adverse Event|0|||
13243643|NCT01625338|26349185|FG002|Overall Study|Adverse Event|1|||
13243644|NCT01625338|26349183|FG000|Overall Study|Study Discontinued by Sponsor|0|||
13243645|NCT01625338|26349184|FG001|Overall Study|Study Discontinued by Sponsor|0|||
13243646|NCT01625338|26349185|FG002|Overall Study|Study Discontinued by Sponsor|1|||
13243647|NCT01625182|26349205|FG000|Overall Study|Administrative problems|1|||
13243648|NCT01625182|26349206|FG001|Overall Study|Administrative problems|0|||
13243649|NCT01625182|26349205|FG000|Overall Study|Protocol deviation|0|||
13243650|NCT01625182|26349206|FG001|Overall Study|Protocol deviation|2|||
13243651|NCT01625182|26349205|FG000|Overall Study|Adverse Event|2|||
13243652|NCT01625182|26349206|FG001|Overall Study|Adverse Event|0|||
13243653|NCT01625182|26349205|FG000|Overall Study|Withdrawal by Subject|5|||
13243654|NCT01625182|26349206|FG001|Overall Study|Withdrawal by Subject|1|||
13243655|NCT01625182|26349205|FG000|Overall Study|Lack of Efficacy|12|||
13243656|NCT01625182|26349206|FG001|Overall Study|Lack of Efficacy|8|||
13243657|NCT01625091|26349225|FG000|Intervention|Death|1|||
13243658|NCT01625091|26349226|FG001|Intervention|Death|1|||
13243659|NCT01625091|26349225|FG000|Intervention|Withdrawal by Subject|4|||
13243660|NCT01625091|26349226|FG001|Intervention|Withdrawal by Subject|1|||
13243661|NCT01625091|26349225|FG000|Intervention|Adverse Event|0|||
13243662|NCT01625091|26349226|FG001|Intervention|Adverse Event|2|||
13243663|NCT01625091|26349225|FG000|Intervention|Lost to Follow-up|4|||
13243664|NCT01625091|26349226|FG001|Intervention|Lost to Follow-up|4|||
13243665|NCT01625091|26349225|FG000|Intervention|Study termination|2|||
13243666|NCT01625091|26349226|FG001|Intervention|Study termination|3|||
13243667|NCT01625091|26349225|FG000|Post-intervention|Death|0|||
13243668|NCT01625091|26349226|FG001|Post-intervention|Death|1|||
13243669|NCT01625091|26349225|FG000|Post-intervention|Lost to Follow-up|2|||
13243670|NCT01625091|26349226|FG001|Post-intervention|Lost to Follow-up|0|||
13243671|NCT01625091|26349225|FG000|Post-intervention|Study termination|2|||
13243672|NCT01625091|26349226|FG001|Post-intervention|Study termination|1|||
13243673|NCT01625000|26349259|FG000|Overall Study|Physician Decision|15|||
13243674|NCT01625000|26349260|FG001|Overall Study|Physician Decision|7|||
13243675|NCT01625000|26349261|FG002|Overall Study|Physician Decision|7|||
13243676|NCT01625000|26349262|FG003|Overall Study|Physician Decision|2|||
13243677|NCT01625000|26349263|FG004|Overall Study|Physician Decision|15|||
13243678|NCT01625000|26349259|FG000|Overall Study|Protocol Violation|3|||
13243679|NCT01625000|26349260|FG001|Overall Study|Protocol Violation|10|||
13243680|NCT01625000|26349261|FG002|Overall Study|Protocol Violation|4|||
13243681|NCT01625000|26349262|FG003|Overall Study|Protocol Violation|1|||
13243682|NCT01625000|26349263|FG004|Overall Study|Protocol Violation|2|||
13243683|NCT01625000|26349259|FG000|Overall Study|Withdrawal by Subject|19|||
13243684|NCT01625000|26349260|FG001|Overall Study|Withdrawal by Subject|16|||
13243685|NCT01625000|26349261|FG002|Overall Study|Withdrawal by Subject|11|||
13243686|NCT01625000|26349262|FG003|Overall Study|Withdrawal by Subject|9|||
13243687|NCT01625000|26349263|FG004|Overall Study|Withdrawal by Subject|17|||
13243688|NCT01625000|26349259|FG000|Overall Study|Adverse Event (including Death)|15|||
13243689|NCT01625000|26349260|FG001|Overall Study|Adverse Event (including Death)|19|||
13243690|NCT01625000|26349261|FG002|Overall Study|Adverse Event (including Death)|11|||
13243691|NCT01625000|26349262|FG003|Overall Study|Adverse Event (including Death)|7|||
13243692|NCT01625000|26349263|FG004|Overall Study|Adverse Event (including Death)|21|||
13243693|NCT01624974|26349292|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0|||
13243694|NCT01624974|26349293|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2|||
13243695|NCT01624974|26349292|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1|||
13243696|NCT01624974|26349293|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2|||
13243697|NCT01624974|26349292|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5|||
13243698|NCT01624974|26349293|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3|||
13243699|NCT01624974|26349292|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1|||
13243700|NCT01624974|26349293|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0|||
13243701|NCT01624974|26349292|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0|||
13243702|NCT01624974|26349293|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1|||
13243703|NCT01624974|26349292|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
13243704|NCT01624974|26349293|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
13243705|NCT01624974|26349292|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0|||
13243706|NCT01624974|26349293|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1|||
13243707|NCT01624974|26349292|FG000|Period IV Washout (4 Weeks)|Adverse Event|2|||
13243708|NCT01624974|26349293|FG001|Period IV Washout (4 Weeks)|Adverse Event|0|||
13243709|NCT01624974|26349292|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0|||
13243710|NCT01624974|26349293|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1|||
13243711|NCT01624974|26349292|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1|||
13243712|NCT01624974|26349293|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0|||
13243713|NCT01624974|26349292|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3|||
13243714|NCT01624974|26349293|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0|||
13243715|NCT01624974|26349292|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1|||
13243716|NCT01624974|26349293|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0|||
13243717|NCT01624870|26349301|FG000|Overall Study|Death|19|||
13243718|NCT01624870|26349301|FG000|Overall Study|Withdrawal by Subject|1|||
13243719|NCT01624870|26349301|FG000|Overall Study|CoreValve not implanted|6|||
13243720|NCT01624870|26349301|FG000|Overall Study|Lost to follow up|1|||
13243721|NCT01624662|26349385|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
13243722|NCT01624662|26349386|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
13243723|NCT01624662|26349387|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
13243724|NCT01624662|26349388|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0|||
13243725|NCT01624662|26349385|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5|||
13243726|NCT01624662|26349386|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1|||
13243727|NCT01624662|26349387|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
13243728|NCT01624662|26349388|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
13243729|NCT01624662|26349385|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
13243730|NCT01624662|26349386|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
13243731|NCT01624662|26349387|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
13243732|NCT01624662|26349388|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
13243733|NCT01624662|26349385|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
13243734|NCT01624662|26349386|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
13243735|NCT01624662|26349387|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
13243736|NCT01624662|26349388|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
13243737|NCT01624662|26349385|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
13243738|NCT01624662|26349386|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
13243739|NCT01624662|26349387|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
13243740|NCT01624662|26349388|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
13243741|NCT01624662|26349385|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
13243742|NCT01624662|26349386|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
13243743|NCT01624662|26349387|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
13243744|NCT01624662|26349388|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
13243745|NCT01624662|26349385|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
13243746|NCT01624662|26349386|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
13243747|NCT01624662|26349387|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
13243748|NCT01624662|26349388|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
13243749|NCT01624506|26349401|FG000|Overall Study|Lost to Follow-up|29|||
13243750|NCT01624506|26349402|FG001|Overall Study|Lost to Follow-up|15|||
13243751|NCT01624506|26349401|FG000|Overall Study|Withdrawal by Subject|9|||
13243752|NCT01624506|26349402|FG001|Overall Study|Withdrawal by Subject|2|||
13243753|NCT01624506|26349401|FG000|Overall Study|Death|1|||
13243754|NCT01624506|26349402|FG001|Overall Study|Death|0|||
13243755|NCT01624506|26349401|FG000|Overall Study|LINX explants|23|||
13243756|NCT01624506|26349402|FG001|Overall Study|LINX explants|0|||
13243757|NCT01624506|26349401|FG000|Overall Study|Adverse Event|3|||
13243758|NCT01624506|26349402|FG001|Overall Study|Adverse Event|0|||
13243759|NCT01624467|26349417|FG000|Overall Study|Withdrawal by Subject|2|||
13243760|NCT01624467|26349417|FG000|Overall Study|Lost to Follow-up|1|||
13243761|NCT01624467|26349417|FG000|Overall Study|Adverse Event|7|||
13243762|NCT01624467|26349417|FG000|Overall Study|Progressive Disease|19|||
13243763|NCT01624467|26349417|FG000|Overall Study|Per Sponsor Requirement|1|||
13243764|NCT01624467|26349417|FG000|Overall Study|Subject Withdrew from Treatment|1|||
13243765|NCT01624259|26349473|FG000|Overall Study|Adverse Event|18|||
13243766|NCT01624259|26349474|FG001|Overall Study|Adverse Event|18|||
13243767|NCT01624259|26349473|FG000|Overall Study|Protocol Violation|1|||
13243768|NCT01624259|26349474|FG001|Overall Study|Protocol Violation|2|||
13243769|NCT01624259|26349473|FG000|Overall Study|Withdrawal by Subject|5|||
13243770|NCT01624259|26349474|FG001|Overall Study|Withdrawal by Subject|7|||
13243771|NCT01624259|26349473|FG000|Overall Study|Physician Decision|1|||
13243772|NCT01624259|26349474|FG001|Overall Study|Physician Decision|1|||
13243773|NCT01624259|26349473|FG000|Overall Study|Lost to Follow-up|2|||
13243774|NCT01624259|26349474|FG001|Overall Study|Lost to Follow-up|3|||
13243775|NCT01624259|26349473|FG000|Overall Study|Abnormal laboratory measure|3|||
13243776|NCT01624259|26349474|FG001|Overall Study|Abnormal laboratory measure|0|||
13243777|NCT01624233|26349506|FG000|Period 2 - Induction|Adverse Event|1|||
13243778|NCT01624233|26349506|FG000|Period 3 - Maintenance|Adverse Event|2|||
13243779|NCT01624233|26349506|FG000|Period 3 - Maintenance|Lack of Efficacy|1|||
13243780|NCT01624233|26349506|FG000|Period 3 - Maintenance|Physician Decision|2|||
13243781|NCT01624233|26349506|FG000|Period 3 - Maintenance|Withdrawal by Subject|2|||
13243782|NCT01624233|26349506|FG000|Period 4 - Drug Free Period|Relapsed|61|||
13243783|NCT01624233|26349506|FG000|Period 5 - Retreatment Period|Adverse Event|5|||
13243784|NCT01624233|26349506|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1|||
13243785|NCT01624233|26349506|FG000|Period 5 - Retreatment Period|Physician Decision|1|||
13243786|NCT01624233|26349506|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3|||
13243787|NCT01624233|26349506|FG000|Period 6: Follow-up|Adverse Event|3|||
13243788|NCT01624233|26349506|FG000|Period 6: Follow-up|Lack of Efficacy|2|||
13243789|NCT01624233|26349506|FG000|Period 6: Follow-up|Physician Decision|1|||
13243790|NCT01624233|26349506|FG000|Period 6: Follow-up|Withdrawal by Subject|3|||
13243791|NCT01624194|26349551|FG000|Overall Study|Lost to Follow-up|1|||
13243792|NCT01624194|26349552|FG001|Overall Study|Lost to Follow-up|0|||
13243793|NCT01624194|26349551|FG000|Overall Study|Withdrawal by Subject|1|||
13243794|NCT01624194|26349552|FG001|Overall Study|Withdrawal by Subject|0|||
13243795|NCT01624090|26349579|FG000|Overall Study|DLT, taken off therapy|0|||
13243796|NCT01624090|26349580|FG001|Overall Study|DLT, taken off therapy|1|||
13243797|NCT01624090|26349581|FG002|Overall Study|DLT, taken off therapy|0|||
13243798|NCT01624090|26349582|FG003|Overall Study|DLT, taken off therapy|0|||
13243799|NCT01624090|26349579|FG000|Overall Study|Withdrew prior to treatment|0|||
13243800|NCT01624090|26349580|FG001|Overall Study|Withdrew prior to treatment|1|||
13243801|NCT01624090|26349581|FG002|Overall Study|Withdrew prior to treatment|0|||
13243802|NCT01624090|26349582|FG003|Overall Study|Withdrew prior to treatment|0|||
13243803|NCT01624090|26349579|FG000|Overall Study|Died on study|0|||
13243804|NCT01624090|26349580|FG001|Overall Study|Died on study|0|||
13243805|NCT01624090|26349581|FG002|Overall Study|Died on study|2|||
13243806|NCT01624090|26349582|FG003|Overall Study|Died on study|0|||
13243807|NCT01624090|26349579|FG000|Overall Study|Did not complete 1 crse of therapy|0|||
13243808|NCT01624090|26349580|FG001|Overall Study|Did not complete 1 crse of therapy|0|||
13243809|NCT01624090|26349581|FG002|Overall Study|Did not complete 1 crse of therapy|2|||
13243810|NCT01624090|26349582|FG003|Overall Study|Did not complete 1 crse of therapy|0|||
13243811|NCT01624090|26349579|FG000|Overall Study|Dose escalated|0|||
13243812|NCT01624090|26349580|FG001|Overall Study|Dose escalated|0|||
13243813|NCT01624090|26349581|FG002|Overall Study|Dose escalated|3|||
13243814|NCT01624090|26349582|FG003|Overall Study|Dose escalated|0|||
13243815|NCT01623830|26349603|FG000|Overall Study|Withdrawal by Subject|6|||
13243816|NCT01623830|26349604|FG001|Overall Study|Withdrawal by Subject|7|||
13243817|NCT01623830|26349603|FG000|Overall Study|Exclusion from Study|1|||
13243818|NCT01623830|26349604|FG001|Overall Study|Exclusion from Study|2|||
13243819|NCT01623752|26349697|FG000|Phase 1 (78 Weeks)|No Data|249|||
13243820|NCT01623752|26349698|FG001|Phase 1 (78 Weeks)|No Data|66|||
13243821|NCT01623752|26349699|FG002|Phase 1 (78 Weeks)|No Data|2|||
13243822|NCT01623752|26349697|FG000|Phase 1 (78 Weeks)|Other|33|||
13243823|NCT01623752|26349698|FG001|Phase 1 (78 Weeks)|Other|20|||
13243824|NCT01623752|26349699|FG002|Phase 1 (78 Weeks)|Other|0|||
13243825|NCT01623752|26349697|FG000|Phase 1 (78 Weeks)|Adverse Event|122|||
13243826|NCT01623752|26349698|FG001|Phase 1 (78 Weeks)|Adverse Event|39|||
13243827|NCT01623752|26349699|FG002|Phase 1 (78 Weeks)|Adverse Event|0|||
13243828|NCT01623752|26349697|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227|||
13243829|NCT01623752|26349698|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82|||
13243830|NCT01623752|26349699|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0|||
13243831|NCT01623752|26349697|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14|||
13243832|NCT01623752|26349698|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2|||
13243833|NCT01623752|26349699|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0|||
13243834|NCT01623752|26349697|FG000|Phase 2 (78 Weeks)|Other|5|||
13243835|NCT01623752|26349698|FG001|Phase 2 (78 Weeks)|Other|1|||
13243836|NCT01623752|26349699|FG002|Phase 2 (78 Weeks)|Other|0|||
13243837|NCT01623752|26349697|FG000|Phase 2 (78 Weeks)|No Data|43|||
13243838|NCT01623752|26349698|FG001|Phase 2 (78 Weeks)|No Data|11|||
13243839|NCT01623752|26349699|FG002|Phase 2 (78 Weeks)|No Data|0|||
13243840|NCT01623752|26349697|FG000|Phase 2 (78 Weeks)|Adverse Event|4|||
13243841|NCT01623752|26349698|FG001|Phase 2 (78 Weeks)|Adverse Event|4|||
13243842|NCT01623752|26349699|FG002|Phase 2 (78 Weeks)|Adverse Event|0|||
13243843|NCT01623596|26349722|FG000|Overall Study|Abnormal laboratory values|2|||
13243844|NCT01623596|26349723|FG001|Overall Study|Abnormal laboratory values|0|||
13243845|NCT01623596|26349722|FG000|Overall Study|Administrative problems|9|||
13243846|NCT01623596|26349723|FG001|Overall Study|Administrative problems|13|||
13243847|NCT01623596|26349722|FG000|Overall Study|Adverse Event|20|||
13243848|NCT01623596|26349723|FG001|Overall Study|Adverse Event|29|||
13243849|NCT01623596|26349722|FG000|Overall Study|Death|0|||
13243850|NCT01623596|26349723|FG001|Overall Study|Death|2|||
13243851|NCT01623596|26349722|FG000|Overall Study|Lost to Follow-up|12|||
13243852|NCT01623596|26349723|FG001|Overall Study|Lost to Follow-up|16|||
13243853|NCT01623596|26349722|FG000|Overall Study|Withdrawal by Subject|13|||
13243854|NCT01623596|26349723|FG001|Overall Study|Withdrawal by Subject|31|||
13243855|NCT01623596|26349722|FG000|Overall Study|Patient no longer requires study drug|1|||
13243856|NCT01623596|26349723|FG001|Overall Study|Patient no longer requires study drug|0|||
13243857|NCT01623596|26349722|FG000|Overall Study|Protocol Violation|0|||
13243858|NCT01623596|26349723|FG001|Overall Study|Protocol Violation|6|||
13243859|NCT01623596|26349722|FG000|Overall Study|Lack of Efficacy|5|||
13243860|NCT01623596|26349723|FG001|Overall Study|Lack of Efficacy|3|||
13243861|NCT01623531|26349770|FG000|Overall Study|Death|1|||
13243862|NCT01623531|26349771|FG001|Overall Study|Death|0|||
13243863|NCT01623531|26349770|FG000|Overall Study|Protocol Violation|2|||
13243864|NCT01623531|26349771|FG001|Overall Study|Protocol Violation|1|||
13243865|NCT01623531|26349770|FG000|Overall Study|Missing data at primary outcome time poi|1|||
13243866|NCT01623531|26349771|FG001|Overall Study|Missing data at primary outcome time poi|1|||
13243867|NCT01623310|26349782|FG000|Overall Study|Adverse Event|21|||
13243868|NCT01623310|26349782|FG000|Overall Study|Lost to Follow-up|18|||
13243869|NCT01623310|26349782|FG000|Overall Study|Lack of Efficacy|6|||
13243870|NCT01623310|26349782|FG000|Overall Study|Protocol Violation|6|||
13243871|NCT01623310|26349782|FG000|Overall Study|Withdrawal by Subject|25|||
13243872|NCT01623310|26349782|FG000|Overall Study|Became potentially child-bearing|1|||
13243873|NCT01623310|26349782|FG000|Overall Study|Diagnoses of bilateral cateracts|1|||
13243874|NCT01623310|26349782|FG000|Overall Study|Investigators Discretion-Noncompliant|1|||
13243875|NCT01623271|26349788|FG000|Overall Study|Withdrawal by Subject|2|||
13243876|NCT01623154|26349796|FG000|Overall Study|Did not drink Pranactin Citric|4|||
13243877|NCT01623115|26349863|FG000|Overall Study|Randomized but not treated|0|||
13243878|NCT01623115|26349864|FG001|Overall Study|Randomized but not treated|1|||
13243879|NCT01623115|26349863|FG000|Overall Study|Physician Decision|1|||
13243880|NCT01623115|26349864|FG001|Overall Study|Physician Decision|0|||
13243881|NCT01623115|26349863|FG000|Overall Study|Participants moved|1|||
13243882|NCT01623115|26349864|FG001|Overall Study|Participants moved|5|||
13243883|NCT01623115|26349863|FG000|Overall Study|Adverse Event|10|||
13243884|NCT01623115|26349864|FG001|Overall Study|Adverse Event|13|||
13243885|NCT01623115|26349863|FG000|Overall Study|Poor compliance to protocol|4|||
13243886|NCT01623115|26349864|FG001|Overall Study|Poor compliance to protocol|10|||
13243887|NCT01623115|26349863|FG000|Overall Study|Consent withdrawn by participant|2|||
13243888|NCT01623115|26349864|FG001|Overall Study|Consent withdrawn by participant|6|||
13243889|NCT01623115|26349863|FG000|Overall Study|Related to study drug administration|0|||
13243890|NCT01623115|26349864|FG001|Overall Study|Related to study drug administration|2|||
13243891|NCT01623115|26349863|FG000|Overall Study|Last visit outside protocol visit window|14|||
13243892|NCT01623115|26349864|FG001|Overall Study|Last visit outside protocol visit window|26|||
13243893|NCT01623115|26349863|FG000|Overall Study|Site closure|1|||
13243894|NCT01623115|26349864|FG001|Overall Study|Site closure|7|||
13243895|NCT01623115|26349863|FG000|Overall Study|Death|0|||
13243896|NCT01623115|26349864|FG001|Overall Study|Death|4|||
13115965|NCT03086057|25920427|FG001|Stage 1: PrEP Uptake|Death|0|||
13115966|NCT03086057|25920428|FG002|Stage 1: PrEP Uptake|Death|0|||
13115967|NCT03086057|25920429|FG003|Stage 1: PrEP Uptake|Death|0|||
13115968|NCT03086057|25920426|FG000|Stage 2: PrEP Adherence|Incarcerated|0|||
13115969|NCT03086057|25920427|FG001|Stage 2: PrEP Adherence|Incarcerated|0|||
13115970|NCT03086057|25920428|FG002|Stage 2: PrEP Adherence|Incarcerated|2|||
13243897|NCT01623115|26349863|FG000|Overall Study|Other than specified above|0|||
13243898|NCT01623115|26349864|FG001|Overall Study|Other than specified above|3|||
13243899|NCT01623050|26349874|FG000|Overall Study|Lost to Follow-up|9|||
13243900|NCT01622868|26349907|FG000|Overall Study|Protocol Violation|7|||
13243901|NCT01622868|26349908|FG001|Overall Study|Protocol Violation|0|||
13243902|NCT01622673|26349962|FG000|Treatment Period 1|Withdrawal by Subject|0|||
13243903|NCT01622673|26349963|FG001|Treatment Period 1|Withdrawal by Subject|0|||
13243904|NCT01622673|26349964|FG002|Treatment Period 1|Withdrawal by Subject|0|||
13243905|NCT01622673|26349965|FG003|Treatment Period 1|Withdrawal by Subject|1|||
13243906|NCT01622673|26349966|FG004|Treatment Period 1|Withdrawal by Subject|0|||
13243907|NCT01622673|26349967|FG005|Treatment Period 1|Withdrawal by Subject|0|||
13243908|NCT01622673|26349962|FG000|Treatment Period 1|Protocol Violation|0|||
13243909|NCT01622673|26349963|FG001|Treatment Period 1|Protocol Violation|1|||
13243910|NCT01622673|26349964|FG002|Treatment Period 1|Protocol Violation|0|||
13243911|NCT01622673|26349965|FG003|Treatment Period 1|Protocol Violation|0|||
13243912|NCT01622673|26349966|FG004|Treatment Period 1|Protocol Violation|0|||
13243913|NCT01622673|26349967|FG005|Treatment Period 1|Protocol Violation|0|||
13243914|NCT01622673|26349962|FG000|Treatment Period 2|Withdrawal by Subject|0|||
13243915|NCT01622673|26349963|FG001|Treatment Period 2|Withdrawal by Subject|0|||
13243916|NCT01622673|26349964|FG002|Treatment Period 2|Withdrawal by Subject|0|||
13243917|NCT01622673|26349965|FG003|Treatment Period 2|Withdrawal by Subject|1|||
13243918|NCT01622673|26349966|FG004|Treatment Period 2|Withdrawal by Subject|0|||
13243919|NCT01622673|26349967|FG005|Treatment Period 2|Withdrawal by Subject|0|||
13243920|NCT01622673|26349962|FG000|Treatment Period 3|Protocol Violation|0|||
13243921|NCT01622673|26349963|FG001|Treatment Period 3|Protocol Violation|1|||
13243922|NCT01622673|26349964|FG002|Treatment Period 3|Protocol Violation|0|||
13243923|NCT01622673|26349965|FG003|Treatment Period 3|Protocol Violation|0|||
13243924|NCT01622673|26349966|FG004|Treatment Period 3|Protocol Violation|0|||
13243925|NCT01622673|26349967|FG005|Treatment Period 3|Protocol Violation|0|||
13243926|NCT01622660|26349973|FG000|Overall Study|Adverse Event|1|||
13243927|NCT01622569|26350053|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4|||
13243928|NCT01622569|26350054|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
13243929|NCT01622569|26350055|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3|||
13243930|NCT01622569|26350056|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
13243931|NCT01622569|26350053|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
13243932|NCT01622569|26350054|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
13243933|NCT01622569|26350055|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1|||
13243934|NCT01622569|26350056|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
13243935|NCT01622569|26350053|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6|||
13243936|NCT01622569|26350054|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
13243937|NCT01622569|26350055|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3|||
13243938|NCT01622569|26350056|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2|||
13243939|NCT01622569|26350053|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
13243940|NCT01622569|26350054|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2|||
13243941|NCT01622569|26350055|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
13243942|NCT01622569|26350056|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
13243943|NCT01622569|26350053|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
13243944|NCT01622569|26350054|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
13243945|NCT01622569|26350055|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
13243946|NCT01622569|26350056|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
13243947|NCT01622569|26350053|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
13243948|NCT01622569|26350054|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2|||
13243949|NCT01622569|26350055|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
13243950|NCT01622569|26350056|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
13243951|NCT01622569|26350053|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
13243952|NCT01622569|26350054|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
13243953|NCT01622569|26350055|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2|||
13243954|NCT01622569|26350056|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
13243955|NCT01622569|26350053|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
13243956|NCT01622569|26350054|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
13243957|NCT01622569|26350055|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
13243958|NCT01622569|26350056|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
13243959|NCT01622348|26350074|FG000|Overall Study|Withdrawal by Subject|1|||
13243960|NCT01622348|26350075|FG001|Overall Study|Withdrawal by Subject|0|||
13243961|NCT01622348|26350076|FG002|Overall Study|Withdrawal by Subject|1|||
13243962|NCT01622231|26350106|FG000|Overall Study|Physician Decision|1|||
13243963|NCT01622231|26350106|FG000|Overall Study|Withdrawal by Subject|1|||
13243964|NCT01622088|26350122|FG000|Overall Study|Adverse Event|20|||
13243965|NCT01622088|26350122|FG000|Overall Study|Lost to Follow-up|1|||
13243966|NCT01622088|26350122|FG000|Overall Study|Withdrawal by Subject|20|||
13243967|NCT01622088|26350122|FG000|Overall Study|Investigator Decision|1|||
13243968|NCT01622088|26350122|FG000|Overall Study|Death|53|||
13243969|NCT01622088|26350122|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521|||
13243970|NCT01621880|26350137|FG000|Overall Study|Adverse Event|5|||
13243971|NCT01621880|26350138|FG001|Overall Study|Adverse Event|1|||
13243972|NCT01621880|26350137|FG000|Overall Study|Withdrawal by Subject|5|||
13243973|NCT01621880|26350138|FG001|Overall Study|Withdrawal by Subject|4|||
13243974|NCT01621802|26350261|FG000|Overall Study|Protocol Violation|0|||
13243975|NCT01621802|26350262|FG001|Overall Study|Protocol Violation|0|||
13243976|NCT01621802|26350263|FG002|Overall Study|Protocol Violation|0|||
13243977|NCT01621802|26350264|FG003|Overall Study|Protocol Violation|0|||
13243978|NCT01621802|26350265|FG004|Overall Study|Protocol Violation|0|||
13243979|NCT01621802|26350266|FG005|Overall Study|Protocol Violation|1|||
13243980|NCT01621802|26350261|FG000|Overall Study|Withdrawal by Subject|8|||
13243981|NCT01621802|26350262|FG001|Overall Study|Withdrawal by Subject|4|||
13243982|NCT01621802|26350263|FG002|Overall Study|Withdrawal by Subject|4|||
13243983|NCT01621802|26350264|FG003|Overall Study|Withdrawal by Subject|2|||
13243984|NCT01621802|26350265|FG004|Overall Study|Withdrawal by Subject|2|||
13243985|NCT01621802|26350266|FG005|Overall Study|Withdrawal by Subject|0|||
13243986|NCT01621802|26350261|FG000|Overall Study|Migrated/moved from study area|0|||
13243987|NCT01621802|26350262|FG001|Overall Study|Migrated/moved from study area|0|||
13243988|NCT01621802|26350263|FG002|Overall Study|Migrated/moved from study area|2|||
13243989|NCT01621802|26350264|FG003|Overall Study|Migrated/moved from study area|0|||
13243990|NCT01621802|26350265|FG004|Overall Study|Migrated/moved from study area|1|||
13243991|NCT01621802|26350266|FG005|Overall Study|Migrated/moved from study area|0|||
13243992|NCT01621802|26350261|FG000|Overall Study|Others|3|||
13243993|NCT01621802|26350262|FG001|Overall Study|Others|3|||
13243994|NCT01621802|26350263|FG002|Overall Study|Others|3|||
13243995|NCT01621802|26350264|FG003|Overall Study|Others|2|||
13243996|NCT01621802|26350265|FG004|Overall Study|Others|1|||
13243997|NCT01621802|26350266|FG005|Overall Study|Others|0|||
13243998|NCT01621802|26350261|FG000|Overall Study|Lost to Follow-up|36|||
13243999|NCT01621802|26350262|FG001|Overall Study|Lost to Follow-up|16|||
13244000|NCT01621802|26350263|FG002|Overall Study|Lost to Follow-up|24|||
13244001|NCT01621802|26350264|FG003|Overall Study|Lost to Follow-up|7|||
13244002|NCT01621802|26350265|FG004|Overall Study|Lost to Follow-up|31|||
13244003|NCT01621802|26350266|FG005|Overall Study|Lost to Follow-up|11|||
13244004|NCT01621568|26350290|FG000|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|1|||
13244005|NCT01621568|26350291|FG001|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|0|||
13244006|NCT01621568|26350290|FG000|Week 5-6 No Treatment|Death|1|||
13244007|NCT01621568|26350291|FG001|Week 5-6 No Treatment|Death|0|||
13244008|NCT01621542|26350342|FG000|Overall Study|Adverse Event|0|||
13244009|NCT01621542|26350343|FG001|Overall Study|Adverse Event|0|||
13244010|NCT01621542|26350344|FG002|Overall Study|Adverse Event|1|||
13244011|NCT01621542|26350345|FG003|Overall Study|Adverse Event|3|||
13244012|NCT01621542|26350346|FG004|Overall Study|Adverse Event|0|||
13244013|NCT01621542|26350347|FG005|Overall Study|Adverse Event|0|||
13244014|NCT01621542|26350342|FG000|Overall Study|Death|0|||
13244015|NCT01621542|26350343|FG001|Overall Study|Death|1|||
13244016|NCT01621542|26350344|FG002|Overall Study|Death|0|||
13244017|NCT01621542|26350345|FG003|Overall Study|Death|0|||
13244018|NCT01621542|26350346|FG004|Overall Study|Death|0|||
13244019|NCT01621542|26350347|FG005|Overall Study|Death|0|||
13244020|NCT01621542|26350342|FG000|Overall Study|Physician Decision|1|||
13244021|NCT01621542|26350343|FG001|Overall Study|Physician Decision|0|||
13244022|NCT01621542|26350344|FG002|Overall Study|Physician Decision|1|||
13244023|NCT01621542|26350345|FG003|Overall Study|Physician Decision|13|||
13244024|NCT01621542|26350346|FG004|Overall Study|Physician Decision|3|||
13244025|NCT01621542|26350347|FG005|Overall Study|Physician Decision|1|||
13244026|NCT01621542|26350342|FG000|Overall Study|Withdrawal by Subject|2|||
13244027|NCT01621542|26350343|FG001|Overall Study|Withdrawal by Subject|0|||
13244028|NCT01621542|26350344|FG002|Overall Study|Withdrawal by Subject|1|||
13244029|NCT01621542|26350345|FG003|Overall Study|Withdrawal by Subject|3|||
13244030|NCT01621542|26350346|FG004|Overall Study|Withdrawal by Subject|3|||
13244031|NCT01621542|26350347|FG005|Overall Study|Withdrawal by Subject|3|||
13244032|NCT01621542|26350342|FG000|Overall Study|progression/treatment failure|2|||
13244033|NCT01621542|26350343|FG001|Overall Study|progression/treatment failure|4|||
13244034|NCT01621542|26350344|FG002|Overall Study|progression/treatment failure|3|||
13244035|NCT01621542|26350345|FG003|Overall Study|progression/treatment failure|7|||
13244036|NCT01621542|26350346|FG004|Overall Study|progression/treatment failure|3|||
13244037|NCT01621542|26350347|FG005|Overall Study|progression/treatment failure|5|||
13244038|NCT01621542|26350342|FG000|Overall Study|Protocol Violation|0|||
13244039|NCT01621542|26350343|FG001|Overall Study|Protocol Violation|0|||
13244040|NCT01621542|26350344|FG002|Overall Study|Protocol Violation|0|||
13244041|NCT01621542|26350345|FG003|Overall Study|Protocol Violation|1|||
13244042|NCT01621542|26350346|FG004|Overall Study|Protocol Violation|0|||
13244043|NCT01621542|26350347|FG005|Overall Study|Protocol Violation|0|||
13244044|NCT01621542|26350342|FG000|Overall Study|study stopped by sponsor|0|||
13244045|NCT01621542|26350343|FG001|Overall Study|study stopped by sponsor|0|||
13244046|NCT01621542|26350344|FG002|Overall Study|study stopped by sponsor|0|||
13244047|NCT01621542|26350345|FG003|Overall Study|study stopped by sponsor|1|||
13244048|NCT01621542|26350346|FG004|Overall Study|study stopped by sponsor|0|||
13244049|NCT01621542|26350347|FG005|Overall Study|study stopped by sponsor|0|||
13244050|NCT01621490|26350601|FG000|Overall Study|Participant completed treatment|4|||
13244051|NCT01621490|26350602|FG001|Overall Study|Participant completed treatment|4|||
13244052|NCT01621490|26350603|FG002|Overall Study|Participant completed treatment|1|||
13244053|NCT01621490|26350604|FG003|Overall Study|Participant completed treatment|0|||
13244054|NCT01621490|26350605|FG004|Overall Study|Participant completed treatment|0|||
13244055|NCT01621490|26350606|FG005|Overall Study|Participant completed treatment|0|||
13244056|NCT01621490|26350607|FG006|Overall Study|Participant completed treatment|0|||
13244057|NCT01621490|26350608|FG007|Overall Study|Participant completed treatment|1|||
13244058|NCT01621490|26350609|FG008|Overall Study|Participant completed treatment|0|||
13244059|NCT01621490|26350601|FG000|Overall Study|Patient could not travel|1|||
13244060|NCT01621490|26350602|FG001|Overall Study|Patient could not travel|0|||
13244061|NCT01621490|26350603|FG002|Overall Study|Patient could not travel|0|||
13244062|NCT01621490|26350604|FG003|Overall Study|Patient could not travel|0|||
13244063|NCT01621490|26350605|FG004|Overall Study|Patient could not travel|0|||
13244064|NCT01621490|26350606|FG005|Overall Study|Patient could not travel|0|||
13244065|NCT01621490|26350607|FG006|Overall Study|Patient could not travel|0|||
13244066|NCT01621490|26350608|FG007|Overall Study|Patient could not travel|0|||
13244067|NCT01621490|26350609|FG008|Overall Study|Patient could not travel|0|||
13244068|NCT01621490|26350601|FG000|Overall Study|Subject no longer meets study criteria|0|||
13244069|NCT01621490|26350602|FG001|Overall Study|Subject no longer meets study criteria|0|||
13244070|NCT01621490|26350603|FG002|Overall Study|Subject no longer meets study criteria|0|||
13244071|NCT01621490|26350604|FG003|Overall Study|Subject no longer meets study criteria|0|||
13244072|NCT01621490|26350605|FG004|Overall Study|Subject no longer meets study criteria|1|||
13244073|NCT01621490|26350606|FG005|Overall Study|Subject no longer meets study criteria|0|||
13244074|NCT01621490|26350607|FG006|Overall Study|Subject no longer meets study criteria|0|||
13244075|NCT01621490|26350608|FG007|Overall Study|Subject no longer meets study criteria|0|||
13244076|NCT01621490|26350609|FG008|Overall Study|Subject no longer meets study criteria|0|||
13244077|NCT01621490|26350601|FG000|Overall Study|Maximum clinical benefit|3|||
13244078|NCT01621490|26350602|FG001|Overall Study|Maximum clinical benefit|2|||
13244079|NCT01621490|26350603|FG002|Overall Study|Maximum clinical benefit|0|||
13244080|NCT01621490|26350604|FG003|Overall Study|Maximum clinical benefit|0|||
13244081|NCT01621490|26350605|FG004|Overall Study|Maximum clinical benefit|0|||
13244082|NCT01621490|26350606|FG005|Overall Study|Maximum clinical benefit|0|||
13244083|NCT01621490|26350607|FG006|Overall Study|Maximum clinical benefit|1|||
13244084|NCT01621490|26350608|FG007|Overall Study|Maximum clinical benefit|2|||
13244085|NCT01621490|26350609|FG008|Overall Study|Maximum clinical benefit|0|||
13244086|NCT01621490|26350601|FG000|Overall Study|Withdrawal by Subject|1|||
13244087|NCT01621490|26350602|FG001|Overall Study|Withdrawal by Subject|0|||
13244088|NCT01621490|26350603|FG002|Overall Study|Withdrawal by Subject|0|||
13244089|NCT01621490|26350604|FG003|Overall Study|Withdrawal by Subject|0|||
13244090|NCT01621490|26350605|FG004|Overall Study|Withdrawal by Subject|0|||
13244091|NCT01621490|26350606|FG005|Overall Study|Withdrawal by Subject|3|||
13244092|NCT01621490|26350607|FG006|Overall Study|Withdrawal by Subject|0|||
13244093|NCT01621490|26350608|FG007|Overall Study|Withdrawal by Subject|0|||
13244094|NCT01621490|26350609|FG008|Overall Study|Withdrawal by Subject|0|||
13244095|NCT01621490|26350601|FG000|Overall Study|Subject request to discontinue study|1|||
13244096|NCT01621490|26350602|FG001|Overall Study|Subject request to discontinue study|3|||
13244097|NCT01621490|26350603|FG002|Overall Study|Subject request to discontinue study|1|||
13244098|NCT01621490|26350604|FG003|Overall Study|Subject request to discontinue study|1|||
13244099|NCT01621490|26350605|FG004|Overall Study|Subject request to discontinue study|0|||
13244100|NCT01621490|26350606|FG005|Overall Study|Subject request to discontinue study|2|||
13244101|NCT01621490|26350607|FG006|Overall Study|Subject request to discontinue study|1|||
13244102|NCT01621490|26350608|FG007|Overall Study|Subject request to discontinue study|0|||
13244103|NCT01621490|26350609|FG008|Overall Study|Subject request to discontinue study|1|||
13244104|NCT01621490|26350601|FG000|Overall Study|Adverse event unrelated to study drug|2|||
13244105|NCT01621490|26350602|FG001|Overall Study|Adverse event unrelated to study drug|1|||
13244106|NCT01621490|26350603|FG002|Overall Study|Adverse event unrelated to study drug|0|||
13244107|NCT01621490|26350604|FG003|Overall Study|Adverse event unrelated to study drug|0|||
13244108|NCT01621490|26350605|FG004|Overall Study|Adverse event unrelated to study drug|0|||
13244109|NCT01621490|26350606|FG005|Overall Study|Adverse event unrelated to study drug|0|||
13244110|NCT01621490|26350607|FG006|Overall Study|Adverse event unrelated to study drug|0|||
13244111|NCT01621490|26350608|FG007|Overall Study|Adverse event unrelated to study drug|2|||
13244112|NCT01621490|26350609|FG008|Overall Study|Adverse event unrelated to study drug|1|||
13244113|NCT01621490|26350601|FG000|Overall Study|Disease progression|27|||
13244114|NCT01621490|26350602|FG001|Overall Study|Disease progression|28|||
13244115|NCT01621490|26350603|FG002|Overall Study|Disease progression|1|||
13244116|NCT01621490|26350604|FG003|Overall Study|Disease progression|5|||
13244117|NCT01621490|26350605|FG004|Overall Study|Disease progression|3|||
13244118|NCT01621490|26350606|FG005|Overall Study|Disease progression|8|||
13244119|NCT01621490|26350607|FG006|Overall Study|Disease progression|7|||
13244120|NCT01621490|26350608|FG007|Overall Study|Disease progression|0|||
13244121|NCT01621490|26350609|FG008|Overall Study|Disease progression|4|||
13244122|NCT01621490|26350601|FG000|Overall Study|Study drug toxicity|1|||
13244123|NCT01621490|26350602|FG001|Overall Study|Study drug toxicity|4|||
13244124|NCT01621490|26350603|FG002|Overall Study|Study drug toxicity|5|||
13244125|NCT01621490|26350604|FG003|Overall Study|Study drug toxicity|3|||
13244126|NCT01621490|26350605|FG004|Overall Study|Study drug toxicity|1|||
13244127|NCT01621490|26350606|FG005|Overall Study|Study drug toxicity|10|||
13244128|NCT01621490|26350607|FG006|Overall Study|Study drug toxicity|1|||
13244129|NCT01621490|26350608|FG007|Overall Study|Study drug toxicity|4|||
13244130|NCT01621490|26350609|FG008|Overall Study|Study drug toxicity|1|||
13244131|NCT01621490|26350601|FG000|Overall Study|Death|0|||
13244132|NCT01621490|26350602|FG001|Overall Study|Death|0|||
13244133|NCT01621490|26350603|FG002|Overall Study|Death|0|||
13244134|NCT01621490|26350604|FG003|Overall Study|Death|0|||
13244135|NCT01621490|26350605|FG004|Overall Study|Death|0|||
13244136|NCT01621490|26350606|FG005|Overall Study|Death|0|||
13244137|NCT01621490|26350607|FG006|Overall Study|Death|0|||
13244138|NCT01621490|26350608|FG007|Overall Study|Death|1|||
13244139|NCT01621490|26350609|FG008|Overall Study|Death|0|||
13244140|NCT01621490|26350601|FG000|Overall Study|Grade 4 Lipase elevation|1|||
13244141|NCT01621490|26350602|FG001|Overall Study|Grade 4 Lipase elevation|0|||
13244142|NCT01621490|26350603|FG002|Overall Study|Grade 4 Lipase elevation|0|||
13244143|NCT01621490|26350604|FG003|Overall Study|Grade 4 Lipase elevation|0|||
13244144|NCT01621490|26350605|FG004|Overall Study|Grade 4 Lipase elevation|0|||
13244145|NCT01621490|26350606|FG005|Overall Study|Grade 4 Lipase elevation|0|||
13244146|NCT01621490|26350607|FG006|Overall Study|Grade 4 Lipase elevation|0|||
13244147|NCT01621490|26350608|FG007|Overall Study|Grade 4 Lipase elevation|0|||
13244148|NCT01621490|26350609|FG008|Overall Study|Grade 4 Lipase elevation|0|||
13244149|NCT01621490|26350601|FG000|Overall Study|BMS informed of patient status|0|||
13244150|NCT01621490|26350602|FG001|Overall Study|BMS informed of patient status|0|||
13244151|NCT01621490|26350603|FG002|Overall Study|BMS informed of patient status|1|||
13244152|NCT01621490|26350604|FG003|Overall Study|BMS informed of patient status|0|||
13244153|NCT01621490|26350605|FG004|Overall Study|BMS informed of patient status|0|||
13244154|NCT01621490|26350606|FG005|Overall Study|BMS informed of patient status|0|||
13244155|NCT01621490|26350607|FG006|Overall Study|BMS informed of patient status|0|||
13244156|NCT01621490|26350608|FG007|Overall Study|BMS informed of patient status|0|||
13244157|NCT01621490|26350609|FG008|Overall Study|BMS informed of patient status|0|||
13244158|NCT01621490|26350601|FG000|Overall Study|Investigator decision|0|||
13244159|NCT01621490|26350602|FG001|Overall Study|Investigator decision|0|||
13244160|NCT01621490|26350603|FG002|Overall Study|Investigator decision|1|||
13244161|NCT01621490|26350604|FG003|Overall Study|Investigator decision|0|||
13244162|NCT01621490|26350605|FG004|Overall Study|Investigator decision|1|||
13244163|NCT01621490|26350606|FG005|Overall Study|Investigator decision|0|||
13244164|NCT01621490|26350607|FG006|Overall Study|Investigator decision|1|||
13244165|NCT01621490|26350608|FG007|Overall Study|Investigator decision|0|||
13244166|NCT01621490|26350609|FG008|Overall Study|Investigator decision|0|||
13244167|NCT01621490|26350601|FG000|Overall Study|Documented disease progression|0|||
13244168|NCT01621490|26350602|FG001|Overall Study|Documented disease progression|0|||
13244169|NCT01621490|26350603|FG002|Overall Study|Documented disease progression|1|||
13244170|NCT01621490|26350604|FG003|Overall Study|Documented disease progression|0|||
13244171|NCT01621490|26350605|FG004|Overall Study|Documented disease progression|0|||
13244172|NCT01621490|26350606|FG005|Overall Study|Documented disease progression|0|||
13244173|NCT01621490|26350607|FG006|Overall Study|Documented disease progression|0|||
13244174|NCT01621490|26350608|FG007|Overall Study|Documented disease progression|0|||
13244175|NCT01621490|26350609|FG008|Overall Study|Documented disease progression|0|||
13244176|NCT01621490|26350601|FG000|Overall Study|Patient reached treatment 2 yr limit|0|||
13244177|NCT01621490|26350602|FG001|Overall Study|Patient reached treatment 2 yr limit|1|||
13244178|NCT01621490|26350603|FG002|Overall Study|Patient reached treatment 2 yr limit|0|||
13244179|NCT01621490|26350604|FG003|Overall Study|Patient reached treatment 2 yr limit|0|||
13244180|NCT01621490|26350605|FG004|Overall Study|Patient reached treatment 2 yr limit|0|||
13244181|NCT01621490|26350606|FG005|Overall Study|Patient reached treatment 2 yr limit|0|||
13244182|NCT01621490|26350607|FG006|Overall Study|Patient reached treatment 2 yr limit|0|||
13244183|NCT01621490|26350608|FG007|Overall Study|Patient reached treatment 2 yr limit|0|||
13244184|NCT01621490|26350609|FG008|Overall Study|Patient reached treatment 2 yr limit|0|||
13244185|NCT01621490|26350601|FG000|Overall Study|Clinical deterioration|0|||
13244186|NCT01621490|26350602|FG001|Overall Study|Clinical deterioration|1|||
13244187|NCT01621490|26350603|FG002|Overall Study|Clinical deterioration|0|||
13244188|NCT01621490|26350604|FG003|Overall Study|Clinical deterioration|0|||
13244189|NCT01621490|26350605|FG004|Overall Study|Clinical deterioration|0|||
13244190|NCT01621490|26350606|FG005|Overall Study|Clinical deterioration|0|||
13244191|NCT01621490|26350607|FG006|Overall Study|Clinical deterioration|0|||
13244192|NCT01621490|26350608|FG007|Overall Study|Clinical deterioration|0|||
13244193|NCT01621490|26350609|FG008|Overall Study|Clinical deterioration|0|||
13244194|NCT01621490|26350601|FG000|Overall Study|Complete response|0|||
13244195|NCT01621490|26350602|FG001|Overall Study|Complete response|0|||
13244196|NCT01621490|26350603|FG002|Overall Study|Complete response|0|||
13244197|NCT01621490|26350604|FG003|Overall Study|Complete response|0|||
13244198|NCT01621490|26350605|FG004|Overall Study|Complete response|0|||
13244199|NCT01621490|26350606|FG005|Overall Study|Complete response|0|||
13244200|NCT01621490|26350607|FG006|Overall Study|Complete response|0|||
13244201|NCT01621490|26350608|FG007|Overall Study|Complete response|0|||
13244202|NCT01621490|26350609|FG008|Overall Study|Complete response|1|||
13244203|NCT01621490|26350601|FG000|Overall Study|Patient delayed due to toxicity|0|||
13244204|NCT01621490|26350602|FG001|Overall Study|Patient delayed due to toxicity|0|||
13244205|NCT01621490|26350603|FG002|Overall Study|Patient delayed due to toxicity|0|||
13244206|NCT01621490|26350604|FG003|Overall Study|Patient delayed due to toxicity|0|||
13244207|NCT01621490|26350605|FG004|Overall Study|Patient delayed due to toxicity|0|||
13244208|NCT01621490|26350606|FG005|Overall Study|Patient delayed due to toxicity|1|||
13244209|NCT01621490|26350607|FG006|Overall Study|Patient delayed due to toxicity|0|||
13244210|NCT01621490|26350608|FG007|Overall Study|Patient delayed due to toxicity|0|||
13244211|NCT01621490|26350609|FG008|Overall Study|Patient delayed due to toxicity|0|||
13244212|NCT01621191|26350622|FG000|Overall Study|Adverse Event|9|||
13244213|NCT01621191|26350622|FG000|Overall Study|Withdrawal by Subject|8|||
13244214|NCT01621191|26350622|FG000|Overall Study|Lack of Efficacy|6|||
13244215|NCT01621191|26350622|FG000|Overall Study|Lost to Follow-up|1|||
13244216|NCT01621191|26350622|FG000|Overall Study|Site Removed From Study|1|||
13244217|NCT01621178|26350724|FG000|Overall Study|Adverse Event|5|||
13244218|NCT01621178|26350725|FG001|Overall Study|Adverse Event|2|||
13244219|NCT01621178|26350726|FG002|Overall Study|Adverse Event|8|||
13244220|NCT01621178|26350724|FG000|Overall Study|Death|6|||
13244221|NCT01621178|26350725|FG001|Overall Study|Death|7|||
13244222|NCT01621178|26350726|FG002|Overall Study|Death|2|||
13244223|NCT01621178|26350724|FG000|Overall Study|Lost to Follow-up|1|||
13244224|NCT01621178|26350725|FG001|Overall Study|Lost to Follow-up|2|||
13244225|NCT01621178|26350726|FG002|Overall Study|Lost to Follow-up|1|||
13244226|NCT01621178|26350724|FG000|Overall Study|Withdrawal by Subject|14|||
13244227|NCT01621178|26350725|FG001|Overall Study|Withdrawal by Subject|17|||
13115971|NCT03086057|25920429|FG003|Stage 2: PrEP Adherence|Incarcerated|0|||
13115972|NCT03086057|25920426|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
13115973|NCT03086057|25920427|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
13115974|NCT03086057|25920428|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1|||
13115975|NCT03086057|25920429|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
13115976|NCT03086057|25920426|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
13115977|NCT03086057|25920427|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
13115978|NCT03086057|25920428|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3|||
13115979|NCT03086057|25920429|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2|||
13115980|NCT03086018|25920439|FG000|Final Testing for End of Trial|Adverse Event|1|||
13115981|NCT03086018|25920439|FG000|Final Testing for End of Trial|Withdrawal by Subject|1|||
13115982|NCT03085927|25920472|FG000|Overall Study|Withdrawal by Subject|1|||
13115983|NCT03085927|25920473|FG001|Overall Study|Withdrawal by Subject|4|||
13115984|NCT03085927|25920472|FG000|Overall Study|Lost to Follow-up|3|||
13115985|NCT03085927|25920473|FG001|Overall Study|Lost to Follow-up|1|||
13115986|NCT03085927|25920472|FG000|Overall Study|Death|1|||
13115987|NCT03085927|25920473|FG001|Overall Study|Death|0|||
13244228|NCT01621178|26350726|FG002|Overall Study|Withdrawal by Subject|18|||
13244229|NCT01621178|26350724|FG000|Overall Study|Physician Decision|5|||
13244230|NCT01621178|26350725|FG001|Overall Study|Physician Decision|2|||
13244231|NCT01621178|26350726|FG002|Overall Study|Physician Decision|7|||
13244232|NCT01621126|26350732|FG000|Overall Study|Physician Decision|6|||
13244233|NCT01620983|26350768|FG000|Overall Study|Lost to Follow-up|8|||
13244234|NCT01620983|26350769|FG001|Overall Study|Lost to Follow-up|4|||
13244235|NCT01620983|26350770|FG002|Overall Study|Lost to Follow-up|9|||
13244236|NCT01620983|26350768|FG000|Overall Study|Withdrawal by Subject|6|||
13244237|NCT01620983|26350769|FG001|Overall Study|Withdrawal by Subject|8|||
13244238|NCT01620983|26350770|FG002|Overall Study|Withdrawal by Subject|1|||
13244239|NCT01620983|26350768|FG000|Overall Study|Death|2|||
13244240|NCT01620983|26350769|FG001|Overall Study|Death|0|||
13244241|NCT01620983|26350770|FG002|Overall Study|Death|0|||
13244242|NCT01620983|26350768|FG000|Overall Study|Physician Decision|3|||
13244243|NCT01620983|26350769|FG001|Overall Study|Physician Decision|10|||
13244244|NCT01620983|26350770|FG002|Overall Study|Physician Decision|5|||
13244245|NCT01620762|26350806|FG000|Overall Study|Protocol Violation|1|||
13244246|NCT01620762|26350807|FG001|Overall Study|Protocol Violation|1|||
13244247|NCT01620762|26350808|FG002|Overall Study|Protocol Violation|1|||
13244248|NCT01620762|26350806|FG000|Overall Study|Adverse Event|9|||
13244249|NCT01620762|26350807|FG001|Overall Study|Adverse Event|5|||
13244250|NCT01620762|26350808|FG002|Overall Study|Adverse Event|2|||
13115988|NCT03085927|25920472|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1|||
13244251|NCT01620762|26350806|FG000|Overall Study|Withdrawal by Subject|23|||
13244252|NCT01620762|26350807|FG001|Overall Study|Withdrawal by Subject|26|||
13244253|NCT01620762|26350808|FG002|Overall Study|Withdrawal by Subject|27|||
13244254|NCT01620762|26350806|FG000|Overall Study|Lost to Follow-up|11|||
13244255|NCT01620762|26350807|FG001|Overall Study|Lost to Follow-up|17|||
13244256|NCT01620762|26350808|FG002|Overall Study|Lost to Follow-up|10|||
13244257|NCT01620762|26350806|FG000|Overall Study|Protocol deviation|1|||
13244258|NCT01620762|26350807|FG001|Overall Study|Protocol deviation|1|||
13244259|NCT01620762|26350808|FG002|Overall Study|Protocol deviation|6|||
13244260|NCT01620762|26350806|FG000|Overall Study|Subject deterioration|0|||
13244261|NCT01620762|26350807|FG001|Overall Study|Subject deterioration|1|||
13244262|NCT01620762|26350808|FG002|Overall Study|Subject deterioration|1|||
13244263|NCT01620762|26350806|FG000|Overall Study|Non-specified|3|||
13244264|NCT01620762|26350807|FG001|Overall Study|Non-specified|6|||
13244265|NCT01620762|26350808|FG002|Overall Study|Non-specified|5|||
13244266|NCT01620762|26350806|FG000|Overall Study|Use of prohibted therapies|0|||
13244267|NCT01620762|26350807|FG001|Overall Study|Use of prohibted therapies|1|||
13244268|NCT01620762|26350808|FG002|Overall Study|Use of prohibted therapies|1|||
13244269|NCT01620528|26351156|FG000|Treatment Period|Did Not Receive Study Drug|0|||
13244270|NCT01620528|26351157|FG001|Treatment Period|Did Not Receive Study Drug|0|||
13244271|NCT01620528|26351158|FG002|Treatment Period|Did Not Receive Study Drug|1|||
13244272|NCT01620528|26351156|FG000|Treatment Period|Withdrawal by Subject|35|||
13244273|NCT01620528|26351157|FG001|Treatment Period|Withdrawal by Subject|21|||
13244274|NCT01620528|26351158|FG002|Treatment Period|Withdrawal by Subject|16|||
13244275|NCT01620528|26351156|FG000|Treatment Period|Adverse Event|17|||
13244276|NCT01620528|26351157|FG001|Treatment Period|Adverse Event|13|||
13244277|NCT01620528|26351158|FG002|Treatment Period|Adverse Event|21|||
13244278|NCT01620528|26351156|FG000|Treatment Period|Lost to Follow-up|16|||
13244279|NCT01620528|26351157|FG001|Treatment Period|Lost to Follow-up|8|||
13244280|NCT01620528|26351158|FG002|Treatment Period|Lost to Follow-up|14|||
13244281|NCT01620528|26351156|FG000|Treatment Period|Other|9|||
13244282|NCT01620528|26351157|FG001|Treatment Period|Other|5|||
13244283|NCT01620528|26351158|FG002|Treatment Period|Other|7|||
13244284|NCT01620528|26351156|FG000|Treatment Period|Subject Noncompliant|11|||
13244285|NCT01620528|26351157|FG001|Treatment Period|Subject Noncompliant|2|||
13244286|NCT01620528|26351158|FG002|Treatment Period|Subject Noncompliant|2|||
13244287|NCT01620528|26351156|FG000|Treatment Period|Pregnancy|7|||
13244288|NCT01620528|26351157|FG001|Treatment Period|Pregnancy|2|||
13244289|NCT01620528|26351158|FG002|Treatment Period|Pregnancy|2|||
13244290|NCT01620528|26351156|FG000|Treatment Period|Surgery/Invasive Intervention|5|||
13244291|NCT01620528|26351157|FG001|Treatment Period|Surgery/Invasive Intervention|1|||
13244292|NCT01620528|26351158|FG002|Treatment Period|Surgery/Invasive Intervention|3|||
13244293|NCT01620528|26351156|FG000|Treatment Period|Exclusionary Medication Received|0|||
13244294|NCT01620528|26351157|FG001|Treatment Period|Exclusionary Medication Received|1|||
13244295|NCT01620528|26351158|FG002|Treatment Period|Exclusionary Medication Received|0|||
13244296|NCT01620528|26351156|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
13244297|NCT01620528|26351157|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
13244298|NCT01620528|26351158|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
13244299|NCT01620528|26351156|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
13244300|NCT01620528|26351157|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
13244301|NCT01620528|26351158|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
13244302|NCT01620528|26351156|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0|||
13244303|NCT01620528|26351157|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
13244304|NCT01620528|26351158|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
13244305|NCT01620528|26351156|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8|||
13244306|NCT01620528|26351157|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3|||
13244307|NCT01620528|26351158|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4|||
13244308|NCT01620528|26351156|FG000|Post-Treatment Follow-Up Period|Other|6|||
13244309|NCT01620528|26351157|FG001|Post-Treatment Follow-Up Period|Other|4|||
13244310|NCT01620528|26351158|FG002|Post-Treatment Follow-Up Period|Other|2|||
13290049|NCT00104650|26480692|FG000|Treatment Period (25 Weeks)|Physician Decision|0|||
13290050|NCT00104650|26480693|FG001|Treatment Period (25 Weeks)|Physician Decision|0|||
13290051|NCT00104650|26480694|FG002|Treatment Period (25 Weeks)|Physician Decision|1|||
13290052|NCT00104650|26480692|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2|||
13290053|NCT00104650|26480693|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
13290054|NCT00104650|26480694|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
13290055|NCT00104650|26480692|FG000|Treatment Period (25 Weeks)|Death|7|||
13290056|NCT00104650|26480693|FG001|Treatment Period (25 Weeks)|Death|5|||
13290057|NCT00104650|26480694|FG002|Treatment Period (25 Weeks)|Death|6|||
13290058|NCT00104650|26480692|FG000|Treatment Period (25 Weeks)|Disease progression|2|||
13290059|NCT00104650|26480693|FG001|Treatment Period (25 Weeks)|Disease progression|3|||
13290060|NCT00104650|26480694|FG002|Treatment Period (25 Weeks)|Disease progression|2|||
13290061|NCT00104650|26480692|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0|||
13290062|NCT00104650|26480693|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1|||
13290063|NCT00104650|26480694|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0|||
13290064|NCT00104650|26480692|FG000|Treatment Period (25 Weeks)|Other|1|||
13290065|NCT00104650|26480693|FG001|Treatment Period (25 Weeks)|Other|0|||
13290066|NCT00104650|26480694|FG002|Treatment Period (25 Weeks)|Other|0|||
13290067|NCT00104650|26480692|FG000|Treatment Period (25 Weeks)|Protocol deviation|0|||
13290068|NCT00104650|26480693|FG001|Treatment Period (25 Weeks)|Protocol deviation|1|||
13290069|NCT00104650|26480694|FG002|Treatment Period (25 Weeks)|Protocol deviation|0|||
13290070|NCT00104650|26480692|FG000|Follow-up Period|Physician Decision|1|||
13290071|NCT00104650|26480693|FG001|Follow-up Period|Physician Decision|1|||
13290072|NCT00104650|26480694|FG002|Follow-up Period|Physician Decision|0|||
13244311|NCT01620489|26351181|FG000|Overall Study|Adverse Event|17|||
13244312|NCT01620489|26351182|FG001|Overall Study|Adverse Event|4|||
13244313|NCT01620489|26351181|FG000|Overall Study|Protocol Violation|0|||
13244314|NCT01620489|26351182|FG001|Overall Study|Protocol Violation|3|||
13244315|NCT01620489|26351181|FG000|Overall Study|Withdrawal Criteria|17|||
13244316|NCT01620489|26351182|FG001|Overall Study|Withdrawal Criteria|25|||
13244317|NCT01620489|26351181|FG000|Overall Study|Unclassified|1|||
13244318|NCT01620489|26351182|FG001|Overall Study|Unclassified|2|||
13244319|NCT01620255|26351275|FG000|Overall Study|Withdrawal by Subject|4|||
13244320|NCT01620255|26351276|FG001|Overall Study|Withdrawal by Subject|1|||
13244321|NCT01620255|26351277|FG002|Overall Study|Withdrawal by Subject|1|||
13244322|NCT01620255|26351278|FG003|Overall Study|Withdrawal by Subject|2|||
13244323|NCT01620255|26351279|FG004|Overall Study|Withdrawal by Subject|4|||
13244324|NCT01620255|26351275|FG000|Overall Study|Participant underwent fecal transplant|0|||
13244325|NCT01620255|26351276|FG001|Overall Study|Participant underwent fecal transplant|0|||
13244326|NCT01620255|26351277|FG002|Overall Study|Participant underwent fecal transplant|1|||
13244327|NCT01620255|26351278|FG003|Overall Study|Participant underwent fecal transplant|0|||
13244328|NCT01620255|26351279|FG004|Overall Study|Participant underwent fecal transplant|0|||
13244329|NCT01620255|26351275|FG000|Overall Study|Non-compliance|0|||
13244330|NCT01620255|26351276|FG001|Overall Study|Non-compliance|1|||
13244331|NCT01620255|26351277|FG002|Overall Study|Non-compliance|0|||
13244332|NCT01620255|26351278|FG003|Overall Study|Non-compliance|0|||
13244333|NCT01620255|26351279|FG004|Overall Study|Non-compliance|0|||
13244334|NCT01620255|26351275|FG000|Overall Study|Adverse Event|0|||
13244335|NCT01620255|26351276|FG001|Overall Study|Adverse Event|4|||
13244336|NCT01620255|26351277|FG002|Overall Study|Adverse Event|0|||
13244337|NCT01620255|26351278|FG003|Overall Study|Adverse Event|1|||
13244338|NCT01620255|26351279|FG004|Overall Study|Adverse Event|1|||
13244339|NCT01620255|26351275|FG000|Overall Study|Withdrawn at discretion of investigator|0|||
13244340|NCT01620255|26351276|FG001|Overall Study|Withdrawn at discretion of investigator|0|||
13244341|NCT01620255|26351277|FG002|Overall Study|Withdrawn at discretion of investigator|0|||
13244342|NCT01620255|26351278|FG003|Overall Study|Withdrawn at discretion of investigator|0|||
13244343|NCT01620255|26351279|FG004|Overall Study|Withdrawn at discretion of investigator|1|||
13244344|NCT01620177|26351304|FG000|Overall Study|Failure at Screening Visit|43|||
13244345|NCT01620177|26351304|FG000|Overall Study|Withdrawal by Subject|26|||
13244346|NCT01620177|26351304|FG000|Overall Study|Lost to Follow-up|7|||
13244347|NCT01620177|26351304|FG000|Overall Study|Physician Decision|2|||
13244348|NCT01620177|26351304|FG000|Overall Study|Randomized, Not Active due to Scheduling|1|||
13244349|NCT01620138|26351317|FG000|Overall Study|Withdrawal by Subject|3|||
13244350|NCT01620138|26351318|FG001|Overall Study|Withdrawal by Subject|0|||
13244351|NCT01620138|26351317|FG000|Overall Study|Lack of Efficacy|1|||
13244352|NCT01620138|26351318|FG001|Overall Study|Lack of Efficacy|0|||
13244353|NCT01620138|26351317|FG000|Overall Study|Adverse Event|2|||
13244354|NCT01620138|26351318|FG001|Overall Study|Adverse Event|0|||
13244355|NCT01620086|26351345|FG000|Overall Study|Withdrawal by Subject|3|||
13244356|NCT01620086|26351346|FG001|Overall Study|Withdrawal by Subject|3|||
13244357|NCT01620086|26351347|FG002|Overall Study|Withdrawal by Subject|0|||
13244358|NCT01620086|26351345|FG000|Overall Study|failed study criteria|1|||
13244359|NCT01620086|26351346|FG001|Overall Study|failed study criteria|4|||
13244360|NCT01620086|26351347|FG002|Overall Study|failed study criteria|0|||
13244361|NCT01620086|26351345|FG000|Overall Study|Physician Decision|1|||
13244362|NCT01620086|26351346|FG001|Overall Study|Physician Decision|0|||
13244363|NCT01620086|26351347|FG002|Overall Study|Physician Decision|0|||
13244364|NCT01620060|26351355|FG000|Overall Study|Adverse Event|9|||
13244365|NCT01620060|26351355|FG000|Overall Study|Protocol Violation|1|||
13244366|NCT01620060|26351355|FG000|Overall Study|Withdrawal by Subject|1|||
13244367|NCT01620060|26351355|FG000|Overall Study|Did not comply with Study Produre|1|||
13244368|NCT01620060|26351355|FG000|Overall Study|Family emergency|1|||
13244369|NCT01620060|26351355|FG000|Overall Study|Per Sponsor Decision|2|||
13244370|NCT01619878|26351369|FG000|6 Week Follow-up Phase|Adverse Event|1|||
13244371|NCT01619878|26351369|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1|||
13244372|NCT01619878|26351369|FG000|Follow-up at 12 Months of Age|Death|2|||
13244373|NCT01619865|26351376|FG000|Overall Study|Adverse Event|1|||
13244374|NCT01619865|26351376|FG000|Overall Study|Death|2|||
13244375|NCT01619865|26351376|FG000|Overall Study|subject not able to comply|1|||
13244376|NCT01619852|26351397|FG000|24 Hour Assessment|Withdrawal by Subject|1|||
13244377|NCT01619852|26351398|FG001|24 Hour Assessment|Withdrawal by Subject|1|||
13244378|NCT01619852|26351397|FG000|3 Month Follow up|Lost to Follow-up|31|||
13244379|NCT01619852|26351398|FG001|3 Month Follow up|Lost to Follow-up|34|||
13244380|NCT01619800|26351411|FG000|Overall Study|study terminated|2|||
13244381|NCT01619800|26351412|FG001|Overall Study|study terminated|0|||
13244382|NCT01619787|26351427|FG000|Overall Study|Lost to Follow-up|5|||
13244383|NCT01619579|26351444|FG000|Overall Study|Withdrawal by Subject|0|||
13244384|NCT01619579|26351445|FG001|Overall Study|Withdrawal by Subject|3|||
13244385|NCT01619423|26351469|FG000|Part 1 (Dose Escalation)|High basal Mn|0|||
13244386|NCT01619423|26351470|FG001|Part 1 (Dose Escalation)|High basal Mn|2|||
13244387|NCT01619423|26351471|FG002|Part 1 (Dose Escalation)|High basal Mn|0|||
13244388|NCT01619423|26351472|FG003|Part 1 (Dose Escalation)|High basal Mn|0|||
13244389|NCT01619410|26351491|FG000|Overall Study|Lost to Follow-up|7|||
13244390|NCT01619410|26351492|FG001|Overall Study|Lost to Follow-up|4|||
13244391|NCT01619059|26351511|FG000|Short-Term (ST) Treatment Period|Adverse Event|1|||
13244392|NCT01619059|26351512|FG001|Short-Term (ST) Treatment Period|Adverse Event|0|||
13244393|NCT01619059|26351511|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2|||
13244394|NCT01619059|26351512|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5|||
13115989|NCT03085927|25920473|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0|||
13115990|NCT03085927|25920472|FG000|Overall Study|Dyad Became Ineligible|0|||
13115991|NCT03085927|25920473|FG001|Overall Study|Dyad Became Ineligible|1|||
13115992|NCT03085914|25920526|FG000|Overall Study|Death|6|||
13115993|NCT03085914|25920527|FG001|Overall Study|Death|6|||
13115994|NCT03085914|25920528|FG002|Overall Study|Death|4|||
13244395|NCT01619059|26351511|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2|||
13244396|NCT01619059|26351512|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4|||
13244397|NCT01619059|26351511|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1|||
13244398|NCT01619059|26351512|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2|||
13244399|NCT01619059|26351511|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0|||
13244400|NCT01619059|26351512|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1|||
13244401|NCT01619059|26351511|FG000|Long-Term (LT) Treatment Period|Adverse Event|2|||
13244402|NCT01619059|26351512|FG001|Long-Term (LT) Treatment Period|Adverse Event|3|||
13244403|NCT01619059|26351511|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3|||
13244404|NCT01619059|26351512|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2|||
13244405|NCT01619059|26351511|FG000|Long-Term (LT) Treatment Period|Death|1|||
13244406|NCT01619059|26351512|FG001|Long-Term (LT) Treatment Period|Death|0|||
13244407|NCT01619059|26351511|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
13244408|NCT01619059|26351512|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
13244409|NCT01619059|26351511|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0|||
13244410|NCT01619059|26351512|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1|||
13244411|NCT01618968|26351540|FG000|Overall Study|Adverse Event|1|||
13244412|NCT01618968|26351541|FG001|Overall Study|Adverse Event|0|||
13244413|NCT01618968|26351542|FG002|Overall Study|Adverse Event|0|||
13244414|NCT01618968|26351543|FG003|Overall Study|Adverse Event|0|||
13244415|NCT01618968|26351540|FG000|Overall Study|Death|0|||
13244416|NCT01618968|26351541|FG001|Overall Study|Death|0|||
13244417|NCT01618968|26351542|FG002|Overall Study|Death|0|||
13244418|NCT01618968|26351543|FG003|Overall Study|Death|1|||
13244419|NCT01618916|26351592|FG000|Overall Study|Adverse Event|1|||
13244420|NCT01618916|26351593|FG001|Overall Study|Adverse Event|0|||
13244421|NCT01618916|26351594|FG002|Overall Study|Adverse Event|0|||
13244422|NCT01618916|26351595|FG003|Overall Study|Adverse Event|0|||
13244423|NCT01618916|26351596|FG004|Overall Study|Adverse Event|0|||
13244424|NCT01618916|26351597|FG005|Overall Study|Adverse Event|0|||
13244425|NCT01618916|26351592|FG000|Overall Study|Withdrawal by Subject|0|||
13244426|NCT01618916|26351593|FG001|Overall Study|Withdrawal by Subject|1|||
13244427|NCT01618916|26351594|FG002|Overall Study|Withdrawal by Subject|1|||
13244428|NCT01618916|26351595|FG003|Overall Study|Withdrawal by Subject|0|||
13244429|NCT01618916|26351596|FG004|Overall Study|Withdrawal by Subject|1|||
13244430|NCT01618916|26351597|FG005|Overall Study|Withdrawal by Subject|0|||
13244431|NCT01618916|26351592|FG000|Overall Study|Lost to Follow-up|1|||
13244432|NCT01618916|26351593|FG001|Overall Study|Lost to Follow-up|0|||
13244433|NCT01618916|26351594|FG002|Overall Study|Lost to Follow-up|0|||
13244434|NCT01618916|26351595|FG003|Overall Study|Lost to Follow-up|2|||
13244435|NCT01618916|26351596|FG004|Overall Study|Lost to Follow-up|0|||
13244436|NCT01618916|26351597|FG005|Overall Study|Lost to Follow-up|0|||
13244437|NCT01618864|26351608|FG000|Overall Study|Withdrawal by Subject|2|||
13244438|NCT01618864|26351608|FG000|Overall Study|Lost to Follow-up|2|||
13244439|NCT01618838|26351616|FG000|Overall Study|slow accrual, trial closed prematurely.|4|||
13244440|NCT01618708|26351635|FG000|Overall Study|Adverse Event|10|||
13244441|NCT01618708|26351636|FG001|Overall Study|Adverse Event|10|||
13244442|NCT01618708|26351635|FG000|Overall Study|Lost to Follow-up|3|||
13244443|NCT01618708|26351636|FG001|Overall Study|Lost to Follow-up|3|||
13244444|NCT01618708|26351635|FG000|Overall Study|Withdrawal by Subject|17|||
13115995|NCT03085914|25920529|FG003|Overall Study|Death|1|||
13244445|NCT01618708|26351636|FG001|Overall Study|Withdrawal by Subject|22|||
13244446|NCT01618708|26351635|FG000|Overall Study|Lack of Efficacy|8|||
13244447|NCT01618708|26351636|FG001|Overall Study|Lack of Efficacy|8|||
13244448|NCT01618708|26351635|FG000|Overall Study|Technical problems|2|||
13244449|NCT01618708|26351636|FG001|Overall Study|Technical problems|0|||
13244450|NCT01618708|26351635|FG000|Overall Study|Other than specified above|1|||
13244451|NCT01618708|26351636|FG001|Overall Study|Other than specified above|1|||
13244452|NCT01618708|26351635|FG000|Overall Study|Randomized but not treated|3|||
13244453|NCT01618708|26351636|FG001|Overall Study|Randomized but not treated|2|||
13244454|NCT01618695|26351672|FG000|Core Phase|Adverse Event|4|||
13115996|NCT03085914|25920530|FG004|Overall Study|Death|5|||
13244455|NCT01618695|26351673|FG001|Core Phase|Adverse Event|5|||
13244456|NCT01618695|26351674|FG002|Core Phase|Adverse Event|15|||
13244457|NCT01618695|26351675|FG003|Core Phase|Adverse Event|20|||
13244458|NCT01618695|26351672|FG000|Core Phase|Lost to Follow-up|0|||
13244459|NCT01618695|26351673|FG001|Core Phase|Lost to Follow-up|0|||
13244460|NCT01618695|26351674|FG002|Core Phase|Lost to Follow-up|1|||
13244461|NCT01618695|26351675|FG003|Core Phase|Lost to Follow-up|0|||
13244462|NCT01618695|26351672|FG000|Core Phase|Withdrawal by Subject|16|||
13244463|NCT01618695|26351673|FG001|Core Phase|Withdrawal by Subject|11|||
13244464|NCT01618695|26351674|FG002|Core Phase|Withdrawal by Subject|9|||
13244465|NCT01618695|26351675|FG003|Core Phase|Withdrawal by Subject|13|||
13244466|NCT01618695|26351672|FG000|Core Phase|Pregnancy|2|||
13244467|NCT01618695|26351673|FG001|Core Phase|Pregnancy|0|||
13244468|NCT01618695|26351674|FG002|Core Phase|Pregnancy|0|||
13244469|NCT01618695|26351675|FG003|Core Phase|Pregnancy|0|||
13244470|NCT01618695|26351672|FG000|Core Phase|Lack of Efficacy|1|||
13244471|NCT01618695|26351673|FG001|Core Phase|Lack of Efficacy|2|||
13244472|NCT01618695|26351674|FG002|Core Phase|Lack of Efficacy|1|||
13244473|NCT01618695|26351675|FG003|Core Phase|Lack of Efficacy|1|||
13244474|NCT01618695|26351672|FG000|Core Phase|Other than specified|1|||
13244475|NCT01618695|26351673|FG001|Core Phase|Other than specified|2|||
13244476|NCT01618695|26351674|FG002|Core Phase|Other than specified|2|||
13244477|NCT01618695|26351675|FG003|Core Phase|Other than specified|2|||
13244478|NCT01618695|26351672|FG000|Core Phase|Not treated|1|||
13244479|NCT01618695|26351673|FG001|Core Phase|Not treated|0|||
13244480|NCT01618695|26351674|FG002|Core Phase|Not treated|2|||
13244481|NCT01618695|26351675|FG003|Core Phase|Not treated|0|||
13244482|NCT01618695|26351672|FG000|Extension Phase|Lack of Efficacy|17|||
13244483|NCT01618695|26351673|FG001|Extension Phase|Lack of Efficacy|33|||
13244484|NCT01618695|26351674|FG002|Extension Phase|Lack of Efficacy|26|||
13244485|NCT01618695|26351675|FG003|Extension Phase|Lack of Efficacy|24|||
13244486|NCT01618695|26351672|FG000|Extension Phase|Pregnancy|2|||
13244487|NCT01618695|26351673|FG001|Extension Phase|Pregnancy|0|||
13244488|NCT01618695|26351674|FG002|Extension Phase|Pregnancy|1|||
13244489|NCT01618695|26351675|FG003|Extension Phase|Pregnancy|1|||
13244490|NCT01618695|26351672|FG000|Extension Phase|Withdrawal by Subject|43|||
13244491|NCT01618695|26351673|FG001|Extension Phase|Withdrawal by Subject|48|||
13244492|NCT01618695|26351674|FG002|Extension Phase|Withdrawal by Subject|42|||
13244493|NCT01618695|26351675|FG003|Extension Phase|Withdrawal by Subject|33|||
13244494|NCT01618695|26351672|FG000|Extension Phase|Adverse Event|18|||
13244495|NCT01618695|26351673|FG001|Extension Phase|Adverse Event|16|||
13244496|NCT01618695|26351674|FG002|Extension Phase|Adverse Event|9|||
13244497|NCT01618695|26351675|FG003|Extension Phase|Adverse Event|20|||
13244498|NCT01618695|26351672|FG000|Extension Phase|Lost to Follow-up|2|||
13244499|NCT01618695|26351673|FG001|Extension Phase|Lost to Follow-up|1|||
13244500|NCT01618695|26351674|FG002|Extension Phase|Lost to Follow-up|1|||
13244501|NCT01618695|26351675|FG003|Extension Phase|Lost to Follow-up|1|||
13244502|NCT01618695|26351672|FG000|Extension Phase|Other than specified|13|||
13244503|NCT01618695|26351673|FG001|Extension Phase|Other than specified|18|||
13244504|NCT01618695|26351674|FG002|Extension Phase|Other than specified|13|||
13244505|NCT01618695|26351675|FG003|Extension Phase|Other than specified|18|||
13244506|NCT01618669|26351726|FG000|Overall Study|Lost to Follow-up|1|||
13244507|NCT01618669|26351727|FG001|Overall Study|Lost to Follow-up|1|||
13244508|NCT01618669|26351726|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
13244509|NCT01618669|26351727|FG001|Overall Study|Randomized but Never Received Study Drug|2|||
13244510|NCT01618669|26351726|FG000|Overall Study|Adverse Event|16|||
13244511|NCT01618669|26351727|FG001|Overall Study|Adverse Event|7|||
13244512|NCT01618669|26351726|FG000|Overall Study|Protocol Violation|5|||
13244513|NCT01618669|26351727|FG001|Overall Study|Protocol Violation|3|||
13244514|NCT01618669|26351726|FG000|Overall Study|Withdrawal by Subject|9|||
13244515|NCT01618669|26351727|FG001|Overall Study|Withdrawal by Subject|9|||
13244516|NCT01618669|26351726|FG000|Overall Study|Miscellaneous Reason|0|||
13244517|NCT01618669|26351727|FG001|Overall Study|Miscellaneous Reason|1|||
13244518|NCT01618305|26351776|FG000|Overall Study|Death|0|||
13244519|NCT01618305|26351777|FG001|Overall Study|Death|1|||
13244520|NCT01618305|26351776|FG000|Overall Study|Lost to Follow-up|11|||
13244521|NCT01618305|26351777|FG001|Overall Study|Lost to Follow-up|7|||
13244522|NCT01618305|26351776|FG000|Overall Study|Protocol Violation|1|||
13244523|NCT01618305|26351777|FG001|Overall Study|Protocol Violation|0|||
13244524|NCT01618305|26351776|FG000|Overall Study|Withdrawal by Subject|3|||
13244525|NCT01618305|26351777|FG001|Overall Study|Withdrawal by Subject|2|||
13244526|NCT01618266|26351794|FG000|Overall Study|Lost to Follow-up|9|||
13244527|NCT01618266|26351794|FG000|Overall Study|Treatment satisfaction|10|||
13244528|NCT01618266|26351794|FG000|Overall Study|Other reasons|11|||
13244529|NCT01618266|26351794|FG000|Overall Study|Lack of Efficacy|23|||
13244530|NCT01618266|26351794|FG000|Overall Study|Protocol Violation|43|||
13244531|NCT01618214|26351815|FG000|Overall Study|Adverse Event|3|||
13244532|NCT01618214|26351816|FG001|Overall Study|Adverse Event|1|||
13244533|NCT01618214|26351815|FG000|Overall Study|Lack of Efficacy|1|||
13244534|NCT01618214|26351816|FG001|Overall Study|Lack of Efficacy|1|||
13244535|NCT01618214|26351815|FG000|Overall Study|Protocol Violation|1|||
13244536|NCT01618214|26351816|FG001|Overall Study|Protocol Violation|4|||
13244537|NCT01618214|26351815|FG000|Overall Study|Withdrawal Criteria|1|||
13244538|NCT01618214|26351816|FG001|Overall Study|Withdrawal Criteria|2|||
13244539|NCT01618214|26351815|FG000|Overall Study|Unclassified|4|||
13244540|NCT01618214|26351816|FG001|Overall Study|Unclassified|5|||
13244541|NCT01618162|26351841|FG000|Overall Study|Protocol Violation|13|||
13244542|NCT01618162|26351842|FG001|Overall Study|Protocol Violation|10|||
13244543|NCT01618162|26351841|FG000|Overall Study|Adverse Event|9|||
13244544|NCT01618162|26351842|FG001|Overall Study|Adverse Event|2|||
13244545|NCT01618162|26351841|FG000|Overall Study|Withdrawal Criteria|2|||
13244546|NCT01618162|26351842|FG001|Overall Study|Withdrawal Criteria|10|||
13244547|NCT01618162|26351841|FG000|Overall Study|Unclassified|14|||
13244548|NCT01618162|26351842|FG001|Overall Study|Unclassified|13|||
13244549|NCT01618019|26351869|FG000|Overall Study|Withdrawal by Subject|14|||
13244550|NCT01618019|26351870|FG001|Overall Study|Withdrawal by Subject|14|||
13244551|NCT01617967|26351939|FG000|Overall Study|Protocol Violation|0|||
13244552|NCT01617967|26351940|FG001|Overall Study|Protocol Violation|0|||
13244553|NCT01617967|26351941|FG002|Overall Study|Protocol Violation|0|||
13244554|NCT01617967|26351942|FG003|Overall Study|Protocol Violation|1|||
13244555|NCT01617967|26351943|FG004|Overall Study|Protocol Violation|0|||
13244556|NCT01617967|26351944|FG005|Overall Study|Protocol Violation|0|||
13244557|NCT01617967|26351939|FG000|Overall Study|Withdrawal by Subject|0|||
13244558|NCT01617967|26351940|FG001|Overall Study|Withdrawal by Subject|0|||
13244559|NCT01617967|26351941|FG002|Overall Study|Withdrawal by Subject|0|||
13244560|NCT01617967|26351942|FG003|Overall Study|Withdrawal by Subject|0|||
13244561|NCT01617967|26351943|FG004|Overall Study|Withdrawal by Subject|0|||
13244562|NCT01617967|26351944|FG005|Overall Study|Withdrawal by Subject|1|||
13244563|NCT01617967|26351939|FG000|Overall Study|Dosing Suspended by Sponsor|1|||
13244564|NCT01617967|26351940|FG001|Overall Study|Dosing Suspended by Sponsor|0|||
13244565|NCT01617967|26351941|FG002|Overall Study|Dosing Suspended by Sponsor|0|||
13244566|NCT01617967|26351942|FG003|Overall Study|Dosing Suspended by Sponsor|0|||
13244567|NCT01617967|26351943|FG004|Overall Study|Dosing Suspended by Sponsor|0|||
13244568|NCT01617967|26351944|FG005|Overall Study|Dosing Suspended by Sponsor|0|||
13244569|NCT01617681|26351977|FG000|Period 1 Double Blind|Adverse Event|2|||
13244570|NCT01617681|26351978|FG001|Period 1 Double Blind|Adverse Event|0|||
13244571|NCT01617681|26351979|FG002|Period 1 Double Blind|Adverse Event|0|||
13244572|NCT01617681|26351980|FG003|Period 1 Double Blind|Adverse Event|2|||
13244573|NCT01617681|26351981|FG004|Period 1 Double Blind|Adverse Event|0|||
13244574|NCT01617681|26351977|FG000|Period 1 Double Blind|Withdrawal by Subject|1|||
13244575|NCT01617681|26351978|FG001|Period 1 Double Blind|Withdrawal by Subject|1|||
13244576|NCT01617681|26351979|FG002|Period 1 Double Blind|Withdrawal by Subject|1|||
13244577|NCT01617681|26351980|FG003|Period 1 Double Blind|Withdrawal by Subject|0|||
13244578|NCT01617681|26351981|FG004|Period 1 Double Blind|Withdrawal by Subject|0|||
13244579|NCT01617681|26351977|FG000|Period 2 Open Label|Adverse Event|0|||
13244580|NCT01617681|26351978|FG001|Period 2 Open Label|Adverse Event|0|||
13244581|NCT01617681|26351979|FG002|Period 2 Open Label|Adverse Event|0|||
13244582|NCT01617681|26351980|FG003|Period 2 Open Label|Adverse Event|0|||
13244583|NCT01617681|26351981|FG004|Period 2 Open Label|Adverse Event|3|||
13244584|NCT01617681|26351977|FG000|Period 2 Open Label|Withdrawal by Subject|0|||
13244585|NCT01617681|26351978|FG001|Period 2 Open Label|Withdrawal by Subject|0|||
13244586|NCT01617681|26351979|FG002|Period 2 Open Label|Withdrawal by Subject|0|||
13244587|NCT01617681|26351980|FG003|Period 2 Open Label|Withdrawal by Subject|0|||
13244588|NCT01617681|26351981|FG004|Period 2 Open Label|Withdrawal by Subject|3|||
13244589|NCT01617668|26352029|FG000|Overall Study|Adverse Event|7|||
13244590|NCT01617668|26352030|FG001|Overall Study|Adverse Event|0|||
13244591|NCT01617668|26352031|FG002|Overall Study|Adverse Event|12|||
13244592|NCT01617668|26352032|FG003|Overall Study|Adverse Event|5|||
13244593|NCT01617668|26352029|FG000|Overall Study|Physician Decision|1|||
13244594|NCT01617668|26352030|FG001|Overall Study|Physician Decision|2|||
13244595|NCT01617668|26352031|FG002|Overall Study|Physician Decision|3|||
13244596|NCT01617668|26352032|FG003|Overall Study|Physician Decision|0|||
13244597|NCT01617668|26352029|FG000|Overall Study|Progressive Disease|4|||
13244598|NCT01617668|26352030|FG001|Overall Study|Progressive Disease|4|||
13244599|NCT01617668|26352031|FG002|Overall Study|Progressive Disease|6|||
13244600|NCT01617668|26352032|FG003|Overall Study|Progressive Disease|9|||
13244601|NCT01617668|26352029|FG000|Overall Study|Subject/guardian decision|1|||
13244602|NCT01617668|26352030|FG001|Overall Study|Subject/guardian decision|3|||
13244603|NCT01617668|26352031|FG002|Overall Study|Subject/guardian decision|2|||
13244604|NCT01617668|26352032|FG003|Overall Study|Subject/guardian decision|1|||
13244605|NCT01617655|26352099|FG000|Overall Study|Adverse Event|2|||
13244606|NCT01617655|26352100|FG001|Overall Study|Adverse Event|3|||
13244607|NCT01617655|26352099|FG000|Overall Study|Poor compliance to protocol|1|||
13244608|NCT01617655|26352100|FG001|Overall Study|Poor compliance to protocol|4|||
13244609|NCT01617655|26352099|FG000|Overall Study|Participants moved|0|||
13244610|NCT01617655|26352100|FG001|Overall Study|Participants moved|4|||
13244611|NCT01617655|26352099|FG000|Overall Study|Consent withdrawn by participant|1|||
13244612|NCT01617655|26352100|FG001|Overall Study|Consent withdrawn by participant|1|||
13290073|NCT00104650|26480692|FG000|Follow-up Period|Adverse Event|1|||
13244613|NCT01617655|26352099|FG000|Overall Study|Last visit outside protocol visit window|1|||
13244614|NCT01617655|26352100|FG001|Overall Study|Last visit outside protocol visit window|10|||
13244615|NCT01617655|26352099|FG000|Overall Study|Site closure|3|||
13244616|NCT01617655|26352100|FG001|Overall Study|Site closure|5|||
13244617|NCT01617655|26352099|FG000|Overall Study|Other than specified above|1|||
13244618|NCT01617655|26352100|FG001|Overall Study|Other than specified above|2|||
13244619|NCT01617629|26352107|FG000|Overall Study|Death|2|||
13244620|NCT01617629|26352107|FG000|Overall Study|Investigator's Clinical Judgement|1|||
13244621|NCT01617629|26352107|FG000|Overall Study|Reason Not Specified|1|||
13244622|NCT01617629|26352107|FG000|Overall Study|Participant Withdrew Consent|2|||
13244623|NCT01617460|26352113|FG000|Overall Study|Adverse Event|10|||
13244624|NCT01617460|26352113|FG000|Overall Study|Physician Decision|16|||
13244625|NCT01617460|26352113|FG000|Overall Study|Protocol Violation|5|||
13244626|NCT01617460|26352113|FG000|Overall Study|Withdrawal by Subject|9|||
13244627|NCT01617447|26352126|FG000|Overall Study|Adverse Event|0|||
13244628|NCT01617447|26352127|FG001|Overall Study|Adverse Event|1|||
13244629|NCT01617447|26352126|FG000|Overall Study|Physician Decision|0|||
13244630|NCT01617447|26352127|FG001|Overall Study|Physician Decision|2|||
13244631|NCT01617434|26352156|FG000|Overall Study|Adverse Event|12|||
13244632|NCT01617434|26352157|FG001|Overall Study|Adverse Event|3|||
13244633|NCT01617434|26352156|FG000|Overall Study|Protocol Violation|8|||
13244634|NCT01617434|26352157|FG001|Overall Study|Protocol Violation|7|||
13244635|NCT01617434|26352156|FG000|Overall Study|Withdrawal Criteria|12|||
13244636|NCT01617434|26352157|FG001|Overall Study|Withdrawal Criteria|37|||
13244637|NCT01617434|26352156|FG000|Overall Study|Unclassified|3|||
13244638|NCT01617434|26352157|FG001|Overall Study|Unclassified|4|||
13244639|NCT01617187|26352240|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
13244640|NCT01617187|26352241|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
13244641|NCT01617187|26352242|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
13244642|NCT01617187|26352243|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1|||
13244643|NCT01617187|26352240|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
13244644|NCT01617187|26352241|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
13244645|NCT01617187|26352242|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
13244646|NCT01617187|26352243|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1|||
13244647|NCT01617187|26352240|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1|||
13244648|NCT01617187|26352241|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
13244649|NCT01617187|26352242|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
13244650|NCT01617187|26352243|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
13244651|NCT01617187|26352240|FG000|Treatment Through Study Completion|Adverse Event|1|||
13244652|NCT01617187|26352241|FG001|Treatment Through Study Completion|Adverse Event|1|||
13244653|NCT01617187|26352242|FG002|Treatment Through Study Completion|Adverse Event|0|||
13244654|NCT01617187|26352243|FG003|Treatment Through Study Completion|Adverse Event|1|||
13244655|NCT01617187|26352240|FG000|Treatment Through Study Completion|Lost to Follow-up|4|||
13244656|NCT01617187|26352241|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
13244657|NCT01617187|26352242|FG002|Treatment Through Study Completion|Lost to Follow-up|2|||
13244658|NCT01617187|26352243|FG003|Treatment Through Study Completion|Lost to Follow-up|2|||
13244659|NCT01617187|26352240|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
13244660|NCT01617187|26352241|FG001|Treatment Through Study Completion|Withdrawal by Subject|8|||
13244661|NCT01617187|26352242|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
13244662|NCT01617187|26352243|FG003|Treatment Through Study Completion|Withdrawal by Subject|6|||
13244663|NCT01617187|26352240|FG000|Treatment Through Study Completion|Protocol Violation|1|||
13244664|NCT01617187|26352241|FG001|Treatment Through Study Completion|Protocol Violation|0|||
13244665|NCT01617187|26352242|FG002|Treatment Through Study Completion|Protocol Violation|0|||
13244666|NCT01617187|26352243|FG003|Treatment Through Study Completion|Protocol Violation|1|||
13244667|NCT01617070|26352263|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1|||
13244668|NCT01617005|26352272|FG000|Overall Study|Pregnancy|1|||
13244669|NCT01617005|26352272|FG000|Overall Study|Lack of motivation for treatment|1|||
13244670|NCT01616953|26352287|FG000|Overall Study|Lost to Follow-up|1|||
13244671|NCT01616953|26352288|FG001|Overall Study|Lost to Follow-up|0|||
13244672|NCT01616953|26352287|FG000|Overall Study|lack of bone and soft tissue|1|||
13244673|NCT01616953|26352288|FG001|Overall Study|lack of bone and soft tissue|0|||
13244674|NCT01616771|26352299|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4|||
13244675|NCT01616693|26352362|FG000|Evaluated for Safety|Physician Decision|1|||
13244676|NCT01616693|26352363|FG001|Evaluated for Safety|Physician Decision|0|||
13244677|NCT01616693|26352364|FG002|Evaluated for Safety|Physician Decision|1|||
13244678|NCT01616693|26352365|FG003|Evaluated for Safety|Physician Decision|0|||
13244679|NCT01616693|26352362|FG000|Received Both Vaccines|Adverse Event|2|||
13244680|NCT01616693|26352363|FG001|Received Both Vaccines|Adverse Event|0|||
13244681|NCT01616693|26352364|FG002|Received Both Vaccines|Adverse Event|0|||
13244682|NCT01616693|26352365|FG003|Received Both Vaccines|Adverse Event|0|||
13244683|NCT01616693|26352362|FG000|Received Both Vaccines|Withdrawal by Subject|7|||
13244684|NCT01616693|26352363|FG001|Received Both Vaccines|Withdrawal by Subject|7|||
13244685|NCT01616693|26352364|FG002|Received Both Vaccines|Withdrawal by Subject|8|||
13244686|NCT01616693|26352365|FG003|Received Both Vaccines|Withdrawal by Subject|15|||
13244687|NCT01616693|26352362|FG000|Received Both Vaccines|Lost to Follow-up|4|||
13244688|NCT01616693|26352363|FG001|Received Both Vaccines|Lost to Follow-up|3|||
13244689|NCT01616693|26352364|FG002|Received Both Vaccines|Lost to Follow-up|4|||
13244690|NCT01616693|26352365|FG003|Received Both Vaccines|Lost to Follow-up|4|||
13244691|NCT01616693|26352362|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4|||
13244692|NCT01616693|26352363|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2|||
13244693|NCT01616693|26352364|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6|||
13244694|NCT01616693|26352365|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1|||
13244695|NCT01616654|26352418|FG000|Overall Study|Lack of Efficacy|1|||
13244696|NCT01616654|26352419|FG001|Overall Study|Lack of Efficacy|0|||
13244697|NCT01616654|26352420|FG002|Overall Study|Lack of Efficacy|0|||
13244698|NCT01616654|26352421|FG003|Overall Study|Lack of Efficacy|0|||
13244699|NCT01616654|26352422|FG004|Overall Study|Lack of Efficacy|1|||
13244700|NCT01616654|26352418|FG000|Overall Study|Adverse Event|0|||
13244701|NCT01616654|26352419|FG001|Overall Study|Adverse Event|1|||
13244702|NCT01616654|26352420|FG002|Overall Study|Adverse Event|2|||
13244703|NCT01616654|26352421|FG003|Overall Study|Adverse Event|1|||
13244704|NCT01616654|26352422|FG004|Overall Study|Adverse Event|0|||
13244705|NCT01616654|26352418|FG000|Overall Study|Withdrawal by Subject|2|||
13244706|NCT01616654|26352419|FG001|Overall Study|Withdrawal by Subject|2|||
13244707|NCT01616654|26352420|FG002|Overall Study|Withdrawal by Subject|3|||
13244708|NCT01616654|26352421|FG003|Overall Study|Withdrawal by Subject|1|||
13244709|NCT01616654|26352422|FG004|Overall Study|Withdrawal by Subject|5|||
13244710|NCT01616654|26352418|FG000|Overall Study|Protocol Violation|0|||
13244711|NCT01616654|26352419|FG001|Overall Study|Protocol Violation|5|||
13244712|NCT01616654|26352420|FG002|Overall Study|Protocol Violation|2|||
13244713|NCT01616654|26352421|FG003|Overall Study|Protocol Violation|4|||
13244714|NCT01616654|26352422|FG004|Overall Study|Protocol Violation|4|||
13244715|NCT01616654|26352418|FG000|Overall Study|Lost to Follow-up|1|||
13244716|NCT01616654|26352419|FG001|Overall Study|Lost to Follow-up|0|||
13244717|NCT01616654|26352420|FG002|Overall Study|Lost to Follow-up|3|||
13244718|NCT01616654|26352421|FG003|Overall Study|Lost to Follow-up|2|||
13244719|NCT01616654|26352422|FG004|Overall Study|Lost to Follow-up|1|||
13244720|NCT01616654|26352418|FG000|Overall Study|Pregnancy|1|||
13244721|NCT01616654|26352419|FG001|Overall Study|Pregnancy|0|||
13244722|NCT01616654|26352420|FG002|Overall Study|Pregnancy|0|||
13244723|NCT01616654|26352421|FG003|Overall Study|Pregnancy|0|||
13244724|NCT01616654|26352422|FG004|Overall Study|Pregnancy|1|||
13244725|NCT01616563|26352436|FG000|Overall Study|Lost to Follow-up|40|||
13244726|NCT01616459|26352547|FG000|Overall Study|Adverse Event|1|||
13244727|NCT01616459|26352548|FG001|Overall Study|Adverse Event|1|||
13244728|NCT01616459|26352549|FG002|Overall Study|Adverse Event|2|||
13244729|NCT01616459|26352550|FG003|Overall Study|Adverse Event|0|||
13244730|NCT01616459|26352547|FG000|Overall Study|Lost to Follow-up|1|||
13244731|NCT01616459|26352548|FG001|Overall Study|Lost to Follow-up|11|||
13244732|NCT01616459|26352549|FG002|Overall Study|Lost to Follow-up|3|||
13244733|NCT01616459|26352550|FG003|Overall Study|Lost to Follow-up|2|||
13244734|NCT01616459|26352547|FG000|Overall Study|Protocol Violation|0|||
13244735|NCT01616459|26352548|FG001|Overall Study|Protocol Violation|0|||
13244736|NCT01616459|26352549|FG002|Overall Study|Protocol Violation|0|||
13244737|NCT01616459|26352550|FG003|Overall Study|Protocol Violation|2|||
13244738|NCT01616459|26352547|FG000|Overall Study|Withdrawal by Subject|2|||
13244739|NCT01616459|26352548|FG001|Overall Study|Withdrawal by Subject|4|||
13244740|NCT01616459|26352549|FG002|Overall Study|Withdrawal by Subject|4|||
13244741|NCT01616459|26352550|FG003|Overall Study|Withdrawal by Subject|4|||
13244742|NCT01616459|26352547|FG000|Overall Study|Other reason|0|||
13244743|NCT01616459|26352548|FG001|Overall Study|Other reason|1|||
13244744|NCT01616459|26352549|FG002|Overall Study|Other reason|1|||
13244745|NCT01616459|26352550|FG003|Overall Study|Other reason|0|||
13244746|NCT01616173|26352574|FG000|Overall Study|Lost to Follow-up|0|||
13244747|NCT01616173|26352575|FG001|Overall Study|Lost to Follow-up|2|||
13244748|NCT01616173|26352576|FG002|Overall Study|Lost to Follow-up|0|||
13244749|NCT01615939|26352593|FG000|Overall Study|Lost to Follow-up|5|||
13244750|NCT01615939|26352594|FG001|Overall Study|Lost to Follow-up|0|||
13244751|NCT01615822|26352621|FG000|Period 1|Withdrawal by Subject|0|||
13244752|NCT01615822|26352622|FG001|Period 1|Withdrawal by Subject|1|||
13244753|NCT01615822|26352623|FG002|Period 1|Withdrawal by Subject|0|||
13244754|NCT01615822|26352621|FG000|Period 1|Adverse Event|1|||
13244755|NCT01615822|26352622|FG001|Period 1|Adverse Event|1|||
13244756|NCT01615822|26352623|FG002|Period 1|Adverse Event|0|||
13244757|NCT01615822|26352621|FG000|Period 2|Lost to Follow-up|0|||
13244758|NCT01615822|26352622|FG001|Period 2|Lost to Follow-up|1|||
13244759|NCT01615822|26352623|FG002|Period 2|Lost to Follow-up|2|||
13244760|NCT01615328|26352640|FG000|Overall Study|Lost to Follow-up|3|||
13244761|NCT01615328|26352641|FG001|Overall Study|Lost to Follow-up|5|||
13244762|NCT01615263|26352660|FG000|Overall Study|Post-randomization exclusion|0|||
13244763|NCT01615263|26352661|FG001|Overall Study|Post-randomization exclusion|2|||
13244764|NCT01615198|26352696|FG000|Overall Study|Withdrawal by Subject|5|||
13244765|NCT01615198|26352697|FG001|Overall Study|Withdrawal by Subject|5|||
13244766|NCT01615198|26352696|FG000|Overall Study|Protocol deviation|1|||
13244767|NCT01615198|26352697|FG001|Overall Study|Protocol deviation|1|||
13244768|NCT01615198|26352696|FG000|Overall Study|Physician Decision|5|||
13244769|NCT01615198|26352697|FG001|Overall Study|Physician Decision|1|||
13244770|NCT01615198|26352696|FG000|Overall Study|Lost to Follow-up|1|||
13244771|NCT01615198|26352697|FG001|Overall Study|Lost to Follow-up|1|||
13244772|NCT01615198|26352696|FG000|Overall Study|Lack of Efficacy|1|||
13244773|NCT01615198|26352697|FG001|Overall Study|Lack of Efficacy|6|||
13244774|NCT01615198|26352696|FG000|Overall Study|Adverse Event|11|||
13244775|NCT01615198|26352697|FG001|Overall Study|Adverse Event|5|||
13244776|NCT01614925|26352724|FG000|Overall Study|Withdrawal by Subject|1|||
13244777|NCT01614925|26352725|FG001|Overall Study|Withdrawal by Subject|0|||
13244778|NCT01614925|26352724|FG000|Overall Study|Protocol Violation|3|||
13244779|NCT01614925|26352725|FG001|Overall Study|Protocol Violation|2|||
13244780|NCT01614886|26352746|FG000|Overall Study|Adverse Event|15|||
13244781|NCT01614886|26352747|FG001|Overall Study|Adverse Event|20|||
13244782|NCT01614886|26352746|FG000|Overall Study|Withdrawal by Subject|4|||
13244783|NCT01614886|26352747|FG001|Overall Study|Withdrawal by Subject|4|||
13244784|NCT01614886|26352746|FG000|Overall Study|Death|1|||
13244785|NCT01614886|26352747|FG001|Overall Study|Death|0|||
13244786|NCT01614886|26352746|FG000|Overall Study|Protocol deviation|0|||
13244787|NCT01614886|26352747|FG001|Overall Study|Protocol deviation|2|||
13244788|NCT01614795|26352780|FG000|Overall Study|Adverse Event|0|||
13244789|NCT01614795|26352781|FG001|Overall Study|Adverse Event|0|||
13244790|NCT01614795|26352782|FG002|Overall Study|Adverse Event|1|||
13244791|NCT01614795|26352783|FG003|Overall Study|Adverse Event|1|||
13244792|NCT01614795|26352780|FG000|Overall Study|Lack of Efficacy|10|||
13244793|NCT01614795|26352781|FG001|Overall Study|Lack of Efficacy|10|||
13244794|NCT01614795|26352782|FG002|Overall Study|Lack of Efficacy|9|||
13244795|NCT01614795|26352783|FG003|Overall Study|Lack of Efficacy|8|||
13244796|NCT01614795|26352780|FG000|Overall Study|Physician Decision|1|||
13244797|NCT01614795|26352781|FG001|Overall Study|Physician Decision|0|||
13244798|NCT01614795|26352782|FG002|Overall Study|Physician Decision|1|||
13244799|NCT01614795|26352783|FG003|Overall Study|Physician Decision|1|||
13244800|NCT01614795|26352780|FG000|Overall Study|Withdrawal by Subject|0|||
13244801|NCT01614795|26352781|FG001|Overall Study|Withdrawal by Subject|1|||
13244802|NCT01614795|26352782|FG002|Overall Study|Withdrawal by Subject|0|||
13244803|NCT01614795|26352783|FG003|Overall Study|Withdrawal by Subject|2|||
13244804|NCT01614795|26352780|FG000|Overall Study|Ineligible|0|||
13244805|NCT01614795|26352781|FG001|Overall Study|Ineligible|1|||
13244806|NCT01614795|26352782|FG002|Overall Study|Ineligible|0|||
13244807|NCT01614795|26352783|FG003|Overall Study|Ineligible|0|||
13244808|NCT01614769|26352804|FG000|Period 1|Discontinued due to Hypoglycemia|0|||
13244809|NCT01614769|26352805|FG001|Period 1|Discontinued due to Hypoglycemia|0|||
13244810|NCT01614769|26352806|FG002|Period 1|Discontinued due to Hypoglycemia|0|||
13244811|NCT01614769|26352807|FG003|Period 1|Discontinued due to Hypoglycemia|1|||
13244812|NCT01614769|26352808|FG004|Period 1|Discontinued due to Hypoglycemia|0|||
13244813|NCT01614769|26352809|FG005|Period 1|Discontinued due to Hypoglycemia|1|||
13244814|NCT01614769|26352804|FG000|Period 1|Protocol Violation|0|||
13244815|NCT01614769|26352805|FG001|Period 1|Protocol Violation|0|||
13244816|NCT01614769|26352806|FG002|Period 1|Protocol Violation|0|||
13244817|NCT01614769|26352807|FG003|Period 1|Protocol Violation|1|||
13244818|NCT01614769|26352808|FG004|Period 1|Protocol Violation|0|||
13244819|NCT01614769|26352809|FG005|Period 1|Protocol Violation|0|||
13244820|NCT01614769|26352804|FG000|Period 1|Withdrawal by Subject|1|||
13244821|NCT01614769|26352805|FG001|Period 1|Withdrawal by Subject|0|||
13244822|NCT01614769|26352806|FG002|Period 1|Withdrawal by Subject|0|||
13244823|NCT01614769|26352807|FG003|Period 1|Withdrawal by Subject|0|||
13244824|NCT01614769|26352808|FG004|Period 1|Withdrawal by Subject|0|||
13244825|NCT01614769|26352809|FG005|Period 1|Withdrawal by Subject|0|||
13244826|NCT01614769|26352804|FG000|Period 3|Withdrawal by Subject|0|||
13244827|NCT01614769|26352805|FG001|Period 3|Withdrawal by Subject|0|||
13244828|NCT01614769|26352806|FG002|Period 3|Withdrawal by Subject|1|||
13244829|NCT01614769|26352807|FG003|Period 3|Withdrawal by Subject|0|||
13244830|NCT01614769|26352808|FG004|Period 3|Withdrawal by Subject|0|||
13244831|NCT01614769|26352809|FG005|Period 3|Withdrawal by Subject|0|||
13244832|NCT01614600|26352815|FG000|Overall Study|Unacceptable fit|1|||
13244833|NCT01614600|26352815|FG000|Overall Study|Discomfort|1|||
13244834|NCT01614600|26352815|FG000|Overall Study|Unable to remove lens at the end of day|1|||
13244835|NCT01614600|26352815|FG000|Overall Study|Protocol deviation|1|||
13244836|NCT01614470|26352843|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
13244837|NCT01614470|26352844|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
13244838|NCT01614470|26352845|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
13244839|NCT01614470|26352843|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
13290074|NCT00104650|26480693|FG001|Follow-up Period|Adverse Event|0|||
13244840|NCT01614470|26352844|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
13244841|NCT01614470|26352845|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0|||
13244842|NCT01614457|26352868|FG000|Overall Study|Non-Compliance|1|||
13244843|NCT01614457|26352869|FG001|Overall Study|Non-Compliance|0|||
13244844|NCT01614457|26352868|FG000|Overall Study|Pregnancy (Self or Partner)|1|||
13244845|NCT01614457|26352869|FG001|Overall Study|Pregnancy (Self or Partner)|0|||
13244846|NCT01614249|26352882|FG000|Overall Study|Lost to Follow-up|11|||
13244847|NCT01614249|26352883|FG001|Overall Study|Lost to Follow-up|23|||
13244848|NCT01614093|26352890|FG000|Overall Study|Withdrawal by Subject|1|||
13244849|NCT01614067|26352915|FG000|Overall Study|Pregnancy|1|||
13244850|NCT01614067|26352916|FG001|Overall Study|Pregnancy|0|||
13244851|NCT01614067|26352915|FG000|Overall Study|Physician Decision|6|||
13244852|NCT01614067|26352916|FG001|Overall Study|Physician Decision|5|||
13244853|NCT01614067|26352915|FG000|Overall Study|Withdrawal by Subject|0|||
13244854|NCT01614067|26352916|FG001|Overall Study|Withdrawal by Subject|1|||
13244855|NCT01614067|26352915|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8|||
13244856|NCT01614067|26352916|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9|||
13244857|NCT01613716|26352923|FG000|Overall Study|screen failures|3|||
13244858|NCT01613716|26352923|FG000|Overall Study|Lost to Follow-up|4|||
13244859|NCT01613599|26352938|FG000|Overall Study|Death|9|||
13244860|NCT01613599|26352938|FG000|Overall Study|Lost to Follow-up|5|||
13244861|NCT01613599|26352938|FG000|Overall Study|Withdrawal by Subject|8|||
13244862|NCT01613599|26352938|FG000|Overall Study|Reason not specified|3|||
13244863|NCT01613417|26352982|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13|||
13244864|NCT01613417|26352983|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7|||
13244865|NCT01613378|26353001|FG000|Overall Study|Lack of Efficacy|13|||
13244866|NCT01613378|26353001|FG000|Overall Study|Adverse Event|11|||
13244867|NCT01613378|26353001|FG000|Overall Study|Withdrawal by Subject|8|||
13244868|NCT01613378|26353001|FG000|Overall Study|Death|2|||
13244869|NCT01613378|26353001|FG000|Overall Study|Lost to Follow-up|1|||
13244870|NCT01613378|26353001|FG000|Overall Study|Other Reason|4|||
13244871|NCT01613326|26353038|FG000|Overall Study|Adverse Event|7|||
13244872|NCT01613326|26353039|FG001|Overall Study|Adverse Event|5|||
13244873|NCT01613326|26353038|FG000|Overall Study|Withdrawal by Subject|3|||
13244874|NCT01613326|26353039|FG001|Overall Study|Withdrawal by Subject|4|||
13244875|NCT01613326|26353038|FG000|Overall Study|Abnormal test procedure result(s)|2|||
13244876|NCT01613326|26353039|FG001|Overall Study|Abnormal test procedure result(s)|0|||
13244877|NCT01613326|26353038|FG000|Overall Study|inability to use device|1|||
13244878|NCT01613326|26353039|FG001|Overall Study|inability to use device|0|||
13244879|NCT01613326|26353038|FG000|Overall Study|Lack of Efficacy|0|||
13244880|NCT01613326|26353039|FG001|Overall Study|Lack of Efficacy|1|||
13244881|NCT01613326|26353038|FG000|Overall Study|Lost to Follow-up|0|||
13244882|NCT01613326|26353039|FG001|Overall Study|Lost to Follow-up|1|||
13244883|NCT01613326|26353038|FG000|Overall Study|Administrative|0|||
13244884|NCT01613326|26353039|FG001|Overall Study|Administrative|2|||
13244885|NCT01613326|26353038|FG000|Overall Study|Protocol Violation|0|||
13244886|NCT01613326|26353039|FG001|Overall Study|Protocol Violation|1|||
13244887|NCT01613248|26353156|FG000|Overall Study|Adverse Event|0|||
13244888|NCT01613248|26353157|FG001|Overall Study|Adverse Event|0|||
13244889|NCT01613248|26353158|FG002|Overall Study|Adverse Event|0|||
13244890|NCT01613248|26353159|FG003|Overall Study|Adverse Event|1|||
13244891|NCT01613248|26353160|FG004|Overall Study|Adverse Event|0|||
13244892|NCT01613248|26353161|FG005|Overall Study|Adverse Event|0|||
13244893|NCT01613248|26353156|FG000|Overall Study|Withdrawal by Subject|3|||
13244894|NCT01613248|26353157|FG001|Overall Study|Withdrawal by Subject|2|||
13244895|NCT01613248|26353158|FG002|Overall Study|Withdrawal by Subject|2|||
13244896|NCT01613248|26353159|FG003|Overall Study|Withdrawal by Subject|5|||
13244897|NCT01613248|26353160|FG004|Overall Study|Withdrawal by Subject|0|||
13244898|NCT01613248|26353161|FG005|Overall Study|Withdrawal by Subject|1|||
13244899|NCT01613248|26353156|FG000|Overall Study|Lost to Follow-up|5|||
13244900|NCT01613248|26353157|FG001|Overall Study|Lost to Follow-up|7|||
13244901|NCT01613248|26353158|FG002|Overall Study|Lost to Follow-up|4|||
13244902|NCT01613248|26353159|FG003|Overall Study|Lost to Follow-up|8|||
13244903|NCT01613248|26353160|FG004|Overall Study|Lost to Follow-up|4|||
13244904|NCT01613248|26353161|FG005|Overall Study|Lost to Follow-up|2|||
13244905|NCT01613248|26353156|FG000|Overall Study|Study Terminated by Sponsor|4|||
13244906|NCT01613248|26353157|FG001|Overall Study|Study Terminated by Sponsor|6|||
13244907|NCT01613248|26353158|FG002|Overall Study|Study Terminated by Sponsor|8|||
13244908|NCT01613248|26353159|FG003|Overall Study|Study Terminated by Sponsor|8|||
13244909|NCT01613248|26353160|FG004|Overall Study|Study Terminated by Sponsor|9|||
13244910|NCT01613248|26353161|FG005|Overall Study|Study Terminated by Sponsor|11|||
13244911|NCT01613248|26353156|FG000|Overall Study|Physician Decision|8|||
13244912|NCT01613248|26353157|FG001|Overall Study|Physician Decision|8|||
13244913|NCT01613248|26353158|FG002|Overall Study|Physician Decision|9|||
13244914|NCT01613248|26353159|FG003|Overall Study|Physician Decision|4|||
13244915|NCT01613248|26353160|FG004|Overall Study|Physician Decision|7|||
13244916|NCT01613248|26353161|FG005|Overall Study|Physician Decision|6|||
13244917|NCT01613248|26353156|FG000|Overall Study|Lack of Qualifying Event|9|||
13244918|NCT01613248|26353157|FG001|Overall Study|Lack of Qualifying Event|11|||
13244919|NCT01613248|26353158|FG002|Overall Study|Lack of Qualifying Event|10|||
13244920|NCT01613248|26353159|FG003|Overall Study|Lack of Qualifying Event|11|||
13244921|NCT01613248|26353160|FG004|Overall Study|Lack of Qualifying Event|15|||
13244922|NCT01613248|26353161|FG005|Overall Study|Lack of Qualifying Event|18|||
13244923|NCT01613248|26353156|FG000|Overall Study|Pregnancy|0|||
13244924|NCT01613248|26353157|FG001|Overall Study|Pregnancy|0|||
13244925|NCT01613248|26353158|FG002|Overall Study|Pregnancy|0|||
13244926|NCT01613248|26353159|FG003|Overall Study|Pregnancy|1|||
13244927|NCT01613248|26353160|FG004|Overall Study|Pregnancy|0|||
13244928|NCT01613248|26353161|FG005|Overall Study|Pregnancy|0|||
13244929|NCT01613222|26353176|FG000|Overall Study|Physician Decision|1|||
13244930|NCT01613222|26353176|FG000|Overall Study|Unable to place arterial line|1|||
13244931|NCT01613222|26353176|FG000|Overall Study|Reused disposable sensors|10|||
13244932|NCT01613131|26353211|FG000|Overall Study|Withdrawal by Subject|3|||
13244933|NCT01613131|26353212|FG001|Overall Study|Withdrawal by Subject|5|||
13244934|NCT01613027|26353233|FG000|Overall Study|Lost to Follow-up|5|||
13244935|NCT01613027|26353233|FG000|Overall Study|Switched Physician|1|||
13244936|NCT01613027|26353233|FG000|Overall Study|Lack of Efficacy|1|||
13244937|NCT01613027|26353233|FG000|Overall Study|Patient's Decision Due to Adverse Event|1|||
13244938|NCT01612858|26353248|FG000|Overall Study|Withdrawal by Subject|5|||
13244939|NCT01612858|26353249|FG001|Overall Study|Withdrawal by Subject|1|||
13244940|NCT01612780|26353257|FG000|Overall Study|Treatment not completed|1|||
13244941|NCT01612780|26353257|FG000|Overall Study|Withdrawal by Subject|5|||
13244942|NCT01612702|26353274|FG000|Overall Study|Protocol Violation|11|||
13244943|NCT01612702|26353275|FG001|Overall Study|Protocol Violation|11|||
13244944|NCT01612676|26353344|FG000|Overall Study|Adverse Event|2|||
13244945|NCT01612676|26353345|FG001|Overall Study|Adverse Event|3|||
13244946|NCT01612676|26353346|FG002|Overall Study|Adverse Event|1|||
13244947|NCT01612676|26353347|FG003|Overall Study|Adverse Event|3|||
13244948|NCT01612676|26353344|FG000|Overall Study|Protocol Violation|0|||
13244949|NCT01612676|26353345|FG001|Overall Study|Protocol Violation|1|||
13244950|NCT01612676|26353346|FG002|Overall Study|Protocol Violation|0|||
13244951|NCT01612676|26353347|FG003|Overall Study|Protocol Violation|0|||
13244952|NCT01612156|26353362|FG000|Overall Study|Protocol Violation|2|||
13244953|NCT01612156|26353363|FG001|Overall Study|Protocol Violation|0|||
13244954|NCT01612000|26353398|FG000|Overall Study|Lost to Follow-up|6|||
13244955|NCT01612000|26353399|FG001|Overall Study|Lost to Follow-up|4|||
13244956|NCT01612000|26353400|FG002|Overall Study|Lost to Follow-up|4|||
13244957|NCT01612000|26353401|FG003|Overall Study|Lost to Follow-up|8|||
13244958|NCT01612000|26353398|FG000|Overall Study|Physician Decision|0|||
13244959|NCT01612000|26353399|FG001|Overall Study|Physician Decision|0|||
13244960|NCT01612000|26353400|FG002|Overall Study|Physician Decision|1|||
13244961|NCT01612000|26353401|FG003|Overall Study|Physician Decision|0|||
13244962|NCT01612000|26353398|FG000|Overall Study|Withdrawal by Subject|3|||
13244963|NCT01612000|26353399|FG001|Overall Study|Withdrawal by Subject|1|||
13244964|NCT01612000|26353400|FG002|Overall Study|Withdrawal by Subject|2|||
13244965|NCT01612000|26353401|FG003|Overall Study|Withdrawal by Subject|2|||
13244966|NCT01611974|26353446|FG000|Overall Study|Death|10|||
13244967|NCT01611974|26353447|FG001|Overall Study|Death|12|||
13244968|NCT01611974|26353448|FG002|Overall Study|Death|10|||
13244969|NCT01611974|26353446|FG000|Overall Study|Lost to Follow-up|0|||
13244970|NCT01611974|26353447|FG001|Overall Study|Lost to Follow-up|1|||
13244971|NCT01611974|26353448|FG002|Overall Study|Lost to Follow-up|0|||
13244972|NCT01611974|26353446|FG000|Overall Study|Physician Decision|5|||
13244973|NCT01611974|26353447|FG001|Overall Study|Physician Decision|1|||
13244974|NCT01611974|26353448|FG002|Overall Study|Physician Decision|2|||
13244975|NCT01611974|26353446|FG000|Overall Study|Withdrawal by Subject|0|||
13244976|NCT01611974|26353447|FG001|Overall Study|Withdrawal by Subject|1|||
13244977|NCT01611974|26353448|FG002|Overall Study|Withdrawal by Subject|4|||
13244978|NCT01611935|26353465|FG000|Overall Study|Family Declined Participation|1|||
13244979|NCT01611935|26353466|FG001|Overall Study|Family Declined Participation|0|||
13244980|NCT01611883|26353497|FG000|Overall Study|Adverse Event|1|||
13244981|NCT01611883|26353498|FG001|Overall Study|Adverse Event|1|||
13244982|NCT01611857|26353515|FG000|Overall Study|Withdrawal by Subject|0|||
13244983|NCT01611857|26353516|FG001|Overall Study|Withdrawal by Subject|2|||
13244984|NCT01611792|26353539|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12|||
13244985|NCT01611792|26353540|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9|||
13244986|NCT01611792|26353539|FG000|Followup: at 6 Months|Lost to Follow-up|6|||
13244987|NCT01611792|26353540|FG001|Followup: at 6 Months|Lost to Follow-up|13|||
13244988|NCT01611558|26353548|FG000|Induction Phase|Study drug toxicity|15|||
13244989|NCT01611558|26353548|FG000|Induction Phase|Disease progression|18|||
13244990|NCT01611558|26353548|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1|||
13244991|NCT01611558|26353548|FG000|Induction Phase|Adverse event unrelated to study drug|3|||
13244992|NCT01611558|26353548|FG000|Induction Phase|Death|1|||
13244993|NCT01611558|26353548|FG000|Maintenance Phase|Withdrawal by Subject|1|||
13244994|NCT01611558|26353548|FG000|Maintenance Phase|Elevated Uric acid|1|||
13244995|NCT01611454|26353567|FG000|Overall Study|Lack of Efficacy|18|||
13244996|NCT01611454|26353568|FG001|Overall Study|Lack of Efficacy|10|||
13244997|NCT01611298|26353575|FG000|Overall Study|Relapsed|2|||
13244998|NCT01611259|26353581|FG000|Overall Study|Physician Decision|1|||
13244999|NCT01611259|26353581|FG000|Overall Study|Lack of Efficacy|2|||
13245000|NCT01611259|26353581|FG000|Overall Study|Adverse Event|4|||
13245001|NCT01611259|26353581|FG000|Overall Study|Withdrawal by Subject|7|||
13245002|NCT01611194|26353624|FG000|Overall Study|Lost to Follow-up|0|||
13245003|NCT01611194|26353625|FG001|Overall Study|Lost to Follow-up|1|||
13245004|NCT01611194|26353624|FG000|Overall Study|Withdrawal by Subject|0|||
13245005|NCT01611194|26353625|FG001|Overall Study|Withdrawal by Subject|1|||
13245006|NCT01611194|26353624|FG000|Overall Study|drug use|0|||
13245007|NCT01611194|26353625|FG001|Overall Study|drug use|1|||
13245008|NCT01611155|26353640|FG000|Overall Study|Adverse Event|1|||
13245009|NCT01611155|26353641|FG001|Overall Study|Adverse Event|1|||
13245010|NCT01611155|26353640|FG000|Overall Study|Refused further treatment|6|||
13245011|NCT01611155|26353641|FG001|Overall Study|Refused further treatment|4|||
13245012|NCT01611155|26353640|FG000|Overall Study|Disease progression|1|||
13245013|NCT01611155|26353641|FG001|Overall Study|Disease progression|0|||
13245014|NCT01611155|26353640|FG000|Overall Study|Withdrawal by Subject|1|||
13245015|NCT01611155|26353641|FG001|Overall Study|Withdrawal by Subject|0|||
13245016|NCT01611155|26353640|FG000|Overall Study|Alternative treatment|0|||
13245017|NCT01611155|26353641|FG001|Overall Study|Alternative treatment|1|||
13245018|NCT01611155|26353640|FG000|Overall Study|Ineligible patient|0|||
13245019|NCT01611155|26353641|FG001|Overall Study|Ineligible patient|1|||
13245020|NCT01611090|26353682|FG000|Randomized Period|Lost to Follow-up|8|||
13245021|NCT01611090|26353683|FG001|Randomized Period|Lost to Follow-up|3|||
13245022|NCT01611090|26353684|FG002|Randomized Period|Lost to Follow-up|0|||
13245023|NCT01611090|26353682|FG000|Randomized Period|Withdrawal by Subject|22|||
13245024|NCT01611090|26353683|FG001|Randomized Period|Withdrawal by Subject|26|||
13245025|NCT01611090|26353684|FG002|Randomized Period|Withdrawal by Subject|0|||
13245026|NCT01611090|26353682|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
13245027|NCT01611090|26353683|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
13245028|NCT01611090|26353684|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4|||
13245029|NCT01611090|26353682|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
13245030|NCT01611090|26353683|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
13245031|NCT01611090|26353684|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1|||
13245032|NCT01610791|26353707|FG000|Overall Study|Lost to Follow-up|7|||
13245033|NCT01610791|26353707|FG000|Overall Study|Adverse Event|6|||
13115997|NCT03085914|25920531|FG005|Overall Study|Death|2|||
13115998|NCT03085914|25920532|FG006|Overall Study|Death|2|||
13115999|NCT03085914|25920526|FG000|Overall Study|Withdrawal by Subject|1|||
13116000|NCT03085914|25920527|FG001|Overall Study|Withdrawal by Subject|1|||
13116001|NCT03085914|25920528|FG002|Overall Study|Withdrawal by Subject|2|||
13116002|NCT03085914|25920529|FG003|Overall Study|Withdrawal by Subject|2|||
13116003|NCT03085914|25920530|FG004|Overall Study|Withdrawal by Subject|2|||
13116004|NCT03085914|25920531|FG005|Overall Study|Withdrawal by Subject|0|||
13116005|NCT03085914|25920532|FG006|Overall Study|Withdrawal by Subject|1|||
13116006|NCT03085914|25920526|FG000|Overall Study|Lost to Follow-up|0|||
13116007|NCT03085914|25920527|FG001|Overall Study|Lost to Follow-up|0|||
13116008|NCT03085914|25920528|FG002|Overall Study|Lost to Follow-up|1|||
13116009|NCT03085914|25920529|FG003|Overall Study|Lost to Follow-up|0|||
13245034|NCT01610791|26353707|FG000|Overall Study|Physician Decision|1|||
13116010|NCT03085914|25920530|FG004|Overall Study|Lost to Follow-up|0|||
13116011|NCT03085914|25920531|FG005|Overall Study|Lost to Follow-up|1|||
13116012|NCT03085914|25920532|FG006|Overall Study|Lost to Follow-up|1|||
13116013|NCT03085914|25920526|FG000|Overall Study|Reason was not specified,|2|||
13116014|NCT03085914|25920527|FG001|Overall Study|Reason was not specified,|2|||
13116015|NCT03085914|25920528|FG002|Overall Study|Reason was not specified,|2|||
13245035|NCT01610791|26353707|FG000|Overall Study|Adverse event and Investigator decision|1|||
13245036|NCT01610791|26353707|FG000|Overall Study|Death|1|||
13116016|NCT03085914|25920529|FG003|Overall Study|Reason was not specified,|3|||
13116017|NCT03085914|25920530|FG004|Overall Study|Reason was not specified,|3|||
13116018|NCT03085914|25920531|FG005|Overall Study|Reason was not specified,|3|||
13116019|NCT03085914|25920532|FG006|Overall Study|Reason was not specified,|6|||
13245037|NCT01610791|26353707|FG000|Overall Study|Not determined|5|||
13245038|NCT01610752|26353737|FG000|Overall Study|Miscarriage/Pregnancy loss|0|||
13245039|NCT01610752|26353738|FG001|Overall Study|Miscarriage/Pregnancy loss|0|||
13245040|NCT01610752|26353739|FG002|Overall Study|Miscarriage/Pregnancy loss|4|||
13245041|NCT01610596|26353758|FG000|Overall Study|Lost to Follow-up|0|||
13245042|NCT01610596|26353759|FG001|Overall Study|Lost to Follow-up|1|||
13245043|NCT01610492|26353805|FG000|Overall Study|Adverse Event|1|||
13245044|NCT01610492|26353805|FG000|Overall Study|Lack of Efficacy|3|||
13245045|NCT01610492|26353805|FG000|Overall Study|Other: Reached stopping criteria|1|||
13116020|NCT03085914|25920526|FG000|Overall Study|Progressive Disease|0|||
13116021|NCT03085914|25920527|FG001|Overall Study|Progressive Disease|0|||
13116022|NCT03085914|25920528|FG002|Overall Study|Progressive Disease|2|||
13245046|NCT01610492|26353805|FG000|Overall Study|Other:Treatment stopped due to remission|1|||
13245047|NCT01610414|26353841|FG000|Study Start - Month 13|Serious Adverse Event|65|||
13245048|NCT01610414|26353842|FG001|Study Start - Month 13|Serious Adverse Event|67|||
13245049|NCT01610414|26353841|FG000|Study Start - Month 13|Adverse Event|14|||
13245050|NCT01610414|26353842|FG001|Study Start - Month 13|Adverse Event|14|||
13245051|NCT01610414|26353841|FG000|Study Start - Month 13|Protocol Violation|3|||
13245052|NCT01610414|26353842|FG001|Study Start - Month 13|Protocol Violation|1|||
13245053|NCT01610414|26353841|FG000|Study Start - Month 13|Withdrawal by Subject|23|||
13245054|NCT01610414|26353842|FG001|Study Start - Month 13|Withdrawal by Subject|30|||
13245055|NCT01610414|26353841|FG000|Study Start - Month 13|Migrated/moved from study area|2|||
13245056|NCT01610414|26353842|FG001|Study Start - Month 13|Migrated/moved from study area|4|||
13245057|NCT01610414|26353841|FG000|Study Start - Month 13|Lost to Follow-up|4|||
13245058|NCT01610414|26353842|FG001|Study Start - Month 13|Lost to Follow-up|6|||
13245059|NCT01610414|26353841|FG000|Study Start - Month 13|Suspected HZ episode|1|||
13245060|NCT01610414|26353842|FG001|Study Start - Month 13|Suspected HZ episode|3|||
13245061|NCT01610414|26353841|FG000|Study Start - Month 13|Other reasons for withdrawal|3|||
13245062|NCT01610414|26353842|FG001|Study Start - Month 13|Other reasons for withdrawal|4|||
13245063|NCT01610414|26353841|FG000|Month 13 - Month 25|Serious Adverse Event|35|||
13245064|NCT01610414|26353842|FG001|Month 13 - Month 25|Serious Adverse Event|38|||
13245065|NCT01610414|26353841|FG000|Month 13 - Month 25|Adverse Event|8|||
13245066|NCT01610414|26353842|FG001|Month 13 - Month 25|Adverse Event|4|||
13245067|NCT01610414|26353841|FG000|Month 13 - Month 25|Withdrawal by Subject|7|||
13245068|NCT01610414|26353842|FG001|Month 13 - Month 25|Withdrawal by Subject|8|||
13245069|NCT01610414|26353841|FG000|Month 13 - Month 25|Migrated/moved from study area|4|||
13245070|NCT01610414|26353842|FG001|Month 13 - Month 25|Migrated/moved from study area|2|||
13245071|NCT01610414|26353841|FG000|Month 13 - Month 25|Protocol Violation|0|||
13245072|NCT01610414|26353842|FG001|Month 13 - Month 25|Protocol Violation|2|||
13245073|NCT01610414|26353841|FG000|Month 13 - Month 25|Lost to Follow-up|5|||
13245074|NCT01610414|26353842|FG001|Month 13 - Month 25|Lost to Follow-up|9|||
13245075|NCT01610414|26353841|FG000|Month 13 - Month 25|Other reasons for withdrawal|6|||
13116023|NCT03085914|25920529|FG003|Overall Study|Progressive Disease|2|||
13116024|NCT03085914|25920530|FG004|Overall Study|Progressive Disease|1|||
13116025|NCT03085914|25920531|FG005|Overall Study|Progressive Disease|1|||
13116026|NCT03085914|25920532|FG006|Overall Study|Progressive Disease|1|||
13116027|NCT03085914|25920526|FG000|Overall Study|Study Terminated by the Sponsor|0|||
13116028|NCT03085914|25920527|FG001|Overall Study|Study Terminated by the Sponsor|0|||
13116029|NCT03085914|25920528|FG002|Overall Study|Study Terminated by the Sponsor|0|||
13116030|NCT03085914|25920529|FG003|Overall Study|Study Terminated by the Sponsor|1|||
13116031|NCT03085914|25920530|FG004|Overall Study|Study Terminated by the Sponsor|2|||
13116032|NCT03085914|25920531|FG005|Overall Study|Study Terminated by the Sponsor|1|||
13116033|NCT03085914|25920532|FG006|Overall Study|Study Terminated by the Sponsor|0|||
13116034|NCT03085797|25920561|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1|||
13116035|NCT03085797|25920562|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0|||
13116036|NCT03085797|25920561|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16|||
13116037|NCT03085797|25920562|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17|||
13245076|NCT01610414|26353842|FG001|Month 13 - Month 25|Other reasons for withdrawal|7|||
13245077|NCT01610414|26353841|FG000|After Month 25|Study end not reached|48|||
13245078|NCT01610414|26353842|FG001|After Month 25|Study end not reached|53|||
13245079|NCT01610336|26354006|FG000|Overall Study|Progressive Disease|4|||
13245080|NCT01610336|26354007|FG001|Overall Study|Progressive Disease|6|||
13245081|NCT01610336|26354008|FG002|Overall Study|Progressive Disease|6|||
13245082|NCT01610336|26354009|FG003|Overall Study|Progressive Disease|5|||
13245083|NCT01610336|26354010|FG004|Overall Study|Progressive Disease|3|||
13245084|NCT01610336|26354011|FG005|Overall Study|Progressive Disease|10|||
13245085|NCT01610336|26354012|FG006|Overall Study|Progressive Disease|1|||
13245086|NCT01610336|26354013|FG007|Overall Study|Progressive Disease|6|||
13245087|NCT01610336|26354014|FG008|Overall Study|Progressive Disease|6|||
13245088|NCT01610336|26354015|FG009|Overall Study|Progressive Disease|40|||
13245089|NCT01610336|26354016|FG010|Overall Study|Progressive Disease|36|||
13245090|NCT01610336|26354006|FG000|Overall Study|Adverse Event|0|||
13245091|NCT01610336|26354007|FG001|Overall Study|Adverse Event|0|||
13245092|NCT01610336|26354008|FG002|Overall Study|Adverse Event|0|||
13245093|NCT01610336|26354009|FG003|Overall Study|Adverse Event|1|||
13245094|NCT01610336|26354010|FG004|Overall Study|Adverse Event|1|||
13245095|NCT01610336|26354011|FG005|Overall Study|Adverse Event|1|||
13245096|NCT01610336|26354012|FG006|Overall Study|Adverse Event|0|||
13245097|NCT01610336|26354013|FG007|Overall Study|Adverse Event|0|||
13245098|NCT01610336|26354014|FG008|Overall Study|Adverse Event|2|||
13245099|NCT01610336|26354015|FG009|Overall Study|Adverse Event|8|||
13245100|NCT01610336|26354016|FG010|Overall Study|Adverse Event|6|||
13245101|NCT01610336|26354006|FG000|Overall Study|Subject/Guardian decision|1|||
13245102|NCT01610336|26354007|FG001|Overall Study|Subject/Guardian decision|1|||
13245103|NCT01610336|26354008|FG002|Overall Study|Subject/Guardian decision|0|||
13116038|NCT03085797|25920561|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0|||
13245104|NCT01610336|26354009|FG003|Overall Study|Subject/Guardian decision|1|||
13245105|NCT01610336|26354010|FG004|Overall Study|Subject/Guardian decision|0|||
13245106|NCT01610336|26354011|FG005|Overall Study|Subject/Guardian decision|0|||
13245107|NCT01610336|26354012|FG006|Overall Study|Subject/Guardian decision|0|||
13245108|NCT01610336|26354013|FG007|Overall Study|Subject/Guardian decision|1|||
13245109|NCT01610336|26354014|FG008|Overall Study|Subject/Guardian decision|0|||
13245110|NCT01610336|26354015|FG009|Overall Study|Subject/Guardian decision|2|||
13245111|NCT01610336|26354016|FG010|Overall Study|Subject/Guardian decision|2|||
13245112|NCT01610336|26354006|FG000|Overall Study|Death|0|||
13245113|NCT01610336|26354007|FG001|Overall Study|Death|0|||
13245114|NCT01610336|26354008|FG002|Overall Study|Death|0|||
13245115|NCT01610336|26354009|FG003|Overall Study|Death|0|||
13245116|NCT01610336|26354010|FG004|Overall Study|Death|0|||
13245117|NCT01610336|26354011|FG005|Overall Study|Death|1|||
13245118|NCT01610336|26354012|FG006|Overall Study|Death|3|||
13245119|NCT01610336|26354013|FG007|Overall Study|Death|0|||
13245120|NCT01610336|26354014|FG008|Overall Study|Death|0|||
13245121|NCT01610336|26354015|FG009|Overall Study|Death|1|||
13245122|NCT01610336|26354016|FG010|Overall Study|Death|2|||
13245123|NCT01610336|26354006|FG000|Overall Study|Non-Compliance with study treatment|0|||
13245124|NCT01610336|26354007|FG001|Overall Study|Non-Compliance with study treatment|0|||
13245125|NCT01610336|26354008|FG002|Overall Study|Non-Compliance with study treatment|0|||
13245126|NCT01610336|26354009|FG003|Overall Study|Non-Compliance with study treatment|0|||
13245127|NCT01610336|26354010|FG004|Overall Study|Non-Compliance with study treatment|0|||
13245128|NCT01610336|26354011|FG005|Overall Study|Non-Compliance with study treatment|0|||
13245129|NCT01610336|26354012|FG006|Overall Study|Non-Compliance with study treatment|0|||
13245130|NCT01610336|26354013|FG007|Overall Study|Non-Compliance with study treatment|0|||
13245131|NCT01610336|26354014|FG008|Overall Study|Non-Compliance with study treatment|0|||
13245132|NCT01610336|26354015|FG009|Overall Study|Non-Compliance with study treatment|1|||
13245133|NCT01610336|26354016|FG010|Overall Study|Non-Compliance with study treatment|0|||
13245134|NCT01610336|26354006|FG000|Overall Study|Physician Decision|0|||
13245135|NCT01610336|26354007|FG001|Overall Study|Physician Decision|0|||
13245136|NCT01610336|26354008|FG002|Overall Study|Physician Decision|0|||
13245137|NCT01610336|26354009|FG003|Overall Study|Physician Decision|0|||
13245138|NCT01610336|26354010|FG004|Overall Study|Physician Decision|0|||
13245139|NCT01610336|26354011|FG005|Overall Study|Physician Decision|0|||
13245140|NCT01610336|26354012|FG006|Overall Study|Physician Decision|1|||
13245141|NCT01610336|26354013|FG007|Overall Study|Physician Decision|0|||
13245142|NCT01610336|26354014|FG008|Overall Study|Physician Decision|0|||
13245143|NCT01610336|26354015|FG009|Overall Study|Physician Decision|0|||
13245144|NCT01610336|26354016|FG010|Overall Study|Physician Decision|0|||
13245145|NCT01610336|26354006|FG000|Overall Study|Protocol Deviation|0|||
13245146|NCT01610336|26354007|FG001|Overall Study|Protocol Deviation|0|||
13245147|NCT01610336|26354008|FG002|Overall Study|Protocol Deviation|0|||
13245148|NCT01610336|26354009|FG003|Overall Study|Protocol Deviation|0|||
13245149|NCT01610336|26354010|FG004|Overall Study|Protocol Deviation|0|||
13245150|NCT01610336|26354011|FG005|Overall Study|Protocol Deviation|0|||
13245151|NCT01610336|26354012|FG006|Overall Study|Protocol Deviation|0|||
13245152|NCT01610336|26354013|FG007|Overall Study|Protocol Deviation|0|||
13245153|NCT01610336|26354014|FG008|Overall Study|Protocol Deviation|0|||
13245154|NCT01610336|26354015|FG009|Overall Study|Protocol Deviation|1|||
13245155|NCT01610336|26354016|FG010|Overall Study|Protocol Deviation|0|||
13245156|NCT01610336|26354006|FG000|Overall Study|Transfer to another trial|0|||
13245157|NCT01610336|26354007|FG001|Overall Study|Transfer to another trial|0|||
13245158|NCT01610336|26354008|FG002|Overall Study|Transfer to another trial|0|||
13245159|NCT01610336|26354009|FG003|Overall Study|Transfer to another trial|0|||
13245160|NCT01610336|26354010|FG004|Overall Study|Transfer to another trial|0|||
13245161|NCT01610336|26354011|FG005|Overall Study|Transfer to another trial|0|||
13245162|NCT01610336|26354012|FG006|Overall Study|Transfer to another trial|0|||
13245163|NCT01610336|26354013|FG007|Overall Study|Transfer to another trial|0|||
13245164|NCT01610336|26354014|FG008|Overall Study|Transfer to another trial|0|||
13245165|NCT01610336|26354015|FG009|Overall Study|Transfer to another trial|0|||
13245166|NCT01610336|26354016|FG010|Overall Study|Transfer to another trial|1|||
13245167|NCT01610297|26354026|FG000|Overall Study|Lost to Follow-up|1|||
13245168|NCT01610284|26354053|FG000|Randomization Phase|Adverse Event|1|||
13245169|NCT01610284|26354054|FG001|Randomization Phase|Adverse Event|0|||
13245170|NCT01610284|26354053|FG000|Randomization Phase|Physician Decision|1|||
13245171|NCT01610284|26354054|FG001|Randomization Phase|Physician Decision|1|||
13245172|NCT01610284|26354053|FG000|Randomization Phase|Death|0|||
13245173|NCT01610284|26354054|FG001|Randomization Phase|Death|1|||
13245174|NCT01610284|26354053|FG000|Treatment Phase|Adverse Event|80|||
13245175|NCT01610284|26354054|FG001|Treatment Phase|Adverse Event|12|||
13245176|NCT01610284|26354053|FG000|Treatment Phase|Lost to Follow-up|1|||
13245177|NCT01610284|26354054|FG001|Treatment Phase|Lost to Follow-up|0|||
13245178|NCT01610284|26354053|FG000|Treatment Phase|Non-compliance with Study Treatment|8|||
13245179|NCT01610284|26354054|FG001|Treatment Phase|Non-compliance with Study Treatment|1|||
13245180|NCT01610284|26354053|FG000|Treatment Phase|Physician Decision|27|||
13245181|NCT01610284|26354054|FG001|Treatment Phase|Physician Decision|24|||
13245182|NCT01610284|26354053|FG000|Treatment Phase|Progressive Disease|377|||
13245183|NCT01610284|26354054|FG001|Treatment Phase|Progressive Disease|486|||
13245184|NCT01610284|26354053|FG000|Treatment Phase|Protocol Deviation|2|||
13245185|NCT01610284|26354054|FG001|Treatment Phase|Protocol Deviation|3|||
13245186|NCT01610284|26354053|FG000|Treatment Phase|Study terminated by Sponsor|18|||
13245187|NCT01610284|26354054|FG001|Treatment Phase|Study terminated by Sponsor|15|||
13245188|NCT01610284|26354053|FG000|Treatment Phase|Subject/Guardian Decision|55|||
13245189|NCT01610284|26354054|FG001|Treatment Phase|Subject/Guardian Decision|23|||
13245190|NCT01610284|26354053|FG000|Treatment Phase|Death|6|||
13245191|NCT01610284|26354054|FG001|Treatment Phase|Death|5|||
13245192|NCT01610284|26354053|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
13245193|NCT01610284|26354054|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
13245194|NCT01610284|26354053|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10|||
13245195|NCT01610284|26354054|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3|||
13245196|NCT01610284|26354053|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24|||
13245197|NCT01610284|26354054|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8|||
13245198|NCT01610284|26354053|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11|||
13245199|NCT01610284|26354054|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
13245200|NCT01610284|26354053|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
13245201|NCT01610284|26354054|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
13245202|NCT01610284|26354053|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38|||
13245203|NCT01610284|26354054|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13|||
13245204|NCT01610271|26354073|FG000|Overall Study|Surgery not complete|0|||
13245205|NCT01610271|26354074|FG001|Overall Study|Surgery not complete|1|||
13245206|NCT01610271|26354073|FG000|Overall Study|Prosthesis not implanted|2|||
13245207|NCT01610271|26354074|FG001|Overall Study|Prosthesis not implanted|3|||
13245208|NCT01610206|26354089|FG000|Overall Study|Adverse Event|10|||
13245209|NCT01610206|26354090|FG001|Overall Study|Adverse Event|30|||
13245210|NCT01610167|26354120|FG000|Overall Study|Scheduling conflict.|0|||
13245211|NCT01610167|26354121|FG001|Overall Study|Scheduling conflict.|0|||
13245212|NCT01610167|26354122|FG002|Overall Study|Scheduling conflict.|2|||
13245213|NCT01610076|26354138|FG000|Overall Study|Technical issue with video|0|||
13245214|NCT01610076|26354139|FG001|Overall Study|Technical issue with video|1|||
13245215|NCT01610076|26354138|FG000|Overall Study|Lost to Follow-up|3|||
13245216|NCT01610076|26354139|FG001|Overall Study|Lost to Follow-up|4|||
13245217|NCT01610063|26354166|FG000|Overall Study|Lost to Follow-up|42|||
13245218|NCT01610063|26354167|FG001|Overall Study|Lost to Follow-up|20|||
13290075|NCT00104650|26480694|FG002|Follow-up Period|Adverse Event|1|||
13290076|NCT00104650|26480692|FG000|Follow-up Period|Withdrawal by Subject|0|||
13290077|NCT00104650|26480693|FG001|Follow-up Period|Withdrawal by Subject|3|||
13290078|NCT00104650|26480694|FG002|Follow-up Period|Withdrawal by Subject|3|||
13290079|NCT00104650|26480692|FG000|Follow-up Period|Death|6|||
13290080|NCT00104650|26480693|FG001|Follow-up Period|Death|6|||
13290081|NCT00104650|26480694|FG002|Follow-up Period|Death|4|||
13290082|NCT00104650|26480692|FG000|Follow-up Period|Disease progression|3|||
13290083|NCT00104650|26480693|FG001|Follow-up Period|Disease progression|1|||
13290084|NCT00104650|26480694|FG002|Follow-up Period|Disease progression|0|||
13290085|NCT00104650|26480692|FG000|Follow-up Period|Lost to Follow-up|0|||
13290086|NCT00104650|26480693|FG001|Follow-up Period|Lost to Follow-up|1|||
13116039|NCT03085797|25920562|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1|||
13116040|NCT03085758|25920725|FG000|Overall Study|Death|26|||
13116041|NCT03085758|25920726|FG001|Overall Study|Death|24|||
13116042|NCT03085758|25920727|FG002|Overall Study|Death|53|||
13116043|NCT03085758|25920725|FG000|Overall Study|Lost to Follow-up|1|||
13116044|NCT03085758|25920726|FG001|Overall Study|Lost to Follow-up|1|||
13116045|NCT03085758|25920727|FG002|Overall Study|Lost to Follow-up|1|||
13116046|NCT03085758|25920725|FG000|Overall Study|Withdrawal by Subject|2|||
13116047|NCT03085758|25920726|FG001|Overall Study|Withdrawal by Subject|2|||
13116048|NCT03085758|25920727|FG002|Overall Study|Withdrawal by Subject|1|||
13116049|NCT03085758|25920725|FG000|Overall Study|Refusal to recall it up to day 90|0|||
13290087|NCT00104650|26480694|FG002|Follow-up Period|Lost to Follow-up|2|||
13290088|NCT00104650|26480692|FG000|Follow-up Period|Other|0|||
13290089|NCT00104650|26480693|FG001|Follow-up Period|Other|1|||
13290090|NCT00104650|26480694|FG002|Follow-up Period|Other|0|||
13290091|NCT00104637|26480723|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1|||
13290092|NCT00104637|26480724|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0|||
13290093|NCT00104416|26480777|FG000|Double-Blind Phase|Adverse Event|2|||
13290094|NCT00104416|26480778|FG001|Double-Blind Phase|Adverse Event|1|||
13290095|NCT00104416|26480779|FG002|Double-Blind Phase|Adverse Event|0|||
13290096|NCT00104416|26480780|FG003|Double-Blind Phase|Adverse Event|0|||
13290097|NCT00104416|26480781|FG004|Double-Blind Phase|Adverse Event|0|||
13290098|NCT00104416|26480777|FG000|Double-Blind Phase|Lost to Follow-up|0|||
13290099|NCT00104416|26480778|FG001|Double-Blind Phase|Lost to Follow-up|1|||
13116050|NCT03085758|25920726|FG001|Overall Study|Refusal to recall it up to day 90|0|||
13116051|NCT03085758|25920727|FG002|Overall Study|Refusal to recall it up to day 90|1|||
13245219|NCT01610037|26354218|FG000|All Patients|Adverse Event|27|||
13245220|NCT01610037|26354219|FG001|All Patients|Adverse Event|22|||
13245221|NCT01610037|26354220|FG002|All Patients|Adverse Event|26|||
13245222|NCT01610037|26354218|FG000|All Patients|Withdrawal by Subject|12|||
13245223|NCT01610037|26354219|FG001|All Patients|Withdrawal by Subject|10|||
13245224|NCT01610037|26354220|FG002|All Patients|Withdrawal by Subject|20|||
13245225|NCT01610037|26354218|FG000|All Patients|Unsatisfactory therapeutic effect|9|||
13245226|NCT01610037|26354219|FG001|All Patients|Unsatisfactory therapeutic effect|8|||
13245227|NCT01610037|26354220|FG002|All Patients|Unsatisfactory therapeutic effect|27|||
13245228|NCT01610037|26354218|FG000|All Patients|Death|4|||
13245229|NCT01610037|26354219|FG001|All Patients|Death|2|||
13245230|NCT01610037|26354220|FG002|All Patients|Death|1|||
13245231|NCT01610037|26354218|FG000|All Patients|Protocol deviation|4|||
13245232|NCT01610037|26354219|FG001|All Patients|Protocol deviation|3|||
13245233|NCT01610037|26354220|FG002|All Patients|Protocol deviation|3|||
13245234|NCT01610037|26354218|FG000|All Patients|Abnormal laboratory value|1|||
13245235|NCT01610037|26354219|FG001|All Patients|Abnormal laboratory value|1|||
13245236|NCT01610037|26354220|FG002|All Patients|Abnormal laboratory value|0|||
13245237|NCT01610037|26354218|FG000|All Patients|Administrative problems|1|||
13245238|NCT01610037|26354219|FG001|All Patients|Administrative problems|4|||
13245239|NCT01610037|26354220|FG002|All Patients|Administrative problems|4|||
13245240|NCT01610037|26354218|FG000|All Patients|Lost to Follow-up|1|||
13245241|NCT01610037|26354219|FG001|All Patients|Lost to Follow-up|0|||
13245242|NCT01610037|26354220|FG002|All Patients|Lost to Follow-up|0|||
13245243|NCT01610037|26354218|FG000|All Patients|Abnormal test procedure result(s)|0|||
13245244|NCT01610037|26354219|FG001|All Patients|Abnormal test procedure result(s)|1|||
13245245|NCT01610037|26354220|FG002|All Patients|Abnormal test procedure result(s)|3|||
13245246|NCT01610037|26354218|FG000|Treatment and Follow up Period|Subject withdrew consent|13|||
13245247|NCT01610037|26354219|FG001|Treatment and Follow up Period|Subject withdrew consent|14|||
13245248|NCT01610037|26354220|FG002|Treatment and Follow up Period|Subject withdrew consent|16|||
13245249|NCT01610037|26354218|FG000|Treatment and Follow up Period|Death|10|||
13245250|NCT01610037|26354219|FG001|Treatment and Follow up Period|Death|5|||
13245251|NCT01610037|26354220|FG002|Treatment and Follow up Period|Death|4|||
13245252|NCT01610037|26354218|FG000|Treatment and Follow up Period|Administrative problems|1|||
13245253|NCT01610037|26354219|FG001|Treatment and Follow up Period|Administrative problems|3|||
13245254|NCT01610037|26354220|FG002|Treatment and Follow up Period|Administrative problems|2|||
13245255|NCT01610037|26354218|FG000|Treatment and Follow up Period|Lost to Follow-up|1|||
13245256|NCT01610037|26354219|FG001|Treatment and Follow up Period|Lost to Follow-up|6|||
13245257|NCT01610037|26354220|FG002|Treatment and Follow up Period|Lost to Follow-up|4|||
13245258|NCT01609933|26354229|FG000|Overall Study|Adverse Event|1|||
13245259|NCT01609933|26354229|FG000|Overall Study|Withdrawal by Subject|3|||
13245260|NCT01609790|26354256|FG000|Overall Study|Protocol Violation|1|||
13245261|NCT01609790|26354257|FG001|Overall Study|Protocol Violation|7|||
13245262|NCT01609790|26354258|FG002|Overall Study|Protocol Violation|8|||
13245263|NCT01609582|26354273|FG000|Overall Study|Adverse Event|20|||
13245264|NCT01609582|26354274|FG001|Overall Study|Adverse Event|18|||
13245265|NCT01609582|26354273|FG000|Overall Study|Lost to Follow-up|10|||
13245266|NCT01609582|26354274|FG001|Overall Study|Lost to Follow-up|10|||
13245267|NCT01609582|26354273|FG000|Overall Study|Withdrawal by Subject|21|||
13245268|NCT01609582|26354274|FG001|Overall Study|Withdrawal by Subject|15|||
13245269|NCT01609582|26354273|FG000|Overall Study|Study Terminated by Sponsor|1543|||
13245270|NCT01609582|26354274|FG001|Overall Study|Study Terminated by Sponsor|1548|||
13245271|NCT01609582|26354273|FG000|Overall Study|Other|9|||
13245272|NCT01609582|26354274|FG001|Overall Study|Other|10|||
13245273|NCT01609582|26354273|FG000|Overall Study|Randomized, but not treated|0|||
13245274|NCT01609582|26354274|FG001|Overall Study|Randomized, but not treated|3|||
13245275|NCT01609556|26354483|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
13245276|NCT01609556|26354484|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
13245277|NCT01609556|26354485|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
13245278|NCT01609556|26354486|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
13116052|NCT03085758|25920725|FG000|Overall Study|Pt seen by doctor in digestive surgery|0|||
13116053|NCT03085758|25920726|FG001|Overall Study|Pt seen by doctor in digestive surgery|1|||
13245279|NCT01609556|26354487|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
13245280|NCT01609556|26354488|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
13245281|NCT01609556|26354489|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
13245282|NCT01609556|26354490|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
13245283|NCT01609556|26354491|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
13245284|NCT01609556|26354492|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
13245285|NCT01609556|26354493|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
13245286|NCT01609556|26354494|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
13245287|NCT01609556|26354495|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
13245288|NCT01609556|26354496|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
13245289|NCT01609556|26354497|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
13245290|NCT01609556|26354498|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
13245291|NCT01609556|26354483|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
13245292|NCT01609556|26354484|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
13245293|NCT01609556|26354485|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
13245294|NCT01609556|26354486|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
13245295|NCT01609556|26354487|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8|||
13245296|NCT01609556|26354488|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13|||
13245297|NCT01609556|26354489|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5|||
13245298|NCT01609556|26354490|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4|||
13245299|NCT01609556|26354491|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
13245300|NCT01609556|26354492|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
13245301|NCT01609556|26354493|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6|||
13245302|NCT01609556|26354494|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
13245303|NCT01609556|26354495|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
13245304|NCT01609556|26354496|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
13245305|NCT01609556|26354497|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
13245306|NCT01609556|26354498|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
13245307|NCT01609556|26354483|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
13245308|NCT01609556|26354484|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
13245309|NCT01609556|26354485|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
13245310|NCT01609556|26354486|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
13245311|NCT01609556|26354487|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
13245312|NCT01609556|26354488|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
13245313|NCT01609556|26354489|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
13245314|NCT01609556|26354490|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
13245315|NCT01609556|26354491|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
13116054|NCT03085758|25920727|FG002|Overall Study|Pt seen by doctor in digestive surgery|0|||
13116055|NCT03085238|25920754|FG000|Overall Study|Adverse Event|2|||
13116056|NCT03085238|25920754|FG000|Overall Study|Death|2|||
13133377|NCT02771210|25987551|FG000|Period 2|Withdrawal of informed consent|0|||
13133378|NCT02771210|25987552|FG001|Period 2|Withdrawal of informed consent|2|||
13133379|NCT02771145|25987593|FG000|Overall Study|Adverse Event|3|||
13133380|NCT02771145|25987593|FG000|Overall Study|Lost to Follow-up|1|||
13133381|NCT02770820|25987601|FG000|Overall Study|Death|1|||
13133382|NCT02770820|25987601|FG000|Overall Study|Physician Decision|2|||
13133383|NCT02770612|25987607|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1|||
13133384|NCT02770547|25987634|FG000|Overall Study|Patient non-compliant|1|||
13133385|NCT02770547|25987635|FG001|Overall Study|Patient non-compliant|0|||
13133386|NCT02770547|25987634|FG000|Overall Study|Adverse Event|0|||
13133387|NCT02770547|25987635|FG001|Overall Study|Adverse Event|1|||
13133388|NCT02770391|25987649|FG000|Overall Study|Lost to Follow-up|2|||
13133389|NCT02770391|25987649|FG000|Overall Study|Withdrawal by Subject|1|||
13133390|NCT02770391|25987649|FG000|Overall Study|Surgery delayed unevaluable|2|||
13133391|NCT02770391|25987649|FG000|Overall Study|Treatment discontinued due to treatment inturruption|1|||
13133392|NCT02770248|25987668|FG000|Overall Study|Adverse Event|0|||
13133393|NCT02770248|25987669|FG001|Overall Study|Adverse Event|1|||
13133394|NCT02770248|25987668|FG000|Overall Study|Randomized in error, prior to treatment|0|||
13485845|NCT00585195|27033421|FG011|Overall Study|Withdrawn Due to Pregnancy|0|||
13485846|NCT00585195|27033422|FG012|Overall Study|Withdrawn Due to Pregnancy|0|||
13245316|NCT01609556|26354492|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
13245317|NCT01609556|26354493|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
13245318|NCT01609556|26354494|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
13245319|NCT01609556|26354495|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
13245320|NCT01609556|26354496|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
13245321|NCT01609556|26354497|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
13245322|NCT01609556|26354498|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
13245323|NCT01609556|26354483|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
13245324|NCT01609556|26354484|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
13245325|NCT01609556|26354485|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
13245326|NCT01609556|26354486|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
13245327|NCT01609556|26354487|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
13245328|NCT01609556|26354488|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
13245329|NCT01609556|26354489|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
13245330|NCT01609556|26354490|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
13133395|NCT02770248|25987669|FG001|Overall Study|Randomized in error, prior to treatment|1|||
13133396|NCT02770170|25987712|FG000|Overall Study|Withdrawal by Subject|0|||
13133397|NCT02770170|25987713|FG001|Overall Study|Withdrawal by Subject|0|||
13133398|NCT02770170|25987714|FG002|Overall Study|Withdrawal by Subject|0|||
13245331|NCT01609556|26354491|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
13245332|NCT01609556|26354492|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
13245333|NCT01609556|26354493|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
13245334|NCT01609556|26354494|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
13245335|NCT01609556|26354495|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
13245336|NCT01609556|26354496|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
13245337|NCT01609556|26354497|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
13245338|NCT01609556|26354498|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
13245339|NCT01609556|26354483|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
13245340|NCT01609556|26354484|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
13245341|NCT01609556|26354485|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
13245342|NCT01609556|26354486|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
13245343|NCT01609556|26354487|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
13245344|NCT01609556|26354488|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1|||
13245345|NCT01609556|26354489|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
13245346|NCT01609556|26354490|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
13245347|NCT01609556|26354491|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
13245348|NCT01609556|26354492|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
13245349|NCT01609556|26354493|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
13245350|NCT01609556|26354494|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
13245351|NCT01609556|26354495|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
13245352|NCT01609556|26354496|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
13245353|NCT01609556|26354497|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
13245354|NCT01609556|26354498|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
13245355|NCT01609556|26354483|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
13245356|NCT01609556|26354484|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
13245357|NCT01609556|26354485|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
13245358|NCT01609556|26354486|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
13245359|NCT01609556|26354487|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
13245360|NCT01609556|26354488|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
13245361|NCT01609556|26354489|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
13245362|NCT01609556|26354490|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
13245363|NCT01609556|26354491|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1|||
13245364|NCT01609556|26354492|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
13245365|NCT01609556|26354493|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
13245366|NCT01609556|26354494|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
13245367|NCT01609556|26354495|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
13245368|NCT01609556|26354496|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
13245369|NCT01609556|26354497|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
13245370|NCT01609556|26354498|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
13245371|NCT01609556|26354483|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2|||
13245372|NCT01609556|26354484|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
13245373|NCT01609556|26354485|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
13245374|NCT01609556|26354486|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
13245375|NCT01609556|26354487|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
13245376|NCT01609556|26354488|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
13245377|NCT01609556|26354489|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
13245378|NCT01609556|26354490|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
13245379|NCT01609556|26354491|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
13245380|NCT01609556|26354492|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
13245381|NCT01609556|26354493|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
13245382|NCT01609556|26354494|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
13245383|NCT01609556|26354495|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
13245384|NCT01609556|26354496|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
13245385|NCT01609556|26354497|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
13245386|NCT01609556|26354498|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
13245387|NCT01609556|26354483|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
13245388|NCT01609556|26354484|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
13245389|NCT01609556|26354485|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
13245390|NCT01609556|26354486|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
13245391|NCT01609556|26354487|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
13245392|NCT01609556|26354488|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
13245393|NCT01609556|26354489|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
13245394|NCT01609556|26354490|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
13245395|NCT01609556|26354491|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
13245396|NCT01609556|26354492|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
13245397|NCT01609556|26354493|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
13245398|NCT01609556|26354494|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
13245399|NCT01609556|26354495|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4|||
13245400|NCT01609556|26354496|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
13245401|NCT01609556|26354497|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
13245402|NCT01609556|26354498|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
13245403|NCT01609556|26354483|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
13245404|NCT01609556|26354484|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
13245405|NCT01609556|26354485|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
13245406|NCT01609556|26354486|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
13245407|NCT01609556|26354487|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
13245408|NCT01609556|26354488|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
13245409|NCT01609556|26354489|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
13245410|NCT01609556|26354490|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
13245411|NCT01609556|26354491|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
13245412|NCT01609556|26354492|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
13245413|NCT01609556|26354493|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
13245414|NCT01609556|26354494|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
13245415|NCT01609556|26354495|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32|||
13245416|NCT01609556|26354496|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13|||
13245417|NCT01609556|26354497|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20|||
13245418|NCT01609556|26354498|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27|||
13245419|NCT01609556|26354483|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
13245420|NCT01609556|26354484|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
13245421|NCT01609556|26354485|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
13245422|NCT01609556|26354486|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
13245423|NCT01609556|26354487|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
13245424|NCT01609556|26354488|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
13245425|NCT01609556|26354489|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
13245426|NCT01609556|26354490|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
13245427|NCT01609556|26354491|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
13245428|NCT01609556|26354492|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
13245429|NCT01609556|26354493|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
13203192|NCT01987479|26223483|FG000|Overall Study|Participant/legal guardian decision|1|||
13203193|NCT01987479|26223483|FG000|Overall Study|Other|5|||
13203194|NCT01987479|26223483|FG000|Overall Study|Lost to Follow-up|1|||
13203195|NCT01987479|26223483|FG000|Overall Study|Adverse Event|7|||
13203196|NCT01987453|26223516|FG000|Overall Study|Death|0|||
13203197|NCT01987453|26223517|FG001|Overall Study|Death|0|||
13203198|NCT01987453|26223518|FG002|Overall Study|Death|1|||
13203199|NCT01987453|26223516|FG000|Overall Study|Lack of Efficacy|1|||
13203200|NCT01987453|26223517|FG001|Overall Study|Lack of Efficacy|12|||
13203201|NCT01987453|26223518|FG002|Overall Study|Lack of Efficacy|0|||
13203202|NCT01987427|26223557|FG000|Overall Study|Adverse Event|4|||
13203203|NCT01987427|26223558|FG001|Overall Study|Adverse Event|2|||
13203204|NCT01987427|26223559|FG002|Overall Study|Adverse Event|8|||
13203205|NCT01987427|26223557|FG000|Overall Study|Lost to Follow-up|6|||
13203206|NCT01987427|26223558|FG001|Overall Study|Lost to Follow-up|6|||
13203207|NCT01987427|26223559|FG002|Overall Study|Lost to Follow-up|9|||
13203208|NCT01987427|26223557|FG000|Overall Study|Withdrawal by Subject|2|||
13203209|NCT01987427|26223558|FG001|Overall Study|Withdrawal by Subject|1|||
13203210|NCT01987427|26223559|FG002|Overall Study|Withdrawal by Subject|3|||
13203211|NCT01987427|26223557|FG000|Overall Study|Lack of Efficacy|1|||
13203212|NCT01987427|26223558|FG001|Overall Study|Lack of Efficacy|0|||
13203213|NCT01987427|26223559|FG002|Overall Study|Lack of Efficacy|0|||
13203214|NCT01987427|26223557|FG000|Overall Study|Other|1|||
13203215|NCT01987427|26223558|FG001|Overall Study|Other|1|||
13203216|NCT01987427|26223559|FG002|Overall Study|Other|0|||
13203217|NCT01987232|26223634|FG000|Overall Study|Ongoing in Study|0|||
13203218|NCT01987232|26223635|FG001|Overall Study|Ongoing in Study|0|||
13245430|NCT01609556|26354494|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
13245431|NCT01609556|26354495|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
13245432|NCT01609556|26354496|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
13245433|NCT01609556|26354497|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
13203219|NCT01987232|26223636|FG002|Overall Study|Ongoing in Study|0|||
13203220|NCT01987232|26223637|FG003|Overall Study|Ongoing in Study|1|||
13203221|NCT01987232|26223638|FG004|Overall Study|Ongoing in Study|0|||
13203222|NCT01987102|26223677|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
13203223|NCT01987102|26223678|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
13203224|NCT01987102|26223677|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1|||
13245434|NCT01609556|26354498|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2|||
13245435|NCT01609556|26354483|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
13245436|NCT01609556|26354484|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
13245437|NCT01609556|26354485|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
13245438|NCT01609556|26354486|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
13245439|NCT01609556|26354487|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
13245440|NCT01609556|26354488|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
13245441|NCT01609556|26354489|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
13245442|NCT01609556|26354490|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
13245443|NCT01609556|26354491|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
13245444|NCT01609556|26354492|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
13245445|NCT01609556|26354493|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
13245446|NCT01609556|26354494|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
13245447|NCT01609556|26354495|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1|||
13245448|NCT01609556|26354496|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
13245449|NCT01609556|26354497|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
13245450|NCT01609556|26354498|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
13245451|NCT01609556|26354483|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
13245452|NCT01609556|26354484|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
13245453|NCT01609556|26354485|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
13245454|NCT01609556|26354486|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
13245455|NCT01609556|26354487|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
13245456|NCT01609556|26354488|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
13245457|NCT01609556|26354489|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
13245458|NCT01609556|26354490|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
13245459|NCT01609556|26354491|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
13245460|NCT01609556|26354492|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
13245461|NCT01609556|26354493|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
13245462|NCT01609556|26354494|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
13245463|NCT01609556|26354495|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1|||
13245464|NCT01609556|26354496|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4|||
13245465|NCT01609556|26354497|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2|||
13245466|NCT01609556|26354498|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5|||
13245467|NCT01609556|26354483|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
13245468|NCT01609556|26354484|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
13245469|NCT01609556|26354485|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
13245470|NCT01609556|26354486|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
13245471|NCT01609556|26354487|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
13245472|NCT01609556|26354488|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
13245473|NCT01609556|26354489|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
13245474|NCT01609556|26354490|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
13245475|NCT01609556|26354491|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
13245476|NCT01609556|26354492|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
13245477|NCT01609556|26354493|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
13245478|NCT01609556|26354494|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
13245479|NCT01609556|26354495|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
13245480|NCT01609556|26354496|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
13203225|NCT01987102|26223678|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2|||
13203226|NCT01987102|26223677|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1|||
13203227|NCT01987102|26223678|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0|||
13203228|NCT01987102|26223677|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0|||
13203229|NCT01987102|26223678|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1|||
13203230|NCT01987102|26223677|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0|||
13203231|NCT01987102|26223678|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1|||
13203232|NCT01987102|26223677|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0|||
13203233|NCT01987102|26223678|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1|||
13203234|NCT01986985|26223684|FG000|Overall Study|Withdrawal by Subject|4|||
13203235|NCT01986985|26223684|FG000|Overall Study|Scan not completed due to malfunction|3|||
13245481|NCT01609556|26354497|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
13245482|NCT01609556|26354498|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1|||
13245483|NCT01609556|26354483|FG000|Dose Expansion: Maximum 124 Weeks|Death|0|||
13245484|NCT01609556|26354484|FG001|Dose Expansion: Maximum 124 Weeks|Death|0|||
13245485|NCT01609556|26354485|FG002|Dose Expansion: Maximum 124 Weeks|Death|0|||
13245486|NCT01609556|26354486|FG003|Dose Expansion: Maximum 124 Weeks|Death|0|||
13245487|NCT01609556|26354487|FG004|Dose Expansion: Maximum 124 Weeks|Death|0|||
13245488|NCT01609556|26354488|FG005|Dose Expansion: Maximum 124 Weeks|Death|0|||
13245489|NCT01609556|26354489|FG006|Dose Expansion: Maximum 124 Weeks|Death|0|||
13245490|NCT01609556|26354490|FG007|Dose Expansion: Maximum 124 Weeks|Death|0|||
13245491|NCT01609556|26354491|FG008|Dose Expansion: Maximum 124 Weeks|Death|0|||
13245492|NCT01609556|26354492|FG009|Dose Expansion: Maximum 124 Weeks|Death|0|||
13245493|NCT01609556|26354493|FG010|Dose Expansion: Maximum 124 Weeks|Death|0|||
13245494|NCT01609556|26354494|FG011|Dose Expansion: Maximum 124 Weeks|Death|0|||
13245495|NCT01609556|26354495|FG012|Dose Expansion: Maximum 124 Weeks|Death|4|||
13245496|NCT01609556|26354496|FG013|Dose Expansion: Maximum 124 Weeks|Death|2|||
13245497|NCT01609556|26354497|FG014|Dose Expansion: Maximum 124 Weeks|Death|0|||
13245498|NCT01609556|26354498|FG015|Dose Expansion: Maximum 124 Weeks|Death|3|||
13245499|NCT01609556|26354483|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
13245500|NCT01609556|26354484|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
13245501|NCT01609556|26354485|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
13245502|NCT01609556|26354486|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
13245503|NCT01609556|26354487|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
13245504|NCT01609556|26354488|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
13245505|NCT01609556|26354489|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
13245506|NCT01609556|26354490|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
13245507|NCT01609556|26354491|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
13245508|NCT01609556|26354492|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
13245509|NCT01609556|26354493|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
13245510|NCT01609556|26354494|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
13245511|NCT01609556|26354495|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1|||
13245512|NCT01609556|26354496|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
13245513|NCT01609556|26354497|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
13245514|NCT01609556|26354498|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
13245515|NCT01609543|26354506|FG000|Overall Study|Disease Progression|28|||
13245516|NCT01609543|26354506|FG000|Overall Study|Adverse Event|5|||
13245517|NCT01609543|26354506|FG000|Overall Study|Withdrawal by Subject|1|||
13245518|NCT01609543|26354506|FG000|Overall Study|Protocol Violation|1|||
13245519|NCT01609543|26354506|FG000|Overall Study|Death|7|||
13245520|NCT01609478|26354580|FG000|Overall Study|Adverse Event|3|||
13245521|NCT01609478|26354581|FG001|Overall Study|Adverse Event|1|||
13245522|NCT01609478|26354582|FG002|Overall Study|Adverse Event|5|||
13245523|NCT01609478|26354580|FG000|Overall Study|Protocol Deviation|0|||
13245524|NCT01609478|26354581|FG001|Overall Study|Protocol Deviation|1|||
13245525|NCT01609478|26354582|FG002|Overall Study|Protocol Deviation|1|||
13245526|NCT01609478|26354580|FG000|Overall Study|Non-Compliance with study treatment|1|||
13245527|NCT01609478|26354581|FG001|Overall Study|Non-Compliance with study treatment|0|||
13245528|NCT01609478|26354582|FG002|Overall Study|Non-Compliance with study treatment|0|||
13245529|NCT01609478|26354580|FG000|Overall Study|Physician Decision|1|||
13245530|NCT01609478|26354581|FG001|Overall Study|Physician Decision|0|||
13245531|NCT01609478|26354582|FG002|Overall Study|Physician Decision|1|||
13245532|NCT01609478|26354580|FG000|Overall Study|Withdrawal by Subject|2|||
13245533|NCT01609478|26354581|FG001|Overall Study|Withdrawal by Subject|0|||
13245534|NCT01609478|26354582|FG002|Overall Study|Withdrawal by Subject|2|||
13245535|NCT01609296|26354738|FG000|Overall Study|Death|253|||
13245536|NCT01609296|26354738|FG000|Overall Study|Withdrawal by Subject|151|||
13245537|NCT01609296|26354738|FG000|Overall Study|Lost to Follow-up|21|||
13245538|NCT01609296|26354738|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35|||
13245539|NCT01609296|26354738|FG000|Overall Study|missed visit but known to be alive|28|||
13245540|NCT01609257|26354815|FG000|Overall Study|Lost to Follow-up|2|||
13245541|NCT01609257|26354816|FG001|Overall Study|Lost to Follow-up|1|||
13245542|NCT01609257|26354815|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
13245543|NCT01609257|26354816|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
13245544|NCT01609257|26354815|FG000|Overall Study|Non-compliance/Protocol deviation|4|||
13245545|NCT01609257|26354816|FG001|Overall Study|Non-compliance/Protocol deviation|6|||
13245546|NCT01609231|26354831|FG000|Overall Study|Adverse Event|1|||
13245547|NCT01609231|26354832|FG001|Overall Study|Adverse Event|3|||
13245548|NCT01609231|26354831|FG000|Overall Study|Physician Decision|1|||
13245549|NCT01609231|26354832|FG001|Overall Study|Physician Decision|0|||
13245550|NCT01609231|26354831|FG000|Overall Study|Withdrawal by Subject|1|||
13245551|NCT01609231|26354832|FG001|Overall Study|Withdrawal by Subject|0|||
13245552|NCT01609218|26354847|FG000|Period 1|Adverse Event|3|||
13245553|NCT01609218|26354848|FG001|Period 1|Adverse Event|5|||
13245554|NCT01609218|26354847|FG000|Period 1|Sponsor Decision|0|||
13245555|NCT01609218|26354848|FG001|Period 1|Sponsor Decision|1|||
13245556|NCT01609218|26354847|FG000|Period 2|Adverse Event|1|||
13245557|NCT01609218|26354848|FG001|Period 2|Adverse Event|0|||
13245558|NCT01609062|26354898|FG000|Extension Phase|Terminated by Sponsor|14|||
13245559|NCT01609062|26354899|FG001|Extension Phase|Terminated by Sponsor|9|||
13245560|NCT01609062|26354898|FG000|Extension Phase|Discontinued drug and then was pregnant|1|||
13245561|NCT01609062|26354899|FG001|Extension Phase|Discontinued drug and then was pregnant|0|||
13245562|NCT01609062|26354898|FG000|Extension Phase|Anticipated surgery & transition to EAP|0|||
13245563|NCT01609062|26354899|FG001|Extension Phase|Anticipated surgery & transition to EAP|1|||
13245564|NCT01609023|26354911|FG000|Overall Study|Lack of Efficacy|3|||
13245565|NCT01609023|26354911|FG000|Overall Study|Withdrawal by Subject|4|||
13245566|NCT01609023|26354911|FG000|Overall Study|Lost to Follow-up|8|||
13245567|NCT01609023|26354911|FG000|Overall Study|Toxicity|3|||
13245568|NCT01609023|26354911|FG000|Overall Study|Disease progression|10|||
13245569|NCT01609023|26354911|FG000|Overall Study|Physician Decision|2|||
13245570|NCT01609023|26354911|FG000|Overall Study|Death|2|||
13245571|NCT01609023|26354911|FG000|Overall Study|Personal reasons|1|||
13245572|NCT01609010|26354942|FG000|Overall Study|Stable disease (SD)|22|||
13245573|NCT01609010|26354943|FG001|Overall Study|Stable disease (SD)|16|||
13245574|NCT01609010|26354942|FG000|Overall Study|Progressive disease (PD)|8|||
13245575|NCT01609010|26354943|FG001|Overall Study|Progressive disease (PD)|10|||
13245576|NCT01609010|26354942|FG000|Overall Study|Adverse Event|3|||
13245577|NCT01609010|26354943|FG001|Overall Study|Adverse Event|6|||
13245578|NCT01609010|26354942|FG000|Overall Study|Withdrawal by Subject|2|||
13245579|NCT01609010|26354943|FG001|Overall Study|Withdrawal by Subject|2|||
13245580|NCT01609010|26354942|FG000|Overall Study|Other|2|||
13245581|NCT01609010|26354943|FG001|Overall Study|Other|0|||
13245582|NCT01609010|26354942|FG000|Overall Study|Other malignancy|1|||
13245583|NCT01609010|26354943|FG001|Overall Study|Other malignancy|0|||
13245584|NCT01609010|26354942|FG000|Overall Study|Pathology review|2|||
13245585|NCT01609010|26354943|FG001|Overall Study|Pathology review|1|||
13245586|NCT01609010|26354942|FG000|Overall Study|Protocol Violation|1|||
13245587|NCT01609010|26354943|FG001|Overall Study|Protocol Violation|1|||
13245588|NCT01609010|26354942|FG000|Overall Study|New cancer|1|||
13245589|NCT01609010|26354943|FG001|Overall Study|New cancer|0|||
13245590|NCT01609010|26354942|FG000|Overall Study|Lost to Follow-up|1|||
13245591|NCT01609010|26354943|FG001|Overall Study|Lost to Follow-up|1|||
13245592|NCT01608724|26354952|FG000|Overall Study|Withdrawal by Subject|131|||
13245593|NCT01608724|26354952|FG000|Overall Study|Lost to Follow-up|41|||
13245594|NCT01608724|26354952|FG000|Overall Study|Study-specific discontinuation criteria|32|||
13245595|NCT01608724|26354952|FG000|Overall Study|Adverse Event|29|||
13245596|NCT01608724|26354952|FG000|Overall Study|Protocol Violation|6|||
13245597|NCT01608724|26354952|FG000|Overall Study|bood sugar too high, etc.|3|||
13245598|NCT01608724|26354952|FG000|Overall Study|Safety reasons|1|||
13245599|NCT01608321|26354965|FG000|Overall Study|Withdrawal by Subject|1|||
13245600|NCT01608321|26354966|FG001|Overall Study|Withdrawal by Subject|0|||
13245601|NCT01608308|26354995|FG000|Overall Study|pretreatment medical and billing reasons|0|||
13245602|NCT01608308|26354996|FG001|Overall Study|pretreatment medical and billing reasons|2|||
13245603|NCT01608087|26355020|FG000|Overall Study|Lost to Follow-up|0|||
13245604|NCT01608087|26355021|FG001|Overall Study|Lost to Follow-up|1|||
13245605|NCT01608087|26355022|FG002|Overall Study|Lost to Follow-up|0|||
13245606|NCT01608087|26355020|FG000|Overall Study|Other Reason|0|||
13245607|NCT01608087|26355021|FG001|Overall Study|Other Reason|1|||
13245608|NCT01608087|26355022|FG002|Overall Study|Other Reason|0|||
13245609|NCT01607957|26355039|FG000|Overall Study|Not treated|1|||
13245610|NCT01607957|26355040|FG001|Overall Study|Not treated|1|||
13245611|NCT01607957|26355039|FG000|Overall Study|Death|367|||
13245612|NCT01607957|26355040|FG001|Overall Study|Death|211|||
13245613|NCT01607957|26355039|FG000|Overall Study|Lost to Follow-up|3|||
13245614|NCT01607957|26355040|FG001|Overall Study|Lost to Follow-up|3|||
13245615|NCT01607957|26355039|FG000|Overall Study|Participant refusal|1|||
13245616|NCT01607957|26355040|FG001|Overall Study|Participant refusal|0|||
13245617|NCT01607593|26355048|FG000|Overall Study|Adverse Event|15|||
13245618|NCT01607593|26355048|FG000|Overall Study|Lack of Efficacy|16|||
13245619|NCT01607593|26355048|FG000|Overall Study|Lost to Follow-up|25|||
13245620|NCT01607593|26355048|FG000|Overall Study|Continuation|33|||
13245621|NCT01607593|26355048|FG000|Overall Study|Other|4|||
13245622|NCT01607554|26355060|FG000|Overall Study|Disease progression|2|||
13245623|NCT01607476|26355081|FG000|Overall Study|Withdrawal by Subject|1|||
13245624|NCT01607476|26355082|FG001|Overall Study|Withdrawal by Subject|0|||
13245625|NCT01607476|26355083|FG002|Overall Study|Withdrawal by Subject|1|||
13245626|NCT01607476|26355081|FG000|Overall Study|Lost to Follow-up|0|||
13245627|NCT01607476|26355082|FG001|Overall Study|Lost to Follow-up|0|||
13245628|NCT01607476|26355083|FG002|Overall Study|Lost to Follow-up|2|||
13245629|NCT01607398|26355134|FG000|Overall Study|Adverse Event|0|||
13245630|NCT01607398|26355135|FG001|Overall Study|Adverse Event|2|||
13245631|NCT01607398|26355134|FG000|Overall Study|Severe COPD|2|||
13245632|NCT01607398|26355135|FG001|Overall Study|Severe COPD|0|||
13245633|NCT01607346|26355153|FG000|Overall Study|Adverse Event|3|||
13245634|NCT01607073|26355164|FG000|Overall Study|Adverse Event|1|||
13245635|NCT01606800|26355177|FG000|Overall Study|Adverse Event|3|||
13245636|NCT01606800|26355178|FG001|Overall Study|Adverse Event|1|||
13245637|NCT01606800|26355177|FG000|Overall Study|Participant withdrew consent|0|||
13245638|NCT01606800|26355178|FG001|Overall Study|Participant withdrew consent|1|||
13245639|NCT01606800|26355177|FG000|Overall Study|Missing completion status|2|||
13245640|NCT01606800|26355178|FG001|Overall Study|Missing completion status|0|||
13245641|NCT01606787|26355193|FG000|Overall Study|Withdrawal by Subject|4|||
13245642|NCT01606787|26355194|FG001|Overall Study|Withdrawal by Subject|5|||
13245643|NCT01606787|26355193|FG000|Overall Study|Surgery canceled|0|||
13245644|NCT01606787|26355194|FG001|Overall Study|Surgery canceled|2|||
13245645|NCT01606761|26355230|FG000|Prior to Week 24|Lost to Follow-up|0|||
13245646|NCT01606761|26355231|FG001|Prior to Week 24|Lost to Follow-up|3|||
13245647|NCT01606761|26355232|FG002|Prior to Week 24|Lost to Follow-up|2|||
13245648|NCT01606761|26355233|FG003|Prior to Week 24|Lost to Follow-up|0|||
13245649|NCT01606761|26355234|FG004|Prior to Week 24|Lost to Follow-up|0|||
13245650|NCT01606761|26355230|FG000|Prior to Week 24|Withdrawal by Subject|12|||
13245651|NCT01606761|26355231|FG001|Prior to Week 24|Withdrawal by Subject|10|||
13245652|NCT01606761|26355232|FG002|Prior to Week 24|Withdrawal by Subject|9|||
13245653|NCT01606761|26355233|FG003|Prior to Week 24|Withdrawal by Subject|0|||
13245654|NCT01606761|26355234|FG004|Prior to Week 24|Withdrawal by Subject|0|||
13245655|NCT01606761|26355230|FG000|Prior to Week 24|Adverse Event|11|||
13245656|NCT01606761|26355231|FG001|Prior to Week 24|Adverse Event|18|||
13245657|NCT01606761|26355232|FG002|Prior to Week 24|Adverse Event|22|||
13245658|NCT01606761|26355233|FG003|Prior to Week 24|Adverse Event|0|||
13245659|NCT01606761|26355234|FG004|Prior to Week 24|Adverse Event|0|||
13245660|NCT01606761|26355230|FG000|Prior to Week 24|Lack of Efficacy|15|||
13245661|NCT01606761|26355231|FG001|Prior to Week 24|Lack of Efficacy|14|||
13245662|NCT01606761|26355232|FG002|Prior to Week 24|Lack of Efficacy|8|||
13245663|NCT01606761|26355233|FG003|Prior to Week 24|Lack of Efficacy|0|||
13245664|NCT01606761|26355234|FG004|Prior to Week 24|Lack of Efficacy|0|||
13245665|NCT01606761|26355230|FG000|Prior to Week 24|Physician Decision|0|||
13245666|NCT01606761|26355231|FG001|Prior to Week 24|Physician Decision|3|||
13245667|NCT01606761|26355232|FG002|Prior to Week 24|Physician Decision|1|||
13245668|NCT01606761|26355233|FG003|Prior to Week 24|Physician Decision|0|||
13245669|NCT01606761|26355234|FG004|Prior to Week 24|Physician Decision|0|||
13245670|NCT01606761|26355230|FG000|Prior to Week 24|Other|4|||
13245671|NCT01606761|26355231|FG001|Prior to Week 24|Other|7|||
13245672|NCT01606761|26355232|FG002|Prior to Week 24|Other|5|||
13245673|NCT01606761|26355233|FG003|Prior to Week 24|Other|0|||
13245674|NCT01606761|26355234|FG004|Prior to Week 24|Other|0|||
13245675|NCT01606761|26355230|FG000|Week 24 to Week 52|Lost to Follow-up|0|||
13245676|NCT01606761|26355231|FG001|Week 24 to Week 52|Lost to Follow-up|1|||
13245677|NCT01606761|26355232|FG002|Week 24 to Week 52|Lost to Follow-up|1|||
13245678|NCT01606761|26355233|FG003|Week 24 to Week 52|Lost to Follow-up|1|||
13245679|NCT01606761|26355234|FG004|Week 24 to Week 52|Lost to Follow-up|0|||
13245680|NCT01606761|26355230|FG000|Week 24 to Week 52|Withdrawal by Subject|0|||
13245681|NCT01606761|26355231|FG001|Week 24 to Week 52|Withdrawal by Subject|6|||
13245682|NCT01606761|26355232|FG002|Week 24 to Week 52|Withdrawal by Subject|3|||
13245683|NCT01606761|26355233|FG003|Week 24 to Week 52|Withdrawal by Subject|0|||
13245684|NCT01606761|26355234|FG004|Week 24 to Week 52|Withdrawal by Subject|0|||
13245685|NCT01606761|26355230|FG000|Week 24 to Week 52|Adverse Event|0|||
13245686|NCT01606761|26355231|FG001|Week 24 to Week 52|Adverse Event|11|||
13245687|NCT01606761|26355232|FG002|Week 24 to Week 52|Adverse Event|14|||
13245688|NCT01606761|26355233|FG003|Week 24 to Week 52|Adverse Event|3|||
13245689|NCT01606761|26355234|FG004|Week 24 to Week 52|Adverse Event|15|||
13245690|NCT01606761|26355230|FG000|Week 24 to Week 52|Death|0|||
13245691|NCT01606761|26355231|FG001|Week 24 to Week 52|Death|0|||
13245692|NCT01606761|26355232|FG002|Week 24 to Week 52|Death|2|||
13245693|NCT01606761|26355233|FG003|Week 24 to Week 52|Death|1|||
13245694|NCT01606761|26355234|FG004|Week 24 to Week 52|Death|0|||
13245695|NCT01606761|26355230|FG000|Week 24 to Week 52|Lack of Efficacy|0|||
13245696|NCT01606761|26355231|FG001|Week 24 to Week 52|Lack of Efficacy|13|||
13245697|NCT01606761|26355232|FG002|Week 24 to Week 52|Lack of Efficacy|7|||
13245698|NCT01606761|26355233|FG003|Week 24 to Week 52|Lack of Efficacy|10|||
13245699|NCT01606761|26355234|FG004|Week 24 to Week 52|Lack of Efficacy|3|||
13245700|NCT01606761|26355230|FG000|Week 24 to Week 52|Physician Decision|0|||
13245701|NCT01606761|26355231|FG001|Week 24 to Week 52|Physician Decision|1|||
13245702|NCT01606761|26355232|FG002|Week 24 to Week 52|Physician Decision|1|||
13245703|NCT01606761|26355233|FG003|Week 24 to Week 52|Physician Decision|0|||
13245704|NCT01606761|26355234|FG004|Week 24 to Week 52|Physician Decision|0|||
13245705|NCT01606761|26355230|FG000|Week 24 to Week 52|Other|0|||
13245706|NCT01606761|26355231|FG001|Week 24 to Week 52|Other|1|||
13245707|NCT01606761|26355232|FG002|Week 24 to Week 52|Other|5|||
13245708|NCT01606761|26355233|FG003|Week 24 to Week 52|Other|2|||
13245709|NCT01606761|26355234|FG004|Week 24 to Week 52|Other|2|||
13245710|NCT01606761|26355230|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
13245711|NCT01606761|26355231|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
13245712|NCT01606761|26355232|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2|||
13245713|NCT01606761|26355233|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
13245714|NCT01606761|26355234|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
13245715|NCT01606761|26355230|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4|||
13245716|NCT01606761|26355231|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
13245717|NCT01606761|26355232|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
13245718|NCT01606761|26355233|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1|||
13245719|NCT01606761|26355234|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3|||
13245720|NCT01606761|26355230|FG000|Safety Follow-up Period (Week 52-68)|Death|0|||
13116057|NCT03085017|25920785|FG000|Overall Study|Death|0|||
13116058|NCT03085017|25920786|FG001|Overall Study|Death|3|||
13116059|NCT03084796|25920957|FG000|Overall Study|Adverse Event|4|||
13116060|NCT03084796|25920958|FG001|Overall Study|Adverse Event|5|||
13116061|NCT03084796|25920959|FG002|Overall Study|Adverse Event|6|||
13116062|NCT03084796|25920960|FG003|Overall Study|Adverse Event|2|||
13116063|NCT03084796|25920961|FG004|Overall Study|Adverse Event|3|||
13116064|NCT03084796|25920962|FG005|Overall Study|Adverse Event|5|||
13116065|NCT03084796|25920957|FG000|Overall Study|Withdrawal by Subject|3|||
13116066|NCT03084796|25920958|FG001|Overall Study|Withdrawal by Subject|5|||
13116067|NCT03084796|25920959|FG002|Overall Study|Withdrawal by Subject|2|||
13116068|NCT03084796|25920960|FG003|Overall Study|Withdrawal by Subject|1|||
13116069|NCT03084796|25920961|FG004|Overall Study|Withdrawal by Subject|3|||
13116070|NCT03084796|25920962|FG005|Overall Study|Withdrawal by Subject|0|||
13116071|NCT03084796|25920957|FG000|Overall Study|Protocol Violation|0|||
13116072|NCT03084796|25920958|FG001|Overall Study|Protocol Violation|0|||
13116073|NCT03084796|25920959|FG002|Overall Study|Protocol Violation|1|||
13116074|NCT03084796|25920960|FG003|Overall Study|Protocol Violation|0|||
13116075|NCT03084796|25920961|FG004|Overall Study|Protocol Violation|1|||
13116076|NCT03084796|25920962|FG005|Overall Study|Protocol Violation|1|||
13245721|NCT01606761|26355231|FG001|Safety Follow-up Period (Week 52-68)|Death|0|||
13245722|NCT01606761|26355232|FG002|Safety Follow-up Period (Week 52-68)|Death|0|||
13116077|NCT03084796|25920957|FG000|Overall Study|Lack of Efficacy|0|||
13116078|NCT03084796|25920958|FG001|Overall Study|Lack of Efficacy|0|||
13116079|NCT03084796|25920959|FG002|Overall Study|Lack of Efficacy|1|||
13116080|NCT03084796|25920960|FG003|Overall Study|Lack of Efficacy|0|||
13116081|NCT03084796|25920961|FG004|Overall Study|Lack of Efficacy|1|||
13245723|NCT01606761|26355233|FG003|Safety Follow-up Period (Week 52-68)|Death|0|||
13245724|NCT01606761|26355234|FG004|Safety Follow-up Period (Week 52-68)|Death|1|||
13245725|NCT01606761|26355230|FG000|Safety Follow-up Period (Week 52-68)|Other|0|||
13245726|NCT01606761|26355231|FG001|Safety Follow-up Period (Week 52-68)|Other|3|||
13245727|NCT01606761|26355232|FG002|Safety Follow-up Period (Week 52-68)|Other|9|||
13245728|NCT01606761|26355233|FG003|Safety Follow-up Period (Week 52-68)|Other|1|||
13245729|NCT01606761|26355234|FG004|Safety Follow-up Period (Week 52-68)|Other|3|||
13245730|NCT01606748|26355269|FG000|Overall Study|Adverse Event|1|||
13245731|NCT01606748|26355270|FG001|Overall Study|Adverse Event|0|||
13245732|NCT01606748|26355269|FG000|Overall Study|Progressive Disease|1|||
13245733|NCT01606748|26355270|FG001|Overall Study|Progressive Disease|0|||
13245734|NCT01606748|26355269|FG000|Overall Study|Withdrawal by Subject|1|||
13245735|NCT01606748|26355270|FG001|Overall Study|Withdrawal by Subject|0|||
13245736|NCT01606670|26355280|FG000|Overall Study|Adverse Event|6|||
13245737|NCT01606670|26355280|FG000|Overall Study|Lack of Efficacy|2|||
13245738|NCT01606670|26355280|FG000|Overall Study|Lost to Follow-up|3|||
13245739|NCT01606670|26355280|FG000|Overall Study|Withdrawal by Subject|3|||
13245740|NCT01606670|26355280|FG000|Overall Study|Other Reason|2|||
13245741|NCT01606319|26355299|FG000|Overall Study|Lost to Follow-up|17|||
13245742|NCT01606319|26355300|FG001|Overall Study|Lost to Follow-up|14|||
13245743|NCT01606319|26355299|FG000|Overall Study|Withdrawal by Subject|9|||
13245744|NCT01606319|26355300|FG001|Overall Study|Withdrawal by Subject|12|||
13245745|NCT01606319|26355299|FG000|Overall Study|Physician Decision|1|||
13245746|NCT01606319|26355300|FG001|Overall Study|Physician Decision|2|||
13245747|NCT01606319|26355299|FG000|Overall Study|Lack of Efficacy|6|||
13245748|NCT01606319|26355300|FG001|Overall Study|Lack of Efficacy|8|||
13245749|NCT01606319|26355299|FG000|Overall Study|Adverse Event|1|||
13245750|NCT01606319|26355300|FG001|Overall Study|Adverse Event|4|||
13245751|NCT01606306|26355325|FG000|Overall Study|Lack of Efficacy|2|||
13245752|NCT01606306|26355326|FG001|Overall Study|Lack of Efficacy|1|||
13245753|NCT01606306|26355327|FG002|Overall Study|Lack of Efficacy|4|||
13245754|NCT01606306|26355328|FG003|Overall Study|Lack of Efficacy|4|||
13245755|NCT01606306|26355329|FG004|Overall Study|Lack of Efficacy|1|||
13245756|NCT01606306|26355330|FG005|Overall Study|Lack of Efficacy|2|||
13245757|NCT01606306|26355325|FG000|Overall Study|Adverse Event|1|||
13245758|NCT01606306|26355326|FG001|Overall Study|Adverse Event|0|||
13245759|NCT01606306|26355327|FG002|Overall Study|Adverse Event|1|||
13245760|NCT01606306|26355328|FG003|Overall Study|Adverse Event|1|||
13245761|NCT01606306|26355329|FG004|Overall Study|Adverse Event|2|||
13245762|NCT01606306|26355330|FG005|Overall Study|Adverse Event|0|||
13245763|NCT01606306|26355325|FG000|Overall Study|Lost to Follow-up|7|||
13245764|NCT01606306|26355326|FG001|Overall Study|Lost to Follow-up|4|||
13245765|NCT01606306|26355327|FG002|Overall Study|Lost to Follow-up|5|||
13245766|NCT01606306|26355328|FG003|Overall Study|Lost to Follow-up|4|||
13245767|NCT01606306|26355329|FG004|Overall Study|Lost to Follow-up|3|||
13245768|NCT01606306|26355330|FG005|Overall Study|Lost to Follow-up|5|||
13116082|NCT03084796|25920962|FG005|Overall Study|Lack of Efficacy|0|||
13116083|NCT03084796|25920957|FG000|Overall Study|Lost to Follow-up|0|||
13116084|NCT03084796|25920958|FG001|Overall Study|Lost to Follow-up|0|||
13116085|NCT03084796|25920959|FG002|Overall Study|Lost to Follow-up|1|||
13245769|NCT01606306|26355325|FG000|Overall Study|Withdrawal by Subject|4|||
13245770|NCT01606306|26355326|FG001|Overall Study|Withdrawal by Subject|3|||
13245771|NCT01606306|26355327|FG002|Overall Study|Withdrawal by Subject|4|||
13245772|NCT01606306|26355328|FG003|Overall Study|Withdrawal by Subject|4|||
13245773|NCT01606306|26355329|FG004|Overall Study|Withdrawal by Subject|5|||
13245774|NCT01606306|26355330|FG005|Overall Study|Withdrawal by Subject|4|||
13245775|NCT01606306|26355325|FG000|Overall Study|Physician Decision|1|||
13245776|NCT01606306|26355326|FG001|Overall Study|Physician Decision|2|||
13245777|NCT01606306|26355327|FG002|Overall Study|Physician Decision|0|||
13245778|NCT01606306|26355328|FG003|Overall Study|Physician Decision|0|||
13245779|NCT01606306|26355329|FG004|Overall Study|Physician Decision|0|||
13245780|NCT01606306|26355330|FG005|Overall Study|Physician Decision|0|||
13245781|NCT01606254|26355425|FG000|Overall Study|Withdrawal by Subject|1|||
13245782|NCT01606254|26355426|FG001|Overall Study|Withdrawal by Subject|3|||
13245783|NCT01606254|26355427|FG002|Overall Study|Withdrawal by Subject|0|||
13245784|NCT01606254|26355428|FG003|Overall Study|Withdrawal by Subject|2|||
13245785|NCT01606254|26355425|FG000|Overall Study|Adverse Event|1|||
13245786|NCT01606254|26355426|FG001|Overall Study|Adverse Event|1|||
13245787|NCT01606254|26355427|FG002|Overall Study|Adverse Event|0|||
13245788|NCT01606254|26355428|FG003|Overall Study|Adverse Event|1|||
13245789|NCT01606228|26355445|FG000|Overall Study|Lost to Follow-up|20|||
13245790|NCT01606228|26355445|FG000|Overall Study|Withdrawal by Subject|3|||
13245791|NCT01606228|26355445|FG000|Overall Study|Non-compliant|3|||
13245792|NCT01606228|26355445|FG000|Overall Study|Lack of Efficacy|2|||
13245793|NCT01606228|26355445|FG000|Overall Study|Adverse Event|1|||
13245794|NCT01606137|26355467|FG000|Overall Study|Adverse Event|85|||
13245795|NCT01606137|26355467|FG000|Overall Study|Withdrawal by Subject|74|||
13245796|NCT01606137|26355467|FG000|Overall Study|Lack of Efficacy|56|||
13245797|NCT01606137|26355467|FG000|Overall Study|Lost to Follow-up|15|||
13245798|NCT01606137|26355467|FG000|Overall Study|Protocol Violation|1|||
13245799|NCT01606137|26355467|FG000|Overall Study|Patient non-compliance|9|||
13245800|NCT01606137|26355467|FG000|Overall Study|Death|1|||
13245801|NCT01606137|26355467|FG000|Overall Study|Decreased/no pain|4|||
13245802|NCT01606137|26355467|FG000|Overall Study|Issues with driving|4|||
13245803|NCT01606137|26355467|FG000|Overall Study|multiple sclerosis less stable|1|||
13245804|NCT01606137|26355467|FG000|Overall Study|Increased bilirubin|1|||
13245805|NCT01606137|26355467|FG000|Overall Study|Spray causes nausea|1|||
13245806|NCT01606137|26355467|FG000|Overall Study|Not enough improvement|4|||
13245807|NCT01606137|26355467|FG000|Overall Study|Wanted to try another treatment|1|||
13245808|NCT01606137|26355467|FG000|Overall Study|Patient leaving country|1|||
13245809|NCT01606137|26355467|FG000|Overall Study|Personal reasons|1|||
13245810|NCT01606137|26355467|FG000|Overall Study|Unable to tolerate study med. taste|1|||
13245811|NCT01606137|26355467|FG000|Overall Study|Patient moving|1|||
13245812|NCT01606137|26355467|FG000|Overall Study|Unable to collect consistent data|1|||
13245813|NCT01606007|26355497|FG000|Overall Study|Reason 'Other' in the protocol|0|||
13245814|NCT01606007|26355498|FG001|Overall Study|Reason 'Other' in the protocol|1|||
13245815|NCT01606007|26355499|FG002|Overall Study|Reason 'Other' in the protocol|1|||
13245816|NCT01606007|26355497|FG000|Overall Study|Pregnancy|0|||
13245817|NCT01606007|26355498|FG001|Overall Study|Pregnancy|1|||
13245818|NCT01606007|26355499|FG002|Overall Study|Pregnancy|1|||
13245819|NCT01606007|26355497|FG000|Overall Study|Withdrawal by Subject|8|||
13245820|NCT01606007|26355498|FG001|Overall Study|Withdrawal by Subject|6|||
13245821|NCT01606007|26355499|FG002|Overall Study|Withdrawal by Subject|1|||
13245822|NCT01606007|26355497|FG000|Overall Study|Adverse Event|0|||
13245823|NCT01606007|26355498|FG001|Overall Study|Adverse Event|1|||
13245824|NCT01606007|26355499|FG002|Overall Study|Adverse Event|1|||
13245825|NCT01606007|26355497|FG000|Overall Study|discontinue study treatment|0|||
13245826|NCT01606007|26355498|FG001|Overall Study|discontinue study treatment|2|||
13245827|NCT01606007|26355499|FG002|Overall Study|discontinue study treatment|1|||
13245828|NCT01606007|26355497|FG000|Overall Study|Lost to Follow-up|6|||
13245829|NCT01606007|26355498|FG001|Overall Study|Lost to Follow-up|8|||
13245830|NCT01606007|26355499|FG002|Overall Study|Lost to Follow-up|5|||
13245831|NCT01606007|26355497|FG000|Overall Study|Poor/Non-compliance|1|||
13245832|NCT01606007|26355498|FG001|Overall Study|Poor/Non-compliance|0|||
13245833|NCT01606007|26355499|FG002|Overall Study|Poor/Non-compliance|0|||
13245834|NCT01605916|26355588|FG000|Overall Study|Adverse Event|1|||
13245835|NCT01605916|26355589|FG001|Overall Study|Adverse Event|0|||
13245836|NCT01605916|26355590|FG002|Overall Study|Adverse Event|0|||
13245837|NCT01605916|26355591|FG003|Overall Study|Adverse Event|1|||
13245838|NCT01605916|26355592|FG004|Overall Study|Adverse Event|0|||
13245839|NCT01605916|26355588|FG000|Overall Study|Lack of Efficacy|2|||
13245840|NCT01605916|26355589|FG001|Overall Study|Lack of Efficacy|3|||
13245841|NCT01605916|26355590|FG002|Overall Study|Lack of Efficacy|3|||
13245842|NCT01605916|26355591|FG003|Overall Study|Lack of Efficacy|5|||
13245843|NCT01605916|26355592|FG004|Overall Study|Lack of Efficacy|4|||
13245844|NCT01605916|26355588|FG000|Overall Study|Withdrawal by Subject|1|||
13245845|NCT01605916|26355589|FG001|Overall Study|Withdrawal by Subject|1|||
13245846|NCT01605916|26355590|FG002|Overall Study|Withdrawal by Subject|0|||
13245847|NCT01605916|26355591|FG003|Overall Study|Withdrawal by Subject|0|||
13245848|NCT01605916|26355592|FG004|Overall Study|Withdrawal by Subject|2|||
13245849|NCT01605877|26355656|FG000|Overall Study|Withdrawal by Subject|1|||
13245850|NCT01605825|26355669|FG000|Overall Study|Adverse Event|4|||
13245851|NCT01605825|26355670|FG001|Overall Study|Adverse Event|2|||
13245852|NCT01605825|26355669|FG000|Overall Study|Withdrawal by Subject|0|||
13245853|NCT01605825|26355670|FG001|Overall Study|Withdrawal by Subject|1|||
13245854|NCT01605825|26355669|FG000|Overall Study|Non-Compliance -Investigational Drug|3|||
13245855|NCT01605825|26355670|FG001|Overall Study|Non-Compliance -Investigational Drug|0|||
13245856|NCT01605825|26355669|FG000|Overall Study|Non-Compliance with Protocol|3|||
13245857|NCT01605825|26355670|FG001|Overall Study|Non-Compliance with Protocol|0|||
13245858|NCT01605799|26355685|FG000|Overall Study|Withdrawal by Subject|2|||
13245859|NCT01605799|26355686|FG001|Overall Study|Withdrawal by Subject|1|||
13245860|NCT01605617|26355711|FG000|First Intervention|Adverse Event|0|||
13245861|NCT01605617|26355712|FG001|First Intervention|Adverse Event|1|||
13245862|NCT01605617|26355711|FG000|Washout Period of 4 Weeks|Study Terminated|2|||
13245863|NCT01605617|26355712|FG001|Washout Period of 4 Weeks|Study Terminated|1|||
13245864|NCT01605461|26355723|FG000|Overall Study|Lost to Follow-up|3|||
13245865|NCT01605461|26355723|FG000|Overall Study|Withdrawal by Subject|1|||
13245866|NCT01605396|26355742|FG000|Overall Study|Adverse Event|5|||
13245867|NCT01605396|26355743|FG001|Overall Study|Adverse Event|3|||
13245868|NCT01605396|26355742|FG000|Overall Study|Lost to Follow-up|1|||
13245869|NCT01605396|26355743|FG001|Overall Study|Lost to Follow-up|0|||
13245870|NCT01605396|26355742|FG000|Overall Study|Non-Compliance With Study Drug|1|||
13245871|NCT01605396|26355743|FG001|Overall Study|Non-Compliance With Study Drug|1|||
13245872|NCT01605396|26355742|FG000|Overall Study|Physician Decision|2|||
13245873|NCT01605396|26355743|FG001|Overall Study|Physician Decision|2|||
13245874|NCT01605396|26355742|FG000|Overall Study|Progressive Disease|23|||
13245875|NCT01605396|26355743|FG001|Overall Study|Progressive Disease|27|||
13245876|NCT01605396|26355742|FG000|Overall Study|Withdrawal by Subject|4|||
13245877|NCT01605396|26355743|FG001|Overall Study|Withdrawal by Subject|2|||
13245878|NCT01605396|26355742|FG000|Overall Study|Transfer Off Study|4|||
13245879|NCT01605396|26355743|FG001|Overall Study|Transfer Off Study|5|||
13245880|NCT01605370|26355756|FG000|Overall Study|Adverse Event|1|||
13245881|NCT01605370|26355757|FG001|Overall Study|Adverse Event|0|||
13245882|NCT01605227|26355774|FG000|Overall Study|Did not receive study treatment|2|||
13245883|NCT01605227|26355775|FG001|Overall Study|Did not receive study treatment|3|||
13245884|NCT01605227|26355774|FG000|Overall Study|Adverse Event|228|||
13245885|NCT01605227|26355775|FG001|Overall Study|Adverse Event|42|||
13245886|NCT01605227|26355774|FG000|Overall Study|Progressive Disease|132|||
13245887|NCT01605227|26355775|FG001|Overall Study|Progressive Disease|128|||
13245888|NCT01605227|26355774|FG000|Overall Study|Clinical Deterioration|227|||
13245889|NCT01605227|26355775|FG001|Overall Study|Clinical Deterioration|133|||
13245890|NCT01605227|26355774|FG000|Overall Study|Lost to Follow-up|1|||
13245891|NCT01605227|26355775|FG001|Overall Study|Lost to Follow-up|0|||
13245892|NCT01605227|26355774|FG000|Overall Study|Protocol Violation|1|||
13245893|NCT01605227|26355775|FG001|Overall Study|Protocol Violation|0|||
13245894|NCT01605227|26355774|FG000|Overall Study|Physician Decision|9|||
13245895|NCT01605227|26355775|FG001|Overall Study|Physician Decision|7|||
13245896|NCT01605227|26355774|FG000|Overall Study|Withdrawal by Subject|18|||
13245897|NCT01605227|26355775|FG001|Overall Study|Withdrawal by Subject|14|||
13245898|NCT01605227|26355774|FG000|Overall Study|Sponsor Decision|2|||
13245899|NCT01605227|26355775|FG001|Overall Study|Sponsor Decision|0|||
13245900|NCT01605227|26355774|FG000|Overall Study|Started New Therapy|1|||
13245901|NCT01605227|26355775|FG001|Overall Study|Started New Therapy|0|||
13245902|NCT01605227|26355774|FG000|Overall Study|Subject Decision|0|||
13245903|NCT01605227|26355775|FG001|Overall Study|Subject Decision|1|||
13245904|NCT01605227|26355774|FG000|Overall Study|Dose Held >6 weeks|0|||
13245905|NCT01605227|26355775|FG001|Overall Study|Dose Held >6 weeks|1|||
13245906|NCT01605136|26355800|FG000|Study Period|Withdrawal by Subject|2|||
13245907|NCT01605136|26355801|FG001|Study Period|Withdrawal by Subject|0|||
13245908|NCT01605136|26355800|FG000|Study Period|Physician Decision|1|||
13245909|NCT01605136|26355801|FG001|Study Period|Physician Decision|1|||
13245910|NCT01605136|26355800|FG000|Study Period|Lost to Follow-up|0|||
13245911|NCT01605136|26355801|FG001|Study Period|Lost to Follow-up|2|||
13245912|NCT01605136|26355800|FG000|Safety Follow-Up Period|Withdrawal by Subject|1|||
13245913|NCT01605136|26355801|FG001|Safety Follow-Up Period|Withdrawal by Subject|2|||
13245914|NCT01605097|26355809|FG000|Overall Study|Protocol Violation|1|||
13245915|NCT01605071|26355830|FG000|Overall Study|Withdrawal by Subject|3|||
13245916|NCT01605071|26355831|FG001|Overall Study|Withdrawal by Subject|2|||
13245917|NCT01605019|26355846|FG000|Overall Study|pt did not meet transplant endpoint|3|||
13245918|NCT01605019|26355847|FG001|Overall Study|pt did not meet transplant endpoint|0|||
13245919|NCT01604941|26355884|FG000|Overall Study|Adverse Event|1|||
13245920|NCT01604941|26355885|FG001|Overall Study|Adverse Event|2|||
13245921|NCT01604941|26355886|FG002|Overall Study|Adverse Event|0|||
13245922|NCT01604941|26355887|FG003|Overall Study|Adverse Event|0|||
13245923|NCT01604941|26355888|FG004|Overall Study|Adverse Event|1|||
13245924|NCT01604941|26355889|FG005|Overall Study|Adverse Event|5|||
13245925|NCT01604941|26355884|FG000|Overall Study|Non-compliance|1|||
13245926|NCT01604941|26355885|FG001|Overall Study|Non-compliance|0|||
13245927|NCT01604941|26355886|FG002|Overall Study|Non-compliance|0|||
13245928|NCT01604941|26355887|FG003|Overall Study|Non-compliance|0|||
13245929|NCT01604941|26355888|FG004|Overall Study|Non-compliance|0|||
13245930|NCT01604941|26355889|FG005|Overall Study|Non-compliance|0|||
13245931|NCT01604941|26355884|FG000|Overall Study|Participant Decision|0|||
13245932|NCT01604941|26355885|FG001|Overall Study|Participant Decision|0|||
13245933|NCT01604941|26355886|FG002|Overall Study|Participant Decision|0|||
13245934|NCT01604941|26355887|FG003|Overall Study|Participant Decision|0|||
13245935|NCT01604941|26355888|FG004|Overall Study|Participant Decision|0|||
13245936|NCT01604941|26355889|FG005|Overall Study|Participant Decision|2|||
13245937|NCT01604941|26355884|FG000|Overall Study|Early Study Termination|9|||
13245938|NCT01604941|26355885|FG001|Overall Study|Early Study Termination|2|||
13245939|NCT01604941|26355886|FG002|Overall Study|Early Study Termination|3|||
13245940|NCT01604941|26355887|FG003|Overall Study|Early Study Termination|3|||
13245941|NCT01604941|26355888|FG004|Overall Study|Early Study Termination|0|||
13245942|NCT01604941|26355889|FG005|Overall Study|Early Study Termination|0|||
13245943|NCT01604850|26355912|FG000|Overall Study|Enrolled but never treated|0|||
13245944|NCT01604850|26355913|FG001|Overall Study|Enrolled but never treated|1|||
13245945|NCT01604850|26355912|FG000|Overall Study|Efficacy Failure|50|||
13245946|NCT01604850|26355913|FG001|Overall Study|Efficacy Failure|29|||
13245947|NCT01604850|26355912|FG000|Overall Study|Lost to Follow-up|1|||
13245948|NCT01604850|26355913|FG001|Overall Study|Lost to Follow-up|0|||
13245949|NCT01604850|26355912|FG000|Overall Study|Subject withdrew consent|1|||
13245950|NCT01604850|26355913|FG001|Overall Study|Subject withdrew consent|0|||
13245951|NCT01604824|26355956|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
13245952|NCT01604824|26355957|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
13245953|NCT01604824|26355958|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
13245954|NCT01604824|26355959|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
13245955|NCT01604824|26355960|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2|||
13245956|NCT01604824|26355961|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
13245957|NCT01604824|26355956|FG000|Open-label Extension (OLE) Period|Refused to come into office|0|||
13245958|NCT01604824|26355957|FG001|Open-label Extension (OLE) Period|Refused to come into office|0|||
13245959|NCT01604824|26355958|FG002|Open-label Extension (OLE) Period|Refused to come into office|0|||
13245960|NCT01604824|26355959|FG003|Open-label Extension (OLE) Period|Refused to come into office|0|||
13245961|NCT01604824|26355960|FG004|Open-label Extension (OLE) Period|Refused to come into office|1|||
13245962|NCT01604824|26355961|FG005|Open-label Extension (OLE) Period|Refused to come into office|0|||
13245963|NCT01604785|26355978|FG000|Overall Study|Repeat Visits Not Included in Analysis|7|||
13245964|NCT01604785|26355979|FG001|Overall Study|Repeat Visits Not Included in Analysis|1|||
13245965|NCT01604408|26355998|FG000|Treatment Period 1|Protocol Violation|0|||
13245966|NCT01604408|26355999|FG001|Treatment Period 1|Protocol Violation|1|||
13245967|NCT01604408|26355998|FG000|Treatment Period 2|Withdrawal by Subject|1|||
13245968|NCT01604408|26355999|FG001|Treatment Period 2|Withdrawal by Subject|1|||
13245969|NCT01604408|26355998|FG000|Treatment Period 2|Protocol Violation|1|||
13245970|NCT01604408|26355999|FG001|Treatment Period 2|Protocol Violation|0|||
13245971|NCT01604408|26355998|FG000|Treatment Period 2|Adverse Event|0|||
13245972|NCT01604408|26355999|FG001|Treatment Period 2|Adverse Event|1|||
13245973|NCT01604408|26355998|FG000|Treatment Period 3|Protocol Violation|1|||
13245974|NCT01604408|26355999|FG001|Treatment Period 3|Protocol Violation|1|||
13245975|NCT01604408|26355998|FG000|Treatment Period 3|Adverse Event|0|||
13245976|NCT01604408|26355999|FG001|Treatment Period 3|Adverse Event|3|||
13245977|NCT01604408|26355998|FG000|Treatment Period 3|Withdrawal by Subject|3|||
13245978|NCT01604408|26355999|FG001|Treatment Period 3|Withdrawal by Subject|1|||
13245979|NCT01604408|26355998|FG000|Treatment Period 3|Sponsor Decision|1|||
13245980|NCT01604408|26355999|FG001|Treatment Period 3|Sponsor Decision|0|||
13245981|NCT01604408|26355998|FG000|Treatment Period 4|Death|1|||
13245982|NCT01604408|26355999|FG001|Treatment Period 4|Death|0|||
13116086|NCT03084796|25920960|FG003|Overall Study|Lost to Follow-up|1|||
13116087|NCT03084796|25920961|FG004|Overall Study|Lost to Follow-up|3|||
13116088|NCT03084796|25920962|FG005|Overall Study|Lost to Follow-up|1|||
13116089|NCT03084796|25920957|FG000|Overall Study|Randomization error|0|||
13116090|NCT03084796|25920958|FG001|Overall Study|Randomization error|0|||
13116091|NCT03084796|25920959|FG002|Overall Study|Randomization error|1|||
13245983|NCT01604408|26355998|FG000|Treatment Period 4|Withdrawal by Subject|2|||
13245984|NCT01604408|26355999|FG001|Treatment Period 4|Withdrawal by Subject|1|||
13245985|NCT01604408|26355998|FG000|Treatment Period 4|Adverse Event|0|||
13245986|NCT01604408|26355999|FG001|Treatment Period 4|Adverse Event|1|||
13245987|NCT01604408|26355998|FG000|Treatment Period 5|Adverse Event|4|||
13245988|NCT01604408|26355999|FG001|Treatment Period 5|Adverse Event|0|||
13245989|NCT01604408|26355998|FG000|Treatment Period 6|Lost to Follow-up|0|||
13116092|NCT03084796|25920960|FG003|Overall Study|Randomization error|0|||
13116093|NCT03084796|25920961|FG004|Overall Study|Randomization error|0|||
13245990|NCT01604408|26355999|FG001|Treatment Period 6|Lost to Follow-up|1|||
13245991|NCT01604408|26355998|FG000|Treatment Period 6|Adverse Event|2|||
13245992|NCT01604408|26355999|FG001|Treatment Period 6|Adverse Event|0|||
13245993|NCT01604408|26355998|FG000|Treatment Period 6|Sponsor decision|0|||
13245994|NCT01604408|26355999|FG001|Treatment Period 6|Sponsor decision|1|||
13245995|NCT01604408|26355998|FG000|Observation Period|Adverse Event|1|||
13245996|NCT01604408|26355999|FG001|Observation Period|Adverse Event|1|||
13245997|NCT01604408|26355998|FG000|Observation Period|Withdrawal by Subject|0|||
13245998|NCT01604408|26355999|FG001|Observation Period|Withdrawal by Subject|2|||
13245999|NCT01604343|26356120|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5|||
13246000|NCT01604343|26356121|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
13246001|NCT01604343|26356122|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4|||
13246002|NCT01604343|26356123|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
13246003|NCT01604343|26356124|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3|||
13246004|NCT01604343|26356120|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19|||
13246005|NCT01604343|26356121|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
13246006|NCT01604343|26356122|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12|||
13246007|NCT01604343|26356123|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
13246008|NCT01604343|26356124|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16|||
13246009|NCT01604343|26356120|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25|||
13246010|NCT01604343|26356121|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0|||
13246011|NCT01604343|26356122|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41|||
13246012|NCT01604343|26356123|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0|||
13246013|NCT01604343|26356124|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42|||
13246014|NCT01604343|26356120|FG000|Prior to W52 Administration(Through W52)|Death|5|||
13246015|NCT01604343|26356121|FG001|Prior to W52 Administration(Through W52)|Death|0|||
13246016|NCT01604343|26356122|FG002|Prior to W52 Administration(Through W52)|Death|2|||
13246017|NCT01604343|26356123|FG003|Prior to W52 Administration(Through W52)|Death|0|||
13246018|NCT01604343|26356124|FG004|Prior to W52 Administration(Through W52)|Death|4|||
13246019|NCT01604343|26356120|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24|||
13246020|NCT01604343|26356121|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
13246021|NCT01604343|26356122|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5|||
13246022|NCT01604343|26356123|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
13246023|NCT01604343|26356124|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14|||
13246024|NCT01604343|26356120|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4|||
13246025|NCT01604343|26356121|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0|||
13246026|NCT01604343|26356122|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1|||
13246027|NCT01604343|26356123|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0|||
13246028|NCT01604343|26356124|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2|||
13246029|NCT01604343|26356120|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1|||
13246030|NCT01604343|26356121|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0|||
13246031|NCT01604343|26356122|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1|||
13246032|NCT01604343|26356123|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0|||
13246033|NCT01604343|26356124|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0|||
13246034|NCT01604343|26356120|FG000|Prior to W52 Administration(Through W52)|Other|15|||
13246035|NCT01604343|26356121|FG001|Prior to W52 Administration(Through W52)|Other|0|||
13246036|NCT01604343|26356122|FG002|Prior to W52 Administration(Through W52)|Other|10|||
13246037|NCT01604343|26356123|FG003|Prior to W52 Administration(Through W52)|Other|0|||
13246038|NCT01604343|26356124|FG004|Prior to W52 Administration(Through W52)|Other|6|||
13246039|NCT01604343|26356120|FG000|Week 52 to Week 104|Lost to Follow-up|0|||
13246040|NCT01604343|26356121|FG001|Week 52 to Week 104|Lost to Follow-up|2|||
13246041|NCT01604343|26356122|FG002|Week 52 to Week 104|Lost to Follow-up|4|||
13246042|NCT01604343|26356123|FG003|Week 52 to Week 104|Lost to Follow-up|2|||
13246043|NCT01604343|26356124|FG004|Week 52 to Week 104|Lost to Follow-up|1|||
13246044|NCT01604343|26356120|FG000|Week 52 to Week 104|Withdrawal by Subject|0|||
13246045|NCT01604343|26356121|FG001|Week 52 to Week 104|Withdrawal by Subject|7|||
13246046|NCT01604343|26356122|FG002|Week 52 to Week 104|Withdrawal by Subject|12|||
13246047|NCT01604343|26356123|FG003|Week 52 to Week 104|Withdrawal by Subject|8|||
13246048|NCT01604343|26356124|FG004|Week 52 to Week 104|Withdrawal by Subject|4|||
13246049|NCT01604343|26356120|FG000|Week 52 to Week 104|Adverse Event|0|||
13246050|NCT01604343|26356121|FG001|Week 52 to Week 104|Adverse Event|12|||
13246051|NCT01604343|26356122|FG002|Week 52 to Week 104|Adverse Event|26|||
13246052|NCT01604343|26356123|FG003|Week 52 to Week 104|Adverse Event|21|||
13246053|NCT01604343|26356124|FG004|Week 52 to Week 104|Adverse Event|27|||
13246054|NCT01604343|26356120|FG000|Week 52 to Week 104|Death|0|||
13246055|NCT01604343|26356121|FG001|Week 52 to Week 104|Death|4|||
13246056|NCT01604343|26356122|FG002|Week 52 to Week 104|Death|2|||
13246057|NCT01604343|26356123|FG003|Week 52 to Week 104|Death|5|||
13246058|NCT01604343|26356124|FG004|Week 52 to Week 104|Death|0|||
13246059|NCT01604343|26356120|FG000|Week 52 to Week 104|Lack of Efficacy|0|||
13246060|NCT01604343|26356121|FG001|Week 52 to Week 104|Lack of Efficacy|6|||
13246061|NCT01604343|26356122|FG002|Week 52 to Week 104|Lack of Efficacy|11|||
13246062|NCT01604343|26356123|FG003|Week 52 to Week 104|Lack of Efficacy|2|||
13246063|NCT01604343|26356124|FG004|Week 52 to Week 104|Lack of Efficacy|3|||
13246064|NCT01604343|26356120|FG000|Week 52 to Week 104|Physician Decision|0|||
13246065|NCT01604343|26356121|FG001|Week 52 to Week 104|Physician Decision|1|||
13246066|NCT01604343|26356122|FG002|Week 52 to Week 104|Physician Decision|0|||
13246067|NCT01604343|26356123|FG003|Week 52 to Week 104|Physician Decision|0|||
13246068|NCT01604343|26356124|FG004|Week 52 to Week 104|Physician Decision|2|||
13246069|NCT01604343|26356120|FG000|Week 52 to Week 104|Pregnancy|0|||
13246070|NCT01604343|26356121|FG001|Week 52 to Week 104|Pregnancy|0|||
13246071|NCT01604343|26356122|FG002|Week 52 to Week 104|Pregnancy|1|||
13246072|NCT01604343|26356123|FG003|Week 52 to Week 104|Pregnancy|2|||
13246073|NCT01604343|26356124|FG004|Week 52 to Week 104|Pregnancy|1|||
13246074|NCT01604343|26356120|FG000|Week 52 to Week 104|Other|0|||
13246075|NCT01604343|26356121|FG001|Week 52 to Week 104|Other|11|||
13246076|NCT01604343|26356122|FG002|Week 52 to Week 104|Other|11|||
13246077|NCT01604343|26356123|FG003|Week 52 to Week 104|Other|6|||
13246078|NCT01604343|26356124|FG004|Week 52 to Week 104|Other|3|||
13246079|NCT01604343|26356120|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3|||
13246080|NCT01604343|26356121|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
13246081|NCT01604343|26356122|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2|||
13246082|NCT01604343|26356123|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
13246083|NCT01604343|26356124|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
13246084|NCT01604343|26356120|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12|||
13246085|NCT01604343|26356121|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4|||
13246086|NCT01604343|26356122|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11|||
13246087|NCT01604343|26356123|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3|||
13246088|NCT01604343|26356124|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14|||
13246089|NCT01604343|26356120|FG000|Safety Follow-up Period (Week 104-120)|Other|15|||
13246090|NCT01604343|26356121|FG001|Safety Follow-up Period (Week 104-120)|Other|2|||
13246091|NCT01604343|26356122|FG002|Safety Follow-up Period (Week 104-120)|Other|20|||
13246092|NCT01604343|26356123|FG003|Safety Follow-up Period (Week 104-120)|Other|6|||
13246093|NCT01604343|26356124|FG004|Safety Follow-up Period (Week 104-120)|Other|14|||
13246094|NCT01604278|26356155|FG000|Overall Study|Lack of Efficacy|0|||
13246095|NCT01604278|26356156|FG001|Overall Study|Lack of Efficacy|1|||
13246096|NCT01604278|26356155|FG000|Overall Study|Lost to Follow-up|1|||
13246097|NCT01604278|26356156|FG001|Overall Study|Lost to Follow-up|0|||
13246098|NCT01604278|26356155|FG000|Overall Study|Administrative problems|2|||
13246099|NCT01604278|26356156|FG001|Overall Study|Administrative problems|1|||
13246100|NCT01604278|26356155|FG000|Overall Study|Withdrawal by Subject|3|||
13246101|NCT01604278|26356156|FG001|Overall Study|Withdrawal by Subject|3|||
13246102|NCT01604278|26356155|FG000|Overall Study|Adverse Event|3|||
13246103|NCT01604278|26356156|FG001|Overall Study|Adverse Event|5|||
13246104|NCT01604278|26356155|FG000|Overall Study|Protocol Deviation|5|||
13246105|NCT01604278|26356156|FG001|Overall Study|Protocol Deviation|3|||
13246106|NCT01603875|26356186|FG000|Overall Study|Preexisting rabies antibody|3|||
13246107|NCT01603875|26356187|FG001|Overall Study|Preexisting rabies antibody|4|||
13246108|NCT01603875|26356188|FG002|Overall Study|Preexisting rabies antibody|3|||
13246109|NCT01603875|26356186|FG000|Overall Study|Lost to Follow-up|4|||
13246110|NCT01603875|26356187|FG001|Overall Study|Lost to Follow-up|3|||
13246111|NCT01603875|26356188|FG002|Overall Study|Lost to Follow-up|6|||
13246112|NCT01603875|26356186|FG000|Overall Study|Protocol Violation|0|||
13246113|NCT01603875|26356187|FG001|Overall Study|Protocol Violation|1|||
13246114|NCT01603875|26356188|FG002|Overall Study|Protocol Violation|0|||
13246115|NCT01603641|26356194|FG000|Overall Study|Did not Receive Treatment|3|||
13246116|NCT01603641|26356194|FG000|Overall Study|Adverse Event|1|||
13246117|NCT01603641|26356194|FG000|Overall Study|Lack of Efficacy|1|||
13246118|NCT01603641|26356194|FG000|Overall Study|Lost to Follow-up|6|||
13246119|NCT01603641|26356194|FG000|Overall Study|Personal Reasons|18|||
13246120|NCT01603641|26356194|FG000|Overall Study|Other Miscellaneous Reasons|6|||
13246121|NCT01603628|26356221|FG000|Overall Study|Personal Reasons|1|||
13246122|NCT01603628|26356222|FG001|Overall Study|Personal Reasons|1|||
13246123|NCT01603628|26356223|FG002|Overall Study|Personal Reasons|2|||
13246124|NCT01603628|26356221|FG000|Overall Study|Protocol Violation|1|||
13246125|NCT01603628|26356222|FG001|Overall Study|Protocol Violation|1|||
13246126|NCT01603628|26356223|FG002|Overall Study|Protocol Violation|0|||
13246127|NCT01603628|26356221|FG000|Overall Study|Lost to Follow-up|0|||
13246128|NCT01603628|26356222|FG001|Overall Study|Lost to Follow-up|1|||
13246129|NCT01603628|26356223|FG002|Overall Study|Lost to Follow-up|0|||
13246130|NCT01603628|26356221|FG000|Overall Study|Other Miscellaneous Reason|1|||
13246131|NCT01603628|26356222|FG001|Overall Study|Other Miscellaneous Reason|0|||
13246132|NCT01603628|26356223|FG002|Overall Study|Other Miscellaneous Reason|0|||
13246133|NCT01603615|26356229|FG000|Overall Study|Did not Receive Treatment|7|||
13246134|NCT01603615|26356229|FG000|Overall Study|Lost to Follow-up|9|||
13246135|NCT01603615|26356229|FG000|Overall Study|Personal Reasons|17|||
13246136|NCT01603615|26356229|FG000|Overall Study|Other Miscellaneous|1|||
13246137|NCT01603602|26356259|FG000|Overall Study|Adverse Event|1|||
13246138|NCT01603602|26356260|FG001|Overall Study|Adverse Event|0|||
13246139|NCT01603602|26356261|FG002|Overall Study|Adverse Event|0|||
13246140|NCT01603602|26356259|FG000|Overall Study|Personal Reasons|1|||
13246141|NCT01603602|26356260|FG001|Overall Study|Personal Reasons|0|||
13246142|NCT01603602|26356261|FG002|Overall Study|Personal Reasons|1|||
13246143|NCT01603459|26356383|FG000|Overall Study|Adverse Event|5|||
13246144|NCT01603459|26356383|FG000|Overall Study|Withdrawal by Subject|5|||
13246145|NCT01603459|26356383|FG000|Overall Study|Lost to Follow-up|3|||
13246146|NCT01603459|26356383|FG000|Overall Study|Predefined discontinuation criteria|3|||
13246147|NCT01603459|26356383|FG000|Overall Study|Non-compliance|1|||
13246148|NCT01603459|26356383|FG000|Overall Study|Administrative reason|1|||
13246149|NCT01603407|26356449|FG000|Overall Study|Adverse Event|1|||
13246150|NCT01603407|26356450|FG001|Overall Study|Adverse Event|1|||
13246151|NCT01603407|26356451|FG002|Overall Study|Adverse Event|1|||
13246152|NCT01603407|26356449|FG000|Overall Study|Protocol Violation|2|||
13246153|NCT01603407|26356450|FG001|Overall Study|Protocol Violation|2|||
13246154|NCT01603407|26356451|FG002|Overall Study|Protocol Violation|0|||
13246155|NCT01603407|26356449|FG000|Overall Study|Withdrawal by Subject|8|||
13246156|NCT01603407|26356450|FG001|Overall Study|Withdrawal by Subject|5|||
13246157|NCT01603407|26356451|FG002|Overall Study|Withdrawal by Subject|7|||
13246158|NCT01603407|26356449|FG000|Overall Study|Lost to Follow-up|0|||
13246159|NCT01603407|26356450|FG001|Overall Study|Lost to Follow-up|3|||
13246160|NCT01603407|26356451|FG002|Overall Study|Lost to Follow-up|2|||
13246161|NCT01603394|26356468|FG000|Overall Study|Adverse Event|1|||
13246162|NCT01603355|26356474|FG000|Overall Study|Lack of Efficacy|2|||
13246163|NCT01603277|26356487|FG000|Overall Study|Adverse Event|1|||
13246164|NCT01603277|26356488|FG001|Overall Study|Adverse Event|2|||
13246165|NCT01603277|26356487|FG000|Overall Study|Physician Decision|0|||
13246166|NCT01603277|26356488|FG001|Overall Study|Physician Decision|1|||
13246167|NCT01603277|26356487|FG000|Overall Study|Protocol Violation|6|||
13246168|NCT01603277|26356488|FG001|Overall Study|Protocol Violation|10|||
13246169|NCT01603277|26356487|FG000|Overall Study|Withdrawal by Subject|5|||
13246170|NCT01603277|26356488|FG001|Overall Study|Withdrawal by Subject|4|||
13246171|NCT01603277|26356487|FG000|Overall Study|Non-Compliance|2|||
13246172|NCT01603277|26356488|FG001|Overall Study|Non-Compliance|1|||
13246173|NCT01603121|26356501|FG000|Second Intervention, 10 Hours|Adverse Event|1|||
13246174|NCT01603121|26356502|FG001|Second Intervention, 10 Hours|Adverse Event|0|||
13246175|NCT01603082|26356517|FG000|Overall Study|Adverse Event|0|||
13246176|NCT01603082|26356518|FG001|Overall Study|Adverse Event|1|||
13246177|NCT01603082|26356517|FG000|Overall Study|Withdrawal by Subject|1|||
13246178|NCT01603082|26356518|FG001|Overall Study|Withdrawal by Subject|0|||
13246179|NCT01603082|26356517|FG000|Overall Study|Failed inclusion criterion after dosed|1|||
13246180|NCT01603082|26356518|FG001|Overall Study|Failed inclusion criterion after dosed|0|||
13246181|NCT01603043|26356535|FG000|Overall Study|Study Futility|7|||
13246182|NCT01603043|26356536|FG001|Overall Study|Study Futility|3|||
13246183|NCT01602965|26356549|FG000|Overall Study|Lost to Follow-up|4|||
13246184|NCT01602965|26356550|FG001|Overall Study|Lost to Follow-up|2|||
13246185|NCT01602744|26356573|FG000|Overall Study|Death|17|||
13246186|NCT01602744|26356574|FG001|Overall Study|Death|15|||
13246187|NCT01602744|26356573|FG000|Overall Study|Lost to Follow-up|13|||
13246188|NCT01602744|26356574|FG001|Overall Study|Lost to Follow-up|8|||
13246189|NCT01602562|26356615|FG000|Overall Study|Adverse Event|3|||
13246190|NCT01602562|26356616|FG001|Overall Study|Adverse Event|1|||
13246191|NCT01602562|26356615|FG000|Overall Study|Physician Decision|1|||
13246192|NCT01602562|26356616|FG001|Overall Study|Physician Decision|1|||
13246193|NCT01602562|26356615|FG000|Overall Study|Withdrawal by Subject|1|||
13246194|NCT01602562|26356616|FG001|Overall Study|Withdrawal by Subject|1|||
13246195|NCT01602549|26356702|FG000|Overall Study|Protocol Violation|0|||
13246196|NCT01602549|26356703|FG001|Overall Study|Protocol Violation|1|||
13246197|NCT01602549|26356702|FG000|Overall Study|Withdrawal by Subject|1|||
13246198|NCT01602549|26356703|FG001|Overall Study|Withdrawal by Subject|0|||
13246199|NCT01602510|26356731|FG000|Open Label Phase|Adverse Event|46|||
13246200|NCT01602510|26356732|FG001|Open Label Phase|Adverse Event|0|||
13246201|NCT01602510|26356733|FG002|Open Label Phase|Adverse Event|0|||
13246202|NCT01602510|26356731|FG000|Open Label Phase|Lack of Efficacy|22|||
13246203|NCT01602510|26356732|FG001|Open Label Phase|Lack of Efficacy|0|||
13246204|NCT01602510|26356733|FG002|Open Label Phase|Lack of Efficacy|0|||
13246205|NCT01602510|26356731|FG000|Open Label Phase|Protocol Violation|15|||
13246206|NCT01602510|26356732|FG001|Open Label Phase|Protocol Violation|0|||
13246207|NCT01602510|26356733|FG002|Open Label Phase|Protocol Violation|0|||
13246208|NCT01602510|26356731|FG000|Open Label Phase|Met protocol-defined stopping criteria|122|||
13246209|NCT01602510|26356732|FG001|Open Label Phase|Met protocol-defined stopping criteria|0|||
13246210|NCT01602510|26356733|FG002|Open Label Phase|Met protocol-defined stopping criteria|0|||
13246211|NCT01602510|26356731|FG000|Open Label Phase|Lost to Follow-up|22|||
13246212|NCT01602510|26356732|FG001|Open Label Phase|Lost to Follow-up|0|||
13246213|NCT01602510|26356733|FG002|Open Label Phase|Lost to Follow-up|0|||
13246214|NCT01602510|26356731|FG000|Open Label Phase|Physician Decision|19|||
13246215|NCT01602510|26356732|FG001|Open Label Phase|Physician Decision|0|||
13246216|NCT01602510|26356733|FG002|Open Label Phase|Physician Decision|0|||
13246217|NCT01602510|26356731|FG000|Open Label Phase|Withdrawal by Subject|57|||
13246218|NCT01602510|26356732|FG001|Open Label Phase|Withdrawal by Subject|0|||
13246219|NCT01602510|26356733|FG002|Open Label Phase|Withdrawal by Subject|0|||
13246220|NCT01602510|26356731|FG000|Randomized Phase|Adverse Event|0|||
13246221|NCT01602510|26356732|FG001|Randomized Phase|Adverse Event|2|||
13246222|NCT01602510|26356733|FG002|Randomized Phase|Adverse Event|6|||
13246223|NCT01602510|26356731|FG000|Randomized Phase|Lack of Efficacy|0|||
13246224|NCT01602510|26356732|FG001|Randomized Phase|Lack of Efficacy|4|||
13116094|NCT03084796|25920962|FG005|Overall Study|Randomization error|0|||
13246225|NCT01602510|26356733|FG002|Randomized Phase|Lack of Efficacy|4|||
13246226|NCT01602510|26356731|FG000|Randomized Phase|Protocol Violation|0|||
13246227|NCT01602510|26356732|FG001|Randomized Phase|Protocol Violation|3|||
13246228|NCT01602510|26356733|FG002|Randomized Phase|Protocol Violation|3|||
13246229|NCT01602510|26356731|FG000|Randomized Phase|Met protocol-defined stopping criteria|0|||
13246230|NCT01602510|26356732|FG001|Randomized Phase|Met protocol-defined stopping criteria|58|||
13246231|NCT01602510|26356733|FG002|Randomized Phase|Met protocol-defined stopping criteria|48|||
13246232|NCT01602510|26356731|FG000|Randomized Phase|Lost to Follow-up|0|||
13246233|NCT01602510|26356732|FG001|Randomized Phase|Lost to Follow-up|1|||
13246234|NCT01602510|26356733|FG002|Randomized Phase|Lost to Follow-up|3|||
13246235|NCT01602510|26356731|FG000|Randomized Phase|Physician Decision|0|||
13246236|NCT01602510|26356732|FG001|Randomized Phase|Physician Decision|0|||
13246237|NCT01602510|26356733|FG002|Randomized Phase|Physician Decision|2|||
13246238|NCT01602510|26356731|FG000|Randomized Phase|Withdrawal by Subject|0|||
13246239|NCT01602510|26356732|FG001|Randomized Phase|Withdrawal by Subject|6|||
13246240|NCT01602510|26356733|FG002|Randomized Phase|Withdrawal by Subject|7|||
13246241|NCT01602484|26356752|FG000|Overall Study|Airway issues unrelated to study|0|||
13246242|NCT01602484|26356753|FG001|Overall Study|Airway issues unrelated to study|1|||
13246243|NCT01602419|26356808|FG000|Overall Study|Not treated with Wilate|9|||
13246244|NCT01602419|26356808|FG000|Overall Study|Adverse Drug Reaction|4|||
13246245|NCT01602419|26356808|FG000|Overall Study|Insurance issues|3|||
13246246|NCT01602419|26356808|FG000|Overall Study|Changed treatment centre|1|||
13246247|NCT01602419|26356808|FG000|Overall Study|Treatment centre closed|1|||
13246248|NCT01602419|26356808|FG000|Overall Study|Withdrawal by Subject|5|||
13116095|NCT03084536|25920987|FG000|Overall Study|Determined to be ineligible|0|||
13116096|NCT03084536|25920988|FG001|Overall Study|Determined to be ineligible|0|||
13246249|NCT01602419|26356808|FG000|Overall Study|Lost to Follow-up|6|||
13246250|NCT01602341|26356849|FG000|Overall Study|Adverse Event|0|||
13246251|NCT01602341|26356850|FG001|Overall Study|Adverse Event|1|||
13246252|NCT01602315|26356958|FG000|Overall Study|Protocol Violation|0|||
13116097|NCT03084536|25920989|FG002|Overall Study|Determined to be ineligible|16|||
13116098|NCT03084536|25920987|FG000|Overall Study|Withdrawal by Subject|0|||
13116099|NCT03084536|25920988|FG001|Overall Study|Withdrawal by Subject|0|||
13116100|NCT03084536|25920989|FG002|Overall Study|Withdrawal by Subject|4|||
13116101|NCT03084536|25920987|FG000|Overall Study|Physician Decision|0|||
13116102|NCT03084536|25920988|FG001|Overall Study|Physician Decision|0|||
13116103|NCT03084536|25920989|FG002|Overall Study|Physician Decision|3|||
13116104|NCT03084536|25920987|FG000|Overall Study|Death|0|||
13116105|NCT03084536|25920988|FG001|Overall Study|Death|0|||
13246253|NCT01602315|26356959|FG001|Overall Study|Protocol Violation|0|||
13246254|NCT01602315|26356960|FG002|Overall Study|Protocol Violation|0|||
13246255|NCT01602315|26356961|FG003|Overall Study|Protocol Violation|0|||
13246256|NCT01602315|26356962|FG004|Overall Study|Protocol Violation|0|||
13246257|NCT01602315|26356963|FG005|Overall Study|Protocol Violation|1|||
13246258|NCT01602315|26356964|FG006|Overall Study|Protocol Violation|0|||
13246259|NCT01602315|26356958|FG000|Overall Study|Physician Decision|2|||
13246260|NCT01602315|26356959|FG001|Overall Study|Physician Decision|0|||
13246261|NCT01602315|26356960|FG002|Overall Study|Physician Decision|0|||
13246262|NCT01602315|26356961|FG003|Overall Study|Physician Decision|0|||
13246263|NCT01602315|26356962|FG004|Overall Study|Physician Decision|2|||
13246264|NCT01602315|26356963|FG005|Overall Study|Physician Decision|1|||
13246265|NCT01602315|26356964|FG006|Overall Study|Physician Decision|1|||
13246266|NCT01602315|26356958|FG000|Overall Study|Disease progression|6|||
13246267|NCT01602315|26356959|FG001|Overall Study|Disease progression|3|||
13246268|NCT01602315|26356960|FG002|Overall Study|Disease progression|10|||
13246269|NCT01602315|26356961|FG003|Overall Study|Disease progression|1|||
13246270|NCT01602315|26356962|FG004|Overall Study|Disease progression|41|||
13246271|NCT01602315|26356963|FG005|Overall Study|Disease progression|12|||
13116106|NCT03084536|25920989|FG002|Overall Study|Death|1|||
13116107|NCT03084536|25920987|FG000|Overall Study|Lost to Follow-up|0|||
13246272|NCT01602315|26356964|FG006|Overall Study|Disease progression|15|||
13246273|NCT01602315|26356958|FG000|Overall Study|Death|1|||
13246274|NCT01602315|26356959|FG001|Overall Study|Death|1|||
13246275|NCT01602315|26356960|FG002|Overall Study|Death|1|||
13246276|NCT01602315|26356961|FG003|Overall Study|Death|1|||
13246277|NCT01602315|26356962|FG004|Overall Study|Death|7|||
13246278|NCT01602315|26356963|FG005|Overall Study|Death|2|||
13246279|NCT01602315|26356964|FG006|Overall Study|Death|2|||
13246280|NCT01602315|26356958|FG000|Overall Study|Withdrawal by Subject|2|||
13246281|NCT01602315|26356959|FG001|Overall Study|Withdrawal by Subject|0|||
13246282|NCT01602315|26356960|FG002|Overall Study|Withdrawal by Subject|2|||
13246283|NCT01602315|26356961|FG003|Overall Study|Withdrawal by Subject|0|||
13246284|NCT01602315|26356962|FG004|Overall Study|Withdrawal by Subject|6|||
13246285|NCT01602315|26356963|FG005|Overall Study|Withdrawal by Subject|0|||
13246286|NCT01602315|26356964|FG006|Overall Study|Withdrawal by Subject|1|||
13246287|NCT01602315|26356958|FG000|Overall Study|Adverse Event|5|||
13246288|NCT01602315|26356959|FG001|Overall Study|Adverse Event|1|||
13246289|NCT01602315|26356960|FG002|Overall Study|Adverse Event|5|||
13246290|NCT01602315|26356961|FG003|Overall Study|Adverse Event|4|||
13246291|NCT01602315|26356962|FG004|Overall Study|Adverse Event|15|||
13246292|NCT01602315|26356963|FG005|Overall Study|Adverse Event|3|||
13246293|NCT01602315|26356964|FG006|Overall Study|Adverse Event|9|||
13246294|NCT01602315|26356958|FG000|Overall Study|Subject/guardian decision|0|||
13246295|NCT01602315|26356959|FG001|Overall Study|Subject/guardian decision|0|||
13246296|NCT01602315|26356960|FG002|Overall Study|Subject/guardian decision|0|||
13116108|NCT03084536|25920988|FG001|Overall Study|Lost to Follow-up|0|||
13116109|NCT03084536|25920989|FG002|Overall Study|Lost to Follow-up|1|||
13116110|NCT03084536|25920987|FG000|Overall Study|Protocol Violation|0|||
13246297|NCT01602315|26356961|FG003|Overall Study|Subject/guardian decision|0|||
13246298|NCT01602315|26356962|FG004|Overall Study|Subject/guardian decision|0|||
13246299|NCT01602315|26356963|FG005|Overall Study|Subject/guardian decision|0|||
13246300|NCT01602315|26356964|FG006|Overall Study|Subject/guardian decision|1|||
13246301|NCT01602315|26356958|FG000|Overall Study|Cross-over patients to combo treatment|0|||
13246302|NCT01602315|26356959|FG001|Overall Study|Cross-over patients to combo treatment|0|||
13246303|NCT01602315|26356960|FG002|Overall Study|Cross-over patients to combo treatment|0|||
13246304|NCT01602315|26356961|FG003|Overall Study|Cross-over patients to combo treatment|0|||
13246305|NCT01602315|26356962|FG004|Overall Study|Cross-over patients to combo treatment|0|||
13246306|NCT01602315|26356963|FG005|Overall Study|Cross-over patients to combo treatment|16|||
13246307|NCT01602315|26356964|FG006|Overall Study|Cross-over patients to combo treatment|0|||
13246308|NCT01602224|26357018|FG000|Overall Study|Adverse Event|0|||
13246309|NCT01602224|26357019|FG001|Overall Study|Adverse Event|1|||
13246310|NCT01602224|26357020|FG002|Overall Study|Adverse Event|0|||
13246311|NCT01602224|26357018|FG000|Overall Study|Investigator Decison|1|||
13246312|NCT01602224|26357019|FG001|Overall Study|Investigator Decison|0|||
13246313|NCT01602224|26357020|FG002|Overall Study|Investigator Decison|0|||
13246314|NCT01602224|26357018|FG000|Overall Study|Lost to Follow-up|0|||
13246315|NCT01602224|26357019|FG001|Overall Study|Lost to Follow-up|0|||
13246316|NCT01602224|26357020|FG002|Overall Study|Lost to Follow-up|1|||
13246317|NCT01602224|26357018|FG000|Overall Study|Protocol Violation|0|||
13246318|NCT01602224|26357019|FG001|Overall Study|Protocol Violation|1|||
13116111|NCT03084536|25920988|FG001|Overall Study|Protocol Violation|0|||
13116112|NCT03084536|25920989|FG002|Overall Study|Protocol Violation|1|||
13116113|NCT03084536|25920987|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
13116114|NCT03084536|25920988|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
13116115|NCT03084536|25920989|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1|||
13116116|NCT03084315|25921006|FG000|Overall Study|Lost to Follow-up|8|||
13116117|NCT03084315|25921007|FG001|Overall Study|Lost to Follow-up|7|||
13116118|NCT03084315|25921006|FG000|Overall Study|Withdrawal by Subject|2|||
13116119|NCT03084315|25921007|FG001|Overall Study|Withdrawal by Subject|2|||
13246319|NCT01602224|26357020|FG002|Overall Study|Protocol Violation|0|||
13116120|NCT03083990|25921042|FG000|Overall Study|Adverse Event|1|||
13116121|NCT03083990|25921043|FG001|Overall Study|Adverse Event|0|||
13116122|NCT03083847|25921110|FG000|Main|Physician Decision|0|||
13116123|NCT03083847|25921111|FG001|Main|Physician Decision|0|||
13246320|NCT01602224|26357018|FG000|Overall Study|Sponsor Decision|2|||
13246321|NCT01602224|26357019|FG001|Overall Study|Sponsor Decision|3|||
13246322|NCT01602224|26357020|FG002|Overall Study|Sponsor Decision|2|||
13246323|NCT01602224|26357018|FG000|Overall Study|Withdrawal by Subject|5|||
13246324|NCT01602224|26357019|FG001|Overall Study|Withdrawal by Subject|3|||
13246325|NCT01602224|26357020|FG002|Overall Study|Withdrawal by Subject|3|||
13246326|NCT01602120|26357045|FG000|Overall Study|Adverse Event|3|||
13246327|NCT01602120|26357046|FG001|Overall Study|Adverse Event|6|||
13246328|NCT01602120|26357047|FG002|Overall Study|Adverse Event|0|||
13246329|NCT01602120|26357048|FG003|Overall Study|Adverse Event|2|||
13246330|NCT01602120|26357045|FG000|Overall Study|Death|0|||
13246331|NCT01602120|26357046|FG001|Overall Study|Death|4|||
13246332|NCT01602120|26357047|FG002|Overall Study|Death|0|||
13246333|NCT01602120|26357048|FG003|Overall Study|Death|0|||
13246334|NCT01602120|26357045|FG000|Overall Study|Lost to Follow-up|0|||
13246335|NCT01602120|26357046|FG001|Overall Study|Lost to Follow-up|1|||
13246336|NCT01602120|26357047|FG002|Overall Study|Lost to Follow-up|0|||
13246337|NCT01602120|26357048|FG003|Overall Study|Lost to Follow-up|1|||
13116124|NCT03083847|25921112|FG002|Main|Physician Decision|0|||
13116125|NCT03083847|25921113|FG003|Main|Physician Decision|0|||
13116126|NCT03083847|25921114|FG004|Main|Physician Decision|0|||
13246338|NCT01602120|26357045|FG000|Overall Study|Protocol Violation|1|||
13246339|NCT01602120|26357046|FG001|Overall Study|Protocol Violation|1|||
13246340|NCT01602120|26357047|FG002|Overall Study|Protocol Violation|0|||
13246341|NCT01602120|26357048|FG003|Overall Study|Protocol Violation|0|||
13246342|NCT01602120|26357045|FG000|Overall Study|Non-compliance|0|||
13246343|NCT01602120|26357046|FG001|Overall Study|Non-compliance|3|||
13246344|NCT01602120|26357047|FG002|Overall Study|Non-compliance|0|||
13246345|NCT01602120|26357048|FG003|Overall Study|Non-compliance|1|||
13246346|NCT01602120|26357045|FG000|Overall Study|Withdrawal by Subject|8|||
13246347|NCT01602120|26357046|FG001|Overall Study|Withdrawal by Subject|17|||
13246348|NCT01602120|26357047|FG002|Overall Study|Withdrawal by Subject|0|||
13246349|NCT01602120|26357048|FG003|Overall Study|Withdrawal by Subject|3|||
13246350|NCT01602120|26357045|FG000|Overall Study|Study Terminated by Sponsor|12|||
13246351|NCT01602120|26357046|FG001|Overall Study|Study Terminated by Sponsor|24|||
13246352|NCT01602120|26357047|FG002|Overall Study|Study Terminated by Sponsor|17|||
13246353|NCT01602120|26357048|FG003|Overall Study|Study Terminated by Sponsor|44|||
13246354|NCT01602120|26357045|FG000|Overall Study|Physician Decision|2|||
13246355|NCT01602120|26357046|FG001|Overall Study|Physician Decision|3|||
13246356|NCT01602120|26357047|FG002|Overall Study|Physician Decision|0|||
13246357|NCT01602120|26357048|FG003|Overall Study|Physician Decision|0|||
13246358|NCT01602120|26357045|FG000|Overall Study|Unspecified Reason|3|||
13246359|NCT01602120|26357046|FG001|Overall Study|Unspecified Reason|1|||
13246360|NCT01602120|26357047|FG002|Overall Study|Unspecified Reason|0|||
13246361|NCT01602120|26357048|FG003|Overall Study|Unspecified Reason|2|||
13246362|NCT01601873|26357079|FG000|Overall Study|Lost to Follow-up|2|||
13246363|NCT01601873|26357080|FG001|Overall Study|Lost to Follow-up|3|||
13246364|NCT01601847|26357097|FG000|Overall Study|Death|1|||
13246365|NCT01601847|26357098|FG001|Overall Study|Death|0|||
13246366|NCT01601847|26357097|FG000|Overall Study|Withdrawal by Subject|11|||
13246367|NCT01601847|26357098|FG001|Overall Study|Withdrawal by Subject|7|||
13246368|NCT01601847|26357097|FG000|Overall Study|Lost to Follow-up|1|||
13246369|NCT01601847|26357098|FG001|Overall Study|Lost to Follow-up|3|||
13246370|NCT01601821|26357135|FG000|Overall Study|Death|2|||
13246371|NCT01601821|26357136|FG001|Overall Study|Death|5|||
13246372|NCT01601821|26357135|FG000|Overall Study|Protocol Violation|2|||
13246373|NCT01601821|26357136|FG001|Overall Study|Protocol Violation|2|||
13246374|NCT01601821|26357135|FG000|Overall Study|Lost to Follow-up|6|||
13246375|NCT01601821|26357136|FG001|Overall Study|Lost to Follow-up|14|||
13246376|NCT01601821|26357135|FG000|Overall Study|Withdrawal by Subject|1|||
13246377|NCT01601821|26357136|FG001|Overall Study|Withdrawal by Subject|0|||
13246378|NCT01601821|26357135|FG000|Overall Study|Graft Loss|6|||
13246379|NCT01601821|26357136|FG001|Overall Study|Graft Loss|6|||
13246380|NCT01601821|26357135|FG000|Overall Study|Study Events|7|||
13246381|NCT01601821|26357136|FG001|Overall Study|Study Events|1|||
13246382|NCT01601821|26357135|FG000|Overall Study|Other|5|||
13246383|NCT01601821|26357136|FG001|Overall Study|Other|1|||
13116127|NCT03083847|25921115|FG005|Main|Physician Decision|1|||
13246384|NCT01601704|26357157|FG000|Overall Study|Randomized but not dispensed study med|1|||
13246385|NCT01601704|26357158|FG001|Overall Study|Randomized but not dispensed study med|4|||
13246386|NCT01601652|26357165|FG000|Overall Study|Death|1|||
13246387|NCT01601626|26357258|FG000|Overall Study|Death|1|||
13246388|NCT01601626|26357259|FG001|Overall Study|Death|1|||
13246389|NCT01601626|26357260|FG002|Overall Study|Death|1|||
13246390|NCT01601626|26357258|FG000|Overall Study|Lost to Follow-up|1|||
13246391|NCT01601626|26357259|FG001|Overall Study|Lost to Follow-up|2|||
13246392|NCT01601626|26357260|FG002|Overall Study|Lost to Follow-up|0|||
13246393|NCT01601626|26357258|FG000|Overall Study|Unable to Get to Clinic|0|||
13246394|NCT01601626|26357259|FG001|Overall Study|Unable to Get to Clinic|1|||
13246395|NCT01601626|26357260|FG002|Overall Study|Unable to Get to Clinic|0|||
13246396|NCT01601626|26357258|FG000|Overall Study|Withdrawal by Subject|0|||
13246397|NCT01601626|26357259|FG001|Overall Study|Withdrawal by Subject|1|||
13246398|NCT01601626|26357260|FG002|Overall Study|Withdrawal by Subject|1|||
13246399|NCT01601626|26357258|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
13246400|NCT01601626|26357259|FG001|Overall Study|Not Willing to Adhere to Requirements|0|||
13246401|NCT01601626|26357260|FG002|Overall Study|Not Willing to Adhere to Requirements|0|||
13246402|NCT01601535|26357335|FG000|Phase 1|Adverse Event|1|||
13246403|NCT01601535|26357336|FG001|Phase 1|Adverse Event|0|||
13246404|NCT01601535|26357337|FG002|Phase 1|Adverse Event|2|||
13246405|NCT01601535|26357338|FG003|Phase 1|Adverse Event|1|||
13246406|NCT01601535|26357339|FG004|Phase 1|Adverse Event|0|||
13246407|NCT01601535|26357340|FG005|Phase 1|Adverse Event|0|||
13246408|NCT01601535|26357335|FG000|Phase 1|Withdrawal by Subject|2|||
13246409|NCT01601535|26357336|FG001|Phase 1|Withdrawal by Subject|1|||
13116128|NCT03083847|25921116|FG006|Main|Physician Decision|0|||
13246410|NCT01601535|26357337|FG002|Phase 1|Withdrawal by Subject|1|||
13246411|NCT01601535|26357338|FG003|Phase 1|Withdrawal by Subject|2|||
13246412|NCT01601535|26357339|FG004|Phase 1|Withdrawal by Subject|0|||
13246413|NCT01601535|26357340|FG005|Phase 1|Withdrawal by Subject|0|||
13246414|NCT01601535|26357335|FG000|Phase 1|Progressive Disease|2|||
13246415|NCT01601535|26357336|FG001|Phase 1|Progressive Disease|3|||
13246416|NCT01601535|26357337|FG002|Phase 1|Progressive Disease|2|||
13246417|NCT01601535|26357338|FG003|Phase 1|Progressive Disease|1|||
13246418|NCT01601535|26357339|FG004|Phase 1|Progressive Disease|0|||
13246419|NCT01601535|26357340|FG005|Phase 1|Progressive Disease|0|||
13246420|NCT01601535|26357335|FG000|Phase 1|Started Another Treatment|1|||
13246421|NCT01601535|26357336|FG001|Phase 1|Started Another Treatment|2|||
13246422|NCT01601535|26357337|FG002|Phase 1|Started Another Treatment|0|||
13246423|NCT01601535|26357338|FG003|Phase 1|Started Another Treatment|0|||
13246424|NCT01601535|26357339|FG004|Phase 1|Started Another Treatment|0|||
13246425|NCT01601535|26357340|FG005|Phase 1|Started Another Treatment|0|||
13246426|NCT01601535|26357335|FG000|Phase 2|Adverse Event|0|||
13246427|NCT01601535|26357336|FG001|Phase 2|Adverse Event|0|||
13246428|NCT01601535|26357337|FG002|Phase 2|Adverse Event|0|||
13246429|NCT01601535|26357338|FG003|Phase 2|Adverse Event|0|||
13246430|NCT01601535|26357339|FG004|Phase 2|Adverse Event|5|||
13246431|NCT01601535|26357340|FG005|Phase 2|Adverse Event|1|||
13246432|NCT01601535|26357335|FG000|Phase 2|Withdrawal by Subject|0|||
13246433|NCT01601535|26357336|FG001|Phase 2|Withdrawal by Subject|0|||
13246434|NCT01601535|26357337|FG002|Phase 2|Withdrawal by Subject|0|||
13246435|NCT01601535|26357338|FG003|Phase 2|Withdrawal by Subject|0|||
13246436|NCT01601535|26357339|FG004|Phase 2|Withdrawal by Subject|8|||
13246437|NCT01601535|26357340|FG005|Phase 2|Withdrawal by Subject|2|||
13246438|NCT01601535|26357335|FG000|Phase 2|Progressive Disease|0|||
13246439|NCT01601535|26357336|FG001|Phase 2|Progressive Disease|0|||
13246440|NCT01601535|26357337|FG002|Phase 2|Progressive Disease|0|||
13246441|NCT01601535|26357338|FG003|Phase 2|Progressive Disease|0|||
13246442|NCT01601535|26357339|FG004|Phase 2|Progressive Disease|5|||
13246443|NCT01601535|26357340|FG005|Phase 2|Progressive Disease|7|||
13246444|NCT01601535|26357335|FG000|Phase 2|Started Another Treatment|0|||
13246445|NCT01601535|26357336|FG001|Phase 2|Started Another Treatment|0|||
13246446|NCT01601535|26357337|FG002|Phase 2|Started Another Treatment|0|||
13246447|NCT01601535|26357338|FG003|Phase 2|Started Another Treatment|0|||
13246448|NCT01601535|26357339|FG004|Phase 2|Started Another Treatment|1|||
13246449|NCT01601535|26357340|FG005|Phase 2|Started Another Treatment|2|||
13246450|NCT01601496|26357350|FG000|Overall Study|Physician Decision|1|||
13246451|NCT01601496|26357350|FG000|Overall Study|Withdrawal by Subject|1|||
13246452|NCT01601496|26357350|FG000|Overall Study|Lost to Follow-up|6|||
13246453|NCT01601496|26357350|FG000|Overall Study|Death|4|||
13246454|NCT01601496|26357350|FG000|Overall Study|Other: patient refusal to continue|3|||
13246455|NCT01601470|26357367|FG000|Period 2 - LCZ696|Physician Decision|1|||
13246456|NCT01601132|26357386|FG000|Overall Study|Patient withdrew consent|1|||
13246457|NCT01601132|26357386|FG000|Overall Study|Protocol deviation|1|||
13246458|NCT01600885|26357399|FG000|First Period|Adverse Event|1|||
13246459|NCT01600885|26357400|FG001|First Period|Adverse Event|1|||
13246460|NCT01600885|26357399|FG000|First Period|moved out of area|1|||
13246461|NCT01600885|26357400|FG001|First Period|moved out of area|0|||
13246462|NCT01600716|26357423|FG000|Overall Study|Other Reasons|3|||
13246463|NCT01600716|26357424|FG001|Overall Study|Other Reasons|1|||
13246464|NCT01600716|26357423|FG000|Overall Study|Personal Reasons|0|||
13246465|NCT01600716|26357424|FG001|Overall Study|Personal Reasons|2|||
13246466|NCT01600716|26357423|FG000|Overall Study|Lost to Follow-up|0|||
13246467|NCT01600716|26357424|FG001|Overall Study|Lost to Follow-up|2|||
13246468|NCT01600716|26357423|FG000|Overall Study|Pregnancy|1|||
13246469|NCT01600716|26357424|FG001|Overall Study|Pregnancy|0|||
13246470|NCT01600716|26357423|FG000|Overall Study|Lack of Efficacy|2|||
13246471|NCT01600716|26357424|FG001|Overall Study|Lack of Efficacy|1|||
13246472|NCT01600716|26357423|FG000|Overall Study|Adverse Event|1|||
13246473|NCT01600716|26357424|FG001|Overall Study|Adverse Event|1|||
13246474|NCT01600586|26357445|FG000|Overall Study|Physician Decision|3|||
13246475|NCT01600586|26357446|FG001|Overall Study|Physician Decision|3|||
13246476|NCT01600326|26357461|FG000|Overall Study|Lost to Follow-up|1|||
13246477|NCT01600326|26357462|FG001|Overall Study|Lost to Follow-up|1|||
13246478|NCT01600105|26357495|FG000|Total Participants|Withdrawal by Subject|1|||
13246479|NCT01600105|26357496|FG001|Total Participants|Withdrawal by Subject|0|||
13246480|NCT01600105|26357495|FG000|Total Participants|No images in PACS|10|||
13246481|NCT01600105|26357496|FG001|Total Participants|No images in PACS|0|||
13246482|NCT01600105|26357495|FG000|Total Participants|Insufficient image quality|30|||
13246483|NCT01600105|26357496|FG001|Total Participants|Insufficient image quality|10|||
13246484|NCT01600105|26357495|FG000|Sub Study I|Insufficient image quality|0|||
13246485|NCT01600105|26357496|FG001|Sub Study I|Insufficient image quality|10|||
13246486|NCT01600105|26357495|FG000|Sub Study II|Withdrawal by Subject|1|||
13246487|NCT01600105|26357496|FG001|Sub Study II|Withdrawal by Subject|0|||
13246488|NCT01600105|26357495|FG000|Sub Study II|No images in PACS|1|||
13246489|NCT01600105|26357496|FG001|Sub Study II|No images in PACS|0|||
13246490|NCT01600105|26357495|FG000|Sub Study II|Insufficient image quality|3|||
13246491|NCT01600105|26357496|FG001|Sub Study II|Insufficient image quality|0|||
13246492|NCT01600105|26357495|FG000|Sub Study III|Insufficient image quality|5|||
13246493|NCT01600105|26357496|FG001|Sub Study III|Insufficient image quality|0|||
13246494|NCT01600105|26357495|FG000|Sub Study V|Poor Image Quality|2|||
13246495|NCT01600105|26357496|FG001|Sub Study V|Poor Image Quality|0|||
13246496|NCT01600092|26357517|FG000|Overall Study|Adverse Event|2|||
13246497|NCT01600092|26357518|FG001|Overall Study|Adverse Event|0|||
13246498|NCT01600092|26357517|FG000|Overall Study|Lost to Follow-up|4|||
13246499|NCT01600092|26357518|FG001|Overall Study|Lost to Follow-up|6|||
13246500|NCT01600092|26357517|FG000|Overall Study|Withdrawal by parent/guardian|8|||
13246501|NCT01600092|26357518|FG001|Overall Study|Withdrawal by parent/guardian|6|||
13246502|NCT01600092|26357517|FG000|Overall Study|Physician Decision|1|||
13246503|NCT01600092|26357518|FG001|Overall Study|Physician Decision|1|||
13246504|NCT01600092|26357517|FG000|Overall Study|Randomized but not vaccinated|3|||
13246505|NCT01600092|26357518|FG001|Overall Study|Randomized but not vaccinated|3|||
13246506|NCT01600053|26357525|FG000|Overall Study|Adverse Event|2|||
13246507|NCT01600053|26357525|FG000|Overall Study|trial will not meet the interim endpoint|9|||
13246508|NCT01600014|26357546|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24|||
13246509|NCT01600014|26357547|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0|||
13246510|NCT01600014|26357546|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203|||
13246511|NCT01600014|26357547|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0|||
13246512|NCT01600014|26357546|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6|||
13246513|NCT01600014|26357547|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0|||
13246514|NCT01600014|26357546|FG000|1. Cycle & Observation Period D1 to W52|Other|27|||
13246515|NCT01600014|26357547|FG001|1. Cycle & Observation Period D1 to W52|Other|0|||
13246516|NCT01600014|26357546|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14|||
13246517|NCT01600014|26357547|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0|||
13246518|NCT01600014|26357546|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6|||
13246519|NCT01600014|26357547|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0|||
13246520|NCT01600014|26357546|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8|||
13246521|NCT01600014|26357547|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0|||
13246522|NCT01600014|26357546|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1|||
13246523|NCT01600014|26357547|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2|||
13246524|NCT01600014|26357546|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1|||
13246525|NCT01600014|26357547|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3|||
13246526|NCT01600014|26357546|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2|||
13246527|NCT01600014|26357547|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1|||
13246528|NCT01600014|26357546|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1|||
13246529|NCT01600014|26357547|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0|||
13246530|NCT01600014|26357546|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5|||
13246531|NCT01600014|26357547|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0|||
13246532|NCT01600014|26357546|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
13246533|NCT01600014|26357547|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
13246534|NCT01600014|26357546|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1|||
13246535|NCT01600014|26357547|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3|||
13246536|NCT01600014|26357546|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1|||
13246537|NCT01600014|26357547|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0|||
13246538|NCT01600014|26357546|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1|||
13246539|NCT01600014|26357547|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0|||
13246540|NCT01600014|26357546|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1|||
13246541|NCT01600014|26357547|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0|||
13246542|NCT01599806|26357678|FG000|Overall Study|Lost to Follow-up|20|||
13246543|NCT01599806|26357679|FG001|Overall Study|Lost to Follow-up|20|||
13246544|NCT01599806|26357678|FG000|Overall Study|Withdrawal by Subject|12|||
13246545|NCT01599806|26357679|FG001|Overall Study|Withdrawal by Subject|12|||
13246546|NCT01599806|26357678|FG000|Overall Study|Other Eligibility criteria|11|||
13246547|NCT01599806|26357679|FG001|Overall Study|Other Eligibility criteria|9|||
13246548|NCT01599793|26357691|FG000|Overall Study|Adverse Event|2|||
13290100|NCT00104416|26480779|FG002|Double-Blind Phase|Lost to Follow-up|0|||
13290101|NCT00104416|26480780|FG003|Double-Blind Phase|Lost to Follow-up|0|||
13290102|NCT00104416|26480781|FG004|Double-Blind Phase|Lost to Follow-up|0|||
13290103|NCT00104416|26480777|FG000|Double-Blind Phase|Protocol Violation|0|||
13290104|NCT00104416|26480778|FG001|Double-Blind Phase|Protocol Violation|1|||
13290105|NCT00104416|26480779|FG002|Double-Blind Phase|Protocol Violation|0|||
13290106|NCT00104416|26480780|FG003|Double-Blind Phase|Protocol Violation|0|||
13290107|NCT00104416|26480781|FG004|Double-Blind Phase|Protocol Violation|0|||
13290108|NCT00104416|26480777|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
13290109|NCT00104416|26480778|FG001|Double-Blind Phase|Withdrawal by Subject|3|||
13290110|NCT00104416|26480779|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
13290111|NCT00104416|26480780|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
13290112|NCT00104416|26480781|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
13290113|NCT00104416|26480777|FG000|Double-Blind Phase|Pregnancy|1|||
13290114|NCT00104416|26480778|FG001|Double-Blind Phase|Pregnancy|0|||
13290115|NCT00104416|26480779|FG002|Double-Blind Phase|Pregnancy|0|||
13246549|NCT01599754|26357720|FG000|Overall Study|Anticancer therapy need not in protocol|5|||
13246550|NCT01599754|26357721|FG001|Overall Study|Anticancer therapy need not in protocol|2|||
13246551|NCT01599754|26357720|FG000|Overall Study|Participant noncompliance|4|||
13246552|NCT01599754|26357721|FG001|Overall Study|Participant noncompliance|4|||
13246553|NCT01599754|26357720|FG000|Overall Study|Lost to Follow-up|13|||
13246554|NCT01599754|26357721|FG001|Overall Study|Lost to Follow-up|6|||
13246555|NCT01599754|26357720|FG000|Overall Study|Death|31|||
13246556|NCT01599754|26357721|FG001|Overall Study|Death|33|||
13246557|NCT01599754|26357720|FG000|Overall Study|Adverse Event|3|||
13246558|NCT01599754|26357721|FG001|Overall Study|Adverse Event|2|||
13246559|NCT01599754|26357720|FG000|Overall Study|Investigator decision|1|||
13246560|NCT01599754|26357721|FG001|Overall Study|Investigator decision|3|||
13246561|NCT01599754|26357720|FG000|Overall Study|Withdrawal by Subject|24|||
13246562|NCT01599754|26357721|FG001|Overall Study|Withdrawal by Subject|25|||
13246563|NCT01599754|26357720|FG000|Overall Study|Study terminated by sponsor|282|||
13246564|NCT01599754|26357721|FG001|Overall Study|Study terminated by sponsor|285|||
13246565|NCT01599650|26357767|FG000|Overall Study|Administrative issue|1|||
13246566|NCT01599650|26357768|FG001|Overall Study|Administrative issue|0|||
13246567|NCT01599650|26357769|FG002|Overall Study|Administrative issue|1|||
13246568|NCT01599650|26357767|FG000|Overall Study|Physician Decision|2|||
13246569|NCT01599650|26357768|FG001|Overall Study|Physician Decision|0|||
13246570|NCT01599650|26357769|FG002|Overall Study|Physician Decision|7|||
13246571|NCT01599650|26357767|FG000|Overall Study|Protocol Violation|0|||
13246572|NCT01599650|26357768|FG001|Overall Study|Protocol Violation|3|||
13246573|NCT01599650|26357769|FG002|Overall Study|Protocol Violation|0|||
13246574|NCT01599650|26357767|FG000|Overall Study|Death|2|||
13246575|NCT01599650|26357768|FG001|Overall Study|Death|1|||
13246576|NCT01599650|26357769|FG002|Overall Study|Death|2|||
13246577|NCT01599650|26357767|FG000|Overall Study|Lost to Follow-up|3|||
13246578|NCT01599650|26357768|FG001|Overall Study|Lost to Follow-up|3|||
13246579|NCT01599650|26357769|FG002|Overall Study|Lost to Follow-up|3|||
13246580|NCT01599650|26357767|FG000|Overall Study|Withdrawal by Subject|11|||
13246581|NCT01599650|26357768|FG001|Overall Study|Withdrawal by Subject|11|||
13246582|NCT01599650|26357769|FG002|Overall Study|Withdrawal by Subject|10|||
13246583|NCT01599650|26357767|FG000|Overall Study|Adverse Event|3|||
13246584|NCT01599650|26357768|FG001|Overall Study|Adverse Event|8|||
13246585|NCT01599650|26357769|FG002|Overall Study|Adverse Event|4|||
13246586|NCT01599637|26357824|FG000|Overall Study|administrative problems|0|||
13246587|NCT01599637|26357825|FG001|Overall Study|administrative problems|2|||
13246588|NCT01599637|26357826|FG002|Overall Study|administrative problems|0|||
13246589|NCT01599637|26357824|FG000|Overall Study|Adverse Event|1|||
13246590|NCT01599637|26357825|FG001|Overall Study|Adverse Event|0|||
13246591|NCT01599637|26357826|FG002|Overall Study|Adverse Event|0|||
13246592|NCT01599585|26357871|FG000|Overall Study|Withdrawal by Subject|16|||
13246593|NCT01599585|26357872|FG001|Overall Study|Withdrawal by Subject|9|||
13246594|NCT01599585|26357871|FG000|Overall Study|Lost to Follow-up|3|||
13246595|NCT01599585|26357872|FG001|Overall Study|Lost to Follow-up|5|||
13246596|NCT01599585|26357871|FG000|Overall Study|randomized did not start treatment|3|||
13246597|NCT01599585|26357872|FG001|Overall Study|randomized did not start treatment|3|||
13246598|NCT01599325|26357896|FG000|Primary Parent Phase|Adverse Event|5|||
13246599|NCT01599325|26357896|FG000|Primary Parent Phase|Disease Progression|7|||
13246600|NCT01599325|26357896|FG000|Primary Parent Phase|Withdrawal by Subject|20|||
13246601|NCT01599325|26357896|FG000|Primary Parent Phase|Death|13|||
13116129|NCT03083847|25921117|FG007|Main|Physician Decision|0|||
13116130|NCT03083847|25921118|FG008|Main|Physician Decision|0|||
13116131|NCT03083847|25921119|FG009|Main|Physician Decision|0|||
13246602|NCT01599325|26357896|FG000|Primary Parent Phase|Protocol Violation|1|||
13246603|NCT01599325|26357896|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9|||
13246604|NCT01599325|26357896|FG000|Primary Parent Phase|Other|2|||
13246605|NCT01599325|26357896|FG000|Extension Phase|Study Closure|1|||
13246606|NCT01599325|26357896|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1|||
13246607|NCT01599325|26357896|FG000|Extension Phase|Lack of Therapeutic Effect|4|||
13246608|NCT01599325|26357896|FG000|Extension Phase|Disease Progression|1|||
13246609|NCT01599325|26357896|FG000|Extension Phase|Withdrawal by Subject|8|||
13246610|NCT01599234|26357925|FG000|Overall Study|Adverse Event|9|||
13246611|NCT01599234|26357926|FG001|Overall Study|Adverse Event|5|||
13246612|NCT01599234|26357925|FG000|Overall Study|Withdrawal by Subject|2|||
13246613|NCT01599234|26357926|FG001|Overall Study|Withdrawal by Subject|1|||
13246614|NCT01599234|26357925|FG000|Overall Study|Lost to Follow-up|1|||
13246615|NCT01599234|26357926|FG001|Overall Study|Lost to Follow-up|2|||
13246616|NCT01599234|26357925|FG000|Overall Study|Lack of Efficacy|2|||
13246617|NCT01599234|26357926|FG001|Overall Study|Lack of Efficacy|4|||
13246618|NCT01599234|26357925|FG000|Overall Study|Unable to operate spray|1|||
13246619|NCT01599234|26357926|FG001|Overall Study|Unable to operate spray|0|||
13246620|NCT01599234|26357925|FG000|Overall Study|Sponsor request as creatinine levels <50|0|||
13246621|NCT01599234|26357926|FG001|Overall Study|Sponsor request as creatinine levels <50|1|||
13246622|NCT01599234|26357925|FG000|Overall Study|Death|1|||
13116132|NCT03083847|25921110|FG000|Main|Pregnancy|0|||
13116133|NCT03083847|25921111|FG001|Main|Pregnancy|0|||
13116134|NCT03083847|25921112|FG002|Main|Pregnancy|0|||
13116135|NCT03083847|25921113|FG003|Main|Pregnancy|0|||
13116136|NCT03083847|25921114|FG004|Main|Pregnancy|0|||
13116137|NCT03083847|25921115|FG005|Main|Pregnancy|0|||
13116138|NCT03083847|25921116|FG006|Main|Pregnancy|0|||
13116139|NCT03083847|25921117|FG007|Main|Pregnancy|1|||
13116140|NCT03083847|25921118|FG008|Main|Pregnancy|0|||
13116141|NCT03083847|25921119|FG009|Main|Pregnancy|0|||
13116142|NCT03083847|25921110|FG000|Main|Adverse Event|0|||
13116143|NCT03083847|25921111|FG001|Main|Adverse Event|0|||
13246623|NCT01599234|26357926|FG001|Overall Study|Death|0|||
13246624|NCT01599234|26357925|FG000|Overall Study|Patient would not stop driving|1|||
13246625|NCT01599234|26357926|FG001|Overall Study|Patient would not stop driving|0|||
13246626|NCT01599234|26357925|FG000|Overall Study|Contra-indication discovered|0|||
13246627|NCT01599234|26357926|FG001|Overall Study|Contra-indication discovered|1|||
13246628|NCT01599234|26357925|FG000|Overall Study|Pregnancy|0|||
13246629|NCT01599234|26357926|FG001|Overall Study|Pregnancy|1|||
13116144|NCT03083847|25921112|FG002|Main|Adverse Event|0|||
13116145|NCT03083847|25921113|FG003|Main|Adverse Event|0|||
13116146|NCT03083847|25921114|FG004|Main|Adverse Event|0|||
13116147|NCT03083847|25921115|FG005|Main|Adverse Event|0|||
13116148|NCT03083847|25921116|FG006|Main|Adverse Event|0|||
13116149|NCT03083847|25921117|FG007|Main|Adverse Event|2|||
13116150|NCT03083847|25921118|FG008|Main|Adverse Event|0|||
13116151|NCT03083847|25921119|FG009|Main|Adverse Event|0|||
13246630|NCT01599104|26357974|FG000|Overall Study|Withdrawal by Subject|1|||
13246631|NCT01599104|26357975|FG001|Overall Study|Withdrawal by Subject|1|||
13246632|NCT01599104|26357976|FG002|Overall Study|Withdrawal by Subject|2|||
13246633|NCT01599104|26357974|FG000|Overall Study|Technical Problems|1|||
13246634|NCT01599104|26357975|FG001|Overall Study|Technical Problems|0|||
13246635|NCT01599104|26357976|FG002|Overall Study|Technical Problems|0|||
13246636|NCT01599104|26357974|FG000|Overall Study|Physician Decision|3|||
13246637|NCT01599104|26357975|FG001|Overall Study|Physician Decision|2|||
13246638|NCT01599104|26357976|FG002|Overall Study|Physician Decision|2|||
13246639|NCT01599104|26357974|FG000|Overall Study|Non-compliance with study treatment|0|||
13116152|NCT03083847|25921110|FG000|Main|Withdrawal by Subject|0|||
13116153|NCT03083847|25921111|FG001|Main|Withdrawal by Subject|0|||
13116154|NCT03083847|25921112|FG002|Main|Withdrawal by Subject|0|||
13116155|NCT03083847|25921113|FG003|Main|Withdrawal by Subject|0|||
13116156|NCT03083847|25921114|FG004|Main|Withdrawal by Subject|0|||
13246640|NCT01599104|26357975|FG001|Overall Study|Non-compliance with study treatment|1|||
13246641|NCT01599104|26357976|FG002|Overall Study|Non-compliance with study treatment|0|||
13246642|NCT01599104|26357974|FG000|Overall Study|Lack of Efficacy|4|||
13246643|NCT01599104|26357975|FG001|Overall Study|Lack of Efficacy|4|||
13246644|NCT01599104|26357976|FG002|Overall Study|Lack of Efficacy|10|||
13246645|NCT01599104|26357974|FG000|Overall Study|Adverse Event|7|||
13246646|NCT01599104|26357975|FG001|Overall Study|Adverse Event|6|||
13246647|NCT01599104|26357976|FG002|Overall Study|Adverse Event|12|||
13246648|NCT01598987|26358012|FG000|Baseline to Month 12|Administrative problems|2|||
13246649|NCT01598987|26358012|FG000|Baseline to Month 12|Withdrawal by Subject|4|||
13246650|NCT01598987|26358012|FG000|Baseline to 24 Month|Withdrawal by Subject|5|||
13246651|NCT01598987|26358012|FG000|Baseline to 24 Month|Administrative problems|2|||
13246652|NCT01598987|26358012|FG000|Baseline to 24 Month|Lost to Follow-up|1|||
13246653|NCT01598896|26358031|FG000|Overall Study|Withdrawal by Subject|0|||
13246654|NCT01598896|26358032|FG001|Overall Study|Withdrawal by Subject|1|||
13246655|NCT01598896|26358031|FG000|Overall Study|Lack of Efficacy|0|||
13246656|NCT01598896|26358032|FG001|Overall Study|Lack of Efficacy|1|||
13246657|NCT01598753|26358055|FG000|Overall Study|Adverse Event|1|||
13246658|NCT01598753|26358056|FG001|Overall Study|Adverse Event|9|||
13246659|NCT01598753|26358057|FG002|Overall Study|Adverse Event|1|||
13246660|NCT01598753|26358058|FG003|Overall Study|Adverse Event|7|||
13246661|NCT01598753|26358055|FG000|Overall Study|Lost to Follow-up|4|||
13246662|NCT01598753|26358056|FG001|Overall Study|Lost to Follow-up|3|||
13246663|NCT01598753|26358057|FG002|Overall Study|Lost to Follow-up|7|||
13246664|NCT01598753|26358058|FG003|Overall Study|Lost to Follow-up|5|||
13246665|NCT01598753|26358055|FG000|Overall Study|Physician Decision|0|||
13246666|NCT01598753|26358056|FG001|Overall Study|Physician Decision|1|||
13246667|NCT01598753|26358057|FG002|Overall Study|Physician Decision|0|||
13246668|NCT01598753|26358058|FG003|Overall Study|Physician Decision|2|||
13246669|NCT01598753|26358055|FG000|Overall Study|Withdrawal by Subject|7|||
13246670|NCT01598753|26358056|FG001|Overall Study|Withdrawal by Subject|2|||
13246671|NCT01598753|26358057|FG002|Overall Study|Withdrawal by Subject|0|||
13246672|NCT01598753|26358058|FG003|Overall Study|Withdrawal by Subject|1|||
13246673|NCT01598662|26358071|FG000|Overall Study|Lost to Follow-up|10|||
13246674|NCT01598662|26358072|FG001|Overall Study|Lost to Follow-up|17|||
13116157|NCT03083847|25921115|FG005|Main|Withdrawal by Subject|0|||
13116158|NCT03083847|25921116|FG006|Main|Withdrawal by Subject|1|||
13116159|NCT03083847|25921117|FG007|Main|Withdrawal by Subject|1|||
13116160|NCT03083847|25921118|FG008|Main|Withdrawal by Subject|0|||
13116161|NCT03083847|25921119|FG009|Main|Withdrawal by Subject|0|||
13246675|NCT01598662|26358071|FG000|Overall Study|Physician Decision|1|||
13116162|NCT03083639|25921136|FG000|Washout Period (at Least 6 Days)|Pregnancy|0|||
13246676|NCT01598662|26358072|FG001|Overall Study|Physician Decision|2|||
13246677|NCT01598662|26358071|FG000|Overall Study|IUD expelled before month 6|0|||
13246678|NCT01598662|26358072|FG001|Overall Study|IUD expelled before month 6|2|||
13246679|NCT01598610|26358083|FG000|Overall Study|Adverse Event|1|||
13246680|NCT01598532|26358094|FG000|Overall Study|Lost to Follow-up|3|||
13246681|NCT01598532|26358094|FG000|Overall Study|Did not meet inclusion criteria|8|||
13116163|NCT03083639|25921137|FG001|Washout Period (at Least 6 Days)|Pregnancy|1|||
13116164|NCT03083639|25921136|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1|||
13246682|NCT01598506|26358101|FG000|Overall Study|Withdrawal by Subject|2|||
13246683|NCT01598311|26358122|FG000|Overall Study|Physician Decision|4|||
13246684|NCT01598311|26358123|FG001|Overall Study|Physician Decision|5|||
13246685|NCT01598311|26358122|FG000|Overall Study|Adverse Event|9|||
13246686|NCT01598311|26358123|FG001|Overall Study|Adverse Event|13|||
13246687|NCT01598311|26358122|FG000|Overall Study|Lost to Follow-up|7|||
13246688|NCT01598311|26358123|FG001|Overall Study|Lost to Follow-up|12|||
13246689|NCT01598311|26358122|FG000|Overall Study|Withdrawal by Subject|9|||
13246690|NCT01598311|26358123|FG001|Overall Study|Withdrawal by Subject|13|||
13246691|NCT01598311|26358122|FG000|Overall Study|No reason provided.|0|||
13246692|NCT01598311|26358123|FG001|Overall Study|No reason provided.|5|||
13246693|NCT01598311|26358122|FG000|Overall Study|Randomized but never treated|8|||
13246694|NCT01598311|26358123|FG001|Overall Study|Randomized but never treated|5|||
13246695|NCT01598311|26358122|FG000|Overall Study|Treated but no confirmed CDAD|9|||
13246696|NCT01598311|26358123|FG001|Overall Study|Treated but no confirmed CDAD|8|||
13246697|NCT01598311|26358122|FG000|Overall Study|Assigned to CB but received vancomycin|1|||
13246698|NCT01598311|26358123|FG001|Overall Study|Assigned to CB but received vancomycin|0|||
13246699|NCT01598129|26358134|FG000|Overall Study|Disease progression|6|||
13246700|NCT01598129|26358134|FG000|Overall Study|Deterioration of WHO status to WHO 4|2|||
13116165|NCT03083639|25921137|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0|||
13116166|NCT03083483|25921161|FG000|Overall Study|Adverse Event|1|||
13116167|NCT03083483|25921162|FG001|Overall Study|Adverse Event|1|||
13116168|NCT03083483|25921163|FG002|Overall Study|Adverse Event|1|||
13116169|NCT03083483|25921161|FG000|Overall Study|Lost to Follow-up|2|||
13246701|NCT01598129|26358134|FG000|Overall Study|Withdrawal by Subject|1|||
13246702|NCT01598090|26358168|FG000|Treatment Period|Poor/non-compliance|0|||
13246703|NCT01598090|26358169|FG001|Treatment Period|Poor/non-compliance|2|||
13246704|NCT01598090|26358170|FG002|Treatment Period|Poor/non-compliance|0|||
13246705|NCT01598090|26358168|FG000|Treatment Period|No longer meet study criteria|0|||
13246706|NCT01598090|26358169|FG001|Treatment Period|No longer meet study criteria|1|||
13246707|NCT01598090|26358170|FG002|Treatment Period|No longer meet study criteria|0|||
13116170|NCT03083483|25921162|FG001|Overall Study|Lost to Follow-up|1|||
13116171|NCT03083483|25921163|FG002|Overall Study|Lost to Follow-up|1|||
13246708|NCT01598090|26358168|FG000|Treatment Period|Lack of Efficacy|5|||
13246709|NCT01598090|26358169|FG001|Treatment Period|Lack of Efficacy|14|||
13246710|NCT01598090|26358170|FG002|Treatment Period|Lack of Efficacy|6|||
13246711|NCT01598090|26358168|FG000|Treatment Period|Adverse Event|2|||
13246712|NCT01598090|26358169|FG001|Treatment Period|Adverse Event|33|||
13246713|NCT01598090|26358170|FG002|Treatment Period|Adverse Event|17|||
13246714|NCT01598090|26358168|FG000|Treatment Period|Other reasons|0|||
13246715|NCT01598090|26358169|FG001|Treatment Period|Other reasons|4|||
13246716|NCT01598090|26358170|FG002|Treatment Period|Other reasons|1|||
13246717|NCT01598090|26358168|FG000|Treatment Period|Withdrawal by Subject|3|||
13246718|NCT01598090|26358169|FG001|Treatment Period|Withdrawal by Subject|13|||
13246719|NCT01598090|26358170|FG002|Treatment Period|Withdrawal by Subject|10|||
13246720|NCT01598090|26358168|FG000|Treatment Period|Lost to Follow-up|1|||
13246721|NCT01598090|26358169|FG001|Treatment Period|Lost to Follow-up|5|||
13246722|NCT01598090|26358170|FG002|Treatment Period|Lost to Follow-up|1|||
13246723|NCT01598090|26358168|FG000|Follow-up Period|Death|0|||
13246724|NCT01598090|26358169|FG001|Follow-up Period|Death|1|||
13246725|NCT01598090|26358170|FG002|Follow-up Period|Death|0|||
13246726|NCT01598090|26358168|FG000|Follow-up Period|No longer required per protocol|1|||
13246727|NCT01598090|26358169|FG001|Follow-up Period|No longer required per protocol|3|||
13246728|NCT01598090|26358170|FG002|Follow-up Period|No longer required per protocol|2|||
13116172|NCT03083483|25921161|FG000|Overall Study|technological issues|1|||
13116173|NCT03083483|25921162|FG001|Overall Study|technological issues|0|||
13116174|NCT03083483|25921163|FG002|Overall Study|technological issues|1|||
13116175|NCT03083470|25921216|FG000|Overall Study|Lost to Follow-up|0|||
13116176|NCT03083470|25921217|FG001|Overall Study|Lost to Follow-up|0|||
13116177|NCT03083470|25921218|FG002|Overall Study|Lost to Follow-up|0|||
13246729|NCT01598090|26358168|FG000|Follow-up Period|Not reported|0|||
13246730|NCT01598090|26358169|FG001|Follow-up Period|Not reported|10|||
13246731|NCT01598090|26358170|FG002|Follow-up Period|Not reported|4|||
13246732|NCT01598090|26358168|FG000|Follow-up Period|Withdrawal by Subject|0|||
13290116|NCT00104416|26480780|FG003|Double-Blind Phase|Pregnancy|0|||
13116178|NCT03083470|25921219|FG003|Overall Study|Lost to Follow-up|0|||
13116179|NCT03083470|25921220|FG004|Overall Study|Lost to Follow-up|1|||
13246733|NCT01598090|26358169|FG001|Follow-up Period|Withdrawal by Subject|3|||
13246734|NCT01598090|26358170|FG002|Follow-up Period|Withdrawal by Subject|2|||
13246735|NCT01598090|26358168|FG000|Follow-up Period|Other reasons|2|||
13246736|NCT01598090|26358169|FG001|Follow-up Period|Other reasons|8|||
13246737|NCT01598090|26358170|FG002|Follow-up Period|Other reasons|8|||
13246738|NCT01598090|26358168|FG000|Follow-up Period|Lost to Follow-up|2|||
13246739|NCT01598090|26358169|FG001|Follow-up Period|Lost to Follow-up|10|||
13246740|NCT01598090|26358170|FG002|Follow-up Period|Lost to Follow-up|12|||
13116180|NCT03083470|25921216|FG000|Overall Study|Withdrawal by Subject|0|||
13116181|NCT03083470|25921217|FG001|Overall Study|Withdrawal by Subject|0|||
13116182|NCT03083470|25921218|FG002|Overall Study|Withdrawal by Subject|0|||
13116183|NCT03083470|25921219|FG003|Overall Study|Withdrawal by Subject|0|||
13246741|NCT01597973|26358191|FG000|Overall Study|Found ineligible before study medication started|4|||
13246742|NCT01597973|26358192|FG001|Overall Study|Found ineligible before study medication started|2|||
13246743|NCT01597973|26358191|FG000|Overall Study|Eligible pathogen not confirmed|14|||
13246744|NCT01597973|26358192|FG001|Overall Study|Eligible pathogen not confirmed|15|||
13246745|NCT01597973|26358191|FG000|Overall Study|LAR not authorized to consent|0|||
13246746|NCT01597973|26358192|FG001|Overall Study|LAR not authorized to consent|1|||
13246747|NCT01597973|26358191|FG000|Overall Study|Ineligible due to early seizures|1|||
13246748|NCT01597973|26358192|FG001|Overall Study|Ineligible due to early seizures|0|||
13246749|NCT01597973|26358191|FG000|Overall Study|Ineligible due to non-target infection|1|||
13246750|NCT01597973|26358192|FG001|Overall Study|Ineligible due to non-target infection|1|||
13246751|NCT01597908|26358217|FG000|Randomized Phase|Death|217|||
13246752|NCT01597908|26358218|FG001|Randomized Phase|Death|238|||
13246753|NCT01597908|26358219|FG002|Randomized Phase|Death|0|||
13116184|NCT03083470|25921220|FG004|Overall Study|Withdrawal by Subject|1|||
13203236|NCT01986920|26223703|FG000|A- 101 25%|Withdrawal by Subject|1|||
13203237|NCT01986920|26223704|FG001|A- 101 25%|Withdrawal by Subject|0|||
13203238|NCT01986920|26223705|FG002|A- 101 25%|Withdrawal by Subject|0|||
13203239|NCT01986920|26223706|FG003|A- 101 25%|Withdrawal by Subject|0|||
13203240|NCT01986920|26223703|FG000|A-101 32.5%|Withdrawal by Subject|0|||
13203241|NCT01986920|26223704|FG001|A-101 32.5%|Withdrawal by Subject|1|||
13203242|NCT01986920|26223705|FG002|A-101 32.5%|Withdrawal by Subject|0|||
13203243|NCT01986920|26223706|FG003|A-101 32.5%|Withdrawal by Subject|0|||
13203244|NCT01986920|26223703|FG000|A-101 40%|Withdrawal by Subject|0|||
13203245|NCT01986920|26223704|FG001|A-101 40%|Withdrawal by Subject|0|||
13203246|NCT01986920|26223705|FG002|A-101 40%|Withdrawal by Subject|1|||
13203247|NCT01986920|26223706|FG003|A-101 40%|Withdrawal by Subject|0|||
13203248|NCT01986920|26223703|FG000|Placebo|Withdrawal by Subject|0|||
13203249|NCT01986920|26223704|FG001|Placebo|Withdrawal by Subject|0|||
13203250|NCT01986920|26223705|FG002|Placebo|Withdrawal by Subject|0|||
13203251|NCT01986920|26223706|FG003|Placebo|Withdrawal by Subject|1|||
13203252|NCT01986907|26223718|FG000|Overall Study|Adverse Event|11|||
13203253|NCT01986907|26223718|FG000|Overall Study|Unsatisfactory therapeutic effect|24|||
13203254|NCT01986907|26223718|FG000|Overall Study|Protocol Violation|4|||
13203255|NCT01986907|26223718|FG000|Overall Study|Withdrawal by Subject|76|||
13203256|NCT01986907|26223718|FG000|Overall Study|Lost to Follow-up|38|||
13203257|NCT01986907|26223718|FG000|Overall Study|Death|9|||
13203258|NCT01986881|26224132|FG000|Overall Study|Death|228|||
13203259|NCT01986881|26224133|FG001|Overall Study|Death|233|||
13203260|NCT01986881|26224134|FG002|Overall Study|Death|247|||
13203261|NCT01986881|26224132|FG000|Overall Study|Lost to Follow-up|51|||
13203262|NCT01986881|26224133|FG001|Overall Study|Lost to Follow-up|44|||
13203263|NCT01986881|26224134|FG002|Overall Study|Lost to Follow-up|55|||
13203264|NCT01986881|26224132|FG000|Overall Study|Physician Decision|7|||
13203265|NCT01986881|26224133|FG001|Overall Study|Physician Decision|4|||
13203266|NCT01986881|26224134|FG002|Overall Study|Physician Decision|6|||
13203267|NCT01986881|26224132|FG000|Overall Study|Study Site Terminated by Sponsor|2|||
13203268|NCT01986881|26224133|FG001|Overall Study|Study Site Terminated by Sponsor|2|||
13203269|NCT01986881|26224134|FG002|Overall Study|Study Site Terminated by Sponsor|3|||
13203270|NCT01986881|26224132|FG000|Overall Study|Withdrawal by Subject|41|||
13203271|NCT01986881|26224133|FG001|Overall Study|Withdrawal by Subject|60|||
13203272|NCT01986881|26224134|FG002|Overall Study|Withdrawal by Subject|45|||
13203273|NCT01986881|26224132|FG000|Overall Study|Subject Moved|0|||
13203274|NCT01986881|26224133|FG001|Overall Study|Subject Moved|1|||
13203275|NCT01986881|26224134|FG002|Overall Study|Subject Moved|0|||
13203276|NCT01986881|26224132|FG000|Overall Study|Other|1|||
13203277|NCT01986881|26224133|FG001|Overall Study|Other|2|||
13203278|NCT01986881|26224134|FG002|Overall Study|Other|2|||
13203279|NCT01986855|26224173|FG000|Overall Study|Adverse Event|1|||
13203280|NCT01986855|26224174|FG001|Overall Study|Adverse Event|0|||
13203281|NCT01986855|26224175|FG002|Overall Study|Adverse Event|0|||
13203282|NCT01986855|26224173|FG000|Overall Study|Death|3|||
13203283|NCT01986855|26224174|FG001|Overall Study|Death|4|||
13203284|NCT01986855|26224175|FG002|Overall Study|Death|4|||
13203285|NCT01986855|26224173|FG000|Overall Study|Lost to Follow-up|2|||
13203286|NCT01986855|26224174|FG001|Overall Study|Lost to Follow-up|1|||
13246754|NCT01597908|26358217|FG000|Randomized Phase|Sponsor Decision|93|||
13246755|NCT01597908|26358218|FG001|Randomized Phase|Sponsor Decision|39|||
13246756|NCT01597908|26358219|FG002|Randomized Phase|Sponsor Decision|0|||
13116185|NCT03083132|25921243|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0|||
13116186|NCT03083132|25921244|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2|||
13116187|NCT03083132|25921243|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1|||
13116188|NCT03083132|25921244|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0|||
13116189|NCT03083132|25921243|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0|||
13116190|NCT03083132|25921244|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1|||
13116191|NCT03082729|25921473|FG000|Overall Study|Lost to Follow-up|7|||
13116192|NCT03082729|25921473|FG000|Overall Study|Physician Decision|2|||
13116193|NCT03082729|25921473|FG000|Overall Study|Withdrawal by Subject|1|||
13246757|NCT01597908|26358217|FG000|Randomized Phase|Lost to Follow-up|9|||
13246758|NCT01597908|26358218|FG001|Randomized Phase|Lost to Follow-up|16|||
13246759|NCT01597908|26358219|FG002|Randomized Phase|Lost to Follow-up|0|||
13246760|NCT01597908|26358217|FG000|Randomized Phase|Physician Decision|6|||
13246761|NCT01597908|26358218|FG001|Randomized Phase|Physician Decision|3|||
13246762|NCT01597908|26358219|FG002|Randomized Phase|Physician Decision|0|||
13246763|NCT01597908|26358217|FG000|Randomized Phase|Withdrawal by Subject|26|||
13246764|NCT01597908|26358218|FG001|Randomized Phase|Withdrawal by Subject|22|||
13246765|NCT01597908|26358219|FG002|Randomized Phase|Withdrawal by Subject|0|||
13116194|NCT03082729|25921473|FG000|Overall Study|Lack of Efficacy|9|||
13116195|NCT03082729|25921473|FG000|Overall Study|Adverse Event|4|||
13116196|NCT03082729|25921473|FG000|Overall Study|Protocol Violation|6|||
13116197|NCT03082729|25921473|FG000|Overall Study|Fear of study procedure|1|||
13116198|NCT03082729|25921473|FG000|Overall Study|Scheduling conflict|1|||
13116199|NCT03082677|25921479|FG000|Overall Study|Not Treated|2|||
13116200|NCT03082599|25921512|FG000|Overall Study|Lost to Follow-up|1|||
13116201|NCT03082599|25921513|FG001|Overall Study|Lost to Follow-up|0|||
13116202|NCT03082261|25921591|FG000|Overall Study|Death|4|||
13116203|NCT03082261|25921591|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1|||
13116204|NCT03082261|25921591|FG000|Overall Study|Insurance denial|1|||
13116205|NCT03082261|25921591|FG000|Overall Study|Peripheral lead added|1|||
13116206|NCT03082261|25921591|FG000|Overall Study|Withdrawal by Subject|40|||
13116207|NCT03082261|25921591|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2|||
13116208|NCT03082261|25921591|FG000|Overall Study|Subject implanted with device other than study device|1|||
13246766|NCT01597908|26358217|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
13116209|NCT03082261|25921591|FG000|Overall Study|Lost to Follow-up|14|||
13116210|NCT03082261|25921591|FG000|Overall Study|Subject moved to a different state|1|||
13116211|NCT03082261|25921591|FG000|Overall Study|Subject non-compliance|2|||
13116212|NCT03082261|25921591|FG000|Overall Study|Subject participation terminated by investigator|9|||
13246767|NCT01597908|26358218|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34|||
13246768|NCT01597908|26358219|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
13246769|NCT01597908|26358217|FG000|Crossover Phase|Death|0|||
13246770|NCT01597908|26358218|FG001|Crossover Phase|Death|0|||
13246771|NCT01597908|26358219|FG002|Crossover Phase|Death|11|||
13246772|NCT01597908|26358217|FG000|Crossover Phase|Withdrawal by Subject|0|||
13246773|NCT01597908|26358218|FG001|Crossover Phase|Withdrawal by Subject|0|||
13246774|NCT01597908|26358219|FG002|Crossover Phase|Withdrawal by Subject|3|||
13246775|NCT01597908|26358217|FG000|Crossover Phase|Sponsor Decision|0|||
13246776|NCT01597908|26358218|FG001|Crossover Phase|Sponsor Decision|0|||
13246777|NCT01597908|26358219|FG002|Crossover Phase|Sponsor Decision|20|||
13246778|NCT01597791|26358232|FG000|Overall Study|Physician Decision|2|||
13246779|NCT01597791|26358233|FG001|Overall Study|Physician Decision|1|||
13246780|NCT01597791|26358232|FG000|Overall Study|Cesarean Section|6|||
13246781|NCT01597791|26358233|FG001|Overall Study|Cesarean Section|7|||
13246782|NCT01597791|26358232|FG000|Overall Study|Subject withdrawal|0|||
13246783|NCT01597791|26358233|FG001|Overall Study|Subject withdrawal|1|||
13246784|NCT01597791|26358232|FG000|Overall Study|Protocol Violation|0|||
13246785|NCT01597791|26358233|FG001|Overall Study|Protocol Violation|1|||
13246786|NCT01597778|26358272|FG000|Overall Study|Death|7|||
13246787|NCT01597778|26358273|FG001|Overall Study|Death|10|||
13246788|NCT01597778|26358272|FG000|Overall Study|Withdrawal by Subject|3|||
13246789|NCT01597778|26358273|FG001|Overall Study|Withdrawal by Subject|4|||
13246790|NCT01597778|26358272|FG000|Overall Study|Adverse Event|1|||
13246791|NCT01597778|26358273|FG001|Overall Study|Adverse Event|1|||
13246792|NCT01597778|26358272|FG000|Overall Study|Protocol Violation|1|||
13246793|NCT01597778|26358273|FG001|Overall Study|Protocol Violation|11|||
13246794|NCT01597778|26358272|FG000|Overall Study|Transplanted off protocol|2|||
13246795|NCT01597778|26358273|FG001|Overall Study|Transplanted off protocol|3|||
13246796|NCT01597635|26358346|FG000|Part A|Adverse Event|3|||
13246797|NCT01597635|26358347|FG001|Part A|Adverse Event|0|||
13246798|NCT01597635|26358348|FG002|Part A|Adverse Event|0|||
13246799|NCT01597635|26358346|FG000|Part B|Adverse Event|0|||
13246800|NCT01597635|26358347|FG001|Part B|Adverse Event|0|||
13246801|NCT01597635|26358348|FG002|Part B|Adverse Event|1|||
13246802|NCT01597635|26358346|FG000|Part B|Protocol Violation|0|||
13246803|NCT01597635|26358347|FG001|Part B|Protocol Violation|1|||
13246804|NCT01597635|26358348|FG002|Part B|Protocol Violation|0|||
13246805|NCT01597635|26358346|FG000|Part B|Protocol-defined stopping criteria|0|||
13246806|NCT01597635|26358347|FG001|Part B|Protocol-defined stopping criteria|4|||
13246807|NCT01597635|26358348|FG002|Part B|Protocol-defined stopping criteria|3|||
13116213|NCT03082261|25921591|FG000|Overall Study|Subject participation terminated by sponsor|4|||
13116214|NCT03082261|25921591|FG000|Overall Study|System explant|19|||
13246808|NCT01597635|26358346|FG000|Part B|Withdrawal by Subject|0|||
13246809|NCT01597635|26358347|FG001|Part B|Withdrawal by Subject|1|||
13246810|NCT01597635|26358348|FG002|Part B|Withdrawal by Subject|0|||
13246811|NCT01597622|26358355|FG000|Overall Study|Adverse Event|7|||
13246812|NCT01597622|26358355|FG000|Overall Study|Lack of Efficacy|3|||
13246813|NCT01597622|26358355|FG000|Overall Study|Protocol Violation|1|||
13246814|NCT01597622|26358355|FG000|Overall Study|Lost to Follow-up|1|||
13246815|NCT01597622|26358355|FG000|Overall Study|Investigator Discretion|5|||
13246816|NCT01597622|26358355|FG000|Overall Study|Withdrawal by Subject|20|||
13246817|NCT01597622|26358355|FG000|Overall Study|Death|1|||
13246818|NCT01597596|26358374|FG000|Overall Study|Study terminated by sponsor|1|||
13246819|NCT01597596|26358375|FG001|Overall Study|Study terminated by sponsor|0|||
13246820|NCT01597596|26358374|FG000|Overall Study|Physician Decision|0|||
13246821|NCT01597596|26358375|FG001|Overall Study|Physician Decision|1|||
13246822|NCT01597557|26358392|FG000|Overall Study|Did not undergo cardioversion procedure|4|||
13246823|NCT01597557|26358393|FG001|Overall Study|Did not undergo cardioversion procedure|3|||
13246824|NCT01597505|26358432|FG000|Overall Study|Physician Decision|5|||
13246825|NCT01597505|26358433|FG001|Overall Study|Physician Decision|0|||
13246826|NCT01597505|26358432|FG000|Overall Study|Adverse Event|19|||
13246827|NCT01597505|26358433|FG001|Overall Study|Adverse Event|7|||
13246828|NCT01597505|26358432|FG000|Overall Study|Lost to Follow-up|4|||
13246829|NCT01597505|26358433|FG001|Overall Study|Lost to Follow-up|2|||
13246830|NCT01597505|26358432|FG000|Overall Study|Withdrawal by Subject|10|||
13116215|NCT03082261|25921591|FG000|Overall Study|Unable to place lead(s)|2|||
13116216|NCT03082261|25921591|FG000|Overall Study|Unsuccessful trial evaluation period|19|||
13116217|NCT03081884|25921599|FG000|Overall Study|deferred prostate cancer treatment|1|||
13116218|NCT03081884|25921599|FG000|Overall Study|metastasis managed with systemic therapy|3|||
13116219|NCT03080961|25921610|FG000|Overall Study|Withdrawal by Subject|3|||
13246831|NCT01597505|26358433|FG001|Overall Study|Withdrawal by Subject|18|||
13246832|NCT01597505|26358432|FG000|Overall Study|Other|5|||
13116220|NCT03080493|25921633|FG000|Overall Study|Did not provide NRS pain results|1|||
13116221|NCT03080493|25921634|FG001|Overall Study|Did not provide NRS pain results|0|||
13116222|NCT03080493|25921633|FG000|Overall Study|Adverse Event|0|||
13116223|NCT03080493|25921634|FG001|Overall Study|Adverse Event|1|||
13116224|NCT03080493|25921633|FG000|Overall Study|Randomization error (parity group)|0|||
13116225|NCT03080493|25921634|FG001|Overall Study|Randomization error (parity group)|1|||
13246833|NCT01597505|26358433|FG001|Overall Study|Other|6|||
13246834|NCT01597505|26358432|FG000|Overall Study|Missing|1|||
13246835|NCT01597505|26358433|FG001|Overall Study|Missing|0|||
13246836|NCT01597492|26358446|FG000|Overall Study|Withdrawal by Subject|1|||
13246837|NCT01597492|26358447|FG001|Overall Study|Withdrawal by Subject|2|||
13246838|NCT01597492|26358446|FG000|Overall Study|Adverse Event|3|||
13246839|NCT01597492|26358447|FG001|Overall Study|Adverse Event|0|||
13246840|NCT01597492|26358446|FG000|Overall Study|Lost to Follow-up|0|||
13246841|NCT01597492|26358447|FG001|Overall Study|Lost to Follow-up|2|||
13246842|NCT01597492|26358446|FG000|Overall Study|Other Reason|2|||
13246843|NCT01597492|26358447|FG001|Overall Study|Other Reason|0|||
13246844|NCT01597479|26358461|FG000|Overall Study|Protocol Violation|1|||
13246845|NCT01597479|26358462|FG001|Overall Study|Protocol Violation|0|||
13246846|NCT01597479|26358461|FG000|Overall Study|Lost to Follow-up|1|||
13246847|NCT01597479|26358462|FG001|Overall Study|Lost to Follow-up|0|||
13246848|NCT01597375|26358482|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1|||
13246849|NCT01597375|26358483|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0|||
13246850|NCT01597375|26358482|FG000|First Intervention (4 Weeks)|Needed surgery|1|||
13246851|NCT01597375|26358483|FG001|First Intervention (4 Weeks)|Needed surgery|0|||
13246852|NCT01597375|26358482|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
13246853|NCT01597375|26358483|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
13246854|NCT01597375|26358482|FG000|Washout (2 Weeks)|Adverse Event|1|||
13246855|NCT01597375|26358483|FG001|Washout (2 Weeks)|Adverse Event|0|||
13246856|NCT01597375|26358482|FG000|Second Intervention|Failed to react at both Aspirin|1|||
13246857|NCT01597375|26358483|FG001|Second Intervention|Failed to react at both Aspirin|1|||
13246858|NCT01597258|26358490|FG000|Overall Study|No Drug Administration|1|||
13116226|NCT03080454|25921645|FG000|Baseline|Adverse Event|2|||
13246859|NCT01597245|26358611|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1|||
13246860|NCT01597245|26358612|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
13246861|NCT01597245|26358613|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
13246862|NCT01597245|26358614|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4|||
13246863|NCT01597245|26358615|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
13290117|NCT00104416|26480781|FG004|Double-Blind Phase|Pregnancy|0|||
13246864|NCT01597245|26358616|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
13246865|NCT01597245|26358617|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
13246866|NCT01597245|26358618|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
13246867|NCT01597245|26358619|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
13116227|NCT03080454|25921645|FG000|Anodal Doublestim (5 Days)|Adverse Event|1|||
13116228|NCT03080454|25921645|FG000|Anodal FU (7 Days)|Lost to Follow-up|4|||
13116229|NCT03079102|25921698|FG000|Overall Study|Physician Decision|0|||
13116230|NCT03079102|25921699|FG001|Overall Study|Physician Decision|1|||
13116231|NCT03078907|25921740|FG000|Overall Study|Adverse Event|2|||
13116232|NCT03078907|25921741|FG001|Overall Study|Adverse Event|0|||
13246868|NCT01597245|26358620|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
13246869|NCT01597245|26358621|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
13246870|NCT01597245|26358622|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
13246871|NCT01597245|26358623|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
13246872|NCT01597245|26358624|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
13246873|NCT01597245|26358625|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
13246874|NCT01597245|26358626|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
13116233|NCT03078907|25921740|FG000|Overall Study|Other|1|||
13116234|NCT03078907|25921741|FG001|Overall Study|Other|0|||
13116235|NCT03078907|25921740|FG000|Overall Study|Protocol Violation|0|||
13116236|NCT03078907|25921741|FG001|Overall Study|Protocol Violation|1|||
13116237|NCT03078868|25921747|FG000|Overall Study|Physician Decision|3|||
13116238|NCT03078816|25921764|FG000|Overall Study|Withdrawal by Subject|1|||
13116239|NCT03078751|25921779|FG000|Overall Study|Adverse Event|4|||
13116240|NCT03078751|25921780|FG001|Overall Study|Adverse Event|0|||
13116241|NCT03078751|25921779|FG000|Overall Study|Physician Decision|1|||
13116242|NCT03078751|25921780|FG001|Overall Study|Physician Decision|0|||
13116243|NCT03078751|25921779|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0|||
13116244|NCT03078751|25921780|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23|||
13116245|NCT03078751|25921779|FG000|Overall Study|Subject/guardian decision|8|||
13116246|NCT03078751|25921780|FG001|Overall Study|Subject/guardian decision|1|||
13116247|NCT03078751|25921779|FG000|Overall Study|Untreated|0|||
13116248|NCT03078751|25921780|FG001|Overall Study|Untreated|4|||
13116249|NCT03078582|25921805|FG000|Overall Study|Adverse Event|0|||
13116250|NCT03078582|25921806|FG001|Overall Study|Adverse Event|8|||
13246875|NCT01597245|26358627|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
13246876|NCT01597245|26358628|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
13116251|NCT03078556|25921953|FG000|Treatment Period 1 (4 Days)|Adverse Event|0|||
13116252|NCT03078556|25921954|FG001|Treatment Period 1 (4 Days)|Adverse Event|1|||
13116253|NCT03078556|25921955|FG002|Treatment Period 1 (4 Days)|Adverse Event|0|||
13116254|NCT03078556|25921956|FG003|Treatment Period 1 (4 Days)|Adverse Event|0|||
13116255|NCT03078556|25921953|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2|||
13116256|NCT03078556|25921954|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
13116257|NCT03078556|25921955|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1|||
13116258|NCT03078556|25921956|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
13116259|NCT03078556|25921953|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
13116260|NCT03078556|25921954|FG001|Washout Period 1 (7 Days)|Adverse Event|1|||
13116261|NCT03078556|25921955|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
13116262|NCT03078556|25921956|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
13116263|NCT03078556|25921953|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
13116264|NCT03078556|25921954|FG001|Washout Period 1 (7 Days)|Physician Decision|1|||
13116265|NCT03078556|25921955|FG002|Washout Period 1 (7 Days)|Physician Decision|0|||
13116266|NCT03078556|25921956|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
13116267|NCT03077919|25921991|FG000|Overall Study|Lost to Follow-up|4|||
13116268|NCT03077919|25921992|FG001|Overall Study|Lost to Follow-up|1|||
13116269|NCT03077724|25922009|FG000|Overall Study|Lost to Follow-up|5|||
13116270|NCT03077724|25922010|FG001|Overall Study|Lost to Follow-up|1|||
13116271|NCT03077724|25922009|FG000|Overall Study|Withdrawal by Subject|3|||
13116272|NCT03077724|25922010|FG001|Overall Study|Withdrawal by Subject|1|||
13116273|NCT03077711|25922033|FG000|Overall Study|Lost to Follow-up|2|||
13116274|NCT03077711|25922034|FG001|Overall Study|Lost to Follow-up|2|||
13116275|NCT03077711|25922033|FG000|Overall Study|noncompliant taking medication|2|||
13116276|NCT03077711|25922034|FG001|Overall Study|noncompliant taking medication|0|||
13116277|NCT03077698|25922050|FG000|Progestin Monotherapy|Stable Disease|8|||
13116278|NCT03077698|25922051|FG001|Progestin Monotherapy|Stable Disease|0|||
13116279|NCT03077698|25922050|FG000|Progestin Monotherapy|Adverse Event|1|||
13116280|NCT03077698|25922051|FG001|Progestin Monotherapy|Adverse Event|0|||
13116281|NCT03077698|25922050|FG000|Progestin Monotherapy|Death|1|||
13116282|NCT03077698|25922051|FG001|Progestin Monotherapy|Death|0|||
13116283|NCT03077698|25922050|FG000|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|0|||
13116284|NCT03077698|25922051|FG001|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|2|||
13116285|NCT03077698|25922050|FG000|Sodium Cridanimod & Progestin Therapy|Disease Progression|6|||
13116286|NCT03077698|25922051|FG001|Sodium Cridanimod & Progestin Therapy|Disease Progression|5|||
13116287|NCT03077698|25922050|FG000|Sodium Cridanimod & Progestin Therapy|Adverse Event|0|||
13116288|NCT03077698|25922051|FG001|Sodium Cridanimod & Progestin Therapy|Adverse Event|2|||
13116289|NCT03077698|25922050|FG000|Safety Follow Up|Withdrawal by Subject|2|||
13116290|NCT03077698|25922051|FG001|Safety Follow Up|Withdrawal by Subject|1|||
13116291|NCT03077698|25922050|FG000|Safety Follow Up|Transfer of care to hospice|1|||
13246877|NCT01597245|26358629|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
13116292|NCT03077698|25922051|FG001|Safety Follow Up|Transfer of care to hospice|0|||
13116293|NCT03077659|25922090|FG000|Overall Study|Withdrawal by Subject|0|||
13116294|NCT03077659|25922091|FG001|Overall Study|Withdrawal by Subject|0|||
13116295|NCT03077659|25922092|FG002|Overall Study|Withdrawal by Subject|1|||
13116296|NCT03077646|25922113|FG000|Overall Study|Lost to Follow-up|29|||
13116297|NCT03077646|25922114|FG001|Overall Study|Lost to Follow-up|30|||
13116298|NCT03077646|25922115|FG002|Overall Study|Lost to Follow-up|31|||
13116299|NCT03077607|25922188|FG000|Period 1 (15 Days)|Adverse Event|1|||
13246878|NCT01597245|26358630|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
13246879|NCT01597245|26358631|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
13246880|NCT01597245|26358611|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
13246881|NCT01597245|26358612|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8|||
13246882|NCT01597245|26358613|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6|||
13246883|NCT01597245|26358614|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
13246884|NCT01597245|26358615|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
13246885|NCT01597245|26358616|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
13246886|NCT01597245|26358617|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
13116300|NCT03077607|25922189|FG001|Period 1 (15 Days)|Adverse Event|0|||
13116301|NCT03077607|25922188|FG000|Period 1 (15 Days)|Death|1|||
13116302|NCT03077607|25922189|FG001|Period 1 (15 Days)|Death|0|||
13116303|NCT03077607|25922188|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1|||
13116304|NCT03077607|25922189|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0|||
13116305|NCT03077607|25922188|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
13116306|NCT03077607|25922189|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
13246887|NCT01597245|26358618|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
13246888|NCT01597245|26358619|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
13246889|NCT01597245|26358620|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
13246890|NCT01597245|26358621|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
13246891|NCT01597245|26358622|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
13246892|NCT01597245|26358623|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
13246893|NCT01597245|26358624|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
13116307|NCT03077438|25922212|FG000|Overall Study|Protocol Violation|3|||
13116308|NCT03077438|25922213|FG001|Overall Study|Protocol Violation|5|||
13246894|NCT01597245|26358625|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
13246895|NCT01597245|26358626|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
13246896|NCT01597245|26358627|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
13246897|NCT01597245|26358628|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
13246898|NCT01597245|26358629|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
13246899|NCT01597245|26358630|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
13246900|NCT01597245|26358631|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
13246901|NCT01597245|26358611|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
13246902|NCT01597245|26358612|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4|||
13246903|NCT01597245|26358613|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5|||
13246904|NCT01597245|26358614|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
13246905|NCT01597245|26358615|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
13246906|NCT01597245|26358616|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
13246907|NCT01597245|26358617|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
13246908|NCT01597245|26358618|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
13246909|NCT01597245|26358619|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
13246910|NCT01597245|26358620|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
13246911|NCT01597245|26358621|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
13246912|NCT01597245|26358622|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
13246913|NCT01597245|26358623|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
13246914|NCT01597245|26358624|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
13246915|NCT01597245|26358625|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
13246916|NCT01597245|26358626|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
13246917|NCT01597245|26358627|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
13246918|NCT01597245|26358628|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
13246919|NCT01597245|26358629|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
13246920|NCT01597245|26358630|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
13116309|NCT03077438|25922212|FG000|Overall Study|Withdrawal by Subject|3|||
13116310|NCT03077438|25922213|FG001|Overall Study|Withdrawal by Subject|6|||
13116311|NCT03077438|25922212|FG000|Overall Study|Lost to Follow-up|6|||
13116312|NCT03077438|25922213|FG001|Overall Study|Lost to Follow-up|3|||
13246921|NCT01597245|26358631|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
13246922|NCT01597245|26358611|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1|||
13246923|NCT01597245|26358612|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5|||
13246924|NCT01597245|26358613|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2|||
13246925|NCT01597245|26358614|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
13246926|NCT01597245|26358615|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
13246927|NCT01597245|26358616|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
13246928|NCT01597245|26358617|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
13246929|NCT01597245|26358618|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
13246930|NCT01597245|26358619|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
13246931|NCT01597245|26358620|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
13246932|NCT01597245|26358621|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
13246933|NCT01597245|26358622|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
13246934|NCT01597245|26358623|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
13246935|NCT01597245|26358624|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
13246936|NCT01597245|26358625|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
13246937|NCT01597245|26358626|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
13246938|NCT01597245|26358627|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
13246939|NCT01597245|26358628|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
13246940|NCT01597245|26358629|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
13246941|NCT01597245|26358630|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
13246942|NCT01597245|26358631|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
13246943|NCT01597245|26358611|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
13246944|NCT01597245|26358612|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
13246945|NCT01597245|26358613|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
13246946|NCT01597245|26358614|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
13246947|NCT01597245|26358615|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
13246948|NCT01597245|26358616|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
13246949|NCT01597245|26358617|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
13246950|NCT01597245|26358618|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
13246951|NCT01597245|26358619|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
13246952|NCT01597245|26358620|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
13246953|NCT01597245|26358621|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
13246954|NCT01597245|26358622|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
13246955|NCT01597245|26358623|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
13246956|NCT01597245|26358624|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
13246957|NCT01597245|26358625|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
13246958|NCT01597245|26358626|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
13246959|NCT01597245|26358627|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
13246960|NCT01597245|26358628|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
13246961|NCT01597245|26358629|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
13246962|NCT01597245|26358630|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
13246963|NCT01597245|26358631|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
13246964|NCT01597245|26358611|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
13246965|NCT01597245|26358612|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
13246966|NCT01597245|26358613|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1|||
13246967|NCT01597245|26358614|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
13246968|NCT01597245|26358615|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
13246969|NCT01597245|26358616|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
13246970|NCT01597245|26358617|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
13246971|NCT01597245|26358618|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
13246972|NCT01597245|26358619|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
13246973|NCT01597245|26358620|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
13246974|NCT01597245|26358621|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
13246975|NCT01597245|26358622|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
13246976|NCT01597245|26358623|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
13246977|NCT01597245|26358624|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
13246978|NCT01597245|26358625|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
13246979|NCT01597245|26358626|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
13246980|NCT01597245|26358627|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
13246981|NCT01597245|26358628|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
13246982|NCT01597245|26358629|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
13246983|NCT01597245|26358630|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
13246984|NCT01597245|26358631|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
13246985|NCT01597245|26358611|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
13246986|NCT01597245|26358612|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
13246987|NCT01597245|26358613|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
13246988|NCT01597245|26358614|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
13246989|NCT01597245|26358615|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
13246990|NCT01597245|26358616|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
13246991|NCT01597245|26358617|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
13246992|NCT01597245|26358618|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
13246993|NCT01597245|26358619|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
13246994|NCT01597245|26358620|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
13246995|NCT01597245|26358621|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
13246996|NCT01597245|26358622|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
13246997|NCT01597245|26358623|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
13246998|NCT01597245|26358624|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
13246999|NCT01597245|26358625|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
13247000|NCT01597245|26358626|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
13247001|NCT01597245|26358627|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
13247002|NCT01597245|26358628|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
13247003|NCT01597245|26358629|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
13247004|NCT01597245|26358630|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
13247005|NCT01597245|26358631|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
13247006|NCT01597245|26358611|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
13247007|NCT01597245|26358612|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
13247008|NCT01597245|26358613|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
13247009|NCT01597245|26358614|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
13247010|NCT01597245|26358615|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150|||
13247011|NCT01597245|26358616|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22|||
13247012|NCT01597245|26358617|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80|||
13247013|NCT01597245|26358618|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2|||
13247014|NCT01597245|26358619|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
13247015|NCT01597245|26358620|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114|||
13247016|NCT01597245|26358621|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
13247017|NCT01597245|26358622|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
13247018|NCT01597245|26358623|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
13247019|NCT01597245|26358624|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
13247020|NCT01597245|26358625|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
13247021|NCT01597245|26358626|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
13247022|NCT01597245|26358627|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
13247023|NCT01597245|26358628|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
13247024|NCT01597245|26358629|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
13247025|NCT01597245|26358630|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
13247026|NCT01597245|26358631|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
13247027|NCT01597245|26358611|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
13247028|NCT01597245|26358612|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
13247029|NCT01597245|26358613|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
13247030|NCT01597245|26358614|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
13247031|NCT01597245|26358615|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
13247032|NCT01597245|26358616|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1|||
13247033|NCT01597245|26358617|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
13247034|NCT01597245|26358618|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
13247035|NCT01597245|26358619|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3|||
13247036|NCT01597245|26358620|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
13247037|NCT01597245|26358621|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2|||
13247038|NCT01597245|26358622|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10|||
13247039|NCT01597245|26358623|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4|||
13247040|NCT01597245|26358624|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
13247041|NCT01597245|26358625|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
13247042|NCT01597245|26358626|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
13247043|NCT01597245|26358627|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
13247044|NCT01597245|26358628|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
13247045|NCT01597245|26358629|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
13247046|NCT01597245|26358630|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
13247047|NCT01597245|26358631|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
13247048|NCT01597245|26358611|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
13247049|NCT01597245|26358612|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
13247050|NCT01597245|26358613|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
13247051|NCT01597245|26358614|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
13247052|NCT01597245|26358615|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4|||
13247053|NCT01597245|26358616|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
13247054|NCT01597245|26358617|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
13247055|NCT01597245|26358618|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
13247056|NCT01597245|26358619|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
13247057|NCT01597245|26358620|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
13247058|NCT01597245|26358621|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
13247059|NCT01597245|26358622|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
13247060|NCT01597245|26358623|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
13247061|NCT01597245|26358624|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
13247062|NCT01597245|26358625|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
13247063|NCT01597245|26358626|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
13247064|NCT01597245|26358627|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
13247065|NCT01597245|26358628|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
13247066|NCT01597245|26358629|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
13247067|NCT01597245|26358630|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
13247068|NCT01597245|26358631|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
13247069|NCT01597245|26358611|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
13247070|NCT01597245|26358612|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
13247071|NCT01597245|26358613|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
13247072|NCT01597245|26358614|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
13247073|NCT01597245|26358615|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
13247074|NCT01597245|26358616|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
13247075|NCT01597245|26358617|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
13247076|NCT01597245|26358618|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
13247077|NCT01597245|26358619|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
13247078|NCT01597245|26358620|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
13247079|NCT01597245|26358621|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6|||
13247080|NCT01597245|26358622|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5|||
13247081|NCT01597245|26358623|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
13247082|NCT01597245|26358624|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
13247083|NCT01597245|26358625|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
13247084|NCT01597245|26358626|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
13247085|NCT01597245|26358627|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
13247086|NCT01597245|26358628|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
13247087|NCT01597245|26358629|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
13247088|NCT01597245|26358630|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
13247089|NCT01597245|26358631|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
13247090|NCT01597245|26358611|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
13247091|NCT01597245|26358612|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
13247092|NCT01597245|26358613|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
13247093|NCT01597245|26358614|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
13247094|NCT01597245|26358615|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
13247095|NCT01597245|26358616|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
13247096|NCT01597245|26358617|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
13247097|NCT01597245|26358618|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
13247098|NCT01597245|26358619|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3|||
13247099|NCT01597245|26358620|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
13247100|NCT01597245|26358621|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2|||
13247101|NCT01597245|26358622|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
13247102|NCT01597245|26358623|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
13247103|NCT01597245|26358624|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
13247104|NCT01597245|26358625|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
13247105|NCT01597245|26358626|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
13247106|NCT01597245|26358627|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
13247107|NCT01597245|26358628|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
13247108|NCT01597245|26358629|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
13247109|NCT01597245|26358630|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
13247110|NCT01597245|26358631|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
13247111|NCT01597245|26358611|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
13247112|NCT01597245|26358612|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
13247113|NCT01597245|26358613|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
13247114|NCT01597245|26358614|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
13247115|NCT01597245|26358615|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3|||
13247116|NCT01597245|26358616|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4|||
13247117|NCT01597245|26358617|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
13247118|NCT01597245|26358618|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
13247119|NCT01597245|26358619|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
13247120|NCT01597245|26358620|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
13247121|NCT01597245|26358621|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
13247122|NCT01597245|26358622|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
13247123|NCT01597245|26358623|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
13247124|NCT01597245|26358624|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
13247125|NCT01597245|26358625|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
13247126|NCT01597245|26358626|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
13247127|NCT01597245|26358627|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
13247128|NCT01597245|26358628|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
13247129|NCT01597245|26358629|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
13247130|NCT01597245|26358630|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
13247131|NCT01597245|26358631|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
13247132|NCT01597245|26358611|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
13247133|NCT01597245|26358612|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
13247134|NCT01597245|26358613|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
13247135|NCT01597245|26358614|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
13247136|NCT01597245|26358615|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
13247137|NCT01597245|26358616|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
13247138|NCT01597245|26358617|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
13247139|NCT01597245|26358618|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
13247140|NCT01597245|26358619|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
13247141|NCT01597245|26358620|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
13247142|NCT01597245|26358621|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
13247143|NCT01597245|26358622|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
13247144|NCT01597245|26358623|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
13247145|NCT01597245|26358624|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
13247146|NCT01597245|26358625|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
13247147|NCT01597245|26358626|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
13247148|NCT01597245|26358627|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
13247149|NCT01597245|26358628|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
13247150|NCT01597245|26358629|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
13247151|NCT01597245|26358630|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
13247152|NCT01597245|26358631|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
13247153|NCT01597245|26358611|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
13247154|NCT01597245|26358612|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
13247155|NCT01597245|26358613|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
13247156|NCT01597245|26358614|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
13247157|NCT01597245|26358615|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
13247158|NCT01597245|26358616|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
13247159|NCT01597245|26358617|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
13247160|NCT01597245|26358618|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
13247161|NCT01597245|26358619|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
13247162|NCT01597245|26358620|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
13247163|NCT01597245|26358621|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1|||
13247164|NCT01597245|26358622|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
13247165|NCT01597245|26358623|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
13247166|NCT01597245|26358624|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
13247167|NCT01597245|26358625|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
13247168|NCT01597245|26358626|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
13247169|NCT01597245|26358627|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
13247170|NCT01597245|26358628|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
13247171|NCT01597245|26358629|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
13247172|NCT01597245|26358630|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
13247173|NCT01597245|26358631|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
13247174|NCT01597245|26358611|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
13247175|NCT01597245|26358612|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
13247176|NCT01597245|26358613|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
13247177|NCT01597245|26358614|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
13247178|NCT01597245|26358615|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
13247179|NCT01597245|26358616|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
13247180|NCT01597245|26358617|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
13247181|NCT01597245|26358618|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
13247182|NCT01597245|26358619|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
13247183|NCT01597245|26358620|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
13247184|NCT01597245|26358621|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
13247185|NCT01597245|26358622|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
13247186|NCT01597245|26358623|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
13247187|NCT01597245|26358624|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1|||
13247188|NCT01597245|26358625|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69|||
13247189|NCT01597245|26358626|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70|||
13247190|NCT01597245|26358627|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
13247191|NCT01597245|26358628|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
13247192|NCT01597245|26358629|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
13247193|NCT01597245|26358630|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
13247194|NCT01597245|26358631|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
13247195|NCT01597245|26358611|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
13247196|NCT01597245|26358612|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
13247197|NCT01597245|26358613|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
13247198|NCT01597245|26358614|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
13247199|NCT01597245|26358615|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
13247200|NCT01597245|26358616|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
13247201|NCT01597245|26358617|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
13247202|NCT01597245|26358618|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
13247203|NCT01597245|26358619|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
13247204|NCT01597245|26358620|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
13247205|NCT01597245|26358621|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
13247206|NCT01597245|26358622|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
13247207|NCT01597245|26358623|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
13247208|NCT01597245|26358624|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1|||
13247209|NCT01597245|26358625|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62|||
13247210|NCT01597245|26358626|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63|||
13247211|NCT01597245|26358627|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
13247212|NCT01597245|26358628|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
13247213|NCT01597245|26358629|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
13247214|NCT01597245|26358630|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
13247215|NCT01597245|26358631|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
13247216|NCT01597245|26358611|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
13247217|NCT01597245|26358612|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
13247218|NCT01597245|26358613|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
13247219|NCT01597245|26358614|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
13247220|NCT01597245|26358615|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
13247221|NCT01597245|26358616|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
13247222|NCT01597245|26358617|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
13247223|NCT01597245|26358618|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
13247224|NCT01597245|26358619|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
13247225|NCT01597245|26358620|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
13247226|NCT01597245|26358621|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
13247227|NCT01597245|26358622|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
13247228|NCT01597245|26358623|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
13247229|NCT01597245|26358624|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
13247230|NCT01597245|26358625|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
13247231|NCT01597245|26358626|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
13247232|NCT01597245|26358627|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
13247233|NCT01597245|26358628|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
13247234|NCT01597245|26358629|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
13247235|NCT01597245|26358630|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
13247236|NCT01597245|26358631|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
13247237|NCT01597245|26358611|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
13247238|NCT01597245|26358612|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
13247239|NCT01597245|26358613|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
13247240|NCT01597245|26358614|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
13247241|NCT01597245|26358615|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
13247242|NCT01597245|26358616|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
13247243|NCT01597245|26358617|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
13247244|NCT01597245|26358618|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
13247245|NCT01597245|26358619|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
13247246|NCT01597245|26358620|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
13247247|NCT01597245|26358621|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
13247248|NCT01597245|26358622|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
13247249|NCT01597245|26358623|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
13247250|NCT01597245|26358624|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
13247251|NCT01597245|26358625|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
13247252|NCT01597245|26358626|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
13247253|NCT01597245|26358627|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
13247254|NCT01597245|26358628|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
13247255|NCT01597245|26358629|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
13247256|NCT01597245|26358630|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
13247257|NCT01597245|26358631|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
13247258|NCT01597245|26358611|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
13247259|NCT01597245|26358612|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
13247260|NCT01597245|26358613|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
13247261|NCT01597245|26358614|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
13247262|NCT01597245|26358615|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
13247263|NCT01597245|26358616|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
13247264|NCT01597245|26358617|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
13247265|NCT01597245|26358618|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
13247266|NCT01597245|26358619|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
13247267|NCT01597245|26358620|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
13247268|NCT01597245|26358621|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
13247269|NCT01597245|26358622|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
13247270|NCT01597245|26358623|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
13247271|NCT01597245|26358624|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1|||
13247272|NCT01597245|26358625|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11|||
13247273|NCT01597245|26358626|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12|||
13247274|NCT01597245|26358627|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
13247275|NCT01597245|26358628|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
13247276|NCT01597245|26358629|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
13247277|NCT01597245|26358630|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
13247278|NCT01597245|26358631|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
13247279|NCT01597245|26358611|FG000|Long Term Extension (Week 60 - Week 264)|Death|0|||
13247280|NCT01597245|26358612|FG001|Long Term Extension (Week 60 - Week 264)|Death|0|||
13247281|NCT01597245|26358613|FG002|Long Term Extension (Week 60 - Week 264)|Death|0|||
13247282|NCT01597245|26358614|FG003|Long Term Extension (Week 60 - Week 264)|Death|0|||
13247283|NCT01597245|26358615|FG004|Long Term Extension (Week 60 - Week 264)|Death|0|||
13247284|NCT01597245|26358616|FG005|Long Term Extension (Week 60 - Week 264)|Death|0|||
13247285|NCT01597245|26358617|FG006|Long Term Extension (Week 60 - Week 264)|Death|0|||
13247286|NCT01597245|26358618|FG007|Long Term Extension (Week 60 - Week 264)|Death|0|||
13247287|NCT01597245|26358619|FG008|Long Term Extension (Week 60 - Week 264)|Death|0|||
13247288|NCT01597245|26358620|FG009|Long Term Extension (Week 60 - Week 264)|Death|0|||
13247289|NCT01597245|26358621|FG010|Long Term Extension (Week 60 - Week 264)|Death|0|||
13247290|NCT01597245|26358622|FG011|Long Term Extension (Week 60 - Week 264)|Death|0|||
13247291|NCT01597245|26358623|FG012|Long Term Extension (Week 60 - Week 264)|Death|0|||
13247292|NCT01597245|26358624|FG013|Long Term Extension (Week 60 - Week 264)|Death|0|||
13247293|NCT01597245|26358625|FG014|Long Term Extension (Week 60 - Week 264)|Death|8|||
13247294|NCT01597245|26358626|FG015|Long Term Extension (Week 60 - Week 264)|Death|8|||
13247295|NCT01597245|26358627|FG016|Long Term Extension (Week 60 - Week 264)|Death|0|||
13247296|NCT01597245|26358628|FG017|Long Term Extension (Week 60 - Week 264)|Death|0|||
13247297|NCT01597245|26358629|FG018|Long Term Extension (Week 60 - Week 264)|Death|0|||
13247298|NCT01597245|26358630|FG019|Long Term Extension (Week 60 - Week 264)|Death|0|||
13247299|NCT01597245|26358631|FG020|Long Term Extension (Week 60 - Week 264)|Death|0|||
13247300|NCT01597245|26358611|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
13247301|NCT01597245|26358612|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
13247302|NCT01597245|26358613|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
13247303|NCT01597245|26358614|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
13247304|NCT01597245|26358615|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
13307585|NCT01284140|26529130|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1|||
13247305|NCT01597245|26358616|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
13247306|NCT01597245|26358617|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
13247307|NCT01597245|26358618|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
13247308|NCT01597245|26358619|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
13247309|NCT01597245|26358620|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
13247310|NCT01597245|26358621|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
13247311|NCT01597245|26358622|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
13247312|NCT01597245|26358623|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
13247313|NCT01597245|26358624|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
13247314|NCT01597245|26358625|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
13247315|NCT01597245|26358626|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
13247316|NCT01597245|26358627|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
13247317|NCT01597245|26358628|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
13247318|NCT01597245|26358629|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
13247319|NCT01597245|26358630|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
13247320|NCT01597245|26358631|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
13247321|NCT01597245|26358611|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
13247322|NCT01597245|26358612|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
13247323|NCT01597245|26358613|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
13247324|NCT01597245|26358614|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
13247325|NCT01597245|26358615|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
13247326|NCT01597245|26358616|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
13247327|NCT01597245|26358617|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
13247328|NCT01597245|26358618|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
13247329|NCT01597245|26358619|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
13247330|NCT01597245|26358620|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
13247331|NCT01597245|26358621|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
13247332|NCT01597245|26358622|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
13247333|NCT01597245|26358623|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
13247334|NCT01597245|26358624|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
13247335|NCT01597245|26358625|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
13247336|NCT01597245|26358626|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
13247337|NCT01597245|26358627|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
13247338|NCT01597245|26358628|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
13247339|NCT01597245|26358629|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
13247340|NCT01597245|26358630|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
13247341|NCT01597245|26358631|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
13247342|NCT01597245|26358611|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
13247343|NCT01597245|26358612|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
13247344|NCT01597245|26358613|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
13247345|NCT01597245|26358614|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
13247346|NCT01597245|26358615|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
13247347|NCT01597245|26358616|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
13247348|NCT01597245|26358617|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
13247349|NCT01597245|26358618|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
13247350|NCT01597245|26358619|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
13247351|NCT01597245|26358620|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
13247352|NCT01597245|26358621|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
13247353|NCT01597245|26358622|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
13247354|NCT01597245|26358623|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
13247355|NCT01597245|26358624|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
13247356|NCT01597245|26358625|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
13247357|NCT01597245|26358626|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
13247358|NCT01597245|26358627|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
13247359|NCT01597245|26358628|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
13247360|NCT01597245|26358629|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
13247361|NCT01597245|26358630|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
13247362|NCT01597245|26358631|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
13247363|NCT01597245|26358611|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
13247364|NCT01597245|26358612|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
13247365|NCT01597245|26358613|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
13247366|NCT01597245|26358614|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
13247367|NCT01597245|26358615|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
13247368|NCT01597245|26358616|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
13247369|NCT01597245|26358617|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
13247370|NCT01597245|26358618|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
13247371|NCT01597245|26358619|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
13247372|NCT01597245|26358620|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
13247373|NCT01597245|26358621|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
13247374|NCT01597245|26358622|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
13247375|NCT01597245|26358623|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
13247376|NCT01597245|26358624|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23|||
13247377|NCT01597245|26358625|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
13247378|NCT01597245|26358626|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
13247379|NCT01597245|26358627|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
13247380|NCT01597245|26358628|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
13247381|NCT01597245|26358629|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
13247382|NCT01597245|26358630|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
13247383|NCT01597245|26358631|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
13247384|NCT01597245|26358611|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
13247385|NCT01597245|26358612|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
13247386|NCT01597245|26358613|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
13247387|NCT01597245|26358614|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
13247388|NCT01597245|26358615|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
13247389|NCT01597245|26358616|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
13247390|NCT01597245|26358617|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
13247391|NCT01597245|26358618|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
13247392|NCT01597245|26358619|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
13247393|NCT01597245|26358620|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
13247394|NCT01597245|26358621|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
13247395|NCT01597245|26358622|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
13247396|NCT01597245|26358623|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
13247397|NCT01597245|26358624|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
13247398|NCT01597245|26358625|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
13247399|NCT01597245|26358626|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
13247400|NCT01597245|26358627|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9|||
13247401|NCT01597245|26358628|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5|||
13247402|NCT01597245|26358629|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8|||
13247403|NCT01597245|26358630|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63|||
13247404|NCT01597245|26358631|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13|||
13247405|NCT01597245|26358611|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
13247406|NCT01597245|26358612|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
13247407|NCT01597245|26358613|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
13247408|NCT01597245|26358614|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
13247409|NCT01597245|26358615|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
13247410|NCT01597245|26358616|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
13247411|NCT01597245|26358617|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
13247412|NCT01597245|26358618|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
13247413|NCT01597245|26358619|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
13247414|NCT01597245|26358620|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
13247415|NCT01597245|26358621|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
13247416|NCT01597245|26358622|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
13247417|NCT01597245|26358623|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
13247418|NCT01597245|26358624|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
13247419|NCT01597245|26358625|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
13247420|NCT01597245|26358626|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
13247421|NCT01597245|26358627|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
13247422|NCT01597245|26358628|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
13247423|NCT01597245|26358629|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
13247424|NCT01597245|26358630|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41|||
13247425|NCT01597245|26358631|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13|||
13247426|NCT01597245|26358611|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
13247427|NCT01597245|26358612|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
13247428|NCT01597245|26358613|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
13247429|NCT01597245|26358614|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
13247430|NCT01597245|26358615|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
13247431|NCT01597245|26358616|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
13247432|NCT01597245|26358617|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
13247433|NCT01597245|26358618|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
13247434|NCT01597245|26358619|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
13247435|NCT01597245|26358620|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
13247436|NCT01597245|26358621|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
13247437|NCT01597245|26358622|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
13247438|NCT01597245|26358623|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
13247439|NCT01597245|26358624|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
13247440|NCT01597245|26358625|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
13247441|NCT01597245|26358626|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
13247442|NCT01597245|26358627|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2|||
13247443|NCT01597245|26358628|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
13247444|NCT01597245|26358629|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
13247445|NCT01597245|26358630|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29|||
13247446|NCT01597245|26358631|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3|||
13247447|NCT01597245|26358611|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
13247448|NCT01597245|26358612|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
13247449|NCT01597245|26358613|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
13247450|NCT01597245|26358614|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
13247451|NCT01597245|26358615|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
13247452|NCT01597245|26358616|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
13247453|NCT01597245|26358617|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
13247454|NCT01597245|26358618|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
13247455|NCT01597245|26358619|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
13247456|NCT01597245|26358620|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
13247457|NCT01597245|26358621|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
13247458|NCT01597245|26358622|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
13247459|NCT01597245|26358623|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
13247460|NCT01597245|26358624|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
13247461|NCT01597245|26358625|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
13247462|NCT01597245|26358626|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
13247463|NCT01597245|26358627|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
13247464|NCT01597245|26358628|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
13247465|NCT01597245|26358629|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1|||
13247466|NCT01597245|26358630|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14|||
13247467|NCT01597245|26358631|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4|||
13247468|NCT01597245|26358611|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
13247469|NCT01597245|26358612|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
13247470|NCT01597245|26358613|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
13247471|NCT01597245|26358614|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
13247472|NCT01597245|26358615|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
13247473|NCT01597245|26358616|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
13247474|NCT01597245|26358617|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
13247475|NCT01597245|26358618|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
13247476|NCT01597245|26358619|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
13247477|NCT01597245|26358620|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
13247478|NCT01597245|26358621|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
13247479|NCT01597245|26358622|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
13247480|NCT01597245|26358623|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
13247481|NCT01597245|26358624|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
13247482|NCT01597245|26358625|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
13247483|NCT01597245|26358626|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
13247484|NCT01597245|26358627|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
13247485|NCT01597245|26358628|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
13247486|NCT01597245|26358629|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
13247487|NCT01597245|26358630|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9|||
13247488|NCT01597245|26358631|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
13247489|NCT01597245|26358611|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
13247490|NCT01597245|26358612|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
13247491|NCT01597245|26358613|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
13247492|NCT01597245|26358614|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
13485847|NCT00585195|27033423|FG013|Overall Study|Withdrawn Due to Pregnancy|0|||
13485848|NCT00585195|27033424|FG014|Overall Study|Withdrawn Due to Pregnancy|1|||
13247493|NCT01597245|26358615|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
13247494|NCT01597245|26358616|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
13247495|NCT01597245|26358617|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
13247496|NCT01597245|26358618|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
13247497|NCT01597245|26358619|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
13247498|NCT01597245|26358620|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
13247499|NCT01597245|26358621|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
13247500|NCT01597245|26358622|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
13247501|NCT01597245|26358623|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
13247502|NCT01597245|26358624|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
13247503|NCT01597245|26358625|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
13247504|NCT01597245|26358626|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
13247505|NCT01597245|26358627|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1|||
13247506|NCT01597245|26358628|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
13247507|NCT01597245|26358629|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
13247508|NCT01597245|26358630|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6|||
13247509|NCT01597245|26358631|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2|||
13247510|NCT01597245|26358611|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
13247511|NCT01597245|26358612|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
13247512|NCT01597245|26358613|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
13247513|NCT01597245|26358614|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
13247514|NCT01597245|26358615|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
13247515|NCT01597245|26358616|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
13247516|NCT01597245|26358617|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
13247517|NCT01597245|26358618|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
13247518|NCT01597245|26358619|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
13247519|NCT01597245|26358620|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
13247520|NCT01597245|26358621|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
13247521|NCT01597245|26358622|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
13247522|NCT01597245|26358623|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
13247523|NCT01597245|26358624|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
13247524|NCT01597245|26358625|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
13247525|NCT01597245|26358626|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
13247526|NCT01597245|26358627|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2|||
13247527|NCT01597245|26358628|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
13247528|NCT01597245|26358629|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
13247529|NCT01597245|26358630|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3|||
13116313|NCT03077412|25922243|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1|||
13116314|NCT03077412|25922244|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5|||
13116315|NCT03077412|25922245|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3|||
13116316|NCT03077412|25922243|FG000|Overall Study|Protocol-Specified Disease Worsening|1|||
13116317|NCT03077412|25922244|FG001|Overall Study|Protocol-Specified Disease Worsening|3|||
13116318|NCT03077412|25922245|FG002|Overall Study|Protocol-Specified Disease Worsening|3|||
13116319|NCT03077412|25922243|FG000|Overall Study|Adverse Event|1|||
13116320|NCT03077412|25922244|FG001|Overall Study|Adverse Event|2|||
13116321|NCT03077412|25922245|FG002|Overall Study|Adverse Event|2|||
13116322|NCT03077412|25922243|FG000|Overall Study|Investigator's Discretion|0|||
13116323|NCT03077412|25922244|FG001|Overall Study|Investigator's Discretion|1|||
13116324|NCT03077412|25922245|FG002|Overall Study|Investigator's Discretion|1|||
13116325|NCT03077412|25922243|FG000|Overall Study|Withdrew Consent|0|||
13116326|NCT03077412|25922244|FG001|Overall Study|Withdrew Consent|2|||
13116327|NCT03077412|25922245|FG002|Overall Study|Withdrew Consent|0|||
13116328|NCT03076996|25922254|FG000|Overall Study|Withdrawal by Subject|2|||
13116329|NCT03076996|25922254|FG000|Overall Study|Lost to Follow-up|3|||
13116330|NCT03076996|25922254|FG000|Overall Study|Literacy precluded participation|1|||
13116331|NCT03076970|25922311|FG000|Washout Period 2|Adverse Event|0|||
13116332|NCT03076970|25922312|FG001|Washout Period 2|Adverse Event|0|||
13116333|NCT03076970|25922313|FG002|Washout Period 2|Adverse Event|0|||
13116334|NCT03076970|25922314|FG003|Washout Period 2|Adverse Event|0|||
13116335|NCT03076970|25922315|FG004|Washout Period 2|Adverse Event|1|||
13116336|NCT03076970|25922316|FG005|Washout Period 2|Adverse Event|0|||
13116337|NCT03076970|25922311|FG000|Period 3|Withdrawal by Subject|0|||
13116338|NCT03076970|25922312|FG001|Period 3|Withdrawal by Subject|0|||
13116339|NCT03076970|25922313|FG002|Period 3|Withdrawal by Subject|0|||
13116340|NCT03076970|25922314|FG003|Period 3|Withdrawal by Subject|0|||
13116341|NCT03076970|25922315|FG004|Period 3|Withdrawal by Subject|0|||
13116342|NCT03076970|25922316|FG005|Period 3|Withdrawal by Subject|1|||
13116343|NCT03076970|25922311|FG000|Period 3|Failure to meet I/E criteria|0|||
13116344|NCT03076970|25922312|FG001|Period 3|Failure to meet I/E criteria|0|||
13116345|NCT03076970|25922313|FG002|Period 3|Failure to meet I/E criteria|0|||
13247530|NCT01597245|26358631|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
13247531|NCT01597245|26358611|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
13247532|NCT01597245|26358612|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
13247533|NCT01597245|26358613|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
13247534|NCT01597245|26358614|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
13247535|NCT01597245|26358615|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
13247536|NCT01597245|26358616|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
13247537|NCT01597245|26358617|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
13247538|NCT01597245|26358618|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
13247539|NCT01597245|26358619|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
13247540|NCT01597245|26358620|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
13247541|NCT01597245|26358621|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
13247542|NCT01597245|26358622|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
13247543|NCT01597245|26358623|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
13247544|NCT01597245|26358624|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
13247545|NCT01597245|26358625|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
13247546|NCT01597245|26358626|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
13247547|NCT01597245|26358627|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
13247548|NCT01597245|26358628|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
13247549|NCT01597245|26358629|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
13247550|NCT01597245|26358630|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
13247551|NCT01597245|26358631|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
13247552|NCT01597245|26358611|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
13247553|NCT01597245|26358612|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
13247554|NCT01597245|26358613|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
13247555|NCT01597245|26358614|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
13247556|NCT01597245|26358615|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
13247557|NCT01597245|26358616|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
13247558|NCT01597245|26358617|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
13247559|NCT01597245|26358618|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
13116346|NCT03076970|25922314|FG003|Period 3|Failure to meet I/E criteria|0|||
13116347|NCT03076970|25922315|FG004|Period 3|Failure to meet I/E criteria|1|||
13247560|NCT01597245|26358619|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
13247561|NCT01597245|26358620|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
13247562|NCT01597245|26358621|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
13247563|NCT01597245|26358622|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
13247564|NCT01597245|26358623|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
13247565|NCT01597245|26358624|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
13247566|NCT01597245|26358625|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
13247567|NCT01597245|26358626|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
13247568|NCT01597245|26358627|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
13247569|NCT01597245|26358628|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
13247570|NCT01597245|26358629|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
13247571|NCT01597245|26358630|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1|||
13247572|NCT01597245|26358631|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
13247573|NCT01597193|26358732|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7|||
13247574|NCT01597193|26358733|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8|||
13247575|NCT01597193|26358734|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
13247576|NCT01597193|26358735|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
13247577|NCT01597193|26358736|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
13247578|NCT01597193|26358737|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
13247579|NCT01597193|26358738|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
13247580|NCT01597193|26358732|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
13247581|NCT01597193|26358733|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
13247582|NCT01597193|26358734|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
13247583|NCT01597193|26358735|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1|||
13247584|NCT01597193|26358736|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2|||
13247585|NCT01597193|26358737|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3|||
13247586|NCT01597193|26358738|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
13247587|NCT01597193|26358732|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
13247588|NCT01597193|26358733|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
13116348|NCT03076970|25922316|FG005|Period 3|Failure to meet I/E criteria|0|||
13247589|NCT01597193|26358734|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
13247590|NCT01597193|26358735|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
13247591|NCT01597193|26358736|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
13247592|NCT01597193|26358737|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
13247593|NCT01597193|26358738|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11|||
13247594|NCT01597193|26358732|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0|||
13116349|NCT03076515|25922329|FG000|Overall Study|DMC decision based on interim analysis|25|||
13116350|NCT03076515|25922330|FG001|Overall Study|DMC decision based on interim analysis|29|||
13116351|NCT03076190|25922350|FG000|Overall Study|Lost to Follow-up|9|||
13116352|NCT03076190|25922351|FG001|Overall Study|Lost to Follow-up|34|||
13116353|NCT03076190|25922350|FG000|Overall Study|Excluded from Analysis (zero duration ev|9|||
13116354|NCT03076190|25922351|FG001|Overall Study|Excluded from Analysis (zero duration ev|7|||
13116355|NCT03075904|25922361|FG000|Overall Study|Physician Decision|3|||
13116356|NCT03075904|25922361|FG000|Overall Study|Need for Medication not Permitted|1|||
13116357|NCT03075891|25922422|FG000|Overall Study|Withdrawal by Subject|3|||
13116358|NCT03075891|25922423|FG001|Overall Study|Withdrawal by Subject|6|||
13116359|NCT03075891|25922422|FG000|Overall Study|Lost to Follow-up|1|||
13116360|NCT03075891|25922423|FG001|Overall Study|Lost to Follow-up|0|||
13247595|NCT01597193|26358733|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0|||
13247596|NCT01597193|26358734|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0|||
13247597|NCT01597193|26358735|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0|||
13247598|NCT01597193|26358736|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0|||
13247599|NCT01597193|26358737|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1|||
13247600|NCT01597193|26358738|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0|||
13247601|NCT01597193|26358732|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
13247602|NCT01597193|26358733|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
13247603|NCT01597193|26358734|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
13247604|NCT01597193|26358735|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
13247605|NCT01597193|26358736|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
13247606|NCT01597193|26358737|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
13247607|NCT01597193|26358738|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
13116361|NCT03075891|25922422|FG000|Overall Study|Pregnancy|3|||
13116362|NCT03075891|25922423|FG001|Overall Study|Pregnancy|1|||
13116363|NCT03075891|25922422|FG000|Overall Study|visits not performed (no time)|1|||
13247608|NCT01597050|26358751|FG000|Overall Study|Withdrawal by Subject|1|||
13247609|NCT01597050|26358752|FG001|Overall Study|Withdrawal by Subject|0|||
13247610|NCT01596972|26358769|FG000|Overall Study|Physician Decision|1|||
13247611|NCT01596972|26358770|FG001|Overall Study|Physician Decision|9|||
13247612|NCT01596972|26358769|FG000|Overall Study|Lost to Follow-up|0|||
13247613|NCT01596972|26358770|FG001|Overall Study|Lost to Follow-up|4|||
13247614|NCT01596972|26358769|FG000|Overall Study|Withdrawal by Subject|0|||
13247615|NCT01596972|26358770|FG001|Overall Study|Withdrawal by Subject|1|||
13247616|NCT01596582|26358801|FG000|Overall Study|Deemed ineligible after study visit|3|||
13247617|NCT01596582|26358802|FG001|Overall Study|Deemed ineligible after study visit|6|||
13247618|NCT01596582|26358801|FG000|Overall Study|Missing all outcome data|1|||
13247619|NCT01596582|26358802|FG001|Overall Study|Missing all outcome data|1|||
13247620|NCT01596504|26358868|FG000|Overall Study|Participant's Private Reason|0|||
13247621|NCT01596504|26358869|FG001|Overall Study|Participant's Private Reason|1|||
13247622|NCT01596504|26358870|FG002|Overall Study|Participant's Private Reason|0|||
13247623|NCT01596504|26358868|FG000|Overall Study|Adverse Event|1|||
13247624|NCT01596504|26358869|FG001|Overall Study|Adverse Event|2|||
13247625|NCT01596504|26358870|FG002|Overall Study|Adverse Event|1|||
13247626|NCT01596504|26358868|FG000|Overall Study|Withdrawal by Subject|1|||
13247627|NCT01596504|26358869|FG001|Overall Study|Withdrawal by Subject|0|||
13247628|NCT01596504|26358870|FG002|Overall Study|Withdrawal by Subject|0|||
13247629|NCT01596335|26358887|FG000|Overall Study|exacerbation of primary disease|5|||
13247630|NCT01596335|26358888|FG001|Overall Study|exacerbation of primary disease|9|||
13247631|NCT01596127|26358895|FG000|Overall Study|Patient Ineligible|1|||
13247632|NCT01596062|26358937|FG000|Overall Study|Adverse Event|1|||
13247633|NCT01596062|26358938|FG001|Overall Study|Adverse Event|0|||
13116364|NCT03075891|25922423|FG001|Overall Study|visits not performed (no time)|0|||
13116365|NCT03075891|25922422|FG000|Overall Study|Drug abuse relapse issue|0|||
13116366|NCT03075891|25922423|FG001|Overall Study|Drug abuse relapse issue|1|||
13203287|NCT01986855|26224175|FG002|Overall Study|Lost to Follow-up|0|||
13203288|NCT01986855|26224173|FG000|Overall Study|Screen Failure|0|||
13203289|NCT01986855|26224174|FG001|Overall Study|Screen Failure|1|||
13203290|NCT01986855|26224175|FG002|Overall Study|Screen Failure|0|||
13203291|NCT01986855|26224173|FG000|Overall Study|Participant Moved|0|||
13203292|NCT01986855|26224174|FG001|Overall Study|Participant Moved|0|||
13203293|NCT01986855|26224175|FG002|Overall Study|Participant Moved|2|||
13203294|NCT01986855|26224173|FG000|Overall Study|Withdrawal by Subject|7|||
13203295|NCT01986855|26224174|FG001|Overall Study|Withdrawal by Subject|8|||
13203296|NCT01986855|26224175|FG002|Overall Study|Withdrawal by Subject|5|||
13203297|NCT01986829|26224204|FG000|Overall Study|Death|1|||
13247634|NCT01596062|26358939|FG002|Overall Study|Adverse Event|2|||
13247635|NCT01596062|26358937|FG000|Overall Study|Lack of Efficacy|0|||
13247636|NCT01596062|26358938|FG001|Overall Study|Lack of Efficacy|0|||
13247637|NCT01596062|26358939|FG002|Overall Study|Lack of Efficacy|1|||
13247638|NCT01595646|26358969|FG000|Overall Study|Withdrawal by Subject|1|||
13247639|NCT01595646|26358970|FG001|Overall Study|Withdrawal by Subject|0|||
13247640|NCT01595646|26358971|FG002|Overall Study|Withdrawal by Subject|0|||
13247641|NCT01595581|26358988|FG000|Overall Study|Withdrawal by Subject|1|||
13247642|NCT01595581|26358989|FG001|Overall Study|Withdrawal by Subject|0|||
13247643|NCT01595529|26359024|FG000|Overall Study|Adverse Event|2|||
13247644|NCT01595529|26359025|FG001|Overall Study|Adverse Event|0|||
13247645|NCT01595529|26359024|FG000|Overall Study|Subject Non-Compliant|2|||
13247646|NCT01595529|26359025|FG001|Overall Study|Subject Non-Compliant|0|||
13116367|NCT03075891|25922422|FG000|Overall Study|Participant requiring study withdrawal|0|||
13116368|NCT03075891|25922423|FG001|Overall Study|Participant requiring study withdrawal|1|||
13116369|NCT03075891|25922422|FG000|Overall Study|Adverse event, non-fatal|1|||
13116370|NCT03075891|25922423|FG001|Overall Study|Adverse event, non-fatal|4|||
13247647|NCT01595529|26359024|FG000|Overall Study|Lost to Follow-up|8|||
13247648|NCT01595529|26359025|FG001|Overall Study|Lost to Follow-up|14|||
13247649|NCT01595529|26359024|FG000|Overall Study|Protocol Violation|1|||
13247650|NCT01595529|26359025|FG001|Overall Study|Protocol Violation|2|||
13247651|NCT01595529|26359024|FG000|Overall Study|Physician Decision|1|||
13247652|NCT01595529|26359025|FG001|Overall Study|Physician Decision|0|||
13247653|NCT01595529|26359024|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
13247654|NCT01595529|26359025|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
13247655|NCT01595529|26359024|FG000|Overall Study|Administrative Decision|1|||
13247656|NCT01595529|26359025|FG001|Overall Study|Administrative Decision|0|||
13247657|NCT01595529|26359024|FG000|Overall Study|Entry Failure/Screening Failure|6|||
13247658|NCT01595529|26359025|FG001|Overall Study|Entry Failure/Screening Failure|1|||
13247659|NCT01595438|26359156|FG000|Overall Study|Lost to Follow-up|20|||
13247660|NCT01595438|26359157|FG001|Overall Study|Lost to Follow-up|20|||
13247661|NCT01595438|26359156|FG000|Overall Study|Withdrawal by Subject|12|||
13247662|NCT01595438|26359157|FG001|Overall Study|Withdrawal by Subject|12|||
13247663|NCT01595438|26359156|FG000|Overall Study|Other Eligibility criteria|11|||
13247664|NCT01595438|26359157|FG001|Overall Study|Other Eligibility criteria|9|||
13247665|NCT01594970|26359184|FG000|Overall Study|Non-Adverse Event Related|4|||
13247666|NCT01594970|26359185|FG001|Overall Study|Non-Adverse Event Related|5|||
13247667|NCT01594970|26359186|FG002|Overall Study|Non-Adverse Event Related|6|||
13247668|NCT01594970|26359184|FG000|Overall Study|Adverse Event|17|||
13247669|NCT01594970|26359185|FG001|Overall Study|Adverse Event|23|||
13247670|NCT01594970|26359186|FG002|Overall Study|Adverse Event|23|||
13247671|NCT01594970|26359184|FG000|Overall Study|Lost to Follow-up|54|||
13247672|NCT01594970|26359185|FG001|Overall Study|Lost to Follow-up|54|||
13247673|NCT01594970|26359186|FG002|Overall Study|Lost to Follow-up|37|||
13247674|NCT01594931|26359222|FG000|Overall Study|Adverse Event|3|||
13247675|NCT01594931|26359223|FG001|Overall Study|Adverse Event|1|||
13247676|NCT01594931|26359224|FG002|Overall Study|Adverse Event|1|||
13247677|NCT01594931|26359222|FG000|Overall Study|Withdrawal by Subject|2|||
13247678|NCT01594931|26359223|FG001|Overall Study|Withdrawal by Subject|1|||
13247679|NCT01594931|26359224|FG002|Overall Study|Withdrawal by Subject|1|||
13247680|NCT01594931|26359222|FG000|Overall Study|Lack of Efficacy|7|||
13247681|NCT01594931|26359223|FG001|Overall Study|Lack of Efficacy|2|||
13247682|NCT01594931|26359224|FG002|Overall Study|Lack of Efficacy|2|||
13247683|NCT01594931|26359222|FG000|Overall Study|Lost to Follow-up|4|||
13247684|NCT01594931|26359223|FG001|Overall Study|Lost to Follow-up|3|||
13247685|NCT01594931|26359224|FG002|Overall Study|Lost to Follow-up|3|||
13247686|NCT01594931|26359222|FG000|Overall Study|Protocol Violation|2|||
13247687|NCT01594931|26359223|FG001|Overall Study|Protocol Violation|1|||
13247688|NCT01594931|26359224|FG002|Overall Study|Protocol Violation|0|||
13247689|NCT01594931|26359222|FG000|Overall Study|No defiined|11|||
13247690|NCT01594931|26359223|FG001|Overall Study|No defiined|4|||
13247691|NCT01594931|26359224|FG002|Overall Study|No defiined|7|||
13247692|NCT01594853|26359237|FG000|Overall Study|Withdrawal by Subject|1|||
13247693|NCT01594853|26359238|FG001|Overall Study|Withdrawal by Subject|1|||
13247694|NCT01594853|26359237|FG000|Overall Study|Lost to Follow-up|1|||
13247695|NCT01594853|26359238|FG001|Overall Study|Lost to Follow-up|1|||
13247696|NCT01594853|26359237|FG000|Overall Study|noncompliance with exercise|0|||
13247697|NCT01594853|26359238|FG001|Overall Study|noncompliance with exercise|1|||
13247698|NCT01594827|26359267|FG000|Overall Study|Adverse Event|1|||
13247699|NCT01594827|26359268|FG001|Overall Study|Adverse Event|0|||
13247700|NCT01594827|26359267|FG000|Overall Study|Physician Decision|3|||
13247701|NCT01594827|26359268|FG001|Overall Study|Physician Decision|0|||
13247702|NCT01594762|26359285|FG000|Overall Study|Withdrawal by Subject|1|||
13247703|NCT01594762|26359286|FG001|Overall Study|Withdrawal by Subject|0|||
13247704|NCT01594762|26359285|FG000|Overall Study|Lost to Follow-up|10|||
13247705|NCT01594762|26359286|FG001|Overall Study|Lost to Follow-up|10|||
13247706|NCT01594749|26359309|FG000|Overall Study|Adverse Event|2|||
13247707|NCT01594749|26359310|FG001|Overall Study|Adverse Event|1|||
13247708|NCT01594749|26359309|FG000|Overall Study|Withdrawal by Subject|2|||
13247709|NCT01594749|26359310|FG001|Overall Study|Withdrawal by Subject|2|||
13247710|NCT01594749|26359309|FG000|Overall Study|Protocol Violation|2|||
13247711|NCT01594749|26359310|FG001|Overall Study|Protocol Violation|0|||
13247712|NCT01594749|26359309|FG000|Overall Study|Physician Decision|1|||
13247713|NCT01594749|26359310|FG001|Overall Study|Physician Decision|1|||
13247714|NCT01594749|26359309|FG000|Overall Study|Non-compliance with Protocol|0|||
13247715|NCT01594749|26359310|FG001|Overall Study|Non-compliance with Protocol|1|||
13247716|NCT01594749|26359309|FG000|Overall Study|Lost to Follow-up|1|||
13247717|NCT01594749|26359310|FG001|Overall Study|Lost to Follow-up|0|||
13247718|NCT01594749|26359309|FG000|Overall Study|Death|9|||
13247719|NCT01594749|26359310|FG001|Overall Study|Death|3|||
13247720|NCT01594749|26359309|FG000|Overall Study|Not Treated|4|||
13247721|NCT01594749|26359310|FG001|Overall Study|Not Treated|10|||
13247722|NCT01594749|26359309|FG000|Overall Study|Lost Source Documentation|1|||
13247723|NCT01594749|26359310|FG001|Overall Study|Lost Source Documentation|0|||
13247724|NCT01594476|26359335|FG000|Overall Study|Protocol Violation|1|||
13247725|NCT01594476|26359336|FG001|Overall Study|Protocol Violation|3|||
13247726|NCT01594411|26359345|FG000|Overall Study|Lost to Follow-up|2|||
13247727|NCT01594333|26359378|FG000|Overall Study|Death|96|||
13247728|NCT01594333|26359379|FG001|Overall Study|Death|83|||
13247729|NCT01594333|26359378|FG000|Overall Study|Lost to Follow-up|5|||
13247730|NCT01594333|26359379|FG001|Overall Study|Lost to Follow-up|5|||
13247731|NCT01594333|26359378|FG000|Overall Study|Withdrawal by Subject|60|||
13247732|NCT01594333|26359379|FG001|Overall Study|Withdrawal by Subject|63|||
13247733|NCT01594281|26359424|FG000|Interventional Core Phase|Protocol Deviation|1|||
13247734|NCT01594281|26359425|FG001|Interventional Core Phase|Protocol Deviation|0|||
13247735|NCT01594281|26359426|FG002|Interventional Core Phase|Protocol Deviation|0|||
13247736|NCT01594281|26359424|FG000|Interventional Core Phase|Subject Withdrew Consent|0|||
13247737|NCT01594281|26359425|FG001|Interventional Core Phase|Subject Withdrew Consent|1|||
13247738|NCT01594281|26359426|FG002|Interventional Core Phase|Subject Withdrew Consent|1|||
13247739|NCT01594281|26359424|FG000|Interventional Core Phase|Death|1|||
13247740|NCT01594281|26359425|FG001|Interventional Core Phase|Death|1|||
13247741|NCT01594281|26359426|FG002|Interventional Core Phase|Death|2|||
13247742|NCT01594281|26359424|FG000|Interventional Core Phase|Lost to Follow-up|1|||
13247743|NCT01594281|26359425|FG001|Interventional Core Phase|Lost to Follow-up|4|||
13247744|NCT01594281|26359426|FG002|Interventional Core Phase|Lost to Follow-up|1|||
13247745|NCT01594281|26359424|FG000|Interventional Core Phase|Adverse Event|4|||
13247746|NCT01594281|26359425|FG001|Interventional Core Phase|Adverse Event|4|||
13247747|NCT01594281|26359426|FG002|Interventional Core Phase|Adverse Event|4|||
13247748|NCT01594281|26359424|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
13247749|NCT01594281|26359425|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
13247750|NCT01594281|26359426|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0|||
13247751|NCT01594281|26359424|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0|||
13116371|NCT03075878|25922433|FG000|Overall Study|Physician Decision|1|||
13116372|NCT03075839|25922441|FG000|Overall Study|Lost to Follow-up|4|||
13116373|NCT03075826|25922448|FG000|Overall Study|Withdrawal by Subject|1|||
13116374|NCT03075826|25922448|FG000|Overall Study|Received less than 3 cycles of study drug|5|||
13247752|NCT01594281|26359425|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0|||
13247753|NCT01594281|26359426|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1|||
13247754|NCT01594281|26359424|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
13247755|NCT01594281|26359425|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0|||
13247756|NCT01594281|26359426|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
13247757|NCT01594125|26359474|FG000|Overall Study|Withdrawal by Subject|1|||
13247758|NCT01594125|26359475|FG001|Overall Study|Withdrawal by Subject|0|||
13247759|NCT01594125|26359476|FG002|Overall Study|Withdrawal by Subject|0|||
13247760|NCT01594125|26359477|FG003|Overall Study|Withdrawal by Subject|1|||
13247761|NCT01594125|26359478|FG004|Overall Study|Withdrawal by Subject|0|||
13247762|NCT01594125|26359474|FG000|Overall Study|Progressive Disease|3|||
13247763|NCT01594125|26359475|FG001|Overall Study|Progressive Disease|12|||
13247764|NCT01594125|26359476|FG002|Overall Study|Progressive Disease|3|||
13247765|NCT01594125|26359477|FG003|Overall Study|Progressive Disease|3|||
13247766|NCT01594125|26359478|FG004|Overall Study|Progressive Disease|7|||
13247767|NCT01593917|26359492|FG000|Overall Study|Death|67|||
13247768|NCT01593917|26359492|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60|||
13247769|NCT01593917|26359492|FG000|Overall Study|Withdrawal by Subject|23|||
13247770|NCT01593917|26359492|FG000|Overall Study|Lost to Follow-up|12|||
13247771|NCT01593917|26359492|FG000|Overall Study|Protocol Violation|5|||
13247772|NCT01593917|26359492|FG000|Overall Study|Physician Decision|3|||
13247773|NCT01593787|26359540|FG000|Overall Study|Adverse Event|1|||
13247774|NCT01593787|26359541|FG001|Overall Study|Adverse Event|0|||
13247775|NCT01593787|26359542|FG002|Overall Study|Adverse Event|0|||
13247776|NCT01593761|26359554|FG000|Overall Study|Lost to Follow-up|1|||
13247777|NCT01593761|26359554|FG000|Overall Study|culture negative for MRSA at baseline|5|||
13247778|NCT01593761|26359554|FG000|Overall Study|positive for hepatitis C virus|1|||
13247779|NCT01593761|26359554|FG000|Overall Study|secondary cellulitis|1|||
13247780|NCT01593696|26359601|FG000|Dose Escalation|Progressive Disease|2|||
13247781|NCT01593696|26359602|FG001|Dose Escalation|Progressive Disease|0|||
13247782|NCT01593696|26359603|FG002|Dose Escalation|Progressive Disease|0|||
13247783|NCT01593696|26359604|FG003|Dose Escalation|Progressive Disease|0|||
13247784|NCT01593696|26359601|FG000|Dose Expansion|Fungal infection|0|||
13247785|NCT01593696|26359602|FG001|Dose Expansion|Fungal infection|0|||
13247786|NCT01593696|26359603|FG002|Dose Expansion|Fungal infection|1|||
13247787|NCT01593696|26359604|FG003|Dose Expansion|Fungal infection|0|||
13247788|NCT01593020|26359621|FG000|Overall Study|Adverse Event|1|||
13247789|NCT01593020|26359622|FG001|Overall Study|Adverse Event|1|||
13247790|NCT01593020|26359621|FG000|Overall Study|Death|0|||
13247791|NCT01593020|26359622|FG001|Overall Study|Death|1|||
13247792|NCT01593020|26359621|FG000|Overall Study|Ineligible|1|||
13247793|NCT01593020|26359622|FG001|Overall Study|Ineligible|0|||
13247794|NCT01592864|26359641|FG000|Overall Study|Withdrawal by Subject|0|||
13247795|NCT01592864|26359642|FG001|Overall Study|Withdrawal by Subject|1|||
13247796|NCT01592786|26359648|FG000|Overall Study|Adverse Event|60|||
13247797|NCT01592786|26359648|FG000|Overall Study|Lack of Efficacy|19|||
13247798|NCT01592786|26359648|FG000|Overall Study|Protocol Violation|14|||
13247799|NCT01592786|26359648|FG000|Overall Study|Withdrawal by Subject|23|||
13247800|NCT01592786|26359648|FG000|Overall Study|Lost to Follow-up|19|||
13247801|NCT01592786|26359648|FG000|Overall Study|Other|3|||
13247802|NCT01592773|26359654|FG000|Overall Study|Study Terminated by Sponsor|582|||
13247803|NCT01592773|26359654|FG000|Overall Study|Withdrawal by Subject|35|||
13247804|NCT01592773|26359654|FG000|Overall Study|Lost to Follow-up|19|||
13247805|NCT01592773|26359654|FG000|Overall Study|Adverse Event|17|||
13247806|NCT01592773|26359654|FG000|Overall Study|Lack of Efficacy|9|||
13247807|NCT01592773|26359654|FG000|Overall Study|Protocol Violation|2|||
13247808|NCT01592773|26359654|FG000|Overall Study|Inclusion/exclusion not meet|1|||
13247809|NCT01592773|26359654|FG000|Overall Study|Other Reason|1|||
13247810|NCT01592760|26359705|FG000|24-hour Follow-Up|Lost to Follow-up|4|||
13247811|NCT01592760|26359706|FG001|24-hour Follow-Up|Lost to Follow-up|3|||
13247812|NCT01592760|26359707|FG002|24-hour Follow-Up|Lost to Follow-up|2|||
13247813|NCT01592747|26359758|FG000|Overall Study|Loss of Therapeutic Response|107|||
13247814|NCT01592747|26359759|FG001|Overall Study|Loss of Therapeutic Response|108|||
13247815|NCT01592747|26359760|FG002|Overall Study|Loss of Therapeutic Response|100|||
13247816|NCT01592747|26359758|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
13247817|NCT01592747|26359759|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
13247818|NCT01592747|26359760|FG002|Overall Study|Inclusion/Exclusion criteria not met|1|||
13247819|NCT01592747|26359758|FG000|Overall Study|Adverse Event|1|||
13247820|NCT01592747|26359759|FG001|Overall Study|Adverse Event|0|||
13247821|NCT01592747|26359760|FG002|Overall Study|Adverse Event|0|||
13247822|NCT01592747|26359758|FG000|Overall Study|Protocol Violation|4|||
13247823|NCT01592747|26359759|FG001|Overall Study|Protocol Violation|0|||
13247824|NCT01592747|26359760|FG002|Overall Study|Protocol Violation|4|||
13247825|NCT01592747|26359758|FG000|Overall Study|Lack of Efficacy|0|||
13247826|NCT01592747|26359759|FG001|Overall Study|Lack of Efficacy|1|||
13247827|NCT01592747|26359760|FG002|Overall Study|Lack of Efficacy|0|||
13247828|NCT01592747|26359758|FG000|Overall Study|Withdrawal by Subject|2|||
13247829|NCT01592747|26359759|FG001|Overall Study|Withdrawal by Subject|0|||
13247830|NCT01592747|26359760|FG002|Overall Study|Withdrawal by Subject|2|||
13247831|NCT01592747|26359758|FG000|Overall Study|Lost to Follow-up|1|||
13247832|NCT01592747|26359759|FG001|Overall Study|Lost to Follow-up|0|||
13247833|NCT01592747|26359760|FG002|Overall Study|Lost to Follow-up|1|||
13247834|NCT01592747|26359758|FG000|Overall Study|Other Reasons|1|||
13247835|NCT01592747|26359759|FG001|Overall Study|Other Reasons|1|||
13247836|NCT01592747|26359760|FG002|Overall Study|Other Reasons|0|||
13247837|NCT01592721|26359770|FG000|Long-term Follow-up|Death|1|||
13247838|NCT01592708|26359791|FG000|Overall Study|Protocol Violation|3|||
13247839|NCT01592708|26359792|FG001|Overall Study|Protocol Violation|0|||
13247840|NCT01592695|26359817|FG000|Overall Study|Lost to Follow-up|8|||
13247841|NCT01592695|26359818|FG001|Overall Study|Lost to Follow-up|4|||
13247842|NCT01592409|26359831|FG000|Overall Study|Withdrawal by Subject|0|||
13247843|NCT01592409|26359832|FG001|Overall Study|Withdrawal by Subject|1|||
13247844|NCT01592383|26359843|FG000|Overall Study|Adverse Event|1|||
13247845|NCT01592370|26359977|FG000|Overall Study|Disease Progression|62|||
13247846|NCT01592370|26359978|FG001|Overall Study|Disease Progression|16|||
13247847|NCT01592370|26359979|FG002|Overall Study|Disease Progression|52|||
13247848|NCT01592370|26359980|FG003|Overall Study|Disease Progression|3|||
13247849|NCT01592370|26359981|FG004|Overall Study|Disease Progression|3|||
13247850|NCT01592370|26359982|FG005|Overall Study|Disease Progression|31|||
13247851|NCT01592370|26359983|FG006|Overall Study|Disease Progression|14|||
13247852|NCT01592370|26359977|FG000|Overall Study|Study Drug Toxicity|14|||
13247853|NCT01592370|26359978|FG001|Overall Study|Study Drug Toxicity|3|||
13247854|NCT01592370|26359979|FG002|Overall Study|Study Drug Toxicity|0|||
13247855|NCT01592370|26359980|FG003|Overall Study|Study Drug Toxicity|0|||
13247856|NCT01592370|26359981|FG004|Overall Study|Study Drug Toxicity|0|||
13247857|NCT01592370|26359982|FG005|Overall Study|Study Drug Toxicity|0|||
13247858|NCT01592370|26359983|FG006|Overall Study|Study Drug Toxicity|1|||
13247859|NCT01592370|26359977|FG000|Overall Study|AE unrelated to study drug|4|||
13247860|NCT01592370|26359978|FG001|Overall Study|AE unrelated to study drug|3|||
13247861|NCT01592370|26359979|FG002|Overall Study|AE unrelated to study drug|0|||
13247862|NCT01592370|26359980|FG003|Overall Study|AE unrelated to study drug|0|||
13247863|NCT01592370|26359981|FG004|Overall Study|AE unrelated to study drug|0|||
13247864|NCT01592370|26359982|FG005|Overall Study|AE unrelated to study drug|0|||
13247865|NCT01592370|26359983|FG006|Overall Study|AE unrelated to study drug|1|||
13247866|NCT01592370|26359977|FG000|Overall Study|Request to discontinue study treatment|5|||
13247867|NCT01592370|26359978|FG001|Overall Study|Request to discontinue study treatment|0|||
13247868|NCT01592370|26359979|FG002|Overall Study|Request to discontinue study treatment|2|||
13247869|NCT01592370|26359980|FG003|Overall Study|Request to discontinue study treatment|0|||
13247870|NCT01592370|26359981|FG004|Overall Study|Request to discontinue study treatment|1|||
13247871|NCT01592370|26359982|FG005|Overall Study|Request to discontinue study treatment|2|||
13247872|NCT01592370|26359983|FG006|Overall Study|Request to discontinue study treatment|0|||
13247873|NCT01592370|26359977|FG000|Overall Study|Withdrew consent|1|||
13247874|NCT01592370|26359978|FG001|Overall Study|Withdrew consent|2|||
13247875|NCT01592370|26359979|FG002|Overall Study|Withdrew consent|1|||
13247876|NCT01592370|26359980|FG003|Overall Study|Withdrew consent|1|||
13247877|NCT01592370|26359981|FG004|Overall Study|Withdrew consent|0|||
13247878|NCT01592370|26359982|FG005|Overall Study|Withdrew consent|0|||
13247879|NCT01592370|26359983|FG006|Overall Study|Withdrew consent|0|||
13247880|NCT01592370|26359977|FG000|Overall Study|Maximum clinical benefit|11|||
13247881|NCT01592370|26359978|FG001|Overall Study|Maximum clinical benefit|1|||
13247882|NCT01592370|26359979|FG002|Overall Study|Maximum clinical benefit|7|||
13247883|NCT01592370|26359980|FG003|Overall Study|Maximum clinical benefit|1|||
13247884|NCT01592370|26359981|FG004|Overall Study|Maximum clinical benefit|0|||
13247885|NCT01592370|26359982|FG005|Overall Study|Maximum clinical benefit|0|||
13247886|NCT01592370|26359983|FG006|Overall Study|Maximum clinical benefit|0|||
13247887|NCT01592370|26359977|FG000|Overall Study|No longer meets study criteria|1|||
13247888|NCT01592370|26359978|FG001|Overall Study|No longer meets study criteria|0|||
13247889|NCT01592370|26359979|FG002|Overall Study|No longer meets study criteria|0|||
13247890|NCT01592370|26359980|FG003|Overall Study|No longer meets study criteria|0|||
13247891|NCT01592370|26359981|FG004|Overall Study|No longer meets study criteria|0|||
13247892|NCT01592370|26359982|FG005|Overall Study|No longer meets study criteria|0|||
13247893|NCT01592370|26359983|FG006|Overall Study|No longer meets study criteria|0|||
13247894|NCT01592370|26359977|FG000|Overall Study|Other Reasons|6|||
13247895|NCT01592370|26359978|FG001|Overall Study|Other Reasons|0|||
13247896|NCT01592370|26359979|FG002|Overall Study|Other Reasons|10|||
13247897|NCT01592370|26359980|FG003|Overall Study|Other Reasons|0|||
13247898|NCT01592370|26359981|FG004|Overall Study|Other Reasons|0|||
13247899|NCT01592370|26359982|FG005|Overall Study|Other Reasons|1|||
13247900|NCT01592370|26359983|FG006|Overall Study|Other Reasons|0|||
13247901|NCT01592344|26360002|FG000|Overall Study|Adverse Event|1|||
13247902|NCT01592344|26360003|FG001|Overall Study|Adverse Event|1|||
13247903|NCT01592344|26360002|FG000|Overall Study|Lack of Efficacy|1|||
13247904|NCT01592344|26360003|FG001|Overall Study|Lack of Efficacy|0|||
13247905|NCT01592344|26360002|FG000|Overall Study|not available at primary outcome visit|2|||
13247906|NCT01592344|26360003|FG001|Overall Study|not available at primary outcome visit|4|||
13247907|NCT01592292|26360044|FG000|Overall Study|Follow-up loss|3|||
13247908|NCT01592292|26360045|FG001|Overall Study|Follow-up loss|3|||
13247909|NCT01592292|26360046|FG002|Overall Study|Follow-up loss|1|||
13247910|NCT01592292|26360047|FG003|Overall Study|Follow-up loss|0|||
13247911|NCT01592292|26360044|FG000|Overall Study|Withdrew consent|2|||
13247912|NCT01592292|26360045|FG001|Overall Study|Withdrew consent|1|||
13247913|NCT01592292|26360046|FG002|Overall Study|Withdrew consent|0|||
13247914|NCT01592292|26360047|FG003|Overall Study|Withdrew consent|0|||
13247915|NCT01592292|26360044|FG000|Overall Study|Other|1|||
13247916|NCT01592292|26360045|FG001|Overall Study|Other|1|||
13247917|NCT01592292|26360046|FG002|Overall Study|Other|2|||
13247918|NCT01592292|26360047|FG003|Overall Study|Other|1|||
13247919|NCT01592240|26360249|FG000|Overall Study|Adverse Event|1|||
13247920|NCT01592240|26360250|FG001|Overall Study|Adverse Event|0|||
13247921|NCT01592240|26360251|FG002|Overall Study|Adverse Event|0|||
13247922|NCT01592240|26360252|FG003|Overall Study|Adverse Event|1|||
13247923|NCT01592240|26360253|FG004|Overall Study|Adverse Event|1|||
13247924|NCT01592240|26360254|FG005|Overall Study|Adverse Event|0|||
13247925|NCT01592240|26360255|FG006|Overall Study|Adverse Event|0|||
13247926|NCT01592240|26360249|FG000|Overall Study|Death|0|||
13247927|NCT01592240|26360250|FG001|Overall Study|Death|1|||
13247928|NCT01592240|26360251|FG002|Overall Study|Death|0|||
13247929|NCT01592240|26360252|FG003|Overall Study|Death|0|||
13247930|NCT01592240|26360253|FG004|Overall Study|Death|0|||
13247931|NCT01592240|26360254|FG005|Overall Study|Death|0|||
13247932|NCT01592240|26360255|FG006|Overall Study|Death|0|||
13247933|NCT01592240|26360249|FG000|Overall Study|Lost to Follow-up|1|||
13247934|NCT01592240|26360250|FG001|Overall Study|Lost to Follow-up|3|||
13247935|NCT01592240|26360251|FG002|Overall Study|Lost to Follow-up|1|||
13247936|NCT01592240|26360252|FG003|Overall Study|Lost to Follow-up|0|||
13247937|NCT01592240|26360253|FG004|Overall Study|Lost to Follow-up|3|||
13247938|NCT01592240|26360254|FG005|Overall Study|Lost to Follow-up|2|||
13247939|NCT01592240|26360255|FG006|Overall Study|Lost to Follow-up|0|||
13247940|NCT01592240|26360249|FG000|Overall Study|Protocol Violation|0|||
13247941|NCT01592240|26360250|FG001|Overall Study|Protocol Violation|0|||
13247942|NCT01592240|26360251|FG002|Overall Study|Protocol Violation|0|||
13247943|NCT01592240|26360252|FG003|Overall Study|Protocol Violation|0|||
13247944|NCT01592240|26360253|FG004|Overall Study|Protocol Violation|0|||
13247945|NCT01592240|26360254|FG005|Overall Study|Protocol Violation|1|||
13247946|NCT01592240|26360255|FG006|Overall Study|Protocol Violation|0|||
13247947|NCT01592240|26360249|FG000|Overall Study|Withdrawal by Subject|0|||
13247948|NCT01592240|26360250|FG001|Overall Study|Withdrawal by Subject|4|||
13247949|NCT01592240|26360251|FG002|Overall Study|Withdrawal by Subject|4|||
13247950|NCT01592240|26360252|FG003|Overall Study|Withdrawal by Subject|1|||
13247951|NCT01592240|26360253|FG004|Overall Study|Withdrawal by Subject|3|||
13247952|NCT01592240|26360254|FG005|Overall Study|Withdrawal by Subject|0|||
13247953|NCT01592240|26360255|FG006|Overall Study|Withdrawal by Subject|2|||
13247954|NCT01592240|26360249|FG000|Overall Study|Other|0|||
13247955|NCT01592240|26360250|FG001|Overall Study|Other|3|||
13247956|NCT01592240|26360251|FG002|Overall Study|Other|1|||
13247957|NCT01592240|26360252|FG003|Overall Study|Other|1|||
13247958|NCT01592240|26360253|FG004|Overall Study|Other|0|||
13247959|NCT01592240|26360254|FG005|Overall Study|Other|0|||
13247960|NCT01592240|26360255|FG006|Overall Study|Other|1|||
13247961|NCT01592240|26360249|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
13247962|NCT01592240|26360250|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
13247963|NCT01592240|26360251|FG002|Overall Study|Did Not Meet Entrance Criteria|1|||
13247964|NCT01592240|26360252|FG003|Overall Study|Did Not Meet Entrance Criteria|0|||
13247965|NCT01592240|26360253|FG004|Overall Study|Did Not Meet Entrance Criteria|0|||
13247966|NCT01592240|26360254|FG005|Overall Study|Did Not Meet Entrance Criteria|0|||
13247967|NCT01592240|26360255|FG006|Overall Study|Did Not Meet Entrance Criteria|0|||
13247968|NCT01592045|26360270|FG000|Overall Study|Disease Progression|1|||
13247969|NCT01592045|26360271|FG001|Overall Study|Disease Progression|1|||
13247970|NCT01592045|26360270|FG000|Overall Study|Adverse Event|1|||
13247971|NCT01592045|26360271|FG001|Overall Study|Adverse Event|1|||
13247972|NCT01592045|26360270|FG000|Overall Study|Withdrawal by Subject|1|||
13247973|NCT01592045|26360271|FG001|Overall Study|Withdrawal by Subject|0|||
13247974|NCT01592045|26360270|FG000|Overall Study|Moved out of country|2|||
13247975|NCT01592045|26360271|FG001|Overall Study|Moved out of country|0|||
13247976|NCT01591863|26360283|FG000|Overall Study|Adverse Event|3|||
13247977|NCT01591863|26360283|FG000|Overall Study|Withdrawal by Subject|1|||
13247978|NCT01591863|26360283|FG000|Overall Study|recurrence|9|||
13247979|NCT01591863|26360283|FG000|Overall Study|Lack of Efficacy|1|||
13247980|NCT01591785|26360302|FG000|Overall Study|worsening condition|1|||
13247981|NCT01591785|26360303|FG001|Overall Study|worsening condition|2|||
13247982|NCT01591785|26360302|FG000|Overall Study|Protocol Violation|2|||
13247983|NCT01591785|26360303|FG001|Overall Study|Protocol Violation|0|||
13247984|NCT01591785|26360302|FG000|Overall Study|Lost to Follow-up|1|||
13247985|NCT01591785|26360303|FG001|Overall Study|Lost to Follow-up|0|||
13247986|NCT01591681|26360331|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3|||
13247987|NCT01591681|26360331|FG000|Overall Study|Failed to use system during run-in|1|||
13247988|NCT01591616|26360472|FG000|Overall Study|Withdrawal by Subject|1|||
13247989|NCT01591499|26360547|FG000|Baseline Visit|Withdrawal by Subject|0|||
13247990|NCT01591499|26360548|FG001|Baseline Visit|Withdrawal by Subject|2|||
13247991|NCT01591499|26360549|FG002|Baseline Visit|Withdrawal by Subject|0|||
13247992|NCT01591499|26360550|FG003|Baseline Visit|Withdrawal by Subject|2|||
13247993|NCT01591499|26360547|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
13247994|NCT01591499|26360548|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
13247995|NCT01591499|26360549|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
13247996|NCT01591499|26360550|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
13247997|NCT01591499|26360547|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4|||
13247998|NCT01591499|26360548|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
13247999|NCT01591499|26360549|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1|||
13248000|NCT01591499|26360550|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
13248001|NCT01591460|26360632|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
13248002|NCT01591460|26360632|FG000|Overall Study|Futility Rule (Week 12)|7|||
13248003|NCT01591460|26360632|FG000|Overall Study|Futility Rule (Week 24)|3|||
13248004|NCT01591460|26360632|FG000|Overall Study|Rebound or Breakthrough|3|||
13248005|NCT01591460|26360632|FG000|Overall Study|Treatment Discontinued by Error|1|||
13248006|NCT01591460|26360632|FG000|Overall Study|Lost to Follow-up|1|||
13248007|NCT01591460|26360632|FG000|Overall Study|Noncompliance|1|||
13248008|NCT01591460|26360632|FG000|Overall Study|Participant Refusal|3|||
13248009|NCT01591460|26360632|FG000|Overall Study|Withdrawal by Subject|1|||
13248010|NCT01591460|26360632|FG000|Overall Study|Protocol Violation|1|||
13248011|NCT01591382|26360653|FG000|Overall Study|Discharged Prior to Study Completion|2|||
13248012|NCT01591382|26360654|FG001|Overall Study|Discharged Prior to Study Completion|1|||
13248013|NCT01591382|26360653|FG000|Overall Study|Participant Opted for Morphine PCA|1|||
13248014|NCT01591382|26360654|FG001|Overall Study|Participant Opted for Morphine PCA|1|||
13248015|NCT01591330|26360713|FG000|Period 1|Adverse Event|1|||
13248016|NCT01591330|26360714|FG001|Period 1|Adverse Event|0|||
13248017|NCT01591330|26360715|FG002|Period 1|Adverse Event|0|||
13248018|NCT01591330|26360716|FG003|Period 1|Adverse Event|0|||
13248019|NCT01591330|26360713|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1|||
13248020|NCT01591330|26360714|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0|||
13248021|NCT01591330|26360715|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0|||
13248022|NCT01591330|26360716|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0|||
13248023|NCT01591330|26360713|FG000|Period 2|Adverse Event|1|||
13248024|NCT01591330|26360714|FG001|Period 2|Adverse Event|0|||
13248025|NCT01591330|26360715|FG002|Period 2|Adverse Event|0|||
13248026|NCT01591330|26360716|FG003|Period 2|Adverse Event|0|||
13248027|NCT01591096|26360724|FG000|Overall Study|Adverse Event|1|||
13248028|NCT01590888|26360778|FG000|Overall Study|Adverse Event|3|||
13248029|NCT01590888|26360779|FG001|Overall Study|Adverse Event|0|||
13248030|NCT01590888|26360780|FG002|Overall Study|Adverse Event|1|||
13248031|NCT01590888|26360778|FG000|Overall Study|Lost to Follow-up|1|||
13248032|NCT01590888|26360779|FG001|Overall Study|Lost to Follow-up|0|||
13248033|NCT01590888|26360780|FG002|Overall Study|Lost to Follow-up|0|||
13248034|NCT01590810|26360939|FG000|Overall Study|Physician Decision|0|||
13248035|NCT01590810|26360940|FG001|Overall Study|Physician Decision|1|||
13248036|NCT01590810|26360941|FG002|Overall Study|Physician Decision|1|||
13248037|NCT01590810|26360942|FG003|Overall Study|Physician Decision|0|||
13248038|NCT01590810|26360943|FG004|Overall Study|Physician Decision|0|||
13248039|NCT01590797|26360964|FG000|Overall Study|Adverse Event|4|||
13248040|NCT01590797|26360965|FG001|Overall Study|Adverse Event|3|||
13248041|NCT01590797|26360964|FG000|Overall Study|Lack of Efficacy|0|||
13248042|NCT01590797|26360965|FG001|Overall Study|Lack of Efficacy|2|||
13248043|NCT01590797|26360964|FG000|Overall Study|Lost to Follow-up|0|||
13248044|NCT01590797|26360965|FG001|Overall Study|Lost to Follow-up|1|||
13248045|NCT01590797|26360964|FG000|Overall Study|Protocol Violation|4|||
13248046|NCT01590797|26360965|FG001|Overall Study|Protocol Violation|1|||
13248047|NCT01590797|26360964|FG000|Overall Study|Withdrawal by Subject|7|||
13248048|NCT01590797|26360965|FG001|Overall Study|Withdrawal by Subject|5|||
13248049|NCT01590797|26360964|FG000|Overall Study|Other Protocol Specified Criteria|2|||
13248050|NCT01590797|26360965|FG001|Overall Study|Other Protocol Specified Criteria|4|||
13248051|NCT01590771|26360998|FG000|Overall Study|Other Protocol Specified Criteria|5|||
13248052|NCT01590771|26360999|FG001|Overall Study|Other Protocol Specified Criteria|14|||
13248053|NCT01590771|26360998|FG000|Overall Study|Withdrawal by Subject|8|||
13248054|NCT01590771|26360999|FG001|Overall Study|Withdrawal by Subject|15|||
13248055|NCT01590771|26360998|FG000|Overall Study|Protocol Violation|1|||
13248056|NCT01590771|26360999|FG001|Overall Study|Protocol Violation|2|||
13248057|NCT01590771|26360998|FG000|Overall Study|Lost to Follow-up|1|||
13248058|NCT01590771|26360999|FG001|Overall Study|Lost to Follow-up|1|||
13248059|NCT01590771|26360998|FG000|Overall Study|Lack of Efficacy|1|||
13248060|NCT01590771|26360999|FG001|Overall Study|Lack of Efficacy|0|||
13248061|NCT01590771|26360998|FG000|Overall Study|Adverse Event|3|||
13248062|NCT01590771|26360999|FG001|Overall Study|Adverse Event|7|||
13248063|NCT01590758|26361016|FG000|Overall Study|Withdrawal by Subject|0|||
13248064|NCT01590758|26361017|FG001|Overall Study|Withdrawal by Subject|3|||
13248065|NCT01590758|26361016|FG000|Overall Study|Physician Decision|1|||
13248066|NCT01590758|26361017|FG001|Overall Study|Physician Decision|2|||
13248067|NCT01590758|26361016|FG000|Overall Study|Lost to Follow-up|4|||
13248068|NCT01590758|26361017|FG001|Overall Study|Lost to Follow-up|2|||
13248069|NCT01590628|26361038|FG000|Overall Study|Death|2|||
13248070|NCT01590628|26361039|FG001|Overall Study|Death|0|||
13248071|NCT01590563|26361047|FG000|Overall Study|simple uterine hyperplasia - not related|1|||
13248072|NCT01590433|26361060|FG000|Overall Study|Lost to Follow-up|20|||
13248073|NCT01590433|26361061|FG001|Overall Study|Lost to Follow-up|8|||
13248074|NCT01590433|26361060|FG000|Overall Study|Withdrawal by Subject|21|||
13248075|NCT01590433|26361061|FG001|Overall Study|Withdrawal by Subject|11|||
13248076|NCT01590433|26361060|FG000|Overall Study|Adverse Event|11|||
13248077|NCT01590433|26361061|FG001|Overall Study|Adverse Event|3|||
13248078|NCT01590212|26361088|FG000|Overall Study|Withdrawal by Subject|2|||
13248079|NCT01590212|26361089|FG001|Overall Study|Withdrawal by Subject|2|||
13248080|NCT01590212|26361090|FG002|Overall Study|Withdrawal by Subject|2|||
13248081|NCT01590212|26361088|FG000|Overall Study|Lost to Follow-up|1|||
13248082|NCT01590212|26361089|FG001|Overall Study|Lost to Follow-up|2|||
13248083|NCT01590212|26361090|FG002|Overall Study|Lost to Follow-up|3|||
13248084|NCT01590082|26361103|FG000|Overall Study|Withdrawal by Subject|1|||
13248085|NCT01590082|26361104|FG001|Overall Study|Withdrawal by Subject|0|||
13248086|NCT01590082|26361103|FG000|Overall Study|Ineligible|1|||
13248087|NCT01590082|26361104|FG001|Overall Study|Ineligible|0|||
13248088|NCT01590017|26361111|FG000|Overall Study|Adverse Event|1|||
13248089|NCT01590017|26361111|FG000|Overall Study|Withdrawal by Subject|1|||
13248090|NCT01590017|26361111|FG000|Overall Study|Lack of Efficacy|1|||
13248091|NCT01590017|26361111|FG000|Overall Study|Physician Decision|1|||
13248092|NCT01589822|26361138|FG000|Overall Study|Withdrawal by Subject|1|||
13248093|NCT01589822|26361139|FG001|Overall Study|Withdrawal by Subject|2|||
13248094|NCT01589822|26361140|FG002|Overall Study|Withdrawal by Subject|0|||
13248095|NCT01589822|26361138|FG000|Overall Study|Death|1|||
13248096|NCT01589822|26361139|FG001|Overall Study|Death|0|||
13248097|NCT01589822|26361140|FG002|Overall Study|Death|0|||
13248098|NCT01589822|26361138|FG000|Overall Study|Missed 90 day visit|2|||
13248099|NCT01589822|26361139|FG001|Overall Study|Missed 90 day visit|1|||
13248100|NCT01589822|26361140|FG002|Overall Study|Missed 90 day visit|1|||
13248101|NCT01589770|26361155|FG000|Overall Study|EGFR <60ml/min|6|||
13248102|NCT01589770|26361156|FG001|Overall Study|EGFR <60ml/min|4|||
13248103|NCT01589770|26361155|FG000|Overall Study|claustrophobic when entering cardiac MRI|2|||
13248104|NCT01589770|26361156|FG001|Overall Study|claustrophobic when entering cardiac MRI|1|||
13248105|NCT01589653|26361177|FG000|Overall Study|Protocol Violation|3|||
13248106|NCT01589653|26361178|FG001|Overall Study|Protocol Violation|1|||
13248107|NCT01589653|26361177|FG000|Overall Study|Withdrawal criteria|4|||
13248108|NCT01589653|26361178|FG001|Overall Study|Withdrawal criteria|7|||
13248109|NCT01589653|26361177|FG000|Overall Study|Unclassified|0|||
13248110|NCT01589653|26361178|FG001|Overall Study|Unclassified|3|||
13248111|NCT01589497|26361292|FG000|Overall Study|Withdrawal by Subject|0|||
13248112|NCT01589497|26361293|FG001|Overall Study|Withdrawal by Subject|1|||
13248113|NCT01589497|26361294|FG002|Overall Study|Withdrawal by Subject|0|||
13248114|NCT01589497|26361295|FG003|Overall Study|Withdrawal by Subject|1|||
13248115|NCT01589497|26361292|FG000|Overall Study|Death|1|||
13248116|NCT01589497|26361293|FG001|Overall Study|Death|0|||
13248117|NCT01589497|26361294|FG002|Overall Study|Death|0|||
13248118|NCT01589497|26361295|FG003|Overall Study|Death|0|||
13248119|NCT01589497|26361292|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0|||
13248120|NCT01589497|26361293|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0|||
13248121|NCT01589497|26361294|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1|||
13485849|NCT00585195|27033425|FG015|Overall Study|Withdrawn Due to Pregnancy|0|||
13485850|NCT00585195|27033426|FG016|Overall Study|Withdrawn Due to Pregnancy|0|||
13485851|NCT00585195|27033427|FG017|Overall Study|Withdrawn Due to Pregnancy|0|||
13485852|NCT00585195|27033428|FG018|Overall Study|Withdrawn Due to Pregnancy|0|||
13485853|NCT00585195|27033429|FG019|Overall Study|Withdrawn Due to Pregnancy|0|||
13485854|NCT00585195|27033430|FG020|Overall Study|Withdrawn Due to Pregnancy|0|||
13485855|NCT04446429|27033443|FG000|Overall Study|Lost to Follow-up|6|||
13485856|NCT04446429|27033444|FG001|Overall Study|Lost to Follow-up|0|||
13488001|NCT01111565|27041931|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1|||
13488002|NCT01111565|27041932|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
13488003|NCT01111565|27041933|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
13488004|NCT01111565|27041934|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
13488005|NCT01111565|27041935|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
13488006|NCT01111565|27041931|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
13488007|NCT01111565|27041932|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
13488008|NCT01111565|27041933|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
13488009|NCT01111565|27041934|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
13488010|NCT01111565|27041935|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
13488011|NCT01111565|27041931|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
13488012|NCT01111565|27041932|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
13488013|NCT01111565|27041933|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2|||
13488014|NCT01111565|27041934|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
13488015|NCT01111565|27041935|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
13488016|NCT01111565|27041931|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
13488017|NCT01111565|27041932|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
13488018|NCT01111565|27041933|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
13488019|NCT01111565|27041934|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2|||
13488020|NCT01111565|27041935|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
13488021|NCT01111565|27041931|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
13488022|NCT01111565|27041932|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
13488023|NCT01111565|27041933|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
13488024|NCT01111565|27041934|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1|||
13488025|NCT01111565|27041935|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
13116375|NCT03075761|25922481|FG000|Overall Study|Lost to Follow-up|1|||
13248122|NCT01589497|26361295|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0|||
13248123|NCT01589445|26361313|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1|||
13248124|NCT01589445|26361313|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1|||
13248125|NCT01589445|26361313|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2|||
13248126|NCT01589445|26361313|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1|||
13248127|NCT01589445|26361313|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2|||
13248128|NCT01589445|26361313|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1|||
13248129|NCT01589445|26361313|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2|||
13248130|NCT01589445|26361313|FG000|002 (Metformin)-3 Months|Protocol Violation|2|||
13248131|NCT01589445|26361313|FG000|002 (Metformin)-3 Months|Adverse Event|2|||
13248132|NCT01589445|26361313|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2|||
13290118|NCT00104416|26480777|FG000|Double-Blind Phase|Participant Did Not Take Drug|3|||
13290119|NCT00104416|26480778|FG001|Double-Blind Phase|Participant Did Not Take Drug|4|||
13290120|NCT00104416|26480779|FG002|Double-Blind Phase|Participant Did Not Take Drug|0|||
13290121|NCT00104416|26480780|FG003|Double-Blind Phase|Participant Did Not Take Drug|0|||
13290122|NCT00104416|26480781|FG004|Double-Blind Phase|Participant Did Not Take Drug|0|||
13290123|NCT00104416|26480777|FG000|Continuation Phase|Adverse Event|0|||
13290124|NCT00104416|26480778|FG001|Continuation Phase|Adverse Event|0|||
13290125|NCT00104416|26480779|FG002|Continuation Phase|Adverse Event|2|||
13290126|NCT00104416|26480780|FG003|Continuation Phase|Adverse Event|0|||
13290127|NCT00104416|26480781|FG004|Continuation Phase|Adverse Event|2|||
13290128|NCT00104416|26480777|FG000|Continuation Phase|Lost to Follow-up|0|||
13290129|NCT00104416|26480778|FG001|Continuation Phase|Lost to Follow-up|0|||
13290130|NCT00104416|26480779|FG002|Continuation Phase|Lost to Follow-up|1|||
13290131|NCT00104416|26480780|FG003|Continuation Phase|Lost to Follow-up|0|||
13290132|NCT00104416|26480781|FG004|Continuation Phase|Lost to Follow-up|1|||
13290133|NCT00104416|26480777|FG000|Continuation Phase|Withdrawal by Subject|0|||
13290134|NCT00104416|26480778|FG001|Continuation Phase|Withdrawal by Subject|0|||
13116376|NCT03075761|25922482|FG001|Overall Study|Lost to Follow-up|6|||
13116377|NCT03075644|25922550|FG000|Overall Study|Withdrawal by Subject|1|||
13116378|NCT03075644|25922551|FG001|Overall Study|Withdrawal by Subject|1|||
13116379|NCT03075527|25922557|FG000|Overall Study|Ongoing treatment|2|||
13290135|NCT00104416|26480779|FG002|Continuation Phase|Withdrawal by Subject|2|||
13116380|NCT03075501|25922572|FG000|Overall Study|Scheduling difficulties|15|||
13116381|NCT03075501|25922573|FG001|Overall Study|Scheduling difficulties|9|||
13116382|NCT03075410|25922765|FG000|Part A-Period 2 (14 Days)|Personal reasons|1|||
13116383|NCT03075410|25922766|FG001|Part A-Period 2 (14 Days)|Personal reasons|0|||
13116384|NCT03075410|25922767|FG002|Part A-Period 2 (14 Days)|Personal reasons|1|||
13116385|NCT03075410|25922768|FG003|Part A-Period 2 (14 Days)|Personal reasons|0|||
13290136|NCT00104416|26480780|FG003|Continuation Phase|Withdrawal by Subject|1|||
13290137|NCT00104416|26480781|FG004|Continuation Phase|Withdrawal by Subject|1|||
13290138|NCT00104416|26480777|FG000|Continuation Phase|Pregnancy|0|||
13290139|NCT00104416|26480778|FG001|Continuation Phase|Pregnancy|0|||
13290140|NCT00104416|26480779|FG002|Continuation Phase|Pregnancy|1|||
13290141|NCT00104416|26480780|FG003|Continuation Phase|Pregnancy|1|||
13290142|NCT00104416|26480781|FG004|Continuation Phase|Pregnancy|0|||
13290143|NCT00104416|26480777|FG000|Continuation Phase|Non-compliance|0|||
13290144|NCT00104416|26480778|FG001|Continuation Phase|Non-compliance|0|||
13290145|NCT00104416|26480779|FG002|Continuation Phase|Non-compliance|0|||
13290146|NCT00104416|26480780|FG003|Continuation Phase|Non-compliance|0|||
13307586|NCT01284127|26529141|FG000|Overall Study|Adverse Event|2|||
13307587|NCT01284127|26529141|FG000|Overall Study|Withdrawal by Subject|4|||
13307588|NCT01284127|26529141|FG000|Overall Study|Physician Decision|1|||
13307589|NCT01284114|26529151|FG000|Overall Study|viral infection|1|||
13307590|NCT01284114|26529151|FG000|Overall Study|From the results of ALLTITUDE study|1|||
13307591|NCT01284114|26529151|FG000|Overall Study|Symptomatic hypotension|1|||
13307592|NCT01284114|26529151|FG000|Overall Study|dizziness|1|||
13307593|NCT01284062|26529236|FG000|Overall Study|Adverse Event|4|||
13307594|NCT01284062|26529237|FG001|Overall Study|Adverse Event|5|||
13307595|NCT01284062|26529238|FG002|Overall Study|Adverse Event|0|||
13307596|NCT01284062|26529239|FG003|Overall Study|Adverse Event|5|||
13307597|NCT01284062|26529236|FG000|Overall Study|Lack of Efficacy|3|||
13307598|NCT01284062|26529237|FG001|Overall Study|Lack of Efficacy|2|||
13307599|NCT01284062|26529238|FG002|Overall Study|Lack of Efficacy|2|||
13307600|NCT01284062|26529239|FG003|Overall Study|Lack of Efficacy|1|||
13307601|NCT01284062|26529236|FG000|Overall Study|Medication error without adverse event|0|||
13307602|NCT01284062|26529237|FG001|Overall Study|Medication error without adverse event|0|||
13307603|NCT01284062|26529238|FG002|Overall Study|Medication error without adverse event|1|||
13307604|NCT01284062|26529239|FG003|Overall Study|Medication error without adverse event|0|||
13307605|NCT01284062|26529236|FG000|Overall Study|Protocol Violation|1|||
13307606|NCT01284062|26529237|FG001|Overall Study|Protocol Violation|0|||
13307607|NCT01284062|26529238|FG002|Overall Study|Protocol Violation|0|||
13307608|NCT01284062|26529239|FG003|Overall Study|Protocol Violation|2|||
13290147|NCT00104416|26480781|FG004|Continuation Phase|Non-compliance|1|||
13290148|NCT00104104|26480802|FG000|Overall Study|Adverse Event|8|||
13290149|NCT00104104|26480803|FG001|Overall Study|Adverse Event|8|||
13290150|NCT00104104|26480802|FG000|Overall Study|Abnormal laboratory value(s)|20|||
13290151|NCT00104104|26480803|FG001|Overall Study|Abnormal laboratory value(s)|14|||
13290152|NCT00104104|26480802|FG000|Overall Study|Lack of Efficacy|0|||
13290153|NCT00104104|26480803|FG001|Overall Study|Lack of Efficacy|3|||
13307609|NCT01284062|26529236|FG000|Overall Study|Withdrawal by Subject|3|||
13307610|NCT01284062|26529237|FG001|Overall Study|Withdrawal by Subject|1|||
13307611|NCT01284062|26529238|FG002|Overall Study|Withdrawal by Subject|2|||
13307612|NCT01284062|26529239|FG003|Overall Study|Withdrawal by Subject|5|||
13307613|NCT01284062|26529236|FG000|Overall Study|Other|0|||
13307614|NCT01284062|26529237|FG001|Overall Study|Other|0|||
13307615|NCT01284062|26529238|FG002|Overall Study|Other|0|||
13307616|NCT01284062|26529239|FG003|Overall Study|Other|1|||
13307617|NCT01284062|26529236|FG000|Overall Study|Site Closed|0|||
13307618|NCT01284062|26529237|FG001|Overall Study|Site Closed|0|||
13307619|NCT01284062|26529238|FG002|Overall Study|Site Closed|1|||
13307620|NCT01284062|26529239|FG003|Overall Study|Site Closed|0|||
13307621|NCT01283971|26529290|FG000|Overall Study|Adverse Event|3|||
13307622|NCT01283971|26529291|FG001|Overall Study|Adverse Event|5|||
13307623|NCT01283971|26529290|FG000|Overall Study|Insufficient therapeutic responses|3|||
13307624|NCT01283971|26529291|FG001|Overall Study|Insufficient therapeutic responses|3|||
13307625|NCT01283971|26529290|FG000|Overall Study|Protocol Violation|5|||
13307626|NCT01283971|26529291|FG001|Overall Study|Protocol Violation|1|||
13307627|NCT01283971|26529290|FG000|Overall Study|Refused treatment|3|||
13307628|NCT01283971|26529291|FG001|Overall Study|Refused treatment|1|||
13307629|NCT01283971|26529290|FG000|Overall Study|Failure to return|0|||
13307630|NCT01283971|26529291|FG001|Overall Study|Failure to return|1|||
13307631|NCT01283971|26529290|FG000|Overall Study|Administrative reasons|1|||
13307632|NCT01283971|26529291|FG001|Overall Study|Administrative reasons|1|||
13248133|NCT01589237|26361372|FG000|Part A (52 Weeks)|Subject/guardian decision|2|||
13248134|NCT01589237|26361373|FG001|Part A (52 Weeks)|Subject/guardian decision|3|||
13248135|NCT01589237|26361374|FG002|Part A (52 Weeks)|Subject/guardian decision|2|||
13248136|NCT01589237|26361375|FG003|Part A (52 Weeks)|Subject/guardian decision|0|||
13248137|NCT01589237|26361372|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
13248138|NCT01589237|26361373|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1|||
13248139|NCT01589237|26361374|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
13248140|NCT01589237|26361375|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
13248141|NCT01589237|26361372|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
13248142|NCT01589237|26361373|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
13248143|NCT01589237|26361374|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4|||
13248144|NCT01589237|26361375|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3|||
13248145|NCT01589237|26361372|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
13248146|NCT01589237|26361373|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
13248147|NCT01589237|26361374|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
13248148|NCT01589237|26361375|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1|||
13248149|NCT01589185|26361424|FG000|Overall Study|Death|1|||
13248150|NCT01589185|26361425|FG001|Overall Study|Death|2|||
13248151|NCT01589185|26361426|FG002|Overall Study|Death|2|||
13248152|NCT01589185|26361427|FG003|Overall Study|Death|0|||
13248153|NCT01589185|26361428|FG004|Overall Study|Death|1|||
13248154|NCT01589185|26361424|FG000|Overall Study|Lost to Follow-up|1|||
13248155|NCT01589185|26361425|FG001|Overall Study|Lost to Follow-up|0|||
13248156|NCT01589185|26361426|FG002|Overall Study|Lost to Follow-up|2|||
13248157|NCT01589185|26361427|FG003|Overall Study|Lost to Follow-up|3|||
13248158|NCT01589185|26361428|FG004|Overall Study|Lost to Follow-up|0|||
13248159|NCT01589094|26361437|FG000|Overall Study|Did not receive treatment|2|||
13248160|NCT01588990|26361464|FG000|Phase A|Withdrawal by Subject|5|||
13248161|NCT01588990|26361464|FG000|Phase A|Physician Decision|11|||
13248162|NCT01588990|26361464|FG000|Phase A|Other|14|||
13248163|NCT01588990|26361464|FG000|Phase A|Lost to Follow-up|1|||
13248164|NCT01588990|26361464|FG000|Phase A|Death|5|||
13248165|NCT01588990|26361464|FG000|Phase A|Adverse Event|28|||
13248166|NCT01588990|26361464|FG000|Phase A|Still on therapy at end of study|6|||
13248167|NCT01588990|26361464|FG000|Phase B|Adverse Event|2|||
13248168|NCT01588990|26361464|FG000|Phase B|Still on therapy at end of study|5|||
13248169|NCT01588990|26361464|FG000|Phase B|Withdrawal by Subject|3|||
13248170|NCT01588990|26361464|FG000|Phase B|Physician Decision|4|||
13248171|NCT01588990|26361464|FG000|Phase B|Other|2|||
13248172|NCT01588951|26361482|FG000|Overall Study|Ineligible in retrospect|0|||
13248173|NCT01588951|26361483|FG001|Overall Study|Ineligible in retrospect|0|||
13248174|NCT01588951|26361484|FG002|Overall Study|Ineligible in retrospect|1|||
13248175|NCT01588548|26361517|FG000|Overall Study|Withdrawal by Subject|0|||
13248176|NCT01588548|26361518|FG001|Overall Study|Withdrawal by Subject|1|||
13248177|NCT01588548|26361519|FG002|Overall Study|Withdrawal by Subject|1|||
13248178|NCT01588548|26361520|FG003|Overall Study|Withdrawal by Subject|1|||
13307633|NCT01283581|26529327|FG000|Overall Study|Lost to Follow-up|8|||
13248179|NCT01588548|26361521|FG004|Overall Study|Withdrawal by Subject|2|||
13248180|NCT01588548|26361522|FG005|Overall Study|Withdrawal by Subject|3|||
13248181|NCT01588548|26361517|FG000|Overall Study|Adverse Event|0|||
13248182|NCT01588548|26361518|FG001|Overall Study|Adverse Event|0|||
13248183|NCT01588548|26361519|FG002|Overall Study|Adverse Event|1|||
13307634|NCT01283581|26529328|FG001|Overall Study|Lost to Follow-up|6|||
13248184|NCT01588548|26361520|FG003|Overall Study|Adverse Event|2|||
13248185|NCT01588548|26361521|FG004|Overall Study|Adverse Event|1|||
13248186|NCT01588548|26361522|FG005|Overall Study|Adverse Event|0|||
13248187|NCT01588548|26361517|FG000|Overall Study|Condition Under Investigation Worsened|3|||
13248188|NCT01588548|26361518|FG001|Overall Study|Condition Under Investigation Worsened|6|||
13248189|NCT01588548|26361519|FG002|Overall Study|Condition Under Investigation Worsened|4|||
13248190|NCT01588548|26361520|FG003|Overall Study|Condition Under Investigation Worsened|4|||
13248191|NCT01588548|26361521|FG004|Overall Study|Condition Under Investigation Worsened|3|||
13248192|NCT01588548|26361522|FG005|Overall Study|Condition Under Investigation Worsened|3|||
13248193|NCT01588509|26361549|FG000|Overall Study|Lost to Follow-up|1|||
13248194|NCT01588509|26361550|FG001|Overall Study|Lost to Follow-up|0|||
13248195|NCT01588496|26361585|FG000|Overall Study|Withdrawal by Subject|0|||
13248196|NCT01588496|26361586|FG001|Overall Study|Withdrawal by Subject|1|||
13248197|NCT01588496|26361587|FG002|Overall Study|Withdrawal by Subject|0|||
13248198|NCT01588405|26361613|FG000|Overall Study|Adverse Event|1|||
13248199|NCT01588405|26361613|FG000|Overall Study|Clinical Worsening|1|||
13248200|NCT01588366|26361655|FG000|Overall Study|Adverse Event|0|||
13248201|NCT01588366|26361656|FG001|Overall Study|Adverse Event|1|||
13248202|NCT01588366|26361657|FG002|Overall Study|Adverse Event|0|||
13248203|NCT01588366|26361658|FG003|Overall Study|Adverse Event|1|||
13248204|NCT01588366|26361659|FG004|Overall Study|Adverse Event|0|||
13248205|NCT01588366|26361660|FG005|Overall Study|Adverse Event|2|||
13248206|NCT01588353|26361686|FG000|Step2|Withdrawal by Subject|0|||
13248207|NCT01588353|26361687|FG001|Step2|Withdrawal by Subject|1|||
13248208|NCT01588353|26361688|FG002|Step2|Withdrawal by Subject|0|||
13248209|NCT01588353|26361686|FG000|Step3|Adverse Event|0|||
13248210|NCT01588353|26361687|FG001|Step3|Adverse Event|0|||
13248211|NCT01588353|26361688|FG002|Step3|Adverse Event|2|||
13248212|NCT01588197|26361705|FG000|Overall Study|Lack of Efficacy|0|||
13248213|NCT01588197|26361706|FG001|Overall Study|Lack of Efficacy|1|||
13248214|NCT01588197|26361705|FG000|Overall Study|No MRI|1|||
13248215|NCT01588197|26361706|FG001|Overall Study|No MRI|0|||
13248216|NCT01588184|26361751|FG000|Overall Study|Death|1|||
13248217|NCT01588184|26361752|FG001|Overall Study|Death|0|||
13248218|NCT01588184|26361753|FG002|Overall Study|Death|0|||
13248219|NCT01588184|26361754|FG003|Overall Study|Death|1|||
13248220|NCT01588184|26361755|FG004|Overall Study|Death|1|||
13248221|NCT01588184|26361756|FG005|Overall Study|Death|1|||
13248222|NCT01588184|26361751|FG000|Overall Study|Withdrawal by Subject|2|||
13248223|NCT01588184|26361752|FG001|Overall Study|Withdrawal by Subject|4|||
13248224|NCT01588184|26361753|FG002|Overall Study|Withdrawal by Subject|0|||
13248225|NCT01588184|26361754|FG003|Overall Study|Withdrawal by Subject|1|||
13248226|NCT01588184|26361755|FG004|Overall Study|Withdrawal by Subject|0|||
13248227|NCT01588184|26361756|FG005|Overall Study|Withdrawal by Subject|0|||
13248228|NCT01588184|26361751|FG000|Overall Study|Bevacizumab treatment provision changed|0|||
13248229|NCT01588184|26361752|FG001|Overall Study|Bevacizumab treatment provision changed|6|||
13248230|NCT01588184|26361753|FG002|Overall Study|Bevacizumab treatment provision changed|2|||
13248231|NCT01588184|26361754|FG003|Overall Study|Bevacizumab treatment provision changed|0|||
13248232|NCT01588184|26361755|FG004|Overall Study|Bevacizumab treatment provision changed|1|||
13248233|NCT01588184|26361756|FG005|Overall Study|Bevacizumab treatment provision changed|3|||
13248234|NCT01588184|26361751|FG000|Overall Study|multiple reasons|0|||
13248235|NCT01588184|26361752|FG001|Overall Study|multiple reasons|3|||
13248236|NCT01588184|26361753|FG002|Overall Study|multiple reasons|0|||
13248237|NCT01588184|26361754|FG003|Overall Study|multiple reasons|1|||
13248238|NCT01588184|26361755|FG004|Overall Study|multiple reasons|0|||
13248239|NCT01588184|26361756|FG005|Overall Study|multiple reasons|0|||
13116386|NCT03075410|25922769|FG004|Part A-Period 2 (14 Days)|Personal reasons|0|||
13116387|NCT03075410|25922770|FG005|Part A-Period 2 (14 Days)|Personal reasons|0|||
13116388|NCT03075410|25922771|FG006|Part A-Period 2 (14 Days)|Personal reasons|0|||
13116389|NCT03075410|25922772|FG007|Part A-Period 2 (14 Days)|Personal reasons|0|||
13116390|NCT03075410|25922773|FG008|Part A-Period 2 (14 Days)|Personal reasons|0|||
13116391|NCT03075410|25922765|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1|||
13116392|NCT03075410|25922766|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
13116393|NCT03075410|25922767|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
13116394|NCT03075410|25922768|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
13116395|NCT03075410|25922769|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
13116396|NCT03075410|25922770|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
13116397|NCT03075410|25922771|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
13116398|NCT03075410|25922772|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
13248240|NCT01588106|26361769|FG000|Overall Study|Withdrawal by Subject|5|||
13248241|NCT01588106|26361770|FG001|Overall Study|Withdrawal by Subject|4|||
13248242|NCT01587989|26361800|FG000|12-Week Open-Label Run-In Period|Physician Decision|7|||
13248243|NCT01587989|26361801|FG001|12-Week Open-Label Run-In Period|Physician Decision|0|||
13248244|NCT01587989|26361802|FG002|12-Week Open-Label Run-In Period|Physician Decision|0|||
13116399|NCT03075410|25922773|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
13116400|NCT03075267|25922915|FG000|Overall Study|Protocol Violation|1|||
13116401|NCT03075267|25922916|FG001|Overall Study|Protocol Violation|0|||
13116402|NCT03075267|25922917|FG002|Overall Study|Protocol Violation|0|||
13116403|NCT03075163|25922930|FG000|Overall Study|not eligible for treatment limb|138|||
13116404|NCT03075163|25922931|FG001|Overall Study|not eligible for treatment limb|138|||
13248245|NCT01587989|26361800|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1|||
13248246|NCT01587989|26361801|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
13116405|NCT03074500|25922967|FG000|Overall Study|Lost to Follow-up|1|||
13116406|NCT03074500|25922968|FG001|Overall Study|Lost to Follow-up|0|||
13116407|NCT03074500|25922969|FG002|Overall Study|Lost to Follow-up|0|||
13116408|NCT03074500|25922967|FG000|Overall Study|Lack of Efficacy|0|||
13116409|NCT03074500|25922968|FG001|Overall Study|Lack of Efficacy|1|||
13116410|NCT03074500|25922969|FG002|Overall Study|Lack of Efficacy|0|||
13116411|NCT03074500|25922967|FG000|Overall Study|Adverse Event|0|||
13116412|NCT03074500|25922968|FG001|Overall Study|Adverse Event|0|||
13116413|NCT03074500|25922969|FG002|Overall Study|Adverse Event|1|||
13116414|NCT03074331|25922977|FG000|Overall Study|Enrolled but Not Treated|1|||
13116415|NCT03074331|25922977|FG000|Overall Study|Lost to Follow-up|5|||
13116416|NCT03074331|25922977|FG000|Overall Study|Withdrew Consent|1|||
13116417|NCT03074162|25923016|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0|||
13116418|NCT03074162|25923017|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0|||
13116419|NCT03074162|25923018|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1|||
13116420|NCT03074162|25923019|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0|||
13248247|NCT01587989|26361802|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
13248248|NCT01587989|26361800|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4|||
13116421|NCT03074162|25923020|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0|||
13248249|NCT01587989|26361801|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0|||
13248250|NCT01587989|26361802|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0|||
13248251|NCT01587989|26361800|FG000|Randomized Study Treatment|Withdrawal by Subject|0|||
13248252|NCT01587989|26361801|FG001|Randomized Study Treatment|Withdrawal by Subject|1|||
13248253|NCT01587989|26361802|FG002|Randomized Study Treatment|Withdrawal by Subject|0|||
13248254|NCT01587989|26361800|FG000|Randomized Study Treatment|Screening failure|0|||
13248255|NCT01587989|26361801|FG001|Randomized Study Treatment|Screening failure|1|||
13248256|NCT01587989|26361802|FG002|Randomized Study Treatment|Screening failure|0|||
13248257|NCT01587989|26361800|FG000|Randomized Study Treatment|Physician Decision|0|||
13248258|NCT01587989|26361801|FG001|Randomized Study Treatment|Physician Decision|0|||
13248259|NCT01587989|26361802|FG002|Randomized Study Treatment|Physician Decision|1|||
13248260|NCT01587924|26361912|FG000|Overall Study|Adverse Event|0|||
13248261|NCT01587924|26361913|FG001|Overall Study|Adverse Event|2|||
13248262|NCT01587924|26361914|FG002|Overall Study|Adverse Event|0|||
13248263|NCT01587924|26361915|FG003|Overall Study|Adverse Event|0|||
13248264|NCT01587924|26361912|FG000|Overall Study|Protocol Violation|2|||
13248265|NCT01587924|26361913|FG001|Overall Study|Protocol Violation|1|||
13248266|NCT01587924|26361914|FG002|Overall Study|Protocol Violation|2|||
13248267|NCT01587924|26361915|FG003|Overall Study|Protocol Violation|1|||
13248268|NCT01587924|26361912|FG000|Overall Study|Met Hemoglobin stopping criteria|2|||
13248269|NCT01587924|26361913|FG001|Overall Study|Met Hemoglobin stopping criteria|0|||
13248270|NCT01587924|26361914|FG002|Overall Study|Met Hemoglobin stopping criteria|1|||
13248271|NCT01587924|26361915|FG003|Overall Study|Met Hemoglobin stopping criteria|0|||
13248272|NCT01587924|26361912|FG000|Overall Study|Withdrawal by Subject|0|||
13248273|NCT01587924|26361913|FG001|Overall Study|Withdrawal by Subject|1|||
13248274|NCT01587924|26361914|FG002|Overall Study|Withdrawal by Subject|1|||
13248275|NCT01587924|26361915|FG003|Overall Study|Withdrawal by Subject|0|||
13248276|NCT01587898|26362104|FG000|Overall Study|Adverse Event|1|||
13248277|NCT01587898|26362105|FG001|Overall Study|Adverse Event|1|||
13248278|NCT01587898|26362106|FG002|Overall Study|Adverse Event|0|||
13248279|NCT01587898|26362107|FG003|Overall Study|Adverse Event|0|||
13248280|NCT01587898|26362104|FG000|Overall Study|Protocol Violation|0|||
13248281|NCT01587898|26362105|FG001|Overall Study|Protocol Violation|2|||
13248282|NCT01587898|26362106|FG002|Overall Study|Protocol Violation|1|||
13248283|NCT01587898|26362107|FG003|Overall Study|Protocol Violation|1|||
13248284|NCT01587898|26362104|FG000|Overall Study|Lost to Follow-up|0|||
13248285|NCT01587898|26362105|FG001|Overall Study|Lost to Follow-up|0|||
13248286|NCT01587898|26362106|FG002|Overall Study|Lost to Follow-up|0|||
13248287|NCT01587898|26362107|FG003|Overall Study|Lost to Follow-up|1|||
13248288|NCT01587898|26362104|FG000|Overall Study|Withdrawal by Subject|2|||
13248289|NCT01587898|26362105|FG001|Overall Study|Withdrawal by Subject|1|||
13248290|NCT01587898|26362106|FG002|Overall Study|Withdrawal by Subject|0|||
13248291|NCT01587898|26362107|FG003|Overall Study|Withdrawal by Subject|0|||
13248292|NCT01587898|26362104|FG000|Overall Study|Met haemoglobin stopping criteria|1|||
13116422|NCT03074162|25923021|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0|||
13116423|NCT03074162|25923016|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0|||
13116424|NCT03074162|25923017|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0|||
13248293|NCT01587898|26362105|FG001|Overall Study|Met haemoglobin stopping criteria|1|||
13248294|NCT01587898|26362106|FG002|Overall Study|Met haemoglobin stopping criteria|1|||
13248295|NCT01587898|26362107|FG003|Overall Study|Met haemoglobin stopping criteria|0|||
13248296|NCT01587885|26362123|FG000|Treatment Period 1|Failure to Return|0|||
13248297|NCT01587885|26362124|FG001|Treatment Period 1|Failure to Return|1|||
13248298|NCT01587885|26362123|FG000|Treatment Period 1|Protocol Violation|0|||
13248299|NCT01587885|26362124|FG001|Treatment Period 1|Protocol Violation|2|||
13248300|NCT01587703|26362584|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1|||
13248301|NCT01587703|26362585|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
13248302|NCT01587703|26362586|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
13248303|NCT01587703|26362587|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
13248304|NCT01587703|26362588|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
13248305|NCT01587703|26362589|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
13248306|NCT01587703|26362590|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
13248307|NCT01587703|26362591|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
13248308|NCT01587703|26362592|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
13248309|NCT01587703|26362593|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
13248310|NCT01587703|26362594|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
13248311|NCT01587703|26362595|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
13248312|NCT01587703|26362596|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
13248313|NCT01587703|26362597|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
13248314|NCT01587703|26362598|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
13248315|NCT01587703|26362599|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
13248316|NCT01587703|26362600|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
13248317|NCT01587703|26362601|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
13248318|NCT01587703|26362602|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
13248319|NCT01587703|26362584|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
13248320|NCT01587703|26362585|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
13248321|NCT01587703|26362586|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
13248322|NCT01587703|26362587|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
13248323|NCT01587703|26362588|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
13248324|NCT01587703|26362589|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1|||
13248325|NCT01587703|26362590|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
13248326|NCT01587703|26362591|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2|||
13248327|NCT01587703|26362592|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
13248328|NCT01587703|26362593|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
13248329|NCT01587703|26362594|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
13248330|NCT01587703|26362595|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
13248331|NCT01587703|26362596|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
13248332|NCT01587703|26362597|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
13248333|NCT01587703|26362598|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
13248334|NCT01587703|26362599|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
13248335|NCT01587703|26362600|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
13248336|NCT01587703|26362601|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
13248337|NCT01587703|26362602|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
13248338|NCT01587703|26362584|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
13248339|NCT01587703|26362585|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
13248340|NCT01587703|26362586|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
13248341|NCT01587703|26362587|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
13248342|NCT01587703|26362588|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
13248343|NCT01587703|26362589|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
13248344|NCT01587703|26362590|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2|||
13248345|NCT01587703|26362591|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
13248346|NCT01587703|26362592|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
13248347|NCT01587703|26362593|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
13248348|NCT01587703|26362594|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
13248349|NCT01587703|26362595|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
13248350|NCT01587703|26362596|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
13248351|NCT01587703|26362597|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
13248352|NCT01587703|26362598|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
13248353|NCT01587703|26362599|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
13248354|NCT01587703|26362600|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
13248355|NCT01587703|26362601|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
13248356|NCT01587703|26362602|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
13248357|NCT01587703|26362584|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2|||
13248358|NCT01587703|26362585|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4|||
13248359|NCT01587703|26362586|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1|||
13248360|NCT01587703|26362587|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3|||
13248361|NCT01587703|26362588|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4|||
13248362|NCT01587703|26362589|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7|||
13248363|NCT01587703|26362590|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30|||
13248364|NCT01587703|26362591|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7|||
13248365|NCT01587703|26362592|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0|||
13248366|NCT01587703|26362593|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0|||
13248367|NCT01587703|26362594|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0|||
13248368|NCT01587703|26362595|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0|||
13248369|NCT01587703|26362596|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0|||
13248370|NCT01587703|26362597|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0|||
13248371|NCT01587703|26362598|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0|||
13248372|NCT01587703|26362599|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0|||
13248373|NCT01587703|26362600|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0|||
13248374|NCT01587703|26362601|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0|||
13248375|NCT01587703|26362602|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0|||
13248376|NCT01587703|26362584|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0|||
13248377|NCT01587703|26362585|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0|||
13248378|NCT01587703|26362586|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0|||
13248379|NCT01587703|26362587|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0|||
13248380|NCT01587703|26362588|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0|||
13248381|NCT01587703|26362589|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0|||
13248382|NCT01587703|26362590|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0|||
13248383|NCT01587703|26362591|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0|||
13248384|NCT01587703|26362592|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1|||
13248385|NCT01587703|26362593|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9|||
13248386|NCT01587703|26362594|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3|||
13248387|NCT01587703|26362595|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0|||
13248388|NCT01587703|26362596|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0|||
13248389|NCT01587703|26362597|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0|||
13248390|NCT01587703|26362598|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0|||
13248391|NCT01587703|26362599|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0|||
13248392|NCT01587703|26362600|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0|||
13248393|NCT01587703|26362601|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0|||
13248394|NCT01587703|26362602|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0|||
13248395|NCT01587703|26362584|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
13248396|NCT01587703|26362585|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
13248397|NCT01587703|26362586|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
13248398|NCT01587703|26362587|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
13248399|NCT01587703|26362588|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
13248400|NCT01587703|26362589|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
13248401|NCT01587703|26362590|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
13248402|NCT01587703|26362591|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
13248403|NCT01587703|26362592|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
13248404|NCT01587703|26362593|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
13248405|NCT01587703|26362594|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
13248406|NCT01587703|26362595|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
13248407|NCT01587703|26362596|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
13248408|NCT01587703|26362597|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
13248409|NCT01587703|26362598|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
13248410|NCT01587703|26362599|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
13248411|NCT01587703|26362600|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
13248412|NCT01587703|26362601|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
13248413|NCT01587703|26362602|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
13248414|NCT01587703|26362584|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
13248415|NCT01587703|26362585|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
13248416|NCT01587703|26362586|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
13248417|NCT01587703|26362587|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
13248418|NCT01587703|26362588|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
13248419|NCT01587703|26362589|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
13248420|NCT01587703|26362590|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
13248421|NCT01587703|26362591|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
13248422|NCT01587703|26362592|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
13248423|NCT01587703|26362593|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
13248424|NCT01587703|26362594|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
13248425|NCT01587703|26362595|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
13248426|NCT01587703|26362596|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
13248427|NCT01587703|26362597|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
13248428|NCT01587703|26362598|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
13248429|NCT01587703|26362599|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
13248430|NCT01587703|26362600|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
13248431|NCT01587703|26362601|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
13248432|NCT01587703|26362602|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
13248433|NCT01587703|26362584|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
13248434|NCT01587703|26362585|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
13248435|NCT01587703|26362586|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
13248436|NCT01587703|26362587|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
13248437|NCT01587703|26362588|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
13248438|NCT01587703|26362589|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
13248439|NCT01587703|26362590|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
13248440|NCT01587703|26362591|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
13248441|NCT01587703|26362592|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1|||
13248442|NCT01587703|26362593|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
13248443|NCT01587703|26362594|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
13248444|NCT01587703|26362595|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
13248445|NCT01587703|26362596|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
13248446|NCT01587703|26362597|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
13248447|NCT01587703|26362598|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
13248448|NCT01587703|26362599|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
13248449|NCT01587703|26362600|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
13248450|NCT01587703|26362601|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
13248451|NCT01587703|26362602|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
13248452|NCT01587703|26362584|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
13248453|NCT01587703|26362585|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
13248454|NCT01587703|26362586|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
13248455|NCT01587703|26362587|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
13248456|NCT01587703|26362588|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
13248457|NCT01587703|26362589|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
13248458|NCT01587703|26362590|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
13248459|NCT01587703|26362591|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
13248460|NCT01587703|26362592|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
13248461|NCT01587703|26362593|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
13248462|NCT01587703|26362594|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
13248463|NCT01587703|26362595|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
13248464|NCT01587703|26362596|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
13248465|NCT01587703|26362597|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
13248466|NCT01587703|26362598|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
13248467|NCT01587703|26362599|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
13248468|NCT01587703|26362600|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
13248469|NCT01587703|26362601|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
13248470|NCT01587703|26362602|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1|||
13248471|NCT01587703|26362584|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
13248472|NCT01587703|26362585|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
13248473|NCT01587703|26362586|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
13248474|NCT01587703|26362587|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
13248475|NCT01587703|26362588|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
13248476|NCT01587703|26362589|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
13248477|NCT01587703|26362590|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
13248478|NCT01587703|26362591|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
13248479|NCT01587703|26362592|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
13248480|NCT01587703|26362593|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
13248481|NCT01587703|26362594|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
13248482|NCT01587703|26362595|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
13248483|NCT01587703|26362596|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
13248484|NCT01587703|26362597|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
13248485|NCT01587703|26362598|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
13248486|NCT01587703|26362599|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
13248487|NCT01587703|26362600|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
13248488|NCT01587703|26362601|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5|||
13248489|NCT01587703|26362602|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4|||
13248490|NCT01587703|26362584|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
13248491|NCT01587703|26362585|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
13248492|NCT01587703|26362586|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
13248493|NCT01587703|26362587|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
13248494|NCT01587703|26362588|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
13248495|NCT01587703|26362589|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
13248496|NCT01587703|26362590|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
13248497|NCT01587703|26362591|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
13248498|NCT01587703|26362592|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
13248499|NCT01587703|26362593|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
13248500|NCT01587703|26362594|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
13248501|NCT01587703|26362595|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
13248502|NCT01587703|26362596|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
13248503|NCT01587703|26362597|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
13248504|NCT01587703|26362598|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
13248505|NCT01587703|26362599|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1|||
13248506|NCT01587703|26362600|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
13248507|NCT01587703|26362601|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
13248508|NCT01587703|26362602|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
13248509|NCT01587703|26362584|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
13248510|NCT01587703|26362585|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
13248511|NCT01587703|26362586|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
13248512|NCT01587703|26362587|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
13248513|NCT01587703|26362588|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
13248514|NCT01587703|26362589|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
13248515|NCT01587703|26362590|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
13248516|NCT01587703|26362591|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
13248517|NCT01587703|26362592|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
13248518|NCT01587703|26362593|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
13248519|NCT01587703|26362594|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
13248520|NCT01587703|26362595|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1|||
13248521|NCT01587703|26362596|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
13248522|NCT01587703|26362597|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
13248523|NCT01587703|26362598|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2|||
13248524|NCT01587703|26362599|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
13248525|NCT01587703|26362600|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
13248526|NCT01587703|26362601|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
13248527|NCT01587703|26362602|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
13248528|NCT01587703|26362584|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
13248529|NCT01587703|26362585|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
13248530|NCT01587703|26362586|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
13248531|NCT01587703|26362587|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
13248532|NCT01587703|26362588|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
13248533|NCT01587703|26362589|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
13248534|NCT01587703|26362590|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
13248535|NCT01587703|26362591|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
13248536|NCT01587703|26362592|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
13248537|NCT01587703|26362593|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
13248538|NCT01587703|26362594|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
13248539|NCT01587703|26362595|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
13248540|NCT01587703|26362596|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
13248541|NCT01587703|26362597|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
13248542|NCT01587703|26362598|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
13248543|NCT01587703|26362599|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3|||
13248544|NCT01587703|26362600|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8|||
13248545|NCT01587703|26362601|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
13248546|NCT01587703|26362602|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
13248547|NCT01587703|26362584|FG000|Part2(Median Exposure of 1.41 Months)|Death|0|||
13248548|NCT01587703|26362585|FG001|Part2(Median Exposure of 1.41 Months)|Death|0|||
13248549|NCT01587703|26362586|FG002|Part2(Median Exposure of 1.41 Months)|Death|0|||
13248550|NCT01587703|26362587|FG003|Part2(Median Exposure of 1.41 Months)|Death|0|||
13248551|NCT01587703|26362588|FG004|Part2(Median Exposure of 1.41 Months)|Death|0|||
13248552|NCT01587703|26362589|FG005|Part2(Median Exposure of 1.41 Months)|Death|0|||
13248553|NCT01587703|26362590|FG006|Part2(Median Exposure of 1.41 Months)|Death|0|||
13248554|NCT01587703|26362591|FG007|Part2(Median Exposure of 1.41 Months)|Death|0|||
13248555|NCT01587703|26362592|FG008|Part2(Median Exposure of 1.41 Months)|Death|0|||
13248556|NCT01587703|26362593|FG009|Part2(Median Exposure of 1.41 Months)|Death|0|||
13248557|NCT01587703|26362594|FG010|Part2(Median Exposure of 1.41 Months)|Death|0|||
13248558|NCT01587703|26362595|FG011|Part2(Median Exposure of 1.41 Months)|Death|8|||
13248559|NCT01587703|26362596|FG012|Part2(Median Exposure of 1.41 Months)|Death|12|||
13248560|NCT01587703|26362597|FG013|Part2(Median Exposure of 1.41 Months)|Death|21|||
13248561|NCT01587703|26362598|FG014|Part2(Median Exposure of 1.41 Months)|Death|16|||
13248562|NCT01587703|26362599|FG015|Part2(Median Exposure of 1.41 Months)|Death|17|||
13248563|NCT01587703|26362600|FG016|Part2(Median Exposure of 1.41 Months)|Death|5|||
13248564|NCT01587703|26362601|FG017|Part2(Median Exposure of 1.41 Months)|Death|0|||
13248565|NCT01587703|26362602|FG018|Part2(Median Exposure of 1.41 Months)|Death|0|||
13248566|NCT01587703|26362584|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
13248567|NCT01587703|26362585|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
13248568|NCT01587703|26362586|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
13248569|NCT01587703|26362587|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
13248570|NCT01587703|26362588|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
13248571|NCT01587703|26362589|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
13248572|NCT01587703|26362590|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
13248573|NCT01587703|26362591|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
13248574|NCT01587703|26362592|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
13248575|NCT01587703|26362593|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
13248576|NCT01587703|26362594|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
13248577|NCT01587703|26362595|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1|||
13248578|NCT01587703|26362596|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
13248579|NCT01587703|26362597|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
13248580|NCT01587703|26362598|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
13248581|NCT01587703|26362599|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
13248582|NCT01587703|26362600|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
13248583|NCT01587703|26362601|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
13248584|NCT01587703|26362602|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
13248585|NCT01587651|26362639|FG000|Overall Study|Adverse Event|0|||
13248586|NCT01587651|26362640|FG001|Overall Study|Adverse Event|1|||
13248587|NCT01587651|26362641|FG002|Overall Study|Adverse Event|0|||
13248588|NCT01587651|26362639|FG000|Overall Study|Protocol Violation|0|||
13248589|NCT01587651|26362640|FG001|Overall Study|Protocol Violation|1|||
13248590|NCT01587651|26362641|FG002|Overall Study|Protocol Violation|1|||
13248591|NCT01587651|26362639|FG000|Overall Study|Withdrawal by Subject|0|||
13248592|NCT01587651|26362640|FG001|Overall Study|Withdrawal by Subject|1|||
13248593|NCT01587651|26362641|FG002|Overall Study|Withdrawal by Subject|0|||
13248594|NCT01587274|26362659|FG000|Overall Study|Lost to Follow-up|4|||
13248595|NCT01587274|26362660|FG001|Overall Study|Lost to Follow-up|5|||
13248596|NCT01587274|26362661|FG002|Overall Study|Lost to Follow-up|3|||
13248597|NCT01587118|26362668|FG000|Overall Study|Adverse Event|3|||
13248598|NCT01587118|26362668|FG000|Overall Study|Lost to Follow-up|2|||
13248599|NCT01587118|26362668|FG000|Overall Study|Relocation|1|||
13248600|NCT01587118|26362668|FG000|Overall Study|nonresponse|1|||
13248601|NCT01587079|26362792|FG000|Overall Study|Protocol-specified criteria|9|||
13248602|NCT01587079|26362792|FG000|Overall Study|Protocol Violation|5|||
13248603|NCT01587079|26362792|FG000|Overall Study|Lost to Follow-up|2|||
13248604|NCT01587079|26362792|FG000|Overall Study|Physician Decision|2|||
13248605|NCT01587079|26362792|FG000|Overall Study|Withdrawal by Subject|7|||
13248606|NCT01587079|26362792|FG000|Overall Study|Adverse Event|14|||
13248607|NCT01587040|26362823|FG000|Overall Study|Protocol Violation|0|||
13248608|NCT01587040|26362824|FG001|Overall Study|Protocol Violation|0|||
13248609|NCT01587040|26362825|FG002|Overall Study|Protocol Violation|1|||
13248610|NCT01587040|26362826|FG003|Overall Study|Protocol Violation|0|||
13248611|NCT01587040|26362823|FG000|Overall Study|Adverse Event|0|||
13248612|NCT01587040|26362824|FG001|Overall Study|Adverse Event|1|||
13248613|NCT01587040|26362825|FG002|Overall Study|Adverse Event|10|||
13248614|NCT01587040|26362826|FG003|Overall Study|Adverse Event|0|||
13248615|NCT01587040|26362823|FG000|Overall Study|Disease progression|12|||
13248616|NCT01587040|26362824|FG001|Overall Study|Disease progression|1|||
13248617|NCT01587040|26362825|FG002|Overall Study|Disease progression|15|||
13248618|NCT01587040|26362826|FG003|Overall Study|Disease progression|3|||
13248619|NCT01587040|26362823|FG000|Overall Study|Other than specified|5|||
13248620|NCT01587040|26362824|FG001|Overall Study|Other than specified|1|||
13248621|NCT01587040|26362825|FG002|Overall Study|Other than specified|11|||
13248622|NCT01587040|26362826|FG003|Overall Study|Other than specified|1|||
13248623|NCT01587014|26362833|FG000|Overall Study|Death|2|||
13248624|NCT01587001|26362848|FG000|Overall Study|Lost to Follow-up|2|||
13248625|NCT01587001|26362849|FG001|Overall Study|Lost to Follow-up|0|||
13248626|NCT01587001|26362848|FG000|Overall Study|Insufficient samples to complete testing|4|||
13248627|NCT01587001|26362849|FG001|Overall Study|Insufficient samples to complete testing|1|||
13248628|NCT01586819|26362864|FG000|Overall Study|Withdrawal by Subject|1|||
13248629|NCT01586819|26362865|FG001|Overall Study|Withdrawal by Subject|0|||
13248630|NCT01586806|26362895|FG000|Overall Study|Protocol Violation|0|||
13248631|NCT01586806|26362896|FG001|Overall Study|Protocol Violation|1|||
13248632|NCT01586806|26362897|FG002|Overall Study|Protocol Violation|0|||
13248633|NCT01586806|26362895|FG000|Overall Study|Withdrawal by Subject|1|||
13248634|NCT01586806|26362896|FG001|Overall Study|Withdrawal by Subject|0|||
13248635|NCT01586806|26362897|FG002|Overall Study|Withdrawal by Subject|0|||
13248636|NCT01586806|26362895|FG000|Overall Study|Lost to Follow-up|2|||
13248637|NCT01586806|26362896|FG001|Overall Study|Lost to Follow-up|3|||
13248638|NCT01586806|26362897|FG002|Overall Study|Lost to Follow-up|2|||
13248639|NCT01586624|26362986|FG000|Overall Study|Adverse Event|3|||
13248640|NCT01586624|26362987|FG001|Overall Study|Adverse Event|0|||
13248641|NCT01586624|26362988|FG002|Overall Study|Adverse Event|2|||
13248642|NCT01586624|26362989|FG003|Overall Study|Adverse Event|1|||
13248643|NCT01586624|26362990|FG004|Overall Study|Adverse Event|3|||
13248644|NCT01586624|26362991|FG005|Overall Study|Adverse Event|3|||
13248645|NCT01586624|26362992|FG006|Overall Study|Adverse Event|2|||
13248646|NCT01586624|26362993|FG007|Overall Study|Adverse Event|3|||
13248647|NCT01586624|26362986|FG000|Overall Study|Physician Decision|0|||
13248648|NCT01586624|26362987|FG001|Overall Study|Physician Decision|1|||
13248649|NCT01586624|26362988|FG002|Overall Study|Physician Decision|1|||
13248650|NCT01586624|26362989|FG003|Overall Study|Physician Decision|0|||
13248651|NCT01586624|26362990|FG004|Overall Study|Physician Decision|2|||
13248652|NCT01586624|26362991|FG005|Overall Study|Physician Decision|0|||
13248653|NCT01586624|26362992|FG006|Overall Study|Physician Decision|1|||
13248654|NCT01586624|26362993|FG007|Overall Study|Physician Decision|1|||
13248655|NCT01586624|26362986|FG000|Overall Study|Withdrawal by Subject|0|||
13248656|NCT01586624|26362987|FG001|Overall Study|Withdrawal by Subject|0|||
13248657|NCT01586624|26362988|FG002|Overall Study|Withdrawal by Subject|0|||
13248658|NCT01586624|26362989|FG003|Overall Study|Withdrawal by Subject|1|||
13248659|NCT01586624|26362990|FG004|Overall Study|Withdrawal by Subject|0|||
13248660|NCT01586624|26362991|FG005|Overall Study|Withdrawal by Subject|0|||
13248661|NCT01586624|26362992|FG006|Overall Study|Withdrawal by Subject|0|||
13248662|NCT01586624|26362993|FG007|Overall Study|Withdrawal by Subject|0|||
13248663|NCT01586624|26362986|FG000|Overall Study|Evidence of disease progression|1|||
13248664|NCT01586624|26362987|FG001|Overall Study|Evidence of disease progression|3|||
13248665|NCT01586624|26362988|FG002|Overall Study|Evidence of disease progression|2|||
13248666|NCT01586624|26362989|FG003|Overall Study|Evidence of disease progression|5|||
13248667|NCT01586624|26362990|FG004|Overall Study|Evidence of disease progression|3|||
13248668|NCT01586624|26362991|FG005|Overall Study|Evidence of disease progression|5|||
13248669|NCT01586624|26362992|FG006|Overall Study|Evidence of disease progression|4|||
13248670|NCT01586624|26362993|FG007|Overall Study|Evidence of disease progression|6|||
13248671|NCT01586624|26362986|FG000|Overall Study|Screen failure (no treatment received)|0|||
13248672|NCT01586624|26362987|FG001|Overall Study|Screen failure (no treatment received)|0|||
13248673|NCT01586624|26362988|FG002|Overall Study|Screen failure (no treatment received)|0|||
13248674|NCT01586624|26362989|FG003|Overall Study|Screen failure (no treatment received)|0|||
13248675|NCT01586624|26362990|FG004|Overall Study|Screen failure (no treatment received)|0|||
13248676|NCT01586624|26362991|FG005|Overall Study|Screen failure (no treatment received)|0|||
13248677|NCT01586624|26362992|FG006|Overall Study|Screen failure (no treatment received)|1|||
13248678|NCT01586624|26362993|FG007|Overall Study|Screen failure (no treatment received)|0|||
13248679|NCT01586364|26363048|FG000|Overall Study|Withdrawal by Subject|40|||
13248680|NCT01586364|26363048|FG000|Overall Study|Adverse Event|37|||
13248681|NCT01586364|26363048|FG000|Overall Study|Lost to Follow-up|17|||
13248682|NCT01586364|26363048|FG000|Overall Study|Protocol Violation|16|||
13248683|NCT01586364|26363048|FG000|Overall Study|Lack of Efficacy|1|||
13248684|NCT01586364|26363048|FG000|Overall Study|Other-Did not feel better post-treatment|1|||
13248685|NCT01586364|26363048|FG000|Overall Study|Other-Subject wasn't getting much relief|1|||
13248686|NCT01586364|26363048|FG000|Overall Study|Other-Site closure due to PI illness|1|||
13248687|NCT01586364|26363048|FG000|Overall Study|Other-PI discretion, site closing|2|||
13248688|NCT01586364|26363048|FG000|Overall Study|Other-Not specified|1|||
13248689|NCT01586338|26363060|FG000|Overall Study|Adverse Event|3|||
13248690|NCT01586338|26363060|FG000|Overall Study|Lost to Follow-up|1|||
13248691|NCT01586338|26363060|FG000|Overall Study|Withdrawal by participant|3|||
13248692|NCT01586338|26363060|FG000|Overall Study|Other|1|||
13248693|NCT01586195|26363073|FG000|Overall Study|Death|11|||
13248694|NCT01586195|26363073|FG000|Overall Study|Withdrawal of Consent|5|||
13248695|NCT01586195|26363073|FG000|Overall Study|Started new anti-melanoma therapy|1|||
13248696|NCT01586195|26363073|FG000|Overall Study|Reason not specified|9|||
13248697|NCT01586156|26363109|FG000|Overall Study|Pregnancy|0|||
13248698|NCT01586156|26363110|FG001|Overall Study|Pregnancy|1|||
13248699|NCT01586156|26363111|FG002|Overall Study|Pregnancy|0|||
13248700|NCT01585987|26363133|FG000|Randomized|Withdrawal by Subject|0|||
13248701|NCT01585987|26363134|FG001|Randomized|Withdrawal by Subject|4|||
13248702|NCT01585987|26363133|FG000|Randomized|No longer met criteria|0|||
13248703|NCT01585987|26363134|FG001|Randomized|No longer met criteria|2|||
13248704|NCT01585987|26363133|FG000|Treated|Disease Progression|39|||
13248705|NCT01585987|26363134|FG001|Treated|Disease Progression|36|||
13248706|NCT01585987|26363133|FG000|Treated|Study Drug Toxicity|9|||
13248707|NCT01585987|26363134|FG001|Treated|Study Drug Toxicity|5|||
13248708|NCT01585987|26363133|FG000|Treated|Adverse Event|3|||
13248709|NCT01585987|26363134|FG001|Treated|Adverse Event|0|||
13248710|NCT01585987|26363133|FG000|Treated|Withdrawal by Subject|1|||
13248711|NCT01585987|26363134|FG001|Treated|Withdrawal by Subject|2|||
13248712|NCT01585987|26363133|FG000|Treated|Death|1|||
13248713|NCT01585987|26363134|FG001|Treated|Death|0|||
13248714|NCT01585987|26363133|FG000|Treated|Lost to Follow-up|0|||
13248715|NCT01585987|26363134|FG001|Treated|Lost to Follow-up|1|||
13248716|NCT01585987|26363133|FG000|Treated|Maximum Clinical Benefit|0|||
13248717|NCT01585987|26363134|FG001|Treated|Maximum Clinical Benefit|1|||
13248718|NCT01585987|26363133|FG000|Treated|Non-Specified|1|||
13248719|NCT01585987|26363134|FG001|Treated|Non-Specified|2|||
13248720|NCT01585987|26363133|FG000|Treated|Subject Request|0|||
13248721|NCT01585987|26363134|FG001|Treated|Subject Request|1|||
13248722|NCT01585987|26363133|FG000|Treated|Poor/Non-Compliance|0|||
13248723|NCT01585987|26363134|FG001|Treated|Poor/Non-Compliance|1|||
13248724|NCT01585961|26363151|FG000|Overall Study|Death|6|||
13248725|NCT01585961|26363151|FG000|Overall Study|Physician Decision|1|||
13248726|NCT01585961|26363151|FG000|Overall Study|Decision to use non-study catheter|1|||
13248727|NCT01585961|26363151|FG000|Overall Study|Withdrawal by Subject|1|||
13116425|NCT03074162|25923018|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1|||
13116426|NCT03074162|25923019|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0|||
13116427|NCT03074162|25923020|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0|||
13116428|NCT03074162|25923021|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1|||
13116429|NCT03074162|25923016|FG000|Period 3|Withdrawal by Subject|1|||
13116430|NCT03074162|25923017|FG001|Period 3|Withdrawal by Subject|0|||
13116431|NCT03074162|25923018|FG002|Period 3|Withdrawal by Subject|0|||
13116432|NCT03074162|25923019|FG003|Period 3|Withdrawal by Subject|0|||
13116433|NCT03074162|25923020|FG004|Period 3|Withdrawal by Subject|1|||
13116434|NCT03074162|25923021|FG005|Period 3|Withdrawal by Subject|0|||
13116435|NCT03074149|25923047|FG000|Overall Study|Reason unknown|22|||
13116436|NCT03074149|25923048|FG001|Overall Study|Reason unknown|35|||
13116437|NCT03074149|25923047|FG000|Overall Study|Death|10|||
13116438|NCT03074149|25923048|FG001|Overall Study|Death|45|||
13116439|NCT03073980|25923081|FG000|Overall Study|Lost to Follow-up|10|||
13116440|NCT03073980|25923082|FG001|Overall Study|Lost to Follow-up|2|||
13116441|NCT03073980|25923083|FG002|Overall Study|Lost to Follow-up|9|||
13116442|NCT03073980|25923081|FG000|Overall Study|No post-procedure data|0|||
13116443|NCT03073980|25923082|FG001|Overall Study|No post-procedure data|0|||
13116444|NCT03073980|25923083|FG002|Overall Study|No post-procedure data|2|||
13248728|NCT01585961|26363151|FG000|Overall Study|Lost to Follow-up|23|||
13248729|NCT01585961|26363151|FG000|Overall Study|Ablation cancelled for slow-heal wound|1|||
13248730|NCT01585831|26363182|FG000|Overall Study|Physician Decision|0|||
13248731|NCT01585831|26363183|FG001|Overall Study|Physician Decision|1|||
13248732|NCT01585831|26363182|FG000|Overall Study|Withdrawal by Subject|2|||
13248733|NCT01585831|26363183|FG001|Overall Study|Withdrawal by Subject|1|||
13248734|NCT01585766|26363301|FG000|Overall Study|Withdrawal by Subject|0|||
13248735|NCT01585766|26363302|FG001|Overall Study|Withdrawal by Subject|1|||
13248736|NCT01585766|26363303|FG002|Overall Study|Withdrawal by Subject|1|||
13248737|NCT01585766|26363304|FG003|Overall Study|Withdrawal by Subject|0|||
13248738|NCT01585766|26363305|FG004|Overall Study|Withdrawal by Subject|0|||
13248739|NCT01585766|26363306|FG005|Overall Study|Withdrawal by Subject|0|||
13248740|NCT01585766|26363301|FG000|Overall Study|Death|0|||
13248741|NCT01585766|26363302|FG001|Overall Study|Death|1|||
13248742|NCT01585766|26363303|FG002|Overall Study|Death|0|||
13248743|NCT01585766|26363304|FG003|Overall Study|Death|0|||
13248744|NCT01585766|26363305|FG004|Overall Study|Death|0|||
13248745|NCT01585766|26363306|FG005|Overall Study|Death|0|||
13248746|NCT01585766|26363301|FG000|Overall Study|Physician Decision|0|||
13248747|NCT01585766|26363302|FG001|Overall Study|Physician Decision|0|||
13248748|NCT01585766|26363303|FG002|Overall Study|Physician Decision|1|||
13116445|NCT03073798|25923096|FG000|Overall Study|Adverse Event|1|||
13116446|NCT03073798|25923096|FG000|Overall Study|Withdrawal by Subject|1|||
13116447|NCT03073213|25923118|FG000|Multiple Dose Period|Protocol Violation|0|||
13248749|NCT01585766|26363304|FG003|Overall Study|Physician Decision|0|||
13248750|NCT01585766|26363305|FG004|Overall Study|Physician Decision|0|||
13248751|NCT01585766|26363306|FG005|Overall Study|Physician Decision|0|||
13248752|NCT01585584|26363312|FG000|Overall Study|Lack of Efficacy|1|||
13248753|NCT01585584|26363312|FG000|Overall Study|Withdrawal by Subject|1|||
13248754|NCT01585584|26363312|FG000|Overall Study|Physician Decision|2|||
13248755|NCT01585558|26363501|FG000|Overall Study|Withdrawal by Subject|4|||
13248756|NCT01585558|26363502|FG001|Overall Study|Withdrawal by Subject|5|||
13116448|NCT03073213|25923119|FG001|Multiple Dose Period|Protocol Violation|0|||
13116449|NCT03073213|25923120|FG002|Multiple Dose Period|Protocol Violation|1|||
13116450|NCT03073200|25923191|FG000|Double Blind Treatment Period|Protocol Violation|1|||
13248757|NCT01585558|26363503|FG002|Overall Study|Withdrawal by Subject|8|||
13248758|NCT01585558|26363501|FG000|Overall Study|Lost to Follow-up|2|||
13248759|NCT01585558|26363502|FG001|Overall Study|Lost to Follow-up|0|||
13248760|NCT01585558|26363503|FG002|Overall Study|Lost to Follow-up|3|||
13248761|NCT01585558|26363501|FG000|Overall Study|Adverse Event|3|||
13248762|NCT01585558|26363502|FG001|Overall Study|Adverse Event|4|||
13248763|NCT01585558|26363503|FG002|Overall Study|Adverse Event|1|||
13248764|NCT01585558|26363501|FG000|Overall Study|Protocol Violation|4|||
13248765|NCT01585558|26363502|FG001|Overall Study|Protocol Violation|3|||
13248766|NCT01585558|26363503|FG002|Overall Study|Protocol Violation|2|||
13248767|NCT01585558|26363501|FG000|Overall Study|Lack of Efficacy|0|||
13248768|NCT01585558|26363502|FG001|Overall Study|Lack of Efficacy|0|||
13248769|NCT01585558|26363503|FG002|Overall Study|Lack of Efficacy|1|||
13248770|NCT01585428|26363518|FG000|Overall Study|Death during treatment|1|||
13248771|NCT01585428|26363519|FG001|Overall Study|Death during treatment|0|||
13248772|NCT01585298|26363529|FG000|Overall Study|Study completion was not documented.|1|||
13248773|NCT01585298|26363529|FG000|Overall Study|Protocol deviation|1|||
13248774|NCT01585298|26363529|FG000|Overall Study|Administrative problems|4|||
13116451|NCT03073200|25923192|FG001|Double Blind Treatment Period|Protocol Violation|0|||
13116452|NCT03073200|25923193|FG002|Double Blind Treatment Period|Protocol Violation|0|||
13248775|NCT01585298|26363529|FG000|Overall Study|Lost to Follow-up|2|||
13248776|NCT01585298|26363529|FG000|Overall Study|Withdrawal by Subject|4|||
13248777|NCT01585298|26363529|FG000|Overall Study|Abnormal test procedure results|1|||
13248778|NCT01585298|26363529|FG000|Overall Study|Adverse Event|24|||
13248779|NCT01585272|26363539|FG000|Overall Study|Adverse Event|22|||
13248780|NCT01585272|26363539|FG000|Overall Study|Protocol Violation|7|||
13248781|NCT01585272|26363539|FG000|Overall Study|Withdrawal by Subject|10|||
13248782|NCT01585246|26363570|FG000|Overall Study|Lost to Follow-up|0|||
13248783|NCT01585246|26363571|FG001|Overall Study|Lost to Follow-up|0|||
13248784|NCT01585246|26363572|FG002|Overall Study|Lost to Follow-up|2|||
13248785|NCT01585246|26363573|FG003|Overall Study|Lost to Follow-up|1|||
13248786|NCT01585246|26363574|FG004|Overall Study|Lost to Follow-up|0|||
13248787|NCT01585246|26363570|FG000|Overall Study|Protocol Violation|0|||
13248788|NCT01585246|26363571|FG001|Overall Study|Protocol Violation|0|||
13248789|NCT01585246|26363572|FG002|Overall Study|Protocol Violation|0|||
13116453|NCT03073200|25923194|FG003|Double Blind Treatment Period|Protocol Violation|0|||
13116454|NCT03073200|25923195|FG004|Double Blind Treatment Period|Protocol Violation|0|||
13116455|NCT03073200|25923196|FG005|Double Blind Treatment Period|Protocol Violation|0|||
13116456|NCT03073200|25923197|FG006|Double Blind Treatment Period|Protocol Violation|0|||
13116457|NCT03073200|25923198|FG007|Double Blind Treatment Period|Protocol Violation|0|||
13116458|NCT03073200|25923199|FG008|Double Blind Treatment Period|Protocol Violation|0|||
13116459|NCT03073200|25923200|FG009|Double Blind Treatment Period|Protocol Violation|0|||
13248790|NCT01585246|26363573|FG003|Overall Study|Protocol Violation|0|||
13248791|NCT01585246|26363574|FG004|Overall Study|Protocol Violation|1|||
13248792|NCT01585246|26363570|FG000|Overall Study|Withdrawal by Subject|0|||
13248793|NCT01585246|26363571|FG001|Overall Study|Withdrawal by Subject|0|||
13248794|NCT01585246|26363572|FG002|Overall Study|Withdrawal by Subject|1|||
13248795|NCT01585246|26363573|FG003|Overall Study|Withdrawal by Subject|2|||
13248796|NCT01585246|26363574|FG004|Overall Study|Withdrawal by Subject|1|||
13248797|NCT01585246|26363570|FG000|Overall Study|Other|0|||
13248798|NCT01585246|26363571|FG001|Overall Study|Other|1|||
13248799|NCT01585246|26363572|FG002|Overall Study|Other|1|||
13248800|NCT01585246|26363573|FG003|Overall Study|Other|1|||
13248801|NCT01585246|26363574|FG004|Overall Study|Other|0|||
13248802|NCT01585194|26363583|FG000|Overall Study|Withdrawal by Subject|1|||
13248803|NCT01585194|26363583|FG000|Overall Study|Physician Decision|2|||
13248804|NCT01585194|26363583|FG000|Overall Study|Lack of insurance|1|||
13248805|NCT01585168|26363612|FG000|Overall Study|Lost to Follow-up|3|||
13248806|NCT01585168|26363613|FG001|Overall Study|Lost to Follow-up|1|||
13248807|NCT01585168|26363614|FG002|Overall Study|Lost to Follow-up|1|||
13248808|NCT01585168|26363615|FG003|Overall Study|Lost to Follow-up|1|||
13248809|NCT01585155|26363624|FG000|Overall Study|Adverse Event|1|||
13248810|NCT01585155|26363624|FG000|Overall Study|Lack of Efficacy|2|||
13248811|NCT01585155|26363624|FG000|Overall Study|Worsening ulcerative colitis|2|||
13248812|NCT01585038|26363643|FG000|Overall Study|Adverse Event|2|||
13248813|NCT01585038|26363644|FG001|Overall Study|Adverse Event|2|||
13248814|NCT01585025|26363680|FG000|Overall Study|Withdrawal by Subject|0|||
13248815|NCT01585025|26363681|FG001|Overall Study|Withdrawal by Subject|3|||
13248816|NCT01585025|26363682|FG002|Overall Study|Withdrawal by Subject|4|||
13248817|NCT01584843|26363806|FG000|First Treatment Period|Adverse Event|0|||
13248818|NCT01584843|26363807|FG001|First Treatment Period|Adverse Event|0|||
13248819|NCT01584843|26363808|FG002|First Treatment Period|Adverse Event|1|||
13248820|NCT01584843|26363809|FG003|First Treatment Period|Adverse Event|0|||
13248821|NCT01584843|26363810|FG004|First Treatment Period|Adverse Event|0|||
13248822|NCT01584843|26363811|FG005|First Treatment Period|Adverse Event|0|||
13248823|NCT01584843|26363806|FG000|First Treatment Period|Protocol Violation|0|||
13248824|NCT01584843|26363807|FG001|First Treatment Period|Protocol Violation|0|||
13248825|NCT01584843|26363808|FG002|First Treatment Period|Protocol Violation|0|||
13248826|NCT01584843|26363809|FG003|First Treatment Period|Protocol Violation|0|||
13248827|NCT01584843|26363810|FG004|First Treatment Period|Protocol Violation|0|||
13248828|NCT01584843|26363811|FG005|First Treatment Period|Protocol Violation|1|||
13248829|NCT01584843|26363806|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
13248830|NCT01584843|26363807|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
13248831|NCT01584843|26363808|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
13248832|NCT01584843|26363809|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
13248833|NCT01584843|26363810|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
13248834|NCT01584843|26363811|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1|||
13248835|NCT01584843|26363806|FG000|Second Treatment Period|Withdrawal by Subject|0|||
13248836|NCT01584843|26363807|FG001|Second Treatment Period|Withdrawal by Subject|0|||
13248837|NCT01584843|26363808|FG002|Second Treatment Period|Withdrawal by Subject|0|||
13248838|NCT01584843|26363809|FG003|Second Treatment Period|Withdrawal by Subject|0|||
13248839|NCT01584843|26363810|FG004|Second Treatment Period|Withdrawal by Subject|0|||
13248840|NCT01584843|26363811|FG005|Second Treatment Period|Withdrawal by Subject|1|||
13248841|NCT01584648|26363842|FG000|Overall Study|Death|136|||
13248842|NCT01584648|26363843|FG001|Overall Study|Death|146|||
13248843|NCT01584648|26363842|FG000|Overall Study|Lost to Follow-up|9|||
13248844|NCT01584648|26363843|FG001|Overall Study|Lost to Follow-up|9|||
13248845|NCT01584648|26363842|FG000|Overall Study|Investigator discretion|3|||
13248846|NCT01584648|26363843|FG001|Overall Study|Investigator discretion|2|||
13248847|NCT01584648|26363842|FG000|Overall Study|Withdrew consent|13|||
13248848|NCT01584648|26363843|FG001|Overall Study|Withdrew consent|4|||
13248849|NCT01584648|26363842|FG000|Overall Study|Study closed/terminated|50|||
13248850|NCT01584648|26363843|FG001|Overall Study|Study closed/terminated|23|||
13248851|NCT01584648|26363842|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0|||
13248852|NCT01584648|26363843|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28|||
13248853|NCT01584440|26363904|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1|||
13248854|NCT01584440|26363905|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
13248855|NCT01584440|26363906|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
13248856|NCT01584440|26363907|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
13248857|NCT01584440|26363908|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
13248858|NCT01584440|26363904|FG000|Stage 1 (5 Weeks)|Adverse Event|5|||
13248859|NCT01584440|26363905|FG001|Stage 1 (5 Weeks)|Adverse Event|3|||
13248860|NCT01584440|26363906|FG002|Stage 1 (5 Weeks)|Adverse Event|0|||
13248861|NCT01584440|26363907|FG003|Stage 1 (5 Weeks)|Adverse Event|0|||
13248862|NCT01584440|26363908|FG004|Stage 1 (5 Weeks)|Adverse Event|0|||
13248863|NCT01584440|26363904|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1|||
13248864|NCT01584440|26363905|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
13248865|NCT01584440|26363906|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
13248866|NCT01584440|26363907|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
13248867|NCT01584440|26363908|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
13248868|NCT01584440|26363904|FG000|Stage 1 (5 Weeks)|Protocol Violation|2|||
13248869|NCT01584440|26363905|FG001|Stage 1 (5 Weeks)|Protocol Violation|3|||
13248870|NCT01584440|26363906|FG002|Stage 1 (5 Weeks)|Protocol Violation|0|||
13248871|NCT01584440|26363907|FG003|Stage 1 (5 Weeks)|Protocol Violation|0|||
13248872|NCT01584440|26363908|FG004|Stage 1 (5 Weeks)|Protocol Violation|0|||
13248873|NCT01584440|26363904|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1|||
13248874|NCT01584440|26363905|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
13248875|NCT01584440|26363906|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
13248876|NCT01584440|26363907|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
13248877|NCT01584440|26363908|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
13248878|NCT01584440|26363904|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
13248879|NCT01584440|26363905|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2|||
13248880|NCT01584440|26363906|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
13248881|NCT01584440|26363907|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
13248882|NCT01584440|26363908|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
13248883|NCT01584440|26363904|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
13248884|NCT01584440|26363905|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
13248885|NCT01584440|26363906|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1|||
13248886|NCT01584440|26363907|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2|||
13248887|NCT01584440|26363908|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
13248888|NCT01584440|26363904|FG000|Stage 2 (5 Weeks)|Adverse Event|0|||
13248889|NCT01584440|26363905|FG001|Stage 2 (5 Weeks)|Adverse Event|0|||
13248890|NCT01584440|26363906|FG002|Stage 2 (5 Weeks)|Adverse Event|1|||
13248891|NCT01584440|26363907|FG003|Stage 2 (5 Weeks)|Adverse Event|2|||
13248892|NCT01584440|26363908|FG004|Stage 2 (5 Weeks)|Adverse Event|1|||
13248893|NCT01584440|26363904|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
13248894|NCT01584440|26363905|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
13248895|NCT01584440|26363906|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1|||
13248896|NCT01584440|26363907|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
13248897|NCT01584440|26363908|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
13248898|NCT01584232|26363931|FG000|Overall Study|Adverse Event|3|||
13248899|NCT01584232|26363932|FG001|Overall Study|Adverse Event|1|||
13248900|NCT01584232|26363931|FG000|Overall Study|Withdrawal by Subject|2|||
13248901|NCT01584232|26363932|FG001|Overall Study|Withdrawal by Subject|1|||
13248902|NCT01584232|26363931|FG000|Overall Study|Physician Decision|2|||
13248903|NCT01584232|26363932|FG001|Overall Study|Physician Decision|1|||
13248904|NCT01584232|26363931|FG000|Overall Study|Lost to Follow-up|1|||
13248905|NCT01584232|26363932|FG001|Overall Study|Lost to Follow-up|0|||
13248906|NCT01584024|26363941|FG000|Overall Study|Lost to Follow-up|10|||
13248907|NCT01584024|26363941|FG000|Overall Study|Withdrawal by Subject|3|||
13248908|NCT01583530|26364004|FG000|Overall Study|Adverse Event|0|||
13248909|NCT01583530|26364005|FG001|Overall Study|Adverse Event|0|||
13248910|NCT01583530|26364006|FG002|Overall Study|Adverse Event|0|||
13248911|NCT01583530|26364007|FG003|Overall Study|Adverse Event|0|||
13248912|NCT01583530|26364008|FG004|Overall Study|Adverse Event|0|||
13248913|NCT01583530|26364009|FG005|Overall Study|Adverse Event|1|||
13248914|NCT01583530|26364004|FG000|Overall Study|Withdrawal by Subject|0|||
13248915|NCT01583530|26364005|FG001|Overall Study|Withdrawal by Subject|3|||
13248916|NCT01583530|26364006|FG002|Overall Study|Withdrawal by Subject|0|||
13248917|NCT01583530|26364007|FG003|Overall Study|Withdrawal by Subject|1|||
13248918|NCT01583530|26364008|FG004|Overall Study|Withdrawal by Subject|1|||
13248919|NCT01583530|26364009|FG005|Overall Study|Withdrawal by Subject|2|||
13248920|NCT01583530|26364004|FG000|Overall Study|Lost to Follow-up|0|||
13248921|NCT01583530|26364005|FG001|Overall Study|Lost to Follow-up|0|||
13248922|NCT01583530|26364006|FG002|Overall Study|Lost to Follow-up|0|||
13248923|NCT01583530|26364007|FG003|Overall Study|Lost to Follow-up|0|||
13248924|NCT01583530|26364008|FG004|Overall Study|Lost to Follow-up|3|||
13248925|NCT01583530|26364009|FG005|Overall Study|Lost to Follow-up|0|||
13248926|NCT01583530|26364004|FG000|Overall Study|Lack of compliance|0|||
13248927|NCT01583530|26364005|FG001|Overall Study|Lack of compliance|0|||
13248928|NCT01583530|26364006|FG002|Overall Study|Lack of compliance|0|||
13248929|NCT01583530|26364007|FG003|Overall Study|Lack of compliance|0|||
13248930|NCT01583530|26364008|FG004|Overall Study|Lack of compliance|1|||
13248931|NCT01583530|26364009|FG005|Overall Study|Lack of compliance|0|||
13248932|NCT01583374|26364065|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6|||
13248933|NCT01583374|26364066|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7|||
13248934|NCT01583374|26364067|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12|||
13248935|NCT01583374|26364068|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
13248936|NCT01583374|26364069|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
13248937|NCT01583374|26364070|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
13248938|NCT01583374|26364071|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
13248939|NCT01583374|26364072|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
13248940|NCT01583374|26364073|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
13248941|NCT01583374|26364065|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3|||
13248942|NCT01583374|26364066|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2|||
13248943|NCT01583374|26364067|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
13248944|NCT01583374|26364068|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
13248945|NCT01583374|26364069|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
13248946|NCT01583374|26364070|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
13248947|NCT01583374|26364071|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
13248948|NCT01583374|26364072|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
13248949|NCT01583374|26364073|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
13248950|NCT01583374|26364065|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
13248951|NCT01583374|26364066|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
13248952|NCT01583374|26364067|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
13248953|NCT01583374|26364068|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
13248954|NCT01583374|26364069|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
13248955|NCT01583374|26364070|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
13248956|NCT01583374|26364071|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
13248957|NCT01583374|26364072|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
13248958|NCT01583374|26364073|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
13248959|NCT01583374|26364065|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8|||
13248960|NCT01583374|26364066|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
13248961|NCT01583374|26364067|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
13248962|NCT01583374|26364068|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
13248963|NCT01583374|26364069|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
13248964|NCT01583374|26364070|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
13248965|NCT01583374|26364071|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
13248966|NCT01583374|26364072|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
13248967|NCT01583374|26364073|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
13248968|NCT01583374|26364065|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1|||
13248969|NCT01583374|26364066|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2|||
13248970|NCT01583374|26364067|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
13248971|NCT01583374|26364068|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
13248972|NCT01583374|26364069|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
13248973|NCT01583374|26364070|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
13248974|NCT01583374|26364071|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
13248975|NCT01583374|26364072|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
13248976|NCT01583374|26364073|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
13248977|NCT01583374|26364065|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
13248978|NCT01583374|26364066|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
13248979|NCT01583374|26364067|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3|||
13248980|NCT01583374|26364068|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
13248981|NCT01583374|26364069|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
13248982|NCT01583374|26364070|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
13248983|NCT01583374|26364071|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
13248984|NCT01583374|26364072|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
13248985|NCT01583374|26364073|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
13248986|NCT01583374|26364065|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
13248987|NCT01583374|26364066|FG001|Placebo-controlled Phase (Week 0-24)|Other|1|||
13248988|NCT01583374|26364067|FG002|Placebo-controlled Phase (Week 0-24)|Other|0|||
13248989|NCT01583374|26364068|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
13248990|NCT01583374|26364069|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
13248991|NCT01583374|26364070|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
13248992|NCT01583374|26364071|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
13248993|NCT01583374|26364072|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
13248994|NCT01583374|26364073|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
13248995|NCT01583374|26364065|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
13248996|NCT01583374|26364066|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
13248997|NCT01583374|26364067|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
13248998|NCT01583374|26364068|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
13248999|NCT01583374|26364069|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
13249000|NCT01583374|26364070|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
13249001|NCT01583374|26364071|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
13249002|NCT01583374|26364072|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
13249003|NCT01583374|26364073|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
13249004|NCT01583374|26364065|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
13249005|NCT01583374|26364066|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
13249006|NCT01583374|26364067|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2|||
13249007|NCT01583374|26364068|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
13249008|NCT01583374|26364069|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
13249009|NCT01583374|26364070|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
13249010|NCT01583374|26364071|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
13249011|NCT01583374|26364072|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
13249012|NCT01583374|26364073|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
13249013|NCT01583374|26364065|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
13249014|NCT01583374|26364066|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
13249015|NCT01583374|26364067|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
13249016|NCT01583374|26364068|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6|||
13249017|NCT01583374|26364069|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3|||
13249018|NCT01583374|26364070|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
13249019|NCT01583374|26364071|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5|||
13249020|NCT01583374|26364072|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
13249021|NCT01583374|26364073|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
13249022|NCT01583374|26364065|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
13249023|NCT01583374|26364066|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2|||
13249024|NCT01583374|26364067|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
13249025|NCT01583374|26364068|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
13249026|NCT01583374|26364069|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
13249027|NCT01583374|26364070|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
13249028|NCT01583374|26364071|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
13249029|NCT01583374|26364072|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
13249030|NCT01583374|26364073|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
13249031|NCT01583374|26364065|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
13249032|NCT01583374|26364066|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
13249033|NCT01583374|26364067|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
13249034|NCT01583374|26364068|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
13249035|NCT01583374|26364069|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
13249036|NCT01583374|26364070|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2|||
13249037|NCT01583374|26364071|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
13249038|NCT01583374|26364072|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
13249039|NCT01583374|26364073|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
13249040|NCT01583374|26364065|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0|||
13249041|NCT01583374|26364066|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5|||
13249042|NCT01583374|26364067|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
13249043|NCT01583374|26364068|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
13249044|NCT01583374|26364069|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6|||
13249045|NCT01583374|26364070|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
13249046|NCT01583374|26364071|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
13249047|NCT01583374|26364072|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3|||
13249048|NCT01583374|26364073|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1|||
13249049|NCT01583374|26364065|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0|||
13249050|NCT01583374|26364066|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
13249051|NCT01583374|26364067|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6|||
13203298|NCT01986751|26224231|FG000|Overall Study|improperly consented|10|||
13203299|NCT01986751|26224232|FG001|Overall Study|improperly consented|2|||
13203300|NCT01986647|26224315|FG000|Overall Study|Lost to Follow-up|4|||
13203301|NCT01986647|26224316|FG001|Overall Study|Lost to Follow-up|1|||
13203302|NCT01986647|26224317|FG002|Overall Study|Lost to Follow-up|4|||
13203303|NCT01986647|26224318|FG003|Overall Study|Lost to Follow-up|4|||
13203304|NCT01986647|26224315|FG000|Overall Study|Withdrawal by Subject|1|||
13203305|NCT01986647|26224316|FG001|Overall Study|Withdrawal by Subject|3|||
13203306|NCT01986647|26224317|FG002|Overall Study|Withdrawal by Subject|2|||
13203307|NCT01986647|26224318|FG003|Overall Study|Withdrawal by Subject|3|||
13203308|NCT01986647|26224315|FG000|Overall Study|Health|5|||
13203309|NCT01986647|26224316|FG001|Overall Study|Health|3|||
13203310|NCT01986647|26224317|FG002|Overall Study|Health|6|||
13203311|NCT01986647|26224318|FG003|Overall Study|Health|4|||
13203312|NCT01986231|26224325|FG000|Overall Study|Adverse Event|1|||
13203313|NCT01986140|26224338|FG000|Overall Study|Withdrawal by Subject|31|||
13249052|NCT01583374|26364068|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
13249053|NCT01583374|26364069|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10|||
13249054|NCT01583374|26364070|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
13249055|NCT01583374|26364071|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
13249056|NCT01583374|26364072|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2|||
13249057|NCT01583374|26364073|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
13249058|NCT01583374|26364065|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
13249059|NCT01583374|26364066|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
13249060|NCT01583374|26364067|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
13249061|NCT01583374|26364068|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
13249062|NCT01583374|26364069|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
13249063|NCT01583374|26364070|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
13249064|NCT01583374|26364071|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
13249065|NCT01583374|26364072|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
13249066|NCT01583374|26364073|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
13249067|NCT01583374|26364065|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0|||
13249068|NCT01583374|26364066|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
13249069|NCT01583374|26364067|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
13249070|NCT01583374|26364068|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1|||
13249071|NCT01583374|26364069|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12|||
13249072|NCT01583374|26364070|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7|||
13249073|NCT01583374|26364071|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5|||
13249074|NCT01583374|26364072|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
13249075|NCT01583374|26364073|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
13249076|NCT01583374|26364065|FG000|Long-Term Extension Phase Weeks 52-260|Death|0|||
13249077|NCT01583374|26364066|FG001|Long-Term Extension Phase Weeks 52-260|Death|0|||
13249078|NCT01583374|26364067|FG002|Long-Term Extension Phase Weeks 52-260|Death|0|||
13249079|NCT01583374|26364068|FG003|Long-Term Extension Phase Weeks 52-260|Death|0|||
13249080|NCT01583374|26364069|FG004|Long-Term Extension Phase Weeks 52-260|Death|1|||
13249081|NCT01583374|26364070|FG005|Long-Term Extension Phase Weeks 52-260|Death|0|||
13249082|NCT01583374|26364071|FG006|Long-Term Extension Phase Weeks 52-260|Death|1|||
13249083|NCT01583374|26364072|FG007|Long-Term Extension Phase Weeks 52-260|Death|0|||
13249084|NCT01583374|26364073|FG008|Long-Term Extension Phase Weeks 52-260|Death|0|||
13203314|NCT01986140|26224339|FG001|Overall Study|Withdrawal by Subject|25|||
13203315|NCT01986140|26224338|FG000|Overall Study|alternative treatment|1|||
13249085|NCT01583374|26364065|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
13249086|NCT01583374|26364066|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
13249087|NCT01583374|26364067|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
13249088|NCT01583374|26364068|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
13249089|NCT01583374|26364069|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
13203316|NCT01986140|26224339|FG001|Overall Study|alternative treatment|1|||
13203317|NCT01986140|26224338|FG000|Overall Study|found not eligible|3|||
13203318|NCT01986140|26224339|FG001|Overall Study|found not eligible|0|||
13203319|NCT01986140|26224338|FG000|Overall Study|Adverse Event|0|||
13203320|NCT01986140|26224339|FG001|Overall Study|Adverse Event|1|||
13203321|NCT01986140|26224338|FG000|Overall Study|progression disease|0|||
13203322|NCT01986140|26224339|FG001|Overall Study|progression disease|1|||
13203323|NCT01986114|26224353|FG000|Overall Study|Adverse Event|59|||
13203324|NCT01986114|26224353|FG000|Overall Study|Lack of Efficacy|23|||
13203325|NCT01986114|26224353|FG000|Overall Study|Withdrawal by Subject|58|||
13203326|NCT01986114|26224353|FG000|Overall Study|Noncompliance|3|||
13203327|NCT01986114|26224353|FG000|Overall Study|Protocol Violation|1|||
13203328|NCT01986114|26224353|FG000|Overall Study|Lost to Follow-up|5|||
13203329|NCT01986114|26224353|FG000|Overall Study|Other reason|7|||
13203330|NCT01986062|26224376|FG000|Overall Study|Lost to Follow-up|1|||
13203331|NCT01986062|26224377|FG001|Overall Study|Lost to Follow-up|0|||
13203332|NCT01986062|26224376|FG000|Overall Study|Withdrawal by Subject|0|||
13203333|NCT01986062|26224377|FG001|Overall Study|Withdrawal by Subject|1|||
13203334|NCT01986010|26224627|FG000|Overall Study|Adverse Event|0|||
13203335|NCT01986010|26224628|FG001|Overall Study|Adverse Event|1|||
13203336|NCT01986010|26224629|FG002|Overall Study|Adverse Event|0|||
13203337|NCT01986010|26224630|FG003|Overall Study|Adverse Event|0|||
13203338|NCT01986010|26224631|FG004|Overall Study|Adverse Event|0|||
13203339|NCT01986010|26224632|FG005|Overall Study|Adverse Event|0|||
13203340|NCT01986010|26224633|FG006|Overall Study|Adverse Event|0|||
13203341|NCT01986010|26224634|FG007|Overall Study|Adverse Event|0|||
13203342|NCT01986010|26224635|FG008|Overall Study|Adverse Event|0|||
13203343|NCT01986010|26224636|FG009|Overall Study|Adverse Event|0|||
13203344|NCT01986010|26224637|FG010|Overall Study|Adverse Event|0|||
13203345|NCT01986010|26224638|FG011|Overall Study|Adverse Event|0|||
13203346|NCT01986010|26224639|FG012|Overall Study|Adverse Event|0|||
13203347|NCT01986010|26224640|FG013|Overall Study|Adverse Event|0|||
13203348|NCT01986010|26224641|FG014|Overall Study|Adverse Event|0|||
13203349|NCT01986010|26224642|FG015|Overall Study|Adverse Event|1|||
13203350|NCT01986010|26224643|FG016|Overall Study|Adverse Event|0|||
13203351|NCT01986010|26224627|FG000|Overall Study|Lost to Follow-up|2|||
13203352|NCT01986010|26224628|FG001|Overall Study|Lost to Follow-up|1|||
13203353|NCT01986010|26224629|FG002|Overall Study|Lost to Follow-up|2|||
13203354|NCT01986010|26224630|FG003|Overall Study|Lost to Follow-up|2|||
13203355|NCT01986010|26224631|FG004|Overall Study|Lost to Follow-up|2|||
13203356|NCT01986010|26224632|FG005|Overall Study|Lost to Follow-up|2|||
13203357|NCT01986010|26224633|FG006|Overall Study|Lost to Follow-up|0|||
13203358|NCT01986010|26224634|FG007|Overall Study|Lost to Follow-up|0|||
13203359|NCT01986010|26224635|FG008|Overall Study|Lost to Follow-up|4|||
13203360|NCT01986010|26224636|FG009|Overall Study|Lost to Follow-up|2|||
13203361|NCT01986010|26224637|FG010|Overall Study|Lost to Follow-up|0|||
13203362|NCT01986010|26224638|FG011|Overall Study|Lost to Follow-up|1|||
13203363|NCT01986010|26224639|FG012|Overall Study|Lost to Follow-up|1|||
13203364|NCT01986010|26224640|FG013|Overall Study|Lost to Follow-up|1|||
13203365|NCT01986010|26224641|FG014|Overall Study|Lost to Follow-up|2|||
13203366|NCT01986010|26224642|FG015|Overall Study|Lost to Follow-up|0|||
13203367|NCT01986010|26224643|FG016|Overall Study|Lost to Follow-up|0|||
13203368|NCT01986010|26224627|FG000|Overall Study|Physician Decision|0|||
13203369|NCT01986010|26224628|FG001|Overall Study|Physician Decision|0|||
13203370|NCT01986010|26224629|FG002|Overall Study|Physician Decision|0|||
13203371|NCT01986010|26224630|FG003|Overall Study|Physician Decision|0|||
13203372|NCT01986010|26224631|FG004|Overall Study|Physician Decision|0|||
13203373|NCT01986010|26224632|FG005|Overall Study|Physician Decision|0|||
13203374|NCT01986010|26224633|FG006|Overall Study|Physician Decision|0|||
13203375|NCT01986010|26224634|FG007|Overall Study|Physician Decision|0|||
13203376|NCT01986010|26224635|FG008|Overall Study|Physician Decision|0|||
13203377|NCT01986010|26224636|FG009|Overall Study|Physician Decision|0|||
13203378|NCT01986010|26224637|FG010|Overall Study|Physician Decision|0|||
13203379|NCT01986010|26224638|FG011|Overall Study|Physician Decision|0|||
13203380|NCT01986010|26224639|FG012|Overall Study|Physician Decision|0|||
13203381|NCT01986010|26224640|FG013|Overall Study|Physician Decision|0|||
13203382|NCT01986010|26224641|FG014|Overall Study|Physician Decision|1|||
13203383|NCT01986010|26224642|FG015|Overall Study|Physician Decision|0|||
13203384|NCT01986010|26224643|FG016|Overall Study|Physician Decision|0|||
13203385|NCT01986010|26224627|FG000|Overall Study|Withdrawal by Subject|2|||
13203386|NCT01986010|26224628|FG001|Overall Study|Withdrawal by Subject|2|||
13203387|NCT01986010|26224629|FG002|Overall Study|Withdrawal by Subject|3|||
13203388|NCT01986010|26224630|FG003|Overall Study|Withdrawal by Subject|0|||
13203389|NCT01986010|26224631|FG004|Overall Study|Withdrawal by Subject|2|||
13249090|NCT01583374|26364070|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
13249091|NCT01583374|26364071|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
13249092|NCT01583374|26364072|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
13249093|NCT01583374|26364073|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
13249094|NCT01583374|26364065|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
13249095|NCT01583374|26364066|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
13249096|NCT01583374|26364067|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
13249097|NCT01583374|26364068|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2|||
13249098|NCT01583374|26364069|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
13249099|NCT01583374|26364070|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
13249100|NCT01583374|26364071|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
13249101|NCT01583374|26364072|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
13249102|NCT01583374|26364073|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
13249103|NCT01583296|26364094|FG000|Overall Study|Withdrawal by Subject|11|||
13249104|NCT01583296|26364095|FG001|Overall Study|Withdrawal by Subject|10|||
13249105|NCT01583218|26364120|FG000|Overall Study|Withdrawal by Subject|43|||
13249106|NCT01583218|26364121|FG001|Overall Study|Withdrawal by Subject|29|||
13249107|NCT01583218|26364120|FG000|Overall Study|Death|206|||
13249108|NCT01583218|26364121|FG001|Overall Study|Death|211|||
13249109|NCT01583218|26364120|FG000|Overall Study|Lost to Follow-up|11|||
13249110|NCT01583218|26364121|FG001|Overall Study|Lost to Follow-up|17|||
13249111|NCT01583218|26364120|FG000|Overall Study|Adverse event or serious adverse event|3|||
13249112|NCT01583218|26364121|FG001|Overall Study|Adverse event or serious adverse event|3|||
13249113|NCT01583218|26364120|FG000|Overall Study|Patient /Family decision|3|||
13249114|NCT01583218|26364121|FG001|Overall Study|Patient /Family decision|0|||
13249115|NCT01583218|26364120|FG000|Overall Study|Cannot contact patient directly|1|||
13249116|NCT01583218|26364121|FG001|Overall Study|Cannot contact patient directly|2|||
13249117|NCT01583218|26364120|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0|||
13249118|NCT01583218|26364121|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2|||
13249119|NCT01583218|26364120|FG000|Overall Study|Patient did not wish to attend visits|0|||
13249120|NCT01583218|26364121|FG001|Overall Study|Patient did not wish to attend visits|1|||
13249121|NCT01583218|26364120|FG000|Overall Study|Patient randomized but not dosed|17|||
13249122|NCT01583218|26364121|FG001|Overall Study|Patient randomized but not dosed|16|||
13249123|NCT01583218|26364120|FG000|Overall Study|Patient was assessed via phone in person|1|||
13249124|NCT01583218|26364121|FG001|Overall Study|Patient was assessed via phone in person|0|||
13249125|NCT01583218|26364120|FG000|Overall Study|Patient deemed ineligible after random|2|||
13249126|NCT01583218|26364121|FG001|Overall Study|Patient deemed ineligible after random|0|||
13249127|NCT01583218|26364120|FG000|Overall Study|Patient was early terminated from study|0|||
13249128|NCT01583218|26364121|FG001|Overall Study|Patient was early terminated from study|1|||
13249129|NCT01583218|26364120|FG000|Overall Study|Patient was randomized due to mistake|1|||
13249130|NCT01583218|26364121|FG001|Overall Study|Patient was randomized due to mistake|0|||
13249131|NCT01583218|26364120|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0|||
13249132|NCT01583218|26364121|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1|||
13249133|NCT01583218|26364120|FG000|Overall Study|Withdraw of consent on day of random|1|||
13249134|NCT01583218|26364121|FG001|Overall Study|Withdraw of consent on day of random|0|||
13249135|NCT01583179|26364136|FG000|Overall Study|Screen failure|1|||
13249136|NCT01583179|26364137|FG001|Overall Study|Screen failure|2|||
13249137|NCT01583166|26364156|FG000|Overall Study|Withdrawal by Subject|4|||
13249138|NCT01583166|26364157|FG001|Overall Study|Withdrawal by Subject|6|||
13249139|NCT01582971|26364182|FG000|Overall Study|Death|2|||
13249140|NCT01582971|26364183|FG001|Overall Study|Death|1|||
13249141|NCT01582971|26364182|FG000|Overall Study|Lost to Follow-up|18|||
13249142|NCT01582971|26364183|FG001|Overall Study|Lost to Follow-up|21|||
13249143|NCT01582971|26364182|FG000|Overall Study|Withdrawal by Subject|4|||
13249144|NCT01582971|26364183|FG001|Overall Study|Withdrawal by Subject|2|||
13249145|NCT01582971|26364182|FG000|Overall Study|Other|15|||
13249146|NCT01582971|26364183|FG001|Overall Study|Other|13|||
13249147|NCT01582945|26364189|FG000|Overall Study|Intolerable side-effects|1|||
13249148|NCT01582945|26364189|FG000|Overall Study|Scheduling conflicts|1|||
13249149|NCT01582854|26364224|FG000|Overall Study|Death|8|||
13249150|NCT01582854|26364225|FG001|Overall Study|Death|5|||
13249151|NCT01582854|26364224|FG000|Overall Study|Adverse Event|2|||
13249152|NCT01582854|26364225|FG001|Overall Study|Adverse Event|3|||
13249153|NCT01582854|26364224|FG000|Overall Study|Withdrawal by Participant|8|||
13249154|NCT01582854|26364225|FG001|Overall Study|Withdrawal by Participant|11|||
13249155|NCT01582854|26364224|FG000|Overall Study|Lost to Follow-up|1|||
13249156|NCT01582854|26364225|FG001|Overall Study|Lost to Follow-up|2|||
13249157|NCT01582854|26364224|FG000|Overall Study|Physician Decision|0|||
13249158|NCT01582854|26364225|FG001|Overall Study|Physician Decision|1|||
13249159|NCT01582854|26364224|FG000|Overall Study|Recurrent Stroke|13|||
13249160|NCT01582854|26364225|FG001|Overall Study|Recurrent Stroke|8|||
13249161|NCT01582854|26364224|FG000|Overall Study|Disallowed Concomitant Medication|3|||
13307635|NCT01283581|26529329|FG002|Overall Study|Lost to Follow-up|8|||
13249162|NCT01582854|26364225|FG001|Overall Study|Disallowed Concomitant Medication|2|||
13249163|NCT01582854|26364224|FG000|Overall Study|Carotid or Neurosurgery|0|||
13249164|NCT01582854|26364225|FG001|Overall Study|Carotid or Neurosurgery|1|||
13249165|NCT01582854|26364224|FG000|Overall Study|General Anaesthesia|0|||
13249166|NCT01582854|26364225|FG001|Overall Study|General Anaesthesia|1|||
13249167|NCT01582854|26364224|FG000|Overall Study|Other Miscellaneous Reason|1|||
13249168|NCT01582854|26364225|FG001|Overall Study|Other Miscellaneous Reason|0|||
13249169|NCT01582789|26364244|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1|||
13249170|NCT01582789|26364245|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0|||
13249171|NCT01582451|26364294|FG000|Overall Study|Adverse Event|1|||
13203390|NCT01986010|26224632|FG005|Overall Study|Withdrawal by Subject|4|||
13203391|NCT01986010|26224633|FG006|Overall Study|Withdrawal by Subject|0|||
13203392|NCT01986010|26224634|FG007|Overall Study|Withdrawal by Subject|0|||
13203393|NCT01986010|26224635|FG008|Overall Study|Withdrawal by Subject|0|||
13203394|NCT01986010|26224636|FG009|Overall Study|Withdrawal by Subject|0|||
13203395|NCT01986010|26224637|FG010|Overall Study|Withdrawal by Subject|0|||
13203396|NCT01986010|26224638|FG011|Overall Study|Withdrawal by Subject|2|||
13203397|NCT01986010|26224639|FG012|Overall Study|Withdrawal by Subject|0|||
13203398|NCT01986010|26224640|FG013|Overall Study|Withdrawal by Subject|1|||
13203399|NCT01986010|26224641|FG014|Overall Study|Withdrawal by Subject|2|||
13203400|NCT01986010|26224642|FG015|Overall Study|Withdrawal by Subject|0|||
13203401|NCT01986010|26224643|FG016|Overall Study|Withdrawal by Subject|0|||
13203402|NCT01986010|26224627|FG000|Overall Study|Status Not Recorded|2|||
13203403|NCT01986010|26224628|FG001|Overall Study|Status Not Recorded|4|||
13203404|NCT01986010|26224629|FG002|Overall Study|Status Not Recorded|2|||
13203405|NCT01986010|26224630|FG003|Overall Study|Status Not Recorded|0|||
13203406|NCT01986010|26224631|FG004|Overall Study|Status Not Recorded|1|||
13203407|NCT01986010|26224632|FG005|Overall Study|Status Not Recorded|2|||
13203408|NCT01986010|26224633|FG006|Overall Study|Status Not Recorded|0|||
13203409|NCT01986010|26224634|FG007|Overall Study|Status Not Recorded|0|||
13203410|NCT01986010|26224635|FG008|Overall Study|Status Not Recorded|2|||
13203411|NCT01986010|26224636|FG009|Overall Study|Status Not Recorded|1|||
13203412|NCT01986010|26224637|FG010|Overall Study|Status Not Recorded|7|||
13203413|NCT01986010|26224638|FG011|Overall Study|Status Not Recorded|7|||
13249172|NCT01582451|26364295|FG001|Overall Study|Adverse Event|3|||
13249173|NCT01582451|26364294|FG000|Overall Study|Death|3|||
13249174|NCT01582451|26364295|FG001|Overall Study|Death|3|||
13249175|NCT01582451|26364294|FG000|Overall Study|Lost to Follow-up|0|||
13249176|NCT01582451|26364295|FG001|Overall Study|Lost to Follow-up|2|||
13249177|NCT01582451|26364294|FG000|Overall Study|Protocol Violation|11|||
13249178|NCT01582451|26364295|FG001|Overall Study|Protocol Violation|3|||
13249179|NCT01582451|26364294|FG000|Overall Study|Withdrawal by Subject|13|||
13249180|NCT01582451|26364295|FG001|Overall Study|Withdrawal by Subject|9|||
13249181|NCT01582451|26364294|FG000|Overall Study|Physician Decision|3|||
13249182|NCT01582451|26364295|FG001|Overall Study|Physician Decision|0|||
13249183|NCT01582451|26364294|FG000|Overall Study|Sponsor Decision|1|||
13249184|NCT01582451|26364295|FG001|Overall Study|Sponsor Decision|0|||
13249185|NCT01582308|26364331|FG000|Period 1|Withdrawal by Subject|0|||
13249186|NCT01582308|26364332|FG001|Period 1|Withdrawal by Subject|0|||
13249187|NCT01582308|26364333|FG002|Period 1|Withdrawal by Subject|0|||
13249188|NCT01582308|26364334|FG003|Period 1|Withdrawal by Subject|0|||
13249189|NCT01582308|26364335|FG004|Period 1|Withdrawal by Subject|0|||
13116460|NCT03073200|25923201|FG010|Double Blind Treatment Period|Protocol Violation|0|||
13116461|NCT03073200|25923202|FG011|Double Blind Treatment Period|Protocol Violation|0|||
13116462|NCT03073200|25923203|FG012|Double Blind Treatment Period|Protocol Violation|0|||
13116463|NCT03073200|25923204|FG013|Double Blind Treatment Period|Protocol Violation|0|||
13116464|NCT03073200|25923205|FG014|Double Blind Treatment Period|Protocol Violation|0|||
13116465|NCT03073200|25923191|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
13116466|NCT03073200|25923192|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1|||
13116467|NCT03073200|25923193|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
13116468|NCT03073200|25923194|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
13116469|NCT03073200|25923195|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
13116470|NCT03073200|25923196|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
13116471|NCT03073200|25923197|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
13116472|NCT03073200|25923198|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
13116473|NCT03073200|25923199|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
13116474|NCT03073200|25923200|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
13116475|NCT03073200|25923201|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
13116476|NCT03073200|25923202|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
13116477|NCT03073200|25923203|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
13116478|NCT03073200|25923204|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
13203414|NCT01986010|26224639|FG012|Overall Study|Status Not Recorded|9|||
13249190|NCT01582308|26364336|FG005|Period 1|Withdrawal by Subject|0|||
13249191|NCT01582308|26364337|FG006|Period 1|Withdrawal by Subject|1|||
13116479|NCT03073200|25923205|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
13116480|NCT03073200|25923191|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
13116481|NCT03073200|25923192|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
13116482|NCT03073200|25923193|FG002|Double Blind Treatment Period|Withdrawal by Subject|0|||
13116483|NCT03073200|25923194|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
13116484|NCT03073200|25923195|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
13116485|NCT03073200|25923196|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
13116486|NCT03073200|25923197|FG006|Double Blind Treatment Period|Withdrawal by Subject|0|||
13116487|NCT03073200|25923198|FG007|Double Blind Treatment Period|Withdrawal by Subject|0|||
13116488|NCT03073200|25923199|FG008|Double Blind Treatment Period|Withdrawal by Subject|0|||
13116489|NCT03073200|25923200|FG009|Double Blind Treatment Period|Withdrawal by Subject|0|||
13116490|NCT03073200|25923201|FG010|Double Blind Treatment Period|Withdrawal by Subject|0|||
13116491|NCT03073200|25923202|FG011|Double Blind Treatment Period|Withdrawal by Subject|0|||
13116492|NCT03073200|25923203|FG012|Double Blind Treatment Period|Withdrawal by Subject|0|||
13116493|NCT03073200|25923204|FG013|Double Blind Treatment Period|Withdrawal by Subject|0|||
13116494|NCT03073200|25923205|FG014|Double Blind Treatment Period|Withdrawal by Subject|0|||
13116495|NCT03073200|25923191|FG000|Open-Label Maintenance Period|Lost to Follow-up|0|||
13116496|NCT03073200|25923192|FG001|Open-Label Maintenance Period|Lost to Follow-up|0|||
13249192|NCT01582308|26364338|FG007|Period 1|Withdrawal by Subject|0|||
13249193|NCT01582308|26364339|FG008|Period 1|Withdrawal by Subject|0|||
13249194|NCT01582308|26364340|FG009|Period 1|Withdrawal by Subject|0|||
13249195|NCT01582308|26364331|FG000|10-day Washout Following Period 1|Physician Decision|0|||
13249196|NCT01582308|26364332|FG001|10-day Washout Following Period 1|Physician Decision|0|||
13249197|NCT01582308|26364333|FG002|10-day Washout Following Period 1|Physician Decision|0|||
13249198|NCT01582308|26364334|FG003|10-day Washout Following Period 1|Physician Decision|0|||
13249199|NCT01582308|26364335|FG004|10-day Washout Following Period 1|Physician Decision|1|||
13249200|NCT01582308|26364336|FG005|10-day Washout Following Period 1|Physician Decision|0|||
13249201|NCT01582308|26364337|FG006|10-day Washout Following Period 1|Physician Decision|0|||
13249202|NCT01582308|26364338|FG007|10-day Washout Following Period 1|Physician Decision|0|||
13249203|NCT01582308|26364339|FG008|10-day Washout Following Period 1|Physician Decision|0|||
13249204|NCT01582308|26364340|FG009|10-day Washout Following Period 1|Physician Decision|0|||
13249205|NCT01582308|26364331|FG000|Period 4|Physician Decision|1|||
13249206|NCT01582308|26364332|FG001|Period 4|Physician Decision|0|||
13249207|NCT01582308|26364333|FG002|Period 4|Physician Decision|0|||
13249208|NCT01582308|26364334|FG003|Period 4|Physician Decision|0|||
13249209|NCT01582308|26364335|FG004|Period 4|Physician Decision|0|||
13249210|NCT01582308|26364336|FG005|Period 4|Physician Decision|1|||
13249211|NCT01582308|26364337|FG006|Period 4|Physician Decision|0|||
13249212|NCT01582308|26364338|FG007|Period 4|Physician Decision|0|||
13249213|NCT01582308|26364339|FG008|Period 4|Physician Decision|0|||
13249214|NCT01582308|26364340|FG009|Period 4|Physician Decision|1|||
13249215|NCT01582282|26364373|FG000|Overall Study|Adverse Event|1|||
13249216|NCT01582282|26364374|FG001|Overall Study|Adverse Event|1|||
13249217|NCT01582282|26364375|FG002|Overall Study|Adverse Event|0|||
13249218|NCT01582282|26364373|FG000|Overall Study|Lost to Follow-up|1|||
13249219|NCT01582282|26364374|FG001|Overall Study|Lost to Follow-up|0|||
13249220|NCT01582282|26364375|FG002|Overall Study|Lost to Follow-up|0|||
13249221|NCT01582282|26364373|FG000|Overall Study|fasting blood glucose outside Protocol|0|||
13249222|NCT01582282|26364374|FG001|Overall Study|fasting blood glucose outside Protocol|1|||
13249223|NCT01582282|26364375|FG002|Overall Study|fasting blood glucose outside Protocol|0|||
13249224|NCT01582243|26364386|FG000|Overall Study|Withdrawal by Subject|1|||
13249225|NCT01582243|26364386|FG000|Overall Study|Adverse Event|1|||
13249226|NCT01582243|26364386|FG000|Overall Study|Lost to Follow-up|1|||
13249227|NCT01582178|26364399|FG000|Overall Study|Physician Decision|6|||
13249228|NCT01582178|26364400|FG001|Overall Study|Physician Decision|5|||
13249229|NCT01582152|26364415|FG000|Overall Study|Disease Progression|4|||
13249230|NCT01582152|26364416|FG001|Overall Study|Disease Progression|5|||
13249231|NCT01582152|26364415|FG000|Overall Study|Adverse Event|2|||
13249232|NCT01582152|26364416|FG001|Overall Study|Adverse Event|1|||
13249233|NCT01582100|26364422|FG000|Overall Study|Adverse Event|1|||
13249234|NCT01582100|26364422|FG000|Overall Study|Withdrawal by Subject|1|||
13249235|NCT01582061|26364479|FG000|Overall Study|Lack of Efficacy|3|||
13249236|NCT01582061|26364480|FG001|Overall Study|Lack of Efficacy|23|||
13249237|NCT01582061|26364479|FG000|Overall Study|Adverse Event|12|||
13249238|NCT01582061|26364480|FG001|Overall Study|Adverse Event|8|||
13249239|NCT01582061|26364479|FG000|Overall Study|Withdrawal by Subject|10|||
13249240|NCT01582061|26364480|FG001|Overall Study|Withdrawal by Subject|4|||
13249241|NCT01582061|26364479|FG000|Overall Study|Abnormal laboratory value(s)|1|||
13249242|NCT01582061|26364480|FG001|Overall Study|Abnormal laboratory value(s)|0|||
13249243|NCT01582061|26364479|FG000|Overall Study|Death|0|||
13249244|NCT01582061|26364480|FG001|Overall Study|Death|1|||
13249245|NCT01582061|26364479|FG000|Overall Study|condition no longer requires study drug|1|||
13249246|NCT01582061|26364480|FG001|Overall Study|condition no longer requires study drug|0|||
13249247|NCT01582061|26364479|FG000|Overall Study|Lost to Follow-up|1|||
13249248|NCT01582061|26364480|FG001|Overall Study|Lost to Follow-up|0|||
13249249|NCT01582009|26364490|FG000|Overall Study|Withdrawal by Subject|1|||
13249250|NCT01582009|26364490|FG000|Overall Study|Physician Decision|1|||
13249251|NCT01581931|26364507|FG000|Washout|Adverse Event|0|||
13249252|NCT01581931|26364508|FG001|Washout|Adverse Event|1|||
13249253|NCT01581684|26364610|FG000|Overall Study|Other reason not defined|0|||
13249254|NCT01581684|26364611|FG001|Overall Study|Other reason not defined|0|||
13249255|NCT01581684|26364612|FG002|Overall Study|Other reason not defined|0|||
13249256|NCT01581684|26364613|FG003|Overall Study|Other reason not defined|0|||
13249257|NCT01581684|26364614|FG004|Overall Study|Other reason not defined|0|||
13249258|NCT01581684|26364615|FG005|Overall Study|Other reason not defined|0|||
13249259|NCT01581684|26364616|FG006|Overall Study|Other reason not defined|0|||
13249260|NCT01581684|26364617|FG007|Overall Study|Other reason not defined|0|||
13249261|NCT01581684|26364618|FG008|Overall Study|Other reason not defined|1|||
13249262|NCT01581684|26364619|FG009|Overall Study|Other reason not defined|0|||
13249263|NCT01581619|26364629|FG000|Overall Study|Withdrawal by Subject|1|||
13249264|NCT01581619|26364629|FG000|Overall Study|Lost to Follow-up|1|||
13249265|NCT01581593|26364649|FG000|Overall Study|Withdrawal by Subject|1|||
13249266|NCT01581307|26364657|FG000|Overall Study|Withdrawal by Subject|1|||
13249267|NCT01581281|26364687|FG000|Overall Study|Early Study Closure|15|||
13249268|NCT01581281|26364688|FG001|Overall Study|Early Study Closure|6|||
13249269|NCT01581281|26364689|FG002|Overall Study|Early Study Closure|12|||
13249270|NCT01581021|26364708|FG000|Overall Study|Lost to Follow-up|4|||
13249271|NCT01581021|26364709|FG001|Overall Study|Lost to Follow-up|6|||
13249272|NCT01581021|26364708|FG000|Overall Study|More than 2 hooks in thoracic|3|||
13249273|NCT01581021|26364709|FG001|Overall Study|More than 2 hooks in thoracic|0|||
13249274|NCT01581021|26364708|FG000|Overall Study|Neuromuscular|2|||
13249275|NCT01581021|26364709|FG001|Overall Study|Neuromuscular|1|||
13249276|NCT01581021|26364708|FG000|Overall Study|Not Randomized|1|||
13249277|NCT01581021|26364709|FG001|Overall Study|Not Randomized|2|||
13249278|NCT01581021|26364708|FG000|Overall Study|Lenke 6 Classification|0|||
13249279|NCT01581021|26364709|FG001|Overall Study|Lenke 6 Classification|1|||
13249280|NCT01581021|26364708|FG000|Overall Study|Lack of Efficacy|0|||
13249281|NCT01581021|26364709|FG001|Overall Study|Lack of Efficacy|1|||
13249282|NCT01580995|26364722|FG000|Overall Study|Lost to Follow-up|2|||
13249283|NCT01580995|26364723|FG001|Overall Study|Lost to Follow-up|2|||
13249284|NCT01580969|26364765|FG000|Overall Study|Physician Decision|3|||
13249285|NCT01580969|26364766|FG001|Overall Study|Physician Decision|0|||
13249286|NCT01580969|26364767|FG002|Overall Study|Physician Decision|0|||
13249287|NCT01580670|26364778|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1|||
13249288|NCT01580670|26364778|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1|||
13249289|NCT01580488|26364824|FG000|Overall Study|Withdrawal by Subject|1|||
13249290|NCT01580293|26364925|FG000|Part A_Main Trial|Adverse Event|0|||
13249291|NCT01580293|26364926|FG001|Part A_Main Trial|Adverse Event|2|||
13249292|NCT01580293|26364927|FG002|Part A_Main Trial|Adverse Event|0|||
13249293|NCT01580293|26364925|FG000|Part A_Main Trial|Withdrawal by Subject|1|||
13249294|NCT01580293|26364926|FG001|Part A_Main Trial|Withdrawal by Subject|4|||
13249295|NCT01580293|26364927|FG002|Part A_Main Trial|Withdrawal by Subject|0|||
13249296|NCT01580293|26364925|FG000|Part A_Main Trial|Non-adherence to the protocol|1|||
13249297|NCT01580293|26364926|FG001|Part A_Main Trial|Non-adherence to the protocol|0|||
13249298|NCT01580293|26364927|FG002|Part A_Main Trial|Non-adherence to the protocol|0|||
13249299|NCT01580293|26364925|FG000|Part A_Extension|Adverse Event|0|||
13249300|NCT01580293|26364926|FG001|Part A_Extension|Adverse Event|2|||
13249301|NCT01580293|26364927|FG002|Part A_Extension|Adverse Event|0|||
13249302|NCT01580293|26364925|FG000|Part A_Extension|Withdrawal by Subject|0|||
13249303|NCT01580293|26364926|FG001|Part A_Extension|Withdrawal by Subject|3|||
13249304|NCT01580293|26364927|FG002|Part A_Extension|Withdrawal by Subject|0|||
13249305|NCT01580293|26364925|FG000|Part A_Extension|Lost to Follow-up|0|||
13249306|NCT01580293|26364926|FG001|Part A_Extension|Lost to Follow-up|1|||
13249307|NCT01580293|26364927|FG002|Part A_Extension|Lost to Follow-up|0|||
13249308|NCT01580293|26364925|FG000|Part A_Extension|Other Reason|0|||
13249309|NCT01580293|26364926|FG001|Part A_Extension|Other Reason|1|||
13249310|NCT01580293|26364927|FG002|Part A_Extension|Other Reason|0|||
13249311|NCT01580293|26364925|FG000|Part A_Extension|Completed Japan only|0|||
13249312|NCT01580293|26364926|FG001|Part A_Extension|Completed Japan only|5|||
13249313|NCT01580293|26364927|FG002|Part A_Extension|Completed Japan only|0|||
13249314|NCT01580293|26364925|FG000|Part B|Withdrawal by Subject|0|||
13249315|NCT01580293|26364926|FG001|Part B|Withdrawal by Subject|0|||
13249316|NCT01580293|26364927|FG002|Part B|Withdrawal by Subject|1|||
13249317|NCT01580293|26364925|FG000|Part B|Other reason|0|||
13249318|NCT01580293|26364926|FG001|Part B|Other reason|0|||
13249319|NCT01580293|26364927|FG002|Part B|Other reason|1|||
13249320|NCT01580020|26364978|FG000|Overall Study|Lack of Efficacy|0|||
13249321|NCT01580020|26364979|FG001|Overall Study|Lack of Efficacy|5|||
13249322|NCT01580020|26364980|FG002|Overall Study|Lack of Efficacy|0|||
13249323|NCT01580020|26364981|FG003|Overall Study|Lack of Efficacy|1|||
13249324|NCT01580020|26364978|FG000|Overall Study|Withdrawal by Subject|0|||
13249325|NCT01580020|26364979|FG001|Overall Study|Withdrawal by Subject|1|||
13249326|NCT01580020|26364980|FG002|Overall Study|Withdrawal by Subject|1|||
13249327|NCT01580020|26364981|FG003|Overall Study|Withdrawal by Subject|0|||
13249328|NCT01580020|26364978|FG000|Overall Study|Adverse Event|1|||
13249329|NCT01580020|26364979|FG001|Overall Study|Adverse Event|1|||
13249330|NCT01580020|26364980|FG002|Overall Study|Adverse Event|1|||
13249331|NCT01580020|26364981|FG003|Overall Study|Adverse Event|1|||
13249332|NCT01580020|26364978|FG000|Overall Study|Administrative Problems|0|||
13249333|NCT01580020|26364979|FG001|Overall Study|Administrative Problems|0|||
13249334|NCT01580020|26364980|FG002|Overall Study|Administrative Problems|1|||
13249335|NCT01580020|26364981|FG003|Overall Study|Administrative Problems|0|||
13249336|NCT01580020|26364978|FG000|Overall Study|Lost to Follow-up|0|||
13249337|NCT01580020|26364979|FG001|Overall Study|Lost to Follow-up|0|||
13249338|NCT01580020|26364980|FG002|Overall Study|Lost to Follow-up|1|||
13249339|NCT01580020|26364981|FG003|Overall Study|Lost to Follow-up|0|||
13249340|NCT01579916|26365014|FG000|Overall Study|Lost to Follow-up|6|||
13249341|NCT01579916|26365015|FG001|Overall Study|Lost to Follow-up|1|||
13249342|NCT01579916|26365014|FG000|Overall Study|Withdrawal by Subject|1|||
13249343|NCT01579916|26365015|FG001|Overall Study|Withdrawal by Subject|1|||
13249344|NCT01579916|26365014|FG000|Overall Study|Death|1|||
13249345|NCT01579916|26365015|FG001|Overall Study|Death|0|||
13249346|NCT01579812|26365025|FG000|Overall Study|Ineligible after treatment start|40|||
13249347|NCT01579812|26365025|FG000|Overall Study|Patient choice|3|||
13249348|NCT01579812|26365025|FG000|Overall Study|Noncompliance|3|||
13249349|NCT01579812|26365025|FG000|Overall Study|Withdrawal by Subject|6|||
13249350|NCT01579578|26365042|FG000|Overall Study|Death|4|||
13249351|NCT01579578|26365043|FG001|Overall Study|Death|1|||
13249352|NCT01579578|26365042|FG000|Overall Study|Lost to Follow-up|1|||
13249353|NCT01579578|26365043|FG001|Overall Study|Lost to Follow-up|1|||
13249354|NCT01579578|26365042|FG000|Overall Study|Withdrawal by Subject|2|||
13249355|NCT01579578|26365043|FG001|Overall Study|Withdrawal by Subject|1|||
13249356|NCT01579578|26365042|FG000|Overall Study|Eligibility criteria|3|||
13249357|NCT01579578|26365043|FG001|Overall Study|Eligibility criteria|9|||
13249358|NCT01579578|26365042|FG000|Overall Study|Ongoing|3|||
13249359|NCT01579578|26365043|FG001|Overall Study|Ongoing|0|||
13249360|NCT01579565|26365078|FG000|Randomized|Adverse Event|1|||
13249361|NCT01579565|26365079|FG001|Randomized|Adverse Event|3|||
13249362|NCT01579565|26365078|FG000|Randomized|Withdrawal by Subject|3|||
13249363|NCT01579565|26365079|FG001|Randomized|Withdrawal by Subject|0|||
13249364|NCT01579565|26365078|FG000|Randomized|inadequate preoperative pupil dilation|0|||
13249365|NCT01579565|26365079|FG001|Randomized|inadequate preoperative pupil dilation|1|||
13249366|NCT01579565|26365078|FG000|Randomized|prohibited preoperative eating|1|||
13249367|NCT01579565|26365079|FG001|Randomized|prohibited preoperative eating|0|||
13249368|NCT01579565|26365078|FG000|Randomized|prohibited preoperative medication|0|||
13249369|NCT01579565|26365079|FG001|Randomized|prohibited preoperative medication|1|||
13249370|NCT01579565|26365078|FG000|Treated|Physician Decision|0|||
13249371|NCT01579565|26365079|FG001|Treated|Physician Decision|1|||
13249372|NCT01579565|26365078|FG000|Treated|Lost to Follow-up|2|||
13249373|NCT01579565|26365079|FG001|Treated|Lost to Follow-up|1|||
13249374|NCT01579565|26365078|FG000|Treated|declined to return for final visit|0|||
13249375|NCT01579565|26365079|FG001|Treated|declined to return for final visit|1|||
13249376|NCT01579474|26365172|FG000|Overall Study|Adverse Event|1|||
13249377|NCT01579474|26365173|FG001|Overall Study|Adverse Event|13|||
13249378|NCT01579474|26365174|FG002|Overall Study|Adverse Event|2|||
13249379|NCT01579474|26365175|FG003|Overall Study|Adverse Event|0|||
13249380|NCT01579474|26365176|FG004|Overall Study|Adverse Event|0|||
13249381|NCT01579474|26365177|FG005|Overall Study|Adverse Event|1|||
13249382|NCT01579474|26365172|FG000|Overall Study|Lack of Efficacy|1|||
13249383|NCT01579474|26365173|FG001|Overall Study|Lack of Efficacy|0|||
13249384|NCT01579474|26365174|FG002|Overall Study|Lack of Efficacy|0|||
13249385|NCT01579474|26365175|FG003|Overall Study|Lack of Efficacy|0|||
13249386|NCT01579474|26365176|FG004|Overall Study|Lack of Efficacy|1|||
13249387|NCT01579474|26365177|FG005|Overall Study|Lack of Efficacy|0|||
13249388|NCT01579474|26365172|FG000|Overall Study|Withdrawal by Subject|1|||
13249389|NCT01579474|26365173|FG001|Overall Study|Withdrawal by Subject|0|||
13249390|NCT01579474|26365174|FG002|Overall Study|Withdrawal by Subject|0|||
13249391|NCT01579474|26365175|FG003|Overall Study|Withdrawal by Subject|0|||
13249392|NCT01579474|26365176|FG004|Overall Study|Withdrawal by Subject|0|||
13249393|NCT01579474|26365177|FG005|Overall Study|Withdrawal by Subject|0|||
13249394|NCT01579318|26365190|FG000|Overall Study|Disease Progression|1|||
13249395|NCT01579006|26365231|FG000|Overall Study|Lack of Efficacy|10|||
13249396|NCT01579006|26365231|FG000|Overall Study|Adverse Event|13|||
13249397|NCT01579006|26365231|FG000|Overall Study|Withdrawal by Subject|5|||
13249398|NCT01579006|26365231|FG000|Overall Study|Non-compliance|3|||
13249399|NCT01579006|26365231|FG000|Overall Study|Due to participant's health fund|1|||
13249400|NCT01579006|26365231|FG000|Overall Study|Scheduled surgery|1|||
13249401|NCT01578850|26365289|FG000|Period 1|Insufficient Clinical Response|1|||
13249402|NCT01578850|26365290|FG001|Period 1|Insufficient Clinical Response|0|||
13249403|NCT01578850|26365291|FG002|Period 1|Insufficient Clinical Response|0|||
13249404|NCT01578850|26365289|FG000|Period 1|Adverse Event|11|||
13249405|NCT01578850|26365290|FG001|Period 1|Adverse Event|0|||
13249406|NCT01578850|26365291|FG002|Period 1|Adverse Event|0|||
13249407|NCT01578850|26365289|FG000|Period 1|Death|1|||
13249408|NCT01578850|26365290|FG001|Period 1|Death|0|||
13249409|NCT01578850|26365291|FG002|Period 1|Death|0|||
13249410|NCT01578850|26365289|FG000|Period 1|Does Not Meet Entrance Criteria|12|||
13249411|NCT01578850|26365290|FG001|Period 1|Does Not Meet Entrance Criteria|0|||
13249412|NCT01578850|26365291|FG002|Period 1|Does Not Meet Entrance Criteria|0|||
13249413|NCT01578850|26365289|FG000|Period 1|Withdrawal by Subject|9|||
13249414|NCT01578850|26365290|FG001|Period 1|Withdrawal by Subject|0|||
13249415|NCT01578850|26365291|FG002|Period 1|Withdrawal by Subject|0|||
13249416|NCT01578850|26365289|FG000|Period 1|Study Terminated by Sponsor|3|||
13249417|NCT01578850|26365290|FG001|Period 1|Study Terminated by Sponsor|0|||
13249418|NCT01578850|26365291|FG002|Period 1|Study Terminated by Sponsor|0|||
13249419|NCT01578850|26365289|FG000|Period 2|Insufficient Clinical Response|0|||
13249420|NCT01578850|26365290|FG001|Period 2|Insufficient Clinical Response|1|||
13249421|NCT01578850|26365291|FG002|Period 2|Insufficient Clinical Response|0|||
13249422|NCT01578850|26365289|FG000|Period 2|Adverse Event|0|||
13249423|NCT01578850|26365290|FG001|Period 2|Adverse Event|3|||
13249424|NCT01578850|26365291|FG002|Period 2|Adverse Event|6|||
13249425|NCT01578850|26365289|FG000|Period 2|Lost to Follow-up|0|||
13249426|NCT01578850|26365290|FG001|Period 2|Lost to Follow-up|1|||
13249427|NCT01578850|26365291|FG002|Period 2|Lost to Follow-up|2|||
13249428|NCT01578850|26365289|FG000|Period 2|Withdrawal by Subject|0|||
13249429|NCT01578850|26365290|FG001|Period 2|Withdrawal by Subject|2|||
13249430|NCT01578850|26365291|FG002|Period 2|Withdrawal by Subject|2|||
13249431|NCT01578850|26365289|FG000|Period 2|Study Terminated by Sponsor|0|||
13249432|NCT01578850|26365290|FG001|Period 2|Study Terminated by Sponsor|5|||
13249433|NCT01578850|26365291|FG002|Period 2|Study Terminated by Sponsor|4|||
13249434|NCT01578850|26365289|FG000|Period 2|Unspecified Reasons|0|||
13249435|NCT01578850|26365290|FG001|Period 2|Unspecified Reasons|1|||
13249436|NCT01578850|26365291|FG002|Period 2|Unspecified Reasons|0|||
13249437|NCT01578785|26365310|FG000|Overall Study|Withdrawal by Subject|0|||
13249438|NCT01578785|26365311|FG001|Overall Study|Withdrawal by Subject|1|||
13249439|NCT01578785|26365310|FG000|Overall Study|Study terminated by sponsor|59|||
13249440|NCT01578785|26365311|FG001|Overall Study|Study terminated by sponsor|118|||
13249441|NCT01578551|26365328|FG000|Overall Study|Adverse Event|1|||
13249442|NCT01578551|26365329|FG001|Overall Study|Adverse Event|0|||
13249443|NCT01578499|26365370|FG000|Overall Study|Reason not Specified|0|||
13249444|NCT01578499|26365371|FG001|Overall Study|Reason not Specified|1|||
13249445|NCT01578499|26365370|FG000|Overall Study|Lost to Follow-up|2|||
13249446|NCT01578499|26365371|FG001|Overall Study|Lost to Follow-up|1|||
13249447|NCT01578499|26365370|FG000|Overall Study|Withdrawal by Subject|10|||
13249448|NCT01578499|26365371|FG001|Overall Study|Withdrawal by Subject|16|||
13249449|NCT01578499|26365370|FG000|Overall Study|Death|20|||
13249450|NCT01578499|26365371|FG001|Overall Study|Death|25|||
13249451|NCT01578499|26365370|FG000|Overall Study|Died and End of Study Page not Completed|2|||
13249452|NCT01578499|26365371|FG001|Overall Study|Died and End of Study Page not Completed|0|||
13249453|NCT01578486|26365384|FG000|Overall Study|Physician Decision|3|||
13249454|NCT01578486|26365384|FG000|Overall Study|Withdrawal by Subject|2|||
13249455|NCT01578330|26365393|FG000|Overall Study|Adverse Event|2|||
13249456|NCT01578330|26365393|FG000|Overall Study|Protocol Violation|5|||
13249457|NCT01578187|26365401|FG000|Usability Phase|Withdrawal by Subject|1|||
13249458|NCT01577758|26365443|FG000|Dose Escalation Phase|Adverse Event|0|||
13249459|NCT01577758|26365444|FG001|Dose Escalation Phase|Adverse Event|0|||
13249460|NCT01577758|26365445|FG002|Dose Escalation Phase|Adverse Event|0|||
13249461|NCT01577758|26365446|FG003|Dose Escalation Phase|Adverse Event|0|||
13249462|NCT01577758|26365447|FG004|Dose Escalation Phase|Adverse Event|0|||
13249463|NCT01577758|26365448|FG005|Dose Escalation Phase|Adverse Event|2|||
13249464|NCT01577758|26365449|FG006|Dose Escalation Phase|Adverse Event|1|||
13249465|NCT01577758|26365450|FG007|Dose Escalation Phase|Adverse Event|0|||
13249466|NCT01577758|26365443|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
13249467|NCT01577758|26365444|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
13249468|NCT01577758|26365445|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
13249469|NCT01577758|26365446|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
13249470|NCT01577758|26365447|FG004|Dose Escalation Phase|Symptomatic Deterioration|1|||
13249471|NCT01577758|26365448|FG005|Dose Escalation Phase|Symptomatic Deterioration|1|||
13249472|NCT01577758|26365449|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
13249473|NCT01577758|26365450|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
13249474|NCT01577758|26365443|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
13249475|NCT01577758|26365444|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
13249476|NCT01577758|26365445|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
13249477|NCT01577758|26365446|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
13249478|NCT01577758|26365447|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
13249479|NCT01577758|26365448|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
13249480|NCT01577758|26365449|FG006|Dose Escalation Phase|Withdrawal by Subject|0|||
13249481|NCT01577758|26365450|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
13249482|NCT01577758|26365443|FG000|Dose Escalation Phase|Progression Disease|2|||
13249483|NCT01577758|26365444|FG001|Dose Escalation Phase|Progression Disease|2|||
13249484|NCT01577758|26365445|FG002|Dose Escalation Phase|Progression Disease|1|||
13249485|NCT01577758|26365446|FG003|Dose Escalation Phase|Progression Disease|2|||
13249486|NCT01577758|26365447|FG004|Dose Escalation Phase|Progression Disease|5|||
13249487|NCT01577758|26365448|FG005|Dose Escalation Phase|Progression Disease|0|||
13249488|NCT01577758|26365449|FG006|Dose Escalation Phase|Progression Disease|0|||
13249489|NCT01577758|26365450|FG007|Dose Escalation Phase|Progression Disease|0|||
13249490|NCT01577758|26365443|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0|||
13249491|NCT01577758|26365444|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0|||
13249492|NCT01577758|26365445|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0|||
13249493|NCT01577758|26365446|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0|||
13249494|NCT01577758|26365447|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0|||
13249495|NCT01577758|26365448|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0|||
13249496|NCT01577758|26365449|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0|||
13249497|NCT01577758|26365450|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4|||
13249498|NCT01577758|26365443|FG000|mCRC Expansion Phase|Withdrawal by Subject|0|||
13249499|NCT01577758|26365444|FG001|mCRC Expansion Phase|Withdrawal by Subject|0|||
13249500|NCT01577758|26365445|FG002|mCRC Expansion Phase|Withdrawal by Subject|0|||
13249501|NCT01577758|26365446|FG003|mCRC Expansion Phase|Withdrawal by Subject|0|||
13249502|NCT01577758|26365447|FG004|mCRC Expansion Phase|Withdrawal by Subject|0|||
13249503|NCT01577758|26365448|FG005|mCRC Expansion Phase|Withdrawal by Subject|0|||
13249504|NCT01577758|26365449|FG006|mCRC Expansion Phase|Withdrawal by Subject|0|||
13249505|NCT01577758|26365450|FG007|mCRC Expansion Phase|Withdrawal by Subject|2|||
13249506|NCT01577758|26365443|FG000|mCRC Expansion Phase|Progression Disease|0|||
13249507|NCT01577758|26365444|FG001|mCRC Expansion Phase|Progression Disease|0|||
13249508|NCT01577758|26365445|FG002|mCRC Expansion Phase|Progression Disease|0|||
13249509|NCT01577758|26365446|FG003|mCRC Expansion Phase|Progression Disease|0|||
13249510|NCT01577758|26365447|FG004|mCRC Expansion Phase|Progression Disease|0|||
13249511|NCT01577758|26365448|FG005|mCRC Expansion Phase|Progression Disease|0|||
13249512|NCT01577758|26365449|FG006|mCRC Expansion Phase|Progression Disease|0|||
13249513|NCT01577758|26365450|FG007|mCRC Expansion Phase|Progression Disease|19|||
13290154|NCT00104104|26480802|FG000|Overall Study|Condition no longer requires study drug|7|||
13290155|NCT00104104|26480803|FG001|Overall Study|Condition no longer requires study drug|4|||
13290156|NCT00104104|26480802|FG000|Overall Study|Protocol Violation|5|||
13290157|NCT00104104|26480803|FG001|Overall Study|Protocol Violation|2|||
13290158|NCT00104104|26480802|FG000|Overall Study|Withdrawal by Subject|11|||
13290159|NCT00104104|26480803|FG001|Overall Study|Withdrawal by Subject|15|||
13290160|NCT00104104|26480802|FG000|Overall Study|Lost to Follow-up|3|||
13290161|NCT00104104|26480803|FG001|Overall Study|Lost to Follow-up|7|||
13116497|NCT03073200|25923193|FG002|Open-Label Maintenance Period|Lost to Follow-up|0|||
13116498|NCT03073200|25923194|FG003|Open-Label Maintenance Period|Lost to Follow-up|1|||
13116499|NCT03073200|25923195|FG004|Open-Label Maintenance Period|Lost to Follow-up|2|||
13116500|NCT03073200|25923196|FG005|Open-Label Maintenance Period|Lost to Follow-up|0|||
13116501|NCT03073200|25923197|FG006|Open-Label Maintenance Period|Lost to Follow-up|0|||
13116502|NCT03073200|25923198|FG007|Open-Label Maintenance Period|Lost to Follow-up|0|||
13116503|NCT03073200|25923199|FG008|Open-Label Maintenance Period|Lost to Follow-up|0|||
13116504|NCT03073200|25923200|FG009|Open-Label Maintenance Period|Lost to Follow-up|0|||
13116505|NCT03073200|25923201|FG010|Open-Label Maintenance Period|Lost to Follow-up|0|||
13116506|NCT03073200|25923202|FG011|Open-Label Maintenance Period|Lost to Follow-up|0|||
13116507|NCT03073200|25923203|FG012|Open-Label Maintenance Period|Lost to Follow-up|0|||
13116508|NCT03073200|25923204|FG013|Open-Label Maintenance Period|Lost to Follow-up|0|||
13116509|NCT03073200|25923205|FG014|Open-Label Maintenance Period|Lost to Follow-up|0|||
13116510|NCT03073200|25923191|FG000|Open-Label Maintenance Period|Participant moved to another city|0|||
13116511|NCT03073200|25923192|FG001|Open-Label Maintenance Period|Participant moved to another city|0|||
13116512|NCT03073200|25923193|FG002|Open-Label Maintenance Period|Participant moved to another city|0|||
13116513|NCT03073200|25923194|FG003|Open-Label Maintenance Period|Participant moved to another city|1|||
13203415|NCT01986010|26224640|FG013|Overall Study|Status Not Recorded|9|||
13290162|NCT00104104|26480802|FG000|Overall Study|Administrative problems|12|||
13290163|NCT00104104|26480803|FG001|Overall Study|Administrative problems|13|||
13290164|NCT00104104|26480802|FG000|Overall Study|Death|9|||
13203416|NCT01986010|26224641|FG014|Overall Study|Status Not Recorded|5|||
13203417|NCT01986010|26224642|FG015|Overall Study|Status Not Recorded|10|||
13203418|NCT01986010|26224643|FG016|Overall Study|Status Not Recorded|4|||
13203419|NCT01985360|26224658|FG000|Overall Study|Withdrawal by Subject|4|||
13203420|NCT01985360|26224659|FG001|Overall Study|Withdrawal by Subject|0|||
13203421|NCT01985360|26224658|FG000|Overall Study|Lost to Follow-up|5|||
13203422|NCT01985360|26224659|FG001|Overall Study|Lost to Follow-up|3|||
13203423|NCT01985334|26224750|FG000|Overall Study|Administrative problems|1|||
13203424|NCT01985334|26224751|FG001|Overall Study|Administrative problems|1|||
13290165|NCT00104104|26480803|FG001|Overall Study|Death|6|||
13290166|NCT00104052|26480809|FG000|Overall Study|Adverse Event|1|||
13249514|NCT01577745|26365586|FG000|Overall Study|Withdrawal by Subject|0|||
13249515|NCT01577745|26365587|FG001|Overall Study|Withdrawal by Subject|1|||
13249516|NCT01577745|26365588|FG002|Overall Study|Withdrawal by Subject|0|||
13249517|NCT01577745|26365589|FG003|Overall Study|Withdrawal by Subject|3|||
13249518|NCT01577745|26365590|FG004|Overall Study|Withdrawal by Subject|2|||
13249519|NCT01577745|26365591|FG005|Overall Study|Withdrawal by Subject|0|||
13249520|NCT01577745|26365586|FG000|Overall Study|Death|3|||
13249521|NCT01577745|26365587|FG001|Overall Study|Death|2|||
13249522|NCT01577745|26365588|FG002|Overall Study|Death|2|||
13249523|NCT01577745|26365589|FG003|Overall Study|Death|1|||
13249524|NCT01577745|26365590|FG004|Overall Study|Death|1|||
13249525|NCT01577745|26365591|FG005|Overall Study|Death|3|||
13116514|NCT03073200|25923195|FG004|Open-Label Maintenance Period|Participant moved to another city|0|||
13116515|NCT03073200|25923196|FG005|Open-Label Maintenance Period|Participant moved to another city|0|||
13249526|NCT01577745|26365586|FG000|Overall Study|Physician Decision|0|||
13116516|NCT03073200|25923197|FG006|Open-Label Maintenance Period|Participant moved to another city|0|||
13116517|NCT03073200|25923198|FG007|Open-Label Maintenance Period|Participant moved to another city|0|||
13116518|NCT03073200|25923199|FG008|Open-Label Maintenance Period|Participant moved to another city|0|||
13116519|NCT03073200|25923200|FG009|Open-Label Maintenance Period|Participant moved to another city|0|||
13249527|NCT01577745|26365587|FG001|Overall Study|Physician Decision|0|||
13249528|NCT01577745|26365588|FG002|Overall Study|Physician Decision|0|||
13249529|NCT01577745|26365589|FG003|Overall Study|Physician Decision|1|||
13249530|NCT01577745|26365590|FG004|Overall Study|Physician Decision|1|||
13249531|NCT01577745|26365591|FG005|Overall Study|Physician Decision|0|||
13249532|NCT01577745|26365586|FG000|Overall Study|Lost to Follow-up|0|||
13249533|NCT01577745|26365587|FG001|Overall Study|Lost to Follow-up|0|||
13249534|NCT01577745|26365588|FG002|Overall Study|Lost to Follow-up|0|||
13249535|NCT01577745|26365589|FG003|Overall Study|Lost to Follow-up|0|||
13249536|NCT01577745|26365590|FG004|Overall Study|Lost to Follow-up|0|||
13249537|NCT01577745|26365591|FG005|Overall Study|Lost to Follow-up|1|||
13249538|NCT01577745|26365586|FG000|Overall Study|Alternative Therapy|0|||
13249539|NCT01577745|26365587|FG001|Overall Study|Alternative Therapy|0|||
13249540|NCT01577745|26365588|FG002|Overall Study|Alternative Therapy|0|||
13249541|NCT01577745|26365589|FG003|Overall Study|Alternative Therapy|1|||
13249542|NCT01577745|26365590|FG004|Overall Study|Alternative Therapy|1|||
13249543|NCT01577745|26365591|FG005|Overall Study|Alternative Therapy|0|||
13249544|NCT01577381|26365733|FG000|Overall Study|Discontinued|2|||
13249545|NCT01577381|26365734|FG001|Overall Study|Discontinued|1|||
13249546|NCT01577381|26365735|FG002|Overall Study|Discontinued|2|||
13249547|NCT01577381|26365736|FG003|Overall Study|Discontinued|2|||
13249548|NCT01577381|26365733|FG000|Overall Study|Ongoing at Date of Cut-Off|0|||
13249549|NCT01577381|26365734|FG001|Overall Study|Ongoing at Date of Cut-Off|2|||
13249550|NCT01577381|26365735|FG002|Overall Study|Ongoing at Date of Cut-Off|1|||
13249551|NCT01577381|26365736|FG003|Overall Study|Ongoing at Date of Cut-Off|0|||
13249552|NCT01577186|26365746|FG000|Overall Study|Adverse Event|23|||
13249553|NCT01577186|26365746|FG000|Overall Study|Death|1|||
13249554|NCT01577186|26365746|FG000|Overall Study|Lost to Follow-up|28|||
13249555|NCT01577186|26365746|FG000|Overall Study|Withdrawal by Subject|35|||
13249556|NCT01577186|26365746|FG000|Overall Study|Insufficient Response|18|||
13249557|NCT01577186|26365746|FG000|Overall Study|Ineligible to Continue|15|||
13249558|NCT01577186|26365746|FG000|Overall Study|Non-Compliant|8|||
13249559|NCT01577186|26365746|FG000|Overall Study|Other|2|||
13249560|NCT01577160|26365756|FG000|Overall Study|Adverse Event|9|||
13249561|NCT01577160|26365756|FG000|Overall Study|Lack of Efficacy|15|||
13249562|NCT01577160|26365756|FG000|Overall Study|Lost to Follow-up|40|||
13249563|NCT01577160|26365756|FG000|Overall Study|Withdrawal by Subject|18|||
13249564|NCT01577160|26365756|FG000|Overall Study|Subject Uncooperative|7|||
13249565|NCT01577160|26365756|FG000|Overall Study|Other|9|||
13249566|NCT01576783|26365805|FG000|Overall Study|Change in Medical Care|1|||
13249567|NCT01576783|26365806|FG001|Overall Study|Change in Medical Care|0|||
13249568|NCT01576783|26365805|FG000|Overall Study|Lost to Follow-up|14|||
13249569|NCT01576783|26365806|FG001|Overall Study|Lost to Follow-up|16|||
13249570|NCT01576783|26365805|FG000|Overall Study|Withdrawal by Subject|5|||
13249571|NCT01576783|26365806|FG001|Overall Study|Withdrawal by Subject|1|||
13249572|NCT01576718|26365918|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49|||
13249573|NCT01576718|26365919|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
13249574|NCT01576718|26365920|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
13249575|NCT01576718|26365921|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
13249576|NCT01576718|26365922|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
13249577|NCT01576718|26365923|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
13249578|NCT01576718|26365924|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
13249579|NCT01576718|26365918|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17|||
13249580|NCT01576718|26365919|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
13249581|NCT01576718|26365920|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
13290167|NCT00104052|26480809|FG000|Overall Study|Lack of Efficacy|26|||
13249582|NCT01576718|26365921|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
13249583|NCT01576718|26365922|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
13249584|NCT01576718|26365923|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
13249585|NCT01576718|26365924|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
13249586|NCT01576718|26365918|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166|||
13249587|NCT01576718|26365919|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
13116520|NCT03073200|25923201|FG010|Open-Label Maintenance Period|Participant moved to another city|0|||
13116521|NCT03073200|25923202|FG011|Open-Label Maintenance Period|Participant moved to another city|0|||
13116522|NCT03073200|25923203|FG012|Open-Label Maintenance Period|Participant moved to another city|0|||
13116523|NCT03073200|25923204|FG013|Open-Label Maintenance Period|Participant moved to another city|0|||
13116524|NCT03073200|25923205|FG014|Open-Label Maintenance Period|Participant moved to another city|0|||
13116525|NCT03073200|25923191|FG000|Open-Label Maintenance Period|Lack of Efficacy|0|||
13116526|NCT03073200|25923192|FG001|Open-Label Maintenance Period|Lack of Efficacy|0|||
13116527|NCT03073200|25923193|FG002|Open-Label Maintenance Period|Lack of Efficacy|0|||
13249588|NCT01576718|26365920|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
13249589|NCT01576718|26365921|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
13249590|NCT01576718|26365922|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
13249591|NCT01576718|26365923|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
13249592|NCT01576718|26365924|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
13249593|NCT01576718|26365918|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2|||
13249594|NCT01576718|26365919|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
13249595|NCT01576718|26365920|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
13249596|NCT01576718|26365921|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
13249597|NCT01576718|26365922|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
13249598|NCT01576718|26365923|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
13249599|NCT01576718|26365924|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
13249600|NCT01576718|26365918|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
13249601|NCT01576718|26365919|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
13249602|NCT01576718|26365920|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
13249603|NCT01576718|26365921|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
13249604|NCT01576718|26365922|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
13249605|NCT01576718|26365923|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
13249606|NCT01576718|26365924|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
13249607|NCT01576718|26365918|FG000|Treatment Period|Adverse Event|0|||
13249608|NCT01576718|26365919|FG001|Treatment Period|Adverse Event|1|||
13249609|NCT01576718|26365920|FG002|Treatment Period|Adverse Event|1|||
13249610|NCT01576718|26365921|FG003|Treatment Period|Adverse Event|1|||
13249611|NCT01576718|26365922|FG004|Treatment Period|Adverse Event|1|||
13249612|NCT01576718|26365923|FG005|Treatment Period|Adverse Event|1|||
13249613|NCT01576718|26365924|FG006|Treatment Period|Adverse Event|0|||
13249614|NCT01576718|26365918|FG000|Treatment Period|Withdrawal by Subject|0|||
13249615|NCT01576718|26365919|FG001|Treatment Period|Withdrawal by Subject|1|||
13249616|NCT01576718|26365920|FG002|Treatment Period|Withdrawal by Subject|1|||
13249617|NCT01576718|26365921|FG003|Treatment Period|Withdrawal by Subject|0|||
13249618|NCT01576718|26365922|FG004|Treatment Period|Withdrawal by Subject|2|||
13249619|NCT01576718|26365923|FG005|Treatment Period|Withdrawal by Subject|4|||
13249620|NCT01576718|26365924|FG006|Treatment Period|Withdrawal by Subject|2|||
13249621|NCT01576718|26365918|FG000|Treatment Period|Physician Decision|0|||
13249622|NCT01576718|26365919|FG001|Treatment Period|Physician Decision|1|||
13249623|NCT01576718|26365920|FG002|Treatment Period|Physician Decision|1|||
13249624|NCT01576718|26365921|FG003|Treatment Period|Physician Decision|1|||
13249625|NCT01576718|26365922|FG004|Treatment Period|Physician Decision|1|||
13249626|NCT01576718|26365923|FG005|Treatment Period|Physician Decision|0|||
13249627|NCT01576718|26365924|FG006|Treatment Period|Physician Decision|0|||
13249628|NCT01576718|26365918|FG000|Treatment Period|Protocol Violation|0|||
13249629|NCT01576718|26365919|FG001|Treatment Period|Protocol Violation|5|||
13249630|NCT01576718|26365920|FG002|Treatment Period|Protocol Violation|4|||
13249631|NCT01576718|26365921|FG003|Treatment Period|Protocol Violation|10|||
13249632|NCT01576718|26365922|FG004|Treatment Period|Protocol Violation|6|||
13249633|NCT01576718|26365923|FG005|Treatment Period|Protocol Violation|8|||
13249634|NCT01576718|26365924|FG006|Treatment Period|Protocol Violation|12|||
13249635|NCT01576718|26365918|FG000|Treatment Period|Sponsor request|0|||
13249636|NCT01576718|26365919|FG001|Treatment Period|Sponsor request|1|||
13249637|NCT01576718|26365920|FG002|Treatment Period|Sponsor request|0|||
13249638|NCT01576718|26365921|FG003|Treatment Period|Sponsor request|0|||
13249639|NCT01576718|26365922|FG004|Treatment Period|Sponsor request|0|||
13249640|NCT01576718|26365923|FG005|Treatment Period|Sponsor request|1|||
13249641|NCT01576718|26365924|FG006|Treatment Period|Sponsor request|0|||
13249642|NCT01576718|26365918|FG000|Treatment Period|Met stopping criteria|0|||
13249643|NCT01576718|26365919|FG001|Treatment Period|Met stopping criteria|16|||
13249644|NCT01576718|26365920|FG002|Treatment Period|Met stopping criteria|13|||
13249645|NCT01576718|26365921|FG003|Treatment Period|Met stopping criteria|19|||
13249646|NCT01576718|26365922|FG004|Treatment Period|Met stopping criteria|16|||
13249647|NCT01576718|26365923|FG005|Treatment Period|Met stopping criteria|33|||
13249648|NCT01576718|26365924|FG006|Treatment Period|Met stopping criteria|15|||
13249649|NCT01576718|26365918|FG000|Treatment Period|Lost to Follow-up|0|||
13249650|NCT01576718|26365919|FG001|Treatment Period|Lost to Follow-up|0|||
13249651|NCT01576718|26365920|FG002|Treatment Period|Lost to Follow-up|0|||
13249652|NCT01576718|26365921|FG003|Treatment Period|Lost to Follow-up|0|||
13249653|NCT01576718|26365922|FG004|Treatment Period|Lost to Follow-up|1|||
13249654|NCT01576718|26365923|FG005|Treatment Period|Lost to Follow-up|0|||
13249655|NCT01576718|26365924|FG006|Treatment Period|Lost to Follow-up|0|||
13249656|NCT01576718|26365918|FG000|Treatment Period|Noncompliance to study medication|0|||
13249657|NCT01576718|26365919|FG001|Treatment Period|Noncompliance to study medication|0|||
13249658|NCT01576718|26365920|FG002|Treatment Period|Noncompliance to study medication|0|||
13249659|NCT01576718|26365921|FG003|Treatment Period|Noncompliance to study medication|0|||
13249660|NCT01576718|26365922|FG004|Treatment Period|Noncompliance to study medication|0|||
13249661|NCT01576718|26365923|FG005|Treatment Period|Noncompliance to study medication|1|||
13249662|NCT01576718|26365924|FG006|Treatment Period|Noncompliance to study medication|1|||
13249663|NCT01576705|26365951|FG000|Overall Study|TSH > 7 mIU/L at baseline|3|||
13249664|NCT01576705|26365952|FG001|Overall Study|TSH > 7 mIU/L at baseline|7|||
13249665|NCT01576705|26365953|FG002|Overall Study|TSH > 7 mIU/L at baseline|5|||
13249666|NCT01576705|26365954|FG003|Overall Study|TSH > 7 mIU/L at baseline|3|||
13249667|NCT01576705|26365951|FG000|Overall Study|invalid ICF|0|||
13249668|NCT01576705|26365952|FG001|Overall Study|invalid ICF|1|||
13249669|NCT01576705|26365953|FG002|Overall Study|invalid ICF|0|||
13249670|NCT01576705|26365954|FG003|Overall Study|invalid ICF|0|||
13249671|NCT01576575|26365966|FG000|Buprenorphine Control|Withdrawal by Subject|3|||
13249672|NCT01576575|26365966|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3|||
13249673|NCT01576575|26365966|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1|||
13249674|NCT01576549|26365976|FG000|Overall Study|Sponsor Decision|2|||
13249675|NCT01576484|26366047|FG000|Overall Study|Adverse Event|1|||
13249676|NCT01576484|26366048|FG001|Overall Study|Adverse Event|1|||
13249677|NCT01576484|26366047|FG000|Overall Study|Protocol Violation|0|||
13249678|NCT01576484|26366048|FG001|Overall Study|Protocol Violation|2|||
13249679|NCT01576484|26366047|FG000|Overall Study|Sponsor Decision|2|||
13249680|NCT01576484|26366048|FG001|Overall Study|Sponsor Decision|8|||
13249681|NCT01576484|26366047|FG000|Overall Study|Withdrawal by Subject|0|||
13249682|NCT01576484|26366048|FG001|Overall Study|Withdrawal by Subject|3|||
13249683|NCT01576484|26366047|FG000|Overall Study|Other|2|||
13249684|NCT01576484|26366048|FG001|Overall Study|Other|5|||
13249685|NCT01576406|26366315|FG000|Overall Study|Lost to Follow-up|1|||
13249686|NCT01576406|26366316|FG001|Overall Study|Lost to Follow-up|2|||
13249687|NCT01576406|26366317|FG002|Overall Study|Lost to Follow-up|0|||
13249688|NCT01576406|26366318|FG003|Overall Study|Lost to Follow-up|0|||
13249689|NCT01576406|26366319|FG004|Overall Study|Lost to Follow-up|0|||
13249690|NCT01576406|26366320|FG005|Overall Study|Lost to Follow-up|0|||
13249691|NCT01576406|26366315|FG000|Overall Study|Death|3|||
13249692|NCT01576406|26366316|FG001|Overall Study|Death|4|||
13249693|NCT01576406|26366317|FG002|Overall Study|Death|8|||
13249694|NCT01576406|26366318|FG003|Overall Study|Death|5|||
13249695|NCT01576406|26366319|FG004|Overall Study|Death|7|||
13249696|NCT01576406|26366320|FG005|Overall Study|Death|9|||
13249697|NCT01576406|26366315|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0|||
13249698|NCT01576406|26366316|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0|||
13249699|NCT01576406|26366317|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1|||
13249700|NCT01576406|26366318|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1|||
13249701|NCT01576406|26366319|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0|||
13249702|NCT01576406|26366320|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0|||
13249703|NCT01576406|26366315|FG000|Overall Study|Withdrawal the consent|2|||
13249704|NCT01576406|26366316|FG001|Overall Study|Withdrawal the consent|2|||
13249705|NCT01576406|26366317|FG002|Overall Study|Withdrawal the consent|5|||
13249706|NCT01576406|26366318|FG003|Overall Study|Withdrawal the consent|1|||
13249707|NCT01576406|26366319|FG004|Overall Study|Withdrawal the consent|1|||
13249708|NCT01576406|26366320|FG005|Overall Study|Withdrawal the consent|3|||
13249709|NCT01576406|26366315|FG000|Overall Study|Other|0|||
13249710|NCT01576406|26366316|FG001|Overall Study|Other|0|||
13249711|NCT01576406|26366317|FG002|Overall Study|Other|2|||
13249712|NCT01576406|26366318|FG003|Overall Study|Other|2|||
13249713|NCT01576406|26366319|FG004|Overall Study|Other|0|||
13249714|NCT01576406|26366320|FG005|Overall Study|Other|0|||
13249715|NCT01576367|26366330|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
13249716|NCT01576367|26366330|FG000|Overall Study|Moved to commercial use after 6 months|1|||
13249717|NCT01576341|26366339|FG000|Overall Study|Withdrawal by Subject|24|||
13249718|NCT01576341|26366339|FG000|Overall Study|Adverse Event|10|||
13249719|NCT01576341|26366339|FG000|Overall Study|Death|21|||
13249720|NCT01576341|26366339|FG000|Overall Study|Physician Decision|2|||
13249721|NCT01576341|26366339|FG000|Overall Study|Lost to Follow-up|2|||
13249722|NCT01576341|26366339|FG000|Overall Study|Kidney transplantation|10|||
13249723|NCT01576341|26366339|FG000|Overall Study|Protocol Violation|12|||
13249724|NCT01576341|26366339|FG000|Overall Study|Other|12|||
13249725|NCT01576172|26366360|FG000|Overall Study|Ineligible|2|||
13249726|NCT01576172|26366361|FG001|Overall Study|Ineligible|1|||
13249727|NCT01576172|26366360|FG000|Overall Study|Withdrawal by Subject|2|||
13249728|NCT01576172|26366361|FG001|Overall Study|Withdrawal by Subject|0|||
13249729|NCT01576172|26366360|FG000|Overall Study|Insurance issue|1|||
13249730|NCT01576172|26366361|FG001|Overall Study|Insurance issue|0|||
13249731|NCT01576159|26366392|FG000|Overall Study|Withdrawal by Subject|0|||
13249732|NCT01576159|26366393|FG001|Overall Study|Withdrawal by Subject|1|||
13249733|NCT01576159|26366394|FG002|Overall Study|Withdrawal by Subject|0|||
13249734|NCT01576159|26366395|FG003|Overall Study|Withdrawal by Subject|0|||
13249735|NCT01576159|26366392|FG000|Overall Study|Physician Decision|0|||
13249736|NCT01576159|26366393|FG001|Overall Study|Physician Decision|0|||
13249737|NCT01576159|26366394|FG002|Overall Study|Physician Decision|1|||
13249738|NCT01576159|26366395|FG003|Overall Study|Physician Decision|0|||
13249739|NCT01576159|26366392|FG000|Overall Study|Lost to Follow-up|0|||
13249740|NCT01576159|26366393|FG001|Overall Study|Lost to Follow-up|0|||
13249741|NCT01576159|26366394|FG002|Overall Study|Lost to Follow-up|0|||
13249742|NCT01576159|26366395|FG003|Overall Study|Lost to Follow-up|1|||
13249743|NCT01576159|26366392|FG000|Overall Study|Protocol Violation|1|||
13249744|NCT01576159|26366393|FG001|Overall Study|Protocol Violation|0|||
13249745|NCT01576159|26366394|FG002|Overall Study|Protocol Violation|0|||
13249746|NCT01576159|26366395|FG003|Overall Study|Protocol Violation|0|||
13249747|NCT01576146|26366404|FG000|Extension Period 1|Adverse Event|2|||
13249748|NCT01576146|26366404|FG000|Extension Period 1|Death|2|||
13249749|NCT01576146|26366404|FG000|Extension Period 1|Physician Decision|2|||
13249750|NCT01576146|26366404|FG000|Extension Period 1|Withdrawal by Subject|1|||
13249751|NCT01576146|26366404|FG000|Extension Period 1|Lost to Follow-up|1|||
13249752|NCT01576146|26366404|FG000|Extension Period 1|Parathyroidectomy|1|||
13249753|NCT01576146|26366404|FG000|Extension Period 1|Renal Transplant|1|||
13249754|NCT01576146|26366404|FG000|Extension Period 2|Sponsor Decision|13|||
13249755|NCT01576146|26366404|FG000|Extension Period 2|Death|1|||
13249756|NCT01576146|26366404|FG000|Extension Period 2|Adverse Event|1|||
13249757|NCT01576146|26366404|FG000|Extension Period 2|Renal Transplant|1|||
13249758|NCT01576146|26366404|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1|||
13249759|NCT01576042|26366431|FG000|Overall Study|Physician Decision|2|||
13249760|NCT01576042|26366432|FG001|Overall Study|Physician Decision|0|||
13249761|NCT01576016|26366455|FG000|Lead Safety|Death|132|||
13249762|NCT01576016|26366456|FG001|Lead Safety|Death|0|||
13249763|NCT01576016|26366455|FG000|Lead Safety|Withdrawal by Subject|81|||
13249764|NCT01576016|26366456|FG001|Lead Safety|Withdrawal by Subject|0|||
13249765|NCT01576016|26366455|FG000|Lead Safety|System Explanted without Replacement|24|||
13249766|NCT01576016|26366456|FG001|Lead Safety|System Explanted without Replacement|0|||
13249767|NCT01576016|26366455|FG000|Lead Safety|Physician Decision|14|||
13249768|NCT01576016|26366456|FG001|Lead Safety|Physician Decision|0|||
13249769|NCT01576016|26366455|FG000|Lead Safety|Lost to Follow-up|13|||
13249770|NCT01576016|26366456|FG001|Lead Safety|Lost to Follow-up|0|||
13249771|NCT01576016|26366455|FG000|Lead Safety|Unsuccessful implant|2|||
13249772|NCT01576016|26366456|FG001|Lead Safety|Unsuccessful implant|0|||
13249773|NCT01576016|26366455|FG000|Lead Safety|Sponsor request|1|||
13249774|NCT01576016|26366456|FG001|Lead Safety|Sponsor request|0|||
13249775|NCT01576016|26366455|FG000|Lead Safety|Device replaced with CRT-D|1|||
13249776|NCT01576016|26366456|FG001|Lead Safety|Device replaced with CRT-D|0|||
13249777|NCT01576016|26366455|FG000|Lead Safety|Patient on Palliative Care|1|||
13249778|NCT01576016|26366456|FG001|Lead Safety|Patient on Palliative Care|0|||
13249779|NCT01576016|26366455|FG000|Lead Safety|Patient noncompliance|1|||
13249780|NCT01576016|26366456|FG001|Lead Safety|Patient noncompliance|0|||
13249781|NCT01576016|26366455|FG000|Lead Safety|Too far from study site|1|||
13249782|NCT01576016|26366456|FG001|Lead Safety|Too far from study site|0|||
13249783|NCT01576016|26366455|FG000|Lead Safety|System deactivated|1|||
13249784|NCT01576016|26366456|FG001|Lead Safety|System deactivated|0|||
13249785|NCT01576016|26366455|FG000|Lead Safety|Patient no longer followed by study PI|1|||
13249786|NCT01576016|26366456|FG001|Lead Safety|Patient no longer followed by study PI|0|||
13249787|NCT01576016|26366455|FG000|MRI Safety|Withdrawal by Subject|0|||
13249788|NCT01576016|26366456|FG001|MRI Safety|Withdrawal by Subject|10|||
13249789|NCT01576016|26366455|FG000|MRI Safety|Non-MRI Compatible Device or Material|0|||
13249790|NCT01576016|26366456|FG001|MRI Safety|Non-MRI Compatible Device or Material|5|||
13249791|NCT01576016|26366455|FG000|MRI Safety|Has not yet completed MRI scan|0|||
13249792|NCT01576016|26366456|FG001|MRI Safety|Has not yet completed MRI scan|56|||
13249793|NCT01576016|26366455|FG000|MRI Safety|MRI scan not performed at MRI visit|0|||
13249794|NCT01576016|26366456|FG001|MRI Safety|MRI scan not performed at MRI visit|3|||
13249795|NCT01575899|26366476|FG000|Overall Study|Lost to Follow-up|3|||
13249796|NCT01575899|26366477|FG001|Overall Study|Lost to Follow-up|4|||
13249797|NCT01575899|26366478|FG002|Overall Study|Lost to Follow-up|2|||
13249798|NCT01575899|26366476|FG000|Overall Study|Protocol Violation|2|||
13249799|NCT01575899|26366477|FG001|Overall Study|Protocol Violation|1|||
13249800|NCT01575899|26366478|FG002|Overall Study|Protocol Violation|0|||
13249801|NCT01575873|26366515|FG000|Overall Study|Withdrawal by Subject|15|||
13249802|NCT01575873|26366516|FG001|Overall Study|Withdrawal by Subject|20|||
13249803|NCT01575873|26366517|FG002|Overall Study|Withdrawal by Subject|34|||
13249804|NCT01575873|26366518|FG003|Overall Study|Withdrawal by Subject|34|||
13249805|NCT01575873|26366515|FG000|Overall Study|Adverse Event|7|||
13249806|NCT01575873|26366516|FG001|Overall Study|Adverse Event|7|||
13249807|NCT01575873|26366517|FG002|Overall Study|Adverse Event|9|||
13249808|NCT01575873|26366518|FG003|Overall Study|Adverse Event|12|||
13249809|NCT01575873|26366515|FG000|Overall Study|Lost to Follow-up|1|||
13249810|NCT01575873|26366516|FG001|Overall Study|Lost to Follow-up|3|||
13249811|NCT01575873|26366517|FG002|Overall Study|Lost to Follow-up|13|||
13249812|NCT01575873|26366518|FG003|Overall Study|Lost to Follow-up|5|||
13249813|NCT01575873|26366515|FG000|Overall Study|Death|3|||
13249814|NCT01575873|26366516|FG001|Overall Study|Death|2|||
13249815|NCT01575873|26366517|FG002|Overall Study|Death|8|||
13249816|NCT01575873|26366518|FG003|Overall Study|Death|9|||
13249817|NCT01575873|26366515|FG000|Overall Study|Noncompliance|1|||
13249818|NCT01575873|26366516|FG001|Overall Study|Noncompliance|2|||
13249819|NCT01575873|26366517|FG002|Overall Study|Noncompliance|4|||
13249820|NCT01575873|26366518|FG003|Overall Study|Noncompliance|3|||
13249821|NCT01575873|26366515|FG000|Overall Study|Administrative decision|1|||
13249822|NCT01575873|26366516|FG001|Overall Study|Administrative decision|1|||
13249823|NCT01575873|26366517|FG002|Overall Study|Administrative decision|1|||
13249824|NCT01575873|26366518|FG003|Overall Study|Administrative decision|0|||
13249825|NCT01575873|26366515|FG000|Overall Study|Protocol deviation|0|||
13249826|NCT01575873|26366516|FG001|Overall Study|Protocol deviation|1|||
13249827|NCT01575873|26366517|FG002|Overall Study|Protocol deviation|0|||
13249828|NCT01575873|26366518|FG003|Overall Study|Protocol deviation|1|||
13249829|NCT01575873|26366515|FG000|Overall Study|Requirement for Alternative Therapy|0|||
13249830|NCT01575873|26366516|FG001|Overall Study|Requirement for Alternative Therapy|0|||
13249831|NCT01575873|26366517|FG002|Overall Study|Requirement for Alternative Therapy|1|||
13249832|NCT01575873|26366518|FG003|Overall Study|Requirement for Alternative Therapy|1|||
13249833|NCT01575873|26366515|FG000|Overall Study|Other|0|||
13249834|NCT01575873|26366516|FG001|Overall Study|Other|0|||
13249835|NCT01575873|26366517|FG002|Overall Study|Other|4|||
13249836|NCT01575873|26366518|FG003|Overall Study|Other|2|||
13249837|NCT01575860|26366526|FG000|Overall Study|Withdrawal by Subject|1|||
13249838|NCT01575860|26366526|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1|||
13249839|NCT01575769|26366554|FG000|Overall Study|Adverse Event|1|||
13249840|NCT01575769|26366554|FG000|Overall Study|Study terminated by sponsor|40|||
13249841|NCT01575561|26366568|FG000|Overall Study|Adverse Event|9|||
13249842|NCT01575561|26366568|FG000|Overall Study|Lack of Efficacy|8|||
13249843|NCT01575561|26366568|FG000|Overall Study|Lost to Follow-up|6|||
13249844|NCT01575561|26366568|FG000|Overall Study|Protocol Violation|4|||
13249845|NCT01575561|26366568|FG000|Overall Study|Withdrawal by Subject|11|||
13249846|NCT01575561|26366568|FG000|Overall Study|administration|1|||
13249847|NCT01575197|26366591|FG000|Overall Study|Migration out of study area|1|||
13249848|NCT01575197|26366592|FG001|Overall Study|Migration out of study area|5|||
13249849|NCT01575197|26366593|FG002|Overall Study|Migration out of study area|4|||
13249850|NCT01575197|26366591|FG000|Overall Study|SAE|0|||
13249851|NCT01575197|26366592|FG001|Overall Study|SAE|1|||
13249852|NCT01575197|26366593|FG002|Overall Study|SAE|0|||
13249853|NCT01575197|26366591|FG000|Overall Study|Lost to Follow-up|0|||
13249854|NCT01575197|26366592|FG001|Overall Study|Lost to Follow-up|1|||
13249855|NCT01575197|26366593|FG002|Overall Study|Lost to Follow-up|0|||
13249856|NCT01575197|26366591|FG000|Overall Study|Withdrawal by Subject|0|||
13249857|NCT01575197|26366592|FG001|Overall Study|Withdrawal by Subject|1|||
13249858|NCT01575197|26366593|FG002|Overall Study|Withdrawal by Subject|1|||
13249859|NCT01575197|26366591|FG000|Overall Study|Protocol Violation|2|||
13249860|NCT01575197|26366592|FG001|Overall Study|Protocol Violation|1|||
13249861|NCT01575197|26366593|FG002|Overall Study|Protocol Violation|1|||
13249862|NCT01575054|26366614|FG000|Overall Study|Other Reasons|5|||
13249863|NCT01575054|26366615|FG001|Overall Study|Other Reasons|3|||
13249864|NCT01575054|26366614|FG000|Overall Study|Protocol Violation|2|||
13249865|NCT01575054|26366615|FG001|Overall Study|Protocol Violation|1|||
13249866|NCT01575054|26366614|FG000|Overall Study|Personal Reasons|10|||
13249867|NCT01575054|26366615|FG001|Overall Study|Personal Reasons|11|||
13249868|NCT01575054|26366614|FG000|Overall Study|Lost to Follow-up|3|||
13249869|NCT01575054|26366615|FG001|Overall Study|Lost to Follow-up|3|||
13249870|NCT01575054|26366614|FG000|Overall Study|Adverse Event|9|||
13249871|NCT01575054|26366615|FG001|Overall Study|Adverse Event|8|||
13249872|NCT01575028|26366628|FG000|Overall Study|Physician Decision|0|||
13249873|NCT01575028|26366629|FG001|Overall Study|Physician Decision|1|||
13249874|NCT01574716|26366664|FG000|Part 1|Death|3|||
13249875|NCT01574716|26366665|FG001|Part 1|Death|1|||
13249876|NCT01574716|26366666|FG002|Part 1|Death|8|||
13249877|NCT01574716|26366667|FG003|Part 1|Death|0|||
13249878|NCT01574716|26366668|FG004|Part 1|Death|0|||
13249879|NCT01574716|26366664|FG000|Part 1|Discontinuation of study by sponsor|0|||
13249880|NCT01574716|26366665|FG001|Part 1|Discontinuation of study by sponsor|0|||
13249881|NCT01574716|26366666|FG002|Part 1|Discontinuation of study by sponsor|1|||
13249882|NCT01574716|26366667|FG003|Part 1|Discontinuation of study by sponsor|0|||
13249883|NCT01574716|26366668|FG004|Part 1|Discontinuation of study by sponsor|0|||
13249884|NCT01574716|26366664|FG000|Part 1|Withdrawal by Subject|0|||
13249885|NCT01574716|26366665|FG001|Part 1|Withdrawal by Subject|2|||
13249886|NCT01574716|26366666|FG002|Part 1|Withdrawal by Subject|0|||
13249887|NCT01574716|26366667|FG003|Part 1|Withdrawal by Subject|0|||
13249888|NCT01574716|26366668|FG004|Part 1|Withdrawal by Subject|0|||
13249889|NCT01574716|26366664|FG000|Part 1|Lost to Follow-up|0|||
13249890|NCT01574716|26366665|FG001|Part 1|Lost to Follow-up|1|||
13249891|NCT01574716|26366666|FG002|Part 1|Lost to Follow-up|0|||
13249892|NCT01574716|26366667|FG003|Part 1|Lost to Follow-up|0|||
13249893|NCT01574716|26366668|FG004|Part 1|Lost to Follow-up|0|||
13249894|NCT01574716|26366664|FG000|Part 2|Progressive disease|0|||
13249895|NCT01574716|26366665|FG001|Part 2|Progressive disease|0|||
13249896|NCT01574716|26366666|FG002|Part 2|Progressive disease|0|||
13249897|NCT01574716|26366667|FG003|Part 2|Progressive disease|1|||
13249898|NCT01574716|26366668|FG004|Part 2|Progressive disease|0|||
13249899|NCT01574716|26366664|FG000|Part 2|Death|0|||
13249900|NCT01574716|26366665|FG001|Part 2|Death|0|||
13249901|NCT01574716|26366666|FG002|Part 2|Death|0|||
13249902|NCT01574716|26366667|FG003|Part 2|Death|76|||
13249903|NCT01574716|26366668|FG004|Part 2|Death|35|||
13249904|NCT01574716|26366664|FG000|Part 2|Discontinuation of study by sponsor|0|||
13249905|NCT01574716|26366665|FG001|Part 2|Discontinuation of study by sponsor|0|||
13249906|NCT01574716|26366666|FG002|Part 2|Discontinuation of study by sponsor|0|||
13249907|NCT01574716|26366667|FG003|Part 2|Discontinuation of study by sponsor|51|||
13249908|NCT01574716|26366668|FG004|Part 2|Discontinuation of study by sponsor|31|||
13249909|NCT01574716|26366664|FG000|Part 2|Withdrawal by Subject|0|||
13249910|NCT01574716|26366665|FG001|Part 2|Withdrawal by Subject|0|||
13249911|NCT01574716|26366666|FG002|Part 2|Withdrawal by Subject|0|||
13249912|NCT01574716|26366667|FG003|Part 2|Withdrawal by Subject|5|||
13249913|NCT01574716|26366668|FG004|Part 2|Withdrawal by Subject|4|||
13249914|NCT01574716|26366664|FG000|Part 2|Brain metastases|0|||
13249915|NCT01574716|26366665|FG001|Part 2|Brain metastases|0|||
13249916|NCT01574716|26366666|FG002|Part 2|Brain metastases|0|||
13249917|NCT01574716|26366667|FG003|Part 2|Brain metastases|1|||
13249918|NCT01574716|26366668|FG004|Part 2|Brain metastases|0|||
13249919|NCT01574716|26366664|FG000|Part 2|Lost to Follow-up|0|||
13249920|NCT01574716|26366665|FG001|Part 2|Lost to Follow-up|0|||
13249921|NCT01574716|26366666|FG002|Part 2|Lost to Follow-up|0|||
13249922|NCT01574716|26366667|FG003|Part 2|Lost to Follow-up|3|||
13249923|NCT01574716|26366668|FG004|Part 2|Lost to Follow-up|0|||
13249924|NCT01574703|26366723|FG000|Overall Study|Adverse Event|0|||
13249925|NCT01574703|26366724|FG001|Overall Study|Adverse Event|2|||
13249926|NCT01574703|26366725|FG002|Overall Study|Adverse Event|1|||
13307636|NCT01283581|26529327|FG000|Overall Study|Withdrawal by Subject|2|||
13307637|NCT01283581|26529328|FG001|Overall Study|Withdrawal by Subject|5|||
13307638|NCT01283581|26529329|FG002|Overall Study|Withdrawal by Subject|2|||
13307639|NCT01283581|26529327|FG000|Overall Study|Adverse Event|1|||
13307640|NCT01283581|26529328|FG001|Overall Study|Adverse Event|1|||
13307641|NCT01283581|26529329|FG002|Overall Study|Adverse Event|4|||
13307642|NCT01283581|26529327|FG000|Overall Study|Physician Decision|0|||
13307643|NCT01283581|26529328|FG001|Overall Study|Physician Decision|1|||
13307644|NCT01283581|26529329|FG002|Overall Study|Physician Decision|2|||
13307645|NCT01283581|26529327|FG000|Overall Study|Protocol Violation|0|||
13307646|NCT01283581|26529328|FG001|Overall Study|Protocol Violation|1|||
13307647|NCT01283581|26529329|FG002|Overall Study|Protocol Violation|2|||
13307648|NCT01283581|26529327|FG000|Overall Study|Noncompliance|1|||
13307649|NCT01283581|26529328|FG001|Overall Study|Noncompliance|0|||
13307650|NCT01283581|26529329|FG002|Overall Study|Noncompliance|0|||
13307651|NCT01283581|26529327|FG000|Overall Study|Investigator unblinded|0|||
13307652|NCT01283581|26529328|FG001|Overall Study|Investigator unblinded|0|||
13116528|NCT03073200|25923194|FG003|Open-Label Maintenance Period|Lack of Efficacy|0|||
13116529|NCT03073200|25923195|FG004|Open-Label Maintenance Period|Lack of Efficacy|1|||
13116530|NCT03073200|25923196|FG005|Open-Label Maintenance Period|Lack of Efficacy|0|||
13307653|NCT01283581|26529329|FG002|Overall Study|Investigator unblinded|1|||
13307654|NCT01283581|26529327|FG000|Overall Study|"Early termination"|0|||
13307655|NCT01283581|26529328|FG001|Overall Study|"Early termination"|0|||
13307656|NCT01283581|26529329|FG002|Overall Study|"Early termination"|1|||
13307657|NCT01283542|26529387|FG000|Main Phase|Acute or progressive vision loss|1|||
13307658|NCT01283542|26529387|FG000|Main Phase|Uncontrolled diabetes mellitus|1|||
13249927|NCT01574703|26366726|FG003|Overall Study|Adverse Event|1|||
13249928|NCT01574703|26366723|FG000|Overall Study|Protocol Violation|0|||
13249929|NCT01574703|26366724|FG001|Overall Study|Protocol Violation|0|||
13249930|NCT01574703|26366725|FG002|Overall Study|Protocol Violation|0|||
13116531|NCT03073200|25923197|FG006|Open-Label Maintenance Period|Lack of Efficacy|0|||
13249931|NCT01574703|26366726|FG003|Overall Study|Protocol Violation|1|||
13307659|NCT01283542|26529387|FG000|Main Phase|abnormal laboratory values|5|||
13249932|NCT01574703|26366723|FG000|Overall Study|Unspecified Reason|27|||
13249933|NCT01574703|26366724|FG001|Overall Study|Unspecified Reason|15|||
13249934|NCT01574703|26366725|FG002|Overall Study|Unspecified Reason|20|||
13249935|NCT01574703|26366726|FG003|Overall Study|Unspecified Reason|16|||
13249936|NCT01574703|26366723|FG000|Overall Study|Withdrawal by Subject|53|||
13249937|NCT01574703|26366724|FG001|Overall Study|Withdrawal by Subject|52|||
13249938|NCT01574703|26366725|FG002|Overall Study|Withdrawal by Subject|36|||
13249939|NCT01574703|26366726|FG003|Overall Study|Withdrawal by Subject|61|||
13249940|NCT01574703|26366723|FG000|Overall Study|Met Withdrawal Criteria|0|||
13249941|NCT01574703|26366724|FG001|Overall Study|Met Withdrawal Criteria|1|||
13249942|NCT01574703|26366725|FG002|Overall Study|Met Withdrawal Criteria|1|||
13249943|NCT01574703|26366726|FG003|Overall Study|Met Withdrawal Criteria|0|||
13249944|NCT01574703|26366723|FG000|Overall Study|Lost to Follow-up|43|||
13249945|NCT01574703|26366724|FG001|Overall Study|Lost to Follow-up|41|||
13249946|NCT01574703|26366725|FG002|Overall Study|Lost to Follow-up|46|||
13249947|NCT01574703|26366726|FG003|Overall Study|Lost to Follow-up|35|||
13249948|NCT01574703|26366723|FG000|Overall Study|Death|2|||
13249949|NCT01574703|26366724|FG001|Overall Study|Death|1|||
13249950|NCT01574703|26366725|FG002|Overall Study|Death|1|||
13249951|NCT01574703|26366726|FG003|Overall Study|Death|0|||
13249952|NCT01574651|26366755|FG000|Overall Study|Lost to Follow-up|2|||
13249953|NCT01574651|26366756|FG001|Overall Study|Lost to Follow-up|4|||
13249954|NCT01574651|26366755|FG000|Overall Study|Administrative problems|0|||
13249955|NCT01574651|26366756|FG001|Overall Study|Administrative problems|1|||
13249956|NCT01574651|26366755|FG000|Overall Study|Death|3|||
13249957|NCT01574651|26366756|FG001|Overall Study|Death|3|||
13249958|NCT01574651|26366755|FG000|Overall Study|Patient's inability to use the device|0|||
13249959|NCT01574651|26366756|FG001|Overall Study|Patient's inability to use the device|1|||
13249960|NCT01574651|26366755|FG000|Overall Study|Adverse Event|36|||
13249961|NCT01574651|26366756|FG001|Overall Study|Adverse Event|27|||
13249962|NCT01574651|26366755|FG000|Overall Study|Abnormal laboratory value(s)|1|||
13249963|NCT01574651|26366756|FG001|Overall Study|Abnormal laboratory value(s)|0|||
13249964|NCT01574651|26366755|FG000|Overall Study|Abnormal test procedure result(s)|1|||
13249965|NCT01574651|26366756|FG001|Overall Study|Abnormal test procedure result(s)|1|||
13249966|NCT01574651|26366755|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
13249967|NCT01574651|26366756|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
13249968|NCT01574651|26366755|FG000|Overall Study|Protocol Violation|3|||
13249969|NCT01574651|26366756|FG001|Overall Study|Protocol Violation|5|||
13249970|NCT01574651|26366755|FG000|Overall Study|Withdrawal by Subject|9|||
13249971|NCT01574651|26366756|FG001|Overall Study|Withdrawal by Subject|10|||
13249972|NCT01574612|26366762|FG000|Overall Study|Adverse Event|3|||
13249973|NCT01574612|26366762|FG000|Overall Study|non compliant with drug|2|||
13249974|NCT01574612|26366762|FG000|Overall Study|Withdrawal by Subject|1|||
13249975|NCT01574612|26366762|FG000|Overall Study|Lost to Follow-up|2|||
13249976|NCT01574352|26366779|FG000|Overall Study|Withdrawal by Subject|6|||
13249977|NCT01574352|26366780|FG001|Overall Study|Withdrawal by Subject|13|||
13249978|NCT01574352|26366779|FG000|Overall Study|Injury in non-camp related sport|1|||
13249979|NCT01574352|26366780|FG001|Overall Study|Injury in non-camp related sport|0|||
13249980|NCT01574326|26366798|FG000|Overall Study|Randomized but not treated|0|||
13249981|NCT01574326|26366799|FG001|Overall Study|Randomized but not treated|1|||
13249982|NCT01574326|26366798|FG000|Overall Study|Withdrawal by Participant|2|||
13249983|NCT01574326|26366799|FG001|Overall Study|Withdrawal by Participant|4|||
13249984|NCT01574326|26366798|FG000|Overall Study|Physician Decision|5|||
13249985|NCT01574326|26366799|FG001|Overall Study|Physician Decision|3|||
13249986|NCT01574326|26366798|FG000|Overall Study|Adverse Event|1|||
13249987|NCT01574326|26366799|FG001|Overall Study|Adverse Event|3|||
13249988|NCT01574326|26366798|FG000|Overall Study|Other: Mainly kidney transplant|8|||
13249989|NCT01574326|26366799|FG001|Overall Study|Other: Mainly kidney transplant|8|||
13249990|NCT01574274|26366814|FG000|Overall Study|Ineligible|0|||
13249991|NCT01574274|26366815|FG001|Overall Study|Ineligible|1|||
13249992|NCT01574274|26366814|FG000|Overall Study|Withdrawal of Consent During Induction|1|||
13249993|NCT01574274|26366815|FG001|Overall Study|Withdrawal of Consent During Induction|1|||
13249994|NCT01574274|26366814|FG000|Overall Study|Ph+ B-ALL|3|||
13249995|NCT01574274|26366815|FG001|Overall Study|Ph+ B-ALL|4|||
13249996|NCT01574274|26366814|FG000|Overall Study|Induction Death|2|||
13249997|NCT01574274|26366815|FG001|Overall Study|Induction Death|0|||
13249998|NCT01574274|26366814|FG000|Overall Study|Induction Failure|4|||
13249999|NCT01574274|26366815|FG001|Overall Study|Induction Failure|1|||
13250000|NCT01574274|26366814|FG000|Overall Study|Adverse Event|16|||
13250001|NCT01574274|26366815|FG001|Overall Study|Adverse Event|13|||
13250002|NCT01574274|26366814|FG000|Overall Study|Remission Death|1|||
13250003|NCT01574274|26366815|FG001|Overall Study|Remission Death|0|||
13250004|NCT01574274|26366814|FG000|Overall Study|Withdrawal from Treatment but Agrees to be Followed|2|||
13250005|NCT01574274|26366815|FG001|Overall Study|Withdrawal from Treatment but Agrees to be Followed|0|||
13250006|NCT01574274|26366814|FG000|Overall Study|Other, unknown|3|||
13250007|NCT01574274|26366815|FG001|Overall Study|Other, unknown|2|||
13250008|NCT01574248|26366840|FG000|Overall Study|Withdrawal by Subject|2|||
13250009|NCT01574248|26366841|FG001|Overall Study|Withdrawal by Subject|0|||
13250010|NCT01574248|26366840|FG000|Overall Study|Missing primary endpoint data|1|||
13250011|NCT01574248|26366841|FG001|Overall Study|Missing primary endpoint data|0|||
13250012|NCT01574157|26366864|FG000|Overall Study|Withdrawal by Subject|4|||
13250013|NCT01574157|26366865|FG001|Overall Study|Withdrawal by Subject|5|||
13250014|NCT01574157|26366864|FG000|Overall Study|Lost to Follow-up|0|||
13250015|NCT01574157|26366865|FG001|Overall Study|Lost to Follow-up|3|||
13250016|NCT01574079|26366882|FG000|Overall Study|Physician Decision|0|||
13250017|NCT01574079|26366883|FG001|Overall Study|Physician Decision|2|||
13250018|NCT01574079|26366882|FG000|Overall Study|Lost to Follow-up|1|||
13250019|NCT01574079|26366883|FG001|Overall Study|Lost to Follow-up|0|||
13250020|NCT01573910|26366898|FG000|Overall Study|Adverse Event|4|||
13250021|NCT01573910|26366899|FG001|Overall Study|Adverse Event|4|||
13250022|NCT01573910|26366898|FG000|Overall Study|Lost to Follow-up|2|||
13250023|NCT01573910|26366899|FG001|Overall Study|Lost to Follow-up|1|||
13250024|NCT01573910|26366898|FG000|Overall Study|Withdrawal by Subject|0|||
13250025|NCT01573910|26366899|FG001|Overall Study|Withdrawal by Subject|1|||
13250026|NCT01573910|26366898|FG000|Overall Study|Protocol Violation|3|||
13250027|NCT01573910|26366899|FG001|Overall Study|Protocol Violation|0|||
13250028|NCT01573910|26366898|FG000|Overall Study|Patient decision unrelated to Advs Event|11|||
13250029|NCT01573910|26366899|FG001|Overall Study|Patient decision unrelated to Advs Event|11|||
13250030|NCT01573767|26366946|FG000|Overall Study|Adverse Event|0|||
13250031|NCT01573767|26366947|FG001|Overall Study|Adverse Event|1|||
13250032|NCT01573767|26366948|FG002|Overall Study|Adverse Event|0|||
13250033|NCT01573767|26366949|FG003|Overall Study|Adverse Event|1|||
13250034|NCT01573767|26366946|FG000|Overall Study|Lack of Efficacy|18|||
13250035|NCT01573767|26366947|FG001|Overall Study|Lack of Efficacy|15|||
13250036|NCT01573767|26366948|FG002|Overall Study|Lack of Efficacy|12|||
13250037|NCT01573767|26366949|FG003|Overall Study|Lack of Efficacy|17|||
13250038|NCT01573767|26366946|FG000|Overall Study|Protocol Violation|3|||
13250039|NCT01573767|26366947|FG001|Overall Study|Protocol Violation|1|||
13250040|NCT01573767|26366948|FG002|Overall Study|Protocol Violation|1|||
13250041|NCT01573767|26366949|FG003|Overall Study|Protocol Violation|3|||
13250042|NCT01573767|26366946|FG000|Overall Study|Lost to Follow-up|0|||
13250043|NCT01573767|26366947|FG001|Overall Study|Lost to Follow-up|1|||
13250044|NCT01573767|26366948|FG002|Overall Study|Lost to Follow-up|1|||
13250045|NCT01573767|26366949|FG003|Overall Study|Lost to Follow-up|1|||
13250046|NCT01573767|26366946|FG000|Overall Study|Physician Decision|1|||
13250047|NCT01573767|26366947|FG001|Overall Study|Physician Decision|2|||
13250048|NCT01573767|26366948|FG002|Overall Study|Physician Decision|0|||
13250049|NCT01573767|26366949|FG003|Overall Study|Physician Decision|2|||
13250050|NCT01573767|26366946|FG000|Overall Study|Withdrawal by Subject|0|||
13250051|NCT01573767|26366947|FG001|Overall Study|Withdrawal by Subject|1|||
13250052|NCT01573767|26366948|FG002|Overall Study|Withdrawal by Subject|0|||
13250053|NCT01573767|26366949|FG003|Overall Study|Withdrawal by Subject|0|||
13250054|NCT01573624|26367004|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
13250055|NCT01573624|26367005|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
13250056|NCT01573624|26367006|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
13250057|NCT01573624|26367007|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
13250058|NCT01573624|26367008|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
13250059|NCT01573624|26367009|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
13250060|NCT01573624|26367010|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
13250061|NCT01573624|26367004|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4|||
13250062|NCT01573624|26367005|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3|||
13250063|NCT01573624|26367006|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6|||
13250064|NCT01573624|26367007|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
13250065|NCT01573624|26367008|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2|||
13250066|NCT01573624|26367009|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
13250067|NCT01573624|26367010|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
13250068|NCT01573624|26367004|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1|||
13250069|NCT01573624|26367005|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
13250070|NCT01573624|26367006|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
13250071|NCT01573624|26367007|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
13250072|NCT01573624|26367008|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
13250073|NCT01573624|26367009|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
13250074|NCT01573624|26367010|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
13250075|NCT01573624|26367004|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
13250076|NCT01573624|26367005|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
13250077|NCT01573624|26367006|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
13250078|NCT01573624|26367007|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
13250079|NCT01573624|26367008|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
13250080|NCT01573624|26367009|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
13250081|NCT01573624|26367010|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
13250082|NCT01573624|26367004|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
13250083|NCT01573624|26367005|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
13250084|NCT01573624|26367006|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
13250085|NCT01573624|26367007|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
13250086|NCT01573624|26367008|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
13250087|NCT01573624|26367009|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
13250088|NCT01573624|26367010|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
13250089|NCT01573624|26367004|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
13250090|NCT01573624|26367005|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
13250091|NCT01573624|26367006|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
13250092|NCT01573624|26367007|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
13250093|NCT01573624|26367008|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
13250094|NCT01573624|26367009|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1|||
13250095|NCT01573624|26367010|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
13250096|NCT01573624|26367004|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
13250097|NCT01573624|26367005|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
13250098|NCT01573624|26367006|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
13250099|NCT01573624|26367007|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
13250100|NCT01573624|26367008|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
13250101|NCT01573624|26367009|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
13250102|NCT01573624|26367010|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
13250103|NCT01573624|26367004|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
13250104|NCT01573624|26367005|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
13250105|NCT01573624|26367006|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2|||
13250106|NCT01573624|26367007|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
13250107|NCT01573624|26367008|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
13250108|NCT01573624|26367009|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
13250109|NCT01573624|26367010|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
13250110|NCT01573624|26367004|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
13250111|NCT01573624|26367005|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
13250112|NCT01573624|26367006|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
13250113|NCT01573624|26367007|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
13250114|NCT01573624|26367008|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
13250115|NCT01573624|26367009|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1|||
13250116|NCT01573624|26367010|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
13250117|NCT01573624|26367004|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
13250118|NCT01573624|26367005|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
13250119|NCT01573624|26367006|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
13250120|NCT01573624|26367007|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2|||
13250121|NCT01573624|26367008|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
13250122|NCT01573624|26367009|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
13250123|NCT01573624|26367010|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
13250124|NCT01573624|26367004|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
13250125|NCT01573624|26367005|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
13250126|NCT01573624|26367006|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
13250127|NCT01573624|26367007|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
13250128|NCT01573624|26367008|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
13250129|NCT01573624|26367009|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
13250130|NCT01573624|26367010|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
13250131|NCT01573624|26367004|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5|||
13250132|NCT01573624|26367005|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4|||
13250133|NCT01573624|26367006|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
13250134|NCT01573624|26367007|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1|||
13250135|NCT01573624|26367008|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3|||
13250136|NCT01573624|26367009|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
13250137|NCT01573624|26367010|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0|||
13250138|NCT01573624|26367004|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
13250139|NCT01573624|26367005|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1|||
13250140|NCT01573624|26367006|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
13250141|NCT01573624|26367007|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
13250142|NCT01573624|26367008|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
13250143|NCT01573624|26367009|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2|||
13250144|NCT01573624|26367010|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
13250145|NCT01573624|26367004|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1|||
13250146|NCT01573624|26367005|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
13250147|NCT01573624|26367006|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
13250148|NCT01573624|26367007|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
13250149|NCT01573624|26367008|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
13250150|NCT01573624|26367009|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
13250151|NCT01573624|26367010|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
13250152|NCT01573624|26367004|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
13250153|NCT01573624|26367005|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
13250154|NCT01573624|26367006|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
13250155|NCT01573624|26367007|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
13250156|NCT01573624|26367008|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
13250157|NCT01573624|26367009|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
13250158|NCT01573624|26367010|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
13250159|NCT01573624|26367004|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1|||
13250160|NCT01573624|26367005|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
13250161|NCT01573624|26367006|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
13250162|NCT01573624|26367007|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
13250163|NCT01573624|26367008|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
13250164|NCT01573624|26367009|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
13250165|NCT01573624|26367010|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
13250166|NCT01573624|26367004|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
13250167|NCT01573624|26367005|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
13250168|NCT01573624|26367006|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
13250169|NCT01573624|26367007|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
13250170|NCT01573624|26367008|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
13250171|NCT01573624|26367009|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
13250172|NCT01573624|26367010|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
13307660|NCT01283542|26529387|FG000|Extension Phase|Physician Decision|1|||
13307661|NCT01283542|26529387|FG000|Extension Phase|Adverse Event|1|||
13307662|NCT01283542|26529387|FG000|Extension Phase|Administrative problems|1|||
13307663|NCT01283516|26529535|FG000|Overall Study|Adverse Event|0|||
13307664|NCT01283516|26529536|FG001|Overall Study|Adverse Event|0|||
13307665|NCT01283516|26529537|FG002|Overall Study|Adverse Event|0|||
13307666|NCT01283516|26529538|FG003|Overall Study|Adverse Event|0|||
13307667|NCT01283516|26529539|FG004|Overall Study|Adverse Event|0|||
13307668|NCT01283516|26529540|FG005|Overall Study|Adverse Event|0|||
13307669|NCT01283516|26529541|FG006|Overall Study|Adverse Event|2|||
13307670|NCT01283516|26529542|FG007|Overall Study|Adverse Event|0|||
13307671|NCT01283516|26529543|FG008|Overall Study|Adverse Event|28|||
13307672|NCT01283516|26529535|FG000|Overall Study|Death|0|||
13307673|NCT01283516|26529536|FG001|Overall Study|Death|0|||
13307674|NCT01283516|26529537|FG002|Overall Study|Death|0|||
13307675|NCT01283516|26529538|FG003|Overall Study|Death|0|||
13307676|NCT01283516|26529539|FG004|Overall Study|Death|0|||
13307677|NCT01283516|26529540|FG005|Overall Study|Death|1|||
13307678|NCT01283516|26529541|FG006|Overall Study|Death|0|||
13307679|NCT01283516|26529542|FG007|Overall Study|Death|1|||
13307680|NCT01283516|26529543|FG008|Overall Study|Death|12|||
13307681|NCT01283516|26529535|FG000|Overall Study|Disease Progression|2|||
13307682|NCT01283516|26529536|FG001|Overall Study|Disease Progression|2|||
13307683|NCT01283516|26529537|FG002|Overall Study|Disease Progression|3|||
13307684|NCT01283516|26529538|FG003|Overall Study|Disease Progression|3|||
13307685|NCT01283516|26529539|FG004|Overall Study|Disease Progression|13|||
13307686|NCT01283516|26529540|FG005|Overall Study|Disease Progression|8|||
13307687|NCT01283516|26529541|FG006|Overall Study|Disease Progression|6|||
13307688|NCT01283516|26529542|FG007|Overall Study|Disease Progression|3|||
13307689|NCT01283516|26529543|FG008|Overall Study|Disease Progression|139|||
13307690|NCT01283516|26529535|FG000|Overall Study|Withdrawal by Subject|0|||
13307691|NCT01283516|26529536|FG001|Overall Study|Withdrawal by Subject|0|||
13307692|NCT01283516|26529537|FG002|Overall Study|Withdrawal by Subject|0|||
13307693|NCT01283516|26529538|FG003|Overall Study|Withdrawal by Subject|0|||
13307694|NCT01283516|26529539|FG004|Overall Study|Withdrawal by Subject|1|||
13307695|NCT01283516|26529540|FG005|Overall Study|Withdrawal by Subject|0|||
13307696|NCT01283516|26529541|FG006|Overall Study|Withdrawal by Subject|1|||
13307697|NCT01283516|26529542|FG007|Overall Study|Withdrawal by Subject|0|||
13307698|NCT01283516|26529543|FG008|Overall Study|Withdrawal by Subject|36|||
13485857|NCT03116685|27033505|FG000|Overall Study|Physician Decision|0|||
13307699|NCT01283516|26529535|FG000|Overall Study|Administrative problems|0|||
13307700|NCT01283516|26529536|FG001|Overall Study|Administrative problems|0|||
13307701|NCT01283516|26529537|FG002|Overall Study|Administrative problems|0|||
13307702|NCT01283516|26529538|FG003|Overall Study|Administrative problems|0|||
13307703|NCT01283516|26529539|FG004|Overall Study|Administrative problems|0|||
13307704|NCT01283516|26529540|FG005|Overall Study|Administrative problems|1|||
13250173|NCT01573624|26367004|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
13250174|NCT01573624|26367005|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
13250175|NCT01573624|26367006|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
13250176|NCT01573624|26367007|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
13250177|NCT01573624|26367008|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
13250178|NCT01573624|26367009|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
13250179|NCT01573624|26367010|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
13250180|NCT01573624|26367004|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
13250181|NCT01573624|26367005|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1|||
13250182|NCT01573624|26367006|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
13250183|NCT01573624|26367007|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
13250184|NCT01573624|26367008|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
13250185|NCT01573624|26367009|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
13250186|NCT01573624|26367010|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
13250187|NCT01573624|26367004|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
13250188|NCT01573624|26367005|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1|||
13250189|NCT01573624|26367006|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
13250190|NCT01573624|26367007|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
13250191|NCT01573624|26367008|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
13250192|NCT01573624|26367009|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
13250193|NCT01573624|26367010|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
13250194|NCT01573624|26367004|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
13250195|NCT01573624|26367005|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
13250196|NCT01573624|26367006|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
13250197|NCT01573624|26367007|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
13250198|NCT01573624|26367008|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
13250199|NCT01573624|26367009|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
13250200|NCT01573624|26367010|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
13250201|NCT01573624|26367004|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
13250202|NCT01573624|26367005|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
13250203|NCT01573624|26367006|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
13250204|NCT01573624|26367007|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
13250205|NCT01573624|26367008|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
13250206|NCT01573624|26367009|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
13250207|NCT01573624|26367010|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
13250208|NCT01573624|26367004|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
13250209|NCT01573624|26367005|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
13250210|NCT01573624|26367006|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
13250211|NCT01573624|26367007|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
13250212|NCT01573624|26367008|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
13250213|NCT01573624|26367009|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
13250214|NCT01573624|26367010|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4|||
13250215|NCT01573624|26367004|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
13250216|NCT01573624|26367005|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
13250217|NCT01573624|26367006|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
13250218|NCT01573624|26367007|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
13250219|NCT01573624|26367008|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
13250220|NCT01573624|26367009|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
13250221|NCT01573624|26367010|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
13250222|NCT01573624|26367004|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1|||
13250223|NCT01573624|26367005|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
13250224|NCT01573624|26367006|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
13250225|NCT01573624|26367007|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
13250226|NCT01573624|26367008|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
13250227|NCT01573624|26367009|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
13307705|NCT01283516|26529541|FG006|Overall Study|Administrative problems|1|||
13116532|NCT03073200|25923198|FG007|Open-Label Maintenance Period|Lack of Efficacy|0|||
13250228|NCT01573624|26367010|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
13250229|NCT01573624|26367004|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
13250230|NCT01573624|26367005|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
13250231|NCT01573624|26367006|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
13250232|NCT01573624|26367007|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
13250233|NCT01573624|26367008|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2|||
13250234|NCT01573624|26367009|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1|||
13250235|NCT01573624|26367010|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
13250236|NCT01573624|26367004|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1|||
13250237|NCT01573624|26367005|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
13250238|NCT01573624|26367006|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
13250239|NCT01573624|26367007|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
13250240|NCT01573624|26367008|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
13250241|NCT01573624|26367009|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
13250242|NCT01573624|26367010|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
13250243|NCT01573442|26367053|FG000|Overall Study|Cancels|9|||
13250244|NCT01573442|26367054|FG001|Overall Study|Cancels|10|||
13250245|NCT01573000|26367155|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27|||
13250246|NCT01573000|26367156|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32|||
13250247|NCT01573000|26367155|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4|||
13250248|NCT01573000|26367156|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
13250249|NCT01573000|26367155|FG000|Dosimetric and Therapeutic Treatment|Death|0|||
13250250|NCT01573000|26367156|FG001|Dosimetric and Therapeutic Treatment|Death|1|||
13250251|NCT01573000|26367155|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2|||
13250252|NCT01573000|26367156|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0|||
13250253|NCT01573000|26367155|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2|||
13250254|NCT01573000|26367156|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0|||
13250255|NCT01573000|26367155|FG000|Crossover Phase|Lack of Efficacy|0|||
13250256|NCT01573000|26367156|FG001|Crossover Phase|Lack of Efficacy|13|||
13250257|NCT01573000|26367155|FG000|Crossover Phase|Lost to Follow-up|0|||
13250258|NCT01573000|26367156|FG001|Crossover Phase|Lost to Follow-up|2|||
13250259|NCT01573000|26367155|FG000|Crossover Phase|Death|0|||
13250260|NCT01573000|26367156|FG001|Crossover Phase|Death|3|||
13250261|NCT01573000|26367155|FG000|Long-Term Follow-Up|Death|3|||
13250262|NCT01573000|26367156|FG001|Long-Term Follow-Up|Death|0|||
13250263|NCT01573000|26367155|FG000|Long-Term Follow-Up|Lost to Follow-up|0|||
13250264|NCT01573000|26367156|FG001|Long-Term Follow-Up|Lost to Follow-up|1|||
13250265|NCT01572948|26367179|FG000|Overall Study|Lost to Follow-up|1|||
13250266|NCT01572948|26367180|FG001|Overall Study|Lost to Follow-up|0|||
13250267|NCT01572948|26367179|FG000|Overall Study|unable to contact|0|||
13250268|NCT01572948|26367180|FG001|Overall Study|unable to contact|1|||
13250269|NCT01572922|26367192|FG000|Overall Study|Adverse Event|1|||
13250270|NCT01572922|26367192|FG000|Overall Study|Protocol Violation|1|||
13250271|NCT01572922|26367192|FG000|Overall Study|Death|1|||
13250272|NCT01572909|26367243|FG000|Overall Study|Adverse Event|7|||
13250273|NCT01572909|26367244|FG001|Overall Study|Adverse Event|2|||
13250274|NCT01572909|26367243|FG000|Overall Study|Death|3|||
13250275|NCT01572909|26367244|FG001|Overall Study|Death|1|||
13250276|NCT01572909|26367243|FG000|Overall Study|Lost to Follow-up|8|||
13250277|NCT01572909|26367244|FG001|Overall Study|Lost to Follow-up|7|||
13250278|NCT01572909|26367243|FG000|Overall Study|Physician Decision|1|||
13250279|NCT01572909|26367244|FG001|Overall Study|Physician Decision|1|||
13250280|NCT01572909|26367243|FG000|Overall Study|Technical Issues|1|||
13250281|NCT01572909|26367244|FG001|Overall Study|Technical Issues|0|||
13250282|NCT01572909|26367243|FG000|Overall Study|Withdrawal by Subject|12|||
13250283|NCT01572909|26367244|FG001|Overall Study|Withdrawal by Subject|11|||
13250284|NCT01572909|26367243|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0|||
13250285|NCT01572909|26367244|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3|||
13250286|NCT01572844|26367260|FG000|Overall Study|Physician Decision|1|||
13250287|NCT01572844|26367261|FG001|Overall Study|Physician Decision|1|||
13250288|NCT01572792|26367324|FG000|Lead-in Study|Lost to Follow-up|5|||
13250289|NCT01572792|26367325|FG001|Lead-in Study|Lost to Follow-up|9|||
13250290|NCT01572792|26367326|FG002|Lead-in Study|Lost to Follow-up|4|||
13250291|NCT01572792|26367327|FG003|Lead-in Study|Lost to Follow-up|2|||
13250292|NCT01572792|26367328|FG004|Lead-in Study|Lost to Follow-up|4|||
13250293|NCT01572792|26367324|FG000|Lead-in Study|Withdrawal by Subject|22|||
13250294|NCT01572792|26367325|FG001|Lead-in Study|Withdrawal by Subject|11|||
13250295|NCT01572792|26367326|FG002|Lead-in Study|Withdrawal by Subject|12|||
13250296|NCT01572792|26367327|FG003|Lead-in Study|Withdrawal by Subject|24|||
13250297|NCT01572792|26367328|FG004|Lead-in Study|Withdrawal by Subject|11|||
13250298|NCT01572792|26367324|FG000|Lead-in Study|Protocol Violation|19|||
13250299|NCT01572792|26367325|FG001|Lead-in Study|Protocol Violation|10|||
13250300|NCT01572792|26367326|FG002|Lead-in Study|Protocol Violation|12|||
13250301|NCT01572792|26367327|FG003|Lead-in Study|Protocol Violation|13|||
13250302|NCT01572792|26367328|FG004|Lead-in Study|Protocol Violation|21|||
13250303|NCT01572792|26367324|FG000|Lead-in Study|Lack of Efficacy|20|||
13250304|NCT01572792|26367325|FG001|Lead-in Study|Lack of Efficacy|5|||
13250305|NCT01572792|26367326|FG002|Lead-in Study|Lack of Efficacy|4|||
13250306|NCT01572792|26367327|FG003|Lead-in Study|Lack of Efficacy|8|||
13250307|NCT01572792|26367328|FG004|Lead-in Study|Lack of Efficacy|10|||
13250308|NCT01572792|26367324|FG000|Lead-in Study|Adverse Event|21|||
13250309|NCT01572792|26367325|FG001|Lead-in Study|Adverse Event|21|||
13250310|NCT01572792|26367326|FG002|Lead-in Study|Adverse Event|22|||
13250311|NCT01572792|26367327|FG003|Lead-in Study|Adverse Event|16|||
13250312|NCT01572792|26367328|FG004|Lead-in Study|Adverse Event|14|||
13250313|NCT01572792|26367324|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14|||
13250314|NCT01572792|26367325|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10|||
13250315|NCT01572792|26367326|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8|||
13250316|NCT01572792|26367327|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9|||
13250317|NCT01572792|26367328|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9|||
13250318|NCT01572792|26367324|FG000|Extension Study|Lost to Follow-up|6|||
13250319|NCT01572792|26367325|FG001|Extension Study|Lost to Follow-up|2|||
13250320|NCT01572792|26367326|FG002|Extension Study|Lost to Follow-up|0|||
13250321|NCT01572792|26367327|FG003|Extension Study|Lost to Follow-up|3|||
13250322|NCT01572792|26367328|FG004|Extension Study|Lost to Follow-up|3|||
13250323|NCT01572792|26367324|FG000|Extension Study|Withdrawal by Subject|7|||
13250324|NCT01572792|26367325|FG001|Extension Study|Withdrawal by Subject|6|||
13250325|NCT01572792|26367326|FG002|Extension Study|Withdrawal by Subject|11|||
13250326|NCT01572792|26367327|FG003|Extension Study|Withdrawal by Subject|8|||
13250327|NCT01572792|26367328|FG004|Extension Study|Withdrawal by Subject|14|||
13250328|NCT01572792|26367324|FG000|Extension Study|Protocol Violation|0|||
13250329|NCT01572792|26367325|FG001|Extension Study|Protocol Violation|4|||
13250330|NCT01572792|26367326|FG002|Extension Study|Protocol Violation|3|||
13250331|NCT01572792|26367327|FG003|Extension Study|Protocol Violation|4|||
13250332|NCT01572792|26367328|FG004|Extension Study|Protocol Violation|3|||
13250333|NCT01572792|26367324|FG000|Extension Study|Lack of Efficacy|2|||
13250334|NCT01572792|26367325|FG001|Extension Study|Lack of Efficacy|3|||
13250335|NCT01572792|26367326|FG002|Extension Study|Lack of Efficacy|3|||
13250336|NCT01572792|26367327|FG003|Extension Study|Lack of Efficacy|2|||
13250337|NCT01572792|26367328|FG004|Extension Study|Lack of Efficacy|2|||
13250338|NCT01572792|26367324|FG000|Extension Study|Adverse Event|7|||
13250339|NCT01572792|26367325|FG001|Extension Study|Adverse Event|6|||
13250340|NCT01572792|26367326|FG002|Extension Study|Adverse Event|5|||
13250341|NCT01572792|26367327|FG003|Extension Study|Adverse Event|6|||
13250342|NCT01572792|26367328|FG004|Extension Study|Adverse Event|4|||
13250343|NCT01572792|26367324|FG000|Extension Study|Site termination/COPD exacerbation/other|3|||
13250344|NCT01572792|26367325|FG001|Extension Study|Site termination/COPD exacerbation/other|8|||
13250345|NCT01572792|26367326|FG002|Extension Study|Site termination/COPD exacerbation/other|4|||
13250346|NCT01572792|26367327|FG003|Extension Study|Site termination/COPD exacerbation/other|6|||
13250347|NCT01572792|26367328|FG004|Extension Study|Site termination/COPD exacerbation/other|6|||
13250348|NCT01572740|26367363|FG000|Overall Study|Adverse Event|1|||
13250349|NCT01572740|26367364|FG001|Overall Study|Adverse Event|1|||
13250350|NCT01572740|26367363|FG000|Overall Study|Withdrawal by Subject|1|||
13250351|NCT01572740|26367364|FG001|Overall Study|Withdrawal by Subject|1|||
13250352|NCT01572740|26367363|FG000|Overall Study|unclassified|4|||
13250353|NCT01572740|26367364|FG001|Overall Study|unclassified|3|||
13250354|NCT01572727|26367391|FG000|Overall Study|Adverse Event|43|||
13250355|NCT01572727|26367392|FG001|Overall Study|Adverse Event|15|||
13250356|NCT01572727|26367391|FG000|Overall Study|Lost to Follow-up|1|||
13250357|NCT01572727|26367392|FG001|Overall Study|Lost to Follow-up|1|||
13250358|NCT01572727|26367391|FG000|Overall Study|Physician Decision|23|||
13250359|NCT01572727|26367392|FG001|Overall Study|Physician Decision|9|||
13250360|NCT01572727|26367391|FG000|Overall Study|Progressive disease|59|||
13116533|NCT03073200|25923199|FG008|Open-Label Maintenance Period|Lack of Efficacy|0|||
13116534|NCT03073200|25923200|FG009|Open-Label Maintenance Period|Lack of Efficacy|0|||
13116535|NCT03073200|25923201|FG010|Open-Label Maintenance Period|Lack of Efficacy|0|||
13116536|NCT03073200|25923202|FG011|Open-Label Maintenance Period|Lack of Efficacy|0|||
13116537|NCT03073200|25923203|FG012|Open-Label Maintenance Period|Lack of Efficacy|0|||
13116538|NCT03073200|25923204|FG013|Open-Label Maintenance Period|Lack of Efficacy|0|||
13116539|NCT03073200|25923205|FG014|Open-Label Maintenance Period|Lack of Efficacy|0|||
13116540|NCT03073200|25923191|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0|||
13116541|NCT03073200|25923192|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0|||
13250361|NCT01572727|26367392|FG001|Overall Study|Progressive disease|82|||
13250362|NCT01572727|26367391|FG000|Overall Study|Protocol Violation|0|||
13250363|NCT01572727|26367392|FG001|Overall Study|Protocol Violation|1|||
13250364|NCT01572727|26367391|FG000|Overall Study|Study terminated by sponsor|61|||
13250365|NCT01572727|26367392|FG001|Overall Study|Study terminated by sponsor|83|||
13250366|NCT01572727|26367391|FG000|Overall Study|Parent/guardian decision|14|||
13116542|NCT03073200|25923193|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0|||
13250367|NCT01572727|26367392|FG001|Overall Study|Parent/guardian decision|9|||
13250368|NCT01572727|26367391|FG000|Overall Study|Death|2|||
13250369|NCT01572727|26367392|FG001|Overall Study|Death|2|||
13250370|NCT01572727|26367391|FG000|Overall Study|Untreated|4|||
13250371|NCT01572727|26367392|FG001|Overall Study|Untreated|7|||
13250372|NCT01572675|26367496|FG000|Overall Study|End of prescribed treatment|140|||
13250373|NCT01572675|26367497|FG001|Overall Study|End of prescribed treatment|118|||
13250374|NCT01572675|26367496|FG000|Overall Study|Recovery|16|||
13250375|NCT01572675|26367497|FG001|Overall Study|Recovery|23|||
13250376|NCT01572675|26367496|FG000|Overall Study|Lack of Efficacy|31|||
13250377|NCT01572675|26367497|FG001|Overall Study|Lack of Efficacy|31|||
13250378|NCT01572675|26367496|FG000|Overall Study|Intolerance|6|||
13250379|NCT01572675|26367497|FG001|Overall Study|Intolerance|5|||
13250380|NCT01572675|26367496|FG000|Overall Study|Improved symptoms|8|||
13250381|NCT01572675|26367497|FG001|Overall Study|Improved symptoms|2|||
13250382|NCT01572675|26367496|FG000|Overall Study|Surgical intervention|3|||
13250383|NCT01572675|26367497|FG001|Overall Study|Surgical intervention|6|||
13250384|NCT01572675|26367496|FG000|Overall Study|Withdrawal by Subject|5|||
13250385|NCT01572675|26367497|FG001|Overall Study|Withdrawal by Subject|1|||
13250386|NCT01572675|26367496|FG000|Overall Study|Physician Decision|2|||
13250387|NCT01572675|26367497|FG001|Overall Study|Physician Decision|2|||
13250388|NCT01572675|26367496|FG000|Overall Study|Death unrelated to coxibs|1|||
13250389|NCT01572675|26367497|FG001|Overall Study|Death unrelated to coxibs|1|||
13250390|NCT01572675|26367496|FG000|Overall Study|Other disease detected|1|||
13250391|NCT01572675|26367497|FG001|Overall Study|Other disease detected|1|||
13250392|NCT01572675|26367496|FG000|Overall Study|Unknown reason|1|||
13250393|NCT01572675|26367497|FG001|Overall Study|Unknown reason|1|||
13250394|NCT01572675|26367496|FG000|Overall Study|Rheumatologist new evaluation|0|||
13250395|NCT01572675|26367497|FG001|Overall Study|Rheumatologist new evaluation|1|||
13250396|NCT01572675|26367496|FG000|Overall Study|Missing data|1|||
13250397|NCT01572675|26367497|FG001|Overall Study|Missing data|4|||
13250398|NCT01572675|26367496|FG000|Overall Study|Lost to Follow-up|22|||
13250399|NCT01572675|26367497|FG001|Overall Study|Lost to Follow-up|27|||
13250400|NCT01572480|26367504|FG000|Participants Enrolled|Withdrawal by Subject|1|||
13250401|NCT01572480|26367504|FG000|Drug Administration|Discontinued drug/Off Study|1|||
13250402|NCT01572480|26367504|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events and withdrew consent|1|||
13250403|NCT01572480|26367504|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events|2|||
13250404|NCT01572389|26367519|FG000|Overall Study|Death|1|||
13250405|NCT01572389|26367520|FG001|Overall Study|Death|3|||
13250406|NCT01572389|26367519|FG000|Overall Study|Withdrawal by Subject|14|||
13250407|NCT01572389|26367520|FG001|Overall Study|Withdrawal by Subject|2|||
13250408|NCT01572389|26367519|FG000|Overall Study|Lost to Follow-up|25|||
13250409|NCT01572389|26367520|FG001|Overall Study|Lost to Follow-up|14|||
13250410|NCT01572389|26367519|FG000|Overall Study|Only A1C or Assessment was Collected|6|||
13250411|NCT01572389|26367520|FG001|Overall Study|Only A1C or Assessment was Collected|2|||
13250412|NCT01572038|26367628|FG000|Overall Study|Death|648|||
13250413|NCT01572038|26367628|FG000|Overall Study|Withdrawal by Subject|204|||
13250414|NCT01572038|26367628|FG000|Overall Study|Lost to Follow-up|81|||
13250415|NCT01572038|26367628|FG000|Overall Study|Physician Decision|20|||
13250416|NCT01572038|26367628|FG000|Overall Study|Patient Decision|14|||
13250417|NCT01572038|26367628|FG000|Overall Study|Progressive Disease|8|||
13250418|NCT01572038|26367628|FG000|Overall Study|Site Closed Before Completing Form|6|||
13250419|NCT01572038|26367628|FG000|Overall Study|Enrolled into Another Trial|3|||
13250420|NCT01572038|26367628|FG000|Overall Study|Participated in Another Trial|3|||
13250421|NCT01572038|26367628|FG000|Overall Study|Termination by Sponsor|2|||
13250422|NCT01572038|26367628|FG000|Overall Study|Patient Deterioration|1|||
13250423|NCT01572038|26367628|FG000|Overall Study|Sponsor Decision|1|||
13250424|NCT01571596|26367649|FG000|Overall Study|Adverse Event|2|||
13250425|NCT01571596|26367650|FG001|Overall Study|Adverse Event|0|||
13250426|NCT01571596|26367651|FG002|Overall Study|Adverse Event|0|||
13250427|NCT01571596|26367649|FG000|Overall Study|Study Terminated by the Sponsor|0|||
13250428|NCT01571596|26367650|FG001|Overall Study|Study Terminated by the Sponsor|1|||
13250429|NCT01571596|26367651|FG002|Overall Study|Study Terminated by the Sponsor|1|||
13250430|NCT01571453|26367674|FG000|Overall Study|Adverse Event|14|||
13250431|NCT01571453|26367675|FG001|Overall Study|Adverse Event|32|||
13250432|NCT01571453|26367674|FG000|Overall Study|Lack of Efficacy|8|||
13250433|NCT01571453|26367675|FG001|Overall Study|Lack of Efficacy|3|||
13250434|NCT01571453|26367674|FG000|Overall Study|Non-compliance|2|||
13250435|NCT01571453|26367675|FG001|Overall Study|Non-compliance|4|||
13250436|NCT01571453|26367674|FG000|Overall Study|Protocol Violation|1|||
13250437|NCT01571453|26367675|FG001|Overall Study|Protocol Violation|5|||
13250438|NCT01571453|26367674|FG000|Overall Study|Withdrawal of consent|5|||
13250439|NCT01571453|26367675|FG001|Overall Study|Withdrawal of consent|13|||
13250440|NCT01571453|26367674|FG000|Overall Study|Lost to Follow-up|4|||
13250441|NCT01571453|26367675|FG001|Overall Study|Lost to Follow-up|2|||
13250442|NCT01571453|26367674|FG000|Overall Study|Administrative or other reason(s)|4|||
13250443|NCT01571453|26367675|FG001|Overall Study|Administrative or other reason(s)|3|||
13250444|NCT01571362|26367849|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11|||
13485858|NCT03116685|27033506|FG001|Overall Study|Physician Decision|1|||
13250445|NCT01571362|26367850|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
13250446|NCT01571362|26367851|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
13250447|NCT01571362|26367849|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7|||
13250448|NCT01571362|26367850|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0|||
13250449|NCT01571362|26367851|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0|||
13250450|NCT01571362|26367849|FG000|Open-Label Conversion + Titration Period|Adverse Event|57|||
13250451|NCT01571362|26367850|FG001|Open-Label Conversion + Titration Period|Adverse Event|0|||
13250452|NCT01571362|26367851|FG002|Open-Label Conversion + Titration Period|Adverse Event|0|||
13250453|NCT01571362|26367849|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10|||
13250454|NCT01571362|26367850|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
13250455|NCT01571362|26367851|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
13250456|NCT01571362|26367849|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41|||
13250457|NCT01571362|26367850|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
13250458|NCT01571362|26367851|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
13250459|NCT01571362|26367849|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3|||
13250460|NCT01571362|26367850|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0|||
13250461|NCT01571362|26367851|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0|||
13250462|NCT01571362|26367849|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
13250463|NCT01571362|26367850|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11|||
13250464|NCT01571362|26367851|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5|||
13250465|NCT01571362|26367849|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
13250466|NCT01571362|26367850|FG001|Double-Blind Treatment Period|Protocol Violation|8|||
13250467|NCT01571362|26367851|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
13250468|NCT01571362|26367849|FG000|Double-Blind Treatment Period|Adverse Event|0|||
13250469|NCT01571362|26367850|FG001|Double-Blind Treatment Period|Adverse Event|9|||
13250470|NCT01571362|26367851|FG002|Double-Blind Treatment Period|Adverse Event|14|||
13250471|NCT01571362|26367849|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
13250472|NCT01571362|26367850|FG001|Double-Blind Treatment Period|Lost to Follow-up|3|||
13250473|NCT01571362|26367851|FG002|Double-Blind Treatment Period|Lost to Follow-up|6|||
13250474|NCT01571362|26367849|FG000|Double-Blind Treatment Period|Insufficient clinical response|0|||
13250475|NCT01571362|26367850|FG001|Double-Blind Treatment Period|Insufficient clinical response|16|||
13250476|NCT01571362|26367851|FG002|Double-Blind Treatment Period|Insufficient clinical response|4|||
13250477|NCT01571362|26367849|FG000|Double-Blind Treatment Period|Other - unspecified|0|||
13250478|NCT01571362|26367850|FG001|Double-Blind Treatment Period|Other - unspecified|6|||
13250479|NCT01571362|26367851|FG002|Double-Blind Treatment Period|Other - unspecified|1|||
13250480|NCT01571284|26367874|FG000|Overall Study|Participant's decision|84|||
13250481|NCT01571284|26367874|FG000|Overall Study|Lost to Follow-up|3|||
13250482|NCT01571284|26367874|FG000|Overall Study|Enrolled but not treated|2|||
13250483|NCT01571284|26367874|FG000|Overall Study|Other than specified above|80|||
13250484|NCT01571232|26367895|FG000|Overall Study|Lost to Follow-up|0|||
13250485|NCT01571232|26367896|FG001|Overall Study|Lost to Follow-up|1|||
13250486|NCT01571232|26367895|FG000|Overall Study|Withdrawal by Subject|1|||
13250487|NCT01571232|26367896|FG001|Overall Study|Withdrawal by Subject|0|||
13250488|NCT01570868|26367913|FG000|Overall Study|Adverse Event|8|||
13250489|NCT01570868|26367914|FG001|Overall Study|Adverse Event|1|||
13250490|NCT01570868|26367913|FG000|Overall Study|FDA Recommendation|23|||
13250491|NCT01570868|26367914|FG001|Overall Study|FDA Recommendation|3|||
13250492|NCT01570868|26367913|FG000|Overall Study|Physician Decision|10|||
13250493|NCT01570868|26367914|FG001|Overall Study|Physician Decision|4|||
13250494|NCT01570868|26367913|FG000|Overall Study|Lost to Follow-up|1|||
13250495|NCT01570868|26367914|FG001|Overall Study|Lost to Follow-up|0|||
13250496|NCT01570868|26367913|FG000|Overall Study|Withdrawal by Subject|1|||
13250497|NCT01570868|26367914|FG001|Overall Study|Withdrawal by Subject|0|||
13250498|NCT01570751|26367937|FG000|Period A (16 Weeks)|Protocol Violation|1|||
13250499|NCT01570751|26367938|FG001|Period A (16 Weeks)|Protocol Violation|1|||
13250500|NCT01570751|26367937|FG000|Period A (16 Weeks)|Withdrawal criteria|0|||
13250501|NCT01570751|26367938|FG001|Period A (16 Weeks)|Withdrawal criteria|1|||
13250502|NCT01570751|26367937|FG000|Period A (16 Weeks)|Unclassified|2|||
13250503|NCT01570751|26367938|FG001|Period A (16 Weeks)|Unclassified|3|||
13250504|NCT01570751|26367937|FG000|Period B (16 Weeks)|Adverse Event|1|||
13250505|NCT01570751|26367938|FG001|Period B (16 Weeks)|Adverse Event|0|||
13250506|NCT01570751|26367937|FG000|Period B (16 Weeks)|Protocol Violation|0|||
13250507|NCT01570751|26367938|FG001|Period B (16 Weeks)|Protocol Violation|1|||
13250508|NCT01570686|26367971|FG000|Overall Study|Abnormal test procedure result(s)|1|||
13250509|NCT01570686|26367972|FG001|Overall Study|Abnormal test procedure result(s)|1|||
13250510|NCT01570686|26367971|FG000|Overall Study|Administrative problems|0|||
13250511|NCT01570686|26367972|FG001|Overall Study|Administrative problems|1|||
13250512|NCT01570686|26367971|FG000|Overall Study|Adverse Event|8|||
13250513|NCT01570686|26367972|FG001|Overall Study|Adverse Event|6|||
13250514|NCT01570686|26367971|FG000|Overall Study|Lost to Follow-up|4|||
13250515|NCT01570686|26367972|FG001|Overall Study|Lost to Follow-up|3|||
13250516|NCT01570686|26367971|FG000|Overall Study|Protocol Deviation|3|||
13250517|NCT01570686|26367972|FG001|Overall Study|Protocol Deviation|0|||
13250518|NCT01570686|26367971|FG000|Overall Study|Withdrawal by Subject|4|||
13250519|NCT01570686|26367972|FG001|Overall Study|Withdrawal by Subject|4|||
13250520|NCT01570686|26367971|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
13250521|NCT01570686|26367972|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
13250522|NCT01570491|26367991|FG000|Overall Study|Lost to Follow-up|3|||
13250523|NCT01570491|26367992|FG001|Overall Study|Lost to Follow-up|1|||
13250524|NCT01570491|26367991|FG000|Overall Study|treatment: not given or discontinued|2|||
13250525|NCT01570491|26367992|FG001|Overall Study|treatment: not given or discontinued|0|||
13250526|NCT01570387|26368015|FG000|Overall Study|Adverse Event|1|||
13250527|NCT01570387|26368016|FG001|Overall Study|Adverse Event|0|||
13250528|NCT01570387|26368017|FG002|Overall Study|Adverse Event|0|||
13250529|NCT01570387|26368018|FG003|Overall Study|Adverse Event|0|||
13250530|NCT01570387|26368015|FG000|Overall Study|Death|0|||
13250531|NCT01570387|26368016|FG001|Overall Study|Death|0|||
13250532|NCT01570387|26368017|FG002|Overall Study|Death|0|||
13250533|NCT01570387|26368018|FG003|Overall Study|Death|1|||
13250534|NCT01570387|26368015|FG000|Overall Study|Withdrawal by Subject|0|||
13250535|NCT01570387|26368016|FG001|Overall Study|Withdrawal by Subject|0|||
13250536|NCT01570387|26368017|FG002|Overall Study|Withdrawal by Subject|0|||
13250537|NCT01570387|26368018|FG003|Overall Study|Withdrawal by Subject|1|||
13250538|NCT01570361|26368052|FG000|Overall Study|Subject discontinued|1|||
13250539|NCT01570361|26368053|FG001|Overall Study|Subject discontinued|2|||
13250540|NCT01570361|26368052|FG000|Overall Study|Sponsor closing the study|51|||
13250541|NCT01570361|26368053|FG001|Overall Study|Sponsor closing the study|50|||
13250542|NCT01570361|26368052|FG000|Overall Study|Subject excluded|5|||
13250543|NCT01570361|26368053|FG001|Overall Study|Subject excluded|3|||
13250544|NCT01570361|26368052|FG000|Overall Study|Subject withdrew consent|14|||
13250545|NCT01570361|26368053|FG001|Overall Study|Subject withdrew consent|9|||
13250546|NCT01570361|26368052|FG000|Overall Study|Adverse Event|2|||
13250547|NCT01570361|26368053|FG001|Overall Study|Adverse Event|1|||
13250548|NCT01570361|26368052|FG000|Overall Study|Lost to Follow-up|4|||
13250549|NCT01570361|26368053|FG001|Overall Study|Lost to Follow-up|4|||
13250550|NCT01570361|26368052|FG000|Overall Study|Death|5|||
13250551|NCT01570361|26368053|FG001|Overall Study|Death|4|||
13250552|NCT01570361|26368052|FG000|Overall Study|Other|0|||
13250553|NCT01570361|26368053|FG001|Overall Study|Other|2|||
13250554|NCT01570309|26368074|FG000|Overall Study|Withdrawal by Subject|3|||
13250555|NCT01570309|26368075|FG001|Overall Study|Withdrawal by Subject|3|||
13250556|NCT01570283|26368105|FG000|Cohort 1: Dose Level 1|Death|0|||
13250557|NCT01570283|26368106|FG001|Cohort 1: Dose Level 1|Death|1|||
13250558|NCT01570283|26368107|FG002|Cohort 1: Dose Level 1|Death|0|||
13250559|NCT01570283|26368108|FG003|Cohort 1: Dose Level 1|Death|0|||
13250560|NCT01570283|26368109|FG004|Cohort 1: Dose Level 1|Death|0|||
13250561|NCT01570283|26368110|FG005|Cohort 1: Dose Level 1|Death|0|||
13250562|NCT01570283|26368105|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
13250563|NCT01570283|26368106|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1|||
13250564|NCT01570283|26368107|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
13250565|NCT01570283|26368108|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
13250566|NCT01570283|26368109|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
13250567|NCT01570283|26368110|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
13250568|NCT01570283|26368105|FG000|Cohort 2: Dose Level 2|Death|0|||
13250569|NCT01570283|26368106|FG001|Cohort 2: Dose Level 2|Death|0|||
13250570|NCT01570283|26368107|FG002|Cohort 2: Dose Level 2|Death|1|||
13250571|NCT01570283|26368108|FG003|Cohort 2: Dose Level 2|Death|0|||
13250572|NCT01570283|26368109|FG004|Cohort 2: Dose Level 2|Death|0|||
13250573|NCT01570283|26368110|FG005|Cohort 2: Dose Level 2|Death|0|||
13250574|NCT01570283|26368105|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
13250575|NCT01570283|26368106|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
13250576|NCT01570283|26368107|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
13250577|NCT01570283|26368108|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1|||
13250578|NCT01570283|26368109|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
13250579|NCT01570283|26368110|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
13250580|NCT01570283|26368105|FG000|Cohort 3: Dose Level 3|Death|0|||
13250581|NCT01570283|26368106|FG001|Cohort 3: Dose Level 3|Death|0|||
13250582|NCT01570283|26368107|FG002|Cohort 3: Dose Level 3|Death|0|||
13250583|NCT01570283|26368108|FG003|Cohort 3: Dose Level 3|Death|0|||
13250584|NCT01570283|26368109|FG004|Cohort 3: Dose Level 3|Death|0|||
13250585|NCT01570283|26368110|FG005|Cohort 3: Dose Level 3|Death|1|||
13250586|NCT01570283|26368105|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
13250587|NCT01570283|26368106|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
13250588|NCT01570283|26368107|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
13250589|NCT01570283|26368108|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
13250590|NCT01570283|26368109|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
13250591|NCT01570283|26368110|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1|||
13250592|NCT01570244|26368132|FG000|Microgynon+Faldaprevir|Adverse Event|1|||
13250593|NCT01570192|26368177|FG000|Overall Study|no qualifying organism|6|||
13250594|NCT01570192|26368178|FG001|Overall Study|no qualifying organism|12|||
13250595|NCT01570192|26368177|FG000|Overall Study|changed to palliative care|1|||
13250596|NCT01570192|26368178|FG001|Overall Study|changed to palliative care|0|||
13250597|NCT01570192|26368177|FG000|Overall Study|Physician Decision|0|||
13250598|NCT01570192|26368178|FG001|Overall Study|Physician Decision|1|||
13250599|NCT01569841|26368197|FG000|Period A (6 Weeks)|Withdrawal by Subject|0|||
13250600|NCT01569841|26368198|FG001|Period A (6 Weeks)|Withdrawal by Subject|1|||
13250601|NCT01569763|26368215|FG000|Overall Study|Lack of Efficacy|2|||
13250602|NCT01569763|26368216|FG001|Overall Study|Lack of Efficacy|7|||
13250603|NCT01569763|26368215|FG000|Overall Study|Adverse Event|1|||
13250604|NCT01569763|26368216|FG001|Overall Study|Adverse Event|0|||
13250605|NCT01569594|26368222|FG000|Overall Study|Physician Decision|4|||
13250606|NCT01569594|26368222|FG000|Overall Study|Death|13|||
13250607|NCT01569594|26368222|FG000|Overall Study|Lost to Follow-up|22|||
13250608|NCT01569594|26368222|FG000|Overall Study|Adverse Event|2|||
13250609|NCT01569594|26368222|FG000|Overall Study|Withdrawal by Subject|13|||
13250610|NCT01569594|26368222|FG000|Overall Study|Other|4|||
13250611|NCT01569594|26368222|FG000|Overall Study|No ECM used|9|||
13250612|NCT01569568|26368241|FG000|Overall Study|Physician Decision|0|||
13250613|NCT01569568|26368242|FG001|Overall Study|Physician Decision|2|||
13250614|NCT01569464|26368285|FG000|Overall Study|Adverse Event|4|||
13250615|NCT01569464|26368286|FG001|Overall Study|Adverse Event|0|||
13250616|NCT01569464|26368285|FG000|Overall Study|Lack of Efficacy|1|||
13250617|NCT01569464|26368286|FG001|Overall Study|Lack of Efficacy|0|||
13250618|NCT01569464|26368285|FG000|Overall Study|Protocol Violation|1|||
13250619|NCT01569464|26368286|FG001|Overall Study|Protocol Violation|0|||
13250620|NCT01569464|26368285|FG000|Overall Study|Lost to Follow-up|2|||
13250621|NCT01569464|26368286|FG001|Overall Study|Lost to Follow-up|3|||
13250622|NCT01569464|26368285|FG000|Overall Study|Withdrawal by Subject|1|||
13250623|NCT01569464|26368286|FG001|Overall Study|Withdrawal by Subject|1|||
13250624|NCT01569464|26368285|FG000|Overall Study|Other|1|||
13250625|NCT01569464|26368286|FG001|Overall Study|Other|1|||
13250626|NCT01569438|26368305|FG000|Overall Study|Lack of Efficacy|1|||
13250627|NCT01569438|26368306|FG001|Overall Study|Lack of Efficacy|2|||
13250628|NCT01569438|26368305|FG000|Overall Study|Withdrawal by Subject|0|||
13250629|NCT01569438|26368306|FG001|Overall Study|Withdrawal by Subject|3|||
13250630|NCT01569438|26368305|FG000|Overall Study|Adverse Event|2|||
13250631|NCT01569438|26368306|FG001|Overall Study|Adverse Event|15|||
13250632|NCT01569438|26368305|FG000|Overall Study|Protocol Violation|2|||
13250633|NCT01569438|26368306|FG001|Overall Study|Protocol Violation|0|||
13250634|NCT01569438|26368305|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1|||
13250635|NCT01569438|26368306|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0|||
13250636|NCT01569438|26368305|FG000|Overall Study|Sponsor/Physician decision|1|||
13250637|NCT01569438|26368306|FG001|Overall Study|Sponsor/Physician decision|1|||
13250638|NCT01569438|26368305|FG000|Overall Study|Unable to adhere to study schedule|0|||
13250639|NCT01569438|26368306|FG001|Overall Study|Unable to adhere to study schedule|1|||
13250640|NCT01569295|26368327|FG000|Overall Study|Progressive Disease|75|||
13250641|NCT01569295|26368328|FG001|Overall Study|Progressive Disease|139|||
13250642|NCT01569295|26368327|FG000|Overall Study|Adverse Event|39|||
13250643|NCT01569295|26368328|FG001|Overall Study|Adverse Event|14|||
13250644|NCT01569295|26368327|FG000|Overall Study|Withdrawal by Subject|25|||
13250645|NCT01569295|26368328|FG001|Overall Study|Withdrawal by Subject|12|||
13250646|NCT01569295|26368327|FG000|Overall Study|Death|19|||
13250647|NCT01569295|26368328|FG001|Overall Study|Death|15|||
13250648|NCT01569295|26368327|FG000|Overall Study|Physician Decision|13|||
13250649|NCT01569295|26368328|FG001|Overall Study|Physician Decision|18|||
13250650|NCT01569295|26368327|FG000|Overall Study|Study Terminated by Sponsor|24|||
13250651|NCT01569295|26368328|FG001|Overall Study|Study Terminated by Sponsor|2|||
13250652|NCT01569295|26368327|FG000|Overall Study|Other Reason not Specified|3|||
13250653|NCT01569295|26368328|FG001|Overall Study|Other Reason not Specified|5|||
13250654|NCT01569295|26368327|FG000|Overall Study|Non-Compliance with Study Drug|6|||
13250655|NCT01569295|26368328|FG001|Overall Study|Non-Compliance with Study Drug|1|||
13250656|NCT01569295|26368327|FG000|Overall Study|Other Anticancer/Experimental Therapy|2|||
13250657|NCT01569295|26368328|FG001|Overall Study|Other Anticancer/Experimental Therapy|2|||
13250658|NCT01569295|26368327|FG000|Overall Study|Lost to Follow-up|1|||
13250659|NCT01569295|26368328|FG001|Overall Study|Lost to Follow-up|1|||
13250660|NCT01569152|26368393|FG000|Phase IIa, Period 1|Early Escape|5|||
13250661|NCT01569152|26368394|FG001|Phase IIa, Period 1|Early Escape|22|||
13250662|NCT01569152|26368395|FG002|Phase IIa, Period 1|Early Escape|0|||
13250663|NCT01569152|26368393|FG000|Phase IIa, Period 1|Adverse Event|4|||
13250664|NCT01569152|26368394|FG001|Phase IIa, Period 1|Adverse Event|0|||
13250665|NCT01569152|26368395|FG002|Phase IIa, Period 1|Adverse Event|0|||
13250666|NCT01569152|26368393|FG000|Phase IIa, Period 1|Lost to Follow-up|1|||
13250667|NCT01569152|26368394|FG001|Phase IIa, Period 1|Lost to Follow-up|0|||
13250668|NCT01569152|26368395|FG002|Phase IIa, Period 1|Lost to Follow-up|0|||
13250669|NCT01569152|26368393|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9|||
13250670|NCT01569152|26368394|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8|||
13250671|NCT01569152|26368395|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0|||
13250672|NCT01569152|26368393|FG000|Phase IIa, Period 1|Protocol Violation|0|||
13250673|NCT01569152|26368394|FG001|Phase IIa, Period 1|Protocol Violation|1|||
13250674|NCT01569152|26368395|FG002|Phase IIa, Period 1|Protocol Violation|0|||
13250675|NCT01569152|26368393|FG000|Phase IIa, Period 1|Withdrawal by Subject|2|||
13250676|NCT01569152|26368394|FG001|Phase IIa, Period 1|Withdrawal by Subject|1|||
13250677|NCT01569152|26368395|FG002|Phase IIa, Period 1|Withdrawal by Subject|0|||
13250678|NCT01569152|26368393|FG000|Safety Extension, Period 3|Adverse Event|0|||
13250679|NCT01569152|26368394|FG001|Safety Extension, Period 3|Adverse Event|0|||
13250680|NCT01569152|26368395|FG002|Safety Extension, Period 3|Adverse Event|4|||
13250681|NCT01569152|26368393|FG000|Safety Extension, Period 3|Withdrawal by Subject|0|||
13250682|NCT01569152|26368394|FG001|Safety Extension, Period 3|Withdrawal by Subject|0|||
13250683|NCT01569152|26368395|FG002|Safety Extension, Period 3|Withdrawal by Subject|2|||
13250684|NCT01569152|26368393|FG000|Safety Extension, Period 3|Physician Decision|0|||
13250685|NCT01569152|26368394|FG001|Safety Extension, Period 3|Physician Decision|0|||
13250686|NCT01569152|26368395|FG002|Safety Extension, Period 3|Physician Decision|2|||
13250687|NCT01569152|26368393|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0|||
13250688|NCT01569152|26368394|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0|||
13250689|NCT01569152|26368395|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47|||
13250690|NCT01569074|26368467|FG000|Overall Study|Study stopped|6|||
13250691|NCT01569074|26368468|FG001|Overall Study|Study stopped|6|||
13250692|NCT01569074|26368469|FG002|Overall Study|Study stopped|8|||
13250693|NCT01569074|26368470|FG003|Overall Study|Study stopped|7|||
13250694|NCT01569074|26368471|FG004|Overall Study|Study stopped|7|||
13250695|NCT01569074|26368467|FG000|Overall Study|Study-specific discontinuation criteria|0|||
13250696|NCT01569074|26368468|FG001|Overall Study|Study-specific discontinuation criteria|1|||
13250697|NCT01569074|26368469|FG002|Overall Study|Study-specific discontinuation criteria|0|||
13250698|NCT01569074|26368470|FG003|Overall Study|Study-specific discontinuation criteria|0|||
13250699|NCT01569074|26368471|FG004|Overall Study|Study-specific discontinuation criteria|0|||
13250700|NCT01569074|26368467|FG000|Overall Study|Severe non-compliance to protocol|0|||
13250701|NCT01569074|26368468|FG001|Overall Study|Severe non-compliance to protocol|0|||
13250702|NCT01569074|26368469|FG002|Overall Study|Severe non-compliance to protocol|1|||
13250703|NCT01569074|26368470|FG003|Overall Study|Severe non-compliance to protocol|0|||
13250704|NCT01569074|26368471|FG004|Overall Study|Severe non-compliance to protocol|0|||
13250705|NCT01569074|26368467|FG000|Overall Study|eg change in circumstances|0|||
13250706|NCT01569074|26368468|FG001|Overall Study|eg change in circumstances|2|||
13250707|NCT01569074|26368469|FG002|Overall Study|eg change in circumstances|0|||
13250708|NCT01569074|26368470|FG003|Overall Study|eg change in circumstances|1|||
13250709|NCT01569074|26368471|FG004|Overall Study|eg change in circumstances|1|||
13250710|NCT01569074|26368467|FG000|Overall Study|Adverse Event|1|||
13250711|NCT01569074|26368468|FG001|Overall Study|Adverse Event|0|||
13250712|NCT01569074|26368469|FG002|Overall Study|Adverse Event|3|||
13250713|NCT01569074|26368470|FG003|Overall Study|Adverse Event|0|||
13250714|NCT01569074|26368471|FG004|Overall Study|Adverse Event|0|||
13250715|NCT01569022|26368486|FG000|First Intervention|Lost to Follow-up|2|||
13250716|NCT01569022|26368487|FG001|First Intervention|Lost to Follow-up|1|||
13250717|NCT01569022|26368486|FG000|Second Intervention|Lost to Follow-up|2|||
13250718|NCT01569022|26368487|FG001|Second Intervention|Lost to Follow-up|2|||
13250719|NCT01568892|26368562|FG000|Open-label Phase|Adverse Event|2|||
13250720|NCT01568892|26368563|FG001|Open-label Phase|Adverse Event|0|||
13250721|NCT01568892|26368562|FG000|Open-label Phase|Lack of Efficacy|4|||
13250722|NCT01568892|26368563|FG001|Open-label Phase|Lack of Efficacy|2|||
13250723|NCT01568892|26368562|FG000|Open-label Phase|Lost to Follow-up|0|||
13250724|NCT01568892|26368563|FG001|Open-label Phase|Lost to Follow-up|1|||
13250725|NCT01568866|26368590|FG000|Overall Study|Disease Progression|208|||
13250726|NCT01568866|26368591|FG001|Overall Study|Disease Progression|183|||
13250727|NCT01568866|26368590|FG000|Overall Study|Adverse Event|94|||
13250728|NCT01568866|26368591|FG001|Overall Study|Adverse Event|96|||
13250729|NCT01568866|26368590|FG000|Overall Study|Patient Request|55|||
13250730|NCT01568866|26368591|FG001|Overall Study|Patient Request|71|||
13250731|NCT01568866|26368590|FG000|Overall Study|Physician Decision|40|||
13250732|NCT01568866|26368591|FG001|Overall Study|Physician Decision|32|||
13250733|NCT01568866|26368590|FG000|Overall Study|Withdrawal by Subject|19|||
13250734|NCT01568866|26368591|FG001|Overall Study|Withdrawal by Subject|11|||
13250735|NCT01568866|26368590|FG000|Overall Study|Death|10|||
13250736|NCT01568866|26368591|FG001|Overall Study|Death|18|||
13250737|NCT01568866|26368590|FG000|Overall Study|Protocol Non-compliance|2|||
13250738|NCT01568866|26368591|FG001|Overall Study|Protocol Non-compliance|4|||
13250739|NCT01568866|26368590|FG000|Overall Study|Lost to Follow-up|1|||
13250740|NCT01568866|26368591|FG001|Overall Study|Lost to Follow-up|0|||
13250741|NCT01568866|26368590|FG000|Overall Study|Randomized but Not Dosed|9|||
13250742|NCT01568866|26368591|FG001|Overall Study|Randomized but Not Dosed|1|||
13250743|NCT01568593|26368604|FG000|Overall Study|Lack of Efficacy|4|||
13250744|NCT01568593|26368605|FG001|Overall Study|Lack of Efficacy|1|||
13250745|NCT01568593|26368604|FG000|Overall Study|Adverse Event|3|||
13250746|NCT01568593|26368605|FG001|Overall Study|Adverse Event|2|||
13250747|NCT01568320|26368612|FG000|Overall Study|Death|20|||
13250748|NCT01568320|26368612|FG000|Overall Study|Lost to Follow-up|9|||
13250749|NCT01568320|26368612|FG000|Overall Study|Withdrawal by Subject|10|||
13250750|NCT01568320|26368612|FG000|Overall Study|Conversion to open repair|1|||
13250751|NCT01568320|26368612|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1|||
13250752|NCT01568112|26368743|FG000|Overall Study|Randomized But Not Treated|0|||
13250753|NCT01568112|26368744|FG001|Overall Study|Randomized But Not Treated|1|||
13250754|NCT01568112|26368745|FG002|Overall Study|Randomized But Not Treated|0|||
13250755|NCT01568112|26368746|FG003|Overall Study|Randomized But Not Treated|0|||
13250756|NCT01568112|26368743|FG000|Overall Study|Withdrew due to Adverse Event|2|||
13250757|NCT01568112|26368744|FG001|Overall Study|Withdrew due to Adverse Event|4|||
13250758|NCT01568112|26368745|FG002|Overall Study|Withdrew due to Adverse Event|6|||
13250759|NCT01568112|26368746|FG003|Overall Study|Withdrew due to Adverse Event|3|||
13250760|NCT01568112|26368743|FG000|Overall Study|Lost to Follow-up|0|||
13250761|NCT01568112|26368744|FG001|Overall Study|Lost to Follow-up|0|||
13250762|NCT01568112|26368745|FG002|Overall Study|Lost to Follow-up|0|||
13250763|NCT01568112|26368746|FG003|Overall Study|Lost to Follow-up|1|||
13250764|NCT01568112|26368743|FG000|Overall Study|Withdrawal by Subject|2|||
13250765|NCT01568112|26368744|FG001|Overall Study|Withdrawal by Subject|3|||
13250766|NCT01568112|26368745|FG002|Overall Study|Withdrawal by Subject|0|||
13250767|NCT01568112|26368746|FG003|Overall Study|Withdrawal by Subject|7|||
13250768|NCT01568112|26368743|FG000|Overall Study|Withdrawal by Physician|1|||
13250769|NCT01568112|26368744|FG001|Overall Study|Withdrawal by Physician|0|||
13250770|NCT01568112|26368745|FG002|Overall Study|Withdrawal by Physician|1|||
13250771|NCT01568112|26368746|FG003|Overall Study|Withdrawal by Physician|1|||
13250772|NCT01568047|26368777|FG000|Overall Study|Ineligibility|1|||
13250773|NCT01568047|26368778|FG001|Overall Study|Ineligibility|0|||
13250774|NCT01568047|26368779|FG002|Overall Study|Ineligibility|0|||
13250775|NCT01568047|26368780|FG003|Overall Study|Ineligibility|0|||
13250776|NCT01568047|26368777|FG000|Overall Study|Withdrawal by Subject|0|||
13250777|NCT01568047|26368778|FG001|Overall Study|Withdrawal by Subject|1|||
13250778|NCT01568047|26368779|FG002|Overall Study|Withdrawal by Subject|0|||
13250779|NCT01568047|26368780|FG003|Overall Study|Withdrawal by Subject|0|||
13250780|NCT01568047|26368777|FG000|Overall Study|Adverse Event|0|||
13250781|NCT01568047|26368778|FG001|Overall Study|Adverse Event|0|||
13250782|NCT01568047|26368779|FG002|Overall Study|Adverse Event|1|||
13250783|NCT01568047|26368780|FG003|Overall Study|Adverse Event|1|||
13250784|NCT01568034|26368803|FG000|Overall Study|Withdrawal by Subject|1|||
13250785|NCT01568034|26368804|FG001|Overall Study|Withdrawal by Subject|0|||
13250786|NCT01568034|26368805|FG002|Overall Study|Withdrawal by Subject|0|||
13250787|NCT01568034|26368806|FG003|Overall Study|Withdrawal by Subject|0|||
13250788|NCT01567865|26368847|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0|||
13250789|NCT01567865|26368848|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1|||
13250790|NCT01567865|26368849|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3|||
13250791|NCT01567865|26368850|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2|||
13250792|NCT01567865|26368847|FG000|Evaluated for Immunogenicity|Missing blood sample|17|||
13250793|NCT01567865|26368848|FG001|Evaluated for Immunogenicity|Missing blood sample|24|||
13250794|NCT01567865|26368849|FG002|Evaluated for Immunogenicity|Missing blood sample|16|||
13250795|NCT01567865|26368850|FG003|Evaluated for Immunogenicity|Missing blood sample|28|||
13250796|NCT01567852|26368865|FG000|Overall Study|Withdrawal by Subject|3|||
13250797|NCT01567852|26368866|FG001|Overall Study|Withdrawal by Subject|6|||
13250798|NCT01567852|26368865|FG000|Overall Study|ECT discontinued|1|||
13250799|NCT01567852|26368866|FG001|Overall Study|ECT discontinued|1|||
13116543|NCT03073200|25923194|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2|||
13250800|NCT01567826|26368897|FG000|Overall Study|Lost to Follow-up|3|||
13250801|NCT01567826|26368898|FG001|Overall Study|Lost to Follow-up|2|||
13250802|NCT01567527|26368923|FG000|Conversion Phase.|Protocol deviation|3|||
13250803|NCT01567527|26368924|FG001|Conversion Phase.|Protocol deviation|0|||
13250804|NCT01567527|26368925|FG002|Conversion Phase.|Protocol deviation|0|||
13250805|NCT01567527|26368926|FG003|Conversion Phase.|Protocol deviation|0|||
13250806|NCT01567527|26368927|FG004|Conversion Phase.|Protocol deviation|0|||
13250807|NCT01567527|26368923|FG000|Conversion Phase.|Met withdrawal criteria|10|||
13250808|NCT01567527|26368924|FG001|Conversion Phase.|Met withdrawal criteria|0|||
13250809|NCT01567527|26368925|FG002|Conversion Phase.|Met withdrawal criteria|0|||
13250810|NCT01567527|26368926|FG003|Conversion Phase.|Met withdrawal criteria|0|||
13250811|NCT01567527|26368927|FG004|Conversion Phase.|Met withdrawal criteria|0|||
13250812|NCT01567527|26368923|FG000|Conversion Phase.|Withdrawal by Subject|32|||
13250813|NCT01567527|26368924|FG001|Conversion Phase.|Withdrawal by Subject|0|||
13250814|NCT01567527|26368925|FG002|Conversion Phase.|Withdrawal by Subject|0|||
13116544|NCT03073200|25923195|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1|||
13116545|NCT03073200|25923196|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0|||
13116546|NCT03073200|25923197|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0|||
13116547|NCT03073200|25923198|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0|||
13116548|NCT03073200|25923199|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0|||
13116549|NCT03073200|25923200|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0|||
13116550|NCT03073200|25923201|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0|||
13116551|NCT03073200|25923202|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0|||
13116552|NCT03073200|25923203|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0|||
13116553|NCT03073200|25923204|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0|||
13116554|NCT03073200|25923205|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0|||
13116555|NCT03073200|25923191|FG000|Extension Period|Lost to Follow-up|0|||
13116556|NCT03073200|25923192|FG001|Extension Period|Lost to Follow-up|0|||
13116557|NCT03073200|25923193|FG002|Extension Period|Lost to Follow-up|0|||
13116558|NCT03073200|25923194|FG003|Extension Period|Lost to Follow-up|0|||
13116559|NCT03073200|25923195|FG004|Extension Period|Lost to Follow-up|0|||
13116560|NCT03073200|25923196|FG005|Extension Period|Lost to Follow-up|0|||
13116561|NCT03073200|25923197|FG006|Extension Period|Lost to Follow-up|1|||
13116562|NCT03073200|25923198|FG007|Extension Period|Lost to Follow-up|1|||
13116563|NCT03073200|25923199|FG008|Extension Period|Lost to Follow-up|0|||
13116564|NCT03073200|25923200|FG009|Extension Period|Lost to Follow-up|0|||
13116565|NCT03073200|25923201|FG010|Extension Period|Lost to Follow-up|0|||
13116566|NCT03073200|25923202|FG011|Extension Period|Lost to Follow-up|0|||
13116567|NCT03073200|25923203|FG012|Extension Period|Lost to Follow-up|0|||
13116568|NCT03073200|25923204|FG013|Extension Period|Lost to Follow-up|0|||
13250815|NCT01567527|26368926|FG003|Conversion Phase.|Withdrawal by Subject|0|||
13250816|NCT01567527|26368927|FG004|Conversion Phase.|Withdrawal by Subject|0|||
13250817|NCT01567527|26368923|FG000|Conversion Phase.|Lost to Follow-up|16|||
13116569|NCT03073200|25923205|FG014|Extension Period|Lost to Follow-up|0|||
13116570|NCT03073200|25923191|FG000|Extension Period|Sponsor Decision|0|||
13116571|NCT03073200|25923192|FG001|Extension Period|Sponsor Decision|0|||
13116572|NCT03073200|25923193|FG002|Extension Period|Sponsor Decision|0|||
13116573|NCT03073200|25923194|FG003|Extension Period|Sponsor Decision|0|||
13116574|NCT03073200|25923195|FG004|Extension Period|Sponsor Decision|0|||
13116575|NCT03073200|25923196|FG005|Extension Period|Sponsor Decision|0|||
13250818|NCT01567527|26368924|FG001|Conversion Phase.|Lost to Follow-up|0|||
13250819|NCT01567527|26368925|FG002|Conversion Phase.|Lost to Follow-up|0|||
13250820|NCT01567527|26368926|FG003|Conversion Phase.|Lost to Follow-up|0|||
13250821|NCT01567527|26368927|FG004|Conversion Phase.|Lost to Follow-up|0|||
13250822|NCT01567527|26368923|FG000|Conversion Phase.|Lack of Efficacy|2|||
13250823|NCT01567527|26368924|FG001|Conversion Phase.|Lack of Efficacy|0|||
13250824|NCT01567527|26368925|FG002|Conversion Phase.|Lack of Efficacy|0|||
13250825|NCT01567527|26368926|FG003|Conversion Phase.|Lack of Efficacy|0|||
13250826|NCT01567527|26368927|FG004|Conversion Phase.|Lack of Efficacy|0|||
13250827|NCT01567527|26368923|FG000|Conversion Phase.|Adverse Event|33|||
13250828|NCT01567527|26368924|FG001|Conversion Phase.|Adverse Event|0|||
13250829|NCT01567527|26368925|FG002|Conversion Phase.|Adverse Event|0|||
13250830|NCT01567527|26368926|FG003|Conversion Phase.|Adverse Event|0|||
13250831|NCT01567527|26368927|FG004|Conversion Phase.|Adverse Event|0|||
13250832|NCT01567527|26368923|FG000|Conversion Phase.|Withdrawn by the investigator|3|||
13250833|NCT01567527|26368924|FG001|Conversion Phase.|Withdrawn by the investigator|0|||
13250834|NCT01567527|26368925|FG002|Conversion Phase.|Withdrawn by the investigator|0|||
13250835|NCT01567527|26368926|FG003|Conversion Phase.|Withdrawn by the investigator|0|||
13250836|NCT01567527|26368927|FG004|Conversion Phase.|Withdrawn by the investigator|0|||
13250837|NCT01567527|26368923|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
13250838|NCT01567527|26368924|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41|||
13250839|NCT01567527|26368925|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
13250840|NCT01567527|26368926|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
13250841|NCT01567527|26368927|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
13250842|NCT01567527|26368923|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
13250843|NCT01567527|26368924|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45|||
13250844|NCT01567527|26368925|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
13250845|NCT01567527|26368926|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
13250846|NCT01567527|26368927|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
13250847|NCT01567527|26368923|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
13250848|NCT01567527|26368924|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44|||
13250849|NCT01567527|26368925|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
13250850|NCT01567527|26368926|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
13116576|NCT03073200|25923197|FG006|Extension Period|Sponsor Decision|0|||
13250851|NCT01567527|26368927|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
13116577|NCT03073200|25923198|FG007|Extension Period|Sponsor Decision|0|||
13116578|NCT03073200|25923199|FG008|Extension Period|Sponsor Decision|1|||
13116579|NCT03073200|25923200|FG009|Extension Period|Sponsor Decision|0|||
13116580|NCT03073200|25923201|FG010|Extension Period|Sponsor Decision|0|||
13116581|NCT03073200|25923202|FG011|Extension Period|Sponsor Decision|0|||
13250852|NCT01567527|26368923|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
13250853|NCT01567527|26368924|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12|||
13250854|NCT01567527|26368925|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
13250855|NCT01567527|26368926|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
13250856|NCT01567527|26368927|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
13250857|NCT01567527|26368923|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
13250858|NCT01567527|26368924|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63|||
13250859|NCT01567527|26368925|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
13250860|NCT01567527|26368926|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
13250861|NCT01567527|26368927|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
13250862|NCT01567527|26368923|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
13250863|NCT01567527|26368924|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2|||
13250864|NCT01567527|26368925|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
13250865|NCT01567527|26368926|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
13250866|NCT01567527|26368927|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
13250867|NCT01567527|26368923|FG000|IM Depot Stabilization.|Protocol deviation|0|||
13250868|NCT01567527|26368924|FG001|IM Depot Stabilization.|Protocol deviation|0|||
13250869|NCT01567527|26368925|FG002|IM Depot Stabilization.|Protocol deviation|5|||
13250870|NCT01567527|26368926|FG003|IM Depot Stabilization.|Protocol deviation|0|||
13250871|NCT01567527|26368927|FG004|IM Depot Stabilization.|Protocol deviation|0|||
13250872|NCT01567527|26368923|FG000|IM Depot Stabilization.|Met withdrawal criteria|0|||
13250873|NCT01567527|26368924|FG001|IM Depot Stabilization.|Met withdrawal criteria|0|||
13250874|NCT01567527|26368925|FG002|IM Depot Stabilization.|Met withdrawal criteria|26|||
13250875|NCT01567527|26368926|FG003|IM Depot Stabilization.|Met withdrawal criteria|0|||
13250876|NCT01567527|26368927|FG004|IM Depot Stabilization.|Met withdrawal criteria|0|||
13250877|NCT01567527|26368923|FG000|IM Depot Stabilization.|Withdrawal by Subject|0|||
13250878|NCT01567527|26368924|FG001|IM Depot Stabilization.|Withdrawal by Subject|0|||
13250879|NCT01567527|26368925|FG002|IM Depot Stabilization.|Withdrawal by Subject|56|||
13250880|NCT01567527|26368926|FG003|IM Depot Stabilization.|Withdrawal by Subject|0|||
13250881|NCT01567527|26368927|FG004|IM Depot Stabilization.|Withdrawal by Subject|0|||
13250882|NCT01567527|26368923|FG000|IM Depot Stabilization.|Sponsor discontinued study|0|||
13250883|NCT01567527|26368924|FG001|IM Depot Stabilization.|Sponsor discontinued study|0|||
13250884|NCT01567527|26368925|FG002|IM Depot Stabilization.|Sponsor discontinued study|1|||
13250885|NCT01567527|26368926|FG003|IM Depot Stabilization.|Sponsor discontinued study|0|||
13250886|NCT01567527|26368927|FG004|IM Depot Stabilization.|Sponsor discontinued study|0|||
13250887|NCT01567527|26368923|FG000|IM Depot Stabilization.|Lost to Follow-up|0|||
13250888|NCT01567527|26368924|FG001|IM Depot Stabilization.|Lost to Follow-up|0|||
13250889|NCT01567527|26368925|FG002|IM Depot Stabilization.|Lost to Follow-up|21|||
13250890|NCT01567527|26368926|FG003|IM Depot Stabilization.|Lost to Follow-up|0|||
13250891|NCT01567527|26368927|FG004|IM Depot Stabilization.|Lost to Follow-up|0|||
13250892|NCT01567527|26368923|FG000|IM Depot Stabilization.|Lack of Efficacy|0|||
13250893|NCT01567527|26368924|FG001|IM Depot Stabilization.|Lack of Efficacy|0|||
13250894|NCT01567527|26368925|FG002|IM Depot Stabilization.|Lack of Efficacy|7|||
13250895|NCT01567527|26368926|FG003|IM Depot Stabilization.|Lack of Efficacy|0|||
13250896|NCT01567527|26368927|FG004|IM Depot Stabilization.|Lack of Efficacy|0|||
13250897|NCT01567527|26368923|FG000|IM Depot Stabilization.|Adverse Event|0|||
13250898|NCT01567527|26368924|FG001|IM Depot Stabilization.|Adverse Event|0|||
13250899|NCT01567527|26368925|FG002|IM Depot Stabilization.|Adverse Event|37|||
13250900|NCT01567527|26368926|FG003|IM Depot Stabilization.|Adverse Event|0|||
13250901|NCT01567527|26368927|FG004|IM Depot Stabilization.|Adverse Event|0|||
13250902|NCT01567527|26368923|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0|||
13250903|NCT01567527|26368924|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0|||
13250904|NCT01567527|26368925|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6|||
13250905|NCT01567527|26368926|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0|||
13250906|NCT01567527|26368927|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0|||
13250907|NCT01567527|26368923|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
13250908|NCT01567527|26368924|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
13250909|NCT01567527|26368925|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
13250910|NCT01567527|26368926|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
13250911|NCT01567527|26368927|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
13250912|NCT01567527|26368923|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
13250913|NCT01567527|26368924|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
13250914|NCT01567527|26368925|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
13250915|NCT01567527|26368926|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16|||
13250916|NCT01567527|26368927|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33|||
13250917|NCT01567527|26368923|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
13250918|NCT01567527|26368924|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
13250919|NCT01567527|26368925|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
13250920|NCT01567527|26368926|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4|||
13250921|NCT01567527|26368927|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7|||
13250922|NCT01567527|26368923|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
13250923|NCT01567527|26368924|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
13250924|NCT01567527|26368925|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
13250925|NCT01567527|26368926|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7|||
13250926|NCT01567527|26368927|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1|||
13250927|NCT01567527|26368923|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
13250928|NCT01567527|26368924|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
13250929|NCT01567527|26368925|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
13250930|NCT01567527|26368926|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13|||
13250931|NCT01567527|26368927|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10|||
13250932|NCT01567527|26368923|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
13250933|NCT01567527|26368924|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
13250934|NCT01567527|26368925|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
13250935|NCT01567527|26368926|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1|||
13250936|NCT01567527|26368927|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3|||
13250937|NCT01567527|26368923|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
13250938|NCT01567527|26368924|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
13250939|NCT01567527|26368925|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
13250940|NCT01567527|26368926|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19|||
13250941|NCT01567527|26368927|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35|||
13250942|NCT01567527|26368923|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
13250943|NCT01567527|26368924|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
13250944|NCT01567527|26368925|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
13250945|NCT01567527|26368926|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8|||
13250946|NCT01567527|26368927|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5|||
13250947|NCT01567462|26368946|FG000|Overall Study|Withdrawal by Subject|4|||
13250948|NCT01567462|26368947|FG001|Overall Study|Withdrawal by Subject|7|||
13250949|NCT01567306|26368980|FG000|Overall Study|Protocol Violation|2|||
13250950|NCT01567306|26368981|FG001|Overall Study|Protocol Violation|2|||
13250951|NCT01567306|26368982|FG002|Overall Study|Protocol Violation|0|||
13250952|NCT01567306|26368983|FG003|Overall Study|Protocol Violation|3|||
13250953|NCT01567306|26368984|FG004|Overall Study|Protocol Violation|1|||
13250954|NCT01567306|26368985|FG005|Overall Study|Protocol Violation|1|||
13250955|NCT01567306|26368980|FG000|Overall Study|Change site living|1|||
13250956|NCT01567306|26368981|FG001|Overall Study|Change site living|0|||
13250957|NCT01567306|26368982|FG002|Overall Study|Change site living|0|||
13250958|NCT01567306|26368983|FG003|Overall Study|Change site living|0|||
13250959|NCT01567306|26368984|FG004|Overall Study|Change site living|0|||
13250960|NCT01567306|26368985|FG005|Overall Study|Change site living|0|||
13250961|NCT01567306|26368980|FG000|Overall Study|Adverse Event|0|||
13250962|NCT01567306|26368981|FG001|Overall Study|Adverse Event|0|||
13250963|NCT01567306|26368982|FG002|Overall Study|Adverse Event|0|||
13250964|NCT01567306|26368983|FG003|Overall Study|Adverse Event|2|||
13250965|NCT01567306|26368984|FG004|Overall Study|Adverse Event|4|||
13250966|NCT01567306|26368985|FG005|Overall Study|Adverse Event|1|||
13250967|NCT01567306|26368980|FG000|Overall Study|Lost to Follow-up|0|||
13250968|NCT01567306|26368981|FG001|Overall Study|Lost to Follow-up|0|||
13250969|NCT01567306|26368982|FG002|Overall Study|Lost to Follow-up|0|||
13250970|NCT01567306|26368983|FG003|Overall Study|Lost to Follow-up|0|||
13250971|NCT01567306|26368984|FG004|Overall Study|Lost to Follow-up|2|||
13250972|NCT01567306|26368985|FG005|Overall Study|Lost to Follow-up|0|||
13250973|NCT01567306|26368980|FG000|Overall Study|Withdrawal by Subject|0|||
13250974|NCT01567306|26368981|FG001|Overall Study|Withdrawal by Subject|0|||
13250975|NCT01567306|26368982|FG002|Overall Study|Withdrawal by Subject|0|||
13250976|NCT01567306|26368983|FG003|Overall Study|Withdrawal by Subject|0|||
13250977|NCT01567306|26368984|FG004|Overall Study|Withdrawal by Subject|0|||
13250978|NCT01567306|26368985|FG005|Overall Study|Withdrawal by Subject|1|||
13250979|NCT01567163|26368997|FG000|Overall Study|Progressive Disease|2|||
13250980|NCT01567163|26368997|FG000|Overall Study|Lost to Follow-up|2|||
13250981|NCT01567085|26369005|FG000|Overall Study|Death|6|||
13250982|NCT01567085|26369005|FG000|Overall Study|Adverse Event|6|||
13250983|NCT01567085|26369005|FG000|Overall Study|Lost to Follow-up|3|||
13250984|NCT01567085|26369005|FG000|Overall Study|Graft loss|2|||
13250985|NCT01567085|26369005|FG000|Overall Study|Renal transplantectomy|1|||
13250986|NCT01567085|26369005|FG000|Overall Study|Returned to chronic dialysis|1|||
13250987|NCT01567085|26369005|FG000|Overall Study|Terminal chronic kidney dysfunction|1|||
13250988|NCT01566981|26369022|FG000|Overall Study|Lost to Follow-up|5|||
13250989|NCT01566981|26369023|FG001|Overall Study|Lost to Follow-up|8|||
13250990|NCT01566773|26369232|FG000|Overall Study|Protocol specified criteria|4|||
13250991|NCT01566773|26369232|FG000|Overall Study|Protocol Violation|4|||
13250992|NCT01566773|26369232|FG000|Overall Study|Withdrawal by Subject|9|||
13250993|NCT01566773|26369232|FG000|Overall Study|Administrative reason|1|||
13250994|NCT01566773|26369232|FG000|Overall Study|Adverse Event|10|||
13250995|NCT01566773|26369232|FG000|Overall Study|Physician Decision|2|||
13250996|NCT01566721|26369270|FG000|Treatment Period|Withdrawal by Subject|35|||
13250997|NCT01566721|26369271|FG001|Treatment Period|Withdrawal by Subject|9|||
13250998|NCT01566721|26369270|FG000|Treatment Period|Disease Progression/Recurrence|37|||
13250999|NCT01566721|26369271|FG001|Treatment Period|Disease Progression/Recurrence|13|||
13251000|NCT01566721|26369270|FG000|Treatment Period|Investigator/Sponsor Decision|6|||
13251001|NCT01566721|26369271|FG001|Treatment Period|Investigator/Sponsor Decision|3|||
13251002|NCT01566721|26369270|FG000|Treatment Period|Other|13|||
13251003|NCT01566721|26369271|FG001|Treatment Period|Other|2|||
13251004|NCT01566721|26369270|FG000|Treatment Period|Lack of Compliance|5|||
13251005|NCT01566721|26369271|FG001|Treatment Period|Lack of Compliance|1|||
13251006|NCT01566721|26369270|FG000|Treatment Period|Adverse Event|100|||
13251007|NCT01566721|26369271|FG001|Treatment Period|Adverse Event|30|||
13251008|NCT01566721|26369270|FG000|Treatment Period|Pregnancy|1|||
13251009|NCT01566721|26369271|FG001|Treatment Period|Pregnancy|0|||
13251010|NCT01566721|26369270|FG000|Safety Follow-up|Physician Decision|6|||
13251011|NCT01566721|26369271|FG001|Safety Follow-up|Physician Decision|4|||
13251012|NCT01566721|26369270|FG000|Safety Follow-up|Lost to Follow-up|101|||
13251013|NCT01566721|26369271|FG001|Safety Follow-up|Lost to Follow-up|48|||
13251014|NCT01566721|26369270|FG000|Safety Follow-up|Withdrawal by Subject|155|||
13251015|NCT01566721|26369271|FG001|Safety Follow-up|Withdrawal by Subject|49|||
13251016|NCT01566721|26369270|FG000|Safety Follow-up|Death|28|||
13251017|NCT01566721|26369271|FG001|Safety Follow-up|Death|4|||
13251018|NCT01566721|26369270|FG000|Safety Follow-up|Non-compliance|7|||
13251019|NCT01566721|26369271|FG001|Safety Follow-up|Non-compliance|3|||
13251020|NCT01566721|26369270|FG000|Safety Follow-up|Protocol Violation|7|||
13251021|NCT01566721|26369271|FG001|Safety Follow-up|Protocol Violation|0|||
13251022|NCT01566721|26369270|FG000|Safety Follow-up|Site closure|2|||
13251023|NCT01566721|26369271|FG001|Safety Follow-up|Site closure|3|||
13251024|NCT01566721|26369270|FG000|Safety Follow-up|Erroneous reporting or late reporting|2|||
13251025|NCT01566721|26369271|FG001|Safety Follow-up|Erroneous reporting or late reporting|0|||
13251026|NCT01566721|26369270|FG000|Safety Follow-up|Missing|7|||
13251027|NCT01566721|26369271|FG001|Safety Follow-up|Missing|2|||
13251028|NCT01566721|26369270|FG000|Safety Follow-up|Disease progression /disease recurrence|223|||
13251029|NCT01566721|26369271|FG001|Safety Follow-up|Disease progression /disease recurrence|90|||
13251030|NCT01566721|26369270|FG000|Safety Follow-up|Sponsor decision|1|||
13251031|NCT01566721|26369271|FG001|Safety Follow-up|Sponsor decision|0|||
13251032|NCT01566721|26369270|FG000|Safety Follow-up|Adverse Event|8|||
13251033|NCT01566721|26369271|FG001|Safety Follow-up|Adverse Event|4|||
13251034|NCT01566604|26369304|FG000|Overall Study|Patient's inability to use the device|1|||
13251035|NCT01566604|26369305|FG001|Overall Study|Patient's inability to use the device|0|||
13251036|NCT01566604|26369304|FG000|Overall Study|Administrative problems|1|||
13251037|NCT01566604|26369305|FG001|Overall Study|Administrative problems|0|||
13251038|NCT01566604|26369304|FG000|Overall Study|Lack of Efficacy|1|||
13251039|NCT01566604|26369305|FG001|Overall Study|Lack of Efficacy|2|||
13251040|NCT01566604|26369304|FG000|Overall Study|Protocol deviation|2|||
13251041|NCT01566604|26369305|FG001|Overall Study|Protocol deviation|0|||
13251042|NCT01566604|26369304|FG000|Overall Study|Abnormal laboratory value|2|||
13251043|NCT01566604|26369305|FG001|Overall Study|Abnormal laboratory value|0|||
13251044|NCT01566604|26369304|FG000|Overall Study|Death|4|||
13251045|NCT01566604|26369305|FG001|Overall Study|Death|1|||
13251046|NCT01566604|26369304|FG000|Overall Study|Adverse Event|4|||
13251047|NCT01566604|26369305|FG001|Overall Study|Adverse Event|2|||
13251048|NCT01566604|26369304|FG000|Overall Study|Withdrawal by Subject|9|||
13251049|NCT01566604|26369305|FG001|Overall Study|Withdrawal by Subject|6|||
13251050|NCT01566435|26369326|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1|||
13251051|NCT01566214|26369363|FG000|Overall Study|Lost to Follow-up|3|||
13251052|NCT01566214|26369364|FG001|Overall Study|Lost to Follow-up|0|||
13251053|NCT01566149|26369385|FG000|Overall Study|Adverse Event|0|||
13251054|NCT01566149|26369386|FG001|Overall Study|Adverse Event|1|||
13251055|NCT01566149|26369385|FG000|Overall Study|Non-compliance with study medication|2|||
13251056|NCT01566149|26369386|FG001|Overall Study|Non-compliance with study medication|0|||
13251057|NCT01566149|26369385|FG000|Overall Study|Protocol Violation|0|||
13251058|NCT01566149|26369386|FG001|Overall Study|Protocol Violation|1|||
13251059|NCT01566149|26369385|FG000|Overall Study|Withdrawal by Subject|1|||
13251060|NCT01566149|26369386|FG001|Overall Study|Withdrawal by Subject|0|||
13251061|NCT01565993|26369399|FG000|Overall Study|Physician Decision|0|||
13251062|NCT01565993|26369400|FG001|Overall Study|Physician Decision|3|||
13290168|NCT00104052|26480809|FG000|Overall Study|Discontinuation unrelated to treatment|2|||
13290169|NCT00103740|26480842|FG000|Period 1 - Core|Adverse Event|1|||
13290170|NCT00103740|26480843|FG001|Period 1 - Core|Adverse Event|0|||
13251063|NCT01565980|26369425|FG000|Overall Study|Death|1|||
13251064|NCT01565980|26369426|FG001|Overall Study|Death|0|||
13251065|NCT01565980|26369425|FG000|Overall Study|Lost to Follow-up|1|||
13251066|NCT01565980|26369426|FG001|Overall Study|Lost to Follow-up|0|||
13251067|NCT01565980|26369425|FG000|Overall Study|health complications|1|||
13251068|NCT01565980|26369426|FG001|Overall Study|health complications|1|||
13251069|NCT01565980|26369425|FG000|Overall Study|stopped medical treatment|1|||
13251070|NCT01565980|26369426|FG001|Overall Study|stopped medical treatment|0|||
13251071|NCT01565980|26369425|FG000|Overall Study|Withdrawal by Subject|0|||
13251072|NCT01565980|26369426|FG001|Overall Study|Withdrawal by Subject|3|||
13251073|NCT01565941|26369479|FG000|Overall Study|Withdrawn by parent/guardian|3|||
13251074|NCT01565941|26369480|FG001|Overall Study|Withdrawn by parent/guardian|2|||
13251075|NCT01565941|26369479|FG000|Overall Study|Randomized; did not receive intevention|8|||
13251076|NCT01565941|26369480|FG001|Overall Study|Randomized; did not receive intevention|2|||
13251077|NCT01565928|26369495|FG000|Overall Study|Adverse Event|3|||
13251078|NCT01565928|26369495|FG000|Overall Study|Other|3|||
13251079|NCT01565928|26369495|FG000|Overall Study|Progressive Disease|13|||
13251080|NCT01565928|26369495|FG000|Overall Study|Withdrawal by Subject|1|||
13251081|NCT01565928|26369495|FG000|Overall Study|Death|2|||
13251082|NCT01565889|26369543|FG000|Part A|Withdrawal by Subject|1|||
13251083|NCT01565889|26369544|FG001|Part A|Withdrawal by Subject|0|||
13251084|NCT01565889|26369545|FG002|Part A|Withdrawal by Subject|0|||
13251085|NCT01565889|26369546|FG003|Part A|Withdrawal by Subject|0|||
13251086|NCT01565889|26369547|FG004|Part A|Withdrawal by Subject|0|||
13251087|NCT01565889|26369548|FG005|Part A|Withdrawal by Subject|0|||
13251088|NCT01565889|26369543|FG000|Part B|Withdrawal by Subject|0|||
13251089|NCT01565889|26369544|FG001|Part B|Withdrawal by Subject|0|||
13251090|NCT01565889|26369545|FG002|Part B|Withdrawal by Subject|0|||
13251091|NCT01565889|26369546|FG003|Part B|Withdrawal by Subject|0|||
13251092|NCT01565889|26369547|FG004|Part B|Withdrawal by Subject|0|||
13251093|NCT01565889|26369548|FG005|Part B|Withdrawal by Subject|1|||
13251094|NCT01565889|26369543|FG000|Part B|Lack of Efficacy|0|||
13251095|NCT01565889|26369544|FG001|Part B|Lack of Efficacy|0|||
13251096|NCT01565889|26369545|FG002|Part B|Lack of Efficacy|0|||
13251097|NCT01565889|26369546|FG003|Part B|Lack of Efficacy|0|||
13251098|NCT01565889|26369547|FG004|Part B|Lack of Efficacy|0|||
13251099|NCT01565889|26369548|FG005|Part B|Lack of Efficacy|2|||
13251100|NCT01565889|26369543|FG000|Part B|Lost to Follow-up|0|||
13251101|NCT01565889|26369544|FG001|Part B|Lost to Follow-up|0|||
13251102|NCT01565889|26369545|FG002|Part B|Lost to Follow-up|0|||
13251103|NCT01565889|26369546|FG003|Part B|Lost to Follow-up|0|||
13251104|NCT01565889|26369547|FG004|Part B|Lost to Follow-up|0|||
13251105|NCT01565889|26369548|FG005|Part B|Lost to Follow-up|1|||
13251106|NCT01565850|26369571|FG000|Overall Study|Adverse Event|0|||
13251107|NCT01565850|26369572|FG001|Overall Study|Adverse Event|1|||
13251108|NCT01565850|26369571|FG000|Overall Study|Lost to Follow-up|12|||
13251109|NCT01565850|26369572|FG001|Overall Study|Lost to Follow-up|4|||
13251110|NCT01565850|26369571|FG000|Overall Study|Investigator's Discretion|2|||
13251111|NCT01565850|26369572|FG001|Overall Study|Investigator's Discretion|1|||
13251112|NCT01565850|26369571|FG000|Overall Study|Participant noncompliance|2|||
13251113|NCT01565850|26369572|FG001|Overall Study|Participant noncompliance|0|||
13251114|NCT01565850|26369571|FG000|Overall Study|Withdrew Consent|4|||
13251115|NCT01565850|26369572|FG001|Overall Study|Withdrew Consent|2|||
13251116|NCT01565707|26369676|FG000|Overall Study|Adverse Event|1|||
13251117|NCT01565707|26369677|FG001|Overall Study|Adverse Event|6|||
13251118|NCT01565707|26369678|FG002|Overall Study|Adverse Event|2|||
13251119|NCT01565707|26369679|FG003|Overall Study|Adverse Event|1|||
13251120|NCT01565707|26369676|FG000|Overall Study|Lost to Follow-up|1|||
13251121|NCT01565707|26369677|FG001|Overall Study|Lost to Follow-up|0|||
13251122|NCT01565707|26369678|FG002|Overall Study|Lost to Follow-up|0|||
13251123|NCT01565707|26369679|FG003|Overall Study|Lost to Follow-up|0|||
13251124|NCT01565707|26369676|FG000|Overall Study|Protocol Violation|1|||
13251125|NCT01565707|26369677|FG001|Overall Study|Protocol Violation|0|||
13251126|NCT01565707|26369678|FG002|Overall Study|Protocol Violation|0|||
13251127|NCT01565707|26369679|FG003|Overall Study|Protocol Violation|1|||
13251128|NCT01565707|26369676|FG000|Overall Study|Withdrawal by Subject|3|||
13251129|NCT01565707|26369677|FG001|Overall Study|Withdrawal by Subject|1|||
13251130|NCT01565707|26369678|FG002|Overall Study|Withdrawal by Subject|1|||
13251131|NCT01565707|26369679|FG003|Overall Study|Withdrawal by Subject|1|||
13251132|NCT01565707|26369676|FG000|Overall Study|Randomized but not evaluable|2|||
13251133|NCT01565707|26369677|FG001|Overall Study|Randomized but not evaluable|0|||
13251134|NCT01565707|26369678|FG002|Overall Study|Randomized but not evaluable|0|||
13251135|NCT01565707|26369679|FG003|Overall Study|Randomized but not evaluable|0|||
13251136|NCT01565707|26369676|FG000|Overall Study|Miscellaneous|1|||
13251137|NCT01565707|26369677|FG001|Overall Study|Miscellaneous|1|||
13251138|NCT01565707|26369678|FG002|Overall Study|Miscellaneous|0|||
13251139|NCT01565707|26369679|FG003|Overall Study|Miscellaneous|2|||
13251140|NCT01565694|26369700|FG000|Dose-Titration Period|Adverse Event|4|||
13251141|NCT01565694|26369700|FG000|Dose-Titration Period|Protocol Violation|10|||
13485859|NCT02682901|27033599|FG000|Overall Study|Adverse Event|10|||
13251142|NCT01565694|26369700|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4|||
13251143|NCT01565668|26369729|FG000|Overall Study|Death|2|||
13251144|NCT01565668|26369730|FG001|Overall Study|Death|1|||
13251145|NCT01565668|26369729|FG000|Overall Study|Lack of Efficacy|4|||
13251146|NCT01565668|26369730|FG001|Overall Study|Lack of Efficacy|2|||
13251147|NCT01565668|26369729|FG000|Overall Study|Participant went on Hospice Care|1|||
13251148|NCT01565668|26369730|FG001|Overall Study|Participant went on Hospice Care|0|||
13251149|NCT01565668|26369729|FG000|Overall Study|Adverse Event|6|||
13251150|NCT01565668|26369730|FG001|Overall Study|Adverse Event|1|||
13251151|NCT01565668|26369729|FG000|Overall Study|Randomized, but never received drug|0|||
13251152|NCT01565668|26369730|FG001|Overall Study|Randomized, but never received drug|2|||
13251153|NCT01565668|26369729|FG000|Overall Study|Progressive disease|13|||
13251154|NCT01565668|26369730|FG001|Overall Study|Progressive disease|14|||
13251155|NCT01565668|26369729|FG000|Overall Study|Withdrawal by Subject|1|||
13251156|NCT01565668|26369730|FG001|Overall Study|Withdrawal by Subject|3|||
13251157|NCT01565668|26369729|FG000|Overall Study|HSCT Transplant|11|||
13251158|NCT01565668|26369730|FG001|Overall Study|HSCT Transplant|15|||
13251159|NCT01565642|26369759|FG000|Overall Study|Withdrawal by Subject|2|||
13251160|NCT01565642|26369760|FG001|Overall Study|Withdrawal by Subject|1|||
13251161|NCT01565564|26369775|FG000|Overall Study|Lost to Follow-up|5|||
13251162|NCT01565564|26369776|FG001|Overall Study|Lost to Follow-up|1|||
13251163|NCT01565499|26369792|FG000|Overall Study|Physician Decision|1|||
13251164|NCT01565499|26369792|FG000|Overall Study|Adverse Event|5|||
13251165|NCT01565499|26369792|FG000|Overall Study|Withdrawal by Subject|2|||
13251166|NCT01565343|26369809|FG000|Overall Study|Administrative decision/technical issues|1|||
13251167|NCT01565343|26369810|FG001|Overall Study|Administrative decision/technical issues|0|||
13251168|NCT01565343|26369811|FG002|Overall Study|Administrative decision/technical issues|0|||
13251169|NCT01565291|26369826|FG000|Overall Study|Withdrawal by Subject|1|||
13251170|NCT01565291|26369827|FG001|Overall Study|Withdrawal by Subject|0|||
13251171|NCT01565148|26369874|FG000|Overall Study|Withdrawal by Subject|1|||
13251172|NCT01565148|26369875|FG001|Overall Study|Withdrawal by Subject|1|||
13251173|NCT01565148|26369876|FG002|Overall Study|Withdrawal by Subject|1|||
13251174|NCT01565148|26369877|FG003|Overall Study|Withdrawal by Subject|2|||
13251175|NCT01565148|26369874|FG000|Overall Study|Lost to Follow-up|4|||
13251176|NCT01565148|26369875|FG001|Overall Study|Lost to Follow-up|4|||
13251177|NCT01565148|26369876|FG002|Overall Study|Lost to Follow-up|0|||
13251178|NCT01565148|26369877|FG003|Overall Study|Lost to Follow-up|3|||
13251179|NCT01565148|26369874|FG000|Overall Study|Rescue Therapy|8|||
13251180|NCT01565148|26369875|FG001|Overall Study|Rescue Therapy|5|||
13251181|NCT01565148|26369876|FG002|Overall Study|Rescue Therapy|5|||
13251182|NCT01565148|26369877|FG003|Overall Study|Rescue Therapy|8|||
13251183|NCT01565148|26369874|FG000|Overall Study|Death|0|||
13251184|NCT01565148|26369875|FG001|Overall Study|Death|0|||
13251185|NCT01565148|26369876|FG002|Overall Study|Death|1|||
13251186|NCT01565148|26369877|FG003|Overall Study|Death|0|||
13251187|NCT01565148|26369874|FG000|Overall Study|Physician Decision|2|||
13251188|NCT01565148|26369875|FG001|Overall Study|Physician Decision|5|||
13251189|NCT01565148|26369876|FG002|Overall Study|Physician Decision|0|||
13251190|NCT01565148|26369877|FG003|Overall Study|Physician Decision|0|||
13251191|NCT01565083|26369910|FG000|Overall Study|Withdrawal by Subject|6|||
13251192|NCT01565083|26369911|FG001|Overall Study|Withdrawal by Subject|4|||
13251193|NCT01565083|26369910|FG000|Overall Study|Lost to Follow-up|2|||
13251194|NCT01565083|26369911|FG001|Overall Study|Lost to Follow-up|7|||
13251195|NCT01565083|26369910|FG000|Overall Study|Death|22|||
13251196|NCT01565083|26369911|FG001|Overall Study|Death|23|||
13251197|NCT01565083|26369910|FG000|Overall Study|Other|3|||
13251198|NCT01565083|26369911|FG001|Overall Study|Other|5|||
13251199|NCT01564862|26369970|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
13251200|NCT01564862|26369971|FG001|Overall Study|Pretreatment Event or Adverse Event|12|||
13251201|NCT01564862|26369972|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
13251202|NCT01564862|26369970|FG000|Overall Study|Major Protocol Deviation|3|||
13251203|NCT01564862|26369971|FG001|Overall Study|Major Protocol Deviation|3|||
13251204|NCT01564862|26369972|FG002|Overall Study|Major Protocol Deviation|4|||
13251205|NCT01564862|26369970|FG000|Overall Study|Lost to Follow-up|10|||
13251206|NCT01564862|26369971|FG001|Overall Study|Lost to Follow-up|8|||
13251207|NCT01564862|26369972|FG002|Overall Study|Lost to Follow-up|6|||
13251208|NCT01564862|26369970|FG000|Overall Study|Voluntary Withdrawal|9|||
13251209|NCT01564862|26369971|FG001|Overall Study|Voluntary Withdrawal|6|||
13251210|NCT01564862|26369972|FG002|Overall Study|Voluntary Withdrawal|8|||
13251211|NCT01564862|26369970|FG000|Overall Study|Lack of Efficacy|1|||
13251212|NCT01564862|26369971|FG001|Overall Study|Lack of Efficacy|5|||
13251213|NCT01564862|26369972|FG002|Overall Study|Lack of Efficacy|6|||
13251214|NCT01564862|26369970|FG000|Overall Study|Other reason(s)|1|||
13251215|NCT01564862|26369971|FG001|Overall Study|Other reason(s)|0|||
13251216|NCT01564862|26369972|FG002|Overall Study|Other reason(s)|0|||
13251217|NCT01564784|26370006|FG000|Overall Study|Other|1|||
13251218|NCT01564784|26370007|FG001|Overall Study|Other|0|||
13251219|NCT01564784|26370006|FG000|Overall Study|Subject refused further follow-up|1|||
13251220|NCT01564784|26370007|FG001|Overall Study|Subject refused further follow-up|6|||
13251221|NCT01564784|26370006|FG000|Overall Study|Lost to Follow-up|1|||
13251222|NCT01564784|26370007|FG001|Overall Study|Lost to Follow-up|1|||
13251223|NCT01564784|26370006|FG000|Overall Study|Death|131|||
13251224|NCT01564784|26370007|FG001|Overall Study|Death|126|||
13251225|NCT01564758|26370014|FG000|Overall Study|Death|8|||
13251226|NCT01564758|26370014|FG000|Overall Study|Adverse Event|3|||
13251227|NCT01564758|26370014|FG000|Overall Study|Other|3|||
13251228|NCT01564732|26370037|FG000|Overall Study|Early termination by the study sponsor|6|||
13251229|NCT01564732|26370038|FG001|Overall Study|Early termination by the study sponsor|5|||
13251230|NCT01564459|26370067|FG000|Run-In|Adverse Event|7|||
13251231|NCT01564459|26370068|FG001|Run-In|Adverse Event|0|||
13251232|NCT01564459|26370069|FG002|Run-In|Adverse Event|0|||
13251233|NCT01564459|26370067|FG000|Run-In|Lost to Follow-up|1|||
13251234|NCT01564459|26370068|FG001|Run-In|Lost to Follow-up|0|||
13251235|NCT01564459|26370069|FG002|Run-In|Lost to Follow-up|0|||
13251236|NCT01564459|26370067|FG000|Run-In|Non-compliance with study drug|2|||
13251237|NCT01564459|26370068|FG001|Run-In|Non-compliance with study drug|0|||
13251238|NCT01564459|26370069|FG002|Run-In|Non-compliance with study drug|0|||
13251239|NCT01564459|26370067|FG000|Run-In|Protocol Violation|1|||
13251240|NCT01564459|26370068|FG001|Run-In|Protocol Violation|0|||
13251241|NCT01564459|26370069|FG002|Run-In|Protocol Violation|0|||
13251242|NCT01564459|26370067|FG000|Run-In|Withdrawal by Subject|1|||
13251243|NCT01564459|26370068|FG001|Run-In|Withdrawal by Subject|0|||
13251244|NCT01564459|26370069|FG002|Run-In|Withdrawal by Subject|0|||
13251245|NCT01564459|26370067|FG000|Double-blind Treatment|Adverse Event|0|||
13251246|NCT01564459|26370068|FG001|Double-blind Treatment|Adverse Event|0|||
13251247|NCT01564459|26370069|FG002|Double-blind Treatment|Adverse Event|1|||
13251248|NCT01564407|26370124|FG000|Overall Study|Lost to Follow-up|0|||
13251249|NCT01564407|26370125|FG001|Overall Study|Lost to Follow-up|1|||
13251250|NCT01564407|26370126|FG002|Overall Study|Lost to Follow-up|0|||
13251251|NCT01564407|26370127|FG003|Overall Study|Lost to Follow-up|0|||
13251252|NCT01564407|26370128|FG004|Overall Study|Lost to Follow-up|0|||
13251253|NCT01564407|26370124|FG000|Overall Study|Withdrawal by Subject|0|||
13251254|NCT01564407|26370125|FG001|Overall Study|Withdrawal by Subject|1|||
13251255|NCT01564407|26370126|FG002|Overall Study|Withdrawal by Subject|0|||
13251256|NCT01564407|26370127|FG003|Overall Study|Withdrawal by Subject|0|||
13251257|NCT01564407|26370128|FG004|Overall Study|Withdrawal by Subject|0|||
13251258|NCT01564407|26370124|FG000|Overall Study|funding lost, study ended|0|||
13251259|NCT01564407|26370125|FG001|Overall Study|funding lost, study ended|0|||
13251260|NCT01564407|26370126|FG002|Overall Study|funding lost, study ended|0|||
13251261|NCT01564407|26370127|FG003|Overall Study|funding lost, study ended|1|||
13251262|NCT01564407|26370128|FG004|Overall Study|funding lost, study ended|0|||
13251263|NCT01564394|26370147|FG000|Overall Study|Withdrawal by Subject|6|||
13251264|NCT01564394|26370148|FG001|Overall Study|Withdrawal by Subject|10|||
13251265|NCT01564277|26370171|FG000|Overall Study|Protocol Violation|0|||
13251266|NCT01564277|26370172|FG001|Overall Study|Protocol Violation|1|||
13251267|NCT01564277|26370171|FG000|Overall Study|Physician Decision|1|||
13251268|NCT01564277|26370172|FG001|Overall Study|Physician Decision|0|||
13251269|NCT01563978|26370203|FG000|Overall Study|Physician Decision|1|||
13251270|NCT01563978|26370204|FG001|Overall Study|Physician Decision|0|||
13251271|NCT01563978|26370203|FG000|Overall Study|Lost to Follow-up|1|||
13251272|NCT01563978|26370204|FG001|Overall Study|Lost to Follow-up|0|||
13251273|NCT01563978|26370203|FG000|Overall Study|Dev. of study specific discont. criteria|1|||
13251274|NCT01563978|26370204|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
13251275|NCT01563978|26370203|FG000|Overall Study|Adverse Event|1|||
13251276|NCT01563978|26370204|FG001|Overall Study|Adverse Event|2|||
13251277|NCT01563913|26370221|FG000|Overall Study|Physician Decision|1|||
13251278|NCT01563913|26370222|FG001|Overall Study|Physician Decision|0|||
13251279|NCT01563913|26370221|FG000|Overall Study|Spouse Passed Away|1|||
13251280|NCT01563913|26370222|FG001|Overall Study|Spouse Passed Away|0|||
13251281|NCT01563536|26370257|FG000|Overall Study|Withdrawal by Subject|0|||
13251282|NCT01563536|26370258|FG001|Overall Study|Withdrawal by Subject|2|||
13251283|NCT01563536|26370257|FG000|Overall Study|Lost to Follow-up|1|||
13251284|NCT01563536|26370258|FG001|Overall Study|Lost to Follow-up|0|||
13251285|NCT01563354|26370309|FG000|Core Phase|Adverse Event|5|||
13251286|NCT01563354|26370310|FG001|Core Phase|Adverse Event|15|||
13251287|NCT01563354|26370311|FG002|Core Phase|Adverse Event|13|||
13251288|NCT01563354|26370309|FG000|Core Phase|Withdrawal by Subject|1|||
13251289|NCT01563354|26370310|FG001|Core Phase|Withdrawal by Subject|0|||
13251290|NCT01563354|26370311|FG002|Core Phase|Withdrawal by Subject|3|||
13251291|NCT01563354|26370309|FG000|Core Phase|Lost to Follow-up|1|||
13251292|NCT01563354|26370310|FG001|Core Phase|Lost to Follow-up|0|||
13251293|NCT01563354|26370311|FG002|Core Phase|Lost to Follow-up|0|||
13251294|NCT01563354|26370309|FG000|Core Phase|Death|1|||
13251295|NCT01563354|26370310|FG001|Core Phase|Death|5|||
13251296|NCT01563354|26370311|FG002|Core Phase|Death|2|||
13251297|NCT01563354|26370309|FG000|Core Phase|Diseasse progression|18|||
13251298|NCT01563354|26370310|FG001|Core Phase|Diseasse progression|7|||
13251299|NCT01563354|26370311|FG002|Core Phase|Diseasse progression|8|||
13251300|NCT01563354|26370309|FG000|Core Phase|Protocol deviation|2|||
13251301|NCT01563354|26370310|FG001|Core Phase|Protocol deviation|0|||
13251302|NCT01563354|26370311|FG002|Core Phase|Protocol deviation|0|||
13251303|NCT01563354|26370309|FG000|Core Phase|PI decision - did not enter extension|0|||
13251304|NCT01563354|26370310|FG001|Core Phase|PI decision - did not enter extension|1|||
13251305|NCT01563354|26370311|FG002|Core Phase|PI decision - did not enter extension|0|||
13251306|NCT01563354|26370309|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1|||
13251307|NCT01563354|26370310|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0|||
13251308|NCT01563354|26370311|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0|||
13251309|NCT01563354|26370309|FG000|Extension Phase|Adverse Event|0|||
13251310|NCT01563354|26370310|FG001|Extension Phase|Adverse Event|3|||
13251311|NCT01563354|26370311|FG002|Extension Phase|Adverse Event|2|||
13251312|NCT01563354|26370309|FG000|Extension Phase|Withdrawal by Subject|0|||
13251313|NCT01563354|26370310|FG001|Extension Phase|Withdrawal by Subject|1|||
13251314|NCT01563354|26370311|FG002|Extension Phase|Withdrawal by Subject|0|||
13251315|NCT01563354|26370309|FG000|Extension Phase|Administration problems|3|||
13251316|NCT01563354|26370310|FG001|Extension Phase|Administration problems|2|||
13251317|NCT01563354|26370311|FG002|Extension Phase|Administration problems|3|||
13251318|NCT01563354|26370309|FG000|Extension Phase|Disease progression|9|||
13251319|NCT01563354|26370310|FG001|Extension Phase|Disease progression|8|||
13251320|NCT01563354|26370311|FG002|Extension Phase|Disease progression|10|||
13251321|NCT01563237|26370319|FG000|Overall Study|Lost to Follow-up|6|||
13251322|NCT01563237|26370320|FG001|Overall Study|Lost to Follow-up|0|||
13251323|NCT01563237|26370319|FG000|Overall Study|Withdrawal by Subject|1|||
13251324|NCT01563237|26370320|FG001|Overall Study|Withdrawal by Subject|0|||
13251325|NCT01563237|26370319|FG000|Overall Study|Adverse Event|1|||
13251326|NCT01563237|26370320|FG001|Overall Study|Adverse Event|0|||
13251327|NCT01563237|26370319|FG000|Overall Study|Medical Reasons|1|||
13251328|NCT01563237|26370320|FG001|Overall Study|Medical Reasons|0|||
13251329|NCT01563237|26370319|FG000|Overall Study|Death|1|||
13251330|NCT01563237|26370320|FG001|Overall Study|Death|0|||
13251331|NCT01563185|26370336|FG000|Overall Study|Withdrawal by Subject|1|||
13251332|NCT01563185|26370336|FG000|Overall Study|Non-Compliance with study drug|1|||
13251333|NCT01563172|26370365|FG000|Overall Study|Adverse Event|5|||
13251334|NCT01563172|26370365|FG000|Overall Study|Lost to Follow-up|2|||
13251335|NCT01563172|26370365|FG000|Overall Study|Other (Protocol deviation)|5|||
13251336|NCT01563172|26370365|FG000|Overall Study|Other (Not specified)|1|||
13251337|NCT01563029|26370429|FG000|Overall Study|Adverse Event|1|||
13251338|NCT01563029|26370430|FG001|Overall Study|Adverse Event|0|||
13251339|NCT01563029|26370431|FG002|Overall Study|Adverse Event|1|||
13251340|NCT01563029|26370432|FG003|Overall Study|Adverse Event|2|||
13251341|NCT01563029|26370433|FG004|Overall Study|Adverse Event|1|||
13251342|NCT01563029|26370429|FG000|Overall Study|Lack of Efficacy|42|||
13251343|NCT01563029|26370430|FG001|Overall Study|Lack of Efficacy|16|||
13251344|NCT01563029|26370431|FG002|Overall Study|Lack of Efficacy|23|||
13251345|NCT01563029|26370432|FG003|Overall Study|Lack of Efficacy|21|||
13251346|NCT01563029|26370433|FG004|Overall Study|Lack of Efficacy|19|||
13251347|NCT01563029|26370429|FG000|Overall Study|Protocol Violation|1|||
13251348|NCT01563029|26370430|FG001|Overall Study|Protocol Violation|2|||
13251349|NCT01563029|26370431|FG002|Overall Study|Protocol Violation|3|||
13251350|NCT01563029|26370432|FG003|Overall Study|Protocol Violation|1|||
13251351|NCT01563029|26370433|FG004|Overall Study|Protocol Violation|3|||
13251352|NCT01563029|26370429|FG000|Overall Study|Protocol defined stopping criteria|1|||
13251353|NCT01563029|26370430|FG001|Overall Study|Protocol defined stopping criteria|0|||
13251354|NCT01563029|26370431|FG002|Overall Study|Protocol defined stopping criteria|0|||
13251355|NCT01563029|26370432|FG003|Overall Study|Protocol defined stopping criteria|0|||
13251356|NCT01563029|26370433|FG004|Overall Study|Protocol defined stopping criteria|0|||
13251357|NCT01563029|26370429|FG000|Overall Study|Lost to Follow-up|1|||
13251358|NCT01563029|26370430|FG001|Overall Study|Lost to Follow-up|0|||
13251359|NCT01563029|26370431|FG002|Overall Study|Lost to Follow-up|1|||
13251360|NCT01563029|26370432|FG003|Overall Study|Lost to Follow-up|1|||
13251361|NCT01563029|26370433|FG004|Overall Study|Lost to Follow-up|1|||
13251362|NCT01563029|26370429|FG000|Overall Study|Physician Decision|3|||
13251363|NCT01563029|26370430|FG001|Overall Study|Physician Decision|5|||
13251364|NCT01563029|26370431|FG002|Overall Study|Physician Decision|2|||
13251365|NCT01563029|26370432|FG003|Overall Study|Physician Decision|4|||
13251366|NCT01563029|26370433|FG004|Overall Study|Physician Decision|2|||
13251367|NCT01563029|26370429|FG000|Overall Study|Withdrawal by Subject|4|||
13251368|NCT01563029|26370430|FG001|Overall Study|Withdrawal by Subject|1|||
13251369|NCT01563029|26370431|FG002|Overall Study|Withdrawal by Subject|3|||
13251370|NCT01563029|26370432|FG003|Overall Study|Withdrawal by Subject|4|||
13251371|NCT01563029|26370433|FG004|Overall Study|Withdrawal by Subject|3|||
13251372|NCT01562873|26370443|FG000|Overall Study|Disease Progression per RECIST|10|||
13251373|NCT01562873|26370444|FG001|Overall Study|Disease Progression per RECIST|0|||
13251374|NCT01562873|26370443|FG000|Overall Study|Adverse Event|1|||
13251375|NCT01562873|26370444|FG001|Overall Study|Adverse Event|0|||
13251376|NCT01562873|26370443|FG000|Overall Study|Clinical Disease Progression|9|||
13251377|NCT01562873|26370444|FG001|Overall Study|Clinical Disease Progression|0|||
13251378|NCT01562873|26370443|FG000|Overall Study|Clinical PD and adverse event|1|||
13251379|NCT01562873|26370444|FG001|Overall Study|Clinical PD and adverse event|0|||
13251380|NCT01562782|26370475|FG000|Overall Study|Withdrawal by Subject|3|||
13251381|NCT01562782|26370476|FG001|Overall Study|Withdrawal by Subject|3|||
13251382|NCT01562782|26370475|FG000|Overall Study|screen failure|1|||
13251383|NCT01562782|26370476|FG001|Overall Study|screen failure|2|||
13251384|NCT01562743|26370488|FG000|Overall Study|Adverse Event|29|||
13251385|NCT01562743|26370488|FG000|Overall Study|Lack of Efficacy|3|||
13251386|NCT01562743|26370488|FG000|Overall Study|Withdrawal by Subject|13|||
13251387|NCT01562743|26370488|FG000|Overall Study|Protocol Violation|1|||
13251388|NCT01562743|26370488|FG000|Overall Study|Discontinuation criteria|2|||
13251389|NCT01562743|26370488|FG000|Overall Study|Lost to Follow-up|2|||
13251390|NCT01562743|26370488|FG000|Overall Study|Physician Decision|2|||
13251391|NCT01562613|26370496|FG000|Overall Study|Lost to Follow-up|2|||
13251392|NCT01562613|26370496|FG000|Overall Study|Withdrawal by Subject|2|||
13251393|NCT01562548|26370559|FG000|Overall Study|Lost to Follow-up|0|||
13251394|NCT01562548|26370560|FG001|Overall Study|Lost to Follow-up|0|||
13251395|NCT01562548|26370561|FG002|Overall Study|Lost to Follow-up|1|||
13251396|NCT01562548|26370562|FG003|Overall Study|Lost to Follow-up|0|||
13251397|NCT01562444|26370817|FG000|Overall Study|Did not meet entry criteria|2|||
13251398|NCT01562444|26370818|FG001|Overall Study|Did not meet entry criteria|0|||
13251399|NCT01562444|26370819|FG002|Overall Study|Did not meet entry criteria|3|||
13251400|NCT01562444|26370817|FG000|Overall Study|Did not comply with blood draw schedule|1|||
13251401|NCT01562444|26370818|FG001|Overall Study|Did not comply with blood draw schedule|0|||
13251402|NCT01562444|26370819|FG002|Overall Study|Did not comply with blood draw schedule|1|||
13251403|NCT01562444|26370817|FG000|Overall Study|Unavailable serological results|0|||
13251404|NCT01562444|26370818|FG001|Overall Study|Unavailable serological results|2|||
13251405|NCT01562444|26370819|FG002|Overall Study|Unavailable serological results|2|||
13251406|NCT01562444|26370817|FG000|Overall Study|Protocol forbidden concomitant vaccine|1|||
13251407|NCT01562444|26370818|FG001|Overall Study|Protocol forbidden concomitant vaccine|0|||
13251408|NCT01562444|26370819|FG002|Overall Study|Protocol forbidden concomitant vaccine|1|||
13251409|NCT01562444|26370817|FG000|Overall Study|Protocol forbidden medication|1|||
13251410|NCT01562444|26370818|FG001|Overall Study|Protocol forbidden medication|0|||
13251411|NCT01562444|26370819|FG002|Overall Study|Protocol forbidden medication|0|||
13251412|NCT01562327|26370849|FG000|Overall Study|Adverse Event|2|||
13251413|NCT01562327|26370849|FG000|Overall Study|Lack of Efficacy|1|||
13251414|NCT01562327|26370849|FG000|Overall Study|Participant drop-out|1|||
13251415|NCT01562327|26370849|FG000|Overall Study|Infusion not received at 6 month window|4|||
13251416|NCT01562314|26370900|FG000|Overall Study|Adverse Event|10|||
13251417|NCT01562314|26370901|FG001|Overall Study|Adverse Event|5|||
13251418|NCT01562314|26370900|FG000|Overall Study|Met Withdrawal Criteria|3|||
13251419|NCT01562314|26370901|FG001|Overall Study|Met Withdrawal Criteria|2|||
13251420|NCT01562314|26370900|FG000|Overall Study|Withdrawal by Subject|0|||
13251421|NCT01562314|26370901|FG001|Overall Study|Withdrawal by Subject|1|||
13251422|NCT01562275|26371071|FG000|Stage 1|Adverse Event|0|||
13251423|NCT01562275|26371072|FG001|Stage 1|Adverse Event|0|||
13251424|NCT01562275|26371073|FG002|Stage 1|Adverse Event|0|||
13251425|NCT01562275|26371074|FG003|Stage 1|Adverse Event|1|||
13251426|NCT01562275|26371075|FG004|Stage 1|Adverse Event|1|||
13251427|NCT01562275|26371076|FG005|Stage 1|Adverse Event|0|||
13251428|NCT01562275|26371077|FG006|Stage 1|Adverse Event|0|||
13251429|NCT01562275|26371078|FG007|Stage 1|Adverse Event|0|||
13251430|NCT01562275|26371079|FG008|Stage 1|Adverse Event|0|||
13251431|NCT01562275|26371080|FG009|Stage 1|Adverse Event|1|||
13251432|NCT01562275|26371081|FG010|Stage 1|Adverse Event|0|||
13251433|NCT01562275|26371082|FG011|Stage 1|Adverse Event|0|||
13251434|NCT01562275|26371083|FG012|Stage 1|Adverse Event|0|||
13251435|NCT01562275|26371071|FG000|Stage 1|Death|1|||
13251436|NCT01562275|26371072|FG001|Stage 1|Death|0|||
13251437|NCT01562275|26371073|FG002|Stage 1|Death|0|||
13251438|NCT01562275|26371074|FG003|Stage 1|Death|0|||
13251439|NCT01562275|26371075|FG004|Stage 1|Death|0|||
13251440|NCT01562275|26371076|FG005|Stage 1|Death|0|||
13251441|NCT01562275|26371077|FG006|Stage 1|Death|0|||
13251442|NCT01562275|26371078|FG007|Stage 1|Death|0|||
13251443|NCT01562275|26371079|FG008|Stage 1|Death|0|||
13251444|NCT01562275|26371080|FG009|Stage 1|Death|0|||
13251445|NCT01562275|26371081|FG010|Stage 1|Death|0|||
13251446|NCT01562275|26371082|FG011|Stage 1|Death|0|||
13251447|NCT01562275|26371083|FG012|Stage 1|Death|0|||
13251448|NCT01562275|26371071|FG000|Stage 1|Non Compliance|0|||
13251449|NCT01562275|26371072|FG001|Stage 1|Non Compliance|0|||
13251450|NCT01562275|26371073|FG002|Stage 1|Non Compliance|1|||
13251451|NCT01562275|26371074|FG003|Stage 1|Non Compliance|0|||
13251452|NCT01562275|26371075|FG004|Stage 1|Non Compliance|0|||
13251453|NCT01562275|26371076|FG005|Stage 1|Non Compliance|0|||
13251454|NCT01562275|26371077|FG006|Stage 1|Non Compliance|0|||
13251455|NCT01562275|26371078|FG007|Stage 1|Non Compliance|0|||
13251456|NCT01562275|26371079|FG008|Stage 1|Non Compliance|0|||
13251457|NCT01562275|26371080|FG009|Stage 1|Non Compliance|0|||
13251458|NCT01562275|26371081|FG010|Stage 1|Non Compliance|0|||
13251459|NCT01562275|26371082|FG011|Stage 1|Non Compliance|0|||
13251460|NCT01562275|26371083|FG012|Stage 1|Non Compliance|0|||
13251461|NCT01562275|26371071|FG000|Stage 1|Physician Decision|0|||
13251462|NCT01562275|26371072|FG001|Stage 1|Physician Decision|0|||
13251463|NCT01562275|26371073|FG002|Stage 1|Physician Decision|0|||
13251464|NCT01562275|26371074|FG003|Stage 1|Physician Decision|0|||
13251465|NCT01562275|26371075|FG004|Stage 1|Physician Decision|1|||
13251466|NCT01562275|26371076|FG005|Stage 1|Physician Decision|0|||
13251467|NCT01562275|26371077|FG006|Stage 1|Physician Decision|1|||
13251468|NCT01562275|26371078|FG007|Stage 1|Physician Decision|0|||
13251469|NCT01562275|26371079|FG008|Stage 1|Physician Decision|1|||
13251470|NCT01562275|26371080|FG009|Stage 1|Physician Decision|0|||
13251471|NCT01562275|26371081|FG010|Stage 1|Physician Decision|0|||
13251472|NCT01562275|26371082|FG011|Stage 1|Physician Decision|0|||
13251473|NCT01562275|26371083|FG012|Stage 1|Physician Decision|0|||
13251474|NCT01562275|26371071|FG000|Stage 1|Progression of Disease|2|||
13251475|NCT01562275|26371072|FG001|Stage 1|Progression of Disease|6|||
13251476|NCT01562275|26371073|FG002|Stage 1|Progression of Disease|2|||
13251477|NCT01562275|26371074|FG003|Stage 1|Progression of Disease|1|||
13251478|NCT01562275|26371075|FG004|Stage 1|Progression of Disease|2|||
13251479|NCT01562275|26371076|FG005|Stage 1|Progression of Disease|4|||
13251480|NCT01562275|26371077|FG006|Stage 1|Progression of Disease|1|||
13251481|NCT01562275|26371078|FG007|Stage 1|Progression of Disease|7|||
13251482|NCT01562275|26371079|FG008|Stage 1|Progression of Disease|2|||
13251483|NCT01562275|26371080|FG009|Stage 1|Progression of Disease|5|||
13251484|NCT01562275|26371081|FG010|Stage 1|Progression of Disease|3|||
13251485|NCT01562275|26371082|FG011|Stage 1|Progression of Disease|0|||
13251486|NCT01562275|26371083|FG012|Stage 1|Progression of Disease|0|||
13251487|NCT01562275|26371071|FG000|Stage 1|Withdrawal by Subject|0|||
13251488|NCT01562275|26371072|FG001|Stage 1|Withdrawal by Subject|1|||
13251489|NCT01562275|26371073|FG002|Stage 1|Withdrawal by Subject|0|||
13251490|NCT01562275|26371074|FG003|Stage 1|Withdrawal by Subject|2|||
13251491|NCT01562275|26371075|FG004|Stage 1|Withdrawal by Subject|0|||
13251492|NCT01562275|26371076|FG005|Stage 1|Withdrawal by Subject|0|||
13251493|NCT01562275|26371077|FG006|Stage 1|Withdrawal by Subject|1|||
13251494|NCT01562275|26371078|FG007|Stage 1|Withdrawal by Subject|0|||
13251495|NCT01562275|26371079|FG008|Stage 1|Withdrawal by Subject|0|||
13251496|NCT01562275|26371080|FG009|Stage 1|Withdrawal by Subject|1|||
13251497|NCT01562275|26371081|FG010|Stage 1|Withdrawal by Subject|0|||
13251498|NCT01562275|26371082|FG011|Stage 1|Withdrawal by Subject|0|||
13251499|NCT01562275|26371083|FG012|Stage 1|Withdrawal by Subject|0|||
13251500|NCT01562275|26371071|FG000|Stage 2|Death|0|||
13251501|NCT01562275|26371072|FG001|Stage 2|Death|0|||
13251502|NCT01562275|26371073|FG002|Stage 2|Death|0|||
13251503|NCT01562275|26371074|FG003|Stage 2|Death|0|||
13251504|NCT01562275|26371075|FG004|Stage 2|Death|0|||
13251505|NCT01562275|26371076|FG005|Stage 2|Death|0|||
13251506|NCT01562275|26371077|FG006|Stage 2|Death|0|||
13251507|NCT01562275|26371078|FG007|Stage 2|Death|0|||
13251508|NCT01562275|26371079|FG008|Stage 2|Death|0|||
13251509|NCT01562275|26371080|FG009|Stage 2|Death|0|||
13251510|NCT01562275|26371081|FG010|Stage 2|Death|0|||
13251511|NCT01562275|26371082|FG011|Stage 2|Death|2|||
13251512|NCT01562275|26371083|FG012|Stage 2|Death|1|||
13251513|NCT01562275|26371071|FG000|Stage 2|Progression of Disease|0|||
13251514|NCT01562275|26371072|FG001|Stage 2|Progression of Disease|0|||
13251515|NCT01562275|26371073|FG002|Stage 2|Progression of Disease|0|||
13251516|NCT01562275|26371074|FG003|Stage 2|Progression of Disease|0|||
13251517|NCT01562275|26371075|FG004|Stage 2|Progression of Disease|0|||
13251518|NCT01562275|26371076|FG005|Stage 2|Progression of Disease|0|||
13251519|NCT01562275|26371077|FG006|Stage 2|Progression of Disease|0|||
13251520|NCT01562275|26371078|FG007|Stage 2|Progression of Disease|0|||
13251521|NCT01562275|26371079|FG008|Stage 2|Progression of Disease|0|||
13251522|NCT01562275|26371080|FG009|Stage 2|Progression of Disease|0|||
13251523|NCT01562275|26371081|FG010|Stage 2|Progression of Disease|0|||
13251524|NCT01562275|26371082|FG011|Stage 2|Progression of Disease|12|||
13251525|NCT01562275|26371083|FG012|Stage 2|Progression of Disease|4|||
13251526|NCT01562028|26371108|FG000|Overall Study|Withdrawal by Subject|1|||
13251527|NCT01562028|26371109|FG001|Overall Study|Withdrawal by Subject|1|||
13251528|NCT01562028|26371108|FG000|Overall Study|Lost to Follow-up|2|||
13251529|NCT01562028|26371109|FG001|Overall Study|Lost to Follow-up|1|||
13251530|NCT01561989|26371132|FG000|Overall Study|accural target not met.|5|||
13251531|NCT01561989|26371133|FG001|Overall Study|accural target not met.|6|||
13251532|NCT01561976|26371181|FG000|Period 1|Adverse Event|0|||
13251533|NCT01561976|26371182|FG001|Period 1|Adverse Event|0|||
13251534|NCT01561976|26371183|FG002|Period 1|Adverse Event|1|||
13251535|NCT01561976|26371184|FG003|Period 1|Adverse Event|0|||
13251536|NCT01561976|26371185|FG004|Period 1|Adverse Event|0|||
13251537|NCT01561976|26371186|FG005|Period 1|Adverse Event|0|||
13251538|NCT01561976|26371181|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
13251539|NCT01561976|26371182|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
13251540|NCT01561976|26371183|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
13251541|NCT01561976|26371184|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
13251542|NCT01561976|26371185|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
13251543|NCT01561976|26371186|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
13251544|NCT01561976|26371181|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
13251545|NCT01561976|26371182|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
13251546|NCT01561976|26371183|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
13251547|NCT01561976|26371184|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
13251548|NCT01561976|26371185|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
13251549|NCT01561976|26371186|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
13251550|NCT01561976|26371181|FG000|Washout Period 2 (7 Days)|Non-compliance|1|||
13251551|NCT01561976|26371182|FG001|Washout Period 2 (7 Days)|Non-compliance|0|||
13251552|NCT01561976|26371183|FG002|Washout Period 2 (7 Days)|Non-compliance|1|||
13251553|NCT01561976|26371184|FG003|Washout Period 2 (7 Days)|Non-compliance|0|||
13251554|NCT01561976|26371185|FG004|Washout Period 2 (7 Days)|Non-compliance|0|||
13251555|NCT01561976|26371186|FG005|Washout Period 2 (7 Days)|Non-compliance|0|||
13251556|NCT01561963|26371215|FG000|Overall Study|Adverse Event|1|||
13251557|NCT01561898|26371240|FG000|Overall Study|Withdrawal by Subject|0|||
13251558|NCT01561898|26371241|FG001|Overall Study|Withdrawal by Subject|8|||
13251559|NCT01561898|26371242|FG002|Overall Study|Withdrawal by Subject|12|||
13251560|NCT01561898|26371243|FG003|Overall Study|Withdrawal by Subject|5|||
13251561|NCT01561898|26371240|FG000|Overall Study|Lack of Efficacy|0|||
13251562|NCT01561898|26371241|FG001|Overall Study|Lack of Efficacy|8|||
13251563|NCT01561898|26371242|FG002|Overall Study|Lack of Efficacy|10|||
13251564|NCT01561898|26371243|FG003|Overall Study|Lack of Efficacy|5|||
13251565|NCT01561898|26371240|FG000|Overall Study|Worsening of complications|0|||
13251566|NCT01561898|26371241|FG001|Overall Study|Worsening of complications|1|||
13251567|NCT01561898|26371242|FG002|Overall Study|Worsening of complications|0|||
13251568|NCT01561898|26371243|FG003|Overall Study|Worsening of complications|0|||
13251569|NCT01561898|26371240|FG000|Overall Study|Lost to Follow-up|0|||
13251570|NCT01561898|26371241|FG001|Overall Study|Lost to Follow-up|0|||
13251571|NCT01561898|26371242|FG002|Overall Study|Lost to Follow-up|1|||
13251572|NCT01561898|26371243|FG003|Overall Study|Lost to Follow-up|0|||
13251573|NCT01561898|26371240|FG000|Overall Study|Adverse Event|1|||
13251574|NCT01561898|26371241|FG001|Overall Study|Adverse Event|19|||
13251575|NCT01561898|26371242|FG002|Overall Study|Adverse Event|14|||
13251576|NCT01561898|26371243|FG003|Overall Study|Adverse Event|9|||
13251577|NCT01561898|26371240|FG000|Overall Study|Physician Decision|1|||
13251578|NCT01561898|26371241|FG001|Overall Study|Physician Decision|5|||
13251579|NCT01561898|26371242|FG002|Overall Study|Physician Decision|7|||
13251580|NCT01561898|26371243|FG003|Overall Study|Physician Decision|1|||
13251581|NCT01561755|26371268|FG000|Overall Study|Lost to Follow-up|0|||
13251582|NCT01561755|26371269|FG001|Overall Study|Lost to Follow-up|1|||
13251583|NCT01561560|26371278|FG000|First Two Weeks of Wear|Time/job conflict|0|||
13251584|NCT01561560|26371279|FG001|First Two Weeks of Wear|Time/job conflict|1|||
13251585|NCT01561560|26371278|FG000|First Two Weeks of Wear|Adverse Event|0|||
13251586|NCT01561560|26371279|FG001|First Two Weeks of Wear|Adverse Event|1|||
13251587|NCT01561560|26371278|FG000|Second Two Weeks of Wear|Adverse Event|0|||
13251588|NCT01561560|26371279|FG001|Second Two Weeks of Wear|Adverse Event|1|||
13251589|NCT01561313|26371304|FG000|Overall Study|Withdrawal by Subject|1|||
13251590|NCT01561313|26371305|FG001|Overall Study|Withdrawal by Subject|0|||
13251591|NCT01561313|26371304|FG000|Overall Study|Adverse event and withdrawal by subject|1|||
13251592|NCT01561313|26371305|FG001|Overall Study|Adverse event and withdrawal by subject|0|||
13251593|NCT01561300|26371319|FG000|Run in on Placebo|Adverse Event|1|||
13251594|NCT01561300|26371320|FG001|Run in on Placebo|Adverse Event|0|||
13251595|NCT01561079|26371365|FG000|Overall Study|Physician Decision|17|||
13251596|NCT01561079|26371365|FG000|Overall Study|Withdrawal by Subject|59|||
13251597|NCT01561079|26371365|FG000|Overall Study|Protocol Violation|2|||
13251598|NCT01560988|26371391|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7|||
13251599|NCT01560988|26371392|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4|||
13251600|NCT01560988|26371391|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3|||
13251601|NCT01560988|26371392|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0|||
13251602|NCT01560988|26371391|FG000|Washout (Six Weeks)|Lost to Follow-up|2|||
13251603|NCT01560988|26371392|FG001|Washout (Six Weeks)|Lost to Follow-up|2|||
13251604|NCT01560949|26371407|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6|||
13251605|NCT01560949|26371407|FG000|Surgery Phase|Physician Decision|3|||
13251606|NCT01560871|26371428|FG000|Overall Study|transportation issues|2|||
13251607|NCT01560871|26371429|FG001|Overall Study|transportation issues|1|||
13251608|NCT01560871|26371428|FG000|Overall Study|relocation|1|||
13251609|NCT01560871|26371429|FG001|Overall Study|relocation|0|||
13251610|NCT01560871|26371428|FG000|Overall Study|readmission to a hospital|2|||
13251611|NCT01560871|26371429|FG001|Overall Study|readmission to a hospital|1|||
13251612|NCT01560871|26371428|FG000|Overall Study|Lost to Follow-up|1|||
13251613|NCT01560871|26371429|FG001|Overall Study|Lost to Follow-up|0|||
13251614|NCT01560819|26371440|FG000|Overall Study|Physician Decision|1|||
13251615|NCT01560819|26371441|FG001|Overall Study|Physician Decision|0|||
13251616|NCT01560780|26371466|FG000|Overall Study|Death|2|||
13251617|NCT01560780|26371467|FG001|Overall Study|Death|1|||
13251618|NCT01560780|26371466|FG000|Overall Study|Patient Preference|11|||
13251619|NCT01560780|26371467|FG001|Overall Study|Patient Preference|11|||
13251620|NCT01560507|26371488|FG000|Overall Study|Lost to Follow-up|3|||
13251621|NCT01560507|26371489|FG001|Overall Study|Lost to Follow-up|1|||
13251622|NCT01560507|26371490|FG002|Overall Study|Lost to Follow-up|2|||
13251623|NCT01560507|26371488|FG000|Overall Study|Withdrawal by Subject|1|||
13251624|NCT01560507|26371489|FG001|Overall Study|Withdrawal by Subject|1|||
13251625|NCT01560507|26371490|FG002|Overall Study|Withdrawal by Subject|0|||
13251626|NCT01560429|26371505|FG000|Overall Study|Protocol Violation|3|||
13251627|NCT01560429|26371506|FG001|Overall Study|Protocol Violation|6|||
13251628|NCT01560416|26371529|FG000|Randomized Phase|Crossover Participants|7|||
13251629|NCT01560416|26371530|FG001|Randomized Phase|Crossover Participants|0|||
13251630|NCT01560403|26371543|FG000|Overall Study|Lost to Follow-up|0|||
13251631|NCT01560403|26371544|FG001|Overall Study|Lost to Follow-up|1|||
13251632|NCT01560234|26371643|FG000|Overall Study|Lost to Follow-up|3|||
13251633|NCT01560234|26371644|FG001|Overall Study|Lost to Follow-up|0|||
13251634|NCT01560234|26371645|FG002|Overall Study|Lost to Follow-up|1|||
13251635|NCT01560234|26371646|FG003|Overall Study|Lost to Follow-up|0|||
13251636|NCT01560234|26371647|FG004|Overall Study|Lost to Follow-up|0|||
13251637|NCT01560234|26371648|FG005|Overall Study|Lost to Follow-up|2|||
13251638|NCT01560234|26371649|FG006|Overall Study|Lost to Follow-up|0|||
13251639|NCT01560234|26371650|FG007|Overall Study|Lost to Follow-up|2|||
13251640|NCT01559935|26371660|FG000|Car Phase|Toxicity|4|||
13251641|NCT01559935|26371660|FG000|Car Phase|Death|1|||
13251642|NCT01559935|26371660|FG000|Car Phase|Lack of Efficacy|2|||
13251643|NCT01559935|26371660|FG000|Car Phase|Lost to Follow-up|1|||
13251644|NCT01559935|26371660|FG000|Car Phase|Physician Decision|1|||
13251645|NCT01559935|26371660|FG000|Car Phase|Withdrawal by Subject|2|||
13251646|NCT01559935|26371660|FG000|Car Phase|Per protocol|1|||
13251647|NCT01559935|26371660|FG000|Car Phase|Insurance|1|||
13251648|NCT01559935|26371660|FG000|Car Phase|non-compliance|1|||
13251649|NCT01559935|26371660|FG000|BiRD Phase|Toxicity|1|||
13251650|NCT01559935|26371660|FG000|BiRD Phase|Lack of Efficacy|1|||
13251651|NCT01559935|26371660|FG000|BiRD Phase|Withdrawal by Subject|2|||
13251652|NCT01559935|26371660|FG000|Maintenance Phase|Remains on study|28|||
13251653|NCT01559935|26371660|FG000|Maintenance Phase|Toxicity|1|||
13251654|NCT01559935|26371660|FG000|Maintenance Phase|Lack of Efficacy|18|||
13251655|NCT01559935|26371660|FG000|Maintenance Phase|Withdrawal by Subject|5|||
13251656|NCT01559935|26371660|FG000|Maintenance Phase|Non-compliance|2|||
13251657|NCT01559844|26371673|FG000|Overall Study|Consent Withdrawn|7|||
13251658|NCT01559844|26371673|FG000|Overall Study|Death|5|||
13251659|NCT01559844|26371673|FG000|Overall Study|Efficacy Failure|10|||
13251660|NCT01559844|26371673|FG000|Overall Study|No Longer A Transplant Candidate|3|||
13251661|NCT01559675|26371686|FG000|Overall Study|Protocol Violation|1|||
13251662|NCT01559675|26371687|FG001|Overall Study|Protocol Violation|2|||
13251663|NCT01559675|26371686|FG000|Overall Study|2nd operation on same patient excluded|14|||
13251664|NCT01559675|26371687|FG001|Overall Study|2nd operation on same patient excluded|12|||
13251665|NCT01559454|26371710|FG000|Overall Study|Lost to Follow-up|3|||
13251666|NCT01559454|26371711|FG001|Overall Study|Lost to Follow-up|2|||
13251667|NCT01559454|26371710|FG000|Overall Study|Withdrawal by Subject|0|||
13251668|NCT01559454|26371711|FG001|Overall Study|Withdrawal by Subject|1|||
13251669|NCT01559454|26371710|FG000|Overall Study|Physician Decision|0|||
13251670|NCT01559454|26371711|FG001|Overall Study|Physician Decision|1|||
13251671|NCT01559454|26371710|FG000|Overall Study|Protocol Violation|0|||
13251672|NCT01559454|26371711|FG001|Overall Study|Protocol Violation|1|||
13251673|NCT01559454|26371710|FG000|Overall Study|Lack of Efficacy|0|||
13251674|NCT01559454|26371711|FG001|Overall Study|Lack of Efficacy|1|||
13251675|NCT01559389|26371728|FG000|Overall Study|Withdrawal by Subject|20|||
13251676|NCT01559389|26371729|FG001|Overall Study|Withdrawal by Subject|20|||
13251677|NCT01559311|26371750|FG000|Overall Study|Protocol Violation|0|||
13251678|NCT01559311|26371751|FG001|Overall Study|Protocol Violation|0|||
13251679|NCT01559311|26371752|FG002|Overall Study|Protocol Violation|2|||
13251680|NCT01559311|26371750|FG000|Overall Study|Difficulty in cannulating the lateral ve|1|||
13251681|NCT01559311|26371751|FG001|Overall Study|Difficulty in cannulating the lateral ve|0|||
13251682|NCT01559311|26371752|FG002|Overall Study|Difficulty in cannulating the lateral ve|0|||
13251683|NCT01559311|26371750|FG000|Overall Study|Withdrawal by Subject|2|||
13116582|NCT03073200|25923203|FG012|Extension Period|Sponsor Decision|0|||
13116583|NCT03073200|25923204|FG013|Extension Period|Sponsor Decision|0|||
13116584|NCT03073200|25923205|FG014|Extension Period|Sponsor Decision|0|||
13116585|NCT03073200|25923191|FG000|Extension Period|Withdrawal by Parent/Guardian|0|||
13116586|NCT03073200|25923192|FG001|Extension Period|Withdrawal by Parent/Guardian|0|||
13116587|NCT03073200|25923193|FG002|Extension Period|Withdrawal by Parent/Guardian|0|||
13116588|NCT03073200|25923194|FG003|Extension Period|Withdrawal by Parent/Guardian|0|||
13116589|NCT03073200|25923195|FG004|Extension Period|Withdrawal by Parent/Guardian|0|||
13116590|NCT03073200|25923196|FG005|Extension Period|Withdrawal by Parent/Guardian|0|||
13116591|NCT03073200|25923197|FG006|Extension Period|Withdrawal by Parent/Guardian|1|||
13116592|NCT03073200|25923198|FG007|Extension Period|Withdrawal by Parent/Guardian|3|||
13116593|NCT03073200|25923199|FG008|Extension Period|Withdrawal by Parent/Guardian|1|||
13251684|NCT01559311|26371751|FG001|Overall Study|Withdrawal by Subject|1|||
13251685|NCT01559311|26371752|FG002|Overall Study|Withdrawal by Subject|0|||
13251686|NCT01559311|26371750|FG000|Overall Study|Death|0|||
13251687|NCT01559311|26371751|FG001|Overall Study|Death|2|||
13251688|NCT01559311|26371752|FG002|Overall Study|Death|3|||
13251689|NCT01559311|26371750|FG000|Overall Study|Lost to Follow-up|0|||
13251690|NCT01559311|26371751|FG001|Overall Study|Lost to Follow-up|3|||
13251691|NCT01559311|26371752|FG002|Overall Study|Lost to Follow-up|2|||
13251692|NCT01559311|26371750|FG000|Overall Study|Adverse Event|0|||
13251693|NCT01559311|26371751|FG001|Overall Study|Adverse Event|0|||
13251694|NCT01559311|26371752|FG002|Overall Study|Adverse Event|1|||
13251695|NCT01559259|26371855|FG000|Overall Study|Withdrawal by Subject|0|||
13251696|NCT01559259|26371856|FG001|Overall Study|Withdrawal by Subject|0|||
13116594|NCT03073200|25923200|FG009|Extension Period|Withdrawal by Parent/Guardian|0|||
13116595|NCT03073200|25923201|FG010|Extension Period|Withdrawal by Parent/Guardian|0|||
13116596|NCT03073200|25923202|FG011|Extension Period|Withdrawal by Parent/Guardian|0|||
13116597|NCT03073200|25923203|FG012|Extension Period|Withdrawal by Parent/Guardian|0|||
13116598|NCT03073200|25923204|FG013|Extension Period|Withdrawal by Parent/Guardian|0|||
13116599|NCT03073200|25923205|FG014|Extension Period|Withdrawal by Parent/Guardian|0|||
13116600|NCT03073200|25923191|FG000|Extension Period|Withdrawal by Subject|0|||
13116601|NCT03073200|25923192|FG001|Extension Period|Withdrawal by Subject|0|||
13116602|NCT03073200|25923193|FG002|Extension Period|Withdrawal by Subject|0|||
13116603|NCT03073200|25923194|FG003|Extension Period|Withdrawal by Subject|0|||
13116604|NCT03073200|25923195|FG004|Extension Period|Withdrawal by Subject|0|||
13116605|NCT03073200|25923196|FG005|Extension Period|Withdrawal by Subject|0|||
13116606|NCT03073200|25923197|FG006|Extension Period|Withdrawal by Subject|1|||
13116607|NCT03073200|25923198|FG007|Extension Period|Withdrawal by Subject|2|||
13116608|NCT03073200|25923199|FG008|Extension Period|Withdrawal by Subject|0|||
13116609|NCT03073200|25923200|FG009|Extension Period|Withdrawal by Subject|0|||
13116610|NCT03073200|25923201|FG010|Extension Period|Withdrawal by Subject|0|||
13116611|NCT03073200|25923202|FG011|Extension Period|Withdrawal by Subject|0|||
13251697|NCT01559259|26371857|FG002|Overall Study|Withdrawal by Subject|0|||
13251698|NCT01559259|26371858|FG003|Overall Study|Withdrawal by Subject|1|||
13251699|NCT01559259|26371859|FG004|Overall Study|Withdrawal by Subject|0|||
13251700|NCT01559259|26371855|FG000|Overall Study|Adverse Event|0|||
13251701|NCT01559259|26371856|FG001|Overall Study|Adverse Event|1|||
13251702|NCT01559259|26371857|FG002|Overall Study|Adverse Event|1|||
13251703|NCT01559259|26371858|FG003|Overall Study|Adverse Event|0|||
13251704|NCT01559259|26371859|FG004|Overall Study|Adverse Event|0|||
13251705|NCT01559129|26371942|FG000|Treatment Phase|Adverse Event|0|||
13251706|NCT01559129|26371943|FG001|Treatment Phase|Adverse Event|2|||
13251707|NCT01559129|26371942|FG000|Treatment Phase|Progressive Disease|1|||
13251708|NCT01559129|26371943|FG001|Treatment Phase|Progressive Disease|1|||
13251709|NCT01559129|26371942|FG000|Treatment Phase|Lack of Efficacy|0|||
13251710|NCT01559129|26371943|FG001|Treatment Phase|Lack of Efficacy|1|||
13251711|NCT01559129|26371942|FG000|Treatment Phase|Study Terminated by Sponsor|3|||
13251712|NCT01559129|26371943|FG001|Treatment Phase|Study Terminated by Sponsor|2|||
13251713|NCT01559129|26371942|FG000|Treatment Phase|Protocol Exclusion Criteria|1|||
13251714|NCT01559129|26371943|FG001|Treatment Phase|Protocol Exclusion Criteria|0|||
13251715|NCT01559129|26371942|FG000|Treatment Phase|Did Not Receive Study Drug|0|||
13251716|NCT01559129|26371943|FG001|Treatment Phase|Did Not Receive Study Drug|1|||
13251717|NCT01559129|26371942|FG000|Open-label Extension Period|Adverse Event|1|||
13251718|NCT01559129|26371943|FG001|Open-label Extension Period|Adverse Event|0|||
13251719|NCT01559129|26371942|FG000|Open-label Extension Period|Study Terminated by Sponsor|5|||
13251720|NCT01559129|26371943|FG001|Open-label Extension Period|Study Terminated by Sponsor|2|||
13251721|NCT01559116|26372013|FG000|Overall Study|Adverse Event|10|||
13251722|NCT01559116|26372013|FG000|Overall Study|Lack of Efficacy|1|||
13116612|NCT03073200|25923203|FG012|Extension Period|Withdrawal by Subject|0|||
13116613|NCT03073200|25923204|FG013|Extension Period|Withdrawal by Subject|0|||
13251723|NCT01559116|26372013|FG000|Overall Study|Lost to Follow-up|1|||
13251724|NCT01559116|26372013|FG000|Overall Study|Protocol Violation|1|||
13251725|NCT01559116|26372013|FG000|Overall Study|Withdrawal by Subject|4|||
13251726|NCT01559116|26372013|FG000|Overall Study|other than stated above|9|||
13251727|NCT01559090|26372040|FG000|Stage I|Withdrawal by Subject|2|||
13251728|NCT01559090|26372041|FG001|Stage I|Withdrawal by Subject|2|||
13251729|NCT01559090|26372042|FG002|Stage I|Withdrawal by Subject|3|||
13251730|NCT01559090|26372040|FG000|Stage II|Withdrawal by Subject|1|||
13116614|NCT03073200|25923205|FG014|Extension Period|Withdrawal by Subject|0|||
13251731|NCT01559090|26372041|FG001|Stage II|Withdrawal by Subject|0|||
13251732|NCT01559090|26372042|FG002|Stage II|Withdrawal by Subject|0|||
13251733|NCT01559012|26372072|FG000|Overall Study|Withdrawal by Subject|0|||
13251734|NCT01559012|26372073|FG001|Overall Study|Withdrawal by Subject|1|||
13251735|NCT01558752|26372086|FG000|Overall Study|Physician Decision|2|||
13251736|NCT01558752|26372087|FG001|Overall Study|Physician Decision|0|||
13251737|NCT01558739|26372101|FG000|Overall Study|Adverse Event|7|||
13251738|NCT01558739|26372101|FG000|Overall Study|Withdrawal by Subject|2|||
13251739|NCT01558739|26372101|FG000|Overall Study|Death|3|||
13251740|NCT01558739|26372101|FG000|Overall Study|Disease Progression|4|||
13251741|NCT01558739|26372101|FG000|Overall Study|Protocol Violation|1|||
13251742|NCT01558674|26372152|FG000|Part 1|Study Terminated by Sponsor|10|||
13251743|NCT01558674|26372153|FG001|Part 1|Study Terminated by Sponsor|0|||
13251744|NCT01558674|26372152|FG000|Part 1|Withdrawal by Subject|1|||
13251745|NCT01558674|26372153|FG001|Part 1|Withdrawal by Subject|0|||
13251746|NCT01558635|26372170|FG000|Overall Study|Death|1|||
13251747|NCT01558635|26372170|FG000|Overall Study|Withdrawal by Subject|2|||
13251748|NCT01558635|26372170|FG000|Overall Study|Physician Decision|1|||
13251749|NCT01558635|26372170|FG000|Overall Study|Subject received other treatment|1|||
13251750|NCT01558635|26372170|FG000|Overall Study|Reveal XT was explanted|1|||
13251751|NCT01558596|26372183|FG000|Overall Study|Withdrawal by Subject|1|||
13251752|NCT01558596|26372184|FG001|Overall Study|Withdrawal by Subject|0|||
13251753|NCT01558596|26372183|FG000|Overall Study|surgery elsewhere or cancelled|1|||
13251754|NCT01558596|26372184|FG001|Overall Study|surgery elsewhere or cancelled|1|||
13251755|NCT01558596|26372183|FG000|Overall Study|Protocol Violation|1|||
13251756|NCT01558596|26372184|FG001|Overall Study|Protocol Violation|0|||
13251757|NCT01558297|26372208|FG000|Overall Study|Withdrawal by Subject|2|||
13251758|NCT01558297|26372209|FG001|Overall Study|Withdrawal by Subject|2|||
13251759|NCT01558297|26372210|FG002|Overall Study|Withdrawal by Subject|1|||
13251760|NCT01558271|26372282|FG000|Overall Study|Adverse Event|6|||
13251761|NCT01558271|26372283|FG001|Overall Study|Adverse Event|3|||
13251762|NCT01558271|26372284|FG002|Overall Study|Adverse Event|4|||
13251763|NCT01558271|26372282|FG000|Overall Study|Lost to Follow-up|1|||
13251764|NCT01558271|26372283|FG001|Overall Study|Lost to Follow-up|0|||
13251765|NCT01558271|26372284|FG002|Overall Study|Lost to Follow-up|0|||
13251766|NCT01558271|26372282|FG000|Overall Study|Protocol Violation|1|||
13251767|NCT01558271|26372283|FG001|Overall Study|Protocol Violation|0|||
13251768|NCT01558271|26372284|FG002|Overall Study|Protocol Violation|0|||
13251769|NCT01558271|26372282|FG000|Overall Study|Withdrawal by Subject|10|||
13251770|NCT01558271|26372283|FG001|Overall Study|Withdrawal by Subject|6|||
13251771|NCT01558271|26372284|FG002|Overall Study|Withdrawal by Subject|12|||
13251772|NCT01558271|26372282|FG000|Overall Study|Physician Decision|0|||
13251773|NCT01558271|26372283|FG001|Overall Study|Physician Decision|2|||
13251774|NCT01558271|26372284|FG002|Overall Study|Physician Decision|1|||
13251775|NCT01558089|26372297|FG000|Overall Study|Adverse Event|1|||
13251776|NCT01558089|26372297|FG000|Overall Study|Lack of Efficacy|1|||
13251777|NCT01558089|26372297|FG000|Overall Study|Lost to Follow-up|5|||
13251778|NCT01558089|26372297|FG000|Overall Study|Withdrawal by Subject|6|||
13251779|NCT01557946|26372310|FG000|Overall Study|Adverse Event|3|||
13251780|NCT01557946|26372311|FG001|Overall Study|Adverse Event|0|||
13251781|NCT01557920|26372347|FG000|Overall Study|Withdrawal by Subject|2|||
13251782|NCT01557920|26372348|FG001|Overall Study|Withdrawal by Subject|3|||
13251783|NCT01557920|26372347|FG000|Overall Study|Lack of Efficacy|1|||
13251784|NCT01557920|26372348|FG001|Overall Study|Lack of Efficacy|0|||
13251785|NCT01557842|26372363|FG000|Overall Study|Lost to Follow-up|0|||
13251786|NCT01557842|26372364|FG001|Overall Study|Lost to Follow-up|1|||
13251787|NCT01557842|26372363|FG000|Overall Study|Death|1|||
13251788|NCT01557842|26372364|FG001|Overall Study|Death|0|||
13251789|NCT01557842|26372363|FG000|Overall Study|Lack of Efficacy|0|||
13251790|NCT01557842|26372364|FG001|Overall Study|Lack of Efficacy|1|||
13251791|NCT01557842|26372363|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3|||
13251792|NCT01557842|26372364|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0|||
13251793|NCT01557842|26372363|FG000|Overall Study|Study Terminated by Sponsor|3|||
13251794|NCT01557842|26372364|FG001|Overall Study|Study Terminated by Sponsor|4|||
13251795|NCT01557842|26372363|FG000|Overall Study|Not Ablated|2|||
13116615|NCT03073200|25923191|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
13116616|NCT03073200|25923192|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
13116617|NCT03073200|25923193|FG002|Randomized Withdrawal Period|Lost to Follow-up|0|||
13116618|NCT03073200|25923194|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
13251796|NCT01557842|26372364|FG001|Overall Study|Not Ablated|0|||
13251797|NCT01557751|26372370|FG000|Overall Study|Physician Decision|3|||
13251798|NCT01557582|26372378|FG000|Overall Study|Protocol Violation|4|||
13251799|NCT01557582|26372378|FG000|Overall Study|Operator error|2|||
13251800|NCT01557569|26372391|FG000|Overall Study|Adverse Event|2|||
13251801|NCT01557569|26372392|FG001|Overall Study|Adverse Event|0|||
13251802|NCT01557569|26372391|FG000|Overall Study|high blood pressure|0|||
13251803|NCT01557569|26372392|FG001|Overall Study|high blood pressure|1|||
13251804|NCT01557569|26372391|FG000|Overall Study|Withdrawal by Subject|3|||
13251805|NCT01557569|26372392|FG001|Overall Study|Withdrawal by Subject|5|||
13251806|NCT01557569|26372391|FG000|Overall Study|noncompliance with rules of residential|0|||
13251807|NCT01557569|26372392|FG001|Overall Study|noncompliance with rules of residential|1|||
13251808|NCT01557517|26372423|FG000|Overall Study|Death|1|||
13251809|NCT01557517|26372424|FG001|Overall Study|Death|0|||
13251810|NCT01557517|26372423|FG000|Overall Study|Refused further treatment|0|||
13251811|NCT01557517|26372424|FG001|Overall Study|Refused further treatment|2|||
13251812|NCT01557517|26372423|FG000|Overall Study|Adverse Event|0|||
13251813|NCT01557517|26372424|FG001|Overall Study|Adverse Event|2|||
13251814|NCT01557517|26372423|FG000|Overall Study|Pt declined before treatment started|1|||
13251815|NCT01557517|26372424|FG001|Overall Study|Pt declined before treatment started|0|||
13251816|NCT01557504|26372454|FG000|Overall Study|Physician Decision|1|||
13251817|NCT01557504|26372455|FG001|Overall Study|Physician Decision|0|||
13251818|NCT01557400|26372467|FG000|Overall Study|Transitioned to Commercial Drug Product|40|||
13251819|NCT01557400|26372467|FG000|Overall Study|Adverse Event|3|||
13251820|NCT01557400|26372467|FG000|Overall Study|Lost to Follow-up|5|||
13251821|NCT01557400|26372467|FG000|Overall Study|Withdrawal by Subject|9|||
13251822|NCT01557348|26372514|FG000|Overall Study|Adverse Event|6|||
13251823|NCT01557348|26372515|FG001|Overall Study|Adverse Event|16|||
13251824|NCT01557348|26372514|FG000|Overall Study|Infusion reaction event|5|||
13251825|NCT01557348|26372515|FG001|Overall Study|Infusion reaction event|5|||
13251826|NCT01557348|26372514|FG000|Overall Study|Death|7|||
13251827|NCT01557348|26372515|FG001|Overall Study|Death|4|||
13251828|NCT01557348|26372514|FG000|Overall Study|Insufficient Therapeutic Response|13|||
13251829|NCT01557348|26372515|FG001|Overall Study|Insufficient Therapeutic Response|28|||
13251830|NCT01557348|26372514|FG000|Overall Study|Withdrawal by Subject|5|||
13251831|NCT01557348|26372515|FG001|Overall Study|Withdrawal by Subject|4|||
13251832|NCT01557348|26372514|FG000|Overall Study|Lost to Follow-up|26|||
13251833|NCT01557348|26372515|FG001|Overall Study|Lost to Follow-up|22|||
13251834|NCT01557348|26372514|FG000|Overall Study|Administrative|18|||
13251835|NCT01557348|26372515|FG001|Overall Study|Administrative|11|||
13251836|NCT01557283|26372527|FG000|Overall Study|Lost to Follow-up|7|||
13251837|NCT01557283|26372527|FG000|Overall Study|Non-responder|19|||
13251838|NCT01557283|26372527|FG000|Overall Study|Adverse Event|7|||
13251839|NCT01557283|26372527|FG000|Overall Study|Lack of Efficacy|1|||
13251840|NCT01557283|26372527|FG000|Overall Study|Non-compliance|1|||
13251841|NCT01557283|26372527|FG000|Overall Study|Withdrawal by Subject|1|||
13251842|NCT01557283|26372527|FG000|Overall Study|Participant's weight too high for dose|1|||
13251843|NCT01557283|26372527|FG000|Overall Study|Worsening of psoriasis|1|||
13251844|NCT01557283|26372527|FG000|Overall Study|Other|6|||
13251845|NCT01557244|26372802|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
13251846|NCT01557244|26372803|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
13251847|NCT01557244|26372804|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
13251848|NCT01557244|26372805|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
13251849|NCT01557244|26372806|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
13251850|NCT01557244|26372807|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
13251851|NCT01557244|26372808|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
13251852|NCT01557244|26372802|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2|||
13251853|NCT01557244|26372803|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
13251854|NCT01557244|26372804|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1|||
13251855|NCT01557244|26372805|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
13251856|NCT01557244|26372806|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
13251857|NCT01557244|26372807|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
13251858|NCT01557244|26372808|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
13251859|NCT01557244|26372802|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1|||
13251860|NCT01557244|26372803|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
13251861|NCT01557244|26372804|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
13251862|NCT01557244|26372805|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
13251863|NCT01557244|26372806|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
13251864|NCT01557244|26372807|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
13251865|NCT01557244|26372808|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
13251866|NCT01557244|26372802|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2|||
13251867|NCT01557244|26372803|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
13251868|NCT01557244|26372804|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
13251869|NCT01557244|26372805|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
13251870|NCT01557244|26372806|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
13251871|NCT01557244|26372807|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3|||
13251872|NCT01557244|26372808|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
13251873|NCT01557244|26372802|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
13251874|NCT01557244|26372803|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1|||
13251875|NCT01557244|26372804|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
13251876|NCT01557244|26372805|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
13251877|NCT01557244|26372806|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
13251878|NCT01557244|26372807|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
13251879|NCT01557244|26372808|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
13251880|NCT01557244|26372802|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
13251881|NCT01557244|26372803|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
13251882|NCT01557244|26372804|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
13251883|NCT01557244|26372805|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
13251884|NCT01557244|26372806|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
13251885|NCT01557244|26372807|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
13251886|NCT01557244|26372808|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
13251887|NCT01557244|26372802|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
13251888|NCT01557244|26372803|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
13251889|NCT01557244|26372804|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
13251890|NCT01557244|26372805|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
13251891|NCT01557244|26372806|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
13251892|NCT01557244|26372807|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
13251893|NCT01557244|26372808|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
13251894|NCT01557244|26372802|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
13251895|NCT01557244|26372803|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
13251896|NCT01557244|26372804|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
13251897|NCT01557244|26372805|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
13251898|NCT01557244|26372806|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
13251899|NCT01557244|26372807|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
13251900|NCT01557244|26372808|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
13251901|NCT01557244|26372802|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
13251902|NCT01557244|26372803|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
13251903|NCT01557244|26372804|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
13251904|NCT01557244|26372805|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
13251905|NCT01557244|26372806|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
13251906|NCT01557244|26372807|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
13251907|NCT01557244|26372808|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
13251908|NCT01557244|26372802|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
13251909|NCT01557244|26372803|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
13251910|NCT01557244|26372804|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
13251911|NCT01557244|26372805|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
13251912|NCT01557244|26372806|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
13251913|NCT01557244|26372807|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
13251914|NCT01557244|26372808|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
13251915|NCT01557244|26372802|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
13251916|NCT01557244|26372803|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
13251917|NCT01557244|26372804|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
13251918|NCT01557244|26372805|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1|||
13251919|NCT01557244|26372806|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
13251920|NCT01557244|26372807|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
13251921|NCT01557244|26372808|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
13251922|NCT01557244|26372802|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1|||
13251923|NCT01557244|26372803|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2|||
13251924|NCT01557244|26372804|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
13251925|NCT01557244|26372805|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
13251926|NCT01557244|26372806|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
13251927|NCT01557244|26372807|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
13251928|NCT01557244|26372808|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
13251929|NCT01557166|26372827|FG000|Overall Study|Adverse Event|20|||
13251930|NCT01557166|26372828|FG001|Overall Study|Adverse Event|6|||
13251931|NCT01557166|26372827|FG000|Overall Study|Lack of Efficacy|2|||
13251932|NCT01557166|26372828|FG001|Overall Study|Lack of Efficacy|1|||
13251933|NCT01557166|26372827|FG000|Overall Study|Protocol Violation|8|||
13251934|NCT01557166|26372828|FG001|Overall Study|Protocol Violation|5|||
13251935|NCT01557166|26372827|FG000|Overall Study|Withdrawn consent|12|||
13251936|NCT01557166|26372828|FG001|Overall Study|Withdrawn consent|20|||
13251937|NCT01557166|26372827|FG000|Overall Study|Target dose not tolerated|1|||
13251938|NCT01557166|26372828|FG001|Overall Study|Target dose not tolerated|0|||
13251939|NCT01557166|26372827|FG000|Overall Study|Psychiatric disorder|1|||
13251940|NCT01557166|26372828|FG001|Overall Study|Psychiatric disorder|0|||
13251941|NCT01557166|26372827|FG000|Overall Study|Unclassified|2|||
13251942|NCT01557166|26372828|FG001|Overall Study|Unclassified|5|||
13251943|NCT01556997|26372849|FG000|Overall Study|Adverse Event|10|||
13251944|NCT01556997|26372850|FG001|Overall Study|Adverse Event|12|||
13251945|NCT01556997|26372851|FG002|Overall Study|Adverse Event|12|||
13251946|NCT01556997|26372849|FG000|Overall Study|Lost to Follow-up|6|||
13251947|NCT01556997|26372850|FG001|Overall Study|Lost to Follow-up|6|||
13251948|NCT01556997|26372851|FG002|Overall Study|Lost to Follow-up|4|||
13251949|NCT01556997|26372849|FG000|Overall Study|Physician Decision|1|||
13251950|NCT01556997|26372850|FG001|Overall Study|Physician Decision|1|||
13251951|NCT01556997|26372851|FG002|Overall Study|Physician Decision|1|||
13251952|NCT01556997|26372849|FG000|Overall Study|Withdrawal by Subject|7|||
13251953|NCT01556997|26372850|FG001|Overall Study|Withdrawal by Subject|6|||
13251954|NCT01556997|26372851|FG002|Overall Study|Withdrawal by Subject|8|||
13251955|NCT01556997|26372849|FG000|Overall Study|Other|2|||
13251956|NCT01556997|26372850|FG001|Overall Study|Other|3|||
13251957|NCT01556997|26372851|FG002|Overall Study|Other|7|||
13251958|NCT01556932|26372859|FG000|Time Point 60 Minutes|Withdrawal by Subject|1|||
13251959|NCT01556932|26372860|FG001|Time Point 60 Minutes|Withdrawal by Subject|1|||
13251960|NCT01556763|26372906|FG000|Overall Study|Withdrawal by Subject|0|||
13251961|NCT01556763|26372907|FG001|Overall Study|Withdrawal by Subject|1|||
13251962|NCT01556763|26372908|FG002|Overall Study|Withdrawal by Subject|0|||
13251963|NCT01556438|26372940|FG000|Overall Study|Adverse Event|4|||
13251964|NCT01556438|26372941|FG001|Overall Study|Adverse Event|2|||
13251965|NCT01556438|26372940|FG000|Overall Study|Sponsor Decision|0|||
13251966|NCT01556438|26372941|FG001|Overall Study|Sponsor Decision|2|||
13251967|NCT01556438|26372940|FG000|Overall Study|Progressive Disease|0|||
13251968|NCT01556438|26372941|FG001|Overall Study|Progressive Disease|6|||
13251969|NCT01556438|26372940|FG000|Overall Study|Death|0|||
13251970|NCT01556438|26372941|FG001|Overall Study|Death|1|||
13251971|NCT01556165|26372960|FG000|Overall Study|Adverse Event|5|||
13251972|NCT01556165|26372961|FG001|Overall Study|Adverse Event|3|||
13251973|NCT01556165|26372960|FG000|Overall Study|Protocol Violation|0|||
13251974|NCT01556165|26372961|FG001|Overall Study|Protocol Violation|3|||
13251975|NCT01556165|26372960|FG000|Overall Study|Withdrawal of Consent|7|||
13251976|NCT01556165|26372961|FG001|Overall Study|Withdrawal of Consent|1|||
13251977|NCT01555983|26372976|FG000|Overall Study|Withdrawal by Subject|1|||
13251978|NCT01555983|26372977|FG001|Overall Study|Withdrawal by Subject|0|||
13251979|NCT01555983|26372978|FG002|Overall Study|Withdrawal by Subject|0|||
13251980|NCT01555983|26372979|FG003|Overall Study|Withdrawal by Subject|0|||
13251981|NCT01555983|26372980|FG004|Overall Study|Withdrawal by Subject|1|||
13251982|NCT01555983|26372981|FG005|Overall Study|Withdrawal by Subject|1|||
13251983|NCT01555931|26372996|FG000|Overall Study|Lost to Follow-up|2|||
13251984|NCT01555931|26372997|FG001|Overall Study|Lost to Follow-up|5|||
13251985|NCT01555762|26373009|FG000|Overall Study|No information on Bevacizumab intake|11|||
13251986|NCT01555762|26373009|FG000|Overall Study|Missing start date of infusion|8|||
13251987|NCT01555762|26373009|FG000|Overall Study|75 years old or more ticked No|1|||
13251988|NCT01555762|26373009|FG000|Overall Study|Treatment with Bevacizumab ticked No|24|||
13251989|NCT01555762|26373009|FG000|Overall Study|Death linked to progression of disease|165|||
13251990|NCT01555762|26373009|FG000|Overall Study|Lost follow-up/moved house/changed team|35|||
13251991|NCT01555762|26373009|FG000|Overall Study|Investigator's decision|10|||
13251992|NCT01555762|26373009|FG000|Overall Study|Participant not wishing to continue|5|||
13251993|NCT01555762|26373009|FG000|Overall Study|Missing data|1|||
13251994|NCT01555762|26373009|FG000|Overall Study|Death linked to an adverse event|14|||
13290171|NCT00103740|26480842|FG000|Period 1 - Core|Protocol Violation|3|||
13290172|NCT00103740|26480843|FG001|Period 1 - Core|Protocol Violation|2|||
13290173|NCT00103740|26480842|FG000|Period 1 - Core|Patient withdrew consent|3|||
13290174|NCT00103740|26480843|FG001|Period 1 - Core|Patient withdrew consent|2|||
13290175|NCT00103740|26480842|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7|||
13290176|NCT00103740|26480843|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6|||
13290177|NCT00103740|26480842|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21|||
13290178|NCT00103740|26480843|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13|||
13290179|NCT00103740|26480842|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5|||
13290180|NCT00103740|26480843|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6|||
13290181|NCT00103740|26480842|FG000|Period 2 - Extended Observation Period|Death|6|||
13290182|NCT00103740|26480843|FG001|Period 2 - Extended Observation Period|Death|2|||
13290183|NCT00103740|26480842|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30|||
13290184|NCT00103740|26480843|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9|||
13290185|NCT00103662|26480874|FG000|Overall Study|Entered Rescue Procedure|0|||
13290186|NCT00103662|26480875|FG001|Overall Study|Entered Rescue Procedure|7|||
13290187|NCT00103662|26480874|FG000|Overall Study|Death|7|||
13290188|NCT00103662|26480875|FG001|Overall Study|Death|7|||
13290189|NCT00103662|26480874|FG000|Overall Study|Elective Withdrawal|5|||
13290190|NCT00103662|26480875|FG001|Overall Study|Elective Withdrawal|5|||
13290191|NCT00103662|26480874|FG000|Overall Study|Lost to Follow-up|0|||
13290192|NCT00103662|26480875|FG001|Overall Study|Lost to Follow-up|1|||
13290193|NCT00103662|26480874|FG000|Overall Study|Other|6|||
13290194|NCT00103662|26480875|FG001|Overall Study|Other|9|||
13290195|NCT00103662|26480874|FG000|Overall Study|Failed mobilization|0|||
13290196|NCT00103662|26480875|FG001|Overall Study|Failed mobilization|4|||
13290197|NCT00103662|26480874|FG000|Overall Study|Intercurrent illness|1|||
13251995|NCT01555671|26373026|FG000|Overall Study|Physician Decision|20|||
13251996|NCT01555671|26373027|FG001|Overall Study|Physician Decision|25|||
13251997|NCT01555463|26373074|FG000|Treatment|Adverse Event|6|||
13251998|NCT01555463|26373075|FG001|Treatment|Adverse Event|12|||
13251999|NCT01555463|26373074|FG000|Treatment|Withdrawal by Subject|24|||
13252000|NCT01555463|26373075|FG001|Treatment|Withdrawal by Subject|36|||
13252001|NCT01555463|26373074|FG000|Treatment|Lost to Follow-up|28|||
13252002|NCT01555463|26373075|FG001|Treatment|Lost to Follow-up|23|||
13252003|NCT01555463|26373074|FG000|Treatment|Protocol Violation|4|||
13252004|NCT01555463|26373075|FG001|Treatment|Protocol Violation|5|||
13252005|NCT01555463|26373074|FG000|Treatment|Other reason|2|||
13252006|NCT01555463|26373075|FG001|Treatment|Other reason|3|||
13252007|NCT01555463|26373074|FG000|Follow up|Adverse Event|2|||
13252008|NCT01555463|26373075|FG001|Follow up|Adverse Event|5|||
13252009|NCT01555463|26373074|FG000|Follow up|Death|0|||
13252010|NCT01555463|26373075|FG001|Follow up|Death|1|||
13252011|NCT01555463|26373074|FG000|Follow up|Withdrawal by Subject|22|||
13252012|NCT01555463|26373075|FG001|Follow up|Withdrawal by Subject|22|||
13252013|NCT01555463|26373074|FG000|Follow up|Lost to Follow-up|9|||
13252014|NCT01555463|26373075|FG001|Follow up|Lost to Follow-up|10|||
13252015|NCT01555463|26373074|FG000|Follow up|Protocol Violation|2|||
13252016|NCT01555463|26373075|FG001|Follow up|Protocol Violation|4|||
13252017|NCT01555463|26373074|FG000|Follow up|Other reason|3|||
13252018|NCT01555463|26373075|FG001|Follow up|Other reason|3|||
13252019|NCT01555164|26373092|FG000|Overall Study|Adverse Event|5|||
13252020|NCT01555164|26373093|FG001|Overall Study|Adverse Event|7|||
13252021|NCT01555164|26373092|FG000|Overall Study|Hyperglycemia|0|||
13252022|NCT01555164|26373093|FG001|Overall Study|Hyperglycemia|1|||
13252023|NCT01555164|26373092|FG000|Overall Study|Investigator's Discretion|2|||
13252024|NCT01555164|26373093|FG001|Overall Study|Investigator's Discretion|2|||
13252025|NCT01555164|26373092|FG000|Overall Study|Lost to Follow-up|4|||
13252026|NCT01555164|26373093|FG001|Overall Study|Lost to Follow-up|3|||
13252027|NCT01555164|26373092|FG000|Overall Study|Protocol Violation|9|||
13252028|NCT01555164|26373093|FG001|Overall Study|Protocol Violation|5|||
13252029|NCT01555164|26373092|FG000|Overall Study|Subject Non-compliance|14|||
13252030|NCT01555164|26373093|FG001|Overall Study|Subject Non-compliance|6|||
13252031|NCT01555164|26373092|FG000|Overall Study|Subject Withdrew Consent|6|||
13252032|NCT01555164|26373093|FG001|Overall Study|Subject Withdrew Consent|11|||
13252033|NCT01555151|26373157|FG000|Overall Study|Withdrawal by Subject|6|||
13252034|NCT01555151|26373158|FG001|Overall Study|Withdrawal by Subject|2|||
13252035|NCT01555151|26373159|FG002|Overall Study|Withdrawal by Subject|0|||
13252036|NCT01555151|26373160|FG003|Overall Study|Withdrawal by Subject|2|||
13252037|NCT01555151|26373157|FG000|Overall Study|Administrative|3|||
13252038|NCT01555151|26373158|FG001|Overall Study|Administrative|1|||
13252039|NCT01555151|26373159|FG002|Overall Study|Administrative|2|||
13252040|NCT01555151|26373160|FG003|Overall Study|Administrative|0|||
13252041|NCT01555151|26373157|FG000|Overall Study|Protocol Violation|3|||
13252042|NCT01555151|26373158|FG001|Overall Study|Protocol Violation|3|||
13252043|NCT01555151|26373159|FG002|Overall Study|Protocol Violation|3|||
13252044|NCT01555151|26373160|FG003|Overall Study|Protocol Violation|5|||
13252045|NCT01555151|26373157|FG000|Overall Study|Adverse Event|1|||
13252046|NCT01555151|26373158|FG001|Overall Study|Adverse Event|2|||
13252047|NCT01555151|26373159|FG002|Overall Study|Adverse Event|1|||
13252048|NCT01555151|26373160|FG003|Overall Study|Adverse Event|2|||
13252049|NCT01555151|26373157|FG000|Overall Study|Lost to Follow-up|0|||
13252050|NCT01555151|26373158|FG001|Overall Study|Lost to Follow-up|0|||
13252051|NCT01555151|26373159|FG002|Overall Study|Lost to Follow-up|0|||
13252052|NCT01555151|26373160|FG003|Overall Study|Lost to Follow-up|1|||
13252053|NCT01555138|26373193|FG000|Overall Study|Death|0|||
13252054|NCT01555138|26373194|FG001|Overall Study|Death|1|||
13252055|NCT01555138|26373193|FG000|Overall Study|Lost to Follow-up|1|||
13252056|NCT01555138|26373194|FG001|Overall Study|Lost to Follow-up|0|||
13252057|NCT01555138|26373193|FG000|Overall Study|Abnormal Lab reults|1|||
13252058|NCT01555138|26373194|FG001|Overall Study|Abnormal Lab reults|3|||
13252059|NCT01555138|26373193|FG000|Overall Study|Lack of Efficacy|2|||
13252060|NCT01555138|26373194|FG001|Overall Study|Lack of Efficacy|2|||
13252061|NCT01555138|26373193|FG000|Overall Study|Protocol Violation|5|||
13252062|NCT01555138|26373194|FG001|Overall Study|Protocol Violation|3|||
13252063|NCT01555138|26373193|FG000|Overall Study|Administrative problems|8|||
13252064|NCT01555138|26373194|FG001|Overall Study|Administrative problems|0|||
13252065|NCT01555138|26373193|FG000|Overall Study|Withdrawal by Subject|16|||
13252066|NCT01555138|26373194|FG001|Overall Study|Withdrawal by Subject|15|||
13252067|NCT01555138|26373193|FG000|Overall Study|Adverse Event|14|||
13252068|NCT01555138|26373194|FG001|Overall Study|Adverse Event|14|||
13252069|NCT01555125|26373295|FG000|Induction Period|Lost to Follow-up|0|||
13252070|NCT01555125|26373296|FG001|Induction Period|Lost to Follow-up|2|||
13252071|NCT01555125|26373297|FG002|Induction Period|Lost to Follow-up|0|||
13252072|NCT01555125|26373298|FG003|Induction Period|Lost to Follow-up|0|||
13252073|NCT01555125|26373299|FG004|Induction Period|Lost to Follow-up|0|||
13252074|NCT01555125|26373295|FG000|Induction Period|Adverse Event|0|||
13252075|NCT01555125|26373296|FG001|Induction Period|Adverse Event|1|||
13252076|NCT01555125|26373297|FG002|Induction Period|Adverse Event|0|||
13252077|NCT01555125|26373298|FG003|Induction Period|Adverse Event|0|||
13252078|NCT01555125|26373299|FG004|Induction Period|Adverse Event|1|||
13252079|NCT01555125|26373295|FG000|Induction Period|Subject / guardian decision|0|||
13252080|NCT01555125|26373296|FG001|Induction Period|Subject / guardian decision|0|||
13252081|NCT01555125|26373297|FG002|Induction Period|Subject / guardian decision|0|||
13252082|NCT01555125|26373298|FG003|Induction Period|Subject / guardian decision|0|||
13252083|NCT01555125|26373299|FG004|Induction Period|Subject / guardian decision|2|||
13252084|NCT01555125|26373295|FG000|Induction Period|Death|1|||
13252085|NCT01555125|26373296|FG001|Induction Period|Death|0|||
13252086|NCT01555125|26373297|FG002|Induction Period|Death|0|||
13252087|NCT01555125|26373298|FG003|Induction Period|Death|0|||
13252088|NCT01555125|26373299|FG004|Induction Period|Death|0|||
13252089|NCT01555125|26373295|FG000|Maintenance Period|Adverse Event|1|||
13252090|NCT01555125|26373296|FG001|Maintenance Period|Adverse Event|1|||
13252091|NCT01555125|26373297|FG002|Maintenance Period|Adverse Event|0|||
13252092|NCT01555125|26373298|FG003|Maintenance Period|Adverse Event|0|||
13252093|NCT01555125|26373299|FG004|Maintenance Period|Adverse Event|0|||
13252094|NCT01555125|26373295|FG000|Maintenance Period|Subject / guardian decision|1|||
13252095|NCT01555125|26373296|FG001|Maintenance Period|Subject / guardian decision|2|||
13252096|NCT01555125|26373297|FG002|Maintenance Period|Subject / guardian decision|0|||
13252097|NCT01555125|26373298|FG003|Maintenance Period|Subject / guardian decision|0|||
13252098|NCT01555125|26373299|FG004|Maintenance Period|Subject / guardian decision|0|||
13252099|NCT01555125|26373295|FG000|Maintenance Period|Lost to Follow-up|2|||
13252100|NCT01555125|26373296|FG001|Maintenance Period|Lost to Follow-up|0|||
13252101|NCT01555125|26373297|FG002|Maintenance Period|Lost to Follow-up|0|||
13252102|NCT01555125|26373298|FG003|Maintenance Period|Lost to Follow-up|1|||
13252103|NCT01555125|26373299|FG004|Maintenance Period|Lost to Follow-up|0|||
13252104|NCT01555125|26373295|FG000|Maintenance Period|Lack of Efficacy|6|||
13252105|NCT01555125|26373296|FG001|Maintenance Period|Lack of Efficacy|1|||
13252106|NCT01555125|26373297|FG002|Maintenance Period|Lack of Efficacy|3|||
13252107|NCT01555125|26373298|FG003|Maintenance Period|Lack of Efficacy|0|||
13252108|NCT01555125|26373299|FG004|Maintenance Period|Lack of Efficacy|0|||
13252109|NCT01555125|26373295|FG000|Maintenance Period|Physician Decision|0|||
13252110|NCT01555125|26373296|FG001|Maintenance Period|Physician Decision|0|||
13252111|NCT01555125|26373297|FG002|Maintenance Period|Physician Decision|1|||
13252112|NCT01555125|26373298|FG003|Maintenance Period|Physician Decision|0|||
13252113|NCT01555125|26373299|FG004|Maintenance Period|Physician Decision|0|||
13252114|NCT01555125|26373295|FG000|Maintenance Period|Death|0|||
13252115|NCT01555125|26373296|FG001|Maintenance Period|Death|0|||
13252116|NCT01555125|26373297|FG002|Maintenance Period|Death|0|||
13252117|NCT01555125|26373298|FG003|Maintenance Period|Death|1|||
13252118|NCT01555125|26373299|FG004|Maintenance Period|Death|0|||
13252119|NCT01555125|26373295|FG000|Extension|Adverse Event|1|||
13252120|NCT01555125|26373296|FG001|Extension|Adverse Event|2|||
13252121|NCT01555125|26373297|FG002|Extension|Adverse Event|1|||
13252122|NCT01555125|26373298|FG003|Extension|Adverse Event|1|||
13252123|NCT01555125|26373299|FG004|Extension|Adverse Event|0|||
13252124|NCT01555125|26373295|FG000|Extension|Protocol deviation|1|||
13252125|NCT01555125|26373296|FG001|Extension|Protocol deviation|0|||
13252126|NCT01555125|26373297|FG002|Extension|Protocol deviation|0|||
13252127|NCT01555125|26373298|FG003|Extension|Protocol deviation|0|||
13252128|NCT01555125|26373299|FG004|Extension|Protocol deviation|0|||
13252129|NCT01555125|26373295|FG000|Extension|Lack of Efficacy|7|||
13252130|NCT01555125|26373296|FG001|Extension|Lack of Efficacy|6|||
13252131|NCT01555125|26373297|FG002|Extension|Lack of Efficacy|3|||
13252132|NCT01555125|26373298|FG003|Extension|Lack of Efficacy|0|||
13252133|NCT01555125|26373299|FG004|Extension|Lack of Efficacy|0|||
13252134|NCT01555125|26373295|FG000|Extension|Lost to Follow-up|2|||
13252135|NCT01555125|26373296|FG001|Extension|Lost to Follow-up|1|||
13252136|NCT01555125|26373297|FG002|Extension|Lost to Follow-up|2|||
13252137|NCT01555125|26373298|FG003|Extension|Lost to Follow-up|0|||
13252138|NCT01555125|26373299|FG004|Extension|Lost to Follow-up|0|||
13252139|NCT01555125|26373295|FG000|Extension|Study terminated by sponsor|32|||
13252140|NCT01555125|26373296|FG001|Extension|Study terminated by sponsor|33|||
13252141|NCT01555125|26373297|FG002|Extension|Study terminated by sponsor|16|||
13252142|NCT01555125|26373298|FG003|Extension|Study terminated by sponsor|20|||
13252143|NCT01555125|26373299|FG004|Extension|Study terminated by sponsor|0|||
13252144|NCT01555125|26373295|FG000|Extension|Subject/guardian decision|1|||
13252145|NCT01555125|26373296|FG001|Extension|Subject/guardian decision|9|||
13252146|NCT01555125|26373297|FG002|Extension|Subject/guardian decision|1|||
13252147|NCT01555125|26373298|FG003|Extension|Subject/guardian decision|0|||
13252148|NCT01555125|26373299|FG004|Extension|Subject/guardian decision|0|||
13252149|NCT01555125|26373295|FG000|Extension|Technical Problems|1|||
13252150|NCT01555125|26373296|FG001|Extension|Technical Problems|0|||
13252151|NCT01555125|26373297|FG002|Extension|Technical Problems|0|||
13252152|NCT01555125|26373298|FG003|Extension|Technical Problems|1|||
13252153|NCT01555125|26373299|FG004|Extension|Technical Problems|0|||
13252154|NCT01555125|26373295|FG000|Follow-Up Period|Lost to Follow-up|1|||
13252155|NCT01555125|26373296|FG001|Follow-Up Period|Lost to Follow-up|0|||
13252156|NCT01555125|26373297|FG002|Follow-Up Period|Lost to Follow-up|0|||
13252157|NCT01555125|26373298|FG003|Follow-Up Period|Lost to Follow-up|0|||
13252158|NCT01555125|26373299|FG004|Follow-Up Period|Lost to Follow-up|0|||
13252159|NCT01555125|26373295|FG000|Follow-Up Period|Subject / guardian decision|3|||
13252160|NCT01555125|26373296|FG001|Follow-Up Period|Subject / guardian decision|1|||
13252161|NCT01555125|26373297|FG002|Follow-Up Period|Subject / guardian decision|1|||
13252162|NCT01555125|26373298|FG003|Follow-Up Period|Subject / guardian decision|1|||
13252163|NCT01555125|26373299|FG004|Follow-Up Period|Subject / guardian decision|0|||
13252164|NCT01555073|26373326|FG000|Overall Study|Lost to Follow-up|1|||
13252165|NCT01555073|26373327|FG001|Overall Study|Lost to Follow-up|2|||
13252166|NCT01555073|26373328|FG002|Overall Study|Lost to Follow-up|0|||
13252167|NCT01555073|26373329|FG003|Overall Study|Lost to Follow-up|5|||
13252168|NCT01554904|26373336|FG000|Overall Study|Withdrawal by Subject|3|||
13252169|NCT01554904|26373336|FG000|Overall Study|Had sleep apnea on Home Study 1|1|||
13252170|NCT01554618|26373394|FG000|Randomized Through Start of Treatment|Adverse Event|1|||
13252171|NCT01554618|26373395|FG001|Randomized Through Start of Treatment|Adverse Event|0|||
13252172|NCT01554618|26373394|FG000|Controlled Assessment Period|Lost to Follow-up|2|||
13252173|NCT01554618|26373395|FG001|Controlled Assessment Period|Lost to Follow-up|1|||
13116619|NCT03073200|25923195|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
13116620|NCT03073200|25923196|FG005|Randomized Withdrawal Period|Lost to Follow-up|0|||
13116621|NCT03073200|25923197|FG006|Randomized Withdrawal Period|Lost to Follow-up|0|||
13116622|NCT03073200|25923198|FG007|Randomized Withdrawal Period|Lost to Follow-up|0|||
13116623|NCT03073200|25923199|FG008|Randomized Withdrawal Period|Lost to Follow-up|0|||
13116624|NCT03073200|25923200|FG009|Randomized Withdrawal Period|Lost to Follow-up|0|||
13116625|NCT03073200|25923201|FG010|Randomized Withdrawal Period|Lost to Follow-up|0|||
13116626|NCT03073200|25923202|FG011|Randomized Withdrawal Period|Lost to Follow-up|1|||
13116627|NCT03073200|25923203|FG012|Randomized Withdrawal Period|Lost to Follow-up|0|||
13116628|NCT03073200|25923204|FG013|Randomized Withdrawal Period|Lost to Follow-up|0|||
13116629|NCT03073200|25923205|FG014|Randomized Withdrawal Period|Lost to Follow-up|0|||
13116630|NCT03073200|25923191|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
13116631|NCT03073200|25923192|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
13116632|NCT03073200|25923193|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
13116633|NCT03073200|25923194|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
13116634|NCT03073200|25923195|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
13116635|NCT03073200|25923196|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
13116636|NCT03073200|25923197|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
13116637|NCT03073200|25923198|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
13116638|NCT03073200|25923199|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
13116639|NCT03073200|25923200|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
13116640|NCT03073200|25923201|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
13116641|NCT03073200|25923202|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1|||
13116642|NCT03073200|25923203|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
13116643|NCT03073200|25923204|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
13116644|NCT03073200|25923205|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
13116645|NCT03073200|25923191|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
13116646|NCT03073200|25923192|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
13116647|NCT03073200|25923193|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
13116648|NCT03073200|25923194|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
13116649|NCT03073200|25923195|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0|||
13116650|NCT03073200|25923196|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0|||
13116651|NCT03073200|25923197|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0|||
13116652|NCT03073200|25923198|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0|||
13116653|NCT03073200|25923199|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0|||
13116654|NCT03073200|25923200|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0|||
13116655|NCT03073200|25923201|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1|||
13116656|NCT03073200|25923202|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1|||
13116657|NCT03073200|25923203|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0|||
13116658|NCT03073200|25923204|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0|||
13116659|NCT03073200|25923205|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0|||
13116660|NCT03073200|25923191|FG000|Randomized Withdrawal Period|Adverse Event|0|||
13116661|NCT03073200|25923192|FG001|Randomized Withdrawal Period|Adverse Event|0|||
13116662|NCT03073200|25923193|FG002|Randomized Withdrawal Period|Adverse Event|0|||
13116663|NCT03073200|25923194|FG003|Randomized Withdrawal Period|Adverse Event|0|||
13116664|NCT03073200|25923195|FG004|Randomized Withdrawal Period|Adverse Event|0|||
13252174|NCT01554618|26373394|FG000|Controlled Assessment Period|Withdrawal by Subject|6|||
13252175|NCT01554618|26373395|FG001|Controlled Assessment Period|Withdrawal by Subject|0|||
13485860|NCT02682901|27033600|FG001|Overall Study|Adverse Event|3|||
13116665|NCT03073200|25923196|FG005|Randomized Withdrawal Period|Adverse Event|0|||
13116666|NCT03073200|25923197|FG006|Randomized Withdrawal Period|Adverse Event|0|||
13116667|NCT03073200|25923198|FG007|Randomized Withdrawal Period|Adverse Event|0|||
13252176|NCT01554618|26373394|FG000|Open-Label Extension Period|Withdrawal by Subject|2|||
13252177|NCT01554618|26373395|FG001|Open-Label Extension Period|Withdrawal by Subject|3|||
13252178|NCT01554618|26373394|FG000|Open-Label Extension Period|Physician Decision|0|||
13252179|NCT01554618|26373395|FG001|Open-Label Extension Period|Physician Decision|1|||
13252180|NCT01554618|26373394|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
13252181|NCT01554618|26373395|FG001|Open-Label Extension Period|Lost to Follow-up|1|||
13252182|NCT01554579|26373412|FG000|Overall Study|Adverse Event|6|||
13252183|NCT01554579|26373413|FG001|Overall Study|Adverse Event|25|||
13252184|NCT01554579|26373412|FG000|Overall Study|Lack of Efficacy|2|||
13252185|NCT01554579|26373413|FG001|Overall Study|Lack of Efficacy|1|||
13252186|NCT01554579|26373412|FG000|Overall Study|Withdrawal by Subject|2|||
13252187|NCT01554579|26373413|FG001|Overall Study|Withdrawal by Subject|1|||
13252188|NCT01554527|26373450|FG000|Overall Study|Withdrawal by Subject|1|||
13252189|NCT01554527|26373451|FG001|Overall Study|Withdrawal by Subject|0|||
13116668|NCT03073200|25923199|FG008|Randomized Withdrawal Period|Adverse Event|0|||
13116669|NCT03073200|25923200|FG009|Randomized Withdrawal Period|Adverse Event|0|||
13252190|NCT01554527|26373452|FG002|Overall Study|Withdrawal by Subject|3|||
13252191|NCT01554527|26373450|FG000|Overall Study|Lost to Follow-up|0|||
13252192|NCT01554527|26373451|FG001|Overall Study|Lost to Follow-up|0|||
13252193|NCT01554527|26373452|FG002|Overall Study|Lost to Follow-up|4|||
13252194|NCT01554527|26373450|FG000|Overall Study|Physician Decision|0|||
13252195|NCT01554527|26373451|FG001|Overall Study|Physician Decision|0|||
13252196|NCT01554527|26373452|FG002|Overall Study|Physician Decision|1|||
13252197|NCT01554514|26373464|FG000|Overall Study|1 patient ineligible with congenital TTP|1|||
13252198|NCT01554514|26373464|FG000|Overall Study|Physician Decision|1|||
13252199|NCT01554241|26373491|FG000|Overall Study|Death|3|||
13252200|NCT01554241|26373492|FG001|Overall Study|Death|1|||
13252201|NCT01554241|26373493|FG002|Overall Study|Death|1|||
13252202|NCT01554241|26373494|FG003|Overall Study|Death|0|||
13252203|NCT01554241|26373491|FG000|Overall Study|protocol specified renal stone|0|||
13252204|NCT01554241|26373492|FG001|Overall Study|protocol specified renal stone|0|||
13252205|NCT01554241|26373493|FG002|Overall Study|protocol specified renal stone|0|||
13252206|NCT01554241|26373494|FG003|Overall Study|protocol specified renal stone|1|||
13252207|NCT01554241|26373491|FG000|Overall Study|protocol specified change in eGFR|0|||
13252208|NCT01554241|26373492|FG001|Overall Study|protocol specified change in eGFR|0|||
13252209|NCT01554241|26373493|FG002|Overall Study|protocol specified change in eGFR|1|||
13252210|NCT01554241|26373494|FG003|Overall Study|protocol specified change in eGFR|0|||
13252211|NCT01554241|26373491|FG000|Overall Study|Withdrawal by Subject|0|||
13252212|NCT01554241|26373492|FG001|Overall Study|Withdrawal by Subject|0|||
13252213|NCT01554241|26373493|FG002|Overall Study|Withdrawal by Subject|2|||
13252214|NCT01554241|26373494|FG003|Overall Study|Withdrawal by Subject|0|||
13252215|NCT01554176|26373529|FG000|Treatment Phase|Protocol Violation|1|||
13252216|NCT01554176|26373530|FG001|Treatment Phase|Protocol Violation|2|||
13252217|NCT01554176|26373531|FG002|Treatment Phase|Protocol Violation|0|||
13252218|NCT01554176|26373532|FG003|Treatment Phase|Protocol Violation|0|||
13252219|NCT01554176|26373533|FG004|Treatment Phase|Protocol Violation|0|||
13252220|NCT01554176|26373529|FG000|Treatment Phase|Physician Decision|1|||
13116670|NCT03073200|25923201|FG010|Randomized Withdrawal Period|Adverse Event|1|||
13116671|NCT03073200|25923202|FG011|Randomized Withdrawal Period|Adverse Event|0|||
13252221|NCT01554176|26373530|FG001|Treatment Phase|Physician Decision|1|||
13252222|NCT01554176|26373531|FG002|Treatment Phase|Physician Decision|0|||
13252223|NCT01554176|26373532|FG003|Treatment Phase|Physician Decision|0|||
13252224|NCT01554176|26373533|FG004|Treatment Phase|Physician Decision|0|||
13252225|NCT01554176|26373529|FG000|Treatment Phase|Lack of Efficacy|0|||
13252226|NCT01554176|26373530|FG001|Treatment Phase|Lack of Efficacy|1|||
13252227|NCT01554176|26373531|FG002|Treatment Phase|Lack of Efficacy|0|||
13252228|NCT01554176|26373532|FG003|Treatment Phase|Lack of Efficacy|0|||
13252229|NCT01554176|26373533|FG004|Treatment Phase|Lack of Efficacy|0|||
13252230|NCT01554176|26373529|FG000|Treatment Phase|Adverse event, non-fatal|1|||
13252231|NCT01554176|26373530|FG001|Treatment Phase|Adverse event, non-fatal|1|||
13252232|NCT01554176|26373531|FG002|Treatment Phase|Adverse event, non-fatal|0|||
13252233|NCT01554176|26373532|FG003|Treatment Phase|Adverse event, non-fatal|0|||
13252234|NCT01554176|26373533|FG004|Treatment Phase|Adverse event, non-fatal|0|||
13252235|NCT01554176|26373529|FG000|Treatment Phase|Non-compliance with study drug|1|||
13252236|NCT01554176|26373530|FG001|Treatment Phase|Non-compliance with study drug|0|||
13252237|NCT01554176|26373531|FG002|Treatment Phase|Non-compliance with study drug|0|||
13252238|NCT01554176|26373532|FG003|Treatment Phase|Non-compliance with study drug|0|||
13252239|NCT01554176|26373533|FG004|Treatment Phase|Non-compliance with study drug|0|||
13252240|NCT01554176|26373529|FG000|Treatment Phase|Withdrawal by Subject|1|||
13252241|NCT01554176|26373530|FG001|Treatment Phase|Withdrawal by Subject|0|||
13252242|NCT01554176|26373531|FG002|Treatment Phase|Withdrawal by Subject|0|||
13252243|NCT01554176|26373532|FG003|Treatment Phase|Withdrawal by Subject|0|||
13252244|NCT01554176|26373533|FG004|Treatment Phase|Withdrawal by Subject|0|||
13252245|NCT01554176|26373529|FG000|Treatment Phase|Lost to Follow-up|3|||
13252246|NCT01554176|26373530|FG001|Treatment Phase|Lost to Follow-up|0|||
13252247|NCT01554176|26373531|FG002|Treatment Phase|Lost to Follow-up|0|||
13252248|NCT01554176|26373532|FG003|Treatment Phase|Lost to Follow-up|0|||
13252249|NCT01554176|26373533|FG004|Treatment Phase|Lost to Follow-up|0|||
13252250|NCT01554176|26373529|FG000|Run-out Phase|Protocol Violation|0|||
13252251|NCT01554176|26373530|FG001|Run-out Phase|Protocol Violation|0|||
13252252|NCT01554176|26373531|FG002|Run-out Phase|Protocol Violation|0|||
13252253|NCT01554176|26373532|FG003|Run-out Phase|Protocol Violation|1|||
13252254|NCT01554176|26373533|FG004|Run-out Phase|Protocol Violation|0|||
13252255|NCT01554163|26373558|FG000|Overall Study|Adverse Event|3|||
13252256|NCT01554163|26373559|FG001|Overall Study|Adverse Event|0|||
13252257|NCT01554163|26373558|FG000|Overall Study|Lack of Efficacy|1|||
13252258|NCT01554163|26373559|FG001|Overall Study|Lack of Efficacy|0|||
13252259|NCT01554163|26373558|FG000|Overall Study|Lost to Follow-up|1|||
13252260|NCT01554163|26373559|FG001|Overall Study|Lost to Follow-up|0|||
13252261|NCT01554163|26373558|FG000|Overall Study|Non-Compliance With Study Drug|1|||
13252262|NCT01554163|26373559|FG001|Overall Study|Non-Compliance With Study Drug|1|||
13252263|NCT01554163|26373558|FG000|Overall Study|Protocol Violation|0|||
13252264|NCT01554163|26373559|FG001|Overall Study|Protocol Violation|4|||
13252265|NCT01554163|26373558|FG000|Overall Study|Withdrawal by Subject|1|||
13252266|NCT01554163|26373559|FG001|Overall Study|Withdrawal by Subject|5|||
13252267|NCT01554163|26373558|FG000|Overall Study|Not Treated|1|||
13252268|NCT01554163|26373559|FG001|Overall Study|Not Treated|0|||
13252269|NCT01553916|26373578|FG000|Overall Study|Withdrawal by Subject|2|||
13252270|NCT01553916|26373578|FG000|Overall Study|Pre-treatment MRI metastatic disease|1|||
13252271|NCT01553851|26373592|FG000|Overall Study|Adverse Event|2|||
13252272|NCT01553851|26373592|FG000|Overall Study|constipation|1|||
13252273|NCT01553747|26373652|FG000|Overall Study|Protocol Violation|0|||
13252274|NCT01553747|26373653|FG001|Overall Study|Protocol Violation|2|||
13252275|NCT01553747|26373654|FG002|Overall Study|Protocol Violation|0|||
13252276|NCT01553747|26373652|FG000|Overall Study|Voluntarily withdrew|70|||
13252277|NCT01553747|26373653|FG001|Overall Study|Voluntarily withdrew|66|||
13252278|NCT01553747|26373654|FG002|Overall Study|Voluntarily withdrew|74|||
13252279|NCT01553747|26373652|FG000|Overall Study|Adverse event or SAE|32|||
13252280|NCT01553747|26373653|FG001|Overall Study|Adverse event or SAE|28|||
13252281|NCT01553747|26373654|FG002|Overall Study|Adverse event or SAE|19|||
13252282|NCT01553747|26373652|FG000|Overall Study|Physician decision: other|10|||
13252283|NCT01553747|26373653|FG001|Overall Study|Physician decision: other|8|||
13252284|NCT01553747|26373654|FG002|Overall Study|Physician decision: other|7|||
13252285|NCT01553747|26373652|FG000|Overall Study|Lost to Follow-up|11|||
13252286|NCT01553747|26373653|FG001|Overall Study|Lost to Follow-up|5|||
13252287|NCT01553747|26373654|FG002|Overall Study|Lost to Follow-up|6|||
13252288|NCT01553747|26373652|FG000|Overall Study|Sponsor decision, specify|7|||
13252289|NCT01553747|26373653|FG001|Overall Study|Sponsor decision, specify|5|||
13252290|NCT01553747|26373654|FG002|Overall Study|Sponsor decision, specify|0|||
13252291|NCT01553747|26373652|FG000|Overall Study|Physician decision: lack of efficacy|1|||
13116672|NCT03073200|25923203|FG012|Randomized Withdrawal Period|Adverse Event|0|||
13116673|NCT03073200|25923204|FG013|Randomized Withdrawal Period|Adverse Event|0|||
13116674|NCT03073200|25923205|FG014|Randomized Withdrawal Period|Adverse Event|0|||
13116675|NCT03073200|25923191|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
13116676|NCT03073200|25923192|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
13116677|NCT03073200|25923193|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
13116678|NCT03073200|25923194|FG003|Post-Treatment Follow-Up Period|Adverse Event|0|||
13116679|NCT03073200|25923195|FG004|Post-Treatment Follow-Up Period|Adverse Event|0|||
13116680|NCT03073200|25923196|FG005|Post-Treatment Follow-Up Period|Adverse Event|0|||
13116681|NCT03073200|25923197|FG006|Post-Treatment Follow-Up Period|Adverse Event|0|||
13116682|NCT03073200|25923198|FG007|Post-Treatment Follow-Up Period|Adverse Event|0|||
13116683|NCT03073200|25923199|FG008|Post-Treatment Follow-Up Period|Adverse Event|0|||
13116684|NCT03073200|25923200|FG009|Post-Treatment Follow-Up Period|Adverse Event|0|||
13116685|NCT03073200|25923201|FG010|Post-Treatment Follow-Up Period|Adverse Event|0|||
13116686|NCT03073200|25923202|FG011|Post-Treatment Follow-Up Period|Adverse Event|0|||
13116687|NCT03073200|25923203|FG012|Post-Treatment Follow-Up Period|Adverse Event|0|||
13116688|NCT03073200|25923204|FG013|Post-Treatment Follow-Up Period|Adverse Event|2|||
13116689|NCT03073200|25923205|FG014|Post-Treatment Follow-Up Period|Adverse Event|0|||
13116690|NCT03073200|25923191|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
13116691|NCT03073200|25923192|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
13116692|NCT03073200|25923193|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
13116693|NCT03073200|25923194|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
13116694|NCT03073200|25923195|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
13116695|NCT03073200|25923196|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
13116696|NCT03073200|25923197|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
13116697|NCT03073200|25923198|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
13252292|NCT01553747|26373653|FG001|Overall Study|Physician decision: lack of efficacy|5|||
13252293|NCT01553747|26373654|FG002|Overall Study|Physician decision: lack of efficacy|3|||
13116698|NCT03073200|25923199|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
13252294|NCT01553591|26373714|FG000|Overall Study|Voluntarily withdrew|94|||
13252295|NCT01553591|26373715|FG001|Overall Study|Voluntarily withdrew|79|||
13252296|NCT01553591|26373716|FG002|Overall Study|Voluntarily withdrew|96|||
13252297|NCT01553591|26373714|FG000|Overall Study|Adverse Event|36|||
13252298|NCT01553591|26373715|FG001|Overall Study|Adverse Event|45|||
13252299|NCT01553591|26373716|FG002|Overall Study|Adverse Event|16|||
13252300|NCT01553591|26373714|FG000|Overall Study|Lost to Follow-up|25|||
13252301|NCT01553591|26373715|FG001|Overall Study|Lost to Follow-up|23|||
13252302|NCT01553591|26373716|FG002|Overall Study|Lost to Follow-up|16|||
13252303|NCT01553591|26373714|FG000|Overall Study|Physician decision: other|11|||
13252304|NCT01553591|26373715|FG001|Overall Study|Physician decision: other|14|||
13252305|NCT01553591|26373716|FG002|Overall Study|Physician decision: other|16|||
13252306|NCT01553591|26373714|FG000|Overall Study|Physician decision: lack of efficacy|2|||
13252307|NCT01553591|26373715|FG001|Overall Study|Physician decision: lack of efficacy|3|||
13252308|NCT01553591|26373716|FG002|Overall Study|Physician decision: lack of efficacy|7|||
13252309|NCT01553591|26373714|FG000|Overall Study|Protocol Violation|3|||
13252310|NCT01553591|26373715|FG001|Overall Study|Protocol Violation|4|||
13252311|NCT01553591|26373716|FG002|Overall Study|Protocol Violation|4|||
13252312|NCT01553591|26373714|FG000|Overall Study|Sponsor decision|1|||
13252313|NCT01553591|26373715|FG001|Overall Study|Sponsor decision|0|||
13252314|NCT01553591|26373716|FG002|Overall Study|Sponsor decision|3|||
13252315|NCT01553591|26373714|FG000|Overall Study|Randomized and never dispensed drug|0|||
13252316|NCT01553591|26373715|FG001|Overall Study|Randomized and never dispensed drug|1|||
13252317|NCT01553591|26373716|FG002|Overall Study|Randomized and never dispensed drug|0|||
13252318|NCT01553318|26373735|FG000|Overall Study|Protocol Violation|3|||
13252319|NCT01553318|26373736|FG001|Overall Study|Protocol Violation|2|||
13252320|NCT01553279|26373800|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1|||
13252321|NCT01553279|26373801|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0|||
13252322|NCT01553279|26373800|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
13252323|NCT01553279|26373801|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
13252324|NCT01553279|26373800|FG000|Interim Period|Withdrawal by Subject|2|||
13252325|NCT01553279|26373801|FG001|Interim Period|Withdrawal by Subject|2|||
13252326|NCT01553279|26373800|FG000|Interim Period|Lost to Follow-up|1|||
13252327|NCT01553279|26373801|FG001|Interim Period|Lost to Follow-up|0|||
13252328|NCT01553279|26373800|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0|||
13252329|NCT01553279|26373801|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5|||
13252330|NCT01553279|26373800|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3|||
13252331|NCT01553279|26373801|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2|||
13252332|NCT01553188|26373839|FG000|Overall Study|Patient choice|1|||
13252333|NCT01553188|26373840|FG001|Overall Study|Patient choice|0|||
13116699|NCT03073200|25923200|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
13116700|NCT03073200|25923201|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
13116701|NCT03073200|25923202|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
13116702|NCT03073200|25923203|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
13116703|NCT03073200|25923204|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
13116704|NCT03073200|25923205|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
13116705|NCT03073200|25923191|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
13252334|NCT01553188|26373841|FG002|Overall Study|Patient choice|0|||
13252335|NCT01553188|26373842|FG003|Overall Study|Patient choice|0|||
13252336|NCT01553188|26373839|FG000|Overall Study|Intercurrent illness and adverse event|0|||
13252337|NCT01553188|26373840|FG001|Overall Study|Intercurrent illness and adverse event|1|||
13252338|NCT01553188|26373841|FG002|Overall Study|Intercurrent illness and adverse event|2|||
13252339|NCT01553188|26373842|FG003|Overall Study|Intercurrent illness and adverse event|0|||
13252340|NCT01553136|26373863|FG000|Overall Study|Adverse Event|3|||
13252341|NCT01553136|26373864|FG001|Overall Study|Adverse Event|2|||
13116706|NCT03073200|25923192|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
13116707|NCT03073200|25923193|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
13116708|NCT03073200|25923194|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
13116709|NCT03073200|25923195|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
13116710|NCT03073200|25923196|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
13252342|NCT01553136|26373863|FG000|Overall Study|Withdrawal by Subject|2|||
13252343|NCT01553136|26373864|FG001|Overall Study|Withdrawal by Subject|3|||
13252344|NCT01553136|26373863|FG000|Overall Study|Lost to Follow-up|4|||
13252345|NCT01553136|26373864|FG001|Overall Study|Lost to Follow-up|10|||
13252346|NCT01553136|26373863|FG000|Overall Study|Physician Decision|2|||
13252347|NCT01553136|26373864|FG001|Overall Study|Physician Decision|3|||
13252348|NCT01553136|26373863|FG000|Overall Study|Scheduling Difficulties|5|||
13252349|NCT01553136|26373864|FG001|Overall Study|Scheduling Difficulties|4|||
13252350|NCT01553084|26373890|FG000|Overall Study|Withdrawal by Subject|15|||
13252351|NCT01553084|26373891|FG001|Overall Study|Withdrawal by Subject|13|||
13252352|NCT01553084|26373892|FG002|Overall Study|Withdrawal by Subject|35|||
13252353|NCT01552954|26373911|FG000|Overall Study|Adverse Event|1|||
13252354|NCT01552954|26373912|FG001|Overall Study|Adverse Event|2|||
13252355|NCT01552954|26373911|FG000|Overall Study|Lost to Follow-up|1|||
13252356|NCT01552954|26373912|FG001|Overall Study|Lost to Follow-up|1|||
13252357|NCT01552954|26373911|FG000|Overall Study|Withdrawal by Subject|1|||
13252358|NCT01552954|26373912|FG001|Overall Study|Withdrawal by Subject|1|||
13252359|NCT01552954|26373911|FG000|Overall Study|Protocol Violation|1|||
13252360|NCT01552954|26373912|FG001|Overall Study|Protocol Violation|2|||
13252361|NCT01552954|26373911|FG000|Overall Study|diagnosed DM|1|||
13252362|NCT01552954|26373912|FG001|Overall Study|diagnosed DM|0|||
13252363|NCT01552928|26373969|FG000|Period 3|Adverse Event|0|||
13252364|NCT01552928|26373970|FG001|Period 3|Adverse Event|0|||
13252365|NCT01552928|26373971|FG002|Period 3|Adverse Event|1|||
13252366|NCT01552928|26373972|FG003|Period 3|Adverse Event|0|||
13252367|NCT01552915|26374002|FG000|Overall Study|Adverse Event|3|||
13252368|NCT01552915|26374003|FG001|Overall Study|Adverse Event|14|||
13252369|NCT01552915|26374004|FG002|Overall Study|Adverse Event|3|||
13252370|NCT01552915|26374002|FG000|Overall Study|Lost to Follow-up|4|||
13252371|NCT01552915|26374003|FG001|Overall Study|Lost to Follow-up|6|||
13252372|NCT01552915|26374004|FG002|Overall Study|Lost to Follow-up|5|||
13252373|NCT01552915|26374002|FG000|Overall Study|Withdrawal by Subject|6|||
13252374|NCT01552915|26374003|FG001|Overall Study|Withdrawal by Subject|4|||
13252375|NCT01552915|26374004|FG002|Overall Study|Withdrawal by Subject|5|||
13252376|NCT01552915|26374002|FG000|Overall Study|Protocol Violation|0|||
13252377|NCT01552915|26374003|FG001|Overall Study|Protocol Violation|4|||
13252378|NCT01552915|26374004|FG002|Overall Study|Protocol Violation|4|||
13252379|NCT01552915|26374002|FG000|Overall Study|Lack of Efficacy|8|||
13252380|NCT01552915|26374003|FG001|Overall Study|Lack of Efficacy|1|||
13252381|NCT01552915|26374004|FG002|Overall Study|Lack of Efficacy|4|||
13252382|NCT01552915|26374002|FG000|Overall Study|Other|2|||
13252383|NCT01552915|26374003|FG001|Overall Study|Other|0|||
13252384|NCT01552915|26374004|FG002|Overall Study|Other|6|||
13252385|NCT01552902|26374034|FG000|Overall Study|Adverse Event|1|||
13252386|NCT01552902|26374035|FG001|Overall Study|Adverse Event|15|||
13252387|NCT01552902|26374036|FG002|Overall Study|Adverse Event|14|||
13252388|NCT01552902|26374034|FG000|Overall Study|Protocol Violation|3|||
13252389|NCT01552902|26374035|FG001|Overall Study|Protocol Violation|3|||
13252390|NCT01552902|26374036|FG002|Overall Study|Protocol Violation|3|||
13252391|NCT01552902|26374034|FG000|Overall Study|Lack of Efficacy|4|||
13252392|NCT01552902|26374035|FG001|Overall Study|Lack of Efficacy|3|||
13252393|NCT01552902|26374036|FG002|Overall Study|Lack of Efficacy|1|||
13252394|NCT01552902|26374034|FG000|Overall Study|Withdrawal by Subject|1|||
13252395|NCT01552902|26374035|FG001|Overall Study|Withdrawal by Subject|9|||
13252396|NCT01552902|26374036|FG002|Overall Study|Withdrawal by Subject|6|||
13252397|NCT01552902|26374034|FG000|Overall Study|Lost to Follow-up|1|||
13252398|NCT01552902|26374035|FG001|Overall Study|Lost to Follow-up|3|||
13252399|NCT01552902|26374036|FG002|Overall Study|Lost to Follow-up|6|||
13252400|NCT01552902|26374034|FG000|Overall Study|Other|3|||
13252401|NCT01552902|26374035|FG001|Overall Study|Other|4|||
13252402|NCT01552902|26374036|FG002|Overall Study|Other|3|||
13252403|NCT01552772|26374052|FG000|Overall Study|Lost to Follow-up|2|||
13252404|NCT01552772|26374052|FG000|Overall Study|Adverse Event|1|||
13252405|NCT01552772|26374052|FG000|Overall Study|Protocol Deviation|1|||
13252406|NCT01552694|26374073|FG000|Overall Study|Lost to Follow-up|0|||
13252407|NCT01552694|26374074|FG001|Overall Study|Lost to Follow-up|1|||
13252408|NCT01552694|26374073|FG000|Overall Study|Protocol Violation|0|||
13252409|NCT01552694|26374074|FG001|Overall Study|Protocol Violation|1|||
13252410|NCT01552681|26374129|FG000|Overall Study|Withdrawal by Subject|4|||
13252411|NCT01552681|26374130|FG001|Overall Study|Withdrawal by Subject|0|||
13252412|NCT01552681|26374129|FG000|Overall Study|Physician Decision|1|||
13252413|NCT01552681|26374130|FG001|Overall Study|Physician Decision|0|||
13252414|NCT01552681|26374129|FG000|Overall Study|Subject moved away|0|||
13252415|NCT01552681|26374130|FG001|Overall Study|Subject moved away|1|||
13252416|NCT01552603|26374137|FG000|Overall Study|Physician Decision|1|||
13252417|NCT01552408|26374164|FG000|Overall Study|Lost to Follow-up|2|||
13252418|NCT01552408|26374165|FG001|Overall Study|Lost to Follow-up|0|||
13252419|NCT01552408|26374164|FG000|Overall Study|Relocation|0|||
13252420|NCT01552408|26374165|FG001|Overall Study|Relocation|1|||
13252421|NCT01552408|26374164|FG000|Overall Study|Withdrawal by Subject|2|||
13252422|NCT01552408|26374165|FG001|Overall Study|Withdrawal by Subject|1|||
13252423|NCT01552369|26374198|FG000|Overall Study|Did not consent to extended follow up|8|||
13252424|NCT01552369|26374199|FG001|Overall Study|Did not consent to extended follow up|9|||
13252425|NCT01552057|26374238|FG000|Overall Study|Adverse Event|14|||
13252426|NCT01552057|26374239|FG001|Overall Study|Adverse Event|15|||
13252427|NCT01552057|26374238|FG000|Overall Study|Lack of Efficacy|8|||
13252428|NCT01552057|26374239|FG001|Overall Study|Lack of Efficacy|23|||
13252429|NCT01552057|26374238|FG000|Overall Study|Withdrawal by Subject|5|||
13252430|NCT01552057|26374239|FG001|Overall Study|Withdrawal by Subject|8|||
13252431|NCT01552057|26374238|FG000|Overall Study|Entry Criteria Not Met|2|||
13252432|NCT01552057|26374239|FG001|Overall Study|Entry Criteria Not Met|2|||
13252433|NCT01552057|26374238|FG000|Overall Study|Physician Decision|1|||
13252434|NCT01552057|26374239|FG001|Overall Study|Physician Decision|0|||
13252435|NCT01551758|26374284|FG000|Overall Study|Adverse Event|29|||
13252436|NCT01551758|26374285|FG001|Overall Study|Adverse Event|43|||
13252437|NCT01551758|26374284|FG000|Overall Study|Lack of Efficacy|0|||
13252438|NCT01551758|26374285|FG001|Overall Study|Lack of Efficacy|1|||
13252439|NCT01551758|26374284|FG000|Overall Study|Protocol Violation|5|||
13252440|NCT01551758|26374285|FG001|Overall Study|Protocol Violation|6|||
13252441|NCT01551758|26374284|FG000|Overall Study|Met Protocol-defined stopping criteria|8|||
13252442|NCT01551758|26374285|FG001|Overall Study|Met Protocol-defined stopping criteria|10|||
13252443|NCT01551758|26374284|FG000|Overall Study|Lost to Follow-up|29|||
13252444|NCT01551758|26374285|FG001|Overall Study|Lost to Follow-up|25|||
13252445|NCT01551758|26374284|FG000|Overall Study|Physician Decision|9|||
13252446|NCT01551758|26374285|FG001|Overall Study|Physician Decision|3|||
13252447|NCT01551758|26374284|FG000|Overall Study|Withdrawal by Subject|14|||
13252448|NCT01551758|26374285|FG001|Overall Study|Withdrawal by Subject|17|||
13252449|NCT01551745|26374294|FG000|Overall Study|Withdrawal by Subject|1|||
13252450|NCT01551745|26374294|FG000|Overall Study|Disease Progression|2|||
13252451|NCT01551693|26374311|FG000|Overall Study|Disease Progression|1|||
13252452|NCT01551693|26374312|FG001|Overall Study|Disease Progression|0|||
13252453|NCT01551693|26374311|FG000|Overall Study|Adverse Event|0|||
13252454|NCT01551693|26374312|FG001|Overall Study|Adverse Event|1|||
13252455|NCT01551693|26374311|FG000|Overall Study|Withdrawal by Subject|0|||
13252456|NCT01551693|26374312|FG001|Overall Study|Withdrawal by Subject|1|||
13252457|NCT01551420|26374343|FG000|In-laboratory (Part A)|Lost to Follow-up|2|||
13252458|NCT01551420|26374344|FG001|In-laboratory (Part A)|Lost to Follow-up|1|||
13252459|NCT01551420|26374343|FG000|In-laboratory (Part A)|Withdrawal by Subject|2|||
13252460|NCT01551420|26374344|FG001|In-laboratory (Part A)|Withdrawal by Subject|0|||
13252461|NCT01551420|26374343|FG000|In-laboratory (Part A)|Scheduling conflict|2|||
13252462|NCT01551420|26374344|FG001|In-laboratory (Part A)|Scheduling conflict|1|||
13252463|NCT01551420|26374343|FG000|Screened for Part B Eligibility|Declined participation|8|||
13252464|NCT01551420|26374344|FG001|Screened for Part B Eligibility|Declined participation|1|||
13252465|NCT01551420|26374343|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1|||
13252466|NCT01551420|26374344|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2|||
13252467|NCT01551420|26374343|FG000|Home Use (Part B)|Withdrawal by Subject|6|||
13252468|NCT01551420|26374344|FG001|Home Use (Part B)|Withdrawal by Subject|0|||
13252469|NCT01551420|26374343|FG000|Home Use (Part B)|Withdrawal by staff|0|||
13252470|NCT01551420|26374344|FG001|Home Use (Part B)|Withdrawal by staff|1|||
13252471|NCT01551355|26374375|FG000|Overall Study|Lost to Follow-up|51|||
13252472|NCT01551355|26374376|FG001|Overall Study|Lost to Follow-up|49|||
13252473|NCT01551355|26374377|FG002|Overall Study|Lost to Follow-up|34|||
13252474|NCT01551355|26374378|FG003|Overall Study|Lost to Follow-up|24|||
13252475|NCT01551355|26374379|FG004|Overall Study|Lost to Follow-up|9|||
13252476|NCT01551355|26374380|FG005|Overall Study|Lost to Follow-up|6|||
13252477|NCT01551303|26374393|FG000|Overall Study|failed awareness check on vision test|4|||
13252478|NCT01551303|26374394|FG001|Overall Study|failed awareness check on vision test|7|||
13252479|NCT01551212|26374419|FG000|Overall Study|Graft loss/Retransplantation|0|||
13252480|NCT01551212|26374420|FG001|Overall Study|Graft loss/Retransplantation|1|||
13252481|NCT01551212|26374419|FG000|Overall Study|Administrative problems|1|||
13252482|NCT01551212|26374420|FG001|Overall Study|Administrative problems|2|||
13252483|NCT01551212|26374419|FG000|Overall Study|Lost to Follow-up|0|||
13252484|NCT01551212|26374420|FG001|Overall Study|Lost to Follow-up|1|||
13252485|NCT01551212|26374419|FG000|Overall Study|Protocol Violation|0|||
13252486|NCT01551212|26374420|FG001|Overall Study|Protocol Violation|1|||
13252487|NCT01551212|26374419|FG000|Overall Study|Withdrawal by Subject|0|||
13252488|NCT01551212|26374420|FG001|Overall Study|Withdrawal by Subject|7|||
13252489|NCT01551212|26374419|FG000|Overall Study|Death|2|||
13252490|NCT01551212|26374420|FG001|Overall Study|Death|4|||
13252491|NCT01551212|26374419|FG000|Overall Study|Never Received Study Treatment|2|||
13252492|NCT01551212|26374420|FG001|Overall Study|Never Received Study Treatment|4|||
13252493|NCT01551173|26374438|FG000|Overall Study|Withdrawal by Subject|11|||
13252494|NCT01551173|26374439|FG001|Overall Study|Withdrawal by Subject|16|||
13252495|NCT01551173|26374438|FG000|Overall Study|Adverse Event|7|||
13252496|NCT01551173|26374439|FG001|Overall Study|Adverse Event|6|||
13116711|NCT03073200|25923197|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
13116712|NCT03073200|25923198|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
13116713|NCT03073200|25923199|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
13116714|NCT03073200|25923200|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
13116715|NCT03073200|25923201|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
13252497|NCT01551173|26374438|FG000|Overall Study|Lost to Follow-up|5|||
13252498|NCT01551173|26374439|FG001|Overall Study|Lost to Follow-up|7|||
13252499|NCT01551173|26374438|FG000|Overall Study|Other|5|||
13252500|NCT01551173|26374439|FG001|Overall Study|Other|3|||
13252501|NCT01550965|26374460|FG000|Overall Study|Adverse Event|26|||
13116716|NCT03073200|25923202|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
13116717|NCT03073200|25923203|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
13116718|NCT03073200|25923204|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1|||
13116719|NCT03073200|25923205|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
13116720|NCT03073200|25923191|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
13116721|NCT03073200|25923192|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
13116722|NCT03073200|25923193|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
13116723|NCT03073200|25923194|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
13252502|NCT01550965|26374460|FG000|Overall Study|Withdrawal by Subject|10|||
13252503|NCT01550965|26374460|FG000|Overall Study|Lost to Follow-up|2|||
13252504|NCT01550965|26374460|FG000|Overall Study|Lack of Efficacy|59|||
13252505|NCT01550965|26374460|FG000|Overall Study|Other|13|||
13252506|NCT01550757|26374483|FG000|Overall Study|Lost to Follow-up|21|||
13252507|NCT01550757|26374484|FG001|Overall Study|Lost to Follow-up|14|||
13252508|NCT01550757|26374485|FG002|Overall Study|Lost to Follow-up|42|||
13252509|NCT01550757|26374486|FG003|Overall Study|Lost to Follow-up|53|||
13252510|NCT01550757|26374483|FG000|Overall Study|Withdrawal by Subject|2|||
13252511|NCT01550757|26374484|FG001|Overall Study|Withdrawal by Subject|0|||
13252512|NCT01550757|26374485|FG002|Overall Study|Withdrawal by Subject|3|||
13252513|NCT01550757|26374486|FG003|Overall Study|Withdrawal by Subject|1|||
13252514|NCT01550744|26374503|FG000|Open-Label|Lost to Follow-up|7|||
13252515|NCT01550744|26374504|FG001|Open-Label|Lost to Follow-up|0|||
13252516|NCT01550744|26374505|FG002|Open-Label|Lost to Follow-up|0|||
13252517|NCT01550744|26374503|FG000|Open-Label|Withdrawal by Subject|13|||
13252518|NCT01550744|26374504|FG001|Open-Label|Withdrawal by Subject|0|||
13252519|NCT01550744|26374505|FG002|Open-Label|Withdrawal by Subject|0|||
13252520|NCT01550744|26374503|FG000|Open-Label|Adverse Event|11|||
13252521|NCT01550744|26374504|FG001|Open-Label|Adverse Event|0|||
13252522|NCT01550744|26374505|FG002|Open-Label|Adverse Event|0|||
13252523|NCT01550744|26374503|FG000|Open-Label|Lack of Efficacy|4|||
13252524|NCT01550744|26374504|FG001|Open-Label|Lack of Efficacy|0|||
13252525|NCT01550744|26374505|FG002|Open-Label|Lack of Efficacy|0|||
13252526|NCT01550744|26374503|FG000|Open-Label|Protocol Violation|4|||
13252527|NCT01550744|26374504|FG001|Open-Label|Protocol Violation|0|||
13252528|NCT01550744|26374505|FG002|Open-Label|Protocol Violation|0|||
13252529|NCT01550744|26374503|FG000|Open-Label|Not all 3 study drug injections received|2|||
13252530|NCT01550744|26374504|FG001|Open-Label|Not all 3 study drug injections received|0|||
13252531|NCT01550744|26374505|FG002|Open-Label|Not all 3 study drug injections received|0|||
13252532|NCT01550744|26374503|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58|||
13252533|NCT01550744|26374504|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0|||
13252534|NCT01550744|26374505|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0|||
13252535|NCT01550744|26374503|FG000|Open-Label|Other|1|||
13252536|NCT01550744|26374504|FG001|Open-Label|Other|0|||
13252537|NCT01550744|26374505|FG002|Open-Label|Other|0|||
13252538|NCT01550744|26374503|FG000|Double-Blind|Lost to Follow-up|0|||
13252539|NCT01550744|26374504|FG001|Double-Blind|Lost to Follow-up|6|||
13252540|NCT01550744|26374505|FG002|Double-Blind|Lost to Follow-up|12|||
13252541|NCT01550744|26374503|FG000|Double-Blind|Withdrawal by Subject|0|||
13252542|NCT01550744|26374504|FG001|Double-Blind|Withdrawal by Subject|2|||
13252543|NCT01550744|26374505|FG002|Double-Blind|Withdrawal by Subject|15|||
13252544|NCT01550744|26374503|FG000|Double-Blind|Adverse Event|0|||
13252545|NCT01550744|26374504|FG001|Double-Blind|Adverse Event|4|||
13252546|NCT01550744|26374505|FG002|Double-Blind|Adverse Event|15|||
13252547|NCT01550744|26374503|FG000|Double-Blind|Death|0|||
13116724|NCT03073200|25923195|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
13116725|NCT03073200|25923196|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
13252548|NCT01550744|26374504|FG001|Double-Blind|Death|1|||
13252549|NCT01550744|26374505|FG002|Double-Blind|Death|0|||
13252550|NCT01550744|26374503|FG000|Double-Blind|Lack of Efficacy|0|||
13252551|NCT01550744|26374504|FG001|Double-Blind|Lack of Efficacy|2|||
13252552|NCT01550744|26374505|FG002|Double-Blind|Lack of Efficacy|8|||
13252553|NCT01550744|26374503|FG000|Double-Blind|Protocol Violation|0|||
13252554|NCT01550744|26374504|FG001|Double-Blind|Protocol Violation|0|||
13252555|NCT01550744|26374505|FG002|Double-Blind|Protocol Violation|4|||
13252556|NCT01550744|26374503|FG000|Double-Blind|Pregnancy|0|||
13252557|NCT01550744|26374504|FG001|Double-Blind|Pregnancy|0|||
13252558|NCT01550744|26374505|FG002|Double-Blind|Pregnancy|3|||
13252559|NCT01550744|26374503|FG000|Double-Blind|Other|0|||
13252560|NCT01550744|26374504|FG001|Double-Blind|Other|2|||
13252561|NCT01550744|26374505|FG002|Double-Blind|Other|10|||
13252562|NCT01550289|26374542|FG000|Overall Study|Protocol Violation|1|||
13252563|NCT01550289|26374543|FG001|Overall Study|Protocol Violation|0|||
13252564|NCT01550289|26374542|FG000|Overall Study|Lost to Follow-up|1|||
13252565|NCT01550289|26374543|FG001|Overall Study|Lost to Follow-up|1|||
13252566|NCT01550289|26374542|FG000|Overall Study|Withdrawal by Subject|11|||
13252567|NCT01550289|26374543|FG001|Overall Study|Withdrawal by Subject|3|||
13252568|NCT01549964|26374574|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50|||
13485861|NCT02682901|27033599|FG000|Overall Study|Lack of Efficacy|0|||
13252569|NCT01549964|26374575|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104|||
13252570|NCT01549964|26374576|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104|||
13252571|NCT01549964|26374577|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105|||
13252572|NCT01549964|26374574|FG000|24-Week Treatment Period|Voluntary Withdrawal|6|||
13252573|NCT01549964|26374575|FG001|24-Week Treatment Period|Voluntary Withdrawal|3|||
13252574|NCT01549964|26374576|FG002|24-Week Treatment Period|Voluntary Withdrawal|3|||
13252575|NCT01549964|26374577|FG003|24-Week Treatment Period|Voluntary Withdrawal|8|||
13252576|NCT01549964|26374574|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1|||
13252577|NCT01549964|26374575|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
13252578|NCT01549964|26374576|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
13252579|NCT01549964|26374577|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
13252580|NCT01549964|26374574|FG000|24-Week Treatment Period|Lost to Follow-up|1|||
13252581|NCT01549964|26374575|FG001|24-Week Treatment Period|Lost to Follow-up|0|||
13252582|NCT01549964|26374576|FG002|24-Week Treatment Period|Lost to Follow-up|1|||
13252583|NCT01549964|26374577|FG003|24-Week Treatment Period|Lost to Follow-up|2|||
13252584|NCT01549964|26374574|FG000|24-Week Treatment Period|Lack of Efficacy|1|||
13252585|NCT01549964|26374575|FG001|24-Week Treatment Period|Lack of Efficacy|0|||
13252586|NCT01549964|26374576|FG002|24-Week Treatment Period|Lack of Efficacy|1|||
13252587|NCT01549964|26374577|FG003|24-Week Treatment Period|Lack of Efficacy|1|||
13252588|NCT01549964|26374574|FG000|24-Week Treatment Period|Other|1|||
13252589|NCT01549964|26374575|FG001|24-Week Treatment Period|Other|0|||
13252590|NCT01549964|26374576|FG002|24-Week Treatment Period|Other|1|||
13252591|NCT01549964|26374577|FG003|24-Week Treatment Period|Other|0|||
13252592|NCT01549964|26374574|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
13252593|NCT01549964|26374575|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
13252594|NCT01549964|26374576|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1|||
13252595|NCT01549964|26374577|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
13252596|NCT01549964|26374574|FG000|24-Week Treatment Period|Randomized but Not Treated|0|||
13252597|NCT01549964|26374575|FG001|24-Week Treatment Period|Randomized but Not Treated|0|||
13252598|NCT01549964|26374576|FG002|24-Week Treatment Period|Randomized but Not Treated|0|||
13252599|NCT01549964|26374577|FG003|24-Week Treatment Period|Randomized but Not Treated|1|||
13252600|NCT01549964|26374574|FG000|24-Week Treatment Period|Completion Status Unknown|1|||
13252601|NCT01549964|26374575|FG001|24-Week Treatment Period|Completion Status Unknown|0|||
13252602|NCT01549964|26374576|FG002|24-Week Treatment Period|Completion Status Unknown|1|||
13252603|NCT01549964|26374577|FG003|24-Week Treatment Period|Completion Status Unknown|0|||
13252604|NCT01549964|26374574|FG000|80-Week Extension Period|Pregnancy|0|||
13252605|NCT01549964|26374575|FG001|80-Week Extension Period|Pregnancy|0|||
13252606|NCT01549964|26374576|FG002|80-Week Extension Period|Pregnancy|1|||
13252607|NCT01549964|26374577|FG003|80-Week Extension Period|Pregnancy|0|||
13252608|NCT01549964|26374574|FG000|80-Week Extension Period|Study Terminated by Sponsor|65|||
13252609|NCT01549964|26374575|FG001|80-Week Extension Period|Study Terminated by Sponsor|137|||
13252610|NCT01549964|26374576|FG002|80-Week Extension Period|Study Terminated by Sponsor|132|||
13252611|NCT01549964|26374577|FG003|80-Week Extension Period|Study Terminated by Sponsor|132|||
13252612|NCT01549964|26374574|FG000|80-Week Extension Period|Voluntary Withdrawal|0|||
13252613|NCT01549964|26374575|FG001|80-Week Extension Period|Voluntary Withdrawal|1|||
13252614|NCT01549964|26374576|FG002|80-Week Extension Period|Voluntary Withdrawal|4|||
13252615|NCT01549964|26374577|FG003|80-Week Extension Period|Voluntary Withdrawal|2|||
13252616|NCT01549964|26374574|FG000|80-Week Extension Period|Lost to Follow-up|1|||
13252617|NCT01549964|26374575|FG001|80-Week Extension Period|Lost to Follow-up|0|||
13252618|NCT01549964|26374576|FG002|80-Week Extension Period|Lost to Follow-up|2|||
13252619|NCT01549964|26374577|FG003|80-Week Extension Period|Lost to Follow-up|1|||
13252620|NCT01549964|26374574|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
13252621|NCT01549964|26374575|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
13252622|NCT01549964|26374576|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1|||
13252623|NCT01549964|26374577|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2|||
13252624|NCT01549951|26374595|FG000|Overall Study|Adverse Event|15|||
13252625|NCT01549951|26374595|FG000|Overall Study|Withdrawal by Subject|2|||
13252626|NCT01549951|26374595|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
13252627|NCT01549951|26374595|FG000|Overall Study|Progressive disease|29|||
13252628|NCT01549951|26374595|FG000|Overall Study|Symptomatic deterioration|1|||
13252629|NCT01549951|26374595|FG000|Overall Study|Other|2|||
13252630|NCT01549886|26374612|FG000|Overall Study|Sponsor's decision|2|||
13252631|NCT01549886|26374613|FG001|Overall Study|Sponsor's decision|3|||
13252632|NCT01549873|26374630|FG000|Overall Study|Physician Decision|0|||
13252633|NCT01549873|26374631|FG001|Overall Study|Physician Decision|1|||
13252634|NCT01549860|26374648|FG000|Overall Study|Withdrawal by Subject|1|||
13252635|NCT01549860|26374649|FG001|Overall Study|Withdrawal by Subject|0|||
13252636|NCT01549860|26374648|FG000|Overall Study|Physician Decision|1|||
13252637|NCT01549860|26374649|FG001|Overall Study|Physician Decision|1|||
13252638|NCT01549652|26374676|FG000|Overall Study|Did Not Receive Allocated Intervention|0|||
13485862|NCT02682901|27033600|FG001|Overall Study|Lack of Efficacy|1|||
13252639|NCT01549652|26374677|FG001|Overall Study|Did Not Receive Allocated Intervention|0|||
13252640|NCT01549652|26374678|FG002|Overall Study|Did Not Receive Allocated Intervention|2|||
13252641|NCT01549652|26374679|FG003|Overall Study|Did Not Receive Allocated Intervention|0|||
13252642|NCT01549652|26374676|FG000|Overall Study|Study Drug Titration Failure|5|||
13252643|NCT01549652|26374677|FG001|Overall Study|Study Drug Titration Failure|6|||
13252644|NCT01549652|26374678|FG002|Overall Study|Study Drug Titration Failure|0|||
13252645|NCT01549652|26374679|FG003|Overall Study|Study Drug Titration Failure|0|||
13252646|NCT01549652|26374676|FG000|Overall Study|Withdrawal Effect|0|||
13252647|NCT01549652|26374677|FG001|Overall Study|Withdrawal Effect|2|||
13252648|NCT01549652|26374678|FG002|Overall Study|Withdrawal Effect|0|||
13252649|NCT01549652|26374679|FG003|Overall Study|Withdrawal Effect|0|||
13252650|NCT01549652|26374676|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5|||
13252651|NCT01549652|26374677|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1|||
13252652|NCT01549652|26374678|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
13252653|NCT01549652|26374679|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
13252654|NCT01549652|26374676|FG000|Overall Study|Problem with Infusion|1|||
13252655|NCT01549652|26374677|FG001|Overall Study|Problem with Infusion|0|||
13252656|NCT01549652|26374678|FG002|Overall Study|Problem with Infusion|0|||
13252657|NCT01549652|26374679|FG003|Overall Study|Problem with Infusion|0|||
13252658|NCT01549652|26374676|FG000|Overall Study|Titration Non-Compliance|1|||
13252659|NCT01549652|26374677|FG001|Overall Study|Titration Non-Compliance|3|||
13252660|NCT01549652|26374678|FG002|Overall Study|Titration Non-Compliance|4|||
13252661|NCT01549652|26374679|FG003|Overall Study|Titration Non-Compliance|5|||
13252662|NCT01549652|26374676|FG000|Overall Study|Titration Side Effects|0|||
13252663|NCT01549652|26374677|FG001|Overall Study|Titration Side Effects|0|||
13252664|NCT01549652|26374678|FG002|Overall Study|Titration Side Effects|6|||
13252665|NCT01549652|26374679|FG003|Overall Study|Titration Side Effects|3|||
13252666|NCT01549652|26374676|FG000|Overall Study|Withdrawal by Subject|0|||
13252667|NCT01549652|26374677|FG001|Overall Study|Withdrawal by Subject|0|||
13252668|NCT01549652|26374678|FG002|Overall Study|Withdrawal by Subject|5|||
13252669|NCT01549652|26374679|FG003|Overall Study|Withdrawal by Subject|3|||
13252670|NCT01549613|26374692|FG000|Overall Study|Lost to Follow-up|11|||
13252671|NCT01549613|26374693|FG001|Overall Study|Lost to Follow-up|11|||
13252672|NCT01549392|26374706|FG000|Overall Study|Withdrawal by Subject|1|||
13252673|NCT01549392|26374707|FG001|Overall Study|Withdrawal by Subject|0|||
13252674|NCT01549275|26374724|FG000|Overall Study|Lost to Follow-up|1|||
13252675|NCT01549275|26374725|FG001|Overall Study|Lost to Follow-up|0|||
13252676|NCT01549041|26374740|FG000|Overall Study|Lack of Efficacy|2|||
13252677|NCT01549041|26374741|FG001|Overall Study|Lack of Efficacy|4|||
13252678|NCT01549041|26374740|FG000|Overall Study|Adverse Event|0|||
13252679|NCT01549041|26374741|FG001|Overall Study|Adverse Event|4|||
13252680|NCT01549002|26374758|FG000|Overall Study|Excessive pain|0|||
13252681|NCT01549002|26374759|FG001|Overall Study|Excessive pain|2|||
13252682|NCT01549002|26374758|FG000|Overall Study|Moderate sedation required|0|||
13252683|NCT01549002|26374759|FG001|Overall Study|Moderate sedation required|2|||
13252684|NCT01548768|26374787|FG000|Overall Study|Withdrawal by Subject|0|||
13252685|NCT01548768|26374788|FG001|Overall Study|Withdrawal by Subject|2|||
13252686|NCT01548768|26374789|FG002|Overall Study|Withdrawal by Subject|1|||
13252687|NCT01548768|26374790|FG003|Overall Study|Withdrawal by Subject|0|||
13252688|NCT01548768|26374787|FG000|Overall Study|Physician Decision|1|||
13252689|NCT01548768|26374788|FG001|Overall Study|Physician Decision|0|||
13252690|NCT01548768|26374789|FG002|Overall Study|Physician Decision|0|||
13252691|NCT01548768|26374790|FG003|Overall Study|Physician Decision|0|||
13252692|NCT01548768|26374787|FG000|Overall Study|Adverse Event|0|||
13252693|NCT01548768|26374788|FG001|Overall Study|Adverse Event|0|||
13252694|NCT01548768|26374789|FG002|Overall Study|Adverse Event|0|||
13252695|NCT01548768|26374790|FG003|Overall Study|Adverse Event|1|||
13252696|NCT01548768|26374787|FG000|Overall Study|Non-Compliance|0|||
13252697|NCT01548768|26374788|FG001|Overall Study|Non-Compliance|0|||
13252698|NCT01548768|26374789|FG002|Overall Study|Non-Compliance|0|||
13252699|NCT01548768|26374790|FG003|Overall Study|Non-Compliance|3|||
13252700|NCT01548638|26374802|FG000|Overall Study|Protocol Violation|3|||
13252701|NCT01548638|26374802|FG000|Overall Study|Withdrawal by Subject|1|||
13252702|NCT01548599|26374825|FG000|Overall Study|Lost to Follow-up|0|||
13252703|NCT01548599|26374826|FG001|Overall Study|Lost to Follow-up|1|||
13252704|NCT01548599|26374825|FG000|Overall Study|Withdrawal by Subject|4|||
13252705|NCT01548599|26374826|FG001|Overall Study|Withdrawal by Subject|0|||
13252706|NCT01548599|26374825|FG000|Overall Study|Death|2|||
13252707|NCT01548599|26374826|FG001|Overall Study|Death|1|||
13252708|NCT01548573|26374835|FG000|Overall Study|Death|3|||
13252709|NCT01548573|26374835|FG000|Overall Study|Withdrawal by Subject|2|||
13252710|NCT01548417|26374850|FG000|Overall Study|Withdrawal by Subject|0|||
13252711|NCT01548417|26374851|FG001|Overall Study|Withdrawal by Subject|2|||
13252712|NCT01548404|26374880|FG000|Overall Study|Adverse Event|3|||
13252713|NCT01548404|26374881|FG001|Overall Study|Adverse Event|1|||
13252714|NCT01548404|26374880|FG000|Overall Study|Physician Decision|2|||
13252715|NCT01548404|26374881|FG001|Overall Study|Physician Decision|1|||
13252716|NCT01548404|26374880|FG000|Overall Study|Inadequate response to study treatment|23|||
13252717|NCT01548404|26374881|FG001|Overall Study|Inadequate response to study treatment|7|||
13252718|NCT01548404|26374880|FG000|Overall Study|Lost to Follow-up|2|||
13252719|NCT01548404|26374881|FG001|Overall Study|Lost to Follow-up|0|||
13252720|NCT01548404|26374880|FG000|Overall Study|Withdrawal by Subject|0|||
13252721|NCT01548404|26374881|FG001|Overall Study|Withdrawal by Subject|3|||
13252722|NCT01548404|26374880|FG000|Overall Study|Other than specified above|0|||
13252723|NCT01548404|26374881|FG001|Overall Study|Other than specified above|2|||
13252724|NCT01548287|26374925|FG000|Screening|No reason provided|0|||
13252725|NCT01548287|26374926|FG001|Screening|No reason provided|0|||
13252726|NCT01548287|26374927|FG002|Screening|No reason provided|0|||
13252727|NCT01548287|26374928|FG003|Screening|No reason provided|0|||
13252728|NCT01548287|26374929|FG004|Screening|No reason provided|9|||
13252729|NCT01548287|26374925|FG000|Screening|Did not meet eligibility criteria|0|||
13252730|NCT01548287|26374926|FG001|Screening|Did not meet eligibility criteria|0|||
13252731|NCT01548287|26374927|FG002|Screening|Did not meet eligibility criteria|0|||
13252732|NCT01548287|26374928|FG003|Screening|Did not meet eligibility criteria|0|||
13252733|NCT01548287|26374929|FG004|Screening|Did not meet eligibility criteria|74|||
13252734|NCT01548287|26374925|FG000|Randomized Period|Did not meet inclusion criteria|0|||
13252735|NCT01548287|26374926|FG001|Randomized Period|Did not meet inclusion criteria|0|||
13252736|NCT01548287|26374927|FG002|Randomized Period|Did not meet inclusion criteria|2|||
13252737|NCT01548287|26374928|FG003|Randomized Period|Did not meet inclusion criteria|0|||
13252738|NCT01548287|26374929|FG004|Randomized Period|Did not meet inclusion criteria|0|||
13252739|NCT01548287|26374925|FG000|Randomized Period|Adverse Event|0|||
13252740|NCT01548287|26374926|FG001|Randomized Period|Adverse Event|2|||
13252741|NCT01548287|26374927|FG002|Randomized Period|Adverse Event|5|||
13252742|NCT01548287|26374928|FG003|Randomized Period|Adverse Event|0|||
13252743|NCT01548287|26374929|FG004|Randomized Period|Adverse Event|0|||
13252744|NCT01547780|26374954|FG000|Baseline PET Scan|Physician Decision|1|||
13252745|NCT01547780|26374955|FG001|Baseline PET Scan|Physician Decision|0|||
13252746|NCT01547780|26374956|FG002|Baseline PET Scan|Physician Decision|1|||
13252747|NCT01547780|26374957|FG003|Baseline PET Scan|Physician Decision|0|||
13252748|NCT01547780|26374954|FG000|Baseline PET Scan|Withdrawal by Subject|2|||
13252749|NCT01547780|26374955|FG001|Baseline PET Scan|Withdrawal by Subject|0|||
13252750|NCT01547780|26374956|FG002|Baseline PET Scan|Withdrawal by Subject|1|||
13252751|NCT01547780|26374957|FG003|Baseline PET Scan|Withdrawal by Subject|0|||
13252752|NCT01547728|26374963|FG000|Overall Study|Change in procedure and equipment|1|||
13252753|NCT01547728|26374963|FG000|Overall Study|Drug not ready for subject|1|||
13252754|NCT01547728|26374963|FG000|Overall Study|Screen failure|39|||
13252755|NCT01547598|26374985|FG000|Overall Study|Withdrew consent|1|||
13252756|NCT01547598|26374986|FG001|Overall Study|Withdrew consent|1|||
13252757|NCT01547598|26374985|FG000|Overall Study|Lost to Follow-up|1|||
13252758|NCT01547598|26374986|FG001|Overall Study|Lost to Follow-up|1|||
13252759|NCT01547598|26374985|FG000|Overall Study|Adverse Event|1|||
13252760|NCT01547598|26374986|FG001|Overall Study|Adverse Event|1|||
13252761|NCT01547598|26374985|FG000|Overall Study|Protocol Violation|1|||
13252762|NCT01547598|26374986|FG001|Overall Study|Protocol Violation|1|||
13252763|NCT01547598|26374985|FG000|Overall Study|Other Miscellaneous Reasons|2|||
13252764|NCT01547598|26374986|FG001|Overall Study|Other Miscellaneous Reasons|1|||
13252765|NCT01547390|26375001|FG000|Overall Study|Withdrawal by Subject|10|||
13252766|NCT01547390|26375002|FG001|Overall Study|Withdrawal by Subject|7|||
13252767|NCT01547390|26375001|FG000|Overall Study|termination of pregnancy|0|||
13252768|NCT01547390|26375002|FG001|Overall Study|termination of pregnancy|1|||
13252769|NCT01547390|26375001|FG000|Overall Study|Lost to Follow-up|0|||
13252770|NCT01547390|26375002|FG001|Overall Study|Lost to Follow-up|2|||
13252771|NCT01547390|26375001|FG000|Overall Study|Adverse Event|3|||
13252772|NCT01547390|26375002|FG001|Overall Study|Adverse Event|0|||
13252773|NCT01547299|26375075|FG000|Overall Study|Withdrawal by Subject|2|||
13252774|NCT01547299|26375076|FG001|Overall Study|Withdrawal by Subject|2|||
13252775|NCT01547286|26375085|FG000|Overall Study|Did not meet all eligibility criteria|1|||
13252776|NCT01547286|26375085|FG000|Overall Study|Physician Decision|1|||
13252777|NCT01547130|26375106|FG000|Overall Study|Lost to Follow-up|9|||
13252778|NCT01547130|26375107|FG001|Overall Study|Lost to Follow-up|5|||
13252779|NCT01546922|26375116|FG000|First Period of 10 Weeks|Protocol Violation|3|||
13252780|NCT01546922|26375117|FG001|First Period of 10 Weeks|Protocol Violation|1|||
13252781|NCT01546922|26375116|FG000|First Period of 10 Weeks|Withdrawal by Subject|1|||
13252782|NCT01546922|26375117|FG001|First Period of 10 Weeks|Withdrawal by Subject|1|||
13252783|NCT01546922|26375116|FG000|First Period of 10 Weeks|Investigator's judgment|1|||
13252784|NCT01546922|26375117|FG001|First Period of 10 Weeks|Investigator's judgment|0|||
13252785|NCT01546922|26375116|FG000|Second Period of 10 Weeks|Protocol Violation|3|||
13252786|NCT01546922|26375117|FG001|Second Period of 10 Weeks|Protocol Violation|1|||
13252787|NCT01546922|26375116|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0|||
13252788|NCT01546922|26375117|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2|||
13252789|NCT01546883|26375123|FG000|Overall Study|Withdrawal by Subject|3|||
13252790|NCT01546883|26375123|FG000|Overall Study|Adverse Event|4|||
13252791|NCT01546883|26375123|FG000|Overall Study|Lost to Follow-up|2|||
13252792|NCT01546883|26375123|FG000|Overall Study|early closure of study|2|||
13252793|NCT01546883|26375123|FG000|Overall Study|other unrelated illness|1|||
13252794|NCT01546857|26375142|FG000|Overall Study|Withdrawal by Subject|2|||
13252795|NCT01546857|26375143|FG001|Overall Study|Withdrawal by Subject|3|||
13252796|NCT01546688|26375162|FG000|Overall Study|Adverse Event|0|||
13252797|NCT01546688|26375163|FG001|Overall Study|Adverse Event|4|||
13252798|NCT01546688|26375162|FG000|Overall Study|Withdrawal by Subject|2|||
13252799|NCT01546688|26375163|FG001|Overall Study|Withdrawal by Subject|1|||
13252800|NCT01546688|26375162|FG000|Overall Study|Lack of Efficacy|1|||
13252801|NCT01546688|26375163|FG001|Overall Study|Lack of Efficacy|0|||
13252802|NCT01546649|26375190|FG000|Overall Study|Adverse Event|4|||
13252803|NCT01546649|26375191|FG001|Overall Study|Adverse Event|5|||
13252804|NCT01546649|26375190|FG000|Overall Study|Protocol Violation|1|||
13252805|NCT01546649|26375191|FG001|Overall Study|Protocol Violation|0|||
13252806|NCT01546649|26375190|FG000|Overall Study|Lack of Efficacy|1|||
13252807|NCT01546649|26375191|FG001|Overall Study|Lack of Efficacy|0|||
13252808|NCT01546649|26375190|FG000|Overall Study|Recurrence|1|||
13252809|NCT01546649|26375191|FG001|Overall Study|Recurrence|1|||
13252810|NCT01546649|26375190|FG000|Overall Study|Discovery of secondary cancer|0|||
13252811|NCT01546649|26375191|FG001|Overall Study|Discovery of secondary cancer|1|||
13252812|NCT01546649|26375190|FG000|Overall Study|Withdrawal by Subject|1|||
13252813|NCT01546649|26375191|FG001|Overall Study|Withdrawal by Subject|2|||
13252814|NCT01546623|26375224|FG000|Overall Study|Adverse Event|2|||
13252815|NCT01546623|26375225|FG001|Overall Study|Adverse Event|3|||
13252816|NCT01546623|26375224|FG000|Overall Study|Major Protocol Deviation|1|||
13252817|NCT01546623|26375225|FG001|Overall Study|Major Protocol Deviation|1|||
13252818|NCT01546623|26375224|FG000|Overall Study|High Prostate specific antigen|2|||
13252819|NCT01546623|26375225|FG001|Overall Study|High Prostate specific antigen|1|||
13252820|NCT01546623|26375224|FG000|Overall Study|Did Not Receive Study Drug|1|||
13252821|NCT01546623|26375225|FG001|Overall Study|Did Not Receive Study Drug|1|||
13252822|NCT01546519|26375280|FG000|Overall Study|Adverse Event|0|||
13252823|NCT01546519|26375281|FG001|Overall Study|Adverse Event|0|||
13252824|NCT01546519|26375282|FG002|Overall Study|Adverse Event|1|||
13252825|NCT01546519|26375283|FG003|Overall Study|Adverse Event|1|||
13252826|NCT01546519|26375280|FG000|Overall Study|Death|0|||
13252827|NCT01546519|26375281|FG001|Overall Study|Death|1|||
13252828|NCT01546519|26375282|FG002|Overall Study|Death|3|||
13252829|NCT01546519|26375283|FG003|Overall Study|Death|1|||
13252830|NCT01546519|26375280|FG000|Overall Study|related to disease progression|2|||
13252831|NCT01546519|26375281|FG001|Overall Study|related to disease progression|2|||
13252832|NCT01546519|26375282|FG002|Overall Study|related to disease progression|2|||
13252833|NCT01546519|26375283|FG003|Overall Study|related to disease progression|1|||
13252834|NCT01546519|26375280|FG000|Overall Study|Physician Decision|6|||
13252835|NCT01546519|26375281|FG001|Overall Study|Physician Decision|5|||
13252836|NCT01546519|26375282|FG002|Overall Study|Physician Decision|2|||
13252837|NCT01546519|26375283|FG003|Overall Study|Physician Decision|3|||
13252838|NCT01546519|26375280|FG000|Overall Study|Withdrawal by Subject|1|||
13252839|NCT01546519|26375281|FG001|Overall Study|Withdrawal by Subject|0|||
13252840|NCT01546519|26375282|FG002|Overall Study|Withdrawal by Subject|0|||
13252841|NCT01546519|26375283|FG003|Overall Study|Withdrawal by Subject|0|||
13252842|NCT01546207|26375289|FG000|Overall Study|Death|1|||
13252843|NCT01546168|26375308|FG000|Overall Study|Lost to Follow-up|1|||
13252844|NCT01546168|26375309|FG001|Overall Study|Lost to Follow-up|0|||
13252845|NCT01546168|26375308|FG000|Overall Study|Withdrawal by Subject|1|||
13252846|NCT01546168|26375309|FG001|Overall Study|Withdrawal by Subject|0|||
13252847|NCT01546168|26375308|FG000|Overall Study|ineligible after signing consent|2|||
13252848|NCT01546168|26375309|FG001|Overall Study|ineligible after signing consent|0|||
13252849|NCT01546155|26375315|FG000|Overall Study|could not tolerate long scan duration|3|||
13252850|NCT01546142|26375334|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
13252851|NCT01546142|26375335|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
13252852|NCT01546142|26375334|FG000|Overall Study|Subject Noncompliance|1|||
13252853|NCT01546142|26375335|FG001|Overall Study|Subject Noncompliance|1|||
13252854|NCT01546142|26375334|FG000|Overall Study|Adverse Event|6|||
13252855|NCT01546142|26375335|FG001|Overall Study|Adverse Event|3|||
13252856|NCT01546142|26375334|FG000|Overall Study|Lost to Follow-up|20|||
13252857|NCT01546142|26375335|FG001|Overall Study|Lost to Follow-up|15|||
13252858|NCT01546142|26375334|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1|||
13252859|NCT01546142|26375335|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0|||
13252860|NCT01546142|26375334|FG000|Overall Study|Subject Randomized but Not Treated|1|||
13252861|NCT01546142|26375335|FG001|Overall Study|Subject Randomized but Not Treated|0|||
13252862|NCT01546038|26375517|FG000|Overall Study|Death|15|||
13252863|NCT01546038|26375518|FG001|Overall Study|Death|6|||
13252864|NCT01546038|26375519|FG002|Overall Study|Death|4|||
13252865|NCT01546038|26375520|FG003|Overall Study|Death|2|||
13252866|NCT01546038|26375521|FG004|Overall Study|Death|9|||
13252867|NCT01546038|26375522|FG005|Overall Study|Death|3|||
13252868|NCT01546038|26375523|FG006|Overall Study|Death|46|||
13252869|NCT01546038|26375524|FG007|Overall Study|Death|76|||
13252870|NCT01546038|26375525|FG008|Overall Study|Death|39|||
13252871|NCT01546038|26375517|FG000|Overall Study|Lost to Follow-up|0|||
13252872|NCT01546038|26375518|FG001|Overall Study|Lost to Follow-up|0|||
13252873|NCT01546038|26375519|FG002|Overall Study|Lost to Follow-up|0|||
13252874|NCT01546038|26375520|FG003|Overall Study|Lost to Follow-up|0|||
13116726|NCT03073200|25923197|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
13116727|NCT03073200|25923198|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
13116728|NCT03073200|25923199|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
13116729|NCT03073200|25923200|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
13116730|NCT03073200|25923201|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
13116731|NCT03073200|25923202|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
13116732|NCT03073200|25923203|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
13116733|NCT03073200|25923204|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
13116734|NCT03073200|25923205|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0|||
13116735|NCT03073200|25923191|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
13116736|NCT03073200|25923192|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
13116737|NCT03073200|25923193|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
13116738|NCT03073200|25923194|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
13116739|NCT03073200|25923195|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
13116740|NCT03073200|25923196|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
13116741|NCT03073200|25923197|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
13116742|NCT03073200|25923198|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
13116743|NCT03073200|25923199|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
13116744|NCT03073200|25923200|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
13116745|NCT03073200|25923201|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
13116746|NCT03073200|25923202|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
13116747|NCT03073200|25923203|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
13116748|NCT03073200|25923204|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
13116749|NCT03073200|25923205|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1|||
13116750|NCT03073200|25923191|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
13116751|NCT03073200|25923192|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
13116752|NCT03073200|25923193|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
13116753|NCT03073200|25923194|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
13116754|NCT03073200|25923195|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
13116755|NCT03073200|25923196|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
13116756|NCT03073200|25923197|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
13116757|NCT03073200|25923198|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
13116758|NCT03073200|25923199|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
13116759|NCT03073200|25923200|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
13116760|NCT03073200|25923201|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
13116761|NCT03073200|25923202|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
13252875|NCT01546038|26375521|FG004|Overall Study|Lost to Follow-up|1|||
13116762|NCT03073200|25923203|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
13252876|NCT01546038|26375522|FG005|Overall Study|Lost to Follow-up|0|||
13252877|NCT01546038|26375523|FG006|Overall Study|Lost to Follow-up|2|||
13252878|NCT01546038|26375524|FG007|Overall Study|Lost to Follow-up|1|||
13252879|NCT01546038|26375525|FG008|Overall Study|Lost to Follow-up|0|||
13252880|NCT01546038|26375517|FG000|Overall Study|Withdrawal by Subject|1|||
13252881|NCT01546038|26375518|FG001|Overall Study|Withdrawal by Subject|0|||
13252882|NCT01546038|26375519|FG002|Overall Study|Withdrawal by Subject|0|||
13252883|NCT01546038|26375520|FG003|Overall Study|Withdrawal by Subject|1|||
13252884|NCT01546038|26375521|FG004|Overall Study|Withdrawal by Subject|0|||
13252885|NCT01546038|26375522|FG005|Overall Study|Withdrawal by Subject|1|||
13252886|NCT01546038|26375523|FG006|Overall Study|Withdrawal by Subject|3|||
13252887|NCT01546038|26375524|FG007|Overall Study|Withdrawal by Subject|3|||
13252888|NCT01546038|26375525|FG008|Overall Study|Withdrawal by Subject|1|||
13252889|NCT01546038|26375517|FG000|Overall Study|: Randomized, not treated|0|||
13252890|NCT01546038|26375518|FG001|Overall Study|: Randomized, not treated|0|||
13252891|NCT01546038|26375519|FG002|Overall Study|: Randomized, not treated|0|||
13252892|NCT01546038|26375520|FG003|Overall Study|: Randomized, not treated|0|||
13252893|NCT01546038|26375521|FG004|Overall Study|: Randomized, not treated|0|||
13252894|NCT01546038|26375522|FG005|Overall Study|: Randomized, not treated|0|||
13252895|NCT01546038|26375523|FG006|Overall Study|: Randomized, not treated|2|||
13252896|NCT01546038|26375524|FG007|Overall Study|: Randomized, not treated|4|||
13252897|NCT01546038|26375525|FG008|Overall Study|: Randomized, not treated|3|||
13252898|NCT01545934|26375546|FG000|Overall Study|Withdrawal by Subject|4|||
13252899|NCT01545934|26375547|FG001|Overall Study|Withdrawal by Subject|3|||
13252900|NCT01545934|26375546|FG000|Overall Study|Lost to Follow-up|1|||
13252901|NCT01545934|26375547|FG001|Overall Study|Lost to Follow-up|0|||
13252902|NCT01545817|26375561|FG000|Pazopanib|Disease progression|51|||
13252903|NCT01545817|26375562|FG001|Pazopanib|Disease progression|0|||
13252904|NCT01545817|26375561|FG000|Pazopanib|Adverse Event|19|||
13252905|NCT01545817|26375562|FG001|Pazopanib|Adverse Event|0|||
13252906|NCT01545817|26375561|FG000|Pazopanib|Other reason|4|||
13252907|NCT01545817|26375562|FG001|Pazopanib|Other reason|0|||
13252908|NCT01545817|26375561|FG000|Everolimus|Other reason|0|||
13252909|NCT01545817|26375562|FG001|Everolimus|Other reason|7|||
13252910|NCT01545817|26375561|FG000|Everolimus|Disease progression|0|||
13252911|NCT01545817|26375562|FG001|Everolimus|Disease progression|25|||
13252912|NCT01545817|26375561|FG000|Everolimus|Adverse Event|0|||
13252913|NCT01545817|26375562|FG001|Everolimus|Adverse Event|6|||
13252914|NCT01545388|26375589|FG000|Overall Study|Adverse Event|2|||
13252915|NCT01545388|26375590|FG001|Overall Study|Adverse Event|4|||
13252916|NCT01545388|26375591|FG002|Overall Study|Adverse Event|1|||
13252917|NCT01545388|26375589|FG000|Overall Study|Lack of Efficacy|3|||
13252918|NCT01545388|26375590|FG001|Overall Study|Lack of Efficacy|2|||
13116763|NCT03073200|25923204|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11|||
13116764|NCT03073200|25923205|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
13116765|NCT03073200|25923191|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
13116766|NCT03073200|25923192|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
13116767|NCT03073200|25923193|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
13116768|NCT03073200|25923194|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
13116769|NCT03073200|25923195|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
13116770|NCT03073200|25923196|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
13116771|NCT03073200|25923197|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
13116772|NCT03073200|25923198|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
13252919|NCT01545388|26375591|FG002|Overall Study|Lack of Efficacy|5|||
13252920|NCT01545388|26375589|FG000|Overall Study|Participant moved or relocated|1|||
13252921|NCT01545388|26375590|FG001|Overall Study|Participant moved or relocated|0|||
13252922|NCT01545388|26375591|FG002|Overall Study|Participant moved or relocated|0|||
13252923|NCT01545388|26375589|FG000|Overall Study|Withdrawal by Subject|1|||
13252924|NCT01545388|26375590|FG001|Overall Study|Withdrawal by Subject|4|||
13252925|NCT01545388|26375591|FG002|Overall Study|Withdrawal by Subject|2|||
13252926|NCT01545388|26375589|FG000|Overall Study|Other|1|||
13252927|NCT01545388|26375590|FG001|Overall Study|Other|1|||
13252928|NCT01545388|26375591|FG002|Overall Study|Other|0|||
13252929|NCT01545375|26375652|FG000|Overall Study|Adverse Event|2|||
13252930|NCT01545375|26375653|FG001|Overall Study|Adverse Event|1|||
13252931|NCT01545375|26375652|FG000|Overall Study|Lost to Follow-up|34|||
13252932|NCT01545375|26375653|FG001|Overall Study|Lost to Follow-up|31|||
13252933|NCT01545375|26375652|FG000|Overall Study|Protocol Violation|3|||
13252934|NCT01545375|26375653|FG001|Overall Study|Protocol Violation|3|||
13252935|NCT01545375|26375652|FG000|Overall Study|Withdrawal by Subject|58|||
13252936|NCT01545375|26375653|FG001|Overall Study|Withdrawal by Subject|55|||
13252937|NCT01545076|26375709|FG000|IgPro10 Restabilization Period|Adverse Event|4|||
13252938|NCT01545076|26375710|FG001|IgPro10 Restabilization Period|Adverse Event|0|||
13252939|NCT01545076|26375711|FG002|IgPro10 Restabilization Period|Adverse Event|0|||
13252940|NCT01545076|26375712|FG003|IgPro10 Restabilization Period|Adverse Event|0|||
13252941|NCT01545076|26375713|FG004|IgPro10 Restabilization Period|Adverse Event|0|||
13252942|NCT01545076|26375709|FG000|IgPro10 Restabilization Period|Physician Decision|2|||
13252943|NCT01545076|26375710|FG001|IgPro10 Restabilization Period|Physician Decision|0|||
13252944|NCT01545076|26375711|FG002|IgPro10 Restabilization Period|Physician Decision|0|||
13252945|NCT01545076|26375712|FG003|IgPro10 Restabilization Period|Physician Decision|0|||
13252946|NCT01545076|26375713|FG004|IgPro10 Restabilization Period|Physician Decision|0|||
13252947|NCT01545076|26375709|FG000|IgPro10 Restabilization Period|Protocol Violation|1|||
13252948|NCT01545076|26375710|FG001|IgPro10 Restabilization Period|Protocol Violation|0|||
13252949|NCT01545076|26375711|FG002|IgPro10 Restabilization Period|Protocol Violation|0|||
13252950|NCT01545076|26375712|FG003|IgPro10 Restabilization Period|Protocol Violation|0|||
13252951|NCT01545076|26375713|FG004|IgPro10 Restabilization Period|Protocol Violation|0|||
13252952|NCT01545076|26375709|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22|||
13252953|NCT01545076|26375710|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
13252954|NCT01545076|26375711|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
13252955|NCT01545076|26375712|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
13252956|NCT01545076|26375713|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
13252957|NCT01545076|26375709|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7|||
13252958|NCT01545076|26375710|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
13252959|NCT01545076|26375711|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
13252960|NCT01545076|26375712|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
13252961|NCT01545076|26375713|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
13252962|NCT01545076|26375709|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
13252963|NCT01545076|26375710|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
13252964|NCT01545076|26375711|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
13252965|NCT01545076|26375712|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1|||
13252966|NCT01545076|26375713|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
13252967|NCT01545076|26375709|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
13252968|NCT01545076|26375710|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10|||
13252969|NCT01545076|26375711|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18|||
13252970|NCT01545076|26375712|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32|||
13252971|NCT01545076|26375713|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
13252972|NCT01545076|26375709|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
13252973|NCT01545076|26375710|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
13252974|NCT01545076|26375711|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
13252975|NCT01545076|26375712|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
13252976|NCT01545076|26375713|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
13252977|NCT01545076|26375709|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
13252978|NCT01545076|26375710|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8|||
13252979|NCT01545076|26375711|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2|||
13252980|NCT01545076|26375712|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3|||
13252981|NCT01545076|26375713|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
13252982|NCT01544920|26375728|FG000|Overall Study|Adverse Event|0|||
13252983|NCT01544920|26375729|FG001|Overall Study|Adverse Event|3|||
13252984|NCT01544920|26375728|FG000|Overall Study|Death|0|||
13252985|NCT01544920|26375729|FG001|Overall Study|Death|1|||
13252986|NCT01544920|26375728|FG000|Overall Study|Lost to Follow-up|11|||
13252987|NCT01544920|26375729|FG001|Overall Study|Lost to Follow-up|12|||
13252988|NCT01544920|26375728|FG000|Overall Study|Protocol Violation|0|||
13252989|NCT01544920|26375729|FG001|Overall Study|Protocol Violation|2|||
13252990|NCT01544920|26375728|FG000|Overall Study|Physician Decision|4|||
13252991|NCT01544920|26375729|FG001|Overall Study|Physician Decision|1|||
13252992|NCT01544920|26375728|FG000|Overall Study|Withdrawal by Subject|4|||
13252993|NCT01544920|26375729|FG001|Overall Study|Withdrawal by Subject|4|||
13252994|NCT01544595|26375821|FG000|Status at Week 68|Adverse Event|3|||
13252995|NCT01544595|26375822|FG001|Status at Week 68|Adverse Event|2|||
13252996|NCT01544595|26375823|FG002|Status at Week 68|Adverse Event|1|||
13252997|NCT01544595|26375824|FG003|Status at Week 68|Adverse Event|0|||
13252998|NCT01544595|26375825|FG004|Status at Week 68|Adverse Event|0|||
13252999|NCT01544595|26375826|FG005|Status at Week 68|Adverse Event|0|||
13253000|NCT01544595|26375821|FG000|Status at Week 68|Lack of Efficacy|1|||
13253001|NCT01544595|26375822|FG001|Status at Week 68|Lack of Efficacy|0|||
13253002|NCT01544595|26375823|FG002|Status at Week 68|Lack of Efficacy|0|||
13253003|NCT01544595|26375824|FG003|Status at Week 68|Lack of Efficacy|0|||
13253004|NCT01544595|26375825|FG004|Status at Week 68|Lack of Efficacy|0|||
13253005|NCT01544595|26375826|FG005|Status at Week 68|Lack of Efficacy|0|||
13253006|NCT01544595|26375821|FG000|Status at Week 68|Lost to Follow-up|1|||
13253007|NCT01544595|26375822|FG001|Status at Week 68|Lost to Follow-up|1|||
13253008|NCT01544595|26375823|FG002|Status at Week 68|Lost to Follow-up|0|||
13253009|NCT01544595|26375824|FG003|Status at Week 68|Lost to Follow-up|0|||
13253010|NCT01544595|26375825|FG004|Status at Week 68|Lost to Follow-up|0|||
13253011|NCT01544595|26375826|FG005|Status at Week 68|Lost to Follow-up|0|||
13253012|NCT01544595|26375821|FG000|Status at Week 68|Non-compliance with study treatment|1|||
13253013|NCT01544595|26375822|FG001|Status at Week 68|Non-compliance with study treatment|0|||
13253014|NCT01544595|26375823|FG002|Status at Week 68|Non-compliance with study treatment|0|||
13253015|NCT01544595|26375824|FG003|Status at Week 68|Non-compliance with study treatment|1|||
13253016|NCT01544595|26375825|FG004|Status at Week 68|Non-compliance with study treatment|0|||
13253017|NCT01544595|26375826|FG005|Status at Week 68|Non-compliance with study treatment|0|||
13253018|NCT01544595|26375821|FG000|Status at Week 68|Protocol Violation|2|||
13253019|NCT01544595|26375822|FG001|Status at Week 68|Protocol Violation|0|||
13253020|NCT01544595|26375823|FG002|Status at Week 68|Protocol Violation|1|||
13253021|NCT01544595|26375824|FG003|Status at Week 68|Protocol Violation|1|||
13253022|NCT01544595|26375825|FG004|Status at Week 68|Protocol Violation|0|||
13253023|NCT01544595|26375826|FG005|Status at Week 68|Protocol Violation|0|||
13253024|NCT01544595|26375821|FG000|Status at Week 68|Technical problems|1|||
13253025|NCT01544595|26375822|FG001|Status at Week 68|Technical problems|0|||
13253026|NCT01544595|26375823|FG002|Status at Week 68|Technical problems|0|||
13253027|NCT01544595|26375824|FG003|Status at Week 68|Technical problems|1|||
13253028|NCT01544595|26375825|FG004|Status at Week 68|Technical problems|0|||
13253029|NCT01544595|26375826|FG005|Status at Week 68|Technical problems|0|||
13253030|NCT01544595|26375821|FG000|Status at Week 68|Withdrawal by Subject|0|||
13253031|NCT01544595|26375822|FG001|Status at Week 68|Withdrawal by Subject|1|||
13253032|NCT01544595|26375823|FG002|Status at Week 68|Withdrawal by Subject|1|||
13253033|NCT01544595|26375824|FG003|Status at Week 68|Withdrawal by Subject|2|||
13253034|NCT01544595|26375825|FG004|Status at Week 68|Withdrawal by Subject|0|||
13253035|NCT01544595|26375826|FG005|Status at Week 68|Withdrawal by Subject|0|||
13485863|NCT02555657|27033646|FG000|Overall Study|Death|274|||
13253036|NCT01544595|26375821|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30|||
13253037|NCT01544595|26375822|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13|||
13253038|NCT01544595|26375823|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60|||
13253039|NCT01544595|26375824|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46|||
13253040|NCT01544595|26375825|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
13253041|NCT01544595|26375826|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
13253042|NCT01544595|26375821|FG000|Status at Week 156|Withdrawal by Subject|9|||
13253043|NCT01544595|26375822|FG001|Status at Week 156|Withdrawal by Subject|10|||
13253044|NCT01544595|26375823|FG002|Status at Week 156|Withdrawal by Subject|4|||
13253045|NCT01544595|26375824|FG003|Status at Week 156|Withdrawal by Subject|9|||
13253046|NCT01544595|26375825|FG004|Status at Week 156|Withdrawal by Subject|20|||
13253047|NCT01544595|26375826|FG005|Status at Week 156|Withdrawal by Subject|6|||
13253048|NCT01544595|26375821|FG000|Status at Week 156|Adverse Event|9|||
13253049|NCT01544595|26375822|FG001|Status at Week 156|Adverse Event|11|||
13253050|NCT01544595|26375823|FG002|Status at Week 156|Adverse Event|1|||
13253051|NCT01544595|26375824|FG003|Status at Week 156|Adverse Event|3|||
13253052|NCT01544595|26375825|FG004|Status at Week 156|Adverse Event|4|||
13253053|NCT01544595|26375826|FG005|Status at Week 156|Adverse Event|2|||
13253054|NCT01544595|26375821|FG000|Status at Week 156|Lost to Follow-up|4|||
13253055|NCT01544595|26375822|FG001|Status at Week 156|Lost to Follow-up|4|||
13253056|NCT01544595|26375823|FG002|Status at Week 156|Lost to Follow-up|0|||
13253057|NCT01544595|26375824|FG003|Status at Week 156|Lost to Follow-up|1|||
13253058|NCT01544595|26375825|FG004|Status at Week 156|Lost to Follow-up|4|||
13253059|NCT01544595|26375826|FG005|Status at Week 156|Lost to Follow-up|1|||
13253060|NCT01544595|26375821|FG000|Status at Week 156|Non-compliance with study treatement|0|||
13253061|NCT01544595|26375822|FG001|Status at Week 156|Non-compliance with study treatement|1|||
13253062|NCT01544595|26375823|FG002|Status at Week 156|Non-compliance with study treatement|0|||
13253063|NCT01544595|26375824|FG003|Status at Week 156|Non-compliance with study treatement|1|||
13253064|NCT01544595|26375825|FG004|Status at Week 156|Non-compliance with study treatement|0|||
13253065|NCT01544595|26375826|FG005|Status at Week 156|Non-compliance with study treatement|1|||
13253066|NCT01544595|26375821|FG000|Status at Week 156|Physician Decision|0|||
13253067|NCT01544595|26375822|FG001|Status at Week 156|Physician Decision|3|||
13253068|NCT01544595|26375823|FG002|Status at Week 156|Physician Decision|1|||
13253069|NCT01544595|26375824|FG003|Status at Week 156|Physician Decision|0|||
13253070|NCT01544595|26375825|FG004|Status at Week 156|Physician Decision|0|||
13253071|NCT01544595|26375826|FG005|Status at Week 156|Physician Decision|0|||
13253072|NCT01544595|26375821|FG000|Status at Week 156|Pregnancy|2|||
13253073|NCT01544595|26375822|FG001|Status at Week 156|Pregnancy|3|||
13253074|NCT01544595|26375823|FG002|Status at Week 156|Pregnancy|0|||
13253075|NCT01544595|26375824|FG003|Status at Week 156|Pregnancy|0|||
13253076|NCT01544595|26375825|FG004|Status at Week 156|Pregnancy|0|||
13253077|NCT01544595|26375826|FG005|Status at Week 156|Pregnancy|0|||
13253078|NCT01544595|26375821|FG000|Status at Week 156|Protocol Violation|3|||
13253079|NCT01544595|26375822|FG001|Status at Week 156|Protocol Violation|1|||
13253080|NCT01544595|26375823|FG002|Status at Week 156|Protocol Violation|2|||
13253081|NCT01544595|26375824|FG003|Status at Week 156|Protocol Violation|2|||
13253082|NCT01544595|26375825|FG004|Status at Week 156|Protocol Violation|0|||
13253083|NCT01544595|26375826|FG005|Status at Week 156|Protocol Violation|0|||
13253084|NCT01544595|26375821|FG000|Status at Week 156|Technical problems|3|||
13253085|NCT01544595|26375822|FG001|Status at Week 156|Technical problems|1|||
13253086|NCT01544595|26375823|FG002|Status at Week 156|Technical problems|0|||
13253087|NCT01544595|26375824|FG003|Status at Week 156|Technical problems|1|||
13253088|NCT01544595|26375825|FG004|Status at Week 156|Technical problems|0|||
13253089|NCT01544595|26375826|FG005|Status at Week 156|Technical problems|0|||
13253090|NCT01544595|26375821|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86|||
13253091|NCT01544595|26375822|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44|||
13253092|NCT01544595|26375823|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131|||
13253093|NCT01544595|26375824|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145|||
13253094|NCT01544595|26375825|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
13253095|NCT01544595|26375826|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
13253096|NCT01544595|26375821|FG000|Status at Week 156|Lack of Efficacy|1|||
13253097|NCT01544595|26375822|FG001|Status at Week 156|Lack of Efficacy|0|||
13253098|NCT01544595|26375823|FG002|Status at Week 156|Lack of Efficacy|1|||
13253099|NCT01544595|26375824|FG003|Status at Week 156|Lack of Efficacy|4|||
13253100|NCT01544595|26375825|FG004|Status at Week 156|Lack of Efficacy|10|||
13253101|NCT01544595|26375826|FG005|Status at Week 156|Lack of Efficacy|5|||
13253102|NCT01544582|26375895|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1|||
13253103|NCT01544582|26375896|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0|||
13253104|NCT01544582|26375897|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0|||
13253105|NCT01544582|26375898|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0|||
13253106|NCT01544582|26375895|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33|||
13253107|NCT01544582|26375896|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0|||
13485864|NCT02555657|27033647|FG001|Overall Study|Death|262|||
13253108|NCT01544582|26375897|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0|||
13253109|NCT01544582|26375898|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0|||
13253110|NCT01544582|26375895|FG000|Analysis Population|Participant Refuses to Continue Study|0|||
13253111|NCT01544582|26375896|FG001|Analysis Population|Participant Refuses to Continue Study|15|||
13253112|NCT01544582|26375897|FG002|Analysis Population|Participant Refuses to Continue Study|17|||
13253113|NCT01544582|26375898|FG003|Analysis Population|Participant Refuses to Continue Study|4|||
13253114|NCT01544582|26375895|FG000|Analysis Population|Physician Decision|0|||
13253115|NCT01544582|26375896|FG001|Analysis Population|Physician Decision|13|||
13253116|NCT01544582|26375897|FG002|Analysis Population|Physician Decision|10|||
13253117|NCT01544582|26375898|FG003|Analysis Population|Physician Decision|9|||
13253118|NCT01544582|26375895|FG000|Analysis Population|Safety Reason|0|||
13253119|NCT01544582|26375896|FG001|Analysis Population|Safety Reason|33|||
13253120|NCT01544582|26375897|FG002|Analysis Population|Safety Reason|31|||
13253121|NCT01544582|26375898|FG003|Analysis Population|Safety Reason|8|||
13253122|NCT01544582|26375895|FG000|Analysis Population|Effectiveness Reason|0|||
13253123|NCT01544582|26375896|FG001|Analysis Population|Effectiveness Reason|48|||
13253124|NCT01544582|26375897|FG002|Analysis Population|Effectiveness Reason|29|||
13253125|NCT01544582|26375898|FG003|Analysis Population|Effectiveness Reason|12|||
13253126|NCT01544582|26375895|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0|||
13253127|NCT01544582|26375896|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0|||
13253128|NCT01544582|26375897|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0|||
13253129|NCT01544582|26375898|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1|||
13253130|NCT01544582|26375895|FG000|Analysis Population|Lost to Follow-up|0|||
13253131|NCT01544582|26375896|FG001|Analysis Population|Lost to Follow-up|6|||
13253132|NCT01544582|26375897|FG002|Analysis Population|Lost to Follow-up|6|||
13253133|NCT01544582|26375898|FG003|Analysis Population|Lost to Follow-up|5|||
13253134|NCT01544582|26375895|FG000|Analysis Population|Bad Tolerance to Treatment|0|||
13253135|NCT01544582|26375896|FG001|Analysis Population|Bad Tolerance to Treatment|0|||
13253136|NCT01544582|26375897|FG002|Analysis Population|Bad Tolerance to Treatment|2|||
13253137|NCT01544582|26375898|FG003|Analysis Population|Bad Tolerance to Treatment|0|||
13253138|NCT01544582|26375895|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0|||
13253139|NCT01544582|26375896|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0|||
13253140|NCT01544582|26375897|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3|||
13253141|NCT01544582|26375898|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0|||
13253142|NCT01544582|26375895|FG000|Analysis Population|Intolerance|0|||
13253143|NCT01544582|26375896|FG001|Analysis Population|Intolerance|1|||
13253144|NCT01544582|26375897|FG002|Analysis Population|Intolerance|0|||
13253145|NCT01544582|26375898|FG003|Analysis Population|Intolerance|0|||
13253146|NCT01544582|26375895|FG000|Analysis Population|Liver Transplantation|0|||
13253147|NCT01544582|26375896|FG001|Analysis Population|Liver Transplantation|0|||
13253148|NCT01544582|26375897|FG002|Analysis Population|Liver Transplantation|1|||
13253149|NCT01544582|26375898|FG003|Analysis Population|Liver Transplantation|0|||
13253150|NCT01544582|26375895|FG000|Analysis Population|No Social Insurance|0|||
13253151|NCT01544582|26375896|FG001|Analysis Population|No Social Insurance|0|||
13253152|NCT01544582|26375897|FG002|Analysis Population|No Social Insurance|1|||
13253153|NCT01544582|26375898|FG003|Analysis Population|No Social Insurance|0|||
13253154|NCT01544582|26375895|FG000|Analysis Population|Poor Adherence|0|||
13253155|NCT01544582|26375896|FG001|Analysis Population|Poor Adherence|0|||
13253156|NCT01544582|26375897|FG002|Analysis Population|Poor Adherence|1|||
13253157|NCT01544582|26375898|FG003|Analysis Population|Poor Adherence|0|||
13253158|NCT01544582|26375895|FG000|Analysis Population|Poor Participant Compliance|0|||
13253159|NCT01544582|26375896|FG001|Analysis Population|Poor Participant Compliance|1|||
13116773|NCT03073200|25923199|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
13116774|NCT03073200|25923200|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
13116775|NCT03073200|25923201|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
13116776|NCT03073200|25923202|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
13116777|NCT03073200|25923203|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
13116778|NCT03073200|25923204|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9|||
13116779|NCT03073200|25923205|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
13116780|NCT03073200|25923191|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
13116781|NCT03073200|25923192|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
13116782|NCT03073200|25923193|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
13116783|NCT03073200|25923194|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
13116784|NCT03073200|25923195|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
13116785|NCT03073200|25923196|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
13116786|NCT03073200|25923197|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
13116787|NCT03073200|25923198|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
13116788|NCT03073200|25923199|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
13116789|NCT03073200|25923200|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
13116790|NCT03073200|25923201|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
13116791|NCT03073200|25923202|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
13116792|NCT03073200|25923203|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
13253160|NCT01544582|26375897|FG002|Analysis Population|Poor Participant Compliance|0|||
13253161|NCT01544582|26375898|FG003|Analysis Population|Poor Participant Compliance|0|||
13253162|NCT01544582|26375895|FG000|Analysis Population|Programmed Surgery|0|||
13253163|NCT01544582|26375896|FG001|Analysis Population|Programmed Surgery|1|||
13253164|NCT01544582|26375897|FG002|Analysis Population|Programmed Surgery|0|||
13253165|NCT01544582|26375898|FG003|Analysis Population|Programmed Surgery|0|||
13253166|NCT01544582|26375895|FG000|Analysis Population|Participant in Jail|0|||
13253167|NCT01544582|26375896|FG001|Analysis Population|Participant in Jail|0|||
13253168|NCT01544582|26375897|FG002|Analysis Population|Participant in Jail|1|||
13253169|NCT01544582|26375898|FG003|Analysis Population|Participant in Jail|0|||
13253170|NCT01544491|26375931|FG000|Overall Study|Withdrawal by Subject|3|||
13253171|NCT01544491|26375932|FG001|Overall Study|Withdrawal by Subject|2|||
13253172|NCT01544491|26375931|FG000|Overall Study|Lost to Follow-up|0|||
13253173|NCT01544491|26375932|FG001|Overall Study|Lost to Follow-up|1|||
13253174|NCT01544491|26375931|FG000|Overall Study|administrative problems|2|||
13253175|NCT01544491|26375932|FG001|Overall Study|administrative problems|0|||
13253176|NCT01544478|26375938|FG000|Overall Study|Adverse Event|1|||
13253177|NCT01544478|26375938|FG000|Overall Study|Death|1|||
13253178|NCT01544478|26375938|FG000|Overall Study|Lost to Follow-up|48|||
13253179|NCT01544478|26375938|FG000|Overall Study|Physician Decision|15|||
13253180|NCT01544478|26375938|FG000|Overall Study|Pregnancy|1|||
13253181|NCT01544478|26375938|FG000|Overall Study|Withdrawal by Subject|52|||
13253182|NCT01544348|26376003|FG000|Overall Study|Lost to Follow-up|1|||
13253183|NCT01544348|26376004|FG001|Overall Study|Lost to Follow-up|0|||
13253184|NCT01544348|26376005|FG002|Overall Study|Lost to Follow-up|0|||
13253185|NCT01544348|26376006|FG003|Overall Study|Lost to Follow-up|0|||
13253186|NCT01544348|26376007|FG004|Overall Study|Lost to Follow-up|0|||
13253187|NCT01544348|26376008|FG005|Overall Study|Lost to Follow-up|0|||
13253188|NCT01544348|26376009|FG006|Overall Study|Lost to Follow-up|1|||
13253189|NCT01544348|26376010|FG007|Overall Study|Lost to Follow-up|0|||
13253190|NCT01544348|26376003|FG000|Overall Study|Withdrawal by Subject|1|||
13253191|NCT01544348|26376004|FG001|Overall Study|Withdrawal by Subject|0|||
13253192|NCT01544348|26376005|FG002|Overall Study|Withdrawal by Subject|0|||
13253193|NCT01544348|26376006|FG003|Overall Study|Withdrawal by Subject|0|||
13253194|NCT01544348|26376007|FG004|Overall Study|Withdrawal by Subject|1|||
13253195|NCT01544348|26376008|FG005|Overall Study|Withdrawal by Subject|2|||
13253196|NCT01544348|26376009|FG006|Overall Study|Withdrawal by Subject|1|||
13253197|NCT01544348|26376010|FG007|Overall Study|Withdrawal by Subject|0|||
13253198|NCT01544348|26376003|FG000|Overall Study|Physician Decision|0|||
13253199|NCT01544348|26376004|FG001|Overall Study|Physician Decision|0|||
13253200|NCT01544348|26376005|FG002|Overall Study|Physician Decision|0|||
13253201|NCT01544348|26376006|FG003|Overall Study|Physician Decision|0|||
13253202|NCT01544348|26376007|FG004|Overall Study|Physician Decision|0|||
13253203|NCT01544348|26376008|FG005|Overall Study|Physician Decision|1|||
13253204|NCT01544348|26376009|FG006|Overall Study|Physician Decision|0|||
13253205|NCT01544348|26376010|FG007|Overall Study|Physician Decision|0|||
13253206|NCT01544335|26376017|FG000|Overall Study|Lost to Follow-up|27|||
13253207|NCT01544335|26376017|FG000|Overall Study|Death|4|||
13253208|NCT01544335|26376017|FG000|Overall Study|Disease progression|3|||
13253209|NCT01544335|26376017|FG000|Overall Study|Baseline Measurements not Available|19|||
13253210|NCT01544309|26376060|FG000|Overall Study|Withdrawal by Subject|12|||
13253211|NCT01544309|26376061|FG001|Overall Study|Withdrawal by Subject|7|||
13253212|NCT01544309|26376060|FG000|Overall Study|Protocol Violation|2|||
13253213|NCT01544309|26376061|FG001|Overall Study|Protocol Violation|1|||
13253214|NCT01544309|26376060|FG000|Overall Study|Physician Decision|4|||
13253215|NCT01544309|26376061|FG001|Overall Study|Physician Decision|1|||
13253216|NCT01544309|26376060|FG000|Overall Study|Not performed pre-dose examination|1|||
13253217|NCT01544309|26376061|FG001|Overall Study|Not performed pre-dose examination|2|||
13253218|NCT01544309|26376060|FG000|Overall Study|Administered prohibit prior medication|1|||
13253219|NCT01544309|26376061|FG001|Overall Study|Administered prohibit prior medication|0|||
13253220|NCT01544179|26376096|FG000|Overall Study|Death|50|||
13253221|NCT01544179|26376097|FG001|Overall Study|Death|37|||
13253222|NCT01544179|26376096|FG000|Overall Study|Lost to Follow-up|0|||
13253223|NCT01544179|26376097|FG001|Overall Study|Lost to Follow-up|1|||
13253224|NCT01544179|26376096|FG000|Overall Study|Adverse Event|0|||
13253225|NCT01544179|26376097|FG001|Overall Study|Adverse Event|1|||
13253226|NCT01544179|26376096|FG000|Overall Study|Withdrawal by Subject|12|||
13253227|NCT01544179|26376097|FG001|Overall Study|Withdrawal by Subject|7|||
13253228|NCT01544179|26376096|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
13253229|NCT01544179|26376097|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
13253230|NCT01544153|26376124|FG000|Overall Study|Under 18|0|||
13253231|NCT01544153|26376125|FG001|Overall Study|Under 18|1|||
13253232|NCT01544153|26376126|FG002|Overall Study|Under 18|0|||
13253233|NCT01544153|26376127|FG003|Overall Study|Under 18|0|||
13253234|NCT01544153|26376124|FG000|Overall Study|Non-smoker|0|||
13253235|NCT01544153|26376125|FG001|Overall Study|Non-smoker|0|||
13253236|NCT01544153|26376126|FG002|Overall Study|Non-smoker|1|||
13253237|NCT01544153|26376127|FG003|Overall Study|Non-smoker|0|||
13253238|NCT01544127|26376154|FG000|Overall Study|Lost to Follow-up|4|||
13253239|NCT01544127|26376155|FG001|Overall Study|Lost to Follow-up|2|||
13253240|NCT01544127|26376156|FG002|Overall Study|Lost to Follow-up|9|||
13253241|NCT01544127|26376154|FG000|Overall Study|Withdrawal by Subject|2|||
13253242|NCT01544127|26376155|FG001|Overall Study|Withdrawal by Subject|2|||
13253243|NCT01544127|26376156|FG002|Overall Study|Withdrawal by Subject|1|||
13253244|NCT01544127|26376154|FG000|Overall Study|Discharged out of catchment area|1|||
13253245|NCT01544127|26376155|FG001|Overall Study|Discharged out of catchment area|1|||
13253246|NCT01544127|26376156|FG002|Overall Study|Discharged out of catchment area|1|||
13253247|NCT01544127|26376154|FG000|Overall Study|Death|1|||
13253248|NCT01544127|26376155|FG001|Overall Study|Death|0|||
13253249|NCT01544127|26376156|FG002|Overall Study|Death|0|||
13253250|NCT01544127|26376154|FG000|Overall Study|Jail or Prison|1|||
13253251|NCT01544127|26376155|FG001|Overall Study|Jail or Prison|1|||
13253252|NCT01544127|26376156|FG002|Overall Study|Jail or Prison|2|||
13253253|NCT01544127|26376154|FG000|Overall Study|Became Psychotic|1|||
13253254|NCT01544127|26376155|FG001|Overall Study|Became Psychotic|0|||
13253255|NCT01544127|26376156|FG002|Overall Study|Became Psychotic|0|||
13253256|NCT01544127|26376154|FG000|Overall Study|Researcher withdrew|1|||
13253257|NCT01544127|26376155|FG001|Overall Study|Researcher withdrew|0|||
13253258|NCT01544127|26376156|FG002|Overall Study|Researcher withdrew|0|||
13253259|NCT01544127|26376154|FG000|Overall Study|Went active duty|0|||
13253260|NCT01544127|26376155|FG001|Overall Study|Went active duty|0|||
13253261|NCT01544127|26376156|FG002|Overall Study|Went active duty|1|||
13290198|NCT00103662|26480875|FG001|Overall Study|Intercurrent illness|0|||
13290199|NCT00103610|26480904|FG000|Overall Study|Entered Rescue Procedure|10|||
13290200|NCT00103610|26480905|FG001|Overall Study|Entered Rescue Procedure|52|||
13290201|NCT00103610|26480904|FG000|Overall Study|Death|16|||
13290202|NCT00103610|26480905|FG001|Overall Study|Death|12|||
13290203|NCT00103610|26480904|FG000|Overall Study|Elective Withdrawal|4|||
13290204|NCT00103610|26480905|FG001|Overall Study|Elective Withdrawal|0|||
13290205|NCT00103610|26480904|FG000|Overall Study|Lost to Follow-up|3|||
13290206|NCT00103610|26480905|FG001|Overall Study|Lost to Follow-up|1|||
13290207|NCT00103610|26480904|FG000|Overall Study|Adverse Event|2|||
13290208|NCT00103610|26480905|FG001|Overall Study|Adverse Event|2|||
13290209|NCT00103610|26480904|FG000|Overall Study|Other|2|||
13290210|NCT00103610|26480905|FG001|Overall Study|Other|7|||
13290211|NCT00103610|26480904|FG000|Overall Study|Failed mobilization|1|||
13290212|NCT00103610|26480905|FG001|Overall Study|Failed mobilization|5|||
13290213|NCT00103610|26480904|FG000|Overall Study|Noncompliance|0|||
13290214|NCT00103610|26480905|FG001|Overall Study|Noncompliance|1|||
13290215|NCT00103506|26480922|FG000|Overall Study|Study closed by sponsor|34|||
13290216|NCT00103506|26480923|FG001|Overall Study|Study closed by sponsor|37|||
13290217|NCT00103506|26480922|FG000|Overall Study|Death|257|||
13290218|NCT00103506|26480923|FG001|Overall Study|Death|253|||
13290219|NCT00103506|26480922|FG000|Overall Study|Lost to Follow-up|13|||
13290220|NCT00103506|26480923|FG001|Overall Study|Lost to Follow-up|13|||
13290221|NCT00103506|26480922|FG000|Overall Study|Withdrawal by Subject|18|||
13290222|NCT00103506|26480923|FG001|Overall Study|Withdrawal by Subject|21|||
13290223|NCT00103311|26480940|FG000|Overall Study|Lost to Follow-up|1|||
13290224|NCT00103311|26480941|FG001|Overall Study|Lost to Follow-up|0|||
13290225|NCT00103311|26480940|FG000|Overall Study|Withdrawal by Subject|2|||
13290226|NCT00103311|26480941|FG001|Overall Study|Withdrawal by Subject|1|||
13290227|NCT00103311|26480940|FG000|Overall Study|Adverse Event|1|||
13290228|NCT00103311|26480941|FG001|Overall Study|Adverse Event|0|||
13290229|NCT00103285|26480977|FG000|Induction|Adverse Event|14|||
13290230|NCT00103285|26480978|FG001|Induction|Adverse Event|0|||
13290231|NCT00103285|26480979|FG002|Induction|Adverse Event|0|||
13290232|NCT00103285|26480980|FG003|Induction|Adverse Event|0|||
13290233|NCT00103285|26480981|FG004|Induction|Adverse Event|0|||
13290234|NCT00103285|26480982|FG005|Induction|Adverse Event|0|||
13290235|NCT00103285|26480983|FG006|Induction|Adverse Event|0|||
13290236|NCT00103285|26480984|FG007|Induction|Adverse Event|0|||
13290237|NCT00103285|26480977|FG000|Induction|Death|24|||
13290238|NCT00103285|26480978|FG001|Induction|Death|0|||
13290239|NCT00103285|26480979|FG002|Induction|Death|0|||
13290240|NCT00103285|26480980|FG003|Induction|Death|0|||
13290241|NCT00103285|26480981|FG004|Induction|Death|0|||
13290242|NCT00103285|26480982|FG005|Induction|Death|0|||
13290243|NCT00103285|26480983|FG006|Induction|Death|0|||
13290244|NCT00103285|26480984|FG007|Induction|Death|0|||
13290245|NCT00103285|26480977|FG000|Induction|Physician Decision|103|||
13290246|NCT00103285|26480978|FG001|Induction|Physician Decision|0|||
13290247|NCT00103285|26480979|FG002|Induction|Physician Decision|0|||
13290248|NCT00103285|26480980|FG003|Induction|Physician Decision|0|||
13290249|NCT00103285|26480981|FG004|Induction|Physician Decision|0|||
13290250|NCT00103285|26480982|FG005|Induction|Physician Decision|0|||
13290251|NCT00103285|26480983|FG006|Induction|Physician Decision|0|||
13290252|NCT00103285|26480984|FG007|Induction|Physician Decision|0|||
13290253|NCT00103285|26480977|FG000|Induction|Withdrawal by Subject|1|||
13290254|NCT00103285|26480978|FG001|Induction|Withdrawal by Subject|0|||
13253262|NCT01544114|26376195|FG000|Overall Study|Withdrawal by Subject|0|||
13253263|NCT01544114|26376196|FG001|Overall Study|Withdrawal by Subject|0|||
13253264|NCT01544114|26376197|FG002|Overall Study|Withdrawal by Subject|3|||
13253265|NCT01544114|26376195|FG000|Overall Study|Lost to Follow-up|0|||
13253266|NCT01544114|26376196|FG001|Overall Study|Lost to Follow-up|2|||
13253267|NCT01544114|26376197|FG002|Overall Study|Lost to Follow-up|0|||
13253268|NCT01544114|26376195|FG000|Overall Study|Adverse Event|1|||
13253269|NCT01544114|26376196|FG001|Overall Study|Adverse Event|1|||
13253270|NCT01544114|26376197|FG002|Overall Study|Adverse Event|2|||
13253271|NCT01544114|26376195|FG000|Overall Study|Protocol Violation|0|||
13253272|NCT01544114|26376196|FG001|Overall Study|Protocol Violation|1|||
13253273|NCT01544114|26376197|FG002|Overall Study|Protocol Violation|0|||
13253274|NCT01543958|26376252|FG000|Overall Study|Loss to follow-up|3|||
13253275|NCT01543958|26376252|FG000|Overall Study|ART initiation|1|||
13253276|NCT01543828|26376267|FG000|Treatment 2|Lost to Follow-up|1|||
13253277|NCT01543828|26376268|FG001|Treatment 2|Lost to Follow-up|0|||
13253278|NCT01543776|26376289|FG000|Overall Study|Withdrawal by Subject|2|||
13253279|NCT01543776|26376290|FG001|Overall Study|Withdrawal by Subject|2|||
13253280|NCT01543685|26376353|FG000|Overall Study|Lack of Efficacy|1|||
13253281|NCT01543685|26376354|FG001|Overall Study|Lack of Efficacy|2|||
13253282|NCT01543685|26376355|FG002|Overall Study|Lack of Efficacy|2|||
13253283|NCT01543685|26376356|FG003|Overall Study|Lack of Efficacy|0|||
13253284|NCT01543685|26376357|FG004|Overall Study|Lack of Efficacy|2|||
13253285|NCT01543685|26376353|FG000|Overall Study|Adverse Event|2|||
13253286|NCT01543685|26376354|FG001|Overall Study|Adverse Event|1|||
13253287|NCT01543685|26376355|FG002|Overall Study|Adverse Event|0|||
13253288|NCT01543685|26376356|FG003|Overall Study|Adverse Event|0|||
13253289|NCT01543685|26376357|FG004|Overall Study|Adverse Event|2|||
13253290|NCT01543503|26376408|FG000|Overall Study|Lost to Follow-up|32|||
13253291|NCT01543503|26376409|FG001|Overall Study|Lost to Follow-up|36|||
13253292|NCT01543503|26376408|FG000|Overall Study|Adverse Event|9|||
13253293|NCT01543503|26376409|FG001|Overall Study|Adverse Event|13|||
13253294|NCT01543503|26376408|FG000|Overall Study|Lack of Efficacy|4|||
13253295|NCT01543503|26376409|FG001|Overall Study|Lack of Efficacy|16|||
13253296|NCT01543503|26376408|FG000|Overall Study|Participant withdrew informed consent|8|||
13253297|NCT01543503|26376409|FG001|Overall Study|Participant withdrew informed consent|10|||
13253298|NCT01543503|26376408|FG000|Overall Study|Change of jobs|0|||
13253299|NCT01543503|26376409|FG001|Overall Study|Change of jobs|1|||
13253300|NCT01543503|26376408|FG000|Overall Study|Intolerance to the biologic treatment|0|||
13253301|NCT01543503|26376409|FG001|Overall Study|Intolerance to the biologic treatment|1|||
13253302|NCT01543503|26376408|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1|||
13253303|NCT01543503|26376409|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0|||
13253304|NCT01543503|26376408|FG000|Overall Study|Participant did not complete last visit|0|||
13253305|NCT01543503|26376409|FG001|Overall Study|Participant did not complete last visit|2|||
13253306|NCT01543503|26376408|FG000|Overall Study|Refused to continue treatment|7|||
13253307|NCT01543503|26376409|FG001|Overall Study|Refused to continue treatment|0|||
13253308|NCT01543503|26376408|FG000|Overall Study|Incorrect medication received|1|||
13253309|NCT01543503|26376409|FG001|Overall Study|Incorrect medication received|0|||
13253310|NCT01543503|26376408|FG000|Overall Study|Participant moved to another city|2|||
13253311|NCT01543503|26376409|FG001|Overall Study|Participant moved to another city|0|||
13253312|NCT01543503|26376408|FG000|Overall Study|Participant will not return for visits|0|||
13253313|NCT01543503|26376409|FG001|Overall Study|Participant will not return for visits|2|||
13253314|NCT01543503|26376408|FG000|Overall Study|Participant transferred to another city|1|||
13253315|NCT01543503|26376409|FG001|Overall Study|Participant transferred to another city|0|||
13253316|NCT01543503|26376408|FG000|Overall Study|Participant moved to Scotland|1|||
13253317|NCT01543503|26376409|FG001|Overall Study|Participant moved to Scotland|0|||
13253318|NCT01543503|26376408|FG000|Overall Study|Participant decision to stop treatment|1|||
13253319|NCT01543503|26376409|FG001|Overall Study|Participant decision to stop treatment|0|||
13253320|NCT01543503|26376408|FG000|Overall Study|Investigator did not wish to participate|1|||
13253321|NCT01543503|26376409|FG001|Overall Study|Investigator did not wish to participate|1|||
13253322|NCT01543503|26376408|FG000|Overall Study|Participant recruited after closing date|0|||
13253323|NCT01543503|26376409|FG001|Overall Study|Participant recruited after closing date|1|||
13253324|NCT01543503|26376408|FG000|Overall Study|Site stopped participation|5|||
13253325|NCT01543503|26376409|FG001|Overall Study|Site stopped participation|1|||
13253326|NCT01543503|26376408|FG000|Overall Study|Participant did not attend a visit|1|||
13253327|NCT01543503|26376409|FG001|Overall Study|Participant did not attend a visit|0|||
13253328|NCT01543503|26376408|FG000|Overall Study|Moved to other rheumatologic site|0|||
13253329|NCT01543503|26376409|FG001|Overall Study|Moved to other rheumatologic site|1|||
13253330|NCT01543503|26376408|FG000|Overall Study|Participant consented to another study|0|||
13253331|NCT01543503|26376409|FG001|Overall Study|Participant consented to another study|2|||
13253332|NCT01543503|26376408|FG000|Overall Study|Participant went to United States|1|||
13253333|NCT01543503|26376409|FG001|Overall Study|Participant went to United States|0|||
13253334|NCT01543503|26376408|FG000|Overall Study|Screen failure|1|||
13253335|NCT01543503|26376409|FG001|Overall Study|Screen failure|0|||
13253336|NCT01543490|26376424|FG000|Overall Study|Adverse Event|4|||
13253337|NCT01543490|26376425|FG001|Overall Study|Adverse Event|0|||
13253338|NCT01543490|26376424|FG000|Overall Study|Physician Decision|1|||
13253339|NCT01543490|26376425|FG001|Overall Study|Physician Decision|0|||
13253340|NCT01543490|26376424|FG000|Overall Study|Lack of Efficacy|3|||
13253341|NCT01543490|26376425|FG001|Overall Study|Lack of Efficacy|3|||
13253342|NCT01543490|26376424|FG000|Overall Study|Lost to Follow-up|5|||
13253343|NCT01543490|26376425|FG001|Overall Study|Lost to Follow-up|0|||
13253344|NCT01543490|26376424|FG000|Overall Study|Withdrawal by Subject|2|||
13253345|NCT01543490|26376425|FG001|Overall Study|Withdrawal by Subject|0|||
13253346|NCT01543490|26376424|FG000|Overall Study|Other-Various Administrative Reasons|1|||
13253347|NCT01543490|26376425|FG001|Overall Study|Other-Various Administrative Reasons|2|||
13253348|NCT01543204|26376471|FG000|Overall Study|Non-compliance|1|||
13253349|NCT01543204|26376471|FG000|Overall Study|Adverse Event|1|||
13253350|NCT01543204|26376471|FG000|Overall Study|Withdrawal by Subject|4|||
13253351|NCT01543204|26376471|FG000|Overall Study|Requirement for Alternative Therapy|1|||
13253352|NCT01543204|26376471|FG000|Overall Study|Lost to Follow-up|1|||
13253353|NCT01543152|26376514|FG000|Overall Study|Withdrawal by Subject|0|||
13253354|NCT01543152|26376515|FG001|Overall Study|Withdrawal by Subject|2|||
13253355|NCT01543152|26376516|FG002|Overall Study|Withdrawal by Subject|0|||
13253356|NCT01543152|26376517|FG003|Overall Study|Withdrawal by Subject|0|||
13253357|NCT01543152|26376518|FG004|Overall Study|Withdrawal by Subject|0|||
13253358|NCT01543087|26376674|FG000|Stage 1 (48 Months)|Lost to Follow-up|3|||
13253359|NCT01543087|26376675|FG001|Stage 1 (48 Months)|Lost to Follow-up|4|||
13253360|NCT01543087|26376676|FG002|Stage 1 (48 Months)|Lost to Follow-up|12|||
13253361|NCT01543087|26376677|FG003|Stage 1 (48 Months)|Lost to Follow-up|0|||
13253362|NCT01543087|26376678|FG004|Stage 1 (48 Months)|Lost to Follow-up|0|||
13253363|NCT01543087|26376679|FG005|Stage 1 (48 Months)|Lost to Follow-up|0|||
13253364|NCT01543087|26376674|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
13253365|NCT01543087|26376675|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
13253366|NCT01543087|26376676|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
13253367|NCT01543087|26376677|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2|||
13253368|NCT01543087|26376678|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
13253369|NCT01543087|26376679|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
13253370|NCT01543087|26376674|FG000|Stage 1 (48 Months)|No longer willing to participate|5|||
13253371|NCT01543087|26376675|FG001|Stage 1 (48 Months)|No longer willing to participate|3|||
13253372|NCT01543087|26376676|FG002|Stage 1 (48 Months)|No longer willing to participate|18|||
13253373|NCT01543087|26376677|FG003|Stage 1 (48 Months)|No longer willing to participate|6|||
13253374|NCT01543087|26376678|FG004|Stage 1 (48 Months)|No longer willing to participate|3|||
13253375|NCT01543087|26376679|FG005|Stage 1 (48 Months)|No longer willing to participate|0|||
13253376|NCT01543087|26376674|FG000|Stage 1 (48 Months)|Other than specified|5|||
13253377|NCT01543087|26376675|FG001|Stage 1 (48 Months)|Other than specified|0|||
13253378|NCT01543087|26376676|FG002|Stage 1 (48 Months)|Other than specified|9|||
13253379|NCT01543087|26376677|FG003|Stage 1 (48 Months)|Other than specified|0|||
13253380|NCT01543087|26376678|FG004|Stage 1 (48 Months)|Other than specified|0|||
13253381|NCT01543087|26376679|FG005|Stage 1 (48 Months)|Other than specified|0|||
13253382|NCT01543087|26376674|FG000|Stage 1 (48 Months)|Protocol Violation|0|||
13253383|NCT01543087|26376675|FG001|Stage 1 (48 Months)|Protocol Violation|3|||
13253384|NCT01543087|26376676|FG002|Stage 1 (48 Months)|Protocol Violation|0|||
13253385|NCT01543087|26376677|FG003|Stage 1 (48 Months)|Protocol Violation|0|||
13253386|NCT01543087|26376678|FG004|Stage 1 (48 Months)|Protocol Violation|0|||
13253387|NCT01543087|26376679|FG005|Stage 1 (48 Months)|Protocol Violation|0|||
13253388|NCT01543087|26376674|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
13253389|NCT01543087|26376675|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1|||
13253390|NCT01543087|26376676|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
13253391|NCT01543087|26376677|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
13253392|NCT01543087|26376678|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2|||
13253393|NCT01543087|26376679|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
13253394|NCT01543087|26376674|FG000|Booster Stage (26 Months)|Lost to Follow-up|0|||
13253395|NCT01543087|26376675|FG001|Booster Stage (26 Months)|Lost to Follow-up|0|||
13253396|NCT01543087|26376676|FG002|Booster Stage (26 Months)|Lost to Follow-up|1|||
13253397|NCT01543087|26376677|FG003|Booster Stage (26 Months)|Lost to Follow-up|0|||
13253398|NCT01543087|26376678|FG004|Booster Stage (26 Months)|Lost to Follow-up|0|||
13253399|NCT01543087|26376679|FG005|Booster Stage (26 Months)|Lost to Follow-up|0|||
13253400|NCT01542788|26376702|FG000|Overall Study|Randomized but Not Treated|2|||
13253401|NCT01542788|26376703|FG001|Overall Study|Randomized but Not Treated|0|||
13253402|NCT01542788|26376702|FG000|Overall Study|Lack of Efficacy|41|||
13253403|NCT01542788|26376703|FG001|Overall Study|Lack of Efficacy|71|||
13253404|NCT01542788|26376702|FG000|Overall Study|Lost to Follow-up|5|||
13253405|NCT01542788|26376703|FG001|Overall Study|Lost to Follow-up|0|||
13253406|NCT01542788|26376702|FG000|Overall Study|Death|3|||
13253407|NCT01542788|26376703|FG001|Overall Study|Death|0|||
13253408|NCT01542788|26376702|FG000|Overall Study|Protocol Violation|2|||
13253409|NCT01542788|26376703|FG001|Overall Study|Protocol Violation|0|||
13253410|NCT01542788|26376702|FG000|Overall Study|Physician Decision|1|||
13253411|NCT01542788|26376703|FG001|Overall Study|Physician Decision|0|||
13253412|NCT01542788|26376702|FG000|Overall Study|Withdrawal by Subject|1|||
13253413|NCT01542788|26376703|FG001|Overall Study|Withdrawal by Subject|0|||
13253414|NCT01542632|26376766|FG000|Overall Study|Withdrawal of Consent|0|||
13253415|NCT01542632|26376767|FG001|Overall Study|Withdrawal of Consent|0|||
13253416|NCT01542632|26376768|FG002|Overall Study|Withdrawal of Consent|0|||
13253417|NCT01542632|26376769|FG003|Overall Study|Withdrawal of Consent|2|||
13253418|NCT01542632|26376770|FG004|Overall Study|Withdrawal of Consent|3|||
13253419|NCT01542632|26376771|FG005|Overall Study|Withdrawal of Consent|0|||
13253420|NCT01542632|26376766|FG000|Overall Study|Adverse Event|0|||
13253421|NCT01542632|26376767|FG001|Overall Study|Adverse Event|0|||
13253422|NCT01542632|26376768|FG002|Overall Study|Adverse Event|1|||
13253423|NCT01542632|26376769|FG003|Overall Study|Adverse Event|0|||
13253424|NCT01542632|26376770|FG004|Overall Study|Adverse Event|0|||
13253425|NCT01542632|26376771|FG005|Overall Study|Adverse Event|0|||
13253426|NCT01542632|26376766|FG000|Overall Study|Lost to Follow-up|0|||
13253427|NCT01542632|26376767|FG001|Overall Study|Lost to Follow-up|1|||
13253428|NCT01542632|26376768|FG002|Overall Study|Lost to Follow-up|0|||
13253429|NCT01542632|26376769|FG003|Overall Study|Lost to Follow-up|0|||
13253430|NCT01542632|26376770|FG004|Overall Study|Lost to Follow-up|0|||
13253431|NCT01542632|26376771|FG005|Overall Study|Lost to Follow-up|0|||
13253432|NCT01542632|26376766|FG000|Overall Study|Sponsor/Investigator Decision|0|||
13253433|NCT01542632|26376767|FG001|Overall Study|Sponsor/Investigator Decision|0|||
13253434|NCT01542632|26376768|FG002|Overall Study|Sponsor/Investigator Decision|0|||
13253435|NCT01542632|26376769|FG003|Overall Study|Sponsor/Investigator Decision|0|||
13253436|NCT01542632|26376770|FG004|Overall Study|Sponsor/Investigator Decision|1|||
13253437|NCT01542632|26376771|FG005|Overall Study|Sponsor/Investigator Decision|0|||
13253438|NCT01542528|26376786|FG000|Overall Study|Lost to Follow-up|2|||
13253439|NCT01542528|26376787|FG001|Overall Study|Lost to Follow-up|1|||
13253440|NCT01542528|26376786|FG000|Overall Study|Physician Decision|1|||
13253441|NCT01542528|26376787|FG001|Overall Study|Physician Decision|0|||
13253442|NCT01542528|26376786|FG000|Overall Study|Withdrawal by Subject|9|||
13253443|NCT01542528|26376787|FG001|Overall Study|Withdrawal by Subject|6|||
13253444|NCT01542034|26376806|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20|||
13253445|NCT01542034|26376807|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12|||
13253446|NCT01542034|26376806|FG000|Overall Study|Administrative decision|0|||
13253447|NCT01542034|26376807|FG001|Overall Study|Administrative decision|3|||
13253448|NCT01542034|26376806|FG000|Overall Study|Subject Noncompliance|1|||
13253449|NCT01542034|26376807|FG001|Overall Study|Subject Noncompliance|0|||
13253450|NCT01542034|26376806|FG000|Overall Study|Adverse Event|2|||
13253451|NCT01542034|26376807|FG001|Overall Study|Adverse Event|2|||
13253452|NCT01542034|26376806|FG000|Overall Study|Lost to Follow-up|7|||
13253453|NCT01542034|26376807|FG001|Overall Study|Lost to Follow-up|6|||
13253454|NCT01541969|26376830|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0|||
13253455|NCT01541969|26376831|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1|||
13253456|NCT01541969|26376830|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
13253457|NCT01541969|26376831|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
13253458|NCT01541969|26376830|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2|||
13253459|NCT01541969|26376831|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0|||
13253460|NCT01541969|26376830|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1|||
13253461|NCT01541969|26376831|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0|||
13253462|NCT01541969|26376830|FG000|Double-blind (0-12 Weeks)|Adverse Event|2|||
13253463|NCT01541969|26376831|FG001|Double-blind (0-12 Weeks)|Adverse Event|0|||
13253464|NCT01541969|26376830|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
13253465|NCT01541969|26376831|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
13253466|NCT01541969|26376830|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1|||
13253467|NCT01541969|26376831|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0|||
13253468|NCT01541969|26376830|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
13253469|NCT01541969|26376831|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
13253470|NCT01541969|26376830|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6|||
13253471|NCT01541969|26376831|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8|||
13253472|NCT01541969|26376830|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2|||
13253473|NCT01541969|26376831|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3|||
13253474|NCT01541930|26376852|FG000|Overall Study|Withdrawal by Subject|1|||
13253475|NCT01541917|26376877|FG000|Overall Study|Lost to Follow-up|2|||
13253476|NCT01541917|26376878|FG001|Overall Study|Lost to Follow-up|2|||
13253477|NCT01541917|26376877|FG000|Overall Study|Withdrawal by Subject|13|||
13253478|NCT01541917|26376878|FG001|Overall Study|Withdrawal by Subject|7|||
13253479|NCT01541865|26376895|FG000|Overall Study|Lost to Follow-up|11|||
13253480|NCT01541865|26376895|FG000|Overall Study|Withdrawal by Subject|9|||
13253481|NCT01541865|26376895|FG000|Overall Study|Adverse Event|1|||
13116793|NCT03073200|25923204|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2|||
13116794|NCT03073200|25923205|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
13116795|NCT03073109|25923240|FG000|Overall Study|Adverse Event|0|||
13116796|NCT03073109|25923241|FG001|Overall Study|Adverse Event|1|||
13116797|NCT03073109|25923240|FG000|Overall Study|Other|2|||
13116798|NCT03073109|25923241|FG001|Overall Study|Other|0|||
13116799|NCT03073109|25923240|FG000|Overall Study|Lost to Follow-up|8|||
13253482|NCT01541865|26376895|FG000|Overall Study|Protocol Violation|1|||
13253483|NCT01541826|26376972|FG000|Overall Study|Lost to Follow-up|2|||
13253484|NCT01541826|26376973|FG001|Overall Study|Lost to Follow-up|3|||
13116800|NCT03073109|25923241|FG001|Overall Study|Lost to Follow-up|1|||
13253485|NCT01541826|26376974|FG002|Overall Study|Lost to Follow-up|0|||
13253486|NCT01541826|26376972|FG000|Overall Study|Withdrawal by Subject|2|||
13116801|NCT03073005|25923272|FG000|Overall Study|Death|6|||
13116802|NCT03073005|25923273|FG001|Overall Study|Death|0|||
13116803|NCT03073005|25923274|FG002|Overall Study|Death|7|||
13116804|NCT03073005|25923275|FG003|Overall Study|Death|0|||
13116805|NCT03073005|25923272|FG000|Overall Study|caregiver withdrew bc of pt death|0|||
13253487|NCT01541826|26376973|FG001|Overall Study|Withdrawal by Subject|0|||
13253488|NCT01541826|26376974|FG002|Overall Study|Withdrawal by Subject|0|||
13253489|NCT01541748|26376997|FG000|Overall Study|Lost to Follow-up|17|||
13253490|NCT01541748|26376997|FG000|Overall Study|Moved out of state|1|||
13253491|NCT01541748|26376997|FG000|Overall Study|Withdrawal by Subject|7|||
13253492|NCT01541748|26376997|FG000|Overall Study|Screen failure|5|||
13253493|NCT01541748|26376997|FG000|Overall Study|Did not receive study device|1|||
13253494|NCT01541644|26377003|FG000|Overall Study|Withdrawal by Subject|3|||
13253495|NCT01541397|26377022|FG000|Overall Study|Study ended prior to data collection|4|||
13253496|NCT01541397|26377023|FG001|Overall Study|Study ended prior to data collection|2|||
13253497|NCT01541371|26377048|FG000|Overall Study|Withdrawal by Subject|14|||
13253498|NCT01541371|26377048|FG000|Overall Study|Lost to Follow-up|21|||
13253499|NCT01541371|26377048|FG000|Overall Study|Adverse Event|15|||
13253500|NCT01541371|26377048|FG000|Overall Study|Lack of Efficacy|12|||
13253501|NCT01541371|26377048|FG000|Overall Study|Protocol Violation|6|||
13253502|NCT01541371|26377048|FG000|Overall Study|Study medication non-compliance|3|||
13253503|NCT01541371|26377048|FG000|Overall Study|Other|6|||
13253504|NCT01541254|26377055|FG000|Overall Study|Withdrawal by Subject|1|||
13253505|NCT01541254|26377055|FG000|Overall Study|excluded - metal allergy|1|||
13253506|NCT01541254|26377055|FG000|Overall Study|enrolled after study closed|1|||
13253507|NCT01541254|26377055|FG000|Overall Study|GI bleed prior to procedure|1|||
13253508|NCT01541254|26377055|FG000|Overall Study|stent not required|1|||
13253509|NCT01541254|26377055|FG000|Overall Study|alternate stent used|1|||
13253510|NCT01541215|26377214|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6|||
13253511|NCT01541215|26377215|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8|||
13253512|NCT01541215|26377214|FG000|Treatment Period (52 Weeks)|Non-compliance|4|||
13253513|NCT01541215|26377215|FG001|Treatment Period (52 Weeks)|Non-compliance|4|||
13253514|NCT01541215|26377214|FG000|Treatment Period (52 Weeks)|Adverse Event|0|||
13253515|NCT01541215|26377215|FG001|Treatment Period (52 Weeks)|Adverse Event|1|||
13253516|NCT01541215|26377214|FG000|Treatment Period (52 Weeks)|Unclassified|0|||
13253517|NCT01541215|26377215|FG001|Treatment Period (52 Weeks)|Unclassified|3|||
13116806|NCT03073005|25923273|FG001|Overall Study|caregiver withdrew bc of pt death|6|||
13253518|NCT01541215|26377214|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1|||
13253519|NCT01541215|26377215|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0|||
13253520|NCT01541215|26377214|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1|||
13253521|NCT01541215|26377215|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0|||
13253522|NCT01540981|26377230|FG000|Overall Study|Withdrawal by Subject|1|||
13253523|NCT01540981|26377231|FG001|Overall Study|Withdrawal by Subject|0|||
13253524|NCT01540851|26377248|FG000|Overall Study|Lost to Follow-up|14|||
13253525|NCT01540851|26377249|FG001|Overall Study|Lost to Follow-up|15|||
13253526|NCT01540851|26377248|FG000|Overall Study|Withdrawal by Subject|7|||
13253527|NCT01540851|26377249|FG001|Overall Study|Withdrawal by Subject|3|||
13116807|NCT03073005|25923274|FG002|Overall Study|caregiver withdrew bc of pt death|0|||
13116808|NCT03073005|25923275|FG003|Overall Study|caregiver withdrew bc of pt death|7|||
13253528|NCT01540838|26377278|FG000|Overall Study|Open nasogastric tube|9|||
13253529|NCT01540838|26377279|FG001|Overall Study|Open nasogastric tube|7|||
13253530|NCT01540838|26377278|FG000|Overall Study|Treatment doses missing|8|||
13253531|NCT01540838|26377279|FG001|Overall Study|Treatment doses missing|12|||
13253532|NCT01540838|26377278|FG000|Overall Study|Additional antibiotic treatment|1|||
13253533|NCT01540838|26377279|FG001|Overall Study|Additional antibiotic treatment|2|||
13253534|NCT01540838|26377278|FG000|Overall Study|Died before treatment initiation|1|||
13253535|NCT01540838|26377279|FG001|Overall Study|Died before treatment initiation|1|||
13253536|NCT01540838|26377278|FG000|Overall Study|Not BM. Other treatment|3|||
13253537|NCT01540838|26377279|FG001|Overall Study|Not BM. Other treatment|1|||
13253538|NCT01540565|26377291|FG000|Overall Study|Ineligible|2|||
13253539|NCT01540487|26377332|FG000|Overall Study|Protocol Violation|1|||
13253540|NCT01540487|26377333|FG001|Overall Study|Protocol Violation|0|||
13253541|NCT01540474|26377372|FG000|Vaccination Period|Lost to Follow-up|0|||
13253542|NCT01540474|26377373|FG001|Vaccination Period|Lost to Follow-up|1|||
13253543|NCT01540474|26377374|FG002|Vaccination Period|Lost to Follow-up|0|||
13253544|NCT01540474|26377375|FG003|Vaccination Period|Lost to Follow-up|0|||
13253545|NCT01539863|26377388|FG000|Overall Study|Lost to Follow-up|5|||
13253546|NCT01539863|26377389|FG001|Overall Study|Lost to Follow-up|4|||
13253547|NCT01539837|26377410|FG000|Overall Study|reduce neutrophil level|0|||
13253548|NCT01539837|26377411|FG001|Overall Study|reduce neutrophil level|1|||
13253549|NCT01539837|26377412|FG002|Overall Study|reduce neutrophil level|1|||
13253550|NCT01539837|26377410|FG000|Overall Study|bad compliance|0|||
13253551|NCT01539837|26377411|FG001|Overall Study|bad compliance|0|||
13253552|NCT01539837|26377412|FG002|Overall Study|bad compliance|1|||
13253553|NCT01539759|26377429|FG000|Overall Study|Lost to Follow-up|6|||
13253554|NCT01539759|26377430|FG001|Overall Study|Lost to Follow-up|8|||
13253555|NCT01539642|26377443|FG000|Overall Study|Lack of Efficacy|20|||
13253556|NCT01539642|26377444|FG001|Overall Study|Lack of Efficacy|18|||
13253557|NCT01539642|26377443|FG000|Overall Study|Patient ready for early discharge|8|||
13253558|NCT01539642|26377444|FG001|Overall Study|Patient ready for early discharge|7|||
13253559|NCT01539642|26377443|FG000|Overall Study|Adverse Event|6|||
13253560|NCT01539642|26377444|FG001|Overall Study|Adverse Event|4|||
13253561|NCT01539642|26377443|FG000|Overall Study|Withdrawal by Subject|2|||
13253562|NCT01539642|26377444|FG001|Overall Study|Withdrawal by Subject|2|||
13253563|NCT01539538|26377457|FG000|Overall Study|Adverse Event|13|||
13253564|NCT01539538|26377458|FG001|Overall Study|Adverse Event|18|||
13253565|NCT01539538|26377457|FG000|Overall Study|Lack of Efficacy|13|||
13253566|NCT01539538|26377458|FG001|Overall Study|Lack of Efficacy|16|||
13253567|NCT01539538|26377457|FG000|Overall Study|Withdrawal by Subject|2|||
13253568|NCT01539538|26377458|FG001|Overall Study|Withdrawal by Subject|3|||
13253569|NCT01539538|26377457|FG000|Overall Study|PCA no longer required or PCA problem|3|||
13253570|NCT01539538|26377458|FG001|Overall Study|PCA no longer required or PCA problem|7|||
13253571|NCT01539525|26377485|FG000|Overall Study|Lost to Follow-up|19|||
13253572|NCT01539525|26377486|FG001|Overall Study|Lost to Follow-up|12|||
13253573|NCT01539525|26377487|FG002|Overall Study|Lost to Follow-up|11|||
13253574|NCT01539525|26377485|FG000|Overall Study|Withdrawal by Subject|0|||
13253575|NCT01539525|26377486|FG001|Overall Study|Withdrawal by Subject|3|||
13253576|NCT01539525|26377487|FG002|Overall Study|Withdrawal by Subject|2|||
13253577|NCT01539525|26377485|FG000|Overall Study|Protocol Violation|1|||
13253578|NCT01539525|26377486|FG001|Overall Study|Protocol Violation|1|||
13253579|NCT01539525|26377487|FG002|Overall Study|Protocol Violation|4|||
13253580|NCT01539512|26377508|FG000|Overall Study|Adverse Event|9|||
13253581|NCT01539512|26377509|FG001|Overall Study|Adverse Event|7|||
13253582|NCT01539512|26377508|FG000|Overall Study|Physician Decision|1|||
13253583|NCT01539512|26377509|FG001|Overall Study|Physician Decision|1|||
13253584|NCT01539512|26377508|FG000|Overall Study|Withdrawal by Subject|12|||
13253585|NCT01539512|26377509|FG001|Overall Study|Withdrawal by Subject|5|||
13253586|NCT01539512|26377508|FG000|Overall Study|Richter's Transformation|1|||
13253587|NCT01539512|26377509|FG001|Overall Study|Richter's Transformation|0|||
13253588|NCT01539317|26377531|FG000|Overall Study|Screening Error. Deleted from analysis.|1|||
13253589|NCT01539317|26377532|FG001|Overall Study|Screening Error. Deleted from analysis.|0|||
13253590|NCT01539291|26377613|FG000|Study GS-US-312-0116|Adverse Event|9|||
13253591|NCT01539291|26377614|FG001|Study GS-US-312-0116|Adverse Event|0|||
13253592|NCT01539291|26377615|FG002|Study GS-US-312-0116|Adverse Event|0|||
13253593|NCT01539291|26377616|FG003|Study GS-US-312-0116|Adverse Event|0|||
13253594|NCT01539291|26377613|FG000|Study GS-US-312-0116|Physician Decision|1|||
13253595|NCT01539291|26377614|FG001|Study GS-US-312-0116|Physician Decision|0|||
13253596|NCT01539291|26377615|FG002|Study GS-US-312-0116|Physician Decision|0|||
13253597|NCT01539291|26377616|FG003|Study GS-US-312-0116|Physician Decision|0|||
13253598|NCT01539291|26377613|FG000|Study GS-US-312-0116|Withdrawal by Subject|12|||
13116809|NCT03073005|25923272|FG000|Overall Study|Lost to Follow-up|2|||
13253599|NCT01539291|26377614|FG001|Study GS-US-312-0116|Withdrawal by Subject|0|||
13253600|NCT01539291|26377615|FG002|Study GS-US-312-0116|Withdrawal by Subject|0|||
13253601|NCT01539291|26377616|FG003|Study GS-US-312-0116|Withdrawal by Subject|0|||
13253602|NCT01539291|26377613|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2|||
13253603|NCT01539291|26377614|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
13253604|NCT01539291|26377615|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
13253605|NCT01539291|26377616|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
13253606|NCT01539291|26377613|FG000|Study GS-US-312-0116|Other|1|||
13253607|NCT01539291|26377614|FG001|Study GS-US-312-0116|Other|0|||
13253608|NCT01539291|26377615|FG002|Study GS-US-312-0116|Other|0|||
13253609|NCT01539291|26377616|FG003|Study GS-US-312-0116|Other|0|||
13253610|NCT01539291|26377613|FG000|Study GS-US-312-0117|Adverse Event|22|||
13253611|NCT01539291|26377614|FG001|Study GS-US-312-0117|Adverse Event|1|||
13253612|NCT01539291|26377615|FG002|Study GS-US-312-0117|Adverse Event|9|||
13253613|NCT01539291|26377616|FG003|Study GS-US-312-0117|Adverse Event|12|||
13253614|NCT01539291|26377613|FG000|Study GS-US-312-0117|Physician Decision|9|||
13253615|NCT01539291|26377614|FG001|Study GS-US-312-0117|Physician Decision|0|||
13253616|NCT01539291|26377615|FG002|Study GS-US-312-0117|Physician Decision|6|||
13253617|NCT01539291|26377616|FG003|Study GS-US-312-0117|Physician Decision|4|||
13253618|NCT01539291|26377613|FG000|Study GS-US-312-0117|Withdrawal by Subject|5|||
13253619|NCT01539291|26377614|FG001|Study GS-US-312-0117|Withdrawal by Subject|0|||
13253620|NCT01539291|26377615|FG002|Study GS-US-312-0117|Withdrawal by Subject|6|||
13253621|NCT01539291|26377616|FG003|Study GS-US-312-0117|Withdrawal by Subject|4|||
13253622|NCT01539291|26377613|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3|||
13253623|NCT01539291|26377614|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
13253624|NCT01539291|26377615|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
13253625|NCT01539291|26377616|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5|||
13253626|NCT01539291|26377613|FG000|Study GS-US-312-0117|Other|2|||
13253627|NCT01539291|26377614|FG001|Study GS-US-312-0117|Other|1|||
13253628|NCT01539291|26377615|FG002|Study GS-US-312-0117|Other|1|||
13253629|NCT01539291|26377616|FG003|Study GS-US-312-0117|Other|1|||
13253630|NCT01539239|26377631|FG000|Overall Study|Death|5|||
13253631|NCT01539239|26377632|FG001|Overall Study|Death|5|||
13253632|NCT01539239|26377631|FG000|Overall Study|Lost to Follow-up|7|||
13253633|NCT01539239|26377632|FG001|Overall Study|Lost to Follow-up|12|||
13253634|NCT01539226|26377658|FG000|Overall Study|Withdrawal by Subject|24|||
13253635|NCT01539226|26377659|FG001|Overall Study|Withdrawal by Subject|54|||
13253636|NCT01539226|26377658|FG000|Overall Study|Lost to Follow-up|20|||
13253637|NCT01539226|26377659|FG001|Overall Study|Lost to Follow-up|54|||
13253638|NCT01539226|26377658|FG000|Overall Study|Death|1|||
13253639|NCT01539226|26377659|FG001|Overall Study|Death|2|||
13253640|NCT01539226|26377658|FG000|Overall Study|Adverse Event|2|||
13253641|NCT01539226|26377659|FG001|Overall Study|Adverse Event|0|||
13253642|NCT01539226|26377658|FG000|Overall Study|Pregnancy|13|||
13253643|NCT01539226|26377659|FG001|Overall Study|Pregnancy|29|||
13253644|NCT01539226|26377658|FG000|Overall Study|inappropriate enrollment|0|||
13253645|NCT01539226|26377659|FG001|Overall Study|inappropriate enrollment|1|||
13253646|NCT01539226|26377658|FG000|Overall Study|Multiple Reasons|3|||
13253647|NCT01539226|26377659|FG001|Overall Study|Multiple Reasons|1|||
13253648|NCT01539226|26377658|FG000|Overall Study|not HIV seroconversion-related|93|||
13253649|NCT01539226|26377659|FG001|Overall Study|not HIV seroconversion-related|176|||
13253650|NCT01539226|26377658|FG000|Overall Study|HIV seroconversion-related|55|||
13253651|NCT01539226|26377659|FG001|Overall Study|HIV seroconversion-related|80|||
13253652|NCT01539226|26377658|FG000|Overall Study|Non-compliance|6|||
13253653|NCT01539226|26377659|FG001|Overall Study|Non-compliance|8|||
13253654|NCT01539083|26377684|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4|||
13253655|NCT01539083|26377685|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
13253656|NCT01539083|26377686|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
13253657|NCT01539083|26377684|FG000|Before Randomization (VCD Induction)|Adverse Event|14|||
13253658|NCT01539083|26377685|FG001|Before Randomization (VCD Induction)|Adverse Event|0|||
13253659|NCT01539083|26377686|FG002|Before Randomization (VCD Induction)|Adverse Event|0|||
13253660|NCT01539083|26377684|FG000|Before Randomization (VCD Induction)|Death|6|||
13253661|NCT01539083|26377685|FG001|Before Randomization (VCD Induction)|Death|0|||
13253662|NCT01539083|26377686|FG002|Before Randomization (VCD Induction)|Death|0|||
13253663|NCT01539083|26377684|FG000|Before Randomization (VCD Induction)|Protocol Violation|2|||
13253664|NCT01539083|26377685|FG001|Before Randomization (VCD Induction)|Protocol Violation|0|||
13253665|NCT01539083|26377686|FG002|Before Randomization (VCD Induction)|Protocol Violation|0|||
13116810|NCT03073005|25923273|FG001|Overall Study|Lost to Follow-up|2|||
13116811|NCT03073005|25923274|FG002|Overall Study|Lost to Follow-up|1|||
13116812|NCT03073005|25923275|FG003|Overall Study|Lost to Follow-up|2|||
13116813|NCT03073005|25923272|FG000|Overall Study|Withdrawal by Subject|0|||
13116814|NCT03073005|25923273|FG001|Overall Study|Withdrawal by Subject|4|||
13116815|NCT03073005|25923274|FG002|Overall Study|Withdrawal by Subject|4|||
13116816|NCT03073005|25923275|FG003|Overall Study|Withdrawal by Subject|4|||
13116817|NCT03072875|25923282|FG000|Overall Study|Lost to Follow-up|1|||
13116818|NCT03072719|25923299|FG000|Overall Study|Adverse Event|1|||
13116819|NCT03072719|25923300|FG001|Overall Study|Adverse Event|1|||
13116820|NCT03072160|25923357|FG000|Overall Study|Adverse Event|3|||
13116821|NCT03072160|25923358|FG001|Overall Study|Adverse Event|1|||
13253666|NCT01539083|26377684|FG000|Before Randomization (VCD Induction)|Physician Decision|14|||
13253667|NCT01539083|26377685|FG001|Before Randomization (VCD Induction)|Physician Decision|0|||
13253668|NCT01539083|26377686|FG002|Before Randomization (VCD Induction)|Physician Decision|0|||
13253669|NCT01539083|26377684|FG000|Before Randomization (VCD Induction)|Progressive Disease|8|||
13253670|NCT01539083|26377685|FG001|Before Randomization (VCD Induction)|Progressive Disease|0|||
13253671|NCT01539083|26377686|FG002|Before Randomization (VCD Induction)|Progressive Disease|0|||
13253672|NCT01539083|26377684|FG000|Before Randomization (VCD Induction)|Other|5|||
13253673|NCT01539083|26377685|FG001|Before Randomization (VCD Induction)|Other|0|||
13253674|NCT01539083|26377686|FG002|Before Randomization (VCD Induction)|Other|0|||
13253675|NCT01539083|26377684|FG000|After Randomization (TP and VTP)|Physician Decision|0|||
13253676|NCT01539083|26377685|FG001|After Randomization (TP and VTP)|Physician Decision|0|||
13253677|NCT01539083|26377686|FG002|After Randomization (TP and VTP)|Physician Decision|1|||
13253678|NCT01539083|26377684|FG000|After Randomization (TP and VTP)|Other|0|||
13253679|NCT01539083|26377685|FG001|After Randomization (TP and VTP)|Other|1|||
13253680|NCT01539083|26377686|FG002|After Randomization (TP and VTP)|Other|1|||
13253681|NCT01539083|26377684|FG000|After Randomization (TP and VTP)|Adverse Event|0|||
13253682|NCT01539083|26377685|FG001|After Randomization (TP and VTP)|Adverse Event|1|||
13253683|NCT01539083|26377686|FG002|After Randomization (TP and VTP)|Adverse Event|1|||
13253684|NCT01539083|26377684|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0|||
13253685|NCT01539083|26377685|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2|||
13253686|NCT01539083|26377686|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2|||
13253687|NCT01539083|26377684|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0|||
13253688|NCT01539083|26377685|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5|||
13253689|NCT01539083|26377686|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4|||
13253690|NCT01539083|26377684|FG000|After Randomization (TP and VTP)|Progressive Disease|0|||
13253691|NCT01539083|26377685|FG001|After Randomization (TP and VTP)|Progressive Disease|6|||
13253692|NCT01539083|26377686|FG002|After Randomization (TP and VTP)|Progressive Disease|3|||
13253693|NCT01539083|26377684|FG000|After Randomization (TP and VTP)|Death|0|||
13253694|NCT01539083|26377685|FG001|After Randomization (TP and VTP)|Death|6|||
13253695|NCT01539083|26377686|FG002|After Randomization (TP and VTP)|Death|11|||
13253696|NCT01538719|26377701|FG000|Overall Study|Lost to Follow-up|2|||
13253697|NCT01538719|26377702|FG001|Overall Study|Lost to Follow-up|0|||
13253698|NCT01538628|26377725|FG000|Overall Study|Withdrawal by Subject|1|||
13253699|NCT01538628|26377726|FG001|Overall Study|Withdrawal by Subject|1|||
13253700|NCT01538628|26377725|FG000|Overall Study|Lost to Follow-up|0|||
13253701|NCT01538628|26377726|FG001|Overall Study|Lost to Follow-up|1|||
13253702|NCT01538472|26377733|FG000|Overall Study|Disease Progression|3|||
13253703|NCT01538472|26377733|FG000|Overall Study|Death|1|||
13253704|NCT01538199|26377773|FG000|Overall Study|Lost to Follow-up|1|||
13253705|NCT01538199|26377774|FG001|Overall Study|Lost to Follow-up|2|||
13253706|NCT01538199|26377775|FG002|Overall Study|Lost to Follow-up|1|||
13253707|NCT01538199|26377776|FG003|Overall Study|Lost to Follow-up|0|||
13253708|NCT01538199|26377773|FG000|Overall Study|participant did not have time|1|||
13253709|NCT01538199|26377774|FG001|Overall Study|participant did not have time|0|||
13253710|NCT01538199|26377775|FG002|Overall Study|participant did not have time|0|||
13253711|NCT01538199|26377776|FG003|Overall Study|participant did not have time|2|||
13253712|NCT01538199|26377773|FG000|Overall Study|Lack of Efficacy|0|||
13253713|NCT01538199|26377774|FG001|Overall Study|Lack of Efficacy|1|||
13253714|NCT01538199|26377775|FG002|Overall Study|Lack of Efficacy|0|||
13253715|NCT01538199|26377776|FG003|Overall Study|Lack of Efficacy|0|||
13253716|NCT01537887|26377794|FG000|Period 1|Physician Decision|0|||
13253717|NCT01537887|26377795|FG001|Period 1|Physician Decision|0|||
13253718|NCT01537887|26377796|FG002|Period 1|Physician Decision|0|||
13253719|NCT01537887|26377797|FG003|Period 1|Physician Decision|0|||
13253720|NCT01537887|26377798|FG004|Period 1|Physician Decision|1|||
13253721|NCT01537887|26377799|FG005|Period 1|Physician Decision|1|||
13253722|NCT01537887|26377794|FG000|Period 1|Did not receive treatment|0|||
13253723|NCT01537887|26377795|FG001|Period 1|Did not receive treatment|0|||
13253724|NCT01537887|26377796|FG002|Period 1|Did not receive treatment|1|||
13253725|NCT01537887|26377797|FG003|Period 1|Did not receive treatment|0|||
13253726|NCT01537887|26377798|FG004|Period 1|Did not receive treatment|0|||
13253727|NCT01537887|26377799|FG005|Period 1|Did not receive treatment|0|||
13253728|NCT01537887|26377794|FG000|Period 2|Withdrawal by Subject|0|||
13253729|NCT01537887|26377795|FG001|Period 2|Withdrawal by Subject|1|||
13253730|NCT01537887|26377796|FG002|Period 2|Withdrawal by Subject|0|||
13253731|NCT01537887|26377797|FG003|Period 2|Withdrawal by Subject|0|||
13253732|NCT01537887|26377798|FG004|Period 2|Withdrawal by Subject|0|||
13253733|NCT01537887|26377799|FG005|Period 2|Withdrawal by Subject|0|||
13253734|NCT01537887|26377794|FG000|Period 3|Adverse Event|0|||
13253735|NCT01537887|26377795|FG001|Period 3|Adverse Event|0|||
13253736|NCT01537887|26377796|FG002|Period 3|Adverse Event|1|||
13253737|NCT01537887|26377797|FG003|Period 3|Adverse Event|0|||
13253738|NCT01537887|26377798|FG004|Period 3|Adverse Event|0|||
13253739|NCT01537887|26377799|FG005|Period 3|Adverse Event|0|||
13253740|NCT01537887|26377794|FG000|Period 3|Withdrawal by Subject|0|||
13253741|NCT01537887|26377795|FG001|Period 3|Withdrawal by Subject|1|||
13253742|NCT01537887|26377796|FG002|Period 3|Withdrawal by Subject|0|||
13253743|NCT01537887|26377797|FG003|Period 3|Withdrawal by Subject|0|||
13253744|NCT01537887|26377798|FG004|Period 3|Withdrawal by Subject|0|||
13253745|NCT01537887|26377799|FG005|Period 3|Withdrawal by Subject|0|||
13253746|NCT01537783|26377812|FG000|Overall Study|Lost to Follow-up|11|||
13253747|NCT01537783|26377813|FG001|Overall Study|Lost to Follow-up|2|||
13253748|NCT01537549|26377821|FG000|Overall Study|Lost to Follow-up|1|||
13253749|NCT01537549|26377821|FG000|Overall Study|Withdrawal by Subject|2|||
13253750|NCT01537432|26377836|FG000|Overall Study|Lost to Follow-up|3|||
13253751|NCT01537432|26377837|FG001|Overall Study|Lost to Follow-up|1|||
13253752|NCT01537432|26377836|FG000|Overall Study|Withdrawal by Subject|0|||
13253753|NCT01537432|26377837|FG001|Overall Study|Withdrawal by Subject|1|||
13253754|NCT01537432|26377836|FG000|Overall Study|Administrative problems|1|||
13253755|NCT01537432|26377837|FG001|Overall Study|Administrative problems|0|||
13253756|NCT01537432|26377836|FG000|Overall Study|Adverse Event|1|||
13253757|NCT01537432|26377837|FG001|Overall Study|Adverse Event|0|||
13253758|NCT01537432|26377836|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
13253759|NCT01537432|26377837|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
13253760|NCT01537393|26377852|FG000|Overall Study|Exclude prior to study|32|||
13253761|NCT01537393|26377853|FG001|Overall Study|Exclude prior to study|44|||
13253762|NCT01537393|26377852|FG000|Overall Study|Death|20|||
13253763|NCT01537393|26377853|FG001|Overall Study|Death|32|||
13253764|NCT01537393|26377852|FG000|Overall Study|Withdrawal by Subject|18|||
13253765|NCT01537393|26377853|FG001|Overall Study|Withdrawal by Subject|17|||
13253766|NCT01537393|26377852|FG000|Overall Study|Lost to Follow-up|53|||
13253767|NCT01537393|26377853|FG001|Overall Study|Lost to Follow-up|48|||
13253768|NCT01537393|26377852|FG000|Overall Study|Failure - Regrafted|28|||
13253769|NCT01537393|26377853|FG001|Overall Study|Failure - Regrafted|43|||
13253770|NCT01537393|26377852|FG000|Overall Study|Failure - Not regrafted|2|||
13253771|NCT01537393|26377853|FG001|Overall Study|Failure - Not regrafted|6|||
13253772|NCT01537393|26377852|FG000|Overall Study|Censored (severe event unrelated to PT)|1|||
13253773|NCT01537393|26377853|FG001|Overall Study|Censored (severe event unrelated to PT)|1|||
13253774|NCT01537211|26377894|FG000|Overall Study|Lost to Follow-up|0|||
13253775|NCT01537211|26377895|FG001|Overall Study|Lost to Follow-up|1|||
13253776|NCT01537198|26377901|FG000|Overall Study|RSV infection|2|||
13253777|NCT01537198|26377901|FG000|Overall Study|Adverse Event|4|||
13253778|NCT01537198|26377901|FG000|Overall Study|No Further Visits to the Clinic|37|||
13253779|NCT01537198|26377901|FG000|Overall Study|Other|111|||
13253780|NCT01537133|26377930|FG000|Overall Study|Withdrawal by Subject|2|||
13116822|NCT03072160|25923357|FG000|Overall Study|Refused further treatment|6|||
13116823|NCT03072160|25923358|FG001|Overall Study|Refused further treatment|1|||
13116824|NCT03072160|25923357|FG000|Overall Study|Physician Decision|1|||
13116825|NCT03072160|25923358|FG001|Overall Study|Physician Decision|0|||
13116826|NCT03072160|25923357|FG000|Overall Study|Disease progression on study|1|||
13116827|NCT03072160|25923358|FG001|Overall Study|Disease progression on study|1|||
13116828|NCT03072160|25923357|FG000|Overall Study|No contact|0|||
13116829|NCT03072160|25923358|FG001|Overall Study|No contact|1|||
13116830|NCT03071276|25923366|FG000|Overall Study|Adverse Event|1|||
13116831|NCT03071276|25923366|FG000|Overall Study|Lack of Efficacy|14|||
13116832|NCT03071263|25923397|FG000|Overall Study|Adverse Event|1|||
13116833|NCT03071263|25923398|FG001|Overall Study|Adverse Event|3|||
13116834|NCT03071263|25923397|FG000|Overall Study|Withdrawal by Subject|1|||
13116835|NCT03071263|25923398|FG001|Overall Study|Withdrawal by Subject|3|||
13116836|NCT03071263|25923397|FG000|Overall Study|Physician Decision|1|||
13116837|NCT03071263|25923398|FG001|Overall Study|Physician Decision|0|||
13116838|NCT03071263|25923397|FG000|Overall Study|Participant moved to another city|0|||
13116839|NCT03071263|25923398|FG001|Overall Study|Participant moved to another city|1|||
13116840|NCT03071094|25923412|FG000|Overall Study|Death|1|||
13116841|NCT03071094|25923413|FG001|Overall Study|Death|1|||
13253781|NCT01537133|26377931|FG001|Overall Study|Withdrawal by Subject|0|||
13253782|NCT01537133|26377932|FG002|Overall Study|Withdrawal by Subject|0|||
13253783|NCT01537133|26377933|FG003|Overall Study|Withdrawal by Subject|0|||
13253784|NCT01537133|26377930|FG000|Overall Study|Lost to Follow-up|1|||
13253785|NCT01537133|26377931|FG001|Overall Study|Lost to Follow-up|0|||
13253786|NCT01537133|26377932|FG002|Overall Study|Lost to Follow-up|0|||
13253787|NCT01537133|26377933|FG003|Overall Study|Lost to Follow-up|0|||
13253788|NCT01537120|26377945|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1|||
13253789|NCT01537120|26377945|FG000|3 Weeks Placebo|Withdrawal by Subject|1|||
13253790|NCT01537081|26377966|FG000|Overall Study|Adverse Event|5|||
13253791|NCT01537081|26377967|FG001|Overall Study|Adverse Event|2|||
13253792|NCT01537081|26377968|FG002|Overall Study|Adverse Event|2|||
13253793|NCT01537081|26377966|FG000|Overall Study|Lack of Efficacy|2|||
13253794|NCT01537081|26377967|FG001|Overall Study|Lack of Efficacy|1|||
13253795|NCT01537081|26377968|FG002|Overall Study|Lack of Efficacy|0|||
13253796|NCT01537081|26377966|FG000|Overall Study|Lost to Follow-up|17|||
13253797|NCT01537081|26377967|FG001|Overall Study|Lost to Follow-up|15|||
13253798|NCT01537081|26377968|FG002|Overall Study|Lost to Follow-up|9|||
13116842|NCT03071094|25923412|FG000|Overall Study|Adverse Event|1|||
13116843|NCT03071094|25923413|FG001|Overall Study|Adverse Event|0|||
13116844|NCT03070964|25923420|FG000|Overall Study|Progressive disease|8|||
13116845|NCT03070964|25923420|FG000|Overall Study|Treatment-unrelated adverse event|2|||
13116846|NCT03070964|25923420|FG000|Overall Study|Never treated|1|||
13116847|NCT03070964|25923420|FG000|Overall Study|Physician Decision|1|||
13253799|NCT01537081|26377966|FG000|Overall Study|Protocol Violation|3|||
13253800|NCT01537081|26377967|FG001|Overall Study|Protocol Violation|2|||
13253801|NCT01537081|26377968|FG002|Overall Study|Protocol Violation|2|||
13253802|NCT01537081|26377966|FG000|Overall Study|Withdrawal by Subject|6|||
13253803|NCT01537081|26377967|FG001|Overall Study|Withdrawal by Subject|11|||
13253804|NCT01537081|26377968|FG002|Overall Study|Withdrawal by Subject|3|||
13253805|NCT01537081|26377966|FG000|Overall Study|Physician Decision|5|||
13253806|NCT01537081|26377967|FG001|Overall Study|Physician Decision|6|||
13253807|NCT01537081|26377968|FG002|Overall Study|Physician Decision|0|||
13116848|NCT03070964|25923420|FG000|Overall Study|Withdrawal by Subject|1|||
13116849|NCT03070964|25923420|FG000|Overall Study|Adverse Event|1|||
13253808|NCT01537081|26377966|FG000|Overall Study|Sponsor decision|0|||
13253809|NCT01537081|26377967|FG001|Overall Study|Sponsor decision|1|||
13253810|NCT01537081|26377968|FG002|Overall Study|Sponsor decision|0|||
13253811|NCT01537081|26377966|FG000|Overall Study|Assigned but never dosed|1|||
13253812|NCT01537081|26377967|FG001|Overall Study|Assigned but never dosed|0|||
13253813|NCT01537081|26377968|FG002|Overall Study|Assigned but never dosed|0|||
13253814|NCT01537068|26377985|FG000|Overall Study|Lost to Follow-up|2|||
13253815|NCT01537068|26377986|FG001|Overall Study|Lost to Follow-up|1|||
13253816|NCT01537068|26377985|FG000|Overall Study|Adverse Event|0|||
13253817|NCT01537068|26377986|FG001|Overall Study|Adverse Event|1|||
13253818|NCT01537068|26377985|FG000|Overall Study|Withdrawal by Subject|1|||
13253819|NCT01537068|26377986|FG001|Overall Study|Withdrawal by Subject|1|||
13253820|NCT01537068|26377985|FG000|Overall Study|Lack of Efficacy|1|||
13253821|NCT01537068|26377986|FG001|Overall Study|Lack of Efficacy|0|||
13253822|NCT01537042|26378029|FG000|Overall Study|Adverse Event|0|||
13116850|NCT03070782|25923507|FG000|Overall Study|Adverse Event|3|||
13116851|NCT03070782|25923508|FG001|Overall Study|Adverse Event|0|||
13253823|NCT01537042|26378030|FG001|Overall Study|Adverse Event|2|||
13253824|NCT01537042|26378029|FG000|Overall Study|Lack of Efficacy|0|||
13116852|NCT03070782|25923509|FG002|Overall Study|Adverse Event|3|||
13116853|NCT03070782|25923510|FG003|Overall Study|Adverse Event|1|||
13116854|NCT03070782|25923511|FG004|Overall Study|Adverse Event|6|||
13116855|NCT03070782|25923512|FG005|Overall Study|Adverse Event|2|||
13116856|NCT03070782|25923507|FG000|Overall Study|Withdrawal by Subject|2|||
13116857|NCT03070782|25923508|FG001|Overall Study|Withdrawal by Subject|1|||
13253825|NCT01537042|26378030|FG001|Overall Study|Lack of Efficacy|1|||
13253826|NCT01537042|26378029|FG000|Overall Study|Protocol Violation|0|||
13253827|NCT01537042|26378030|FG001|Overall Study|Protocol Violation|1|||
13253828|NCT01537042|26378029|FG000|Overall Study|Other|0|||
13253829|NCT01537042|26378030|FG001|Overall Study|Other|1|||
13253830|NCT01536951|26378071|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
13253831|NCT01536951|26378072|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
13253832|NCT01536951|26378073|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1|||
13253833|NCT01536951|26378074|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
13253834|NCT01536951|26378075|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
13253835|NCT01536951|26378076|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
13253836|NCT01536951|26378077|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
13253837|NCT01536951|26378078|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
13253838|NCT01536951|26378079|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
13253839|NCT01536951|26378071|FG000|Second Intervention and Washout Period 2|Adverse Event|0|||
13253840|NCT01536951|26378072|FG001|Second Intervention and Washout Period 2|Adverse Event|0|||
13253841|NCT01536951|26378073|FG002|Second Intervention and Washout Period 2|Adverse Event|0|||
13253842|NCT01536951|26378074|FG003|Second Intervention and Washout Period 2|Adverse Event|0|||
13253843|NCT01536951|26378075|FG004|Second Intervention and Washout Period 2|Adverse Event|0|||
13253844|NCT01536951|26378076|FG005|Second Intervention and Washout Period 2|Adverse Event|0|||
13253845|NCT01536951|26378077|FG006|Second Intervention and Washout Period 2|Adverse Event|0|||
13253846|NCT01536951|26378078|FG007|Second Intervention and Washout Period 2|Adverse Event|1|||
13253847|NCT01536951|26378079|FG008|Second Intervention and Washout Period 2|Adverse Event|0|||
13253848|NCT01536860|26378091|FG000|Washout Period (3 Days)|Lost to Follow-up|1|||
13253849|NCT01536860|26378092|FG001|Washout Period (3 Days)|Lost to Follow-up|0|||
13253850|NCT01536860|26378093|FG002|Washout Period (3 Days)|Lost to Follow-up|0|||
13116858|NCT03070782|25923509|FG002|Overall Study|Withdrawal by Subject|1|||
13116859|NCT03070782|25923510|FG003|Overall Study|Withdrawal by Subject|0|||
13116860|NCT03070782|25923511|FG004|Overall Study|Withdrawal by Subject|4|||
13116861|NCT03070782|25923512|FG005|Overall Study|Withdrawal by Subject|3|||
13116862|NCT03070782|25923507|FG000|Overall Study|Reason Not Specified|2|||
13116863|NCT03070782|25923508|FG001|Overall Study|Reason Not Specified|0|||
13253851|NCT01536795|26378114|FG000|Overall Study|Lost to Follow-up|0|||
13253852|NCT01536795|26378115|FG001|Overall Study|Lost to Follow-up|2|||
13253853|NCT01536795|26378114|FG000|Overall Study|Lack of Efficacy|1|||
13253854|NCT01536795|26378115|FG001|Overall Study|Lack of Efficacy|0|||
13253855|NCT01536704|26378150|FG000|Washout Period 1|Withdrawal by Subject|1|||
13253856|NCT01536704|26378151|FG001|Washout Period 1|Withdrawal by Subject|2|||
13116864|NCT03070782|25923509|FG002|Overall Study|Reason Not Specified|0|||
13116865|NCT03070782|25923510|FG003|Overall Study|Reason Not Specified|1|||
13253857|NCT01536704|26378152|FG002|Washout Period 1|Withdrawal by Subject|0|||
13253858|NCT01536704|26378153|FG003|Washout Period 1|Withdrawal by Subject|0|||
13253859|NCT01536704|26378150|FG000|Washout Period 2|Adverse Event|1|||
13253860|NCT01536704|26378151|FG001|Washout Period 2|Adverse Event|0|||
13253861|NCT01536704|26378152|FG002|Washout Period 2|Adverse Event|0|||
13253862|NCT01536704|26378153|FG003|Washout Period 2|Adverse Event|0|||
13253863|NCT01536704|26378150|FG000|Washout Period 2|Withdrawal by Subject|0|||
13253864|NCT01536704|26378151|FG001|Washout Period 2|Withdrawal by Subject|0|||
13253865|NCT01536704|26378152|FG002|Washout Period 2|Withdrawal by Subject|0|||
13253866|NCT01536704|26378153|FG003|Washout Period 2|Withdrawal by Subject|1|||
13253867|NCT01536704|26378150|FG000|Period 3|Adverse Event|0|||
13253868|NCT01536704|26378151|FG001|Period 3|Adverse Event|0|||
13253869|NCT01536704|26378152|FG002|Period 3|Adverse Event|0|||
13253870|NCT01536704|26378153|FG003|Period 3|Adverse Event|1|||
13253871|NCT01536704|26378150|FG000|Washout Period 3|Adverse Event|0|||
13253872|NCT01536704|26378151|FG001|Washout Period 3|Adverse Event|0|||
13253873|NCT01536704|26378152|FG002|Washout Period 3|Adverse Event|1|||
13253874|NCT01536704|26378153|FG003|Washout Period 3|Adverse Event|0|||
13253875|NCT01536587|26378192|FG000|Overall Study|Adverse Event|2|||
13253876|NCT01536574|26378217|FG000|Overall Study|Adverse Event|4|||
13253877|NCT01536574|26378218|FG001|Overall Study|Adverse Event|5|||
13253878|NCT01536574|26378217|FG000|Overall Study|Withdrawal by Subject|1|||
13253879|NCT01536574|26378218|FG001|Overall Study|Withdrawal by Subject|2|||
13253880|NCT01536574|26378217|FG000|Overall Study|Lack of Efficacy|1|||
13253881|NCT01536574|26378218|FG001|Overall Study|Lack of Efficacy|0|||
13253882|NCT01536561|26378258|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40|||
13253883|NCT01536561|26378258|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2|||
13253884|NCT01536561|26378258|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
13253885|NCT01536561|26378258|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1|||
13253886|NCT01536561|26378258|FG000|Dosimetric and Therapeutic Treatment|Death|2|||
13253887|NCT01536561|26378258|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13|||
13253888|NCT01536535|26378275|FG000|Overall Study|Withdrawal by Subject|10|||
13253889|NCT01536535|26378276|FG001|Overall Study|Withdrawal by Subject|5|||
13253890|NCT01536535|26378275|FG000|Overall Study|Lost to Follow-up|4|||
13253891|NCT01536535|26378276|FG001|Overall Study|Lost to Follow-up|6|||
13253892|NCT01536535|26378275|FG000|Overall Study|Physician Decision|1|||
13253893|NCT01536535|26378276|FG001|Overall Study|Physician Decision|1|||
13253894|NCT01536535|26378275|FG000|Overall Study|Participant moved|0|||
13253895|NCT01536535|26378276|FG001|Overall Study|Participant moved|1|||
13253896|NCT01536418|26378301|FG000|Overall Study|Protocol Violation|2|||
13253897|NCT01536418|26378302|FG001|Overall Study|Protocol Violation|3|||
13253898|NCT01536418|26378301|FG000|Overall Study|Physician Decision|1|||
13253899|NCT01536418|26378302|FG001|Overall Study|Physician Decision|3|||
13253900|NCT01536418|26378301|FG000|Overall Study|Study closed/terminated|41|||
13253901|NCT01536418|26378302|FG001|Overall Study|Study closed/terminated|37|||
13253902|NCT01536418|26378301|FG000|Overall Study|Lack of Efficacy|10|||
13253903|NCT01536418|26378302|FG001|Overall Study|Lack of Efficacy|16|||
13253904|NCT01536418|26378301|FG000|Overall Study|Adverse Event|9|||
13253905|NCT01536418|26378302|FG001|Overall Study|Adverse Event|4|||
13253906|NCT01536418|26378301|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1|||
13253907|NCT01536418|26378302|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0|||
13253908|NCT01536418|26378301|FG000|Overall Study|Withdrawal by Subject|5|||
13253909|NCT01536418|26378302|FG001|Overall Study|Withdrawal by Subject|3|||
13253910|NCT01536405|26378345|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8|||
13253911|NCT01536405|26378346|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4|||
13253912|NCT01536405|26378345|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12|||
13253913|NCT01536405|26378346|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18|||
13253914|NCT01536405|26378345|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20|||
13253915|NCT01536405|26378346|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22|||
13253916|NCT01536405|26378345|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17|||
13253917|NCT01536405|26378346|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13|||
13253918|NCT01536405|26378345|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
13253919|NCT01536405|26378346|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
13253920|NCT01536405|26378345|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9|||
13253921|NCT01536405|26378346|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10|||
13253922|NCT01536405|26378345|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
13253923|NCT01536405|26378346|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
13253924|NCT01536405|26378345|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3|||
13253925|NCT01536405|26378346|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2|||
13253926|NCT01536405|26378345|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1|||
13253927|NCT01536405|26378346|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0|||
13253928|NCT01536405|26378345|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16|||
13253929|NCT01536405|26378346|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14|||
13253930|NCT01536405|26378345|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0|||
13253931|NCT01536405|26378346|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2|||
13253932|NCT01536405|26378345|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0|||
13253933|NCT01536405|26378346|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1|||
13253934|NCT01536405|26378345|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
13253935|NCT01536405|26378346|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
13253936|NCT01536392|26378361|FG000|Overall Study|Adverse Event|2|||
13253937|NCT01536392|26378362|FG001|Overall Study|Adverse Event|2|||
13253938|NCT01536392|26378361|FG000|Overall Study|Physician Decision|2|||
13253939|NCT01536392|26378362|FG001|Overall Study|Physician Decision|3|||
13253940|NCT01536392|26378361|FG000|Overall Study|Withdrawal by Subject|3|||
13253941|NCT01536392|26378362|FG001|Overall Study|Withdrawal by Subject|6|||
13253942|NCT01536392|26378361|FG000|Overall Study|Non Compliance|3|||
13253943|NCT01536392|26378362|FG001|Overall Study|Non Compliance|4|||
13253944|NCT01536392|26378361|FG000|Overall Study|Completed therapy early|3|||
13253945|NCT01536392|26378362|FG001|Overall Study|Completed therapy early|0|||
13253946|NCT01536379|26378443|FG000|Overall Study|Adverse Event|1|||
13253947|NCT01536379|26378444|FG001|Overall Study|Adverse Event|2|||
13253948|NCT01536379|26378443|FG000|Overall Study|Withdrawal by Subject|1|||
13253949|NCT01536379|26378444|FG001|Overall Study|Withdrawal by Subject|1|||
13253950|NCT01536262|26378468|FG000|Overall Study|Adverse Event|6|||
13253951|NCT01536262|26378469|FG001|Overall Study|Adverse Event|1|||
13253952|NCT01536262|26378470|FG002|Overall Study|Adverse Event|2|||
13253953|NCT01536262|26378468|FG000|Overall Study|Withdrawal by Subject|1|||
13253954|NCT01536262|26378469|FG001|Overall Study|Withdrawal by Subject|1|||
13253955|NCT01536262|26378470|FG002|Overall Study|Withdrawal by Subject|0|||
13253956|NCT01536262|26378468|FG000|Overall Study|Other than stated above|1|||
13253957|NCT01536262|26378469|FG001|Overall Study|Other than stated above|0|||
13253958|NCT01536262|26378470|FG002|Overall Study|Other than stated above|0|||
13253959|NCT01536171|26378477|FG000|Overall Study|Withdrawal by Subject|1|||
13253960|NCT01536145|26378594|FG000|Overall Study|Progressive disease|3|||
13253961|NCT01536145|26378595|FG001|Overall Study|Progressive disease|4|||
13253962|NCT01536145|26378596|FG002|Overall Study|Progressive disease|1|||
13253963|NCT01536145|26378597|FG003|Overall Study|Progressive disease|2|||
13253964|NCT01536145|26378598|FG004|Overall Study|Progressive disease|1|||
13253965|NCT01536145|26378599|FG005|Overall Study|Progressive disease|2|||
13253966|NCT01536145|26378600|FG006|Overall Study|Progressive disease|1|||
13253967|NCT01536145|26378601|FG007|Overall Study|Progressive disease|2|||
13253968|NCT01536145|26378602|FG008|Overall Study|Progressive disease|1|||
13253969|NCT01536145|26378603|FG009|Overall Study|Progressive disease|3|||
13253970|NCT01536145|26378604|FG010|Overall Study|Progressive disease|3|||
13253971|NCT01536145|26378594|FG000|Overall Study|Withdrawal by Subject|0|||
13253972|NCT01536145|26378595|FG001|Overall Study|Withdrawal by Subject|0|||
13253973|NCT01536145|26378596|FG002|Overall Study|Withdrawal by Subject|1|||
13253974|NCT01536145|26378597|FG003|Overall Study|Withdrawal by Subject|0|||
13253975|NCT01536145|26378598|FG004|Overall Study|Withdrawal by Subject|0|||
13253976|NCT01536145|26378599|FG005|Overall Study|Withdrawal by Subject|1|||
13253977|NCT01536145|26378600|FG006|Overall Study|Withdrawal by Subject|0|||
13253978|NCT01536145|26378601|FG007|Overall Study|Withdrawal by Subject|0|||
13253979|NCT01536145|26378602|FG008|Overall Study|Withdrawal by Subject|2|||
13116866|NCT03070782|25923511|FG004|Overall Study|Reason Not Specified|2|||
13253980|NCT01536145|26378603|FG009|Overall Study|Withdrawal by Subject|0|||
13253981|NCT01536145|26378604|FG010|Overall Study|Withdrawal by Subject|2|||
13253982|NCT01536145|26378594|FG000|Overall Study|Other|0|||
13253983|NCT01536145|26378595|FG001|Overall Study|Other|0|||
13253984|NCT01536145|26378596|FG002|Overall Study|Other|0|||
13253985|NCT01536145|26378597|FG003|Overall Study|Other|0|||
13253986|NCT01536145|26378598|FG004|Overall Study|Other|1|||
13253987|NCT01536145|26378599|FG005|Overall Study|Other|0|||
13253988|NCT01536145|26378600|FG006|Overall Study|Other|0|||
13253989|NCT01536145|26378601|FG007|Overall Study|Other|0|||
13253990|NCT01536145|26378602|FG008|Overall Study|Other|0|||
13253991|NCT01536145|26378603|FG009|Overall Study|Other|3|||
13253992|NCT01536145|26378604|FG010|Overall Study|Other|2|||
13253993|NCT01536145|26378594|FG000|Overall Study|Death|0|||
13253994|NCT01536145|26378595|FG001|Overall Study|Death|0|||
13253995|NCT01536145|26378596|FG002|Overall Study|Death|0|||
13253996|NCT01536145|26378597|FG003|Overall Study|Death|0|||
13253997|NCT01536145|26378598|FG004|Overall Study|Death|0|||
13253998|NCT01536145|26378599|FG005|Overall Study|Death|0|||
13253999|NCT01536145|26378600|FG006|Overall Study|Death|1|||
13254000|NCT01536145|26378601|FG007|Overall Study|Death|0|||
13254001|NCT01536145|26378602|FG008|Overall Study|Death|0|||
13254002|NCT01536145|26378603|FG009|Overall Study|Death|0|||
13254003|NCT01536145|26378604|FG010|Overall Study|Death|0|||
13254004|NCT01536145|26378594|FG000|Overall Study|Adverse Event|0|||
13254005|NCT01536145|26378595|FG001|Overall Study|Adverse Event|0|||
13254006|NCT01536145|26378596|FG002|Overall Study|Adverse Event|0|||
13254007|NCT01536145|26378597|FG003|Overall Study|Adverse Event|0|||
13254008|NCT01536145|26378598|FG004|Overall Study|Adverse Event|0|||
13254009|NCT01536145|26378599|FG005|Overall Study|Adverse Event|0|||
13254010|NCT01536145|26378600|FG006|Overall Study|Adverse Event|0|||
13254011|NCT01536145|26378601|FG007|Overall Study|Adverse Event|2|||
13254012|NCT01536145|26378602|FG008|Overall Study|Adverse Event|0|||
13254013|NCT01536145|26378603|FG009|Overall Study|Adverse Event|0|||
13254014|NCT01536145|26378604|FG010|Overall Study|Adverse Event|3|||
13254015|NCT01536119|26378635|FG000|Overall Study|Lost to Follow-up|17|||
13254016|NCT01536119|26378636|FG001|Overall Study|Lost to Follow-up|14|||
13254017|NCT01536093|26378659|FG000|Overall Study|Death|1|||
13254018|NCT01536093|26378660|FG001|Overall Study|Death|2|||
13254019|NCT01536093|26378659|FG000|Overall Study|absence of maternal colostrum|2|||
13254020|NCT01536093|26378660|FG001|Overall Study|absence of maternal colostrum|0|||
13254021|NCT01536093|26378659|FG000|Overall Study|Withdrawal by Subject|0|||
13254022|NCT01536093|26378660|FG001|Overall Study|Withdrawal by Subject|1|||
13254023|NCT01536067|26378673|FG000|Overall Study|Disease Progression|1|||
13254024|NCT01536015|26378696|FG000|Overall Study|Adverse Event|1|||
13254025|NCT01536015|26378697|FG001|Overall Study|Adverse Event|4|||
13254026|NCT01536015|26378696|FG000|Overall Study|Lost to Follow-up|0|||
13254027|NCT01536015|26378697|FG001|Overall Study|Lost to Follow-up|1|||
13254028|NCT01536015|26378696|FG000|Overall Study|Inclusion Criterion not met|2|||
13254029|NCT01536015|26378697|FG001|Overall Study|Inclusion Criterion not met|0|||
13254030|NCT01536015|26378696|FG000|Overall Study|Study closure|5|||
13254031|NCT01536015|26378697|FG001|Overall Study|Study closure|5|||
13254032|NCT01535729|26378726|FG000|Overall Study|Withdrawal by Subject|2|||
13254033|NCT01535729|26378726|FG000|Overall Study|Disease progression|230|||
13254034|NCT01535729|26378726|FG000|Overall Study|Discontinued treatment|25|||
13254035|NCT01535729|26378726|FG000|Overall Study|Lost to Follow-up|8|||
13254036|NCT01535729|26378726|FG000|Overall Study|Death|52|||
13254037|NCT01535729|26378726|FG000|Overall Study|Other|19|||
13254038|NCT01535729|26378726|FG000|Overall Study|Did not sign informed consent|1|||
13254039|NCT01535729|26378726|FG000|Overall Study|No previous chemotherapy|33|||
13254040|NCT01535729|26378726|FG000|Overall Study|NSCLC grade IV histology not confirmed|20|||
13254041|NCT01535729|26378726|FG000|Overall Study|Protocol Violation|11|||
13254042|NCT01535729|26378726|FG000|Overall Study|Screening failure|1|||
13254043|NCT01535729|26378726|FG000|Overall Study|Not treated|9|||
13254044|NCT01535729|26378726|FG000|Overall Study|No participant record available|5|||
13254045|NCT01535638|26378745|FG000|Treatment 1 (Single Dose)|Protocol Violation|0|||
13254046|NCT01535638|26378746|FG001|Treatment 1 (Single Dose)|Protocol Violation|0|||
13254047|NCT01535638|26378747|FG002|Treatment 1 (Single Dose)|Protocol Violation|0|||
13254048|NCT01535638|26378748|FG003|Treatment 1 (Single Dose)|Protocol Violation|0|||
13254049|NCT01535638|26378749|FG004|Treatment 1 (Single Dose)|Protocol Violation|0|||
13254050|NCT01535638|26378750|FG005|Treatment 1 (Single Dose)|Protocol Violation|1|||
13254051|NCT01535638|26378745|FG000|Treatment 3 (Single Dose)|Protocol Violation|0|||
13254052|NCT01535638|26378746|FG001|Treatment 3 (Single Dose)|Protocol Violation|0|||
13254053|NCT01535638|26378747|FG002|Treatment 3 (Single Dose)|Protocol Violation|0|||
13254054|NCT01535638|26378748|FG003|Treatment 3 (Single Dose)|Protocol Violation|1|||
13254055|NCT01535638|26378749|FG004|Treatment 3 (Single Dose)|Protocol Violation|0|||
13254056|NCT01535638|26378750|FG005|Treatment 3 (Single Dose)|Protocol Violation|0|||
13254057|NCT01535599|26378767|FG000|Overall Study|Adverse Event|6|||
13254058|NCT01535599|26378768|FG001|Overall Study|Adverse Event|15|||
13254059|NCT01535599|26378767|FG000|Overall Study|Lost to Follow-up|3|||
13254060|NCT01535599|26378768|FG001|Overall Study|Lost to Follow-up|4|||
13254061|NCT01535599|26378767|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4|||
13254062|NCT01535599|26378768|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3|||
13254063|NCT01535599|26378767|FG000|Overall Study|Treatment Failure|33|||
13254064|NCT01535599|26378768|FG001|Overall Study|Treatment Failure|66|||
13254065|NCT01535599|26378767|FG000|Overall Study|BL Culture + for Group A Strep|0|||
13254066|NCT01535599|26378768|FG001|Overall Study|BL Culture + for Group A Strep|1|||
13254067|NCT01535599|26378767|FG000|Overall Study|BL Culture + for Yeast//Fungi|0|||
13254068|NCT01535599|26378768|FG001|Overall Study|BL Culture + for Yeast//Fungi|1|||
13254069|NCT01535599|26378767|FG000|Overall Study|Randomized in Error|2|||
13254070|NCT01535599|26378768|FG001|Overall Study|Randomized in Error|4|||
13254071|NCT01535599|26378767|FG000|Overall Study|Did not use product|1|||
13254072|NCT01535599|26378768|FG001|Overall Study|Did not use product|0|||
13254073|NCT01535599|26378767|FG000|Overall Study|Other|1|||
13254074|NCT01535599|26378768|FG001|Overall Study|Other|0|||
13254075|NCT01535599|26378767|FG000|Overall Study|Stopped medication|0|||
13254076|NCT01535599|26378768|FG001|Overall Study|Stopped medication|1|||
13254077|NCT01535599|26378767|FG000|Overall Study|Noncompliance|0|||
13254078|NCT01535599|26378768|FG001|Overall Study|Noncompliance|1|||
13254079|NCT01535560|26378785|FG000|Overall Study|Adverse Event|12|||
13254080|NCT01535560|26378786|FG001|Overall Study|Adverse Event|7|||
13254081|NCT01535560|26378785|FG000|Overall Study|Lost to Follow-up|1|||
13254082|NCT01535560|26378786|FG001|Overall Study|Lost to Follow-up|3|||
13254083|NCT01535560|26378785|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3|||
13254084|NCT01535560|26378786|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1|||
13254085|NCT01535560|26378785|FG000|Overall Study|Treatment Failure|21|||
13254086|NCT01535560|26378786|FG001|Overall Study|Treatment Failure|83|||
13254087|NCT01535560|26378785|FG000|Overall Study|Other|0|||
13254088|NCT01535560|26378786|FG001|Overall Study|Other|1|||
13254089|NCT01535560|26378785|FG000|Overall Study|Randomized in Error|0|||
13254090|NCT01535560|26378786|FG001|Overall Study|Randomized in Error|1|||
13254091|NCT01535443|26378803|FG000|Overall Study|Physician Decision|3|||
13254092|NCT01535287|26378826|FG000|Overall Study|drug not prepared in time|5|||
13254093|NCT01535287|26378827|FG001|Overall Study|drug not prepared in time|6|||
13254094|NCT01535274|26378842|FG000|Overall Study|Determined to be ineligible|0|||
13254095|NCT01535274|26378843|FG001|Overall Study|Determined to be ineligible|1|||
13254096|NCT01535274|26378842|FG000|Overall Study|Misallocated to propofol intervention|0|||
13254097|NCT01535274|26378843|FG001|Overall Study|Misallocated to propofol intervention|1|||
13254098|NCT01535261|26378856|FG000|Overall Study|Physician Decision|8|||
13254099|NCT01535261|26378856|FG000|Overall Study|Protocol Violation|3|||
13254100|NCT01535261|26378856|FG000|Overall Study|Death|5|||
13254101|NCT01535261|26378856|FG000|Overall Study|Lost to Follow-up|8|||
13254102|NCT01535261|26378856|FG000|Overall Study|Withdrawal by Subject|14|||
13254103|NCT01535261|26378856|FG000|Overall Study|Adverse Event|12|||
13254104|NCT01535235|26378871|FG000|Overall Study|Adverse Event|1|||
13254105|NCT01535235|26378872|FG001|Overall Study|Adverse Event|0|||
13254106|NCT01535222|26378911|FG000|Overall Study|Inclusion/exclusion|0|||
13254107|NCT01535222|26378912|FG001|Overall Study|Inclusion/exclusion|0|||
13254108|NCT01535222|26378913|FG002|Overall Study|Inclusion/exclusion|1|||
13254109|NCT01535222|26378914|FG003|Overall Study|Inclusion/exclusion|0|||
13254110|NCT01535222|26378915|FG004|Overall Study|Inclusion/exclusion|0|||
13254111|NCT01535222|26378916|FG005|Overall Study|Inclusion/exclusion|0|||
13254112|NCT01535053|26378939|FG000|Overall Study|Ineligible|1|||
13254113|NCT01535053|26378940|FG001|Overall Study|Ineligible|2|||
13254114|NCT01535040|26378959|FG000|Overall Study|Physician Decision|0|||
13254115|NCT01535040|26378960|FG001|Overall Study|Physician Decision|1|||
13254116|NCT01535040|26378959|FG000|Overall Study|Withdrawal by Subject|13|||
13254117|NCT01535040|26378960|FG001|Overall Study|Withdrawal by Subject|10|||
13254118|NCT01535040|26378959|FG000|Overall Study|Never Started|9|||
13254119|NCT01535040|26378960|FG001|Overall Study|Never Started|4|||
13254120|NCT01535040|26378959|FG000|Overall Study|Toxicity|7|||
13254121|NCT01535040|26378960|FG001|Overall Study|Toxicity|5|||
13254122|NCT01535040|26378959|FG000|Overall Study|Multiple Reasons|1|||
13254123|NCT01535040|26378960|FG001|Overall Study|Multiple Reasons|1|||
13254124|NCT01534962|26379003|FG000|Overall Study|Randomized but did not start treatment|2|||
13254125|NCT01534962|26379004|FG001|Overall Study|Randomized but did not start treatment|0|||
13254126|NCT01534962|26379005|FG002|Overall Study|Randomized but did not start treatment|0|||
13254127|NCT01534962|26379006|FG003|Overall Study|Randomized but did not start treatment|1|||
13254128|NCT01534962|26379003|FG000|Overall Study|Discontinued at AF recurrence|35|||
13254129|NCT01534962|26379004|FG001|Overall Study|Discontinued at AF recurrence|26|||
13254130|NCT01534962|26379005|FG002|Overall Study|Discontinued at AF recurrence|24|||
13254131|NCT01534962|26379006|FG003|Overall Study|Discontinued at AF recurrence|31|||
13254132|NCT01534676|26379019|FG000|Overall Study|Study closed due to poor enrollment|2|||
13254133|NCT01534676|26379020|FG001|Overall Study|Study closed due to poor enrollment|1|||
13254134|NCT01534663|26379061|FG000|Overall Study|Lost to Follow-up|0|||
13254135|NCT01534663|26379062|FG001|Overall Study|Lost to Follow-up|2|||
13254136|NCT01534663|26379061|FG000|Overall Study|Adverse Event|2|||
13254137|NCT01534663|26379062|FG001|Overall Study|Adverse Event|1|||
13254138|NCT01534637|26379070|FG000|Overall Study|Physician Decision|3|||
13254139|NCT01534637|26379070|FG000|Overall Study|Lack of Efficacy|3|||
13254140|NCT01534637|26379070|FG000|Overall Study|Withdrawal by Subject|1|||
13254141|NCT01534637|26379070|FG000|Overall Study|Adverse Event|1|||
13254142|NCT01534637|26379070|FG000|Overall Study|Liver Mets before treatment|1|||
13254143|NCT01534533|26379109|FG000|Overall Study|Lost to Follow-up|3|||
13254144|NCT01534533|26379110|FG001|Overall Study|Lost to Follow-up|0|||
13254145|NCT01534533|26379111|FG002|Overall Study|Lost to Follow-up|4|||
13254146|NCT01534533|26379112|FG003|Overall Study|Lost to Follow-up|3|||
13254147|NCT01534533|26379109|FG000|Overall Study|Withdrawal by Subject|5|||
13254148|NCT01534533|26379110|FG001|Overall Study|Withdrawal by Subject|3|||
13254149|NCT01534533|26379111|FG002|Overall Study|Withdrawal by Subject|4|||
13254150|NCT01534533|26379112|FG003|Overall Study|Withdrawal by Subject|1|||
13254151|NCT01534520|26379131|FG000|Overall Study|Adverse Event|0|||
13254152|NCT01534520|26379132|FG001|Overall Study|Adverse Event|1|||
13254153|NCT01534351|26379159|FG000|Overall Study|Study Terminated Early|1|||
13254154|NCT01534351|26379160|FG001|Overall Study|Study Terminated Early|0|||
13254155|NCT01534351|26379161|FG002|Overall Study|Study Terminated Early|0|||
13254156|NCT01534273|26379202|FG000|Period 1|Physician Decision|0|||
13254157|NCT01534273|26379203|FG001|Period 1|Physician Decision|0|||
13254158|NCT01534273|26379204|FG002|Period 1|Physician Decision|0|||
13254159|NCT01534273|26379205|FG003|Period 1|Physician Decision|1|||
13254160|NCT01534273|26379206|FG004|Period 1|Physician Decision|0|||
13254161|NCT01534273|26379207|FG005|Period 1|Physician Decision|0|||
13254162|NCT01534273|26379208|FG006|Period 1|Physician Decision|0|||
13254163|NCT01534260|26379223|FG000|Overall Study|Adverse Event|1|||
13254164|NCT01534260|26379224|FG001|Overall Study|Adverse Event|8|||
13254165|NCT01534260|26379223|FG000|Overall Study|Death|2|||
13254166|NCT01534260|26379224|FG001|Overall Study|Death|0|||
13254167|NCT01534260|26379223|FG000|Overall Study|Lack of Efficacy|1|||
13254168|NCT01534260|26379224|FG001|Overall Study|Lack of Efficacy|1|||
13254169|NCT01534260|26379223|FG000|Overall Study|Withdrawal by Subject|1|||
13254170|NCT01534260|26379224|FG001|Overall Study|Withdrawal by Subject|3|||
13254171|NCT01534260|26379223|FG000|Overall Study|Disease Progression|8|||
13254172|NCT01534260|26379224|FG001|Overall Study|Disease Progression|6|||
13254173|NCT01534260|26379223|FG000|Overall Study|Physician Decision|3|||
13254174|NCT01534260|26379224|FG001|Overall Study|Physician Decision|1|||
13254175|NCT01534260|26379223|FG000|Overall Study|No treatment, per protocol|0|||
13254176|NCT01534260|26379224|FG001|Overall Study|No treatment, per protocol|1|||
13290255|NCT00103285|26480979|FG002|Induction|Withdrawal by Subject|0|||
13290256|NCT00103285|26480980|FG003|Induction|Withdrawal by Subject|0|||
13290257|NCT00103285|26480981|FG004|Induction|Withdrawal by Subject|0|||
13290258|NCT00103285|26480982|FG005|Induction|Withdrawal by Subject|0|||
13290259|NCT00103285|26480983|FG006|Induction|Withdrawal by Subject|0|||
13290260|NCT00103285|26480984|FG007|Induction|Withdrawal by Subject|0|||
13290261|NCT00103285|26480977|FG000|Induction|Ineligible|43|||
13290262|NCT00103285|26480978|FG001|Induction|Ineligible|0|||
13290263|NCT00103285|26480979|FG002|Induction|Ineligible|0|||
13290264|NCT00103285|26480980|FG003|Induction|Ineligible|0|||
13290265|NCT00103285|26480981|FG004|Induction|Ineligible|0|||
13290266|NCT00103285|26480982|FG005|Induction|Ineligible|0|||
13290267|NCT00103285|26480983|FG006|Induction|Ineligible|0|||
13290268|NCT00103285|26480984|FG007|Induction|Ineligible|0|||
13290269|NCT00103285|26480977|FG000|Induction|Refusal|906|||
13290270|NCT00103285|26480978|FG001|Induction|Refusal|0|||
13290271|NCT00103285|26480979|FG002|Induction|Refusal|0|||
13290272|NCT00103285|26480980|FG003|Induction|Refusal|0|||
13290273|NCT00103285|26480981|FG004|Induction|Refusal|0|||
13290274|NCT00103285|26480982|FG005|Induction|Refusal|0|||
13290275|NCT00103285|26480983|FG006|Induction|Refusal|0|||
13290276|NCT00103285|26480984|FG007|Induction|Refusal|0|||
13290277|NCT00103285|26480977|FG000|Induction|Other|258|||
13290278|NCT00103285|26480978|FG001|Induction|Other|0|||
13290279|NCT00103285|26480979|FG002|Induction|Other|0|||
13290280|NCT00103285|26480980|FG003|Induction|Other|0|||
13290281|NCT00103285|26480981|FG004|Induction|Other|0|||
13290282|NCT00103285|26480982|FG005|Induction|Other|0|||
13290283|NCT00103285|26480983|FG006|Induction|Other|0|||
13290284|NCT00103285|26480984|FG007|Induction|Other|0|||
13290285|NCT00103285|26480977|FG000|Response Assignment|Adverse Event|0|||
13290286|NCT00103285|26480978|FG001|Response Assignment|Adverse Event|8|||
13290287|NCT00103285|26480979|FG002|Response Assignment|Adverse Event|3|||
13290288|NCT00103285|26480980|FG003|Response Assignment|Adverse Event|2|||
13290289|NCT00103285|26480981|FG004|Response Assignment|Adverse Event|3|||
13290290|NCT00103285|26480982|FG005|Response Assignment|Adverse Event|1|||
13290291|NCT00103285|26480983|FG006|Response Assignment|Adverse Event|1|||
13290292|NCT00103285|26480984|FG007|Response Assignment|Adverse Event|2|||
13485865|NCT02555657|27033646|FG000|Overall Study|Physician Decision|0|||
13485866|NCT02555657|27033647|FG001|Overall Study|Physician Decision|1|||
13485867|NCT02555657|27033646|FG000|Overall Study|Sponsor Decision|27|||
13290293|NCT00103285|26480977|FG000|Response Assignment|Death|0|||
13290294|NCT00103285|26480978|FG001|Response Assignment|Death|5|||
13290295|NCT00103285|26480979|FG002|Response Assignment|Death|2|||
13290296|NCT00103285|26480980|FG003|Response Assignment|Death|2|||
13290297|NCT00103285|26480981|FG004|Response Assignment|Death|3|||
13290298|NCT00103285|26480982|FG005|Response Assignment|Death|1|||
13290299|NCT00103285|26480983|FG006|Response Assignment|Death|0|||
13290300|NCT00103285|26480984|FG007|Response Assignment|Death|8|||
13290301|NCT00103285|26480977|FG000|Response Assignment|Lost to Follow-up|0|||
13290302|NCT00103285|26480978|FG001|Response Assignment|Lost to Follow-up|9|||
13290303|NCT00103285|26480979|FG002|Response Assignment|Lost to Follow-up|5|||
13290304|NCT00103285|26480980|FG003|Response Assignment|Lost to Follow-up|5|||
13290305|NCT00103285|26480981|FG004|Response Assignment|Lost to Follow-up|1|||
13290306|NCT00103285|26480982|FG005|Response Assignment|Lost to Follow-up|2|||
13290307|NCT00103285|26480983|FG006|Response Assignment|Lost to Follow-up|2|||
13290308|NCT00103285|26480984|FG007|Response Assignment|Lost to Follow-up|5|||
13290309|NCT00103285|26480977|FG000|Response Assignment|Physician Decision|0|||
13290310|NCT00103285|26480978|FG001|Response Assignment|Physician Decision|13|||
13290311|NCT00103285|26480979|FG002|Response Assignment|Physician Decision|14|||
13290312|NCT00103285|26480980|FG003|Response Assignment|Physician Decision|9|||
13290313|NCT00103285|26480981|FG004|Response Assignment|Physician Decision|13|||
13290314|NCT00103285|26480982|FG005|Response Assignment|Physician Decision|7|||
13290315|NCT00103285|26480983|FG006|Response Assignment|Physician Decision|4|||
13290316|NCT00103285|26480984|FG007|Response Assignment|Physician Decision|35|||
13290317|NCT00103285|26480977|FG000|Response Assignment|Protocol Violation|0|||
13290318|NCT00103285|26480978|FG001|Response Assignment|Protocol Violation|2|||
13290319|NCT00103285|26480979|FG002|Response Assignment|Protocol Violation|0|||
13290320|NCT00103285|26480980|FG003|Response Assignment|Protocol Violation|0|||
13290321|NCT00103285|26480981|FG004|Response Assignment|Protocol Violation|0|||
13290322|NCT00103285|26480982|FG005|Response Assignment|Protocol Violation|0|||
13290323|NCT00103285|26480983|FG006|Response Assignment|Protocol Violation|0|||
13290324|NCT00103285|26480984|FG007|Response Assignment|Protocol Violation|0|||
13290325|NCT00103285|26480977|FG000|Response Assignment|Withdrawal by Subject|0|||
13290326|NCT00103285|26480978|FG001|Response Assignment|Withdrawal by Subject|4|||
13290327|NCT00103285|26480979|FG002|Response Assignment|Withdrawal by Subject|1|||
13290328|NCT00103285|26480980|FG003|Response Assignment|Withdrawal by Subject|1|||
13485868|NCT02555657|27033647|FG001|Overall Study|Sponsor Decision|15|||
13254177|NCT01534208|26379247|FG000|Overall Study|Lost to Follow-up|19|||
13254178|NCT01534208|26379248|FG001|Overall Study|Lost to Follow-up|14|||
13254179|NCT01534208|26379247|FG000|Overall Study|Withdrawal by Subject|6|||
13254180|NCT01534208|26379248|FG001|Overall Study|Withdrawal by Subject|20|||
13254181|NCT01534208|26379247|FG000|Overall Study|Adverse Event|15|||
13254182|NCT01534208|26379248|FG001|Overall Study|Adverse Event|8|||
13254183|NCT01534208|26379247|FG000|Overall Study|Physician Decision|2|||
13254184|NCT01534208|26379248|FG001|Overall Study|Physician Decision|0|||
13254185|NCT01534208|26379247|FG000|Overall Study|Lack of Efficacy|0|||
13254186|NCT01534208|26379248|FG001|Overall Study|Lack of Efficacy|3|||
13254187|NCT01534208|26379247|FG000|Overall Study|Protocol Violation|2|||
13254188|NCT01534208|26379248|FG001|Overall Study|Protocol Violation|2|||
13254189|NCT01534208|26379247|FG000|Overall Study|Sponsor decision|4|||
13254190|NCT01534208|26379248|FG001|Overall Study|Sponsor decision|1|||
13254191|NCT01534208|26379247|FG000|Overall Study|Subject relocation|2|||
13254192|NCT01534208|26379248|FG001|Overall Study|Subject relocation|0|||
13254193|NCT01534208|26379247|FG000|Overall Study|Lab assessment|2|||
13254194|NCT01534208|26379248|FG001|Overall Study|Lab assessment|1|||
13254195|NCT01534208|26379247|FG000|Overall Study|Eligibility error|3|||
13254196|NCT01534208|26379248|FG001|Overall Study|Eligibility error|0|||
13254197|NCT01534208|26379247|FG000|Overall Study|PCP decision|1|||
13254198|NCT01534208|26379248|FG001|Overall Study|PCP decision|0|||
13254199|NCT01534208|26379247|FG000|Overall Study|Needed prohibited meds|1|||
13254200|NCT01534208|26379248|FG001|Overall Study|Needed prohibited meds|0|||
13254201|NCT01534195|26379267|FG000|Overall Study|Withdrawal by Subject|1|||
13254202|NCT01534195|26379268|FG001|Overall Study|Withdrawal by Subject|1|||
13254203|NCT01534182|26379290|FG000|Overall Study|Administrative problems|1|||
13254204|NCT01534182|26379291|FG001|Overall Study|Administrative problems|0|||
13254205|NCT01534182|26379290|FG000|Overall Study|Withdrawal by Subject|4|||
13254206|NCT01534182|26379291|FG001|Overall Study|Withdrawal by Subject|7|||
13254207|NCT01534182|26379290|FG000|Overall Study|Adverse Event|7|||
13254208|NCT01534182|26379291|FG001|Overall Study|Adverse Event|3|||
13254209|NCT01534078|26379300|FG000|Overall Study|Death|1|||
13254210|NCT01534078|26379300|FG000|Overall Study|Withdrawal by Subject|1|||
13254211|NCT01533935|26379333|FG000|Overall Study|Adverse Event|5|||
13254212|NCT01533935|26379334|FG001|Overall Study|Adverse Event|7|||
13254213|NCT01533935|26379335|FG002|Overall Study|Adverse Event|1|||
13254214|NCT01533935|26379336|FG003|Overall Study|Adverse Event|5|||
13254215|NCT01533935|26379337|FG004|Overall Study|Adverse Event|3|||
13254216|NCT01533935|26379333|FG000|Overall Study|Protocol Violation|0|||
13254217|NCT01533935|26379334|FG001|Overall Study|Protocol Violation|2|||
13254218|NCT01533935|26379335|FG002|Overall Study|Protocol Violation|0|||
13254219|NCT01533935|26379336|FG003|Overall Study|Protocol Violation|0|||
13254220|NCT01533935|26379337|FG004|Overall Study|Protocol Violation|0|||
13254221|NCT01533935|26379333|FG000|Overall Study|Lost to Follow-up|0|||
13254222|NCT01533935|26379334|FG001|Overall Study|Lost to Follow-up|0|||
13254223|NCT01533935|26379335|FG002|Overall Study|Lost to Follow-up|1|||
13254224|NCT01533935|26379336|FG003|Overall Study|Lost to Follow-up|0|||
13254225|NCT01533935|26379337|FG004|Overall Study|Lost to Follow-up|0|||
13254226|NCT01533935|26379333|FG000|Overall Study|Withdrawal by Subject|0|||
13254227|NCT01533935|26379334|FG001|Overall Study|Withdrawal by Subject|4|||
13254228|NCT01533935|26379335|FG002|Overall Study|Withdrawal by Subject|5|||
13254229|NCT01533935|26379336|FG003|Overall Study|Withdrawal by Subject|2|||
13254230|NCT01533935|26379337|FG004|Overall Study|Withdrawal by Subject|4|||
13254231|NCT01533935|26379333|FG000|Overall Study|Other reason not defined above|1|||
13254232|NCT01533935|26379334|FG001|Overall Study|Other reason not defined above|0|||
13254233|NCT01533935|26379335|FG002|Overall Study|Other reason not defined above|1|||
13254234|NCT01533935|26379336|FG003|Overall Study|Other reason not defined above|0|||
13254235|NCT01533935|26379337|FG004|Overall Study|Other reason not defined above|1|||
13254236|NCT01533922|26379370|FG000|Overall Study|Adverse Event|5|||
13254237|NCT01533922|26379371|FG001|Overall Study|Adverse Event|8|||
13254238|NCT01533922|26379372|FG002|Overall Study|Adverse Event|6|||
13254239|NCT01533922|26379373|FG003|Overall Study|Adverse Event|3|||
13254240|NCT01533922|26379374|FG004|Overall Study|Adverse Event|4|||
13254241|NCT01533922|26379370|FG000|Overall Study|Lack of Efficacy|0|||
13254242|NCT01533922|26379371|FG001|Overall Study|Lack of Efficacy|0|||
13254243|NCT01533922|26379372|FG002|Overall Study|Lack of Efficacy|1|||
13254244|NCT01533922|26379373|FG003|Overall Study|Lack of Efficacy|0|||
13254245|NCT01533922|26379374|FG004|Overall Study|Lack of Efficacy|0|||
13254246|NCT01533922|26379370|FG000|Overall Study|Protocol Violation|0|||
13254247|NCT01533922|26379371|FG001|Overall Study|Protocol Violation|3|||
13254248|NCT01533922|26379372|FG002|Overall Study|Protocol Violation|0|||
13254249|NCT01533922|26379373|FG003|Overall Study|Protocol Violation|0|||
13254250|NCT01533922|26379374|FG004|Overall Study|Protocol Violation|1|||
13254251|NCT01533922|26379370|FG000|Overall Study|Withdrawal by Subject|3|||
13254252|NCT01533922|26379371|FG001|Overall Study|Withdrawal by Subject|1|||
13254253|NCT01533922|26379372|FG002|Overall Study|Withdrawal by Subject|2|||
13254254|NCT01533922|26379373|FG003|Overall Study|Withdrawal by Subject|2|||
13254255|NCT01533922|26379374|FG004|Overall Study|Withdrawal by Subject|1|||
13254256|NCT01533922|26379370|FG000|Overall Study|Other reason not defined above|2|||
13254257|NCT01533922|26379371|FG001|Overall Study|Other reason not defined above|0|||
13254258|NCT01533922|26379372|FG002|Overall Study|Other reason not defined above|1|||
13254259|NCT01533922|26379373|FG003|Overall Study|Other reason not defined above|0|||
13254260|NCT01533922|26379374|FG004|Overall Study|Other reason not defined above|0|||
13254261|NCT01533714|26379527|FG000|Overall Study|Adverse Event|0|||
13254262|NCT01533714|26379528|FG001|Overall Study|Adverse Event|1|||
13254263|NCT01533714|26379529|FG002|Overall Study|Adverse Event|2|||
13254264|NCT01533714|26379530|FG003|Overall Study|Adverse Event|2|||
13254265|NCT01533714|26379531|FG004|Overall Study|Adverse Event|2|||
13254266|NCT01533714|26379532|FG005|Overall Study|Adverse Event|1|||
13254267|NCT01533714|26379527|FG000|Overall Study|Lack of Efficacy|0|||
13254268|NCT01533714|26379528|FG001|Overall Study|Lack of Efficacy|0|||
13254269|NCT01533714|26379529|FG002|Overall Study|Lack of Efficacy|0|||
13254270|NCT01533714|26379530|FG003|Overall Study|Lack of Efficacy|0|||
13254271|NCT01533714|26379531|FG004|Overall Study|Lack of Efficacy|0|||
13254272|NCT01533714|26379532|FG005|Overall Study|Lack of Efficacy|1|||
13254273|NCT01533714|26379527|FG000|Overall Study|Withdrawal by Subject|0|||
13254274|NCT01533714|26379528|FG001|Overall Study|Withdrawal by Subject|1|||
13254275|NCT01533714|26379529|FG002|Overall Study|Withdrawal by Subject|0|||
13254276|NCT01533714|26379530|FG003|Overall Study|Withdrawal by Subject|1|||
13254277|NCT01533714|26379531|FG004|Overall Study|Withdrawal by Subject|1|||
13254278|NCT01533714|26379532|FG005|Overall Study|Withdrawal by Subject|0|||
13254279|NCT01533714|26379527|FG000|Overall Study|Exclusion criteria|0|||
13254280|NCT01533714|26379528|FG001|Overall Study|Exclusion criteria|1|||
13254281|NCT01533714|26379529|FG002|Overall Study|Exclusion criteria|0|||
13254282|NCT01533714|26379530|FG003|Overall Study|Exclusion criteria|0|||
13254283|NCT01533714|26379531|FG004|Overall Study|Exclusion criteria|0|||
13254284|NCT01533714|26379532|FG005|Overall Study|Exclusion criteria|0|||
13254285|NCT01533714|26379527|FG000|Overall Study|Positive for purified protein derivative|0|||
13254286|NCT01533714|26379528|FG001|Overall Study|Positive for purified protein derivative|0|||
13254287|NCT01533714|26379529|FG002|Overall Study|Positive for purified protein derivative|1|||
13254288|NCT01533714|26379530|FG003|Overall Study|Positive for purified protein derivative|0|||
13254289|NCT01533714|26379531|FG004|Overall Study|Positive for purified protein derivative|1|||
13254290|NCT01533714|26379532|FG005|Overall Study|Positive for purified protein derivative|0|||
13254291|NCT01533714|26379527|FG000|Overall Study|Withdrawal criteria|0|||
13254292|NCT01533714|26379528|FG001|Overall Study|Withdrawal criteria|0|||
13254293|NCT01533714|26379529|FG002|Overall Study|Withdrawal criteria|1|||
13254294|NCT01533714|26379530|FG003|Overall Study|Withdrawal criteria|0|||
13254295|NCT01533714|26379531|FG004|Overall Study|Withdrawal criteria|3|||
13254296|NCT01533714|26379532|FG005|Overall Study|Withdrawal criteria|1|||
13254297|NCT01533714|26379527|FG000|Overall Study|Ineligibility reason|0|||
13254298|NCT01533714|26379528|FG001|Overall Study|Ineligibility reason|0|||
13254299|NCT01533714|26379529|FG002|Overall Study|Ineligibility reason|0|||
13254300|NCT01533714|26379530|FG003|Overall Study|Ineligibility reason|1|||
13254301|NCT01533714|26379531|FG004|Overall Study|Ineligibility reason|0|||
13254302|NCT01533714|26379532|FG005|Overall Study|Ineligibility reason|0|||
13254303|NCT01533688|26379553|FG000|Overall Study|Withdrawal by Subject|5|||
13254304|NCT01533688|26379554|FG001|Overall Study|Withdrawal by Subject|4|||
13254305|NCT01533688|26379555|FG002|Overall Study|Withdrawal by Subject|3|||
13254306|NCT01533688|26379553|FG000|Overall Study|Medically unstable|1|||
13254307|NCT01533688|26379554|FG001|Overall Study|Medically unstable|3|||
13254308|NCT01533688|26379555|FG002|Overall Study|Medically unstable|3|||
13254309|NCT01533688|26379553|FG000|Overall Study|Had colonoscopy at outside hospital|2|||
13254310|NCT01533688|26379554|FG001|Overall Study|Had colonoscopy at outside hospital|3|||
13254311|NCT01533688|26379555|FG002|Overall Study|Had colonoscopy at outside hospital|2|||
13254312|NCT01533493|26379568|FG000|Overall Study|Adverse Event|2|||
13254313|NCT01533493|26379569|FG001|Overall Study|Adverse Event|1|||
13254314|NCT01533493|26379568|FG000|Overall Study|Withdrawal by Subject|1|||
13254315|NCT01533493|26379569|FG001|Overall Study|Withdrawal by Subject|2|||
13254316|NCT01533493|26379568|FG000|Overall Study|Lost to Follow-up|2|||
13254317|NCT01533493|26379569|FG001|Overall Study|Lost to Follow-up|0|||
13254318|NCT01533428|26379616|FG000|Overall Study|Adverse Event|0|||
13254319|NCT01533428|26379617|FG001|Overall Study|Adverse Event|1|||
13254320|NCT01533428|26379616|FG000|Overall Study|Lost to Follow-up|2|||
13254321|NCT01533428|26379617|FG001|Overall Study|Lost to Follow-up|1|||
13254322|NCT01533428|26379616|FG000|Overall Study|Withdrawal by Subject|7|||
13254323|NCT01533428|26379617|FG001|Overall Study|Withdrawal by Subject|6|||
13254324|NCT01533246|26379628|FG000|Overall Study|Adverse Event|1|||
13254325|NCT01533246|26379628|FG000|Overall Study|Withdrawal by Subject|1|||
13254326|NCT01533181|26379647|FG000|Overall Study|Disease progression pre-active treatment|0|||
13254327|NCT01533181|26379648|FG001|Overall Study|Disease progression pre-active treatment|1|||
13254328|NCT01533181|26379647|FG000|Overall Study|Patient withdrawal pre-active treatment|1|||
13254329|NCT01533181|26379648|FG001|Overall Study|Patient withdrawal pre-active treatment|0|||
13254330|NCT01532999|26379677|FG000|Overall Study|Lost to Follow-up|14|||
13254331|NCT01532999|26379678|FG001|Overall Study|Lost to Follow-up|8|||
13254332|NCT01532999|26379677|FG000|Overall Study|Physician Decision|1|||
13254333|NCT01532999|26379678|FG001|Overall Study|Physician Decision|2|||
13254334|NCT01532999|26379677|FG000|Overall Study|Withdrawal by Subject|5|||
13254335|NCT01532999|26379678|FG001|Overall Study|Withdrawal by Subject|0|||
13254336|NCT01532999|26379677|FG000|Overall Study|Relocated|2|||
13254337|NCT01532999|26379678|FG001|Overall Study|Relocated|0|||
13254338|NCT01532999|26379677|FG000|Overall Study|should not have been randomized|1|||
13254339|NCT01532999|26379678|FG001|Overall Study|should not have been randomized|0|||
13254340|NCT01532999|26379677|FG000|Overall Study|substantial noncompliance|2|||
13254341|NCT01532999|26379678|FG001|Overall Study|substantial noncompliance|0|||
13254342|NCT01532999|26379677|FG000|Overall Study|no show for week 9 assessments|6|||
13254343|NCT01532999|26379678|FG001|Overall Study|no show for week 9 assessments|4|||
13254344|NCT01532999|26379677|FG000|Overall Study|Adverse Event|0|||
13254345|NCT01532999|26379678|FG001|Overall Study|Adverse Event|1|||
13254346|NCT01532999|26379677|FG000|Overall Study|incarcerated|0|||
13254347|NCT01532999|26379678|FG001|Overall Study|incarcerated|1|||
13254348|NCT01532999|26379677|FG000|Overall Study|New job|0|||
13254349|NCT01532999|26379678|FG001|Overall Study|New job|2|||
13254350|NCT01532986|26379709|FG000|Overall Study|Death|9|||
13254351|NCT01532986|26379710|FG001|Overall Study|Death|9|||
13254352|NCT01532986|26379709|FG000|Overall Study|Withdrawal by Subject|7|||
13254353|NCT01532986|26379710|FG001|Overall Study|Withdrawal by Subject|10|||
13254354|NCT01532986|26379709|FG000|Overall Study|Physician Decision|7|||
13254355|NCT01532986|26379710|FG001|Overall Study|Physician Decision|5|||
13254356|NCT01532934|26379727|FG000|Overall Study|Lost to Follow-up|11|||
13254357|NCT01532934|26379728|FG001|Overall Study|Lost to Follow-up|11|||
13254358|NCT01532934|26379727|FG000|Overall Study|In controlled environment|3|||
13254359|NCT01532934|26379728|FG001|Overall Study|In controlled environment|2|||
13254360|NCT01532921|26379750|FG000|Overall Study|Death|3|||
13254361|NCT01532921|26379750|FG000|Overall Study|Withdrawal by Subject|2|||
13254362|NCT01532921|26379750|FG000|Overall Study|Lost to Follow-up|3|||
13254363|NCT01532921|26379750|FG000|Overall Study|Physician Decision|7|||
13254364|NCT01532921|26379750|FG000|Overall Study|Device was explanted during procedure|1|||
13254365|NCT01532908|26379773|FG000|Overall Study|Not Transplanted|1|||
13254366|NCT01532908|26379774|FG001|Overall Study|Not Transplanted|0|||
13254367|NCT01532869|26379818|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0|||
13254368|NCT01532869|26379819|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1|||
13254369|NCT01532869|26379818|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2|||
13254370|NCT01532869|26379819|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3|||
13254371|NCT01532869|26379818|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0|||
13254372|NCT01532869|26379819|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1|||
13254373|NCT01532869|26379818|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1|||
13254374|NCT01532869|26379819|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0|||
13254375|NCT01532869|26379818|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
13254376|NCT01532869|26379819|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
13254377|NCT01532869|26379818|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4|||
13254378|NCT01532869|26379819|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2|||
13254379|NCT01532869|26379818|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0|||
13254380|NCT01532869|26379819|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3|||
13254381|NCT01532869|26379818|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4|||
13254382|NCT01532869|26379819|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5|||
13254383|NCT01532869|26379818|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0|||
13254384|NCT01532869|26379819|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1|||
13254385|NCT01532869|26379818|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1|||
13254386|NCT01532869|26379819|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0|||
13254387|NCT01532869|26379818|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0|||
13254388|NCT01532869|26379819|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1|||
13254389|NCT01532869|26379818|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5|||
13254390|NCT01532869|26379819|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3|||
13254391|NCT01532869|26379818|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1|||
13254392|NCT01532869|26379819|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0|||
13254393|NCT01532869|26379818|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4|||
13254394|NCT01532869|26379819|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1|||
13254395|NCT01532869|26379818|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1|||
13254396|NCT01532869|26379819|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0|||
13254397|NCT01532869|26379818|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
13254398|NCT01532869|26379819|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
13254399|NCT01532869|26379818|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
13254400|NCT01532869|26379819|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
13254401|NCT01532687|26379838|FG000|Overall Study|Death|2|||
13254402|NCT01532687|26379839|FG001|Overall Study|Death|0|||
13254403|NCT01532687|26379838|FG000|Overall Study|Adverse Event|6|||
13254404|NCT01532687|26379839|FG001|Overall Study|Adverse Event|1|||
13254405|NCT01532687|26379838|FG000|Overall Study|Withdrawal by Subject|1|||
13254406|NCT01532687|26379839|FG001|Overall Study|Withdrawal by Subject|0|||
13254407|NCT01532687|26379838|FG000|Overall Study|Physician Decision|2|||
13254408|NCT01532687|26379839|FG001|Overall Study|Physician Decision|1|||
13254409|NCT01532687|26379838|FG000|Overall Study|Protocol-defined delay > 3 weeks|3|||
13254410|NCT01532687|26379839|FG001|Overall Study|Protocol-defined delay > 3 weeks|0|||
13254411|NCT01532648|26379864|FG000|Overall Study|Lost to Follow-up|3|||
13485869|NCT02555657|27033646|FG000|Overall Study|Withdrawal by Subject|11|||
13485870|NCT02555657|27033647|FG001|Overall Study|Withdrawal by Subject|32|||
13485871|NCT02190721|27033761|FG000|Overall Study|Patient was out of the city|0|||
13485872|NCT02190721|27033762|FG001|Overall Study|Patient was out of the city|1|||
13485873|NCT02190721|27033763|FG002|Overall Study|Patient was out of the city|0|||
13485874|NCT00739401|27033825|FG000|Overall Study|patients were not due for the 2 year follow-up|34|||
13485875|NCT00739401|27033825|FG000|Overall Study|Death|3|||
13116867|NCT03070782|25923512|FG005|Overall Study|Reason Not Specified|1|||
13116868|NCT03070782|25923507|FG000|Overall Study|Ineligibility|0|||
13116869|NCT03070782|25923508|FG001|Overall Study|Ineligibility|0|||
13116870|NCT03070782|25923509|FG002|Overall Study|Ineligibility|0|||
13116871|NCT03070782|25923510|FG003|Overall Study|Ineligibility|1|||
13116872|NCT03070782|25923511|FG004|Overall Study|Ineligibility|0|||
13116873|NCT03070782|25923512|FG005|Overall Study|Ineligibility|1|||
13116874|NCT03070782|25923507|FG000|Overall Study|Pregnancy|0|||
13116875|NCT03070782|25923508|FG001|Overall Study|Pregnancy|0|||
13116876|NCT03070782|25923509|FG002|Overall Study|Pregnancy|0|||
13116877|NCT03070782|25923510|FG003|Overall Study|Pregnancy|1|||
13116878|NCT03070782|25923511|FG004|Overall Study|Pregnancy|0|||
13116879|NCT03070782|25923512|FG005|Overall Study|Pregnancy|0|||
13116880|NCT03070782|25923507|FG000|Overall Study|Investigator Judgement|0|||
13116881|NCT03070782|25923508|FG001|Overall Study|Investigator Judgement|0|||
13485876|NCT00739401|27033825|FG000|Overall Study|Withdrawal by Subject|4|||
13485877|NCT00651742|27033839|FG000|Overall Study|Objective Disease Progression|22|||
13485878|NCT00651742|27033839|FG000|Overall Study|Toxicity|3|||
13485879|NCT00651742|27033839|FG000|Overall Study|Investigator Judgment|1|||
13485880|NCT00651742|27033839|FG000|Overall Study|Withdrawal of Consent|1|||
13485881|NCT00651742|27033839|FG000|Overall Study|Enrolled but not treated|1|||
13485882|NCT04930263|27033882|FG000|Overall Study|Withdrawal by Subject|3|||
13485883|NCT04930263|27033883|FG001|Overall Study|Withdrawal by Subject|5|||
13488026|NCT01111565|27041931|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
13488027|NCT01111565|27041932|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
13488028|NCT01111565|27041933|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
13116882|NCT03070782|25923509|FG002|Overall Study|Investigator Judgement|0|||
13116883|NCT03070782|25923510|FG003|Overall Study|Investigator Judgement|1|||
13116884|NCT03070782|25923511|FG004|Overall Study|Investigator Judgement|0|||
13116885|NCT03070782|25923512|FG005|Overall Study|Investigator Judgement|0|||
13116886|NCT03070483|25923523|FG000|Overall Study|Lost to Follow-up|2|||
13116887|NCT03070431|25923538|FG000|Overall Study|Withdrawal by Subject|2|||
13116888|NCT03070431|25923538|FG000|Overall Study|Lost to Follow-up|2|||
13116889|NCT03070171|25923561|FG000|Treatment Period 2 + Washout|Other Adverse Event|0|||
13116890|NCT03070171|25923562|FG001|Treatment Period 2 + Washout|Other Adverse Event|1|||
13116891|NCT03070171|25923561|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0|||
13116892|NCT03070171|25923562|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1|||
13116893|NCT03070002|25923570|FG000|Follow up for 2 Years|Death|1|||
13116894|NCT03069989|25923663|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1|||
13116895|NCT03069989|25923664|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0|||
13488029|NCT01111565|27041934|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
13488030|NCT01111565|27041935|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1|||
13488031|NCT01092117|27041942|FG000|Index Procedure to 1 Month|Death|1|||
13488032|NCT01092117|27041942|FG000|1 Month|Death|1|||
13488033|NCT01092117|27041942|FG000|1 Month|Withdrawal by Subject|1|||
13488034|NCT01092117|27041942|FG000|1 Month|Lost to Follow-up|1|||
13488035|NCT01092117|27041942|FG000|6 Months|Death|2|||
13488036|NCT01092117|27041942|FG000|6 Months|Withdrawal by Subject|3|||
13488037|NCT01092117|27041942|FG000|12 Month|Death|11|||
13488038|NCT01092117|27041942|FG000|12 Month|Withdrawal by Subject|2|||
13488039|NCT01092117|27041942|FG000|12 Month|Lost to Follow-up|1|||
13254412|NCT01532648|26379865|FG001|Overall Study|Lost to Follow-up|4|||
13488040|NCT01092117|27041942|FG000|Year 2|Death|5|||
13488041|NCT01092117|27041942|FG000|Year 2|Withdrawal by Subject|4|||
13488042|NCT01092117|27041942|FG000|Year 2|Lost to Follow-up|1|||
13488043|NCT01092117|27041942|FG000|Year 3|Death|7|||
13488044|NCT01092117|27041942|FG000|Year 3|Withdrawal by Subject|9|||
13116896|NCT03069716|25923706|FG000|Run-in Period (2 Weeks)|Adverse Event|1|||
13116897|NCT03069716|25923707|FG001|Run-in Period (2 Weeks)|Adverse Event|0|||
13254413|NCT01532648|26379864|FG000|Overall Study|Lack of Efficacy|4|||
13254414|NCT01532648|26379865|FG001|Overall Study|Lack of Efficacy|1|||
13488045|NCT01092117|27041942|FG000|Year 3|Lost to Follow-up|3|||
13254415|NCT01532648|26379864|FG000|Overall Study|Protocol Violation|1|||
13254416|NCT01532648|26379865|FG001|Overall Study|Protocol Violation|1|||
13254417|NCT01532648|26379864|FG000|Overall Study|Adverse Event|12|||
13254418|NCT01532648|26379865|FG001|Overall Study|Adverse Event|9|||
13254419|NCT01532648|26379864|FG000|Overall Study|Withdrawal by Subject|16|||
13254420|NCT01532648|26379865|FG001|Overall Study|Withdrawal by Subject|2|||
13254421|NCT01532570|26379909|FG000|Overall Study|Lack of Efficacy|1|||
13254422|NCT01532570|26379910|FG001|Overall Study|Lack of Efficacy|0|||
13254423|NCT01532570|26379911|FG002|Overall Study|Lack of Efficacy|0|||
13254424|NCT01532570|26379912|FG003|Overall Study|Lack of Efficacy|0|||
13254425|NCT01532570|26379909|FG000|Overall Study|Withdrawal by Subject|0|||
13254426|NCT01532570|26379910|FG001|Overall Study|Withdrawal by Subject|1|||
13254427|NCT01532570|26379911|FG002|Overall Study|Withdrawal by Subject|0|||
13254428|NCT01532570|26379912|FG003|Overall Study|Withdrawal by Subject|0|||
13254429|NCT01532414|26379930|FG000|Overall Study|Lost to Follow-up|3|||
13254430|NCT01532414|26379931|FG001|Overall Study|Lost to Follow-up|0|||
13254431|NCT01532414|26379932|FG002|Overall Study|Lost to Follow-up|1|||
13254432|NCT01532414|26379930|FG000|Overall Study|Withdrawal by Subject|3|||
13254433|NCT01532414|26379931|FG001|Overall Study|Withdrawal by Subject|0|||
13254434|NCT01532414|26379932|FG002|Overall Study|Withdrawal by Subject|0|||
13254435|NCT01532414|26379930|FG000|Overall Study|No V6 semen sample|0|||
13254436|NCT01532414|26379931|FG001|Overall Study|No V6 semen sample|1|||
13254437|NCT01532414|26379932|FG002|Overall Study|No V6 semen sample|0|||
13254438|NCT01532414|26379930|FG000|Overall Study|Adverse Event|0|||
13254439|NCT01532414|26379931|FG001|Overall Study|Adverse Event|1|||
13254440|NCT01532414|26379932|FG002|Overall Study|Adverse Event|1|||
13254441|NCT01532414|26379930|FG000|Overall Study|Unable to complete 24 hour PK|0|||
13254442|NCT01532414|26379931|FG001|Overall Study|Unable to complete 24 hour PK|0|||
13254443|NCT01532414|26379932|FG002|Overall Study|Unable to complete 24 hour PK|1|||
13254444|NCT01532414|26379930|FG000|Overall Study|Withdrawn by sponsor|1|||
13254445|NCT01532414|26379931|FG001|Overall Study|Withdrawn by sponsor|0|||
13254446|NCT01532414|26379932|FG002|Overall Study|Withdrawn by sponsor|0|||
13254447|NCT01532388|26379967|FG000|3-month Follow-up|Lost to Follow-up|68|||
13254448|NCT01532388|26379968|FG001|3-month Follow-up|Lost to Follow-up|68|||
13254449|NCT01532388|26379967|FG000|6-month Follow-up|Lost to Follow-up|74|||
13254450|NCT01532388|26379968|FG001|6-month Follow-up|Lost to Follow-up|66|||
13254451|NCT01532388|26379967|FG000|12-month Follow-up|Lost to Follow-up|69|||
13254452|NCT01532388|26379968|FG001|12-month Follow-up|Lost to Follow-up|67|||
13254453|NCT01531998|26379975|FG000|Overall Study|Withdrawal by Subject|3|||
13254454|NCT01531894|26379981|FG000|Overall Study|Physician Decision|8|||
13254455|NCT01531894|26379981|FG000|Overall Study|Death|1|||
13254456|NCT01531725|26379988|FG000|Overall Study|Protocol Violation|5|||
13254457|NCT01531673|26380137|FG000|Overall Study|Non-Compliance|0|||
13254458|NCT01531673|26380138|FG001|Overall Study|Non-Compliance|0|||
13254459|NCT01531673|26380139|FG002|Overall Study|Non-Compliance|0|||
13254460|NCT01531673|26380140|FG003|Overall Study|Non-Compliance|0|||
13254461|NCT01531673|26380141|FG004|Overall Study|Non-Compliance|0|||
13254462|NCT01531673|26380142|FG005|Overall Study|Non-Compliance|1|||
13254463|NCT01531673|26380143|FG006|Overall Study|Non-Compliance|0|||
13254464|NCT01531673|26380144|FG007|Overall Study|Non-Compliance|0|||
13254465|NCT01531673|26380145|FG008|Overall Study|Non-Compliance|0|||
13254466|NCT01531673|26380146|FG009|Overall Study|Non-Compliance|0|||
13254467|NCT01531673|26380147|FG010|Overall Study|Non-Compliance|0|||
13254468|NCT01531673|26380148|FG011|Overall Study|Non-Compliance|0|||
13254469|NCT01531673|26380149|FG012|Overall Study|Non-Compliance|0|||
13254470|NCT01531673|26380137|FG000|Overall Study|Adverse Event|0|||
13254471|NCT01531673|26380138|FG001|Overall Study|Adverse Event|1|||
13254472|NCT01531673|26380139|FG002|Overall Study|Adverse Event|0|||
13254473|NCT01531673|26380140|FG003|Overall Study|Adverse Event|0|||
13254474|NCT01531673|26380141|FG004|Overall Study|Adverse Event|0|||
13254475|NCT01531673|26380142|FG005|Overall Study|Adverse Event|0|||
13254476|NCT01531673|26380143|FG006|Overall Study|Adverse Event|0|||
13254477|NCT01531673|26380144|FG007|Overall Study|Adverse Event|0|||
13254478|NCT01531673|26380145|FG008|Overall Study|Adverse Event|0|||
13254479|NCT01531673|26380146|FG009|Overall Study|Adverse Event|0|||
13254480|NCT01531673|26380147|FG010|Overall Study|Adverse Event|0|||
13254481|NCT01531673|26380148|FG011|Overall Study|Adverse Event|0|||
13254482|NCT01531673|26380149|FG012|Overall Study|Adverse Event|0|||
13254483|NCT01531673|26380137|FG000|Overall Study|Lost to Follow-up|0|||
13254484|NCT01531673|26380138|FG001|Overall Study|Lost to Follow-up|0|||
13254485|NCT01531673|26380139|FG002|Overall Study|Lost to Follow-up|0|||
13254486|NCT01531673|26380140|FG003|Overall Study|Lost to Follow-up|0|||
13254487|NCT01531673|26380141|FG004|Overall Study|Lost to Follow-up|1|||
13254488|NCT01531673|26380142|FG005|Overall Study|Lost to Follow-up|0|||
13254489|NCT01531673|26380143|FG006|Overall Study|Lost to Follow-up|0|||
13254490|NCT01531673|26380144|FG007|Overall Study|Lost to Follow-up|0|||
13254491|NCT01531673|26380145|FG008|Overall Study|Lost to Follow-up|0|||
13254492|NCT01531673|26380146|FG009|Overall Study|Lost to Follow-up|0|||
13254493|NCT01531673|26380147|FG010|Overall Study|Lost to Follow-up|0|||
13254494|NCT01531673|26380148|FG011|Overall Study|Lost to Follow-up|0|||
13254495|NCT01531673|26380149|FG012|Overall Study|Lost to Follow-up|0|||
13254496|NCT01531673|26380137|FG000|Overall Study|Other|0|||
13254497|NCT01531673|26380138|FG001|Overall Study|Other|0|||
13254498|NCT01531673|26380139|FG002|Overall Study|Other|0|||
13254499|NCT01531673|26380140|FG003|Overall Study|Other|1|||
13254500|NCT01531673|26380141|FG004|Overall Study|Other|0|||
13254501|NCT01531673|26380142|FG005|Overall Study|Other|0|||
13254502|NCT01531673|26380143|FG006|Overall Study|Other|0|||
13254503|NCT01531673|26380144|FG007|Overall Study|Other|0|||
13254504|NCT01531673|26380145|FG008|Overall Study|Other|0|||
13254505|NCT01531673|26380146|FG009|Overall Study|Other|1|||
13254506|NCT01531673|26380147|FG010|Overall Study|Other|0|||
13254507|NCT01531673|26380148|FG011|Overall Study|Other|0|||
13254508|NCT01531673|26380149|FG012|Overall Study|Other|0|||
13254509|NCT01531387|26380170|FG000|Overall Study|Early termination of study|11|||
13254510|NCT01531387|26380171|FG001|Overall Study|Early termination of study|11|||
13254511|NCT01531205|26380182|FG000|Overall Study|Did not proceed to surgery|1|||
13254512|NCT01531153|26380248|FG000|Overall Study|Withdrawal by Subject|10|||
13254513|NCT01531153|26380249|FG001|Overall Study|Withdrawal by Subject|9|||
13254514|NCT01531153|26380250|FG002|Overall Study|Withdrawal by Subject|15|||
13254515|NCT01530464|26380284|FG000|Washout (24h)|Withdrawal by Subject|1|||
13254516|NCT01530464|26380285|FG001|Washout (24h)|Withdrawal by Subject|0|||
13254517|NCT01530464|26380284|FG000|Washout (24h)|Withdrawal by Subject|0|||
13254518|NCT01530464|26380285|FG001|Washout (24h)|Withdrawal by Subject|1|||
13254519|NCT01530334|26380296|FG000|Overall Study|Adverse Event|3|||
13254520|NCT01530334|26380296|FG000|Overall Study|unknown reason|1|||
13254521|NCT01530334|26380296|FG000|Overall Study|Progressive disease|47|||
13254522|NCT01530256|26380306|FG000|Overall Study|Death|2|||
13254523|NCT01530087|26380313|FG000|Overall Study|Physician Decision|2|||
13254524|NCT01529749|26380400|FG000|Overall Study|Lost to Follow-up|0|||
13254525|NCT01529749|26380401|FG001|Overall Study|Lost to Follow-up|1|||
13254526|NCT01529749|26380402|FG002|Overall Study|Lost to Follow-up|1|||
13254527|NCT01529749|26380403|FG003|Overall Study|Lost to Follow-up|0|||
13254528|NCT01529749|26380400|FG000|Overall Study|Physician Decision|0|||
13254529|NCT01529749|26380401|FG001|Overall Study|Physician Decision|0|||
13254530|NCT01529749|26380402|FG002|Overall Study|Physician Decision|0|||
13254531|NCT01529749|26380403|FG003|Overall Study|Physician Decision|1|||
13254532|NCT01529749|26380400|FG000|Overall Study|Withdrawal by Subject|0|||
13254533|NCT01529749|26380401|FG001|Overall Study|Withdrawal by Subject|1|||
13254534|NCT01529749|26380402|FG002|Overall Study|Withdrawal by Subject|1|||
13254535|NCT01529749|26380403|FG003|Overall Study|Withdrawal by Subject|0|||
13254536|NCT01529749|26380400|FG000|Overall Study|Protocol Violation|0|||
13254537|NCT01529749|26380401|FG001|Overall Study|Protocol Violation|0|||
13254538|NCT01529749|26380402|FG002|Overall Study|Protocol Violation|0|||
13254539|NCT01529749|26380403|FG003|Overall Study|Protocol Violation|1|||
13254540|NCT01529645|26380530|FG000|Overall Study|Lost to Follow-up|0|||
13254541|NCT01529645|26380531|FG001|Overall Study|Lost to Follow-up|1|||
13116898|NCT03069716|25923708|FG002|Run-in Period (2 Weeks)|Adverse Event|0|||
13254542|NCT01529645|26380532|FG002|Overall Study|Lost to Follow-up|1|||
13254543|NCT01529645|26380533|FG003|Overall Study|Lost to Follow-up|1|||
13254544|NCT01529645|26380534|FG004|Overall Study|Lost to Follow-up|1|||
13254545|NCT01529645|26380535|FG005|Overall Study|Lost to Follow-up|0|||
13254546|NCT01529645|26380536|FG006|Overall Study|Lost to Follow-up|2|||
13254547|NCT01529645|26380537|FG007|Overall Study|Lost to Follow-up|0|||
13254548|NCT01529645|26380538|FG008|Overall Study|Lost to Follow-up|1|||
13254549|NCT01529645|26380539|FG009|Overall Study|Lost to Follow-up|0|||
13254550|NCT01529645|26380530|FG000|Overall Study|SAE - Premature contractions|0|||
13254551|NCT01529645|26380531|FG001|Overall Study|SAE - Premature contractions|0|||
13254552|NCT01529645|26380532|FG002|Overall Study|SAE - Premature contractions|1|||
13254553|NCT01529645|26380533|FG003|Overall Study|SAE - Premature contractions|0|||
13254554|NCT01529645|26380534|FG004|Overall Study|SAE - Premature contractions|0|||
13254555|NCT01529645|26380535|FG005|Overall Study|SAE - Premature contractions|0|||
13254556|NCT01529645|26380536|FG006|Overall Study|SAE - Premature contractions|0|||
13254557|NCT01529645|26380537|FG007|Overall Study|SAE - Premature contractions|0|||
13254558|NCT01529645|26380538|FG008|Overall Study|SAE - Premature contractions|0|||
13254559|NCT01529645|26380539|FG009|Overall Study|SAE - Premature contractions|0|||
13254560|NCT01529645|26380530|FG000|Overall Study|Withdrawal by Subject|2|||
13254561|NCT01529645|26380531|FG001|Overall Study|Withdrawal by Subject|0|||
13254562|NCT01529645|26380532|FG002|Overall Study|Withdrawal by Subject|0|||
13254563|NCT01529645|26380533|FG003|Overall Study|Withdrawal by Subject|1|||
13254564|NCT01529645|26380534|FG004|Overall Study|Withdrawal by Subject|1|||
13254565|NCT01529645|26380535|FG005|Overall Study|Withdrawal by Subject|1|||
13254566|NCT01529645|26380536|FG006|Overall Study|Withdrawal by Subject|0|||
13254567|NCT01529645|26380537|FG007|Overall Study|Withdrawal by Subject|0|||
13254568|NCT01529645|26380538|FG008|Overall Study|Withdrawal by Subject|0|||
13254569|NCT01529645|26380539|FG009|Overall Study|Withdrawal by Subject|0|||
13254570|NCT01529632|26380564|FG000|Overall Study|Administrative problem|2|||
13254571|NCT01529632|26380565|FG001|Overall Study|Administrative problem|1|||
13254572|NCT01529632|26380564|FG000|Overall Study|Protocol Violation|0|||
13254573|NCT01529632|26380565|FG001|Overall Study|Protocol Violation|1|||
13254574|NCT01529632|26380564|FG000|Overall Study|Adverse Event|1|||
13254575|NCT01529632|26380565|FG001|Overall Study|Adverse Event|1|||
13254576|NCT01529606|26380582|FG000|Overall Study|Lost to Follow-up|21|||
13254577|NCT01529606|26380583|FG001|Overall Study|Lost to Follow-up|18|||
13254578|NCT01529515|26380605|FG000|TRANSITION PHASE|Adverse Event|16|||
13254579|NCT01529515|26380606|FG001|TRANSITION PHASE|Adverse Event|0|||
13254580|NCT01529515|26380607|FG002|TRANSITION PHASE|Adverse Event|0|||
13254581|NCT01529515|26380608|FG003|TRANSITION PHASE|Adverse Event|0|||
13254582|NCT01529515|26380605|FG000|TRANSITION PHASE|Death|1|||
13254583|NCT01529515|26380606|FG001|TRANSITION PHASE|Death|0|||
13254584|NCT01529515|26380607|FG002|TRANSITION PHASE|Death|0|||
13254585|NCT01529515|26380608|FG003|TRANSITION PHASE|Death|0|||
13254586|NCT01529515|26380605|FG000|TRANSITION PHASE|Lack of Efficacy|19|||
13254587|NCT01529515|26380606|FG001|TRANSITION PHASE|Lack of Efficacy|0|||
13254588|NCT01529515|26380607|FG002|TRANSITION PHASE|Lack of Efficacy|0|||
13254589|NCT01529515|26380608|FG003|TRANSITION PHASE|Lack of Efficacy|0|||
13254590|NCT01529515|26380605|FG000|TRANSITION PHASE|Lost to Follow-up|19|||
13254591|NCT01529515|26380606|FG001|TRANSITION PHASE|Lost to Follow-up|0|||
13254592|NCT01529515|26380607|FG002|TRANSITION PHASE|Lost to Follow-up|0|||
13254593|NCT01529515|26380608|FG003|TRANSITION PHASE|Lost to Follow-up|0|||
13254594|NCT01529515|26380605|FG000|TRANSITION PHASE|Protocol Violation|4|||
13254595|NCT01529515|26380606|FG001|TRANSITION PHASE|Protocol Violation|0|||
13254596|NCT01529515|26380607|FG002|TRANSITION PHASE|Protocol Violation|0|||
13254597|NCT01529515|26380608|FG003|TRANSITION PHASE|Protocol Violation|0|||
13254598|NCT01529515|26380605|FG000|TRANSITION PHASE|Withdrawal by Subject|51|||
13254599|NCT01529515|26380606|FG001|TRANSITION PHASE|Withdrawal by Subject|0|||
13254600|NCT01529515|26380607|FG002|TRANSITION PHASE|Withdrawal by Subject|0|||
13254601|NCT01529515|26380608|FG003|TRANSITION PHASE|Withdrawal by Subject|0|||
13254602|NCT01529515|26380605|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8|||
13254603|NCT01529515|26380606|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
13254604|NCT01529515|26380607|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
13254605|NCT01529515|26380608|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
13254606|NCT01529515|26380605|FG000|TRANSITION PHASE|Other|9|||
13254607|NCT01529515|26380606|FG001|TRANSITION PHASE|Other|0|||
13254608|NCT01529515|26380607|FG002|TRANSITION PHASE|Other|0|||
13254609|NCT01529515|26380608|FG003|TRANSITION PHASE|Other|0|||
13116899|NCT03069716|25923706|FG000|Run-in Period (2 Weeks)|Protocol Violation|1|||
13254610|NCT01529515|26380605|FG000|MAINTENANCE PHASE|Adverse Event|0|||
13254611|NCT01529515|26380606|FG001|MAINTENANCE PHASE|Adverse Event|10|||
13116900|NCT03069716|25923707|FG001|Run-in Period (2 Weeks)|Protocol Violation|0|||
13116901|NCT03069716|25923708|FG002|Run-in Period (2 Weeks)|Protocol Violation|0|||
13116902|NCT03069716|25923706|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5|||
13116903|NCT03069716|25923707|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
13116904|NCT03069716|25923708|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
13116905|NCT03069716|25923706|FG000|Randomized Treatment|Withdrawal by Subject|0|||
13116906|NCT03069716|25923707|FG001|Randomized Treatment|Withdrawal by Subject|2|||
13254612|NCT01529515|26380607|FG002|MAINTENANCE PHASE|Adverse Event|0|||
13254613|NCT01529515|26380608|FG003|MAINTENANCE PHASE|Adverse Event|0|||
13254614|NCT01529515|26380605|FG000|MAINTENANCE PHASE|Lack of Efficacy|0|||
13254615|NCT01529515|26380606|FG001|MAINTENANCE PHASE|Lack of Efficacy|9|||
13254616|NCT01529515|26380607|FG002|MAINTENANCE PHASE|Lack of Efficacy|0|||
13254617|NCT01529515|26380608|FG003|MAINTENANCE PHASE|Lack of Efficacy|0|||
13116907|NCT03069716|25923708|FG002|Randomized Treatment|Withdrawal by Subject|0|||
13116908|NCT03069482|25923825|FG000|Overall Study|Lost to Follow-up|0|||
13116909|NCT03069482|25923826|FG001|Overall Study|Lost to Follow-up|1|||
13116910|NCT03069482|25923825|FG000|Overall Study|Physician Decision|1|||
13116911|NCT03069482|25923826|FG001|Overall Study|Physician Decision|0|||
13116912|NCT03069365|25923834|FG000|Overall Study|Adverse Event|1|||
13116913|NCT03069352|25923883|FG000|Overall Study|Ongoing|12|||
13116914|NCT03069352|25923884|FG001|Overall Study|Ongoing|40|||
13116915|NCT03069313|25923893|FG000|Overall Study|Adverse Event|5|||
13116916|NCT03068767|25923908|FG000|Overall Study|Lost to Follow-up|7|||
13116917|NCT03068767|25923909|FG001|Overall Study|Lost to Follow-up|3|||
13116918|NCT03068767|25923908|FG000|Overall Study|Protocol Violation|3|||
13116919|NCT03068767|25923909|FG001|Overall Study|Protocol Violation|0|||
13116920|NCT03068754|25923936|FG000|Randomized Treatment Period (RTP)|Adverse Event|1|||
13116921|NCT03068754|25923937|FG001|Randomized Treatment Period (RTP)|Adverse Event|3|||
13254618|NCT01529515|26380605|FG000|MAINTENANCE PHASE|Lost to Follow-up|0|||
13254619|NCT01529515|26380606|FG001|MAINTENANCE PHASE|Lost to Follow-up|5|||
13254620|NCT01529515|26380607|FG002|MAINTENANCE PHASE|Lost to Follow-up|0|||
13254621|NCT01529515|26380608|FG003|MAINTENANCE PHASE|Lost to Follow-up|0|||
13254622|NCT01529515|26380605|FG000|MAINTENANCE PHASE|Protocol Violation|0|||
13254623|NCT01529515|26380606|FG001|MAINTENANCE PHASE|Protocol Violation|12|||
13254624|NCT01529515|26380607|FG002|MAINTENANCE PHASE|Protocol Violation|0|||
13116922|NCT03068754|25923938|FG002|Randomized Treatment Period (RTP)|Adverse Event|0|||
13254625|NCT01529515|26380608|FG003|MAINTENANCE PHASE|Protocol Violation|0|||
13254626|NCT01529515|26380605|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0|||
13254627|NCT01529515|26380606|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15|||
13254628|NCT01529515|26380607|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0|||
13254629|NCT01529515|26380608|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0|||
13254630|NCT01529515|26380605|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
13254631|NCT01529515|26380606|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13|||
13254632|NCT01529515|26380607|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
13254633|NCT01529515|26380608|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
13254634|NCT01529515|26380605|FG000|MAINTENANCE PHASE|Other|0|||
13116923|NCT03068754|25923939|FG003|Randomized Treatment Period (RTP)|Adverse Event|0|||
13116924|NCT03068754|25923936|FG000|Randomized Treatment Period (RTP)|Death|2|||
13116925|NCT03068754|25923937|FG001|Randomized Treatment Period (RTP)|Death|2|||
13116926|NCT03068754|25923938|FG002|Randomized Treatment Period (RTP)|Death|0|||
13116927|NCT03068754|25923939|FG003|Randomized Treatment Period (RTP)|Death|0|||
13116928|NCT03068754|25923936|FG000|Randomized Treatment Period (RTP)|Disease progression|1|||
13116929|NCT03068754|25923937|FG001|Randomized Treatment Period (RTP)|Disease progression|2|||
13116930|NCT03068754|25923938|FG002|Randomized Treatment Period (RTP)|Disease progression|0|||
13116931|NCT03068754|25923939|FG003|Randomized Treatment Period (RTP)|Disease progression|0|||
13116932|NCT03068754|25923936|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1|||
13116933|NCT03068754|25923937|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
13116934|NCT03068754|25923938|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
13116935|NCT03068754|25923939|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
13116936|NCT03068754|25923936|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6|||
13116937|NCT03068754|25923937|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2|||
13116938|NCT03068754|25923938|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
13116939|NCT03068754|25923939|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
13116940|NCT03068754|25923936|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1|||
13116941|NCT03068754|25923937|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
13116942|NCT03068754|25923938|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
13116943|NCT03068754|25923939|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
13116944|NCT03068754|25923936|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
13116945|NCT03068754|25923937|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1|||
13116946|NCT03068754|25923938|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
13116947|NCT03068754|25923939|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
13116948|NCT03068754|25923936|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55|||
13116949|NCT03068754|25923937|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29|||
13116950|NCT03068754|25923938|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
13116951|NCT03068754|25923939|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
13116952|NCT03068754|25923936|FG000|Open Label Extension Period (OLE)|Adverse Event|0|||
13116953|NCT03068754|25923937|FG001|Open Label Extension Period (OLE)|Adverse Event|0|||
13116954|NCT03068754|25923938|FG002|Open Label Extension Period (OLE)|Adverse Event|0|||
13116955|NCT03068754|25923939|FG003|Open Label Extension Period (OLE)|Adverse Event|1|||
13116956|NCT03068754|25923936|FG000|Open Label Extension Period (OLE)|Death|0|||
13116957|NCT03068754|25923937|FG001|Open Label Extension Period (OLE)|Death|0|||
13254635|NCT01529515|26380606|FG001|MAINTENANCE PHASE|Other|10|||
13254636|NCT01529515|26380607|FG002|MAINTENANCE PHASE|Other|0|||
13254637|NCT01529515|26380608|FG003|MAINTENANCE PHASE|Other|0|||
13254638|NCT01529515|26380605|FG000|DOUBLE BLIND PHASE|Adverse Event|0|||
13254639|NCT01529515|26380606|FG001|DOUBLE BLIND PHASE|Adverse Event|0|||
13254640|NCT01529515|26380607|FG002|DOUBLE BLIND PHASE|Adverse Event|1|||
13254641|NCT01529515|26380608|FG003|DOUBLE BLIND PHASE|Adverse Event|0|||
13254642|NCT01529515|26380605|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
13254643|NCT01529515|26380606|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
13254644|NCT01529515|26380607|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1|||
13254645|NCT01529515|26380608|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3|||
13254646|NCT01529515|26380605|FG000|DOUBLE BLIND PHASE|Pregnancy|0|||
13254647|NCT01529515|26380606|FG001|DOUBLE BLIND PHASE|Pregnancy|0|||
13254648|NCT01529515|26380607|FG002|DOUBLE BLIND PHASE|Pregnancy|1|||
13254649|NCT01529515|26380608|FG003|DOUBLE BLIND PHASE|Pregnancy|0|||
13254650|NCT01529515|26380605|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
13254651|NCT01529515|26380606|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
13254652|NCT01529515|26380607|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10|||
13254653|NCT01529515|26380608|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7|||
13254654|NCT01529515|26380605|FG000|DOUBLE BLIND PHASE|Protocol Violation|0|||
13254655|NCT01529515|26380606|FG001|DOUBLE BLIND PHASE|Protocol Violation|0|||
13254656|NCT01529515|26380607|FG002|DOUBLE BLIND PHASE|Protocol Violation|1|||
13254657|NCT01529515|26380608|FG003|DOUBLE BLIND PHASE|Protocol Violation|0|||
13254658|NCT01529515|26380605|FG000|DOUBLE BLIND PHASE|Other|0|||
13254659|NCT01529515|26380606|FG001|DOUBLE BLIND PHASE|Other|0|||
13254660|NCT01529515|26380607|FG002|DOUBLE BLIND PHASE|Other|9|||
13254661|NCT01529515|26380608|FG003|DOUBLE BLIND PHASE|Other|2|||
13254662|NCT01529385|26380639|FG000|Overall Study|Lost to Follow-up|2|||
13254663|NCT01529385|26380640|FG001|Overall Study|Lost to Follow-up|1|||
13254664|NCT01529346|26380742|FG000|Overall Study|Lost to Follow-up|2|||
13254665|NCT01529346|26380743|FG001|Overall Study|Lost to Follow-up|0|||
13254666|NCT01529346|26380744|FG002|Overall Study|Lost to Follow-up|1|||
13254667|NCT01529346|26380745|FG003|Overall Study|Lost to Follow-up|0|||
13254668|NCT01529346|26380746|FG004|Overall Study|Lost to Follow-up|0|||
13254669|NCT01529346|26380742|FG000|Overall Study|Other|0|||
13254670|NCT01529346|26380743|FG001|Overall Study|Other|1|||
13254671|NCT01529346|26380744|FG002|Overall Study|Other|1|||
13254672|NCT01529346|26380745|FG003|Overall Study|Other|0|||
13254673|NCT01529346|26380746|FG004|Overall Study|Other|0|||
13254674|NCT01529268|26380807|FG000|Overall Study|Lost to Follow-up|9|||
13254675|NCT01529268|26380808|FG001|Overall Study|Lost to Follow-up|3|||
13254676|NCT01529268|26380807|FG000|Overall Study|Moved|3|||
13254677|NCT01529268|26380808|FG001|Overall Study|Moved|0|||
13254678|NCT01529112|26380840|FG000|Overall Study|Adverse Event|2|||
13254679|NCT01529112|26380841|FG001|Overall Study|Adverse Event|0|||
13254680|NCT01529112|26380840|FG000|Overall Study|Death|59|||
13254681|NCT01529112|26380841|FG001|Overall Study|Death|38|||
13254682|NCT01529112|26380840|FG000|Overall Study|Protocol Violation|1|||
13254683|NCT01529112|26380841|FG001|Overall Study|Protocol Violation|0|||
13254684|NCT01529112|26380840|FG000|Overall Study|Withdrawal by Subject|7|||
13254685|NCT01529112|26380841|FG001|Overall Study|Withdrawal by Subject|3|||
13254686|NCT01529008|26380854|FG000|Bone Marrow Harvesting|Physician Decision|1|||
13254687|NCT01529008|26380855|FG001|Bone Marrow Harvesting|Physician Decision|1|||
13254688|NCT01529008|26380854|FG000|Bone Marrow Harvesting|Withdrawal by Subject|0|||
13254689|NCT01529008|26380855|FG001|Bone Marrow Harvesting|Withdrawal by Subject|2|||
13254690|NCT01529008|26380854|FG000|Treatment|Adverse Event|6|||
13254691|NCT01529008|26380855|FG001|Treatment|Adverse Event|0|||
13254692|NCT01529008|26380854|FG000|Treatment|Other|3|||
13254693|NCT01529008|26380855|FG001|Treatment|Other|1|||
13254694|NCT01529008|26380854|FG000|Efficacy Analysis|Protocol Violation|2|||
13254695|NCT01529008|26380855|FG001|Efficacy Analysis|Protocol Violation|0|||
13254696|NCT01529008|26380854|FG000|Efficacy Analysis|Physician Decision|0|||
13254697|NCT01529008|26380855|FG001|Efficacy Analysis|Physician Decision|1|||
13254698|NCT01529008|26380854|FG000|Efficacy Analysis|Withdrawal by Subject|0|||
13254699|NCT01529008|26380855|FG001|Efficacy Analysis|Withdrawal by Subject|2|||
13254700|NCT01528969|26380868|FG000|Overall Study|absent from the school at baseline|2|||
13254701|NCT01528969|26380869|FG001|Overall Study|absent from the school at baseline|0|||
13254702|NCT01528787|26380892|FG000|Overall Study|Withdrawal by Subject|0|||
13254703|NCT01528787|26380893|FG001|Overall Study|Withdrawal by Subject|0|||
13254704|NCT01528787|26380894|FG002|Overall Study|Withdrawal by Subject|0|||
13254705|NCT01528787|26380895|FG003|Overall Study|Withdrawal by Subject|1|||
13254706|NCT01528787|26380892|FG000|Overall Study|Family Emergency|0|||
13254707|NCT01528787|26380893|FG001|Overall Study|Family Emergency|0|||
13254708|NCT01528787|26380894|FG002|Overall Study|Family Emergency|1|||
13254709|NCT01528787|26380895|FG003|Overall Study|Family Emergency|0|||
13254710|NCT01528735|26381002|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
13254711|NCT01528735|26381003|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
13254712|NCT01528735|26381002|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1|||
13254713|NCT01528735|26381003|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0|||
13254714|NCT01528709|26381018|FG000|Overall Study|Death|2|||
13254715|NCT01528709|26381019|FG001|Overall Study|Death|0|||
13254716|NCT01528709|26381018|FG000|Overall Study|Withdrawal by Subject|10|||
13254717|NCT01528709|26381019|FG001|Overall Study|Withdrawal by Subject|15|||
13254718|NCT01528709|26381018|FG000|Overall Study|allergy|1|||
13254719|NCT01528709|26381019|FG001|Overall Study|allergy|0|||
13254720|NCT01528696|26381036|FG000|Overall Study|See detailed description|18|||
13254721|NCT01528696|26381037|FG001|Overall Study|See detailed description|19|||
13254722|NCT01528605|26381080|FG000|Overall Study|Lost to Follow-up|1|||
13254723|NCT01528605|26381081|FG001|Overall Study|Lost to Follow-up|0|||
13254724|NCT01528605|26381082|FG002|Overall Study|Lost to Follow-up|1|||
13254725|NCT01528605|26381083|FG003|Overall Study|Lost to Follow-up|1|||
13254726|NCT01528605|26381084|FG004|Overall Study|Lost to Follow-up|0|||
13254727|NCT01528605|26381085|FG005|Overall Study|Lost to Follow-up|0|||
13254728|NCT01528605|26381080|FG000|Overall Study|Death|1|||
13254729|NCT01528605|26381081|FG001|Overall Study|Death|0|||
13254730|NCT01528605|26381082|FG002|Overall Study|Death|0|||
13254731|NCT01528605|26381083|FG003|Overall Study|Death|0|||
13254732|NCT01528605|26381084|FG004|Overall Study|Death|0|||
13254733|NCT01528605|26381085|FG005|Overall Study|Death|0|||
13254734|NCT01528345|26381108|FG000|Overall Study|Adverse Event|10|||
13254735|NCT01528345|26381109|FG001|Overall Study|Adverse Event|1|||
13254736|NCT01528345|26381108|FG000|Overall Study|Death|1|||
13254737|NCT01528345|26381109|FG001|Overall Study|Death|1|||
13254738|NCT01528345|26381108|FG000|Overall Study|Non-compliance with study treatment|1|||
13254739|NCT01528345|26381109|FG001|Overall Study|Non-compliance with study treatment|0|||
13254740|NCT01528345|26381108|FG000|Overall Study|Progressive Disease|26|||
13254741|NCT01528345|26381109|FG001|Overall Study|Progressive Disease|40|||
13254742|NCT01528345|26381108|FG000|Overall Study|Study Terminated by Sponsor|4|||
13254743|NCT01528345|26381109|FG001|Overall Study|Study Terminated by Sponsor|8|||
13254744|NCT01528345|26381108|FG000|Overall Study|Subject/Guardian Decision|5|||
13254745|NCT01528345|26381109|FG001|Overall Study|Subject/Guardian Decision|0|||
13254746|NCT01528254|26381137|FG000|Overall Study|Administrative problems|96|||
13254747|NCT01528254|26381138|FG001|Overall Study|Administrative problems|94|||
13254748|NCT01528254|26381137|FG000|Overall Study|Adverse Event|28|||
13254749|NCT01528254|26381138|FG001|Overall Study|Adverse Event|44|||
13254750|NCT01528254|26381137|FG000|Overall Study|Lost to Follow-up|17|||
13254751|NCT01528254|26381138|FG001|Overall Study|Lost to Follow-up|24|||
13254752|NCT01528254|26381137|FG000|Overall Study|Death|13|||
13254753|NCT01528254|26381138|FG001|Overall Study|Death|9|||
13254754|NCT01528254|26381137|FG000|Overall Study|Protocol deviation|9|||
13254755|NCT01528254|26381138|FG001|Overall Study|Protocol deviation|19|||
13254756|NCT01528254|26381137|FG000|Overall Study|New therapy for study indication|8|||
13254757|NCT01528254|26381138|FG001|Overall Study|New therapy for study indication|6|||
13254758|NCT01528254|26381137|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
13254759|NCT01528254|26381138|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
13254760|NCT01528254|26381137|FG000|Overall Study|Withdrawal by Subject|5|||
13254761|NCT01528254|26381138|FG001|Overall Study|Withdrawal by Subject|4|||
13254762|NCT01528254|26381137|FG000|Overall Study|Abnormal laboratory value(s)|3|||
13254763|NCT01528254|26381138|FG001|Overall Study|Abnormal laboratory value(s)|7|||
13254764|NCT01528254|26381137|FG000|Overall Study|Abnormal test procedure result(s)|1|||
13254765|NCT01528254|26381138|FG001|Overall Study|Abnormal test procedure result(s)|0|||
13254766|NCT01528254|26381137|FG000|Overall Study|No longer requires study drug|1|||
13254767|NCT01528254|26381138|FG001|Overall Study|No longer requires study drug|1|||
13254768|NCT01528215|26381153|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4|||
13254769|NCT01528215|26381154|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1|||
13254770|NCT01528215|26381153|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
13254771|NCT01528215|26381154|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
13254772|NCT01528215|26381153|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10|||
13254773|NCT01528215|26381154|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13|||
13254774|NCT01528215|26381153|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3|||
13254775|NCT01528215|26381154|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0|||
13254776|NCT01528072|26381160|FG000|Overall Study|Withdrawal by Subject|5|||
13254777|NCT01528072|26381160|FG000|Overall Study|Physician Decision|1|||
13254778|NCT01528072|26381160|FG000|Overall Study|Determined not eligible by AEAC|1|||
13254779|NCT01528072|26381160|FG000|Overall Study|Missed Visit|2|||
13254780|NCT01528072|26381160|FG000|Overall Study|Lost to Follow-up|5|||
13254781|NCT01528072|26381160|FG000|Overall Study|Explanted|2|||
13254782|NCT01528072|26381160|FG000|Overall Study|Site Closure|4|||
13254783|NCT01528072|26381160|FG000|Overall Study|Death|2|||
13254784|NCT01528072|26381160|FG000|Overall Study|Early Termination of Study|52|||
13254785|NCT01528033|26381177|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8|||
13254786|NCT01528033|26381178|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7|||
13254787|NCT01528033|26381177|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
13254788|NCT01528033|26381178|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
13254789|NCT01528033|26381177|FG000|Primary Endpoint Assessment ITT|Death|2|||
13254790|NCT01528033|26381178|FG001|Primary Endpoint Assessment ITT|Death|2|||
13254791|NCT01528033|26381177|FG000|Primary Endpoint Assessment ITT|Physician Decision|2|||
13254792|NCT01528033|26381178|FG001|Primary Endpoint Assessment ITT|Physician Decision|1|||
13254793|NCT01528033|26381177|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
13254794|NCT01528033|26381178|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
13254795|NCT01528033|26381177|FG000|Follow Up|No data available|46|||
13254796|NCT01528033|26381178|FG001|Follow Up|No data available|44|||
13254797|NCT01527682|26381186|FG000|Overall Study|Protocol Violation|8|||
13254798|NCT01527500|26381225|FG000|Part A|Administrative|11|||
13254799|NCT01527500|26381226|FG001|Part A|Administrative|7|||
13254800|NCT01527500|26381225|FG000|Part A|Adverse Event|4|||
13254801|NCT01527500|26381226|FG001|Part A|Adverse Event|2|||
13203425|NCT01985334|26224752|FG002|Overall Study|Administrative problems|0|||
13203426|NCT01985334|26224753|FG003|Overall Study|Administrative problems|2|||
13203427|NCT01985334|26224754|FG004|Overall Study|Administrative problems|0|||
13203428|NCT01985334|26224755|FG005|Overall Study|Administrative problems|1|||
13203429|NCT01985334|26224756|FG006|Overall Study|Administrative problems|1|||
13203430|NCT01985334|26224757|FG007|Overall Study|Administrative problems|3|||
13203431|NCT01985334|26224750|FG000|Overall Study|Death|1|||
13203432|NCT01985334|26224751|FG001|Overall Study|Death|0|||
13203433|NCT01985334|26224752|FG002|Overall Study|Death|0|||
13203434|NCT01985334|26224753|FG003|Overall Study|Death|3|||
13203435|NCT01985334|26224754|FG004|Overall Study|Death|0|||
13203436|NCT01985334|26224755|FG005|Overall Study|Death|0|||
13254802|NCT01527500|26381225|FG000|Part A|Death|4|||
13254803|NCT01527500|26381226|FG001|Part A|Death|1|||
13254804|NCT01527500|26381225|FG000|Part A|Lost to Follow-up|0|||
13254805|NCT01527500|26381226|FG001|Part A|Lost to Follow-up|1|||
13254806|NCT01527500|26381225|FG000|Part A|Protocol Deviation|9|||
13254807|NCT01527500|26381226|FG001|Part A|Protocol Deviation|2|||
13254808|NCT01527500|26381225|FG000|Part A|Withdrawal by Subject|2|||
13254809|NCT01527500|26381226|FG001|Part A|Withdrawal by Subject|0|||
13254810|NCT01527500|26381225|FG000|Part B|Adverse Event|1|||
13254811|NCT01527500|26381226|FG001|Part B|Adverse Event|0|||
13254812|NCT01527487|26381245|FG000|Overall Study|MD Discretion/Lack of Efficacy|3|||
13254813|NCT01527487|26381246|FG001|Overall Study|MD Discretion/Lack of Efficacy|4|||
13254814|NCT01527487|26381245|FG000|Overall Study|Disease Progression|4|||
13254815|NCT01527487|26381246|FG001|Overall Study|Disease Progression|1|||
13254816|NCT01527487|26381245|FG000|Overall Study|Adverse Event|1|||
13254817|NCT01527487|26381246|FG001|Overall Study|Adverse Event|1|||
13254818|NCT01527487|26381245|FG000|Overall Study|Death|0|||
13254819|NCT01527487|26381246|FG001|Overall Study|Death|1|||
13254820|NCT01527383|26381267|FG000|Overall Study|Adverse Event|5|||
13254821|NCT01527383|26381268|FG001|Overall Study|Adverse Event|0|||
13254822|NCT01527383|26381267|FG000|Overall Study|Lost to Follow-up|3|||
13254823|NCT01527383|26381268|FG001|Overall Study|Lost to Follow-up|0|||
13254824|NCT01527383|26381267|FG000|Overall Study|Physician Decision|2|||
13254825|NCT01527383|26381268|FG001|Overall Study|Physician Decision|0|||
13254826|NCT01527383|26381267|FG000|Overall Study|Pregnancy|1|||
13254827|NCT01527383|26381268|FG001|Overall Study|Pregnancy|0|||
13254828|NCT01527383|26381267|FG000|Overall Study|Protocol Violation|1|||
13254829|NCT01527383|26381268|FG001|Overall Study|Protocol Violation|0|||
13254830|NCT01527383|26381267|FG000|Overall Study|Screen failure|1|||
13254831|NCT01527383|26381268|FG001|Overall Study|Screen failure|0|||
13254832|NCT01527383|26381267|FG000|Overall Study|Participant moved|0|||
13254833|NCT01527383|26381268|FG001|Overall Study|Participant moved|1|||
13254834|NCT01527383|26381267|FG000|Overall Study|Withdrawal by Subject|2|||
13254835|NCT01527383|26381268|FG001|Overall Study|Withdrawal by Subject|3|||
13254836|NCT01527370|26381276|FG000|Overall Study|Withdrawal by Subject|4|||
13254837|NCT01527370|26381276|FG000|Overall Study|Physician Decision|1|||
13254838|NCT01527370|26381276|FG000|Overall Study|Death|1|||
13254839|NCT01527357|26381303|FG000|Overall Study|Death|8|||
13254840|NCT01527357|26381304|FG001|Overall Study|Death|2|||
13254841|NCT01527357|26381303|FG000|Overall Study|Lost to Follow-up|6|||
13254842|NCT01527357|26381304|FG001|Overall Study|Lost to Follow-up|4|||
13254843|NCT01527357|26381303|FG000|Overall Study|Withdrew Consent|1|||
13254844|NCT01527357|26381304|FG001|Overall Study|Withdrew Consent|1|||
13254845|NCT01527357|26381303|FG000|Overall Study|Non-compliance|0|||
13254846|NCT01527357|26381304|FG001|Overall Study|Non-compliance|1|||
13254847|NCT01527357|26381303|FG000|Overall Study|No Day 29 Visit|0|||
13254848|NCT01527357|26381304|FG001|Overall Study|No Day 29 Visit|1|||
13254849|NCT01527357|26381303|FG000|Overall Study|Did Not Receive Treatment|2|||
13254850|NCT01527357|26381304|FG001|Overall Study|Did Not Receive Treatment|0|||
13254851|NCT01527292|26381327|FG000|Overall Study|Physician Decision|0|||
13254852|NCT01527292|26381328|FG001|Overall Study|Physician Decision|3|||
13254853|NCT01527149|26381345|FG000|Overall Study|Death|2|||
13254854|NCT01527110|26381392|FG000|Overall Study|Adverse Event|1|||
13254855|NCT01527006|26381449|FG000|Core Study|Adverse Event|0|||
13254856|NCT01527006|26381450|FG001|Core Study|Adverse Event|2|||
13254857|NCT01527006|26381449|FG000|Core Study|Lost to Follow-up|0|||
13254858|NCT01527006|26381450|FG001|Core Study|Lost to Follow-up|1|||
13254859|NCT01527006|26381449|FG000|Core Study|Subject Choice|1|||
13254860|NCT01527006|26381450|FG001|Core Study|Subject Choice|0|||
13254861|NCT01527006|26381449|FG000|Core Study|Inadequate Therapeutic Effect|1|||
13254862|NCT01527006|26381450|FG001|Core Study|Inadequate Therapeutic Effect|0|||
13254863|NCT01527006|26381449|FG000|Core Study|Withdrawal by Subject|0|||
13254864|NCT01527006|26381450|FG001|Core Study|Withdrawal by Subject|1|||
13254865|NCT01527006|26381449|FG000|Core Study|Other|0|||
13254866|NCT01527006|26381450|FG001|Core Study|Other|2|||
13254867|NCT01527006|26381449|FG000|Extension Phase|Adverse Event|4|||
13254868|NCT01527006|26381450|FG001|Extension Phase|Adverse Event|2|||
13254869|NCT01527006|26381449|FG000|Extension Phase|Lost to Follow-up|0|||
13254870|NCT01527006|26381450|FG001|Extension Phase|Lost to Follow-up|1|||
13254871|NCT01527006|26381449|FG000|Extension Phase|Subject Choice|1|||
13254872|NCT01527006|26381450|FG001|Extension Phase|Subject Choice|1|||
13254873|NCT01527006|26381449|FG000|Extension Phase|Inadequate therapeutic effect|1|||
13254874|NCT01527006|26381450|FG001|Extension Phase|Inadequate therapeutic effect|1|||
13254875|NCT01527006|26381449|FG000|Extension Phase|Other|0|||
13254876|NCT01527006|26381450|FG001|Extension Phase|Other|3|||
13254877|NCT01526928|26381588|FG000|Overall Study|Progressive Disease|35|||
13254878|NCT01526928|26381589|FG001|Overall Study|Progressive Disease|17|||
13254879|NCT01526928|26381590|FG002|Overall Study|Progressive Disease|150|||
13254880|NCT01526928|26381591|FG003|Overall Study|Progressive Disease|182|||
13254881|NCT01526928|26381592|FG004|Overall Study|Progressive Disease|76|||
13254882|NCT01526928|26381593|FG005|Overall Study|Progressive Disease|4|||
13254883|NCT01526928|26381588|FG000|Overall Study|Adverse Event|2|||
13254884|NCT01526928|26381589|FG001|Overall Study|Adverse Event|1|||
13254885|NCT01526928|26381590|FG002|Overall Study|Adverse Event|29|||
13254886|NCT01526928|26381591|FG003|Overall Study|Adverse Event|40|||
13254887|NCT01526928|26381592|FG004|Overall Study|Adverse Event|13|||
13254888|NCT01526928|26381593|FG005|Overall Study|Adverse Event|2|||
13254889|NCT01526928|26381588|FG000|Overall Study|Death|0|||
13254890|NCT01526928|26381589|FG001|Overall Study|Death|0|||
13254891|NCT01526928|26381590|FG002|Overall Study|Death|3|||
13254892|NCT01526928|26381591|FG003|Overall Study|Death|0|||
13254893|NCT01526928|26381592|FG004|Overall Study|Death|0|||
13254894|NCT01526928|26381593|FG005|Overall Study|Death|0|||
13254895|NCT01526928|26381588|FG000|Overall Study|Withdrawal by Subject|1|||
13254896|NCT01526928|26381589|FG001|Overall Study|Withdrawal by Subject|0|||
13254897|NCT01526928|26381590|FG002|Overall Study|Withdrawal by Subject|13|||
13254898|NCT01526928|26381591|FG003|Overall Study|Withdrawal by Subject|11|||
13254899|NCT01526928|26381592|FG004|Overall Study|Withdrawal by Subject|3|||
13254900|NCT01526928|26381593|FG005|Overall Study|Withdrawal by Subject|0|||
13254901|NCT01526928|26381588|FG000|Overall Study|Physician Decision|0|||
13254902|NCT01526928|26381589|FG001|Overall Study|Physician Decision|0|||
13254903|NCT01526928|26381590|FG002|Overall Study|Physician Decision|2|||
13254904|NCT01526928|26381591|FG003|Overall Study|Physician Decision|5|||
13254905|NCT01526928|26381592|FG004|Overall Study|Physician Decision|0|||
13254906|NCT01526928|26381593|FG005|Overall Study|Physician Decision|0|||
13254907|NCT01526928|26381588|FG000|Overall Study|Other Reason|0|||
13254908|NCT01526928|26381589|FG001|Overall Study|Other Reason|1|||
13254909|NCT01526928|26381590|FG002|Overall Study|Other Reason|11|||
13254910|NCT01526928|26381591|FG003|Overall Study|Other Reason|4|||
13254911|NCT01526928|26381592|FG004|Overall Study|Other Reason|1|||
13254912|NCT01526928|26381593|FG005|Overall Study|Other Reason|0|||
13254913|NCT01526928|26381588|FG000|Overall Study|Lost to Follow-up|0|||
13254914|NCT01526928|26381589|FG001|Overall Study|Lost to Follow-up|0|||
13254915|NCT01526928|26381590|FG002|Overall Study|Lost to Follow-up|0|||
13254916|NCT01526928|26381591|FG003|Overall Study|Lost to Follow-up|1|||
13254917|NCT01526928|26381592|FG004|Overall Study|Lost to Follow-up|0|||
13254918|NCT01526928|26381593|FG005|Overall Study|Lost to Follow-up|0|||
13254919|NCT01526928|26381588|FG000|Overall Study|Protocol Deviation|0|||
13254920|NCT01526928|26381589|FG001|Overall Study|Protocol Deviation|0|||
13254921|NCT01526928|26381590|FG002|Overall Study|Protocol Deviation|0|||
13254922|NCT01526928|26381591|FG003|Overall Study|Protocol Deviation|2|||
13254923|NCT01526928|26381592|FG004|Overall Study|Protocol Deviation|0|||
13254924|NCT01526928|26381593|FG005|Overall Study|Protocol Deviation|0|||
13254925|NCT01526928|26381588|FG000|Overall Study|Missing|0|||
13254926|NCT01526928|26381589|FG001|Overall Study|Missing|0|||
13254927|NCT01526928|26381590|FG002|Overall Study|Missing|1|||
13254928|NCT01526928|26381591|FG003|Overall Study|Missing|0|||
13254929|NCT01526928|26381592|FG004|Overall Study|Missing|2|||
13254930|NCT01526928|26381593|FG005|Overall Study|Missing|0|||
13254931|NCT01526889|26381621|FG000|Treatment Period|Adverse Event|2|||
13254932|NCT01526889|26381622|FG001|Treatment Period|Adverse Event|0|||
13254933|NCT01526889|26381621|FG000|Treatment Extension Period|Administrative problems|1|||
13254934|NCT01526889|26381622|FG001|Treatment Extension Period|Administrative problems|0|||
13254935|NCT01526785|26381634|FG000|Overall Study|Study Terminated by Sponsor|8|||
13254936|NCT01526785|26381634|FG000|Overall Study|Death|2|||
13254937|NCT01526785|26381634|FG000|Overall Study|Physician Decision|1|||
13254938|NCT01526785|26381634|FG000|Overall Study|Withdrawal by Subject|2|||
13254939|NCT01526733|26381655|FG000|Phase 1|Protocol Violation|1|||
13254940|NCT01526733|26381656|FG001|Phase 1|Protocol Violation|0|||
13254941|NCT01526733|26381655|FG000|Phase 1|Withdrawal by Subject|1|||
13254942|NCT01526733|26381656|FG001|Phase 1|Withdrawal by Subject|1|||
13254943|NCT01526551|26381663|FG000|Overall Study|Lack of returned parental consent form|424|||
13254944|NCT01526148|26381678|FG000|Overall Study|Adverse Event|6|||
13254945|NCT01526148|26381679|FG001|Overall Study|Adverse Event|5|||
13254946|NCT01526148|26381678|FG000|Overall Study|Lost to Follow-up|3|||
13254947|NCT01526148|26381679|FG001|Overall Study|Lost to Follow-up|6|||
13254948|NCT01526148|26381678|FG000|Overall Study|Withdrawal by Subject|2|||
13254949|NCT01526148|26381679|FG001|Overall Study|Withdrawal by Subject|0|||
13254950|NCT01526148|26381678|FG000|Overall Study|Unstable Medical Condition|1|||
13254951|NCT01526148|26381679|FG001|Overall Study|Unstable Medical Condition|0|||
13254952|NCT01526148|26381678|FG000|Overall Study|Unable to discontinue concomitant med|1|||
13254953|NCT01526148|26381679|FG001|Overall Study|Unable to discontinue concomitant med|0|||
13254954|NCT01526148|26381678|FG000|Overall Study|Moved out of state|1|||
13254955|NCT01526148|26381679|FG001|Overall Study|Moved out of state|0|||
13254956|NCT01526148|26381678|FG000|Overall Study|Incarcerated|0|||
13254957|NCT01526148|26381679|FG001|Overall Study|Incarcerated|2|||
13254958|NCT01526057|26381772|FG000|Overall Study|Withdrawal by Subject|3|||
13254959|NCT01526057|26381773|FG001|Overall Study|Withdrawal by Subject|2|||
13254960|NCT01526057|26381774|FG002|Overall Study|Withdrawal by Subject|2|||
13254961|NCT01526057|26381772|FG000|Overall Study|Adverse Event|3|||
13254962|NCT01526057|26381773|FG001|Overall Study|Adverse Event|1|||
13254963|NCT01526057|26381774|FG002|Overall Study|Adverse Event|1|||
13254964|NCT01526057|26381772|FG000|Overall Study|Death|1|||
13254965|NCT01526057|26381773|FG001|Overall Study|Death|0|||
13254966|NCT01526057|26381774|FG002|Overall Study|Death|0|||
13254967|NCT01526057|26381772|FG000|Overall Study|Lost to Follow-up|1|||
13254968|NCT01526057|26381773|FG001|Overall Study|Lost to Follow-up|0|||
13254969|NCT01526057|26381774|FG002|Overall Study|Lost to Follow-up|1|||
13254970|NCT01526057|26381772|FG000|Overall Study|Other|1|||
13254971|NCT01526057|26381773|FG001|Overall Study|Other|0|||
13254972|NCT01526057|26381774|FG002|Overall Study|Other|1|||
13254973|NCT01526057|26381772|FG000|Overall Study|Protocol Violation|0|||
13254974|NCT01526057|26381773|FG001|Overall Study|Protocol Violation|0|||
13254975|NCT01526057|26381774|FG002|Overall Study|Protocol Violation|1|||
13254976|NCT01525901|26381807|FG000|Period 2: 12 Weeks|Adverse Event|0|||
13254977|NCT01525901|26381808|FG001|Period 2: 12 Weeks|Adverse Event|1|||
13254978|NCT01525901|26381809|FG002|Period 2: 12 Weeks|Adverse Event|0|||
13254979|NCT01525901|26381810|FG003|Period 2: 12 Weeks|Adverse Event|0|||
13254980|NCT01525875|26381831|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
13254981|NCT01525875|26381832|FG001|Placebo-controlled Period|Withdrawal by Subject|2|||
13254982|NCT01525875|26381831|FG000|Open-label Period|Lost to Follow-up|0|||
13254983|NCT01525875|26381832|FG001|Open-label Period|Lost to Follow-up|2|||
13254984|NCT01525849|26381853|FG000|Overall Study|Lost to Follow-up|3|||
13254985|NCT01525849|26381854|FG001|Overall Study|Lost to Follow-up|2|||
13254986|NCT01525849|26381853|FG000|Overall Study|Withdrawal by Subject|1|||
13254987|NCT01525849|26381854|FG001|Overall Study|Withdrawal by Subject|9|||
13254988|NCT01525849|26381853|FG000|Overall Study|Unrelated medical issue (not treated)|1|||
13254989|NCT01525849|26381854|FG001|Overall Study|Unrelated medical issue (not treated)|2|||
13254990|NCT01525849|26381853|FG000|Overall Study|Anatomic exclusion criteria identified|0|||
13254991|NCT01525849|26381854|FG001|Overall Study|Anatomic exclusion criteria identified|3|||
13254992|NCT01525641|26381865|FG000|Overall Study|Case report form not collected|25|||
13254993|NCT01525641|26381865|FG000|Overall Study|No visit since the first visit|16|||
13254994|NCT01525641|26381865|FG000|Overall Study|Adverse Event|73|||
13254995|NCT01525641|26381865|FG000|Overall Study|Lack of Efficacy|24|||
13254996|NCT01525641|26381865|FG000|Overall Study|Improvement|5|||
13254997|NCT01525641|26381865|FG000|Overall Study|Lost to follow-up (relocation)|1|||
13254998|NCT01525641|26381865|FG000|Overall Study|Lost to follow-up (Unknown reason)|10|||
13254999|NCT01525641|26381865|FG000|Overall Study|Lost to follow-up (Changing hospital)|19|||
13255000|NCT01525641|26381865|FG000|Overall Study|Other than stated above|7|||
13255001|NCT01525628|26381945|FG000|Overall Study|Adverse Event|1|||
13255002|NCT01525628|26381946|FG001|Overall Study|Adverse Event|1|||
13255003|NCT01525628|26381947|FG002|Overall Study|Adverse Event|2|||
13255004|NCT01525628|26381948|FG003|Overall Study|Adverse Event|0|||
13255005|NCT01525628|26381949|FG004|Overall Study|Adverse Event|1|||
13255006|NCT01525628|26381945|FG000|Overall Study|Lack of Efficacy|0|||
13255007|NCT01525628|26381946|FG001|Overall Study|Lack of Efficacy|2|||
13255008|NCT01525628|26381947|FG002|Overall Study|Lack of Efficacy|2|||
13255009|NCT01525628|26381948|FG003|Overall Study|Lack of Efficacy|1|||
13255010|NCT01525628|26381949|FG004|Overall Study|Lack of Efficacy|2|||
13255011|NCT01525628|26381945|FG000|Overall Study|Protocol Violation|0|||
13255012|NCT01525628|26381946|FG001|Overall Study|Protocol Violation|0|||
13255013|NCT01525628|26381947|FG002|Overall Study|Protocol Violation|1|||
13255014|NCT01525628|26381948|FG003|Overall Study|Protocol Violation|0|||
13255015|NCT01525628|26381949|FG004|Overall Study|Protocol Violation|0|||
13255016|NCT01525628|26381945|FG000|Overall Study|Lost to Follow-up|1|||
13255017|NCT01525628|26381946|FG001|Overall Study|Lost to Follow-up|1|||
13255018|NCT01525628|26381947|FG002|Overall Study|Lost to Follow-up|0|||
13255019|NCT01525628|26381948|FG003|Overall Study|Lost to Follow-up|0|||
13255020|NCT01525628|26381949|FG004|Overall Study|Lost to Follow-up|0|||
13255021|NCT01525628|26381945|FG000|Overall Study|Withdrawal by Subject|0|||
13255022|NCT01525628|26381946|FG001|Overall Study|Withdrawal by Subject|1|||
13255023|NCT01525628|26381947|FG002|Overall Study|Withdrawal by Subject|0|||
13255024|NCT01525628|26381948|FG003|Overall Study|Withdrawal by Subject|0|||
13255025|NCT01525628|26381949|FG004|Overall Study|Withdrawal by Subject|0|||
13255026|NCT01525628|26381945|FG000|Overall Study|Other reason not defined above|0|||
13255027|NCT01525628|26381946|FG001|Overall Study|Other reason not defined above|0|||
13255028|NCT01525628|26381947|FG002|Overall Study|Other reason not defined above|0|||
13255029|NCT01525628|26381948|FG003|Overall Study|Other reason not defined above|3|||
13255030|NCT01525628|26381949|FG004|Overall Study|Other reason not defined above|0|||
13255031|NCT01525615|26382003|FG000|Overall Study|Adverse Event|11|||
13255032|NCT01525615|26382004|FG001|Overall Study|Adverse Event|7|||
13255033|NCT01525615|26382005|FG002|Overall Study|Adverse Event|5|||
13255034|NCT01525615|26382003|FG000|Overall Study|Lost to Follow-up|1|||
13255035|NCT01525615|26382004|FG001|Overall Study|Lost to Follow-up|0|||
13255036|NCT01525615|26382005|FG002|Overall Study|Lost to Follow-up|0|||
13255037|NCT01525615|26382003|FG000|Overall Study|Withdrawal by Subject|1|||
13255038|NCT01525615|26382004|FG001|Overall Study|Withdrawal by Subject|0|||
13255039|NCT01525615|26382005|FG002|Overall Study|Withdrawal by Subject|0|||
13255040|NCT01525615|26382003|FG000|Overall Study|Other reason not described above|1|||
13255041|NCT01525615|26382004|FG001|Overall Study|Other reason not described above|0|||
13255042|NCT01525615|26382005|FG002|Overall Study|Other reason not described above|1|||
13255043|NCT01525602|26382098|FG000|Overall Study|Adverse Event|1|||
13255044|NCT01525602|26382099|FG001|Overall Study|Adverse Event|0|||
13255045|NCT01525602|26382100|FG002|Overall Study|Adverse Event|1|||
13255046|NCT01525602|26382101|FG003|Overall Study|Adverse Event|1|||
13255047|NCT01525602|26382102|FG004|Overall Study|Adverse Event|3|||
13255048|NCT01525602|26382103|FG005|Overall Study|Adverse Event|3|||
13255049|NCT01525602|26382104|FG006|Overall Study|Adverse Event|0|||
13255050|NCT01525602|26382105|FG007|Overall Study|Adverse Event|1|||
13255051|NCT01525602|26382098|FG000|Overall Study|Disease progression|6|||
13255052|NCT01525602|26382099|FG001|Overall Study|Disease progression|3|||
13255053|NCT01525602|26382100|FG002|Overall Study|Disease progression|2|||
13255054|NCT01525602|26382101|FG003|Overall Study|Disease progression|5|||
13255055|NCT01525602|26382102|FG004|Overall Study|Disease progression|22|||
13255056|NCT01525602|26382103|FG005|Overall Study|Disease progression|2|||
13255057|NCT01525602|26382104|FG006|Overall Study|Disease progression|3|||
13255058|NCT01525602|26382105|FG007|Overall Study|Disease progression|3|||
13255059|NCT01525602|26382098|FG000|Overall Study|Clinical progression|2|||
13255060|NCT01525602|26382099|FG001|Overall Study|Clinical progression|0|||
13255061|NCT01525602|26382100|FG002|Overall Study|Clinical progression|0|||
13255062|NCT01525602|26382101|FG003|Overall Study|Clinical progression|0|||
13255063|NCT01525602|26382102|FG004|Overall Study|Clinical progression|0|||
13255064|NCT01525602|26382103|FG005|Overall Study|Clinical progression|0|||
13255065|NCT01525602|26382104|FG006|Overall Study|Clinical progression|1|||
13255066|NCT01525602|26382105|FG007|Overall Study|Clinical progression|1|||
13255067|NCT01525602|26382098|FG000|Overall Study|Non-compliance|0|||
13255068|NCT01525602|26382099|FG001|Overall Study|Non-compliance|0|||
13255069|NCT01525602|26382100|FG002|Overall Study|Non-compliance|0|||
13255070|NCT01525602|26382101|FG003|Overall Study|Non-compliance|0|||
13255071|NCT01525602|26382102|FG004|Overall Study|Non-compliance|1|||
13255072|NCT01525602|26382103|FG005|Overall Study|Non-compliance|0|||
13255073|NCT01525602|26382104|FG006|Overall Study|Non-compliance|0|||
13255074|NCT01525602|26382105|FG007|Overall Study|Non-compliance|0|||
13255075|NCT01525602|26382098|FG000|Overall Study|Withdrawal by Subject|0|||
13255076|NCT01525602|26382099|FG001|Overall Study|Withdrawal by Subject|0|||
13255077|NCT01525602|26382100|FG002|Overall Study|Withdrawal by Subject|0|||
13485884|NCT04321252|27033989|FG000|Overall Study|Withdrawal by Subject|0|||
13485885|NCT04321252|27033990|FG001|Overall Study|Withdrawal by Subject|0|||
13485886|NCT04321252|27033991|FG002|Overall Study|Withdrawal by Subject|0|||
13485887|NCT04321252|27033992|FG003|Overall Study|Withdrawal by Subject|0|||
13485888|NCT04321252|27033993|FG004|Overall Study|Withdrawal by Subject|0|||
13485889|NCT04321252|27033994|FG005|Overall Study|Withdrawal by Subject|1|||
13485890|NCT04321252|27033995|FG006|Overall Study|Withdrawal by Subject|0|||
13485891|NCT04321252|27033996|FG007|Overall Study|Withdrawal by Subject|0|||
13485892|NCT04321252|27033997|FG008|Overall Study|Withdrawal by Subject|0|||
13485893|NCT04176445|27034029|FG000|Overall Study|Adverse Event|0|||
13485894|NCT04176445|27034030|FG001|Overall Study|Adverse Event|1|||
13485895|NCT04176445|27034029|FG000|Overall Study|change plans weaning after first intervention|0|||
13485896|NCT04176445|27034030|FG001|Overall Study|change plans weaning after first intervention|1|||
13485897|NCT03672188|27034235|FG000|Overall Study|Withdrawal by Subject|0|||
13485898|NCT03672188|27034236|FG001|Overall Study|Withdrawal by Subject|0|||
13485899|NCT03672188|27034237|FG002|Overall Study|Withdrawal by Subject|0|||
13485900|NCT03672188|27034238|FG003|Overall Study|Withdrawal by Subject|3|||
13485901|NCT03672188|27034239|FG004|Overall Study|Withdrawal by Subject|0|||
13485902|NCT03672188|27034240|FG005|Overall Study|Withdrawal by Subject|0|||
13485903|NCT03672188|27034241|FG006|Overall Study|Withdrawal by Subject|0|||
13485904|NCT03672188|27034242|FG007|Overall Study|Withdrawal by Subject|0|||
13485905|NCT03672188|27034243|FG008|Overall Study|Withdrawal by Subject|0|||
13485906|NCT03672188|27034244|FG009|Overall Study|Withdrawal by Subject|0|||
13203437|NCT01985334|26224756|FG006|Overall Study|Death|1|||
13203438|NCT01985334|26224757|FG007|Overall Study|Death|2|||
13203439|NCT01985334|26224750|FG000|Overall Study|Worsening of disease|0|||
13203440|NCT01985334|26224751|FG001|Overall Study|Worsening of disease|0|||
13203441|NCT01985334|26224752|FG002|Overall Study|Worsening of disease|0|||
13203442|NCT01985334|26224753|FG003|Overall Study|Worsening of disease|1|||
13203443|NCT01985334|26224754|FG004|Overall Study|Worsening of disease|0|||
13203444|NCT01985334|26224755|FG005|Overall Study|Worsening of disease|3|||
13203445|NCT01985334|26224756|FG006|Overall Study|Worsening of disease|0|||
13203446|NCT01985334|26224757|FG007|Overall Study|Worsening of disease|1|||
13203447|NCT01985334|26224750|FG000|Overall Study|Other|2|||
13203448|NCT01985334|26224751|FG001|Overall Study|Other|9|||
13203449|NCT01985334|26224752|FG002|Overall Study|Other|7|||
13203450|NCT01985334|26224753|FG003|Overall Study|Other|17|||
13203451|NCT01985334|26224754|FG004|Overall Study|Other|4|||
13203452|NCT01985334|26224755|FG005|Overall Study|Other|8|||
13203453|NCT01985334|26224756|FG006|Overall Study|Other|4|||
13203454|NCT01985334|26224757|FG007|Overall Study|Other|7|||
13203455|NCT01985334|26224750|FG000|Overall Study|Protocol deviation|6|||
13203456|NCT01985334|26224751|FG001|Overall Study|Protocol deviation|31|||
13203457|NCT01985334|26224752|FG002|Overall Study|Protocol deviation|25|||
13485907|NCT03672188|27034245|FG010|Overall Study|Withdrawal by Subject|0|||
13485908|NCT03672188|27034246|FG011|Overall Study|Withdrawal by Subject|0|||
13485909|NCT03672188|27034247|FG012|Overall Study|Withdrawal by Subject|0|||
13485910|NCT03672188|27034248|FG013|Overall Study|Withdrawal by Subject|0|||
13485911|NCT03672188|27034249|FG014|Overall Study|Withdrawal by Subject|0|||
13485912|NCT03672188|27034235|FG000|Overall Study|Death|0|||
13485913|NCT03672188|27034236|FG001|Overall Study|Death|0|||
13485914|NCT03672188|27034237|FG002|Overall Study|Death|0|||
13485915|NCT03672188|27034238|FG003|Overall Study|Death|0|||
13255078|NCT01525602|26382101|FG003|Overall Study|Withdrawal by Subject|0|||
13255079|NCT01525602|26382102|FG004|Overall Study|Withdrawal by Subject|3|||
13255080|NCT01525602|26382103|FG005|Overall Study|Withdrawal by Subject|1|||
13255081|NCT01525602|26382104|FG006|Overall Study|Withdrawal by Subject|0|||
13255082|NCT01525602|26382105|FG007|Overall Study|Withdrawal by Subject|1|||
13255083|NCT01525602|26382098|FG000|Overall Study|Physician Decision|0|||
13255084|NCT01525602|26382099|FG001|Overall Study|Physician Decision|0|||
13255085|NCT01525602|26382100|FG002|Overall Study|Physician Decision|0|||
13255086|NCT01525602|26382101|FG003|Overall Study|Physician Decision|0|||
13255087|NCT01525602|26382102|FG004|Overall Study|Physician Decision|3|||
13255088|NCT01525602|26382103|FG005|Overall Study|Physician Decision|0|||
13255089|NCT01525602|26382104|FG006|Overall Study|Physician Decision|1|||
13255090|NCT01525602|26382105|FG007|Overall Study|Physician Decision|0|||
13255091|NCT01525602|26382098|FG000|Overall Study|Death|0|||
13255092|NCT01525602|26382099|FG001|Overall Study|Death|0|||
13255093|NCT01525602|26382100|FG002|Overall Study|Death|0|||
13255094|NCT01525602|26382101|FG003|Overall Study|Death|0|||
13255095|NCT01525602|26382102|FG004|Overall Study|Death|1|||
13255096|NCT01525602|26382103|FG005|Overall Study|Death|1|||
13255097|NCT01525602|26382104|FG006|Overall Study|Death|0|||
13255098|NCT01525602|26382105|FG007|Overall Study|Death|0|||
13255099|NCT01525602|26382098|FG000|Overall Study|Unqualified based on biopsy; not dosed|0|||
13255100|NCT01525602|26382099|FG001|Overall Study|Unqualified based on biopsy; not dosed|0|||
13255101|NCT01525602|26382100|FG002|Overall Study|Unqualified based on biopsy; not dosed|0|||
13255102|NCT01525602|26382101|FG003|Overall Study|Unqualified based on biopsy; not dosed|0|||
13255103|NCT01525602|26382102|FG004|Overall Study|Unqualified based on biopsy; not dosed|0|||
13255104|NCT01525602|26382103|FG005|Overall Study|Unqualified based on biopsy; not dosed|0|||
13255105|NCT01525602|26382104|FG006|Overall Study|Unqualified based on biopsy; not dosed|1|||
13255106|NCT01525602|26382105|FG007|Overall Study|Unqualified based on biopsy; not dosed|1|||
13255107|NCT01525589|26382159|FG000|Overall Study|Non-treatment-related AE|1|||
13255108|NCT01525589|26382160|FG001|Overall Study|Non-treatment-related AE|0|||
13255109|NCT01525589|26382161|FG002|Overall Study|Non-treatment-related AE|0|||
13255110|NCT01525589|26382159|FG000|Overall Study|Progressive disease|48|||
13255111|NCT01525589|26382160|FG001|Overall Study|Progressive disease|15|||
13255112|NCT01525589|26382161|FG002|Overall Study|Progressive disease|29|||
13255113|NCT01525589|26382159|FG000|Overall Study|Never treated|2|||
13255114|NCT01525589|26382160|FG001|Overall Study|Never treated|0|||
13255115|NCT01525589|26382161|FG002|Overall Study|Never treated|0|||
13255116|NCT01525589|26382159|FG000|Overall Study|Physician Decision|4|||
13255117|NCT01525589|26382160|FG001|Overall Study|Physician Decision|2|||
13255118|NCT01525589|26382161|FG002|Overall Study|Physician Decision|2|||
13255119|NCT01525589|26382159|FG000|Overall Study|Death|0|||
13255120|NCT01525589|26382160|FG001|Overall Study|Death|0|||
13255121|NCT01525589|26382161|FG002|Overall Study|Death|2|||
13255122|NCT01525589|26382159|FG000|Overall Study|Treatment-related AE|1|||
13255123|NCT01525589|26382160|FG001|Overall Study|Treatment-related AE|1|||
13255124|NCT01525589|26382161|FG002|Overall Study|Treatment-related AE|2|||
13255125|NCT01525589|26382159|FG000|Overall Study|Other reasons|0|||
13255126|NCT01525589|26382160|FG001|Overall Study|Other reasons|1|||
13255127|NCT01525589|26382161|FG002|Overall Study|Other reasons|0|||
13255128|NCT01525589|26382159|FG000|Overall Study|Withdrawal by Subject|0|||
13255129|NCT01525589|26382160|FG001|Overall Study|Withdrawal by Subject|1|||
13255130|NCT01525589|26382161|FG002|Overall Study|Withdrawal by Subject|0|||
13255131|NCT01525550|26382228|FG000|Overall Study|Lost to Follow-up|8|||
13255132|NCT01525550|26382229|FG001|Overall Study|Lost to Follow-up|2|||
13255133|NCT01525550|26382228|FG000|Overall Study|Death|19|||
13255134|NCT01525550|26382229|FG001|Overall Study|Death|28|||
13255135|NCT01525550|26382228|FG000|Overall Study|Other|0|||
13255136|NCT01525550|26382229|FG001|Overall Study|Other|4|||
13255137|NCT01525550|26382228|FG000|Overall Study|Sponsor's Decision|30|||
13255138|NCT01525550|26382229|FG001|Overall Study|Sponsor's Decision|11|||
13255139|NCT01525550|26382228|FG000|Overall Study|Withdrawal by Subject|4|||
13255140|NCT01525550|26382229|FG001|Overall Study|Withdrawal by Subject|0|||
13255141|NCT01525407|26382250|FG000|Overall Study|Change in recipient treatment plan|2|||
13255142|NCT01525407|26382251|FG001|Overall Study|Change in recipient treatment plan|2|||
13255143|NCT01525407|26382250|FG000|Overall Study|Withdrawal by Subject|0|||
13255144|NCT01525407|26382251|FG001|Overall Study|Withdrawal by Subject|1|||
13255145|NCT01525407|26382250|FG000|Overall Study|Transplant was delayed|0|||
13485916|NCT03672188|27034239|FG004|Overall Study|Death|0|||
13485917|NCT03672188|27034240|FG005|Overall Study|Death|0|||
13255146|NCT01525407|26382251|FG001|Overall Study|Transplant was delayed|1|||
13255147|NCT01525407|26382250|FG000|Overall Study|Delay in Transplant|1|||
13255148|NCT01525407|26382251|FG001|Overall Study|Delay in Transplant|0|||
13255149|NCT01525238|26382326|FG000|Overall Study|Withdrawal by Subject|1|||
13255150|NCT01525238|26382327|FG001|Overall Study|Withdrawal by Subject|0|||
13255151|NCT01525238|26382328|FG002|Overall Study|Withdrawal by Subject|0|||
13255152|NCT01525225|26382335|FG000|Enrollment|No longer met study criteria|1|||
13116958|NCT03068754|25923938|FG002|Open Label Extension Period (OLE)|Death|0|||
13116959|NCT03068754|25923939|FG003|Open Label Extension Period (OLE)|Death|1|||
13116960|NCT03068754|25923936|FG000|Open Label Extension Period (OLE)|Disease progression|0|||
13116961|NCT03068754|25923937|FG001|Open Label Extension Period (OLE)|Disease progression|0|||
13116962|NCT03068754|25923938|FG002|Open Label Extension Period (OLE)|Disease progression|3|||
13116963|NCT03068754|25923939|FG003|Open Label Extension Period (OLE)|Disease progression|1|||
13116964|NCT03068754|25923936|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
13116965|NCT03068754|25923937|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
13116966|NCT03068754|25923938|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5|||
13116967|NCT03068754|25923939|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
13116968|NCT03068754|25923936|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
13116969|NCT03068754|25923937|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
13116970|NCT03068754|25923938|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1|||
13116971|NCT03068754|25923939|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
13116972|NCT03068754|25923936|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
13116973|NCT03068754|25923937|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
13116974|NCT03068754|25923938|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12|||
13116975|NCT03068754|25923939|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3|||
13116976|NCT03068715|25923968|FG000|Overall Study|No longer met inclusion criteria|1|||
13116977|NCT03068715|25923969|FG001|Overall Study|No longer met inclusion criteria|0|||
13116978|NCT03068468|25924014|FG000|Placebo-Controlled Period|Randomized but not Treated|1|||
13255153|NCT01525225|26382335|FG000|Enrollment|Other|1|||
13255154|NCT01525082|26382348|FG000|Overall Study|Death|1|||
13255155|NCT01524991|26382357|FG000|Overall Study|Adverse Event|12|||
13255156|NCT01524991|26382357|FG000|Overall Study|Death|1|||
13255157|NCT01524991|26382357|FG000|Overall Study|Disease ProgressionDu|17|||
13255158|NCT01524991|26382357|FG000|Overall Study|Other complicating disease|1|||
13116979|NCT03068468|25924015|FG001|Placebo-Controlled Period|Randomized but not Treated|3|||
13116980|NCT03068468|25924016|FG002|Placebo-Controlled Period|Randomized but not Treated|0|||
13116981|NCT03068468|25924017|FG003|Placebo-Controlled Period|Randomized but not Treated|0|||
13116982|NCT03068468|25924014|FG000|Placebo-Controlled Period|Lack of Efficacy|0|||
13203458|NCT01985334|26224753|FG003|Overall Study|Protocol deviation|84|||
13255159|NCT01524991|26382357|FG000|Overall Study|Withdrawal by Subject|2|||
13255160|NCT01524991|26382357|FG000|Overall Study|Symptomatic Deterioration|1|||
13255161|NCT01524978|26382516|FG000|Overall Study|Other|16|||
13255162|NCT01524978|26382517|FG001|Overall Study|Other|2|||
13255163|NCT01524978|26382518|FG002|Overall Study|Other|1|||
13255164|NCT01524978|26382519|FG003|Overall Study|Other|2|||
13255165|NCT01524978|26382520|FG004|Overall Study|Other|1|||
13255166|NCT01524978|26382521|FG005|Overall Study|Other|3|||
13255167|NCT01524978|26382522|FG006|Overall Study|Other|17|||
13255168|NCT01524978|26382523|FG007|Overall Study|Other|1|||
13255169|NCT01524978|26382524|FG008|Overall Study|Other|2|||
13255170|NCT01524978|26382525|FG009|Overall Study|Other|2|||
13255171|NCT01524978|26382526|FG010|Overall Study|Other|5|||
13255172|NCT01524978|26382516|FG000|Overall Study|Withdrawal by Subject|12|||
13255173|NCT01524978|26382517|FG001|Overall Study|Withdrawal by Subject|0|||
13255174|NCT01524978|26382518|FG002|Overall Study|Withdrawal by Subject|1|||
13255175|NCT01524978|26382519|FG003|Overall Study|Withdrawal by Subject|1|||
13255176|NCT01524978|26382520|FG004|Overall Study|Withdrawal by Subject|3|||
13255177|NCT01524978|26382521|FG005|Overall Study|Withdrawal by Subject|1|||
13255178|NCT01524978|26382522|FG006|Overall Study|Withdrawal by Subject|6|||
13255179|NCT01524978|26382523|FG007|Overall Study|Withdrawal by Subject|2|||
13255180|NCT01524978|26382524|FG008|Overall Study|Withdrawal by Subject|4|||
13255181|NCT01524978|26382525|FG009|Overall Study|Withdrawal by Subject|0|||
13255182|NCT01524978|26382526|FG010|Overall Study|Withdrawal by Subject|5|||
13255183|NCT01524978|26382516|FG000|Overall Study|Lost to Follow-up|0|||
13255184|NCT01524978|26382517|FG001|Overall Study|Lost to Follow-up|0|||
13255185|NCT01524978|26382518|FG002|Overall Study|Lost to Follow-up|3|||
13255186|NCT01524978|26382519|FG003|Overall Study|Lost to Follow-up|0|||
13255187|NCT01524978|26382520|FG004|Overall Study|Lost to Follow-up|1|||
13255188|NCT01524978|26382521|FG005|Overall Study|Lost to Follow-up|1|||
13255189|NCT01524978|26382522|FG006|Overall Study|Lost to Follow-up|2|||
13255190|NCT01524978|26382523|FG007|Overall Study|Lost to Follow-up|0|||
13255191|NCT01524978|26382524|FG008|Overall Study|Lost to Follow-up|1|||
13255192|NCT01524978|26382525|FG009|Overall Study|Lost to Follow-up|1|||
13255193|NCT01524978|26382526|FG010|Overall Study|Lost to Follow-up|1|||
13255194|NCT01524978|26382516|FG000|Overall Study|Death|34|||
13255195|NCT01524978|26382517|FG001|Overall Study|Death|2|||
13255196|NCT01524978|26382518|FG002|Overall Study|Death|5|||
13255197|NCT01524978|26382519|FG003|Overall Study|Death|24|||
13255198|NCT01524978|26382520|FG004|Overall Study|Death|4|||
13255199|NCT01524978|26382521|FG005|Overall Study|Death|4|||
13255200|NCT01524978|26382522|FG006|Overall Study|Death|1|||
13255201|NCT01524978|26382523|FG007|Overall Study|Death|9|||
13255202|NCT01524978|26382524|FG008|Overall Study|Death|5|||
13255203|NCT01524978|26382525|FG009|Overall Study|Death|6|||
13255204|NCT01524978|26382526|FG010|Overall Study|Death|17|||
13255205|NCT01524913|26382553|FG000|Overall Study|Lost to Follow-up|4|||
13255206|NCT01524913|26382554|FG001|Overall Study|Lost to Follow-up|0|||
13255207|NCT01524913|26382555|FG002|Overall Study|Lost to Follow-up|0|||
13255208|NCT01524900|26382613|FG000|Overall Study|Lost to Follow-up|3|||
13255209|NCT01524900|26382614|FG001|Overall Study|Lost to Follow-up|12|||
13255210|NCT01524900|26382615|FG002|Overall Study|Lost to Follow-up|1|||
13255211|NCT01524900|26382616|FG003|Overall Study|Lost to Follow-up|0|||
13255212|NCT01524900|26382617|FG004|Overall Study|Lost to Follow-up|0|||
13255213|NCT01524900|26382613|FG000|Overall Study|Other reason than stated above|1|||
13255214|NCT01524900|26382614|FG001|Overall Study|Other reason than stated above|1|||
13255215|NCT01524900|26382615|FG002|Overall Study|Other reason than stated above|0|||
13255216|NCT01524900|26382616|FG003|Overall Study|Other reason than stated above|0|||
13255217|NCT01524900|26382617|FG004|Overall Study|Other reason than stated above|0|||
13255218|NCT01524900|26382613|FG000|Overall Study|No reason documented|2|||
13255219|NCT01524900|26382614|FG001|Overall Study|No reason documented|1|||
13255220|NCT01524900|26382615|FG002|Overall Study|No reason documented|0|||
13255221|NCT01524900|26382616|FG003|Overall Study|No reason documented|1|||
13255222|NCT01524900|26382617|FG004|Overall Study|No reason documented|0|||
13255223|NCT01524887|26382671|FG000|Overall Study|Withdrawal by Subject|6|||
13255224|NCT01524887|26382672|FG001|Overall Study|Withdrawal by Subject|2|||
13255225|NCT01524887|26382673|FG002|Overall Study|Withdrawal by Subject|3|||
13255226|NCT01524887|26382671|FG000|Overall Study|Adverse Event|5|||
13116983|NCT03068468|25924015|FG001|Placebo-Controlled Period|Lack of Efficacy|1|||
13116984|NCT03068468|25924016|FG002|Placebo-Controlled Period|Lack of Efficacy|0|||
13255227|NCT01524887|26382672|FG001|Overall Study|Adverse Event|1|||
13255228|NCT01524887|26382673|FG002|Overall Study|Adverse Event|1|||
13255229|NCT01524887|26382671|FG000|Overall Study|Protocol Violation|0|||
13255230|NCT01524887|26382672|FG001|Overall Study|Protocol Violation|0|||
13255231|NCT01524887|26382673|FG002|Overall Study|Protocol Violation|1|||
13255232|NCT01524887|26382671|FG000|Overall Study|Study termination|73|||
13255233|NCT01524887|26382672|FG001|Overall Study|Study termination|87|||
13255234|NCT01524887|26382673|FG002|Overall Study|Study termination|79|||
13255235|NCT01524887|26382671|FG000|Overall Study|Withdrawal by Caregiver|0|||
13255236|NCT01524887|26382672|FG001|Overall Study|Withdrawal by Caregiver|0|||
13255237|NCT01524887|26382673|FG002|Overall Study|Withdrawal by Caregiver|2|||
13255238|NCT01524887|26382671|FG000|Overall Study|Use of prohibited medication|1|||
13255239|NCT01524887|26382672|FG001|Overall Study|Use of prohibited medication|0|||
13255240|NCT01524887|26382673|FG002|Overall Study|Use of prohibited medication|0|||
13255241|NCT01524796|26382688|FG000|Overall Study|Adverse Event|13|||
13255242|NCT01524796|26382688|FG000|Overall Study|Lack of Efficacy|3|||
13255243|NCT01524796|26382688|FG000|Overall Study|Lost to Follow-up|1|||
13255244|NCT01524796|26382688|FG000|Overall Study|The price|1|||
13255245|NCT01524796|26382688|FG000|Overall Study|Withdrawal by Subject|4|||
13255246|NCT01524796|26382688|FG000|Overall Study|Move|1|||
13255247|NCT01524796|26382688|FG000|Overall Study|Deterioration of pains|1|||
13255248|NCT01524796|26382688|FG000|Overall Study|Gall stone surgery|1|||
13255249|NCT01524796|26382688|FG000|Overall Study|Nervous about confidentiality|1|||
13255250|NCT01524796|26382688|FG000|Overall Study|Switch to carbamazapine|1|||
13255251|NCT01524796|26382688|FG000|Overall Study|Adverse Event and Lack of Efficacy|1|||
13255252|NCT01524783|26382723|FG000|Blinded Period|Adverse Event|64|||
13255253|NCT01524783|26382724|FG001|Blinded Period|Adverse Event|7|||
13255254|NCT01524783|26382725|FG002|Blinded Period|Adverse Event|0|||
13255255|NCT01524783|26382723|FG000|Blinded Period|Disease Progression|89|||
13255256|NCT01524783|26382724|FG001|Blinded Period|Disease Progression|75|||
13255257|NCT01524783|26382725|FG002|Blinded Period|Disease Progression|0|||
13255258|NCT01524783|26382723|FG000|Blinded Period|Withdrawal by Subject|19|||
13255259|NCT01524783|26382724|FG001|Blinded Period|Withdrawal by Subject|6|||
13255260|NCT01524783|26382725|FG002|Blinded Period|Withdrawal by Subject|0|||
13255261|NCT01524783|26382723|FG000|Blinded Period|Protocol deviation|2|||
13255262|NCT01524783|26382724|FG001|Blinded Period|Protocol deviation|1|||
13255263|NCT01524783|26382725|FG002|Blinded Period|Protocol deviation|0|||
13255264|NCT01524783|26382723|FG000|Blinded Period|Death|5|||
13255265|NCT01524783|26382724|FG001|Blinded Period|Death|2|||
13255266|NCT01524783|26382725|FG002|Blinded Period|Death|0|||
13255267|NCT01524783|26382723|FG000|Open-label Period|Disease progression|13|||
13255268|NCT01524783|26382724|FG001|Open-label Period|Disease progression|0|||
13255269|NCT01524783|26382725|FG002|Open-label Period|Disease progression|2|||
13255270|NCT01524783|26382723|FG000|Open-label Period|Administrative problems|5|||
13255271|NCT01524783|26382724|FG001|Open-label Period|Administrative problems|0|||
13255272|NCT01524783|26382725|FG002|Open-label Period|Administrative problems|2|||
13255273|NCT01524783|26382723|FG000|Open-label Period|Adverse Event|5|||
13255274|NCT01524783|26382724|FG001|Open-label Period|Adverse Event|0|||
13255275|NCT01524783|26382725|FG002|Open-label Period|Adverse Event|1|||
13255276|NCT01524783|26382723|FG000|Open-label Period|Withdrawal by Subject|2|||
13255277|NCT01524783|26382724|FG001|Open-label Period|Withdrawal by Subject|0|||
13255278|NCT01524783|26382725|FG002|Open-label Period|Withdrawal by Subject|1|||
13255279|NCT01524783|26382723|FG000|Open-label Period|Protocol deviation|1|||
13255280|NCT01524783|26382724|FG001|Open-label Period|Protocol deviation|0|||
13255281|NCT01524783|26382725|FG002|Open-label Period|Protocol deviation|0|||
13255282|NCT01524770|26382738|FG000|First Intervention|Withdrawal by Subject|1|||
13255283|NCT01524770|26382739|FG001|First Intervention|Withdrawal by Subject|0|||
13255284|NCT01524770|26382738|FG000|First Intervention|Adverse Event|1|||
13255285|NCT01524770|26382739|FG001|First Intervention|Adverse Event|1|||
13255286|NCT01524770|26382738|FG000|First Intervention|Protocol Violation|1|||
13255287|NCT01524770|26382739|FG001|First Intervention|Protocol Violation|0|||
13255288|NCT01524692|26382749|FG000|Overall Study|Withdrawal by Subject|3|||
13255289|NCT01524679|26382766|FG000|Overall Study|Lost to Follow-up|1|||
13255290|NCT01524679|26382767|FG001|Overall Study|Lost to Follow-up|4|||
13255291|NCT01524679|26382766|FG000|Overall Study|Withdrawal by Subject|4|||
13255292|NCT01524679|26382767|FG001|Overall Study|Withdrawal by Subject|4|||
13255293|NCT01524679|26382766|FG000|Overall Study|Adverse Event|9|||
13255294|NCT01524679|26382767|FG001|Overall Study|Adverse Event|0|||
13255295|NCT01524679|26382766|FG000|Overall Study|Protocol Violation|1|||
13255296|NCT01524679|26382767|FG001|Overall Study|Protocol Violation|0|||
13255297|NCT01524679|26382766|FG000|Overall Study|Lack of Efficacy|2|||
13255298|NCT01524679|26382767|FG001|Overall Study|Lack of Efficacy|0|||
13255299|NCT01524679|26382766|FG000|Overall Study|e.g.wish for children, relocation|6|||
13255300|NCT01524679|26382767|FG001|Overall Study|e.g.wish for children, relocation|1|||
13255301|NCT01524627|26382780|FG000|Overall Study|Physician Decision|0|||
13255302|NCT01524627|26382781|FG001|Overall Study|Physician Decision|1|||
13255303|NCT01524627|26382780|FG000|Overall Study|Lost to Follow-up|1|||
13255304|NCT01524627|26382781|FG001|Overall Study|Lost to Follow-up|1|||
13255305|NCT01524289|26382838|FG000|Overall Study|Lost to Follow-up|0|||
13255306|NCT01524289|26382839|FG001|Overall Study|Lost to Follow-up|1|||
13255307|NCT01524289|26382838|FG000|Overall Study|Physician Decision|1|||
13255308|NCT01524289|26382839|FG001|Overall Study|Physician Decision|0|||
13255309|NCT01524289|26382838|FG000|Overall Study|Protocol Violation|5|||
13255310|NCT01524289|26382839|FG001|Overall Study|Protocol Violation|1|||
13255311|NCT01524289|26382838|FG000|Overall Study|Withdrawal by Subject|11|||
13255312|NCT01524289|26382839|FG001|Overall Study|Withdrawal by Subject|7|||
13255313|NCT01524289|26382838|FG000|Overall Study|Adverse Event|12|||
13255314|NCT01524289|26382839|FG001|Overall Study|Adverse Event|5|||
13255315|NCT01524289|26382838|FG000|Overall Study|Did not take study medication|1|||
13255316|NCT01524289|26382839|FG001|Overall Study|Did not take study medication|0|||
13255317|NCT01524224|26382898|FG000|Overall Study|Progressive Disease|1|||
13255318|NCT01524224|26382899|FG001|Overall Study|Progressive Disease|0|||
13255319|NCT01524224|26382900|FG002|Overall Study|Progressive Disease|2|||
13255320|NCT01524224|26382901|FG003|Overall Study|Progressive Disease|1|||
13255321|NCT01524224|26382902|FG004|Overall Study|Progressive Disease|2|||
13255322|NCT01524224|26382903|FG005|Overall Study|Progressive Disease|1|||
13255323|NCT01524224|26382904|FG006|Overall Study|Progressive Disease|1|||
13255324|NCT01524224|26382905|FG007|Overall Study|Progressive Disease|5|||
13255325|NCT01524224|26382898|FG000|Overall Study|Withdrawal by Subject|2|||
13255326|NCT01524224|26382899|FG001|Overall Study|Withdrawal by Subject|0|||
13255327|NCT01524224|26382900|FG002|Overall Study|Withdrawal by Subject|0|||
13255328|NCT01524224|26382901|FG003|Overall Study|Withdrawal by Subject|0|||
13255329|NCT01524224|26382902|FG004|Overall Study|Withdrawal by Subject|0|||
13255330|NCT01524224|26382903|FG005|Overall Study|Withdrawal by Subject|0|||
13255331|NCT01524224|26382904|FG006|Overall Study|Withdrawal by Subject|2|||
13255332|NCT01524224|26382905|FG007|Overall Study|Withdrawal by Subject|0|||
13255333|NCT01524224|26382898|FG000|Overall Study|Adverse Event|0|||
13255334|NCT01524224|26382899|FG001|Overall Study|Adverse Event|1|||
13255335|NCT01524224|26382900|FG002|Overall Study|Adverse Event|0|||
13255336|NCT01524224|26382901|FG003|Overall Study|Adverse Event|0|||
13255337|NCT01524224|26382902|FG004|Overall Study|Adverse Event|0|||
13255338|NCT01524224|26382903|FG005|Overall Study|Adverse Event|1|||
13255339|NCT01524224|26382904|FG006|Overall Study|Adverse Event|0|||
13255340|NCT01524224|26382905|FG007|Overall Study|Adverse Event|0|||
13255341|NCT01524224|26382898|FG000|Overall Study|Physician Decision|0|||
13255342|NCT01524224|26382899|FG001|Overall Study|Physician Decision|0|||
13255343|NCT01524224|26382900|FG002|Overall Study|Physician Decision|0|||
13255344|NCT01524224|26382901|FG003|Overall Study|Physician Decision|1|||
13255345|NCT01524224|26382902|FG004|Overall Study|Physician Decision|1|||
13255346|NCT01524224|26382903|FG005|Overall Study|Physician Decision|0|||
13255347|NCT01524224|26382904|FG006|Overall Study|Physician Decision|0|||
13255348|NCT01524224|26382905|FG007|Overall Study|Physician Decision|1|||
13255349|NCT01524224|26382898|FG000|Overall Study|Sponsor Decision|0|||
13255350|NCT01524224|26382899|FG001|Overall Study|Sponsor Decision|0|||
13255351|NCT01524224|26382900|FG002|Overall Study|Sponsor Decision|0|||
13255352|NCT01524224|26382901|FG003|Overall Study|Sponsor Decision|0|||
13255353|NCT01524224|26382902|FG004|Overall Study|Sponsor Decision|1|||
13255354|NCT01524224|26382903|FG005|Overall Study|Sponsor Decision|0|||
13255355|NCT01524224|26382904|FG006|Overall Study|Sponsor Decision|0|||
13255356|NCT01524224|26382905|FG007|Overall Study|Sponsor Decision|0|||
13255357|NCT01524198|26382920|FG000|Overall Study|Protocol Violation|8|||
13255358|NCT01524198|26382921|FG001|Overall Study|Protocol Violation|6|||
13255359|NCT01524198|26382920|FG000|Overall Study|Withdrawal by Subject|15|||
13255360|NCT01524198|26382921|FG001|Overall Study|Withdrawal by Subject|10|||
13255361|NCT01524133|26382942|FG000|Treatment Phase|Withdrawal by Subject|13|||
13255362|NCT01524133|26382943|FG001|Treatment Phase|Withdrawal by Subject|28|||
13255363|NCT01524133|26382944|FG002|Treatment Phase|Withdrawal by Subject|31|||
13255364|NCT01524133|26382942|FG000|Treatment Phase|Physician Decision|6|||
13255365|NCT01524133|26382943|FG001|Treatment Phase|Physician Decision|3|||
13255366|NCT01524133|26382944|FG002|Treatment Phase|Physician Decision|3|||
13255367|NCT01524133|26382942|FG000|Treatment Phase|Lost to Follow-up|0|||
13255368|NCT01524133|26382943|FG001|Treatment Phase|Lost to Follow-up|1|||
13255369|NCT01524133|26382944|FG002|Treatment Phase|Lost to Follow-up|2|||
13255370|NCT01524133|26382942|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4|||
13255371|NCT01524133|26382943|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5|||
13255372|NCT01524133|26382944|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10|||
13255373|NCT01524133|26382942|FG000|Overall Study 52 Weeks|Physician Decision|1|||
13255374|NCT01524133|26382943|FG001|Overall Study 52 Weeks|Physician Decision|0|||
13255375|NCT01524133|26382944|FG002|Overall Study 52 Weeks|Physician Decision|2|||
13255376|NCT01524133|26382942|FG000|Overall Study 52 Weeks|Lost to Follow-up|16|||
13255377|NCT01524133|26382943|FG001|Overall Study 52 Weeks|Lost to Follow-up|15|||
13255378|NCT01524133|26382944|FG002|Overall Study 52 Weeks|Lost to Follow-up|15|||
13290329|NCT00103285|26480981|FG004|Response Assignment|Withdrawal by Subject|2|||
13290330|NCT00103285|26480982|FG005|Response Assignment|Withdrawal by Subject|2|||
13290331|NCT00103285|26480983|FG006|Response Assignment|Withdrawal by Subject|0|||
13290332|NCT00103285|26480984|FG007|Response Assignment|Withdrawal by Subject|2|||
13290333|NCT00103285|26480977|FG000|Response Assignment|Ineligible|0|||
13290334|NCT00103285|26480978|FG001|Response Assignment|Ineligible|8|||
13290335|NCT00103285|26480979|FG002|Response Assignment|Ineligible|6|||
13290336|NCT00103285|26480980|FG003|Response Assignment|Ineligible|2|||
13290337|NCT00103285|26480981|FG004|Response Assignment|Ineligible|0|||
13290338|NCT00103285|26480982|FG005|Response Assignment|Ineligible|3|||
13290339|NCT00103285|26480983|FG006|Response Assignment|Ineligible|1|||
13290340|NCT00103285|26480984|FG007|Response Assignment|Ineligible|5|||
13290341|NCT00103285|26480977|FG000|Response Assignment|Refusal|0|||
13290342|NCT00103285|26480978|FG001|Response Assignment|Refusal|53|||
13290343|NCT00103285|26480979|FG002|Response Assignment|Refusal|5|||
13290344|NCT00103285|26480980|FG003|Response Assignment|Refusal|3|||
13290345|NCT00103285|26480981|FG004|Response Assignment|Refusal|25|||
13290346|NCT00103285|26480982|FG005|Response Assignment|Refusal|15|||
13290347|NCT00103285|26480983|FG006|Response Assignment|Refusal|30|||
13290348|NCT00103285|26480984|FG007|Response Assignment|Refusal|10|||
13290349|NCT00103285|26480977|FG000|Response Assignment|Other|0|||
13290350|NCT00103285|26480978|FG001|Response Assignment|Other|30|||
13290351|NCT00103285|26480979|FG002|Response Assignment|Other|48|||
13290352|NCT00103285|26480980|FG003|Response Assignment|Other|38|||
13290353|NCT00103285|26480981|FG004|Response Assignment|Other|37|||
13290354|NCT00103285|26480982|FG005|Response Assignment|Other|17|||
13290355|NCT00103285|26480983|FG006|Response Assignment|Other|11|||
13290356|NCT00103285|26480984|FG007|Response Assignment|Other|53|||
13290357|NCT00103259|26481003|FG000|Overall Study|Death|3|||
13290358|NCT00103259|26481004|FG001|Overall Study|Death|2|||
13290359|NCT00103259|26481003|FG000|Overall Study|Withdrawal by Subject|2|||
13290360|NCT00103259|26481004|FG001|Overall Study|Withdrawal by Subject|3|||
13290361|NCT00103259|26481003|FG000|Overall Study|alternative therapy|1|||
13290362|NCT00103259|26481004|FG001|Overall Study|alternative therapy|0|||
13290363|NCT00103259|26481003|FG000|Overall Study|other (reasons were not specified)|2|||
13290364|NCT00103259|26481004|FG001|Overall Study|other (reasons were not specified)|1|||
13290365|NCT00103259|26481003|FG000|Overall Study|ineligible/no protocol therapy|4|||
13290366|NCT00103259|26481004|FG001|Overall Study|ineligible/no protocol therapy|6|||
13290367|NCT00103207|26481016|FG000|Overall Study|Adverse Event|3|||
13290368|NCT00103207|26481016|FG000|Overall Study|Death|1|||
13290369|NCT00103207|26481016|FG000|Overall Study|Withdrawal by Subject|2|||
13290370|NCT00103207|26481016|FG000|Overall Study|Other complicating disease|1|||
13290371|NCT00103207|26481016|FG000|Overall Study|Ineligible|4|||
13290372|NCT00103207|26481016|FG000|Overall Study|Diagnosis of BAC not confirmed|27|||
13290373|NCT00103142|26481031|FG000|Overall Study|Adverse Event|1|||
13290374|NCT00103142|26481032|FG001|Overall Study|Adverse Event|0|||
13290375|NCT00103142|26481031|FG000|Overall Study|Progression of disease|2|||
13290376|NCT00103142|26481032|FG001|Overall Study|Progression of disease|1|||
13290377|NCT00102960|26481089|FG000|Overall Study|Death|23|||
13290378|NCT00102960|26481090|FG001|Overall Study|Death|11|||
13255379|NCT01523886|26382957|FG000|Overall Study|surgery cancelled|0|||
13255380|NCT01523886|26382958|FG001|Overall Study|surgery cancelled|1|||
13255381|NCT01523873|26382967|FG000|Overall Study|Protocol Violation|422|||
13255382|NCT01523756|26382978|FG000|Baseline Period|Adverse Event|0|||
13255383|NCT01523756|26382979|FG001|Baseline Period|Adverse Event|1|||
13255384|NCT01523756|26382978|FG000|Test Period 1|Adverse Event|1|||
13255385|NCT01523756|26382979|FG001|Test Period 1|Adverse Event|0|||
13255386|NCT01523756|26382978|FG000|Test Period 2|Withdrawal by Subject|0|||
13255387|NCT01523756|26382979|FG001|Test Period 2|Withdrawal by Subject|1|||
13255388|NCT01523743|26382988|FG000|Period 1|Adverse Event|1|||
13255389|NCT01523743|26382989|FG001|Period 1|Adverse Event|0|||
13255390|NCT01523743|26382988|FG000|Period 1|Withdrawal by Subject|6|||
13255391|NCT01523743|26382989|FG001|Period 1|Withdrawal by Subject|2|||
13255392|NCT01523743|26382988|FG000|Period 1|Lost to Follow-up|1|||
13255393|NCT01523743|26382989|FG001|Period 1|Lost to Follow-up|0|||
13255394|NCT01523743|26382988|FG000|Period 1|Lack of Efficacy|1|||
13255395|NCT01523743|26382989|FG001|Period 1|Lack of Efficacy|0|||
13255396|NCT01523743|26382988|FG000|Period 1|Felt unable to empty bladder|1|||
13255397|NCT01523743|26382989|FG001|Period 1|Felt unable to empty bladder|0|||
13255398|NCT01523743|26382988|FG000|Period 2|Withdrawal by Subject|0|||
13255399|NCT01523743|26382989|FG001|Period 2|Withdrawal by Subject|2|||
13255400|NCT01523743|26382988|FG000|Period 2|Adverse Event|1|||
13255401|NCT01523743|26382989|FG001|Period 2|Adverse Event|0|||
13255402|NCT01523587|26383016|FG000|Overall Study|Other than listed|5|||
13255403|NCT01523587|26383017|FG001|Overall Study|Other than listed|5|||
13255404|NCT01523587|26383016|FG000|Overall Study|Worsening of underlying cancer disease|19|||
13255405|NCT01523587|26383017|FG001|Overall Study|Worsening of underlying cancer disease|34|||
13116985|NCT03068468|25924017|FG003|Placebo-Controlled Period|Lack of Efficacy|0|||
13255406|NCT01523587|26383016|FG000|Overall Study|Adverse Event|68|||
13255407|NCT01523587|26383017|FG001|Overall Study|Adverse Event|52|||
13255408|NCT01523587|26383016|FG000|Overall Study|Protocol Violation|5|||
13255409|NCT01523587|26383017|FG001|Overall Study|Protocol Violation|3|||
13255410|NCT01523587|26383016|FG000|Overall Study|Lost to Follow-up|2|||
13255411|NCT01523587|26383017|FG001|Overall Study|Lost to Follow-up|2|||
13255412|NCT01523587|26383016|FG000|Overall Study|Withdrawal by Subject|28|||
13255413|NCT01523587|26383017|FG001|Overall Study|Withdrawal by Subject|20|||
13255414|NCT01523587|26383016|FG000|Overall Study|Withdrew due to Progressive disease|265|||
13255415|NCT01523587|26383017|FG001|Overall Study|Withdrew due to Progressive disease|279|||
13255416|NCT01523587|26383016|FG000|Overall Study|Randomised but bot treated|6|||
13255417|NCT01523587|26383017|FG001|Overall Study|Randomised but bot treated|2|||
13255418|NCT01523457|26383040|FG000|Overall Study|Withdrawal by Subject|7|||
13255419|NCT01523457|26383041|FG001|Overall Study|Withdrawal by Subject|2|||
13255420|NCT01523392|26383062|FG000|Treatment Period 1|Withdrawal by Subject|2|||
13255421|NCT01523392|26383063|FG001|Treatment Period 1|Withdrawal by Subject|0|||
13255422|NCT01523392|26383062|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1|||
13255423|NCT01523392|26383063|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0|||
13255424|NCT01523392|26383062|FG000|Washout Period - 10 to 14 Days|Adverse Event|1|||
13255425|NCT01523392|26383063|FG001|Washout Period - 10 to 14 Days|Adverse Event|0|||
13255426|NCT01523366|26383084|FG000|Treatment Period 1|Withdrawal by Subject|1|||
13255427|NCT01523366|26383085|FG001|Treatment Period 1|Withdrawal by Subject|0|||
13255428|NCT01523366|26383084|FG000|Treatment Period 2|Not completed at least 7 days treatment|1|||
13255429|NCT01523366|26383085|FG001|Treatment Period 2|Not completed at least 7 days treatment|0|||
13255430|NCT01523301|26383110|FG000|Overall Study|Adverse Event|25|||
13255431|NCT01523301|26383111|FG001|Overall Study|Adverse Event|16|||
13255432|NCT01523301|26383110|FG000|Overall Study|Lack of Efficacy|0|||
13255433|NCT01523301|26383111|FG001|Overall Study|Lack of Efficacy|2|||
13255434|NCT01523301|26383110|FG000|Overall Study|Protocol Violation|3|||
13255435|NCT01523301|26383111|FG001|Overall Study|Protocol Violation|4|||
13255436|NCT01523301|26383110|FG000|Overall Study|Lost to Follow-up|1|||
13255437|NCT01523301|26383111|FG001|Overall Study|Lost to Follow-up|0|||
13255438|NCT01523301|26383110|FG000|Overall Study|Withdrawal by Subject|6|||
13255439|NCT01523301|26383111|FG001|Overall Study|Withdrawal by Subject|8|||
13255440|NCT01523301|26383110|FG000|Overall Study|Other Reason|0|||
13255441|NCT01523301|26383111|FG001|Overall Study|Other Reason|2|||
13255442|NCT01523275|26383128|FG000|Overall Study|Lost to Follow-up|1|||
13255443|NCT01523275|26383129|FG001|Overall Study|Lost to Follow-up|2|||
13116986|NCT03068468|25924014|FG000|Placebo-Controlled Period|Adverse Event|16|||
13116987|NCT03068468|25924015|FG001|Placebo-Controlled Period|Adverse Event|21|||
13255444|NCT01523275|26383128|FG000|Overall Study|Withdrawal by Subject|1|||
13116988|NCT03068468|25924016|FG002|Placebo-Controlled Period|Adverse Event|0|||
13116989|NCT03068468|25924017|FG003|Placebo-Controlled Period|Adverse Event|0|||
13116990|NCT03068468|25924014|FG000|Placebo-Controlled Period|Withdrawal by Subject|3|||
13116991|NCT03068468|25924015|FG001|Placebo-Controlled Period|Withdrawal by Subject|11|||
13116992|NCT03068468|25924016|FG002|Placebo-Controlled Period|Withdrawal by Subject|0|||
13116993|NCT03068468|25924017|FG003|Placebo-Controlled Period|Withdrawal by Subject|0|||
13116994|NCT03068468|25924014|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
13116995|NCT03068468|25924015|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2|||
13116996|NCT03068468|25924016|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
13116997|NCT03068468|25924017|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
13116998|NCT03068468|25924014|FG000|Placebo-Controlled Period|Reason Not Specified|1|||
13116999|NCT03068468|25924015|FG001|Placebo-Controlled Period|Reason Not Specified|6|||
13117000|NCT03068468|25924016|FG002|Placebo-Controlled Period|Reason Not Specified|0|||
13117001|NCT03068468|25924017|FG003|Placebo-Controlled Period|Reason Not Specified|0|||
13117002|NCT03068468|25924014|FG000|Placebo-Controlled Period|Death|0|||
13117003|NCT03068468|25924015|FG001|Placebo-Controlled Period|Death|1|||
13117004|NCT03068468|25924016|FG002|Placebo-Controlled Period|Death|0|||
13117005|NCT03068468|25924017|FG003|Placebo-Controlled Period|Death|0|||
13117006|NCT03068468|25924014|FG000|Open-Label Extension Period|Lack of Efficacy|0|||
13117007|NCT03068468|25924015|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
13117008|NCT03068468|25924016|FG002|Open-Label Extension Period|Lack of Efficacy|1|||
13117009|NCT03068468|25924017|FG003|Open-Label Extension Period|Lack of Efficacy|2|||
13117010|NCT03068468|25924014|FG000|Open-Label Extension Period|Adverse Event|0|||
13117011|NCT03068468|25924015|FG001|Open-Label Extension Period|Adverse Event|0|||
13117012|NCT03068468|25924016|FG002|Open-Label Extension Period|Adverse Event|13|||
13117013|NCT03068468|25924017|FG003|Open-Label Extension Period|Adverse Event|17|||
13117014|NCT03068468|25924014|FG000|Open-Label Extension Period|Withdrawal by Subject|0|||
13117015|NCT03068468|25924015|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
13117016|NCT03068468|25924016|FG002|Open-Label Extension Period|Withdrawal by Subject|7|||
13117017|NCT03068468|25924017|FG003|Open-Label Extension Period|Withdrawal by Subject|20|||
13117018|NCT03068468|25924014|FG000|Open-Label Extension Period|Death|0|||
13117019|NCT03068468|25924015|FG001|Open-Label Extension Period|Death|0|||
13117020|NCT03068468|25924016|FG002|Open-Label Extension Period|Death|0|||
13203459|NCT01985334|26224754|FG004|Overall Study|Protocol deviation|17|||
13203460|NCT01985334|26224755|FG005|Overall Study|Protocol deviation|47|||
13203461|NCT01985334|26224756|FG006|Overall Study|Protocol deviation|15|||
13203462|NCT01985334|26224757|FG007|Overall Study|Protocol deviation|42|||
13117021|NCT03068468|25924017|FG003|Open-Label Extension Period|Death|1|||
13117022|NCT03068468|25924014|FG000|Open-Label Extension Period|Lost to Follow-up|0|||
13117023|NCT03068468|25924015|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
13117024|NCT03068468|25924016|FG002|Open-Label Extension Period|Lost to Follow-up|1|||
13117025|NCT03068468|25924017|FG003|Open-Label Extension Period|Lost to Follow-up|0|||
13117026|NCT03068468|25924014|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
13117027|NCT03068468|25924015|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
13203463|NCT01985334|26224750|FG000|Overall Study|Moderate / severe COPD exacerbation|5|||
13203464|NCT01985334|26224751|FG001|Overall Study|Moderate / severe COPD exacerbation|14|||
13203465|NCT01985334|26224752|FG002|Overall Study|Moderate / severe COPD exacerbation|12|||
13203466|NCT01985334|26224753|FG003|Overall Study|Moderate / severe COPD exacerbation|40|||
13203467|NCT01985334|26224754|FG004|Overall Study|Moderate / severe COPD exacerbation|6|||
13203468|NCT01985334|26224755|FG005|Overall Study|Moderate / severe COPD exacerbation|40|||
13203469|NCT01985334|26224756|FG006|Overall Study|Moderate / severe COPD exacerbation|8|||
13203470|NCT01985334|26224757|FG007|Overall Study|Moderate / severe COPD exacerbation|19|||
13203471|NCT01985334|26224750|FG000|Overall Study|Subject withdrawal of consent|3|||
13203472|NCT01985334|26224751|FG001|Overall Study|Subject withdrawal of consent|6|||
13203473|NCT01985334|26224752|FG002|Overall Study|Subject withdrawal of consent|2|||
13203474|NCT01985334|26224753|FG003|Overall Study|Subject withdrawal of consent|28|||
13203475|NCT01985334|26224754|FG004|Overall Study|Subject withdrawal of consent|4|||
13203476|NCT01985334|26224755|FG005|Overall Study|Subject withdrawal of consent|19|||
13255445|NCT01523275|26383129|FG001|Overall Study|Withdrawal by Subject|0|||
13255446|NCT01522950|26383156|FG000|Overall Study|Withdrawal by Subject|3|||
13255447|NCT01522950|26383157|FG001|Overall Study|Withdrawal by Subject|2|||
13255448|NCT01522950|26383158|FG002|Overall Study|Withdrawal by Subject|1|||
13255449|NCT01522950|26383156|FG000|Overall Study|Adverse Event|3|||
13255450|NCT01522950|26383157|FG001|Overall Study|Adverse Event|1|||
13255451|NCT01522950|26383158|FG002|Overall Study|Adverse Event|1|||
13255452|NCT01522950|26383156|FG000|Overall Study|Protocol Violation|0|||
13255453|NCT01522950|26383157|FG001|Overall Study|Protocol Violation|0|||
13255454|NCT01522950|26383158|FG002|Overall Study|Protocol Violation|2|||
13255455|NCT01522950|26383156|FG000|Overall Study|Death|0|||
13255456|NCT01522950|26383157|FG001|Overall Study|Death|1|||
13255457|NCT01522950|26383158|FG002|Overall Study|Death|1|||
13255458|NCT01522950|26383156|FG000|Overall Study|Study Medication Sensitivity|0|||
13255459|NCT01522950|26383157|FG001|Overall Study|Study Medication Sensitivity|1|||
13255460|NCT01522950|26383158|FG002|Overall Study|Study Medication Sensitivity|0|||
13255461|NCT01522651|26383201|FG000|Overall Study|Adverse Event|3|||
13255462|NCT01522651|26383202|FG001|Overall Study|Adverse Event|4|||
13255463|NCT01522651|26383203|FG002|Overall Study|Adverse Event|4|||
13255464|NCT01522651|26383204|FG003|Overall Study|Adverse Event|5|||
13255465|NCT01522651|26383205|FG004|Overall Study|Adverse Event|4|||
13255466|NCT01522651|26383201|FG000|Overall Study|Cardioversion|1|||
13255467|NCT01522651|26383202|FG001|Overall Study|Cardioversion|0|||
13255468|NCT01522651|26383203|FG002|Overall Study|Cardioversion|0|||
13255469|NCT01522651|26383204|FG003|Overall Study|Cardioversion|0|||
13255470|NCT01522651|26383205|FG004|Overall Study|Cardioversion|0|||
13255471|NCT01522651|26383201|FG000|Overall Study|Device Malfunction|0|||
13255472|NCT01522651|26383202|FG001|Overall Study|Device Malfunction|1|||
13255473|NCT01522651|26383203|FG002|Overall Study|Device Malfunction|0|||
13255474|NCT01522651|26383204|FG003|Overall Study|Device Malfunction|0|||
13255475|NCT01522651|26383205|FG004|Overall Study|Device Malfunction|0|||
13255476|NCT01522651|26383201|FG000|Overall Study|Investigator's Discretion|0|||
13255477|NCT01522651|26383202|FG001|Overall Study|Investigator's Discretion|1|||
13255478|NCT01522651|26383203|FG002|Overall Study|Investigator's Discretion|0|||
13255479|NCT01522651|26383204|FG003|Overall Study|Investigator's Discretion|0|||
13255480|NCT01522651|26383205|FG004|Overall Study|Investigator's Discretion|0|||
13255481|NCT01522651|26383201|FG000|Overall Study|Protocol Violation|3|||
13255482|NCT01522651|26383202|FG001|Overall Study|Protocol Violation|0|||
13255483|NCT01522651|26383203|FG002|Overall Study|Protocol Violation|0|||
13255484|NCT01522651|26383204|FG003|Overall Study|Protocol Violation|0|||
13255485|NCT01522651|26383205|FG004|Overall Study|Protocol Violation|0|||
13255486|NCT01522651|26383201|FG000|Overall Study|Reason Not Specified|0|||
13255487|NCT01522651|26383202|FG001|Overall Study|Reason Not Specified|0|||
13255488|NCT01522651|26383203|FG002|Overall Study|Reason Not Specified|0|||
13255489|NCT01522651|26383204|FG003|Overall Study|Reason Not Specified|1|||
13255490|NCT01522651|26383205|FG004|Overall Study|Reason Not Specified|0|||
13255491|NCT01522651|26383201|FG000|Overall Study|Participant Non-Compliance|1|||
13255492|NCT01522651|26383202|FG001|Overall Study|Participant Non-Compliance|0|||
13255493|NCT01522651|26383203|FG002|Overall Study|Participant Non-Compliance|0|||
13255494|NCT01522651|26383204|FG003|Overall Study|Participant Non-Compliance|0|||
13255495|NCT01522651|26383205|FG004|Overall Study|Participant Non-Compliance|0|||
13255496|NCT01522651|26383201|FG000|Overall Study|Withdrew Consent|1|||
13255497|NCT01522651|26383202|FG001|Overall Study|Withdrew Consent|1|||
13255498|NCT01522651|26383203|FG002|Overall Study|Withdrew Consent|0|||
13255499|NCT01522651|26383204|FG003|Overall Study|Withdrew Consent|1|||
13255500|NCT01522651|26383205|FG004|Overall Study|Withdrew Consent|1|||
13255501|NCT01522651|26383201|FG000|Overall Study|Randomized but Never Treated|0|||
13255502|NCT01522651|26383202|FG001|Overall Study|Randomized but Never Treated|1|||
13255503|NCT01522651|26383203|FG002|Overall Study|Randomized but Never Treated|0|||
13255504|NCT01522651|26383204|FG003|Overall Study|Randomized but Never Treated|1|||
13255505|NCT01522651|26383205|FG004|Overall Study|Randomized but Never Treated|1|||
13255506|NCT01522456|26383268|FG000|Overall Study|Adverse Event|2|||
13255507|NCT01522456|26383268|FG000|Overall Study|Lost to Follow-up|2|||
13255508|NCT01522456|26383268|FG000|Overall Study|Withdrawal by Subject|2|||
13255509|NCT01522456|26383268|FG000|Overall Study|Pregnancy|1|||
13255510|NCT01522456|26383268|FG000|Overall Study|Tolerability Assessment|1|||
13255511|NCT01522443|26383285|FG000|Overall Study|No longer receiving clinical benefit|36|||
13255512|NCT01522443|26383286|FG001|Overall Study|No longer receiving clinical benefit|28|||
13255513|NCT01522443|26383285|FG000|Overall Study|Adverse Event|10|||
13255514|NCT01522443|26383286|FG001|Overall Study|Adverse Event|15|||
13255515|NCT01522443|26383285|FG000|Overall Study|Withdrawal by Subject|5|||
13255516|NCT01522443|26383286|FG001|Overall Study|Withdrawal by Subject|8|||
13255517|NCT01522443|26383285|FG000|Overall Study|No study treatment given|1|||
13255518|NCT01522443|26383286|FG001|Overall Study|No study treatment given|1|||
13255519|NCT01522443|26383285|FG000|Overall Study|Other|1|||
13255520|NCT01522443|26383286|FG001|Overall Study|Other|3|||
13255521|NCT01522404|26383309|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1|||
13255522|NCT01522404|26383310|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0|||
13255523|NCT01522404|26383309|FG000|First Intervention (up to Week 29)|Adverse Event|1|||
13255524|NCT01522404|26383310|FG001|First Intervention (up to Week 29)|Adverse Event|0|||
13255525|NCT01522404|26383309|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1|||
13255526|NCT01522404|26383310|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0|||
13255527|NCT01522365|26383326|FG000|Overall Study|Withdrawal by Subject|1|||
13255528|NCT01522365|26383327|FG001|Overall Study|Withdrawal by Subject|1|||
13255529|NCT01522365|26383326|FG000|Overall Study|Lost to Follow-up|1|||
13255530|NCT01522365|26383327|FG001|Overall Study|Lost to Follow-up|1|||
13255531|NCT01522248|26383347|FG000|Overall Study|Lost to Follow-up|1|||
13255532|NCT01522248|26383348|FG001|Overall Study|Lost to Follow-up|0|||
13255533|NCT01522235|26383371|FG000|Overall Study|Physician Decision|1|||
13255534|NCT01522235|26383372|FG001|Overall Study|Physician Decision|1|||
13255535|NCT01521923|26383505|FG000|Overall Study|AE, serious fatal|1|||
13255536|NCT01521923|26383506|FG001|Overall Study|AE, serious fatal|0|||
13255537|NCT01521923|26383507|FG002|Overall Study|AE, serious fatal|0|||
13255538|NCT01521923|26383508|FG003|Overall Study|AE, serious fatal|0|||
13255539|NCT01521923|26383505|FG000|Overall Study|SAE, non-fatal|0|||
13255540|NCT01521923|26383506|FG001|Overall Study|SAE, non-fatal|2|||
13255541|NCT01521923|26383507|FG002|Overall Study|SAE, non-fatal|2|||
13255542|NCT01521923|26383508|FG003|Overall Study|SAE, non-fatal|0|||
13255543|NCT01521923|26383505|FG000|Overall Study|AE, non-serious, non-fatal|1|||
13255544|NCT01521923|26383506|FG001|Overall Study|AE, non-serious, non-fatal|3|||
13255545|NCT01521923|26383507|FG002|Overall Study|AE, non-serious, non-fatal|6|||
13255546|NCT01521923|26383508|FG003|Overall Study|AE, non-serious, non-fatal|2|||
13255547|NCT01521923|26383505|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
13255548|NCT01521923|26383506|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
13255549|NCT01521923|26383507|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
13255550|NCT01521923|26383508|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1|||
13255551|NCT01521923|26383505|FG000|Overall Study|Lack of Efficacy|1|||
13255552|NCT01521923|26383506|FG001|Overall Study|Lack of Efficacy|1|||
13255553|NCT01521923|26383507|FG002|Overall Study|Lack of Efficacy|0|||
13255554|NCT01521923|26383508|FG003|Overall Study|Lack of Efficacy|0|||
13255555|NCT01521923|26383505|FG000|Overall Study|Protocol Violation|0|||
13255556|NCT01521923|26383506|FG001|Overall Study|Protocol Violation|0|||
13255557|NCT01521923|26383507|FG002|Overall Study|Protocol Violation|1|||
13255558|NCT01521923|26383508|FG003|Overall Study|Protocol Violation|0|||
13255559|NCT01521923|26383505|FG000|Overall Study|Lost to Follow-up|1|||
13255560|NCT01521923|26383506|FG001|Overall Study|Lost to Follow-up|0|||
13255561|NCT01521923|26383507|FG002|Overall Study|Lost to Follow-up|2|||
13255562|NCT01521923|26383508|FG003|Overall Study|Lost to Follow-up|1|||
13255563|NCT01521923|26383505|FG000|Overall Study|Withdrawal by Subject|1|||
13255564|NCT01521923|26383506|FG001|Overall Study|Withdrawal by Subject|1|||
13255565|NCT01521923|26383507|FG002|Overall Study|Withdrawal by Subject|1|||
13255566|NCT01521923|26383508|FG003|Overall Study|Withdrawal by Subject|2|||
13255567|NCT01521923|26383505|FG000|Overall Study|Other|2|||
13255568|NCT01521923|26383506|FG001|Overall Study|Other|1|||
13255569|NCT01521923|26383507|FG002|Overall Study|Other|3|||
13255570|NCT01521923|26383508|FG003|Overall Study|Other|6|||
13255571|NCT01521923|26383505|FG000|Overall Study|AE, captured in Period 1|0|||
13255572|NCT01521923|26383506|FG001|Overall Study|AE, captured in Period 1|1|||
13255573|NCT01521923|26383507|FG002|Overall Study|AE, captured in Period 1|0|||
13255574|NCT01521923|26383508|FG003|Overall Study|AE, captured in Period 1|1|||
13255575|NCT01521897|26383522|FG000|Overall Study|Protocol Violation|18|||
13255576|NCT01521897|26383522|FG000|Overall Study|Lost to Follow-up|5|||
13255577|NCT01521884|26383541|FG000|Overall Study|Non Responders|10|||
13255578|NCT01521884|26383541|FG000|Overall Study|Adverse Event|5|||
13255579|NCT01521884|26383541|FG000|Overall Study|Pregnancy|1|||
13255580|NCT01521884|26383541|FG000|Overall Study|Withdrawal by Subject|1|||
13255581|NCT01521884|26383541|FG000|Overall Study|Physician Decision|2|||
13255582|NCT01521884|26383541|FG000|Overall Study|Protocol Violation|3|||
13255583|NCT01521884|26383541|FG000|Overall Study|Participant non-eligible|1|||
13255584|NCT01521884|26383541|FG000|Overall Study|Lost to Follow-up|4|||
13255585|NCT01521559|26383560|FG000|Overall Study|Adverse Event|0|||
13255586|NCT01521559|26383561|FG001|Overall Study|Adverse Event|4|||
13255587|NCT01521559|26383560|FG000|Overall Study|Death|1|||
13255588|NCT01521559|26383561|FG001|Overall Study|Death|0|||
13255589|NCT01521559|26383560|FG000|Overall Study|Withdrawal by Subject|9|||
13255590|NCT01521559|26383561|FG001|Overall Study|Withdrawal by Subject|11|||
13255591|NCT01521559|26383560|FG000|Overall Study|Lost to Follow-up|3|||
13255592|NCT01521559|26383561|FG001|Overall Study|Lost to Follow-up|1|||
13255593|NCT01521559|26383560|FG000|Overall Study|Protocol Violation|1|||
13255594|NCT01521559|26383561|FG001|Overall Study|Protocol Violation|0|||
13255595|NCT01521559|26383560|FG000|Overall Study|Other|1|||
13255596|NCT01521559|26383561|FG001|Overall Study|Other|2|||
13255597|NCT01521507|26383585|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2|||
13255598|NCT01521507|26383586|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0|||
13255599|NCT01521507|26383585|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1|||
13255600|NCT01521507|26383586|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3|||
13255601|NCT01521507|26383585|FG000|Stage 1: Randomized Design|Lost to Follow-up|0|||
13255602|NCT01521507|26383586|FG001|Stage 1: Randomized Design|Lost to Follow-up|2|||
13255603|NCT01521507|26383585|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0|||
13255604|NCT01521507|26383586|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1|||
13255605|NCT01521507|26383585|FG000|Stage 2: Observational Design|Withdrawal by Subject|3|||
13255606|NCT01521507|26383586|FG001|Stage 2: Observational Design|Withdrawal by Subject|1|||
13255607|NCT01521507|26383585|FG000|Stage 2: Observational Design|Physician Decision|1|||
13255608|NCT01521507|26383586|FG001|Stage 2: Observational Design|Physician Decision|0|||
13255609|NCT01521494|26383624|FG000|Overall Study|Adverse Event|1|||
13255610|NCT01521494|26383625|FG001|Overall Study|Adverse Event|2|||
13255611|NCT01521494|26383626|FG002|Overall Study|Adverse Event|9|||
13255612|NCT01521494|26383627|FG003|Overall Study|Adverse Event|6|||
13255613|NCT01521494|26383628|FG004|Overall Study|Adverse Event|2|||
13255614|NCT01521494|26383624|FG000|Overall Study|Lack of Efficacy|0|||
13255615|NCT01521494|26383625|FG001|Overall Study|Lack of Efficacy|0|||
13255616|NCT01521494|26383626|FG002|Overall Study|Lack of Efficacy|0|||
13255617|NCT01521494|26383627|FG003|Overall Study|Lack of Efficacy|0|||
13255618|NCT01521494|26383628|FG004|Overall Study|Lack of Efficacy|2|||
13255619|NCT01521494|26383624|FG000|Overall Study|Withdrawal by Subject|1|||
13255620|NCT01521494|26383625|FG001|Overall Study|Withdrawal by Subject|1|||
13255621|NCT01521494|26383626|FG002|Overall Study|Withdrawal by Subject|0|||
13255622|NCT01521494|26383627|FG003|Overall Study|Withdrawal by Subject|2|||
13255623|NCT01521494|26383628|FG004|Overall Study|Withdrawal by Subject|0|||
13255624|NCT01521494|26383624|FG000|Overall Study|Decrease in serum phosphate|0|||
13255625|NCT01521494|26383625|FG001|Overall Study|Decrease in serum phosphate|2|||
13255626|NCT01521494|26383626|FG002|Overall Study|Decrease in serum phosphate|3|||
13255627|NCT01521494|26383627|FG003|Overall Study|Decrease in serum phosphate|12|||
13255628|NCT01521494|26383628|FG004|Overall Study|Decrease in serum phosphate|0|||
13255629|NCT01521494|26383624|FG000|Overall Study|Decrease in serum calcium|0|||
13255630|NCT01521494|26383625|FG001|Overall Study|Decrease in serum calcium|0|||
13255631|NCT01521494|26383626|FG002|Overall Study|Decrease in serum calcium|0|||
13255632|NCT01521494|26383627|FG003|Overall Study|Decrease in serum calcium|1|||
13255633|NCT01521494|26383628|FG004|Overall Study|Decrease in serum calcium|1|||
13255634|NCT01521494|26383624|FG000|Overall Study|Physician Decision|0|||
13255635|NCT01521494|26383625|FG001|Overall Study|Physician Decision|0|||
13255636|NCT01521494|26383626|FG002|Overall Study|Physician Decision|0|||
13255637|NCT01521494|26383627|FG003|Overall Study|Physician Decision|0|||
13255638|NCT01521494|26383628|FG004|Overall Study|Physician Decision|2|||
13255639|NCT01521364|26383641|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1|||
13255640|NCT01521364|26383641|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1|||
13255641|NCT01521117|26383654|FG000|First Intervention (6 Weeks)|Adverse Event|5|||
13255642|NCT01521117|26383655|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
13255643|NCT01521117|26383654|FG000|First Intervention (6 Weeks)|Scheduling Issues|0|||
13255644|NCT01521117|26383655|FG001|First Intervention (6 Weeks)|Scheduling Issues|2|||
13255645|NCT01521117|26383654|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
13255646|NCT01521117|26383655|FG001|Second Intervention (6 Weeks)|Adverse Event|3|||
13255647|NCT01520987|26383738|FG000|Overall Study|Withdrawal by Subject|1|||
13255648|NCT01520987|26383739|FG001|Overall Study|Withdrawal by Subject|0|||
13255649|NCT01520987|26383740|FG002|Overall Study|Withdrawal by Subject|0|||
13255650|NCT01520987|26383741|FG003|Overall Study|Withdrawal by Subject|0|||
13255651|NCT01520987|26383742|FG004|Overall Study|Withdrawal by Subject|0|||
13255652|NCT01520987|26383743|FG005|Overall Study|Withdrawal by Subject|1|||
13255653|NCT01520987|26383744|FG006|Overall Study|Withdrawal by Subject|0|||
13255654|NCT01520987|26383745|FG007|Overall Study|Withdrawal by Subject|0|||
13255655|NCT01520922|26383812|FG000|Treatment Phase|Physician Decision|2|||
13255656|NCT01520922|26383813|FG001|Treatment Phase|Physician Decision|1|||
13255657|NCT01520922|26383812|FG000|Treatment Phase|Progression|0|||
13255658|NCT01520922|26383813|FG001|Treatment Phase|Progression|2|||
13255659|NCT01520922|26383812|FG000|Treatment Phase|Adverse Event|3|||
13255660|NCT01520922|26383813|FG001|Treatment Phase|Adverse Event|5|||
13255661|NCT01520922|26383812|FG000|Follow up|Lost to Follow-up|0|||
13255662|NCT01520922|26383813|FG001|Follow up|Lost to Follow-up|1|||
13255663|NCT01520922|26383812|FG000|Survival Follow-up|Withdrawal by Subject|1|||
13255664|NCT01520922|26383813|FG001|Survival Follow-up|Withdrawal by Subject|0|||
13255665|NCT01520909|26383883|FG000|Part 1 (Randomized Period)|Adverse Event|1|||
13255666|NCT01520909|26383884|FG001|Part 1 (Randomized Period)|Adverse Event|2|||
13255667|NCT01520909|26383885|FG002|Part 1 (Randomized Period)|Adverse Event|0|||
13255668|NCT01520909|26383883|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
13255669|NCT01520909|26383884|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
13255670|NCT01520909|26383885|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4|||
13255671|NCT01520909|26383883|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
13255672|NCT01520909|26383884|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
13255673|NCT01520909|26383885|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2|||
13255674|NCT01520909|26383883|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
13255675|NCT01520909|26383884|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
13255676|NCT01520909|26383885|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1|||
13255677|NCT01520870|26383897|FG000|Overall Study|Withdrawal by Subject|2|||
13255678|NCT01520714|26383910|FG000|Overall Study|Protocol Violation|0|||
13255679|NCT01520714|26383911|FG001|Overall Study|Protocol Violation|3|||
13255680|NCT01520714|26383910|FG000|Overall Study|Adverse Event|0|||
13255681|NCT01520714|26383911|FG001|Overall Study|Adverse Event|2|||
13255682|NCT01520714|26383910|FG000|Overall Study|Lack of Efficacy|0|||
13255683|NCT01520714|26383911|FG001|Overall Study|Lack of Efficacy|1|||
13255684|NCT01520506|26383919|FG000|Overall Study|Missed Visit|4|||
13255685|NCT01520506|26383919|FG000|Overall Study|Lost to Follow-up|1|||
13255686|NCT01520506|26383919|FG000|Overall Study|Withdrawal by Subject|1|||
13255687|NCT01520402|26383932|FG000|Overall Study|Withdrawal by Subject|2|||
13255688|NCT01520402|26383932|FG000|Overall Study|Physician Decision|3|||
13255689|NCT01520363|26384013|FG000|Overall Study|Withdrawal by Subject|2|||
13255690|NCT01520363|26384014|FG001|Overall Study|Withdrawal by Subject|0|||
13255691|NCT01520324|26384027|FG000|Overall Study|Subject discontinued (moderate illness)|1|||
13255692|NCT01519960|26384153|FG000|Overall Study|Withdrawal from the study|26|||
13255693|NCT01519960|26384154|FG001|Overall Study|Withdrawal from the study|22|||
13255694|NCT01519960|26384155|FG002|Overall Study|Withdrawal from the study|5|||
13255695|NCT01519947|26384198|FG000|Overall Study|Death|0|||
13255696|NCT01519947|26384199|FG001|Overall Study|Death|0|||
13255697|NCT01519947|26384200|FG002|Overall Study|Death|0|||
13255698|NCT01519947|26384201|FG003|Overall Study|Death|1|||
13255699|NCT01519947|26384198|FG000|Overall Study|Protocol Violation|0|||
13255700|NCT01519947|26384199|FG001|Overall Study|Protocol Violation|0|||
13255701|NCT01519947|26384200|FG002|Overall Study|Protocol Violation|2|||
13255702|NCT01519947|26384201|FG003|Overall Study|Protocol Violation|1|||
13255703|NCT01519947|26384198|FG000|Overall Study|Peritoneal Dialysis Needed|0|||
13255704|NCT01519947|26384199|FG001|Overall Study|Peritoneal Dialysis Needed|1|||
13255705|NCT01519947|26384200|FG002|Overall Study|Peritoneal Dialysis Needed|0|||
13255706|NCT01519947|26384201|FG003|Overall Study|Peritoneal Dialysis Needed|0|||
13255707|NCT01519947|26384198|FG000|Overall Study|Development of Anemia|0|||
13255708|NCT01519947|26384199|FG001|Overall Study|Development of Anemia|1|||
13255709|NCT01519947|26384200|FG002|Overall Study|Development of Anemia|0|||
13255710|NCT01519947|26384201|FG003|Overall Study|Development of Anemia|1|||
13255711|NCT01519947|26384198|FG000|Overall Study|Blood Transfusion|0|||
13255712|NCT01519947|26384199|FG001|Overall Study|Blood Transfusion|1|||
13255713|NCT01519947|26384200|FG002|Overall Study|Blood Transfusion|1|||
13255714|NCT01519947|26384201|FG003|Overall Study|Blood Transfusion|0|||
13255715|NCT01519947|26384198|FG000|Overall Study|Withdrawal by Subject|0|||
13255716|NCT01519947|26384199|FG001|Overall Study|Withdrawal by Subject|1|||
13255717|NCT01519947|26384200|FG002|Overall Study|Withdrawal by Subject|0|||
13255718|NCT01519947|26384201|FG003|Overall Study|Withdrawal by Subject|1|||
13255719|NCT01519947|26384198|FG000|Overall Study|Lost to Follow-up|0|||
13255720|NCT01519947|26384199|FG001|Overall Study|Lost to Follow-up|0|||
13255721|NCT01519947|26384200|FG002|Overall Study|Lost to Follow-up|3|||
13255722|NCT01519947|26384201|FG003|Overall Study|Lost to Follow-up|2|||
13255723|NCT01519947|26384198|FG000|Overall Study|Poor Response|1|||
13255724|NCT01519947|26384199|FG001|Overall Study|Poor Response|0|||
13255725|NCT01519947|26384200|FG002|Overall Study|Poor Response|0|||
13255726|NCT01519947|26384201|FG003|Overall Study|Poor Response|1|||
13255727|NCT01519947|26384198|FG000|Overall Study|Adverse Event|1|||
13255728|NCT01519947|26384199|FG001|Overall Study|Adverse Event|0|||
13255729|NCT01519947|26384200|FG002|Overall Study|Adverse Event|1|||
13255730|NCT01519947|26384201|FG003|Overall Study|Adverse Event|1|||
13255731|NCT01519934|26384210|FG000|Overall Study|Lost to Follow-up|3|||
13255732|NCT01519921|26384239|FG000|Overall Study|Adverse Event|10|||
13255733|NCT01519921|26384240|FG001|Overall Study|Adverse Event|9|||
13255734|NCT01519921|26384239|FG000|Overall Study|Lack of Efficacy|4|||
13255735|NCT01519921|26384240|FG001|Overall Study|Lack of Efficacy|3|||
13255736|NCT01519921|26384239|FG000|Overall Study|Withdrawal by Subject|3|||
13255737|NCT01519921|26384240|FG001|Overall Study|Withdrawal by Subject|0|||
13255738|NCT01519921|26384239|FG000|Overall Study|Lost to Follow-up|2|||
13255739|NCT01519921|26384240|FG001|Overall Study|Lost to Follow-up|1|||
13255740|NCT01519921|26384239|FG000|Overall Study|Treatment refusal|2|||
13255741|NCT01519921|26384240|FG001|Overall Study|Treatment refusal|1|||
13255742|NCT01519921|26384239|FG000|Overall Study|High alanine aminotransferase (ALT)|0|||
13255743|NCT01519921|26384240|FG001|Overall Study|High alanine aminotransferase (ALT)|1|||
13255744|NCT01519869|26384246|FG000|Overall Study|Lost to Follow-up|1|||
13255745|NCT01519817|26384289|FG000|Overall Study|Withdrawal by Subject|1|||
13255746|NCT01519817|26384290|FG001|Overall Study|Withdrawal by Subject|0|||
13255747|NCT01519817|26384291|FG002|Overall Study|Withdrawal by Subject|0|||
13255748|NCT01519817|26384292|FG003|Overall Study|Withdrawal by Subject|0|||
13255749|NCT01519817|26384289|FG000|Overall Study|Off study due to infection|0|||
13255750|NCT01519817|26384290|FG001|Overall Study|Off study due to infection|0|||
13255751|NCT01519817|26384291|FG002|Overall Study|Off study due to infection|0|||
13255752|NCT01519817|26384292|FG003|Overall Study|Off study due to infection|1|||
13255753|NCT01519791|26384363|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2|||
13255754|NCT01519791|26384364|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1|||
13255755|NCT01519791|26384363|FG000|Overall Study|Protocol Violation|6|||
13255756|NCT01519791|26384364|FG001|Overall Study|Protocol Violation|19|||
13255757|NCT01519791|26384363|FG000|Overall Study|Other Reason|87|||
13255758|NCT01519791|26384364|FG001|Overall Study|Other Reason|222|||
13255759|NCT01519791|26384363|FG000|Overall Study|subjects randomized in error|2|||
13255760|NCT01519791|26384364|FG001|Overall Study|subjects randomized in error|0|||
13255761|NCT01519791|26384363|FG000|Overall Study|Lack of Efficacy|16|||
13255762|NCT01519791|26384364|FG001|Overall Study|Lack of Efficacy|20|||
13255763|NCT01519791|26384363|FG000|Overall Study|SAE, non-fatal|6|||
13255764|NCT01519791|26384364|FG001|Overall Study|SAE, non-fatal|22|||
13255765|NCT01519791|26384363|FG000|Overall Study|AE, serious fatal|0|||
13255766|NCT01519791|26384364|FG001|Overall Study|AE, serious fatal|1|||
13255767|NCT01519791|26384363|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0|||
13255768|NCT01519791|26384364|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1|||
13255769|NCT01519791|26384363|FG000|Overall Study|AE, non-serious non-fatal|12|||
13255770|NCT01519791|26384364|FG001|Overall Study|AE, non-serious non-fatal|31|||
13255771|NCT01519791|26384363|FG000|Overall Study|Withdrawal by Subject|15|||
13255772|NCT01519791|26384364|FG001|Overall Study|Withdrawal by Subject|37|||
13255773|NCT01519791|26384363|FG000|Overall Study|Lost to Follow-up|6|||
13255774|NCT01519791|26384364|FG001|Overall Study|Lost to Follow-up|14|||
13255775|NCT01519778|26384370|FG000|Overall Study|Withdrawal by Subject|3|||
13255776|NCT01519778|26384370|FG000|Overall Study|Lost to Follow-up|10|||
13255777|NCT01519778|26384370|FG000|Overall Study|Physician Decision|1|||
13255778|NCT01519765|26384423|FG000|Overall Study|Adverse Event|0|||
13255779|NCT01519765|26384424|FG001|Overall Study|Adverse Event|1|||
13255780|NCT01519765|26384423|FG000|Overall Study|Lack of Efficacy|2|||
13255781|NCT01519765|26384424|FG001|Overall Study|Lack of Efficacy|0|||
13255782|NCT01519765|26384423|FG000|Overall Study|Protocol Violation|1|||
13255783|NCT01519765|26384424|FG001|Overall Study|Protocol Violation|0|||
13255784|NCT01519765|26384423|FG000|Overall Study|Withdrawal by Subject|0|||
13255785|NCT01519765|26384424|FG001|Overall Study|Withdrawal by Subject|1|||
13255786|NCT01519700|26384469|FG000|Overall Study|Death|1|||
13255787|NCT01519700|26384470|FG001|Overall Study|Death|0|||
13255788|NCT01519700|26384471|FG002|Overall Study|Death|0|||
13255789|NCT01519700|26384472|FG003|Overall Study|Death|0|||
13255790|NCT01519700|26384469|FG000|Overall Study|Lost to Follow-up|0|||
13255791|NCT01519700|26384470|FG001|Overall Study|Lost to Follow-up|0|||
13255792|NCT01519700|26384471|FG002|Overall Study|Lost to Follow-up|1|||
13255793|NCT01519700|26384472|FG003|Overall Study|Lost to Follow-up|1|||
13255794|NCT01519700|26384469|FG000|Overall Study|Physician Decision|1|||
13255795|NCT01519700|26384470|FG001|Overall Study|Physician Decision|1|||
13255796|NCT01519700|26384471|FG002|Overall Study|Physician Decision|3|||
13255797|NCT01519700|26384472|FG003|Overall Study|Physician Decision|0|||
13255798|NCT01519700|26384469|FG000|Overall Study|Withdrawal by Subject|5|||
13255799|NCT01519700|26384470|FG001|Overall Study|Withdrawal by Subject|3|||
13255800|NCT01519700|26384471|FG002|Overall Study|Withdrawal by Subject|3|||
13255801|NCT01519700|26384472|FG003|Overall Study|Withdrawal by Subject|2|||
13255802|NCT01519700|26384469|FG000|Overall Study|Other Reason|2|||
13255803|NCT01519700|26384470|FG001|Overall Study|Other Reason|2|||
13255804|NCT01519700|26384471|FG002|Overall Study|Other Reason|0|||
13255805|NCT01519700|26384472|FG003|Overall Study|Other Reason|4|||
13255806|NCT01519674|26384520|FG000|Overall Study|Adverse Event|3|||
13255807|NCT01519674|26384521|FG001|Overall Study|Adverse Event|3|||
13255808|NCT01519674|26384522|FG002|Overall Study|Adverse Event|0|||
13255809|NCT01519674|26384520|FG000|Overall Study|Lack of Efficacy|1|||
13255810|NCT01519674|26384521|FG001|Overall Study|Lack of Efficacy|1|||
13255811|NCT01519674|26384522|FG002|Overall Study|Lack of Efficacy|1|||
13255812|NCT01519674|26384520|FG000|Overall Study|Protocol Violation|0|||
13255813|NCT01519674|26384521|FG001|Overall Study|Protocol Violation|3|||
13255814|NCT01519674|26384522|FG002|Overall Study|Protocol Violation|1|||
13255815|NCT01519674|26384520|FG000|Overall Study|Withdrawal Criteria|7|||
13255816|NCT01519674|26384521|FG001|Overall Study|Withdrawal Criteria|2|||
13255817|NCT01519674|26384522|FG002|Overall Study|Withdrawal Criteria|7|||
13255818|NCT01519674|26384520|FG000|Overall Study|Unsclassified|10|||
13255819|NCT01519674|26384521|FG001|Overall Study|Unsclassified|4|||
13255820|NCT01519674|26384522|FG002|Overall Study|Unsclassified|3|||
13255821|NCT01519661|26384539|FG000|Overall Study|Protocol deviation|6|||
13255822|NCT01519661|26384539|FG000|Overall Study|Lost to Follow-up|3|||
13255823|NCT01519661|26384539|FG000|Overall Study|Withdrawal by Subject|17|||
13255824|NCT01519661|26384539|FG000|Overall Study|Lack of Efficacy|6|||
13255825|NCT01519661|26384539|FG000|Overall Study|Adverse Event|29|||
13255826|NCT01519635|26384552|FG000|Overall Study|Withdrawal by Subject|0|||
13255827|NCT01519635|26384553|FG001|Overall Study|Withdrawal by Subject|1|||
13255828|NCT01519635|26384552|FG000|Overall Study|No possibility to put a catheter|1|||
13255829|NCT01519635|26384553|FG001|Overall Study|No possibility to put a catheter|2|||
13255830|NCT01519518|26384572|FG000|Overall Study|Consent not available|7|||
13255831|NCT01519518|26384573|FG001|Overall Study|Consent not available|10|||
13255832|NCT01519427|26384582|FG000|Overall Study|disease progression|2|||
13255833|NCT01519323|26384596|FG000|Overall Study|Death|3|||
13255834|NCT01519323|26384597|FG001|Overall Study|Death|2|||
13255835|NCT01519323|26384596|FG000|Overall Study|Study terminated by sponsor|0|||
13255836|NCT01519323|26384597|FG001|Overall Study|Study terminated by sponsor|1|||
13255837|NCT01519245|26384616|FG000|Overall Study|Met exclusion criteria, not analysed|1|||
13255838|NCT01519245|26384617|FG001|Overall Study|Met exclusion criteria, not analysed|2|||
13255839|NCT01519206|26384631|FG000|Overall Study|Lost to Follow-up|3|||
13255840|NCT01519206|26384631|FG000|Overall Study|Missed Visit|2|||
13255841|NCT01519167|26384662|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0|||
13255842|NCT01519167|26384663|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3|||
13255843|NCT01519167|26384662|FG000|Overall Study|Adverse Event|0|||
13255844|NCT01519167|26384663|FG001|Overall Study|Adverse Event|1|||
13255845|NCT01519167|26384662|FG000|Overall Study|Lack of Efficacy|0|||
13255846|NCT01519167|26384663|FG001|Overall Study|Lack of Efficacy|1|||
13255847|NCT01519167|26384662|FG000|Overall Study|Medical condition changes&deep sedation|0|||
13255848|NCT01519167|26384663|FG001|Overall Study|Medical condition changes&deep sedation|2|||
13255849|NCT01519167|26384662|FG000|Overall Study|Physician Decision|0|||
13255850|NCT01519167|26384663|FG001|Overall Study|Physician Decision|1|||
13255851|NCT01519089|26384789|FG000|Overall Study|Adverse Event|4|||
13255852|NCT01519089|26384790|FG001|Overall Study|Adverse Event|4|||
13255853|NCT01519089|26384789|FG000|Overall Study|Lack of Efficacy|0|||
13255854|NCT01519089|26384790|FG001|Overall Study|Lack of Efficacy|2|||
13255855|NCT01519089|26384789|FG000|Overall Study|Lost to Follow-up|1|||
13255856|NCT01519089|26384790|FG001|Overall Study|Lost to Follow-up|0|||
13255857|NCT01519089|26384789|FG000|Overall Study|Withdrawal by Subject|0|||
13255858|NCT01519089|26384790|FG001|Overall Study|Withdrawal by Subject|2|||
13255859|NCT01519089|26384789|FG000|Overall Study|Other|2|||
13255860|NCT01519089|26384790|FG001|Overall Study|Other|6|||
13255861|NCT01519089|26384789|FG000|Overall Study|Not received study drug|0|||
13255862|NCT01519089|26384790|FG001|Overall Study|Not received study drug|1|||
13255863|NCT01518972|26384809|FG000|Overall Study|Lost to Follow-up|2|||
13255864|NCT01518972|26384810|FG001|Overall Study|Lost to Follow-up|1|||
13255865|NCT01518972|26384809|FG000|Overall Study|Withdrawal by Subject|1|||
13255866|NCT01518972|26384810|FG001|Overall Study|Withdrawal by Subject|0|||
13255867|NCT01518972|26384809|FG000|Overall Study|Moved from area|1|||
13255868|NCT01518972|26384810|FG001|Overall Study|Moved from area|0|||
13255869|NCT01518972|26384809|FG000|Overall Study|Transportation problems|1|||
13255870|NCT01518972|26384810|FG001|Overall Study|Transportation problems|0|||
13255871|NCT01518972|26384809|FG000|Overall Study|Exclusionary medical condition|1|||
13255872|NCT01518972|26384810|FG001|Overall Study|Exclusionary medical condition|0|||
13255873|NCT01518972|26384809|FG000|Overall Study|Missed safety visits|0|||
13255874|NCT01518972|26384810|FG001|Overall Study|Missed safety visits|1|||
13255875|NCT01518972|26384809|FG000|Overall Study|Exclusionary medication|0|||
13255876|NCT01518972|26384810|FG001|Overall Study|Exclusionary medication|1|||
13255877|NCT01518972|26384809|FG000|Overall Study|Declined medication starting on day 12|0|||
13255878|NCT01518972|26384810|FG001|Overall Study|Declined medication starting on day 12|1|||
13255879|NCT01518946|26384825|FG000|Open-label Phase|Other|4|||
13255880|NCT01518946|26384826|FG001|Open-label Phase|Other|0|||
13255881|NCT01518946|26384827|FG002|Open-label Phase|Other|0|||
13255882|NCT01518946|26384825|FG000|Randomized Phase (First Intervention)|Other|0|||
13255883|NCT01518946|26384826|FG001|Randomized Phase (First Intervention)|Other|1|||
13255884|NCT01518946|26384827|FG002|Randomized Phase (First Intervention)|Other|0|||
13255885|NCT01518699|26384854|FG000|Period 2|Protocol Violation|1|||
13255886|NCT01518699|26384855|FG001|Period 2|Protocol Violation|1|||
13255887|NCT01518699|26384856|FG002|Period 2|Protocol Violation|0|||
13255888|NCT01518699|26384857|FG003|Period 2|Protocol Violation|0|||
13255889|NCT01518699|26384858|FG004|Period 2|Protocol Violation|0|||
13255890|NCT01518699|26384859|FG005|Period 2|Protocol Violation|0|||
13255891|NCT01518699|26384854|FG000|Period 2|Lost to Follow-up|0|||
13255892|NCT01518699|26384855|FG001|Period 2|Lost to Follow-up|1|||
13255893|NCT01518699|26384856|FG002|Period 2|Lost to Follow-up|0|||
13255894|NCT01518699|26384857|FG003|Period 2|Lost to Follow-up|0|||
13255895|NCT01518699|26384858|FG004|Period 2|Lost to Follow-up|0|||
13255896|NCT01518699|26384859|FG005|Period 2|Lost to Follow-up|0|||
13255897|NCT01518699|26384854|FG000|Period 2|Adverse Event|1|||
13255898|NCT01518699|26384855|FG001|Period 2|Adverse Event|0|||
13255899|NCT01518699|26384856|FG002|Period 2|Adverse Event|0|||
13255900|NCT01518699|26384857|FG003|Period 2|Adverse Event|0|||
13255901|NCT01518699|26384858|FG004|Period 2|Adverse Event|0|||
13255902|NCT01518699|26384859|FG005|Period 2|Adverse Event|0|||
13255903|NCT01518374|26384865|FG000|Overall Study|Withdrawal by Subject|2|||
13255904|NCT01518374|26384865|FG000|Overall Study|Protocol Violation|3|||
13255905|NCT01518374|26384865|FG000|Overall Study|Lost to Follow-up|2|||
13255906|NCT01518322|26384880|FG000|Overall Study|FeNO measurement was missing|13|||
13255907|NCT01518309|26384886|FG000|Overall Study|Adverse Event|6|||
13255908|NCT01518309|26384886|FG000|Overall Study|Death|6|||
13255909|NCT01518309|26384886|FG000|Overall Study|Lack of Efficacy|7|||
13255910|NCT01518309|26384886|FG000|Overall Study|Withdrawal by Subject|6|||
13255911|NCT01518309|26384886|FG000|Overall Study|Physician Decision|3|||
13255912|NCT01518309|26384886|FG000|Overall Study|Sponsor Decision|2|||
13255913|NCT01518309|26384886|FG000|Overall Study|Not in Predefined Categories|9|||
13255914|NCT01518257|26384915|FG000|Overall Study|Lost to Follow-up|1|||
13255915|NCT01518257|26384916|FG001|Overall Study|Lost to Follow-up|0|||
13255916|NCT01518257|26384915|FG000|Overall Study|Other Miscellaneous Reason|1|||
13255917|NCT01518257|26384916|FG001|Overall Study|Other Miscellaneous Reason|0|||
13255918|NCT01518244|26384923|FG000|Overall Study|Adverse Event|3|||
13255919|NCT01518192|26384954|FG000|Overall Study|Lost to Follow-up|29|||
13255920|NCT01518192|26384955|FG001|Overall Study|Lost to Follow-up|26|||
13255921|NCT01518192|26384956|FG002|Overall Study|Lost to Follow-up|35|||
13255922|NCT01518153|26384968|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5|||
13255923|NCT01518153|26384969|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
13255924|NCT01518153|26384970|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
13255925|NCT01518153|26384968|FG000|Stem Cell Transplant|Death|2|||
13255926|NCT01518153|26384969|FG001|Stem Cell Transplant|Death|0|||
13255927|NCT01518153|26384970|FG002|Stem Cell Transplant|Death|0|||
13255928|NCT01518153|26384968|FG000|Stem Cell Transplant|Secondary graft failure|1|||
13255929|NCT01518153|26384969|FG001|Stem Cell Transplant|Secondary graft failure|0|||
13255930|NCT01518153|26384970|FG002|Stem Cell Transplant|Secondary graft failure|0|||
13255931|NCT01518153|26384968|FG000|Stem Cell Transplant|Adverse Event|1|||
13255932|NCT01518153|26384969|FG001|Stem Cell Transplant|Adverse Event|0|||
13255933|NCT01518153|26384970|FG002|Stem Cell Transplant|Adverse Event|0|||
13255934|NCT01518153|26384968|FG000|Donor Lymphocyte Infusion|Death|0|||
13255935|NCT01518153|26384969|FG001|Donor Lymphocyte Infusion|Death|2|||
13255936|NCT01518153|26384970|FG002|Donor Lymphocyte Infusion|Death|1|||
13255937|NCT01517984|26385005|FG000|Overall Study|Lost to Follow-up|0|||
13255938|NCT01517984|26385006|FG001|Overall Study|Lost to Follow-up|1|||
13255939|NCT01517984|26385007|FG002|Overall Study|Lost to Follow-up|0|||
13255940|NCT01517984|26385008|FG003|Overall Study|Lost to Follow-up|0|||
13255941|NCT01517984|26385005|FG000|Overall Study|Withdrawal by Subject|1|||
13255942|NCT01517984|26385006|FG001|Overall Study|Withdrawal by Subject|8|||
13255943|NCT01517984|26385007|FG002|Overall Study|Withdrawal by Subject|4|||
13255944|NCT01517984|26385008|FG003|Overall Study|Withdrawal by Subject|1|||
13255945|NCT01517984|26385005|FG000|Overall Study|Screen Failure|4|||
13255946|NCT01517984|26385006|FG001|Overall Study|Screen Failure|0|||
13255947|NCT01517984|26385007|FG002|Overall Study|Screen Failure|0|||
13255948|NCT01517984|26385008|FG003|Overall Study|Screen Failure|0|||
13255949|NCT01517984|26385005|FG000|Overall Study|Ineligible for randomization|0|||
13255950|NCT01517984|26385006|FG001|Overall Study|Ineligible for randomization|14|||
13255951|NCT01517984|26385007|FG002|Overall Study|Ineligible for randomization|0|||
13255952|NCT01517984|26385008|FG003|Overall Study|Ineligible for randomization|0|||
13255953|NCT01517893|26385035|FG000|Overall Study|Withdrawal by Subject|3|||
13255954|NCT01517893|26385036|FG001|Overall Study|Withdrawal by Subject|0|||
13255955|NCT01517867|26385051|FG000|Overall Study|never started treatment|29|||
13255956|NCT01517867|26385052|FG001|Overall Study|never started treatment|32|||
13255957|NCT01517867|26385051|FG000|Overall Study|Withdrawal by Subject|34|||
13255958|NCT01517867|26385052|FG001|Overall Study|Withdrawal by Subject|30|||
13255959|NCT01517867|26385051|FG000|Overall Study|Still in treatment at study end|0|||
13255960|NCT01517867|26385052|FG001|Overall Study|Still in treatment at study end|3|||
13255961|NCT01517802|26385058|FG000|Overall Study|Death|1|||
13255962|NCT01517750|26385101|FG000|Overall Study|Lost to Follow-up|1|||
13255963|NCT01517750|26385102|FG001|Overall Study|Lost to Follow-up|2|||
13255964|NCT01517750|26385103|FG002|Overall Study|Lost to Follow-up|4|||
13255965|NCT01517750|26385104|FG003|Overall Study|Lost to Follow-up|1|||
13255966|NCT01517412|26385135|FG000|Overall Study|Adverse Event|10|||
13255967|NCT01517412|26385136|FG001|Overall Study|Adverse Event|11|||
13255968|NCT01517412|26385135|FG000|Overall Study|Lack of Efficacy|10|||
13255969|NCT01517412|26385136|FG001|Overall Study|Lack of Efficacy|5|||
13255970|NCT01517412|26385135|FG000|Overall Study|Poor compliance to protocol|8|||
13255971|NCT01517412|26385136|FG001|Overall Study|Poor compliance to protocol|3|||
13255972|NCT01517412|26385135|FG000|Overall Study|Other than specified above|8|||
13255973|NCT01517412|26385136|FG001|Overall Study|Other than specified above|5|||
13255974|NCT01517373|26385221|FG000|Run-in Period|Death|1|||
13255975|NCT01517373|26385222|FG001|Run-in Period|Death|0|||
13255976|NCT01517373|26385223|FG002|Run-in Period|Death|0|||
13255977|NCT01517373|26385224|FG003|Run-in Period|Death|0|||
13255978|NCT01517373|26385225|FG004|Run-in Period|Death|0|||
13255979|NCT01517373|26385226|FG005|Run-in Period|Death|0|||
13255980|NCT01517373|26385221|FG000|Run-in Period|Adverse Event|5|||
13255981|NCT01517373|26385222|FG001|Run-in Period|Adverse Event|0|||
13255982|NCT01517373|26385223|FG002|Run-in Period|Adverse Event|0|||
13255983|NCT01517373|26385224|FG003|Run-in Period|Adverse Event|0|||
13255984|NCT01517373|26385225|FG004|Run-in Period|Adverse Event|0|||
13255985|NCT01517373|26385226|FG005|Run-in Period|Adverse Event|0|||
13255986|NCT01517373|26385221|FG000|Run-in Period|Did not meet eligibility criteria|34|||
13255987|NCT01517373|26385222|FG001|Run-in Period|Did not meet eligibility criteria|0|||
13255988|NCT01517373|26385223|FG002|Run-in Period|Did not meet eligibility criteria|0|||
13255989|NCT01517373|26385224|FG003|Run-in Period|Did not meet eligibility criteria|0|||
13255990|NCT01517373|26385225|FG004|Run-in Period|Did not meet eligibility criteria|0|||
13255991|NCT01517373|26385226|FG005|Run-in Period|Did not meet eligibility criteria|0|||
13255992|NCT01517373|26385221|FG000|Run-in Period|Lost to Follow-up|1|||
13255993|NCT01517373|26385222|FG001|Run-in Period|Lost to Follow-up|0|||
13255994|NCT01517373|26385223|FG002|Run-in Period|Lost to Follow-up|0|||
13255995|NCT01517373|26385224|FG003|Run-in Period|Lost to Follow-up|0|||
13255996|NCT01517373|26385225|FG004|Run-in Period|Lost to Follow-up|0|||
13255997|NCT01517373|26385226|FG005|Run-in Period|Lost to Follow-up|0|||
13255998|NCT01517373|26385221|FG000|Run-in Period|Withdrawal by Subject|12|||
13255999|NCT01517373|26385222|FG001|Run-in Period|Withdrawal by Subject|0|||
13256000|NCT01517373|26385223|FG002|Run-in Period|Withdrawal by Subject|0|||
13256001|NCT01517373|26385224|FG003|Run-in Period|Withdrawal by Subject|0|||
13256002|NCT01517373|26385225|FG004|Run-in Period|Withdrawal by Subject|0|||
13256003|NCT01517373|26385226|FG005|Run-in Period|Withdrawal by Subject|0|||
13256004|NCT01517373|26385221|FG000|Run-in Period|Sponsor Decision|3|||
13256005|NCT01517373|26385222|FG001|Run-in Period|Sponsor Decision|0|||
13256006|NCT01517373|26385223|FG002|Run-in Period|Sponsor Decision|0|||
13256007|NCT01517373|26385224|FG003|Run-in Period|Sponsor Decision|0|||
13256008|NCT01517373|26385225|FG004|Run-in Period|Sponsor Decision|0|||
13256009|NCT01517373|26385226|FG005|Run-in Period|Sponsor Decision|0|||
13256010|NCT01517373|26385221|FG000|Run-in Period|Other|1|||
13256011|NCT01517373|26385222|FG001|Run-in Period|Other|0|||
13256012|NCT01517373|26385223|FG002|Run-in Period|Other|0|||
13256013|NCT01517373|26385224|FG003|Run-in Period|Other|0|||
13256014|NCT01517373|26385225|FG004|Run-in Period|Other|0|||
13256015|NCT01517373|26385226|FG005|Run-in Period|Other|0|||
13256016|NCT01517373|26385221|FG000|Treatment Period|Adverse Event|0|||
13256017|NCT01517373|26385222|FG001|Treatment Period|Adverse Event|0|||
13256018|NCT01517373|26385223|FG002|Treatment Period|Adverse Event|0|||
13256019|NCT01517373|26385224|FG003|Treatment Period|Adverse Event|0|||
13256020|NCT01517373|26385225|FG004|Treatment Period|Adverse Event|0|||
13256021|NCT01517373|26385226|FG005|Treatment Period|Adverse Event|2|||
13256022|NCT01517373|26385221|FG000|Treatment Period|Lost to Follow-up|0|||
13256023|NCT01517373|26385222|FG001|Treatment Period|Lost to Follow-up|0|||
13256024|NCT01517373|26385223|FG002|Treatment Period|Lost to Follow-up|1|||
13256025|NCT01517373|26385224|FG003|Treatment Period|Lost to Follow-up|1|||
13256026|NCT01517373|26385225|FG004|Treatment Period|Lost to Follow-up|0|||
13256027|NCT01517373|26385226|FG005|Treatment Period|Lost to Follow-up|0|||
13256028|NCT01517373|26385221|FG000|Treatment Period|Withdrawal by Subject|0|||
13256029|NCT01517373|26385222|FG001|Treatment Period|Withdrawal by Subject|3|||
13256030|NCT01517373|26385223|FG002|Treatment Period|Withdrawal by Subject|2|||
13256031|NCT01517373|26385224|FG003|Treatment Period|Withdrawal by Subject|2|||
13256032|NCT01517373|26385225|FG004|Treatment Period|Withdrawal by Subject|2|||
13256033|NCT01517373|26385226|FG005|Treatment Period|Withdrawal by Subject|3|||
13256034|NCT01517373|26385221|FG000|Treatment Period|Other|0|||
13256035|NCT01517373|26385222|FG001|Treatment Period|Other|0|||
13256036|NCT01517373|26385223|FG002|Treatment Period|Other|0|||
13256037|NCT01517373|26385224|FG003|Treatment Period|Other|0|||
13256038|NCT01517373|26385225|FG004|Treatment Period|Other|1|||
13256039|NCT01517373|26385226|FG005|Treatment Period|Other|0|||
13256040|NCT01517373|26385221|FG000|Treatment Period|Protocol Violation|0|||
13256041|NCT01517373|26385222|FG001|Treatment Period|Protocol Violation|0|||
13256042|NCT01517373|26385223|FG002|Treatment Period|Protocol Violation|0|||
13256043|NCT01517373|26385224|FG003|Treatment Period|Protocol Violation|0|||
13256044|NCT01517373|26385225|FG004|Treatment Period|Protocol Violation|1|||
13256045|NCT01517373|26385226|FG005|Treatment Period|Protocol Violation|0|||
13256046|NCT01517373|26385221|FG000|Treatment Period|Lack of Efficacy|0|||
13256047|NCT01517373|26385222|FG001|Treatment Period|Lack of Efficacy|1|||
13256048|NCT01517373|26385223|FG002|Treatment Period|Lack of Efficacy|1|||
13256049|NCT01517373|26385224|FG003|Treatment Period|Lack of Efficacy|3|||
13256050|NCT01517373|26385225|FG004|Treatment Period|Lack of Efficacy|2|||
13256051|NCT01517373|26385226|FG005|Treatment Period|Lack of Efficacy|0|||
13256052|NCT01517373|26385221|FG000|Treatment Period|Medication error without AEs|0|||
13256053|NCT01517373|26385222|FG001|Treatment Period|Medication error without AEs|0|||
13256054|NCT01517373|26385223|FG002|Treatment Period|Medication error without AEs|2|||
13256055|NCT01517373|26385224|FG003|Treatment Period|Medication error without AEs|1|||
13256056|NCT01517373|26385225|FG004|Treatment Period|Medication error without AEs|0|||
13256057|NCT01517373|26385226|FG005|Treatment Period|Medication error without AEs|2|||
13256058|NCT01517295|26385243|FG000|Overall Study|Physician Decision|1|||
13256059|NCT01517295|26385244|FG001|Overall Study|Physician Decision|0|||
13256060|NCT01517282|26385291|FG000|Overall Study|Consent withdrawn|0|||
13256061|NCT01517282|26385292|FG001|Overall Study|Consent withdrawn|1|||
13256062|NCT01517282|26385293|FG002|Overall Study|Consent withdrawn|1|||
13256063|NCT01517282|26385294|FG003|Overall Study|Consent withdrawn|1|||
13256064|NCT01517282|26385291|FG000|Overall Study|Physician Decision|1|||
13256065|NCT01517282|26385292|FG001|Overall Study|Physician Decision|0|||
13256066|NCT01517282|26385293|FG002|Overall Study|Physician Decision|0|||
13256067|NCT01517282|26385294|FG003|Overall Study|Physician Decision|0|||
13256068|NCT01517178|26385303|FG000|Period 1|Adverse Event|1|||
13256069|NCT01517178|26385304|FG001|Period 1|Adverse Event|2|||
13256070|NCT01517178|26385303|FG000|Period 1|Lack of Efficacy|0|||
13256071|NCT01517178|26385304|FG001|Period 1|Lack of Efficacy|1|||
13256072|NCT01517178|26385303|FG000|Period 1|E.g. study termination|3|||
13256073|NCT01517178|26385304|FG001|Period 1|E.g. study termination|1|||
13256074|NCT01517178|26385303|FG000|Period 1|Withdrawal by Subject|0|||
13256075|NCT01517178|26385304|FG001|Period 1|Withdrawal by Subject|1|||
13256076|NCT01517178|26385303|FG000|Period 2|Adverse Event|1|||
13256077|NCT01517178|26385304|FG001|Period 2|Adverse Event|0|||
13256078|NCT01517178|26385303|FG000|Period 2|Withdrawal by Subject|3|||
13256079|NCT01517178|26385304|FG001|Period 2|Withdrawal by Subject|0|||
13256080|NCT01517178|26385303|FG000|Period 2|E.g. study termination|2|||
13256081|NCT01517178|26385304|FG001|Period 2|E.g. study termination|2|||
13256082|NCT01516970|26385323|FG000|Overall Study|Lost to Follow-up|7|||
13256083|NCT01516970|26385324|FG001|Overall Study|Lost to Follow-up|8|||
13256084|NCT01516970|26385323|FG000|Overall Study|Adverse Event|1|||
13256085|NCT01516970|26385324|FG001|Overall Study|Adverse Event|5|||
13256086|NCT01516970|26385323|FG000|Overall Study|Withdrawal by Subject|1|||
13256087|NCT01516970|26385324|FG001|Overall Study|Withdrawal by Subject|1|||
13256088|NCT01516970|26385323|FG000|Overall Study|Other|9|||
13256089|NCT01516970|26385324|FG001|Overall Study|Other|7|||
13256090|NCT01516892|26385332|FG000|Overall Study|Adverse Event|25|||
13256091|NCT01516892|26385332|FG000|Overall Study|Lack of Efficacy|35|||
13256092|NCT01516892|26385332|FG000|Overall Study|Pregnancy|5|||
13256093|NCT01516892|26385332|FG000|Overall Study|Lost to Follow-up|82|||
13256094|NCT01516892|26385332|FG000|Overall Study|Subject Withdrew Consent|92|||
13256095|NCT01516892|26385332|FG000|Overall Study|Protocol Violation|60|||
13256096|NCT01516892|26385332|FG000|Overall Study|Other Miscellaneous Reasons|43|||
13256097|NCT01516892|26385332|FG000|Overall Study|Missing|1|||
13256098|NCT01516879|26385373|FG000|Overall Study|Withdrawal by Subject|9|||
13256099|NCT01516879|26385374|FG001|Overall Study|Withdrawal by Subject|11|||
13256100|NCT01516879|26385373|FG000|Overall Study|Death|0|||
13256101|NCT01516879|26385374|FG001|Overall Study|Death|2|||
13256102|NCT01516879|26385373|FG000|Overall Study|Lost to Follow-up|2|||
13256103|NCT01516879|26385374|FG001|Overall Study|Lost to Follow-up|11|||
13256104|NCT01516879|26385373|FG000|Overall Study|Other|5|||
13256105|NCT01516879|26385374|FG001|Overall Study|Other|10|||
13256106|NCT01516749|26385383|FG000|Active Therapy|Lost to Follow-up|1|||
13256107|NCT01516749|26385383|FG000|Follow-up Off Therapy|Lost to Follow-up|1|||
13256108|NCT01516736|26385410|FG000|Overall Study|Withdrawal by Subject|10|||
13256109|NCT01516736|26385411|FG001|Overall Study|Withdrawal by Subject|4|||
13256110|NCT01516736|26385410|FG000|Overall Study|Adverse Event|4|||
13256111|NCT01516736|26385411|FG001|Overall Study|Adverse Event|5|||
13256112|NCT01516736|26385410|FG000|Overall Study|Death|3|||
13256113|NCT01516736|26385411|FG001|Overall Study|Death|1|||
13256114|NCT01516736|26385410|FG000|Overall Study|Physician Decision|2|||
13256115|NCT01516736|26385411|FG001|Overall Study|Physician Decision|1|||
13256116|NCT01516736|26385410|FG000|Overall Study|Lack of Efficacy|1|||
13256117|NCT01516736|26385411|FG001|Overall Study|Lack of Efficacy|0|||
13256118|NCT01516736|26385410|FG000|Overall Study|Protocol Violation|0|||
13256119|NCT01516736|26385411|FG001|Overall Study|Protocol Violation|1|||
13256120|NCT01516736|26385410|FG000|Overall Study|Other (not specified)|0|||
13256121|NCT01516736|26385411|FG001|Overall Study|Other (not specified)|1|||
13256122|NCT01516437|26385478|FG000|Overall Study|Reason not specified|0|||
13256123|NCT01516437|26385479|FG001|Overall Study|Reason not specified|0|||
13256124|NCT01516437|26385480|FG002|Overall Study|Reason not specified|1|||
13256125|NCT01516437|26385481|FG003|Overall Study|Reason not specified|1|||
13256126|NCT01516216|26385508|FG000|Overall Study|Adverse Event|2|||
13256127|NCT01516216|26385509|FG001|Overall Study|Adverse Event|4|||
13256128|NCT01516216|26385508|FG000|Overall Study|Disease Progression|38|||
13256129|NCT01516216|26385509|FG001|Overall Study|Disease Progression|34|||
13256130|NCT01516216|26385508|FG000|Overall Study|Withdrawal by Subject|9|||
13256131|NCT01516216|26385509|FG001|Overall Study|Withdrawal by Subject|11|||
13256132|NCT01516216|26385508|FG000|Overall Study|Potentially Curative Resection|6|||
13256133|NCT01516216|26385509|FG001|Overall Study|Potentially Curative Resection|12|||
13256134|NCT01516216|26385508|FG000|Overall Study|Nonadherence|2|||
13256135|NCT01516216|26385509|FG001|Overall Study|Nonadherence|3|||
13256136|NCT01516216|26385508|FG000|Overall Study|Physician Decision|6|||
13256137|NCT01516216|26385509|FG001|Overall Study|Physician Decision|3|||
13256138|NCT01516216|26385508|FG000|Overall Study|Prolonged Treatment Delay|5|||
13256139|NCT01516216|26385509|FG001|Overall Study|Prolonged Treatment Delay|1|||
13256140|NCT01516216|26385508|FG000|Overall Study|Intercurrent Illness|1|||
13256141|NCT01516216|26385509|FG001|Overall Study|Intercurrent Illness|0|||
13256142|NCT01516216|26385508|FG000|Overall Study|Death|1|||
13256143|NCT01516216|26385509|FG001|Overall Study|Death|1|||
13256144|NCT01516034|26385515|FG000|Overall Study|Physician Decision|1|||
13256145|NCT01516034|26385515|FG000|Overall Study|Lack of Efficacy|7|||
13256146|NCT01516008|26385557|FG000|Overall Study|Adverse Event|0|||
13256147|NCT01516008|26385558|FG001|Overall Study|Adverse Event|2|||
13256148|NCT01516008|26385559|FG002|Overall Study|Adverse Event|7|||
13256149|NCT01516008|26385557|FG000|Overall Study|Lack of Efficacy|44|||
13256150|NCT01516008|26385558|FG001|Overall Study|Lack of Efficacy|14|||
13256151|NCT01516008|26385559|FG002|Overall Study|Lack of Efficacy|10|||
13256152|NCT01516008|26385557|FG000|Overall Study|Protocol Violation|1|||
13256153|NCT01516008|26385558|FG001|Overall Study|Protocol Violation|0|||
13256154|NCT01516008|26385559|FG002|Overall Study|Protocol Violation|0|||
13256155|NCT01516008|26385557|FG000|Overall Study|Reason not specified|0|||
13256156|NCT01516008|26385558|FG001|Overall Study|Reason not specified|0|||
13256157|NCT01516008|26385559|FG002|Overall Study|Reason not specified|1|||
13256158|NCT01515865|26385571|FG000|Part A (Open-label)|Other|3|||
13256159|NCT01515865|26385572|FG001|Part A (Open-label)|Other|0|||
13256160|NCT01515865|26385573|FG002|Part A (Open-label)|Other|0|||
13256161|NCT01515865|26385571|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
13256162|NCT01515865|26385572|FG001|Part B (Open-label)|Withdrawal by Subject|0|||
13256163|NCT01515865|26385573|FG002|Part B (Open-label)|Withdrawal by Subject|0|||
13256164|NCT01515865|26385571|FG000|Part B (Open-label)|Other|1|||
13256165|NCT01515865|26385572|FG001|Part B (Open-label)|Other|0|||
13256166|NCT01515865|26385573|FG002|Part B (Open-label)|Other|0|||
13256167|NCT01515475|26385658|FG000|Overall Study|Lost to Follow-up|20|||
13256168|NCT01515475|26385659|FG001|Overall Study|Lost to Follow-up|15|||
13256169|NCT01515475|26385660|FG002|Overall Study|Lost to Follow-up|12|||
13256170|NCT01515475|26385661|FG003|Overall Study|Lost to Follow-up|12|||
13256171|NCT01515423|26385688|FG000|Open Label Phase|Adverse Event|57|||
13256172|NCT01515423|26385689|FG001|Open Label Phase|Adverse Event|0|||
13256173|NCT01515423|26385690|FG002|Open Label Phase|Adverse Event|0|||
13256174|NCT01515423|26385688|FG000|Open Label Phase|Death|2|||
13256175|NCT01515423|26385689|FG001|Open Label Phase|Death|0|||
13256176|NCT01515423|26385690|FG002|Open Label Phase|Death|0|||
13256177|NCT01515423|26385688|FG000|Open Label Phase|Lack of Efficacy|117|||
13256178|NCT01515423|26385689|FG001|Open Label Phase|Lack of Efficacy|0|||
13256179|NCT01515423|26385690|FG002|Open Label Phase|Lack of Efficacy|0|||
13256180|NCT01515423|26385688|FG000|Open Label Phase|Lost to Follow-up|21|||
13256181|NCT01515423|26385689|FG001|Open Label Phase|Lost to Follow-up|0|||
13256182|NCT01515423|26385690|FG002|Open Label Phase|Lost to Follow-up|0|||
13256183|NCT01515423|26385688|FG000|Open Label Phase|Withdrawal by Subject|118|||
13256184|NCT01515423|26385689|FG001|Open Label Phase|Withdrawal by Subject|0|||
13256185|NCT01515423|26385690|FG002|Open Label Phase|Withdrawal by Subject|0|||
13256186|NCT01515423|26385688|FG000|Open Label Phase|excluded from DB Phase|70|||
13256187|NCT01515423|26385689|FG001|Open Label Phase|excluded from DB Phase|0|||
13256188|NCT01515423|26385690|FG002|Open Label Phase|excluded from DB Phase|0|||
13256189|NCT01515423|26385688|FG000|Open Label Phase|Other|28|||
13256190|NCT01515423|26385689|FG001|Open Label Phase|Other|0|||
13256191|NCT01515423|26385690|FG002|Open Label Phase|Other|0|||
13256192|NCT01515423|26385688|FG000|DOUBLE BLIND|Adverse Event|0|||
13256193|NCT01515423|26385689|FG001|DOUBLE BLIND|Adverse Event|15|||
13256194|NCT01515423|26385690|FG002|DOUBLE BLIND|Adverse Event|13|||
13256195|NCT01515423|26385688|FG000|DOUBLE BLIND|Death|0|||
13256196|NCT01515423|26385689|FG001|DOUBLE BLIND|Death|1|||
13256197|NCT01515423|26385690|FG002|DOUBLE BLIND|Death|2|||
13256198|NCT01515423|26385688|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
13256199|NCT01515423|26385689|FG001|DOUBLE BLIND|Lost to Follow-up|7|||
13256200|NCT01515423|26385690|FG002|DOUBLE BLIND|Lost to Follow-up|12|||
13256201|NCT01515423|26385688|FG000|DOUBLE BLIND|Pregnancy|0|||
13256202|NCT01515423|26385689|FG001|DOUBLE BLIND|Pregnancy|2|||
13256203|NCT01515423|26385690|FG002|DOUBLE BLIND|Pregnancy|0|||
13256204|NCT01515423|26385688|FG000|DOUBLE BLIND|Withdrawal by Subject|0|||
13256205|NCT01515423|26385689|FG001|DOUBLE BLIND|Withdrawal by Subject|50|||
13256206|NCT01515423|26385690|FG002|DOUBLE BLIND|Withdrawal by Subject|53|||
13256207|NCT01515423|26385688|FG000|DOUBLE BLIND|Other|0|||
13256208|NCT01515423|26385689|FG001|DOUBLE BLIND|Other|6|||
13256209|NCT01515423|26385690|FG002|DOUBLE BLIND|Other|12|||
13256210|NCT01515423|26385688|FG000|DOUBLE BLIND|Blind broken by investigator|0|||
13256211|NCT01515423|26385689|FG001|DOUBLE BLIND|Blind broken by investigator|1|||
13256212|NCT01515423|26385690|FG002|DOUBLE BLIND|Blind broken by investigator|0|||
13256213|NCT01515319|26385753|FG000|Overall Study|Withdrawal by Subject|0|||
13256214|NCT01515319|26385754|FG001|Overall Study|Withdrawal by Subject|0|||
13256215|NCT01515319|26385755|FG002|Overall Study|Withdrawal by Subject|0|||
13256216|NCT01515319|26385756|FG003|Overall Study|Withdrawal by Subject|0|||
13256217|NCT01515319|26385757|FG004|Overall Study|Withdrawal by Subject|0|||
13256218|NCT01515319|26385758|FG005|Overall Study|Withdrawal by Subject|0|||
13256219|NCT01515319|26385759|FG006|Overall Study|Withdrawal by Subject|1|||
13256220|NCT01515319|26385760|FG007|Overall Study|Withdrawal by Subject|0|||
13256221|NCT01515319|26385761|FG008|Overall Study|Withdrawal by Subject|0|||
13256222|NCT01515319|26385762|FG009|Overall Study|Withdrawal by Subject|0|||
13256223|NCT01515319|26385753|FG000|Overall Study|Adverse Event|0|||
13256224|NCT01515319|26385754|FG001|Overall Study|Adverse Event|0|||
13256225|NCT01515319|26385755|FG002|Overall Study|Adverse Event|0|||
13256226|NCT01515319|26385756|FG003|Overall Study|Adverse Event|0|||
13256227|NCT01515319|26385757|FG004|Overall Study|Adverse Event|0|||
13256228|NCT01515319|26385758|FG005|Overall Study|Adverse Event|0|||
13256229|NCT01515319|26385759|FG006|Overall Study|Adverse Event|0|||
13256230|NCT01515319|26385760|FG007|Overall Study|Adverse Event|0|||
13256231|NCT01515319|26385761|FG008|Overall Study|Adverse Event|3|||
13256232|NCT01515319|26385762|FG009|Overall Study|Adverse Event|0|||
13256233|NCT01515319|26385753|FG000|Overall Study|Protocol Violation|0|||
13256234|NCT01515319|26385754|FG001|Overall Study|Protocol Violation|0|||
13256235|NCT01515319|26385755|FG002|Overall Study|Protocol Violation|0|||
13256236|NCT01515319|26385756|FG003|Overall Study|Protocol Violation|0|||
13256237|NCT01515319|26385757|FG004|Overall Study|Protocol Violation|0|||
13256238|NCT01515319|26385758|FG005|Overall Study|Protocol Violation|0|||
13256239|NCT01515319|26385759|FG006|Overall Study|Protocol Violation|0|||
13256240|NCT01515319|26385760|FG007|Overall Study|Protocol Violation|0|||
13256241|NCT01515319|26385761|FG008|Overall Study|Protocol Violation|2|||
13256242|NCT01515319|26385762|FG009|Overall Study|Protocol Violation|0|||
13256243|NCT01515189|26385789|FG000|Induction|Disease Progression|109|||
13256244|NCT01515189|26385790|FG001|Induction|Disease Progression|155|||
13256245|NCT01515189|26385789|FG000|Induction|Study drug toxicity|86|||
13256246|NCT01515189|26385790|FG001|Induction|Study drug toxicity|36|||
13256247|NCT01515189|26385789|FG000|Induction|Death|24|||
13256248|NCT01515189|26385790|FG001|Induction|Death|17|||
13256249|NCT01515189|26385789|FG000|Induction|Adverse Event|14|||
13256250|NCT01515189|26385790|FG001|Induction|Adverse Event|9|||
13256251|NCT01515189|26385789|FG000|Induction|Withdrawal by Subject|3|||
13256252|NCT01515189|26385790|FG001|Induction|Withdrawal by Subject|9|||
13256253|NCT01515189|26385789|FG000|Induction|No longer meets study criteria|0|||
13256254|NCT01515189|26385790|FG001|Induction|No longer meets study criteria|2|||
13256255|NCT01515189|26385789|FG000|Induction|Lost to Follow-up|1|||
13256256|NCT01515189|26385790|FG001|Induction|Lost to Follow-up|0|||
13256257|NCT01515189|26385789|FG000|Induction|Other|0|||
13256258|NCT01515189|26385790|FG001|Induction|Other|4|||
13256259|NCT01515189|26385789|FG000|First Re-Induction Phase|Disease progression|6|||
13256260|NCT01515189|26385790|FG001|First Re-Induction Phase|Disease progression|14|||
13256261|NCT01515189|26385789|FG000|First Re-Induction Phase|Study drug toxicity|5|||
13256262|NCT01515189|26385790|FG001|First Re-Induction Phase|Study drug toxicity|0|||
13256263|NCT01515189|26385789|FG000|First Re-Induction Phase|Withdrawal by Subject|1|||
13256264|NCT01515189|26385790|FG001|First Re-Induction Phase|Withdrawal by Subject|1|||
13256265|NCT01515189|26385789|FG000|First Re-Induction Phase|No longer meets study criteria|1|||
13256266|NCT01515189|26385790|FG001|First Re-Induction Phase|No longer meets study criteria|0|||
13256267|NCT01515189|26385789|FG000|First Re-Induction Phase|Other|1|||
13256268|NCT01515189|26385790|FG001|First Re-Induction Phase|Other|0|||
13256269|NCT01514864|26385813|FG000|Overall Study|Disease progression|7|||
13256270|NCT01514864|26385814|FG001|Overall Study|Disease progression|5|||
13256271|NCT01514864|26385813|FG000|Overall Study|Study drug toxicity|2|||
13256272|NCT01514864|26385814|FG001|Overall Study|Study drug toxicity|0|||
13256273|NCT01514760|26385823|FG000|Overall Study|Lost to Follow-up|2|||
13256274|NCT01514682|26385846|FG000|Overall Study|Withdrawal by Subject|2|||
13256275|NCT01514682|26385847|FG001|Overall Study|Withdrawal by Subject|3|||
13256276|NCT01514682|26385846|FG000|Overall Study|Physician Decision|4|||
13256277|NCT01514682|26385847|FG001|Overall Study|Physician Decision|3|||
13256278|NCT01514461|26385894|FG000|Overall Study|Adverse Event|2|||
13256279|NCT01514461|26385895|FG001|Overall Study|Adverse Event|1|||
13256280|NCT01514461|26385896|FG002|Overall Study|Adverse Event|3|||
13256281|NCT01514461|26385894|FG000|Overall Study|Physician Decision|1|||
13256282|NCT01514461|26385895|FG001|Overall Study|Physician Decision|1|||
13256283|NCT01514461|26385896|FG002|Overall Study|Physician Decision|0|||
13256284|NCT01514461|26385894|FG000|Overall Study|Patient/guardian decision|1|||
13256285|NCT01514461|26385895|FG001|Overall Study|Patient/guardian decision|1|||
13256286|NCT01514461|26385896|FG002|Overall Study|Patient/guardian decision|1|||
13256287|NCT01514461|26385894|FG000|Overall Study|Death|1|||
13256288|NCT01514461|26385895|FG001|Overall Study|Death|0|||
13256289|NCT01514461|26385896|FG002|Overall Study|Death|0|||
13256290|NCT01514448|26385918|FG000|Overall Study|Death|7|||
13256291|NCT01514448|26385919|FG001|Overall Study|Death|8|||
13256292|NCT01514448|26385918|FG000|Overall Study|Withdrawal by Subject|2|||
13256293|NCT01514448|26385919|FG001|Overall Study|Withdrawal by Subject|0|||
13256294|NCT01514448|26385918|FG000|Overall Study|Lost to Follow-up|2|||
13256295|NCT01514448|26385919|FG001|Overall Study|Lost to Follow-up|0|||
13256296|NCT01514448|26385918|FG000|Overall Study|New Cancer Therapy|1|||
13256297|NCT01514448|26385919|FG001|Overall Study|New Cancer Therapy|0|||
13117028|NCT03068468|25924016|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2|||
13117029|NCT03068468|25924017|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
13117030|NCT03068468|25924014|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0|||
13117031|NCT03068468|25924015|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0|||
13117032|NCT03068468|25924016|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115|||
13117033|NCT03068468|25924017|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228|||
13117034|NCT03068468|25924014|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
13117035|NCT03068468|25924015|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
13117036|NCT03068468|25924016|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
13117037|NCT03068468|25924017|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4|||
13117038|NCT03068468|25924014|FG000|Open-Label Extension Period|Reason not Specified|0|||
13117039|NCT03068468|25924015|FG001|Open-Label Extension Period|Reason not Specified|0|||
13117040|NCT03068468|25924016|FG002|Open-Label Extension Period|Reason not Specified|1|||
13117041|NCT03068468|25924017|FG003|Open-Label Extension Period|Reason not Specified|4|||
13117042|NCT03068455|25924050|FG000|Pre-treatment Period|Disease progression|0|||
13117043|NCT03068455|25924051|FG001|Pre-treatment Period|Disease progression|1|||
13256298|NCT01514422|26385927|FG000|Overall Study|Lost to Follow-up|1|||
13256299|NCT01514370|26385978|FG000|Overall Study|Protocol Violation|2|||
13256300|NCT01514370|26385979|FG001|Overall Study|Protocol Violation|3|||
13256301|NCT01514370|26385978|FG000|Overall Study|Lost to Follow-up|0|||
13256302|NCT01514370|26385979|FG001|Overall Study|Lost to Follow-up|2|||
13256303|NCT01514370|26385978|FG000|Overall Study|Withdrawal by Subject|2|||
13256304|NCT01514370|26385979|FG001|Overall Study|Withdrawal by Subject|1|||
13256305|NCT01514370|26385978|FG000|Overall Study|Adverse Event|1|||
13256306|NCT01514370|26385979|FG001|Overall Study|Adverse Event|3|||
13256307|NCT01514370|26385978|FG000|Overall Study|Other|6|||
13256308|NCT01514370|26385979|FG001|Overall Study|Other|7|||
13256309|NCT01514357|26385992|FG000|Overall Study|Screen failure|2|||
13256310|NCT01514357|26385993|FG001|Overall Study|Screen failure|0|||
13256311|NCT01514357|26385992|FG000|Overall Study|Withdrawal by Subject|2|||
13256312|NCT01514357|26385993|FG001|Overall Study|Withdrawal by Subject|0|||
13256313|NCT01514240|26386074|FG000|Overall Study|Adverse Event|4|||
13256314|NCT01514240|26386075|FG001|Overall Study|Adverse Event|4|||
13256315|NCT01514240|26386074|FG000|Overall Study|Subject Decision|2|||
13256316|NCT01514240|26386075|FG001|Overall Study|Subject Decision|7|||
13256317|NCT01514201|26386147|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1|||
13256318|NCT01514201|26386148|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
13256319|NCT01514201|26386149|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
13256320|NCT01514201|26386150|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
13256321|NCT01514201|26386147|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
13256322|NCT01514201|26386148|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
13256323|NCT01514201|26386149|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
13256324|NCT01514201|26386150|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
13256325|NCT01514201|26386147|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
13256326|NCT01514201|26386148|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
13256327|NCT01514201|26386149|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5|||
13256328|NCT01514201|26386150|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
13256329|NCT01514201|26386147|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
13256330|NCT01514201|26386148|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
13256331|NCT01514201|26386149|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
13256332|NCT01514201|26386150|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
13256333|NCT01514201|26386147|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
13256334|NCT01514201|26386148|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
13256335|NCT01514201|26386149|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
13256336|NCT01514201|26386150|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1|||
13256337|NCT01514201|26386147|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
13256338|NCT01514201|26386148|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
13256339|NCT01514201|26386149|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
13256340|NCT01514201|26386150|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2|||
13256341|NCT01514201|26386147|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0|||
13256342|NCT01514201|26386148|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0|||
13256343|NCT01514201|26386149|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0|||
13256344|NCT01514201|26386150|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1|||
13256345|NCT01514201|26386147|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
13256346|NCT01514201|26386148|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
13256347|NCT01514201|26386149|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
13256348|NCT01514201|26386150|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2|||
13256349|NCT01514201|26386147|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
13256350|NCT01514201|26386148|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
13256351|NCT01514201|26386149|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
13256352|NCT01514201|26386150|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6|||
13256353|NCT01514201|26386147|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
13256354|NCT01514201|26386148|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
13256355|NCT01514201|26386149|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
13256356|NCT01514201|26386150|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4|||
13256357|NCT01514201|26386147|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
13256358|NCT01514201|26386148|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
13256359|NCT01514201|26386149|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
13256360|NCT01514201|26386150|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7|||
13256361|NCT01514201|26386147|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
13256362|NCT01514201|26386148|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
13256363|NCT01514201|26386149|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
13256364|NCT01514201|26386150|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22|||
13256365|NCT01514136|26386189|FG000|Test Period 1; Test A|Protocol Violation|1|||
13256366|NCT01514136|26386190|FG001|Test Period 1; Test A|Protocol Violation|0|||
13256367|NCT01514136|26386191|FG002|Test Period 1; Test A|Protocol Violation|0|||
13256368|NCT01514136|26386192|FG003|Test Period 1; Test A|Protocol Violation|0|||
13256369|NCT01514136|26386193|FG004|Test Period 1; Test A|Protocol Violation|0|||
13256370|NCT01514136|26386194|FG005|Test Period 1; Test A|Protocol Violation|0|||
13256371|NCT01514136|26386195|FG006|Test Period 1; Test A|Protocol Violation|0|||
13256372|NCT01514136|26386196|FG007|Test Period 1; Test A|Protocol Violation|0|||
13256373|NCT01514136|26386189|FG000|Test Period 1; Test A|Break from study holiday|2|||
13256374|NCT01514136|26386190|FG001|Test Period 1; Test A|Break from study holiday|0|||
13256375|NCT01514136|26386191|FG002|Test Period 1; Test A|Break from study holiday|0|||
13256376|NCT01514136|26386192|FG003|Test Period 1; Test A|Break from study holiday|0|||
13256377|NCT01514136|26386193|FG004|Test Period 1; Test A|Break from study holiday|0|||
13256378|NCT01514136|26386194|FG005|Test Period 1; Test A|Break from study holiday|0|||
13256379|NCT01514136|26386195|FG006|Test Period 1; Test A|Break from study holiday|0|||
13256380|NCT01514136|26386196|FG007|Test Period 1; Test A|Break from study holiday|0|||
13256381|NCT01514136|26386189|FG000|Test Period 1; Test B|Withdrawal by Subject|0|||
13256382|NCT01514136|26386190|FG001|Test Period 1; Test B|Withdrawal by Subject|1|||
13256383|NCT01514136|26386191|FG002|Test Period 1; Test B|Withdrawal by Subject|0|||
13256384|NCT01514136|26386192|FG003|Test Period 1; Test B|Withdrawal by Subject|0|||
13256385|NCT01514136|26386193|FG004|Test Period 1; Test B|Withdrawal by Subject|0|||
13256386|NCT01514136|26386194|FG005|Test Period 1; Test B|Withdrawal by Subject|0|||
13256387|NCT01514136|26386195|FG006|Test Period 1; Test B|Withdrawal by Subject|0|||
13256388|NCT01514136|26386196|FG007|Test Period 1; Test B|Withdrawal by Subject|0|||
13256389|NCT01514136|26386189|FG000|Test Period 1; Test D|Subject took a break due to holiday|0|||
13256390|NCT01514136|26386190|FG001|Test Period 1; Test D|Subject took a break due to holiday|0|||
13256391|NCT01514136|26386191|FG002|Test Period 1; Test D|Subject took a break due to holiday|0|||
13256392|NCT01514136|26386192|FG003|Test Period 1; Test D|Subject took a break due to holiday|2|||
13256393|NCT01514136|26386193|FG004|Test Period 1; Test D|Subject took a break due to holiday|0|||
13256394|NCT01514136|26386194|FG005|Test Period 1; Test D|Subject took a break due to holiday|0|||
13256395|NCT01514136|26386195|FG006|Test Period 1; Test D|Subject took a break due to holiday|0|||
13256396|NCT01514136|26386196|FG007|Test Period 1; Test D|Subject took a break due to holiday|0|||
13256397|NCT01514136|26386189|FG000|Test Period 2; Test A*|Adverse Event|0|||
13256398|NCT01514136|26386190|FG001|Test Period 2; Test A*|Adverse Event|0|||
13256399|NCT01514136|26386191|FG002|Test Period 2; Test A*|Adverse Event|0|||
13256400|NCT01514136|26386192|FG003|Test Period 2; Test A*|Adverse Event|0|||
13256401|NCT01514136|26386193|FG004|Test Period 2; Test A*|Adverse Event|1|||
13256402|NCT01514136|26386194|FG005|Test Period 2; Test A*|Adverse Event|0|||
13256403|NCT01514136|26386195|FG006|Test Period 2; Test A*|Adverse Event|0|||
13256404|NCT01514136|26386196|FG007|Test Period 2; Test A*|Adverse Event|0|||
13256405|NCT01514136|26386189|FG000|Test Period 2; Test A*|Holiday|0|||
13256406|NCT01514136|26386190|FG001|Test Period 2; Test A*|Holiday|0|||
13256407|NCT01514136|26386191|FG002|Test Period 2; Test A*|Holiday|0|||
13256408|NCT01514136|26386192|FG003|Test Period 2; Test A*|Holiday|0|||
13256409|NCT01514136|26386193|FG004|Test Period 2; Test A*|Holiday|1|||
13256410|NCT01514136|26386194|FG005|Test Period 2; Test A*|Holiday|0|||
13256411|NCT01514136|26386195|FG006|Test Period 2; Test A*|Holiday|0|||
13256412|NCT01514136|26386196|FG007|Test Period 2; Test A*|Holiday|0|||
13256413|NCT01514136|26386189|FG000|Test Period 2; Test B*|Withdrawal by Subject|0|||
13256414|NCT01514136|26386190|FG001|Test Period 2; Test B*|Withdrawal by Subject|0|||
13256415|NCT01514136|26386191|FG002|Test Period 2; Test B*|Withdrawal by Subject|0|||
13256416|NCT01514136|26386192|FG003|Test Period 2; Test B*|Withdrawal by Subject|0|||
13256417|NCT01514136|26386193|FG004|Test Period 2; Test B*|Withdrawal by Subject|0|||
13256418|NCT01514136|26386194|FG005|Test Period 2; Test B*|Withdrawal by Subject|2|||
13256419|NCT01514136|26386195|FG006|Test Period 2; Test B*|Withdrawal by Subject|0|||
13256420|NCT01514136|26386196|FG007|Test Period 2; Test B*|Withdrawal by Subject|0|||
13256421|NCT01514136|26386189|FG000|Test Period 2; Test C*|Withdrawal by Subject|0|||
13256422|NCT01514136|26386190|FG001|Test Period 2; Test C*|Withdrawal by Subject|0|||
13256423|NCT01514136|26386191|FG002|Test Period 2; Test C*|Withdrawal by Subject|0|||
13256424|NCT01514136|26386192|FG003|Test Period 2; Test C*|Withdrawal by Subject|0|||
13256425|NCT01514136|26386193|FG004|Test Period 2; Test C*|Withdrawal by Subject|0|||
13256426|NCT01514136|26386194|FG005|Test Period 2; Test C*|Withdrawal by Subject|0|||
13256427|NCT01514136|26386195|FG006|Test Period 2; Test C*|Withdrawal by Subject|1|||
13256428|NCT01514136|26386196|FG007|Test Period 2; Test C*|Withdrawal by Subject|0|||
13256429|NCT01514136|26386189|FG000|Test Period 2; Test C*|holiday|0|||
13256430|NCT01514136|26386190|FG001|Test Period 2; Test C*|holiday|0|||
13256431|NCT01514136|26386191|FG002|Test Period 2; Test C*|holiday|0|||
13256432|NCT01514136|26386192|FG003|Test Period 2; Test C*|holiday|0|||
13256433|NCT01514136|26386193|FG004|Test Period 2; Test C*|holiday|0|||
13256434|NCT01514136|26386194|FG005|Test Period 2; Test C*|holiday|0|||
13256435|NCT01514136|26386195|FG006|Test Period 2; Test C*|holiday|1|||
13256436|NCT01514136|26386196|FG007|Test Period 2; Test C*|holiday|0|||
13256437|NCT01514136|26386189|FG000|Test Period 2; Test C*|Protocol Violation|0|||
13256438|NCT01514136|26386190|FG001|Test Period 2; Test C*|Protocol Violation|0|||
13256439|NCT01514136|26386191|FG002|Test Period 2; Test C*|Protocol Violation|0|||
13256440|NCT01514136|26386192|FG003|Test Period 2; Test C*|Protocol Violation|0|||
13256441|NCT01514136|26386193|FG004|Test Period 2; Test C*|Protocol Violation|0|||
13256442|NCT01514136|26386194|FG005|Test Period 2; Test C*|Protocol Violation|0|||
13256443|NCT01514136|26386195|FG006|Test Period 2; Test C*|Protocol Violation|1|||
13256444|NCT01514136|26386196|FG007|Test Period 2; Test C*|Protocol Violation|0|||
13290379|NCT00102960|26481091|FG002|Overall Study|Death|11|||
13290380|NCT00102960|26481089|FG000|Overall Study|Lost to Follow-up|6|||
13290381|NCT00102960|26481090|FG001|Overall Study|Lost to Follow-up|12|||
13290382|NCT00102960|26481091|FG002|Overall Study|Lost to Follow-up|16|||
13290383|NCT00102960|26481089|FG000|Overall Study|Withdrawal by Subject|1|||
13290384|NCT00102960|26481090|FG001|Overall Study|Withdrawal by Subject|0|||
13290385|NCT00102960|26481091|FG002|Overall Study|Withdrawal by Subject|1|||
13256445|NCT01513967|26386239|FG000|Overall Study|Pregnancy|0|||
13256446|NCT01513967|26386240|FG001|Overall Study|Pregnancy|0|||
13256447|NCT01513967|26386241|FG002|Overall Study|Pregnancy|0|||
13256448|NCT01513967|26386242|FG003|Overall Study|Pregnancy|0|||
13256449|NCT01513967|26386243|FG004|Overall Study|Pregnancy|0|||
13256450|NCT01513967|26386244|FG005|Overall Study|Pregnancy|0|||
13256451|NCT01513967|26386245|FG006|Overall Study|Pregnancy|1|||
13256452|NCT01513967|26386246|FG007|Overall Study|Pregnancy|0|||
13256453|NCT01513967|26386239|FG000|Overall Study|missed a study visit|0|||
13256454|NCT01513967|26386240|FG001|Overall Study|missed a study visit|0|||
13256455|NCT01513967|26386241|FG002|Overall Study|missed a study visit|0|||
13256456|NCT01513967|26386242|FG003|Overall Study|missed a study visit|0|||
13256457|NCT01513967|26386243|FG004|Overall Study|missed a study visit|0|||
13256458|NCT01513967|26386244|FG005|Overall Study|missed a study visit|0|||
13256459|NCT01513967|26386245|FG006|Overall Study|missed a study visit|1|||
13256460|NCT01513967|26386246|FG007|Overall Study|missed a study visit|0|||
13256461|NCT01513967|26386239|FG000|Overall Study|excluded due to positive drug screen|0|||
13256462|NCT01513967|26386240|FG001|Overall Study|excluded due to positive drug screen|0|||
13256463|NCT01513967|26386241|FG002|Overall Study|excluded due to positive drug screen|0|||
13256464|NCT01513967|26386242|FG003|Overall Study|excluded due to positive drug screen|0|||
13256465|NCT01513967|26386243|FG004|Overall Study|excluded due to positive drug screen|0|||
13256466|NCT01513967|26386244|FG005|Overall Study|excluded due to positive drug screen|0|||
13256467|NCT01513967|26386245|FG006|Overall Study|excluded due to positive drug screen|0|||
13256468|NCT01513967|26386246|FG007|Overall Study|excluded due to positive drug screen|2|||
13256469|NCT01513967|26386239|FG000|Overall Study|Physician Decision|0|||
13256470|NCT01513967|26386240|FG001|Overall Study|Physician Decision|0|||
13256471|NCT01513967|26386241|FG002|Overall Study|Physician Decision|0|||
13256472|NCT01513967|26386242|FG003|Overall Study|Physician Decision|0|||
13256473|NCT01513967|26386243|FG004|Overall Study|Physician Decision|0|||
13256474|NCT01513967|26386244|FG005|Overall Study|Physician Decision|1|||
13256475|NCT01513967|26386245|FG006|Overall Study|Physician Decision|0|||
13256476|NCT01513967|26386246|FG007|Overall Study|Physician Decision|0|||
13256477|NCT01513759|26386257|FG000|Overall Study|Protocol Violation|4|||
13256478|NCT01513759|26386257|FG000|Overall Study|Death during catheter placement|1|||
13256479|NCT01513590|26386282|FG000|Overall Study|Adverse Event|2|||
13117044|NCT03068455|25924050|FG000|Pre-treatment Period|Participant withdrew consent|1|||
13117045|NCT03068455|25924051|FG001|Pre-treatment Period|Participant withdrew consent|1|||
13117046|NCT03068455|25924050|FG000|Pre-treatment Period|Poor/non-compliance|0|||
13117047|NCT03068455|25924051|FG001|Pre-treatment Period|Poor/non-compliance|1|||
13117048|NCT03068455|25924050|FG000|Pre-treatment Period|Participant no longer meets study criteria|1|||
13117049|NCT03068455|25924051|FG001|Pre-treatment Period|Participant no longer meets study criteria|3|||
13117050|NCT03068455|25924050|FG000|Pre-treatment Period|Not reported|2|||
13117051|NCT03068455|25924051|FG001|Pre-treatment Period|Not reported|1|||
13117052|NCT03068455|25924050|FG000|Treatment Period|Disease progression|166|||
13117053|NCT03068455|25924051|FG001|Treatment Period|Disease progression|208|||
13117054|NCT03068455|25924050|FG000|Treatment Period|Study drug toxicity|317|||
13117055|NCT03068455|25924051|FG001|Treatment Period|Study drug toxicity|104|||
13117056|NCT03068455|25924050|FG000|Treatment Period|Adverse Event unrelated to study drug|15|||
13117057|NCT03068455|25924051|FG001|Treatment Period|Adverse Event unrelated to study drug|7|||
13117058|NCT03068455|25924050|FG000|Treatment Period|Participant request to stop therapy|33|||
13117059|NCT03068455|25924051|FG001|Treatment Period|Participant request to stop therapy|20|||
13117060|NCT03068455|25924050|FG000|Treatment Period|Participant withdrew consent|5|||
13117061|NCT03068455|25924051|FG001|Treatment Period|Participant withdrew consent|10|||
13117062|NCT03068455|25924050|FG000|Treatment Period|Poor/non-compliance|3|||
13117063|NCT03068455|25924051|FG001|Treatment Period|Poor/non-compliance|0|||
13117064|NCT03068455|25924050|FG000|Treatment Period|Participant no longer meets study criteria|1|||
13117065|NCT03068455|25924051|FG001|Treatment Period|Participant no longer meets study criteria|3|||
13117066|NCT03068455|25924050|FG000|Treatment Period|Other reasons|12|||
13117067|NCT03068455|25924051|FG001|Treatment Period|Other reasons|4|||
13117068|NCT03067987|25924070|FG000|Overall Study|Lost to Follow-up|7|||
13117069|NCT03067987|25924071|FG001|Overall Study|Lost to Follow-up|10|||
13117070|NCT03067987|25924070|FG000|Overall Study|Protocol Violation|1|||
13117071|NCT03067987|25924071|FG001|Overall Study|Protocol Violation|2|||
13117072|NCT03067987|25924070|FG000|Overall Study|Withdrawal by Subject|2|||
13117073|NCT03067987|25924071|FG001|Overall Study|Withdrawal by Subject|1|||
13117074|NCT03067441|25924134|FG000|Overall Study|Withdrawal by Subject|16|||
13117075|NCT03067441|25924135|FG001|Overall Study|Withdrawal by Subject|34|||
13117076|NCT03067441|25924134|FG000|Overall Study|Lost to Follow-up|7|||
13117077|NCT03067441|25924135|FG001|Overall Study|Lost to Follow-up|5|||
13117078|NCT03067441|25924134|FG000|Overall Study|Adverse Event|7|||
13117079|NCT03067441|25924135|FG001|Overall Study|Adverse Event|14|||
13117080|NCT03067441|25924134|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1|||
13256480|NCT01513590|26386283|FG001|Overall Study|Adverse Event|3|||
13256481|NCT01513590|26386282|FG000|Overall Study|Withdrawal Criteria|3|||
13256482|NCT01513590|26386283|FG001|Overall Study|Withdrawal Criteria|0|||
13117081|NCT03067441|25924135|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0|||
13117082|NCT03067441|25924134|FG000|Overall Study|Physician Decision|1|||
13117083|NCT03067441|25924135|FG001|Overall Study|Physician Decision|3|||
13117084|NCT03067441|25924134|FG000|Overall Study|Other|1|||
13117085|NCT03067441|25924135|FG001|Overall Study|Other|1|||
13117086|NCT03067311|25924170|FG000|Overall Study|Lost to Follow-up|1|||
13117087|NCT03067311|25924171|FG001|Overall Study|Lost to Follow-up|1|||
13256483|NCT01513590|26386282|FG000|Overall Study|Unclassified|5|||
13256484|NCT01513590|26386283|FG001|Overall Study|Unclassified|10|||
13256485|NCT01513551|26386319|FG000|Overall Study|Death|0|||
13256486|NCT01513551|26386320|FG001|Overall Study|Death|1|||
13117088|NCT03067311|25924170|FG000|Overall Study|Moved away|1|||
13117089|NCT03067311|25924171|FG001|Overall Study|Moved away|1|||
13117090|NCT03067129|25924264|FG000|Overall Study|Ongoing|45|||
13117091|NCT03067129|25924265|FG001|Overall Study|Ongoing|28|||
13117092|NCT03067129|25924266|FG002|Overall Study|Ongoing|27|||
13117093|NCT03067129|25924267|FG003|Overall Study|Ongoing|23|||
13117094|NCT03067129|25924264|FG000|Overall Study|Partially dosed; refused to swallow entire dose|0|||
13256487|NCT01513551|26386321|FG002|Overall Study|Death|0|||
13117095|NCT03067129|25924265|FG001|Overall Study|Partially dosed; refused to swallow entire dose|0|||
13117096|NCT03067129|25924266|FG002|Overall Study|Partially dosed; refused to swallow entire dose|0|||
13117097|NCT03067129|25924267|FG003|Overall Study|Partially dosed; refused to swallow entire dose|1|||
13256488|NCT01513551|26386319|FG000|Overall Study|Lost to Follow-up|3|||
13256489|NCT01513551|26386320|FG001|Overall Study|Lost to Follow-up|5|||
13256490|NCT01513551|26386321|FG002|Overall Study|Lost to Follow-up|2|||
13256491|NCT01513551|26386319|FG000|Overall Study|Withdrawal by Subject|1|||
13256492|NCT01513551|26386320|FG001|Overall Study|Withdrawal by Subject|0|||
13256493|NCT01513551|26386321|FG002|Overall Study|Withdrawal by Subject|2|||
13256494|NCT01513551|26386319|FG000|Overall Study|Randomized but not vaccinated|0|||
13256495|NCT01513551|26386320|FG001|Overall Study|Randomized but not vaccinated|0|||
13256496|NCT01513551|26386321|FG002|Overall Study|Randomized but not vaccinated|1|||
13256497|NCT01513473|26386352|FG000|Main Trial (26 Weeks)|Adverse Event|0|||
13256498|NCT01513473|26386353|FG001|Main Trial (26 Weeks)|Adverse Event|2|||
13256499|NCT01513473|26386352|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4|||
13256500|NCT01513473|26386353|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7|||
13256501|NCT01513473|26386352|FG000|Main Trial (26 Weeks)|Unclassified|0|||
13256502|NCT01513473|26386353|FG001|Main Trial (26 Weeks)|Unclassified|2|||
13256503|NCT01513473|26386352|FG000|Extension Trial (26 Weeks)|Adverse Event|0|||
13256504|NCT01513473|26386353|FG001|Extension Trial (26 Weeks)|Adverse Event|1|||
13256505|NCT01513473|26386352|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1|||
13256506|NCT01513473|26386353|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5|||
13256507|NCT01513460|26386387|FG000|Overall Study|Death|0|||
13256508|NCT01513460|26386388|FG001|Overall Study|Death|0|||
13256509|NCT01513460|26386389|FG002|Overall Study|Death|1|||
13256510|NCT01513460|26386387|FG000|Overall Study|Lost to Follow-up|0|||
13256511|NCT01513460|26386388|FG001|Overall Study|Lost to Follow-up|0|||
13256512|NCT01513460|26386389|FG002|Overall Study|Lost to Follow-up|2|||
13256513|NCT01513460|26386387|FG000|Overall Study|Abnormal laboratory value|1|||
13256514|NCT01513460|26386388|FG001|Overall Study|Abnormal laboratory value|0|||
13256515|NCT01513460|26386389|FG002|Overall Study|Abnormal laboratory value|1|||
13256516|NCT01513460|26386387|FG000|Overall Study|Lack of Efficacy|1|||
13256517|NCT01513460|26386388|FG001|Overall Study|Lack of Efficacy|2|||
13256518|NCT01513460|26386389|FG002|Overall Study|Lack of Efficacy|5|||
13256519|NCT01513460|26386387|FG000|Overall Study|Protocol deviations|3|||
13256520|NCT01513460|26386388|FG001|Overall Study|Protocol deviations|4|||
13256521|NCT01513460|26386389|FG002|Overall Study|Protocol deviations|3|||
13256522|NCT01513460|26386387|FG000|Overall Study|Withdrawal by Subject|7|||
13256523|NCT01513460|26386388|FG001|Overall Study|Withdrawal by Subject|8|||
13256524|NCT01513460|26386389|FG002|Overall Study|Withdrawal by Subject|21|||
13256525|NCT01513460|26386387|FG000|Overall Study|Adverse Event|16|||
13485918|NCT03672188|27034241|FG006|Overall Study|Death|0|||
13485919|NCT03672188|27034242|FG007|Overall Study|Death|0|||
13485920|NCT03672188|27034243|FG008|Overall Study|Death|0|||
13485921|NCT03672188|27034244|FG009|Overall Study|Death|0|||
13117098|NCT03066999|25924292|FG000|Overall Study|abnormal urethraBladder neck contracture|0|||
13256526|NCT01513460|26386388|FG001|Overall Study|Adverse Event|18|||
13256527|NCT01513460|26386389|FG002|Overall Study|Adverse Event|23|||
13256528|NCT01513460|26386387|FG000|Overall Study|Abnormal test procedure|1|||
13256529|NCT01513460|26386388|FG001|Overall Study|Abnormal test procedure|0|||
13256530|NCT01513460|26386389|FG002|Overall Study|Abnormal test procedure|0|||
13256531|NCT01513330|26386398|FG000|SenSura Mio First,|Adverse Event|2|||
13256532|NCT01513330|26386399|FG001|SenSura Mio First,|Adverse Event|0|||
13256533|NCT01513330|26386398|FG000|SenSura Mio First,|Lack of Efficacy|0|||
13117099|NCT03066999|25924293|FG001|Overall Study|abnormal urethraBladder neck contracture|2|||
13256534|NCT01513330|26386399|FG001|SenSura Mio First,|Lack of Efficacy|1|||
13256535|NCT01513330|26386398|FG000|SenSura Mio First,|Withdrawal by Subject|1|||
13485922|NCT03672188|27034245|FG010|Overall Study|Death|0|||
13485923|NCT03672188|27034246|FG011|Overall Study|Death|0|||
13256536|NCT01513330|26386399|FG001|SenSura Mio First,|Withdrawal by Subject|1|||
13256537|NCT01513330|26386398|FG000|SenSura Mio First,|Other|1|||
13256538|NCT01513330|26386399|FG001|SenSura Mio First,|Other|0|||
13256539|NCT01513330|26386398|FG000|Standard Care First,|Lack of Efficacy|2|||
13256540|NCT01513330|26386399|FG001|Standard Care First,|Lack of Efficacy|2|||
13256541|NCT01513330|26386398|FG000|Standard Care First,|Withdrawal by Subject|1|||
13256542|NCT01513330|26386399|FG001|Standard Care First,|Withdrawal by Subject|2|||
13256543|NCT01513330|26386398|FG000|Standard Care First,|Other|1|||
13256544|NCT01513330|26386399|FG001|Standard Care First,|Other|0|||
13256545|NCT01513317|26386422|FG000|Overall Study|Withdrawal by Subject|15|||
13256546|NCT01513317|26386423|FG001|Overall Study|Withdrawal by Subject|4|||
13256547|NCT01513317|26386422|FG000|Overall Study|Death|1|||
13256548|NCT01513317|26386423|FG001|Overall Study|Death|1|||
13256549|NCT01513317|26386422|FG000|Overall Study|Study terminated by sponsor|18|||
13256550|NCT01513317|26386423|FG001|Overall Study|Study terminated by sponsor|18|||
13256551|NCT01513317|26386422|FG000|Overall Study|Other|0|||
13256552|NCT01513317|26386423|FG001|Overall Study|Other|1|||
13256553|NCT01513291|26386458|FG000|Treatment Period|Adverse Event|8|||
13256554|NCT01513291|26386459|FG001|Treatment Period|Adverse Event|4|||
13485924|NCT03672188|27034247|FG012|Overall Study|Death|1|||
13485925|NCT03672188|27034248|FG013|Overall Study|Death|0|||
13485926|NCT03672188|27034249|FG014|Overall Study|Death|0|||
13485927|NCT03672188|27034235|FG000|Overall Study|Lost to Follow-up|0|||
13485928|NCT03672188|27034236|FG001|Overall Study|Lost to Follow-up|0|||
13485929|NCT03672188|27034237|FG002|Overall Study|Lost to Follow-up|1|||
13485930|NCT03672188|27034238|FG003|Overall Study|Lost to Follow-up|0|||
13485931|NCT03672188|27034239|FG004|Overall Study|Lost to Follow-up|0|||
13485932|NCT03672188|27034240|FG005|Overall Study|Lost to Follow-up|0|||
13485933|NCT03672188|27034241|FG006|Overall Study|Lost to Follow-up|0|||
13485934|NCT03672188|27034242|FG007|Overall Study|Lost to Follow-up|0|||
13485935|NCT03672188|27034243|FG008|Overall Study|Lost to Follow-up|0|||
13256555|NCT01513291|26386460|FG002|Treatment Period|Adverse Event|0|||
13256556|NCT01513291|26386461|FG003|Treatment Period|Adverse Event|0|||
13256557|NCT01513291|26386462|FG004|Treatment Period|Adverse Event|0|||
13256558|NCT01513291|26386458|FG000|Treatment Period|Lack of Efficacy|3|||
13256559|NCT01513291|26386459|FG001|Treatment Period|Lack of Efficacy|0|||
13256560|NCT01513291|26386460|FG002|Treatment Period|Lack of Efficacy|0|||
13256561|NCT01513291|26386461|FG003|Treatment Period|Lack of Efficacy|0|||
13256562|NCT01513291|26386462|FG004|Treatment Period|Lack of Efficacy|0|||
13256563|NCT01513291|26386458|FG000|Treatment Period|Lost to Follow-up|2|||
13256564|NCT01513291|26386459|FG001|Treatment Period|Lost to Follow-up|3|||
13256565|NCT01513291|26386460|FG002|Treatment Period|Lost to Follow-up|0|||
13256566|NCT01513291|26386461|FG003|Treatment Period|Lost to Follow-up|0|||
13256567|NCT01513291|26386462|FG004|Treatment Period|Lost to Follow-up|0|||
13256568|NCT01513291|26386458|FG000|Treatment Period|Physician Decision|1|||
13256569|NCT01513291|26386459|FG001|Treatment Period|Physician Decision|0|||
13256570|NCT01513291|26386460|FG002|Treatment Period|Physician Decision|0|||
13256571|NCT01513291|26386461|FG003|Treatment Period|Physician Decision|0|||
13256572|NCT01513291|26386462|FG004|Treatment Period|Physician Decision|0|||
13256573|NCT01513291|26386458|FG000|Treatment Period|Protocol Violation|1|||
13256574|NCT01513291|26386459|FG001|Treatment Period|Protocol Violation|2|||
13256575|NCT01513291|26386460|FG002|Treatment Period|Protocol Violation|0|||
13256576|NCT01513291|26386461|FG003|Treatment Period|Protocol Violation|0|||
13256577|NCT01513291|26386462|FG004|Treatment Period|Protocol Violation|0|||
13256578|NCT01513291|26386458|FG000|Treatment Period|Withdrawal by Subject|8|||
13256579|NCT01513291|26386459|FG001|Treatment Period|Withdrawal by Subject|5|||
13256580|NCT01513291|26386460|FG002|Treatment Period|Withdrawal by Subject|0|||
13256581|NCT01513291|26386461|FG003|Treatment Period|Withdrawal by Subject|0|||
13256582|NCT01513291|26386462|FG004|Treatment Period|Withdrawal by Subject|0|||
13256583|NCT01513291|26386458|FG000|Treatment Period|Randomized not treated|0|||
13256584|NCT01513291|26386459|FG001|Treatment Period|Randomized not treated|2|||
13256585|NCT01513291|26386460|FG002|Treatment Period|Randomized not treated|0|||
13256586|NCT01513291|26386461|FG003|Treatment Period|Randomized not treated|0|||
13256587|NCT01513291|26386462|FG004|Treatment Period|Randomized not treated|0|||
13256588|NCT01513291|26386458|FG000|Run-out Period|Lost to Follow-up|0|||
13256589|NCT01513291|26386459|FG001|Run-out Period|Lost to Follow-up|0|||
13256590|NCT01513291|26386460|FG002|Run-out Period|Lost to Follow-up|0|||
13256591|NCT01513291|26386461|FG003|Run-out Period|Lost to Follow-up|1|||
13256592|NCT01513291|26386462|FG004|Run-out Period|Lost to Follow-up|0|||
13256593|NCT01513291|26386458|FG000|Run-out Period|Withdrawal by Subject|0|||
13256594|NCT01513291|26386459|FG001|Run-out Period|Withdrawal by Subject|0|||
13256595|NCT01513291|26386460|FG002|Run-out Period|Withdrawal by Subject|0|||
13256596|NCT01513291|26386461|FG003|Run-out Period|Withdrawal by Subject|1|||
13256597|NCT01513291|26386462|FG004|Run-out Period|Withdrawal by Subject|0|||
13256598|NCT01513239|26386526|FG000|Period 1: Main Phase|Adverse Event|1|||
13485936|NCT03672188|27034244|FG009|Overall Study|Lost to Follow-up|0|||
13485937|NCT03672188|27034245|FG010|Overall Study|Lost to Follow-up|0|||
13485938|NCT03672188|27034246|FG011|Overall Study|Lost to Follow-up|0|||
13485939|NCT03672188|27034247|FG012|Overall Study|Lost to Follow-up|0|||
13256599|NCT01513239|26386527|FG001|Period 1: Main Phase|Adverse Event|1|||
13256600|NCT01513239|26386528|FG002|Period 1: Main Phase|Adverse Event|2|||
13256601|NCT01513239|26386529|FG003|Period 1: Main Phase|Adverse Event|0|||
13256602|NCT01513239|26386530|FG004|Period 1: Main Phase|Adverse Event|0|||
13256603|NCT01513239|26386531|FG005|Period 1: Main Phase|Adverse Event|0|||
13256604|NCT01513239|26386526|FG000|Period 1: Main Phase|Death|29|||
13256605|NCT01513239|26386527|FG001|Period 1: Main Phase|Death|22|||
13256606|NCT01513239|26386528|FG002|Period 1: Main Phase|Death|32|||
13256607|NCT01513239|26386529|FG003|Period 1: Main Phase|Death|0|||
13256608|NCT01513239|26386530|FG004|Period 1: Main Phase|Death|0|||
13256609|NCT01513239|26386531|FG005|Period 1: Main Phase|Death|0|||
13256610|NCT01513239|26386526|FG000|Period 1: Main Phase|Lost to Follow-up|11|||
13256611|NCT01513239|26386527|FG001|Period 1: Main Phase|Lost to Follow-up|10|||
13256612|NCT01513239|26386528|FG002|Period 1: Main Phase|Lost to Follow-up|6|||
13256613|NCT01513239|26386529|FG003|Period 1: Main Phase|Lost to Follow-up|0|||
13256614|NCT01513239|26386530|FG004|Period 1: Main Phase|Lost to Follow-up|0|||
13256615|NCT01513239|26386531|FG005|Period 1: Main Phase|Lost to Follow-up|0|||
13256616|NCT01513239|26386526|FG000|Period 1: Main Phase|Physician Decision|4|||
13256617|NCT01513239|26386527|FG001|Period 1: Main Phase|Physician Decision|4|||
13256618|NCT01513239|26386528|FG002|Period 1: Main Phase|Physician Decision|4|||
13256619|NCT01513239|26386529|FG003|Period 1: Main Phase|Physician Decision|0|||
13256620|NCT01513239|26386530|FG004|Period 1: Main Phase|Physician Decision|0|||
13256621|NCT01513239|26386531|FG005|Period 1: Main Phase|Physician Decision|0|||
13256622|NCT01513239|26386526|FG000|Period 1: Main Phase|Protocol Violation|2|||
13256623|NCT01513239|26386527|FG001|Period 1: Main Phase|Protocol Violation|2|||
13256624|NCT01513239|26386528|FG002|Period 1: Main Phase|Protocol Violation|2|||
13256625|NCT01513239|26386529|FG003|Period 1: Main Phase|Protocol Violation|0|||
13256626|NCT01513239|26386530|FG004|Period 1: Main Phase|Protocol Violation|0|||
13256627|NCT01513239|26386531|FG005|Period 1: Main Phase|Protocol Violation|0|||
13256628|NCT01513239|26386526|FG000|Period 1: Main Phase|Technical Problems|1|||
13256629|NCT01513239|26386527|FG001|Period 1: Main Phase|Technical Problems|2|||
13256630|NCT01513239|26386528|FG002|Period 1: Main Phase|Technical Problems|0|||
13256631|NCT01513239|26386529|FG003|Period 1: Main Phase|Technical Problems|0|||
13256632|NCT01513239|26386530|FG004|Period 1: Main Phase|Technical Problems|0|||
13256633|NCT01513239|26386531|FG005|Period 1: Main Phase|Technical Problems|0|||
13256634|NCT01513239|26386526|FG000|Period 1: Main Phase|Withdrawal by Subject|27|||
13256635|NCT01513239|26386527|FG001|Period 1: Main Phase|Withdrawal by Subject|29|||
13256636|NCT01513239|26386528|FG002|Period 1: Main Phase|Withdrawal by Subject|42|||
13256637|NCT01513239|26386529|FG003|Period 1: Main Phase|Withdrawal by Subject|0|||
13256638|NCT01513239|26386530|FG004|Period 1: Main Phase|Withdrawal by Subject|0|||
13256639|NCT01513239|26386531|FG005|Period 1: Main Phase|Withdrawal by Subject|0|||
13256640|NCT01513239|26386526|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
13256641|NCT01513239|26386527|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
13256642|NCT01513239|26386528|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
13256643|NCT01513239|26386529|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5|||
13256644|NCT01513239|26386530|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3|||
13256645|NCT01513239|26386531|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2|||
13256646|NCT01513239|26386526|FG000|Period 2: 9 Month Extension Phase|Death|0|||
13256647|NCT01513239|26386527|FG001|Period 2: 9 Month Extension Phase|Death|0|||
13117100|NCT03066830|25924320|FG000|Overall Study|At the Participant's own Request|16|||
13117101|NCT03066830|25924321|FG001|Overall Study|At the Participant's own Request|17|||
13117102|NCT03066830|25924320|FG000|Overall Study|Other|3|||
13117103|NCT03066830|25924321|FG001|Overall Study|Other|0|||
13117104|NCT03066830|25924320|FG000|Overall Study|Poor Compliance to Protocol|1|||
13117105|NCT03066830|25924321|FG001|Overall Study|Poor Compliance to Protocol|0|||
13117106|NCT03066830|25924320|FG000|Overall Study|Adverse Event|2|||
13117107|NCT03066830|25924321|FG001|Overall Study|Adverse Event|2|||
13117108|NCT03066830|25924320|FG000|Overall Study|Lost to Follow-up|11|||
13256648|NCT01513239|26386528|FG002|Period 2: 9 Month Extension Phase|Death|0|||
13256649|NCT01513239|26386529|FG003|Period 2: 9 Month Extension Phase|Death|2|||
13256650|NCT01513239|26386530|FG004|Period 2: 9 Month Extension Phase|Death|5|||
13256651|NCT01513239|26386531|FG005|Period 2: 9 Month Extension Phase|Death|2|||
13256652|NCT01513239|26386526|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
13256653|NCT01513239|26386527|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
13256654|NCT01513239|26386528|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
13256655|NCT01513239|26386529|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2|||
13256656|NCT01513239|26386530|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1|||
13256657|NCT01513239|26386531|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
13256658|NCT01513239|26386526|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0|||
13117109|NCT03066830|25924321|FG001|Overall Study|Lost to Follow-up|3|||
13256659|NCT01513239|26386527|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0|||
13256660|NCT01513239|26386528|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0|||
13256661|NCT01513239|26386529|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1|||
13256662|NCT01513239|26386530|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0|||
13256663|NCT01513239|26386531|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0|||
13256664|NCT01513239|26386526|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0|||
13256665|NCT01513239|26386527|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0|||
13256666|NCT01513239|26386528|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0|||
13256667|NCT01513239|26386529|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0|||
13256668|NCT01513239|26386530|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1|||
13256669|NCT01513239|26386531|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1|||
13256670|NCT01513148|26386584|FG000|Overall Study|Protocol Violation|2|||
13256671|NCT01513148|26386585|FG001|Overall Study|Protocol Violation|2|||
13256672|NCT01512979|26386610|FG000|Overall Study|Adverse Event|2|||
13256673|NCT01512979|26386611|FG001|Overall Study|Adverse Event|2|||
13256674|NCT01512979|26386610|FG000|Overall Study|Protocol Violation|1|||
13256675|NCT01512979|26386611|FG001|Overall Study|Protocol Violation|4|||
13256676|NCT01512979|26386610|FG000|Overall Study|Lost to Follow-up|2|||
13256677|NCT01512979|26386611|FG001|Overall Study|Lost to Follow-up|5|||
13256678|NCT01512979|26386610|FG000|Overall Study|Withdrawal by Subject|1|||
13256679|NCT01512979|26386611|FG001|Overall Study|Withdrawal by Subject|2|||
13256680|NCT01512979|26386610|FG000|Overall Study|Reason other than stated above|13|||
13256681|NCT01512979|26386611|FG001|Overall Study|Reason other than stated above|9|||
13256682|NCT01512745|26386632|FG000|Overall Study|Adverse Event|22|||
13256683|NCT01512745|26386633|FG001|Overall Study|Adverse Event|3|||
13256684|NCT01512745|26386632|FG000|Overall Study|Death|9|||
13256685|NCT01512745|26386633|FG001|Overall Study|Death|13|||
13256686|NCT01512745|26386632|FG000|Overall Study|Withdrawal by Subject|2|||
13256687|NCT01512745|26386633|FG001|Overall Study|Withdrawal by Subject|2|||
13256688|NCT01512745|26386632|FG000|Overall Study|Lost to Follow-up|4|||
13256689|NCT01512745|26386633|FG001|Overall Study|Lost to Follow-up|0|||
13256690|NCT01512745|26386632|FG000|Overall Study|Lack of Efficacy|2|||
13256691|NCT01512745|26386633|FG001|Overall Study|Lack of Efficacy|2|||
13256692|NCT01512745|26386632|FG000|Overall Study|Protocol Violation|1|||
13256693|NCT01512745|26386633|FG001|Overall Study|Protocol Violation|0|||
13256694|NCT01512693|26386652|FG000|Overall Study|Withdrawal by Subject|0|||
13256695|NCT01512693|26386653|FG001|Overall Study|Withdrawal by Subject|1|||
13256696|NCT01512368|26386664|FG000|Overall Study|Protocol Violation|3|||
13256697|NCT01512264|26386767|FG000|Overall Study|Lost to Follow-up|0|||
13256698|NCT01512264|26386768|FG001|Overall Study|Lost to Follow-up|0|||
13256699|NCT01512264|26386769|FG002|Overall Study|Lost to Follow-up|0|||
13256700|NCT01512264|26386770|FG003|Overall Study|Lost to Follow-up|1|||
13256701|NCT01512160|26386873|FG000|Overall Study|Lost to Follow-up|1|||
13256702|NCT01512160|26386874|FG001|Overall Study|Lost to Follow-up|0|||
13256703|NCT01512160|26386875|FG002|Overall Study|Lost to Follow-up|0|||
13256704|NCT01512160|26386876|FG003|Overall Study|Lost to Follow-up|0|||
13256705|NCT01512160|26386873|FG000|Overall Study|Withdrawal by Subject|1|||
13256706|NCT01512160|26386874|FG001|Overall Study|Withdrawal by Subject|0|||
13256707|NCT01512160|26386875|FG002|Overall Study|Withdrawal by Subject|0|||
13256708|NCT01512160|26386876|FG003|Overall Study|Withdrawal by Subject|1|||
13256709|NCT01512108|26386895|FG000|Overall Study|Adverse Event|9|||
13256710|NCT01512108|26386896|FG001|Overall Study|Adverse Event|4|||
13256711|NCT01512108|26386895|FG000|Overall Study|Protocol Violation|1|||
13256712|NCT01512108|26386896|FG001|Overall Study|Protocol Violation|2|||
13256713|NCT01512108|26386895|FG000|Overall Study|Withdrawal Criteria|1|||
13256714|NCT01512108|26386896|FG001|Overall Study|Withdrawal Criteria|0|||
13256715|NCT01512108|26386895|FG000|Overall Study|Unclassified|11|||
13256716|NCT01512108|26386896|FG001|Overall Study|Unclassified|3|||
13256717|NCT01511939|26386923|FG000|Overall Study|Withdrawal by Subject|2|||
13256718|NCT01511939|26386924|FG001|Overall Study|Withdrawal by Subject|1|||
13256719|NCT01511939|26386925|FG002|Overall Study|Withdrawal by Subject|0|||
13256720|NCT01511536|26386955|FG000|Phase 1|Other|0|||
13256721|NCT01511536|26386956|FG001|Phase 1|Other|1|||
13256722|NCT01511536|26386957|FG002|Phase 1|Other|0|||
13256723|NCT01511536|26386955|FG000|Phase 2|Other|0|||
13256724|NCT01511536|26386956|FG001|Phase 2|Other|0|||
13256725|NCT01511536|26386957|FG002|Phase 2|Other|9|||
13256726|NCT01511445|26386972|FG000|Overall Study|Lost to Follow-up|3|||
13256727|NCT01511445|26386973|FG001|Overall Study|Lost to Follow-up|1|||
13256728|NCT01511445|26386972|FG000|Overall Study|Protocol Violation|1|||
13256729|NCT01511445|26386973|FG001|Overall Study|Protocol Violation|3|||
13256730|NCT01511445|26386972|FG000|Overall Study|Protocol Violation|1|||
13256731|NCT01511445|26386973|FG001|Overall Study|Protocol Violation|0|||
13256732|NCT01511419|26387072|FG000|Dose 2|Physician Decision|1|||
13256733|NCT01511419|26387073|FG001|Dose 2|Physician Decision|0|||
13256734|NCT01511250|26387250|FG000|Overall Study|Withdrawal of Consent|1|||
13256735|NCT01511250|26387251|FG001|Overall Study|Withdrawal of Consent|0|||
13256736|NCT01511250|26387252|FG002|Overall Study|Withdrawal of Consent|0|||
13256737|NCT01511250|26387253|FG003|Overall Study|Withdrawal of Consent|0|||
13256738|NCT01511250|26387254|FG004|Overall Study|Withdrawal of Consent|0|||
13256739|NCT01511250|26387255|FG005|Overall Study|Withdrawal of Consent|0|||
13256740|NCT01511250|26387256|FG006|Overall Study|Withdrawal of Consent|0|||
13256741|NCT01511250|26387257|FG007|Overall Study|Withdrawal of Consent|1|||
13256742|NCT01511250|26387258|FG008|Overall Study|Withdrawal of Consent|1|||
13256743|NCT01511250|26387259|FG009|Overall Study|Withdrawal of Consent|0|||
13256744|NCT01511250|26387250|FG000|Overall Study|Sponsor/Investigator Decision|1|||
13256745|NCT01511250|26387251|FG001|Overall Study|Sponsor/Investigator Decision|0|||
13256746|NCT01511250|26387252|FG002|Overall Study|Sponsor/Investigator Decision|0|||
13256747|NCT01511250|26387253|FG003|Overall Study|Sponsor/Investigator Decision|0|||
13256748|NCT01511250|26387254|FG004|Overall Study|Sponsor/Investigator Decision|0|||
13256749|NCT01511250|26387255|FG005|Overall Study|Sponsor/Investigator Decision|0|||
13256750|NCT01511250|26387256|FG006|Overall Study|Sponsor/Investigator Decision|0|||
13256751|NCT01511250|26387257|FG007|Overall Study|Sponsor/Investigator Decision|0|||
13256752|NCT01511250|26387258|FG008|Overall Study|Sponsor/Investigator Decision|0|||
13256753|NCT01511250|26387259|FG009|Overall Study|Sponsor/Investigator Decision|0|||
13256754|NCT01511250|26387250|FG000|Overall Study|Lost to Follow-up|7|||
13256755|NCT01511250|26387251|FG001|Overall Study|Lost to Follow-up|3|||
13256756|NCT01511250|26387252|FG002|Overall Study|Lost to Follow-up|3|||
13256757|NCT01511250|26387253|FG003|Overall Study|Lost to Follow-up|3|||
13256758|NCT01511250|26387254|FG004|Overall Study|Lost to Follow-up|0|||
13256759|NCT01511250|26387255|FG005|Overall Study|Lost to Follow-up|0|||
13256760|NCT01511250|26387256|FG006|Overall Study|Lost to Follow-up|2|||
13256761|NCT01511250|26387257|FG007|Overall Study|Lost to Follow-up|3|||
13256762|NCT01511250|26387258|FG008|Overall Study|Lost to Follow-up|13|||
13256763|NCT01511250|26387259|FG009|Overall Study|Lost to Follow-up|5|||
13256764|NCT01511250|26387250|FG000|Overall Study|Protocol Violation|0|||
13256765|NCT01511250|26387251|FG001|Overall Study|Protocol Violation|2|||
13256766|NCT01511250|26387252|FG002|Overall Study|Protocol Violation|1|||
13256767|NCT01511250|26387253|FG003|Overall Study|Protocol Violation|0|||
13256768|NCT01511250|26387254|FG004|Overall Study|Protocol Violation|0|||
13256769|NCT01511250|26387255|FG005|Overall Study|Protocol Violation|0|||
13256770|NCT01511250|26387256|FG006|Overall Study|Protocol Violation|0|||
13256771|NCT01511250|26387257|FG007|Overall Study|Protocol Violation|0|||
13256772|NCT01511250|26387258|FG008|Overall Study|Protocol Violation|0|||
13256773|NCT01511250|26387259|FG009|Overall Study|Protocol Violation|0|||
13256774|NCT01511107|26387314|FG000|Overall Study|Ineligible|3|||
13256775|NCT01511107|26387315|FG001|Overall Study|Ineligible|2|||
13256776|NCT01511107|26387314|FG000|Overall Study|Lost to Follow-up|10|||
13256777|NCT01511107|26387315|FG001|Overall Study|Lost to Follow-up|19|||
13256778|NCT01511107|26387314|FG000|Overall Study|Withdrawal by Subject|9|||
13256779|NCT01511107|26387315|FG001|Overall Study|Withdrawal by Subject|20|||
13256780|NCT01511055|26387322|FG000|Overall Study|Withdrawal by Subject|6|||
13256781|NCT01510912|26387330|FG000|Overall Study|Adverse Event|99|||
13256782|NCT01510912|26387330|FG000|Overall Study|Lack of Efficacy|12|||
13256783|NCT01510912|26387330|FG000|Overall Study|Non-compliance with trial drug|23|||
13256784|NCT01510912|26387330|FG000|Overall Study|Withdrawal by Subject|49|||
13256785|NCT01510912|26387330|FG000|Overall Study|Physician Decision|1|||
13256786|NCT01510912|26387330|FG000|Overall Study|Protocol Violation|27|||
13256787|NCT01510912|26387330|FG000|Overall Study|Lost to Follow-up|26|||
13256788|NCT01510912|26387330|FG000|Overall Study|Other, including joint replacement|5|||
13256789|NCT01510769|26387357|FG000|Overall Study|Adverse Event|7|||
13256790|NCT01510769|26387358|FG001|Overall Study|Adverse Event|6|||
13256791|NCT01510769|26387359|FG002|Overall Study|Adverse Event|4|||
13256792|NCT01510769|26387357|FG000|Overall Study|Gout Flare|0|||
13256793|NCT01510769|26387358|FG001|Overall Study|Gout Flare|3|||
13256794|NCT01510769|26387359|FG002|Overall Study|Gout Flare|1|||
13256795|NCT01510769|26387357|FG000|Overall Study|Protocol Violation|11|||
13256796|NCT01510769|26387358|FG001|Overall Study|Protocol Violation|10|||
13256797|NCT01510769|26387359|FG002|Overall Study|Protocol Violation|9|||
13256798|NCT01510769|26387357|FG000|Overall Study|Lost to Follow-up|5|||
13256799|NCT01510769|26387358|FG001|Overall Study|Lost to Follow-up|1|||
13256800|NCT01510769|26387359|FG002|Overall Study|Lost to Follow-up|5|||
13256801|NCT01510769|26387357|FG000|Overall Study|Withdrawal by Subject|3|||
13256802|NCT01510769|26387358|FG001|Overall Study|Withdrawal by Subject|4|||
13256803|NCT01510769|26387359|FG002|Overall Study|Withdrawal by Subject|3|||
13256804|NCT01510769|26387357|FG000|Overall Study|Death|1|||
13256805|NCT01510769|26387358|FG001|Overall Study|Death|1|||
13256806|NCT01510769|26387359|FG002|Overall Study|Death|0|||
13256807|NCT01510756|26387367|FG000|Overall Study|Death|1|||
13256808|NCT01510756|26387367|FG000|Overall Study|Lack of Efficacy|2|||
13256809|NCT01510756|26387367|FG000|Overall Study|Physician Decision|1|||
13256810|NCT01510717|26387398|FG000|Overall Study|Adverse Event|1|||
13256811|NCT01510717|26387399|FG001|Overall Study|Adverse Event|2|||
13256812|NCT01510717|26387398|FG000|Overall Study|Death|1|||
13256813|NCT01510717|26387399|FG001|Overall Study|Death|0|||
13256814|NCT01510717|26387398|FG000|Overall Study|Lost to Follow-up|0|||
13256815|NCT01510717|26387399|FG001|Overall Study|Lost to Follow-up|1|||
13256816|NCT01510717|26387398|FG000|Overall Study|Withdrawal by Subject|0|||
13256817|NCT01510717|26387399|FG001|Overall Study|Withdrawal by Subject|2|||
13256818|NCT01510158|26387423|FG000|Overall Study|Adverse Event|7|||
13256819|NCT01510158|26387424|FG001|Overall Study|Adverse Event|8|||
13256820|NCT01510158|26387425|FG002|Overall Study|Adverse Event|5|||
13256821|NCT01510158|26387423|FG000|Overall Study|Gout flare|1|||
13256822|NCT01510158|26387424|FG001|Overall Study|Gout flare|0|||
13256823|NCT01510158|26387425|FG002|Overall Study|Gout flare|0|||
13256824|NCT01510158|26387423|FG000|Overall Study|Protocol Violation|17|||
13256825|NCT01510158|26387424|FG001|Overall Study|Protocol Violation|16|||
13256826|NCT01510158|26387425|FG002|Overall Study|Protocol Violation|24|||
13256827|NCT01510158|26387423|FG000|Overall Study|Sponsor terminated study.|2|||
13256828|NCT01510158|26387424|FG001|Overall Study|Sponsor terminated study.|0|||
13256829|NCT01510158|26387425|FG002|Overall Study|Sponsor terminated study.|2|||
13256830|NCT01510158|26387423|FG000|Overall Study|Lost to Follow-up|13|||
13256831|NCT01510158|26387424|FG001|Overall Study|Lost to Follow-up|16|||
13256832|NCT01510158|26387425|FG002|Overall Study|Lost to Follow-up|9|||
13256833|NCT01510158|26387423|FG000|Overall Study|Withdrawal by Subject|10|||
13256834|NCT01510158|26387424|FG001|Overall Study|Withdrawal by Subject|13|||
13256835|NCT01510158|26387425|FG002|Overall Study|Withdrawal by Subject|10|||
13256836|NCT01510158|26387423|FG000|Overall Study|Death|1|||
13256837|NCT01510158|26387424|FG001|Overall Study|Death|0|||
13256838|NCT01510158|26387425|FG002|Overall Study|Death|0|||
13256839|NCT01510145|26387432|FG000|Overall Study|Adverse Event|6|||
13256840|NCT01510145|26387432|FG000|Overall Study|Lost to Follow-up|5|||
13256841|NCT01510145|26387432|FG000|Overall Study|Withdrawal by Subject|6|||
13256842|NCT01510145|26387432|FG000|Overall Study|Relative reported subject withdrew|1|||
13256843|NCT01510028|26387559|FG000|Overall Study|Lack of Efficacy|1|||
13256844|NCT01510028|26387560|FG001|Overall Study|Lack of Efficacy|0|||
13256845|NCT01510028|26387561|FG002|Overall Study|Lack of Efficacy|0|||
13256846|NCT01510028|26387562|FG003|Overall Study|Lack of Efficacy|0|||
13256847|NCT01509846|26387646|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
13256848|NCT01509846|26387647|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
13256849|NCT01509846|26387648|FG002|Received Vaccination 2|Withdrawal by Subject|1|||
13256850|NCT01509846|26387649|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
13256851|NCT01509846|26387650|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
13256852|NCT01509846|26387646|FG000|Received Vaccination 2|Illness|0|||
13256853|NCT01509846|26387647|FG001|Received Vaccination 2|Illness|0|||
13256854|NCT01509846|26387648|FG002|Received Vaccination 2|Illness|0|||
13256855|NCT01509846|26387649|FG003|Received Vaccination 2|Illness|0|||
13256856|NCT01509846|26387650|FG004|Received Vaccination 2|Illness|1|||
13256857|NCT01509846|26387646|FG000|Received Vaccination 2|Not vaccinated per protocol|5|||
13256858|NCT01509846|26387647|FG001|Received Vaccination 2|Not vaccinated per protocol|0|||
13256859|NCT01509846|26387648|FG002|Received Vaccination 2|Not vaccinated per protocol|0|||
13256860|NCT01509846|26387649|FG003|Received Vaccination 2|Not vaccinated per protocol|0|||
13256861|NCT01509846|26387650|FG004|Received Vaccination 2|Not vaccinated per protocol|2|||
13256862|NCT01509846|26387646|FG000|Received Vaccination 3|Withdrawal by Subject|0|||
13256863|NCT01509846|26387647|FG001|Received Vaccination 3|Withdrawal by Subject|1|||
13256864|NCT01509846|26387648|FG002|Received Vaccination 3|Withdrawal by Subject|0|||
13256865|NCT01509846|26387649|FG003|Received Vaccination 3|Withdrawal by Subject|0|||
13256866|NCT01509846|26387650|FG004|Received Vaccination 3|Withdrawal by Subject|0|||
13256867|NCT01509846|26387646|FG000|Received Vaccination 3|Pregnancy|0|||
13256868|NCT01509846|26387647|FG001|Received Vaccination 3|Pregnancy|0|||
13256869|NCT01509846|26387648|FG002|Received Vaccination 3|Pregnancy|0|||
13256870|NCT01509846|26387649|FG003|Received Vaccination 3|Pregnancy|1|||
13256871|NCT01509846|26387650|FG004|Received Vaccination 3|Pregnancy|0|||
13256872|NCT01509846|26387646|FG000|Received Vaccination 3|Lost to Follow-up|0|||
13256873|NCT01509846|26387647|FG001|Received Vaccination 3|Lost to Follow-up|0|||
13256874|NCT01509846|26387648|FG002|Received Vaccination 3|Lost to Follow-up|1|||
13256875|NCT01509846|26387649|FG003|Received Vaccination 3|Lost to Follow-up|0|||
13256876|NCT01509846|26387650|FG004|Received Vaccination 3|Lost to Follow-up|0|||
13485940|NCT03672188|27034248|FG013|Overall Study|Lost to Follow-up|0|||
13117110|NCT03066804|25924347|FG000|Overall Study|Physician Decision|0|||
13485941|NCT03672188|27034249|FG014|Overall Study|Lost to Follow-up|0|||
13485942|NCT03230916|27034490|FG000|Overall Study|Withdrawal by Subject|0|||
13485943|NCT03230916|27034491|FG001|Overall Study|Withdrawal by Subject|0|||
13485944|NCT03230916|27034492|FG002|Overall Study|Withdrawal by Subject|0|||
13485945|NCT03230916|27034493|FG003|Overall Study|Withdrawal by Subject|0|||
13485946|NCT03230916|27034494|FG004|Overall Study|Withdrawal by Subject|0|||
13485947|NCT03230916|27034495|FG005|Overall Study|Withdrawal by Subject|1|||
13485948|NCT03230916|27034496|FG006|Overall Study|Withdrawal by Subject|0|||
13485949|NCT03230916|27034497|FG007|Overall Study|Withdrawal by Subject|0|||
13485950|NCT03230916|27034498|FG008|Overall Study|Withdrawal by Subject|0|||
13485951|NCT03230916|27034499|FG009|Overall Study|Withdrawal by Subject|0|||
13485952|NCT03230916|27034500|FG010|Overall Study|Withdrawal by Subject|0|||
13256877|NCT01509664|26387663|FG000|Overall Study|Lost to Follow-up|15|||
13256878|NCT01509664|26387664|FG001|Overall Study|Lost to Follow-up|21|||
13256879|NCT01509547|26387685|FG000|Overall Study|Lost to Follow-up|24|||
13256880|NCT01509547|26387686|FG001|Overall Study|Lost to Follow-up|14|||
13256881|NCT01509547|26387685|FG000|Overall Study|Withdrawal by Subject|11|||
13256882|NCT01509547|26387686|FG001|Overall Study|Withdrawal by Subject|24|||
13485953|NCT03195894|27034563|FG000|Overall Study|"An example is Started other treatment."|4|||
13485954|NCT03195894|27034564|FG001|Overall Study|"An example is Started other treatment."|5|||
13485955|NCT03195894|27034563|FG000|Overall Study|Withdrawal by Subject|15|||
13485956|NCT03195894|27034564|FG001|Overall Study|Withdrawal by Subject|4|||
13485957|NCT03195894|27034563|FG000|Overall Study|Lost to Follow-up|14|||
13485958|NCT03195894|27034564|FG001|Overall Study|Lost to Follow-up|19|||
13485959|NCT03032705|27034581|FG000|Overall Study|Lost to Follow-up|16|||
13485960|NCT03032705|27034582|FG001|Overall Study|Lost to Follow-up|17|||
13485961|NCT03032705|27034581|FG000|Overall Study|did not quality|6|||
13485962|NCT03032705|27034582|FG001|Overall Study|did not quality|6|||
13485963|NCT02573259|27034728|FG000|Overall Study|Death|1|||
13485964|NCT02573259|27034729|FG001|Overall Study|Death|6|||
13485965|NCT02573259|27034730|FG002|Overall Study|Death|5|||
13485966|NCT02573259|27034731|FG003|Overall Study|Death|6|||
13485967|NCT02573259|27034732|FG004|Overall Study|Death|9|||
13256883|NCT01509547|26387685|FG000|Overall Study|Physician Decision|0|||
13256884|NCT01509547|26387686|FG001|Overall Study|Physician Decision|1|||
13256885|NCT01509079|26387713|FG000|Overall Study|Lack of Efficacy|0|||
13256886|NCT01509079|26387714|FG001|Overall Study|Lack of Efficacy|2|||
13256887|NCT01509079|26387713|FG000|Overall Study|started an excluded medication|0|||
13256888|NCT01509079|26387714|FG001|Overall Study|started an excluded medication|1|||
13256889|NCT01509053|26387727|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11|||
13256890|NCT01509053|26387727|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1|||
13256891|NCT01509053|26387727|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13|||
13256892|NCT01509053|26387727|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1|||
13256893|NCT01509053|26387727|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1|||
13256894|NCT01509053|26387727|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3|||
13256895|NCT01508936|26387770|FG000|Overall Study|Adverse Event|11|||
13256896|NCT01508936|26387771|FG001|Overall Study|Adverse Event|32|||
13256897|NCT01508936|26387770|FG000|Overall Study|Lack of Efficacy|0|||
13256898|NCT01508936|26387771|FG001|Overall Study|Lack of Efficacy|1|||
13256899|NCT01508936|26387770|FG000|Overall Study|Withdrawal by Subject|4|||
13256900|NCT01508936|26387771|FG001|Overall Study|Withdrawal by Subject|18|||
13256901|NCT01508936|26387770|FG000|Overall Study|Protocol Violation|2|||
13256902|NCT01508936|26387771|FG001|Overall Study|Protocol Violation|3|||
13256903|NCT01508936|26387770|FG000|Overall Study|Lost to Follow-up|2|||
13256904|NCT01508936|26387771|FG001|Overall Study|Lost to Follow-up|9|||
13256905|NCT01508936|26387770|FG000|Overall Study|Other|0|||
13256906|NCT01508936|26387771|FG001|Overall Study|Other|5|||
13256907|NCT01508936|26387770|FG000|Overall Study|Data from 2 sites deemed invalid|4|||
13256908|NCT01508936|26387771|FG001|Overall Study|Data from 2 sites deemed invalid|11|||
13256909|NCT01508910|26387804|FG000|Treatment|Death|2|||
13256910|NCT01508910|26387805|FG001|Treatment|Death|3|||
13256911|NCT01508910|26387806|FG002|Treatment|Death|2|||
13256912|NCT01508910|26387807|FG003|Treatment|Death|0|||
13256913|NCT01508910|26387804|FG000|Treatment|Lost to Follow-up|0|||
13256914|NCT01508910|26387805|FG001|Treatment|Lost to Follow-up|0|||
13256915|NCT01508910|26387806|FG002|Treatment|Lost to Follow-up|2|||
13256916|NCT01508910|26387807|FG003|Treatment|Lost to Follow-up|1|||
13256917|NCT01508910|26387804|FG000|Treatment|Withdrawal by Subject|0|||
13256918|NCT01508910|26387805|FG001|Treatment|Withdrawal by Subject|1|||
13256919|NCT01508910|26387806|FG002|Treatment|Withdrawal by Subject|6|||
13256920|NCT01508910|26387807|FG003|Treatment|Withdrawal by Subject|1|||
13256921|NCT01508910|26387804|FG000|Treatment|Sponsor Decision|0|||
13256922|NCT01508910|26387805|FG001|Treatment|Sponsor Decision|0|||
13256923|NCT01508910|26387806|FG002|Treatment|Sponsor Decision|0|||
13256924|NCT01508910|26387807|FG003|Treatment|Sponsor Decision|1|||
13256925|NCT01508702|26387820|FG000|Overall Study|Adverse Event|7|||
13256926|NCT01508702|26387821|FG001|Overall Study|Adverse Event|3|||
13256927|NCT01508702|26387820|FG000|Overall Study|Gout flare|2|||
13256928|NCT01508702|26387821|FG001|Overall Study|Gout flare|0|||
13256929|NCT01508702|26387820|FG000|Overall Study|Protocol Violation|2|||
13256930|NCT01508702|26387821|FG001|Overall Study|Protocol Violation|1|||
13256931|NCT01508702|26387820|FG000|Overall Study|Lost to Follow-up|1|||
13256932|NCT01508702|26387821|FG001|Overall Study|Lost to Follow-up|2|||
13256933|NCT01508702|26387820|FG000|Overall Study|Withdrawal by Subject|11|||
13256934|NCT01508702|26387821|FG001|Overall Study|Withdrawal by Subject|7|||
13256935|NCT01508676|26387838|FG000|Phase I (2 Weeks)|Medication Exclusion|1|||
13256936|NCT01508676|26387839|FG001|Phase I (2 Weeks)|Medication Exclusion|1|||
13256937|NCT01508676|26387838|FG000|Phase I (2 Weeks)|Wrong Pain Type|1|||
13256938|NCT01508676|26387839|FG001|Phase I (2 Weeks)|Wrong Pain Type|0|||
13256939|NCT01508676|26387838|FG000|Phase I (2 Weeks)|Positive Drug Screen|0|||
13256940|NCT01508676|26387839|FG001|Phase I (2 Weeks)|Positive Drug Screen|2|||
13256941|NCT01508676|26387838|FG000|Phase II (2 Weeks)|Skin Sensitivity|0|||
13256942|NCT01508676|26387839|FG001|Phase II (2 Weeks)|Skin Sensitivity|1|||
13256943|NCT01508676|26387838|FG000|Phase II (2 Weeks)|Medication Exclusion|1|||
13256944|NCT01508676|26387839|FG001|Phase II (2 Weeks)|Medication Exclusion|0|||
13256945|NCT01508650|26387854|FG000|Overall Study|Lost to Follow-up|0|||
13256946|NCT01508650|26387855|FG001|Overall Study|Lost to Follow-up|3|||
13256947|NCT01508325|26387890|FG000|Overall Study|Withdrawal by Subject|8|||
13256948|NCT01508325|26387891|FG001|Overall Study|Withdrawal by Subject|9|||
13256949|NCT01508325|26387890|FG000|Overall Study|Protocol Violation|0|||
13256950|NCT01508325|26387891|FG001|Overall Study|Protocol Violation|3|||
13256951|NCT01508325|26387890|FG000|Overall Study|Physician Decision|2|||
13256952|NCT01508325|26387891|FG001|Overall Study|Physician Decision|1|||
13256953|NCT01508325|26387890|FG000|Overall Study|Adverse Event|1|||
13256954|NCT01508325|26387891|FG001|Overall Study|Adverse Event|0|||
13256955|NCT01508325|26387890|FG000|Overall Study|Lost to Follow-up|5|||
13256956|NCT01508325|26387891|FG001|Overall Study|Lost to Follow-up|6|||
13256957|NCT01508325|26387890|FG000|Overall Study|Other|2|||
13256958|NCT01508325|26387891|FG001|Overall Study|Other|2|||
13256959|NCT01508169|26387910|FG000|Overall Study|Adverse Event|1|||
13117111|NCT03066804|25924348|FG001|Overall Study|Physician Decision|4|||
13256960|NCT01508169|26387911|FG001|Overall Study|Adverse Event|0|||
13256961|NCT01508169|26387910|FG000|Overall Study|Withdrawal by Subject|1|||
13256962|NCT01508169|26387911|FG001|Overall Study|Withdrawal by Subject|0|||
13256963|NCT01508169|26387910|FG000|Overall Study|Lost to Follow-up|1|||
13256964|NCT01508169|26387911|FG001|Overall Study|Lost to Follow-up|2|||
13117112|NCT03066804|25924347|FG000|Overall Study|Death|23|||
13256965|NCT01508130|26387960|FG000|Overall Study|Adverse Event|81|||
13256966|NCT01508130|26387961|FG001|Overall Study|Adverse Event|28|||
13256967|NCT01508130|26387960|FG000|Overall Study|Death|3|||
13256968|NCT01508130|26387961|FG001|Overall Study|Death|1|||
13256969|NCT01508130|26387960|FG000|Overall Study|Protocol Violation|2|||
13256970|NCT01508130|26387961|FG001|Overall Study|Protocol Violation|0|||
13256971|NCT01508130|26387960|FG000|Overall Study|Lost to Follow-up|25|||
13256972|NCT01508130|26387961|FG001|Overall Study|Lost to Follow-up|2|||
13256973|NCT01508130|26387960|FG000|Overall Study|Withdrawal by Subject|3|||
13256974|NCT01508130|26387961|FG001|Overall Study|Withdrawal by Subject|3|||
13256975|NCT01508130|26387960|FG000|Overall Study|Subject's substantial non-compliance|25|||
13256976|NCT01508130|26387961|FG001|Overall Study|Subject's substantial non-compliance|9|||
13256977|NCT01508130|26387960|FG000|Overall Study|Insufficient therapeutic response|74|||
13256978|NCT01508130|26387961|FG001|Overall Study|Insufficient therapeutic response|23|||
13256979|NCT01508130|26387960|FG000|Overall Study|Administrative|14|||
13256980|NCT01508130|26387961|FG001|Overall Study|Administrative|3|||
13256981|NCT01507896|26388004|FG000|Overall Study|Withdrawal by Subject|1|||
13256982|NCT01507896|26388004|FG000|Overall Study|The surgery was denied by the sponsor.|1|||
13256983|NCT01507831|26388079|FG000|Overall Study|Randomized but not treated|0|||
13256984|NCT01507831|26388080|FG001|Overall Study|Randomized but not treated|3|||
13256985|NCT01507831|26388079|FG000|Overall Study|Adverse Event|48|||
13256986|NCT01507831|26388080|FG001|Overall Study|Adverse Event|113|||
13256987|NCT01507831|26388079|FG000|Overall Study|Death|6|||
13256988|NCT01507831|26388080|FG001|Overall Study|Death|2|||
13256989|NCT01507831|26388079|FG000|Overall Study|Poor compliance to protocol|38|||
13117113|NCT03066804|25924348|FG001|Overall Study|Death|17|||
13117114|NCT03066804|25924347|FG000|Overall Study|Withdrawal by Subject|19|||
13117115|NCT03066804|25924348|FG001|Overall Study|Withdrawal by Subject|25|||
13117116|NCT03066804|25924347|FG000|Overall Study|Lost to Follow-up|2|||
13117117|NCT03066804|25924348|FG001|Overall Study|Lost to Follow-up|0|||
13256990|NCT01507831|26388080|FG001|Overall Study|Poor compliance to protocol|60|||
13256991|NCT01507831|26388079|FG000|Overall Study|Physician Decision|0|||
13256992|NCT01507831|26388080|FG001|Overall Study|Physician Decision|4|||
13256993|NCT01507831|26388079|FG000|Overall Study|Participant moved|5|||
13256994|NCT01507831|26388080|FG001|Overall Study|Participant moved|19|||
13256995|NCT01507831|26388079|FG000|Overall Study|Consent withdrawn by participant|34|||
13256996|NCT01507831|26388080|FG001|Overall Study|Consent withdrawn by participant|72|||
13256997|NCT01507831|26388079|FG000|Overall Study|Related to study drug administration|5|||
13256998|NCT01507831|26388080|FG001|Overall Study|Related to study drug administration|14|||
13256999|NCT01507831|26388079|FG000|Overall Study|Last visit outside protocol visit window|51|||
13257000|NCT01507831|26388080|FG001|Overall Study|Last visit outside protocol visit window|143|||
13257001|NCT01507831|26388079|FG000|Overall Study|Selection criteria finally not met|0|||
13257002|NCT01507831|26388080|FG001|Overall Study|Selection criteria finally not met|1|||
13257003|NCT01507831|26388079|FG000|Overall Study|Site closure|0|||
13257004|NCT01507831|26388080|FG001|Overall Study|Site closure|3|||
13257005|NCT01507831|26388079|FG000|Overall Study|Potential lost to follow-up|3|||
13257006|NCT01507831|26388080|FG001|Overall Study|Potential lost to follow-up|0|||
13257007|NCT01507831|26388079|FG000|Overall Study|Other|3|||
13257008|NCT01507831|26388080|FG001|Overall Study|Other|6|||
13257009|NCT01507662|26388093|FG000|Overall Study|Death|26|||
13257010|NCT01507662|26388094|FG001|Overall Study|Death|18|||
13257011|NCT01507662|26388093|FG000|Overall Study|Withdrawal by Subject|290|||
13257012|NCT01507662|26388094|FG001|Overall Study|Withdrawal by Subject|287|||
13117118|NCT03066804|25924347|FG000|Overall Study|Adverse Event|2|||
13257013|NCT01507662|26388093|FG000|Overall Study|Lost to Follow-up|498|||
13257014|NCT01507662|26388094|FG001|Overall Study|Lost to Follow-up|523|||
13257015|NCT01507662|26388093|FG000|Overall Study|Proxy interview done|2|||
13257016|NCT01507662|26388094|FG001|Overall Study|Proxy interview done|3|||
13257017|NCT01507545|26388119|FG000|Overall Study|Withdrawal by Subject|6|||
13257018|NCT01507545|26388120|FG001|Overall Study|Withdrawal by Subject|2|||
13257019|NCT01507545|26388119|FG000|Overall Study|Lost to Follow-up|1|||
13257020|NCT01507545|26388120|FG001|Overall Study|Lost to Follow-up|0|||
13257021|NCT01507545|26388119|FG000|Overall Study|Discontinuation of the study by sponsor|11|||
13257022|NCT01507545|26388120|FG001|Overall Study|Discontinuation of the study by sponsor|9|||
13257023|NCT01507545|26388119|FG000|Overall Study|Progressive disease|60|||
13257024|NCT01507545|26388120|FG001|Overall Study|Progressive disease|27|||
13257025|NCT01507545|26388119|FG000|Overall Study|Other|6|||
13257026|NCT01507545|26388120|FG001|Overall Study|Other|4|||
13257027|NCT01507298|26388135|FG000|Overall Study|Protocol Violation|0|||
13257028|NCT01507298|26388136|FG001|Overall Study|Protocol Violation|6|||
13257029|NCT01507246|26388155|FG000|Overall Study|Required different surgical procedures|2|||
13257030|NCT01507246|26388156|FG001|Overall Study|Required different surgical procedures|1|||
13257031|NCT01507090|26388193|FG000|Overall Study|incomplete dataset|18|||
13257032|NCT01507051|26388324|FG000|Overall Study|Withdrawal by Subject|1|||
13257033|NCT01507051|26388325|FG001|Overall Study|Withdrawal by Subject|3|||
13257034|NCT01507051|26388326|FG002|Overall Study|Withdrawal by Subject|1|||
13257035|NCT01507051|26388327|FG003|Overall Study|Withdrawal by Subject|6|||
13257036|NCT01507051|26388324|FG000|Overall Study|Physician Decision|0|||
13257037|NCT01507051|26388325|FG001|Overall Study|Physician Decision|0|||
13257038|NCT01507051|26388326|FG002|Overall Study|Physician Decision|0|||
13257039|NCT01507051|26388327|FG003|Overall Study|Physician Decision|1|||
13257040|NCT01507051|26388324|FG000|Overall Study|Adverse Event|1|||
13257041|NCT01507051|26388325|FG001|Overall Study|Adverse Event|0|||
13257042|NCT01507051|26388326|FG002|Overall Study|Adverse Event|0|||
13257043|NCT01507051|26388327|FG003|Overall Study|Adverse Event|0|||
13257044|NCT01506960|26388335|FG000|Overall Study|Did not meet angiographic criteria|47|||
13257045|NCT01506947|26388353|FG000|Overall Study|Lost to Follow-up|7|||
13257046|NCT01506947|26388353|FG000|Overall Study|Adverse Event|5|||
13257047|NCT01506947|26388353|FG000|Overall Study|Death|1|||
13257048|NCT01506947|26388353|FG000|Overall Study|Did Not Meet Eligibility Criteria|3|||
13257049|NCT01506908|26388376|FG000|Overall Study|Adverse Event|1|||
13257050|NCT01506908|26388377|FG001|Overall Study|Adverse Event|0|||
13257051|NCT01506882|26388396|FG000|Overall Study|Lack of Efficacy|4|||
13257052|NCT01506882|26388397|FG001|Overall Study|Lack of Efficacy|3|||
13257053|NCT01506882|26388396|FG000|Overall Study|Lost to Follow-up|1|||
13257054|NCT01506882|26388397|FG001|Overall Study|Lost to Follow-up|0|||
13257055|NCT01506882|26388396|FG000|Overall Study|Withdrawal by Subject|9|||
13257056|NCT01506882|26388397|FG001|Overall Study|Withdrawal by Subject|3|||
13257057|NCT01506882|26388396|FG000|Overall Study|SAE, non-fatal|2|||
13257058|NCT01506882|26388397|FG001|Overall Study|SAE, non-fatal|0|||
13257059|NCT01506882|26388396|FG000|Overall Study|AE, non-serious non-fatal|3|||
13257060|NCT01506882|26388397|FG001|Overall Study|AE, non-serious non-fatal|1|||
13257061|NCT01506882|26388396|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
13257062|NCT01506882|26388397|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
13257063|NCT01506882|26388396|FG000|Overall Study|Other Reason|2|||
13257064|NCT01506882|26388397|FG001|Overall Study|Other Reason|0|||
13257065|NCT01506726|26388444|FG000|Overall Study|Adverse Event|1|||
13257066|NCT01506726|26388445|FG001|Overall Study|Adverse Event|2|||
13257067|NCT01506609|26388486|FG000|Overall Study|Adverse Event Related to Progression|0|||
13257068|NCT01506609|26388487|FG001|Overall Study|Adverse Event Related to Progression|0|||
13257069|NCT01506609|26388488|FG002|Overall Study|Adverse Event Related to Progression|0|||
13257070|NCT01506609|26388489|FG003|Overall Study|Adverse Event Related to Progression|3|||
13257071|NCT01506609|26388490|FG004|Overall Study|Adverse Event Related to Progression|7|||
13257072|NCT01506609|26388491|FG005|Overall Study|Adverse Event Related to Progression|3|||
13257073|NCT01506609|26388486|FG000|Overall Study|Adverse Event Not Related to Progression|0|||
13257074|NCT01506609|26388487|FG001|Overall Study|Adverse Event Not Related to Progression|1|||
13257075|NCT01506609|26388488|FG002|Overall Study|Adverse Event Not Related to Progression|0|||
13257076|NCT01506609|26388489|FG003|Overall Study|Adverse Event Not Related to Progression|6|||
13257077|NCT01506609|26388490|FG004|Overall Study|Adverse Event Not Related to Progression|10|||
13257078|NCT01506609|26388491|FG005|Overall Study|Adverse Event Not Related to Progression|5|||
13257079|NCT01506609|26388486|FG000|Overall Study|Withdrawal by Subject|0|||
13257080|NCT01506609|26388487|FG001|Overall Study|Withdrawal by Subject|0|||
13257081|NCT01506609|26388488|FG002|Overall Study|Withdrawal by Subject|0|||
13257082|NCT01506609|26388489|FG003|Overall Study|Withdrawal by Subject|9|||
13257083|NCT01506609|26388490|FG004|Overall Study|Withdrawal by Subject|7|||
13257084|NCT01506609|26388491|FG005|Overall Study|Withdrawal by Subject|7|||
13257085|NCT01506609|26388486|FG000|Overall Study|Lost to Follow-up|0|||
13257086|NCT01506609|26388487|FG001|Overall Study|Lost to Follow-up|0|||
13257087|NCT01506609|26388488|FG002|Overall Study|Lost to Follow-up|0|||
13257088|NCT01506609|26388489|FG003|Overall Study|Lost to Follow-up|1|||
13257089|NCT01506609|26388490|FG004|Overall Study|Lost to Follow-up|2|||
13257090|NCT01506609|26388491|FG005|Overall Study|Lost to Follow-up|0|||
13257091|NCT01506609|26388486|FG000|Overall Study|Sponsor Discontinued Study|0|||
13257092|NCT01506609|26388487|FG001|Overall Study|Sponsor Discontinued Study|0|||
13257093|NCT01506609|26388488|FG002|Overall Study|Sponsor Discontinued Study|0|||
13257094|NCT01506609|26388489|FG003|Overall Study|Sponsor Discontinued Study|2|||
13257095|NCT01506609|26388490|FG004|Overall Study|Sponsor Discontinued Study|2|||
13257096|NCT01506609|26388491|FG005|Overall Study|Sponsor Discontinued Study|0|||
13257097|NCT01506609|26388486|FG000|Overall Study|Progressive Disease per Protocol|1|||
13257098|NCT01506609|26388487|FG001|Overall Study|Progressive Disease per Protocol|0|||
13257099|NCT01506609|26388488|FG002|Overall Study|Progressive Disease per Protocol|0|||
13257100|NCT01506609|26388489|FG003|Overall Study|Progressive Disease per Protocol|64|||
13257101|NCT01506609|26388490|FG004|Overall Study|Progressive Disease per Protocol|57|||
13257102|NCT01506609|26388491|FG005|Overall Study|Progressive Disease per Protocol|74|||
13257103|NCT01506609|26388486|FG000|Overall Study|Other, Not Specified|0|||
13257104|NCT01506609|26388487|FG001|Overall Study|Other, Not Specified|0|||
13257105|NCT01506609|26388488|FG002|Overall Study|Other, Not Specified|0|||
13257106|NCT01506609|26388489|FG003|Overall Study|Other, Not Specified|10|||
13257107|NCT01506609|26388490|FG004|Overall Study|Other, Not Specified|7|||
13257108|NCT01506609|26388491|FG005|Overall Study|Other, Not Specified|3|||
13257109|NCT01506609|26388486|FG000|Overall Study|Missing / Unknown Reason|1|||
13257110|NCT01506609|26388487|FG001|Overall Study|Missing / Unknown Reason|0|||
13257111|NCT01506609|26388488|FG002|Overall Study|Missing / Unknown Reason|1|||
13257112|NCT01506609|26388489|FG003|Overall Study|Missing / Unknown Reason|4|||
13257113|NCT01506609|26388490|FG004|Overall Study|Missing / Unknown Reason|4|||
13257114|NCT01506609|26388491|FG005|Overall Study|Missing / Unknown Reason|2|||
13257115|NCT01506596|26388501|FG000|Overall Study|ineligible pathology|1|||
13257116|NCT01506479|26388523|FG000|Overall Study|Lost to Follow-up|1|||
13257117|NCT01506479|26388524|FG001|Overall Study|Lost to Follow-up|2|||
13257118|NCT01506479|26388525|FG002|Overall Study|Lost to Follow-up|2|||
13257119|NCT01506479|26388523|FG000|Overall Study|Withdrawal by Subject|1|||
13257120|NCT01506479|26388524|FG001|Overall Study|Withdrawal by Subject|2|||
13257121|NCT01506479|26388525|FG002|Overall Study|Withdrawal by Subject|1|||
13257122|NCT01506479|26388523|FG000|Overall Study|Missing assessment|1|||
13257123|NCT01506479|26388524|FG001|Overall Study|Missing assessment|0|||
13257124|NCT01506479|26388525|FG002|Overall Study|Missing assessment|0|||
13257125|NCT01506479|26388523|FG000|Overall Study|Adverse Event|0|||
13257126|NCT01506479|26388524|FG001|Overall Study|Adverse Event|1|||
13257127|NCT01506479|26388525|FG002|Overall Study|Adverse Event|0|||
13257128|NCT01506453|26388542|FG000|Overall Study|Withdrawal prior to treatment|0|||
13257129|NCT01506453|26388543|FG001|Overall Study|Withdrawal prior to treatment|2|||
13257130|NCT01506323|26388576|FG000|Overall Study|Lost to Follow-up|5|||
13257131|NCT01506323|26388577|FG001|Overall Study|Lost to Follow-up|4|||
13257132|NCT01506323|26388576|FG000|Overall Study|Withdrawal by Subject|4|||
13257133|NCT01506323|26388577|FG001|Overall Study|Withdrawal by Subject|4|||
13257134|NCT01506323|26388576|FG000|Overall Study|Lack of Efficacy|1|||
13257135|NCT01506323|26388577|FG001|Overall Study|Lack of Efficacy|3|||
13257136|NCT01506323|26388576|FG000|Overall Study|Moved out of area|5|||
13257137|NCT01506323|26388577|FG001|Overall Study|Moved out of area|2|||
13257138|NCT01506323|26388576|FG000|Overall Study|Schedule or Transportation conflict|8|||
13257139|NCT01506323|26388577|FG001|Overall Study|Schedule or Transportation conflict|0|||
13257140|NCT01506323|26388576|FG000|Overall Study|Started another treatment|1|||
13257141|NCT01506323|26388577|FG001|Overall Study|Started another treatment|0|||
13257142|NCT01506271|26388646|FG000|Overall Study|Progressive disease|0|||
13257143|NCT01506271|26388647|FG001|Overall Study|Progressive disease|1|||
13257144|NCT01506271|26388648|FG002|Overall Study|Progressive disease|0|||
13257145|NCT01506271|26388646|FG000|Overall Study|Protocol Violation|3|||
13257146|NCT01506271|26388647|FG001|Overall Study|Protocol Violation|1|||
13257147|NCT01506271|26388648|FG002|Overall Study|Protocol Violation|0|||
13257148|NCT01506271|26388646|FG000|Overall Study|Death|0|||
13257149|NCT01506271|26388647|FG001|Overall Study|Death|1|||
13257150|NCT01506271|26388648|FG002|Overall Study|Death|0|||
13257151|NCT01506271|26388646|FG000|Overall Study|Adverse Event|0|||
13257152|NCT01506271|26388647|FG001|Overall Study|Adverse Event|2|||
13257153|NCT01506271|26388648|FG002|Overall Study|Adverse Event|0|||
13257154|NCT01506271|26388646|FG000|Overall Study|Insufficient supply of study drug|1|||
13257155|NCT01506271|26388647|FG001|Overall Study|Insufficient supply of study drug|0|||
13257156|NCT01506271|26388648|FG002|Overall Study|Insufficient supply of study drug|0|||
13257157|NCT01506271|26388646|FG000|Overall Study|Withdrawal by Subject|0|||
13257158|NCT01506271|26388647|FG001|Overall Study|Withdrawal by Subject|1|||
13257159|NCT01506271|26388648|FG002|Overall Study|Withdrawal by Subject|1|||
13257160|NCT01506271|26388646|FG000|Overall Study|Lost to Follow-up|0|||
13257161|NCT01506271|26388647|FG001|Overall Study|Lost to Follow-up|1|||
13257162|NCT01506271|26388648|FG002|Overall Study|Lost to Follow-up|2|||
13257163|NCT01506193|26388689|FG000|Overall Study|Protocol Violation|1|||
13257164|NCT01506193|26388690|FG001|Overall Study|Protocol Violation|0|||
13257165|NCT01506193|26388691|FG002|Overall Study|Protocol Violation|1|||
13257166|NCT01506193|26388689|FG000|Overall Study|Migrated/moved from study area|0|||
13257167|NCT01506193|26388690|FG001|Overall Study|Migrated/moved from study area|0|||
13257168|NCT01506193|26388691|FG002|Overall Study|Migrated/moved from study area|1|||
13257169|NCT01506193|26388689|FG000|Overall Study|Adverse event, non-fatal|0|||
13257170|NCT01506193|26388690|FG001|Overall Study|Adverse event, non-fatal|0|||
13257171|NCT01506193|26388691|FG002|Overall Study|Adverse event, non-fatal|1|||
13257172|NCT01506193|26388689|FG000|Overall Study|Withdrawal by Subject|5|||
13257173|NCT01506193|26388690|FG001|Overall Study|Withdrawal by Subject|1|||
13257174|NCT01506193|26388691|FG002|Overall Study|Withdrawal by Subject|8|||
13257175|NCT01506193|26388689|FG000|Overall Study|Lost to Follow-up|8|||
13257176|NCT01506193|26388690|FG001|Overall Study|Lost to Follow-up|3|||
13257177|NCT01506193|26388691|FG002|Overall Study|Lost to Follow-up|3|||
13257178|NCT01505881|26388710|FG000|Overall Study|Adverse Event|0|||
13257179|NCT01505881|26388711|FG001|Overall Study|Adverse Event|1|||
13257180|NCT01505881|26388710|FG000|Overall Study|Lost to Follow-up|2|||
13257181|NCT01505881|26388711|FG001|Overall Study|Lost to Follow-up|0|||
13257182|NCT01505881|26388710|FG000|Overall Study|Withdrawal by Subject|2|||
13257183|NCT01505881|26388711|FG001|Overall Study|Withdrawal by Subject|0|||
13257184|NCT01505868|26388749|FG000|Overall Study|Withdrawal by Subject|1|||
13257185|NCT01505868|26388750|FG001|Overall Study|Withdrawal by Subject|0|||
13257186|NCT01505868|26388751|FG002|Overall Study|Withdrawal by Subject|0|||
13257187|NCT01505868|26388752|FG003|Overall Study|Withdrawal by Subject|0|||
13257188|NCT01505868|26388753|FG004|Overall Study|Withdrawal by Subject|0|||
13257189|NCT01505647|26388774|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1|||
13257190|NCT01505647|26388775|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0|||
13257191|NCT01505647|26388774|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1|||
13257192|NCT01505647|26388775|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0|||
13257193|NCT01505647|26388774|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1|||
13257194|NCT01505647|26388775|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0|||
13257195|NCT01505647|26388774|FG000|Day 43 Through Day 182 Follow-up|Death|0|||
13257196|NCT01505647|26388775|FG001|Day 43 Through Day 182 Follow-up|Death|1|||
13257197|NCT01505647|26388774|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1|||
13257198|NCT01505647|26388775|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2|||
13257199|NCT01505634|26388838|FG000|Overall Study|Withdrawal by Subject|2|||
13257200|NCT01505634|26388839|FG001|Overall Study|Withdrawal by Subject|5|||
13257201|NCT01505634|26388840|FG002|Overall Study|Withdrawal by Subject|1|||
13257202|NCT01505634|26388838|FG000|Overall Study|Physician Decision|1|||
13257203|NCT01505634|26388839|FG001|Overall Study|Physician Decision|1|||
13257204|NCT01505634|26388840|FG002|Overall Study|Physician Decision|0|||
13257205|NCT01505634|26388838|FG000|Overall Study|Adverse Event|1|||
13257206|NCT01505634|26388839|FG001|Overall Study|Adverse Event|0|||
13257207|NCT01505634|26388840|FG002|Overall Study|Adverse Event|0|||
13257208|NCT01505634|26388838|FG000|Overall Study|Insufficient supply of drug at site|1|||
13257209|NCT01505634|26388839|FG001|Overall Study|Insufficient supply of drug at site|0|||
13257210|NCT01505634|26388840|FG002|Overall Study|Insufficient supply of drug at site|0|||
13257211|NCT01505634|26388838|FG000|Overall Study|Protocol Violation|2|||
13257212|NCT01505634|26388839|FG001|Overall Study|Protocol Violation|0|||
13257213|NCT01505634|26388840|FG002|Overall Study|Protocol Violation|0|||
13257214|NCT01505634|26388838|FG000|Overall Study|Lost to Follow-up|1|||
13257215|NCT01505634|26388839|FG001|Overall Study|Lost to Follow-up|4|||
13257216|NCT01505634|26388840|FG002|Overall Study|Lost to Follow-up|4|||
13257217|NCT01505634|26388838|FG000|Overall Study|Death|1|||
13257218|NCT01505634|26388839|FG001|Overall Study|Death|0|||
13257219|NCT01505634|26388840|FG002|Overall Study|Death|0|||
13257220|NCT01505634|26388838|FG000|Overall Study|In a conflict zone|0|||
13257221|NCT01505634|26388839|FG001|Overall Study|In a conflict zone|0|||
13485968|NCT02573259|27034733|FG005|Overall Study|Death|32|||
13485969|NCT02573259|27034734|FG006|Overall Study|Death|21|||
13485970|NCT02573259|27034728|FG000|Overall Study|Lost to Follow-up|0|||
13485971|NCT02573259|27034729|FG001|Overall Study|Lost to Follow-up|0|||
13485972|NCT02573259|27034730|FG002|Overall Study|Lost to Follow-up|0|||
13485973|NCT02573259|27034731|FG003|Overall Study|Lost to Follow-up|0|||
13485974|NCT02573259|27034732|FG004|Overall Study|Lost to Follow-up|0|||
13485975|NCT02573259|27034733|FG005|Overall Study|Lost to Follow-up|2|||
13485976|NCT02573259|27034734|FG006|Overall Study|Lost to Follow-up|1|||
13485977|NCT02573259|27034728|FG000|Overall Study|Participant refused further follow-up|0|||
13485978|NCT02573259|27034729|FG001|Overall Study|Participant refused further follow-up|2|||
13485979|NCT02573259|27034730|FG002|Overall Study|Participant refused further follow-up|1|||
13485980|NCT02573259|27034731|FG003|Overall Study|Participant refused further follow-up|0|||
13485981|NCT02573259|27034732|FG004|Overall Study|Participant refused further follow-up|3|||
13485982|NCT02573259|27034733|FG005|Overall Study|Participant refused further follow-up|20|||
13485983|NCT02573259|27034734|FG006|Overall Study|Participant refused further follow-up|7|||
13485984|NCT02573259|27034728|FG000|Overall Study|Other|0|||
13485985|NCT02573259|27034729|FG001|Overall Study|Other|0|||
13485986|NCT02573259|27034730|FG002|Overall Study|Other|0|||
13485987|NCT02573259|27034731|FG003|Overall Study|Other|0|||
13117119|NCT03066804|25924348|FG001|Overall Study|Adverse Event|3|||
13257222|NCT01505634|26388840|FG002|Overall Study|In a conflict zone|1|||
13257223|NCT01505608|26388863|FG000|Phase I|Lack of Efficacy|0|||
13485988|NCT02573259|27034732|FG004|Overall Study|Other|1|||
13485989|NCT02573259|27034733|FG005|Overall Study|Other|4|||
13485990|NCT02573259|27034734|FG006|Overall Study|Other|5|||
13485991|NCT02318329|27034821|FG000|Overall Study|Progressive Disease|2|||
13485992|NCT02318329|27034822|FG001|Overall Study|Progressive Disease|3|||
13485993|NCT02318329|27034823|FG002|Overall Study|Progressive Disease|2|||
13485994|NCT02318329|27034824|FG003|Overall Study|Progressive Disease|3|||
13117120|NCT03066804|25924347|FG000|Overall Study|Technical problems|5|||
13117121|NCT03066804|25924348|FG001|Overall Study|Technical problems|1|||
13117122|NCT03066778|25924382|FG000|Overall Study|Death|195|||
13117123|NCT03066778|25924383|FG001|Overall Study|Death|205|||
13117124|NCT03066778|25924382|FG000|Overall Study|Withdrawal by Subject|5|||
13117125|NCT03066778|25924383|FG001|Overall Study|Withdrawal by Subject|7|||
13117126|NCT03066609|25924424|FG000|INDUCTION|Pregnancy|0|||
13117127|NCT03066609|25924425|FG001|INDUCTION|Pregnancy|0|||
13117128|NCT03066609|25924426|FG002|INDUCTION|Pregnancy|1|||
13117129|NCT03066609|25924427|FG003|INDUCTION|Pregnancy|0|||
13117130|NCT03066609|25924424|FG000|INDUCTION|Lack of Efficacy|0|||
13117131|NCT03066609|25924425|FG001|INDUCTION|Lack of Efficacy|0|||
13117132|NCT03066609|25924426|FG002|INDUCTION|Lack of Efficacy|1|||
13117133|NCT03066609|25924427|FG003|INDUCTION|Lack of Efficacy|0|||
13117134|NCT03066609|25924424|FG000|INDUCTION|Adverse Event|2|||
13117135|NCT03066609|25924425|FG001|INDUCTION|Adverse Event|2|||
13117136|NCT03066609|25924426|FG002|INDUCTION|Adverse Event|0|||
13117137|NCT03066609|25924427|FG003|INDUCTION|Adverse Event|0|||
13117138|NCT03066609|25924424|FG000|MAINTENANCE|Adverse Event|0|||
13117139|NCT03066609|25924425|FG001|MAINTENANCE|Adverse Event|0|||
13117140|NCT03066609|25924426|FG002|MAINTENANCE|Adverse Event|0|||
13485995|NCT02318329|27034825|FG004|Overall Study|Progressive Disease|3|||
13485996|NCT02318329|27034826|FG005|Overall Study|Progressive Disease|3|||
13117141|NCT03066609|25924427|FG003|MAINTENANCE|Adverse Event|1|||
13117142|NCT03066609|25924424|FG000|MAINTENANCE|Withdrawal by Subject|4|||
13117143|NCT03066609|25924425|FG001|MAINTENANCE|Withdrawal by Subject|2|||
13117144|NCT03066609|25924426|FG002|MAINTENANCE|Withdrawal by Subject|1|||
13117145|NCT03066609|25924427|FG003|MAINTENANCE|Withdrawal by Subject|1|||
13117146|NCT03066609|25924424|FG000|MAINTENANCE|Lost to Follow-up|0|||
13117147|NCT03066609|25924425|FG001|MAINTENANCE|Lost to Follow-up|1|||
13117148|NCT03066609|25924426|FG002|MAINTENANCE|Lost to Follow-up|1|||
13117149|NCT03066609|25924427|FG003|MAINTENANCE|Lost to Follow-up|0|||
13117150|NCT03066609|25924424|FG000|MAINTENANCE|Pregnancy|1|||
13117151|NCT03066609|25924425|FG001|MAINTENANCE|Pregnancy|0|||
13117152|NCT03066609|25924426|FG002|MAINTENANCE|Pregnancy|0|||
13117153|NCT03066609|25924427|FG003|MAINTENANCE|Pregnancy|0|||
13117154|NCT03066609|25924424|FG000|MAINTENANCE|Lack of Efficacy|2|||
13117155|NCT03066609|25924425|FG001|MAINTENANCE|Lack of Efficacy|1|||
13117156|NCT03066609|25924426|FG002|MAINTENANCE|Lack of Efficacy|0|||
13117157|NCT03066609|25924427|FG003|MAINTENANCE|Lack of Efficacy|1|||
13117158|NCT03066609|25924424|FG000|OVERALL STUDY|Adverse Event|2|||
13117159|NCT03066609|25924425|FG001|OVERALL STUDY|Adverse Event|2|||
13117160|NCT03066609|25924426|FG002|OVERALL STUDY|Adverse Event|0|||
13117161|NCT03066609|25924427|FG003|OVERALL STUDY|Adverse Event|1|||
13117162|NCT03066609|25924424|FG000|OVERALL STUDY|Withdrawal by Subject|4|||
13117163|NCT03066609|25924425|FG001|OVERALL STUDY|Withdrawal by Subject|2|||
13117164|NCT03066609|25924426|FG002|OVERALL STUDY|Withdrawal by Subject|1|||
13117165|NCT03066609|25924427|FG003|OVERALL STUDY|Withdrawal by Subject|2|||
13117166|NCT03066609|25924424|FG000|OVERALL STUDY|Lost to Follow-up|1|||
13117167|NCT03066609|25924425|FG001|OVERALL STUDY|Lost to Follow-up|1|||
13117168|NCT03066609|25924426|FG002|OVERALL STUDY|Lost to Follow-up|1|||
13117169|NCT03066609|25924427|FG003|OVERALL STUDY|Lost to Follow-up|1|||
13485997|NCT02318329|27034827|FG006|Overall Study|Progressive Disease|1|||
13485998|NCT02318329|27034828|FG007|Overall Study|Progressive Disease|1|||
13485999|NCT02318329|27034829|FG008|Overall Study|Progressive Disease|5|||
13486000|NCT02318329|27034830|FG009|Overall Study|Progressive Disease|39|||
13486001|NCT02318329|27034821|FG000|Overall Study|Death|0|||
13486002|NCT02318329|27034822|FG001|Overall Study|Death|0|||
13486003|NCT02318329|27034823|FG002|Overall Study|Death|0|||
13486004|NCT02318329|27034824|FG003|Overall Study|Death|0|||
13486005|NCT02318329|27034825|FG004|Overall Study|Death|0|||
13486006|NCT02318329|27034826|FG005|Overall Study|Death|0|||
13486007|NCT02318329|27034827|FG006|Overall Study|Death|0|||
13486008|NCT02318329|27034828|FG007|Overall Study|Death|0|||
13486009|NCT02318329|27034829|FG008|Overall Study|Death|0|||
13117170|NCT03066609|25924424|FG000|OVERALL STUDY|Pregnancy|1|||
13117171|NCT03066609|25924425|FG001|OVERALL STUDY|Pregnancy|0|||
13117172|NCT03066609|25924426|FG002|OVERALL STUDY|Pregnancy|1|||
13117173|NCT03066609|25924427|FG003|OVERALL STUDY|Pregnancy|0|||
13117174|NCT03066609|25924424|FG000|OVERALL STUDY|Lack of Efficacy|2|||
13117175|NCT03066609|25924425|FG001|OVERALL STUDY|Lack of Efficacy|1|||
13486010|NCT02318329|27034830|FG009|Overall Study|Death|5|||
13486011|NCT02318329|27034821|FG000|Overall Study|Lost to Follow-up|0|||
13117176|NCT03066609|25924426|FG002|OVERALL STUDY|Lack of Efficacy|1|||
13117177|NCT03066609|25924427|FG003|OVERALL STUDY|Lack of Efficacy|1|||
13486012|NCT02318329|27034822|FG001|Overall Study|Lost to Follow-up|0|||
13486013|NCT02318329|27034823|FG002|Overall Study|Lost to Follow-up|0|||
13486014|NCT02318329|27034824|FG003|Overall Study|Lost to Follow-up|0|||
13486015|NCT02318329|27034825|FG004|Overall Study|Lost to Follow-up|0|||
13486016|NCT02318329|27034826|FG005|Overall Study|Lost to Follow-up|0|||
13486017|NCT02318329|27034827|FG006|Overall Study|Lost to Follow-up|0|||
13486018|NCT02318329|27034828|FG007|Overall Study|Lost to Follow-up|0|||
13486019|NCT02318329|27034829|FG008|Overall Study|Lost to Follow-up|0|||
13486020|NCT02318329|27034830|FG009|Overall Study|Lost to Follow-up|1|||
13486021|NCT02318329|27034821|FG000|Overall Study|Withdrawal by Subject|0|||
13486022|NCT02318329|27034822|FG001|Overall Study|Withdrawal by Subject|0|||
13486023|NCT02318329|27034823|FG002|Overall Study|Withdrawal by Subject|0|||
13486024|NCT02318329|27034824|FG003|Overall Study|Withdrawal by Subject|0|||
13486025|NCT02318329|27034825|FG004|Overall Study|Withdrawal by Subject|0|||
13486026|NCT02318329|27034826|FG005|Overall Study|Withdrawal by Subject|0|||
13117178|NCT03066609|25924424|FG000|OVERALL STUDY|discontinued follow up|0|||
13117179|NCT03066609|25924425|FG001|OVERALL STUDY|discontinued follow up|2|||
13117180|NCT03066609|25924426|FG002|OVERALL STUDY|discontinued follow up|0|||
13486027|NCT02318329|27034827|FG006|Overall Study|Withdrawal by Subject|0|||
13486028|NCT02318329|27034828|FG007|Overall Study|Withdrawal by Subject|0|||
13486029|NCT02318329|27034829|FG008|Overall Study|Withdrawal by Subject|0|||
13486030|NCT02318329|27034830|FG009|Overall Study|Withdrawal by Subject|6|||
13486031|NCT02318329|27034821|FG000|Overall Study|Other|1|||
13486032|NCT02318329|27034822|FG001|Overall Study|Other|1|||
13486033|NCT02318329|27034823|FG002|Overall Study|Other|1|||
13486034|NCT02318329|27034824|FG003|Overall Study|Other|0|||
13486035|NCT02318329|27034825|FG004|Overall Study|Other|0|||
13486036|NCT02318329|27034826|FG005|Overall Study|Other|0|||
13486037|NCT02318329|27034827|FG006|Overall Study|Other|0|||
13486038|NCT02318329|27034828|FG007|Overall Study|Other|0|||
13486039|NCT02318329|27034829|FG008|Overall Study|Other|1|||
13486040|NCT02318329|27034830|FG009|Overall Study|Other|1|||
13486041|NCT01224106|27034929|FG000|Double-Blind Treatment Phase|Death|3|||
13486042|NCT01224106|27034930|FG001|Double-Blind Treatment Phase|Death|0|||
13486043|NCT01224106|27034931|FG002|Double-Blind Treatment Phase|Death|0|||
13486044|NCT01224106|27034932|FG003|Double-Blind Treatment Phase|Death|0|||
13486045|NCT01224106|27034933|FG004|Double-Blind Treatment Phase|Death|0|||
13486046|NCT01224106|27034929|FG000|Double-Blind Treatment Phase|Physician Decision|6|||
13486047|NCT01224106|27034930|FG001|Double-Blind Treatment Phase|Physician Decision|5|||
13486048|NCT01224106|27034931|FG002|Double-Blind Treatment Phase|Physician Decision|4|||
13486049|NCT01224106|27034932|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
13486050|NCT01224106|27034933|FG004|Double-Blind Treatment Phase|Physician Decision|0|||
13486051|NCT01224106|27034929|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
13486052|NCT01224106|27034930|FG001|Double-Blind Treatment Phase|Adverse Event|5|||
13486053|NCT01224106|27034931|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
13486054|NCT01224106|27034932|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
13486055|NCT01224106|27034933|FG004|Double-Blind Treatment Phase|Adverse Event|0|||
13486056|NCT01224106|27034929|FG000|Double-Blind Treatment Phase|Other|0|||
13486057|NCT01224106|27034930|FG001|Double-Blind Treatment Phase|Other|0|||
13486058|NCT01224106|27034931|FG002|Double-Blind Treatment Phase|Other|1|||
13486059|NCT01224106|27034932|FG003|Double-Blind Treatment Phase|Other|0|||
13486060|NCT01224106|27034933|FG004|Double-Blind Treatment Phase|Other|0|||
13486061|NCT01224106|27034929|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7|||
13486062|NCT01224106|27034930|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
13486063|NCT01224106|27034931|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
13486064|NCT01224106|27034932|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
13486065|NCT01224106|27034933|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
13486066|NCT01224106|27034929|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62|||
13486067|NCT01224106|27034930|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68|||
13486068|NCT01224106|27034931|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63|||
13486069|NCT01224106|27034932|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
13486070|NCT01224106|27034933|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
13486071|NCT01224106|27034929|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1|||
13486072|NCT01224106|27034930|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
13486073|NCT01224106|27034931|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
13486074|NCT01224106|27034932|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
13486075|NCT01224106|27034933|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0|||
13486076|NCT01224106|27034929|FG000|Open-Label Extension (OLE) Phase|Death|0|||
13486077|NCT01224106|27034930|FG001|Open-Label Extension (OLE) Phase|Death|0|||
13486078|NCT01224106|27034931|FG002|Open-Label Extension (OLE) Phase|Death|0|||
13486079|NCT01224106|27034932|FG003|Open-Label Extension (OLE) Phase|Death|1|||
13486080|NCT01224106|27034933|FG004|Open-Label Extension (OLE) Phase|Death|3|||
13486081|NCT01224106|27034929|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0|||
13486082|NCT01224106|27034930|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
13486083|NCT01224106|27034931|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0|||
13486084|NCT01224106|27034932|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2|||
13486085|NCT01224106|27034933|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6|||
13486086|NCT01224106|27034929|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0|||
13486087|NCT01224106|27034930|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0|||
13486088|NCT01224106|27034931|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0|||
13486089|NCT01224106|27034932|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2|||
13486090|NCT01224106|27034933|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7|||
13486091|NCT01224106|27034929|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
13486092|NCT01224106|27034930|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
13486093|NCT01224106|27034931|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
13486094|NCT01224106|27034932|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6|||
13486095|NCT01224106|27034933|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15|||
13486096|NCT01224106|27034929|FG000|Open-Label Extension (OLE) Phase|Other|0|||
13486097|NCT01224106|27034930|FG001|Open-Label Extension (OLE) Phase|Other|0|||
13486098|NCT01224106|27034931|FG002|Open-Label Extension (OLE) Phase|Other|0|||
13486099|NCT01224106|27034932|FG003|Open-Label Extension (OLE) Phase|Other|5|||
13486100|NCT01224106|27034933|FG004|Open-Label Extension (OLE) Phase|Other|3|||
13488046|NCT01092117|27041942|FG000|Year 4|Death|8|||
13488047|NCT01092117|27041942|FG000|Year 4|Withdrawal by Subject|4|||
13488048|NCT01092117|27041942|FG000|Year 4|Lost to Follow-up|4|||
13488049|NCT00950989|27041990|FG000|Overall Study|Death|0|||
13488050|NCT00950989|27041991|FG001|Overall Study|Death|0|||
13488051|NCT00950989|27041992|FG002|Overall Study|Death|1|||
13488052|NCT00950989|27041993|FG003|Overall Study|Death|0|||
13488053|NCT00950989|27041990|FG000|Overall Study|Administrative Decision|0|||
13488054|NCT00950989|27041991|FG001|Overall Study|Administrative Decision|1|||
13488055|NCT00950989|27041992|FG002|Overall Study|Administrative Decision|0|||
13488056|NCT00950989|27041993|FG003|Overall Study|Administrative Decision|0|||
13488057|NCT00950989|27041990|FG000|Overall Study|Disease Progression|0|||
13488058|NCT00950989|27041991|FG001|Overall Study|Disease Progression|0|||
13488059|NCT00950989|27041992|FG002|Overall Study|Disease Progression|1|||
13488060|NCT00950989|27041993|FG003|Overall Study|Disease Progression|0|||
13488061|NCT00950989|27041990|FG000|Overall Study|Withdrawal by Subject|2|||
13488062|NCT00950989|27041991|FG001|Overall Study|Withdrawal by Subject|1|||
13488063|NCT00950989|27041992|FG002|Overall Study|Withdrawal by Subject|0|||
13488064|NCT00950989|27041993|FG003|Overall Study|Withdrawal by Subject|0|||
13488065|NCT00950989|27041990|FG000|Overall Study|Adverse Event|2|||
13488066|NCT00950989|27041991|FG001|Overall Study|Adverse Event|1|||
13488067|NCT00950989|27041992|FG002|Overall Study|Adverse Event|1|||
13488068|NCT00950989|27041993|FG003|Overall Study|Adverse Event|0|||
13488366|NCT02959918|27043330|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
13488367|NCT02959918|27043331|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
13488368|NCT02959918|27043332|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
13488369|NCT02959918|27043333|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
13488370|NCT02959918|27043320|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0|||
13488371|NCT02959918|27043321|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0|||
13488372|NCT02959918|27043322|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0|||
13117181|NCT03066609|25924427|FG003|OVERALL STUDY|discontinued follow up|0|||
13117182|NCT03066193|25924433|FG000|Overall Study|Withdrawal by Subject|1|||
13117183|NCT03065933|25924439|FG000|Overall Study|study terminated|5|||
13117184|NCT03065530|25924529|FG000|Overall Study|Lack of Efficacy|1|||
13117185|NCT03065530|25924530|FG001|Overall Study|Lack of Efficacy|1|||
13117186|NCT03065530|25924531|FG002|Overall Study|Lack of Efficacy|0|||
13117187|NCT03065530|25924532|FG003|Overall Study|Lack of Efficacy|1|||
13117188|NCT03065530|25924529|FG000|Overall Study|Protocol Violation|1|||
13117189|NCT03065530|25924530|FG001|Overall Study|Protocol Violation|0|||
13117190|NCT03065530|25924531|FG002|Overall Study|Protocol Violation|1|||
13117191|NCT03065530|25924532|FG003|Overall Study|Protocol Violation|1|||
13117192|NCT03065400|25924539|FG000|Overall Study|Adverse Event|1|||
13117193|NCT03065400|25924539|FG000|Overall Study|Physician Decision|3|||
13117194|NCT03065400|25924539|FG000|Overall Study|Withdrawal by Subject|1|||
13117195|NCT03065400|25924539|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5|||
13117196|NCT03065023|25924619|FG000|Overall Study|Progressive Disease|0|||
13117197|NCT03065023|25924620|FG001|Overall Study|Progressive Disease|1|||
13117198|NCT03065023|25924621|FG002|Overall Study|Progressive Disease|0|||
13488373|NCT02959918|27043323|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0|||
13488374|NCT02959918|27043324|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0|||
13488375|NCT02959918|27043325|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0|||
13488376|NCT02959918|27043326|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0|||
13488377|NCT02959918|27043327|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0|||
13117199|NCT03065023|25924622|FG003|Overall Study|Progressive Disease|0|||
13117200|NCT03065023|25924623|FG004|Overall Study|Progressive Disease|0|||
13117201|NCT03065023|25924619|FG000|Overall Study|Death|2|||
13117202|NCT03065023|25924620|FG001|Overall Study|Death|0|||
13117203|NCT03065023|25924621|FG002|Overall Study|Death|1|||
13486101|NCT04531241|27034968|FG000|Period 1|Withdrawal by Subject|2|||
13486102|NCT04531241|27034969|FG001|Period 1|Withdrawal by Subject|0|||
13486103|NCT04531241|27034968|FG000|Period 1|Dispesed incorrect lens power|1|||
13486104|NCT04531241|27034969|FG001|Period 1|Dispesed incorrect lens power|0|||
13486105|NCT04531241|27034968|FG000|Period 1|Protocol Violation|1|||
13486106|NCT04531241|27034969|FG001|Period 1|Protocol Violation|0|||
13486107|NCT04531241|27034968|FG000|Period 1|No longer eligible|0|||
13486108|NCT04531241|27034969|FG001|Period 1|No longer eligible|1|||
13486109|NCT04531241|27034968|FG000|Period 1|Lens Discomfort|0|||
13486110|NCT04531241|27034969|FG001|Period 1|Lens Discomfort|1|||
13486111|NCT04531241|27034968|FG000|Period 2|Covid-19 Related|1|||
13486112|NCT04531241|27034969|FG001|Period 2|Covid-19 Related|1|||
13488069|NCT04498247|27042193|FG000|Overall Study|Lost to Follow-up|0|||
13488070|NCT04498247|27042194|FG001|Overall Study|Lost to Follow-up|0|||
13488071|NCT04498247|27042195|FG002|Overall Study|Lost to Follow-up|0|||
13488072|NCT04498247|27042196|FG003|Overall Study|Lost to Follow-up|1|||
13488073|NCT04498247|27042197|FG004|Overall Study|Lost to Follow-up|0|||
13488074|NCT04498247|27042198|FG005|Overall Study|Lost to Follow-up|0|||
13488075|NCT04498247|27042199|FG006|Overall Study|Lost to Follow-up|0|||
13488076|NCT04498247|27042200|FG007|Overall Study|Lost to Follow-up|0|||
13488077|NCT04498247|27042193|FG000|Overall Study|Mistakenly Randomized; Not Treated|1|||
13488078|NCT04498247|27042194|FG001|Overall Study|Mistakenly Randomized; Not Treated|0|||
13488079|NCT04498247|27042195|FG002|Overall Study|Mistakenly Randomized; Not Treated|0|||
13488080|NCT04498247|27042196|FG003|Overall Study|Mistakenly Randomized; Not Treated|0|||
13488081|NCT04498247|27042197|FG004|Overall Study|Mistakenly Randomized; Not Treated|0|||
13488082|NCT04498247|27042198|FG005|Overall Study|Mistakenly Randomized; Not Treated|0|||
13488083|NCT04498247|27042199|FG006|Overall Study|Mistakenly Randomized; Not Treated|0|||
13488084|NCT04498247|27042200|FG007|Overall Study|Mistakenly Randomized; Not Treated|0|||
13488085|NCT04498247|27042193|FG000|Overall Study|Withdrawal by Subject|0|||
13488086|NCT04498247|27042194|FG001|Overall Study|Withdrawal by Subject|8|||
13488087|NCT04498247|27042195|FG002|Overall Study|Withdrawal by Subject|0|||
13488088|NCT04498247|27042196|FG003|Overall Study|Withdrawal by Subject|7|||
13488089|NCT04498247|27042197|FG004|Overall Study|Withdrawal by Subject|0|||
13488090|NCT04498247|27042198|FG005|Overall Study|Withdrawal by Subject|0|||
13488091|NCT04498247|27042199|FG006|Overall Study|Withdrawal by Subject|1|||
13488092|NCT04498247|27042200|FG007|Overall Study|Withdrawal by Subject|0|||
13488093|NCT04498247|27042193|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0|||
13488094|NCT04498247|27042194|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4|||
13488095|NCT04498247|27042195|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0|||
13488096|NCT04498247|27042196|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3|||
13117204|NCT03065023|25924622|FG003|Overall Study|Death|1|||
13117205|NCT03065023|25924623|FG004|Overall Study|Death|0|||
13117206|NCT03065023|25924619|FG000|Overall Study|Lost to Follow-up|0|||
13117207|NCT03065023|25924620|FG001|Overall Study|Lost to Follow-up|1|||
13117208|NCT03065023|25924621|FG002|Overall Study|Lost to Follow-up|0|||
13117209|NCT03065023|25924622|FG003|Overall Study|Lost to Follow-up|0|||
13117210|NCT03065023|25924623|FG004|Overall Study|Lost to Follow-up|0|||
13117211|NCT03065023|25924619|FG000|Overall Study|Participant Decision|0|||
13117212|NCT03065023|25924620|FG001|Overall Study|Participant Decision|0|||
13117213|NCT03065023|25924621|FG002|Overall Study|Participant Decision|0|||
13117214|NCT03065023|25924622|FG003|Overall Study|Participant Decision|1|||
13117215|NCT03065023|25924623|FG004|Overall Study|Participant Decision|0|||
13117216|NCT03065023|25924619|FG000|Overall Study|Withdrawal by Subject|0|||
13117217|NCT03065023|25924620|FG001|Overall Study|Withdrawal by Subject|0|||
13117218|NCT03065023|25924621|FG002|Overall Study|Withdrawal by Subject|0|||
13117219|NCT03065023|25924622|FG003|Overall Study|Withdrawal by Subject|1|||
13117220|NCT03065023|25924623|FG004|Overall Study|Withdrawal by Subject|0|||
13117221|NCT03064841|25924640|FG000|Overall Study|Inclusion/exclusion criteria violation|4|||
13488097|NCT04498247|27042197|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0|||
13488098|NCT04498247|27042198|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0|||
13488099|NCT04498247|27042199|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7|||
13488100|NCT04498247|27042200|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0|||
13488101|NCT04472650|27042227|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1|||
13488102|NCT04472650|27042228|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0|||
13488103|NCT04151290|27042252|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286|||
13488104|NCT04038385|27042319|FG000|Overall Study|Completed baseline assessment only|7|||
13488105|NCT04038385|27042320|FG001|Overall Study|Completed baseline assessment only|4|||
13488106|NCT04038385|27042319|FG000|Overall Study|Moved out of area|4|||
13488107|NCT04038385|27042320|FG001|Overall Study|Moved out of area|2|||
13257224|NCT01505608|26388864|FG001|Phase I|Lack of Efficacy|4|||
13488108|NCT04038385|27042319|FG000|Overall Study|Discontinued study involvement|6|||
13117222|NCT03064841|25924640|FG000|Overall Study|No glycated haemoglobinA1c measurement|11|||
13117223|NCT03064841|25924640|FG000|Overall Study|Screen failure|2|||
13117224|NCT03064451|25924656|FG000|Overall Study|Lost to Follow-up|1|||
13257225|NCT01505608|26388863|FG000|Phase I|Adverse Event|0|||
13486113|NCT03600714|27035059|FG000|Overall Study|Out of country and could not return for post-treatment visits|1|||
13486114|NCT03470441|27035174|FG000|Overall Study|Death|0|||
13486115|NCT03470441|27035175|FG001|Overall Study|Death|1|||
13486116|NCT03470441|27035176|FG002|Overall Study|Death|1|||
13486117|NCT03470441|27035177|FG003|Overall Study|Death|0|||
13486118|NCT03470441|27035174|FG000|Overall Study|Adverse Event|0|||
13486119|NCT03470441|27035175|FG001|Overall Study|Adverse Event|0|||
13486120|NCT03470441|27035176|FG002|Overall Study|Adverse Event|0|||
13486121|NCT03470441|27035177|FG003|Overall Study|Adverse Event|1|||
13486122|NCT03470441|27035174|FG000|Overall Study|Withdrawal by Subject|1|||
13486123|NCT03470441|27035175|FG001|Overall Study|Withdrawal by Subject|4|||
13486124|NCT03470441|27035176|FG002|Overall Study|Withdrawal by Subject|1|||
13486125|NCT03470441|27035177|FG003|Overall Study|Withdrawal by Subject|3|||
13486126|NCT03448939|27035194|FG000|Overall Study|Adverse Event|5|||
13486127|NCT03448939|27035195|FG001|Overall Study|Adverse Event|1|||
13486128|NCT03448939|27035194|FG000|Overall Study|Lost to Follow-up|6|||
13486129|NCT03448939|27035195|FG001|Overall Study|Lost to Follow-up|6|||
13486130|NCT03448939|27035194|FG000|Overall Study|Pregnancy|1|||
13486131|NCT03448939|27035195|FG001|Overall Study|Pregnancy|1|||
13486132|NCT03448939|27035194|FG000|Overall Study|Withdrawal by Subject|9|||
13486133|NCT03448939|27035195|FG001|Overall Study|Withdrawal by Subject|3|||
13486134|NCT03283371|27035264|FG000|Placebo-controlled|Adverse Event|1|||
13486135|NCT03283371|27035265|FG001|Placebo-controlled|Adverse Event|1|||
13486136|NCT03283371|27035266|FG002|Placebo-controlled|Adverse Event|0|||
13486137|NCT03283371|27035267|FG003|Placebo-controlled|Adverse Event|0|||
13486138|NCT03283371|27035264|FG000|Placebo-controlled|Lack of Efficacy|1|||
13486139|NCT03283371|27035265|FG001|Placebo-controlled|Lack of Efficacy|0|||
13486140|NCT03283371|27035266|FG002|Placebo-controlled|Lack of Efficacy|0|||
13486141|NCT03283371|27035267|FG003|Placebo-controlled|Lack of Efficacy|0|||
13486142|NCT03283371|27035264|FG000|Placebo-controlled|Withdrawal by Subject|1|||
13486143|NCT03283371|27035265|FG001|Placebo-controlled|Withdrawal by Subject|1|||
13486144|NCT03283371|27035266|FG002|Placebo-controlled|Withdrawal by Subject|0|||
13486145|NCT03283371|27035267|FG003|Placebo-controlled|Withdrawal by Subject|0|||
13486146|NCT03283371|27035264|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
13486147|NCT03283371|27035265|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1|||
13486148|NCT03283371|27035266|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
13486149|NCT03283371|27035267|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
13486150|NCT03283371|27035264|FG000|Open-label Phase|Adverse Event|0|||
13486151|NCT03283371|27035265|FG001|Open-label Phase|Adverse Event|0|||
13486152|NCT03283371|27035266|FG002|Open-label Phase|Adverse Event|2|||
13486153|NCT03283371|27035267|FG003|Open-label Phase|Adverse Event|0|||
13486154|NCT03283371|27035264|FG000|Open-label Phase|Withdrawal by Subject|0|||
13486155|NCT03283371|27035265|FG001|Open-label Phase|Withdrawal by Subject|0|||
13486156|NCT03283371|27035266|FG002|Open-label Phase|Withdrawal by Subject|1|||
13486157|NCT03283371|27035267|FG003|Open-label Phase|Withdrawal by Subject|0|||
13486158|NCT03283371|27035264|FG000|Open-label Phase|Other|0|||
13486159|NCT03283371|27035265|FG001|Open-label Phase|Other|0|||
13486160|NCT03283371|27035266|FG002|Open-label Phase|Other|1|||
13486161|NCT03283371|27035267|FG003|Open-label Phase|Other|1|||
13486162|NCT03257254|27035281|FG000|Overall Study|Withdrawal by Subject|7|||
13486163|NCT03257254|27035281|FG000|Overall Study|Lost to Follow-up|9|||
13486164|NCT03257254|27035281|FG000|Overall Study|Study discontinued by sponsor|5|||
13486165|NCT03084718|27035384|FG000|Overall Study|Withdrawal by Subject|4|||
13486166|NCT03084718|27035385|FG001|Overall Study|Withdrawal by Subject|3|||
13486167|NCT03084718|27035386|FG002|Overall Study|Withdrawal by Subject|4|||
13486168|NCT03084718|27035387|FG003|Overall Study|Withdrawal by Subject|0|||
13486169|NCT03084718|27035388|FG004|Overall Study|Withdrawal by Subject|0|||
13486170|NCT03084718|27035384|FG000|Overall Study|Physician Decision|1|||
13117225|NCT03064451|25924656|FG000|Overall Study|Mapping Failure|4|||
13486171|NCT03084718|27035385|FG001|Overall Study|Physician Decision|0|||
13486172|NCT03084718|27035386|FG002|Overall Study|Physician Decision|0|||
13486173|NCT03084718|27035387|FG003|Overall Study|Physician Decision|0|||
13486174|NCT03084718|27035388|FG004|Overall Study|Physician Decision|0|||
13486175|NCT03084718|27035384|FG000|Overall Study|Adverse Event|3|||
13486176|NCT03084718|27035385|FG001|Overall Study|Adverse Event|5|||
13486177|NCT03084718|27035386|FG002|Overall Study|Adverse Event|5|||
13486178|NCT03084718|27035387|FG003|Overall Study|Adverse Event|8|||
13486179|NCT03084718|27035388|FG004|Overall Study|Adverse Event|2|||
13486180|NCT03084718|27035384|FG000|Overall Study|Lack of Efficacy|2|||
13486181|NCT03084718|27035385|FG001|Overall Study|Lack of Efficacy|0|||
13486182|NCT03084718|27035386|FG002|Overall Study|Lack of Efficacy|1|||
13486183|NCT03084718|27035387|FG003|Overall Study|Lack of Efficacy|4|||
13486184|NCT03084718|27035388|FG004|Overall Study|Lack of Efficacy|0|||
13486185|NCT03084718|27035384|FG000|Overall Study|Lost to Follow-up|0|||
13486186|NCT03084718|27035385|FG001|Overall Study|Lost to Follow-up|1|||
13486187|NCT03084718|27035386|FG002|Overall Study|Lost to Follow-up|0|||
13486188|NCT03084718|27035387|FG003|Overall Study|Lost to Follow-up|0|||
13486189|NCT03084718|27035388|FG004|Overall Study|Lost to Follow-up|2|||
13486190|NCT03084718|27035384|FG000|Overall Study|Protocol Violation|0|||
13486191|NCT03084718|27035385|FG001|Overall Study|Protocol Violation|0|||
13486192|NCT03084718|27035386|FG002|Overall Study|Protocol Violation|1|||
13486193|NCT03084718|27035387|FG003|Overall Study|Protocol Violation|0|||
13486194|NCT03084718|27035388|FG004|Overall Study|Protocol Violation|0|||
13486195|NCT03084718|27035384|FG000|Overall Study|Death|0|||
13486196|NCT03084718|27035385|FG001|Overall Study|Death|1|||
13486197|NCT03084718|27035386|FG002|Overall Study|Death|0|||
13486198|NCT03084718|27035387|FG003|Overall Study|Death|0|||
13486199|NCT03084718|27035388|FG004|Overall Study|Death|0|||
13486200|NCT03084718|27035384|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
13486201|NCT03084718|27035385|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
13486202|NCT03084718|27035386|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
13486203|NCT03084718|27035387|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2|||
13486204|NCT03084718|27035388|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
13486205|NCT03069417|27035411|FG000|Overall Study|Lost to Follow-up|2|||
13486206|NCT03069417|27035412|FG001|Overall Study|Lost to Follow-up|0|||
13486207|NCT03069417|27035411|FG000|Overall Study|Reason Unknown|4|||
13486208|NCT03069417|27035412|FG001|Overall Study|Reason Unknown|7|||
13486209|NCT02936323|27035565|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
13486210|NCT02936323|27035566|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
13486211|NCT02936323|27035567|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
13486212|NCT02936323|27035568|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
13486213|NCT02936323|27035569|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
13486214|NCT02936323|27035570|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
13486215|NCT02936323|27035571|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
13486216|NCT02936323|27035572|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
13486217|NCT02936323|27035573|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
13486218|NCT02936323|27035574|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
13486219|NCT02936323|27035565|FG000|Phase 1 Dose Escalation|Death|2|||
13486220|NCT02936323|27035566|FG001|Phase 1 Dose Escalation|Death|1|||
13486221|NCT02936323|27035567|FG002|Phase 1 Dose Escalation|Death|3|||
13486222|NCT02936323|27035568|FG003|Phase 1 Dose Escalation|Death|1|||
13486223|NCT02936323|27035569|FG004|Phase 1 Dose Escalation|Death|2|||
13486224|NCT02936323|27035570|FG005|Phase 1 Dose Escalation|Death|3|||
13486225|NCT02936323|27035571|FG006|Phase 1 Dose Escalation|Death|3|||
13486226|NCT02936323|27035572|FG007|Phase 1 Dose Escalation|Death|0|||
13486227|NCT02936323|27035573|FG008|Phase 1 Dose Escalation|Death|0|||
13486228|NCT02936323|27035574|FG009|Phase 1 Dose Escalation|Death|0|||
13486229|NCT02936323|27035565|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
13486230|NCT02936323|27035566|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
13486231|NCT02936323|27035567|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
13486232|NCT02936323|27035568|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
13486233|NCT02936323|27035569|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
13486234|NCT02936323|27035570|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1|||
13486235|NCT02936323|27035571|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
13486236|NCT02936323|27035572|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
13486237|NCT02936323|27035573|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
13486238|NCT02936323|27035574|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
13486239|NCT02936323|27035565|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
13486240|NCT02936323|27035566|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
13486241|NCT02936323|27035567|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
13486242|NCT02936323|27035568|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
13486243|NCT02936323|27035569|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
13486244|NCT02936323|27035570|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
13486245|NCT02936323|27035571|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
13486246|NCT02936323|27035572|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11|||
13486247|NCT02936323|27035573|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4|||
13486248|NCT02936323|27035574|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2|||
13486249|NCT02936323|27035565|FG000|Phase 2a Dose Expansion|Physician Decision|0|||
13486250|NCT02936323|27035566|FG001|Phase 2a Dose Expansion|Physician Decision|0|||
13486251|NCT02936323|27035567|FG002|Phase 2a Dose Expansion|Physician Decision|0|||
13486252|NCT02936323|27035568|FG003|Phase 2a Dose Expansion|Physician Decision|0|||
13486253|NCT02936323|27035569|FG004|Phase 2a Dose Expansion|Physician Decision|0|||
13486254|NCT02936323|27035570|FG005|Phase 2a Dose Expansion|Physician Decision|0|||
13486255|NCT02936323|27035571|FG006|Phase 2a Dose Expansion|Physician Decision|0|||
13486256|NCT02936323|27035572|FG007|Phase 2a Dose Expansion|Physician Decision|0|||
13486257|NCT02936323|27035573|FG008|Phase 2a Dose Expansion|Physician Decision|0|||
13486258|NCT02936323|27035574|FG009|Phase 2a Dose Expansion|Physician Decision|1|||
13257226|NCT01505608|26388864|FG001|Phase I|Adverse Event|1|||
13486259|NCT02936323|27035565|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0|||
13486260|NCT02936323|27035566|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0|||
13486261|NCT02936323|27035567|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0|||
13486262|NCT02936323|27035568|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0|||
13486263|NCT02936323|27035569|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0|||
13486264|NCT02936323|27035570|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0|||
13486265|NCT02936323|27035571|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0|||
13486266|NCT02936323|27035572|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2|||
13486267|NCT02936323|27035573|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1|||
13486268|NCT02936323|27035574|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0|||
13486269|NCT02936323|27035565|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
13486270|NCT02936323|27035566|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
13486271|NCT02936323|27035567|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
13486272|NCT02936323|27035568|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
13486273|NCT02936323|27035569|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
13486274|NCT02936323|27035570|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
13486275|NCT02936323|27035571|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
13486276|NCT02936323|27035572|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
13486277|NCT02936323|27035573|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
13486278|NCT02936323|27035574|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1|||
13486279|NCT02936323|27035565|FG000|Phase 2a Dose Expansion|Death|0|||
13486280|NCT02936323|27035566|FG001|Phase 2a Dose Expansion|Death|0|||
13486281|NCT02936323|27035567|FG002|Phase 2a Dose Expansion|Death|0|||
13486282|NCT02936323|27035568|FG003|Phase 2a Dose Expansion|Death|0|||
13486283|NCT02936323|27035569|FG004|Phase 2a Dose Expansion|Death|0|||
13486284|NCT02936323|27035570|FG005|Phase 2a Dose Expansion|Death|0|||
13486285|NCT02936323|27035571|FG006|Phase 2a Dose Expansion|Death|0|||
13486286|NCT02936323|27035572|FG007|Phase 2a Dose Expansion|Death|4|||
13486287|NCT02936323|27035573|FG008|Phase 2a Dose Expansion|Death|8|||
13486288|NCT02936323|27035574|FG009|Phase 2a Dose Expansion|Death|10|||
13486289|NCT02429791|27035711|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6|||
13486290|NCT02429791|27035712|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2|||
13486291|NCT02429791|27035711|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
13486292|NCT02429791|27035712|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2|||
13257227|NCT01505608|26388863|FG000|Phase I|Withdrawal by Subject|0|||
13257228|NCT01505608|26388864|FG001|Phase I|Withdrawal by Subject|1|||
13257229|NCT01505608|26388863|FG000|Phase II|Lack of Efficacy|2|||
13257230|NCT01505608|26388864|FG001|Phase II|Lack of Efficacy|1|||
13257231|NCT01505608|26388863|FG000|Phase II|Protocol Violation|0|||
13257232|NCT01505608|26388864|FG001|Phase II|Protocol Violation|1|||
13257233|NCT01505530|26388915|FG000|Overall Study|Progressive Disease|19|||
13257234|NCT01505530|26388916|FG001|Overall Study|Progressive Disease|17|||
13257235|NCT01505530|26388917|FG002|Overall Study|Progressive Disease|18|||
13257236|NCT01505530|26388915|FG000|Overall Study|Adverse Event|1|||
13257237|NCT01505530|26388916|FG001|Overall Study|Adverse Event|1|||
13257238|NCT01505530|26388917|FG002|Overall Study|Adverse Event|0|||
13257239|NCT01505530|26388915|FG000|Overall Study|Withdrawal by Subject|7|||
13257240|NCT01505530|26388916|FG001|Overall Study|Withdrawal by Subject|8|||
13257241|NCT01505530|26388917|FG002|Overall Study|Withdrawal by Subject|6|||
13257242|NCT01505530|26388915|FG000|Overall Study|Physician Decision|6|||
13257243|NCT01505530|26388916|FG001|Overall Study|Physician Decision|2|||
13257244|NCT01505530|26388917|FG002|Overall Study|Physician Decision|5|||
13257245|NCT01505530|26388915|FG000|Overall Study|Sponsor Decision|1|||
13257246|NCT01505530|26388916|FG001|Overall Study|Sponsor Decision|8|||
13257247|NCT01505530|26388917|FG002|Overall Study|Sponsor Decision|7|||
13257248|NCT01505530|26388915|FG000|Overall Study|Death|7|||
13257249|NCT01505530|26388916|FG001|Overall Study|Death|6|||
13257250|NCT01505530|26388917|FG002|Overall Study|Death|5|||
13257251|NCT01505530|26388915|FG000|Overall Study|entry criteria not met|0|||
13257252|NCT01505530|26388916|FG001|Overall Study|entry criteria not met|1|||
13257253|NCT01505530|26388917|FG002|Overall Study|entry criteria not met|0|||
13257254|NCT01505491|26388947|FG000|Overall Study|Other reason not listed|1|||
13257255|NCT01505491|26388948|FG001|Overall Study|Other reason not listed|0|||
13257256|NCT01505491|26388949|FG002|Overall Study|Other reason not listed|0|||
13257257|NCT01505491|26388947|FG000|Overall Study|Withdrawal by Subject|1|||
13257258|NCT01505491|26388948|FG001|Overall Study|Withdrawal by Subject|1|||
13257259|NCT01505491|26388949|FG002|Overall Study|Withdrawal by Subject|4|||
13257260|NCT01505491|26388947|FG000|Overall Study|Lost to Follow-up|0|||
13257261|NCT01505491|26388948|FG001|Overall Study|Lost to Follow-up|0|||
13257262|NCT01505491|26388949|FG002|Overall Study|Lost to Follow-up|1|||
13257263|NCT01505387|26388962|FG000|Overall Study|Protocol Violation|1|||
13257264|NCT01505387|26388963|FG001|Overall Study|Protocol Violation|0|||
13257265|NCT01505387|26388962|FG000|Overall Study|Withdrawal by Subject|1|||
13257266|NCT01505387|26388963|FG001|Overall Study|Withdrawal by Subject|1|||
13257267|NCT01505374|26388980|FG000|Overall Study|Lost to Follow-up|1|||
13257268|NCT01505374|26388981|FG001|Overall Study|Lost to Follow-up|0|||
13257269|NCT01505114|26389004|FG000|Overall Study|Withdrawal by Subject|5|||
13257270|NCT01505114|26389005|FG001|Overall Study|Withdrawal by Subject|4|||
13257271|NCT01505114|26389006|FG002|Overall Study|Withdrawal by Subject|4|||
13257272|NCT01505114|26389007|FG003|Overall Study|Withdrawal by Subject|7|||
13257273|NCT01505114|26389004|FG000|Overall Study|Death|1|||
13257274|NCT01505114|26389005|FG001|Overall Study|Death|0|||
13257275|NCT01505114|26389006|FG002|Overall Study|Death|0|||
13257276|NCT01505114|26389007|FG003|Overall Study|Death|1|||
13257277|NCT01505114|26389004|FG000|Overall Study|unable to adhere to visit schedule|3|||
13257278|NCT01505114|26389005|FG001|Overall Study|unable to adhere to visit schedule|2|||
13257279|NCT01505114|26389006|FG002|Overall Study|unable to adhere to visit schedule|3|||
13257280|NCT01505114|26389007|FG003|Overall Study|unable to adhere to visit schedule|3|||
13257281|NCT01505114|26389004|FG000|Overall Study|Lost to Follow-up|11|||
13257282|NCT01505114|26389005|FG001|Overall Study|Lost to Follow-up|5|||
13257283|NCT01505114|26389006|FG002|Overall Study|Lost to Follow-up|8|||
13257284|NCT01505114|26389007|FG003|Overall Study|Lost to Follow-up|7|||
13257285|NCT01505114|26389004|FG000|Overall Study|relocated|4|||
13257286|NCT01505114|26389005|FG001|Overall Study|relocated|2|||
13257287|NCT01505114|26389006|FG002|Overall Study|relocated|2|||
13257288|NCT01505114|26389007|FG003|Overall Study|relocated|3|||
13257289|NCT01505114|26389004|FG000|Overall Study|inadvertent enrollment due to peanut all|0|||
13257290|NCT01505114|26389005|FG001|Overall Study|inadvertent enrollment due to peanut all|0|||
13257291|NCT01505114|26389006|FG002|Overall Study|inadvertent enrollment due to peanut all|0|||
13257292|NCT01505114|26389007|FG003|Overall Study|inadvertent enrollment due to peanut all|1|||
13257293|NCT01505114|26389004|FG000|Overall Study|staff safety concerns|0|||
13257294|NCT01505114|26389005|FG001|Overall Study|staff safety concerns|0|||
13257295|NCT01505114|26389006|FG002|Overall Study|staff safety concerns|0|||
13257296|NCT01505114|26389007|FG003|Overall Study|staff safety concerns|1|||
13257297|NCT01505114|26389004|FG000|Overall Study|investigator decision|1|||
13257298|NCT01505114|26389005|FG001|Overall Study|investigator decision|0|||
13257299|NCT01505114|26389006|FG002|Overall Study|investigator decision|1|||
13257300|NCT01505114|26389007|FG003|Overall Study|investigator decision|0|||
13257301|NCT01505010|26389024|FG000|Overall Study|Protocol Violation|0|||
13257302|NCT01505010|26389025|FG001|Overall Study|Protocol Violation|1|||
13257303|NCT01505010|26389024|FG000|Overall Study|Lost to Follow-up|0|||
13257304|NCT01505010|26389025|FG001|Overall Study|Lost to Follow-up|1|||
13257305|NCT01504971|26389035|FG000|Overall Study|Physician Decision|13|||
13257306|NCT01504867|26389060|FG000|Overall Study|Inclusion criteria not met|2|||
13257307|NCT01504867|26389061|FG001|Overall Study|Inclusion criteria not met|2|||
13257308|NCT01504867|26389060|FG000|Overall Study|Consent revoked|5|||
13257309|NCT01504867|26389061|FG001|Overall Study|Consent revoked|1|||
13257310|NCT01504841|26389104|FG000|Overall Study|Withdrawal by Subject|1|||
13257311|NCT01504841|26389105|FG001|Overall Study|Withdrawal by Subject|1|||
13257312|NCT01504841|26389106|FG002|Overall Study|Withdrawal by Subject|0|||
13257313|NCT01504412|26389139|FG000|Overall Study|Adverse Event|1|||
13257314|NCT01504412|26389140|FG001|Overall Study|Adverse Event|8|||
13257315|NCT01504412|26389141|FG002|Overall Study|Adverse Event|1|||
13257316|NCT01504412|26389142|FG003|Overall Study|Adverse Event|7|||
13257317|NCT01504412|26389143|FG004|Overall Study|Adverse Event|10|||
13257318|NCT01504412|26389139|FG000|Overall Study|Withdrawal by Subject|2|||
13257319|NCT01504412|26389140|FG001|Overall Study|Withdrawal by Subject|1|||
13257320|NCT01504412|26389141|FG002|Overall Study|Withdrawal by Subject|1|||
13257321|NCT01504412|26389142|FG003|Overall Study|Withdrawal by Subject|5|||
13257322|NCT01504412|26389143|FG004|Overall Study|Withdrawal by Subject|1|||
13257323|NCT01504412|26389139|FG000|Overall Study|Other|2|||
13257324|NCT01504412|26389140|FG001|Overall Study|Other|1|||
13257325|NCT01504412|26389141|FG002|Overall Study|Other|1|||
13257326|NCT01504412|26389142|FG003|Overall Study|Other|6|||
13257327|NCT01504412|26389143|FG004|Overall Study|Other|1|||
13257328|NCT01504412|26389139|FG000|Overall Study|Lost to Follow-up|0|||
13257329|NCT01504412|26389140|FG001|Overall Study|Lost to Follow-up|2|||
13257330|NCT01504412|26389141|FG002|Overall Study|Lost to Follow-up|0|||
13257331|NCT01504412|26389142|FG003|Overall Study|Lost to Follow-up|0|||
13257332|NCT01504412|26389143|FG004|Overall Study|Lost to Follow-up|0|||
13257333|NCT01504412|26389139|FG000|Overall Study|Lack of Efficacy|0|||
13257334|NCT01504412|26389140|FG001|Overall Study|Lack of Efficacy|0|||
13257335|NCT01504412|26389141|FG002|Overall Study|Lack of Efficacy|1|||
13257336|NCT01504412|26389142|FG003|Overall Study|Lack of Efficacy|0|||
13257337|NCT01504412|26389143|FG004|Overall Study|Lack of Efficacy|1|||
13257338|NCT01504412|26389139|FG000|Overall Study|Death|0|||
13257339|NCT01504412|26389140|FG001|Overall Study|Death|0|||
13257340|NCT01504412|26389141|FG002|Overall Study|Death|0|||
13257341|NCT01504412|26389142|FG003|Overall Study|Death|1|||
13257342|NCT01504412|26389143|FG004|Overall Study|Death|0|||
13257343|NCT01504204|26389160|FG000|Overall Study|Lost to Follow-up|1|||
13257344|NCT01504204|26389161|FG001|Overall Study|Lost to Follow-up|1|||
13257345|NCT01503229|26389167|FG000|Overall Study|Withdrew consent|1|||
13257346|NCT01503164|26389202|FG000|Overall Study|Withdrawal by Subject|2|||
13257347|NCT01503164|26389203|FG001|Overall Study|Withdrawal by Subject|1|||
13257348|NCT01503021|26389257|FG000|Overall Study|Adverse Event|7|||
13257349|NCT01503021|26389258|FG001|Overall Study|Adverse Event|6|||
13257350|NCT01503021|26389257|FG000|Overall Study|Death|0|||
13257351|NCT01503021|26389258|FG001|Overall Study|Death|2|||
13257352|NCT01503021|26389257|FG000|Overall Study|Lost to Follow-up|2|||
13257353|NCT01503021|26389258|FG001|Overall Study|Lost to Follow-up|0|||
13257354|NCT01503021|26389257|FG000|Overall Study|Physician Decision|3|||
13257355|NCT01503021|26389258|FG001|Overall Study|Physician Decision|0|||
13257356|NCT01503021|26389257|FG000|Overall Study|Protocol Violation|1|||
13257357|NCT01503021|26389258|FG001|Overall Study|Protocol Violation|3|||
13257358|NCT01503021|26389257|FG000|Overall Study|Withdrawal by Subject|9|||
13257359|NCT01503021|26389258|FG001|Overall Study|Withdrawal by Subject|8|||
13257360|NCT01503021|26389257|FG000|Overall Study|Moved, received transplant, etc.|5|||
13257361|NCT01503021|26389258|FG001|Overall Study|Moved, received transplant, etc.|7|||
13257362|NCT01502956|26389289|FG000|Overall Study|Death|0|||
13257363|NCT01502956|26389290|FG001|Overall Study|Death|2|||
13257364|NCT01502956|26389289|FG000|Overall Study|Lost to Follow-up|14|||
13257365|NCT01502956|26389290|FG001|Overall Study|Lost to Follow-up|11|||
13257366|NCT01502956|26389289|FG000|Overall Study|Physician Decision|2|||
13257367|NCT01502956|26389290|FG001|Overall Study|Physician Decision|3|||
13257368|NCT01502956|26389289|FG000|Overall Study|Withdrawal by Subject|8|||
13257369|NCT01502956|26389290|FG001|Overall Study|Withdrawal by Subject|10|||
13257370|NCT01502709|26389307|FG000|Overall Study|Lost to Follow-up|4|||
13257371|NCT01502709|26389308|FG001|Overall Study|Lost to Follow-up|0|||
13257372|NCT01502644|26389327|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1|||
13257373|NCT01502644|26389328|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
13257374|NCT01502644|26389329|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
13257375|NCT01502644|26389330|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
13257376|NCT01502644|26389327|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2|||
13257377|NCT01502644|26389328|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
13257378|NCT01502644|26389329|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
13257379|NCT01502644|26389330|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
13257380|NCT01502644|26389327|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6|||
13257381|NCT01502644|26389328|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
13257382|NCT01502644|26389329|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
13257383|NCT01502644|26389330|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
13257384|NCT01502644|26389327|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0|||
13257385|NCT01502644|26389328|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6|||
13257386|NCT01502644|26389329|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2|||
13257387|NCT01502644|26389330|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7|||
13257388|NCT01502644|26389327|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
13257389|NCT01502644|26389328|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
13257390|NCT01502644|26389329|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
13257391|NCT01502644|26389330|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
13257392|NCT01502631|26389355|FG000|Overall Study|Adverse Event|5|||
13257393|NCT01502631|26389356|FG001|Overall Study|Adverse Event|8|||
13257394|NCT01502631|26389355|FG000|Overall Study|Lost to Follow-up|2|||
13257395|NCT01502631|26389356|FG001|Overall Study|Lost to Follow-up|2|||
13257396|NCT01502631|26389355|FG000|Overall Study|Participant withdrew consent|2|||
13257397|NCT01502631|26389356|FG001|Overall Study|Participant withdrew consent|4|||
13257398|NCT01502631|26389355|FG000|Overall Study|Participant non-compliant|1|||
13257399|NCT01502631|26389356|FG001|Overall Study|Participant non-compliant|0|||
13257400|NCT01502631|26389355|FG000|Overall Study|Investigator's decision|0|||
13257401|NCT01502631|26389356|FG001|Overall Study|Investigator's decision|1|||
13257402|NCT01502631|26389355|FG000|Overall Study|Other|10|||
13257403|NCT01502631|26389356|FG001|Overall Study|Other|5|||
13257404|NCT01502423|26389381|FG000|Overall Study|Withdrawal by Subject|0|||
13257405|NCT01502423|26389382|FG001|Overall Study|Withdrawal by Subject|1|||
13257406|NCT01502410|26389408|FG000|Overall Study|Adverse Event|1|||
13257407|NCT01502410|26389409|FG001|Overall Study|Adverse Event|2|||
13257408|NCT01502410|26389410|FG002|Overall Study|Adverse Event|0|||
13257409|NCT01502410|26389411|FG003|Overall Study|Adverse Event|0|||
13257410|NCT01502410|26389408|FG000|Overall Study|Lack of Efficacy|7|||
13257411|NCT01502410|26389409|FG001|Overall Study|Lack of Efficacy|7|||
13257412|NCT01502410|26389410|FG002|Overall Study|Lack of Efficacy|0|||
13257413|NCT01502410|26389411|FG003|Overall Study|Lack of Efficacy|0|||
13257414|NCT01502410|26389408|FG000|Overall Study|Physician Decision|0|||
13257415|NCT01502410|26389409|FG001|Overall Study|Physician Decision|1|||
13257416|NCT01502410|26389410|FG002|Overall Study|Physician Decision|0|||
13257417|NCT01502410|26389411|FG003|Overall Study|Physician Decision|0|||
13257418|NCT01502410|26389408|FG000|Overall Study|Withdrawal by Subject|2|||
13257419|NCT01502410|26389409|FG001|Overall Study|Withdrawal by Subject|0|||
13257420|NCT01502410|26389410|FG002|Overall Study|Withdrawal by Subject|0|||
13257421|NCT01502410|26389411|FG003|Overall Study|Withdrawal by Subject|0|||
13257422|NCT01502371|26389450|FG000|Overall Study|Withdrawal by Subject|1|||
13257423|NCT01502371|26389451|FG001|Overall Study|Withdrawal by Subject|2|||
13257424|NCT01502371|26389452|FG002|Overall Study|Withdrawal by Subject|1|||
13257425|NCT01502371|26389453|FG003|Overall Study|Withdrawal by Subject|1|||
13257426|NCT01502371|26389454|FG004|Overall Study|Withdrawal by Subject|1|||
13257427|NCT01502371|26389450|FG000|Overall Study|Adverse Event|2|||
13257428|NCT01502371|26389451|FG001|Overall Study|Adverse Event|1|||
13257429|NCT01502371|26389452|FG002|Overall Study|Adverse Event|0|||
13257430|NCT01502371|26389453|FG003|Overall Study|Adverse Event|4|||
13257431|NCT01502371|26389454|FG004|Overall Study|Adverse Event|3|||
13257432|NCT01502371|26389450|FG000|Overall Study|Treatment Failure|22|||
13257433|NCT01502371|26389451|FG001|Overall Study|Treatment Failure|20|||
13257434|NCT01502371|26389452|FG002|Overall Study|Treatment Failure|12|||
13257435|NCT01502371|26389453|FG003|Overall Study|Treatment Failure|19|||
13257436|NCT01502371|26389454|FG004|Overall Study|Treatment Failure|30|||
13257437|NCT01502371|26389450|FG000|Overall Study|Lack of Efficacy|3|||
13257438|NCT01502371|26389451|FG001|Overall Study|Lack of Efficacy|3|||
13257439|NCT01502371|26389452|FG002|Overall Study|Lack of Efficacy|2|||
13257440|NCT01502371|26389453|FG003|Overall Study|Lack of Efficacy|2|||
13257441|NCT01502371|26389454|FG004|Overall Study|Lack of Efficacy|4|||
13257442|NCT01502371|26389450|FG000|Overall Study|Physician Decision|3|||
13257443|NCT01502371|26389451|FG001|Overall Study|Physician Decision|0|||
13257444|NCT01502371|26389452|FG002|Overall Study|Physician Decision|0|||
13257445|NCT01502371|26389453|FG003|Overall Study|Physician Decision|0|||
13257446|NCT01502371|26389454|FG004|Overall Study|Physician Decision|1|||
13257447|NCT01502371|26389450|FG000|Overall Study|Noncompliance with Study Drug|0|||
13257448|NCT01502371|26389451|FG001|Overall Study|Noncompliance with Study Drug|0|||
13257449|NCT01502371|26389452|FG002|Overall Study|Noncompliance with Study Drug|1|||
13257450|NCT01502371|26389453|FG003|Overall Study|Noncompliance with Study Drug|2|||
13257451|NCT01502371|26389454|FG004|Overall Study|Noncompliance with Study Drug|1|||
13257452|NCT01502371|26389450|FG000|Overall Study|Technical Problems|1|||
13257453|NCT01502371|26389451|FG001|Overall Study|Technical Problems|0|||
13257454|NCT01502371|26389452|FG002|Overall Study|Technical Problems|2|||
13257455|NCT01502371|26389453|FG003|Overall Study|Technical Problems|4|||
13257456|NCT01502371|26389454|FG004|Overall Study|Technical Problems|1|||
13257457|NCT01502371|26389450|FG000|Overall Study|Protocol Violation|9|||
13257458|NCT01502371|26389451|FG001|Overall Study|Protocol Violation|5|||
13257459|NCT01502371|26389452|FG002|Overall Study|Protocol Violation|6|||
13257460|NCT01502371|26389453|FG003|Overall Study|Protocol Violation|5|||
13257461|NCT01502371|26389454|FG004|Overall Study|Protocol Violation|10|||
13257462|NCT01502371|26389450|FG000|Overall Study|Excluded Medication|0|||
13257463|NCT01502371|26389451|FG001|Overall Study|Excluded Medication|1|||
13257464|NCT01502371|26389452|FG002|Overall Study|Excluded Medication|1|||
13257465|NCT01502371|26389453|FG003|Overall Study|Excluded Medication|0|||
13257466|NCT01502371|26389454|FG004|Overall Study|Excluded Medication|1|||
13257467|NCT01502293|26389493|FG000|Overall Study|Progressive Disease|20|||
13257468|NCT01502293|26389494|FG001|Overall Study|Progressive Disease|12|||
13257469|NCT01502293|26389495|FG002|Overall Study|Progressive Disease|2|||
13257470|NCT01502293|26389493|FG000|Overall Study|Withdrawal by Subject|3|||
13257471|NCT01502293|26389494|FG001|Overall Study|Withdrawal by Subject|3|||
13257472|NCT01502293|26389495|FG002|Overall Study|Withdrawal by Subject|1|||
13257473|NCT01502293|26389493|FG000|Overall Study|Adverse Event|0|||
13257474|NCT01502293|26389494|FG001|Overall Study|Adverse Event|2|||
13257475|NCT01502293|26389495|FG002|Overall Study|Adverse Event|0|||
13257476|NCT01502293|26389493|FG000|Overall Study|Reason Not Specified|2|||
13257477|NCT01502293|26389494|FG001|Overall Study|Reason Not Specified|0|||
13257478|NCT01502293|26389495|FG002|Overall Study|Reason Not Specified|0|||
13257479|NCT01502293|26389493|FG000|Overall Study|Physician Decision|0|||
13257480|NCT01502293|26389494|FG001|Overall Study|Physician Decision|0|||
13257481|NCT01502293|26389495|FG002|Overall Study|Physician Decision|1|||
13257482|NCT01502228|26389502|FG000|Overall Study|Death|1|||
13257483|NCT01502072|26389520|FG000|Overall Study|Withdrawal by Subject|1|||
13257484|NCT01502072|26389521|FG001|Overall Study|Withdrawal by Subject|0|||
13257485|NCT01502072|26389522|FG002|Overall Study|Withdrawal by Subject|0|||
13257486|NCT01502072|26389520|FG000|Overall Study|Death|0|||
13257487|NCT01502072|26389521|FG001|Overall Study|Death|1|||
13257488|NCT01502072|26389522|FG002|Overall Study|Death|0|||
13257489|NCT01502033|26389530|FG000|Overall Study|1 participant had scalp discomfort|1|||
13257490|NCT01502033|26389530|FG000|Overall Study|1 participant had worsening depression|1|||
13257491|NCT01502033|26389530|FG000|Overall Study|1 participant went back to school|1|||
13257492|NCT01501110|26389543|FG000|Overall Study|Death|0|||
13257493|NCT01501110|26389544|FG001|Overall Study|Death|1|||
13257494|NCT01500720|26389563|FG000|Overall Study|Randomized But Not Treated|1|||
13257495|NCT01500720|26389564|FG001|Overall Study|Randomized But Not Treated|1|||
13257496|NCT01500720|26389563|FG000|Overall Study|Other|4|||
13257497|NCT01500720|26389564|FG001|Overall Study|Other|8|||
13257498|NCT01500694|26389595|FG000|Overall Study|Adverse Event|4|||
13257499|NCT01500694|26389596|FG001|Overall Study|Adverse Event|3|||
13257500|NCT01500694|26389595|FG000|Overall Study|Protocol Violation|0|||
13257501|NCT01500694|26389596|FG001|Overall Study|Protocol Violation|1|||
13257502|NCT01500694|26389595|FG000|Overall Study|Withdrawal by Subject|23|||
13257503|NCT01500694|26389596|FG001|Overall Study|Withdrawal by Subject|14|||
13257504|NCT01500694|26389595|FG000|Overall Study|Lost to Follow-up|2|||
13257505|NCT01500694|26389596|FG001|Overall Study|Lost to Follow-up|3|||
13257506|NCT01500694|26389595|FG000|Overall Study|Lack of Efficacy|14|||
13257507|NCT01500694|26389596|FG001|Overall Study|Lack of Efficacy|5|||
13257508|NCT01500694|26389595|FG000|Overall Study|Other|9|||
13257509|NCT01500694|26389596|FG001|Overall Study|Other|3|||
13257510|NCT01500629|26389687|FG000|Washout Period of 14 to 30 Days|Pregnancy|1|||
13257511|NCT01500629|26389688|FG001|Washout Period of 14 to 30 Days|Pregnancy|0|||
13290386|NCT00102804|26481116|FG000|Overall Study|Progressive Disease (PD)|307|||
13290387|NCT00102804|26481117|FG001|Overall Study|Progressive Disease (PD)|196|||
13290388|NCT00102804|26481116|FG000|Overall Study|Withdrawal by Subject|46|||
13290389|NCT00102804|26481117|FG001|Overall Study|Withdrawal by Subject|7|||
13290390|NCT00102804|26481116|FG000|Overall Study|Adverse Event|37|||
13290391|NCT00102804|26481117|FG001|Overall Study|Adverse Event|3|||
13290392|NCT00102804|26481116|FG000|Overall Study|Physician Decision|24|||
13290393|NCT00102804|26481117|FG001|Overall Study|Physician Decision|6|||
13290394|NCT00102804|26481116|FG000|Overall Study|Death|5|||
13290395|NCT00102804|26481117|FG001|Overall Study|Death|6|||
13290396|NCT00102804|26481116|FG000|Overall Study|Enrollment Criteria Not Met|6|||
13290397|NCT00102804|26481117|FG001|Overall Study|Enrollment Criteria Not Met|0|||
13290398|NCT00102804|26481116|FG000|Overall Study|Lost to Follow-up|4|||
13290399|NCT00102804|26481117|FG001|Overall Study|Lost to Follow-up|1|||
13290400|NCT00102804|26481116|FG000|Overall Study|Protocol Violation|2|||
13290401|NCT00102804|26481117|FG001|Overall Study|Protocol Violation|1|||
13290402|NCT00102804|26481116|FG000|Overall Study|Satisfactory Response|2|||
13290403|NCT00102804|26481117|FG001|Overall Study|Satisfactory Response|0|||
13290404|NCT00102804|26481116|FG000|Overall Study|Sponsor Decision|1|||
13290405|NCT00102804|26481117|FG001|Overall Study|Sponsor Decision|0|||
13290406|NCT00102804|26481116|FG000|Overall Study|Alive, Receiving Treatment|7|||
13290407|NCT00102804|26481117|FG001|Overall Study|Alive, Receiving Treatment|2|||
13290408|NCT00102687|26481193|FG000|Initial Period|Withdrawal by Subject|6|||
13290409|NCT00102687|26481194|FG001|Initial Period|Withdrawal by Subject|3|||
13290410|NCT00102687|26481195|FG002|Initial Period|Withdrawal by Subject|5|||
13290411|NCT00102687|26481196|FG003|Initial Period|Withdrawal by Subject|0|||
13290412|NCT00102687|26481197|FG004|Initial Period|Withdrawal by Subject|0|||
13290413|NCT00102687|26481193|FG000|Initial Period|Adverse Event|4|||
13290414|NCT00102687|26481194|FG001|Initial Period|Adverse Event|7|||
13290415|NCT00102687|26481195|FG002|Initial Period|Adverse Event|9|||
13290416|NCT00102687|26481196|FG003|Initial Period|Adverse Event|0|||
13290417|NCT00102687|26481197|FG004|Initial Period|Adverse Event|0|||
13290418|NCT00102687|26481193|FG000|Initial Period|Transformation to AML (blast > 30%)|1|||
13290419|NCT00102687|26481194|FG001|Initial Period|Transformation to AML (blast > 30%)|3|||
13290420|NCT00102687|26481195|FG002|Initial Period|Transformation to AML (blast > 30%)|0|||
13290421|NCT00102687|26481196|FG003|Initial Period|Transformation to AML (blast > 30%)|0|||
13290422|NCT00102687|26481197|FG004|Initial Period|Transformation to AML (blast > 30%)|0|||
13290423|NCT00102687|26481193|FG000|Initial Period|Protocol Violation|0|||
13290424|NCT00102687|26481194|FG001|Initial Period|Protocol Violation|0|||
13290425|NCT00102687|26481195|FG002|Initial Period|Protocol Violation|2|||
13290426|NCT00102687|26481196|FG003|Initial Period|Protocol Violation|0|||
13290427|NCT00102687|26481197|FG004|Initial Period|Protocol Violation|0|||
13290428|NCT00102687|26481193|FG000|Initial Period|Physician Decision|2|||
13290429|NCT00102687|26481194|FG001|Initial Period|Physician Decision|9|||
13290430|NCT00102687|26481195|FG002|Initial Period|Physician Decision|6|||
13290431|NCT00102687|26481196|FG003|Initial Period|Physician Decision|0|||
13290432|NCT00102687|26481197|FG004|Initial Period|Physician Decision|0|||
13290433|NCT00102687|26481193|FG000|Initial Period|Sponsor's decision|0|||
13290434|NCT00102687|26481194|FG001|Initial Period|Sponsor's decision|1|||
13290435|NCT00102687|26481195|FG002|Initial Period|Sponsor's decision|1|||
13290436|NCT00102687|26481196|FG003|Initial Period|Sponsor's decision|0|||
13290437|NCT00102687|26481197|FG004|Initial Period|Sponsor's decision|0|||
13290438|NCT00102687|26481193|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4|||
13290439|NCT00102687|26481194|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4|||
13290440|NCT00102687|26481195|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2|||
13290441|NCT00102687|26481196|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0|||
13290442|NCT00102687|26481197|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0|||
13290443|NCT00102687|26481193|FG000|Initial Period|Death|1|||
13290444|NCT00102687|26481194|FG001|Initial Period|Death|1|||
13290445|NCT00102687|26481195|FG002|Initial Period|Death|1|||
13290446|NCT00102687|26481196|FG003|Initial Period|Death|0|||
13290447|NCT00102687|26481197|FG004|Initial Period|Death|0|||
13290448|NCT00102687|26481193|FG000|Maintenance Period|Withdrawal by Subject|4|||
13290449|NCT00102687|26481194|FG001|Maintenance Period|Withdrawal by Subject|0|||
13290450|NCT00102687|26481195|FG002|Maintenance Period|Withdrawal by Subject|2|||
13290451|NCT00102687|26481196|FG003|Maintenance Period|Withdrawal by Subject|3|||
13257512|NCT01500434|26389719|FG000|Overall Study|Death|1|||
13257513|NCT01500434|26389719|FG000|Overall Study|Withdrawal by Subject|1|||
13257514|NCT01500434|26389719|FG000|Overall Study|Missed 12-month follow-up|5|||
13257515|NCT01500382|26389754|FG000|Washout Period|Study site went out of business|0|||
13257516|NCT01500382|26389755|FG001|Washout Period|Study site went out of business|0|||
13257517|NCT01500382|26389756|FG002|Washout Period|Study site went out of business|1|||
13257518|NCT01500382|26389757|FG003|Washout Period|Study site went out of business|0|||
13257519|NCT01500317|26389787|FG000|Overall Study|Withdrawal by Subject|3|||
13257520|NCT01500317|26389788|FG001|Overall Study|Withdrawal by Subject|2|||
13257521|NCT01500317|26389789|FG002|Overall Study|Withdrawal by Subject|0|||
13257522|NCT01500278|26389818|FG000|Week 0 - Week 12|Lack of Efficacy|0|||
13257523|NCT01500278|26389819|FG001|Week 0 - Week 12|Lack of Efficacy|1|||
13257524|NCT01500278|26389818|FG000|Week 0 - Week 12|Protocol Violation|10|||
13257525|NCT01500278|26389819|FG001|Week 0 - Week 12|Protocol Violation|16|||
13257526|NCT01500278|26389818|FG000|Week 0 - Week 12|Lost to Follow-up|1|||
13257527|NCT01500278|26389819|FG001|Week 0 - Week 12|Lost to Follow-up|1|||
13257528|NCT01500278|26389818|FG000|Week 0 - Week 12|Withdrawal by Subject|7|||
13257529|NCT01500278|26389819|FG001|Week 0 - Week 12|Withdrawal by Subject|2|||
13257530|NCT01500278|26389818|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1|||
13257531|NCT01500278|26389819|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0|||
13257532|NCT01500278|26389818|FG000|Week 0 - Week 12|Patient decision|1|||
13257533|NCT01500278|26389819|FG001|Week 0 - Week 12|Patient decision|0|||
13257534|NCT01500278|26389818|FG000|Week 0 - Week 12|Exclusion criteria not met|1|||
13257535|NCT01500278|26389819|FG001|Week 0 - Week 12|Exclusion criteria not met|0|||
13257536|NCT01500278|26389818|FG000|Week 0 - Week 12|Investigator decision|1|||
13257537|NCT01500278|26389819|FG001|Week 0 - Week 12|Investigator decision|0|||
13257538|NCT01500278|26389818|FG000|Week 0 - Week 12|Prior history of serious disease|1|||
13257539|NCT01500278|26389819|FG001|Week 0 - Week 12|Prior history of serious disease|0|||
13257540|NCT01500278|26389818|FG000|Week 0 - Week 12|Sponsor decision|1|||
13257541|NCT01500278|26389819|FG001|Week 0 - Week 12|Sponsor decision|0|||
13203477|NCT01985334|26224756|FG006|Overall Study|Subject withdrawal of consent|0|||
13203478|NCT01985334|26224757|FG007|Overall Study|Subject withdrawal of consent|20|||
13203479|NCT01985334|26224750|FG000|Overall Study|Adverse Event|0|||
13203480|NCT01985334|26224751|FG001|Overall Study|Adverse Event|8|||
13203481|NCT01985334|26224752|FG002|Overall Study|Adverse Event|2|||
13203482|NCT01985334|26224753|FG003|Overall Study|Adverse Event|26|||
13203483|NCT01985334|26224754|FG004|Overall Study|Adverse Event|3|||
13203484|NCT01985334|26224755|FG005|Overall Study|Adverse Event|18|||
13203485|NCT01985334|26224756|FG006|Overall Study|Adverse Event|3|||
13257542|NCT01500278|26389818|FG000|Week 0 - Week 12|Personal reason|0|||
13257543|NCT01500278|26389819|FG001|Week 0 - Week 12|Personal reason|1|||
13257544|NCT01500278|26389818|FG000|Week 0 - Week 12|Other serious disease|0|||
13257545|NCT01500278|26389819|FG001|Week 0 - Week 12|Other serious disease|1|||
13257546|NCT01500278|26389818|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7|||
13257547|NCT01500278|26389819|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8|||
13257548|NCT01500278|26389818|FG000|Week 13 - Week 104|Lack of Efficacy|11|||
13257549|NCT01500278|26389819|FG001|Week 13 - Week 104|Lack of Efficacy|12|||
13257550|NCT01500278|26389818|FG000|Week 13 - Week 104|Protocol Violation|6|||
13257551|NCT01500278|26389819|FG001|Week 13 - Week 104|Protocol Violation|6|||
13257552|NCT01500278|26389818|FG000|Week 13 - Week 104|Lost to Follow-up|6|||
13257553|NCT01500278|26389819|FG001|Week 13 - Week 104|Lost to Follow-up|5|||
13257554|NCT01500278|26389818|FG000|Week 13 - Week 104|Withdrawal by Subject|22|||
13257555|NCT01500278|26389819|FG001|Week 13 - Week 104|Withdrawal by Subject|13|||
13257556|NCT01500278|26389818|FG000|Week 13 - Week 104|Week 24 Non-Responder|20|||
13257557|NCT01500278|26389819|FG001|Week 13 - Week 104|Week 24 Non-Responder|16|||
13257558|NCT01500278|26389818|FG000|Week 13 - Week 104|Non/bad compliance|7|||
13257559|NCT01500278|26389819|FG001|Week 13 - Week 104|Non/bad compliance|5|||
13257560|NCT01500278|26389818|FG000|Week 13 - Week 104|Recurrent infections|1|||
13257561|NCT01500278|26389819|FG001|Week 13 - Week 104|Recurrent infections|0|||
13257562|NCT01500278|26389818|FG000|Week 13 - Week 104|False positive test|1|||
13257563|NCT01500278|26389819|FG001|Week 13 - Week 104|False positive test|2|||
13257564|NCT01500278|26389818|FG000|Week 13 - Week 104|Sponsor request|4|||
13257565|NCT01500278|26389819|FG001|Week 13 - Week 104|Sponsor request|0|||
13257566|NCT01500278|26389818|FG000|Week 13 - Week 104|Withdrawn in error|1|||
13257567|NCT01500278|26389819|FG001|Week 13 - Week 104|Withdrawn in error|0|||
13257568|NCT01500278|26389818|FG000|Week 13 - Week 104|Exclusion criteria not met|1|||
13257569|NCT01500278|26389819|FG001|Week 13 - Week 104|Exclusion criteria not met|0|||
13257570|NCT01500278|26389818|FG000|Week 13 - Week 104|Protocol deviation|1|||
13257571|NCT01500278|26389819|FG001|Week 13 - Week 104|Protocol deviation|0|||
13257572|NCT01500278|26389818|FG000|Week 13 - Week 104|Principal investigator retiring|1|||
13257573|NCT01500278|26389819|FG001|Week 13 - Week 104|Principal investigator retiring|0|||
13257574|NCT01500278|26389818|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1|||
13257575|NCT01500278|26389819|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0|||
13257576|NCT01500278|26389818|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0|||
13257577|NCT01500278|26389819|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2|||
13257578|NCT01500278|26389818|FG000|Week 13 - Week 104|Relocation|0|||
13257579|NCT01500278|26389819|FG001|Week 13 - Week 104|Relocation|1|||
13257580|NCT01500278|26389818|FG000|Week 13 - Week 104|Sponsor decision|0|||
13257581|NCT01500278|26389819|FG001|Week 13 - Week 104|Sponsor decision|2|||
13257582|NCT01500278|26389818|FG000|Week 13 - Week 104|Medical monitor decision|0|||
13257583|NCT01500278|26389819|FG001|Week 13 - Week 104|Medical monitor decision|2|||
13257584|NCT01500278|26389818|FG000|Week 13 - Week 104|Personal reason|0|||
13257585|NCT01500278|26389819|FG001|Week 13 - Week 104|Personal reason|1|||
13257586|NCT01500278|26389818|FG000|Week 13 - Week 104|Not completed|0|||
13257587|NCT01500278|26389819|FG001|Week 13 - Week 104|Not completed|1|||
13257588|NCT01500278|26389818|FG000|Week 13 - Week 104|Death|2|||
13257589|NCT01500278|26389819|FG001|Week 13 - Week 104|Death|4|||
13257590|NCT01500278|26389818|FG000|Week 13 - Week 104|Adverse Event|54|||
13257591|NCT01500278|26389819|FG001|Week 13 - Week 104|Adverse Event|54|||
13257592|NCT01500252|26389850|FG000|Overall Study|Death|4|||
13257593|NCT01500252|26389851|FG001|Overall Study|Death|2|||
13257594|NCT01500252|26389850|FG000|Overall Study|Lost to Follow-up|5|||
13257595|NCT01500252|26389851|FG001|Overall Study|Lost to Follow-up|4|||
13257596|NCT01500226|26389868|FG000|Overall Study|Adverse Event|31|||
13257597|NCT01500226|26389869|FG001|Overall Study|Adverse Event|38|||
13257598|NCT01500226|26389868|FG000|Overall Study|Chemo Completed or Change in Therapy|235|||
13257599|NCT01500226|26389869|FG001|Overall Study|Chemo Completed or Change in Therapy|237|||
13257600|NCT01500226|26389868|FG000|Overall Study|Withdrawal by Subject|93|||
13257601|NCT01500226|26389869|FG001|Overall Study|Withdrawal by Subject|96|||
13257602|NCT01500226|26389868|FG000|Overall Study|Death|12|||
13257603|NCT01500226|26389869|FG001|Overall Study|Death|4|||
13257604|NCT01500226|26389868|FG000|Overall Study|Disease Progression|16|||
13257605|NCT01500226|26389869|FG001|Overall Study|Disease Progression|14|||
13257606|NCT01500226|26389868|FG000|Overall Study|Protocol Violation|53|||
13257607|NCT01500226|26389869|FG001|Overall Study|Protocol Violation|39|||
13257608|NCT01500226|26389868|FG000|Overall Study|Physician Decision|17|||
13257609|NCT01500226|26389869|FG001|Overall Study|Physician Decision|15|||
13257610|NCT01500226|26389868|FG000|Overall Study|Lack of Efficacy|14|||
13257611|NCT01500226|26389869|FG001|Overall Study|Lack of Efficacy|30|||
13257612|NCT01500226|26389868|FG000|Overall Study|Lost to Follow-up|9|||
13257613|NCT01500226|26389869|FG001|Overall Study|Lost to Follow-up|5|||
13257614|NCT01500226|26389868|FG000|Overall Study|Other Reasons|19|||
13257615|NCT01500226|26389869|FG001|Overall Study|Other Reasons|16|||
13257616|NCT01500213|26389886|FG000|Overall Study|Adverse Event|35|||
13257617|NCT01500213|26389887|FG001|Overall Study|Adverse Event|35|||
13257618|NCT01500213|26389886|FG000|Overall Study|Chemo Completed or Change in Therapy|84|||
13257619|NCT01500213|26389887|FG001|Overall Study|Chemo Completed or Change in Therapy|81|||
13257620|NCT01500213|26389886|FG000|Overall Study|Withdrawal by Subject|28|||
13257621|NCT01500213|26389887|FG001|Overall Study|Withdrawal by Subject|37|||
13257622|NCT01500213|26389886|FG000|Overall Study|Death|7|||
13257623|NCT01500213|26389887|FG001|Overall Study|Death|3|||
13257624|NCT01500213|26389886|FG000|Overall Study|Disease Progression|13|||
13257625|NCT01500213|26389887|FG001|Overall Study|Disease Progression|21|||
13257626|NCT01500213|26389886|FG000|Overall Study|Protocol Violation|19|||
13257627|NCT01500213|26389887|FG001|Overall Study|Protocol Violation|19|||
13257628|NCT01500213|26389886|FG000|Overall Study|Physician Decision|12|||
13257629|NCT01500213|26389887|FG001|Overall Study|Physician Decision|10|||
13257630|NCT01500213|26389886|FG000|Overall Study|Lack of Efficacy|9|||
13257631|NCT01500213|26389887|FG001|Overall Study|Lack of Efficacy|7|||
13257632|NCT01500213|26389886|FG000|Overall Study|Lost to Follow-up|3|||
13257633|NCT01500213|26389887|FG001|Overall Study|Lost to Follow-up|6|||
13257634|NCT01500213|26389886|FG000|Overall Study|Other Reasons|7|||
13257635|NCT01500213|26389887|FG001|Overall Study|Other Reasons|5|||
13257636|NCT01500200|26389932|FG000|Stage 1|Adverse Event|1|||
13257637|NCT01500200|26389933|FG001|Stage 1|Adverse Event|4|||
13257638|NCT01500200|26389934|FG002|Stage 1|Adverse Event|5|||
13257639|NCT01500200|26389935|FG003|Stage 1|Adverse Event|0|||
13257640|NCT01500200|26389936|FG004|Stage 1|Adverse Event|0|||
13257641|NCT01500200|26389937|FG005|Stage 1|Adverse Event|0|||
13257642|NCT01500200|26389932|FG000|Stage 1|Lost to Follow-up|2|||
13257643|NCT01500200|26389933|FG001|Stage 1|Lost to Follow-up|2|||
13257644|NCT01500200|26389934|FG002|Stage 1|Lost to Follow-up|1|||
13257645|NCT01500200|26389935|FG003|Stage 1|Lost to Follow-up|0|||
13257646|NCT01500200|26389936|FG004|Stage 1|Lost to Follow-up|0|||
13257647|NCT01500200|26389937|FG005|Stage 1|Lost to Follow-up|0|||
13257648|NCT01500200|26389932|FG000|Stage 1|Withdrawal by Subject|3|||
13257649|NCT01500200|26389933|FG001|Stage 1|Withdrawal by Subject|0|||
13257650|NCT01500200|26389934|FG002|Stage 1|Withdrawal by Subject|0|||
13257651|NCT01500200|26389935|FG003|Stage 1|Withdrawal by Subject|0|||
13257652|NCT01500200|26389936|FG004|Stage 1|Withdrawal by Subject|0|||
13257653|NCT01500200|26389937|FG005|Stage 1|Withdrawal by Subject|0|||
13257654|NCT01500200|26389932|FG000|Stage 1|Noncompliance with Study Drug|1|||
13257655|NCT01500200|26389933|FG001|Stage 1|Noncompliance with Study Drug|0|||
13257656|NCT01500200|26389934|FG002|Stage 1|Noncompliance with Study Drug|0|||
13257657|NCT01500200|26389935|FG003|Stage 1|Noncompliance with Study Drug|0|||
13257658|NCT01500200|26389936|FG004|Stage 1|Noncompliance with Study Drug|0|||
13257659|NCT01500200|26389937|FG005|Stage 1|Noncompliance with Study Drug|0|||
13257660|NCT01500200|26389932|FG000|Stage 1|Physician Decision|1|||
13257661|NCT01500200|26389933|FG001|Stage 1|Physician Decision|0|||
13257662|NCT01500200|26389934|FG002|Stage 1|Physician Decision|0|||
13257663|NCT01500200|26389935|FG003|Stage 1|Physician Decision|0|||
13257664|NCT01500200|26389936|FG004|Stage 1|Physician Decision|0|||
13257665|NCT01500200|26389937|FG005|Stage 1|Physician Decision|0|||
13257666|NCT01500200|26389932|FG000|Stage 2|Adverse Event|0|||
13257667|NCT01500200|26389933|FG001|Stage 2|Adverse Event|0|||
13257668|NCT01500200|26389934|FG002|Stage 2|Adverse Event|0|||
13257669|NCT01500200|26389935|FG003|Stage 2|Adverse Event|0|||
13257670|NCT01500200|26389936|FG004|Stage 2|Adverse Event|5|||
13257671|NCT01500200|26389937|FG005|Stage 2|Adverse Event|4|||
13257672|NCT01500187|26389950|FG000|Overall Study|Lost to Follow-up|6|||
13257673|NCT01500187|26389951|FG001|Overall Study|Lost to Follow-up|0|||
13257674|NCT01500135|26389968|FG000|Overall Study|Withdrawal of Consent|4|||
13257675|NCT01500135|26389969|FG001|Overall Study|Withdrawal of Consent|0|||
13257676|NCT01500135|26389968|FG000|Overall Study|Lost to Follow-up|6|||
13257677|NCT01500135|26389969|FG001|Overall Study|Lost to Follow-up|4|||
13257678|NCT01500135|26389968|FG000|Overall Study|Fatal Adverse Event (AE)|5|||
13257679|NCT01500135|26389969|FG001|Overall Study|Fatal Adverse Event (AE)|5|||
13257680|NCT01500135|26389968|FG000|Overall Study|Principal Investigator (PI) Discretion|1|||
13257681|NCT01500135|26389969|FG001|Overall Study|Principal Investigator (PI) Discretion|0|||
13257682|NCT01500135|26389968|FG000|Overall Study|Patient Missed Scheduled Appointments|0|||
13257683|NCT01500135|26389969|FG001|Overall Study|Patient Missed Scheduled Appointments|1|||
13257684|NCT01500135|26389968|FG000|Overall Study|Participant was a Safety Concern|1|||
13257685|NCT01500135|26389969|FG001|Overall Study|Participant was a Safety Concern|0|||
13257686|NCT01500135|26389968|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0|||
13257687|NCT01500135|26389969|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1|||
13257688|NCT01500096|26390036|FG000|Overall Study|Lost to Follow-up|1|||
13257689|NCT01500096|26390037|FG001|Overall Study|Lost to Follow-up|0|||
13257690|NCT01500096|26390038|FG002|Overall Study|Lost to Follow-up|0|||
13257691|NCT01500096|26390039|FG003|Overall Study|Lost to Follow-up|2|||
13257692|NCT01500083|26390052|FG000|Overall Study|Adverse Event|4|||
13257693|NCT01500083|26390053|FG001|Overall Study|Adverse Event|17|||
13257694|NCT01500083|26390052|FG000|Overall Study|Death|0|||
13257695|NCT01500083|26390053|FG001|Overall Study|Death|2|||
13257696|NCT01500083|26390052|FG000|Overall Study|Lost to Follow-up|1|||
13257697|NCT01500083|26390053|FG001|Overall Study|Lost to Follow-up|0|||
13257698|NCT01500083|26390052|FG000|Overall Study|Withdrawal of Consent|0|||
13257699|NCT01500083|26390053|FG001|Overall Study|Withdrawal of Consent|1|||
13257700|NCT01500083|26390052|FG000|Overall Study|Disease Progression|2|||
13257701|NCT01500083|26390053|FG001|Overall Study|Disease Progression|10|||
13257702|NCT01500083|26390052|FG000|Overall Study|Investigator Discretion|3|||
13257703|NCT01500083|26390053|FG001|Overall Study|Investigator Discretion|8|||
13257704|NCT01500083|26390052|FG000|Overall Study|Other Reasons|2|||
13257705|NCT01500083|26390053|FG001|Overall Study|Other Reasons|5|||
13257706|NCT01500057|26390070|FG000|Overall Study|Lost to Follow-up|6|||
13257707|NCT01500057|26390071|FG001|Overall Study|Lost to Follow-up|4|||
13257708|NCT01500031|26390088|FG000|Overall Study|Death|1|||
13257709|NCT01500031|26390088|FG000|Overall Study|Withdrawal by Subject|4|||
13257710|NCT01499940|26390094|FG000|Overall Study|Study was withdrawn before completion.|9|||
13257711|NCT01499849|26390111|FG000|Overall Study|Adverse Event|28|||
13257712|NCT01499849|26390112|FG001|Overall Study|Adverse Event|32|||
13257713|NCT01499849|26390111|FG000|Overall Study|Chemo completed or Change in Therapy|70|||
13257714|NCT01499849|26390112|FG001|Overall Study|Chemo completed or Change in Therapy|67|||
13257715|NCT01499849|26390111|FG000|Overall Study|Withdrawal by Subject|43|||
13257716|NCT01499849|26390112|FG001|Overall Study|Withdrawal by Subject|43|||
13257717|NCT01499849|26390111|FG000|Overall Study|Death|5|||
13257718|NCT01499849|26390112|FG001|Overall Study|Death|7|||
13257719|NCT01499849|26390111|FG000|Overall Study|Disease Progression|11|||
13257720|NCT01499849|26390112|FG001|Overall Study|Disease Progression|10|||
13257721|NCT01499849|26390111|FG000|Overall Study|Protocol Violation|11|||
13257722|NCT01499849|26390112|FG001|Overall Study|Protocol Violation|11|||
13257723|NCT01499849|26390111|FG000|Overall Study|Physician Decision|20|||
13257724|NCT01499849|26390112|FG001|Overall Study|Physician Decision|19|||
13257725|NCT01499849|26390111|FG000|Overall Study|Lack of Efficacy|3|||
13257726|NCT01499849|26390112|FG001|Overall Study|Lack of Efficacy|4|||
13257727|NCT01499849|26390111|FG000|Overall Study|Lost to Follow-up|6|||
13257728|NCT01499849|26390112|FG001|Overall Study|Lost to Follow-up|3|||
13257729|NCT01499849|26390111|FG000|Overall Study|Other Reasons|27|||
13257730|NCT01499849|26390112|FG001|Overall Study|Other Reasons|30|||
13257731|NCT01499810|26390161|FG000|Overall Study|Lost to Follow-up|10|||
13257732|NCT01499810|26390161|FG000|Overall Study|Protocol Violation|1|||
13257733|NCT01499810|26390161|FG000|Overall Study|Withdrawal by Subject|1|||
13257734|NCT01499667|26390200|FG000|Overall Study|administrative problems|4|||
13257735|NCT01499667|26390201|FG001|Overall Study|administrative problems|5|||
13257736|NCT01499667|26390202|FG002|Overall Study|administrative problems|5|||
13257737|NCT01499667|26390200|FG000|Overall Study|Protocol Violation|1|||
13257738|NCT01499667|26390201|FG001|Overall Study|Protocol Violation|3|||
13257739|NCT01499667|26390202|FG002|Overall Study|Protocol Violation|2|||
13257740|NCT01499667|26390200|FG000|Overall Study|Adverse Event|0|||
13257741|NCT01499667|26390201|FG001|Overall Study|Adverse Event|2|||
13257742|NCT01499667|26390202|FG002|Overall Study|Adverse Event|2|||
13257743|NCT01499667|26390200|FG000|Overall Study|Withdrawal by Subject|2|||
13257744|NCT01499667|26390201|FG001|Overall Study|Withdrawal by Subject|1|||
13257745|NCT01499667|26390202|FG002|Overall Study|Withdrawal by Subject|1|||
13257746|NCT01499667|26390200|FG000|Overall Study|Lack of Efficacy|2|||
13257747|NCT01499667|26390201|FG001|Overall Study|Lack of Efficacy|0|||
13257748|NCT01499667|26390202|FG002|Overall Study|Lack of Efficacy|0|||
13257749|NCT01499576|26390210|FG000|Overall Study|Physician Decision|12|||
13257750|NCT01499576|26390210|FG000|Overall Study|Withdrawal by Subject|9|||
13257751|NCT01499511|26390234|FG000|Overall Study|Death|1|||
13257752|NCT01499511|26390235|FG001|Overall Study|Death|0|||
13257753|NCT01499368|26390262|FG000|Overall Study|Did not meet I/E criteria|8|||
13257754|NCT01499368|26390263|FG001|Overall Study|Did not meet I/E criteria|4|||
13257755|NCT01499368|26390264|FG002|Overall Study|Did not meet I/E criteria|4|||
13257756|NCT01499368|26390262|FG000|Overall Study|Prohibited Concomitant medication|1|||
13257757|NCT01499368|26390263|FG001|Overall Study|Prohibited Concomitant medication|1|||
13257758|NCT01499368|26390264|FG002|Overall Study|Prohibited Concomitant medication|0|||
13257759|NCT01499368|26390262|FG000|Overall Study|Withdrawal by Subject|11|||
13257760|NCT01499368|26390263|FG001|Overall Study|Withdrawal by Subject|10|||
13257761|NCT01499368|26390264|FG002|Overall Study|Withdrawal by Subject|8|||
13257762|NCT01499368|26390262|FG000|Overall Study|Lost to Follow-up|3|||
13257763|NCT01499368|26390263|FG001|Overall Study|Lost to Follow-up|2|||
13257764|NCT01499368|26390264|FG002|Overall Study|Lost to Follow-up|5|||
13257765|NCT01499368|26390262|FG000|Overall Study|Adverse Event|4|||
13117226|NCT03064451|25924656|FG000|Overall Study|Exited prior to procedure|8|||
13117227|NCT03064451|25924656|FG000|Overall Study|Withdrew consent: 3-month FU visit|1|||
13117228|NCT03064438|25924687|FG000|Overall Study|Lost to Follow-up|1|||
13117229|NCT03064438|25924688|FG001|Overall Study|Lost to Follow-up|0|||
13117230|NCT03064438|25924687|FG000|Overall Study|Withdrawal by Subject|0|||
13117231|NCT03064438|25924688|FG001|Overall Study|Withdrawal by Subject|1|||
13133399|NCT02770170|25987715|FG003|Overall Study|Withdrawal by Subject|2|||
13133400|NCT02770170|25987712|FG000|Overall Study|due to pregnancy|1|||
13133401|NCT02770170|25987713|FG001|Overall Study|due to pregnancy|0|||
13133402|NCT02770170|25987714|FG002|Overall Study|due to pregnancy|0|||
13133403|NCT02770170|25987715|FG003|Overall Study|due to pregnancy|0|||
13133404|NCT02770170|25987712|FG000|Overall Study|Lack of Efficacy|2|||
13133405|NCT02770170|25987713|FG001|Overall Study|Lack of Efficacy|0|||
13133406|NCT02770170|25987714|FG002|Overall Study|Lack of Efficacy|0|||
13257766|NCT01499368|26390263|FG001|Overall Study|Adverse Event|0|||
13257767|NCT01499368|26390264|FG002|Overall Study|Adverse Event|2|||
13257768|NCT01499368|26390262|FG000|Overall Study|Physician Decision|0|||
13257769|NCT01499368|26390263|FG001|Overall Study|Physician Decision|1|||
13257770|NCT01499368|26390264|FG002|Overall Study|Physician Decision|0|||
13257771|NCT01499368|26390262|FG000|Overall Study|Deviation from visit window|0|||
13257772|NCT01499368|26390263|FG001|Overall Study|Deviation from visit window|0|||
13257773|NCT01499368|26390264|FG002|Overall Study|Deviation from visit window|1|||
13257774|NCT01499368|26390262|FG000|Overall Study|Error of Prescriptions|0|||
13257775|NCT01499368|26390263|FG001|Overall Study|Error of Prescriptions|0|||
13257776|NCT01499368|26390264|FG002|Overall Study|Error of Prescriptions|1|||
13257777|NCT01499355|26390300|FG000|Run-In Period|Study Termination|15|||
13257778|NCT01499355|26390301|FG001|Run-In Period|Study Termination|0|||
13257779|NCT01499355|26390302|FG002|Run-In Period|Study Termination|0|||
13257780|NCT01499355|26390303|FG003|Run-In Period|Study Termination|0|||
13257781|NCT01499355|26390300|FG000|Run-In Period|Other|3|||
13257782|NCT01499355|26390301|FG001|Run-In Period|Other|0|||
13257783|NCT01499355|26390302|FG002|Run-In Period|Other|0|||
13257784|NCT01499355|26390303|FG003|Run-In Period|Other|0|||
13257785|NCT01499355|26390300|FG000|Run-In Period|Death|2|||
13257786|NCT01499355|26390301|FG001|Run-In Period|Death|0|||
13257787|NCT01499355|26390302|FG002|Run-In Period|Death|0|||
13257788|NCT01499355|26390303|FG003|Run-In Period|Death|0|||
13257789|NCT01499355|26390300|FG000|Run-In Period|Investigator Decision|2|||
13257790|NCT01499355|26390301|FG001|Run-In Period|Investigator Decision|0|||
13257791|NCT01499355|26390302|FG002|Run-In Period|Investigator Decision|0|||
13257792|NCT01499355|26390303|FG003|Run-In Period|Investigator Decision|0|||
13257793|NCT01499355|26390300|FG000|Run-In Period|Consent Withdrawn|1|||
13133407|NCT02770170|25987715|FG003|Overall Study|Lack of Efficacy|1|||
13133408|NCT02770170|25987712|FG000|Overall Study|Adverse Event|4|||
13133409|NCT02770170|25987713|FG001|Overall Study|Adverse Event|3|||
13257794|NCT01499355|26390301|FG001|Run-In Period|Consent Withdrawn|0|||
13257795|NCT01499355|26390302|FG002|Run-In Period|Consent Withdrawn|0|||
13257796|NCT01499355|26390303|FG003|Run-In Period|Consent Withdrawn|0|||
13257797|NCT01499355|26390300|FG000|Run-In Period|Adverse Event|8|||
13257798|NCT01499355|26390301|FG001|Run-In Period|Adverse Event|0|||
13257799|NCT01499355|26390302|FG002|Run-In Period|Adverse Event|0|||
13257800|NCT01499355|26390303|FG003|Run-In Period|Adverse Event|0|||
13257801|NCT01499355|26390300|FG000|Double-Blind Period|Adverse Event|0|||
13257802|NCT01499355|26390301|FG001|Double-Blind Period|Adverse Event|2|||
13257803|NCT01499355|26390302|FG002|Double-Blind Period|Adverse Event|3|||
13257804|NCT01499355|26390303|FG003|Double-Blind Period|Adverse Event|2|||
13257805|NCT01499355|26390300|FG000|Double-Blind Period|Study Termination|0|||
13257806|NCT01499355|26390301|FG001|Double-Blind Period|Study Termination|18|||
13257807|NCT01499355|26390302|FG002|Double-Blind Period|Study Termination|16|||
13257808|NCT01499355|26390303|FG003|Double-Blind Period|Study Termination|14|||
13257809|NCT01499355|26390300|FG000|Double-Blind Period|Other|0|||
13257810|NCT01499355|26390301|FG001|Double-Blind Period|Other|1|||
13257811|NCT01499355|26390302|FG002|Double-Blind Period|Other|2|||
13257812|NCT01499355|26390303|FG003|Double-Blind Period|Other|2|||
13257813|NCT01499355|26390300|FG000|Double-Blind Period|Death|0|||
13257814|NCT01499355|26390301|FG001|Double-Blind Period|Death|1|||
13257815|NCT01499355|26390302|FG002|Double-Blind Period|Death|0|||
13257816|NCT01499355|26390303|FG003|Double-Blind Period|Death|0|||
13257817|NCT01499355|26390300|FG000|Double-Blind Period|Investigator Decision|0|||
13257818|NCT01499355|26390301|FG001|Double-Blind Period|Investigator Decision|0|||
13257819|NCT01499355|26390302|FG002|Double-Blind Period|Investigator Decision|3|||
13257820|NCT01499355|26390303|FG003|Double-Blind Period|Investigator Decision|3|||
13257821|NCT01499355|26390300|FG000|Double-Blind Period|Consent Withdrawn|0|||
13257822|NCT01499355|26390301|FG001|Double-Blind Period|Consent Withdrawn|0|||
13257823|NCT01499355|26390302|FG002|Double-Blind Period|Consent Withdrawn|1|||
13257824|NCT01499355|26390303|FG003|Double-Blind Period|Consent Withdrawn|2|||
13257825|NCT01499355|26390300|FG000|Double-Blind Period|Lost to Follow-up|0|||
13257826|NCT01499355|26390301|FG001|Double-Blind Period|Lost to Follow-up|1|||
13257827|NCT01499355|26390302|FG002|Double-Blind Period|Lost to Follow-up|0|||
13257828|NCT01499355|26390303|FG003|Double-Blind Period|Lost to Follow-up|0|||
13257829|NCT01499303|26390316|FG000|Overall Study|Ongoing|2|||
13257830|NCT01499303|26390317|FG001|Overall Study|Ongoing|1|||
13257831|NCT01499303|26390316|FG000|Overall Study|Withdrawal by Subject|0|||
13257832|NCT01499303|26390317|FG001|Overall Study|Withdrawal by Subject|1|||
13257833|NCT01499303|26390316|FG000|Overall Study|Adverse Event|1|||
13257834|NCT01499303|26390317|FG001|Overall Study|Adverse Event|4|||
13257835|NCT01499303|26390316|FG000|Overall Study|Other|0|||
13257836|NCT01499303|26390317|FG001|Overall Study|Other|1|||
13257837|NCT01499290|26390372|FG000|Overall Study|Withdrawal by Subject|22|||
13257838|NCT01499290|26390373|FG001|Overall Study|Withdrawal by Subject|15|||
13257839|NCT01499290|26390372|FG000|Overall Study|Not specified in study report|11|||
13257840|NCT01499290|26390373|FG001|Overall Study|Not specified in study report|5|||
13257841|NCT01499290|26390372|FG000|Overall Study|Condition improved/subject recovered|1|||
13257842|NCT01499290|26390373|FG001|Overall Study|Condition improved/subject recovered|0|||
13257843|NCT01499290|26390372|FG000|Overall Study|Lack of Efficacy|7|||
13257844|NCT01499290|26390373|FG001|Overall Study|Lack of Efficacy|8|||
13257845|NCT01499290|26390372|FG000|Overall Study|Adverse Event|14|||
13257846|NCT01499290|26390373|FG001|Overall Study|Adverse Event|7|||
13257847|NCT01499277|26390402|FG000|Overall Study|Adverse Event|3|||
13257848|NCT01499277|26390403|FG001|Overall Study|Adverse Event|6|||
13257849|NCT01499277|26390402|FG000|Overall Study|Death|3|||
13257850|NCT01499277|26390403|FG001|Overall Study|Death|2|||
13257851|NCT01499277|26390402|FG000|Overall Study|Lost to Follow-up|15|||
13257852|NCT01499277|26390403|FG001|Overall Study|Lost to Follow-up|8|||
13257853|NCT01499277|26390402|FG000|Overall Study|Protocol Violation|2|||
13257854|NCT01499277|26390403|FG001|Overall Study|Protocol Violation|3|||
13257855|NCT01499277|26390402|FG000|Overall Study|Withdrawal by Subject|16|||
13257856|NCT01499277|26390403|FG001|Overall Study|Withdrawal by Subject|6|||
13257857|NCT01499277|26390402|FG000|Overall Study|Lack of therapeutic response and other|8|||
13257858|NCT01499277|26390403|FG001|Overall Study|Lack of therapeutic response and other|7|||
13257859|NCT01499199|26390424|FG000|Overall Study|Adverse Event|1|||
13257860|NCT01499199|26390424|FG000|Overall Study|Lack of Efficacy|1|||
13257861|NCT01499160|26390431|FG000|Overall Study|Adverse Event|1|||
13257862|NCT01499160|26390431|FG000|Overall Study|Withdrawal by Subject|1|||
13257863|NCT01499134|26390458|FG000|Overall Study|Withdrawal by Subject|0|||
13257864|NCT01499134|26390459|FG001|Overall Study|Withdrawal by Subject|1|||
13257865|NCT01499043|26390471|FG000|Overall Study|Progressive disease (radiographic)|2|||
13257866|NCT01499043|26390471|FG000|Overall Study|Progressive disease (clinical)|1|||
13257867|NCT01499043|26390471|FG000|Overall Study|Withdrawal by Subject|2|||
13257868|NCT01499043|26390471|FG000|Overall Study|Adverse Event|1|||
13257869|NCT01498952|26390521|FG000|Overall Study|Death|2|||
13257870|NCT01498952|26390522|FG001|Overall Study|Death|2|||
13257871|NCT01498952|26390523|FG002|Overall Study|Death|0|||
13257872|NCT01498952|26390524|FG003|Overall Study|Death|0|||
13257873|NCT01498952|26390525|FG004|Overall Study|Death|0|||
13257874|NCT01498887|26390551|FG000|Overall Study|Administrative problems|1|||
13257875|NCT01498887|26390552|FG001|Overall Study|Administrative problems|0|||
13257876|NCT01498887|26390551|FG000|Overall Study|Lost to Follow-up|1|||
13257877|NCT01498887|26390552|FG001|Overall Study|Lost to Follow-up|1|||
13257878|NCT01498887|26390551|FG000|Overall Study|Withdrawal by Subject|1|||
13257879|NCT01498887|26390552|FG001|Overall Study|Withdrawal by Subject|0|||
13257880|NCT01498887|26390551|FG000|Overall Study|Protocol Violation|1|||
13257881|NCT01498887|26390552|FG001|Overall Study|Protocol Violation|3|||
13257882|NCT01498887|26390551|FG000|Overall Study|Lack of Efficacy|5|||
13257883|NCT01498887|26390552|FG001|Overall Study|Lack of Efficacy|3|||
13257884|NCT01498887|26390551|FG000|Overall Study|Abnormal result from test procedure|1|||
13257885|NCT01498887|26390552|FG001|Overall Study|Abnormal result from test procedure|1|||
13257886|NCT01498887|26390551|FG000|Overall Study|Abnormal laboratory value|2|||
13257887|NCT01498887|26390552|FG001|Overall Study|Abnormal laboratory value|2|||
13257888|NCT01498887|26390551|FG000|Overall Study|Adverse Event|4|||
13257889|NCT01498887|26390552|FG001|Overall Study|Adverse Event|1|||
13257890|NCT01498822|26390571|FG000|Overall Study|Protocol Violation|8|||
13257891|NCT01498822|26390572|FG001|Overall Study|Protocol Violation|4|||
13257892|NCT01498822|26390571|FG000|Overall Study|Other Reason|5|||
13257893|NCT01498822|26390572|FG001|Overall Study|Other Reason|2|||
13257894|NCT01498822|26390571|FG000|Overall Study|Lack of Efficacy|7|||
13257895|NCT01498822|26390572|FG001|Overall Study|Lack of Efficacy|2|||
13257896|NCT01498822|26390571|FG000|Overall Study|AE, non-serious non-fatal|8|||
13257897|NCT01498822|26390572|FG001|Overall Study|AE, non-serious non-fatal|17|||
13257898|NCT01498822|26390571|FG000|Overall Study|SAE, non-fatal|2|||
13257899|NCT01498822|26390572|FG001|Overall Study|SAE, non-fatal|2|||
13257900|NCT01498822|26390571|FG000|Overall Study|Adverse Event, serious fatal|1|||
13257901|NCT01498822|26390572|FG001|Overall Study|Adverse Event, serious fatal|1|||
13257902|NCT01498822|26390571|FG000|Overall Study|Withdrawal by Subject|15|||
13257903|NCT01498822|26390572|FG001|Overall Study|Withdrawal by Subject|25|||
13257904|NCT01498822|26390571|FG000|Overall Study|Lost to Follow-up|8|||
13257905|NCT01498822|26390572|FG001|Overall Study|Lost to Follow-up|3|||
13257906|NCT01498692|26390603|FG000|Overall Study|Death|4|||
13257907|NCT01498692|26390603|FG000|Overall Study|Withdrawal by Subject|1|||
13257908|NCT01498692|26390603|FG000|Overall Study|Missed 12-month visit|3|||
13257909|NCT01498679|26390624|FG000|Overall Study|Adverse Event|1|||
13257910|NCT01498679|26390625|FG001|Overall Study|Adverse Event|4|||
13257911|NCT01498679|26390624|FG000|Overall Study|Lack of Efficacy|72|||
13257912|NCT01498679|26390625|FG001|Overall Study|Lack of Efficacy|12|||
13257913|NCT01498679|26390624|FG000|Overall Study|Protocol Violation|4|||
13257914|NCT01498679|26390625|FG001|Overall Study|Protocol Violation|0|||
13257915|NCT01498679|26390624|FG000|Overall Study|Physician Decision|0|||
13257916|NCT01498679|26390625|FG001|Overall Study|Physician Decision|2|||
13257917|NCT01498679|26390624|FG000|Overall Study|Withdrawal by Subject|12|||
13257918|NCT01498679|26390625|FG001|Overall Study|Withdrawal by Subject|4|||
13257919|NCT01498653|26390646|FG000|Overall Study|Adverse Event|2|||
13257920|NCT01498653|26390647|FG001|Overall Study|Adverse Event|2|||
13257921|NCT01498653|26390646|FG000|Overall Study|Lack of Efficacy|12|||
13257922|NCT01498653|26390647|FG001|Overall Study|Lack of Efficacy|26|||
13257923|NCT01498653|26390646|FG000|Overall Study|Protocol Violation|0|||
13257924|NCT01498653|26390647|FG001|Overall Study|Protocol Violation|4|||
13257925|NCT01498653|26390646|FG000|Overall Study|Lost to Follow-up|1|||
13257926|NCT01498653|26390647|FG001|Overall Study|Lost to Follow-up|0|||
13257927|NCT01498653|26390646|FG000|Overall Study|Physician Decision|2|||
13257928|NCT01498653|26390647|FG001|Overall Study|Physician Decision|0|||
13257929|NCT01498653|26390646|FG000|Overall Study|Withdrawal by Subject|2|||
13257930|NCT01498653|26390647|FG001|Overall Study|Withdrawal by Subject|3|||
13257931|NCT01498640|26390663|FG000|Overall Study|Lost to Follow-up|1|||
13257932|NCT01498640|26390663|FG000|Overall Study|Death|1|||
13257933|NCT01498640|26390663|FG000|Overall Study|Other|3|||
13257934|NCT01498575|26390676|FG000|Overall Sample|Withdrawal by Subject|60|||
13257935|NCT01498575|26390677|FG001|Overall Sample|Withdrawal by Subject|14|||
13257936|NCT01498575|26390676|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19|||
13257937|NCT01498575|26390677|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6|||
13257938|NCT01498575|26390676|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23|||
13257939|NCT01498575|26390677|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18|||
13257940|NCT01498484|26390718|FG000|Overall Study|Death|6|||
13257941|NCT01498484|26390719|FG001|Overall Study|Death|3|||
13257942|NCT01498484|26390720|FG002|Overall Study|Death|1|||
13257943|NCT01498484|26390721|FG003|Overall Study|Death|1|||
13257944|NCT01498484|26390722|FG004|Overall Study|Death|0|||
13257945|NCT01498484|26390723|FG005|Overall Study|Death|0|||
13257946|NCT01498484|26390724|FG006|Overall Study|Death|10|||
13257947|NCT01498484|26390725|FG007|Overall Study|Death|1|||
13257948|NCT01498484|26390726|FG008|Overall Study|Death|0|||
13257949|NCT01498484|26390718|FG000|Overall Study|Physician Decision|3|||
13257950|NCT01498484|26390719|FG001|Overall Study|Physician Decision|2|||
13257951|NCT01498484|26390720|FG002|Overall Study|Physician Decision|1|||
13257952|NCT01498484|26390721|FG003|Overall Study|Physician Decision|1|||
13257953|NCT01498484|26390722|FG004|Overall Study|Physician Decision|0|||
13257954|NCT01498484|26390723|FG005|Overall Study|Physician Decision|0|||
13257955|NCT01498484|26390724|FG006|Overall Study|Physician Decision|8|||
13257956|NCT01498484|26390725|FG007|Overall Study|Physician Decision|13|||
13257957|NCT01498484|26390726|FG008|Overall Study|Physician Decision|1|||
13257958|NCT01498484|26390718|FG000|Overall Study|Adverse Event|0|||
13257959|NCT01498484|26390719|FG001|Overall Study|Adverse Event|0|||
13257960|NCT01498484|26390720|FG002|Overall Study|Adverse Event|0|||
13257961|NCT01498484|26390721|FG003|Overall Study|Adverse Event|0|||
13257962|NCT01498484|26390722|FG004|Overall Study|Adverse Event|0|||
13257963|NCT01498484|26390723|FG005|Overall Study|Adverse Event|1|||
13257964|NCT01498484|26390724|FG006|Overall Study|Adverse Event|0|||
13257965|NCT01498484|26390725|FG007|Overall Study|Adverse Event|0|||
13257966|NCT01498484|26390726|FG008|Overall Study|Adverse Event|0|||
13257967|NCT01498484|26390718|FG000|Overall Study|Withdrawal by Subject|0|||
13257968|NCT01498484|26390719|FG001|Overall Study|Withdrawal by Subject|0|||
13257969|NCT01498484|26390720|FG002|Overall Study|Withdrawal by Subject|0|||
13257970|NCT01498484|26390721|FG003|Overall Study|Withdrawal by Subject|1|||
13257971|NCT01498484|26390722|FG004|Overall Study|Withdrawal by Subject|0|||
13257972|NCT01498484|26390723|FG005|Overall Study|Withdrawal by Subject|0|||
13257973|NCT01498484|26390724|FG006|Overall Study|Withdrawal by Subject|1|||
13257974|NCT01498484|26390725|FG007|Overall Study|Withdrawal by Subject|0|||
13257975|NCT01498484|26390726|FG008|Overall Study|Withdrawal by Subject|0|||
13257976|NCT01498484|26390718|FG000|Overall Study|Other|5|||
13257977|NCT01498484|26390719|FG001|Overall Study|Other|2|||
13257978|NCT01498484|26390720|FG002|Overall Study|Other|0|||
13257979|NCT01498484|26390721|FG003|Overall Study|Other|0|||
13257980|NCT01498484|26390722|FG004|Overall Study|Other|1|||
13257981|NCT01498484|26390723|FG005|Overall Study|Other|0|||
13257982|NCT01498484|26390724|FG006|Overall Study|Other|3|||
13257983|NCT01498484|26390725|FG007|Overall Study|Other|0|||
13257984|NCT01498484|26390726|FG008|Overall Study|Other|1|||
13257985|NCT01498445|26390777|FG000|Overall Study|Lack of Efficacy|0|||
13257986|NCT01498445|26390778|FG001|Overall Study|Lack of Efficacy|0|||
13257987|NCT01498445|26390779|FG002|Overall Study|Lack of Efficacy|1|||
13257988|NCT01498445|26390780|FG003|Overall Study|Lack of Efficacy|2|||
13257989|NCT01498445|26390781|FG004|Overall Study|Lack of Efficacy|0|||
13257990|NCT01498445|26390782|FG005|Overall Study|Lack of Efficacy|0|||
13257991|NCT01498445|26390777|FG000|Overall Study|Screen Failure|0|||
13257992|NCT01498445|26390778|FG001|Overall Study|Screen Failure|0|||
13257993|NCT01498445|26390779|FG002|Overall Study|Screen Failure|0|||
13257994|NCT01498445|26390780|FG003|Overall Study|Screen Failure|0|||
13257995|NCT01498445|26390781|FG004|Overall Study|Screen Failure|1|||
13257996|NCT01498445|26390782|FG005|Overall Study|Screen Failure|1|||
13257997|NCT01498289|26390805|FG000|Overall Study|Adverse Event|16|||
13257998|NCT01498289|26390806|FG001|Overall Study|Adverse Event|18|||
13257999|NCT01498289|26390805|FG000|Overall Study|Death|6|||
13258000|NCT01498289|26390806|FG001|Overall Study|Death|8|||
13258001|NCT01498289|26390805|FG000|Overall Study|Withdrawal unrelated to AE|16|||
13258002|NCT01498289|26390806|FG001|Overall Study|Withdrawal unrelated to AE|16|||
13258003|NCT01498289|26390805|FG000|Overall Study|Progression/relapse|53|||
13258004|NCT01498289|26390806|FG001|Overall Study|Progression/relapse|59|||
13258005|NCT01498289|26390805|FG000|Overall Study|Not protocol specified|7|||
13258006|NCT01498289|26390806|FG001|Overall Study|Not protocol specified|2|||
13258007|NCT01498289|26390805|FG000|Overall Study|Reason under review|0|||
13258008|NCT01498289|26390806|FG001|Overall Study|Reason under review|1|||
13258009|NCT01498185|26390862|FG000|Overall Study|Adverse Event|0|||
13258010|NCT01498185|26390863|FG001|Overall Study|Adverse Event|0|||
13258011|NCT01498185|26390864|FG002|Overall Study|Adverse Event|0|||
13258012|NCT01498185|26390865|FG003|Overall Study|Adverse Event|1|||
13258013|NCT01498185|26390866|FG004|Overall Study|Adverse Event|0|||
13258014|NCT01498185|26390862|FG000|Overall Study|Withdrawal by Subject|1|||
13258015|NCT01498185|26390863|FG001|Overall Study|Withdrawal by Subject|1|||
13258016|NCT01498185|26390864|FG002|Overall Study|Withdrawal by Subject|0|||
13258017|NCT01498185|26390865|FG003|Overall Study|Withdrawal by Subject|2|||
13258018|NCT01498185|26390866|FG004|Overall Study|Withdrawal by Subject|1|||
13258019|NCT01498185|26390862|FG000|Overall Study|No longer met criteria, etc|0|||
13258020|NCT01498185|26390863|FG001|Overall Study|No longer met criteria, etc|0|||
13258021|NCT01498185|26390864|FG002|Overall Study|No longer met criteria, etc|0|||
13258022|NCT01498185|26390865|FG003|Overall Study|No longer met criteria, etc|0|||
13258023|NCT01498185|26390866|FG004|Overall Study|No longer met criteria, etc|2|||
13258024|NCT01498120|26390873|FG000|Overall Study|Lost to Follow-up|1|||
13258025|NCT01498120|26390873|FG000|Overall Study|Withdrawal by Subject|5|||
13258026|NCT01498120|26390873|FG000|Overall Study|AE, non-serious non-fatal|3|||
13258027|NCT01498120|26390873|FG000|Overall Study|Other|4|||
13258028|NCT01498068|26390896|FG000|Overall Study|Withdrawal by Subject|1|||
13258029|NCT01498068|26390897|FG001|Overall Study|Withdrawal by Subject|1|||
13258030|NCT01497938|26390912|FG000|Overall Study|Adverse Event|0|||
13258031|NCT01497938|26390913|FG001|Overall Study|Adverse Event|1|||
13258032|NCT01497938|26390912|FG000|Overall Study|Physician Decision|0|||
13258033|NCT01497938|26390913|FG001|Overall Study|Physician Decision|1|||
13258034|NCT01497938|26390912|FG000|Overall Study|Withdrawal by Subject|4|||
13258035|NCT01497938|26390913|FG001|Overall Study|Withdrawal by Subject|0|||
13258036|NCT01497938|26390912|FG000|Overall Study|Device Violation|1|||
13258037|NCT01497938|26390913|FG001|Overall Study|Device Violation|0|||
13258038|NCT01497899|26390939|FG000|Double-Blind Phase|Randomized but not Treated|1|||
13258039|NCT01497899|26390940|FG001|Double-Blind Phase|Randomized but not Treated|0|||
13258040|NCT01497899|26390941|FG002|Double-Blind Phase|Randomized but not Treated|0|||
13258041|NCT01497899|26390942|FG003|Double-Blind Phase|Randomized but not Treated|0|||
13258042|NCT01497899|26390939|FG000|Double-Blind Phase|Adverse Event|1|||
13258043|NCT01497899|26390940|FG001|Double-Blind Phase|Adverse Event|0|||
13258044|NCT01497899|26390941|FG002|Double-Blind Phase|Adverse Event|0|||
13258045|NCT01497899|26390942|FG003|Double-Blind Phase|Adverse Event|0|||
13258046|NCT01497899|26390939|FG000|Double-Blind Phase|Lack of Efficacy|0|||
13258047|NCT01497899|26390940|FG001|Double-Blind Phase|Lack of Efficacy|1|||
13258048|NCT01497899|26390941|FG002|Double-Blind Phase|Lack of Efficacy|0|||
13258049|NCT01497899|26390942|FG003|Double-Blind Phase|Lack of Efficacy|0|||
13258050|NCT01497899|26390939|FG000|Double-Blind Phase|Investigator's Discretion|1|||
13258051|NCT01497899|26390940|FG001|Double-Blind Phase|Investigator's Discretion|0|||
13258052|NCT01497899|26390941|FG002|Double-Blind Phase|Investigator's Discretion|0|||
13258053|NCT01497899|26390942|FG003|Double-Blind Phase|Investigator's Discretion|0|||
13258054|NCT01497899|26390939|FG000|Double-Blind Phase|Withdrew Consent|0|||
13258055|NCT01497899|26390940|FG001|Double-Blind Phase|Withdrew Consent|1|||
13258056|NCT01497899|26390941|FG002|Double-Blind Phase|Withdrew Consent|0|||
13258057|NCT01497899|26390942|FG003|Double-Blind Phase|Withdrew Consent|0|||
13258058|NCT01497899|26390939|FG000|Double-Blind Phase|Lost to Follow-up|3|||
13258059|NCT01497899|26390940|FG001|Double-Blind Phase|Lost to Follow-up|2|||
13258060|NCT01497899|26390941|FG002|Double-Blind Phase|Lost to Follow-up|0|||
13258061|NCT01497899|26390942|FG003|Double-Blind Phase|Lost to Follow-up|0|||
13258062|NCT01497899|26390939|FG000|Double-Blind Phase|Subject Non-Compliance|0|||
13258063|NCT01497899|26390940|FG001|Double-Blind Phase|Subject Non-Compliance|1|||
13258064|NCT01497899|26390941|FG002|Double-Blind Phase|Subject Non-Compliance|0|||
13258065|NCT01497899|26390942|FG003|Double-Blind Phase|Subject Non-Compliance|0|||
13258066|NCT01497899|26390939|FG000|Open-Label Extension Phase|Adverse Event|1|||
13258067|NCT01497899|26390940|FG001|Open-Label Extension Phase|Adverse Event|0|||
13258068|NCT01497899|26390941|FG002|Open-Label Extension Phase|Adverse Event|0|||
13258069|NCT01497899|26390942|FG003|Open-Label Extension Phase|Adverse Event|0|||
13258070|NCT01497899|26390939|FG000|Open-Label Extension Phase|Death|1|||
13258071|NCT01497899|26390940|FG001|Open-Label Extension Phase|Death|0|||
13258072|NCT01497899|26390941|FG002|Open-Label Extension Phase|Death|0|||
13258073|NCT01497899|26390942|FG003|Open-Label Extension Phase|Death|0|||
13258074|NCT01497899|26390939|FG000|Open-Label Extension Phase|Withdrew Consent|8|||
13258075|NCT01497899|26390940|FG001|Open-Label Extension Phase|Withdrew Consent|3|||
13258076|NCT01497899|26390941|FG002|Open-Label Extension Phase|Withdrew Consent|2|||
13258077|NCT01497899|26390942|FG003|Open-Label Extension Phase|Withdrew Consent|0|||
13258078|NCT01497899|26390939|FG000|Open-Label Extension Phase|Pregnancy|0|||
13258079|NCT01497899|26390940|FG001|Open-Label Extension Phase|Pregnancy|1|||
13258080|NCT01497899|26390941|FG002|Open-Label Extension Phase|Pregnancy|1|||
13258081|NCT01497899|26390942|FG003|Open-Label Extension Phase|Pregnancy|0|||
13258082|NCT01497899|26390939|FG000|Open-Label Extension Phase|Protocol Violation|0|||
13258083|NCT01497899|26390940|FG001|Open-Label Extension Phase|Protocol Violation|0|||
13258084|NCT01497899|26390941|FG002|Open-Label Extension Phase|Protocol Violation|1|||
13258085|NCT01497899|26390942|FG003|Open-Label Extension Phase|Protocol Violation|0|||
13258086|NCT01497899|26390939|FG000|Open-Label Extension Phase|Lost to Follow-up|9|||
13258087|NCT01497899|26390940|FG001|Open-Label Extension Phase|Lost to Follow-up|3|||
13258088|NCT01497899|26390941|FG002|Open-Label Extension Phase|Lost to Follow-up|5|||
13258089|NCT01497899|26390942|FG003|Open-Label Extension Phase|Lost to Follow-up|5|||
13258090|NCT01497366|26390967|FG000|Overall Study|Virologic failure|2|||
13258091|NCT01497366|26390968|FG001|Overall Study|Virologic failure|50|||
13258092|NCT01497366|26390967|FG000|Overall Study|Lost to Follow-up|11|||
13258093|NCT01497366|26390968|FG001|Overall Study|Lost to Follow-up|10|||
13258094|NCT01497366|26390967|FG000|Overall Study|Withdrawal by Subject|6|||
13258095|NCT01497366|26390968|FG001|Overall Study|Withdrawal by Subject|6|||
13258096|NCT01497366|26390967|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7|||
13258097|NCT01497366|26390968|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0|||
13486293|NCT02429791|27035711|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
13258098|NCT01497366|26390967|FG000|Overall Study|Other|5|||
13258099|NCT01497366|26390968|FG001|Overall Study|Other|0|||
13258100|NCT01497366|26390967|FG000|Overall Study|Death|1|||
13258101|NCT01497366|26390968|FG001|Overall Study|Death|1|||
13258102|NCT01497366|26390967|FG000|Overall Study|Randomized but not treated|7|||
13258103|NCT01497366|26390968|FG001|Overall Study|Randomized but not treated|21|||
13258104|NCT01497275|26390977|FG000|Overall Study|Death|1|||
13258105|NCT01497275|26390977|FG000|Overall Study|Adverse Event|1|||
13258106|NCT01497262|26390984|FG000|Overall Study|Abnormal Lab Values|4|||
13258107|NCT01497262|26390984|FG000|Overall Study|Abnormal Test Procedure Result|1|||
13258108|NCT01497262|26390984|FG000|Overall Study|Physician Decision|1|||
13258109|NCT01497262|26390984|FG000|Overall Study|Withdrawal by Subject|2|||
13258110|NCT01497262|26390984|FG000|Overall Study|Adverse Event|2|||
13258111|NCT01497262|26390984|FG000|Overall Study|Protocol Violation|1|||
13258112|NCT01497197|26391017|FG000|Overall Study|Lost to Follow-up|1|||
13258113|NCT01497197|26391018|FG001|Overall Study|Lost to Follow-up|0|||
13258114|NCT01497197|26391017|FG000|Overall Study|Protocol Violation|0|||
13258115|NCT01497197|26391018|FG001|Overall Study|Protocol Violation|2|||
13258116|NCT01497197|26391017|FG000|Overall Study|Withdrawal by Subject|2|||
13258117|NCT01497197|26391018|FG001|Overall Study|Withdrawal by Subject|1|||
13258118|NCT01497197|26391017|FG000|Overall Study|Excessive/lack of response to treatment|1|||
13258119|NCT01497197|26391018|FG001|Overall Study|Excessive/lack of response to treatment|0|||
13258120|NCT01497197|26391017|FG000|Overall Study|Risk of OHSS|1|||
13258121|NCT01497197|26391018|FG001|Overall Study|Risk of OHSS|0|||
13258122|NCT01497197|26391017|FG000|Overall Study|No oocytes retrieved|3|||
13258123|NCT01497197|26391018|FG001|Overall Study|No oocytes retrieved|2|||
13117232|NCT03063632|25924701|FG000|Overall Study|Death|3|||
13117233|NCT03063632|25924702|FG001|Overall Study|Death|6|||
13117234|NCT03063632|25924701|FG000|Overall Study|Lost to Follow-up|0|||
13117235|NCT03063632|25924702|FG001|Overall Study|Lost to Follow-up|1|||
13117236|NCT03063632|25924701|FG000|Overall Study|Withdrawal by Subject|0|||
13258124|NCT01497197|26391017|FG000|Overall Study|No fertilisation|6|||
13258125|NCT01497197|26391018|FG001|Overall Study|No fertilisation|5|||
13258126|NCT01497197|26391017|FG000|Overall Study|Intention to freeze all embryos|0|||
13258127|NCT01497197|26391018|FG001|Overall Study|Intention to freeze all embryos|1|||
13258128|NCT01497197|26391017|FG000|Overall Study|All embryos discarded|0|||
13258129|NCT01497197|26391018|FG001|Overall Study|All embryos discarded|3|||
13258130|NCT01497197|26391017|FG000|Overall Study|Other|3|||
13258131|NCT01497197|26391018|FG001|Overall Study|Other|1|||
13258132|NCT01497067|26391025|FG000|Overall Study|Lost to Follow-up|56|||
13258133|NCT01497067|26391025|FG000|Overall Study|Adverse Event|3|||
13258134|NCT01497067|26391025|FG000|Overall Study|Patient decision unrel to Adverse Event|10|||
13258135|NCT01497067|26391025|FG000|Overall Study|Other|13|||
13258136|NCT01496976|26391034|FG000|Overall Study|Withdrew - received stem cell transplant|1|||
13258137|NCT01496885|26391045|FG000|Overall Study|Lost to Follow-up|13|||
13258138|NCT01496885|26391045|FG000|Overall Study|Withdrawal by Subject|7|||
13258139|NCT01496885|26391045|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2|||
13258140|NCT01496885|26391045|FG000|Overall Study|Death|1|||
13258141|NCT01496846|26391075|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
13258142|NCT01496846|26391076|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
13258143|NCT01496846|26391077|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
13258144|NCT01496846|26391078|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
13258145|NCT01496846|26391079|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
13258146|NCT01496846|26391080|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
13258147|NCT01496807|26391092|FG000|Overall Study|Progressive Disease|21|||
13258148|NCT01496807|26391092|FG000|Overall Study|Participant preference/toxicity|8|||
13258149|NCT01496807|26391092|FG000|Overall Study|Change in diagnosis|1|||
13258150|NCT01496612|26391115|FG000|1st Intervention|Adverse Event|1|||
13258151|NCT01496612|26391116|FG001|1st Intervention|Adverse Event|0|||
13258152|NCT01496612|26391115|FG000|1st Intervention|Withdrawal by Subject|1|||
13258153|NCT01496612|26391116|FG001|1st Intervention|Withdrawal by Subject|0|||
13258154|NCT01496469|26391133|FG000|Overall Study|Adverse Event|1|||
13258155|NCT01496469|26391134|FG001|Overall Study|Adverse Event|0|||
13258156|NCT01496469|26391133|FG000|Overall Study|Protocol Violation|2|||
13258157|NCT01496469|26391134|FG001|Overall Study|Protocol Violation|0|||
13258158|NCT01496469|26391133|FG000|Overall Study|Lost to Follow-up|1|||
13258159|NCT01496469|26391134|FG001|Overall Study|Lost to Follow-up|1|||
13258160|NCT01496469|26391133|FG000|Overall Study|Withdrawal by Subject|4|||
13258161|NCT01496469|26391134|FG001|Overall Study|Withdrawal by Subject|4|||
13258162|NCT01496469|26391133|FG000|Overall Study|BP exceeds protocol limits|1|||
13258163|NCT01496469|26391134|FG001|Overall Study|BP exceeds protocol limits|2|||
13258164|NCT01496469|26391133|FG000|Overall Study|Other|1|||
13258165|NCT01496469|26391134|FG001|Overall Study|Other|1|||
13258166|NCT01496456|26391146|FG000|Overall Study|Protocol Violation|1|||
13258167|NCT01496456|26391146|FG000|Overall Study|Lost to Follow-up|7|||
13258168|NCT01496430|26391230|FG000|Overall Study|Adverse Event|0|||
13258169|NCT01496430|26391231|FG001|Overall Study|Adverse Event|0|||
13258170|NCT01496430|26391232|FG002|Overall Study|Adverse Event|1|||
13258171|NCT01496430|26391230|FG000|Overall Study|Major Protocol Deviation|0|||
13258172|NCT01496430|26391231|FG001|Overall Study|Major Protocol Deviation|0|||
13258173|NCT01496430|26391232|FG002|Overall Study|Major Protocol Deviation|1|||
13258174|NCT01496430|26391230|FG000|Overall Study|Lost to Follow-up|2|||
13258175|NCT01496430|26391231|FG001|Overall Study|Lost to Follow-up|3|||
13258176|NCT01496430|26391232|FG002|Overall Study|Lost to Follow-up|1|||
13258177|NCT01496430|26391230|FG000|Overall Study|Voluntary Withdrawal|2|||
13117237|NCT03063632|25924702|FG001|Overall Study|Withdrawal by Subject|2|||
13258178|NCT01496430|26391231|FG001|Overall Study|Voluntary Withdrawal|1|||
13258179|NCT01496430|26391232|FG002|Overall Study|Voluntary Withdrawal|6|||
13258180|NCT01496430|26391230|FG000|Overall Study|Principal Investigator Discretion|0|||
13258181|NCT01496430|26391231|FG001|Overall Study|Principal Investigator Discretion|1|||
13258182|NCT01496430|26391232|FG002|Overall Study|Principal Investigator Discretion|1|||
13258183|NCT01496430|26391230|FG000|Overall Study|Other|2|||
13258184|NCT01496430|26391231|FG001|Overall Study|Other|0|||
13258185|NCT01496430|26391232|FG002|Overall Study|Other|0|||
13258186|NCT01496365|26391354|FG000|Overall Study|Adverse Event|2|||
13258187|NCT01496365|26391355|FG001|Overall Study|Adverse Event|3|||
13258188|NCT01496365|26391356|FG002|Overall Study|Adverse Event|3|||
13258189|NCT01496365|26391357|FG003|Overall Study|Adverse Event|2|||
13258190|NCT01496365|26391358|FG004|Overall Study|Adverse Event|5|||
13258191|NCT01496365|26391359|FG005|Overall Study|Adverse Event|6|||
13258192|NCT01496365|26391360|FG006|Overall Study|Adverse Event|4|||
13258193|NCT01496365|26391354|FG000|Overall Study|Withdrawal by Subject|6|||
13258194|NCT01496365|26391355|FG001|Overall Study|Withdrawal by Subject|6|||
13258195|NCT01496365|26391356|FG002|Overall Study|Withdrawal by Subject|0|||
13258196|NCT01496365|26391357|FG003|Overall Study|Withdrawal by Subject|1|||
13258197|NCT01496365|26391358|FG004|Overall Study|Withdrawal by Subject|3|||
13258198|NCT01496365|26391359|FG005|Overall Study|Withdrawal by Subject|2|||
13258199|NCT01496365|26391360|FG006|Overall Study|Withdrawal by Subject|1|||
13258200|NCT01496365|26391354|FG000|Overall Study|Protocol Violation|2|||
13258201|NCT01496365|26391355|FG001|Overall Study|Protocol Violation|1|||
13258202|NCT01496365|26391356|FG002|Overall Study|Protocol Violation|1|||
13258203|NCT01496365|26391357|FG003|Overall Study|Protocol Violation|0|||
13258204|NCT01496365|26391358|FG004|Overall Study|Protocol Violation|0|||
13258205|NCT01496365|26391359|FG005|Overall Study|Protocol Violation|1|||
13258206|NCT01496365|26391360|FG006|Overall Study|Protocol Violation|0|||
13258207|NCT01496365|26391354|FG000|Overall Study|Lack of Efficacy|1|||
13258208|NCT01496365|26391355|FG001|Overall Study|Lack of Efficacy|0|||
13258209|NCT01496365|26391356|FG002|Overall Study|Lack of Efficacy|0|||
13258210|NCT01496365|26391357|FG003|Overall Study|Lack of Efficacy|0|||
13258211|NCT01496365|26391358|FG004|Overall Study|Lack of Efficacy|0|||
13258212|NCT01496365|26391359|FG005|Overall Study|Lack of Efficacy|1|||
13258213|NCT01496365|26391360|FG006|Overall Study|Lack of Efficacy|0|||
13258214|NCT01496365|26391354|FG000|Overall Study|Lost to Follow-up|0|||
13258215|NCT01496365|26391355|FG001|Overall Study|Lost to Follow-up|1|||
13258216|NCT01496365|26391356|FG002|Overall Study|Lost to Follow-up|0|||
13258217|NCT01496365|26391357|FG003|Overall Study|Lost to Follow-up|0|||
13258218|NCT01496365|26391358|FG004|Overall Study|Lost to Follow-up|2|||
13258219|NCT01496365|26391359|FG005|Overall Study|Lost to Follow-up|0|||
13258220|NCT01496365|26391360|FG006|Overall Study|Lost to Follow-up|0|||
13258221|NCT01496365|26391354|FG000|Overall Study|Other|4|||
13258222|NCT01496365|26391355|FG001|Overall Study|Other|4|||
13258223|NCT01496365|26391356|FG002|Overall Study|Other|2|||
13258224|NCT01496365|26391357|FG003|Overall Study|Other|1|||
13258225|NCT01496365|26391358|FG004|Overall Study|Other|3|||
13258226|NCT01496365|26391359|FG005|Overall Study|Other|0|||
13258227|NCT01496365|26391360|FG006|Overall Study|Other|1|||
13258228|NCT01496287|26391370|FG000|Overall Study|Lost to Follow-up|1|||
13258229|NCT01496287|26391370|FG000|Overall Study|Incomplete anesthesia|5|||
13258230|NCT01496274|26391409|FG000|Overall Study|Protocol Violation|0|||
13258231|NCT01496274|26391410|FG001|Overall Study|Protocol Violation|1|||
13258232|NCT01496274|26391409|FG000|Overall Study|Adverse Event|1|||
13258233|NCT01496274|26391410|FG001|Overall Study|Adverse Event|1|||
13258234|NCT01496274|26391409|FG000|Overall Study|Withdrawal by Subject|2|||
13258235|NCT01496274|26391410|FG001|Overall Study|Withdrawal by Subject|0|||
13258236|NCT01496274|26391409|FG000|Overall Study|Lost to Follow-up|0|||
13258237|NCT01496274|26391410|FG001|Overall Study|Lost to Follow-up|3|||
13258238|NCT01496183|26391447|FG000|Overall Study|Physician Decision|3|||
13258239|NCT01496183|26391448|FG001|Overall Study|Physician Decision|1|||
13258240|NCT01496183|26391447|FG000|Overall Study|Withdrawal by Subject|0|||
13258241|NCT01496183|26391448|FG001|Overall Study|Withdrawal by Subject|1|||
13258242|NCT01496066|26391474|FG000|Overall Study|Lost to Follow-up|8|||
13258243|NCT01496066|26391475|FG001|Overall Study|Lost to Follow-up|5|||
13258244|NCT01496066|26391474|FG000|Overall Study|Explant|3|||
13117238|NCT03063632|25924701|FG000|Overall Study|Physician Decision|2|||
13258245|NCT01496066|26391475|FG001|Overall Study|Explant|0|||
13258246|NCT01496066|26391474|FG000|Overall Study|Death|1|||
13258247|NCT01496066|26391475|FG001|Overall Study|Death|4|||
13258248|NCT01495975|26391488|FG000|Overall Study|Lost to Follow-up|1|||
13258249|NCT01495975|26391489|FG001|Overall Study|Lost to Follow-up|0|||
13258250|NCT01495793|26391502|FG000|Overall Study|Lost to Follow-up|1|||
13258251|NCT01495793|26391502|FG000|Overall Study|Violation of inclusion criteria|1|||
13258252|NCT01495702|26391522|FG000|Randomized Phase|Randomized But Not Treated|1|||
13258253|NCT01495702|26391523|FG001|Randomized Phase|Randomized But Not Treated|4|||
13258254|NCT01495702|26391522|FG000|Randomized Phase|Adverse Event|2|||
13258255|NCT01495702|26391523|FG001|Randomized Phase|Adverse Event|2|||
13258256|NCT01495702|26391522|FG000|Randomized Phase|Death|1|||
13258257|NCT01495702|26391523|FG001|Randomized Phase|Death|0|||
13258258|NCT01495702|26391522|FG000|Randomized Phase|Lack of Efficacy|2|||
13258259|NCT01495702|26391523|FG001|Randomized Phase|Lack of Efficacy|0|||
13258260|NCT01495702|26391522|FG000|Randomized Phase|Investigators Discretion|2|||
13258261|NCT01495702|26391523|FG001|Randomized Phase|Investigators Discretion|0|||
13258262|NCT01495702|26391522|FG000|Randomized Phase|Withdrew Consent|10|||
13258263|NCT01495702|26391523|FG001|Randomized Phase|Withdrew Consent|18|||
13258264|NCT01495702|26391522|FG000|Randomized Phase|Lost to Follow-up|4|||
13258265|NCT01495702|26391523|FG001|Randomized Phase|Lost to Follow-up|3|||
13258266|NCT01495702|26391522|FG000|Randomized Phase|Participant Noncompliance|1|||
13258267|NCT01495702|26391523|FG001|Randomized Phase|Participant Noncompliance|0|||
13258268|NCT01495702|26391522|FG000|Randomized Phase|Protocol Violation|3|||
13258269|NCT01495702|26391523|FG001|Randomized Phase|Protocol Violation|1|||
13258270|NCT01495000|26391570|FG000|Overall Study|Lost to Follow-up|2|||
13258271|NCT01495000|26391571|FG001|Overall Study|Lost to Follow-up|2|||
13258272|NCT01495000|26391570|FG000|Overall Study|Protocol Violation|1|||
13258273|NCT01495000|26391571|FG001|Overall Study|Protocol Violation|0|||
13258274|NCT01495000|26391570|FG000|Overall Study|Withdrawal by Subject|10|||
13258275|NCT01495000|26391571|FG001|Overall Study|Withdrawal by Subject|10|||
13258276|NCT01494987|26391590|FG000|Overall Study|Adverse Event|6|||
13258277|NCT01494987|26391591|FG001|Overall Study|Adverse Event|5|||
13258278|NCT01494987|26391590|FG000|Overall Study|Hyperglycemia|6|||
13258279|NCT01494987|26391591|FG001|Overall Study|Hyperglycemia|4|||
13258280|NCT01494987|26391590|FG000|Overall Study|Investigator's Discretion|1|||
13258281|NCT01494987|26391591|FG001|Overall Study|Investigator's Discretion|2|||
13258282|NCT01494987|26391590|FG000|Overall Study|Lost to Follow-up|1|||
13258283|NCT01494987|26391591|FG001|Overall Study|Lost to Follow-up|1|||
13258284|NCT01494987|26391590|FG000|Overall Study|Protocol Violation|3|||
13258285|NCT01494987|26391591|FG001|Overall Study|Protocol Violation|3|||
13258286|NCT01494987|26391590|FG000|Overall Study|Subject Non-Compliance|9|||
13258287|NCT01494987|26391591|FG001|Overall Study|Subject Non-Compliance|10|||
13258288|NCT01494987|26391590|FG000|Overall Study|Subject Withdrew Consent|2|||
13258289|NCT01494987|26391591|FG001|Overall Study|Subject Withdrew Consent|3|||
13258290|NCT01494922|26391606|FG000|Overall Study|Adverse Event|1|||
13258291|NCT01494818|26391633|FG000|Overall Study|Relocation|1|||
13258292|NCT01494818|26391634|FG001|Overall Study|Relocation|2|||
13258293|NCT01494818|26391633|FG000|Overall Study|Lost to Follow-up|1|||
13258294|NCT01494818|26391634|FG001|Overall Study|Lost to Follow-up|0|||
13258295|NCT01494649|26391657|FG000|Overall Study|Lost to Follow-up|0|||
13258296|NCT01494649|26391658|FG001|Overall Study|Lost to Follow-up|1|||
13258297|NCT01494610|26391729|FG000|Period 1|Withdrawal by Subject|1|||
13258298|NCT01494610|26391730|FG001|Period 1|Withdrawal by Subject|1|||
13258299|NCT01494610|26391729|FG000|Period 3|Adverse Event|1|||
13258300|NCT01494610|26391730|FG001|Period 3|Adverse Event|0|||
13258301|NCT01494610|26391729|FG000|Period 3|Withdrawal by Subject|1|||
13258302|NCT01494610|26391730|FG001|Period 3|Withdrawal by Subject|0|||
13258303|NCT01494610|26391729|FG000|Period 4|Protocol Violation|1|||
13258304|NCT01494610|26391730|FG001|Period 4|Protocol Violation|0|||
13258305|NCT01494584|26391821|FG000|Overall Study|Study Closed/Terminated|1|||
13258306|NCT01494532|26391992|FG000|Overall Study|Adverse Event|4|||
13258307|NCT01494532|26391993|FG001|Overall Study|Adverse Event|1|||
13258308|NCT01494532|26391994|FG002|Overall Study|Adverse Event|8|||
13258309|NCT01494532|26391995|FG003|Overall Study|Adverse Event|6|||
13258310|NCT01494532|26391996|FG004|Overall Study|Adverse Event|5|||
13258311|NCT01494532|26391997|FG005|Overall Study|Adverse Event|0|||
13258312|NCT01494532|26391992|FG000|Overall Study|Lack of Efficacy|0|||
13258313|NCT01494532|26391993|FG001|Overall Study|Lack of Efficacy|0|||
13258314|NCT01494532|26391994|FG002|Overall Study|Lack of Efficacy|0|||
13258315|NCT01494532|26391995|FG003|Overall Study|Lack of Efficacy|0|||
13258316|NCT01494532|26391996|FG004|Overall Study|Lack of Efficacy|2|||
13258317|NCT01494532|26391997|FG005|Overall Study|Lack of Efficacy|0|||
13258318|NCT01494532|26391992|FG000|Overall Study|Protocol deviation|2|||
13258319|NCT01494532|26391993|FG001|Overall Study|Protocol deviation|1|||
13258320|NCT01494532|26391994|FG002|Overall Study|Protocol deviation|3|||
13258321|NCT01494532|26391995|FG003|Overall Study|Protocol deviation|2|||
13258322|NCT01494532|26391996|FG004|Overall Study|Protocol deviation|3|||
13258323|NCT01494532|26391997|FG005|Overall Study|Protocol deviation|0|||
13258324|NCT01494532|26391992|FG000|Overall Study|Protocol-defined stopping criteria|0|||
13258325|NCT01494532|26391993|FG001|Overall Study|Protocol-defined stopping criteria|0|||
13258326|NCT01494532|26391994|FG002|Overall Study|Protocol-defined stopping criteria|1|||
13258327|NCT01494532|26391995|FG003|Overall Study|Protocol-defined stopping criteria|0|||
13258328|NCT01494532|26391996|FG004|Overall Study|Protocol-defined stopping criteria|0|||
13258329|NCT01494532|26391997|FG005|Overall Study|Protocol-defined stopping criteria|0|||
13258330|NCT01494532|26391992|FG000|Overall Study|Lost to Follow-up|1|||
13258331|NCT01494532|26391993|FG001|Overall Study|Lost to Follow-up|0|||
13258332|NCT01494532|26391994|FG002|Overall Study|Lost to Follow-up|0|||
13258333|NCT01494532|26391995|FG003|Overall Study|Lost to Follow-up|2|||
13258334|NCT01494532|26391996|FG004|Overall Study|Lost to Follow-up|0|||
13258335|NCT01494532|26391997|FG005|Overall Study|Lost to Follow-up|0|||
13258336|NCT01494532|26391992|FG000|Overall Study|Physician Decision|0|||
13258337|NCT01494532|26391993|FG001|Overall Study|Physician Decision|1|||
13258338|NCT01494532|26391994|FG002|Overall Study|Physician Decision|1|||
13258339|NCT01494532|26391995|FG003|Overall Study|Physician Decision|2|||
13258340|NCT01494532|26391996|FG004|Overall Study|Physician Decision|0|||
13258341|NCT01494532|26391997|FG005|Overall Study|Physician Decision|0|||
13258342|NCT01494532|26391992|FG000|Overall Study|Withdrawal by Subject|3|||
13258343|NCT01494532|26391993|FG001|Overall Study|Withdrawal by Subject|1|||
13258344|NCT01494532|26391994|FG002|Overall Study|Withdrawal by Subject|4|||
13258345|NCT01494532|26391995|FG003|Overall Study|Withdrawal by Subject|3|||
13258346|NCT01494532|26391996|FG004|Overall Study|Withdrawal by Subject|2|||
13258347|NCT01494532|26391997|FG005|Overall Study|Withdrawal by Subject|0|||
13258348|NCT01494506|26392042|FG000|Overall Study|Lack of Efficacy|77|||
13258349|NCT01494506|26392043|FG001|Overall Study|Lack of Efficacy|83|||
13258350|NCT01494506|26392044|FG002|Overall Study|Lack of Efficacy|57|||
13258351|NCT01494506|26392042|FG000|Overall Study|Adverse Event|17|||
13258352|NCT01494506|26392043|FG001|Overall Study|Adverse Event|10|||
13258353|NCT01494506|26392044|FG002|Overall Study|Adverse Event|11|||
13258354|NCT01494506|26392042|FG000|Overall Study|Death|9|||
13258355|NCT01494506|26392043|FG001|Overall Study|Death|5|||
13258356|NCT01494506|26392044|FG002|Overall Study|Death|2|||
13258357|NCT01494506|26392042|FG000|Overall Study|Physician Decision|7|||
13258358|NCT01494506|26392043|FG001|Overall Study|Physician Decision|5|||
13258359|NCT01494506|26392044|FG002|Overall Study|Physician Decision|4|||
13258360|NCT01494506|26392042|FG000|Overall Study|Withdrawal by Subject|17|||
13258361|NCT01494506|26392043|FG001|Overall Study|Withdrawal by Subject|20|||
13258362|NCT01494506|26392044|FG002|Overall Study|Withdrawal by Subject|14|||
13258363|NCT01494506|26392042|FG000|Overall Study|Clinical Deterioration|21|||
13258364|NCT01494506|26392043|FG001|Overall Study|Clinical Deterioration|17|||
13258365|NCT01494506|26392044|FG002|Overall Study|Clinical Deterioration|13|||
13258366|NCT01494506|26392042|FG000|Overall Study|Sponsor Decision|0|||
13258367|NCT01494506|26392043|FG001|Overall Study|Sponsor Decision|0|||
13258368|NCT01494506|26392044|FG002|Overall Study|Sponsor Decision|1|||
13258369|NCT01494506|26392042|FG000|Overall Study|Other|0|||
13258370|NCT01494506|26392043|FG001|Overall Study|Other|3|||
13258371|NCT01494506|26392044|FG002|Overall Study|Other|1|||
13258372|NCT01494467|26392067|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1|||
13258373|NCT01494467|26392068|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
13258374|NCT01494467|26392067|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6|||
13258375|NCT01494467|26392068|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
13258376|NCT01494467|26392067|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9|||
13258377|NCT01494467|26392068|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8|||
13258378|NCT01494467|26392067|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4|||
13258379|NCT01494467|26392068|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0|||
13258380|NCT01494467|26392067|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
13258381|NCT01494467|26392068|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
13258382|NCT01494467|26392067|FG000|Part A Vehicle Control (12 Weeks)|Other|1|||
13258383|NCT01494467|26392068|FG001|Part A Vehicle Control (12 Weeks)|Other|1|||
13258384|NCT01494467|26392067|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
13258385|NCT01494467|26392068|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
13258386|NCT01494467|26392067|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2|||
13258387|NCT01494467|26392068|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0|||
13258388|NCT01494467|26392067|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1|||
13258389|NCT01494467|26392068|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
13258390|NCT01494467|26392067|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3|||
13258391|NCT01494467|26392068|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
13258392|NCT01494467|26392067|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32|||
13258393|NCT01494467|26392068|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24|||
13258394|NCT01494467|26392067|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3|||
13258395|NCT01494467|26392068|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5|||
13258396|NCT01494467|26392067|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26|||
13258397|NCT01494467|26392068|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
13258398|NCT01494467|26392067|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8|||
13258399|NCT01494467|26392068|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2|||
13258400|NCT01494350|26392078|FG000|Overall Study|Worsening of lesion|1|||
13258401|NCT01494298|26392095|FG000|Overall Study|Protocol Violation|2|||
13258402|NCT01494298|26392096|FG001|Overall Study|Protocol Violation|8|||
13258403|NCT01494038|26392189|FG000|Overall Study|Protocol Violation|1|||
13258404|NCT01494038|26392190|FG001|Overall Study|Protocol Violation|1|||
13258405|NCT01494038|26392189|FG000|Overall Study|Lost to Follow-up|18|||
13258406|NCT01494038|26392190|FG001|Overall Study|Lost to Follow-up|20|||
13258407|NCT01494038|26392189|FG000|Overall Study|Withdrawal by Subject|44|||
13258408|NCT01494038|26392190|FG001|Overall Study|Withdrawal by Subject|34|||
13258409|NCT01494038|26392189|FG000|Overall Study|Not able to get to clinic|21|||
13258410|NCT01494038|26392190|FG001|Overall Study|Not able to get to clinic|15|||
13258411|NCT01494038|26392189|FG000|Overall Study|Not willing to adhere to reqs|2|||
13258412|NCT01494038|26392190|FG001|Overall Study|Not willing to adhere to reqs|9|||
13258413|NCT01494038|26392189|FG000|Overall Study|Death|2|||
13258414|NCT01494038|26392190|FG001|Overall Study|Death|4|||
13258415|NCT01493778|26392252|FG000|Overall Study|Withdrawal by Subject|8|||
13258416|NCT01493687|26392275|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2|||
13258417|NCT01493687|26392276|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
13258418|NCT01493687|26392275|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
13258419|NCT01493687|26392276|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
13258420|NCT01493687|26392275|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7|||
13258421|NCT01493687|26392276|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
13258422|NCT01493687|26392275|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18|||
13258423|NCT01493687|26392276|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7|||
13258424|NCT01493687|26392275|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2|||
13258425|NCT01493687|26392276|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1|||
13258426|NCT01493687|26392275|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7|||
13258427|NCT01493687|26392276|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
13258428|NCT01493687|26392275|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
13258429|NCT01493687|26392276|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
13258430|NCT01493687|26392275|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5|||
13258431|NCT01493687|26392276|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1|||
13258432|NCT01493687|26392275|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2|||
13258433|NCT01493687|26392276|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
13258434|NCT01493687|26392275|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
13258435|NCT01493687|26392276|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4|||
13258436|NCT01493687|26392275|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27|||
13258437|NCT01493687|26392276|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16|||
13258438|NCT01493687|26392275|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1|||
13258439|NCT01493687|26392276|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0|||
13258440|NCT01493687|26392275|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16|||
13258441|NCT01493687|26392276|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
13258442|NCT01493687|26392275|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5|||
13258443|NCT01493687|26392276|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1|||
13258444|NCT01493687|26392275|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0|||
13258445|NCT01493687|26392276|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1|||
13258446|NCT01493557|26392311|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
13258447|NCT01493557|26392312|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
13258448|NCT01493557|26392313|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1|||
13258449|NCT01493557|26392311|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
13258450|NCT01493557|26392312|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
13258451|NCT01493557|26392313|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9|||
13258452|NCT01493557|26392311|FG000|Not Randomized to Management Strategies|Other adverse event|0|||
13258453|NCT01493557|26392312|FG001|Not Randomized to Management Strategies|Other adverse event|0|||
13258454|NCT01493557|26392313|FG002|Not Randomized to Management Strategies|Other adverse event|54|||
13258455|NCT01493557|26392311|FG000|Not Randomized to Management Strategies|Protocol Violation|0|||
13258456|NCT01493557|26392312|FG001|Not Randomized to Management Strategies|Protocol Violation|0|||
13258457|NCT01493557|26392313|FG002|Not Randomized to Management Strategies|Protocol Violation|1|||
13258458|NCT01493557|26392311|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0|||
13258459|NCT01493557|26392312|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0|||
13258460|NCT01493557|26392313|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4|||
13258461|NCT01493557|26392311|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
13258462|NCT01493557|26392312|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
13258463|NCT01493557|26392313|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10|||
13258464|NCT01493557|26392311|FG000|Not Randomized to Management Strategies|Early termination|0|||
13258465|NCT01493557|26392312|FG001|Not Randomized to Management Strategies|Early termination|0|||
13258466|NCT01493557|26392313|FG002|Not Randomized to Management Strategies|Early termination|34|||
13258467|NCT01493557|26392311|FG000|Not Randomized to Management Strategies|Other than stated above|0|||
13258468|NCT01493557|26392312|FG001|Not Randomized to Management Strategies|Other than stated above|0|||
13258469|NCT01493557|26392313|FG002|Not Randomized to Management Strategies|Other than stated above|21|||
13258470|NCT01493557|26392311|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3|||
13258471|NCT01493557|26392312|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2|||
13258472|NCT01493557|26392313|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0|||
13258473|NCT01493557|26392311|FG000|Randomized to Management Strategies|Other adverse event|8|||
13258474|NCT01493557|26392312|FG001|Randomized to Management Strategies|Other adverse event|5|||
13258475|NCT01493557|26392313|FG002|Randomized to Management Strategies|Other adverse event|0|||
13258476|NCT01493557|26392311|FG000|Randomized to Management Strategies|Protocol Violation|3|||
13258477|NCT01493557|26392312|FG001|Randomized to Management Strategies|Protocol Violation|0|||
13258478|NCT01493557|26392313|FG002|Randomized to Management Strategies|Protocol Violation|0|||
13258479|NCT01493557|26392311|FG000|Randomized to Management Strategies|Withdrawal by Subject|0|||
13258480|NCT01493557|26392312|FG001|Randomized to Management Strategies|Withdrawal by Subject|1|||
13258481|NCT01493557|26392313|FG002|Randomized to Management Strategies|Withdrawal by Subject|0|||
13258482|NCT01493557|26392311|FG000|Randomized to Management Strategies|Other than stated above|1|||
13258483|NCT01493557|26392312|FG001|Randomized to Management Strategies|Other than stated above|3|||
13258484|NCT01493557|26392313|FG002|Randomized to Management Strategies|Other than stated above|0|||
13258485|NCT01493557|26392311|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1|||
13258486|NCT01493557|26392312|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1|||
13258487|NCT01493557|26392313|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0|||
13258488|NCT01493557|26392311|FG000|Adding the Second Strategy|Other adverse event|1|||
13258489|NCT01493557|26392312|FG001|Adding the Second Strategy|Other adverse event|2|||
13258490|NCT01493557|26392313|FG002|Adding the Second Strategy|Other adverse event|0|||
13258491|NCT01493557|26392311|FG000|Adding the Second Strategy|Withdrawal by Subject|0|||
13258492|NCT01493557|26392312|FG001|Adding the Second Strategy|Withdrawal by Subject|1|||
13258493|NCT01493557|26392313|FG002|Adding the Second Strategy|Withdrawal by Subject|0|||
13258494|NCT01493531|26392337|FG000|Overall Study|Adverse Event|4|||
13258495|NCT01493531|26392338|FG001|Overall Study|Adverse Event|12|||
13258496|NCT01493531|26392339|FG002|Overall Study|Adverse Event|9|||
13258497|NCT01493531|26392337|FG000|Overall Study|Gout flare|3|||
13258498|NCT01493531|26392338|FG001|Overall Study|Gout flare|0|||
13258499|NCT01493531|26392339|FG002|Overall Study|Gout flare|2|||
13258500|NCT01493531|26392337|FG000|Overall Study|Protocol Violation|8|||
13258501|NCT01493531|26392338|FG001|Overall Study|Protocol Violation|15|||
13258502|NCT01493531|26392339|FG002|Overall Study|Protocol Violation|12|||
13258503|NCT01493531|26392337|FG000|Overall Study|Sponsor terminated study|5|||
13258504|NCT01493531|26392338|FG001|Overall Study|Sponsor terminated study|2|||
13258505|NCT01493531|26392339|FG002|Overall Study|Sponsor terminated study|3|||
13258506|NCT01493531|26392337|FG000|Overall Study|Lost to Follow-up|5|||
13258507|NCT01493531|26392338|FG001|Overall Study|Lost to Follow-up|7|||
13258508|NCT01493531|26392339|FG002|Overall Study|Lost to Follow-up|11|||
13258509|NCT01493531|26392337|FG000|Overall Study|Withdrawal by Subject|16|||
13258510|NCT01493531|26392338|FG001|Overall Study|Withdrawal by Subject|13|||
13258511|NCT01493531|26392339|FG002|Overall Study|Withdrawal by Subject|11|||
13258512|NCT01493531|26392337|FG000|Overall Study|Death|0|||
13258513|NCT01493531|26392338|FG001|Overall Study|Death|1|||
13258514|NCT01493531|26392339|FG002|Overall Study|Death|0|||
13258515|NCT01493427|26392346|FG000|Overall Study|Adverse Event|10|||
13258516|NCT01493427|26392346|FG000|Overall Study|Personal Reasons|4|||
13258517|NCT01493427|26392346|FG000|Overall Study|Lost to Follow-up|2|||
13258518|NCT01493427|26392346|FG000|Overall Study|Inability to Follow Instructions|2|||
13258519|NCT01493427|26392346|FG000|Overall Study|Other|2|||
13258520|NCT01493414|26392361|FG000|Overall Study|Adverse Event|405|||
13258521|NCT01493414|26392361|FG000|Overall Study|Disease progression|204|||
13258522|NCT01493414|26392361|FG000|Overall Study|Death|101|||
13258523|NCT01493414|26392361|FG000|Overall Study|Physician Decision|93|||
13258524|NCT01493414|26392361|FG000|Overall Study|Withdrawal by Subject|79|||
13258525|NCT01493414|26392361|FG000|Overall Study|Protocol deviation|27|||
13258526|NCT01493414|26392361|FG000|Overall Study|Administrative problems|25|||
13258527|NCT01493414|26392361|FG000|Overall Study|Lost to Follow-up|16|||
13258528|NCT01493284|26392370|FG000|Overall Study|Death|29|||
13258529|NCT01493284|26392370|FG000|Overall Study|Withdrawal by Subject|32|||
13258530|NCT01493089|26392393|FG000|Overall Study|Protocol Violation|2|||
13258531|NCT01493089|26392394|FG001|Overall Study|Protocol Violation|2|||
13258532|NCT01493089|26392393|FG000|Overall Study|Withdrawal by Subject|1|||
13258533|NCT01493089|26392394|FG001|Overall Study|Withdrawal by Subject|0|||
13258534|NCT01493089|26392393|FG000|Overall Study|Physician Decision|0|||
13258535|NCT01493089|26392394|FG001|Overall Study|Physician Decision|1|||
13258536|NCT01492686|26392425|FG000|Double-blind Phase|Adverse Event|0|||
13258537|NCT01492686|26392426|FG001|Double-blind Phase|Adverse Event|2|||
13258538|NCT01492686|26392425|FG000|Double-blind Phase|Physician Decision|0|||
13258539|NCT01492686|26392426|FG001|Double-blind Phase|Physician Decision|1|||
13258540|NCT01492686|26392425|FG000|Double-blind Phase|Withdrawal by Subject|0|||
13258541|NCT01492686|26392426|FG001|Double-blind Phase|Withdrawal by Subject|2|||
13258542|NCT01492686|26392425|FG000|Double-blind Phase|Due to a discontinuation criterion|2|||
13258543|NCT01492686|26392426|FG001|Double-blind Phase|Due to a discontinuation criterion|3|||
13258544|NCT01492686|26392425|FG000|Open-label Phase|Adverse Event|1|||
13258545|NCT01492686|26392426|FG001|Open-label Phase|Adverse Event|2|||
13258546|NCT01492686|26392425|FG000|Open-label Phase|Physician Decision|1|||
13258547|NCT01492686|26392426|FG001|Open-label Phase|Physician Decision|0|||
13258548|NCT01492686|26392425|FG000|Open-label Phase|Withdrawal by Subject|6|||
13258549|NCT01492686|26392426|FG001|Open-label Phase|Withdrawal by Subject|7|||
13258550|NCT01492686|26392425|FG000|Open-label Phase|Due to a discontinuation criterion|4|||
13258551|NCT01492686|26392426|FG001|Open-label Phase|Due to a discontinuation criterion|9|||
13258552|NCT01492439|26392479|FG000|Overall Study|Withdrew from RTE|4|||
13258553|NCT01492439|26392480|FG001|Overall Study|Withdrew from RTE|9|||
13258554|NCT01492426|26392503|FG000|Treatment|Death|0|||
13258555|NCT01492426|26392504|FG001|Treatment|Death|1|||
13258556|NCT01492426|26392503|FG000|Treatment|Other|1|||
13258557|NCT01492426|26392504|FG001|Treatment|Other|0|||
13258558|NCT01492426|26392503|FG000|Treatment|Adverse Event|25|||
13258559|NCT01492426|26392504|FG001|Treatment|Adverse Event|25|||
13258560|NCT01492426|26392503|FG000|Treatment|Lack of Efficacy|38|||
13258561|NCT01492426|26392504|FG001|Treatment|Lack of Efficacy|5|||
13258562|NCT01492426|26392503|FG000|Treatment|Participant withdrew consent|1|||
13258563|NCT01492426|26392504|FG001|Treatment|Participant withdrew consent|2|||
13258564|NCT01492426|26392503|FG000|Treatment|Poor compliance/noncompliance|1|||
13258565|NCT01492426|26392504|FG001|Treatment|Poor compliance/noncompliance|0|||
13258566|NCT01492426|26392503|FG000|Treatment|Subject requested discontinue study drug|7|||
13258567|NCT01492426|26392504|FG001|Treatment|Subject requested discontinue study drug|3|||
13258568|NCT01492426|26392503|FG000|Treatment|Lost to Follow-up|9|||
13258569|NCT01492426|26392504|FG001|Treatment|Lost to Follow-up|4|||
13258570|NCT01492426|26392503|FG000|Treatment|Participant does not meet study criteria|1|||
13258571|NCT01492426|26392504|FG001|Treatment|Participant does not meet study criteria|0|||
13258572|NCT01492426|26392503|FG000|Follow-Up|Protocol Requires no Follow-Up|2|||
13258573|NCT01492426|26392504|FG001|Follow-Up|Protocol Requires no Follow-Up|1|||
13258574|NCT01492426|26392503|FG000|Follow-Up|Death|1|||
13258575|NCT01492426|26392504|FG001|Follow-Up|Death|0|||
13258576|NCT01492426|26392503|FG000|Follow-Up|Other|4|||
13258577|NCT01492426|26392504|FG001|Follow-Up|Other|2|||
13258578|NCT01492426|26392503|FG000|Follow-Up|Participant Withdrew Consent|6|||
13258579|NCT01492426|26392504|FG001|Follow-Up|Participant Withdrew Consent|1|||
13258580|NCT01492426|26392503|FG000|Follow-Up|Lost to Follow-up|12|||
13258581|NCT01492426|26392504|FG001|Follow-Up|Lost to Follow-up|6|||
13258582|NCT01492400|26392521|FG000|Overall Study|Miscellaneous Reasons|2|||
13258583|NCT01492400|26392522|FG001|Overall Study|Miscellaneous Reasons|3|||
13258584|NCT01492400|26392521|FG000|Overall Study|Personal Reasons|0|||
13258585|NCT01492400|26392522|FG001|Overall Study|Personal Reasons|5|||
13258586|NCT01492400|26392521|FG000|Overall Study|Lost to Follow-up|3|||
13258587|NCT01492400|26392522|FG001|Overall Study|Lost to Follow-up|1|||
13258588|NCT01492400|26392521|FG000|Overall Study|Pregnancy|0|||
13258589|NCT01492400|26392522|FG001|Overall Study|Pregnancy|1|||
13258590|NCT01492400|26392521|FG000|Overall Study|Lack of Efficacy|1|||
13258591|NCT01492400|26392522|FG001|Overall Study|Lack of Efficacy|1|||
13258592|NCT01492400|26392521|FG000|Overall Study|Adverse Event|10|||
13258593|NCT01492400|26392522|FG001|Overall Study|Adverse Event|5|||
13258594|NCT01492361|26392553|FG000|Overall Study|Withdrawal by Subject|281|||
13258595|NCT01492361|26392554|FG001|Overall Study|Withdrawal by Subject|297|||
13258596|NCT01492361|26392553|FG000|Overall Study|Physician Decision|12|||
13258597|NCT01492361|26392554|FG001|Overall Study|Physician Decision|12|||
13258598|NCT01492361|26392553|FG000|Overall Study|Lost to Follow-up|6|||
13258599|NCT01492361|26392554|FG001|Overall Study|Lost to Follow-up|13|||
13258600|NCT01492361|26392553|FG000|Overall Study|Other than specified above|106|||
13258601|NCT01492361|26392554|FG001|Overall Study|Other than specified above|138|||
13258602|NCT01492101|26392588|FG000|Overall Study|Death|323|||
13258603|NCT01492101|26392589|FG001|Overall Study|Death|322|||
13258604|NCT01492101|26392588|FG000|Overall Study|Withdrawal by Subject|14|||
13258605|NCT01492101|26392589|FG001|Overall Study|Withdrawal by Subject|18|||
13258606|NCT01492101|26392588|FG000|Overall Study|Lost to Follow-up|0|||
13258607|NCT01492101|26392589|FG001|Overall Study|Lost to Follow-up|2|||
13258608|NCT01492088|26392657|FG000|Overall Study|Withdrawal by Patient|0|||
13258609|NCT01492088|26392658|FG001|Overall Study|Withdrawal by Patient|2|||
13258610|NCT01492088|26392659|FG002|Overall Study|Withdrawal by Patient|0|||
13258611|NCT01492088|26392657|FG000|Overall Study|Death|1|||
13258612|NCT01492088|26392658|FG001|Overall Study|Death|6|||
13258613|NCT01492088|26392659|FG002|Overall Study|Death|2|||
13258614|NCT01492088|26392657|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2|||
13258615|NCT01492088|26392658|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0|||
13258616|NCT01492088|26392659|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1|||
13258617|NCT01492088|26392657|FG000|Overall Study|Alive at Last Follow-up|0|||
13258618|NCT01492088|26392658|FG001|Overall Study|Alive at Last Follow-up|6|||
13117239|NCT03063632|25924702|FG001|Overall Study|Physician Decision|0|||
13117240|NCT03063632|25924701|FG000|Overall Study|Other: Disease progression; starting another treatment|2|||
13117241|NCT03063632|25924702|FG001|Overall Study|Other: Disease progression; starting another treatment|1|||
13117242|NCT03063086|25924732|FG000|Overall Study|technical problems|1|||
13258619|NCT01492088|26392659|FG002|Overall Study|Alive at Last Follow-up|11|||
13258620|NCT01491945|26392677|FG000|Overall Study|Death|30|||
13258621|NCT01491945|26392677|FG000|Overall Study|Withdrwan/LTF|16|||
13258622|NCT01491945|26392677|FG000|Overall Study|Conversion|4|||
13258623|NCT01491945|26392677|FG000|Overall Study|Missed Visit|1|||
13258624|NCT01491919|26392733|FG000|Overall Study|Insufficient PK sampling|1|||
13258625|NCT01491919|26392734|FG001|Overall Study|Insufficient PK sampling|2|||
13258626|NCT01491919|26392735|FG002|Overall Study|Insufficient PK sampling|1|||
13258627|NCT01491854|26392748|FG000|Overall Study|mainly due to premature termination|93|||
13258628|NCT01491854|26392748|FG000|Overall Study|Death|1|||
13258629|NCT01491854|26392748|FG000|Overall Study|Withdrawal by Subject|3|||
13258630|NCT01491854|26392748|FG000|Overall Study|Lost to Follow-up|33|||
13258631|NCT01491841|26392764|FG000|Overall Study|Screen Failure|10|||
13117243|NCT03063086|25924733|FG001|Overall Study|technical problems|0|||
13117244|NCT03063086|25924734|FG002|Overall Study|technical problems|0|||
13117245|NCT03063086|25924735|FG003|Overall Study|technical problems|0|||
13117246|NCT03063086|25924736|FG004|Overall Study|technical problems|0|||
13117247|NCT03063086|25924737|FG005|Overall Study|technical problems|0|||
13117248|NCT03063086|25924732|FG000|Overall Study|Adverse Event|1|||
13117249|NCT03063086|25924733|FG001|Overall Study|Adverse Event|1|||
13117250|NCT03063086|25924734|FG002|Overall Study|Adverse Event|1|||
13117251|NCT03063086|25924735|FG003|Overall Study|Adverse Event|1|||
13117252|NCT03063086|25924736|FG004|Overall Study|Adverse Event|0|||
13117253|NCT03063086|25924737|FG005|Overall Study|Adverse Event|0|||
13117254|NCT03063086|25924732|FG000|Overall Study|subject/guardian decision|1|||
13117255|NCT03063086|25924733|FG001|Overall Study|subject/guardian decision|0|||
13117256|NCT03063086|25924734|FG002|Overall Study|subject/guardian decision|0|||
13117257|NCT03063086|25924735|FG003|Overall Study|subject/guardian decision|0|||
13117258|NCT03063086|25924736|FG004|Overall Study|subject/guardian decision|0|||
13117259|NCT03063086|25924737|FG005|Overall Study|subject/guardian decision|0|||
13117260|NCT03063086|25924732|FG000|Overall Study|Non-compliance with study treatment|0|||
13117261|NCT03063086|25924733|FG001|Overall Study|Non-compliance with study treatment|0|||
13117262|NCT03063086|25924734|FG002|Overall Study|Non-compliance with study treatment|0|||
13117263|NCT03063086|25924735|FG003|Overall Study|Non-compliance with study treatment|1|||
13258632|NCT01491841|26392764|FG000|Overall Study|Withdrawal by Subject|1|||
13258633|NCT01491802|26392792|FG000|Overall Study|Adverse Event|1|||
13258634|NCT01491802|26392793|FG001|Overall Study|Adverse Event|1|||
13258635|NCT01491802|26392792|FG000|Overall Study|Withdrawal by Subject|0|||
13258636|NCT01491802|26392793|FG001|Overall Study|Withdrawal by Subject|1|||
13258637|NCT01491737|26392824|FG000|Overall Study|Withdrawal by Subject|20|||
13258638|NCT01491737|26392825|FG001|Overall Study|Withdrawal by Subject|17|||
13258639|NCT01491737|26392824|FG000|Overall Study|Lost to Follow-up|2|||
13258640|NCT01491737|26392825|FG001|Overall Study|Lost to Follow-up|10|||
13258641|NCT01491737|26392824|FG000|Overall Study|Death|63|||
13258642|NCT01491737|26392825|FG001|Overall Study|Death|57|||
13258643|NCT01491737|26392824|FG000|Overall Study|Study Termination by Sponsor|36|||
13258644|NCT01491737|26392825|FG001|Overall Study|Study Termination by Sponsor|36|||
13258645|NCT01491737|26392824|FG000|Overall Study|Reason Not Specified|8|||
13258646|NCT01491737|26392825|FG001|Overall Study|Reason Not Specified|9|||
13290452|NCT00102687|26481197|FG004|Maintenance Period|Withdrawal by Subject|1|||
13290453|NCT00102687|26481193|FG000|Maintenance Period|Adverse Event|1|||
13290454|NCT00102687|26481194|FG001|Maintenance Period|Adverse Event|0|||
13290455|NCT00102687|26481195|FG002|Maintenance Period|Adverse Event|0|||
13290456|NCT00102687|26481196|FG003|Maintenance Period|Adverse Event|1|||
13290457|NCT00102687|26481197|FG004|Maintenance Period|Adverse Event|3|||
13290458|NCT00102687|26481193|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0|||
13290459|NCT00102687|26481194|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1|||
13290460|NCT00102687|26481195|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0|||
13290461|NCT00102687|26481196|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2|||
13290462|NCT00102687|26481197|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0|||
13290463|NCT00102687|26481193|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
13290464|NCT00102687|26481194|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
13290465|NCT00102687|26481195|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
13290466|NCT00102687|26481196|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3|||
13290467|NCT00102687|26481197|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4|||
13290468|NCT00102687|26481193|FG000|Maintenance Period|Death|0|||
13290469|NCT00102687|26481194|FG001|Maintenance Period|Death|0|||
13290470|NCT00102687|26481195|FG002|Maintenance Period|Death|0|||
13290471|NCT00102687|26481196|FG003|Maintenance Period|Death|1|||
13290472|NCT00102687|26481197|FG004|Maintenance Period|Death|1|||
13290473|NCT00102687|26481193|FG000|Maintenance Period|Physician Decision|1|||
13290474|NCT00102687|26481194|FG001|Maintenance Period|Physician Decision|2|||
13290475|NCT00102687|26481195|FG002|Maintenance Period|Physician Decision|3|||
13290476|NCT00102687|26481196|FG003|Maintenance Period|Physician Decision|0|||
13117264|NCT03063086|25924736|FG004|Overall Study|Non-compliance with study treatment|0|||
13117265|NCT03063086|25924737|FG005|Overall Study|Non-compliance with study treatment|1|||
13117266|NCT03063086|25924732|FG000|Overall Study|Physician Decision|0|||
13117267|NCT03063086|25924733|FG001|Overall Study|Physician Decision|0|||
13290477|NCT00102687|26481197|FG004|Maintenance Period|Physician Decision|4|||
13290478|NCT00102531|26481210|FG000|Overall Study|Adverse Event|0|||
13290479|NCT00102531|26481211|FG001|Overall Study|Adverse Event|1|||
13258647|NCT01491672|26392860|FG000|Overall Study|Lost to Follow-up|0|||
13258648|NCT01491672|26392861|FG001|Overall Study|Lost to Follow-up|4|||
13258649|NCT01491672|26392862|FG002|Overall Study|Lost to Follow-up|1|||
13258650|NCT01491672|26392860|FG000|Overall Study|Withdrawal by Subject|6|||
13258651|NCT01491672|26392861|FG001|Overall Study|Withdrawal by Subject|7|||
13258652|NCT01491672|26392862|FG002|Overall Study|Withdrawal by Subject|0|||
13258653|NCT01491672|26392860|FG000|Overall Study|Adverse Event|8|||
13258654|NCT01491672|26392861|FG001|Overall Study|Adverse Event|10|||
13258655|NCT01491672|26392862|FG002|Overall Study|Adverse Event|4|||
13258656|NCT01491672|26392860|FG000|Overall Study|Disease progression|42|||
13258657|NCT01491672|26392861|FG001|Overall Study|Disease progression|34|||
13258658|NCT01491672|26392862|FG002|Overall Study|Disease progression|6|||
13258659|NCT01491672|26392860|FG000|Overall Study|Protocol deviation|0|||
13258660|NCT01491672|26392861|FG001|Overall Study|Protocol deviation|1|||
13258661|NCT01491672|26392862|FG002|Overall Study|Protocol deviation|0|||
13258662|NCT01491672|26392860|FG000|Overall Study|Death|0|||
13258663|NCT01491672|26392861|FG001|Overall Study|Death|4|||
13258664|NCT01491672|26392862|FG002|Overall Study|Death|0|||
13258665|NCT01491607|26392968|FG000|Overall Study|Lost to Follow-up|7|||
13258666|NCT01491607|26392968|FG000|Overall Study|Withdrawal by Subject|3|||
13258667|NCT01491178|26392975|FG000|Overall Study|Adverse Event|1016|||
13258668|NCT01491178|26392975|FG000|Overall Study|Improvement of NVAF|210|||
13258669|NCT01491178|26392975|FG000|Overall Study|To conduct invasive treatment|59|||
13258670|NCT01491178|26392975|FG000|Overall Study|Lost to follow-up (unknown reason)|287|||
13258671|NCT01491178|26392975|FG000|Overall Study|Lost to follow-up (changing hospital)|545|||
13258672|NCT01491178|26392975|FG000|Overall Study|To take a contraindication|20|||
13258673|NCT01491178|26392975|FG000|Overall Study|Other than specified above|657|||
13258674|NCT01491035|26393066|FG000|Overall Study|Lost to Follow-up|0|||
13258675|NCT01491035|26393067|FG001|Overall Study|Lost to Follow-up|0|||
13258676|NCT01491035|26393068|FG002|Overall Study|Lost to Follow-up|0|||
13258677|NCT01491035|26393069|FG003|Overall Study|Lost to Follow-up|0|||
13258678|NCT01491035|26393070|FG004|Overall Study|Lost to Follow-up|1|||
13258679|NCT01491035|26393071|FG005|Overall Study|Lost to Follow-up|0|||
13258680|NCT01491035|26393072|FG006|Overall Study|Lost to Follow-up|0|||
13258681|NCT01491035|26393073|FG007|Overall Study|Lost to Follow-up|0|||
13258682|NCT01490918|26393116|FG000|Overall Study|Lost to Follow-up|2|||
13258683|NCT01490918|26393117|FG001|Overall Study|Lost to Follow-up|1|||
13258684|NCT01490918|26393118|FG002|Overall Study|Lost to Follow-up|0|||
13258685|NCT01490918|26393116|FG000|Overall Study|Withdrawal by Subject|7|||
13258686|NCT01490918|26393117|FG001|Overall Study|Withdrawal by Subject|8|||
13258687|NCT01490918|26393118|FG002|Overall Study|Withdrawal by Subject|3|||
13258688|NCT01490918|26393116|FG000|Overall Study|Adverse Event|0|||
13258689|NCT01490918|26393117|FG001|Overall Study|Adverse Event|0|||
13258690|NCT01490918|26393118|FG002|Overall Study|Adverse Event|1|||
13258691|NCT01490918|26393116|FG000|Overall Study|other cause|4|||
13258692|NCT01490918|26393117|FG001|Overall Study|other cause|5|||
13258693|NCT01490918|26393118|FG002|Overall Study|other cause|8|||
13258694|NCT01490866|26393129|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6|||
13258695|NCT01490866|26393129|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6|||
13258696|NCT01490866|26393129|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5|||
13258697|NCT01490866|26393129|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1|||
13258698|NCT01490866|26393129|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1|||
13258699|NCT01490866|26393129|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2|||
13258700|NCT01490866|26393129|FG000|Axitinib Maintenance Therapy|Disease Progression|30|||
13258701|NCT01490866|26393129|FG000|Axitinib Maintenance Therapy|Adverse Event|12|||
13258702|NCT01490866|26393129|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3|||
13258703|NCT01490866|26393129|FG000|Axitinib Maintenance Therapy|Protocol Violation|2|||
13258704|NCT01490866|26393129|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2|||
13258705|NCT01490840|26393158|FG000|Phase 1|Lost to Follow-up|1|||
13258706|NCT01490840|26393159|FG001|Phase 1|Lost to Follow-up|0|||
13258707|NCT01490840|26393158|FG000|Phase 1|Adverse Event|2|||
13258708|NCT01490840|26393159|FG001|Phase 1|Adverse Event|1|||
13258709|NCT01490840|26393158|FG000|Phase 1|Withdrawal by Subject|6|||
13258710|NCT01490840|26393159|FG001|Phase 1|Withdrawal by Subject|5|||
13258711|NCT01490840|26393158|FG000|Phase 1|Visit 6a omitted|1|||
13258712|NCT01490840|26393159|FG001|Phase 1|Visit 6a omitted|0|||
13258713|NCT01490840|26393158|FG000|Phase 2|Withdrawal by Subject|4|||
13258714|NCT01490840|26393159|FG001|Phase 2|Withdrawal by Subject|3|||
13258715|NCT01490840|26393158|FG000|Phase 2|Permanent interruption of fingolimod|0|||
13258716|NCT01490840|26393159|FG001|Phase 2|Permanent interruption of fingolimod|1|||
13258717|NCT01490840|26393158|FG000|Phase 2|Lost to Follow-up|1|||
13258718|NCT01490840|26393159|FG001|Phase 2|Lost to Follow-up|1|||
13258719|NCT01490840|26393158|FG000|Phase 2|Adverse Event|1|||
13258720|NCT01490840|26393159|FG001|Phase 2|Adverse Event|1|||
13258721|NCT01490814|26393186|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
13258722|NCT01490814|26393187|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
13258723|NCT01490814|26393186|FG000|Overall Study|Physician Decision|1|||
13258724|NCT01490814|26393187|FG001|Overall Study|Physician Decision|0|||
13258725|NCT01490814|26393186|FG000|Overall Study|Withdrawal by Subject|0|||
13258726|NCT01490814|26393187|FG001|Overall Study|Withdrawal by Subject|5|||
13258727|NCT01490697|26393202|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1|||
13258728|NCT01490697|26393203|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2|||
13258729|NCT01490632|26393362|FG000|Part A: Initial Treatment Period|Adverse Event|0|||
13258730|NCT01490632|26393363|FG001|Part A: Initial Treatment Period|Adverse Event|0|||
13258731|NCT01490632|26393364|FG002|Part A: Initial Treatment Period|Adverse Event|2|||
13258732|NCT01490632|26393365|FG003|Part A: Initial Treatment Period|Adverse Event|4|||
13258733|NCT01490632|26393366|FG004|Part A: Initial Treatment Period|Adverse Event|4|||
13258734|NCT01490632|26393367|FG005|Part A: Initial Treatment Period|Adverse Event|0|||
13258735|NCT01490632|26393368|FG006|Part A: Initial Treatment Period|Adverse Event|0|||
13258736|NCT01490632|26393369|FG007|Part A: Initial Treatment Period|Adverse Event|0|||
13258737|NCT01490632|26393370|FG008|Part A: Initial Treatment Period|Adverse Event|0|||
13258738|NCT01490632|26393371|FG009|Part A: Initial Treatment Period|Adverse Event|0|||
13258739|NCT01490632|26393372|FG010|Part A: Initial Treatment Period|Adverse Event|0|||
13258740|NCT01490632|26393373|FG011|Part A: Initial Treatment Period|Adverse Event|0|||
13258741|NCT01490632|26393374|FG012|Part A: Initial Treatment Period|Adverse Event|0|||
13258742|NCT01490632|26393375|FG013|Part A: Initial Treatment Period|Adverse Event|0|||
13258743|NCT01490632|26393376|FG014|Part A: Initial Treatment Period|Adverse Event|0|||
13258744|NCT01490632|26393377|FG015|Part A: Initial Treatment Period|Adverse Event|0|||
13258745|NCT01490632|26393378|FG016|Part A: Initial Treatment Period|Adverse Event|0|||
13258746|NCT01490632|26393379|FG017|Part A: Initial Treatment Period|Adverse Event|0|||
13258747|NCT01490632|26393380|FG018|Part A: Initial Treatment Period|Adverse Event|0|||
13258748|NCT01490632|26393381|FG019|Part A: Initial Treatment Period|Adverse Event|0|||
13258749|NCT01490632|26393362|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3|||
13258750|NCT01490632|26393363|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1|||
13258751|NCT01490632|26393364|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2|||
13258752|NCT01490632|26393365|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2|||
13258753|NCT01490632|26393366|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0|||
13258754|NCT01490632|26393367|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0|||
13258755|NCT01490632|26393368|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0|||
13258756|NCT01490632|26393369|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0|||
13258757|NCT01490632|26393370|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0|||
13258758|NCT01490632|26393371|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0|||
13258759|NCT01490632|26393372|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0|||
13258760|NCT01490632|26393373|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0|||
13258761|NCT01490632|26393374|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0|||
13258762|NCT01490632|26393375|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0|||
13258763|NCT01490632|26393376|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0|||
13258764|NCT01490632|26393377|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0|||
13258765|NCT01490632|26393378|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0|||
13258766|NCT01490632|26393379|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0|||
13258767|NCT01490632|26393380|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0|||
13258768|NCT01490632|26393381|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0|||
13258769|NCT01490632|26393362|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0|||
13258770|NCT01490632|26393363|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0|||
13258771|NCT01490632|26393364|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1|||
13258772|NCT01490632|26393365|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1|||
13258773|NCT01490632|26393366|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2|||
13258774|NCT01490632|26393367|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0|||
13258775|NCT01490632|26393368|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0|||
13258776|NCT01490632|26393369|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0|||
13258777|NCT01490632|26393370|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0|||
13258778|NCT01490632|26393371|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0|||
13258779|NCT01490632|26393372|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0|||
13258780|NCT01490632|26393373|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0|||
13258781|NCT01490632|26393374|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0|||
13258782|NCT01490632|26393375|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0|||
13258783|NCT01490632|26393376|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0|||
13258784|NCT01490632|26393377|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0|||
13258785|NCT01490632|26393378|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0|||
13258786|NCT01490632|26393379|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0|||
13258787|NCT01490632|26393380|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0|||
13258788|NCT01490632|26393381|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0|||
13258789|NCT01490632|26393362|FG000|Part A: Initial Treatment Period|Physician Decision|0|||
13258790|NCT01490632|26393363|FG001|Part A: Initial Treatment Period|Physician Decision|1|||
13258791|NCT01490632|26393364|FG002|Part A: Initial Treatment Period|Physician Decision|0|||
13258792|NCT01490632|26393365|FG003|Part A: Initial Treatment Period|Physician Decision|1|||
13258793|NCT01490632|26393366|FG004|Part A: Initial Treatment Period|Physician Decision|0|||
13258794|NCT01490632|26393367|FG005|Part A: Initial Treatment Period|Physician Decision|0|||
13258795|NCT01490632|26393368|FG006|Part A: Initial Treatment Period|Physician Decision|0|||
13258796|NCT01490632|26393369|FG007|Part A: Initial Treatment Period|Physician Decision|0|||
13258797|NCT01490632|26393370|FG008|Part A: Initial Treatment Period|Physician Decision|0|||
13258798|NCT01490632|26393371|FG009|Part A: Initial Treatment Period|Physician Decision|0|||
13258799|NCT01490632|26393372|FG010|Part A: Initial Treatment Period|Physician Decision|0|||
13258800|NCT01490632|26393373|FG011|Part A: Initial Treatment Period|Physician Decision|0|||
13258801|NCT01490632|26393374|FG012|Part A: Initial Treatment Period|Physician Decision|0|||
13258802|NCT01490632|26393375|FG013|Part A: Initial Treatment Period|Physician Decision|0|||
13258803|NCT01490632|26393376|FG014|Part A: Initial Treatment Period|Physician Decision|0|||
13258804|NCT01490632|26393377|FG015|Part A: Initial Treatment Period|Physician Decision|0|||
13258805|NCT01490632|26393378|FG016|Part A: Initial Treatment Period|Physician Decision|0|||
13258806|NCT01490632|26393379|FG017|Part A: Initial Treatment Period|Physician Decision|0|||
13258807|NCT01490632|26393380|FG018|Part A: Initial Treatment Period|Physician Decision|0|||
13258808|NCT01490632|26393381|FG019|Part A: Initial Treatment Period|Physician Decision|0|||
13258809|NCT01490632|26393362|FG000|Part A: Initial Treatment Period|Sponsor Decision|2|||
13258810|NCT01490632|26393363|FG001|Part A: Initial Treatment Period|Sponsor Decision|0|||
13258811|NCT01490632|26393364|FG002|Part A: Initial Treatment Period|Sponsor Decision|0|||
13258812|NCT01490632|26393365|FG003|Part A: Initial Treatment Period|Sponsor Decision|0|||
13258813|NCT01490632|26393366|FG004|Part A: Initial Treatment Period|Sponsor Decision|0|||
13258814|NCT01490632|26393367|FG005|Part A: Initial Treatment Period|Sponsor Decision|0|||
13258815|NCT01490632|26393368|FG006|Part A: Initial Treatment Period|Sponsor Decision|0|||
13258816|NCT01490632|26393369|FG007|Part A: Initial Treatment Period|Sponsor Decision|0|||
13258817|NCT01490632|26393370|FG008|Part A: Initial Treatment Period|Sponsor Decision|0|||
13258818|NCT01490632|26393371|FG009|Part A: Initial Treatment Period|Sponsor Decision|0|||
13258819|NCT01490632|26393372|FG010|Part A: Initial Treatment Period|Sponsor Decision|0|||
13258820|NCT01490632|26393373|FG011|Part A: Initial Treatment Period|Sponsor Decision|0|||
13258821|NCT01490632|26393374|FG012|Part A: Initial Treatment Period|Sponsor Decision|0|||
13258822|NCT01490632|26393375|FG013|Part A: Initial Treatment Period|Sponsor Decision|0|||
13258823|NCT01490632|26393376|FG014|Part A: Initial Treatment Period|Sponsor Decision|0|||
13258824|NCT01490632|26393377|FG015|Part A: Initial Treatment Period|Sponsor Decision|0|||
13258825|NCT01490632|26393378|FG016|Part A: Initial Treatment Period|Sponsor Decision|0|||
13258826|NCT01490632|26393379|FG017|Part A: Initial Treatment Period|Sponsor Decision|0|||
13258827|NCT01490632|26393380|FG018|Part A: Initial Treatment Period|Sponsor Decision|0|||
13258828|NCT01490632|26393381|FG019|Part A: Initial Treatment Period|Sponsor Decision|0|||
13258829|NCT01490632|26393362|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
13258830|NCT01490632|26393363|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
13258831|NCT01490632|26393364|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
13258832|NCT01490632|26393365|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1|||
13258833|NCT01490632|26393366|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
13258834|NCT01490632|26393367|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
13258835|NCT01490632|26393368|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
13258836|NCT01490632|26393369|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
13258837|NCT01490632|26393370|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
13258838|NCT01490632|26393371|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
13258839|NCT01490632|26393372|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
13258840|NCT01490632|26393373|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
13258841|NCT01490632|26393374|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
13258842|NCT01490632|26393375|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
13258843|NCT01490632|26393376|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
13258844|NCT01490632|26393377|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
13258845|NCT01490632|26393378|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
13258846|NCT01490632|26393379|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
13258847|NCT01490632|26393380|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
13258848|NCT01490632|26393381|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
13258849|NCT01490632|26393362|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
13258850|NCT01490632|26393363|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
13117268|NCT03063086|25924734|FG002|Overall Study|Physician Decision|0|||
13117269|NCT03063086|25924735|FG003|Overall Study|Physician Decision|1|||
13117270|NCT03063086|25924736|FG004|Overall Study|Physician Decision|0|||
13117271|NCT03063086|25924737|FG005|Overall Study|Physician Decision|0|||
13117272|NCT03062891|25924787|FG000|Overall Study|Withdrawal by Subject|2|||
13258851|NCT01490632|26393364|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
13258852|NCT01490632|26393365|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
13258853|NCT01490632|26393366|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9|||
13117273|NCT03062891|25924788|FG001|Overall Study|Withdrawal by Subject|0|||
13117274|NCT03062891|25924787|FG000|Overall Study|Lost to Follow-up|50|||
13117275|NCT03062891|25924788|FG001|Overall Study|Lost to Follow-up|38|||
13117276|NCT03061331|25924801|FG000|Washout Period (8 Weeks)|Adverse Event|2|||
13117277|NCT03061331|25924802|FG001|Washout Period (8 Weeks)|Adverse Event|1|||
13117278|NCT03061214|25925034|FG000|Overall Study|Withdrawal by Subject|21|||
13117279|NCT03061214|25925035|FG001|Overall Study|Withdrawal by Subject|26|||
13117280|NCT03061214|25925036|FG002|Overall Study|Withdrawal by Subject|9|||
13117281|NCT03061214|25925034|FG000|Overall Study|Lost to Follow-up|3|||
13117282|NCT03061214|25925035|FG001|Overall Study|Lost to Follow-up|1|||
13258854|NCT01490632|26393367|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
13258855|NCT01490632|26393368|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
13258856|NCT01490632|26393369|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
13258857|NCT01490632|26393370|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
13258858|NCT01490632|26393371|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
13258859|NCT01490632|26393372|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
13258860|NCT01490632|26393373|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
13258861|NCT01490632|26393374|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
13258862|NCT01490632|26393375|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
13258863|NCT01490632|26393376|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
13258864|NCT01490632|26393377|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
13258865|NCT01490632|26393378|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
13258866|NCT01490632|26393379|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
13258867|NCT01490632|26393380|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
13258868|NCT01490632|26393381|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
13258869|NCT01490632|26393362|FG000|Part B: Extension or Step-Up Period|Adverse Event|0|||
13258870|NCT01490632|26393363|FG001|Part B: Extension or Step-Up Period|Adverse Event|0|||
13258871|NCT01490632|26393364|FG002|Part B: Extension or Step-Up Period|Adverse Event|0|||
13258872|NCT01490632|26393365|FG003|Part B: Extension or Step-Up Period|Adverse Event|0|||
13258873|NCT01490632|26393366|FG004|Part B: Extension or Step-Up Period|Adverse Event|0|||
13258874|NCT01490632|26393367|FG005|Part B: Extension or Step-Up Period|Adverse Event|2|||
13258875|NCT01490632|26393368|FG006|Part B: Extension or Step-Up Period|Adverse Event|2|||
13258876|NCT01490632|26393369|FG007|Part B: Extension or Step-Up Period|Adverse Event|0|||
13258877|NCT01490632|26393370|FG008|Part B: Extension or Step-Up Period|Adverse Event|0|||
13258878|NCT01490632|26393371|FG009|Part B: Extension or Step-Up Period|Adverse Event|2|||
13258879|NCT01490632|26393372|FG010|Part B: Extension or Step-Up Period|Adverse Event|3|||
13258880|NCT01490632|26393373|FG011|Part B: Extension or Step-Up Period|Adverse Event|1|||
13258881|NCT01490632|26393374|FG012|Part B: Extension or Step-Up Period|Adverse Event|0|||
13258882|NCT01490632|26393375|FG013|Part B: Extension or Step-Up Period|Adverse Event|0|||
13258883|NCT01490632|26393376|FG014|Part B: Extension or Step-Up Period|Adverse Event|0|||
13258884|NCT01490632|26393377|FG015|Part B: Extension or Step-Up Period|Adverse Event|0|||
13258885|NCT01490632|26393378|FG016|Part B: Extension or Step-Up Period|Adverse Event|0|||
13258886|NCT01490632|26393379|FG017|Part B: Extension or Step-Up Period|Adverse Event|0|||
13258887|NCT01490632|26393380|FG018|Part B: Extension or Step-Up Period|Adverse Event|0|||
13258888|NCT01490632|26393381|FG019|Part B: Extension or Step-Up Period|Adverse Event|0|||
13258889|NCT01490632|26393362|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
13258890|NCT01490632|26393363|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
13258891|NCT01490632|26393364|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
13258892|NCT01490632|26393365|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
13258893|NCT01490632|26393366|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
13258894|NCT01490632|26393367|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
13258895|NCT01490632|26393368|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
13258896|NCT01490632|26393369|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
13258897|NCT01490632|26393370|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
13258898|NCT01490632|26393371|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3|||
13258899|NCT01490632|26393372|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
13258900|NCT01490632|26393373|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
13258901|NCT01490632|26393374|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
13258902|NCT01490632|26393375|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
13258903|NCT01490632|26393376|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
13258904|NCT01490632|26393377|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
13258905|NCT01490632|26393378|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
13258906|NCT01490632|26393379|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
13258907|NCT01490632|26393380|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
13290480|NCT00102531|26481210|FG000|Overall Study|Disease Progression|5|||
13117283|NCT03061214|25925036|FG002|Overall Study|Lost to Follow-up|1|||
13117284|NCT03061214|25925034|FG000|Overall Study|Death|1|||
13117285|NCT03061214|25925035|FG001|Overall Study|Death|1|||
13258908|NCT01490632|26393381|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
13258909|NCT01490632|26393362|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
13258910|NCT01490632|26393363|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
13258911|NCT01490632|26393364|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
13258912|NCT01490632|26393365|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
13258913|NCT01490632|26393366|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
13258914|NCT01490632|26393367|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
13258915|NCT01490632|26393368|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2|||
13258916|NCT01490632|26393369|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
13258917|NCT01490632|26393370|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
13258918|NCT01490632|26393371|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1|||
13258919|NCT01490632|26393372|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
13258920|NCT01490632|26393373|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
13258921|NCT01490632|26393374|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
13258922|NCT01490632|26393375|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
13258923|NCT01490632|26393376|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
13258924|NCT01490632|26393377|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
13117286|NCT03061214|25925036|FG002|Overall Study|Death|0|||
13258925|NCT01490632|26393378|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
13258926|NCT01490632|26393379|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
13258927|NCT01490632|26393380|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
13258928|NCT01490632|26393381|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
13258929|NCT01490632|26393362|FG000|Part B: Extension or Step-Up Period|Physician Decision|0|||
13258930|NCT01490632|26393363|FG001|Part B: Extension or Step-Up Period|Physician Decision|0|||
13258931|NCT01490632|26393364|FG002|Part B: Extension or Step-Up Period|Physician Decision|0|||
13258932|NCT01490632|26393365|FG003|Part B: Extension or Step-Up Period|Physician Decision|0|||
13258933|NCT01490632|26393366|FG004|Part B: Extension or Step-Up Period|Physician Decision|0|||
13258934|NCT01490632|26393367|FG005|Part B: Extension or Step-Up Period|Physician Decision|0|||
13258935|NCT01490632|26393368|FG006|Part B: Extension or Step-Up Period|Physician Decision|1|||
13258936|NCT01490632|26393369|FG007|Part B: Extension or Step-Up Period|Physician Decision|0|||
13258937|NCT01490632|26393370|FG008|Part B: Extension or Step-Up Period|Physician Decision|0|||
13258938|NCT01490632|26393371|FG009|Part B: Extension or Step-Up Period|Physician Decision|0|||
13258939|NCT01490632|26393372|FG010|Part B: Extension or Step-Up Period|Physician Decision|0|||
13258940|NCT01490632|26393373|FG011|Part B: Extension or Step-Up Period|Physician Decision|0|||
13258941|NCT01490632|26393374|FG012|Part B: Extension or Step-Up Period|Physician Decision|0|||
13258942|NCT01490632|26393375|FG013|Part B: Extension or Step-Up Period|Physician Decision|0|||
13258943|NCT01490632|26393376|FG014|Part B: Extension or Step-Up Period|Physician Decision|0|||
13258944|NCT01490632|26393377|FG015|Part B: Extension or Step-Up Period|Physician Decision|0|||
13258945|NCT01490632|26393378|FG016|Part B: Extension or Step-Up Period|Physician Decision|0|||
13258946|NCT01490632|26393379|FG017|Part B: Extension or Step-Up Period|Physician Decision|0|||
13258947|NCT01490632|26393380|FG018|Part B: Extension or Step-Up Period|Physician Decision|0|||
13258948|NCT01490632|26393381|FG019|Part B: Extension or Step-Up Period|Physician Decision|0|||
13258949|NCT01490632|26393362|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
13258950|NCT01490632|26393363|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
13258951|NCT01490632|26393364|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
13258952|NCT01490632|26393365|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
13258953|NCT01490632|26393366|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
13258954|NCT01490632|26393367|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1|||
13258955|NCT01490632|26393368|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
13258956|NCT01490632|26393369|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
13258957|NCT01490632|26393370|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
13258958|NCT01490632|26393371|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
13258959|NCT01490632|26393372|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
13258960|NCT01490632|26393373|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
13258961|NCT01490632|26393374|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
13258962|NCT01490632|26393375|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
13258963|NCT01490632|26393376|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
13258964|NCT01490632|26393377|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
13258965|NCT01490632|26393378|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
13258966|NCT01490632|26393379|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
13258967|NCT01490632|26393380|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
13258968|NCT01490632|26393381|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
13258969|NCT01490632|26393362|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
13258970|NCT01490632|26393363|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
13290481|NCT00102531|26481211|FG001|Overall Study|Disease Progression|9|||
13133410|NCT02770170|25987714|FG002|Overall Study|Adverse Event|5|||
13258971|NCT01490632|26393364|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
13258972|NCT01490632|26393365|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
13258973|NCT01490632|26393366|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
13258974|NCT01490632|26393367|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
13258975|NCT01490632|26393368|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
13258976|NCT01490632|26393369|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
13258977|NCT01490632|26393370|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
13258978|NCT01490632|26393371|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
13258979|NCT01490632|26393372|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
13258980|NCT01490632|26393373|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2|||
13258981|NCT01490632|26393374|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
13258982|NCT01490632|26393375|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
13258983|NCT01490632|26393376|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
13258984|NCT01490632|26393377|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
13258985|NCT01490632|26393378|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
13258986|NCT01490632|26393379|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
13258987|NCT01490632|26393380|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
13258988|NCT01490632|26393381|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
13258989|NCT01490632|26393362|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
13258990|NCT01490632|26393363|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
13258991|NCT01490632|26393364|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
13258992|NCT01490632|26393365|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
13258993|NCT01490632|26393366|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
13258994|NCT01490632|26393367|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1|||
13258995|NCT01490632|26393368|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
13258996|NCT01490632|26393369|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
13258997|NCT01490632|26393370|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8|||
13258998|NCT01490632|26393371|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19|||
13258999|NCT01490632|26393372|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16|||
13259000|NCT01490632|26393373|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5|||
13259001|NCT01490632|26393374|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
13259002|NCT01490632|26393375|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
13259003|NCT01490632|26393376|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
13259004|NCT01490632|26393377|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
13259005|NCT01490632|26393378|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
13259006|NCT01490632|26393379|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
13259007|NCT01490632|26393380|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
13259008|NCT01490632|26393381|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
13259009|NCT01490632|26393362|FG000|Part C: Washout or Step-Down Period|Adverse Event|0|||
13259010|NCT01490632|26393363|FG001|Part C: Washout or Step-Down Period|Adverse Event|0|||
13259011|NCT01490632|26393364|FG002|Part C: Washout or Step-Down Period|Adverse Event|0|||
13259012|NCT01490632|26393365|FG003|Part C: Washout or Step-Down Period|Adverse Event|0|||
13259013|NCT01490632|26393366|FG004|Part C: Washout or Step-Down Period|Adverse Event|0|||
13259014|NCT01490632|26393367|FG005|Part C: Washout or Step-Down Period|Adverse Event|0|||
13259015|NCT01490632|26393368|FG006|Part C: Washout or Step-Down Period|Adverse Event|0|||
13259016|NCT01490632|26393369|FG007|Part C: Washout or Step-Down Period|Adverse Event|0|||
13259017|NCT01490632|26393370|FG008|Part C: Washout or Step-Down Period|Adverse Event|0|||
13259018|NCT01490632|26393371|FG009|Part C: Washout or Step-Down Period|Adverse Event|0|||
13259019|NCT01490632|26393372|FG010|Part C: Washout or Step-Down Period|Adverse Event|0|||
13259020|NCT01490632|26393373|FG011|Part C: Washout or Step-Down Period|Adverse Event|0|||
13259021|NCT01490632|26393374|FG012|Part C: Washout or Step-Down Period|Adverse Event|0|||
13259022|NCT01490632|26393375|FG013|Part C: Washout or Step-Down Period|Adverse Event|0|||
13259023|NCT01490632|26393376|FG014|Part C: Washout or Step-Down Period|Adverse Event|2|||
13259024|NCT01490632|26393377|FG015|Part C: Washout or Step-Down Period|Adverse Event|2|||
13259025|NCT01490632|26393378|FG016|Part C: Washout or Step-Down Period|Adverse Event|0|||
13259026|NCT01490632|26393379|FG017|Part C: Washout or Step-Down Period|Adverse Event|0|||
13259027|NCT01490632|26393380|FG018|Part C: Washout or Step-Down Period|Adverse Event|0|||
13259028|NCT01490632|26393381|FG019|Part C: Washout or Step-Down Period|Adverse Event|0|||
13259029|NCT01490632|26393362|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
13259030|NCT01490632|26393363|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
13259031|NCT01490632|26393364|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
13259032|NCT01490632|26393365|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
13259033|NCT01490632|26393366|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
13259034|NCT01490632|26393367|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
13259035|NCT01490632|26393368|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
13259036|NCT01490632|26393369|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
13259037|NCT01490632|26393370|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
13259038|NCT01490632|26393371|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
13259039|NCT01490632|26393372|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
13259040|NCT01490632|26393373|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
13259041|NCT01490632|26393374|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
13259042|NCT01490632|26393375|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1|||
13259043|NCT01490632|26393376|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
13259044|NCT01490632|26393377|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
13259045|NCT01490632|26393378|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
13259046|NCT01490632|26393379|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
13259047|NCT01490632|26393380|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
13259048|NCT01490632|26393381|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
13259049|NCT01490632|26393362|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
13259050|NCT01490632|26393363|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
13259051|NCT01490632|26393364|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
13259052|NCT01490632|26393365|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
13259053|NCT01490632|26393366|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
13259054|NCT01490632|26393367|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
13259055|NCT01490632|26393368|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
13259056|NCT01490632|26393369|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
13259057|NCT01490632|26393370|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
13259058|NCT01490632|26393371|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
13259059|NCT01490632|26393372|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
13259060|NCT01490632|26393373|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
13259061|NCT01490632|26393374|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
13259062|NCT01490632|26393375|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
13259063|NCT01490632|26393376|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2|||
13259064|NCT01490632|26393377|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1|||
13259065|NCT01490632|26393378|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
13259066|NCT01490632|26393379|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
13259067|NCT01490632|26393380|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
13259068|NCT01490632|26393381|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
13259069|NCT01490632|26393362|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
13259070|NCT01490632|26393363|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
13259071|NCT01490632|26393364|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
13259072|NCT01490632|26393365|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
13259073|NCT01490632|26393366|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
13259074|NCT01490632|26393367|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
13259075|NCT01490632|26393368|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
13259076|NCT01490632|26393369|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
13259077|NCT01490632|26393370|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
13259078|NCT01490632|26393371|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
13259079|NCT01490632|26393372|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
13259080|NCT01490632|26393373|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
13259081|NCT01490632|26393374|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5|||
13259082|NCT01490632|26393375|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9|||
13259083|NCT01490632|26393376|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14|||
13259084|NCT01490632|26393377|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34|||
13259085|NCT01490632|26393378|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
13259086|NCT01490632|26393379|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
13259087|NCT01490632|26393380|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
13259088|NCT01490632|26393381|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
13259089|NCT01490632|26393362|FG000|Part D: Re-Treatment Period|Adverse Event|0|||
13259090|NCT01490632|26393363|FG001|Part D: Re-Treatment Period|Adverse Event|0|||
13259091|NCT01490632|26393364|FG002|Part D: Re-Treatment Period|Adverse Event|0|||
13259092|NCT01490632|26393365|FG003|Part D: Re-Treatment Period|Adverse Event|0|||
13259093|NCT01490632|26393366|FG004|Part D: Re-Treatment Period|Adverse Event|0|||
13259094|NCT01490632|26393367|FG005|Part D: Re-Treatment Period|Adverse Event|0|||
13259095|NCT01490632|26393368|FG006|Part D: Re-Treatment Period|Adverse Event|0|||
13259096|NCT01490632|26393369|FG007|Part D: Re-Treatment Period|Adverse Event|0|||
13259097|NCT01490632|26393370|FG008|Part D: Re-Treatment Period|Adverse Event|0|||
13259098|NCT01490632|26393371|FG009|Part D: Re-Treatment Period|Adverse Event|0|||
13259099|NCT01490632|26393372|FG010|Part D: Re-Treatment Period|Adverse Event|0|||
13259100|NCT01490632|26393373|FG011|Part D: Re-Treatment Period|Adverse Event|0|||
13259101|NCT01490632|26393374|FG012|Part D: Re-Treatment Period|Adverse Event|0|||
13259102|NCT01490632|26393375|FG013|Part D: Re-Treatment Period|Adverse Event|0|||
13259103|NCT01490632|26393376|FG014|Part D: Re-Treatment Period|Adverse Event|0|||
13259104|NCT01490632|26393377|FG015|Part D: Re-Treatment Period|Adverse Event|0|||
13259105|NCT01490632|26393378|FG016|Part D: Re-Treatment Period|Adverse Event|0|||
13259106|NCT01490632|26393379|FG017|Part D: Re-Treatment Period|Adverse Event|1|||
13259107|NCT01490632|26393380|FG018|Part D: Re-Treatment Period|Adverse Event|1|||
13259108|NCT01490632|26393381|FG019|Part D: Re-Treatment Period|Adverse Event|3|||
13259109|NCT01490632|26393362|FG000|Part D: Re-Treatment Period|Death|0|||
13259110|NCT01490632|26393363|FG001|Part D: Re-Treatment Period|Death|0|||
13259111|NCT01490632|26393364|FG002|Part D: Re-Treatment Period|Death|0|||
13259112|NCT01490632|26393365|FG003|Part D: Re-Treatment Period|Death|0|||
13259113|NCT01490632|26393366|FG004|Part D: Re-Treatment Period|Death|0|||
13259114|NCT01490632|26393367|FG005|Part D: Re-Treatment Period|Death|0|||
13259115|NCT01490632|26393368|FG006|Part D: Re-Treatment Period|Death|0|||
13259116|NCT01490632|26393369|FG007|Part D: Re-Treatment Period|Death|0|||
13259117|NCT01490632|26393370|FG008|Part D: Re-Treatment Period|Death|0|||
13259118|NCT01490632|26393371|FG009|Part D: Re-Treatment Period|Death|0|||
13259119|NCT01490632|26393372|FG010|Part D: Re-Treatment Period|Death|0|||
13259120|NCT01490632|26393373|FG011|Part D: Re-Treatment Period|Death|0|||
13259121|NCT01490632|26393374|FG012|Part D: Re-Treatment Period|Death|0|||
13259122|NCT01490632|26393375|FG013|Part D: Re-Treatment Period|Death|0|||
13259123|NCT01490632|26393376|FG014|Part D: Re-Treatment Period|Death|0|||
13259124|NCT01490632|26393377|FG015|Part D: Re-Treatment Period|Death|0|||
13259125|NCT01490632|26393378|FG016|Part D: Re-Treatment Period|Death|0|||
13259126|NCT01490632|26393379|FG017|Part D: Re-Treatment Period|Death|0|||
13259127|NCT01490632|26393380|FG018|Part D: Re-Treatment Period|Death|1|||
13259128|NCT01490632|26393381|FG019|Part D: Re-Treatment Period|Death|0|||
13259129|NCT01490632|26393362|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0|||
13259130|NCT01490632|26393363|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0|||
13259131|NCT01490632|26393364|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0|||
13259132|NCT01490632|26393365|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0|||
13259133|NCT01490632|26393366|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0|||
13259134|NCT01490632|26393367|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0|||
13259135|NCT01490632|26393368|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0|||
13259136|NCT01490632|26393369|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0|||
13259137|NCT01490632|26393370|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0|||
13259138|NCT01490632|26393371|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0|||
13259139|NCT01490632|26393372|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0|||
13259140|NCT01490632|26393373|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0|||
13259141|NCT01490632|26393374|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0|||
13259142|NCT01490632|26393375|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0|||
13259143|NCT01490632|26393376|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0|||
13259144|NCT01490632|26393377|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0|||
13259145|NCT01490632|26393378|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0|||
13259146|NCT01490632|26393379|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3|||
13259147|NCT01490632|26393380|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1|||
13259148|NCT01490632|26393381|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2|||
13259149|NCT01490632|26393362|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0|||
13259150|NCT01490632|26393363|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0|||
13259151|NCT01490632|26393364|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0|||
13259152|NCT01490632|26393365|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0|||
13259153|NCT01490632|26393366|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0|||
13259154|NCT01490632|26393367|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0|||
13259155|NCT01490632|26393368|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0|||
13259156|NCT01490632|26393369|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0|||
13259157|NCT01490632|26393370|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0|||
13259158|NCT01490632|26393371|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0|||
13259159|NCT01490632|26393372|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0|||
13259160|NCT01490632|26393373|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0|||
13259161|NCT01490632|26393374|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0|||
13259162|NCT01490632|26393375|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0|||
13259163|NCT01490632|26393376|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0|||
13259164|NCT01490632|26393377|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0|||
13259165|NCT01490632|26393378|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0|||
13259166|NCT01490632|26393379|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0|||
13259167|NCT01490632|26393380|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1|||
13259168|NCT01490632|26393381|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0|||
13259169|NCT01490632|26393362|FG000|Part D: Re-Treatment Period|Physician Decision|0|||
13259170|NCT01490632|26393363|FG001|Part D: Re-Treatment Period|Physician Decision|0|||
13259171|NCT01490632|26393364|FG002|Part D: Re-Treatment Period|Physician Decision|0|||
13259172|NCT01490632|26393365|FG003|Part D: Re-Treatment Period|Physician Decision|0|||
13259173|NCT01490632|26393366|FG004|Part D: Re-Treatment Period|Physician Decision|0|||
13259174|NCT01490632|26393367|FG005|Part D: Re-Treatment Period|Physician Decision|0|||
13259175|NCT01490632|26393368|FG006|Part D: Re-Treatment Period|Physician Decision|0|||
13259176|NCT01490632|26393369|FG007|Part D: Re-Treatment Period|Physician Decision|0|||
13259177|NCT01490632|26393370|FG008|Part D: Re-Treatment Period|Physician Decision|0|||
13259178|NCT01490632|26393371|FG009|Part D: Re-Treatment Period|Physician Decision|0|||
13259179|NCT01490632|26393372|FG010|Part D: Re-Treatment Period|Physician Decision|0|||
13259180|NCT01490632|26393373|FG011|Part D: Re-Treatment Period|Physician Decision|0|||
13259181|NCT01490632|26393374|FG012|Part D: Re-Treatment Period|Physician Decision|0|||
13259182|NCT01490632|26393375|FG013|Part D: Re-Treatment Period|Physician Decision|0|||
13259183|NCT01490632|26393376|FG014|Part D: Re-Treatment Period|Physician Decision|0|||
13259184|NCT01490632|26393377|FG015|Part D: Re-Treatment Period|Physician Decision|0|||
13259185|NCT01490632|26393378|FG016|Part D: Re-Treatment Period|Physician Decision|0|||
13259186|NCT01490632|26393379|FG017|Part D: Re-Treatment Period|Physician Decision|0|||
13259187|NCT01490632|26393380|FG018|Part D: Re-Treatment Period|Physician Decision|1|||
13259188|NCT01490632|26393381|FG019|Part D: Re-Treatment Period|Physician Decision|1|||
13259189|NCT01490632|26393362|FG000|Part D: Re-Treatment Period|Protocol Violation|0|||
13259190|NCT01490632|26393363|FG001|Part D: Re-Treatment Period|Protocol Violation|0|||
13259191|NCT01490632|26393364|FG002|Part D: Re-Treatment Period|Protocol Violation|0|||
13259192|NCT01490632|26393365|FG003|Part D: Re-Treatment Period|Protocol Violation|0|||
13259193|NCT01490632|26393366|FG004|Part D: Re-Treatment Period|Protocol Violation|0|||
13259194|NCT01490632|26393367|FG005|Part D: Re-Treatment Period|Protocol Violation|0|||
13259195|NCT01490632|26393368|FG006|Part D: Re-Treatment Period|Protocol Violation|0|||
13259196|NCT01490632|26393369|FG007|Part D: Re-Treatment Period|Protocol Violation|0|||
13259197|NCT01490632|26393370|FG008|Part D: Re-Treatment Period|Protocol Violation|0|||
13259198|NCT01490632|26393371|FG009|Part D: Re-Treatment Period|Protocol Violation|0|||
13259199|NCT01490632|26393372|FG010|Part D: Re-Treatment Period|Protocol Violation|0|||
13259200|NCT01490632|26393373|FG011|Part D: Re-Treatment Period|Protocol Violation|0|||
13259201|NCT01490632|26393374|FG012|Part D: Re-Treatment Period|Protocol Violation|0|||
13259202|NCT01490632|26393375|FG013|Part D: Re-Treatment Period|Protocol Violation|0|||
13259203|NCT01490632|26393376|FG014|Part D: Re-Treatment Period|Protocol Violation|0|||
13259204|NCT01490632|26393377|FG015|Part D: Re-Treatment Period|Protocol Violation|0|||
13259205|NCT01490632|26393378|FG016|Part D: Re-Treatment Period|Protocol Violation|0|||
13259206|NCT01490632|26393379|FG017|Part D: Re-Treatment Period|Protocol Violation|0|||
13259207|NCT01490632|26393380|FG018|Part D: Re-Treatment Period|Protocol Violation|1|||
13259208|NCT01490632|26393381|FG019|Part D: Re-Treatment Period|Protocol Violation|0|||
13259209|NCT01490632|26393362|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
13259210|NCT01490632|26393363|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
13259211|NCT01490632|26393364|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
13259212|NCT01490632|26393365|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
13259213|NCT01490632|26393366|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
13259214|NCT01490632|26393367|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
13259215|NCT01490632|26393368|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
13259216|NCT01490632|26393369|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
13259217|NCT01490632|26393370|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
13259218|NCT01490632|26393371|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
13259219|NCT01490632|26393372|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
13486294|NCT02429791|27035712|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
13486295|NCT02429791|27035711|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
13486296|NCT02429791|27035712|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2|||
13259220|NCT01490632|26393373|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
13259221|NCT01490632|26393374|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
13259222|NCT01490632|26393375|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
13259223|NCT01490632|26393376|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
13259224|NCT01490632|26393377|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
13259225|NCT01490632|26393378|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
13259226|NCT01490632|26393379|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
13259227|NCT01490632|26393380|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
13259228|NCT01490632|26393381|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
13259229|NCT01490580|26393410|FG000|Overall Study|Parents withdrew consent|0|||
13259230|NCT01490580|26393411|FG001|Overall Study|Parents withdrew consent|2|||
13259231|NCT01490450|26393461|FG000|Period 1|Lack of Efficacy|2|||
13259232|NCT01490450|26393462|FG001|Period 1|Lack of Efficacy|0|||
13259233|NCT01490450|26393463|FG002|Period 1|Lack of Efficacy|3|||
13259234|NCT01490450|26393464|FG003|Period 1|Lack of Efficacy|0|||
13259235|NCT01490450|26393461|FG000|Period 1|Adverse Event|0|||
13259236|NCT01490450|26393462|FG001|Period 1|Adverse Event|0|||
13259237|NCT01490450|26393463|FG002|Period 1|Adverse Event|0|||
13259238|NCT01490450|26393464|FG003|Period 1|Adverse Event|5|||
13259239|NCT01490450|26393461|FG000|Period 1|Request to discontinue treatment|1|||
13259240|NCT01490450|26393462|FG001|Period 1|Request to discontinue treatment|0|||
13259241|NCT01490450|26393463|FG002|Period 1|Request to discontinue treatment|0|||
13259242|NCT01490450|26393464|FG003|Period 1|Request to discontinue treatment|0|||
13259243|NCT01490450|26393461|FG000|Period 1|Withdrawal by Subject|0|||
13259244|NCT01490450|26393462|FG001|Period 1|Withdrawal by Subject|0|||
13259245|NCT01490450|26393463|FG002|Period 1|Withdrawal by Subject|0|||
13259246|NCT01490450|26393464|FG003|Period 1|Withdrawal by Subject|3|||
13259247|NCT01490450|26393461|FG000|Period 1|No longer met study criteria|0|||
13259248|NCT01490450|26393462|FG001|Period 1|No longer met study criteria|1|||
13259249|NCT01490450|26393463|FG002|Period 1|No longer met study criteria|1|||
13259250|NCT01490450|26393464|FG003|Period 1|No longer met study criteria|0|||
13259251|NCT01490450|26393461|FG000|Period 2|Lack of Efficacy|0|||
13259252|NCT01490450|26393462|FG001|Period 2|Lack of Efficacy|0|||
13259253|NCT01490450|26393463|FG002|Period 2|Lack of Efficacy|0|||
13259254|NCT01490450|26393464|FG003|Period 2|Lack of Efficacy|1|||
13259255|NCT01490450|26393461|FG000|Period 2|Adverse Event|1|||
13259256|NCT01490450|26393462|FG001|Period 2|Adverse Event|1|||
13259257|NCT01490450|26393463|FG002|Period 2|Adverse Event|0|||
13259258|NCT01490450|26393464|FG003|Period 2|Adverse Event|1|||
13259259|NCT01490450|26393461|FG000|Period 2|Withdrawal by Subject|1|||
13259260|NCT01490450|26393462|FG001|Period 2|Withdrawal by Subject|0|||
13259261|NCT01490450|26393463|FG002|Period 2|Withdrawal by Subject|0|||
13259262|NCT01490450|26393464|FG003|Period 2|Withdrawal by Subject|0|||
13259263|NCT01490450|26393461|FG000|Period 2|Lost to Follow-up|0|||
13259264|NCT01490450|26393462|FG001|Period 2|Lost to Follow-up|0|||
13259265|NCT01490450|26393463|FG002|Period 2|Lost to Follow-up|0|||
13259266|NCT01490450|26393464|FG003|Period 2|Lost to Follow-up|2|||
13259267|NCT01490294|26393711|FG000|Overall Study|Prematurely discontinuation|4|||
13259268|NCT01490294|26393712|FG001|Overall Study|Prematurely discontinuation|0|||
13259269|NCT01490294|26393713|FG002|Overall Study|Prematurely discontinuation|1|||
13259270|NCT01490294|26393714|FG003|Overall Study|Prematurely discontinuation|1|||
13259271|NCT01490294|26393711|FG000|Overall Study|Adverse Event|1|||
13259272|NCT01490294|26393712|FG001|Overall Study|Adverse Event|0|||
13259273|NCT01490294|26393713|FG002|Overall Study|Adverse Event|0|||
13259274|NCT01490294|26393714|FG003|Overall Study|Adverse Event|0|||
13259275|NCT01490190|26393737|FG000|Overall Study|Withdrawal by Subject|9|||
13259276|NCT01490190|26393737|FG000|Overall Study|Adverse Event|17|||
13259277|NCT01490190|26393737|FG000|Overall Study|Protocol Violation|5|||
13259278|NCT01490190|26393737|FG000|Overall Study|Lost to Follow-up|13|||
13259279|NCT01490190|26393737|FG000|Overall Study|Relocation|1|||
13259280|NCT01490190|26393737|FG000|Overall Study|Inconvenience|1|||
13259281|NCT01490190|26393737|FG000|Overall Study|Ring expulsion|2|||
13259282|NCT01490125|26393767|FG000|Period I|Adverse Event|4|||
13259283|NCT01490125|26393768|FG001|Period I|Adverse Event|1|||
13259284|NCT01490125|26393769|FG002|Period I|Adverse Event|1|||
13259285|NCT01490125|26393770|FG003|Period I|Adverse Event|3|||
13259286|NCT01490125|26393771|FG004|Period I|Adverse Event|2|||
13259287|NCT01490125|26393772|FG005|Period I|Adverse Event|4|||
13259288|NCT01490125|26393767|FG000|Period I|Protocol Violation|1|||
13259289|NCT01490125|26393768|FG001|Period I|Protocol Violation|1|||
13259290|NCT01490125|26393769|FG002|Period I|Protocol Violation|1|||
13259291|NCT01490125|26393770|FG003|Period I|Protocol Violation|1|||
13259292|NCT01490125|26393771|FG004|Period I|Protocol Violation|0|||
13259293|NCT01490125|26393772|FG005|Period I|Protocol Violation|0|||
13259294|NCT01490125|26393767|FG000|Period I|Withdrawal by Subject|1|||
13259295|NCT01490125|26393768|FG001|Period I|Withdrawal by Subject|3|||
13259296|NCT01490125|26393769|FG002|Period I|Withdrawal by Subject|2|||
13259297|NCT01490125|26393770|FG003|Period I|Withdrawal by Subject|1|||
13259298|NCT01490125|26393771|FG004|Period I|Withdrawal by Subject|2|||
13259299|NCT01490125|26393772|FG005|Period I|Withdrawal by Subject|1|||
13259300|NCT01490125|26393767|FG000|Period II|Adverse Event|2|||
13259301|NCT01490125|26393768|FG001|Period II|Adverse Event|3|||
13259302|NCT01490125|26393769|FG002|Period II|Adverse Event|2|||
13259303|NCT01490125|26393770|FG003|Period II|Adverse Event|2|||
13259304|NCT01490125|26393771|FG004|Period II|Adverse Event|4|||
13259305|NCT01490125|26393772|FG005|Period II|Adverse Event|2|||
13259306|NCT01490125|26393767|FG000|Period II|Protocol Violation|0|||
13259307|NCT01490125|26393768|FG001|Period II|Protocol Violation|0|||
13259308|NCT01490125|26393769|FG002|Period II|Protocol Violation|1|||
13259309|NCT01490125|26393770|FG003|Period II|Protocol Violation|1|||
13259310|NCT01490125|26393771|FG004|Period II|Protocol Violation|0|||
13259311|NCT01490125|26393772|FG005|Period II|Protocol Violation|0|||
13259312|NCT01490125|26393767|FG000|Period II|Lost to Follow-up|0|||
13259313|NCT01490125|26393768|FG001|Period II|Lost to Follow-up|1|||
13259314|NCT01490125|26393769|FG002|Period II|Lost to Follow-up|0|||
13259315|NCT01490125|26393770|FG003|Period II|Lost to Follow-up|0|||
13259316|NCT01490125|26393771|FG004|Period II|Lost to Follow-up|0|||
13259317|NCT01490125|26393772|FG005|Period II|Lost to Follow-up|0|||
13259318|NCT01490125|26393767|FG000|Period II|Withdrawal by Subject|1|||
13259319|NCT01490125|26393768|FG001|Period II|Withdrawal by Subject|0|||
13259320|NCT01490125|26393769|FG002|Period II|Withdrawal by Subject|0|||
13259321|NCT01490125|26393770|FG003|Period II|Withdrawal by Subject|0|||
13259322|NCT01490125|26393771|FG004|Period II|Withdrawal by Subject|0|||
13259323|NCT01490125|26393772|FG005|Period II|Withdrawal by Subject|0|||
13259324|NCT01490125|26393767|FG000|Period III|Adverse Event|3|||
13117287|NCT03061188|25925069|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0|||
13117288|NCT03061188|25925070|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0|||
13117289|NCT03061188|25925071|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1|||
13117290|NCT03061188|25925072|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1|||
13117291|NCT03061188|25925069|FG000|On Follow-up for 3 Years|Death|0|||
13259325|NCT01490125|26393768|FG001|Period III|Adverse Event|1|||
13259326|NCT01490125|26393769|FG002|Period III|Adverse Event|0|||
13259327|NCT01490125|26393770|FG003|Period III|Adverse Event|1|||
13259328|NCT01490125|26393771|FG004|Period III|Adverse Event|0|||
13259329|NCT01490125|26393772|FG005|Period III|Adverse Event|0|||
13259330|NCT01490125|26393767|FG000|Period III|Death|0|||
13259331|NCT01490125|26393768|FG001|Period III|Death|0|||
13259332|NCT01490125|26393769|FG002|Period III|Death|0|||
13259333|NCT01490125|26393770|FG003|Period III|Death|1|||
13259334|NCT01490125|26393771|FG004|Period III|Death|0|||
13259335|NCT01490125|26393772|FG005|Period III|Death|0|||
13259336|NCT01490125|26393767|FG000|Period III|Lack of Efficacy|0|||
13259337|NCT01490125|26393768|FG001|Period III|Lack of Efficacy|0|||
13259338|NCT01490125|26393769|FG002|Period III|Lack of Efficacy|0|||
13259339|NCT01490125|26393770|FG003|Period III|Lack of Efficacy|0|||
13259340|NCT01490125|26393771|FG004|Period III|Lack of Efficacy|1|||
13117292|NCT03061188|25925070|FG001|On Follow-up for 3 Years|Death|3|||
13117293|NCT03061188|25925071|FG002|On Follow-up for 3 Years|Death|5|||
13259341|NCT01490125|26393772|FG005|Period III|Lack of Efficacy|0|||
13259342|NCT01490086|26393820|FG000|Overall Study|Consent withdrawn|4|||
13259343|NCT01490086|26393821|FG001|Overall Study|Consent withdrawn|4|||
13259344|NCT01490086|26393822|FG002|Overall Study|Consent withdrawn|3|||
13259345|NCT01490086|26393823|FG003|Overall Study|Consent withdrawn|0|||
13259346|NCT01490086|26393824|FG004|Overall Study|Consent withdrawn|1|||
13259347|NCT01490086|26393820|FG000|Overall Study|Non-compliance|0|||
13259348|NCT01490086|26393821|FG001|Overall Study|Non-compliance|1|||
13259349|NCT01490086|26393822|FG002|Overall Study|Non-compliance|0|||
13259350|NCT01490086|26393823|FG003|Overall Study|Non-compliance|0|||
13259351|NCT01490086|26393824|FG004|Overall Study|Non-compliance|0|||
13259352|NCT01490086|26393820|FG000|Overall Study|Abnormal laboratory findings|1|||
13259353|NCT01490086|26393821|FG001|Overall Study|Abnormal laboratory findings|0|||
13259354|NCT01490086|26393822|FG002|Overall Study|Abnormal laboratory findings|0|||
13259355|NCT01490086|26393823|FG003|Overall Study|Abnormal laboratory findings|0|||
13259356|NCT01490086|26393824|FG004|Overall Study|Abnormal laboratory findings|0|||
13259357|NCT01490086|26393820|FG000|Overall Study|Lost to Follow-up|0|||
13259358|NCT01490086|26393821|FG001|Overall Study|Lost to Follow-up|0|||
13259359|NCT01490086|26393822|FG002|Overall Study|Lost to Follow-up|0|||
13259360|NCT01490086|26393823|FG003|Overall Study|Lost to Follow-up|0|||
13259361|NCT01490086|26393824|FG004|Overall Study|Lost to Follow-up|1|||
13117294|NCT03061188|25925072|FG003|On Follow-up for 3 Years|Death|2|||
13117295|NCT03061188|25925069|FG000|On Follow-up for 3 Years|Still in follow-up|0|||
13117296|NCT03061188|25925070|FG001|On Follow-up for 3 Years|Still in follow-up|0|||
13117297|NCT03061188|25925071|FG002|On Follow-up for 3 Years|Still in follow-up|0|||
13117298|NCT03061188|25925072|FG003|On Follow-up for 3 Years|Still in follow-up|3|||
13117299|NCT03061175|25925101|FG000|Baseline|Participant was deemed ineligible|1|||
13117300|NCT03061175|25925102|FG001|Baseline|Participant was deemed ineligible|0|||
13117301|NCT03061175|25925101|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6|||
13117302|NCT03061175|25925102|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2|||
13117303|NCT03061175|25925101|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0|||
13117304|NCT03061175|25925102|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1|||
13117305|NCT03061175|25925101|FG000|Followup 2 at 6 Months|Lost to Follow-up|4|||
13117306|NCT03061175|25925102|FG001|Followup 2 at 6 Months|Lost to Follow-up|7|||
13117307|NCT03061097|25925121|FG000|Overall Study|Withdrawal by Subject|0|||
13117308|NCT03061097|25925122|FG001|Overall Study|Withdrawal by Subject|3|||
13117309|NCT03060551|25925143|FG000|Overall Study|Withdrawal by Subject|1|||
13117310|NCT03060551|25925143|FG000|Overall Study|Adverse Event|1|||
13117311|NCT03060512|25925167|FG000|Overall Study|Adverse Event|4|||
13117312|NCT03060512|25925168|FG001|Overall Study|Adverse Event|6|||
13117313|NCT03060512|25925167|FG000|Overall Study|Lost to Follow-up|1|||
13117314|NCT03060512|25925168|FG001|Overall Study|Lost to Follow-up|1|||
13117315|NCT03060512|25925167|FG000|Overall Study|Withdrawal by Subject|1|||
13259362|NCT01490086|26393820|FG000|Overall Study|Physician Decision|3|||
13259363|NCT01490086|26393821|FG001|Overall Study|Physician Decision|4|||
13259364|NCT01490086|26393822|FG002|Overall Study|Physician Decision|2|||
13259365|NCT01490086|26393823|FG003|Overall Study|Physician Decision|3|||
13117316|NCT03060512|25925168|FG001|Overall Study|Withdrawal by Subject|0|||
13117317|NCT03060512|25925167|FG000|Overall Study|Non-compliance with study medication|1|||
13259366|NCT01490086|26393824|FG004|Overall Study|Physician Decision|1|||
13259367|NCT01490086|26393820|FG000|Overall Study|Adverse Event|0|||
13117318|NCT03060512|25925168|FG001|Overall Study|Non-compliance with study medication|2|||
13117319|NCT03060447|25925204|FG000|Overall Study|Withdrawal by Subject|2|||
13117320|NCT03060447|25925205|FG001|Overall Study|Withdrawal by Subject|0|||
13117321|NCT03058991|25925241|FG000|Overall Study|Lost to Follow-up|17|||
13117322|NCT03058991|25925242|FG001|Overall Study|Lost to Follow-up|12|||
13117323|NCT03058991|25925243|FG002|Overall Study|Lost to Follow-up|12|||
13117324|NCT03058991|25925241|FG000|Overall Study|Withdrawal by Subject|1|||
13117325|NCT03058991|25925242|FG001|Overall Study|Withdrawal by Subject|0|||
13117326|NCT03058991|25925243|FG002|Overall Study|Withdrawal by Subject|0|||
13117327|NCT03058705|25925249|FG000|Overall Study|Withdrawal by Subject|2|||
13117328|NCT03058705|25925249|FG000|Overall Study|Physician Decision|2|||
13117329|NCT03058692|25925368|FG000|Overall Study|Lost to Follow-up|2|||
13117330|NCT03058692|25925369|FG001|Overall Study|Lost to Follow-up|1|||
13117331|NCT03058692|25925368|FG000|Overall Study|Withdrawal by Subject|1|||
13117332|NCT03058692|25925369|FG001|Overall Study|Withdrawal by Subject|1|||
13117333|NCT03058679|25925388|FG000|Baseline to Week 6|Lost to Follow-up|3|||
13117334|NCT03058679|25925389|FG001|Baseline to Week 6|Lost to Follow-up|2|||
13117335|NCT03058679|25925388|FG000|Baseline to Week 6|Change in Crohn's disease medication|4|||
13259368|NCT01490086|26393821|FG001|Overall Study|Adverse Event|0|||
13259369|NCT01490086|26393822|FG002|Overall Study|Adverse Event|1|||
13259370|NCT01490086|26393823|FG003|Overall Study|Adverse Event|2|||
13117336|NCT03058679|25925389|FG001|Baseline to Week 6|Change in Crohn's disease medication|2|||
13117337|NCT03058679|25925388|FG000|Baseline to Week 6|Adverse Event|6|||
13259371|NCT01490086|26393824|FG004|Overall Study|Adverse Event|0|||
13259372|NCT01490086|26393820|FG000|Overall Study|Lack of Efficacy|0|||
13259373|NCT01490086|26393821|FG001|Overall Study|Lack of Efficacy|3|||
13259374|NCT01490086|26393822|FG002|Overall Study|Lack of Efficacy|1|||
13259375|NCT01490086|26393823|FG003|Overall Study|Lack of Efficacy|0|||
13259376|NCT01490086|26393824|FG004|Overall Study|Lack of Efficacy|8|||
13259377|NCT01490086|26393820|FG000|Overall Study|Worsening of symptoms|0|||
13259378|NCT01490086|26393821|FG001|Overall Study|Worsening of symptoms|1|||
13259379|NCT01490086|26393822|FG002|Overall Study|Worsening of symptoms|0|||
13259380|NCT01490086|26393823|FG003|Overall Study|Worsening of symptoms|1|||
13259381|NCT01490086|26393824|FG004|Overall Study|Worsening of symptoms|0|||
13259382|NCT01490086|26393820|FG000|Overall Study|Subject uncontrollable and abusive|0|||
13259383|NCT01490086|26393821|FG001|Overall Study|Subject uncontrollable and abusive|1|||
13259384|NCT01490086|26393822|FG002|Overall Study|Subject uncontrollable and abusive|0|||
13259385|NCT01490086|26393823|FG003|Overall Study|Subject uncontrollable and abusive|0|||
13259386|NCT01490086|26393824|FG004|Overall Study|Subject uncontrollable and abusive|0|||
13259387|NCT01490086|26393820|FG000|Overall Study|Subject left hospital|0|||
13259388|NCT01490086|26393821|FG001|Overall Study|Subject left hospital|1|||
13259389|NCT01490086|26393822|FG002|Overall Study|Subject left hospital|0|||
13259390|NCT01490086|26393823|FG003|Overall Study|Subject left hospital|1|||
13259391|NCT01490086|26393824|FG004|Overall Study|Subject left hospital|0|||
13259392|NCT01490060|26393841|FG000|Cycle 1|Change of Treatment|0|||
13259393|NCT01490060|26393842|FG001|Cycle 1|Change of Treatment|1|||
13259394|NCT01490060|26393843|FG002|Cycle 1|Change of Treatment|1|||
13259395|NCT01490060|26393844|FG003|Cycle 1|Change of Treatment|1|||
13259396|NCT01490060|26393841|FG000|Cycle 1|Insurance Denied|0|||
13259397|NCT01490060|26393842|FG001|Cycle 1|Insurance Denied|0|||
13259398|NCT01490060|26393843|FG002|Cycle 1|Insurance Denied|2|||
13259399|NCT01490060|26393844|FG003|Cycle 1|Insurance Denied|0|||
13259400|NCT01490060|26393841|FG000|Cycle 1|Withdrawal by Subject|0|||
13259401|NCT01490060|26393842|FG001|Cycle 1|Withdrawal by Subject|0|||
13259402|NCT01490060|26393843|FG002|Cycle 1|Withdrawal by Subject|0|||
13259403|NCT01490060|26393844|FG003|Cycle 1|Withdrawal by Subject|1|||
13259404|NCT01490060|26393841|FG000|Cycle 1|Treatment at Another Facility|0|||
13259405|NCT01490060|26393842|FG001|Cycle 1|Treatment at Another Facility|0|||
13259406|NCT01490060|26393843|FG002|Cycle 1|Treatment at Another Facility|0|||
13259407|NCT01490060|26393844|FG003|Cycle 1|Treatment at Another Facility|1|||
13259408|NCT01490060|26393841|FG000|Cycle 2|Change of Treatment|1|||
13259409|NCT01490060|26393842|FG001|Cycle 2|Change of Treatment|1|||
13259410|NCT01490060|26393843|FG002|Cycle 2|Change of Treatment|0|||
13259411|NCT01490060|26393844|FG003|Cycle 2|Change of Treatment|0|||
13259412|NCT01490060|26393841|FG000|Cycle 2|Non-Compliance|0|||
13259413|NCT01490060|26393842|FG001|Cycle 2|Non-Compliance|0|||
13259414|NCT01490060|26393843|FG002|Cycle 2|Non-Compliance|1|||
13259415|NCT01490060|26393844|FG003|Cycle 2|Non-Compliance|0|||
13259416|NCT01490060|26393841|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1|||
13259417|NCT01490060|26393842|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0|||
13259418|NCT01490060|26393843|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0|||
13259419|NCT01490060|26393844|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0|||
13259420|NCT01489956|26393887|FG000|Overall Study|Lost to Follow-up|1|||
13259421|NCT01489956|26393888|FG001|Overall Study|Lost to Follow-up|0|||
13259422|NCT01489956|26393889|FG002|Overall Study|Lost to Follow-up|0|||
13259423|NCT01489956|26393887|FG000|Overall Study|Withdrawal by Subject|0|||
13259424|NCT01489956|26393888|FG001|Overall Study|Withdrawal by Subject|0|||
13117338|NCT03058679|25925389|FG001|Baseline to Week 6|Adverse Event|6|||
13259425|NCT01489956|26393889|FG002|Overall Study|Withdrawal by Subject|1|||
13259426|NCT01489891|26393908|FG000|Overall Study|Endoscopy failure|1|||
13259427|NCT01489891|26393909|FG001|Overall Study|Endoscopy failure|0|||
13259428|NCT01489527|26393930|FG000|Overall Study|Pregnancy|9|||
13259429|NCT01489527|26393931|FG001|Overall Study|Pregnancy|14|||
13259430|NCT01489527|26393930|FG000|Overall Study|Participant moved|6|||
13259431|NCT01489527|26393931|FG001|Overall Study|Participant moved|7|||
13259432|NCT01489527|26393930|FG000|Overall Study|Withdrawal by Subject|0|||
13259433|NCT01489527|26393931|FG001|Overall Study|Withdrawal by Subject|4|||
13259434|NCT01489527|26393930|FG000|Overall Study|Lost to Follow-up|5|||
13259435|NCT01489527|26393931|FG001|Overall Study|Lost to Follow-up|1|||
13259436|NCT01489527|26393930|FG000|Overall Study|Procedures|1|||
13259437|NCT01489527|26393931|FG001|Overall Study|Procedures|0|||
13259438|NCT01489527|26393930|FG000|Overall Study|Not compliant|1|||
13259439|NCT01489527|26393931|FG001|Overall Study|Not compliant|0|||
13259440|NCT01489358|26393988|FG000|Overall Study|Lost to Follow-up|0|||
13259441|NCT01489358|26393989|FG001|Overall Study|Lost to Follow-up|0|||
13259442|NCT01489358|26393990|FG002|Overall Study|Lost to Follow-up|2|||
13259443|NCT01489254|26394010|FG000|Double-blind Part|Adverse Event|7|||
13259444|NCT01489254|26394011|FG001|Double-blind Part|Adverse Event|2|||
13259445|NCT01489254|26394012|FG002|Double-blind Part|Adverse Event|2|||
13259446|NCT01489254|26394013|FG003|Double-blind Part|Adverse Event|0|||
13259447|NCT01489254|26394010|FG000|Double-blind Part|Pregnancy|1|||
13259448|NCT01489254|26394011|FG001|Double-blind Part|Pregnancy|3|||
13259449|NCT01489254|26394012|FG002|Double-blind Part|Pregnancy|0|||
13259450|NCT01489254|26394013|FG003|Double-blind Part|Pregnancy|0|||
13259451|NCT01489254|26394010|FG000|Double-blind Part|Withdrawal by Subject|12|||
13259452|NCT01489254|26394011|FG001|Double-blind Part|Withdrawal by Subject|20|||
13259453|NCT01489254|26394012|FG002|Double-blind Part|Withdrawal by Subject|1|||
13259454|NCT01489254|26394013|FG003|Double-blind Part|Withdrawal by Subject|0|||
13259455|NCT01489254|26394010|FG000|Double-blind Part|Lost to Follow-up|1|||
13259456|NCT01489254|26394011|FG001|Double-blind Part|Lost to Follow-up|2|||
13259457|NCT01489254|26394012|FG002|Double-blind Part|Lost to Follow-up|0|||
13259458|NCT01489254|26394013|FG003|Double-blind Part|Lost to Follow-up|0|||
13259459|NCT01489254|26394010|FG000|Double-blind Part|Other reasons for not completing study|4|||
13259460|NCT01489254|26394011|FG001|Double-blind Part|Other reasons for not completing study|6|||
13259461|NCT01489254|26394012|FG002|Double-blind Part|Other reasons for not completing study|0|||
13259462|NCT01489254|26394013|FG003|Double-blind Part|Other reasons for not completing study|0|||
13259463|NCT01489254|26394010|FG000|Open-label Extension Part|Adverse Event|0|||
13259464|NCT01489254|26394011|FG001|Open-label Extension Part|Adverse Event|0|||
13259465|NCT01489254|26394012|FG002|Open-label Extension Part|Adverse Event|0|||
13259466|NCT01489254|26394013|FG003|Open-label Extension Part|Adverse Event|10|||
13259467|NCT01489254|26394010|FG000|Open-label Extension Part|Pregnancy|0|||
13259468|NCT01489254|26394011|FG001|Open-label Extension Part|Pregnancy|0|||
13259469|NCT01489254|26394012|FG002|Open-label Extension Part|Pregnancy|0|||
13259470|NCT01489254|26394013|FG003|Open-label Extension Part|Pregnancy|3|||
13259471|NCT01489254|26394010|FG000|Open-label Extension Part|Withdrawal by Subject|0|||
13259472|NCT01489254|26394011|FG001|Open-label Extension Part|Withdrawal by Subject|0|||
13259473|NCT01489254|26394012|FG002|Open-label Extension Part|Withdrawal by Subject|0|||
13259474|NCT01489254|26394013|FG003|Open-label Extension Part|Withdrawal by Subject|30|||
13259475|NCT01489254|26394010|FG000|Open-label Extension Part|Protocol Violation|0|||
13259476|NCT01489254|26394011|FG001|Open-label Extension Part|Protocol Violation|0|||
13259477|NCT01489254|26394012|FG002|Open-label Extension Part|Protocol Violation|0|||
13259478|NCT01489254|26394013|FG003|Open-label Extension Part|Protocol Violation|1|||
13259479|NCT01489254|26394010|FG000|Open-label Extension Part|Lost to Follow-up|0|||
13259480|NCT01489254|26394011|FG001|Open-label Extension Part|Lost to Follow-up|0|||
13259481|NCT01489254|26394012|FG002|Open-label Extension Part|Lost to Follow-up|0|||
13259482|NCT01489254|26394013|FG003|Open-label Extension Part|Lost to Follow-up|9|||
13259483|NCT01489254|26394010|FG000|Open-label Extension Part|Other reasons for not completing study|0|||
13259484|NCT01489254|26394011|FG001|Open-label Extension Part|Other reasons for not completing study|0|||
13259485|NCT01489254|26394012|FG002|Open-label Extension Part|Other reasons for not completing study|0|||
13259486|NCT01489254|26394013|FG003|Open-label Extension Part|Other reasons for not completing study|5|||
13259487|NCT01489189|26394045|FG000|Overall Study|Withdrawal by Subject|20|||
13259488|NCT01489189|26394046|FG001|Overall Study|Withdrawal by Subject|23|||
13259489|NCT01489189|26394045|FG000|Overall Study|Death|10|||
13259490|NCT01489189|26394046|FG001|Overall Study|Death|8|||
13259491|NCT01489189|26394045|FG000|Overall Study|Missed Visit|1|||
13259492|NCT01489189|26394046|FG001|Overall Study|Missed Visit|4|||
13259493|NCT01489111|26394063|FG000|Overall Study|Withdrawal criterion|1|||
13259494|NCT01489020|26394114|FG000|Overall Study|Withdrawal by Subject|1|||
13259495|NCT01489020|26394115|FG001|Overall Study|Withdrawal by Subject|0|||
13259496|NCT01489020|26394116|FG002|Overall Study|Withdrawal by Subject|0|||
13259497|NCT01489020|26394117|FG003|Overall Study|Withdrawal by Subject|0|||
13259498|NCT01489020|26394118|FG004|Overall Study|Withdrawal by Subject|0|||
13259499|NCT01489020|26394119|FG005|Overall Study|Withdrawal by Subject|0|||
13259500|NCT01489020|26394114|FG000|Overall Study|Adverse Event|0|||
13259501|NCT01489020|26394115|FG001|Overall Study|Adverse Event|0|||
13259502|NCT01489020|26394116|FG002|Overall Study|Adverse Event|3|||
13259503|NCT01489020|26394117|FG003|Overall Study|Adverse Event|0|||
13259504|NCT01489020|26394118|FG004|Overall Study|Adverse Event|3|||
13259505|NCT01489020|26394119|FG005|Overall Study|Adverse Event|0|||
13259506|NCT01489020|26394114|FG000|Overall Study|Concomitant disease|0|||
13259507|NCT01489020|26394115|FG001|Overall Study|Concomitant disease|0|||
13259508|NCT01489020|26394116|FG002|Overall Study|Concomitant disease|0|||
13259509|NCT01489020|26394117|FG003|Overall Study|Concomitant disease|0|||
13259510|NCT01489020|26394118|FG004|Overall Study|Concomitant disease|3|||
13259511|NCT01489020|26394119|FG005|Overall Study|Concomitant disease|0|||
13259512|NCT01488994|26394213|FG000|Overall Study|Withdrawal by Subject|0|||
13259513|NCT01488994|26394214|FG001|Overall Study|Withdrawal by Subject|1|||
13259514|NCT01488578|26394250|FG000|Overall Study|Protocol Violation|1836|||
13259515|NCT01488487|26394259|FG000|Overall Study|Adverse Event|6|||
13259516|NCT01488487|26394259|FG000|Overall Study|Death|1|||
13259517|NCT01488487|26394259|FG000|Overall Study|Withdrawal by Subject|2|||
13259518|NCT01488448|26394288|FG000|Overall Study|Withdrawal by Subject|3|||
13259519|NCT01488448|26394289|FG001|Overall Study|Withdrawal by Subject|1|||
13259520|NCT01488448|26394288|FG000|Overall Study|Adverse Event|9|||
13259521|NCT01488448|26394289|FG001|Overall Study|Adverse Event|4|||
13259522|NCT01488448|26394288|FG000|Overall Study|Physician Decision|4|||
13259523|NCT01488448|26394289|FG001|Overall Study|Physician Decision|9|||
13259524|NCT01488448|26394288|FG000|Overall Study|Protocol Violation|4|||
13259525|NCT01488448|26394289|FG001|Overall Study|Protocol Violation|3|||
13259526|NCT01488370|26394319|FG000|Overall Study|Protocol Violation|0|||
13259527|NCT01488370|26394320|FG001|Overall Study|Protocol Violation|1|||
13259528|NCT01488370|26394321|FG002|Overall Study|Protocol Violation|1|||
13259529|NCT01488097|26394334|FG000|Overall Study|Lost to Follow-up|1|||
13259530|NCT01488071|26394373|FG000|Overall Study|Adverse Event|15|||
13259531|NCT01488071|26394374|FG001|Overall Study|Adverse Event|23|||
13259532|NCT01488071|26394373|FG000|Overall Study|Lack of Efficacy|11|||
13259533|NCT01488071|26394374|FG001|Overall Study|Lack of Efficacy|17|||
13259534|NCT01488071|26394373|FG000|Overall Study|Non-compliance with study drug|2|||
13259535|NCT01488071|26394374|FG001|Overall Study|Non-compliance with study drug|0|||
13259536|NCT01488071|26394373|FG000|Overall Study|Protocol Violation|5|||
13259537|NCT01488071|26394374|FG001|Overall Study|Protocol Violation|7|||
13259538|NCT01488071|26394373|FG000|Overall Study|Withdrawal of Consent|14|||
13259539|NCT01488071|26394374|FG001|Overall Study|Withdrawal of Consent|12|||
13259540|NCT01488071|26394373|FG000|Overall Study|Lost to Follow-up|1|||
13259541|NCT01488071|26394374|FG001|Overall Study|Lost to Follow-up|0|||
13259542|NCT01488071|26394373|FG000|Overall Study|Administrative or Other Reason(s)|5|||
13259543|NCT01488071|26394374|FG001|Overall Study|Administrative or Other Reason(s)|4|||
13259544|NCT01487863|26394387|FG000|Overall Study|Death|19|||
13259545|NCT01487863|26394388|FG001|Overall Study|Death|19|||
13259546|NCT01487577|26394402|FG000|Overall Study|Became ineligible after signing consent|1|||
13259547|NCT01487525|26394419|FG000|Overall Study|Withdrawal by Subject|0|||
13259548|NCT01487525|26394420|FG001|Overall Study|Withdrawal by Subject|1|||
13259549|NCT01487265|26394430|FG000|Overall Study|Adverse Event|8|||
13259550|NCT01487265|26394430|FG000|Overall Study|Withdrawal by Subject|5|||
13259551|NCT01487265|26394430|FG000|Overall Study|Disease Progression|21|||
13259552|NCT01487265|26394430|FG000|Overall Study|Death|2|||
13259553|NCT01487265|26394430|FG000|Overall Study|Still on Treatment|1|||
13259554|NCT01487200|26394469|FG000|Overall Study|Withdrawal by Subject|0|||
13259555|NCT01487200|26394470|FG001|Overall Study|Withdrawal by Subject|1|||
13259556|NCT01487200|26394471|FG002|Overall Study|Withdrawal by Subject|0|||
13259557|NCT01487200|26394472|FG003|Overall Study|Withdrawal by Subject|0|||
13259558|NCT01487161|26394548|FG000|Overall Study|Adverse Event|1|||
13259559|NCT01487161|26394549|FG001|Overall Study|Adverse Event|0|||
13259560|NCT01487161|26394550|FG002|Overall Study|Adverse Event|0|||
13259561|NCT01487161|26394551|FG003|Overall Study|Adverse Event|0|||
13259562|NCT01487161|26394548|FG000|Overall Study|Withdrawal by Subject|1|||
13259563|NCT01487161|26394549|FG001|Overall Study|Withdrawal by Subject|1|||
13259564|NCT01487161|26394550|FG002|Overall Study|Withdrawal by Subject|1|||
13259565|NCT01487161|26394551|FG003|Overall Study|Withdrawal by Subject|2|||
13259566|NCT01487161|26394548|FG000|Overall Study|missing data|0|||
13259567|NCT01487161|26394549|FG001|Overall Study|missing data|1|||
13259568|NCT01487161|26394550|FG002|Overall Study|missing data|0|||
13259569|NCT01487161|26394551|FG003|Overall Study|missing data|0|||
13259570|NCT01486966|26394582|FG000|Overall Study|Adverse Event|0|||
13259571|NCT01486966|26394583|FG001|Overall Study|Adverse Event|1|||
13259572|NCT01486966|26394582|FG000|Overall Study|Withdrawal by Subject|0|||
13259573|NCT01486966|26394583|FG001|Overall Study|Withdrawal by Subject|1|||
13259574|NCT01486927|26394616|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1|||
13259575|NCT01486927|26394616|FG000|Overall Study|Physician Decision|1|||
13259576|NCT01486927|26394616|FG000|Overall Study|50 Exposure days not reached|2|||
13259577|NCT01486927|26394616|FG000|Overall Study|Withdrawal by Subject|8|||
13290482|NCT00102531|26481210|FG000|Overall Study|Physician Decision|0|||
13259578|NCT01486927|26394616|FG000|Overall Study|Subject did not reach 6 mo of treatment|1|||
13259579|NCT01486784|26394655|FG000|Overall Study|Withdrawal by Subject|0|||
13259580|NCT01486784|26394656|FG001|Overall Study|Withdrawal by Subject|0|||
13259581|NCT01486784|26394657|FG002|Overall Study|Withdrawal by Subject|1|||
13259582|NCT01486784|26394658|FG003|Overall Study|Withdrawal by Subject|0|||
13259583|NCT01486784|26394659|FG004|Overall Study|Withdrawal by Subject|1|||
13259584|NCT01486784|26394660|FG005|Overall Study|Withdrawal by Subject|2|||
13259585|NCT01486784|26394655|FG000|Overall Study|Subject did not meet entry criteria|0|||
13259586|NCT01486784|26394656|FG001|Overall Study|Subject did not meet entry criteria|0|||
13259587|NCT01486784|26394657|FG002|Overall Study|Subject did not meet entry criteria|0|||
13259588|NCT01486784|26394658|FG003|Overall Study|Subject did not meet entry criteria|0|||
13259589|NCT01486784|26394659|FG004|Overall Study|Subject did not meet entry criteria|1|||
13259590|NCT01486784|26394660|FG005|Overall Study|Subject did not meet entry criteria|0|||
13259591|NCT01486784|26394655|FG000|Overall Study|Death|0|||
13259592|NCT01486784|26394656|FG001|Overall Study|Death|0|||
13259593|NCT01486784|26394657|FG002|Overall Study|Death|0|||
13259594|NCT01486784|26394658|FG003|Overall Study|Death|0|||
13259595|NCT01486784|26394659|FG004|Overall Study|Death|0|||
13117339|NCT03058679|25925388|FG000|Baseline to Week 6|Withdrawal by Subject|4|||
13259596|NCT01486784|26394660|FG005|Overall Study|Death|1|||
13259597|NCT01486758|26394687|FG000|Overall Study|Lost to Follow-up|0|||
13259598|NCT01486758|26394688|FG001|Overall Study|Lost to Follow-up|1|||
13259599|NCT01486446|26394715|FG000|Overall Study|Adverse Event|1|||
13259600|NCT01486446|26394716|FG001|Overall Study|Adverse Event|0|||
13259601|NCT01486316|26394737|FG000|Overall Study|Device explanted with/without re-implant|3|||
13259602|NCT01486316|26394738|FG001|Overall Study|Device explanted with/without re-implant|2|||
13259603|NCT01486316|26394739|FG002|Overall Study|Device explanted with/without re-implant|0|||
13259604|NCT01486316|26394740|FG003|Overall Study|Device explanted with/without re-implant|2|||
13259605|NCT01486316|26394737|FG000|Overall Study|Not meeting eligibility criteria|0|||
13259606|NCT01486316|26394738|FG001|Overall Study|Not meeting eligibility criteria|0|||
13259607|NCT01486316|26394739|FG002|Overall Study|Not meeting eligibility criteria|1|||
13259608|NCT01486316|26394740|FG003|Overall Study|Not meeting eligibility criteria|0|||
13259609|NCT01486316|26394737|FG000|Overall Study|Withdrawal by Subject|1|||
13259610|NCT01486316|26394738|FG001|Overall Study|Withdrawal by Subject|0|||
13259611|NCT01486316|26394739|FG002|Overall Study|Withdrawal by Subject|3|||
13259612|NCT01486316|26394740|FG003|Overall Study|Withdrawal by Subject|0|||
13259613|NCT01486316|26394737|FG000|Overall Study|Physician Decision|0|||
13259614|NCT01486316|26394738|FG001|Overall Study|Physician Decision|0|||
13259615|NCT01486316|26394739|FG002|Overall Study|Physician Decision|1|||
13259616|NCT01486316|26394740|FG003|Overall Study|Physician Decision|0|||
13259617|NCT01486316|26394737|FG000|Overall Study|Death|0|||
13259618|NCT01486316|26394738|FG001|Overall Study|Death|1|||
13259619|NCT01486316|26394739|FG002|Overall Study|Death|0|||
13259620|NCT01486316|26394740|FG003|Overall Study|Death|0|||
13117340|NCT03058679|25925389|FG001|Baseline to Week 6|Withdrawal by Subject|3|||
13117341|NCT03058679|25925388|FG000|Baseline to Week 6|Difficulty following the diet|0|||
13117342|NCT03058679|25925389|FG001|Baseline to Week 6|Difficulty following the diet|2|||
13117343|NCT03058679|25925388|FG000|Baseline to Week 6|Physician Decision|1|||
13117344|NCT03058679|25925389|FG001|Baseline to Week 6|Physician Decision|0|||
13117345|NCT03058679|25925388|FG000|Week 6 to Week 12|Change in medication|5|||
13117346|NCT03058679|25925389|FG001|Week 6 to Week 12|Change in medication|7|||
13117347|NCT03058679|25925388|FG000|Week 6 to Week 12|Adverse Event|4|||
13117348|NCT03058679|25925389|FG001|Week 6 to Week 12|Adverse Event|3|||
13259621|NCT01486238|26394753|FG000|Overall Study|Death|0|||
13259622|NCT01486238|26394754|FG001|Overall Study|Death|2|||
13259623|NCT01486238|26394753|FG000|Overall Study|Withdrawal by Subject|2|||
13259624|NCT01486238|26394754|FG001|Overall Study|Withdrawal by Subject|1|||
13259625|NCT01486238|26394753|FG000|Overall Study|Lost to Follow-up|0|||
13259626|NCT01486238|26394754|FG001|Overall Study|Lost to Follow-up|3|||
13259627|NCT01486199|26394773|FG000|Two Year Period Between Study Days|Physician Decision|1|||
13259628|NCT01486199|26394774|FG001|Two Year Period Between Study Days|Physician Decision|0|||
13259629|NCT01485991|26394791|FG000|Overall Study|Adverse Event|0|||
13259630|NCT01485991|26394792|FG001|Overall Study|Adverse Event|4|||
13259631|NCT01485991|26394791|FG000|Overall Study|Lost to Follow-up|13|||
13259632|NCT01485991|26394792|FG001|Overall Study|Lost to Follow-up|10|||
13259633|NCT01485991|26394791|FG000|Overall Study|Withdrawal by Subject|13|||
13259634|NCT01485991|26394792|FG001|Overall Study|Withdrawal by Subject|20|||
13259635|NCT01485991|26394791|FG000|Overall Study|randomized but not treated|6|||
13117349|NCT03058679|25925388|FG000|Week 6 to Week 12|Withdrawal by Subject|9|||
13117350|NCT03058679|25925389|FG001|Week 6 to Week 12|Withdrawal by Subject|4|||
13259636|NCT01485991|26394792|FG001|Overall Study|randomized but not treated|2|||
13259637|NCT01485887|26394806|FG000|Overall Study|Withdrawal by Subject|2|||
13259638|NCT01485887|26394806|FG000|Overall Study|Adverse Event|8|||
13259639|NCT01485887|26394806|FG000|Overall Study|Deterioration of primary disease|1|||
13259640|NCT01485887|26394806|FG000|Overall Study|Primary disease markedly improved|1|||
13259641|NCT01485796|26394830|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1|||
13117351|NCT03058679|25925388|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2|||
13117352|NCT03058679|25925389|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3|||
13117353|NCT03057977|25925420|FG000|Discontinuation From Treatment|Withdrawal by Subject|124|||
13117354|NCT03057977|25925421|FG001|Discontinuation From Treatment|Withdrawal by Subject|92|||
13117355|NCT03057977|25925420|FG000|Discontinuation From Treatment|Lost to Follow-up|11|||
13117356|NCT03057977|25925421|FG001|Discontinuation From Treatment|Lost to Follow-up|17|||
13117357|NCT03057977|25925420|FG000|Discontinuation From Treatment|Protocol Violation|6|||
13117358|NCT03057977|25925421|FG001|Discontinuation From Treatment|Protocol Violation|5|||
13117359|NCT03057977|25925420|FG000|Discontinuation From Treatment|Not treated|4|||
13117360|NCT03057977|25925421|FG001|Discontinuation From Treatment|Not treated|0|||
13117361|NCT03057977|25925420|FG000|Discontinuation From Treatment|Adverse Event|343|||
13117362|NCT03057977|25925421|FG001|Discontinuation From Treatment|Adverse Event|337|||
13117363|NCT03057977|25925420|FG000|Discontinuation From Treatment|Reason Unknown|0|||
13117364|NCT03057977|25925421|FG001|Discontinuation From Treatment|Reason Unknown|1|||
13117365|NCT03057977|25925420|FG000|Discontinuation From Treatment|Personal Reasons|1|||
13117366|NCT03057977|25925421|FG001|Discontinuation From Treatment|Personal Reasons|1|||
13117367|NCT03057977|25925420|FG000|Discontinuation From Treatment|Unblinded medication|1|||
13117368|NCT03057977|25925421|FG001|Discontinuation From Treatment|Unblinded medication|0|||
13259642|NCT01485796|26394830|FG000|Period 2: Epoch 2|Withdrawal by Subject|6|||
13259643|NCT01485796|26394830|FG000|Period 2: Epoch 2|Adverse Event|3|||
13259644|NCT01485796|26394830|FG000|Period 2: Epoch 2|Switch to safety follow-up|26|||
13259645|NCT01485796|26394830|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1|||
13259646|NCT01485796|26394830|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6|||
13259647|NCT01485796|26394830|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3|||
13259648|NCT01485796|26394830|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2|||
13259649|NCT01485640|26394837|FG000|Overall Study|Adverse Event|10|||
13259650|NCT01485640|26394837|FG000|Overall Study|Lack of Efficacy|2|||
13259651|NCT01485640|26394837|FG000|Overall Study|Protocol Violation|1|||
13259652|NCT01485640|26394837|FG000|Overall Study|Withdrawal by Subject|14|||
13259653|NCT01485640|26394837|FG000|Overall Study|Terminated by Sponsor|95|||
13259654|NCT01485627|26394862|FG000|Overall Study|Patient withdrew|6|||
13259655|NCT01485627|26394863|FG001|Overall Study|Patient withdrew|5|||
13259656|NCT01485627|26394862|FG000|Overall Study|Patient died|3|||
13259657|NCT01485627|26394863|FG001|Overall Study|Patient died|1|||
13259658|NCT01485627|26394862|FG000|Overall Study|Patient lost to followup|0|||
13259659|NCT01485627|26394863|FG001|Overall Study|Patient lost to followup|1|||
13259660|NCT01485627|26394862|FG000|Overall Study|Caregiver withdrew|3|||
13259661|NCT01485627|26394863|FG001|Overall Study|Caregiver withdrew|3|||
13259662|NCT01485627|26394862|FG000|Overall Study|Caregiver lost to follow up|11|||
13259663|NCT01485627|26394863|FG001|Overall Study|Caregiver lost to follow up|12|||
13259664|NCT01485627|26394862|FG000|Overall Study|Caregiver died|1|||
13259665|NCT01485627|26394863|FG001|Overall Study|Caregiver died|0|||
13486297|NCT02429791|27035711|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1|||
13133411|NCT02770170|25987715|FG003|Overall Study|Adverse Event|3|||
13259666|NCT01485627|26394862|FG000|Overall Study|caregiver was not bereaved|42|||
13259667|NCT01485627|26394863|FG001|Overall Study|caregiver was not bereaved|35|||
13259668|NCT01485614|26395232|FG000|Randomization|Not Treated|1|||
13259669|NCT01485614|26395233|FG001|Randomization|Not Treated|0|||
13259670|NCT01485614|26395234|FG002|Randomization|Not Treated|0|||
13259671|NCT01485614|26395235|FG003|Randomization|Not Treated|0|||
13259672|NCT01485614|26395232|FG000|Weeks 0-20|Lost to Follow-up|2|||
13259673|NCT01485614|26395233|FG001|Weeks 0-20|Lost to Follow-up|0|||
13259674|NCT01485614|26395234|FG002|Weeks 0-20|Lost to Follow-up|0|||
13259675|NCT01485614|26395235|FG003|Weeks 0-20|Lost to Follow-up|0|||
13259676|NCT01485614|26395232|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5|||
13259677|NCT01485614|26395233|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2|||
13259678|NCT01485614|26395234|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
13259679|NCT01485614|26395235|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
13259680|NCT01485614|26395232|FG000|Weeks 0-20|Withdrawal by Subject|3|||
13259681|NCT01485614|26395233|FG001|Weeks 0-20|Withdrawal by Subject|2|||
13259682|NCT01485614|26395234|FG002|Weeks 0-20|Withdrawal by Subject|1|||
13259683|NCT01485614|26395235|FG003|Weeks 0-20|Withdrawal by Subject|0|||
13259684|NCT01485614|26395232|FG000|Weeks 20-54|Lost to Follow-up|4|||
13259685|NCT01485614|26395233|FG001|Weeks 20-54|Lost to Follow-up|3|||
13259686|NCT01485614|26395234|FG002|Weeks 20-54|Lost to Follow-up|1|||
13259687|NCT01485614|26395235|FG003|Weeks 20-54|Lost to Follow-up|0|||
13259688|NCT01485614|26395232|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
13259689|NCT01485614|26395233|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
13259690|NCT01485614|26395234|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1|||
13259691|NCT01485614|26395235|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0|||
13259692|NCT01485614|26395232|FG000|Weeks 20-54|Withdrawal by Subject|5|||
13259693|NCT01485614|26395233|FG001|Weeks 20-54|Withdrawal by Subject|3|||
13259694|NCT01485614|26395234|FG002|Weeks 20-54|Withdrawal by Subject|0|||
13259695|NCT01485614|26395235|FG003|Weeks 20-54|Withdrawal by Subject|0|||
13259696|NCT01485536|26395242|FG000|Overall Study|Withdrawal by Subject|3|||
13259697|NCT01485536|26395242|FG000|Overall Study|Adverse Event|1|||
13259698|NCT01485354|26395252|FG000|Overall Study|Withdrawal by Subject|5|||
13259699|NCT01485172|26395345|FG000|Overall Study|Adverse Event|2|||
13259700|NCT01485172|26395346|FG001|Overall Study|Adverse Event|1|||
13259701|NCT01485172|26395347|FG002|Overall Study|Adverse Event|2|||
13259702|NCT01485172|26395348|FG003|Overall Study|Adverse Event|2|||
13259703|NCT01485172|26395349|FG004|Overall Study|Adverse Event|1|||
13259704|NCT01485172|26395350|FG005|Overall Study|Adverse Event|2|||
13259705|NCT01485172|26395345|FG000|Overall Study|Lack of Efficacy|2|||
13259706|NCT01485172|26395346|FG001|Overall Study|Lack of Efficacy|0|||
13259707|NCT01485172|26395347|FG002|Overall Study|Lack of Efficacy|0|||
13259708|NCT01485172|26395348|FG003|Overall Study|Lack of Efficacy|0|||
13259709|NCT01485172|26395349|FG004|Overall Study|Lack of Efficacy|0|||
13259710|NCT01485172|26395350|FG005|Overall Study|Lack of Efficacy|0|||
13259711|NCT01485172|26395345|FG000|Overall Study|Protocol Violation|0|||
13259712|NCT01485172|26395346|FG001|Overall Study|Protocol Violation|0|||
13259713|NCT01485172|26395347|FG002|Overall Study|Protocol Violation|4|||
13259714|NCT01485172|26395348|FG003|Overall Study|Protocol Violation|5|||
13259715|NCT01485172|26395349|FG004|Overall Study|Protocol Violation|1|||
13259716|NCT01485172|26395350|FG005|Overall Study|Protocol Violation|0|||
13259717|NCT01485172|26395345|FG000|Overall Study|Protocol defined stopping criteria|1|||
13259718|NCT01485172|26395346|FG001|Overall Study|Protocol defined stopping criteria|0|||
13259719|NCT01485172|26395347|FG002|Overall Study|Protocol defined stopping criteria|0|||
13259720|NCT01485172|26395348|FG003|Overall Study|Protocol defined stopping criteria|0|||
13259721|NCT01485172|26395349|FG004|Overall Study|Protocol defined stopping criteria|1|||
13259722|NCT01485172|26395350|FG005|Overall Study|Protocol defined stopping criteria|0|||
13259723|NCT01485172|26395345|FG000|Overall Study|Lost to Follow-up|0|||
13259724|NCT01485172|26395346|FG001|Overall Study|Lost to Follow-up|0|||
13259725|NCT01485172|26395347|FG002|Overall Study|Lost to Follow-up|1|||
13259726|NCT01485172|26395348|FG003|Overall Study|Lost to Follow-up|0|||
13259727|NCT01485172|26395349|FG004|Overall Study|Lost to Follow-up|0|||
13259728|NCT01485172|26395350|FG005|Overall Study|Lost to Follow-up|1|||
13259729|NCT01485172|26395345|FG000|Overall Study|Physician Decision|0|||
13259730|NCT01485172|26395346|FG001|Overall Study|Physician Decision|0|||
13259731|NCT01485172|26395347|FG002|Overall Study|Physician Decision|0|||
13259732|NCT01485172|26395348|FG003|Overall Study|Physician Decision|0|||
13259733|NCT01485172|26395349|FG004|Overall Study|Physician Decision|1|||
13259734|NCT01485172|26395350|FG005|Overall Study|Physician Decision|0|||
13259735|NCT01485172|26395345|FG000|Overall Study|Withdrawal by Subject|2|||
13259736|NCT01485172|26395346|FG001|Overall Study|Withdrawal by Subject|0|||
13259737|NCT01485172|26395347|FG002|Overall Study|Withdrawal by Subject|0|||
13259738|NCT01485172|26395348|FG003|Overall Study|Withdrawal by Subject|1|||
13259739|NCT01485172|26395349|FG004|Overall Study|Withdrawal by Subject|1|||
13259740|NCT01485172|26395350|FG005|Overall Study|Withdrawal by Subject|1|||
13259741|NCT01485120|26395357|FG000|Overall Study|Withdrawal by Subject|2|||
13259742|NCT01485094|26395408|FG000|Overall Study|Adverse Event|1|||
13259743|NCT01485094|26395409|FG001|Overall Study|Adverse Event|1|||
13259744|NCT01485094|26395410|FG002|Overall Study|Adverse Event|1|||
13259745|NCT01485094|26395408|FG000|Overall Study|Lost to Follow-up|1|||
13259746|NCT01485094|26395409|FG001|Overall Study|Lost to Follow-up|0|||
13259747|NCT01485094|26395410|FG002|Overall Study|Lost to Follow-up|0|||
13259748|NCT01485094|26395408|FG000|Overall Study|Withdrawal by Subject|1|||
13259749|NCT01485094|26395409|FG001|Overall Study|Withdrawal by Subject|1|||
13259750|NCT01485094|26395410|FG002|Overall Study|Withdrawal by Subject|0|||
13259751|NCT01484977|26395416|FG000|Overall Study|Adverse Event|8|||
13259752|NCT01484977|26395416|FG000|Overall Study|Lack of Efficacy|4|||
13259753|NCT01484977|26395416|FG000|Overall Study|Protocol Violation|6|||
13259754|NCT01484977|26395416|FG000|Overall Study|Lost to Follow-up|1|||
13259755|NCT01484977|26395416|FG000|Overall Study|Withdrawal by Subject|4|||
13259756|NCT01484977|26395416|FG000|Overall Study|Subject Protocol Non-compliant|1|||
13259757|NCT01484977|26395416|FG000|Overall Study|Moving Overseas|1|||
13259758|NCT01484977|26395416|FG000|Overall Study|Low White Blood Cell Count|1|||
13259759|NCT01484977|26395416|FG000|Overall Study|Lack of Compliance|1|||
13259760|NCT01484951|26395423|FG000|Overall Study|Adverse Event|3|||
13259761|NCT01484951|26395423|FG000|Overall Study|Personal Reasons|1|||
13259762|NCT01484951|26395423|FG000|Overall Study|Non-Compliance|1|||
13259763|NCT01484938|26395430|FG000|Overall Study|Adverse Event|2|||
13259764|NCT01484938|26395430|FG000|Overall Study|Lost to Follow-up|1|||
13259765|NCT01484938|26395430|FG000|Overall Study|Noncompliance|1|||
13259766|NCT01484912|26395447|FG000|Overall Study|Withdrawal by Subject|1|||
13259767|NCT01484912|26395448|FG001|Overall Study|Withdrawal by Subject|0|||
13259768|NCT01484912|26395447|FG000|Overall Study|Physician Decision|0|||
13259769|NCT01484912|26395448|FG001|Overall Study|Physician Decision|1|||
13259770|NCT01484873|26395458|FG000|Overall Study|Withdrawal by Subject|2|||
13259771|NCT01484834|26395497|FG000|Overall Study|Lost to Follow-up|5|||
13259772|NCT01484834|26395498|FG001|Overall Study|Lost to Follow-up|8|||
13259773|NCT01484834|26395499|FG002|Overall Study|Lost to Follow-up|1|||
13259774|NCT01484834|26395500|FG003|Overall Study|Lost to Follow-up|4|||
13259775|NCT01484691|26395519|FG000|Overall Study|Withdrawal by Subject|1|||
13259776|NCT01484691|26395520|FG001|Overall Study|Withdrawal by Subject|1|||
13259777|NCT01484691|26395521|FG002|Overall Study|Withdrawal by Subject|1|||
13259778|NCT01484691|26395519|FG000|Overall Study|Physician Decision|0|||
13259779|NCT01484691|26395520|FG001|Overall Study|Physician Decision|2|||
13259780|NCT01484691|26395521|FG002|Overall Study|Physician Decision|1|||
13259781|NCT01484561|26395616|FG000|Overall Study|Lack of Efficacy|3|||
13259782|NCT01484561|26395617|FG001|Overall Study|Lack of Efficacy|1|||
13259783|NCT01484561|26395616|FG000|Overall Study|Lost to Follow-up|1|||
13259784|NCT01484561|26395617|FG001|Overall Study|Lost to Follow-up|0|||
13259785|NCT01484561|26395616|FG000|Overall Study|Withdrawal by Subject|3|||
13259786|NCT01484561|26395617|FG001|Overall Study|Withdrawal by Subject|0|||
13259787|NCT01484561|26395616|FG000|Overall Study|Other|1|||
13259788|NCT01484561|26395617|FG001|Overall Study|Other|1|||
13259789|NCT01484561|26395616|FG000|Overall Study|Adverse Event|1|||
13259790|NCT01484561|26395617|FG001|Overall Study|Adverse Event|4|||
13259791|NCT01484496|26395638|FG000|Period 1|Protocol Violation|3|||
13259792|NCT01484496|26395639|FG001|Period 1|Protocol Violation|4|||
13259793|NCT01484496|26395640|FG002|Period 1|Protocol Violation|0|||
13259794|NCT01484496|26395641|FG003|Period 1|Protocol Violation|0|||
13259795|NCT01484496|26395638|FG000|Period 1|Physician Decision|5|||
13259796|NCT01484496|26395639|FG001|Period 1|Physician Decision|1|||
13259797|NCT01484496|26395640|FG002|Period 1|Physician Decision|0|||
13259798|NCT01484496|26395641|FG003|Period 1|Physician Decision|0|||
13259799|NCT01484496|26395638|FG000|Period 1|Lack of Efficacy|10|||
13259800|NCT01484496|26395639|FG001|Period 1|Lack of Efficacy|15|||
13259801|NCT01484496|26395640|FG002|Period 1|Lack of Efficacy|0|||
13259802|NCT01484496|26395641|FG003|Period 1|Lack of Efficacy|0|||
13259803|NCT01484496|26395638|FG000|Period 1|Adverse Event|25|||
13259804|NCT01484496|26395639|FG001|Period 1|Adverse Event|40|||
13259805|NCT01484496|26395640|FG002|Period 1|Adverse Event|0|||
13259806|NCT01484496|26395641|FG003|Period 1|Adverse Event|0|||
13259807|NCT01484496|26395638|FG000|Period 1|Withdrawal by Subject|15|||
13259808|NCT01484496|26395639|FG001|Period 1|Withdrawal by Subject|12|||
13259809|NCT01484496|26395640|FG002|Period 1|Withdrawal by Subject|0|||
13259810|NCT01484496|26395641|FG003|Period 1|Withdrawal by Subject|0|||
13259811|NCT01484496|26395638|FG000|Period 1|Lost to Follow-up|2|||
13259812|NCT01484496|26395639|FG001|Period 1|Lost to Follow-up|6|||
13259813|NCT01484496|26395640|FG002|Period 1|Lost to Follow-up|0|||
13259814|NCT01484496|26395641|FG003|Period 1|Lost to Follow-up|0|||
13259815|NCT01484496|26395638|FG000|Period 1|Positive Pregnancy|1|||
13259816|NCT01484496|26395639|FG001|Period 1|Positive Pregnancy|6|||
13259817|NCT01484496|26395640|FG002|Period 1|Positive Pregnancy|0|||
13259818|NCT01484496|26395641|FG003|Period 1|Positive Pregnancy|0|||
13259819|NCT01484496|26395638|FG000|Period 1|Treatment Failure|3|||
13259820|NCT01484496|26395639|FG001|Period 1|Treatment Failure|6|||
13259821|NCT01484496|26395640|FG002|Period 1|Treatment Failure|0|||
13259822|NCT01484496|26395641|FG003|Period 1|Treatment Failure|0|||
13259823|NCT01484496|26395638|FG000|Period 1|Lack of Compliance|2|||
13259824|NCT01484496|26395639|FG001|Period 1|Lack of Compliance|1|||
13259825|NCT01484496|26395640|FG002|Period 1|Lack of Compliance|0|||
13259826|NCT01484496|26395641|FG003|Period 1|Lack of Compliance|0|||
13259827|NCT01484496|26395638|FG000|Period 1|Unable to Visit Site|0|||
13259828|NCT01484496|26395639|FG001|Period 1|Unable to Visit Site|2|||
13259829|NCT01484496|26395640|FG002|Period 1|Unable to Visit Site|0|||
13259830|NCT01484496|26395641|FG003|Period 1|Unable to Visit Site|0|||
13259831|NCT01484496|26395638|FG000|Period 2|Lack of Efficacy|0|||
13259832|NCT01484496|26395639|FG001|Period 2|Lack of Efficacy|0|||
13259833|NCT01484496|26395640|FG002|Period 2|Lack of Efficacy|1|||
13259834|NCT01484496|26395641|FG003|Period 2|Lack of Efficacy|3|||
13259835|NCT01484496|26395638|FG000|Period 2|Adverse Event|0|||
13259836|NCT01484496|26395639|FG001|Period 2|Adverse Event|0|||
13259837|NCT01484496|26395640|FG002|Period 2|Adverse Event|5|||
13259838|NCT01484496|26395641|FG003|Period 2|Adverse Event|13|||
13259839|NCT01484496|26395638|FG000|Period 2|Other|0|||
13259840|NCT01484496|26395639|FG001|Period 2|Other|0|||
13259841|NCT01484496|26395640|FG002|Period 2|Other|9|||
13259842|NCT01484496|26395641|FG003|Period 2|Other|6|||
13259843|NCT01484431|26395666|FG000|Period 1: High Dose|Physician Decision|0|||
13259844|NCT01484431|26395667|FG001|Period 1: High Dose|Physician Decision|1|||
13259845|NCT01484431|26395668|FG002|Period 1: High Dose|Physician Decision|0|||
13259846|NCT01484431|26395666|FG000|Period 2|Death|0|||
13259847|NCT01484431|26395667|FG001|Period 2|Death|1|||
13259848|NCT01484431|26395668|FG002|Period 2|Death|1|||
13259849|NCT01484431|26395666|FG000|Period 2|Physician Decision|0|||
13259850|NCT01484431|26395667|FG001|Period 2|Physician Decision|0|||
13259851|NCT01484431|26395668|FG002|Period 2|Physician Decision|1|||
13259852|NCT01484431|26395666|FG000|Period 2|Non-Compliance with Study Drug|1|||
13259853|NCT01484431|26395667|FG001|Period 2|Non-Compliance with Study Drug|0|||
13259854|NCT01484431|26395668|FG002|Period 2|Non-Compliance with Study Drug|0|||
13259855|NCT01484275|26395697|FG000|Overall Study|Study terminated by sponsor|28|||
13259856|NCT01484275|26395698|FG001|Overall Study|Study terminated by sponsor|32|||
13259857|NCT01484275|26395697|FG000|Overall Study|Other|10|||
13259858|NCT01484275|26395698|FG001|Overall Study|Other|0|||
13259859|NCT01484275|26395697|FG000|Overall Study|Death|3|||
13259860|NCT01484275|26395698|FG001|Overall Study|Death|4|||
13259861|NCT01484275|26395697|FG000|Overall Study|Withdrawal by Subject|1|||
13259862|NCT01484275|26395698|FG001|Overall Study|Withdrawal by Subject|5|||
13259863|NCT01484275|26395697|FG000|Overall Study|Lost to Follow-up|1|||
13259864|NCT01484275|26395698|FG001|Overall Study|Lost to Follow-up|1|||
13259865|NCT01484197|26395786|FG000|Treatment Period 1|Adverse Event|1|||
13259866|NCT01484197|26395787|FG001|Treatment Period 1|Adverse Event|0|||
13259867|NCT01484197|26395788|FG002|Treatment Period 1|Adverse Event|0|||
13259868|NCT01484197|26395789|FG003|Treatment Period 1|Adverse Event|0|||
13259869|NCT01484197|26395786|FG000|Treatment Period 2|Subject withdrew consent|0|||
13259870|NCT01484197|26395787|FG001|Treatment Period 2|Subject withdrew consent|0|||
13259871|NCT01484197|26395788|FG002|Treatment Period 2|Subject withdrew consent|0|||
13259872|NCT01484197|26395789|FG003|Treatment Period 2|Subject withdrew consent|1|||
13259873|NCT01484132|26395799|FG000|Overall Study|Lost to Follow-up|8|||
13259874|NCT01484132|26395799|FG000|Overall Study|Difficulty with time commitment|2|||
13259875|NCT01484132|26395799|FG000|Overall Study|Ineligible|1|||
13259876|NCT01484132|26395799|FG000|Overall Study|No pre-treatment urine sample collected|1|||
13259877|NCT01484132|26395799|FG000|Overall Study|No post-treatment urine sample collected|10|||
13259878|NCT01484054|26395812|FG000|Period 1|Withdrawal by Subject|0|||
13259879|NCT01484054|26395813|FG001|Period 1|Withdrawal by Subject|1|||
13259880|NCT01484028|26395828|FG000|Period 1|Lost to Follow-up|0|||
13259881|NCT01484028|26395829|FG001|Period 1|Lost to Follow-up|1|||
13259882|NCT01484028|26395830|FG002|Period 1|Lost to Follow-up|0|||
13259883|NCT01484028|26395831|FG003|Period 1|Lost to Follow-up|0|||
13259884|NCT01484028|26395828|FG000|Period 1|Non-Compliance to Protocol|0|||
13259885|NCT01484028|26395829|FG001|Period 1|Non-Compliance to Protocol|1|||
13259886|NCT01484028|26395830|FG002|Period 1|Non-Compliance to Protocol|0|||
13259887|NCT01484028|26395831|FG003|Period 1|Non-Compliance to Protocol|1|||
13259888|NCT01484028|26395828|FG000|Period 1|Lens Discomfort|0|||
13259889|NCT01484028|26395829|FG001|Period 1|Lens Discomfort|1|||
13259890|NCT01484028|26395830|FG002|Period 1|Lens Discomfort|0|||
13259891|NCT01484028|26395831|FG003|Period 1|Lens Discomfort|0|||
13259892|NCT01483937|26395860|FG000|Overall Study|Withdrawal by Subject|4|||
13259893|NCT01483937|26395861|FG001|Overall Study|Withdrawal by Subject|3|||
13259894|NCT01483924|26395925|FG000|Overall Study|Withdrawal by Subject|2|||
13259895|NCT01483924|26395926|FG001|Overall Study|Withdrawal by Subject|0|||
13259896|NCT01483924|26395927|FG002|Overall Study|Withdrawal by Subject|0|||
13259897|NCT01483924|26395928|FG003|Overall Study|Withdrawal by Subject|1|||
13259898|NCT01483924|26395929|FG004|Overall Study|Withdrawal by Subject|1|||
13259899|NCT01483924|26395925|FG000|Overall Study|Adverse Event|0|||
13259900|NCT01483924|26395926|FG001|Overall Study|Adverse Event|0|||
13259901|NCT01483924|26395927|FG002|Overall Study|Adverse Event|1|||
13259902|NCT01483924|26395928|FG003|Overall Study|Adverse Event|1|||
13259903|NCT01483924|26395929|FG004|Overall Study|Adverse Event|0|||
13259904|NCT01483924|26395925|FG000|Overall Study|Non-compliance|0|||
13259905|NCT01483924|26395926|FG001|Overall Study|Non-compliance|0|||
13259906|NCT01483924|26395927|FG002|Overall Study|Non-compliance|0|||
13259907|NCT01483924|26395928|FG003|Overall Study|Non-compliance|1|||
13259908|NCT01483924|26395929|FG004|Overall Study|Non-compliance|1|||
13259909|NCT01483924|26395925|FG000|Overall Study|Sponsor concern over ECG result|0|||
13259910|NCT01483924|26395926|FG001|Overall Study|Sponsor concern over ECG result|0|||
13259911|NCT01483924|26395927|FG002|Overall Study|Sponsor concern over ECG result|0|||
13259912|NCT01483924|26395928|FG003|Overall Study|Sponsor concern over ECG result|1|||
13259913|NCT01483924|26395929|FG004|Overall Study|Sponsor concern over ECG result|0|||
13259914|NCT01483820|26395940|FG000|Overall Study|Lack of Efficacy|6|||
13259915|NCT01483820|26395940|FG000|Overall Study|Adverse Event|1|||
13259916|NCT01483820|26395940|FG000|Overall Study|Death|1|||
13259917|NCT01483690|26395955|FG000|Overall Study|Adverse Event|1|||
13259918|NCT01483690|26395956|FG001|Overall Study|Adverse Event|2|||
13259919|NCT01483690|26395955|FG000|Overall Study|clinical deterioration|1|||
13259920|NCT01483690|26395956|FG001|Overall Study|clinical deterioration|0|||
13259921|NCT01483690|26395955|FG000|Overall Study|Physician Decision|0|||
13259922|NCT01483690|26395956|FG001|Overall Study|Physician Decision|2|||
13259923|NCT01483690|26395955|FG000|Overall Study|exclusionary procedure|0|||
13259924|NCT01483690|26395956|FG001|Overall Study|exclusionary procedure|1|||
13259925|NCT01483651|26395971|FG000|Overall Study|Withdrawal by Subject|0|||
13259926|NCT01483651|26395972|FG001|Overall Study|Withdrawal by Subject|1|||
13259927|NCT01483651|26395973|FG002|Overall Study|Withdrawal by Subject|1|||
13259928|NCT01483651|26395974|FG003|Overall Study|Withdrawal by Subject|0|||
13259929|NCT01483651|26395975|FG004|Overall Study|Withdrawal by Subject|0|||
13259930|NCT01483651|26395976|FG005|Overall Study|Withdrawal by Subject|1|||
13259931|NCT01483625|26395999|FG000|Overall Study|Adverse Event|1|||
13259932|NCT01483625|26396000|FG001|Overall Study|Adverse Event|1|||
13259933|NCT01483625|26395999|FG000|Overall Study|Refused to continue medication|2|||
13259934|NCT01483625|26396000|FG001|Overall Study|Refused to continue medication|1|||
13259935|NCT01483625|26395999|FG000|Overall Study|Due to other reason|1|||
13259936|NCT01483625|26396000|FG001|Overall Study|Due to other reason|0|||
13259937|NCT01483599|26396078|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2|||
13259938|NCT01483599|26396079|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
13259939|NCT01483599|26396080|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
13259940|NCT01483599|26396081|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
13259941|NCT01483599|26396082|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
13259942|NCT01483599|26396083|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4|||
13259943|NCT01483599|26396084|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3|||
13259944|NCT01483599|26396085|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
13259945|NCT01483599|26396086|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
13259946|NCT01483599|26396087|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
13259947|NCT01483599|26396088|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
13259948|NCT01483599|26396089|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
13259949|NCT01483599|26396090|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
13259950|NCT01483599|26396091|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
13259951|NCT01483599|26396078|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
13259952|NCT01483599|26396079|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
13259953|NCT01483599|26396080|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
13259954|NCT01483599|26396081|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
13259955|NCT01483599|26396082|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
13259956|NCT01483599|26396083|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
13259957|NCT01483599|26396084|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
13259958|NCT01483599|26396085|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
13259959|NCT01483599|26396086|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
13259960|NCT01483599|26396087|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
13259961|NCT01483599|26396088|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
13259962|NCT01483599|26396089|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
13259963|NCT01483599|26396090|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
13259964|NCT01483599|26396091|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
13259965|NCT01483599|26396078|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1|||
13259966|NCT01483599|26396079|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
13259967|NCT01483599|26396080|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
13259968|NCT01483599|26396081|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
13259969|NCT01483599|26396082|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
13259970|NCT01483599|26396083|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
13259971|NCT01483599|26396084|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
13259972|NCT01483599|26396085|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
13259973|NCT01483599|26396086|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
13259974|NCT01483599|26396087|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
13259975|NCT01483599|26396088|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
13259976|NCT01483599|26396089|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
13259977|NCT01483599|26396090|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
13259978|NCT01483599|26396091|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
13259979|NCT01483599|26396078|FG000|Controlled Period (CP) (up to Week 16)|Other|0|||
13259980|NCT01483599|26396079|FG001|Controlled Period (CP) (up to Week 16)|Other|2|||
13259981|NCT01483599|26396080|FG002|Controlled Period (CP) (up to Week 16)|Other|0|||
13259982|NCT01483599|26396081|FG003|Controlled Period (CP) (up to Week 16)|Other|1|||
13259983|NCT01483599|26396082|FG004|Controlled Period (CP) (up to Week 16)|Other|1|||
13259984|NCT01483599|26396083|FG005|Controlled Period (CP) (up to Week 16)|Other|0|||
13259985|NCT01483599|26396084|FG006|Controlled Period (CP) (up to Week 16)|Other|0|||
13259986|NCT01483599|26396085|FG007|Controlled Period (CP) (up to Week 16)|Other|0|||
13259987|NCT01483599|26396086|FG008|Controlled Period (CP) (up to Week 16)|Other|0|||
13259988|NCT01483599|26396087|FG009|Controlled Period (CP) (up to Week 16)|Other|0|||
13259989|NCT01483599|26396088|FG010|Controlled Period (CP) (up to Week 16)|Other|0|||
13259990|NCT01483599|26396089|FG011|Controlled Period (CP) (up to Week 16)|Other|0|||
13259991|NCT01483599|26396090|FG012|Controlled Period (CP) (up to Week 16)|Other|0|||
13259992|NCT01483599|26396091|FG013|Controlled Period (CP) (up to Week 16)|Other|0|||
13259993|NCT01483599|26396078|FG000|After Controlled Period(Week 16-Week 40)|Death|0|||
13259994|NCT01483599|26396079|FG001|After Controlled Period(Week 16-Week 40)|Death|0|||
13259995|NCT01483599|26396080|FG002|After Controlled Period(Week 16-Week 40)|Death|0|||
13259996|NCT01483599|26396081|FG003|After Controlled Period(Week 16-Week 40)|Death|0|||
13259997|NCT01483599|26396082|FG004|After Controlled Period(Week 16-Week 40)|Death|0|||
13259998|NCT01483599|26396083|FG005|After Controlled Period(Week 16-Week 40)|Death|0|||
13259999|NCT01483599|26396084|FG006|After Controlled Period(Week 16-Week 40)|Death|0|||
13260000|NCT01483599|26396085|FG007|After Controlled Period(Week 16-Week 40)|Death|0|||
13260001|NCT01483599|26396086|FG008|After Controlled Period(Week 16-Week 40)|Death|1|||
13260002|NCT01483599|26396087|FG009|After Controlled Period(Week 16-Week 40)|Death|0|||
13260003|NCT01483599|26396088|FG010|After Controlled Period(Week 16-Week 40)|Death|0|||
13260004|NCT01483599|26396089|FG011|After Controlled Period(Week 16-Week 40)|Death|0|||
13260005|NCT01483599|26396090|FG012|After Controlled Period(Week 16-Week 40)|Death|0|||
13260006|NCT01483599|26396091|FG013|After Controlled Period(Week 16-Week 40)|Death|0|||
13260007|NCT01483599|26396078|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
13260008|NCT01483599|26396079|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
13260009|NCT01483599|26396080|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
13260010|NCT01483599|26396081|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
13260011|NCT01483599|26396082|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
13260012|NCT01483599|26396083|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
13260013|NCT01483599|26396084|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
13260014|NCT01483599|26396085|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
13260015|NCT01483599|26396086|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
13260016|NCT01483599|26396087|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
13260017|NCT01483599|26396088|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
13260018|NCT01483599|26396089|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
13260019|NCT01483599|26396090|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
13260020|NCT01483599|26396091|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
13260021|NCT01483599|26396078|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
13260022|NCT01483599|26396079|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
13260023|NCT01483599|26396080|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
13260024|NCT01483599|26396081|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
13260025|NCT01483599|26396082|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
13260026|NCT01483599|26396083|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
13260027|NCT01483599|26396084|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
13260028|NCT01483599|26396085|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
13260029|NCT01483599|26396086|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
13260030|NCT01483599|26396087|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
13260031|NCT01483599|26396088|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
13260032|NCT01483599|26396089|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
13260033|NCT01483599|26396090|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
13260034|NCT01483599|26396091|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
13260035|NCT01483599|26396078|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
13260036|NCT01483599|26396079|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
13260037|NCT01483599|26396080|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
13260038|NCT01483599|26396081|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
13260039|NCT01483599|26396082|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
13260040|NCT01483599|26396083|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
13260041|NCT01483599|26396084|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
13260042|NCT01483599|26396085|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
13260043|NCT01483599|26396086|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
13260044|NCT01483599|26396087|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
13260045|NCT01483599|26396088|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2|||
13260046|NCT01483599|26396089|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
13260047|NCT01483599|26396090|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
13260048|NCT01483599|26396091|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
13260049|NCT01483599|26396078|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
13260050|NCT01483599|26396079|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
13260051|NCT01483599|26396080|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
13260052|NCT01483599|26396081|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
13260053|NCT01483599|26396082|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
13260054|NCT01483599|26396083|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
13260055|NCT01483599|26396084|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
13260056|NCT01483599|26396085|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
13260057|NCT01483599|26396086|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5|||
13260058|NCT01483599|26396087|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
13260059|NCT01483599|26396088|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
13260060|NCT01483599|26396089|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
13260061|NCT01483599|26396090|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1|||
13260062|NCT01483599|26396091|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4|||
13260063|NCT01483599|26396078|FG000|After Controlled Period(Week 16-Week 40)|Other|0|||
13260064|NCT01483599|26396079|FG001|After Controlled Period(Week 16-Week 40)|Other|0|||
13260065|NCT01483599|26396080|FG002|After Controlled Period(Week 16-Week 40)|Other|0|||
13260066|NCT01483599|26396081|FG003|After Controlled Period(Week 16-Week 40)|Other|0|||
13260067|NCT01483599|26396082|FG004|After Controlled Period(Week 16-Week 40)|Other|0|||
13260068|NCT01483599|26396083|FG005|After Controlled Period(Week 16-Week 40)|Other|0|||
13260069|NCT01483599|26396084|FG006|After Controlled Period(Week 16-Week 40)|Other|0|||
13260070|NCT01483599|26396085|FG007|After Controlled Period(Week 16-Week 40)|Other|1|||
13260071|NCT01483599|26396086|FG008|After Controlled Period(Week 16-Week 40)|Other|0|||
13260072|NCT01483599|26396087|FG009|After Controlled Period(Week 16-Week 40)|Other|4|||
13260073|NCT01483599|26396088|FG010|After Controlled Period(Week 16-Week 40)|Other|0|||
13260074|NCT01483599|26396089|FG011|After Controlled Period(Week 16-Week 40)|Other|0|||
13260075|NCT01483599|26396090|FG012|After Controlled Period(Week 16-Week 40)|Other|1|||
13260076|NCT01483599|26396091|FG013|After Controlled Period(Week 16-Week 40)|Other|0|||
13260077|NCT01483183|26396190|FG000|Overall Study|Physician Decision|0|||
13260078|NCT01483183|26396191|FG001|Overall Study|Physician Decision|0|||
13260079|NCT01483183|26396192|FG002|Overall Study|Physician Decision|0|||
13260080|NCT01483183|26396193|FG003|Overall Study|Physician Decision|0|||
13260081|NCT01483183|26396194|FG004|Overall Study|Physician Decision|0|||
13260082|NCT01483183|26396195|FG005|Overall Study|Physician Decision|0|||
13260083|NCT01483183|26396196|FG006|Overall Study|Physician Decision|2|||
13260084|NCT01483183|26396197|FG007|Overall Study|Physician Decision|0|||
13260085|NCT01483183|26396198|FG008|Overall Study|Physician Decision|0|||
13260086|NCT01483183|26396199|FG009|Overall Study|Physician Decision|0|||
13260087|NCT01483183|26396190|FG000|Overall Study|Withdrawal by Subject|0|||
13260088|NCT01483183|26396191|FG001|Overall Study|Withdrawal by Subject|0|||
13260089|NCT01483183|26396192|FG002|Overall Study|Withdrawal by Subject|0|||
13260090|NCT01483183|26396193|FG003|Overall Study|Withdrawal by Subject|0|||
13260091|NCT01483183|26396194|FG004|Overall Study|Withdrawal by Subject|0|||
13260092|NCT01483183|26396195|FG005|Overall Study|Withdrawal by Subject|0|||
13260093|NCT01483183|26396196|FG006|Overall Study|Withdrawal by Subject|0|||
13260094|NCT01483183|26396197|FG007|Overall Study|Withdrawal by Subject|0|||
13260095|NCT01483183|26396198|FG008|Overall Study|Withdrawal by Subject|0|||
13260096|NCT01483183|26396199|FG009|Overall Study|Withdrawal by Subject|1|||
13260097|NCT01483144|26396223|FG000|Overall Study|Adverse Event|9|||
13260098|NCT01483144|26396224|FG001|Overall Study|Adverse Event|4|||
13260099|NCT01483144|26396225|FG002|Overall Study|Adverse Event|6|||
13260100|NCT01483144|26396223|FG000|Overall Study|Withdrawal by Subject|0|||
13260101|NCT01483144|26396224|FG001|Overall Study|Withdrawal by Subject|2|||
13260102|NCT01483144|26396225|FG002|Overall Study|Withdrawal by Subject|5|||
13260103|NCT01483144|26396223|FG000|Overall Study|Physician Decision|1|||
13260104|NCT01483144|26396224|FG001|Overall Study|Physician Decision|0|||
13260105|NCT01483144|26396225|FG002|Overall Study|Physician Decision|0|||
13260106|NCT01483144|26396223|FG000|Overall Study|Lost to Follow-up|2|||
13260107|NCT01483144|26396224|FG001|Overall Study|Lost to Follow-up|4|||
13260108|NCT01483144|26396225|FG002|Overall Study|Lost to Follow-up|1|||
13260109|NCT01483144|26396223|FG000|Overall Study|Protocol Violation|3|||
13260110|NCT01483144|26396224|FG001|Overall Study|Protocol Violation|3|||
13260111|NCT01483144|26396225|FG002|Overall Study|Protocol Violation|3|||
13260112|NCT01483118|26396242|FG000|Overall Study|Lost to Follow-up|12|||
13260113|NCT01483118|26396243|FG001|Overall Study|Lost to Follow-up|16|||
13260114|NCT01483027|26396260|FG000|Overall Study|Administrative Reasons|2|||
13260115|NCT01483027|26396261|FG001|Overall Study|Administrative Reasons|1|||
13260116|NCT01483027|26396260|FG000|Overall Study|Withdrawal by Subject|21|||
13260117|NCT01483027|26396261|FG001|Overall Study|Withdrawal by Subject|32|||
13260118|NCT01483027|26396260|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22|||
13260119|NCT01483027|26396261|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24|||
13260120|NCT01483027|26396260|FG000|Overall Study|Lost to Follow-up|1|||
13260121|NCT01483027|26396261|FG001|Overall Study|Lost to Follow-up|1|||
13260122|NCT01483027|26396260|FG000|Overall Study|Adverse Event|0|||
13260123|NCT01483027|26396261|FG001|Overall Study|Adverse Event|1|||
13260124|NCT01483027|26396260|FG000|Overall Study|Withdrawal by Subject|0|||
13260125|NCT01483027|26396261|FG001|Overall Study|Withdrawal by Subject|1|||
13260126|NCT01482962|26396299|FG000|Overall Study|Progressive Disease|65|||
13260127|NCT01482962|26396300|FG001|Overall Study|Progressive Disease|53|||
13260128|NCT01482962|26396299|FG000|Overall Study|Unsatisfactory Therapeutic Response|37|||
13260129|NCT01482962|26396300|FG001|Overall Study|Unsatisfactory Therapeutic Response|23|||
13260130|NCT01482962|26396299|FG000|Overall Study|Adverse Event|18|||
13260131|NCT01482962|26396300|FG001|Overall Study|Adverse Event|22|||
13260132|NCT01482962|26396299|FG000|Overall Study|Withdrawal by Participant|8|||
13260133|NCT01482962|26396300|FG001|Overall Study|Withdrawal by Participant|13|||
13260134|NCT01482962|26396299|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3|||
13260135|NCT01482962|26396300|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9|||
13117369|NCT03057977|25925420|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
13260136|NCT01482962|26396299|FG000|Overall Study|Other Reason|1|||
13260137|NCT01482962|26396300|FG001|Overall Study|Other Reason|5|||
13133412|NCT02770170|25987712|FG000|Overall Study|due to disease worsening|0|||
13260138|NCT01482962|26396299|FG000|Overall Study|Study Terminated by Sponsor|5|||
13260139|NCT01482962|26396300|FG001|Overall Study|Study Terminated by Sponsor|2|||
13260140|NCT01482962|26396299|FG000|Overall Study|Did not Receive Study Drug|1|||
13260141|NCT01482962|26396300|FG001|Overall Study|Did not Receive Study Drug|6|||
13260142|NCT01482910|26396317|FG000|Overall Study|Adverse Event|6|||
13260143|NCT01482910|26396318|FG001|Overall Study|Adverse Event|5|||
13260144|NCT01482910|26396317|FG000|Overall Study|Lost to Follow-up|0|||
13260145|NCT01482910|26396318|FG001|Overall Study|Lost to Follow-up|1|||
13260146|NCT01482910|26396317|FG000|Overall Study|Protocol Violation|1|||
13260147|NCT01482910|26396318|FG001|Overall Study|Protocol Violation|1|||
13260148|NCT01482910|26396317|FG000|Overall Study|Withdrawal by Subject|7|||
13260149|NCT01482910|26396318|FG001|Overall Study|Withdrawal by Subject|2|||
13260150|NCT01482910|26396317|FG000|Overall Study|Death|1|||
13260151|NCT01482910|26396318|FG001|Overall Study|Death|0|||
13260152|NCT01482884|26396351|FG000|Overall Study|Medical decision due to lack of efficacy|0|||
13260153|NCT01482884|26396352|FG001|Overall Study|Medical decision due to lack of efficacy|1|||
13260154|NCT01482884|26396351|FG000|Overall Study|Protocol Violation|1|||
13260155|NCT01482884|26396352|FG001|Overall Study|Protocol Violation|0|||
13260156|NCT01482884|26396351|FG000|Overall Study|Lost to Follow-up|2|||
13260157|NCT01482884|26396352|FG001|Overall Study|Lost to Follow-up|2|||
13260158|NCT01482884|26396351|FG000|Overall Study|Lack of Efficacy|0|||
13260159|NCT01482884|26396352|FG001|Overall Study|Lack of Efficacy|1|||
13260160|NCT01482884|26396351|FG000|Overall Study|Adverse Event|2|||
13260161|NCT01482884|26396352|FG001|Overall Study|Adverse Event|1|||
13260162|NCT01482884|26396351|FG000|Overall Study|Withdrawal by Subject|8|||
13260163|NCT01482884|26396352|FG001|Overall Study|Withdrawal by Subject|13|||
13260164|NCT01482819|26396372|FG000|Overall Study|Lost to Follow-up|2|||
13260165|NCT01482767|26396399|FG000|Overall Study|Death|1|||
13260166|NCT01482767|26396400|FG001|Overall Study|Death|1|||
13260167|NCT01482767|26396399|FG000|Overall Study|Withdrawal by Subject|7|||
13260168|NCT01482767|26396400|FG001|Overall Study|Withdrawal by Subject|5|||
13260169|NCT01482767|26396399|FG000|Overall Study|Lost to Follow-up|12|||
13260170|NCT01482767|26396400|FG001|Overall Study|Lost to Follow-up|6|||
13260171|NCT01482767|26396399|FG000|Overall Study|Adverse Event|0|||
13260172|NCT01482767|26396400|FG001|Overall Study|Adverse Event|3|||
13260173|NCT01482767|26396399|FG000|Overall Study|Site closure|22|||
13260174|NCT01482767|26396400|FG001|Overall Study|Site closure|14|||
13260175|NCT01482767|26396399|FG000|Overall Study|Non-adherence to study requirements|4|||
13260176|NCT01482767|26396400|FG001|Overall Study|Non-adherence to study requirements|7|||
13260177|NCT01482767|26396399|FG000|Overall Study|Alternate HCV treatment|7|||
13260178|NCT01482767|26396400|FG001|Overall Study|Alternate HCV treatment|8|||
13260179|NCT01482767|26396399|FG000|Overall Study|Ineligible|0|||
13260180|NCT01482767|26396400|FG001|Overall Study|Ineligible|5|||
13260181|NCT01482767|26396399|FG000|Overall Study|Nurse error|1|||
13260182|NCT01482767|26396400|FG001|Overall Study|Nurse error|0|||
13260183|NCT01482598|26396413|FG000|Overall Study|Death|7|||
13260184|NCT01482598|26396414|FG001|Overall Study|Death|10|||
13260185|NCT01482598|26396413|FG000|Overall Study|Physician Decision|0|||
13260186|NCT01482598|26396414|FG001|Overall Study|Physician Decision|3|||
13260187|NCT01482598|26396413|FG000|Overall Study|Withdrawal by Subject|4|||
13260188|NCT01482598|26396414|FG001|Overall Study|Withdrawal by Subject|5|||
13260189|NCT01482598|26396413|FG000|Overall Study|Lost to Follow-up|5|||
13260190|NCT01482598|26396414|FG001|Overall Study|Lost to Follow-up|4|||
13260191|NCT01482429|26396429|FG000|Care Usual|Protocol Violation|0|||
13260192|NCT01482429|26396430|FG001|Care Usual|Protocol Violation|172|||
13260193|NCT01482429|26396429|FG000|Care Usual|Lost to Follow-up|0|||
13260194|NCT01482429|26396430|FG001|Care Usual|Lost to Follow-up|1|||
13260195|NCT01482429|26396429|FG000|Protocol|Protocol Violation|275|||
13260196|NCT01482429|26396430|FG001|Protocol|Protocol Violation|0|||
13260197|NCT01482312|26396445|FG000|Period 1, 90 Minutes of Wear|Other|1|||
13260198|NCT01482312|26396446|FG001|Period 1, 90 Minutes of Wear|Other|0|||
13260199|NCT01482312|26396447|FG002|Period 1, 90 Minutes of Wear|Other|0|||
13260200|NCT01482312|26396445|FG000|Period 2, 90 Minutes of Wear|Other|1|||
13260201|NCT01482312|26396446|FG001|Period 2, 90 Minutes of Wear|Other|0|||
13260202|NCT01482312|26396447|FG002|Period 2, 90 Minutes of Wear|Other|0|||
13260203|NCT01482221|26396498|FG000|Overall Study|Lack of Efficacy|1|||
13260204|NCT01482221|26396499|FG001|Overall Study|Lack of Efficacy|0|||
13260205|NCT01482221|26396500|FG002|Overall Study|Lack of Efficacy|1|||
13260206|NCT01482221|26396498|FG000|Overall Study|Lost to Follow-up|3|||
13260207|NCT01482221|26396499|FG001|Overall Study|Lost to Follow-up|2|||
13260208|NCT01482221|26396500|FG002|Overall Study|Lost to Follow-up|1|||
13260209|NCT01482221|26396498|FG000|Overall Study|Study-Specific Withdrawal Criteria|2|||
13260210|NCT01482221|26396499|FG001|Overall Study|Study-Specific Withdrawal Criteria|0|||
13260211|NCT01482221|26396500|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
13260212|NCT01482221|26396498|FG000|Overall Study|Condition under Investigation Worsened|3|||
13260213|NCT01482221|26396499|FG001|Overall Study|Condition under Investigation Worsened|2|||
13260214|NCT01482221|26396500|FG002|Overall Study|Condition under Investigation Worsened|4|||
13260215|NCT01482221|26396498|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
13260216|NCT01482221|26396499|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
13117370|NCT03057977|25925421|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
13260217|NCT01482221|26396500|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
13260218|NCT01482221|26396498|FG000|Overall Study|Adverse Event|1|||
13260219|NCT01482221|26396499|FG001|Overall Study|Adverse Event|7|||
13260220|NCT01482221|26396500|FG002|Overall Study|Adverse Event|3|||
13260221|NCT01482221|26396498|FG000|Overall Study|Withdrawal by Subject|10|||
13260222|NCT01482221|26396499|FG001|Overall Study|Withdrawal by Subject|7|||
13260223|NCT01482221|26396500|FG002|Overall Study|Withdrawal by Subject|12|||
13260224|NCT01482221|26396498|FG000|Overall Study|Incorrect randomization|0|||
13260225|NCT01482221|26396499|FG001|Overall Study|Incorrect randomization|1|||
13260226|NCT01482221|26396500|FG002|Overall Study|Incorrect randomization|0|||
13260227|NCT01482221|26396498|FG000|Overall Study|Physician Decision|0|||
13260228|NCT01482221|26396499|FG001|Overall Study|Physician Decision|1|||
13260229|NCT01482221|26396500|FG002|Overall Study|Physician Decision|0|||
13260230|NCT01482169|26396509|FG000|Overall Study|Physician Decision|2|||
13260231|NCT01482065|26396528|FG000|Overall Study|Withdrawal by Subject|0|||
13260232|NCT01482065|26396529|FG001|Overall Study|Withdrawal by Subject|1|||
13260233|NCT01481896|26396545|FG000|Overall Study|Lost to Follow-up|12|||
13260234|NCT01481779|26396598|FG000|Overall Study|Adverse Event|23|||
13260235|NCT01481779|26396599|FG001|Overall Study|Adverse Event|5|||
13260236|NCT01481779|26396598|FG000|Overall Study|Lost to Follow-up|3|||
13260237|NCT01481779|26396599|FG001|Overall Study|Lost to Follow-up|2|||
13260238|NCT01481779|26396598|FG000|Overall Study|Protocol Violation|2|||
13260239|NCT01481779|26396599|FG001|Overall Study|Protocol Violation|3|||
13260240|NCT01481779|26396598|FG000|Overall Study|Withdrawal by Subject|26|||
13260241|NCT01481779|26396599|FG001|Overall Study|Withdrawal by Subject|13|||
13260242|NCT01481779|26396598|FG000|Overall Study|Physician Decision|13|||
13260243|NCT01481779|26396599|FG001|Overall Study|Physician Decision|4|||
13260244|NCT01481779|26396598|FG000|Overall Study|Sponsor Decision|3|||
13260245|NCT01481779|26396599|FG001|Overall Study|Sponsor Decision|1|||
13260246|NCT01481324|26396617|FG000|Overall Study|Missing Data|0|||
13260247|NCT01481324|26396618|FG001|Overall Study|Missing Data|2|||
13260248|NCT01481324|26396619|FG002|Overall Study|Missing Data|2|||
13260249|NCT01481116|26396655|FG000|Overall Study|Adverse Event|26|||
13260250|NCT01481116|26396656|FG001|Overall Study|Adverse Event|26|||
13260251|NCT01481116|26396657|FG002|Overall Study|Adverse Event|42|||
13260252|NCT01481116|26396655|FG000|Overall Study|Major Protocol Deviation|3|||
13260253|NCT01481116|26396656|FG001|Overall Study|Major Protocol Deviation|7|||
13260254|NCT01481116|26396657|FG002|Overall Study|Major Protocol Deviation|1|||
13260255|NCT01481116|26396655|FG000|Overall Study|Lost to Follow-up|8|||
13260256|NCT01481116|26396656|FG001|Overall Study|Lost to Follow-up|12|||
13260257|NCT01481116|26396657|FG002|Overall Study|Lost to Follow-up|11|||
13260258|NCT01481116|26396655|FG000|Overall Study|Withdrawal by Subject|37|||
13260259|NCT01481116|26396656|FG001|Overall Study|Withdrawal by Subject|33|||
13260260|NCT01481116|26396657|FG002|Overall Study|Withdrawal by Subject|37|||
13260261|NCT01481116|26396655|FG000|Overall Study|Study Termination|730|||
13260262|NCT01481116|26396656|FG001|Overall Study|Study Termination|729|||
13260263|NCT01481116|26396657|FG002|Overall Study|Study Termination|713|||
13260264|NCT01481116|26396655|FG000|Overall Study|Pregnancy|0|||
13260265|NCT01481116|26396656|FG001|Overall Study|Pregnancy|0|||
13260266|NCT01481116|26396657|FG002|Overall Study|Pregnancy|1|||
13260267|NCT01481116|26396655|FG000|Overall Study|Lack of Efficacy|3|||
13260268|NCT01481116|26396656|FG001|Overall Study|Lack of Efficacy|3|||
13260269|NCT01481116|26396657|FG002|Overall Study|Lack of Efficacy|1|||
13260270|NCT01481116|26396655|FG000|Overall Study|Contraindications|1|||
13260271|NCT01481116|26396656|FG001|Overall Study|Contraindications|1|||
13260272|NCT01481116|26396657|FG002|Overall Study|Contraindications|0|||
13260273|NCT01481116|26396655|FG000|Overall Study|Other|1|||
13260274|NCT01481116|26396656|FG001|Overall Study|Other|1|||
13260275|NCT01481116|26396657|FG002|Overall Study|Other|0|||
13260276|NCT01481116|26396655|FG000|Overall Study|Participant Started Taking Glipizide|1|||
13260277|NCT01481116|26396656|FG001|Overall Study|Participant Started Taking Glipizide|0|||
13260278|NCT01481116|26396657|FG002|Overall Study|Participant Started Taking Glipizide|0|||
13260279|NCT01481116|26396655|FG000|Overall Study|Participant Moved Out of Area|2|||
13260280|NCT01481116|26396656|FG001|Overall Study|Participant Moved Out of Area|0|||
13260281|NCT01481116|26396657|FG002|Overall Study|Participant Moved Out of Area|1|||
13260282|NCT01481116|26396655|FG000|Overall Study|Participant Moved Out of Country|1|||
13260283|NCT01481116|26396656|FG001|Overall Study|Participant Moved Out of Country|0|||
13260284|NCT01481116|26396657|FG002|Overall Study|Participant Moved Out of Country|1|||
13260285|NCT01481116|26396655|FG000|Overall Study|Investigator Decision|3|||
13260286|NCT01481116|26396656|FG001|Overall Study|Investigator Decision|2|||
13260287|NCT01481116|26396657|FG002|Overall Study|Investigator Decision|1|||
13260288|NCT01481116|26396655|FG000|Overall Study|Sponsor Decision|0|||
13260289|NCT01481116|26396656|FG001|Overall Study|Sponsor Decision|1|||
13260290|NCT01481116|26396657|FG002|Overall Study|Sponsor Decision|3|||
13260291|NCT01481116|26396655|FG000|Overall Study|Non-Compliant With Study Drug|0|||
13260292|NCT01481116|26396656|FG001|Overall Study|Non-Compliant With Study Drug|1|||
13260293|NCT01481116|26396657|FG002|Overall Study|Non-Compliant With Study Drug|1|||
13260294|NCT01481116|26396655|FG000|Overall Study|Investigator's Discretion|2|||
13260295|NCT01481116|26396656|FG001|Overall Study|Investigator's Discretion|0|||
13260296|NCT01481116|26396657|FG002|Overall Study|Investigator's Discretion|0|||
13260297|NCT01481116|26396655|FG000|Overall Study|Death|2|||
13260298|NCT01481116|26396656|FG001|Overall Study|Death|1|||
13260299|NCT01481116|26396657|FG002|Overall Study|Death|0|||
13260300|NCT01481116|26396655|FG000|Overall Study|Hypoglycemic Event|4|||
13260301|NCT01481116|26396656|FG001|Overall Study|Hypoglycemic Event|0|||
13260302|NCT01481116|26396657|FG002|Overall Study|Hypoglycemic Event|0|||
13260303|NCT01480674|26396671|FG000|Overall Study|Death|23|||
13260304|NCT01480674|26396671|FG000|Overall Study|Lost to Follow-up|2|||
13260305|NCT01480674|26396671|FG000|Overall Study|visit not done|10|||
13260306|NCT01480596|26396720|FG000|Overall Study|Adverse Event|3|||
13260307|NCT01480596|26396721|FG001|Overall Study|Adverse Event|0|||
13260308|NCT01480596|26396720|FG000|Overall Study|MG exacerbation or change in medication|2|||
13260309|NCT01480596|26396721|FG001|Overall Study|MG exacerbation or change in medication|2|||
13117371|NCT03057977|25925420|FG000|Discontinuation From Treatment|Principle Investigator Decision|2|||
13117372|NCT03057977|25925421|FG001|Discontinuation From Treatment|Principle Investigator Decision|0|||
13117373|NCT03057977|25925420|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2|||
13117374|NCT03057977|25925421|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4|||
13117375|NCT03057977|25925420|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4|||
13117376|NCT03057977|25925421|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3|||
13117377|NCT03057977|25925420|FG000|Discontinuation From Treatment|Unable to continue treatment|4|||
13117378|NCT03057977|25925421|FG001|Discontinuation From Treatment|Unable to continue treatment|1|||
13117379|NCT03057977|25925420|FG000|Discontinuation From Treatment|Not attending study visit|3|||
13117380|NCT03057977|25925421|FG001|Discontinuation From Treatment|Not attending study visit|10|||
13117381|NCT03057977|25925420|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1|||
13117382|NCT03057977|25925421|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4|||
13117383|NCT03057977|25925420|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8|||
13117384|NCT03057977|25925421|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6|||
13117385|NCT03057977|25925420|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
13117386|NCT03057977|25925421|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
13117387|NCT03057977|25925420|FG000|Discontinuation From Trial|Limited follow-up agreed|2|||
13117388|NCT03057977|25925421|FG001|Discontinuation From Trial|Limited follow-up agreed|2|||
13117389|NCT03057977|25925420|FG000|Discontinuation From Trial|Withdrawal by Subject|9|||
13117390|NCT03057977|25925421|FG001|Discontinuation From Trial|Withdrawal by Subject|11|||
13117391|NCT03057951|25925452|FG000|Overall Study|Adverse Event|553|||
13117392|NCT03057951|25925453|FG001|Overall Study|Adverse Event|575|||
13117393|NCT03057951|25925452|FG000|Overall Study|Protocol Violation|30|||
13117394|NCT03057951|25925453|FG001|Overall Study|Protocol Violation|24|||
13117395|NCT03057951|25925452|FG000|Overall Study|Lost to Follow-up|6|||
13117396|NCT03057951|25925453|FG001|Overall Study|Lost to Follow-up|16|||
13117397|NCT03057951|25925452|FG000|Overall Study|Patient refusal to continue, not due to AE|304|||
13290483|NCT00102531|26481211|FG001|Overall Study|Physician Decision|1|||
13290484|NCT00102440|26481268|FG000|Overall Study|Lost to Follow-up|25|||
13290485|NCT00102440|26481269|FG001|Overall Study|Lost to Follow-up|18|||
13290486|NCT00102440|26481270|FG002|Overall Study|Lost to Follow-up|21|||
13290487|NCT00102440|26481268|FG000|Overall Study|Adverse Event|16|||
13290488|NCT00102440|26481269|FG001|Overall Study|Adverse Event|23|||
13117398|NCT03057951|25925453|FG001|Overall Study|Patient refusal to continue, not due to AE|284|||
13117399|NCT03057951|25925452|FG000|Overall Study|Study drug stopped, reason missing|6|||
13117400|NCT03057951|25925453|FG001|Overall Study|Study drug stopped, reason missing|1|||
13117401|NCT03057951|25925452|FG000|Overall Study|Medical advice|6|||
13117402|NCT03057951|25925453|FG001|Overall Study|Medical advice|2|||
13117403|NCT03057951|25925452|FG000|Overall Study|Due to Covid-19 Pandemic|2|||
13117404|NCT03057951|25925453|FG001|Overall Study|Due to Covid-19 Pandemic|8|||
13117405|NCT03057951|25925452|FG000|Overall Study|Investigator decision|2|||
13117406|NCT03057951|25925453|FG001|Overall Study|Investigator decision|0|||
13117407|NCT03057951|25925452|FG000|Overall Study|Patient decision|5|||
13117408|NCT03057951|25925453|FG001|Overall Study|Patient decision|2|||
13117409|NCT03057951|25925452|FG000|Overall Study|Not attending study visits|3|||
13117410|NCT03057951|25925453|FG001|Overall Study|Not attending study visits|0|||
13290489|NCT00102440|26481270|FG002|Overall Study|Adverse Event|8|||
13290490|NCT00102440|26481268|FG000|Overall Study|Gout Flare|10|||
13290491|NCT00102440|26481269|FG001|Overall Study|Gout Flare|28|||
13290492|NCT00102440|26481270|FG002|Overall Study|Gout Flare|9|||
13117411|NCT03057951|25925452|FG000|Overall Study|Patient moved away|3|||
13117412|NCT03057951|25925453|FG001|Overall Study|Patient moved away|4|||
13117413|NCT03057951|25925452|FG000|Overall Study|Other reason than stated above|23|||
13290493|NCT00102440|26481268|FG000|Overall Study|Personal Reason(s)|19|||
13290494|NCT00102440|26481269|FG001|Overall Study|Personal Reason(s)|13|||
13290495|NCT00102440|26481270|FG002|Overall Study|Personal Reason(s)|13|||
13290496|NCT00102440|26481268|FG000|Overall Study|Other|11|||
13117414|NCT03057951|25925453|FG001|Overall Study|Other reason than stated above|29|||
13290497|NCT00102440|26481269|FG001|Overall Study|Other|14|||
13290498|NCT00102440|26481270|FG002|Overall Study|Other|14|||
13290499|NCT00102440|26481268|FG000|Overall Study|Protocol Violation|7|||
13117415|NCT03057951|25925452|FG000|Overall Study|Not treated|2|||
13117416|NCT03057951|25925453|FG001|Overall Study|Not treated|1|||
13117417|NCT03057600|25925492|FG000|Overall Study|Adverse Event|0|||
13117418|NCT03057600|25925493|FG001|Overall Study|Adverse Event|0|||
13260310|NCT01480284|26396756|FG000|Overall Study|Withdrawal by Subject|2|||
13260311|NCT01480284|26396757|FG001|Overall Study|Withdrawal by Subject|0|||
13260312|NCT01480284|26396756|FG000|Overall Study|Adverse Event|1|||
13260313|NCT01480284|26396757|FG001|Overall Study|Adverse Event|0|||
13260314|NCT01480284|26396756|FG000|Overall Study|Study closed/terminated|3|||
13260315|NCT01480284|26396757|FG001|Overall Study|Study closed/terminated|0|||
13260316|NCT01480284|26396756|FG000|Overall Study|Lost to Follow-up|1|||
13260317|NCT01480284|26396757|FG001|Overall Study|Lost to Follow-up|0|||
13260318|NCT01480284|26396756|FG000|Overall Study|Physician Decision|1|||
13260319|NCT01480284|26396757|FG001|Overall Study|Physician Decision|0|||
13260320|NCT01480258|26396786|FG000|Infant Series|Protocol Violation|2|||
13260321|NCT01480258|26396787|FG001|Infant Series|Protocol Violation|0|||
13260322|NCT01480258|26396786|FG000|Infant Series|Physician Decision|0|||
13260323|NCT01480258|26396787|FG001|Infant Series|Physician Decision|1|||
13260324|NCT01480258|26396786|FG000|Infant Series|Not Vaccinated|3|||
13260325|NCT01480258|26396787|FG001|Infant Series|Not Vaccinated|0|||
13260326|NCT01480258|26396786|FG000|Infant Series|Adverse Event|1|||
13260327|NCT01480258|26396787|FG001|Infant Series|Adverse Event|1|||
13260328|NCT01480258|26396786|FG000|Infant Series|Withdrawal by Subject|1|||
13260329|NCT01480258|26396787|FG001|Infant Series|Withdrawal by Subject|6|||
13260330|NCT01480258|26396786|FG000|Interim Period|Lost to Follow-up|0|||
13260331|NCT01480258|26396787|FG001|Interim Period|Lost to Follow-up|2|||
13260332|NCT01480258|26396786|FG000|Interim Period|Physician Decision|1|||
13260333|NCT01480258|26396787|FG001|Interim Period|Physician Decision|0|||
13260334|NCT01480258|26396786|FG000|Interim Period|Protocol Violation|0|||
13260335|NCT01480258|26396787|FG001|Interim Period|Protocol Violation|1|||
13260336|NCT01480258|26396786|FG000|Interim Period|Withdrawal by Subject|9|||
13260337|NCT01480258|26396787|FG001|Interim Period|Withdrawal by Subject|6|||
13260338|NCT01480076|26396912|FG000|Overall Study|Run-in Failure|52|||
13260339|NCT01480076|26396912|FG000|Overall Study|Adverse Event|39|||
13260340|NCT01480076|26396912|FG000|Overall Study|Death|2|||
13260341|NCT01480076|26396912|FG000|Overall Study|Disease Progression|5|||
13260342|NCT01480076|26396912|FG000|Overall Study|Non-compliance With Study Protocol|15|||
13260343|NCT01480076|26396912|FG000|Overall Study|Withdrawal by Subject|105|||
13260344|NCT01480076|26396912|FG000|Overall Study|Lost to Follow-up|7|||
13260345|NCT01480076|26396912|FG000|Overall Study|Investigator Decision|13|||
13260346|NCT01480076|26396912|FG000|Overall Study|Other|52|||
13260347|NCT01479985|26396927|FG000|Overall Study|Tablet malfunction, no data saved|1|||
13260348|NCT01479985|26396928|FG001|Overall Study|Tablet malfunction, no data saved|1|||
13260349|NCT01479985|26396927|FG000|Overall Study|No decisional conflict scale responses|0|||
13260350|NCT01479985|26396928|FG001|Overall Study|No decisional conflict scale responses|2|||
13260351|NCT01479985|26396927|FG000|Overall Study|No post-visit survey|5|||
13260352|NCT01479985|26396928|FG001|Overall Study|No post-visit survey|3|||
13260353|NCT01479868|26396945|FG000|Overall Study|Adverse Event|1|||
13260354|NCT01479868|26396945|FG000|Overall Study|Lost to Follow-up|4|||
13260355|NCT01479868|26396945|FG000|Overall Study|Protocol Violation|1|||
13260356|NCT01479868|26396945|FG000|Overall Study|Withdrawal by Subject|1|||
13260357|NCT01479868|26396945|FG000|Overall Study|Sponsor's Decision|1|||
13260358|NCT01479868|26396945|FG000|Overall Study|Initiation of new HCV Therapy|1|||
13260359|NCT01479777|26396957|FG000|Overall Study|Physician Decision|2|||
13260360|NCT01479764|26396972|FG000|Randomized|Adverse Event|1|||
13260361|NCT01479764|26396973|FG001|Randomized|Adverse Event|1|||
13260362|NCT01479764|26396972|FG000|Randomized|Withdrawal by Subject|1|||
13260363|NCT01479764|26396973|FG001|Randomized|Withdrawal by Subject|0|||
13260364|NCT01479764|26396972|FG000|Treated|Lost to Follow-up|0|||
13260365|NCT01479764|26396973|FG001|Treated|Lost to Follow-up|2|||
13260366|NCT01479621|26397079|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93|||
13260367|NCT01479621|26397080|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
13260368|NCT01479621|26397081|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
13260369|NCT01479621|26397082|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
13260370|NCT01479621|26397083|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
13260371|NCT01479621|26397084|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
13260372|NCT01479621|26397085|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
13260373|NCT01479621|26397079|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19|||
13260374|NCT01479621|26397080|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
13260375|NCT01479621|26397081|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
13260376|NCT01479621|26397082|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
13260377|NCT01479621|26397083|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
13260378|NCT01479621|26397084|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
13260379|NCT01479621|26397085|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
13117419|NCT03057600|25925494|FG002|Overall Study|Adverse Event|4|||
13260380|NCT01479621|26397079|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153|||
13260381|NCT01479621|26397080|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
13260382|NCT01479621|26397081|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
13260383|NCT01479621|26397082|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
13260384|NCT01479621|26397083|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
13260385|NCT01479621|26397084|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
13260386|NCT01479621|26397085|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
13260387|NCT01479621|26397079|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7|||
13260388|NCT01479621|26397080|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
13260389|NCT01479621|26397081|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
13260390|NCT01479621|26397082|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
13260391|NCT01479621|26397083|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
13260392|NCT01479621|26397084|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
13260393|NCT01479621|26397085|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
13260394|NCT01479621|26397079|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
13260395|NCT01479621|26397080|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
13260396|NCT01479621|26397081|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
13260397|NCT01479621|26397082|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
13260398|NCT01479621|26397083|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
13260399|NCT01479621|26397084|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
13260400|NCT01479621|26397085|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
13260401|NCT01479621|26397079|FG000|Treatment Period|Adverse Event|0|||
13260402|NCT01479621|26397080|FG001|Treatment Period|Adverse Event|0|||
13260403|NCT01479621|26397081|FG002|Treatment Period|Adverse Event|0|||
13260404|NCT01479621|26397082|FG003|Treatment Period|Adverse Event|0|||
13260405|NCT01479621|26397083|FG004|Treatment Period|Adverse Event|1|||
13260406|NCT01479621|26397084|FG005|Treatment Period|Adverse Event|2|||
13260407|NCT01479621|26397085|FG006|Treatment Period|Adverse Event|2|||
13260408|NCT01479621|26397079|FG000|Treatment Period|Withdrawal by Subject|0|||
13260409|NCT01479621|26397080|FG001|Treatment Period|Withdrawal by Subject|4|||
13260410|NCT01479621|26397081|FG002|Treatment Period|Withdrawal by Subject|2|||
13260411|NCT01479621|26397082|FG003|Treatment Period|Withdrawal by Subject|2|||
13260412|NCT01479621|26397083|FG004|Treatment Period|Withdrawal by Subject|5|||
13260413|NCT01479621|26397084|FG005|Treatment Period|Withdrawal by Subject|5|||
13260414|NCT01479621|26397085|FG006|Treatment Period|Withdrawal by Subject|1|||
13260415|NCT01479621|26397079|FG000|Treatment Period|Physician Decision|0|||
13260416|NCT01479621|26397080|FG001|Treatment Period|Physician Decision|0|||
13260417|NCT01479621|26397081|FG002|Treatment Period|Physician Decision|0|||
13260418|NCT01479621|26397082|FG003|Treatment Period|Physician Decision|0|||
13260419|NCT01479621|26397083|FG004|Treatment Period|Physician Decision|1|||
13260420|NCT01479621|26397084|FG005|Treatment Period|Physician Decision|1|||
13260421|NCT01479621|26397085|FG006|Treatment Period|Physician Decision|0|||
13260422|NCT01479621|26397079|FG000|Treatment Period|Non-compliance to study drug|0|||
13260423|NCT01479621|26397080|FG001|Treatment Period|Non-compliance to study drug|1|||
13260424|NCT01479621|26397081|FG002|Treatment Period|Non-compliance to study drug|0|||
13260425|NCT01479621|26397082|FG003|Treatment Period|Non-compliance to study drug|0|||
13260426|NCT01479621|26397083|FG004|Treatment Period|Non-compliance to study drug|0|||
13260427|NCT01479621|26397084|FG005|Treatment Period|Non-compliance to study drug|0|||
13260428|NCT01479621|26397085|FG006|Treatment Period|Non-compliance to study drug|1|||
13260429|NCT01479621|26397079|FG000|Treatment Period|Protocol Violation|0|||
13260430|NCT01479621|26397080|FG001|Treatment Period|Protocol Violation|9|||
13260431|NCT01479621|26397081|FG002|Treatment Period|Protocol Violation|6|||
13260432|NCT01479621|26397082|FG003|Treatment Period|Protocol Violation|5|||
13260433|NCT01479621|26397083|FG004|Treatment Period|Protocol Violation|2|||
13260434|NCT01479621|26397084|FG005|Treatment Period|Protocol Violation|10|||
13260435|NCT01479621|26397085|FG006|Treatment Period|Protocol Violation|6|||
13260436|NCT01479621|26397079|FG000|Treatment Period|Pregnancy|0|||
13260437|NCT01479621|26397080|FG001|Treatment Period|Pregnancy|0|||
13260438|NCT01479621|26397081|FG002|Treatment Period|Pregnancy|2|||
13260439|NCT01479621|26397082|FG003|Treatment Period|Pregnancy|0|||
13260440|NCT01479621|26397083|FG004|Treatment Period|Pregnancy|0|||
13260441|NCT01479621|26397084|FG005|Treatment Period|Pregnancy|0|||
13260442|NCT01479621|26397085|FG006|Treatment Period|Pregnancy|0|||
13260443|NCT01479621|26397079|FG000|Treatment Period|Sponsor request subject to be withdrawn|0|||
13260444|NCT01479621|26397080|FG001|Treatment Period|Sponsor request subject to be withdrawn|2|||
13260445|NCT01479621|26397081|FG002|Treatment Period|Sponsor request subject to be withdrawn|3|||
13260446|NCT01479621|26397082|FG003|Treatment Period|Sponsor request subject to be withdrawn|1|||
13260447|NCT01479621|26397083|FG004|Treatment Period|Sponsor request subject to be withdrawn|1|||
13260448|NCT01479621|26397084|FG005|Treatment Period|Sponsor request subject to be withdrawn|1|||
13260449|NCT01479621|26397085|FG006|Treatment Period|Sponsor request subject to be withdrawn|3|||
13260450|NCT01479621|26397079|FG000|Treatment Period|Lost to Follow-up|0|||
13260451|NCT01479621|26397080|FG001|Treatment Period|Lost to Follow-up|0|||
13260452|NCT01479621|26397081|FG002|Treatment Period|Lost to Follow-up|1|||
13260453|NCT01479621|26397082|FG003|Treatment Period|Lost to Follow-up|0|||
13260454|NCT01479621|26397083|FG004|Treatment Period|Lost to Follow-up|2|||
13260455|NCT01479621|26397084|FG005|Treatment Period|Lost to Follow-up|2|||
13260456|NCT01479621|26397085|FG006|Treatment Period|Lost to Follow-up|1|||
13260457|NCT01479621|26397079|FG000|Treatment Period|Met stopping criteria|0|||
13260458|NCT01479621|26397080|FG001|Treatment Period|Met stopping criteria|8|||
13260459|NCT01479621|26397081|FG002|Treatment Period|Met stopping criteria|7|||
13260460|NCT01479621|26397082|FG003|Treatment Period|Met stopping criteria|4|||
13260461|NCT01479621|26397083|FG004|Treatment Period|Met stopping criteria|9|||
13260462|NCT01479621|26397084|FG005|Treatment Period|Met stopping criteria|20|||
13260463|NCT01479621|26397085|FG006|Treatment Period|Met stopping criteria|6|||
13260464|NCT01479595|26397114|FG000|Overall Study|Protocol deviation|0|||
13260465|NCT01479595|26397115|FG001|Overall Study|Protocol deviation|1|||
13260466|NCT01479595|26397114|FG000|Overall Study|Adverse Event|2|||
13260467|NCT01479595|26397115|FG001|Overall Study|Adverse Event|1|||
13260468|NCT01479530|26397134|FG000|Overall Study|Adverse Event|5|||
13260469|NCT01479530|26397135|FG001|Overall Study|Adverse Event|6|||
13260470|NCT01479530|26397134|FG000|Overall Study|Lack of Efficacy|0|||
13260471|NCT01479530|26397135|FG001|Overall Study|Lack of Efficacy|1|||
13260472|NCT01479530|26397134|FG000|Overall Study|Protocol Violation|2|||
13260473|NCT01479530|26397135|FG001|Overall Study|Protocol Violation|3|||
13260474|NCT01479530|26397134|FG000|Overall Study|Withdrawal of Consent|3|||
13260475|NCT01479530|26397135|FG001|Overall Study|Withdrawal of Consent|2|||
13260476|NCT01479465|26397166|FG000|Overall Study|Disease Progression|9|||
13260477|NCT01479465|26397167|FG001|Overall Study|Disease Progression|61|||
13260478|NCT01479465|26397168|FG002|Overall Study|Disease Progression|65|||
13260479|NCT01479465|26397169|FG003|Overall Study|Disease Progression|70|||
13260480|NCT01479465|26397166|FG000|Overall Study|Study Discontinued by Sponsor|0|||
13260481|NCT01479465|26397167|FG001|Overall Study|Study Discontinued by Sponsor|7|||
13260482|NCT01479465|26397168|FG002|Overall Study|Study Discontinued by Sponsor|5|||
13260483|NCT01479465|26397169|FG003|Overall Study|Study Discontinued by Sponsor|3|||
13260484|NCT01479465|26397166|FG000|Overall Study|Adverse Event|0|||
13260485|NCT01479465|26397167|FG001|Overall Study|Adverse Event|3|||
13260486|NCT01479465|26397168|FG002|Overall Study|Adverse Event|6|||
13260487|NCT01479465|26397169|FG003|Overall Study|Adverse Event|4|||
13260488|NCT01479465|26397166|FG000|Overall Study|Investigator Discretion|1|||
13260489|NCT01479465|26397167|FG001|Overall Study|Investigator Discretion|4|||
13260490|NCT01479465|26397168|FG002|Overall Study|Investigator Discretion|2|||
13260491|NCT01479465|26397169|FG003|Overall Study|Investigator Discretion|4|||
13260492|NCT01479465|26397166|FG000|Overall Study|Subject Request|1|||
13260493|NCT01479465|26397167|FG001|Overall Study|Subject Request|3|||
13260494|NCT01479465|26397168|FG002|Overall Study|Subject Request|4|||
13260495|NCT01479465|26397169|FG003|Overall Study|Subject Request|2|||
13260496|NCT01479465|26397166|FG000|Overall Study|Subject Withdrew Consent|0|||
13260497|NCT01479465|26397167|FG001|Overall Study|Subject Withdrew Consent|5|||
13260498|NCT01479465|26397168|FG002|Overall Study|Subject Withdrew Consent|2|||
13260499|NCT01479465|26397169|FG003|Overall Study|Subject Withdrew Consent|1|||
13260500|NCT01479465|26397166|FG000|Overall Study|Protocol Violation|0|||
13260501|NCT01479465|26397167|FG001|Overall Study|Protocol Violation|1|||
13260502|NCT01479465|26397168|FG002|Overall Study|Protocol Violation|1|||
13260503|NCT01479465|26397169|FG003|Overall Study|Protocol Violation|0|||
13260504|NCT01479465|26397166|FG000|Overall Study|Death|0|||
13260505|NCT01479465|26397167|FG001|Overall Study|Death|0|||
13260506|NCT01479465|26397168|FG002|Overall Study|Death|0|||
13260507|NCT01479465|26397169|FG003|Overall Study|Death|1|||
13260508|NCT01479465|26397166|FG000|Overall Study|Lost to Follow-up|0|||
13260509|NCT01479465|26397167|FG001|Overall Study|Lost to Follow-up|0|||
13260510|NCT01479465|26397168|FG002|Overall Study|Lost to Follow-up|1|||
13260511|NCT01479465|26397169|FG003|Overall Study|Lost to Follow-up|0|||
13260512|NCT01479439|26397193|FG000|Overall Study|Adverse Event|1|||
13260513|NCT01479439|26397194|FG001|Overall Study|Adverse Event|0|||
13260514|NCT01479439|26397195|FG002|Overall Study|Adverse Event|0|||
13260515|NCT01479439|26397193|FG000|Overall Study|Lost to Follow-up|0|||
13260516|NCT01479439|26397194|FG001|Overall Study|Lost to Follow-up|1|||
13260517|NCT01479439|26397195|FG002|Overall Study|Lost to Follow-up|0|||
13260518|NCT01479439|26397193|FG000|Overall Study|Protocol Violation|0|||
13260519|NCT01479439|26397194|FG001|Overall Study|Protocol Violation|0|||
13260520|NCT01479439|26397195|FG002|Overall Study|Protocol Violation|2|||
13260521|NCT01479374|26397231|FG000|Overall Study|Adverse Event|2|||
13260522|NCT01479374|26397232|FG001|Overall Study|Adverse Event|1|||
13260523|NCT01479374|26397233|FG002|Overall Study|Adverse Event|0|||
13260524|NCT01479374|26397231|FG000|Overall Study|Lost to Follow-up|1|||
13260525|NCT01479374|26397232|FG001|Overall Study|Lost to Follow-up|2|||
13260526|NCT01479374|26397233|FG002|Overall Study|Lost to Follow-up|0|||
13260527|NCT01479374|26397231|FG000|Overall Study|Decision Unrelated to Adverse Event|0|||
13260528|NCT01479374|26397232|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
13260529|NCT01479374|26397233|FG002|Overall Study|Decision Unrelated to Adverse Event|0|||
13260530|NCT01479374|26397231|FG000|Overall Study|Other|0|||
13260531|NCT01479374|26397232|FG001|Overall Study|Other|4|||
13260532|NCT01479374|26397233|FG002|Overall Study|Other|5|||
13260533|NCT01478971|26397249|FG000|Standard of Care Period|Adverse Event|1|||
13260534|NCT01478971|26397249|FG000|Standard of Care Period|Withdrawal by Subject|3|||
13260535|NCT01478971|26397249|FG000|Standard of Care Period|Death|8|||
13260536|NCT01478971|26397249|FG000|Standard of Care Period|Lost to Follow-up|9|||
13260537|NCT01478971|26397249|FG000|Standard of Care Period|Other|4|||
13260538|NCT01478971|26397249|FG000|Peginesatide Treatment Period|Adverse Event|1|||
13260539|NCT01478971|26397249|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1|||
13260540|NCT01478971|26397249|FG000|Peginesatide Treatment Period|Death|4|||
13260541|NCT01478971|26397249|FG000|Peginesatide Treatment Period|Lost to Follow-up|4|||
13260542|NCT01478971|26397249|FG000|Peginesatide Treatment Period|Other|4|||
13260543|NCT01478958|26397267|FG000|Overall Study|Withdrawal by Subject|1|||
13260544|NCT01478958|26397268|FG001|Overall Study|Withdrawal by Subject|1|||
13260545|NCT01478958|26397269|FG002|Overall Study|Withdrawal by Subject|1|||
13260546|NCT01478958|26397267|FG000|Overall Study|Weight loss|1|||
13260547|NCT01478958|26397268|FG001|Overall Study|Weight loss|0|||
13260548|NCT01478958|26397269|FG002|Overall Study|Weight loss|0|||
13260549|NCT01478958|26397267|FG000|Overall Study|Re-located|0|||
13260550|NCT01478958|26397268|FG001|Overall Study|Re-located|1|||
13260551|NCT01478958|26397269|FG002|Overall Study|Re-located|0|||
13260552|NCT01478958|26397267|FG000|Overall Study|Unable to comply|0|||
13260553|NCT01478958|26397268|FG001|Overall Study|Unable to comply|0|||
13260554|NCT01478958|26397269|FG002|Overall Study|Unable to comply|2|||
13260555|NCT01478828|26397282|FG000|Overall Study|Adverse Event|1|||
13260556|NCT01478620|26397288|FG000|Overall Study|Lost to Follow-up|6|||
13260557|NCT01478594|26397367|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
13260558|NCT01478594|26397368|FG001|Overall Study|Randomized but Never Received Study Drug|1|||
13260559|NCT01478594|26397367|FG000|Overall Study|Death|45|||
13260560|NCT01478594|26397368|FG001|Overall Study|Death|18|||
13260561|NCT01478594|26397367|FG000|Overall Study|Lost to Follow-up|3|||
13260562|NCT01478594|26397368|FG001|Overall Study|Lost to Follow-up|1|||
13260563|NCT01478594|26397367|FG000|Overall Study|Withdrawal by Subject|9|||
13260564|NCT01478594|26397368|FG001|Overall Study|Withdrawal by Subject|3|||
13260565|NCT01478594|26397367|FG000|Overall Study|Study Closed by Sponsor|8|||
13260566|NCT01478594|26397368|FG001|Overall Study|Study Closed by Sponsor|5|||
13260567|NCT01478373|26397381|FG000|Treatment Phase|Protocol Violation|1|||
13260568|NCT01478373|26397381|FG000|Survival Phase|Adverse Event|8|||
13260569|NCT01478373|26397381|FG000|Survival Phase|Protocol Violation|1|||
13260570|NCT01478373|26397381|FG000|Survival Phase|crossover to another study|2|||
13260571|NCT01478373|26397381|FG000|Survival Phase|Progressive Disease|27|||
13260572|NCT01478360|26397394|FG000|Overall Study|Lost to Follow-up|1|||
13260573|NCT01478360|26397395|FG001|Overall Study|Lost to Follow-up|0|||
13260574|NCT01478360|26397394|FG000|Overall Study|Adverse Event|0|||
13260575|NCT01478360|26397395|FG001|Overall Study|Adverse Event|1|||
13260576|NCT01478360|26397394|FG000|Overall Study|Administrative problems|1|||
13260577|NCT01478360|26397395|FG001|Overall Study|Administrative problems|2|||
13260578|NCT01478347|26397402|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1|||
13260579|NCT01478347|26397402|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4|||
13260580|NCT01478347|26397402|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4|||
13260581|NCT01478321|26397414|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4|||
13260582|NCT01478321|26397414|FG000|Concurrent Therapy (5 Weeks)|Death|2|||
13260583|NCT01478321|26397414|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5|||
13260584|NCT01478321|26397414|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5|||
13260585|NCT01478321|26397414|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1|||
13260586|NCT01478321|26397414|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1|||
13260587|NCT01478321|26397414|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1|||
13260588|NCT01478321|26397414|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8|||
13260589|NCT01478113|26397439|FG000|Overall Study|Withdrawal by Subject|0|||
13260590|NCT01478113|26397440|FG001|Overall Study|Withdrawal by Subject|1|||
13260591|NCT01478113|26397439|FG000|Overall Study|Physician Decision|1|||
13260592|NCT01478113|26397440|FG001|Overall Study|Physician Decision|0|||
13260593|NCT01478087|26397447|FG000|Overall Study|due to sponsor closing study|1|||
13260594|NCT01478048|26397470|FG000|Overall Study|Disease Progression|52|||
13260595|NCT01478048|26397471|FG001|Overall Study|Disease Progression|35|||
13260596|NCT01478048|26397470|FG000|Overall Study|study drug toxicity|11|||
13260597|NCT01478048|26397471|FG001|Overall Study|study drug toxicity|14|||
13260598|NCT01478048|26397470|FG000|Overall Study|Adverse Event|2|||
13260599|NCT01478048|26397471|FG001|Overall Study|Adverse Event|11|||
13260600|NCT01478048|26397470|FG000|Overall Study|subject request to discontinue treatment|3|||
13260601|NCT01478048|26397471|FG001|Overall Study|subject request to discontinue treatment|5|||
13260602|NCT01478048|26397470|FG000|Overall Study|Withdrawal by Subject|2|||
13260603|NCT01478048|26397471|FG001|Overall Study|Withdrawal by Subject|5|||
13260604|NCT01478048|26397470|FG000|Overall Study|non-specified|6|||
13260605|NCT01478048|26397471|FG001|Overall Study|non-specified|4|||
13260606|NCT01478048|26397470|FG000|Overall Study|poor/non-compliance|0|||
13260607|NCT01478048|26397471|FG001|Overall Study|poor/non-compliance|1|||
13260608|NCT01478048|26397470|FG000|Overall Study|no longer meets study criteria|1|||
13260609|NCT01478048|26397471|FG001|Overall Study|no longer meets study criteria|0|||
13260610|NCT01477892|26397486|FG000|Overall Study|Withdrawal by Subject|0|||
13260611|NCT01477892|26397487|FG001|Overall Study|Withdrawal by Subject|2|||
13260612|NCT01477853|26397535|FG000|Phase A|Adverse Event|1|||
13260613|NCT01477853|26397536|FG001|Phase A|Adverse Event|2|||
13260614|NCT01477853|26397537|FG002|Phase A|Adverse Event|2|||
13260615|NCT01477853|26397535|FG000|Phase A|Lost to Follow-up|4|||
13260616|NCT01477853|26397536|FG001|Phase A|Lost to Follow-up|3|||
13260617|NCT01477853|26397537|FG002|Phase A|Lost to Follow-up|2|||
13260618|NCT01477853|26397535|FG000|Phase A|Physician Decision|1|||
13260619|NCT01477853|26397536|FG001|Phase A|Physician Decision|0|||
13260620|NCT01477853|26397537|FG002|Phase A|Physician Decision|1|||
13260621|NCT01477853|26397535|FG000|Phase A|Study terminated by sponsor|37|||
13260622|NCT01477853|26397536|FG001|Phase A|Study terminated by sponsor|40|||
13260623|NCT01477853|26397537|FG002|Phase A|Study terminated by sponsor|39|||
13260624|NCT01477853|26397535|FG000|Phase B|Lost to Follow-up|0|||
13260625|NCT01477853|26397536|FG001|Phase B|Lost to Follow-up|1|||
13260626|NCT01477853|26397537|FG002|Phase B|Lost to Follow-up|0|||
13260627|NCT01477853|26397535|FG000|Phase B|Study terminated by sponsor|12|||
13260628|NCT01477853|26397536|FG001|Phase B|Study terminated by sponsor|10|||
13260629|NCT01477853|26397537|FG002|Phase B|Study terminated by sponsor|11|||
13260630|NCT01477749|26397546|FG000|Overall Study|Physician Decision|4|||
13260631|NCT01477333|26397564|FG000|Overall Study|Adverse Event|1|||
13260632|NCT01477333|26397564|FG000|Overall Study|Withdrawal by Subject|1|||
13260633|NCT01477333|26397564|FG000|Overall Study|Clinical Deterioration|1|||
13260634|NCT01476722|26397573|FG000|Overall Study|Adverse Event|1|||
13260635|NCT01476696|26397591|FG000|Overall Study|Sponsor decision|2|||
13260636|NCT01476696|26397592|FG001|Overall Study|Sponsor decision|1|||
13260637|NCT01476696|26397593|FG002|Overall Study|Sponsor decision|0|||
13260638|NCT01476696|26397591|FG000|Overall Study|Withdrawal by Subject|1|||
13260639|NCT01476696|26397592|FG001|Overall Study|Withdrawal by Subject|0|||
13260640|NCT01476696|26397593|FG002|Overall Study|Withdrawal by Subject|0|||
13260641|NCT01476644|26397600|FG000|Overall Study|Death|5|||
13260642|NCT01476644|26397600|FG000|Overall Study|moved to another state|2|||
13260643|NCT01476644|26397600|FG000|Overall Study|Lost to Follow-up|19|||
13260644|NCT01476644|26397600|FG000|Overall Study|Withdrawal by Subject|13|||
13260645|NCT01476475|26397639|FG000|Overall Study|Adverse Event|6|||
13260646|NCT01476475|26397640|FG001|Overall Study|Adverse Event|0|||
13260647|NCT01476475|26397639|FG000|Overall Study|Poor compliance to protocol|1|||
13260648|NCT01476475|26397640|FG001|Overall Study|Poor compliance to protocol|1|||
13260649|NCT01476475|26397639|FG000|Overall Study|Other reasons|4|||
13260650|NCT01476475|26397640|FG001|Overall Study|Other reasons|2|||
13260651|NCT01475851|26397673|FG000|Overall Study|Protocol defined stopping criteria|1|||
13260652|NCT01475851|26397674|FG001|Overall Study|Protocol defined stopping criteria|0|||
13260653|NCT01475838|26397694|FG000|Randomized Phase|Randomized but Not Treated|0|||
13260654|NCT01475838|26397695|FG001|Randomized Phase|Randomized but Not Treated|5|||
13260655|NCT01475838|26397694|FG000|Randomized Phase|Adverse Event|6|||
13260656|NCT01475838|26397695|FG001|Randomized Phase|Adverse Event|1|||
13260657|NCT01475838|26397694|FG000|Randomized Phase|Pregnancy|0|||
13260658|NCT01475838|26397695|FG001|Randomized Phase|Pregnancy|1|||
13260659|NCT01475838|26397694|FG000|Randomized Phase|Investigators Discretion|1|||
13260660|NCT01475838|26397695|FG001|Randomized Phase|Investigators Discretion|2|||
13260661|NCT01475838|26397694|FG000|Randomized Phase|Withdrew Consent|10|||
13260662|NCT01475838|26397695|FG001|Randomized Phase|Withdrew Consent|14|||
13260663|NCT01475838|26397694|FG000|Randomized Phase|Lost to Follow-up|3|||
13260664|NCT01475838|26397695|FG001|Randomized Phase|Lost to Follow-up|4|||
13260665|NCT01475838|26397694|FG000|Randomized Phase|Participant Noncompliance|1|||
13260666|NCT01475838|26397695|FG001|Randomized Phase|Participant Noncompliance|5|||
13260667|NCT01475838|26397694|FG000|Randomized Phase|Protocol Violation|9|||
13260668|NCT01475838|26397695|FG001|Randomized Phase|Protocol Violation|4|||
13260669|NCT01475838|26397694|FG000|Extension Phase|Participant Noncompliance|1|||
13260670|NCT01475838|26397695|FG001|Extension Phase|Participant Noncompliance|0|||
13260671|NCT01475825|26397738|FG000|Overall Study|Adverse Event|41|||
13260672|NCT01475825|26397739|FG001|Overall Study|Adverse Event|15|||
13260673|NCT01475825|26397740|FG002|Overall Study|Adverse Event|27|||
13260674|NCT01475825|26397741|FG003|Overall Study|Adverse Event|11|||
13260675|NCT01475825|26397738|FG000|Overall Study|Death|1|||
13260676|NCT01475825|26397739|FG001|Overall Study|Death|0|||
13260677|NCT01475825|26397740|FG002|Overall Study|Death|1|||
13260678|NCT01475825|26397741|FG003|Overall Study|Death|0|||
13260679|NCT01475825|26397738|FG000|Overall Study|Lack of Efficacy|0|||
13260680|NCT01475825|26397739|FG001|Overall Study|Lack of Efficacy|0|||
13260681|NCT01475825|26397740|FG002|Overall Study|Lack of Efficacy|1|||
13260682|NCT01475825|26397741|FG003|Overall Study|Lack of Efficacy|0|||
13260683|NCT01475825|26397738|FG000|Overall Study|Lost to Follow-up|0|||
13260684|NCT01475825|26397739|FG001|Overall Study|Lost to Follow-up|0|||
13260685|NCT01475825|26397740|FG002|Overall Study|Lost to Follow-up|3|||
13260686|NCT01475825|26397741|FG003|Overall Study|Lost to Follow-up|1|||
13260687|NCT01475825|26397738|FG000|Overall Study|Non-compliance with Study Drug|1|||
13260688|NCT01475825|26397739|FG001|Overall Study|Non-compliance with Study Drug|2|||
13260689|NCT01475825|26397740|FG002|Overall Study|Non-compliance with Study Drug|4|||
13260690|NCT01475825|26397741|FG003|Overall Study|Non-compliance with Study Drug|0|||
13260691|NCT01475825|26397738|FG000|Overall Study|Other: Not available|0|||
13260692|NCT01475825|26397739|FG001|Overall Study|Other: Not available|0|||
13260693|NCT01475825|26397740|FG002|Overall Study|Other: Not available|2|||
13260694|NCT01475825|26397741|FG003|Overall Study|Other: Not available|0|||
13260695|NCT01475825|26397738|FG000|Overall Study|Protocol Violation|1|||
13260696|NCT01475825|26397739|FG001|Overall Study|Protocol Violation|0|||
13260697|NCT01475825|26397740|FG002|Overall Study|Protocol Violation|0|||
13260698|NCT01475825|26397741|FG003|Overall Study|Protocol Violation|0|||
13260699|NCT01475825|26397738|FG000|Overall Study|Physician Decision|0|||
13260700|NCT01475825|26397739|FG001|Overall Study|Physician Decision|1|||
13260701|NCT01475825|26397740|FG002|Overall Study|Physician Decision|0|||
13260702|NCT01475825|26397741|FG003|Overall Study|Physician Decision|0|||
13260703|NCT01475825|26397738|FG000|Overall Study|Withdrawal by Subject|8|||
13260704|NCT01475825|26397739|FG001|Overall Study|Withdrawal by Subject|3|||
13260705|NCT01475825|26397740|FG002|Overall Study|Withdrawal by Subject|11|||
13260706|NCT01475825|26397741|FG003|Overall Study|Withdrawal by Subject|7|||
13260707|NCT01475825|26397738|FG000|Overall Study|Did not enter OLC|15|||
13260708|NCT01475825|26397739|FG001|Overall Study|Did not enter OLC|11|||
13260709|NCT01475825|26397740|FG002|Overall Study|Did not enter OLC|15|||
13260710|NCT01475825|26397741|FG003|Overall Study|Did not enter OLC|11|||
13260711|NCT01475734|26397774|FG000|Overall Study|Withdrawal by Subject|1|||
13260712|NCT01475734|26397775|FG001|Overall Study|Withdrawal by Subject|0|||
13260713|NCT01475734|26397774|FG000|Overall Study|Protocol Violation|1|||
13260714|NCT01475734|26397775|FG001|Overall Study|Protocol Violation|0|||
13260715|NCT01475734|26397774|FG000|Overall Study|Physician Decision|0|||
13260716|NCT01475734|26397775|FG001|Overall Study|Physician Decision|1|||
13260717|NCT01475721|26397796|FG000|Overall Study|Death|3|||
13260718|NCT01475721|26397797|FG001|Overall Study|Death|6|||
13260719|NCT01475721|26397796|FG000|Overall Study|Withdrawal by Subject|8|||
13260720|NCT01475721|26397797|FG001|Overall Study|Withdrawal by Subject|8|||
13260721|NCT01475487|26397816|FG000|Overall Study|had to leave early for personal reasons|2|||
13260722|NCT01475487|26397817|FG001|Overall Study|had to leave early for personal reasons|1|||
13260723|NCT01475474|26397824|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4|||
13260724|NCT01475474|26397824|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2|||
13260725|NCT01475461|26397922|FG000|Run-in Period|Not meet eligibility criteria|16|||
13260726|NCT01475461|26397923|FG001|Run-in Period|Not meet eligibility criteria|0|||
13260727|NCT01475461|26397924|FG002|Run-in Period|Not meet eligibility criteria|0|||
13260728|NCT01475461|26397925|FG003|Run-in Period|Not meet eligibility criteria|0|||
13260729|NCT01475461|26397926|FG004|Run-in Period|Not meet eligibility criteria|0|||
13260730|NCT01475461|26397927|FG005|Run-in Period|Not meet eligibility criteria|0|||
13260731|NCT01475461|26397928|FG006|Run-in Period|Not meet eligibility criteria|0|||
13260732|NCT01475461|26397922|FG000|Run-in Period|Lost to Follow-up|7|||
13260733|NCT01475461|26397923|FG001|Run-in Period|Lost to Follow-up|0|||
13260734|NCT01475461|26397924|FG002|Run-in Period|Lost to Follow-up|0|||
13260735|NCT01475461|26397925|FG003|Run-in Period|Lost to Follow-up|0|||
13260736|NCT01475461|26397926|FG004|Run-in Period|Lost to Follow-up|0|||
13260737|NCT01475461|26397927|FG005|Run-in Period|Lost to Follow-up|0|||
13260738|NCT01475461|26397928|FG006|Run-in Period|Lost to Follow-up|0|||
13260739|NCT01475461|26397922|FG000|Run-in Period|Withdrawal by Subject|11|||
13260740|NCT01475461|26397923|FG001|Run-in Period|Withdrawal by Subject|0|||
13260741|NCT01475461|26397924|FG002|Run-in Period|Withdrawal by Subject|0|||
13260742|NCT01475461|26397925|FG003|Run-in Period|Withdrawal by Subject|0|||
13260743|NCT01475461|26397926|FG004|Run-in Period|Withdrawal by Subject|0|||
13260744|NCT01475461|26397927|FG005|Run-in Period|Withdrawal by Subject|0|||
13260745|NCT01475461|26397928|FG006|Run-in Period|Withdrawal by Subject|0|||
13260746|NCT01475461|26397922|FG000|Run-in Period|Other|3|||
13260747|NCT01475461|26397923|FG001|Run-in Period|Other|0|||
13260748|NCT01475461|26397924|FG002|Run-in Period|Other|0|||
13260749|NCT01475461|26397925|FG003|Run-in Period|Other|0|||
13260750|NCT01475461|26397926|FG004|Run-in Period|Other|0|||
13260751|NCT01475461|26397927|FG005|Run-in Period|Other|0|||
13260752|NCT01475461|26397928|FG006|Run-in Period|Other|0|||
13260753|NCT01475461|26397922|FG000|Run-in Period|Protocol Violation|4|||
13260754|NCT01475461|26397923|FG001|Run-in Period|Protocol Violation|0|||
13260755|NCT01475461|26397924|FG002|Run-in Period|Protocol Violation|0|||
13260756|NCT01475461|26397925|FG003|Run-in Period|Protocol Violation|0|||
13260757|NCT01475461|26397926|FG004|Run-in Period|Protocol Violation|0|||
13260758|NCT01475461|26397927|FG005|Run-in Period|Protocol Violation|0|||
13260759|NCT01475461|26397928|FG006|Run-in Period|Protocol Violation|0|||
13260760|NCT01475461|26397922|FG000|Treatment Period|Death|0|||
13260761|NCT01475461|26397923|FG001|Treatment Period|Death|0|||
13260762|NCT01475461|26397924|FG002|Treatment Period|Death|0|||
13260763|NCT01475461|26397925|FG003|Treatment Period|Death|1|||
13260764|NCT01475461|26397926|FG004|Treatment Period|Death|0|||
13260765|NCT01475461|26397927|FG005|Treatment Period|Death|0|||
13260766|NCT01475461|26397928|FG006|Treatment Period|Death|0|||
13260767|NCT01475461|26397922|FG000|Treatment Period|Lost to Follow-up|0|||
13260768|NCT01475461|26397923|FG001|Treatment Period|Lost to Follow-up|3|||
13260769|NCT01475461|26397924|FG002|Treatment Period|Lost to Follow-up|2|||
13260770|NCT01475461|26397925|FG003|Treatment Period|Lost to Follow-up|3|||
13260771|NCT01475461|26397926|FG004|Treatment Period|Lost to Follow-up|1|||
13260772|NCT01475461|26397927|FG005|Treatment Period|Lost to Follow-up|2|||
13260773|NCT01475461|26397928|FG006|Treatment Period|Lost to Follow-up|1|||
13260774|NCT01475461|26397922|FG000|Treatment Period|Withdrawal by Subject|0|||
13260775|NCT01475461|26397923|FG001|Treatment Period|Withdrawal by Subject|2|||
13260776|NCT01475461|26397924|FG002|Treatment Period|Withdrawal by Subject|2|||
13260777|NCT01475461|26397925|FG003|Treatment Period|Withdrawal by Subject|0|||
13260778|NCT01475461|26397926|FG004|Treatment Period|Withdrawal by Subject|2|||
13260779|NCT01475461|26397927|FG005|Treatment Period|Withdrawal by Subject|2|||
13260780|NCT01475461|26397928|FG006|Treatment Period|Withdrawal by Subject|0|||
13260781|NCT01475461|26397922|FG000|Treatment Period|Other|0|||
13260782|NCT01475461|26397923|FG001|Treatment Period|Other|1|||
13260783|NCT01475461|26397924|FG002|Treatment Period|Other|0|||
13260784|NCT01475461|26397925|FG003|Treatment Period|Other|0|||
13260785|NCT01475461|26397926|FG004|Treatment Period|Other|0|||
13260786|NCT01475461|26397927|FG005|Treatment Period|Other|0|||
13260787|NCT01475461|26397928|FG006|Treatment Period|Other|0|||
13260788|NCT01475461|26397922|FG000|Treatment Period|Protocol Violation|0|||
13260789|NCT01475461|26397923|FG001|Treatment Period|Protocol Violation|1|||
13260790|NCT01475461|26397924|FG002|Treatment Period|Protocol Violation|0|||
13260791|NCT01475461|26397925|FG003|Treatment Period|Protocol Violation|0|||
13260792|NCT01475461|26397926|FG004|Treatment Period|Protocol Violation|0|||
13260793|NCT01475461|26397927|FG005|Treatment Period|Protocol Violation|0|||
13260794|NCT01475461|26397928|FG006|Treatment Period|Protocol Violation|1|||
13260795|NCT01475461|26397922|FG000|Treatment Period|Lack of Efficacy|0|||
13260796|NCT01475461|26397923|FG001|Treatment Period|Lack of Efficacy|2|||
13260797|NCT01475461|26397924|FG002|Treatment Period|Lack of Efficacy|0|||
13260798|NCT01475461|26397925|FG003|Treatment Period|Lack of Efficacy|2|||
13260799|NCT01475461|26397926|FG004|Treatment Period|Lack of Efficacy|1|||
13260800|NCT01475461|26397927|FG005|Treatment Period|Lack of Efficacy|1|||
13260801|NCT01475461|26397928|FG006|Treatment Period|Lack of Efficacy|0|||
13260802|NCT01475461|26397922|FG000|Treatment Period|Medication Error|0|||
13260803|NCT01475461|26397923|FG001|Treatment Period|Medication Error|0|||
13260804|NCT01475461|26397924|FG002|Treatment Period|Medication Error|0|||
13260805|NCT01475461|26397925|FG003|Treatment Period|Medication Error|1|||
13260806|NCT01475461|26397926|FG004|Treatment Period|Medication Error|0|||
13260807|NCT01475461|26397927|FG005|Treatment Period|Medication Error|0|||
13260808|NCT01475461|26397928|FG006|Treatment Period|Medication Error|0|||
13260809|NCT01475461|26397922|FG000|Treatment Period|Adverse Event|0|||
13260810|NCT01475461|26397923|FG001|Treatment Period|Adverse Event|0|||
13260811|NCT01475461|26397924|FG002|Treatment Period|Adverse Event|0|||
13260812|NCT01475461|26397925|FG003|Treatment Period|Adverse Event|1|||
13260813|NCT01475461|26397926|FG004|Treatment Period|Adverse Event|0|||
13260814|NCT01475461|26397927|FG005|Treatment Period|Adverse Event|0|||
13260815|NCT01475461|26397928|FG006|Treatment Period|Adverse Event|0|||
13260816|NCT01475370|26397946|FG000|Overall Study|Exacerbation of primary disease|2|||
13260817|NCT01475370|26397947|FG001|Overall Study|Exacerbation of primary disease|2|||
13260818|NCT01475370|26397948|FG002|Overall Study|Exacerbation of primary disease|2|||
13260819|NCT01475370|26397946|FG000|Overall Study|Study drug administration difficult|0|||
13260820|NCT01475370|26397947|FG001|Overall Study|Study drug administration difficult|1|||
13260821|NCT01475370|26397948|FG002|Overall Study|Study drug administration difficult|1|||
13260822|NCT01475370|26397946|FG000|Overall Study|Other than specified|1|||
13260823|NCT01475370|26397947|FG001|Overall Study|Other than specified|0|||
13260824|NCT01475370|26397948|FG002|Overall Study|Other than specified|0|||
13260825|NCT01475331|26397961|FG000|Overall Study|Osteophyte obstruction of the proximal|1|||
13260826|NCT01475331|26397962|FG001|Overall Study|Osteophyte obstruction of the proximal|0|||
13260827|NCT01475331|26397961|FG000|Overall Study|excessive main duct communication|1|||
13260828|NCT01475331|26397962|FG001|Overall Study|excessive main duct communication|1|||
13260829|NCT01475331|26397961|FG000|Overall Study|Loss of needle positioning due pt. cough|1|||
13260830|NCT01475331|26397962|FG001|Overall Study|Loss of needle positioning due pt. cough|0|||
13260831|NCT01475331|26397961|FG000|Overall Study|Sign of malignancy during the procedure|2|||
13260832|NCT01475331|26397962|FG001|Overall Study|Sign of malignancy during the procedure|0|||
13260833|NCT01475331|26397961|FG000|Overall Study|cyst found to be prohibitively small|0|||
13260834|NCT01475331|26397962|FG001|Overall Study|cyst found to be prohibitively small|1|||
13260835|NCT01475253|26397999|FG000|Randomized, Blinded Study|Withdrawal by Subject|1|||
13260836|NCT01475253|26398000|FG001|Randomized, Blinded Study|Withdrawal by Subject|1|||
13260837|NCT01475253|26398001|FG002|Randomized, Blinded Study|Withdrawal by Subject|0|||
13260838|NCT01475253|26398002|FG003|Randomized, Blinded Study|Withdrawal by Subject|0|||
13260839|NCT01475253|26397999|FG000|Randomized, Blinded Study|Lost to Follow-up|1|||
13260840|NCT01475253|26398000|FG001|Randomized, Blinded Study|Lost to Follow-up|0|||
13260841|NCT01475253|26398001|FG002|Randomized, Blinded Study|Lost to Follow-up|0|||
13260842|NCT01475253|26398002|FG003|Randomized, Blinded Study|Lost to Follow-up|0|||
13260843|NCT01475214|26398023|FG000|Overall Study|Lost to Follow-up|1|||
13260844|NCT01475214|26398024|FG001|Overall Study|Lost to Follow-up|0|||
13260845|NCT01475214|26398025|FG002|Overall Study|Lost to Follow-up|1|||
13260846|NCT01475214|26398023|FG000|Overall Study|Physician Decision|2|||
13260847|NCT01475214|26398024|FG001|Overall Study|Physician Decision|0|||
13260848|NCT01475214|26398025|FG002|Overall Study|Physician Decision|0|||
13260849|NCT01475214|26398023|FG000|Overall Study|Withdrawal by Subject|2|||
13260850|NCT01475214|26398024|FG001|Overall Study|Withdrawal by Subject|4|||
13260851|NCT01475214|26398025|FG002|Overall Study|Withdrawal by Subject|1|||
13260852|NCT01475162|26398038|FG000|Overall Study|Physician Decision|1|||
13260853|NCT01475162|26398038|FG000|Overall Study|Death|10|||
13260854|NCT01475162|26398038|FG000|Overall Study|Study closed for safety|3|||
13260855|NCT01475136|26398069|FG000|Overall Study|Sponsor Decision|0|||
13260856|NCT01475136|26398070|FG001|Overall Study|Sponsor Decision|1|||
13260857|NCT01475136|26398071|FG002|Overall Study|Sponsor Decision|0|||
13260858|NCT01475136|26398072|FG003|Overall Study|Sponsor Decision|0|||
13260859|NCT01475136|26398069|FG000|Overall Study|Entry Criteria Not Met|0|||
13260860|NCT01475136|26398070|FG001|Overall Study|Entry Criteria Not Met|2|||
13260861|NCT01475136|26398071|FG002|Overall Study|Entry Criteria Not Met|3|||
13260862|NCT01475136|26398072|FG003|Overall Study|Entry Criteria Not Met|1|||
13260863|NCT01475136|26398069|FG000|Overall Study|Withdrawal by Subject|0|||
13260864|NCT01475136|26398070|FG001|Overall Study|Withdrawal by Subject|0|||
13260865|NCT01475136|26398071|FG002|Overall Study|Withdrawal by Subject|0|||
13260866|NCT01475136|26398072|FG003|Overall Study|Withdrawal by Subject|2|||
13260867|NCT01475136|26398069|FG000|Overall Study|Adverse Event|1|||
13260868|NCT01475136|26398070|FG001|Overall Study|Adverse Event|0|||
13260869|NCT01475136|26398071|FG002|Overall Study|Adverse Event|0|||
13260870|NCT01475136|26398072|FG003|Overall Study|Adverse Event|1|||
13260871|NCT01475136|26398069|FG000|Overall Study|Death|0|||
13260872|NCT01475136|26398070|FG001|Overall Study|Death|0|||
13260873|NCT01475136|26398071|FG002|Overall Study|Death|0|||
13260874|NCT01475136|26398072|FG003|Overall Study|Death|1|||
13260875|NCT01475097|26398087|FG000|Overall Study|Protocol Violation|1|||
13260876|NCT01475097|26398088|FG001|Overall Study|Protocol Violation|1|||
13260877|NCT01475071|26398098|FG000|Overall Study|Physician Decision|1|||
13260878|NCT01475071|26398098|FG000|Overall Study|Withdrawal by Subject|6|||
13260879|NCT01475071|26398098|FG000|Overall Study|Lost to Follow-up|1|||
13260880|NCT01474993|26398133|FG000|Overall Study|Lost to Follow-up|1|||
13260881|NCT01474993|26398134|FG001|Overall Study|Lost to Follow-up|2|||
13260882|NCT01474993|26398133|FG000|Overall Study|Adverse Event|0|||
13260883|NCT01474993|26398134|FG001|Overall Study|Adverse Event|1|||
13260884|NCT01474876|26398175|FG000|Overall Study|Adverse Event|11|||
13260885|NCT01474876|26398176|FG001|Overall Study|Adverse Event|5|||
13260886|NCT01474876|26398177|FG002|Overall Study|Adverse Event|0|||
13260887|NCT01474876|26398175|FG000|Overall Study|Serious Adverse Event|2|||
13260888|NCT01474876|26398176|FG001|Overall Study|Serious Adverse Event|3|||
13260889|NCT01474876|26398177|FG002|Overall Study|Serious Adverse Event|0|||
13260890|NCT01474876|26398175|FG000|Overall Study|Lost to Follow-up|5|||
13260891|NCT01474876|26398176|FG001|Overall Study|Lost to Follow-up|4|||
13260892|NCT01474876|26398177|FG002|Overall Study|Lost to Follow-up|0|||
13260893|NCT01474876|26398175|FG000|Overall Study|Investigator's decision|28|||
13260894|NCT01474876|26398176|FG001|Overall Study|Investigator's decision|6|||
13260895|NCT01474876|26398177|FG002|Overall Study|Investigator's decision|0|||
13260896|NCT01474876|26398175|FG000|Overall Study|Patient's request|19|||
13260897|NCT01474876|26398176|FG001|Overall Study|Patient's request|5|||
13260898|NCT01474876|26398177|FG002|Overall Study|Patient's request|0|||
13260899|NCT01474876|26398175|FG000|Overall Study|Investigator's decision and pt request|1|||
13260900|NCT01474876|26398176|FG001|Overall Study|Investigator's decision and pt request|0|||
13260901|NCT01474876|26398177|FG002|Overall Study|Investigator's decision and pt request|0|||
13260902|NCT01474772|26398232|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6|||
13260903|NCT01474772|26398233|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1|||
13260904|NCT01474772|26398232|FG000|Period 1|AE not Related to Study Drug|1|||
13260905|NCT01474772|26398233|FG001|Period 1|AE not Related to Study Drug|0|||
13260906|NCT01474772|26398232|FG000|Period 1|Withdrawal by Subject|3|||
13260907|NCT01474772|26398233|FG001|Period 1|Withdrawal by Subject|1|||
13260908|NCT01474772|26398232|FG000|Period 1|Lost to Follow-up|1|||
13260909|NCT01474772|26398233|FG001|Period 1|Lost to Follow-up|0|||
13260910|NCT01474772|26398232|FG000|Period 1|Reason not Specified|1|||
13260911|NCT01474772|26398233|FG001|Period 1|Reason not Specified|1|||
13260912|NCT01474772|26398232|FG000|Washout|AE not Related to Study Drug|2|||
13260913|NCT01474772|26398233|FG001|Washout|AE not Related to Study Drug|0|||
13260914|NCT01474772|26398232|FG000|Washout|Withdrawal by Subject|1|||
13260915|NCT01474772|26398233|FG001|Washout|Withdrawal by Subject|0|||
13260916|NCT01474772|26398232|FG000|Washout|Lost to Follow-up|0|||
13260917|NCT01474772|26398233|FG001|Washout|Lost to Follow-up|1|||
13260918|NCT01474772|26398232|FG000|Washout|Reason not Specified|0|||
13260919|NCT01474772|26398233|FG001|Washout|Reason not Specified|1|||
13260920|NCT01474772|26398232|FG000|Period 2|Death|0|||
13260921|NCT01474772|26398233|FG001|Period 2|Death|1|||
13260922|NCT01474772|26398232|FG000|Period 2|AE Related to Study Drug|0|||
13260923|NCT01474772|26398233|FG001|Period 2|AE Related to Study Drug|1|||
13260924|NCT01474772|26398232|FG000|Period 2|AE not Related to Study Drug|4|||
13260925|NCT01474772|26398233|FG001|Period 2|AE not Related to Study Drug|1|||
13260926|NCT01474772|26398232|FG000|Period 2|Lack of Efficacy|1|||
13260927|NCT01474772|26398233|FG001|Period 2|Lack of Efficacy|0|||
13260928|NCT01474772|26398232|FG000|Period 2|Withdrawal by Subject|3|||
13260929|NCT01474772|26398233|FG001|Period 2|Withdrawal by Subject|4|||
13260930|NCT01474772|26398232|FG000|Period 2|Lost to Follow-up|1|||
13260931|NCT01474772|26398233|FG001|Period 2|Lost to Follow-up|1|||
13260932|NCT01474772|26398232|FG000|Period 2|Reason not Specified|0|||
13260933|NCT01474772|26398233|FG001|Period 2|Reason not Specified|2|||
13260934|NCT01474772|26398232|FG000|Follow-up|AE not Related to Study Drug|0|||
13260935|NCT01474772|26398233|FG001|Follow-up|AE not Related to Study Drug|1|||
13260936|NCT01474746|26398302|FG000|Overall Study|Lost to Follow-up|1|||
13260937|NCT01474746|26398303|FG001|Overall Study|Lost to Follow-up|1|||
13260938|NCT01474746|26398302|FG000|Overall Study|Withdrawal by Subject|2|||
13260939|NCT01474746|26398303|FG001|Overall Study|Withdrawal by Subject|1|||
13260940|NCT01474681|26398354|FG000|Overall Study|Death|0|||
13260941|NCT01474681|26398355|FG001|Overall Study|Death|3|||
13260942|NCT01474681|26398356|FG002|Overall Study|Death|2|||
13260943|NCT01474681|26398357|FG003|Overall Study|Death|6|||
13260944|NCT01474551|26398363|FG000|Overall Study|Death|1|||
13260945|NCT01474538|26398384|FG000|Treatment Period 1|Death|1|||
13260946|NCT01474538|26398385|FG001|Treatment Period 1|Death|0|||
13260947|NCT01474538|26398384|FG000|Treatment Period 1|Physician Decision|1|||
13260948|NCT01474538|26398385|FG001|Treatment Period 1|Physician Decision|0|||
13260949|NCT01474538|26398384|FG000|Treatment Period 1|Withdrawal by Subject|1|||
13260950|NCT01474538|26398385|FG001|Treatment Period 1|Withdrawal by Subject|3|||
13260951|NCT01474538|26398384|FG000|Treatment Period 1|Protocol Violation|0|||
13260952|NCT01474538|26398385|FG001|Treatment Period 1|Protocol Violation|1|||
13260953|NCT01474538|26398384|FG000|Treatment Period 2|Death|1|||
13260954|NCT01474538|26398385|FG001|Treatment Period 2|Death|0|||
13260955|NCT01474538|26398384|FG000|Treatment Period 2|Adverse Event|1|||
13260956|NCT01474538|26398385|FG001|Treatment Period 2|Adverse Event|1|||
13260957|NCT01474538|26398384|FG000|Treatment Period 2|Withdrawal by Subject|2|||
13260958|NCT01474538|26398385|FG001|Treatment Period 2|Withdrawal by Subject|0|||
13260959|NCT01474538|26398384|FG000|Treatment Period 2|Sponsor decision|1|||
13260960|NCT01474538|26398385|FG001|Treatment Period 2|Sponsor decision|0|||
13260961|NCT01474538|26398384|FG000|Treatment Period 2|Physician Decision|0|||
13260962|NCT01474538|26398385|FG001|Treatment Period 2|Physician Decision|1|||
13260963|NCT01474538|26398384|FG000|Treatment Period 2|Protocol Violation|1|||
13260964|NCT01474538|26398385|FG001|Treatment Period 2|Protocol Violation|0|||
13260965|NCT01474512|26398482|FG000|Induction Period|Adverse Event|6|||
13260966|NCT01474512|26398483|FG001|Induction Period|Adverse Event|10|||
13260967|NCT01474512|26398484|FG002|Induction Period|Adverse Event|10|||
13260968|NCT01474512|26398485|FG003|Induction Period|Adverse Event|0|||
13260969|NCT01474512|26398486|FG004|Induction Period|Adverse Event|0|||
13260970|NCT01474512|26398487|FG005|Induction Period|Adverse Event|0|||
13260971|NCT01474512|26398488|FG006|Induction Period|Adverse Event|0|||
13260972|NCT01474512|26398489|FG007|Induction Period|Adverse Event|0|||
13260973|NCT01474512|26398490|FG008|Induction Period|Adverse Event|0|||
13260974|NCT01474512|26398491|FG009|Induction Period|Adverse Event|0|||
13260975|NCT01474512|26398492|FG010|Induction Period|Adverse Event|0|||
13260976|NCT01474512|26398493|FG011|Induction Period|Adverse Event|0|||
13260977|NCT01474512|26398494|FG012|Induction Period|Adverse Event|0|||
13260978|NCT01474512|26398495|FG013|Induction Period|Adverse Event|0|||
13260979|NCT01474512|26398496|FG014|Induction Period|Adverse Event|0|||
13260980|NCT01474512|26398497|FG015|Induction Period|Adverse Event|0|||
13260981|NCT01474512|26398498|FG016|Induction Period|Adverse Event|0|||
13260982|NCT01474512|26398499|FG017|Induction Period|Adverse Event|0|||
13260983|NCT01474512|26398482|FG000|Induction Period|Lack of Efficacy|7|||
13260984|NCT01474512|26398483|FG001|Induction Period|Lack of Efficacy|1|||
13260985|NCT01474512|26398484|FG002|Induction Period|Lack of Efficacy|0|||
13260986|NCT01474512|26398485|FG003|Induction Period|Lack of Efficacy|0|||
13260987|NCT01474512|26398486|FG004|Induction Period|Lack of Efficacy|0|||
13260988|NCT01474512|26398487|FG005|Induction Period|Lack of Efficacy|0|||
13260989|NCT01474512|26398488|FG006|Induction Period|Lack of Efficacy|0|||
13260990|NCT01474512|26398489|FG007|Induction Period|Lack of Efficacy|0|||
13260991|NCT01474512|26398490|FG008|Induction Period|Lack of Efficacy|0|||
13260992|NCT01474512|26398491|FG009|Induction Period|Lack of Efficacy|0|||
13260993|NCT01474512|26398492|FG010|Induction Period|Lack of Efficacy|0|||
13260994|NCT01474512|26398493|FG011|Induction Period|Lack of Efficacy|0|||
13260995|NCT01474512|26398494|FG012|Induction Period|Lack of Efficacy|0|||
13260996|NCT01474512|26398495|FG013|Induction Period|Lack of Efficacy|0|||
13260997|NCT01474512|26398496|FG014|Induction Period|Lack of Efficacy|0|||
13260998|NCT01474512|26398497|FG015|Induction Period|Lack of Efficacy|0|||
13260999|NCT01474512|26398498|FG016|Induction Period|Lack of Efficacy|0|||
13261000|NCT01474512|26398499|FG017|Induction Period|Lack of Efficacy|0|||
13261001|NCT01474512|26398482|FG000|Induction Period|Withdrawal by Subject|6|||
13261002|NCT01474512|26398483|FG001|Induction Period|Withdrawal by Subject|6|||
13261003|NCT01474512|26398484|FG002|Induction Period|Withdrawal by Subject|5|||
13261004|NCT01474512|26398485|FG003|Induction Period|Withdrawal by Subject|0|||
13261005|NCT01474512|26398486|FG004|Induction Period|Withdrawal by Subject|0|||
13261006|NCT01474512|26398487|FG005|Induction Period|Withdrawal by Subject|0|||
13261007|NCT01474512|26398488|FG006|Induction Period|Withdrawal by Subject|0|||
13261008|NCT01474512|26398489|FG007|Induction Period|Withdrawal by Subject|0|||
13261009|NCT01474512|26398490|FG008|Induction Period|Withdrawal by Subject|0|||
13261010|NCT01474512|26398491|FG009|Induction Period|Withdrawal by Subject|0|||
13261011|NCT01474512|26398492|FG010|Induction Period|Withdrawal by Subject|0|||
13261012|NCT01474512|26398493|FG011|Induction Period|Withdrawal by Subject|0|||
13261013|NCT01474512|26398494|FG012|Induction Period|Withdrawal by Subject|0|||
13261014|NCT01474512|26398495|FG013|Induction Period|Withdrawal by Subject|0|||
13261015|NCT01474512|26398496|FG014|Induction Period|Withdrawal by Subject|0|||
13261016|NCT01474512|26398497|FG015|Induction Period|Withdrawal by Subject|0|||
13261017|NCT01474512|26398498|FG016|Induction Period|Withdrawal by Subject|0|||
13261018|NCT01474512|26398499|FG017|Induction Period|Withdrawal by Subject|0|||
13261019|NCT01474512|26398482|FG000|Induction Period|Protocol Violation|3|||
13261020|NCT01474512|26398483|FG001|Induction Period|Protocol Violation|6|||
13261021|NCT01474512|26398484|FG002|Induction Period|Protocol Violation|0|||
13261022|NCT01474512|26398485|FG003|Induction Period|Protocol Violation|0|||
13261023|NCT01474512|26398486|FG004|Induction Period|Protocol Violation|0|||
13261024|NCT01474512|26398487|FG005|Induction Period|Protocol Violation|0|||
13261025|NCT01474512|26398488|FG006|Induction Period|Protocol Violation|0|||
13261026|NCT01474512|26398489|FG007|Induction Period|Protocol Violation|0|||
13261027|NCT01474512|26398490|FG008|Induction Period|Protocol Violation|0|||
13261028|NCT01474512|26398491|FG009|Induction Period|Protocol Violation|0|||
13261029|NCT01474512|26398492|FG010|Induction Period|Protocol Violation|0|||
13261030|NCT01474512|26398493|FG011|Induction Period|Protocol Violation|0|||
13261031|NCT01474512|26398494|FG012|Induction Period|Protocol Violation|0|||
13261032|NCT01474512|26398495|FG013|Induction Period|Protocol Violation|0|||
13261033|NCT01474512|26398496|FG014|Induction Period|Protocol Violation|0|||
13261034|NCT01474512|26398497|FG015|Induction Period|Protocol Violation|0|||
13261035|NCT01474512|26398498|FG016|Induction Period|Protocol Violation|0|||
13261036|NCT01474512|26398499|FG017|Induction Period|Protocol Violation|0|||
13261037|NCT01474512|26398482|FG000|Induction Period|Sponsor Decision|1|||
13261038|NCT01474512|26398483|FG001|Induction Period|Sponsor Decision|1|||
13261039|NCT01474512|26398484|FG002|Induction Period|Sponsor Decision|1|||
13261040|NCT01474512|26398485|FG003|Induction Period|Sponsor Decision|0|||
13261041|NCT01474512|26398486|FG004|Induction Period|Sponsor Decision|0|||
13261042|NCT01474512|26398487|FG005|Induction Period|Sponsor Decision|0|||
13261043|NCT01474512|26398488|FG006|Induction Period|Sponsor Decision|0|||
13261044|NCT01474512|26398489|FG007|Induction Period|Sponsor Decision|0|||
13261045|NCT01474512|26398490|FG008|Induction Period|Sponsor Decision|0|||
13261046|NCT01474512|26398491|FG009|Induction Period|Sponsor Decision|0|||
13261047|NCT01474512|26398492|FG010|Induction Period|Sponsor Decision|0|||
13261048|NCT01474512|26398493|FG011|Induction Period|Sponsor Decision|0|||
13261049|NCT01474512|26398494|FG012|Induction Period|Sponsor Decision|0|||
13261050|NCT01474512|26398495|FG013|Induction Period|Sponsor Decision|0|||
13261051|NCT01474512|26398496|FG014|Induction Period|Sponsor Decision|0|||
13261052|NCT01474512|26398497|FG015|Induction Period|Sponsor Decision|0|||
13261053|NCT01474512|26398498|FG016|Induction Period|Sponsor Decision|0|||
13261054|NCT01474512|26398499|FG017|Induction Period|Sponsor Decision|0|||
13261055|NCT01474512|26398482|FG000|Induction Period|Lost to Follow-up|1|||
13261056|NCT01474512|26398483|FG001|Induction Period|Lost to Follow-up|0|||
13261057|NCT01474512|26398484|FG002|Induction Period|Lost to Follow-up|2|||
13261058|NCT01474512|26398485|FG003|Induction Period|Lost to Follow-up|0|||
13261059|NCT01474512|26398486|FG004|Induction Period|Lost to Follow-up|0|||
13261060|NCT01474512|26398487|FG005|Induction Period|Lost to Follow-up|0|||
13261061|NCT01474512|26398488|FG006|Induction Period|Lost to Follow-up|0|||
13261062|NCT01474512|26398489|FG007|Induction Period|Lost to Follow-up|0|||
13261063|NCT01474512|26398490|FG008|Induction Period|Lost to Follow-up|0|||
13261064|NCT01474512|26398491|FG009|Induction Period|Lost to Follow-up|0|||
13261065|NCT01474512|26398492|FG010|Induction Period|Lost to Follow-up|0|||
13261066|NCT01474512|26398493|FG011|Induction Period|Lost to Follow-up|0|||
13261067|NCT01474512|26398494|FG012|Induction Period|Lost to Follow-up|0|||
13261068|NCT01474512|26398495|FG013|Induction Period|Lost to Follow-up|0|||
13261069|NCT01474512|26398496|FG014|Induction Period|Lost to Follow-up|0|||
13261070|NCT01474512|26398497|FG015|Induction Period|Lost to Follow-up|0|||
13261071|NCT01474512|26398498|FG016|Induction Period|Lost to Follow-up|0|||
13261072|NCT01474512|26398499|FG017|Induction Period|Lost to Follow-up|0|||
13261073|NCT01474512|26398482|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0|||
13261074|NCT01474512|26398483|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0|||
13261075|NCT01474512|26398484|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0|||
13261076|NCT01474512|26398485|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186|||
13261077|NCT01474512|26398486|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111|||
13261078|NCT01474512|26398487|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39|||
13261079|NCT01474512|26398488|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9|||
13261080|NCT01474512|26398489|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0|||
13261081|NCT01474512|26398490|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0|||
13261082|NCT01474512|26398491|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0|||
13261083|NCT01474512|26398492|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0|||
13261084|NCT01474512|26398493|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0|||
13261085|NCT01474512|26398494|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0|||
13261086|NCT01474512|26398495|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0|||
13261087|NCT01474512|26398496|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0|||
13261088|NCT01474512|26398497|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0|||
13261089|NCT01474512|26398498|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0|||
13261090|NCT01474512|26398499|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0|||
13261091|NCT01474512|26398482|FG000|Maintenance Period|Adverse Event|0|||
13261092|NCT01474512|26398483|FG001|Maintenance Period|Adverse Event|0|||
13261093|NCT01474512|26398484|FG002|Maintenance Period|Adverse Event|0|||
13261094|NCT01474512|26398485|FG003|Maintenance Period|Adverse Event|4|||
13261095|NCT01474512|26398486|FG004|Maintenance Period|Adverse Event|2|||
13261096|NCT01474512|26398487|FG005|Maintenance Period|Adverse Event|7|||
13261097|NCT01474512|26398488|FG006|Maintenance Period|Adverse Event|0|||
13261098|NCT01474512|26398489|FG007|Maintenance Period|Adverse Event|19|||
13261099|NCT01474512|26398490|FG008|Maintenance Period|Adverse Event|1|||
13261100|NCT01474512|26398491|FG009|Maintenance Period|Adverse Event|3|||
13261101|NCT01474512|26398492|FG010|Maintenance Period|Adverse Event|0|||
13117420|NCT03057600|25925495|FG003|Overall Study|Adverse Event|0|||
13117421|NCT03057600|25925492|FG000|Overall Study|Radiologic Disease Progression|8|||
13117422|NCT03057600|25925493|FG001|Overall Study|Radiologic Disease Progression|7|||
13117423|NCT03057600|25925494|FG002|Overall Study|Radiologic Disease Progression|13|||
13117424|NCT03057600|25925495|FG003|Overall Study|Radiologic Disease Progression|10|||
13117425|NCT03057600|25925492|FG000|Overall Study|Symptomatic Deterioration|0|||
13117426|NCT03057600|25925493|FG001|Overall Study|Symptomatic Deterioration|1|||
13117427|NCT03057600|25925494|FG002|Overall Study|Symptomatic Deterioration|1|||
13117428|NCT03057600|25925495|FG003|Overall Study|Symptomatic Deterioration|0|||
13117429|NCT03057600|25925492|FG000|Overall Study|Investigator Decision|0|||
13117430|NCT03057600|25925493|FG001|Overall Study|Investigator Decision|0|||
13117431|NCT03057600|25925494|FG002|Overall Study|Investigator Decision|1|||
13117432|NCT03057600|25925495|FG003|Overall Study|Investigator Decision|0|||
13117433|NCT03057600|25925492|FG000|Overall Study|Study Termination by Sponsor|0|||
13117434|NCT03057600|25925493|FG001|Overall Study|Study Termination by Sponsor|0|||
13117435|NCT03057600|25925494|FG002|Overall Study|Study Termination by Sponsor|0|||
13261102|NCT01474512|26398493|FG011|Maintenance Period|Adverse Event|0|||
13261103|NCT01474512|26398494|FG012|Maintenance Period|Adverse Event|0|||
13261104|NCT01474512|26398495|FG013|Maintenance Period|Adverse Event|0|||
13261105|NCT01474512|26398496|FG014|Maintenance Period|Adverse Event|0|||
13261106|NCT01474512|26398497|FG015|Maintenance Period|Adverse Event|0|||
13261107|NCT01474512|26398498|FG016|Maintenance Period|Adverse Event|0|||
13261108|NCT01474512|26398499|FG017|Maintenance Period|Adverse Event|0|||
13261109|NCT01474512|26398482|FG000|Maintenance Period|Withdrawal by Subject|0|||
13261110|NCT01474512|26398483|FG001|Maintenance Period|Withdrawal by Subject|0|||
13261111|NCT01474512|26398484|FG002|Maintenance Period|Withdrawal by Subject|0|||
13261112|NCT01474512|26398485|FG003|Maintenance Period|Withdrawal by Subject|6|||
13261113|NCT01474512|26398486|FG004|Maintenance Period|Withdrawal by Subject|2|||
13261114|NCT01474512|26398487|FG005|Maintenance Period|Withdrawal by Subject|3|||
13261115|NCT01474512|26398488|FG006|Maintenance Period|Withdrawal by Subject|1|||
13261116|NCT01474512|26398489|FG007|Maintenance Period|Withdrawal by Subject|6|||
13261117|NCT01474512|26398490|FG008|Maintenance Period|Withdrawal by Subject|3|||
13261118|NCT01474512|26398491|FG009|Maintenance Period|Withdrawal by Subject|1|||
13261119|NCT01474512|26398492|FG010|Maintenance Period|Withdrawal by Subject|0|||
13261120|NCT01474512|26398493|FG011|Maintenance Period|Withdrawal by Subject|0|||
13261121|NCT01474512|26398494|FG012|Maintenance Period|Withdrawal by Subject|0|||
13261122|NCT01474512|26398495|FG013|Maintenance Period|Withdrawal by Subject|0|||
13261123|NCT01474512|26398496|FG014|Maintenance Period|Withdrawal by Subject|0|||
13117436|NCT03057600|25925495|FG003|Overall Study|Study Termination by Sponsor|2|||
13117437|NCT03057600|25925492|FG000|Overall Study|Withdrawal by Subject|0|||
13261124|NCT01474512|26398497|FG015|Maintenance Period|Withdrawal by Subject|0|||
13261125|NCT01474512|26398498|FG016|Maintenance Period|Withdrawal by Subject|0|||
13261126|NCT01474512|26398499|FG017|Maintenance Period|Withdrawal by Subject|0|||
13261127|NCT01474512|26398482|FG000|Maintenance Period|Lost to Follow-up|0|||
13261128|NCT01474512|26398483|FG001|Maintenance Period|Lost to Follow-up|0|||
13261129|NCT01474512|26398484|FG002|Maintenance Period|Lost to Follow-up|0|||
13261130|NCT01474512|26398485|FG003|Maintenance Period|Lost to Follow-up|3|||
13261131|NCT01474512|26398486|FG004|Maintenance Period|Lost to Follow-up|3|||
13261132|NCT01474512|26398487|FG005|Maintenance Period|Lost to Follow-up|0|||
13261133|NCT01474512|26398488|FG006|Maintenance Period|Lost to Follow-up|0|||
13261134|NCT01474512|26398489|FG007|Maintenance Period|Lost to Follow-up|2|||
13261135|NCT01474512|26398490|FG008|Maintenance Period|Lost to Follow-up|1|||
13261136|NCT01474512|26398491|FG009|Maintenance Period|Lost to Follow-up|1|||
13261137|NCT01474512|26398492|FG010|Maintenance Period|Lost to Follow-up|0|||
13261138|NCT01474512|26398493|FG011|Maintenance Period|Lost to Follow-up|0|||
13261139|NCT01474512|26398494|FG012|Maintenance Period|Lost to Follow-up|0|||
13261140|NCT01474512|26398495|FG013|Maintenance Period|Lost to Follow-up|0|||
13261141|NCT01474512|26398496|FG014|Maintenance Period|Lost to Follow-up|0|||
13261142|NCT01474512|26398497|FG015|Maintenance Period|Lost to Follow-up|0|||
13261143|NCT01474512|26398498|FG016|Maintenance Period|Lost to Follow-up|0|||
13261144|NCT01474512|26398499|FG017|Maintenance Period|Lost to Follow-up|0|||
13261145|NCT01474512|26398482|FG000|Maintenance Period|Death|0|||
13261146|NCT01474512|26398483|FG001|Maintenance Period|Death|0|||
13261147|NCT01474512|26398484|FG002|Maintenance Period|Death|0|||
13261148|NCT01474512|26398485|FG003|Maintenance Period|Death|0|||
13261149|NCT01474512|26398486|FG004|Maintenance Period|Death|0|||
13261150|NCT01474512|26398487|FG005|Maintenance Period|Death|2|||
13261151|NCT01474512|26398488|FG006|Maintenance Period|Death|0|||
13261152|NCT01474512|26398489|FG007|Maintenance Period|Death|0|||
13261153|NCT01474512|26398490|FG008|Maintenance Period|Death|0|||
13261154|NCT01474512|26398491|FG009|Maintenance Period|Death|0|||
13261155|NCT01474512|26398492|FG010|Maintenance Period|Death|0|||
13261156|NCT01474512|26398493|FG011|Maintenance Period|Death|0|||
13261157|NCT01474512|26398494|FG012|Maintenance Period|Death|0|||
13261158|NCT01474512|26398495|FG013|Maintenance Period|Death|0|||
13261159|NCT01474512|26398496|FG014|Maintenance Period|Death|0|||
13261160|NCT01474512|26398497|FG015|Maintenance Period|Death|0|||
13261161|NCT01474512|26398498|FG016|Maintenance Period|Death|0|||
13261162|NCT01474512|26398499|FG017|Maintenance Period|Death|0|||
13261163|NCT01474512|26398482|FG000|Maintenance Period|Physician Decision|0|||
13261164|NCT01474512|26398483|FG001|Maintenance Period|Physician Decision|0|||
13261165|NCT01474512|26398484|FG002|Maintenance Period|Physician Decision|0|||
13261166|NCT01474512|26398485|FG003|Maintenance Period|Physician Decision|0|||
13261167|NCT01474512|26398486|FG004|Maintenance Period|Physician Decision|0|||
13261168|NCT01474512|26398487|FG005|Maintenance Period|Physician Decision|1|||
13261169|NCT01474512|26398488|FG006|Maintenance Period|Physician Decision|0|||
13261170|NCT01474512|26398489|FG007|Maintenance Period|Physician Decision|2|||
13261171|NCT01474512|26398490|FG008|Maintenance Period|Physician Decision|0|||
13261172|NCT01474512|26398491|FG009|Maintenance Period|Physician Decision|0|||
13261173|NCT01474512|26398492|FG010|Maintenance Period|Physician Decision|0|||
13261174|NCT01474512|26398493|FG011|Maintenance Period|Physician Decision|0|||
13261175|NCT01474512|26398494|FG012|Maintenance Period|Physician Decision|0|||
13261176|NCT01474512|26398495|FG013|Maintenance Period|Physician Decision|0|||
13261177|NCT01474512|26398496|FG014|Maintenance Period|Physician Decision|0|||
13261178|NCT01474512|26398497|FG015|Maintenance Period|Physician Decision|0|||
13261179|NCT01474512|26398498|FG016|Maintenance Period|Physician Decision|0|||
13261180|NCT01474512|26398499|FG017|Maintenance Period|Physician Decision|0|||
13261181|NCT01474512|26398482|FG000|Maintenance Period|Clinical Relapse|0|||
13261182|NCT01474512|26398483|FG001|Maintenance Period|Clinical Relapse|0|||
13261183|NCT01474512|26398484|FG002|Maintenance Period|Clinical Relapse|0|||
13261184|NCT01474512|26398485|FG003|Maintenance Period|Clinical Relapse|1|||
13261185|NCT01474512|26398486|FG004|Maintenance Period|Clinical Relapse|0|||
13261186|NCT01474512|26398487|FG005|Maintenance Period|Clinical Relapse|0|||
13261187|NCT01474512|26398488|FG006|Maintenance Period|Clinical Relapse|0|||
13261188|NCT01474512|26398489|FG007|Maintenance Period|Clinical Relapse|0|||
13261189|NCT01474512|26398490|FG008|Maintenance Period|Clinical Relapse|0|||
13261190|NCT01474512|26398491|FG009|Maintenance Period|Clinical Relapse|0|||
13261191|NCT01474512|26398492|FG010|Maintenance Period|Clinical Relapse|0|||
13261192|NCT01474512|26398493|FG011|Maintenance Period|Clinical Relapse|0|||
13261193|NCT01474512|26398494|FG012|Maintenance Period|Clinical Relapse|0|||
13261194|NCT01474512|26398495|FG013|Maintenance Period|Clinical Relapse|0|||
13261195|NCT01474512|26398496|FG014|Maintenance Period|Clinical Relapse|0|||
13261196|NCT01474512|26398497|FG015|Maintenance Period|Clinical Relapse|0|||
13261197|NCT01474512|26398498|FG016|Maintenance Period|Clinical Relapse|0|||
13261198|NCT01474512|26398499|FG017|Maintenance Period|Clinical Relapse|0|||
13261199|NCT01474512|26398482|FG000|Maintenance Period|Lack of Efficacy|0|||
13261200|NCT01474512|26398483|FG001|Maintenance Period|Lack of Efficacy|0|||
13261201|NCT01474512|26398484|FG002|Maintenance Period|Lack of Efficacy|0|||
13261202|NCT01474512|26398485|FG003|Maintenance Period|Lack of Efficacy|1|||
13261203|NCT01474512|26398486|FG004|Maintenance Period|Lack of Efficacy|0|||
13261204|NCT01474512|26398487|FG005|Maintenance Period|Lack of Efficacy|0|||
13261205|NCT01474512|26398488|FG006|Maintenance Period|Lack of Efficacy|0|||
13261206|NCT01474512|26398489|FG007|Maintenance Period|Lack of Efficacy|11|||
13261207|NCT01474512|26398490|FG008|Maintenance Period|Lack of Efficacy|11|||
13261208|NCT01474512|26398491|FG009|Maintenance Period|Lack of Efficacy|12|||
13261209|NCT01474512|26398492|FG010|Maintenance Period|Lack of Efficacy|0|||
13261210|NCT01474512|26398493|FG011|Maintenance Period|Lack of Efficacy|0|||
13261211|NCT01474512|26398494|FG012|Maintenance Period|Lack of Efficacy|0|||
13261212|NCT01474512|26398495|FG013|Maintenance Period|Lack of Efficacy|0|||
13261213|NCT01474512|26398496|FG014|Maintenance Period|Lack of Efficacy|0|||
13261214|NCT01474512|26398497|FG015|Maintenance Period|Lack of Efficacy|0|||
13261215|NCT01474512|26398498|FG016|Maintenance Period|Lack of Efficacy|0|||
13261216|NCT01474512|26398499|FG017|Maintenance Period|Lack of Efficacy|0|||
13261217|NCT01474512|26398482|FG000|Maintenance Period|Protocol Violation|0|||
13261218|NCT01474512|26398483|FG001|Maintenance Period|Protocol Violation|0|||
13261219|NCT01474512|26398484|FG002|Maintenance Period|Protocol Violation|0|||
13261220|NCT01474512|26398485|FG003|Maintenance Period|Protocol Violation|1|||
13261221|NCT01474512|26398486|FG004|Maintenance Period|Protocol Violation|0|||
13261222|NCT01474512|26398487|FG005|Maintenance Period|Protocol Violation|0|||
13261223|NCT01474512|26398488|FG006|Maintenance Period|Protocol Violation|0|||
13261224|NCT01474512|26398489|FG007|Maintenance Period|Protocol Violation|1|||
13261225|NCT01474512|26398490|FG008|Maintenance Period|Protocol Violation|0|||
13261226|NCT01474512|26398491|FG009|Maintenance Period|Protocol Violation|1|||
13261227|NCT01474512|26398492|FG010|Maintenance Period|Protocol Violation|0|||
13261228|NCT01474512|26398493|FG011|Maintenance Period|Protocol Violation|0|||
13261229|NCT01474512|26398494|FG012|Maintenance Period|Protocol Violation|0|||
13261230|NCT01474512|26398495|FG013|Maintenance Period|Protocol Violation|0|||
13261231|NCT01474512|26398496|FG014|Maintenance Period|Protocol Violation|0|||
13261232|NCT01474512|26398497|FG015|Maintenance Period|Protocol Violation|0|||
13261233|NCT01474512|26398498|FG016|Maintenance Period|Protocol Violation|0|||
13261234|NCT01474512|26398499|FG017|Maintenance Period|Protocol Violation|0|||
13261235|NCT01474512|26398482|FG000|Maintenance Period|Treated but Discontinued in Induction|0|||
13261236|NCT01474512|26398483|FG001|Maintenance Period|Treated but Discontinued in Induction|0|||
13261237|NCT01474512|26398484|FG002|Maintenance Period|Treated but Discontinued in Induction|0|||
13261238|NCT01474512|26398485|FG003|Maintenance Period|Treated but Discontinued in Induction|0|||
13261239|NCT01474512|26398486|FG004|Maintenance Period|Treated but Discontinued in Induction|1|||
13261240|NCT01474512|26398487|FG005|Maintenance Period|Treated but Discontinued in Induction|0|||
13261241|NCT01474512|26398488|FG006|Maintenance Period|Treated but Discontinued in Induction|0|||
13261242|NCT01474512|26398489|FG007|Maintenance Period|Treated but Discontinued in Induction|0|||
13261243|NCT01474512|26398490|FG008|Maintenance Period|Treated but Discontinued in Induction|0|||
13261244|NCT01474512|26398491|FG009|Maintenance Period|Treated but Discontinued in Induction|0|||
13261245|NCT01474512|26398492|FG010|Maintenance Period|Treated but Discontinued in Induction|0|||
13261246|NCT01474512|26398493|FG011|Maintenance Period|Treated but Discontinued in Induction|0|||
13261247|NCT01474512|26398494|FG012|Maintenance Period|Treated but Discontinued in Induction|0|||
13261248|NCT01474512|26398495|FG013|Maintenance Period|Treated but Discontinued in Induction|0|||
13261249|NCT01474512|26398496|FG014|Maintenance Period|Treated but Discontinued in Induction|0|||
13261250|NCT01474512|26398497|FG015|Maintenance Period|Treated but Discontinued in Induction|0|||
13261251|NCT01474512|26398498|FG016|Maintenance Period|Treated but Discontinued in Induction|0|||
13261252|NCT01474512|26398499|FG017|Maintenance Period|Treated but Discontinued in Induction|0|||
13261253|NCT01474512|26398482|FG000|Long-Term Extension Period|Withdrawal by Subject|0|||
13261254|NCT01474512|26398483|FG001|Long-Term Extension Period|Withdrawal by Subject|0|||
13261255|NCT01474512|26398484|FG002|Long-Term Extension Period|Withdrawal by Subject|0|||
13261256|NCT01474512|26398485|FG003|Long-Term Extension Period|Withdrawal by Subject|0|||
13261257|NCT01474512|26398486|FG004|Long-Term Extension Period|Withdrawal by Subject|0|||
13261258|NCT01474512|26398487|FG005|Long-Term Extension Period|Withdrawal by Subject|0|||
13261259|NCT01474512|26398488|FG006|Long-Term Extension Period|Withdrawal by Subject|0|||
13261260|NCT01474512|26398489|FG007|Long-Term Extension Period|Withdrawal by Subject|0|||
13261261|NCT01474512|26398490|FG008|Long-Term Extension Period|Withdrawal by Subject|0|||
13261262|NCT01474512|26398491|FG009|Long-Term Extension Period|Withdrawal by Subject|0|||
13261263|NCT01474512|26398492|FG010|Long-Term Extension Period|Withdrawal by Subject|0|||
13261264|NCT01474512|26398493|FG011|Long-Term Extension Period|Withdrawal by Subject|3|||
13261265|NCT01474512|26398494|FG012|Long-Term Extension Period|Withdrawal by Subject|61|||
13261266|NCT01474512|26398495|FG013|Long-Term Extension Period|Withdrawal by Subject|61|||
13261267|NCT01474512|26398496|FG014|Long-Term Extension Period|Withdrawal by Subject|0|||
13261268|NCT01474512|26398497|FG015|Long-Term Extension Period|Withdrawal by Subject|0|||
13261269|NCT01474512|26398498|FG016|Long-Term Extension Period|Withdrawal by Subject|0|||
13261270|NCT01474512|26398499|FG017|Long-Term Extension Period|Withdrawal by Subject|0|||
13261271|NCT01474512|26398482|FG000|Long-Term Extension Period|Adverse Event|0|||
13261272|NCT01474512|26398483|FG001|Long-Term Extension Period|Adverse Event|0|||
13261273|NCT01474512|26398484|FG002|Long-Term Extension Period|Adverse Event|0|||
13261274|NCT01474512|26398485|FG003|Long-Term Extension Period|Adverse Event|0|||
13261275|NCT01474512|26398486|FG004|Long-Term Extension Period|Adverse Event|0|||
13261276|NCT01474512|26398487|FG005|Long-Term Extension Period|Adverse Event|0|||
13261277|NCT01474512|26398488|FG006|Long-Term Extension Period|Adverse Event|0|||
13261278|NCT01474512|26398489|FG007|Long-Term Extension Period|Adverse Event|0|||
13261279|NCT01474512|26398490|FG008|Long-Term Extension Period|Adverse Event|0|||
13261280|NCT01474512|26398491|FG009|Long-Term Extension Period|Adverse Event|0|||
13261281|NCT01474512|26398492|FG010|Long-Term Extension Period|Adverse Event|0|||
13261282|NCT01474512|26398493|FG011|Long-Term Extension Period|Adverse Event|1|||
13261283|NCT01474512|26398494|FG012|Long-Term Extension Period|Adverse Event|57|||
13261284|NCT01474512|26398495|FG013|Long-Term Extension Period|Adverse Event|58|||
13261285|NCT01474512|26398496|FG014|Long-Term Extension Period|Adverse Event|0|||
13261286|NCT01474512|26398497|FG015|Long-Term Extension Period|Adverse Event|0|||
13261287|NCT01474512|26398498|FG016|Long-Term Extension Period|Adverse Event|0|||
13261288|NCT01474512|26398499|FG017|Long-Term Extension Period|Adverse Event|0|||
13261289|NCT01474512|26398482|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
13261290|NCT01474512|26398483|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
13261291|NCT01474512|26398484|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
13261292|NCT01474512|26398485|FG003|Long-Term Extension Period|Lost to Follow-up|0|||
13261293|NCT01474512|26398486|FG004|Long-Term Extension Period|Lost to Follow-up|0|||
13261294|NCT01474512|26398487|FG005|Long-Term Extension Period|Lost to Follow-up|0|||
13261295|NCT01474512|26398488|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
13261296|NCT01474512|26398489|FG007|Long-Term Extension Period|Lost to Follow-up|0|||
13261297|NCT01474512|26398490|FG008|Long-Term Extension Period|Lost to Follow-up|0|||
13261298|NCT01474512|26398491|FG009|Long-Term Extension Period|Lost to Follow-up|0|||
13261299|NCT01474512|26398492|FG010|Long-Term Extension Period|Lost to Follow-up|0|||
13261300|NCT01474512|26398493|FG011|Long-Term Extension Period|Lost to Follow-up|0|||
13261301|NCT01474512|26398494|FG012|Long-Term Extension Period|Lost to Follow-up|25|||
13261302|NCT01474512|26398495|FG013|Long-Term Extension Period|Lost to Follow-up|25|||
13261303|NCT01474512|26398496|FG014|Long-Term Extension Period|Lost to Follow-up|0|||
13261304|NCT01474512|26398497|FG015|Long-Term Extension Period|Lost to Follow-up|0|||
13261305|NCT01474512|26398498|FG016|Long-Term Extension Period|Lost to Follow-up|0|||
13261306|NCT01474512|26398499|FG017|Long-Term Extension Period|Lost to Follow-up|0|||
13261307|NCT01474512|26398482|FG000|Long-Term Extension Period|Lack of Efficacy|0|||
13261308|NCT01474512|26398483|FG001|Long-Term Extension Period|Lack of Efficacy|0|||
13261309|NCT01474512|26398484|FG002|Long-Term Extension Period|Lack of Efficacy|0|||
13261310|NCT01474512|26398485|FG003|Long-Term Extension Period|Lack of Efficacy|0|||
13261311|NCT01474512|26398486|FG004|Long-Term Extension Period|Lack of Efficacy|0|||
13261312|NCT01474512|26398487|FG005|Long-Term Extension Period|Lack of Efficacy|0|||
13261313|NCT01474512|26398488|FG006|Long-Term Extension Period|Lack of Efficacy|0|||
13261314|NCT01474512|26398489|FG007|Long-Term Extension Period|Lack of Efficacy|0|||
13261315|NCT01474512|26398490|FG008|Long-Term Extension Period|Lack of Efficacy|0|||
13261316|NCT01474512|26398491|FG009|Long-Term Extension Period|Lack of Efficacy|0|||
13261317|NCT01474512|26398492|FG010|Long-Term Extension Period|Lack of Efficacy|0|||
13261318|NCT01474512|26398493|FG011|Long-Term Extension Period|Lack of Efficacy|1|||
13261319|NCT01474512|26398494|FG012|Long-Term Extension Period|Lack of Efficacy|24|||
13261320|NCT01474512|26398495|FG013|Long-Term Extension Period|Lack of Efficacy|25|||
13261321|NCT01474512|26398496|FG014|Long-Term Extension Period|Lack of Efficacy|0|||
13261322|NCT01474512|26398497|FG015|Long-Term Extension Period|Lack of Efficacy|0|||
13261323|NCT01474512|26398498|FG016|Long-Term Extension Period|Lack of Efficacy|0|||
13261324|NCT01474512|26398499|FG017|Long-Term Extension Period|Lack of Efficacy|0|||
13261325|NCT01474512|26398482|FG000|Long-Term Extension Period|Physician Decision|0|||
13261326|NCT01474512|26398483|FG001|Long-Term Extension Period|Physician Decision|0|||
13261327|NCT01474512|26398484|FG002|Long-Term Extension Period|Physician Decision|0|||
13261328|NCT01474512|26398485|FG003|Long-Term Extension Period|Physician Decision|0|||
13261329|NCT01474512|26398486|FG004|Long-Term Extension Period|Physician Decision|0|||
13261330|NCT01474512|26398487|FG005|Long-Term Extension Period|Physician Decision|0|||
13261331|NCT01474512|26398488|FG006|Long-Term Extension Period|Physician Decision|0|||
13261332|NCT01474512|26398489|FG007|Long-Term Extension Period|Physician Decision|0|||
13261333|NCT01474512|26398490|FG008|Long-Term Extension Period|Physician Decision|0|||
13261334|NCT01474512|26398491|FG009|Long-Term Extension Period|Physician Decision|0|||
13261335|NCT01474512|26398492|FG010|Long-Term Extension Period|Physician Decision|0|||
13261336|NCT01474512|26398493|FG011|Long-Term Extension Period|Physician Decision|0|||
13261337|NCT01474512|26398494|FG012|Long-Term Extension Period|Physician Decision|21|||
13261338|NCT01474512|26398495|FG013|Long-Term Extension Period|Physician Decision|21|||
13261339|NCT01474512|26398496|FG014|Long-Term Extension Period|Physician Decision|0|||
13261340|NCT01474512|26398497|FG015|Long-Term Extension Period|Physician Decision|0|||
13261341|NCT01474512|26398498|FG016|Long-Term Extension Period|Physician Decision|0|||
13261342|NCT01474512|26398499|FG017|Long-Term Extension Period|Physician Decision|0|||
13261343|NCT01474512|26398482|FG000|Long-Term Extension Period|Clinical Relapse|0|||
13261344|NCT01474512|26398483|FG001|Long-Term Extension Period|Clinical Relapse|0|||
13261345|NCT01474512|26398484|FG002|Long-Term Extension Period|Clinical Relapse|0|||
13261346|NCT01474512|26398485|FG003|Long-Term Extension Period|Clinical Relapse|0|||
13261347|NCT01474512|26398486|FG004|Long-Term Extension Period|Clinical Relapse|0|||
13261348|NCT01474512|26398487|FG005|Long-Term Extension Period|Clinical Relapse|0|||
13261349|NCT01474512|26398488|FG006|Long-Term Extension Period|Clinical Relapse|0|||
13261350|NCT01474512|26398489|FG007|Long-Term Extension Period|Clinical Relapse|0|||
13261351|NCT01474512|26398490|FG008|Long-Term Extension Period|Clinical Relapse|0|||
13290500|NCT00102440|26481269|FG001|Overall Study|Protocol Violation|2|||
13261352|NCT01474512|26398491|FG009|Long-Term Extension Period|Clinical Relapse|0|||
13261353|NCT01474512|26398492|FG010|Long-Term Extension Period|Clinical Relapse|0|||
13261354|NCT01474512|26398493|FG011|Long-Term Extension Period|Clinical Relapse|0|||
13261355|NCT01474512|26398494|FG012|Long-Term Extension Period|Clinical Relapse|9|||
13261356|NCT01474512|26398495|FG013|Long-Term Extension Period|Clinical Relapse|9|||
13261357|NCT01474512|26398496|FG014|Long-Term Extension Period|Clinical Relapse|0|||
13261358|NCT01474512|26398497|FG015|Long-Term Extension Period|Clinical Relapse|0|||
13261359|NCT01474512|26398498|FG016|Long-Term Extension Period|Clinical Relapse|0|||
13261360|NCT01474512|26398499|FG017|Long-Term Extension Period|Clinical Relapse|0|||
13261361|NCT01474512|26398482|FG000|Long-Term Extension Period|Death|0|||
13261362|NCT01474512|26398483|FG001|Long-Term Extension Period|Death|0|||
13261363|NCT01474512|26398484|FG002|Long-Term Extension Period|Death|0|||
13261364|NCT01474512|26398485|FG003|Long-Term Extension Period|Death|0|||
13261365|NCT01474512|26398486|FG004|Long-Term Extension Period|Death|0|||
13261366|NCT01474512|26398487|FG005|Long-Term Extension Period|Death|0|||
13261367|NCT01474512|26398488|FG006|Long-Term Extension Period|Death|0|||
13261368|NCT01474512|26398489|FG007|Long-Term Extension Period|Death|0|||
13261369|NCT01474512|26398490|FG008|Long-Term Extension Period|Death|0|||
13261370|NCT01474512|26398491|FG009|Long-Term Extension Period|Death|0|||
13261371|NCT01474512|26398492|FG010|Long-Term Extension Period|Death|0|||
13261372|NCT01474512|26398493|FG011|Long-Term Extension Period|Death|0|||
13261373|NCT01474512|26398494|FG012|Long-Term Extension Period|Death|9|||
13261374|NCT01474512|26398495|FG013|Long-Term Extension Period|Death|9|||
13261375|NCT01474512|26398496|FG014|Long-Term Extension Period|Death|0|||
13261376|NCT01474512|26398497|FG015|Long-Term Extension Period|Death|0|||
13261377|NCT01474512|26398498|FG016|Long-Term Extension Period|Death|0|||
13261378|NCT01474512|26398499|FG017|Long-Term Extension Period|Death|0|||
13261379|NCT01474512|26398482|FG000|Long-Term Extension Period|Sponsor Decision|0|||
13261380|NCT01474512|26398483|FG001|Long-Term Extension Period|Sponsor Decision|0|||
13261381|NCT01474512|26398484|FG002|Long-Term Extension Period|Sponsor Decision|0|||
13261382|NCT01474512|26398485|FG003|Long-Term Extension Period|Sponsor Decision|0|||
13261383|NCT01474512|26398486|FG004|Long-Term Extension Period|Sponsor Decision|0|||
13261384|NCT01474512|26398487|FG005|Long-Term Extension Period|Sponsor Decision|0|||
13261385|NCT01474512|26398488|FG006|Long-Term Extension Period|Sponsor Decision|0|||
13261386|NCT01474512|26398489|FG007|Long-Term Extension Period|Sponsor Decision|0|||
13261387|NCT01474512|26398490|FG008|Long-Term Extension Period|Sponsor Decision|0|||
13261388|NCT01474512|26398491|FG009|Long-Term Extension Period|Sponsor Decision|0|||
13261389|NCT01474512|26398492|FG010|Long-Term Extension Period|Sponsor Decision|0|||
13261390|NCT01474512|26398493|FG011|Long-Term Extension Period|Sponsor Decision|0|||
13261391|NCT01474512|26398494|FG012|Long-Term Extension Period|Sponsor Decision|6|||
13261392|NCT01474512|26398495|FG013|Long-Term Extension Period|Sponsor Decision|6|||
13261393|NCT01474512|26398496|FG014|Long-Term Extension Period|Sponsor Decision|0|||
13261394|NCT01474512|26398497|FG015|Long-Term Extension Period|Sponsor Decision|0|||
13261395|NCT01474512|26398498|FG016|Long-Term Extension Period|Sponsor Decision|0|||
13261396|NCT01474512|26398499|FG017|Long-Term Extension Period|Sponsor Decision|0|||
13261397|NCT01474512|26398482|FG000|Long-Term Extension Period|Protocol Violation|0|||
13261398|NCT01474512|26398483|FG001|Long-Term Extension Period|Protocol Violation|0|||
13261399|NCT01474512|26398484|FG002|Long-Term Extension Period|Protocol Violation|0|||
13261400|NCT01474512|26398485|FG003|Long-Term Extension Period|Protocol Violation|0|||
13261401|NCT01474512|26398486|FG004|Long-Term Extension Period|Protocol Violation|0|||
13261402|NCT01474512|26398487|FG005|Long-Term Extension Period|Protocol Violation|0|||
13261403|NCT01474512|26398488|FG006|Long-Term Extension Period|Protocol Violation|0|||
13261404|NCT01474512|26398489|FG007|Long-Term Extension Period|Protocol Violation|0|||
13261405|NCT01474512|26398490|FG008|Long-Term Extension Period|Protocol Violation|0|||
13261406|NCT01474512|26398491|FG009|Long-Term Extension Period|Protocol Violation|0|||
13261407|NCT01474512|26398492|FG010|Long-Term Extension Period|Protocol Violation|0|||
13261408|NCT01474512|26398493|FG011|Long-Term Extension Period|Protocol Violation|0|||
13261409|NCT01474512|26398494|FG012|Long-Term Extension Period|Protocol Violation|5|||
13261410|NCT01474512|26398495|FG013|Long-Term Extension Period|Protocol Violation|5|||
13261411|NCT01474512|26398496|FG014|Long-Term Extension Period|Protocol Violation|0|||
13261412|NCT01474512|26398497|FG015|Long-Term Extension Period|Protocol Violation|0|||
13261413|NCT01474512|26398498|FG016|Long-Term Extension Period|Protocol Violation|0|||
13261414|NCT01474512|26398499|FG017|Long-Term Extension Period|Protocol Violation|0|||
13261415|NCT01474512|26398482|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0|||
13261416|NCT01474512|26398483|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0|||
13261417|NCT01474512|26398484|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0|||
13261418|NCT01474512|26398485|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0|||
13261419|NCT01474512|26398486|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0|||
13261420|NCT01474512|26398487|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0|||
13261421|NCT01474512|26398488|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0|||
13261422|NCT01474512|26398489|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0|||
13261423|NCT01474512|26398490|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0|||
13261424|NCT01474512|26398491|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0|||
13261425|NCT01474512|26398492|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0|||
13261426|NCT01474512|26398493|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0|||
13261427|NCT01474512|26398494|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1|||
13261428|NCT01474512|26398495|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1|||
13261429|NCT01474512|26398496|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0|||
13261430|NCT01474512|26398497|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0|||
13261431|NCT01474512|26398498|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0|||
13261432|NCT01474512|26398499|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0|||
13261433|NCT01474512|26398482|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0|||
13261434|NCT01474512|26398483|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0|||
13261435|NCT01474512|26398484|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0|||
13261436|NCT01474512|26398485|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0|||
13261437|NCT01474512|26398486|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0|||
13261438|NCT01474512|26398487|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0|||
13261439|NCT01474512|26398488|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0|||
13261440|NCT01474512|26398489|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0|||
13261441|NCT01474512|26398490|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0|||
13261442|NCT01474512|26398491|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0|||
13261443|NCT01474512|26398492|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0|||
13261444|NCT01474512|26398493|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21|||
13261445|NCT01474512|26398494|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0|||
13261446|NCT01474512|26398495|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0|||
13261447|NCT01474512|26398496|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0|||
13261448|NCT01474512|26398497|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0|||
13261449|NCT01474512|26398498|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0|||
13261450|NCT01474512|26398499|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0|||
13261451|NCT01474512|26398482|FG000|Post-Treatment Follow-Up|Adverse Event|0|||
13261452|NCT01474512|26398483|FG001|Post-Treatment Follow-Up|Adverse Event|0|||
13261453|NCT01474512|26398484|FG002|Post-Treatment Follow-Up|Adverse Event|0|||
13261454|NCT01474512|26398485|FG003|Post-Treatment Follow-Up|Adverse Event|0|||
13261455|NCT01474512|26398486|FG004|Post-Treatment Follow-Up|Adverse Event|0|||
13261456|NCT01474512|26398487|FG005|Post-Treatment Follow-Up|Adverse Event|0|||
13261457|NCT01474512|26398488|FG006|Post-Treatment Follow-Up|Adverse Event|0|||
13261458|NCT01474512|26398489|FG007|Post-Treatment Follow-Up|Adverse Event|0|||
13261459|NCT01474512|26398490|FG008|Post-Treatment Follow-Up|Adverse Event|0|||
13261460|NCT01474512|26398491|FG009|Post-Treatment Follow-Up|Adverse Event|0|||
13261461|NCT01474512|26398492|FG010|Post-Treatment Follow-Up|Adverse Event|0|||
13261462|NCT01474512|26398493|FG011|Post-Treatment Follow-Up|Adverse Event|0|||
13261463|NCT01474512|26398494|FG012|Post-Treatment Follow-Up|Adverse Event|0|||
13261464|NCT01474512|26398495|FG013|Post-Treatment Follow-Up|Adverse Event|0|||
13117438|NCT03057600|25925493|FG001|Overall Study|Withdrawal by Subject|1|||
13117439|NCT03057600|25925494|FG002|Overall Study|Withdrawal by Subject|0|||
13117440|NCT03057600|25925495|FG003|Overall Study|Withdrawal by Subject|0|||
13117441|NCT03057600|25925492|FG000|Overall Study|Other, Not Specified|1|||
13117442|NCT03057600|25925493|FG001|Overall Study|Other, Not Specified|1|||
13117443|NCT03057600|25925494|FG002|Overall Study|Other, Not Specified|1|||
13117444|NCT03057600|25925495|FG003|Overall Study|Other, Not Specified|1|||
13117445|NCT03057496|25925505|FG000|Overall Study|Withdrawal by Subject|8|||
13117446|NCT03057496|25925505|FG000|Overall Study|Lost to Follow-up|5|||
13261465|NCT01474512|26398496|FG014|Post-Treatment Follow-Up|Adverse Event|8|||
13261466|NCT01474512|26398497|FG015|Post-Treatment Follow-Up|Adverse Event|2|||
13261467|NCT01474512|26398498|FG016|Post-Treatment Follow-Up|Adverse Event|58|||
13261468|NCT01474512|26398499|FG017|Post-Treatment Follow-Up|Adverse Event|11|||
13261469|NCT01474512|26398482|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
13261470|NCT01474512|26398483|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
13261471|NCT01474512|26398484|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
13261472|NCT01474512|26398485|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
13261473|NCT01474512|26398486|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
13261474|NCT01474512|26398487|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
13261475|NCT01474512|26398488|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
13261476|NCT01474512|26398489|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
13261477|NCT01474512|26398490|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
13261478|NCT01474512|26398491|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
13261479|NCT01474512|26398492|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
13261480|NCT01474512|26398493|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
13261481|NCT01474512|26398494|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
13261482|NCT01474512|26398495|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
13117447|NCT03057496|25925505|FG000|Overall Study|Did not use device during home trial|3|||
13117448|NCT03057496|25925505|FG000|Overall Study|Device failure|2|||
13261483|NCT01474512|26398496|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3|||
13261484|NCT01474512|26398497|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2|||
13261485|NCT01474512|26398498|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36|||
13261486|NCT01474512|26398499|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17|||
13261487|NCT01474512|26398482|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0|||
13261488|NCT01474512|26398483|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0|||
13261489|NCT01474512|26398484|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0|||
13261490|NCT01474512|26398485|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0|||
13261491|NCT01474512|26398486|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0|||
13261492|NCT01474512|26398487|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0|||
13261493|NCT01474512|26398488|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0|||
13261494|NCT01474512|26398489|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0|||
13261495|NCT01474512|26398490|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0|||
13261496|NCT01474512|26398491|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0|||
13261497|NCT01474512|26398492|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0|||
13261498|NCT01474512|26398493|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0|||
13261499|NCT01474512|26398494|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0|||
13261500|NCT01474512|26398495|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0|||
13261501|NCT01474512|26398496|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3|||
13261502|NCT01474512|26398497|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2|||
13261503|NCT01474512|26398498|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31|||
13261504|NCT01474512|26398499|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3|||
13261505|NCT01474512|26398482|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0|||
13261506|NCT01474512|26398483|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0|||
13261507|NCT01474512|26398484|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0|||
13261508|NCT01474512|26398485|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0|||
13261509|NCT01474512|26398486|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0|||
13261510|NCT01474512|26398487|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0|||
13261511|NCT01474512|26398488|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0|||
13261512|NCT01474512|26398489|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0|||
13261513|NCT01474512|26398490|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0|||
13261514|NCT01474512|26398491|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0|||
13261515|NCT01474512|26398492|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0|||
13261516|NCT01474512|26398493|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0|||
13261517|NCT01474512|26398494|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0|||
13261518|NCT01474512|26398495|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0|||
13261519|NCT01474512|26398496|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0|||
13261520|NCT01474512|26398497|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0|||
13261521|NCT01474512|26398498|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12|||
13261522|NCT01474512|26398499|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7|||
13261523|NCT01474512|26398482|FG000|Post-Treatment Follow-Up|Physician Decision|0|||
13261524|NCT01474512|26398483|FG001|Post-Treatment Follow-Up|Physician Decision|0|||
13261525|NCT01474512|26398484|FG002|Post-Treatment Follow-Up|Physician Decision|0|||
13261526|NCT01474512|26398485|FG003|Post-Treatment Follow-Up|Physician Decision|0|||
13261527|NCT01474512|26398486|FG004|Post-Treatment Follow-Up|Physician Decision|0|||
13261528|NCT01474512|26398487|FG005|Post-Treatment Follow-Up|Physician Decision|0|||
13261529|NCT01474512|26398488|FG006|Post-Treatment Follow-Up|Physician Decision|0|||
13261530|NCT01474512|26398489|FG007|Post-Treatment Follow-Up|Physician Decision|0|||
13261531|NCT01474512|26398490|FG008|Post-Treatment Follow-Up|Physician Decision|0|||
13261532|NCT01474512|26398491|FG009|Post-Treatment Follow-Up|Physician Decision|0|||
13261533|NCT01474512|26398492|FG010|Post-Treatment Follow-Up|Physician Decision|0|||
13261534|NCT01474512|26398493|FG011|Post-Treatment Follow-Up|Physician Decision|0|||
13261535|NCT01474512|26398494|FG012|Post-Treatment Follow-Up|Physician Decision|0|||
13261536|NCT01474512|26398495|FG013|Post-Treatment Follow-Up|Physician Decision|0|||
13261537|NCT01474512|26398496|FG014|Post-Treatment Follow-Up|Physician Decision|0|||
13261538|NCT01474512|26398497|FG015|Post-Treatment Follow-Up|Physician Decision|0|||
13261539|NCT01474512|26398498|FG016|Post-Treatment Follow-Up|Physician Decision|4|||
13261540|NCT01474512|26398499|FG017|Post-Treatment Follow-Up|Physician Decision|5|||
13261541|NCT01474512|26398482|FG000|Post-Treatment Follow-Up|Clinical Relapse|0|||
13261542|NCT01474512|26398483|FG001|Post-Treatment Follow-Up|Clinical Relapse|0|||
13261543|NCT01474512|26398484|FG002|Post-Treatment Follow-Up|Clinical Relapse|0|||
13261544|NCT01474512|26398485|FG003|Post-Treatment Follow-Up|Clinical Relapse|0|||
13261545|NCT01474512|26398486|FG004|Post-Treatment Follow-Up|Clinical Relapse|0|||
13261546|NCT01474512|26398487|FG005|Post-Treatment Follow-Up|Clinical Relapse|0|||
13261547|NCT01474512|26398488|FG006|Post-Treatment Follow-Up|Clinical Relapse|0|||
13261548|NCT01474512|26398489|FG007|Post-Treatment Follow-Up|Clinical Relapse|0|||
13261549|NCT01474512|26398490|FG008|Post-Treatment Follow-Up|Clinical Relapse|0|||
13261550|NCT01474512|26398491|FG009|Post-Treatment Follow-Up|Clinical Relapse|0|||
13261551|NCT01474512|26398492|FG010|Post-Treatment Follow-Up|Clinical Relapse|0|||
13261552|NCT01474512|26398493|FG011|Post-Treatment Follow-Up|Clinical Relapse|0|||
13261553|NCT01474512|26398494|FG012|Post-Treatment Follow-Up|Clinical Relapse|0|||
13261554|NCT01474512|26398495|FG013|Post-Treatment Follow-Up|Clinical Relapse|0|||
13261555|NCT01474512|26398496|FG014|Post-Treatment Follow-Up|Clinical Relapse|0|||
13261556|NCT01474512|26398497|FG015|Post-Treatment Follow-Up|Clinical Relapse|0|||
13261557|NCT01474512|26398498|FG016|Post-Treatment Follow-Up|Clinical Relapse|6|||
13261558|NCT01474512|26398499|FG017|Post-Treatment Follow-Up|Clinical Relapse|2|||
13261559|NCT01474512|26398482|FG000|Post-Treatment Follow-Up|Protocol Violation|0|||
13261560|NCT01474512|26398483|FG001|Post-Treatment Follow-Up|Protocol Violation|0|||
13261561|NCT01474512|26398484|FG002|Post-Treatment Follow-Up|Protocol Violation|0|||
13261562|NCT01474512|26398485|FG003|Post-Treatment Follow-Up|Protocol Violation|0|||
13261563|NCT01474512|26398486|FG004|Post-Treatment Follow-Up|Protocol Violation|0|||
13261564|NCT01474512|26398487|FG005|Post-Treatment Follow-Up|Protocol Violation|0|||
13261565|NCT01474512|26398488|FG006|Post-Treatment Follow-Up|Protocol Violation|0|||
13261566|NCT01474512|26398489|FG007|Post-Treatment Follow-Up|Protocol Violation|0|||
13261567|NCT01474512|26398490|FG008|Post-Treatment Follow-Up|Protocol Violation|0|||
13261568|NCT01474512|26398491|FG009|Post-Treatment Follow-Up|Protocol Violation|0|||
13261569|NCT01474512|26398492|FG010|Post-Treatment Follow-Up|Protocol Violation|0|||
13261570|NCT01474512|26398493|FG011|Post-Treatment Follow-Up|Protocol Violation|0|||
13261571|NCT01474512|26398494|FG012|Post-Treatment Follow-Up|Protocol Violation|0|||
13261572|NCT01474512|26398495|FG013|Post-Treatment Follow-Up|Protocol Violation|0|||
13261573|NCT01474512|26398496|FG014|Post-Treatment Follow-Up|Protocol Violation|2|||
13261574|NCT01474512|26398497|FG015|Post-Treatment Follow-Up|Protocol Violation|2|||
13261575|NCT01474512|26398498|FG016|Post-Treatment Follow-Up|Protocol Violation|4|||
13261576|NCT01474512|26398499|FG017|Post-Treatment Follow-Up|Protocol Violation|0|||
13261577|NCT01474512|26398482|FG000|Post-Treatment Follow-Up|Sponsor Decision|0|||
13261578|NCT01474512|26398483|FG001|Post-Treatment Follow-Up|Sponsor Decision|0|||
13261579|NCT01474512|26398484|FG002|Post-Treatment Follow-Up|Sponsor Decision|0|||
13261580|NCT01474512|26398485|FG003|Post-Treatment Follow-Up|Sponsor Decision|0|||
13261581|NCT01474512|26398486|FG004|Post-Treatment Follow-Up|Sponsor Decision|0|||
13261582|NCT01474512|26398487|FG005|Post-Treatment Follow-Up|Sponsor Decision|0|||
13261583|NCT01474512|26398488|FG006|Post-Treatment Follow-Up|Sponsor Decision|0|||
13261584|NCT01474512|26398489|FG007|Post-Treatment Follow-Up|Sponsor Decision|0|||
13261585|NCT01474512|26398490|FG008|Post-Treatment Follow-Up|Sponsor Decision|0|||
13261586|NCT01474512|26398491|FG009|Post-Treatment Follow-Up|Sponsor Decision|0|||
13261587|NCT01474512|26398492|FG010|Post-Treatment Follow-Up|Sponsor Decision|0|||
13261588|NCT01474512|26398493|FG011|Post-Treatment Follow-Up|Sponsor Decision|0|||
13261589|NCT01474512|26398494|FG012|Post-Treatment Follow-Up|Sponsor Decision|0|||
13261590|NCT01474512|26398495|FG013|Post-Treatment Follow-Up|Sponsor Decision|0|||
13261591|NCT01474512|26398496|FG014|Post-Treatment Follow-Up|Sponsor Decision|1|||
13261592|NCT01474512|26398497|FG015|Post-Treatment Follow-Up|Sponsor Decision|0|||
13261593|NCT01474512|26398498|FG016|Post-Treatment Follow-Up|Sponsor Decision|4|||
13261594|NCT01474512|26398499|FG017|Post-Treatment Follow-Up|Sponsor Decision|0|||
13261595|NCT01474512|26398482|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
13261596|NCT01474512|26398483|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
13261597|NCT01474512|26398484|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
13261598|NCT01474512|26398485|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
13261599|NCT01474512|26398486|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
13261600|NCT01474512|26398487|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
13261601|NCT01474512|26398488|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
13261602|NCT01474512|26398489|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
13261603|NCT01474512|26398490|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
13261604|NCT01474512|26398491|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
13261605|NCT01474512|26398492|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
13261606|NCT01474512|26398493|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
13261607|NCT01474512|26398494|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
13261608|NCT01474512|26398495|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
13261609|NCT01474512|26398496|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
13261610|NCT01474512|26398497|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
13261611|NCT01474512|26398498|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
13261612|NCT01474512|26398499|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
13261613|NCT01474512|26398482|FG000|Post-Treatment Follow-Up|Death|0|||
13261614|NCT01474512|26398483|FG001|Post-Treatment Follow-Up|Death|0|||
13261615|NCT01474512|26398484|FG002|Post-Treatment Follow-Up|Death|0|||
13261616|NCT01474512|26398485|FG003|Post-Treatment Follow-Up|Death|0|||
13261617|NCT01474512|26398486|FG004|Post-Treatment Follow-Up|Death|0|||
13261618|NCT01474512|26398487|FG005|Post-Treatment Follow-Up|Death|0|||
13261619|NCT01474512|26398488|FG006|Post-Treatment Follow-Up|Death|0|||
13261620|NCT01474512|26398489|FG007|Post-Treatment Follow-Up|Death|0|||
13261621|NCT01474512|26398490|FG008|Post-Treatment Follow-Up|Death|0|||
13261622|NCT01474512|26398491|FG009|Post-Treatment Follow-Up|Death|0|||
13261623|NCT01474512|26398492|FG010|Post-Treatment Follow-Up|Death|0|||
13261624|NCT01474512|26398493|FG011|Post-Treatment Follow-Up|Death|0|||
13261625|NCT01474512|26398494|FG012|Post-Treatment Follow-Up|Death|0|||
13261626|NCT01474512|26398495|FG013|Post-Treatment Follow-Up|Death|0|||
13261627|NCT01474512|26398496|FG014|Post-Treatment Follow-Up|Death|0|||
13261628|NCT01474512|26398497|FG015|Post-Treatment Follow-Up|Death|0|||
13261629|NCT01474512|26398498|FG016|Post-Treatment Follow-Up|Death|1|||
13261630|NCT01474512|26398499|FG017|Post-Treatment Follow-Up|Death|0|||
13261631|NCT01474486|26398512|FG000|Overall Study|Death|2|||
13261632|NCT01474486|26398512|FG000|Overall Study|Withdrawal by Subject|4|||
13261633|NCT01474486|26398512|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2|||
13261634|NCT01474434|26398567|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
13261635|NCT01474434|26398568|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
13261636|NCT01474434|26398569|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
13261637|NCT01474434|26398570|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
13261638|NCT01474434|26398567|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
13261639|NCT01474434|26398568|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
13261640|NCT01474434|26398569|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
13261641|NCT01474434|26398570|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1|||
13261642|NCT01474434|26398567|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1|||
13261643|NCT01474434|26398568|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
13261644|NCT01474434|26398569|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
13261645|NCT01474434|26398570|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
13261646|NCT01474317|26398579|FG000|Overall Study|Adverse Event|1|||
13261647|NCT01474317|26398579|FG000|Overall Study|Subject ineligible for study|1|||
13261648|NCT01474291|26398627|FG000|Overall Study|Not Evaluable for Efficacy|26|||
13261649|NCT01474291|26398627|FG000|Overall Study|Lack of Treatment Efficacy|88|||
13261650|NCT01474291|26398627|FG000|Overall Study|Adverse Event|53|||
13261651|NCT01474291|26398627|FG000|Overall Study|Lost to Follow-up|29|||
13261652|NCT01474291|26398627|FG000|Overall Study|Patient No Longer Wanted to Participate|12|||
13261653|NCT01474291|26398627|FG000|Overall Study|No Reason Reported|10|||
13261654|NCT01474291|26398627|FG000|Overall Study|Death|2|||
13261655|NCT01474239|26398670|FG000|Overall Study|Disease Progression|37|||
13261656|NCT01474239|26398671|FG001|Overall Study|Disease Progression|25|||
13261657|NCT01474239|26398670|FG000|Overall Study|Adverse Event|12|||
13261658|NCT01474239|26398671|FG001|Overall Study|Adverse Event|3|||
13261659|NCT01474239|26398670|FG000|Overall Study|Withdrawal by Subject|1|||
13261660|NCT01474239|26398671|FG001|Overall Study|Withdrawal by Subject|2|||
13261661|NCT01474239|26398670|FG000|Overall Study|Death|1|||
13261662|NCT01474239|26398671|FG001|Overall Study|Death|1|||
13261663|NCT01474239|26398670|FG000|Overall Study|Clinical Disease Progression|7|||
13261664|NCT01474239|26398671|FG001|Overall Study|Clinical Disease Progression|1|||
13261665|NCT01474239|26398670|FG000|Overall Study|Withdrawal for Economic Reason|1|||
13261666|NCT01474239|26398671|FG001|Overall Study|Withdrawal for Economic Reason|0|||
13261667|NCT01474018|26398686|FG000|Overall Study|Lost to Follow-up|0|||
13261668|NCT01474018|26398687|FG001|Overall Study|Lost to Follow-up|1|||
13261669|NCT01474018|26398686|FG000|Overall Study|Withdrawal by Subject|0|||
13261670|NCT01474018|26398687|FG001|Overall Study|Withdrawal by Subject|2|||
13261671|NCT01473953|26398745|FG000|Overall Study|Other|1|||
13261672|NCT01473953|26398746|FG001|Overall Study|Other|0|||
13261673|NCT01473953|26398747|FG002|Overall Study|Other|0|||
13261674|NCT01473953|26398748|FG003|Overall Study|Other|0|||
13261675|NCT01473953|26398749|FG004|Overall Study|Other|0|||
13261676|NCT01473940|26398792|FG000|Induction Therapy|Death|0|||
13261677|NCT01473940|26398793|FG001|Induction Therapy|Death|0|||
13261678|NCT01473940|26398794|FG002|Induction Therapy|Death|1|||
13261679|NCT01473940|26398795|FG003|Induction Therapy|Death|1|||
13261680|NCT01473940|26398792|FG000|Induction Therapy|Progressive Disease|0|||
13261681|NCT01473940|26398793|FG001|Induction Therapy|Progressive Disease|1|||
13261682|NCT01473940|26398794|FG002|Induction Therapy|Progressive Disease|1|||
13261683|NCT01473940|26398795|FG003|Induction Therapy|Progressive Disease|0|||
13261684|NCT01473940|26398792|FG000|Maintenance Therapy|Progressive Disease|1|||
13261685|NCT01473940|26398793|FG001|Maintenance Therapy|Progressive Disease|2|||
13261686|NCT01473940|26398794|FG002|Maintenance Therapy|Progressive Disease|1|||
13261687|NCT01473940|26398795|FG003|Maintenance Therapy|Progressive Disease|4|||
13261688|NCT01473836|26398806|FG000|Overall Study|Adverse Event|4|||
13261689|NCT01473836|26398806|FG000|Overall Study|Lack of Efficacy|1|||
13261690|NCT01473836|26398806|FG000|Overall Study|Does not meet entrance criteria|1|||
13261691|NCT01473758|26398937|FG000|Cycle 1|Adverse Event|10|||
13261692|NCT01473758|26398938|FG001|Cycle 1|Adverse Event|2|||
13261693|NCT01473758|26398939|FG002|Cycle 1|Adverse Event|0|||
13261694|NCT01473758|26398940|FG003|Cycle 1|Adverse Event|0|||
13261695|NCT01473758|26398937|FG000|Cycle 1|Withdrawal by Subject|1|||
13261696|NCT01473758|26398938|FG001|Cycle 1|Withdrawal by Subject|1|||
13261697|NCT01473758|26398939|FG002|Cycle 1|Withdrawal by Subject|0|||
13261698|NCT01473758|26398940|FG003|Cycle 1|Withdrawal by Subject|0|||
13261699|NCT01473758|26398937|FG000|Cycle 2|Adverse Event|0|||
13261700|NCT01473758|26398938|FG001|Cycle 2|Adverse Event|0|||
13261701|NCT01473758|26398939|FG002|Cycle 2|Adverse Event|5|||
13261702|NCT01473758|26398940|FG003|Cycle 2|Adverse Event|0|||
13261703|NCT01473732|26398953|FG000|Overall Study|Adverse Event|1|||
13261704|NCT01473732|26398954|FG001|Overall Study|Adverse Event|0|||
13261705|NCT01473732|26398953|FG000|Overall Study|Death|1|||
13261706|NCT01473732|26398954|FG001|Overall Study|Death|0|||
13261707|NCT01473602|26398995|FG000|Overall Study|Adverse Event|1|||
13261708|NCT01473602|26398996|FG001|Overall Study|Adverse Event|2|||
13261709|NCT01473602|26398995|FG000|Overall Study|Death|0|||
13261710|NCT01473602|26398996|FG001|Overall Study|Death|1|||
13261711|NCT01473602|26398995|FG000|Overall Study|Lost to Follow-up|1|||
13261712|NCT01473602|26398996|FG001|Overall Study|Lost to Follow-up|1|||
13261713|NCT01473602|26398995|FG000|Overall Study|Withdrawal by Subject|5|||
13261714|NCT01473602|26398996|FG001|Overall Study|Withdrawal by Subject|4|||
13261715|NCT01473602|26398995|FG000|Overall Study|Physician Decision|1|||
13261716|NCT01473602|26398996|FG001|Overall Study|Physician Decision|0|||
13261717|NCT01473589|26399037|FG000|Overall Study|Adverse Event|1|||
13261718|NCT01473589|26399038|FG001|Overall Study|Adverse Event|1|||
13261719|NCT01473589|26399037|FG000|Overall Study|Death|2|||
13261720|NCT01473589|26399038|FG001|Overall Study|Death|0|||
13261721|NCT01473589|26399037|FG000|Overall Study|Lost to Follow-up|2|||
13261722|NCT01473589|26399038|FG001|Overall Study|Lost to Follow-up|2|||
13261723|NCT01473589|26399037|FG000|Overall Study|Protocol Violation|1|||
13261724|NCT01473589|26399038|FG001|Overall Study|Protocol Violation|0|||
13261725|NCT01473589|26399037|FG000|Overall Study|Withdrawal by Subject|5|||
13261726|NCT01473589|26399038|FG001|Overall Study|Withdrawal by Subject|11|||
13261727|NCT01473589|26399037|FG000|Overall Study|Physician Decision|0|||
13261728|NCT01473589|26399038|FG001|Overall Study|Physician Decision|1|||
13261729|NCT01473589|26399037|FG000|Overall Study|Entry criteria not met|0|||
13261730|NCT01473589|26399038|FG001|Overall Study|Entry criteria not met|1|||
13261731|NCT01473563|26399059|FG000|Overall Study|Lost to FU post tx discontinuation|1|||
13261732|NCT01473524|26399119|FG000|DB Phase|Adverse Event|4|||
13261733|NCT01473524|26399120|FG001|DB Phase|Adverse Event|8|||
13261734|NCT01473524|26399121|FG002|DB Phase|Adverse Event|2|||
13261735|NCT01473524|26399122|FG003|DB Phase|Adverse Event|0|||
13261736|NCT01473524|26399123|FG004|DB Phase|Adverse Event|0|||
13261737|NCT01473524|26399124|FG005|DB Phase|Adverse Event|0|||
13261738|NCT01473524|26399119|FG000|DB Phase|Death|1|||
13261739|NCT01473524|26399120|FG001|DB Phase|Death|0|||
13261740|NCT01473524|26399121|FG002|DB Phase|Death|0|||
13261741|NCT01473524|26399122|FG003|DB Phase|Death|0|||
13261742|NCT01473524|26399123|FG004|DB Phase|Death|0|||
13261743|NCT01473524|26399124|FG005|DB Phase|Death|0|||
13261744|NCT01473524|26399119|FG000|DB Phase|Withdrawal by Subject|2|||
13261745|NCT01473524|26399120|FG001|DB Phase|Withdrawal by Subject|1|||
13261746|NCT01473524|26399121|FG002|DB Phase|Withdrawal by Subject|1|||
13261747|NCT01473524|26399122|FG003|DB Phase|Withdrawal by Subject|0|||
13261748|NCT01473524|26399123|FG004|DB Phase|Withdrawal by Subject|0|||
13261749|NCT01473524|26399124|FG005|DB Phase|Withdrawal by Subject|0|||
13261750|NCT01473524|26399119|FG000|LTSE Phase|Withdrawal by Subject|0|||
13261751|NCT01473524|26399120|FG001|LTSE Phase|Withdrawal by Subject|0|||
13261752|NCT01473524|26399121|FG002|LTSE Phase|Withdrawal by Subject|0|||
13261753|NCT01473524|26399122|FG003|LTSE Phase|Withdrawal by Subject|3|||
13261754|NCT01473524|26399123|FG004|LTSE Phase|Withdrawal by Subject|3|||
13261755|NCT01473524|26399124|FG005|LTSE Phase|Withdrawal by Subject|6|||
13261756|NCT01473524|26399119|FG000|LTSE Phase|Death|0|||
13261757|NCT01473524|26399120|FG001|LTSE Phase|Death|0|||
13261758|NCT01473524|26399121|FG002|LTSE Phase|Death|0|||
13261759|NCT01473524|26399122|FG003|LTSE Phase|Death|0|||
13261760|NCT01473524|26399123|FG004|LTSE Phase|Death|1|||
13261761|NCT01473524|26399124|FG005|LTSE Phase|Death|0|||
13261762|NCT01473524|26399119|FG000|LTSE Phase|Adverse Event of Pruritus|0|||
13261763|NCT01473524|26399120|FG001|LTSE Phase|Adverse Event of Pruritus|0|||
13261764|NCT01473524|26399121|FG002|LTSE Phase|Adverse Event of Pruritus|0|||
13261765|NCT01473524|26399122|FG003|LTSE Phase|Adverse Event of Pruritus|1|||
13261766|NCT01473524|26399123|FG004|LTSE Phase|Adverse Event of Pruritus|5|||
13261767|NCT01473524|26399124|FG005|LTSE Phase|Adverse Event of Pruritus|2|||
13261768|NCT01473524|26399119|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
13261769|NCT01473524|26399120|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
13261770|NCT01473524|26399121|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
13261771|NCT01473524|26399122|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2|||
13261772|NCT01473524|26399123|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4|||
13261773|NCT01473524|26399124|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6|||
13261774|NCT01473524|26399119|FG000|LTSE Phase|Lost to Follow-up|0|||
13261775|NCT01473524|26399120|FG001|LTSE Phase|Lost to Follow-up|0|||
13261776|NCT01473524|26399121|FG002|LTSE Phase|Lost to Follow-up|0|||
13261777|NCT01473524|26399122|FG003|LTSE Phase|Lost to Follow-up|1|||
13261778|NCT01473524|26399123|FG004|LTSE Phase|Lost to Follow-up|3|||
13261779|NCT01473524|26399124|FG005|LTSE Phase|Lost to Follow-up|2|||
13261780|NCT01473524|26399119|FG000|LTSE Phase|Principal Investigator Decision|0|||
13261781|NCT01473524|26399120|FG001|LTSE Phase|Principal Investigator Decision|0|||
13261782|NCT01473524|26399121|FG002|LTSE Phase|Principal Investigator Decision|0|||
13261783|NCT01473524|26399122|FG003|LTSE Phase|Principal Investigator Decision|1|||
13261784|NCT01473524|26399123|FG004|LTSE Phase|Principal Investigator Decision|1|||
13261785|NCT01473524|26399124|FG005|LTSE Phase|Principal Investigator Decision|3|||
13261786|NCT01473524|26399119|FG000|LTSE Phase|Liver Transplantation|0|||
13261787|NCT01473524|26399120|FG001|LTSE Phase|Liver Transplantation|0|||
13261788|NCT01473524|26399121|FG002|LTSE Phase|Liver Transplantation|0|||
13261789|NCT01473524|26399122|FG003|LTSE Phase|Liver Transplantation|0|||
13261790|NCT01473524|26399123|FG004|LTSE Phase|Liver Transplantation|0|||
13261791|NCT01473524|26399124|FG005|LTSE Phase|Liver Transplantation|1|||
13261792|NCT01473524|26399119|FG000|LTSE Phase|Pregnancy|0|||
13261793|NCT01473524|26399120|FG001|LTSE Phase|Pregnancy|0|||
13261794|NCT01473524|26399121|FG002|LTSE Phase|Pregnancy|0|||
13261795|NCT01473524|26399122|FG003|LTSE Phase|Pregnancy|1|||
13261796|NCT01473524|26399123|FG004|LTSE Phase|Pregnancy|0|||
13261797|NCT01473524|26399124|FG005|LTSE Phase|Pregnancy|0|||
13261798|NCT01473524|26399119|FG000|LTSE Phase|Protocol Violation|0|||
13261799|NCT01473524|26399120|FG001|LTSE Phase|Protocol Violation|0|||
13261800|NCT01473524|26399121|FG002|LTSE Phase|Protocol Violation|0|||
13261801|NCT01473524|26399122|FG003|LTSE Phase|Protocol Violation|0|||
13261802|NCT01473524|26399123|FG004|LTSE Phase|Protocol Violation|0|||
13261803|NCT01473524|26399124|FG005|LTSE Phase|Protocol Violation|1|||
13261804|NCT01473420|26399213|FG000|Titration Period (18 Weeks)|Adverse Event|4|||
13261805|NCT01473420|26399214|FG001|Titration Period (18 Weeks)|Adverse Event|6|||
13261806|NCT01473420|26399213|FG000|Titration Period (18 Weeks)|Did not meet criteria|32|||
13261807|NCT01473420|26399214|FG001|Titration Period (18 Weeks)|Did not meet criteria|32|||
13261808|NCT01473420|26399213|FG000|Maintenance Period (16 Weeks)|Adverse Event|3|||
13261809|NCT01473420|26399214|FG001|Maintenance Period (16 Weeks)|Adverse Event|2|||
13261810|NCT01473420|26399213|FG000|Maintenance Period (16 Weeks)|Physician Decision|1|||
13261811|NCT01473420|26399214|FG001|Maintenance Period (16 Weeks)|Physician Decision|2|||
13261812|NCT01473420|26399213|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0|||
13261813|NCT01473420|26399214|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2|||
13261814|NCT01473420|26399213|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3|||
13261815|NCT01473420|26399214|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1|||
13261816|NCT01473420|26399213|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1|||
13261817|NCT01473420|26399214|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2|||
13261818|NCT01473420|26399213|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4|||
13261819|NCT01473420|26399214|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6|||
13261820|NCT01473420|26399213|FG000|Maintenance Period (16 Weeks)|Site closure|3|||
13261821|NCT01473420|26399214|FG001|Maintenance Period (16 Weeks)|Site closure|1|||
13261822|NCT01473420|26399213|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1|||
13261823|NCT01473420|26399214|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0|||
13261824|NCT01473420|26399213|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0|||
13261825|NCT01473420|26399214|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1|||
13261826|NCT01473420|26399213|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1|||
13261827|NCT01473420|26399214|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0|||
13261828|NCT01473420|26399213|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1|||
13261829|NCT01473420|26399214|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0|||
13261830|NCT01473407|26399273|FG000|Overall Study|Physician Decision|1|||
13261831|NCT01473407|26399274|FG001|Overall Study|Physician Decision|4|||
13261832|NCT01473407|26399273|FG000|Overall Study|Lost to Follow-up|10|||
13261833|NCT01473407|26399274|FG001|Overall Study|Lost to Follow-up|4|||
13261834|NCT01473407|26399273|FG000|Overall Study|Adverse Event|8|||
13261835|NCT01473407|26399274|FG001|Overall Study|Adverse Event|8|||
13261836|NCT01473407|26399273|FG000|Overall Study|Randomization Error|3|||
13261837|NCT01473407|26399274|FG001|Overall Study|Randomization Error|1|||
13261838|NCT01473407|26399273|FG000|Overall Study|Withdrawal by Subject|4|||
13261839|NCT01473407|26399274|FG001|Overall Study|Withdrawal by Subject|7|||
13261840|NCT01473407|26399273|FG000|Overall Study|Kidney Transplant|7|||
13261841|NCT01473407|26399274|FG001|Overall Study|Kidney Transplant|6|||
13261842|NCT01473407|26399273|FG000|Overall Study|Vacation/Travel|1|||
13261843|NCT01473407|26399274|FG001|Overall Study|Vacation/Travel|1|||
13261844|NCT01473407|26399273|FG000|Overall Study|Elevated Hemoglobin|1|||
13261845|NCT01473407|26399274|FG001|Overall Study|Elevated Hemoglobin|0|||
13261846|NCT01473407|26399273|FG000|Overall Study|Patient Received Aranesp|1|||
13261847|NCT01473407|26399274|FG001|Overall Study|Patient Received Aranesp|0|||
13261848|NCT01473407|26399273|FG000|Overall Study|Patient Lost Green Card Status|1|||
13261849|NCT01473407|26399274|FG001|Overall Study|Patient Lost Green Card Status|0|||
13261850|NCT01473407|26399273|FG000|Overall Study|Temperature Excursion|2|||
13261851|NCT01473407|26399274|FG001|Overall Study|Temperature Excursion|3|||
13261852|NCT01473407|26399273|FG000|Overall Study|Transfer to Another Facility/Unit|4|||
13261853|NCT01473407|26399274|FG001|Overall Study|Transfer to Another Facility/Unit|3|||
13261854|NCT01473407|26399273|FG000|Overall Study|Sponsor's Decision|10|||
13261855|NCT01473407|26399274|FG001|Overall Study|Sponsor's Decision|10|||
13261856|NCT01473407|26399273|FG000|Overall Study|Site Closure|1|||
13261857|NCT01473407|26399274|FG001|Overall Study|Site Closure|0|||
13261858|NCT01473394|26399291|FG000|Overall Study|Adverse Event|13|||
13261859|NCT01473394|26399292|FG001|Overall Study|Adverse Event|16|||
13261860|NCT01473394|26399291|FG000|Overall Study|Insufficient Therapeutic Response|4|||
13261861|NCT01473394|26399292|FG001|Overall Study|Insufficient Therapeutic Response|1|||
13261862|NCT01473394|26399291|FG000|Overall Study|Protocol Violation|7|||
13261863|NCT01473394|26399292|FG001|Overall Study|Protocol Violation|5|||
13261864|NCT01473394|26399291|FG000|Overall Study|Withdrew Consent|12|||
13261865|NCT01473394|26399292|FG001|Overall Study|Withdrew Consent|10|||
13261866|NCT01473394|26399291|FG000|Overall Study|Lost to Follow-up|9|||
13261867|NCT01473394|26399292|FG001|Overall Study|Lost to Follow-up|11|||
13261868|NCT01473381|26399323|FG000|Overall Study|Adverse Event|8|||
13261869|NCT01473381|26399324|FG001|Overall Study|Adverse Event|20|||
13261870|NCT01473381|26399325|FG002|Overall Study|Adverse Event|25|||
13261871|NCT01473381|26399326|FG003|Overall Study|Adverse Event|17|||
13261872|NCT01473381|26399323|FG000|Overall Study|Insufficient Therapeutic Response|10|||
13261873|NCT01473381|26399324|FG001|Overall Study|Insufficient Therapeutic Response|1|||
13261874|NCT01473381|26399325|FG002|Overall Study|Insufficient Therapeutic Response|2|||
13261875|NCT01473381|26399326|FG003|Overall Study|Insufficient Therapeutic Response|3|||
13261876|NCT01473381|26399323|FG000|Overall Study|Protocol Violation|17|||
13261877|NCT01473381|26399324|FG001|Overall Study|Protocol Violation|23|||
13261878|NCT01473381|26399325|FG002|Overall Study|Protocol Violation|19|||
13261879|NCT01473381|26399326|FG003|Overall Study|Protocol Violation|17|||
13261880|NCT01473381|26399323|FG000|Overall Study|Withdrawal of Consent|20|||
13261881|NCT01473381|26399324|FG001|Overall Study|Withdrawal of Consent|21|||
13261882|NCT01473381|26399325|FG002|Overall Study|Withdrawal of Consent|20|||
13261883|NCT01473381|26399326|FG003|Overall Study|Withdrawal of Consent|26|||
13261884|NCT01473381|26399323|FG000|Overall Study|Lost to Follow-up|25|||
13261885|NCT01473381|26399324|FG001|Overall Study|Lost to Follow-up|28|||
13261886|NCT01473381|26399325|FG002|Overall Study|Lost to Follow-up|35|||
13261887|NCT01473381|26399326|FG003|Overall Study|Lost to Follow-up|23|||
13261888|NCT01473381|26399323|FG000|Overall Study|Other Reasons|0|||
13261889|NCT01473381|26399324|FG001|Overall Study|Other Reasons|0|||
13261890|NCT01473381|26399325|FG002|Overall Study|Other Reasons|1|||
13261891|NCT01473381|26399326|FG003|Overall Study|Other Reasons|3|||
13261892|NCT01473355|26399337|FG000|Overall Study|Protocol Violation|2|||
13261893|NCT01473355|26399337|FG000|Overall Study|Adverse Event|2|||
13261894|NCT01473355|26399337|FG000|Overall Study|Lost to Follow-up|2|||
13261895|NCT01472965|26399360|FG000|Overall Study|Withdrawal by Subject|1|||
13261896|NCT01472965|26399361|FG001|Overall Study|Withdrawal by Subject|0|||
13261897|NCT01472939|26399401|FG000|Overall Study|Adverse Event|3|||
13261898|NCT01472939|26399402|FG001|Overall Study|Adverse Event|7|||
13261899|NCT01472939|26399403|FG002|Overall Study|Adverse Event|7|||
13261900|NCT01472939|26399404|FG003|Overall Study|Adverse Event|14|||
13261901|NCT01472939|26399401|FG000|Overall Study|Lack of Efficacy|1|||
13261902|NCT01472939|26399402|FG001|Overall Study|Lack of Efficacy|0|||
13261903|NCT01472939|26399403|FG002|Overall Study|Lack of Efficacy|0|||
13261904|NCT01472939|26399404|FG003|Overall Study|Lack of Efficacy|1|||
13261905|NCT01472939|26399401|FG000|Overall Study|Lost to Follow-up|3|||
13261906|NCT01472939|26399402|FG001|Overall Study|Lost to Follow-up|0|||
13261907|NCT01472939|26399403|FG002|Overall Study|Lost to Follow-up|2|||
13261908|NCT01472939|26399404|FG003|Overall Study|Lost to Follow-up|0|||
13261909|NCT01472939|26399401|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0|||
13261910|NCT01472939|26399402|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0|||
13261911|NCT01472939|26399403|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1|||
13261912|NCT01472939|26399404|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0|||
13261913|NCT01472939|26399401|FG000|Overall Study|Prohibited Medication|0|||
13261914|NCT01472939|26399402|FG001|Overall Study|Prohibited Medication|1|||
13261915|NCT01472939|26399403|FG002|Overall Study|Prohibited Medication|0|||
13261916|NCT01472939|26399404|FG003|Overall Study|Prohibited Medication|0|||
13261917|NCT01472939|26399401|FG000|Overall Study|Withdrawal By PI|1|||
13261918|NCT01472939|26399402|FG001|Overall Study|Withdrawal By PI|0|||
13261919|NCT01472939|26399403|FG002|Overall Study|Withdrawal By PI|0|||
13261920|NCT01472939|26399404|FG003|Overall Study|Withdrawal By PI|0|||
13261921|NCT01472939|26399401|FG000|Overall Study|Protocol Violation|3|||
13261922|NCT01472939|26399402|FG001|Overall Study|Protocol Violation|3|||
13261923|NCT01472939|26399403|FG002|Overall Study|Protocol Violation|0|||
13261924|NCT01472939|26399404|FG003|Overall Study|Protocol Violation|1|||
13261925|NCT01472939|26399401|FG000|Overall Study|Withdrawal by Subject|9|||
13261926|NCT01472939|26399402|FG001|Overall Study|Withdrawal by Subject|3|||
13261927|NCT01472939|26399403|FG002|Overall Study|Withdrawal by Subject|1|||
13261928|NCT01472939|26399404|FG003|Overall Study|Withdrawal by Subject|4|||
13261929|NCT01472835|26399425|FG000|Overall Study|Lost to Follow-up|2|||
13261930|NCT01472835|26399426|FG001|Overall Study|Lost to Follow-up|0|||
13261931|NCT01472757|26399461|FG000|Overall Study|Withdrawal by Subject|1|||
13261932|NCT01472757|26399462|FG001|Overall Study|Withdrawal by Subject|2|||
13261933|NCT01472757|26399463|FG002|Overall Study|Withdrawal by Subject|2|||
13261934|NCT01472757|26399464|FG003|Overall Study|Withdrawal by Subject|0|||
13261935|NCT01472757|26399461|FG000|Overall Study|Asthma exacerbation|4|||
13261936|NCT01472757|26399462|FG001|Overall Study|Asthma exacerbation|1|||
13261937|NCT01472757|26399463|FG002|Overall Study|Asthma exacerbation|2|||
13261938|NCT01472757|26399464|FG003|Overall Study|Asthma exacerbation|1|||
13261939|NCT01472757|26399461|FG000|Overall Study|Treatment period withdrawal criteria met|21|||
13261940|NCT01472757|26399462|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
13261941|NCT01472757|26399463|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
13261942|NCT01472757|26399464|FG003|Overall Study|Treatment period withdrawal criteria met|12|||
13261943|NCT01472757|26399461|FG000|Overall Study|Protocol Violation|3|||
13261944|NCT01472757|26399462|FG001|Overall Study|Protocol Violation|2|||
13261945|NCT01472757|26399463|FG002|Overall Study|Protocol Violation|4|||
13261946|NCT01472757|26399464|FG003|Overall Study|Protocol Violation|4|||
13261947|NCT01472757|26399461|FG000|Overall Study|Other reasons|1|||
13261948|NCT01472757|26399462|FG001|Overall Study|Other reasons|0|||
13261949|NCT01472757|26399463|FG002|Overall Study|Other reasons|2|||
13261950|NCT01472757|26399464|FG003|Overall Study|Other reasons|2|||
13261951|NCT01472380|26399477|FG000|Efavirenz Alone|Withdrawal by Subject|1|||
13261952|NCT01472380|26399477|FG000|1 Day Period Between Dosing|Protocol Violation|1|||
13261953|NCT01472341|26399485|FG000|Overall Study|Started insulin therapy|55|||
13261954|NCT01472341|26399485|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92|||
13261955|NCT01472341|26399485|FG000|Overall Study|Withdrawal by Subject|39|||
13261956|NCT01472341|26399485|FG000|Overall Study|Lost to Follow-up|52|||
13261957|NCT01472341|26399485|FG000|Overall Study|Laboratory parameters unavailable|25|||
13261958|NCT01472341|26399485|FG000|Overall Study|Death|9|||
13261959|NCT01472289|26399497|FG000|Overall Study|Death|2|||
13261960|NCT01472185|26399518|FG000|Overall Study|Randomized but Not Treated|0|||
13261961|NCT01472185|26399519|FG001|Overall Study|Randomized but Not Treated|1|||
13261962|NCT01472185|26399518|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3|||
13261963|NCT01472185|26399519|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10|||
13261964|NCT01472185|26399518|FG000|Overall Study|Hyperglycemia|5|||
13261965|NCT01472185|26399519|FG001|Overall Study|Hyperglycemia|2|||
13261966|NCT01472185|26399518|FG000|Overall Study|Investigator's Discretion|3|||
13261967|NCT01472185|26399519|FG001|Overall Study|Investigator's Discretion|1|||
13261968|NCT01472185|26399518|FG000|Overall Study|Lost to Follow-up|4|||
13261969|NCT01472185|26399519|FG001|Overall Study|Lost to Follow-up|1|||
13261970|NCT01472185|26399518|FG000|Overall Study|Protocol Violation|5|||
13261971|NCT01472185|26399519|FG001|Overall Study|Protocol Violation|1|||
13261972|NCT01472185|26399518|FG000|Overall Study|Subject Noncompliance|8|||
13261973|NCT01472185|26399519|FG001|Overall Study|Subject Noncompliance|15|||
13261974|NCT01472185|26399518|FG000|Overall Study|Subject Withdrew Consent|6|||
13261975|NCT01472185|26399519|FG001|Overall Study|Subject Withdrew Consent|3|||
13261976|NCT01472081|26399581|FG000|Overall Study|Continuing treatment at time of analysis|1|||
13261977|NCT01472081|26399582|FG001|Overall Study|Continuing treatment at time of analysis|4|||
13261978|NCT01472081|26399583|FG002|Overall Study|Continuing treatment at time of analysis|1|||
13261979|NCT01472081|26399584|FG003|Overall Study|Continuing treatment at time of analysis|8|||
13261980|NCT01472081|26399585|FG004|Overall Study|Continuing treatment at time of analysis|9|||
13261981|NCT01472081|26399586|FG005|Overall Study|Continuing treatment at time of analysis|0|||
13261982|NCT01472081|26399581|FG000|Overall Study|Disease Progression|4|||
13261983|NCT01472081|26399582|FG001|Overall Study|Disease Progression|10|||
13261984|NCT01472081|26399583|FG002|Overall Study|Disease Progression|12|||
13261985|NCT01472081|26399584|FG003|Overall Study|Disease Progression|31|||
13261986|NCT01472081|26399585|FG004|Overall Study|Disease Progression|22|||
13261987|NCT01472081|26399586|FG005|Overall Study|Disease Progression|3|||
13261988|NCT01472081|26399581|FG000|Overall Study|Study drug toxicity|2|||
13261989|NCT01472081|26399582|FG001|Overall Study|Study drug toxicity|9|||
13261990|NCT01472081|26399583|FG002|Overall Study|Study drug toxicity|4|||
13261991|NCT01472081|26399584|FG003|Overall Study|Study drug toxicity|6|||
13261992|NCT01472081|26399585|FG004|Overall Study|Study drug toxicity|13|||
13261993|NCT01472081|26399586|FG005|Overall Study|Study drug toxicity|2|||
13261994|NCT01472081|26399581|FG000|Overall Study|Death|0|||
13261995|NCT01472081|26399582|FG001|Overall Study|Death|0|||
13261996|NCT01472081|26399583|FG002|Overall Study|Death|0|||
13261997|NCT01472081|26399584|FG003|Overall Study|Death|0|||
13261998|NCT01472081|26399585|FG004|Overall Study|Death|1|||
13261999|NCT01472081|26399586|FG005|Overall Study|Death|0|||
13262000|NCT01472081|26399581|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
13262001|NCT01472081|26399582|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
13262002|NCT01472081|26399583|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
13262003|NCT01472081|26399584|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
13262004|NCT01472081|26399585|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
13262005|NCT01472081|26399586|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
13262006|NCT01472081|26399581|FG000|Overall Study|Withdrawal by Subject|0|||
13262007|NCT01472081|26399582|FG001|Overall Study|Withdrawal by Subject|0|||
13262008|NCT01472081|26399583|FG002|Overall Study|Withdrawal by Subject|0|||
13262009|NCT01472081|26399584|FG003|Overall Study|Withdrawal by Subject|0|||
13262010|NCT01472081|26399585|FG004|Overall Study|Withdrawal by Subject|0|||
13262011|NCT01472081|26399586|FG005|Overall Study|Withdrawal by Subject|1|||
13262012|NCT01472081|26399581|FG000|Overall Study|Poor/non-compliance|0|||
13262013|NCT01472081|26399582|FG001|Overall Study|Poor/non-compliance|0|||
13262014|NCT01472081|26399583|FG002|Overall Study|Poor/non-compliance|1|||
13262015|NCT01472081|26399584|FG003|Overall Study|Poor/non-compliance|0|||
13262016|NCT01472081|26399585|FG004|Overall Study|Poor/non-compliance|1|||
13262017|NCT01472081|26399586|FG005|Overall Study|Poor/non-compliance|0|||
13262018|NCT01472081|26399581|FG000|Overall Study|No longer meets study criteria|0|||
13262019|NCT01472081|26399582|FG001|Overall Study|No longer meets study criteria|0|||
13262020|NCT01472081|26399583|FG002|Overall Study|No longer meets study criteria|1|||
13262021|NCT01472081|26399584|FG003|Overall Study|No longer meets study criteria|0|||
13262022|NCT01472081|26399585|FG004|Overall Study|No longer meets study criteria|0|||
13262023|NCT01472081|26399586|FG005|Overall Study|No longer meets study criteria|0|||
13262024|NCT01472081|26399581|FG000|Overall Study|Subject request to discontinue treatment|0|||
13262025|NCT01472081|26399582|FG001|Overall Study|Subject request to discontinue treatment|3|||
13262026|NCT01472081|26399583|FG002|Overall Study|Subject request to discontinue treatment|1|||
13262027|NCT01472081|26399584|FG003|Overall Study|Subject request to discontinue treatment|1|||
13262028|NCT01472081|26399585|FG004|Overall Study|Subject request to discontinue treatment|0|||
13262029|NCT01472081|26399586|FG005|Overall Study|Subject request to discontinue treatment|0|||
13262030|NCT01471782|26399657|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
13262031|NCT01471782|26399658|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
13262032|NCT01471782|26399659|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1|||
13262033|NCT01471782|26399660|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0|||
13262034|NCT01471782|26399661|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5|||
13262035|NCT01471782|26399662|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3|||
13262036|NCT01471782|26399657|FG000|Overall Study|Lack of Efficacy|1|||
13262037|NCT01471782|26399658|FG001|Overall Study|Lack of Efficacy|2|||
13262038|NCT01471782|26399659|FG002|Overall Study|Lack of Efficacy|1|||
13262039|NCT01471782|26399660|FG003|Overall Study|Lack of Efficacy|1|||
13262040|NCT01471782|26399661|FG004|Overall Study|Lack of Efficacy|5|||
13262041|NCT01471782|26399662|FG005|Overall Study|Lack of Efficacy|18|||
13262042|NCT01471782|26399657|FG000|Overall Study|Adverse Event|1|||
13262043|NCT01471782|26399658|FG001|Overall Study|Adverse Event|1|||
13262044|NCT01471782|26399659|FG002|Overall Study|Adverse Event|2|||
13262045|NCT01471782|26399660|FG003|Overall Study|Adverse Event|2|||
13262046|NCT01471782|26399661|FG004|Overall Study|Adverse Event|3|||
13262047|NCT01471782|26399662|FG005|Overall Study|Adverse Event|1|||
13262048|NCT01471782|26399657|FG000|Overall Study|Other|0|||
13262049|NCT01471782|26399658|FG001|Overall Study|Other|0|||
13262050|NCT01471782|26399659|FG002|Overall Study|Other|1|||
13262051|NCT01471782|26399660|FG003|Overall Study|Other|1|||
13262052|NCT01471782|26399661|FG004|Overall Study|Other|6|||
13262053|NCT01471782|26399662|FG005|Overall Study|Other|5|||
13262054|NCT01471782|26399657|FG000|Overall Study|Change of Chemotherapy|1|||
13262055|NCT01471782|26399658|FG001|Overall Study|Change of Chemotherapy|1|||
13262056|NCT01471782|26399659|FG002|Overall Study|Change of Chemotherapy|0|||
13262057|NCT01471782|26399660|FG003|Overall Study|Change of Chemotherapy|0|||
13262058|NCT01471782|26399661|FG004|Overall Study|Change of Chemotherapy|1|||
13262059|NCT01471782|26399662|FG005|Overall Study|Change of Chemotherapy|4|||
13262060|NCT01471782|26399657|FG000|Overall Study|Disease Relapse|0|||
13262061|NCT01471782|26399658|FG001|Overall Study|Disease Relapse|0|||
13262062|NCT01471782|26399659|FG002|Overall Study|Disease Relapse|0|||
13262063|NCT01471782|26399660|FG003|Overall Study|Disease Relapse|1|||
13262064|NCT01471782|26399661|FG004|Overall Study|Disease Relapse|2|||
13262065|NCT01471782|26399662|FG005|Overall Study|Disease Relapse|1|||
13262066|NCT01471782|26399657|FG000|Overall Study|Physician Decision|0|||
13262067|NCT01471782|26399658|FG001|Overall Study|Physician Decision|0|||
13262068|NCT01471782|26399659|FG002|Overall Study|Physician Decision|0|||
13262069|NCT01471782|26399660|FG003|Overall Study|Physician Decision|0|||
13262070|NCT01471782|26399661|FG004|Overall Study|Physician Decision|3|||
13262071|NCT01471782|26399662|FG005|Overall Study|Physician Decision|8|||
13262072|NCT01471782|26399657|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
13262073|NCT01471782|26399658|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
13262074|NCT01471782|26399659|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
13262075|NCT01471782|26399660|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
13262076|NCT01471782|26399661|FG004|Overall Study|Withdrawal by Parent/Guardian|1|||
13262077|NCT01471782|26399662|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
13262078|NCT01471782|26399657|FG000|Overall Study|Death|0|||
13262079|NCT01471782|26399658|FG001|Overall Study|Death|0|||
13262080|NCT01471782|26399659|FG002|Overall Study|Death|0|||
13262081|NCT01471782|26399660|FG003|Overall Study|Death|0|||
13262082|NCT01471782|26399661|FG004|Overall Study|Death|0|||
13262083|NCT01471782|26399662|FG005|Overall Study|Death|1|||
13262084|NCT01471691|26399675|FG000|Overall Study|Lack of Efficacy|0|||
13262085|NCT01471691|26399676|FG001|Overall Study|Lack of Efficacy|1|||
13262086|NCT01471574|26399718|FG000|Treatment Period|Lack of Efficacy|12|||
13262087|NCT01471574|26399719|FG001|Treatment Period|Lack of Efficacy|4|||
13262088|NCT01471574|26399720|FG002|Treatment Period|Lack of Efficacy|14|||
13262089|NCT01471574|26399721|FG003|Treatment Period|Lack of Efficacy|1|||
13262090|NCT01471574|26399718|FG000|Treatment Period|Adverse Event|7|||
13262091|NCT01471574|26399719|FG001|Treatment Period|Adverse Event|3|||
13262092|NCT01471574|26399720|FG002|Treatment Period|Adverse Event|6|||
13262093|NCT01471574|26399721|FG003|Treatment Period|Adverse Event|1|||
13262094|NCT01471574|26399718|FG000|Treatment Period|Withdrawal by Subject|5|||
13262095|NCT01471574|26399719|FG001|Treatment Period|Withdrawal by Subject|1|||
13262096|NCT01471574|26399720|FG002|Treatment Period|Withdrawal by Subject|1|||
13262097|NCT01471574|26399721|FG003|Treatment Period|Withdrawal by Subject|0|||
13262098|NCT01471574|26399718|FG000|Treatment Period|Patient Requested Discontinue Study drug|4|||
13262099|NCT01471574|26399719|FG001|Treatment Period|Patient Requested Discontinue Study drug|0|||
13262100|NCT01471574|26399720|FG002|Treatment Period|Patient Requested Discontinue Study drug|1|||
13262101|NCT01471574|26399721|FG003|Treatment Period|Patient Requested Discontinue Study drug|1|||
13262102|NCT01471574|26399718|FG000|Treatment Period|Lost to Follow-up|1|||
13262103|NCT01471574|26399719|FG001|Treatment Period|Lost to Follow-up|2|||
13262104|NCT01471574|26399720|FG002|Treatment Period|Lost to Follow-up|2|||
13262105|NCT01471574|26399721|FG003|Treatment Period|Lost to Follow-up|0|||
13262106|NCT01471574|26399718|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1|||
13262107|NCT01471574|26399719|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0|||
13262108|NCT01471574|26399720|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0|||
13262109|NCT01471574|26399721|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0|||
13262110|NCT01471574|26399718|FG000|Treatment Period|Other|1|||
13262111|NCT01471574|26399719|FG001|Treatment Period|Other|0|||
13262112|NCT01471574|26399720|FG002|Treatment Period|Other|0|||
13262113|NCT01471574|26399721|FG003|Treatment Period|Other|0|||
13262114|NCT01471574|26399718|FG000|Follow-up Period|Withdrawal by Subject|3|||
13262115|NCT01471574|26399719|FG001|Follow-up Period|Withdrawal by Subject|0|||
13262116|NCT01471574|26399720|FG002|Follow-up Period|Withdrawal by Subject|3|||
13262117|NCT01471574|26399721|FG003|Follow-up Period|Withdrawal by Subject|1|||
13262118|NCT01471574|26399718|FG000|Follow-up Period|Lost to Follow-up|4|||
13262119|NCT01471574|26399719|FG001|Follow-up Period|Lost to Follow-up|1|||
13262120|NCT01471574|26399720|FG002|Follow-up Period|Lost to Follow-up|3|||
13262121|NCT01471574|26399721|FG003|Follow-up Period|Lost to Follow-up|2|||
13262122|NCT01471574|26399718|FG000|Follow-up Period|Death|0|||
13262123|NCT01471574|26399719|FG001|Follow-up Period|Death|0|||
13262124|NCT01471574|26399720|FG002|Follow-up Period|Death|1|||
13262125|NCT01471574|26399721|FG003|Follow-up Period|Death|0|||
13262126|NCT01471574|26399718|FG000|Follow-up Period|Follow-up no longer required|0|||
13262127|NCT01471574|26399719|FG001|Follow-up Period|Follow-up no longer required|1|||
13262128|NCT01471574|26399720|FG002|Follow-up Period|Follow-up no longer required|0|||
13262129|NCT01471574|26399721|FG003|Follow-up Period|Follow-up no longer required|0|||
13262130|NCT01471522|26399752|FG000|Overall Study|Withdrawal by Subject|28|||
13262131|NCT01471522|26399753|FG001|Overall Study|Withdrawal by Subject|22|||
13262132|NCT01471522|26399752|FG000|Overall Study|Lost to Follow-up|36|||
13262133|NCT01471522|26399753|FG001|Overall Study|Lost to Follow-up|26|||
13262134|NCT01471379|26399783|FG000|Overall Study|Adverse Event|1|||
13262135|NCT01471379|26399784|FG001|Overall Study|Adverse Event|0|||
13262136|NCT01471379|26399785|FG002|Overall Study|Adverse Event|0|||
13262137|NCT01471379|26399783|FG000|Overall Study|Study terminated|0|||
13262138|NCT01471379|26399784|FG001|Overall Study|Study terminated|1|||
13262139|NCT01471379|26399785|FG002|Overall Study|Study terminated|0|||
13262140|NCT01471353|26399796|FG000|Overall Study|remain on study|3|||
13262141|NCT01471340|26399813|FG000|Overall Study|Death|5|||
13262142|NCT01471340|26399814|FG001|Overall Study|Death|4|||
13262143|NCT01471340|26399813|FG000|Overall Study|Lost to Follow-up|0|||
13262144|NCT01471340|26399814|FG001|Overall Study|Lost to Follow-up|1|||
13262145|NCT01471340|26399813|FG000|Overall Study|Investigational site closure|0|||
13262146|NCT01471340|26399814|FG001|Overall Study|Investigational site closure|1|||
13262147|NCT01471340|26399813|FG000|Overall Study|Invalid informed consent|1|||
13262148|NCT01471340|26399814|FG001|Overall Study|Invalid informed consent|0|||
13262149|NCT01471197|26399831|FG000|Overall Study|Disease Progression|4|||
13262150|NCT01471197|26399832|FG001|Overall Study|Disease Progression|2|||
13262151|NCT01471197|26399831|FG000|Overall Study|Death|1|||
13262152|NCT01471197|26399832|FG001|Overall Study|Death|0|||
13262153|NCT01471197|26399831|FG000|Overall Study|Study Drug Toxicity|1|||
13262154|NCT01471197|26399832|FG001|Overall Study|Study Drug Toxicity|0|||
13262155|NCT01471171|26399845|FG000|Treatment Period 1|Adverse Event|4|||
13262156|NCT01471171|26399846|FG001|Treatment Period 1|Adverse Event|1|||
13262157|NCT01471171|26399845|FG000|Treatment Period 2|Adverse Event|1|||
13262158|NCT01471171|26399846|FG001|Treatment Period 2|Adverse Event|0|||
13262159|NCT01471093|26399863|FG000|Overall Study|Adverse Event|1|||
13262160|NCT01471093|26399864|FG001|Overall Study|Adverse Event|0|||
13262161|NCT01471093|26399865|FG002|Overall Study|Adverse Event|0|||
13262162|NCT01471093|26399866|FG003|Overall Study|Adverse Event|0|||
13262163|NCT01471054|26399889|FG000|Overall Study|Study terminated prematurely|4|||
13262164|NCT01471054|26399890|FG001|Overall Study|Study terminated prematurely|0|||
13262165|NCT01471028|26399909|FG000|VTI-208|Adverse Event|39|||
13262166|NCT01471028|26399910|FG001|VTI-208|Adverse Event|41|||
13262167|NCT01471028|26399909|FG000|VTI-208|Withdrawal by Subject|0|||
13262168|NCT01471028|26399910|FG001|VTI-208|Withdrawal by Subject|2|||
13262169|NCT01471028|26399909|FG000|VTI-208|Lost to Follow-up|1|||
13262170|NCT01471028|26399910|FG001|VTI-208|Lost to Follow-up|1|||
13262171|NCT01471028|26399909|FG000|VTI-208E|Death|7|||
13262172|NCT01471028|26399910|FG001|VTI-208E|Death|10|||
13262173|NCT01471028|26399909|FG000|VTI-208E|Withdrawal by Subject|1|||
13262174|NCT01471028|26399910|FG001|VTI-208E|Withdrawal by Subject|0|||
13262175|NCT01471028|26399909|FG000|VTI-208E|Lost to Follow-up|0|||
13262176|NCT01471028|26399910|FG001|VTI-208E|Lost to Follow-up|2|||
13262177|NCT01471015|26399932|FG000|Overall Study|Death|0|||
13262178|NCT01471015|26399933|FG001|Overall Study|Death|1|||
13262179|NCT01471015|26399934|FG002|Overall Study|Death|1|||
13262180|NCT01470989|26399951|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103|||
13262181|NCT01470989|26399952|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136|||
13262182|NCT01470989|26399951|FG000|Overall Study|Adverse Event|2|||
13262183|NCT01470989|26399952|FG001|Overall Study|Adverse Event|5|||
13262184|NCT01470989|26399951|FG000|Overall Study|Abnormal laboratory value|1|||
13262185|NCT01470989|26399952|FG001|Overall Study|Abnormal laboratory value|1|||
13262186|NCT01470989|26399951|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
13262187|NCT01470989|26399952|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
13262188|NCT01470989|26399951|FG000|Overall Study|Withdrawal by Subject|19|||
13262189|NCT01470989|26399952|FG001|Overall Study|Withdrawal by Subject|17|||
13262190|NCT01470989|26399951|FG000|Overall Study|Lost to Follow-up|18|||
13262191|NCT01470989|26399952|FG001|Overall Study|Lost to Follow-up|13|||
13262192|NCT01470989|26399951|FG000|Overall Study|Administrative problems|2|||
13262193|NCT01470989|26399952|FG001|Overall Study|Administrative problems|4|||
13262194|NCT01470989|26399951|FG000|Overall Study|Death|2|||
13262195|NCT01470989|26399952|FG001|Overall Study|Death|2|||
13262196|NCT01470989|26399951|FG000|Overall Study|Protocol deviation|1|||
13262197|NCT01470989|26399952|FG001|Overall Study|Protocol deviation|2|||
13290501|NCT00102440|26481270|FG002|Overall Study|Protocol Violation|1|||
13290502|NCT00101907|26481329|FG000|Overall Study|Adverse Event|1|||
13290503|NCT00101907|26481330|FG001|Overall Study|Adverse Event|0|||
13290504|NCT00101907|26481331|FG002|Overall Study|Adverse Event|0|||
13290505|NCT00101907|26481332|FG003|Overall Study|Adverse Event|0|||
13290506|NCT00101907|26481333|FG004|Overall Study|Adverse Event|0|||
13290507|NCT00101907|26481334|FG005|Overall Study|Adverse Event|0|||
13290508|NCT00101907|26481329|FG000|Overall Study|Death|0|||
13290509|NCT00101907|26481330|FG001|Overall Study|Death|1|||
13290510|NCT00101907|26481331|FG002|Overall Study|Death|0|||
13290511|NCT00101907|26481332|FG003|Overall Study|Death|0|||
13290512|NCT00101907|26481333|FG004|Overall Study|Death|3|||
13290513|NCT00101907|26481334|FG005|Overall Study|Death|0|||
13290514|NCT00101907|26481329|FG000|Overall Study|Physician Decision|0|||
13290515|NCT00101907|26481330|FG001|Overall Study|Physician Decision|0|||
13290516|NCT00101907|26481331|FG002|Overall Study|Physician Decision|0|||
13290517|NCT00101907|26481332|FG003|Overall Study|Physician Decision|1|||
13290518|NCT00101907|26481333|FG004|Overall Study|Physician Decision|1|||
13290519|NCT00101907|26481334|FG005|Overall Study|Physician Decision|0|||
13290520|NCT00101907|26481329|FG000|Overall Study|Withdrawal by Subject|1|||
13290521|NCT00101907|26481330|FG001|Overall Study|Withdrawal by Subject|0|||
13290522|NCT00101907|26481331|FG002|Overall Study|Withdrawal by Subject|1|||
13290523|NCT00101907|26481332|FG003|Overall Study|Withdrawal by Subject|0|||
13290524|NCT00101907|26481333|FG004|Overall Study|Withdrawal by Subject|1|||
13290525|NCT00101907|26481334|FG005|Overall Study|Withdrawal by Subject|0|||
13290526|NCT00101686|26481410|FG000|Overall Study|Progressive Disease|37|||
13290527|NCT00101686|26481411|FG001|Overall Study|Progressive Disease|28|||
13290528|NCT00101686|26481412|FG002|Overall Study|Progressive Disease|37|||
13290529|NCT00101686|26481413|FG003|Overall Study|Progressive Disease|38|||
13290530|NCT00101686|26481414|FG004|Overall Study|Progressive Disease|28|||
13290531|NCT00101686|26481415|FG005|Overall Study|Progressive Disease|25|||
13290532|NCT00101686|26481416|FG006|Overall Study|Progressive Disease|5|||
13290533|NCT00101686|26481417|FG007|Overall Study|Progressive Disease|7|||
13290534|NCT00101686|26481418|FG008|Overall Study|Progressive Disease|10|||
13290535|NCT00101686|26481419|FG009|Overall Study|Progressive Disease|8|||
13290536|NCT00101686|26481410|FG000|Overall Study|initiation other anti-cancer treatment|4|||
13290537|NCT00101686|26481411|FG001|Overall Study|initiation other anti-cancer treatment|3|||
13290538|NCT00101686|26481412|FG002|Overall Study|initiation other anti-cancer treatment|4|||
13290539|NCT00101686|26481413|FG003|Overall Study|initiation other anti-cancer treatment|3|||
13290540|NCT00101686|26481414|FG004|Overall Study|initiation other anti-cancer treatment|1|||
13290541|NCT00101686|26481415|FG005|Overall Study|initiation other anti-cancer treatment|1|||
13290542|NCT00101686|26481416|FG006|Overall Study|initiation other anti-cancer treatment|2|||
13290543|NCT00101686|26481417|FG007|Overall Study|initiation other anti-cancer treatment|2|||
13290544|NCT00101686|26481418|FG008|Overall Study|initiation other anti-cancer treatment|3|||
13290545|NCT00101686|26481419|FG009|Overall Study|initiation other anti-cancer treatment|3|||
13290546|NCT00101686|26481410|FG000|Overall Study|>3 week delay treatment due toxicity|6|||
13290547|NCT00101686|26481411|FG001|Overall Study|>3 week delay treatment due toxicity|2|||
13290548|NCT00101686|26481412|FG002|Overall Study|>3 week delay treatment due toxicity|1|||
13262198|NCT01470612|26399995|FG000|Overall Study|Adverse Event|20|||
13262199|NCT01470612|26399996|FG001|Overall Study|Adverse Event|80|||
13262200|NCT01470612|26399995|FG000|Overall Study|Death|0|||
13262201|NCT01470612|26399996|FG001|Overall Study|Death|1|||
13262202|NCT01470612|26399995|FG000|Overall Study|Lack of Efficacy|20|||
13262203|NCT01470612|26399996|FG001|Overall Study|Lack of Efficacy|326|||
13262204|NCT01470612|26399995|FG000|Overall Study|Lost to Follow-up|2|||
13262205|NCT01470612|26399996|FG001|Overall Study|Lost to Follow-up|5|||
13262206|NCT01470612|26399995|FG000|Overall Study|Did not meet entrance criteria|0|||
13262207|NCT01470612|26399996|FG001|Overall Study|Did not meet entrance criteria|1|||
13262208|NCT01470612|26399995|FG000|Overall Study|Pregnancy|2|||
13262209|NCT01470612|26399996|FG001|Overall Study|Pregnancy|10|||
13262210|NCT01470612|26399995|FG000|Overall Study|Protocol Violation|2|||
13262211|NCT01470612|26399996|FG001|Overall Study|Protocol Violation|7|||
13262212|NCT01470612|26399995|FG000|Overall Study|Withdrawal by Subject|24|||
13262213|NCT01470612|26399996|FG001|Overall Study|Withdrawal by Subject|79|||
13262214|NCT01470612|26399995|FG000|Overall Study|Other|14|||
13262215|NCT01470612|26399996|FG001|Overall Study|Other|156|||
13262216|NCT01470599|26400065|FG000|Overall Study|Did not meet entrance criteria|1|||
13262217|NCT01470599|26400066|FG001|Overall Study|Did not meet entrance criteria|0|||
13262218|NCT01470599|26400065|FG000|Overall Study|Lost to Follow-up|2|||
13262219|NCT01470599|26400066|FG001|Overall Study|Lost to Follow-up|1|||
13262220|NCT01470599|26400065|FG000|Overall Study|Withdrawal by Subject|3|||
13262221|NCT01470599|26400066|FG001|Overall Study|Withdrawal by Subject|4|||
13262222|NCT01470599|26400065|FG000|Overall Study|Other|1|||
13262223|NCT01470599|26400066|FG001|Overall Study|Other|0|||
13262224|NCT01470599|26400065|FG000|Overall Study|Protocol Violation|3|||
13262225|NCT01470599|26400066|FG001|Overall Study|Protocol Violation|1|||
13262226|NCT01470599|26400065|FG000|Overall Study|Adverse event related to study drug|2|||
13262227|NCT01470599|26400066|FG001|Overall Study|Adverse event related to study drug|5|||
13262228|NCT01470599|26400065|FG000|Overall Study|Insufficient clinical response|6|||
13262229|NCT01470599|26400066|FG001|Overall Study|Insufficient clinical response|27|||
13262230|NCT01470599|26400065|FG000|Overall Study|Adverse event not related to study drug|1|||
13262231|NCT01470599|26400066|FG001|Overall Study|Adverse event not related to study drug|5|||
13262232|NCT01470469|26400091|FG000|Overall Study|Withdrawal by Subject|4|||
13117449|NCT03056690|25925544|FG000|Overall Study|Adverse Event|3|||
13117450|NCT03056690|25925545|FG001|Overall Study|Adverse Event|2|||
13117451|NCT03056690|25925544|FG000|Overall Study|Lack of Efficacy|1|||
13117452|NCT03056690|25925545|FG001|Overall Study|Lack of Efficacy|2|||
13117453|NCT03056690|25925544|FG000|Overall Study|Lost to Follow-up|3|||
13117454|NCT03056690|25925545|FG001|Overall Study|Lost to Follow-up|2|||
13117455|NCT03056690|25925544|FG000|Overall Study|Protocol Violation|2|||
13117456|NCT03056690|25925545|FG001|Overall Study|Protocol Violation|2|||
13117457|NCT03056690|25925544|FG000|Overall Study|Withdrawal by Subject|3|||
13117458|NCT03056690|25925545|FG001|Overall Study|Withdrawal by Subject|6|||
13117459|NCT03056690|25925544|FG000|Overall Study|Non-compliance with Study Drug|1|||
13117460|NCT03056690|25925545|FG001|Overall Study|Non-compliance with Study Drug|0|||
13117461|NCT03056690|25925544|FG000|Overall Study|Miscellaneous|1|||
13262233|NCT01470469|26400092|FG001|Overall Study|Withdrawal by Subject|6|||
13262234|NCT01470469|26400091|FG000|Overall Study|Lack of Efficacy|1|||
13117462|NCT03056690|25925545|FG001|Overall Study|Miscellaneous|2|||
13117463|NCT03056573|25925596|FG000|Overall Study|Death|2|||
13117464|NCT03056573|25925597|FG001|Overall Study|Death|4|||
13117465|NCT03056573|25925596|FG000|Overall Study|Withdrawal by Subject|2|||
13117466|NCT03056573|25925597|FG001|Overall Study|Withdrawal by Subject|0|||
13117467|NCT03056573|25925596|FG000|Overall Study|Lost to Follow-up|1|||
13117468|NCT03056573|25925597|FG001|Overall Study|Lost to Follow-up|1|||
13117469|NCT03056352|25925605|FG000|Overall Study|Lost to Follow-up|1|||
13117470|NCT03056300|25925612|FG000|Overall Study|Surgical reason per study protocol|3|||
13117471|NCT03056040|25925633|FG000|Primary Evaluation Period|Withdrawal by Subject|1|||
13117472|NCT03056040|25925634|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
13117473|NCT03056040|25925633|FG000|Primary Evaluation Period|Lack of Efficacy|0|||
13117474|NCT03056040|25925634|FG001|Primary Evaluation Period|Lack of Efficacy|1|||
13117475|NCT03056040|25925633|FG000|Primary Evaluation Period|Pregnancy|0|||
13117476|NCT03056040|25925634|FG001|Primary Evaluation Period|Pregnancy|1|||
13117477|NCT03055988|25925659|FG000|Period 1|Adverse Event|0|||
13117478|NCT03055988|25925660|FG001|Period 1|Adverse Event|1|||
13262235|NCT01470469|26400092|FG001|Overall Study|Lack of Efficacy|7|||
13262236|NCT01470469|26400091|FG000|Overall Study|Adverse Event|0|||
13262237|NCT01470469|26400092|FG001|Overall Study|Adverse Event|7|||
13262238|NCT01470469|26400091|FG000|Overall Study|Lost to Follow-up|2|||
13117479|NCT03055988|25925659|FG000|Period 1|Lost to Follow-up|1|||
13117480|NCT03055988|25925660|FG001|Period 1|Lost to Follow-up|0|||
13262239|NCT01470469|26400092|FG001|Overall Study|Lost to Follow-up|2|||
13262240|NCT01470469|26400091|FG000|Overall Study|Protocol Violation|1|||
13262241|NCT01470469|26400092|FG001|Overall Study|Protocol Violation|1|||
13262242|NCT01470469|26400091|FG000|Overall Study|Other|2|||
13117481|NCT03055988|25925659|FG000|Period 1|Withdrawal by Subject|0|||
13117482|NCT03055988|25925660|FG001|Period 1|Withdrawal by Subject|4|||
13117483|NCT03055988|25925659|FG000|Period 2|Adverse Event|0|||
13262243|NCT01470469|26400092|FG001|Overall Study|Other|1|||
13262244|NCT01470417|26400111|FG000|Overall Study|Disease progression|0|||
13262245|NCT01470417|26400112|FG001|Overall Study|Disease progression|2|||
13262246|NCT01470248|26400121|FG000|Overall Study|Withdrawal by Subject|1|||
13262247|NCT01470144|26400128|FG000|Overall Study|Adverse Event|2|||
13262248|NCT01470144|26400128|FG000|Overall Study|Death|1|||
13262249|NCT01470144|26400128|FG000|Overall Study|Lung transplant|6|||
13262250|NCT01470144|26400128|FG000|Overall Study|Patient's and investigator's decision|1|||
13262251|NCT01470001|26400145|FG000|Overall Study|Lost to Follow-up|1|||
13262252|NCT01470001|26400146|FG001|Overall Study|Lost to Follow-up|1|||
13262253|NCT01470001|26400145|FG000|Overall Study|Physician Decision|2|||
13262254|NCT01470001|26400146|FG001|Overall Study|Physician Decision|0|||
13262255|NCT01470001|26400145|FG000|Overall Study|Withdrawal by Subject|2|||
13262256|NCT01470001|26400146|FG001|Overall Study|Withdrawal by Subject|1|||
13262257|NCT01469819|26400158|FG000|Overall Study|Withdrawal by Subject|1|||
13262258|NCT01469819|26400158|FG000|Overall Study|Did not meet inclusionary criteria|2|||
13262259|NCT01469819|26400158|FG000|Overall Study|Could not swallow SmartPill|2|||
13262260|NCT01469819|26400158|FG000|Overall Study|Technical malfunction of SmartPill data|3|||
13262261|NCT01469637|26400173|FG000|First Intervention|Unacceptable behavior|0|||
13262262|NCT01469637|26400174|FG001|First Intervention|Unacceptable behavior|1|||
13262263|NCT01469637|26400173|FG000|Second Intervention|Incarcerated|1|||
13262264|NCT01469637|26400174|FG001|Second Intervention|Incarcerated|0|||
13486298|NCT02429791|27035712|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4|||
13486299|NCT02429791|27035711|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3|||
13486300|NCT02429791|27035712|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
13486301|NCT02429791|27035711|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11|||
13486302|NCT02429791|27035712|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12|||
13486303|NCT02429791|27035711|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
13486304|NCT02429791|27035712|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4|||
13486305|NCT02429791|27035711|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4|||
13486306|NCT02429791|27035712|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
13486307|NCT02429791|27035711|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0|||
13486308|NCT02429791|27035712|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1|||
13486309|NCT02429791|27035711|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
13486310|NCT02429791|27035712|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
13486311|NCT02429791|27035711|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7|||
13486312|NCT02429791|27035712|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5|||
13486313|NCT02422797|27035805|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11|||
13486314|NCT02422797|27035806|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1|||
13486315|NCT02422797|27035805|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
13486316|NCT02422797|27035806|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1|||
13486317|NCT02422797|27035805|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
13486318|NCT02422797|27035806|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
13486319|NCT02422797|27035805|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
13486320|NCT02422797|27035806|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
13486321|NCT02422797|27035805|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0|||
13486322|NCT02422797|27035806|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3|||
13486323|NCT02422797|27035805|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
13486324|NCT02422797|27035806|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
13486325|NCT02422797|27035805|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2|||
13486326|NCT02422797|27035806|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
13486327|NCT02422797|27035805|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
13486328|NCT02422797|27035806|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1|||
13486329|NCT02422797|27035805|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10|||
13486330|NCT02422797|27035806|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6|||
13486331|NCT02422797|27035805|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5|||
13486332|NCT02422797|27035806|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
13486333|NCT02422797|27035805|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
13486334|NCT02422797|27035806|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
13486335|NCT02422797|27035805|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2|||
13117484|NCT03055988|25925660|FG001|Period 2|Adverse Event|1|||
13262265|NCT01469546|26400183|FG000|Received 5 mg Dose|Adverse Event|13|||
13262266|NCT01469546|26400183|FG000|Received 5 mg Dose|Death|2|||
13262267|NCT01469546|26400183|FG000|Received 5 mg Dose|Protocol Violation|2|||
13262268|NCT01469546|26400183|FG000|Received 5 mg Dose|Progressive Disease|3|||
13262269|NCT01469546|26400183|FG000|Received 5 mg Dose|Physician Decision|3|||
13262270|NCT01469377|26400204|FG000|Overall Study|Protocol Deviation|7|||
13262271|NCT01469377|26400205|FG001|Overall Study|Protocol Deviation|10|||
13262272|NCT01469377|26400206|FG002|Overall Study|Protocol Deviation|10|||
13262273|NCT01469377|26400204|FG000|Overall Study|Lost to Follow-up|3|||
13262274|NCT01469377|26400205|FG001|Overall Study|Lost to Follow-up|2|||
13262275|NCT01469377|26400206|FG002|Overall Study|Lost to Follow-up|5|||
13262276|NCT01469377|26400204|FG000|Overall Study|Withdrawal of Consent|12|||
13262277|NCT01469377|26400205|FG001|Overall Study|Withdrawal of Consent|14|||
13262278|NCT01469377|26400206|FG002|Overall Study|Withdrawal of Consent|15|||
13262279|NCT01469377|26400204|FG000|Overall Study|Adverse Event|8|||
13262280|NCT01469377|26400205|FG001|Overall Study|Adverse Event|18|||
13262281|NCT01469377|26400206|FG002|Overall Study|Adverse Event|36|||
13262282|NCT01469377|26400204|FG000|Overall Study|Insufficient Therapeutic Response|3|||
13262283|NCT01469377|26400205|FG001|Overall Study|Insufficient Therapeutic Response|4|||
13262284|NCT01469377|26400206|FG002|Overall Study|Insufficient Therapeutic Response|0|||
13262285|NCT01469377|26400204|FG000|Overall Study|Other Miscellaneous Reasons|2|||
13262286|NCT01469377|26400205|FG001|Overall Study|Other Miscellaneous Reasons|0|||
13262287|NCT01469377|26400206|FG002|Overall Study|Other Miscellaneous Reasons|0|||
13262288|NCT01469364|26400223|FG000|Overall Study|Adverse Event|1|||
13262289|NCT01469364|26400223|FG000|Overall Study|Withdrawal by Subject|1|||
13262290|NCT01469221|26400240|FG000|Double Blind Phase|Protocol Violation|1|||
13262291|NCT01469221|26400241|FG001|Double Blind Phase|Protocol Violation|0|||
13262292|NCT01469221|26400242|FG002|Double Blind Phase|Protocol Violation|0|||
13262293|NCT01469221|26400240|FG000|Double Blind Phase|Physician Decision|1|||
13262294|NCT01469221|26400241|FG001|Double Blind Phase|Physician Decision|1|||
13262295|NCT01469221|26400242|FG002|Double Blind Phase|Physician Decision|0|||
13262296|NCT01469221|26400240|FG000|Double Blind Phase|Sponsor Terminate Study|12|||
13262297|NCT01469221|26400241|FG001|Double Blind Phase|Sponsor Terminate Study|16|||
13262298|NCT01469221|26400242|FG002|Double Blind Phase|Sponsor Terminate Study|0|||
13262299|NCT01469182|26400271|FG000|Overall Study|Adverse Event|21|||
13262300|NCT01469182|26400272|FG001|Overall Study|Adverse Event|3|||
13262301|NCT01469182|26400271|FG000|Overall Study|Lost to Follow-up|3|||
13262302|NCT01469182|26400272|FG001|Overall Study|Lost to Follow-up|0|||
13262303|NCT01469182|26400271|FG000|Overall Study|Withdrawal by Subject|4|||
13262304|NCT01469182|26400272|FG001|Overall Study|Withdrawal by Subject|1|||
13262305|NCT01469182|26400271|FG000|Overall Study|Protocol Violation|4|||
13262306|NCT01469182|26400272|FG001|Overall Study|Protocol Violation|2|||
13262307|NCT01469182|26400271|FG000|Overall Study|Did not meet Protocol Eligibility|3|||
13262308|NCT01469182|26400272|FG001|Overall Study|Did not meet Protocol Eligibility|0|||
13262309|NCT01469065|26400378|FG000|Overall Study|Lack of Efficacy|0|||
13262310|NCT01469065|26400379|FG001|Overall Study|Lack of Efficacy|0|||
13262311|NCT01469065|26400380|FG002|Overall Study|Lack of Efficacy|0|||
13262312|NCT01469065|26400381|FG003|Overall Study|Lack of Efficacy|0|||
13262313|NCT01469065|26400382|FG004|Overall Study|Lack of Efficacy|1|||
13262314|NCT01469065|26400378|FG000|Overall Study|Other|0|||
13262315|NCT01469065|26400379|FG001|Overall Study|Other|1|||
13262316|NCT01469065|26400380|FG002|Overall Study|Other|0|||
13262317|NCT01469065|26400381|FG003|Overall Study|Other|0|||
13262318|NCT01469065|26400382|FG004|Overall Study|Other|0|||
13262319|NCT01469052|26400445|FG000|Overall Study|Adverse Event|2|||
13262320|NCT01469052|26400446|FG001|Overall Study|Adverse Event|3|||
13262321|NCT01469052|26400447|FG002|Overall Study|Adverse Event|0|||
13262322|NCT01469052|26400448|FG003|Overall Study|Adverse Event|2|||
13262323|NCT01469052|26400449|FG004|Overall Study|Adverse Event|0|||
13262324|NCT01469052|26400450|FG005|Overall Study|Adverse Event|1|||
13262325|NCT01469052|26400445|FG000|Overall Study|Progressive disease|3|||
13262326|NCT01469052|26400446|FG001|Overall Study|Progressive disease|0|||
13262327|NCT01469052|26400447|FG002|Overall Study|Progressive disease|5|||
13262328|NCT01469052|26400448|FG003|Overall Study|Progressive disease|3|||
13262329|NCT01469052|26400449|FG004|Overall Study|Progressive disease|7|||
13262330|NCT01469052|26400450|FG005|Overall Study|Progressive disease|2|||
13262331|NCT01469052|26400445|FG000|Overall Study|Lack of Efficacy|0|||
13262332|NCT01469052|26400446|FG001|Overall Study|Lack of Efficacy|0|||
13262333|NCT01469052|26400447|FG002|Overall Study|Lack of Efficacy|0|||
13262334|NCT01469052|26400448|FG003|Overall Study|Lack of Efficacy|0|||
13262335|NCT01469052|26400449|FG004|Overall Study|Lack of Efficacy|0|||
13262336|NCT01469052|26400450|FG005|Overall Study|Lack of Efficacy|2|||
13117485|NCT03055988|25925659|FG000|Period 2|Other than listed|1|||
13117486|NCT03055988|25925660|FG001|Period 2|Other than listed|1|||
13117487|NCT03055936|25925739|FG000|Overall Study|Adverse Event|0|||
13262337|NCT01469052|26400445|FG000|Overall Study|Moved to rollover protocol|1|||
13262338|NCT01469052|26400446|FG001|Overall Study|Moved to rollover protocol|0|||
13262339|NCT01469052|26400447|FG002|Overall Study|Moved to rollover protocol|1|||
13262340|NCT01469052|26400448|FG003|Overall Study|Moved to rollover protocol|0|||
13262341|NCT01469052|26400449|FG004|Overall Study|Moved to rollover protocol|0|||
13262342|NCT01469052|26400450|FG005|Overall Study|Moved to rollover protocol|1|||
13262343|NCT01469052|26400445|FG000|Overall Study|Other|0|||
13262344|NCT01469052|26400446|FG001|Overall Study|Other|1|||
13262345|NCT01469052|26400447|FG002|Overall Study|Other|0|||
13262346|NCT01469052|26400448|FG003|Overall Study|Other|0|||
13262347|NCT01469052|26400449|FG004|Overall Study|Other|1|||
13262348|NCT01469052|26400450|FG005|Overall Study|Other|0|||
13262349|NCT01469013|26400557|FG000|Part A (Treatment Period)|Adverse Event|1|||
13262350|NCT01469013|26400558|FG001|Part A (Treatment Period)|Adverse Event|0|||
13262351|NCT01469013|26400559|FG002|Part A (Treatment Period)|Adverse Event|0|||
13262352|NCT01469013|26400560|FG003|Part A (Treatment Period)|Adverse Event|0|||
13262353|NCT01469013|26400561|FG004|Part A (Treatment Period)|Adverse Event|1|||
13262354|NCT01469013|26400562|FG005|Part A (Treatment Period)|Adverse Event|0|||
13262355|NCT01469013|26400563|FG006|Part A (Treatment Period)|Adverse Event|0|||
13262356|NCT01469013|26400564|FG007|Part A (Treatment Period)|Adverse Event|0|||
13262357|NCT01469013|26400565|FG008|Part A (Treatment Period)|Adverse Event|0|||
13262358|NCT01469013|26400566|FG009|Part A (Treatment Period)|Adverse Event|0|||
13262359|NCT01469013|26400567|FG010|Part A (Treatment Period)|Adverse Event|0|||
13262360|NCT01469013|26400568|FG011|Part A (Treatment Period)|Adverse Event|0|||
13262361|NCT01469013|26400569|FG012|Part A (Treatment Period)|Adverse Event|0|||
13262362|NCT01469013|26400557|FG000|Part A (Treatment Period)|Withdrawal by Subject|0|||
13262363|NCT01469013|26400558|FG001|Part A (Treatment Period)|Withdrawal by Subject|0|||
13262364|NCT01469013|26400559|FG002|Part A (Treatment Period)|Withdrawal by Subject|1|||
13262365|NCT01469013|26400560|FG003|Part A (Treatment Period)|Withdrawal by Subject|0|||
13262366|NCT01469013|26400561|FG004|Part A (Treatment Period)|Withdrawal by Subject|0|||
13262367|NCT01469013|26400562|FG005|Part A (Treatment Period)|Withdrawal by Subject|0|||
13262368|NCT01469013|26400563|FG006|Part A (Treatment Period)|Withdrawal by Subject|0|||
13262369|NCT01469013|26400564|FG007|Part A (Treatment Period)|Withdrawal by Subject|0|||
13262370|NCT01469013|26400565|FG008|Part A (Treatment Period)|Withdrawal by Subject|0|||
13262371|NCT01469013|26400566|FG009|Part A (Treatment Period)|Withdrawal by Subject|0|||
13262372|NCT01469013|26400567|FG010|Part A (Treatment Period)|Withdrawal by Subject|0|||
13262373|NCT01469013|26400568|FG011|Part A (Treatment Period)|Withdrawal by Subject|0|||
13262374|NCT01469013|26400569|FG012|Part A (Treatment Period)|Withdrawal by Subject|0|||
13262375|NCT01469013|26400557|FG000|Part B (Extension Period)|Adverse Event|0|||
13262376|NCT01469013|26400558|FG001|Part B (Extension Period)|Adverse Event|0|||
13262377|NCT01469013|26400559|FG002|Part B (Extension Period)|Adverse Event|0|||
13262378|NCT01469013|26400560|FG003|Part B (Extension Period)|Adverse Event|0|||
13262379|NCT01469013|26400561|FG004|Part B (Extension Period)|Adverse Event|0|||
13262380|NCT01469013|26400562|FG005|Part B (Extension Period)|Adverse Event|2|||
13262381|NCT01469013|26400563|FG006|Part B (Extension Period)|Adverse Event|5|||
13262382|NCT01469013|26400564|FG007|Part B (Extension Period)|Adverse Event|5|||
13262383|NCT01469013|26400565|FG008|Part B (Extension Period)|Adverse Event|3|||
13262384|NCT01469013|26400566|FG009|Part B (Extension Period)|Adverse Event|3|||
13262385|NCT01469013|26400567|FG010|Part B (Extension Period)|Adverse Event|1|||
13262386|NCT01469013|26400568|FG011|Part B (Extension Period)|Adverse Event|6|||
13262387|NCT01469013|26400569|FG012|Part B (Extension Period)|Adverse Event|3|||
13262388|NCT01469013|26400557|FG000|Part B (Extension Period)|Withdrawal by Subject|0|||
13262389|NCT01469013|26400558|FG001|Part B (Extension Period)|Withdrawal by Subject|0|||
13262390|NCT01469013|26400559|FG002|Part B (Extension Period)|Withdrawal by Subject|0|||
13262391|NCT01469013|26400560|FG003|Part B (Extension Period)|Withdrawal by Subject|0|||
13262392|NCT01469013|26400561|FG004|Part B (Extension Period)|Withdrawal by Subject|0|||
13262393|NCT01469013|26400562|FG005|Part B (Extension Period)|Withdrawal by Subject|0|||
13262394|NCT01469013|26400563|FG006|Part B (Extension Period)|Withdrawal by Subject|0|||
13262395|NCT01469013|26400564|FG007|Part B (Extension Period)|Withdrawal by Subject|0|||
13262396|NCT01469013|26400565|FG008|Part B (Extension Period)|Withdrawal by Subject|1|||
13262397|NCT01469013|26400566|FG009|Part B (Extension Period)|Withdrawal by Subject|0|||
13117488|NCT03055936|25925740|FG001|Overall Study|Adverse Event|1|||
13117489|NCT03055936|25925741|FG002|Overall Study|Adverse Event|1|||
13117490|NCT03055936|25925742|FG003|Overall Study|Adverse Event|1|||
13117491|NCT03055936|25925739|FG000|Overall Study|Personal reason|2|||
13117492|NCT03055936|25925740|FG001|Overall Study|Personal reason|0|||
13117493|NCT03055936|25925741|FG002|Overall Study|Personal reason|1|||
13117494|NCT03055936|25925742|FG003|Overall Study|Personal reason|0|||
13117495|NCT03055832|25925805|FG000|Week 2|Withdrawal by Subject|1|||
13117496|NCT03055832|25925806|FG001|Week 2|Withdrawal by Subject|0|||
13117497|NCT03055806|25925861|FG000|Overall Study|Adverse Event|0|||
13117498|NCT03055806|25925862|FG001|Overall Study|Adverse Event|0|||
13117499|NCT03055806|25925863|FG002|Overall Study|Adverse Event|1|||
13117500|NCT03055806|25925864|FG003|Overall Study|Adverse Event|1|||
13117501|NCT03055806|25925861|FG000|Overall Study|Lost to Follow-up|0|||
13117502|NCT03055806|25925862|FG001|Overall Study|Lost to Follow-up|3|||
13117503|NCT03055806|25925863|FG002|Overall Study|Lost to Follow-up|6|||
13262398|NCT01469013|26400567|FG010|Part B (Extension Period)|Withdrawal by Subject|1|||
13117504|NCT03055806|25925864|FG003|Overall Study|Lost to Follow-up|7|||
13262399|NCT01469013|26400568|FG011|Part B (Extension Period)|Withdrawal by Subject|0|||
13262400|NCT01469013|26400569|FG012|Part B (Extension Period)|Withdrawal by Subject|3|||
13262401|NCT01469000|26400594|FG000|Overall Study|Withdrawal by Subject|16|||
13117505|NCT03055806|25925861|FG000|Overall Study|Physician Decision|1|||
13117506|NCT03055806|25925862|FG001|Overall Study|Physician Decision|0|||
13117507|NCT03055806|25925863|FG002|Overall Study|Physician Decision|0|||
13262402|NCT01469000|26400595|FG001|Overall Study|Withdrawal by Subject|3|||
13262403|NCT01469000|26400594|FG000|Overall Study|Sponsor Decision|4|||
13262404|NCT01469000|26400595|FG001|Overall Study|Sponsor Decision|1|||
13262405|NCT01468987|26400646|FG000|Overall Study|Adverse Event|12|||
13262406|NCT01468987|26400647|FG001|Overall Study|Adverse Event|9|||
13262407|NCT01468987|26400646|FG000|Overall Study|Death|4|||
13262408|NCT01468987|26400647|FG001|Overall Study|Death|1|||
13262409|NCT01468987|26400646|FG000|Overall Study|Lost to Follow-up|10|||
13262410|NCT01468987|26400647|FG001|Overall Study|Lost to Follow-up|5|||
13262411|NCT01468987|26400646|FG000|Overall Study|Protocol Violation|8|||
13262412|NCT01468987|26400647|FG001|Overall Study|Protocol Violation|2|||
13262413|NCT01468987|26400646|FG000|Overall Study|Withdrawal by Subject|28|||
13262414|NCT01468987|26400647|FG001|Overall Study|Withdrawal by Subject|28|||
13262415|NCT01468987|26400646|FG000|Overall Study|Physician Decision|8|||
13262416|NCT01468987|26400647|FG001|Overall Study|Physician Decision|15|||
13262417|NCT01468987|26400646|FG000|Overall Study|Sponsor Decision|1|||
13262418|NCT01468987|26400647|FG001|Overall Study|Sponsor Decision|0|||
13262419|NCT01468909|26400668|FG000|Overall Study|Never Treated|2|||
13262420|NCT01468909|26400669|FG001|Overall Study|Never Treated|2|||
13262421|NCT01468844|26400714|FG000|Overall Study|Adverse Event|1|||
13262422|NCT01468844|26400715|FG001|Overall Study|Adverse Event|0|||
13262423|NCT01468844|26400714|FG000|Overall Study|Withdrawal by Subject|1|||
13262424|NCT01468844|26400715|FG001|Overall Study|Withdrawal by Subject|0|||
13262425|NCT01468818|26400722|FG000|Overall Study|Death during treatment|2|||
13262426|NCT01468701|26400819|FG000|Overall Study|Not eligible|91|||
13262427|NCT01468701|26400820|FG001|Overall Study|Not eligible|140|||
13262428|NCT01468701|26400821|FG002|Overall Study|Not eligible|29|||
13262429|NCT01468701|26400822|FG003|Overall Study|Not eligible|12|||
13262430|NCT01468701|26400823|FG004|Overall Study|Not eligible|22|||
13262431|NCT01468701|26400824|FG005|Overall Study|Not eligible|2|||
13262432|NCT01468701|26400825|FG006|Overall Study|Not eligible|39|||
13262433|NCT01468701|26400826|FG007|Overall Study|Not eligible|1|||
13262434|NCT01468701|26400827|FG008|Overall Study|Not eligible|40|||
13262435|NCT01468701|26400828|FG009|Overall Study|Not eligible|126|||
13262436|NCT01468701|26400829|FG010|Overall Study|Not eligible|39|||
13262437|NCT01468701|26400830|FG011|Overall Study|Not eligible|33|||
13262438|NCT01468701|26400831|FG012|Overall Study|Not eligible|1|||
13262439|NCT01468701|26400832|FG013|Overall Study|Not eligible|19|||
13262440|NCT01468701|26400833|FG014|Overall Study|Not eligible|1|||
13262441|NCT01468701|26400834|FG015|Overall Study|Not eligible|32|||
13262442|NCT01468701|26400835|FG016|Overall Study|Not eligible|0|||
13262443|NCT01468701|26400819|FG000|Overall Study|Lost to Follow-up|306|||
13262444|NCT01468701|26400820|FG001|Overall Study|Lost to Follow-up|0|||
13262445|NCT01468701|26400821|FG002|Overall Study|Lost to Follow-up|0|||
13262446|NCT01468701|26400822|FG003|Overall Study|Lost to Follow-up|0|||
13262447|NCT01468701|26400823|FG004|Overall Study|Lost to Follow-up|0|||
13262448|NCT01468701|26400824|FG005|Overall Study|Lost to Follow-up|0|||
13262449|NCT01468701|26400825|FG006|Overall Study|Lost to Follow-up|0|||
13262450|NCT01468701|26400826|FG007|Overall Study|Lost to Follow-up|0|||
13262451|NCT01468701|26400827|FG008|Overall Study|Lost to Follow-up|215|||
13262452|NCT01468701|26400828|FG009|Overall Study|Lost to Follow-up|309|||
13262453|NCT01468701|26400829|FG010|Overall Study|Lost to Follow-up|224|||
13117508|NCT03055806|25925864|FG003|Overall Study|Physician Decision|1|||
13117509|NCT03055806|25925861|FG000|Overall Study|Protocol Violation|1|||
13117510|NCT03055806|25925862|FG001|Overall Study|Protocol Violation|0|||
13262454|NCT01468701|26400830|FG011|Overall Study|Lost to Follow-up|212|||
13262455|NCT01468701|26400831|FG012|Overall Study|Lost to Follow-up|11|||
13262456|NCT01468701|26400832|FG013|Overall Study|Lost to Follow-up|164|||
13262457|NCT01468701|26400833|FG014|Overall Study|Lost to Follow-up|17|||
13262458|NCT01468701|26400834|FG015|Overall Study|Lost to Follow-up|127|||
13262459|NCT01468701|26400835|FG016|Overall Study|Lost to Follow-up|1|||
13262460|NCT01468701|26400819|FG000|Overall Study|Withdrawal by Subject|165|||
13262461|NCT01468701|26400820|FG001|Overall Study|Withdrawal by Subject|0|||
13262462|NCT01468701|26400821|FG002|Overall Study|Withdrawal by Subject|0|||
13262463|NCT01468701|26400822|FG003|Overall Study|Withdrawal by Subject|0|||
13262464|NCT01468701|26400823|FG004|Overall Study|Withdrawal by Subject|0|||
13262465|NCT01468701|26400824|FG005|Overall Study|Withdrawal by Subject|0|||
13262466|NCT01468701|26400825|FG006|Overall Study|Withdrawal by Subject|0|||
13262467|NCT01468701|26400826|FG007|Overall Study|Withdrawal by Subject|0|||
13262468|NCT01468701|26400827|FG008|Overall Study|Withdrawal by Subject|83|||
13262469|NCT01468701|26400828|FG009|Overall Study|Withdrawal by Subject|88|||
13262470|NCT01468701|26400829|FG010|Overall Study|Withdrawal by Subject|100|||
13262471|NCT01468701|26400830|FG011|Overall Study|Withdrawal by Subject|114|||
13262472|NCT01468701|26400831|FG012|Overall Study|Withdrawal by Subject|9|||
13262473|NCT01468701|26400832|FG013|Overall Study|Withdrawal by Subject|47|||
13262474|NCT01468701|26400833|FG014|Overall Study|Withdrawal by Subject|6|||
13262475|NCT01468701|26400834|FG015|Overall Study|Withdrawal by Subject|31|||
13117511|NCT03055806|25925863|FG002|Overall Study|Protocol Violation|0|||
13262476|NCT01468701|26400835|FG016|Overall Study|Withdrawal by Subject|0|||
13262477|NCT01468701|26400819|FG000|Overall Study|Other reasons than listed|437|||
13262478|NCT01468701|26400820|FG001|Overall Study|Other reasons than listed|0|||
13262479|NCT01468701|26400821|FG002|Overall Study|Other reasons than listed|0|||
13262480|NCT01468701|26400822|FG003|Overall Study|Other reasons than listed|0|||
13262481|NCT01468701|26400823|FG004|Overall Study|Other reasons than listed|0|||
13262482|NCT01468701|26400824|FG005|Overall Study|Other reasons than listed|0|||
13262483|NCT01468701|26400825|FG006|Overall Study|Other reasons than listed|0|||
13262484|NCT01468701|26400826|FG007|Overall Study|Other reasons than listed|0|||
13262485|NCT01468701|26400827|FG008|Overall Study|Other reasons than listed|318|||
13262486|NCT01468701|26400828|FG009|Overall Study|Other reasons than listed|658|||
13262487|NCT01468701|26400829|FG010|Overall Study|Other reasons than listed|433|||
13262488|NCT01468701|26400830|FG011|Overall Study|Other reasons than listed|504|||
13262489|NCT01468701|26400831|FG012|Overall Study|Other reasons than listed|28|||
13262490|NCT01468701|26400832|FG013|Overall Study|Other reasons than listed|239|||
13262491|NCT01468701|26400833|FG014|Overall Study|Other reasons than listed|39|||
13262492|NCT01468701|26400834|FG015|Overall Study|Other reasons than listed|172|||
13262493|NCT01468701|26400835|FG016|Overall Study|Other reasons than listed|0|||
13262494|NCT01468701|26400819|FG000|Overall Study|No end of study case report form|0|||
13262495|NCT01468701|26400820|FG001|Overall Study|No end of study case report form|0|||
13262496|NCT01468701|26400821|FG002|Overall Study|No end of study case report form|0|||
13262497|NCT01468701|26400822|FG003|Overall Study|No end of study case report form|0|||
13262498|NCT01468701|26400823|FG004|Overall Study|No end of study case report form|0|||
13262499|NCT01468701|26400824|FG005|Overall Study|No end of study case report form|0|||
13262500|NCT01468701|26400825|FG006|Overall Study|No end of study case report form|0|||
13262501|NCT01468701|26400826|FG007|Overall Study|No end of study case report form|0|||
13262502|NCT01468701|26400827|FG008|Overall Study|No end of study case report form|4|||
13262503|NCT01468701|26400828|FG009|Overall Study|No end of study case report form|1|||
13262504|NCT01468701|26400829|FG010|Overall Study|No end of study case report form|2|||
13262505|NCT01468701|26400830|FG011|Overall Study|No end of study case report form|3|||
13262506|NCT01468701|26400831|FG012|Overall Study|No end of study case report form|0|||
13262507|NCT01468701|26400832|FG013|Overall Study|No end of study case report form|1|||
13262508|NCT01468701|26400833|FG014|Overall Study|No end of study case report form|0|||
13262509|NCT01468701|26400834|FG015|Overall Study|No end of study case report form|0|||
13262510|NCT01468701|26400835|FG016|Overall Study|No end of study case report form|0|||
13262511|NCT01468701|26400819|FG000|Overall Study|Not being followed up|0|||
13262512|NCT01468701|26400820|FG001|Overall Study|Not being followed up|4963|||
13262513|NCT01468701|26400821|FG002|Overall Study|Not being followed up|1755|||
13262514|NCT01468701|26400822|FG003|Overall Study|Not being followed up|703|||
13262515|NCT01468701|26400823|FG004|Overall Study|Not being followed up|1714|||
13262516|NCT01468701|26400824|FG005|Overall Study|Not being followed up|126|||
13262517|NCT01468701|26400825|FG006|Overall Study|Not being followed up|1170|||
13262518|NCT01468701|26400826|FG007|Overall Study|Not being followed up|4|||
13262519|NCT01468701|26400827|FG008|Overall Study|Not being followed up|0|||
13262520|NCT01468701|26400828|FG009|Overall Study|Not being followed up|0|||
13262521|NCT01468701|26400829|FG010|Overall Study|Not being followed up|0|||
13262522|NCT01468701|26400830|FG011|Overall Study|Not being followed up|0|||
13262523|NCT01468701|26400831|FG012|Overall Study|Not being followed up|0|||
13262524|NCT01468701|26400832|FG013|Overall Study|Not being followed up|0|||
13262525|NCT01468701|26400833|FG014|Overall Study|Not being followed up|0|||
13262526|NCT01468701|26400834|FG015|Overall Study|Not being followed up|0|||
13262527|NCT01468701|26400835|FG016|Overall Study|Not being followed up|0|||
13262528|NCT01468597|26400842|FG000|Overall Study|Found ineligible|17|||
13262529|NCT01468597|26400842|FG000|Overall Study|concomitant valves|12|||
13262530|NCT01468597|26400842|FG000|Overall Study|off-pump CABG|1|||
13262531|NCT01468597|26400842|FG000|Overall Study|no platelet function data|5|||
13262532|NCT01468311|26400854|FG000|Overall Study|mobilization failure|1|||
13262533|NCT01468311|26400854|FG000|Overall Study|Withdrawal by Subject|1|||
13262534|NCT01468233|26400885|FG000|Treatment Period 1|Adverse Event|5|||
13262535|NCT01468233|26400886|FG001|Treatment Period 1|Adverse Event|3|||
13262536|NCT01468233|26400887|FG002|Treatment Period 1|Adverse Event|0|||
13262537|NCT01468233|26400888|FG003|Treatment Period 1|Adverse Event|0|||
13262538|NCT01468233|26400889|FG004|Treatment Period 1|Adverse Event|0|||
13262539|NCT01468233|26400890|FG005|Treatment Period 1|Adverse Event|0|||
13262540|NCT01468233|26400885|FG000|Treatment Period 1|Withdrawal by Subject|3|||
13262541|NCT01468233|26400886|FG001|Treatment Period 1|Withdrawal by Subject|4|||
13262542|NCT01468233|26400887|FG002|Treatment Period 1|Withdrawal by Subject|0|||
13262543|NCT01468233|26400888|FG003|Treatment Period 1|Withdrawal by Subject|0|||
13262544|NCT01468233|26400889|FG004|Treatment Period 1|Withdrawal by Subject|0|||
13262545|NCT01468233|26400890|FG005|Treatment Period 1|Withdrawal by Subject|0|||
13262546|NCT01468233|26400885|FG000|Treatment Period 1|Lost to Follow-up|3|||
13262547|NCT01468233|26400886|FG001|Treatment Period 1|Lost to Follow-up|0|||
13262548|NCT01468233|26400887|FG002|Treatment Period 1|Lost to Follow-up|0|||
13262549|NCT01468233|26400888|FG003|Treatment Period 1|Lost to Follow-up|0|||
13262550|NCT01468233|26400889|FG004|Treatment Period 1|Lost to Follow-up|0|||
13262551|NCT01468233|26400890|FG005|Treatment Period 1|Lost to Follow-up|0|||
13262552|NCT01468233|26400885|FG000|Treatment Period 1|Other|1|||
13262553|NCT01468233|26400886|FG001|Treatment Period 1|Other|1|||
13262554|NCT01468233|26400887|FG002|Treatment Period 1|Other|0|||
13262555|NCT01468233|26400888|FG003|Treatment Period 1|Other|0|||
13262556|NCT01468233|26400889|FG004|Treatment Period 1|Other|0|||
13262557|NCT01468233|26400890|FG005|Treatment Period 1|Other|0|||
13262558|NCT01468233|26400885|FG000|Treatment Period 2|Adverse Event|0|||
13262559|NCT01468233|26400886|FG001|Treatment Period 2|Adverse Event|0|||
13262560|NCT01468233|26400887|FG002|Treatment Period 2|Adverse Event|3|||
13262561|NCT01468233|26400888|FG003|Treatment Period 2|Adverse Event|0|||
13262562|NCT01468233|26400889|FG004|Treatment Period 2|Adverse Event|2|||
13262563|NCT01468233|26400890|FG005|Treatment Period 2|Adverse Event|1|||
13262564|NCT01468233|26400885|FG000|Treatment Period 2|Lack of Efficacy|0|||
13262565|NCT01468233|26400886|FG001|Treatment Period 2|Lack of Efficacy|0|||
13262566|NCT01468233|26400887|FG002|Treatment Period 2|Lack of Efficacy|9|||
13262567|NCT01468233|26400888|FG003|Treatment Period 2|Lack of Efficacy|2|||
13262568|NCT01468233|26400889|FG004|Treatment Period 2|Lack of Efficacy|0|||
13262569|NCT01468233|26400890|FG005|Treatment Period 2|Lack of Efficacy|1|||
13262570|NCT01468233|26400885|FG000|Treatment Period 2|Withdrawal by Subject|0|||
13262571|NCT01468233|26400886|FG001|Treatment Period 2|Withdrawal by Subject|0|||
13262572|NCT01468233|26400887|FG002|Treatment Period 2|Withdrawal by Subject|9|||
13262573|NCT01468233|26400888|FG003|Treatment Period 2|Withdrawal by Subject|1|||
13262574|NCT01468233|26400889|FG004|Treatment Period 2|Withdrawal by Subject|1|||
13262575|NCT01468233|26400890|FG005|Treatment Period 2|Withdrawal by Subject|1|||
13262576|NCT01468233|26400885|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0|||
13262577|NCT01468233|26400886|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0|||
13262578|NCT01468233|26400887|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84|||
13262579|NCT01468233|26400888|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25|||
13262580|NCT01468233|26400889|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22|||
13262581|NCT01468233|26400890|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20|||
13262582|NCT01468233|26400885|FG000|Treatment Period 2|Lost to Follow-up|0|||
13262583|NCT01468233|26400886|FG001|Treatment Period 2|Lost to Follow-up|0|||
13262584|NCT01468233|26400887|FG002|Treatment Period 2|Lost to Follow-up|3|||
13262585|NCT01468233|26400888|FG003|Treatment Period 2|Lost to Follow-up|0|||
13262586|NCT01468233|26400889|FG004|Treatment Period 2|Lost to Follow-up|2|||
13262587|NCT01468233|26400890|FG005|Treatment Period 2|Lost to Follow-up|0|||
13262588|NCT01468233|26400885|FG000|Treatment Period 2|Other|0|||
13262589|NCT01468233|26400886|FG001|Treatment Period 2|Other|0|||
13262590|NCT01468233|26400887|FG002|Treatment Period 2|Other|3|||
13262591|NCT01468233|26400888|FG003|Treatment Period 2|Other|0|||
13262592|NCT01468233|26400889|FG004|Treatment Period 2|Other|1|||
13262593|NCT01468233|26400890|FG005|Treatment Period 2|Other|0|||
13262594|NCT01468207|26400921|FG000|Treatment Period 1|Adverse Event|1|||
13262595|NCT01468207|26400922|FG001|Treatment Period 1|Adverse Event|0|||
13262596|NCT01468207|26400923|FG002|Treatment Period 1|Adverse Event|0|||
13262597|NCT01468207|26400924|FG003|Treatment Period 1|Adverse Event|0|||
13262598|NCT01468207|26400925|FG004|Treatment Period 1|Adverse Event|0|||
13262599|NCT01468207|26400926|FG005|Treatment Period 1|Adverse Event|0|||
13262600|NCT01468207|26400921|FG000|Treatment Period 1|Protocol Violation|1|||
13262601|NCT01468207|26400922|FG001|Treatment Period 1|Protocol Violation|1|||
13262602|NCT01468207|26400923|FG002|Treatment Period 1|Protocol Violation|0|||
13262603|NCT01468207|26400924|FG003|Treatment Period 1|Protocol Violation|0|||
13262604|NCT01468207|26400925|FG004|Treatment Period 1|Protocol Violation|0|||
13262605|NCT01468207|26400926|FG005|Treatment Period 1|Protocol Violation|0|||
13262606|NCT01468207|26400921|FG000|Treatment Period 1|Withdrawal by Subject|5|||
13262607|NCT01468207|26400922|FG001|Treatment Period 1|Withdrawal by Subject|4|||
13262608|NCT01468207|26400923|FG002|Treatment Period 1|Withdrawal by Subject|0|||
13262609|NCT01468207|26400924|FG003|Treatment Period 1|Withdrawal by Subject|0|||
13262610|NCT01468207|26400925|FG004|Treatment Period 1|Withdrawal by Subject|0|||
13262611|NCT01468207|26400926|FG005|Treatment Period 1|Withdrawal by Subject|0|||
13262612|NCT01468207|26400921|FG000|Treatment Period 1|Lost to Follow-up|2|||
13262613|NCT01468207|26400922|FG001|Treatment Period 1|Lost to Follow-up|1|||
13262614|NCT01468207|26400923|FG002|Treatment Period 1|Lost to Follow-up|0|||
13262615|NCT01468207|26400924|FG003|Treatment Period 1|Lost to Follow-up|0|||
13262616|NCT01468207|26400925|FG004|Treatment Period 1|Lost to Follow-up|0|||
13262617|NCT01468207|26400926|FG005|Treatment Period 1|Lost to Follow-up|0|||
13262618|NCT01468207|26400921|FG000|Treatment Period 1|Other|0|||
13262619|NCT01468207|26400922|FG001|Treatment Period 1|Other|2|||
13262620|NCT01468207|26400923|FG002|Treatment Period 1|Other|0|||
13262621|NCT01468207|26400924|FG003|Treatment Period 1|Other|0|||
13262622|NCT01468207|26400925|FG004|Treatment Period 1|Other|0|||
13262623|NCT01468207|26400926|FG005|Treatment Period 1|Other|0|||
13262624|NCT01468207|26400921|FG000|Treatment Period 2|Adverse Event|0|||
13262625|NCT01468207|26400922|FG001|Treatment Period 2|Adverse Event|0|||
13262626|NCT01468207|26400923|FG002|Treatment Period 2|Adverse Event|6|||
13262627|NCT01468207|26400924|FG003|Treatment Period 2|Adverse Event|1|||
13262628|NCT01468207|26400925|FG004|Treatment Period 2|Adverse Event|2|||
13262629|NCT01468207|26400926|FG005|Treatment Period 2|Adverse Event|1|||
13262630|NCT01468207|26400921|FG000|Treatment Period 2|Lack of Efficacy|0|||
13262631|NCT01468207|26400922|FG001|Treatment Period 2|Lack of Efficacy|0|||
13262632|NCT01468207|26400923|FG002|Treatment Period 2|Lack of Efficacy|1|||
13262633|NCT01468207|26400924|FG003|Treatment Period 2|Lack of Efficacy|1|||
13262634|NCT01468207|26400925|FG004|Treatment Period 2|Lack of Efficacy|0|||
13262635|NCT01468207|26400926|FG005|Treatment Period 2|Lack of Efficacy|2|||
13262636|NCT01468207|26400921|FG000|Treatment Period 2|Withdrawal by Subject|0|||
13262637|NCT01468207|26400922|FG001|Treatment Period 2|Withdrawal by Subject|0|||
13262638|NCT01468207|26400923|FG002|Treatment Period 2|Withdrawal by Subject|5|||
13262639|NCT01468207|26400924|FG003|Treatment Period 2|Withdrawal by Subject|0|||
13262640|NCT01468207|26400925|FG004|Treatment Period 2|Withdrawal by Subject|0|||
13262641|NCT01468207|26400926|FG005|Treatment Period 2|Withdrawal by Subject|2|||
13262642|NCT01468207|26400921|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
13262643|NCT01468207|26400922|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
13262644|NCT01468207|26400923|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30|||
13262645|NCT01468207|26400924|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23|||
13262646|NCT01468207|26400925|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18|||
13262647|NCT01468207|26400926|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13|||
13262648|NCT01468207|26400921|FG000|Treatment Period 2|Lost to Follow-up|0|||
13262649|NCT01468207|26400922|FG001|Treatment Period 2|Lost to Follow-up|0|||
13262650|NCT01468207|26400923|FG002|Treatment Period 2|Lost to Follow-up|5|||
13262651|NCT01468207|26400924|FG003|Treatment Period 2|Lost to Follow-up|1|||
13262652|NCT01468207|26400925|FG004|Treatment Period 2|Lost to Follow-up|0|||
13262653|NCT01468207|26400926|FG005|Treatment Period 2|Lost to Follow-up|0|||
13262654|NCT01468207|26400921|FG000|Treatment Period 2|Other|0|||
13262655|NCT01468207|26400922|FG001|Treatment Period 2|Other|0|||
13262656|NCT01468207|26400923|FG002|Treatment Period 2|Other|5|||
13262657|NCT01468207|26400924|FG003|Treatment Period 2|Other|1|||
13262658|NCT01468207|26400925|FG004|Treatment Period 2|Other|1|||
13262659|NCT01468207|26400926|FG005|Treatment Period 2|Other|2|||
13262660|NCT01468181|26400989|FG000|Overall Study|Adverse Event|8|||
13262661|NCT01468181|26400990|FG001|Overall Study|Adverse Event|1|||
13262662|NCT01468181|26400991|FG002|Overall Study|Adverse Event|6|||
13262663|NCT01468181|26400992|FG003|Overall Study|Adverse Event|2|||
13262664|NCT01468181|26400993|FG004|Overall Study|Adverse Event|2|||
13262665|NCT01468181|26400989|FG000|Overall Study|Protocol Violation|2|||
13262666|NCT01468181|26400990|FG001|Overall Study|Protocol Violation|0|||
13262667|NCT01468181|26400991|FG002|Overall Study|Protocol Violation|1|||
13262668|NCT01468181|26400992|FG003|Overall Study|Protocol Violation|0|||
13262669|NCT01468181|26400993|FG004|Overall Study|Protocol Violation|1|||
13262670|NCT01468181|26400989|FG000|Overall Study|Physician Decision|0|||
13262671|NCT01468181|26400990|FG001|Overall Study|Physician Decision|0|||
13262672|NCT01468181|26400991|FG002|Overall Study|Physician Decision|0|||
13262673|NCT01468181|26400992|FG003|Overall Study|Physician Decision|1|||
13262674|NCT01468181|26400993|FG004|Overall Study|Physician Decision|1|||
13262675|NCT01468181|26400989|FG000|Overall Study|Lost to Follow-up|0|||
13262676|NCT01468181|26400990|FG001|Overall Study|Lost to Follow-up|0|||
13262677|NCT01468181|26400991|FG002|Overall Study|Lost to Follow-up|1|||
13262678|NCT01468181|26400992|FG003|Overall Study|Lost to Follow-up|0|||
13262679|NCT01468181|26400993|FG004|Overall Study|Lost to Follow-up|1|||
13262680|NCT01468181|26400989|FG000|Overall Study|Withdrawal by Subject|0|||
13262681|NCT01468181|26400990|FG001|Overall Study|Withdrawal by Subject|1|||
13262682|NCT01468181|26400991|FG002|Overall Study|Withdrawal by Subject|0|||
13262683|NCT01468181|26400992|FG003|Overall Study|Withdrawal by Subject|0|||
13262684|NCT01468181|26400993|FG004|Overall Study|Withdrawal by Subject|0|||
13262685|NCT01468077|26401036|FG000|Overall Study|Adverse Event|2|||
13262686|NCT01468077|26401037|FG001|Overall Study|Adverse Event|2|||
13262687|NCT01468077|26401036|FG000|Overall Study|Lack of Efficacy|1|||
13262688|NCT01468077|26401037|FG001|Overall Study|Lack of Efficacy|1|||
13262689|NCT01468077|26401036|FG000|Overall Study|Physician Decision|1|||
13262690|NCT01468077|26401037|FG001|Overall Study|Physician Decision|0|||
13262691|NCT01467960|26401070|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
13262692|NCT01467960|26401071|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
13262693|NCT01467960|26401072|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
13262694|NCT01467960|26401073|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
13262695|NCT01467960|26401074|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
13262696|NCT01467960|26401075|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
13262697|NCT01467713|26401138|FG000|Overall Study|Pretreatment Event or Adverse Event|9|||
13262698|NCT01467713|26401139|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
13262699|NCT01467713|26401140|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
13262700|NCT01467713|26401141|FG003|Overall Study|Pretreatment Event or Adverse Event|5|||
13262701|NCT01467713|26401138|FG000|Overall Study|Major Protocol Deviation|2|||
13262702|NCT01467713|26401139|FG001|Overall Study|Major Protocol Deviation|4|||
13262703|NCT01467713|26401140|FG002|Overall Study|Major Protocol Deviation|4|||
13262704|NCT01467713|26401141|FG003|Overall Study|Major Protocol Deviation|1|||
13262705|NCT01467713|26401138|FG000|Overall Study|Lost to Follow-up|9|||
13262706|NCT01467713|26401139|FG001|Overall Study|Lost to Follow-up|12|||
13262707|NCT01467713|26401140|FG002|Overall Study|Lost to Follow-up|6|||
13262708|NCT01467713|26401141|FG003|Overall Study|Lost to Follow-up|9|||
13262709|NCT01467713|26401138|FG000|Overall Study|Voluntary Withdrawal|18|||
13262710|NCT01467713|26401139|FG001|Overall Study|Voluntary Withdrawal|14|||
13262711|NCT01467713|26401140|FG002|Overall Study|Voluntary Withdrawal|21|||
13262712|NCT01467713|26401141|FG003|Overall Study|Voluntary Withdrawal|20|||
13262713|NCT01467713|26401138|FG000|Overall Study|Study Termination|23|||
13262714|NCT01467713|26401139|FG001|Overall Study|Study Termination|33|||
13262715|NCT01467713|26401140|FG002|Overall Study|Study Termination|28|||
13262716|NCT01467713|26401141|FG003|Overall Study|Study Termination|29|||
13262717|NCT01467713|26401138|FG000|Overall Study|Pregnancy|0|||
13262718|NCT01467713|26401139|FG001|Overall Study|Pregnancy|1|||
13262719|NCT01467713|26401140|FG002|Overall Study|Pregnancy|1|||
13262720|NCT01467713|26401141|FG003|Overall Study|Pregnancy|3|||
13262721|NCT01467713|26401138|FG000|Overall Study|Relapse|35|||
13262722|NCT01467713|26401139|FG001|Overall Study|Relapse|25|||
13262723|NCT01467713|26401140|FG002|Overall Study|Relapse|28|||
13262724|NCT01467713|26401141|FG003|Overall Study|Relapse|35|||
13262725|NCT01467713|26401138|FG000|Overall Study|Reason not Specified|6|||
13262726|NCT01467713|26401139|FG001|Overall Study|Reason not Specified|11|||
13262727|NCT01467713|26401140|FG002|Overall Study|Reason not Specified|8|||
13262728|NCT01467713|26401141|FG003|Overall Study|Reason not Specified|7|||
13262729|NCT01467700|26401196|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
13262730|NCT01467700|26401197|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
13262731|NCT01467700|26401198|FG002|Overall Study|Pretreatment Event or Adverse Event|2|||
13262732|NCT01467700|26401199|FG003|Overall Study|Pretreatment Event or Adverse Event|3|||
13262733|NCT01467700|26401196|FG000|Overall Study|Major Protocol Deviation|3|||
13262734|NCT01467700|26401197|FG001|Overall Study|Major Protocol Deviation|3|||
13262735|NCT01467700|26401198|FG002|Overall Study|Major Protocol Deviation|2|||
13262736|NCT01467700|26401199|FG003|Overall Study|Major Protocol Deviation|3|||
13262737|NCT01467700|26401196|FG000|Overall Study|Lost to Follow-up|6|||
13262738|NCT01467700|26401197|FG001|Overall Study|Lost to Follow-up|5|||
13262739|NCT01467700|26401198|FG002|Overall Study|Lost to Follow-up|2|||
13262740|NCT01467700|26401199|FG003|Overall Study|Lost to Follow-up|3|||
13262741|NCT01467700|26401196|FG000|Overall Study|Voluntary Withdrawal|5|||
13262742|NCT01467700|26401197|FG001|Overall Study|Voluntary Withdrawal|7|||
13262743|NCT01467700|26401198|FG002|Overall Study|Voluntary Withdrawal|6|||
13262744|NCT01467700|26401199|FG003|Overall Study|Voluntary Withdrawal|2|||
13262745|NCT01467700|26401196|FG000|Overall Study|Study Termination|6|||
13262746|NCT01467700|26401197|FG001|Overall Study|Study Termination|5|||
13262747|NCT01467700|26401198|FG002|Overall Study|Study Termination|10|||
13262748|NCT01467700|26401199|FG003|Overall Study|Study Termination|7|||
13262749|NCT01467700|26401196|FG000|Overall Study|Pregnancy|0|||
13262750|NCT01467700|26401197|FG001|Overall Study|Pregnancy|1|||
13262751|NCT01467700|26401198|FG002|Overall Study|Pregnancy|1|||
13262752|NCT01467700|26401199|FG003|Overall Study|Pregnancy|0|||
13262753|NCT01467700|26401196|FG000|Overall Study|Lack of Efficacy|2|||
13262754|NCT01467700|26401197|FG001|Overall Study|Lack of Efficacy|0|||
13262755|NCT01467700|26401198|FG002|Overall Study|Lack of Efficacy|2|||
13262756|NCT01467700|26401199|FG003|Overall Study|Lack of Efficacy|1|||
13262757|NCT01467700|26401196|FG000|Overall Study|Reason not Specified|1|||
13262758|NCT01467700|26401197|FG001|Overall Study|Reason not Specified|3|||
13262759|NCT01467700|26401198|FG002|Overall Study|Reason not Specified|2|||
13262760|NCT01467700|26401199|FG003|Overall Study|Reason not Specified|8|||
13262761|NCT01467661|26401218|FG000|Overall Study|Adverse Event|16|||
13262762|NCT01467661|26401218|FG000|Overall Study|Withdrawal by Subject|1|||
13262763|NCT01467661|26401218|FG000|Overall Study|Lack of Efficacy|3|||
13262764|NCT01467661|26401218|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1|||
13262765|NCT01467583|26401239|FG000|Overall Study|Death|1|||
13262766|NCT01467583|26401240|FG001|Overall Study|Death|1|||
13262767|NCT01467583|26401241|FG002|Overall Study|Death|0|||
13262768|NCT01467583|26401239|FG000|Overall Study|Withdrawal by Subject|1|||
13262769|NCT01467583|26401240|FG001|Overall Study|Withdrawal by Subject|0|||
13262770|NCT01467583|26401241|FG002|Overall Study|Withdrawal by Subject|0|||
13262771|NCT01467583|26401239|FG000|Overall Study|Protocol Violation|0|||
13262772|NCT01467583|26401240|FG001|Overall Study|Protocol Violation|0|||
13262773|NCT01467583|26401241|FG002|Overall Study|Protocol Violation|2|||
13262774|NCT01467570|26401272|FG000|Overall Study|Lost to Follow-up|8|||
13262775|NCT01467570|26401273|FG001|Overall Study|Lost to Follow-up|9|||
13262776|NCT01467505|26401310|FG000|Overall Study|Adverse Event|1|||
13262777|NCT01467505|26401311|FG001|Overall Study|Adverse Event|0|||
13262778|NCT01467505|26401310|FG000|Overall Study|Withdrawal by Subject|4|||
13262779|NCT01467505|26401311|FG001|Overall Study|Withdrawal by Subject|0|||
13262780|NCT01467505|26401310|FG000|Overall Study|Study Terminated by Sponsor|28|||
13262781|NCT01467505|26401311|FG001|Overall Study|Study Terminated by Sponsor|3|||
13262782|NCT01467492|26401339|FG000|Overall Study|Withdrawal by Subject|6|||
13262783|NCT01467492|26401340|FG001|Overall Study|Withdrawal by Subject|4|||
13262784|NCT01467492|26401339|FG000|Overall Study|Study Terminated by Sponsor|6|||
13262785|NCT01467492|26401340|FG001|Overall Study|Study Terminated by Sponsor|4|||
13262786|NCT01467492|26401339|FG000|Overall Study|Adverse Event|4|||
13262787|NCT01467492|26401340|FG001|Overall Study|Adverse Event|3|||
13262788|NCT01467492|26401339|FG000|Overall Study|Lost to Follow-up|3|||
13262789|NCT01467492|26401340|FG001|Overall Study|Lost to Follow-up|2|||
13262790|NCT01467492|26401339|FG000|Overall Study|Undefined|2|||
13262791|NCT01467492|26401340|FG001|Overall Study|Undefined|0|||
13262792|NCT01467492|26401339|FG000|Overall Study|Enrolled But Not Treated|1|||
13262793|NCT01467492|26401340|FG001|Overall Study|Enrolled But Not Treated|0|||
13262794|NCT01467479|26401377|FG000|Overall Study|No Study Medication|1|||
13262795|NCT01467479|26401378|FG001|Overall Study|No Study Medication|0|||
13262796|NCT01467479|26401379|FG002|Overall Study|No Study Medication|2|||
13262797|NCT01467479|26401377|FG000|Overall Study|Adverse Event|1|||
13262798|NCT01467479|26401378|FG001|Overall Study|Adverse Event|2|||
13117512|NCT03055806|25925864|FG003|Overall Study|Protocol Violation|0|||
13262799|NCT01467479|26401379|FG002|Overall Study|Adverse Event|0|||
13262800|NCT01467479|26401377|FG000|Overall Study|Death|0|||
13262801|NCT01467479|26401378|FG001|Overall Study|Death|0|||
13262802|NCT01467479|26401379|FG002|Overall Study|Death|1|||
13262803|NCT01467479|26401377|FG000|Overall Study|Lost to Follow-up|2|||
13262804|NCT01467479|26401378|FG001|Overall Study|Lost to Follow-up|5|||
13262805|NCT01467479|26401379|FG002|Overall Study|Lost to Follow-up|3|||
13262806|NCT01467479|26401377|FG000|Overall Study|Withdrawal of Consent|3|||
13262807|NCT01467479|26401378|FG001|Overall Study|Withdrawal of Consent|7|||
13262808|NCT01467479|26401379|FG002|Overall Study|Withdrawal of Consent|7|||
13262809|NCT01467479|26401377|FG000|Overall Study|Study Terminated by Sponsor|1|||
13262810|NCT01467479|26401378|FG001|Overall Study|Study Terminated by Sponsor|3|||
13262811|NCT01467479|26401379|FG002|Overall Study|Study Terminated by Sponsor|3|||
13262812|NCT01467479|26401377|FG000|Overall Study|Other|1|||
13262813|NCT01467479|26401378|FG001|Overall Study|Other|0|||
13262814|NCT01467479|26401379|FG002|Overall Study|Other|0|||
13262815|NCT01467466|26401402|FG000|Overall Study|Withdrawal by Subject|15|||
13262816|NCT01467466|26401403|FG001|Overall Study|Withdrawal by Subject|18|||
13262817|NCT01467466|26401404|FG002|Overall Study|Withdrawal by Subject|13|||
13262818|NCT01467466|26401405|FG003|Overall Study|Withdrawal by Subject|11|||
13262819|NCT01467466|26401402|FG000|Overall Study|Revoked Consent Prior To Procedure|10|||
13262820|NCT01467466|26401403|FG001|Overall Study|Revoked Consent Prior To Procedure|9|||
13262821|NCT01467466|26401404|FG002|Overall Study|Revoked Consent Prior To Procedure|15|||
13262822|NCT01467466|26401405|FG003|Overall Study|Revoked Consent Prior To Procedure|5|||
13262823|NCT01467466|26401402|FG000|Overall Study|Procedure Cancelled|46|||
13262824|NCT01467466|26401403|FG001|Overall Study|Procedure Cancelled|45|||
13262825|NCT01467466|26401404|FG002|Overall Study|Procedure Cancelled|25|||
13262826|NCT01467466|26401405|FG003|Overall Study|Procedure Cancelled|29|||
13262827|NCT01467466|26401402|FG000|Overall Study|No Endpoint Blood Draw|38|||
13262828|NCT01467466|26401403|FG001|Overall Study|No Endpoint Blood Draw|32|||
13262829|NCT01467466|26401404|FG002|Overall Study|No Endpoint Blood Draw|51|||
13262830|NCT01467466|26401405|FG003|Overall Study|No Endpoint Blood Draw|43|||
13262831|NCT01467427|26401430|FG000|Overall Study|Withdrawal by Subject|1|||
13262832|NCT01467427|26401431|FG001|Overall Study|Withdrawal by Subject|0|||
13262833|NCT01467427|26401430|FG000|Overall Study|Entered extension phase|11|||
13262834|NCT01467427|26401431|FG001|Overall Study|Entered extension phase|11|||
13117513|NCT03055806|25925861|FG000|Overall Study|Withdrawal of consent to continue drug|1|||
13117514|NCT03055806|25925862|FG001|Overall Study|Withdrawal of consent to continue drug|1|||
13117515|NCT03055806|25925863|FG002|Overall Study|Withdrawal of consent to continue drug|2|||
13117516|NCT03055806|25925864|FG003|Overall Study|Withdrawal of consent to continue drug|0|||
13117517|NCT03055806|25925861|FG000|Overall Study|Withdrawal of consent to continue study|2|||
13117518|NCT03055806|25925862|FG001|Overall Study|Withdrawal of consent to continue study|3|||
13117519|NCT03055806|25925863|FG002|Overall Study|Withdrawal of consent to continue study|4|||
13117520|NCT03055806|25925864|FG003|Overall Study|Withdrawal of consent to continue study|6|||
13117521|NCT03055806|25925861|FG000|Overall Study|Partner not willing to try intercourse|1|||
13117522|NCT03055806|25925862|FG001|Overall Study|Partner not willing to try intercourse|0|||
13117523|NCT03055806|25925863|FG002|Overall Study|Partner not willing to try intercourse|0|||
13117524|NCT03055806|25925864|FG003|Overall Study|Partner not willing to try intercourse|0|||
13117525|NCT03055624|25925875|FG000|Overall Study|Study closed|9|||
13262835|NCT01467427|26401430|FG000|Overall Study|Not continuing in extension phase|0|||
13262836|NCT01467427|26401431|FG001|Overall Study|Not continuing in extension phase|2|||
13262837|NCT01467271|26401437|FG000|Overall Study|Death|84|||
13262838|NCT01467271|26401437|FG000|Overall Study|Lost to Follow-up|83|||
13262839|NCT01467271|26401437|FG000|Overall Study|Retraction of patient's consent|21|||
13262840|NCT01467271|26401437|FG000|Overall Study|Other reason|14|||
13262841|NCT01467076|26401482|FG000|Overall Study|Lost to Follow-up|1|||
13262842|NCT01467076|26401483|FG001|Overall Study|Lost to Follow-up|0|||
13262843|NCT01467076|26401484|FG002|Overall Study|Lost to Follow-up|0|||
13262844|NCT01466881|26401495|FG000|Overall Study|Ineligible|5|||
13262845|NCT01466881|26401495|FG000|Overall Study|Adverse Event|6|||
13262846|NCT01466881|26401495|FG000|Overall Study|Progression/relapse|20|||
13262847|NCT01466881|26401495|FG000|Overall Study|Death|4|||
13262848|NCT01466881|26401495|FG000|Overall Study|Other reason not protocol specified|5|||
13262849|NCT01466790|26401582|FG000|Overall Study|Adverse Event|1|||
13262850|NCT01466790|26401583|FG001|Overall Study|Adverse Event|0|||
13262851|NCT01466790|26401584|FG002|Overall Study|Adverse Event|0|||
13262852|NCT01466790|26401585|FG003|Overall Study|Adverse Event|0|||
13262853|NCT01466790|26401586|FG004|Overall Study|Adverse Event|2|||
13262854|NCT01466790|26401587|FG005|Overall Study|Adverse Event|0|||
13262855|NCT01466790|26401588|FG006|Overall Study|Adverse Event|0|||
13262856|NCT01466790|26401589|FG007|Overall Study|Adverse Event|0|||
13262857|NCT01466790|26401582|FG000|Overall Study|Lost to Follow-up|2|||
13262858|NCT01466790|26401583|FG001|Overall Study|Lost to Follow-up|0|||
13262859|NCT01466790|26401584|FG002|Overall Study|Lost to Follow-up|0|||
13262860|NCT01466790|26401585|FG003|Overall Study|Lost to Follow-up|0|||
13262861|NCT01466790|26401586|FG004|Overall Study|Lost to Follow-up|0|||
13262862|NCT01466790|26401587|FG005|Overall Study|Lost to Follow-up|0|||
13262863|NCT01466790|26401588|FG006|Overall Study|Lost to Follow-up|0|||
13262864|NCT01466790|26401589|FG007|Overall Study|Lost to Follow-up|0|||
13262865|NCT01466790|26401582|FG000|Overall Study|Withdrawal by Subject|1|||
13262866|NCT01466790|26401583|FG001|Overall Study|Withdrawal by Subject|1|||
13262867|NCT01466790|26401584|FG002|Overall Study|Withdrawal by Subject|0|||
13262868|NCT01466790|26401585|FG003|Overall Study|Withdrawal by Subject|0|||
13262869|NCT01466790|26401586|FG004|Overall Study|Withdrawal by Subject|1|||
13262870|NCT01466790|26401587|FG005|Overall Study|Withdrawal by Subject|0|||
13262871|NCT01466790|26401588|FG006|Overall Study|Withdrawal by Subject|1|||
13262872|NCT01466790|26401589|FG007|Overall Study|Withdrawal by Subject|1|||
13262873|NCT01466673|26401620|FG000|Overall Study|Non-compliance with study treatment|2|||
13262874|NCT01466673|26401621|FG001|Overall Study|Non-compliance with study treatment|0|||
13262875|NCT01466673|26401620|FG000|Overall Study|Lost to Follow-up|3|||
13262876|NCT01466673|26401621|FG001|Overall Study|Lost to Follow-up|5|||
13262877|NCT01466673|26401620|FG000|Overall Study|Adverse Event|2|||
13262878|NCT01466673|26401621|FG001|Overall Study|Adverse Event|1|||
13262879|NCT01466660|26401652|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120|||
13262880|NCT01466660|26401653|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127|||
13262881|NCT01466660|26401652|FG000|Overall Study|Worsening of underlying cancer disease|5|||
13262882|NCT01466660|26401653|FG001|Overall Study|Worsening of underlying cancer disease|2|||
13262883|NCT01466660|26401652|FG000|Overall Study|Other adverse event|19|||
13262884|NCT01466660|26401653|FG001|Overall Study|Other adverse event|18|||
13262885|NCT01466660|26401652|FG000|Overall Study|Protocol Violation|2|||
13262886|NCT01466660|26401653|FG001|Overall Study|Protocol Violation|1|||
13262887|NCT01466660|26401652|FG000|Overall Study|Refused continuation of trial medication|4|||
13262888|NCT01466660|26401653|FG001|Overall Study|Refused continuation of trial medication|3|||
13262889|NCT01466660|26401652|FG000|Overall Study|Other reason not defined above|10|||
13262890|NCT01466660|26401653|FG001|Overall Study|Other reason not defined above|8|||
13262891|NCT01466595|26401750|FG000|Overall Study|Withdrawal by Subject|0|||
13262892|NCT01466595|26401751|FG001|Overall Study|Withdrawal by Subject|1|||
13262893|NCT01466491|26401778|FG000|Overall Study|Protocol Violation|0|||
13262894|NCT01466491|26401779|FG001|Overall Study|Protocol Violation|3|||
13262895|NCT01466491|26401780|FG002|Overall Study|Protocol Violation|2|||
13262896|NCT01466491|26401781|FG003|Overall Study|Protocol Violation|0|||
13262897|NCT01466491|26401778|FG000|Overall Study|Missing Data|0|||
13262898|NCT01466491|26401779|FG001|Overall Study|Missing Data|0|||
13262899|NCT01466491|26401780|FG002|Overall Study|Missing Data|1|||
13262900|NCT01466491|26401781|FG003|Overall Study|Missing Data|0|||
13262901|NCT01466387|26401838|FG000|Overall Study|Adverse Event|0|||
13262902|NCT01466387|26401839|FG001|Overall Study|Adverse Event|0|||
13262903|NCT01466387|26401840|FG002|Overall Study|Adverse Event|1|||
13262904|NCT01466387|26401841|FG003|Overall Study|Adverse Event|1|||
13262905|NCT01466387|26401842|FG004|Overall Study|Adverse Event|0|||
13262906|NCT01466387|26401843|FG005|Overall Study|Adverse Event|0|||
13262907|NCT01466387|26401838|FG000|Overall Study|Lost to Follow-up|0|||
13262908|NCT01466387|26401839|FG001|Overall Study|Lost to Follow-up|0|||
13262909|NCT01466387|26401840|FG002|Overall Study|Lost to Follow-up|0|||
13262910|NCT01466387|26401841|FG003|Overall Study|Lost to Follow-up|0|||
13262911|NCT01466387|26401842|FG004|Overall Study|Lost to Follow-up|0|||
13262912|NCT01466387|26401843|FG005|Overall Study|Lost to Follow-up|1|||
13262913|NCT01466387|26401838|FG000|Overall Study|Protocol Violation|1|||
13262914|NCT01466387|26401839|FG001|Overall Study|Protocol Violation|0|||
13262915|NCT01466387|26401840|FG002|Overall Study|Protocol Violation|0|||
13262916|NCT01466387|26401841|FG003|Overall Study|Protocol Violation|1|||
13262917|NCT01466387|26401842|FG004|Overall Study|Protocol Violation|0|||
13262918|NCT01466387|26401843|FG005|Overall Study|Protocol Violation|0|||
13262919|NCT01466348|26401872|FG000|Period I - First Intervention|Withdrawal by Subject|0|||
13262920|NCT01466348|26401873|FG001|Period I - First Intervention|Withdrawal by Subject|1|||
13262921|NCT01466270|26401892|FG000|Overall Study|Withdrawal by Subject|4|||
13262922|NCT01466270|26401893|FG001|Overall Study|Withdrawal by Subject|1|||
13117526|NCT03055494|25925910|FG000|Overall Study|Lost to Follow-up|6|||
13262923|NCT01466270|26401892|FG000|Overall Study|Physician Decision|1|||
13262924|NCT01466270|26401893|FG001|Overall Study|Physician Decision|0|||
13262925|NCT01466270|26401892|FG000|Overall Study|Lost to Follow-up|1|||
13262926|NCT01466270|26401893|FG001|Overall Study|Lost to Follow-up|3|||
13262927|NCT01466270|26401892|FG000|Overall Study|Progression|1|||
13262928|NCT01466270|26401893|FG001|Overall Study|Progression|0|||
13262929|NCT01466270|26401892|FG000|Overall Study|Toxicity|4|||
13262930|NCT01466270|26401893|FG001|Overall Study|Toxicity|1|||
13262931|NCT01466270|26401892|FG000|Overall Study|Multiple|1|||
13262932|NCT01466270|26401893|FG001|Overall Study|Multiple|1|||
13262933|NCT01466192|26401899|FG000|Overall Study|Physician Decision|1|||
13262934|NCT01466192|26401899|FG000|Overall Study|Withdrawal by Subject|3|||
13262935|NCT01466179|26401921|FG000|Overall Study|Ongoing in core study|2|||
13262936|NCT01466179|26401921|FG000|Overall Study|Physician Decision|46|||
13262937|NCT01466179|26401921|FG000|Overall Study|Progressive disease|43|||
13262938|NCT01466179|26401921|FG000|Overall Study|Adverse Event|32|||
13262939|NCT01466179|26401921|FG000|Overall Study|Disease relapse|23|||
13262940|NCT01466179|26401921|FG000|Overall Study|Lack of Efficacy|14|||
13262941|NCT01466179|26401921|FG000|Overall Study|Death|7|||
13262942|NCT01466179|26401921|FG000|Overall Study|Withdrawal by Subject|7|||
13262943|NCT01466179|26401921|FG000|Overall Study|Protocol Violation|2|||
13262944|NCT01466179|26401921|FG000|Overall Study|Other|3|||
13262945|NCT01466166|26401934|FG000|Overall Study|Death|1|||
13262946|NCT01466166|26401934|FG000|Overall Study|Lost to Follow-up|7|||
13262947|NCT01466166|26401934|FG000|Overall Study|Infusion Reaction (IR)|27|||
13262948|NCT01466166|26401934|FG000|Overall Study|Adverse Event (Other than IR)|11|||
13262949|NCT01466166|26401934|FG000|Overall Study|Elevated Serum Uric Acid|78|||
13262950|NCT01466166|26401934|FG000|Overall Study|Withdrawal by Subject|13|||
13262951|NCT01466166|26401934|FG000|Overall Study|Sponsor Decision|4|||
13262952|NCT01466166|26401934|FG000|Overall Study|Protocol Violation/Noncompliance|2|||
13262953|NCT01466166|26401934|FG000|Overall Study|Other|20|||
13262954|NCT01466153|26401983|FG000|Overall Study|Disease Progression|2|||
13262955|NCT01466153|26401984|FG001|Overall Study|Disease Progression|2|||
13262956|NCT01466153|26401985|FG002|Overall Study|Disease Progression|0|||
13262957|NCT01466153|26401983|FG000|Overall Study|Adverse Event|14|||
13262958|NCT01466153|26401984|FG001|Overall Study|Adverse Event|13|||
13262959|NCT01466153|26401985|FG002|Overall Study|Adverse Event|17|||
13262960|NCT01466153|26401983|FG000|Overall Study|Withdrawal of Consent|2|||
13262961|NCT01466153|26401984|FG001|Overall Study|Withdrawal of Consent|0|||
13262962|NCT01466153|26401985|FG002|Overall Study|Withdrawal of Consent|0|||
13117527|NCT03055494|25925911|FG001|Overall Study|Lost to Follow-up|0|||
13117528|NCT03055494|25925910|FG000|Overall Study|Physician Decision|2|||
13117529|NCT03055494|25925911|FG001|Overall Study|Physician Decision|0|||
13117530|NCT03055494|25925910|FG000|Overall Study|Withdrawal by Subject|1|||
13117531|NCT03055494|25925911|FG001|Overall Study|Withdrawal by Subject|0|||
13117532|NCT03055494|25925910|FG000|Overall Study|Adverse Event|0|||
13117533|NCT03055494|25925911|FG001|Overall Study|Adverse Event|1|||
13117534|NCT03055494|25925910|FG000|Overall Study|Non-compliance with study treatment|1|||
13117535|NCT03055494|25925911|FG001|Overall Study|Non-compliance with study treatment|0|||
13117536|NCT03055338|25925938|FG000|Overall Study|Lost to Follow-up|9|||
13262963|NCT01466153|26401983|FG000|Overall Study|Investigator Discretion|3|||
13262964|NCT01466153|26401984|FG001|Overall Study|Investigator Discretion|2|||
13262965|NCT01466153|26401985|FG002|Overall Study|Investigator Discretion|2|||
13262966|NCT01466153|26401983|FG000|Overall Study|Randomized-Not Treated|2|||
13262967|NCT01466153|26401984|FG001|Overall Study|Randomized-Not Treated|3|||
13262968|NCT01466153|26401985|FG002|Overall Study|Randomized-Not Treated|4|||
13262969|NCT01466153|26401983|FG000|Overall Study|Other-Unspecified|6|||
13117537|NCT03055338|25925939|FG001|Overall Study|Lost to Follow-up|2|||
13117538|NCT03055338|25925940|FG002|Overall Study|Lost to Follow-up|3|||
13117539|NCT03055338|25925938|FG000|Overall Study|No Post-treatment Protocol Contact|0|||
13117540|NCT03055338|25925939|FG001|Overall Study|No Post-treatment Protocol Contact|1|||
13117541|NCT03055338|25925940|FG002|Overall Study|No Post-treatment Protocol Contact|0|||
13117542|NCT03055338|25925938|FG000|Overall Study|Physician Decision|0|||
13117543|NCT03055338|25925939|FG001|Overall Study|Physician Decision|0|||
13262970|NCT01466153|26401984|FG001|Overall Study|Other-Unspecified|4|||
13262971|NCT01466153|26401985|FG002|Overall Study|Other-Unspecified|2|||
13262972|NCT01466062|26402008|FG000|Overall Study|Adverse Event|1|||
13262973|NCT01466062|26402008|FG000|Overall Study|Withdrawal by Subject|1|||
13262974|NCT01465997|26402025|FG000|Overall Study|Adverse Event|12|||
13262975|NCT01465997|26402026|FG001|Overall Study|Adverse Event|22|||
13262976|NCT01465997|26402025|FG000|Overall Study|Lack of Efficacy|13|||
13262977|NCT01465997|26402026|FG001|Overall Study|Lack of Efficacy|1|||
13262978|NCT01465997|26402025|FG000|Overall Study|Protocol Violation|1|||
13262979|NCT01465997|26402026|FG001|Overall Study|Protocol Violation|4|||
13262980|NCT01465997|26402025|FG000|Overall Study|Lost to Follow-up|6|||
13117544|NCT03055338|25925940|FG002|Overall Study|Physician Decision|2|||
13262981|NCT01465997|26402026|FG001|Overall Study|Lost to Follow-up|9|||
13262982|NCT01465997|26402025|FG000|Overall Study|Withdrawal by Subject|32|||
13262983|NCT01465997|26402026|FG001|Overall Study|Withdrawal by Subject|35|||
13262984|NCT01465997|26402025|FG000|Overall Study|investigator's decision|1|||
13262985|NCT01465997|26402026|FG001|Overall Study|investigator's decision|1|||
13262986|NCT01465997|26402025|FG000|Overall Study|Death|0|||
13262987|NCT01465997|26402026|FG001|Overall Study|Death|1|||
13262988|NCT01465997|26402025|FG000|Overall Study|sponsor's decision|1|||
13262989|NCT01465997|26402026|FG001|Overall Study|sponsor's decision|1|||
13262990|NCT01465997|26402025|FG000|Overall Study|subject withdrew consent|1|||
13262991|NCT01465997|26402026|FG001|Overall Study|subject withdrew consent|0|||
13262992|NCT01465997|26402025|FG000|Overall Study|local lab unblinded site|1|||
13262993|NCT01465997|26402026|FG001|Overall Study|local lab unblinded site|0|||
13262994|NCT01465997|26402025|FG000|Overall Study|withdrew before follow-up|0|||
13262995|NCT01465997|26402026|FG001|Overall Study|withdrew before follow-up|13|||
13262996|NCT01465997|26402025|FG000|Overall Study|decision by site staff|0|||
13262997|NCT01465997|26402026|FG001|Overall Study|decision by site staff|1|||
13262998|NCT01465997|26402025|FG000|Overall Study|subject left participation SP0993|0|||
13262999|NCT01465997|26402026|FG001|Overall Study|subject left participation SP0993|1|||
13263000|NCT01465958|26402037|FG000|Run-in Phase|Protocol Violation|1|||
13263001|NCT01465958|26402038|FG001|Run-in Phase|Protocol Violation|0|||
13263002|NCT01465958|26402037|FG000|Subcutaneous (SC) Phase|Adverse Event|0|||
13263003|NCT01465958|26402038|FG001|Subcutaneous (SC) Phase|Adverse Event|1|||
13263004|NCT01465802|26402103|FG000|Overall Study|Study terminated by sponsor|1|||
13263005|NCT01465802|26402104|FG001|Overall Study|Study terminated by sponsor|0|||
13263006|NCT01465802|26402105|FG002|Overall Study|Study terminated by sponsor|0|||
13263007|NCT01465802|26402106|FG003|Overall Study|Study terminated by sponsor|1|||
13263008|NCT01465802|26402107|FG004|Overall Study|Study terminated by sponsor|7|||
13263009|NCT01465802|26402103|FG000|Overall Study|Withdrawal by Subject|7|||
13263010|NCT01465802|26402104|FG001|Overall Study|Withdrawal by Subject|7|||
13263011|NCT01465802|26402105|FG002|Overall Study|Withdrawal by Subject|0|||
13263012|NCT01465802|26402106|FG003|Overall Study|Withdrawal by Subject|8|||
13263013|NCT01465802|26402107|FG004|Overall Study|Withdrawal by Subject|1|||
13263014|NCT01465802|26402103|FG000|Overall Study|Lost to Follow-up|1|||
13263015|NCT01465802|26402104|FG001|Overall Study|Lost to Follow-up|1|||
13263016|NCT01465802|26402105|FG002|Overall Study|Lost to Follow-up|0|||
13263017|NCT01465802|26402106|FG003|Overall Study|Lost to Follow-up|0|||
13263018|NCT01465802|26402107|FG004|Overall Study|Lost to Follow-up|0|||
13263019|NCT01465802|26402103|FG000|Overall Study|Reason not specified|9|||
13263020|NCT01465802|26402104|FG001|Overall Study|Reason not specified|4|||
13263021|NCT01465802|26402105|FG002|Overall Study|Reason not specified|0|||
13263022|NCT01465802|26402106|FG003|Overall Study|Reason not specified|10|||
13263023|NCT01465802|26402107|FG004|Overall Study|Reason not specified|2|||
13263024|NCT01465802|26402103|FG000|Overall Study|Death|15|||
13263025|NCT01465802|26402104|FG001|Overall Study|Death|12|||
13263026|NCT01465802|26402105|FG002|Overall Study|Death|0|||
13263027|NCT01465802|26402106|FG003|Overall Study|Death|10|||
13263028|NCT01465802|26402107|FG004|Overall Study|Death|2|||
13263029|NCT01465763|26402142|FG000|Overall Study|Withdrawal by Subject|4|||
13263030|NCT01465763|26402143|FG001|Overall Study|Withdrawal by Subject|0|||
13263031|NCT01465763|26402144|FG002|Overall Study|Withdrawal by Subject|1|||
13263032|NCT01465763|26402142|FG000|Overall Study|Insufficient Clinical Response|11|||
13263033|NCT01465763|26402143|FG001|Overall Study|Insufficient Clinical Response|0|||
13263034|NCT01465763|26402144|FG002|Overall Study|Insufficient Clinical Response|1|||
13203486|NCT01985334|26224757|FG007|Overall Study|Adverse Event|15|||
13203487|NCT01985334|26224750|FG000|Overall Study|Other|4|||
13203488|NCT01985334|26224751|FG001|Overall Study|Other|2|||
13203489|NCT01985334|26224752|FG002|Overall Study|Other|3|||
13203490|NCT01985334|26224753|FG003|Overall Study|Other|10|||
13203491|NCT01985334|26224754|FG004|Overall Study|Other|1|||
13203492|NCT01985334|26224755|FG005|Overall Study|Other|6|||
13203493|NCT01985334|26224756|FG006|Overall Study|Other|2|||
13203494|NCT01985334|26224757|FG007|Overall Study|Other|2|||
13203495|NCT01985334|26224750|FG000|Overall Study|Medication non-compliance|0|||
13203496|NCT01985334|26224751|FG001|Overall Study|Medication non-compliance|4|||
13203497|NCT01985334|26224752|FG002|Overall Study|Medication non-compliance|1|||
13203498|NCT01985334|26224753|FG003|Overall Study|Medication non-compliance|6|||
13203499|NCT01985334|26224754|FG004|Overall Study|Medication non-compliance|2|||
13203500|NCT01985334|26224755|FG005|Overall Study|Medication non-compliance|3|||
13203501|NCT01985334|26224756|FG006|Overall Study|Medication non-compliance|1|||
13203502|NCT01985334|26224757|FG007|Overall Study|Medication non-compliance|3|||
13203503|NCT01985334|26224750|FG000|Overall Study|Use of prohibited treatment|1|||
13203504|NCT01985334|26224751|FG001|Overall Study|Use of prohibited treatment|4|||
13203505|NCT01985334|26224752|FG002|Overall Study|Use of prohibited treatment|1|||
13203506|NCT01985334|26224753|FG003|Overall Study|Use of prohibited treatment|2|||
13203507|NCT01985334|26224754|FG004|Overall Study|Use of prohibited treatment|1|||
13203508|NCT01985334|26224755|FG005|Overall Study|Use of prohibited treatment|6|||
13203509|NCT01985334|26224756|FG006|Overall Study|Use of prohibited treatment|2|||
13203510|NCT01985334|26224757|FG007|Overall Study|Use of prohibited treatment|0|||
13203511|NCT01985334|26224750|FG000|Overall Study|Investigator decision|0|||
13203512|NCT01985334|26224751|FG001|Overall Study|Investigator decision|3|||
13203513|NCT01985334|26224752|FG002|Overall Study|Investigator decision|0|||
13263035|NCT01465763|26402142|FG000|Overall Study|Adverse Event|9|||
13263036|NCT01465763|26402143|FG001|Overall Study|Adverse Event|0|||
13263037|NCT01465763|26402144|FG002|Overall Study|Adverse Event|1|||
13263038|NCT01465763|26402142|FG000|Overall Study|Other|2|||
13263039|NCT01465763|26402143|FG001|Overall Study|Other|0|||
13263040|NCT01465763|26402144|FG002|Overall Study|Other|0|||
13263041|NCT01465763|26402142|FG000|Overall Study|Protocol Violation|4|||
13263042|NCT01465763|26402143|FG001|Overall Study|Protocol Violation|1|||
13263043|NCT01465763|26402144|FG002|Overall Study|Protocol Violation|1|||
13263044|NCT01465763|26402142|FG000|Overall Study|Death|1|||
13263045|NCT01465763|26402143|FG001|Overall Study|Death|0|||
13263046|NCT01465763|26402144|FG002|Overall Study|Death|0|||
13263047|NCT01465659|26402174|FG000|Completed 1 Cycle of Treatment|Death|0|||
13263048|NCT01465659|26402175|FG001|Completed 1 Cycle of Treatment|Death|1|||
13263049|NCT01465659|26402176|FG002|Completed 1 Cycle of Treatment|Death|0|||
13263050|NCT01465659|26402177|FG003|Completed 1 Cycle of Treatment|Death|0|||
13263051|NCT01465659|26402174|FG000|Completed 1 Cycle of Treatment|Adverse Event|0|||
13263052|NCT01465659|26402175|FG001|Completed 1 Cycle of Treatment|Adverse Event|0|||
13263053|NCT01465659|26402176|FG002|Completed 1 Cycle of Treatment|Adverse Event|0|||
13263054|NCT01465659|26402177|FG003|Completed 1 Cycle of Treatment|Adverse Event|1|||
13263055|NCT01465659|26402174|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
13263056|NCT01465659|26402175|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0|||
13263057|NCT01465659|26402176|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
13263058|NCT01465659|26402177|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
13263059|NCT01465659|26402174|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
13263060|NCT01465659|26402175|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
13263061|NCT01465659|26402176|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
13263062|NCT01465659|26402177|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
13263063|NCT01465659|26402174|FG000|Completed Follow for 1 Year|Death|6|||
13263064|NCT01465659|26402175|FG001|Completed Follow for 1 Year|Death|3|||
13263065|NCT01465659|26402176|FG002|Completed Follow for 1 Year|Death|2|||
13263066|NCT01465659|26402177|FG003|Completed Follow for 1 Year|Death|4|||
13263067|NCT01465464|26402192|FG000|Overall Study|Adverse Event|96|||
13263068|NCT01465464|26402193|FG001|Overall Study|Adverse Event|49|||
13263069|NCT01465464|26402192|FG000|Overall Study|Lack of Efficacy|139|||
13263070|NCT01465464|26402193|FG001|Overall Study|Lack of Efficacy|190|||
13263071|NCT01465464|26402192|FG000|Overall Study|Physician Decision|13|||
13263072|NCT01465464|26402193|FG001|Overall Study|Physician Decision|5|||
13263073|NCT01465464|26402192|FG000|Overall Study|Protocol Violation|1|||
13263074|NCT01465464|26402193|FG001|Overall Study|Protocol Violation|1|||
13263075|NCT01465464|26402192|FG000|Overall Study|Withdrawal by Subject|46|||
13263076|NCT01465464|26402193|FG001|Overall Study|Withdrawal by Subject|30|||
13263077|NCT01465464|26402192|FG000|Overall Study|Other|9|||
13263078|NCT01465464|26402193|FG001|Overall Study|Other|3|||
13263079|NCT01465464|26402192|FG000|Overall Study|Ongoing treatment at cutoff date|140|||
13263080|NCT01465464|26402193|FG001|Overall Study|Ongoing treatment at cutoff date|166|||
13263081|NCT01465386|26402199|FG000|Overall Study|Lack of Efficacy|3|||
13263082|NCT01465386|26402199|FG000|Overall Study|Adverse Event|1|||
13263083|NCT01465347|26402212|FG000|Overall Study|Withdrawal by Subject|1|||
13263084|NCT01465347|26402213|FG001|Overall Study|Withdrawal by Subject|1|||
13263085|NCT01465347|26402212|FG000|Overall Study|Physician Decision|0|||
13263086|NCT01465347|26402213|FG001|Overall Study|Physician Decision|1|||
13263087|NCT01465347|26402212|FG000|Overall Study|Admitted to hospice|0|||
13263088|NCT01465347|26402213|FG001|Overall Study|Admitted to hospice|1|||
13263097|NCT01465230|26402253|FG000|Overall Study|Withdrawal by Subject|2|||
13263098|NCT01465191|26402310|FG000|Overall Study|Protocol Violation|6|||
13263099|NCT01465191|26402311|FG001|Overall Study|Protocol Violation|3|||
13263100|NCT01465191|26402312|FG002|Overall Study|Protocol Violation|3|||
13263101|NCT01465191|26402310|FG000|Overall Study|Lost to Follow-up|3|||
13263102|NCT01465191|26402311|FG001|Overall Study|Lost to Follow-up|6|||
13263103|NCT01465191|26402312|FG002|Overall Study|Lost to Follow-up|4|||
13263104|NCT01465178|26402327|FG000|Overall Study|Withdrawal by Subject|1|||
13263105|NCT01465178|26402328|FG001|Overall Study|Withdrawal by Subject|0|||
13263106|NCT01465022|26402352|FG000|Overall Study|Lost to Follow-up|15|||
13263107|NCT01465022|26402353|FG001|Overall Study|Lost to Follow-up|14|||
13263108|NCT01465022|26402354|FG002|Overall Study|Lost to Follow-up|0|||
13263109|NCT01465022|26402352|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8|||
13263110|NCT01465022|26402353|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9|||
13263111|NCT01465022|26402354|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0|||
13263112|NCT01465022|26402352|FG000|Overall Study|Not Randomized|0|||
13263113|NCT01465022|26402353|FG001|Overall Study|Not Randomized|0|||
13263114|NCT01465022|26402354|FG002|Overall Study|Not Randomized|70|||
13263115|NCT01464931|26402398|FG000|Overall Study|Withdrawal by Subject|1|||
13263116|NCT01464931|26402399|FG001|Overall Study|Withdrawal by Subject|0|||
13263117|NCT01464879|26402435|FG000|Overall Study|Physician Decision|1|||
13263118|NCT01464879|26402435|FG000|Overall Study|Non-compliance|1|||
13263119|NCT01464827|26402522|FG000|Overall Study|Adverse Event|0|||
13263120|NCT01464827|26402523|FG001|Overall Study|Adverse Event|0|||
13263121|NCT01464827|26402524|FG002|Overall Study|Adverse Event|0|||
13263122|NCT01464827|26402525|FG003|Overall Study|Adverse Event|0|||
13263123|NCT01464827|26402526|FG004|Overall Study|Adverse Event|0|||
13263124|NCT01464827|26402527|FG005|Overall Study|Adverse Event|0|||
13263125|NCT01464827|26402528|FG006|Overall Study|Adverse Event|0|||
13263126|NCT01464827|26402529|FG007|Overall Study|Adverse Event|0|||
13263127|NCT01464827|26402530|FG008|Overall Study|Adverse Event|0|||
13263128|NCT01464827|26402531|FG009|Overall Study|Adverse Event|0|||
13263129|NCT01464827|26402532|FG010|Overall Study|Adverse Event|0|||
13263130|NCT01464827|26402533|FG011|Overall Study|Adverse Event|0|||
13263131|NCT01464827|26402534|FG012|Overall Study|Adverse Event|1|||
13263132|NCT01464827|26402535|FG013|Overall Study|Adverse Event|0|||
13263133|NCT01464827|26402522|FG000|Overall Study|Withdrawal by Subject|1|||
13263134|NCT01464827|26402523|FG001|Overall Study|Withdrawal by Subject|0|||
13263135|NCT01464827|26402524|FG002|Overall Study|Withdrawal by Subject|0|||
13263136|NCT01464827|26402525|FG003|Overall Study|Withdrawal by Subject|0|||
13263137|NCT01464827|26402526|FG004|Overall Study|Withdrawal by Subject|1|||
13263138|NCT01464827|26402527|FG005|Overall Study|Withdrawal by Subject|0|||
13263139|NCT01464827|26402528|FG006|Overall Study|Withdrawal by Subject|0|||
13263140|NCT01464827|26402529|FG007|Overall Study|Withdrawal by Subject|1|||
13263141|NCT01464827|26402530|FG008|Overall Study|Withdrawal by Subject|0|||
13263142|NCT01464827|26402531|FG009|Overall Study|Withdrawal by Subject|0|||
13263143|NCT01464827|26402532|FG010|Overall Study|Withdrawal by Subject|0|||
13263144|NCT01464827|26402533|FG011|Overall Study|Withdrawal by Subject|0|||
13263145|NCT01464827|26402534|FG012|Overall Study|Withdrawal by Subject|0|||
13263146|NCT01464827|26402535|FG013|Overall Study|Withdrawal by Subject|0|||
13263147|NCT01464827|26402522|FG000|Overall Study|Lost to Follow-up|0|||
13263148|NCT01464827|26402523|FG001|Overall Study|Lost to Follow-up|2|||
13263149|NCT01464827|26402524|FG002|Overall Study|Lost to Follow-up|0|||
13263150|NCT01464827|26402525|FG003|Overall Study|Lost to Follow-up|2|||
13263151|NCT01464827|26402526|FG004|Overall Study|Lost to Follow-up|3|||
13263152|NCT01464827|26402527|FG005|Overall Study|Lost to Follow-up|1|||
13263153|NCT01464827|26402528|FG006|Overall Study|Lost to Follow-up|2|||
13263154|NCT01464827|26402529|FG007|Overall Study|Lost to Follow-up|2|||
13263155|NCT01464827|26402530|FG008|Overall Study|Lost to Follow-up|0|||
13263156|NCT01464827|26402531|FG009|Overall Study|Lost to Follow-up|0|||
13263157|NCT01464827|26402532|FG010|Overall Study|Lost to Follow-up|0|||
13263158|NCT01464827|26402533|FG011|Overall Study|Lost to Follow-up|1|||
13263159|NCT01464827|26402534|FG012|Overall Study|Lost to Follow-up|0|||
13263160|NCT01464827|26402535|FG013|Overall Study|Lost to Follow-up|1|||
13263161|NCT01464827|26402522|FG000|Overall Study|Other|2|||
13263162|NCT01464827|26402523|FG001|Overall Study|Other|3|||
13263163|NCT01464827|26402524|FG002|Overall Study|Other|0|||
13263164|NCT01464827|26402525|FG003|Overall Study|Other|2|||
13263165|NCT01464827|26402526|FG004|Overall Study|Other|3|||
13263166|NCT01464827|26402527|FG005|Overall Study|Other|0|||
13263167|NCT01464827|26402528|FG006|Overall Study|Other|1|||
13263168|NCT01464827|26402529|FG007|Overall Study|Other|0|||
13263169|NCT01464827|26402530|FG008|Overall Study|Other|3|||
13263170|NCT01464827|26402531|FG009|Overall Study|Other|1|||
13263171|NCT01464827|26402532|FG010|Overall Study|Other|2|||
13263172|NCT01464827|26402533|FG011|Overall Study|Other|0|||
13263173|NCT01464827|26402534|FG012|Overall Study|Other|1|||
13263174|NCT01464827|26402535|FG013|Overall Study|Other|0|||
13263175|NCT01464827|26402522|FG000|Overall Study|Not Treated|0|||
13263176|NCT01464827|26402523|FG001|Overall Study|Not Treated|2|||
13263177|NCT01464827|26402524|FG002|Overall Study|Not Treated|0|||
13263178|NCT01464827|26402525|FG003|Overall Study|Not Treated|0|||
13263179|NCT01464827|26402526|FG004|Overall Study|Not Treated|1|||
13263180|NCT01464827|26402527|FG005|Overall Study|Not Treated|0|||
13263181|NCT01464827|26402528|FG006|Overall Study|Not Treated|1|||
13263182|NCT01464827|26402529|FG007|Overall Study|Not Treated|0|||
13263183|NCT01464827|26402530|FG008|Overall Study|Not Treated|0|||
13263184|NCT01464827|26402531|FG009|Overall Study|Not Treated|2|||
13263185|NCT01464827|26402532|FG010|Overall Study|Not Treated|0|||
13263186|NCT01464827|26402533|FG011|Overall Study|Not Treated|1|||
13263187|NCT01464827|26402534|FG012|Overall Study|Not Treated|0|||
13263188|NCT01464827|26402535|FG013|Overall Study|Not Treated|2|||
13263189|NCT01464788|26402556|FG000|Overall Study|Lost to Follow-up|0|||
13263190|NCT01464788|26402557|FG001|Overall Study|Lost to Follow-up|1|||
13263191|NCT01464788|26402558|FG002|Overall Study|Lost to Follow-up|0|||
13263192|NCT01464788|26402556|FG000|Overall Study|Patient had hemorrhage after tPA started|0|||
13263193|NCT01464788|26402557|FG001|Overall Study|Patient had hemorrhage after tPA started|1|||
13263194|NCT01464788|26402558|FG002|Overall Study|Patient had hemorrhage after tPA started|0|||
13263195|NCT01464619|26402585|FG000|Overall Study|Lost to Follow-up|3|||
13263196|NCT01464619|26402586|FG001|Overall Study|Lost to Follow-up|4|||
13263197|NCT01464424|26402597|FG000|Period 1, First 6 Weeks|Adverse Event|0|||
13263198|NCT01464424|26402598|FG001|Period 1, First 6 Weeks|Adverse Event|1|||
13263199|NCT01464346|26402611|FG000|Overall Study|Withdrawal by Subject|0|||
13263200|NCT01464346|26402612|FG001|Overall Study|Withdrawal by Subject|0|||
13263201|NCT01464346|26402613|FG002|Overall Study|Withdrawal by Subject|1|||
13263202|NCT01464333|26402626|FG000|Overall Study|Adverse Event|34|||
13263203|NCT01464333|26402626|FG000|Overall Study|Lack of Efficacy|72|||
13263204|NCT01464333|26402626|FG000|Overall Study|Withdrawal by Subject|11|||
13263205|NCT01464333|26402626|FG000|Overall Study|Other|4|||
13263206|NCT01464333|26402626|FG000|Overall Study|No Hospital Visit|42|||
13263207|NCT01464307|26402646|FG000|Main Period|Death|0|||
13263208|NCT01464307|26402647|FG001|Main Period|Death|1|||
13263209|NCT01464307|26402646|FG000|Main Period|Adverse Event|6|||
13263210|NCT01464307|26402647|FG001|Main Period|Adverse Event|1|||
13263211|NCT01464307|26402646|FG000|Main Period|Lack of Efficacy|2|||
13263212|NCT01464307|26402647|FG001|Main Period|Lack of Efficacy|0|||
13263213|NCT01464307|26402646|FG000|Main Period|Withdrawal by Subject|5|||
13263214|NCT01464307|26402647|FG001|Main Period|Withdrawal by Subject|2|||
13263215|NCT01464307|26402646|FG000|Main Period|Predefined discontinuation criteria|2|||
13263216|NCT01464307|26402647|FG001|Main Period|Predefined discontinuation criteria|1|||
13263217|NCT01464307|26402646|FG000|Open-Label Extension Period|Adverse Event|15|||
13263218|NCT01464307|26402647|FG001|Open-Label Extension Period|Adverse Event|0|||
13263219|NCT01464307|26402646|FG000|Open-Label Extension Period|Withdrawal by Subject|14|||
13263220|NCT01464307|26402647|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
13263221|NCT01464307|26402646|FG000|Open-Label Extension Period|Lack of Efficacy|5|||
13263222|NCT01464307|26402647|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
13263223|NCT01464307|26402646|FG000|Open-Label Extension Period|Death|1|||
13263224|NCT01464307|26402647|FG001|Open-Label Extension Period|Death|0|||
13263225|NCT01464307|26402646|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
13263226|NCT01464307|26402647|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
13263227|NCT01464307|26402646|FG000|Open-Label Extension Period|Non-compliance|9|||
13263228|NCT01464307|26402647|FG001|Open-Label Extension Period|Non-compliance|0|||
13263229|NCT01464307|26402646|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6|||
13263230|NCT01464307|26402647|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0|||
13263231|NCT01464255|26402677|FG000|Overall Study|unresolve corneal staining|0|||
13263232|NCT01464255|26402678|FG001|Overall Study|unresolve corneal staining|1|||
13263233|NCT01464021|26402692|FG000|Overall Study|Withdrawal by Subject|13|||
13263234|NCT01464021|26402692|FG000|Overall Study|Lost to Follow-up|1|||
13263235|NCT01464021|26402692|FG000|Overall Study|Lack of Efficacy|1|||
13263236|NCT01464021|26402692|FG000|Overall Study|various|11|||
13263237|NCT01463982|26402719|FG000|Overall Study|Withdrawal by Subject|0|||
13263238|NCT01463982|26402720|FG001|Overall Study|Withdrawal by Subject|1|||
13263239|NCT01463982|26402721|FG002|Overall Study|Withdrawal by Subject|1|||
13263240|NCT01463982|26402722|FG003|Overall Study|Withdrawal by Subject|0|||
13263241|NCT01463982|26402719|FG000|Overall Study|Treatment delay over 5 week|0|||
13263242|NCT01463982|26402720|FG001|Overall Study|Treatment delay over 5 week|0|||
13263243|NCT01463982|26402721|FG002|Overall Study|Treatment delay over 5 week|1|||
13263244|NCT01463982|26402722|FG003|Overall Study|Treatment delay over 5 week|0|||
13263245|NCT01463878|26402735|FG000|Overall Study|no longer met criteria for tube feed|2|||
13263246|NCT01463878|26402736|FG001|Overall Study|no longer met criteria for tube feed|2|||
13263247|NCT01463696|26402811|FG000|Overall Study|Adverse Event|0|||
13263248|NCT01463696|26402812|FG001|Overall Study|Adverse Event|1|||
13263249|NCT01463696|26402813|FG002|Overall Study|Adverse Event|0|||
13263250|NCT01463696|26402814|FG003|Overall Study|Adverse Event|2|||
13263251|NCT01463696|26402815|FG004|Overall Study|Adverse Event|0|||
13263252|NCT01463696|26402816|FG005|Overall Study|Adverse Event|1|||
13263253|NCT01463696|26402817|FG006|Overall Study|Adverse Event|3|||
13263254|NCT01463696|26402818|FG007|Overall Study|Adverse Event|2|||
13263255|NCT01463696|26402811|FG000|Overall Study|Lost to Follow-up|0|||
13263256|NCT01463696|26402812|FG001|Overall Study|Lost to Follow-up|0|||
13263257|NCT01463696|26402813|FG002|Overall Study|Lost to Follow-up|1|||
13263258|NCT01463696|26402814|FG003|Overall Study|Lost to Follow-up|0|||
13263259|NCT01463696|26402815|FG004|Overall Study|Lost to Follow-up|0|||
13263260|NCT01463696|26402816|FG005|Overall Study|Lost to Follow-up|0|||
13263261|NCT01463696|26402817|FG006|Overall Study|Lost to Follow-up|0|||
13263262|NCT01463696|26402818|FG007|Overall Study|Lost to Follow-up|0|||
13263263|NCT01463696|26402811|FG000|Overall Study|Progressive Disease|0|||
13263264|NCT01463696|26402812|FG001|Overall Study|Progressive Disease|1|||
13263265|NCT01463696|26402813|FG002|Overall Study|Progressive Disease|0|||
13263266|NCT01463696|26402814|FG003|Overall Study|Progressive Disease|1|||
13263267|NCT01463696|26402815|FG004|Overall Study|Progressive Disease|0|||
13263268|NCT01463696|26402816|FG005|Overall Study|Progressive Disease|1|||
13263269|NCT01463696|26402817|FG006|Overall Study|Progressive Disease|4|||
13263270|NCT01463696|26402818|FG007|Overall Study|Progressive Disease|2|||
13263271|NCT01463696|26402811|FG000|Overall Study|Withdrawal by Subject|0|||
13263272|NCT01463696|26402812|FG001|Overall Study|Withdrawal by Subject|0|||
13263273|NCT01463696|26402813|FG002|Overall Study|Withdrawal by Subject|0|||
13263274|NCT01463696|26402814|FG003|Overall Study|Withdrawal by Subject|1|||
13263275|NCT01463696|26402815|FG004|Overall Study|Withdrawal by Subject|1|||
13263276|NCT01463696|26402816|FG005|Overall Study|Withdrawal by Subject|1|||
13263277|NCT01463696|26402817|FG006|Overall Study|Withdrawal by Subject|2|||
13263278|NCT01463696|26402818|FG007|Overall Study|Withdrawal by Subject|0|||
13263279|NCT01463696|26402811|FG000|Overall Study|Not Treated|0|||
13263280|NCT01463696|26402812|FG001|Overall Study|Not Treated|0|||
13263281|NCT01463696|26402813|FG002|Overall Study|Not Treated|0|||
13263282|NCT01463696|26402814|FG003|Overall Study|Not Treated|0|||
13263283|NCT01463696|26402815|FG004|Overall Study|Not Treated|0|||
13263284|NCT01463696|26402816|FG005|Overall Study|Not Treated|0|||
13263285|NCT01463696|26402817|FG006|Overall Study|Not Treated|1|||
13263286|NCT01463696|26402818|FG007|Overall Study|Not Treated|0|||
13263287|NCT01463683|26402841|FG000|Overall Study|Adverse Event|2|||
13263288|NCT01463683|26402842|FG001|Overall Study|Adverse Event|0|||
13263289|NCT01463683|26402843|FG002|Overall Study|Adverse Event|0|||
13263290|NCT01463683|26402841|FG000|Overall Study|Lost to Follow-up|10|||
13203514|NCT01985334|26224753|FG003|Overall Study|Investigator decision|7|||
13203515|NCT01985334|26224754|FG004|Overall Study|Investigator decision|1|||
13203516|NCT01985334|26224755|FG005|Overall Study|Investigator decision|1|||
13203517|NCT01985334|26224756|FG006|Overall Study|Investigator decision|0|||
13203518|NCT01985334|26224757|FG007|Overall Study|Investigator decision|4|||
13203519|NCT01985334|26224750|FG000|Overall Study|Lost to Follow-up|0|||
13203520|NCT01985334|26224751|FG001|Overall Study|Lost to Follow-up|2|||
13203521|NCT01985334|26224752|FG002|Overall Study|Lost to Follow-up|0|||
13203522|NCT01985334|26224753|FG003|Overall Study|Lost to Follow-up|3|||
13203523|NCT01985334|26224754|FG004|Overall Study|Lost to Follow-up|1|||
13203524|NCT01985334|26224755|FG005|Overall Study|Lost to Follow-up|4|||
13203525|NCT01985334|26224756|FG006|Overall Study|Lost to Follow-up|0|||
13203526|NCT01985334|26224757|FG007|Overall Study|Lost to Follow-up|3|||
13203527|NCT01985321|26224772|FG000|Overall Study|Protocol Violation|4|||
13203528|NCT01985321|26224773|FG001|Overall Study|Protocol Violation|3|||
13203529|NCT01985321|26224772|FG000|Overall Study|Withdrawal by Subject|1|||
13203530|NCT01985321|26224773|FG001|Overall Study|Withdrawal by Subject|0|||
13203531|NCT01985321|26224772|FG000|Overall Study|Lost to Follow-up|5|||
13203532|NCT01985321|26224773|FG001|Overall Study|Lost to Follow-up|2|||
13203533|NCT01985321|26224772|FG000|Overall Study|Subject treated wrong type of sore|1|||
13263291|NCT01463683|26402842|FG001|Overall Study|Lost to Follow-up|9|||
13263292|NCT01463683|26402843|FG002|Overall Study|Lost to Follow-up|7|||
13263293|NCT01463683|26402841|FG000|Overall Study|Physician Decision|0|||
13263294|NCT01463683|26402842|FG001|Overall Study|Physician Decision|3|||
13263295|NCT01463683|26402843|FG002|Overall Study|Physician Decision|1|||
13263296|NCT01463683|26402841|FG000|Overall Study|Pregnancy|2|||
13263297|NCT01463683|26402842|FG001|Overall Study|Pregnancy|2|||
13263298|NCT01463683|26402843|FG002|Overall Study|Pregnancy|1|||
13263299|NCT01463683|26402841|FG000|Overall Study|Withdrawal by Subject|5|||
13263300|NCT01463683|26402842|FG001|Overall Study|Withdrawal by Subject|17|||
13263301|NCT01463683|26402843|FG002|Overall Study|Withdrawal by Subject|2|||
13263302|NCT01463631|26402876|FG000|Overall Study|Withdrawal by Subject|0|||
13263303|NCT01463631|26402877|FG001|Overall Study|Withdrawal by Subject|0|||
13263304|NCT01463631|26402878|FG002|Overall Study|Withdrawal by Subject|0|||
13263305|NCT01463631|26402879|FG003|Overall Study|Withdrawal by Subject|1|||
13263306|NCT01463631|26402876|FG000|Overall Study|Death|0|||
13263307|NCT01463631|26402877|FG001|Overall Study|Death|0|||
13263308|NCT01463631|26402878|FG002|Overall Study|Death|1|||
13263309|NCT01463631|26402879|FG003|Overall Study|Death|0|||
13263310|NCT01463631|26402876|FG000|Overall Study|Progressive Disease|0|||
13263311|NCT01463631|26402877|FG001|Overall Study|Progressive Disease|0|||
13263312|NCT01463631|26402878|FG002|Overall Study|Progressive Disease|0|||
13263313|NCT01463631|26402879|FG003|Overall Study|Progressive Disease|5|||
13263314|NCT01463527|26402894|FG000|Overall Study|Protocol Violation|1|||
13263315|NCT01463527|26402895|FG001|Overall Study|Protocol Violation|1|||
13263316|NCT01463527|26402894|FG000|Overall Study|Crying >20% of sedation|5|||
13263317|NCT01463527|26402895|FG001|Overall Study|Crying >20% of sedation|6|||
13263318|NCT01463306|26402973|FG000|Overall Study|Adverse Event|6|||
13263319|NCT01463306|26402974|FG001|Overall Study|Adverse Event|9|||
13263320|NCT01463306|26402975|FG002|Overall Study|Adverse Event|3|||
13263321|NCT01463306|26402973|FG000|Overall Study|Death|3|||
13263322|NCT01463306|26402974|FG001|Overall Study|Death|3|||
13263323|NCT01463306|26402975|FG002|Overall Study|Death|0|||
13263324|NCT01463306|26402973|FG000|Overall Study|Lack of Efficacy|22|||
13263325|NCT01463306|26402974|FG001|Overall Study|Lack of Efficacy|16|||
13263326|NCT01463306|26402975|FG002|Overall Study|Lack of Efficacy|1|||
13263327|NCT01463306|26402973|FG000|Overall Study|Lost to Follow-up|5|||
13263328|NCT01463306|26402974|FG001|Overall Study|Lost to Follow-up|2|||
13263329|NCT01463306|26402975|FG002|Overall Study|Lost to Follow-up|0|||
13263330|NCT01463306|26402973|FG000|Overall Study|Protocol Violation|4|||
13263331|NCT01463306|26402974|FG001|Overall Study|Protocol Violation|0|||
13263332|NCT01463306|26402975|FG002|Overall Study|Protocol Violation|0|||
13263333|NCT01463306|26402973|FG000|Overall Study|Withdrawal by Subject|19|||
13263334|NCT01463306|26402974|FG001|Overall Study|Withdrawal by Subject|9|||
13263335|NCT01463306|26402975|FG002|Overall Study|Withdrawal by Subject|1|||
13263336|NCT01463306|26402973|FG000|Overall Study|Other|26|||
13263337|NCT01463306|26402974|FG001|Overall Study|Other|13|||
13263338|NCT01463306|26402975|FG002|Overall Study|Other|0|||
13263339|NCT01463306|26402973|FG000|Overall Study|Approval expiry at site|1|||
13263340|NCT01463306|26402974|FG001|Overall Study|Approval expiry at site|0|||
13263341|NCT01463306|26402975|FG002|Overall Study|Approval expiry at site|0|||
13263342|NCT01463293|26402993|FG000|Overall Study|Lost to Follow-up|1|||
13263343|NCT01463293|26402994|FG001|Overall Study|Lost to Follow-up|4|||
13263344|NCT01463293|26402995|FG002|Overall Study|Lost to Follow-up|5|||
13263345|NCT01463293|26402993|FG000|Overall Study|Adverse Event|1|||
13263346|NCT01463293|26402994|FG001|Overall Study|Adverse Event|2|||
13263347|NCT01463293|26402995|FG002|Overall Study|Adverse Event|0|||
13263348|NCT01463293|26402993|FG000|Overall Study|Withdrawal by Subject|4|||
13263349|NCT01463293|26402994|FG001|Overall Study|Withdrawal by Subject|10|||
13263350|NCT01463293|26402995|FG002|Overall Study|Withdrawal by Subject|5|||
13263351|NCT01463293|26402993|FG000|Overall Study|Other|0|||
13263352|NCT01463293|26402994|FG001|Overall Study|Other|0|||
13263353|NCT01463293|26402995|FG002|Overall Study|Other|2|||
13263354|NCT01463111|26403005|FG000|Overall Study|Withdrawal by Subject|2|||
13263355|NCT01463111|26403005|FG000|Overall Study|Lost to Follow-up|5|||
13263356|NCT01463111|26403005|FG000|Overall Study|Physician Decision|2|||
13263357|NCT01463098|26403369|FG000|Part A (11 Days)|Participant Choice|2|||
13263358|NCT01463098|26403370|FG001|Part A (11 Days)|Participant Choice|0|||
13263359|NCT01463098|26403371|FG002|Part A (11 Days)|Participant Choice|0|||
13263360|NCT01463098|26403372|FG003|Part A (11 Days)|Participant Choice|0|||
13263361|NCT01463098|26403373|FG004|Part A (11 Days)|Participant Choice|0|||
13263362|NCT01463098|26403374|FG005|Part A (11 Days)|Participant Choice|0|||
13263363|NCT01463098|26403375|FG006|Part A (11 Days)|Participant Choice|0|||
13263364|NCT01463098|26403376|FG007|Part A (11 Days)|Participant Choice|0|||
13263365|NCT01463098|26403377|FG008|Part A (11 Days)|Participant Choice|1|||
13263366|NCT01463098|26403378|FG009|Part A (11 Days)|Participant Choice|0|||
13263367|NCT01463098|26403379|FG010|Part A (11 Days)|Participant Choice|0|||
13117545|NCT03055338|25925938|FG000|Overall Study|Withdrawal by Subject|9|||
13117546|NCT03055338|25925939|FG001|Overall Study|Withdrawal by Subject|8|||
13117547|NCT03055338|25925940|FG002|Overall Study|Withdrawal by Subject|7|||
13117548|NCT03055260|25925955|FG000|Overall Study|Withdrawal by Subject|1|||
13117549|NCT03055260|25925956|FG001|Overall Study|Withdrawal by Subject|0|||
13263368|NCT01463098|26403380|FG011|Part A (11 Days)|Participant Choice|0|||
13263369|NCT01463098|26403381|FG012|Part A (11 Days)|Participant Choice|0|||
13263370|NCT01463098|26403382|FG013|Part A (11 Days)|Participant Choice|0|||
13117550|NCT03055221|25925963|FG000|Overall Study|Adverse Event|2|||
13117551|NCT03055221|25925963|FG000|Overall Study|Withdrawal by Subject|4|||
13117552|NCT03055221|25925963|FG000|Overall Study|Death|6|||
13117553|NCT03055221|25925963|FG000|Overall Study|Physician Decision|1|||
13117554|NCT03055221|25925963|FG000|Overall Study|Study terminated by Sponsor|3|||
13117555|NCT03055195|25926022|FG000|Overall Study|Lack of Efficacy|1|||
13117556|NCT03055195|25926023|FG001|Overall Study|Lack of Efficacy|0|||
13117557|NCT03055195|25926022|FG000|Overall Study|Withdrawal by Subject|6|||
13117558|NCT03055195|25926023|FG001|Overall Study|Withdrawal by Subject|7|||
13117559|NCT03055195|25926022|FG000|Overall Study|Study Terminated by Sponsor|2|||
13117560|NCT03055195|25926023|FG001|Overall Study|Study Terminated by Sponsor|6|||
13117561|NCT03055195|25926022|FG000|Overall Study|Protocol Violation|2|||
13117562|NCT03055195|25926023|FG001|Overall Study|Protocol Violation|1|||
13117563|NCT03055195|25926022|FG000|Overall Study|Physician Decision|1|||
13117564|NCT03055195|25926023|FG001|Overall Study|Physician Decision|0|||
13263371|NCT01463098|26403369|FG000|Part A (11 Days)|Lost to Follow-up|0|||
13263372|NCT01463098|26403370|FG001|Part A (11 Days)|Lost to Follow-up|0|||
13263373|NCT01463098|26403371|FG002|Part A (11 Days)|Lost to Follow-up|0|||
13263374|NCT01463098|26403372|FG003|Part A (11 Days)|Lost to Follow-up|0|||
13263375|NCT01463098|26403373|FG004|Part A (11 Days)|Lost to Follow-up|1|||
13263376|NCT01463098|26403374|FG005|Part A (11 Days)|Lost to Follow-up|0|||
13263377|NCT01463098|26403375|FG006|Part A (11 Days)|Lost to Follow-up|0|||
13263378|NCT01463098|26403376|FG007|Part A (11 Days)|Lost to Follow-up|0|||
13263379|NCT01463098|26403377|FG008|Part A (11 Days)|Lost to Follow-up|0|||
13117565|NCT03054870|25926040|FG000|Day of Ventilation Imaging|Protocol Violation|4|||
13117566|NCT03054870|25926040|FG000|Day of Ventilation Imaging|Lost to Follow-up|1|||
13117567|NCT03054428|25926115|FG000|Overall Study|Physician Decision|0|||
13263380|NCT01463098|26403378|FG009|Part A (11 Days)|Lost to Follow-up|0|||
13263381|NCT01463098|26403379|FG010|Part A (11 Days)|Lost to Follow-up|0|||
13263382|NCT01463098|26403380|FG011|Part A (11 Days)|Lost to Follow-up|0|||
13263383|NCT01463098|26403381|FG012|Part A (11 Days)|Lost to Follow-up|0|||
13263384|NCT01463098|26403382|FG013|Part A (11 Days)|Lost to Follow-up|0|||
13263385|NCT01463098|26403369|FG000|Part B (11 Days)|Participant Choice|0|||
13263386|NCT01463098|26403370|FG001|Part B (11 Days)|Participant Choice|0|||
13263387|NCT01463098|26403371|FG002|Part B (11 Days)|Participant Choice|0|||
13263388|NCT01463098|26403372|FG003|Part B (11 Days)|Participant Choice|0|||
13263389|NCT01463098|26403373|FG004|Part B (11 Days)|Participant Choice|0|||
13263390|NCT01463098|26403374|FG005|Part B (11 Days)|Participant Choice|0|||
13263391|NCT01463098|26403375|FG006|Part B (11 Days)|Participant Choice|0|||
13263392|NCT01463098|26403376|FG007|Part B (11 Days)|Participant Choice|0|||
13263393|NCT01463098|26403377|FG008|Part B (11 Days)|Participant Choice|0|||
13263394|NCT01463098|26403378|FG009|Part B (11 Days)|Participant Choice|0|||
13203534|NCT01985321|26224773|FG001|Overall Study|Subject treated wrong type of sore|0|||
13203535|NCT01985126|26224798|FG000|Overall Study|Death|15|||
13203536|NCT01985126|26224799|FG001|Overall Study|Death|69|||
13203537|NCT01985126|26224798|FG000|Overall Study|Lost to Follow-up|0|||
13203538|NCT01985126|26224799|FG001|Overall Study|Lost to Follow-up|8|||
13203539|NCT01985126|26224798|FG000|Overall Study|Study Terminated By Sponsor|1|||
13203540|NCT01985126|26224799|FG001|Overall Study|Study Terminated By Sponsor|22|||
13203541|NCT01985126|26224798|FG000|Overall Study|Withdrawal by Subject|2|||
13203542|NCT01985126|26224799|FG001|Overall Study|Withdrawal by Subject|7|||
13203543|NCT01984892|26224807|FG000|Overall Study|Progressive disease|7|||
13203544|NCT01984697|26224940|FG000|Overall Study|Adverse Event|0|||
13203545|NCT01984697|26224941|FG001|Overall Study|Adverse Event|0|||
13203546|NCT01984697|26224942|FG002|Overall Study|Adverse Event|2|||
13203547|NCT01984697|26224943|FG003|Overall Study|Adverse Event|0|||
13203548|NCT01984697|26224944|FG004|Overall Study|Adverse Event|0|||
13203549|NCT01984697|26224940|FG000|Overall Study|Lost to Follow-up|14|||
13203550|NCT01984697|26224941|FG001|Overall Study|Lost to Follow-up|5|||
13203551|NCT01984697|26224942|FG002|Overall Study|Lost to Follow-up|10|||
13203552|NCT01984697|26224943|FG003|Overall Study|Lost to Follow-up|6|||
13203553|NCT01984697|26224944|FG004|Overall Study|Lost to Follow-up|21|||
13203554|NCT01984697|26224940|FG000|Overall Study|Physician Decision|3|||
13203555|NCT01984697|26224941|FG001|Overall Study|Physician Decision|0|||
13263395|NCT01463098|26403379|FG010|Part B (11 Days)|Participant Choice|0|||
13263396|NCT01463098|26403380|FG011|Part B (11 Days)|Participant Choice|1|||
13263397|NCT01463098|26403381|FG012|Part B (11 Days)|Participant Choice|0|||
13263398|NCT01463098|26403382|FG013|Part B (11 Days)|Participant Choice|0|||
13263399|NCT01463033|26403396|FG000|Overall Study|Lost to Follow-up|4|||
13263400|NCT01463033|26403397|FG001|Overall Study|Lost to Follow-up|4|||
13263401|NCT01463033|26403396|FG000|Overall Study|Death|3|||
13263402|NCT01463033|26403397|FG001|Overall Study|Death|2|||
13263403|NCT01463007|26403405|FG000|Overall Study|Physician Decision|1|||
13263404|NCT01462942|26403448|FG000|Overall Study|Adverse Event|7|||
13263405|NCT01462942|26403449|FG001|Overall Study|Adverse Event|12|||
13263406|NCT01462942|26403450|FG002|Overall Study|Adverse Event|10|||
13263407|NCT01462942|26403451|FG003|Overall Study|Adverse Event|11|||
13263408|NCT01462942|26403452|FG004|Overall Study|Adverse Event|11|||
13263409|NCT01462942|26403448|FG000|Overall Study|Other, including COPD exacerbation|3|||
13263410|NCT01462942|26403449|FG001|Overall Study|Other, including COPD exacerbation|5|||
13263411|NCT01462942|26403450|FG002|Overall Study|Other, including COPD exacerbation|2|||
13263412|NCT01462942|26403451|FG003|Overall Study|Other, including COPD exacerbation|8|||
13263413|NCT01462942|26403452|FG004|Overall Study|Other, including COPD exacerbation|5|||
13263414|NCT01462942|26403448|FG000|Overall Study|Withdrawal by Subject|14|||
13263415|NCT01462942|26403449|FG001|Overall Study|Withdrawal by Subject|10|||
13263416|NCT01462942|26403450|FG002|Overall Study|Withdrawal by Subject|14|||
13263417|NCT01462942|26403451|FG003|Overall Study|Withdrawal by Subject|16|||
13263418|NCT01462942|26403452|FG004|Overall Study|Withdrawal by Subject|19|||
13263419|NCT01462942|26403448|FG000|Overall Study|Lack of Efficacy|6|||
13263420|NCT01462942|26403449|FG001|Overall Study|Lack of Efficacy|0|||
13263421|NCT01462942|26403450|FG002|Overall Study|Lack of Efficacy|4|||
13263422|NCT01462942|26403451|FG003|Overall Study|Lack of Efficacy|5|||
13263423|NCT01462942|26403452|FG004|Overall Study|Lack of Efficacy|3|||
13263424|NCT01462942|26403448|FG000|Overall Study|Lost to Follow-up|0|||
13263425|NCT01462942|26403449|FG001|Overall Study|Lost to Follow-up|1|||
13263426|NCT01462942|26403450|FG002|Overall Study|Lost to Follow-up|1|||
13263427|NCT01462942|26403451|FG003|Overall Study|Lost to Follow-up|1|||
13263428|NCT01462942|26403452|FG004|Overall Study|Lost to Follow-up|1|||
13263429|NCT01462942|26403448|FG000|Overall Study|Protocol Violation|4|||
13263430|NCT01462942|26403449|FG001|Overall Study|Protocol Violation|6|||
13263431|NCT01462942|26403450|FG002|Overall Study|Protocol Violation|9|||
13263432|NCT01462942|26403451|FG003|Overall Study|Protocol Violation|9|||
13263433|NCT01462942|26403452|FG004|Overall Study|Protocol Violation|6|||
13263434|NCT01462929|26403473|FG000|Overall Study|Adverse Event|3|||
13263435|NCT01462929|26403474|FG001|Overall Study|Adverse Event|3|||
13263436|NCT01462929|26403475|FG002|Overall Study|Adverse Event|4|||
13263437|NCT01462929|26403473|FG000|Overall Study|Withdrawal by Subject|2|||
13263438|NCT01462929|26403474|FG001|Overall Study|Withdrawal by Subject|1|||
13263439|NCT01462929|26403475|FG002|Overall Study|Withdrawal by Subject|0|||
13263440|NCT01462929|26403473|FG000|Overall Study|Lack of Efficacy|0|||
13203556|NCT01984697|26224942|FG002|Overall Study|Physician Decision|0|||
13263441|NCT01462929|26403474|FG001|Overall Study|Lack of Efficacy|0|||
13263442|NCT01462929|26403475|FG002|Overall Study|Lack of Efficacy|1|||
13263443|NCT01462695|26403488|FG000|Overall Study|Adverse Event|1|||
13263444|NCT01462695|26403489|FG001|Overall Study|Adverse Event|1|||
13263445|NCT01462695|26403488|FG000|Overall Study|Death|2|||
13263446|NCT01462695|26403489|FG001|Overall Study|Death|0|||
13263447|NCT01462695|26403488|FG000|Overall Study|Lack of Efficacy|6|||
13263448|NCT01462695|26403489|FG001|Overall Study|Lack of Efficacy|12|||
13263449|NCT01462695|26403488|FG000|Overall Study|Physician Decision|5|||
13263450|NCT01462695|26403489|FG001|Overall Study|Physician Decision|0|||
13263451|NCT01462695|26403488|FG000|Overall Study|Withdrawal by Subject|2|||
13263452|NCT01462695|26403489|FG001|Overall Study|Withdrawal by Subject|0|||
13263453|NCT01462695|26403488|FG000|Overall Study|Inevaluable (did not receive study drug)|1|||
13263454|NCT01462695|26403489|FG001|Overall Study|Inevaluable (did not receive study drug)|0|||
13263455|NCT01462630|26403500|FG000|Overall Study|Did not initiate therapy|3|||
13263456|NCT01462630|26403500|FG000|Overall Study|Death|1|||
13263457|NCT01462630|26403500|FG000|Overall Study|Protocol Violation|2|||
13263458|NCT01462630|26403500|FG000|Overall Study|Adverse Event|1|||
13263459|NCT01462435|26403551|FG000|Overall Study|Lack of Efficacy|1|||
13263460|NCT01462435|26403552|FG001|Overall Study|Lack of Efficacy|0|||
13263461|NCT01462435|26403553|FG002|Overall Study|Lack of Efficacy|0|||
13263462|NCT01462435|26403554|FG003|Overall Study|Lack of Efficacy|3|||
13263463|NCT01462435|26403551|FG000|Overall Study|Physician Decision|0|||
13263464|NCT01462435|26403552|FG001|Overall Study|Physician Decision|0|||
13263465|NCT01462435|26403553|FG002|Overall Study|Physician Decision|1|||
13263466|NCT01462435|26403554|FG003|Overall Study|Physician Decision|0|||
13263467|NCT01462435|26403551|FG000|Overall Study|Withdrawal by Subject|0|||
13263468|NCT01462435|26403552|FG001|Overall Study|Withdrawal by Subject|0|||
13263469|NCT01462435|26403553|FG002|Overall Study|Withdrawal by Subject|0|||
13263470|NCT01462435|26403554|FG003|Overall Study|Withdrawal by Subject|1|||
13263471|NCT01462435|26403551|FG000|Overall Study|Lost to Follow-up|0|||
13263472|NCT01462435|26403552|FG001|Overall Study|Lost to Follow-up|0|||
13263473|NCT01462435|26403553|FG002|Overall Study|Lost to Follow-up|0|||
13263474|NCT01462435|26403554|FG003|Overall Study|Lost to Follow-up|1|||
13263475|NCT01462370|26403589|FG000|Overall Study|Lack of Qualifying Event|1|||
13263476|NCT01462370|26403590|FG001|Overall Study|Lack of Qualifying Event|1|||
13263477|NCT01462370|26403589|FG000|Overall Study|Physician Decision|0|||
13263478|NCT01462370|26403590|FG001|Overall Study|Physician Decision|1|||
13263479|NCT01462370|26403589|FG000|Overall Study|Withdrawal by Subject|0|||
13263480|NCT01462370|26403590|FG001|Overall Study|Withdrawal by Subject|3|||
13263481|NCT01462357|26403671|FG000|Overall Study|Death|0|||
13263482|NCT01462357|26403672|FG001|Overall Study|Death|0|||
13263483|NCT01462357|26403673|FG002|Overall Study|Death|1|||
13263484|NCT01462357|26403671|FG000|Overall Study|Withdrawal by Subject|3|||
13263485|NCT01462357|26403672|FG001|Overall Study|Withdrawal by Subject|11|||
13263486|NCT01462357|26403673|FG002|Overall Study|Withdrawal by Subject|3|||
13263487|NCT01462357|26403671|FG000|Overall Study|Migrated/moved from study area|2|||
13263488|NCT01462357|26403672|FG001|Overall Study|Migrated/moved from study area|3|||
13263489|NCT01462357|26403673|FG002|Overall Study|Migrated/moved from study area|1|||
13263490|NCT01462357|26403671|FG000|Overall Study|Lost to Follow-up|3|||
13263491|NCT01462357|26403672|FG001|Overall Study|Lost to Follow-up|5|||
13263492|NCT01462357|26403673|FG002|Overall Study|Lost to Follow-up|7|||
13263493|NCT01462344|26403700|FG000|Overall Study|Withdrawal by Subject|245|||
13263494|NCT01462344|26403701|FG001|Overall Study|Withdrawal by Subject|226|||
13263495|NCT01462344|26403700|FG000|Overall Study|Adverse Event|24|||
13263496|NCT01462344|26403701|FG001|Overall Study|Adverse Event|23|||
13263497|NCT01462344|26403700|FG000|Overall Study|Asthma Exacerbation|34|||
13263498|NCT01462344|26403701|FG001|Overall Study|Asthma Exacerbation|35|||
13263499|NCT01462344|26403700|FG000|Overall Study|Lack of Efficacy|5|||
13263500|NCT01462344|26403701|FG001|Overall Study|Lack of Efficacy|6|||
13263501|NCT01462344|26403700|FG000|Overall Study|Protocol Violation|68|||
13263502|NCT01462344|26403701|FG001|Overall Study|Protocol Violation|53|||
13263503|NCT01462344|26403700|FG000|Overall Study|Lost to Follow-up|7|||
13263504|NCT01462344|26403701|FG001|Overall Study|Lost to Follow-up|7|||
13290549|NCT00101686|26481413|FG003|Overall Study|>3 week delay treatment due toxicity|2|||
13290550|NCT00101686|26481414|FG004|Overall Study|>3 week delay treatment due toxicity|7|||
13290551|NCT00101686|26481415|FG005|Overall Study|>3 week delay treatment due toxicity|3|||
13290552|NCT00101686|26481416|FG006|Overall Study|>3 week delay treatment due toxicity|2|||
13290553|NCT00101686|26481417|FG007|Overall Study|>3 week delay treatment due toxicity|1|||
13290554|NCT00101686|26481418|FG008|Overall Study|>3 week delay treatment due toxicity|3|||
13290555|NCT00101686|26481419|FG009|Overall Study|>3 week delay treatment due toxicity|0|||
13290556|NCT00101686|26481410|FG000|Overall Study|unacceptable toxicity|3|||
13290557|NCT00101686|26481411|FG001|Overall Study|unacceptable toxicity|9|||
13290558|NCT00101686|26481412|FG002|Overall Study|unacceptable toxicity|10|||
13290559|NCT00101686|26481413|FG003|Overall Study|unacceptable toxicity|6|||
13290560|NCT00101686|26481414|FG004|Overall Study|unacceptable toxicity|16|||
13290561|NCT00101686|26481415|FG005|Overall Study|unacceptable toxicity|10|||
13263505|NCT01462318|26403726|FG000|Main Study / TP-DI Study|Other|2|||
13263506|NCT01462318|26403727|FG001|Main Study / TP-DI Study|Other|0|||
13263507|NCT01462318|26403728|FG002|Main Study / TP-DI Study|Other|0|||
13263508|NCT01462318|26403726|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2|||
13263509|NCT01462318|26403727|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0|||
13263510|NCT01462318|26403728|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0|||
13263511|NCT01462318|26403726|FG000|Main Study / TP-DI Study|Adverse Event|4|||
13263512|NCT01462318|26403727|FG001|Main Study / TP-DI Study|Adverse Event|0|||
13263513|NCT01462318|26403728|FG002|Main Study / TP-DI Study|Adverse Event|0|||
13263514|NCT01462318|26403726|FG000|Extension Phase|Lost to Follow-up|0|||
13263515|NCT01462318|26403727|FG001|Extension Phase|Lost to Follow-up|0|||
13263516|NCT01462318|26403728|FG002|Extension Phase|Lost to Follow-up|1|||
13263517|NCT01462318|26403726|FG000|Extension Phase|Other|0|||
13263518|NCT01462318|26403727|FG001|Extension Phase|Other|0|||
13263519|NCT01462318|26403728|FG002|Extension Phase|Other|1|||
13263520|NCT01462318|26403726|FG000|Extension Phase|Disease Progression|0|||
13263521|NCT01462318|26403727|FG001|Extension Phase|Disease Progression|0|||
13263522|NCT01462318|26403728|FG002|Extension Phase|Disease Progression|1|||
13263523|NCT01462318|26403726|FG000|Extension Phase|Withdrawal by Subject|0|||
13263524|NCT01462318|26403727|FG001|Extension Phase|Withdrawal by Subject|0|||
13263525|NCT01462318|26403728|FG002|Extension Phase|Withdrawal by Subject|15|||
13263526|NCT01462318|26403726|FG000|Extension Phase|Investigator Decision|0|||
13263527|NCT01462318|26403727|FG001|Extension Phase|Investigator Decision|0|||
13263528|NCT01462318|26403728|FG002|Extension Phase|Investigator Decision|5|||
13263529|NCT01462318|26403726|FG000|Extension Phase|Adverse Event|0|||
13263530|NCT01462318|26403727|FG001|Extension Phase|Adverse Event|0|||
13263531|NCT01462318|26403728|FG002|Extension Phase|Adverse Event|22|||
13263532|NCT01462266|26403749|FG000|Overall Study|Adverse Event|7|||
13263533|NCT01462266|26403750|FG001|Overall Study|Adverse Event|6|||
13263534|NCT01462266|26403749|FG000|Overall Study|Death|2|||
13263535|NCT01462266|26403750|FG001|Overall Study|Death|1|||
13263536|NCT01462266|26403749|FG000|Overall Study|Lack of Efficacy|0|||
13263537|NCT01462266|26403750|FG001|Overall Study|Lack of Efficacy|2|||
13263538|NCT01462266|26403749|FG000|Overall Study|Lost to Follow-up|4|||
13263539|NCT01462266|26403750|FG001|Overall Study|Lost to Follow-up|3|||
13263540|NCT01462266|26403749|FG000|Overall Study|Non-compliance with study drug|3|||
13263541|NCT01462266|26403750|FG001|Overall Study|Non-compliance with study drug|0|||
13263542|NCT01462266|26403749|FG000|Overall Study|Creatinine and eGFR, excluded medication|8|||
13263543|NCT01462266|26403750|FG001|Overall Study|Creatinine and eGFR, excluded medication|4|||
13263544|NCT01462266|26403749|FG000|Overall Study|Physician Decision|2|||
13263545|NCT01462266|26403750|FG001|Overall Study|Physician Decision|5|||
13263546|NCT01462266|26403749|FG000|Overall Study|Protocol Violation|1|||
13263547|NCT01462266|26403750|FG001|Overall Study|Protocol Violation|3|||
13263548|NCT01462266|26403749|FG000|Overall Study|Withdrawal by Subject|7|||
13263549|NCT01462266|26403750|FG001|Overall Study|Withdrawal by Subject|2|||
13263550|NCT01462266|26403749|FG000|Overall Study|Screen failure|1|||
13263551|NCT01462266|26403750|FG001|Overall Study|Screen failure|1|||
13263552|NCT01462227|26403777|FG000|Second Assignment|Lost to Follow-up|1|||
13263553|NCT01462227|26403778|FG001|Second Assignment|Lost to Follow-up|0|||
13263554|NCT01462227|26403779|FG002|Second Assignment|Lost to Follow-up|0|||
13263555|NCT01462227|26403780|FG003|Second Assignment|Lost to Follow-up|0|||
13263556|NCT01462227|26403777|FG000|Second Assignment|Protocol Violation|0|||
13263557|NCT01462227|26403778|FG001|Second Assignment|Protocol Violation|1|||
13263558|NCT01462227|26403779|FG002|Second Assignment|Protocol Violation|1|||
13263559|NCT01462227|26403780|FG003|Second Assignment|Protocol Violation|0|||
13263560|NCT01462162|26403807|FG000|Overall Study|Adverse Event|5|||
13263561|NCT01462162|26403807|FG000|Overall Study|Lack of Efficacy|4|||
13263562|NCT01462162|26403807|FG000|Overall Study|Abnormal laboratory parameters|1|||
13263563|NCT01462162|26403807|FG000|Overall Study|Other|2|||
13263564|NCT01462110|26403834|FG000|Overall Study|Adverse Event|1|||
13263565|NCT01462110|26403835|FG001|Overall Study|Adverse Event|0|||
13263566|NCT01462084|26403846|FG000|Overall Study|Withdrawal by Subject|1|||
13263567|NCT01462084|26403847|FG001|Overall Study|Withdrawal by Subject|0|||
13263568|NCT01462084|26403846|FG000|Overall Study|Protocol Violation|1|||
13263569|NCT01462084|26403847|FG001|Overall Study|Protocol Violation|1|||
13263570|NCT01462045|26403868|FG000|Overall Study|Family matter|0|||
13263571|NCT01462045|26403869|FG001|Overall Study|Family matter|1|||
13263572|NCT01462045|26403870|FG002|Overall Study|Family matter|0|||
13263573|NCT01461993|26403902|FG000|Overall Study|Withdrawal by Subject|60|||
13263574|NCT01461993|26403903|FG001|Overall Study|Withdrawal by Subject|53|||
13263575|NCT01461993|26403904|FG002|Overall Study|Withdrawal by Subject|16|||
13263576|NCT01461993|26403902|FG000|Overall Study|Lost to Follow-up|44|||
13263577|NCT01461993|26403903|FG001|Overall Study|Lost to Follow-up|48|||
13263578|NCT01461993|26403904|FG002|Overall Study|Lost to Follow-up|22|||
13263579|NCT01461993|26403902|FG000|Overall Study|Protocol Violation|10|||
13263580|NCT01461993|26403903|FG001|Overall Study|Protocol Violation|9|||
13263581|NCT01461993|26403904|FG002|Overall Study|Protocol Violation|7|||
13263582|NCT01461993|26403902|FG000|Overall Study|Adverse Event|9|||
13263583|NCT01461993|26403903|FG001|Overall Study|Adverse Event|11|||
13263584|NCT01461993|26403904|FG002|Overall Study|Adverse Event|3|||
13263585|NCT01461993|26403902|FG000|Overall Study|No longer met eligibility criteria|13|||
13263586|NCT01461993|26403903|FG001|Overall Study|No longer met eligibility criteria|18|||
13263587|NCT01461993|26403904|FG002|Overall Study|No longer met eligibility criteria|10|||
13263588|NCT01461993|26403902|FG000|Overall Study|Did not meet entrance criteria|2|||
13263589|NCT01461993|26403903|FG001|Overall Study|Did not meet entrance criteria|3|||
13263590|NCT01461993|26403904|FG002|Overall Study|Did not meet entrance criteria|0|||
13263591|NCT01461993|26403902|FG000|Overall Study|Other|13|||
13263592|NCT01461993|26403903|FG001|Overall Study|Other|15|||
13263593|NCT01461993|26403904|FG002|Overall Study|Other|6|||
13263594|NCT01461980|26403944|FG000|Overall Study|Other|9|||
13263595|NCT01461980|26403945|FG001|Overall Study|Other|8|||
13263596|NCT01461980|26403946|FG002|Overall Study|Other|6|||
13263597|NCT01461980|26403944|FG000|Overall Study|Medication error|7|||
13263598|NCT01461980|26403945|FG001|Overall Study|Medication error|5|||
13263599|NCT01461980|26403946|FG002|Overall Study|Medication error|6|||
13263600|NCT01461980|26403944|FG000|Overall Study|Adverse Event|12|||
13263601|NCT01461980|26403945|FG001|Overall Study|Adverse Event|5|||
13263602|NCT01461980|26403946|FG002|Overall Study|Adverse Event|6|||
13117568|NCT03054428|25926116|FG001|Overall Study|Physician Decision|1|||
13117569|NCT03054428|25926117|FG002|Overall Study|Physician Decision|1|||
13117570|NCT03054428|25926115|FG000|Overall Study|Lack of Efficacy|3|||
13117571|NCT03054428|25926116|FG001|Overall Study|Lack of Efficacy|1|||
13117572|NCT03054428|25926117|FG002|Overall Study|Lack of Efficacy|0|||
13263603|NCT01461980|26403944|FG000|Overall Study|Protocol Violation|12|||
13263604|NCT01461980|26403945|FG001|Overall Study|Protocol Violation|19|||
13263605|NCT01461980|26403946|FG002|Overall Study|Protocol Violation|16|||
13263606|NCT01461980|26403944|FG000|Overall Study|No longer meets eligibility criteria|18|||
13263607|NCT01461980|26403945|FG001|Overall Study|No longer meets eligibility criteria|9|||
13117573|NCT03054428|25926115|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
13117574|NCT03054428|25926116|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
13117575|NCT03054428|25926117|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1|||
13117576|NCT03054428|25926115|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1|||
13117577|NCT03054428|25926116|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
13117578|NCT03054428|25926117|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
13117579|NCT03054428|25926115|FG000|Overall Study|Transitioned to OLE study|76|||
13117580|NCT03054428|25926116|FG001|Overall Study|Transitioned to OLE study|76|||
13117581|NCT03054428|25926117|FG002|Overall Study|Transitioned to OLE study|73|||
13117582|NCT03054428|25926115|FG000|Overall Study|Withdrawal by Subject|3|||
13117583|NCT03054428|25926116|FG001|Overall Study|Withdrawal by Subject|2|||
13117584|NCT03054428|25926117|FG002|Overall Study|Withdrawal by Subject|3|||
13117585|NCT03054428|25926115|FG000|Overall Study|Lost to Follow-up|0|||
13263608|NCT01461980|26403946|FG002|Overall Study|No longer meets eligibility criteria|19|||
13263609|NCT01461980|26403944|FG000|Overall Study|Lost to Follow-up|52|||
13263610|NCT01461980|26403945|FG001|Overall Study|Lost to Follow-up|53|||
13263611|NCT01461980|26403946|FG002|Overall Study|Lost to Follow-up|51|||
13263612|NCT01461980|26403944|FG000|Overall Study|No longer willing to participate|52|||
13263613|NCT01461980|26403945|FG001|Overall Study|No longer willing to participate|38|||
13263614|NCT01461980|26403946|FG002|Overall Study|No longer willing to participate|54|||
13263615|NCT01461980|26403944|FG000|Overall Study|Randomized but not vaccinated|4|||
13263616|NCT01461980|26403945|FG001|Overall Study|Randomized but not vaccinated|8|||
13263617|NCT01461980|26403946|FG002|Overall Study|Randomized but not vaccinated|7|||
13263618|NCT01461928|26403969|FG000|Induction (up to 8 Months)|Adverse Event|76|||
13263619|NCT01461928|26403970|FG001|Induction (up to 8 Months)|Adverse Event|0|||
13263620|NCT01461928|26403971|FG002|Induction (up to 8 Months)|Adverse Event|0|||
13263621|NCT01461928|26403969|FG000|Induction (up to 8 Months)|Death|3|||
13263622|NCT01461928|26403970|FG001|Induction (up to 8 Months)|Death|0|||
13263623|NCT01461928|26403971|FG002|Induction (up to 8 Months)|Death|0|||
13263624|NCT01461928|26403969|FG000|Induction (up to 8 Months)|Lost to Follow-up|5|||
13263625|NCT01461928|26403970|FG001|Induction (up to 8 Months)|Lost to Follow-up|0|||
13263626|NCT01461928|26403971|FG002|Induction (up to 8 Months)|Lost to Follow-up|0|||
13263627|NCT01461928|26403969|FG000|Induction (up to 8 Months)|Physician Decision|9|||
13263628|NCT01461928|26403970|FG001|Induction (up to 8 Months)|Physician Decision|0|||
13263629|NCT01461928|26403971|FG002|Induction (up to 8 Months)|Physician Decision|0|||
13263630|NCT01461928|26403969|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18|||
13263631|NCT01461928|26403970|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0|||
13263632|NCT01461928|26403971|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0|||
13263633|NCT01461928|26403969|FG000|Induction (up to 8 Months)|Disease progression|45|||
13263634|NCT01461928|26403970|FG001|Induction (up to 8 Months)|Disease progression|0|||
13263635|NCT01461928|26403971|FG002|Induction (up to 8 Months)|Disease progression|0|||
13263636|NCT01461928|26403969|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10|||
13263637|NCT01461928|26403970|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
13263638|NCT01461928|26403971|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
13263639|NCT01461928|26403969|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11|||
13263640|NCT01461928|26403970|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
13263641|NCT01461928|26403971|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
13263642|NCT01461928|26403969|FG000|Induction (up to 8 Months)|Not responding to treatment|11|||
13263643|NCT01461928|26403970|FG001|Induction (up to 8 Months)|Not responding to treatment|0|||
13263644|NCT01461928|26403971|FG002|Induction (up to 8 Months)|Not responding to treatment|0|||
13263645|NCT01461928|26403969|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1|||
13263646|NCT01461928|26403970|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
13263647|NCT01461928|26403971|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
13263648|NCT01461928|26403969|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1|||
13263649|NCT01461928|26403970|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
13263650|NCT01461928|26403971|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
13263651|NCT01461928|26403969|FG000|Induction (up to 8 Months)|Sponsor decision|1|||
13263652|NCT01461928|26403970|FG001|Induction (up to 8 Months)|Sponsor decision|0|||
13263653|NCT01461928|26403971|FG002|Induction (up to 8 Months)|Sponsor decision|0|||
13263654|NCT01461928|26403969|FG000|Induction (up to 8 Months)|Protocol deviation|2|||
13263655|NCT01461928|26403970|FG001|Induction (up to 8 Months)|Protocol deviation|0|||
13263656|NCT01461928|26403971|FG002|Induction (up to 8 Months)|Protocol deviation|0|||
13263657|NCT01461928|26403969|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1|||
13263658|NCT01461928|26403970|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
13263659|NCT01461928|26403971|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
13263660|NCT01461928|26403969|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1|||
13263661|NCT01461928|26403970|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
13263662|NCT01461928|26403971|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
13263663|NCT01461928|26403969|FG000|Induction (up to 8 Months)|Promotor request|1|||
13263664|NCT01461928|26403970|FG001|Induction (up to 8 Months)|Promotor request|0|||
13263665|NCT01461928|26403971|FG002|Induction (up to 8 Months)|Promotor request|0|||
13263666|NCT01461928|26403969|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1|||
13263667|NCT01461928|26403970|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
13263668|NCT01461928|26403971|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
13263669|NCT01461928|26403969|FG000|Induction (up to 8 Months)|Medical advisor request|1|||
13263670|NCT01461928|26403970|FG001|Induction (up to 8 Months)|Medical advisor request|0|||
13263671|NCT01461928|26403971|FG002|Induction (up to 8 Months)|Medical advisor request|0|||
13263672|NCT01461928|26403969|FG000|Maintenance I (24 Months)|Death|3|||
13263673|NCT01461928|26403970|FG001|Maintenance I (24 Months)|Death|0|||
13263674|NCT01461928|26403971|FG002|Maintenance I (24 Months)|Death|0|||
13263675|NCT01461928|26403969|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32|||
13263676|NCT01461928|26403970|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0|||
13117586|NCT03054428|25926116|FG001|Overall Study|Lost to Follow-up|0|||
13117587|NCT03054428|25926117|FG002|Overall Study|Lost to Follow-up|1|||
13117588|NCT03054350|25926272|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
13117589|NCT03054350|25926273|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
13203557|NCT01984697|26224943|FG003|Overall Study|Physician Decision|1|||
13263677|NCT01461928|26403971|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0|||
13263678|NCT01461928|26403969|FG000|Maintenance I (24 Months)|Lost to Follow-up|2|||
13263679|NCT01461928|26403970|FG001|Maintenance I (24 Months)|Lost to Follow-up|0|||
13263680|NCT01461928|26403971|FG002|Maintenance I (24 Months)|Lost to Follow-up|0|||
13263681|NCT01461928|26403969|FG000|Maintenance I (24 Months)|Diseases progression|91|||
13263682|NCT01461928|26403970|FG001|Maintenance I (24 Months)|Diseases progression|0|||
13263683|NCT01461928|26403971|FG002|Maintenance I (24 Months)|Diseases progression|0|||
13263684|NCT01461928|26403969|FG000|Maintenance I (24 Months)|Adverse Event|70|||
13263685|NCT01461928|26403970|FG001|Maintenance I (24 Months)|Adverse Event|0|||
13263686|NCT01461928|26403971|FG002|Maintenance I (24 Months)|Adverse Event|0|||
13263687|NCT01461928|26403969|FG000|Maintenance I (24 Months)|Physician Decision|9|||
13263688|NCT01461928|26403970|FG001|Maintenance I (24 Months)|Physician Decision|0|||
13263689|NCT01461928|26403971|FG002|Maintenance I (24 Months)|Physician Decision|0|||
13486336|NCT02422797|27035806|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6|||
13203558|NCT01984697|26224944|FG004|Overall Study|Physician Decision|0|||
13203559|NCT01984697|26224940|FG000|Overall Study|Protocol Violation|8|||
13203560|NCT01984697|26224941|FG001|Overall Study|Protocol Violation|5|||
13203561|NCT01984697|26224942|FG002|Overall Study|Protocol Violation|3|||
13203562|NCT01984697|26224943|FG003|Overall Study|Protocol Violation|2|||
13203563|NCT01984697|26224944|FG004|Overall Study|Protocol Violation|0|||
13203564|NCT01984697|26224940|FG000|Overall Study|Withdrawal by Subject|15|||
13203565|NCT01984697|26224941|FG001|Overall Study|Withdrawal by Subject|21|||
13203566|NCT01984697|26224942|FG002|Overall Study|Withdrawal by Subject|13|||
13203567|NCT01984697|26224943|FG003|Overall Study|Withdrawal by Subject|11|||
13203568|NCT01984697|26224944|FG004|Overall Study|Withdrawal by Subject|13|||
13263690|NCT01461928|26403969|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2|||
13263691|NCT01461928|26403970|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
13263692|NCT01461928|26403971|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
13263693|NCT01461928|26403969|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2|||
13263694|NCT01461928|26403970|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
13263695|NCT01461928|26403971|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
13263696|NCT01461928|26403969|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1|||
13263697|NCT01461928|26403970|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0|||
13263698|NCT01461928|26403971|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0|||
13263699|NCT01461928|26403969|FG000|Maintenance I (24 Months)|Not compliant|1|||
13263700|NCT01461928|26403970|FG001|Maintenance I (24 Months)|Not compliant|0|||
13263701|NCT01461928|26403971|FG002|Maintenance I (24 Months)|Not compliant|0|||
13263702|NCT01461928|26403969|FG000|Maintenance I (24 Months)|Did not meet criteria|5|||
13263703|NCT01461928|26403970|FG001|Maintenance I (24 Months)|Did not meet criteria|0|||
13263704|NCT01461928|26403971|FG002|Maintenance I (24 Months)|Did not meet criteria|0|||
13263705|NCT01461928|26403969|FG000|Maintenance II (15 Months)|Adverse Event|0|||
13263706|NCT01461928|26403970|FG001|Maintenance II (15 Months)|Adverse Event|2|||
13263707|NCT01461928|26403971|FG002|Maintenance II (15 Months)|Adverse Event|0|||
13263708|NCT01461928|26403969|FG000|Maintenance II (15 Months)|Death|0|||
13263709|NCT01461928|26403970|FG001|Maintenance II (15 Months)|Death|10|||
13263710|NCT01461928|26403971|FG002|Maintenance II (15 Months)|Death|8|||
13263711|NCT01461928|26403969|FG000|Maintenance II (15 Months)|Physician Decision|0|||
13263712|NCT01461928|26403970|FG001|Maintenance II (15 Months)|Physician Decision|0|||
13263713|NCT01461928|26403971|FG002|Maintenance II (15 Months)|Physician Decision|4|||
13263714|NCT01461928|26403969|FG000|Maintenance II (15 Months)|Lost to Follow-up|0|||
13263715|NCT01461928|26403970|FG001|Maintenance II (15 Months)|Lost to Follow-up|1|||
13263716|NCT01461928|26403971|FG002|Maintenance II (15 Months)|Lost to Follow-up|0|||
13263717|NCT01461928|26403969|FG000|Maintenance II (15 Months)|Moved to another town|0|||
13263718|NCT01461928|26403970|FG001|Maintenance II (15 Months)|Moved to another town|1|||
13263719|NCT01461928|26403971|FG002|Maintenance II (15 Months)|Moved to another town|0|||
13263720|NCT01461928|26403969|FG000|Maintenance II (15 Months)|Disease progression|0|||
13263721|NCT01461928|26403970|FG001|Maintenance II (15 Months)|Disease progression|0|||
13263722|NCT01461928|26403971|FG002|Maintenance II (15 Months)|Disease progression|3|||
13263723|NCT01461928|26403969|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0|||
13263724|NCT01461928|26403970|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9|||
13263725|NCT01461928|26403971|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8|||
13263726|NCT01461928|26403969|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0|||
13263727|NCT01461928|26403970|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0|||
13263728|NCT01461928|26403971|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1|||
13263729|NCT01461928|26403969|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
13263730|NCT01461928|26403970|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
13263731|NCT01461928|26403971|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1|||
13117590|NCT03054350|25926274|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1|||
13263732|NCT01461928|26403969|FG000|Maintenance II (15 Months)|Withdrew informed consent|0|||
13263733|NCT01461928|26403970|FG001|Maintenance II (15 Months)|Withdrew informed consent|0|||
13263734|NCT01461928|26403971|FG002|Maintenance II (15 Months)|Withdrew informed consent|1|||
13263735|NCT01461928|26403969|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
13263736|NCT01461928|26403970|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
13263737|NCT01461928|26403971|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1|||
13263738|NCT01461811|26404006|FG000|Overall Study|Adverse Event|2|||
13263739|NCT01461811|26404007|FG001|Overall Study|Adverse Event|1|||
13263740|NCT01461811|26404006|FG000|Overall Study|Subject decision unrelated to an AE|1|||
13263741|NCT01461811|26404007|FG001|Overall Study|Subject decision unrelated to an AE|1|||
13263742|NCT01461811|26404006|FG000|Overall Study|Noncompliance|1|||
13263743|NCT01461811|26404007|FG001|Overall Study|Noncompliance|1|||
13263744|NCT01461707|26404022|FG000|Overall Study|Withdrawal by Subject|1|||
13263745|NCT01461707|26404023|FG001|Overall Study|Withdrawal by Subject|0|||
13263746|NCT01461551|26404041|FG000|Overall Study|Physician Decision|2|||
13263747|NCT01461551|26404042|FG001|Overall Study|Physician Decision|1|||
13263748|NCT01461551|26404043|FG002|Overall Study|Physician Decision|2|||
13263749|NCT01461538|26404089|FG000|Overall Study|Death|15|||
13263750|NCT01461538|26404090|FG001|Overall Study|Death|6|||
13263751|NCT01461538|26404091|FG002|Overall Study|Death|2|||
13263752|NCT01461538|26404089|FG000|Overall Study|Study Stopped by Sponsor|2|||
13263753|NCT01461538|26404090|FG001|Overall Study|Study Stopped by Sponsor|1|||
13263754|NCT01461538|26404091|FG002|Overall Study|Study Stopped by Sponsor|0|||
13263755|NCT01461538|26404089|FG000|Overall Study|Withdrawal by Subject|1|||
13263756|NCT01461538|26404090|FG001|Overall Study|Withdrawal by Subject|1|||
13263757|NCT01461538|26404091|FG002|Overall Study|Withdrawal by Subject|0|||
13263758|NCT01461369|26404124|FG000|Overall Study|Lack of Efficacy|2|||
13263759|NCT01461369|26404125|FG001|Overall Study|Lack of Efficacy|0|||
13263760|NCT01461369|26404126|FG002|Overall Study|Lack of Efficacy|6|||
13263761|NCT01461369|26404124|FG000|Overall Study|Lost to Follow-up|0|||
13263762|NCT01461369|26404125|FG001|Overall Study|Lost to Follow-up|0|||
13263763|NCT01461369|26404126|FG002|Overall Study|Lost to Follow-up|3|||
13263764|NCT01461369|26404124|FG000|Overall Study|Adverse Event|9|||
13263765|NCT01461369|26404125|FG001|Overall Study|Adverse Event|12|||
13263766|NCT01461369|26404126|FG002|Overall Study|Adverse Event|4|||
13263767|NCT01461369|26404124|FG000|Overall Study|Protocol Violation|1|||
13263768|NCT01461369|26404125|FG001|Overall Study|Protocol Violation|2|||
13263769|NCT01461369|26404126|FG002|Overall Study|Protocol Violation|2|||
13263770|NCT01461369|26404124|FG000|Overall Study|Withdrawal by Subject|1|||
13263771|NCT01461369|26404125|FG001|Overall Study|Withdrawal by Subject|3|||
13263772|NCT01461369|26404126|FG002|Overall Study|Withdrawal by Subject|2|||
13263773|NCT01461096|26404147|FG000|Overall Study|Death|3|||
13263774|NCT01461096|26404148|FG001|Overall Study|Death|6|||
13263775|NCT01461096|26404147|FG000|Overall Study|Severe debilitation, unable to continue|1|||
13263776|NCT01461096|26404148|FG001|Overall Study|Severe debilitation, unable to continue|1|||
13263777|NCT01461096|26404147|FG000|Overall Study|Subj not able to get to clinic|15|||
13263778|NCT01461096|26404148|FG001|Overall Study|Subj not able to get to clinic|13|||
13263779|NCT01461096|26404147|FG000|Overall Study|Site is closing|27|||
13263780|NCT01461096|26404148|FG001|Overall Study|Site is closing|30|||
13263781|NCT01461096|26404147|FG000|Overall Study|Withdrawal by Subject|5|||
13263782|NCT01461096|26404148|FG001|Overall Study|Withdrawal by Subject|3|||
13263783|NCT01461096|26404147|FG000|Overall Study|Subj not willing to adhere to reqs|3|||
13117591|NCT03054350|25926275|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
13117592|NCT03054350|25926276|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
13117593|NCT03054350|25926277|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3|||
13117594|NCT03054350|25926272|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
13117595|NCT03054350|25926273|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
13117596|NCT03054350|25926274|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1|||
13117597|NCT03054350|25926275|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
13117598|NCT03054350|25926276|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
13263784|NCT01461096|26404148|FG001|Overall Study|Subj not willing to adhere to reqs|4|||
13263785|NCT01461096|26404147|FG000|Overall Study|Lost to Follow-up|8|||
13263786|NCT01461096|26404148|FG001|Overall Study|Lost to Follow-up|4|||
13263787|NCT01461057|26404163|FG000|Overall Study|Death|10|||
13263788|NCT01461057|26404164|FG001|Overall Study|Death|9|||
13263789|NCT01461057|26404163|FG000|Overall Study|Withdrawal by Subject|2|||
13263790|NCT01461057|26404164|FG001|Overall Study|Withdrawal by Subject|3|||
13263791|NCT01461057|26404163|FG000|Overall Study|Physician Decision|0|||
13263792|NCT01461057|26404164|FG001|Overall Study|Physician Decision|2|||
13263793|NCT01461057|26404163|FG000|Overall Study|Adverse Event|0|||
13263794|NCT01461057|26404164|FG001|Overall Study|Adverse Event|1|||
13263795|NCT01461057|26404163|FG000|Overall Study|Progression of Disease|1|||
13263796|NCT01461057|26404164|FG001|Overall Study|Progression of Disease|0|||
13263797|NCT01461057|26404163|FG000|Overall Study|Study Terminated by Sponsor|2|||
13263798|NCT01461057|26404164|FG001|Overall Study|Study Terminated by Sponsor|0|||
13263799|NCT01461044|26404244|FG000|Overall Study|Death|58|||
13263800|NCT01461044|26404245|FG001|Overall Study|Death|35|||
13263801|NCT01461044|26404244|FG000|Overall Study|Lost to Follow-up|12|||
13263802|NCT01461044|26404245|FG001|Overall Study|Lost to Follow-up|5|||
13263803|NCT01461005|26404256|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1|||
13263804|NCT01460901|26404266|FG000|Overall Study|Withdrawal by Subject|2|||
13263805|NCT01460719|26404278|FG000|Overall Study|Adverse Event|1|||
13263806|NCT01460719|26404278|FG000|Overall Study|Withdrawal by Subject|1|||
13263807|NCT01460628|26404290|FG000|Overall Study|Adverse Event|3|||
13263808|NCT01460628|26404290|FG000|Overall Study|Withdrawal by Subject|2|||
13263809|NCT01460446|26404324|FG000|Overall Study|Non-compliance|2|||
13263810|NCT01460446|26404325|FG001|Overall Study|Non-compliance|9|||
13263811|NCT01460446|26404324|FG000|Overall Study|Consent Withdrawn|0|||
13263812|NCT01460446|26404325|FG001|Overall Study|Consent Withdrawn|4|||
13263813|NCT01460446|26404324|FG000|Overall Study|Non-compliance & Consent Withdrawn|1|||
13263814|NCT01460446|26404325|FG001|Overall Study|Non-compliance & Consent Withdrawn|3|||
13263815|NCT01460446|26404324|FG000|Overall Study|Surgery/Illness|1|||
13263816|NCT01460446|26404325|FG001|Overall Study|Surgery/Illness|1|||
13263817|NCT01460446|26404324|FG000|Overall Study|Pregnancy|1|||
13263818|NCT01460446|26404325|FG001|Overall Study|Pregnancy|0|||
13263819|NCT01460446|26404324|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0|||
13263820|NCT01460446|26404325|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3|||
13263821|NCT01460407|26404339|FG000|Period 2: Day 6 to Day 14|Adverse Event|0|||
13263822|NCT01460407|26404340|FG001|Period 2: Day 6 to Day 14|Adverse Event|1|||
13263823|NCT01460381|26404361|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1|||
13263824|NCT01460381|26404362|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0|||
13263825|NCT01460368|26404384|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
13263826|NCT01460368|26404385|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
13263827|NCT01460368|26404386|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
13263828|NCT01460368|26404387|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
13263829|NCT01460368|26404388|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1|||
13263830|NCT01460368|26404389|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
13263831|NCT01460368|26404390|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
13263832|NCT01460368|26404384|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
13263833|NCT01460368|26404385|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
13263834|NCT01460368|26404386|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
13263835|NCT01460368|26404387|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
13263836|NCT01460368|26404388|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
13263837|NCT01460368|26404389|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
13263838|NCT01460368|26404390|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
13263839|NCT01460368|26404384|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
13263840|NCT01460368|26404385|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1|||
13263841|NCT01460368|26404386|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
13263842|NCT01460368|26404387|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
13263843|NCT01460368|26404388|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
13263844|NCT01460368|26404389|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
13263845|NCT01460368|26404390|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
13263846|NCT01460368|26404384|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
13263847|NCT01460368|26404385|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
13263848|NCT01460368|26404386|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1|||
13263849|NCT01460368|26404387|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
13263850|NCT01460368|26404388|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
13263851|NCT01460368|26404389|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
13263852|NCT01460368|26404390|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
13263853|NCT01460368|26404384|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
13263854|NCT01460368|26404385|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
13263855|NCT01460368|26404386|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
13263856|NCT01460368|26404387|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
13263857|NCT01460368|26404388|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
13263858|NCT01460368|26404389|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
13263859|NCT01460368|26404390|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
13263860|NCT01460342|26404417|FG000|Overall Study|Adverse Event|5|||
13263861|NCT01460342|26404418|FG001|Overall Study|Adverse Event|4|||
13263862|NCT01460342|26404417|FG000|Overall Study|Lost to Follow-up|1|||
13263863|NCT01460342|26404418|FG001|Overall Study|Lost to Follow-up|2|||
13263864|NCT01460342|26404417|FG000|Overall Study|Protocol Violation|0|||
13263865|NCT01460342|26404418|FG001|Overall Study|Protocol Violation|1|||
13263866|NCT01460342|26404417|FG000|Overall Study|Withdrawal by Subject|3|||
13263867|NCT01460342|26404418|FG001|Overall Study|Withdrawal by Subject|4|||
13263868|NCT01460342|26404417|FG000|Overall Study|Physician Decision|1|||
13263869|NCT01460342|26404418|FG001|Overall Study|Physician Decision|3|||
13263870|NCT01460342|26404417|FG000|Overall Study|Lack of Efficacy|1|||
13263871|NCT01460342|26404418|FG001|Overall Study|Lack of Efficacy|0|||
13263872|NCT01460290|26404440|FG000|Overall Study|Adverse Event|3|||
13263873|NCT01460290|26404440|FG000|Overall Study|Elevated liver function|1|||
13263874|NCT01459913|26404482|FG000|Overall Study|Adverse Event|0|||
13263875|NCT01459913|26404483|FG001|Overall Study|Adverse Event|0|||
13263876|NCT01459913|26404484|FG002|Overall Study|Adverse Event|0|||
13263877|NCT01459913|26404485|FG003|Overall Study|Adverse Event|3|||
13263878|NCT01459913|26404482|FG000|Overall Study|Withdrawal by Subject|4|||
13263879|NCT01459913|26404483|FG001|Overall Study|Withdrawal by Subject|0|||
13263880|NCT01459913|26404484|FG002|Overall Study|Withdrawal by Subject|0|||
13263881|NCT01459913|26404485|FG003|Overall Study|Withdrawal by Subject|5|||
13263882|NCT01459913|26404482|FG000|Overall Study|Lost to Follow-up|7|||
13263883|NCT01459913|26404483|FG001|Overall Study|Lost to Follow-up|4|||
13263884|NCT01459913|26404484|FG002|Overall Study|Lost to Follow-up|1|||
13263885|NCT01459913|26404485|FG003|Overall Study|Lost to Follow-up|8|||
13263886|NCT01459913|26404482|FG000|Overall Study|Death|0|||
13263887|NCT01459913|26404483|FG001|Overall Study|Death|0|||
13263888|NCT01459913|26404484|FG002|Overall Study|Death|0|||
13263889|NCT01459913|26404485|FG003|Overall Study|Death|1|||
13263890|NCT01459913|26404482|FG000|Overall Study|Non- Compliance|0|||
13263891|NCT01459913|26404483|FG001|Overall Study|Non- Compliance|0|||
13263892|NCT01459913|26404484|FG002|Overall Study|Non- Compliance|0|||
13263893|NCT01459913|26404485|FG003|Overall Study|Non- Compliance|3|||
13263894|NCT01459913|26404482|FG000|Overall Study|Physician Decision|0|||
13263895|NCT01459913|26404483|FG001|Overall Study|Physician Decision|1|||
13263896|NCT01459913|26404484|FG002|Overall Study|Physician Decision|0|||
13263897|NCT01459913|26404485|FG003|Overall Study|Physician Decision|0|||
13263898|NCT01459913|26404482|FG000|Overall Study|Study Terminated by Sponsor|30|||
13263899|NCT01459913|26404483|FG001|Overall Study|Study Terminated by Sponsor|15|||
13263900|NCT01459913|26404484|FG002|Overall Study|Study Terminated by Sponsor|9|||
13263901|NCT01459913|26404485|FG003|Overall Study|Study Terminated by Sponsor|11|||
13263902|NCT01459913|26404482|FG000|Overall Study|Other|0|||
13263903|NCT01459913|26404483|FG001|Overall Study|Other|0|||
13263904|NCT01459913|26404484|FG002|Overall Study|Other|3|||
13263905|NCT01459913|26404485|FG003|Overall Study|Other|1|||
13263906|NCT01459913|26404482|FG000|Overall Study|Did Not Meet Inclusion Criteria|0|||
13263907|NCT01459913|26404483|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
13263908|NCT01459913|26404484|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
13263909|NCT01459913|26404485|FG003|Overall Study|Did Not Meet Inclusion Criteria|1|||
13263910|NCT01459796|26404508|FG000|Overall Study|Non compliance with protocol|2|||
13263911|NCT01459796|26404509|FG001|Overall Study|Non compliance with protocol|4|||
13263912|NCT01459796|26404508|FG000|Overall Study|Adverse Event|5|||
13263913|NCT01459796|26404509|FG001|Overall Study|Adverse Event|5|||
13263914|NCT01459796|26404508|FG000|Overall Study|Withdrawal by Subject|6|||
13263915|NCT01459796|26404509|FG001|Overall Study|Withdrawal by Subject|3|||
13263916|NCT01459796|26404508|FG000|Overall Study|Lost to Follow-up|5|||
13263917|NCT01459796|26404509|FG001|Overall Study|Lost to Follow-up|4|||
13263918|NCT01459796|26404508|FG000|Overall Study|Reason unspecified|1|||
13263919|NCT01459796|26404509|FG001|Overall Study|Reason unspecified|2|||
13263920|NCT01459796|26404508|FG000|Overall Study|Decision by the sponsor|75|||
13263921|NCT01459796|26404509|FG001|Overall Study|Decision by the sponsor|108|||
13263922|NCT01459783|26404524|FG000|Baseline to 6 Months|Death|1|||
13263923|NCT01459783|26404525|FG001|Baseline to 6 Months|Death|0|||
13263924|NCT01459783|26404524|FG000|Baseline to 6 Months|Withdrawal by Subject|12|||
13263925|NCT01459783|26404525|FG001|Baseline to 6 Months|Withdrawal by Subject|6|||
13263926|NCT01459783|26404524|FG000|Baseline to 6 Months|Lost to Follow-up|19|||
13263927|NCT01459783|26404525|FG001|Baseline to 6 Months|Lost to Follow-up|14|||
13263928|NCT01459783|26404524|FG000|6 Months to 12 Months|Death|0|||
13263929|NCT01459783|26404525|FG001|6 Months to 12 Months|Death|1|||
13263930|NCT01459783|26404524|FG000|6 Months to 12 Months|Withdrawal by Subject|6|||
13263931|NCT01459783|26404525|FG001|6 Months to 12 Months|Withdrawal by Subject|5|||
13263932|NCT01459783|26404524|FG000|6 Months to 12 Months|Lost to Follow-up|2|||
13263933|NCT01459783|26404525|FG001|6 Months to 12 Months|Lost to Follow-up|7|||
13263934|NCT01459783|26404524|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11|||
13263935|NCT01459783|26404525|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17|||
13263936|NCT01459718|26404538|FG000|Overall Study|Physician Decision|1|||
13263937|NCT01459718|26404538|FG000|Overall Study|Lost to Follow-up|1|||
13263938|NCT01459718|26404538|FG000|Overall Study|Adverse Event|1|||
13263939|NCT01459666|26404555|FG000|Overall Study|PI left institution|5|||
13263940|NCT01459666|26404556|FG001|Overall Study|PI left institution|4|||
13263941|NCT01459614|26404575|FG000|Overall Study|Adverse Event|1|||
13263942|NCT01459614|26404576|FG001|Overall Study|Adverse Event|0|||
13263943|NCT01459068|26404599|FG000|Overall Study|Withdrawal by Subject|8|||
13263944|NCT01459068|26404600|FG001|Overall Study|Withdrawal by Subject|18|||
13263945|NCT01459068|26404599|FG000|Overall Study|Lost to Follow-up|31|||
13263946|NCT01459068|26404600|FG001|Overall Study|Lost to Follow-up|15|||
13263947|NCT01459068|26404599|FG000|Overall Study|Death|0|||
13263948|NCT01459068|26404600|FG001|Overall Study|Death|1|||
13263949|NCT01459016|26404616|FG000|Overall Study|Withdrawal by Subject|11|||
13263950|NCT01459016|26404616|FG000|Overall Study|Amendment Discontinuation Criteria|4|||
13263951|NCT01458951|26404651|FG000|Overall Study|Other|1|||
13263952|NCT01458951|26404652|FG001|Overall Study|Other|0|||
13263953|NCT01458951|26404653|FG002|Overall Study|Other|0|||
13263954|NCT01458951|26404651|FG000|Overall Study|Protocol Violation|5|||
13263955|NCT01458951|26404652|FG001|Overall Study|Protocol Violation|1|||
13263956|NCT01458951|26404653|FG002|Overall Study|Protocol Violation|0|||
13263957|NCT01458951|26404651|FG000|Overall Study|Withdrawal by Subject|2|||
13263958|NCT01458951|26404652|FG001|Overall Study|Withdrawal by Subject|0|||
13263959|NCT01458951|26404653|FG002|Overall Study|Withdrawal by Subject|2|||
13263960|NCT01458951|26404651|FG000|Overall Study|Adverse Event|7|||
13263961|NCT01458951|26404652|FG001|Overall Study|Adverse Event|0|||
13263962|NCT01458951|26404653|FG002|Overall Study|Adverse Event|2|||
13263963|NCT01458951|26404651|FG000|Overall Study|Insufficient Clinical Response|17|||
13263964|NCT01458951|26404652|FG001|Overall Study|Insufficient Clinical Response|0|||
13263965|NCT01458951|26404653|FG002|Overall Study|Insufficient Clinical Response|11|||
13263966|NCT01458639|26404665|FG000|Overall Study|Physician Decision|4|||
13486337|NCT02422797|27035805|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1|||
13486338|NCT02422797|27035806|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0|||
13263967|NCT01458639|26404665|FG000|Overall Study|Equipment issue|1|||
13263968|NCT01458639|26404665|FG000|Overall Study|Inability to obtain subject blood sample|1|||
13263969|NCT01458587|26404832|FG000|Overall Study|Withdrawal by Subject|1|||
13263970|NCT01458587|26404833|FG001|Overall Study|Withdrawal by Subject|0|||
13263971|NCT01458574|26404926|FG000|Overall Study|Adverse Event|5|||
13263972|NCT01458574|26404927|FG001|Overall Study|Adverse Event|9|||
13263973|NCT01458574|26404928|FG002|Overall Study|Adverse Event|7|||
13263974|NCT01458574|26404926|FG000|Overall Study|Lack of Efficacy|70|||
13263975|NCT01458574|26404927|FG001|Overall Study|Lack of Efficacy|53|||
13263976|NCT01458574|26404928|FG002|Overall Study|Lack of Efficacy|132|||
13263977|NCT01458574|26404926|FG000|Overall Study|Lost to Follow-up|3|||
13263978|NCT01458574|26404927|FG001|Overall Study|Lost to Follow-up|2|||
13263979|NCT01458574|26404928|FG002|Overall Study|Lost to Follow-up|1|||
13263980|NCT01458574|26404926|FG000|Overall Study|Pregnancy|1|||
13263981|NCT01458574|26404927|FG001|Overall Study|Pregnancy|1|||
13263982|NCT01458574|26404928|FG002|Overall Study|Pregnancy|0|||
13263983|NCT01458574|26404926|FG000|Overall Study|Protocol Violation|0|||
13263984|NCT01458574|26404927|FG001|Overall Study|Protocol Violation|1|||
13263985|NCT01458574|26404928|FG002|Overall Study|Protocol Violation|0|||
13263986|NCT01458574|26404926|FG000|Overall Study|Withdrawal by Subject|6|||
13263987|NCT01458574|26404927|FG001|Overall Study|Withdrawal by Subject|3|||
13263988|NCT01458574|26404928|FG002|Overall Study|Withdrawal by Subject|5|||
13263989|NCT01458574|26404926|FG000|Overall Study|Other|2|||
13263990|NCT01458574|26404927|FG001|Overall Study|Other|1|||
13263991|NCT01458574|26404928|FG002|Overall Study|Other|0|||
13263992|NCT01458574|26404926|FG000|Overall Study|Randomized but not treated|0|||
13263993|NCT01458574|26404927|FG001|Overall Study|Randomized but not treated|1|||
13263994|NCT01458574|26404928|FG002|Overall Study|Randomized but not treated|0|||
13263995|NCT01458535|26404997|FG000|Overall Study|Other|0|||
13263996|NCT01458535|26404998|FG001|Overall Study|Other|0|||
13263997|NCT01458535|26404999|FG002|Overall Study|Other|0|||
13263998|NCT01458535|26405000|FG003|Overall Study|Other|0|||
13263999|NCT01458535|26405001|FG004|Overall Study|Other|1|||
13264000|NCT01458535|26405002|FG005|Overall Study|Other|1|||
13264001|NCT01458535|26404997|FG000|Overall Study|Withdrawal by Subject|0|||
13264002|NCT01458535|26404998|FG001|Overall Study|Withdrawal by Subject|0|||
13264003|NCT01458535|26404999|FG002|Overall Study|Withdrawal by Subject|2|||
13264004|NCT01458535|26405000|FG003|Overall Study|Withdrawal by Subject|0|||
13264005|NCT01458535|26405001|FG004|Overall Study|Withdrawal by Subject|1|||
13264006|NCT01458535|26405002|FG005|Overall Study|Withdrawal by Subject|1|||
13486339|NCT02422797|27035805|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
13486340|NCT02422797|27035806|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0|||
13486341|NCT02132611|27035833|FG000|Overall Study|Death|2|||
13264007|NCT01458535|26404997|FG000|Overall Study|Lost to Follow-up|0|||
13264008|NCT01458535|26404998|FG001|Overall Study|Lost to Follow-up|2|||
13264009|NCT01458535|26404999|FG002|Overall Study|Lost to Follow-up|0|||
13264010|NCT01458535|26405000|FG003|Overall Study|Lost to Follow-up|3|||
13264011|NCT01458535|26405001|FG004|Overall Study|Lost to Follow-up|2|||
13264012|NCT01458535|26405002|FG005|Overall Study|Lost to Follow-up|2|||
13264013|NCT01458535|26404997|FG000|Overall Study|Adverse Event|0|||
13264014|NCT01458535|26404998|FG001|Overall Study|Adverse Event|0|||
13264015|NCT01458535|26404999|FG002|Overall Study|Adverse Event|0|||
13264016|NCT01458535|26405000|FG003|Overall Study|Adverse Event|1|||
13264017|NCT01458535|26405001|FG004|Overall Study|Adverse Event|0|||
13264018|NCT01458535|26405002|FG005|Overall Study|Adverse Event|0|||
13264019|NCT01458522|26405035|FG000|Overall Study|Withdrawal by Subject|2|||
13264020|NCT01458522|26405036|FG001|Overall Study|Withdrawal by Subject|2|||
13264021|NCT01458522|26405035|FG000|Overall Study|Physician Decision|1|||
13264022|NCT01458522|26405036|FG001|Overall Study|Physician Decision|9|||
13264023|NCT01458392|26405066|FG000|Overall Study|Death|2|||
13264024|NCT01458392|26405067|FG001|Overall Study|Death|11|||
13264025|NCT01458392|26405068|FG002|Overall Study|Death|22|||
13264026|NCT01458392|26405066|FG000|Overall Study|At the discretion of the sponsor|0|||
13264027|NCT01458392|26405067|FG001|Overall Study|At the discretion of the sponsor|2|||
13264028|NCT01458392|26405068|FG002|Overall Study|At the discretion of the sponsor|7|||
13264029|NCT01458392|26405066|FG000|Overall Study|Patient unwilling to comply with protoco|0|||
13264030|NCT01458392|26405067|FG001|Overall Study|Patient unwilling to comply with protoco|0|||
13264031|NCT01458392|26405068|FG002|Overall Study|Patient unwilling to comply with protoco|2|||
13264032|NCT01458366|26405099|FG000|Period 1: 70mg/m^2|Physician Decision|2|||
13264033|NCT01458366|26405100|FG001|Period 1: 70mg/m^2|Physician Decision|0|||
13264034|NCT01458366|26405101|FG002|Period 1: 70mg/m^2|Physician Decision|0|||
13264035|NCT01458366|26405102|FG003|Period 1: 70mg/m^2|Physician Decision|0|||
13264036|NCT01458366|26405103|FG004|Period 1: 70mg/m^2|Physician Decision|0|||
13264037|NCT01458366|26405099|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
13264038|NCT01458366|26405100|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
13264039|NCT01458366|26405101|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
13264040|NCT01458366|26405102|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
13264041|NCT01458366|26405103|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1|||
13264042|NCT01458275|26405153|FG000|Overall Study|Adverse Event|3|||
13264043|NCT01458275|26405154|FG001|Overall Study|Adverse Event|4|||
13264044|NCT01458275|26405155|FG002|Overall Study|Adverse Event|1|||
13264045|NCT01458275|26405153|FG000|Overall Study|Lost to Follow-up|3|||
13264046|NCT01458275|26405154|FG001|Overall Study|Lost to Follow-up|2|||
13486342|NCT01147822|27035854|FG000|Overall Study|Death|66|||
13264047|NCT01458275|26405155|FG002|Overall Study|Lost to Follow-up|5|||
13264048|NCT01458275|26405153|FG000|Overall Study|Protocol Violation|5|||
13264049|NCT01458275|26405154|FG001|Overall Study|Protocol Violation|5|||
13264050|NCT01458275|26405155|FG002|Overall Study|Protocol Violation|2|||
13264051|NCT01458275|26405153|FG000|Overall Study|Withdrawal by Subject|3|||
13264052|NCT01458275|26405154|FG001|Overall Study|Withdrawal by Subject|2|||
13264053|NCT01458275|26405155|FG002|Overall Study|Withdrawal by Subject|1|||
13264054|NCT01458249|26405180|FG000|Overall Study|Not treated|1|||
13264055|NCT01458249|26405180|FG000|Overall Study|Adverse Event|4|||
13264056|NCT01458249|26405180|FG000|Overall Study|Other|2|||
13264057|NCT01458249|26405180|FG000|Overall Study|Ongoing|1|||
13264058|NCT01458210|26405199|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2|||
13264059|NCT01458210|26405199|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2|||
13264060|NCT01458210|26405199|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2|||
13264061|NCT01458210|26405199|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1|||
13264062|NCT01458171|26405222|FG000|Overall Study|Adverse Event|1|||
13264063|NCT01458132|26405237|FG000|Overall Study|Other|15|||
13264064|NCT01458132|26405238|FG001|Overall Study|Other|3|||
13264065|NCT01458119|26405245|FG000|Overall Study|Physician Decision|4|||
13264066|NCT01458119|26405245|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1|||
13264067|NCT01458119|26405245|FG000|Overall Study|Pregnancy|1|||
13264068|NCT01458119|26405245|FG000|Overall Study|Death|2|||
13264069|NCT01458119|26405245|FG000|Overall Study|Adverse Event|1|||
13264070|NCT01458119|26405245|FG000|Overall Study|Consent Withdrawn by Participant|8|||
13264071|NCT01458119|26405245|FG000|Overall Study|Non-compliance With Study Drug|3|||
13264072|NCT01458106|26405327|FG000|Overall Study|Withdrawal by Subject|2|||
13264073|NCT01458106|26405328|FG001|Overall Study|Withdrawal by Subject|0|||
13264074|NCT01458106|26405327|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1|||
13264075|NCT01458106|26405328|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0|||
13264076|NCT01458106|26405327|FG000|Overall Study|Withdrawn Per Protocol|0|||
13264077|NCT01458106|26405328|FG001|Overall Study|Withdrawn Per Protocol|1|||
13264078|NCT01457950|26405411|FG000|Double-Blind Phase|Continuation Criteria Not Met|1|||
13264079|NCT01457950|26405412|FG001|Double-Blind Phase|Continuation Criteria Not Met|0|||
13264080|NCT01457950|26405413|FG002|Double-Blind Phase|Continuation Criteria Not Met|0|||
13264081|NCT01457950|26405414|FG003|Double-Blind Phase|Continuation Criteria Not Met|0|||
13264082|NCT01457950|26405411|FG000|Double-Blind Phase|Protocol Violation|2|||
13264083|NCT01457950|26405412|FG001|Double-Blind Phase|Protocol Violation|1|||
13264084|NCT01457950|26405413|FG002|Double-Blind Phase|Protocol Violation|0|||
13264085|NCT01457950|26405414|FG003|Double-Blind Phase|Protocol Violation|0|||
13264086|NCT01457950|26405411|FG000|Double-Blind Phase|Withdrawal by Subject|6|||
13264087|NCT01457950|26405412|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
13264088|NCT01457950|26405413|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
13264089|NCT01457950|26405414|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
13264090|NCT01457950|26405411|FG000|Open-Label Phase|Adverse Event|0|||
13264091|NCT01457950|26405412|FG001|Open-Label Phase|Adverse Event|0|||
13264092|NCT01457950|26405413|FG002|Open-Label Phase|Adverse Event|0|||
13264093|NCT01457950|26405414|FG003|Open-Label Phase|Adverse Event|1|||
13264094|NCT01457950|26405411|FG000|Open-Label Phase|Protocol Violation|0|||
13264095|NCT01457950|26405412|FG001|Open-Label Phase|Protocol Violation|0|||
13264096|NCT01457950|26405413|FG002|Open-Label Phase|Protocol Violation|0|||
13264097|NCT01457950|26405414|FG003|Open-Label Phase|Protocol Violation|1|||
13264098|NCT01457950|26405411|FG000|Open-Label Phase|Withdrawal by Subject|0|||
13264099|NCT01457950|26405412|FG001|Open-Label Phase|Withdrawal by Subject|0|||
13264100|NCT01457950|26405413|FG002|Open-Label Phase|Withdrawal by Subject|2|||
13264101|NCT01457950|26405414|FG003|Open-Label Phase|Withdrawal by Subject|0|||
13264102|NCT01457924|26405492|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
13264103|NCT01457924|26405493|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4|||
13264104|NCT01457924|26405494|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1|||
13264105|NCT01457924|26405495|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
13264106|NCT01457924|26405496|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2|||
13264107|NCT01457924|26405492|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
13264108|NCT01457924|26405493|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
13264109|NCT01457924|26405494|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
13117599|NCT03054350|25926277|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
13117600|NCT03054350|25926272|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
13117601|NCT03054350|25926273|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
13264110|NCT01457924|26405495|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
13264111|NCT01457924|26405496|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1|||
13264112|NCT01457924|26405492|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1|||
13264113|NCT01457924|26405493|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
13264114|NCT01457924|26405494|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
13264115|NCT01457924|26405495|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
13264116|NCT01457924|26405496|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
13264117|NCT01457924|26405492|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
13117602|NCT03054350|25926274|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
13117603|NCT03054350|25926275|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
13117604|NCT03054350|25926276|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
13117605|NCT03054350|25926277|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
13117606|NCT03054350|25926272|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0|||
13117607|NCT03054350|25926273|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0|||
13264118|NCT01457924|26405493|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
13264119|NCT01457924|26405494|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
13264120|NCT01457924|26405495|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
13264121|NCT01457924|26405496|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
13264122|NCT01457924|26405492|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
13264123|NCT01457924|26405493|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
13264124|NCT01457924|26405494|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
13264125|NCT01457924|26405495|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
13264126|NCT01457924|26405496|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
13264127|NCT01457924|26405492|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
13264128|NCT01457924|26405493|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
13117608|NCT03054350|25926274|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1|||
13117609|NCT03054350|25926275|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0|||
13264129|NCT01457924|26405494|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
13264130|NCT01457924|26405495|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
13264131|NCT01457924|26405496|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2|||
13264132|NCT01457924|26405492|FG000|FUP (Weeks 24-48)|Adverse Event|0|||
13264133|NCT01457924|26405493|FG001|FUP (Weeks 24-48)|Adverse Event|0|||
13264134|NCT01457924|26405494|FG002|FUP (Weeks 24-48)|Adverse Event|1|||
13264135|NCT01457924|26405495|FG003|FUP (Weeks 24-48)|Adverse Event|0|||
13264136|NCT01457924|26405496|FG004|FUP (Weeks 24-48)|Adverse Event|0|||
13264137|NCT01457924|26405492|FG000|FUP (Weeks 24-48)|Physician Decision|1|||
13264138|NCT01457924|26405493|FG001|FUP (Weeks 24-48)|Physician Decision|0|||
13264139|NCT01457924|26405494|FG002|FUP (Weeks 24-48)|Physician Decision|1|||
13264140|NCT01457924|26405495|FG003|FUP (Weeks 24-48)|Physician Decision|0|||
13264141|NCT01457924|26405496|FG004|FUP (Weeks 24-48)|Physician Decision|0|||
13264142|NCT01457924|26405492|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0|||
13264143|NCT01457924|26405493|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0|||
13264144|NCT01457924|26405494|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0|||
13264145|NCT01457924|26405495|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1|||
13264146|NCT01457924|26405496|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0|||
13264147|NCT01457924|26405492|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
13264148|NCT01457924|26405493|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1|||
13264149|NCT01457924|26405494|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
13264150|NCT01457924|26405495|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
13264151|NCT01457924|26405496|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
13264152|NCT01457924|26405492|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
13264153|NCT01457924|26405493|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
13264154|NCT01457924|26405494|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
13264155|NCT01457924|26405495|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
13264156|NCT01457924|26405496|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
13264157|NCT01457924|26405492|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
13264158|NCT01457924|26405493|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4|||
13264159|NCT01457924|26405494|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2|||
13264160|NCT01457924|26405495|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
13264161|NCT01457924|26405496|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5|||
13264162|NCT01457924|26405492|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
13264163|NCT01457924|26405493|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0|||
13264164|NCT01457924|26405494|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
13264165|NCT01457924|26405495|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2|||
13264166|NCT01457924|26405496|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
13264167|NCT01457846|26405517|FG000|Overall Study|Death before treatment|1|||
13264168|NCT01457846|26405518|FG001|Overall Study|Death before treatment|2|||
13264169|NCT01457846|26405517|FG000|Overall Study|Did not receive treatment|0|||
13264170|NCT01457846|26405518|FG001|Overall Study|Did not receive treatment|1|||
13264171|NCT01457846|26405517|FG000|Overall Study|Death|27|||
13264172|NCT01457846|26405518|FG001|Overall Study|Death|16|||
13264173|NCT01457846|26405517|FG000|Overall Study|Unclassified reason for not completed|11|||
13264174|NCT01457846|26405518|FG001|Overall Study|Unclassified reason for not completed|10|||
13264175|NCT01457846|26405517|FG000|Overall Study|Withdrawal by Subject|1|||
13264176|NCT01457846|26405518|FG001|Overall Study|Withdrawal by Subject|1|||
13264177|NCT01457846|26405517|FG000|Overall Study|Lost to Follow-up|1|||
13264178|NCT01457846|26405518|FG001|Overall Study|Lost to Follow-up|0|||
13264179|NCT01457703|26405539|FG000|Overall Study|Screen Failure|5|||
13264180|NCT01457703|26405540|FG001|Overall Study|Screen Failure|7|||
13264181|NCT01457703|26405539|FG000|Overall Study|Withdrawal by Subject|1|||
13264182|NCT01457703|26405540|FG001|Overall Study|Withdrawal by Subject|4|||
13264183|NCT01457352|26405557|FG000|Period 1|Adverse Event|2|||
13264184|NCT01457352|26405558|FG001|Period 1|Adverse Event|0|||
13264185|NCT01457352|26405557|FG000|Period 1|Withdrawal by Subject|2|||
13264186|NCT01457352|26405558|FG001|Period 1|Withdrawal by Subject|0|||
13264187|NCT01457352|26405557|FG000|Period 1|Physician Decision|2|||
13264188|NCT01457352|26405558|FG001|Period 1|Physician Decision|0|||
13264189|NCT01457352|26405557|FG000|Period 1|MS related disease progression|1|||
13264190|NCT01457352|26405558|FG001|Period 1|MS related disease progression|0|||
13264191|NCT01457352|26405557|FG000|Period 1|Withdrawn|1|||
13264192|NCT01457352|26405558|FG001|Period 1|Withdrawn|0|||
13264193|NCT01457352|26405557|FG000|Period 1|withdrew per sponsor|1|||
13264194|NCT01457352|26405558|FG001|Period 1|withdrew per sponsor|0|||
13264195|NCT01457352|26405557|FG000|Period 1|Protocol Violation|4|||
13264196|NCT01457352|26405558|FG001|Period 1|Protocol Violation|0|||
13264197|NCT01457352|26405557|FG000|Period 1|Did not meet eligibility criteria|3|||
13264198|NCT01457352|26405558|FG001|Period 1|Did not meet eligibility criteria|0|||
13264199|NCT01457352|26405557|FG000|Period 2|Withdrawal by Subject|23|||
13264200|NCT01457352|26405558|FG001|Period 2|Withdrawal by Subject|0|||
13264201|NCT01457352|26405557|FG000|Period 2|Adverse Event|22|||
13264202|NCT01457352|26405558|FG001|Period 2|Adverse Event|0|||
13264203|NCT01457352|26405557|FG000|Period 2|no analysis|10|||
13264204|NCT01457352|26405558|FG001|Period 2|no analysis|0|||
13264205|NCT01457352|26405557|FG000|Period 2|Lack of Efficacy|8|||
13264206|NCT01457352|26405558|FG001|Period 2|Lack of Efficacy|0|||
13264207|NCT01457352|26405557|FG000|Period 2|Protocol Violation|4|||
13264208|NCT01457352|26405558|FG001|Period 2|Protocol Violation|0|||
13264209|NCT01457352|26405557|FG000|Period 2|Sponsor's withdrawal|7|||
13264210|NCT01457352|26405558|FG001|Period 2|Sponsor's withdrawal|0|||
13264211|NCT01457352|26405557|FG000|Period 2|Lost to Follow-up|1|||
13264212|NCT01457352|26405558|FG001|Period 2|Lost to Follow-up|0|||
13264213|NCT01457352|26405557|FG000|Period 2|dose change|1|||
13264214|NCT01457352|26405558|FG001|Period 2|dose change|0|||
13264215|NCT01457352|26405557|FG000|Period 2|Physician Decision|1|||
13264216|NCT01457352|26405558|FG001|Period 2|Physician Decision|0|||
13264217|NCT01457352|26405557|FG000|Period 2|Did not meet eligibility criteria|3|||
13264218|NCT01457352|26405558|FG001|Period 2|Did not meet eligibility criteria|0|||
13264219|NCT01457352|26405557|FG000|Period 3|Adverse Event|1|||
13264220|NCT01457352|26405558|FG001|Period 3|Adverse Event|1|||
13264221|NCT01457352|26405557|FG000|Period 3|Withdrawal by Subject|0|||
13264222|NCT01457352|26405558|FG001|Period 3|Withdrawal by Subject|2|||
13264223|NCT01457352|26405557|FG000|Period 3|incorrect treatment|0|||
13264224|NCT01457352|26405558|FG001|Period 3|incorrect treatment|1|||
13264225|NCT01457352|26405557|FG000|Period 3|Sponsor's withdrawal|0|||
13264226|NCT01457352|26405558|FG001|Period 3|Sponsor's withdrawal|1|||
13264227|NCT01457339|26405731|FG000|Period 3 (100 mg)|Adverse Event|0|||
13264228|NCT01457339|26405732|FG001|Period 3 (100 mg)|Adverse Event|1|||
13264229|NCT01457339|26405731|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0|||
13264230|NCT01457339|26405732|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1|||
13264231|NCT01457339|26405731|FG000|Period 6 (250 mg)|Family Emergency|1|||
13264232|NCT01457339|26405732|FG001|Period 6 (250 mg)|Family Emergency|0|||
13264233|NCT01457339|26405731|FG000|Period 6 (250 mg)|Personal appointment|0|||
13264234|NCT01457339|26405732|FG001|Period 6 (250 mg)|Personal appointment|1|||
13264235|NCT01457118|26405767|FG000|Overall Study|Adverse Event|1|||
13264236|NCT01457118|26405768|FG001|Overall Study|Adverse Event|0|||
13264237|NCT01457118|26405769|FG002|Overall Study|Adverse Event|0|||
13264238|NCT01457118|26405770|FG003|Overall Study|Adverse Event|1|||
13264239|NCT01457118|26405767|FG000|Overall Study|Clinical Progression|0|||
13264240|NCT01457118|26405768|FG001|Overall Study|Clinical Progression|1|||
13264241|NCT01457118|26405769|FG002|Overall Study|Clinical Progression|0|||
13264242|NCT01457118|26405770|FG003|Overall Study|Clinical Progression|1|||
13264243|NCT01457118|26405767|FG000|Overall Study|Physician Decision|2|||
13264244|NCT01457118|26405768|FG001|Overall Study|Physician Decision|0|||
13264245|NCT01457118|26405769|FG002|Overall Study|Physician Decision|0|||
13264246|NCT01457118|26405770|FG003|Overall Study|Physician Decision|0|||
13264247|NCT01457118|26405767|FG000|Overall Study|Progressive Disease by RECIST|12|||
13264248|NCT01457118|26405768|FG001|Overall Study|Progressive Disease by RECIST|3|||
13264249|NCT01457118|26405769|FG002|Overall Study|Progressive Disease by RECIST|1|||
13264250|NCT01457118|26405770|FG003|Overall Study|Progressive Disease by RECIST|0|||
13264251|NCT01457118|26405767|FG000|Overall Study|Withdrawal by Subject|5|||
13264252|NCT01457118|26405768|FG001|Overall Study|Withdrawal by Subject|0|||
13264253|NCT01457118|26405769|FG002|Overall Study|Withdrawal by Subject|0|||
13264254|NCT01457118|26405770|FG003|Overall Study|Withdrawal by Subject|0|||
13264255|NCT01457053|26405779|FG000|Overall Study|Unable to undergo selected treatment|1|||
13264256|NCT01457053|26405780|FG001|Overall Study|Unable to undergo selected treatment|1|||
13264257|NCT01457014|26405800|FG000|First Night|Didn't meet inclusion/exclusion criteria|37|||
13264258|NCT01457014|26405801|FG001|First Night|Didn't meet inclusion/exclusion criteria|0|||
13264259|NCT01457014|26405802|FG002|First Night|Didn't meet inclusion/exclusion criteria|0|||
13264260|NCT01457014|26405803|FG003|First Night|Didn't meet inclusion/exclusion criteria|0|||
13264261|NCT01457014|26405800|FG000|First Night|Withdrawal by Subject|3|||
13264262|NCT01457014|26405801|FG001|First Night|Withdrawal by Subject|0|||
13264263|NCT01457014|26405802|FG002|First Night|Withdrawal by Subject|0|||
13264264|NCT01457014|26405803|FG003|First Night|Withdrawal by Subject|0|||
13264265|NCT01456962|26405816|FG000|Overall Study|Lost to Follow-up|2|||
13264266|NCT01456962|26405817|FG001|Overall Study|Lost to Follow-up|1|||
13264267|NCT01456949|26405826|FG000|Enrollment|PI death- incomplete data|6|||
13264268|NCT01456949|26405826|FG000|Enrollment|Death|1|||
13264269|NCT01456949|26405826|FG000|Enrollment|I/E criteria not met prior to procedure|13|||
13264270|NCT01456949|26405826|FG000|Enrollment|Physician Decision|10|||
13264271|NCT01456949|26405826|FG000|Enrollment|Withdrawal by Subject|7|||
13264272|NCT01456949|26405826|FG000|Study Cryoablation Procedure & Follow-up|Death|5|||
13264273|NCT01456949|26405826|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23|||
13264274|NCT01456949|26405826|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11|||
13264275|NCT01456949|26405826|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1|||
13264276|NCT01456949|26405826|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10|||
13264277|NCT01456949|26405826|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2|||
13264278|NCT01456949|26405826|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6|||
13264279|NCT01456949|26405826|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4|||
13264280|NCT01456936|26405945|FG000|Overall Study|Other reason|41|||
13264281|NCT01456936|26405946|FG001|Overall Study|Other reason|30|||
13264282|NCT01456936|26405947|FG002|Overall Study|Other reason|36|||
13264283|NCT01456936|26405948|FG003|Overall Study|Other reason|33|||
13264284|NCT01456936|26405945|FG000|Overall Study|No longer meets eligibility criteria|4|||
13264285|NCT01456936|26405946|FG001|Overall Study|No longer meets eligibility criteria|8|||
13264286|NCT01456936|26405947|FG002|Overall Study|No longer meets eligibility criteria|6|||
13264287|NCT01456936|26405948|FG003|Overall Study|No longer meets eligibility criteria|5|||
13264288|NCT01456936|26405945|FG000|Overall Study|Protocol Violation|4|||
13264289|NCT01456936|26405946|FG001|Overall Study|Protocol Violation|2|||
13264290|NCT01456936|26405947|FG002|Overall Study|Protocol Violation|5|||
13264291|NCT01456936|26405948|FG003|Overall Study|Protocol Violation|5|||
13264292|NCT01456936|26405945|FG000|Overall Study|Pregnancy|1|||
13264293|NCT01456936|26405946|FG001|Overall Study|Pregnancy|0|||
13264294|NCT01456936|26405947|FG002|Overall Study|Pregnancy|0|||
13264295|NCT01456936|26405948|FG003|Overall Study|Pregnancy|1|||
13264296|NCT01456936|26405945|FG000|Overall Study|Insufficient clinical response|4|||
13264297|NCT01456936|26405946|FG001|Overall Study|Insufficient clinical response|4|||
13264298|NCT01456936|26405947|FG002|Overall Study|Insufficient clinical response|14|||
13264299|NCT01456936|26405948|FG003|Overall Study|Insufficient clinical response|13|||
13264300|NCT01456936|26405945|FG000|Overall Study|No longer willing to participate|195|||
13264301|NCT01456936|26405946|FG001|Overall Study|No longer willing to participate|218|||
13264302|NCT01456936|26405947|FG002|Overall Study|No longer willing to participate|224|||
13264303|NCT01456936|26405948|FG003|Overall Study|No longer willing to participate|248|||
13264304|NCT01456936|26405945|FG000|Overall Study|Lost to Follow-up|135|||
13264305|NCT01456936|26405946|FG001|Overall Study|Lost to Follow-up|126|||
13264306|NCT01456936|26405947|FG002|Overall Study|Lost to Follow-up|144|||
13264307|NCT01456936|26405948|FG003|Overall Study|Lost to Follow-up|127|||
13264308|NCT01456936|26405945|FG000|Overall Study|Medication error|0|||
13264309|NCT01456936|26405946|FG001|Overall Study|Medication error|1|||
13264310|NCT01456936|26405947|FG002|Overall Study|Medication error|0|||
13264311|NCT01456936|26405948|FG003|Overall Study|Medication error|1|||
13264312|NCT01456936|26405945|FG000|Overall Study|Adverse event (study drug)|25|||
13264313|NCT01456936|26405946|FG001|Overall Study|Adverse event (study drug)|21|||
13264314|NCT01456936|26405947|FG002|Overall Study|Adverse event (study drug)|26|||
13264315|NCT01456936|26405948|FG003|Overall Study|Adverse event (study drug)|17|||
13264316|NCT01456936|26405945|FG000|Overall Study|Adverse event (study drug unrelated)|9|||
13264317|NCT01456936|26405946|FG001|Overall Study|Adverse event (study drug unrelated)|7|||
13264318|NCT01456936|26405947|FG002|Overall Study|Adverse event (study drug unrelated)|9|||
13264319|NCT01456936|26405948|FG003|Overall Study|Adverse event (study drug unrelated)|9|||
13264320|NCT01456936|26405945|FG000|Overall Study|Death|0|||
13264321|NCT01456936|26405946|FG001|Overall Study|Death|3|||
13264322|NCT01456936|26405947|FG002|Overall Study|Death|1|||
13264323|NCT01456936|26405948|FG003|Overall Study|Death|3|||
13264324|NCT01456936|26405945|FG000|Overall Study|Randomized but not treated|21|||
13264325|NCT01456936|26405946|FG001|Overall Study|Randomized but not treated|28|||
13264326|NCT01456936|26405947|FG002|Overall Study|Randomized but not treated|16|||
13264327|NCT01456936|26405948|FG003|Overall Study|Randomized but not treated|21|||
13264328|NCT01456897|26405971|FG000|Overall Study|Adverse Event|19|||
13264329|NCT01456897|26405972|FG001|Overall Study|Adverse Event|22|||
13264330|NCT01456897|26405971|FG000|Overall Study|Protocol Violation|3|||
13264331|NCT01456897|26405972|FG001|Overall Study|Protocol Violation|4|||
13264332|NCT01456897|26405971|FG000|Overall Study|Physician Decision|5|||
13264333|NCT01456897|26405972|FG001|Overall Study|Physician Decision|3|||
13264334|NCT01456897|26405971|FG000|Overall Study|Withdrawal by Subject|44|||
13264335|NCT01456897|26405972|FG001|Overall Study|Withdrawal by Subject|17|||
13264336|NCT01456897|26405971|FG000|Overall Study|Lack of Efficacy|4|||
13264337|NCT01456897|26405972|FG001|Overall Study|Lack of Efficacy|11|||
13264338|NCT01456780|26405999|FG000|Overall Study|Lost to Follow-up|3|||
13264339|NCT01456780|26406000|FG001|Overall Study|Lost to Follow-up|3|||
13264340|NCT01456780|26406001|FG002|Overall Study|Lost to Follow-up|0|||
13264341|NCT01456221|26406020|FG000|Overall Study|Withdrawal by Subject|56|||
13264342|NCT01456221|26406021|FG001|Overall Study|Withdrawal by Subject|49|||
13264343|NCT01456221|26406020|FG000|Overall Study|Lost to Follow-up|1|||
13264344|NCT01456221|26406021|FG001|Overall Study|Lost to Follow-up|4|||
13264345|NCT01456221|26406020|FG000|Overall Study|Received medication|3|||
13264346|NCT01456221|26406021|FG001|Overall Study|Received medication|2|||
13264347|NCT01456221|26406020|FG000|Overall Study|Incomplete data|4|||
13264348|NCT01456221|26406021|FG001|Overall Study|Incomplete data|2|||
13264349|NCT01456195|26406048|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
13264350|NCT01456195|26406049|FG001|Overall Study|Pretreatment Event/Adverse Event|4|||
13264351|NCT01456195|26406050|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
13264352|NCT01456195|26406048|FG000|Overall Study|Lost to Follow-up|3|||
13264353|NCT01456195|26406049|FG001|Overall Study|Lost to Follow-up|1|||
13264354|NCT01456195|26406050|FG002|Overall Study|Lost to Follow-up|3|||
13264355|NCT01456195|26406048|FG000|Overall Study|Voluntary Withdrawal|5|||
13264356|NCT01456195|26406049|FG001|Overall Study|Voluntary Withdrawal|3|||
13264357|NCT01456195|26406050|FG002|Overall Study|Voluntary Withdrawal|7|||
13264358|NCT01456195|26406048|FG000|Overall Study|Lack of Efficacy|0|||
13264359|NCT01456195|26406049|FG001|Overall Study|Lack of Efficacy|1|||
13264360|NCT01456195|26406050|FG002|Overall Study|Lack of Efficacy|0|||
13264361|NCT01456195|26406048|FG000|Overall Study|Other Reasons|2|||
13264362|NCT01456195|26406049|FG001|Overall Study|Other Reasons|1|||
13264363|NCT01456195|26406050|FG002|Overall Study|Other Reasons|3|||
13264364|NCT01456169|26406111|FG000|Overall Study|Adverse Event|1|||
13264365|NCT01456169|26406112|FG001|Overall Study|Adverse Event|2|||
13264366|NCT01456169|26406113|FG002|Overall Study|Adverse Event|7|||
13264367|NCT01456169|26406111|FG000|Overall Study|Major Protocol Deviation|3|||
13264368|NCT01456169|26406112|FG001|Overall Study|Major Protocol Deviation|2|||
13264369|NCT01456169|26406113|FG002|Overall Study|Major Protocol Deviation|3|||
13264370|NCT01456169|26406111|FG000|Overall Study|Voluntary Withdrawal|3|||
13264371|NCT01456169|26406112|FG001|Overall Study|Voluntary Withdrawal|0|||
13264372|NCT01456169|26406113|FG002|Overall Study|Voluntary Withdrawal|2|||
13264373|NCT01456169|26406111|FG000|Overall Study|Lack of Efficacy|2|||
13264374|NCT01456169|26406112|FG001|Overall Study|Lack of Efficacy|0|||
13264375|NCT01456169|26406113|FG002|Overall Study|Lack of Efficacy|0|||
13264376|NCT01456169|26406111|FG000|Overall Study|Other|1|||
13264377|NCT01456169|26406112|FG001|Overall Study|Other|1|||
13264378|NCT01456169|26406113|FG002|Overall Study|Other|0|||
13264379|NCT01456130|26406122|FG000|Overall Study|Adverse Event|4|||
13264380|NCT01456130|26406122|FG000|Overall Study|Voluntary Withdrawal|1|||
13264381|NCT01456130|26406122|FG000|Overall Study|Lack of Efficacy|4|||
13264382|NCT01456130|26406122|FG000|Overall Study|Other|1|||
13264383|NCT01456052|26406149|FG000|Overall Study|Adverse Event|1|||
13264384|NCT01456052|26406150|FG001|Overall Study|Adverse Event|1|||
13264385|NCT01456052|26406151|FG002|Overall Study|Adverse Event|2|||
13264386|NCT01456052|26406149|FG000|Overall Study|Consent withdrawn|0|||
13264387|NCT01456052|26406150|FG001|Overall Study|Consent withdrawn|2|||
13264388|NCT01456052|26406151|FG002|Overall Study|Consent withdrawn|1|||
13264389|NCT01456052|26406149|FG000|Overall Study|Protocol Violation|0|||
13264390|NCT01456052|26406150|FG001|Overall Study|Protocol Violation|1|||
13264391|NCT01456052|26406151|FG002|Overall Study|Protocol Violation|0|||
13264392|NCT01456052|26406149|FG000|Overall Study|Physician Decision|1|||
13264393|NCT01456052|26406150|FG001|Overall Study|Physician Decision|0|||
13264394|NCT01456052|26406151|FG002|Overall Study|Physician Decision|1|||
13264395|NCT01456052|26406149|FG000|Overall Study|Treatment Failure|0|||
13264396|NCT01456052|26406150|FG001|Overall Study|Treatment Failure|1|||
13264397|NCT01456052|26406151|FG002|Overall Study|Treatment Failure|1|||
13264398|NCT01456039|26406231|FG000|Phase 1 (First Step)|Disease Progression|1|||
13264399|NCT01456039|26406232|FG001|Phase 1 (First Step)|Disease Progression|1|||
13264400|NCT01456039|26406233|FG002|Phase 1 (First Step)|Disease Progression|0|||
13264401|NCT01456039|26406231|FG000|Phase 1 (First Step)|Withdrawal by Subject|1|||
13264402|NCT01456039|26406232|FG001|Phase 1 (First Step)|Withdrawal by Subject|2|||
13264403|NCT01456039|26406233|FG002|Phase 1 (First Step)|Withdrawal by Subject|0|||
13264404|NCT01456039|26406231|FG000|Phase 1 (First Step)|Adverse Event|0|||
13264405|NCT01456039|26406232|FG001|Phase 1 (First Step)|Adverse Event|3|||
13264406|NCT01456039|26406233|FG002|Phase 1 (First Step)|Adverse Event|0|||
13264407|NCT01456039|26406231|FG000|Phase 1 (First Step)|Other|0|||
13264408|NCT01456039|26406232|FG001|Phase 1 (First Step)|Other|1|||
13264409|NCT01456039|26406233|FG002|Phase 1 (First Step)|Other|0|||
13264410|NCT01456039|26406231|FG000|Phase 2 (Second Step)|Disease Progression|0|||
13264411|NCT01456039|26406232|FG001|Phase 2 (Second Step)|Disease Progression|0|||
13264412|NCT01456039|26406233|FG002|Phase 2 (Second Step)|Disease Progression|17|||
13264413|NCT01456039|26406231|FG000|Phase 2 (Second Step)|Adverse Event|0|||
13264414|NCT01456039|26406232|FG001|Phase 2 (Second Step)|Adverse Event|0|||
13264415|NCT01456039|26406233|FG002|Phase 2 (Second Step)|Adverse Event|10|||
13264416|NCT01456039|26406231|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0|||
13264417|NCT01456039|26406232|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0|||
13264418|NCT01456039|26406233|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4|||
13264419|NCT01456039|26406231|FG000|Phase 2 (Second Step)|Protocol Violation|0|||
13264420|NCT01456039|26406232|FG001|Phase 2 (Second Step)|Protocol Violation|0|||
13264421|NCT01456039|26406233|FG002|Phase 2 (Second Step)|Protocol Violation|1|||
13264422|NCT01456039|26406231|FG000|Phase 2 (Second Step)|Other|0|||
13264423|NCT01456039|26406232|FG001|Phase 2 (Second Step)|Other|0|||
13264424|NCT01456039|26406233|FG002|Phase 2 (Second Step)|Other|1|||
13264425|NCT01455428|26406294|FG000|Overall Study|Protocol Violation|2|||
13264426|NCT01455428|26406295|FG001|Overall Study|Protocol Violation|1|||
13264427|NCT01455428|26406294|FG000|Overall Study|Adverse Event|6|||
13264428|NCT01455428|26406295|FG001|Overall Study|Adverse Event|2|||
13264429|NCT01455428|26406294|FG000|Overall Study|Lost to Follow-up|1|||
13264430|NCT01455428|26406295|FG001|Overall Study|Lost to Follow-up|1|||
13264431|NCT01455428|26406294|FG000|Overall Study|Withdrawal by Subject|2|||
13264432|NCT01455428|26406295|FG001|Overall Study|Withdrawal by Subject|5|||
13264433|NCT01455428|26406294|FG000|Overall Study|Did not meet entrance criteria|0|||
13264434|NCT01455428|26406295|FG001|Overall Study|Did not meet entrance criteria|2|||
13264435|NCT01455428|26406294|FG000|Overall Study|Insufficient clinical response|0|||
13264436|NCT01455428|26406295|FG001|Overall Study|Insufficient clinical response|2|||
13264437|NCT01455428|26406294|FG000|Overall Study|Did not receive treatment|1|||
13264438|NCT01455428|26406295|FG001|Overall Study|Did not receive treatment|1|||
13264439|NCT01455428|26406294|FG000|Overall Study|Other|2|||
13264440|NCT01455428|26406295|FG001|Overall Study|Other|4|||
13264441|NCT01455415|26406352|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9|||
13264442|NCT01455415|26406353|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6|||
13264443|NCT01455415|26406352|FG000|Period 1|Lost To Follow-up Related to Study Drug|3|||
13264444|NCT01455415|26406353|FG001|Period 1|Lost To Follow-up Related to Study Drug|3|||
13264445|NCT01455415|26406352|FG000|Period 1|Drug Error not Associated to AE|0|||
13264446|NCT01455415|26406353|FG001|Period 1|Drug Error not Associated to AE|1|||
13264447|NCT01455415|26406352|FG000|Period 1|AE Not Related to Study Drug|2|||
13264448|NCT01455415|26406353|FG001|Period 1|AE Not Related to Study Drug|6|||
13264449|NCT01455415|26406352|FG000|Period 1|Withdrawal by Subject|4|||
13264450|NCT01455415|26406353|FG001|Period 1|Withdrawal by Subject|5|||
13264451|NCT01455415|26406352|FG000|Period 1|Unspecified Reason|1|||
13264452|NCT01455415|26406353|FG001|Period 1|Unspecified Reason|1|||
13264453|NCT01455415|26406352|FG000|Period 1|Protocol Violation|0|||
13264454|NCT01455415|26406353|FG001|Period 1|Protocol Violation|2|||
13264455|NCT01455415|26406352|FG000|Washout|AE Related to Study Drug|2|||
13264456|NCT01455415|26406353|FG001|Washout|AE Related to Study Drug|0|||
13264457|NCT01455415|26406352|FG000|Washout|Lost to Follow-up|1|||
13264458|NCT01455415|26406353|FG001|Washout|Lost to Follow-up|0|||
13264459|NCT01455415|26406352|FG000|Washout|Drug Error not Associated to AE|2|||
13264460|NCT01455415|26406353|FG001|Washout|Drug Error not Associated to AE|1|||
13264461|NCT01455415|26406352|FG000|Washout|AE Not Related to Study Drug|2|||
13264462|NCT01455415|26406353|FG001|Washout|AE Not Related to Study Drug|3|||
13264463|NCT01455415|26406352|FG000|Washout|Unspecified Reason|1|||
13264464|NCT01455415|26406353|FG001|Washout|Unspecified Reason|2|||
13264465|NCT01455415|26406352|FG000|Washout|Protocol Violation|0|||
13264466|NCT01455415|26406353|FG001|Washout|Protocol Violation|1|||
13264467|NCT01455415|26406352|FG000|Period 2|AE Related to Study Drug|1|||
13264468|NCT01455415|26406353|FG001|Period 2|AE Related to Study Drug|2|||
13264469|NCT01455415|26406352|FG000|Period 2|Lost to Follow-up|2|||
13264470|NCT01455415|26406353|FG001|Period 2|Lost to Follow-up|1|||
13264471|NCT01455415|26406352|FG000|Period 2|AE Not Related to Study Drug|2|||
13264472|NCT01455415|26406353|FG001|Period 2|AE Not Related to Study Drug|1|||
13264473|NCT01455415|26406352|FG000|Period 2|Lack of Efficacy|2|||
13264474|NCT01455415|26406353|FG001|Period 2|Lack of Efficacy|0|||
13264475|NCT01455415|26406352|FG000|Period 2|Withdrawal by Subject|2|||
13264476|NCT01455415|26406353|FG001|Period 2|Withdrawal by Subject|3|||
13264477|NCT01455415|26406352|FG000|Period 2|Unspecified Reason|2|||
13264478|NCT01455415|26406353|FG001|Period 2|Unspecified Reason|3|||
13264479|NCT01455415|26406352|FG000|Period 2|Protocol Violation|2|||
13264480|NCT01455415|26406353|FG001|Period 2|Protocol Violation|0|||
13264481|NCT01455415|26406352|FG000|Follow-up|AE Related to Study Drug|0|||
13264482|NCT01455415|26406353|FG001|Follow-up|AE Related to Study Drug|1|||
13264483|NCT01455415|26406352|FG000|Follow-up|Lack of Efficacy|0|||
13264484|NCT01455415|26406353|FG001|Follow-up|Lack of Efficacy|1|||
13264485|NCT01455415|26406352|FG000|Follow-up|Withdrawal by Subject|2|||
13264486|NCT01455415|26406353|FG001|Follow-up|Withdrawal by Subject|0|||
13264487|NCT01455415|26406352|FG000|Follow-up|Unspecified Reason|1|||
13264488|NCT01455415|26406353|FG001|Follow-up|Unspecified Reason|0|||
13264489|NCT01455220|26406362|FG000|Overall Study|screen fail|30|||
13264490|NCT01455194|26406422|FG000|Overall Study|Screen Failure|20|||
13264491|NCT01455194|26406423|FG001|Overall Study|Screen Failure|0|||
13264492|NCT01455194|26406424|FG002|Overall Study|Screen Failure|0|||
13264493|NCT01455194|26406425|FG003|Overall Study|Screen Failure|0|||
13264494|NCT01455194|26406422|FG000|Overall Study|Randomisation Failure|90|||
13264495|NCT01455194|26406423|FG001|Overall Study|Randomisation Failure|0|||
13264496|NCT01455194|26406424|FG002|Overall Study|Randomisation Failure|0|||
13264497|NCT01455194|26406425|FG003|Overall Study|Randomisation Failure|0|||
13264498|NCT01455194|26406422|FG000|Overall Study|Deterioration in asthma|12|||
13264499|NCT01455194|26406423|FG001|Overall Study|Deterioration in asthma|6|||
13264500|NCT01455194|26406424|FG002|Overall Study|Deterioration in asthma|14|||
13117610|NCT03054350|25926276|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0|||
13117611|NCT03054350|25926277|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0|||
13117612|NCT03054337|25926442|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
13264501|NCT01455194|26406425|FG003|Overall Study|Deterioration in asthma|9|||
13264502|NCT01455194|26406422|FG000|Overall Study|Adverse Event|1|||
13264503|NCT01455194|26406423|FG001|Overall Study|Adverse Event|1|||
13264504|NCT01455194|26406424|FG002|Overall Study|Adverse Event|1|||
13264505|NCT01455194|26406425|FG003|Overall Study|Adverse Event|3|||
13264506|NCT01455194|26406422|FG000|Overall Study|Withdrawal by Subject|21|||
13264507|NCT01455194|26406423|FG001|Overall Study|Withdrawal by Subject|16|||
13264508|NCT01455194|26406424|FG002|Overall Study|Withdrawal by Subject|12|||
13264509|NCT01455194|26406425|FG003|Overall Study|Withdrawal by Subject|9|||
13264510|NCT01455194|26406422|FG000|Overall Study|Lost to Follow-up|2|||
13264511|NCT01455194|26406423|FG001|Overall Study|Lost to Follow-up|0|||
13264512|NCT01455194|26406424|FG002|Overall Study|Lost to Follow-up|1|||
13264513|NCT01455194|26406425|FG003|Overall Study|Lost to Follow-up|1|||
13264514|NCT01455194|26406422|FG000|Overall Study|Pregnancy|0|||
13264515|NCT01455194|26406423|FG001|Overall Study|Pregnancy|1|||
13264516|NCT01455194|26406424|FG002|Overall Study|Pregnancy|1|||
13264517|NCT01455194|26406425|FG003|Overall Study|Pregnancy|0|||
13264518|NCT01455194|26406422|FG000|Overall Study|Discontinuation criterion fulfilled|3|||
13264519|NCT01455194|26406423|FG001|Overall Study|Discontinuation criterion fulfilled|2|||
13264520|NCT01455194|26406424|FG002|Overall Study|Discontinuation criterion fulfilled|0|||
13264521|NCT01455194|26406425|FG003|Overall Study|Discontinuation criterion fulfilled|2|||
13264522|NCT01455194|26406422|FG000|Overall Study|Miscellaneous|4|||
13264523|NCT01455194|26406423|FG001|Overall Study|Miscellaneous|5|||
13264524|NCT01455194|26406424|FG002|Overall Study|Miscellaneous|1|||
13264525|NCT01455194|26406425|FG003|Overall Study|Miscellaneous|4|||
13264526|NCT01455012|26406464|FG000|Overall Study|Adverse Event|0|||
13264527|NCT01455012|26406465|FG001|Overall Study|Adverse Event|2|||
13264528|NCT01455012|26406464|FG000|Overall Study|Lack of Efficacy|6|||
13264529|NCT01455012|26406465|FG001|Overall Study|Lack of Efficacy|1|||
13264530|NCT01455012|26406464|FG000|Overall Study|Withdrawal by Subject|3|||
13264531|NCT01455012|26406465|FG001|Overall Study|Withdrawal by Subject|1|||
13264532|NCT01455012|26406464|FG000|Overall Study|Unknown reason|2|||
13264533|NCT01455012|26406465|FG001|Overall Study|Unknown reason|0|||
13264534|NCT01454934|26406482|FG000|Overall Study|Clinical progression|28|||
13264535|NCT01454934|26406483|FG001|Overall Study|Clinical progression|25|||
13264536|NCT01454934|26406482|FG000|Overall Study|Other|6|||
13264537|NCT01454934|26406483|FG001|Overall Study|Other|17|||
13264538|NCT01454934|26406482|FG000|Overall Study|Adverse Event|28|||
13264539|NCT01454934|26406483|FG001|Overall Study|Adverse Event|24|||
13264540|NCT01454934|26406482|FG000|Overall Study|Withdrawn consent|2|||
13264541|NCT01454934|26406483|FG001|Overall Study|Withdrawn consent|5|||
13264542|NCT01454934|26406482|FG000|Overall Study|Withdrawal by Subject|11|||
13264543|NCT01454934|26406483|FG001|Overall Study|Withdrawal by Subject|15|||
13264544|NCT01454934|26406482|FG000|Overall Study|Disease progression|194|||
13264545|NCT01454934|26406483|FG001|Overall Study|Disease progression|181|||
13264546|NCT01454934|26406482|FG000|Overall Study|Lost to Follow-up|0|||
13264547|NCT01454934|26406483|FG001|Overall Study|Lost to Follow-up|1|||
13264548|NCT01454934|26406482|FG000|Overall Study|Not treated|1|||
13264549|NCT01454934|26406483|FG001|Overall Study|Not treated|2|||
13264550|NCT01454830|26406508|FG000|Overall Study|Withdrawal by Subject|4|||
13264551|NCT01454830|26406509|FG001|Overall Study|Withdrawal by Subject|4|||
13264552|NCT01454830|26406508|FG000|Overall Study|Post-allocation Exclude- AHI<10|18|||
13264553|NCT01454830|26406509|FG001|Overall Study|Post-allocation Exclude- AHI<10|12|||
13264554|NCT01454830|26406508|FG000|Overall Study|Post-allocation Exclude-refused PAP|0|||
13264555|NCT01454830|26406509|FG001|Overall Study|Post-allocation Exclude-refused PAP|2|||
13264556|NCT01454830|26406508|FG000|Overall Study|Post-allocation Exclude-other treatment|6|||
13264557|NCT01454830|26406509|FG001|Overall Study|Post-allocation Exclude-other treatment|7|||
13264558|NCT01454830|26406508|FG000|Overall Study|Withdrawal - no polysomnography|3|||
13264559|NCT01454830|26406509|FG001|Overall Study|Withdrawal - no polysomnography|2|||
13264560|NCT01454778|26406520|FG000|Overall Study|Lost to Follow-up|2|||
13264561|NCT01454778|26406520|FG000|Overall Study|Death|1|||
13264562|NCT01454739|26406554|FG000|Overall Study|Protocol Violation|2|||
13264563|NCT01454739|26406555|FG001|Overall Study|Protocol Violation|3|||
13117613|NCT03054337|25926443|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2|||
13264564|NCT01454739|26406554|FG000|Overall Study|Withdrawal by Subject|2|||
13264565|NCT01454739|26406555|FG001|Overall Study|Withdrawal by Subject|6|||
13264566|NCT01454739|26406554|FG000|Overall Study|Other|3|||
13264567|NCT01454739|26406555|FG001|Overall Study|Other|5|||
13264568|NCT01454739|26406554|FG000|Overall Study|Physician Decision|0|||
13264569|NCT01454739|26406555|FG001|Overall Study|Physician Decision|5|||
13264570|NCT01454739|26406554|FG000|Overall Study|Lost to Follow-up|0|||
13264571|NCT01454739|26406555|FG001|Overall Study|Lost to Follow-up|1|||
13264572|NCT01454739|26406554|FG000|Overall Study|Adverse Event|0|||
13264573|NCT01454739|26406555|FG001|Overall Study|Adverse Event|1|||
13264574|NCT01454726|26406568|FG000|Overall Study|Withdrawal by Subject|0|||
13264575|NCT01454726|26406569|FG001|Overall Study|Withdrawal by Subject|1|||
13264576|NCT01454596|26406680|FG000|Overall Study|Death|0|||
13264577|NCT01454596|26406681|FG001|Overall Study|Death|0|||
13264578|NCT01454596|26406682|FG002|Overall Study|Death|0|||
13264579|NCT01454596|26406683|FG003|Overall Study|Death|0|||
13264580|NCT01454596|26406684|FG004|Overall Study|Death|0|||
13264581|NCT01454596|26406685|FG005|Overall Study|Death|0|||
13264582|NCT01454596|26406686|FG006|Overall Study|Death|0|||
13264583|NCT01454596|26406687|FG007|Overall Study|Death|0|||
13264584|NCT01454596|26406688|FG008|Overall Study|Death|0|||
13264585|NCT01454596|26406689|FG009|Overall Study|Death|1|||
13264586|NCT01454596|26406690|FG010|Overall Study|Death|1|||
13264587|NCT01454596|26406691|FG011|Overall Study|Death|0|||
13264588|NCT01454583|26406769|FG000|1st Year|Lost to Follow-up|1057|||
13264589|NCT01454583|26406770|FG001|1st Year|Lost to Follow-up|318|||
13264590|NCT01454583|26406771|FG002|1st Year|Lost to Follow-up|180|||
13264591|NCT01454583|26406769|FG000|2nd Year|Lost to Follow-up|3965|||
13264592|NCT01454583|26406770|FG001|2nd Year|Lost to Follow-up|1049|||
13264593|NCT01454583|26406771|FG002|2nd Year|Lost to Follow-up|737|||
13264594|NCT01454583|26406769|FG000|3rd Year|Lost to Follow-up|1959|||
13264595|NCT01454583|26406770|FG001|3rd Year|Lost to Follow-up|512|||
13264596|NCT01454583|26406771|FG002|3rd Year|Lost to Follow-up|297|||
13264597|NCT01454570|26406777|FG000|Overall Study|Withdrawal by Subject|2|||
13264598|NCT01454570|26406777|FG000|Overall Study|Screen Failure|7|||
13264599|NCT01454531|26406788|FG000|Overall Study|Adverse Event|14|||
13264600|NCT01454531|26406788|FG000|Overall Study|Withdrawal by Subject|5|||
13264601|NCT01454531|26406788|FG000|Overall Study|Lost to Follow-up|1|||
13264602|NCT01454531|26406788|FG000|Overall Study|Physician Decision|1|||
13264603|NCT01454531|26406788|FG000|Overall Study|Delay in IMP administration|1|||
13264604|NCT01454531|26406788|FG000|Overall Study|Other|1|||
13117614|NCT03054337|25926444|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
13117615|NCT03054337|25926445|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
13117616|NCT03054337|25926446|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
13117617|NCT03054337|25926447|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
13117618|NCT03054064|25926457|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1|||
13117619|NCT03054064|25926457|FG000|Overall Study|Investigator Decision|2|||
13117620|NCT03054064|25926457|FG000|Overall Study|Bladder Issue|1|||
13117621|NCT03054064|25926457|FG000|Overall Study|High Blood Pressure|1|||
13117622|NCT03054064|25926457|FG000|Overall Study|Change in Status|1|||
13117623|NCT03053518|25926463|FG000|Overall Study|Withdrawal by Subject|3|||
13117624|NCT03053518|25926463|FG000|Overall Study|Lost to Follow-up|2|||
13117625|NCT03053518|25926463|FG000|Overall Study|Ineligible|5|||
13117626|NCT03053492|25926482|FG000|Overall Study|Adverse Event|1|||
13117627|NCT03053492|25926483|FG001|Overall Study|Adverse Event|1|||
13117628|NCT03053492|25926482|FG000|Overall Study|Withdrawal by Subject|7|||
13117629|NCT03053492|25926483|FG001|Overall Study|Withdrawal by Subject|5|||
13117630|NCT03053427|25926512|FG000|Overall Study|Adverse Event|4|||
13117631|NCT03053427|25926513|FG001|Overall Study|Adverse Event|4|||
13117632|NCT03053427|25926512|FG000|Overall Study|Lack of Efficacy|1|||
13117633|NCT03053427|25926513|FG001|Overall Study|Lack of Efficacy|3|||
13117634|NCT03053427|25926512|FG000|Overall Study|Lost to Follow-up|2|||
13117635|NCT03053427|25926513|FG001|Overall Study|Lost to Follow-up|2|||
13264605|NCT01454401|26406795|FG000|Overall Study|Death|1|||
13264606|NCT01454401|26406795|FG000|Overall Study|hospitalised|1|||
13264607|NCT01454401|26406795|FG000|Overall Study|osteomyelitis|2|||
13264608|NCT01454401|26406795|FG000|Overall Study|non-adherence|1|||
13264609|NCT01454284|26406850|FG000|Overall Study|Adverse Event|20|||
13264610|NCT01454284|26406851|FG001|Overall Study|Adverse Event|7|||
13264611|NCT01454284|26406850|FG000|Overall Study|Death|0|||
13117636|NCT03053427|25926512|FG000|Overall Study|Worsening of the target disease|0|||
13117637|NCT03053427|25926513|FG001|Overall Study|Worsening of the target disease|1|||
13117638|NCT03053427|25926512|FG000|Overall Study|Protocol Deviation|3|||
13117639|NCT03053427|25926513|FG001|Overall Study|Protocol Deviation|3|||
13117640|NCT03053427|25926512|FG000|Overall Study|Withdrawal by Subject|3|||
13117641|NCT03053427|25926513|FG001|Overall Study|Withdrawal by Subject|2|||
13264612|NCT01454284|26406851|FG001|Overall Study|Death|3|||
13264613|NCT01454284|26406850|FG000|Overall Study|Lost to Follow-up|13|||
13264614|NCT01454284|26406851|FG001|Overall Study|Lost to Follow-up|8|||
13264615|NCT01454284|26406850|FG000|Overall Study|Protocol Violation|9|||
13264616|NCT01454284|26406851|FG001|Overall Study|Protocol Violation|6|||
13264617|NCT01454284|26406850|FG000|Overall Study|Withdrawal by Subject|58|||
13117642|NCT03053427|25926512|FG000|Overall Study|Miscellaneous|0|||
13264618|NCT01454284|26406851|FG001|Overall Study|Withdrawal by Subject|36|||
13264619|NCT01454284|26406850|FG000|Overall Study|Physician Decision|16|||
13264620|NCT01454284|26406851|FG001|Overall Study|Physician Decision|11|||
13264621|NCT01454284|26406850|FG000|Overall Study|Sponsor Decision|0|||
13264622|NCT01454284|26406851|FG001|Overall Study|Sponsor Decision|2|||
13264623|NCT01454102|26407015|FG000|Overall Study|Continuing in the treatment period|0|||
13264624|NCT01454102|26407016|FG001|Overall Study|Continuing in the treatment period|0|||
13264625|NCT01454102|26407017|FG002|Overall Study|Continuing in the treatment period|0|||
13264626|NCT01454102|26407018|FG003|Overall Study|Continuing in the treatment period|0|||
13264627|NCT01454102|26407019|FG004|Overall Study|Continuing in the treatment period|3|||
13264628|NCT01454102|26407020|FG005|Overall Study|Continuing in the treatment period|3|||
13264629|NCT01454102|26407021|FG006|Overall Study|Continuing in the treatment period|2|||
13264630|NCT01454102|26407022|FG007|Overall Study|Continuing in the treatment period|0|||
13264631|NCT01454102|26407023|FG008|Overall Study|Continuing in the treatment period|1|||
13264632|NCT01454102|26407024|FG009|Overall Study|Continuing in the treatment period|0|||
13264633|NCT01454102|26407025|FG010|Overall Study|Continuing in the treatment period|0|||
13264634|NCT01454102|26407026|FG011|Overall Study|Continuing in the treatment period|4|||
13264635|NCT01454102|26407027|FG012|Overall Study|Continuing in the treatment period|7|||
13264636|NCT01454102|26407028|FG013|Overall Study|Continuing in the treatment period|4|||
13264637|NCT01454102|26407029|FG014|Overall Study|Continuing in the treatment period|3|||
13264638|NCT01454102|26407030|FG015|Overall Study|Continuing in the treatment period|1|||
13264639|NCT01454076|26407097|FG000|Overall Study|Other|2|||
13264640|NCT01454076|26407098|FG001|Overall Study|Other|0|||
13117643|NCT03053427|25926513|FG001|Overall Study|Miscellaneous|1|||
13264641|NCT01454076|26407099|FG002|Overall Study|Other|0|||
13264642|NCT01454076|26407100|FG003|Overall Study|Other|1|||
13264643|NCT01454076|26407101|FG004|Overall Study|Other|2|||
13264644|NCT01454076|26407097|FG000|Overall Study|Withdrawal by Subject|3|||
13264645|NCT01454076|26407098|FG001|Overall Study|Withdrawal by Subject|4|||
13264646|NCT01454076|26407099|FG002|Overall Study|Withdrawal by Subject|2|||
13264647|NCT01454076|26407100|FG003|Overall Study|Withdrawal by Subject|1|||
13264648|NCT01454076|26407101|FG004|Overall Study|Withdrawal by Subject|2|||
13264649|NCT01454076|26407097|FG000|Overall Study|Adverse Event|8|||
13264650|NCT01454076|26407098|FG001|Overall Study|Adverse Event|2|||
13264651|NCT01454076|26407099|FG002|Overall Study|Adverse Event|7|||
13264652|NCT01454076|26407100|FG003|Overall Study|Adverse Event|0|||
13264653|NCT01454076|26407101|FG004|Overall Study|Adverse Event|2|||
13264654|NCT01454063|26407126|FG000|Randomized|Adverse Event|1|||
13264655|NCT01454063|26407127|FG001|Randomized|Adverse Event|1|||
13264656|NCT01454063|26407126|FG000|Randomized|Protocol Violation|0|||
13264657|NCT01454063|26407127|FG001|Randomized|Protocol Violation|1|||
13264658|NCT01453998|26407301|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1|||
13264659|NCT01453998|26407302|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0|||
13264660|NCT01453998|26407303|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0|||
13264661|NCT01453855|26407316|FG000|Overall Study|Adverse Event|3|||
13264662|NCT01453855|26407317|FG001|Overall Study|Adverse Event|4|||
13264663|NCT01453855|26407316|FG000|Overall Study|Lost to Follow-up|2|||
13264664|NCT01453855|26407317|FG001|Overall Study|Lost to Follow-up|1|||
13264665|NCT01453855|26407316|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3|||
13264666|NCT01453855|26407317|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3|||
13264667|NCT01453855|26407316|FG000|Overall Study|Noncompliance|1|||
13264668|NCT01453855|26407317|FG001|Overall Study|Noncompliance|0|||
13264669|NCT01453855|26407316|FG000|Overall Study|Inadequate Control of IOP|1|||
13264670|NCT01453855|26407317|FG001|Overall Study|Inadequate Control of IOP|5|||
13264671|NCT01453855|26407316|FG000|Overall Study|Other|0|||
13264672|NCT01453855|26407317|FG001|Overall Study|Other|1|||
13264673|NCT01453725|26407344|FG000|Overall Study|Adverse Event|3|||
13264674|NCT01453725|26407345|FG001|Overall Study|Adverse Event|3|||
13264675|NCT01453725|26407344|FG000|Overall Study|Lost to Follow-up|4|||
13264676|NCT01453725|26407345|FG001|Overall Study|Lost to Follow-up|0|||
13264677|NCT01453725|26407344|FG000|Overall Study|Non-compliance With Protocol|1|||
13264678|NCT01453725|26407345|FG001|Overall Study|Non-compliance With Protocol|2|||
13264679|NCT01453725|26407344|FG000|Overall Study|Protocol Violation|1|||
13264680|NCT01453725|26407345|FG001|Overall Study|Protocol Violation|0|||
13264681|NCT01453725|26407344|FG000|Overall Study|Withdrawal by Subject|2|||
13264682|NCT01453725|26407345|FG001|Overall Study|Withdrawal by Subject|3|||
13264683|NCT01453725|26407344|FG000|Overall Study|Pregnancy Wish|0|||
13264684|NCT01453725|26407345|FG001|Overall Study|Pregnancy Wish|2|||
13264685|NCT01453725|26407344|FG000|Overall Study|Pregnancy|1|||
13264686|NCT01453725|26407345|FG001|Overall Study|Pregnancy|0|||
13264687|NCT01453725|26407344|FG000|Overall Study|Physician Decision|1|||
13264688|NCT01453725|26407345|FG001|Overall Study|Physician Decision|1|||
13264689|NCT01453595|26407361|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
13264690|NCT01453595|26407362|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1|||
13264691|NCT01453595|26407363|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
13264692|NCT01453439|26407390|FG000|Treatment Phase|Withdrawal by Subject|13|||
13264693|NCT01453439|26407391|FG001|Treatment Phase|Withdrawal by Subject|10|||
13264694|NCT01453439|26407390|FG000|Treatment Phase|Suicidal Ideation|2|||
13264695|NCT01453439|26407391|FG001|Treatment Phase|Suicidal Ideation|0|||
13264696|NCT01453439|26407390|FG000|Treatment Phase|Need for higher level of care|1|||
13264697|NCT01453439|26407391|FG001|Treatment Phase|Need for higher level of care|1|||
13264698|NCT01453439|26407390|FG000|Treatment Phase|Therapist conflict of interest|1|||
13264699|NCT01453439|26407391|FG001|Treatment Phase|Therapist conflict of interest|0|||
13264700|NCT01453439|26407390|FG000|Follow-up|Withdrawal by Subject|0|||
13264701|NCT01453439|26407391|FG001|Follow-up|Withdrawal by Subject|1|||
13264702|NCT01453439|26407390|FG000|Follow-up|Lost to Follow-up|5|||
13264703|NCT01453439|26407391|FG001|Follow-up|Lost to Follow-up|10|||
13264704|NCT01453374|26407409|FG000|Overall Study|Adverse Event|7|||
13264705|NCT01453374|26407409|FG000|Overall Study|Lack of Efficacy|1|||
13264706|NCT01453374|26407409|FG000|Overall Study|Lost to Follow-up|3|||
13264707|NCT01453374|26407409|FG000|Overall Study|Withdrawal by Subject|5|||
13264708|NCT01453374|26407409|FG000|Overall Study|Incarcerated|2|||
13264709|NCT01453361|26407416|FG000|Overall Study|Disease Progression|6|||
13264710|NCT01453361|26407416|FG000|Overall Study|Screen-Failures|10|||
13264711|NCT01453348|26407442|FG000|Overall Study|Death|0|||
13264712|NCT01453348|26407443|FG001|Overall Study|Death|0|||
13264713|NCT01453348|26407444|FG002|Overall Study|Death|1|||
13264714|NCT01453348|26407442|FG000|Overall Study|Withdrawal by Subject|0|||
13264715|NCT01453348|26407443|FG001|Overall Study|Withdrawal by Subject|1|||
13264716|NCT01453348|26407444|FG002|Overall Study|Withdrawal by Subject|0|||
13264717|NCT01453348|26407442|FG000|Overall Study|Protocol Violation|1|||
13264718|NCT01453348|26407443|FG001|Overall Study|Protocol Violation|0|||
13264719|NCT01453348|26407444|FG002|Overall Study|Protocol Violation|0|||
13264720|NCT01453296|26407511|FG000|Treatment Period 1|Adverse Event|0|||
13264721|NCT01453296|26407512|FG001|Treatment Period 1|Adverse Event|1|||
13264722|NCT01453296|26407511|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1|||
13264723|NCT01453296|26407512|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0|||
13264724|NCT01453296|26407511|FG000|Treatment Period 2|Adverse Event|1|||
13264725|NCT01453296|26407512|FG001|Treatment Period 2|Adverse Event|0|||
13264726|NCT01453296|26407511|FG000|Treatment Period 2|Withdrawal by Subject|1|||
13264727|NCT01453296|26407512|FG001|Treatment Period 2|Withdrawal by Subject|0|||
13264728|NCT01453205|26407570|FG000|Overall Study|Lost to Follow-up|3|||
13264729|NCT01453205|26407571|FG001|Overall Study|Lost to Follow-up|0|||
13264730|NCT01453205|26407572|FG002|Overall Study|Lost to Follow-up|1|||
13264731|NCT01453205|26407570|FG000|Overall Study|Withdrawal by Subject|8|||
13264732|NCT01453205|26407571|FG001|Overall Study|Withdrawal by Subject|3|||
13264733|NCT01453205|26407572|FG002|Overall Study|Withdrawal by Subject|0|||
13264734|NCT01453205|26407570|FG000|Overall Study|Death|24|||
13264735|NCT01453205|26407571|FG001|Overall Study|Death|22|||
13264736|NCT01453205|26407572|FG002|Overall Study|Death|18|||
13264737|NCT01453205|26407570|FG000|Overall Study|Other|45|||
13264738|NCT01453205|26407571|FG001|Overall Study|Other|27|||
13264739|NCT01453205|26407572|FG002|Overall Study|Other|35|||
13290562|NCT00101686|26481416|FG006|Overall Study|unacceptable toxicity|4|||
13290563|NCT00101686|26481417|FG007|Overall Study|unacceptable toxicity|2|||
13290564|NCT00101686|26481418|FG008|Overall Study|unacceptable toxicity|1|||
13290565|NCT00101686|26481419|FG009|Overall Study|unacceptable toxicity|4|||
13290566|NCT00101686|26481410|FG000|Overall Study|Randomized but did not receive treament|1|||
13290567|NCT00101686|26481411|FG001|Overall Study|Randomized but did not receive treament|6|||
13290568|NCT00101686|26481412|FG002|Overall Study|Randomized but did not receive treament|2|||
13290569|NCT00101686|26481413|FG003|Overall Study|Randomized but did not receive treament|2|||
13290570|NCT00101686|26481414|FG004|Overall Study|Randomized but did not receive treament|2|||
13290571|NCT00101686|26481415|FG005|Overall Study|Randomized but did not receive treament|2|||
13290572|NCT00101686|26481416|FG006|Overall Study|Randomized but did not receive treament|0|||
13290573|NCT00101686|26481417|FG007|Overall Study|Randomized but did not receive treament|1|||
13290574|NCT00101686|26481418|FG008|Overall Study|Randomized but did not receive treament|0|||
13290575|NCT00101686|26481419|FG009|Overall Study|Randomized but did not receive treament|1|||
13290576|NCT00101686|26481410|FG000|Overall Study|intercurrent non-cancer related illness|0|||
13290577|NCT00101686|26481411|FG001|Overall Study|intercurrent non-cancer related illness|0|||
13290578|NCT00101686|26481412|FG002|Overall Study|intercurrent non-cancer related illness|2|||
13290579|NCT00101686|26481413|FG003|Overall Study|intercurrent non-cancer related illness|0|||
13290580|NCT00101686|26481414|FG004|Overall Study|intercurrent non-cancer related illness|1|||
13290581|NCT00101686|26481415|FG005|Overall Study|intercurrent non-cancer related illness|3|||
13290582|NCT00101686|26481416|FG006|Overall Study|intercurrent non-cancer related illness|1|||
13290583|NCT00101686|26481417|FG007|Overall Study|intercurrent non-cancer related illness|0|||
13290584|NCT00101686|26481418|FG008|Overall Study|intercurrent non-cancer related illness|1|||
13486343|NCT01147822|27035855|FG001|Overall Study|Death|59|||
13264740|NCT01453153|26407653|FG000|Overall Study|Physician Decision|0|||
13264741|NCT01453153|26407654|FG001|Overall Study|Physician Decision|0|||
13264742|NCT01453153|26407655|FG002|Overall Study|Physician Decision|1|||
13264743|NCT01453153|26407653|FG000|Overall Study|Progressive Disease|3|||
13264744|NCT01453153|26407654|FG001|Overall Study|Progressive Disease|2|||
13264745|NCT01453153|26407655|FG002|Overall Study|Progressive Disease|16|||
13264746|NCT01453153|26407653|FG000|Overall Study|Withdrawal by Subject|0|||
13264747|NCT01453153|26407654|FG001|Overall Study|Withdrawal by Subject|1|||
13264748|NCT01453153|26407655|FG002|Overall Study|Withdrawal by Subject|2|||
13264749|NCT01453153|26407653|FG000|Overall Study|Adverse Event|1|||
13264750|NCT01453153|26407654|FG001|Overall Study|Adverse Event|1|||
13264751|NCT01453153|26407655|FG002|Overall Study|Adverse Event|1|||
13264752|NCT01453140|26407665|FG000|Overall Study|Adverse Event|3|||
13290585|NCT00101686|26481419|FG009|Overall Study|intercurrent non-cancer related illness|1|||
13290586|NCT00101686|26481410|FG000|Overall Study|Physician Decision|10|||
13290587|NCT00101686|26481411|FG001|Overall Study|Physician Decision|13|||
13290588|NCT00101686|26481412|FG002|Overall Study|Physician Decision|6|||
13290589|NCT00101686|26481413|FG003|Overall Study|Physician Decision|7|||
13290590|NCT00101686|26481414|FG004|Overall Study|Physician Decision|8|||
13290591|NCT00101686|26481415|FG005|Overall Study|Physician Decision|9|||
13290592|NCT00101686|26481416|FG006|Overall Study|Physician Decision|5|||
13290593|NCT00101686|26481417|FG007|Overall Study|Physician Decision|5|||
13290594|NCT00101686|26481418|FG008|Overall Study|Physician Decision|1|||
13290595|NCT00101686|26481419|FG009|Overall Study|Physician Decision|1|||
13290596|NCT00101686|26481410|FG000|Overall Study|Other|1|||
13290597|NCT00101686|26481411|FG001|Overall Study|Other|4|||
13290598|NCT00101686|26481412|FG002|Overall Study|Other|1|||
13290599|NCT00101686|26481413|FG003|Overall Study|Other|6|||
13290600|NCT00101686|26481414|FG004|Overall Study|Other|2|||
13290601|NCT00101686|26481415|FG005|Overall Study|Other|12|||
13290602|NCT00101686|26481416|FG006|Overall Study|Other|1|||
13117644|NCT03053271|25926523|FG000|Overall Study|Did not meet randomization criteria|3|||
13290603|NCT00101686|26481417|FG007|Overall Study|Other|5|||
13290604|NCT00101686|26481418|FG008|Overall Study|Other|3|||
13290605|NCT00101686|26481419|FG009|Overall Study|Other|3|||
13290606|NCT00101686|26481410|FG000|Overall Study|Withdrawal by Subject|9|||
13290607|NCT00101686|26481411|FG001|Overall Study|Withdrawal by Subject|8|||
13290608|NCT00101686|26481412|FG002|Overall Study|Withdrawal by Subject|6|||
13290609|NCT00101686|26481413|FG003|Overall Study|Withdrawal by Subject|8|||
13290610|NCT00101686|26481414|FG004|Overall Study|Withdrawal by Subject|8|||
13290611|NCT00101686|26481415|FG005|Overall Study|Withdrawal by Subject|7|||
13290612|NCT00101686|26481416|FG006|Overall Study|Withdrawal by Subject|7|||
13290613|NCT00101686|26481417|FG007|Overall Study|Withdrawal by Subject|7|||
13290614|NCT00101686|26481418|FG008|Overall Study|Withdrawal by Subject|8|||
13290615|NCT00101686|26481419|FG009|Overall Study|Withdrawal by Subject|9|||
13290616|NCT00101582|26481446|FG000|Overall Study|Ineligibility determined|0|||
13290617|NCT00101582|26481447|FG001|Overall Study|Ineligibility determined|1|||
13290618|NCT00101582|26481446|FG000|Overall Study|Adverse Event|1|||
13290619|NCT00101582|26481447|FG001|Overall Study|Adverse Event|4|||
13290620|NCT00101582|26481446|FG000|Overall Study|Withdrawal by Subject|6|||
13290621|NCT00101582|26481447|FG001|Overall Study|Withdrawal by Subject|4|||
13290622|NCT00101582|26481446|FG000|Overall Study|Physician Decision|1|||
13290623|NCT00101582|26481447|FG001|Overall Study|Physician Decision|0|||
13290624|NCT00101582|26481446|FG000|Overall Study|Death|3|||
13290625|NCT00101582|26481447|FG001|Overall Study|Death|5|||
13290626|NCT00101582|26481446|FG000|Overall Study|Other|0|||
13290627|NCT00101582|26481447|FG001|Overall Study|Other|1|||
13290628|NCT00101452|26481469|FG000|Overall Study|Adverse Event|2|||
13290629|NCT00101452|26481470|FG001|Overall Study|Adverse Event|0|||
13290630|NCT00101452|26481471|FG002|Overall Study|Adverse Event|1|||
13290631|NCT00101452|26481469|FG000|Overall Study|Lost to Follow-up|13|||
13290632|NCT00101452|26481470|FG001|Overall Study|Lost to Follow-up|8|||
13290633|NCT00101452|26481471|FG002|Overall Study|Lost to Follow-up|14|||
13290634|NCT00101452|26481469|FG000|Overall Study|Withdrawal by Subject|10|||
13290635|NCT00101452|26481470|FG001|Overall Study|Withdrawal by Subject|14|||
13290636|NCT00101452|26481471|FG002|Overall Study|Withdrawal by Subject|9|||
13290637|NCT00101452|26481469|FG000|Overall Study|Baseline Fail|2|||
13290638|NCT00101452|26481470|FG001|Overall Study|Baseline Fail|1|||
13290639|NCT00101452|26481471|FG002|Overall Study|Baseline Fail|2|||
13290640|NCT00101452|26481469|FG000|Overall Study|Physician Decision|0|||
13290641|NCT00101452|26481470|FG001|Overall Study|Physician Decision|3|||
13290642|NCT00101452|26481471|FG002|Overall Study|Physician Decision|2|||
13290643|NCT00101452|26481469|FG000|Overall Study|Protocol Violation|2|||
13290644|NCT00101452|26481470|FG001|Overall Study|Protocol Violation|1|||
13290645|NCT00101452|26481471|FG002|Overall Study|Protocol Violation|3|||
13290646|NCT00101452|26481469|FG000|Overall Study|Other|15|||
13290647|NCT00101452|26481470|FG001|Overall Study|Other|16|||
13290648|NCT00101452|26481471|FG002|Overall Study|Other|12|||
13290649|NCT00101439|26481486|FG000|Period 2|Withdrawal by Subject|0|||
13290650|NCT00101439|26481487|FG001|Period 2|Withdrawal by Subject|2|||
13486344|NCT01147822|27035854|FG000|Overall Study|Protocol Violation|0|||
13264753|NCT01453049|26407742|FG000|Overall Study|Protocol Violation|2|||
13264754|NCT01453049|26407743|FG001|Overall Study|Protocol Violation|5|||
13264755|NCT01453049|26407742|FG000|Overall Study|Lost to Follow-up|2|||
13264756|NCT01453049|26407743|FG001|Overall Study|Lost to Follow-up|1|||
13264757|NCT01453049|26407742|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35|||
13264758|NCT01453049|26407743|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36|||
13264759|NCT01453049|26407742|FG000|Overall Study|Withdrawal by Subject|1|||
13264760|NCT01453049|26407743|FG001|Overall Study|Withdrawal by Subject|0|||
13264761|NCT01453049|26407742|FG000|Overall Study|Randomized in Error|1|||
13264762|NCT01453049|26407743|FG001|Overall Study|Randomized in Error|0|||
13264763|NCT01453036|26407761|FG000|Overall Study|Lost to Follow-up|26|||
13264764|NCT01453036|26407762|FG001|Overall Study|Lost to Follow-up|115|||
13264765|NCT01453036|26407763|FG002|Overall Study|Lost to Follow-up|31|||
13264766|NCT01453023|26407834|FG000|Treatment Period (TP) 1|Protocol Violation|1|||
13264767|NCT01453023|26407835|FG001|Treatment Period (TP) 1|Protocol Violation|0|||
13117645|NCT03053271|25926523|FG000|Overall Study|Withdrawal by Subject|1|||
13117646|NCT03053180|25926534|FG000|Overall Study|Failure to Return|1|||
13117647|NCT03053102|25926550|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1|||
13117648|NCT03053102|25926550|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1|||
13117649|NCT03053063|25926588|FG000|Randomized Phase|Study Terminated by Sponsor|326|||
13117650|NCT03053063|25926589|FG001|Randomized Phase|Study Terminated by Sponsor|317|||
13117651|NCT03053063|25926590|FG002|Randomized Phase|Study Terminated by Sponsor|161|||
13117652|NCT03053063|25926591|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
13117653|NCT03053063|25926588|FG000|Randomized Phase|Withdrew consent|8|||
13117654|NCT03053063|25926589|FG001|Randomized Phase|Withdrew consent|11|||
13117655|NCT03053063|25926590|FG002|Randomized Phase|Withdrew consent|5|||
13117656|NCT03053063|25926591|FG003|Randomized Phase|Withdrew consent|0|||
13117657|NCT03053063|25926588|FG000|Randomized Phase|Investigator's Discretion|8|||
13117658|NCT03053063|25926589|FG001|Randomized Phase|Investigator's Discretion|6|||
13117659|NCT03053063|25926590|FG002|Randomized Phase|Investigator's Discretion|2|||
13117660|NCT03053063|25926591|FG003|Randomized Phase|Investigator's Discretion|0|||
13117661|NCT03053063|25926588|FG000|Randomized Phase|Lost to Follow-up|3|||
13117662|NCT03053063|25926589|FG001|Randomized Phase|Lost to Follow-up|5|||
13117663|NCT03053063|25926590|FG002|Randomized Phase|Lost to Follow-up|1|||
13117664|NCT03053063|25926591|FG003|Randomized Phase|Lost to Follow-up|0|||
13117665|NCT03053063|25926588|FG000|Randomized Phase|Adverse Event|0|||
13117666|NCT03053063|25926589|FG001|Randomized Phase|Adverse Event|1|||
13117667|NCT03053063|25926590|FG002|Randomized Phase|Adverse Event|0|||
13117668|NCT03053063|25926591|FG003|Randomized Phase|Adverse Event|0|||
13117669|NCT03053063|25926588|FG000|Randomized Phase|Randomized but Never Treated|1|||
13117670|NCT03053063|25926589|FG001|Randomized Phase|Randomized but Never Treated|3|||
13117671|NCT03053063|25926590|FG002|Randomized Phase|Randomized but Never Treated|2|||
13117672|NCT03053063|25926591|FG003|Randomized Phase|Randomized but Never Treated|0|||
13117673|NCT03053063|25926588|FG000|Randomized Phase|Entered the Open-Label Phase|9|||
13117674|NCT03053063|25926589|FG001|Randomized Phase|Entered the Open-Label Phase|11|||
13117675|NCT03053063|25926590|FG002|Randomized Phase|Entered the Open-Label Phase|3|||
13117676|NCT03053063|25926591|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
13117677|NCT03053063|25926588|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
13117678|NCT03053063|25926589|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
13117679|NCT03053063|25926590|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
13117680|NCT03053063|25926591|FG003|Open-Label Phase|Study Terminated by Sponsor|19|||
13117681|NCT03053063|25926588|FG000|Open-Label Phase|Death|0|||
13117682|NCT03053063|25926589|FG001|Open-Label Phase|Death|0|||
13117683|NCT03053063|25926590|FG002|Open-Label Phase|Death|0|||
13117684|NCT03053063|25926591|FG003|Open-Label Phase|Death|2|||
13117685|NCT03053063|25926588|FG000|Open-Label Phase|Investigator's discretion|0|||
13117686|NCT03053063|25926589|FG001|Open-Label Phase|Investigator's discretion|0|||
13117687|NCT03053063|25926590|FG002|Open-Label Phase|Investigator's discretion|0|||
13117688|NCT03053063|25926591|FG003|Open-Label Phase|Investigator's discretion|2|||
13117689|NCT03053050|25926632|FG000|Randomized Phase|Study Terminated by Sponsor|259|||
13117690|NCT03053050|25926633|FG001|Randomized Phase|Study Terminated by Sponsor|260|||
13117691|NCT03053050|25926634|FG002|Randomized Phase|Study Terminated by Sponsor|128|||
13117692|NCT03053050|25926635|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
13117693|NCT03053050|25926632|FG000|Randomized Phase|Withdrew Consent|16|||
13117694|NCT03053050|25926633|FG001|Randomized Phase|Withdrew Consent|8|||
13117695|NCT03053050|25926634|FG002|Randomized Phase|Withdrew Consent|9|||
13117696|NCT03053050|25926635|FG003|Randomized Phase|Withdrew Consent|0|||
13117697|NCT03053050|25926632|FG000|Randomized Phase|Investigator's Discretion|6|||
13117698|NCT03053050|25926633|FG001|Randomized Phase|Investigator's Discretion|6|||
13117699|NCT03053050|25926634|FG002|Randomized Phase|Investigator's Discretion|3|||
13117700|NCT03053050|25926635|FG003|Randomized Phase|Investigator's Discretion|0|||
13117701|NCT03053050|25926632|FG000|Randomized Phase|Lost to Follow-up|5|||
13264768|NCT01453023|26407834|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0|||
13264769|NCT01453023|26407835|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1|||
13117702|NCT03053050|25926633|FG001|Randomized Phase|Lost to Follow-up|1|||
13117703|NCT03053050|25926634|FG002|Randomized Phase|Lost to Follow-up|1|||
13264770|NCT01453023|26407834|FG000|Treatment Period 2|Protocol Violation|0|||
13264771|NCT01453023|26407835|FG001|Treatment Period 2|Protocol Violation|1|||
13264772|NCT01452919|26407861|FG000|Open-Label Treatment|Adverse Event|5|||
13264773|NCT01452919|26407862|FG001|Open-Label Treatment|Adverse Event|0|||
13264774|NCT01452919|26407863|FG002|Open-Label Treatment|Adverse Event|0|||
13264775|NCT01452919|26407861|FG000|Open-Label Treatment|Lost to Follow-up|4|||
13264776|NCT01452919|26407862|FG001|Open-Label Treatment|Lost to Follow-up|0|||
13264777|NCT01452919|26407863|FG002|Open-Label Treatment|Lost to Follow-up|0|||
13264778|NCT01452919|26407861|FG000|Open-Label Treatment|Perceived lack of efficacy|3|||
13264779|NCT01452919|26407862|FG001|Open-Label Treatment|Perceived lack of efficacy|0|||
13264780|NCT01452919|26407863|FG002|Open-Label Treatment|Perceived lack of efficacy|0|||
13264781|NCT01452919|26407861|FG000|Open-Label Treatment|Protocol Violation|4|||
13264782|NCT01452919|26407862|FG001|Open-Label Treatment|Protocol Violation|0|||
13264783|NCT01452919|26407863|FG002|Open-Label Treatment|Protocol Violation|0|||
13264784|NCT01452919|26407861|FG000|Open-Label Treatment|Sponsor Decision|1|||
13264785|NCT01452919|26407862|FG001|Open-Label Treatment|Sponsor Decision|0|||
13264786|NCT01452919|26407863|FG002|Open-Label Treatment|Sponsor Decision|0|||
13264787|NCT01452919|26407861|FG000|Open-Label Treatment|Withdrawal by Subject|2|||
13264788|NCT01452919|26407862|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
13264789|NCT01452919|26407863|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
13264790|NCT01452919|26407861|FG000|Open-Label Treatment|Subject is moving or has moved|1|||
13264791|NCT01452919|26407862|FG001|Open-Label Treatment|Subject is moving or has moved|0|||
13264792|NCT01452919|26407863|FG002|Open-Label Treatment|Subject is moving or has moved|0|||
13264793|NCT01452919|26407861|FG000|Randomization Treatment|Adverse Event|0|||
13264794|NCT01452919|26407862|FG001|Randomization Treatment|Adverse Event|0|||
13264795|NCT01452919|26407863|FG002|Randomization Treatment|Adverse Event|2|||
13264796|NCT01452919|26407861|FG000|Randomization Treatment|Sponsor Decision|0|||
13264797|NCT01452919|26407862|FG001|Randomization Treatment|Sponsor Decision|1|||
13264798|NCT01452919|26407863|FG002|Randomization Treatment|Sponsor Decision|0|||
13264799|NCT01452919|26407861|FG000|Randomization Treatment|Withdrawal by Subject|0|||
13264800|NCT01452919|26407862|FG001|Randomization Treatment|Withdrawal by Subject|1|||
13264801|NCT01452919|26407863|FG002|Randomization Treatment|Withdrawal by Subject|0|||
13264802|NCT01452919|26407861|FG000|Randomization Treatment|Subject is moving or has moved|0|||
13264803|NCT01452919|26407862|FG001|Randomization Treatment|Subject is moving or has moved|1|||
13264804|NCT01452919|26407863|FG002|Randomization Treatment|Subject is moving or has moved|0|||
13264805|NCT01452789|26407882|FG000|Overall Study|Withdrawal by Subject|3|||
13264806|NCT01452789|26407883|FG001|Overall Study|Withdrawal by Subject|2|||
13264807|NCT01452529|26407906|FG000|Run-in Period|Adverse Event|96|||
13264808|NCT01452529|26407907|FG001|Run-in Period|Adverse Event|0|||
13264809|NCT01452529|26407908|FG002|Run-in Period|Adverse Event|0|||
13264810|NCT01452529|26407906|FG000|Run-in Period|Withdrawal by Subject|49|||
13264811|NCT01452529|26407907|FG001|Run-in Period|Withdrawal by Subject|0|||
13264812|NCT01452529|26407908|FG002|Run-in Period|Withdrawal by Subject|0|||
13264813|NCT01452529|26407906|FG000|Run-in Period|Lost to Follow-up|19|||
13264814|NCT01452529|26407907|FG001|Run-in Period|Lost to Follow-up|0|||
13264815|NCT01452529|26407908|FG002|Run-in Period|Lost to Follow-up|0|||
13264816|NCT01452529|26407906|FG000|Run-in Period|Lack of Efficacy|46|||
13264817|NCT01452529|26407907|FG001|Run-in Period|Lack of Efficacy|0|||
13264818|NCT01452529|26407908|FG002|Run-in Period|Lack of Efficacy|0|||
13264819|NCT01452529|26407906|FG000|Run-in Period|Confirmed or suspected diversion|23|||
13264820|NCT01452529|26407907|FG001|Run-in Period|Confirmed or suspected diversion|0|||
13264821|NCT01452529|26407908|FG002|Run-in Period|Confirmed or suspected diversion|0|||
13264822|NCT01452529|26407906|FG000|Run-in Period|Administrative|21|||
13264823|NCT01452529|26407907|FG001|Run-in Period|Administrative|0|||
13264824|NCT01452529|26407908|FG002|Run-in Period|Administrative|0|||
13264825|NCT01452529|26407906|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59|||
13264826|NCT01452529|26407907|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0|||
13264827|NCT01452529|26407908|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0|||
13264828|NCT01452529|26407906|FG000|Double-blind (DB) Period|Adverse Event|0|||
13264829|NCT01452529|26407907|FG001|Double-blind (DB) Period|Adverse Event|18|||
13264830|NCT01452529|26407908|FG002|Double-blind (DB) Period|Adverse Event|11|||
13264831|NCT01452529|26407906|FG000|Double-blind (DB) Period|Withdrawal by Subject|0|||
13264832|NCT01452529|26407907|FG001|Double-blind (DB) Period|Withdrawal by Subject|15|||
13264833|NCT01452529|26407908|FG002|Double-blind (DB) Period|Withdrawal by Subject|14|||
13264834|NCT01452529|26407906|FG000|Double-blind (DB) Period|Lost to Follow-up|0|||
13264835|NCT01452529|26407907|FG001|Double-blind (DB) Period|Lost to Follow-up|5|||
13264836|NCT01452529|26407908|FG002|Double-blind (DB) Period|Lost to Follow-up|3|||
13264837|NCT01452529|26407906|FG000|Double-blind (DB) Period|Lack of Efficacy|0|||
13264838|NCT01452529|26407907|FG001|Double-blind (DB) Period|Lack of Efficacy|16|||
13264839|NCT01452529|26407908|FG002|Double-blind (DB) Period|Lack of Efficacy|44|||
13117704|NCT03053050|25926635|FG003|Randomized Phase|Lost to Follow-up|0|||
13264840|NCT01452529|26407906|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0|||
13264841|NCT01452529|26407907|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2|||
13264842|NCT01452529|26407908|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3|||
13264843|NCT01452529|26407906|FG000|Double-blind (DB) Period|Administrative|0|||
13264844|NCT01452529|26407907|FG001|Double-blind (DB) Period|Administrative|11|||
13264845|NCT01452529|26407908|FG002|Double-blind (DB) Period|Administrative|7|||
13264846|NCT01452412|26407929|FG000|Overall Study|Withdrawal by Subject|15|||
13264847|NCT01452412|26407930|FG001|Overall Study|Withdrawal by Subject|11|||
13117705|NCT03053050|25926632|FG000|Randomized Phase|Adverse Event|0|||
13264848|NCT01452412|26407929|FG000|Overall Study|Adverse Event|4|||
13264849|NCT01452412|26407930|FG001|Overall Study|Adverse Event|3|||
13264850|NCT01452412|26407929|FG000|Overall Study|Lost to Follow-up|5|||
13264851|NCT01452412|26407930|FG001|Overall Study|Lost to Follow-up|3|||
13264852|NCT01452412|26407929|FG000|Overall Study|Death|1|||
13264853|NCT01452412|26407930|FG001|Overall Study|Death|0|||
13264854|NCT01452412|26407929|FG000|Overall Study|Initiated dialysis|1|||
13264855|NCT01452412|26407930|FG001|Overall Study|Initiated dialysis|0|||
13264856|NCT01452412|26407929|FG000|Overall Study|Other|2|||
13264857|NCT01452412|26407930|FG001|Overall Study|Other|0|||
13264858|NCT01452347|26407953|FG000|Overall Study|Adverse Event|2|||
13264859|NCT01452347|26407954|FG001|Overall Study|Adverse Event|1|||
13264860|NCT01452347|26407953|FG000|Overall Study|Non compliance protocol|2|||
13264861|NCT01452347|26407954|FG001|Overall Study|Non compliance protocol|0|||
13264862|NCT01452347|26407953|FG000|Overall Study|Lost to Follow-up|2|||
13264863|NCT01452347|26407954|FG001|Overall Study|Lost to Follow-up|0|||
13264864|NCT01452347|26407953|FG000|Overall Study|Withdrawal by Subject|3|||
13264865|NCT01452347|26407954|FG001|Overall Study|Withdrawal by Subject|3|||
13264866|NCT01452347|26407953|FG000|Overall Study|Not treated|6|||
13264867|NCT01452347|26407954|FG001|Overall Study|Not treated|3|||
13264868|NCT01452347|26407953|FG000|Overall Study|Other reason not defined above|2|||
13264869|NCT01452347|26407954|FG001|Overall Study|Other reason not defined above|0|||
13117706|NCT03053050|25926633|FG001|Randomized Phase|Adverse Event|1|||
13264870|NCT01452152|26407987|FG000|Overall Study|Study termination by sponsor|5|||
13264871|NCT01452152|26407988|FG001|Overall Study|Study termination by sponsor|0|||
13264872|NCT01452152|26407989|FG002|Overall Study|Study termination by sponsor|4|||
13264873|NCT01451931|26408019|FG000|Overall Study|Lost to Follow-up|17|||
13264874|NCT01451931|26408020|FG001|Overall Study|Lost to Follow-up|36|||
13264875|NCT01451931|26408021|FG002|Overall Study|Lost to Follow-up|21|||
13264876|NCT01451931|26408019|FG000|Overall Study|Withdrawal by Subject|16|||
13264877|NCT01451931|26408020|FG001|Overall Study|Withdrawal by Subject|22|||
13264878|NCT01451931|26408021|FG002|Overall Study|Withdrawal by Subject|22|||
13264879|NCT01451827|26408052|FG000|Overall Study|Adverse Event|2|||
13264880|NCT01451827|26408053|FG001|Overall Study|Adverse Event|0|||
13264881|NCT01451827|26408054|FG002|Overall Study|Adverse Event|1|||
13264882|NCT01451827|26408055|FG003|Overall Study|Adverse Event|1|||
13264883|NCT01451827|26408052|FG000|Overall Study|Protocol deviation|1|||
13264884|NCT01451827|26408053|FG001|Overall Study|Protocol deviation|0|||
13264885|NCT01451827|26408054|FG002|Overall Study|Protocol deviation|0|||
13264886|NCT01451827|26408055|FG003|Overall Study|Protocol deviation|0|||
13264887|NCT01451827|26408052|FG000|Overall Study|Lost to Follow-up|0|||
13264888|NCT01451827|26408053|FG001|Overall Study|Lost to Follow-up|3|||
13264889|NCT01451827|26408054|FG002|Overall Study|Lost to Follow-up|0|||
13264890|NCT01451827|26408055|FG003|Overall Study|Lost to Follow-up|2|||
13264891|NCT01451827|26408052|FG000|Overall Study|Participant met withdrawal criteria|0|||
13264892|NCT01451827|26408053|FG001|Overall Study|Participant met withdrawal criteria|2|||
13264893|NCT01451827|26408054|FG002|Overall Study|Participant met withdrawal criteria|0|||
13264894|NCT01451827|26408055|FG003|Overall Study|Participant met withdrawal criteria|0|||
13264895|NCT01451827|26408052|FG000|Overall Study|Withdrawal by Subject|0|||
13264896|NCT01451827|26408053|FG001|Overall Study|Withdrawal by Subject|0|||
13264897|NCT01451827|26408054|FG002|Overall Study|Withdrawal by Subject|1|||
13264898|NCT01451827|26408055|FG003|Overall Study|Withdrawal by Subject|1|||
13264899|NCT01451814|26408072|FG000|Overall Study|Withdrawal by Subject|1|||
13264900|NCT01451814|26408073|FG001|Overall Study|Withdrawal by Subject|1|||
13264901|NCT01451814|26408072|FG000|Overall Study|Lost to Follow-up|5|||
13264902|NCT01451814|26408073|FG001|Overall Study|Lost to Follow-up|4|||
13264903|NCT01451762|26408091|FG000|Overall Study|Lost to Follow-up|3|||
13264904|NCT01451762|26408092|FG001|Overall Study|Lost to Follow-up|6|||
13264905|NCT01451762|26408093|FG002|Overall Study|Lost to Follow-up|6|||
13264906|NCT01451749|26408110|FG000|Overall Study|Protocol Violation|14|||
13264907|NCT01451749|26408111|FG001|Overall Study|Protocol Violation|7|||
13264908|NCT01451749|26408110|FG000|Overall Study|Lost to Follow-up|15|||
13264909|NCT01451749|26408111|FG001|Overall Study|Lost to Follow-up|5|||
13264910|NCT01451749|26408110|FG000|Overall Study|Meet the exclusion criteria,and|1|||
13264911|NCT01451749|26408111|FG001|Overall Study|Meet the exclusion criteria,and|1|||
13264912|NCT01451749|26408110|FG000|Overall Study|Adverse Event|2|||
13264913|NCT01451749|26408111|FG001|Overall Study|Adverse Event|0|||
13264914|NCT01451749|26408110|FG000|Overall Study|Withdrawal by Subject|0|||
13264915|NCT01451749|26408111|FG001|Overall Study|Withdrawal by Subject|1|||
13264916|NCT01451723|26408126|FG000|Overall Study|study halted|6|||
13264917|NCT01451723|26408127|FG001|Overall Study|study halted|5|||
13264918|NCT01451645|26408146|FG000|Overall Study|Protocol Violation|1|||
13264919|NCT01451645|26408147|FG001|Overall Study|Protocol Violation|0|||
13264920|NCT01451645|26408146|FG000|Overall Study|Adverse Event|0|||
13264921|NCT01451645|26408147|FG001|Overall Study|Adverse Event|3|||
13264922|NCT01451645|26408146|FG000|Overall Study|Withdrawal by Subject|4|||
13264923|NCT01451645|26408147|FG001|Overall Study|Withdrawal by Subject|2|||
13264924|NCT01451645|26408146|FG000|Overall Study|Lost to Follow-up|4|||
13264925|NCT01451645|26408147|FG001|Overall Study|Lost to Follow-up|3|||
13264926|NCT01451606|26408162|FG000|Overall Study|Withdrawal by Subject|4|||
13264927|NCT01451606|26408163|FG001|Overall Study|Withdrawal by Subject|3|||
13264928|NCT01451554|26408178|FG000|Overall Study|Withdrawal by Subject|14|||
13264929|NCT01451554|26408179|FG001|Overall Study|Withdrawal by Subject|9|||
13264930|NCT01451541|26408229|FG000|Overall Study|Adverse Event|4|||
13264931|NCT01451541|26408230|FG001|Overall Study|Adverse Event|3|||
13264932|NCT01451541|26408231|FG002|Overall Study|Adverse Event|6|||
13264933|NCT01451541|26408229|FG000|Overall Study|Lack of Efficacy|2|||
13264934|NCT01451541|26408230|FG001|Overall Study|Lack of Efficacy|0|||
13264935|NCT01451541|26408231|FG002|Overall Study|Lack of Efficacy|0|||
13264936|NCT01451541|26408229|FG000|Overall Study|Lost to Follow-up|4|||
13264937|NCT01451541|26408230|FG001|Overall Study|Lost to Follow-up|4|||
13264938|NCT01451541|26408231|FG002|Overall Study|Lost to Follow-up|7|||
13264939|NCT01451541|26408229|FG000|Overall Study|Withdrawal by Subject|15|||
13264940|NCT01451541|26408230|FG001|Overall Study|Withdrawal by Subject|8|||
13264941|NCT01451541|26408231|FG002|Overall Study|Withdrawal by Subject|6|||
13117707|NCT03053050|25926634|FG002|Randomized Phase|Adverse Event|0|||
13117708|NCT03053050|25926635|FG003|Randomized Phase|Adverse Event|0|||
13117709|NCT03053050|25926632|FG000|Randomized Phase|Randomized but Never Treated|2|||
13117710|NCT03053050|25926633|FG001|Randomized Phase|Randomized but Never Treated|2|||
13117711|NCT03053050|25926634|FG002|Randomized Phase|Randomized but Never Treated|2|||
13264942|NCT01451541|26408229|FG000|Overall Study|randomization error, noncompliance|11|||
13264943|NCT01451541|26408230|FG001|Overall Study|randomization error, noncompliance|10|||
13264944|NCT01451541|26408231|FG002|Overall Study|randomization error, noncompliance|8|||
13264945|NCT01451515|26408261|FG000|Overall Study|Death|0|||
13264946|NCT01451515|26408262|FG001|Overall Study|Death|1|||
13264947|NCT01451515|26408263|FG002|Overall Study|Death|0|||
13264948|NCT01451515|26408261|FG000|Overall Study|Withdrawal by Subject|0|||
13264949|NCT01451515|26408262|FG001|Overall Study|Withdrawal by Subject|1|||
13264950|NCT01451515|26408263|FG002|Overall Study|Withdrawal by Subject|0|||
13264951|NCT01451515|26408261|FG000|Overall Study|Development of unacceptable toxicity during treatment|0|||
13264952|NCT01451515|26408262|FG001|Overall Study|Development of unacceptable toxicity during treatment|0|||
13264953|NCT01451515|26408263|FG002|Overall Study|Development of unacceptable toxicity during treatment|1|||
13264954|NCT01451515|26408261|FG000|Overall Study|Relapse (except CNS)|1|||
13264955|NCT01451515|26408262|FG001|Overall Study|Relapse (except CNS)|1|||
13264956|NCT01451515|26408263|FG002|Overall Study|Relapse (except CNS)|0|||
13264957|NCT01451437|26408419|FG000|Overall Study|Adverse Event|0|||
13264958|NCT01451437|26408420|FG001|Overall Study|Adverse Event|0|||
13264959|NCT01451437|26408421|FG002|Overall Study|Adverse Event|0|||
13264960|NCT01451437|26408422|FG003|Overall Study|Adverse Event|0|||
13264961|NCT01451437|26408423|FG004|Overall Study|Adverse Event|0|||
13264962|NCT01451437|26408424|FG005|Overall Study|Adverse Event|1|||
13264963|NCT01451437|26408425|FG006|Overall Study|Adverse Event|1|||
13264964|NCT01451437|26408426|FG007|Overall Study|Adverse Event|2|||
13264965|NCT01451437|26408427|FG008|Overall Study|Adverse Event|1|||
13264966|NCT01451437|26408419|FG000|Overall Study|Physician Decision|1|||
13264967|NCT01451437|26408420|FG001|Overall Study|Physician Decision|1|||
13264968|NCT01451437|26408421|FG002|Overall Study|Physician Decision|2|||
13264969|NCT01451437|26408422|FG003|Overall Study|Physician Decision|0|||
13264970|NCT01451437|26408423|FG004|Overall Study|Physician Decision|0|||
13264971|NCT01451437|26408424|FG005|Overall Study|Physician Decision|0|||
13264972|NCT01451437|26408425|FG006|Overall Study|Physician Decision|0|||
13264973|NCT01451437|26408426|FG007|Overall Study|Physician Decision|0|||
13264974|NCT01451437|26408427|FG008|Overall Study|Physician Decision|0|||
13264975|NCT01451437|26408419|FG000|Overall Study|Disease Progression|0|||
13264976|NCT01451437|26408420|FG001|Overall Study|Disease Progression|0|||
13264977|NCT01451437|26408421|FG002|Overall Study|Disease Progression|1|||
13264978|NCT01451437|26408422|FG003|Overall Study|Disease Progression|1|||
13264979|NCT01451437|26408423|FG004|Overall Study|Disease Progression|3|||
13264980|NCT01451437|26408424|FG005|Overall Study|Disease Progression|2|||
13264981|NCT01451437|26408425|FG006|Overall Study|Disease Progression|3|||
13264982|NCT01451437|26408426|FG007|Overall Study|Disease Progression|1|||
13264983|NCT01451437|26408427|FG008|Overall Study|Disease Progression|3|||
13264984|NCT01451437|26408419|FG000|Overall Study|Protocol Violation|0|||
13264985|NCT01451437|26408420|FG001|Overall Study|Protocol Violation|0|||
13264986|NCT01451437|26408421|FG002|Overall Study|Protocol Violation|0|||
13117712|NCT03053050|25926635|FG003|Randomized Phase|Randomized but Never Treated|0|||
13264987|NCT01451437|26408422|FG003|Overall Study|Protocol Violation|0|||
13264988|NCT01451437|26408423|FG004|Overall Study|Protocol Violation|0|||
13264989|NCT01451437|26408424|FG005|Overall Study|Protocol Violation|0|||
13264990|NCT01451437|26408425|FG006|Overall Study|Protocol Violation|1|||
13264991|NCT01451437|26408426|FG007|Overall Study|Protocol Violation|0|||
13264992|NCT01451437|26408427|FG008|Overall Study|Protocol Violation|0|||
13264993|NCT01451437|26408419|FG000|Overall Study|Withdrawal by Subject|0|||
13264994|NCT01451437|26408420|FG001|Overall Study|Withdrawal by Subject|0|||
13264995|NCT01451437|26408421|FG002|Overall Study|Withdrawal by Subject|0|||
13264996|NCT01451437|26408422|FG003|Overall Study|Withdrawal by Subject|0|||
13264997|NCT01451437|26408423|FG004|Overall Study|Withdrawal by Subject|1|||
13264998|NCT01451437|26408424|FG005|Overall Study|Withdrawal by Subject|0|||
13264999|NCT01451437|26408425|FG006|Overall Study|Withdrawal by Subject|1|||
13265000|NCT01451437|26408426|FG007|Overall Study|Withdrawal by Subject|0|||
13265001|NCT01451437|26408427|FG008|Overall Study|Withdrawal by Subject|0|||
13265002|NCT01451424|26408471|FG000|Overall Study|Withdrawal by Subject|1|||
13265003|NCT01451424|26408472|FG001|Overall Study|Withdrawal by Subject|1|||
13265004|NCT01451424|26408473|FG002|Overall Study|Withdrawal by Subject|0|||
13265005|NCT01451424|26408474|FG003|Overall Study|Withdrawal by Subject|2|||
13265006|NCT01451424|26408471|FG000|Overall Study|Lost to Follow-up|0|||
13265007|NCT01451424|26408472|FG001|Overall Study|Lost to Follow-up|1|||
13265008|NCT01451424|26408473|FG002|Overall Study|Lost to Follow-up|0|||
13265009|NCT01451424|26408474|FG003|Overall Study|Lost to Follow-up|1|||
13265010|NCT01451424|26408471|FG000|Overall Study|Physician Decision|0|||
13265011|NCT01451424|26408472|FG001|Overall Study|Physician Decision|0|||
13265012|NCT01451424|26408473|FG002|Overall Study|Physician Decision|1|||
13265013|NCT01451424|26408474|FG003|Overall Study|Physician Decision|1|||
13265014|NCT01451424|26408471|FG000|Overall Study|Adverse Event|0|||
13265015|NCT01451424|26408472|FG001|Overall Study|Adverse Event|0|||
13265016|NCT01451424|26408473|FG002|Overall Study|Adverse Event|0|||
13265017|NCT01451424|26408474|FG003|Overall Study|Adverse Event|1|||
13265018|NCT01451398|26408513|FG000|Overall Study|Adverse Event|7|||
13265019|NCT01451398|26408514|FG001|Overall Study|Adverse Event|9|||
13265020|NCT01451398|26408513|FG000|Overall Study|Protocol Violation|1|||
13265021|NCT01451398|26408514|FG001|Overall Study|Protocol Violation|2|||
13265022|NCT01451398|26408513|FG000|Overall Study|Physician Decision|1|||
13265023|NCT01451398|26408514|FG001|Overall Study|Physician Decision|1|||
13265024|NCT01451398|26408513|FG000|Overall Study|Withdrawal by Subject|10|||
13265025|NCT01451398|26408514|FG001|Overall Study|Withdrawal by Subject|14|||
13265026|NCT01451398|26408513|FG000|Overall Study|Lost to Follow-up|6|||
13265027|NCT01451398|26408514|FG001|Overall Study|Lost to Follow-up|4|||
13265028|NCT01451398|26408513|FG000|Overall Study|Non-compliance with study drug|1|||
13265029|NCT01451398|26408514|FG001|Overall Study|Non-compliance with study drug|3|||
13265030|NCT01451398|26408513|FG000|Overall Study|Non-compliance with protocol|1|||
13265031|NCT01451398|26408514|FG001|Overall Study|Non-compliance with protocol|1|||
13265032|NCT01451398|26408513|FG000|Overall Study|Moved out of country|0|||
13265033|NCT01451398|26408514|FG001|Overall Study|Moved out of country|1|||
13265034|NCT01451398|26408513|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0|||
13265035|NCT01451398|26408514|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1|||
13265036|NCT01451398|26408513|FG000|Overall Study|Lack of Efficacy|0|||
13265037|NCT01451398|26408514|FG001|Overall Study|Lack of Efficacy|1|||
13265038|NCT01451203|26408535|FG000|Double-blind Treatment Period|Did not receive treatment|1|||
13265039|NCT01451203|26408536|FG001|Double-blind Treatment Period|Did not receive treatment|2|||
13265040|NCT01451203|26408535|FG000|Double-blind Treatment Period|Consent Withdrawn|3|||
13265041|NCT01451203|26408536|FG001|Double-blind Treatment Period|Consent Withdrawn|2|||
13265042|NCT01451203|26408535|FG000|Double-blind Treatment Period|Lack of Efficacy|71|||
13265043|NCT01451203|26408536|FG001|Double-blind Treatment Period|Lack of Efficacy|36|||
13265044|NCT01451203|26408535|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0|||
13265045|NCT01451203|26408536|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1|||
13265046|NCT01451203|26408535|FG000|Double-blind Treatment Period|Adverse Event|6|||
13265047|NCT01451203|26408536|FG001|Double-blind Treatment Period|Adverse Event|9|||
13265048|NCT01451203|26408535|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1|||
13265049|NCT01451203|26408536|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0|||
13265050|NCT01451203|26408535|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1|||
13265051|NCT01451203|26408536|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0|||
13265052|NCT01451203|26408535|FG000|Double-blind Treatment Period|Investigator decision|2|||
13265053|NCT01451203|26408536|FG001|Double-blind Treatment Period|Investigator decision|0|||
13265054|NCT01451203|26408535|FG000|Post-treatment Period|Consent withdrawn|2|||
13265055|NCT01451203|26408536|FG001|Post-treatment Period|Consent withdrawn|4|||
13265056|NCT01451203|26408535|FG000|Post-treatment Period|Lack of Efficacy|12|||
13265057|NCT01451203|26408536|FG001|Post-treatment Period|Lack of Efficacy|28|||
13265058|NCT01451203|26408535|FG000|Post-treatment Period|Adverse Event|0|||
13265059|NCT01451203|26408536|FG001|Post-treatment Period|Adverse Event|1|||
13265060|NCT01451203|26408535|FG000|Post-treatment Period|Investigator decision|0|||
13265061|NCT01451203|26408536|FG001|Post-treatment Period|Investigator decision|1|||
13265062|NCT01451164|26408575|FG000|Overall Study|Adverse Event|19|||
13265063|NCT01451164|26408576|FG001|Overall Study|Adverse Event|12|||
13265064|NCT01451164|26408577|FG002|Overall Study|Adverse Event|18|||
13265065|NCT01451164|26408578|FG003|Overall Study|Adverse Event|21|||
13265066|NCT01451164|26408575|FG000|Overall Study|Withdrawal Criteria|1|||
13265067|NCT01451164|26408576|FG001|Overall Study|Withdrawal Criteria|1|||
13265068|NCT01451164|26408577|FG002|Overall Study|Withdrawal Criteria|1|||
13265069|NCT01451164|26408578|FG003|Overall Study|Withdrawal Criteria|1|||
13265070|NCT01451164|26408575|FG000|Overall Study|Physician Decision|2|||
13265071|NCT01451164|26408576|FG001|Overall Study|Physician Decision|0|||
13265072|NCT01451164|26408577|FG002|Overall Study|Physician Decision|1|||
13265073|NCT01451164|26408578|FG003|Overall Study|Physician Decision|0|||
13265074|NCT01451164|26408575|FG000|Overall Study|Withdrawal by Subject|14|||
13265075|NCT01451164|26408576|FG001|Overall Study|Withdrawal by Subject|11|||
13265076|NCT01451164|26408577|FG002|Overall Study|Withdrawal by Subject|16|||
13265077|NCT01451164|26408578|FG003|Overall Study|Withdrawal by Subject|17|||
13265078|NCT01451164|26408575|FG000|Overall Study|Protocol Violation|0|||
13265079|NCT01451164|26408576|FG001|Overall Study|Protocol Violation|1|||
13265080|NCT01451164|26408577|FG002|Overall Study|Protocol Violation|0|||
13265081|NCT01451164|26408578|FG003|Overall Study|Protocol Violation|0|||
13265082|NCT01451164|26408575|FG000|Overall Study|Lack of Efficacy|7|||
13265083|NCT01451164|26408576|FG001|Overall Study|Lack of Efficacy|9|||
13265084|NCT01451164|26408577|FG002|Overall Study|Lack of Efficacy|9|||
13265085|NCT01451164|26408578|FG003|Overall Study|Lack of Efficacy|7|||
13265086|NCT01450943|26408602|FG000|Overall Study|Screen failure, loss to follow-up|2|||
13265087|NCT01450943|26408603|FG001|Overall Study|Screen failure, loss to follow-up|7|||
13265088|NCT01450943|26408604|FG002|Overall Study|Screen failure, loss to follow-up|6|||
13265089|NCT01450813|26408629|FG000|Overall Study|Physician Decision|1|||
13265090|NCT01450813|26408630|FG001|Overall Study|Physician Decision|1|||
13265091|NCT01450813|26408631|FG002|Overall Study|Physician Decision|0|||
13265092|NCT01450813|26408632|FG003|Overall Study|Physician Decision|3|||
13265093|NCT01450800|26408653|FG000|Overall Study|Protocol Violation|1|||
13265094|NCT01450800|26408654|FG001|Overall Study|Protocol Violation|3|||
13265095|NCT01450761|26408671|FG000|Randomization|Subject no longer meets study criteria|1|||
13265096|NCT01450761|26408672|FG001|Randomization|Subject no longer meets study criteria|2|||
13265097|NCT01450761|26408671|FG000|Randomization|Withdrawal by Subject|2|||
13265098|NCT01450761|26408672|FG001|Randomization|Withdrawal by Subject|0|||
13265099|NCT01450761|26408671|FG000|Randomization|Disease progression|0|||
13265100|NCT01450761|26408672|FG001|Randomization|Disease progression|2|||
13265101|NCT01450761|26408671|FG000|Randomization|Adverse Event unrelated to study drug|1|||
13265102|NCT01450761|26408672|FG001|Randomization|Adverse Event unrelated to study drug|0|||
13265103|NCT01450761|26408671|FG000|Randomization|Other|0|||
13265104|NCT01450761|26408672|FG001|Randomization|Other|1|||
13265105|NCT01450761|26408671|FG000|Lead-in Chemotherapy|Disease progression|33|||
13265106|NCT01450761|26408672|FG001|Lead-in Chemotherapy|Disease progression|32|||
13265107|NCT01450761|26408671|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21|||
13265108|NCT01450761|26408672|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19|||
13265109|NCT01450761|26408671|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14|||
13265110|NCT01450761|26408672|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12|||
13265111|NCT01450761|26408671|FG000|Lead-in Chemotherapy|Study drug toxicity|6|||
13265112|NCT01450761|26408672|FG001|Lead-in Chemotherapy|Study drug toxicity|10|||
13265113|NCT01450761|26408671|FG000|Lead-in Chemotherapy|No longer meets study criteria|3|||
13265114|NCT01450761|26408672|FG001|Lead-in Chemotherapy|No longer meets study criteria|7|||
13265115|NCT01450761|26408671|FG000|Lead-in Chemotherapy|Death|3|||
13265116|NCT01450761|26408672|FG001|Lead-in Chemotherapy|Death|3|||
13265117|NCT01450761|26408671|FG000|Lead-in Chemotherapy|Other|2|||
13265118|NCT01450761|26408672|FG001|Lead-in Chemotherapy|Other|2|||
13265119|NCT01450761|26408671|FG000|Lead-in Chemotherapy|Lost to Follow-up|2|||
13265120|NCT01450761|26408672|FG001|Lead-in Chemotherapy|Lost to Follow-up|0|||
13265121|NCT01450761|26408671|FG000|Treatment With Blinded Study Therapy|Disease progression|318|||
13265122|NCT01450761|26408672|FG001|Treatment With Blinded Study Therapy|Disease progression|415|||
13265123|NCT01450761|26408671|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87|||
13265124|NCT01450761|26408672|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9|||
13265125|NCT01450761|26408671|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27|||
13265126|NCT01450761|26408672|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19|||
13117713|NCT03053050|25926632|FG000|Randomized Phase|Entered the Open-Label Phase|36|||
13117714|NCT03053050|25926633|FG001|Randomized Phase|Entered the Open-Label Phase|45|||
13117715|NCT03053050|25926634|FG002|Randomized Phase|Entered the Open-Label Phase|18|||
13265127|NCT01450761|26408671|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15|||
13265128|NCT01450761|26408672|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8|||
13265129|NCT01450761|26408671|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12|||
13265130|NCT01450761|26408672|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5|||
13265131|NCT01450761|26408671|FG000|Treatment With Blinded Study Therapy|Death|5|||
13265132|NCT01450761|26408672|FG001|Treatment With Blinded Study Therapy|Death|6|||
13265133|NCT01450761|26408671|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5|||
13265134|NCT01450761|26408672|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4|||
13265135|NCT01450761|26408671|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2|||
13265136|NCT01450761|26408672|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1|||
13265137|NCT01450761|26408671|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1|||
13265138|NCT01450761|26408672|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2|||
13265139|NCT01450761|26408671|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1|||
13265140|NCT01450761|26408672|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2|||
13265141|NCT01450761|26408671|FG000|Treatment With Blinded Study Therapy|Not reported|2|||
13265142|NCT01450761|26408672|FG001|Treatment With Blinded Study Therapy|Not reported|2|||
13265143|NCT01450761|26408671|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1|||
13265144|NCT01450761|26408672|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0|||
13265145|NCT01450761|26408671|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2|||
13265146|NCT01450761|26408672|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3|||
13265147|NCT01450696|26408701|FG000|Overall Study|Never Treated|1|||
13265148|NCT01450696|26408702|FG001|Overall Study|Never Treated|1|||
13265149|NCT01450696|26408701|FG000|Overall Study|Death|77|||
13265150|NCT01450696|26408702|FG001|Overall Study|Death|84|||
13265151|NCT01450696|26408701|FG000|Overall Study|Lost to Follow-up|3|||
13265152|NCT01450696|26408702|FG001|Overall Study|Lost to Follow-up|3|||
13265153|NCT01450696|26408701|FG000|Overall Study|Non-Compliance|1|||
13265154|NCT01450696|26408702|FG001|Overall Study|Non-Compliance|0|||
13265155|NCT01450696|26408701|FG000|Overall Study|Withdrawal by Subject|13|||
13265156|NCT01450696|26408702|FG001|Overall Study|Withdrawal by Subject|2|||
13265157|NCT01450696|26408701|FG000|Overall Study|Study Terminated by Sponsor|53|||
13265158|NCT01450696|26408702|FG001|Overall Study|Study Terminated by Sponsor|58|||
13265159|NCT01450683|26408708|FG000|Overall Study|Adverse Event|2|||
13265160|NCT01450631|26408723|FG000|Overall Study|Lost to Follow-up|2|||
13265161|NCT01450631|26408724|FG001|Overall Study|Lost to Follow-up|4|||
13265162|NCT01450631|26408723|FG000|Overall Study|Withdrawal by Subject|1|||
13265163|NCT01450631|26408724|FG001|Overall Study|Withdrawal by Subject|0|||
13265164|NCT01450540|26408741|FG000|Overall Study|Withdrawal by Subject|19|||
13265165|NCT01450540|26408742|FG001|Overall Study|Withdrawal by Subject|13|||
13265166|NCT01450540|26408741|FG000|Overall Study|protocol deviation|3|||
13265167|NCT01450540|26408742|FG001|Overall Study|protocol deviation|23|||
13265168|NCT01450137|26408761|FG000|Up to Week 12|Adverse Event|2|||
13265169|NCT01450137|26408762|FG001|Up to Week 12|Adverse Event|1|||
13265170|NCT01450137|26408761|FG000|Up to Week 12|Withdrawal by Subject|0|||
13265171|NCT01450137|26408762|FG001|Up to Week 12|Withdrawal by Subject|2|||
13265172|NCT01450137|26408761|FG000|Week 12 to Study End|Death|0|||
13265173|NCT01450137|26408762|FG001|Week 12 to Study End|Death|1|||
13265174|NCT01450137|26408761|FG000|Week 12 to Study End|Withdrawal by Subject|0|||
13265175|NCT01450137|26408762|FG001|Week 12 to Study End|Withdrawal by Subject|1|||
13265176|NCT01450098|26408785|FG000|Period 3|Protocol Violation|0|||
13265177|NCT01450098|26408786|FG001|Period 3|Protocol Violation|1|||
13265178|NCT01450098|26408785|FG000|Period 3|Withdrawal by Subject|0|||
13265179|NCT01450098|26408786|FG001|Period 3|Withdrawal by Subject|2|||
13265180|NCT01450007|26408813|FG000|Overall Study|Late exclusion before treatment|2|||
13265181|NCT01450007|26408814|FG001|Overall Study|Late exclusion before treatment|3|||
13265182|NCT01450007|26408815|FG002|Overall Study|Late exclusion before treatment|2|||
13265183|NCT01450007|26408813|FG000|Overall Study|Protocol Violation|0|||
13265184|NCT01450007|26408814|FG001|Overall Study|Protocol Violation|1|||
13265185|NCT01450007|26408815|FG002|Overall Study|Protocol Violation|1|||
13265186|NCT01450007|26408813|FG000|Overall Study|Adverse Event|0|||
13265187|NCT01450007|26408814|FG001|Overall Study|Adverse Event|1|||
13265188|NCT01450007|26408815|FG002|Overall Study|Adverse Event|0|||
13265189|NCT01449955|26408848|FG000|Overall Study|Withdrawal by Subject|1|||
13265190|NCT01449955|26408849|FG001|Overall Study|Withdrawal by Subject|2|||
13265191|NCT01449929|26408894|FG000|Randomization Phase 96 Week|Adverse Event|5|||
13265192|NCT01449929|26408895|FG001|Randomization Phase 96 Week|Adverse Event|13|||
13265193|NCT01449929|26408896|FG002|Randomization Phase 96 Week|Adverse Event|0|||
13265194|NCT01449929|26408894|FG000|Randomization Phase 96 Week|Lack of Efficacy|3|||
13265195|NCT01449929|26408895|FG001|Randomization Phase 96 Week|Lack of Efficacy|4|||
13265196|NCT01449929|26408896|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
13265197|NCT01449929|26408894|FG000|Randomization Phase 96 Week|Protocol Violation|5|||
13265198|NCT01449929|26408895|FG001|Randomization Phase 96 Week|Protocol Violation|6|||
13265199|NCT01449929|26408896|FG002|Randomization Phase 96 Week|Protocol Violation|0|||
13265200|NCT01449929|26408894|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1|||
13265201|NCT01449929|26408895|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
13265202|NCT01449929|26408896|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
13265203|NCT01449929|26408894|FG000|Randomization Phase 96 Week|Lost to Follow-up|15|||
13265204|NCT01449929|26408895|FG001|Randomization Phase 96 Week|Lost to Follow-up|18|||
13265205|NCT01449929|26408896|FG002|Randomization Phase 96 Week|Lost to Follow-up|0|||
13265206|NCT01449929|26408894|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
13265207|NCT01449929|26408895|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8|||
13265208|NCT01449929|26408896|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0|||
13265209|NCT01449929|26408894|FG000|Randomization Phase 96 Week|Physician Decision|2|||
13265210|NCT01449929|26408895|FG001|Randomization Phase 96 Week|Physician Decision|3|||
13265211|NCT01449929|26408896|FG002|Randomization Phase 96 Week|Physician Decision|0|||
13265212|NCT01449929|26408894|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0|||
13265213|NCT01449929|26408895|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1|||
13265214|NCT01449929|26408896|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0|||
13265215|NCT01449929|26408894|FG000|Extension Phase Approximately 3 Years|Adverse Event|0|||
13265216|NCT01449929|26408895|FG001|Extension Phase Approximately 3 Years|Adverse Event|0|||
13265217|NCT01449929|26408896|FG002|Extension Phase Approximately 3 Years|Adverse Event|2|||
13265218|NCT01449929|26408894|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
13265219|NCT01449929|26408895|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
13265220|NCT01449929|26408896|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2|||
13265221|NCT01449929|26408894|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
13265222|NCT01449929|26408895|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
13265223|NCT01449929|26408896|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4|||
13265224|NCT01449812|26408998|FG000|Overall Study|Migrated/moved from study area|1|||
13265225|NCT01449812|26408999|FG001|Overall Study|Migrated/moved from study area|0|||
13265226|NCT01449812|26409000|FG002|Overall Study|Migrated/moved from study area|0|||
13265227|NCT01449812|26408998|FG000|Overall Study|Withdrawal by Subject|0|||
13265228|NCT01449812|26408999|FG001|Overall Study|Withdrawal by Subject|0|||
13265229|NCT01449812|26409000|FG002|Overall Study|Withdrawal by Subject|1|||
13265230|NCT01449812|26408998|FG000|Overall Study|Lost to Follow-up|1|||
13265231|NCT01449812|26408999|FG001|Overall Study|Lost to Follow-up|0|||
13265232|NCT01449812|26409000|FG002|Overall Study|Lost to Follow-up|0|||
13265233|NCT01449721|26409017|FG000|Overall Study|Physician Decision|0|||
13265234|NCT01449721|26409018|FG001|Overall Study|Physician Decision|1|||
13265235|NCT01449721|26409017|FG000|Overall Study|Physician Decision|0|||
13265236|NCT01449721|26409018|FG001|Overall Study|Physician Decision|1|||
13265237|NCT01449708|26409034|FG000|Overall Study|Protocol Violation|0|||
13265238|NCT01449708|26409035|FG001|Overall Study|Protocol Violation|1|||
13117716|NCT03053050|25926635|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
13117717|NCT03053050|25926632|FG000|Open-label Phase|Study Terminated by Sponsor|0|||
13117718|NCT03053050|25926633|FG001|Open-label Phase|Study Terminated by Sponsor|0|||
13265239|NCT01449708|26409034|FG000|Overall Study|surgical complication|1|||
13265240|NCT01449708|26409035|FG001|Overall Study|surgical complication|2|||
13265241|NCT01449708|26409034|FG000|Overall Study|respiratory failure|1|||
13265242|NCT01449708|26409035|FG001|Overall Study|respiratory failure|0|||
13265243|NCT01449682|26409054|FG000|Overall Study|Death|0|||
13265244|NCT01449682|26409055|FG001|Overall Study|Death|1|||
13265245|NCT01449682|26409054|FG000|Overall Study|Adverse Event|1|||
13486345|NCT01147822|27035855|FG001|Overall Study|Protocol Violation|1|||
13486346|NCT01147822|27035854|FG000|Overall Study|Lost to Follow-up|3|||
13486347|NCT01147822|27035855|FG001|Overall Study|Lost to Follow-up|2|||
13486348|NCT01147822|27035854|FG000|Overall Study|Physician Decision|0|||
13486349|NCT01147822|27035855|FG001|Overall Study|Physician Decision|2|||
13486350|NCT01147822|27035854|FG000|Overall Study|Withdrawal by Subject|8|||
13486351|NCT01147822|27035855|FG001|Overall Study|Withdrawal by Subject|13|||
13486352|NCT01147822|27035854|FG000|Overall Study|Not Completed/Ongoing|111|||
13486353|NCT01147822|27035855|FG001|Overall Study|Not Completed/Ongoing|102|||
13488109|NCT04038385|27042320|FG001|Overall Study|Discontinued study involvement|1|||
13488110|NCT03923738|27042342|FG000|Period 1|Adverse Event|1|||
13488111|NCT03923738|27042342|FG000|Period 1|Withdrawal by Subject|1|||
13488112|NCT03887117|27042556|FG000|Overall Study|Discontinued prematurely|0|||
13488113|NCT03887117|27042557|FG001|Overall Study|Discontinued prematurely|1|||
13488114|NCT03887117|27042558|FG002|Overall Study|Discontinued prematurely|1|||
13488115|NCT03887117|27042559|FG003|Overall Study|Discontinued prematurely|2|||
13488116|NCT03858634|27042764|FG000|Overall Study|Withdrawal by Subject|1|||
13488117|NCT03858634|27042765|FG001|Overall Study|Withdrawal by Subject|0|||
13488118|NCT03858634|27042764|FG000|Overall Study|Adverse Event|1|||
13488119|NCT03858634|27042765|FG001|Overall Study|Adverse Event|0|||
13117719|NCT03053050|25926634|FG002|Open-label Phase|Study Terminated by Sponsor|0|||
13265246|NCT01449682|26409055|FG001|Overall Study|Adverse Event|0|||
13265247|NCT01449630|26409153|FG000|Period 1|Physician Decision|1|||
13265248|NCT01449630|26409154|FG001|Period 1|Physician Decision|0|||
13265249|NCT01449630|26409155|FG002|Period 1|Physician Decision|0|||
13265250|NCT01449630|26409156|FG003|Period 1|Physician Decision|1|||
13265251|NCT01449630|26409157|FG004|Period 1|Physician Decision|0|||
13265252|NCT01449630|26409158|FG005|Period 1|Physician Decision|0|||
13265253|NCT01449630|26409159|FG006|Period 1|Physician Decision|0|||
13265254|NCT01449630|26409160|FG007|Period 1|Physician Decision|0|||
13488120|NCT03858634|27042764|FG000|Overall Study|Lost to Follow-up|0|||
13265255|NCT01449630|26409161|FG008|Period 1|Physician Decision|0|||
13265256|NCT01449630|26409153|FG000|Period 1|Sponsor Decision|0|||
13265257|NCT01449630|26409154|FG001|Period 1|Sponsor Decision|0|||
13265258|NCT01449630|26409155|FG002|Period 1|Sponsor Decision|0|||
13265259|NCT01449630|26409156|FG003|Period 1|Sponsor Decision|0|||
13265260|NCT01449630|26409157|FG004|Period 1|Sponsor Decision|0|||
13265261|NCT01449630|26409158|FG005|Period 1|Sponsor Decision|1|||
13265262|NCT01449630|26409159|FG006|Period 1|Sponsor Decision|0|||
13265263|NCT01449630|26409160|FG007|Period 1|Sponsor Decision|0|||
13265264|NCT01449630|26409161|FG008|Period 1|Sponsor Decision|0|||
13265265|NCT01449630|26409153|FG000|Period 2|Sponsor Decision|0|||
13265266|NCT01449630|26409154|FG001|Period 2|Sponsor Decision|0|||
13265267|NCT01449630|26409155|FG002|Period 2|Sponsor Decision|0|||
13265268|NCT01449630|26409156|FG003|Period 2|Sponsor Decision|0|||
13265269|NCT01449630|26409157|FG004|Period 2|Sponsor Decision|0|||
13265270|NCT01449630|26409158|FG005|Period 2|Sponsor Decision|0|||
13265271|NCT01449630|26409159|FG006|Period 2|Sponsor Decision|1|||
13265272|NCT01449630|26409160|FG007|Period 2|Sponsor Decision|0|||
13265273|NCT01449630|26409161|FG008|Period 2|Sponsor Decision|0|||
13265274|NCT01449539|26409167|FG000|Overall Study|Withdrawal by Subject|3|||
13265275|NCT01449539|26409167|FG000|Overall Study|Toxicity not study related|1|||
13265276|NCT01449526|26409182|FG000|Overall Study|Lost to Follow-up|1|||
13265277|NCT01449526|26409183|FG001|Overall Study|Lost to Follow-up|2|||
13265278|NCT01449526|26409182|FG000|Overall Study|Withdrawal by Subject|1|||
13265279|NCT01449526|26409183|FG001|Overall Study|Withdrawal by Subject|1|||
13265280|NCT01449526|26409182|FG000|Overall Study|Symptoms/complaints|0|||
13265281|NCT01449526|26409183|FG001|Overall Study|Symptoms/complaints|1|||
13265282|NCT01449526|26409182|FG000|Overall Study|Lack of Motivation|0|||
13265283|NCT01449526|26409183|FG001|Overall Study|Lack of Motivation|1|||
13265284|NCT01449526|26409182|FG000|Overall Study|Cannot maintain visits|0|||
13265285|NCT01449526|26409183|FG001|Overall Study|Cannot maintain visits|1|||
13265286|NCT01449461|26409322|FG000|Overall Study|Adverse Event|0|||
13265287|NCT01449461|26409323|FG001|Overall Study|Adverse Event|3|||
13265288|NCT01449461|26409324|FG002|Overall Study|Adverse Event|2|||
13265289|NCT01449461|26409325|FG003|Overall Study|Adverse Event|3|||
13265290|NCT01449461|26409326|FG004|Overall Study|Adverse Event|4|||
13265291|NCT01449461|26409327|FG005|Overall Study|Adverse Event|4|||
13265292|NCT01449461|26409322|FG000|Overall Study|Death|0|||
13265293|NCT01449461|26409323|FG001|Overall Study|Death|2|||
13265294|NCT01449461|26409324|FG002|Overall Study|Death|0|||
13265295|NCT01449461|26409325|FG003|Overall Study|Death|0|||
13265296|NCT01449461|26409326|FG004|Overall Study|Death|7|||
13265297|NCT01449461|26409327|FG005|Overall Study|Death|1|||
13265298|NCT01449461|26409322|FG000|Overall Study|Physician Decision|0|||
13265299|NCT01449461|26409323|FG001|Overall Study|Physician Decision|1|||
13265300|NCT01449461|26409324|FG002|Overall Study|Physician Decision|0|||
13265301|NCT01449461|26409325|FG003|Overall Study|Physician Decision|4|||
13265302|NCT01449461|26409326|FG004|Overall Study|Physician Decision|1|||
13265303|NCT01449461|26409327|FG005|Overall Study|Physician Decision|0|||
13265304|NCT01449461|26409322|FG000|Overall Study|Documented Progressive Disease|4|||
13265305|NCT01449461|26409323|FG001|Overall Study|Documented Progressive Disease|7|||
13265306|NCT01449461|26409324|FG002|Overall Study|Documented Progressive Disease|14|||
13265307|NCT01449461|26409325|FG003|Overall Study|Documented Progressive Disease|15|||
13265308|NCT01449461|26409326|FG004|Overall Study|Documented Progressive Disease|24|||
13265309|NCT01449461|26409327|FG005|Overall Study|Documented Progressive Disease|5|||
13265310|NCT01449461|26409322|FG000|Overall Study|Clinical Progressive Disease|2|||
13265311|NCT01449461|26409323|FG001|Overall Study|Clinical Progressive Disease|2|||
13265312|NCT01449461|26409324|FG002|Overall Study|Clinical Progressive Disease|0|||
13265313|NCT01449461|26409325|FG003|Overall Study|Clinical Progressive Disease|3|||
13265314|NCT01449461|26409326|FG004|Overall Study|Clinical Progressive Disease|4|||
13265315|NCT01449461|26409327|FG005|Overall Study|Clinical Progressive Disease|2|||
13265316|NCT01449461|26409322|FG000|Overall Study|Protocol Violation|0|||
13265317|NCT01449461|26409323|FG001|Overall Study|Protocol Violation|0|||
13265318|NCT01449461|26409324|FG002|Overall Study|Protocol Violation|0|||
13265319|NCT01449461|26409325|FG003|Overall Study|Protocol Violation|1|||
13265320|NCT01449461|26409326|FG004|Overall Study|Protocol Violation|0|||
13265321|NCT01449461|26409327|FG005|Overall Study|Protocol Violation|0|||
13265322|NCT01449461|26409322|FG000|Overall Study|Site Terminated by Sponsor|0|||
13265323|NCT01449461|26409323|FG001|Overall Study|Site Terminated by Sponsor|1|||
13265324|NCT01449461|26409324|FG002|Overall Study|Site Terminated by Sponsor|2|||
13265325|NCT01449461|26409325|FG003|Overall Study|Site Terminated by Sponsor|3|||
13265326|NCT01449461|26409326|FG004|Overall Study|Site Terminated by Sponsor|4|||
13265327|NCT01449461|26409327|FG005|Overall Study|Site Terminated by Sponsor|1|||
13265328|NCT01449461|26409322|FG000|Overall Study|Withdrawal by Subject|0|||
13265329|NCT01449461|26409323|FG001|Overall Study|Withdrawal by Subject|1|||
13265330|NCT01449461|26409324|FG002|Overall Study|Withdrawal by Subject|0|||
13265331|NCT01449461|26409325|FG003|Overall Study|Withdrawal by Subject|0|||
13265332|NCT01449461|26409326|FG004|Overall Study|Withdrawal by Subject|2|||
13265333|NCT01449461|26409327|FG005|Overall Study|Withdrawal by Subject|1|||
13265334|NCT01449461|26409322|FG000|Overall Study|Reason not Specified|0|||
13265335|NCT01449461|26409323|FG001|Overall Study|Reason not Specified|1|||
13265336|NCT01449461|26409324|FG002|Overall Study|Reason not Specified|0|||
13265337|NCT01449461|26409325|FG003|Overall Study|Reason not Specified|3|||
13265338|NCT01449461|26409326|FG004|Overall Study|Reason not Specified|2|||
13265339|NCT01449461|26409327|FG005|Overall Study|Reason not Specified|1|||
13265340|NCT01449370|26409776|FG000|Overall Study|Disease Progression|5|||
13265341|NCT01449370|26409777|FG001|Overall Study|Disease Progression|4|||
13265342|NCT01449370|26409778|FG002|Overall Study|Disease Progression|8|||
13265343|NCT01449370|26409779|FG003|Overall Study|Disease Progression|3|||
13265344|NCT01449370|26409780|FG004|Overall Study|Disease Progression|3|||
13265345|NCT01449370|26409781|FG005|Overall Study|Disease Progression|3|||
13265346|NCT01449370|26409782|FG006|Overall Study|Disease Progression|3|||
13265347|NCT01449370|26409783|FG007|Overall Study|Disease Progression|2|||
13265348|NCT01449370|26409784|FG008|Overall Study|Disease Progression|9|||
13265349|NCT01449370|26409785|FG009|Overall Study|Disease Progression|1|||
13265350|NCT01449370|26409786|FG010|Overall Study|Disease Progression|3|||
13265351|NCT01449370|26409787|FG011|Overall Study|Disease Progression|3|||
13265352|NCT01449370|26409788|FG012|Overall Study|Disease Progression|2|||
13265353|NCT01449370|26409789|FG013|Overall Study|Disease Progression|8|||
13265354|NCT01449370|26409790|FG014|Overall Study|Disease Progression|3|||
13265355|NCT01449370|26409791|FG015|Overall Study|Disease Progression|1|||
13265356|NCT01449370|26409792|FG016|Overall Study|Disease Progression|4|||
13265357|NCT01449370|26409793|FG017|Overall Study|Disease Progression|3|||
13265358|NCT01449370|26409794|FG018|Overall Study|Disease Progression|1|||
13265359|NCT01449370|26409795|FG019|Overall Study|Disease Progression|2|||
13265360|NCT01449370|26409796|FG020|Overall Study|Disease Progression|5|||
13265361|NCT01449370|26409797|FG021|Overall Study|Disease Progression|2|||
13265362|NCT01449370|26409798|FG022|Overall Study|Disease Progression|3|||
13265363|NCT01449370|26409799|FG023|Overall Study|Disease Progression|7|||
13265364|NCT01449370|26409800|FG024|Overall Study|Disease Progression|3|||
13265365|NCT01449370|26409776|FG000|Overall Study|Adverse Event|1|||
13265366|NCT01449370|26409777|FG001|Overall Study|Adverse Event|2|||
13265367|NCT01449370|26409778|FG002|Overall Study|Adverse Event|0|||
13265368|NCT01449370|26409779|FG003|Overall Study|Adverse Event|1|||
13265369|NCT01449370|26409780|FG004|Overall Study|Adverse Event|0|||
13265370|NCT01449370|26409781|FG005|Overall Study|Adverse Event|0|||
13265371|NCT01449370|26409782|FG006|Overall Study|Adverse Event|0|||
13265372|NCT01449370|26409783|FG007|Overall Study|Adverse Event|0|||
13265373|NCT01449370|26409784|FG008|Overall Study|Adverse Event|1|||
13265374|NCT01449370|26409785|FG009|Overall Study|Adverse Event|1|||
13265375|NCT01449370|26409786|FG010|Overall Study|Adverse Event|0|||
13265376|NCT01449370|26409787|FG011|Overall Study|Adverse Event|0|||
13265377|NCT01449370|26409788|FG012|Overall Study|Adverse Event|0|||
13265378|NCT01449370|26409789|FG013|Overall Study|Adverse Event|2|||
13265379|NCT01449370|26409790|FG014|Overall Study|Adverse Event|0|||
13265380|NCT01449370|26409791|FG015|Overall Study|Adverse Event|1|||
13265381|NCT01449370|26409792|FG016|Overall Study|Adverse Event|0|||
13265382|NCT01449370|26409793|FG017|Overall Study|Adverse Event|0|||
13265383|NCT01449370|26409794|FG018|Overall Study|Adverse Event|1|||
13265384|NCT01449370|26409795|FG019|Overall Study|Adverse Event|1|||
13265385|NCT01449370|26409796|FG020|Overall Study|Adverse Event|0|||
13265386|NCT01449370|26409797|FG021|Overall Study|Adverse Event|1|||
13265387|NCT01449370|26409798|FG022|Overall Study|Adverse Event|0|||
13265388|NCT01449370|26409799|FG023|Overall Study|Adverse Event|1|||
13265389|NCT01449370|26409800|FG024|Overall Study|Adverse Event|3|||
13265390|NCT01449370|26409776|FG000|Overall Study|Participant Decision|0|||
13265391|NCT01449370|26409777|FG001|Overall Study|Participant Decision|0|||
13265392|NCT01449370|26409778|FG002|Overall Study|Participant Decision|0|||
13265393|NCT01449370|26409779|FG003|Overall Study|Participant Decision|0|||
13265394|NCT01449370|26409780|FG004|Overall Study|Participant Decision|0|||
13265395|NCT01449370|26409781|FG005|Overall Study|Participant Decision|0|||
13265396|NCT01449370|26409782|FG006|Overall Study|Participant Decision|0|||
13265397|NCT01449370|26409783|FG007|Overall Study|Participant Decision|1|||
13265398|NCT01449370|26409784|FG008|Overall Study|Participant Decision|1|||
13265399|NCT01449370|26409785|FG009|Overall Study|Participant Decision|0|||
13265400|NCT01449370|26409786|FG010|Overall Study|Participant Decision|0|||
13265401|NCT01449370|26409787|FG011|Overall Study|Participant Decision|0|||
13265402|NCT01449370|26409788|FG012|Overall Study|Participant Decision|1|||
13265403|NCT01449370|26409789|FG013|Overall Study|Participant Decision|1|||
13265404|NCT01449370|26409790|FG014|Overall Study|Participant Decision|0|||
13265405|NCT01449370|26409791|FG015|Overall Study|Participant Decision|1|||
13265406|NCT01449370|26409792|FG016|Overall Study|Participant Decision|3|||
13265407|NCT01449370|26409793|FG017|Overall Study|Participant Decision|0|||
13265408|NCT01449370|26409794|FG018|Overall Study|Participant Decision|1|||
13265409|NCT01449370|26409795|FG019|Overall Study|Participant Decision|0|||
13265410|NCT01449370|26409796|FG020|Overall Study|Participant Decision|0|||
13265411|NCT01449370|26409797|FG021|Overall Study|Participant Decision|1|||
13265412|NCT01449370|26409798|FG022|Overall Study|Participant Decision|0|||
13265413|NCT01449370|26409799|FG023|Overall Study|Participant Decision|0|||
13265414|NCT01449370|26409800|FG024|Overall Study|Participant Decision|1|||
13265415|NCT01449370|26409776|FG000|Overall Study|Lost to Follow-up|0|||
13265416|NCT01449370|26409777|FG001|Overall Study|Lost to Follow-up|0|||
13265417|NCT01449370|26409778|FG002|Overall Study|Lost to Follow-up|0|||
13265418|NCT01449370|26409779|FG003|Overall Study|Lost to Follow-up|0|||
13265419|NCT01449370|26409780|FG004|Overall Study|Lost to Follow-up|0|||
13265420|NCT01449370|26409781|FG005|Overall Study|Lost to Follow-up|0|||
13265421|NCT01449370|26409782|FG006|Overall Study|Lost to Follow-up|0|||
13265422|NCT01449370|26409783|FG007|Overall Study|Lost to Follow-up|0|||
13265423|NCT01449370|26409784|FG008|Overall Study|Lost to Follow-up|0|||
13265424|NCT01449370|26409785|FG009|Overall Study|Lost to Follow-up|0|||
13265425|NCT01449370|26409786|FG010|Overall Study|Lost to Follow-up|0|||
13265426|NCT01449370|26409787|FG011|Overall Study|Lost to Follow-up|0|||
13265427|NCT01449370|26409788|FG012|Overall Study|Lost to Follow-up|0|||
13265428|NCT01449370|26409789|FG013|Overall Study|Lost to Follow-up|0|||
13265429|NCT01449370|26409790|FG014|Overall Study|Lost to Follow-up|0|||
13265430|NCT01449370|26409791|FG015|Overall Study|Lost to Follow-up|0|||
13265431|NCT01449370|26409792|FG016|Overall Study|Lost to Follow-up|0|||
13265432|NCT01449370|26409793|FG017|Overall Study|Lost to Follow-up|0|||
13265433|NCT01449370|26409794|FG018|Overall Study|Lost to Follow-up|0|||
13265434|NCT01449370|26409795|FG019|Overall Study|Lost to Follow-up|0|||
13265435|NCT01449370|26409796|FG020|Overall Study|Lost to Follow-up|1|||
13265436|NCT01449370|26409797|FG021|Overall Study|Lost to Follow-up|0|||
13265437|NCT01449370|26409798|FG022|Overall Study|Lost to Follow-up|0|||
13265438|NCT01449370|26409799|FG023|Overall Study|Lost to Follow-up|0|||
13265439|NCT01449370|26409800|FG024|Overall Study|Lost to Follow-up|0|||
13265440|NCT01449370|26409776|FG000|Overall Study|Other|0|||
13265441|NCT01449370|26409777|FG001|Overall Study|Other|0|||
13265442|NCT01449370|26409778|FG002|Overall Study|Other|0|||
13265443|NCT01449370|26409779|FG003|Overall Study|Other|0|||
13265444|NCT01449370|26409780|FG004|Overall Study|Other|0|||
13265445|NCT01449370|26409781|FG005|Overall Study|Other|0|||
13265446|NCT01449370|26409782|FG006|Overall Study|Other|0|||
13265447|NCT01449370|26409783|FG007|Overall Study|Other|0|||
13265448|NCT01449370|26409784|FG008|Overall Study|Other|1|||
13265449|NCT01449370|26409785|FG009|Overall Study|Other|1|||
13265450|NCT01449370|26409786|FG010|Overall Study|Other|0|||
13265451|NCT01449370|26409787|FG011|Overall Study|Other|0|||
13265452|NCT01449370|26409788|FG012|Overall Study|Other|0|||
13265453|NCT01449370|26409789|FG013|Overall Study|Other|0|||
13265454|NCT01449370|26409790|FG014|Overall Study|Other|0|||
13265455|NCT01449370|26409791|FG015|Overall Study|Other|0|||
13265456|NCT01449370|26409792|FG016|Overall Study|Other|0|||
13265457|NCT01449370|26409793|FG017|Overall Study|Other|0|||
13265458|NCT01449370|26409794|FG018|Overall Study|Other|0|||
13265459|NCT01449370|26409795|FG019|Overall Study|Other|0|||
13265460|NCT01449370|26409796|FG020|Overall Study|Other|0|||
13307706|NCT01283516|26529542|FG007|Overall Study|Administrative problems|1|||
13307707|NCT01283516|26529543|FG008|Overall Study|Administrative problems|39|||
13307708|NCT01283516|26529535|FG000|Overall Study|Lost to Follow-up|0|||
13307709|NCT01283516|26529536|FG001|Overall Study|Lost to Follow-up|0|||
13307710|NCT01283516|26529537|FG002|Overall Study|Lost to Follow-up|0|||
13307711|NCT01283516|26529538|FG003|Overall Study|Lost to Follow-up|0|||
13307712|NCT01283516|26529539|FG004|Overall Study|Lost to Follow-up|0|||
13307713|NCT01283516|26529540|FG005|Overall Study|Lost to Follow-up|0|||
13307714|NCT01283516|26529541|FG006|Overall Study|Lost to Follow-up|0|||
13307715|NCT01283516|26529542|FG007|Overall Study|Lost to Follow-up|0|||
13307716|NCT01283516|26529543|FG008|Overall Study|Lost to Follow-up|1|||
13307717|NCT01283464|26529556|FG000|Overall Study|Lost to Follow-up|0|||
13307718|NCT01283464|26529557|FG001|Overall Study|Lost to Follow-up|1|||
13307719|NCT01283464|26529556|FG000|Overall Study|Withdrawal by Subject|1|||
13307720|NCT01283464|26529557|FG001|Overall Study|Withdrawal by Subject|0|||
13307721|NCT01283464|26529556|FG000|Overall Study|Physician Decision|1|||
13307722|NCT01283464|26529557|FG001|Overall Study|Physician Decision|0|||
13307723|NCT01283386|26529588|FG000|Overall Study|Death|2|||
13307724|NCT01283386|26529589|FG001|Overall Study|Death|0|||
13307725|NCT01283386|26529588|FG000|Overall Study|Withdrawal by Subject|2|||
13265461|NCT01449370|26409797|FG021|Overall Study|Other|0|||
13265462|NCT01449370|26409798|FG022|Overall Study|Other|1|||
13265463|NCT01449370|26409799|FG023|Overall Study|Other|1|||
13265464|NCT01449370|26409800|FG024|Overall Study|Other|0|||
13265465|NCT01449370|26409776|FG000|Overall Study|Medication Prohibited by Protocol|0|||
13265466|NCT01449370|26409777|FG001|Overall Study|Medication Prohibited by Protocol|0|||
13265467|NCT01449370|26409778|FG002|Overall Study|Medication Prohibited by Protocol|0|||
13265468|NCT01449370|26409779|FG003|Overall Study|Medication Prohibited by Protocol|0|||
13265469|NCT01449370|26409780|FG004|Overall Study|Medication Prohibited by Protocol|0|||
13265470|NCT01449370|26409781|FG005|Overall Study|Medication Prohibited by Protocol|0|||
13307726|NCT01283386|26529589|FG001|Overall Study|Withdrawal by Subject|1|||
13307727|NCT01283386|26529588|FG000|Overall Study|Relapse of underlying disease|1|||
13307728|NCT01283386|26529589|FG001|Overall Study|Relapse of underlying disease|3|||
13307729|NCT01283386|26529588|FG000|Overall Study|Progression of underlying disease|2|||
13265471|NCT01449370|26409782|FG006|Overall Study|Medication Prohibited by Protocol|0|||
13265472|NCT01449370|26409783|FG007|Overall Study|Medication Prohibited by Protocol|0|||
13265473|NCT01449370|26409784|FG008|Overall Study|Medication Prohibited by Protocol|0|||
13265474|NCT01449370|26409785|FG009|Overall Study|Medication Prohibited by Protocol|0|||
13265475|NCT01449370|26409786|FG010|Overall Study|Medication Prohibited by Protocol|0|||
13265476|NCT01449370|26409787|FG011|Overall Study|Medication Prohibited by Protocol|0|||
13265477|NCT01449370|26409788|FG012|Overall Study|Medication Prohibited by Protocol|0|||
13265478|NCT01449370|26409789|FG013|Overall Study|Medication Prohibited by Protocol|0|||
13265479|NCT01449370|26409790|FG014|Overall Study|Medication Prohibited by Protocol|0|||
13265480|NCT01449370|26409791|FG015|Overall Study|Medication Prohibited by Protocol|0|||
13307730|NCT01283386|26529589|FG001|Overall Study|Progression of underlying disease|7|||
13307731|NCT01283386|26529588|FG000|Overall Study|Reason not specified|1|||
13307732|NCT01283386|26529589|FG001|Overall Study|Reason not specified|0|||
13307733|NCT01283386|26529588|FG000|Overall Study|Protocol Violation|0|||
13307734|NCT01283386|26529589|FG001|Overall Study|Protocol Violation|1|||
13307735|NCT01283334|26529597|FG000|Overall Study|Withdrawal by Subject|1|||
13307736|NCT01283334|26529597|FG000|Overall Study|Inability to Swallow Everolimus Pills|1|||
13307737|NCT01283334|26529597|FG000|Overall Study|Adverse Event|4|||
13307738|NCT01283334|26529597|FG000|Overall Study|Physician Decision|1|||
13307739|NCT01283282|26529618|FG000|First Intervention (6 Weeks)|Physician Decision|0|||
13307740|NCT01283282|26529619|FG001|First Intervention (6 Weeks)|Physician Decision|1|||
13117720|NCT03053050|25926635|FG003|Open-label Phase|Study Terminated by Sponsor|89|||
13307741|NCT01283282|26529618|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2|||
13307742|NCT01283282|26529619|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3|||
13307743|NCT01283282|26529618|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1|||
13307744|NCT01283282|26529619|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0|||
13265481|NCT01449370|26409792|FG016|Overall Study|Medication Prohibited by Protocol|0|||
13265482|NCT01449370|26409793|FG017|Overall Study|Medication Prohibited by Protocol|0|||
13265483|NCT01449370|26409794|FG018|Overall Study|Medication Prohibited by Protocol|0|||
13265484|NCT01449370|26409795|FG019|Overall Study|Medication Prohibited by Protocol|0|||
13265485|NCT01449370|26409796|FG020|Overall Study|Medication Prohibited by Protocol|0|||
13265486|NCT01449370|26409797|FG021|Overall Study|Medication Prohibited by Protocol|0|||
13265487|NCT01449370|26409798|FG022|Overall Study|Medication Prohibited by Protocol|0|||
13265488|NCT01449370|26409799|FG023|Overall Study|Medication Prohibited by Protocol|1|||
13265489|NCT01449370|26409800|FG024|Overall Study|Medication Prohibited by Protocol|0|||
13265490|NCT01449370|26409776|FG000|Overall Study|Death|0|||
13117721|NCT03053050|25926632|FG000|Open-label Phase|Withdrew Consent|0|||
13265491|NCT01449370|26409777|FG001|Overall Study|Death|0|||
13117722|NCT03053050|25926633|FG001|Open-label Phase|Withdrew Consent|0|||
13265492|NCT01449370|26409778|FG002|Overall Study|Death|0|||
13265493|NCT01449370|26409779|FG003|Overall Study|Death|0|||
13265494|NCT01449370|26409780|FG004|Overall Study|Death|0|||
13265495|NCT01449370|26409781|FG005|Overall Study|Death|0|||
13265496|NCT01449370|26409782|FG006|Overall Study|Death|0|||
13265497|NCT01449370|26409783|FG007|Overall Study|Death|0|||
13265498|NCT01449370|26409784|FG008|Overall Study|Death|0|||
13265499|NCT01449370|26409785|FG009|Overall Study|Death|0|||
13265500|NCT01449370|26409786|FG010|Overall Study|Death|0|||
13265501|NCT01449370|26409787|FG011|Overall Study|Death|0|||
13265502|NCT01449370|26409788|FG012|Overall Study|Death|0|||
13265503|NCT01449370|26409789|FG013|Overall Study|Death|0|||
13265504|NCT01449370|26409790|FG014|Overall Study|Death|0|||
13265505|NCT01449370|26409791|FG015|Overall Study|Death|0|||
13265506|NCT01449370|26409792|FG016|Overall Study|Death|0|||
13265507|NCT01449370|26409793|FG017|Overall Study|Death|0|||
13265508|NCT01449370|26409794|FG018|Overall Study|Death|0|||
13265509|NCT01449370|26409795|FG019|Overall Study|Death|0|||
13265510|NCT01449370|26409796|FG020|Overall Study|Death|0|||
13265511|NCT01449370|26409797|FG021|Overall Study|Death|0|||
13265512|NCT01449370|26409798|FG022|Overall Study|Death|0|||
13265513|NCT01449370|26409799|FG023|Overall Study|Death|0|||
13265514|NCT01449370|26409800|FG024|Overall Study|Death|1|||
13265515|NCT01449279|26409813|FG000|Overall Study|Lack of Efficacy|5|||
13265516|NCT01449279|26409813|FG000|Overall Study|Toxicity|2|||
13265517|NCT01449006|26409832|FG000|Overall Study|Lost to Follow-up|1|||
13265518|NCT01449006|26409833|FG001|Overall Study|Lost to Follow-up|0|||
13265519|NCT01449006|26409832|FG000|Overall Study|Withdrawal by Subject|1|||
13265520|NCT01449006|26409833|FG001|Overall Study|Withdrawal by Subject|0|||
13265521|NCT01449006|26409832|FG000|Overall Study|Protocol Violation|1|||
13117723|NCT03053050|25926634|FG002|Open-label Phase|Withdrew Consent|0|||
13265522|NCT01449006|26409833|FG001|Overall Study|Protocol Violation|0|||
13265523|NCT01448850|26409863|FG000|Overall Study|Death|3|||
13265524|NCT01448850|26409864|FG001|Overall Study|Death|6|||
13265525|NCT01448850|26409863|FG000|Overall Study|Withdrawal by Subject|13|||
13265526|NCT01448850|26409864|FG001|Overall Study|Withdrawal by Subject|21|||
13265527|NCT01448850|26409863|FG000|Overall Study|Lost to Follow-up|3|||
13265528|NCT01448850|26409864|FG001|Overall Study|Lost to Follow-up|1|||
13265529|NCT01448850|26409863|FG000|Overall Study|Other|15|||
13265530|NCT01448850|26409864|FG001|Overall Study|Other|12|||
13265531|NCT01448824|26409938|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
13265532|NCT01448824|26409939|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
13265533|NCT01448824|26409940|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
13265534|NCT01448824|26409941|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
13265535|NCT01448824|26409942|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
13265536|NCT01448824|26409943|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
13265537|NCT01448824|26409944|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1|||
13265538|NCT01448824|26409945|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
13265539|NCT01448824|26409938|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
13265540|NCT01448824|26409939|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
13265541|NCT01448824|26409940|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
13265542|NCT01448824|26409941|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
13265543|NCT01448824|26409942|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2|||
13265544|NCT01448824|26409943|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
13265545|NCT01448824|26409944|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
13265546|NCT01448824|26409945|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
13265547|NCT01448824|26409938|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
13265548|NCT01448824|26409939|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
13265549|NCT01448824|26409940|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
13265550|NCT01448824|26409941|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
13265551|NCT01448824|26409942|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
13265552|NCT01448824|26409943|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1|||
13265553|NCT01448824|26409944|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
13265554|NCT01448824|26409945|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
13265555|NCT01448824|26409938|FG000|Part 1: Washout Period|Lost to Follow-up|1|||
13265556|NCT01448824|26409939|FG001|Part 1: Washout Period|Lost to Follow-up|0|||
13265557|NCT01448824|26409940|FG002|Part 1: Washout Period|Lost to Follow-up|0|||
13265558|NCT01448824|26409941|FG003|Part 1: Washout Period|Lost to Follow-up|0|||
13265559|NCT01448824|26409942|FG004|Part 1: Washout Period|Lost to Follow-up|0|||
13265560|NCT01448824|26409943|FG005|Part 1: Washout Period|Lost to Follow-up|0|||
13265561|NCT01448824|26409944|FG006|Part 1: Washout Period|Lost to Follow-up|0|||
13265562|NCT01448824|26409945|FG007|Part 1: Washout Period|Lost to Follow-up|0|||
13265563|NCT01448824|26409938|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
13265564|NCT01448824|26409939|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
13265565|NCT01448824|26409940|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
13265566|NCT01448824|26409941|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
13265567|NCT01448824|26409942|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
13265568|NCT01448824|26409943|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
13265569|NCT01448824|26409944|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
13265570|NCT01448824|26409945|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1|||
13265571|NCT01448824|26409938|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
13265572|NCT01448824|26409939|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
13265573|NCT01448824|26409940|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
13265574|NCT01448824|26409941|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
13265575|NCT01448824|26409942|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
13265576|NCT01448824|26409943|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
13265577|NCT01448824|26409944|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
13265578|NCT01448824|26409945|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1|||
13265579|NCT01448824|26409938|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
13265580|NCT01448824|26409939|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
13265581|NCT01448824|26409940|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
13265582|NCT01448824|26409941|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
13265583|NCT01448824|26409942|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
13265584|NCT01448824|26409943|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
13265585|NCT01448824|26409944|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
13265586|NCT01448824|26409945|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1|||
13265587|NCT01448824|26409938|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
13265588|NCT01448824|26409939|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
13265589|NCT01448824|26409940|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
13265590|NCT01448824|26409941|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
13265591|NCT01448824|26409942|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
13265592|NCT01448824|26409943|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
13265593|NCT01448824|26409944|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
13265594|NCT01448824|26409945|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1|||
13265595|NCT01448707|26409970|FG000|Overall Study|Adverse Event|3|||
13265596|NCT01448707|26409971|FG001|Overall Study|Adverse Event|1|||
13265597|NCT01448707|26409970|FG000|Overall Study|Lost to Follow-up|2|||
13265598|NCT01448707|26409971|FG001|Overall Study|Lost to Follow-up|6|||
13265599|NCT01448707|26409970|FG000|Overall Study|Withdrawal by Subject|6|||
13265600|NCT01448707|26409971|FG001|Overall Study|Withdrawal by Subject|7|||
13265601|NCT01448707|26409970|FG000|Overall Study|Other|7|||
13265602|NCT01448707|26409971|FG001|Overall Study|Other|4|||
13265603|NCT01448616|26410000|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3|||
13265604|NCT01448616|26410001|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0|||
13265605|NCT01448616|26410002|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0|||
13265606|NCT01448616|26410003|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0|||
13265607|NCT01448616|26410000|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6|||
13265608|NCT01448616|26410001|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
13265609|NCT01448616|26410002|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
13265610|NCT01448616|26410003|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
13265611|NCT01448616|26410000|FG000|Study Drug (Treatment Phase)|Adverse Event|0|||
13265612|NCT01448616|26410001|FG001|Study Drug (Treatment Phase)|Adverse Event|1|||
13265613|NCT01448616|26410002|FG002|Study Drug (Treatment Phase)|Adverse Event|1|||
13265614|NCT01448616|26410003|FG003|Study Drug (Treatment Phase)|Adverse Event|0|||
13265615|NCT01448616|26410000|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0|||
13265616|NCT01448616|26410001|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0|||
13265617|NCT01448616|26410002|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1|||
13265618|NCT01448616|26410003|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2|||
13265619|NCT01448616|26410000|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0|||
13265620|NCT01448616|26410001|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1|||
13265621|NCT01448616|26410002|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
13265622|NCT01448616|26410003|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
13117724|NCT03053050|25926635|FG003|Open-label Phase|Withdrew Consent|6|||
13117725|NCT03053050|25926632|FG000|Open-label Phase|Investigator's Discretion|0|||
13117726|NCT03053050|25926633|FG001|Open-label Phase|Investigator's Discretion|0|||
13117727|NCT03053050|25926634|FG002|Open-label Phase|Investigator's Discretion|0|||
13117728|NCT03053050|25926635|FG003|Open-label Phase|Investigator's Discretion|4|||
13117729|NCT03052959|25926652|FG000|Overall Study|Lost to Follow-up|4|||
13117730|NCT03052959|25926653|FG001|Overall Study|Lost to Follow-up|5|||
13117731|NCT03052816|25926684|FG000|Overall Study|Withdrawal by Subject|1|||
13117732|NCT03052816|25926685|FG001|Overall Study|Withdrawal by Subject|0|||
13117733|NCT03052816|25926684|FG000|Overall Study|Desired opioids|2|||
13117734|NCT03052816|25926685|FG001|Overall Study|Desired opioids|0|||
13117735|NCT03052764|25926710|FG000|Double-Blind Treatment Period|Adverse Event|2|||
13117736|NCT03052764|25926711|FG001|Double-Blind Treatment Period|Adverse Event|0|||
13117737|NCT03052764|25926710|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
13117738|NCT03052764|25926711|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
13117739|NCT03052764|25926710|FG000|Double-Blind Treatment Period|Protocol Violation|2|||
13117740|NCT03052764|25926711|FG001|Double-Blind Treatment Period|Protocol Violation|1|||
13117741|NCT03052764|25926710|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3|||
13117742|NCT03052764|25926711|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
13117743|NCT03052764|25926710|FG000|Double-Blind Treatment Period|Reason not Specified|2|||
13117744|NCT03052764|25926711|FG001|Double-Blind Treatment Period|Reason not Specified|1|||
13117745|NCT03052751|25926736|FG000|Dosing Period 1|Adverse Event|0|||
13117746|NCT03052751|25926737|FG001|Dosing Period 1|Adverse Event|1|||
13117747|NCT03052751|25926738|FG002|Dosing Period 1|Adverse Event|0|||
13117748|NCT03052751|25926739|FG003|Dosing Period 1|Adverse Event|0|||
13117749|NCT03052751|25926740|FG004|Dosing Period 1|Adverse Event|0|||
13117750|NCT03052751|25926741|FG005|Dosing Period 1|Adverse Event|0|||
13117751|NCT03052751|25926736|FG000|Dosing Period 2|Adverse Event|0|||
13117752|NCT03052751|25926737|FG001|Dosing Period 2|Adverse Event|0|||
13117753|NCT03052751|25926738|FG002|Dosing Period 2|Adverse Event|3|||
13117754|NCT03052751|25926739|FG003|Dosing Period 2|Adverse Event|0|||
13117755|NCT03052751|25926740|FG004|Dosing Period 2|Adverse Event|0|||
13265623|NCT01448213|26410018|FG000|Overall Study|Lost to Follow-up|12|||
13265624|NCT01448213|26410019|FG001|Overall Study|Lost to Follow-up|10|||
13265625|NCT01448213|26410018|FG000|Overall Study|Adverse Event|4|||
13265626|NCT01448213|26410019|FG001|Overall Study|Adverse Event|10|||
13265627|NCT01448213|26410018|FG000|Overall Study|Protocol Violation|1|||
13265628|NCT01448213|26410019|FG001|Overall Study|Protocol Violation|2|||
13265629|NCT01448057|26410034|FG000|Overall Study|Protocol Violation|3|||
13265630|NCT01448057|26410035|FG001|Overall Study|Protocol Violation|2|||
13117756|NCT03052751|25926741|FG005|Dosing Period 2|Adverse Event|0|||
13117757|NCT03052751|25926736|FG000|Observation Period|Adverse Event|0|||
13117758|NCT03052751|25926737|FG001|Observation Period|Adverse Event|0|||
13117759|NCT03052751|25926738|FG002|Observation Period|Adverse Event|0|||
13117760|NCT03052751|25926739|FG003|Observation Period|Adverse Event|0|||
13117761|NCT03052751|25926740|FG004|Observation Period|Adverse Event|1|||
13265631|NCT01448057|26410034|FG000|Overall Study|Lost to Follow-up|3|||
13265632|NCT01448057|26410035|FG001|Overall Study|Lost to Follow-up|0|||
13265633|NCT01448057|26410034|FG000|Overall Study|Adverse Event|0|||
13265634|NCT01448057|26410035|FG001|Overall Study|Adverse Event|2|||
13265635|NCT01448057|26410034|FG000|Overall Study|Withdrawal by Subject|2|||
13265636|NCT01448057|26410035|FG001|Overall Study|Withdrawal by Subject|0|||
13265637|NCT01448044|26410056|FG000|Treatment Period|Adverse Event|4|||
13265638|NCT01448044|26410057|FG001|Treatment Period|Adverse Event|3|||
13265639|NCT01448044|26410056|FG000|Treatment Period|Lack of Efficacy|5|||
13265640|NCT01448044|26410057|FG001|Treatment Period|Lack of Efficacy|12|||
13265641|NCT01448044|26410056|FG000|Treatment Period|Subject requested discontinue study drug|1|||
13265642|NCT01448044|26410057|FG001|Treatment Period|Subject requested discontinue study drug|0|||
13265643|NCT01448044|26410056|FG000|Treatment Period|Completed 24 weeks treatment period only|8|||
13265644|NCT01448044|26410057|FG001|Treatment Period|Completed 24 weeks treatment period only|0|||
13265645|NCT01448044|26410056|FG000|Treatment Period|Participant does not meet study criteria|1|||
13265646|NCT01448044|26410057|FG001|Treatment Period|Participant does not meet study criteria|0|||
13265647|NCT01448044|26410056|FG000|Treatment Period|Lost to Follow-up|2|||
13265648|NCT01448044|26410057|FG001|Treatment Period|Lost to Follow-up|1|||
13117762|NCT03052751|25926741|FG005|Observation Period|Adverse Event|0|||
13117763|NCT03052517|25926792|FG000|Overall Study|Study Terminated By Sponsor|928|||
13265649|NCT01448044|26410056|FG000|Treatment Period|Other reason|2|||
13265650|NCT01448044|26410057|FG001|Treatment Period|Other reason|0|||
13265651|NCT01448044|26410056|FG000|Follow Up Period|Withdrawal by Subject|1|||
13265652|NCT01448044|26410057|FG001|Follow Up Period|Withdrawal by Subject|1|||
13265653|NCT01448044|26410056|FG000|Follow Up Period|Lost to Follow-up|6|||
13265654|NCT01448044|26410057|FG001|Follow Up Period|Lost to Follow-up|2|||
13265655|NCT01448044|26410056|FG000|Follow Up Period|Other|5|||
13265656|NCT01448044|26410057|FG001|Follow Up Period|Other|11|||
13265657|NCT01447927|26410072|FG000|Overall Study|Adverse Event|4|||
13265658|NCT01447927|26410073|FG001|Overall Study|Adverse Event|3|||
13265659|NCT01447927|26410072|FG000|Overall Study|Withdrawal by Subject|1|||
13265660|NCT01447927|26410073|FG001|Overall Study|Withdrawal by Subject|0|||
13265661|NCT01447719|26410086|FG000|Overall Study|Image acquisition failure|2|||
13265662|NCT01447719|26410086|FG000|Overall Study|Invalid image or not imaged|3|||
13265663|NCT01447719|26410086|FG000|Overall Study|Subject still living at end of study|79|||
13265664|NCT01447719|26410086|FG000|Overall Study|Withdrawal by Subject|2|||
13265665|NCT01447719|26410086|FG000|Overall Study|Family withdrew autopsy consent|7|||
13265666|NCT01447576|26410094|FG000|Overall Study|Lost to Follow-up|52|||
13265667|NCT01447576|26410094|FG000|Overall Study|Adverse Event|127|||
13265668|NCT01447576|26410094|FG000|Overall Study|Participant met withdrawal criteria|40|||
13265669|NCT01447576|26410094|FG000|Overall Study|Withdrawal by Subject|100|||
13265670|NCT01447576|26410094|FG000|Overall Study|Protocol deviation|83|||
13265671|NCT01447576|26410094|FG000|Overall Study|Lack of Efficacy|68|||
13265672|NCT01447576|26410094|FG000|Overall Study|Physician Decision|6|||
13265673|NCT01447446|26410201|FG000|Overall Study|Death|6|||
13265674|NCT01447446|26410202|FG001|Overall Study|Death|3|||
13265675|NCT01447446|26410203|FG002|Overall Study|Death|2|||
13265676|NCT01447446|26410204|FG003|Overall Study|Death|1|||
13265677|NCT01447446|26410205|FG004|Overall Study|Death|7|||
13265678|NCT01447446|26410206|FG005|Overall Study|Death|0|||
13265679|NCT01447446|26410201|FG000|Overall Study|Adverse Event|3|||
13265680|NCT01447446|26410202|FG001|Overall Study|Adverse Event|0|||
13265681|NCT01447446|26410203|FG002|Overall Study|Adverse Event|1|||
13265682|NCT01447446|26410204|FG003|Overall Study|Adverse Event|0|||
13265683|NCT01447446|26410205|FG004|Overall Study|Adverse Event|2|||
13265684|NCT01447446|26410206|FG005|Overall Study|Adverse Event|0|||
13265685|NCT01447446|26410201|FG000|Overall Study|Failure to Return/Consent Withdrawn|357|||
13265686|NCT01447446|26410202|FG001|Overall Study|Failure to Return/Consent Withdrawn|78|||
13265687|NCT01447446|26410203|FG002|Overall Study|Failure to Return/Consent Withdrawn|31|||
13265688|NCT01447446|26410204|FG003|Overall Study|Failure to Return/Consent Withdrawn|7|||
13265689|NCT01447446|26410205|FG004|Overall Study|Failure to Return/Consent Withdrawn|69|||
13265690|NCT01447446|26410206|FG005|Overall Study|Failure to Return/Consent Withdrawn|9|||
13265691|NCT01447446|26410201|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300|||
13265692|NCT01447446|26410202|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71|||
13265693|NCT01447446|26410203|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52|||
13265694|NCT01447446|26410204|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21|||
13265695|NCT01447446|26410205|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92|||
13265696|NCT01447446|26410206|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14|||
13265697|NCT01447446|26410201|FG000|Overall Study|Administrative/Other|34|||
13265698|NCT01447446|26410202|FG001|Overall Study|Administrative/Other|9|||
13265699|NCT01447446|26410203|FG002|Overall Study|Administrative/Other|10|||
13265700|NCT01447446|26410204|FG003|Overall Study|Administrative/Other|2|||
13265701|NCT01447446|26410205|FG004|Overall Study|Administrative/Other|33|||
13265702|NCT01447446|26410206|FG005|Overall Study|Administrative/Other|4|||
13265703|NCT01447446|26410201|FG000|Overall Study|SVR12 Assessment|13|||
13265704|NCT01447446|26410202|FG001|Overall Study|SVR12 Assessment|1|||
13265705|NCT01447446|26410203|FG002|Overall Study|SVR12 Assessment|2|||
13265706|NCT01447446|26410204|FG003|Overall Study|SVR12 Assessment|1|||
13265707|NCT01447446|26410205|FG004|Overall Study|SVR12 Assessment|5|||
13265708|NCT01447446|26410206|FG005|Overall Study|SVR12 Assessment|5|||
13265709|NCT01447446|26410201|FG000|Overall Study|New Treatment Started|8|||
13265710|NCT01447446|26410202|FG001|Overall Study|New Treatment Started|2|||
13265711|NCT01447446|26410203|FG002|Overall Study|New Treatment Started|1|||
13265712|NCT01447446|26410204|FG003|Overall Study|New Treatment Started|0|||
13265713|NCT01447446|26410205|FG004|Overall Study|New Treatment Started|2|||
13265714|NCT01447446|26410206|FG005|Overall Study|New Treatment Started|0|||
13265715|NCT01447446|26410201|FG000|Overall Study|Reason not Specified|1|||
13265716|NCT01447446|26410202|FG001|Overall Study|Reason not Specified|1|||
13265717|NCT01447446|26410203|FG002|Overall Study|Reason not Specified|1|||
13265718|NCT01447446|26410204|FG003|Overall Study|Reason not Specified|1|||
13265719|NCT01447446|26410205|FG004|Overall Study|Reason not Specified|1|||
13265720|NCT01447446|26410206|FG005|Overall Study|Reason not Specified|0|||
13265721|NCT01447433|26410237|FG000|Overall Study|Lost to Follow-up|0|||
13265722|NCT01447433|26410238|FG001|Overall Study|Lost to Follow-up|2|||
13265723|NCT01447433|26410237|FG000|Overall Study|Withdrawal by Subject|3|||
13265724|NCT01447433|26410238|FG001|Overall Study|Withdrawal by Subject|3|||
13265725|NCT01447433|26410237|FG000|Overall Study|Protocol Violation|1|||
13265726|NCT01447433|26410238|FG001|Overall Study|Protocol Violation|1|||
13265727|NCT01447420|26410264|FG000|Overall Study|Adverse Event|2|||
13265728|NCT01447420|26410265|FG001|Overall Study|Adverse Event|4|||
13265729|NCT01447420|26410266|FG002|Overall Study|Adverse Event|2|||
13265730|NCT01447420|26410264|FG000|Overall Study|Protocol Violation|3|||
13265731|NCT01447420|26410265|FG001|Overall Study|Protocol Violation|3|||
13265732|NCT01447420|26410266|FG002|Overall Study|Protocol Violation|0|||
13265733|NCT01447420|26410264|FG000|Overall Study|Withdrawal by Subject|4|||
13265734|NCT01447420|26410265|FG001|Overall Study|Withdrawal by Subject|1|||
13265735|NCT01447420|26410266|FG002|Overall Study|Withdrawal by Subject|0|||
13265736|NCT01447420|26410264|FG000|Overall Study|Lack of Efficacy|1|||
13265737|NCT01447420|26410265|FG001|Overall Study|Lack of Efficacy|19|||
13265738|NCT01447420|26410266|FG002|Overall Study|Lack of Efficacy|8|||
13265739|NCT01447407|26410313|FG000|Overall Study|Withdrawal by Subject|2|||
13265740|NCT01447407|26410314|FG001|Overall Study|Withdrawal by Subject|0|||
13265741|NCT01447407|26410315|FG002|Overall Study|Withdrawal by Subject|0|||
13265742|NCT01447407|26410316|FG003|Overall Study|Withdrawal by Subject|1|||
13265743|NCT01447407|26410313|FG000|Overall Study|Physician Decision|0|||
13265744|NCT01447407|26410314|FG001|Overall Study|Physician Decision|0|||
13265745|NCT01447407|26410315|FG002|Overall Study|Physician Decision|1|||
13265746|NCT01447407|26410316|FG003|Overall Study|Physician Decision|1|||
13265747|NCT01446965|26410333|FG000|Randominization|One site was dismissed due to IRB irregularity|30|||
13265748|NCT01446965|26410334|FG001|Randominization|One site was dismissed due to IRB irregularity|16|||
13265749|NCT01446965|26410333|FG000|Participants Followed and Analyzed|Lost to Follow-up|10|||
13265750|NCT01446965|26410334|FG001|Participants Followed and Analyzed|Lost to Follow-up|12|||
13265751|NCT01446913|26410402|FG000|Overall Study|Significant illness|1|||
13265752|NCT01446913|26410403|FG001|Overall Study|Significant illness|1|||
13265753|NCT01446913|26410404|FG002|Overall Study|Significant illness|1|||
13265754|NCT01446913|26410402|FG000|Overall Study|Withdrawal by Subject|5|||
13265755|NCT01446913|26410403|FG001|Overall Study|Withdrawal by Subject|3|||
13265756|NCT01446913|26410404|FG002|Overall Study|Withdrawal by Subject|5|||
13265757|NCT01446913|26410402|FG000|Overall Study|Physician Decision|0|||
13265758|NCT01446913|26410403|FG001|Overall Study|Physician Decision|0|||
13265759|NCT01446913|26410404|FG002|Overall Study|Physician Decision|2|||
13265760|NCT01446913|26410402|FG000|Overall Study|Lost to Follow-up|3|||
13265761|NCT01446913|26410403|FG001|Overall Study|Lost to Follow-up|5|||
13265762|NCT01446913|26410404|FG002|Overall Study|Lost to Follow-up|3|||
13265763|NCT01446874|26410440|FG000|Overall Study|Not eligible|1|||
13265764|NCT01446874|26410441|FG001|Overall Study|Not eligible|0|||
13265765|NCT01446874|26410442|FG002|Overall Study|Not eligible|0|||
13265766|NCT01446874|26410440|FG000|Overall Study|No surgery/No qualifying surgery|1|||
13265767|NCT01446874|26410441|FG001|Overall Study|No surgery/No qualifying surgery|0|||
13265768|NCT01446874|26410442|FG002|Overall Study|No surgery/No qualifying surgery|12|||
13265769|NCT01446874|26410440|FG000|Overall Study|Non-compliance|0|||
13265770|NCT01446874|26410441|FG001|Overall Study|Non-compliance|4|||
13265771|NCT01446874|26410442|FG002|Overall Study|Non-compliance|0|||
13265772|NCT01446874|26410440|FG000|Overall Study|Antibiotics for pre-op infection|0|||
13265773|NCT01446874|26410441|FG001|Overall Study|Antibiotics for pre-op infection|0|||
13117764|NCT03052517|25926793|FG001|Overall Study|Study Terminated By Sponsor|938|||
13117765|NCT03052517|25926794|FG002|Overall Study|Study Terminated By Sponsor|296|||
13117766|NCT03052517|25926792|FG000|Overall Study|Subject/Guardian Decision|50|||
13117767|NCT03052517|25926793|FG001|Overall Study|Subject/Guardian Decision|45|||
13265774|NCT01446874|26410442|FG002|Overall Study|Antibiotics for pre-op infection|2|||
13265775|NCT01446874|26410440|FG000|Overall Study|Withdrawal by Subject|0|||
13265776|NCT01446874|26410441|FG001|Overall Study|Withdrawal by Subject|0|||
13265777|NCT01446874|26410442|FG002|Overall Study|Withdrawal by Subject|4|||
13117768|NCT03052517|25926794|FG002|Overall Study|Subject/Guardian Decision|22|||
13117769|NCT03052517|25926792|FG000|Overall Study|Lack of Efficacy|23|||
13117770|NCT03052517|25926793|FG001|Overall Study|Lack of Efficacy|14|||
13117771|NCT03052517|25926794|FG002|Overall Study|Lack of Efficacy|7|||
13117772|NCT03052517|25926792|FG000|Overall Study|Adverse Event|6|||
13117773|NCT03052517|25926793|FG001|Overall Study|Adverse Event|5|||
13117774|NCT03052517|25926794|FG002|Overall Study|Adverse Event|0|||
13117775|NCT03052517|25926792|FG000|Overall Study|Physician Decision|4|||
13117776|NCT03052517|25926793|FG001|Overall Study|Physician Decision|5|||
13117777|NCT03052517|25926794|FG002|Overall Study|Physician Decision|1|||
13117778|NCT03052517|25926792|FG000|Overall Study|Death|3|||
13117779|NCT03052517|25926793|FG001|Overall Study|Death|0|||
13117780|NCT03052517|25926794|FG002|Overall Study|Death|1|||
13117781|NCT03052517|25926792|FG000|Overall Study|Lost to Follow-up|2|||
13117782|NCT03052517|25926793|FG001|Overall Study|Lost to Follow-up|4|||
13117783|NCT03052517|25926794|FG002|Overall Study|Lost to Follow-up|0|||
13117784|NCT03052517|25926792|FG000|Overall Study|Pregnancy|1|||
13117785|NCT03052517|25926793|FG001|Overall Study|Pregnancy|0|||
13117786|NCT03052517|25926794|FG002|Overall Study|Pregnancy|1|||
13117787|NCT03052517|25926792|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
13117788|NCT03052517|25926793|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
13117789|NCT03052517|25926794|FG002|Overall Study|Non-Compliance With Study Treatment|0|||
13117790|NCT03052517|25926792|FG000|Overall Study|Technical Problems|0|||
13117791|NCT03052517|25926793|FG001|Overall Study|Technical Problems|1|||
13117792|NCT03052517|25926794|FG002|Overall Study|Technical Problems|0|||
13117793|NCT03052426|25926817|FG000|Overall Study|Withdrawal by Subject|0|||
13117794|NCT03052426|25926818|FG001|Overall Study|Withdrawal by Subject|1|||
13117795|NCT03052426|25926819|FG002|Overall Study|Withdrawal by Subject|0|||
13117796|NCT03052426|25926817|FG000|Overall Study|Lost to Follow-up|2|||
13117797|NCT03052426|25926818|FG001|Overall Study|Lost to Follow-up|0|||
13117798|NCT03052426|25926819|FG002|Overall Study|Lost to Follow-up|1|||
13117799|NCT03052400|25926856|FG000|Overall Study|Lost to Follow-up|1|||
13117800|NCT03052400|25926857|FG001|Overall Study|Lost to Follow-up|0|||
13117801|NCT03052400|25926856|FG000|Overall Study|Withdrawal by Subject|0|||
13117802|NCT03052400|25926857|FG001|Overall Study|Withdrawal by Subject|1|||
13117803|NCT03052322|25926914|FG000|Overall Study|Other un-specified|1|||
13117804|NCT03052322|25926915|FG001|Overall Study|Other un-specified|2|||
13117805|NCT03052322|25926914|FG000|Overall Study|Withdrawal by Subject|10|||
13117806|NCT03052322|25926915|FG001|Overall Study|Withdrawal by Subject|9|||
13117807|NCT03052322|25926914|FG000|Overall Study|Death|0|||
13117808|NCT03052322|25926915|FG001|Overall Study|Death|2|||
13117809|NCT03052322|25926914|FG000|Overall Study|Lack of Efficacy|1|||
13117810|NCT03052322|25926915|FG001|Overall Study|Lack of Efficacy|2|||
13117811|NCT03052322|25926914|FG000|Overall Study|Protocol Violation|1|||
13117812|NCT03052322|25926915|FG001|Overall Study|Protocol Violation|0|||
13117813|NCT03052322|25926914|FG000|Overall Study|Lost to Follow-up|2|||
13117814|NCT03052322|25926915|FG001|Overall Study|Lost to Follow-up|4|||
13117815|NCT03052322|25926914|FG000|Overall Study|Adverse Event|6|||
13117816|NCT03052322|25926915|FG001|Overall Study|Adverse Event|13|||
13117817|NCT03051659|25926938|FG000|Treatment Period|Withdrawal by Subject|0|||
13117818|NCT03051659|25926939|FG001|Treatment Period|Withdrawal by Subject|2|||
13117819|NCT03051659|25926938|FG000|Survival Follow-up|Lost to Follow-up|23|||
13117820|NCT03051659|25926939|FG001|Survival Follow-up|Lost to Follow-up|22|||
13117821|NCT03051620|25926949|FG000|Overall Study|Lost to Follow-up|6|||
13265778|NCT01446809|26410473|FG000|Overall Study|Adverse Event|0|||
13265779|NCT01446809|26410474|FG001|Overall Study|Adverse Event|0|||
13265780|NCT01446809|26410475|FG002|Overall Study|Adverse Event|1|||
13265781|NCT01446809|26410473|FG000|Overall Study|Failure to complete study procedures|0|||
13265782|NCT01446809|26410474|FG001|Overall Study|Failure to complete study procedures|0|||
13265783|NCT01446809|26410475|FG002|Overall Study|Failure to complete study procedures|1|||
13265784|NCT01446796|26410490|FG000|Overall Study|Withdrawal by Subject|1|||
13265785|NCT01446796|26410491|FG001|Overall Study|Withdrawal by Subject|0|||
13265786|NCT01446419|26410508|FG000|Overall Study|Death|1|||
13265787|NCT01446419|26410509|FG001|Overall Study|Death|0|||
13265788|NCT01446419|26410508|FG000|Overall Study|Withdrawal by Subject|1|||
13265789|NCT01446419|26410509|FG001|Overall Study|Withdrawal by Subject|1|||
13265790|NCT01446419|26410508|FG000|Overall Study|Terminated per protocol|3|||
13265791|NCT01446419|26410509|FG001|Overall Study|Terminated per protocol|0|||
13265792|NCT01446289|26410550|FG000|Overall Study|Withdrawal by Subject|1|||
13265793|NCT01446289|26410551|FG001|Overall Study|Withdrawal by Subject|0|||
13265794|NCT01446289|26410552|FG002|Overall Study|Withdrawal by Subject|1|||
13117822|NCT03051620|25926949|FG000|Overall Study|n=124 enrolled in extension (all completed)|12|||
13117823|NCT03051607|25926958|FG000|Overall Study|Adverse Event|66|||
13117824|NCT03051178|25926964|FG000|Overall Study|Withdrawal by Subject|5|||
13117825|NCT03051165|25926978|FG000|Overall Study|Withdrawal by Subject|1|||
13117826|NCT03051165|25926978|FG000|Overall Study|Early termination of study|12|||
13117827|NCT03051100|25926999|FG000|Overall Study|Withdrawal by Subject|1|||
13265795|NCT01446289|26410553|FG003|Overall Study|Withdrawal by Subject|0|||
13117828|NCT03051100|25927000|FG001|Overall Study|Withdrawal by Subject|0|||
13117829|NCT03050801|25927039|FG000|Experiment 1|Lost to Follow-up|0|||
13265796|NCT01446237|26410563|FG000|Overall Study|Adverse Event|1|||
13265797|NCT01446237|26410563|FG000|Overall Study|Lost to Follow-up|2|||
13265798|NCT01446237|26410563|FG000|Overall Study|Withdrawal by Subject|7|||
13265799|NCT01446159|26410648|FG000|Overall Study|Withdrawal by Subject|1|||
13265800|NCT01446159|26410649|FG001|Overall Study|Withdrawal by Subject|0|||
13265801|NCT01446159|26410650|FG002|Overall Study|Withdrawal by Subject|14|||
13265802|NCT01446159|26410651|FG003|Overall Study|Withdrawal by Subject|11|||
13265803|NCT01446159|26410648|FG000|Overall Study|Lost to Follow-up|0|||
13265804|NCT01446159|26410649|FG001|Overall Study|Lost to Follow-up|0|||
13265805|NCT01446159|26410650|FG002|Overall Study|Lost to Follow-up|1|||
13265806|NCT01446159|26410651|FG003|Overall Study|Lost to Follow-up|2|||
13265807|NCT01446159|26410648|FG000|Overall Study|Death|2|||
13265808|NCT01446159|26410649|FG001|Overall Study|Death|3|||
13265809|NCT01446159|26410650|FG002|Overall Study|Death|43|||
13265810|NCT01446159|26410651|FG003|Overall Study|Death|36|||
13117830|NCT03050801|25927040|FG001|Experiment 1|Lost to Follow-up|1|||
13117831|NCT03050801|25927041|FG002|Experiment 1|Lost to Follow-up|0|||
13117832|NCT03050801|25927042|FG003|Experiment 1|Lost to Follow-up|0|||
13265811|NCT01446159|26410648|FG000|Overall Study|Other|0|||
13265812|NCT01446159|26410649|FG001|Overall Study|Other|0|||
13265813|NCT01446159|26410650|FG002|Overall Study|Other|13|||
13265814|NCT01446159|26410651|FG003|Overall Study|Other|13|||
13265815|NCT01446042|26410672|FG000|Overall Study|Withdrawal by Subject|12|||
13265816|NCT01446042|26410673|FG001|Overall Study|Withdrawal by Subject|2|||
13265817|NCT01446042|26410674|FG002|Overall Study|Withdrawal by Subject|4|||
13265818|NCT01446042|26410672|FG000|Overall Study|Adverse Event|1|||
13265819|NCT01446042|26410673|FG001|Overall Study|Adverse Event|0|||
13265820|NCT01446042|26410674|FG002|Overall Study|Adverse Event|4|||
13265821|NCT01446042|26410672|FG000|Overall Study|Lost to Follow-up|5|||
13265822|NCT01446042|26410673|FG001|Overall Study|Lost to Follow-up|0|||
13265823|NCT01446042|26410674|FG002|Overall Study|Lost to Follow-up|0|||
13265824|NCT01446042|26410672|FG000|Overall Study|Other reasons|2|||
13265825|NCT01446042|26410673|FG001|Overall Study|Other reasons|1|||
13265826|NCT01446042|26410674|FG002|Overall Study|Other reasons|1|||
13265827|NCT01446003|26410695|FG000|Period 1|Protocol Violation|2|||
13265828|NCT01446003|26410696|FG001|Period 1|Protocol Violation|0|||
13265829|NCT01446003|26410695|FG000|Period 2|Adverse Event|1|||
13265830|NCT01446003|26410696|FG001|Period 2|Adverse Event|0|||
13265831|NCT01445951|26410744|FG000|Overall Study|Adverse Event|16|||
13265832|NCT01445951|26410745|FG001|Overall Study|Adverse Event|9|||
13265833|NCT01445951|26410746|FG002|Overall Study|Adverse Event|0|||
13265834|NCT01445951|26410744|FG000|Overall Study|Protocol Violation|2|||
13265835|NCT01445951|26410745|FG001|Overall Study|Protocol Violation|2|||
13265836|NCT01445951|26410746|FG002|Overall Study|Protocol Violation|2|||
13265837|NCT01445951|26410744|FG000|Overall Study|Withdrawal by Subject|21|||
13265838|NCT01445951|26410745|FG001|Overall Study|Withdrawal by Subject|16|||
13265839|NCT01445951|26410746|FG002|Overall Study|Withdrawal by Subject|8|||
13265840|NCT01445951|26410744|FG000|Overall Study|Physician Decision|3|||
13265841|NCT01445951|26410745|FG001|Overall Study|Physician Decision|1|||
13265842|NCT01445951|26410746|FG002|Overall Study|Physician Decision|0|||
13265843|NCT01445951|26410744|FG000|Overall Study|Lost to Follow-up|1|||
13265844|NCT01445951|26410745|FG001|Overall Study|Lost to Follow-up|2|||
13265845|NCT01445951|26410746|FG002|Overall Study|Lost to Follow-up|4|||
13265846|NCT01445951|26410744|FG000|Overall Study|Pregnancy|0|||
13265847|NCT01445951|26410745|FG001|Overall Study|Pregnancy|1|||
13265848|NCT01445951|26410746|FG002|Overall Study|Pregnancy|4|||
13265849|NCT01445951|26410744|FG000|Overall Study|Death|0|||
13265850|NCT01445951|26410745|FG001|Overall Study|Death|0|||
13265851|NCT01445951|26410746|FG002|Overall Study|Death|1|||
13265852|NCT01445951|26410744|FG000|Overall Study|Non-compliance with study drug|1|||
13265853|NCT01445951|26410745|FG001|Overall Study|Non-compliance with study drug|2|||
13265854|NCT01445951|26410746|FG002|Overall Study|Non-compliance with study drug|0|||
13265855|NCT01445951|26410744|FG000|Overall Study|Non-compliance with protocol|0|||
13265856|NCT01445951|26410745|FG001|Overall Study|Non-compliance with protocol|1|||
13265857|NCT01445951|26410746|FG002|Overall Study|Non-compliance with protocol|0|||
13265858|NCT01445951|26410744|FG000|Overall Study|Sponsor decision - subject travel|0|||
13265859|NCT01445951|26410745|FG001|Overall Study|Sponsor decision - subject travel|1|||
13265860|NCT01445951|26410746|FG002|Overall Study|Sponsor decision - subject travel|0|||
13265861|NCT01445951|26410744|FG000|Overall Study|Cough|0|||
13265862|NCT01445951|26410745|FG001|Overall Study|Cough|1|||
13265863|NCT01445951|26410746|FG002|Overall Study|Cough|0|||
13265864|NCT01445886|26410758|FG000|Overall Study|Lost to Follow-up|2|||
13265865|NCT01445886|26410758|FG000|Overall Study|Protocol Violation|3|||
13265866|NCT01445847|26410771|FG000|Overall Study|Protocol Violation|13|||
13265867|NCT01445847|26410772|FG001|Overall Study|Protocol Violation|14|||
13265868|NCT01445847|26410771|FG000|Overall Study|Missed Data|1|||
13265869|NCT01445847|26410772|FG001|Overall Study|Missed Data|0|||
13265870|NCT01445769|26410792|FG000|Overall Study|Consent Withdrawn|2|||
13265871|NCT01445769|26410792|FG000|Overall Study|Disease Progression|1|||
13265872|NCT01445769|26410792|FG000|Overall Study|Lost to Follow-up|5|||
13265873|NCT01445730|26410804|FG000|Overall Study|Adverse Event|1|||
13265874|NCT01445730|26410804|FG000|Overall Study|For the advice of a dentist|1|||
13265875|NCT01445730|26410804|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9|||
13265876|NCT01445678|26410827|FG000|Overall Study|Adverse Event|12|||
13265877|NCT01445678|26410828|FG001|Overall Study|Adverse Event|8|||
13265878|NCT01445678|26410827|FG000|Overall Study|Lack of Efficacy|0|||
13265879|NCT01445678|26410828|FG001|Overall Study|Lack of Efficacy|2|||
13265880|NCT01445678|26410827|FG000|Overall Study|Lost to Follow-up|8|||
13265881|NCT01445678|26410828|FG001|Overall Study|Lost to Follow-up|5|||
13265882|NCT01445678|26410827|FG000|Overall Study|Protocol Violation|1|||
13265883|NCT01445678|26410828|FG001|Overall Study|Protocol Violation|1|||
13265884|NCT01445678|26410827|FG000|Overall Study|Withdrawal by Subject|9|||
13265885|NCT01445678|26410828|FG001|Overall Study|Withdrawal by Subject|5|||
13265886|NCT01445652|26410843|FG000|Overall Study|Not comfortable in lenses|5|||
13265887|NCT01445652|26410844|FG001|Overall Study|Not comfortable in lenses|0|||
13265888|NCT01445652|26410843|FG000|Overall Study|Failed to attend scheduled visit|2|||
13265889|NCT01445652|26410844|FG001|Overall Study|Failed to attend scheduled visit|3|||
13265890|NCT01445652|26410843|FG000|Overall Study|Failed teach session|2|||
13265891|NCT01445652|26410844|FG001|Overall Study|Failed teach session|0|||
13265892|NCT01445652|26410843|FG000|Overall Study|Adverse Event|1|||
13265893|NCT01445652|26410844|FG001|Overall Study|Adverse Event|0|||
13265894|NCT01445613|26410864|FG000|30-day Follow-up|Withdrawal by Subject|6|||
13265895|NCT01445613|26410864|FG000|30-day Follow-up|Physician Decision|3|||
13265896|NCT01445613|26410864|FG000|30-day Follow-up|Missed visit|23|||
13265897|NCT01445613|26410864|FG000|30-day Follow-up|Death|3|||
13265898|NCT01445613|26410864|FG000|1-year Follow-up|Withdrawal by Subject|12|||
13265899|NCT01445613|26410864|FG000|1-year Follow-up|Missed visit|29|||
13265900|NCT01445613|26410864|FG000|1-year Follow-up|Lost to Follow-up|2|||
13265901|NCT01445613|26410864|FG000|1-year Follow-up|Death|30|||
13265902|NCT01445613|26410864|FG000|1-year Follow-up|Physician Decision|2|||
13265903|NCT01445613|26410864|FG000|1-year Follow-up|Received a non-study stent|2|||
13265904|NCT01445548|26410888|FG000|Overall Study|Adverse Event|1|||
13265905|NCT01445535|26410922|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0|||
13265906|NCT01445535|26410923|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0|||
13265907|NCT01445535|26410924|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0|||
13265908|NCT01445535|26410925|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1|||
13265909|NCT01445535|26410922|FG000|Overall Study|Disease progression|1|||
13265910|NCT01445535|26410923|FG001|Overall Study|Disease progression|0|||
13265911|NCT01445535|26410924|FG002|Overall Study|Disease progression|1|||
13265912|NCT01445535|26410925|FG003|Overall Study|Disease progression|0|||
13265913|NCT01445535|26410922|FG000|Overall Study|PI discretion|0|||
13265914|NCT01445535|26410923|FG001|Overall Study|PI discretion|0|||
13265915|NCT01445535|26410924|FG002|Overall Study|PI discretion|0|||
13265916|NCT01445535|26410925|FG003|Overall Study|PI discretion|1|||
13265917|NCT01445301|26410970|FG000|Overall Study|Adverse Event|15|||
13265918|NCT01445301|26410971|FG001|Overall Study|Adverse Event|25|||
13265919|NCT01445301|26410972|FG002|Overall Study|Adverse Event|4|||
13265920|NCT01445301|26410970|FG000|Overall Study|Lack of Efficacy|0|||
13265921|NCT01445301|26410971|FG001|Overall Study|Lack of Efficacy|1|||
13265922|NCT01445301|26410972|FG002|Overall Study|Lack of Efficacy|0|||
13265923|NCT01445301|26410970|FG000|Overall Study|Protocol Violation|1|||
13265924|NCT01445301|26410971|FG001|Overall Study|Protocol Violation|0|||
13265925|NCT01445301|26410972|FG002|Overall Study|Protocol Violation|0|||
13265926|NCT01445301|26410970|FG000|Overall Study|Protocol-Defined Stopping Criteria|0|||
13265927|NCT01445301|26410971|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
13265928|NCT01445301|26410972|FG002|Overall Study|Protocol-Defined Stopping Criteria|1|||
13265929|NCT01445301|26410970|FG000|Overall Study|Physician Decision|0|||
13265930|NCT01445301|26410971|FG001|Overall Study|Physician Decision|2|||
13265931|NCT01445301|26410972|FG002|Overall Study|Physician Decision|0|||
13265932|NCT01445301|26410970|FG000|Overall Study|Withdrawal by Subject|5|||
13265933|NCT01445301|26410971|FG001|Overall Study|Withdrawal by Subject|6|||
13265934|NCT01445301|26410972|FG002|Overall Study|Withdrawal by Subject|4|||
13265935|NCT01445171|26410995|FG000|Overall Study|Lost to Follow-up|11|||
13265936|NCT01445171|26410995|FG000|Overall Study|Withdrawal by Subject|16|||
13265937|NCT01445171|26410995|FG000|Overall Study|Death|51|||
13265938|NCT01445171|26410995|FG000|Overall Study|Subjects declined to return for followup|9|||
13265939|NCT01445171|26410995|FG000|Overall Study|Consented but did not receive device|8|||
13265940|NCT01445080|26411107|FG000|Overall Study|Adverse Event|5|||
13265941|NCT01445080|26411108|FG001|Overall Study|Adverse Event|3|||
13265942|NCT01445080|26411109|FG002|Overall Study|Adverse Event|11|||
13265943|NCT01445080|26411110|FG003|Overall Study|Adverse Event|6|||
13265944|NCT01445080|26411111|FG004|Overall Study|Adverse Event|2|||
13265945|NCT01445080|26411112|FG005|Overall Study|Adverse Event|3|||
13265946|NCT01445080|26411113|FG006|Overall Study|Adverse Event|0|||
13265947|NCT01445080|26411114|FG007|Overall Study|Adverse Event|3|||
13265948|NCT01445080|26411115|FG008|Overall Study|Adverse Event|10|||
13265949|NCT01445080|26411107|FG000|Overall Study|Physician Decision|0|||
13265950|NCT01445080|26411108|FG001|Overall Study|Physician Decision|0|||
13265951|NCT01445080|26411109|FG002|Overall Study|Physician Decision|1|||
13265952|NCT01445080|26411110|FG003|Overall Study|Physician Decision|0|||
13265953|NCT01445080|26411111|FG004|Overall Study|Physician Decision|0|||
13265954|NCT01445080|26411112|FG005|Overall Study|Physician Decision|3|||
13265955|NCT01445080|26411113|FG006|Overall Study|Physician Decision|2|||
13265956|NCT01445080|26411114|FG007|Overall Study|Physician Decision|2|||
13265957|NCT01445080|26411115|FG008|Overall Study|Physician Decision|0|||
13265958|NCT01445080|26411107|FG000|Overall Study|Withdrawal by Subject|1|||
13265959|NCT01445080|26411108|FG001|Overall Study|Withdrawal by Subject|0|||
13265960|NCT01445080|26411109|FG002|Overall Study|Withdrawal by Subject|0|||
13265961|NCT01445080|26411110|FG003|Overall Study|Withdrawal by Subject|1|||
13265962|NCT01445080|26411111|FG004|Overall Study|Withdrawal by Subject|0|||
13265963|NCT01445080|26411112|FG005|Overall Study|Withdrawal by Subject|0|||
13265964|NCT01445080|26411113|FG006|Overall Study|Withdrawal by Subject|0|||
13265965|NCT01445080|26411114|FG007|Overall Study|Withdrawal by Subject|0|||
13265966|NCT01445080|26411115|FG008|Overall Study|Withdrawal by Subject|2|||
13265967|NCT01445080|26411107|FG000|Overall Study|Ineligible/Inevaluable|1|||
13265968|NCT01445080|26411108|FG001|Overall Study|Ineligible/Inevaluable|2|||
13265969|NCT01445080|26411109|FG002|Overall Study|Ineligible/Inevaluable|0|||
13265970|NCT01445080|26411110|FG003|Overall Study|Ineligible/Inevaluable|1|||
13265971|NCT01445080|26411111|FG004|Overall Study|Ineligible/Inevaluable|2|||
13265972|NCT01445080|26411112|FG005|Overall Study|Ineligible/Inevaluable|3|||
13265973|NCT01445080|26411113|FG006|Overall Study|Ineligible/Inevaluable|0|||
13265974|NCT01445080|26411114|FG007|Overall Study|Ineligible/Inevaluable|0|||
13265975|NCT01445080|26411115|FG008|Overall Study|Ineligible/Inevaluable|6|||
13265976|NCT01444898|26411129|FG000|Overall Study|Withdrawal by Subject|1|||
13265977|NCT01444781|26411177|FG000|Overall Study|Lost to Follow-up|0|||
13265978|NCT01444781|26411178|FG001|Overall Study|Lost to Follow-up|3|||
13265979|NCT01444781|26411179|FG002|Overall Study|Lost to Follow-up|1|||
13265980|NCT01444781|26411177|FG000|Overall Study|Withdrawal by Subject|3|||
13265981|NCT01444781|26411178|FG001|Overall Study|Withdrawal by Subject|1|||
13265982|NCT01444781|26411179|FG002|Overall Study|Withdrawal by Subject|2|||
13265983|NCT01444742|26411186|FG000|Overall Study|Death|1|||
13265984|NCT01444651|26411209|FG000|Overall Study|Adverse Event|3|||
13265985|NCT01444651|26411210|FG001|Overall Study|Adverse Event|2|||
13265986|NCT01444651|26411209|FG000|Overall Study|Lost to Follow-up|5|||
13265987|NCT01444651|26411210|FG001|Overall Study|Lost to Follow-up|5|||
13265988|NCT01444651|26411209|FG000|Overall Study|Non-fasting|2|||
13265989|NCT01444651|26411210|FG001|Overall Study|Non-fasting|1|||
13265990|NCT01444651|26411209|FG000|Overall Study|Missing data|1|||
13265991|NCT01444651|26411210|FG001|Overall Study|Missing data|1|||
13265992|NCT01444456|26411221|FG000|Overall Study|Withdrawal by Subject|21|||
13265993|NCT01444456|26411221|FG000|Overall Study|Physician Decision|9|||
13265994|NCT01444456|26411221|FG000|Overall Study|Lost to Follow-up|37|||
13265995|NCT01444456|26411221|FG000|Overall Study|Death|73|||
13265996|NCT01444456|26411221|FG000|Overall Study|Ineligibility determined|23|||
13265997|NCT01444456|26411221|FG000|Overall Study|Other|18|||
13265998|NCT01444456|26411221|FG000|Overall Study|Not treated|104|||
13265999|NCT01444430|26411248|FG000|Overall Study|Withdrawal by Subject|53|||
13266000|NCT01444430|26411249|FG001|Overall Study|Withdrawal by Subject|72|||
13266001|NCT01444430|26411248|FG000|Overall Study|Death|6|||
13266002|NCT01444430|26411249|FG001|Overall Study|Death|8|||
13266003|NCT01444430|26411248|FG000|Overall Study|Lost to Follow-up|2|||
13266004|NCT01444430|26411249|FG001|Overall Study|Lost to Follow-up|0|||
13266005|NCT01444430|26411248|FG000|Overall Study|CRF termination module not completed.|0|||
13266006|NCT01444430|26411249|FG001|Overall Study|CRF termination module not completed.|1|||
13266007|NCT01444417|26411272|FG000|Overall Study|Ineligibility Determined|0|||
13266008|NCT01444417|26411273|FG001|Overall Study|Ineligibility Determined|1|||
13266009|NCT01444417|26411272|FG000|Overall Study|Withdrawal by Subject|2|||
13266010|NCT01444417|26411273|FG001|Overall Study|Withdrawal by Subject|0|||
13266011|NCT01444391|26411283|FG000|Overall Study|Death|1|||
13266012|NCT01444378|26411395|FG000|Overall Study|Lost to Follow-up|1|||
13266013|NCT01444378|26411395|FG000|Overall Study|Withdrawal by Subject|1|||
13266014|NCT01444378|26411395|FG000|Overall Study|Death|3|||
13266015|NCT01444378|26411395|FG000|Overall Study|Administrative Closure Of The Study|2|||
13266016|NCT01444378|26411395|FG000|Overall Study|Missed Visits|10|||
13266017|NCT01444300|26411412|FG000|Overall Study|Adverse Event|4|||
13266018|NCT01444300|26411413|FG001|Overall Study|Adverse Event|0|||
13266019|NCT01444027|26411443|FG000|Overall Study|Withdrawal by Subject|4|||
13266020|NCT01444027|26411444|FG001|Overall Study|Withdrawal by Subject|10|||
13266021|NCT01444027|26411445|FG002|Overall Study|Withdrawal by Subject|24|||
13266022|NCT01444027|26411443|FG000|Overall Study|Lost to Follow-up|26|||
13266023|NCT01444027|26411444|FG001|Overall Study|Lost to Follow-up|20|||
13266024|NCT01444027|26411445|FG002|Overall Study|Lost to Follow-up|14|||
13290651|NCT00101283|26481504|FG000|Overall Study|Withdrawal by Subject|0|||
13486354|NCT04476251|27035897|FG000|Overall Study|Not treated|1|||
13266025|NCT01443923|26411466|FG000|Overall Study|Adverse Event|1|||
13266026|NCT01443923|26411467|FG001|Overall Study|Adverse Event|0|||
13266027|NCT01443858|26411497|FG000|Overall Study|Withdrawal by Subject|9|||
13266028|NCT01443858|26411498|FG001|Overall Study|Withdrawal by Subject|8|||
13266029|NCT01443858|26411499|FG002|Overall Study|Withdrawal by Subject|5|||
13266030|NCT01443858|26411497|FG000|Overall Study|Lack of Efficacy|1|||
13266031|NCT01443858|26411498|FG001|Overall Study|Lack of Efficacy|0|||
13266032|NCT01443858|26411499|FG002|Overall Study|Lack of Efficacy|0|||
13266033|NCT01443858|26411497|FG000|Overall Study|Lost to Follow-up|5|||
13266034|NCT01443858|26411498|FG001|Overall Study|Lost to Follow-up|5|||
13266035|NCT01443858|26411499|FG002|Overall Study|Lost to Follow-up|2|||
13266036|NCT01443845|26411518|FG000|Overall Study|Protocol Violation|43|||
13266037|NCT01443845|26411519|FG001|Overall Study|Protocol Violation|45|||
13266038|NCT01443845|26411518|FG000|Overall Study|Other reasons, such as COPD exacerbation|44|||
13266039|NCT01443845|26411519|FG001|Overall Study|Other reasons, such as COPD exacerbation|44|||
13266040|NCT01443845|26411518|FG000|Overall Study|Deterioration in pulmonary function|1|||
13266041|NCT01443845|26411519|FG001|Overall Study|Deterioration in pulmonary function|4|||
13266042|NCT01443845|26411518|FG000|Overall Study|Lack of Efficacy|10|||
13266043|NCT01443845|26411519|FG001|Overall Study|Lack of Efficacy|5|||
13266044|NCT01443845|26411518|FG000|Overall Study|Adverse Event|64|||
13266045|NCT01443845|26411519|FG001|Overall Study|Adverse Event|138|||
13266046|NCT01443845|26411518|FG000|Overall Study|Withdrawal by Subject|63|||
13266047|NCT01443845|26411519|FG001|Overall Study|Withdrawal by Subject|67|||
13266048|NCT01443845|26411518|FG000|Overall Study|Military Conflict - Site Terminated|20|||
13266049|NCT01443845|26411519|FG001|Overall Study|Military Conflict - Site Terminated|21|||
13266050|NCT01443845|26411518|FG000|Overall Study|Lost to Follow-up|9|||
13266051|NCT01443845|26411519|FG001|Overall Study|Lost to Follow-up|13|||
13266052|NCT01443403|26411679|FG000|Overall Study|Adverse Event|1|||
13266053|NCT01443403|26411680|FG001|Overall Study|Adverse Event|1|||
13266054|NCT01443403|26411681|FG002|Overall Study|Adverse Event|4|||
13266055|NCT01443403|26411682|FG003|Overall Study|Adverse Event|5|||
13266056|NCT01443403|26411679|FG000|Overall Study|Withdrawal by Subject|0|||
13266057|NCT01443403|26411680|FG001|Overall Study|Withdrawal by Subject|1|||
13266058|NCT01443403|26411681|FG002|Overall Study|Withdrawal by Subject|2|||
13266059|NCT01443403|26411682|FG003|Overall Study|Withdrawal by Subject|1|||
13266060|NCT01443403|26411679|FG000|Overall Study|Lost to Follow-up|0|||
13266061|NCT01443403|26411680|FG001|Overall Study|Lost to Follow-up|0|||
13266062|NCT01443403|26411681|FG002|Overall Study|Lost to Follow-up|0|||
13266063|NCT01443403|26411682|FG003|Overall Study|Lost to Follow-up|1|||
13266064|NCT01443403|26411679|FG000|Overall Study|Protocol Violation|2|||
13266065|NCT01443403|26411680|FG001|Overall Study|Protocol Violation|1|||
13266066|NCT01443403|26411681|FG002|Overall Study|Protocol Violation|1|||
13266067|NCT01443403|26411682|FG003|Overall Study|Protocol Violation|1|||
13266068|NCT01443403|26411679|FG000|Overall Study|Use of Prohibited Treatment|2|||
13266069|NCT01443403|26411680|FG001|Overall Study|Use of Prohibited Treatment|3|||
13266070|NCT01443403|26411681|FG002|Overall Study|Use of Prohibited Treatment|0|||
13266071|NCT01443403|26411682|FG003|Overall Study|Use of Prohibited Treatment|0|||
13266072|NCT01443403|26411679|FG000|Overall Study|Other - Miscellaneous|1|||
13266073|NCT01443403|26411680|FG001|Overall Study|Other - Miscellaneous|0|||
13266074|NCT01443403|26411681|FG002|Overall Study|Other - Miscellaneous|0|||
13266075|NCT01443403|26411682|FG003|Overall Study|Other - Miscellaneous|1|||
13266076|NCT01443364|26411807|FG000|Overall Study|Lack of Efficacy|14|||
13266077|NCT01443364|26411807|FG000|Overall Study|Lost to Follow-up|3|||
13266078|NCT01443364|26411807|FG000|Overall Study|Withdrawal by Subject|5|||
13266079|NCT01443364|26411807|FG000|Overall Study|Other Reason|4|||
13266080|NCT01443364|26411807|FG000|Overall Study|SAE, non-fatal|6|||
13266081|NCT01443364|26411807|FG000|Overall Study|AE, non-serious non-fatal|8|||
13266082|NCT01443364|26411807|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
13266083|NCT01443130|26411876|FG000|Overall Study|Lost to Follow-up|44|||
13266084|NCT01443130|26411877|FG001|Overall Study|Lost to Follow-up|42|||
13266085|NCT01443130|26411878|FG002|Overall Study|Lost to Follow-up|50|||
13266086|NCT01443130|26411879|FG003|Overall Study|Lost to Follow-up|23|||
13266087|NCT01443130|26411880|FG004|Overall Study|Lost to Follow-up|25|||
13266088|NCT01443130|26411881|FG005|Overall Study|Lost to Follow-up|21|||
13266089|NCT01443130|26411876|FG000|Overall Study|Death|0|||
13266090|NCT01443130|26411877|FG001|Overall Study|Death|1|||
13266091|NCT01443130|26411878|FG002|Overall Study|Death|0|||
13266092|NCT01443130|26411879|FG003|Overall Study|Death|7|||
13266093|NCT01443130|26411880|FG004|Overall Study|Death|10|||
13266094|NCT01443130|26411881|FG005|Overall Study|Death|8|||
13266095|NCT01443130|26411876|FG000|Overall Study|Adverse Event|2|||
13266096|NCT01443130|26411877|FG001|Overall Study|Adverse Event|1|||
13266097|NCT01443130|26411878|FG002|Overall Study|Adverse Event|1|||
13266098|NCT01443130|26411879|FG003|Overall Study|Adverse Event|0|||
13266099|NCT01443130|26411880|FG004|Overall Study|Adverse Event|0|||
13266100|NCT01443130|26411881|FG005|Overall Study|Adverse Event|0|||
13266101|NCT01443130|26411876|FG000|Overall Study|Protocol Violation|2|||
13266102|NCT01443130|26411877|FG001|Overall Study|Protocol Violation|1|||
13266103|NCT01443130|26411878|FG002|Overall Study|Protocol Violation|3|||
13266104|NCT01443130|26411879|FG003|Overall Study|Protocol Violation|2|||
13266105|NCT01443130|26411880|FG004|Overall Study|Protocol Violation|2|||
13266106|NCT01443130|26411881|FG005|Overall Study|Protocol Violation|3|||
13266107|NCT01443130|26411876|FG000|Overall Study|Withdrawal by Subject|15|||
13266108|NCT01443130|26411877|FG001|Overall Study|Withdrawal by Subject|14|||
13266109|NCT01443130|26411878|FG002|Overall Study|Withdrawal by Subject|12|||
13266110|NCT01443130|26411879|FG003|Overall Study|Withdrawal by Subject|7|||
13266111|NCT01443130|26411880|FG004|Overall Study|Withdrawal by Subject|7|||
13266112|NCT01443130|26411881|FG005|Overall Study|Withdrawal by Subject|2|||
13266113|NCT01443130|26411876|FG000|Overall Study|Death of Subject's Infant|5|||
13266114|NCT01443130|26411877|FG001|Overall Study|Death of Subject's Infant|10|||
13266115|NCT01443130|26411878|FG002|Overall Study|Death of Subject's Infant|11|||
13266116|NCT01443130|26411879|FG003|Overall Study|Death of Subject's Infant|0|||
13266117|NCT01443130|26411880|FG004|Overall Study|Death of Subject's Infant|0|||
13266118|NCT01443130|26411881|FG005|Overall Study|Death of Subject's Infant|0|||
13266119|NCT01443078|26411888|FG000|Overall Study|Responded to neoadjuvant platinum txt|27|||
13266120|NCT01443078|26411888|FG000|Overall Study|Withdrawal by Subject|1|||
13266121|NCT01443078|26411888|FG000|Overall Study|Patient had brain mets|1|||
13266122|NCT01443026|26411901|FG000|Overall Study|Physician Decision|1|||
13266123|NCT01443026|26411902|FG001|Overall Study|Physician Decision|0|||
13266124|NCT01443026|26411901|FG000|Overall Study|Death|0|||
13266125|NCT01443026|26411902|FG001|Overall Study|Death|1|||
13266126|NCT01443026|26411901|FG000|Overall Study|Withdrawal by Subject|0|||
13266127|NCT01443026|26411902|FG001|Overall Study|Withdrawal by Subject|3|||
13266128|NCT01443026|26411901|FG000|Overall Study|Lost to Follow-up|2|||
13266129|NCT01443026|26411902|FG001|Overall Study|Lost to Follow-up|1|||
13266130|NCT01442779|26411910|FG000|Overall Study|Withdrawal by Subject|3|||
13266131|NCT01442779|26411910|FG000|Overall Study|Death|3|||
13266132|NCT01442779|26411910|FG000|Overall Study|Non-compliance|1|||
13266133|NCT01442714|26411918|FG000|Overall Study|Death|11|||
13266134|NCT01442714|26411918|FG000|Overall Study|Withdrawal by Subject|1|||
13266135|NCT01442688|26411933|FG000|First Intervention|Withdrawal by Subject|1|||
13266136|NCT01442688|26411934|FG001|First Intervention|Withdrawal by Subject|0|||
13266137|NCT01442688|26411933|FG000|First Intervention|subject incarcerated|1|||
13266138|NCT01442688|26411934|FG001|First Intervention|subject incarcerated|0|||
13266139|NCT01442688|26411933|FG000|Second Intervention|Adverse Event|1|||
13266140|NCT01442688|26411934|FG001|Second Intervention|Adverse Event|0|||
13266141|NCT01442675|26411946|FG000|Overall Study|Protocol Violation|6|||
13266142|NCT01442675|26411946|FG000|Overall Study|Lost to Follow-up|2|||
13266143|NCT01442675|26411946|FG000|Overall Study|Withdrawal by Subject|4|||
13266144|NCT01442493|26411971|FG000|Overall Study|withdrawn from study|3|||
13266145|NCT01442493|26411972|FG001|Overall Study|withdrawn from study|2|||
13266146|NCT01442376|26411993|FG000|Overall Study|Adverse Event|0|||
13266147|NCT01442376|26411994|FG001|Overall Study|Adverse Event|3|||
13266148|NCT01442376|26411995|FG002|Overall Study|Adverse Event|2|||
13266149|NCT01442376|26411993|FG000|Overall Study|Death|0|||
13266150|NCT01442376|26411994|FG001|Overall Study|Death|1|||
13266151|NCT01442376|26411995|FG002|Overall Study|Death|1|||
13266152|NCT01442376|26411993|FG000|Overall Study|Withdrawal of consent|0|||
13266153|NCT01442376|26411994|FG001|Overall Study|Withdrawal of consent|0|||
13266154|NCT01442376|26411995|FG002|Overall Study|Withdrawal of consent|1|||
13266155|NCT01442376|26411993|FG000|Overall Study|Patients not treated|2|||
13266156|NCT01442376|26411994|FG001|Overall Study|Patients not treated|3|||
13266157|NCT01442376|26411995|FG002|Overall Study|Patients not treated|1|||
13266158|NCT01442376|26411993|FG000|Overall Study|Not eligible for subsequent cycles|1|||
13266159|NCT01442376|26411994|FG001|Overall Study|Not eligible for subsequent cycles|2|||
13266160|NCT01442376|26411995|FG002|Overall Study|Not eligible for subsequent cycles|0|||
13266161|NCT01442181|26412026|FG000|Overall Study|patient refused surgery|1|||
13266162|NCT01442181|26412027|FG001|Overall Study|patient refused surgery|0|||
13266163|NCT01442181|26412026|FG000|Overall Study|no insurance for surgery|1|||
13266164|NCT01442181|26412027|FG001|Overall Study|no insurance for surgery|0|||
13266165|NCT01442181|26412026|FG000|Overall Study|low ejection factor|0|||
13266166|NCT01442181|26412027|FG001|Overall Study|low ejection factor|1|||
13266167|NCT01442181|26412026|FG000|Overall Study|Lost to Follow-up|1|||
13266168|NCT01442181|26412027|FG001|Overall Study|Lost to Follow-up|1|||
13266169|NCT01442181|26412026|FG000|Overall Study|patient in an additional study|1|||
13266170|NCT01442181|26412027|FG001|Overall Study|patient in an additional study|0|||
13266171|NCT01442181|26412026|FG000|Overall Study|atrial fibrillation not noted|0|||
13266172|NCT01442181|26412027|FG001|Overall Study|atrial fibrillation not noted|1|||
13266173|NCT01442155|26412034|FG000|Overall Study|Complete remission|35|||
13266174|NCT01442155|26412034|FG000|Overall Study|Recurrence|26|||
13266175|NCT01442155|26412034|FG000|Overall Study|Adverse Event|2|||
13266176|NCT01442155|26412034|FG000|Overall Study|Lost to Follow-up|2|||
13266177|NCT01442103|26412040|FG000|Overall Study|Lost to Follow-up|2|||
13266178|NCT01442064|26412094|FG000|Overall Study|Adverse Event|2|||
13266179|NCT01442064|26412095|FG001|Overall Study|Adverse Event|2|||
13266180|NCT01442064|26412096|FG002|Overall Study|Adverse Event|2|||
13266181|NCT01442064|26412097|FG003|Overall Study|Adverse Event|1|||
13266182|NCT01442064|26412098|FG004|Overall Study|Adverse Event|2|||
13266183|NCT01442064|26412099|FG005|Overall Study|Adverse Event|0|||
13266184|NCT01442064|26412094|FG000|Overall Study|Death|0|||
13266185|NCT01442064|26412095|FG001|Overall Study|Death|1|||
13266186|NCT01442064|26412096|FG002|Overall Study|Death|3|||
13266187|NCT01442064|26412097|FG003|Overall Study|Death|3|||
13266188|NCT01442064|26412098|FG004|Overall Study|Death|1|||
13266189|NCT01442064|26412099|FG005|Overall Study|Death|3|||
13266190|NCT01442064|26412094|FG000|Overall Study|Lost to Follow-up|5|||
13266191|NCT01442064|26412095|FG001|Overall Study|Lost to Follow-up|5|||
13266192|NCT01442064|26412096|FG002|Overall Study|Lost to Follow-up|1|||
13266193|NCT01442064|26412097|FG003|Overall Study|Lost to Follow-up|1|||
13266194|NCT01442064|26412098|FG004|Overall Study|Lost to Follow-up|3|||
13266195|NCT01442064|26412099|FG005|Overall Study|Lost to Follow-up|3|||
13266196|NCT01442064|26412094|FG000|Overall Study|Physician Decision|1|||
13266197|NCT01442064|26412095|FG001|Overall Study|Physician Decision|1|||
13266198|NCT01442064|26412096|FG002|Overall Study|Physician Decision|2|||
13266199|NCT01442064|26412097|FG003|Overall Study|Physician Decision|3|||
13266200|NCT01442064|26412098|FG004|Overall Study|Physician Decision|3|||
13266201|NCT01442064|26412099|FG005|Overall Study|Physician Decision|1|||
13266202|NCT01442064|26412094|FG000|Overall Study|Withdrawal by Subject|6|||
13266203|NCT01442064|26412095|FG001|Overall Study|Withdrawal by Subject|3|||
13266204|NCT01442064|26412096|FG002|Overall Study|Withdrawal by Subject|2|||
13266205|NCT01442064|26412097|FG003|Overall Study|Withdrawal by Subject|2|||
13266206|NCT01442064|26412098|FG004|Overall Study|Withdrawal by Subject|2|||
13266207|NCT01442064|26412099|FG005|Overall Study|Withdrawal by Subject|1|||
13266208|NCT01442064|26412094|FG000|Overall Study|Sponsor decision|82|||
13266209|NCT01442064|26412095|FG001|Overall Study|Sponsor decision|88|||
13266210|NCT01442064|26412096|FG002|Overall Study|Sponsor decision|92|||
13266211|NCT01442064|26412097|FG003|Overall Study|Sponsor decision|88|||
13266212|NCT01442064|26412098|FG004|Overall Study|Sponsor decision|95|||
13266213|NCT01442064|26412099|FG005|Overall Study|Sponsor decision|87|||
13266214|NCT01442064|26412094|FG000|Overall Study|Subject non-compliance|0|||
13266215|NCT01442064|26412095|FG001|Overall Study|Subject non-compliance|0|||
13266216|NCT01442064|26412096|FG002|Overall Study|Subject non-compliance|0|||
13266217|NCT01442064|26412097|FG003|Overall Study|Subject non-compliance|0|||
13266218|NCT01442064|26412098|FG004|Overall Study|Subject non-compliance|0|||
13266219|NCT01442064|26412099|FG005|Overall Study|Subject non-compliance|2|||
13266220|NCT01442064|26412094|FG000|Overall Study|Condition mandated other intervention|1|||
13266221|NCT01442064|26412095|FG001|Overall Study|Condition mandated other intervention|1|||
13266222|NCT01442064|26412096|FG002|Overall Study|Condition mandated other intervention|2|||
13266223|NCT01442064|26412097|FG003|Overall Study|Condition mandated other intervention|0|||
13266224|NCT01442064|26412098|FG004|Overall Study|Condition mandated other intervention|0|||
13266225|NCT01442064|26412099|FG005|Overall Study|Condition mandated other intervention|2|||
13266226|NCT01442038|26412118|FG000|Overall Study|Death|35|||
13266227|NCT01442038|26412119|FG001|Overall Study|Death|29|||
13266228|NCT01442038|26412118|FG000|Overall Study|Investigator-Initiated Early Closure|44|||
13266229|NCT01442038|26412119|FG001|Overall Study|Investigator-Initiated Early Closure|43|||
13266230|NCT01442038|26412118|FG000|Overall Study|Participant Withdrew Consent|137|||
13266231|NCT01442038|26412119|FG001|Overall Study|Participant Withdrew Consent|102|||
13266232|NCT01442038|26412118|FG000|Overall Study|Lost to Follow-up|37|||
13266233|NCT01442038|26412119|FG001|Overall Study|Lost to Follow-up|51|||
13266234|NCT01442038|26412118|FG000|Overall Study|Adverse Event|26|||
13266235|NCT01442038|26412119|FG001|Overall Study|Adverse Event|15|||
13266236|NCT01442038|26412118|FG000|Overall Study|Protocol Deviation|9|||
13266237|NCT01442038|26412119|FG001|Overall Study|Protocol Deviation|20|||
13266238|NCT01442038|26412118|FG000|Overall Study|Investigator's Discretion|13|||
13266239|NCT01442038|26412119|FG001|Overall Study|Investigator's Discretion|16|||
13266240|NCT01442038|26412118|FG000|Overall Study|Study Terminated By Sponsor|2|||
13266241|NCT01442038|26412119|FG001|Overall Study|Study Terminated By Sponsor|3|||
13266242|NCT01441973|26412148|FG000|Overall Study|Disease progression|8|||
13266243|NCT01441973|26412149|FG001|Overall Study|Disease progression|6|||
13266244|NCT01441973|26412148|FG000|Overall Study|Adverse event unrelated to study drug|3|||
13266245|NCT01441973|26412149|FG001|Overall Study|Adverse event unrelated to study drug|2|||
13266246|NCT01441973|26412148|FG000|Overall Study|Participant request to discontinue|1|||
13266247|NCT01441973|26412149|FG001|Overall Study|Participant request to discontinue|1|||
13266248|NCT01441973|26412148|FG000|Overall Study|Poor compliance/noncompliance|0|||
13266249|NCT01441973|26412149|FG001|Overall Study|Poor compliance/noncompliance|1|||
13266250|NCT01441973|26412148|FG000|Overall Study|Administrative reason by sponsor|3|||
13266251|NCT01441973|26412149|FG001|Overall Study|Administrative reason by sponsor|5|||
13266252|NCT01441973|26412148|FG000|Overall Study|Participant withdrew consent|0|||
13266253|NCT01441973|26412149|FG001|Overall Study|Participant withdrew consent|1|||
13266254|NCT01441960|26412162|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6|||
13266255|NCT01441960|26412163|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5|||
13266256|NCT01441960|26412162|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
13266257|NCT01441960|26412163|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
13266258|NCT01441960|26412162|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1|||
13266259|NCT01441960|26412163|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0|||
13266260|NCT01441765|26412184|FG000|Overall Study|Death|1|||
13266261|NCT01441765|26412185|FG001|Overall Study|Death|0|||
13266262|NCT01441635|26412428|FG000|Overall Study|Adverse Event|4|||
13266263|NCT01441635|26412429|FG001|Overall Study|Adverse Event|3|||
13266264|NCT01441635|26412430|FG002|Overall Study|Adverse Event|1|||
13266265|NCT01441635|26412431|FG003|Overall Study|Adverse Event|5|||
13266266|NCT01441635|26412432|FG004|Overall Study|Adverse Event|1|||
13266267|NCT01441635|26412433|FG005|Overall Study|Adverse Event|2|||
13266268|NCT01441635|26412434|FG006|Overall Study|Adverse Event|2|||
13266269|NCT01441635|26412435|FG007|Overall Study|Adverse Event|2|||
13266270|NCT01441635|26412436|FG008|Overall Study|Adverse Event|1|||
13266271|NCT01441635|26412437|FG009|Overall Study|Adverse Event|0|||
13266272|NCT01441635|26412428|FG000|Overall Study|Withdrawal by Subject|1|||
13266273|NCT01441635|26412429|FG001|Overall Study|Withdrawal by Subject|1|||
13266274|NCT01441635|26412430|FG002|Overall Study|Withdrawal by Subject|0|||
13266275|NCT01441635|26412431|FG003|Overall Study|Withdrawal by Subject|1|||
13266276|NCT01441635|26412432|FG004|Overall Study|Withdrawal by Subject|0|||
13266277|NCT01441635|26412433|FG005|Overall Study|Withdrawal by Subject|0|||
13266278|NCT01441635|26412434|FG006|Overall Study|Withdrawal by Subject|2|||
13266279|NCT01441635|26412435|FG007|Overall Study|Withdrawal by Subject|0|||
13266280|NCT01441635|26412436|FG008|Overall Study|Withdrawal by Subject|1|||
13266281|NCT01441635|26412437|FG009|Overall Study|Withdrawal by Subject|1|||
13266282|NCT01441635|26412428|FG000|Overall Study|Lost to Follow-up|0|||
13266283|NCT01441635|26412429|FG001|Overall Study|Lost to Follow-up|1|||
13266284|NCT01441635|26412430|FG002|Overall Study|Lost to Follow-up|1|||
13266285|NCT01441635|26412431|FG003|Overall Study|Lost to Follow-up|1|||
13266286|NCT01441635|26412432|FG004|Overall Study|Lost to Follow-up|1|||
13266287|NCT01441635|26412433|FG005|Overall Study|Lost to Follow-up|3|||
13266288|NCT01441635|26412434|FG006|Overall Study|Lost to Follow-up|1|||
13266289|NCT01441635|26412435|FG007|Overall Study|Lost to Follow-up|1|||
13266290|NCT01441635|26412436|FG008|Overall Study|Lost to Follow-up|0|||
13266291|NCT01441635|26412437|FG009|Overall Study|Lost to Follow-up|1|||
13266292|NCT01441635|26412428|FG000|Overall Study|Noncompliance|0|||
13266293|NCT01441635|26412429|FG001|Overall Study|Noncompliance|1|||
13266294|NCT01441635|26412430|FG002|Overall Study|Noncompliance|0|||
13266295|NCT01441635|26412431|FG003|Overall Study|Noncompliance|0|||
13266296|NCT01441635|26412432|FG004|Overall Study|Noncompliance|0|||
13266297|NCT01441635|26412433|FG005|Overall Study|Noncompliance|0|||
13266298|NCT01441635|26412434|FG006|Overall Study|Noncompliance|1|||
13266299|NCT01441635|26412435|FG007|Overall Study|Noncompliance|0|||
13266300|NCT01441635|26412436|FG008|Overall Study|Noncompliance|0|||
13266301|NCT01441635|26412437|FG009|Overall Study|Noncompliance|0|||
13266302|NCT01441635|26412428|FG000|Overall Study|Surgery or Invasive Intervention|0|||
13266303|NCT01441635|26412429|FG001|Overall Study|Surgery or Invasive Intervention|0|||
13266304|NCT01441635|26412430|FG002|Overall Study|Surgery or Invasive Intervention|1|||
13266305|NCT01441635|26412431|FG003|Overall Study|Surgery or Invasive Intervention|0|||
13266306|NCT01441635|26412432|FG004|Overall Study|Surgery or Invasive Intervention|0|||
13266307|NCT01441635|26412433|FG005|Overall Study|Surgery or Invasive Intervention|0|||
13266308|NCT01441635|26412434|FG006|Overall Study|Surgery or Invasive Intervention|0|||
13266309|NCT01441635|26412435|FG007|Overall Study|Surgery or Invasive Intervention|0|||
13266310|NCT01441635|26412436|FG008|Overall Study|Surgery or Invasive Intervention|0|||
13266311|NCT01441635|26412437|FG009|Overall Study|Surgery or Invasive Intervention|0|||
13266312|NCT01441635|26412428|FG000|Overall Study|Received Exclusionary Medication|1|||
13266313|NCT01441635|26412429|FG001|Overall Study|Received Exclusionary Medication|0|||
13266314|NCT01441635|26412430|FG002|Overall Study|Received Exclusionary Medication|0|||
13266315|NCT01441635|26412431|FG003|Overall Study|Received Exclusionary Medication|0|||
13266316|NCT01441635|26412432|FG004|Overall Study|Received Exclusionary Medication|0|||
13266317|NCT01441635|26412433|FG005|Overall Study|Received Exclusionary Medication|0|||
13266318|NCT01441635|26412434|FG006|Overall Study|Received Exclusionary Medication|0|||
13266319|NCT01441635|26412435|FG007|Overall Study|Received Exclusionary Medication|0|||
13266320|NCT01441635|26412436|FG008|Overall Study|Received Exclusionary Medication|0|||
13266321|NCT01441635|26412437|FG009|Overall Study|Received Exclusionary Medication|0|||
13266322|NCT01441635|26412428|FG000|Overall Study|Other|0|||
13266323|NCT01441635|26412429|FG001|Overall Study|Other|0|||
13266324|NCT01441635|26412430|FG002|Overall Study|Other|0|||
13266325|NCT01441635|26412431|FG003|Overall Study|Other|0|||
13486355|NCT03915860|27035920|FG000|Overall Study|Adverse Event|3|||
13266326|NCT01441635|26412432|FG004|Overall Study|Other|0|||
13266327|NCT01441635|26412433|FG005|Overall Study|Other|0|||
13266328|NCT01441635|26412434|FG006|Overall Study|Other|0|||
13266329|NCT01441635|26412435|FG007|Overall Study|Other|1|||
13266330|NCT01441635|26412436|FG008|Overall Study|Other|0|||
13266331|NCT01441635|26412437|FG009|Overall Study|Other|0|||
13266332|NCT01441596|26412461|FG000|Overall Study|Other reason not defined below|0|||
13266333|NCT01441596|26412462|FG001|Overall Study|Other reason not defined below|2|||
13266334|NCT01441596|26412463|FG002|Overall Study|Other reason not defined below|1|||
13266335|NCT01441596|26412461|FG000|Overall Study|Withdrawal by Subject|4|||
13266336|NCT01441596|26412462|FG001|Overall Study|Withdrawal by Subject|0|||
13266337|NCT01441596|26412463|FG002|Overall Study|Withdrawal by Subject|2|||
13266338|NCT01441596|26412461|FG000|Overall Study|Not treated|0|||
13266339|NCT01441596|26412462|FG001|Overall Study|Not treated|1|||
13266340|NCT01441596|26412463|FG002|Overall Study|Not treated|1|||
13266341|NCT01441440|26412496|FG000|Overall Study|Death|1|||
13266342|NCT01441440|26412497|FG001|Overall Study|Death|0|||
13266343|NCT01441440|26412498|FG002|Overall Study|Death|1|||
13266344|NCT01441440|26412496|FG000|Overall Study|Adverse Event|2|||
13266345|NCT01441440|26412497|FG001|Overall Study|Adverse Event|9|||
13266346|NCT01441440|26412498|FG002|Overall Study|Adverse Event|9|||
13266347|NCT01441440|26412496|FG000|Overall Study|Lost to Follow-up|0|||
13266348|NCT01441440|26412497|FG001|Overall Study|Lost to Follow-up|2|||
13266349|NCT01441440|26412498|FG002|Overall Study|Lost to Follow-up|1|||
13266350|NCT01441440|26412496|FG000|Overall Study|Withdrawal by Subject|11|||
13266351|NCT01441440|26412497|FG001|Overall Study|Withdrawal by Subject|9|||
13266352|NCT01441440|26412498|FG002|Overall Study|Withdrawal by Subject|9|||
13266353|NCT01441440|26412496|FG000|Overall Study|Pregnancy|1|||
13266354|NCT01441440|26412497|FG001|Overall Study|Pregnancy|0|||
13266355|NCT01441440|26412498|FG002|Overall Study|Pregnancy|0|||
13117833|NCT03050801|25927043|FG004|Experiment 1|Lost to Follow-up|0|||
13117834|NCT03050801|25927044|FG005|Experiment 1|Lost to Follow-up|0|||
13266356|NCT01441440|26412496|FG000|Overall Study|Lack of Efficacy|1|||
13266357|NCT01441440|26412497|FG001|Overall Study|Lack of Efficacy|0|||
13266358|NCT01441440|26412498|FG002|Overall Study|Lack of Efficacy|1|||
13266359|NCT01441440|26412496|FG000|Overall Study|Moving|0|||
13266360|NCT01441440|26412497|FG001|Overall Study|Moving|1|||
13266361|NCT01441440|26412498|FG002|Overall Study|Moving|1|||
13266362|NCT01441440|26412496|FG000|Overall Study|Work-related matter|0|||
13266363|NCT01441440|26412497|FG001|Overall Study|Work-related matter|1|||
13266364|NCT01441440|26412498|FG002|Overall Study|Work-related matter|0|||
13266365|NCT01441440|26412496|FG000|Overall Study|Difficllty in keeping the schedule|1|||
13266366|NCT01441440|26412497|FG001|Overall Study|Difficllty in keeping the schedule|1|||
13266367|NCT01441440|26412498|FG002|Overall Study|Difficllty in keeping the schedule|0|||
13266368|NCT01441414|26412525|FG000|Overall Study|Participant died|9|||
13266369|NCT01441414|26412525|FG000|Overall Study|Other reasons|3|||
13266370|NCT01441414|26412525|FG000|Overall Study|Study terminated by sponsor|2|||
13266371|NCT01441414|26412525|FG000|Overall Study|Subject refused further follow-up|1|||
13266372|NCT01441180|26412546|FG000|Overall Study|Lost to Follow-up|1|||
13266373|NCT01441180|26412547|FG001|Overall Study|Lost to Follow-up|1|||
13266374|NCT01441180|26412548|FG002|Overall Study|Lost to Follow-up|1|||
13117835|NCT03050801|25927039|FG000|Experiment 1|Physician Decision|0|||
13117836|NCT03050801|25927040|FG001|Experiment 1|Physician Decision|3|||
13117837|NCT03050801|25927041|FG002|Experiment 1|Physician Decision|0|||
13117838|NCT03050801|25927042|FG003|Experiment 1|Physician Decision|0|||
13117839|NCT03050801|25927043|FG004|Experiment 1|Physician Decision|0|||
13117840|NCT03050801|25927044|FG005|Experiment 1|Physician Decision|0|||
13117841|NCT03050801|25927039|FG000|Experiment 1|Change of experimental design|0|||
13117842|NCT03050801|25927040|FG001|Experiment 1|Change of experimental design|3|||
13117843|NCT03050801|25927041|FG002|Experiment 1|Change of experimental design|0|||
13117844|NCT03050801|25927042|FG003|Experiment 1|Change of experimental design|0|||
13117845|NCT03050801|25927043|FG004|Experiment 1|Change of experimental design|0|||
13117846|NCT03050801|25927044|FG005|Experiment 1|Change of experimental design|0|||
13117847|NCT03050801|25927039|FG000|Experiment 1|Unable to obtain critical rTMS measure|0|||
13117848|NCT03050801|25927040|FG001|Experiment 1|Unable to obtain critical rTMS measure|0|||
13117849|NCT03050801|25927041|FG002|Experiment 1|Unable to obtain critical rTMS measure|2|||
13117850|NCT03050801|25927042|FG003|Experiment 1|Unable to obtain critical rTMS measure|0|||
13117851|NCT03050801|25927043|FG004|Experiment 1|Unable to obtain critical rTMS measure|0|||
13117852|NCT03050801|25927044|FG005|Experiment 1|Unable to obtain critical rTMS measure|0|||
13117853|NCT03050801|25927039|FG000|Experiment 2|Lost to Follow-up|0|||
13117854|NCT03050801|25927040|FG001|Experiment 2|Lost to Follow-up|0|||
13117855|NCT03050801|25927041|FG002|Experiment 2|Lost to Follow-up|0|||
13117856|NCT03050801|25927042|FG003|Experiment 2|Lost to Follow-up|1|||
13117857|NCT03050801|25927043|FG004|Experiment 2|Lost to Follow-up|1|||
13117858|NCT03050801|25927044|FG005|Experiment 2|Lost to Follow-up|0|||
13117859|NCT03050801|25927039|FG000|Experiment 2|Physician Decision|0|||
13117860|NCT03050801|25927040|FG001|Experiment 2|Physician Decision|0|||
13117861|NCT03050801|25927041|FG002|Experiment 2|Physician Decision|0|||
13117862|NCT03050801|25927042|FG003|Experiment 2|Physician Decision|0|||
13266375|NCT01441180|26412546|FG000|Overall Study|Discontinued|0|||
13266376|NCT01441180|26412547|FG001|Overall Study|Discontinued|0|||
13266377|NCT01441180|26412548|FG002|Overall Study|Discontinued|2|||
13266378|NCT01441102|26412570|FG000|Overall Study|Adverse Event|1|||
13266379|NCT01441102|26412570|FG000|Overall Study|Withdrawal by Subject|2|||
13266380|NCT01441063|26412601|FG000|Tocilizumab Alone|Required AZT/VGC addition|3|||
13266381|NCT01441063|26412601|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1|||
13266382|NCT01440972|26412622|FG000|Overall Study|Withdrawal by Subject|3|||
13266383|NCT01440972|26412623|FG001|Overall Study|Withdrawal by Subject|2|||
13266384|NCT01440946|26412667|FG000|Overall Study|Lost to Follow-up|1|||
13266385|NCT01440946|26412668|FG001|Overall Study|Lost to Follow-up|1|||
13266386|NCT01440946|26412667|FG000|Overall Study|Physician Decision|1|||
13266387|NCT01440946|26412668|FG001|Overall Study|Physician Decision|0|||
13266388|NCT01440881|26412687|FG000|Overall Study|Death|0|||
13266389|NCT01440881|26412688|FG001|Overall Study|Death|1|||
13266390|NCT01440816|26412709|FG000|Overall Study|Disease Progression|0|||
13266391|NCT01440816|26412710|FG001|Overall Study|Disease Progression|9|||
13266392|NCT01440816|26412709|FG000|Overall Study|To Be Seen By Local Oncologist|1|||
13266393|NCT01440816|26412710|FG001|Overall Study|To Be Seen By Local Oncologist|2|||
13266394|NCT01440803|26412724|FG000|Overall Study|Met study stopping rule|2|||
13266395|NCT01440803|26412725|FG001|Overall Study|Met study stopping rule|1|||
13266396|NCT01440803|26412724|FG000|Overall Study|Lost to Follow-up|0|||
13266397|NCT01440803|26412725|FG001|Overall Study|Lost to Follow-up|2|||
13266398|NCT01440803|26412724|FG000|Overall Study|Withdrawal by Subject|0|||
13117863|NCT03050801|25927043|FG004|Experiment 2|Physician Decision|1|||
13117864|NCT03050801|25927044|FG005|Experiment 2|Physician Decision|0|||
13117865|NCT03050801|25927039|FG000|Experiment 2|Pregnancy|0|||
13117866|NCT03050801|25927040|FG001|Experiment 2|Pregnancy|0|||
13117867|NCT03050801|25927041|FG002|Experiment 2|Pregnancy|0|||
13117868|NCT03050801|25927042|FG003|Experiment 2|Pregnancy|0|||
13117869|NCT03050801|25927043|FG004|Experiment 2|Pregnancy|1|||
13266399|NCT01440803|26412725|FG001|Overall Study|Withdrawal by Subject|1|||
13266400|NCT01440647|26412740|FG000|Overall Study|Death|2|||
13266401|NCT01440647|26412741|FG001|Overall Study|Death|3|||
13266402|NCT01440595|26412767|FG000|Overall Study|Lost to Follow-up|0|||
13266403|NCT01440595|26412768|FG001|Overall Study|Lost to Follow-up|1|||
13266404|NCT01440595|26412769|FG002|Overall Study|Lost to Follow-up|0|||
13266405|NCT01440595|26412767|FG000|Overall Study|Study terminated by sponsor.|1|||
13266406|NCT01440595|26412768|FG001|Overall Study|Study terminated by sponsor.|2|||
13266407|NCT01440595|26412769|FG002|Overall Study|Study terminated by sponsor.|1|||
13266408|NCT01440569|26412794|FG000|Main Study|Enrolled but not treated|1|||
13266409|NCT01440569|26412795|FG001|Main Study|Enrolled but not treated|0|||
13266410|NCT01440569|26412794|FG000|Main Study|Adverse Event|9|||
13266411|NCT01440569|26412795|FG001|Main Study|Adverse Event|0|||
13266412|NCT01440569|26412794|FG000|Main Study|Pregnancy|1|||
13266413|NCT01440569|26412795|FG001|Main Study|Pregnancy|0|||
13266414|NCT01440569|26412794|FG000|Main Study|Investigator's Discretion|1|||
13266415|NCT01440569|26412795|FG001|Main Study|Investigator's Discretion|1|||
13266416|NCT01440569|26412794|FG000|Main Study|Withdrew Consent|7|||
13266417|NCT01440569|26412795|FG001|Main Study|Withdrew Consent|1|||
13266418|NCT01440569|26412794|FG000|Main Study|Lost to Follow-up|13|||
13266419|NCT01440569|26412795|FG001|Main Study|Lost to Follow-up|2|||
13266420|NCT01440569|26412794|FG000|Main Study|Subject Non-Compliance|3|||
13266421|NCT01440569|26412795|FG001|Main Study|Subject Non-Compliance|0|||
13266422|NCT01440569|26412794|FG000|Main Study|Protocol Violation|1|||
13266423|NCT01440569|26412795|FG001|Main Study|Protocol Violation|0|||
13266424|NCT01440569|26412794|FG000|Open-Label Rollover Phase|Adverse Event|3|||
13266425|NCT01440569|26412795|FG001|Open-Label Rollover Phase|Adverse Event|0|||
13266426|NCT01440569|26412794|FG000|Open-Label Rollover Phase|Pregnancy|1|||
13266427|NCT01440569|26412795|FG001|Open-Label Rollover Phase|Pregnancy|0|||
13266428|NCT01440569|26412794|FG000|Open-Label Rollover Phase|Lack of Efficacy|2|||
13266429|NCT01440569|26412795|FG001|Open-Label Rollover Phase|Lack of Efficacy|0|||
13266430|NCT01440569|26412794|FG000|Open-Label Rollover Phase|Investigator's Discretion|3|||
13266431|NCT01440569|26412795|FG001|Open-Label Rollover Phase|Investigator's Discretion|1|||
13266432|NCT01440569|26412794|FG000|Open-Label Rollover Phase|Withdrew Consent|11|||
13266433|NCT01440569|26412795|FG001|Open-Label Rollover Phase|Withdrew Consent|1|||
13266434|NCT01440569|26412794|FG000|Open-Label Rollover Phase|Lost to Follow-up|26|||
13266435|NCT01440569|26412795|FG001|Open-Label Rollover Phase|Lost to Follow-up|3|||
13266436|NCT01440569|26412794|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1|||
13266437|NCT01440569|26412795|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1|||
13266438|NCT01440517|26412802|FG000|Overall Study|Subject withdrawn prior to dosing|1|||
13266439|NCT01440374|26412846|FG000|Part 1: Open-label Phase|Adverse Event|5|||
13266440|NCT01440374|26412847|FG001|Part 1: Open-label Phase|Adverse Event|0|||
13266441|NCT01440374|26412848|FG002|Part 1: Open-label Phase|Adverse Event|0|||
13266442|NCT01440374|26412849|FG003|Part 1: Open-label Phase|Adverse Event|0|||
13266443|NCT01440374|26412846|FG000|Part 1: Open-label Phase|Physician Decision|1|||
13266444|NCT01440374|26412847|FG001|Part 1: Open-label Phase|Physician Decision|0|||
13117870|NCT03050801|25927044|FG005|Experiment 2|Pregnancy|0|||
13117871|NCT03050801|25927039|FG000|Experiment 2|Withdrawal by Subject|0|||
13266445|NCT01440374|26412848|FG002|Part 1: Open-label Phase|Physician Decision|0|||
13266446|NCT01440374|26412849|FG003|Part 1: Open-label Phase|Physician Decision|0|||
13266447|NCT01440374|26412846|FG000|Part 2; Double-blind Phase|Physician Decision|0|||
13266448|NCT01440374|26412847|FG001|Part 2; Double-blind Phase|Physician Decision|8|||
13266449|NCT01440374|26412848|FG002|Part 2; Double-blind Phase|Physician Decision|17|||
13266450|NCT01440374|26412849|FG003|Part 2; Double-blind Phase|Physician Decision|0|||
13266451|NCT01440374|26412846|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
13266452|NCT01440374|26412847|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4|||
13266453|NCT01440374|26412848|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5|||
13266454|NCT01440374|26412849|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
13266455|NCT01440374|26412846|FG000|Part 2; Double-blind Phase|Protocol Violation|0|||
13266456|NCT01440374|26412847|FG001|Part 2; Double-blind Phase|Protocol Violation|0|||
13266457|NCT01440374|26412848|FG002|Part 2; Double-blind Phase|Protocol Violation|1|||
13266458|NCT01440374|26412849|FG003|Part 2; Double-blind Phase|Protocol Violation|0|||
13266459|NCT01440374|26412846|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0|||
13266460|NCT01440374|26412847|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1|||
13266461|NCT01440374|26412848|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0|||
13266462|NCT01440374|26412849|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0|||
13266463|NCT01440374|26412846|FG000|Part 2; Double-blind Phase|Adverse Event|0|||
13266464|NCT01440374|26412847|FG001|Part 2; Double-blind Phase|Adverse Event|7|||
13266465|NCT01440374|26412848|FG002|Part 2; Double-blind Phase|Adverse Event|31|||
13266466|NCT01440374|26412849|FG003|Part 2; Double-blind Phase|Adverse Event|0|||
13266467|NCT01440374|26412846|FG000|Part 2; Double-blind Phase|Not treated|0|||
13266468|NCT01440374|26412847|FG001|Part 2; Double-blind Phase|Not treated|0|||
13266469|NCT01440374|26412848|FG002|Part 2; Double-blind Phase|Not treated|1|||
13266470|NCT01440374|26412849|FG003|Part 2; Double-blind Phase|Not treated|0|||
13117872|NCT03050801|25927040|FG001|Experiment 2|Withdrawal by Subject|0|||
13266471|NCT01440374|26412846|FG000|Part 3: Extension|Withdrawal by Subject|0|||
13266472|NCT01440374|26412847|FG001|Part 3: Extension|Withdrawal by Subject|0|||
13266473|NCT01440374|26412848|FG002|Part 3: Extension|Withdrawal by Subject|0|||
13266474|NCT01440374|26412849|FG003|Part 3: Extension|Withdrawal by Subject|5|||
13266475|NCT01440374|26412846|FG000|Part 3: Extension|Adverse Event|0|||
13266476|NCT01440374|26412847|FG001|Part 3: Extension|Adverse Event|0|||
13266477|NCT01440374|26412848|FG002|Part 3: Extension|Adverse Event|0|||
13266478|NCT01440374|26412849|FG003|Part 3: Extension|Adverse Event|13|||
13266479|NCT01440374|26412846|FG000|Part 3: Extension|Physician Decision|0|||
13266480|NCT01440374|26412847|FG001|Part 3: Extension|Physician Decision|0|||
13266481|NCT01440374|26412848|FG002|Part 3: Extension|Physician Decision|0|||
13266482|NCT01440374|26412849|FG003|Part 3: Extension|Physician Decision|14|||
13266483|NCT01440322|26412878|FG000|Overall Study|Discomfort|2|||
13266484|NCT01440322|26412879|FG001|Overall Study|Discomfort|0|||
13266485|NCT01440322|26412878|FG000|Overall Study|Biomicroscopy|1|||
13266486|NCT01440322|26412879|FG001|Overall Study|Biomicroscopy|0|||
13266487|NCT01440322|26412878|FG000|Overall Study|Symptoms and Problems|1|||
13117873|NCT03050801|25927041|FG002|Experiment 2|Withdrawal by Subject|0|||
13117874|NCT03050801|25927042|FG003|Experiment 2|Withdrawal by Subject|1|||
13117875|NCT03050801|25927043|FG004|Experiment 2|Withdrawal by Subject|0|||
13117876|NCT03050801|25927044|FG005|Experiment 2|Withdrawal by Subject|0|||
13117877|NCT03050801|25927039|FG000|Experiment 2|Poor data quality|0|||
13117878|NCT03050801|25927040|FG001|Experiment 2|Poor data quality|0|||
13117879|NCT03050801|25927041|FG002|Experiment 2|Poor data quality|0|||
13266488|NCT01440322|26412879|FG001|Overall Study|Symptoms and Problems|0|||
13266489|NCT01440322|26412878|FG000|Overall Study|Unacceptable Subjective Vision|1|||
13266490|NCT01440322|26412879|FG001|Overall Study|Unacceptable Subjective Vision|0|||
13266491|NCT01440322|26412878|FG000|Overall Study|Other Product Related|1|||
13266492|NCT01440322|26412879|FG001|Overall Study|Other Product Related|0|||
13266493|NCT01440322|26412878|FG000|Overall Study|Unrelated Medical Problem|0|||
13266494|NCT01440322|26412879|FG001|Overall Study|Unrelated Medical Problem|1|||
13266495|NCT01440322|26412878|FG000|Overall Study|Other Non-Product Related|1|||
13266496|NCT01440322|26412879|FG001|Overall Study|Other Non-Product Related|0|||
13266497|NCT01440283|26412893|FG000|Overall Study|Death|3|||
13266498|NCT01440283|26412893|FG000|Overall Study|Withdrawal by Subject|4|||
13266499|NCT01440283|26412893|FG000|Overall Study|Physician Decision|3|||
13266500|NCT01440101|26412936|FG000|Overall Study|Adverse Event|2|||
13266501|NCT01440101|26412937|FG001|Overall Study|Adverse Event|0|||
13266502|NCT01440101|26412938|FG002|Overall Study|Adverse Event|0|||
13266503|NCT01440101|26412936|FG000|Overall Study|Withdrawal by Subject|0|||
13266504|NCT01440101|26412937|FG001|Overall Study|Withdrawal by Subject|3|||
13266505|NCT01440101|26412938|FG002|Overall Study|Withdrawal by Subject|1|||
13266506|NCT01440101|26412936|FG000|Overall Study|Other|0|||
13266507|NCT01440101|26412937|FG001|Overall Study|Other|1|||
13266508|NCT01440101|26412938|FG002|Overall Study|Other|0|||
13266509|NCT01440049|26412967|FG000|Overall Study|Adverse Event|5|||
13266510|NCT01439971|26413160|FG000|Overall Study|Required number in cohort dosed|0|||
13266511|NCT01439971|26413161|FG001|Overall Study|Required number in cohort dosed|1|||
13266512|NCT01439971|26413162|FG002|Overall Study|Required number in cohort dosed|2|||
13266513|NCT01439971|26413163|FG003|Overall Study|Required number in cohort dosed|0|||
13266514|NCT01439971|26413164|FG004|Overall Study|Required number in cohort dosed|1|||
13488121|NCT03858634|27042765|FG001|Overall Study|Lost to Follow-up|1|||
13117880|NCT03050801|25927042|FG003|Experiment 2|Poor data quality|4|||
13266515|NCT01439945|26413198|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
13266516|NCT01439945|26413199|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
13266517|NCT01439945|26413200|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
13266518|NCT01439945|26413201|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
13266519|NCT01439945|26413198|FG000|Double-Blind Treatment Phase|Ineligible|1|||
13266520|NCT01439945|26413199|FG001|Double-Blind Treatment Phase|Ineligible|2|||
13266521|NCT01439945|26413200|FG002|Double-Blind Treatment Phase|Ineligible|0|||
13266522|NCT01439945|26413201|FG003|Double-Blind Treatment Phase|Ineligible|1|||
13266523|NCT01439880|26413249|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24|||
13266524|NCT01439880|26413250|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38|||
13266525|NCT01439880|26413249|FG000|SOC-controlled Period (Year 1)|Death|2|||
13266526|NCT01439880|26413250|FG001|SOC-controlled Period (Year 1)|Death|1|||
13266527|NCT01439880|26413249|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0|||
13266528|NCT01439880|26413250|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1|||
13266529|NCT01439880|26413249|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10|||
13266530|NCT01439880|26413250|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5|||
13266531|NCT01439880|26413249|FG000|SOC-controlled Period (Year 1)|Other|8|||
13266532|NCT01439880|26413250|FG001|SOC-controlled Period (Year 1)|Other|13|||
13266533|NCT01439880|26413249|FG000|SOC-controlled Period (Year 1)|Reason Missing|0|||
13266534|NCT01439880|26413250|FG001|SOC-controlled Period (Year 1)|Reason Missing|2|||
13266535|NCT01439880|26413249|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21|||
13266536|NCT01439880|26413250|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30|||
13266537|NCT01439880|26413249|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30|||
13266538|NCT01439880|26413250|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66|||
13266539|NCT01439880|26413249|FG000|All-IP Period (Years 2 to 5)|Death|3|||
13266540|NCT01439880|26413250|FG001|All-IP Period (Years 2 to 5)|Death|13|||
13266541|NCT01439880|26413249|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1|||
13266542|NCT01439880|26413250|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0|||
13266543|NCT01439880|26413249|FG000|All-IP Period (Years 2 to 5)|Other|14|||
13266544|NCT01439880|26413250|FG001|All-IP Period (Years 2 to 5)|Other|31|||
13266545|NCT01439880|26413249|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1|||
13266546|NCT01439880|26413250|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0|||
13266547|NCT01439867|26413296|FG000|Overall Study|Non-compliance|0|||
13266548|NCT01439867|26413297|FG001|Overall Study|Non-compliance|1|||
13266549|NCT01439867|26413296|FG000|Overall Study|Withdrawal by Subject|1|||
13266550|NCT01439867|26413297|FG001|Overall Study|Withdrawal by Subject|2|||
13266551|NCT01439867|26413296|FG000|Overall Study|Administrative Decision|4|||
13266552|NCT01439867|26413297|FG001|Overall Study|Administrative Decision|5|||
13266553|NCT01439867|26413296|FG000|Overall Study|Protocol-specified Criteria|1|||
13266554|NCT01439867|26413297|FG001|Overall Study|Protocol-specified Criteria|0|||
13266555|NCT01439724|26413310|FG000|Overall Study|missing consultation|9|||
13266556|NCT01439724|26413311|FG001|Overall Study|missing consultation|8|||
13266557|NCT01439711|26413324|FG000|Overall Study|Ineligible|13|||
13266558|NCT01439711|26413324|FG000|Overall Study|Cancel|3|||
13266559|NCT01439711|26413324|FG000|Overall Study|Progression Prior to Beginning Tx|1|||
13266560|NCT01439711|26413324|FG000|Overall Study|Adverse Event|5|||
13266561|NCT01439711|26413324|FG000|Overall Study|Withdrawal by Subject|3|||
13266562|NCT01439711|26413324|FG000|Overall Study|Progression During Active Tx|3|||
13266563|NCT01439711|26413324|FG000|Overall Study|Noncompliance|3|||
13266564|NCT01439711|26413324|FG000|Overall Study|No MRI|9|||
13266565|NCT01439568|26413343|FG000|Overall Study|Lost to Follow-up|1|||
13266566|NCT01439568|26413344|FG001|Overall Study|Lost to Follow-up|0|||
13266567|NCT01439568|26413343|FG000|Overall Study|Withdrawal by Subject|2|||
13266568|NCT01439568|26413344|FG001|Overall Study|Withdrawal by Subject|2|||
13266569|NCT01439555|26413356|FG000|Overall Study|Protocol Violation|1|||
13266570|NCT01439373|26413404|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0|||
13266571|NCT01439373|26413405|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1|||
13266572|NCT01439373|26413404|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2|||
13266573|NCT01439373|26413405|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0|||
13266574|NCT01439360|26413460|FG000|Overall Study|Adverse Event|4|||
13266575|NCT01439360|26413461|FG001|Overall Study|Adverse Event|16|||
13266576|NCT01439360|26413460|FG000|Overall Study|Lost to Follow-up|43|||
13266577|NCT01439360|26413461|FG001|Overall Study|Lost to Follow-up|58|||
13266578|NCT01439360|26413460|FG000|Overall Study|Others|10|||
13266579|NCT01439360|26413461|FG001|Overall Study|Others|5|||
13266580|NCT01439360|26413460|FG000|Overall Study|Protocol Violation|1|||
13266581|NCT01439360|26413461|FG001|Overall Study|Protocol Violation|0|||
13266582|NCT01439360|26413460|FG000|Overall Study|Withdrawal by Subject|140|||
13266583|NCT01439360|26413461|FG001|Overall Study|Withdrawal by Subject|129|||
13266584|NCT01439347|26413474|FG000|Overall Study|Death|10|||
13266585|NCT01439347|26413475|FG001|Overall Study|Death|9|||
13266586|NCT01439347|26413474|FG000|Overall Study|Withdrawal by Subject|0|||
13266587|NCT01439347|26413475|FG001|Overall Study|Withdrawal by Subject|1|||
13266588|NCT01439347|26413474|FG000|Overall Study|Physician Decision|1|||
13266589|NCT01439347|26413475|FG001|Overall Study|Physician Decision|0|||
13266590|NCT01439347|26413474|FG000|Overall Study|Sponsor Terminated Study|2|||
13266591|NCT01439347|26413475|FG001|Overall Study|Sponsor Terminated Study|3|||
13266592|NCT01439282|26413492|FG000|Overall Study|Adverse Event|5|||
13266593|NCT01439282|26413493|FG001|Overall Study|Adverse Event|0|||
13266594|NCT01439282|26413492|FG000|Overall Study|Withdrawal by Subject|2|||
13266595|NCT01439282|26413493|FG001|Overall Study|Withdrawal by Subject|0|||
13266596|NCT01439282|26413492|FG000|Overall Study|Other|1|||
13266597|NCT01439282|26413493|FG001|Overall Study|Other|1|||
13266598|NCT01439204|26413532|FG000|Overall Study|Withdrawal by Subject|0|||
13266599|NCT01439204|26413533|FG001|Overall Study|Withdrawal by Subject|1|||
13266600|NCT01439204|26413532|FG000|Overall Study|Lost to Follow-up|0|||
13266601|NCT01439204|26413533|FG001|Overall Study|Lost to Follow-up|2|||
13266602|NCT01439204|26413532|FG000|Overall Study|No longer meets study criteria|1|||
13266603|NCT01439204|26413533|FG001|Overall Study|No longer meets study criteria|0|||
13266604|NCT01439204|26413532|FG000|Overall Study|poor/non-compliance|3|||
13266605|NCT01439204|26413533|FG001|Overall Study|poor/non-compliance|0|||
13266606|NCT01439165|26413552|FG000|Overall Study|Protocol Violation|3|||
13266607|NCT01439165|26413553|FG001|Overall Study|Protocol Violation|0|||
13266608|NCT01439165|26413552|FG000|Overall Study|Lost to Follow-up|11|||
13266609|NCT01439165|26413553|FG001|Overall Study|Lost to Follow-up|1|||
13266610|NCT01439165|26413552|FG000|Overall Study|Withdrawal by Subject|7|||
13266611|NCT01439165|26413553|FG001|Overall Study|Withdrawal by Subject|1|||
13266612|NCT01439126|26413580|FG000|Overall Study|Adverse Event|2|||
13266613|NCT01439126|26413581|FG001|Overall Study|Adverse Event|0|||
13266614|NCT01439126|26413580|FG000|Overall Study|Withdrawal by Subject|5|||
13266615|NCT01439126|26413581|FG001|Overall Study|Withdrawal by Subject|21|||
13266616|NCT01439126|26413580|FG000|Overall Study|Protocol Violation|6|||
13266617|NCT01439126|26413581|FG001|Overall Study|Protocol Violation|4|||
13266618|NCT01439126|26413580|FG000|Overall Study|Lost to Follow-up|6|||
13266619|NCT01439126|26413581|FG001|Overall Study|Lost to Follow-up|3|||
13266620|NCT01439126|26413580|FG000|Overall Study|Other-Use of prohibited treatment|0|||
13266621|NCT01439126|26413581|FG001|Overall Study|Other-Use of prohibited treatment|2|||
13307745|NCT01283152|26529636|FG000|Overall Study|Discharged prior to 24 hr assessment|1|||
13307746|NCT01283152|26529637|FG001|Overall Study|Discharged prior to 24 hr assessment|0|||
13307747|NCT01283152|26529636|FG000|Overall Study|Refused HESA|1|||
13307748|NCT01283152|26529637|FG001|Overall Study|Refused HESA|0|||
13307749|NCT01283139|26529692|FG000|Overall Study|Lost to Follow-up|5|||
13307750|NCT01283139|26529693|FG001|Overall Study|Lost to Follow-up|2|||
13307751|NCT01283139|26529694|FG002|Overall Study|Lost to Follow-up|3|||
13307752|NCT01283139|26529695|FG003|Overall Study|Lost to Follow-up|1|||
13307753|NCT01283139|26529692|FG000|Overall Study|Withdrawal by Subject|8|||
13307754|NCT01283139|26529693|FG001|Overall Study|Withdrawal by Subject|8|||
13307755|NCT01283139|26529694|FG002|Overall Study|Withdrawal by Subject|6|||
13307756|NCT01283139|26529695|FG003|Overall Study|Withdrawal by Subject|8|||
13307757|NCT01283139|26529692|FG000|Overall Study|Death|2|||
13307758|NCT01283139|26529693|FG001|Overall Study|Death|0|||
13307759|NCT01283139|26529694|FG002|Overall Study|Death|2|||
13307760|NCT01283139|26529695|FG003|Overall Study|Death|2|||
13307761|NCT01283139|26529692|FG000|Overall Study|Lack of Efficacy|1|||
13307762|NCT01283139|26529693|FG001|Overall Study|Lack of Efficacy|2|||
13307763|NCT01283139|26529694|FG002|Overall Study|Lack of Efficacy|2|||
13307764|NCT01283139|26529695|FG003|Overall Study|Lack of Efficacy|1|||
13307765|NCT01283139|26529692|FG000|Overall Study|Early termination due to AE/SAE|1|||
13307766|NCT01283139|26529693|FG001|Overall Study|Early termination due to AE/SAE|1|||
13307767|NCT01283139|26529694|FG002|Overall Study|Early termination due to AE/SAE|0|||
13307768|NCT01283139|26529695|FG003|Overall Study|Early termination due to AE/SAE|0|||
13307769|NCT01283139|26529692|FG000|Overall Study|Participant's refusal to continue|0|||
13307770|NCT01283139|26529693|FG001|Overall Study|Participant's refusal to continue|3|||
13307771|NCT01283139|26529694|FG002|Overall Study|Participant's refusal to continue|1|||
13307772|NCT01283139|26529695|FG003|Overall Study|Participant's refusal to continue|1|||
13307773|NCT01283139|26529692|FG000|Overall Study|Pregnancy|0|||
13307774|NCT01283139|26529693|FG001|Overall Study|Pregnancy|1|||
13307775|NCT01283139|26529694|FG002|Overall Study|Pregnancy|1|||
13307776|NCT01283139|26529695|FG003|Overall Study|Pregnancy|0|||
13307777|NCT01283139|26529692|FG000|Overall Study|Missed follow-up visit|0|||
13307778|NCT01283139|26529693|FG001|Overall Study|Missed follow-up visit|1|||
13307779|NCT01283139|26529694|FG002|Overall Study|Missed follow-up visit|2|||
13307780|NCT01283139|26529695|FG003|Overall Study|Missed follow-up visit|2|||
13307781|NCT01283139|26529692|FG000|Overall Study|Participant randomized in error|0|||
13307782|NCT01283139|26529693|FG001|Overall Study|Participant randomized in error|0|||
13307783|NCT01283139|26529694|FG002|Overall Study|Participant randomized in error|1|||
13307784|NCT01283139|26529695|FG003|Overall Study|Participant randomized in error|0|||
13117881|NCT03050801|25927043|FG004|Experiment 2|Poor data quality|1|||
13307785|NCT01283035|26529706|FG000|Overall Study|Subject later found ineligible|1|||
13307786|NCT01283009|26529719|FG000|Overall Study|Death|83|||
13117882|NCT03050801|25927044|FG005|Experiment 2|Poor data quality|0|||
13266622|NCT01439126|26413580|FG000|Overall Study|Other-Miscellaneous|12|||
13266623|NCT01439126|26413581|FG001|Overall Study|Other-Miscellaneous|12|||
13266624|NCT01439074|26413600|FG000|Overall Study|Lost to Follow-up|3|||
13266625|NCT01439074|26413601|FG001|Overall Study|Lost to Follow-up|4|||
13266626|NCT01439074|26413600|FG000|Overall Study|Subject shedding|1|||
13266627|NCT01439074|26413601|FG001|Overall Study|Subject shedding|0|||
13266628|NCT01439074|26413600|FG000|Overall Study|Withdrawal by Subject|1|||
13266629|NCT01439074|26413601|FG001|Overall Study|Withdrawal by Subject|5|||
13266630|NCT01439074|26413600|FG000|Overall Study|Other|4|||
13266631|NCT01439074|26413601|FG001|Overall Study|Other|4|||
13266632|NCT01439009|26413638|FG000|Overall Study|Physician Decision|5|||
13266633|NCT01439009|26413639|FG001|Overall Study|Physician Decision|3|||
13266634|NCT01439009|26413638|FG000|Overall Study|Protocol Violation|2|||
13266635|NCT01439009|26413639|FG001|Overall Study|Protocol Violation|0|||
13266636|NCT01439009|26413638|FG000|Overall Study|Deviation of exclusion criteria|1|||
13266637|NCT01439009|26413639|FG001|Overall Study|Deviation of exclusion criteria|0|||
13266638|NCT01438996|26413681|FG000|Overall Study|Not meeting Inclusion Criteria|4|||
13266639|NCT01438996|26413682|FG001|Overall Study|Not meeting Inclusion Criteria|1|||
13266640|NCT01438996|26413683|FG002|Overall Study|Not meeting Inclusion Criteria|0|||
13266641|NCT01438957|26413806|FG000|Overall Study|Physician Decision|1|||
13266642|NCT01438957|26413807|FG001|Overall Study|Physician Decision|1|||
13266643|NCT01438957|26413808|FG002|Overall Study|Physician Decision|0|||
13266644|NCT01438957|26413809|FG003|Overall Study|Physician Decision|1|||
13266645|NCT01438957|26413810|FG004|Overall Study|Physician Decision|0|||
13266646|NCT01438840|26413829|FG000|Core Study|Adverse Event|0|||
13266647|NCT01438840|26413830|FG001|Core Study|Adverse Event|3|||
13266648|NCT01438840|26413831|FG002|Core Study|Adverse Event|0|||
13266649|NCT01438840|26413829|FG000|Core Study|Lack of Efficacy|15|||
13266650|NCT01438840|26413830|FG001|Core Study|Lack of Efficacy|7|||
13266651|NCT01438840|26413831|FG002|Core Study|Lack of Efficacy|0|||
13266652|NCT01438840|26413829|FG000|Core Study|Withdrawal of consent|1|||
13266653|NCT01438840|26413830|FG001|Core Study|Withdrawal of consent|0|||
13266654|NCT01438840|26413831|FG002|Core Study|Withdrawal of consent|0|||
13266655|NCT01438840|26413829|FG000|Extension Phase|Adverse Event|0|||
13266656|NCT01438840|26413830|FG001|Extension Phase|Adverse Event|0|||
13266657|NCT01438840|26413831|FG002|Extension Phase|Adverse Event|3|||
13266658|NCT01438840|26413829|FG000|Extension Phase|Lost to Follow-up|0|||
13266659|NCT01438840|26413830|FG001|Extension Phase|Lost to Follow-up|0|||
13266660|NCT01438840|26413831|FG002|Extension Phase|Lost to Follow-up|1|||
13266661|NCT01438840|26413829|FG000|Extension Phase|Withdrawal by Subject|0|||
13266662|NCT01438840|26413830|FG001|Extension Phase|Withdrawal by Subject|0|||
13266663|NCT01438840|26413831|FG002|Extension Phase|Withdrawal by Subject|3|||
13266664|NCT01438840|26413829|FG000|Extension Phase|Lack of Efficacy|0|||
13266665|NCT01438840|26413830|FG001|Extension Phase|Lack of Efficacy|0|||
13266666|NCT01438840|26413831|FG002|Extension Phase|Lack of Efficacy|2|||
13266667|NCT01438840|26413829|FG000|Extension Phase|Other|0|||
13266668|NCT01438840|26413830|FG001|Extension Phase|Other|0|||
13266669|NCT01438840|26413831|FG002|Extension Phase|Other|1|||
13266670|NCT01438814|26413868|FG000|Overall Study|Adverse Event|3|||
13266671|NCT01438814|26413869|FG001|Overall Study|Adverse Event|3|||
13266672|NCT01438814|26413868|FG000|Overall Study|Protocol Violation|1|||
13266673|NCT01438814|26413869|FG001|Overall Study|Protocol Violation|2|||
13266674|NCT01438814|26413868|FG000|Overall Study|Lost to Follow-up|4|||
13266675|NCT01438814|26413869|FG001|Overall Study|Lost to Follow-up|3|||
13266676|NCT01438814|26413868|FG000|Overall Study|Withdrawal by Subject|4|||
13266677|NCT01438814|26413869|FG001|Overall Study|Withdrawal by Subject|2|||
13266678|NCT01438814|26413868|FG000|Overall Study|Other|2|||
13266679|NCT01438814|26413869|FG001|Overall Study|Other|4|||
13266680|NCT01438541|26413877|FG000|Overall Study|Physician Decision|1|||
13266681|NCT01438541|26413877|FG000|Overall Study|Withdrawal by Subject|1|||
13266682|NCT01438541|26413877|FG000|Overall Study|discharge from the hospital|5|||
13266683|NCT01438489|26413930|FG000|Overall Study|Lost to Follow-up|4|||
13266684|NCT01438489|26413931|FG001|Overall Study|Lost to Follow-up|2|||
13266685|NCT01438489|26413932|FG002|Overall Study|Lost to Follow-up|2|||
13266686|NCT01438489|26413930|FG000|Overall Study|Withdrawal by Subject|11|||
13266687|NCT01438489|26413931|FG001|Overall Study|Withdrawal by Subject|3|||
13266688|NCT01438489|26413932|FG002|Overall Study|Withdrawal by Subject|8|||
13266689|NCT01438489|26413930|FG000|Overall Study|Death|0|||
13117883|NCT03050801|25927039|FG000|Experiment 2|Discomfort during stimulation|0|||
13117884|NCT03050801|25927040|FG001|Experiment 2|Discomfort during stimulation|0|||
13117885|NCT03050801|25927041|FG002|Experiment 2|Discomfort during stimulation|0|||
13117886|NCT03050801|25927042|FG003|Experiment 2|Discomfort during stimulation|0|||
13117887|NCT03050801|25927043|FG004|Experiment 2|Discomfort during stimulation|0|||
13266690|NCT01438489|26413931|FG001|Overall Study|Death|0|||
13266691|NCT01438489|26413932|FG002|Overall Study|Death|1|||
13266692|NCT01438489|26413930|FG000|Overall Study|Sponsor decision|4|||
13266693|NCT01438489|26413931|FG001|Overall Study|Sponsor decision|1|||
13266694|NCT01438489|26413932|FG002|Overall Study|Sponsor decision|4|||
13266695|NCT01438489|26413930|FG000|Overall Study|Subject choice/Subject moved|2|||
13266696|NCT01438489|26413931|FG001|Overall Study|Subject choice/Subject moved|1|||
13266697|NCT01438489|26413932|FG002|Overall Study|Subject choice/Subject moved|1|||
13266698|NCT01438489|26413930|FG000|Overall Study|Investigator decision|0|||
13266699|NCT01438489|26413931|FG001|Overall Study|Investigator decision|1|||
13203569|NCT01984697|26224940|FG000|Overall Study|Missed last follow-up visit|1|||
13203570|NCT01984697|26224941|FG001|Overall Study|Missed last follow-up visit|0|||
13203571|NCT01984697|26224942|FG002|Overall Study|Missed last follow-up visit|0|||
13203572|NCT01984697|26224943|FG003|Overall Study|Missed last follow-up visit|0|||
13203573|NCT01984697|26224944|FG004|Overall Study|Missed last follow-up visit|0|||
13203574|NCT01984697|26224940|FG000|Overall Study|Death|0|||
13203575|NCT01984697|26224941|FG001|Overall Study|Death|0|||
13203576|NCT01984697|26224942|FG002|Overall Study|Death|0|||
13203577|NCT01984697|26224943|FG003|Overall Study|Death|1|||
13203578|NCT01984697|26224944|FG004|Overall Study|Death|0|||
13203579|NCT01984697|26224940|FG000|Overall Study|Pregnancy|2|||
13203580|NCT01984697|26224941|FG001|Overall Study|Pregnancy|0|||
13203581|NCT01984697|26224942|FG002|Overall Study|Pregnancy|1|||
13203582|NCT01984697|26224943|FG003|Overall Study|Pregnancy|0|||
13203583|NCT01984697|26224944|FG004|Overall Study|Pregnancy|1|||
13203584|NCT01984684|26224961|FG000|Overall Study|Lost to Follow-up|25|||
13203585|NCT01984684|26224962|FG001|Overall Study|Lost to Follow-up|24|||
13203586|NCT01984684|26224961|FG000|Overall Study|Adverse Event|8|||
13266700|NCT01438489|26413932|FG002|Overall Study|Investigator decision|0|||
13266701|NCT01438489|26413930|FG000|Overall Study|AE/SAEs|2|||
13266702|NCT01438489|26413931|FG001|Overall Study|AE/SAEs|1|||
13266703|NCT01438489|26413932|FG002|Overall Study|AE/SAEs|1|||
13266704|NCT01438489|26413930|FG000|Overall Study|Received prohibited medication|1|||
13266705|NCT01438489|26413931|FG001|Overall Study|Received prohibited medication|0|||
13266706|NCT01438489|26413932|FG002|Overall Study|Received prohibited medication|0|||
13266707|NCT01438489|26413930|FG000|Overall Study|Did not complete all 3 follow-up visits|2|||
13266708|NCT01438489|26413931|FG001|Overall Study|Did not complete all 3 follow-up visits|5|||
13266709|NCT01438489|26413932|FG002|Overall Study|Did not complete all 3 follow-up visits|2|||
13266710|NCT01438489|26413930|FG000|Overall Study|Inadequate venous access|0|||
13266711|NCT01438489|26413931|FG001|Overall Study|Inadequate venous access|2|||
13266712|NCT01438489|26413932|FG002|Overall Study|Inadequate venous access|0|||
13266713|NCT01438476|26413945|FG000|Overall Study|Protocol Violation|1|||
13266714|NCT01438476|26413946|FG001|Overall Study|Protocol Violation|0|||
13266715|NCT01438476|26413945|FG000|Overall Study|Withdrawal by Subject|1|||
13266716|NCT01438476|26413946|FG001|Overall Study|Withdrawal by Subject|0|||
13266717|NCT01438476|26413945|FG000|Overall Study|No Surgery- Disease|8|||
13266718|NCT01438476|26413946|FG001|Overall Study|No Surgery- Disease|10|||
13266719|NCT01438476|26413945|FG000|Overall Study|Communication barrier|0|||
13266720|NCT01438476|26413946|FG001|Overall Study|Communication barrier|1|||
13266721|NCT01438424|26413984|FG000|Overall Study|Continuing treatment|29|||
13266722|NCT01438424|26413984|FG000|Overall Study|Minimal virologic response|95|||
13266723|NCT01438424|26413984|FG000|Overall Study|Not identified|55|||
13266724|NCT01438424|26413984|FG000|Overall Study|Withdrawal by Subject|104|||
13266725|NCT01438424|26413984|FG000|Overall Study|Progression of chronic hepatitis B|22|||
13266726|NCT01438424|26413984|FG000|Overall Study|Death|22|||
13266727|NCT01438424|26413984|FG000|Overall Study|Adverse Event|17|||
13266728|NCT01438424|26413984|FG000|Overall Study|Lost to Follow-up|17|||
13266729|NCT01438424|26413984|FG000|Overall Study|Abnormal laboratory test result|14|||
13266730|NCT01438424|26413984|FG000|Overall Study|Need for drug prohibited by protocol|14|||
13266731|NCT01438424|26413984|FG000|Overall Study|Pregnancy|7|||
13266732|NCT01438424|26413984|FG000|Overall Study|No longer met inclusion criteria|1|||
13266733|NCT01438424|26413984|FG000|Overall Study|Participant noncompliance|20|||
13266734|NCT01438411|26413999|FG000|Overall Study|Adverse Event|8|||
13266735|NCT01438411|26413999|FG000|Overall Study|Lost to Follow-up|1|||
13266736|NCT01438411|26413999|FG000|Overall Study|Lack of Efficacy|1|||
13266737|NCT01438411|26413999|FG000|Overall Study|Withdrawal by Subject|3|||
13266738|NCT01438307|26414018|FG000|Overall Study|Death|1|||
13266739|NCT01438307|26414019|FG001|Overall Study|Death|1|||
13266740|NCT01438294|26414036|FG000|Overall Study|Lost to Follow-up|3|||
13266741|NCT01438294|26414037|FG001|Overall Study|Lost to Follow-up|7|||
13266742|NCT01438177|26414046|FG000|Overall Study|Withdrawal by Subject|1|||
13266743|NCT01438177|26414046|FG000|Overall Study|Initiation of new therapy|1|||
13266744|NCT01438151|26414052|FG000|Overall Study|study terminated|8|||
13266745|NCT01438060|26414137|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7|||
13266746|NCT01438060|26414138|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9|||
13266747|NCT01438060|26414137|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6|||
13266748|NCT01438060|26414138|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3|||
13266749|NCT01438060|26414137|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3|||
13266750|NCT01438060|26414138|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4|||
13203587|NCT01984684|26224962|FG001|Overall Study|Adverse Event|12|||
13266751|NCT01438060|26414137|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1|||
13266752|NCT01438060|26414138|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0|||
13266753|NCT01438060|26414137|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0|||
13266754|NCT01438060|26414138|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2|||
13266755|NCT01438060|26414137|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1|||
13266756|NCT01438060|26414138|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0|||
13266757|NCT01438060|26414137|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15|||
13266758|NCT01438060|26414138|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16|||
13266759|NCT01438060|26414137|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
13266760|NCT01438060|26414138|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
13266761|NCT01438060|26414137|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3|||
13266762|NCT01438060|26414138|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5|||
13266763|NCT01438060|26414137|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1|||
13266764|NCT01438060|26414138|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0|||
13266765|NCT01438060|26414137|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2|||
13266766|NCT01438060|26414138|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0|||
13266767|NCT01438060|26414137|FG000|Extension Phase: Week 10 to Week 130|Death|22|||
13266768|NCT01438060|26414138|FG001|Extension Phase: Week 10 to Week 130|Death|12|||
13266769|NCT01438060|26414137|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7|||
13266770|NCT01438060|26414138|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15|||
13266771|NCT01438060|26414137|FG000|On Study Beyond Week 140|Adverse Event|0|||
13266772|NCT01438060|26414138|FG001|On Study Beyond Week 140|Adverse Event|2|||
13266773|NCT01438060|26414137|FG000|On Study Beyond Week 140|Lack of Efficacy|0|||
13266774|NCT01438060|26414138|FG001|On Study Beyond Week 140|Lack of Efficacy|1|||
13266775|NCT01438060|26414137|FG000|On Study Beyond Week 140|Withdrawal by Subject|0|||
13266776|NCT01438060|26414138|FG001|On Study Beyond Week 140|Withdrawal by Subject|1|||
13266777|NCT01438060|26414137|FG000|On Study Beyond Week 140|Death|0|||
13266778|NCT01438060|26414138|FG001|On Study Beyond Week 140|Death|1|||
13266779|NCT01438060|26414137|FG000|On Study Beyond Week 140|Other Reason|0|||
13266780|NCT01438060|26414138|FG001|On Study Beyond Week 140|Other Reason|3|||
13266781|NCT01437995|26414168|FG000|Overall Study|Lost to Follow-up|11|||
13266782|NCT01437995|26414169|FG001|Overall Study|Lost to Follow-up|18|||
13266783|NCT01437995|26414170|FG002|Overall Study|Lost to Follow-up|20|||
13266784|NCT01437943|26414183|FG000|Overall Study|Aliskiren trials terminated by Novartis|4|||
13266785|NCT01437943|26414184|FG001|Overall Study|Aliskiren trials terminated by Novartis|2|||
13266786|NCT01437943|26414183|FG000|Overall Study|Subject expressed pregnancy plans|1|||
13266787|NCT01437943|26414184|FG001|Overall Study|Subject expressed pregnancy plans|0|||
13266788|NCT01437943|26414183|FG000|Overall Study|Adverse Event|2|||
13266789|NCT01437943|26414184|FG001|Overall Study|Adverse Event|0|||
13266790|NCT01437878|26414231|FG000|Overall Study|Withdrawal by Subject|1|||
13266791|NCT01437878|26414232|FG001|Overall Study|Withdrawal by Subject|0|||
13266792|NCT01437540|26414251|FG000|Overall Study|Not listed below|7|||
13266793|NCT01437540|26414252|FG001|Overall Study|Not listed below|6|||
13266794|NCT01437540|26414251|FG000|Overall Study|COPD exacerbation|13|||
13266795|NCT01437540|26414252|FG001|Overall Study|COPD exacerbation|3|||
13266796|NCT01437540|26414251|FG000|Overall Study|Lost to Follow-up|3|||
13266797|NCT01437540|26414252|FG001|Overall Study|Lost to Follow-up|5|||
13266798|NCT01437540|26414251|FG000|Overall Study|Lack of Efficacy|23|||
13266799|NCT01437540|26414252|FG001|Overall Study|Lack of Efficacy|11|||
13266800|NCT01437540|26414251|FG000|Overall Study|Protocol Violation|24|||
13266801|NCT01437540|26414252|FG001|Overall Study|Protocol Violation|12|||
13266802|NCT01437540|26414251|FG000|Overall Study|Adverse Event|26|||
13266803|NCT01437540|26414252|FG001|Overall Study|Adverse Event|13|||
13266804|NCT01437540|26414251|FG000|Overall Study|Withdrawal by Subject|31|||
13266805|NCT01437540|26414252|FG001|Overall Study|Withdrawal by Subject|15|||
13266806|NCT01437423|26414261|FG000|Overall Study|Lost to Follow-up|12|||
13266807|NCT01437423|26414261|FG000|Overall Study|Off label usage|3|||
13266808|NCT01437397|26414304|FG000|Overall Study|Lost to Follow-up|9|||
13266809|NCT01437397|26414305|FG001|Overall Study|Lost to Follow-up|4|||
13266810|NCT01437397|26414306|FG002|Overall Study|Lost to Follow-up|2|||
13266811|NCT01437397|26414307|FG003|Overall Study|Lost to Follow-up|4|||
13266812|NCT01437397|26414308|FG004|Overall Study|Lost to Follow-up|5|||
13266813|NCT01437397|26414304|FG000|Overall Study|Withdrawal by Subject|11|||
13266814|NCT01437397|26414305|FG001|Overall Study|Withdrawal by Subject|12|||
13266815|NCT01437397|26414306|FG002|Overall Study|Withdrawal by Subject|24|||
13266816|NCT01437397|26414307|FG003|Overall Study|Withdrawal by Subject|11|||
13266817|NCT01437397|26414308|FG004|Overall Study|Withdrawal by Subject|22|||
13266818|NCT01437397|26414304|FG000|Overall Study|Protocol Violation|10|||
13266819|NCT01437397|26414305|FG001|Overall Study|Protocol Violation|12|||
13266820|NCT01437397|26414306|FG002|Overall Study|Protocol Violation|13|||
13266821|NCT01437397|26414307|FG003|Overall Study|Protocol Violation|21|||
13266822|NCT01437397|26414308|FG004|Overall Study|Protocol Violation|19|||
13266823|NCT01437397|26414304|FG000|Overall Study|Lack of Efficacy|5|||
13266824|NCT01437397|26414305|FG001|Overall Study|Lack of Efficacy|4|||
13266825|NCT01437397|26414306|FG002|Overall Study|Lack of Efficacy|8|||
13266826|NCT01437397|26414307|FG003|Overall Study|Lack of Efficacy|10|||
13266827|NCT01437397|26414308|FG004|Overall Study|Lack of Efficacy|20|||
13266828|NCT01437397|26414304|FG000|Overall Study|Adverse Event|21|||
13266829|NCT01437397|26414305|FG001|Overall Study|Adverse Event|22|||
13266830|NCT01437397|26414306|FG002|Overall Study|Adverse Event|16|||
13266831|NCT01437397|26414307|FG003|Overall Study|Adverse Event|14|||
13266832|NCT01437397|26414308|FG004|Overall Study|Adverse Event|21|||
13266833|NCT01437397|26414304|FG000|Overall Study|Site termination/COPD exacerbation/other|10|||
13266834|NCT01437397|26414305|FG001|Overall Study|Site termination/COPD exacerbation/other|8|||
13266835|NCT01437397|26414306|FG002|Overall Study|Site termination/COPD exacerbation/other|9|||
13266836|NCT01437397|26414307|FG003|Overall Study|Site termination/COPD exacerbation/other|9|||
13266837|NCT01437397|26414308|FG004|Overall Study|Site termination/COPD exacerbation/other|14|||
13266838|NCT01437319|26414321|FG000|Phase I|Lost to Follow-up|2|||
13266839|NCT01437319|26414322|FG001|Phase I|Lost to Follow-up|0|||
13266840|NCT01437319|26414323|FG002|Phase I|Lost to Follow-up|0|||
13266841|NCT01437319|26414321|FG000|Phase I|Protocol Violation|1|||
13266842|NCT01437319|26414322|FG001|Phase I|Protocol Violation|0|||
13266843|NCT01437319|26414323|FG002|Phase I|Protocol Violation|0|||
13266844|NCT01437319|26414321|FG000|Phase I|Study related symptoms/complaints|27|||
13266845|NCT01437319|26414322|FG001|Phase I|Study related symptoms/complaints|0|||
13266846|NCT01437319|26414323|FG002|Phase I|Study related symptoms/complaints|0|||
13266847|NCT01437319|26414321|FG000|Phase I|Withdrawal by Subject|25|||
13266848|NCT01437319|26414322|FG001|Phase I|Withdrawal by Subject|0|||
13266849|NCT01437319|26414323|FG002|Phase I|Withdrawal by Subject|0|||
13266850|NCT01437319|26414321|FG000|Phase II|Withdrawal by Subject|0|||
13266851|NCT01437319|26414322|FG001|Phase II|Withdrawal by Subject|8|||
13266852|NCT01437319|26414323|FG002|Phase II|Withdrawal by Subject|16|||
13266853|NCT01437319|26414321|FG000|Phase II|Lost to Follow-up|0|||
13266854|NCT01437319|26414322|FG001|Phase II|Lost to Follow-up|7|||
13266855|NCT01437319|26414323|FG002|Phase II|Lost to Follow-up|2|||
13266856|NCT01437319|26414321|FG000|Phase II|Study related symptoms/complaints|0|||
13266857|NCT01437319|26414322|FG001|Phase II|Study related symptoms/complaints|28|||
13266858|NCT01437319|26414323|FG002|Phase II|Study related symptoms/complaints|19|||
13266859|NCT01437319|26414321|FG000|Phase II|Protocol Violation|0|||
13266860|NCT01437319|26414322|FG001|Phase II|Protocol Violation|1|||
13266861|NCT01437319|26414323|FG002|Phase II|Protocol Violation|0|||
13266862|NCT01437267|26414380|FG000|Overall Study|Withdrawal by Subject|0|||
13266863|NCT01437267|26414381|FG001|Overall Study|Withdrawal by Subject|0|||
13266864|NCT01437267|26414382|FG002|Overall Study|Withdrawal by Subject|0|||
13266865|NCT01437267|26414383|FG003|Overall Study|Withdrawal by Subject|1|||
13266866|NCT01437267|26414384|FG004|Overall Study|Withdrawal by Subject|0|||
13266867|NCT01437267|26414385|FG005|Overall Study|Withdrawal by Subject|0|||
13266868|NCT01437267|26414380|FG000|Overall Study|Protocol Violation|0|||
13266869|NCT01437267|26414381|FG001|Overall Study|Protocol Violation|1|||
13266870|NCT01437267|26414382|FG002|Overall Study|Protocol Violation|0|||
13266871|NCT01437267|26414383|FG003|Overall Study|Protocol Violation|0|||
13266872|NCT01437267|26414384|FG004|Overall Study|Protocol Violation|0|||
13266873|NCT01437267|26414385|FG005|Overall Study|Protocol Violation|0|||
13266874|NCT01437111|26414398|FG000|Overall Study|Adverse Event|2|||
13266875|NCT01437111|26414398|FG000|Overall Study|Withdrawal by Subject|4|||
13266876|NCT01437111|26414398|FG000|Overall Study|Not reported|5|||
13266877|NCT01437111|26414398|FG000|Overall Study|Physician Decision|1|||
13266878|NCT01437111|26414398|FG000|Overall Study|Lost to Follow-up|5|||
13266879|NCT01437111|26414398|FG000|Overall Study|Protocol Violation|1|||
13266880|NCT01436643|26414419|FG000|2-week Pre-treatment|Abnormal test result|0|||
13266881|NCT01436643|26414420|FG001|2-week Pre-treatment|Abnormal test result|0|||
13266882|NCT01436643|26414421|FG002|2-week Pre-treatment|Abnormal test result|0|||
13266883|NCT01436643|26414422|FG003|2-week Pre-treatment|Abnormal test result|1|||
13266884|NCT01436643|26414419|FG000|2-week Pre-treatment|Adverse Event|0|||
13266885|NCT01436643|26414420|FG001|2-week Pre-treatment|Adverse Event|0|||
13266886|NCT01436643|26414421|FG002|2-week Pre-treatment|Adverse Event|0|||
13266887|NCT01436643|26414422|FG003|2-week Pre-treatment|Adverse Event|5|||
13266888|NCT01436643|26414419|FG000|2-week Pre-treatment|Protocol Violation|0|||
13266889|NCT01436643|26414420|FG001|2-week Pre-treatment|Protocol Violation|0|||
13266890|NCT01436643|26414421|FG002|2-week Pre-treatment|Protocol Violation|0|||
13266891|NCT01436643|26414422|FG003|2-week Pre-treatment|Protocol Violation|4|||
13266892|NCT01436643|26414419|FG000|Core Phase (16 Weeks)|Adverse Event|0|||
13266893|NCT01436643|26414420|FG001|Core Phase (16 Weeks)|Adverse Event|3|||
13266894|NCT01436643|26414421|FG002|Core Phase (16 Weeks)|Adverse Event|1|||
13266895|NCT01436643|26414422|FG003|Core Phase (16 Weeks)|Adverse Event|0|||
13266896|NCT01436643|26414419|FG000|Core Phase (16 Weeks)|Abnormal Test result|0|||
13266897|NCT01436643|26414420|FG001|Core Phase (16 Weeks)|Abnormal Test result|0|||
13266898|NCT01436643|26414421|FG002|Core Phase (16 Weeks)|Abnormal Test result|1|||
13266899|NCT01436643|26414422|FG003|Core Phase (16 Weeks)|Abnormal Test result|0|||
13266900|NCT01436643|26414419|FG000|Core Phase (16 Weeks)|Protocol Violation|1|||
13266901|NCT01436643|26414420|FG001|Core Phase (16 Weeks)|Protocol Violation|1|||
13266902|NCT01436643|26414421|FG002|Core Phase (16 Weeks)|Protocol Violation|1|||
13266903|NCT01436643|26414422|FG003|Core Phase (16 Weeks)|Protocol Violation|0|||
13266904|NCT01436500|26414465|FG000|Overall Study|Death|1|||
13266905|NCT01436500|26414466|FG001|Overall Study|Death|0|||
13266906|NCT01436500|26414467|FG002|Overall Study|Death|0|||
13266907|NCT01436500|26414468|FG003|Overall Study|Death|0|||
13266908|NCT01436500|26414469|FG004|Overall Study|Death|0|||
13266909|NCT01436500|26414465|FG000|Overall Study|Adverse Event|0|||
13266910|NCT01436500|26414466|FG001|Overall Study|Adverse Event|2|||
13266911|NCT01436500|26414467|FG002|Overall Study|Adverse Event|2|||
13266912|NCT01436500|26414468|FG003|Overall Study|Adverse Event|0|||
13266913|NCT01436500|26414469|FG004|Overall Study|Adverse Event|1|||
13266914|NCT01436500|26414465|FG000|Overall Study|Withdrawal by Subject|0|||
13266915|NCT01436500|26414466|FG001|Overall Study|Withdrawal by Subject|0|||
13266916|NCT01436500|26414467|FG002|Overall Study|Withdrawal by Subject|2|||
13266917|NCT01436500|26414468|FG003|Overall Study|Withdrawal by Subject|0|||
13266918|NCT01436500|26414469|FG004|Overall Study|Withdrawal by Subject|2|||
13266919|NCT01436500|26414465|FG000|Overall Study|Physician Decision|0|||
13266920|NCT01436500|26414466|FG001|Overall Study|Physician Decision|0|||
13266921|NCT01436500|26414467|FG002|Overall Study|Physician Decision|1|||
13266922|NCT01436500|26414468|FG003|Overall Study|Physician Decision|0|||
13266923|NCT01436500|26414469|FG004|Overall Study|Physician Decision|0|||
13266924|NCT01436500|26414465|FG000|Overall Study|liver transplant|1|||
13266925|NCT01436500|26414466|FG001|Overall Study|liver transplant|0|||
13266926|NCT01436500|26414467|FG002|Overall Study|liver transplant|0|||
13266927|NCT01436500|26414468|FG003|Overall Study|liver transplant|0|||
13266928|NCT01436500|26414469|FG004|Overall Study|liver transplant|0|||
13266929|NCT01436500|26414465|FG000|Overall Study|initiation of dialysis|0|||
13266930|NCT01436500|26414466|FG001|Overall Study|initiation of dialysis|0|||
13266931|NCT01436500|26414467|FG002|Overall Study|initiation of dialysis|0|||
13266932|NCT01436500|26414468|FG003|Overall Study|initiation of dialysis|0|||
13266933|NCT01436500|26414469|FG004|Overall Study|initiation of dialysis|1|||
13266934|NCT01436500|26414465|FG000|Overall Study|discontinued study drug|1|||
13266935|NCT01436500|26414466|FG001|Overall Study|discontinued study drug|0|||
13266936|NCT01436500|26414467|FG002|Overall Study|discontinued study drug|0|||
13266937|NCT01436500|26414468|FG003|Overall Study|discontinued study drug|0|||
13266938|NCT01436500|26414469|FG004|Overall Study|discontinued study drug|0|||
13266939|NCT01436500|26414465|FG000|Overall Study|Other|0|||
13266940|NCT01436500|26414466|FG001|Overall Study|Other|1|||
13266941|NCT01436500|26414467|FG002|Overall Study|Other|0|||
13266942|NCT01436500|26414468|FG003|Overall Study|Other|1|||
13266943|NCT01436500|26414469|FG004|Overall Study|Other|0|||
13266944|NCT01436370|26414572|FG000|Overall Study|Lost to Follow-up|0|||
13266945|NCT01436370|26414573|FG001|Overall Study|Lost to Follow-up|0|||
13266946|NCT01436370|26414574|FG002|Overall Study|Lost to Follow-up|0|||
13266947|NCT01436370|26414575|FG003|Overall Study|Lost to Follow-up|0|||
13266948|NCT01436370|26414576|FG004|Overall Study|Lost to Follow-up|1|||
13266949|NCT01436370|26414577|FG005|Overall Study|Lost to Follow-up|0|||
13266950|NCT01436370|26414578|FG006|Overall Study|Lost to Follow-up|0|||
13266951|NCT01436370|26414579|FG007|Overall Study|Lost to Follow-up|0|||
13266952|NCT01436357|26414604|FG000|Overall Study|Death|5|||
13266953|NCT01436357|26414605|FG001|Overall Study|Death|1|||
13266954|NCT01436357|26414604|FG000|Overall Study|Enrolled but not vaccinated|1|||
13266955|NCT01436357|26414605|FG001|Overall Study|Enrolled but not vaccinated|1|||
13266956|NCT01436357|26414604|FG000|Overall Study|Incarceration|18|||
13266957|NCT01436357|26414605|FG001|Overall Study|Incarceration|20|||
13266958|NCT01436357|26414604|FG000|Overall Study|Lost to Follow-up|67|||
13266959|NCT01436357|26414605|FG001|Overall Study|Lost to Follow-up|61|||
13266960|NCT01436357|26414604|FG000|Overall Study|Protocol Violation|1|||
13266961|NCT01436357|26414605|FG001|Overall Study|Protocol Violation|0|||
13266962|NCT01436357|26414604|FG000|Overall Study|Withdrawal by Subject|26|||
13266963|NCT01436357|26414605|FG001|Overall Study|Withdrawal by Subject|38|||
13266964|NCT01436357|26414604|FG000|Overall Study|Physician Decision|3|||
13266965|NCT01436357|26414605|FG001|Overall Study|Physician Decision|4|||
13266966|NCT01436357|26414604|FG000|Overall Study|Moved out of area|1|||
13266967|NCT01436357|26414605|FG001|Overall Study|Moved out of area|2|||
13266968|NCT01436357|26414604|FG000|Overall Study|Subject in rehab|0|||
13266969|NCT01436357|26414605|FG001|Overall Study|Subject in rehab|1|||
13266970|NCT01436305|26414710|FG000|Overall Study|Death|1|||
13266971|NCT01436305|26414711|FG001|Overall Study|Death|0|||
13266972|NCT01436305|26414712|FG002|Overall Study|Death|0|||
13266973|NCT01436305|26414710|FG000|Overall Study|Lost to Follow-up|0|||
13266974|NCT01436305|26414711|FG001|Overall Study|Lost to Follow-up|1|||
13266975|NCT01436305|26414712|FG002|Overall Study|Lost to Follow-up|0|||
13266976|NCT01436305|26414710|FG000|Overall Study|Withdrawal by Subject|1|||
13266977|NCT01436305|26414711|FG001|Overall Study|Withdrawal by Subject|3|||
13266978|NCT01436305|26414712|FG002|Overall Study|Withdrawal by Subject|0|||
13266979|NCT01436253|26414719|FG000|Overall Study|Lost to Follow-up|182|||
13266980|NCT01436253|26414719|FG000|Overall Study|Not meeting all eligibility criteria|117|||
13266981|NCT01436201|26414731|FG000|Overall Study|Adverse Event|2|||
13266982|NCT01436201|26414731|FG000|Overall Study|Withdrawal by Subject|1|||
13266983|NCT01436201|26414731|FG000|Overall Study|Protocol Violation|1|||
13266984|NCT01436175|26414758|FG000|Overall Study|Adverse Event|111|||
13266985|NCT01436175|26414758|FG000|Overall Study|Protocol Violation|49|||
13266986|NCT01436175|26414758|FG000|Overall Study|Withdrawal by Subject|108|||
13266987|NCT01436175|26414758|FG000|Overall Study|Lost to Follow-up|89|||
13266988|NCT01436175|26414758|FG000|Overall Study|Lack of Efficacy|24|||
13266989|NCT01436175|26414758|FG000|Overall Study|Met blood pressure or pulse withdrawal|63|||
13266990|NCT01436175|26414758|FG000|Overall Study|Other|826|||
13266991|NCT01436162|26414798|FG000|Single-blind Lead-in Phase|Adverse Event|26|||
13266992|NCT01436162|26414799|FG001|Single-blind Lead-in Phase|Adverse Event|0|||
13266993|NCT01436162|26414800|FG002|Single-blind Lead-in Phase|Adverse Event|0|||
13266994|NCT01436162|26414798|FG000|Single-blind Lead-in Phase|Protocol Violation|24|||
13266995|NCT01436162|26414799|FG001|Single-blind Lead-in Phase|Protocol Violation|0|||
13266996|NCT01436162|26414800|FG002|Single-blind Lead-in Phase|Protocol Violation|0|||
13266997|NCT01436162|26414798|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69|||
13266998|NCT01436162|26414799|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
13266999|NCT01436162|26414800|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
13267000|NCT01436162|26414798|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43|||
13267001|NCT01436162|26414799|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0|||
13267002|NCT01436162|26414800|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0|||
13267003|NCT01436162|26414798|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13|||
13267004|NCT01436162|26414799|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
13267005|NCT01436162|26414800|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
13267006|NCT01436162|26414798|FG000|Single-blind Lead-in Phase|Other|107|||
13267007|NCT01436162|26414799|FG001|Single-blind Lead-in Phase|Other|0|||
13267008|NCT01436162|26414800|FG002|Single-blind Lead-in Phase|Other|0|||
13267009|NCT01436162|26414798|FG000|Randomized Phase|Adverse Event|1|||
13267010|NCT01436162|26414799|FG001|Randomized Phase|Adverse Event|5|||
13267011|NCT01436162|26414800|FG002|Randomized Phase|Adverse Event|6|||
13267012|NCT01436162|26414798|FG000|Randomized Phase|Protocol Violation|4|||
13267013|NCT01436162|26414799|FG001|Randomized Phase|Protocol Violation|4|||
13267014|NCT01436162|26414800|FG002|Randomized Phase|Protocol Violation|2|||
13267015|NCT01436162|26414798|FG000|Randomized Phase|Withdrawal by Subject|16|||
13267016|NCT01436162|26414799|FG001|Randomized Phase|Withdrawal by Subject|9|||
13267017|NCT01436162|26414800|FG002|Randomized Phase|Withdrawal by Subject|8|||
13267018|NCT01436162|26414798|FG000|Randomized Phase|Lost to Follow-up|17|||
13267019|NCT01436162|26414799|FG001|Randomized Phase|Lost to Follow-up|5|||
13267020|NCT01436162|26414800|FG002|Randomized Phase|Lost to Follow-up|4|||
13267021|NCT01436162|26414798|FG000|Randomized Phase|Lack of Efficacy|0|||
13267022|NCT01436162|26414799|FG001|Randomized Phase|Lack of Efficacy|1|||
13267023|NCT01436162|26414800|FG002|Randomized Phase|Lack of Efficacy|1|||
13267024|NCT01436162|26414798|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4|||
13267025|NCT01436162|26414799|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
13267026|NCT01436162|26414800|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0|||
13267027|NCT01436162|26414798|FG000|Randomized Phase|Other|2|||
13267028|NCT01436162|26414799|FG001|Randomized Phase|Other|5|||
13267029|NCT01436162|26414800|FG002|Randomized Phase|Other|4|||
13267030|NCT01436149|26414836|FG000|Antidepressant Lead-in Phase|Adverse Event|39|||
13267031|NCT01436149|26414837|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
13117888|NCT03050801|25927044|FG005|Experiment 2|Discomfort during stimulation|2|||
13117889|NCT03050450|25927087|FG000|Overall Study|Physician Decision|1|||
13117890|NCT03050450|25927088|FG001|Overall Study|Physician Decision|0|||
13117891|NCT03050450|25927089|FG002|Overall Study|Physician Decision|0|||
13117892|NCT03050450|25927090|FG003|Overall Study|Physician Decision|0|||
13117893|NCT03050450|25927091|FG004|Overall Study|Physician Decision|0|||
13117894|NCT03050398|25927098|FG000|Overall Study|Study terminated by sponsor|8|||
13117895|NCT03050372|25927122|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1|||
13117896|NCT03050372|25927123|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0|||
13117897|NCT03050372|25927122|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0|||
13117898|NCT03050372|25927123|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1|||
13117899|NCT03050359|25927142|FG000|Overall Study|Randomized But Not Treated|2|||
13117900|NCT03050359|25927143|FG001|Overall Study|Randomized But Not Treated|0|||
13117901|NCT03050359|25927142|FG000|Overall Study|Pretreatment Event/Adverse Event|5|||
13117902|NCT03050359|25927143|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
13117903|NCT03050359|25927142|FG000|Overall Study|Significant Protocol Deviation|2|||
13117904|NCT03050359|25927143|FG001|Overall Study|Significant Protocol Deviation|3|||
13267032|NCT01436149|26414838|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
13267033|NCT01436149|26414836|FG000|Antidepressant Lead-in Phase|Protocol Violation|29|||
13267034|NCT01436149|26414837|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
13267035|NCT01436149|26414838|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
13267036|NCT01436149|26414836|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61|||
13267037|NCT01436149|26414837|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
13267038|NCT01436149|26414838|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
13267039|NCT01436149|26414836|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96|||
13267040|NCT01436149|26414837|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
13267041|NCT01436149|26414838|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
13267042|NCT01436149|26414836|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22|||
13267043|NCT01436149|26414837|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
13267044|NCT01436149|26414838|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
13267045|NCT01436149|26414836|FG000|Antidepressant Lead-in Phase|Other|119|||
13267046|NCT01436149|26414837|FG001|Antidepressant Lead-in Phase|Other|0|||
13267047|NCT01436149|26414838|FG002|Antidepressant Lead-in Phase|Other|0|||
13267048|NCT01436149|26414836|FG000|Randomized Phase|Adverse Event|9|||
13267049|NCT01436149|26414837|FG001|Randomized Phase|Adverse Event|10|||
13267050|NCT01436149|26414838|FG002|Randomized Phase|Adverse Event|11|||
13267051|NCT01436149|26414836|FG000|Randomized Phase|Protocol Violation|4|||
13267052|NCT01436149|26414837|FG001|Randomized Phase|Protocol Violation|5|||
13117905|NCT03050359|25927142|FG000|Overall Study|Lost to Follow-up|2|||
13267053|NCT01436149|26414838|FG002|Randomized Phase|Protocol Violation|0|||
13267054|NCT01436149|26414836|FG000|Randomized Phase|Withdrawal by Subject|16|||
13267055|NCT01436149|26414837|FG001|Randomized Phase|Withdrawal by Subject|10|||
13267056|NCT01436149|26414838|FG002|Randomized Phase|Withdrawal by Subject|10|||
13267057|NCT01436149|26414836|FG000|Randomized Phase|Lost to Follow-up|34|||
13267058|NCT01436149|26414837|FG001|Randomized Phase|Lost to Follow-up|5|||
13267059|NCT01436149|26414838|FG002|Randomized Phase|Lost to Follow-up|6|||
13267060|NCT01436149|26414836|FG000|Randomized Phase|Lack of Efficacy|0|||
13267061|NCT01436149|26414837|FG001|Randomized Phase|Lack of Efficacy|0|||
13267062|NCT01436149|26414838|FG002|Randomized Phase|Lack of Efficacy|1|||
13267063|NCT01436149|26414836|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
13267064|NCT01436149|26414837|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
13267065|NCT01436149|26414838|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
13267066|NCT01436149|26414836|FG000|Randomized Phase|Other|12|||
13267067|NCT01436149|26414837|FG001|Randomized Phase|Other|5|||
13267068|NCT01436149|26414838|FG002|Randomized Phase|Other|11|||
13267069|NCT01436110|26414871|FG000|Overall Study|Lack of Efficacy|23|||
13267070|NCT01436110|26414872|FG001|Overall Study|Lack of Efficacy|14|||
13267071|NCT01436110|26414873|FG002|Overall Study|Lack of Efficacy|9|||
13267072|NCT01436110|26414871|FG000|Overall Study|Withdrawal by Subject|6|||
13267073|NCT01436110|26414872|FG001|Overall Study|Withdrawal by Subject|8|||
13267074|NCT01436110|26414873|FG002|Overall Study|Withdrawal by Subject|4|||
13267075|NCT01436110|26414871|FG000|Overall Study|Adverse Event|2|||
13267076|NCT01436110|26414872|FG001|Overall Study|Adverse Event|1|||
13267077|NCT01436110|26414873|FG002|Overall Study|Adverse Event|2|||
13267078|NCT01436110|26414871|FG000|Overall Study|Physician Decision|3|||
13267079|NCT01436110|26414872|FG001|Overall Study|Physician Decision|1|||
13267080|NCT01436110|26414873|FG002|Overall Study|Physician Decision|1|||
13267081|NCT01436110|26414871|FG000|Overall Study|Lost to Follow-up|1|||
13267082|NCT01436110|26414872|FG001|Overall Study|Lost to Follow-up|1|||
13267083|NCT01436110|26414873|FG002|Overall Study|Lost to Follow-up|3|||
13267084|NCT01436110|26414871|FG000|Overall Study|Protocol Violation|3|||
13267085|NCT01436110|26414872|FG001|Overall Study|Protocol Violation|1|||
13267086|NCT01436110|26414873|FG002|Overall Study|Protocol Violation|1|||
13267087|NCT01436110|26414871|FG000|Overall Study|Did Not Receive Trial Medication|1|||
13267088|NCT01436110|26414872|FG001|Overall Study|Did Not Receive Trial Medication|0|||
13267089|NCT01436110|26414873|FG002|Overall Study|Did Not Receive Trial Medication|3|||
13267090|NCT01436084|26414879|FG000|Overall Study|Disease Progression|2|||
13267091|NCT01436084|26414879|FG000|Overall Study|Withdrawal by Subject|1|||
13267092|NCT01436084|26414879|FG000|Overall Study|Early Closure of Study|1|||
13267093|NCT01436071|26414902|FG000|Overall Study|Adverse Event|1|||
13267094|NCT01436071|26414903|FG001|Overall Study|Adverse Event|0|||
13267095|NCT01436071|26414902|FG000|Overall Study|Lack of Efficacy|16|||
13267096|NCT01436071|26414903|FG001|Overall Study|Lack of Efficacy|7|||
13267097|NCT01436071|26414902|FG000|Overall Study|Protocol Violation|0|||
13267098|NCT01436071|26414903|FG001|Overall Study|Protocol Violation|1|||
13267099|NCT01436071|26414902|FG000|Overall Study|Lost to Follow-up|3|||
13267100|NCT01436071|26414903|FG001|Overall Study|Lost to Follow-up|1|||
13267101|NCT01436071|26414902|FG000|Overall Study|Physician Decision|1|||
13267102|NCT01436071|26414903|FG001|Overall Study|Physician Decision|0|||
13267103|NCT01436071|26414902|FG000|Overall Study|Withdrawal by Subject|2|||
13267104|NCT01436071|26414903|FG001|Overall Study|Withdrawal by Subject|2|||
13267105|NCT01436071|26414902|FG000|Overall Study|Did Not Receive Trial Medication|3|||
13267106|NCT01436071|26414903|FG001|Overall Study|Did Not Receive Trial Medication|3|||
13267107|NCT01435928|26414938|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83|||
13267108|NCT01435928|26414939|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
13267109|NCT01435928|26414940|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
13267110|NCT01435928|26414938|FG000|Open Label Phase - up to 24 Weeks|Death|1|||
13267111|NCT01435928|26414939|FG001|Open Label Phase - up to 24 Weeks|Death|0|||
13307787|NCT01283009|26529720|FG001|Overall Study|Death|78|||
13267112|NCT01435928|26414940|FG002|Open Label Phase - up to 24 Weeks|Death|0|||
13267113|NCT01435928|26414938|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46|||
13267114|NCT01435928|26414939|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
13267115|NCT01435928|26414940|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
13267116|NCT01435928|26414938|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60|||
13267117|NCT01435928|26414939|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
13267118|NCT01435928|26414940|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
13267119|NCT01435928|26414938|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39|||
13267120|NCT01435928|26414939|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
13267121|NCT01435928|26414940|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
13267122|NCT01435928|26414938|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96|||
13267123|NCT01435928|26414939|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
13267124|NCT01435928|26414940|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
13267125|NCT01435928|26414938|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44|||
13267126|NCT01435928|26414939|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
13267127|NCT01435928|26414940|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
13267128|NCT01435928|26414938|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6|||
13267129|NCT01435928|26414939|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
13267130|NCT01435928|26414940|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
13267131|NCT01435928|26414938|FG000|Open Label Phase - up to 24 Weeks|Administrative|14|||
13267132|NCT01435928|26414939|FG001|Open Label Phase - up to 24 Weeks|Administrative|0|||
13267133|NCT01435928|26414940|FG002|Open Label Phase - up to 24 Weeks|Administrative|0|||
13267134|NCT01435928|26414938|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0|||
13267135|NCT01435928|26414939|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3|||
13267136|NCT01435928|26414940|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1|||
13267137|NCT01435928|26414938|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0|||
13267138|NCT01435928|26414939|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2|||
13267139|NCT01435928|26414940|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5|||
13267140|NCT01435928|26414938|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0|||
13267141|NCT01435928|26414939|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11|||
13267142|NCT01435928|26414940|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4|||
13267143|NCT01435928|26414938|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0|||
13267144|NCT01435928|26414939|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5|||
13267145|NCT01435928|26414940|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12|||
13267146|NCT01435928|26414938|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0|||
13267147|NCT01435928|26414939|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47|||
13267148|NCT01435928|26414940|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39|||
13267149|NCT01435928|26414938|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0|||
13267150|NCT01435928|26414939|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43|||
13267151|NCT01435928|26414940|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58|||
13267152|NCT01435928|26414938|FG000|Double Blind Phase - 28 Weeks|Administrative|0|||
13267153|NCT01435928|26414939|FG001|Double Blind Phase - 28 Weeks|Administrative|5|||
13267154|NCT01435928|26414940|FG002|Double Blind Phase - 28 Weeks|Administrative|2|||
13267155|NCT01435798|26414956|FG000|Overall Study|Withdrawal by Subject|1|||
13267156|NCT01435772|26415011|FG000|Overall Study|Adverse Event|1|||
13267157|NCT01435772|26415012|FG001|Overall Study|Adverse Event|0|||
13267158|NCT01435772|26415013|FG002|Overall Study|Adverse Event|2|||
13267159|NCT01435772|26415011|FG000|Overall Study|Withdrawal by Subject|0|||
13267160|NCT01435772|26415012|FG001|Overall Study|Withdrawal by Subject|1|||
13267161|NCT01435772|26415013|FG002|Overall Study|Withdrawal by Subject|3|||
13267162|NCT01435772|26415011|FG000|Overall Study|Other - study termination|2|||
13267163|NCT01435772|26415012|FG001|Overall Study|Other - study termination|2|||
13267164|NCT01435772|26415013|FG002|Overall Study|Other - study termination|10|||
13267165|NCT01435759|26415057|FG000|Antidepressant Lead-in Phase|Adverse Event|40|||
13267166|NCT01435759|26415058|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
13267167|NCT01435759|26415059|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
13267168|NCT01435759|26415060|FG003|Antidepressant Lead-in Phase|Adverse Event|0|||
13267169|NCT01435759|26415061|FG004|Antidepressant Lead-in Phase|Adverse Event|0|||
13267170|NCT01435759|26415062|FG005|Antidepressant Lead-in Phase|Adverse Event|0|||
13267171|NCT01435759|26415057|FG000|Antidepressant Lead-in Phase|Protocol Violation|16|||
13267172|NCT01435759|26415058|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
13267173|NCT01435759|26415059|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
13267174|NCT01435759|26415060|FG003|Antidepressant Lead-in Phase|Protocol Violation|0|||
13267175|NCT01435759|26415061|FG004|Antidepressant Lead-in Phase|Protocol Violation|0|||
13267176|NCT01435759|26415062|FG005|Antidepressant Lead-in Phase|Protocol Violation|0|||
13267177|NCT01435759|26415057|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74|||
13267178|NCT01435759|26415058|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
13267179|NCT01435759|26415059|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
13267180|NCT01435759|26415060|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
13307788|NCT01283009|26529719|FG000|Overall Study|Study ended early|23|||
13267181|NCT01435759|26415061|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
13267182|NCT01435759|26415062|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
13267183|NCT01435759|26415057|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83|||
13267184|NCT01435759|26415058|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
13267185|NCT01435759|26415059|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
13267186|NCT01435759|26415060|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
13267187|NCT01435759|26415061|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
13267188|NCT01435759|26415062|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
13267189|NCT01435759|26415057|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10|||
13267190|NCT01435759|26415058|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
13267191|NCT01435759|26415059|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
13267192|NCT01435759|26415060|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
13267193|NCT01435759|26415061|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
13267194|NCT01435759|26415062|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
13267195|NCT01435759|26415057|FG000|Antidepressant Lead-in Phase|Other|119|||
13267196|NCT01435759|26415058|FG001|Antidepressant Lead-in Phase|Other|0|||
13267197|NCT01435759|26415059|FG002|Antidepressant Lead-in Phase|Other|0|||
13267198|NCT01435759|26415060|FG003|Antidepressant Lead-in Phase|Other|0|||
13267199|NCT01435759|26415061|FG004|Antidepressant Lead-in Phase|Other|0|||
13267200|NCT01435759|26415062|FG005|Antidepressant Lead-in Phase|Other|0|||
13267201|NCT01435759|26415057|FG000|Double-blind Phase|Adverse Event|7|||
13267202|NCT01435759|26415058|FG001|Double-blind Phase|Adverse Event|0|||
13267203|NCT01435759|26415059|FG002|Double-blind Phase|Adverse Event|1|||
13267204|NCT01435759|26415060|FG003|Double-blind Phase|Adverse Event|1|||
13267205|NCT01435759|26415061|FG004|Double-blind Phase|Adverse Event|1|||
13267206|NCT01435759|26415062|FG005|Double-blind Phase|Adverse Event|3|||
13267207|NCT01435759|26415057|FG000|Double-blind Phase|Protocol Violation|2|||
13267208|NCT01435759|26415058|FG001|Double-blind Phase|Protocol Violation|0|||
13267209|NCT01435759|26415059|FG002|Double-blind Phase|Protocol Violation|1|||
13267210|NCT01435759|26415060|FG003|Double-blind Phase|Protocol Violation|2|||
13267211|NCT01435759|26415061|FG004|Double-blind Phase|Protocol Violation|0|||
13267212|NCT01435759|26415062|FG005|Double-blind Phase|Protocol Violation|1|||
13267213|NCT01435759|26415057|FG000|Double-blind Phase|Withdrawal by Subject|17|||
13267214|NCT01435759|26415058|FG001|Double-blind Phase|Withdrawal by Subject|4|||
13267215|NCT01435759|26415059|FG002|Double-blind Phase|Withdrawal by Subject|3|||
13267216|NCT01435759|26415060|FG003|Double-blind Phase|Withdrawal by Subject|4|||
13267217|NCT01435759|26415061|FG004|Double-blind Phase|Withdrawal by Subject|2|||
13267218|NCT01435759|26415062|FG005|Double-blind Phase|Withdrawal by Subject|2|||
13267219|NCT01435759|26415057|FG000|Double-blind Phase|Lost to Follow-up|31|||
13267220|NCT01435759|26415058|FG001|Double-blind Phase|Lost to Follow-up|1|||
13267221|NCT01435759|26415059|FG002|Double-blind Phase|Lost to Follow-up|2|||
13267222|NCT01435759|26415060|FG003|Double-blind Phase|Lost to Follow-up|0|||
13267223|NCT01435759|26415061|FG004|Double-blind Phase|Lost to Follow-up|3|||
13267224|NCT01435759|26415062|FG005|Double-blind Phase|Lost to Follow-up|3|||
13267225|NCT01435759|26415057|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1|||
13267226|NCT01435759|26415058|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
13267227|NCT01435759|26415059|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
13267228|NCT01435759|26415060|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
13267229|NCT01435759|26415061|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3|||
13267230|NCT01435759|26415062|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
13267231|NCT01435759|26415057|FG000|Double-blind Phase|Other|8|||
13267232|NCT01435759|26415058|FG001|Double-blind Phase|Other|2|||
13267233|NCT01435759|26415059|FG002|Double-blind Phase|Other|0|||
13267234|NCT01435759|26415060|FG003|Double-blind Phase|Other|2|||
13267235|NCT01435759|26415061|FG004|Double-blind Phase|Other|0|||
13267236|NCT01435759|26415062|FG005|Double-blind Phase|Other|0|||
13290652|NCT00101283|26481505|FG001|Overall Study|Withdrawal by Subject|1|||
13290653|NCT00101283|26481504|FG000|Overall Study|Insurance Refusal|0|||
13290654|NCT00101283|26481505|FG001|Overall Study|Insurance Refusal|1|||
13290655|NCT00101283|26481504|FG000|Overall Study|Prostate Cancer Recurrence|0|||
13290656|NCT00101283|26481505|FG001|Overall Study|Prostate Cancer Recurrence|1|||
13290657|NCT00101192|26481511|FG000|Overall Study|Ineligible|6|||
13290658|NCT00101192|26481511|FG000|Overall Study|Inevaluable|1|||
13290659|NCT00101166|26481521|FG000|Overall Study|progressive disease|10|||
13290660|NCT00101101|26481529|FG000|Overall Study|never received vaccine|20|||
13290661|NCT00101010|26481536|FG000|Overall Study|Physician Decision|1|||
13290662|NCT00100932|26481553|FG000|Overall Study|Adverse Event|11|||
13290663|NCT00100932|26481554|FG001|Overall Study|Adverse Event|2|||
13290664|NCT00100932|26481553|FG000|Overall Study|Withdrawal by Subject|6|||
13290665|NCT00100932|26481554|FG001|Overall Study|Withdrawal by Subject|0|||
13290666|NCT00100932|26481553|FG000|Overall Study|Progressive Disease|44|||
13290667|NCT00100932|26481554|FG001|Overall Study|Progressive Disease|18|||
13290668|NCT00100932|26481553|FG000|Overall Study|Physician Decision|7|||
13290669|NCT00100932|26481554|FG001|Overall Study|Physician Decision|5|||
13290670|NCT00100932|26481553|FG000|Overall Study|Other|5|||
13290671|NCT00100932|26481554|FG001|Overall Study|Other|2|||
13290672|NCT00100828|26481560|FG000|Overall Study|Physician Decision|6|||
13267237|NCT01435655|26415076|FG000|Overall Study|Death|2|||
13267238|NCT01435655|26415076|FG000|Overall Study|Other|1|||
13267239|NCT01435616|26415127|FG000|Overall Study|Adverse Event|39|||
13267240|NCT01435616|26415128|FG001|Overall Study|Adverse Event|21|||
13267241|NCT01435616|26415127|FG000|Overall Study|Death|7|||
13267242|NCT01435616|26415128|FG001|Overall Study|Death|2|||
13267243|NCT01435616|26415127|FG000|Overall Study|Lost to Follow-up|22|||
13267244|NCT01435616|26415128|FG001|Overall Study|Lost to Follow-up|13|||
13267245|NCT01435616|26415127|FG000|Overall Study|Protocol Violation|16|||
13267246|NCT01435616|26415128|FG001|Overall Study|Protocol Violation|13|||
13267247|NCT01435616|26415127|FG000|Overall Study|Withdrawal by Subject|66|||
13267248|NCT01435616|26415128|FG001|Overall Study|Withdrawal by Subject|24|||
13267249|NCT01435616|26415127|FG000|Overall Study|Physician Decision|20|||
13267250|NCT01435616|26415128|FG001|Overall Study|Physician Decision|7|||
13267251|NCT01435616|26415127|FG000|Overall Study|Sponsor Decision|1|||
13267252|NCT01435616|26415128|FG001|Overall Study|Sponsor Decision|0|||
13267253|NCT01435577|26415183|FG000|Overall Study|Adverse Event|10|||
13267254|NCT01435577|26415184|FG001|Overall Study|Adverse Event|0|||
13267255|NCT01435577|26415183|FG000|Overall Study|Lack of Efficacy|7|||
13267256|NCT01435577|26415184|FG001|Overall Study|Lack of Efficacy|51|||
13267257|NCT01435577|26415183|FG000|Overall Study|Alternative treatment started|0|||
13267258|NCT01435577|26415184|FG001|Overall Study|Alternative treatment started|1|||
13267259|NCT01435460|26415203|FG000|Overall Study|Adverse Event|2|||
13267260|NCT01435460|26415204|FG001|Overall Study|Adverse Event|1|||
13267261|NCT01435460|26415203|FG000|Overall Study|Lost to Follow-up|6|||
13267262|NCT01435460|26415204|FG001|Overall Study|Lost to Follow-up|1|||
13267263|NCT01435460|26415203|FG000|Overall Study|Withdrawal by Subject|1|||
13267264|NCT01435460|26415204|FG001|Overall Study|Withdrawal by Subject|3|||
13267265|NCT01435460|26415203|FG000|Overall Study|Protocol Violation|0|||
13267266|NCT01435460|26415204|FG001|Overall Study|Protocol Violation|1|||
13267267|NCT01435460|26415203|FG000|Overall Study|Did not meet eligibility criteria|2|||
13267268|NCT01435460|26415204|FG001|Overall Study|Did not meet eligibility criteria|0|||
13267269|NCT01435382|26415304|FG000|Overall Study|Lost to Follow-up|1|||
13267270|NCT01435382|26415305|FG001|Overall Study|Lost to Follow-up|0|||
13267271|NCT01435382|26415306|FG002|Overall Study|Lost to Follow-up|1|||
13267272|NCT01435382|26415307|FG003|Overall Study|Lost to Follow-up|0|||
13267273|NCT01435382|26415304|FG000|Overall Study|Withdrawal by Subject|0|||
13267274|NCT01435382|26415305|FG001|Overall Study|Withdrawal by Subject|2|||
13267275|NCT01435382|26415306|FG002|Overall Study|Withdrawal by Subject|0|||
13267276|NCT01435382|26415307|FG003|Overall Study|Withdrawal by Subject|1|||
13267277|NCT01435356|26415326|FG000|Overall Study|Adverse Event|2|||
13267278|NCT01435356|26415327|FG001|Overall Study|Adverse Event|0|||
13267279|NCT01435356|26415326|FG000|Overall Study|Disease progression/recurrence|17|||
13267280|NCT01435356|26415327|FG001|Overall Study|Disease progression/recurrence|10|||
13267281|NCT01435356|26415326|FG000|Overall Study|Protocol Violation|0|||
13267282|NCT01435356|26415327|FG001|Overall Study|Protocol Violation|1|||
13267283|NCT01435356|26415326|FG000|Overall Study|Study Discontinuation, amendment 4|5|||
13267284|NCT01435356|26415327|FG001|Overall Study|Study Discontinuation, amendment 4|11|||
13267285|NCT01435356|26415326|FG000|Overall Study|Withdrawal by Subject|1|||
13267286|NCT01435356|26415327|FG001|Overall Study|Withdrawal by Subject|1|||
13267287|NCT01435356|26415326|FG000|Overall Study|Facial palsy|1|||
13267288|NCT01435356|26415327|FG001|Overall Study|Facial palsy|0|||
13267289|NCT01435356|26415326|FG000|Overall Study|IC withdrawal due to study cancellation|1|||
13267290|NCT01435356|26415327|FG001|Overall Study|IC withdrawal due to study cancellation|0|||
13267291|NCT01435356|26415326|FG000|Overall Study|Physician Decision|1|||
13267292|NCT01435356|26415327|FG001|Overall Study|Physician Decision|0|||
13267293|NCT01435356|26415326|FG000|Overall Study|Patient decision|3|||
13267294|NCT01435356|26415327|FG001|Overall Study|Patient decision|0|||
13267295|NCT01435356|26415326|FG000|Overall Study|Patient moved to another city|1|||
13267296|NCT01435356|26415327|FG001|Overall Study|Patient moved to another city|1|||
13267297|NCT01435265|26415344|FG000|Overall Study|Lost to Follow-up|0|||
13267298|NCT01435265|26415345|FG001|Overall Study|Lost to Follow-up|1|||
13267299|NCT01435122|26415356|FG000|Overall Study|Early withdrawal due to toxicity|8|||
13267300|NCT01435031|26415456|FG000|ITT at 1 Month|Withdrawal by Subject|1|||
13267301|NCT01435031|26415456|FG000|ITT at 1 Month|Death|1|||
13267302|NCT01435031|26415456|FG000|ITT at 1 Month|Lost to Follow-up|4|||
13267303|NCT01435031|26415456|FG000|ITT at 6 Months|Death|2|||
13267304|NCT01435031|26415456|FG000|ITT at 6 Months|Lost to Follow-up|3|||
13267305|NCT01435031|26415456|FG000|ITT at 1 Year|Death|1|||
13267306|NCT01435031|26415456|FG000|ITT at 1 Year|Withdrawal by Subject|2|||
13267307|NCT01435031|26415456|FG000|ITT at 1 Year|Lost to Follow-up|6|||
13267308|NCT01435031|26415456|FG000|ITT at 2 Years|Death|7|||
13267309|NCT01435031|26415456|FG000|ITT at 2 Years|Withdrawal by Subject|2|||
13267310|NCT01435031|26415456|FG000|ITT at 2 Years|Lost to Follow-up|4|||
13267311|NCT01435031|26415456|FG000|ITT at 3 Years|Death|5|||
13267312|NCT01435031|26415456|FG000|ITT at 3 Years|Withdrawal by Subject|2|||
13267313|NCT01435031|26415456|FG000|ITT at 3 Years|Lost to Follow-up|4|||
13267314|NCT01435031|26415456|FG000|ITT at 4 Years|Death|4|||
13267315|NCT01435031|26415456|FG000|ITT at 4 Years|Withdrawal by Subject|2|||
13267316|NCT01435031|26415456|FG000|ITT at 4 Years|Lost to Follow-up|1|||
13267317|NCT01435018|26415557|FG000|Overall Study|Death|37|||
13267318|NCT01435018|26415558|FG001|Overall Study|Death|18|||
13267319|NCT01435018|26415559|FG002|Overall Study|Death|25|||
13267320|NCT01435018|26415557|FG000|Overall Study|Site is closing|4|||
13267321|NCT01435018|26415558|FG001|Overall Study|Site is closing|9|||
13267322|NCT01435018|26415559|FG002|Overall Study|Site is closing|7|||
13267323|NCT01435018|26415557|FG000|Overall Study|Withdrew consent|0|||
13267324|NCT01435018|26415558|FG001|Overall Study|Withdrew consent|3|||
13267325|NCT01435018|26415559|FG002|Overall Study|Withdrew consent|1|||
13267326|NCT01435018|26415557|FG000|Overall Study|Not willing to adhere to requirements|0|||
13267327|NCT01435018|26415558|FG001|Overall Study|Not willing to adhere to requirements|2|||
13267328|NCT01435018|26415559|FG002|Overall Study|Not willing to adhere to requirements|3|||
13267329|NCT01435018|26415557|FG000|Overall Study|Not able to get to clinic|2|||
13267330|NCT01435018|26415558|FG001|Overall Study|Not able to get to clinic|0|||
13267331|NCT01435018|26415559|FG002|Overall Study|Not able to get to clinic|2|||
13267332|NCT01435018|26415557|FG000|Overall Study|Severe debilitation, unable to continue|0|||
13267333|NCT01435018|26415558|FG001|Overall Study|Severe debilitation, unable to continue|0|||
13267334|NCT01435018|26415559|FG002|Overall Study|Severe debilitation, unable to continue|1|||
13267335|NCT01435018|26415557|FG000|Overall Study|Unable to contact participant/parent|1|||
13267336|NCT01435018|26415558|FG001|Overall Study|Unable to contact participant/parent|1|||
13267337|NCT01435018|26415559|FG002|Overall Study|Unable to contact participant/parent|1|||
13267338|NCT01435018|26415557|FG000|Overall Study|Enrollment Violation|0|||
13267339|NCT01435018|26415558|FG001|Overall Study|Enrollment Violation|1|||
13267340|NCT01435018|26415559|FG002|Overall Study|Enrollment Violation|0|||
13267341|NCT01435018|26415557|FG000|Overall Study|Never started chemotherapy|3|||
13267342|NCT01435018|26415558|FG001|Overall Study|Never started chemotherapy|0|||
13267343|NCT01435018|26415559|FG002|Overall Study|Never started chemotherapy|1|||
13267344|NCT01434823|26415582|FG000|Overall Study|Incomplete data in medical record|4|||
13267345|NCT01434823|26415583|FG001|Overall Study|Incomplete data in medical record|7|||
13267346|NCT01434810|26415600|FG000|Overall Study|Did not receive treatment|11|||
13267347|NCT01434810|26415601|FG001|Overall Study|Did not receive treatment|3|||
13267348|NCT01434810|26415600|FG000|Overall Study|Missing data/received <5hr phototherapy|12|||
13267349|NCT01434810|26415601|FG001|Overall Study|Missing data/received <5hr phototherapy|7|||
13267350|NCT01434693|26415624|FG000|Overall Study|Adverse Event|1|||
13267351|NCT01434693|26415625|FG001|Overall Study|Adverse Event|0|||
13267352|NCT01434693|26415626|FG002|Overall Study|Adverse Event|0|||
13267353|NCT01434693|26415627|FG003|Overall Study|Adverse Event|0|||
13267354|NCT01434693|26415624|FG000|Overall Study|Withdrawal by Subject|1|||
13267355|NCT01434693|26415625|FG001|Overall Study|Withdrawal by Subject|0|||
13267356|NCT01434693|26415626|FG002|Overall Study|Withdrawal by Subject|1|||
13267357|NCT01434693|26415627|FG003|Overall Study|Withdrawal by Subject|1|||
13267358|NCT01434693|26415624|FG000|Overall Study|Lost to Follow-up|1|||
13267359|NCT01434693|26415625|FG001|Overall Study|Lost to Follow-up|0|||
13267360|NCT01434693|26415626|FG002|Overall Study|Lost to Follow-up|0|||
13267361|NCT01434693|26415627|FG003|Overall Study|Lost to Follow-up|0|||
13267362|NCT01434680|26415655|FG000|Overall Study|Withdrawal by Subject|1|||
13267363|NCT01434680|26415656|FG001|Overall Study|Withdrawal by Subject|0|||
13267364|NCT01434680|26415657|FG002|Overall Study|Withdrawal by Subject|2|||
13267365|NCT01434680|26415658|FG003|Overall Study|Withdrawal by Subject|0|||
13267366|NCT01434680|26415655|FG000|Overall Study|Lost to Follow-up|1|||
13267367|NCT01434680|26415656|FG001|Overall Study|Lost to Follow-up|1|||
13267368|NCT01434680|26415657|FG002|Overall Study|Lost to Follow-up|0|||
13267369|NCT01434680|26415658|FG003|Overall Study|Lost to Follow-up|0|||
13267370|NCT01434680|26415655|FG000|Overall Study|Protocol Violation|1|||
13267371|NCT01434680|26415656|FG001|Overall Study|Protocol Violation|1|||
13267372|NCT01434680|26415657|FG002|Overall Study|Protocol Violation|0|||
13267373|NCT01434680|26415658|FG003|Overall Study|Protocol Violation|0|||
13267374|NCT01434667|26415689|FG000|Overall Study|Lost to Follow-up|5|||
13267375|NCT01434667|26415690|FG001|Overall Study|Lost to Follow-up|10|||
13267376|NCT01434654|26415709|FG000|Overall Study|Withdrawal by Subject|1|||
13267377|NCT01434654|26415710|FG001|Overall Study|Withdrawal by Subject|0|||
13267378|NCT01434654|26415709|FG000|Overall Study|Lost to Follow-up|1|||
13267379|NCT01434654|26415710|FG001|Overall Study|Lost to Follow-up|0|||
13267380|NCT01433991|26415863|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2|||
13267381|NCT01433991|26415864|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
13267382|NCT01433991|26415865|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
13267383|NCT01433991|26415866|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
13267384|NCT01433991|26415863|FG000|Treatment Phase (Combination Agent)|Adverse Event|1|||
13267385|NCT01433991|26415864|FG001|Treatment Phase (Combination Agent)|Adverse Event|0|||
13267386|NCT01433991|26415865|FG002|Treatment Phase (Combination Agent)|Adverse Event|3|||
13267387|NCT01433991|26415866|FG003|Treatment Phase (Combination Agent)|Adverse Event|1|||
13267388|NCT01433991|26415863|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
13267389|NCT01433991|26415864|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
13267390|NCT01433991|26415865|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
13267391|NCT01433991|26415866|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1|||
13267392|NCT01433991|26415863|FG000|Treatment Phase (Combination Agent)|Participant Choice|0|||
13267393|NCT01433991|26415864|FG001|Treatment Phase (Combination Agent)|Participant Choice|0|||
13267394|NCT01433991|26415865|FG002|Treatment Phase (Combination Agent)|Participant Choice|0|||
13267395|NCT01433991|26415866|FG003|Treatment Phase (Combination Agent)|Participant Choice|1|||
13267396|NCT01433991|26415863|FG000|Treatment Phase (Combination Agent)|Clinical progression|0|||
13267397|NCT01433991|26415864|FG001|Treatment Phase (Combination Agent)|Clinical progression|1|||
13267398|NCT01433991|26415865|FG002|Treatment Phase (Combination Agent)|Clinical progression|2|||
13267399|NCT01433991|26415866|FG003|Treatment Phase (Combination Agent)|Clinical progression|3|||
13267400|NCT01433991|26415863|FG000|Treatment Phase (Combination Agent)|Progressive disease|1|||
13267401|NCT01433991|26415864|FG001|Treatment Phase (Combination Agent)|Progressive disease|0|||
13267402|NCT01433991|26415865|FG002|Treatment Phase (Combination Agent)|Progressive disease|0|||
13267403|NCT01433991|26415866|FG003|Treatment Phase (Combination Agent)|Progressive disease|0|||
13267404|NCT01433991|26415863|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
13267405|NCT01433991|26415864|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
13267406|NCT01433991|26415865|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1|||
13267407|NCT01433991|26415866|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
13267408|NCT01433978|26415881|FG000|Core Study|Adverse Event, Non-Fatal|0|||
13267409|NCT01433978|26415882|FG001|Core Study|Adverse Event, Non-Fatal|1|||
13267410|NCT01433978|26415883|FG002|Core Study|Adverse Event, Non-Fatal|0|||
13267411|NCT01433978|26415881|FG000|Core Study|Lack of Efficacy|5|||
13267412|NCT01433978|26415882|FG001|Core Study|Lack of Efficacy|1|||
13267413|NCT01433978|26415883|FG002|Core Study|Lack of Efficacy|0|||
13267414|NCT01433978|26415881|FG000|Core Study|Study Terminated by Sponsor|6|||
13267415|NCT01433978|26415882|FG001|Core Study|Study Terminated by Sponsor|9|||
13267416|NCT01433978|26415883|FG002|Core Study|Study Terminated by Sponsor|0|||
13267417|NCT01433978|26415881|FG000|Extension Phase|Adverse Event, Non-Fatal|0|||
13267418|NCT01433978|26415882|FG001|Extension Phase|Adverse Event, Non-Fatal|0|||
13267419|NCT01433978|26415883|FG002|Extension Phase|Adverse Event, Non-Fatal|1|||
13267420|NCT01433978|26415881|FG000|Extension Phase|Lack of Efficacy|0|||
13267421|NCT01433978|26415882|FG001|Extension Phase|Lack of Efficacy|0|||
13267422|NCT01433978|26415883|FG002|Extension Phase|Lack of Efficacy|1|||
13267423|NCT01433978|26415881|FG000|Extension Phase|Study Terminated by Sponsor|0|||
13267424|NCT01433978|26415882|FG001|Extension Phase|Study Terminated by Sponsor|0|||
13267425|NCT01433978|26415883|FG002|Extension Phase|Study Terminated by Sponsor|4|||
13267426|NCT01433549|26415894|FG000|Phase 2: Second Study Product|Adverse Event|0|||
13267427|NCT01433549|26415895|FG001|Phase 2: Second Study Product|Adverse Event|1|||
13267428|NCT01433471|26415918|FG000|Overall Study|Withdrawal by Subject|0|||
13267429|NCT01433471|26415919|FG001|Overall Study|Withdrawal by Subject|1|||
13267430|NCT01433354|26415935|FG000|Overall Study|Adverse Event|6|||
13267431|NCT01433354|26415935|FG000|Overall Study|Lost to Follow-up|1|||
13267432|NCT01433354|26415935|FG000|Overall Study|Administrative problems|90|||
13267433|NCT01433354|26415935|FG000|Overall Study|Protocol Violation|2|||
13267434|NCT01433354|26415935|FG000|Overall Study|Lack of Efficacy|17|||
13267435|NCT01433354|26415935|FG000|Overall Study|Subject Withdrew Consent|3|||
13267436|NCT01433263|26415969|FG000|Overall Study|Adverse Event|3|||
13267437|NCT01433263|26415970|FG001|Overall Study|Adverse Event|1|||
13267438|NCT01433263|26415969|FG000|Overall Study|Death|5|||
13267439|NCT01433263|26415970|FG001|Overall Study|Death|3|||
13267440|NCT01433263|26415969|FG000|Overall Study|Lost to Follow-up|0|||
13267441|NCT01433263|26415970|FG001|Overall Study|Lost to Follow-up|1|||
13267442|NCT01433263|26415969|FG000|Overall Study|Protocol Deviation|1|||
13267443|NCT01433263|26415970|FG001|Overall Study|Protocol Deviation|0|||
13267444|NCT01433263|26415969|FG000|Overall Study|Withdrawal by Subject|10|||
13267445|NCT01433263|26415970|FG001|Overall Study|Withdrawal by Subject|7|||
13267446|NCT01433250|26415993|FG000|Overall Study|Protocol Violation|0|||
13267447|NCT01433250|26415994|FG001|Overall Study|Protocol Violation|1|||
13267448|NCT01433250|26415993|FG000|Overall Study|Withdrawal by Subject|3|||
13267449|NCT01433250|26415994|FG001|Overall Study|Withdrawal by Subject|2|||
13267450|NCT01433172|26416014|FG000|Overall Study|Withdrawal by Subject|0|||
13267451|NCT01433172|26416015|FG001|Overall Study|Withdrawal by Subject|1|||
13267452|NCT01433172|26416016|FG002|Overall Study|Withdrawal by Subject|0|||
13267453|NCT01433172|26416014|FG000|Overall Study|Disease Progression|0|||
13267454|NCT01433172|26416015|FG001|Overall Study|Disease Progression|0|||
13267455|NCT01433172|26416016|FG002|Overall Study|Disease Progression|1|||
13267456|NCT01433172|26416014|FG000|Overall Study|Death|0|||
13267457|NCT01433172|26416015|FG001|Overall Study|Death|2|||
13307789|NCT01283009|26529720|FG001|Overall Study|Study ended early|26|||
13267458|NCT01433172|26416016|FG002|Overall Study|Death|0|||
13267459|NCT01433159|26416029|FG000|Overall Study|Adverse Event|1|||
13267460|NCT01433159|26416030|FG001|Overall Study|Adverse Event|0|||
13267461|NCT01433159|26416029|FG000|Overall Study|Physician Decision|1|||
13267462|NCT01433159|26416030|FG001|Overall Study|Physician Decision|0|||
13267463|NCT01433159|26416029|FG000|Overall Study|Protocol Violation|0|||
13267464|NCT01433159|26416030|FG001|Overall Study|Protocol Violation|1|||
13267465|NCT01433055|26416051|FG000|Overall Study|Diagnosed with cancer unrelated to study|1|||
13267466|NCT01433055|26416052|FG001|Overall Study|Diagnosed with cancer unrelated to study|0|||
13267467|NCT01433055|26416051|FG000|Overall Study|Severely elevated triglycerides at entry|1|||
13267468|NCT01433055|26416052|FG001|Overall Study|Severely elevated triglycerides at entry|0|||
13267469|NCT01432951|26416063|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1|||
13267470|NCT01432938|26416081|FG000|First Intervention|Protocol Violation|1|||
13267471|NCT01432938|26416082|FG001|First Intervention|Protocol Violation|0|||
13267472|NCT01432938|26416081|FG000|First Intervention|Physician Decision|1|||
13267473|NCT01432938|26416082|FG001|First Intervention|Physician Decision|0|||
13267474|NCT01432938|26416081|FG000|Second Intervention|Adverse Event|1|||
13267475|NCT01432938|26416082|FG001|Second Intervention|Adverse Event|0|||
13267476|NCT01432756|26416103|FG000|Overall Study|Lost to Follow-up|1|||
13267477|NCT01432756|26416104|FG001|Overall Study|Lost to Follow-up|0|||
13267478|NCT01432756|26416105|FG002|Overall Study|Lost to Follow-up|2|||
13267479|NCT01432756|26416106|FG003|Overall Study|Lost to Follow-up|1|||
13267480|NCT01432730|26416145|FG000|Period 1|Adverse Event|2|||
13267481|NCT01432730|26416146|FG001|Period 1|Adverse Event|0|||
13267482|NCT01432730|26416145|FG000|Period 2|Adverse Event|0|||
13267483|NCT01432730|26416146|FG001|Period 2|Adverse Event|4|||
13267484|NCT01432626|26416152|FG000|Overall Study|LV function recovered|2|||
13267485|NCT01432626|26416152|FG000|Overall Study|Withdrawal by Subject|2|||
13267486|NCT01432626|26416152|FG000|Overall Study|Only 1 image competed|2|||
13267487|NCT01432626|26416152|FG000|Overall Study|Imaging agent not available|1|||
13267488|NCT01432600|26416178|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0|||
13267489|NCT01432600|26416179|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
13267490|NCT01432600|26416180|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
13267491|NCT01432574|26416188|FG000|Overall Study|Moved|2|||
13267492|NCT01432574|26416188|FG000|Overall Study|Not interested|1|||
13267493|NCT01432457|26416227|FG000|Overall Study|Adverse Event|7|||
13267494|NCT01432457|26416228|FG001|Overall Study|Adverse Event|10|||
13267495|NCT01432457|26416229|FG002|Overall Study|Adverse Event|16|||
13267496|NCT01432457|26416227|FG000|Overall Study|Lack of Efficacy|2|||
13267497|NCT01432457|26416228|FG001|Overall Study|Lack of Efficacy|1|||
13267498|NCT01432457|26416229|FG002|Overall Study|Lack of Efficacy|1|||
13267499|NCT01432457|26416227|FG000|Overall Study|Lost to Follow-up|11|||
13267500|NCT01432457|26416228|FG001|Overall Study|Lost to Follow-up|15|||
13267501|NCT01432457|26416229|FG002|Overall Study|Lost to Follow-up|20|||
13267502|NCT01432457|26416227|FG000|Overall Study|Protocol Violation|3|||
13267503|NCT01432457|26416228|FG001|Overall Study|Protocol Violation|2|||
13267504|NCT01432457|26416229|FG002|Overall Study|Protocol Violation|6|||
13267505|NCT01432457|26416227|FG000|Overall Study|Withdrawal by Subject|6|||
13267506|NCT01432457|26416228|FG001|Overall Study|Withdrawal by Subject|11|||
13267507|NCT01432457|26416229|FG002|Overall Study|Withdrawal by Subject|9|||
13267508|NCT01432457|26416227|FG000|Overall Study|Reasons not defined|2|||
13267509|NCT01432457|26416228|FG001|Overall Study|Reasons not defined|3|||
13267510|NCT01432457|26416229|FG002|Overall Study|Reasons not defined|4|||
13267511|NCT01432457|26416227|FG000|Overall Study|Did not take study drug|6|||
13267512|NCT01432457|26416228|FG001|Overall Study|Did not take study drug|6|||
13267513|NCT01432457|26416229|FG002|Overall Study|Did not take study drug|3|||
13267514|NCT01432444|26416243|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10|||
13267515|NCT01432444|26416244|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
13267516|NCT01432444|26416245|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
13267517|NCT01432444|26416243|FG000|Tolerability/Cross-titration Phase|Adverse Event|16|||
13267518|NCT01432444|26416244|FG001|Tolerability/Cross-titration Phase|Adverse Event|0|||
13267519|NCT01432444|26416245|FG002|Tolerability/Cross-titration Phase|Adverse Event|0|||
13267520|NCT01432444|26416243|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5|||
13267521|NCT01432444|26416244|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
13267522|NCT01432444|26416245|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
13267523|NCT01432444|26416243|FG000|Tolerability/Cross-titration Phase|Physician Decision|8|||
13267524|NCT01432444|26416244|FG001|Tolerability/Cross-titration Phase|Physician Decision|0|||
13267525|NCT01432444|26416245|FG002|Tolerability/Cross-titration Phase|Physician Decision|0|||
13267526|NCT01432444|26416243|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15|||
13267527|NCT01432444|26416244|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
13267528|NCT01432444|26416245|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
13267529|NCT01432444|26416243|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1|||
13267530|NCT01432444|26416244|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
13267531|NCT01432444|26416245|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
13267532|NCT01432444|26416243|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5|||
13267533|NCT01432444|26416244|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
13267534|NCT01432444|26416245|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
13267535|NCT01432444|26416243|FG000|Treatment Phase|Lost to Follow-up|0|||
13267536|NCT01432444|26416244|FG001|Treatment Phase|Lost to Follow-up|33|||
13267537|NCT01432444|26416245|FG002|Treatment Phase|Lost to Follow-up|0|||
13267538|NCT01432444|26416243|FG000|Treatment Phase|Adverse Event|0|||
13267539|NCT01432444|26416244|FG001|Treatment Phase|Adverse Event|37|||
13267540|NCT01432444|26416245|FG002|Treatment Phase|Adverse Event|0|||
13267541|NCT01432444|26416243|FG000|Treatment Phase|Met Withdrawal Criteria|0|||
13267542|NCT01432444|26416244|FG001|Treatment Phase|Met Withdrawal Criteria|11|||
13267543|NCT01432444|26416245|FG002|Treatment Phase|Met Withdrawal Criteria|0|||
13267544|NCT01432444|26416243|FG000|Treatment Phase|Physician Decision|0|||
13267545|NCT01432444|26416244|FG001|Treatment Phase|Physician Decision|5|||
13267546|NCT01432444|26416245|FG002|Treatment Phase|Physician Decision|0|||
13267547|NCT01432444|26416243|FG000|Treatment Phase|Withdrawal by Subject|0|||
13267548|NCT01432444|26416244|FG001|Treatment Phase|Withdrawal by Subject|41|||
13267549|NCT01432444|26416245|FG002|Treatment Phase|Withdrawal by Subject|0|||
13267550|NCT01432444|26416243|FG000|Treatment Phase|Protocol Deviation|0|||
13267551|NCT01432444|26416244|FG001|Treatment Phase|Protocol Deviation|3|||
13267552|NCT01432444|26416245|FG002|Treatment Phase|Protocol Deviation|0|||
13267553|NCT01432444|26416243|FG000|Treatment Phase|Lack of Efficacy|0|||
13267554|NCT01432444|26416244|FG001|Treatment Phase|Lack of Efficacy|10|||
13267555|NCT01432444|26416245|FG002|Treatment Phase|Lack of Efficacy|0|||
13267556|NCT01432444|26416243|FG000|Extension Phase|Lost to Follow-up|0|||
13267557|NCT01432444|26416244|FG001|Extension Phase|Lost to Follow-up|0|||
13267558|NCT01432444|26416245|FG002|Extension Phase|Lost to Follow-up|17|||
13267559|NCT01432444|26416243|FG000|Extension Phase|Adverse Event|0|||
13267560|NCT01432444|26416244|FG001|Extension Phase|Adverse Event|0|||
13267561|NCT01432444|26416245|FG002|Extension Phase|Adverse Event|10|||
13267562|NCT01432444|26416243|FG000|Extension Phase|Sponsor Discontinued Trial|0|||
13267563|NCT01432444|26416244|FG001|Extension Phase|Sponsor Discontinued Trial|0|||
13267564|NCT01432444|26416245|FG002|Extension Phase|Sponsor Discontinued Trial|7|||
13267565|NCT01432444|26416243|FG000|Extension Phase|Met Withdrawal Criteria|0|||
13267566|NCT01432444|26416244|FG001|Extension Phase|Met Withdrawal Criteria|0|||
13267567|NCT01432444|26416245|FG002|Extension Phase|Met Withdrawal Criteria|144|||
13267568|NCT01432444|26416243|FG000|Extension Phase|Physician Decision|0|||
13267569|NCT01432444|26416244|FG001|Extension Phase|Physician Decision|0|||
13267570|NCT01432444|26416245|FG002|Extension Phase|Physician Decision|1|||
13267571|NCT01432444|26416243|FG000|Extension Phase|Withdrawal by Subject|0|||
13267572|NCT01432444|26416244|FG001|Extension Phase|Withdrawal by Subject|0|||
13267573|NCT01432444|26416245|FG002|Extension Phase|Withdrawal by Subject|13|||
13267574|NCT01432366|26416265|FG000|Overall Study|Non-Responder|7|||
13267575|NCT01432366|26416265|FG000|Overall Study|Adverse Event|8|||
13267576|NCT01432366|26416265|FG000|Overall Study|Withdrawal Due to Non-Compliance|3|||
13267577|NCT01432366|26416265|FG000|Overall Study|Pregnancy|1|||
13267578|NCT01432366|26416265|FG000|Overall Study|Lost to Follow-up|13|||
13267579|NCT01432366|26416265|FG000|Overall Study|Lack of Efficacy|1|||
13267580|NCT01432366|26416265|FG000|Overall Study|Site Closed|20|||
13267581|NCT01432366|26416265|FG000|Overall Study|Investigator Forget to Complete Visits|1|||
13267582|NCT01432366|26416265|FG000|Overall Study|Other|14|||
13267583|NCT01432327|26416288|FG000|Posttest 3 Months|depression|3|||
13267584|NCT01432327|26416289|FG001|Posttest 3 Months|depression|0|||
13267585|NCT01432327|26416290|FG002|Posttest 3 Months|depression|0|||
13267586|NCT01432327|26416291|FG003|Posttest 3 Months|depression|0|||
13267587|NCT01432327|26416288|FG000|Posttest 3 Months|Lost to Follow-up|1|||
13267588|NCT01432327|26416289|FG001|Posttest 3 Months|Lost to Follow-up|0|||
13267589|NCT01432327|26416290|FG002|Posttest 3 Months|Lost to Follow-up|2|||
13267590|NCT01432327|26416291|FG003|Posttest 3 Months|Lost to Follow-up|1|||
13267591|NCT01432327|26416288|FG000|Posttest 3 Months|Allergic reaction|0|||
13267592|NCT01432327|26416289|FG001|Posttest 3 Months|Allergic reaction|2|||
13267593|NCT01432327|26416290|FG002|Posttest 3 Months|Allergic reaction|0|||
13267594|NCT01432327|26416291|FG003|Posttest 3 Months|Allergic reaction|0|||
13267595|NCT01432327|26416288|FG000|Posttest 6 Months|Lost to Follow-up|0|||
13267596|NCT01432327|26416289|FG001|Posttest 6 Months|Lost to Follow-up|0|||
13267597|NCT01432327|26416290|FG002|Posttest 6 Months|Lost to Follow-up|3|||
13267598|NCT01432327|26416291|FG003|Posttest 6 Months|Lost to Follow-up|2|||
13267599|NCT01432327|26416288|FG000|Posttest 6 Months|Allergic reaction|0|||
13267600|NCT01432327|26416289|FG001|Posttest 6 Months|Allergic reaction|0|||
13267601|NCT01432327|26416290|FG002|Posttest 6 Months|Allergic reaction|1|||
13267602|NCT01432327|26416291|FG003|Posttest 6 Months|Allergic reaction|0|||
13267603|NCT01432327|26416288|FG000|Posttest 6 Months|Withdrawal by Subject|0|||
13267604|NCT01432327|26416289|FG001|Posttest 6 Months|Withdrawal by Subject|0|||
13267605|NCT01432327|26416290|FG002|Posttest 6 Months|Withdrawal by Subject|1|||
13267606|NCT01432327|26416291|FG003|Posttest 6 Months|Withdrawal by Subject|0|||
13267607|NCT01432327|26416288|FG000|Posttest 1 Year|Measurement have to take place in future|24|||
13267608|NCT01432327|26416289|FG001|Posttest 1 Year|Measurement have to take place in future|28|||
13267609|NCT01432327|26416290|FG002|Posttest 1 Year|Measurement have to take place in future|15|||
13267610|NCT01432327|26416291|FG003|Posttest 1 Year|Measurement have to take place in future|20|||
13267611|NCT01432327|26416288|FG000|Posttest 1 Year|Lost to Follow-up|0|||
13267612|NCT01432327|26416289|FG001|Posttest 1 Year|Lost to Follow-up|0|||
13267613|NCT01432327|26416290|FG002|Posttest 1 Year|Lost to Follow-up|4|||
13267614|NCT01432327|26416291|FG003|Posttest 1 Year|Lost to Follow-up|2|||
13267615|NCT01432327|26416288|FG000|Posttest 1 Year|Allergic reaction|0|||
13267616|NCT01432327|26416289|FG001|Posttest 1 Year|Allergic reaction|0|||
13267617|NCT01432327|26416290|FG002|Posttest 1 Year|Allergic reaction|1|||
13267618|NCT01432327|26416291|FG003|Posttest 1 Year|Allergic reaction|1|||
13267619|NCT01432275|26416301|FG000|First BG Meter System (7 Days)|Adverse Event|0|||
13267620|NCT01432275|26416302|FG001|First BG Meter System (7 Days)|Adverse Event|2|||
13267621|NCT01432275|26416301|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0|||
13267622|NCT01432275|26416302|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1|||
13267623|NCT01432275|26416301|FG000|Second BG Meter System (7 Days)|Adverse Event|1|||
13267624|NCT01432275|26416302|FG001|Second BG Meter System (7 Days)|Adverse Event|1|||
13267625|NCT01432275|26416301|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1|||
13267626|NCT01432275|26416302|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0|||
13307790|NCT01283009|26529719|FG000|Overall Study|Withdrawal by Subject|10|||
13307791|NCT01283009|26529720|FG001|Overall Study|Withdrawal by Subject|8|||
13307792|NCT01283009|26529719|FG000|Overall Study|Physician Decision|1|||
13307793|NCT01283009|26529720|FG001|Overall Study|Physician Decision|1|||
13307794|NCT01283009|26529719|FG000|Overall Study|Lost to Follow-up|1|||
13307795|NCT01283009|26529720|FG001|Overall Study|Lost to Follow-up|0|||
13307796|NCT01283009|26529719|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0|||
13307797|NCT01283009|26529720|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4|||
13307798|NCT01282866|26529728|FG000|Overall Study|Adverse Event|1|||
13307799|NCT01282814|26529745|FG000|First Intervention|Emesis During Dosing Interval|0|||
13307800|NCT01282814|26529746|FG001|First Intervention|Emesis During Dosing Interval|3|||
13307801|NCT01282814|26529745|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
13307802|NCT01282814|26529746|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
13307803|NCT01282801|26529769|FG000|Second Intervention|Emesis During Critical Breakfast|0|||
13307804|NCT01282801|26529770|FG001|Second Intervention|Emesis During Critical Breakfast|1|||
13307805|NCT01282476|26529778|FG000|Overall Study|Death|11|||
13307806|NCT01282463|26529826|FG000|Overall Study|Lost to Follow-up|1|||
13307807|NCT01282463|26529827|FG001|Overall Study|Lost to Follow-up|0|||
13307808|NCT01282463|26529828|FG002|Overall Study|Lost to Follow-up|0|||
13307809|NCT01282463|26529826|FG000|Overall Study|Withdrawal by Subject|6|||
13307810|NCT01282463|26529827|FG001|Overall Study|Withdrawal by Subject|2|||
13307811|NCT01282463|26529828|FG002|Overall Study|Withdrawal by Subject|3|||
13307812|NCT01282463|26529826|FG000|Overall Study|"Never Treated Death"|0|||
13307813|NCT01282463|26529827|FG001|Overall Study|"Never Treated Death"|1|||
13307814|NCT01282463|26529828|FG002|Overall Study|"Never Treated Death"|0|||
13307815|NCT01282463|26529826|FG000|Overall Study|"Never Treated PD"|0|||
13307816|NCT01282463|26529827|FG001|Overall Study|"Never Treated PD"|1|||
13307817|NCT01282463|26529828|FG002|Overall Study|"Never Treated PD"|0|||
13307818|NCT01282463|26529826|FG000|Overall Study|Protocol Violation|0|||
13307819|NCT01282463|26529827|FG001|Overall Study|Protocol Violation|0|||
13307820|NCT01282463|26529828|FG002|Overall Study|Protocol Violation|1|||
13307821|NCT01282463|26529826|FG000|Overall Study|Physician Decision|1|||
13307822|NCT01282463|26529827|FG001|Overall Study|Physician Decision|0|||
13307823|NCT01282463|26529828|FG002|Overall Study|Physician Decision|0|||
13307824|NCT01282424|26529847|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30|||
13307825|NCT01282424|26529847|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6|||
13307826|NCT01282424|26529847|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7|||
13307827|NCT01282424|26529847|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3|||
13307828|NCT01282424|26529847|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2|||
13307829|NCT01282424|26529847|FG000|Long-term Follow-up Period (5 Years)|Death|40|||
13307830|NCT01282424|26529847|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1|||
13307831|NCT01282424|26529847|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21|||
13307832|NCT01282372|26529877|FG000|Overall Study|Lack of Efficacy / Exacerbation|25|||
13307833|NCT01282372|26529877|FG000|Overall Study|Lost to Follow-up|23|||
13307834|NCT01282372|26529877|FG000|Overall Study|Withdrawal by Subject|11|||
13307835|NCT01282372|26529877|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4|||
13307836|NCT01282372|26529877|FG000|Overall Study|Death|1|||
13307837|NCT01282372|26529877|FG000|Overall Study|Presence of AE, Lack of Efficacy|1|||
13307838|NCT01282372|26529877|FG000|Overall Study|Presence of AE, Regression of Symptoms|1|||
13307839|NCT01282372|26529877|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1|||
13307840|NCT01282372|26529877|FG000|Overall Study|Adverse Event|12|||
13307841|NCT01282294|26529897|FG000|Overall Study|Lost to Follow-up|14|||
13307842|NCT01282294|26529897|FG000|Overall Study|Screening failure|1|||
13307843|NCT01282294|26529897|FG000|Overall Study|Adverse Event|1|||
13307844|NCT01282294|26529897|FG000|Overall Study|Patient non-compliance|2|||
13307845|NCT01282294|26529897|FG000|Overall Study|Physician Decision|1|||
13307846|NCT01282229|26529929|FG000|Overall Study|Protocol Violation|2|||
13307847|NCT01282216|26529948|FG000|Overall Study|Graft failure|0|||
13307848|NCT01282216|26529949|FG001|Overall Study|Graft failure|0|||
13307849|NCT01282216|26529950|FG002|Overall Study|Graft failure|3|||
13307850|NCT01282216|26529951|FG003|Overall Study|Graft failure|2|||
13307851|NCT01282216|26529948|FG000|Overall Study|Physician Decision|0|||
13267627|NCT01432275|26416301|FG000|Second BG Meter System (7 Days)|Physician Decision|0|||
13267628|NCT01432275|26416302|FG001|Second BG Meter System (7 Days)|Physician Decision|1|||
13267629|NCT01432275|26416301|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0|||
13267630|NCT01432275|26416302|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1|||
13267631|NCT01432275|26416301|FG000|ADC With Calculator (10 Days)|Physician Decision|1|||
13267632|NCT01432275|26416302|FG001|ADC With Calculator (10 Days)|Physician Decision|1|||
13267633|NCT01432275|26416301|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2|||
13267634|NCT01432275|26416302|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0|||
13267635|NCT01432275|26416301|FG000|ADC With Calculator (10 Days)|Protocol Violation|0|||
13267636|NCT01432275|26416302|FG001|ADC With Calculator (10 Days)|Protocol Violation|1|||
13267637|NCT01432262|26416325|FG000|Overall Study|Withdrawal by Subject|2|||
13267638|NCT01432262|26416326|FG001|Overall Study|Withdrawal by Subject|1|||
13267639|NCT01432171|26416339|FG000|Overall Study|Death|1|||
13267640|NCT01432171|26416340|FG001|Overall Study|Death|2|||
13267641|NCT01432171|26416339|FG000|Overall Study|Lost to Follow-up|6|||
13267642|NCT01432171|26416340|FG001|Overall Study|Lost to Follow-up|5|||
13267643|NCT01432171|26416339|FG000|Overall Study|Withdrawal by Subject|3|||
13267644|NCT01432171|26416340|FG001|Overall Study|Withdrawal by Subject|1|||
13267645|NCT01432171|26416339|FG000|Overall Study|Noncompliance|2|||
13267646|NCT01432171|26416340|FG001|Overall Study|Noncompliance|3|||
13267647|NCT01432171|26416339|FG000|Overall Study|Insurance denial trial coverage|1|||
13267648|NCT01432171|26416340|FG001|Overall Study|Insurance denial trial coverage|0|||
13267649|NCT01432171|26416339|FG000|Overall Study|Patient moved to palliative care|1|||
13267650|NCT01432171|26416340|FG001|Overall Study|Patient moved to palliative care|0|||
13267651|NCT01431976|26416353|FG000|Overall Study|Adverse Event|6|||
13267652|NCT01431976|26416353|FG000|Overall Study|Lack of Efficacy|2|||
13267653|NCT01431976|26416353|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4|||
13267654|NCT01431976|26416353|FG000|Overall Study|Physician Decision|1|||
13267655|NCT01431976|26416353|FG000|Overall Study|Withdrawal by Subject|1|||
13267656|NCT01431963|26416361|FG000|Overall Study|Adverse Event|18|||
13267657|NCT01431963|26416361|FG000|Overall Study|Lack of Efficacy|7|||
13267658|NCT01431963|26416361|FG000|Overall Study|Protocol Violation|1|||
13267659|NCT01431963|26416361|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
13267660|NCT01431963|26416361|FG000|Overall Study|Physician Decision|4|||
13267661|NCT01431963|26416361|FG000|Overall Study|Withdrawal by Subject|3|||
13267662|NCT01431950|26416382|FG000|Overall Study|Study Site Closed/Terminated|7|||
13267663|NCT01431950|26416383|FG001|Overall Study|Study Site Closed/Terminated|3|||
13267664|NCT01431950|26416382|FG000|Overall Study|Withdrawal by Subject|4|||
13267665|NCT01431950|26416383|FG001|Overall Study|Withdrawal by Subject|3|||
13267666|NCT01431950|26416382|FG000|Overall Study|Protocol Violation|2|||
13267667|NCT01431950|26416383|FG001|Overall Study|Protocol Violation|3|||
13267668|NCT01431950|26416382|FG000|Overall Study|Adverse Event|2|||
13267669|NCT01431950|26416383|FG001|Overall Study|Adverse Event|2|||
13267670|NCT01431950|26416382|FG000|Overall Study|Physician Decision|2|||
13267671|NCT01431950|26416383|FG001|Overall Study|Physician Decision|1|||
13267672|NCT01431950|26416382|FG000|Overall Study|Lack of Efficacy|2|||
13267673|NCT01431950|26416383|FG001|Overall Study|Lack of Efficacy|1|||
13267674|NCT01431950|26416382|FG000|Overall Study|Lost to Follow-up|0|||
13267675|NCT01431950|26416383|FG001|Overall Study|Lost to Follow-up|1|||
13267676|NCT01431950|26416382|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0|||
13267677|NCT01431950|26416383|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
13267678|NCT01431716|26416402|FG000|Overall Study|Withdrawal of consent|1|||
13267679|NCT01431638|26416441|FG000|Overall Study|Adverse Event|1|||
13267680|NCT01431638|26416442|FG001|Overall Study|Adverse Event|3|||
13267681|NCT01431638|26416443|FG002|Overall Study|Adverse Event|1|||
13267682|NCT01431638|26416441|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
13267683|NCT01431638|26416442|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
13267684|NCT01431638|26416443|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
13267685|NCT01431638|26416441|FG000|Overall Study|Participants condition no longer requires study drug|0|||
13267686|NCT01431638|26416442|FG001|Overall Study|Participants condition no longer requires study drug|1|||
13267687|NCT01431638|26416443|FG002|Overall Study|Participants condition no longer requires study drug|0|||
13267688|NCT01431638|26416441|FG000|Overall Study|Participant withdrew consent|14|||
13267689|NCT01431638|26416442|FG001|Overall Study|Participant withdrew consent|5|||
13267690|NCT01431638|26416443|FG002|Overall Study|Participant withdrew consent|8|||
13267691|NCT01431638|26416441|FG000|Overall Study|Lost to Follow-up|7|||
13267692|NCT01431638|26416442|FG001|Overall Study|Lost to Follow-up|9|||
13267693|NCT01431638|26416443|FG002|Overall Study|Lost to Follow-up|7|||
13267694|NCT01431638|26416441|FG000|Overall Study|Administrative problems|1|||
13267695|NCT01431638|26416442|FG001|Overall Study|Administrative problems|4|||
13267696|NCT01431638|26416443|FG002|Overall Study|Administrative problems|6|||
13267697|NCT01431638|26416441|FG000|Overall Study|Death|1|||
13267698|NCT01431638|26416442|FG001|Overall Study|Death|0|||
13267699|NCT01431638|26416443|FG002|Overall Study|Death|0|||
13267700|NCT01431638|26416441|FG000|Overall Study|Protocol deviation|1|||
13267701|NCT01431638|26416442|FG001|Overall Study|Protocol deviation|1|||
13267702|NCT01431638|26416443|FG002|Overall Study|Protocol deviation|4|||
13267703|NCT01431638|26416441|FG000|Overall Study|Participants Did not enter extension study from core study|39|||
13267704|NCT01431638|26416442|FG001|Overall Study|Participants Did not enter extension study from core study|46|||
13267705|NCT01431638|26416443|FG002|Overall Study|Participants Did not enter extension study from core study|32|||
13267706|NCT01431534|26416464|FG000|Treatment Phase|Adverse Event|0|||
13267707|NCT01431534|26416465|FG001|Treatment Phase|Adverse Event|0|||
13267708|NCT01431534|26416466|FG002|Treatment Phase|Adverse Event|1|||
13267709|NCT01431534|26416464|FG000|Treatment Phase|Progressive Disease|4|||
13267710|NCT01431534|26416465|FG001|Treatment Phase|Progressive Disease|3|||
13267711|NCT01431534|26416466|FG002|Treatment Phase|Progressive Disease|10|||
13267712|NCT01431521|26416500|FG000|Overall Study|Withdrawal by Subject|0|||
13267713|NCT01431521|26416501|FG001|Overall Study|Withdrawal by Subject|0|||
13267714|NCT01431521|26416502|FG002|Overall Study|Withdrawal by Subject|1|||
13267715|NCT01431521|26416503|FG003|Overall Study|Withdrawal by Subject|0|||
13267716|NCT01431287|26416676|FG000|Overall Study|not treated|0|||
13267717|NCT01431287|26416677|FG001|Overall Study|not treated|0|||
13267718|NCT01431287|26416678|FG002|Overall Study|not treated|1|||
13267719|NCT01431287|26416679|FG003|Overall Study|not treated|0|||
13267720|NCT01431287|26416680|FG004|Overall Study|not treated|0|||
13267721|NCT01431287|26416676|FG000|Overall Study|Adverse Event|59|||
13267722|NCT01431287|26416677|FG001|Overall Study|Adverse Event|57|||
13267723|NCT01431287|26416678|FG002|Overall Study|Adverse Event|53|||
13267724|NCT01431287|26416679|FG003|Overall Study|Adverse Event|33|||
13267725|NCT01431287|26416680|FG004|Overall Study|Adverse Event|41|||
13267726|NCT01431287|26416676|FG000|Overall Study|Non compliant with protocol|6|||
13267727|NCT01431287|26416677|FG001|Overall Study|Non compliant with protocol|6|||
13267728|NCT01431287|26416678|FG002|Overall Study|Non compliant with protocol|5|||
13267729|NCT01431287|26416679|FG003|Overall Study|Non compliant with protocol|6|||
13267730|NCT01431287|26416680|FG004|Overall Study|Non compliant with protocol|5|||
13267731|NCT01431287|26416676|FG000|Overall Study|Lost to Follow-up|0|||
13267732|NCT01431287|26416677|FG001|Overall Study|Lost to Follow-up|3|||
13267733|NCT01431287|26416678|FG002|Overall Study|Lost to Follow-up|2|||
13267734|NCT01431287|26416679|FG003|Overall Study|Lost to Follow-up|3|||
13267735|NCT01431287|26416680|FG004|Overall Study|Lost to Follow-up|1|||
13267736|NCT01431287|26416676|FG000|Overall Study|Consent withdrawn not due to AE|29|||
13267737|NCT01431287|26416677|FG001|Overall Study|Consent withdrawn not due to AE|30|||
13267738|NCT01431287|26416678|FG002|Overall Study|Consent withdrawn not due to AE|34|||
13267739|NCT01431287|26416679|FG003|Overall Study|Consent withdrawn not due to AE|19|||
13267740|NCT01431287|26416680|FG004|Overall Study|Consent withdrawn not due to AE|29|||
13267741|NCT01431287|26416676|FG000|Overall Study|not stated above|4|||
13267742|NCT01431287|26416677|FG001|Overall Study|not stated above|2|||
13267743|NCT01431287|26416678|FG002|Overall Study|not stated above|2|||
13267744|NCT01431287|26416679|FG003|Overall Study|not stated above|2|||
13267745|NCT01431287|26416680|FG004|Overall Study|not stated above|1|||
13267746|NCT01431274|26416853|FG000|Overall Study|Adverse Event|51|||
13267747|NCT01431274|26416854|FG001|Overall Study|Adverse Event|37|||
13267748|NCT01431274|26416855|FG002|Overall Study|Adverse Event|43|||
13267749|NCT01431274|26416856|FG003|Overall Study|Adverse Event|30|||
13267750|NCT01431274|26416857|FG004|Overall Study|Adverse Event|37|||
13267751|NCT01431274|26416853|FG000|Overall Study|Consent withdrawn not due to AE|29|||
13267752|NCT01431274|26416854|FG001|Overall Study|Consent withdrawn not due to AE|20|||
13267753|NCT01431274|26416855|FG002|Overall Study|Consent withdrawn not due to AE|17|||
13267754|NCT01431274|26416856|FG003|Overall Study|Consent withdrawn not due to AE|20|||
13267755|NCT01431274|26416857|FG004|Overall Study|Consent withdrawn not due to AE|11|||
13267756|NCT01431274|26416853|FG000|Overall Study|Non compliant with protocol|5|||
13267757|NCT01431274|26416854|FG001|Overall Study|Non compliant with protocol|8|||
13267758|NCT01431274|26416855|FG002|Overall Study|Non compliant with protocol|4|||
13267759|NCT01431274|26416856|FG003|Overall Study|Non compliant with protocol|4|||
13267760|NCT01431274|26416857|FG004|Overall Study|Non compliant with protocol|4|||
13267761|NCT01431274|26416853|FG000|Overall Study|Lost to Follow-up|6|||
13267762|NCT01431274|26416854|FG001|Overall Study|Lost to Follow-up|7|||
13267763|NCT01431274|26416855|FG002|Overall Study|Lost to Follow-up|1|||
13267764|NCT01431274|26416856|FG003|Overall Study|Lost to Follow-up|4|||
13267765|NCT01431274|26416857|FG004|Overall Study|Lost to Follow-up|0|||
13267766|NCT01431274|26416853|FG000|Overall Study|Other reason not stated above|6|||
13267767|NCT01431274|26416854|FG001|Overall Study|Other reason not stated above|5|||
13267768|NCT01431274|26416855|FG002|Overall Study|Other reason not stated above|7|||
13267769|NCT01431274|26416856|FG003|Overall Study|Other reason not stated above|2|||
13267770|NCT01431274|26416857|FG004|Overall Study|Other reason not stated above|4|||
13267771|NCT01431144|26416870|FG000|Overall Study|Implant mobility and removal|2|||
13267772|NCT01431144|26416871|FG001|Overall Study|Implant mobility and removal|0|||
13267773|NCT01431079|26416930|FG000|Overall Study|Lost to Follow-up|35|||
13267774|NCT01431079|26416931|FG001|Overall Study|Lost to Follow-up|39|||
13267775|NCT01430754|26416958|FG000|Run-In Phase|Circadian Period Ineligible|24|||
13267776|NCT01430754|26416959|FG001|Run-In Phase|Circadian Period Ineligible|0|||
13267777|NCT01430754|26416958|FG000|Run-In Phase|Protocol Violation|6|||
13267778|NCT01430754|26416959|FG001|Run-In Phase|Protocol Violation|0|||
13267779|NCT01430754|26416958|FG000|Run-In Phase|Adverse Event|2|||
13267780|NCT01430754|26416959|FG001|Run-In Phase|Adverse Event|0|||
13267781|NCT01430754|26416958|FG000|Run-In Phase|Other|2|||
13267782|NCT01430754|26416959|FG001|Run-In Phase|Other|0|||
13267783|NCT01430754|26416958|FG000|Run-In Phase|Withdrawal by Subject|2|||
13267784|NCT01430754|26416959|FG001|Run-In Phase|Withdrawal by Subject|0|||
13267785|NCT01430754|26416958|FG000|Run-In Phase|Lost to Follow-up|1|||
13267786|NCT01430754|26416959|FG001|Run-In Phase|Lost to Follow-up|0|||
13267787|NCT01430624|26416998|FG000|Overall Study|Lost to Follow-up|23|||
13267788|NCT01430624|26416999|FG001|Overall Study|Lost to Follow-up|29|||
13267789|NCT01430624|26417000|FG002|Overall Study|Lost to Follow-up|27|||
13267790|NCT01430624|26416998|FG000|Overall Study|technical or eligibility|5|||
13267791|NCT01430624|26416999|FG001|Overall Study|technical or eligibility|5|||
13267792|NCT01430624|26417000|FG002|Overall Study|technical or eligibility|2|||
13267793|NCT01430611|26417025|FG000|Overall Study|Adverse Event|0|||
13267794|NCT01430611|26417026|FG001|Overall Study|Adverse Event|1|||
13267795|NCT01430611|26417025|FG000|Overall Study|Protocol Violation|1|||
13267796|NCT01430611|26417026|FG001|Overall Study|Protocol Violation|0|||
13267797|NCT01430611|26417025|FG000|Overall Study|Lost to Follow-up|1|||
13267798|NCT01430611|26417026|FG001|Overall Study|Lost to Follow-up|0|||
13267799|NCT01430611|26417025|FG000|Overall Study|Withdrawal by Subject|15|||
13267800|NCT01430611|26417026|FG001|Overall Study|Withdrawal by Subject|14|||
13267801|NCT01430585|26417061|FG000|Overall Study|Death|1|||
13267802|NCT01430585|26417061|FG000|Overall Study|Objective Progression or Relapse|3|||
13267803|NCT01430585|26417061|FG000|Overall Study|Study Terminated by Sponsor|3|||
13267804|NCT01430585|26417061|FG000|Overall Study|Other|7|||
13267805|NCT01430559|26417102|FG000|Overall Study|Adverse Event|7|||
13267806|NCT01430559|26417103|FG001|Overall Study|Adverse Event|3|||
13267807|NCT01430559|26417102|FG000|Overall Study|Entry criteria not met|1|||
13267808|NCT01430559|26417103|FG001|Overall Study|Entry criteria not met|1|||
13267809|NCT01430559|26417102|FG000|Overall Study|Lost to Follow-up|1|||
13267810|NCT01430559|26417103|FG001|Overall Study|Lost to Follow-up|0|||
13267811|NCT01430559|26417102|FG000|Overall Study|Medication error|1|||
13267812|NCT01430559|26417103|FG001|Overall Study|Medication error|0|||
13267813|NCT01430559|26417102|FG000|Overall Study|Withdrawal by Subject|3|||
13267814|NCT01430559|26417103|FG001|Overall Study|Withdrawal by Subject|2|||
13267815|NCT01430559|26417102|FG000|Overall Study|Protocol Violation|1|||
13267816|NCT01430559|26417103|FG001|Overall Study|Protocol Violation|0|||
13267817|NCT01430559|26417102|FG000|Overall Study|Other|3|||
13267818|NCT01430559|26417103|FG001|Overall Study|Other|3|||
13267819|NCT01430559|26417102|FG000|Overall Study|Randomized, Not Treated|3|||
13267820|NCT01430559|26417103|FG001|Overall Study|Randomized, Not Treated|3|||
13267821|NCT01430468|26417118|FG000|Overall Study|Physician Decision|2|||
13267822|NCT01430468|26417119|FG001|Overall Study|Physician Decision|1|||
13267823|NCT01430468|26417118|FG000|Overall Study|Withdrawal by Subject|5|||
13267824|NCT01430468|26417119|FG001|Overall Study|Withdrawal by Subject|5|||
13267825|NCT01430455|26417125|FG000|Overall Study|Withdrawal by Subject|1|||
13267826|NCT01430455|26417125|FG000|Overall Study|Switched to follow-up phase|1|||
13267827|NCT01430403|26417184|FG000|Overall Study|Lost to Follow-up|5|||
13267828|NCT01430403|26417185|FG001|Overall Study|Lost to Follow-up|5|||
13267829|NCT01430403|26417186|FG002|Overall Study|Lost to Follow-up|3|||
13267830|NCT01430403|26417184|FG000|Overall Study|Physician Decision|1|||
13267831|NCT01430403|26417185|FG001|Overall Study|Physician Decision|0|||
13267832|NCT01430403|26417186|FG002|Overall Study|Physician Decision|0|||
13267833|NCT01430403|26417184|FG000|Overall Study|Protocol Violation|2|||
13267834|NCT01430403|26417185|FG001|Overall Study|Protocol Violation|3|||
13267835|NCT01430403|26417186|FG002|Overall Study|Protocol Violation|2|||
13267836|NCT01430403|26417184|FG000|Overall Study|Withdrawal by Subject|9|||
13267837|NCT01430403|26417185|FG001|Overall Study|Withdrawal by Subject|1|||
13267838|NCT01430403|26417186|FG002|Overall Study|Withdrawal by Subject|3|||
13267839|NCT01430130|26417194|FG000|Overall Study|Lost to Follow-up|1|||
13267840|NCT01430130|26417194|FG000|Overall Study|Infection on Control Side of Incision|1|||
13267841|NCT01430104|26417208|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1|||
13267842|NCT01429792|26417222|FG000|Overall Study|Other Reasons|67|||
13267843|NCT01429792|26417222|FG000|Overall Study|Unknown Disposition|94|||
13267844|NCT01429792|26417222|FG000|Overall Study|Negative HCV-RNA at Week 4|1|||
13267845|NCT01429792|26417222|FG000|Overall Study|Negative HCV-RNA at Week 12|4|||
13267846|NCT01429792|26417222|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32|||
13267847|NCT01429792|26417222|FG000|Overall Study|Positive HCV-RNA at Week 24|50|||
13267848|NCT01429792|26417222|FG000|Overall Study|Withdrawal by Subject|70|||
13267849|NCT01429792|26417222|FG000|Overall Study|Lost to Follow-up|88|||
13267850|NCT01429623|26417241|FG000|Overall Study|Death|1|||
13267851|NCT01429623|26417242|FG001|Overall Study|Death|0|||
13267852|NCT01429623|26417241|FG000|Overall Study|Adverse Event|7|||
13267853|NCT01429623|26417242|FG001|Overall Study|Adverse Event|14|||
13267854|NCT01429623|26417241|FG000|Overall Study|Withdrawal by Subject|19|||
13267855|NCT01429623|26417242|FG001|Overall Study|Withdrawal by Subject|13|||
13117906|NCT03050359|25927143|FG001|Overall Study|Lost to Follow-up|1|||
13267856|NCT01429623|26417241|FG000|Overall Study|Physician Decision|2|||
13267857|NCT01429623|26417242|FG001|Overall Study|Physician Decision|3|||
13267858|NCT01429623|26417241|FG000|Overall Study|Protocol Violation|3|||
13267859|NCT01429623|26417242|FG001|Overall Study|Protocol Violation|2|||
13267860|NCT01429623|26417241|FG000|Overall Study|Assorted|1|||
13267861|NCT01429623|26417242|FG001|Overall Study|Assorted|2|||
13267862|NCT01429623|26417241|FG000|Overall Study|Conversion to Alzheimer's disease|14|||
13267863|NCT01429623|26417242|FG001|Overall Study|Conversion to Alzheimer's disease|21|||
13117907|NCT03050359|25927142|FG000|Overall Study|Voluntary Withdrawal|4|||
13267864|NCT01429623|26417241|FG000|Overall Study|No post baseline data|4|||
13267865|NCT01429623|26417242|FG001|Overall Study|No post baseline data|4|||
13267866|NCT01429584|26417259|FG000|Overall Study|Withdrawal by Subject|1|||
13267867|NCT01429584|26417260|FG001|Overall Study|Withdrawal by Subject|0|||
13267868|NCT01429584|26417259|FG000|Overall Study|Protocol Violation|0|||
13267869|NCT01429584|26417260|FG001|Overall Study|Protocol Violation|1|||
13267870|NCT01429441|26417275|FG000|Overall Study|Adverse Event|5|||
13267871|NCT01429441|26417276|FG001|Overall Study|Adverse Event|1|||
13267872|NCT01429441|26417275|FG000|Overall Study|Death|0|||
13267873|NCT01429441|26417276|FG001|Overall Study|Death|2|||
13117908|NCT03050359|25927143|FG001|Overall Study|Voluntary Withdrawal|6|||
13267874|NCT01429441|26417275|FG000|Overall Study|Lost to Follow-up|5|||
13267875|NCT01429441|26417276|FG001|Overall Study|Lost to Follow-up|2|||
13267876|NCT01429441|26417275|FG000|Overall Study|Physician Decision|1|||
13267877|NCT01429441|26417276|FG001|Overall Study|Physician Decision|0|||
13267878|NCT01429441|26417275|FG000|Overall Study|Withdrawal by Subject|27|||
13267879|NCT01429441|26417276|FG001|Overall Study|Withdrawal by Subject|18|||
13267880|NCT01429298|26417297|FG000|Overall Study|Protocol Violation|4|||
13267881|NCT01429298|26417298|FG001|Overall Study|Protocol Violation|6|||
13267882|NCT01429285|26417323|FG000|Overall Study|Protocol Violation|9|||
13267883|NCT01429285|26417324|FG001|Overall Study|Protocol Violation|4|||
13267884|NCT01429285|26417323|FG000|Overall Study|Missing Data|5|||
13267885|NCT01429285|26417324|FG001|Overall Study|Missing Data|3|||
13267886|NCT01429285|26417323|FG000|Overall Study|Erroneously Enrolled Twice|8|||
13267887|NCT01429285|26417324|FG001|Overall Study|Erroneously Enrolled Twice|2|||
13267888|NCT01429077|26417337|FG000|Overall Study|Lost to Follow-up|0|||
13267889|NCT01429077|26417338|FG001|Overall Study|Lost to Follow-up|3|||
13267890|NCT01429051|26417361|FG000|Titration Phase|Death|1|||
13267891|NCT01429051|26417361|FG000|Titration Phase|Withdrawal by Subject|7|||
13267892|NCT01429051|26417361|FG000|Titration Phase|Physician Decision|1|||
13267893|NCT01429051|26417361|FG000|Titration Phase|Unsuccessful titration at any dose|1|||
13267894|NCT01429051|26417361|FG000|Titration Phase|Less than 3 BTP episodes per week|2|||
13117909|NCT03050359|25927142|FG000|Overall Study|Pregnancy|1|||
13117910|NCT03050359|25927143|FG001|Overall Study|Pregnancy|0|||
13117911|NCT03050359|25927142|FG000|Overall Study|Reason Not Specified|1|||
13117912|NCT03050359|25927143|FG001|Overall Study|Reason Not Specified|0|||
13117913|NCT03050307|25927162|FG000|Overall Study|Adverse Event|4|||
13117914|NCT03050307|25927163|FG001|Overall Study|Adverse Event|2|||
13117915|NCT03050307|25927162|FG000|Overall Study|Significant Protocol Deviation|0|||
13117916|NCT03050307|25927163|FG001|Overall Study|Significant Protocol Deviation|1|||
13117917|NCT03050307|25927162|FG000|Overall Study|Lost to Follow-up|0|||
13117918|NCT03050307|25927163|FG001|Overall Study|Lost to Follow-up|1|||
13267895|NCT01429051|26417361|FG000|Efficacy Phase|Adverse Event|1|||
13267896|NCT01429051|26417361|FG000|Efficacy Phase|Death|1|||
13267897|NCT01429051|26417361|FG000|Tolerability Phase|Death|5|||
13267898|NCT01429051|26417361|FG000|Tolerability Phase|Adverse Event|2|||
13267899|NCT01429051|26417361|FG000|Tolerability Phase|Withdrawal by Subject|5|||
13267900|NCT01429051|26417361|FG000|Tolerability Phase|Physician Decision|1|||
13267901|NCT01429051|26417361|FG000|Tolerability Phase|Other|2|||
13267902|NCT01428882|26417380|FG000|Overall Study|Lack of Efficacy|2|||
13267903|NCT01428882|26417381|FG001|Overall Study|Lack of Efficacy|7|||
13267904|NCT01428882|26417380|FG000|Overall Study|Protocol Violation|4|||
13267905|NCT01428882|26417381|FG001|Overall Study|Protocol Violation|3|||
13117919|NCT03050307|25927162|FG000|Overall Study|Voluntary Withdrawal|3|||
13117920|NCT03050307|25927163|FG001|Overall Study|Voluntary Withdrawal|4|||
13117921|NCT03050307|25927162|FG000|Overall Study|Reason not Specified|1|||
13117922|NCT03050307|25927163|FG001|Overall Study|Reason not Specified|1|||
13117923|NCT03050060|25927173|FG000|Overall Study|Adverse Event|7|||
13117924|NCT03050060|25927173|FG000|Overall Study|Withdrawal by Subject|1|||
13117925|NCT03050060|25927173|FG000|Overall Study|Progression|7|||
13117926|NCT03049852|25927193|FG000|Overall Study|Lost to Follow-up|0|||
13117927|NCT03049852|25927194|FG001|Overall Study|Lost to Follow-up|1|||
13117928|NCT03049852|25927195|FG002|Overall Study|Lost to Follow-up|0|||
13267906|NCT01428713|26417390|FG000|Overall Study|Non-compliance|2|||
13267907|NCT01428713|26417391|FG001|Overall Study|Non-compliance|2|||
13267908|NCT01428713|26417390|FG000|Overall Study|Withdrawal by Subject|1|||
13267909|NCT01428713|26417391|FG001|Overall Study|Withdrawal by Subject|1|||
13267910|NCT01428713|26417390|FG000|Overall Study|Adverse Event|0|||
13267911|NCT01428713|26417391|FG001|Overall Study|Adverse Event|2|||
13267912|NCT01428661|26417409|FG000|Double-Masked Phase|Protocol Violation|9|||
13117929|NCT03049813|25927226|FG000|Randomized Control Trial Phase|Participant placed in nursing home|0|||
13117930|NCT03049813|25927227|FG001|Randomized Control Trial Phase|Participant placed in nursing home|1|||
13117931|NCT03049813|25927228|FG002|Randomized Control Trial Phase|Participant placed in nursing home|0|||
13117932|NCT03049813|25927229|FG003|Randomized Control Trial Phase|Participant placed in nursing home|0|||
13117933|NCT03049813|25927226|FG000|Randomized Control Trial Phase|COVID Quarantine|2|||
13117934|NCT03049813|25927227|FG001|Randomized Control Trial Phase|COVID Quarantine|3|||
13117935|NCT03049813|25927228|FG002|Randomized Control Trial Phase|COVID Quarantine|0|||
13117936|NCT03049813|25927229|FG003|Randomized Control Trial Phase|COVID Quarantine|0|||
13117937|NCT03049813|25927226|FG000|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
13117938|NCT03049813|25927227|FG001|Randomized Control Trial Phase|Participant was in another concurrent study|1|||
13117939|NCT03049813|25927228|FG002|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
13117940|NCT03049813|25927229|FG003|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
13117941|NCT03049813|25927226|FG000|Randomized Control Trial Phase|Lost to Follow-up|0|||
13267913|NCT01428661|26417410|FG001|Double-Masked Phase|Protocol Violation|4|||
13267914|NCT01428661|26417411|FG002|Double-Masked Phase|Protocol Violation|0|||
13267915|NCT01428661|26417409|FG000|Double-Masked Phase|Adverse Event|13|||
13267916|NCT01428661|26417410|FG001|Double-Masked Phase|Adverse Event|4|||
13267917|NCT01428661|26417411|FG002|Double-Masked Phase|Adverse Event|0|||
13267918|NCT01428661|26417409|FG000|Double-Masked Phase|Lost to Follow-up|14|||
13267919|NCT01428661|26417410|FG001|Double-Masked Phase|Lost to Follow-up|14|||
13267920|NCT01428661|26417411|FG002|Double-Masked Phase|Lost to Follow-up|0|||
13267921|NCT01428661|26417409|FG000|Double-Masked Phase|Withdrawal by Subject|18|||
13267922|NCT01428661|26417410|FG001|Double-Masked Phase|Withdrawal by Subject|20|||
13267923|NCT01428661|26417411|FG002|Double-Masked Phase|Withdrawal by Subject|0|||
13267924|NCT01428661|26417409|FG000|Double-Masked Phase|Lack of Efficacy|2|||
13267925|NCT01428661|26417410|FG001|Double-Masked Phase|Lack of Efficacy|1|||
13267926|NCT01428661|26417411|FG002|Double-Masked Phase|Lack of Efficacy|0|||
13267927|NCT01428661|26417409|FG000|Double-Masked Phase|*Various|1|||
13267928|NCT01428661|26417410|FG001|Double-Masked Phase|*Various|6|||
13267929|NCT01428661|26417411|FG002|Double-Masked Phase|*Various|0|||
13267930|NCT01428661|26417409|FG000|Open Label Extension|Protocol Violation|0|||
13267931|NCT01428661|26417410|FG001|Open Label Extension|Protocol Violation|0|||
13267932|NCT01428661|26417411|FG002|Open Label Extension|Protocol Violation|9|||
13267933|NCT01428661|26417409|FG000|Open Label Extension|Adverse Event|0|||
13267934|NCT01428661|26417410|FG001|Open Label Extension|Adverse Event|0|||
13267935|NCT01428661|26417411|FG002|Open Label Extension|Adverse Event|15|||
13267936|NCT01428661|26417409|FG000|Open Label Extension|Lost to Follow-up|0|||
13267937|NCT01428661|26417410|FG001|Open Label Extension|Lost to Follow-up|0|||
13267938|NCT01428661|26417411|FG002|Open Label Extension|Lost to Follow-up|38|||
13267939|NCT01428661|26417409|FG000|Open Label Extension|Withdrawal by Subject|0|||
13267940|NCT01428661|26417410|FG001|Open Label Extension|Withdrawal by Subject|0|||
13267941|NCT01428661|26417411|FG002|Open Label Extension|Withdrawal by Subject|49|||
13267942|NCT01428661|26417409|FG000|Open Label Extension|Lack of Efficacy|0|||
13267943|NCT01428661|26417410|FG001|Open Label Extension|Lack of Efficacy|0|||
13267944|NCT01428661|26417411|FG002|Open Label Extension|Lack of Efficacy|24|||
13267945|NCT01428661|26417409|FG000|Open Label Extension|**Various|0|||
13267946|NCT01428661|26417410|FG001|Open Label Extension|**Various|0|||
13267947|NCT01428661|26417411|FG002|Open Label Extension|**Various|185|||
13267948|NCT01428583|26417435|FG000|Overall Study|Adverse Event|75|||
13267949|NCT01428583|26417435|FG000|Overall Study|Withdrawal by Subject|51|||
13267950|NCT01428583|26417435|FG000|Overall Study|Lack of Efficacy|37|||
13267951|NCT01428583|26417435|FG000|Overall Study|Lost to Follow-up|17|||
13267952|NCT01428583|26417435|FG000|Overall Study|Death|1|||
13267953|NCT01428583|26417435|FG000|Overall Study|Pregnancy|1|||
13267954|NCT01428583|26417435|FG000|Overall Study|Protocol Violation|1|||
13267955|NCT01428583|26417435|FG000|Overall Study|Physician Decision|12|||
13267956|NCT01428583|26417435|FG000|Overall Study|Non-compliant|25|||
13267957|NCT01428583|26417435|FG000|Overall Study|Confirmed positive urine drug test|8|||
13267958|NCT01428583|26417435|FG000|Overall Study|Sponsor's request|3|||
13267959|NCT01428583|26417435|FG000|Overall Study|Other|6|||
13267960|NCT01428453|26417466|FG000|Overall Study|Adverse Event|2|||
13267961|NCT01428453|26417467|FG001|Overall Study|Adverse Event|7|||
13267962|NCT01428453|26417466|FG000|Overall Study|Protocol Violation|1|||
13267963|NCT01428453|26417467|FG001|Overall Study|Protocol Violation|0|||
13267964|NCT01428453|26417466|FG000|Overall Study|Lost to Follow-up|0|||
13267965|NCT01428453|26417467|FG001|Overall Study|Lost to Follow-up|1|||
13267966|NCT01428453|26417466|FG000|Overall Study|Withdrawal by Subject|3|||
13267967|NCT01428453|26417467|FG001|Overall Study|Withdrawal by Subject|1|||
13267968|NCT01428258|26417492|FG000|Intervention 1|Withdrawal by Subject|2|||
13267969|NCT01428258|26417493|FG001|Intervention 1|Withdrawal by Subject|0|||
13267970|NCT01428219|26417506|FG000|Overall Study|25 patients enrolled, 3 were not treated|3|||
13267971|NCT01428193|26417512|FG000|Overall Study|Physician Decision|1|||
13267972|NCT01428193|26417512|FG000|Overall Study|Elevated screening liver enzymes|1|||
13267973|NCT01428128|26417519|FG000|Overall Study|Withdrawal by Subject|4|||
13267974|NCT01428128|26417519|FG000|Overall Study|Screen failure by p53|10|||
13267975|NCT01428128|26417519|FG000|Overall Study|Received Neulasta in one cycle|2|||
13267976|NCT01428128|26417519|FG000|Overall Study|Adverse Event|1|||
13267977|NCT01428115|26417534|FG000|Overall Study|Lack of Efficacy|3|||
13267978|NCT01428115|26417534|FG000|Overall Study|Lost to Follow-up|10|||
13267979|NCT01428115|26417534|FG000|Overall Study|Pregnancy|1|||
13117942|NCT03049813|25927227|FG001|Randomized Control Trial Phase|Lost to Follow-up|2|||
13267980|NCT01428115|26417534|FG000|Overall Study|Protocol Violation|3|||
13267981|NCT01428115|26417534|FG000|Overall Study|Withdrawal by Subject|4|||
13267982|NCT01428076|26417549|FG000|Overall Study|Adverse Event|0|||
13267983|NCT01428076|26417550|FG001|Overall Study|Adverse Event|1|||
13267984|NCT01428063|26417629|FG000|Overall Study|Lack of Efficacy|8|||
13267985|NCT01428063|26417630|FG001|Overall Study|Lack of Efficacy|4|||
13267986|NCT01428063|26417631|FG002|Overall Study|Lack of Efficacy|1|||
13267987|NCT01428063|26417629|FG000|Overall Study|Adverse Event|2|||
13267988|NCT01428063|26417630|FG001|Overall Study|Adverse Event|3|||
13267989|NCT01428063|26417631|FG002|Overall Study|Adverse Event|0|||
13267990|NCT01428063|26417629|FG000|Overall Study|Lost to Follow-up|0|||
13267991|NCT01428063|26417630|FG001|Overall Study|Lost to Follow-up|2|||
13267992|NCT01428063|26417631|FG002|Overall Study|Lost to Follow-up|0|||
13267993|NCT01428063|26417629|FG000|Overall Study|No longer meets study criteria|0|||
13267994|NCT01428063|26417630|FG001|Overall Study|No longer meets study criteria|1|||
13267995|NCT01428063|26417631|FG002|Overall Study|No longer meets study criteria|0|||
13267996|NCT01427972|26417692|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0|||
13267997|NCT01427972|26417693|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0|||
13267998|NCT01427972|26417694|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0|||
13267999|NCT01427972|26417695|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0|||
13268000|NCT01427972|26417696|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0|||
13268001|NCT01427972|26417697|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0|||
13268002|NCT01427972|26417698|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0|||
13268003|NCT01427972|26417699|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1|||
13268004|NCT01427972|26417700|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0|||
13117943|NCT03049813|25927228|FG002|Randomized Control Trial Phase|Lost to Follow-up|3|||
13117944|NCT03049813|25927229|FG003|Randomized Control Trial Phase|Lost to Follow-up|0|||
13268005|NCT01427972|26417701|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0|||
13268006|NCT01427972|26417702|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0|||
13268007|NCT01427972|26417703|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0|||
13268008|NCT01427972|26417692|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
13268009|NCT01427972|26417693|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
13117945|NCT03049748|25927252|FG000|Overall Study|Lost to Follow-up|1|||
13117946|NCT03049748|25927253|FG001|Overall Study|Lost to Follow-up|0|||
13117947|NCT03049748|25927252|FG000|Overall Study|Death|3|||
13117948|NCT03049748|25927253|FG001|Overall Study|Death|0|||
13117949|NCT03049748|25927252|FG000|Overall Study|Withdrawal by Subject|0|||
13117950|NCT03049748|25927253|FG001|Overall Study|Withdrawal by Subject|3|||
13117951|NCT03049748|25927252|FG000|Overall Study|Protocol Violation|0|||
13268010|NCT01427972|26417694|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
13268011|NCT01427972|26417695|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
13268012|NCT01427972|26417696|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
13268013|NCT01427972|26417697|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2|||
13268014|NCT01427972|26417698|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
13268015|NCT01427972|26417699|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
13268016|NCT01427972|26417700|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
13268017|NCT01427972|26417701|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
13268018|NCT01427972|26417702|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
13268019|NCT01427972|26417703|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
13268020|NCT01427972|26417692|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
13268021|NCT01427972|26417693|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1|||
13268022|NCT01427972|26417694|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
13268023|NCT01427972|26417695|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
13268024|NCT01427972|26417696|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
13268025|NCT01427972|26417697|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
13268026|NCT01427972|26417698|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
13268027|NCT01427972|26417699|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
13268028|NCT01427972|26417700|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
13268029|NCT01427972|26417701|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
13268030|NCT01427972|26417702|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
13268031|NCT01427972|26417703|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
13268032|NCT01427933|26417728|FG000|Overall Study|Withdrawal by Subject|5|||
13268033|NCT01427933|26417729|FG001|Overall Study|Withdrawal by Subject|8|||
13268034|NCT01427933|26417728|FG000|Overall Study|Lost to Follow-up|1|||
13268035|NCT01427933|26417729|FG001|Overall Study|Lost to Follow-up|5|||
13117952|NCT03049748|25927253|FG001|Overall Study|Protocol Violation|2|||
13268036|NCT01427933|26417728|FG000|Overall Study|Other|1|||
13268037|NCT01427933|26417729|FG001|Overall Study|Other|0|||
13268038|NCT01427933|26417728|FG000|Overall Study|Investigator's Decision|1|||
13268039|NCT01427933|26417729|FG001|Overall Study|Investigator's Decision|0|||
13268040|NCT01427920|26417754|FG000|Overall Study|Adverse Event|1|||
13268041|NCT01427920|26417755|FG001|Overall Study|Adverse Event|2|||
13268042|NCT01427920|26417754|FG000|Overall Study|Lack of Efficacy|1|||
13268043|NCT01427920|26417755|FG001|Overall Study|Lack of Efficacy|0|||
13268044|NCT01427920|26417754|FG000|Overall Study|Protocol Violation|1|||
13268045|NCT01427920|26417755|FG001|Overall Study|Protocol Violation|3|||
13268046|NCT01427920|26417754|FG000|Overall Study|Withdrawal Criteria|4|||
13268047|NCT01427920|26417755|FG001|Overall Study|Withdrawal Criteria|4|||
13268048|NCT01427920|26417754|FG000|Overall Study|Unclassified|2|||
13268049|NCT01427920|26417755|FG001|Overall Study|Unclassified|8|||
13268050|NCT01427907|26417768|FG000|Overall Study|Withdrawal by Subject|3|||
13268051|NCT01427907|26417769|FG001|Overall Study|Withdrawal by Subject|4|||
13117953|NCT03049748|25927252|FG000|Overall Study|Moved out of state (relocation)|0|||
13268052|NCT01427803|26417788|FG000|Overall Study|Lost to Follow-up|32|||
13268053|NCT01427803|26417789|FG001|Overall Study|Lost to Follow-up|26|||
13268054|NCT01427803|26417788|FG000|Overall Study|Withdrawal by Subject|20|||
13268055|NCT01427803|26417789|FG001|Overall Study|Withdrawal by Subject|0|||
13268056|NCT01427803|26417788|FG000|Overall Study|Unable to complete full treatment period|6|||
13268057|NCT01427803|26417789|FG001|Overall Study|Unable to complete full treatment period|0|||
13268058|NCT01427803|26417788|FG000|Overall Study|Protocol Violation|1|||
13268059|NCT01427803|26417789|FG001|Overall Study|Protocol Violation|0|||
13117954|NCT03049748|25927253|FG001|Overall Study|Moved out of state (relocation)|1|||
13268060|NCT01427803|26417788|FG000|Overall Study|Physician Decision|3|||
13268061|NCT01427803|26417789|FG001|Overall Study|Physician Decision|0|||
13268062|NCT01427803|26417788|FG000|Overall Study|did not take product|1|||
13268063|NCT01427803|26417789|FG001|Overall Study|did not take product|0|||
13268064|NCT01427751|26417814|FG000|Overall Study|Adverse Event|18|||
13268065|NCT01427751|26417815|FG001|Overall Study|Adverse Event|2|||
13268066|NCT01427751|26417814|FG000|Overall Study|No further treatment benefit expected|5|||
13268067|NCT01427751|26417815|FG001|Overall Study|No further treatment benefit expected|1|||
13268068|NCT01427751|26417814|FG000|Overall Study|Lost to Follow-up|3|||
13268069|NCT01427751|26417815|FG001|Overall Study|Lost to Follow-up|1|||
13268070|NCT01427751|26417814|FG000|Overall Study|Withdrawal of consent|2|||
13268071|NCT01427751|26417815|FG001|Overall Study|Withdrawal of consent|2|||
13268072|NCT01427751|26417814|FG000|Overall Study|Protocol Violation|6|||
13268073|NCT01427751|26417815|FG001|Overall Study|Protocol Violation|4|||
13268074|NCT01427751|26417814|FG000|Overall Study|Death|2|||
13268075|NCT01427751|26417815|FG001|Overall Study|Death|0|||
13268076|NCT01427751|26417814|FG000|Overall Study|Other miscellaneous reasons|6|||
13268077|NCT01427751|26417815|FG001|Overall Study|Other miscellaneous reasons|4|||
13268078|NCT01427738|26417840|FG000|Overall Study|Death|12|||
13268079|NCT01427738|26417841|FG001|Overall Study|Death|9|||
13268080|NCT01427738|26417840|FG000|Overall Study|Severe debilitation, unable to continue|0|||
13268081|NCT01427738|26417841|FG001|Overall Study|Severe debilitation, unable to continue|1|||
13268082|NCT01427738|26417840|FG000|Overall Study|Subject unable to get to clinic|5|||
13268083|NCT01427738|26417841|FG001|Overall Study|Subject unable to get to clinic|2|||
13268084|NCT01427738|26417840|FG000|Overall Study|Withdrawal by Subject|0|||
13268085|NCT01427738|26417841|FG001|Overall Study|Withdrawal by Subject|2|||
13268086|NCT01427738|26417840|FG000|Overall Study|Subject not willing to adhere to reqs|1|||
13268087|NCT01427738|26417841|FG001|Overall Study|Subject not willing to adhere to reqs|2|||
13268088|NCT01427738|26417840|FG000|Overall Study|Lost to Follow-up|1|||
13268089|NCT01427738|26417841|FG001|Overall Study|Lost to Follow-up|5|||
13268090|NCT01427608|26417860|FG000|Overall Study|Death|1|||
13268091|NCT01427608|26417861|FG001|Overall Study|Death|0|||
13268092|NCT01427608|26417860|FG000|Overall Study|Withdrawal by Subject|7|||
13268093|NCT01427608|26417861|FG001|Overall Study|Withdrawal by Subject|3|||
13268094|NCT01427608|26417860|FG000|Overall Study|Relapsed-all cause|13|||
13268095|NCT01427608|26417861|FG001|Overall Study|Relapsed-all cause|34|||
13268096|NCT01427608|26417860|FG000|Overall Study|Events not attributed to study meds|0|||
13268097|NCT01427608|26417861|FG001|Overall Study|Events not attributed to study meds|1|||
13268098|NCT01427309|26417912|FG000|Overall Study|Lost to Follow-up|130|||
13268099|NCT01427309|26417913|FG001|Overall Study|Lost to Follow-up|145|||
13268100|NCT01427309|26417914|FG002|Overall Study|Lost to Follow-up|122|||
13268101|NCT01427309|26417915|FG003|Overall Study|Lost to Follow-up|135|||
13268102|NCT01427309|26417912|FG000|Overall Study|Protocol Violation|42|||
13117955|NCT03049735|25927353|FG000|Overall Study|Discontinued due to AE (not dosed)|0|||
13117956|NCT03049735|25927354|FG001|Overall Study|Discontinued due to AE (not dosed)|0|||
13117957|NCT03049735|25927355|FG002|Overall Study|Discontinued due to AE (not dosed)|1|||
13117958|NCT03049735|25927353|FG000|Overall Study|Other|5|||
13117959|NCT03049735|25927354|FG001|Overall Study|Other|3|||
13117960|NCT03049735|25927355|FG002|Overall Study|Other|1|||
13268103|NCT01427309|26417913|FG001|Overall Study|Protocol Violation|69|||
13268104|NCT01427309|26417914|FG002|Overall Study|Protocol Violation|125|||
13117961|NCT03049735|25927353|FG000|Overall Study|Lack of Efficacy|4|||
13117962|NCT03049735|25927354|FG001|Overall Study|Lack of Efficacy|0|||
13117963|NCT03049735|25927355|FG002|Overall Study|Lack of Efficacy|3|||
13117964|NCT03049735|25927353|FG000|Overall Study|Protocol deviation|1|||
13117965|NCT03049735|25927354|FG001|Overall Study|Protocol deviation|0|||
13268105|NCT01427309|26417915|FG003|Overall Study|Protocol Violation|124|||
13268106|NCT01427309|26417912|FG000|Overall Study|Adverse Event|0|||
13268107|NCT01427309|26417913|FG001|Overall Study|Adverse Event|0|||
13268108|NCT01427309|26417914|FG002|Overall Study|Adverse Event|3|||
13268109|NCT01427309|26417915|FG003|Overall Study|Adverse Event|1|||
13268110|NCT01427309|26417912|FG000|Overall Study|Serious adverse event|52|||
13268111|NCT01427309|26417913|FG001|Overall Study|Serious adverse event|45|||
13268112|NCT01427309|26417914|FG002|Overall Study|Serious adverse event|50|||
13268113|NCT01427309|26417915|FG003|Overall Study|Serious adverse event|61|||
13268114|NCT01427309|26417912|FG000|Overall Study|Withdrawal by Subject|148|||
13268115|NCT01427309|26417913|FG001|Overall Study|Withdrawal by Subject|148|||
13268116|NCT01427309|26417914|FG002|Overall Study|Withdrawal by Subject|61|||
13268117|NCT01427309|26417915|FG003|Overall Study|Withdrawal by Subject|55|||
13268118|NCT01426958|26417931|FG000|Overall Study|Adverse Event|2|||
13268119|NCT01426854|26417946|FG000|Overall Study|Adverse Event|1|||
13268120|NCT01426854|26417947|FG001|Overall Study|Adverse Event|5|||
13268121|NCT01426854|26417946|FG000|Overall Study|Subject Decision Unrelated to AE|5|||
13268122|NCT01426854|26417947|FG001|Overall Study|Subject Decision Unrelated to AE|6|||
13268123|NCT01426854|26417946|FG000|Overall Study|Lost to Follow-up|3|||
13268124|NCT01426854|26417947|FG001|Overall Study|Lost to Follow-up|0|||
13268125|NCT01426854|26417946|FG000|Overall Study|Noncompliance|0|||
13268126|NCT01426854|26417947|FG001|Overall Study|Noncompliance|1|||
13268127|NCT01426854|26417946|FG000|Overall Study|Treatment Failure|0|||
13268128|NCT01426854|26417947|FG001|Overall Study|Treatment Failure|16|||
13268129|NCT01426854|26417946|FG000|Overall Study|Protocol Deviation|0|||
13268130|NCT01426854|26417947|FG001|Overall Study|Protocol Deviation|1|||
13268131|NCT01426854|26417946|FG000|Overall Study|Other|3|||
13268132|NCT01426854|26417947|FG001|Overall Study|Other|2|||
13268133|NCT01426789|26417972|FG000|Part 1|Protocol deviation|0|||
13268134|NCT01426789|26417973|FG001|Part 1|Protocol deviation|1|||
13268135|NCT01426789|26417974|FG002|Part 1|Protocol deviation|0|||
13268136|NCT01426789|26417975|FG003|Part 1|Protocol deviation|0|||
13268137|NCT01426789|26417976|FG004|Part 1|Protocol deviation|0|||
13268138|NCT01426789|26417977|FG005|Part 1|Protocol deviation|0|||
13268139|NCT01426789|26417972|FG000|Part 1|Lost to Follow-up|1|||
13268140|NCT01426789|26417973|FG001|Part 1|Lost to Follow-up|2|||
13268141|NCT01426789|26417974|FG002|Part 1|Lost to Follow-up|0|||
13268142|NCT01426789|26417975|FG003|Part 1|Lost to Follow-up|0|||
13268143|NCT01426789|26417976|FG004|Part 1|Lost to Follow-up|0|||
13268144|NCT01426789|26417977|FG005|Part 1|Lost to Follow-up|0|||
13268145|NCT01426789|26417972|FG000|Part 1|Lack of Efficacy|2|||
13268146|NCT01426789|26417973|FG001|Part 1|Lack of Efficacy|1|||
13268147|NCT01426789|26417974|FG002|Part 1|Lack of Efficacy|0|||
13268148|NCT01426789|26417975|FG003|Part 1|Lack of Efficacy|0|||
13268149|NCT01426789|26417976|FG004|Part 1|Lack of Efficacy|0|||
13268150|NCT01426789|26417977|FG005|Part 1|Lack of Efficacy|0|||
13268151|NCT01426789|26417972|FG000|Part 1|Adverse Event|3|||
13268152|NCT01426789|26417973|FG001|Part 1|Adverse Event|0|||
13268153|NCT01426789|26417974|FG002|Part 1|Adverse Event|0|||
13268154|NCT01426789|26417975|FG003|Part 1|Adverse Event|0|||
13268155|NCT01426789|26417976|FG004|Part 1|Adverse Event|0|||
13268156|NCT01426789|26417977|FG005|Part 1|Adverse Event|0|||
13268157|NCT01426789|26417972|FG000|Part 2|Protocol deviation|0|||
13268158|NCT01426789|26417973|FG001|Part 2|Protocol deviation|0|||
13268159|NCT01426789|26417974|FG002|Part 2|Protocol deviation|1|||
13268160|NCT01426789|26417975|FG003|Part 2|Protocol deviation|0|||
13268161|NCT01426789|26417976|FG004|Part 2|Protocol deviation|0|||
13268162|NCT01426789|26417977|FG005|Part 2|Protocol deviation|0|||
13268163|NCT01426789|26417972|FG000|Part 2|Death|0|||
13268164|NCT01426789|26417973|FG001|Part 2|Death|0|||
13268165|NCT01426789|26417974|FG002|Part 2|Death|1|||
13268166|NCT01426789|26417975|FG003|Part 2|Death|0|||
13268167|NCT01426789|26417976|FG004|Part 2|Death|1|||
13268168|NCT01426789|26417977|FG005|Part 2|Death|0|||
13268169|NCT01426789|26417972|FG000|Part 2|Administrative problems|0|||
13268170|NCT01426789|26417973|FG001|Part 2|Administrative problems|0|||
13268171|NCT01426789|26417974|FG002|Part 2|Administrative problems|2|||
13268172|NCT01426789|26417975|FG003|Part 2|Administrative problems|0|||
13268173|NCT01426789|26417976|FG004|Part 2|Administrative problems|1|||
13268174|NCT01426789|26417977|FG005|Part 2|Administrative problems|0|||
13268175|NCT01426789|26417972|FG000|Part 2|Lost to Follow-up|0|||
13117966|NCT03049735|25927355|FG002|Overall Study|Protocol deviation|0|||
13117967|NCT03049735|25927353|FG000|Overall Study|Pregnancy|0|||
13268176|NCT01426789|26417973|FG001|Part 2|Lost to Follow-up|0|||
13268177|NCT01426789|26417974|FG002|Part 2|Lost to Follow-up|4|||
13268178|NCT01426789|26417975|FG003|Part 2|Lost to Follow-up|0|||
13268179|NCT01426789|26417976|FG004|Part 2|Lost to Follow-up|1|||
13268180|NCT01426789|26417977|FG005|Part 2|Lost to Follow-up|0|||
13268181|NCT01426789|26417972|FG000|Part 2|Withdrawal by Subject|0|||
13268182|NCT01426789|26417973|FG001|Part 2|Withdrawal by Subject|0|||
13268183|NCT01426789|26417974|FG002|Part 2|Withdrawal by Subject|0|||
13268184|NCT01426789|26417975|FG003|Part 2|Withdrawal by Subject|1|||
13268185|NCT01426789|26417976|FG004|Part 2|Withdrawal by Subject|2|||
13268186|NCT01426789|26417977|FG005|Part 2|Withdrawal by Subject|0|||
13268187|NCT01426789|26417972|FG000|Part 2|Lack of Efficacy|0|||
13268188|NCT01426789|26417973|FG001|Part 2|Lack of Efficacy|0|||
13268189|NCT01426789|26417974|FG002|Part 2|Lack of Efficacy|5|||
13268190|NCT01426789|26417975|FG003|Part 2|Lack of Efficacy|0|||
13268191|NCT01426789|26417976|FG004|Part 2|Lack of Efficacy|2|||
13268192|NCT01426789|26417977|FG005|Part 2|Lack of Efficacy|0|||
13268193|NCT01426789|26417972|FG000|Part 2|Adverse Event|0|||
13268194|NCT01426789|26417973|FG001|Part 2|Adverse Event|0|||
13268195|NCT01426789|26417974|FG002|Part 2|Adverse Event|2|||
13268196|NCT01426789|26417975|FG003|Part 2|Adverse Event|0|||
13268197|NCT01426789|26417976|FG004|Part 2|Adverse Event|1|||
13268198|NCT01426789|26417977|FG005|Part 2|Adverse Event|0|||
13268199|NCT01426438|26418016|FG000|Overall Study|Lost to Follow-up|1|||
13268200|NCT01426438|26418017|FG001|Overall Study|Lost to Follow-up|3|||
13268201|NCT01426438|26418016|FG000|Overall Study|Off study Treatment|9|||
13268202|NCT01426438|26418017|FG001|Overall Study|Off study Treatment|3|||
13268203|NCT01426438|26418016|FG000|Overall Study|Poor scan quality|3|||
13268204|NCT01426438|26418017|FG001|Overall Study|Poor scan quality|2|||
13268205|NCT01426438|26418016|FG000|Overall Study|Missed Scan|2|||
13268206|NCT01426438|26418017|FG001|Overall Study|Missed Scan|2|||
13268207|NCT01426425|26418025|FG000|Overall Study|Exited prior to EP study|22|||
13268208|NCT01426425|26418025|FG000|Overall Study|Inclusion/exclusion criteria not met|151|||
13268209|NCT01426425|26418025|FG000|Overall Study|Met inclusion/exclusion, not treated|2|||
13268210|NCT01426412|26418110|FG000|Overall Study|Withdrawal by Subject|1|||
13268211|NCT01426412|26418111|FG001|Overall Study|Withdrawal by Subject|0|||
13268212|NCT01426412|26418112|FG002|Overall Study|Withdrawal by Subject|0|||
13268213|NCT01426412|26418113|FG003|Overall Study|Withdrawal by Subject|0|||
13268214|NCT01426412|26418114|FG004|Overall Study|Withdrawal by Subject|1|||
13268215|NCT01426412|26418115|FG005|Overall Study|Withdrawal by Subject|0|||
13268216|NCT01426412|26418116|FG006|Overall Study|Withdrawal by Subject|0|||
13268217|NCT01426412|26418117|FG007|Overall Study|Withdrawal by Subject|3|||
13268218|NCT01426412|26418118|FG008|Overall Study|Withdrawal by Subject|1|||
13268219|NCT01426386|26418193|FG000|Overall Study|Adverse Event|0|||
13268220|NCT01426386|26418194|FG001|Overall Study|Adverse Event|1|||
13268221|NCT01426386|26418195|FG002|Overall Study|Adverse Event|0|||
13268222|NCT01426386|26418196|FG003|Overall Study|Adverse Event|0|||
13268223|NCT01426386|26418197|FG004|Overall Study|Adverse Event|0|||
13268224|NCT01426386|26418198|FG005|Overall Study|Adverse Event|0|||
13268225|NCT01426386|26418193|FG000|Overall Study|Did not attend scheduled visit|1|||
13268226|NCT01426386|26418194|FG001|Overall Study|Did not attend scheduled visit|4|||
13268227|NCT01426386|26418195|FG002|Overall Study|Did not attend scheduled visit|0|||
13268228|NCT01426386|26418196|FG003|Overall Study|Did not attend scheduled visit|0|||
13268229|NCT01426386|26418197|FG004|Overall Study|Did not attend scheduled visit|2|||
13268230|NCT01426386|26418198|FG005|Overall Study|Did not attend scheduled visit|1|||
13268231|NCT01426386|26418193|FG000|Overall Study|Poor response|2|||
13268232|NCT01426386|26418194|FG001|Overall Study|Poor response|1|||
13268233|NCT01426386|26418195|FG002|Overall Study|Poor response|2|||
13268234|NCT01426386|26418196|FG003|Overall Study|Poor response|0|||
13268235|NCT01426386|26418197|FG004|Overall Study|Poor response|1|||
13268236|NCT01426386|26418198|FG005|Overall Study|Poor response|0|||
13268237|NCT01426386|26418193|FG000|Overall Study|Personal reasons|0|||
13268238|NCT01426386|26418194|FG001|Overall Study|Personal reasons|0|||
13268239|NCT01426386|26418195|FG002|Overall Study|Personal reasons|0|||
13268240|NCT01426386|26418196|FG003|Overall Study|Personal reasons|0|||
13268241|NCT01426386|26418197|FG004|Overall Study|Personal reasons|1|||
13268242|NCT01426386|26418198|FG005|Overall Study|Personal reasons|0|||
13268243|NCT01426373|26418216|FG000|Overall Study|Adverse Event|6|||
13268244|NCT01426373|26418216|FG000|Overall Study|Lost to Follow-up|14|||
13268245|NCT01426373|26418216|FG000|Overall Study|Participant Convenience|10|||
13268246|NCT01426373|26418216|FG000|Overall Study|Miscellaneous Reasons|4|||
13268247|NCT01426347|26418231|FG000|Overall Study|Lost to Follow-up|0|||
13268248|NCT01426347|26418232|FG001|Overall Study|Lost to Follow-up|3|||
13268249|NCT01426347|26418231|FG000|Overall Study|Protocol Violation|2|||
13268250|NCT01426347|26418232|FG001|Overall Study|Protocol Violation|0|||
13268251|NCT01426347|26418231|FG000|Overall Study|Withdrawal by Subject|5|||
13268252|NCT01426347|26418232|FG001|Overall Study|Withdrawal by Subject|0|||
13268253|NCT01426269|26418261|FG000|Period 1: 12 Weeks|Adverse Event|5|||
13268254|NCT01426269|26418262|FG001|Period 1: 12 Weeks|Adverse Event|0|||
13268255|NCT01426269|26418263|FG002|Period 1: 12 Weeks|Adverse Event|0|||
13268256|NCT01426269|26418261|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22|||
13268257|NCT01426269|26418262|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0|||
13268258|NCT01426269|26418263|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0|||
13268259|NCT01426269|26418261|FG000|Period 1: 12 Weeks|Protocol Violation|5|||
13268260|NCT01426269|26418262|FG001|Period 1: 12 Weeks|Protocol Violation|0|||
13268261|NCT01426269|26418263|FG002|Period 1: 12 Weeks|Protocol Violation|0|||
13268262|NCT01426269|26418261|FG000|Period 1: 12 Weeks|Lost to Follow-up|22|||
13268263|NCT01426269|26418262|FG001|Period 1: 12 Weeks|Lost to Follow-up|0|||
13268264|NCT01426269|26418263|FG002|Period 1: 12 Weeks|Lost to Follow-up|0|||
13268265|NCT01426269|26418261|FG000|Period 1: 12 Weeks|Pregnancy|1|||
13268266|NCT01426269|26418262|FG001|Period 1: 12 Weeks|Pregnancy|0|||
13268267|NCT01426269|26418263|FG002|Period 1: 12 Weeks|Pregnancy|0|||
13268268|NCT01426269|26418261|FG000|Eligibility for Period 2, Randomization|Did not qualify|42|||
13268269|NCT01426269|26418262|FG001|Eligibility for Period 2, Randomization|Did not qualify|0|||
13268270|NCT01426269|26418263|FG002|Eligibility for Period 2, Randomization|Did not qualify|0|||
13268271|NCT01426269|26418261|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8|||
13268272|NCT01426269|26418262|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
13268273|NCT01426269|26418263|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
13268274|NCT01426269|26418261|FG000|Period 2: 40 Weeks|Adverse Event|0|||
13268275|NCT01426269|26418262|FG001|Period 2: 40 Weeks|Adverse Event|1|||
13268276|NCT01426269|26418263|FG002|Period 2: 40 Weeks|Adverse Event|2|||
13268277|NCT01426269|26418261|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0|||
13268278|NCT01426269|26418262|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9|||
13268279|NCT01426269|26418263|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11|||
13268280|NCT01426269|26418261|FG000|Period 2: 40 Weeks|Protocol Violation|0|||
13268281|NCT01426269|26418262|FG001|Period 2: 40 Weeks|Protocol Violation|5|||
13268282|NCT01426269|26418263|FG002|Period 2: 40 Weeks|Protocol Violation|5|||
13268283|NCT01426269|26418261|FG000|Period 2: 40 Weeks|Lost to Follow-up|0|||
13268284|NCT01426269|26418262|FG001|Period 2: 40 Weeks|Lost to Follow-up|8|||
13268285|NCT01426269|26418263|FG002|Period 2: 40 Weeks|Lost to Follow-up|6|||
13268286|NCT01426269|26418261|FG000|Period 2: 40 Weeks|Site closed|0|||
13268287|NCT01426269|26418262|FG001|Period 2: 40 Weeks|Site closed|6|||
13268288|NCT01426269|26418263|FG002|Period 2: 40 Weeks|Site closed|5|||
13268289|NCT01426269|26418261|FG000|Period 2: 40 Weeks|Relapsed|0|||
13268290|NCT01426269|26418262|FG001|Period 2: 40 Weeks|Relapsed|9|||
13268291|NCT01426269|26418263|FG002|Period 2: 40 Weeks|Relapsed|18|||
13290673|NCT00100815|26481570|FG000|Overall Study|Progression|24|||
13290674|NCT00100815|26481570|FG000|Overall Study|Adverse Event|18|||
13290675|NCT00100815|26481570|FG000|Overall Study|Death|4|||
13290676|NCT00100815|26481570|FG000|Overall Study|Other|3|||
13290677|NCT00100802|26481577|FG000|Overall Study|Adverse Event|9|||
13290678|NCT00100802|26481577|FG000|Overall Study|Death|1|||
13290679|NCT00100802|26481577|FG000|Overall Study|Lack of Efficacy|47|||
13290680|NCT00100802|26481577|FG000|Overall Study|Physician Decision|5|||
13290681|NCT00100802|26481577|FG000|Overall Study|Protocol Violation|1|||
13290682|NCT00100802|26481577|FG000|Overall Study|Withdrawal by Subject|5|||
13290683|NCT00100802|26481577|FG000|Overall Study|Ineligible|12|||
13290684|NCT00100789|26481586|FG000|Overall Study|Adverse Event|10|||
13290685|NCT00100789|26481586|FG000|Overall Study|Withdrawal by Subject|1|||
13290686|NCT00100789|26481586|FG000|Overall Study|Progression/relapse|42|||
13290687|NCT00100789|26481586|FG000|Overall Study|Death|2|||
13290688|NCT00100789|26481586|FG000|Overall Study|Not protocol specified|5|||
13290689|NCT00100789|26481586|FG000|Overall Study|Ineligible|3|||
13290690|NCT00100789|26481586|FG000|Overall Study|Never received treatment|1|||
13290691|NCT00100048|26481710|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2|||
13290692|NCT00100048|26481711|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
13290693|NCT00100048|26481712|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
13290694|NCT00100048|26481713|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
13290695|NCT00100048|26481714|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
13290696|NCT00100048|26481715|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1|||
13290697|NCT00100048|26481710|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
13290698|NCT00100048|26481711|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
13290699|NCT00100048|26481712|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2|||
13290700|NCT00100048|26481713|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
13290701|NCT00100048|26481714|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
13290702|NCT00100048|26481715|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
13290703|NCT00100048|26481710|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1|||
13290704|NCT00100048|26481711|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3|||
13290705|NCT00100048|26481712|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
13290706|NCT00100048|26481713|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
13290707|NCT00100048|26481714|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
13290708|NCT00100048|26481715|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2|||
13290709|NCT00100048|26481710|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
13290710|NCT00100048|26481711|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1|||
13290711|NCT00100048|26481712|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
13290712|NCT00100048|26481713|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
13290713|NCT00100048|26481714|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0|||
13117968|NCT03049735|25927354|FG001|Overall Study|Pregnancy|0|||
13268292|NCT01426217|26418276|FG000|Overall Study|lost sample|8|||
13268293|NCT01426217|26418277|FG001|Overall Study|lost sample|14|||
13268294|NCT01426113|26418290|FG000|Overall Study|Study Discontinued|1|||
13268295|NCT01426113|26418291|FG001|Overall Study|Study Discontinued|1|||
13268296|NCT01426113|26418290|FG000|Overall Study|Adverse Event|0|||
13268297|NCT01426113|26418291|FG001|Overall Study|Adverse Event|1|||
13268298|NCT01426009|26418349|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1|||
13268299|NCT01426009|26418349|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1|||
13268300|NCT01426009|26418349|FG000|Washout 1|Withdrawal by Subject|1|||
13268301|NCT01426009|26418349|FG000|Washout 1|Personal Reasons|1|||
13268302|NCT01426009|26418349|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4|||
13268303|NCT01426009|26418349|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1|||
13268304|NCT01426009|26418349|FG000|Washout 2|electrive surgery|1|||
13268305|NCT01426009|26418349|FG000|Washout 3|personal reasons|1|||
13268306|NCT01426009|26418349|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1|||
13268307|NCT01426009|26418349|FG000|Washout 4|Lost to Follow-up|1|||
13268308|NCT01425814|26418448|FG000|Period 1|Stability criteria not fulfilled|0|||
13268309|NCT01425814|26418449|FG001|Period 1|Stability criteria not fulfilled|1|||
13268310|NCT01425814|26418450|FG002|Period 1|Stability criteria not fulfilled|0|||
13268311|NCT01425814|26418451|FG003|Period 1|Stability criteria not fulfilled|0|||
13268312|NCT01425814|26418452|FG004|Period 1|Stability criteria not fulfilled|0|||
13268313|NCT01425814|26418453|FG005|Period 1|Stability criteria not fulfilled|0|||
13268314|NCT01425814|26418448|FG000|Period 2|Stability criteria not fulfilled|0|||
13268315|NCT01425814|26418449|FG001|Period 2|Stability criteria not fulfilled|1|||
13268316|NCT01425814|26418450|FG002|Period 2|Stability criteria not fulfilled|0|||
13268317|NCT01425814|26418451|FG003|Period 2|Stability criteria not fulfilled|0|||
13268318|NCT01425814|26418452|FG004|Period 2|Stability criteria not fulfilled|0|||
13268319|NCT01425814|26418453|FG005|Period 2|Stability criteria not fulfilled|0|||
13268320|NCT01425814|26418448|FG000|Period 3|Adverse Event|0|||
13268321|NCT01425814|26418449|FG001|Period 3|Adverse Event|0|||
13268322|NCT01425814|26418450|FG002|Period 3|Adverse Event|0|||
13268323|NCT01425814|26418451|FG003|Period 3|Adverse Event|0|||
13268324|NCT01425814|26418452|FG004|Period 3|Adverse Event|0|||
13268325|NCT01425814|26418453|FG005|Period 3|Adverse Event|1|||
13268326|NCT01425814|26418448|FG000|Period 4|Adverse Event|1|||
13268327|NCT01425814|26418449|FG001|Period 4|Adverse Event|0|||
13268328|NCT01425814|26418450|FG002|Period 4|Adverse Event|1|||
13268329|NCT01425814|26418451|FG003|Period 4|Adverse Event|0|||
13268330|NCT01425814|26418452|FG004|Period 4|Adverse Event|0|||
13268331|NCT01425814|26418453|FG005|Period 4|Adverse Event|0|||
13268332|NCT01425814|26418448|FG000|Period 5|Stability criteria not fulfilled|0|||
13268333|NCT01425814|26418449|FG001|Period 5|Stability criteria not fulfilled|0|||
13268334|NCT01425814|26418450|FG002|Period 5|Stability criteria not fulfilled|1|||
13268335|NCT01425814|26418451|FG003|Period 5|Stability criteria not fulfilled|0|||
13268336|NCT01425814|26418452|FG004|Period 5|Stability criteria not fulfilled|0|||
13268337|NCT01425814|26418453|FG005|Period 5|Stability criteria not fulfilled|1|||
13268338|NCT01425801|26418564|FG000|Period 1|Withdrawal by Subject|0|||
13268339|NCT01425801|26418565|FG001|Period 1|Withdrawal by Subject|0|||
13268340|NCT01425801|26418566|FG002|Period 1|Withdrawal by Subject|0|||
13268341|NCT01425801|26418567|FG003|Period 1|Withdrawal by Subject|0|||
13268342|NCT01425801|26418568|FG004|Period 1|Withdrawal by Subject|1|||
13268343|NCT01425801|26418569|FG005|Period 1|Withdrawal by Subject|0|||
13268344|NCT01425801|26418564|FG000|Period 2|Withdrawal by Subject|0|||
13268345|NCT01425801|26418565|FG001|Period 2|Withdrawal by Subject|0|||
13268346|NCT01425801|26418566|FG002|Period 2|Withdrawal by Subject|0|||
13268347|NCT01425801|26418567|FG003|Period 2|Withdrawal by Subject|0|||
13268348|NCT01425801|26418568|FG004|Period 2|Withdrawal by Subject|1|||
13268349|NCT01425801|26418569|FG005|Period 2|Withdrawal by Subject|0|||
13268350|NCT01425801|26418564|FG000|Period 3|Stability criteria not fullfilled|0|||
13268351|NCT01425801|26418565|FG001|Period 3|Stability criteria not fullfilled|0|||
13268352|NCT01425801|26418566|FG002|Period 3|Stability criteria not fullfilled|1|||
13268353|NCT01425801|26418567|FG003|Period 3|Stability criteria not fullfilled|0|||
13268354|NCT01425801|26418568|FG004|Period 3|Stability criteria not fullfilled|0|||
13268355|NCT01425801|26418569|FG005|Period 3|Stability criteria not fullfilled|0|||
13268356|NCT01425801|26418564|FG000|Period 4|Not able to maintain visit schedule|0|||
13268357|NCT01425801|26418565|FG001|Period 4|Not able to maintain visit schedule|0|||
13268358|NCT01425801|26418566|FG002|Period 4|Not able to maintain visit schedule|1|||
13268359|NCT01425801|26418567|FG003|Period 4|Not able to maintain visit schedule|0|||
13268360|NCT01425801|26418568|FG004|Period 4|Not able to maintain visit schedule|0|||
13268361|NCT01425801|26418569|FG005|Period 4|Not able to maintain visit schedule|0|||
13268362|NCT01425749|26418591|FG000|Overall Study|progression of melanoma|0|||
13268363|NCT01425749|26418592|FG001|Overall Study|progression of melanoma|1|||
13268364|NCT01425723|26418626|FG000|Overall Study|Lack of Efficacy|0|||
13268365|NCT01425723|26418627|FG001|Overall Study|Lack of Efficacy|1|||
13268366|NCT01425723|26418626|FG000|Overall Study|Withdrawal by Subject|1|||
13268367|NCT01425723|26418627|FG001|Overall Study|Withdrawal by Subject|4|||
13268368|NCT01425723|26418626|FG000|Overall Study|Lost to Follow-up|0|||
13268369|NCT01425723|26418627|FG001|Overall Study|Lost to Follow-up|3|||
13268370|NCT01425723|26418626|FG000|Overall Study|Physician Decision|2|||
13268371|NCT01425723|26418627|FG001|Overall Study|Physician Decision|0|||
13268372|NCT01425723|26418626|FG000|Overall Study|Other|1|||
13268373|NCT01425723|26418627|FG001|Overall Study|Other|10|||
13268374|NCT01425632|26418645|FG000|Overall Study|Adverse Event|0|||
13268375|NCT01425632|26418646|FG001|Overall Study|Adverse Event|1|||
13268376|NCT01425632|26418647|FG002|Overall Study|Adverse Event|1|||
13268377|NCT01425632|26418645|FG000|Overall Study|Physician Decision|1|||
13268378|NCT01425632|26418646|FG001|Overall Study|Physician Decision|0|||
13268379|NCT01425632|26418647|FG002|Overall Study|Physician Decision|0|||
13268380|NCT01425632|26418645|FG000|Overall Study|Protocol Violation|0|||
13268381|NCT01425632|26418646|FG001|Overall Study|Protocol Violation|0|||
13268382|NCT01425632|26418647|FG002|Overall Study|Protocol Violation|2|||
13268383|NCT01425632|26418645|FG000|Overall Study|Withdrawal by Subject|0|||
13268384|NCT01425632|26418646|FG001|Overall Study|Withdrawal by Subject|0|||
13268385|NCT01425632|26418647|FG002|Overall Study|Withdrawal by Subject|1|||
13268386|NCT01425528|26418660|FG000|Overall Study|Withdrawal by Subject|1|||
13268387|NCT01425528|26418661|FG001|Overall Study|Withdrawal by Subject|1|||
13268388|NCT01425463|26418682|FG000|Overall Study|Adverse Event|5|||
13268389|NCT01425463|26418683|FG001|Overall Study|Adverse Event|7|||
13268390|NCT01425463|26418682|FG000|Overall Study|Lack of Efficacy|1|||
13268391|NCT01425463|26418683|FG001|Overall Study|Lack of Efficacy|1|||
13268392|NCT01425463|26418682|FG000|Overall Study|Protocol Violation|2|||
13268393|NCT01425463|26418683|FG001|Overall Study|Protocol Violation|2|||
13268394|NCT01425463|26418682|FG000|Overall Study|Lost to Follow-up|5|||
13268395|NCT01425463|26418683|FG001|Overall Study|Lost to Follow-up|2|||
13268396|NCT01425463|26418682|FG000|Overall Study|Withdrawal by Subject|7|||
13268397|NCT01425463|26418683|FG001|Overall Study|Withdrawal by Subject|5|||
13268398|NCT01425463|26418682|FG000|Overall Study|Unknown Reason|4|||
13268399|NCT01425463|26418683|FG001|Overall Study|Unknown Reason|7|||
13268400|NCT01425359|26418706|FG000|Overall Study|Randomized but Not Treated|2|||
13268401|NCT01425359|26418707|FG001|Overall Study|Randomized but Not Treated|3|||
13268402|NCT01425359|26418706|FG000|Overall Study|Adverse Event|9|||
13268403|NCT01425359|26418707|FG001|Overall Study|Adverse Event|8|||
13268404|NCT01425359|26418706|FG000|Overall Study|Revascularization|0|||
13268405|NCT01425359|26418707|FG001|Overall Study|Revascularization|1|||
13268406|NCT01425359|26418706|FG000|Overall Study|Death|0|||
13268407|NCT01425359|26418707|FG001|Overall Study|Death|1|||
13268408|NCT01425359|26418706|FG000|Overall Study|Unsatisfactory Response|1|||
13268409|NCT01425359|26418707|FG001|Overall Study|Unsatisfactory Response|0|||
13268410|NCT01425359|26418706|FG000|Overall Study|Protocol Violation|1|||
13268411|NCT01425359|26418707|FG001|Overall Study|Protocol Violation|2|||
13268412|NCT01425359|26418706|FG000|Overall Study|Subject Withdrew Consent|1|||
13268413|NCT01425359|26418707|FG001|Overall Study|Subject Withdrew Consent|2|||
13268414|NCT01425359|26418706|FG000|Overall Study|Investigator's Discretion|2|||
13268415|NCT01425359|26418707|FG001|Overall Study|Investigator's Discretion|0|||
13268416|NCT01425359|26418706|FG000|Overall Study|Did Not Meet Qualifying Criteria|3|||
13268417|NCT01425359|26418707|FG001|Overall Study|Did Not Meet Qualifying Criteria|5|||
13268418|NCT01425281|26418930|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1|||
13268419|NCT01425281|26418931|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0|||
13268420|NCT01425281|26418930|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3|||
13268421|NCT01425281|26418931|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0|||
13268422|NCT01425281|26418930|FG000|At 180-day Clinical Follow-up|Death|0|||
13268423|NCT01425281|26418931|FG001|At 180-day Clinical Follow-up|Death|1|||
13268424|NCT01425281|26418930|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
13268425|NCT01425281|26418931|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
13268426|NCT01425281|26418930|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1|||
13268427|NCT01425281|26418931|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0|||
13268428|NCT01425281|26418930|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2|||
13268429|NCT01425281|26418931|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1|||
13268430|NCT01425281|26418930|FG000|At 2-year Clinical Follow-up|Death|2|||
13268431|NCT01425281|26418931|FG001|At 2-year Clinical Follow-up|Death|0|||
13268432|NCT01425281|26418930|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1|||
13268433|NCT01425281|26418931|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0|||
13268434|NCT01425281|26418930|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1|||
13268435|NCT01425281|26418931|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0|||
13268436|NCT01425281|26418930|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
13268437|NCT01425281|26418931|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
13268438|NCT01425281|26418930|FG000|At 3-year Clinical Follow-up|Death|2|||
13268439|NCT01425281|26418931|FG001|At 3-year Clinical Follow-up|Death|3|||
13268440|NCT01425281|26418930|FG000|At 4-year Clinical Follow-up|Death|7|||
13268441|NCT01425281|26418931|FG001|At 4-year Clinical Follow-up|Death|3|||
13268442|NCT01425281|26418930|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3|||
13268443|NCT01425281|26418931|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2|||
13268444|NCT01425281|26418930|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
13268445|NCT01425281|26418931|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
13268446|NCT01425281|26418930|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6|||
13268447|NCT01425281|26418931|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5|||
13268448|NCT01425281|26418930|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4|||
13268449|NCT01425281|26418931|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1|||
13268450|NCT01425281|26418930|FG000|At 5-year Clinical Follow-up|Death|2|||
13268451|NCT01425281|26418931|FG001|At 5-year Clinical Follow-up|Death|0|||
13268452|NCT01425281|26418930|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2|||
13268453|NCT01425281|26418931|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1|||
13268454|NCT01425281|26418930|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19|||
13268455|NCT01425281|26418931|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7|||
13268456|NCT01425281|26418930|FG000|At 5-year Clinical Follow-up|Refused/terminated|9|||
13268457|NCT01425281|26418931|FG001|At 5-year Clinical Follow-up|Refused/terminated|3|||
13268458|NCT01425268|26418946|FG000|Overall Study|Withdrawal by Subject|2|||
13268459|NCT01425268|26418947|FG001|Overall Study|Withdrawal by Subject|0|||
13268460|NCT01425268|26418946|FG000|Overall Study|Sponsor Decision|5|||
13268461|NCT01425268|26418947|FG001|Overall Study|Sponsor Decision|0|||
13268462|NCT01425268|26418946|FG000|Overall Study|Physician Decision|1|||
13268463|NCT01425268|26418947|FG001|Overall Study|Physician Decision|0|||
13268464|NCT01425203|26418969|FG000|Treatment Phase|DC during PR Lead-in Phase|3|||
13268465|NCT01425203|26418970|FG001|Treatment Phase|DC during PR Lead-in Phase|1|||
13268466|NCT01425203|26418971|FG002|Treatment Phase|DC during PR Lead-in Phase|0|||
13268467|NCT01425203|26418969|FG000|Treatment Phase|Failure at futility timepoint|8|||
13268468|NCT01425203|26418970|FG001|Treatment Phase|Failure at futility timepoint|27|||
13268469|NCT01425203|26418971|FG002|Treatment Phase|Failure at futility timepoint|0|||
13268470|NCT01425203|26418969|FG000|Treatment Phase|Other virologic failure criteria|5|||
13268471|NCT01425203|26418970|FG001|Treatment Phase|Other virologic failure criteria|3|||
13268472|NCT01425203|26418971|FG002|Treatment Phase|Other virologic failure criteria|0|||
13268473|NCT01425203|26418969|FG000|Treatment Phase|Unidentified reasons|11|||
13268474|NCT01425203|26418970|FG001|Treatment Phase|Unidentified reasons|5|||
13268475|NCT01425203|26418971|FG002|Treatment Phase|Unidentified reasons|0|||
13268476|NCT01425203|26418969|FG000|Treatment Phase|Did not receive treatment|0|||
13268477|NCT01425203|26418970|FG001|Treatment Phase|Did not receive treatment|1|||
13268478|NCT01425203|26418971|FG002|Treatment Phase|Did not receive treatment|0|||
13268479|NCT01425203|26418969|FG000|Crossover Phase|Failure at futility timepoint|0|||
13268480|NCT01425203|26418970|FG001|Crossover Phase|Failure at futility timepoint|0|||
13268481|NCT01425203|26418971|FG002|Crossover Phase|Failure at futility timepoint|3|||
13268482|NCT01425203|26418969|FG000|Crossover Phase|Other virologic failure criteria|0|||
13268483|NCT01425203|26418970|FG001|Crossover Phase|Other virologic failure criteria|0|||
13268484|NCT01425203|26418971|FG002|Crossover Phase|Other virologic failure criteria|3|||
13268485|NCT01425190|26418998|FG000|Overall Study|Full dose not consumed.|1|||
13268486|NCT01425190|26418999|FG001|Overall Study|Full dose not consumed.|0|||
13268487|NCT01425190|26419000|FG002|Overall Study|Full dose not consumed.|0|||
13268488|NCT01424930|26419019|FG000|Overall Study|Adverse Event|0|||
13268489|NCT01424930|26419020|FG001|Overall Study|Adverse Event|1|||
13268490|NCT01424930|26419019|FG000|Overall Study|Death|1|||
13268491|NCT01424930|26419020|FG001|Overall Study|Death|0|||
13268492|NCT01424930|26419019|FG000|Overall Study|Progressive Disease|3|||
13268493|NCT01424930|26419020|FG001|Overall Study|Progressive Disease|6|||
13268494|NCT01424930|26419019|FG000|Overall Study|Screen Failure|0|||
13268495|NCT01424930|26419020|FG001|Overall Study|Screen Failure|1|||
13268496|NCT01424930|26419019|FG000|Overall Study|Reason not specified|0|||
13268497|NCT01424930|26419020|FG001|Overall Study|Reason not specified|6|||
13268498|NCT01424813|26419045|FG000|Overall Study|Withdrawal by Subject|3|||
13268499|NCT01424813|26419046|FG001|Overall Study|Withdrawal by Subject|0|||
13268500|NCT01424813|26419045|FG000|Overall Study|Protocol Violation|1|||
13268501|NCT01424813|26419046|FG001|Overall Study|Protocol Violation|0|||
13268502|NCT01424813|26419045|FG000|Overall Study|Other|1|||
13268503|NCT01424813|26419046|FG001|Overall Study|Other|2|||
13268504|NCT01424722|26419052|FG000|Overall Study|Sponsor terminated investigation|2258|||
13268505|NCT01424670|26419079|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2|||
13268506|NCT01424670|26419080|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2|||
13268507|NCT01424670|26419079|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0|||
13268508|NCT01424670|26419080|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1|||
13268509|NCT01424670|26419079|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2|||
13268510|NCT01424670|26419080|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1|||
13268511|NCT01424670|26419079|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2|||
13268512|NCT01424670|26419080|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3|||
13268513|NCT01424670|26419079|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13|||
13268514|NCT01424670|26419080|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7|||
13268515|NCT01424670|26419079|FG000|Continuation Period|Adverse Event|13|||
13268516|NCT01424670|26419080|FG001|Continuation Period|Adverse Event|5|||
13268517|NCT01424670|26419079|FG000|Continuation Period|Lost to Follow-up|2|||
13268518|NCT01424670|26419080|FG001|Continuation Period|Lost to Follow-up|0|||
13268519|NCT01424670|26419079|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1|||
13268520|NCT01424670|26419080|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1|||
13268521|NCT01424670|26419079|FG000|Continuation Period|Physician Decision|5|||
13268522|NCT01424670|26419080|FG001|Continuation Period|Physician Decision|4|||
13268523|NCT01424670|26419079|FG000|Continuation Period|Withdrawal by Subject|13|||
13268524|NCT01424670|26419080|FG001|Continuation Period|Withdrawal by Subject|4|||
13268525|NCT01424644|26419101|FG000|Overall Study|Adverse Event|2|||
13268526|NCT01424644|26419102|FG001|Overall Study|Adverse Event|0|||
13268527|NCT01424644|26419101|FG000|Overall Study|Withdrawal by Subject|9|||
13268528|NCT01424644|26419102|FG001|Overall Study|Withdrawal by Subject|12|||
13268529|NCT01424644|26419101|FG000|Overall Study|Lost to Follow-up|16|||
13268530|NCT01424644|26419102|FG001|Overall Study|Lost to Follow-up|12|||
13268531|NCT01424644|26419101|FG000|Overall Study|Protocol Violation|4|||
13268532|NCT01424644|26419102|FG001|Overall Study|Protocol Violation|3|||
13268533|NCT01424644|26419101|FG000|Overall Study|Administrative Reason|1|||
13268534|NCT01424644|26419102|FG001|Overall Study|Administrative Reason|0|||
13268535|NCT01424644|26419101|FG000|Overall Study|Unable to Classify|1|||
13268536|NCT01424644|26419102|FG001|Overall Study|Unable to Classify|0|||
13268537|NCT01424566|26419133|FG000|Single-blind Treatment|Adverse Event|71|||
13268538|NCT01424566|26419134|FG001|Single-blind Treatment|Adverse Event|0|||
13268539|NCT01424566|26419135|FG002|Single-blind Treatment|Adverse Event|0|||
13268540|NCT01424566|26419133|FG000|Single-blind Treatment|Withdrawal by Subject|16|||
13268541|NCT01424566|26419134|FG001|Single-blind Treatment|Withdrawal by Subject|0|||
13268542|NCT01424566|26419135|FG002|Single-blind Treatment|Withdrawal by Subject|0|||
13268543|NCT01424566|26419133|FG000|Single-blind Treatment|Withdrawal by Investigator|2|||
13268544|NCT01424566|26419134|FG001|Single-blind Treatment|Withdrawal by Investigator|0|||
13268545|NCT01424566|26419135|FG002|Single-blind Treatment|Withdrawal by Investigator|0|||
13268546|NCT01424566|26419133|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108|||
13268547|NCT01424566|26419134|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
13268548|NCT01424566|26419135|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
13268549|NCT01424566|26419133|FG000|Single-blind Treatment|Met Exclusion Criteria|1|||
13268550|NCT01424566|26419134|FG001|Single-blind Treatment|Met Exclusion Criteria|0|||
13268551|NCT01424566|26419135|FG002|Single-blind Treatment|Met Exclusion Criteria|0|||
13268552|NCT01424566|26419133|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2|||
13268553|NCT01424566|26419134|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
13268554|NCT01424566|26419135|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
13268555|NCT01424566|26419133|FG000|Double-blind Treatment|Adverse Event|0|||
13268556|NCT01424566|26419134|FG001|Double-blind Treatment|Adverse Event|21|||
13268557|NCT01424566|26419135|FG002|Double-blind Treatment|Adverse Event|13|||
13268558|NCT01424566|26419133|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
13268559|NCT01424566|26419134|FG001|Double-blind Treatment|Withdrawal by Subject|2|||
13268560|NCT01424566|26419135|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
13268561|NCT01424566|26419133|FG000|Double-blind Treatment|Withdrawal by Investigator|0|||
13268562|NCT01424566|26419134|FG001|Double-blind Treatment|Withdrawal by Investigator|1|||
13268563|NCT01424566|26419135|FG002|Double-blind Treatment|Withdrawal by Investigator|1|||
13268564|NCT01424566|26419133|FG000|Double-blind Treatment|Lack of Efficacy|0|||
13268565|NCT01424566|26419134|FG001|Double-blind Treatment|Lack of Efficacy|1|||
13268566|NCT01424566|26419135|FG002|Double-blind Treatment|Lack of Efficacy|1|||
13268567|NCT01424514|26419177|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
13268568|NCT01424514|26419178|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
13268569|NCT01424514|26419177|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1|||
13268570|NCT01424514|26419178|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0|||
13268571|NCT01424501|26419361|FG000|Overall Study|Withdrawal by Subject|1|||
13268572|NCT01424501|26419362|FG001|Overall Study|Withdrawal by Subject|0|||
13268573|NCT01424501|26419363|FG002|Overall Study|Withdrawal by Subject|1|||
13268574|NCT01424501|26419364|FG003|Overall Study|Withdrawal by Subject|0|||
13268575|NCT01424501|26419365|FG004|Overall Study|Withdrawal by Subject|0|||
13268576|NCT01424501|26419366|FG005|Overall Study|Withdrawal by Subject|0|||
13268577|NCT01424501|26419361|FG000|Overall Study|Lost to Follow-up|0|||
13268578|NCT01424501|26419362|FG001|Overall Study|Lost to Follow-up|1|||
13268579|NCT01424501|26419363|FG002|Overall Study|Lost to Follow-up|1|||
13268580|NCT01424501|26419364|FG003|Overall Study|Lost to Follow-up|0|||
13268581|NCT01424501|26419365|FG004|Overall Study|Lost to Follow-up|0|||
13268582|NCT01424501|26419366|FG005|Overall Study|Lost to Follow-up|0|||
13268583|NCT01424397|26419449|FG000|Period-2 (8 Days)|Withdrawal by Subject|0|||
13268584|NCT01424397|26419450|FG001|Period-2 (8 Days)|Withdrawal by Subject|0|||
13268585|NCT01424397|26419451|FG002|Period-2 (8 Days)|Withdrawal by Subject|1|||
13268586|NCT01424397|26419452|FG003|Period-2 (8 Days)|Withdrawal by Subject|0|||
13268587|NCT01424397|26419453|FG004|Period-2 (8 Days)|Withdrawal by Subject|0|||
13268588|NCT01424397|26419454|FG005|Period-2 (8 Days)|Withdrawal by Subject|0|||
13268589|NCT01424397|26419455|FG006|Period-2 (8 Days)|Withdrawal by Subject|0|||
13268590|NCT01424397|26419456|FG007|Period-2 (8 Days)|Withdrawal by Subject|0|||
13268591|NCT01424397|26419457|FG008|Period-2 (8 Days)|Withdrawal by Subject|0|||
13268592|NCT01424397|26419458|FG009|Period-2 (8 Days)|Withdrawal by Subject|0|||
13268593|NCT01424397|26419459|FG010|Period-2 (8 Days)|Withdrawal by Subject|0|||
13268594|NCT01424397|26419460|FG011|Period-2 (8 Days)|Withdrawal by Subject|0|||
13268595|NCT01424306|26419514|FG000|Overall Study|Protocol Violation|0|||
13268596|NCT01424306|26419515|FG001|Overall Study|Protocol Violation|0|||
13268597|NCT01424306|26419516|FG002|Overall Study|Protocol Violation|0|||
13268598|NCT01424306|26419517|FG003|Overall Study|Protocol Violation|0|||
13268599|NCT01424306|26419518|FG004|Overall Study|Protocol Violation|1|||
13268600|NCT01424306|26419519|FG005|Overall Study|Protocol Violation|0|||
13268601|NCT01424228|26419564|FG000|Overall Study|Withdrawal by Subject|27|||
13268602|NCT01424228|26419565|FG001|Overall Study|Withdrawal by Subject|11|||
13268603|NCT01424228|26419564|FG000|Overall Study|Adverse Event|10|||
13268604|NCT01424228|26419565|FG001|Overall Study|Adverse Event|14|||
13268605|NCT01424228|26419564|FG000|Overall Study|Sponsor's decision|9|||
13268606|NCT01424228|26419565|FG001|Overall Study|Sponsor's decision|12|||
13268607|NCT01424228|26419564|FG000|Overall Study|Lack of Efficacy|5|||
13268608|NCT01424228|26419565|FG001|Overall Study|Lack of Efficacy|7|||
13268609|NCT01424228|26419564|FG000|Overall Study|inclusion/exclusion criteria not met|2|||
13268610|NCT01424228|26419565|FG001|Overall Study|inclusion/exclusion criteria not met|2|||
13268611|NCT01424228|26419564|FG000|Overall Study|Non-compliance|2|||
13268612|NCT01424228|26419565|FG001|Overall Study|Non-compliance|0|||
13268613|NCT01424228|26419564|FG000|Overall Study|Worsening of symptoms|1|||
13268614|NCT01424228|26419565|FG001|Overall Study|Worsening of symptoms|0|||
13268615|NCT01424228|26419564|FG000|Overall Study|Unplanned journey|0|||
13268616|NCT01424228|26419565|FG001|Overall Study|Unplanned journey|1|||
13268617|NCT01424189|26419584|FG000|Overall Study|Adverse Event|1|||
13268618|NCT01424189|26419585|FG001|Overall Study|Adverse Event|0|||
13268619|NCT01424189|26419584|FG000|Overall Study|Lost to Follow-up|4|||
13268620|NCT01424189|26419585|FG001|Overall Study|Lost to Follow-up|1|||
13268621|NCT01424189|26419584|FG000|Overall Study|Withdrawal by Subject|4|||
13268622|NCT01424189|26419585|FG001|Overall Study|Withdrawal by Subject|4|||
13268623|NCT01424189|26419584|FG000|Overall Study|Subject moved|1|||
13268624|NCT01424189|26419585|FG001|Overall Study|Subject moved|0|||
13268625|NCT01424189|26419584|FG000|Overall Study|Death|3|||
13268626|NCT01424189|26419585|FG001|Overall Study|Death|1|||
13268627|NCT01423916|26419649|FG000|Overall Study|Adverse Event|5|||
13268628|NCT01423916|26419650|FG001|Overall Study|Adverse Event|9|||
13268629|NCT01423916|26419651|FG002|Overall Study|Adverse Event|2|||
13268630|NCT01423916|26419649|FG000|Overall Study|Met Withdrawal Criteria|1|||
13268631|NCT01423916|26419650|FG001|Overall Study|Met Withdrawal Criteria|1|||
13268632|NCT01423916|26419651|FG002|Overall Study|Met Withdrawal Criteria|1|||
13268633|NCT01423916|26419649|FG000|Overall Study|Physician Decision|1|||
13268634|NCT01423916|26419650|FG001|Overall Study|Physician Decision|0|||
13268635|NCT01423916|26419651|FG002|Overall Study|Physician Decision|1|||
13268636|NCT01423916|26419649|FG000|Overall Study|Withdrawal by Subject|3|||
13268637|NCT01423916|26419650|FG001|Overall Study|Withdrawal by Subject|10|||
13268638|NCT01423916|26419651|FG002|Overall Study|Withdrawal by Subject|3|||
13268639|NCT01423916|26419649|FG000|Overall Study|Protocol Deviation|1|||
13268640|NCT01423916|26419650|FG001|Overall Study|Protocol Deviation|0|||
13268641|NCT01423916|26419651|FG002|Overall Study|Protocol Deviation|0|||
13268642|NCT01423812|26419666|FG000|Overall Study|Lost to Follow-up|2|||
13268643|NCT01423812|26419667|FG001|Overall Study|Lost to Follow-up|2|||
13117969|NCT03049735|25927355|FG002|Overall Study|Pregnancy|1|||
13268644|NCT01423812|26419666|FG000|Overall Study|Withdrawal by Subject|1|||
13117970|NCT03049735|25927353|FG000|Overall Study|Adverse Event|7|||
13117971|NCT03049735|25927354|FG001|Overall Study|Adverse Event|18|||
13117972|NCT03049735|25927355|FG002|Overall Study|Adverse Event|5|||
13117973|NCT03049735|25927353|FG000|Overall Study|Withdrawal by Subject|10|||
13117974|NCT03049735|25927354|FG001|Overall Study|Withdrawal by Subject|3|||
13117975|NCT03049735|25927355|FG002|Overall Study|Withdrawal by Subject|7|||
13117976|NCT03049735|25927353|FG000|Overall Study|Lost to Follow-up|1|||
13117977|NCT03049735|25927354|FG001|Overall Study|Lost to Follow-up|5|||
13117978|NCT03049735|25927355|FG002|Overall Study|Lost to Follow-up|5|||
13117979|NCT03049488|25927457|FG000|Overall Study|Lost to Follow-up|1|||
13117980|NCT03049488|25927458|FG001|Overall Study|Lost to Follow-up|1|||
13117981|NCT03049488|25927459|FG002|Overall Study|Lost to Follow-up|0|||
13268645|NCT01423812|26419667|FG001|Overall Study|Withdrawal by Subject|2|||
13268646|NCT01423617|26419688|FG000|Overall Study|Lost to Follow-up|0|||
13268647|NCT01423617|26419689|FG001|Overall Study|Lost to Follow-up|1|||
13117982|NCT03049488|25927460|FG003|Overall Study|Lost to Follow-up|0|||
13117983|NCT03049488|25927461|FG004|Overall Study|Lost to Follow-up|0|||
13268648|NCT01423604|26419713|FG000|Safety Run-In|Adverse Event|3|||
13268649|NCT01423604|26419714|FG001|Safety Run-In|Adverse Event|0|||
13268650|NCT01423604|26419713|FG000|Safety Run-In|Death|1|||
13268651|NCT01423604|26419714|FG001|Safety Run-In|Death|0|||
13268652|NCT01423604|26419713|FG000|Safety Run-In|Physician Decision|1|||
13268653|NCT01423604|26419714|FG001|Safety Run-In|Physician Decision|0|||
13268654|NCT01423604|26419713|FG000|Safety Run-In|Disease progression|3|||
13268655|NCT01423604|26419714|FG001|Safety Run-In|Disease progression|0|||
13268656|NCT01423604|26419713|FG000|Safety Run-In|Patient decision|1|||
13268657|NCT01423604|26419714|FG001|Safety Run-In|Patient decision|0|||
13268658|NCT01423604|26419713|FG000|Randomized|Adverse Event|4|||
13268659|NCT01423604|26419714|FG001|Randomized|Adverse Event|10|||
13268660|NCT01423604|26419713|FG000|Randomized|Death|1|||
13268661|NCT01423604|26419714|FG001|Randomized|Death|0|||
13268662|NCT01423604|26419713|FG000|Randomized|Physician Decision|16|||
13268663|NCT01423604|26419714|FG001|Randomized|Physician Decision|13|||
13268664|NCT01423604|26419713|FG000|Randomized|Other - unspecified|37|||
13268665|NCT01423604|26419714|FG001|Randomized|Other - unspecified|31|||
13268666|NCT01423604|26419713|FG000|Randomized|Patient decision|5|||
13268667|NCT01423604|26419714|FG001|Randomized|Patient decision|9|||
13268668|NCT01423253|26419727|FG000|Overall Study|Adverse Event|2|||
13268669|NCT01423253|26419727|FG000|Overall Study|Lack of Efficacy|2|||
13268670|NCT01423253|26419727|FG000|Overall Study|Lost to Follow-up|1|||
13268671|NCT01423253|26419727|FG000|Overall Study|Protocol Violation|2|||
13268672|NCT01423253|26419727|FG000|Overall Study|Withdrawal by Subject|2|||
13268673|NCT01423084|26419764|FG000|Overall Study|Adverse Event|0|||
13268674|NCT01423084|26419765|FG001|Overall Study|Adverse Event|1|||
13268675|NCT01423084|26419764|FG000|Overall Study|Withdrawal by Subject|2|||
13268676|NCT01423084|26419765|FG001|Overall Study|Withdrawal by Subject|3|||
13268677|NCT01422915|26419772|FG000|Overall Study|Adverse Event|1|||
13268678|NCT01422889|26419779|FG000|Overall Study|No Data Entered for Study Stent|9|||
13268679|NCT01422876|26419857|FG000|Week 24|Lost to Follow-up|1|||
13268680|NCT01422876|26419858|FG001|Week 24|Lost to Follow-up|1|||
13268681|NCT01422876|26419859|FG002|Week 24|Lost to Follow-up|2|||
13268682|NCT01422876|26419860|FG003|Week 24|Lost to Follow-up|4|||
13268683|NCT01422876|26419861|FG004|Week 24|Lost to Follow-up|2|||
13268684|NCT01422876|26419862|FG005|Week 24|Lost to Follow-up|0|||
13268685|NCT01422876|26419863|FG006|Week 24|Lost to Follow-up|1|||
13268686|NCT01422876|26419864|FG007|Week 24|Lost to Follow-up|3|||
13268687|NCT01422876|26419865|FG008|Week 24|Lost to Follow-up|3|||
13268688|NCT01422876|26419866|FG009|Week 24|Lost to Follow-up|4|||
13268689|NCT01422876|26419857|FG000|Week 24|Consent withdrawn|5|||
13268690|NCT01422876|26419858|FG001|Week 24|Consent withdrawn|1|||
13268691|NCT01422876|26419859|FG002|Week 24|Consent withdrawn|3|||
13268692|NCT01422876|26419860|FG003|Week 24|Consent withdrawn|4|||
13268693|NCT01422876|26419861|FG004|Week 24|Consent withdrawn|5|||
13268694|NCT01422876|26419862|FG005|Week 24|Consent withdrawn|6|||
13268695|NCT01422876|26419863|FG006|Week 24|Consent withdrawn|5|||
13268696|NCT01422876|26419864|FG007|Week 24|Consent withdrawn|4|||
13268697|NCT01422876|26419865|FG008|Week 24|Consent withdrawn|3|||
13268698|NCT01422876|26419866|FG009|Week 24|Consent withdrawn|6|||
13268699|NCT01422876|26419857|FG000|Week 24|Death|0|||
13268700|NCT01422876|26419858|FG001|Week 24|Death|1|||
13268701|NCT01422876|26419859|FG002|Week 24|Death|0|||
13268702|NCT01422876|26419860|FG003|Week 24|Death|0|||
13268703|NCT01422876|26419861|FG004|Week 24|Death|0|||
13268704|NCT01422876|26419862|FG005|Week 24|Death|0|||
13268705|NCT01422876|26419863|FG006|Week 24|Death|0|||
13268706|NCT01422876|26419864|FG007|Week 24|Death|0|||
13268707|NCT01422876|26419865|FG008|Week 24|Death|0|||
13268708|NCT01422876|26419866|FG009|Week 24|Death|0|||
13268709|NCT01422876|26419857|FG000|Week 52|Lost to Follow-up|3|||
13268710|NCT01422876|26419858|FG001|Week 52|Lost to Follow-up|5|||
13268711|NCT01422876|26419859|FG002|Week 52|Lost to Follow-up|7|||
13268712|NCT01422876|26419860|FG003|Week 52|Lost to Follow-up|5|||
13268713|NCT01422876|26419861|FG004|Week 52|Lost to Follow-up|8|||
13268714|NCT01422876|26419862|FG005|Week 52|Lost to Follow-up|5|||
13268715|NCT01422876|26419863|FG006|Week 52|Lost to Follow-up|5|||
13268716|NCT01422876|26419864|FG007|Week 52|Lost to Follow-up|8|||
13268717|NCT01422876|26419865|FG008|Week 52|Lost to Follow-up|7|||
13268718|NCT01422876|26419866|FG009|Week 52|Lost to Follow-up|8|||
13268719|NCT01422876|26419857|FG000|Week 52|Consent withdrawn|9|||
13268720|NCT01422876|26419858|FG001|Week 52|Consent withdrawn|4|||
13268721|NCT01422876|26419859|FG002|Week 52|Consent withdrawn|6|||
13268722|NCT01422876|26419860|FG003|Week 52|Consent withdrawn|12|||
13268723|NCT01422876|26419861|FG004|Week 52|Consent withdrawn|7|||
13268724|NCT01422876|26419862|FG005|Week 52|Consent withdrawn|12|||
13268725|NCT01422876|26419863|FG006|Week 52|Consent withdrawn|10|||
13268726|NCT01422876|26419864|FG007|Week 52|Consent withdrawn|12|||
13268727|NCT01422876|26419865|FG008|Week 52|Consent withdrawn|13|||
13268728|NCT01422876|26419866|FG009|Week 52|Consent withdrawn|9|||
13268729|NCT01422876|26419857|FG000|Week 52|Death|0|||
13268730|NCT01422876|26419858|FG001|Week 52|Death|1|||
13268731|NCT01422876|26419859|FG002|Week 52|Death|0|||
13268732|NCT01422876|26419860|FG003|Week 52|Death|1|||
13268733|NCT01422876|26419861|FG004|Week 52|Death|0|||
13268734|NCT01422876|26419862|FG005|Week 52|Death|0|||
13268735|NCT01422876|26419863|FG006|Week 52|Death|1|||
13268736|NCT01422876|26419864|FG007|Week 52|Death|3|||
13268737|NCT01422876|26419865|FG008|Week 52|Death|1|||
13268738|NCT01422876|26419866|FG009|Week 52|Death|0|||
13268739|NCT01422850|26419874|FG000|Overall Study|Physician Decision|3|||
13268740|NCT01422824|26419881|FG000|Overall Study|Case record form not evaluated|1|||
13268741|NCT01422824|26419881|FG000|Overall Study|Lost to Follow-up|37|||
13268742|NCT01422720|26419891|FG000|Overall Study|Adverse Event|16|||
13268743|NCT01422720|26419891|FG000|Overall Study|Lack of Efficacy|1|||
13268744|NCT01422720|26419891|FG000|Overall Study|Withdrawal by Subject|4|||
13268745|NCT01422720|26419891|FG000|Overall Study|Ineligibility|1|||
13268746|NCT01422538|26419923|FG000|Overall Study|Lost to Follow-up|0|||
13268747|NCT01422538|26419924|FG001|Overall Study|Lost to Follow-up|1|||
13268748|NCT01422538|26419925|FG002|Overall Study|Lost to Follow-up|1|||
13268749|NCT01422538|26419923|FG000|Overall Study|Missed visit|0|||
13268750|NCT01422538|26419924|FG001|Overall Study|Missed visit|1|||
13268751|NCT01422538|26419925|FG002|Overall Study|Missed visit|1|||
13268752|NCT01422408|26419956|FG000|Overall Study|Adverse Event|1|||
13268753|NCT01422408|26419956|FG000|Overall Study|Withdrawal by Subject|3|||
13268754|NCT01422382|26419963|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1|||
13268755|NCT01422304|26420000|FG000|Overall Study|Adverse Event|0|||
13268756|NCT01422304|26420001|FG001|Overall Study|Adverse Event|1|||
13268757|NCT01422304|26420000|FG000|Overall Study|Lost to Follow-up|14|||
13268758|NCT01422304|26420001|FG001|Overall Study|Lost to Follow-up|20|||
13268759|NCT01422304|26420000|FG000|Overall Study|Never Entered Follow-up|2|||
13268760|NCT01422304|26420001|FG001|Overall Study|Never Entered Follow-up|1|||
13268761|NCT01422304|26420000|FG000|Overall Study|Protocol Violation|1|||
13268762|NCT01422304|26420001|FG001|Overall Study|Protocol Violation|0|||
13268763|NCT01422304|26420000|FG000|Overall Study|Withdrawal by Subject|4|||
13268764|NCT01422304|26420001|FG001|Overall Study|Withdrawal by Subject|2|||
13268765|NCT01422304|26420000|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
13268766|NCT01422304|26420001|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
13268767|NCT01422304|26420000|FG000|Overall Study|Not Treated|3|||
13268768|NCT01422304|26420001|FG001|Overall Study|Not Treated|11|||
13268769|NCT01422239|26420018|FG000|Overall Study|Lost to Follow-up|4|||
13268770|NCT01422239|26420019|FG001|Overall Study|Lost to Follow-up|3|||
13268771|NCT01422213|26420087|FG000|Overall Study|Adverse Event|8|||
13268772|NCT01422213|26420088|FG001|Overall Study|Adverse Event|7|||
13268773|NCT01422213|26420089|FG002|Overall Study|Adverse Event|11|||
13268774|NCT01422213|26420087|FG000|Overall Study|Lack of Efficacy|10|||
13268775|NCT01422213|26420088|FG001|Overall Study|Lack of Efficacy|2|||
13268776|NCT01422213|26420089|FG002|Overall Study|Lack of Efficacy|2|||
13268777|NCT01422213|26420087|FG000|Overall Study|Non-compliance with study drug|0|||
13268778|NCT01422213|26420088|FG001|Overall Study|Non-compliance with study drug|1|||
13268779|NCT01422213|26420089|FG002|Overall Study|Non-compliance with study drug|0|||
13268780|NCT01422213|26420087|FG000|Overall Study|Protocol Violation|0|||
13268781|NCT01422213|26420088|FG001|Overall Study|Protocol Violation|2|||
13268782|NCT01422213|26420089|FG002|Overall Study|Protocol Violation|4|||
13268783|NCT01422213|26420087|FG000|Overall Study|Withdrawal of Consent|7|||
13268784|NCT01422213|26420088|FG001|Overall Study|Withdrawal of Consent|3|||
13268785|NCT01422213|26420089|FG002|Overall Study|Withdrawal of Consent|5|||
13268786|NCT01422213|26420087|FG000|Overall Study|Lost to Follow-up|3|||
13268787|NCT01422213|26420088|FG001|Overall Study|Lost to Follow-up|3|||
13268788|NCT01422213|26420089|FG002|Overall Study|Lost to Follow-up|5|||
13268789|NCT01422213|26420087|FG000|Overall Study|Administrative or Other Reason(s)|5|||
13268790|NCT01422213|26420088|FG001|Overall Study|Administrative or Other Reason(s)|4|||
13268791|NCT01422213|26420089|FG002|Overall Study|Administrative or Other Reason(s)|2|||
13268792|NCT01422187|26420116|FG000|Overall Study|Personal reason|1|||
13268793|NCT01422187|26420117|FG001|Overall Study|Personal reason|0|||
13268794|NCT01422187|26420118|FG002|Overall Study|Personal reason|0|||
13268795|NCT01422187|26420116|FG000|Overall Study|Lost to Follow-up|0|||
13268796|NCT01422187|26420117|FG001|Overall Study|Lost to Follow-up|1|||
13268797|NCT01422187|26420118|FG002|Overall Study|Lost to Follow-up|0|||
13268798|NCT01421719|26420125|FG000|Overall Study|Withdrawal by Subject|4|||
13268799|NCT01421667|26420188|FG000|Overall Study|Withdrawal by Subject|0|||
13268800|NCT01421667|26420189|FG001|Overall Study|Withdrawal by Subject|1|||
13268801|NCT01421667|26420190|FG002|Overall Study|Withdrawal by Subject|2|||
13268802|NCT01421667|26420191|FG003|Overall Study|Withdrawal by Subject|1|||
13268803|NCT01421667|26420188|FG000|Overall Study|Lost to Follow-up|0|||
13268804|NCT01421667|26420189|FG001|Overall Study|Lost to Follow-up|1|||
13268805|NCT01421667|26420190|FG002|Overall Study|Lost to Follow-up|0|||
13268806|NCT01421667|26420191|FG003|Overall Study|Lost to Follow-up|0|||
13268807|NCT01421641|26420208|FG000|Overall Study|Protocol Violation|2|||
13268808|NCT01421641|26420209|FG001|Overall Study|Protocol Violation|2|||
13268809|NCT01421511|26420236|FG000|Overall Study|Lost to Follow-up|11|||
13268810|NCT01421511|26420237|FG001|Overall Study|Lost to Follow-up|14|||
13268811|NCT01421511|26420236|FG000|Overall Study|Randomized but didn't receive study drug|1|||
13268812|NCT01421511|26420237|FG001|Overall Study|Randomized but didn't receive study drug|7|||
13268813|NCT01421511|26420236|FG000|Overall Study|Physician Decision|0|||
13268814|NCT01421511|26420237|FG001|Overall Study|Physician Decision|1|||
13268815|NCT01421511|26420236|FG000|Overall Study|Withdrawal by Subject|6|||
13268816|NCT01421511|26420237|FG001|Overall Study|Withdrawal by Subject|5|||
13268817|NCT01421511|26420236|FG000|Overall Study|Death|1|||
13268818|NCT01421511|26420237|FG001|Overall Study|Death|1|||
13268819|NCT01421459|26420278|FG000|Overall Study|Adverse Event|6|||
13268820|NCT01421459|26420279|FG001|Overall Study|Adverse Event|10|||
13268821|NCT01421459|26420278|FG000|Overall Study|Death|1|||
13268822|NCT01421459|26420279|FG001|Overall Study|Death|1|||
13268823|NCT01421459|26420278|FG000|Overall Study|Lack of Efficacy|1|||
13268824|NCT01421459|26420279|FG001|Overall Study|Lack of Efficacy|2|||
13268825|NCT01421459|26420278|FG000|Overall Study|Lost to Follow-up|8|||
13268826|NCT01421459|26420279|FG001|Overall Study|Lost to Follow-up|9|||
13268827|NCT01421459|26420278|FG000|Overall Study|Physician Decision|9|||
13268828|NCT01421459|26420279|FG001|Overall Study|Physician Decision|9|||
13268829|NCT01421459|26420278|FG000|Overall Study|Protocol Violation|8|||
13268830|NCT01421459|26420279|FG001|Overall Study|Protocol Violation|5|||
13268831|NCT01421459|26420278|FG000|Overall Study|Withdrawal by Subject|12|||
13268832|NCT01421459|26420279|FG001|Overall Study|Withdrawal by Subject|16|||
13268833|NCT01421342|26420306|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49|||
13268834|NCT01421342|26420307|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28|||
13268835|NCT01421342|26420308|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13|||
13268836|NCT01421342|26420306|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53|||
13117984|NCT03049488|25927462|FG005|Overall Study|Lost to Follow-up|0|||
13117985|NCT03049488|25927457|FG000|Overall Study|Moved from Area|1|||
13117986|NCT03049488|25927458|FG001|Overall Study|Moved from Area|0|||
13117987|NCT03049488|25927459|FG002|Overall Study|Moved from Area|0|||
13117988|NCT03049488|25927460|FG003|Overall Study|Moved from Area|1|||
13117989|NCT03049488|25927461|FG004|Overall Study|Moved from Area|1|||
13117990|NCT03049488|25927462|FG005|Overall Study|Moved from Area|0|||
13117991|NCT03049488|25927457|FG000|Overall Study|Physician Decision|0|||
13117992|NCT03049488|25927458|FG001|Overall Study|Physician Decision|1|||
13117993|NCT03049488|25927459|FG002|Overall Study|Physician Decision|0|||
13117994|NCT03049488|25927460|FG003|Overall Study|Physician Decision|0|||
13117995|NCT03049488|25927461|FG004|Overall Study|Physician Decision|0|||
13117996|NCT03049488|25927462|FG005|Overall Study|Physician Decision|0|||
13117997|NCT03049488|25927457|FG000|Overall Study|Withdrawal by Subject|0|||
13268837|NCT01421342|26420307|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38|||
13268838|NCT01421342|26420308|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27|||
13268839|NCT01421342|26420306|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23|||
13268840|NCT01421342|26420307|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20|||
13268841|NCT01421342|26420308|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13|||
13268842|NCT01421342|26420306|FG000|Acute Treatment Phase (12 Weeks)|Death|0|||
13268843|NCT01421342|26420307|FG001|Acute Treatment Phase (12 Weeks)|Death|0|||
13268844|NCT01421342|26420308|FG002|Acute Treatment Phase (12 Weeks)|Death|3|||
13268845|NCT01421342|26420306|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6|||
13268846|NCT01421342|26420307|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18|||
13268847|NCT01421342|26420308|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21|||
13268848|NCT01421342|26420306|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15|||
13268849|NCT01421342|26420307|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7|||
13268850|NCT01421342|26420308|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13|||
13268851|NCT01421342|26420306|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3|||
13268852|NCT01421342|26420307|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2|||
13268853|NCT01421342|26420308|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4|||
13268854|NCT01421342|26420306|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
13268855|NCT01421342|26420307|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6|||
13268856|NCT01421342|26420308|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
13268857|NCT01421342|26420306|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8|||
13307852|NCT01282216|26529949|FG001|Overall Study|Physician Decision|0|||
13307853|NCT01282216|26529950|FG002|Overall Study|Physician Decision|11|||
13307854|NCT01282216|26529951|FG003|Overall Study|Physician Decision|0|||
13307855|NCT01282216|26529948|FG000|Overall Study|Relapse|0|||
13307856|NCT01282216|26529949|FG001|Overall Study|Relapse|0|||
13307857|NCT01282216|26529950|FG002|Overall Study|Relapse|17|||
13307858|NCT01282216|26529951|FG003|Overall Study|Relapse|6|||
13307859|NCT01282216|26529948|FG000|Overall Study|Death|0|||
13307860|NCT01282216|26529949|FG001|Overall Study|Death|0|||
13307861|NCT01282216|26529950|FG002|Overall Study|Death|2|||
13307862|NCT01282216|26529951|FG003|Overall Study|Death|0|||
13307863|NCT01282203|26529973|FG000|Overall Study|Adverse Event|1|||
13307864|NCT01282164|26530003|FG000|Overall Study|Lack of hypoglycemia during ITT|1|||
13307865|NCT01282164|26530004|FG001|Overall Study|Lack of hypoglycemia during ITT|0|||
13307866|NCT01281969|26530024|FG000|Overall Study|not randomized didn't meet criteria|0|||
13307867|NCT01281969|26530025|FG001|Overall Study|not randomized didn't meet criteria|0|||
13307868|NCT01281969|26530026|FG002|Overall Study|not randomized didn't meet criteria|7|||
13307869|NCT01281969|26530024|FG000|Overall Study|AE during LP prior to IVIG admin|1|||
13307870|NCT01281969|26530025|FG001|Overall Study|AE during LP prior to IVIG admin|0|||
13307871|NCT01281969|26530026|FG002|Overall Study|AE during LP prior to IVIG admin|3|||
13117998|NCT03049488|25927458|FG001|Overall Study|Withdrawal by Subject|0|||
13117999|NCT03049488|25927459|FG002|Overall Study|Withdrawal by Subject|0|||
13268858|NCT01421342|26420307|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9|||
13268859|NCT01421342|26420308|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4|||
13268860|NCT01421342|26420306|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111|||
13268861|NCT01421342|26420307|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93|||
13118000|NCT03049488|25927460|FG003|Overall Study|Withdrawal by Subject|1|||
13268862|NCT01421342|26420308|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88|||
13268863|NCT01421342|26420306|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7|||
13268864|NCT01421342|26420307|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10|||
13268865|NCT01421342|26420308|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12|||
13268866|NCT01421342|26420306|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4|||
13268867|NCT01421342|26420307|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3|||
13268868|NCT01421342|26420308|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6|||
13268869|NCT01421342|26420306|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13|||
13268870|NCT01421342|26420307|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4|||
13268871|NCT01421342|26420308|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11|||
13118001|NCT03049488|25927461|FG004|Overall Study|Withdrawal by Subject|1|||
13118002|NCT03049488|25927462|FG005|Overall Study|Withdrawal by Subject|0|||
13118003|NCT03049280|25927470|FG000|Overall Study|Physician Decision|1|||
13268872|NCT01421342|26420306|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4|||
13118004|NCT03048747|25927477|FG000|Overall Study|Adverse Event|2|||
13118005|NCT03048747|25927477|FG000|Overall Study|Participant Met Withdrawal Criteria|2|||
13118006|NCT03048747|25927477|FG000|Overall Study|Physician Decision|1|||
13118007|NCT03048500|25927484|FG000|2 Cycles of Treatment|Withdrawal by Subject|1|||
13118008|NCT03048500|25927484|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4|||
13118009|NCT03048500|25927484|FG000|Reached 1st Response/Continued Treatment|Death|1|||
13118010|NCT03048500|25927484|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1|||
13118011|NCT03048500|25927484|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1|||
13118012|NCT03048500|25927484|FG000|Follow up for 3 Years|Currently in Follow-up|4|||
13118013|NCT03048500|25927484|FG000|Follow up for 3 Years|Death|12|||
13118014|NCT03048422|25927570|FG000|Overall Study|Death|1|||
13118015|NCT03048422|25927571|FG001|Overall Study|Death|0|||
13118016|NCT03048422|25927572|FG002|Overall Study|Death|0|||
13118017|NCT03048422|25927570|FG000|Overall Study|Lost to Follow-up|5|||
13118018|NCT03048422|25927571|FG001|Overall Study|Lost to Follow-up|0|||
13118019|NCT03048422|25927572|FG002|Overall Study|Lost to Follow-up|1|||
13118020|NCT03048422|25927570|FG000|Overall Study|Withdrawal by Subject|5|||
13118021|NCT03048422|25927571|FG001|Overall Study|Withdrawal by Subject|7|||
13268873|NCT01421342|26420307|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
13268874|NCT01421342|26420308|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
13268875|NCT01421342|26420306|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
13268876|NCT01421342|26420307|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4|||
13268877|NCT01421342|26420308|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
13268878|NCT01421342|26420306|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1|||
13268879|NCT01421342|26420307|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0|||
13268880|NCT01421342|26420308|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2|||
13268881|NCT01421342|26420306|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1|||
13268882|NCT01421342|26420307|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
13268883|NCT01421342|26420308|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
13268884|NCT01421342|26420306|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
13268885|NCT01421342|26420307|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
13268886|NCT01421342|26420308|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4|||
13268887|NCT01421342|26420306|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
13268888|NCT01421342|26420307|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
13268889|NCT01421342|26420308|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2|||
13268890|NCT01421342|26420306|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
13268891|NCT01421342|26420307|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5|||
13268892|NCT01421342|26420308|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
13268893|NCT01421342|26420306|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0|||
13268894|NCT01421342|26420307|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6|||
13268895|NCT01421342|26420308|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11|||
13268896|NCT01421342|26420306|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7|||
13268897|NCT01421342|26420307|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6|||
13268898|NCT01421342|26420308|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4|||
13118022|NCT03048422|25927572|FG002|Overall Study|Withdrawal by Subject|4|||
13118023|NCT03048422|25927570|FG000|Overall Study|Moved|3|||
13118024|NCT03048422|25927571|FG001|Overall Study|Moved|2|||
13118025|NCT03048422|25927572|FG002|Overall Study|Moved|2|||
13118026|NCT03048422|25927570|FG000|Overall Study|Noncompliant with Study Requirements|2|||
13118027|NCT03048422|25927571|FG001|Overall Study|Noncompliant with Study Requirements|1|||
13268899|NCT01421342|26420306|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4|||
13268900|NCT01421342|26420307|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11|||
13268901|NCT01421342|26420308|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9|||
13268902|NCT01421342|26420306|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3|||
13268903|NCT01421342|26420307|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8|||
13268904|NCT01421342|26420308|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4|||
13268905|NCT01421342|26420306|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15|||
13268906|NCT01421342|26420307|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20|||
13268907|NCT01421342|26420308|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14|||
13268908|NCT01421342|26420306|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4|||
13268909|NCT01421342|26420307|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1|||
13268910|NCT01421342|26420308|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3|||
13268911|NCT01421342|26420306|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
13268912|NCT01421342|26420307|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
13268913|NCT01421342|26420308|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
13268914|NCT01421342|26420306|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6|||
13268915|NCT01421342|26420307|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0|||
13268916|NCT01421342|26420308|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7|||
13268917|NCT01421303|26420335|FG000|Overall Study|Lost to Follow-up|13|||
13268918|NCT01421303|26420335|FG000|Overall Study|Non compliance with study procedure|1|||
13268919|NCT01421303|26420335|FG000|Overall Study|Other|7|||
13268920|NCT01421303|26420335|FG000|Overall Study|Withdrawal by Subject|1|||
13268921|NCT01421277|26420352|FG000|Overall Study|Lack of qualifying event|0|||
13268922|NCT01421277|26420353|FG001|Overall Study|Lack of qualifying event|61|||
13268923|NCT01421277|26420352|FG000|Overall Study|Incomplete baseline data|0|||
13268924|NCT01421277|26420353|FG001|Overall Study|Incomplete baseline data|31|||
13268925|NCT01421225|26420372|FG000|Overall Study|Withdrawal by Subject|0|||
13268926|NCT01421225|26420373|FG001|Overall Study|Withdrawal by Subject|1|||
13268927|NCT01421147|26420410|FG000|Treatment Period|Adverse Event|2|||
13268928|NCT01421147|26420411|FG001|Treatment Period|Adverse Event|3|||
13118028|NCT03048422|25927572|FG002|Overall Study|Noncompliant with Study Requirements|2|||
13118029|NCT03048422|25927570|FG000|Overall Study|Not Able to Get to Clinic|1|||
13118030|NCT03048422|25927571|FG001|Overall Study|Not Able to Get to Clinic|0|||
13118031|NCT03048422|25927572|FG002|Overall Study|Not Able to Get to Clinic|0|||
13118032|NCT03048058|25927597|FG000|Overall Study|Lost to Follow-up|4|||
13118033|NCT03048058|25927598|FG001|Overall Study|Lost to Follow-up|0|||
13118034|NCT03048058|25927597|FG000|Overall Study|Withdrawal by Subject|0|||
13268929|NCT01421147|26420410|FG000|Treatment Period|Lost to Follow-up|2|||
13268930|NCT01421147|26420411|FG001|Treatment Period|Lost to Follow-up|1|||
13268931|NCT01421147|26420410|FG000|Treatment Period|Physician Decision|2|||
13268932|NCT01421147|26420411|FG001|Treatment Period|Physician Decision|2|||
13268933|NCT01421147|26420410|FG000|Treatment Period|Withdrawal by Subject|10|||
13268934|NCT01421147|26420411|FG001|Treatment Period|Withdrawal by Subject|5|||
13268935|NCT01421147|26420410|FG000|Extension Period|Adverse Event|0|||
13268936|NCT01421147|26420411|FG001|Extension Period|Adverse Event|2|||
13268937|NCT01421147|26420410|FG000|Extension Period|Death|0|||
13268938|NCT01421147|26420411|FG001|Extension Period|Death|1|||
13268939|NCT01421147|26420410|FG000|Extension Period|Lost to Follow-up|2|||
13268940|NCT01421147|26420411|FG001|Extension Period|Lost to Follow-up|5|||
13268941|NCT01421147|26420410|FG000|Extension Period|Physician Decision|1|||
13268942|NCT01421147|26420411|FG001|Extension Period|Physician Decision|0|||
13268943|NCT01421147|26420410|FG000|Extension Period|Withdrawal by Subject|5|||
13268944|NCT01421147|26420411|FG001|Extension Period|Withdrawal by Subject|3|||
13268945|NCT01421134|26420436|FG000|Overall Study|Adverse Event|3|||
13268946|NCT01421134|26420437|FG001|Overall Study|Adverse Event|5|||
13268947|NCT01421134|26420436|FG000|Overall Study|Lack of Efficacy|2|||
13268948|NCT01421134|26420437|FG001|Overall Study|Lack of Efficacy|4|||
13268949|NCT01421134|26420436|FG000|Overall Study|Protocol Violation|0|||
13268950|NCT01421134|26420437|FG001|Overall Study|Protocol Violation|3|||
13268951|NCT01421134|26420436|FG000|Overall Study|Withdrawal by Subject|1|||
13268952|NCT01421134|26420437|FG001|Overall Study|Withdrawal by Subject|1|||
13268953|NCT01421134|26420436|FG000|Overall Study|Administrative|0|||
13268954|NCT01421134|26420437|FG001|Overall Study|Administrative|1|||
13268955|NCT01421134|26420436|FG000|Overall Study|Lost to Follow-up|1|||
13268956|NCT01421134|26420437|FG001|Overall Study|Lost to Follow-up|1|||
13268957|NCT01421069|26420522|FG000|Parent Study|drug ineffective+prohibited drug taken|1|||
13268958|NCT01421069|26420522|FG000|Parent Study|Failed to return|3|||
13268959|NCT01421069|26420522|FG000|Parent Study|Withdrawal by Subject|1|||
13268960|NCT01421069|26420522|FG000|Parent Study|Lost to Follow-up|2|||
13118035|NCT03048058|25927598|FG001|Overall Study|Withdrawal by Subject|4|||
13118036|NCT03047980|25927607|FG000|Overall Study|Adverse Event|1|||
13268961|NCT01421069|26420522|FG000|Parent Study|Lack of Efficacy|1|||
13268962|NCT01421069|26420522|FG000|Overall Period for Extension Study|Other|2|||
13268963|NCT01421069|26420522|FG000|Overall Period for Extension Study|Medication error without associated adverse event|1|||
13268964|NCT01421069|26420522|FG000|Overall Period for Extension Study|No longer willing to participate|14|||
13268965|NCT01421069|26420522|FG000|Overall Period for Extension Study|Pregnancy|1|||
13268966|NCT01421069|26420522|FG000|Overall Period for Extension Study|Adverse Event|1|||
13268967|NCT01421069|26420522|FG000|Overall Period for Extension Study|Protocol Violation|1|||
13268968|NCT01421069|26420522|FG000|Overall Period for Extension Study|Lost to Follow-up|4|||
13268969|NCT01421069|26420522|FG000|Overall Period for Extension Study|Lack of Efficacy|1|||
13268970|NCT01421069|26420522|FG000|Active Treatment Period|Other|1|||
13268971|NCT01421069|26420522|FG000|Active Treatment Period|No longer willing to participate in study|8|||
13268972|NCT01421069|26420522|FG000|Active Treatment Period|Insufficient clinical response|1|||
13268973|NCT01421069|26420522|FG000|Active Treatment Period|Medication error without associated adverse event|1|||
13268974|NCT01421069|26420522|FG000|Active Treatment Period|Pregnancy|1|||
13268975|NCT01421069|26420522|FG000|Active Treatment Period|Adverse Event|1|||
13268976|NCT01421069|26420522|FG000|Active Treatment Period|Enrolled in withdrawal period|30|||
13268977|NCT01421069|26420522|FG000|Active Treatment Period|Enrolled in observational period|29|||
13268978|NCT01421069|26420522|FG000|2a. Withdrawal Period|No longer willing to participate in study|2|||
13268979|NCT01421069|26420522|FG000|2a. Withdrawal Period|Lost to Follow-up|1|||
13268980|NCT01421069|26420522|FG000|2a. Withdrawal Period|Enrolled in observational period|7|||
13268981|NCT01421069|26420522|FG000|2a. Withdrawal Period|Enrolled in re-treatment period|13|||
13268982|NCT01421069|26420522|FG000|2b. Retreatment Period|Enrolled in observational period|7|||
13268983|NCT01421069|26420522|FG000|2b. Retreatment Period|Protocol Violation|1|||
13268984|NCT01421069|26420522|FG000|Observational Period|Other|1|||
13268985|NCT01421069|26420522|FG000|Observational Period|No longer willing to participate in study|4|||
13268986|NCT01421069|26420522|FG000|Observational Period|Lost to Follow-up|3|||
13268987|NCT01421017|26420542|FG000|Overall Study|Withdrawal by Subject|2|||
13268988|NCT01421017|26420543|FG001|Overall Study|Withdrawal by Subject|0|||
13268989|NCT01421017|26420544|FG002|Overall Study|Withdrawal by Subject|0|||
13268990|NCT01421017|26420542|FG000|Overall Study|POD|0|||
13268991|NCT01421017|26420543|FG001|Overall Study|POD|6|||
13268992|NCT01421017|26420544|FG002|Overall Study|POD|3|||
13268993|NCT01420965|26420565|FG000|Overall Study|Withdrawal by Subject|1|||
13268994|NCT01420965|26420566|FG001|Overall Study|Withdrawal by Subject|0|||
13268995|NCT01420965|26420567|FG002|Overall Study|Withdrawal by Subject|0|||
13268996|NCT01420965|26420565|FG000|Overall Study|Adverse Event|0|||
13268997|NCT01420965|26420566|FG001|Overall Study|Adverse Event|1|||
13268998|NCT01420965|26420567|FG002|Overall Study|Adverse Event|0|||
13268999|NCT01420926|26420588|FG000|Overall Study|Adverse Event|6|||
13269000|NCT01420926|26420589|FG001|Overall Study|Adverse Event|4|||
13269001|NCT01420926|26420588|FG000|Overall Study|Death|18|||
13269002|NCT01420926|26420589|FG001|Overall Study|Death|17|||
13269003|NCT01420926|26420588|FG000|Overall Study|Withdrawal by Subject|11|||
13269004|NCT01420926|26420589|FG001|Overall Study|Withdrawal by Subject|16|||
13269005|NCT01420926|26420588|FG000|Overall Study|Non-protocol treatment|17|||
13269006|NCT01420926|26420589|FG001|Overall Study|Non-protocol treatment|20|||
13269007|NCT01420926|26420588|FG000|Overall Study|Physician Decision|7|||
13269008|NCT01420926|26420589|FG001|Overall Study|Physician Decision|5|||
13269009|NCT01420926|26420588|FG000|Overall Study|Continues on active treatment|1|||
13269010|NCT01420926|26420589|FG001|Overall Study|Continues on active treatment|3|||
13269011|NCT01420679|26420608|FG000|Overall Study|Disease Progression|3|||
13269012|NCT01420679|26420609|FG001|Overall Study|Disease Progression|2|||
13269013|NCT01420679|26420608|FG000|Overall Study|Adverse Event|4|||
13269014|NCT01420679|26420609|FG001|Overall Study|Adverse Event|0|||
13269015|NCT01420679|26420608|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1|||
13269016|NCT01420679|26420609|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0|||
13269017|NCT01420679|26420608|FG000|Overall Study|Patient Decision|1|||
13269018|NCT01420679|26420609|FG001|Overall Study|Patient Decision|0|||
13269019|NCT01420679|26420608|FG000|Overall Study|Investigator Decision|1|||
13269020|NCT01420679|26420609|FG001|Overall Study|Investigator Decision|2|||
13269021|NCT01420679|26420608|FG000|Overall Study|Sponsor Decision|3|||
13269022|NCT01420679|26420609|FG001|Overall Study|Sponsor Decision|3|||
13269023|NCT01420679|26420608|FG000|Overall Study|Other|1|||
13269024|NCT01420679|26420609|FG001|Overall Study|Other|0|||
13269025|NCT01420627|26420625|FG000|EZN-2279 Treatment Period|Adverse Event|1|||
13269026|NCT01420549|26420638|FG000|Overall Study|Adverse Event|1|||
13269027|NCT01420549|26420639|FG001|Overall Study|Adverse Event|1|||
13269028|NCT01420549|26420638|FG000|Overall Study|Lost to Follow-up|2|||
13269029|NCT01420549|26420639|FG001|Overall Study|Lost to Follow-up|2|||
13269030|NCT01420549|26420638|FG000|Overall Study|Protocol Violation|0|||
13269031|NCT01420549|26420639|FG001|Overall Study|Protocol Violation|1|||
13269032|NCT01420549|26420638|FG000|Overall Study|Non-adherence to medication|4|||
13269033|NCT01420549|26420639|FG001|Overall Study|Non-adherence to medication|1|||
13269034|NCT01420536|26420676|FG000|Period 1 (30 Days)|Withdrawal by Subject|3|||
13269035|NCT01420536|26420677|FG001|Period 1 (30 Days)|Withdrawal by Subject|0|||
13269036|NCT01420081|26420784|FG000|Overall Study|Death|1|||
13269037|NCT01420081|26420785|FG001|Overall Study|Death|0|||
13269038|NCT01420081|26420786|FG002|Overall Study|Death|8|||
13269039|NCT01420081|26420787|FG003|Overall Study|Death|0|||
13269040|NCT01420081|26420788|FG004|Overall Study|Death|7|||
13269041|NCT01420081|26420789|FG005|Overall Study|Death|12|||
13269042|NCT01420081|26420790|FG006|Overall Study|Death|0|||
13269043|NCT01420081|26420791|FG007|Overall Study|Death|1|||
13269044|NCT01420081|26420792|FG008|Overall Study|Death|1|||
13269045|NCT01420081|26420784|FG000|Overall Study|Lost to Follow-up|0|||
13269046|NCT01420081|26420785|FG001|Overall Study|Lost to Follow-up|0|||
13269047|NCT01420081|26420786|FG002|Overall Study|Lost to Follow-up|0|||
13269048|NCT01420081|26420787|FG003|Overall Study|Lost to Follow-up|0|||
13269049|NCT01420081|26420788|FG004|Overall Study|Lost to Follow-up|1|||
13269050|NCT01420081|26420789|FG005|Overall Study|Lost to Follow-up|1|||
13269051|NCT01420081|26420790|FG006|Overall Study|Lost to Follow-up|0|||
13269052|NCT01420081|26420791|FG007|Overall Study|Lost to Follow-up|0|||
13269053|NCT01420081|26420792|FG008|Overall Study|Lost to Follow-up|0|||
13269054|NCT01420081|26420784|FG000|Overall Study|Study Terminated by Sponsor|2|||
13269055|NCT01420081|26420785|FG001|Overall Study|Study Terminated by Sponsor|1|||
13269056|NCT01420081|26420786|FG002|Overall Study|Study Terminated by Sponsor|1|||
13269057|NCT01420081|26420787|FG003|Overall Study|Study Terminated by Sponsor|3|||
13269058|NCT01420081|26420788|FG004|Overall Study|Study Terminated by Sponsor|11|||
13269059|NCT01420081|26420789|FG005|Overall Study|Study Terminated by Sponsor|7|||
13269060|NCT01420081|26420790|FG006|Overall Study|Study Terminated by Sponsor|3|||
13269061|NCT01420081|26420791|FG007|Overall Study|Study Terminated by Sponsor|2|||
13269062|NCT01420081|26420792|FG008|Overall Study|Study Terminated by Sponsor|2|||
13269063|NCT01420081|26420784|FG000|Overall Study|Subject Refused Futher Follow-up|0|||
13269064|NCT01420081|26420785|FG001|Overall Study|Subject Refused Futher Follow-up|0|||
13269065|NCT01420081|26420786|FG002|Overall Study|Subject Refused Futher Follow-up|1|||
13269066|NCT01420081|26420787|FG003|Overall Study|Subject Refused Futher Follow-up|0|||
13269067|NCT01420081|26420788|FG004|Overall Study|Subject Refused Futher Follow-up|1|||
13269068|NCT01420081|26420789|FG005|Overall Study|Subject Refused Futher Follow-up|0|||
13269069|NCT01420081|26420790|FG006|Overall Study|Subject Refused Futher Follow-up|0|||
13269070|NCT01420081|26420791|FG007|Overall Study|Subject Refused Futher Follow-up|0|||
13269071|NCT01420081|26420792|FG008|Overall Study|Subject Refused Futher Follow-up|0|||
13269072|NCT01420081|26420784|FG000|Overall Study|Other Reasons|0|||
13269073|NCT01420081|26420785|FG001|Overall Study|Other Reasons|0|||
13269074|NCT01420081|26420786|FG002|Overall Study|Other Reasons|1|||
13269075|NCT01420081|26420787|FG003|Overall Study|Other Reasons|0|||
13269076|NCT01420081|26420788|FG004|Overall Study|Other Reasons|0|||
13269077|NCT01420081|26420789|FG005|Overall Study|Other Reasons|0|||
13269078|NCT01420081|26420790|FG006|Overall Study|Other Reasons|0|||
13269079|NCT01420081|26420791|FG007|Overall Study|Other Reasons|0|||
13269080|NCT01420081|26420792|FG008|Overall Study|Other Reasons|0|||
13269081|NCT01420068|26420819|FG000|Overall Study|Administrative problems|1|||
13269082|NCT01420068|26420820|FG001|Overall Study|Administrative problems|3|||
13269083|NCT01420068|26420819|FG000|Overall Study|Withdrawal by Subject|1|||
13269084|NCT01420068|26420820|FG001|Overall Study|Withdrawal by Subject|2|||
13269085|NCT01419769|26420835|FG000|Overall Study|Did not receive the AXIOS stent|3|||
13269086|NCT01419769|26420835|FG000|Overall Study|Not evaluable due to pigtail stents|1|||
13269087|NCT01419717|26420842|FG000|Overall Study|Protocol-specified Criteria|62|||
13269088|NCT01419717|26420842|FG000|Overall Study|Adverse Event|19|||
13269089|NCT01419717|26420842|FG000|Overall Study|Death|17|||
13269090|NCT01419717|26420842|FG000|Overall Study|Withdrawal by Subject|10|||
13269091|NCT01419717|26420842|FG000|Overall Study|Disease Progression|9|||
13269092|NCT01419717|26420842|FG000|Overall Study|Other|4|||
13269093|NCT01419717|26420842|FG000|Overall Study|Lost to Follow-up|2|||
13269094|NCT01419717|26420842|FG000|Overall Study|Administrative Decision|1|||
13269095|NCT01419717|26420842|FG000|Overall Study|Noncompliance|1|||
13269096|NCT01419665|26420875|FG000|Combination Treatment|Adverse Event|7|||
13269097|NCT01419665|26420876|FG001|Combination Treatment|Adverse Event|10|||
13269098|NCT01419665|26420875|FG000|Combination Treatment|Physician Decision|5|||
13269099|NCT01419665|26420876|FG001|Combination Treatment|Physician Decision|8|||
13269100|NCT01419665|26420875|FG000|Combination Treatment|Protocol Violation|6|||
13269101|NCT01419665|26420876|FG001|Combination Treatment|Protocol Violation|2|||
13269102|NCT01419665|26420875|FG000|Combination Treatment|disease progression|10|||
13269103|NCT01419665|26420876|FG001|Combination Treatment|disease progression|9|||
13269104|NCT01419665|26420875|FG000|Combination Treatment|Death|5|||
13269105|NCT01419665|26420876|FG001|Combination Treatment|Death|7|||
13269106|NCT01419665|26420875|FG000|Combination Treatment|administrative problems|0|||
13269107|NCT01419665|26420876|FG001|Combination Treatment|administrative problems|1|||
13269108|NCT01419665|26420875|FG000|Combination Treatment|Withdrawal by Subject|5|||
13269109|NCT01419665|26420876|FG001|Combination Treatment|Withdrawal by Subject|4|||
13269110|NCT01419665|26420875|FG000|Maintenance Treatment and/or Follow up|switch to open label|44|||
13269111|NCT01419665|26420876|FG001|Maintenance Treatment and/or Follow up|switch to open label|39|||
13269112|NCT01419665|26420875|FG000|Maintenance Treatment and/or Follow up|administrative problems|0|||
13269113|NCT01419665|26420876|FG001|Maintenance Treatment and/or Follow up|administrative problems|6|||
13269114|NCT01419665|26420875|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
13269115|NCT01419665|26420876|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
13269116|NCT01419665|26420875|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
13269117|NCT01419665|26420876|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
13269118|NCT01419665|26420875|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5|||
13269119|NCT01419665|26420876|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2|||
13269120|NCT01419665|26420875|FG000|Maintenance Treatment and/or Follow up|disease progression|53|||
13269121|NCT01419665|26420876|FG001|Maintenance Treatment and/or Follow up|disease progression|37|||
13269122|NCT01419665|26420875|FG000|Maintenance Treatment and/or Follow up|Death|1|||
13269123|NCT01419665|26420876|FG001|Maintenance Treatment and/or Follow up|Death|2|||
13269124|NCT01419665|26420875|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11|||
13269125|NCT01419665|26420876|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7|||
13269126|NCT01419665|26420875|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1|||
13269127|NCT01419665|26420876|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2|||
13269128|NCT01419665|26420875|FG000|Open Label Phase|Death|1|||
13269129|NCT01419665|26420876|FG001|Open Label Phase|Death|0|||
13269130|NCT01419665|26420875|FG000|Open Label Phase|disease progression|0|||
13269131|NCT01419665|26420876|FG001|Open Label Phase|disease progression|1|||
13269132|NCT01419626|26420915|FG000|Overall Study|Protocol Violation|3|||
13269133|NCT01419626|26420916|FG001|Overall Study|Protocol Violation|2|||
13269134|NCT01419626|26420917|FG002|Overall Study|Protocol Violation|2|||
13269135|NCT01419626|26420915|FG000|Overall Study|Withdrawal by Subject|1|||
13269136|NCT01419626|26420916|FG001|Overall Study|Withdrawal by Subject|0|||
13269137|NCT01419626|26420917|FG002|Overall Study|Withdrawal by Subject|0|||
13269138|NCT01419626|26420915|FG000|Overall Study|Lost to Follow-up|0|||
13269139|NCT01419626|26420916|FG001|Overall Study|Lost to Follow-up|1|||
13269140|NCT01419626|26420917|FG002|Overall Study|Lost to Follow-up|1|||
13269141|NCT01419535|26420940|FG000|Overall Study|could not maintain iv line|1|||
13269142|NCT01419535|26420941|FG001|Overall Study|could not maintain iv line|1|||
13269143|NCT01419535|26420940|FG000|Overall Study|Withdrawal by Subject|0|||
13269144|NCT01419535|26420941|FG001|Overall Study|Withdrawal by Subject|1|||
13269145|NCT01419314|26420968|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3|||
13269146|NCT01419314|26420969|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1|||
13269147|NCT01419314|26420968|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3|||
13269148|NCT01419314|26420969|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0|||
13269149|NCT01419314|26420968|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1|||
13269150|NCT01419314|26420969|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2|||
13269151|NCT01419236|26420998|FG000|Overall Study|Adverse Event|1|||
13269152|NCT01419236|26420999|FG001|Overall Study|Adverse Event|0|||
13269153|NCT01419236|26420998|FG000|Overall Study|Lack of Efficacy|0|||
13269154|NCT01419236|26420999|FG001|Overall Study|Lack of Efficacy|1|||
13269155|NCT01419236|26420998|FG000|Overall Study|Lost to Follow-up|1|||
13269156|NCT01419236|26420999|FG001|Overall Study|Lost to Follow-up|0|||
13269157|NCT01419236|26420998|FG000|Overall Study|Physician Decision|1|||
13269158|NCT01419236|26420999|FG001|Overall Study|Physician Decision|0|||
13269159|NCT01419236|26420998|FG000|Overall Study|Withdrawal by Subject|1|||
13269160|NCT01419236|26420999|FG001|Overall Study|Withdrawal by Subject|4|||
13269161|NCT01419236|26420998|FG000|Overall Study|Entry Criteria Not Met|1|||
13269162|NCT01419236|26420999|FG001|Overall Study|Entry Criteria Not Met|0|||
13269163|NCT01419197|26421029|FG000|Overall Study|Death|247|||
13269164|NCT01419197|26421030|FG001|Overall Study|Death|122|||
13269165|NCT01419197|26421029|FG000|Overall Study|Physician Decision|4|||
13269166|NCT01419197|26421030|FG001|Overall Study|Physician Decision|4|||
13269167|NCT01419197|26421029|FG000|Overall Study|Non-compliance|3|||
13269168|NCT01419197|26421030|FG001|Overall Study|Non-compliance|1|||
13269169|NCT01419197|26421029|FG000|Overall Study|Withdrawal by Subject|33|||
13269170|NCT01419197|26421030|FG001|Overall Study|Withdrawal by Subject|32|||
13269171|NCT01419197|26421029|FG000|Overall Study|Study Completed by Sponsor|103|||
13269172|NCT01419197|26421030|FG001|Overall Study|Study Completed by Sponsor|34|||
13269173|NCT01419197|26421029|FG000|Overall Study|Reason Not Specified|0|||
13269174|NCT01419197|26421030|FG001|Overall Study|Reason Not Specified|1|||
13269175|NCT01419197|26421029|FG000|Overall Study|Lost to Follow-up|14|||
13269176|NCT01419197|26421030|FG001|Overall Study|Lost to Follow-up|4|||
13269177|NCT01419184|26421053|FG000|Overall Study|Site data not available|3|||
13269178|NCT01419184|26421054|FG001|Overall Study|Site data not available|2|||
13269179|NCT01419184|26421053|FG000|Overall Study|No IRLOS-No in-patient end date reported|3|||
13269180|NCT01419184|26421054|FG001|Overall Study|No IRLOS-No in-patient end date reported|6|||
13269181|NCT01419184|26421053|FG000|Overall Study|No IRLOS-randomized, not treated|2|||
13269182|NCT01419184|26421054|FG001|Overall Study|No IRLOS-randomized, not treated|4|||
13269183|NCT01419184|26421053|FG000|Overall Study|No IRLOS-non trial antibiotic used|1|||
13269184|NCT01419184|26421054|FG001|Overall Study|No IRLOS-non trial antibiotic used|2|||
13269185|NCT01419184|26421053|FG000|Overall Study|No IRLOS-No adverse event treatment date|0|||
13269186|NCT01419184|26421054|FG001|Overall Study|No IRLOS-No adverse event treatment date|1|||
13269187|NCT01419184|26421053|FG000|Overall Study|Participant randomized, not treated|1|||
13269188|NCT01419184|26421054|FG001|Overall Study|Participant randomized, not treated|0|||
13269189|NCT01419080|26421062|FG000|Overall Study|Withdrawal by Subject|75|||
13269190|NCT01419080|26421062|FG000|Overall Study|Death|30|||
13269191|NCT01419080|26421062|FG000|Overall Study|Lost to Follow-up|23|||
13269192|NCT01419080|26421062|FG000|Overall Study|Too Ill|3|||
13269193|NCT01419015|26421068|FG000|Overall Study|Death|2|||
13269194|NCT01418937|26421077|FG000|Overall Study|Lost to Follow-up|5|||
13269195|NCT01418937|26421077|FG000|Overall Study|Protocol Violation|1|||
13269196|NCT01418937|26421077|FG000|Overall Study|Pregnancy|1|||
13269197|NCT01418937|26421077|FG000|Overall Study|Withdrawal by Subject|1|||
13269198|NCT01418378|26421156|FG000|Overall Study|Death|1|||
13269199|NCT01418378|26421157|FG001|Overall Study|Death|2|||
13269200|NCT01418378|26421156|FG000|Overall Study|Physician Decision|0|||
13269201|NCT01418378|26421157|FG001|Overall Study|Physician Decision|1|||
13269202|NCT01418378|26421156|FG000|Overall Study|ligament imbalance|0|||
13269203|NCT01418378|26421157|FG001|Overall Study|ligament imbalance|1|||
13269204|NCT01418378|26421156|FG000|Overall Study|developed chronic myopathy|0|||
13269205|NCT01418378|26421157|FG001|Overall Study|developed chronic myopathy|1|||
13269206|NCT01418365|26421172|FG000|First Intervention|Withdrawal by Subject|0|||
13269207|NCT01418365|26421173|FG001|First Intervention|Withdrawal by Subject|1|||
13269208|NCT01418365|26421172|FG000|First Intervention|Non-compliance|1|||
13269209|NCT01418365|26421173|FG001|First Intervention|Non-compliance|0|||
13269210|NCT01418365|26421172|FG000|Second Intervention|Withdrawal by Subject|0|||
13269211|NCT01418365|26421173|FG001|Second Intervention|Withdrawal by Subject|1|||
13269212|NCT01418352|26421204|FG000|Overall Study|Lost to Follow-up|2|||
13269213|NCT01418352|26421205|FG001|Overall Study|Lost to Follow-up|0|||
13269214|NCT01418352|26421206|FG002|Overall Study|Lost to Follow-up|0|||
13269215|NCT01418352|26421207|FG003|Overall Study|Lost to Follow-up|0|||
13269216|NCT01418352|26421204|FG000|Overall Study|Adverse Event|0|||
13269217|NCT01418352|26421205|FG001|Overall Study|Adverse Event|1|||
13269218|NCT01418352|26421206|FG002|Overall Study|Adverse Event|0|||
13269219|NCT01418352|26421207|FG003|Overall Study|Adverse Event|0|||
13269220|NCT01418352|26421204|FG000|Overall Study|Sponsor Discontinued Trial Site|0|||
13269221|NCT01418352|26421205|FG001|Overall Study|Sponsor Discontinued Trial Site|2|||
13269222|NCT01418352|26421206|FG002|Overall Study|Sponsor Discontinued Trial Site|2|||
13269223|NCT01418352|26421207|FG003|Overall Study|Sponsor Discontinued Trial Site|2|||
13269224|NCT01418352|26421204|FG000|Overall Study|Subject Withdrew Consent|0|||
13269225|NCT01418352|26421205|FG001|Overall Study|Subject Withdrew Consent|1|||
13269226|NCT01418352|26421206|FG002|Overall Study|Subject Withdrew Consent|2|||
13269227|NCT01418352|26421207|FG003|Overall Study|Subject Withdrew Consent|1|||
13269228|NCT01418352|26421204|FG000|Overall Study|Protocol Deviation|0|||
13269229|NCT01418352|26421205|FG001|Overall Study|Protocol Deviation|0|||
13269230|NCT01418352|26421206|FG002|Overall Study|Protocol Deviation|1|||
13269231|NCT01418352|26421207|FG003|Overall Study|Protocol Deviation|0|||
13269232|NCT01418352|26421204|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1|||
13269233|NCT01418352|26421205|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
13269234|NCT01418352|26421206|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
13269235|NCT01418352|26421207|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
13269236|NCT01418339|26421224|FG000|Overall Study|Adverse Event|5|||
13269237|NCT01418339|26421225|FG001|Overall Study|Adverse Event|2|||
13269238|NCT01418339|26421224|FG000|Overall Study|Subject Withdrew Consent|1|||
13269239|NCT01418339|26421225|FG001|Overall Study|Subject Withdrew Consent|2|||
13269240|NCT01418339|26421224|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
13269241|NCT01418339|26421225|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
13269242|NCT01418209|26421264|FG000|Overall Study|Withdrawal by Subject|1|||
13269243|NCT01418209|26421265|FG001|Overall Study|Withdrawal by Subject|0|||
13269244|NCT01418209|26421266|FG002|Overall Study|Withdrawal by Subject|1|||
13269245|NCT01418209|26421264|FG000|Overall Study|Did not provide hot flash diary data|1|||
13269246|NCT01418209|26421265|FG001|Overall Study|Did not provide hot flash diary data|3|||
13269247|NCT01418209|26421266|FG002|Overall Study|Did not provide hot flash diary data|3|||
13269248|NCT01417481|26421297|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
13269249|NCT01417481|26421298|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
13269250|NCT01417377|26421307|FG000|Overall Study|Lost to Follow-up|12|||
13269251|NCT01417377|26421307|FG000|Overall Study|Enrolled, but not treated|1|||
13269252|NCT01417234|26421316|FG000|Overall Study|Subject non-compliant|3|||
13269253|NCT01417195|26421339|FG000|Overall Study|Stimulation failure|1|||
13269254|NCT01417195|26421340|FG001|Overall Study|Stimulation failure|0|||
13269255|NCT01417195|26421339|FG000|Overall Study|No embryos for transfer|0|||
13269256|NCT01417195|26421340|FG001|Overall Study|No embryos for transfer|1|||
13269257|NCT01417195|26421339|FG000|Overall Study|No transfer due to risk of OHSS|1|||
13269258|NCT01417195|26421340|FG001|Overall Study|No transfer due to risk of OHSS|0|||
13269259|NCT01417195|26421339|FG000|Overall Study|No transfer due to elevated progesterone|1|||
13269260|NCT01417195|26421340|FG001|Overall Study|No transfer due to elevated progesterone|0|||
13269261|NCT01417156|26421350|FG000|Overall Study|Adverse Event|12|||
13269262|NCT01417156|26421350|FG000|Overall Study|Protocol Violation|2|||
13269263|NCT01417104|26421367|FG000|Overall Study|Withdrawal by Subject|5|||
13269264|NCT01417104|26421368|FG001|Overall Study|Withdrawal by Subject|1|||
13269265|NCT01417104|26421367|FG000|Overall Study|Failure to make contact|0|||
13269266|NCT01417104|26421368|FG001|Overall Study|Failure to make contact|1|||
13269267|NCT01417104|26421367|FG000|Overall Study|Adverse Event|1|||
13269268|NCT01417104|26421368|FG001|Overall Study|Adverse Event|0|||
13269269|NCT01417078|26421380|FG000|Overall Study|Withdrawal by Subject|1|||
13269270|NCT01417000|26421395|FG000|Overall Study|Death|59|||
13269271|NCT01417000|26421396|FG001|Overall Study|Death|28|||
13269272|NCT01417000|26421395|FG000|Overall Study|Lost to Follow-up|1|||
13269273|NCT01417000|26421396|FG001|Overall Study|Lost to Follow-up|0|||
13269274|NCT01417000|26421395|FG000|Overall Study|Study Terminated by Sponsor|1|||
13269275|NCT01417000|26421396|FG001|Overall Study|Study Terminated by Sponsor|1|||
13269276|NCT01416831|26421411|FG000|Cycles 1 & 2 (Weeks 1-14)|Death|1|||
13269277|NCT01416831|26421412|FG001|Cycles 1 & 2 (Weeks 1-14)|Death|2|||
13269278|NCT01416805|26421427|FG000|Overall Study|Lost to Follow-up|4|||
13269279|NCT01416805|26421428|FG001|Overall Study|Lost to Follow-up|4|||
13269280|NCT01416610|26421444|FG000|Overall Study|Adverse Event|4|||
13269281|NCT01416610|26421444|FG000|Overall Study|Adverse Event -Patient decision|3|||
13269282|NCT01416610|26421444|FG000|Overall Study|Lack of Efficacy|4|||
13269283|NCT01416610|26421444|FG000|Overall Study|No reason given|5|||
13269284|NCT01416610|26421444|FG000|Overall Study|Withdrawal by Subject|13|||
13269285|NCT01416610|26421444|FG000|Overall Study|Lost to Follow-up|7|||
13269286|NCT01416610|26421444|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7|||
13269287|NCT01416571|26421473|FG000|Overall Study|Lost to Follow-up|2|||
13269288|NCT01416441|26421499|FG000|Overall Study|Lost to Follow-up|5|||
13269289|NCT01416441|26421499|FG000|Overall Study|Adverse Event|6|||
13269290|NCT01416441|26421499|FG000|Overall Study|Sponsor Discontinued Trial Site|43|||
13269291|NCT01416441|26421499|FG000|Overall Study|Subject Met Withdrawal Criteria|10|||
13269292|NCT01416441|26421499|FG000|Overall Study|Investigator Withdrew Subject|2|||
13269293|NCT01416441|26421499|FG000|Overall Study|Subject Withdrew Consent|12|||
13269294|NCT01416441|26421499|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3|||
13269295|NCT01416389|26421523|FG000|Overall Study|Lost to Follow-up|1|||
13269296|NCT01416389|26421524|FG001|Overall Study|Lost to Follow-up|0|||
13269297|NCT01416389|26421523|FG000|Overall Study|Started New Therapy|2|||
13269298|NCT01416389|26421524|FG001|Overall Study|Started New Therapy|0|||
13269299|NCT01416272|26421532|FG000|Overall Study|Unacceptable distance visual acuity|2|||
13269300|NCT01416272|26421532|FG000|Overall Study|Lost to Follow-up|1|||
13269301|NCT01416272|26421532|FG000|Overall Study|Study related complaints|1|||
13269302|NCT01416181|26421601|FG000|Part 1|Other|10|||
13269303|NCT01416181|26421602|FG001|Part 1|Other|24|||
13269304|NCT01416181|26421601|FG000|Part 1|Death|0|||
13269305|NCT01416181|26421602|FG001|Part 1|Death|1|||
13269306|NCT01416181|26421601|FG000|Part 1|Investigator Decision|7|||
13269307|NCT01416181|26421602|FG001|Part 1|Investigator Decision|6|||
13269308|NCT01416181|26421601|FG000|Part 1|Withdrawal by Subject|74|||
13269309|NCT01416181|26421602|FG001|Part 1|Withdrawal by Subject|48|||
13269310|NCT01416181|26421601|FG000|Part 1|Lack of Efficacy|16|||
13269311|NCT01416181|26421602|FG001|Part 1|Lack of Efficacy|8|||
13269312|NCT01416181|26421601|FG000|Part 1|Lost to Follow-up|1|||
13269313|NCT01416181|26421602|FG001|Part 1|Lost to Follow-up|1|||
13269314|NCT01416181|26421601|FG000|Part 1|Adverse Event|15|||
13269315|NCT01416181|26421602|FG001|Part 1|Adverse Event|18|||
13269316|NCT01416181|26421601|FG000|Part 1|Ongoing in Follow-Up|14|||
13269317|NCT01416181|26421602|FG001|Part 1|Ongoing in Follow-Up|8|||
13269318|NCT01416181|26421601|FG000|Part 2|Adverse Event|11|||
13269319|NCT01416181|26421602|FG001|Part 2|Adverse Event|4|||
13269320|NCT01416181|26421601|FG000|Part 2|Other|234|||
13269321|NCT01416181|26421602|FG001|Part 2|Other|267|||
13269322|NCT01416181|26421601|FG000|Part 2|Investigator Decision|6|||
13269323|NCT01416181|26421602|FG001|Part 2|Investigator Decision|7|||
13269324|NCT01416181|26421601|FG000|Part 2|Withdrawal by Subject|14|||
13269325|NCT01416181|26421602|FG001|Part 2|Withdrawal by Subject|5|||
13269326|NCT01416181|26421601|FG000|Part 2|Lack of Efficacy|4|||
13269327|NCT01416181|26421602|FG001|Part 2|Lack of Efficacy|1|||
13269328|NCT01416181|26421601|FG000|Part 2|Lost to Follow-up|2|||
13269329|NCT01416181|26421602|FG001|Part 2|Lost to Follow-up|2|||
13290714|NCT00100048|26481715|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
13290715|NCT00100048|26481710|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1|||
13290716|NCT00100048|26481711|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
13290717|NCT00100048|26481712|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
13290718|NCT00100048|26481713|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5|||
13290719|NCT00100048|26481714|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0|||
13290720|NCT00100048|26481715|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4|||
13290721|NCT00100048|26481710|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7|||
13269330|NCT01416155|26421611|FG000|Overall Study|Adverse Event|8|||
13269331|NCT01416155|26421611|FG000|Overall Study|Positive for anti-BG00002 antibodies|2|||
13269332|NCT01416155|26421611|FG000|Overall Study|Withdrawal by Subject|33|||
13269333|NCT01416155|26421611|FG000|Overall Study|Investigator decision|8|||
13269334|NCT01416155|26421611|FG000|Overall Study|Other|7|||
13269335|NCT01416142|26421624|FG000|PureVision2 HD|Inability to maintain lens wear|0|||
13269336|NCT01416142|26421625|FG001|PureVision2 HD|Inability to maintain lens wear|0|||
13269337|NCT01416142|26421626|FG002|PureVision2 HD|Inability to maintain lens wear|1|||
13269338|NCT01415986|26421633|FG000|Overall Study|Lost to Follow-up|1|||
13269339|NCT01415921|26421648|FG000|Overall Study|Adverse Event|0|||
13269340|NCT01415921|26421649|FG001|Overall Study|Adverse Event|1|||
13269341|NCT01415921|26421648|FG000|Overall Study|Physician Decision|1|||
13269342|NCT01415921|26421649|FG001|Overall Study|Physician Decision|1|||
13269343|NCT01415921|26421648|FG000|Overall Study|Withdrawal by Subject|0|||
13269344|NCT01415921|26421649|FG001|Overall Study|Withdrawal by Subject|1|||
13269345|NCT01415921|26421648|FG000|Overall Study|Other|2|||
13269346|NCT01415921|26421649|FG001|Overall Study|Other|0|||
13269347|NCT01415908|26421682|FG000|Overall Study|Withdrawal by Subject|1|||
13269348|NCT01415908|26421683|FG001|Overall Study|Withdrawal by Subject|0|||
13269349|NCT01415531|26421698|FG000|Overall Study|Adverse Event|7|||
13269350|NCT01415531|26421699|FG001|Overall Study|Adverse Event|10|||
13269351|NCT01415531|26421698|FG000|Overall Study|Lack of Efficacy|3|||
13269352|NCT01415531|26421699|FG001|Overall Study|Lack of Efficacy|2|||
13269353|NCT01415531|26421698|FG000|Overall Study|Protocol Violation|0|||
13269354|NCT01415531|26421699|FG001|Overall Study|Protocol Violation|1|||
13269355|NCT01415531|26421698|FG000|Overall Study|Withdrawal by Subject|5|||
13269356|NCT01415531|26421699|FG001|Overall Study|Withdrawal by Subject|4|||
13269357|NCT01415531|26421698|FG000|Overall Study|Lost to Follow-up|6|||
13269358|NCT01415531|26421699|FG001|Overall Study|Lost to Follow-up|14|||
13269359|NCT01415531|26421698|FG000|Overall Study|Lack of Compliance|1|||
13269360|NCT01415531|26421699|FG001|Overall Study|Lack of Compliance|4|||
13269361|NCT01415531|26421698|FG000|Overall Study|Other Reasons|3|||
13269362|NCT01415531|26421699|FG001|Overall Study|Other Reasons|2|||
13269363|NCT01415518|26421758|FG000|Overall Study|Withdrawal by Subject|2|||
13269364|NCT01415518|26421759|FG001|Overall Study|Withdrawal by Subject|12|||
13269365|NCT01415518|26421758|FG000|Overall Study|Protocol Violation|6|||
13269366|NCT01415518|26421759|FG001|Overall Study|Protocol Violation|8|||
13269367|NCT01415518|26421758|FG000|Overall Study|Lost to Follow-up|3|||
13269368|NCT01415518|26421759|FG001|Overall Study|Lost to Follow-up|5|||
13269369|NCT01415518|26421758|FG000|Overall Study|Adverse Event|3|||
13269370|NCT01415518|26421759|FG001|Overall Study|Adverse Event|4|||
13269371|NCT01415518|26421758|FG000|Overall Study|Death|1|||
13269372|NCT01415518|26421759|FG001|Overall Study|Death|1|||
13269373|NCT01415518|26421758|FG000|Overall Study|Condition under Investigation Worsened|1|||
13269374|NCT01415518|26421759|FG001|Overall Study|Condition under Investigation Worsened|1|||
13269375|NCT01415440|26421776|FG000|Overall Study|Lost to Follow-up|0|||
13269376|NCT01415440|26421777|FG001|Overall Study|Lost to Follow-up|1|||
13269377|NCT01415440|26421778|FG002|Overall Study|Lost to Follow-up|2|||
13269378|NCT01415440|26421776|FG000|Overall Study|Physician Decision|3|||
13269379|NCT01415440|26421777|FG001|Overall Study|Physician Decision|0|||
13269380|NCT01415440|26421778|FG002|Overall Study|Physician Decision|0|||
13269381|NCT01415440|26421776|FG000|Overall Study|Withdrawal by Subject|1|||
13269382|NCT01415440|26421777|FG001|Overall Study|Withdrawal by Subject|0|||
13269383|NCT01415440|26421778|FG002|Overall Study|Withdrawal by Subject|0|||
13269384|NCT01415401|26421785|FG000|Overall Study|Adverse Event|5|||
13269385|NCT01415401|26421785|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1|||
13269386|NCT01415401|26421785|FG000|Overall Study|Terminated by Sponsor|1|||
13269387|NCT01415349|26421796|FG000|Treatment Period 1|Adverse Event|0|||
13269388|NCT01415349|26421797|FG001|Treatment Period 1|Adverse Event|1|||
13269389|NCT01415349|26421796|FG000|Treatment Period 1|Withdrawal by Subject|0|||
13269390|NCT01415349|26421797|FG001|Treatment Period 1|Withdrawal by Subject|1|||
13269391|NCT01414855|26421815|FG000|Overall Study|Death|17|||
13269392|NCT01414855|26421815|FG000|Overall Study|Lost to Follow-up|5|||
13269393|NCT01414855|26421815|FG000|Overall Study|Withdrawal by Subject|7|||
13269394|NCT01414738|26421838|FG000|Overall Study|Death|26|||
13269395|NCT01414738|26421838|FG000|Overall Study|Refused testing|5|||
13269396|NCT01414738|26421838|FG000|Overall Study|Lost to Follow-up|2|||
13269397|NCT01414738|26421838|FG000|Overall Study|Refused, disease progression|8|||
13269398|NCT01414738|26421838|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3|||
13269399|NCT01414257|26421851|FG000|Overall Study|No Visit After First Day of Treatment|12|||
13269400|NCT01414257|26421851|FG000|Overall Study|Protocol Violation|10|||
13269401|NCT01414205|26421890|FG000|Overall Study|Death|5|||
13269402|NCT01414205|26421891|FG001|Overall Study|Death|1|||
13269403|NCT01414205|26421890|FG000|Overall Study|Lost to Follow-up|1|||
13269404|NCT01414205|26421891|FG001|Overall Study|Lost to Follow-up|4|||
13269405|NCT01414205|26421890|FG000|Overall Study|Physician Decision|0|||
13269406|NCT01414205|26421891|FG001|Overall Study|Physician Decision|1|||
13269407|NCT01414205|26421890|FG000|Overall Study|Randomized but not Treated|1|||
13269408|NCT01414205|26421891|FG001|Overall Study|Randomized but not Treated|1|||
13269409|NCT01414166|26421920|FG000|Overall Study|Adverse Event|10|||
13269410|NCT01414166|26421921|FG001|Overall Study|Adverse Event|2|||
13269411|NCT01414166|26421920|FG000|Overall Study|Lost to Follow-up|4|||
13269412|NCT01414166|26421921|FG001|Overall Study|Lost to Follow-up|1|||
13269413|NCT01414166|26421920|FG000|Overall Study|Non-compliance with study drug|2|||
13269414|NCT01414166|26421921|FG001|Overall Study|Non-compliance with study drug|0|||
13269415|NCT01414166|26421920|FG000|Overall Study|Physician Decision|2|||
13269416|NCT01414166|26421921|FG001|Overall Study|Physician Decision|0|||
13269417|NCT01414166|26421920|FG000|Overall Study|Protocol Violation|2|||
13269418|NCT01414166|26421921|FG001|Overall Study|Protocol Violation|0|||
13269419|NCT01414166|26421920|FG000|Overall Study|Study terminated by Sponsor|68|||
13269420|NCT01414166|26421921|FG001|Overall Study|Study terminated by Sponsor|75|||
13269421|NCT01414166|26421920|FG000|Overall Study|Withdrawal by Subject|3|||
13269422|NCT01414166|26421921|FG001|Overall Study|Withdrawal by Subject|5|||
13269423|NCT01414114|26421941|FG000|Overall Study|Adverse Event|2|||
13269424|NCT01414114|26421941|FG000|Overall Study|Withdrawal by Subject|1|||
13269425|NCT01414114|26421941|FG000|Overall Study|Other|2|||
13269426|NCT01414075|26422064|FG000|Overall Study|Adverse Event|1|||
13269427|NCT01414075|26422065|FG001|Overall Study|Adverse Event|0|||
13269428|NCT01414075|26422066|FG002|Overall Study|Adverse Event|1|||
13269429|NCT01414075|26422067|FG003|Overall Study|Adverse Event|0|||
13269430|NCT01414075|26422064|FG000|Overall Study|Death|1|||
13269431|NCT01414075|26422065|FG001|Overall Study|Death|0|||
13269432|NCT01414075|26422066|FG002|Overall Study|Death|0|||
13269433|NCT01414075|26422067|FG003|Overall Study|Death|1|||
13269434|NCT01414075|26422064|FG000|Overall Study|Withdrawal by Subject|0|||
13269435|NCT01414075|26422065|FG001|Overall Study|Withdrawal by Subject|0|||
13269436|NCT01414075|26422066|FG002|Overall Study|Withdrawal by Subject|0|||
13269437|NCT01414075|26422067|FG003|Overall Study|Withdrawal by Subject|1|||
13269438|NCT01414075|26422064|FG000|Overall Study|Other than specified|1|||
13269439|NCT01414075|26422065|FG001|Overall Study|Other than specified|0|||
13269440|NCT01414075|26422066|FG002|Overall Study|Other than specified|1|||
13269441|NCT01414075|26422067|FG003|Overall Study|Other than specified|0|||
13269442|NCT01413958|26422105|FG000|Overall Study|Lost to Follow-up|0|||
13269443|NCT01413958|26422106|FG001|Overall Study|Lost to Follow-up|1|||
13269444|NCT01413542|26422128|FG000|Overall Study|Physician Decision|1|||
13269445|NCT01413542|26422129|FG001|Overall Study|Physician Decision|0|||
13269446|NCT01413542|26422130|FG002|Overall Study|Physician Decision|3|||
13269447|NCT01413542|26422131|FG003|Overall Study|Physician Decision|0|||
13269448|NCT01413542|26422128|FG000|Overall Study|Adverse Event|0|||
13269449|NCT01413542|26422129|FG001|Overall Study|Adverse Event|0|||
13269450|NCT01413542|26422130|FG002|Overall Study|Adverse Event|0|||
13269451|NCT01413542|26422131|FG003|Overall Study|Adverse Event|1|||
13269452|NCT01413503|26422137|FG000|Overall Study|Lost to Follow-up|1|||
13269453|NCT01413360|26422144|FG000|Overall Study|Lost to Follow-up|2|||
13269454|NCT01413360|26422144|FG000|Overall Study|Adverse Event|1|||
13269455|NCT01413204|26422162|FG000|Overall Study|Adverse Event|1|||
13269456|NCT01413204|26422163|FG001|Overall Study|Adverse Event|2|||
13269457|NCT01413204|26422164|FG002|Overall Study|Adverse Event|2|||
13269458|NCT01413204|26422162|FG000|Overall Study|Physician Decision|3|||
13269459|NCT01413204|26422163|FG001|Overall Study|Physician Decision|0|||
13269460|NCT01413204|26422164|FG002|Overall Study|Physician Decision|2|||
13269461|NCT01413204|26422162|FG000|Overall Study|Withdrawal by Subject|1|||
13269462|NCT01413204|26422163|FG001|Overall Study|Withdrawal by Subject|4|||
13269463|NCT01413204|26422164|FG002|Overall Study|Withdrawal by Subject|4|||
13269464|NCT01413204|26422162|FG000|Overall Study|Clearly not eligible for the study|0|||
13269465|NCT01413204|26422163|FG001|Overall Study|Clearly not eligible for the study|0|||
13269466|NCT01413204|26422164|FG002|Overall Study|Clearly not eligible for the study|1|||
13269467|NCT01413204|26422162|FG000|Overall Study|Fasting plasma glucose level increased|1|||
13269468|NCT01413204|26422163|FG001|Overall Study|Fasting plasma glucose level increased|0|||
13269469|NCT01413204|26422164|FG002|Overall Study|Fasting plasma glucose level increased|10|||
13269470|NCT01413191|26422176|FG000|Overall Study|Lost to Follow-up|5|||
13269471|NCT01413191|26422176|FG000|Overall Study|Disease Progression|5|||
13269472|NCT01413191|26422176|FG000|Overall Study|Death|1|||
13269473|NCT01413178|26422197|FG000|Overall Study|Toxicity|1|||
13269474|NCT01413178|26422198|FG001|Overall Study|Toxicity|0|||
13269475|NCT01413178|26422197|FG000|Overall Study|Ineligible|0|||
13269476|NCT01413178|26422198|FG001|Overall Study|Ineligible|2|||
13269477|NCT01412983|26422209|FG000|1st Period|Ineligible|0|||
13269478|NCT01412983|26422210|FG001|1st Period|Ineligible|1|||
13269479|NCT01412983|26422209|FG000|1st Period|Positive slit lamp finding|0|||
13269480|NCT01412983|26422210|FG001|1st Period|Positive slit lamp finding|1|||
13269481|NCT01412983|26422209|FG000|1st Period|Unacceptable lens movement|0|||
13269482|NCT01412983|26422210|FG001|1st Period|Unacceptable lens movement|1|||
13269483|NCT01412983|26422209|FG000|1st Period|Inability to maintain wear|0|||
13269484|NCT01412983|26422210|FG001|1st Period|Inability to maintain wear|1|||
13269485|NCT01412957|26422237|FG000|Overall Study|Withdrawal by Subject|6|||
13269486|NCT01412957|26422238|FG001|Overall Study|Withdrawal by Subject|22|||
13269487|NCT01412957|26422237|FG000|Overall Study|Lost to Follow-up|7|||
13269488|NCT01412957|26422238|FG001|Overall Study|Lost to Follow-up|2|||
13269489|NCT01412957|26422237|FG000|Overall Study|Death|136|||
13269490|NCT01412957|26422238|FG001|Overall Study|Death|133|||
13269491|NCT01412944|26422283|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
13269492|NCT01412944|26422284|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
13269493|NCT01412944|26422285|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1|||
13269494|NCT01412944|26422286|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
13269495|NCT01412944|26422287|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
13269496|NCT01412944|26422288|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
13269497|NCT01412944|26422283|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
13269498|NCT01412944|26422284|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
13269499|NCT01412944|26422285|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
13269500|NCT01412944|26422286|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
13269501|NCT01412944|26422287|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
13269502|NCT01412944|26422288|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1|||
13269503|NCT01412944|26422283|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
13269504|NCT01412944|26422284|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
13269505|NCT01412944|26422285|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
13269506|NCT01412944|26422286|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
13269507|NCT01412944|26422287|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
13269508|NCT01412944|26422288|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1|||
13269509|NCT01412944|26422283|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1|||
13269510|NCT01412944|26422284|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
13269511|NCT01412944|26422285|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
13269512|NCT01412944|26422286|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
13269513|NCT01412944|26422287|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
13269514|NCT01412944|26422288|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
13269515|NCT01412944|26422283|FG000|IV: Per CAIN457A2307|Protocol deviation|0|||
13269516|NCT01412944|26422284|FG001|IV: Per CAIN457A2307|Protocol deviation|1|||
13269517|NCT01412944|26422285|FG002|IV: Per CAIN457A2307|Protocol deviation|0|||
13269518|NCT01412944|26422286|FG003|IV: Per CAIN457A2307|Protocol deviation|0|||
13269519|NCT01412944|26422287|FG004|IV: Per CAIN457A2307|Protocol deviation|0|||
13269520|NCT01412944|26422288|FG005|IV: Per CAIN457A2307|Protocol deviation|0|||
13269521|NCT01412944|26422283|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0|||
13269522|NCT01412944|26422284|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1|||
13269523|NCT01412944|26422285|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0|||
13269524|NCT01412944|26422286|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0|||
13269525|NCT01412944|26422287|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0|||
13203588|NCT01984684|26224961|FG000|Overall Study|Withdrawal by Subject|9|||
13203589|NCT01984684|26224962|FG001|Overall Study|Withdrawal by Subject|9|||
13203590|NCT01984684|26224961|FG000|Overall Study|Lack of Efficacy|3|||
13203591|NCT01984684|26224962|FG001|Overall Study|Lack of Efficacy|6|||
13203592|NCT01984684|26224961|FG000|Overall Study|Physician Decision|4|||
13203593|NCT01984684|26224962|FG001|Overall Study|Physician Decision|2|||
13203594|NCT01984684|26224961|FG000|Overall Study|Protocol Violation|4|||
13203595|NCT01984684|26224962|FG001|Overall Study|Protocol Violation|2|||
13203596|NCT01984684|26224961|FG000|Overall Study|Death|0|||
13203597|NCT01984684|26224962|FG001|Overall Study|Death|1|||
13203598|NCT01984684|26224961|FG000|Overall Study|Noncompliance with study drug|2|||
13203599|NCT01984684|26224962|FG001|Overall Study|Noncompliance with study drug|1|||
13203600|NCT01984684|26224961|FG000|Overall Study|Subject incarcerated|1|||
13203601|NCT01984684|26224962|FG001|Overall Study|Subject incarcerated|0|||
13203602|NCT01984684|26224961|FG000|Overall Study|Study drug not available at site|1|||
13269526|NCT01412944|26422288|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0|||
13269527|NCT01412944|26422283|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0|||
13269528|NCT01412944|26422284|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0|||
13269529|NCT01412944|26422285|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1|||
13269530|NCT01412944|26422286|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1|||
13269531|NCT01412944|26422287|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1|||
13269532|NCT01412944|26422288|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
13269533|NCT01412944|26422283|FG000|Entire: IV + Maintenance|Adverse Event|0|||
13269534|NCT01412944|26422284|FG001|Entire: IV + Maintenance|Adverse Event|0|||
13269535|NCT01412944|26422285|FG002|Entire: IV + Maintenance|Adverse Event|0|||
13269536|NCT01412944|26422286|FG003|Entire: IV + Maintenance|Adverse Event|0|||
13269537|NCT01412944|26422287|FG004|Entire: IV + Maintenance|Adverse Event|1|||
13269538|NCT01412944|26422288|FG005|Entire: IV + Maintenance|Adverse Event|0|||
13269539|NCT01412944|26422283|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
13269540|NCT01412944|26422284|FG001|Entire: IV + Maintenance|Protocol deviation|0|||
13269541|NCT01412944|26422285|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
13269542|NCT01412944|26422286|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
13269543|NCT01412944|26422287|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
13269544|NCT01412944|26422288|FG005|Entire: IV + Maintenance|Protocol deviation|1|||
13269545|NCT01412944|26422283|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
13269546|NCT01412944|26422284|FG001|Entire: IV + Maintenance|Lost to Follow-up|0|||
13269547|NCT01412944|26422285|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
13269548|NCT01412944|26422286|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
13269549|NCT01412944|26422287|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
13269550|NCT01412944|26422288|FG005|Entire: IV + Maintenance|Lost to Follow-up|1|||
13269551|NCT01412944|26422283|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
13269552|NCT01412944|26422284|FG001|Entire: IV + Maintenance|Lack of Efficacy|0|||
13269553|NCT01412944|26422285|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
13269554|NCT01412944|26422286|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
13269555|NCT01412944|26422287|FG004|Entire: IV + Maintenance|Lack of Efficacy|1|||
13269556|NCT01412944|26422288|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
13269557|NCT01412944|26422283|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2|||
13269558|NCT01412944|26422284|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1|||
13269559|NCT01412944|26422285|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0|||
13269560|NCT01412944|26422286|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0|||
13269561|NCT01412944|26422287|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0|||
13269562|NCT01412944|26422288|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
13269563|NCT01412944|26422283|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
13269564|NCT01412944|26422284|FG001|Entire: IV + Maintenance|Protocol deviation|1|||
13269565|NCT01412944|26422285|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
13269566|NCT01412944|26422286|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
13269567|NCT01412944|26422287|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
13269568|NCT01412944|26422288|FG005|Entire: IV + Maintenance|Protocol deviation|0|||
13269569|NCT01412944|26422283|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
13269570|NCT01412944|26422284|FG001|Entire: IV + Maintenance|Lost to Follow-up|1|||
13269571|NCT01412944|26422285|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
13269572|NCT01412944|26422286|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
13269573|NCT01412944|26422287|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
13269574|NCT01412944|26422288|FG005|Entire: IV + Maintenance|Lost to Follow-up|0|||
13269575|NCT01412944|26422283|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
13269576|NCT01412944|26422284|FG001|Entire: IV + Maintenance|Lack of Efficacy|1|||
13269577|NCT01412944|26422285|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
13269578|NCT01412944|26422286|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
13269579|NCT01412944|26422287|FG004|Entire: IV + Maintenance|Lack of Efficacy|0|||
13269580|NCT01412944|26422288|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
13269581|NCT01412944|26422283|FG000|Entire: IV + Maintenance|Adverse Event|0|||
13269582|NCT01412944|26422284|FG001|Entire: IV + Maintenance|Adverse Event|1|||
13269583|NCT01412944|26422285|FG002|Entire: IV + Maintenance|Adverse Event|0|||
13269584|NCT01412944|26422286|FG003|Entire: IV + Maintenance|Adverse Event|0|||
13269585|NCT01412944|26422287|FG004|Entire: IV + Maintenance|Adverse Event|0|||
13269586|NCT01412944|26422288|FG005|Entire: IV + Maintenance|Adverse Event|0|||
13269587|NCT01412879|26422310|FG000|Initial Registration (Induction Therapy)|Adverse Event|5|||
13269588|NCT01412879|26422311|FG001|Initial Registration (Induction Therapy)|Adverse Event|3|||
13269589|NCT01412879|26422312|FG002|Initial Registration (Induction Therapy)|Adverse Event|0|||
13269590|NCT01412879|26422310|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1|||
13269591|NCT01412879|26422311|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3|||
13269592|NCT01412879|26422312|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0|||
13269593|NCT01412879|26422310|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
13269594|NCT01412879|26422311|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1|||
13269595|NCT01412879|26422312|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
13269596|NCT01412879|26422310|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6|||
13269597|NCT01412879|26422311|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1|||
13269598|NCT01412879|26422312|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0|||
13269599|NCT01412879|26422310|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1|||
13269600|NCT01412879|26422311|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0|||
13269601|NCT01412879|26422312|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0|||
13269602|NCT01412801|26422368|FG000|Overall Study|Death|0|||
13269603|NCT01412801|26422369|FG001|Overall Study|Death|1|||
13269604|NCT01412801|26422370|FG002|Overall Study|Death|0|||
13269605|NCT01412801|26422371|FG003|Overall Study|Death|4|||
13269606|NCT01412801|26422372|FG004|Overall Study|Death|2|||
13269607|NCT01412801|26422373|FG005|Overall Study|Death|2|||
13269608|NCT01412801|26422368|FG000|Overall Study|Lost to Follow-up|1|||
13269609|NCT01412801|26422369|FG001|Overall Study|Lost to Follow-up|2|||
13269610|NCT01412801|26422370|FG002|Overall Study|Lost to Follow-up|4|||
13269611|NCT01412801|26422371|FG003|Overall Study|Lost to Follow-up|0|||
13269612|NCT01412801|26422372|FG004|Overall Study|Lost to Follow-up|1|||
13269613|NCT01412801|26422373|FG005|Overall Study|Lost to Follow-up|1|||
13269614|NCT01412801|26422368|FG000|Overall Study|Withdrawal by Subject|3|||
13269615|NCT01412801|26422369|FG001|Overall Study|Withdrawal by Subject|2|||
13269616|NCT01412801|26422370|FG002|Overall Study|Withdrawal by Subject|1|||
13269617|NCT01412801|26422371|FG003|Overall Study|Withdrawal by Subject|0|||
13269618|NCT01412801|26422372|FG004|Overall Study|Withdrawal by Subject|0|||
13269619|NCT01412801|26422373|FG005|Overall Study|Withdrawal by Subject|0|||
13269620|NCT01412801|26422368|FG000|Overall Study|Relocated to another area|0|||
13269621|NCT01412801|26422369|FG001|Overall Study|Relocated to another area|0|||
13269622|NCT01412801|26422370|FG002|Overall Study|Relocated to another area|2|||
13269623|NCT01412801|26422371|FG003|Overall Study|Relocated to another area|0|||
13269624|NCT01412801|26422372|FG004|Overall Study|Relocated to another area|0|||
13269625|NCT01412801|26422373|FG005|Overall Study|Relocated to another area|0|||
13269626|NCT01412424|26422391|FG000|Core Treatment Period|Treatment Failure|24|||
13269627|NCT01412424|26422391|FG000|Core Treatment Period|Adverse Event|21|||
13269628|NCT01412424|26422391|FG000|Core Treatment Period|Patient Request|5|||
13269629|NCT01412424|26422391|FG000|Core Treatment Period|Lost to Follow-up|2|||
13269630|NCT01412424|26422391|FG000|Core Treatment Period|Sponsor Request|1|||
13269631|NCT01412424|26422391|FG000|Extension Treatment Period|Adverse Event|2|||
13269632|NCT01412424|26422391|FG000|Extension Treatment Period|Treatment Failure|2|||
13269633|NCT01412424|26422391|FG000|Extension Treatment Period|Patient Request|2|||
13269634|NCT01412229|26422405|FG000|Overall Study|Physician Decision|1|||
13269635|NCT01412151|26422413|FG000|Week 0 - 306 - Treatment Period|Death|1|||
13269636|NCT01412151|26422413|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1|||
13269637|NCT01412151|26422413|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3|||
13269638|NCT01412151|26422413|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2|||
13269639|NCT01412060|26422427|FG000|Open-label Run-in Period (RIP)|Adverse Event|86|||
13269640|NCT01412060|26422428|FG001|Open-label Run-in Period (RIP)|Adverse Event|0|||
13269641|NCT01412060|26422429|FG002|Open-label Run-in Period (RIP)|Adverse Event|0|||
13269642|NCT01412060|26422427|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66|||
13269643|NCT01412060|26422428|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
13269644|NCT01412060|26422429|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
13269645|NCT01412060|26422427|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27|||
13269646|NCT01412060|26422428|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0|||
13269647|NCT01412060|26422429|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0|||
13269648|NCT01412060|26422427|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117|||
13269649|NCT01412060|26422428|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
13269650|NCT01412060|26422429|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
13269651|NCT01412060|26422427|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32|||
13269652|NCT01412060|26422428|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
13269653|NCT01412060|26422429|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
13269654|NCT01412060|26422427|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19|||
13269655|NCT01412060|26422428|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
13269656|NCT01412060|26422429|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
13269657|NCT01412060|26422427|FG000|Period Between RIP and SP|Adverse Event|4|||
13269658|NCT01412060|26422428|FG001|Period Between RIP and SP|Adverse Event|0|||
13269659|NCT01412060|26422429|FG002|Period Between RIP and SP|Adverse Event|0|||
13269660|NCT01412060|26422427|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19|||
13269661|NCT01412060|26422428|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
13269662|NCT01412060|26422429|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
13269663|NCT01412060|26422427|FG000|Period Between RIP and SP|Protocol Violation|2|||
13269664|NCT01412060|26422428|FG001|Period Between RIP and SP|Protocol Violation|0|||
13269665|NCT01412060|26422429|FG002|Period Between RIP and SP|Protocol Violation|0|||
13269666|NCT01412060|26422427|FG000|Period Between RIP and SP|Withdrawal of Consent|1|||
13269667|NCT01412060|26422428|FG001|Period Between RIP and SP|Withdrawal of Consent|0|||
13269668|NCT01412060|26422429|FG002|Period Between RIP and SP|Withdrawal of Consent|0|||
13269669|NCT01412060|26422427|FG000|Period Between RIP and SP|Lost to Follow-up|5|||
13269670|NCT01412060|26422428|FG001|Period Between RIP and SP|Lost to Follow-up|0|||
13269671|NCT01412060|26422429|FG002|Period Between RIP and SP|Lost to Follow-up|0|||
13269672|NCT01412060|26422427|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23|||
13269673|NCT01412060|26422428|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
13269674|NCT01412060|26422429|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
13269675|NCT01412060|26422427|FG000|Open-label Stabilization Period (SP)|Adverse Event|9|||
13269676|NCT01412060|26422428|FG001|Open-label Stabilization Period (SP)|Adverse Event|0|||
13269677|NCT01412060|26422429|FG002|Open-label Stabilization Period (SP)|Adverse Event|0|||
13269678|NCT01412060|26422427|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9|||
13269679|NCT01412060|26422428|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
13269680|NCT01412060|26422429|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
13269681|NCT01412060|26422427|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14|||
13269682|NCT01412060|26422428|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0|||
13269683|NCT01412060|26422429|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0|||
13269684|NCT01412060|26422427|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40|||
13269685|NCT01412060|26422428|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
13269686|NCT01412060|26422429|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
13269687|NCT01412060|26422427|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9|||
13269688|NCT01412060|26422428|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
13269689|NCT01412060|26422429|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
13269690|NCT01412060|26422427|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19|||
13269691|NCT01412060|26422428|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
13269692|NCT01412060|26422429|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
13269693|NCT01412060|26422427|FG000|Period Between SP and DBP|Protocol Violation|2|||
13269694|NCT01412060|26422428|FG001|Period Between SP and DBP|Protocol Violation|0|||
13269695|NCT01412060|26422429|FG002|Period Between SP and DBP|Protocol Violation|0|||
13269696|NCT01412060|26422427|FG000|Period Between SP and DBP|Withdrawal of Consent|2|||
13269697|NCT01412060|26422428|FG001|Period Between SP and DBP|Withdrawal of Consent|0|||
13269698|NCT01412060|26422429|FG002|Period Between SP and DBP|Withdrawal of Consent|0|||
13269699|NCT01412060|26422427|FG000|Period Between SP and DBP|Lost to Follow-up|1|||
13269700|NCT01412060|26422428|FG001|Period Between SP and DBP|Lost to Follow-up|0|||
13269701|NCT01412060|26422429|FG002|Period Between SP and DBP|Lost to Follow-up|0|||
13269702|NCT01412060|26422427|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4|||
13269703|NCT01412060|26422428|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
13269704|NCT01412060|26422429|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
13269705|NCT01412060|26422427|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55|||
13269706|NCT01412060|26422428|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
13269707|NCT01412060|26422429|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
13269708|NCT01412060|26422427|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0|||
13269709|NCT01412060|26422428|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5|||
13269710|NCT01412060|26422429|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6|||
13269711|NCT01412060|26422427|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0|||
13269712|NCT01412060|26422428|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4|||
13269713|NCT01412060|26422429|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5|||
13269714|NCT01412060|26422427|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0|||
13269715|NCT01412060|26422428|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10|||
13269716|NCT01412060|26422429|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15|||
13269717|NCT01412060|26422427|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0|||
13269718|NCT01412060|26422428|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6|||
13269719|NCT01412060|26422429|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5|||
13269720|NCT01412060|26422427|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0|||
13269721|NCT01412060|26422428|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11|||
13269722|NCT01412060|26422429|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27|||
13269723|NCT01412060|26422427|FG000|Double-blind Treatment Phase (DBP)|Relapse|0|||
13269724|NCT01412060|26422428|FG001|Double-blind Treatment Phase (DBP)|Relapse|47|||
13269725|NCT01412060|26422429|FG002|Double-blind Treatment Phase (DBP)|Relapse|25|||
13269726|NCT01412021|26422466|FG000|Overall Study|Case Report Forms Not Retrieved|7|||
13269727|NCT01412021|26422466|FG000|Overall Study|Treatment Prior to Approval|3|||
13269728|NCT01412021|26422466|FG000|Overall Study|Transferred to Other Hospital|9|||
13269729|NCT01411995|26422479|FG000|Overall Study|Failed IUD insertion|0|||
13269730|NCT01411995|26422480|FG001|Overall Study|Failed IUD insertion|1|||
13269731|NCT01411917|26422507|FG000|Overall Study|Patient did not undergo scheduled surger|0|||
13269732|NCT01411917|26422508|FG001|Overall Study|Patient did not undergo scheduled surger|1|||
13269733|NCT01411891|26422523|FG000|Overall Study|Catheter dislodgement or loss to follow-|3|||
13269734|NCT01411891|26422524|FG001|Overall Study|Catheter dislodgement or loss to follow-|2|||
13269735|NCT01411852|26422574|FG000|Prehospital Intervention Phase|No qualifying SBP|5|||
13269736|NCT01411852|26422575|FG001|Prehospital Intervention Phase|No qualifying SBP|4|||
13269737|NCT01411852|26422574|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
13269738|NCT01411852|26422575|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
13269739|NCT01411852|26422574|FG000|Prehospital Intervention Phase|Found to be under age|0|||
13269740|NCT01411852|26422575|FG001|Prehospital Intervention Phase|Found to be under age|1|||
13269741|NCT01411852|26422574|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5|||
13269742|NCT01411852|26422575|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0|||
13269743|NCT01411852|26422574|FG000|Hospital Intervention Phase|Severe head injury|5|||
13269744|NCT01411852|26422575|FG001|Hospital Intervention Phase|Severe head injury|4|||
13269745|NCT01411852|26422574|FG000|Hospital Intervention Phase|No qualifying SBP|5|||
13269746|NCT01411852|26422575|FG001|Hospital Intervention Phase|No qualifying SBP|1|||
13269747|NCT01411852|26422574|FG000|Hospital Intervention Phase|Miscommunication error|1|||
13269748|NCT01411852|26422575|FG001|Hospital Intervention Phase|Miscommunication error|2|||
13269749|NCT01411852|26422574|FG000|Hospital Intervention Phase|CPR administered|3|||
13269750|NCT01411852|26422575|FG001|Hospital Intervention Phase|CPR administered|1|||
13269751|NCT01411852|26422574|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4|||
13269752|NCT01411852|26422575|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1|||
13269753|NCT01411852|26422574|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0|||
13269754|NCT01411852|26422575|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2|||
13269755|NCT01411852|26422574|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0|||
13269756|NCT01411852|26422575|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1|||
13118037|NCT03047720|25927626|FG000|First Intervention (6weeks)|Participant data entry insufficient|7|||
13118038|NCT03047720|25927627|FG001|First Intervention (6weeks)|Participant data entry insufficient|0|||
13118039|NCT03047551|25927642|FG000|Overall Study|Did not receive TAS|1|||
13269757|NCT01411852|26422574|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0|||
13269758|NCT01411852|26422575|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4|||
13269759|NCT01411852|26422574|FG000|Hospital Intervention Phase|Other ineligible|2|||
13269760|NCT01411852|26422575|FG001|Hospital Intervention Phase|Other ineligible|2|||
13269761|NCT01411852|26422574|FG000|Hospital Intervention Phase|Spinal cord injury|2|||
13269762|NCT01411852|26422575|FG001|Hospital Intervention Phase|Spinal cord injury|0|||
13269763|NCT01411852|26422574|FG000|Hospital Intervention Phase|Withdrawal by Subject|1|||
13269764|NCT01411852|26422575|FG001|Hospital Intervention Phase|Withdrawal by Subject|0|||
13269765|NCT01411852|26422574|FG000|Hospital Intervention Phase|Vascular access failed|1|||
13269766|NCT01411852|26422575|FG001|Hospital Intervention Phase|Vascular access failed|0|||
13269767|NCT01411839|26422592|FG000|Overall Study|Lost to Follow-up|4|||
13269768|NCT01411839|26422593|FG001|Overall Study|Lost to Follow-up|3|||
13269769|NCT01411774|26422608|FG000|Overall Study|Withdrawal by Subject|0|||
13269770|NCT01411774|26422609|FG001|Overall Study|Withdrawal by Subject|3|||
13269771|NCT01411319|26422622|FG000|Overall Study|Lost to Follow-up|1|||
13269772|NCT01411228|26422652|FG000|Overall Study|Lost to Follow-up|0|||
13269773|NCT01411228|26422653|FG001|Overall Study|Lost to Follow-up|0|||
13269774|NCT01411228|26422654|FG002|Overall Study|Lost to Follow-up|1|||
13269775|NCT01411228|26422652|FG000|Overall Study|Withdrawal by Subject|1|||
13269776|NCT01411228|26422653|FG001|Overall Study|Withdrawal by Subject|0|||
13269777|NCT01411228|26422654|FG002|Overall Study|Withdrawal by Subject|0|||
13269778|NCT01411215|26422694|FG000|Overall Study|Adverse Event|1|||
13269779|NCT01411215|26422695|FG001|Overall Study|Adverse Event|2|||
13269780|NCT01411215|26422694|FG000|Overall Study|Lack of Efficacy|2|||
13269781|NCT01411215|26422695|FG001|Overall Study|Lack of Efficacy|4|||
13269782|NCT01411215|26422694|FG000|Overall Study|Lost to Follow-up|12|||
13269783|NCT01411215|26422695|FG001|Overall Study|Lost to Follow-up|18|||
13269784|NCT01411215|26422694|FG000|Overall Study|Did not meet entrance criteria|0|||
13269785|NCT01411215|26422695|FG001|Overall Study|Did not meet entrance criteria|1|||
13269786|NCT01411215|26422694|FG000|Overall Study|Study terminated by sponsor|2|||
13269787|NCT01411215|26422695|FG001|Overall Study|Study terminated by sponsor|15|||
13269788|NCT01411215|26422694|FG000|Overall Study|Protocol Violation|3|||
13269789|NCT01411215|26422695|FG001|Overall Study|Protocol Violation|5|||
13269790|NCT01411215|26422694|FG000|Overall Study|Withdrawal by Subject|34|||
13269791|NCT01411215|26422695|FG001|Overall Study|Withdrawal by Subject|21|||
13269792|NCT01411215|26422694|FG000|Overall Study|Other|12|||
13269793|NCT01411215|26422695|FG001|Overall Study|Other|17|||
13269794|NCT01411215|26422694|FG000|Overall Study|Screen failure|0|||
13269795|NCT01411215|26422695|FG001|Overall Study|Screen failure|1|||
13269796|NCT01411085|26422701|FG000|Overall Study|Physician Decision|1|||
13269797|NCT01411085|26422701|FG000|Overall Study|Protocol Violation|1|||
13269798|NCT01411085|26422701|FG000|Overall Study|Adverse Event|1|||
13269799|NCT01410890|26422740|FG000|Overall Study|Withdrawal by Subject|0|||
13269800|NCT01410890|26422741|FG001|Overall Study|Withdrawal by Subject|1|||
13269801|NCT01410799|26422752|FG000|Overall Study|PI decision|13|||
13269802|NCT01410604|26422779|FG000|Overall Study|Adverse Event|2|||
13269803|NCT01410604|26422780|FG001|Overall Study|Adverse Event|1|||
13269804|NCT01410604|26422779|FG000|Overall Study|Lost to Follow-up|1|||
13269805|NCT01410604|26422780|FG001|Overall Study|Lost to Follow-up|0|||
13269806|NCT01410604|26422779|FG000|Overall Study|Physician Decision|0|||
13269807|NCT01410604|26422780|FG001|Overall Study|Physician Decision|1|||
13269808|NCT01410474|26422808|FG000|Overall Study|Withdrawal by Subject|0|||
13269809|NCT01410474|26422809|FG001|Overall Study|Withdrawal by Subject|1|||
13269810|NCT01410448|26422854|FG000|Overall Study|No conversion to everolimus|0|||
13269811|NCT01410448|26422855|FG001|Overall Study|No conversion to everolimus|24|||
13269812|NCT01410448|26422854|FG000|Overall Study|Graft loss|4|||
13269813|NCT01410448|26422855|FG001|Overall Study|Graft loss|1|||
13269814|NCT01410448|26422854|FG000|Overall Study|Administrative issues|2|||
13269815|NCT01410448|26422855|FG001|Overall Study|Administrative issues|1|||
13269816|NCT01410448|26422854|FG000|Overall Study|Lost to Follow-up|1|||
13269817|NCT01410448|26422855|FG001|Overall Study|Lost to Follow-up|0|||
13269818|NCT01410448|26422854|FG000|Overall Study|Withdrawal by Subject|3|||
13269819|NCT01410448|26422855|FG001|Overall Study|Withdrawal by Subject|2|||
13269820|NCT01410448|26422854|FG000|Overall Study|Protocol Violation|0|||
13269821|NCT01410448|26422855|FG001|Overall Study|Protocol Violation|4|||
13269822|NCT01410448|26422854|FG000|Overall Study|Death|2|||
13269823|NCT01410448|26422855|FG001|Overall Study|Death|3|||
13269824|NCT01410357|26422916|FG000|Overall Study|Death|2|||
13269825|NCT01410357|26422917|FG001|Overall Study|Death|1|||
13269826|NCT01410357|26422916|FG000|Overall Study|Withdrawal by Subject|1|||
13269827|NCT01410357|26422917|FG001|Overall Study|Withdrawal by Subject|2|||
13269828|NCT01410357|26422916|FG000|Overall Study|Lost to Follow-up|23|||
13269829|NCT01410357|26422917|FG001|Overall Study|Lost to Follow-up|21|||
13269830|NCT01410240|26422998|FG000|Overall Study|Physician Decision|0|||
13269831|NCT01410240|26422999|FG001|Overall Study|Physician Decision|0|||
13269832|NCT01410240|26423000|FG002|Overall Study|Physician Decision|1|||
13269833|NCT01410240|26422998|FG000|Overall Study|Missed week 6 assessments|1|||
13269834|NCT01410240|26422999|FG001|Overall Study|Missed week 6 assessments|1|||
13269835|NCT01410240|26423000|FG002|Overall Study|Missed week 6 assessments|1|||
13269836|NCT01410227|26423075|FG000|Overall Study|Adverse Event|1|||
13269837|NCT01410227|26423076|FG001|Overall Study|Adverse Event|0|||
13269838|NCT01410227|26423077|FG002|Overall Study|Adverse Event|0|||
13269839|NCT01410227|26423078|FG003|Overall Study|Adverse Event|0|||
13269840|NCT01410227|26423075|FG000|Overall Study|Withdrawal by Subject|3|||
13269841|NCT01410227|26423076|FG001|Overall Study|Withdrawal by Subject|0|||
13269842|NCT01410227|26423077|FG002|Overall Study|Withdrawal by Subject|1|||
13269843|NCT01410227|26423078|FG003|Overall Study|Withdrawal by Subject|0|||
13269844|NCT01410227|26423075|FG000|Overall Study|Pregnancy|0|||
13269845|NCT01410227|26423076|FG001|Overall Study|Pregnancy|0|||
13269846|NCT01410227|26423077|FG002|Overall Study|Pregnancy|0|||
13269847|NCT01410227|26423078|FG003|Overall Study|Pregnancy|1|||
13269848|NCT01410227|26423075|FG000|Overall Study|Met Excl. Criteria After Starting Study|0|||
13269849|NCT01410227|26423076|FG001|Overall Study|Met Excl. Criteria After Starting Study|0|||
13269850|NCT01410227|26423077|FG002|Overall Study|Met Excl. Criteria After Starting Study|1|||
13269851|NCT01410227|26423078|FG003|Overall Study|Met Excl. Criteria After Starting Study|0|||
13269852|NCT01410110|26423107|FG000|Overall Study|Withdrawal by Subject|4|||
13269853|NCT01410110|26423108|FG001|Overall Study|Withdrawal by Subject|2|||
13269854|NCT01409993|26423135|FG000|Overall Study|Adverse Event|4|||
13269855|NCT01409993|26423136|FG001|Overall Study|Adverse Event|4|||
13269856|NCT01409993|26423137|FG002|Overall Study|Adverse Event|3|||
13269857|NCT01409993|26423138|FG003|Overall Study|Adverse Event|1|||
13269858|NCT01409993|26423135|FG000|Overall Study|Withdrawal by Subject|0|||
13269859|NCT01409993|26423136|FG001|Overall Study|Withdrawal by Subject|0|||
13269860|NCT01409993|26423137|FG002|Overall Study|Withdrawal by Subject|0|||
13269861|NCT01409993|26423138|FG003|Overall Study|Withdrawal by Subject|4|||
13269862|NCT01409993|26423135|FG000|Overall Study|Lost to Follow-up|0|||
13269863|NCT01409993|26423136|FG001|Overall Study|Lost to Follow-up|1|||
13269864|NCT01409993|26423137|FG002|Overall Study|Lost to Follow-up|0|||
13269865|NCT01409993|26423138|FG003|Overall Study|Lost to Follow-up|0|||
13269866|NCT01409928|26423144|FG000|Overall Study|Physician Decision|12|||
13269867|NCT01409915|26423167|FG000|Overall Study|Adverse Event|0|||
13269868|NCT01409915|26423168|FG001|Overall Study|Adverse Event|2|||
13269869|NCT01409915|26423167|FG000|Overall Study|Withdrawal by Subject|0|||
13269870|NCT01409915|26423168|FG001|Overall Study|Withdrawal by Subject|1|||
13269871|NCT01409915|26423167|FG000|Overall Study|Protocol Violation|1|||
13269872|NCT01409915|26423168|FG001|Overall Study|Protocol Violation|0|||
13269873|NCT01409837|26423197|FG000|Overall Study|Withdrawal by Subject|2|||
13269874|NCT01409837|26423198|FG001|Overall Study|Withdrawal by Subject|1|||
13269875|NCT01409837|26423197|FG000|Overall Study|Lost to Follow-up|1|||
13269876|NCT01409837|26423198|FG001|Overall Study|Lost to Follow-up|0|||
13269877|NCT01409837|26423197|FG000|Overall Study|Physician Decision|0|||
13269878|NCT01409837|26423198|FG001|Overall Study|Physician Decision|1|||
13118040|NCT03047551|25927643|FG001|Overall Study|Did not receive TAS|0|||
13118041|NCT03047551|25927642|FG000|Overall Study|Physician Decision|1|||
13118042|NCT03047551|25927643|FG001|Overall Study|Physician Decision|0|||
13118043|NCT03047551|25927642|FG000|Overall Study|Withdrawal by Subject|0|||
13118044|NCT03047551|25927643|FG001|Overall Study|Withdrawal by Subject|1|||
13118045|NCT03047551|25927642|FG000|Overall Study|Probe malfunction|0|||
13269879|NCT01409811|26423204|FG000|Overall Study|Insurance denial|1|||
13269880|NCT01409707|26423224|FG000|Overall Study|Withdrawal by Subject|5|||
13269881|NCT01409707|26423225|FG001|Overall Study|Withdrawal by Subject|17|||
13269882|NCT01409707|26423226|FG002|Overall Study|Withdrawal by Subject|16|||
13269883|NCT01409564|26423251|FG000|Overall Study|low medication compliance|4|||
13269884|NCT01409564|26423252|FG001|Overall Study|low medication compliance|3|||
13269885|NCT01409564|26423251|FG000|Overall Study|brain abnormalities found in T1 MR|1|||
13269886|NCT01409564|26423252|FG001|Overall Study|brain abnormalities found in T1 MR|2|||
13269887|NCT01409434|26423262|FG000|Overall Study|Protocol Violation|4|||
13269888|NCT01409382|26423281|FG000|Overall Study|Lost to Follow-up|1|||
13269889|NCT01409382|26423282|FG001|Overall Study|Lost to Follow-up|1|||
13269890|NCT01409382|26423281|FG000|Overall Study|Protocol Violation|0|||
13269891|NCT01409382|26423282|FG001|Overall Study|Protocol Violation|3|||
13118046|NCT03047551|25927643|FG001|Overall Study|Probe malfunction|1|||
13269892|NCT01409382|26423281|FG000|Overall Study|Multiple pregnancy|2|||
13269893|NCT01409382|26423282|FG001|Overall Study|Multiple pregnancy|4|||
13269894|NCT01409382|26423281|FG000|Overall Study|Still pregnant when study ended|13|||
13269895|NCT01409382|26423282|FG001|Overall Study|Still pregnant when study ended|2|||
13269896|NCT01409382|26423281|FG000|Overall Study|Did not manage to get pregnant|64|||
13269897|NCT01409382|26423282|FG001|Overall Study|Did not manage to get pregnant|70|||
13269898|NCT01409382|26423281|FG000|Overall Study|Had a 2nd trimester loss after accident|1|||
13269899|NCT01409382|26423282|FG001|Overall Study|Had a 2nd trimester loss after accident|0|||
13269900|NCT01409031|26423305|FG000|Overall Study|transferred to other hosp|1|||
13269901|NCT01409031|26423306|FG001|Overall Study|transferred to other hosp|0|||
13269902|NCT01408914|26423330|FG000|Overall Study|Could not complete tx in protocol period|5|||
13269903|NCT01408914|26423331|FG001|Overall Study|Could not complete tx in protocol period|5|||
13269904|NCT01408914|26423332|FG002|Overall Study|Could not complete tx in protocol period|6|||
13269905|NCT01408914|26423330|FG000|Overall Study|Lost to Follow-up|4|||
13269906|NCT01408914|26423331|FG001|Overall Study|Lost to Follow-up|1|||
13269907|NCT01408914|26423332|FG002|Overall Study|Lost to Follow-up|2|||
13269908|NCT01408914|26423330|FG000|Overall Study|Physician Decision|1|||
13269909|NCT01408914|26423331|FG001|Overall Study|Physician Decision|1|||
13269910|NCT01408914|26423332|FG002|Overall Study|Physician Decision|0|||
13269911|NCT01408914|26423330|FG000|Overall Study|Withdrawal by Subject|1|||
13269912|NCT01408914|26423331|FG001|Overall Study|Withdrawal by Subject|0|||
13269913|NCT01408914|26423332|FG002|Overall Study|Withdrawal by Subject|1|||
13269914|NCT01408914|26423330|FG000|Overall Study|Moved out of study jurisdiction|1|||
13269915|NCT01408914|26423331|FG001|Overall Study|Moved out of study jurisdiction|1|||
13269916|NCT01408914|26423332|FG002|Overall Study|Moved out of study jurisdiction|0|||
13269917|NCT01408914|26423330|FG000|Overall Study|Late exclusion|0|||
13269918|NCT01408914|26423331|FG001|Overall Study|Late exclusion|3|||
13269919|NCT01408914|26423332|FG002|Overall Study|Late exclusion|3|||
13269920|NCT01408914|26423330|FG000|Overall Study|Change in local TB/HIV norms|0|||
13269921|NCT01408914|26423331|FG001|Overall Study|Change in local TB/HIV norms|1|||
13269922|NCT01408914|26423332|FG002|Overall Study|Change in local TB/HIV norms|1|||
13269923|NCT01408901|26423371|FG000|6-Week Follow-Up|Lost to Follow-up|2|||
13269924|NCT01408901|26423372|FG001|6-Week Follow-Up|Lost to Follow-up|1|||
13269925|NCT01408901|26423373|FG002|6-Week Follow-Up|Lost to Follow-up|3|||
13269926|NCT01408901|26423374|FG003|6-Week Follow-Up|Lost to Follow-up|2|||
13269927|NCT01408901|26423371|FG000|6-Week Follow-Up|Death|1|||
13269928|NCT01408901|26423372|FG001|6-Week Follow-Up|Death|0|||
13269929|NCT01408901|26423373|FG002|6-Week Follow-Up|Death|0|||
13269930|NCT01408901|26423374|FG003|6-Week Follow-Up|Death|0|||
13269931|NCT01408901|26423371|FG000|6-Week Follow-Up|Cancelled visit|0|||
13269932|NCT01408901|26423372|FG001|6-Week Follow-Up|Cancelled visit|1|||
13269933|NCT01408901|26423373|FG002|6-Week Follow-Up|Cancelled visit|0|||
13118047|NCT03047551|25927642|FG000|Overall Study|Ineligible|0|||
13118048|NCT03047551|25927643|FG001|Overall Study|Ineligible|1|||
13269934|NCT01408901|26423374|FG003|6-Week Follow-Up|Cancelled visit|2|||
13269935|NCT01408901|26423371|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
13269936|NCT01408901|26423372|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
13269937|NCT01408901|26423373|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
13269938|NCT01408901|26423374|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2|||
13269939|NCT01408901|26423371|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1|||
13269940|NCT01408901|26423372|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0|||
13269941|NCT01408901|26423373|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0|||
13269942|NCT01408901|26423374|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0|||
13269943|NCT01408901|26423371|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
13269944|NCT01408901|26423372|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2|||
13269945|NCT01408901|26423373|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
13269946|NCT01408901|26423374|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1|||
13269947|NCT01408901|26423371|FG000|26-Week Follow-Up|Lost to Follow-up|1|||
13269948|NCT01408901|26423372|FG001|26-Week Follow-Up|Lost to Follow-up|1|||
13269949|NCT01408901|26423373|FG002|26-Week Follow-Up|Lost to Follow-up|0|||
13269950|NCT01408901|26423374|FG003|26-Week Follow-Up|Lost to Follow-up|1|||
13269951|NCT01408901|26423371|FG000|26-Week Follow-Up|Death|0|||
13269952|NCT01408901|26423372|FG001|26-Week Follow-Up|Death|1|||
13269953|NCT01408901|26423373|FG002|26-Week Follow-Up|Death|0|||
13269954|NCT01408901|26423374|FG003|26-Week Follow-Up|Death|0|||
13269955|NCT01408888|26423400|FG000|First Intervention|Adverse Event|0|||
13269956|NCT01408888|26423401|FG001|First Intervention|Adverse Event|1|||
13269957|NCT01408888|26423400|FG000|First Intervention|Withdrawal by Subject|0|||
13269958|NCT01408888|26423401|FG001|First Intervention|Withdrawal by Subject|2|||
13269959|NCT01408888|26423400|FG000|Second Intervention|Withdrawal by Subject|1|||
13269960|NCT01408888|26423401|FG001|Second Intervention|Withdrawal by Subject|0|||
13269961|NCT01408888|26423400|FG000|Second Intervention|Adverse Event|1|||
13269962|NCT01408888|26423401|FG001|Second Intervention|Adverse Event|0|||
13269963|NCT01408732|26423410|FG000|Overall Study|Withdrawal by Subject|2|||
13118049|NCT03046446|25927653|FG000|Overall Study|Lack of Efficacy|7|||
13269964|NCT01408732|26423411|FG001|Overall Study|Withdrawal by Subject|2|||
13269965|NCT01408706|26423428|FG000|Overall Study|Physician Decision|1|||
13269966|NCT01408706|26423429|FG001|Overall Study|Physician Decision|0|||
13269967|NCT01408641|26423444|FG000|Overall Study|Physician Decision|1|||
13269968|NCT01408641|26423445|FG001|Overall Study|Physician Decision|0|||
13269969|NCT01408628|26423453|FG000|Consented|Withdrawal by Subject|12|||
13269970|NCT01408628|26423453|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3|||
13269971|NCT01408628|26423453|FG000|Completed 6 Month Follow-Up|Protocol Violation|6|||
13269972|NCT01408628|26423453|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5|||
13269973|NCT01408576|26423510|FG000|Overall Study|Lack of Efficacy|17|||
13269974|NCT01408576|26423511|FG001|Overall Study|Lack of Efficacy|30|||
13269975|NCT01408576|26423512|FG002|Overall Study|Lack of Efficacy|48|||
13269976|NCT01408576|26423510|FG000|Overall Study|Protocol Violation|1|||
13269977|NCT01408576|26423511|FG001|Overall Study|Protocol Violation|2|||
13269978|NCT01408576|26423512|FG002|Overall Study|Protocol Violation|2|||
13269979|NCT01408576|26423510|FG000|Overall Study|Lost to Follow-up|10|||
13269980|NCT01408576|26423511|FG001|Overall Study|Lost to Follow-up|9|||
13269981|NCT01408576|26423512|FG002|Overall Study|Lost to Follow-up|17|||
13269982|NCT01408576|26423510|FG000|Overall Study|Withdrawal by Subject|34|||
13269983|NCT01408576|26423511|FG001|Overall Study|Withdrawal by Subject|60|||
13269984|NCT01408576|26423512|FG002|Overall Study|Withdrawal by Subject|66|||
13269985|NCT01408576|26423510|FG000|Overall Study|Sponsor terminated study|89|||
13269986|NCT01408576|26423511|FG001|Overall Study|Sponsor terminated study|333|||
13269987|NCT01408576|26423512|FG002|Overall Study|Sponsor terminated study|330|||
13269988|NCT01408576|26423510|FG000|Overall Study|AE, serious fatal|4|||
13269989|NCT01408576|26423511|FG001|Overall Study|AE, serious fatal|4|||
13269990|NCT01408576|26423512|FG002|Overall Study|AE, serious fatal|1|||
13269991|NCT01408576|26423510|FG000|Overall Study|SAE, non-fatal|11|||
13269992|NCT01408576|26423511|FG001|Overall Study|SAE, non-fatal|23|||
13269993|NCT01408576|26423512|FG002|Overall Study|SAE, non-fatal|14|||
13269994|NCT01408576|26423510|FG000|Overall Study|AE, non-serious non-fatal|12|||
13269995|NCT01408576|26423511|FG001|Overall Study|AE, non-serious non-fatal|19|||
13269996|NCT01408576|26423512|FG002|Overall Study|AE, non-serious non-fatal|11|||
13269997|NCT01408576|26423510|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
13269998|NCT01408576|26423511|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
13269999|NCT01408576|26423512|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
13270000|NCT01408576|26423510|FG000|Overall Study|AE, unknown type|0|||
13270001|NCT01408576|26423511|FG001|Overall Study|AE, unknown type|1|||
13270002|NCT01408576|26423512|FG002|Overall Study|AE, unknown type|0|||
13270003|NCT01408576|26423510|FG000|Overall Study|Other|10|||
13270004|NCT01408576|26423511|FG001|Overall Study|Other|16|||
13270005|NCT01408576|26423512|FG002|Overall Study|Other|18|||
13270006|NCT01408563|26423530|FG000|Overall Study|Ineligible after consent/ registration|2|||
13270007|NCT01408537|26423548|FG000|Overall Study|Withdrawal by Subject|2|||
13270008|NCT01408537|26423548|FG000|Overall Study|Protocol Violation|3|||
13270009|NCT01408537|26423548|FG000|Overall Study|Lost to Follow-up|3|||
13270010|NCT01408485|26423556|FG000|Overall Study|Withdrawal by Subject|21|||
13270011|NCT01408459|26423577|FG000|Overall Study|Withdrawal by Subject|1|||
13270012|NCT01408459|26423578|FG001|Overall Study|Withdrawal by Subject|1|||
13270013|NCT01408303|26423596|FG000|Overall Study|Adverse Event|3|||
13270014|NCT01408303|26423597|FG001|Overall Study|Adverse Event|7|||
13270015|NCT01408303|26423598|FG002|Overall Study|Adverse Event|2|||
13270016|NCT01408303|26423596|FG000|Overall Study|Lost to Follow-up|0|||
13270017|NCT01408303|26423597|FG001|Overall Study|Lost to Follow-up|1|||
13270018|NCT01408303|26423598|FG002|Overall Study|Lost to Follow-up|2|||
13270019|NCT01408303|26423596|FG000|Overall Study|Withdrawal by Subject|2|||
13270020|NCT01408303|26423597|FG001|Overall Study|Withdrawal by Subject|3|||
13270021|NCT01408303|26423598|FG002|Overall Study|Withdrawal by Subject|1|||
13270022|NCT01408303|26423596|FG000|Overall Study|Protocol Violation|0|||
13270023|NCT01408303|26423597|FG001|Overall Study|Protocol Violation|1|||
13270024|NCT01408303|26423598|FG002|Overall Study|Protocol Violation|0|||
13270025|NCT01408303|26423596|FG000|Overall Study|Noncompliance|1|||
13270026|NCT01408303|26423597|FG001|Overall Study|Noncompliance|0|||
13270027|NCT01408303|26423598|FG002|Overall Study|Noncompliance|1|||
13270028|NCT01408277|26423611|FG000|Overall Study|Adverse Event|3|||
13270029|NCT01408277|26423612|FG001|Overall Study|Adverse Event|4|||
13270030|NCT01408277|26423611|FG000|Overall Study|Lost to Follow-up|1|||
13270031|NCT01408277|26423612|FG001|Overall Study|Lost to Follow-up|0|||
13270032|NCT01408277|26423611|FG000|Overall Study|Withdrawal by Subject|2|||
13270033|NCT01408277|26423612|FG001|Overall Study|Withdrawal by Subject|0|||
13270034|NCT01408277|26423611|FG000|Overall Study|Protocol Violation|2|||
13270035|NCT01408277|26423612|FG001|Overall Study|Protocol Violation|0|||
13270036|NCT01408147|26423627|FG000|Overall Study|Withdrawal by Subject|0|||
13270037|NCT01408147|26423628|FG001|Overall Study|Withdrawal by Subject|1|||
13270038|NCT01408043|26423645|FG000|Overall Study|unable to collect cells|1|||
13270039|NCT01408030|26423688|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1|||
13270040|NCT01408030|26423689|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0|||
13270041|NCT01408030|26423690|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1|||
13270042|NCT01408030|26423691|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0|||
13270043|NCT01408030|26423688|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2|||
13270044|NCT01408030|26423689|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6|||
13270045|NCT01408030|26423690|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0|||
13270046|NCT01408030|26423691|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3|||
13270047|NCT01408030|26423688|FG000|Treatment Phase (on Drug)|Protocol Violation|0|||
13270048|NCT01408030|26423689|FG001|Treatment Phase (on Drug)|Protocol Violation|1|||
13270049|NCT01408030|26423690|FG002|Treatment Phase (on Drug)|Protocol Violation|0|||
13270050|NCT01408030|26423691|FG003|Treatment Phase (on Drug)|Protocol Violation|0|||
13270051|NCT01408030|26423688|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0|||
13270052|NCT01408030|26423689|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2|||
13270053|NCT01408030|26423690|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2|||
13270054|NCT01408030|26423691|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0|||
13270055|NCT01408030|26423688|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
13270056|NCT01408030|26423689|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2|||
13270057|NCT01408030|26423690|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1|||
13270058|NCT01408030|26423691|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
13270059|NCT01408030|26423688|FG000|Observation Phase (Off Drug)|Physician Decision|0|||
13270060|NCT01408030|26423689|FG001|Observation Phase (Off Drug)|Physician Decision|1|||
13270061|NCT01408030|26423690|FG002|Observation Phase (Off Drug)|Physician Decision|2|||
13270062|NCT01408030|26423691|FG003|Observation Phase (Off Drug)|Physician Decision|0|||
13270063|NCT01408030|26423688|FG000|Observation Phase (Off Drug)|Other|1|||
13270064|NCT01408030|26423689|FG001|Observation Phase (Off Drug)|Other|1|||
13270065|NCT01408030|26423690|FG002|Observation Phase (Off Drug)|Other|1|||
13270066|NCT01408030|26423691|FG003|Observation Phase (Off Drug)|Other|1|||
13270067|NCT01407926|26423708|FG000|Overall Study|Lost to Follow-up|55|||
13270068|NCT01407367|26423729|FG000|Overall Study|Death|24|||
13270069|NCT01407367|26423730|FG001|Overall Study|Death|32|||
13270070|NCT01407367|26423729|FG000|Overall Study|Renal Replacement Therapy (RRT)|12|||
13270071|NCT01407367|26423730|FG001|Overall Study|Renal Replacement Therapy (RRT)|29|||
13270072|NCT01407367|26423729|FG000|Overall Study|Withdrawal by Subject|4|||
13270073|NCT01407367|26423730|FG001|Overall Study|Withdrawal by Subject|15|||
13270074|NCT01407367|26423729|FG000|Overall Study|Lost to Follow-up|0|||
13270075|NCT01407367|26423730|FG001|Overall Study|Lost to Follow-up|2|||
13270076|NCT01407354|26423741|FG000|First Intervention|Withdrawal by Subject|0|||
13270077|NCT01407354|26423742|FG001|First Intervention|Withdrawal by Subject|2|||
13270078|NCT01407354|26423741|FG000|First Intervention|Adverse Event|1|||
13270079|NCT01407354|26423742|FG001|First Intervention|Adverse Event|0|||
13270080|NCT01407354|26423741|FG000|First Intervention|Physician Decision|1|||
13270081|NCT01407354|26423742|FG001|First Intervention|Physician Decision|0|||
13270082|NCT01407276|26423891|FG000|Overall Study|Withdrawal by Subject|0|||
13270083|NCT01407276|26423892|FG001|Overall Study|Withdrawal by Subject|0|||
13270084|NCT01407276|26423893|FG002|Overall Study|Withdrawal by Subject|0|||
13270085|NCT01407276|26423894|FG003|Overall Study|Withdrawal by Subject|0|||
13270086|NCT01407276|26423895|FG004|Overall Study|Withdrawal by Subject|0|||
13270087|NCT01407276|26423896|FG005|Overall Study|Withdrawal by Subject|0|||
13270088|NCT01407276|26423897|FG006|Overall Study|Withdrawal by Subject|0|||
13270089|NCT01407276|26423898|FG007|Overall Study|Withdrawal by Subject|1|||
13270090|NCT01406938|26424025|FG000|Induction Period|Subject/guardian decision|6|||
13270091|NCT01406938|26424026|FG001|Induction Period|Subject/guardian decision|8|||
13270092|NCT01406938|26424027|FG002|Induction Period|Subject/guardian decision|0|||
13270093|NCT01406938|26424028|FG003|Induction Period|Subject/guardian decision|0|||
13270094|NCT01406938|26424029|FG004|Induction Period|Subject/guardian decision|0|||
13270095|NCT01406938|26424030|FG005|Induction Period|Subject/guardian decision|0|||
13270096|NCT01406938|26424025|FG000|Induction Period|Protocol deviation|1|||
13270097|NCT01406938|26424026|FG001|Induction Period|Protocol deviation|0|||
13270098|NCT01406938|26424027|FG002|Induction Period|Protocol deviation|0|||
13270099|NCT01406938|26424028|FG003|Induction Period|Protocol deviation|0|||
13270100|NCT01406938|26424029|FG004|Induction Period|Protocol deviation|0|||
13270101|NCT01406938|26424030|FG005|Induction Period|Protocol deviation|0|||
13270102|NCT01406938|26424025|FG000|Induction Period|Adverse Event|8|||
13270103|NCT01406938|26424026|FG001|Induction Period|Adverse Event|9|||
13270104|NCT01406938|26424027|FG002|Induction Period|Adverse Event|0|||
13270105|NCT01406938|26424028|FG003|Induction Period|Adverse Event|0|||
13270106|NCT01406938|26424029|FG004|Induction Period|Adverse Event|0|||
13270107|NCT01406938|26424030|FG005|Induction Period|Adverse Event|0|||
13270108|NCT01406938|26424025|FG000|Induction Period|Lack of Efficacy|1|||
13270109|NCT01406938|26424026|FG001|Induction Period|Lack of Efficacy|0|||
13270110|NCT01406938|26424027|FG002|Induction Period|Lack of Efficacy|0|||
13270111|NCT01406938|26424028|FG003|Induction Period|Lack of Efficacy|0|||
13270112|NCT01406938|26424029|FG004|Induction Period|Lack of Efficacy|0|||
13270113|NCT01406938|26424030|FG005|Induction Period|Lack of Efficacy|0|||
13270114|NCT01406938|26424025|FG000|Induction Period|Lost to Follow-up|2|||
13270115|NCT01406938|26424026|FG001|Induction Period|Lost to Follow-up|3|||
13270116|NCT01406938|26424027|FG002|Induction Period|Lost to Follow-up|0|||
13270117|NCT01406938|26424028|FG003|Induction Period|Lost to Follow-up|0|||
13270118|NCT01406938|26424029|FG004|Induction Period|Lost to Follow-up|0|||
13270119|NCT01406938|26424030|FG005|Induction Period|Lost to Follow-up|0|||
13270120|NCT01406938|26424025|FG000|Maintenance Period|Adverse Event|0|||
13270121|NCT01406938|26424026|FG001|Maintenance Period|Adverse Event|0|||
13270122|NCT01406938|26424027|FG002|Maintenance Period|Adverse Event|2|||
13270123|NCT01406938|26424028|FG003|Maintenance Period|Adverse Event|8|||
13270124|NCT01406938|26424029|FG004|Maintenance Period|Adverse Event|4|||
13270125|NCT01406938|26424030|FG005|Maintenance Period|Adverse Event|2|||
13270126|NCT01406938|26424025|FG000|Maintenance Period|Death|0|||
13270127|NCT01406938|26424026|FG001|Maintenance Period|Death|0|||
13270128|NCT01406938|26424027|FG002|Maintenance Period|Death|0|||
13270129|NCT01406938|26424028|FG003|Maintenance Period|Death|0|||
13270130|NCT01406938|26424029|FG004|Maintenance Period|Death|1|||
13270131|NCT01406938|26424030|FG005|Maintenance Period|Death|0|||
13270132|NCT01406938|26424025|FG000|Maintenance Period|Subject/guardian decision|0|||
13270133|NCT01406938|26424026|FG001|Maintenance Period|Subject/guardian decision|0|||
13270134|NCT01406938|26424027|FG002|Maintenance Period|Subject/guardian decision|11|||
13270135|NCT01406938|26424028|FG003|Maintenance Period|Subject/guardian decision|7|||
13270136|NCT01406938|26424029|FG004|Maintenance Period|Subject/guardian decision|10|||
13270137|NCT01406938|26424030|FG005|Maintenance Period|Subject/guardian decision|7|||
13270138|NCT01406938|26424025|FG000|Maintenance Period|Protocol Violation|0|||
13270139|NCT01406938|26424026|FG001|Maintenance Period|Protocol Violation|0|||
13270140|NCT01406938|26424027|FG002|Maintenance Period|Protocol Violation|2|||
13270141|NCT01406938|26424028|FG003|Maintenance Period|Protocol Violation|2|||
13270142|NCT01406938|26424029|FG004|Maintenance Period|Protocol Violation|2|||
13270143|NCT01406938|26424030|FG005|Maintenance Period|Protocol Violation|2|||
13270144|NCT01406938|26424025|FG000|Maintenance Period|Pregnancy|0|||
13270145|NCT01406938|26424026|FG001|Maintenance Period|Pregnancy|0|||
13270146|NCT01406938|26424027|FG002|Maintenance Period|Pregnancy|0|||
13270147|NCT01406938|26424028|FG003|Maintenance Period|Pregnancy|0|||
13270148|NCT01406938|26424029|FG004|Maintenance Period|Pregnancy|1|||
13270149|NCT01406938|26424030|FG005|Maintenance Period|Pregnancy|0|||
13270150|NCT01406938|26424025|FG000|Maintenance Period|Lost to Follow-up|0|||
13270151|NCT01406938|26424026|FG001|Maintenance Period|Lost to Follow-up|0|||
13270152|NCT01406938|26424027|FG002|Maintenance Period|Lost to Follow-up|0|||
13270153|NCT01406938|26424028|FG003|Maintenance Period|Lost to Follow-up|0|||
13270154|NCT01406938|26424029|FG004|Maintenance Period|Lost to Follow-up|4|||
13270155|NCT01406938|26424030|FG005|Maintenance Period|Lost to Follow-up|0|||
13270156|NCT01406938|26424025|FG000|Maintenance Period|Lack of Efficacy|0|||
13270157|NCT01406938|26424026|FG001|Maintenance Period|Lack of Efficacy|0|||
13270158|NCT01406938|26424027|FG002|Maintenance Period|Lack of Efficacy|2|||
13270159|NCT01406938|26424028|FG003|Maintenance Period|Lack of Efficacy|1|||
13270160|NCT01406938|26424029|FG004|Maintenance Period|Lack of Efficacy|3|||
13270161|NCT01406938|26424030|FG005|Maintenance Period|Lack of Efficacy|5|||
13270162|NCT01406938|26424025|FG000|Follow up|Lack of Efficacy|3|||
13270163|NCT01406938|26424026|FG001|Follow up|Lack of Efficacy|2|||
13270164|NCT01406938|26424027|FG002|Follow up|Lack of Efficacy|1|||
13270165|NCT01406938|26424028|FG003|Follow up|Lack of Efficacy|0|||
13270166|NCT01406938|26424029|FG004|Follow up|Lack of Efficacy|0|||
13270167|NCT01406938|26424030|FG005|Follow up|Lack of Efficacy|0|||
13270168|NCT01406938|26424025|FG000|Follow up|Patient/guardian decision|4|||
13270169|NCT01406938|26424026|FG001|Follow up|Patient/guardian decision|2|||
13270170|NCT01406938|26424027|FG002|Follow up|Patient/guardian decision|4|||
13270171|NCT01406938|26424028|FG003|Follow up|Patient/guardian decision|2|||
13270172|NCT01406938|26424029|FG004|Follow up|Patient/guardian decision|4|||
13270173|NCT01406938|26424030|FG005|Follow up|Patient/guardian decision|1|||
13270174|NCT01406938|26424025|FG000|Follow up|Protocol Violation|0|||
13270175|NCT01406938|26424026|FG001|Follow up|Protocol Violation|0|||
13270176|NCT01406938|26424027|FG002|Follow up|Protocol Violation|1|||
13270177|NCT01406938|26424028|FG003|Follow up|Protocol Violation|0|||
13270178|NCT01406938|26424029|FG004|Follow up|Protocol Violation|0|||
13270179|NCT01406938|26424030|FG005|Follow up|Protocol Violation|0|||
13270180|NCT01406938|26424025|FG000|Follow up|Physician Decision|0|||
13270181|NCT01406938|26424026|FG001|Follow up|Physician Decision|0|||
13270182|NCT01406938|26424027|FG002|Follow up|Physician Decision|2|||
13270183|NCT01406938|26424028|FG003|Follow up|Physician Decision|0|||
13270184|NCT01406938|26424029|FG004|Follow up|Physician Decision|3|||
13270185|NCT01406938|26424030|FG005|Follow up|Physician Decision|1|||
13270186|NCT01406938|26424025|FG000|Follow up|Lost to Follow-up|1|||
13270187|NCT01406938|26424026|FG001|Follow up|Lost to Follow-up|1|||
13270188|NCT01406938|26424027|FG002|Follow up|Lost to Follow-up|0|||
13270189|NCT01406938|26424028|FG003|Follow up|Lost to Follow-up|1|||
13270190|NCT01406938|26424029|FG004|Follow up|Lost to Follow-up|2|||
13270191|NCT01406938|26424030|FG005|Follow up|Lost to Follow-up|1|||
13270192|NCT01406873|26424053|FG000|Overall Study|Withdrawal by Subject|1|||
13270193|NCT01406873|26424054|FG001|Overall Study|Withdrawal by Subject|1|||
13270194|NCT01406795|26424070|FG000|Overall Study|Withdrawal by Subject|1|||
13270195|NCT01406717|26424105|FG000|Overall Study|Subject non-compliance|4|||
13270196|NCT01406717|26424106|FG001|Overall Study|Subject non-compliance|3|||
13270197|NCT01406717|26424105|FG000|Overall Study|Protocol Violation|5|||
13270198|NCT01406717|26424106|FG001|Overall Study|Protocol Violation|1|||
13270199|NCT01406717|26424105|FG000|Overall Study|Lost to Follow-up|14|||
13270200|NCT01406717|26424106|FG001|Overall Study|Lost to Follow-up|8|||
13270201|NCT01406717|26424105|FG000|Overall Study|Withdrawal by Subject|19|||
13270202|NCT01406717|26424106|FG001|Overall Study|Withdrawal by Subject|15|||
13270203|NCT01406717|26424105|FG000|Overall Study|Adverse Event|1|||
13270204|NCT01406717|26424106|FG001|Overall Study|Adverse Event|2|||
13270205|NCT01406717|26424105|FG000|Overall Study|Lack of Efficacy|0|||
13270206|NCT01406717|26424106|FG001|Overall Study|Lack of Efficacy|1|||
13270207|NCT01406717|26424105|FG000|Overall Study|Non-completion of visit activity|0|||
13270208|NCT01406717|26424106|FG001|Overall Study|Non-completion of visit activity|1|||
13270209|NCT01406652|26424121|FG000|Overall Study|Lost-to-follow-up|3|||
13270210|NCT01406652|26424122|FG001|Overall Study|Lost-to-follow-up|4|||
13270211|NCT01406652|26424121|FG000|Overall Study|Withdrawal by Subject|2|||
13270212|NCT01406652|26424122|FG001|Overall Study|Withdrawal by Subject|2|||
13270213|NCT01406652|26424121|FG000|Overall Study|Insufficient follow-up|5|||
13270214|NCT01406652|26424122|FG001|Overall Study|Insufficient follow-up|4|||
13270215|NCT01406652|26424121|FG000|Overall Study|Infection not sure|10|||
13270216|NCT01406652|26424122|FG001|Overall Study|Infection not sure|10|||
13270217|NCT01406574|26424139|FG000|Overall Study|Adverse Event|0|||
13270218|NCT01406574|26424140|FG001|Overall Study|Adverse Event|0|||
13270219|NCT01406574|26424141|FG002|Overall Study|Adverse Event|1|||
13270220|NCT01406574|26424142|FG003|Overall Study|Adverse Event|3|||
13270221|NCT01406574|26424139|FG000|Overall Study|Physician Decision|0|||
13270222|NCT01406574|26424140|FG001|Overall Study|Physician Decision|0|||
13270223|NCT01406574|26424141|FG002|Overall Study|Physician Decision|0|||
13270224|NCT01406574|26424142|FG003|Overall Study|Physician Decision|1|||
13270225|NCT01406574|26424139|FG000|Overall Study|Withdrawal by Subject|0|||
13270226|NCT01406574|26424140|FG001|Overall Study|Withdrawal by Subject|1|||
13270227|NCT01406574|26424141|FG002|Overall Study|Withdrawal by Subject|0|||
13270228|NCT01406574|26424142|FG003|Overall Study|Withdrawal by Subject|0|||
13270229|NCT01406574|26424139|FG000|Overall Study|Definite progression of primary disease|1|||
13270230|NCT01406574|26424140|FG001|Overall Study|Definite progression of primary disease|0|||
13270231|NCT01406574|26424141|FG002|Overall Study|Definite progression of primary disease|0|||
13270232|NCT01406574|26424142|FG003|Overall Study|Definite progression of primary disease|0|||
13270233|NCT01406015|26424163|FG000|Overall Study|Withdrawal by Subject|3|||
13270234|NCT01406015|26424164|FG001|Overall Study|Withdrawal by Subject|3|||
13270235|NCT01405950|26424185|FG000|Overall Study|Withdrawal by Subject|1|||
13270236|NCT01405950|26424186|FG001|Overall Study|Withdrawal by Subject|0|||
13270237|NCT01405950|26424187|FG002|Overall Study|Withdrawal by Subject|0|||
13270238|NCT01405950|26424188|FG003|Overall Study|Withdrawal by Subject|0|||
13270239|NCT01405924|26424200|FG000|Overall Study|Protocol Violation|8|||
13270240|NCT01405924|26424200|FG000|Overall Study|Missing/Incomplete Data|2|||
13270241|NCT01405911|26424227|FG000|Overall Study|Pre-treatment lab AE|0|||
13270242|NCT01405911|26424228|FG001|Overall Study|Pre-treatment lab AE|1|||
13270243|NCT01405911|26424229|FG002|Overall Study|Pre-treatment lab AE|0|||
13270244|NCT01405911|26424227|FG000|Overall Study|Lost to Follow-up|0|||
13270245|NCT01405911|26424228|FG001|Overall Study|Lost to Follow-up|1|||
13270246|NCT01405911|26424229|FG002|Overall Study|Lost to Follow-up|0|||
13270247|NCT01405911|26424227|FG000|Overall Study|Protocol Violation|1|||
13270248|NCT01405911|26424228|FG001|Overall Study|Protocol Violation|0|||
13270249|NCT01405911|26424229|FG002|Overall Study|Protocol Violation|0|||
13270250|NCT01405911|26424227|FG000|Overall Study|Withdrawal by Subject|3|||
13270251|NCT01405911|26424228|FG001|Overall Study|Withdrawal by Subject|1|||
13270252|NCT01405911|26424229|FG002|Overall Study|Withdrawal by Subject|1|||
13270253|NCT01405898|26424254|FG000|Overall Study|Withdrawal by Subject|2|||
13270254|NCT01405898|26424255|FG001|Overall Study|Withdrawal by Subject|2|||
13270255|NCT01405820|26424294|FG000|Randomized Treatment Period|Adverse Event|3|||
13270256|NCT01405820|26424295|FG001|Randomized Treatment Period|Adverse Event|3|||
13270257|NCT01405820|26424296|FG002|Randomized Treatment Period|Adverse Event|3|||
13270258|NCT01405820|26424297|FG003|Randomized Treatment Period|Adverse Event|0|||
13270259|NCT01405820|26424298|FG004|Randomized Treatment Period|Adverse Event|2|||
13270260|NCT01405820|26424299|FG005|Randomized Treatment Period|Adverse Event|1|||
13118050|NCT03046446|25927653|FG000|Overall Study|Adverse Event|6|||
13270261|NCT01405820|26424294|FG000|Randomized Treatment Period|Withdrawal by Subject|6|||
13270262|NCT01405820|26424295|FG001|Randomized Treatment Period|Withdrawal by Subject|2|||
13270263|NCT01405820|26424296|FG002|Randomized Treatment Period|Withdrawal by Subject|2|||
13270264|NCT01405820|26424297|FG003|Randomized Treatment Period|Withdrawal by Subject|2|||
13270265|NCT01405820|26424298|FG004|Randomized Treatment Period|Withdrawal by Subject|0|||
13270266|NCT01405820|26424299|FG005|Randomized Treatment Period|Withdrawal by Subject|0|||
13270267|NCT01405820|26424294|FG000|Randomized Treatment Period|Other|2|||
13270268|NCT01405820|26424295|FG001|Randomized Treatment Period|Other|2|||
13270269|NCT01405820|26424296|FG002|Randomized Treatment Period|Other|1|||
13270270|NCT01405820|26424297|FG003|Randomized Treatment Period|Other|1|||
13307872|NCT01281969|26530024|FG000|Overall Study|not randomized, child consent not given|0|||
13307873|NCT01281969|26530025|FG001|Overall Study|not randomized, child consent not given|0|||
13307874|NCT01281969|26530026|FG002|Overall Study|not randomized, child consent not given|2|||
13307875|NCT01281956|26530060|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1|||
13307876|NCT01281956|26530061|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0|||
13307877|NCT01281917|26530073|FG000|Overall Study|Withdrawal by Subject|1|||
13307878|NCT01281865|26530086|FG000|Overall Study|Adverse Event|1|||
13307879|NCT01281865|26530087|FG001|Overall Study|Adverse Event|1|||
13307880|NCT01281865|26530086|FG000|Overall Study|Withdrawal by Subject|1|||
13307881|NCT01281865|26530087|FG001|Overall Study|Withdrawal by Subject|0|||
13307882|NCT01281865|26530086|FG000|Overall Study|Lack of Efficacy|1|||
13307883|NCT01281865|26530087|FG001|Overall Study|Lack of Efficacy|0|||
13307884|NCT01281839|26530155|FG000|Overall Study|Lost to Follow-up|6|||
13307885|NCT01281839|26530156|FG001|Overall Study|Lost to Follow-up|3|||
13307886|NCT01281839|26530155|FG000|Overall Study|Withdrawal by Subject|4|||
13307887|NCT01281839|26530156|FG001|Overall Study|Withdrawal by Subject|10|||
13307888|NCT01281839|26530155|FG000|Overall Study|Reason not specified|0|||
13307889|NCT01281839|26530156|FG001|Overall Study|Reason not specified|1|||
13307890|NCT01281813|26530180|FG000|Overall Study|Adverse Event|0|||
13307891|NCT01281813|26530181|FG001|Overall Study|Adverse Event|0|||
13307892|NCT01281813|26530182|FG002|Overall Study|Adverse Event|10|||
13307893|NCT01281813|26530180|FG000|Overall Study|Lost to Follow-up|0|||
13307894|NCT01281813|26530181|FG001|Overall Study|Lost to Follow-up|0|||
13307895|NCT01281813|26530182|FG002|Overall Study|Lost to Follow-up|31|||
13307896|NCT01281813|26530180|FG000|Overall Study|Withdrawal by Subject|0|||
13307897|NCT01281813|26530181|FG001|Overall Study|Withdrawal by Subject|0|||
13307898|NCT01281813|26530182|FG002|Overall Study|Withdrawal by Subject|13|||
13307899|NCT01281813|26530180|FG000|Overall Study|Subject Non-Compliant|0|||
13307900|NCT01281813|26530181|FG001|Overall Study|Subject Non-Compliant|0|||
13307901|NCT01281813|26530182|FG002|Overall Study|Subject Non-Compliant|6|||
13307902|NCT01281813|26530180|FG000|Overall Study|Subject Reached A Virologic Endpoint|0|||
13307903|NCT01281813|26530181|FG001|Overall Study|Subject Reached A Virologic Endpoint|0|||
13307904|NCT01281813|26530182|FG002|Overall Study|Subject Reached A Virologic Endpoint|5|||
13307905|NCT01281813|26530180|FG000|Overall Study|Sponsor's Decision|4|||
13307906|NCT01281813|26530181|FG001|Overall Study|Sponsor's Decision|3|||
13307907|NCT01281813|26530182|FG002|Overall Study|Sponsor's Decision|7|||
13307908|NCT01281813|26530180|FG000|Overall Study|Switched to Commercially Available Medication|0|||
13307909|NCT01281813|26530181|FG001|Overall Study|Switched to Commercially Available Medication|0|||
13307910|NCT01281813|26530182|FG002|Overall Study|Switched to Commercially Available Medication|26|||
13307911|NCT01281813|26530180|FG000|Overall Study|Other|0|||
13307912|NCT01281813|26530181|FG001|Overall Study|Other|1|||
13307913|NCT01281813|26530182|FG002|Overall Study|Other|39|||
13307914|NCT01281306|26530318|FG000|Overall Study|Lack of Efficacy|0|||
13307915|NCT01281306|26530319|FG001|Overall Study|Lack of Efficacy|1|||
13307916|NCT01281306|26530320|FG002|Overall Study|Lack of Efficacy|3|||
13307917|NCT01281306|26530321|FG003|Overall Study|Lack of Efficacy|0|||
13307918|NCT01281306|26530322|FG004|Overall Study|Lack of Efficacy|2|||
13307919|NCT01281306|26530323|FG005|Overall Study|Lack of Efficacy|0|||
13307920|NCT01281306|26530324|FG006|Overall Study|Lack of Efficacy|1|||
13307921|NCT01281306|26530318|FG000|Overall Study|Withdrawal by Subject|1|||
13307922|NCT01281306|26530319|FG001|Overall Study|Withdrawal by Subject|0|||
13307923|NCT01281306|26530320|FG002|Overall Study|Withdrawal by Subject|2|||
13307924|NCT01281306|26530321|FG003|Overall Study|Withdrawal by Subject|4|||
13307925|NCT01281306|26530322|FG004|Overall Study|Withdrawal by Subject|1|||
13307926|NCT01281306|26530323|FG005|Overall Study|Withdrawal by Subject|3|||
13307927|NCT01281306|26530324|FG006|Overall Study|Withdrawal by Subject|1|||
13307928|NCT01281306|26530318|FG000|Overall Study|Protocol deviation|0|||
13307929|NCT01281306|26530319|FG001|Overall Study|Protocol deviation|1|||
13307930|NCT01281306|26530320|FG002|Overall Study|Protocol deviation|1|||
13270271|NCT01405820|26424298|FG004|Randomized Treatment Period|Other|0|||
13270272|NCT01405820|26424299|FG005|Randomized Treatment Period|Other|0|||
13270273|NCT01405820|26424294|FG000|Randomized Treatment Period|Physician Decision|0|||
13270274|NCT01405820|26424295|FG001|Randomized Treatment Period|Physician Decision|2|||
13270275|NCT01405820|26424296|FG002|Randomized Treatment Period|Physician Decision|1|||
13270276|NCT01405820|26424297|FG003|Randomized Treatment Period|Physician Decision|0|||
13270277|NCT01405820|26424298|FG004|Randomized Treatment Period|Physician Decision|0|||
13270278|NCT01405820|26424299|FG005|Randomized Treatment Period|Physician Decision|0|||
13270279|NCT01405820|26424294|FG000|Randomized Treatment Period|Rescue|0|||
13307931|NCT01281306|26530321|FG003|Overall Study|Protocol deviation|1|||
13307932|NCT01281306|26530322|FG004|Overall Study|Protocol deviation|1|||
13307933|NCT01281306|26530323|FG005|Overall Study|Protocol deviation|0|||
13307934|NCT01281306|26530324|FG006|Overall Study|Protocol deviation|0|||
13307935|NCT01281306|26530318|FG000|Overall Study|Condition no longer requires study drug|1|||
13307936|NCT01281306|26530319|FG001|Overall Study|Condition no longer requires study drug|0|||
13270280|NCT01405820|26424295|FG001|Randomized Treatment Period|Rescue|1|||
13270281|NCT01405820|26424296|FG002|Randomized Treatment Period|Rescue|13|||
13270282|NCT01405820|26424297|FG003|Randomized Treatment Period|Rescue|10|||
13270283|NCT01405820|26424298|FG004|Randomized Treatment Period|Rescue|8|||
13270284|NCT01405820|26424299|FG005|Randomized Treatment Period|Rescue|8|||
13270285|NCT01405820|26424294|FG000|Randomized Treatment Period|Incorrect Study Treatment|0|||
13270286|NCT01405820|26424295|FG001|Randomized Treatment Period|Incorrect Study Treatment|0|||
13270287|NCT01405820|26424296|FG002|Randomized Treatment Period|Incorrect Study Treatment|3|||
13270288|NCT01405820|26424297|FG003|Randomized Treatment Period|Incorrect Study Treatment|0|||
13270289|NCT01405820|26424298|FG004|Randomized Treatment Period|Incorrect Study Treatment|2|||
13270290|NCT01405820|26424299|FG005|Randomized Treatment Period|Incorrect Study Treatment|0|||
13270291|NCT01405820|26424294|FG000|Randomized Treatment Period|Treatment Arm Closed|0|||
13270292|NCT01405820|26424295|FG001|Randomized Treatment Period|Treatment Arm Closed|0|||
13270293|NCT01405820|26424296|FG002|Randomized Treatment Period|Treatment Arm Closed|20|||
13118051|NCT03046446|25927653|FG000|Overall Study|Lost to Follow-up|3|||
13270294|NCT01405820|26424297|FG003|Randomized Treatment Period|Treatment Arm Closed|36|||
13270295|NCT01405820|26424298|FG004|Randomized Treatment Period|Treatment Arm Closed|33|||
13270296|NCT01405820|26424299|FG005|Randomized Treatment Period|Treatment Arm Closed|28|||
13270297|NCT01405820|26424294|FG000|Randomized Treatment Period|Death|0|||
13270298|NCT01405820|26424295|FG001|Randomized Treatment Period|Death|0|||
13270299|NCT01405820|26424296|FG002|Randomized Treatment Period|Death|0|||
13270300|NCT01405820|26424297|FG003|Randomized Treatment Period|Death|1|||
13270301|NCT01405820|26424298|FG004|Randomized Treatment Period|Death|0|||
13270302|NCT01405820|26424299|FG005|Randomized Treatment Period|Death|0|||
13270303|NCT01405820|26424294|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
13270304|NCT01405820|26424295|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
13270305|NCT01405820|26424296|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
13270306|NCT01405820|26424297|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1|||
13270307|NCT01405820|26424298|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
13270308|NCT01405820|26424299|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
13270309|NCT01405820|26424294|FG000|Open-Label Treatment Period|Withdrawal by Subject|3|||
13270310|NCT01405820|26424295|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
13270311|NCT01405820|26424296|FG002|Open-Label Treatment Period|Withdrawal by Subject|1|||
13270312|NCT01405820|26424297|FG003|Open-Label Treatment Period|Withdrawal by Subject|1|||
13270313|NCT01405820|26424298|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
13270314|NCT01405820|26424299|FG005|Open-Label Treatment Period|Withdrawal by Subject|1|||
13270315|NCT01405820|26424294|FG000|Open-Label Treatment Period|Other|1|||
13270316|NCT01405820|26424295|FG001|Open-Label Treatment Period|Other|1|||
13270317|NCT01405820|26424296|FG002|Open-Label Treatment Period|Other|1|||
13270318|NCT01405820|26424297|FG003|Open-Label Treatment Period|Other|1|||
13270319|NCT01405820|26424298|FG004|Open-Label Treatment Period|Other|1|||
13270320|NCT01405820|26424299|FG005|Open-Label Treatment Period|Other|1|||
13270321|NCT01405820|26424294|FG000|Open-Label Treatment Period|Physician Decision|0|||
13270322|NCT01405820|26424295|FG001|Open-Label Treatment Period|Physician Decision|0|||
13270323|NCT01405820|26424296|FG002|Open-Label Treatment Period|Physician Decision|1|||
13270324|NCT01405820|26424297|FG003|Open-Label Treatment Period|Physician Decision|2|||
13270325|NCT01405820|26424298|FG004|Open-Label Treatment Period|Physician Decision|1|||
13270326|NCT01405820|26424299|FG005|Open-Label Treatment Period|Physician Decision|0|||
13270327|NCT01405820|26424294|FG000|Open-Label Treatment Period|Adverse Event|0|||
13270328|NCT01405820|26424295|FG001|Open-Label Treatment Period|Adverse Event|0|||
13270329|NCT01405820|26424296|FG002|Open-Label Treatment Period|Adverse Event|0|||
13270330|NCT01405820|26424297|FG003|Open-Label Treatment Period|Adverse Event|1|||
13270331|NCT01405820|26424298|FG004|Open-Label Treatment Period|Adverse Event|0|||
13270332|NCT01405820|26424299|FG005|Open-Label Treatment Period|Adverse Event|0|||
13270333|NCT01405768|26424318|FG000|Overall Study|Didn't complete questionnaire correctly|4|||
13270334|NCT01405768|26424319|FG001|Overall Study|Didn't complete questionnaire correctly|0|||
13270335|NCT01405742|26424332|FG000|Overall Study|Lost to Follow-up|1|||
13270336|NCT01405742|26424333|FG001|Overall Study|Lost to Follow-up|0|||
13270337|NCT01405560|26424346|FG000|Overall Study|Physician Decision|1|||
13270338|NCT01405508|26424377|FG000|Overall Study|AE, non-serious non-fatal|1|||
13270339|NCT01405508|26424378|FG001|Overall Study|AE, non-serious non-fatal|1|||
13270340|NCT01405508|26424379|FG002|Overall Study|AE, non-serious non-fatal|0|||
13270341|NCT01405508|26424380|FG003|Overall Study|AE, non-serious non-fatal|0|||
13290722|NCT00100048|26481711|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1|||
13290723|NCT00100048|26481712|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4|||
13290724|NCT00100048|26481713|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2|||
13290725|NCT00100048|26481714|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
13290726|NCT00100048|26481715|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
13290727|NCT00100048|26481710|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
13290728|NCT00100048|26481711|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
13290729|NCT00100048|26481712|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
13270342|NCT01405456|26424415|FG000|Overall Study|Lost to Follow-up|2|||
13270343|NCT01405456|26424416|FG001|Overall Study|Lost to Follow-up|1|||
13270344|NCT01405456|26424415|FG000|Overall Study|Physician Decision|1|||
13270345|NCT01405456|26424416|FG001|Overall Study|Physician Decision|0|||
13270346|NCT01405196|26424514|FG000|Overall Study|Study Terminated by Sponsor|0|||
13270347|NCT01405196|26424515|FG001|Overall Study|Study Terminated by Sponsor|0|||
13270348|NCT01405196|26424516|FG002|Overall Study|Study Terminated by Sponsor|9|||
13270349|NCT01405196|26424517|FG003|Overall Study|Study Terminated by Sponsor|0|||
13270350|NCT01405196|26424514|FG000|Overall Study|Other|2|||
13270351|NCT01405196|26424515|FG001|Overall Study|Other|2|||
13270352|NCT01405196|26424516|FG002|Overall Study|Other|5|||
13270353|NCT01405196|26424517|FG003|Overall Study|Other|0|||
13270354|NCT01405196|26424514|FG000|Overall Study|Withdrawal by Subject|4|||
13270355|NCT01405196|26424515|FG001|Overall Study|Withdrawal by Subject|6|||
13270356|NCT01405196|26424516|FG002|Overall Study|Withdrawal by Subject|3|||
13270357|NCT01405196|26424517|FG003|Overall Study|Withdrawal by Subject|6|||
13270358|NCT01405196|26424514|FG000|Overall Study|Adverse Event|2|||
13270359|NCT01405196|26424515|FG001|Overall Study|Adverse Event|2|||
13270360|NCT01405196|26424516|FG002|Overall Study|Adverse Event|0|||
13270361|NCT01405196|26424517|FG003|Overall Study|Adverse Event|2|||
13270362|NCT01405196|26424514|FG000|Overall Study|Death|1|||
13270363|NCT01405196|26424515|FG001|Overall Study|Death|0|||
13270364|NCT01405196|26424516|FG002|Overall Study|Death|3|||
13270365|NCT01405196|26424517|FG003|Overall Study|Death|0|||
13270366|NCT01405196|26424514|FG000|Overall Study|Lost to Follow-up|2|||
13270367|NCT01405196|26424515|FG001|Overall Study|Lost to Follow-up|2|||
13270368|NCT01405196|26424516|FG002|Overall Study|Lost to Follow-up|3|||
13270369|NCT01405196|26424517|FG003|Overall Study|Lost to Follow-up|1|||
13270370|NCT01405053|26424548|FG000|Overall Study|Adverse Event|3|||
13270371|NCT01405053|26424549|FG001|Overall Study|Adverse Event|0|||
13270372|NCT01405053|26424548|FG000|Overall Study|Lost to Follow-up|0|||
13270373|NCT01405053|26424549|FG001|Overall Study|Lost to Follow-up|1|||
13270374|NCT01405053|26424548|FG000|Overall Study|Participant choice|2|||
13270375|NCT01405053|26424549|FG001|Overall Study|Participant choice|1|||
13270376|NCT01405053|26424548|FG000|Overall Study|Inadequate therapeutic effect|2|||
13270377|NCT01405053|26424549|FG001|Overall Study|Inadequate therapeutic effect|1|||
13270378|NCT01405053|26424548|FG000|Overall Study|Withdrawal by Subject|3|||
13270379|NCT01405053|26424549|FG001|Overall Study|Withdrawal by Subject|4|||
13270380|NCT01405053|26424548|FG000|Overall Study|Other|0|||
13270381|NCT01405053|26424549|FG001|Overall Study|Other|1|||
13270382|NCT01405027|26424570|FG000|Overall Study|Withdrawn consent|3|||
13270383|NCT01405027|26424571|FG001|Overall Study|Withdrawn consent|0|||
13270384|NCT01405027|26424570|FG000|Overall Study|Lost to Follow-up|16|||
13270385|NCT01405027|26424571|FG001|Overall Study|Lost to Follow-up|24|||
13270386|NCT01405027|26424570|FG000|Overall Study|Investigator judgement|0|||
13270387|NCT01405027|26424571|FG001|Overall Study|Investigator judgement|2|||
13270388|NCT01405027|26424570|FG000|Overall Study|Death|1|||
13270389|NCT01405027|26424571|FG001|Overall Study|Death|0|||
13270390|NCT01405027|26424570|FG000|Overall Study|Other or Unknown|12|||
13270391|NCT01405027|26424571|FG001|Overall Study|Other or Unknown|25|||
13270392|NCT01404988|26424598|FG000|Overall Study|Death|2|||
13270393|NCT01404988|26424599|FG001|Overall Study|Death|0|||
13270394|NCT01404988|26424600|FG002|Overall Study|Death|2|||
13270395|NCT01404988|26424598|FG000|Overall Study|Adverse Event|1|||
13270396|NCT01404988|26424599|FG001|Overall Study|Adverse Event|0|||
13270397|NCT01404988|26424600|FG002|Overall Study|Adverse Event|0|||
13270398|NCT01404988|26424598|FG000|Overall Study|Withdrawal by Subject|2|||
13270399|NCT01404988|26424599|FG001|Overall Study|Withdrawal by Subject|2|||
13270400|NCT01404988|26424600|FG002|Overall Study|Withdrawal by Subject|0|||
13270401|NCT01404988|26424598|FG000|Overall Study|Lost to Follow-up|1|||
13270402|NCT01404988|26424599|FG001|Overall Study|Lost to Follow-up|2|||
13270403|NCT01404988|26424600|FG002|Overall Study|Lost to Follow-up|1|||
13270404|NCT01404949|26424612|FG000|Overall Study|Not Treated|1|||
13118052|NCT03046446|25927653|FG000|Overall Study|Withdrawal by Subject|14|||
13118053|NCT03046446|25927653|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3|||
13118054|NCT03046446|25927653|FG000|Overall Study|Disease Progression (see caveats)|25|||
13118055|NCT03046446|25927653|FG000|Overall Study|Non OA related knee surgery|1|||
13118056|NCT03046056|25927713|FG000|Overall Study|Non-responder at Week 10|6|||
13118057|NCT03046056|25927714|FG001|Overall Study|Non-responder at Week 10|6|||
13118058|NCT03046056|25927715|FG002|Overall Study|Non-responder at Week 10|4|||
13118059|NCT03046056|25927713|FG000|Overall Study|Protocol-specified Disease Worsening|3|||
13270405|NCT01404325|26424675|FG000|Overall Study|Lost to Follow-up|1|||
13270406|NCT01404325|26424676|FG001|Overall Study|Lost to Follow-up|0|||
13270407|NCT01404325|26424675|FG000|Overall Study|Death|2|||
13270408|NCT01404325|26424676|FG001|Overall Study|Death|0|||
13270409|NCT01404325|26424675|FG000|Overall Study|Graft loss/Retransplantation|1|||
13270410|NCT01404325|26424676|FG001|Overall Study|Graft loss/Retransplantation|0|||
13270411|NCT01404325|26424675|FG000|Overall Study|non-specified reason|0|||
13270412|NCT01404325|26424676|FG001|Overall Study|non-specified reason|2|||
13270413|NCT01404234|26424692|FG000|Overall Study|Withdrawal by Subject|2|||
13118060|NCT03046056|25927714|FG001|Overall Study|Protocol-specified Disease Worsening|3|||
13118061|NCT03046056|25927715|FG002|Overall Study|Protocol-specified Disease Worsening|1|||
13118062|NCT03046056|25927713|FG000|Overall Study|Adverse Event|1|||
13118063|NCT03046056|25927714|FG001|Overall Study|Adverse Event|5|||
13118064|NCT03046056|25927715|FG002|Overall Study|Adverse Event|0|||
13118065|NCT03046056|25927713|FG000|Overall Study|Non-compliance With Study Drug|0|||
13118066|NCT03046056|25927714|FG001|Overall Study|Non-compliance With Study Drug|0|||
13118067|NCT03046056|25927715|FG002|Overall Study|Non-compliance With Study Drug|2|||
13118068|NCT03046056|25927713|FG000|Overall Study|Protocol Violation|1|||
13118069|NCT03046056|25927714|FG001|Overall Study|Protocol Violation|1|||
13118070|NCT03046056|25927715|FG002|Overall Study|Protocol Violation|0|||
13118071|NCT03046056|25927713|FG000|Overall Study|Investigator's Discretion|0|||
13270414|NCT01404208|26424707|FG000|Overall Study|Discontinued|3|||
13270415|NCT01404208|26424708|FG001|Overall Study|Discontinued|0|||
13270416|NCT01403987|26424732|FG000|Overall Study|Residents forgot their secret PIN|18|||
13270417|NCT01403987|26424733|FG001|Overall Study|Residents forgot their secret PIN|17|||
13270418|NCT01403987|26424734|FG002|Overall Study|Residents forgot their secret PIN|18|||
13270419|NCT01403805|26424753|FG000|Overall Study|Withdrawal by Subject|0|||
13270420|NCT01403805|26424754|FG001|Overall Study|Withdrawal by Subject|4|||
13270421|NCT01403805|26424753|FG000|Overall Study|Lost to Follow-up|0|||
13270422|NCT01403805|26424754|FG001|Overall Study|Lost to Follow-up|2|||
13270423|NCT01403805|26424753|FG000|Overall Study|Death|0|||
13270424|NCT01403805|26424754|FG001|Overall Study|Death|1|||
13270425|NCT01403610|26424777|FG000|Overall Study|Withdrawal by Subject|2|||
13270426|NCT01403610|26424778|FG001|Overall Study|Withdrawal by Subject|0|||
13270427|NCT01403610|26424779|FG002|Overall Study|Withdrawal by Subject|0|||
13270428|NCT01403610|26424780|FG003|Overall Study|Withdrawal by Subject|0|||
13270429|NCT01403610|26424777|FG000|Overall Study|Didn't recover from surgery sufficiently|0|||
13270430|NCT01403610|26424778|FG001|Overall Study|Didn't recover from surgery sufficiently|3|||
13270431|NCT01403610|26424779|FG002|Overall Study|Didn't recover from surgery sufficiently|0|||
13270432|NCT01403610|26424780|FG003|Overall Study|Didn't recover from surgery sufficiently|0|||
13270433|NCT01403194|26424788|FG000|Overall Study|Screen Failure|2|||
13270434|NCT01403194|26424788|FG000|Overall Study|Lost to Follow-up|8|||
13270435|NCT01403116|26424802|FG000|Overall Study|Adverse Event|7|||
13270436|NCT01403116|26424803|FG001|Overall Study|Adverse Event|4|||
13270437|NCT01403116|26424802|FG000|Overall Study|Lost to Follow-up|7|||
13270438|NCT01403116|26424803|FG001|Overall Study|Lost to Follow-up|5|||
13270439|NCT01403116|26424802|FG000|Overall Study|Withdrawal by Subject|12|||
13270440|NCT01403116|26424803|FG001|Overall Study|Withdrawal by Subject|15|||
13270441|NCT01403116|26424802|FG000|Overall Study|Non-compliance of study drug|3|||
13270442|NCT01403116|26424803|FG001|Overall Study|Non-compliance of study drug|0|||
13270443|NCT01403116|26424802|FG000|Overall Study|Protocol Violation|0|||
13270444|NCT01403116|26424803|FG001|Overall Study|Protocol Violation|1|||
13270445|NCT01403116|26424802|FG000|Overall Study|undisclosed Hx of Prostate Ca|1|||
13270446|NCT01403116|26424803|FG001|Overall Study|undisclosed Hx of Prostate Ca|0|||
13270447|NCT01403116|26424802|FG000|Overall Study|Hct >54%|2|||
13270448|NCT01403116|26424803|FG001|Overall Study|Hct >54%|0|||
13270449|NCT01403116|26424802|FG000|Overall Study|unable to keep appointments|0|||
13270450|NCT01403116|26424803|FG001|Overall Study|unable to keep appointments|2|||
13270451|NCT01403064|26424877|FG000|Overall Study|Death|0|||
13270452|NCT01403064|26424878|FG001|Overall Study|Death|0|||
13270453|NCT01403064|26424879|FG002|Overall Study|Death|1|||
13270454|NCT01403064|26424880|FG003|Overall Study|Death|1|||
13270455|NCT01403064|26424877|FG000|Overall Study|Withdrawal by Subject|0|||
13270456|NCT01403064|26424878|FG001|Overall Study|Withdrawal by Subject|0|||
13270457|NCT01403064|26424879|FG002|Overall Study|Withdrawal by Subject|1|||
13270458|NCT01403064|26424880|FG003|Overall Study|Withdrawal by Subject|1|||
13270459|NCT01403064|26424877|FG000|Overall Study|Other|1|||
13270460|NCT01403064|26424878|FG001|Overall Study|Other|0|||
13270461|NCT01403064|26424879|FG002|Overall Study|Other|2|||
13270462|NCT01403064|26424880|FG003|Overall Study|Other|1|||
13270463|NCT01403051|26424919|FG000|Overall Study|Protocol Violation|2|||
13270464|NCT01403051|26424920|FG001|Overall Study|Protocol Violation|0|||
13270465|NCT01403051|26424919|FG000|Overall Study|Death|1|||
13270466|NCT01403051|26424920|FG001|Overall Study|Death|0|||
13270467|NCT01403051|26424919|FG000|Overall Study|Withdrawal by Subject|2|||
13270468|NCT01403051|26424920|FG001|Overall Study|Withdrawal by Subject|1|||
13270469|NCT01403051|26424919|FG000|Overall Study|Lost to Follow-up|5|||
13270470|NCT01403051|26424920|FG001|Overall Study|Lost to Follow-up|5|||
13270471|NCT01402986|26425066|FG000|Overall Study|Withdrawal by Subject|7|||
13270472|NCT01402986|26425067|FG001|Overall Study|Withdrawal by Subject|10|||
13270473|NCT01402986|26425068|FG002|Overall Study|Withdrawal by Subject|7|||
13270474|NCT01402986|26425069|FG003|Overall Study|Withdrawal by Subject|13|||
13118072|NCT03046056|25927714|FG001|Overall Study|Investigator's Discretion|1|||
13118073|NCT03046056|25927715|FG002|Overall Study|Investigator's Discretion|0|||
13270475|NCT01402986|26425066|FG000|Overall Study|Death|0|||
13270476|NCT01402986|26425067|FG001|Overall Study|Death|0|||
13270477|NCT01402986|26425068|FG002|Overall Study|Death|0|||
13270478|NCT01402986|26425069|FG003|Overall Study|Death|2|||
13270479|NCT01402986|26425066|FG000|Overall Study|Lost to Follow-up|0|||
13270480|NCT01402986|26425067|FG001|Overall Study|Lost to Follow-up|0|||
13270481|NCT01402986|26425068|FG002|Overall Study|Lost to Follow-up|0|||
13270482|NCT01402986|26425069|FG003|Overall Study|Lost to Follow-up|1|||
13270483|NCT01402986|26425066|FG000|Overall Study|Other|2|||
13270484|NCT01402986|26425067|FG001|Overall Study|Other|5|||
13270485|NCT01402986|26425068|FG002|Overall Study|Other|1|||
13270486|NCT01402986|26425069|FG003|Overall Study|Other|6|||
13270487|NCT01402947|26425084|FG000|First Intervention|Adverse Event|0|||
13270488|NCT01402947|26425085|FG001|First Intervention|Adverse Event|1|||
13270489|NCT01402908|26425104|FG000|Overall Study|Withdrawal by Subject|30|||
13270490|NCT01402908|26425105|FG001|Overall Study|Withdrawal by Subject|17|||
13270491|NCT01402908|26425104|FG000|Overall Study|Lost to Follow-up|3|||
13270492|NCT01402908|26425105|FG001|Overall Study|Lost to Follow-up|1|||
13270493|NCT01402908|26425104|FG000|Overall Study|Physician Decision|1|||
13270494|NCT01402908|26425105|FG001|Overall Study|Physician Decision|0|||
13270495|NCT01402869|26425129|FG000|Overall Study|Required Tooth Extraction|0|||
13270496|NCT01402869|26425130|FG001|Overall Study|Required Tooth Extraction|0|||
13270497|NCT01402869|26425131|FG002|Overall Study|Required Tooth Extraction|1|||
13270498|NCT01402817|26425138|FG000|Overall Study|Withdrawal by Subject|3|||
13270499|NCT01402817|26425138|FG000|Overall Study|Study Suspended by FDA|8|||
13270500|NCT01402700|26425144|FG000|Overall Study|Death|3|||
13270501|NCT01402700|26425144|FG000|Overall Study|Withdrawal by Subject|3|||
13270502|NCT01402700|26425144|FG000|Overall Study|Missed Visit|1|||
13270503|NCT01402570|26425153|FG000|Overall Study|Adverse Event|1|||
13270504|NCT01402544|26425161|FG000|Overall Study|Withdrawal by Subject|6|||
13270505|NCT01402492|26425179|FG000|Overall Study|Withdrawal by Subject|17|||
13270506|NCT01402492|26425180|FG001|Overall Study|Withdrawal by Subject|11|||
13270507|NCT01402492|26425181|FG002|Overall Study|Withdrawal by Subject|11|||
13270508|NCT01402492|26425179|FG000|Overall Study|Adverse Event|2|||
13270509|NCT01402492|26425180|FG001|Overall Study|Adverse Event|3|||
13270510|NCT01402492|26425181|FG002|Overall Study|Adverse Event|4|||
13270511|NCT01402492|26425179|FG000|Overall Study|Physician Decision|0|||
13270512|NCT01402492|26425180|FG001|Overall Study|Physician Decision|3|||
13270513|NCT01402492|26425181|FG002|Overall Study|Physician Decision|0|||
13270514|NCT01402492|26425179|FG000|Overall Study|Incarcerated (N=3)|2|||
13118074|NCT03046056|25927713|FG000|Overall Study|Withdrew Consent|1|||
13270515|NCT01402492|26425180|FG001|Overall Study|Incarcerated (N=3)|0|||
13270516|NCT01402492|26425181|FG002|Overall Study|Incarcerated (N=3)|1|||
13270517|NCT01402284|26425194|FG000|Overall Study|Withdrawal consent|2|||
13270518|NCT01402284|26425194|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1|||
13270519|NCT01402284|26425194|FG000|Overall Study|Physician Decision|1|||
13270520|NCT01402284|26425194|FG000|Overall Study|Disease progression on study|10|||
13270521|NCT01402102|26425219|FG000|Overall Study|Protocol Violation|1|||
13270522|NCT01402102|26425220|FG001|Overall Study|Protocol Violation|0|||
13270523|NCT01402102|26425219|FG000|Overall Study|Insufficiency of compliance|1|||
13270524|NCT01402102|26425220|FG001|Overall Study|Insufficiency of compliance|1|||
13270525|NCT01402102|26425219|FG000|Overall Study|Withdrawal by Subject|0|||
13270526|NCT01402102|26425220|FG001|Overall Study|Withdrawal by Subject|2|||
13270527|NCT01402063|26425233|FG000|Overall Study|Withdrawal by Subject|3|||
13270528|NCT01402063|26425234|FG001|Overall Study|Withdrawal by Subject|3|||
13270529|NCT01402011|26425270|FG000|Delayed Treatment Period|Withdrawal by Subject|1|||
13270530|NCT01402011|26425271|FG001|Delayed Treatment Period|Withdrawal by Subject|0|||
13270531|NCT01402011|26425272|FG002|Delayed Treatment Period|Withdrawal by Subject|0|||
13270532|NCT01402011|26425270|FG000|Active Treatment Period|Withdrawal by Subject|1|||
13270533|NCT01402011|26425271|FG001|Active Treatment Period|Withdrawal by Subject|3|||
13270534|NCT01402011|26425272|FG002|Active Treatment Period|Withdrawal by Subject|0|||
13270535|NCT01402011|26425270|FG000|Nine Month Follow-up|Withdrawal by Subject|0|||
13270536|NCT01402011|26425271|FG001|Nine Month Follow-up|Withdrawal by Subject|1|||
13270537|NCT01402011|26425272|FG002|Nine Month Follow-up|Withdrawal by Subject|0|||
13270538|NCT01401959|26425296|FG000|Enrolled|Withdrawal by Subject|1|||
13270539|NCT01401959|26425297|FG001|Enrolled|Withdrawal by Subject|0|||
13270540|NCT01401959|26425298|FG002|Enrolled|Withdrawal by Subject|0|||
13270541|NCT01401959|26425296|FG000|Treated|Disease Progression|2|||
13270542|NCT01401959|26425297|FG001|Treated|Disease Progression|2|||
13270543|NCT01401959|26425298|FG002|Treated|Disease Progression|1|||
13270544|NCT01401959|26425296|FG000|Treated|Adverse Event|4|||
13270545|NCT01401959|26425297|FG001|Treated|Adverse Event|3|||
13270546|NCT01401959|26425298|FG002|Treated|Adverse Event|2|||
13270547|NCT01401959|26425296|FG000|Treated|Withdrawal by Subject|1|||
13270548|NCT01401959|26425297|FG001|Treated|Withdrawal by Subject|2|||
13270549|NCT01401959|26425298|FG002|Treated|Withdrawal by Subject|2|||
13270550|NCT01401959|26425296|FG000|Treated|Protocol Violation|0|||
13270551|NCT01401959|26425297|FG001|Treated|Protocol Violation|1|||
13270552|NCT01401959|26425298|FG002|Treated|Protocol Violation|0|||
13270553|NCT01401842|26425315|FG000|Overall Study|Withdrawal by Subject|3|||
13307937|NCT01281306|26530320|FG002|Overall Study|Condition no longer requires study drug|0|||
13270554|NCT01401842|26425316|FG001|Overall Study|Withdrawal by Subject|2|||
13270555|NCT01401842|26425315|FG000|Overall Study|academic reason|4|||
13270556|NCT01401842|26425316|FG001|Overall Study|academic reason|1|||
13270557|NCT01401842|26425315|FG000|Overall Study|changed companies|20|||
13270558|NCT01401842|26425316|FG001|Overall Study|changed companies|34|||
13270559|NCT01401842|26425315|FG000|Overall Study|discharged from US Army|3|||
13270560|NCT01401842|26425316|FG001|Overall Study|discharged from US Army|4|||
13270561|NCT01401842|26425315|FG000|Overall Study|invalid follow-up strength data|1|||
13270562|NCT01401842|26425316|FG001|Overall Study|invalid follow-up strength data|4|||
13270563|NCT01401842|26425315|FG000|Overall Study|on profile|9|||
13270564|NCT01401842|26425316|FG001|Overall Study|on profile|5|||
13270565|NCT01401842|26425315|FG000|Overall Study|other/unknown|28|||
13270566|NCT01401842|26425316|FG001|Overall Study|other/unknown|17|||
13270567|NCT01401647|26425337|FG000|Overall Study|Withdrawal by Subject|1|||
13270568|NCT01401647|26425338|FG001|Overall Study|Withdrawal by Subject|5|||
13270569|NCT01401647|26425339|FG002|Overall Study|Withdrawal by Subject|2|||
13270570|NCT01401647|26425337|FG000|Overall Study|Lost to Follow-up|3|||
13270571|NCT01401647|26425338|FG001|Overall Study|Lost to Follow-up|3|||
13270572|NCT01401647|26425339|FG002|Overall Study|Lost to Follow-up|1|||
13270573|NCT01401530|26425386|FG000|Overall Study|Disease Progression|1|||
13270574|NCT01401530|26425387|FG001|Overall Study|Disease Progression|2|||
13270575|NCT01401530|26425388|FG002|Overall Study|Disease Progression|1|||
13270576|NCT01401530|26425386|FG000|Overall Study|Adverse Event|1|||
13270577|NCT01401530|26425387|FG001|Overall Study|Adverse Event|1|||
13270578|NCT01401530|26425388|FG002|Overall Study|Adverse Event|1|||
13270579|NCT01401530|26425386|FG000|Overall Study|Participant Choice|1|||
13270580|NCT01401530|26425387|FG001|Overall Study|Participant Choice|2|||
13270581|NCT01401530|26425388|FG002|Overall Study|Participant Choice|1|||
13270582|NCT01401530|26425386|FG000|Overall Study|Physician Decision|0|||
13270583|NCT01401530|26425387|FG001|Overall Study|Physician Decision|1|||
13270584|NCT01401530|26425388|FG002|Overall Study|Physician Decision|0|||
13270585|NCT01401478|26425401|FG000|Overall Study|Study drug not available|6|||
13270586|NCT01401478|26425401|FG000|Overall Study|Adverse Event|5|||
13270587|NCT01401478|26425401|FG000|Overall Study|Hyperphosphatemia|5|||
13270588|NCT01401478|26425401|FG000|Overall Study|Lost to Follow-up|5|||
13270589|NCT01401478|26425401|FG000|Overall Study|Kidney transplantation|3|||
13270590|NCT01401478|26425401|FG000|Overall Study|Withdrawal by Subject|3|||
13270591|NCT01401478|26425401|FG000|Overall Study|Blood samples not available|1|||
13270592|NCT01401478|26425401|FG000|Overall Study|Hyperphosphatemia and adverse event|1|||
13270593|NCT01401478|26425401|FG000|Overall Study|Low intact parathyroid hormone|1|||
13270594|NCT01401478|26425401|FG000|Overall Study|Serious adverse event|1|||
13270595|NCT01401465|26425471|FG000|Treatment Period 1|Adverse Event|4|||
13270596|NCT01401465|26425472|FG001|Treatment Period 1|Adverse Event|1|||
13270597|NCT01401465|26425471|FG000|Treatment Period 1|Pregnancy|0|||
13270598|NCT01401465|26425472|FG001|Treatment Period 1|Pregnancy|1|||
13270599|NCT01401465|26425471|FG000|Treatment Period 1|Protocol Violation|5|||
13270600|NCT01401465|26425472|FG001|Treatment Period 1|Protocol Violation|0|||
13270601|NCT01401465|26425471|FG000|Treatment Period 1|Withdrawal by Subject|1|||
13270602|NCT01401465|26425472|FG001|Treatment Period 1|Withdrawal by Subject|4|||
13270603|NCT01401465|26425471|FG000|Treatment Period 1|Non-Compliance to Study Drug|1|||
13270604|NCT01401465|26425472|FG001|Treatment Period 1|Non-Compliance to Study Drug|0|||
13270605|NCT01401465|26425471|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3|||
13270606|NCT01401465|26425472|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9|||
13270607|NCT01401465|26425471|FG000|Treatment Period 1|Scheduling Difficulties|1|||
13270608|NCT01401465|26425472|FG001|Treatment Period 1|Scheduling Difficulties|1|||
13270609|NCT01401465|26425471|FG000|Treatment Period 2|Lost to Follow-up|0|||
13270610|NCT01401465|26425472|FG001|Treatment Period 2|Lost to Follow-up|1|||
13270611|NCT01401465|26425471|FG000|Treatment Period 2|Withdrawal by Subject|0|||
13270612|NCT01401465|26425472|FG001|Treatment Period 2|Withdrawal by Subject|1|||
13270613|NCT01401452|26425486|FG000|Overall Study|Adverse reaction|9|||
13270614|NCT01401452|26425486|FG000|Overall Study|Lost to Follow-up|12|||
13270615|NCT01401452|26425486|FG000|Overall Study|Lack of Efficacy|30|||
13270616|NCT01401452|26425486|FG000|Overall Study|Participant developed breast cancer|1|||
13270617|NCT01401452|26425486|FG000|Overall Study|Tx stopped due to financial reasons|1|||
13270618|NCT01401452|26425486|FG000|Overall Study|Tx stopped by psychiatrist|1|||
13270619|NCT01401452|26425486|FG000|Overall Study|No more visits within the 36 wk followup|4|||
13118075|NCT03046056|25927714|FG001|Overall Study|Withdrew Consent|0|||
13118076|NCT03046056|25927715|FG002|Overall Study|Withdrew Consent|0|||
13118077|NCT03045887|25927884|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3|||
13118078|NCT03045887|25927885|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
13118079|NCT03045887|25927886|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
13118080|NCT03045887|25927887|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
13270620|NCT01401452|26425486|FG000|Overall Study|Subject did not come to follow up visits|2|||
13270621|NCT01401452|26425486|FG000|Overall Study|Subject didn't return for routine visits|1|||
13270622|NCT01401452|26425486|FG000|Overall Study|Subject moved to another city|1|||
13118081|NCT03045887|25927888|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
13118082|NCT03045887|25927889|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
13118083|NCT03045887|25927890|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
13118084|NCT03045887|25927891|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
13118085|NCT03045887|25927892|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
13118086|NCT03045887|25927893|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
13118087|NCT03045887|25927884|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
13118088|NCT03045887|25927885|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
13118089|NCT03045887|25927886|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
13118090|NCT03045887|25927887|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1|||
13118091|NCT03045887|25927888|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
13118092|NCT03045887|25927889|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
13118093|NCT03045887|25927890|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
13118094|NCT03045887|25927891|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
13118095|NCT03045887|25927892|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
13118096|NCT03045887|25927893|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
13118097|NCT03045887|25927884|FG000|Part A, Period 2 (1 Day)|Adverse Event|1|||
13118098|NCT03045887|25927885|FG001|Part A, Period 2 (1 Day)|Adverse Event|0|||
13118099|NCT03045887|25927886|FG002|Part A, Period 2 (1 Day)|Adverse Event|0|||
13270623|NCT01401452|26425486|FG000|Overall Study|Subject's wife wants to get pregnant|1|||
13270624|NCT01401452|26425486|FG000|Overall Study|Psoriatic arthritis|1|||
13270625|NCT01401452|26425486|FG000|Overall Study|Participant stopped Tx|2|||
13270626|NCT01401452|26425486|FG000|Overall Study|Discontinuation for personal reasons|1|||
13270627|NCT01401452|26425486|FG000|Overall Study|Treatment failure|1|||
13270628|NCT01401452|26425486|FG000|Overall Study|Unsatisfactory output|1|||
13270629|NCT01401452|26425486|FG000|Overall Study|Subject withdrew because of Tx success|1|||
13270630|NCT01401452|26425486|FG000|Overall Study|Subject chose to discontinue treatment|1|||
13270631|NCT01401452|26425486|FG000|Overall Study|Participant withdrew consent|1|||
13270632|NCT01401361|26425494|FG000|Overall Study|Withdrawal by Subject|16|||
13270633|NCT01401361|26425494|FG000|Overall Study|Lack of Efficacy|6|||
13270634|NCT01401361|26425494|FG000|Overall Study|Physician Decision|1|||
13270635|NCT01401361|26425494|FG000|Overall Study|Lost to Follow-up|3|||
13270636|NCT01401361|26425494|FG000|Overall Study|Subject/family decision post procedure|2|||
13270637|NCT01401322|26425500|FG000|Overall Study|Withdrawal by Subject|1|||
13270638|NCT01401322|26425500|FG000|Overall Study|Physician Decision|1|||
13270639|NCT01401283|26425515|FG000|Overall Study|surgery cancelled|5|||
13270640|NCT01401283|26425516|FG001|Overall Study|surgery cancelled|8|||
13270641|NCT01401283|26425515|FG000|Overall Study|preoperative arrhythmia|5|||
13270642|NCT01401283|26425516|FG001|Overall Study|preoperative arrhythmia|0|||
13270643|NCT01401283|26425515|FG000|Overall Study|no central venous access|0|||
13270644|NCT01401283|26425516|FG001|Overall Study|no central venous access|1|||
13270645|NCT01401283|26425515|FG000|Overall Study|suspicion of malignant hyperthermia|0|||
13270646|NCT01401283|26425516|FG001|Overall Study|suspicion of malignant hyperthermia|1|||
13270647|NCT01401153|26425555|FG000|First Test Day|Learning disabilities; illness|1|||
13270648|NCT01401153|26425556|FG001|First Test Day|Learning disabilities; illness|10|||
13270649|NCT01401153|26425555|FG000|Second Test Day|illness|0|||
13270650|NCT01401153|26425556|FG001|Second Test Day|illness|5|||
13270651|NCT01401062|26425569|FG000|Overall Study|Death|9|||
13270652|NCT01401062|26425570|FG001|Overall Study|Death|7|||
13270653|NCT01401062|26425569|FG000|Overall Study|Physician Decision|1|||
13270654|NCT01401062|26425570|FG001|Overall Study|Physician Decision|0|||
13270655|NCT01401062|26425569|FG000|Overall Study|Withdrawal by Subject|1|||
13270656|NCT01401062|26425570|FG001|Overall Study|Withdrawal by Subject|1|||
13270657|NCT01401010|26425600|FG000|Overall Study|Could not interpret assay results|1|||
13270658|NCT01401010|26425601|FG001|Overall Study|Could not interpret assay results|0|||
13270659|NCT01400971|26425610|FG000|Overall Study|Death|82|||
13270660|NCT01400971|26425610|FG000|Overall Study|Lost to Follow-up|196|||
13270661|NCT01400971|26425610|FG000|Overall Study|Lost to follow up + Subject Decision|2|||
13270662|NCT01400971|26425610|FG000|Overall Study|Physician Decision|57|||
13270663|NCT01400971|26425610|FG000|Overall Study|Withdrawal by Subject|158|||
13270664|NCT01400971|26425610|FG000|Overall Study|Other|422|||
13270665|NCT01400958|26425625|FG000|Overall Study|Physician Decision|0|||
13270666|NCT01400958|26425626|FG001|Overall Study|Physician Decision|1|||
13270667|NCT01400958|26425625|FG000|Overall Study|Withdrawal by Subject|0|||
13270668|NCT01400958|26425626|FG001|Overall Study|Withdrawal by Subject|1|||
13270669|NCT01400958|26425625|FG000|Overall Study|Adverse Event|1|||
13270670|NCT01400958|26425626|FG001|Overall Study|Adverse Event|0|||
13270671|NCT01400932|26425655|FG000|Overall Study|Adverse Event|10|||
13270672|NCT01400932|26425656|FG001|Overall Study|Adverse Event|5|||
13118100|NCT03045887|25927887|FG003|Part A, Period 2 (1 Day)|Adverse Event|0|||
13118101|NCT03045887|25927888|FG004|Part A, Period 2 (1 Day)|Adverse Event|0|||
13270673|NCT01400932|26425655|FG000|Overall Study|Lack of Efficacy|0|||
13270674|NCT01400932|26425656|FG001|Overall Study|Lack of Efficacy|3|||
13270675|NCT01400932|26425655|FG000|Overall Study|Withdrawal by Subject|2|||
13270676|NCT01400932|26425656|FG001|Overall Study|Withdrawal by Subject|6|||
13270677|NCT01400932|26425655|FG000|Overall Study|Lost to Follow-up|1|||
13270678|NCT01400932|26425656|FG001|Overall Study|Lost to Follow-up|0|||
13270679|NCT01400932|26425655|FG000|Overall Study|Protocol Deviation|0|||
13270680|NCT01400932|26425656|FG001|Overall Study|Protocol Deviation|1|||
13270681|NCT01400932|26425655|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
13270682|NCT01400932|26425656|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
13270683|NCT01400919|26425662|FG000|Overall Study|Withdrawal by Subject|4|||
13270684|NCT01400919|26425662|FG000|Overall Study|Lost to Follow-up|2|||
13270685|NCT01400919|26425662|FG000|Overall Study|Missed visit|2|||
13270686|NCT01400893|26425677|FG000|Overall Study|Death|27|||
13270687|NCT01400893|26425678|FG001|Overall Study|Death|21|||
13270688|NCT01400893|26425677|FG000|Overall Study|Lost to Follow-up|0|||
13270689|NCT01400893|26425678|FG001|Overall Study|Lost to Follow-up|6|||
13270690|NCT01400841|26425714|FG000|Initial Study Phase (6 Months)|Death|1|||
13270691|NCT01400841|26425714|FG000|Extended Study Phase (2 Years)|Adverse Event|2|||
13270692|NCT01400815|26425727|FG000|Overall Study|Adverse Event|3|||
13270693|NCT01400815|26425728|FG001|Overall Study|Adverse Event|0|||
13270694|NCT01400815|26425727|FG000|Overall Study|Death|0|||
13270695|NCT01400815|26425728|FG001|Overall Study|Death|1|||
13270696|NCT01400815|26425727|FG000|Overall Study|Lost to Follow-up|18|||
13270697|NCT01400815|26425728|FG001|Overall Study|Lost to Follow-up|11|||
13270698|NCT01400815|26425727|FG000|Overall Study|Protocol Violation|0|||
13270699|NCT01400815|26425728|FG001|Overall Study|Protocol Violation|1|||
13270700|NCT01400815|26425727|FG000|Overall Study|Physician Decision|1|||
13270701|NCT01400815|26425728|FG001|Overall Study|Physician Decision|0|||
13270702|NCT01400815|26425727|FG000|Overall Study|Withdrawal by Subject|15|||
13270703|NCT01400815|26425728|FG001|Overall Study|Withdrawal by Subject|8|||
13270704|NCT01400815|26425727|FG000|Overall Study|Subject in jail|1|||
13270705|NCT01400815|26425728|FG001|Overall Study|Subject in jail|0|||
13270706|NCT01400698|26425765|FG000|Overall Study|Lost to Follow-up|2|||
13270707|NCT01400698|26425766|FG001|Overall Study|Lost to Follow-up|5|||
13270708|NCT01400698|26425767|FG002|Overall Study|Lost to Follow-up|2|||
13270709|NCT01400698|26425768|FG003|Overall Study|Lost to Follow-up|1|||
13270710|NCT01400698|26425769|FG004|Overall Study|Lost to Follow-up|4|||
13270711|NCT01400698|26425770|FG005|Overall Study|Lost to Follow-up|3|||
13270712|NCT01400698|26425765|FG000|Overall Study|Withdrawal by Subject|8|||
13270713|NCT01400698|26425766|FG001|Overall Study|Withdrawal by Subject|2|||
13270714|NCT01400698|26425767|FG002|Overall Study|Withdrawal by Subject|0|||
13270715|NCT01400698|26425768|FG003|Overall Study|Withdrawal by Subject|4|||
13270716|NCT01400698|26425769|FG004|Overall Study|Withdrawal by Subject|1|||
13270717|NCT01400698|26425770|FG005|Overall Study|Withdrawal by Subject|3|||
13270718|NCT01400698|26425765|FG000|Overall Study|Protocol Violation|0|||
13270719|NCT01400698|26425766|FG001|Overall Study|Protocol Violation|1|||
13270720|NCT01400698|26425767|FG002|Overall Study|Protocol Violation|0|||
13270721|NCT01400698|26425768|FG003|Overall Study|Protocol Violation|0|||
13270722|NCT01400698|26425769|FG004|Overall Study|Protocol Violation|1|||
13270723|NCT01400698|26425770|FG005|Overall Study|Protocol Violation|0|||
13270724|NCT01400698|26425765|FG000|Overall Study|Non-compliance|0|||
13270725|NCT01400698|26425766|FG001|Overall Study|Non-compliance|1|||
13270726|NCT01400698|26425767|FG002|Overall Study|Non-compliance|0|||
13270727|NCT01400698|26425768|FG003|Overall Study|Non-compliance|1|||
13270728|NCT01400698|26425769|FG004|Overall Study|Non-compliance|0|||
13270729|NCT01400698|26425770|FG005|Overall Study|Non-compliance|0|||
13270730|NCT01400698|26425765|FG000|Overall Study|Adverse Event|1|||
13270731|NCT01400698|26425766|FG001|Overall Study|Adverse Event|0|||
13270732|NCT01400698|26425767|FG002|Overall Study|Adverse Event|0|||
13270733|NCT01400698|26425768|FG003|Overall Study|Adverse Event|0|||
13270734|NCT01400698|26425769|FG004|Overall Study|Adverse Event|0|||
13270735|NCT01400698|26425770|FG005|Overall Study|Adverse Event|0|||
13270736|NCT01400698|26425765|FG000|Overall Study|Other|4|||
13270737|NCT01400698|26425766|FG001|Overall Study|Other|2|||
13270738|NCT01400698|26425767|FG002|Overall Study|Other|0|||
13270739|NCT01400698|26425768|FG003|Overall Study|Other|2|||
13270740|NCT01400698|26425769|FG004|Overall Study|Other|1|||
13270741|NCT01400698|26425770|FG005|Overall Study|Other|0|||
13270742|NCT01400516|26425787|FG000|Primary Trial|Withdrawal by Subject|0|||
13270743|NCT01400516|26425788|FG001|Primary Trial|Withdrawal by Subject|2|||
13270744|NCT01400503|26425799|FG000|Overall Study|Withdrawal by Subject|1|||
13270745|NCT01400503|26425799|FG000|Overall Study|Study Terminated by Sponsor|58|||
13270746|NCT01400503|26425799|FG000|Overall Study|Other|1|||
13270747|NCT01400451|26425823|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2|||
13270748|NCT01400451|26425824|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
13270749|NCT01400451|26425825|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
13270750|NCT01400451|26425823|FG000|Combination Treatment (or Intended)|Drug Toxicity|0|||
13270751|NCT01400451|26425824|FG001|Combination Treatment (or Intended)|Drug Toxicity|1|||
13270752|NCT01400451|26425825|FG002|Combination Treatment (or Intended)|Drug Toxicity|0|||
13270753|NCT01400451|26425823|FG000|Combination Treatment (or Intended)|Adverse Event|1|||
13270754|NCT01400451|26425824|FG001|Combination Treatment (or Intended)|Adverse Event|0|||
13270755|NCT01400451|26425825|FG002|Combination Treatment (or Intended)|Adverse Event|0|||
13270756|NCT01400451|26425823|FG000|Combination Treatment (or Intended)|Disease Progression|3|||
13270757|NCT01400451|26425824|FG001|Combination Treatment (or Intended)|Disease Progression|1|||
13270758|NCT01400451|26425825|FG002|Combination Treatment (or Intended)|Disease Progression|1|||
13270759|NCT01400451|26425823|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
13270760|NCT01400451|26425824|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1|||
13270761|NCT01400451|26425825|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
13270762|NCT01400425|26425838|FG000|Overall Study|Withdrawal by Subject|10|||
13270763|NCT01400412|26425889|FG000|Overall Study|Lost to Follow-up|4|||
13270764|NCT01400412|26425890|FG001|Overall Study|Lost to Follow-up|7|||
13270765|NCT01400412|26425889|FG000|Overall Study|Withdrawal by Subject|3|||
13270766|NCT01400412|26425890|FG001|Overall Study|Withdrawal by Subject|4|||
13270767|NCT01400412|26425889|FG000|Overall Study|Unable to complete|3|||
13270768|NCT01400412|26425890|FG001|Overall Study|Unable to complete|3|||
13270769|NCT01400412|26425889|FG000|Overall Study|Never started study treatment|0|||
13270770|NCT01400412|26425890|FG001|Overall Study|Never started study treatment|3|||
13270771|NCT01400243|26425919|FG000|Overall Study|Protocol Violation|8|||
13270772|NCT01400243|26425920|FG001|Overall Study|Protocol Violation|11|||
13270773|NCT01400139|26425943|FG000|HYD Core Study|Adverse Event|210|||
13270774|NCT01400139|26425943|FG000|HYD Core Study|Lack of Efficacy|59|||
13270775|NCT01400139|26425943|FG000|HYD Core Study|Withdrawal by Subject|114|||
13270776|NCT01400139|26425943|FG000|HYD Core Study|Lost to Follow-up|39|||
13270777|NCT01400139|26425943|FG000|HYD Core Study|Confirmed or suspected diversion|20|||
13270778|NCT01400139|26425943|FG000|HYD Core Study|Administrative|56|||
13270779|NCT01400139|26425943|FG000|HYD Core Study|Did not qualify for Maintenance Period|14|||
13270780|NCT01400139|26425943|FG000|HYD Extension Period|Adverse Event|8|||
13270781|NCT01400139|26425943|FG000|HYD Extension Period|Withdrawal by Subject|5|||
13270782|NCT01400139|26425943|FG000|HYD Extension Period|Administrative|10|||
13270783|NCT01400113|26425956|FG000|Overall Study|Withdrawal by Subject|1|||
13270784|NCT01400113|26425957|FG001|Overall Study|Withdrawal by Subject|1|||
13270785|NCT01399905|26425976|FG000|Overall Study|Withdrawal by Subject|1|||
13270786|NCT01399905|26425977|FG001|Overall Study|Withdrawal by Subject|1|||
13270787|NCT01399788|26426000|FG000|First Intervention Period|Adverse Event|1|||
13270788|NCT01399788|26426001|FG001|First Intervention Period|Adverse Event|0|||
13270789|NCT01399736|26426082|FG000|Overall Study|Withdrawal by Subject|4|||
13270790|NCT01399736|26426083|FG001|Overall Study|Withdrawal by Subject|2|||
13270791|NCT01399736|26426082|FG000|Overall Study|Lost to Follow-up|0|||
13270792|NCT01399736|26426083|FG001|Overall Study|Lost to Follow-up|2|||
13270793|NCT01399723|26426100|FG000|Overall Study|Lost to Follow-up|0|||
13270794|NCT01399723|26426101|FG001|Overall Study|Lost to Follow-up|1|||
13270795|NCT01399697|26426136|FG000|Overall Study|Adverse Event|13|||
13270796|NCT01399697|26426137|FG001|Overall Study|Adverse Event|3|||
13270797|NCT01399697|26426138|FG002|Overall Study|Adverse Event|1|||
13270798|NCT01399697|26426136|FG000|Overall Study|Lost to Follow-up|2|||
13270799|NCT01399697|26426137|FG001|Overall Study|Lost to Follow-up|0|||
13270800|NCT01399697|26426138|FG002|Overall Study|Lost to Follow-up|0|||
13270801|NCT01399697|26426136|FG000|Overall Study|Withdrawal by Subject|8|||
13270802|NCT01399697|26426137|FG001|Overall Study|Withdrawal by Subject|0|||
13270803|NCT01399697|26426138|FG002|Overall Study|Withdrawal by Subject|0|||
13270804|NCT01399697|26426136|FG000|Overall Study|Investigator Decisión|1|||
13270805|NCT01399697|26426137|FG001|Overall Study|Investigator Decisión|0|||
13270806|NCT01399697|26426138|FG002|Overall Study|Investigator Decisión|2|||
13270807|NCT01399697|26426136|FG000|Overall Study|Lack of Efficacy|9|||
13270808|NCT01399697|26426137|FG001|Overall Study|Lack of Efficacy|0|||
13270809|NCT01399697|26426138|FG002|Overall Study|Lack of Efficacy|1|||
13270810|NCT01399697|26426136|FG000|Overall Study|Protocol Violation|2|||
13270811|NCT01399697|26426137|FG001|Overall Study|Protocol Violation|0|||
13270812|NCT01399697|26426138|FG002|Overall Study|Protocol Violation|0|||
13270813|NCT01399697|26426136|FG000|Overall Study|Non-Compliant|1|||
13270814|NCT01399697|26426137|FG001|Overall Study|Non-Compliant|0|||
13270815|NCT01399697|26426138|FG002|Overall Study|Non-Compliant|0|||
13270816|NCT01399697|26426136|FG000|Overall Study|Inclusion Error|2|||
13270817|NCT01399697|26426137|FG001|Overall Study|Inclusion Error|0|||
13270818|NCT01399697|26426138|FG002|Overall Study|Inclusion Error|0|||
13270819|NCT01399697|26426136|FG000|Overall Study|Positive result for hepatitis B|1|||
13270820|NCT01399697|26426137|FG001|Overall Study|Positive result for hepatitis B|0|||
13270821|NCT01399697|26426138|FG002|Overall Study|Positive result for hepatitis B|0|||
13270822|NCT01399697|26426136|FG000|Overall Study|Clinical RA remission|1|||
13270823|NCT01399697|26426137|FG001|Overall Study|Clinical RA remission|0|||
13270824|NCT01399697|26426138|FG002|Overall Study|Clinical RA remission|0|||
13270825|NCT01399697|26426136|FG000|Overall Study|Sponsor Decision|1|||
13270826|NCT01399697|26426137|FG001|Overall Study|Sponsor Decision|0|||
13270827|NCT01399697|26426138|FG002|Overall Study|Sponsor Decision|0|||
13270828|NCT01399619|26426208|FG000|Overall Study|Adverse Event|10|||
13270829|NCT01399619|26426209|FG001|Overall Study|Adverse Event|0|||
13270830|NCT01399619|26426210|FG002|Overall Study|Adverse Event|4|||
13270831|NCT01399619|26426211|FG003|Overall Study|Adverse Event|10|||
13270832|NCT01399619|26426208|FG000|Overall Study|Lack of Efficacy|9|||
13270833|NCT01399619|26426209|FG001|Overall Study|Lack of Efficacy|0|||
13270834|NCT01399619|26426210|FG002|Overall Study|Lack of Efficacy|5|||
13270835|NCT01399619|26426211|FG003|Overall Study|Lack of Efficacy|0|||
13270836|NCT01399619|26426208|FG000|Overall Study|Withdrawal by Subject|6|||
13270837|NCT01399619|26426209|FG001|Overall Study|Withdrawal by Subject|0|||
13270838|NCT01399619|26426210|FG002|Overall Study|Withdrawal by Subject|3|||
13270839|NCT01399619|26426211|FG003|Overall Study|Withdrawal by Subject|4|||
13270840|NCT01399619|26426208|FG000|Overall Study|Protocol Violation|0|||
13270841|NCT01399619|26426209|FG001|Overall Study|Protocol Violation|0|||
13270842|NCT01399619|26426210|FG002|Overall Study|Protocol Violation|0|||
13270843|NCT01399619|26426211|FG003|Overall Study|Protocol Violation|1|||
13270844|NCT01399619|26426208|FG000|Overall Study|Not treated|0|||
13270845|NCT01399619|26426209|FG001|Overall Study|Not treated|0|||
13270846|NCT01399619|26426210|FG002|Overall Study|Not treated|0|||
13270847|NCT01399619|26426211|FG003|Overall Study|Not treated|2|||
13270848|NCT01399593|26426224|FG000|Overall Study|Physician Decision|1|||
13270849|NCT01399593|26426225|FG001|Overall Study|Physician Decision|0|||
13270850|NCT01399593|26426224|FG000|Overall Study|Adverse Event|1|||
13270851|NCT01399593|26426225|FG001|Overall Study|Adverse Event|0|||
13270852|NCT01399593|26426224|FG000|Overall Study|Death|1|||
13270853|NCT01399593|26426225|FG001|Overall Study|Death|1|||
13270854|NCT01399593|26426224|FG000|Overall Study|Transplantectomy|0|||
13270855|NCT01399593|26426225|FG001|Overall Study|Transplantectomy|1|||
13270856|NCT01399372|26426244|FG000|Overall Study|Protocol Violation|3|||
13270857|NCT01399372|26426245|FG001|Overall Study|Protocol Violation|1|||
13270858|NCT01399190|26426253|FG000|Overall Study|Not Eligible for Final Analysis|5|||
13270859|NCT01399190|26426253|FG000|Overall Study|Adverse Event|8|||
13270860|NCT01399190|26426253|FG000|Overall Study|Participant's Request|5|||
13270861|NCT01399190|26426253|FG000|Overall Study|Physician Decision|2|||
13270862|NCT01399125|26426274|FG000|Overall Study|Adverse Event|32|||
13270863|NCT01399125|26426275|FG001|Overall Study|Adverse Event|30|||
13270864|NCT01399125|26426274|FG000|Overall Study|Abnormal Lab values|0|||
13270865|NCT01399125|26426275|FG001|Overall Study|Abnormal Lab values|1|||
13270866|NCT01399125|26426274|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
13270867|NCT01399125|26426275|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4|||
13270868|NCT01399125|26426274|FG000|Overall Study|Withdrawal by Subject|5|||
13270869|NCT01399125|26426275|FG001|Overall Study|Withdrawal by Subject|8|||
13270870|NCT01399125|26426274|FG000|Overall Study|Lost to Follow-up|2|||
13270871|NCT01399125|26426275|FG001|Overall Study|Lost to Follow-up|3|||
13270872|NCT01399125|26426274|FG000|Overall Study|Administrative Problems|7|||
13270873|NCT01399125|26426275|FG001|Overall Study|Administrative Problems|11|||
13270874|NCT01399125|26426274|FG000|Overall Study|Death|0|||
13270875|NCT01399125|26426275|FG001|Overall Study|Death|1|||
13270876|NCT01399125|26426274|FG000|Overall Study|Protocol Deviation|5|||
13270877|NCT01399125|26426275|FG001|Overall Study|Protocol Deviation|2|||
13270878|NCT01399099|26426282|FG000|Overall Study|Lost to Follow-up|11|||
13270879|NCT01399099|26426282|FG000|Overall Study|Physician Decision|1|||
13270880|NCT01399099|26426282|FG000|Overall Study|Protocol Violation|1|||
13270881|NCT01399099|26426282|FG000|Overall Study|Skin Irritation|13|||
13270882|NCT01399099|26426282|FG000|Overall Study|Infection|1|||
13270883|NCT01399099|26426282|FG000|Overall Study|Miscellaneous|4|||
13270884|NCT01399047|26426303|FG000|Overall Study|Withdrawal by Subject|0|||
13270885|NCT01399047|26426304|FG001|Overall Study|Withdrawal by Subject|1|||
13270886|NCT01398956|26426312|FG000|Overall Study|Withdrawal by Subject|4|||
13270887|NCT01398956|26426312|FG000|Overall Study|AE, non-serious non-fatal|4|||
13270888|NCT01398956|26426312|FG000|Overall Study|Withdrawal Criteria No.3|1|||
13270889|NCT01398956|26426312|FG000|Overall Study|Subject moved a long distance|1|||
13270890|NCT01398787|26426330|FG000|Overall Study|Adverse Event|1|||
13270891|NCT01398514|26426349|FG000|Overall Study|Adverse Event|1|||
13270892|NCT01398514|26426350|FG001|Overall Study|Adverse Event|0|||
13270893|NCT01398514|26426349|FG000|Overall Study|Non-compliance with study procedures|2|||
13270894|NCT01398514|26426350|FG001|Overall Study|Non-compliance with study procedures|0|||
13270895|NCT01398514|26426349|FG000|Overall Study|Physiologic non-responsiveness|1|||
13118102|NCT03045887|25927889|FG005|Part A, Period 2 (1 Day)|Adverse Event|0|||
13118103|NCT03045887|25927890|FG006|Part A, Period 2 (1 Day)|Adverse Event|0|||
13118104|NCT03045887|25927891|FG007|Part A, Period 2 (1 Day)|Adverse Event|0|||
13270896|NCT01398514|26426350|FG001|Overall Study|Physiologic non-responsiveness|3|||
13270897|NCT01398514|26426349|FG000|Overall Study|Failure to show a conditioned response|4|||
13270898|NCT01398514|26426350|FG001|Overall Study|Failure to show a conditioned response|3|||
13270899|NCT01398410|26426365|FG000|Overall Study|Adverse Event|12|||
13270900|NCT01398410|26426366|FG001|Overall Study|Adverse Event|16|||
13270901|NCT01398410|26426365|FG000|Overall Study|Participants Choice|8|||
13270902|NCT01398410|26426366|FG001|Overall Study|Participants Choice|11|||
13270903|NCT01398410|26426365|FG000|Overall Study|Inadequate Therapeutic Effect|2|||
13270904|NCT01398410|26426366|FG001|Overall Study|Inadequate Therapeutic Effect|0|||
13270905|NCT01398410|26426365|FG000|Overall Study|Other|36|||
13270906|NCT01398410|26426366|FG001|Overall Study|Other|29|||
13270907|NCT01398358|26426387|FG000|Overall Study|Lost to Follow-up|11|||
13270908|NCT01398358|26426388|FG001|Overall Study|Lost to Follow-up|21|||
13270909|NCT01398358|26426389|FG002|Overall Study|Lost to Follow-up|18|||
13270910|NCT01398358|26426387|FG000|Overall Study|Withdrawal by Subject|3|||
13270911|NCT01398358|26426388|FG001|Overall Study|Withdrawal by Subject|2|||
13270912|NCT01398358|26426389|FG002|Overall Study|Withdrawal by Subject|2|||
13270913|NCT01398358|26426387|FG000|Overall Study|no longer eligible|1|||
13270914|NCT01398358|26426388|FG001|Overall Study|no longer eligible|0|||
13270915|NCT01398358|26426389|FG002|Overall Study|no longer eligible|1|||
13270916|NCT01398176|26426402|FG000|Overall Study|Lost to Follow-up|1|||
13270917|NCT01398176|26426403|FG001|Overall Study|Lost to Follow-up|3|||
13270918|NCT01398176|26426402|FG000|Overall Study|Physician Decision|2|||
13270919|NCT01398176|26426403|FG001|Overall Study|Physician Decision|3|||
13270920|NCT01397890|26426462|FG000|Overall Study|Withdrawal by Subject|7|||
13270921|NCT01397890|26426463|FG001|Overall Study|Withdrawal by Subject|11|||
13270922|NCT01397890|26426462|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7|||
13270923|NCT01397890|26426463|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
13270924|NCT01397890|26426462|FG000|Overall Study|Death|2|||
13270925|NCT01397890|26426463|FG001|Overall Study|Death|3|||
13270926|NCT01397890|26426462|FG000|Overall Study|Lost to Follow-up|1|||
13270927|NCT01397890|26426463|FG001|Overall Study|Lost to Follow-up|4|||
13270928|NCT01397890|26426462|FG000|Overall Study|Condition under Investigation Worsened|1|||
13270929|NCT01397890|26426463|FG001|Overall Study|Condition under Investigation Worsened|3|||
13270930|NCT01397890|26426462|FG000|Overall Study|Adverse Event|1|||
13270931|NCT01397890|26426463|FG001|Overall Study|Adverse Event|2|||
13270932|NCT01397890|26426462|FG000|Overall Study|Severe Non-Compliance to Protocol|2|||
13270933|NCT01397890|26426463|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
13270934|NCT01397890|26426462|FG000|Overall Study|Others|2|||
13270935|NCT01397890|26426463|FG001|Overall Study|Others|1|||
13270936|NCT01397825|26426544|FG000|Overall Study|Progressive Disease|10|||
13270937|NCT01397825|26426545|FG001|Overall Study|Progressive Disease|3|||
13270938|NCT01397825|26426546|FG002|Overall Study|Progressive Disease|11|||
13270939|NCT01397825|26426547|FG003|Overall Study|Progressive Disease|1|||
13270940|NCT01397825|26426548|FG004|Overall Study|Progressive Disease|0|||
13270941|NCT01397825|26426544|FG000|Overall Study|Symptomatic Deterioration|2|||
13270942|NCT01397825|26426545|FG001|Overall Study|Symptomatic Deterioration|0|||
13270943|NCT01397825|26426546|FG002|Overall Study|Symptomatic Deterioration|4|||
13270944|NCT01397825|26426547|FG003|Overall Study|Symptomatic Deterioration|0|||
13270945|NCT01397825|26426548|FG004|Overall Study|Symptomatic Deterioration|0|||
13270946|NCT01397825|26426544|FG000|Overall Study|Adverse Event|0|||
13270947|NCT01397825|26426545|FG001|Overall Study|Adverse Event|1|||
13270948|NCT01397825|26426546|FG002|Overall Study|Adverse Event|5|||
13270949|NCT01397825|26426547|FG003|Overall Study|Adverse Event|1|||
13270950|NCT01397825|26426548|FG004|Overall Study|Adverse Event|0|||
13270951|NCT01397825|26426544|FG000|Overall Study|Withdrawal by Subject|1|||
13270952|NCT01397825|26426545|FG001|Overall Study|Withdrawal by Subject|0|||
13270953|NCT01397825|26426546|FG002|Overall Study|Withdrawal by Subject|5|||
13270954|NCT01397825|26426547|FG003|Overall Study|Withdrawal by Subject|1|||
13270955|NCT01397825|26426548|FG004|Overall Study|Withdrawal by Subject|0|||
13270956|NCT01397786|26426624|FG000|Phase A|Lost to Follow-up|0|||
13270957|NCT01397786|26426625|FG001|Phase A|Lost to Follow-up|0|||
13270958|NCT01397786|26426626|FG002|Phase A|Lost to Follow-up|6|||
13270959|NCT01397786|26426624|FG000|Phase A|Adverse Event|0|||
13270960|NCT01397786|26426625|FG001|Phase A|Adverse Event|0|||
13270961|NCT01397786|26426626|FG002|Phase A|Adverse Event|8|||
13270962|NCT01397786|26426624|FG000|Phase A|Subject Met Withdrawal Criteria|0|||
13270963|NCT01397786|26426625|FG001|Phase A|Subject Met Withdrawal Criteria|0|||
13270964|NCT01397786|26426626|FG002|Phase A|Subject Met Withdrawal Criteria|7|||
13270965|NCT01397786|26426624|FG000|Phase A|Physician Decision|0|||
13270966|NCT01397786|26426625|FG001|Phase A|Physician Decision|0|||
13270967|NCT01397786|26426626|FG002|Phase A|Physician Decision|1|||
13270968|NCT01397786|26426624|FG000|Phase A|Withdrawal by Subject|0|||
13270969|NCT01397786|26426625|FG001|Phase A|Withdrawal by Subject|0|||
13270970|NCT01397786|26426626|FG002|Phase A|Withdrawal by Subject|5|||
13270971|NCT01397786|26426624|FG000|Phase A|Lack of Efficacy|0|||
13270972|NCT01397786|26426625|FG001|Phase A|Lack of Efficacy|0|||
13270973|NCT01397786|26426626|FG002|Phase A|Lack of Efficacy|1|||
13270974|NCT01397786|26426624|FG000|Phase B|Lost to Follow-up|22|||
13118105|NCT03045887|25927892|FG008|Part A, Period 2 (1 Day)|Adverse Event|0|||
13118106|NCT03045887|25927893|FG009|Part A, Period 2 (1 Day)|Adverse Event|0|||
13270975|NCT01397786|26426625|FG001|Phase B|Lost to Follow-up|12|||
13270976|NCT01397786|26426626|FG002|Phase B|Lost to Follow-up|22|||
13270977|NCT01397786|26426624|FG000|Phase B|Adverse Event|109|||
13270978|NCT01397786|26426625|FG001|Phase B|Adverse Event|23|||
13270979|NCT01397786|26426626|FG002|Phase B|Adverse Event|27|||
13270980|NCT01397786|26426624|FG000|Phase B|Subject Met Withdrawal Criteria|38|||
13270981|NCT01397786|26426625|FG001|Phase B|Subject Met Withdrawal Criteria|5|||
13270982|NCT01397786|26426626|FG002|Phase B|Subject Met Withdrawal Criteria|38|||
13270983|NCT01397786|26426624|FG000|Phase B|Physician Decision|9|||
13270984|NCT01397786|26426625|FG001|Phase B|Physician Decision|1|||
13270985|NCT01397786|26426626|FG002|Phase B|Physician Decision|3|||
13270986|NCT01397786|26426624|FG000|Phase B|Withdrawal by Subject|102|||
13270987|NCT01397786|26426625|FG001|Phase B|Withdrawal by Subject|45|||
13270988|NCT01397786|26426626|FG002|Phase B|Withdrawal by Subject|30|||
13270989|NCT01397786|26426624|FG000|Phase B|Protocol Deviation|1|||
13270990|NCT01397786|26426625|FG001|Phase B|Protocol Deviation|2|||
13270991|NCT01397786|26426626|FG002|Phase B|Protocol Deviation|4|||
13270992|NCT01397786|26426624|FG000|Phase B|Lack of Efficacy|22|||
13270993|NCT01397786|26426625|FG001|Phase B|Lack of Efficacy|7|||
13270994|NCT01397786|26426626|FG002|Phase B|Lack of Efficacy|14|||
13270995|NCT01397747|26426633|FG000|Overall Study|Multitarget DNA test excluded|689|||
13270996|NCT01397747|26426633|FG000|Overall Study|Colonoscopy excluded|304|||
13270997|NCT01397747|26426633|FG000|Overall Study|FIT excluded|34|||
13270998|NCT01397552|26426646|FG000|Overall Study|Adverse Event|1|||
13270999|NCT01397552|26426647|FG001|Overall Study|Adverse Event|0|||
13271000|NCT01397552|26426646|FG000|Overall Study|Withdrawal by Subject|2|||
13271001|NCT01397552|26426647|FG001|Overall Study|Withdrawal by Subject|1|||
13271002|NCT01397461|26426665|FG000|Overall Study|Withdrawal by Subject|2|||
13271003|NCT01397461|26426666|FG001|Overall Study|Withdrawal by Subject|1|||
13271004|NCT01397461|26426667|FG002|Overall Study|Withdrawal by Subject|0|||
13271005|NCT01397461|26426665|FG000|Overall Study|Lost to Follow-up|0|||
13271006|NCT01397461|26426666|FG001|Overall Study|Lost to Follow-up|2|||
13271007|NCT01397461|26426667|FG002|Overall Study|Lost to Follow-up|1|||
13271008|NCT01397461|26426665|FG000|Overall Study|Lack of Efficacy|0|||
13271009|NCT01397461|26426666|FG001|Overall Study|Lack of Efficacy|3|||
13271010|NCT01397461|26426667|FG002|Overall Study|Lack of Efficacy|0|||
13271011|NCT01397461|26426665|FG000|Overall Study|Not treated|0|||
13271012|NCT01397461|26426666|FG001|Overall Study|Not treated|0|||
13271013|NCT01397461|26426667|FG002|Overall Study|Not treated|1|||
13271014|NCT01397448|26426688|FG000|Overall Study|Adverse Event|4|||
13271015|NCT01397448|26426689|FG001|Overall Study|Adverse Event|4|||
13271016|NCT01397448|26426690|FG002|Overall Study|Adverse Event|6|||
13271017|NCT01397448|26426688|FG000|Overall Study|Withdrawal by Subject|4|||
13271018|NCT01397448|26426689|FG001|Overall Study|Withdrawal by Subject|4|||
13271019|NCT01397448|26426690|FG002|Overall Study|Withdrawal by Subject|3|||
13271020|NCT01397448|26426688|FG000|Overall Study|Lack of Efficacy|2|||
13271021|NCT01397448|26426689|FG001|Overall Study|Lack of Efficacy|0|||
13271022|NCT01397448|26426690|FG002|Overall Study|Lack of Efficacy|5|||
13271023|NCT01397448|26426688|FG000|Overall Study|Other|8|||
13271024|NCT01397448|26426689|FG001|Overall Study|Other|7|||
13271025|NCT01397448|26426690|FG002|Overall Study|Other|4|||
13271026|NCT01397422|26426733|FG000|Overall Study|Adverse Event|0|||
13271027|NCT01397422|26426734|FG001|Overall Study|Adverse Event|3|||
13271028|NCT01397422|26426735|FG002|Overall Study|Adverse Event|3|||
13271029|NCT01397422|26426736|FG003|Overall Study|Adverse Event|8|||
13271030|NCT01397422|26426733|FG000|Overall Study|Withdrawal by Subject|1|||
13271031|NCT01397422|26426734|FG001|Overall Study|Withdrawal by Subject|0|||
13271032|NCT01397422|26426735|FG002|Overall Study|Withdrawal by Subject|0|||
13271033|NCT01397422|26426736|FG003|Overall Study|Withdrawal by Subject|0|||
13271034|NCT01397422|26426733|FG000|Overall Study|Increased bradykinesia related to PD|1|||
13271035|NCT01397422|26426734|FG001|Overall Study|Increased bradykinesia related to PD|0|||
13271036|NCT01397422|26426735|FG002|Overall Study|Increased bradykinesia related to PD|0|||
13271037|NCT01397422|26426736|FG003|Overall Study|Increased bradykinesia related to PD|0|||
13271038|NCT01397409|26426805|FG000|Stage 2|Adverse Event|0|||
13271039|NCT01397409|26426806|FG001|Stage 2|Adverse Event|0|||
13271040|NCT01397409|26426807|FG002|Stage 2|Adverse Event|0|||
13271041|NCT01397409|26426808|FG003|Stage 2|Adverse Event|0|||
13271042|NCT01397409|26426809|FG004|Stage 2|Adverse Event|6|||
13271043|NCT01397409|26426810|FG005|Stage 2|Adverse Event|3|||
13271044|NCT01397409|26426811|FG006|Stage 2|Adverse Event|0|||
13271045|NCT01397409|26426812|FG007|Stage 2|Adverse Event|0|||
13271046|NCT01397409|26426813|FG008|Stage 2|Adverse Event|0|||
13271047|NCT01397409|26426814|FG009|Stage 2|Adverse Event|0|||
13271048|NCT01397409|26426805|FG000|Stage 2|Personal Reasons|0|||
13271049|NCT01397409|26426806|FG001|Stage 2|Personal Reasons|0|||
13271050|NCT01397409|26426807|FG002|Stage 2|Personal Reasons|0|||
13271051|NCT01397409|26426808|FG003|Stage 2|Personal Reasons|0|||
13271052|NCT01397409|26426809|FG004|Stage 2|Personal Reasons|1|||
13271053|NCT01397409|26426810|FG005|Stage 2|Personal Reasons|0|||
13271054|NCT01397409|26426811|FG006|Stage 2|Personal Reasons|0|||
13271055|NCT01397409|26426812|FG007|Stage 2|Personal Reasons|0|||
13271056|NCT01397409|26426813|FG008|Stage 2|Personal Reasons|0|||
13271057|NCT01397409|26426814|FG009|Stage 2|Personal Reasons|0|||
13271058|NCT01397409|26426805|FG000|Stage 2|Other Miscellaneous Reasons|0|||
13271059|NCT01397409|26426806|FG001|Stage 2|Other Miscellaneous Reasons|0|||
13271060|NCT01397409|26426807|FG002|Stage 2|Other Miscellaneous Reasons|0|||
13271061|NCT01397409|26426808|FG003|Stage 2|Other Miscellaneous Reasons|0|||
13271062|NCT01397409|26426809|FG004|Stage 2|Other Miscellaneous Reasons|1|||
13271063|NCT01397409|26426810|FG005|Stage 2|Other Miscellaneous Reasons|1|||
13271064|NCT01397409|26426811|FG006|Stage 2|Other Miscellaneous Reasons|0|||
13271065|NCT01397409|26426812|FG007|Stage 2|Other Miscellaneous Reasons|0|||
13271066|NCT01397409|26426813|FG008|Stage 2|Other Miscellaneous Reasons|0|||
13271067|NCT01397409|26426814|FG009|Stage 2|Other Miscellaneous Reasons|0|||
13271068|NCT01397409|26426805|FG000|Stage 3|Adverse Event|0|||
13271069|NCT01397409|26426806|FG001|Stage 3|Adverse Event|0|||
13271070|NCT01397409|26426807|FG002|Stage 3|Adverse Event|0|||
13271071|NCT01397409|26426808|FG003|Stage 3|Adverse Event|0|||
13271072|NCT01397409|26426809|FG004|Stage 3|Adverse Event|0|||
13271073|NCT01397409|26426810|FG005|Stage 3|Adverse Event|0|||
13271074|NCT01397409|26426811|FG006|Stage 3|Adverse Event|0|||
13271075|NCT01397409|26426812|FG007|Stage 3|Adverse Event|1|||
13271076|NCT01397409|26426813|FG008|Stage 3|Adverse Event|0|||
13271077|NCT01397409|26426814|FG009|Stage 3|Adverse Event|0|||
13271078|NCT01397409|26426805|FG000|Stage 3|Other Miscellaneous Reasons|0|||
13271079|NCT01397409|26426806|FG001|Stage 3|Other Miscellaneous Reasons|0|||
13271080|NCT01397409|26426807|FG002|Stage 3|Other Miscellaneous Reasons|0|||
13271081|NCT01397409|26426808|FG003|Stage 3|Other Miscellaneous Reasons|0|||
13271082|NCT01397409|26426809|FG004|Stage 3|Other Miscellaneous Reasons|0|||
13271083|NCT01397409|26426810|FG005|Stage 3|Other Miscellaneous Reasons|0|||
13271084|NCT01397409|26426811|FG006|Stage 3|Other Miscellaneous Reasons|0|||
13271085|NCT01397409|26426812|FG007|Stage 3|Other Miscellaneous Reasons|1|||
13271086|NCT01397409|26426813|FG008|Stage 3|Other Miscellaneous Reasons|0|||
13271087|NCT01397409|26426814|FG009|Stage 3|Other Miscellaneous Reasons|0|||
13271088|NCT01397253|26426827|FG000|Overall Study|Reviewed by only 1 pharmacist|126|||
13271089|NCT01397253|26426828|FG001|Overall Study|Reviewed by only 1 pharmacist|149|||
13271090|NCT01397201|26426896|FG000|Overall Study|Not treated|0|||
13271091|NCT01397201|26426897|FG001|Overall Study|Not treated|0|||
13271092|NCT01397201|26426898|FG002|Overall Study|Not treated|1|||
13271093|NCT01397201|26426899|FG003|Overall Study|Not treated|0|||
13271094|NCT01397201|26426900|FG004|Overall Study|Not treated|0|||
13271095|NCT01397201|26426896|FG000|Overall Study|Not yet defined|3|||
13271096|NCT01397201|26426897|FG001|Overall Study|Not yet defined|6|||
13271097|NCT01397201|26426898|FG002|Overall Study|Not yet defined|5|||
13271098|NCT01397201|26426899|FG003|Overall Study|Not yet defined|5|||
13271099|NCT01397201|26426900|FG004|Overall Study|Not yet defined|4|||
13271100|NCT01397201|26426896|FG000|Overall Study|Adverse Event|2|||
13271101|NCT01397201|26426897|FG001|Overall Study|Adverse Event|0|||
13271102|NCT01397201|26426898|FG002|Overall Study|Adverse Event|0|||
13271103|NCT01397201|26426899|FG003|Overall Study|Adverse Event|0|||
13271104|NCT01397201|26426900|FG004|Overall Study|Adverse Event|0|||
13271105|NCT01397162|26426968|FG000|Overall Study|Adverse Event|4|||
13271106|NCT01397162|26426969|FG001|Overall Study|Adverse Event|0|||
13271107|NCT01397162|26426970|FG002|Overall Study|Adverse Event|0|||
13271108|NCT01397162|26426971|FG003|Overall Study|Adverse Event|0|||
13271109|NCT01397162|26426972|FG004|Overall Study|Adverse Event|0|||
13271110|NCT01397162|26426968|FG000|Overall Study|Not yet defined|3|||
13271111|NCT01397162|26426969|FG001|Overall Study|Not yet defined|4|||
13271112|NCT01397162|26426970|FG002|Overall Study|Not yet defined|3|||
13271113|NCT01397162|26426971|FG003|Overall Study|Not yet defined|5|||
13271114|NCT01397162|26426972|FG004|Overall Study|Not yet defined|3|||
13271115|NCT01397084|26426981|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
13271116|NCT01397084|26426981|FG000|Overall Study|Protocol Violation|2|||
13271117|NCT01397084|26426981|FG000|Overall Study|Adverse Event|2|||
13271118|NCT01397084|26426981|FG000|Overall Study|Withdrawal by Subject|1|||
13271119|NCT01397084|26426981|FG000|Overall Study|Lost to Follow-up|1|||
13271120|NCT01397084|26426981|FG000|Overall Study|Used other proton pump inhibitor|1|||
13271121|NCT01396525|26427081|FG000|Overall Study|Withdrawal by Subject|8|||
13271122|NCT01396525|26427081|FG000|Overall Study|Death|14|||
13271123|NCT01396525|26427081|FG000|Overall Study|Lost to Follow-up|4|||
13271124|NCT01396512|26427100|FG000|Overall Study|Withdrawal by Subject|0|||
13271125|NCT01396512|26427101|FG001|Overall Study|Withdrawal by Subject|1|||
13271126|NCT01396447|26427128|FG000|Overall Study|Did Not Receive Treatment|3|||
13271127|NCT01396447|26427129|FG001|Overall Study|Did Not Receive Treatment|2|||
13271128|NCT01396447|26427130|FG002|Overall Study|Did Not Receive Treatment|1|||
13271129|NCT01396447|26427131|FG003|Overall Study|Did Not Receive Treatment|0|||
13271130|NCT01396447|26427128|FG000|Overall Study|Adverse Event|15|||
13271131|NCT01396447|26427129|FG001|Overall Study|Adverse Event|12|||
13271132|NCT01396447|26427130|FG002|Overall Study|Adverse Event|12|||
13271133|NCT01396447|26427131|FG003|Overall Study|Adverse Event|17|||
13271134|NCT01396447|26427128|FG000|Overall Study|Insufficient Therapeutic Response|5|||
13271135|NCT01396447|26427129|FG001|Overall Study|Insufficient Therapeutic Response|5|||
13271136|NCT01396447|26427130|FG002|Overall Study|Insufficient Therapeutic Response|2|||
13271137|NCT01396447|26427131|FG003|Overall Study|Insufficient Therapeutic Response|4|||
13271138|NCT01396447|26427128|FG000|Overall Study|Protocol Violation|5|||
13271139|NCT01396447|26427129|FG001|Overall Study|Protocol Violation|2|||
13271140|NCT01396447|26427130|FG002|Overall Study|Protocol Violation|3|||
13271141|NCT01396447|26427131|FG003|Overall Study|Protocol Violation|7|||
13271142|NCT01396447|26427128|FG000|Overall Study|Withdrawal of Consent|11|||
13271143|NCT01396447|26427129|FG001|Overall Study|Withdrawal of Consent|9|||
13271144|NCT01396447|26427130|FG002|Overall Study|Withdrawal of Consent|4|||
13271145|NCT01396447|26427131|FG003|Overall Study|Withdrawal of Consent|15|||
13271146|NCT01396447|26427128|FG000|Overall Study|Lost to Follow-up|4|||
13271147|NCT01396447|26427129|FG001|Overall Study|Lost to Follow-up|8|||
13271148|NCT01396447|26427130|FG002|Overall Study|Lost to Follow-up|7|||
13271149|NCT01396447|26427131|FG003|Overall Study|Lost to Follow-up|9|||
13271150|NCT01396447|26427128|FG000|Overall Study|Other Miscellaneous Reasons|0|||
13271151|NCT01396447|26427129|FG001|Overall Study|Other Miscellaneous Reasons|2|||
13271152|NCT01396447|26427130|FG002|Overall Study|Other Miscellaneous Reasons|1|||
13271153|NCT01396447|26427131|FG003|Overall Study|Other Miscellaneous Reasons|0|||
13271154|NCT01396434|26427149|FG000|Overall Study|Lost to Follow-up|1|||
13271155|NCT01396434|26427150|FG001|Overall Study|Lost to Follow-up|0|||
13271156|NCT01396434|26427151|FG002|Overall Study|Lost to Follow-up|0|||
13271157|NCT01396434|26427149|FG000|Overall Study|Other|10|||
13271158|NCT01396434|26427150|FG001|Overall Study|Other|0|||
13271159|NCT01396434|26427151|FG002|Overall Study|Other|0|||
13271160|NCT01396421|26427234|FG000|Overall Study|Lost to Follow-up|0|||
13271161|NCT01396421|26427235|FG001|Overall Study|Lost to Follow-up|0|||
13271162|NCT01396421|26427236|FG002|Overall Study|Lost to Follow-up|0|||
13271163|NCT01396421|26427237|FG003|Overall Study|Lost to Follow-up|1|||
13271164|NCT01396421|26427234|FG000|Overall Study|Adverse Event|17|||
13271165|NCT01396421|26427235|FG001|Overall Study|Adverse Event|15|||
13271166|NCT01396421|26427236|FG002|Overall Study|Adverse Event|12|||
13271167|NCT01396421|26427237|FG003|Overall Study|Adverse Event|32|||
13271168|NCT01396421|26427234|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
13271169|NCT01396421|26427235|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
13271170|NCT01396421|26427236|FG002|Overall Study|Participant Met Withdrawal Criteria|1|||
13271171|NCT01396421|26427237|FG003|Overall Study|Participant Met Withdrawal Criteria|0|||
13271172|NCT01396421|26427234|FG000|Overall Study|Physician Decision|1|||
13271173|NCT01396421|26427235|FG001|Overall Study|Physician Decision|1|||
13271174|NCT01396421|26427236|FG002|Overall Study|Physician Decision|0|||
13271175|NCT01396421|26427237|FG003|Overall Study|Physician Decision|3|||
13271176|NCT01396421|26427234|FG000|Overall Study|Withdrawal by Subject|31|||
13271177|NCT01396421|26427235|FG001|Overall Study|Withdrawal by Subject|24|||
13271178|NCT01396421|26427236|FG002|Overall Study|Withdrawal by Subject|13|||
13271179|NCT01396421|26427237|FG003|Overall Study|Withdrawal by Subject|21|||
13271180|NCT01396421|26427234|FG000|Overall Study|Protocol Deviation|2|||
13271181|NCT01396421|26427235|FG001|Overall Study|Protocol Deviation|1|||
13271182|NCT01396421|26427236|FG002|Overall Study|Protocol Deviation|1|||
13271183|NCT01396421|26427237|FG003|Overall Study|Protocol Deviation|0|||
13271184|NCT01396421|26427234|FG000|Overall Study|Lack of Efficacy|7|||
13271185|NCT01396421|26427235|FG001|Overall Study|Lack of Efficacy|17|||
13271186|NCT01396421|26427236|FG002|Overall Study|Lack of Efficacy|7|||
13271187|NCT01396421|26427237|FG003|Overall Study|Lack of Efficacy|18|||
13271188|NCT01396395|26427279|FG000|Overall Study|Withdrawal by Subject|10|||
13271189|NCT01396395|26427280|FG001|Overall Study|Withdrawal by Subject|12|||
13271190|NCT01396395|26427279|FG000|Overall Study|Protocol Violation|3|||
13271191|NCT01396395|26427280|FG001|Overall Study|Protocol Violation|1|||
13271192|NCT01396395|26427279|FG000|Overall Study|Adverse Event|10|||
13271193|NCT01396395|26427280|FG001|Overall Study|Adverse Event|2|||
13271194|NCT01396395|26427279|FG000|Overall Study|Lost to Follow-up|17|||
13271195|NCT01396395|26427280|FG001|Overall Study|Lost to Follow-up|11|||
13271196|NCT01396395|26427279|FG000|Overall Study|Other|0|||
13271197|NCT01396395|26427280|FG001|Overall Study|Other|1|||
13271198|NCT01396317|26427301|FG000|Overall Study|Adverse Event|1|||
13271199|NCT01396317|26427302|FG001|Overall Study|Adverse Event|0|||
13271200|NCT01396278|26427370|FG000|Overall Study|Adverse Event|0|||
13271201|NCT01396278|26427371|FG001|Overall Study|Adverse Event|0|||
13271202|NCT01396278|26427372|FG002|Overall Study|Adverse Event|0|||
13271203|NCT01396278|26427373|FG003|Overall Study|Adverse Event|2|||
13271204|NCT01396278|26427374|FG004|Overall Study|Adverse Event|0|||
13118107|NCT03045887|25927884|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
13118108|NCT03045887|25927885|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
13118109|NCT03045887|25927886|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
13118110|NCT03045887|25927887|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
13118111|NCT03045887|25927888|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
13118112|NCT03045887|25927889|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
13271205|NCT01396278|26427370|FG000|Overall Study|Withdraw due to trial termination|2|||
13271206|NCT01396278|26427371|FG001|Overall Study|Withdraw due to trial termination|1|||
13271207|NCT01396278|26427372|FG002|Overall Study|Withdraw due to trial termination|1|||
13271208|NCT01396278|26427373|FG003|Overall Study|Withdraw due to trial termination|0|||
13271209|NCT01396278|26427374|FG004|Overall Study|Withdraw due to trial termination|2|||
13271210|NCT01396265|26427400|FG000|Rifa+Afatinib|Withdrawal by Subject|1|||
13271211|NCT01396187|26427509|FG000|Overall Study|Adverse Event|0|||
13271212|NCT01396187|26427510|FG001|Overall Study|Adverse Event|1|||
13271213|NCT01396187|26427511|FG002|Overall Study|Adverse Event|0|||
13271214|NCT01396187|26427512|FG003|Overall Study|Adverse Event|0|||
13271215|NCT01396187|26427513|FG004|Overall Study|Adverse Event|0|||
13118113|NCT03045887|25927890|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
13118114|NCT03045887|25927891|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
13118115|NCT03045887|25927892|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
13118116|NCT03045887|25927893|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
13118117|NCT03045887|25927884|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
13118118|NCT03045887|25927885|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
13118119|NCT03045887|25927886|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
13118120|NCT03045887|25927887|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1|||
13271216|NCT01396187|26427509|FG000|Overall Study|Withdrawal by Subject|0|||
13271217|NCT01396187|26427510|FG001|Overall Study|Withdrawal by Subject|1|||
13271218|NCT01396187|26427511|FG002|Overall Study|Withdrawal by Subject|1|||
13271219|NCT01396187|26427512|FG003|Overall Study|Withdrawal by Subject|0|||
13271220|NCT01396187|26427513|FG004|Overall Study|Withdrawal by Subject|0|||
13271221|NCT01396187|26427509|FG000|Overall Study|Other|1|||
13271222|NCT01396187|26427510|FG001|Overall Study|Other|1|||
13271223|NCT01396187|26427511|FG002|Overall Study|Other|0|||
13271224|NCT01396187|26427512|FG003|Overall Study|Other|0|||
13271225|NCT01396187|26427513|FG004|Overall Study|Other|1|||
13271226|NCT01396161|26427588|FG000|Overall Study|Withdrawal by Subject|0|||
13271227|NCT01396161|26427589|FG001|Overall Study|Withdrawal by Subject|0|||
13271228|NCT01396161|26427590|FG002|Overall Study|Withdrawal by Subject|0|||
13271229|NCT01396161|26427591|FG003|Overall Study|Withdrawal by Subject|0|||
13271230|NCT01396161|26427592|FG004|Overall Study|Withdrawal by Subject|1|||
13271231|NCT01396161|26427593|FG005|Overall Study|Withdrawal by Subject|0|||
13271232|NCT01396161|26427594|FG006|Overall Study|Withdrawal by Subject|0|||
13271233|NCT01396161|26427588|FG000|Overall Study|Other|0|||
13271234|NCT01396161|26427589|FG001|Overall Study|Other|0|||
13271235|NCT01396161|26427590|FG002|Overall Study|Other|0|||
13271236|NCT01396161|26427591|FG003|Overall Study|Other|0|||
13271237|NCT01396161|26427592|FG004|Overall Study|Other|0|||
13271238|NCT01396161|26427593|FG005|Overall Study|Other|0|||
13271239|NCT01396161|26427594|FG006|Overall Study|Other|1|||
13290730|NCT00100048|26481713|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
13290731|NCT00100048|26481714|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
13290732|NCT00100048|26481715|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
13290733|NCT00100048|26481710|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
13290734|NCT00100048|26481711|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
13290735|NCT00100048|26481712|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
13290736|NCT00100048|26481713|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1|||
13290737|NCT00100048|26481714|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
13290738|NCT00100048|26481715|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
13290739|NCT00103038|26481727|FG000|Overall Study|Withdrawal by Subject|8|||
13290740|NCT00103038|26481727|FG000|Overall Study|Screen failure|3|||
13290741|NCT00103038|26481727|FG000|Overall Study|Death|1|||
13290742|NCT00103038|26481727|FG000|Overall Study|Physician Decision|1|||
13290743|NCT00106626|26481755|FG000|Overall Study|Adverse Event|5|||
13290744|NCT00106626|26481756|FG001|Overall Study|Adverse Event|4|||
13290745|NCT00106626|26481757|FG002|Overall Study|Adverse Event|3|||
13290746|NCT00106626|26481758|FG003|Overall Study|Adverse Event|3|||
13290747|NCT00106626|26481755|FG000|Overall Study|Progressive Disease|4|||
13290748|NCT00106626|26481756|FG001|Overall Study|Progressive Disease|1|||
13290749|NCT00106626|26481757|FG002|Overall Study|Progressive Disease|9|||
13290750|NCT00106626|26481758|FG003|Overall Study|Progressive Disease|10|||
13290751|NCT00106626|26481755|FG000|Overall Study|Received radiation on new therapy|1|||
13290752|NCT00106626|26481756|FG001|Overall Study|Received radiation on new therapy|0|||
13290753|NCT00106626|26481757|FG002|Overall Study|Received radiation on new therapy|0|||
13290754|NCT00106626|26481758|FG003|Overall Study|Received radiation on new therapy|0|||
13290755|NCT00106626|26481755|FG000|Overall Study|> 14 day delay in therapy start|0|||
13290756|NCT00106626|26481756|FG001|Overall Study|> 14 day delay in therapy start|1|||
13290757|NCT00106626|26481757|FG002|Overall Study|> 14 day delay in therapy start|0|||
13290758|NCT00106626|26481758|FG003|Overall Study|> 14 day delay in therapy start|0|||
13290759|NCT00108745|26481788|FG000|Overall Study|Withdrawal by Subject|19|||
13290760|NCT00108745|26481789|FG001|Overall Study|Withdrawal by Subject|12|||
13290761|NCT00108745|26481790|FG002|Overall Study|Withdrawal by Subject|12|||
13290762|NCT00108745|26481788|FG000|Overall Study|Never Treated|8|||
13290763|NCT00108745|26481789|FG001|Overall Study|Never Treated|10|||
13290764|NCT00108745|26481790|FG002|Overall Study|Never Treated|12|||
13290765|NCT00108745|26481788|FG000|Overall Study|Ineligible|7|||
13290766|NCT00108745|26481789|FG001|Overall Study|Ineligible|13|||
13290767|NCT00108745|26481790|FG002|Overall Study|Ineligible|13|||
13290768|NCT00106080|26481805|FG000|Overall Study|Withdrew/Loss to follow-up|43|||
13290769|NCT00106080|26481806|FG001|Overall Study|Withdrew/Loss to follow-up|27|||
13292343|NCT00706654|26485250|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
13292344|NCT00706654|26485251|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
13271240|NCT01396148|26427624|FG000|Overall Study|Patient Decision|1|||
13271241|NCT01396083|26427655|FG000|Overall Study|Adverse Event|2|||
13271242|NCT01396083|26427656|FG001|Overall Study|Adverse Event|28|||
13271243|NCT01396083|26427655|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
13271244|NCT01396083|26427656|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
13271245|NCT01396083|26427655|FG000|Overall Study|Consent withdrawn|4|||
13271246|NCT01396083|26427656|FG001|Overall Study|Consent withdrawn|5|||
13271247|NCT01396083|26427655|FG000|Overall Study|Protocol deviation(s)|0|||
13271248|NCT01396083|26427656|FG001|Overall Study|Protocol deviation(s)|1|||
13271249|NCT01396083|26427655|FG000|Overall Study|Abnormal laboratory value(s)|1|||
13271250|NCT01396083|26427656|FG001|Overall Study|Abnormal laboratory value(s)|0|||
13271251|NCT01396083|26427655|FG000|Overall Study|Administrative problems|1|||
13271252|NCT01396083|26427656|FG001|Overall Study|Administrative problems|0|||
13271253|NCT01396083|26427655|FG000|Overall Study|Lost to Follow-up|1|||
13271254|NCT01396083|26427656|FG001|Overall Study|Lost to Follow-up|0|||
13271255|NCT01396070|26427665|FG000|Overall Study|Withdrawal by Subject|2|||
13271256|NCT01396070|26427665|FG000|Overall Study|Death|2|||
13271257|NCT01396070|26427665|FG000|Overall Study|Adverse Event|8|||
13271258|NCT01396070|26427665|FG000|Overall Study|Physician Decision|3|||
13271259|NCT01396070|26427665|FG000|Overall Study|Lack of Efficacy|4|||
13271260|NCT01396057|26427696|FG000|Overall Study|Adverse Event|2|||
13271261|NCT01396057|26427697|FG001|Overall Study|Adverse Event|6|||
13271262|NCT01396057|26427696|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
13271263|NCT01396057|26427697|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
13271264|NCT01396057|26427696|FG000|Overall Study|Protocol deviation|4|||
13271265|NCT01396057|26427697|FG001|Overall Study|Protocol deviation|4|||
13271266|NCT01396057|26427696|FG000|Overall Study|Consent withdrawn|3|||
13271267|NCT01396057|26427697|FG001|Overall Study|Consent withdrawn|2|||
13271268|NCT01396005|26427720|FG000|Overall Study|Withdrawal by Subject|0|||
13271269|NCT01396005|26427721|FG001|Overall Study|Withdrawal by Subject|1|||
13271270|NCT01396005|26427720|FG000|Overall Study|Non-compliance with protocol|0|||
13271271|NCT01396005|26427721|FG001|Overall Study|Non-compliance with protocol|1|||
13271272|NCT01395914|26427740|FG000|Overall Study|Unrelated to study drug AE|6|||
13271273|NCT01395914|26427741|FG001|Overall Study|Unrelated to study drug AE|1|||
13271274|NCT01395914|26427740|FG000|Overall Study|Death|23|||
13271275|NCT01395914|26427741|FG001|Overall Study|Death|17|||
13271276|NCT01395914|26427740|FG000|Overall Study|Other|9|||
13271277|NCT01395914|26427741|FG001|Overall Study|Other|3|||
13271278|NCT01395914|26427740|FG000|Overall Study|Withdrawal by patient|27|||
13271279|NCT01395914|26427741|FG001|Overall Study|Withdrawal by patient|14|||
13271280|NCT01395914|26427740|FG000|Overall Study|Study drug-related AE|1|||
13271281|NCT01395914|26427741|FG001|Overall Study|Study drug-related AE|0|||
13271282|NCT01395914|26427740|FG000|Overall Study|Lost to Follow-up|6|||
13271283|NCT01395914|26427741|FG001|Overall Study|Lost to Follow-up|2|||
13271284|NCT01395901|26427762|FG000|Overall Study|Lost to Follow-up|4|||
13271285|NCT01395901|26427763|FG001|Overall Study|Lost to Follow-up|0|||
13271286|NCT01395901|26427762|FG000|Overall Study|Randomized but not received study drug|5|||
13271287|NCT01395901|26427763|FG001|Overall Study|Randomized but not received study drug|4|||
13271288|NCT01395901|26427762|FG000|Overall Study|Adverse Event|0|||
13271289|NCT01395901|26427763|FG001|Overall Study|Adverse Event|1|||
13271290|NCT01395901|26427762|FG000|Overall Study|Withdrawal of consent|1|||
13271291|NCT01395901|26427763|FG001|Overall Study|Withdrawal of consent|0|||
13271292|NCT01395888|26427777|FG000|2-week Run-in Period|Adverse Event|2|||
13271293|NCT01395888|26427778|FG001|2-week Run-in Period|Adverse Event|0|||
13271294|NCT01395888|26427779|FG002|2-week Run-in Period|Adverse Event|0|||
13271295|NCT01395888|26427777|FG000|2-week Run-in Period|Continuation Criteria Not Met|13|||
13271296|NCT01395888|26427778|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
13271297|NCT01395888|26427779|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
13271298|NCT01395888|26427777|FG000|2-week Run-in Period|Lost to Follow-up|1|||
13271299|NCT01395888|26427778|FG001|2-week Run-in Period|Lost to Follow-up|0|||
13271300|NCT01395888|26427779|FG002|2-week Run-in Period|Lost to Follow-up|0|||
13271301|NCT01395888|26427777|FG000|2-week Run-in Period|Protocol Violation|2|||
13271302|NCT01395888|26427778|FG001|2-week Run-in Period|Protocol Violation|0|||
13271303|NCT01395888|26427779|FG002|2-week Run-in Period|Protocol Violation|0|||
13271304|NCT01395888|26427777|FG000|2-week Run-in Period|Withdrawal by Subject|4|||
13271305|NCT01395888|26427778|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
13271306|NCT01395888|26427779|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
13271307|NCT01395888|26427777|FG000|Treatment Period (TP)|Adverse Event|0|||
13271308|NCT01395888|26427778|FG001|Treatment Period (TP)|Adverse Event|7|||
13307938|NCT01281306|26530321|FG003|Overall Study|Condition no longer requires study drug|0|||
13271309|NCT01395888|26427779|FG002|Treatment Period (TP)|Adverse Event|6|||
13271310|NCT01395888|26427777|FG000|Treatment Period (TP)|Lack of Efficacy|0|||
13271311|NCT01395888|26427778|FG001|Treatment Period (TP)|Lack of Efficacy|4|||
13271312|NCT01395888|26427779|FG002|Treatment Period (TP)|Lack of Efficacy|3|||
13271313|NCT01395888|26427777|FG000|Treatment Period (TP)|Protocol Violation|0|||
13271314|NCT01395888|26427778|FG001|Treatment Period (TP)|Protocol Violation|1|||
13271315|NCT01395888|26427779|FG002|Treatment Period (TP)|Protocol Violation|5|||
13271316|NCT01395888|26427777|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
13271317|NCT01395888|26427778|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1|||
13271318|NCT01395888|26427779|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
13271319|NCT01395888|26427777|FG000|Treatment Period (TP)|Withdrawal by Subject|0|||
13271320|NCT01395888|26427778|FG001|Treatment Period (TP)|Withdrawal by Subject|2|||
13271321|NCT01395888|26427779|FG002|Treatment Period (TP)|Withdrawal by Subject|3|||
13271322|NCT01395823|26427792|FG000|Overall Study|Death|4|||
13271323|NCT01395823|26427793|FG001|Overall Study|Death|4|||
13271324|NCT01395823|26427792|FG000|Overall Study|Physician Decision|3|||
13271325|NCT01395823|26427793|FG001|Overall Study|Physician Decision|1|||
13271326|NCT01395823|26427792|FG000|Overall Study|Lost to Follow-up|1|||
13271327|NCT01395823|26427793|FG001|Overall Study|Lost to Follow-up|0|||
13271328|NCT01395823|26427792|FG000|Overall Study|Transplant|1|||
13271329|NCT01395823|26427793|FG001|Overall Study|Transplant|0|||
13271330|NCT01395823|26427792|FG000|Overall Study|GI symptoms|1|||
13271331|NCT01395823|26427793|FG001|Overall Study|GI symptoms|0|||
13271332|NCT01395823|26427792|FG000|Overall Study|Withdrawal by Subject|5|||
13271333|NCT01395823|26427793|FG001|Overall Study|Withdrawal by Subject|4|||
13271334|NCT01395810|26427834|FG000|Overall Study|Adverse Event|0|||
13271335|NCT01395810|26427835|FG001|Overall Study|Adverse Event|1|||
13271336|NCT01395810|26427836|FG002|Overall Study|Adverse Event|0|||
13271337|NCT01395810|26427837|FG003|Overall Study|Adverse Event|0|||
13271338|NCT01395810|26427834|FG000|Overall Study|Lack of Efficacy|0|||
13271339|NCT01395810|26427835|FG001|Overall Study|Lack of Efficacy|1|||
13271340|NCT01395810|26427836|FG002|Overall Study|Lack of Efficacy|0|||
13271341|NCT01395810|26427837|FG003|Overall Study|Lack of Efficacy|0|||
13271342|NCT01395810|26427834|FG000|Overall Study|Withdrawal criteria|0|||
13271343|NCT01395810|26427835|FG001|Overall Study|Withdrawal criteria|2|||
13271344|NCT01395810|26427836|FG002|Overall Study|Withdrawal criteria|0|||
13271345|NCT01395810|26427837|FG003|Overall Study|Withdrawal criteria|0|||
13271346|NCT01395810|26427834|FG000|Overall Study|Unclassified|2|||
13271347|NCT01395810|26427835|FG001|Overall Study|Unclassified|0|||
13271348|NCT01395810|26427836|FG002|Overall Study|Unclassified|0|||
13271349|NCT01395810|26427837|FG003|Overall Study|Unclassified|0|||
13271350|NCT01395784|26427844|FG000|Overall Study|Lost to Follow-up|7|||
13271351|NCT01395784|26427844|FG000|Overall Study|Withdrawal by Subject|3|||
13271352|NCT01395784|26427844|FG000|Overall Study|Physician Decision|5|||
13271353|NCT01395758|26427863|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
13271354|NCT01395758|26427864|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
13271355|NCT01395758|26427865|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
13271356|NCT01395524|26427895|FG000|Overall Study|Non-compliance with study schedule|1|||
13271357|NCT01395524|26427896|FG001|Overall Study|Non-compliance with study schedule|0|||
13271358|NCT01395524|26427897|FG002|Overall Study|Non-compliance with study schedule|1|||
13271359|NCT01395524|26427895|FG000|Overall Study|Lost to Follow-up|3|||
13271360|NCT01395524|26427896|FG001|Overall Study|Lost to Follow-up|1|||
13271361|NCT01395524|26427897|FG002|Overall Study|Lost to Follow-up|1|||
13271362|NCT01395524|26427895|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
13271363|NCT01395524|26427896|FG001|Overall Study|Study-Specific Withdrawal Criteria|2|||
13271364|NCT01395524|26427897|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
13271365|NCT01395524|26427895|FG000|Overall Study|Severe noncompliance with protocol|1|||
13271366|NCT01395524|26427896|FG001|Overall Study|Severe noncompliance with protocol|0|||
13271367|NCT01395524|26427897|FG002|Overall Study|Severe noncompliance with protocol|0|||
13271368|NCT01395524|26427895|FG000|Overall Study|Adverse Event|4|||
13271369|NCT01395524|26427896|FG001|Overall Study|Adverse Event|4|||
13271370|NCT01395524|26427897|FG002|Overall Study|Adverse Event|3|||
13271371|NCT01395524|26427895|FG000|Overall Study|Death|1|||
13271372|NCT01395524|26427896|FG001|Overall Study|Death|0|||
13271373|NCT01395524|26427897|FG002|Overall Study|Death|0|||
13271374|NCT01395524|26427895|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
13271375|NCT01395524|26427896|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
13271376|NCT01395524|26427897|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0|||
13271377|NCT01395524|26427895|FG000|Overall Study|Withdrawal by Subject|4|||
13271378|NCT01395524|26427896|FG001|Overall Study|Withdrawal by Subject|8|||
13271379|NCT01395524|26427897|FG002|Overall Study|Withdrawal by Subject|8|||
13271380|NCT01395524|26427895|FG000|Overall Study|Did not receive treatment|1|||
13271381|NCT01395524|26427896|FG001|Overall Study|Did not receive treatment|1|||
13271382|NCT01395524|26427897|FG002|Overall Study|Did not receive treatment|3|||
13271383|NCT01395524|26427895|FG000|Overall Study|Subject had spinal surgery|0|||
13271384|NCT01395524|26427896|FG001|Overall Study|Subject had spinal surgery|0|||
13271385|NCT01395524|26427897|FG002|Overall Study|Subject had spinal surgery|1|||
13271386|NCT01395394|26427918|FG000|Baseline Study Visit|Protocol Violation|1|||
13271387|NCT01395394|26427919|FG001|Baseline Study Visit|Protocol Violation|0|||
13271388|NCT01395394|26427920|FG002|Baseline Study Visit|Protocol Violation|0|||
13271389|NCT01395368|26427926|FG000|Overall Study|Physician Decision|14|||
13271390|NCT01395368|26427926|FG000|Overall Study|Withdrawal by Subject|2|||
13271391|NCT01395316|26427932|FG000|Overall Study|Lost to Follow-up|2|||
13271392|NCT01395316|26427932|FG000|Overall Study|poor MRI quality|1|||
13271393|NCT01395030|26427942|FG000|Overall Study|Did not complete FCH PET/CT|7|||
13271394|NCT01395017|26427957|FG000|Overall Study|Lost to Follow-up|1|||
13271395|NCT01395017|26427958|FG001|Overall Study|Lost to Follow-up|0|||
13271396|NCT01395017|26427957|FG000|Overall Study|Adverse Event|26|||
13271397|NCT01395017|26427958|FG001|Overall Study|Adverse Event|12|||
13271398|NCT01395017|26427957|FG000|Overall Study|Physician Decision|11|||
13271399|NCT01395017|26427958|FG001|Overall Study|Physician Decision|15|||
13271400|NCT01395017|26427957|FG000|Overall Study|Withdrawal by Subject|14|||
13271401|NCT01395017|26427958|FG001|Overall Study|Withdrawal by Subject|8|||
13271402|NCT01395017|26427957|FG000|Overall Study|Protocol deviation|1|||
13271403|NCT01395017|26427958|FG001|Overall Study|Protocol deviation|2|||
13271404|NCT01395017|26427957|FG000|Overall Study|Death|4|||
13271405|NCT01395017|26427958|FG001|Overall Study|Death|3|||
13271406|NCT01395017|26427957|FG000|Overall Study|Disease progression|42|||
13271407|NCT01395017|26427958|FG001|Overall Study|Disease progression|58|||
13271408|NCT01395017|26427957|FG000|Overall Study|Sponsor discontinued study|1|||
13271409|NCT01395017|26427958|FG001|Overall Study|Sponsor discontinued study|4|||
13271410|NCT01394991|26427985|FG000|Overall Study|Adverse Event|0|||
13271411|NCT01394991|26427986|FG001|Overall Study|Adverse Event|4|||
13271412|NCT01394991|26427985|FG000|Overall Study|Lack of Efficacy|5|||
13271413|NCT01394991|26427986|FG001|Overall Study|Lack of Efficacy|7|||
13271414|NCT01394991|26427985|FG000|Overall Study|Lost to Follow-up|6|||
13271415|NCT01394991|26427986|FG001|Overall Study|Lost to Follow-up|8|||
13271416|NCT01394991|26427985|FG000|Overall Study|Physician Decision|1|||
13271417|NCT01394991|26427986|FG001|Overall Study|Physician Decision|3|||
13271418|NCT01394991|26427985|FG000|Overall Study|Protocol Violation|1|||
13271419|NCT01394991|26427986|FG001|Overall Study|Protocol Violation|1|||
13271420|NCT01394991|26427985|FG000|Overall Study|Withdrawal by Subject|20|||
13271421|NCT01394991|26427986|FG001|Overall Study|Withdrawal by Subject|17|||
13271422|NCT01394991|26427985|FG000|Overall Study|Chemotherapy Termination|10|||
13271423|NCT01394991|26427986|FG001|Overall Study|Chemotherapy Termination|15|||
13271424|NCT01394991|26427985|FG000|Overall Study|Disease Progression|7|||
13271425|NCT01394991|26427986|FG001|Overall Study|Disease Progression|7|||
13271426|NCT01394991|26427985|FG000|Overall Study|Prematurely Termination of Trial|9|||
13271427|NCT01394991|26427986|FG001|Overall Study|Prematurely Termination of Trial|10|||
13271428|NCT01394978|26428002|FG000|Overall Study|Withdrawal by Subject|2|||
13271429|NCT01394978|26428003|FG001|Overall Study|Withdrawal by Subject|4|||
13271430|NCT01394978|26428002|FG000|Overall Study|Lost to Follow-up|13|||
13271431|NCT01394978|26428003|FG001|Overall Study|Lost to Follow-up|20|||
13271432|NCT01394978|26428002|FG000|Overall Study|Death|6|||
13271433|NCT01394978|26428003|FG001|Overall Study|Death|7|||
13271434|NCT01394952|26428026|FG000|Overall Study|Lost to Follow-up|0|||
13271435|NCT01394952|26428027|FG001|Overall Study|Lost to Follow-up|5|||
13271436|NCT01394952|26428026|FG000|Overall Study|Withdrawal by Subject|10|||
13271437|NCT01394952|26428027|FG001|Overall Study|Withdrawal by Subject|5|||
13271438|NCT01394952|26428026|FG000|Overall Study|Physician Decision|2|||
13271439|NCT01394952|26428027|FG001|Overall Study|Physician Decision|0|||
13271440|NCT01394952|26428026|FG000|Overall Study|Sponsor Decision|5|||
13271441|NCT01394952|26428027|FG001|Overall Study|Sponsor Decision|7|||
13271442|NCT01394939|26428050|FG000|Overall Study|Adverse Event|1|||
13271443|NCT01394939|26428051|FG001|Overall Study|Adverse Event|3|||
13271444|NCT01394939|26428052|FG002|Overall Study|Adverse Event|0|||
13271445|NCT01394939|26428053|FG003|Overall Study|Adverse Event|2|||
13271446|NCT01394939|26428050|FG000|Overall Study|Death|0|||
13271447|NCT01394939|26428051|FG001|Overall Study|Death|2|||
13271448|NCT01394939|26428052|FG002|Overall Study|Death|0|||
13271449|NCT01394939|26428053|FG003|Overall Study|Death|0|||
13271450|NCT01394939|26428050|FG000|Overall Study|Physician Decision|0|||
13271451|NCT01394939|26428051|FG001|Overall Study|Physician Decision|1|||
13271452|NCT01394939|26428052|FG002|Overall Study|Physician Decision|0|||
13271453|NCT01394939|26428053|FG003|Overall Study|Physician Decision|0|||
13271454|NCT01394939|26428050|FG000|Overall Study|Withdrawal by Subject|0|||
13271455|NCT01394939|26428051|FG001|Overall Study|Withdrawal by Subject|2|||
13271456|NCT01394939|26428052|FG002|Overall Study|Withdrawal by Subject|0|||
13271457|NCT01394939|26428053|FG003|Overall Study|Withdrawal by Subject|2|||
13271458|NCT01394939|26428050|FG000|Overall Study|Others|0|||
13271459|NCT01394939|26428051|FG001|Overall Study|Others|2|||
13271460|NCT01394939|26428052|FG002|Overall Study|Others|0|||
13271461|NCT01394939|26428053|FG003|Overall Study|Others|3|||
13271462|NCT01394718|26428072|FG000|Overall Study|Met protocol-specific stopping criteria|2|||
13271463|NCT01394718|26428073|FG001|Overall Study|Met protocol-specific stopping criteria|1|||
13271464|NCT01394627|26428084|FG000|First Intervention (1 Day)|poor intravenous access|0|||
13271465|NCT01394627|26428085|FG001|First Intervention (1 Day)|poor intravenous access|1|||
13271466|NCT01394627|26428084|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1|||
13271467|NCT01394627|26428085|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0|||
13271468|NCT01394523|26428103|FG000|Overall Study|Unable to place block|1|||
13271469|NCT01394523|26428104|FG001|Overall Study|Unable to place block|0|||
13271470|NCT01394523|26428105|FG002|Overall Study|Unable to place block|0|||
13271471|NCT01394276|26428129|FG000|Overall Study|Related Adverse event (AEs)|15|||
13271472|NCT01394276|26428129|FG000|Overall Study|Not related AEs|9|||
13271473|NCT01394276|26428129|FG000|Overall Study|Remission of disease|2|||
13271474|NCT01394276|26428129|FG000|Overall Study|Insufficient therapeutic effect|17|||
13271475|NCT01394276|26428129|FG000|Overall Study|Insufficient compliance|9|||
13271476|NCT01394276|26428129|FG000|Overall Study|Lost to Follow-up|5|||
13271477|NCT01394276|26428129|FG000|Overall Study|Participant moved to another site|1|||
13271478|NCT01394276|26428129|FG000|Overall Study|Pregnancy|1|||
13271479|NCT01394276|26428129|FG000|Overall Study|unavailability of drug at the Hospital|2|||
13271480|NCT01394276|26428129|FG000|Overall Study|Symptoms of concurrent diseases|1|||
13271481|NCT01394250|26428144|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14|||
13271482|NCT01394250|26428145|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13|||
13271483|NCT01394250|26428144|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6|||
13271484|NCT01394250|26428145|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11|||
13271485|NCT01394185|26428163|FG000|Overall Study|Withdrawal by Subject|2|||
13271486|NCT01394185|26428164|FG001|Overall Study|Withdrawal by Subject|0|||
13271487|NCT01394185|26428165|FG002|Overall Study|Withdrawal by Subject|0|||
13271488|NCT01394185|26428166|FG003|Overall Study|Withdrawal by Subject|0|||
13271489|NCT01394185|26428167|FG004|Overall Study|Withdrawal by Subject|1|||
13271490|NCT01394185|26428168|FG005|Overall Study|Withdrawal by Subject|0|||
13271491|NCT01394185|26428163|FG000|Overall Study|Change in protocol|3|||
13271492|NCT01394185|26428164|FG001|Overall Study|Change in protocol|0|||
13271493|NCT01394185|26428165|FG002|Overall Study|Change in protocol|0|||
13271494|NCT01394185|26428166|FG003|Overall Study|Change in protocol|0|||
13271495|NCT01394185|26428167|FG004|Overall Study|Change in protocol|3|||
13271496|NCT01394185|26428168|FG005|Overall Study|Change in protocol|0|||
13271497|NCT01394185|26428163|FG000|Overall Study|Protocol Violation|1|||
13271498|NCT01394185|26428164|FG001|Overall Study|Protocol Violation|0|||
13271499|NCT01394185|26428165|FG002|Overall Study|Protocol Violation|0|||
13271500|NCT01394185|26428166|FG003|Overall Study|Protocol Violation|1|||
13271501|NCT01394185|26428167|FG004|Overall Study|Protocol Violation|0|||
13271502|NCT01394185|26428168|FG005|Overall Study|Protocol Violation|1|||
13271503|NCT01393990|26428311|FG000|Overall Study|Adverse Event|0|||
13271504|NCT01393990|26428312|FG001|Overall Study|Adverse Event|0|||
13271505|NCT01393990|26428313|FG002|Overall Study|Adverse Event|0|||
13271506|NCT01393990|26428314|FG003|Overall Study|Adverse Event|0|||
13271507|NCT01393990|26428315|FG004|Overall Study|Adverse Event|0|||
13271508|NCT01393990|26428316|FG005|Overall Study|Adverse Event|0|||
13271509|NCT01393990|26428317|FG006|Overall Study|Adverse Event|0|||
13271510|NCT01393990|26428318|FG007|Overall Study|Adverse Event|0|||
13271511|NCT01393990|26428319|FG008|Overall Study|Adverse Event|0|||
13271512|NCT01393990|26428320|FG009|Overall Study|Adverse Event|0|||
13271513|NCT01393990|26428321|FG010|Overall Study|Adverse Event|0|||
13271514|NCT01393990|26428322|FG011|Overall Study|Adverse Event|0|||
13271515|NCT01393990|26428323|FG012|Overall Study|Adverse Event|0|||
13271516|NCT01393990|26428324|FG013|Overall Study|Adverse Event|0|||
13271517|NCT01393990|26428325|FG014|Overall Study|Adverse Event|1|||
13307939|NCT01281306|26530322|FG004|Overall Study|Condition no longer requires study drug|0|||
13307940|NCT01281306|26530323|FG005|Overall Study|Condition no longer requires study drug|1|||
13307941|NCT01281306|26530324|FG006|Overall Study|Condition no longer requires study drug|1|||
13307942|NCT01281306|26530318|FG000|Overall Study|Lost to Follow-up|1|||
13307943|NCT01281306|26530319|FG001|Overall Study|Lost to Follow-up|0|||
13307944|NCT01281306|26530320|FG002|Overall Study|Lost to Follow-up|0|||
13307945|NCT01281306|26530321|FG003|Overall Study|Lost to Follow-up|2|||
13307946|NCT01281306|26530322|FG004|Overall Study|Lost to Follow-up|0|||
13307947|NCT01281306|26530323|FG005|Overall Study|Lost to Follow-up|0|||
13307948|NCT01281306|26530324|FG006|Overall Study|Lost to Follow-up|1|||
13307949|NCT01281306|26530318|FG000|Overall Study|Death|1|||
13307950|NCT01281306|26530319|FG001|Overall Study|Death|0|||
13271518|NCT01393990|26428326|FG015|Overall Study|Adverse Event|1|||
13271519|NCT01393990|26428327|FG016|Overall Study|Adverse Event|0|||
13271520|NCT01393990|26428328|FG017|Overall Study|Adverse Event|0|||
13271521|NCT01393990|26428311|FG000|Overall Study|Progressive Disease|1|||
13271522|NCT01393990|26428312|FG001|Overall Study|Progressive Disease|0|||
13271523|NCT01393990|26428313|FG002|Overall Study|Progressive Disease|0|||
13271524|NCT01393990|26428314|FG003|Overall Study|Progressive Disease|1|||
13271525|NCT01393990|26428315|FG004|Overall Study|Progressive Disease|1|||
13271526|NCT01393990|26428316|FG005|Overall Study|Progressive Disease|1|||
13271527|NCT01393990|26428317|FG006|Overall Study|Progressive Disease|1|||
13271528|NCT01393990|26428318|FG007|Overall Study|Progressive Disease|1|||
13271529|NCT01393990|26428319|FG008|Overall Study|Progressive Disease|3|||
13271530|NCT01393990|26428320|FG009|Overall Study|Progressive Disease|1|||
13271531|NCT01393990|26428321|FG010|Overall Study|Progressive Disease|0|||
13271532|NCT01393990|26428322|FG011|Overall Study|Progressive Disease|0|||
13307951|NCT01281306|26530320|FG002|Overall Study|Death|0|||
13307952|NCT01281306|26530321|FG003|Overall Study|Death|0|||
13307953|NCT01281306|26530322|FG004|Overall Study|Death|0|||
13307954|NCT01281306|26530323|FG005|Overall Study|Death|0|||
13271533|NCT01393990|26428323|FG012|Overall Study|Progressive Disease|0|||
13271534|NCT01393990|26428324|FG013|Overall Study|Progressive Disease|1|||
13271535|NCT01393990|26428325|FG014|Overall Study|Progressive Disease|6|||
13271536|NCT01393990|26428326|FG015|Overall Study|Progressive Disease|1|||
13271537|NCT01393990|26428327|FG016|Overall Study|Progressive Disease|0|||
13271538|NCT01393990|26428328|FG017|Overall Study|Progressive Disease|0|||
13271539|NCT01393990|26428311|FG000|Overall Study|Death|0|||
13271540|NCT01393990|26428312|FG001|Overall Study|Death|0|||
13271541|NCT01393990|26428313|FG002|Overall Study|Death|0|||
13271542|NCT01393990|26428314|FG003|Overall Study|Death|0|||
13271543|NCT01393990|26428315|FG004|Overall Study|Death|1|||
13271544|NCT01393990|26428316|FG005|Overall Study|Death|0|||
13271545|NCT01393990|26428317|FG006|Overall Study|Death|0|||
13271546|NCT01393990|26428318|FG007|Overall Study|Death|0|||
13271547|NCT01393990|26428319|FG008|Overall Study|Death|0|||
13271548|NCT01393990|26428320|FG009|Overall Study|Death|0|||
13271549|NCT01393990|26428321|FG010|Overall Study|Death|0|||
13271550|NCT01393990|26428322|FG011|Overall Study|Death|0|||
13271551|NCT01393990|26428323|FG012|Overall Study|Death|0|||
13271552|NCT01393990|26428324|FG013|Overall Study|Death|1|||
13271553|NCT01393990|26428325|FG014|Overall Study|Death|1|||
13271554|NCT01393990|26428326|FG015|Overall Study|Death|0|||
13271555|NCT01393990|26428327|FG016|Overall Study|Death|0|||
13271556|NCT01393990|26428328|FG017|Overall Study|Death|0|||
13271557|NCT01393990|26428311|FG000|Overall Study|Withdrawal by Subject|0|||
13271558|NCT01393990|26428312|FG001|Overall Study|Withdrawal by Subject|0|||
13271559|NCT01393990|26428313|FG002|Overall Study|Withdrawal by Subject|0|||
13271560|NCT01393990|26428314|FG003|Overall Study|Withdrawal by Subject|0|||
13271561|NCT01393990|26428315|FG004|Overall Study|Withdrawal by Subject|0|||
13271562|NCT01393990|26428316|FG005|Overall Study|Withdrawal by Subject|0|||
13271563|NCT01393990|26428317|FG006|Overall Study|Withdrawal by Subject|0|||
13271564|NCT01393990|26428318|FG007|Overall Study|Withdrawal by Subject|0|||
13271565|NCT01393990|26428319|FG008|Overall Study|Withdrawal by Subject|0|||
13271566|NCT01393990|26428320|FG009|Overall Study|Withdrawal by Subject|0|||
13118121|NCT03045887|25927888|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
13118122|NCT03045887|25927889|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
13118123|NCT03045887|25927890|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
13118124|NCT03045887|25927891|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
13118125|NCT03045887|25927892|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
13118126|NCT03045887|25927893|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
13118127|NCT03045328|25927906|FG000|Overall Study|Withdrawal by Subject|2|||
13118128|NCT03045302|25927912|FG000|Overall Study|Pre-treatment adverse event|1|||
13118129|NCT03045081|25927935|FG000|Overall Study|Withdrawal by Subject|6|||
13118130|NCT03045081|25927936|FG001|Overall Study|Withdrawal by Subject|11|||
13118131|NCT03044886|25927987|FG000|Overall Study|Lost to Follow-up|15|||
13118132|NCT03044886|25927988|FG001|Overall Study|Lost to Follow-up|10|||
13118133|NCT03044886|25927989|FG002|Overall Study|Lost to Follow-up|12|||
13118134|NCT03044730|25928000|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1|||
13118135|NCT03044730|25928000|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1|||
13118136|NCT03044730|25928000|FG000|3 Cycles of Pembro + Capecitab|Death|1|||
13118137|NCT03044730|25928000|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1|||
13118138|NCT03044730|25928000|FG000|Cycles 4 and Beyond|Progressive Disease|9|||
13118139|NCT03044730|25928000|FG000|Cycles 4 and Beyond|Adverse Event|1|||
13118140|NCT03044730|25928000|FG000|On Follow-up for 2 Years|Still in follow-up|7|||
13118141|NCT03044730|25928000|FG000|On Follow-up for 2 Years|Lost to Follow-up|1|||
13118142|NCT03044730|25928000|FG000|On Follow-up for 2 Years|Death|17|||
13118143|NCT03044574|25928033|FG000|Overall Study|Lost to Follow-up|37|||
13118144|NCT03044574|25928034|FG001|Overall Study|Lost to Follow-up|45|||
13118145|NCT03044431|25928046|FG000|Overall Study|Lost to Follow-up|59|||
13271567|NCT01393990|26428321|FG010|Overall Study|Withdrawal by Subject|0|||
13118146|NCT03044353|25928137|FG000|Overall Study|Adverse Event|0|||
13118147|NCT03044353|25928138|FG001|Overall Study|Adverse Event|1|||
13118148|NCT03044353|25928139|FG002|Overall Study|Adverse Event|0|||
13118149|NCT03044249|25928168|FG000|Overall Study|Adverse Event|4|||
13118150|NCT03044249|25928169|FG001|Overall Study|Adverse Event|9|||
13118151|NCT03044249|25928168|FG000|Overall Study|Lost to Follow-up|1|||
13118152|NCT03044249|25928169|FG001|Overall Study|Lost to Follow-up|0|||
13118153|NCT03044249|25928168|FG000|Overall Study|Non-compliance with Study Drug|1|||
13118154|NCT03044249|25928169|FG001|Overall Study|Non-compliance with Study Drug|0|||
13118155|NCT03044249|25928168|FG000|Overall Study|Study Terminated by Sponsor|2|||
13118156|NCT03044249|25928169|FG001|Overall Study|Study Terminated by Sponsor|0|||
13118157|NCT03044249|25928168|FG000|Overall Study|Withdrawal by Subject|2|||
13118158|NCT03044249|25928169|FG001|Overall Study|Withdrawal by Subject|5|||
13118159|NCT03044197|25928186|FG000|Overall Study|Withdrawal by Subject|3|||
13118160|NCT03044197|25928187|FG001|Overall Study|Withdrawal by Subject|1|||
13118161|NCT03044106|25928204|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
13271568|NCT01393990|26428322|FG011|Overall Study|Withdrawal by Subject|0|||
13271569|NCT01393990|26428323|FG012|Overall Study|Withdrawal by Subject|0|||
13118162|NCT03044106|25928205|FG001|Washout (1 Week)|Withdrawal by Subject|2|||
13118163|NCT03043664|25928214|FG000|Overall Study|Lost to Follow-up|1|||
13118164|NCT03043664|25928214|FG000|Overall Study|In Observation for Overall Survival|6|||
13118165|NCT03043651|25928220|FG000|Overall Study|Death|1|||
13118166|NCT03043651|25928220|FG000|Overall Study|Progressive Disease|2|||
13118167|NCT03043651|25928220|FG000|Overall Study|Adverse Event|2|||
13118168|NCT03043651|25928220|FG000|Overall Study|Withdrawal by Subject|4|||
13118169|NCT03043651|25928220|FG000|Overall Study|Study Terminated by Sponsor|39|||
13118170|NCT03043560|25928249|FG000|Overall Study|Discontinued Intervention|1|||
13118171|NCT03043560|25928250|FG001|Overall Study|Discontinued Intervention|2|||
13118172|NCT03043560|25928249|FG000|Overall Study|Lost to Follow-up|0|||
13118173|NCT03043560|25928250|FG001|Overall Study|Lost to Follow-up|1|||
13271570|NCT01393990|26428324|FG013|Overall Study|Withdrawal by Subject|0|||
13271571|NCT01393990|26428325|FG014|Overall Study|Withdrawal by Subject|1|||
13271572|NCT01393990|26428326|FG015|Overall Study|Withdrawal by Subject|1|||
13271573|NCT01393990|26428327|FG016|Overall Study|Withdrawal by Subject|0|||
13271574|NCT01393990|26428328|FG017|Overall Study|Withdrawal by Subject|0|||
13271575|NCT01393964|26428376|FG000|Overall Study|Disease Progression|4|||
13271576|NCT01393964|26428377|FG001|Overall Study|Disease Progression|3|||
13271577|NCT01393964|26428378|FG002|Overall Study|Disease Progression|5|||
13271578|NCT01393964|26428376|FG000|Overall Study|Study drug toxicity|1|||
13271579|NCT01393964|26428377|FG001|Overall Study|Study drug toxicity|0|||
13271580|NCT01393964|26428378|FG002|Overall Study|Study drug toxicity|0|||
13271581|NCT01393964|26428376|FG000|Overall Study|Withdrawal by Subject|0|||
13271582|NCT01393964|26428377|FG001|Overall Study|Withdrawal by Subject|0|||
13271583|NCT01393964|26428378|FG002|Overall Study|Withdrawal by Subject|1|||
13271584|NCT01393964|26428376|FG000|Overall Study|Adverse event unrelated to study drug|0|||
13271585|NCT01393964|26428377|FG001|Overall Study|Adverse event unrelated to study drug|3|||
13271586|NCT01393964|26428378|FG002|Overall Study|Adverse event unrelated to study drug|0|||
13271587|NCT01393964|26428376|FG000|Overall Study|Subject request stop study treatment|0|||
13271588|NCT01393964|26428377|FG001|Overall Study|Subject request stop study treatment|1|||
13271589|NCT01393964|26428378|FG002|Overall Study|Subject request stop study treatment|0|||
13271590|NCT01393964|26428376|FG000|Overall Study|Subject decided to move to transplant|1|||
13271591|NCT01393964|26428377|FG001|Overall Study|Subject decided to move to transplant|0|||
13271592|NCT01393964|26428378|FG002|Overall Study|Subject decided to move to transplant|0|||
13271593|NCT01393964|26428376|FG000|Overall Study|Subject switched to commercial supply|1|||
13271594|NCT01393964|26428377|FG001|Overall Study|Subject switched to commercial supply|0|||
13271595|NCT01393964|26428378|FG002|Overall Study|Subject switched to commercial supply|2|||
13271596|NCT01393964|26428376|FG000|Overall Study|Subject plateaued in terms of effect|1|||
13271597|NCT01393964|26428377|FG001|Overall Study|Subject plateaued in terms of effect|0|||
13271598|NCT01393964|26428378|FG002|Overall Study|Subject plateaued in terms of effect|0|||
13271599|NCT01393964|26428376|FG000|Overall Study|Investigator removed subject from study|0|||
13271600|NCT01393964|26428377|FG001|Overall Study|Investigator removed subject from study|1|||
13271601|NCT01393964|26428378|FG002|Overall Study|Investigator removed subject from study|0|||
13271602|NCT01393964|26428376|FG000|Overall Study|Subject converted to roll-over study|0|||
13271603|NCT01393964|26428377|FG001|Overall Study|Subject converted to roll-over study|1|||
13271604|NCT01393964|26428378|FG002|Overall Study|Subject converted to roll-over study|0|||
13271605|NCT01393964|26428376|FG000|Overall Study|Subject to receive non-protocol therapy|0|||
13271606|NCT01393964|26428377|FG001|Overall Study|Subject to receive non-protocol therapy|0|||
13271607|NCT01393964|26428378|FG002|Overall Study|Subject to receive non-protocol therapy|1|||
13271608|NCT01393899|26428440|FG000|Overall Study|Study terminated by sponsor|1|||
13271609|NCT01393899|26428441|FG001|Overall Study|Study terminated by sponsor|0|||
13271610|NCT01393899|26428442|FG002|Overall Study|Study terminated by sponsor|1|||
13271611|NCT01393899|26428440|FG000|Overall Study|Other|1|||
13271612|NCT01393899|26428441|FG001|Overall Study|Other|0|||
13271613|NCT01393899|26428442|FG002|Overall Study|Other|0|||
13271614|NCT01393899|26428440|FG000|Overall Study|Withdrawal by Subject|2|||
13271615|NCT01393899|26428441|FG001|Overall Study|Withdrawal by Subject|2|||
13271616|NCT01393899|26428442|FG002|Overall Study|Withdrawal by Subject|1|||
13271617|NCT01393899|26428440|FG000|Overall Study|Lost to Follow-up|0|||
13271618|NCT01393899|26428441|FG001|Overall Study|Lost to Follow-up|0|||
13271619|NCT01393899|26428442|FG002|Overall Study|Lost to Follow-up|1|||
13271620|NCT01393899|26428440|FG000|Overall Study|Does not meet entrance criteria|1|||
13271621|NCT01393899|26428441|FG001|Overall Study|Does not meet entrance criteria|0|||
13271622|NCT01393899|26428442|FG002|Overall Study|Does not meet entrance criteria|1|||
13271623|NCT01393899|26428440|FG000|Overall Study|Lack of Efficacy|26|||
13271624|NCT01393899|26428441|FG001|Overall Study|Lack of Efficacy|21|||
13271625|NCT01393899|26428442|FG002|Overall Study|Lack of Efficacy|16|||
13271626|NCT01393899|26428440|FG000|Overall Study|Adverse Event|1|||
13271627|NCT01393899|26428441|FG001|Overall Study|Adverse Event|5|||
13118174|NCT03043365|25928268|FG000|Weeks 0 to Week 8|Adverse Event|1|||
13118175|NCT03043365|25928269|FG001|Weeks 0 to Week 8|Adverse Event|3|||
13118176|NCT03043365|25928268|FG000|Weeks 0 to Week 8|Lost to Follow-up|2|||
13271628|NCT01393899|26428442|FG002|Overall Study|Adverse Event|3|||
13271629|NCT01393821|26428461|FG000|Overall Study|Cancel|1|||
13271630|NCT01393821|26428462|FG001|Overall Study|Cancel|1|||
13271631|NCT01393821|26428461|FG000|Overall Study|not evaluable for primary endpoint|4|||
13271632|NCT01393821|26428462|FG001|Overall Study|not evaluable for primary endpoint|2|||
13271633|NCT01393743|26428493|FG000|Core Study|Adverse Event|5|||
13271634|NCT01393743|26428494|FG001|Core Study|Adverse Event|9|||
13271635|NCT01393743|26428495|FG002|Core Study|Adverse Event|0|||
13271636|NCT01393743|26428493|FG000|Core Study|Lost to Follow-up|1|||
13271637|NCT01393743|26428494|FG001|Core Study|Lost to Follow-up|1|||
13271638|NCT01393743|26428495|FG002|Core Study|Lost to Follow-up|0|||
13271639|NCT01393743|26428493|FG000|Core Study|Participant's Choice|2|||
13271640|NCT01393743|26428494|FG001|Core Study|Participant's Choice|3|||
13271641|NCT01393743|26428495|FG002|Core Study|Participant's Choice|0|||
13271642|NCT01393743|26428493|FG000|Core Study|Inadequate therapeutic effect|2|||
13271643|NCT01393743|26428494|FG001|Core Study|Inadequate therapeutic effect|0|||
13271644|NCT01393743|26428495|FG002|Core Study|Inadequate therapeutic effect|0|||
13271645|NCT01393743|26428493|FG000|Extension Phase|Adverse Event|0|||
13271646|NCT01393743|26428494|FG001|Extension Phase|Adverse Event|0|||
13271647|NCT01393743|26428495|FG002|Extension Phase|Adverse Event|12|||
13271648|NCT01393743|26428493|FG000|Extension Phase|Lost to Follow-up|0|||
13271649|NCT01393743|26428494|FG001|Extension Phase|Lost to Follow-up|0|||
13271650|NCT01393743|26428495|FG002|Extension Phase|Lost to Follow-up|2|||
13271651|NCT01393743|26428493|FG000|Extension Phase|Participant choice|0|||
13271652|NCT01393743|26428494|FG001|Extension Phase|Participant choice|0|||
13118177|NCT03043365|25928269|FG001|Weeks 0 to Week 8|Lost to Follow-up|0|||
13118178|NCT03043365|25928268|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1|||
13118179|NCT03043365|25928269|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0|||
13133413|NCT02770170|25987713|FG001|Overall Study|due to disease worsening|0|||
13133414|NCT02770170|25987714|FG002|Overall Study|due to disease worsening|0|||
13133415|NCT02770170|25987715|FG003|Overall Study|due to disease worsening|1|||
13133416|NCT02769858|25987723|FG000|Overall Study|Withdrawal by Subject|2|||
13133417|NCT02769624|25987742|FG000|Overall Study|Lost to Follow-up|0|||
13133418|NCT02769624|25987743|FG001|Overall Study|Lost to Follow-up|1|||
13133419|NCT02769481|25987764|FG000|Overall Study|Protocol Violation|1|||
13133420|NCT02769481|25987765|FG001|Overall Study|Protocol Violation|0|||
13133421|NCT02769481|25987764|FG000|Overall Study|Adverse Event|3|||
13133422|NCT02769481|25987765|FG001|Overall Study|Adverse Event|6|||
13133423|NCT02769481|25987764|FG000|Overall Study|Entry Criteria Not Met|1|||
13133424|NCT02769481|25987765|FG001|Overall Study|Entry Criteria Not Met|2|||
13133425|NCT02769481|25987764|FG000|Overall Study|Withdrawal by Subject|14|||
13133426|NCT02769481|25987765|FG001|Overall Study|Withdrawal by Subject|16|||
13133427|NCT02769481|25987764|FG000|Overall Study|Lost to Follow-up|9|||
13133428|NCT02769481|25987765|FG001|Overall Study|Lost to Follow-up|9|||
13133429|NCT02769481|25987764|FG000|Overall Study|Physician Decision|0|||
13133430|NCT02769481|25987765|FG001|Overall Study|Physician Decision|1|||
13133431|NCT02769481|25987764|FG000|Overall Study|Terminated by Sponsor|1|||
13133432|NCT02769481|25987765|FG001|Overall Study|Terminated by Sponsor|0|||
13133433|NCT02769481|25987764|FG000|Overall Study|Death|0|||
13133434|NCT02769481|25987765|FG001|Overall Study|Death|1|||
13133435|NCT02769481|25987764|FG000|Overall Study|Undefined|4|||
13133436|NCT02769481|25987765|FG001|Overall Study|Undefined|1|||
13133437|NCT02769312|25987785|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
13133438|NCT02769312|25987786|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
13271653|NCT01393743|26428495|FG002|Extension Phase|Participant choice|16|||
13271654|NCT01393743|26428493|FG000|Extension Phase|Inadequate therapeutic effect|0|||
13271655|NCT01393743|26428494|FG001|Extension Phase|Inadequate therapeutic effect|0|||
13271656|NCT01393743|26428495|FG002|Extension Phase|Inadequate therapeutic effect|7|||
13271657|NCT01393743|26428493|FG000|Extension Phase|Withdrawal by Subject|0|||
13271658|NCT01393743|26428494|FG001|Extension Phase|Withdrawal by Subject|0|||
13271659|NCT01393743|26428495|FG002|Extension Phase|Withdrawal by Subject|8|||
13271660|NCT01393743|26428493|FG000|Extension Phase|Pregnancy|0|||
13271661|NCT01393743|26428494|FG001|Extension Phase|Pregnancy|0|||
13271662|NCT01393743|26428495|FG002|Extension Phase|Pregnancy|1|||
13271663|NCT01393743|26428493|FG000|Extension Phase|Other|0|||
13271664|NCT01393743|26428494|FG001|Extension Phase|Other|0|||
13133439|NCT02769312|25987785|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1|||
13133440|NCT02769312|25987786|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0|||
13133441|NCT02769312|25987785|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1|||
13133442|NCT02769312|25987786|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0|||
13133443|NCT02769312|25987785|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0|||
13133444|NCT02769312|25987786|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1|||
13271665|NCT01393743|26428495|FG002|Extension Phase|Other|14|||
13271666|NCT01393730|26428509|FG000|Overall Study|Withdrawal by Subject|3|||
13271667|NCT01393730|26428509|FG000|Overall Study|Other|2|||
13271668|NCT01393730|26428509|FG000|Overall Study|Adverse Event|1|||
13271669|NCT01393626|26428598|FG000|Overall Study|Adverse Event|2|||
13271670|NCT01393626|26428599|FG001|Overall Study|Adverse Event|1|||
13271671|NCT01393626|26428600|FG002|Overall Study|Adverse Event|5|||
13271672|NCT01393626|26428601|FG003|Overall Study|Adverse Event|0|||
13271673|NCT01393626|26428598|FG000|Overall Study|Did not meet entrance criteria|1|||
13271674|NCT01393626|26428599|FG001|Overall Study|Did not meet entrance criteria|0|||
13271675|NCT01393626|26428600|FG002|Overall Study|Did not meet entrance criteria|0|||
13271676|NCT01393626|26428601|FG003|Overall Study|Did not meet entrance criteria|0|||
13271677|NCT01393626|26428598|FG000|Overall Study|Lack of Efficacy|6|||
13271678|NCT01393626|26428599|FG001|Overall Study|Lack of Efficacy|6|||
13271679|NCT01393626|26428600|FG002|Overall Study|Lack of Efficacy|4|||
13271680|NCT01393626|26428601|FG003|Overall Study|Lack of Efficacy|1|||
13271681|NCT01393626|26428598|FG000|Overall Study|Lost to Follow-up|1|||
13271682|NCT01393626|26428599|FG001|Overall Study|Lost to Follow-up|1|||
13271683|NCT01393626|26428600|FG002|Overall Study|Lost to Follow-up|1|||
13271684|NCT01393626|26428601|FG003|Overall Study|Lost to Follow-up|0|||
13271685|NCT01393626|26428598|FG000|Overall Study|Withdrawal by Subject|6|||
13271686|NCT01393626|26428599|FG001|Overall Study|Withdrawal by Subject|4|||
13271687|NCT01393626|26428600|FG002|Overall Study|Withdrawal by Subject|0|||
13271688|NCT01393626|26428601|FG003|Overall Study|Withdrawal by Subject|0|||
13271689|NCT01393626|26428598|FG000|Overall Study|Other|1|||
13271690|NCT01393626|26428599|FG001|Overall Study|Other|0|||
13271691|NCT01393626|26428600|FG002|Overall Study|Other|0|||
13271692|NCT01393626|26428601|FG003|Overall Study|Other|0|||
13271693|NCT01393626|26428598|FG000|Overall Study|Protocol Violation|1|||
13271694|NCT01393626|26428599|FG001|Overall Study|Protocol Violation|0|||
13271695|NCT01393626|26428600|FG002|Overall Study|Protocol Violation|2|||
13271696|NCT01393626|26428601|FG003|Overall Study|Protocol Violation|0|||
13271697|NCT01393613|26428676|FG000|Overall Study|Adverse Event|11|||
13118180|NCT03042910|25928294|FG000|Overall Study|Adverse Event|1|||
13118181|NCT03042910|25928294|FG000|Overall Study|Disease Progression|2|||
13118182|NCT03042910|25928294|FG000|Overall Study|Withdrawal by Subject|3|||
13118183|NCT03042910|25928294|FG000|Overall Study|Enrolled but not treated|1|||
13118184|NCT03042767|25928337|FG000|Overall Study|Lost to Follow-up|1|||
13118185|NCT03042767|25928338|FG001|Overall Study|Lost to Follow-up|2|||
13118186|NCT03042611|25928367|FG000|Core Phase|Withdrawal by Subject|13|||
13118187|NCT03042611|25928368|FG001|Core Phase|Withdrawal by Subject|4|||
13118188|NCT03042611|25928369|FG002|Core Phase|Withdrawal by Subject|0|||
13118189|NCT03042611|25928370|FG003|Core Phase|Withdrawal by Subject|0|||
13118190|NCT03042611|25928367|FG000|Core Phase|Death|232|||
13118191|NCT03042611|25928368|FG001|Core Phase|Death|110|||
13118192|NCT03042611|25928369|FG002|Core Phase|Death|0|||
13118193|NCT03042611|25928370|FG003|Core Phase|Death|0|||
13118194|NCT03042611|25928367|FG000|Core Phase|Lost to Follow-up|4|||
13118195|NCT03042611|25928368|FG001|Core Phase|Lost to Follow-up|7|||
13118196|NCT03042611|25928369|FG002|Core Phase|Lost to Follow-up|0|||
13118197|NCT03042611|25928370|FG003|Core Phase|Lost to Follow-up|0|||
13118198|NCT03042611|25928367|FG000|Core Phase|Physician Decision|7|||
13118199|NCT03042611|25928368|FG001|Core Phase|Physician Decision|2|||
13118200|NCT03042611|25928369|FG002|Core Phase|Physician Decision|0|||
13118201|NCT03042611|25928370|FG003|Core Phase|Physician Decision|0|||
13118202|NCT03042611|25928367|FG000|Core Phase|Study Closed|0|||
13118203|NCT03042611|25928368|FG001|Core Phase|Study Closed|1|||
13271698|NCT01393613|26428677|FG001|Overall Study|Adverse Event|11|||
13271699|NCT01393613|26428678|FG002|Overall Study|Adverse Event|13|||
13271700|NCT01393613|26428679|FG003|Overall Study|Adverse Event|22|||
13271701|NCT01393613|26428676|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
13271702|NCT01393613|26428677|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
13271703|NCT01393613|26428678|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
13271704|NCT01393613|26428679|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
13271705|NCT01393613|26428676|FG000|Overall Study|Physician Decision|2|||
13271706|NCT01393613|26428677|FG001|Overall Study|Physician Decision|0|||
13271707|NCT01393613|26428678|FG002|Overall Study|Physician Decision|0|||
13271708|NCT01393613|26428679|FG003|Overall Study|Physician Decision|1|||
13271709|NCT01393613|26428676|FG000|Overall Study|Withdrawal by Subject|15|||
13271710|NCT01393613|26428677|FG001|Overall Study|Withdrawal by Subject|25|||
13271711|NCT01393613|26428678|FG002|Overall Study|Withdrawal by Subject|23|||
13271712|NCT01393613|26428679|FG003|Overall Study|Withdrawal by Subject|21|||
13271713|NCT01393613|26428676|FG000|Overall Study|Protocol Deviation|2|||
13271714|NCT01393613|26428677|FG001|Overall Study|Protocol Deviation|1|||
13271715|NCT01393613|26428678|FG002|Overall Study|Protocol Deviation|0|||
13271716|NCT01393613|26428679|FG003|Overall Study|Protocol Deviation|0|||
13271717|NCT01393613|26428676|FG000|Overall Study|Lack of Efficacy|9|||
13271718|NCT01393613|26428677|FG001|Overall Study|Lack of Efficacy|20|||
13271719|NCT01393613|26428678|FG002|Overall Study|Lack of Efficacy|16|||
13118204|NCT03042611|25928369|FG002|Core Phase|Study Closed|0|||
13118205|NCT03042611|25928370|FG003|Core Phase|Study Closed|0|||
13118206|NCT03042611|25928367|FG000|Extension Phase|Death|0|||
13118207|NCT03042611|25928368|FG001|Extension Phase|Death|0|||
13118208|NCT03042611|25928369|FG002|Extension Phase|Death|34|||
13118209|NCT03042611|25928370|FG003|Extension Phase|Death|16|||
13271720|NCT01393613|26428679|FG003|Overall Study|Lack of Efficacy|21|||
13118210|NCT03042611|25928367|FG000|Extension Phase|Lost to Follow-up|0|||
13118211|NCT03042611|25928368|FG001|Extension Phase|Lost to Follow-up|0|||
13118212|NCT03042611|25928369|FG002|Extension Phase|Lost to Follow-up|1|||
13118213|NCT03042611|25928370|FG003|Extension Phase|Lost to Follow-up|1|||
13118214|NCT03042611|25928367|FG000|Extension Phase|Study Closed|0|||
13118215|NCT03042611|25928368|FG001|Extension Phase|Study Closed|0|||
13118216|NCT03042611|25928369|FG002|Extension Phase|Study Closed|17|||
13118217|NCT03042611|25928370|FG003|Extension Phase|Study Closed|11|||
13118218|NCT03042559|25928437|FG000|Overall Study|drop out|1|||
13118219|NCT03042559|25928438|FG001|Overall Study|drop out|1|||
13118220|NCT03042312|25928469|FG000|Overall Study|Administrative Reason|1|||
13271721|NCT01393600|26428699|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
13271722|NCT01393600|26428700|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1|||
13271723|NCT01393600|26428701|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
13118221|NCT03042312|25928470|FG001|Overall Study|Administrative Reason|1|||
13271724|NCT01393600|26428702|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
13271725|NCT01393600|26428699|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
13271726|NCT01393600|26428700|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
13271727|NCT01393600|26428701|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1|||
13271728|NCT01393600|26428702|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
13271729|NCT01393600|26428699|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
13118222|NCT03042312|25928469|FG000|Overall Study|Adverse Event|0|||
13118223|NCT03042312|25928470|FG001|Overall Study|Adverse Event|1|||
13118224|NCT03042312|25928469|FG000|Overall Study|Lost to Follow-up|1|||
13118225|NCT03042312|25928470|FG001|Overall Study|Lost to Follow-up|3|||
13118226|NCT03042312|25928469|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4|||
13118227|NCT03042312|25928470|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2|||
13118228|NCT03042312|25928469|FG000|Overall Study|Withdrawal by Subject|4|||
13118229|NCT03042312|25928470|FG001|Overall Study|Withdrawal by Subject|5|||
13118230|NCT03041792|25928499|FG000|Overall Study|Adverse Event|4|||
13118231|NCT03041792|25928500|FG001|Overall Study|Adverse Event|0|||
13118232|NCT03041792|25928499|FG000|Overall Study|Death in the family|0|||
13118233|NCT03041792|25928500|FG001|Overall Study|Death in the family|2|||
13118234|NCT03041792|25928499|FG000|Overall Study|Randomized but not treated|0|||
13118235|NCT03041792|25928500|FG001|Overall Study|Randomized but not treated|1|||
13118236|NCT03041701|25928532|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
13118237|NCT03041701|25928533|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
13118238|NCT03041701|25928534|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0|||
13118239|NCT03041701|25928532|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
13118240|NCT03041701|25928533|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
13118241|NCT03041701|25928534|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1|||
13118242|NCT03041467|25928579|FG000|Overall Study|Death|36|||
13118243|NCT03041467|25928580|FG001|Overall Study|Death|32|||
13118244|NCT03041467|25928579|FG000|Overall Study|Withdrawal by Subject|26|||
13118245|NCT03041467|25928580|FG001|Overall Study|Withdrawal by Subject|28|||
13118246|NCT03041467|25928579|FG000|Overall Study|Lost to Follow-up|6|||
13118247|NCT03041467|25928580|FG001|Overall Study|Lost to Follow-up|7|||
13118248|NCT03041467|25928579|FG000|Overall Study|Declined consent for study extension|21|||
13118249|NCT03041467|25928580|FG001|Overall Study|Declined consent for study extension|33|||
13118250|NCT03041467|25928579|FG000|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|4|||
13118251|NCT03041467|25928580|FG001|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|2|||
13118252|NCT03041467|25928579|FG000|Overall Study|36 Month visit not completed|2|||
13118253|NCT03041467|25928580|FG001|Overall Study|36 Month visit not completed|0|||
13118254|NCT03041311|25928645|FG000|Overall Study|Death|39|||
13118255|NCT03041311|25928646|FG001|Overall Study|Death|42|||
13118256|NCT03041311|25928645|FG000|Overall Study|Lost to Follow-up|0|||
13118257|NCT03041311|25928646|FG001|Overall Study|Lost to Follow-up|1|||
13118258|NCT03041311|25928645|FG000|Overall Study|Withdrawal by Subject|8|||
13271730|NCT01393600|26428700|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
13271731|NCT01393600|26428701|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
13271732|NCT01393600|26428702|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1|||
13271733|NCT01393600|26428699|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
13271734|NCT01393600|26428700|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
13271735|NCT01393600|26428701|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
13271736|NCT01393600|26428702|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1|||
13271737|NCT01393600|26428699|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
13271738|NCT01393600|26428700|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
13271739|NCT01393600|26428701|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1|||
13271740|NCT01393600|26428702|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
13271741|NCT01393600|26428699|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
13290770|NCT02030938|26481819|FG000|Overall Study|Lost to Follow-up|4|||
13271742|NCT01393600|26428700|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
13271743|NCT01393600|26428701|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1|||
13271744|NCT01393600|26428702|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
13271745|NCT01393600|26428699|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
13271746|NCT01393600|26428700|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
13271747|NCT01393600|26428701|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1|||
13271748|NCT01393600|26428702|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
13271749|NCT01393444|26428709|FG000|Overall Study|Withdrawal by Subject|1|||
13271750|NCT01393444|26428709|FG000|Overall Study|Determined ineligible during screening.|2|||
13271751|NCT01393405|26428730|FG000|Induction Period (week1-16)|Lack of Efficacy|70|||
13271752|NCT01393405|26428731|FG001|Induction Period (week1-16)|Lack of Efficacy|0|||
13271753|NCT01393405|26428732|FG002|Induction Period (week1-16)|Lack of Efficacy|0|||
13271754|NCT01393405|26428730|FG000|Induction Period (week1-16)|Adverse Event|16|||
13271755|NCT01393405|26428731|FG001|Induction Period (week1-16)|Adverse Event|0|||
13271756|NCT01393405|26428732|FG002|Induction Period (week1-16)|Adverse Event|0|||
13271757|NCT01393405|26428730|FG000|Induction Period (week1-16)|Withdrawal by Subject|9|||
13271758|NCT01393405|26428731|FG001|Induction Period (week1-16)|Withdrawal by Subject|0|||
13271759|NCT01393405|26428732|FG002|Induction Period (week1-16)|Withdrawal by Subject|0|||
13271760|NCT01393405|26428730|FG000|Maintenance Period Week|Lack of Efficacy|0|||
13271761|NCT01393405|26428731|FG001|Maintenance Period Week|Lack of Efficacy|22|||
13271762|NCT01393405|26428732|FG002|Maintenance Period Week|Lack of Efficacy|22|||
13271763|NCT01393405|26428730|FG000|Maintenance Period Week|Adverse Event|0|||
13271764|NCT01393405|26428731|FG001|Maintenance Period Week|Adverse Event|5|||
13271765|NCT01393405|26428732|FG002|Maintenance Period Week|Adverse Event|2|||
13271766|NCT01393405|26428730|FG000|Maintenance Period Week|Withdrawal by Subject|0|||
13271767|NCT01393405|26428731|FG001|Maintenance Period Week|Withdrawal by Subject|1|||
13271768|NCT01393405|26428732|FG002|Maintenance Period Week|Withdrawal by Subject|0|||
13271769|NCT01393405|26428730|FG000|Maintenance Period Week|Lost to Follow-up|0|||
13271770|NCT01393405|26428731|FG001|Maintenance Period Week|Lost to Follow-up|1|||
13271771|NCT01393405|26428732|FG002|Maintenance Period Week|Lost to Follow-up|0|||
13271772|NCT01393301|26428750|FG000|Overall Study|Lost to Follow-up|5|||
13271773|NCT01393301|26428751|FG001|Overall Study|Lost to Follow-up|3|||
13271774|NCT01393301|26428750|FG000|Overall Study|Withdrawal by Subject|2|||
13271775|NCT01393301|26428751|FG001|Overall Study|Withdrawal by Subject|0|||
13271776|NCT01393301|26428750|FG000|Overall Study|Completed <7 sessions (intervention)|2|||
13271777|NCT01393301|26428751|FG001|Overall Study|Completed <7 sessions (intervention)|0|||
13271778|NCT01393158|26428770|FG000|Overall Study|Adverse Event|1|||
13271779|NCT01393158|26428771|FG001|Overall Study|Adverse Event|0|||
13271780|NCT01393106|26428790|FG000|Overall Study|Adverse Event|3|||
13271781|NCT01393106|26428790|FG000|Overall Study|Withdrawal by Subject|1|||
13271782|NCT01393106|26428790|FG000|Overall Study|Lack of Efficacy|1|||
13271783|NCT01392963|26428805|FG000|Week 0 (First Intervention)|Lost to Follow-up|0|||
13271784|NCT01392963|26428806|FG001|Week 0 (First Intervention)|Lost to Follow-up|1|||
13271785|NCT01392963|26428805|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0|||
13271786|NCT01392963|26428806|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1|||
13271787|NCT01392963|26428805|FG000|Week 24 Follow-up|Lost to Follow-up|2|||
13271788|NCT01392963|26428806|FG001|Week 24 Follow-up|Lost to Follow-up|0|||
13271789|NCT01392742|26428823|FG000|Overall Study|Premature study termination|42|||
13271790|NCT01392742|26428823|FG000|Overall Study|Failure to return|35|||
13271791|NCT01392742|26428823|FG000|Overall Study|No treatment/no cooperation/withdrew|12|||
13271792|NCT01392742|26428823|FG000|Overall Study|Lost to Follow-up|34|||
13271793|NCT01392742|26428823|FG000|Overall Study|Insufficient therapeutic response (ITR)|30|||
13271794|NCT01392742|26428823|FG000|Overall Study|ITR and Protocol deviation|1|||
13271795|NCT01392742|26428823|FG000|Overall Study|Adverse event/intercurrent illness|17|||
13271796|NCT01392742|26428823|FG000|Overall Study|Protocol Violation|14|||
13271797|NCT01392742|26428823|FG000|Overall Study|Other|3|||
13271798|NCT01392742|26428823|FG000|Overall Study|Missing information|13|||
13271799|NCT01392677|26428844|FG000|Overall Study|Adverse Event|3|||
13271800|NCT01392677|26428845|FG001|Overall Study|Adverse Event|1|||
13271801|NCT01392677|26428844|FG000|Overall Study|Withdrawal by Subject|0|||
13271802|NCT01392677|26428845|FG001|Overall Study|Withdrawal by Subject|2|||
13271803|NCT01392677|26428844|FG000|Overall Study|Incorrect enrollment|2|||
13271804|NCT01392677|26428845|FG001|Overall Study|Incorrect enrollment|3|||
13271805|NCT01392677|26428844|FG000|Overall Study|Other reason|3|||
13271806|NCT01392677|26428845|FG001|Overall Study|Other reason|2|||
13271807|NCT01392573|26428860|FG000|Overall Study|Adverse Event|1|||
13271808|NCT01392573|26428861|FG001|Overall Study|Adverse Event|3|||
13271809|NCT01392573|26428860|FG000|Overall Study|Lack of Efficacy|1|||
13271810|NCT01392573|26428861|FG001|Overall Study|Lack of Efficacy|2|||
13271811|NCT01392573|26428860|FG000|Overall Study|Protocol Violation|0|||
13271812|NCT01392573|26428861|FG001|Overall Study|Protocol Violation|2|||
13271813|NCT01392573|26428860|FG000|Overall Study|Withdrawal Criteria|13|||
13271814|NCT01392573|26428861|FG001|Overall Study|Withdrawal Criteria|15|||
13271815|NCT01392573|26428860|FG000|Overall Study|Site closure|8|||
13271816|NCT01392573|26428861|FG001|Overall Study|Site closure|7|||
13271817|NCT01392573|26428860|FG000|Overall Study|Unclassified|9|||
13271818|NCT01392573|26428861|FG001|Overall Study|Unclassified|6|||
13271819|NCT01392560|26428869|FG000|Overall Study|Adverse Event|2|||
13271820|NCT01392560|26428869|FG000|Overall Study|not entered|8|||
13271821|NCT01392560|26428869|FG000|Overall Study|discontinued during placebo run-in|2|||
13271822|NCT01392547|26428885|FG000|Overall Study|Adverse Event|2|||
13271823|NCT01392547|26428885|FG000|Overall Study|Non-compliance|2|||
13271824|NCT01392547|26428885|FG000|Overall Study|Withdrawal criteria|3|||
13271825|NCT01392547|26428885|FG000|Overall Study|Unclassified|1|||
13271826|NCT01392495|26428899|FG000|Overall Study|Death|3|||
13271827|NCT01392495|26428899|FG000|Overall Study|Administrative problems|8|||
13271828|NCT01392495|26428899|FG000|Overall Study|Withdrawal by Subject|2|||
13271829|NCT01392495|26428899|FG000|Overall Study|Adverse Event|3|||
13271830|NCT01392469|26428926|FG000|Overall Study|Adverse Event|2|||
13271831|NCT01392469|26428926|FG000|Overall Study|Withdrawal by Subject|1|||
13271832|NCT01392469|26428926|FG000|Overall Study|Protocol Violation|1|||
13271833|NCT01392443|26428936|FG000|Overall Study|Disease progression|30|||
13271834|NCT01392443|26428936|FG000|Overall Study|Adverse Event|24|||
13271835|NCT01392443|26428936|FG000|Overall Study|Death|7|||
13271836|NCT01392443|26428936|FG000|Overall Study|Withdrawal by Subject|5|||
13271837|NCT01392443|26428936|FG000|Overall Study|Lost to Follow-up|1|||
13271838|NCT01392443|26428936|FG000|Overall Study|Protocol Violation|1|||
13271839|NCT01392378|26429089|FG000|Infant Series|Adverse Event|0|||
13271840|NCT01392378|26429090|FG001|Infant Series|Adverse Event|0|||
13271841|NCT01392378|26429091|FG002|Infant Series|Adverse Event|0|||
13271842|NCT01392378|26429092|FG003|Infant Series|Adverse Event|1|||
13271843|NCT01392378|26429093|FG004|Infant Series|Adverse Event|0|||
13271844|NCT01392378|26429089|FG000|Infant Series|Lost to Follow-up|0|||
13271845|NCT01392378|26429090|FG001|Infant Series|Lost to Follow-up|0|||
13271846|NCT01392378|26429091|FG002|Infant Series|Lost to Follow-up|0|||
13271847|NCT01392378|26429092|FG003|Infant Series|Lost to Follow-up|1|||
13271848|NCT01392378|26429093|FG004|Infant Series|Lost to Follow-up|0|||
13271849|NCT01392378|26429089|FG000|Infant Series|Protocol Violation|0|||
13271850|NCT01392378|26429090|FG001|Infant Series|Protocol Violation|1|||
13271851|NCT01392378|26429091|FG002|Infant Series|Protocol Violation|0|||
13271852|NCT01392378|26429092|FG003|Infant Series|Protocol Violation|0|||
13271853|NCT01392378|26429093|FG004|Infant Series|Protocol Violation|0|||
13271854|NCT01392378|26429089|FG000|Infant Series|Withdrawal by Parent|4|||
13271855|NCT01392378|26429090|FG001|Infant Series|Withdrawal by Parent|1|||
13271856|NCT01392378|26429091|FG002|Infant Series|Withdrawal by Parent|0|||
13271857|NCT01392378|26429092|FG003|Infant Series|Withdrawal by Parent|0|||
13271858|NCT01392378|26429093|FG004|Infant Series|Withdrawal by Parent|0|||
13271859|NCT01392378|26429089|FG000|After Infant Series|Lost to Follow-up|0|||
13271860|NCT01392378|26429090|FG001|After Infant Series|Lost to Follow-up|0|||
13271861|NCT01392378|26429091|FG002|After Infant Series|Lost to Follow-up|1|||
13271862|NCT01392378|26429092|FG003|After Infant Series|Lost to Follow-up|0|||
13271863|NCT01392378|26429093|FG004|After Infant Series|Lost to Follow-up|0|||
13271864|NCT01392378|26429089|FG000|After Infant Series|Withdrawal by Parent|0|||
13271865|NCT01392378|26429090|FG001|After Infant Series|Withdrawal by Parent|1|||
13271866|NCT01392378|26429091|FG002|After Infant Series|Withdrawal by Parent|1|||
13271867|NCT01392378|26429092|FG003|After Infant Series|Withdrawal by Parent|0|||
13118259|NCT03041311|25928646|FG001|Overall Study|Withdrawal by Subject|5|||
13118260|NCT03041311|25928645|FG000|Overall Study|Sponsor Terminated Study|2|||
13118261|NCT03041311|25928646|FG001|Overall Study|Sponsor Terminated Study|4|||
13118262|NCT03041311|25928645|FG000|Overall Study|Disease Progression|3|||
13118263|NCT03041311|25928646|FG001|Overall Study|Disease Progression|1|||
13271868|NCT01392378|26429093|FG004|After Infant Series|Withdrawal by Parent|1|||
13271869|NCT01392378|26429089|FG000|Toddler Dose|Lost to Follow-up|0|||
13271870|NCT01392378|26429090|FG001|Toddler Dose|Lost to Follow-up|0|||
13271871|NCT01392378|26429091|FG002|Toddler Dose|Lost to Follow-up|0|||
13271872|NCT01392378|26429092|FG003|Toddler Dose|Lost to Follow-up|1|||
13271873|NCT01392378|26429093|FG004|Toddler Dose|Lost to Follow-up|0|||
13271874|NCT01392378|26429089|FG000|Toddler Dose|Withdrawal by Parent|0|||
13271875|NCT01392378|26429090|FG001|Toddler Dose|Withdrawal by Parent|1|||
13271876|NCT01392378|26429091|FG002|Toddler Dose|Withdrawal by Parent|0|||
13271877|NCT01392378|26429092|FG003|Toddler Dose|Withdrawal by Parent|1|||
13271878|NCT01392378|26429093|FG004|Toddler Dose|Withdrawal by Parent|1|||
13271879|NCT01392326|26429138|FG000|Overall Study|Death|2|||
13271880|NCT01392326|26429139|FG001|Overall Study|Death|0|||
13271881|NCT01392326|26429140|FG002|Overall Study|Death|0|||
13271882|NCT01392326|26429138|FG000|Overall Study|Withdrawal by Subject|12|||
13118264|NCT03041311|25928645|FG000|Overall Study|Randomized in error, did not receive drug|2|||
13271883|NCT01392326|26429139|FG001|Overall Study|Withdrawal by Subject|11|||
13271884|NCT01392326|26429140|FG002|Overall Study|Withdrawal by Subject|15|||
13271885|NCT01392326|26429138|FG000|Overall Study|Protocol Violation|2|||
13271886|NCT01392326|26429139|FG001|Overall Study|Protocol Violation|0|||
13271887|NCT01392326|26429140|FG002|Overall Study|Protocol Violation|0|||
13271888|NCT01392326|26429138|FG000|Overall Study|Pregnancy|0|||
13271889|NCT01392326|26429139|FG001|Overall Study|Pregnancy|0|||
13271890|NCT01392326|26429140|FG002|Overall Study|Pregnancy|1|||
13271891|NCT01392326|26429138|FG000|Overall Study|Physician Decision|7|||
13271892|NCT01392326|26429139|FG001|Overall Study|Physician Decision|5|||
13271893|NCT01392326|26429140|FG002|Overall Study|Physician Decision|2|||
13271894|NCT01392326|26429138|FG000|Overall Study|Lost to Follow-up|1|||
13271895|NCT01392326|26429139|FG001|Overall Study|Lost to Follow-up|3|||
13271896|NCT01392326|26429140|FG002|Overall Study|Lost to Follow-up|4|||
13271897|NCT01392326|26429138|FG000|Overall Study|Lack of Efficacy|14|||
13271898|NCT01392326|26429139|FG001|Overall Study|Lack of Efficacy|10|||
13271899|NCT01392326|26429140|FG002|Overall Study|Lack of Efficacy|15|||
13271900|NCT01392326|26429138|FG000|Overall Study|Adverse Event|9|||
13271901|NCT01392326|26429139|FG001|Overall Study|Adverse Event|6|||
13271902|NCT01392326|26429140|FG002|Overall Study|Adverse Event|11|||
13271903|NCT01392300|26429253|FG000|Main Period (MP)|Predefined discontinuation criteria|2|||
13271904|NCT01392300|26429254|FG001|Main Period (MP)|Predefined discontinuation criteria|3|||
13271905|NCT01392300|26429255|FG002|Main Period (MP)|Predefined discontinuation criteria|0|||
13271906|NCT01392300|26429253|FG000|Main Period (MP)|Withdrawal by Subject|5|||
13271907|NCT01392300|26429254|FG001|Main Period (MP)|Withdrawal by Subject|1|||
13271908|NCT01392300|26429255|FG002|Main Period (MP)|Withdrawal by Subject|0|||
13271909|NCT01392300|26429253|FG000|Main Period (MP)|Lost to Follow-up|3|||
13271910|NCT01392300|26429254|FG001|Main Period (MP)|Lost to Follow-up|3|||
13271911|NCT01392300|26429255|FG002|Main Period (MP)|Lost to Follow-up|0|||
13271912|NCT01392300|26429253|FG000|Main Period (MP)|Non-compliance|1|||
13271913|NCT01392300|26429254|FG001|Main Period (MP)|Non-compliance|0|||
13271914|NCT01392300|26429255|FG002|Main Period (MP)|Non-compliance|0|||
13271915|NCT01392300|26429253|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0|||
13271916|NCT01392300|26429254|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0|||
13271917|NCT01392300|26429255|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13|||
13271918|NCT01392300|26429253|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
13271919|NCT01392300|26429254|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
13271920|NCT01392300|26429255|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3|||
13271921|NCT01392300|26429253|FG000|Open Label Extension (OLEX) Period|Non-compliance|0|||
13271922|NCT01392300|26429254|FG001|Open Label Extension (OLEX) Period|Non-compliance|0|||
13271923|NCT01392300|26429255|FG002|Open Label Extension (OLEX) Period|Non-compliance|1|||
13271924|NCT01392300|26429253|FG000|Open Label Extension (OLEX) Period|Death|0|||
13271925|NCT01392300|26429254|FG001|Open Label Extension (OLEX) Period|Death|0|||
13271926|NCT01392300|26429255|FG002|Open Label Extension (OLEX) Period|Death|4|||
13271927|NCT01392300|26429253|FG000|Open Label Extension (OLEX) Period|Adverse Event|0|||
13271928|NCT01392300|26429254|FG001|Open Label Extension (OLEX) Period|Adverse Event|0|||
13271929|NCT01392300|26429255|FG002|Open Label Extension (OLEX) Period|Adverse Event|7|||
13271930|NCT01392300|26429253|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
13271931|NCT01392300|26429254|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
13271932|NCT01392300|26429255|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17|||
13118265|NCT03041311|25928646|FG001|Overall Study|Randomized in error, did not receive drug|0|||
13118266|NCT03041181|25928667|FG000|Overall Study|Disease Progression|1|||
13118267|NCT03041181|25928668|FG001|Overall Study|Disease Progression|2|||
13118268|NCT03041116|25928689|FG000|Double-blind|Death|0|||
13118269|NCT03041116|25928690|FG001|Double-blind|Death|2|||
13271933|NCT01392300|26429253|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
13271934|NCT01392300|26429254|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
13271935|NCT01392300|26429255|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6|||
13271936|NCT01392183|26429270|FG000|First Drug Administration|Adverse Event|3|||
13271937|NCT01392183|26429271|FG001|First Drug Administration|Adverse Event|2|||
13271938|NCT01392183|26429270|FG000|First Drug Administration|Death|1|||
13271939|NCT01392183|26429271|FG001|First Drug Administration|Death|0|||
13271940|NCT01392183|26429270|FG000|First Drug Administration|Withdrawal by Subject|10|||
13271941|NCT01392183|26429271|FG001|First Drug Administration|Withdrawal by Subject|17|||
13271942|NCT01392170|26429277|FG000|Overall Study|Withdrawal by Subject|1|||
13271943|NCT01392170|26429277|FG000|Overall Study|Ineligible|1|||
13271944|NCT01391832|26429292|FG000|Overall Study|Withdrawal by Subject|21|||
13271945|NCT01391832|26429293|FG001|Overall Study|Withdrawal by Subject|22|||
13271946|NCT01391832|26429292|FG000|Overall Study|Lost to Follow-up|0|||
13271947|NCT01391832|26429293|FG001|Overall Study|Lost to Follow-up|1|||
13271948|NCT01391819|26429337|FG000|Overall Study|Withdrawal by Subject|56|||
13271949|NCT01391819|26429337|FG000|Overall Study|Migrated/moved from study area|82|||
13271950|NCT01391819|26429337|FG000|Overall Study|Lost to Follow-up|252|||
13271951|NCT01391819|26429337|FG000|Overall Study|Death|3|||
13271952|NCT01391819|26429337|FG000|Overall Study|Other|9|||
13271953|NCT01391793|26429354|FG000|Overall Study|Ineligible|3|||
13271954|NCT01391793|26429355|FG001|Overall Study|Ineligible|0|||
13271955|NCT01391793|26429354|FG000|Overall Study|Urine Culture Negative or Indeterminate|71|||
13271956|NCT01391793|26429355|FG001|Overall Study|Urine Culture Negative or Indeterminate|87|||
13271957|NCT01391793|26429354|FG000|Overall Study|No DMSA|73|||
13118270|NCT03041116|25928689|FG000|Double-blind|Withdrawal by Subject|0|||
13271958|NCT01391793|26429355|FG001|Overall Study|No DMSA|57|||
13271959|NCT01391663|26429398|FG000|Overall Study|Withdrawal by Subject|0|||
13271960|NCT01391663|26429399|FG001|Overall Study|Withdrawal by Subject|0|||
13271961|NCT01391663|26429400|FG002|Overall Study|Withdrawal by Subject|1|||
13271962|NCT01391663|26429401|FG003|Overall Study|Withdrawal by Subject|0|||
13271963|NCT01391546|26429426|FG000|Overall Study|History of Herpes Zoster (HZ)|1|||
13271964|NCT01391546|26429427|FG001|Overall Study|History of Herpes Zoster (HZ)|0|||
13271965|NCT01391507|26429486|FG000|Overall Study|Death|0|||
13271966|NCT01391507|26429487|FG001|Overall Study|Death|0|||
13271967|NCT01391507|26429488|FG002|Overall Study|Death|0|||
13271968|NCT01391507|26429489|FG003|Overall Study|Death|1|||
13271969|NCT01391507|26429486|FG000|Overall Study|Adverse Event|1|||
13271970|NCT01391507|26429487|FG001|Overall Study|Adverse Event|1|||
13271971|NCT01391507|26429488|FG002|Overall Study|Adverse Event|2|||
13271972|NCT01391507|26429489|FG003|Overall Study|Adverse Event|2|||
13271973|NCT01391507|26429486|FG000|Overall Study|Withdrawal by Subject|1|||
13271974|NCT01391507|26429487|FG001|Overall Study|Withdrawal by Subject|2|||
13271975|NCT01391507|26429488|FG002|Overall Study|Withdrawal by Subject|1|||
13271976|NCT01391507|26429489|FG003|Overall Study|Withdrawal by Subject|1|||
13271977|NCT01391507|26429486|FG000|Overall Study|Lack of Efficacy|0|||
13271978|NCT01391507|26429487|FG001|Overall Study|Lack of Efficacy|0|||
13271979|NCT01391507|26429488|FG002|Overall Study|Lack of Efficacy|0|||
13271980|NCT01391507|26429489|FG003|Overall Study|Lack of Efficacy|1|||
13271981|NCT01391507|26429486|FG000|Overall Study|Protocol Violation|2|||
13271982|NCT01391507|26429487|FG001|Overall Study|Protocol Violation|1|||
13271983|NCT01391507|26429488|FG002|Overall Study|Protocol Violation|1|||
13271984|NCT01391507|26429489|FG003|Overall Study|Protocol Violation|2|||
13271985|NCT01391130|26429510|FG000|Overall Study|Withdrawal by Subject|3|||
13271986|NCT01391130|26429511|FG001|Overall Study|Withdrawal by Subject|2|||
13271987|NCT01391130|26429510|FG000|Overall Study|Physician Decision|2|||
13271988|NCT01391130|26429511|FG001|Overall Study|Physician Decision|3|||
13271989|NCT01391130|26429510|FG000|Overall Study|Did not Receive Drug|1|||
13271990|NCT01391130|26429511|FG001|Overall Study|Did not Receive Drug|1|||
13271991|NCT01391000|26429528|FG000|Overall Study|Lost to Follow-up|2|||
13271992|NCT01391000|26429529|FG001|Overall Study|Lost to Follow-up|0|||
13271993|NCT01390948|26429574|FG000|Overall Study|End of Study|1|||
13271994|NCT01390948|26429575|FG001|Overall Study|End of Study|0|||
13271995|NCT01390948|26429576|FG002|Overall Study|End of Study|0|||
13271996|NCT01390948|26429574|FG000|Overall Study|Withdrew consent|2|||
13271997|NCT01390948|26429575|FG001|Overall Study|Withdrew consent|2|||
13271998|NCT01390948|26429576|FG002|Overall Study|Withdrew consent|0|||
13271999|NCT01390948|26429574|FG000|Overall Study|Progressive Disease|2|||
13272000|NCT01390948|26429575|FG001|Overall Study|Progressive Disease|5|||
13272001|NCT01390948|26429576|FG002|Overall Study|Progressive Disease|0|||
13272002|NCT01390948|26429574|FG000|Overall Study|Death during follow-up|10|||
13272003|NCT01390948|26429575|FG001|Overall Study|Death during follow-up|11|||
13272004|NCT01390948|26429576|FG002|Overall Study|Death during follow-up|1|||
13272005|NCT01390857|26429585|FG000|Overall Study|Protocol Violation|2|||
13272006|NCT01390857|26429585|FG000|Overall Study|Lost to Follow-up|1|||
13272007|NCT01390857|26429585|FG000|Overall Study|No Visit after the First Visit|7|||
13272008|NCT01390844|26429624|FG000|Treatment Phase|Adverse Event|12|||
13272009|NCT01390844|26429625|FG001|Treatment Phase|Adverse Event|2|||
13272010|NCT01390844|26429626|FG002|Treatment Phase|Adverse Event|3|||
13272011|NCT01390844|26429627|FG003|Treatment Phase|Adverse Event|2|||
13272012|NCT01390844|26429624|FG000|Treatment Phase|Treatment Failure|23|||
13272013|NCT01390844|26429625|FG001|Treatment Phase|Treatment Failure|25|||
13272014|NCT01390844|26429626|FG002|Treatment Phase|Treatment Failure|10|||
13272015|NCT01390844|26429627|FG003|Treatment Phase|Treatment Failure|13|||
13272016|NCT01390844|26429624|FG000|Treatment Phase|Non-Medical Reasons|5|||
13272017|NCT01390844|26429625|FG001|Treatment Phase|Non-Medical Reasons|1|||
13272018|NCT01390844|26429626|FG002|Treatment Phase|Non-Medical Reasons|8|||
13272019|NCT01390844|26429627|FG003|Treatment Phase|Non-Medical Reasons|1|||
13272020|NCT01390844|26429624|FG000|Treatment Phase|Non-GCP Compliant|0|||
13272021|NCT01390844|26429625|FG001|Treatment Phase|Non-GCP Compliant|0|||
13272022|NCT01390844|26429626|FG002|Treatment Phase|Non-GCP Compliant|10|||
13272023|NCT01390844|26429627|FG003|Treatment Phase|Non-GCP Compliant|3|||
13272024|NCT01390844|26429624|FG000|Follow-Up Phase|Non-Medical Reasons|1|||
13272025|NCT01390844|26429625|FG001|Follow-Up Phase|Non-Medical Reasons|1|||
13272026|NCT01390844|26429626|FG002|Follow-Up Phase|Non-Medical Reasons|1|||
13272027|NCT01390844|26429627|FG003|Follow-Up Phase|Non-Medical Reasons|0|||
13272028|NCT01390779|26429634|FG000|Overall Study|Physician Decision|1|||
13272029|NCT01390649|26429641|FG000|Overall Study|Physician Decision|1|||
13272030|NCT01390584|26429666|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
13272031|NCT01390584|26429667|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
13272032|NCT01390584|26429668|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1|||
13272033|NCT01390441|26429743|FG000|Treatment Period|Protocol Violation|0|||
13272034|NCT01390441|26429744|FG001|Treatment Period|Protocol Violation|1|||
13272035|NCT01390441|26429745|FG002|Treatment Period|Protocol Violation|0|||
13272036|NCT01390441|26429746|FG003|Treatment Period|Protocol Violation|0|||
13272037|NCT01390441|26429747|FG004|Treatment Period|Protocol Violation|0|||
13272038|NCT01390441|26429743|FG000|Treatment Period|Physician Decision|0|||
13272039|NCT01390441|26429744|FG001|Treatment Period|Physician Decision|0|||
13272040|NCT01390441|26429745|FG002|Treatment Period|Physician Decision|0|||
13272041|NCT01390441|26429746|FG003|Treatment Period|Physician Decision|1|||
13272042|NCT01390441|26429747|FG004|Treatment Period|Physician Decision|0|||
13272043|NCT01390441|26429743|FG000|Treatment Period|Lack of Efficacy|0|||
13272044|NCT01390441|26429744|FG001|Treatment Period|Lack of Efficacy|0|||
13272045|NCT01390441|26429745|FG002|Treatment Period|Lack of Efficacy|0|||
13272046|NCT01390441|26429746|FG003|Treatment Period|Lack of Efficacy|0|||
13272047|NCT01390441|26429747|FG004|Treatment Period|Lack of Efficacy|1|||
13272048|NCT01390441|26429743|FG000|Treatment Period|Unknown due to early stopping of study|0|||
13272049|NCT01390441|26429744|FG001|Treatment Period|Unknown due to early stopping of study|0|||
13272050|NCT01390441|26429745|FG002|Treatment Period|Unknown due to early stopping of study|8|||
13272051|NCT01390441|26429746|FG003|Treatment Period|Unknown due to early stopping of study|11|||
13272052|NCT01390441|26429747|FG004|Treatment Period|Unknown due to early stopping of study|7|||
13272053|NCT01390441|26429743|FG000|Treatment Period|Adverse Event|0|||
13272054|NCT01390441|26429744|FG001|Treatment Period|Adverse Event|0|||
13272055|NCT01390441|26429745|FG002|Treatment Period|Adverse Event|1|||
13272056|NCT01390441|26429746|FG003|Treatment Period|Adverse Event|1|||
13272057|NCT01390441|26429747|FG004|Treatment Period|Adverse Event|2|||
13272058|NCT01390441|26429743|FG000|Treatment Period|Withdrawal by Subject|0|||
13272059|NCT01390441|26429744|FG001|Treatment Period|Withdrawal by Subject|0|||
13272060|NCT01390441|26429745|FG002|Treatment Period|Withdrawal by Subject|1|||
13272061|NCT01390441|26429746|FG003|Treatment Period|Withdrawal by Subject|0|||
13272062|NCT01390441|26429747|FG004|Treatment Period|Withdrawal by Subject|1|||
13272063|NCT01390441|26429743|FG000|Treatment Period|Lost to Follow-up|1|||
13272064|NCT01390441|26429744|FG001|Treatment Period|Lost to Follow-up|0|||
13272065|NCT01390441|26429745|FG002|Treatment Period|Lost to Follow-up|0|||
13272066|NCT01390441|26429746|FG003|Treatment Period|Lost to Follow-up|0|||
13272067|NCT01390441|26429747|FG004|Treatment Period|Lost to Follow-up|0|||
13272068|NCT01390441|26429743|FG000|Extension Period|Protocol Violation|3|||
13272069|NCT01390441|26429744|FG001|Extension Period|Protocol Violation|1|||
13272070|NCT01390441|26429745|FG002|Extension Period|Protocol Violation|0|||
13272071|NCT01390441|26429746|FG003|Extension Period|Protocol Violation|1|||
13272072|NCT01390441|26429747|FG004|Extension Period|Protocol Violation|0|||
13272073|NCT01390428|26429816|FG000|Overall Study|Elective Surgery|0|||
13272074|NCT01390428|26429817|FG001|Overall Study|Elective Surgery|0|||
13272075|NCT01390428|26429818|FG002|Overall Study|Elective Surgery|0|||
13272076|NCT01390428|26429819|FG003|Overall Study|Elective Surgery|0|||
13272077|NCT01390428|26429820|FG004|Overall Study|Elective Surgery|1|||
13272078|NCT01390428|26429821|FG005|Overall Study|Elective Surgery|0|||
13272079|NCT01390428|26429816|FG000|Overall Study|Withdrawal by Subject|0|||
13272080|NCT01390428|26429817|FG001|Overall Study|Withdrawal by Subject|0|||
13272081|NCT01390428|26429818|FG002|Overall Study|Withdrawal by Subject|1|||
13272082|NCT01390428|26429819|FG003|Overall Study|Withdrawal by Subject|0|||
13272083|NCT01390428|26429820|FG004|Overall Study|Withdrawal by Subject|0|||
13272084|NCT01390428|26429821|FG005|Overall Study|Withdrawal by Subject|0|||
13272085|NCT01390402|26429827|FG000|Overall Study|Death|1|||
13272086|NCT01390402|26429827|FG000|Overall Study|Disease Progression|4|||
13272087|NCT01390389|26429844|FG000|Overall Study|Withdrawal by Subject|2|||
13272088|NCT01390389|26429845|FG001|Overall Study|Withdrawal by Subject|0|||
13272089|NCT01390389|26429844|FG000|Overall Study|Screen Fail|2|||
13272090|NCT01390389|26429845|FG001|Overall Study|Screen Fail|1|||
13272091|NCT01390298|26429851|FG000|Overall Study|Death|1|||
13272092|NCT01390298|26429851|FG000|Overall Study|long term ICU admission|1|||
13272093|NCT01390298|26429851|FG000|Overall Study|Withdrawal by Subject|14|||
13272094|NCT01390298|26429851|FG000|Overall Study|Lost to Follow-up|7|||
13272095|NCT01390298|26429851|FG000|Overall Study|Surgery cancelled|1|||
13272096|NCT01390272|26429888|FG000|Overall Study|Death|3|||
13272097|NCT01390272|26429889|FG001|Overall Study|Death|2|||
13272098|NCT01390272|26429888|FG000|Overall Study|Withdrawal by Subject|9|||
13272099|NCT01390272|26429889|FG001|Overall Study|Withdrawal by Subject|5|||
13272100|NCT01390272|26429888|FG000|Overall Study|Patient moved, no longer eligible|5|||
13272101|NCT01390272|26429889|FG001|Overall Study|Patient moved, no longer eligible|8|||
13272102|NCT01390220|26429908|FG000|Test Dose Phase|Adverse Event|17|||
13272103|NCT01390220|26429909|FG001|Test Dose Phase|Adverse Event|0|||
13272104|NCT01390220|26429910|FG002|Test Dose Phase|Adverse Event|0|||
13272105|NCT01390220|26429908|FG000|Test Dose Phase|Withdrawal by Subject|8|||
13307955|NCT01281306|26530324|FG006|Overall Study|Death|0|||
13272106|NCT01390220|26429909|FG001|Test Dose Phase|Withdrawal by Subject|0|||
13272107|NCT01390220|26429910|FG002|Test Dose Phase|Withdrawal by Subject|0|||
13272108|NCT01390220|26429908|FG000|Test Dose Phase|Lost to Follow-up|2|||
13272109|NCT01390220|26429909|FG001|Test Dose Phase|Lost to Follow-up|0|||
13272110|NCT01390220|26429910|FG002|Test Dose Phase|Lost to Follow-up|0|||
13272111|NCT01390220|26429908|FG000|Test Dose Phase|Protocol Violation|8|||
13272112|NCT01390220|26429909|FG001|Test Dose Phase|Protocol Violation|0|||
13272113|NCT01390220|26429910|FG002|Test Dose Phase|Protocol Violation|0|||
13272114|NCT01390220|26429908|FG000|Test Dose Phase|No treated seizure cluster episode|37|||
13272115|NCT01390220|26429909|FG001|Test Dose Phase|No treated seizure cluster episode|0|||
13272116|NCT01390220|26429910|FG002|Test Dose Phase|No treated seizure cluster episode|0|||
13272117|NCT01390220|26429908|FG000|Test Dose Phase|Study/Site closure|6|||
13272118|NCT01390220|26429909|FG001|Test Dose Phase|Study/Site closure|0|||
13272119|NCT01390220|26429910|FG002|Test Dose Phase|Study/Site closure|0|||
13272120|NCT01390220|26429908|FG000|Test Dose Phase|Caregiver no longer available|5|||
13272121|NCT01390220|26429909|FG001|Test Dose Phase|Caregiver no longer available|0|||
13272122|NCT01390220|26429910|FG002|Test Dose Phase|Caregiver no longer available|0|||
13272123|NCT01390220|26429908|FG000|Test Dose Phase|Noncompliance|2|||
13272124|NCT01390220|26429909|FG001|Test Dose Phase|Noncompliance|0|||
13272125|NCT01390220|26429910|FG002|Test Dose Phase|Noncompliance|0|||
13272126|NCT01390220|26429908|FG000|Test Dose Phase|Logistical|6|||
13272127|NCT01390220|26429909|FG001|Test Dose Phase|Logistical|0|||
13272128|NCT01390220|26429910|FG002|Test Dose Phase|Logistical|0|||
13272129|NCT01390220|26429908|FG000|Comparative Phase|Withdrawal by Subject|0|||
13272130|NCT01390220|26429909|FG001|Comparative Phase|Withdrawal by Subject|1|||
13272131|NCT01390220|26429910|FG002|Comparative Phase|Withdrawal by Subject|0|||
13272132|NCT01390181|26429916|FG000|Overall Study|Lost to Follow-up|1|||
13272133|NCT01390181|26429916|FG000|Overall Study|Study Terminated due to Low Accrual|3|||
13272134|NCT01390038|26429928|FG000|Overall Study|Death|1|||
13272135|NCT01390038|26429928|FG000|Overall Study|Lost to Follow-up|1|||
13272136|NCT01390038|26429928|FG000|Overall Study|Withdrawal by Subject|4|||
13272137|NCT01390038|26429928|FG000|Overall Study|Simpliciti System Removal|2|||
13272138|NCT01389973|26429938|FG000|Overall Study|Lost to Follow-up|1|||
13272139|NCT01389973|26429938|FG000|Overall Study|Trial Stopped by Sponsor|9|||
13272140|NCT01389973|26429938|FG000|Overall Study|Other|10|||
13272141|NCT01389882|26429973|FG000|Overall Study|Respiratory rate > 80/min during study|1|||
13272142|NCT01389882|26429974|FG001|Overall Study|Respiratory rate > 80/min during study|3|||
13272143|NCT01389882|26429973|FG000|Overall Study|Withdrawal by Subject|0|||
13272144|NCT01389882|26429974|FG001|Overall Study|Withdrawal by Subject|1|||
13272145|NCT01389817|26429987|FG000|Overall Study|Physician Decision|1|||
13272146|NCT01389817|26429988|FG001|Overall Study|Physician Decision|0|||
13272147|NCT01389817|26429987|FG000|Overall Study|Lost to Follow-up|1|||
13272148|NCT01389817|26429988|FG001|Overall Study|Lost to Follow-up|0|||
13272149|NCT01389817|26429987|FG000|Overall Study|Withdrawal by Subject|2|||
13272150|NCT01389817|26429988|FG001|Overall Study|Withdrawal by Subject|0|||
13272151|NCT01389752|26430001|FG000|Study Period 1|Sponsor decision|0|||
13272152|NCT01389752|26430002|FG001|Study Period 1|Sponsor decision|2|||
13272153|NCT01389752|26430001|FG000|Study Period 2|Sponsor decision|1|||
13272154|NCT01389752|26430002|FG001|Study Period 2|Sponsor decision|0|||
13272155|NCT01389596|26430071|FG000|Overall Study|Protocol Violation|3|||
13272156|NCT01389596|26430072|FG001|Overall Study|Protocol Violation|4|||
13272157|NCT01389596|26430073|FG002|Overall Study|Protocol Violation|3|||
13272158|NCT01389596|26430071|FG000|Overall Study|Withdrawal by Subject|1|||
13272159|NCT01389596|26430072|FG001|Overall Study|Withdrawal by Subject|2|||
13272160|NCT01389596|26430073|FG002|Overall Study|Withdrawal by Subject|2|||
13272161|NCT01389596|26430071|FG000|Overall Study|Insufficient Clinical Response|3|||
13272162|NCT01389596|26430072|FG001|Overall Study|Insufficient Clinical Response|4|||
13272163|NCT01389596|26430073|FG002|Overall Study|Insufficient Clinical Response|5|||
13272164|NCT01389596|26430071|FG000|Overall Study|Adverse Event|1|||
13272165|NCT01389596|26430072|FG001|Overall Study|Adverse Event|4|||
13272166|NCT01389596|26430073|FG002|Overall Study|Adverse Event|0|||
13272167|NCT01389596|26430071|FG000|Overall Study|Death|0|||
13272168|NCT01389596|26430072|FG001|Overall Study|Death|1|||
13272169|NCT01389596|26430073|FG002|Overall Study|Death|0|||
13272170|NCT01389596|26430071|FG000|Overall Study|Other Unspecified|2|||
13272171|NCT01389596|26430072|FG001|Overall Study|Other Unspecified|1|||
13272172|NCT01389596|26430073|FG002|Overall Study|Other Unspecified|0|||
13272173|NCT01389323|26430095|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41|||
13272174|NCT01389323|26430095|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24|||
13272175|NCT01389323|26430095|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6|||
13272176|NCT01389323|26430095|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7|||
13272177|NCT01389323|26430095|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10|||
13272178|NCT01389323|26430095|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5|||
13272179|NCT01389323|26430095|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2|||
13272180|NCT01389323|26430095|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10|||
13272181|NCT01389323|26430095|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22|||
13272182|NCT01389323|26430095|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2|||
13272183|NCT01389323|26430095|FG000|Follow-up Period (up to 48 Weeks)|Other|3|||
13272184|NCT01389258|26430107|FG000|Overall Study|Lost to Follow-up|5|||
13272185|NCT01389245|26430117|FG000|Overall Study|Protocol Violation|10|||
13272186|NCT01389245|26430117|FG000|Overall Study|Lost to Follow-up|3|||
13272187|NCT01389245|26430117|FG000|Overall Study|Withdrawal by Subject|2|||
13272188|NCT01389232|26430135|FG000|Overall Study|Had scaffold removed|15|||
13272189|NCT01389232|26430135|FG000|Overall Study|Personal reasons|2|||
13272190|NCT01389232|26430135|FG000|Overall Study|Adverse Event|1|||
13272191|NCT01389232|26430135|FG000|Overall Study|Death|1|||
13272192|NCT01389128|26430160|FG000|Overall Study|Fetal distress|1|||
13272193|NCT01389128|26430161|FG001|Overall Study|Fetal distress|0|||
13272194|NCT01389128|26430160|FG000|Overall Study|Cervix dilation stop|1|||
13272195|NCT01389128|26430161|FG001|Overall Study|Cervix dilation stop|2|||
13272196|NCT01389128|26430160|FG000|Overall Study|Rapid labor evolution|3|||
13272197|NCT01389128|26430161|FG001|Overall Study|Rapid labor evolution|2|||
13272198|NCT01389128|26430160|FG000|Overall Study|Intolerance to procedure|0|||
13272199|NCT01389128|26430161|FG001|Overall Study|Intolerance to procedure|2|||
13272200|NCT01389102|26430200|FG000|Overall Study|Adverse Event|1|||
13272201|NCT01389102|26430201|FG001|Overall Study|Adverse Event|3|||
13272202|NCT01389102|26430202|FG002|Overall Study|Adverse Event|2|||
13272203|NCT01389102|26430203|FG003|Overall Study|Adverse Event|2|||
13272204|NCT01389102|26430204|FG004|Overall Study|Adverse Event|2|||
13272205|NCT01389102|26430205|FG005|Overall Study|Adverse Event|2|||
13272206|NCT01389102|26430200|FG000|Overall Study|Hurricane Katrina|4|||
13272207|NCT01389102|26430201|FG001|Overall Study|Hurricane Katrina|2|||
13272208|NCT01389102|26430202|FG002|Overall Study|Hurricane Katrina|3|||
13272209|NCT01389102|26430203|FG003|Overall Study|Hurricane Katrina|0|||
13272210|NCT01389102|26430204|FG004|Overall Study|Hurricane Katrina|3|||
13272211|NCT01389102|26430205|FG005|Overall Study|Hurricane Katrina|1|||
13272212|NCT01389102|26430200|FG000|Overall Study|Lost to Follow-up|4|||
13272213|NCT01389102|26430201|FG001|Overall Study|Lost to Follow-up|1|||
13272214|NCT01389102|26430202|FG002|Overall Study|Lost to Follow-up|1|||
13272215|NCT01389102|26430203|FG003|Overall Study|Lost to Follow-up|2|||
13272216|NCT01389102|26430204|FG004|Overall Study|Lost to Follow-up|4|||
13272217|NCT01389102|26430205|FG005|Overall Study|Lost to Follow-up|1|||
13272218|NCT01389102|26430200|FG000|Overall Study|Protocol Violation|0|||
13272219|NCT01389102|26430201|FG001|Overall Study|Protocol Violation|0|||
13272220|NCT01389102|26430202|FG002|Overall Study|Protocol Violation|3|||
13272221|NCT01389102|26430203|FG003|Overall Study|Protocol Violation|0|||
13272222|NCT01389102|26430204|FG004|Overall Study|Protocol Violation|1|||
13272223|NCT01389102|26430205|FG005|Overall Study|Protocol Violation|1|||
13272224|NCT01389102|26430200|FG000|Overall Study|Withdrawal by Subject|7|||
13272225|NCT01389102|26430201|FG001|Overall Study|Withdrawal by Subject|4|||
13272226|NCT01389102|26430202|FG002|Overall Study|Withdrawal by Subject|9|||
13272227|NCT01389102|26430203|FG003|Overall Study|Withdrawal by Subject|2|||
13272228|NCT01389102|26430204|FG004|Overall Study|Withdrawal by Subject|3|||
13272229|NCT01389102|26430205|FG005|Overall Study|Withdrawal by Subject|3|||
13272230|NCT01389102|26430200|FG000|Overall Study|Subject Traveling Out of Country|0|||
13272231|NCT01389102|26430201|FG001|Overall Study|Subject Traveling Out of Country|0|||
13272232|NCT01389102|26430202|FG002|Overall Study|Subject Traveling Out of Country|0|||
13272233|NCT01389102|26430203|FG003|Overall Study|Subject Traveling Out of Country|1|||
13272234|NCT01389102|26430204|FG004|Overall Study|Subject Traveling Out of Country|0|||
13272235|NCT01389102|26430205|FG005|Overall Study|Subject Traveling Out of Country|0|||
13272236|NCT01389102|26430200|FG000|Overall Study|Subject Moved|2|||
13272237|NCT01389102|26430201|FG001|Overall Study|Subject Moved|0|||
13272238|NCT01389102|26430202|FG002|Overall Study|Subject Moved|1|||
13272239|NCT01389102|26430203|FG003|Overall Study|Subject Moved|0|||
13272240|NCT01389102|26430204|FG004|Overall Study|Subject Moved|0|||
13272241|NCT01389102|26430205|FG005|Overall Study|Subject Moved|0|||
13272242|NCT01389102|26430200|FG000|Overall Study|Unavailable due to husband's illness|0|||
13272243|NCT01389102|26430201|FG001|Overall Study|Unavailable due to husband's illness|1|||
13272244|NCT01389102|26430202|FG002|Overall Study|Unavailable due to husband's illness|0|||
13272245|NCT01389102|26430203|FG003|Overall Study|Unavailable due to husband's illness|0|||
13272246|NCT01389102|26430204|FG004|Overall Study|Unavailable due to husband's illness|0|||
13272247|NCT01389102|26430205|FG005|Overall Study|Unavailable due to husband's illness|0|||
13272248|NCT01389102|26430200|FG000|Overall Study|Investigator Judgement|0|||
13272249|NCT01389102|26430201|FG001|Overall Study|Investigator Judgement|1|||
13272250|NCT01389102|26430202|FG002|Overall Study|Investigator Judgement|0|||
13272251|NCT01389102|26430203|FG003|Overall Study|Investigator Judgement|0|||
13272252|NCT01389102|26430204|FG004|Overall Study|Investigator Judgement|0|||
13272253|NCT01389102|26430205|FG005|Overall Study|Investigator Judgement|0|||
13272254|NCT01388985|26430226|FG000|Overall Study|Death|0|||
13272255|NCT01388985|26430227|FG001|Overall Study|Death|1|||
13272256|NCT01388985|26430226|FG000|Overall Study|Lost to Follow-up|30|||
13272257|NCT01388985|26430227|FG001|Overall Study|Lost to Follow-up|30|||
13272258|NCT01388985|26430226|FG000|Overall Study|Withdrawal by Subject|13|||
13272259|NCT01388985|26430227|FG001|Overall Study|Withdrawal by Subject|4|||
13272260|NCT01388985|26430226|FG000|Overall Study|Subject unavailable|1|||
13272261|NCT01388985|26430227|FG001|Overall Study|Subject unavailable|1|||
13272262|NCT01388985|26430226|FG000|Overall Study|Other (no reason)|0|||
13272263|NCT01388985|26430227|FG001|Overall Study|Other (no reason)|1|||
13272264|NCT01388985|26430226|FG000|Overall Study|Error of nurse|5|||
13272265|NCT01388985|26430227|FG001|Overall Study|Error of nurse|1|||
13272266|NCT01388907|26430246|FG000|Overall Study|Adverse Event|2|||
13272267|NCT01388907|26430247|FG001|Overall Study|Adverse Event|0|||
13272268|NCT01388816|26430289|FG000|Overall Study|Adverse Event|0|||
13272269|NCT01388816|26430290|FG001|Overall Study|Adverse Event|2|||
13272270|NCT01388816|26430291|FG002|Overall Study|Adverse Event|0|||
13272271|NCT01388816|26430292|FG003|Overall Study|Adverse Event|0|||
13272272|NCT01388816|26430289|FG000|Overall Study|Lost to Follow-up|0|||
13272273|NCT01388816|26430290|FG001|Overall Study|Lost to Follow-up|1|||
13272274|NCT01388816|26430291|FG002|Overall Study|Lost to Follow-up|0|||
13272275|NCT01388816|26430292|FG003|Overall Study|Lost to Follow-up|0|||
13272276|NCT01388816|26430289|FG000|Overall Study|Withdrawal by Subject|2|||
13272277|NCT01388816|26430290|FG001|Overall Study|Withdrawal by Subject|1|||
13272278|NCT01388816|26430291|FG002|Overall Study|Withdrawal by Subject|1|||
13272279|NCT01388816|26430292|FG003|Overall Study|Withdrawal by Subject|0|||
13272280|NCT01388816|26430289|FG000|Overall Study|Protocol Violation|0|||
13272281|NCT01388816|26430290|FG001|Overall Study|Protocol Violation|0|||
13272282|NCT01388816|26430291|FG002|Overall Study|Protocol Violation|2|||
13272283|NCT01388816|26430292|FG003|Overall Study|Protocol Violation|0|||
13272284|NCT01388790|26430299|FG000|Overall Study|Ongoing at data cut-off date|8|||
13272285|NCT01388647|26430317|FG000|Overall Study|Adverse Event|1|||
13272286|NCT01388647|26430318|FG001|Overall Study|Adverse Event|2|||
13272287|NCT01388543|26430331|FG000|Day 14|Adverse Event|1|||
13272288|NCT01388543|26430332|FG001|Day 14|Adverse Event|4|||
13272289|NCT01388530|26430341|FG000|Overall Study|Lost to Follow-up|5|||
13272290|NCT01388478|26430347|FG000|Overall Study|Adverse Event|4|||
13272291|NCT01388478|26430347|FG000|Overall Study|Withdrawal by Subject|1|||
13272292|NCT01388361|26430374|FG000|Overall Study|Adverse Event|0|||
13272293|NCT01388361|26430375|FG001|Overall Study|Adverse Event|5|||
13272294|NCT01388361|26430376|FG002|Overall Study|Adverse Event|1|||
13272295|NCT01388361|26430374|FG000|Overall Study|Protocol Violation|0|||
13272296|NCT01388361|26430375|FG001|Overall Study|Protocol Violation|0|||
13272297|NCT01388361|26430376|FG002|Overall Study|Protocol Violation|2|||
13272298|NCT01388361|26430374|FG000|Overall Study|Withdrawal criteria|12|||
13272299|NCT01388361|26430375|FG001|Overall Study|Withdrawal criteria|7|||
13272300|NCT01388361|26430376|FG002|Overall Study|Withdrawal criteria|10|||
13272301|NCT01388361|26430374|FG000|Overall Study|Unclassified|0|||
13272302|NCT01388361|26430375|FG001|Overall Study|Unclassified|0|||
13272303|NCT01388361|26430376|FG002|Overall Study|Unclassified|1|||
13272304|NCT01388335|26430405|FG000|Period 1|Progressive Disease|1|||
13272305|NCT01388335|26430405|FG000|Period 2|Progressive Disease|2|||
13272306|NCT01388335|26430405|FG000|Period 2|Sponsor Decision|1|||
13272307|NCT01388335|26430405|FG000|Safety Extension|Progressive Disease|7|||
13290771|NCT02030938|26481819|FG000|Overall Study|Withdrawal by Subject|1|||
13290772|NCT02035137|26481840|FG000|Overall Study|Physician Decision|0|||
13290773|NCT02035137|26481841|FG001|Overall Study|Physician Decision|0|||
13290774|NCT02035137|26481842|FG002|Overall Study|Physician Decision|1|||
13290775|NCT02035137|26481840|FG000|Overall Study|Withdrawal by Subject|0|||
13290776|NCT02035137|26481841|FG001|Overall Study|Withdrawal by Subject|1|||
13290777|NCT02035137|26481842|FG002|Overall Study|Withdrawal by Subject|2|||
13290778|NCT02035137|26481840|FG000|Overall Study|Ineligible|0|||
13290779|NCT02035137|26481841|FG001|Overall Study|Ineligible|1|||
13290780|NCT02035137|26481842|FG002|Overall Study|Ineligible|2|||
13290781|NCT02035137|26481840|FG000|Overall Study|Disease progression prior to treatment start|2|||
13290782|NCT02035137|26481841|FG001|Overall Study|Disease progression prior to treatment start|0|||
13290783|NCT02035137|26481842|FG002|Overall Study|Disease progression prior to treatment start|0|||
13290784|NCT02034123|26482216|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
13290785|NCT02034123|26482217|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
13290786|NCT02034123|26482218|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
13290787|NCT02034123|26482219|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
13290788|NCT02034123|26482220|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
13290789|NCT02034123|26482221|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
13290790|NCT02034123|26482222|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
13290791|NCT02034123|26482223|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
13290792|NCT02034123|26482224|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
13290793|NCT02034123|26482225|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
13290794|NCT02034123|26482226|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
13290795|NCT02034123|26482227|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
13290796|NCT02034123|26482228|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
13290797|NCT02034123|26482229|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
13290798|NCT02034123|26482230|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
13290799|NCT02034123|26482231|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
13290800|NCT02034123|26482232|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
13290801|NCT02034123|26482233|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
13272308|NCT01388166|26430413|FG000|Overall Study|Adverse Event|16|||
13272309|NCT01388166|26430413|FG000|Overall Study|Lost to Follow-up|30|||
13272310|NCT01388166|26430413|FG000|Overall Study|Others than specified above|13|||
13272311|NCT01387932|26430430|FG000|Randomized and Treated|Physician Decision|3|||
13272312|NCT01387932|26430431|FG001|Randomized and Treated|Physician Decision|2|||
13272313|NCT01387932|26430430|FG000|Randomized and Treated|Withdrawal by Subject|4|||
13272314|NCT01387932|26430431|FG001|Randomized and Treated|Withdrawal by Subject|2|||
13272315|NCT01387932|26430430|FG000|Survival Follow-up|Liver Transplant|24|||
13272316|NCT01387932|26430431|FG001|Survival Follow-up|Liver Transplant|28|||
13272317|NCT01387932|26430430|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52|||
13272318|NCT01387932|26430431|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53|||
13272319|NCT01387932|26430430|FG000|Survival Follow-up|Withdrawal by Subject|2|||
13272320|NCT01387932|26430431|FG001|Survival Follow-up|Withdrawal by Subject|4|||
13272321|NCT01387932|26430430|FG000|Survival Follow-up|Lost to Follow-up|6|||
13272322|NCT01387932|26430431|FG001|Survival Follow-up|Lost to Follow-up|5|||
13272323|NCT01387789|26430445|FG000|Overall Study|Adverse Event|5|||
13272324|NCT01387789|26430445|FG000|Overall Study|Lack of Efficacy|2|||
13272325|NCT01387789|26430445|FG000|Overall Study|Lost to Follow-up|1|||
13272326|NCT01387737|26430458|FG000|Overall Study|Adverse Event|20|||
13272327|NCT01387737|26430459|FG001|Overall Study|Adverse Event|30|||
13118271|NCT03041116|25928690|FG001|Double-blind|Withdrawal by Subject|4|||
13118272|NCT03041116|25928689|FG000|Open-label|Death|1|||
13118273|NCT03041116|25928690|FG001|Open-label|Death|0|||
13118274|NCT03041116|25928689|FG000|Open-label|Termination of the study by Sponsor|39|||
13118275|NCT03041116|25928690|FG001|Open-label|Termination of the study by Sponsor|37|||
13118276|NCT03041116|25928689|FG000|Open-label|Withdrawal by Subject|1|||
13118277|NCT03041116|25928690|FG001|Open-label|Withdrawal by Subject|0|||
13118278|NCT03041090|25928707|FG000|Overall Study|technical error|0|||
13118279|NCT03041090|25928708|FG001|Overall Study|technical error|3|||
13118280|NCT03041038|25928725|FG000|Overall Study|Withdrawal by Subject|4|||
13118281|NCT03041038|25928726|FG001|Overall Study|Withdrawal by Subject|0|||
13118282|NCT03041038|25928725|FG000|Overall Study|Lost to Follow-up|1|||
13118283|NCT03041038|25928726|FG001|Overall Study|Lost to Follow-up|1|||
13118284|NCT03041038|25928725|FG000|Overall Study|Protocol Violation|1|||
13118285|NCT03041038|25928726|FG001|Overall Study|Protocol Violation|1|||
13118286|NCT03041025|25928819|FG000|Overall Study|Adverse Event|0|||
13118287|NCT03041025|25928820|FG001|Overall Study|Adverse Event|0|||
13118288|NCT03041025|25928821|FG002|Overall Study|Adverse Event|1|||
13118289|NCT03041025|25928819|FG000|Overall Study|Lost to Follow-up|1|||
13118290|NCT03041025|25928820|FG001|Overall Study|Lost to Follow-up|0|||
13118291|NCT03041025|25928821|FG002|Overall Study|Lost to Follow-up|0|||
13118292|NCT03041025|25928819|FG000|Overall Study|Withdrawal by Subject|0|||
13118293|NCT03041025|25928820|FG001|Overall Study|Withdrawal by Subject|0|||
13118294|NCT03041025|25928821|FG002|Overall Study|Withdrawal by Subject|1|||
13118295|NCT03040986|25928867|FG000|Overall Study|Hospice|1|||
13118296|NCT03040986|25928868|FG001|Overall Study|Hospice|0|||
13118297|NCT03040986|25928867|FG000|Overall Study|Adverse Event|2|||
13118298|NCT03040986|25928868|FG001|Overall Study|Adverse Event|1|||
13118299|NCT03040986|25928867|FG000|Overall Study|Disease progression on study|3|||
13118300|NCT03040986|25928868|FG001|Overall Study|Disease progression on study|1|||
13118301|NCT03040713|25928875|FG000|Overall Study|Positive amyloid scan|3|||
13118302|NCT03040687|25928896|FG000|Overall Study|Withdrawal by Subject|1|||
13272328|NCT01387737|26430458|FG000|Overall Study|Lack of Efficacy|1|||
13272329|NCT01387737|26430459|FG001|Overall Study|Lack of Efficacy|0|||
13272330|NCT01387737|26430458|FG000|Overall Study|Physician Decision|3|||
13272331|NCT01387737|26430459|FG001|Overall Study|Physician Decision|10|||
13118303|NCT03040687|25928897|FG001|Overall Study|Withdrawal by Subject|0|||
13118304|NCT03040687|25928898|FG002|Overall Study|Withdrawal by Subject|0|||
13272332|NCT01387737|26430458|FG000|Overall Study|Withdrawal by Subject|27|||
13272333|NCT01387737|26430459|FG001|Overall Study|Withdrawal by Subject|31|||
13272334|NCT01387737|26430458|FG000|Overall Study|Clearly not eligible for the study|1|||
13272335|NCT01387737|26430459|FG001|Overall Study|Clearly not eligible for the study|3|||
13272336|NCT01387607|26430518|FG000|Overall Study|Adverse Event|23|||
13272337|NCT01387607|26430519|FG001|Overall Study|Adverse Event|11|||
13272338|NCT01387607|26430518|FG000|Overall Study|Lack of Efficacy|8|||
13272339|NCT01387607|26430519|FG001|Overall Study|Lack of Efficacy|6|||
13272340|NCT01387607|26430518|FG000|Overall Study|Lost to Follow-up|2|||
13272341|NCT01387607|26430519|FG001|Overall Study|Lost to Follow-up|1|||
13272342|NCT01387607|26430518|FG000|Overall Study|No longer meets eligibility criteria|0|||
13272343|NCT01387607|26430519|FG001|Overall Study|No longer meets eligibility criteria|1|||
13272344|NCT01387607|26430518|FG000|Overall Study|Protocol Violation|1|||
13272345|NCT01387607|26430519|FG001|Overall Study|Protocol Violation|5|||
13272346|NCT01387607|26430518|FG000|Overall Study|Withdrawal by Subject|13|||
13272347|NCT01387607|26430519|FG001|Overall Study|Withdrawal by Subject|14|||
13118305|NCT03040674|25928906|FG000|Overall Study|Lost to Follow-up|225|||
13118306|NCT03040674|25928906|FG000|Overall Study|Death|23|||
13118307|NCT03040336|25928943|FG000|Overall Study|Death|1|||
13272348|NCT01387607|26430518|FG000|Overall Study|Other|1|||
13272349|NCT01387607|26430519|FG001|Overall Study|Other|1|||
13272350|NCT01387607|26430518|FG000|Overall Study|Randomized, not treated|3|||
13272351|NCT01387607|26430519|FG001|Overall Study|Randomized, not treated|6|||
13272352|NCT01387594|26430538|FG000|Overall Study|Withdrawal by Subject|0|||
13272353|NCT01387594|26430539|FG001|Overall Study|Withdrawal by Subject|2|||
13272354|NCT01387594|26430538|FG000|Overall Study|Lost to Follow-up|0|||
13272355|NCT01387594|26430539|FG001|Overall Study|Lost to Follow-up|1|||
13272356|NCT01387542|26430548|FG000|Overall Study|Adverse Event|3|||
13272357|NCT01387542|26430548|FG000|Overall Study|Withdrawal by Subject|1|||
13272358|NCT01387542|26430548|FG000|Overall Study|Changed diagnosis|1|||
13272359|NCT01387542|26430548|FG000|Overall Study|Insufficient response|1|||
13272360|NCT01387542|26430548|FG000|Overall Study|Non-compliant|1|||
13272361|NCT01387542|26430548|FG000|Overall Study|Lost to Follow-up|1|||
13272362|NCT01387516|26430583|FG000|Overall Study|Lost to Follow-up|4|||
13272363|NCT01387516|26430584|FG001|Overall Study|Lost to Follow-up|4|||
13272364|NCT01387516|26430585|FG002|Overall Study|Lost to Follow-up|2|||
13272365|NCT01387516|26430586|FG003|Overall Study|Lost to Follow-up|3|||
13272366|NCT01387516|26430583|FG000|Overall Study|Withdrawal by Subject|1|||
13272367|NCT01387516|26430584|FG001|Overall Study|Withdrawal by Subject|1|||
13272368|NCT01387516|26430585|FG002|Overall Study|Withdrawal by Subject|2|||
13272369|NCT01387516|26430586|FG003|Overall Study|Withdrawal by Subject|0|||
13272370|NCT01387516|26430583|FG000|Overall Study|Death|0|||
13272371|NCT01387516|26430584|FG001|Overall Study|Death|0|||
13272372|NCT01387516|26430585|FG002|Overall Study|Death|0|||
13272373|NCT01387516|26430586|FG003|Overall Study|Death|1|||
13272374|NCT01387347|26430603|FG000|Overall Study|Lost to Follow-up|2|||
13272375|NCT01387347|26430604|FG001|Overall Study|Lost to Follow-up|1|||
13272376|NCT01387282|26430625|FG000|Overall Study|Death|47|||
13272377|NCT01387282|26430626|FG001|Overall Study|Death|16|||
13272378|NCT01387282|26430625|FG000|Overall Study|Other|5|||
13272379|NCT01387282|26430626|FG001|Overall Study|Other|1|||
13272380|NCT01387282|26430625|FG000|Overall Study|Unrelated AE|6|||
13272381|NCT01387282|26430626|FG001|Overall Study|Unrelated AE|4|||
13272382|NCT01387282|26430625|FG000|Overall Study|Withdrawal by patient|33|||
13272383|NCT01387282|26430626|FG001|Overall Study|Withdrawal by patient|23|||
13118308|NCT03040336|25928944|FG001|Overall Study|Death|0|||
13118309|NCT03040336|25928943|FG000|Overall Study|Withdrawal by Subject|2|||
13118310|NCT03040336|25928944|FG001|Overall Study|Withdrawal by Subject|3|||
13118311|NCT03040024|25928983|FG000|Overall Study|Adverse Event|0|||
13272384|NCT01387282|26430625|FG000|Overall Study|Study drug-related AE|2|||
13272385|NCT01387282|26430626|FG001|Overall Study|Study drug-related AE|2|||
13272386|NCT01387282|26430625|FG000|Overall Study|Lost to Follow-up|4|||
13272387|NCT01387282|26430626|FG001|Overall Study|Lost to Follow-up|1|||
13272388|NCT01387269|26430647|FG000|Overall Study|Death|38|||
13272389|NCT01387269|26430648|FG001|Overall Study|Death|20|||
13272390|NCT01387269|26430647|FG000|Overall Study|Other|8|||
13272391|NCT01387269|26430648|FG001|Overall Study|Other|7|||
13272392|NCT01387269|26430647|FG000|Overall Study|Unrelated AE|12|||
13272393|NCT01387269|26430648|FG001|Overall Study|Unrelated AE|3|||
13272394|NCT01387269|26430647|FG000|Overall Study|Withdrawal by patient|32|||
13272395|NCT01387269|26430648|FG001|Overall Study|Withdrawal by patient|10|||
13272396|NCT01387269|26430647|FG000|Overall Study|Study drug-related AE|1|||
13272397|NCT01387269|26430648|FG001|Overall Study|Study drug-related AE|0|||
13272398|NCT01387269|26430647|FG000|Overall Study|Lost to Follow-up|1|||
13272399|NCT01387269|26430648|FG001|Overall Study|Lost to Follow-up|0|||
13272400|NCT01387230|26430672|FG000|Overall Study|Adverse Event|0|||
13272401|NCT01387230|26430673|FG001|Overall Study|Adverse Event|1|||
13272402|NCT01387230|26430674|FG002|Overall Study|Adverse Event|3|||
13272403|NCT01387230|26430672|FG000|Overall Study|Lack of Efficacy|8|||
13272404|NCT01387230|26430673|FG001|Overall Study|Lack of Efficacy|5|||
13272405|NCT01387230|26430674|FG002|Overall Study|Lack of Efficacy|4|||
13272406|NCT01387230|26430672|FG000|Overall Study|Protocol-defined Stopping Criteria|6|||
13272407|NCT01387230|26430673|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
13272408|NCT01387230|26430674|FG002|Overall Study|Protocol-defined Stopping Criteria|5|||
13272409|NCT01387230|26430672|FG000|Overall Study|Lost to Follow-up|0|||
13272410|NCT01387230|26430673|FG001|Overall Study|Lost to Follow-up|0|||
13272411|NCT01387230|26430674|FG002|Overall Study|Lost to Follow-up|1|||
13272412|NCT01387230|26430672|FG000|Overall Study|Withdrawal by Subject|4|||
13272413|NCT01387230|26430673|FG001|Overall Study|Withdrawal by Subject|1|||
13272414|NCT01387230|26430674|FG002|Overall Study|Withdrawal by Subject|0|||
13272415|NCT01387074|26430687|FG000|Overall Study|Lost to Follow-up|7|||
13272416|NCT01387074|26430687|FG000|Overall Study|Lack of Efficacy|1|||
13272417|NCT01387022|26430710|FG000|Overall Study|Death|1|||
13272418|NCT01387022|26430711|FG001|Overall Study|Death|1|||
13118312|NCT03040024|25928984|FG001|Overall Study|Adverse Event|1|||
13118313|NCT03040024|25928985|FG002|Overall Study|Adverse Event|0|||
13118314|NCT03040024|25928983|FG000|Overall Study|Death|0|||
13272419|NCT01387022|26430710|FG000|Overall Study|Lost to Follow-up|0|||
13272420|NCT01387022|26430711|FG001|Overall Study|Lost to Follow-up|3|||
13272421|NCT01386970|26430726|FG000|Overall Study|Withdrawal by Subject|0|||
13272422|NCT01386970|26430727|FG001|Overall Study|Withdrawal by Subject|1|||
13272423|NCT01386970|26430726|FG000|Overall Study|Adverse Event|4|||
13272424|NCT01386970|26430727|FG001|Overall Study|Adverse Event|1|||
13272425|NCT01386944|26430739|FG000|Overall Study|Adverse Event|26|||
13272426|NCT01386944|26430739|FG000|Overall Study|Lack of Efficacy|14|||
13272427|NCT01386944|26430739|FG000|Overall Study|Lost to Follow-up|8|||
13272428|NCT01386944|26430739|FG000|Overall Study|Unspecified reason|8|||
13272429|NCT01386788|26430746|FG000|Overall Study|Lost to Follow-up|2|||
13272430|NCT01386645|26430770|FG000|Overall Study|Physician Decision|0|||
13272431|NCT01386645|26430771|FG001|Overall Study|Physician Decision|0|||
13272432|NCT01386645|26430772|FG002|Overall Study|Physician Decision|1|||
13272433|NCT01386645|26430770|FG000|Overall Study|Withdrawal by Subject|0|||
13272434|NCT01386645|26430771|FG001|Overall Study|Withdrawal by Subject|1|||
13272435|NCT01386645|26430772|FG002|Overall Study|Withdrawal by Subject|1|||
13272436|NCT01386606|26430813|FG000|Overall Study|Adverse Event|0|||
13272437|NCT01386606|26430814|FG001|Overall Study|Adverse Event|1|||
13272438|NCT01386606|26430815|FG002|Overall Study|Adverse Event|0|||
13272439|NCT01386606|26430816|FG003|Overall Study|Adverse Event|0|||
13272440|NCT01386606|26430813|FG000|Overall Study|Withdrawal by Subject|0|||
13272441|NCT01386606|26430814|FG001|Overall Study|Withdrawal by Subject|1|||
13272442|NCT01386606|26430815|FG002|Overall Study|Withdrawal by Subject|1|||
13272443|NCT01386606|26430816|FG003|Overall Study|Withdrawal by Subject|0|||
13272444|NCT01386606|26430813|FG000|Overall Study|Protocol Violation|1|||
13272445|NCT01386606|26430814|FG001|Overall Study|Protocol Violation|0|||
13272446|NCT01386606|26430815|FG002|Overall Study|Protocol Violation|1|||
13272447|NCT01386606|26430816|FG003|Overall Study|Protocol Violation|1|||
13272448|NCT01386606|26430813|FG000|Overall Study|Lost to Follow-up|2|||
13272449|NCT01386606|26430814|FG001|Overall Study|Lost to Follow-up|0|||
13272450|NCT01386606|26430815|FG002|Overall Study|Lost to Follow-up|0|||
13272451|NCT01386606|26430816|FG003|Overall Study|Lost to Follow-up|0|||
13272452|NCT01386606|26430813|FG000|Overall Study|Subject incarcerated|0|||
13272453|NCT01386606|26430814|FG001|Overall Study|Subject incarcerated|1|||
13272454|NCT01386606|26430815|FG002|Overall Study|Subject incarcerated|0|||
13272455|NCT01386606|26430816|FG003|Overall Study|Subject incarcerated|0|||
13272456|NCT01386606|26430813|FG000|Overall Study|Unable to draw PK|1|||
13272457|NCT01386606|26430814|FG001|Overall Study|Unable to draw PK|0|||
13272458|NCT01386606|26430815|FG002|Overall Study|Unable to draw PK|0|||
13272459|NCT01386606|26430816|FG003|Overall Study|Unable to draw PK|0|||
13272460|NCT01386606|26430813|FG000|Overall Study|T levels too high|0|||
13272461|NCT01386606|26430814|FG001|Overall Study|T levels too high|1|||
13272462|NCT01386606|26430815|FG002|Overall Study|T levels too high|1|||
13272463|NCT01386606|26430816|FG003|Overall Study|T levels too high|0|||
13272464|NCT01386554|26430837|FG000|Overall Study|Lost to Follow-up|0|||
13272465|NCT01386554|26430838|FG001|Overall Study|Lost to Follow-up|0|||
13272466|NCT01386554|26430839|FG002|Overall Study|Lost to Follow-up|1|||
13272467|NCT01386554|26430837|FG000|Overall Study|Adverse Event|2|||
13272468|NCT01386554|26430838|FG001|Overall Study|Adverse Event|5|||
13272469|NCT01386554|26430839|FG002|Overall Study|Adverse Event|2|||
13272470|NCT01386554|26430837|FG000|Overall Study|Progressive disease|1|||
13272471|NCT01386554|26430838|FG001|Overall Study|Progressive disease|2|||
13272472|NCT01386554|26430839|FG002|Overall Study|Progressive disease|2|||
13272473|NCT01386554|26430837|FG000|Overall Study|Administration of live vaccines|0|||
13272474|NCT01386554|26430838|FG001|Overall Study|Administration of live vaccines|1|||
13272475|NCT01386554|26430839|FG002|Overall Study|Administration of live vaccines|0|||
13272476|NCT01386554|26430837|FG000|Overall Study|Investigator discretion|0|||
13272477|NCT01386554|26430838|FG001|Overall Study|Investigator discretion|0|||
13272478|NCT01386554|26430839|FG002|Overall Study|Investigator discretion|1|||
13272479|NCT01386554|26430837|FG000|Overall Study|Reason not collected|0|||
13272480|NCT01386554|26430838|FG001|Overall Study|Reason not collected|1|||
13272481|NCT01386554|26430839|FG002|Overall Study|Reason not collected|0|||
13272482|NCT01386385|26430883|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1|||
13272483|NCT01386385|26430884|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
13272484|NCT01386385|26430885|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
13272485|NCT01386385|26430886|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
13272486|NCT01386385|26430887|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
13272487|NCT01386385|26430888|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
13272488|NCT01386385|26430889|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
13272489|NCT01386385|26430890|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
13272490|NCT01386385|26430883|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1|||
13272491|NCT01386385|26430884|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
13272492|NCT01386385|26430885|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
13272493|NCT01386385|26430886|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
13272494|NCT01386385|26430887|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
13272495|NCT01386385|26430888|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
13272496|NCT01386385|26430889|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
13307956|NCT01281306|26530318|FG000|Overall Study|Adverse Event|3|||
13272497|NCT01386385|26430890|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
13272498|NCT01386385|26430883|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
13272499|NCT01386385|26430884|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
13272500|NCT01386385|26430885|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2|||
13272501|NCT01386385|26430886|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
13272502|NCT01386385|26430887|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
13272503|NCT01386385|26430888|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
13272504|NCT01386385|26430889|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
13272505|NCT01386385|26430890|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
13272506|NCT01386385|26430883|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
13272507|NCT01386385|26430884|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
13272508|NCT01386385|26430885|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
13272509|NCT01386385|26430886|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
13272510|NCT01386385|26430887|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1|||
13272511|NCT01386385|26430888|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
13272512|NCT01386385|26430889|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
13272513|NCT01386385|26430890|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
13272514|NCT01386385|26430883|FG000|Phase II Concurrent CRT|Adverse Event|0|||
13272515|NCT01386385|26430884|FG001|Phase II Concurrent CRT|Adverse Event|0|||
13272516|NCT01386385|26430885|FG002|Phase II Concurrent CRT|Adverse Event|0|||
13272517|NCT01386385|26430886|FG003|Phase II Concurrent CRT|Adverse Event|0|||
13272518|NCT01386385|26430887|FG004|Phase II Concurrent CRT|Adverse Event|0|||
13272519|NCT01386385|26430888|FG005|Phase II Concurrent CRT|Adverse Event|0|||
13272520|NCT01386385|26430889|FG006|Phase II Concurrent CRT|Adverse Event|3|||
13272521|NCT01386385|26430890|FG007|Phase II Concurrent CRT|Adverse Event|3|||
13272522|NCT01386385|26430883|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
13272523|NCT01386385|26430884|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
13272524|NCT01386385|26430885|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
13272525|NCT01386385|26430886|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
13272526|NCT01386385|26430887|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
13272527|NCT01386385|26430888|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
13272528|NCT01386385|26430889|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3|||
13272529|NCT01386385|26430890|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
13272530|NCT01386385|26430883|FG000|Phase II: Consolidation Therapy|Adverse Event|0|||
13272531|NCT01386385|26430884|FG001|Phase II: Consolidation Therapy|Adverse Event|0|||
13272532|NCT01386385|26430885|FG002|Phase II: Consolidation Therapy|Adverse Event|0|||
13272533|NCT01386385|26430886|FG003|Phase II: Consolidation Therapy|Adverse Event|0|||
13272534|NCT01386385|26430887|FG004|Phase II: Consolidation Therapy|Adverse Event|0|||
13203603|NCT01984684|26224962|FG001|Overall Study|Study drug not available at site|1|||
13203604|NCT01984684|26224961|FG000|Overall Study|Subject had inadequate IV access|0|||
13203605|NCT01984684|26224962|FG001|Overall Study|Subject had inadequate IV access|1|||
13203606|NCT01984424|26225021|FG000|Overall Study|Withdrawal by Subject|3|||
13203607|NCT01984424|26225022|FG001|Overall Study|Withdrawal by Subject|5|||
13203608|NCT01984424|26225021|FG000|Overall Study|Sponsor Decision|0|||
13203609|NCT01984424|26225022|FG001|Overall Study|Sponsor Decision|1|||
13203610|NCT01984424|26225021|FG000|Overall Study|Lost to Follow-up|0|||
13203611|NCT01984424|26225022|FG001|Overall Study|Lost to Follow-up|1|||
13203612|NCT01984346|26225055|FG000|Overall Study|Physician Decision|4|||
13203613|NCT01984346|26225056|FG001|Overall Study|Physician Decision|2|||
13203614|NCT01984346|26225055|FG000|Overall Study|Withdrawal by Subject|2|||
13203615|NCT01984346|26225056|FG001|Overall Study|Withdrawal by Subject|2|||
13203616|NCT01984346|26225055|FG000|Overall Study|Enrollment Closed|8|||
13203617|NCT01984346|26225056|FG001|Overall Study|Enrollment Closed|1|||
13203618|NCT01984346|26225055|FG000|Overall Study|Insurance Coverage|1|||
13203619|NCT01984346|26225056|FG001|Overall Study|Insurance Coverage|0|||
13203620|NCT01984346|26225055|FG000|Overall Study|Intra-operative Exclusion|2|||
13203621|NCT01984346|26225056|FG001|Overall Study|Intra-operative Exclusion|0|||
13203622|NCT01984294|26225086|FG000|Overall Study|Randomized but Never Treated|0|||
13203623|NCT01984294|26225087|FG001|Overall Study|Randomized but Never Treated|0|||
13203624|NCT01984294|26225088|FG002|Overall Study|Randomized but Never Treated|1|||
13203625|NCT01984294|26225086|FG000|Overall Study|Lack of Efficacy|4|||
13203626|NCT01984294|26225087|FG001|Overall Study|Lack of Efficacy|2|||
13203627|NCT01984294|26225088|FG002|Overall Study|Lack of Efficacy|6|||
13203628|NCT01984294|26225086|FG000|Overall Study|Adverse Event|0|||
13203629|NCT01984294|26225087|FG001|Overall Study|Adverse Event|1|||
13203630|NCT01984294|26225088|FG002|Overall Study|Adverse Event|0|||
13203631|NCT01984268|26225099|FG000|Overall Study|Study Terminated|15|||
13203632|NCT01984242|26225257|FG000|Overall Study|Death|52|||
13203633|NCT01984242|26225258|FG001|Overall Study|Death|50|||
13203634|NCT01984242|26225259|FG002|Overall Study|Death|52|||
13203635|NCT01984242|26225257|FG000|Overall Study|Withdrawal by Subject|5|||
13203636|NCT01984242|26225258|FG001|Overall Study|Withdrawal by Subject|3|||
13272535|NCT01386385|26430888|FG005|Phase II: Consolidation Therapy|Adverse Event|0|||
13272536|NCT01386385|26430889|FG006|Phase II: Consolidation Therapy|Adverse Event|2|||
13272537|NCT01386385|26430890|FG007|Phase II: Consolidation Therapy|Adverse Event|1|||
13272538|NCT01386385|26430883|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
13272539|NCT01386385|26430884|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
13272540|NCT01386385|26430885|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
13272541|NCT01386385|26430886|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
13272542|NCT01386385|26430887|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
13272543|NCT01386385|26430888|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
13272544|NCT01386385|26430889|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2|||
13272545|NCT01386385|26430890|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
13272546|NCT01386385|26430883|FG000|Phase II: Consolidation Therapy|Progression/relapse|0|||
13272547|NCT01386385|26430884|FG001|Phase II: Consolidation Therapy|Progression/relapse|0|||
13272548|NCT01386385|26430885|FG002|Phase II: Consolidation Therapy|Progression/relapse|0|||
13272549|NCT01386385|26430886|FG003|Phase II: Consolidation Therapy|Progression/relapse|0|||
13272550|NCT01386385|26430887|FG004|Phase II: Consolidation Therapy|Progression/relapse|0|||
13272551|NCT01386385|26430888|FG005|Phase II: Consolidation Therapy|Progression/relapse|0|||
13272552|NCT01386385|26430889|FG006|Phase II: Consolidation Therapy|Progression/relapse|1|||
13272553|NCT01386385|26430890|FG007|Phase II: Consolidation Therapy|Progression/relapse|1|||
13272554|NCT01386125|26430905|FG000|Overall Study|Lost to Follow-up|3|||
13272555|NCT01386125|26430906|FG001|Overall Study|Lost to Follow-up|9|||
13272556|NCT01386125|26430905|FG000|Overall Study|Physician Decision|0|||
13272557|NCT01386125|26430906|FG001|Overall Study|Physician Decision|1|||
13272558|NCT01386125|26430905|FG000|Overall Study|Protocol Violation|5|||
13272559|NCT01386125|26430906|FG001|Overall Study|Protocol Violation|7|||
13272560|NCT01386125|26430905|FG000|Overall Study|Disease Progress|1|||
13272561|NCT01386125|26430906|FG001|Overall Study|Disease Progress|2|||
13272562|NCT01386125|26430905|FG000|Overall Study|Withdrawal by Subject|13|||
13272563|NCT01386125|26430906|FG001|Overall Study|Withdrawal by Subject|12|||
13272564|NCT01386125|26430905|FG000|Overall Study|Adverse Event|2|||
13272565|NCT01386125|26430906|FG001|Overall Study|Adverse Event|5|||
13272566|NCT01386125|26430905|FG000|Overall Study|Lack of Efficacy|0|||
13272567|NCT01386125|26430906|FG001|Overall Study|Lack of Efficacy|1|||
13272568|NCT01386125|26430905|FG000|Overall Study|Participant Leaving Country|1|||
13272569|NCT01386125|26430906|FG001|Overall Study|Participant Leaving Country|0|||
13272570|NCT01386008|26430915|FG000|Overall Study|exited w/o incident /study discontinued|17|||
13272571|NCT01386008|26430915|FG000|Overall Study|Adverse Event|3|||
13272572|NCT01385995|26430936|FG000|Period 1, 2 Months|Physician Decision|1|||
13272573|NCT01385995|26430937|FG001|Period 1, 2 Months|Physician Decision|0|||
13272574|NCT01385748|26430992|FG000|Overall Study|Withdrawal by Subject|7|||
13272575|NCT01385748|26430993|FG001|Overall Study|Withdrawal by Subject|4|||
13272576|NCT01385748|26430994|FG002|Overall Study|Withdrawal by Subject|5|||
13272577|NCT01385748|26430992|FG000|Overall Study|Noncompliance|3|||
13272578|NCT01385748|26430993|FG001|Overall Study|Noncompliance|1|||
13272579|NCT01385748|26430994|FG002|Overall Study|Noncompliance|6|||
13272580|NCT01385748|26430992|FG000|Overall Study|Other|1|||
13272581|NCT01385748|26430993|FG001|Overall Study|Other|7|||
13272582|NCT01385748|26430994|FG002|Overall Study|Other|1|||
13272583|NCT01385748|26430992|FG000|Overall Study|Adverse Event|4|||
13272584|NCT01385748|26430993|FG001|Overall Study|Adverse Event|2|||
13272585|NCT01385748|26430994|FG002|Overall Study|Adverse Event|1|||
13272586|NCT01385566|26431065|FG000|Overall Study|Lost to Follow-up|1|||
13272587|NCT01385566|26431066|FG001|Overall Study|Lost to Follow-up|0|||
13272588|NCT01385566|26431067|FG002|Overall Study|Lost to Follow-up|0|||
13272589|NCT01385566|26431068|FG003|Overall Study|Lost to Follow-up|0|||
13272590|NCT01385566|26431069|FG004|Overall Study|Lost to Follow-up|0|||
13272591|NCT01385566|26431070|FG005|Overall Study|Lost to Follow-up|0|||
13272592|NCT01385566|26431065|FG000|Overall Study|Withdrawal by Subject|0|||
13272593|NCT01385566|26431066|FG001|Overall Study|Withdrawal by Subject|0|||
13272594|NCT01385566|26431067|FG002|Overall Study|Withdrawal by Subject|0|||
13272595|NCT01385566|26431068|FG003|Overall Study|Withdrawal by Subject|1|||
13272596|NCT01385566|26431069|FG004|Overall Study|Withdrawal by Subject|0|||
13272597|NCT01385566|26431070|FG005|Overall Study|Withdrawal by Subject|0|||
13272598|NCT01385371|26431097|FG000|Overall Study|Adverse Event|54|||
13272599|NCT01385371|26431098|FG001|Overall Study|Adverse Event|19|||
13272600|NCT01385371|26431097|FG000|Overall Study|Lost to Follow-up|16|||
13272601|NCT01385371|26431098|FG001|Overall Study|Lost to Follow-up|16|||
13272602|NCT01385371|26431097|FG000|Overall Study|Withdrawal by Subject|52|||
13272603|NCT01385371|26431098|FG001|Overall Study|Withdrawal by Subject|39|||
13272604|NCT01385371|26431097|FG000|Overall Study|Protocol Violation|25|||
13272605|NCT01385371|26431098|FG001|Overall Study|Protocol Violation|21|||
13272606|NCT01385371|26431097|FG000|Overall Study|Administrative|2|||
13272607|NCT01385371|26431098|FG001|Overall Study|Administrative|2|||
13272608|NCT01385202|26431107|FG000|Overall Study|Lost to Follow-up|6|||
13272609|NCT01385202|26431107|FG000|Overall Study|Not Eligible|11|||
13272610|NCT01385202|26431107|FG000|Overall Study|Withdrawn|1|||
13272611|NCT01385098|26431115|FG000|Overall Study|Adverse Event|10|||
13272612|NCT01385098|26431115|FG000|Overall Study|Lost to Follow-up|4|||
13272613|NCT01384877|26431146|FG000|Treatment 2|Lost to Follow-up|2|||
13272614|NCT01384877|26431147|FG001|Treatment 2|Lost to Follow-up|2|||
13272615|NCT01384760|26431162|FG000|Overall Study|Lost to Follow-up|0|||
13272616|NCT01384760|26431163|FG001|Overall Study|Lost to Follow-up|6|||
13272617|NCT01384760|26431162|FG000|Overall Study|Protocol Violation|16|||
13272618|NCT01384760|26431163|FG001|Overall Study|Protocol Violation|0|||
13272619|NCT01384734|26431259|FG000|Overall Study|Adverse Event|0|||
13272620|NCT01384734|26431260|FG001|Overall Study|Adverse Event|3|||
13272621|NCT01384734|26431261|FG002|Overall Study|Adverse Event|0|||
13272622|NCT01384734|26431262|FG003|Overall Study|Adverse Event|2|||
13272623|NCT01384734|26431263|FG004|Overall Study|Adverse Event|7|||
13272624|NCT01384734|26431259|FG000|Overall Study|Death|1|||
13272625|NCT01384734|26431260|FG001|Overall Study|Death|0|||
13272626|NCT01384734|26431261|FG002|Overall Study|Death|1|||
13272627|NCT01384734|26431262|FG003|Overall Study|Death|0|||
13272628|NCT01384734|26431263|FG004|Overall Study|Death|0|||
13272629|NCT01384734|26431259|FG000|Overall Study|Continuation criteria not met|0|||
13272630|NCT01384734|26431260|FG001|Overall Study|Continuation criteria not met|0|||
13272631|NCT01384734|26431261|FG002|Overall Study|Continuation criteria not met|1|||
13272632|NCT01384734|26431262|FG003|Overall Study|Continuation criteria not met|1|||
13272633|NCT01384734|26431263|FG004|Overall Study|Continuation criteria not met|0|||
13272634|NCT01384734|26431259|FG000|Overall Study|Lack of Efficacy|3|||
13272635|NCT01384734|26431260|FG001|Overall Study|Lack of Efficacy|7|||
13272636|NCT01384734|26431261|FG002|Overall Study|Lack of Efficacy|4|||
13272637|NCT01384734|26431262|FG003|Overall Study|Lack of Efficacy|4|||
13272638|NCT01384734|26431263|FG004|Overall Study|Lack of Efficacy|2|||
13272639|NCT01384734|26431259|FG000|Overall Study|Lost to Follow-up|5|||
13272640|NCT01384734|26431260|FG001|Overall Study|Lost to Follow-up|3|||
13272641|NCT01384734|26431261|FG002|Overall Study|Lost to Follow-up|3|||
13272642|NCT01384734|26431262|FG003|Overall Study|Lost to Follow-up|8|||
13272643|NCT01384734|26431263|FG004|Overall Study|Lost to Follow-up|5|||
13272644|NCT01384734|26431259|FG000|Overall Study|Non-compliance with study drug|1|||
13272645|NCT01384734|26431260|FG001|Overall Study|Non-compliance with study drug|2|||
13272646|NCT01384734|26431261|FG002|Overall Study|Non-compliance with study drug|6|||
13272647|NCT01384734|26431262|FG003|Overall Study|Non-compliance with study drug|0|||
13272648|NCT01384734|26431263|FG004|Overall Study|Non-compliance with study drug|2|||
13272649|NCT01384734|26431259|FG000|Overall Study|Pregnancy|0|||
13272650|NCT01384734|26431260|FG001|Overall Study|Pregnancy|1|||
13272651|NCT01384734|26431261|FG002|Overall Study|Pregnancy|0|||
13272652|NCT01384734|26431262|FG003|Overall Study|Pregnancy|0|||
13272653|NCT01384734|26431263|FG004|Overall Study|Pregnancy|1|||
13272654|NCT01384734|26431259|FG000|Overall Study|Sponsor terminated|0|||
13272655|NCT01384734|26431260|FG001|Overall Study|Sponsor terminated|0|||
13272656|NCT01384734|26431261|FG002|Overall Study|Sponsor terminated|0|||
13272657|NCT01384734|26431262|FG003|Overall Study|Sponsor terminated|0|||
13272658|NCT01384734|26431263|FG004|Overall Study|Sponsor terminated|1|||
13272659|NCT01384734|26431259|FG000|Overall Study|Withdrawal by Subject|5|||
13272660|NCT01384734|26431260|FG001|Overall Study|Withdrawal by Subject|5|||
13272661|NCT01384734|26431261|FG002|Overall Study|Withdrawal by Subject|6|||
13272662|NCT01384734|26431262|FG003|Overall Study|Withdrawal by Subject|7|||
13272663|NCT01384734|26431263|FG004|Overall Study|Withdrawal by Subject|9|||
13272664|NCT01384734|26431259|FG000|Overall Study|Investigator relocating|0|||
13272665|NCT01384734|26431260|FG001|Overall Study|Investigator relocating|2|||
13272666|NCT01384734|26431261|FG002|Overall Study|Investigator relocating|0|||
13272667|NCT01384734|26431262|FG003|Overall Study|Investigator relocating|3|||
13272668|NCT01384734|26431263|FG004|Overall Study|Investigator relocating|1|||
13272669|NCT01384734|26431259|FG000|Overall Study|Unable to come back for visit|1|||
13272670|NCT01384734|26431260|FG001|Overall Study|Unable to come back for visit|0|||
13272671|NCT01384734|26431261|FG002|Overall Study|Unable to come back for visit|1|||
13272672|NCT01384734|26431262|FG003|Overall Study|Unable to come back for visit|1|||
13272673|NCT01384734|26431263|FG004|Overall Study|Unable to come back for visit|0|||
13272674|NCT01384734|26431259|FG000|Overall Study|Prison|0|||
13272675|NCT01384734|26431260|FG001|Overall Study|Prison|0|||
13272676|NCT01384734|26431261|FG002|Overall Study|Prison|1|||
13272677|NCT01384734|26431262|FG003|Overall Study|Prison|0|||
13272678|NCT01384734|26431263|FG004|Overall Study|Prison|0|||
13272679|NCT01384734|26431259|FG000|Overall Study|As per Exclusion criteria|0|||
13272680|NCT01384734|26431260|FG001|Overall Study|As per Exclusion criteria|1|||
13272681|NCT01384734|26431261|FG002|Overall Study|As per Exclusion criteria|0|||
13272682|NCT01384734|26431262|FG003|Overall Study|As per Exclusion criteria|0|||
13272683|NCT01384734|26431263|FG004|Overall Study|As per Exclusion criteria|0|||
13272684|NCT01384734|26431259|FG000|Overall Study|Missed End of treatment visit|0|||
13272685|NCT01384734|26431260|FG001|Overall Study|Missed End of treatment visit|0|||
13272686|NCT01384734|26431261|FG002|Overall Study|Missed End of treatment visit|0|||
13272687|NCT01384734|26431262|FG003|Overall Study|Missed End of treatment visit|1|||
13272688|NCT01384734|26431263|FG004|Overall Study|Missed End of treatment visit|0|||
13272689|NCT01384734|26431259|FG000|Overall Study|Adhesion problem|0|||
13272690|NCT01384734|26431260|FG001|Overall Study|Adhesion problem|0|||
13272691|NCT01384734|26431261|FG002|Overall Study|Adhesion problem|0|||
13272692|NCT01384734|26431262|FG003|Overall Study|Adhesion problem|1|||
13272693|NCT01384734|26431263|FG004|Overall Study|Adhesion problem|0|||
13272694|NCT01384734|26431259|FG000|Overall Study|Early termination|0|||
13272695|NCT01384734|26431260|FG001|Overall Study|Early termination|0|||
13272696|NCT01384734|26431261|FG002|Overall Study|Early termination|0|||
13272697|NCT01384734|26431262|FG003|Overall Study|Early termination|0|||
13272698|NCT01384734|26431263|FG004|Overall Study|Early termination|1|||
13272699|NCT01384734|26431259|FG000|Overall Study|Physician Decision|1|||
13272700|NCT01384734|26431260|FG001|Overall Study|Physician Decision|0|||
13272701|NCT01384734|26431261|FG002|Overall Study|Physician Decision|0|||
13272702|NCT01384734|26431262|FG003|Overall Study|Physician Decision|0|||
13272703|NCT01384734|26431263|FG004|Overall Study|Physician Decision|0|||
13272704|NCT01384292|26431283|FG000|Part B|Severe non-compliance to protocol|1|||
13272705|NCT01384292|26431284|FG001|Part B|Severe non-compliance to protocol|0|||
13272706|NCT01384292|26431285|FG002|Part B|Severe non-compliance to protocol|0|||
13272707|NCT01384019|26431298|FG000|Overall Study|Withdrawal by Subject|3|||
13272708|NCT01384019|26431299|FG001|Overall Study|Withdrawal by Subject|0|||
13272709|NCT01384019|26431298|FG000|Overall Study|Death|1|||
13272710|NCT01384019|26431299|FG001|Overall Study|Death|0|||
13272711|NCT01384019|26431298|FG000|Overall Study|MRI refusal|6|||
13272712|NCT01384019|26431299|FG001|Overall Study|MRI refusal|6|||
13272713|NCT01383993|26431356|FG000|Overall Study|Adverse Event|1|||
13272714|NCT01383993|26431357|FG001|Overall Study|Adverse Event|1|||
13272715|NCT01383993|26431358|FG002|Overall Study|Adverse Event|0|||
13272716|NCT01383993|26431356|FG000|Overall Study|Withdrawal by Subject|0|||
13272717|NCT01383993|26431357|FG001|Overall Study|Withdrawal by Subject|0|||
13272718|NCT01383993|26431358|FG002|Overall Study|Withdrawal by Subject|1|||
13272719|NCT01383993|26431356|FG000|Overall Study|Marketed voriconazole in post-therapy|2|||
13272720|NCT01383993|26431357|FG001|Overall Study|Marketed voriconazole in post-therapy|0|||
13272721|NCT01383993|26431358|FG002|Overall Study|Marketed voriconazole in post-therapy|0|||
13272722|NCT01383954|26431365|FG000|Overall Study|Lack of Efficacy|2|||
13272723|NCT01383954|26431365|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2|||
13272724|NCT01383954|26431365|FG000|Overall Study|Adverse Event|1|||
13272725|NCT01383954|26431365|FG000|Overall Study|Reason Not Specified|9|||
13272726|NCT01383928|26431417|FG000|Overall Study|Initiation of ASCT|2|||
13272727|NCT01383928|26431418|FG001|Overall Study|Initiation of ASCT|1|||
13272728|NCT01383928|26431419|FG002|Overall Study|Initiation of ASCT|18|||
13272729|NCT01383928|26431417|FG000|Overall Study|Adverse Event|1|||
13272730|NCT01383928|26431418|FG001|Overall Study|Adverse Event|2|||
13272731|NCT01383928|26431419|FG002|Overall Study|Adverse Event|8|||
13272732|NCT01383928|26431417|FG000|Overall Study|Other|1|||
13272733|NCT01383928|26431418|FG001|Overall Study|Other|3|||
13272734|NCT01383928|26431419|FG002|Overall Study|Other|4|||
13272735|NCT01383928|26431417|FG000|Overall Study|Progressive Disease|1|||
13272736|NCT01383928|26431418|FG001|Overall Study|Progressive Disease|1|||
13272737|NCT01383928|26431419|FG002|Overall Study|Progressive Disease|5|||
13272738|NCT01383928|26431417|FG000|Overall Study|Withdrawal by Subject|0|||
13272739|NCT01383928|26431418|FG001|Overall Study|Withdrawal by Subject|0|||
13272740|NCT01383928|26431419|FG002|Overall Study|Withdrawal by Subject|4|||
13272741|NCT01383928|26431417|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
13272742|NCT01383928|26431418|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
13272743|NCT01383928|26431419|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
13272744|NCT01383707|26431430|FG000|Overall Study|Consent withdrawal|6|||
13272745|NCT01383707|26431430|FG000|Overall Study|Death|19|||
13272746|NCT01383707|26431430|FG000|Overall Study|Other|8|||
13272747|NCT01383707|26431430|FG000|Overall Study|Sponsor's decision|2|||
13272748|NCT01383707|26431430|FG000|Overall Study|Adverse Event|14|||
13272749|NCT01383707|26431430|FG000|Overall Study|Progressive disease|23|||
13272750|NCT01383499|26431485|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
13272751|NCT01383499|26431486|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
13272752|NCT01383499|26431487|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
13272753|NCT01383499|26431488|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
13272754|NCT01383486|26431496|FG000|Overall Study|Lost to Follow-up|10|||
13272755|NCT01383486|26431496|FG000|Overall Study|Incomplete information for analysis|2|||
13272756|NCT01383486|26431496|FG000|Overall Study|Did not take any product|6|||
13272757|NCT01383356|26431509|FG000|Period 1|Adverse Event|5|||
13272758|NCT01383356|26431510|FG001|Period 1|Adverse Event|3|||
13272759|NCT01383356|26431509|FG000|Period 1|Non-compliance|3|||
13272760|NCT01383356|26431510|FG001|Period 1|Non-compliance|0|||
13272761|NCT01383356|26431509|FG000|Period 1|Out of Range Mid-study-Test|0|||
13272762|NCT01383356|26431510|FG001|Period 1|Out of Range Mid-study-Test|1|||
13272763|NCT01383356|26431509|FG000|Period 1|Personal|0|||
13272764|NCT01383356|26431510|FG001|Period 1|Personal|2|||
13272765|NCT01383317|26431539|FG000|Overall Study|Lost to Follow-up|2|||
13272766|NCT01383317|26431540|FG001|Overall Study|Lost to Follow-up|1|||
13272767|NCT01383317|26431539|FG000|Overall Study|Death|1|||
13272768|NCT01383317|26431540|FG001|Overall Study|Death|0|||
13272769|NCT01383317|26431539|FG000|Overall Study|Adverse Event|0|||
13272770|NCT01383317|26431540|FG001|Overall Study|Adverse Event|1|||
13272771|NCT01383174|26431571|FG000|3 Month Assessment|Death|0|||
13272772|NCT01383174|26431572|FG001|3 Month Assessment|Death|1|||
13272773|NCT01383174|26431571|FG000|3 Month Assessment|Lost to Follow-up|2|||
13272774|NCT01383174|26431572|FG001|3 Month Assessment|Lost to Follow-up|0|||
13272775|NCT01383174|26431571|FG000|3 Month Assessment|Refused to complete|4|||
13272776|NCT01383174|26431572|FG001|3 Month Assessment|Refused to complete|0|||
13272777|NCT01383174|26431571|FG000|6 Month Assessment|Lost to Follow-up|1|||
13272778|NCT01383174|26431572|FG001|6 Month Assessment|Lost to Follow-up|1|||
13272779|NCT01383174|26431571|FG000|6 Month Assessment|Refused to complete|4|||
13272780|NCT01383174|26431572|FG001|6 Month Assessment|Refused to complete|0|||
13272781|NCT01383161|26431595|FG000|Overall Study|Adverse Event|5|||
13272782|NCT01383161|26431596|FG001|Overall Study|Adverse Event|1|||
13272783|NCT01383161|26431595|FG000|Overall Study|Withdrawal by Subject|0|||
13272784|NCT01383161|26431596|FG001|Overall Study|Withdrawal by Subject|2|||
13272785|NCT01383161|26431595|FG000|Overall Study|Lack of Efficacy|0|||
13272786|NCT01383161|26431596|FG001|Overall Study|Lack of Efficacy|1|||
13272787|NCT01383096|26431652|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
13272788|NCT01383096|26431653|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
13272789|NCT01383096|26431654|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
13272790|NCT01383096|26431652|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
13272791|NCT01383096|26431653|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
13272792|NCT01383096|26431654|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
13272793|NCT01383096|26431652|FG000|Third Intervention (8 Days)|Elevated AST|0|||
13272794|NCT01383096|26431653|FG001|Third Intervention (8 Days)|Elevated AST|1|||
13272795|NCT01383096|26431654|FG002|Third Intervention (8 Days)|Elevated AST|0|||
13272796|NCT01383096|26431652|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
13272797|NCT01383096|26431653|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3|||
13272798|NCT01383096|26431654|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
13272799|NCT01383096|26431652|FG000|Third Intervention (8 Days)|Adverse Event|1|||
13272800|NCT01383096|26431653|FG001|Third Intervention (8 Days)|Adverse Event|0|||
13272801|NCT01383096|26431654|FG002|Third Intervention (8 Days)|Adverse Event|0|||
13272802|NCT01383096|26431652|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1|||
13272803|NCT01383096|26431653|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0|||
13272804|NCT01383096|26431654|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0|||
13272805|NCT01383096|26431652|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1|||
13272806|NCT01383096|26431653|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
13272807|NCT01383096|26431654|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
13272808|NCT01383096|26431652|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
13272809|NCT01383096|26431653|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
13272810|NCT01383096|26431654|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
13272811|NCT01383096|26431652|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1|||
13272812|NCT01383096|26431653|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
13272813|NCT01383096|26431654|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
13272814|NCT01383096|26431652|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1|||
13272815|NCT01383096|26431653|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
13272816|NCT01383096|26431654|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
13272817|NCT01383096|26431652|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1|||
13272818|NCT01383096|26431653|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
13272819|NCT01383096|26431654|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
13272820|NCT01383018|26431696|FG000|Overall Study|Adverse Event|14|||
13272821|NCT01383018|26431696|FG000|Overall Study|Death|10|||
13272822|NCT01383018|26431696|FG000|Overall Study|Lost to Follow-up|5|||
13272823|NCT01383018|26431696|FG000|Overall Study|Physician Decision|5|||
13272824|NCT01383018|26431696|FG000|Overall Study|Withdrawal by Subject|9|||
13272825|NCT01383018|26431696|FG000|Overall Study|Subject not implanted|76|||
13272826|NCT01383018|26431696|FG000|Overall Study|Missed Visit|247|||
13272827|NCT01383018|26431696|FG000|Overall Study|Site closed early-not compliance related|7|||
13272828|NCT01383018|26431696|FG000|Overall Study|Patient moved away from site|1|||
13272829|NCT01383018|26431696|FG000|Overall Study|Subject Incarcerated|1|||
13272830|NCT01382940|26431708|FG000|Overall Study|Adverse Event|19|||
13272831|NCT01382940|26431708|FG000|Overall Study|Lost to Follow-up|4|||
13272832|NCT01382940|26431708|FG000|Overall Study|Physician Decision|7|||
13272833|NCT01382940|26431708|FG000|Overall Study|Withdrawal by Subject|23|||
13272834|NCT01382940|26431708|FG000|Overall Study|Protocol Violation|20|||
13272835|NCT01382602|26431721|FG000|Overall Study|Protocol Violation|0|||
13272836|NCT01382602|26431722|FG001|Overall Study|Protocol Violation|3|||
13272837|NCT01382602|26431721|FG000|Overall Study|Withdrawal by Subject|0|||
13272838|NCT01382602|26431722|FG001|Overall Study|Withdrawal by Subject|1|||
13272839|NCT01382446|26431735|FG000|Overall Study|Withdrawal by Subject|0|||
13272840|NCT01382446|26431736|FG001|Overall Study|Withdrawal by Subject|1|||
13272841|NCT01382446|26431735|FG000|Overall Study|Removal from Mechanical Ventilation|3|||
13272842|NCT01382446|26431736|FG001|Overall Study|Removal from Mechanical Ventilation|3|||
13272843|NCT01382251|26431754|FG000|Overall Study|Surgeries cancelled or delayed|16|||
13272844|NCT01382251|26431755|FG001|Overall Study|Surgeries cancelled or delayed|16|||
13272845|NCT01382251|26431754|FG000|Overall Study|Lost to Follow-up|4|||
13272846|NCT01382251|26431755|FG001|Overall Study|Lost to Follow-up|4|||
13272847|NCT01382251|26431754|FG000|Overall Study|Contacted after study closed|1|||
13272848|NCT01382251|26431755|FG001|Overall Study|Contacted after study closed|1|||
13272849|NCT01382225|26431784|FG000|Overall Study|Adverse Event|3|||
13272850|NCT01382225|26431785|FG001|Overall Study|Adverse Event|2|||
13272851|NCT01382225|26431784|FG000|Overall Study|Protocol Violation|2|||
13272852|NCT01382225|26431785|FG001|Overall Study|Protocol Violation|1|||
13272853|NCT01382225|26431784|FG000|Overall Study|Subject Withdrew Consent|5|||
13272854|NCT01382225|26431785|FG001|Overall Study|Subject Withdrew Consent|2|||
13272855|NCT01382225|26431784|FG000|Overall Study|Other|4|||
13272856|NCT01382225|26431785|FG001|Overall Study|Other|2|||
13272857|NCT01382212|26431811|FG000|Overall Study|Kidney transplant|1|||
13272858|NCT01382212|26431811|FG000|Overall Study|Withdrew consent|1|||
13272859|NCT01381926|26431828|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2|||
13272860|NCT01381926|26431829|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0|||
13272861|NCT01381926|26431828|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0|||
13272862|NCT01381926|26431829|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1|||
13272863|NCT01381900|26431859|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2|||
13272864|NCT01381900|26431860|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0|||
13272865|NCT01381900|26431861|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0|||
13272866|NCT01381900|26431859|FG000|Overall Study|Adverse Event|4|||
13272867|NCT01381900|26431860|FG001|Overall Study|Adverse Event|6|||
13272868|NCT01381900|26431861|FG002|Overall Study|Adverse Event|7|||
13272869|NCT01381900|26431859|FG000|Overall Study|Noncompliance with study drug|0|||
13272870|NCT01381900|26431860|FG001|Overall Study|Noncompliance with study drug|0|||
13272871|NCT01381900|26431861|FG002|Overall Study|Noncompliance with study drug|1|||
13272872|NCT01381900|26431859|FG000|Overall Study|Physician Decision|0|||
13272873|NCT01381900|26431860|FG001|Overall Study|Physician Decision|1|||
13272874|NCT01381900|26431861|FG002|Overall Study|Physician Decision|1|||
13272875|NCT01381900|26431859|FG000|Overall Study|Protocol Violation|0|||
13272876|NCT01381900|26431860|FG001|Overall Study|Protocol Violation|1|||
13272877|NCT01381900|26431861|FG002|Overall Study|Protocol Violation|1|||
13272878|NCT01381900|26431859|FG000|Overall Study|Withdrawal by Subject|0|||
13272879|NCT01381900|26431860|FG001|Overall Study|Withdrawal by Subject|0|||
13272880|NCT01381900|26431861|FG002|Overall Study|Withdrawal by Subject|1|||
13272881|NCT01381900|26431859|FG000|Overall Study|Early withdraw|3|||
13272882|NCT01381900|26431860|FG001|Overall Study|Early withdraw|1|||
13272883|NCT01381900|26431861|FG002|Overall Study|Early withdraw|1|||
13272884|NCT01381874|26431897|FG000|Overall Study|Lost to Follow-up|1|||
13272885|NCT01381874|26431898|FG001|Overall Study|Lost to Follow-up|1|||
13272886|NCT01381874|26431899|FG002|Overall Study|Lost to Follow-up|0|||
13272887|NCT01381874|26431897|FG000|Overall Study|Withdrawal by Subject|9|||
13272888|NCT01381874|26431898|FG001|Overall Study|Withdrawal by Subject|10|||
13272889|NCT01381874|26431899|FG002|Overall Study|Withdrawal by Subject|9|||
13272890|NCT01381874|26431897|FG000|Overall Study|Other|67|||
13272891|NCT01381874|26431898|FG001|Overall Study|Other|52|||
13272892|NCT01381874|26431899|FG002|Overall Study|Other|67|||
13272893|NCT01381718|26431918|FG000|Overall Study|Withdrawal by Subject|2|||
13272894|NCT01381718|26431919|FG001|Overall Study|Withdrawal by Subject|5|||
13272895|NCT01381718|26431918|FG000|Overall Study|Lost to Follow-up|3|||
13272896|NCT01381718|26431919|FG001|Overall Study|Lost to Follow-up|5|||
13272897|NCT01381718|26431918|FG000|Overall Study|Toxicity, side effects or complications related to study|0|||
13272898|NCT01381718|26431919|FG001|Overall Study|Toxicity, side effects or complications related to study|3|||
13272899|NCT01381692|26431952|FG000|Overall Study|Adverse Event|1|||
13272900|NCT01381692|26431953|FG001|Overall Study|Adverse Event|0|||
13272901|NCT01381692|26431954|FG002|Overall Study|Adverse Event|0|||
13272902|NCT01381692|26431955|FG003|Overall Study|Adverse Event|0|||
13272903|NCT01381692|26431956|FG004|Overall Study|Adverse Event|0|||
13272904|NCT01381692|26431957|FG005|Overall Study|Adverse Event|0|||
13272905|NCT01381679|26431971|FG000|Overall Study|Adverse Event|3|||
13272906|NCT01381679|26431971|FG000|Overall Study|Lost to Follow-up|885|||
13272907|NCT01381575|26432035|FG000|Overall Study|Serious Adverse Event|1|||
13272908|NCT01381575|26432036|FG001|Overall Study|Serious Adverse Event|0|||
13272909|NCT01381575|26432037|FG002|Overall Study|Serious Adverse Event|0|||
13272910|NCT01381575|26432035|FG000|Overall Study|Non-Serious Adverse Event|0|||
13272911|NCT01381575|26432036|FG001|Overall Study|Non-Serious Adverse Event|0|||
13272912|NCT01381575|26432037|FG002|Overall Study|Non-Serious Adverse Event|1|||
13272913|NCT01381575|26432035|FG000|Overall Study|Protocol Violation|0|||
13272914|NCT01381575|26432036|FG001|Overall Study|Protocol Violation|1|||
13272915|NCT01381575|26432037|FG002|Overall Study|Protocol Violation|1|||
13272916|NCT01381575|26432035|FG000|Overall Study|Withdrawal by Subject|15|||
13272917|NCT01381575|26432036|FG001|Overall Study|Withdrawal by Subject|9|||
13272918|NCT01381575|26432037|FG002|Overall Study|Withdrawal by Subject|7|||
13272919|NCT01381575|26432035|FG000|Overall Study|Migrated/moved from study area|2|||
13272920|NCT01381575|26432036|FG001|Overall Study|Migrated/moved from study area|12|||
13272921|NCT01381575|26432037|FG002|Overall Study|Migrated/moved from study area|2|||
13272922|NCT01381575|26432035|FG000|Overall Study|Lost to Follow-up|8|||
13272923|NCT01381575|26432036|FG001|Overall Study|Lost to Follow-up|17|||
13272924|NCT01381575|26432037|FG002|Overall Study|Lost to Follow-up|9|||
13272925|NCT01381562|26432112|FG000|Overall Study|Adverse Event|0|||
13272926|NCT01381562|26432113|FG001|Overall Study|Adverse Event|1|||
13272927|NCT01381562|26432114|FG002|Overall Study|Adverse Event|0|||
13272928|NCT01381549|26432219|FG000|Overall Study|Ineligible: No organisms isolated|0|||
13272929|NCT01381549|26432220|FG001|Overall Study|Ineligible: No organisms isolated|0|||
13272930|NCT01381549|26432221|FG002|Overall Study|Ineligible: No organisms isolated|1|||
13272931|NCT01381068|26432246|FG000|Overall Study|Death|1|||
13272932|NCT01381068|26432247|FG001|Overall Study|Death|0|||
13272933|NCT01381016|26432262|FG000|Overall Study|Lost to Follow-up|1|||
13272934|NCT01381016|26432263|FG001|Overall Study|Lost to Follow-up|1|||
13272935|NCT01381016|26432262|FG000|Overall Study|Screen Failure|2|||
13272936|NCT01381016|26432263|FG001|Overall Study|Screen Failure|2|||
13272937|NCT01381016|26432262|FG000|Overall Study|Withdrawal by Subject|0|||
13272938|NCT01381016|26432263|FG001|Overall Study|Withdrawal by Subject|1|||
13272939|NCT01381016|26432262|FG000|Overall Study|Physician Decision|0|||
13272940|NCT01381016|26432263|FG001|Overall Study|Physician Decision|2|||
13272941|NCT01380990|26432323|FG000|Overall Study|Treatment Failure|1|||
13272942|NCT01380990|26432324|FG001|Overall Study|Treatment Failure|0|||
13272943|NCT01380990|26432323|FG000|Overall Study|Death|0|||
13272944|NCT01380990|26432324|FG001|Overall Study|Death|1|||
13272945|NCT01380834|26432341|FG000|Overall Study|Physician Decision|1|||
13272946|NCT01380834|26432342|FG001|Overall Study|Physician Decision|0|||
13272947|NCT01380782|26432372|FG000|Overall Study|Adverse Event|0|||
13272948|NCT01380782|26432373|FG001|Overall Study|Adverse Event|1|||
13272949|NCT01380782|26432374|FG002|Overall Study|Adverse Event|0|||
13272950|NCT01380782|26432375|FG003|Overall Study|Adverse Event|0|||
13272951|NCT01380782|26432372|FG000|Overall Study|Death|1|||
13272952|NCT01380782|26432373|FG001|Overall Study|Death|0|||
13272953|NCT01380782|26432374|FG002|Overall Study|Death|0|||
13272954|NCT01380782|26432375|FG003|Overall Study|Death|0|||
13272955|NCT01380782|26432372|FG000|Overall Study|Lack of Efficacy|10|||
13272956|NCT01380782|26432373|FG001|Overall Study|Lack of Efficacy|9|||
13272957|NCT01380782|26432374|FG002|Overall Study|Lack of Efficacy|10|||
13272958|NCT01380782|26432375|FG003|Overall Study|Lack of Efficacy|3|||
13272959|NCT01380782|26432372|FG000|Overall Study|Physician Decision|1|||
13272960|NCT01380782|26432373|FG001|Overall Study|Physician Decision|0|||
13272961|NCT01380782|26432374|FG002|Overall Study|Physician Decision|0|||
13272962|NCT01380782|26432375|FG003|Overall Study|Physician Decision|0|||
13272963|NCT01380782|26432372|FG000|Overall Study|Withdrawal by Subject|0|||
13272964|NCT01380782|26432373|FG001|Overall Study|Withdrawal by Subject|0|||
13272965|NCT01380782|26432374|FG002|Overall Study|Withdrawal by Subject|1|||
13272966|NCT01380782|26432375|FG003|Overall Study|Withdrawal by Subject|1|||
13272967|NCT01380769|26432390|FG000|Overall Study|Withdrawal by Subject|7|||
13272968|NCT01380769|26432391|FG001|Overall Study|Withdrawal by Subject|11|||
13272969|NCT01380769|26432390|FG000|Overall Study|Physician Decision|1|||
13272970|NCT01380769|26432391|FG001|Overall Study|Physician Decision|1|||
13272971|NCT01380769|26432390|FG000|Overall Study|Adverse Event|1|||
13272972|NCT01380769|26432391|FG001|Overall Study|Adverse Event|1|||
13272973|NCT01380769|26432390|FG000|Overall Study|Protocol Violation|0|||
13272974|NCT01380769|26432391|FG001|Overall Study|Protocol Violation|1|||
13272975|NCT01380730|26432474|FG000|Overall Study|Death|0|||
13272976|NCT01380730|26432475|FG001|Overall Study|Death|0|||
13272977|NCT01380730|26432476|FG002|Overall Study|Death|0|||
13272978|NCT01380730|26432477|FG003|Overall Study|Death|0|||
13272979|NCT01380730|26432478|FG004|Overall Study|Death|1|||
13272980|NCT01380730|26432479|FG005|Overall Study|Death|0|||
13272981|NCT01380730|26432480|FG006|Overall Study|Death|0|||
13272982|NCT01380730|26432481|FG007|Overall Study|Death|0|||
13272983|NCT01380691|26432536|FG000|Washout (7 Days)|Protocol Violation|0|||
13272984|NCT01380691|26432537|FG001|Washout (7 Days)|Protocol Violation|0|||
13272985|NCT01380691|26432538|FG002|Washout (7 Days)|Protocol Violation|0|||
13272986|NCT01380691|26432539|FG003|Washout (7 Days)|Protocol Violation|1|||
13272987|NCT01380691|26432536|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
13272988|NCT01380691|26432537|FG001|Washout (7 Days)|Withdrawal by Subject|0|||
13272989|NCT01380691|26432538|FG002|Washout (7 Days)|Withdrawal by Subject|1|||
13272990|NCT01380691|26432539|FG003|Washout (7 Days)|Withdrawal by Subject|0|||
13272991|NCT01380535|26432552|FG000|Overall Study|Adverse Event|3|||
13272992|NCT01380535|26432553|FG001|Overall Study|Adverse Event|3|||
13272993|NCT01380535|26432552|FG000|Overall Study|Death|3|||
13272994|NCT01380535|26432553|FG001|Overall Study|Death|0|||
13272995|NCT01380535|26432552|FG000|Overall Study|Study site closed|0|||
13272996|NCT01380535|26432553|FG001|Overall Study|Study site closed|5|||
13272997|NCT01380535|26432552|FG000|Overall Study|Withdrawal by Subject|1|||
13272998|NCT01380535|26432553|FG001|Overall Study|Withdrawal by Subject|2|||
13272999|NCT01380535|26432552|FG000|Overall Study|Protocol Violation|0|||
13273000|NCT01380535|26432553|FG001|Overall Study|Protocol Violation|2|||
13273001|NCT01380535|26432552|FG000|Overall Study|Lack of Efficacy|0|||
13273002|NCT01380535|26432553|FG001|Overall Study|Lack of Efficacy|3|||
13273003|NCT01380379|26432560|FG000|Overall Study|Pregnancy|1|||
13273004|NCT01380327|26432590|FG000|Overall Study|Lost to Follow-up|0|||
13273005|NCT01380327|26432591|FG001|Overall Study|Lost to Follow-up|1|||
13273006|NCT01380327|26432592|FG002|Overall Study|Lost to Follow-up|1|||
13273007|NCT01380327|26432590|FG000|Overall Study|Protocol Violation|3|||
13273008|NCT01380327|26432591|FG001|Overall Study|Protocol Violation|2|||
13273009|NCT01380327|26432592|FG002|Overall Study|Protocol Violation|3|||
13273010|NCT01380327|26432590|FG000|Overall Study|Withdrawal by Subject|0|||
13273011|NCT01380327|26432591|FG001|Overall Study|Withdrawal by Subject|0|||
13273012|NCT01380327|26432592|FG002|Overall Study|Withdrawal by Subject|1|||
13273013|NCT01380327|26432590|FG000|Overall Study|Housing situation precluded ability to k|0|||
13273014|NCT01380327|26432591|FG001|Overall Study|Housing situation precluded ability to k|0|||
13273015|NCT01380327|26432592|FG002|Overall Study|Housing situation precluded ability to k|1|||
13273016|NCT01380327|26432590|FG000|Overall Study|Questionable onset of epilepsy|0|||
13273017|NCT01380327|26432591|FG001|Overall Study|Questionable onset of epilepsy|0|||
13273018|NCT01380327|26432592|FG002|Overall Study|Questionable onset of epilepsy|1|||
13273019|NCT01380184|26432605|FG000|Part 1 (19 Days)|Adverse Event|1|||
13273020|NCT01380184|26432605|FG000|Part 2|Adverse Event|5|||
13273021|NCT01380184|26432605|FG000|Part 2|Disease Progression|8|||
13273022|NCT01380184|26432605|FG000|Part 2|Lost to Follow-up|1|||
13273023|NCT01380145|26432615|FG000|Overall Study|Progressive disease|4|||
13290802|NCT02034123|26482216|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
13290803|NCT02034123|26482217|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
13290804|NCT02034123|26482218|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
13290805|NCT02034123|26482219|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1|||
13290806|NCT02034123|26482220|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
13290807|NCT02034123|26482221|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
13290808|NCT02034123|26482222|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
13290809|NCT02034123|26482223|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
13290810|NCT02034123|26482224|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
13290811|NCT02034123|26482225|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
13290812|NCT02034123|26482226|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
13290813|NCT02034123|26482227|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
13290814|NCT02034123|26482228|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
13290815|NCT02034123|26482229|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
13290816|NCT02034123|26482230|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
13290817|NCT02034123|26482231|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
13290818|NCT02034123|26482232|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
13290819|NCT02034123|26482233|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
13290820|NCT02034123|26482216|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
13290821|NCT02034123|26482217|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
13290822|NCT02034123|26482218|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
13290823|NCT02034123|26482219|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
13290824|NCT02034123|26482220|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
13290825|NCT02034123|26482221|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
13290826|NCT02034123|26482222|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
13290827|NCT02034123|26482223|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
13290828|NCT02034123|26482224|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1|||
13290829|NCT02034123|26482225|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
13290830|NCT02034123|26482226|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
13290831|NCT02034123|26482227|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
13290832|NCT02034123|26482228|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
13290833|NCT02034123|26482229|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
13290834|NCT02034123|26482230|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
13290835|NCT02034123|26482231|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
13290836|NCT02034123|26482232|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
13290837|NCT02034123|26482233|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
13290838|NCT02034123|26482216|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
13290839|NCT02034123|26482217|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
13290840|NCT02034123|26482218|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
13290841|NCT02034123|26482219|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
13273024|NCT00219349|26432628|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6|||
13273025|NCT00219349|26432628|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2|||
13273026|NCT00219349|26432628|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2|||
13273027|NCT00219349|26432628|FG000|Escitalopram Phase|Withdrawal by Subject|3|||
13273028|NCT00219284|26432657|FG000|Treatment Phase - 16 Weeks|Adverse Event|26|||
13273029|NCT00219284|26432658|FG001|Treatment Phase - 16 Weeks|Adverse Event|24|||
13273030|NCT00219284|26432657|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0|||
13273031|NCT00219284|26432658|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1|||
13273032|NCT00219284|26432657|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3|||
13273033|NCT00219284|26432658|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10|||
13273034|NCT00219284|26432657|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9|||
13273035|NCT00219284|26432658|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5|||
13273036|NCT00219284|26432657|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5|||
13273037|NCT00219284|26432658|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9|||
13273038|NCT00219284|26432657|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1|||
13273039|NCT00219284|26432658|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2|||
13273040|NCT00219284|26432657|FG000|Extension Phase - 8 Weeks|Adverse Event|2|||
13273041|NCT00219284|26432658|FG001|Extension Phase - 8 Weeks|Adverse Event|3|||
13273042|NCT00219284|26432657|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0|||
13273043|NCT00219284|26432658|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2|||
13273044|NCT00219284|26432657|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0|||
13118315|NCT03040024|25928984|FG001|Overall Study|Death|1|||
13118316|NCT03040024|25928985|FG002|Overall Study|Death|0|||
13118317|NCT03040024|25928983|FG000|Overall Study|Physician Decision|0|||
13118318|NCT03040024|25928984|FG001|Overall Study|Physician Decision|0|||
13118319|NCT03040024|25928985|FG002|Overall Study|Physician Decision|1|||
13118320|NCT03039790|25929148|FG000|Overall Study|Lost to Follow-up|2|||
13118321|NCT03039790|25929149|FG001|Overall Study|Lost to Follow-up|0|||
13118322|NCT03039790|25929150|FG002|Overall Study|Lost to Follow-up|1|||
13118323|NCT03039790|25929151|FG003|Overall Study|Lost to Follow-up|1|||
13118324|NCT03039790|25929152|FG004|Overall Study|Lost to Follow-up|0|||
13118325|NCT03039790|25929153|FG005|Overall Study|Lost to Follow-up|1|||
13118326|NCT03039790|25929154|FG006|Overall Study|Lost to Follow-up|1|||
13118327|NCT03039790|25929155|FG007|Overall Study|Lost to Follow-up|1|||
13118328|NCT03039790|25929156|FG008|Overall Study|Lost to Follow-up|0|||
13118329|NCT03039790|25929157|FG009|Overall Study|Lost to Follow-up|1|||
13118330|NCT03039790|25929158|FG010|Overall Study|Lost to Follow-up|1|||
13118331|NCT03039790|25929159|FG011|Overall Study|Lost to Follow-up|0|||
13118332|NCT03039790|25929160|FG012|Overall Study|Lost to Follow-up|1|||
13118333|NCT03039790|25929161|FG013|Overall Study|Lost to Follow-up|0|||
13118334|NCT03039790|25929162|FG014|Overall Study|Lost to Follow-up|3|||
13118335|NCT03039790|25929163|FG015|Overall Study|Lost to Follow-up|1|||
13118336|NCT03039790|25929164|FG016|Overall Study|Lost to Follow-up|2|||
13118337|NCT03039790|25929165|FG017|Overall Study|Lost to Follow-up|2|||
13118338|NCT03039790|25929166|FG018|Overall Study|Lost to Follow-up|1|||
13118339|NCT03039790|25929167|FG019|Overall Study|Lost to Follow-up|3|||
13118340|NCT03039790|25929148|FG000|Overall Study|Withdrawal of Consent|1|||
13118341|NCT03039790|25929149|FG001|Overall Study|Withdrawal of Consent|0|||
13118342|NCT03039790|25929150|FG002|Overall Study|Withdrawal of Consent|0|||
13118343|NCT03039790|25929151|FG003|Overall Study|Withdrawal of Consent|1|||
13273045|NCT00219284|26432658|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2|||
13273046|NCT00218634|26432685|FG000|Overall Study|Lost to Follow-up|8|||
13273047|NCT00218634|26432686|FG001|Overall Study|Lost to Follow-up|15|||
13273048|NCT00218543|26432693|FG000|Overall Study|Lost to Follow-up|8|||
13273049|NCT00218543|26432693|FG000|Overall Study|relocated|1|||
13273050|NCT00218543|26432693|FG000|Overall Study|Withdrawal by Subject|1|||
13273051|NCT00218543|26432693|FG000|Overall Study|Physician Decision|3|||
13118344|NCT03039790|25929152|FG004|Overall Study|Withdrawal of Consent|0|||
13118345|NCT03039790|25929153|FG005|Overall Study|Withdrawal of Consent|0|||
13118346|NCT03039790|25929154|FG006|Overall Study|Withdrawal of Consent|0|||
13118347|NCT03039790|25929155|FG007|Overall Study|Withdrawal of Consent|0|||
13118348|NCT03039790|25929156|FG008|Overall Study|Withdrawal of Consent|0|||
13118349|NCT03039790|25929157|FG009|Overall Study|Withdrawal of Consent|1|||
13118350|NCT03039790|25929158|FG010|Overall Study|Withdrawal of Consent|0|||
13273052|NCT00218543|26432693|FG000|Overall Study|Adverse Event|2|||
13273053|NCT00218296|26432716|FG000|Overall Study|Lost to Follow-up|9|||
13273054|NCT00218296|26432717|FG001|Overall Study|Lost to Follow-up|7|||
13118351|NCT03039790|25929159|FG011|Overall Study|Withdrawal of Consent|0|||
13273055|NCT00218296|26432716|FG000|Overall Study|Withdrawal by Subject|36|||
13273056|NCT00218296|26432717|FG001|Overall Study|Withdrawal by Subject|47|||
13273057|NCT00218296|26432716|FG000|Overall Study|Randomized but did not enter treatment|66|||
13273058|NCT00218296|26432717|FG001|Overall Study|Randomized but did not enter treatment|67|||
13273059|NCT00218257|26432734|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4|||
13273060|NCT00218257|26432735|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3|||
13273061|NCT00217971|26432748|FG000|Overall Study|Adverse Event|1|||
13273062|NCT00217971|26432749|FG001|Overall Study|Adverse Event|1|||
13273063|NCT00217971|26432748|FG000|Overall Study|Lost to Follow-up|15|||
13273064|NCT00217971|26432749|FG001|Overall Study|Lost to Follow-up|19|||
13273065|NCT00217971|26432748|FG000|Overall Study|Physician Decision|0|||
13273066|NCT00217971|26432749|FG001|Overall Study|Physician Decision|1|||
13273067|NCT00217971|26432748|FG000|Overall Study|Withdrawal by Subject|7|||
13273068|NCT00217971|26432749|FG001|Overall Study|Withdrawal by Subject|12|||
13273069|NCT00217971|26432748|FG000|Overall Study|non compliant|1|||
13273070|NCT00217971|26432749|FG001|Overall Study|non compliant|0|||
13273071|NCT00217672|26432758|FG000|Allocation|Ineligible|2|||
13273072|NCT00217672|26432759|FG001|Allocation|Ineligible|0|||
13273073|NCT00217672|26432758|FG000|Treatment|disease progression|33|||
13273074|NCT00217672|26432759|FG001|Treatment|disease progression|4|||
13273075|NCT00217672|26432758|FG000|Treatment|Adverse Event|18|||
13273076|NCT00217672|26432759|FG001|Treatment|Adverse Event|2|||
13273077|NCT00217672|26432758|FG000|Treatment|reqd treatment not permitted by protocol|6|||
13273078|NCT00217672|26432759|FG001|Treatment|reqd treatment not permitted by protocol|0|||
13273079|NCT00217672|26432758|FG000|Treatment|Physician Decision|6|||
13273080|NCT00217672|26432759|FG001|Treatment|Physician Decision|0|||
13273081|NCT00217672|26432758|FG000|Treatment|insurance issues|1|||
13273082|NCT00217672|26432759|FG001|Treatment|insurance issues|1|||
13273083|NCT00217672|26432758|FG000|Treatment|Death|2|||
13273084|NCT00217672|26432759|FG001|Treatment|Death|0|||
13273085|NCT00217672|26432758|FG000|Treatment|secondary malignancy|1|||
13273086|NCT00217672|26432759|FG001|Treatment|secondary malignancy|0|||
13273087|NCT00217672|26432758|FG000|Follow-up|Withdrawal by Subject|4|||
13273088|NCT00217672|26432759|FG001|Follow-up|Withdrawal by Subject|0|||
13273089|NCT00217672|26432758|FG000|Follow-up|Lost to Follow-up|1|||
13273090|NCT00217672|26432759|FG001|Follow-up|Lost to Follow-up|0|||
13273091|NCT00217620|26432772|FG000|Overall Study|Adverse Event|2|||
13273092|NCT00217620|26432772|FG000|Overall Study|Progression|31|||
13273093|NCT00217620|26432772|FG000|Overall Study|Not Protocol Specified|4|||
13273094|NCT00217620|26432772|FG000|Overall Study|Ineligible|13|||
13273095|NCT00217620|26432772|FG000|Overall Study|Never received treatment|1|||
13273096|NCT00217581|26432782|FG000|Overall Study|Withdrawal by Subject|1|||
13273097|NCT00217464|26432789|FG000|Overall Study|Progression|15|||
13273098|NCT00217464|26432789|FG000|Overall Study|Other|2|||
13273099|NCT00217425|26432797|FG000|Overall Study|Never started treatment|2|||
13273100|NCT00217425|26432797|FG000|Overall Study|Patient ineligible|5|||
13273101|NCT00217425|26432797|FG000|Overall Study|Lack of Efficacy|13|||
13273102|NCT00217425|26432797|FG000|Overall Study|Adverse Event|8|||
13273103|NCT00217425|26432797|FG000|Overall Study|Withdrawal by Subject|4|||
13273104|NCT00217425|26432797|FG000|Overall Study|Other complicating disease|1|||
13273105|NCT00217425|26432797|FG000|Overall Study|Other|4|||
13273106|NCT00217087|26432816|FG000|Overall Study|decided to have esophagectomy|1|||
13273107|NCT00217087|26432817|FG001|Overall Study|decided to have esophagectomy|2|||
13273108|NCT00217087|26432816|FG000|Overall Study|completed less than 12 months return|10|||
13273109|NCT00217087|26432817|FG001|Overall Study|completed less than 12 months return|18|||
13273110|NCT00216736|26432836|FG000|Overall Study|Lost to Follow-up|1|||
13273111|NCT00216736|26432837|FG001|Overall Study|Lost to Follow-up|1|||
13118352|NCT03039790|25929160|FG012|Overall Study|Withdrawal of Consent|2|||
13118353|NCT03039790|25929161|FG013|Overall Study|Withdrawal of Consent|0|||
13273112|NCT00216671|26432860|FG000|Overall Study|Adverse Event|4|||
13273113|NCT00216671|26432861|FG001|Overall Study|Adverse Event|9|||
13273114|NCT00216671|26432860|FG000|Overall Study|Pregnancy|0|||
13273115|NCT00216671|26432861|FG001|Overall Study|Pregnancy|1|||
13273116|NCT00216671|26432860|FG000|Overall Study|Withdrawal by Subject|4|||
13273117|NCT00216671|26432861|FG001|Overall Study|Withdrawal by Subject|2|||
13273118|NCT00216671|26432860|FG000|Overall Study|Refused Injections|3|||
13273119|NCT00216671|26432861|FG001|Overall Study|Refused Injections|13|||
13273120|NCT00216671|26432860|FG000|Overall Study|No Need to Continue Medication|1|||
13273121|NCT00216671|26432861|FG001|Overall Study|No Need to Continue Medication|1|||
13273122|NCT00216671|26432860|FG000|Overall Study|Insufficient Response|9|||
13273123|NCT00216671|26432861|FG001|Overall Study|Insufficient Response|4|||
13273124|NCT00216671|26432860|FG000|Overall Study|Lost to Follow-up|3|||
13273125|NCT00216671|26432861|FG001|Overall Study|Lost to Follow-up|5|||
13273126|NCT00216671|26432860|FG000|Overall Study|Non compliant|2|||
13273127|NCT00216671|26432861|FG001|Overall Study|Non compliant|2|||
13273128|NCT00216671|26432860|FG000|Overall Study|Ineligible|0|||
13273129|NCT00216671|26432861|FG001|Overall Study|Ineligible|2|||
13273130|NCT00216671|26432860|FG000|Overall Study|Physician Decision|1|||
13273131|NCT00216671|26432861|FG001|Overall Study|Physician Decision|1|||
13273132|NCT00216671|26432860|FG000|Overall Study|Protocol Violation|3|||
13273133|NCT00216671|26432861|FG001|Overall Study|Protocol Violation|5|||
13273134|NCT00216671|26432860|FG000|Overall Study|Relapse|1|||
13273135|NCT00216671|26432861|FG001|Overall Study|Relapse|0|||
13273136|NCT00216671|26432860|FG000|Overall Study|Investigator Illness|0|||
13273137|NCT00216671|26432861|FG001|Overall Study|Investigator Illness|1|||
13273138|NCT00216671|26432860|FG000|Overall Study|Patient Moved|0|||
13273139|NCT00216671|26432861|FG001|Overall Study|Patient Moved|1|||
13273140|NCT00216671|26432860|FG000|Overall Study|Ineligible, no efficacy data|2|||
13273141|NCT00216671|26432861|FG001|Overall Study|Ineligible, no efficacy data|2|||
13273142|NCT00216671|26432860|FG000|Overall Study|Insufficient Response Adverse Event|2|||
13273143|NCT00216671|26432861|FG001|Overall Study|Insufficient Response Adverse Event|1|||
13273144|NCT00216476|26432886|FG000|Overall Study|Withdrawal by Subject|59|||
13273145|NCT00216476|26432887|FG001|Overall Study|Withdrawal by Subject|72|||
13273146|NCT00216476|26432888|FG002|Overall Study|Withdrawal by Subject|9|||
13273147|NCT00216476|26432886|FG000|Overall Study|Lost to Follow-up|10|||
13273148|NCT00216476|26432887|FG001|Overall Study|Lost to Follow-up|9|||
13273149|NCT00216476|26432888|FG002|Overall Study|Lost to Follow-up|1|||
13273150|NCT00216476|26432886|FG000|Overall Study|Adverse Event|6|||
13273151|NCT00216476|26432887|FG001|Overall Study|Adverse Event|10|||
13273152|NCT00216476|26432888|FG002|Overall Study|Adverse Event|1|||
13273153|NCT00216476|26432886|FG000|Overall Study|Lack of Efficacy|4|||
13273154|NCT00216476|26432887|FG001|Overall Study|Lack of Efficacy|3|||
13273155|NCT00216476|26432888|FG002|Overall Study|Lack of Efficacy|0|||
13273156|NCT00216476|26432886|FG000|Overall Study|Death|2|||
13273157|NCT00216476|26432887|FG001|Overall Study|Death|0|||
13273158|NCT00216476|26432888|FG002|Overall Study|Death|0|||
13273159|NCT00216476|26432886|FG000|Overall Study|Pregnancy|0|||
13273160|NCT00216476|26432887|FG001|Overall Study|Pregnancy|1|||
13273161|NCT00216476|26432888|FG002|Overall Study|Pregnancy|1|||
13273162|NCT00216476|26432886|FG000|Overall Study|Other|0|||
13273163|NCT00216476|26432887|FG001|Overall Study|Other|0|||
13273164|NCT00216476|26432888|FG002|Overall Study|Other|1|||
13273165|NCT00216476|26432886|FG000|Overall Study|Refuses Injection|11|||
13273166|NCT00216476|26432887|FG001|Overall Study|Refuses Injection|0|||
13273167|NCT00216476|26432888|FG002|Overall Study|Refuses Injection|0|||
13273168|NCT00216476|26432886|FG000|Overall Study|No Further Need for Treatment|3|||
13273169|NCT00216476|26432887|FG001|Overall Study|No Further Need for Treatment|4|||
13273170|NCT00216476|26432888|FG002|Overall Study|No Further Need for Treatment|1|||
13273171|NCT00216476|26432886|FG000|Overall Study|Non-compliance|0|||
13273172|NCT00216476|26432887|FG001|Overall Study|Non-compliance|4|||
13273173|NCT00216476|26432888|FG002|Overall Study|Non-compliance|1|||
13273174|NCT00216476|26432886|FG000|Overall Study|Higher dose/Extra Medication Required|2|||
13273175|NCT00216476|26432887|FG001|Overall Study|Higher dose/Extra Medication Required|0|||
13273176|NCT00216476|26432888|FG002|Overall Study|Higher dose/Extra Medication Required|2|||
13273177|NCT00216476|26432886|FG000|Overall Study|Administrative Reasons|1|||
13273178|NCT00216476|26432887|FG001|Overall Study|Administrative Reasons|1|||
13273179|NCT00216476|26432888|FG002|Overall Study|Administrative Reasons|0|||
13273180|NCT00216476|26432886|FG000|Overall Study|Protocol Deviation|5|||
13273181|NCT00216476|26432887|FG001|Overall Study|Protocol Deviation|1|||
13273182|NCT00216476|26432888|FG002|Overall Study|Protocol Deviation|0|||
13273183|NCT00216476|26432886|FG000|Overall Study|Patient Moved|2|||
13273184|NCT00216476|26432887|FG001|Overall Study|Patient Moved|2|||
13273185|NCT00216476|26432888|FG002|Overall Study|Patient Moved|0|||
13273186|NCT00216203|26432898|FG000|Overall Study|Withdrawal by Subject|2|||
13273187|NCT00216086|26432907|FG000|Overall Study|Protocol Violation|1|||
13273188|NCT00216086|26432907|FG000|Overall Study|Diagnosis of Metastatic Disease|1|||
13273189|NCT00216086|26432907|FG000|Overall Study|Social Reasons|2|||
13273190|NCT00215943|26432926|FG000|Overall Study|Disease Progression|3|||
13273191|NCT00215943|26432927|FG001|Overall Study|Disease Progression|5|||
13273192|NCT00215943|26432926|FG000|Overall Study|Alternate therapy|0|||
13273193|NCT00215943|26432927|FG001|Overall Study|Alternate therapy|1|||
13273194|NCT00215943|26432926|FG000|Overall Study|Adverse Event|3|||
13273195|NCT00215943|26432927|FG001|Overall Study|Adverse Event|6|||
13273196|NCT00215943|26432926|FG000|Overall Study|Other disease|0|||
13273197|NCT00215943|26432927|FG001|Overall Study|Other disease|1|||
13273198|NCT00215943|26432926|FG000|Overall Study|Other complications|3|||
13273199|NCT00215943|26432927|FG001|Overall Study|Other complications|1|||
13273200|NCT00215683|26432948|FG000|Overall Study|Adverse Event|15|||
13273201|NCT00215683|26432949|FG001|Overall Study|Adverse Event|16|||
13273202|NCT00215683|26432950|FG002|Overall Study|Adverse Event|15|||
13273203|NCT00215683|26432948|FG000|Overall Study|Lack of Efficacy|5|||
13273204|NCT00215683|26432949|FG001|Overall Study|Lack of Efficacy|1|||
13273205|NCT00215683|26432950|FG002|Overall Study|Lack of Efficacy|2|||
13273206|NCT00215683|26432948|FG000|Overall Study|Lost to Follow-up|0|||
13273207|NCT00215683|26432949|FG001|Overall Study|Lost to Follow-up|2|||
13273208|NCT00215683|26432950|FG002|Overall Study|Lost to Follow-up|1|||
13273209|NCT00215683|26432948|FG000|Overall Study|Withdrawal by Subject|9|||
13273210|NCT00215683|26432949|FG001|Overall Study|Withdrawal by Subject|4|||
13273211|NCT00215683|26432950|FG002|Overall Study|Withdrawal by Subject|13|||
13273212|NCT00215683|26432948|FG000|Overall Study|Physician Decision|0|||
13273213|NCT00215683|26432949|FG001|Overall Study|Physician Decision|0|||
13273214|NCT00215683|26432950|FG002|Overall Study|Physician Decision|1|||
13273215|NCT00215683|26432948|FG000|Overall Study|Difficult to attend visits|0|||
13273216|NCT00215683|26432949|FG001|Overall Study|Difficult to attend visits|1|||
13273217|NCT00215683|26432950|FG002|Overall Study|Difficult to attend visits|0|||
13273218|NCT00215683|26432948|FG000|Overall Study|No study drug available|0|||
13273219|NCT00215683|26432949|FG001|Overall Study|No study drug available|1|||
13273220|NCT00215683|26432950|FG002|Overall Study|No study drug available|0|||
13273221|NCT00215683|26432948|FG000|Overall Study|Intermittent therapy required|0|||
13273222|NCT00215683|26432949|FG001|Overall Study|Intermittent therapy required|1|||
13273223|NCT00215683|26432950|FG002|Overall Study|Intermittent therapy required|0|||
13273224|NCT00215657|26433001|FG000|Overall Study|Adverse Event|5|||
13273225|NCT00215657|26433002|FG001|Overall Study|Adverse Event|1|||
13273226|NCT00215657|26433003|FG002|Overall Study|Adverse Event|3|||
13273227|NCT00215657|26433004|FG003|Overall Study|Adverse Event|0|||
13273228|NCT00215657|26433005|FG004|Overall Study|Adverse Event|3|||
13273229|NCT00215657|26433006|FG005|Overall Study|Adverse Event|1|||
13273230|NCT00215657|26433007|FG006|Overall Study|Adverse Event|0|||
13273231|NCT00215657|26433008|FG007|Overall Study|Adverse Event|3|||
13273232|NCT00215657|26433001|FG000|Overall Study|Withdrawal by Subject|6|||
13273233|NCT00215657|26433002|FG001|Overall Study|Withdrawal by Subject|3|||
13273234|NCT00215657|26433003|FG002|Overall Study|Withdrawal by Subject|3|||
13273235|NCT00215657|26433004|FG003|Overall Study|Withdrawal by Subject|1|||
13273236|NCT00215657|26433005|FG004|Overall Study|Withdrawal by Subject|6|||
13273237|NCT00215657|26433006|FG005|Overall Study|Withdrawal by Subject|1|||
13273238|NCT00215657|26433007|FG006|Overall Study|Withdrawal by Subject|10|||
13273239|NCT00215657|26433008|FG007|Overall Study|Withdrawal by Subject|3|||
13273240|NCT00215657|26433001|FG000|Overall Study|Insuff prostate specific antigen resp|3|||
13273241|NCT00215657|26433002|FG001|Overall Study|Insuff prostate specific antigen resp|2|||
13273242|NCT00215657|26433003|FG002|Overall Study|Insuff prostate specific antigen resp|2|||
13273243|NCT00215657|26433004|FG003|Overall Study|Insuff prostate specific antigen resp|2|||
13273244|NCT00215657|26433005|FG004|Overall Study|Insuff prostate specific antigen resp|1|||
13273245|NCT00215657|26433006|FG005|Overall Study|Insuff prostate specific antigen resp|2|||
13273246|NCT00215657|26433007|FG006|Overall Study|Insuff prostate specific antigen resp|3|||
13273247|NCT00215657|26433008|FG007|Overall Study|Insuff prostate specific antigen resp|2|||
13273248|NCT00215657|26433001|FG000|Overall Study|Insufficient testosterone response|5|||
13273249|NCT00215657|26433002|FG001|Overall Study|Insufficient testosterone response|4|||
13273250|NCT00215657|26433003|FG002|Overall Study|Insufficient testosterone response|1|||
13273251|NCT00215657|26433004|FG003|Overall Study|Insufficient testosterone response|12|||
13273252|NCT00215657|26433005|FG004|Overall Study|Insufficient testosterone response|8|||
13273253|NCT00215657|26433006|FG005|Overall Study|Insufficient testosterone response|12|||
13273254|NCT00215657|26433007|FG006|Overall Study|Insufficient testosterone response|4|||
13273255|NCT00215657|26433008|FG007|Overall Study|Insufficient testosterone response|7|||
13273256|NCT00215657|26433001|FG000|Overall Study|Other|3|||
13273257|NCT00215657|26433002|FG001|Overall Study|Other|1|||
13273258|NCT00215657|26433003|FG002|Overall Study|Other|2|||
13273259|NCT00215657|26433004|FG003|Overall Study|Other|3|||
13273260|NCT00215657|26433005|FG004|Overall Study|Other|5|||
13273261|NCT00215657|26433006|FG005|Overall Study|Other|4|||
13273262|NCT00215657|26433007|FG006|Overall Study|Other|6|||
13273263|NCT00215657|26433008|FG007|Overall Study|Other|1|||
13273264|NCT00215644|26433035|FG000|Overall Study|Disease Progression|28|||
13273265|NCT00215644|26433036|FG001|Overall Study|Disease Progression|10|||
13273266|NCT00215644|26433035|FG000|Overall Study|Adverse Event|2|||
13273267|NCT00215644|26433036|FG001|Overall Study|Adverse Event|9|||
13273268|NCT00215644|26433035|FG000|Overall Study|Death|1|||
13273269|NCT00215644|26433036|FG001|Overall Study|Death|2|||
13273270|NCT00215644|26433035|FG000|Overall Study|Withdrawal by Subject|1|||
13273271|NCT00215644|26433036|FG001|Overall Study|Withdrawal by Subject|0|||
13273272|NCT00215644|26433035|FG000|Overall Study|Other|3|||
13273273|NCT00215644|26433036|FG001|Overall Study|Other|15|||
13273274|NCT00215644|26433035|FG000|Overall Study|Randomized but Not Treated|1|||
13273275|NCT00215644|26433036|FG001|Overall Study|Randomized but Not Treated|0|||
13273276|NCT00215553|26433088|FG000|Overall Study|Adverse Event|0|||
13273277|NCT00215553|26433089|FG001|Overall Study|Adverse Event|1|||
13273278|NCT00215553|26433090|FG002|Overall Study|Adverse Event|2|||
13273279|NCT00215553|26433091|FG003|Overall Study|Adverse Event|1|||
13273280|NCT00215553|26433092|FG004|Overall Study|Adverse Event|2|||
13273281|NCT00215553|26433093|FG005|Overall Study|Adverse Event|6|||
13273282|NCT00215553|26433094|FG006|Overall Study|Adverse Event|0|||
13273283|NCT00215150|26433104|FG000|Open Label Phase|Lost to Follow-up|7|||
13273284|NCT00215150|26433104|FG000|Open Label Phase|Withdrawal by Subject|1|||
13273285|NCT00215150|26433104|FG000|Open Label Phase|Did not complete a post base visit|13|||
13273286|NCT00215150|26433104|FG000|Open Label Phase|Did not meet randomization criteria|9|||
13273287|NCT00215150|26433104|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2|||
13273288|NCT00215150|26433104|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1|||
13273289|NCT00215150|26433104|FG000|Randomization Phase Placebo|Withdrawal by Subject|1|||
13273290|NCT00215137|26433116|FG000|Open Label Escitalopram|Lack of Efficacy|1|||
13273291|NCT00215137|26433117|FG001|Open Label Escitalopram|Lack of Efficacy|0|||
13118354|NCT03039790|25929162|FG014|Overall Study|Withdrawal of Consent|1|||
13118355|NCT03039790|25929163|FG015|Overall Study|Withdrawal of Consent|5|||
13118356|NCT03039790|25929164|FG016|Overall Study|Withdrawal of Consent|3|||
13273292|NCT00215137|26433118|FG002|Open Label Escitalopram|Lack of Efficacy|0|||
13118357|NCT03039790|25929165|FG017|Overall Study|Withdrawal of Consent|0|||
13118358|NCT03039790|25929166|FG018|Overall Study|Withdrawal of Consent|2|||
13118359|NCT03039790|25929167|FG019|Overall Study|Withdrawal of Consent|5|||
13118360|NCT03039790|25929148|FG000|Overall Study|Death|0|||
13118361|NCT03039790|25929149|FG001|Overall Study|Death|0|||
13118362|NCT03039790|25929150|FG002|Overall Study|Death|0|||
13118363|NCT03039790|25929151|FG003|Overall Study|Death|0|||
13118364|NCT03039790|25929152|FG004|Overall Study|Death|0|||
13118365|NCT03039790|25929153|FG005|Overall Study|Death|0|||
13118366|NCT03039790|25929154|FG006|Overall Study|Death|0|||
13118367|NCT03039790|25929155|FG007|Overall Study|Death|0|||
13118368|NCT03039790|25929156|FG008|Overall Study|Death|0|||
13118369|NCT03039790|25929157|FG009|Overall Study|Death|0|||
13118370|NCT03039790|25929158|FG010|Overall Study|Death|0|||
13118371|NCT03039790|25929159|FG011|Overall Study|Death|0|||
13118372|NCT03039790|25929160|FG012|Overall Study|Death|0|||
13118373|NCT03039790|25929161|FG013|Overall Study|Death|0|||
13273293|NCT00215137|26433116|FG000|Randomization Period|Lost to Follow-up|0|||
13273294|NCT00215137|26433117|FG001|Randomization Period|Lost to Follow-up|1|||
13273295|NCT00215137|26433118|FG002|Randomization Period|Lost to Follow-up|0|||
13273296|NCT00215137|26433116|FG000|Randomization Period|Withdrawal by Subject|0|||
13273297|NCT00215137|26433117|FG001|Randomization Period|Withdrawal by Subject|1|||
13273298|NCT00215137|26433118|FG002|Randomization Period|Withdrawal by Subject|0|||
13273299|NCT00214500|26433128|FG000|Treatment Period|Adverse Event|1|||
13273300|NCT00214500|26433128|FG000|Extension Period|Withdrawal by Subject|2|||
13273301|NCT00214461|26433155|FG000|Overall Study|Adverse Event|0|||
13273302|NCT00214461|26433156|FG001|Overall Study|Adverse Event|0|||
13273303|NCT00214461|26433157|FG002|Overall Study|Adverse Event|1|||
13273304|NCT00214461|26433158|FG003|Overall Study|Adverse Event|1|||
13273305|NCT00214461|26433155|FG000|Overall Study|Withdrawal by Subject|0|||
13273306|NCT00214461|26433156|FG001|Overall Study|Withdrawal by Subject|0|||
13273307|NCT00214461|26433157|FG002|Overall Study|Withdrawal by Subject|1|||
13273308|NCT00214461|26433158|FG003|Overall Study|Withdrawal by Subject|0|||
13273309|NCT00214383|26433175|FG000|Overall Study|Lost to Follow-up|16|||
13273310|NCT00214383|26433176|FG001|Overall Study|Lost to Follow-up|26|||
13273311|NCT00214201|26433193|FG000|Overall Study|Withdrawal by Subject|2|||
13273312|NCT00214201|26433194|FG001|Overall Study|Withdrawal by Subject|0|||
13273313|NCT00214201|26433193|FG000|Overall Study|Death|0|||
13273314|NCT00214201|26433194|FG001|Overall Study|Death|2|||
13273315|NCT00214136|26433201|FG000|Overall Study|Death|5|||
13273316|NCT00214019|26433210|FG000|Overall Study|Lost to Follow-up|11|||
13273317|NCT00214019|26433210|FG000|Overall Study|Withdrawal by Subject|2|||
13273318|NCT00214019|26433210|FG000|Overall Study|Screen Failed prior to randomization|17|||
13273319|NCT00213980|26433229|FG000|Overall Study|Withdrawal by Subject|3|||
13273320|NCT00213980|26433230|FG001|Overall Study|Withdrawal by Subject|1|||
13273321|NCT00213980|26433229|FG000|Overall Study|Adverse Event|1|||
13273322|NCT00213980|26433230|FG001|Overall Study|Adverse Event|1|||
13273323|NCT00213980|26433229|FG000|Overall Study|Disease progression|0|||
13273324|NCT00213980|26433230|FG001|Overall Study|Disease progression|2|||
13273325|NCT00213980|26433229|FG000|Overall Study|Developed ovarian cancer|1|||
13273326|NCT00213980|26433230|FG001|Overall Study|Developed ovarian cancer|0|||
13273327|NCT00213980|26433229|FG000|Overall Study|Failed to obtain all 3 DXAs|1|||
13273328|NCT00213980|26433230|FG001|Overall Study|Failed to obtain all 3 DXAs|3|||
13273329|NCT00213148|26433268|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1|||
13273330|NCT00213148|26433269|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0|||
13273331|NCT00213148|26433270|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2|||
13273332|NCT00213148|26433271|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2|||
13273333|NCT00213148|26433272|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1|||
13203637|NCT01984242|26225259|FG002|Overall Study|Withdrawal by Subject|10|||
13203638|NCT01984242|26225257|FG000|Overall Study|Physician Decision|0|||
13203639|NCT01984242|26225258|FG001|Overall Study|Physician Decision|0|||
13203640|NCT01984242|26225259|FG002|Overall Study|Physician Decision|1|||
13203641|NCT01984242|26225257|FG000|Overall Study|Lost to Follow-up|4|||
13203642|NCT01984242|26225258|FG001|Overall Study|Lost to Follow-up|0|||
13203643|NCT01984242|26225259|FG002|Overall Study|Lost to Follow-up|3|||
13203644|NCT01984242|26225257|FG000|Overall Study|Sponsor Decision|1|||
13203645|NCT01984242|26225258|FG001|Overall Study|Sponsor Decision|0|||
13203646|NCT01984242|26225259|FG002|Overall Study|Sponsor Decision|0|||
13203647|NCT01984242|26225257|FG000|Overall Study|Non-Compliance|1|||
13203648|NCT01984242|26225258|FG001|Overall Study|Non-Compliance|0|||
13203649|NCT01984242|26225259|FG002|Overall Study|Non-Compliance|0|||
13203650|NCT01984242|26225257|FG000|Overall Study|Study terminated by Sponsor|38|||
13203651|NCT01984242|26225258|FG001|Overall Study|Study terminated by Sponsor|50|||
13203652|NCT01984242|26225259|FG002|Overall Study|Study terminated by Sponsor|34|||
13203653|NCT01984242|26225257|FG000|Overall Study|Disease Progression|0|||
13203654|NCT01984242|26225258|FG001|Overall Study|Disease Progression|0|||
13203655|NCT01984242|26225259|FG002|Overall Study|Disease Progression|1|||
13203656|NCT01984229|26225316|FG000|Safety Follow-up Period|Adverse Event|1|||
13118374|NCT03039790|25929162|FG014|Overall Study|Death|0|||
13273334|NCT00213148|26433268|FG000|Cycle 1 (1 Month)|Adverse Event|0|||
13203657|NCT01984229|26225317|FG001|Safety Follow-up Period|Adverse Event|1|||
13273335|NCT00213148|26433269|FG001|Cycle 1 (1 Month)|Adverse Event|0|||
13273336|NCT00213148|26433270|FG002|Cycle 1 (1 Month)|Adverse Event|1|||
13273337|NCT00213148|26433271|FG003|Cycle 1 (1 Month)|Adverse Event|0|||
13273338|NCT00213148|26433272|FG004|Cycle 1 (1 Month)|Adverse Event|0|||
13273339|NCT00213148|26433268|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4|||
13273340|NCT00213148|26433269|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0|||
13273341|NCT00213148|26433270|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8|||
13273342|NCT00213148|26433271|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5|||
13118375|NCT03039790|25929163|FG015|Overall Study|Death|1|||
13118376|NCT03039790|25929164|FG016|Overall Study|Death|3|||
13118377|NCT03039790|25929165|FG017|Overall Study|Death|0|||
13118378|NCT03039790|25929166|FG018|Overall Study|Death|2|||
13118379|NCT03039790|25929167|FG019|Overall Study|Death|0|||
13118380|NCT03039790|25929148|FG000|Overall Study|Reason, not Specified|1|||
13118381|NCT03039790|25929149|FG001|Overall Study|Reason, not Specified|0|||
13118382|NCT03039790|25929150|FG002|Overall Study|Reason, not Specified|0|||
13118383|NCT03039790|25929151|FG003|Overall Study|Reason, not Specified|0|||
13118384|NCT03039790|25929152|FG004|Overall Study|Reason, not Specified|0|||
13118385|NCT03039790|25929153|FG005|Overall Study|Reason, not Specified|0|||
13118386|NCT03039790|25929154|FG006|Overall Study|Reason, not Specified|0|||
13118387|NCT03039790|25929155|FG007|Overall Study|Reason, not Specified|0|||
13118388|NCT03039790|25929156|FG008|Overall Study|Reason, not Specified|0|||
13118389|NCT03039790|25929157|FG009|Overall Study|Reason, not Specified|0|||
13273343|NCT00213148|26433272|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8|||
13273344|NCT00213148|26433268|FG000|Cycle 1 (1 Month)|Protocol Violation|1|||
13273345|NCT00213148|26433269|FG001|Cycle 1 (1 Month)|Protocol Violation|0|||
13273346|NCT00213148|26433270|FG002|Cycle 1 (1 Month)|Protocol Violation|1|||
13273347|NCT00213148|26433271|FG003|Cycle 1 (1 Month)|Protocol Violation|0|||
13273348|NCT00213148|26433272|FG004|Cycle 1 (1 Month)|Protocol Violation|0|||
13118390|NCT03039790|25929158|FG010|Overall Study|Reason, not Specified|0|||
13118391|NCT03039790|25929159|FG011|Overall Study|Reason, not Specified|0|||
13118392|NCT03039790|25929160|FG012|Overall Study|Reason, not Specified|0|||
13118393|NCT03039790|25929161|FG013|Overall Study|Reason, not Specified|0|||
13118394|NCT03039790|25929162|FG014|Overall Study|Reason, not Specified|0|||
13118395|NCT03039790|25929163|FG015|Overall Study|Reason, not Specified|0|||
13118396|NCT03039790|25929164|FG016|Overall Study|Reason, not Specified|2|||
13203658|NCT01984229|26225316|FG000|Safety Follow-up Period|Lost to Follow-up|1|||
13203659|NCT01984229|26225317|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
13203660|NCT01984164|26225344|FG000|Overall Study|Withdrawal by Subject|4|||
13203661|NCT01984164|26225345|FG001|Overall Study|Withdrawal by Subject|3|||
13203662|NCT01984164|26225344|FG000|Overall Study|Adverse Event|5|||
13203663|NCT01984164|26225345|FG001|Overall Study|Adverse Event|19|||
13203664|NCT01984164|26225344|FG000|Overall Study|Lost to Follow-up|1|||
13203665|NCT01984164|26225345|FG001|Overall Study|Lost to Follow-up|3|||
13203666|NCT01983969|26225367|FG000|Overall Study|Disease Progression|0|||
13203667|NCT01983969|26225368|FG001|Overall Study|Disease Progression|1|||
13203668|NCT01983969|26225369|FG002|Overall Study|Disease Progression|0|||
13203669|NCT01983930|26225388|FG000|Overall Study|Withdrawal by Subject|9|||
13203670|NCT01983930|26225389|FG001|Overall Study|Withdrawal by Subject|8|||
13203671|NCT01983930|26225388|FG000|Overall Study|Adverse Event|0|||
13203672|NCT01983930|26225389|FG001|Overall Study|Adverse Event|1|||
13203673|NCT01983774|26225408|FG000|Overall Study|Lung Transplant|0|||
13203674|NCT01983774|26225409|FG001|Overall Study|Lung Transplant|1|||
13203675|NCT01983774|26225408|FG000|Overall Study|Lost to Follow-up|1|||
13203676|NCT01983774|26225409|FG001|Overall Study|Lost to Follow-up|0|||
13203677|NCT01983683|26225440|FG000|Overall Study|Withdrawal by Subject|14|||
13203678|NCT01983683|26225441|FG001|Overall Study|Withdrawal by Subject|18|||
13203679|NCT01983683|26225440|FG000|Overall Study|Death|11|||
13203680|NCT01983683|26225441|FG001|Overall Study|Death|15|||
13203681|NCT01983683|26225440|FG000|Overall Study|Physician Decision|8|||
13203682|NCT01983683|26225441|FG001|Overall Study|Physician Decision|9|||
13203683|NCT01983683|26225440|FG000|Overall Study|Lost to Follow-up|4|||
13203684|NCT01983683|26225441|FG001|Overall Study|Lost to Follow-up|8|||
13203685|NCT01983683|26225440|FG000|Overall Study|Sponsor Decision|1|||
13203686|NCT01983683|26225441|FG001|Overall Study|Sponsor Decision|1|||
13203687|NCT01983293|26225454|FG000|Overall Study|Withdrawal by Subject|29|||
13203688|NCT01983293|26225455|FG001|Overall Study|Withdrawal by Subject|15|||
13203689|NCT01983293|26225454|FG000|Overall Study|Missing 12-month visit|3|||
13203690|NCT01983293|26225455|FG001|Overall Study|Missing 12-month visit|3|||
13203691|NCT01983293|26225454|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1|||
13203692|NCT01983293|26225455|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1|||
13203693|NCT01983254|26225472|FG000|Overall Study|Death|6|||
13203694|NCT01983254|26225473|FG001|Overall Study|Death|6|||
13203695|NCT01983254|26225472|FG000|Overall Study|Lost to Follow-up|17|||
13203696|NCT01983254|26225473|FG001|Overall Study|Lost to Follow-up|16|||
13203697|NCT01983254|26225472|FG000|Overall Study|too ill|11|||
13273349|NCT00213148|26433268|FG000|Cycle 1 (1 Month)|Other|3|||
13273350|NCT00213148|26433269|FG001|Cycle 1 (1 Month)|Other|0|||
13273351|NCT00213148|26433270|FG002|Cycle 1 (1 Month)|Other|2|||
13273352|NCT00213148|26433271|FG003|Cycle 1 (1 Month)|Other|2|||
13273353|NCT00213148|26433272|FG004|Cycle 1 (1 Month)|Other|7|||
13273354|NCT00213148|26433268|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
13273355|NCT00213148|26433269|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
13273356|NCT00213148|26433270|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
13273357|NCT00213148|26433271|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1|||
13273358|NCT00213148|26433272|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
13273359|NCT00213148|26433268|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
13273360|NCT00213148|26433269|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
13273361|NCT00213148|26433270|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
13273362|NCT00213148|26433271|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
13273363|NCT00213148|26433272|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1|||
13273364|NCT00213148|26433268|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15|||
13273365|NCT00213148|26433269|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0|||
13273366|NCT00213148|26433270|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
13273367|NCT00213148|26433271|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8|||
13273368|NCT00213148|26433272|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
13273369|NCT00213148|26433268|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0|||
13273370|NCT00213148|26433269|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0|||
13273371|NCT00213148|26433270|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2|||
13273372|NCT00213148|26433271|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2|||
13273373|NCT00213148|26433272|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1|||
13273374|NCT00213148|26433268|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1|||
13273375|NCT00213148|26433269|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3|||
13273376|NCT00213148|26433270|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7|||
13273377|NCT00213148|26433271|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6|||
13273378|NCT00213148|26433272|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16|||
13273379|NCT00213148|26433268|FG000|Cycle 2 (1 Month)|Other|2|||
13273380|NCT00213148|26433269|FG001|Cycle 2 (1 Month)|Other|1|||
13273381|NCT00213148|26433270|FG002|Cycle 2 (1 Month)|Other|2|||
13273382|NCT00213148|26433271|FG003|Cycle 2 (1 Month)|Other|8|||
13273383|NCT00213148|26433272|FG004|Cycle 2 (1 Month)|Other|7|||
13273384|NCT00213148|26433268|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
13273385|NCT00213148|26433269|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1|||
13273386|NCT00213148|26433270|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
13273387|NCT00213148|26433271|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
13273388|NCT00213148|26433272|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
13273389|NCT00213148|26433268|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1|||
13273390|NCT00213148|26433269|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
13273391|NCT00213148|26433270|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
13273392|NCT00213148|26433271|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
13273393|NCT00213148|26433272|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
13273394|NCT00213148|26433268|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10|||
13273395|NCT00213148|26433269|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1|||
13273396|NCT00213148|26433270|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
13273397|NCT00213148|26433271|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
13273398|NCT00213148|26433272|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6|||
13273399|NCT00213148|26433268|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0|||
13273400|NCT00213148|26433269|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2|||
13273401|NCT00213148|26433270|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0|||
13273402|NCT00213148|26433271|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0|||
13273403|NCT00213148|26433272|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1|||
13273404|NCT00213148|26433268|FG000|Cycle 3 (1 Month)|Other|0|||
13273405|NCT00213148|26433269|FG001|Cycle 3 (1 Month)|Other|0|||
13273406|NCT00213148|26433270|FG002|Cycle 3 (1 Month)|Other|1|||
13273407|NCT00213148|26433271|FG003|Cycle 3 (1 Month)|Other|1|||
13273408|NCT00213148|26433272|FG004|Cycle 3 (1 Month)|Other|0|||
13273409|NCT00212758|26433281|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1|||
13273410|NCT00212758|26433282|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0|||
13273411|NCT00212758|26433281|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
13273412|NCT00212758|26433282|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
13273413|NCT00212355|26433288|FG000|Overall Study|Adverse Event|1|||
13273414|NCT00212355|26433288|FG000|Overall Study|Withdrawal by Subject|1|||
13273415|NCT00212355|26433288|FG000|Overall Study|A change of address|1|||
13273416|NCT00211887|26433315|FG000|Overall Study|Adverse Event|8|||
13273417|NCT00211887|26433316|FG001|Overall Study|Adverse Event|4|||
13273418|NCT00211887|26433317|FG002|Overall Study|Adverse Event|6|||
13273419|NCT00211887|26433315|FG000|Overall Study|Death|1|||
13273420|NCT00211887|26433316|FG001|Overall Study|Death|1|||
13273421|NCT00211887|26433317|FG002|Overall Study|Death|1|||
13273422|NCT00211887|26433315|FG000|Overall Study|Lost to Follow-up|28|||
13273423|NCT00211887|26433316|FG001|Overall Study|Lost to Follow-up|13|||
13273424|NCT00211887|26433317|FG002|Overall Study|Lost to Follow-up|9|||
13273425|NCT00211887|26433315|FG000|Overall Study|Non-medical reason|31|||
13273426|NCT00211887|26433316|FG001|Overall Study|Non-medical reason|14|||
13273427|NCT00211887|26433317|FG002|Overall Study|Non-medical reason|8|||
13273428|NCT00211887|26433315|FG000|Overall Study|Other medical reason|15|||
13273429|NCT00211887|26433316|FG001|Overall Study|Other medical reason|11|||
13273430|NCT00211887|26433317|FG002|Overall Study|Other medical reason|7|||
13273431|NCT00211887|26433315|FG000|Overall Study|Side effects|19|||
13273432|NCT00211887|26433316|FG001|Overall Study|Side effects|13|||
13273433|NCT00211887|26433317|FG002|Overall Study|Side effects|5|||
13273434|NCT00211757|26433332|FG000|Overall Study|Withdrawal by Subject|1|||
13273435|NCT00211757|26433333|FG001|Overall Study|Withdrawal by Subject|1|||
13273436|NCT00211757|26433332|FG000|Overall Study|Lack of Efficacy|0|||
13273437|NCT00211757|26433333|FG001|Overall Study|Lack of Efficacy|1|||
13273438|NCT00211536|26433354|FG000|Overall Study|Withdrawal by Subject|2|||
13273439|NCT00211536|26433355|FG001|Overall Study|Withdrawal by Subject|2|||
13273440|NCT00211536|26433354|FG000|Overall Study|Physician Decision|0|||
13273441|NCT00211536|26433355|FG001|Overall Study|Physician Decision|5|||
13273442|NCT00211536|26433354|FG000|Overall Study|Adverse Event|2|||
13273443|NCT00211536|26433355|FG001|Overall Study|Adverse Event|0|||
13273444|NCT00211510|26433378|FG000|Overall Study|Physician Decision|3|||
13273445|NCT00211510|26433379|FG001|Overall Study|Physician Decision|1|||
13273446|NCT00211510|26433378|FG000|Overall Study|Withdrawal by Subject|3|||
13273447|NCT00211510|26433379|FG001|Overall Study|Withdrawal by Subject|1|||
13118397|NCT03039790|25929165|FG017|Overall Study|Reason, not Specified|0|||
13118398|NCT03039790|25929166|FG018|Overall Study|Reason, not Specified|1|||
13118399|NCT03039790|25929167|FG019|Overall Study|Reason, not Specified|0|||
13118400|NCT03039738|25929194|FG000|Overall Study|Incomplete data sets|54|||
13118401|NCT03039738|25929195|FG001|Overall Study|Incomplete data sets|0|||
13118402|NCT03039699|25929222|FG000|Overall Study|Incorrect inclusion|5|||
13118403|NCT03039699|25929223|FG001|Overall Study|Incorrect inclusion|4|||
13118404|NCT03039699|25929222|FG000|Overall Study|Lack of data to assess study endpoint|5|||
13118405|NCT03039699|25929223|FG001|Overall Study|Lack of data to assess study endpoint|3|||
13118406|NCT03039699|25929222|FG000|Overall Study|Bacterial infection|12|||
13118407|NCT03039699|25929223|FG001|Overall Study|Bacterial infection|28|||
13118408|NCT03039686|25929297|FG000|Double-blind Period|Administrative Reason by Sponsor|24|||
13118409|NCT03039686|25929298|FG001|Double-blind Period|Administrative Reason by Sponsor|25|||
13118410|NCT03039686|25929299|FG002|Double-blind Period|Administrative Reason by Sponsor|21|||
13118411|NCT03039686|25929297|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1|||
13118412|NCT03039686|25929298|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2|||
13118413|NCT03039686|25929299|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0|||
13118414|NCT03039686|25929297|FG000|Double-blind Period|Withdrawal by Subject|2|||
13118415|NCT03039686|25929298|FG001|Double-blind Period|Withdrawal by Subject|2|||
13118416|NCT03039686|25929299|FG002|Double-blind Period|Withdrawal by Subject|1|||
13118417|NCT03039686|25929297|FG000|Double-blind Period|Death|0|||
13273448|NCT00211185|26433393|FG000|Overall Study|Death|2|||
13273449|NCT00211185|26433393|FG000|Overall Study|Disease progression|7|||
13273450|NCT00211185|26433393|FG000|Overall Study|Withdrawal by Subject|6|||
13273451|NCT00211185|26433393|FG000|Overall Study|Physician Decision|5|||
13273452|NCT00211172|26433406|FG000|Overall Study|Died or lost health plan eligibility|39|||
13273453|NCT00211172|26433407|FG001|Overall Study|Died or lost health plan eligibility|32|||
13273454|NCT00210639|26433420|FG000|Overall Study|Lost to Follow-up|37|||
13273455|NCT00210639|26433421|FG001|Overall Study|Lost to Follow-up|29|||
13273456|NCT00210639|26433420|FG000|Overall Study|Withdrawal by Subject|8|||
13273457|NCT00210639|26433421|FG001|Overall Study|Withdrawal by Subject|1|||
13273458|NCT00210639|26433420|FG000|Overall Study|Other|18|||
13273459|NCT00210639|26433421|FG001|Overall Study|Other|12|||
13273460|NCT00210626|26433436|FG000|Overall Study|Adverse Event|1|||
13273461|NCT00210626|26433437|FG001|Overall Study|Adverse Event|2|||
13273462|NCT00210626|26433436|FG000|Overall Study|Protocol Violation|1|||
13273463|NCT00210626|26433437|FG001|Overall Study|Protocol Violation|5|||
13273464|NCT00210626|26433436|FG000|Overall Study|Lost to Follow-up|11|||
13273465|NCT00210626|26433437|FG001|Overall Study|Lost to Follow-up|11|||
13273466|NCT00210626|26433436|FG000|Overall Study|Death|1|||
13273467|NCT00210626|26433437|FG001|Overall Study|Death|0|||
13273468|NCT00210626|26433436|FG000|Overall Study|Withdrawal by Subject|29|||
13273469|NCT00210626|26433437|FG001|Overall Study|Withdrawal by Subject|20|||
13273470|NCT00210626|26433436|FG000|Overall Study|Physician Decision|0|||
13273471|NCT00210626|26433437|FG001|Overall Study|Physician Decision|2|||
13273472|NCT00210626|26433436|FG000|Overall Study|Sponser Request|1|||
13273473|NCT00210626|26433437|FG001|Overall Study|Sponser Request|0|||
13273474|NCT00210626|26433436|FG000|Overall Study|Other|4|||
13273475|NCT00210626|26433437|FG001|Overall Study|Other|5|||
13273476|NCT00210184|26433445|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2|||
13273477|NCT00210119|26433452|FG000|Overall Study|Protocol Violation|1|||
13273478|NCT00210119|26433452|FG000|Overall Study|Withdrawal by Subject|1|||
13273479|NCT00210106|26433460|FG000|Overall Study|Death|1|||
13273480|NCT00210106|26433460|FG000|Overall Study|Protocol Violation|13|||
13273481|NCT00211237|26433558|FG000|Baseline|Withdrew|1|||
13273482|NCT00211237|26433559|FG001|Baseline|Withdrew|3|||
13273483|NCT00211237|26433560|FG002|Baseline|Withdrew|0|||
13273484|NCT00211237|26433558|FG000|Baseline|Refused random assignment|1|||
13273485|NCT00211237|26433559|FG001|Baseline|Refused random assignment|0|||
13273486|NCT00211237|26433560|FG002|Baseline|Refused random assignment|0|||
13273487|NCT00211237|26433558|FG000|1 Month|Death|2|||
13273488|NCT00211237|26433559|FG001|1 Month|Death|1|||
13273489|NCT00211237|26433560|FG002|1 Month|Death|0|||
13273490|NCT00211237|26433558|FG000|1 Month|Lost to Follow-up|0|||
13273491|NCT00211237|26433559|FG001|1 Month|Lost to Follow-up|2|||
13118418|NCT03039686|25929298|FG001|Double-blind Period|Death|0|||
13118419|NCT03039686|25929299|FG002|Double-blind Period|Death|1|||
13118420|NCT03039686|25929297|FG000|Open Label Period|Administrative Reason by Sponsor|0|||
13118421|NCT03039686|25929298|FG001|Open Label Period|Administrative Reason by Sponsor|34|||
13118422|NCT03039686|25929299|FG002|Open Label Period|Administrative Reason by Sponsor|41|||
13118423|NCT03039686|25929297|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
13118424|NCT03039686|25929298|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1|||
13118425|NCT03039686|25929299|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
13118426|NCT03039686|25929297|FG000|Open Label Period|Withdrawal by Subject|0|||
13118427|NCT03039686|25929298|FG001|Open Label Period|Withdrawal by Subject|3|||
13118428|NCT03039686|25929299|FG002|Open Label Period|Withdrawal by Subject|1|||
13118429|NCT03039621|25929328|FG000|Overall Study|Violation of inclusion criteria|3|||
13273492|NCT00211237|26433560|FG002|1 Month|Lost to Follow-up|0|||
13273493|NCT00211237|26433558|FG000|1 Month|Withdrew|0|||
13273494|NCT00211237|26433559|FG001|1 Month|Withdrew|4|||
13273495|NCT00211237|26433560|FG002|1 Month|Withdrew|0|||
13273496|NCT00211237|26433558|FG000|1 Month|Additional surgery needed|1|||
13273497|NCT00211237|26433559|FG001|1 Month|Additional surgery needed|0|||
13273498|NCT00211237|26433560|FG002|1 Month|Additional surgery needed|0|||
13273499|NCT00211237|26433558|FG000|1 Month|Non-medical problem|0|||
13273500|NCT00211237|26433559|FG001|1 Month|Non-medical problem|2|||
13273501|NCT00211237|26433560|FG002|1 Month|Non-medical problem|0|||
13273502|NCT00211237|26433558|FG000|3 Months|Death|7|||
13273503|NCT00211237|26433559|FG001|3 Months|Death|3|||
13273504|NCT00211237|26433560|FG002|3 Months|Death|0|||
13273505|NCT00211237|26433558|FG000|3 Months|Could not comply with protocol|1|||
13273506|NCT00211237|26433559|FG001|3 Months|Could not comply with protocol|0|||
13273507|NCT00211237|26433560|FG002|3 Months|Could not comply with protocol|0|||
13273508|NCT00211237|26433558|FG000|3 Months|Withdrew|0|||
13273509|NCT00211237|26433559|FG001|3 Months|Withdrew|1|||
13273510|NCT00211237|26433560|FG002|3 Months|Withdrew|0|||
13273511|NCT00211237|26433558|FG000|3 Months|Non-medical problem|0|||
13273512|NCT00211237|26433559|FG001|3 Months|Non-medical problem|0|||
13273513|NCT00211237|26433560|FG002|3 Months|Non-medical problem|1|||
13273514|NCT00211237|26433558|FG000|6 Months|Death|6|||
13273515|NCT00211237|26433559|FG001|6 Months|Death|0|||
13273516|NCT00211237|26433560|FG002|6 Months|Death|3|||
13273517|NCT00211237|26433558|FG000|6 Months|Lost to Follow-up|2|||
13118430|NCT03039621|25929329|FG001|Overall Study|Violation of inclusion criteria|2|||
13273518|NCT00211237|26433559|FG001|6 Months|Lost to Follow-up|0|||
13273519|NCT00211237|26433560|FG002|6 Months|Lost to Follow-up|0|||
13273520|NCT00211237|26433558|FG000|6 Months|Could not comply with protocol|0|||
13273521|NCT00211237|26433559|FG001|6 Months|Could not comply with protocol|2|||
13273522|NCT00211237|26433560|FG002|6 Months|Could not comply with protocol|0|||
13273523|NCT00211237|26433558|FG000|12 Months|Death|8|||
13273524|NCT00211237|26433559|FG001|12 Months|Death|2|||
13273525|NCT00211237|26433560|FG002|12 Months|Death|3|||
13273526|NCT00211237|26433558|FG000|12 Months|Lost to Follow-up|1|||
13273527|NCT00211237|26433559|FG001|12 Months|Lost to Follow-up|0|||
13273528|NCT00211237|26433560|FG002|12 Months|Lost to Follow-up|1|||
13273529|NCT00211237|26433558|FG000|12 Months|Withdrew|0|||
13273530|NCT00211237|26433559|FG001|12 Months|Withdrew|0|||
13273531|NCT00211237|26433560|FG002|12 Months|Withdrew|1|||
13273532|NCT00211237|26433558|FG000|12 Months|unrelated medical problem|0|||
13273533|NCT00211237|26433559|FG001|12 Months|unrelated medical problem|0|||
13273534|NCT00211237|26433560|FG002|12 Months|unrelated medical problem|1|||
13273535|NCT00217022|26433575|FG000|Overall Study|Withdrawal by Subject|1|||
13273536|NCT00217022|26433576|FG001|Overall Study|Withdrawal by Subject|1|||
13273537|NCT00214422|26433607|FG000|Overall Study|Physician Decision|2|||
13273538|NCT00214422|26433608|FG001|Overall Study|Physician Decision|0|||
13273539|NCT00214422|26433609|FG002|Overall Study|Physician Decision|0|||
13273540|NCT00214422|26433607|FG000|Overall Study|Developed esophageal ca|1|||
13273541|NCT00214422|26433608|FG001|Overall Study|Developed esophageal ca|0|||
13273542|NCT00214422|26433609|FG002|Overall Study|Developed esophageal ca|0|||
13118431|NCT03039621|25929328|FG000|Overall Study|Non-compliance with protocol requirement|4|||
13273543|NCT00214422|26433607|FG000|Overall Study|Pt taken off study|1|||
13273544|NCT00214422|26433608|FG001|Overall Study|Pt taken off study|1|||
13273545|NCT00214422|26433609|FG002|Overall Study|Pt taken off study|0|||
13273546|NCT00214422|26433607|FG000|Overall Study|Disease progression on study|1|||
13273547|NCT00214422|26433608|FG001|Overall Study|Disease progression on study|0|||
13273548|NCT00214422|26433609|FG002|Overall Study|Disease progression on study|0|||
13273549|NCT00214422|26433607|FG000|Overall Study|Unable to make a radiation treatment|0|||
13273550|NCT00214422|26433608|FG001|Overall Study|Unable to make a radiation treatment|0|||
13273551|NCT00214422|26433609|FG002|Overall Study|Unable to make a radiation treatment|1|||
13290842|NCT02034123|26482220|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
13290843|NCT02034123|26482221|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
13290844|NCT02034123|26482222|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
13290845|NCT02034123|26482223|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
13290846|NCT02034123|26482224|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
13290847|NCT02034123|26482225|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
13290848|NCT02034123|26482226|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
13290849|NCT02034123|26482227|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
13290850|NCT02034123|26482228|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
13290851|NCT02034123|26482229|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
13290852|NCT02034123|26482230|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
13290853|NCT02034123|26482231|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
13290854|NCT02034123|26482232|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
13290855|NCT02034123|26482233|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
13290856|NCT02036970|26482296|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0|||
13290857|NCT02036970|26482297|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0|||
13290858|NCT02036970|26482298|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3|||
13290859|NCT02036970|26482299|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2|||
13290860|NCT02036970|26482300|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0|||
13290861|NCT02036970|26482301|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1|||
13290862|NCT02036970|26482302|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0|||
13290863|NCT02036970|26482303|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1|||
13290864|NCT02036970|26482304|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3|||
13290865|NCT02036970|26482305|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1|||
13290866|NCT02036970|26482296|FG000|Part 1: Day 1 Through Week 16|Death|0|||
13290867|NCT02036970|26482297|FG001|Part 1: Day 1 Through Week 16|Death|0|||
13290868|NCT02036970|26482298|FG002|Part 1: Day 1 Through Week 16|Death|0|||
13290869|NCT02036970|26482299|FG003|Part 1: Day 1 Through Week 16|Death|0|||
13290870|NCT02036970|26482300|FG004|Part 1: Day 1 Through Week 16|Death|0|||
13290871|NCT02036970|26482301|FG005|Part 1: Day 1 Through Week 16|Death|0|||
13290872|NCT02036970|26482302|FG006|Part 1: Day 1 Through Week 16|Death|0|||
13290873|NCT02036970|26482303|FG007|Part 1: Day 1 Through Week 16|Death|0|||
13290874|NCT02036970|26482304|FG008|Part 1: Day 1 Through Week 16|Death|1|||
13290875|NCT02036970|26482305|FG009|Part 1: Day 1 Through Week 16|Death|0|||
13290876|NCT02036970|26482296|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
13290877|NCT02036970|26482297|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
13290878|NCT02036970|26482298|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
13290879|NCT02036970|26482299|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
13290880|NCT02036970|26482300|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
13290881|NCT02036970|26482301|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
13290882|NCT02036970|26482302|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
13290883|NCT02036970|26482303|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
13290884|NCT02036970|26482304|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2|||
13290885|NCT02036970|26482305|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
13290886|NCT02036970|26482296|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
13290887|NCT02036970|26482297|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
13290888|NCT02036970|26482298|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
13290889|NCT02036970|26482299|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
13290890|NCT02036970|26482300|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1|||
13290891|NCT02036970|26482301|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
13290892|NCT02036970|26482302|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
13290893|NCT02036970|26482303|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
13290894|NCT02036970|26482304|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2|||
13290895|NCT02036970|26482305|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4|||
13290896|NCT02036970|26482296|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
13290897|NCT02036970|26482297|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
13290898|NCT02036970|26482298|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
13290899|NCT02036970|26482299|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1|||
13290900|NCT02036970|26482300|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
13290901|NCT02036970|26482301|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
13290902|NCT02036970|26482302|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
13290903|NCT02036970|26482303|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
13290904|NCT02036970|26482304|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
13273552|NCT03598777|26433749|FG000|Overall Study|Study Terminated by Sponsor|3|||
13273553|NCT03598777|26433750|FG001|Overall Study|Study Terminated by Sponsor|0|||
13273554|NCT03598777|26433751|FG002|Overall Study|Study Terminated by Sponsor|0|||
13273555|NCT03598777|26433752|FG003|Overall Study|Study Terminated by Sponsor|0|||
13273556|NCT03598777|26433753|FG004|Overall Study|Study Terminated by Sponsor|15|||
13273557|NCT03598777|26433749|FG000|Overall Study|Withdrawal by Subject|1|||
13273558|NCT03598777|26433750|FG001|Overall Study|Withdrawal by Subject|1|||
13273559|NCT03598777|26433751|FG002|Overall Study|Withdrawal by Subject|0|||
13273560|NCT03598777|26433752|FG003|Overall Study|Withdrawal by Subject|0|||
13273561|NCT03598777|26433753|FG004|Overall Study|Withdrawal by Subject|0|||
13273562|NCT03598777|26433749|FG000|Overall Study|Adverse Event|1|||
13273563|NCT03598777|26433750|FG001|Overall Study|Adverse Event|0|||
13273564|NCT03598777|26433751|FG002|Overall Study|Adverse Event|0|||
13273565|NCT03598777|26433752|FG003|Overall Study|Adverse Event|0|||
13273566|NCT03598777|26433753|FG004|Overall Study|Adverse Event|0|||
13273567|NCT03598777|26433749|FG000|Overall Study|Lost to Follow-up|1|||
13273568|NCT03598777|26433750|FG001|Overall Study|Lost to Follow-up|0|||
13273569|NCT03598777|26433751|FG002|Overall Study|Lost to Follow-up|0|||
13273570|NCT03598777|26433752|FG003|Overall Study|Lost to Follow-up|0|||
13273571|NCT03598777|26433753|FG004|Overall Study|Lost to Follow-up|0|||
13273572|NCT03594955|26433767|FG000|Overall Study|Adverse Event|1|||
13273573|NCT03594955|26433767|FG000|Overall Study|Progressive disease|5|||
13273574|NCT03594955|26433767|FG000|Overall Study|Sponsor's decision|1|||
13273575|NCT03592186|26433784|FG000|Overall Study|Withdrawal by Subject|1|||
13273576|NCT03592186|26433785|FG001|Overall Study|Withdrawal by Subject|0|||
13273577|NCT03592186|26433784|FG000|Overall Study|Lost to Follow-up|16|||
13273578|NCT03592186|26433785|FG001|Overall Study|Lost to Follow-up|11|||
13273579|NCT03593213|26433816|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39|||
13273580|NCT03593213|26433817|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
13273581|NCT03593213|26433818|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
13273582|NCT03593213|26433819|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
13273583|NCT03593213|26433816|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14|||
13273584|NCT03593213|26433817|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
13273585|NCT03593213|26433818|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
13273586|NCT03593213|26433819|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
13273587|NCT03593213|26433816|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85|||
13273588|NCT03593213|26433817|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
13273589|NCT03593213|26433818|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
13273590|NCT03593213|26433819|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
13273591|NCT03593213|26433816|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51|||
13118432|NCT03039621|25929329|FG001|Overall Study|Non-compliance with protocol requirement|5|||
13118433|NCT03039621|25929328|FG000|Overall Study|Necessity to use drugs forbidden by pro|4|||
13118434|NCT03039621|25929329|FG001|Overall Study|Necessity to use drugs forbidden by pro|7|||
13118435|NCT03039621|25929328|FG000|Overall Study|Violation of non-inclusion criteria|1|||
13118436|NCT03039621|25929329|FG001|Overall Study|Violation of non-inclusion criteria|2|||
13118437|NCT03039569|25929364|FG000|Overall Study|Lost to Follow-up|5|||
13118438|NCT03039569|25929365|FG001|Overall Study|Lost to Follow-up|4|||
13118439|NCT03039283|25929376|FG000|Overall Study|Protocol Violation|2|||
13118440|NCT03039192|25929433|FG000|Overall Study|Lost to Follow-up|4|||
13273592|NCT03593213|26433817|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
13273593|NCT03593213|26433818|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
13273594|NCT03593213|26433819|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
13273595|NCT03593213|26433816|FG000|Open-label Treatment Period (18 Weeks)|Death|1|||
13273596|NCT03593213|26433817|FG001|Open-label Treatment Period (18 Weeks)|Death|0|||
13273597|NCT03593213|26433818|FG002|Open-label Treatment Period (18 Weeks)|Death|0|||
13273598|NCT03593213|26433819|FG003|Open-label Treatment Period (18 Weeks)|Death|0|||
13273599|NCT03593213|26433816|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5|||
13273600|NCT03593213|26433817|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
13273601|NCT03593213|26433818|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
13273602|NCT03593213|26433819|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
13273603|NCT03593213|26433816|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23|||
13273604|NCT03593213|26433817|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
13118441|NCT03039192|25929434|FG001|Overall Study|Lost to Follow-up|4|||
13118442|NCT03039192|25929433|FG000|Overall Study|Adverse event, serious fatal|0|||
13118443|NCT03039192|25929434|FG001|Overall Study|Adverse event, serious fatal|1|||
13118444|NCT03039192|25929433|FG000|Overall Study|Adverse event, non-fatal|0|||
13118445|NCT03039192|25929434|FG001|Overall Study|Adverse event, non-fatal|2|||
13118446|NCT03039192|25929433|FG000|Overall Study|Withdrawal by Subject|6|||
13118447|NCT03039192|25929434|FG001|Overall Study|Withdrawal by Subject|9|||
13118448|NCT03039192|25929433|FG000|Overall Study|Discontinued from treatment phase|19|||
13118449|NCT03039192|25929434|FG001|Overall Study|Discontinued from treatment phase|12|||
13118450|NCT03039192|25929433|FG000|Overall Study|Other|3|||
13118451|NCT03039192|25929434|FG001|Overall Study|Other|2|||
13118452|NCT03039023|25929507|FG000|Overall Study|Withdrawal by Subject|1|||
13118453|NCT03039023|25929508|FG001|Overall Study|Withdrawal by Subject|0|||
13118454|NCT03039023|25929509|FG002|Overall Study|Withdrawal by Subject|1|||
13118455|NCT03039023|25929510|FG003|Overall Study|Withdrawal by Subject|1|||
13118456|NCT03039023|25929511|FG004|Overall Study|Withdrawal by Subject|0|||
13118457|NCT03039023|25929507|FG000|Overall Study|Physician Decision|0|||
13118458|NCT03039023|25929508|FG001|Overall Study|Physician Decision|0|||
13118459|NCT03039023|25929509|FG002|Overall Study|Physician Decision|0|||
13118460|NCT03039023|25929510|FG003|Overall Study|Physician Decision|1|||
13118461|NCT03039023|25929511|FG004|Overall Study|Physician Decision|0|||
13118462|NCT03038880|25929582|FG000|Overall Study|Death|1|||
13118463|NCT03038880|25929583|FG001|Overall Study|Death|2|||
13118464|NCT03038880|25929584|FG002|Overall Study|Death|0|||
13118465|NCT03038880|25929582|FG000|Overall Study|Physician Decision|2|||
13118466|NCT03038880|25929583|FG001|Overall Study|Physician Decision|1|||
13118467|NCT03038880|25929584|FG002|Overall Study|Physician Decision|0|||
13118468|NCT03038620|25929669|FG000|Overall Study|Lost to Follow-up|18|||
13118469|NCT03038620|25929670|FG001|Overall Study|Lost to Follow-up|23|||
13118470|NCT03038620|25929669|FG000|Overall Study|Withdrawal by Subject|0|||
13118471|NCT03038620|25929670|FG001|Overall Study|Withdrawal by Subject|15|||
13118472|NCT03038620|25929669|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1|||
13118473|NCT03038620|25929670|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0|||
13118474|NCT03038126|25929687|FG000|Overall Study|Death|1|||
13273605|NCT03593213|26433818|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
13118475|NCT03038126|25929688|FG001|Overall Study|Death|1|||
13118476|NCT03038126|25929687|FG000|Overall Study|Withdrawal by Subject|5|||
13118477|NCT03038126|25929688|FG001|Overall Study|Withdrawal by Subject|0|||
13118478|NCT03038126|25929687|FG000|Overall Study|Lost to Follow-up|0|||
13118479|NCT03038126|25929688|FG001|Overall Study|Lost to Follow-up|1|||
13118480|NCT03038126|25929687|FG000|Overall Study|Long Term Hospitalization|2|||
13118481|NCT03038126|25929688|FG001|Overall Study|Long Term Hospitalization|0|||
13118482|NCT03038126|25929687|FG000|Overall Study|Too Ill to Participate|1|||
13118483|NCT03038126|25929688|FG001|Overall Study|Too Ill to Participate|2|||
13118484|NCT03038113|25929940|FG000|Overall Study|Withdrawal by Subject|0|||
13118485|NCT03038113|25929941|FG001|Overall Study|Withdrawal by Subject|0|||
13118486|NCT03038113|25929942|FG002|Overall Study|Withdrawal by Subject|1|||
13118487|NCT03038113|25929943|FG003|Overall Study|Withdrawal by Subject|0|||
13118488|NCT03038113|25929944|FG004|Overall Study|Withdrawal by Subject|0|||
13118489|NCT03038113|25929945|FG005|Overall Study|Withdrawal by Subject|0|||
13118490|NCT03038113|25929946|FG006|Overall Study|Withdrawal by Subject|0|||
13118491|NCT03038113|25929947|FG007|Overall Study|Withdrawal by Subject|0|||
13118492|NCT03038113|25929948|FG008|Overall Study|Withdrawal by Subject|0|||
13273606|NCT03593213|26433819|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
13273607|NCT03593213|26433816|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90|||
13273608|NCT03593213|26433817|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
13273609|NCT03593213|26433818|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
13273610|NCT03593213|26433819|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
13273611|NCT03593213|26433816|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13|||
13273612|NCT03593213|26433817|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
13273613|NCT03593213|26433818|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
13273614|NCT03593213|26433819|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
13273615|NCT03593213|26433816|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104|||
13273616|NCT03593213|26433817|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
13273617|NCT03593213|26433818|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
13273618|NCT03593213|26433819|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
13273619|NCT03593213|26433816|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0|||
13273620|NCT03593213|26433817|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15|||
13273621|NCT03593213|26433818|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9|||
13273622|NCT03593213|26433819|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8|||
13273623|NCT03593213|26433816|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
13273624|NCT03593213|26433817|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2|||
13273625|NCT03593213|26433818|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
13273626|NCT03593213|26433819|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4|||
13273627|NCT03593213|26433816|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0|||
13118493|NCT03038113|25929949|FG009|Overall Study|Withdrawal by Subject|0|||
13118494|NCT03038113|25929950|FG010|Overall Study|Withdrawal by Subject|0|||
13118495|NCT03038113|25929951|FG011|Overall Study|Withdrawal by Subject|0|||
13118496|NCT03038113|25929952|FG012|Overall Study|Withdrawal by Subject|0|||
13273628|NCT03593213|26433817|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4|||
13273629|NCT03593213|26433818|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2|||
13273630|NCT03593213|26433819|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3|||
13273631|NCT03593213|26433816|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0|||
13273632|NCT03593213|26433817|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5|||
13273633|NCT03593213|26433818|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4|||
13273634|NCT03593213|26433819|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1|||
13273635|NCT03593213|26433816|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
13273636|NCT03593213|26433817|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
13273637|NCT03593213|26433818|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
13273638|NCT03593213|26433819|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1|||
13273639|NCT03593213|26433816|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0|||
13273640|NCT03593213|26433817|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3|||
13273641|NCT03593213|26433818|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2|||
13273642|NCT03593213|26433819|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5|||
13273643|NCT03593213|26433816|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
13273644|NCT03593213|26433817|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1|||
13273645|NCT03593213|26433818|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2|||
13273646|NCT03593213|26433819|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
13273647|NCT03593213|26433816|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0|||
13273648|NCT03593213|26433817|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9|||
13273649|NCT03593213|26433818|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11|||
13273650|NCT03593213|26433819|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13|||
13273651|NCT03593213|26433816|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
13273652|NCT03593213|26433817|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1|||
13273653|NCT03593213|26433818|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3|||
13273654|NCT03593213|26433819|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
13290905|NCT02036970|26482305|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
13290906|NCT02036970|26482296|FG000|Part 2: Week 16 Onwards|Adverse Event|0|||
13290907|NCT02036970|26482297|FG001|Part 2: Week 16 Onwards|Adverse Event|2|||
13290908|NCT02036970|26482298|FG002|Part 2: Week 16 Onwards|Adverse Event|1|||
13290909|NCT02036970|26482299|FG003|Part 2: Week 16 Onwards|Adverse Event|1|||
13290910|NCT02036970|26482300|FG004|Part 2: Week 16 Onwards|Adverse Event|1|||
13290911|NCT02036970|26482301|FG005|Part 2: Week 16 Onwards|Adverse Event|0|||
13290912|NCT02036970|26482302|FG006|Part 2: Week 16 Onwards|Adverse Event|1|||
13290913|NCT02036970|26482303|FG007|Part 2: Week 16 Onwards|Adverse Event|0|||
13290914|NCT02036970|26482304|FG008|Part 2: Week 16 Onwards|Adverse Event|6|||
13290915|NCT02036970|26482305|FG009|Part 2: Week 16 Onwards|Adverse Event|3|||
13290916|NCT02036970|26482296|FG000|Part 2: Week 16 Onwards|Protocol Violation|0|||
13290917|NCT02036970|26482297|FG001|Part 2: Week 16 Onwards|Protocol Violation|0|||
13290918|NCT02036970|26482298|FG002|Part 2: Week 16 Onwards|Protocol Violation|0|||
13290919|NCT02036970|26482299|FG003|Part 2: Week 16 Onwards|Protocol Violation|0|||
13290920|NCT02036970|26482300|FG004|Part 2: Week 16 Onwards|Protocol Violation|0|||
13290921|NCT02036970|26482301|FG005|Part 2: Week 16 Onwards|Protocol Violation|0|||
13290922|NCT02036970|26482302|FG006|Part 2: Week 16 Onwards|Protocol Violation|0|||
13290923|NCT02036970|26482303|FG007|Part 2: Week 16 Onwards|Protocol Violation|1|||
13290924|NCT02036970|26482304|FG008|Part 2: Week 16 Onwards|Protocol Violation|0|||
13290925|NCT02036970|26482305|FG009|Part 2: Week 16 Onwards|Protocol Violation|0|||
13290926|NCT02036970|26482296|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
13290927|NCT02036970|26482297|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
13290928|NCT02036970|26482298|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
13290929|NCT02036970|26482299|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
13290930|NCT02036970|26482300|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
13290931|NCT02036970|26482301|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
13290932|NCT02036970|26482302|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
13290933|NCT02036970|26482303|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
13290934|NCT02036970|26482304|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3|||
13290935|NCT02036970|26482305|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
13290936|NCT02036970|26482296|FG000|Part 2: Week 16 Onwards|Progressive Disease|0|||
13290937|NCT02036970|26482297|FG001|Part 2: Week 16 Onwards|Progressive Disease|2|||
13290938|NCT02036970|26482298|FG002|Part 2: Week 16 Onwards|Progressive Disease|1|||
13290939|NCT02036970|26482299|FG003|Part 2: Week 16 Onwards|Progressive Disease|1|||
13290940|NCT02036970|26482300|FG004|Part 2: Week 16 Onwards|Progressive Disease|0|||
13290941|NCT02036970|26482301|FG005|Part 2: Week 16 Onwards|Progressive Disease|0|||
13290942|NCT02036970|26482302|FG006|Part 2: Week 16 Onwards|Progressive Disease|0|||
13290943|NCT02036970|26482303|FG007|Part 2: Week 16 Onwards|Progressive Disease|0|||
13290944|NCT02036970|26482304|FG008|Part 2: Week 16 Onwards|Progressive Disease|0|||
13273655|NCT04196686|26433832|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0|||
13273656|NCT04196686|26433833|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3|||
13273657|NCT04191382|26433863|FG000|Overall Study|Withdrawal by Subject|1|||
13273658|NCT04191382|26433864|FG001|Overall Study|Withdrawal by Subject|0|||
13273659|NCT04191382|26433865|FG002|Overall Study|Withdrawal by Subject|0|||
13273660|NCT04194528|26433882|FG000|Overall Study|Adverse Event|1|||
13273661|NCT04193202|26433901|FG000|Overall Study|Adverse Event|2|||
13273662|NCT04193202|26433902|FG001|Overall Study|Adverse Event|1|||
13273663|NCT04193202|26433901|FG000|Overall Study|Death|0|||
13273664|NCT04193202|26433902|FG001|Overall Study|Death|1|||
13273665|NCT04193202|26433901|FG000|Overall Study|Physician Decision|1|||
13273666|NCT04193202|26433902|FG001|Overall Study|Physician Decision|1|||
13273667|NCT04193202|26433901|FG000|Overall Study|Protocol Violation|2|||
13273668|NCT04193202|26433902|FG001|Overall Study|Protocol Violation|2|||
13273669|NCT04193202|26433901|FG000|Overall Study|Withdrawal by Subject|11|||
13273670|NCT04193202|26433902|FG001|Overall Study|Withdrawal by Subject|5|||
13273671|NCT04022889|26434088|FG000|Stage 1: Period 1|Adverse Event|1|||
13273672|NCT04022889|26434089|FG001|Stage 1: Period 1|Adverse Event|0|||
13273673|NCT04022889|26434090|FG002|Stage 1: Period 1|Adverse Event|0|||
13273674|NCT04022889|26434088|FG000|Stage 1: Period 1|Platelet component did not meet input specifications|1|||
13118497|NCT03038113|25929953|FG013|Overall Study|Withdrawal by Subject|1|||
13118498|NCT03038113|25929940|FG000|Overall Study|Lost to Follow-up|0|||
13118499|NCT03038113|25929941|FG001|Overall Study|Lost to Follow-up|0|||
13118500|NCT03038113|25929942|FG002|Overall Study|Lost to Follow-up|0|||
13118501|NCT03038113|25929943|FG003|Overall Study|Lost to Follow-up|0|||
13118502|NCT03038113|25929944|FG004|Overall Study|Lost to Follow-up|0|||
13118503|NCT03038113|25929945|FG005|Overall Study|Lost to Follow-up|0|||
13118504|NCT03038113|25929946|FG006|Overall Study|Lost to Follow-up|1|||
13118505|NCT03038113|25929947|FG007|Overall Study|Lost to Follow-up|0|||
13273675|NCT04022889|26434089|FG001|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
13273676|NCT04022889|26434090|FG002|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
13273677|NCT04022889|26434088|FG000|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
13273678|NCT04022889|26434089|FG001|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
13273679|NCT04022889|26434090|FG002|Stage 1: Period 2|Site closure due to COVID-19 pandemic|0|||
13273680|NCT04022889|26434088|FG000|Stage 2|Screen Failure|0|||
13273681|NCT04022889|26434089|FG001|Stage 2|Screen Failure|0|||
13273682|NCT04022889|26434090|FG002|Stage 2|Screen Failure|3|||
13273683|NCT04022889|26434088|FG000|Stage 2|Ineligible for apheresis donation|0|||
13273684|NCT04022889|26434089|FG001|Stage 2|Ineligible for apheresis donation|0|||
13273685|NCT04022889|26434090|FG002|Stage 2|Ineligible for apheresis donation|2|||
13273686|NCT04022889|26434088|FG000|Stage 2|Adverse Event|0|||
13273687|NCT04022889|26434089|FG001|Stage 2|Adverse Event|0|||
13273688|NCT04022889|26434090|FG002|Stage 2|Adverse Event|2|||
13118506|NCT03038113|25929948|FG008|Overall Study|Lost to Follow-up|0|||
13118507|NCT03038113|25929949|FG009|Overall Study|Lost to Follow-up|0|||
13118508|NCT03038113|25929950|FG010|Overall Study|Lost to Follow-up|0|||
13273689|NCT04022889|26434088|FG000|Stage 2|Protocol Violation|0|||
13273690|NCT04022889|26434089|FG001|Stage 2|Protocol Violation|0|||
13273691|NCT04022889|26434090|FG002|Stage 2|Protocol Violation|1|||
13273692|NCT04022889|26434088|FG000|Stage 2|Site closure due to COVID-19 pandemic|1|||
13273693|NCT04022889|26434089|FG001|Stage 2|Site closure due to COVID-19 pandemic|0|||
13273694|NCT04022889|26434090|FG002|Stage 2|Site closure due to COVID-19 pandemic|0|||
13273695|NCT04027348|26434106|FG000|Overall Study|Adverse Event|2|||
13273696|NCT02704403|26434173|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4|||
13273697|NCT02704403|26434174|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3|||
13273698|NCT02704403|26434173|FG000|Overall Study|Administrative reasons by sponsor|1251|||
13273699|NCT02704403|26434174|FG001|Overall Study|Administrative reasons by sponsor|616|||
13273700|NCT02704403|26434173|FG000|Overall Study|Death|4|||
13273701|NCT02704403|26434174|FG001|Overall Study|Death|3|||
13273702|NCT02704403|26434173|FG000|Overall Study|Endpoint event|52|||
13273703|NCT02704403|26434174|FG001|Overall Study|Endpoint event|24|||
13273704|NCT02704403|26434173|FG000|Overall Study|Lost to Follow-up|22|||
13273705|NCT02704403|26434174|FG001|Overall Study|Lost to Follow-up|11|||
13273706|NCT02704403|26434173|FG000|Overall Study|Protocol Violation|15|||
13273707|NCT02704403|26434174|FG001|Overall Study|Protocol Violation|15|||
13273708|NCT02704403|26434173|FG000|Overall Study|Adverse Event|2|||
13273709|NCT02704403|26434174|FG001|Overall Study|Adverse Event|0|||
13273710|NCT02704403|26434173|FG000|Overall Study|Withdrawal by Subject|85|||
13273711|NCT02704403|26434174|FG001|Overall Study|Withdrawal by Subject|45|||
13273712|NCT02704403|26434173|FG000|Overall Study|Investigator decision|1|||
13273713|NCT02704403|26434174|FG001|Overall Study|Investigator decision|1|||
13273714|NCT02704403|26434173|FG000|Overall Study|Follow-up not possible|1|||
13273715|NCT02704403|26434174|FG001|Overall Study|Follow-up not possible|2|||
13273716|NCT02702271|26434189|FG000|Overall Study|Death|36|||
13273717|NCT02702271|26434190|FG001|Overall Study|Death|7|||
13118509|NCT03038113|25929951|FG011|Overall Study|Lost to Follow-up|0|||
13118510|NCT03038113|25929952|FG012|Overall Study|Lost to Follow-up|0|||
13273718|NCT02702271|26434189|FG000|Overall Study|Lost to Follow-up|12|||
13273719|NCT02702271|26434190|FG001|Overall Study|Lost to Follow-up|0|||
13273720|NCT02702271|26434189|FG000|Overall Study|Withdrawal by Subject|8|||
13273721|NCT02702271|26434190|FG001|Overall Study|Withdrawal by Subject|1|||
13273722|NCT02702271|26434189|FG000|Overall Study|Physician Decision|2|||
13273723|NCT02702271|26434190|FG001|Overall Study|Physician Decision|0|||
13273724|NCT02702271|26434189|FG000|Overall Study|Unsuccessful Implant Attempt|5|||
13273725|NCT02702271|26434190|FG001|Overall Study|Unsuccessful Implant Attempt|1|||
13290945|NCT02036970|26482305|FG009|Part 2: Week 16 Onwards|Progressive Disease|2|||
13290946|NCT02039674|26482392|FG000|Overall Study|Adverse Event|0|||
13290947|NCT02039674|26482393|FG001|Overall Study|Adverse Event|0|||
13290948|NCT02039674|26482394|FG002|Overall Study|Adverse Event|0|||
13290949|NCT02039674|26482395|FG003|Overall Study|Adverse Event|1|||
13290950|NCT02039674|26482396|FG004|Overall Study|Adverse Event|0|||
13290951|NCT02039674|26482397|FG005|Overall Study|Adverse Event|0|||
13290952|NCT02039674|26482398|FG006|Overall Study|Adverse Event|0|||
13290953|NCT02039674|26482399|FG007|Overall Study|Adverse Event|0|||
13290954|NCT02039674|26482400|FG008|Overall Study|Adverse Event|2|||
13290955|NCT02039674|26482401|FG009|Overall Study|Adverse Event|1|||
13290956|NCT02039674|26482402|FG010|Overall Study|Adverse Event|0|||
13290957|NCT02039674|26482403|FG011|Overall Study|Adverse Event|2|||
13290958|NCT02039674|26482404|FG012|Overall Study|Adverse Event|3|||
13290959|NCT02039674|26482405|FG013|Overall Study|Adverse Event|1|||
13290960|NCT02039674|26482392|FG000|Overall Study|Death|2|||
13290961|NCT02039674|26482393|FG001|Overall Study|Death|0|||
13290962|NCT02039674|26482394|FG002|Overall Study|Death|2|||
13290963|NCT02039674|26482395|FG003|Overall Study|Death|3|||
13290964|NCT02039674|26482396|FG004|Overall Study|Death|0|||
13290965|NCT02039674|26482397|FG005|Overall Study|Death|0|||
13290966|NCT02039674|26482398|FG006|Overall Study|Death|1|||
13290967|NCT02039674|26482399|FG007|Overall Study|Death|0|||
13290968|NCT02039674|26482400|FG008|Overall Study|Death|2|||
13290969|NCT02039674|26482401|FG009|Overall Study|Death|0|||
13290970|NCT02039674|26482402|FG010|Overall Study|Death|1|||
13290971|NCT02039674|26482403|FG011|Overall Study|Death|3|||
13290972|NCT02039674|26482404|FG012|Overall Study|Death|2|||
13290973|NCT02039674|26482405|FG013|Overall Study|Death|8|||
13290974|NCT02039674|26482392|FG000|Overall Study|Excluded Medication|1|||
13290975|NCT02039674|26482393|FG001|Overall Study|Excluded Medication|1|||
13290976|NCT02039674|26482394|FG002|Overall Study|Excluded Medication|0|||
13290977|NCT02039674|26482395|FG003|Overall Study|Excluded Medication|1|||
13290978|NCT02039674|26482396|FG004|Overall Study|Excluded Medication|0|||
13290979|NCT02039674|26482397|FG005|Overall Study|Excluded Medication|1|||
13290980|NCT02039674|26482398|FG006|Overall Study|Excluded Medication|0|||
13290981|NCT02039674|26482399|FG007|Overall Study|Excluded Medication|0|||
13290982|NCT02039674|26482400|FG008|Overall Study|Excluded Medication|2|||
13290983|NCT02039674|26482401|FG009|Overall Study|Excluded Medication|3|||
13290984|NCT02039674|26482402|FG010|Overall Study|Excluded Medication|5|||
13290985|NCT02039674|26482403|FG011|Overall Study|Excluded Medication|6|||
13290986|NCT02039674|26482404|FG012|Overall Study|Excluded Medication|8|||
13290987|NCT02039674|26482405|FG013|Overall Study|Excluded Medication|3|||
13290988|NCT02039674|26482392|FG000|Overall Study|Lost to Follow-up|0|||
13290989|NCT02039674|26482393|FG001|Overall Study|Lost to Follow-up|0|||
13290990|NCT02039674|26482394|FG002|Overall Study|Lost to Follow-up|0|||
13290991|NCT02039674|26482395|FG003|Overall Study|Lost to Follow-up|0|||
13290992|NCT02039674|26482396|FG004|Overall Study|Lost to Follow-up|1|||
13290993|NCT02039674|26482397|FG005|Overall Study|Lost to Follow-up|1|||
13290994|NCT02039674|26482398|FG006|Overall Study|Lost to Follow-up|0|||
13290995|NCT02039674|26482399|FG007|Overall Study|Lost to Follow-up|0|||
13290996|NCT02039674|26482400|FG008|Overall Study|Lost to Follow-up|0|||
13290997|NCT02039674|26482401|FG009|Overall Study|Lost to Follow-up|0|||
13290998|NCT02039674|26482402|FG010|Overall Study|Lost to Follow-up|0|||
13290999|NCT02039674|26482403|FG011|Overall Study|Lost to Follow-up|2|||
13291000|NCT02039674|26482404|FG012|Overall Study|Lost to Follow-up|2|||
13291001|NCT02039674|26482405|FG013|Overall Study|Lost to Follow-up|1|||
13291002|NCT02039674|26482392|FG000|Overall Study|Physician Decision|0|||
13291003|NCT02039674|26482393|FG001|Overall Study|Physician Decision|0|||
13291004|NCT02039674|26482394|FG002|Overall Study|Physician Decision|0|||
13291005|NCT02039674|26482395|FG003|Overall Study|Physician Decision|0|||
13291006|NCT02039674|26482396|FG004|Overall Study|Physician Decision|0|||
13291007|NCT02039674|26482397|FG005|Overall Study|Physician Decision|0|||
13291008|NCT02039674|26482398|FG006|Overall Study|Physician Decision|0|||
13291009|NCT02039674|26482399|FG007|Overall Study|Physician Decision|0|||
13291010|NCT02039674|26482400|FG008|Overall Study|Physician Decision|0|||
13291011|NCT02039674|26482401|FG009|Overall Study|Physician Decision|0|||
13291012|NCT02039674|26482402|FG010|Overall Study|Physician Decision|0|||
13291013|NCT02039674|26482403|FG011|Overall Study|Physician Decision|1|||
13291014|NCT02039674|26482404|FG012|Overall Study|Physician Decision|1|||
13291015|NCT02039674|26482405|FG013|Overall Study|Physician Decision|0|||
13291016|NCT02039674|26482392|FG000|Overall Study|Progressive Disease|8|||
13291017|NCT02039674|26482393|FG001|Overall Study|Progressive Disease|8|||
13291018|NCT02039674|26482394|FG002|Overall Study|Progressive Disease|6|||
13273726|NCT04149002|26434305|FG000|Overall Study|Lost to Follow-up|1|||
13273727|NCT04149002|26434306|FG001|Overall Study|Lost to Follow-up|0|||
13273728|NCT04149002|26434305|FG000|Overall Study|Withdrawal by Subject|1|||
13273729|NCT04149002|26434306|FG001|Overall Study|Withdrawal by Subject|0|||
13273730|NCT04146363|26434420|FG000|Induction Period|Adverse Event|1|||
13273731|NCT04146363|26434421|FG001|Induction Period|Adverse Event|2|||
13273732|NCT04146363|26434422|FG002|Induction Period|Adverse Event|0|||
13273733|NCT04146363|26434423|FG003|Induction Period|Adverse Event|0|||
13273734|NCT04146363|26434424|FG004|Induction Period|Adverse Event|0|||
13273735|NCT04146363|26434425|FG005|Induction Period|Adverse Event|0|||
13273736|NCT04146363|26434426|FG006|Induction Period|Adverse Event|0|||
13273737|NCT04146363|26434427|FG007|Induction Period|Adverse Event|0|||
13273738|NCT04146363|26434428|FG008|Induction Period|Adverse Event|0|||
13273739|NCT04146363|26434429|FG009|Induction Period|Adverse Event|0|||
13273740|NCT04146363|26434430|FG010|Induction Period|Adverse Event|0|||
13273741|NCT04146363|26434420|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
13273742|NCT04146363|26434421|FG001|Induction Period|Due to Epidemic/Pandemic|2|||
13273743|NCT04146363|26434422|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
13273744|NCT04146363|26434423|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
13273745|NCT04146363|26434424|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
13273746|NCT04146363|26434425|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
13273747|NCT04146363|26434426|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
13273748|NCT04146363|26434427|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
13273749|NCT04146363|26434428|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
13273750|NCT04146363|26434429|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
13273751|NCT04146363|26434430|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
13273752|NCT04146363|26434420|FG000|Induction Period|Lack of Efficacy|7|||
13273753|NCT04146363|26434421|FG001|Induction Period|Lack of Efficacy|2|||
13273754|NCT04146363|26434422|FG002|Induction Period|Lack of Efficacy|0|||
13273755|NCT04146363|26434423|FG003|Induction Period|Lack of Efficacy|0|||
13273756|NCT04146363|26434424|FG004|Induction Period|Lack of Efficacy|0|||
13273757|NCT04146363|26434425|FG005|Induction Period|Lack of Efficacy|0|||
13273758|NCT04146363|26434426|FG006|Induction Period|Lack of Efficacy|0|||
13273759|NCT04146363|26434427|FG007|Induction Period|Lack of Efficacy|0|||
13273760|NCT04146363|26434428|FG008|Induction Period|Lack of Efficacy|0|||
13273761|NCT04146363|26434429|FG009|Induction Period|Lack of Efficacy|0|||
13273762|NCT04146363|26434430|FG010|Induction Period|Lack of Efficacy|0|||
13273763|NCT04146363|26434420|FG000|Induction Period|Lost to Follow-up|1|||
13273764|NCT04146363|26434421|FG001|Induction Period|Lost to Follow-up|4|||
13273765|NCT04146363|26434422|FG002|Induction Period|Lost to Follow-up|0|||
13273766|NCT04146363|26434423|FG003|Induction Period|Lost to Follow-up|0|||
13273767|NCT04146363|26434424|FG004|Induction Period|Lost to Follow-up|0|||
13273768|NCT04146363|26434425|FG005|Induction Period|Lost to Follow-up|0|||
13273769|NCT04146363|26434426|FG006|Induction Period|Lost to Follow-up|0|||
13273770|NCT04146363|26434427|FG007|Induction Period|Lost to Follow-up|0|||
13273771|NCT04146363|26434428|FG008|Induction Period|Lost to Follow-up|0|||
13273772|NCT04146363|26434429|FG009|Induction Period|Lost to Follow-up|0|||
13273773|NCT04146363|26434430|FG010|Induction Period|Lost to Follow-up|0|||
13273774|NCT04146363|26434420|FG000|Induction Period|Positive quantiferon test|0|||
13273775|NCT04146363|26434421|FG001|Induction Period|Positive quantiferon test|1|||
13273776|NCT04146363|26434422|FG002|Induction Period|Positive quantiferon test|0|||
13273777|NCT04146363|26434423|FG003|Induction Period|Positive quantiferon test|0|||
13273778|NCT04146363|26434424|FG004|Induction Period|Positive quantiferon test|0|||
13273779|NCT04146363|26434425|FG005|Induction Period|Positive quantiferon test|0|||
13273780|NCT04146363|26434426|FG006|Induction Period|Positive quantiferon test|0|||
13273781|NCT04146363|26434427|FG007|Induction Period|Positive quantiferon test|0|||
13273782|NCT04146363|26434428|FG008|Induction Period|Positive quantiferon test|0|||
13273783|NCT04146363|26434429|FG009|Induction Period|Positive quantiferon test|0|||
13273784|NCT04146363|26434430|FG010|Induction Period|Positive quantiferon test|0|||
13273785|NCT04146363|26434420|FG000|Induction Period|Protocol Deviation|5|||
13273786|NCT04146363|26434421|FG001|Induction Period|Protocol Deviation|6|||
13273787|NCT04146363|26434422|FG002|Induction Period|Protocol Deviation|0|||
13273788|NCT04146363|26434423|FG003|Induction Period|Protocol Deviation|0|||
13273789|NCT04146363|26434424|FG004|Induction Period|Protocol Deviation|0|||
13273790|NCT04146363|26434425|FG005|Induction Period|Protocol Deviation|0|||
13273791|NCT04146363|26434426|FG006|Induction Period|Protocol Deviation|0|||
13273792|NCT04146363|26434427|FG007|Induction Period|Protocol Deviation|0|||
13273793|NCT04146363|26434428|FG008|Induction Period|Protocol Deviation|0|||
13273794|NCT04146363|26434429|FG009|Induction Period|Protocol Deviation|0|||
13273795|NCT04146363|26434430|FG010|Induction Period|Protocol Deviation|0|||
13273796|NCT04146363|26434420|FG000|Induction Period|Withdrawal by Subject|6|||
13273797|NCT04146363|26434421|FG001|Induction Period|Withdrawal by Subject|3|||
13273798|NCT04146363|26434422|FG002|Induction Period|Withdrawal by Subject|0|||
13273799|NCT04146363|26434423|FG003|Induction Period|Withdrawal by Subject|0|||
13273800|NCT04146363|26434424|FG004|Induction Period|Withdrawal by Subject|0|||
13273801|NCT04146363|26434425|FG005|Induction Period|Withdrawal by Subject|0|||
13273802|NCT04146363|26434426|FG006|Induction Period|Withdrawal by Subject|0|||
13273803|NCT04146363|26434427|FG007|Induction Period|Withdrawal by Subject|0|||
13273804|NCT04146363|26434428|FG008|Induction Period|Withdrawal by Subject|0|||
13273805|NCT04146363|26434429|FG009|Induction Period|Withdrawal by Subject|0|||
13273806|NCT04146363|26434430|FG010|Induction Period|Withdrawal by Subject|0|||
13273807|NCT04146363|26434420|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
13273808|NCT04146363|26434421|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
13273809|NCT04146363|26434422|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
13273810|NCT04146363|26434423|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
13273811|NCT04146363|26434424|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
13273812|NCT04146363|26434425|FG005|Maintenance Blinded Treatment Period|Adverse Event|0|||
13273813|NCT04146363|26434426|FG006|Maintenance Blinded Treatment Period|Adverse Event|1|||
13273814|NCT04146363|26434427|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
13273815|NCT04146363|26434428|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
13273816|NCT04146363|26434429|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
13273817|NCT04146363|26434430|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
13273818|NCT04146363|26434420|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
13273819|NCT04146363|26434421|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
13273820|NCT04146363|26434422|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
13273821|NCT04146363|26434423|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
13273822|NCT04146363|26434424|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
13273823|NCT04146363|26434425|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
13273824|NCT04146363|26434426|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
13273825|NCT04146363|26434427|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
13273826|NCT04146363|26434428|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
13273827|NCT04146363|26434429|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
13273828|NCT04146363|26434430|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
13273829|NCT04146363|26434420|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
13273830|NCT04146363|26434421|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
13273831|NCT04146363|26434422|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
13273832|NCT04146363|26434423|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
13273833|NCT04146363|26434424|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
13273834|NCT04146363|26434425|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
13273835|NCT04146363|26434426|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
13273836|NCT04146363|26434427|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
13273837|NCT04146363|26434428|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
13273838|NCT04146363|26434429|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
13273839|NCT04146363|26434430|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
13273840|NCT04146363|26434420|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
13273841|NCT04146363|26434421|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
13273842|NCT04146363|26434422|FG002|Maintenance Blinded Treatment Period|Physician Decision|1|||
13118511|NCT03038113|25929953|FG013|Overall Study|Lost to Follow-up|0|||
13118512|NCT03037619|25929972|FG000|Overall Study|Lost to Follow-up|0|||
13118513|NCT03037619|25929973|FG001|Overall Study|Lost to Follow-up|1|||
13118514|NCT03037580|25929992|FG000|Overall Study|Withdrawal by Subject|3|||
13118515|NCT03037580|25929993|FG001|Overall Study|Withdrawal by Subject|0|||
13118516|NCT03037580|25929992|FG000|Overall Study|Adverse Event|1|||
13118517|NCT03037580|25929993|FG001|Overall Study|Adverse Event|0|||
13118518|NCT03037580|25929992|FG000|Overall Study|Study Terminated by Sponsor|12|||
13273843|NCT04146363|26434423|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
13118519|NCT03037580|25929993|FG001|Overall Study|Study Terminated by Sponsor|15|||
13118520|NCT03037580|25929992|FG000|Overall Study|Death|0|||
13118521|NCT03037580|25929993|FG001|Overall Study|Death|1|||
13118522|NCT03037489|25930006|FG000|Overall Study|Adverse Event|4|||
13118523|NCT03037489|25930007|FG001|Overall Study|Adverse Event|0|||
13118524|NCT03037489|25930006|FG000|Overall Study|Withdrawal by Subject|3|||
13118525|NCT03037489|25930007|FG001|Overall Study|Withdrawal by Subject|0|||
13118526|NCT03037307|25930024|FG000|Period 1|Did Not Meet Study Criteria|0|||
13118527|NCT03037307|25930025|FG001|Period 1|Did Not Meet Study Criteria|0|||
13118528|NCT03037307|25930026|FG002|Period 1|Did Not Meet Study Criteria|0|||
13118529|NCT03037307|25930027|FG003|Period 1|Did Not Meet Study Criteria|1|||
13118530|NCT03037307|25930028|FG004|Period 1|Did Not Meet Study Criteria|0|||
13118531|NCT03037307|25930029|FG005|Period 1|Did Not Meet Study Criteria|0|||
13118532|NCT03036852|25930097|FG000|Overall Study|Death|2|||
13118533|NCT03036852|25930097|FG000|Overall Study|Lack of Efficacy|2|||
13273844|NCT04146363|26434424|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
13118534|NCT03036852|25930097|FG000|Overall Study|Adverse Event|1|||
13118535|NCT03036852|25930097|FG000|Overall Study|Lost to Follow-up|1|||
13118536|NCT03036839|25930157|FG000|Overall Study|Adverse Event|0|||
13118537|NCT03036839|25930158|FG001|Overall Study|Adverse Event|0|||
13118538|NCT03036839|25930159|FG002|Overall Study|Adverse Event|1|||
13273845|NCT04146363|26434425|FG005|Maintenance Blinded Treatment Period|Physician Decision|1|||
13273846|NCT04146363|26434426|FG006|Maintenance Blinded Treatment Period|Physician Decision|0|||
13118539|NCT03036839|25930157|FG000|Overall Study|Death|3|||
13118540|NCT03036839|25930158|FG001|Overall Study|Death|0|||
13118541|NCT03036839|25930159|FG002|Overall Study|Death|3|||
13118542|NCT03036839|25930157|FG000|Overall Study|Withdrew Consent|0|||
13118543|NCT03036839|25930158|FG001|Overall Study|Withdrew Consent|0|||
13118544|NCT03036839|25930159|FG002|Overall Study|Withdrew Consent|1|||
13118545|NCT03036813|25930192|FG000|Overall Study|Adverse Event|6|||
13118546|NCT03036813|25930193|FG001|Overall Study|Adverse Event|11|||
13118547|NCT03036813|25930194|FG002|Overall Study|Adverse Event|6|||
13118548|NCT03036813|25930192|FG000|Overall Study|Withdrawal by Subject|12|||
13118549|NCT03036813|25930193|FG001|Overall Study|Withdrawal by Subject|6|||
13118550|NCT03036813|25930194|FG002|Overall Study|Withdrawal by Subject|10|||
13118551|NCT03036813|25930192|FG000|Overall Study|Lost to Follow-up|1|||
13118552|NCT03036813|25930193|FG001|Overall Study|Lost to Follow-up|1|||
13118553|NCT03036813|25930194|FG002|Overall Study|Lost to Follow-up|0|||
13118554|NCT03036813|25930192|FG000|Overall Study|Physician Decision|2|||
13273847|NCT04146363|26434427|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
13273848|NCT04146363|26434428|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
13273849|NCT04146363|26434429|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
13273850|NCT04146363|26434430|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
13273851|NCT04146363|26434420|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
13273852|NCT04146363|26434421|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
13273853|NCT04146363|26434422|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
13273854|NCT04146363|26434423|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
13273855|NCT04146363|26434424|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
13273856|NCT04146363|26434425|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
13273857|NCT04146363|26434426|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|3|||
13273858|NCT04146363|26434427|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|5|||
13273859|NCT04146363|26434428|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
13273860|NCT04146363|26434429|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
13273861|NCT04146363|26434430|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
13273862|NCT04146363|26434420|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
13273863|NCT04146363|26434421|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
13273864|NCT04146363|26434422|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
13273865|NCT04146363|26434423|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
13273866|NCT04146363|26434424|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
13273867|NCT04146363|26434425|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|7|||
13273868|NCT04146363|26434426|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|4|||
13118555|NCT03036813|25930193|FG001|Overall Study|Physician Decision|1|||
13118556|NCT03036813|25930194|FG002|Overall Study|Physician Decision|1|||
13118557|NCT03036813|25930192|FG000|Overall Study|Non-Compliance|1|||
13118558|NCT03036813|25930193|FG001|Overall Study|Non-Compliance|5|||
13118559|NCT03036813|25930194|FG002|Overall Study|Non-Compliance|3|||
13118560|NCT03036813|25930192|FG000|Overall Study|Pregnancy|0|||
13273869|NCT04146363|26434427|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
13273870|NCT04146363|26434428|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
13273871|NCT04146363|26434429|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
13118561|NCT03036813|25930193|FG001|Overall Study|Pregnancy|0|||
13273872|NCT04146363|26434430|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
13273873|NCT04146363|26434420|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
13273874|NCT04146363|26434421|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
13273875|NCT04146363|26434422|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
13273876|NCT04146363|26434423|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
13273877|NCT04146363|26434424|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
13273878|NCT04146363|26434425|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
13273879|NCT04146363|26434426|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
13273880|NCT04146363|26434427|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
13273881|NCT04146363|26434428|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
13273882|NCT04146363|26434429|FG009|Maintenance Open Label Escape Arm|Adverse Event|4|||
13273883|NCT04146363|26434430|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
13273884|NCT04146363|26434420|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
13273885|NCT04146363|26434421|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
13273886|NCT04146363|26434422|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
13273887|NCT04146363|26434423|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
13273888|NCT04146363|26434424|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
13273889|NCT04146363|26434425|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
13118562|NCT03036813|25930194|FG002|Overall Study|Pregnancy|1|||
13118563|NCT03036813|25930192|FG000|Overall Study|Other|0|||
13273890|NCT04146363|26434426|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
13273891|NCT04146363|26434427|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
13273892|NCT04146363|26434428|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|11|||
13273893|NCT04146363|26434429|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|17|||
13273894|NCT04146363|26434430|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
13273895|NCT04146363|26434420|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
13273896|NCT04146363|26434421|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
13273897|NCT04146363|26434422|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
13273898|NCT04146363|26434423|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
13273899|NCT04146363|26434424|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
13273900|NCT04146363|26434425|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
13273901|NCT04146363|26434426|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
13273902|NCT04146363|26434427|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
13273903|NCT04146363|26434428|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
13273904|NCT04146363|26434429|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
13273905|NCT04146363|26434430|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
13273906|NCT04146363|26434420|FG000|Maintenance Open Label Escape Arm|Physician Decision|0|||
13273907|NCT04146363|26434421|FG001|Maintenance Open Label Escape Arm|Physician Decision|0|||
13273908|NCT04146363|26434422|FG002|Maintenance Open Label Escape Arm|Physician Decision|0|||
13273909|NCT04146363|26434423|FG003|Maintenance Open Label Escape Arm|Physician Decision|0|||
13273910|NCT04146363|26434424|FG004|Maintenance Open Label Escape Arm|Physician Decision|0|||
13273911|NCT04146363|26434425|FG005|Maintenance Open Label Escape Arm|Physician Decision|0|||
13273912|NCT04146363|26434426|FG006|Maintenance Open Label Escape Arm|Physician Decision|0|||
13273913|NCT04146363|26434427|FG007|Maintenance Open Label Escape Arm|Physician Decision|0|||
13273914|NCT04146363|26434428|FG008|Maintenance Open Label Escape Arm|Physician Decision|1|||
13273915|NCT04146363|26434429|FG009|Maintenance Open Label Escape Arm|Physician Decision|1|||
13273916|NCT04146363|26434430|FG010|Maintenance Open Label Escape Arm|Physician Decision|0|||
13273917|NCT04146363|26434420|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
13273918|NCT04146363|26434421|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
13273919|NCT04146363|26434422|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
13273920|NCT04146363|26434423|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
13273921|NCT04146363|26434424|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
13273922|NCT04146363|26434425|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
13273923|NCT04146363|26434426|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
13273924|NCT04146363|26434427|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
13273925|NCT04146363|26434428|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|5|||
13273926|NCT04146363|26434429|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
13273927|NCT04146363|26434430|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
13273928|NCT04146363|26434420|FG000|Maintenance Open Label Escape Arm|Pregnancy|0|||
13273929|NCT04146363|26434421|FG001|Maintenance Open Label Escape Arm|Pregnancy|0|||
13273930|NCT04146363|26434422|FG002|Maintenance Open Label Escape Arm|Pregnancy|0|||
13273931|NCT04146363|26434423|FG003|Maintenance Open Label Escape Arm|Pregnancy|0|||
13273932|NCT04146363|26434424|FG004|Maintenance Open Label Escape Arm|Pregnancy|0|||
13273933|NCT04146363|26434425|FG005|Maintenance Open Label Escape Arm|Pregnancy|0|||
13273934|NCT04146363|26434426|FG006|Maintenance Open Label Escape Arm|Pregnancy|0|||
13273935|NCT04146363|26434427|FG007|Maintenance Open Label Escape Arm|Pregnancy|0|||
13273936|NCT04146363|26434428|FG008|Maintenance Open Label Escape Arm|Pregnancy|0|||
13273937|NCT04146363|26434429|FG009|Maintenance Open Label Escape Arm|Pregnancy|1|||
13273938|NCT04146363|26434430|FG010|Maintenance Open Label Escape Arm|Pregnancy|0|||
13273939|NCT04146363|26434420|FG000|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
13273940|NCT04146363|26434421|FG001|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
13273941|NCT04146363|26434422|FG002|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
13273942|NCT04146363|26434423|FG003|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
13273943|NCT04146363|26434424|FG004|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
13273944|NCT04146363|26434425|FG005|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
13273945|NCT04146363|26434426|FG006|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
13273946|NCT04146363|26434427|FG007|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
13273947|NCT04146363|26434428|FG008|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
13273948|NCT04146363|26434429|FG009|Maintenance Open Label Escape Arm|EASI Scoring Error|2|||
13273949|NCT04146363|26434430|FG010|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
13291019|NCT02039674|26482395|FG003|Overall Study|Progressive Disease|7|||
13291020|NCT02039674|26482396|FG004|Overall Study|Progressive Disease|9|||
13291021|NCT02039674|26482397|FG005|Overall Study|Progressive Disease|10|||
13291022|NCT02039674|26482398|FG006|Overall Study|Progressive Disease|1|||
13291023|NCT02039674|26482399|FG007|Overall Study|Progressive Disease|3|||
13291024|NCT02039674|26482400|FG008|Overall Study|Progressive Disease|6|||
13291025|NCT02039674|26482401|FG009|Overall Study|Progressive Disease|4|||
13291026|NCT02039674|26482402|FG010|Overall Study|Progressive Disease|0|||
13273950|NCT03589976|26434445|FG000|Overall Study|Death|5|||
13273951|NCT03589976|26434446|FG001|Overall Study|Death|1|||
13273952|NCT03589976|26434445|FG000|Overall Study|Adverse Event|5|||
13273953|NCT03589976|26434446|FG001|Overall Study|Adverse Event|1|||
13273954|NCT03589976|26434445|FG000|Overall Study|Withdrawal by Subject|4|||
13273955|NCT03589976|26434446|FG001|Overall Study|Withdrawal by Subject|1|||
13273956|NCT03589976|26434445|FG000|Overall Study|Lost to Follow-up|1|||
13273957|NCT03589976|26434446|FG001|Overall Study|Lost to Follow-up|0|||
13273958|NCT03589976|26434445|FG000|Overall Study|Other|4|||
13273959|NCT03589976|26434446|FG001|Overall Study|Other|3|||
13273960|NCT03153111|26434576|FG000|Overall Study|Death|2|||
13273961|NCT03153111|26434577|FG001|Overall Study|Death|5|||
13273962|NCT03153111|26434576|FG000|Overall Study|Lost to Follow-up|1|||
13273963|NCT03153111|26434577|FG001|Overall Study|Lost to Follow-up|0|||
13273964|NCT03153111|26434576|FG000|Overall Study|Physician Decision|5|||
13273965|NCT03153111|26434577|FG001|Overall Study|Physician Decision|1|||
13273966|NCT03153111|26434576|FG000|Overall Study|Withdrawal by Subject|3|||
13273967|NCT03153111|26434577|FG001|Overall Study|Withdrawal by Subject|3|||
13273968|NCT01675479|26434636|FG000|Overall Study|Lost to Follow-up|11|||
13273969|NCT01670500|26434657|FG000|Overall Study|Withdrawal by Subject|1|||
13273970|NCT01670500|26434658|FG001|Overall Study|Withdrawal by Subject|0|||
13273971|NCT02400736|26434691|FG000|Overall Study|Lost to Follow-up|6|||
13273972|NCT02400736|26434692|FG001|Overall Study|Lost to Follow-up|6|||
13273973|NCT02400736|26434691|FG000|Overall Study|Withdrawal by Subject|2|||
13273974|NCT02400736|26434692|FG001|Overall Study|Withdrawal by Subject|1|||
13273975|NCT02400736|26434691|FG000|Overall Study|Moved from the area|3|||
13273976|NCT02400736|26434692|FG001|Overall Study|Moved from the area|1|||
13273977|NCT02400671|26434725|FG000|Overall Study|Death|5|||
13273978|NCT02400671|26434726|FG001|Overall Study|Death|3|||
13273979|NCT02400671|26434727|FG002|Overall Study|Death|4|||
13273980|NCT02400671|26434725|FG000|Overall Study|Lost to Follow-up|20|||
13273981|NCT02400671|26434726|FG001|Overall Study|Lost to Follow-up|27|||
13273982|NCT02400671|26434727|FG002|Overall Study|Lost to Follow-up|24|||
13273983|NCT02400671|26434725|FG000|Overall Study|Withdrawal by Subject|2|||
13273984|NCT02400671|26434726|FG001|Overall Study|Withdrawal by Subject|2|||
13273985|NCT02400671|26434727|FG002|Overall Study|Withdrawal by Subject|0|||
13273986|NCT02406027|26434769|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
13273987|NCT02406027|26434770|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2|||
13273988|NCT02406027|26434771|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1|||
13273989|NCT02406027|26434772|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
13273990|NCT02406027|26434773|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
13273991|NCT02406027|26434774|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
13273992|NCT02406027|26434775|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
13273993|NCT02406027|26434769|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3|||
13273994|NCT02406027|26434770|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
13273995|NCT02406027|26434771|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1|||
13273996|NCT02406027|26434772|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
13273997|NCT02406027|26434773|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
13273998|NCT02406027|26434774|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
13273999|NCT02406027|26434775|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
13274000|NCT02406027|26434769|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2|||
13274001|NCT02406027|26434770|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
13274002|NCT02406027|26434771|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
13274003|NCT02406027|26434772|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
13274004|NCT02406027|26434773|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
13274005|NCT02406027|26434774|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
13274006|NCT02406027|26434775|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
13274007|NCT02406027|26434769|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
13274008|NCT02406027|26434770|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
13274009|NCT02406027|26434771|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
13274010|NCT02406027|26434772|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
13274011|NCT02406027|26434773|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
13274012|NCT02406027|26434774|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
13274013|NCT02406027|26434775|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
13274014|NCT02406027|26434769|FG000|Open-label Phase (Period 2)|Adverse Event|0|||
13274015|NCT02406027|26434770|FG001|Open-label Phase (Period 2)|Adverse Event|0|||
13274016|NCT02406027|26434771|FG002|Open-label Phase (Period 2)|Adverse Event|0|||
13274017|NCT02406027|26434772|FG003|Open-label Phase (Period 2)|Adverse Event|2|||
13274018|NCT02406027|26434773|FG004|Open-label Phase (Period 2)|Adverse Event|2|||
13274019|NCT02406027|26434774|FG005|Open-label Phase (Period 2)|Adverse Event|0|||
13274020|NCT02406027|26434775|FG006|Open-label Phase (Period 2)|Adverse Event|0|||
13274021|NCT02406027|26434769|FG000|Open-label Phase (Period 2)|Physician Decision|0|||
13274022|NCT02406027|26434770|FG001|Open-label Phase (Period 2)|Physician Decision|0|||
13274023|NCT02406027|26434771|FG002|Open-label Phase (Period 2)|Physician Decision|0|||
13274024|NCT02406027|26434772|FG003|Open-label Phase (Period 2)|Physician Decision|0|||
13274025|NCT02406027|26434773|FG004|Open-label Phase (Period 2)|Physician Decision|0|||
13274026|NCT02406027|26434774|FG005|Open-label Phase (Period 2)|Physician Decision|1|||
13274027|NCT02406027|26434775|FG006|Open-label Phase (Period 2)|Physician Decision|1|||
13274028|NCT02406027|26434769|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
13274029|NCT02406027|26434770|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
13274030|NCT02406027|26434771|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
13274031|NCT02406027|26434772|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
13274032|NCT02406027|26434773|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4|||
13274033|NCT02406027|26434774|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
13274034|NCT02406027|26434775|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
13274035|NCT02406027|26434769|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
13274036|NCT02406027|26434770|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
13118564|NCT03036813|25930193|FG001|Overall Study|Other|3|||
13118565|NCT03036813|25930194|FG002|Overall Study|Other|5|||
13118566|NCT03036150|25930213|FG000|Overall Study|Withdrawal by Subject|8|||
13118567|NCT03036150|25930214|FG001|Overall Study|Withdrawal by Subject|3|||
13118568|NCT03036150|25930213|FG000|Overall Study|Lost to Follow-up|2|||
13118569|NCT03036150|25930214|FG001|Overall Study|Lost to Follow-up|2|||
13118570|NCT03036124|25930237|FG000|Overall Study|Lost to Follow-up|0|||
13118571|NCT03036124|25930238|FG001|Overall Study|Lost to Follow-up|2|||
13118572|NCT03036124|25930237|FG000|Overall Study|Withdrawal by Subject|5|||
13118573|NCT03036124|25930238|FG001|Overall Study|Withdrawal by Subject|4|||
13118574|NCT03036072|25930253|FG000|Overall Study|Death|0|||
13118575|NCT03036072|25930254|FG001|Overall Study|Death|1|||
13118576|NCT03036072|25930253|FG000|Overall Study|Withdrawal by Subject|0|||
13118577|NCT03036072|25930254|FG001|Overall Study|Withdrawal by Subject|1|||
13118578|NCT03036072|25930253|FG000|Overall Study|Physician Decision|0|||
13118579|NCT03036072|25930254|FG001|Overall Study|Physician Decision|1|||
13118580|NCT03035942|25930281|FG000|Overall Study|Adverse Event|8|||
13118581|NCT03035942|25930282|FG001|Overall Study|Adverse Event|4|||
13118582|NCT03035942|25930283|FG002|Overall Study|Adverse Event|5|||
13118583|NCT03035916|25930340|FG000|Overall Study|Puncture failed|0|||
13118584|NCT03035916|25930341|FG001|Overall Study|Puncture failed|2|||
13118585|NCT03035916|25930342|FG002|Overall Study|Puncture failed|0|||
13118586|NCT03035864|25930365|FG000|Treatment Period|Adverse Event|1|||
13118587|NCT03035864|25930366|FG001|Treatment Period|Adverse Event|0|||
13118588|NCT03035864|25930365|FG000|Treatment Period|Other|3|||
13118589|NCT03035864|25930366|FG001|Treatment Period|Other|1|||
13118590|NCT03035864|25930365|FG000|Follow-up Period|Adverse Event|1|||
13118591|NCT03035864|25930366|FG001|Follow-up Period|Adverse Event|0|||
13118592|NCT03035864|25930365|FG000|Follow-up Period|Lost to Follow-up|6|||
13274037|NCT02406027|26434771|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
13274038|NCT02406027|26434772|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11|||
13274039|NCT02406027|26434773|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7|||
13274040|NCT02406027|26434774|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24|||
13274041|NCT02406027|26434775|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19|||
13274042|NCT02406027|26434769|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
13274043|NCT02406027|26434770|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
13274044|NCT02406027|26434771|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
13274045|NCT02406027|26434772|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
13274046|NCT02406027|26434773|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
13274047|NCT02406027|26434774|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1|||
13274048|NCT02406027|26434775|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
13274049|NCT02406027|26434769|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
13274050|NCT02406027|26434770|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
13274051|NCT02406027|26434771|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
13274052|NCT02406027|26434772|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
13274053|NCT02406027|26434773|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1|||
13274054|NCT02406027|26434774|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
13274055|NCT02406027|26434775|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
13274056|NCT02409342|26434827|FG000|Overall Study|Death|181|||
13274057|NCT02409342|26434828|FG001|Overall Study|Death|174|||
13274058|NCT02409342|26434827|FG000|Overall Study|Withdrawal by Subject|24|||
13274059|NCT02409342|26434828|FG001|Overall Study|Withdrawal by Subject|16|||
13274060|NCT02409342|26434827|FG000|Overall Study|On-going in study|79|||
13274061|NCT02409342|26434828|FG001|Overall Study|On-going in study|92|||
13274062|NCT02409342|26434827|FG000|Overall Study|Lost to Follow-up|3|||
13118593|NCT03035864|25930366|FG001|Follow-up Period|Lost to Follow-up|2|||
13274063|NCT02409342|26434828|FG001|Overall Study|Lost to Follow-up|3|||
13274064|NCT00089999|26434855|FG000|Overall Study|Adverse Event|4|||
13274065|NCT00089999|26434856|FG001|Overall Study|Adverse Event|7|||
13274066|NCT00089999|26434855|FG000|Overall Study|Withdrawal by Subject|0|||
13274067|NCT00089999|26434856|FG001|Overall Study|Withdrawal by Subject|4|||
13274068|NCT00089999|26434855|FG000|Overall Study|Lost to Follow-up|2|||
13274069|NCT00089999|26434856|FG001|Overall Study|Lost to Follow-up|1|||
13274070|NCT00089999|26434855|FG000|Overall Study|Radiological Progression of Cancer|52|||
13274071|NCT00089999|26434856|FG001|Overall Study|Radiological Progression of Cancer|44|||
13274072|NCT00089999|26434855|FG000|Overall Study|Symptomatic Progression of Cancer|2|||
13274073|NCT00089999|26434856|FG001|Overall Study|Symptomatic Progression of Cancer|5|||
13274074|NCT00089999|26434855|FG000|Overall Study|Death|3|||
13274075|NCT00089999|26434856|FG001|Overall Study|Death|3|||
13274076|NCT00089999|26434855|FG000|Overall Study|Poor General Condition|1|||
13274077|NCT00089999|26434856|FG001|Overall Study|Poor General Condition|0|||
13274078|NCT00089999|26434855|FG000|Overall Study|Clinical Progression|1|||
13274079|NCT00089999|26434856|FG001|Overall Study|Clinical Progression|2|||
13274080|NCT00089999|26434855|FG000|Overall Study|Physician Decision|2|||
13274081|NCT00089999|26434856|FG001|Overall Study|Physician Decision|2|||
13274082|NCT00089999|26434855|FG000|Overall Study|Patient Underwent Surgery|2|||
13274083|NCT00089999|26434856|FG001|Overall Study|Patient Underwent Surgery|0|||
13274084|NCT00089999|26434855|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0|||
13274085|NCT00089999|26434856|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1|||
13291027|NCT02039674|26482403|FG011|Overall Study|Progressive Disease|34|||
13291028|NCT02039674|26482404|FG012|Overall Study|Progressive Disease|34|||
13291029|NCT02039674|26482405|FG013|Overall Study|Progressive Disease|18|||
13291030|NCT02039674|26482392|FG000|Overall Study|Withdrawal by Subject|1|||
13291031|NCT02039674|26482393|FG001|Overall Study|Withdrawal by Subject|2|||
13291032|NCT02039674|26482394|FG002|Overall Study|Withdrawal by Subject|3|||
13291033|NCT02039674|26482395|FG003|Overall Study|Withdrawal by Subject|0|||
13291034|NCT02039674|26482396|FG004|Overall Study|Withdrawal by Subject|1|||
13291035|NCT02039674|26482397|FG005|Overall Study|Withdrawal by Subject|0|||
13291036|NCT02039674|26482398|FG006|Overall Study|Withdrawal by Subject|0|||
13291037|NCT02039674|26482399|FG007|Overall Study|Withdrawal by Subject|0|||
13291038|NCT02039674|26482400|FG008|Overall Study|Withdrawal by Subject|0|||
13291039|NCT02039674|26482401|FG009|Overall Study|Withdrawal by Subject|1|||
13291040|NCT02039674|26482402|FG010|Overall Study|Withdrawal by Subject|1|||
13291041|NCT02039674|26482403|FG011|Overall Study|Withdrawal by Subject|4|||
13291042|NCT02039674|26482404|FG012|Overall Study|Withdrawal by Subject|6|||
13291043|NCT02039674|26482405|FG013|Overall Study|Withdrawal by Subject|2|||
13291044|NCT02039674|26482392|FG000|Overall Study|Clinical Progression|0|||
13291045|NCT02039674|26482393|FG001|Overall Study|Clinical Progression|0|||
13291046|NCT02039674|26482394|FG002|Overall Study|Clinical Progression|0|||
13291047|NCT02039674|26482395|FG003|Overall Study|Clinical Progression|0|||
13291048|NCT02039674|26482396|FG004|Overall Study|Clinical Progression|0|||
13291049|NCT02039674|26482397|FG005|Overall Study|Clinical Progression|0|||
13291050|NCT02039674|26482398|FG006|Overall Study|Clinical Progression|1|||
13291051|NCT02039674|26482399|FG007|Overall Study|Clinical Progression|0|||
13291052|NCT02039674|26482400|FG008|Overall Study|Clinical Progression|0|||
13291053|NCT02039674|26482401|FG009|Overall Study|Clinical Progression|0|||
13291054|NCT02039674|26482402|FG010|Overall Study|Clinical Progression|0|||
13291055|NCT02039674|26482403|FG011|Overall Study|Clinical Progression|0|||
13291056|NCT02039674|26482404|FG012|Overall Study|Clinical Progression|1|||
13291057|NCT02039674|26482405|FG013|Overall Study|Clinical Progression|0|||
13291058|NCT02039674|26482392|FG000|Overall Study|Sponsor Decision|1|||
13291059|NCT02039674|26482393|FG001|Overall Study|Sponsor Decision|1|||
13291060|NCT02039674|26482394|FG002|Overall Study|Sponsor Decision|1|||
13291061|NCT02039674|26482395|FG003|Overall Study|Sponsor Decision|1|||
13291062|NCT02039674|26482396|FG004|Overall Study|Sponsor Decision|1|||
13291063|NCT02039674|26482397|FG005|Overall Study|Sponsor Decision|0|||
13291064|NCT02039674|26482398|FG006|Overall Study|Sponsor Decision|0|||
13291065|NCT02039674|26482399|FG007|Overall Study|Sponsor Decision|0|||
13291066|NCT02039674|26482400|FG008|Overall Study|Sponsor Decision|0|||
13291067|NCT02039674|26482401|FG009|Overall Study|Sponsor Decision|3|||
13118594|NCT03035864|25930365|FG000|Follow-up Period|Physician Decision|1|||
13118595|NCT03035864|25930366|FG001|Follow-up Period|Physician Decision|0|||
13118596|NCT03035864|25930365|FG000|Follow-up Period|Other|3|||
13291068|NCT02039674|26482402|FG010|Overall Study|Sponsor Decision|0|||
13291069|NCT02039674|26482403|FG011|Overall Study|Sponsor Decision|8|||
13291070|NCT02039674|26482404|FG012|Overall Study|Sponsor Decision|5|||
13291071|NCT02039674|26482405|FG013|Overall Study|Sponsor Decision|0|||
13291072|NCT02039674|26482392|FG000|Overall Study|Other|0|||
13291073|NCT02039674|26482393|FG001|Overall Study|Other|0|||
13291074|NCT02039674|26482394|FG002|Overall Study|Other|0|||
13291075|NCT02039674|26482395|FG003|Overall Study|Other|0|||
13291076|NCT02039674|26482396|FG004|Overall Study|Other|0|||
13291077|NCT02039674|26482397|FG005|Overall Study|Other|0|||
13291078|NCT02039674|26482398|FG006|Overall Study|Other|0|||
13118597|NCT03035864|25930366|FG001|Follow-up Period|Other|2|||
13118598|NCT03035409|25930375|FG000|Overall Study|Adverse Event|5|||
13118599|NCT03035409|25930375|FG000|Overall Study|Death|2|||
13118600|NCT03035409|25930375|FG000|Overall Study|Withdrawal by Subject|2|||
13118601|NCT03035409|25930375|FG000|Overall Study|Non compliance|4|||
13118602|NCT03035409|25930375|FG000|Overall Study|Patient was jittery|1|||
13118603|NCT03035409|25930375|FG000|Overall Study|Did not like Questionnaire|1|||
13118604|NCT03035409|25930375|FG000|Overall Study|Aspartate Aminotransferase increased|1|||
13118605|NCT03035409|25930375|FG000|Overall Study|Did not like taking drugs|1|||
13118606|NCT03035227|25930404|FG000|Overall Study|study stopped due to PI leaving institut|1|||
13118607|NCT03035227|25930405|FG001|Overall Study|study stopped due to PI leaving institut|1|||
13118608|NCT03035032|25930422|FG000|Overall Study|Adverse Event|2|||
13274086|NCT00089986|26434883|FG000|Overall Study|Adverse Event|6|||
13274087|NCT00089986|26434884|FG001|Overall Study|Adverse Event|9|||
13274088|NCT00089986|26434885|FG002|Overall Study|Adverse Event|6|||
13274089|NCT00089986|26434883|FG000|Overall Study|Lost to Follow-up|3|||
13274090|NCT00089986|26434884|FG001|Overall Study|Lost to Follow-up|1|||
13274091|NCT00089986|26434885|FG002|Overall Study|Lost to Follow-up|1|||
13274092|NCT00089986|26434883|FG000|Overall Study|Protocol Violation|0|||
13274093|NCT00089986|26434884|FG001|Overall Study|Protocol Violation|1|||
13274094|NCT00089986|26434885|FG002|Overall Study|Protocol Violation|0|||
13274095|NCT00089986|26434883|FG000|Overall Study|Patient transferred to another hospital|2|||
13274096|NCT00089986|26434884|FG001|Overall Study|Patient transferred to another hospital|1|||
13274097|NCT00089986|26434885|FG002|Overall Study|Patient transferred to another hospital|0|||
13274098|NCT00089986|26434883|FG000|Overall Study|Subject withdrew but agreed follow up|1|||
13274099|NCT00089986|26434884|FG001|Overall Study|Subject withdrew but agreed follow up|2|||
13274100|NCT00089986|26434885|FG002|Overall Study|Subject withdrew but agreed follow up|0|||
13274101|NCT00089986|26434883|FG000|Overall Study|Hemohlobin stopping rule|0|||
13274102|NCT00089986|26434884|FG001|Overall Study|Hemohlobin stopping rule|1|||
13274103|NCT00089986|26434885|FG002|Overall Study|Hemohlobin stopping rule|0|||
13274104|NCT00089986|26434883|FG000|Overall Study|Investigator decision to withdrew|0|||
13274105|NCT00089986|26434884|FG001|Overall Study|Investigator decision to withdrew|1|||
13274106|NCT00089986|26434885|FG002|Overall Study|Investigator decision to withdrew|0|||
13274107|NCT00089986|26434883|FG000|Overall Study|Enrollment in another study|0|||
13274108|NCT00089986|26434884|FG001|Overall Study|Enrollment in another study|1|||
13274109|NCT00089986|26434885|FG002|Overall Study|Enrollment in another study|0|||
13274110|NCT00089986|26434883|FG000|Overall Study|Family decision|0|||
13274111|NCT00089986|26434884|FG001|Overall Study|Family decision|1|||
13274112|NCT00089986|26434885|FG002|Overall Study|Family decision|0|||
13274113|NCT00089986|26434883|FG000|Overall Study|Do not resuscitate (DNR)|0|||
13274114|NCT00089986|26434884|FG001|Overall Study|Do not resuscitate (DNR)|0|||
13274115|NCT00089986|26434885|FG002|Overall Study|Do not resuscitate (DNR)|1|||
13274116|NCT00089986|26434883|FG000|Overall Study|Withdrawal by Subject|3|||
13274117|NCT00089986|26434884|FG001|Overall Study|Withdrawal by Subject|6|||
13274118|NCT00089986|26434885|FG002|Overall Study|Withdrawal by Subject|2|||
13274119|NCT00089973|26434900|FG000|Overall Study|Adverse Event|3|||
13274120|NCT00089973|26434900|FG000|Overall Study|Withdrawal by Subject|1|||
13274121|NCT00089973|26434900|FG000|Overall Study|Disease progression|45|||
13118609|NCT03035032|25930422|FG000|Overall Study|Death|9|||
13274122|NCT00089973|26434900|FG000|Overall Study|Death|1|||
13274123|NCT00089843|26434923|FG000|Overall Study|Withdrawal by Subject|1|||
13274124|NCT00089843|26434924|FG001|Overall Study|Withdrawal by Subject|4|||
13274125|NCT00089843|26434925|FG002|Overall Study|Withdrawal by Subject|5|||
13274126|NCT00089843|26434926|FG003|Overall Study|Withdrawal by Subject|6|||
13274127|NCT00089843|26434923|FG000|Overall Study|Physician Decision|1|||
13274128|NCT00089843|26434924|FG001|Overall Study|Physician Decision|0|||
13274129|NCT00089843|26434925|FG002|Overall Study|Physician Decision|0|||
13274130|NCT00089843|26434926|FG003|Overall Study|Physician Decision|1|||
13274131|NCT00089778|26434947|FG000|Overall Study|Protocol Violation|0|||
13274132|NCT00089778|26434948|FG001|Overall Study|Protocol Violation|0|||
13274133|NCT00089778|26434949|FG002|Overall Study|Protocol Violation|1|||
13274134|NCT00089661|26434972|FG000|Overall Study|Adverse Event|0|||
13274135|NCT00089661|26434973|FG001|Overall Study|Adverse Event|2|||
13274136|NCT00089661|26434972|FG000|Overall Study|Death|1|||
13274137|NCT00089661|26434973|FG001|Overall Study|Death|0|||
13274138|NCT00089661|26434972|FG000|Overall Study|Lost to Follow-up|0|||
13274139|NCT00089661|26434973|FG001|Overall Study|Lost to Follow-up|3|||
13274140|NCT00089661|26434972|FG000|Overall Study|Withdrawal by Subject|11|||
13274141|NCT00089661|26434973|FG001|Overall Study|Withdrawal by Subject|9|||
13274142|NCT00089661|26434972|FG000|Overall Study|Disease progression|1|||
13118610|NCT03035032|25930422|FG000|Overall Study|Lost to Follow-up|1|||
13274143|NCT00089661|26434973|FG001|Overall Study|Disease progression|3|||
13274144|NCT00089661|26434972|FG000|Overall Study|Ineligibility determined|4|||
13274145|NCT00089661|26434973|FG001|Overall Study|Ineligibility determined|4|||
13118611|NCT03035032|25930422|FG000|Overall Study|Progressive Disease|22|||
13274146|NCT00089661|26434972|FG000|Overall Study|Noncompliance|2|||
13274147|NCT00089661|26434973|FG001|Overall Study|Noncompliance|4|||
13274148|NCT00089661|26434972|FG000|Overall Study|Other|2|||
13274149|NCT00089661|26434973|FG001|Overall Study|Other|1|||
13274150|NCT00089583|26435072|FG000|Overall Study|Adverse Event|0|||
13274151|NCT00089583|26435073|FG001|Overall Study|Adverse Event|3|||
13274152|NCT00089583|26435072|FG000|Overall Study|Insufficient Viral Load Response|5|||
13274153|NCT00089583|26435073|FG001|Overall Study|Insufficient Viral Load Response|5|||
13274154|NCT00089583|26435072|FG000|Overall Study|Withdrawal by Subject|0|||
13274155|NCT00089583|26435073|FG001|Overall Study|Withdrawal by Subject|4|||
13274156|NCT00089583|26435072|FG000|Overall Study|Participant (Par) Didn't Take Medication|1|||
13274157|NCT00089583|26435073|FG001|Overall Study|Participant (Par) Didn't Take Medication|0|||
13274158|NCT00089583|26435072|FG000|Overall Study|Participant Refused Study Medication|0|||
13274159|NCT00089583|26435073|FG001|Overall Study|Participant Refused Study Medication|2|||
13274160|NCT00089583|26435072|FG000|Overall Study|Non-Compliance|0|||
13274161|NCT00089583|26435073|FG001|Overall Study|Non-Compliance|4|||
13274162|NCT00089583|26435072|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0|||
13274163|NCT00089583|26435073|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3|||
13274164|NCT00089583|26435072|FG000|Overall Study|Participant Management Criteria Met|0|||
13274165|NCT00089583|26435073|FG001|Overall Study|Participant Management Criteria Met|1|||
13274166|NCT00089583|26435072|FG000|Overall Study|Reason Not Provided|0|||
13274167|NCT00089583|26435073|FG001|Overall Study|Reason Not Provided|1|||
13274168|NCT00089583|26435072|FG000|Overall Study|Protocol Violation|0|||
13274169|NCT00089583|26435073|FG001|Overall Study|Protocol Violation|3|||
13274170|NCT00089583|26435072|FG000|Overall Study|Principal Investigator Decision|0|||
13274171|NCT00089583|26435073|FG001|Overall Study|Principal Investigator Decision|10|||
13274172|NCT00089583|26435072|FG000|Overall Study|Start of Disallowed Medication|0|||
13274173|NCT00089583|26435073|FG001|Overall Study|Start of Disallowed Medication|1|||
13274174|NCT00089583|26435072|FG000|Overall Study|Necessity to Use Prohibited Drug|1|||
13274175|NCT00089583|26435073|FG001|Overall Study|Necessity to Use Prohibited Drug|0|||
13274176|NCT00089583|26435072|FG000|Overall Study|Participant Incarcerated|0|||
13274177|NCT00089583|26435073|FG001|Overall Study|Participant Incarcerated|1|||
13274178|NCT00089544|26435090|FG000|Overall Study|Ineligible|1|||
13274179|NCT00089544|26435091|FG001|Overall Study|Ineligible|0|||
13274180|NCT00089479|26435122|FG000|Overall Study|Death|108|||
13274181|NCT00089479|26435123|FG001|Overall Study|Death|75|||
13274182|NCT00089479|26435122|FG000|Overall Study|Withdrawal by Subject|86|||
13274183|NCT00089479|26435123|FG001|Overall Study|Withdrawal by Subject|107|||
13274184|NCT00089479|26435122|FG000|Overall Study|Lost to Follow-up|137|||
13274185|NCT00089479|26435123|FG001|Overall Study|Lost to Follow-up|107|||
13274186|NCT00089297|26435132|FG000|Overall Study|Adverse Event|9|||
13274187|NCT00089297|26435132|FG000|Overall Study|Death|1|||
13274188|NCT00089297|26435132|FG000|Overall Study|Withdrawal by Subject|12|||
13274189|NCT00089297|26435132|FG000|Overall Study|Disease progression|2|||
13274190|NCT00089297|26435132|FG000|Overall Study|Ineligible|11|||
13274191|NCT00089297|26435132|FG000|Overall Study|Secondary malignancy|1|||
13274192|NCT00089297|26435132|FG000|Overall Study|IRB approval not ready|1|||
13274193|NCT00089297|26435132|FG000|Overall Study|Non-compliance|1|||
13274194|NCT00089284|26435185|FG000|Overall Study|Adverse event before starting treatment|0|||
13274195|NCT00089284|26435186|FG001|Overall Study|Adverse event before starting treatment|0|||
13274196|NCT00089284|26435187|FG002|Overall Study|Adverse event before starting treatment|0|||
13274197|NCT00089284|26435188|FG003|Overall Study|Adverse event before starting treatment|0|||
13274198|NCT00089284|26435189|FG004|Overall Study|Adverse event before starting treatment|0|||
13274199|NCT00089284|26435190|FG005|Overall Study|Adverse event before starting treatment|0|||
13274200|NCT00089284|26435191|FG006|Overall Study|Adverse event before starting treatment|1|||
13274201|NCT00089076|26435204|FG000|Overall Study|Alternate Therapy|1|||
13274202|NCT00089076|26435204|FG000|Overall Study|Withdrawal by Subject|2|||
13274203|NCT00089076|26435204|FG000|Overall Study|Progression|7|||
13274204|NCT00088907|26435222|FG000|Randomized Study (Step 1)|Lack of Efficacy|55|||
13274205|NCT00088907|26435223|FG001|Randomized Study (Step 1)|Lack of Efficacy|62|||
13274206|NCT00088907|26435222|FG000|Randomized Study (Step 1)|Adverse Event|14|||
13274207|NCT00088907|26435223|FG001|Randomized Study (Step 1)|Adverse Event|19|||
13274208|NCT00088907|26435222|FG000|Randomized Study (Step 1)|Death|11|||
13274209|NCT00088907|26435223|FG001|Randomized Study (Step 1)|Death|12|||
13274210|NCT00088907|26435222|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10|||
13274211|NCT00088907|26435223|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15|||
13274212|NCT00088907|26435222|FG000|Randomized Study (Step 1)|complicating disease|3|||
13274213|NCT00088907|26435223|FG001|Randomized Study (Step 1)|complicating disease|1|||
13274214|NCT00088907|26435222|FG000|Randomized Study (Step 1)|unknown/not specify|24|||
13274215|NCT00088907|26435223|FG001|Randomized Study (Step 1)|unknown/not specify|13|||
13274216|NCT00088907|26435222|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19|||
13274217|NCT00088907|26435223|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12|||
13274218|NCT00088907|26435222|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16|||
13274219|NCT00088907|26435223|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0|||
13274220|NCT00088907|26435222|FG000|Single Gefitinib Treatment (Step 2)|Death|1|||
13274221|NCT00088907|26435223|FG001|Single Gefitinib Treatment (Step 2)|Death|0|||
13274222|NCT00088907|26435222|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2|||
13274223|NCT00088907|26435223|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0|||
13274224|NCT00088907|26435222|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5|||
13274225|NCT00088907|26435223|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0|||
13274226|NCT00088881|26435234|FG000|Step 1 - R-CHOP|Patient ineligible|9|||
13274227|NCT00088881|26435234|FG000|Step 1 - R-CHOP|Adverse Event|1|||
13274228|NCT00088881|26435234|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2|||
13274229|NCT00088881|26435234|FG000|Step 1 - R-CHOP|Physician Decision|1|||
13274230|NCT00088881|26435234|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1|||
13274231|NCT00088881|26435234|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8|||
13274232|NCT00088881|26435234|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3|||
13274233|NCT00088829|26435240|FG000|Overall Study|PI left institution and study was close|22|||
13274234|NCT00088595|26435258|FG000|Overall Study|Adverse Event|11|||
13274235|NCT00088595|26435258|FG000|Overall Study|Withdrawal by Subject|8|||
13274236|NCT00088595|26435258|FG000|Overall Study|Ongoing (After Core)|7|||
13274237|NCT00088595|26435258|FG000|Overall Study|New Cancer Therapy|2|||
13274238|NCT00088465|26435283|FG000|Overall Study|Withdrawal by Subject|290|||
13274239|NCT00088465|26435283|FG000|Overall Study|Adverse Event|77|||
13274240|NCT00088465|26435283|FG000|Overall Study|Lost to Follow-up|57|||
13274241|NCT00088465|26435283|FG000|Overall Study|Physician Decision|45|||
13274242|NCT00088465|26435283|FG000|Overall Study|Sponsor Decision|37|||
13274243|NCT00088465|26435283|FG000|Overall Study|Lack of Efficacy|27|||
13274244|NCT00088465|26435283|FG000|Overall Study|Protocol Violation|17|||
13274245|NCT00088465|26435283|FG000|Overall Study|Death|11|||
13274246|NCT00088374|26435294|FG000|Overall Study|patient did not receive any 17AAG|1|||
13274247|NCT00088374|26435294|FG000|Overall Study|patient received <1 cycle only of 17AAG|1|||
13274248|NCT00088205|26435311|FG000|Overall Study|Adverse Event|4|||
13274249|NCT00088205|26435311|FG000|Overall Study|Progressive Disease|51|||
13274250|NCT00088205|26435311|FG000|Overall Study|Physician Decision|1|||
13274251|NCT00088205|26435311|FG000|Overall Study|Death Due to Study Disease|4|||
13274252|NCT00088166|26435340|FG000|Overall Study|Adverse Event|11|||
13274253|NCT00088166|26435341|FG001|Overall Study|Adverse Event|9|||
13274254|NCT00088166|26435340|FG000|Overall Study|Death|3|||
13274255|NCT00088166|26435341|FG001|Overall Study|Death|1|||
13274256|NCT00088166|26435340|FG000|Overall Study|Lost to Follow-up|0|||
13274257|NCT00088166|26435341|FG001|Overall Study|Lost to Follow-up|1|||
13274258|NCT00088166|26435340|FG000|Overall Study|Physician Decision|4|||
13274259|NCT00088166|26435341|FG001|Overall Study|Physician Decision|1|||
13274260|NCT00088166|26435340|FG000|Overall Study|Protocol Violation|1|||
13274261|NCT00088166|26435341|FG001|Overall Study|Protocol Violation|5|||
13274262|NCT00088166|26435340|FG000|Overall Study|Patient deterioration|29|||
13274263|NCT00088166|26435341|FG001|Overall Study|Patient deterioration|39|||
13274264|NCT00088166|26435340|FG000|Overall Study|Withdrawal by Subject|5|||
13274265|NCT00088166|26435341|FG001|Overall Study|Withdrawal by Subject|5|||
13274266|NCT00088153|26435358|FG000|Overall Study|Physician Decision|3|||
13274267|NCT00088153|26435359|FG001|Overall Study|Physician Decision|3|||
13274268|NCT00088153|26435358|FG000|Overall Study|Withdrawal by Subject|10|||
13274269|NCT00088153|26435359|FG001|Overall Study|Withdrawal by Subject|10|||
13274270|NCT00088153|26435358|FG000|Overall Study|Lost to Follow-up|11|||
13274271|NCT00088153|26435359|FG001|Overall Study|Lost to Follow-up|12|||
13274272|NCT00087698|26435370|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14|||
13274273|NCT00087698|26435370|FG000|Overall Study|Death from Other Causes|3|||
13274274|NCT00087698|26435370|FG000|Overall Study|Adverse Event|4|||
13274275|NCT00087698|26435370|FG000|Overall Study|Withdrawal by Subject|4|||
13274276|NCT00087698|26435370|FG000|Overall Study|Lack of Efficacy, Physician Perception|3|||
13274277|NCT00087698|26435370|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
13274278|NCT00087698|26435370|FG000|Overall Study|Clinical Relapse|1|||
13274279|NCT00087698|26435370|FG000|Overall Study|Death from Study Disease|2|||
13274280|NCT00087698|26435370|FG000|Overall Study|Death from Study Drug Toxicity|2|||
13274281|NCT00087698|26435370|FG000|Overall Study|Protocol Violation|1|||
13274282|NCT00087685|26435377|FG000|Overall Study|Adverse Event|5|||
13274283|NCT00087685|26435377|FG000|Overall Study|Non-Compliance|1|||
13274284|NCT00087685|26435377|FG000|Overall Study|Progressive Disease|5|||
13274285|NCT00087685|26435377|FG000|Overall Study|Withdrawal by Subject|3|||
13274286|NCT00087646|26435416|FG000|Overall Study|Adverse Event|37|||
13274287|NCT00087646|26435417|FG001|Overall Study|Adverse Event|6|||
13274288|NCT00087646|26435418|FG002|Overall Study|Adverse Event|18|||
13274289|NCT00087646|26435419|FG003|Overall Study|Adverse Event|20|||
13274290|NCT00087646|26435416|FG000|Overall Study|Death|0|||
13118612|NCT03035032|25930422|FG000|Overall Study|Protocol Violation|2|||
13118613|NCT03035032|25930422|FG000|Overall Study|Withdrawal by Subject|2|||
13118614|NCT03035032|25930422|FG000|Overall Study|Physician Decision|5|||
13274291|NCT00087646|26435417|FG001|Overall Study|Death|1|||
13274292|NCT00087646|26435418|FG002|Overall Study|Death|0|||
13274293|NCT00087646|26435419|FG003|Overall Study|Death|0|||
13274294|NCT00087646|26435416|FG000|Overall Study|Withdrawal by Subject|6|||
13274295|NCT00087646|26435417|FG001|Overall Study|Withdrawal by Subject|1|||
13118615|NCT03034967|25930637|FG000|Overall Study|Withdrawal by Subject|9|||
13118616|NCT03034967|25930638|FG001|Overall Study|Withdrawal by Subject|2|||
13118617|NCT03034967|25930639|FG002|Overall Study|Withdrawal by Subject|6|||
13118618|NCT03034967|25930640|FG003|Overall Study|Withdrawal by Subject|6|||
13118619|NCT03034967|25930641|FG004|Overall Study|Withdrawal by Subject|9|||
13118620|NCT03034967|25930642|FG005|Overall Study|Withdrawal by Subject|2|||
13118621|NCT03034967|25930637|FG000|Overall Study|Physician Decision|1|||
13118622|NCT03034967|25930638|FG001|Overall Study|Physician Decision|0|||
13118623|NCT03034967|25930639|FG002|Overall Study|Physician Decision|1|||
13118624|NCT03034967|25930640|FG003|Overall Study|Physician Decision|1|||
13118625|NCT03034967|25930641|FG004|Overall Study|Physician Decision|1|||
13118626|NCT03034967|25930642|FG005|Overall Study|Physician Decision|0|||
13118627|NCT03034967|25930637|FG000|Overall Study|Lost to Follow-up|0|||
13118628|NCT03034967|25930638|FG001|Overall Study|Lost to Follow-up|0|||
13118629|NCT03034967|25930639|FG002|Overall Study|Lost to Follow-up|0|||
13118630|NCT03034967|25930640|FG003|Overall Study|Lost to Follow-up|1|||
13118631|NCT03034967|25930641|FG004|Overall Study|Lost to Follow-up|0|||
13118632|NCT03034967|25930642|FG005|Overall Study|Lost to Follow-up|2|||
13118633|NCT03034967|25930637|FG000|Overall Study|Liver function test abnormality|0|||
13118634|NCT03034967|25930638|FG001|Overall Study|Liver function test abnormality|0|||
13118635|NCT03034967|25930639|FG002|Overall Study|Liver function test abnormality|1|||
13118636|NCT03034967|25930640|FG003|Overall Study|Liver function test abnormality|0|||
13118637|NCT03034967|25930641|FG004|Overall Study|Liver function test abnormality|0|||
13118638|NCT03034967|25930642|FG005|Overall Study|Liver function test abnormality|0|||
13118639|NCT03034967|25930637|FG000|Overall Study|Protocol Violation|1|||
13118640|NCT03034967|25930638|FG001|Overall Study|Protocol Violation|0|||
13118641|NCT03034967|25930639|FG002|Overall Study|Protocol Violation|0|||
13118642|NCT03034967|25930640|FG003|Overall Study|Protocol Violation|0|||
13118643|NCT03034967|25930641|FG004|Overall Study|Protocol Violation|0|||
13118644|NCT03034967|25930642|FG005|Overall Study|Protocol Violation|2|||
13118645|NCT03034967|25930637|FG000|Overall Study|Lack of Efficacy|0|||
13118646|NCT03034967|25930638|FG001|Overall Study|Lack of Efficacy|1|||
13118647|NCT03034967|25930639|FG002|Overall Study|Lack of Efficacy|2|||
13118648|NCT03034967|25930640|FG003|Overall Study|Lack of Efficacy|1|||
13118649|NCT03034967|25930641|FG004|Overall Study|Lack of Efficacy|1|||
13118650|NCT03034967|25930642|FG005|Overall Study|Lack of Efficacy|0|||
13118651|NCT03034967|25930637|FG000|Overall Study|Adverse Event, non-fatal|3|||
13118652|NCT03034967|25930638|FG001|Overall Study|Adverse Event, non-fatal|1|||
13118653|NCT03034967|25930639|FG002|Overall Study|Adverse Event, non-fatal|2|||
13118654|NCT03034967|25930640|FG003|Overall Study|Adverse Event, non-fatal|0|||
13118655|NCT03034967|25930641|FG004|Overall Study|Adverse Event, non-fatal|2|||
13118656|NCT03034967|25930642|FG005|Overall Study|Adverse Event, non-fatal|8|||
13118657|NCT03034967|25930637|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
13118658|NCT03034967|25930638|FG001|Overall Study|Adverse Event, Serious Fatal|1|||
13118659|NCT03034967|25930639|FG002|Overall Study|Adverse Event, Serious Fatal|1|||
13118660|NCT03034967|25930640|FG003|Overall Study|Adverse Event, Serious Fatal|2|||
13118661|NCT03034967|25930641|FG004|Overall Study|Adverse Event, Serious Fatal|1|||
13118662|NCT03034967|25930642|FG005|Overall Study|Adverse Event, Serious Fatal|1|||
13274296|NCT00087646|26435418|FG002|Overall Study|Withdrawal by Subject|2|||
13274297|NCT00087646|26435419|FG003|Overall Study|Withdrawal by Subject|2|||
13274298|NCT00087646|26435416|FG000|Overall Study|Insufficient therapeutic response|64|||
13274299|NCT00087646|26435417|FG001|Overall Study|Insufficient therapeutic response|24|||
13274300|NCT00087646|26435418|FG002|Overall Study|Insufficient therapeutic response|38|||
13274301|NCT00087646|26435419|FG003|Overall Study|Insufficient therapeutic response|51|||
13274302|NCT00087646|26435416|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13|||
13274303|NCT00087646|26435417|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6|||
13274304|NCT00087646|26435418|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4|||
13274305|NCT00087646|26435419|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5|||
13274306|NCT00087646|26435416|FG000|Overall Study|Failure to Return|5|||
13274307|NCT00087646|26435417|FG001|Overall Study|Failure to Return|2|||
13274308|NCT00087646|26435418|FG002|Overall Study|Failure to Return|2|||
13274309|NCT00087646|26435419|FG003|Overall Study|Failure to Return|3|||
13274310|NCT00087646|26435416|FG000|Overall Study|Administrative/Other|6|||
13274311|NCT00087646|26435417|FG001|Overall Study|Administrative/Other|1|||
13274312|NCT00087646|26435418|FG002|Overall Study|Administrative/Other|1|||
13274313|NCT00087646|26435419|FG003|Overall Study|Administrative/Other|2|||
13274314|NCT00087646|26435416|FG000|Overall Study|Other Protocol Violation|3|||
13274315|NCT00087646|26435417|FG001|Overall Study|Other Protocol Violation|1|||
13274316|NCT00087646|26435418|FG002|Overall Study|Other Protocol Violation|0|||
13274317|NCT00087646|26435419|FG003|Overall Study|Other Protocol Violation|0|||
13274318|NCT00087646|26435416|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
13274319|NCT00087646|26435417|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
13274320|NCT00087646|26435418|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
13274321|NCT00087646|26435419|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
13133445|NCT02769312|25987785|FG000|Follow-up|Lost to Follow-up|1|||
13274322|NCT00087594|26435458|FG000|Overall Study|Adverse Event|2|||
13274323|NCT00087594|26435459|FG001|Overall Study|Adverse Event|3|||
13274324|NCT00087594|26435458|FG000|Overall Study|Lost to Follow-up|0|||
13274325|NCT00087594|26435459|FG001|Overall Study|Lost to Follow-up|2|||
13274326|NCT00087594|26435458|FG000|Overall Study|Withdrawal by Subject|4|||
13274327|NCT00087594|26435459|FG001|Overall Study|Withdrawal by Subject|2|||
13274328|NCT00087594|26435458|FG000|Overall Study|Lack of Efficacy|2|||
13274329|NCT00087594|26435459|FG001|Overall Study|Lack of Efficacy|5|||
13274330|NCT00087568|26435490|FG000|Overall Study|Adverse Event|4|||
13274331|NCT00087568|26435491|FG001|Overall Study|Adverse Event|0|||
13274332|NCT00087568|26435490|FG000|Overall Study|Withdrawal by Subject|1|||
13274333|NCT00087568|26435491|FG001|Overall Study|Withdrawal by Subject|1|||
13274334|NCT00087568|26435490|FG000|Overall Study|Lost to Follow-up|1|||
13274335|NCT00087568|26435491|FG001|Overall Study|Lost to Follow-up|0|||
13274336|NCT00087568|26435490|FG000|Overall Study|Lack of Efficacy|24|||
13274337|NCT00087568|26435491|FG001|Overall Study|Lack of Efficacy|1|||
13274338|NCT00087555|26435509|FG000|Overall Study|Adverse Event|3|||
13274339|NCT00087555|26435510|FG001|Overall Study|Adverse Event|6|||
13274340|NCT00087555|26435511|FG002|Overall Study|Adverse Event|14|||
13274341|NCT00087555|26435509|FG000|Overall Study|Lost to Follow-up|0|||
13274342|NCT00087555|26435510|FG001|Overall Study|Lost to Follow-up|1|||
13274343|NCT00087555|26435511|FG002|Overall Study|Lost to Follow-up|1|||
13274344|NCT00087555|26435509|FG000|Overall Study|Non - Compliance|1|||
13274345|NCT00087555|26435510|FG001|Overall Study|Non - Compliance|0|||
13274346|NCT00087555|26435511|FG002|Overall Study|Non - Compliance|0|||
13274347|NCT00087555|26435509|FG000|Overall Study|Protocol Violation|0|||
13274348|NCT00087555|26435510|FG001|Overall Study|Protocol Violation|0|||
13274349|NCT00087555|26435511|FG002|Overall Study|Protocol Violation|2|||
13118663|NCT03034954|25930701|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1|||
13118664|NCT03034954|25930702|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0|||
13118665|NCT03034915|25930750|FG000|Overall Study|Adverse Event|29|||
13118666|NCT03034915|25930751|FG001|Overall Study|Adverse Event|32|||
13118667|NCT03034915|25930752|FG002|Overall Study|Adverse Event|22|||
13118668|NCT03034915|25930750|FG000|Overall Study|Lost to Follow-up|5|||
13118669|NCT03034915|25930751|FG001|Overall Study|Lost to Follow-up|13|||
13118670|NCT03034915|25930752|FG002|Overall Study|Lost to Follow-up|3|||
13118671|NCT03034915|25930750|FG000|Overall Study|Withdrawal by Subject|29|||
13118672|NCT03034915|25930751|FG001|Overall Study|Withdrawal by Subject|46|||
13118673|NCT03034915|25930752|FG002|Overall Study|Withdrawal by Subject|41|||
13118674|NCT03034915|25930750|FG000|Overall Study|Protocol Deviation|2|||
13118675|NCT03034915|25930751|FG001|Overall Study|Protocol Deviation|14|||
13118676|NCT03034915|25930752|FG002|Overall Study|Protocol Deviation|7|||
13118677|NCT03034915|25930750|FG000|Overall Study|Lack of Efficacy|8|||
13118678|NCT03034915|25930751|FG001|Overall Study|Lack of Efficacy|16|||
13118679|NCT03034915|25930752|FG002|Overall Study|Lack of Efficacy|18|||
13118680|NCT03034915|25930750|FG000|Overall Study|Site closed|2|||
13118681|NCT03034915|25930751|FG001|Overall Study|Site closed|2|||
13118682|NCT03034915|25930752|FG002|Overall Study|Site closed|4|||
13118683|NCT03034915|25930750|FG000|Overall Study|Protocol-defined withdrawal criteria met|19|||
13118684|NCT03034915|25930751|FG001|Overall Study|Protocol-defined withdrawal criteria met|26|||
13274350|NCT00087555|26435509|FG000|Overall Study|Screen Failure|1|||
13274351|NCT00087555|26435510|FG001|Overall Study|Screen Failure|1|||
13274352|NCT00087555|26435511|FG002|Overall Study|Screen Failure|0|||
13274353|NCT00087555|26435509|FG000|Overall Study|Pregnancy|0|||
13274354|NCT00087555|26435510|FG001|Overall Study|Pregnancy|1|||
13274355|NCT00087555|26435511|FG002|Overall Study|Pregnancy|1|||
13274356|NCT00087555|26435509|FG000|Overall Study|Withdrawal by Subject|3|||
13274357|NCT00087555|26435510|FG001|Overall Study|Withdrawal by Subject|2|||
13274358|NCT00087555|26435511|FG002|Overall Study|Withdrawal by Subject|1|||
13274359|NCT00087555|26435509|FG000|Overall Study|Lack of Efficacy|2|||
13274360|NCT00087555|26435510|FG001|Overall Study|Lack of Efficacy|0|||
13274361|NCT00087555|26435511|FG002|Overall Study|Lack of Efficacy|1|||
13274362|NCT00087555|26435509|FG000|Overall Study|Non Compliance|0|||
13274363|NCT00087555|26435510|FG001|Overall Study|Non Compliance|0|||
13274364|NCT00087555|26435511|FG002|Overall Study|Non Compliance|1|||
13274365|NCT00087555|26435509|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1|||
13274366|NCT00087555|26435510|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0|||
13274367|NCT00087555|26435511|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0|||
13274368|NCT00087555|26435509|FG000|Overall Study|Patient wanted to go back on Med|1|||
13274369|NCT00087555|26435510|FG001|Overall Study|Patient wanted to go back on Med|0|||
13274370|NCT00087555|26435511|FG002|Overall Study|Patient wanted to go back on Med|0|||
13274371|NCT00087529|26435530|FG000|Overall Study|Death|1|||
13274372|NCT00087529|26435531|FG001|Overall Study|Death|0|||
13274373|NCT00087529|26435530|FG000|Overall Study|Adverse Event|0|||
13274374|NCT00087529|26435531|FG001|Overall Study|Adverse Event|8|||
13274375|NCT00087529|26435530|FG000|Overall Study|Pregnancy|0|||
13274376|NCT00087529|26435531|FG001|Overall Study|Pregnancy|1|||
13118685|NCT03034915|25930752|FG002|Overall Study|Protocol-defined withdrawal criteria met|29|||
13118686|NCT03034915|25930750|FG000|Overall Study|Physician Decision|1|||
13274377|NCT00087529|26435530|FG000|Overall Study|Lost to Follow-up|2|||
13274378|NCT00087529|26435531|FG001|Overall Study|Lost to Follow-up|3|||
13274379|NCT00087529|26435530|FG000|Overall Study|Participant Decision|14|||
13274380|NCT00087529|26435531|FG001|Overall Study|Participant Decision|37|||
13274381|NCT00087529|26435530|FG000|Overall Study|Physician Decision|4|||
13274382|NCT00087529|26435531|FG001|Overall Study|Physician Decision|8|||
13274383|NCT00087529|26435530|FG000|Overall Study|Initiation of Excluded Therapy|0|||
13274384|NCT00087529|26435531|FG001|Overall Study|Initiation of Excluded Therapy|1|||
13274385|NCT00087529|26435530|FG000|Overall Study|Participant Noncompliance|0|||
13274386|NCT00087529|26435531|FG001|Overall Study|Participant Noncompliance|1|||
13274387|NCT00087529|26435530|FG000|Overall Study|Disease Progression|5|||
13274388|NCT00087529|26435531|FG001|Overall Study|Disease Progression|4|||
13274389|NCT00087529|26435530|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5|||
13274390|NCT00087529|26435531|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5|||
13274391|NCT00087516|26435569|FG000|Overall Study|Adverse Event|10|||
13274392|NCT00087516|26435570|FG001|Overall Study|Adverse Event|10|||
13274393|NCT00087516|26435571|FG002|Overall Study|Adverse Event|3|||
13274394|NCT00087516|26435572|FG003|Overall Study|Adverse Event|6|||
13274395|NCT00087516|26435569|FG000|Overall Study|Lack of Efficacy|82|||
13274396|NCT00087516|26435570|FG001|Overall Study|Lack of Efficacy|80|||
13274397|NCT00087516|26435571|FG002|Overall Study|Lack of Efficacy|39|||
13274398|NCT00087516|26435572|FG003|Overall Study|Lack of Efficacy|29|||
13274399|NCT00087516|26435569|FG000|Overall Study|Lost to Follow-up|8|||
13274400|NCT00087516|26435570|FG001|Overall Study|Lost to Follow-up|6|||
13274401|NCT00087516|26435571|FG002|Overall Study|Lost to Follow-up|5|||
13274402|NCT00087516|26435572|FG003|Overall Study|Lost to Follow-up|5|||
13274403|NCT00087516|26435569|FG000|Overall Study|Protocol Violation|4|||
13274404|NCT00087516|26435570|FG001|Overall Study|Protocol Violation|8|||
13274405|NCT00087516|26435571|FG002|Overall Study|Protocol Violation|3|||
13274406|NCT00087516|26435572|FG003|Overall Study|Protocol Violation|6|||
13274407|NCT00087516|26435569|FG000|Overall Study|Withdrawal by Subject|16|||
13274408|NCT00087516|26435570|FG001|Overall Study|Withdrawal by Subject|27|||
13274409|NCT00087516|26435571|FG002|Overall Study|Withdrawal by Subject|11|||
13274410|NCT00087516|26435572|FG003|Overall Study|Withdrawal by Subject|12|||
13274411|NCT00087516|26435569|FG000|Overall Study|Site terminated|0|||
13274412|NCT00087516|26435570|FG001|Overall Study|Site terminated|2|||
13274413|NCT00087516|26435571|FG002|Overall Study|Site terminated|1|||
13274414|NCT00087516|26435572|FG003|Overall Study|Site terminated|0|||
13274415|NCT00087516|26435569|FG000|Overall Study|Protocol specified discontinuation|35|||
13274416|NCT00087516|26435570|FG001|Overall Study|Protocol specified discontinuation|33|||
13274417|NCT00087516|26435571|FG002|Overall Study|Protocol specified discontinuation|33|||
13274418|NCT00087516|26435572|FG003|Overall Study|Protocol specified discontinuation|26|||
13274419|NCT00087516|26435569|FG000|Overall Study|Patient moved|3|||
13118687|NCT03034915|25930751|FG001|Overall Study|Physician Decision|5|||
13118688|NCT03034915|25930752|FG002|Overall Study|Physician Decision|2|||
13118689|NCT03034772|25930773|FG000|Overall Study|Adverse Event|0|||
13274420|NCT00087516|26435570|FG001|Overall Study|Patient moved|2|||
13274421|NCT00087516|26435571|FG002|Overall Study|Patient moved|1|||
13274422|NCT00087516|26435572|FG003|Overall Study|Patient moved|0|||
13274423|NCT00087516|26435569|FG000|Overall Study|Patient was non-compliant|3|||
13274424|NCT00087516|26435570|FG001|Overall Study|Patient was non-compliant|1|||
13274425|NCT00087516|26435571|FG002|Overall Study|Patient was non-compliant|0|||
13274426|NCT00087516|26435572|FG003|Overall Study|Patient was non-compliant|0|||
13274427|NCT00087516|26435569|FG000|Overall Study|Recommendation of Primary Care Physician|0|||
13274428|NCT00087516|26435570|FG001|Overall Study|Recommendation of Primary Care Physician|0|||
13274429|NCT00087516|26435571|FG002|Overall Study|Recommendation of Primary Care Physician|0|||
13274430|NCT00087516|26435572|FG003|Overall Study|Recommendation of Primary Care Physician|1|||
13274431|NCT00087516|26435569|FG000|Overall Study|Other|0|||
13274432|NCT00087516|26435570|FG001|Overall Study|Other|0|||
13118690|NCT03034772|25930774|FG001|Overall Study|Adverse Event|1|||
13118691|NCT03034772|25930773|FG000|Overall Study|Withdrawal by Subject|0|||
13118692|NCT03034772|25930774|FG001|Overall Study|Withdrawal by Subject|1|||
13118693|NCT03034577|25930797|FG000|Overall Study|Withdrawal by Subject|6|||
13118694|NCT03034577|25930798|FG001|Overall Study|Withdrawal by Subject|9|||
13118695|NCT03034577|25930797|FG000|Overall Study|Lost to Follow-up|25|||
13118696|NCT03034577|25930798|FG001|Overall Study|Lost to Follow-up|26|||
13118697|NCT03034460|25930847|FG000|Overall Study|Adverse Event|0|||
13118698|NCT03034460|25930848|FG001|Overall Study|Adverse Event|1|||
13118699|NCT03034460|25930847|FG000|Overall Study|Withdrawal by Subject|2|||
13274433|NCT00087516|26435571|FG002|Overall Study|Other|1|||
13274434|NCT00087516|26435572|FG003|Overall Study|Other|0|||
13274435|NCT00087152|26435580|FG000|Overall Study|Ineligible|6|||
13274436|NCT00087139|26435605|FG000|Overall Study|Adverse Event|18|||
13274437|NCT00087139|26435606|FG001|Overall Study|Adverse Event|17|||
13274438|NCT00087139|26435607|FG002|Overall Study|Adverse Event|13|||
13274439|NCT00087139|26435605|FG000|Overall Study|Death|2|||
13274440|NCT00087139|26435606|FG001|Overall Study|Death|1|||
13274441|NCT00087139|26435607|FG002|Overall Study|Death|0|||
13118700|NCT03034460|25930848|FG001|Overall Study|Withdrawal by Subject|2|||
13118701|NCT03034460|25930847|FG000|Overall Study|Personal Reasons|1|||
13118702|NCT03034460|25930848|FG001|Overall Study|Personal Reasons|0|||
13118703|NCT03034135|25930859|FG000|Overall Study|Withdrawal by Subject|2|||
13118704|NCT03034057|25930867|FG000|Overall Study|Withdrawal by Subject|10|||
13118705|NCT03034057|25930867|FG000|Overall Study|Protocol Violation|1|||
13274442|NCT00087139|26435605|FG000|Overall Study|Withdrawal by Subject|3|||
13274443|NCT00087139|26435606|FG001|Overall Study|Withdrawal by Subject|2|||
13274444|NCT00087139|26435607|FG002|Overall Study|Withdrawal by Subject|2|||
13274445|NCT00087139|26435605|FG000|Overall Study|Physician Decision|1|||
13274446|NCT00087139|26435606|FG001|Overall Study|Physician Decision|1|||
13274447|NCT00087139|26435607|FG002|Overall Study|Physician Decision|1|||
13274448|NCT00087139|26435605|FG000|Overall Study|Disease progression|9|||
13274449|NCT00087139|26435606|FG001|Overall Study|Disease progression|19|||
13274450|NCT00087139|26435607|FG002|Overall Study|Disease progression|12|||
13274451|NCT00087139|26435605|FG000|Overall Study|Ineligible|4|||
13274452|NCT00087139|26435606|FG001|Overall Study|Ineligible|7|||
13274453|NCT00087139|26435607|FG002|Overall Study|Ineligible|4|||
13274454|NCT00087139|26435605|FG000|Overall Study|Symptomatic deterioration|1|||
13274455|NCT00087139|26435606|FG001|Overall Study|Symptomatic deterioration|1|||
13274456|NCT00087139|26435607|FG002|Overall Study|Symptomatic deterioration|3|||
13274457|NCT00087139|26435605|FG000|Overall Study|Use of coumadin|1|||
13274458|NCT00087139|26435606|FG001|Overall Study|Use of coumadin|0|||
13274459|NCT00087139|26435607|FG002|Overall Study|Use of coumadin|0|||
13274460|NCT00087139|26435605|FG000|Overall Study|Response achieved|0|||
13274461|NCT00087139|26435606|FG001|Overall Study|Response achieved|1|||
13274462|NCT00087139|26435607|FG002|Overall Study|Response achieved|0|||
13274463|NCT00087139|26435605|FG000|Overall Study|Extradural disease|0|||
13274464|NCT00087139|26435606|FG001|Overall Study|Extradural disease|0|||
13274465|NCT00087139|26435607|FG002|Overall Study|Extradural disease|1|||
13274466|NCT00087126|26435618|FG000|Overall Study|Ineligible - second primary|1|||
13274467|NCT00087126|26435618|FG000|Overall Study|Never treated|1|||
13274468|NCT00086996|26435627|FG000|Overall Study|Adverse Event|29|||
13274469|NCT00086996|26435627|FG000|Overall Study|Death|4|||
13274470|NCT00086996|26435627|FG000|Overall Study|progression/relapse|7|||
13274471|NCT00086996|26435627|FG000|Overall Study|Withdrawal by Subject|13|||
13274472|NCT00086996|26435627|FG000|Overall Study|Other|6|||
13118706|NCT03034057|25930867|FG000|Overall Study|Not defined|2|||
13118707|NCT03034057|25930867|FG000|Overall Study|Lost to Follow-up|19|||
13118708|NCT03034057|25930867|FG000|Overall Study|Adverse Event|22|||
13118709|NCT03034057|25930867|FG000|Overall Study|Medication error without associated AE|1|||
13118710|NCT03034044|25930889|FG000|Overall Study|Enrolled, but not received Xyntha|1|||
13118711|NCT03033784|25930945|FG000|Overall Study|Anxiety related to MRI scanner|0|||
13118712|NCT03033784|25930946|FG001|Overall Study|Anxiety related to MRI scanner|1|||
13118713|NCT03033784|25930947|FG002|Overall Study|Anxiety related to MRI scanner|0|||
13274473|NCT00086996|26435627|FG000|Overall Study|not eligible|5|||
13274474|NCT00086684|26435648|FG000|Overall Study|Adverse Event|12|||
13274475|NCT00086684|26435649|FG001|Overall Study|Adverse Event|17|||
13274476|NCT00086684|26435650|FG002|Overall Study|Adverse Event|14|||
13274477|NCT00086684|26435648|FG000|Overall Study|Lack of Efficacy|6|||
13274478|NCT00086684|26435649|FG001|Overall Study|Lack of Efficacy|6|||
13274479|NCT00086684|26435650|FG002|Overall Study|Lack of Efficacy|5|||
13274480|NCT00086684|26435648|FG000|Overall Study|Lost to Follow-up|15|||
13274481|NCT00086684|26435649|FG001|Overall Study|Lost to Follow-up|8|||
13274482|NCT00086684|26435650|FG002|Overall Study|Lost to Follow-up|10|||
13274483|NCT00086684|26435648|FG000|Overall Study|Protocol Violation|8|||
13274484|NCT00086684|26435649|FG001|Overall Study|Protocol Violation|3|||
13274485|NCT00086684|26435650|FG002|Overall Study|Protocol Violation|0|||
13274486|NCT00086684|26435648|FG000|Overall Study|Withdrawal by Subject|0|||
13274487|NCT00086684|26435649|FG001|Overall Study|Withdrawal by Subject|4|||
13274488|NCT00086684|26435650|FG002|Overall Study|Withdrawal by Subject|10|||
13274489|NCT00086684|26435648|FG000|Overall Study|NONCOMPLIANCE|5|||
13274490|NCT00086684|26435649|FG001|Overall Study|NONCOMPLIANCE|7|||
13274491|NCT00086684|26435650|FG002|Overall Study|NONCOMPLIANCE|6|||
13274492|NCT00086684|26435648|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
13274493|NCT00086684|26435649|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
13274494|NCT00086684|26435650|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
13274495|NCT00086684|26435648|FG000|Overall Study|WITHDRAWAL OF CONSENT|5|||
13274496|NCT00086684|26435649|FG001|Overall Study|WITHDRAWAL OF CONSENT|7|||
13274497|NCT00086684|26435650|FG002|Overall Study|WITHDRAWAL OF CONSENT|5|||
13274498|NCT00086684|26435648|FG000|Overall Study|Other|4|||
13274499|NCT00086684|26435649|FG001|Overall Study|Other|2|||
13274500|NCT00086684|26435650|FG002|Overall Study|Other|3|||
13274501|NCT00086619|26435665|FG000|Overall Study|Withdrawal by Subject|6|||
13274502|NCT00086619|26435666|FG001|Overall Study|Withdrawal by Subject|6|||
13307957|NCT01281306|26530319|FG001|Overall Study|Adverse Event|2|||
13274503|NCT00086619|26435665|FG000|Overall Study|Adverse Event|8|||
13274504|NCT00086619|26435666|FG001|Overall Study|Adverse Event|10|||
13274505|NCT00086619|26435665|FG000|Overall Study|Protocol Violation|1|||
13274506|NCT00086619|26435666|FG001|Overall Study|Protocol Violation|1|||
13274507|NCT00086346|26435685|FG000|Randomization|Did not receive test article|4|||
13274508|NCT00086346|26435686|FG001|Randomization|Did not receive test article|4|||
13274509|NCT00086346|26435685|FG000|Patients Dosed With Test Article|Adverse Event|94|||
13274510|NCT00086346|26435686|FG001|Patients Dosed With Test Article|Adverse Event|11|||
13274511|NCT00086346|26435685|FG000|Patients Dosed With Test Article|Lost to Follow-up|1|||
13274512|NCT00086346|26435686|FG001|Patients Dosed With Test Article|Lost to Follow-up|3|||
13274513|NCT00086346|26435685|FG000|Patients Dosed With Test Article|Nonmedical event|7|||
13274514|NCT00086346|26435686|FG001|Patients Dosed With Test Article|Nonmedical event|3|||
13274515|NCT00086346|26435685|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16|||
13274516|NCT00086346|26435686|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3|||
13274517|NCT00086346|26435685|FG000|Patients Dosed With Test Article|Protocol Violation|11|||
13274518|NCT00086346|26435686|FG001|Patients Dosed With Test Article|Protocol Violation|3|||
13274519|NCT00086346|26435685|FG000|Patients Dosed With Test Article|Lack of Efficacy|11|||
13274520|NCT00086346|26435686|FG001|Patients Dosed With Test Article|Lack of Efficacy|0|||
13274521|NCT00086281|26435742|FG000|Phase 1|Adverse Event|0|||
13274522|NCT00086281|26435743|FG001|Phase 1|Adverse Event|0|||
13274523|NCT00086281|26435744|FG002|Phase 1|Adverse Event|0|||
13274524|NCT00086281|26435745|FG003|Phase 1|Adverse Event|0|||
13274525|NCT00086281|26435746|FG004|Phase 1|Adverse Event|0|||
13274526|NCT00086281|26435747|FG005|Phase 1|Adverse Event|0|||
13274527|NCT00086281|26435748|FG006|Phase 1|Adverse Event|0|||
13274528|NCT00086281|26435749|FG007|Phase 1|Adverse Event|0|||
13274529|NCT00086281|26435750|FG008|Phase 1|Adverse Event|0|||
13274530|NCT00086281|26435751|FG009|Phase 1|Adverse Event|1|||
13274531|NCT00086281|26435752|FG010|Phase 1|Adverse Event|2|||
13274532|NCT00086281|26435753|FG011|Phase 1|Adverse Event|1|||
13274533|NCT00086281|26435754|FG012|Phase 1|Adverse Event|1|||
13274534|NCT00086281|26435755|FG013|Phase 1|Adverse Event|1|||
13274535|NCT00086281|26435756|FG014|Phase 1|Adverse Event|2|||
13274536|NCT00086281|26435742|FG000|Phase 1|Protocol Violation|0|||
13274537|NCT00086281|26435743|FG001|Phase 1|Protocol Violation|0|||
13274538|NCT00086281|26435744|FG002|Phase 1|Protocol Violation|0|||
13274539|NCT00086281|26435745|FG003|Phase 1|Protocol Violation|0|||
13274540|NCT00086281|26435746|FG004|Phase 1|Protocol Violation|0|||
13274541|NCT00086281|26435747|FG005|Phase 1|Protocol Violation|0|||
13274542|NCT00086281|26435748|FG006|Phase 1|Protocol Violation|0|||
13118714|NCT03033784|25930948|FG003|Overall Study|Anxiety related to MRI scanner|0|||
13118715|NCT03033784|25930949|FG004|Overall Study|Anxiety related to MRI scanner|0|||
13118716|NCT03033784|25930950|FG005|Overall Study|Anxiety related to MRI scanner|0|||
13274543|NCT00086281|26435749|FG007|Phase 1|Protocol Violation|0|||
13274544|NCT00086281|26435750|FG008|Phase 1|Protocol Violation|0|||
13274545|NCT00086281|26435751|FG009|Phase 1|Protocol Violation|0|||
13274546|NCT00086281|26435752|FG010|Phase 1|Protocol Violation|1|||
13118717|NCT03033784|25930951|FG006|Overall Study|Anxiety related to MRI scanner|0|||
13118718|NCT03033784|25930952|FG007|Overall Study|Anxiety related to MRI scanner|0|||
13118719|NCT03033784|25930953|FG008|Overall Study|Anxiety related to MRI scanner|0|||
13118720|NCT03033784|25930954|FG009|Overall Study|Anxiety related to MRI scanner|0|||
13118721|NCT03033784|25930955|FG010|Overall Study|Anxiety related to MRI scanner|0|||
13118722|NCT03033784|25930956|FG011|Overall Study|Anxiety related to MRI scanner|0|||
13118723|NCT03033784|25930957|FG012|Overall Study|Anxiety related to MRI scanner|0|||
13118724|NCT03033784|25930945|FG000|Overall Study|Withdrawal by Subject|0|||
13118725|NCT03033784|25930946|FG001|Overall Study|Withdrawal by Subject|0|||
13118726|NCT03033784|25930947|FG002|Overall Study|Withdrawal by Subject|0|||
13118727|NCT03033784|25930948|FG003|Overall Study|Withdrawal by Subject|0|||
13118728|NCT03033784|25930949|FG004|Overall Study|Withdrawal by Subject|0|||
13118729|NCT03033784|25930950|FG005|Overall Study|Withdrawal by Subject|0|||
13118730|NCT03033784|25930951|FG006|Overall Study|Withdrawal by Subject|0|||
13118731|NCT03033784|25930952|FG007|Overall Study|Withdrawal by Subject|0|||
13118732|NCT03033784|25930953|FG008|Overall Study|Withdrawal by Subject|0|||
13274547|NCT00086281|26435753|FG011|Phase 1|Protocol Violation|0|||
13274548|NCT00086281|26435754|FG012|Phase 1|Protocol Violation|0|||
13274549|NCT00086281|26435755|FG013|Phase 1|Protocol Violation|0|||
13274550|NCT00086281|26435756|FG014|Phase 1|Protocol Violation|0|||
13274551|NCT00086281|26435742|FG000|Phase 1|Serious Adverse Event|0|||
13274552|NCT00086281|26435743|FG001|Phase 1|Serious Adverse Event|0|||
13274553|NCT00086281|26435744|FG002|Phase 1|Serious Adverse Event|0|||
13274554|NCT00086281|26435745|FG003|Phase 1|Serious Adverse Event|0|||
13118733|NCT03033784|25930954|FG009|Overall Study|Withdrawal by Subject|0|||
13274555|NCT00086281|26435746|FG004|Phase 1|Serious Adverse Event|0|||
13274556|NCT00086281|26435747|FG005|Phase 1|Serious Adverse Event|0|||
13274557|NCT00086281|26435748|FG006|Phase 1|Serious Adverse Event|0|||
13274558|NCT00086281|26435749|FG007|Phase 1|Serious Adverse Event|0|||
13274559|NCT00086281|26435750|FG008|Phase 1|Serious Adverse Event|0|||
13274560|NCT00086281|26435751|FG009|Phase 1|Serious Adverse Event|0|||
13274561|NCT00086281|26435752|FG010|Phase 1|Serious Adverse Event|0|||
13274562|NCT00086281|26435753|FG011|Phase 1|Serious Adverse Event|0|||
13274563|NCT00086281|26435754|FG012|Phase 1|Serious Adverse Event|0|||
13274564|NCT00086281|26435755|FG013|Phase 1|Serious Adverse Event|0|||
13274565|NCT00086281|26435756|FG014|Phase 1|Serious Adverse Event|1|||
13274566|NCT00086281|26435742|FG000|Phase 2|Adverse Event|0|||
13274567|NCT00086281|26435743|FG001|Phase 2|Adverse Event|0|||
13274568|NCT00086281|26435744|FG002|Phase 2|Adverse Event|0|||
13274569|NCT00086281|26435745|FG003|Phase 2|Adverse Event|0|||
13274570|NCT00086281|26435746|FG004|Phase 2|Adverse Event|0|||
13274571|NCT00086281|26435747|FG005|Phase 2|Adverse Event|0|||
13274572|NCT00086281|26435748|FG006|Phase 2|Adverse Event|0|||
13274573|NCT00086281|26435749|FG007|Phase 2|Adverse Event|0|||
13274574|NCT00086281|26435750|FG008|Phase 2|Adverse Event|0|||
13274575|NCT00086281|26435751|FG009|Phase 2|Adverse Event|0|||
13274576|NCT00086281|26435752|FG010|Phase 2|Adverse Event|0|||
13274577|NCT00086281|26435753|FG011|Phase 2|Adverse Event|0|||
13274578|NCT00086281|26435754|FG012|Phase 2|Adverse Event|1|||
13274579|NCT00086281|26435755|FG013|Phase 2|Adverse Event|1|||
13274580|NCT00086281|26435756|FG014|Phase 2|Adverse Event|0|||
13274581|NCT00086047|26435769|FG000|Overall Study|Lost to Follow-up|7|||
13274582|NCT00086047|26435770|FG001|Overall Study|Lost to Follow-up|6|||
13274583|NCT00086047|26435769|FG000|Overall Study|Physician Decision|0|||
13274584|NCT00086047|26435770|FG001|Overall Study|Physician Decision|1|||
13274585|NCT00085917|26435787|FG000|Overall Study|Adverse Event|4|||
13274586|NCT00085917|26435788|FG001|Overall Study|Adverse Event|3|||
13274587|NCT00085735|26435860|FG000|Overall Study|Adverse Event|1|||
13274588|NCT00085735|26435861|FG001|Overall Study|Adverse Event|0|||
13274589|NCT00085735|26435862|FG002|Overall Study|Adverse Event|0|||
13274590|NCT00085735|26435863|FG003|Overall Study|Adverse Event|0|||
13274591|NCT00085735|26435864|FG004|Overall Study|Adverse Event|0|||
13274592|NCT00085735|26435865|FG005|Overall Study|Adverse Event|0|||
13274593|NCT00085735|26435860|FG000|Overall Study|Lack of Efficacy|2|||
13274594|NCT00085735|26435861|FG001|Overall Study|Lack of Efficacy|4|||
13274595|NCT00085735|26435862|FG002|Overall Study|Lack of Efficacy|6|||
13274596|NCT00085735|26435863|FG003|Overall Study|Lack of Efficacy|3|||
13274597|NCT00085735|26435864|FG004|Overall Study|Lack of Efficacy|4|||
13274598|NCT00085735|26435865|FG005|Overall Study|Lack of Efficacy|3|||
13274599|NCT00085735|26435860|FG000|Overall Study|Lost to Follow-up|0|||
13274600|NCT00085735|26435861|FG001|Overall Study|Lost to Follow-up|1|||
13274601|NCT00085735|26435862|FG002|Overall Study|Lost to Follow-up|0|||
13274602|NCT00085735|26435863|FG003|Overall Study|Lost to Follow-up|0|||
13274603|NCT00085735|26435864|FG004|Overall Study|Lost to Follow-up|1|||
13118734|NCT03033784|25930955|FG010|Overall Study|Withdrawal by Subject|0|||
13118735|NCT03033784|25930956|FG011|Overall Study|Withdrawal by Subject|0|||
13118736|NCT03033784|25930957|FG012|Overall Study|Withdrawal by Subject|2|||
13274604|NCT00085735|26435865|FG005|Overall Study|Lost to Follow-up|0|||
13274605|NCT00085735|26435860|FG000|Overall Study|Physician Decision|2|||
13274606|NCT00085735|26435861|FG001|Overall Study|Physician Decision|3|||
13274607|NCT00085735|26435862|FG002|Overall Study|Physician Decision|2|||
13274608|NCT00085735|26435863|FG003|Overall Study|Physician Decision|3|||
13274609|NCT00085735|26435864|FG004|Overall Study|Physician Decision|11|||
13274610|NCT00085735|26435865|FG005|Overall Study|Physician Decision|8|||
13274611|NCT00085735|26435860|FG000|Overall Study|Protocol Violation|1|||
13118737|NCT03033745|25931000|FG000|Overall Study|Protocol Violation|0|||
13118738|NCT03033745|25931001|FG001|Overall Study|Protocol Violation|0|||
13118739|NCT03033745|25931002|FG002|Overall Study|Protocol Violation|1|||
13118740|NCT03033745|25931000|FG000|Overall Study|Adverse Event|1|||
13118741|NCT03033745|25931001|FG001|Overall Study|Adverse Event|0|||
13118742|NCT03033745|25931002|FG002|Overall Study|Adverse Event|1|||
13118743|NCT03033745|25931000|FG000|Overall Study|Withdrawal by Subject|0|||
13118744|NCT03033745|25931001|FG001|Overall Study|Withdrawal by Subject|1|||
13118745|NCT03033745|25931002|FG002|Overall Study|Withdrawal by Subject|0|||
13118746|NCT03033394|25931013|FG000|Completed Pharmacokinetic Analysis|Missing data|1|||
13118747|NCT03033394|25931013|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3|||
13118748|NCT03033394|25931013|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1|||
13118749|NCT03033394|25931013|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1|||
13118750|NCT03033394|25931013|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1|||
13274612|NCT00085735|26435861|FG001|Overall Study|Protocol Violation|0|||
13274613|NCT00085735|26435862|FG002|Overall Study|Protocol Violation|0|||
13274614|NCT00085735|26435863|FG003|Overall Study|Protocol Violation|0|||
13274615|NCT00085735|26435864|FG004|Overall Study|Protocol Violation|0|||
13274616|NCT00085735|26435865|FG005|Overall Study|Protocol Violation|0|||
13274617|NCT00085735|26435860|FG000|Overall Study|Withdrawal by Subject|1|||
13274618|NCT00085735|26435861|FG001|Overall Study|Withdrawal by Subject|0|||
13274619|NCT00085735|26435862|FG002|Overall Study|Withdrawal by Subject|4|||
13274620|NCT00085735|26435863|FG003|Overall Study|Withdrawal by Subject|5|||
13274621|NCT00085735|26435864|FG004|Overall Study|Withdrawal by Subject|7|||
13274622|NCT00085735|26435865|FG005|Overall Study|Withdrawal by Subject|8|||
13274623|NCT00085735|26435860|FG000|Overall Study|Patient ineligible|1|||
13274624|NCT00085735|26435861|FG001|Overall Study|Patient ineligible|0|||
13118751|NCT03032523|25931030|FG000|Overall Study|Withdrawal by Subject|2|||
13118752|NCT03032523|25931031|FG001|Overall Study|Withdrawal by Subject|2|||
13118753|NCT03032523|25931030|FG000|Overall Study|Physician Decision|1|||
13118754|NCT03032523|25931031|FG001|Overall Study|Physician Decision|0|||
13118755|NCT03032380|25931068|FG000|Overall Study|Adverse Event|0|||
13118756|NCT03032380|25931069|FG001|Overall Study|Adverse Event|1|||
13118757|NCT03032380|25931068|FG000|Overall Study|Lack of Efficacy|1|||
13118758|NCT03032380|25931069|FG001|Overall Study|Lack of Efficacy|0|||
13118759|NCT03032380|25931068|FG000|Overall Study|Withdrawal by Subject|2|||
13118760|NCT03032380|25931069|FG001|Overall Study|Withdrawal by Subject|3|||
13118761|NCT03032380|25931068|FG000|Overall Study|Recovery|0|||
13118762|NCT03032380|25931069|FG001|Overall Study|Recovery|1|||
13118763|NCT03032380|25931068|FG000|Overall Study|Death|39|||
13118764|NCT03032380|25931069|FG001|Overall Study|Death|34|||
13118765|NCT03032380|25931068|FG000|Overall Study|Other - Miscellaneous|0|||
13118766|NCT03032380|25931069|FG001|Overall Study|Other - Miscellaneous|1|||
13118767|NCT03032198|25931075|FG000|Overall Study|Screen Fail|1|||
13118768|NCT03031938|25931238|FG000|Overall Study|Death|1|||
13118769|NCT03031938|25931239|FG001|Overall Study|Death|0|||
13118770|NCT03031899|25931249|FG000|Overall Study|Protocol Violation|1|||
13118771|NCT03031899|25931249|FG000|Overall Study|lesion disappeared after stopping habit|1|||
13118772|NCT03031847|25931288|FG000|Overall Study|Death|1|||
13118773|NCT03031847|25931289|FG001|Overall Study|Death|1|||
13118774|NCT03031847|25931290|FG002|Overall Study|Death|2|||
13118775|NCT03031847|25931291|FG003|Overall Study|Death|3|||
13118776|NCT03031847|25931288|FG000|Overall Study|Lost to Follow-up|1|||
13118777|NCT03031847|25931289|FG001|Overall Study|Lost to Follow-up|1|||
13118778|NCT03031847|25931290|FG002|Overall Study|Lost to Follow-up|2|||
13118779|NCT03031847|25931291|FG003|Overall Study|Lost to Follow-up|3|||
13118780|NCT03031782|25931317|FG000|Treatment Period 1|Lack of Efficacy|3|||
13118781|NCT03031782|25931318|FG001|Treatment Period 1|Lack of Efficacy|0|||
13118782|NCT03031782|25931319|FG002|Treatment Period 1|Lack of Efficacy|0|||
13118783|NCT03031782|25931320|FG003|Treatment Period 1|Lack of Efficacy|0|||
13118784|NCT03031782|25931321|FG004|Treatment Period 1|Lack of Efficacy|0|||
13118785|NCT03031782|25931317|FG000|Treatment Period 2|Physician Decision|0|||
13118786|NCT03031782|25931318|FG001|Treatment Period 2|Physician Decision|1|||
13118787|NCT03031782|25931319|FG002|Treatment Period 2|Physician Decision|0|||
13118788|NCT03031782|25931320|FG003|Treatment Period 2|Physician Decision|0|||
13118789|NCT03031782|25931321|FG004|Treatment Period 2|Physician Decision|3|||
13118790|NCT03031782|25931317|FG000|Treatment Period 2|Lack of Efficacy|0|||
13118791|NCT03031782|25931318|FG001|Treatment Period 2|Lack of Efficacy|1|||
13118792|NCT03031782|25931319|FG002|Treatment Period 2|Lack of Efficacy|0|||
13118793|NCT03031782|25931320|FG003|Treatment Period 2|Lack of Efficacy|0|||
13274625|NCT00085735|26435862|FG002|Overall Study|Patient ineligible|3|||
13274626|NCT00085735|26435863|FG003|Overall Study|Patient ineligible|7|||
13274627|NCT00085735|26435864|FG004|Overall Study|Patient ineligible|17|||
13274628|NCT00085735|26435865|FG005|Overall Study|Patient ineligible|8|||
13274629|NCT00085735|26435860|FG000|Overall Study|Excess residual disease|2|||
13274630|NCT00085735|26435861|FG001|Overall Study|Excess residual disease|2|||
13274631|NCT00085735|26435862|FG002|Overall Study|Excess residual disease|1|||
13274632|NCT00085735|26435863|FG003|Overall Study|Excess residual disease|1|||
13274633|NCT00085735|26435864|FG004|Overall Study|Excess residual disease|1|||
13274634|NCT00085735|26435865|FG005|Overall Study|Excess residual disease|4|||
13274635|NCT00085735|26435860|FG000|Overall Study|Reason not documented|1|||
13274636|NCT00085735|26435861|FG001|Overall Study|Reason not documented|0|||
13274637|NCT00085735|26435862|FG002|Overall Study|Reason not documented|1|||
13274638|NCT00085735|26435863|FG003|Overall Study|Reason not documented|0|||
13274639|NCT00085735|26435864|FG004|Overall Study|Reason not documented|1|||
13274640|NCT00085735|26435865|FG005|Overall Study|Reason not documented|0|||
13274641|NCT00085735|26435860|FG000|Overall Study|Pt transferred to inst w/out study open|1|||
13274642|NCT00085735|26435861|FG001|Overall Study|Pt transferred to inst w/out study open|0|||
13274643|NCT00085735|26435862|FG002|Overall Study|Pt transferred to inst w/out study open|0|||
13274644|NCT00085735|26435863|FG003|Overall Study|Pt transferred to inst w/out study open|0|||
13274645|NCT00085735|26435864|FG004|Overall Study|Pt transferred to inst w/out study open|0|||
13274646|NCT00085735|26435865|FG005|Overall Study|Pt transferred to inst w/out study open|0|||
13274647|NCT00085709|26435886|FG000|Overall Study|Adverse Event|8|||
13274648|NCT00085709|26435887|FG001|Overall Study|Adverse Event|0|||
13274649|NCT00085709|26435886|FG000|Overall Study|Death|8|||
13274650|NCT00085709|26435887|FG001|Overall Study|Death|2|||
13274651|NCT00085709|26435886|FG000|Overall Study|Refusal unrelated to adverse events|1|||
13274652|NCT00085709|26435887|FG001|Overall Study|Refusal unrelated to adverse events|2|||
13274653|NCT00085709|26435886|FG000|Overall Study|Progression|3|||
13274654|NCT00085709|26435887|FG001|Overall Study|Progression|4|||
13118794|NCT03031782|25931321|FG004|Treatment Period 2|Lack of Efficacy|1|||
13118795|NCT03031782|25931317|FG000|Treatment Period 2|Withdrawal by Subject|0|||
13274655|NCT00085709|26435886|FG000|Overall Study|Not protocol specified|12|||
13274656|NCT00085709|26435887|FG001|Overall Study|Not protocol specified|22|||
13274657|NCT00085709|26435886|FG000|Overall Study|Not eligible|19|||
13274658|NCT00085709|26435887|FG001|Overall Study|Not eligible|19|||
13274659|NCT00085709|26435886|FG000|Overall Study|Withdrawal by Subject|2|||
13274660|NCT00085709|26435887|FG001|Overall Study|Withdrawal by Subject|1|||
13274661|NCT00085631|26435898|FG000|Overall Study|Missing Data|4|||
13274662|NCT00085631|26435899|FG001|Overall Study|Missing Data|11|||
13274663|NCT00085631|26435900|FG002|Overall Study|Missing Data|7|||
13274664|NCT00085566|26435918|FG000|Overall Study|Adverse Event|0|||
13274665|NCT00085566|26435919|FG001|Overall Study|Adverse Event|0|||
13274666|NCT00085566|26435920|FG002|Overall Study|Adverse Event|10|||
13274667|NCT00085566|26435918|FG000|Overall Study|Patient Not treated|0|||
13274668|NCT00085566|26435919|FG001|Overall Study|Patient Not treated|0|||
13274669|NCT00085566|26435920|FG002|Overall Study|Patient Not treated|3|||
13274670|NCT00085566|26435918|FG000|Overall Study|Clinical progression|0|||
13274671|NCT00085566|26435919|FG001|Overall Study|Clinical progression|0|||
13274672|NCT00085566|26435920|FG002|Overall Study|Clinical progression|1|||
13274673|NCT00085540|26435934|FG000|Overall Study|Withdrawal by Subject|0|||
13274674|NCT00085540|26435935|FG001|Overall Study|Withdrawal by Subject|1|||
13274675|NCT00085540|26435934|FG000|Overall Study|Protocol Violation|0|||
13274676|NCT00085540|26435935|FG001|Overall Study|Protocol Violation|1|||
13274677|NCT00085423|26435943|FG000|Overall Study|Withdrawal by Subject|1|||
13274678|NCT00085423|26435943|FG000|Overall Study|screen failure|1|||
13274679|NCT00085098|26435960|FG000|Overall Study|Withdrawal by Subject|0|||
13274680|NCT00085098|26435961|FG001|Overall Study|Withdrawal by Subject|1|||
13274681|NCT00085098|26435960|FG000|Overall Study|Ineligible|1|||
13274682|NCT00085098|26435961|FG001|Overall Study|Ineligible|1|||
13274683|NCT00084929|26435981|FG000|Overall Study|ineligible - medical contraindication|1|||
13274684|NCT00084929|26435981|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1|||
13274685|NCT00084929|26435981|FG000|Overall Study|Ineligible - Medical history|6|||
13118796|NCT03031782|25931318|FG001|Treatment Period 2|Withdrawal by Subject|3|||
13118797|NCT03031782|25931319|FG002|Treatment Period 2|Withdrawal by Subject|0|||
13118798|NCT03031782|25931320|FG003|Treatment Period 2|Withdrawal by Subject|0|||
13118799|NCT03031782|25931321|FG004|Treatment Period 2|Withdrawal by Subject|1|||
13118800|NCT03031782|25931317|FG000|Treatment Period 2|Adverse Event|0|||
13118801|NCT03031782|25931318|FG001|Treatment Period 2|Adverse Event|1|||
13118802|NCT03031782|25931319|FG002|Treatment Period 2|Adverse Event|2|||
13118803|NCT03031782|25931320|FG003|Treatment Period 2|Adverse Event|0|||
13118804|NCT03031782|25931321|FG004|Treatment Period 2|Adverse Event|0|||
13118805|NCT03031782|25931317|FG000|Treatment Period 3|Withdrawal by Subject|0|||
13118806|NCT03031782|25931318|FG001|Treatment Period 3|Withdrawal by Subject|0|||
13118807|NCT03031782|25931319|FG002|Treatment Period 3|Withdrawal by Subject|0|||
13118808|NCT03031782|25931320|FG003|Treatment Period 3|Withdrawal by Subject|1|||
13118809|NCT03031782|25931321|FG004|Treatment Period 3|Withdrawal by Subject|0|||
13118810|NCT03031678|25931332|FG000|Overall Study|Study closed prior to completion|1|||
13118811|NCT03031496|25931371|FG000|Period 1|Adverse Event|2|||
13118812|NCT03031496|25931372|FG001|Period 1|Adverse Event|0|||
13118813|NCT03031496|25931371|FG000|Period 1|Withdrawal by Subject|0|||
13118814|NCT03031496|25931372|FG001|Period 1|Withdrawal by Subject|2|||
13118815|NCT03031431|25931381|FG000|Overall Study|Infant removed by maternal request|1|||
13118816|NCT03030989|25931396|FG000|Overall Study|Fever|2|||
13118817|NCT03030989|25931397|FG001|Overall Study|Fever|2|||
13118818|NCT03030989|25931396|FG000|Overall Study|Rash|2|||
13118819|NCT03030989|25931397|FG001|Overall Study|Rash|1|||
13118820|NCT03030989|25931396|FG000|Overall Study|Fatigue/Overwhelmed|1|||
13118821|NCT03030989|25931397|FG001|Overall Study|Fatigue/Overwhelmed|5|||
13118822|NCT03030989|25931396|FG000|Overall Study|Positive Blood Cultures|2|||
13118823|NCT03030989|25931397|FG001|Overall Study|Positive Blood Cultures|1|||
13118824|NCT03030989|25931396|FG000|Overall Study|Line Removed|0|||
13118825|NCT03030989|25931397|FG001|Overall Study|Line Removed|2|||
13118826|NCT03030989|25931396|FG000|Overall Study|No longer interested|5|||
13118827|NCT03030989|25931397|FG001|Overall Study|No longer interested|3|||
13118828|NCT03030599|25931417|FG000|Open Label Treatment and Titration|Protocol deviation|8|||
13118829|NCT03030599|25931418|FG001|Open Label Treatment and Titration|Protocol deviation|0|||
13118830|NCT03030599|25931419|FG002|Open Label Treatment and Titration|Protocol deviation|0|||
13274686|NCT00084929|26435981|FG000|Overall Study|Withdrawal by Subject|10|||
13274687|NCT00084929|26435981|FG000|Overall Study|Missing/incomplete CTC exam|9|||
13274688|NCT00084929|26435981|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42|||
13274689|NCT00084864|26436020|FG000|Overall Study|Adverse Event|1|||
13274690|NCT00084864|26436021|FG001|Overall Study|Adverse Event|0|||
13274691|NCT00084864|26436022|FG002|Overall Study|Adverse Event|0|||
13274692|NCT00084864|26436023|FG003|Overall Study|Adverse Event|0|||
13274693|NCT00084838|26436047|FG000|Overall Study|Death|1|||
13274694|NCT00084838|26436047|FG000|Overall Study|Adverse Event|2|||
13274695|NCT00084838|26436047|FG000|Overall Study|Withdrawal by Subject|1|||
13274696|NCT00084838|26436047|FG000|Overall Study|Progressive Disease|4|||
13118831|NCT03030599|25931417|FG000|Open Label Treatment and Titration|Other|1|||
13118832|NCT03030599|25931418|FG001|Open Label Treatment and Titration|Other|0|||
13118833|NCT03030599|25931419|FG002|Open Label Treatment and Titration|Other|0|||
13274697|NCT00084838|26436047|FG000|Overall Study|Pt Non-Compliance|1|||
13274698|NCT00084838|26436047|FG000|Overall Study|Ineligible|4|||
13274699|NCT00084747|26436054|FG000|Overall Study|Relapsed|8|||
13274700|NCT00084747|26436054|FG000|Overall Study|Death|3|||
13274701|NCT00084747|26436054|FG000|Overall Study|Withdrawal by Subject|2|||
13274702|NCT00084682|26436063|FG000|Overall Study|Withdrawal by Subject|1|||
13274703|NCT00084617|26436071|FG000|Overall Study|Withdrawal by Subject|7|||
13274704|NCT00084617|26436071|FG000|Overall Study|Lack of Efficacy|1|||
13274705|NCT00084617|26436071|FG000|Overall Study|Protocol Violation|1|||
13274706|NCT00084487|26436081|FG000|Overall Study|Death|1|||
13274707|NCT00084318|26436106|FG000|Overall Study|Withdrawal by Subject|5|||
13274708|NCT00084318|26436107|FG001|Overall Study|Withdrawal by Subject|2|||
13274709|NCT00084318|26436106|FG000|Overall Study|Protocol Violation|15|||
13274710|NCT00084318|26436107|FG001|Overall Study|Protocol Violation|11|||
13274711|NCT00084318|26436106|FG000|Overall Study|No protocol treatment|2|||
13274712|NCT00084318|26436107|FG001|Overall Study|No protocol treatment|0|||
13274713|NCT00084084|26436123|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1|||
13118834|NCT03030599|25931417|FG000|Open Label Treatment and Titration|Physician Decision|3|||
13118835|NCT03030599|25931418|FG001|Open Label Treatment and Titration|Physician Decision|0|||
13118836|NCT03030599|25931419|FG002|Open Label Treatment and Titration|Physician Decision|0|||
13118837|NCT03030599|25931417|FG000|Open Label Treatment and Titration|Lack of Efficacy|1|||
13118838|NCT03030599|25931418|FG001|Open Label Treatment and Titration|Lack of Efficacy|0|||
13118839|NCT03030599|25931419|FG002|Open Label Treatment and Titration|Lack of Efficacy|0|||
13118840|NCT03030599|25931417|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4|||
13118841|NCT03030599|25931418|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
13118842|NCT03030599|25931419|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
13118843|NCT03030599|25931417|FG000|Open Label Treatment and Titration|Adverse Event|18|||
13118844|NCT03030599|25931418|FG001|Open Label Treatment and Titration|Adverse Event|0|||
13118845|NCT03030599|25931419|FG002|Open Label Treatment and Titration|Adverse Event|0|||
13118846|NCT03030599|25931417|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6|||
13118847|NCT03030599|25931418|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0|||
13118848|NCT03030599|25931419|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0|||
13118849|NCT03030599|25931417|FG000|Open Label Treatment and Titration|Sponsor decision|2|||
13274714|NCT00084084|26436123|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1|||
13118850|NCT03030599|25931418|FG001|Open Label Treatment and Titration|Sponsor decision|0|||
13274715|NCT00083915|26436136|FG000|Overall Study|Death|6|||
13274716|NCT00083915|26436137|FG001|Overall Study|Death|3|||
13274717|NCT00083915|26436136|FG000|Overall Study|Physician Decision|11|||
13274718|NCT00083915|26436137|FG001|Overall Study|Physician Decision|6|||
13274719|NCT00083915|26436136|FG000|Overall Study|Withdrawal by Subject|8|||
13274720|NCT00083915|26436137|FG001|Overall Study|Withdrawal by Subject|3|||
13274721|NCT00083915|26436136|FG000|Overall Study|disease progression|18|||
13274722|NCT00083915|26436137|FG001|Overall Study|disease progression|23|||
13274723|NCT00083915|26436136|FG000|Overall Study|Failure to collect|3|||
13274724|NCT00083915|26436137|FG001|Overall Study|Failure to collect|0|||
13274725|NCT00083915|26436136|FG000|Overall Study|No response|3|||
13274726|NCT00083915|26436137|FG001|Overall Study|No response|1|||
13274727|NCT00083915|26436136|FG000|Overall Study|Insurance issues|1|||
13274728|NCT00083915|26436137|FG001|Overall Study|Insurance issues|1|||
13274729|NCT00083616|26436151|FG000|Overall Study|Disease Progression|16|||
13274730|NCT00083616|26436151|FG000|Overall Study|Lost to Follow-up|1|||
13274731|NCT00083616|26436151|FG000|Overall Study|Physician Decision|2|||
13274732|NCT00083616|26436151|FG000|Overall Study|Withdrawal by Subject|3|||
13274733|NCT00083616|26436151|FG000|Overall Study|Ineligibility determined|2|||
13274734|NCT00083616|26436151|FG000|Overall Study|Non-compliance|1|||
13274735|NCT00083616|26436151|FG000|Overall Study|Other|6|||
13274736|NCT00083226|26436159|FG000|Overall Study|Lack of Efficacy|19|||
13274737|NCT00083226|26436159|FG000|Overall Study|Adverse Event|9|||
13274738|NCT00083226|26436159|FG000|Overall Study|Death|4|||
13274739|NCT00083226|26436159|FG000|Overall Study|Withdrawal by Subject|4|||
13274740|NCT00083226|26436159|FG000|Overall Study|Other|2|||
13274741|NCT00083226|26436159|FG000|Overall Study|ineligible or not receiving treatment|4|||
13274742|NCT00082888|26436189|FG000|Overall Study|Ineligible|1|||
13274743|NCT00082888|26436190|FG001|Overall Study|Ineligible|0|||
13274744|NCT00082888|26436191|FG002|Overall Study|Ineligible|0|||
13274745|NCT00082810|26436201|FG000|Overall Study|Adverse Event|3|||
13274746|NCT00082810|26436201|FG000|Overall Study|Progressive disease|24|||
13274747|NCT00082810|26436201|FG000|Overall Study|Withdrawal by Subject|4|||
13274748|NCT00082758|26436219|FG000|Overall Study|Adverse Event|0|||
13274749|NCT00082758|26436220|FG001|Overall Study|Adverse Event|2|||
13274750|NCT00082758|26436221|FG002|Overall Study|Adverse Event|0|||
13274751|NCT00082758|26436219|FG000|Overall Study|Lack of Efficacy|12|||
13274752|NCT00082758|26436220|FG001|Overall Study|Lack of Efficacy|13|||
13274753|NCT00082758|26436221|FG002|Overall Study|Lack of Efficacy|0|||
13274754|NCT00082758|26436219|FG000|Overall Study|Physician Decision|0|||
13274755|NCT00082758|26436220|FG001|Overall Study|Physician Decision|1|||
13274756|NCT00082758|26436221|FG002|Overall Study|Physician Decision|0|||
13274757|NCT00082758|26436219|FG000|Overall Study|Withdrawal by Subject|3|||
13274758|NCT00082758|26436220|FG001|Overall Study|Withdrawal by Subject|0|||
13274759|NCT00082758|26436221|FG002|Overall Study|Withdrawal by Subject|0|||
13274760|NCT00082758|26436219|FG000|Overall Study|Protocol Violation|0|||
13274761|NCT00082758|26436220|FG001|Overall Study|Protocol Violation|1|||
13274762|NCT00082758|26436221|FG002|Overall Study|Protocol Violation|0|||
13274763|NCT00082628|26436249|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
13274764|NCT00082628|26436250|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1|||
13274765|NCT00082628|26436251|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
13274766|NCT00082628|26436252|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
13274767|NCT00082628|26436253|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
13274768|NCT00082628|26436249|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2|||
13274769|NCT00082628|26436250|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1|||
13274770|NCT00082628|26436251|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
13274771|NCT00082628|26436252|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
13274772|NCT00082628|26436253|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
13274773|NCT00082628|26436249|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5|||
13274774|NCT00082628|26436250|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43|||
13274775|NCT00082628|26436251|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
13274776|NCT00082628|26436252|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
13274777|NCT00082628|26436253|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
13274778|NCT00082628|26436249|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1|||
13274779|NCT00082628|26436250|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15|||
13274780|NCT00082628|26436251|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
13274781|NCT00082628|26436252|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
13274782|NCT00082628|26436253|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
13274783|NCT00082628|26436249|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
13274784|NCT00082628|26436250|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
13274785|NCT00082628|26436251|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
13274786|NCT00082628|26436252|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
13274787|NCT00082628|26436253|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1|||
13274788|NCT00082628|26436249|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
13274789|NCT00082628|26436250|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
13274790|NCT00082628|26436251|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
13274791|NCT00082628|26436252|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1|||
13274792|NCT00082628|26436253|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
13274793|NCT00082628|26436249|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
13274794|NCT00082628|26436250|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
13274795|NCT00082628|26436251|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
13274796|NCT00082628|26436252|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
13274797|NCT00082628|26436253|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17|||
13274798|NCT00081770|26436280|FG000|Overall Study|Adverse Event|130|||
13274799|NCT00081770|26436281|FG001|Overall Study|Adverse Event|98|||
13274800|NCT00081770|26436282|FG002|Overall Study|Adverse Event|136|||
13274801|NCT00081770|26436280|FG000|Overall Study|Lack of Efficacy|262|||
13274802|NCT00081770|26436281|FG001|Overall Study|Lack of Efficacy|357|||
13274803|NCT00081770|26436282|FG002|Overall Study|Lack of Efficacy|211|||
13274804|NCT00081770|26436280|FG000|Overall Study|Lost to Follow-up|45|||
13274805|NCT00081770|26436281|FG001|Overall Study|Lost to Follow-up|34|||
13274806|NCT00081770|26436282|FG002|Overall Study|Lost to Follow-up|45|||
13274807|NCT00081770|26436280|FG000|Overall Study|Protocol Violation|15|||
13274808|NCT00081770|26436281|FG001|Overall Study|Protocol Violation|10|||
13274809|NCT00081770|26436282|FG002|Overall Study|Protocol Violation|10|||
13274810|NCT00081770|26436280|FG000|Overall Study|Withdrawal by Subject|45|||
13274811|NCT00081770|26436281|FG001|Overall Study|Withdrawal by Subject|40|||
13274812|NCT00081770|26436282|FG002|Overall Study|Withdrawal by Subject|42|||
13274813|NCT00081770|26436280|FG000|Overall Study|Did not meet protocol eligibility|2|||
13274814|NCT00081770|26436281|FG001|Overall Study|Did not meet protocol eligibility|0|||
13274815|NCT00081770|26436282|FG002|Overall Study|Did not meet protocol eligibility|3|||
13274816|NCT00081770|26436280|FG000|Overall Study|Administrative|1|||
13274817|NCT00081770|26436281|FG001|Overall Study|Administrative|0|||
13274818|NCT00081770|26436282|FG002|Overall Study|Administrative|1|||
13274819|NCT00081770|26436280|FG000|Overall Study|Other|2|||
13274820|NCT00081770|26436281|FG001|Overall Study|Other|7|||
13274821|NCT00081770|26436282|FG002|Overall Study|Other|8|||
13274822|NCT00081653|26436305|FG000|Overall Study|Adverse Event|23|||
13274823|NCT00081653|26436306|FG001|Overall Study|Adverse Event|17|||
13274824|NCT00081653|26436305|FG000|Overall Study|Lost to Follow-up|2|||
13274825|NCT00081653|26436306|FG001|Overall Study|Lost to Follow-up|4|||
13274826|NCT00081653|26436305|FG000|Overall Study|Refused Treatment|18|||
13274827|NCT00081653|26436306|FG001|Overall Study|Refused Treatment|14|||
13274828|NCT00081653|26436305|FG000|Overall Study|Low bone mineral density|1|||
13274829|NCT00081653|26436306|FG001|Overall Study|Low bone mineral density|0|||
13274830|NCT00081653|26436305|FG000|Overall Study|Bone loss|2|||
13274831|NCT00081653|26436306|FG001|Overall Study|Bone loss|0|||
13274832|NCT00081653|26436305|FG000|Overall Study|Participant leaving country|1|||
13274833|NCT00081653|26436306|FG001|Overall Study|Participant leaving country|0|||
13274834|NCT00081653|26436305|FG000|Overall Study|Loss of bone mass|0|||
13274835|NCT00081653|26436306|FG001|Overall Study|Loss of bone mass|2|||
13274836|NCT00081497|26436328|FG000|Overall Study|Adverse Event|2|||
13274837|NCT00081497|26436329|FG001|Overall Study|Adverse Event|0|||
13274838|NCT00081497|26436328|FG000|Overall Study|Death|0|||
13274839|NCT00081497|26436329|FG001|Overall Study|Death|1|||
13274840|NCT00081497|26436328|FG000|Overall Study|Withdrawal by Subject|1|||
13274841|NCT00081497|26436329|FG001|Overall Study|Withdrawal by Subject|0|||
13274842|NCT00081497|26436328|FG000|Overall Study|Non-compliance|0|||
13274843|NCT00081497|26436329|FG001|Overall Study|Non-compliance|1|||
13274844|NCT00081458|26436350|FG000|Overall Study|Adverse Event|1|||
13274845|NCT00081458|26436351|FG001|Overall Study|Adverse Event|5|||
13274846|NCT00081458|26436352|FG002|Overall Study|Adverse Event|2|||
13274847|NCT00081458|26436350|FG000|Overall Study|Withdrawal by Subject|0|||
13274848|NCT00081458|26436351|FG001|Overall Study|Withdrawal by Subject|3|||
13274849|NCT00081458|26436352|FG002|Overall Study|Withdrawal by Subject|1|||
13274850|NCT00081458|26436350|FG000|Overall Study|Randomized but not dosed|0|||
13274851|NCT00081458|26436351|FG001|Overall Study|Randomized but not dosed|0|||
13274852|NCT00081458|26436352|FG002|Overall Study|Randomized but not dosed|1|||
13274853|NCT00081289|26436401|FG000|Overall Study|Accrued prior to chemotherapy amendment|18|||
13274854|NCT00081289|26436402|FG001|Overall Study|Accrued prior to chemotherapy amendment|17|||
13274855|NCT00081289|26436401|FG000|Overall Study|Ineligible / no protocol treatment|3|||
13274856|NCT00081289|26436402|FG001|Overall Study|Ineligible / no protocol treatment|4|||
13274857|NCT00081263|26436417|FG000|Overall Study|clerical error|1|||
13274858|NCT00081263|26436418|FG001|Overall Study|clerical error|0|||
13274859|NCT00081263|26436417|FG000|Overall Study|wrong cell type|7|||
13274860|NCT00081263|26436418|FG001|Overall Study|wrong cell type|5|||
13118851|NCT03030599|25931419|FG002|Open Label Treatment and Titration|Sponsor decision|0|||
13118852|NCT03030599|25931417|FG000|Open Label Treatment and Titration|Lost to Follow-up|3|||
13118853|NCT03030599|25931418|FG001|Open Label Treatment and Titration|Lost to Follow-up|0|||
13118854|NCT03030599|25931419|FG002|Open Label Treatment and Titration|Lost to Follow-up|0|||
13118855|NCT03030599|25931417|FG000|Stable Dose|Protocol deviation|3|||
13274861|NCT00081263|26436417|FG000|Overall Study|improper pre-protocol therapy|0|||
13274862|NCT00081263|26436418|FG001|Overall Study|improper pre-protocol therapy|1|||
13274863|NCT00081263|26436417|FG000|Overall Study|Inadequate pathology|0|||
13274864|NCT00081263|26436418|FG001|Overall Study|Inadequate pathology|1|||
13274865|NCT00081263|26436417|FG000|Overall Study|Never treated|4|||
13274866|NCT00081263|26436418|FG001|Overall Study|Never treated|5|||
13274867|NCT00081263|26436417|FG000|Overall Study|Inadequate data|5|||
13274868|NCT00081263|26436418|FG001|Overall Study|Inadequate data|10|||
13274869|NCT00081159|26436435|FG000|Overall Study|Withdrawal by Subject|0|||
13274870|NCT00081159|26436436|FG001|Overall Study|Withdrawal by Subject|3|||
13274871|NCT00081159|26436435|FG000|Overall Study|Myelosuppression prior to treatment|0|||
13274872|NCT00081159|26436436|FG001|Overall Study|Myelosuppression prior to treatment|1|||
13274873|NCT00081159|26436435|FG000|Overall Study|Lost to Follow-up|2|||
13274874|NCT00081159|26436436|FG001|Overall Study|Lost to Follow-up|1|||
13274875|NCT00080938|26436445|FG000|Overall Study|Adverse Event|3|||
13274876|NCT00080938|26436445|FG000|Overall Study|Withdrawal by Subject|6|||
13274877|NCT00080938|26436445|FG000|Overall Study|Death|2|||
13274878|NCT00080938|26436445|FG000|Overall Study|Lack of Efficacy|7|||
13274879|NCT00080938|26436445|FG000|Overall Study|other disease|1|||
13274880|NCT00080938|26436445|FG000|Overall Study|Not started protocol therapy|1|||
13274881|NCT00080938|26436445|FG000|Overall Study|Ineligible|4|||
13274882|NCT00080899|26436452|FG000|Overall Study|Adverse Event|1|||
13274883|NCT00080483|26436465|FG000|Overall Study|Lost to Follow-up|1|||
13274884|NCT00080483|26436466|FG001|Overall Study|Lost to Follow-up|1|||
13274885|NCT00080483|26436465|FG000|Overall Study|Physician Decision|1|||
13274886|NCT00080483|26436466|FG001|Overall Study|Physician Decision|1|||
13274887|NCT00080288|26436481|FG000|Overall Study|Adverse Event|7|||
13274888|NCT00080288|26436482|FG001|Overall Study|Adverse Event|4|||
13274889|NCT00080288|26436481|FG000|Overall Study|Lost to Follow-up|3|||
13274890|NCT00080288|26436482|FG001|Overall Study|Lost to Follow-up|5|||
13274891|NCT00080288|26436481|FG000|Overall Study|Physician Decision|6|||
13274892|NCT00080288|26436482|FG001|Overall Study|Physician Decision|2|||
13274893|NCT00080288|26436481|FG000|Overall Study|Withdrawal by Subject|3|||
13274894|NCT00080288|26436482|FG001|Overall Study|Withdrawal by Subject|16|||
13274895|NCT00080288|26436481|FG000|Overall Study|Miscellaneous|11|||
13274896|NCT00080288|26436482|FG001|Overall Study|Miscellaneous|11|||
13274897|NCT00080223|26436492|FG000|Overall Study|Adverse Event|23|||
13274898|NCT00080223|26436492|FG000|Overall Study|Death|21|||
13274899|NCT00080223|26436492|FG000|Overall Study|Withdrawal by Subject|13|||
13274900|NCT00080223|26436492|FG000|Overall Study|Lung Transplantation|9|||
13274901|NCT00080223|26436492|FG000|Overall Study|Non-compliance With Study Treatment|7|||
13274902|NCT00080223|26436492|FG000|Overall Study|Participant unwilling to continue|2|||
13274903|NCT00080223|26436492|FG000|Overall Study|Physician Decision|1|||
13274904|NCT00089635|26436506|FG000|Overall Study|Adverse Event|2|||
13274905|NCT00089635|26436506|FG000|Overall Study|Death|17|||
13274906|NCT00089635|26436506|FG000|Overall Study|Disease Progression|12|||
13274907|NCT00089635|26436506|FG000|Overall Study|Lost to Follow-up|3|||
13274908|NCT00089635|26436506|FG000|Overall Study|Withdrawal by Subject|6|||
13274909|NCT00089635|26436506|FG000|Overall Study|Ineligibility determined|1|||
13274910|NCT00089635|26436506|FG000|Overall Study|Other|2|||
13274911|NCT00089141|26436535|FG000|Overall Study|Termination of trial|18|||
13274912|NCT00089141|26436536|FG001|Overall Study|Termination of trial|24|||
13274913|NCT00083759|26436551|FG000|Overall Study|Adverse Event|5|||
13274914|NCT00083759|26436552|FG001|Overall Study|Adverse Event|3|||
13274915|NCT00083759|26436551|FG000|Overall Study|Lost to Follow-up|1|||
13274916|NCT00083759|26436552|FG001|Overall Study|Lost to Follow-up|0|||
13274917|NCT00083759|26436551|FG000|Overall Study|Death|1|||
13274918|NCT00083759|26436552|FG001|Overall Study|Death|1|||
13274919|NCT00083759|26436551|FG000|Overall Study|Inadequate Therapeutic Response|32|||
13274920|NCT00083759|26436552|FG001|Overall Study|Inadequate Therapeutic Response|35|||
13274921|NCT00083759|26436551|FG000|Overall Study|Subject Withdrew Consent|2|||
13274922|NCT00083759|26436552|FG001|Overall Study|Subject Withdrew Consent|2|||
13274923|NCT00083759|26436551|FG000|Overall Study|Non-Compliance|1|||
13274924|NCT00083759|26436552|FG001|Overall Study|Non-Compliance|0|||
13274925|NCT00083759|26436551|FG000|Overall Study|Sponsor's Discretion|28|||
13274926|NCT00083759|26436552|FG001|Overall Study|Sponsor's Discretion|29|||
13274927|NCT00083759|26436551|FG000|Overall Study|Other|14|||
13274928|NCT00083759|26436552|FG001|Overall Study|Other|13|||
13274929|NCT00089609|26436576|FG000|Overall Study|Withdrawal by Subject|3|||
13274930|NCT00089609|26436577|FG001|Overall Study|Withdrawal by Subject|1|||
13274931|NCT00088452|26436601|FG000|Overall Study|Did not receive intervention|1|||
13274932|NCT00088452|26436602|FG001|Overall Study|Did not receive intervention|0|||
13274933|NCT00088452|26436603|FG002|Overall Study|Did not receive intervention|1|||
13291079|NCT02039674|26482399|FG007|Overall Study|Other|0|||
13291080|NCT02039674|26482400|FG008|Overall Study|Other|0|||
13291081|NCT02039674|26482401|FG009|Overall Study|Other|0|||
13291082|NCT02039674|26482402|FG010|Overall Study|Other|0|||
13291083|NCT02039674|26482403|FG011|Overall Study|Other|0|||
13291084|NCT02039674|26482404|FG012|Overall Study|Other|1|||
13291085|NCT02039674|26482405|FG013|Overall Study|Other|0|||
13291086|NCT02038946|26482416|FG000|Overall Study|Death|5|||
13291087|NCT02038946|26482416|FG000|Overall Study|Withdrawal by Subject|3|||
13291088|NCT02038946|26482416|FG000|Overall Study|Lost to Follow-up|2|||
13291089|NCT02038946|26482416|FG000|Overall Study|Other reasons|2|||
13291090|NCT00159783|26482456|FG000|Overall Study|Adverse Event|5|||
13291091|NCT00159783|26482457|FG001|Overall Study|Adverse Event|7|||
13291092|NCT00159783|26482458|FG002|Overall Study|Adverse Event|9|||
13291093|NCT00159783|26482456|FG000|Overall Study|Lack of Efficacy|1|||
13291094|NCT00159783|26482457|FG001|Overall Study|Lack of Efficacy|2|||
13291095|NCT00159783|26482458|FG002|Overall Study|Lack of Efficacy|3|||
13291096|NCT00159783|26482456|FG000|Overall Study|Withdrawal by Subject|7|||
13291097|NCT00159783|26482457|FG001|Overall Study|Withdrawal by Subject|11|||
13291098|NCT00159783|26482458|FG002|Overall Study|Withdrawal by Subject|12|||
13291099|NCT00159783|26482456|FG000|Overall Study|Lost to Follow-up|6|||
13291100|NCT00159783|26482457|FG001|Overall Study|Lost to Follow-up|5|||
13291101|NCT00159783|26482458|FG002|Overall Study|Lost to Follow-up|11|||
13291102|NCT00159783|26482456|FG000|Overall Study|Other|0|||
13291103|NCT00159783|26482457|FG001|Overall Study|Other|2|||
13291104|NCT00159783|26482458|FG002|Overall Study|Other|4|||
13291105|NCT00159432|26482465|FG000|Overall Study|Adverse Event|1|||
13291106|NCT00159432|26482465|FG000|Overall Study|Death|1|||
13291107|NCT00159432|26482465|FG000|Overall Study|Lack of Efficacy|8|||
13291108|NCT00158860|26482486|FG000|Overall Study|Adverse Event|3|||
13291109|NCT00158860|26482487|FG001|Overall Study|Adverse Event|6|||
13291110|NCT00158860|26482486|FG000|Overall Study|Lost to Follow-up|11|||
13291111|NCT00158860|26482487|FG001|Overall Study|Lost to Follow-up|17|||
13291112|NCT00158860|26482486|FG000|Overall Study|Protocol Violation|8|||
13291113|NCT00158860|26482487|FG001|Overall Study|Protocol Violation|23|||
13291114|NCT00158860|26482486|FG000|Overall Study|Withdrawal by Subject|7|||
13291115|NCT00158860|26482487|FG001|Overall Study|Withdrawal by Subject|17|||
13291116|NCT00158860|26482486|FG000|Overall Study|MOVING OUT OF STATE|1|||
13291117|NCT00158860|26482487|FG001|Overall Study|MOVING OUT OF STATE|0|||
13291118|NCT00158860|26482486|FG000|Overall Study|Pregnancy|3|||
13291119|NCT00158860|26482487|FG001|Overall Study|Pregnancy|3|||
13291120|NCT00158860|26482486|FG000|Overall Study|SPONSOR STOPPED STUDY|2|||
13291121|NCT00158860|26482487|FG001|Overall Study|SPONSOR STOPPED STUDY|2|||
13274934|NCT04999111|26436800|FG000|Overall Study|Lost to Follow-up|0|||
13274935|NCT04999111|26436801|FG001|Overall Study|Lost to Follow-up|3|||
13274936|NCT04999111|26436802|FG002|Overall Study|Lost to Follow-up|1|||
13274937|NCT04999111|26436803|FG003|Overall Study|Lost to Follow-up|1|||
13274938|NCT04999111|26436804|FG004|Overall Study|Lost to Follow-up|1|||
13274939|NCT04999111|26436805|FG005|Overall Study|Lost to Follow-up|1|||
13274940|NCT04999111|26436800|FG000|Overall Study|Physician Decision|0|||
13274941|NCT04999111|26436801|FG001|Overall Study|Physician Decision|0|||
13274942|NCT04999111|26436802|FG002|Overall Study|Physician Decision|0|||
13274943|NCT04999111|26436803|FG003|Overall Study|Physician Decision|1|||
13274944|NCT04999111|26436804|FG004|Overall Study|Physician Decision|0|||
13274945|NCT04999111|26436805|FG005|Overall Study|Physician Decision|0|||
13274946|NCT04999111|26436800|FG000|Overall Study|Withdrawal by Subject|3|||
13274947|NCT04999111|26436801|FG001|Overall Study|Withdrawal by Subject|3|||
13274948|NCT04999111|26436802|FG002|Overall Study|Withdrawal by Subject|2|||
13274949|NCT04999111|26436803|FG003|Overall Study|Withdrawal by Subject|1|||
13274950|NCT04999111|26436804|FG004|Overall Study|Withdrawal by Subject|3|||
13274951|NCT04999111|26436805|FG005|Overall Study|Withdrawal by Subject|0|||
13274952|NCT04999111|26436800|FG000|Overall Study|Other|1|||
13274953|NCT04999111|26436801|FG001|Overall Study|Other|1|||
13274954|NCT04999111|26436802|FG002|Overall Study|Other|1|||
13274955|NCT04999111|26436803|FG003|Overall Study|Other|0|||
13274956|NCT04999111|26436804|FG004|Overall Study|Other|0|||
13274957|NCT04999111|26436805|FG005|Overall Study|Other|0|||
13274958|NCT04999111|26436800|FG000|Overall Study|Ongoing|326|||
13274959|NCT04999111|26436801|FG001|Overall Study|Ongoing|321|||
13274960|NCT04999111|26436802|FG002|Overall Study|Ongoing|112|||
13274961|NCT04999111|26436803|FG003|Overall Study|Ongoing|323|||
13274962|NCT04999111|26436804|FG004|Overall Study|Ongoing|322|||
13274963|NCT04999111|26436805|FG005|Overall Study|Ongoing|105|||
13274964|NCT04999111|26436800|FG000|Overall Study|Randomized but not vaccinated|1|||
13274965|NCT04999111|26436801|FG001|Overall Study|Randomized but not vaccinated|2|||
13274966|NCT04999111|26436802|FG002|Overall Study|Randomized but not vaccinated|0|||
13274967|NCT04999111|26436803|FG003|Overall Study|Randomized but not vaccinated|3|||
13274968|NCT04999111|26436804|FG004|Overall Study|Randomized but not vaccinated|3|||
13274969|NCT04999111|26436805|FG005|Overall Study|Randomized but not vaccinated|0|||
13274970|NCT04828161|26436878|FG000|Overall Study|Withdrawal by Subject|0|||
13274971|NCT04828161|26436879|FG001|Overall Study|Withdrawal by Subject|3|||
13274972|NCT04828161|26436880|FG002|Overall Study|Withdrawal by Subject|3|||
13274973|NCT04828161|26436881|FG003|Overall Study|Withdrawal by Subject|4|||
13274974|NCT04828161|26436878|FG000|Overall Study|Lost to Follow-up|1|||
13274975|NCT04828161|26436879|FG001|Overall Study|Lost to Follow-up|4|||
13274976|NCT04828161|26436880|FG002|Overall Study|Lost to Follow-up|2|||
13274977|NCT04828161|26436881|FG003|Overall Study|Lost to Follow-up|2|||
13274978|NCT04828161|26436878|FG000|Overall Study|Other|2|||
13274979|NCT04828161|26436879|FG001|Overall Study|Other|0|||
13274980|NCT04828161|26436880|FG002|Overall Study|Other|2|||
13274981|NCT04828161|26436881|FG003|Overall Study|Other|0|||
13274982|NCT04828161|26436878|FG000|Overall Study|Death|0|||
13274983|NCT04828161|26436879|FG001|Overall Study|Death|0|||
13274984|NCT04828161|26436880|FG002|Overall Study|Death|0|||
13274985|NCT04828161|26436881|FG003|Overall Study|Death|2|||
13274986|NCT04723394|26436896|FG000|Overall Study|Adverse Event|0|||
13274987|NCT04723394|26436897|FG001|Overall Study|Adverse Event|2|||
13274988|NCT04723394|26436896|FG000|Overall Study|Death|6|||
13274989|NCT04723394|26436897|FG001|Overall Study|Death|5|||
13274990|NCT04723394|26436896|FG000|Overall Study|Lost to Follow-up|2|||
13274991|NCT04723394|26436897|FG001|Overall Study|Lost to Follow-up|2|||
13274992|NCT04723394|26436896|FG000|Overall Study|Physician Decision|2|||
13274993|NCT04723394|26436897|FG001|Overall Study|Physician Decision|0|||
13274994|NCT04723394|26436896|FG000|Overall Study|Withdrawal by Subject|10|||
13274995|NCT04723394|26436897|FG001|Overall Study|Withdrawal by Subject|8|||
13274996|NCT04723394|26436896|FG000|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|0|||
13274997|NCT04723394|26436897|FG001|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|5|||
13274998|NCT04723394|26436896|FG000|Overall Study|Still Ongoing at Data Cut-Off|436|||
13274999|NCT04723394|26436897|FG001|Overall Study|Still Ongoing at Data Cut-Off|432|||
13275000|NCT04686084|26436904|FG000|Overall Study|Lost to Follow-up|1|||
13275001|NCT04685538|26436937|FG000|Overall Study|Adverse Event|0|||
13275002|NCT04685538|26436938|FG001|Overall Study|Adverse Event|1|||
13275003|NCT04685538|26436937|FG000|Overall Study|Lost to Follow-up|0|||
13275004|NCT04685538|26436938|FG001|Overall Study|Lost to Follow-up|2|||
13275005|NCT04575584|26437085|FG000|Overall Study|Death|6|||
13275006|NCT04575584|26437086|FG001|Overall Study|Death|4|||
13275007|NCT04575584|26437087|FG002|Overall Study|Death|6|||
13275008|NCT04575584|26437088|FG003|Overall Study|Death|2|||
13275009|NCT04575584|26437089|FG004|Overall Study|Death|0|||
13275010|NCT04575584|26437090|FG005|Overall Study|Death|0|||
13275011|NCT04575584|26437085|FG000|Overall Study|Lost to Follow-up|1|||
13275012|NCT04575584|26437086|FG001|Overall Study|Lost to Follow-up|1|||
13275013|NCT04575584|26437087|FG002|Overall Study|Lost to Follow-up|1|||
13275014|NCT04575584|26437088|FG003|Overall Study|Lost to Follow-up|1|||
13275015|NCT04575584|26437089|FG004|Overall Study|Lost to Follow-up|0|||
13275016|NCT04575584|26437090|FG005|Overall Study|Lost to Follow-up|0|||
13275017|NCT04575584|26437085|FG000|Overall Study|Physician Decision|0|||
13275018|NCT04575584|26437086|FG001|Overall Study|Physician Decision|1|||
13275019|NCT04575584|26437087|FG002|Overall Study|Physician Decision|1|||
13275020|NCT04575584|26437088|FG003|Overall Study|Physician Decision|1|||
13275021|NCT04575584|26437089|FG004|Overall Study|Physician Decision|0|||
13275022|NCT04575584|26437090|FG005|Overall Study|Physician Decision|0|||
13275023|NCT04575584|26437085|FG000|Overall Study|Withdrawal by Subject|7|||
13275024|NCT04575584|26437086|FG001|Overall Study|Withdrawal by Subject|9|||
13275025|NCT04575584|26437087|FG002|Overall Study|Withdrawal by Subject|5|||
13275026|NCT04575584|26437088|FG003|Overall Study|Withdrawal by Subject|3|||
13275027|NCT04575584|26437089|FG004|Overall Study|Withdrawal by Subject|0|||
13275028|NCT04575584|26437090|FG005|Overall Study|Withdrawal by Subject|0|||
13275029|NCT04575584|26437085|FG000|Overall Study|Not recorded|0|||
13275030|NCT04575584|26437086|FG001|Overall Study|Not recorded|0|||
13275031|NCT04575584|26437087|FG002|Overall Study|Not recorded|0|||
13275032|NCT04575584|26437088|FG003|Overall Study|Not recorded|1|||
13118856|NCT03030599|25931418|FG001|Stable Dose|Protocol deviation|0|||
13118857|NCT03030599|25931419|FG002|Stable Dose|Protocol deviation|0|||
13118858|NCT03030599|25931417|FG000|Stable Dose|Adverse Event|1|||
13118859|NCT03030599|25931418|FG001|Stable Dose|Adverse Event|0|||
13118860|NCT03030599|25931419|FG002|Stable Dose|Adverse Event|0|||
13118861|NCT03030599|25931417|FG000|Stable Dose|Lost to Follow-up|1|||
13118862|NCT03030599|25931418|FG001|Stable Dose|Lost to Follow-up|0|||
13118863|NCT03030599|25931419|FG002|Stable Dose|Lost to Follow-up|0|||
13118864|NCT03030599|25931417|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
13118865|NCT03030599|25931418|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
13118866|NCT03030599|25931419|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2|||
13118867|NCT03030599|25931417|FG000|Double Blind Randomized Withdrawal|Adverse Event|0|||
13118868|NCT03030599|25931418|FG001|Double Blind Randomized Withdrawal|Adverse Event|0|||
13118869|NCT03030599|25931419|FG002|Double Blind Randomized Withdrawal|Adverse Event|3|||
13118870|NCT03030599|25931417|FG000|Double Blind Randomized Withdrawal|Randomized in error|0|||
13118871|NCT03030599|25931418|FG001|Double Blind Randomized Withdrawal|Randomized in error|0|||
13118872|NCT03030599|25931419|FG002|Double Blind Randomized Withdrawal|Randomized in error|2|||
13118873|NCT03030599|25931417|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
13275033|NCT04575584|26437089|FG004|Overall Study|Not recorded|0|||
13275034|NCT04575584|26437090|FG005|Overall Study|Not recorded|0|||
13291122|NCT00158860|26482486|FG000|Overall Study|SPONSOR REQUEST|0|||
13291123|NCT00158860|26482487|FG001|Overall Study|SPONSOR REQUEST|1|||
13291124|NCT00158860|26482486|FG000|Overall Study|Lost to Follow up but returned per GSK|0|||
13291125|NCT00158860|26482487|FG001|Overall Study|Lost to Follow up but returned per GSK|1|||
13291126|NCT00158860|26482486|FG000|Overall Study|Closed per sponsor|0|||
13291127|NCT00158860|26482487|FG001|Overall Study|Closed per sponsor|1|||
13291128|NCT00158756|26482598|FG000|Overall Study|Withdrawal by Subject|5|||
13291129|NCT00158756|26482599|FG001|Overall Study|Withdrawal by Subject|0|||
13291130|NCT00158756|26482600|FG002|Overall Study|Withdrawal by Subject|6|||
13291131|NCT00158756|26482601|FG003|Overall Study|Withdrawal by Subject|1|||
13291132|NCT00158756|26482602|FG004|Overall Study|Withdrawal by Subject|3|||
13291133|NCT00158756|26482598|FG000|Overall Study|Adverse Event|0|||
13291134|NCT00158756|26482599|FG001|Overall Study|Adverse Event|0|||
13291135|NCT00158756|26482600|FG002|Overall Study|Adverse Event|1|||
13291136|NCT00158756|26482601|FG003|Overall Study|Adverse Event|0|||
13291137|NCT00158756|26482602|FG004|Overall Study|Adverse Event|0|||
13291138|NCT00158756|26482598|FG000|Overall Study|Serious adverse event|0|||
13291139|NCT00158756|26482599|FG001|Overall Study|Serious adverse event|0|||
13291140|NCT00158756|26482600|FG002|Overall Study|Serious adverse event|1|||
13291141|NCT00158756|26482601|FG003|Overall Study|Serious adverse event|0|||
13291142|NCT00158756|26482602|FG004|Overall Study|Serious adverse event|0|||
13291143|NCT00158600|26482627|FG000|Overall Study|unable to commit time to study|0|||
13291144|NCT00158600|26482628|FG001|Overall Study|unable to commit time to study|1|||
13291145|NCT00158600|26482627|FG000|Overall Study|Adverse Event|2|||
13291146|NCT00158600|26482628|FG001|Overall Study|Adverse Event|1|||
13291147|NCT00158600|26482627|FG000|Overall Study|Death|1|||
13291148|NCT00158600|26482628|FG001|Overall Study|Death|0|||
13291149|NCT00158600|26482627|FG000|Overall Study|Withdrawal by Subject|2|||
13291150|NCT00158600|26482628|FG001|Overall Study|Withdrawal by Subject|2|||
13291151|NCT00158184|26482643|FG000|Overall Study|personal issues|3|||
13291152|NCT00158184|26482644|FG001|Overall Study|personal issues|1|||
13291153|NCT00158184|26482643|FG000|Overall Study|failed for follow unit/study rules|2|||
13291154|NCT00158184|26482644|FG001|Overall Study|failed for follow unit/study rules|0|||
13291155|NCT00158184|26482643|FG000|Overall Study|Adverse Event|1|||
13291156|NCT00158184|26482644|FG001|Overall Study|Adverse Event|1|||
13291157|NCT00158054|26482663|FG000|Overall Study|Refused to continue|3|||
13291158|NCT00158054|26482664|FG001|Overall Study|Refused to continue|0|||
13291159|NCT00158054|26482663|FG000|Overall Study|Unavailable for follow up|7|||
13275035|NCT04542291|26437105|FG000|Overall Study|Adverse Event|1|||
13275036|NCT04542291|26437105|FG000|Overall Study|Physician Decision|2|||
13275037|NCT04440007|26437130|FG000|Overall Study|Adverse Event|0|||
13275038|NCT04440007|26437131|FG001|Overall Study|Adverse Event|1|||
13275039|NCT04440007|26437130|FG000|Overall Study|Lost to Follow-up|1|||
13275040|NCT04440007|26437131|FG001|Overall Study|Lost to Follow-up|3|||
13275041|NCT04440007|26437130|FG000|Overall Study|Death|7|||
13275042|NCT04440007|26437131|FG001|Overall Study|Death|2|||
13275043|NCT04440007|26437130|FG000|Overall Study|Physician Decision|1|||
13275044|NCT04440007|26437131|FG001|Overall Study|Physician Decision|1|||
13275045|NCT04440007|26437130|FG000|Overall Study|Withdrawal by Subject|2|||
13275046|NCT04440007|26437131|FG001|Overall Study|Withdrawal by Subject|1|||
13275047|NCT04440007|26437130|FG000|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|1|||
13275048|NCT04440007|26437131|FG001|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|2|||
13275049|NCT04440007|26437130|FG000|Overall Study|Discontinued prior to dosing|0|||
13275050|NCT04440007|26437131|FG001|Overall Study|Discontinued prior to dosing|2|||
13275051|NCT04276090|26437213|FG000|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|1|||
13275052|NCT04276090|26437214|FG001|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|0|||
13275053|NCT04213326|26437227|FG000|Overall Study|Consent withdrawn|51|||
13275054|NCT04213326|26437228|FG001|Overall Study|Consent withdrawn|241|||
13275055|NCT04213326|26437227|FG000|Overall Study|Lost to Follow-up|50|||
13275056|NCT04213326|26437228|FG001|Overall Study|Lost to Follow-up|902|||
13275057|NCT04213326|26437227|FG000|Overall Study|Protocol Violation|3|||
13275058|NCT04213326|26437228|FG001|Overall Study|Protocol Violation|25|||
13275059|NCT04213326|26437227|FG000|Overall Study|Participant eligibility changed|106|||
13275060|NCT04213326|26437228|FG001|Overall Study|Participant eligibility changed|19|||
13275061|NCT04213326|26437227|FG000|Overall Study|SCRI confirmed to be withdrawal|0|||
13275062|NCT04213326|26437228|FG001|Overall Study|SCRI confirmed to be withdrawal|16|||
13275063|NCT04213326|26437227|FG000|Overall Study|Incomplete study visit|0|||
13275064|NCT04213326|26437228|FG001|Overall Study|Incomplete study visit|367|||
13275065|NCT04115293|26437280|FG000|Overall Study|Adverse Event|0|||
13275066|NCT04115293|26437281|FG001|Overall Study|Adverse Event|2|||
13275067|NCT04115293|26437280|FG000|Overall Study|Withdrawal by Subject|2|||
13275068|NCT04115293|26437281|FG001|Overall Study|Withdrawal by Subject|1|||
13275069|NCT04115293|26437280|FG000|Overall Study|Physician Decision|1|||
13275070|NCT04115293|26437281|FG001|Overall Study|Physician Decision|0|||
13275071|NCT04115293|26437280|FG000|Overall Study|Death|1|||
13275072|NCT04115293|26437281|FG001|Overall Study|Death|1|||
13275073|NCT04083222|26437300|FG000|Overall Study|Voluntary Withdrawal|0|||
13275074|NCT04083222|26437301|FG001|Overall Study|Voluntary Withdrawal|1|||
13275075|NCT04083222|26437300|FG000|Overall Study|Reason not Specified|0|||
13275076|NCT04083222|26437301|FG001|Overall Study|Reason not Specified|1|||
13275077|NCT03905694|26437404|FG000|Long-term Extension Period|Remained in this Period at Time of Data Cut|18|||
13275078|NCT03873116|26437431|FG000|Overall Study|Study drug discontinuation due to rash|0|||
13275079|NCT03873116|26437432|FG001|Overall Study|Study drug discontinuation due to rash|0|||
13275080|NCT03873116|26437433|FG002|Overall Study|Study drug discontinuation due to rash|1|||
13275081|NCT03845023|26437456|FG000|Follow-Up (14 Days)|Lost to Follow-up|1|||
13275082|NCT03845023|26437457|FG001|Follow-Up (14 Days)|Lost to Follow-up|0|||
13275083|NCT03845023|26437458|FG002|Follow-Up (14 Days)|Lost to Follow-up|0|||
13275084|NCT03845023|26437459|FG003|Follow-Up (14 Days)|Lost to Follow-up|0|||
13275085|NCT03845023|26437456|FG000|Follow-Up (14 Days)|Adverse Event|0|||
13275086|NCT03845023|26437457|FG001|Follow-Up (14 Days)|Adverse Event|0|||
13275087|NCT03845023|26437458|FG002|Follow-Up (14 Days)|Adverse Event|1|||
13275088|NCT03845023|26437459|FG003|Follow-Up (14 Days)|Adverse Event|1|||
13275089|NCT03830333|26437538|FG000|Overall Study|Death|0|||
13275090|NCT03830333|26437539|FG001|Overall Study|Death|1|||
13275091|NCT03830333|26437538|FG000|Overall Study|Withdrawal by Subject|5|||
13275092|NCT03830333|26437539|FG001|Overall Study|Withdrawal by Subject|1|||
13275093|NCT03830333|26437538|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3|||
13275094|NCT03830333|26437539|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2|||
13275095|NCT03686384|26437570|FG000|Overall Study|Lack of Efficacy|4|||
13275096|NCT03686384|26437571|FG001|Overall Study|Lack of Efficacy|13|||
13275097|NCT03686384|26437570|FG000|Overall Study|Lost to Follow-up|3|||
13275098|NCT03686384|26437571|FG001|Overall Study|Lost to Follow-up|0|||
13275099|NCT03686384|26437570|FG000|Overall Study|Physician Decision|0|||
13118874|NCT03030599|25931418|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
13275100|NCT03686384|26437571|FG001|Overall Study|Physician Decision|1|||
13275101|NCT03686384|26437570|FG000|Overall Study|Took prohibited medication|0|||
13275102|NCT03686384|26437571|FG001|Overall Study|Took prohibited medication|1|||
13275103|NCT03681184|26437602|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0|||
13275104|NCT03681184|26437603|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1|||
13275105|NCT03681184|26437602|FG000|3-Month Blinded Extension Period|Remained in this Period at Time of Data Cut|12|||
13275106|NCT03681184|26437603|FG001|3-Month Blinded Extension Period|Remained in this Period at Time of Data Cut|23|||
13275107|NCT03681184|26437602|FG000|Open-Label Extension Period|Remained in this Period at Time of Data Cut|1|||
13275108|NCT03681184|26437603|FG001|Open-Label Extension Period|Remained in this Period at Time of Data Cut|1|||
13275109|NCT03620162|26437673|FG000|Overall Study|Physician Decision|4|||
13275110|NCT03620162|26437674|FG001|Overall Study|Physician Decision|0|||
13275111|NCT03620162|26437675|FG002|Overall Study|Physician Decision|1|||
13275112|NCT03620162|26437676|FG003|Overall Study|Physician Decision|0|||
13275113|NCT03620162|26437677|FG004|Overall Study|Physician Decision|2|||
13275114|NCT03620162|26437673|FG000|Overall Study|Lost to Follow-up|2|||
13275115|NCT03620162|26437674|FG001|Overall Study|Lost to Follow-up|6|||
13275116|NCT03620162|26437675|FG002|Overall Study|Lost to Follow-up|7|||
13275117|NCT03620162|26437676|FG003|Overall Study|Lost to Follow-up|3|||
13275118|NCT03620162|26437677|FG004|Overall Study|Lost to Follow-up|2|||
13275119|NCT03620162|26437673|FG000|Overall Study|Consent withdrawn by parent/guardian|9|||
13275120|NCT03620162|26437674|FG001|Overall Study|Consent withdrawn by parent/guardian|8|||
13275121|NCT03620162|26437675|FG002|Overall Study|Consent withdrawn by parent/guardian|25|||
13275122|NCT03620162|26437676|FG003|Overall Study|Consent withdrawn by parent/guardian|17|||
13275123|NCT03620162|26437677|FG004|Overall Study|Consent withdrawn by parent/guardian|9|||
13275124|NCT03485911|26437712|FG000|Overall Study|Withdrawal by Subject|0|||
13275125|NCT03485911|26437713|FG001|Overall Study|Withdrawal by Subject|2|||
13275126|NCT03485911|26437714|FG002|Overall Study|Withdrawal by Subject|2|||
13275127|NCT03485911|26437712|FG000|Overall Study|Adverse Event|1|||
13275128|NCT03485911|26437713|FG001|Overall Study|Adverse Event|0|||
13275129|NCT03485911|26437714|FG002|Overall Study|Adverse Event|1|||
13275130|NCT03485911|26437712|FG000|Overall Study|High frequency of HAE attacks|0|||
13275131|NCT03485911|26437713|FG001|Overall Study|High frequency of HAE attacks|0|||
13275132|NCT03485911|26437714|FG002|Overall Study|High frequency of HAE attacks|1|||
13275133|NCT03474107|26437743|FG000|Overall Study|Adverse Event|42|||
13275134|NCT03474107|26437744|FG001|Overall Study|Adverse Event|46|||
13275135|NCT03474107|26437743|FG000|Overall Study|Death|2|||
13275136|NCT03474107|26437744|FG001|Overall Study|Death|2|||
13275137|NCT03474107|26437743|FG000|Overall Study|Lost to Follow-up|0|||
13275138|NCT03474107|26437744|FG001|Overall Study|Lost to Follow-up|1|||
13275139|NCT03474107|26437743|FG000|Overall Study|Progressive Disease|177|||
13275140|NCT03474107|26437744|FG001|Overall Study|Progressive Disease|180|||
13275141|NCT03474107|26437743|FG000|Overall Study|Protocol Violation|1|||
13275142|NCT03474107|26437744|FG001|Overall Study|Protocol Violation|1|||
13275143|NCT03474107|26437743|FG000|Overall Study|Withdrawal by Subject|15|||
13275144|NCT03474107|26437744|FG001|Overall Study|Withdrawal by Subject|27|||
13275145|NCT03474107|26437743|FG000|Overall Study|Physician Decision|7|||
13275146|NCT03474107|26437744|FG001|Overall Study|Physician Decision|22|||
13275147|NCT03474107|26437743|FG000|Overall Study|Miscellaneous|1|||
13275148|NCT03474107|26437744|FG001|Overall Study|Miscellaneous|6|||
13275149|NCT03451045|26437777|FG000|Overall Study|Lack of Efficacy|3|||
13275150|NCT03451045|26437778|FG001|Overall Study|Lack of Efficacy|2|||
13275151|NCT03451045|26437779|FG002|Overall Study|Lack of Efficacy|2|||
13275152|NCT03451045|26437777|FG000|Overall Study|Physician Decision|1|||
13275153|NCT03451045|26437778|FG001|Overall Study|Physician Decision|1|||
13275154|NCT03451045|26437779|FG002|Overall Study|Physician Decision|1|||
13275155|NCT03451045|26437777|FG000|Overall Study|Withdrawal by Subject|4|||
13275156|NCT03451045|26437778|FG001|Overall Study|Withdrawal by Subject|0|||
13275157|NCT03451045|26437779|FG002|Overall Study|Withdrawal by Subject|5|||
13275158|NCT03451045|26437777|FG000|Overall Study|Pregnancy|0|||
13275159|NCT03451045|26437778|FG001|Overall Study|Pregnancy|0|||
13275160|NCT03451045|26437779|FG002|Overall Study|Pregnancy|2|||
13275161|NCT03451045|26437777|FG000|Overall Study|Adverse Event|7|||
13275162|NCT03451045|26437778|FG001|Overall Study|Adverse Event|1|||
13275163|NCT03451045|26437779|FG002|Overall Study|Adverse Event|3|||
13275164|NCT03451045|26437777|FG000|Overall Study|Non-compliance with study|2|||
13275165|NCT03451045|26437778|FG001|Overall Study|Non-compliance with study|0|||
13275166|NCT03451045|26437779|FG002|Overall Study|Non-compliance with study|1|||
13275167|NCT03451045|26437777|FG000|Overall Study|any other reason|10|||
13275168|NCT03451045|26437778|FG001|Overall Study|any other reason|2|||
13275169|NCT03451045|26437779|FG002|Overall Study|any other reason|13|||
13275170|NCT03412565|26437832|FG000|Overall Study|Other|0|||
13275171|NCT03412565|26437833|FG001|Overall Study|Other|0|||
13275172|NCT03412565|26437834|FG002|Overall Study|Other|0|||
13275173|NCT03412565|26437835|FG003|Overall Study|Other|3|||
13275174|NCT03412565|26437832|FG000|Overall Study|Withdrawal by Subject|0|||
13275175|NCT03412565|26437833|FG001|Overall Study|Withdrawal by Subject|0|||
13275176|NCT03412565|26437834|FG002|Overall Study|Withdrawal by Subject|1|||
13275177|NCT03412565|26437835|FG003|Overall Study|Withdrawal by Subject|5|||
13275178|NCT03412565|26437832|FG000|Overall Study|Physician Decision|0|||
13275179|NCT03412565|26437833|FG001|Overall Study|Physician Decision|1|||
13275180|NCT03412565|26437834|FG002|Overall Study|Physician Decision|0|||
13275181|NCT03412565|26437835|FG003|Overall Study|Physician Decision|1|||
13275182|NCT03412565|26437832|FG000|Overall Study|Death|1|||
13275183|NCT03412565|26437833|FG001|Overall Study|Death|2|||
13275184|NCT03412565|26437834|FG002|Overall Study|Death|2|||
13275185|NCT03412565|26437835|FG003|Overall Study|Death|4|||
13275186|NCT03412565|26437832|FG000|Overall Study|Still ongoing|0|||
13275187|NCT03412565|26437833|FG001|Overall Study|Still ongoing|62|||
13275188|NCT03412565|26437834|FG002|Overall Study|Still ongoing|59|||
13275189|NCT03412565|26437835|FG003|Overall Study|Still ongoing|41|||
13275190|NCT03286842|26437873|FG000|Overall Study|Patients rolled over to another study|80|||
13275191|NCT03281629|26437894|FG000|Overall Study|The two participants dropped out due to COVID-19 lockdown.|2|||
13275192|NCT03281629|26437895|FG001|Overall Study|The two participants dropped out due to COVID-19 lockdown.|0|||
13275193|NCT03281629|26437894|FG000|Overall Study|Death|0|||
13275194|NCT03281629|26437895|FG001|Overall Study|Death|1|||
13275195|NCT03281629|26437894|FG000|Overall Study|Participant's schedule change and cannot participate in the study|0|||
13275196|NCT03281629|26437895|FG001|Overall Study|Participant's schedule change and cannot participate in the study|1|||
13275197|NCT03277105|26437932|FG000|Overall Study|Death|77|||
13275198|NCT03277105|26437933|FG001|Overall Study|Death|73|||
13275199|NCT03277105|26437932|FG000|Overall Study|Lost to Follow-up|0|||
13275200|NCT03277105|26437933|FG001|Overall Study|Lost to Follow-up|3|||
13275201|NCT03277105|26437932|FG000|Overall Study|Withdrawal by Subject|10|||
13275202|NCT03277105|26437933|FG001|Overall Study|Withdrawal by Subject|9|||
13275203|NCT03277105|26437932|FG000|Overall Study|Other|1|||
13275204|NCT03277105|26437933|FG001|Overall Study|Other|3|||
13275205|NCT03277105|26437932|FG000|Overall Study|Ongoing|171|||
13275206|NCT03277105|26437933|FG001|Overall Study|Ongoing|175|||
13291160|NCT00158054|26482664|FG001|Overall Study|Unavailable for follow up|3|||
13291161|NCT00157755|26482697|FG000|Overall Study|Death|2|||
13291162|NCT00157755|26482698|FG001|Overall Study|Death|3|||
13291163|NCT00157755|26482699|FG002|Overall Study|Death|3|||
13291164|NCT00157755|26482700|FG003|Overall Study|Death|2|||
13291165|NCT00157755|26482701|FG004|Overall Study|Death|0|||
13291166|NCT00157755|26482702|FG005|Overall Study|Death|0|||
13291167|NCT00157755|26482697|FG000|Overall Study|Lost to Follow-up|0|||
13291168|NCT00157755|26482698|FG001|Overall Study|Lost to Follow-up|0|||
13291169|NCT00157755|26482699|FG002|Overall Study|Lost to Follow-up|1|||
13291170|NCT00157755|26482700|FG003|Overall Study|Lost to Follow-up|0|||
13291171|NCT00157755|26482701|FG004|Overall Study|Lost to Follow-up|0|||
13291172|NCT00157755|26482702|FG005|Overall Study|Lost to Follow-up|0|||
13291173|NCT00157755|26482697|FG000|Overall Study|Withdrawal by Subject|0|||
13291174|NCT00157755|26482698|FG001|Overall Study|Withdrawal by Subject|0|||
13291175|NCT00157755|26482699|FG002|Overall Study|Withdrawal by Subject|1|||
13291176|NCT00157755|26482700|FG003|Overall Study|Withdrawal by Subject|1|||
13291177|NCT00157755|26482701|FG004|Overall Study|Withdrawal by Subject|1|||
13291178|NCT00157755|26482702|FG005|Overall Study|Withdrawal by Subject|2|||
13291179|NCT00157755|26482697|FG000|Overall Study|Explant due to infection|0|||
13291180|NCT00157755|26482698|FG001|Overall Study|Explant due to infection|0|||
13291181|NCT00157755|26482699|FG002|Overall Study|Explant due to infection|1|||
13291182|NCT00157755|26482700|FG003|Overall Study|Explant due to infection|0|||
13291183|NCT00157755|26482701|FG004|Overall Study|Explant due to infection|0|||
13291184|NCT00157755|26482702|FG005|Overall Study|Explant due to infection|0|||
13291185|NCT00157755|26482697|FG000|Overall Study|Medical reason|0|||
13291186|NCT00157755|26482698|FG001|Overall Study|Medical reason|0|||
13291187|NCT00157755|26482699|FG002|Overall Study|Medical reason|1|||
13291188|NCT00157755|26482700|FG003|Overall Study|Medical reason|1|||
13291189|NCT00157755|26482701|FG004|Overall Study|Medical reason|0|||
13291190|NCT00157755|26482702|FG005|Overall Study|Medical reason|0|||
13291191|NCT00157755|26482697|FG000|Overall Study|Study site closure|0|||
13291192|NCT00157755|26482698|FG001|Overall Study|Study site closure|1|||
13291193|NCT00157755|26482699|FG002|Overall Study|Study site closure|0|||
13118875|NCT03030599|25931419|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1|||
13118876|NCT03030599|25931417|FG000|Open-label Extension|Adverse Event|3|||
13118877|NCT03030599|25931418|FG001|Open-label Extension|Adverse Event|0|||
13118878|NCT03030599|25931419|FG002|Open-label Extension|Adverse Event|0|||
13118879|NCT03030599|25931417|FG000|Open-label Extension|Lost to Follow-up|2|||
13118880|NCT03030599|25931418|FG001|Open-label Extension|Lost to Follow-up|0|||
13118881|NCT03030599|25931419|FG002|Open-label Extension|Lost to Follow-up|0|||
13118882|NCT03030599|25931417|FG000|Open-label Extension|Lack of Efficacy|1|||
13118883|NCT03030599|25931418|FG001|Open-label Extension|Lack of Efficacy|0|||
13291194|NCT00157755|26482700|FG003|Overall Study|Study site closure|0|||
13291195|NCT00157755|26482701|FG004|Overall Study|Study site closure|0|||
13291196|NCT00157755|26482702|FG005|Overall Study|Study site closure|0|||
13291197|NCT00157755|26482697|FG000|Overall Study|Subject non-compliance|0|||
13291198|NCT00157755|26482698|FG001|Overall Study|Subject non-compliance|0|||
13291199|NCT00157755|26482699|FG002|Overall Study|Subject non-compliance|0|||
13291200|NCT00157755|26482700|FG003|Overall Study|Subject non-compliance|0|||
13291201|NCT00157755|26482701|FG004|Overall Study|Subject non-compliance|0|||
13291202|NCT00157755|26482702|FG005|Overall Study|Subject non-compliance|1|||
13118884|NCT03030599|25931419|FG002|Open-label Extension|Lack of Efficacy|0|||
13291203|NCT00157755|26482697|FG000|Overall Study|Study completion|0|||
13291204|NCT00157755|26482698|FG001|Overall Study|Study completion|0|||
13118885|NCT03030599|25931417|FG000|Open-label Extension|Other Reason|1|||
13118886|NCT03030599|25931418|FG001|Open-label Extension|Other Reason|0|||
13118887|NCT03030599|25931419|FG002|Open-label Extension|Other Reason|0|||
13118888|NCT03029832|25931454|FG000|Overall Study|Safety Follow-Up Completed|2|||
13118889|NCT03029832|25931455|FG001|Overall Study|Safety Follow-Up Completed|0|||
13118890|NCT03029832|25931454|FG000|Overall Study|Death due to Disease Progression|1|||
13118891|NCT03029832|25931455|FG001|Overall Study|Death due to Disease Progression|0|||
13118892|NCT03029832|25931454|FG000|Overall Study|Study Terminated By Sponsor|1|||
13118893|NCT03029832|25931455|FG001|Overall Study|Study Terminated By Sponsor|1|||
13118894|NCT03029819|25931474|FG000|Overall Study|Lost to Follow-up|3|||
13118895|NCT03029819|25931475|FG001|Overall Study|Lost to Follow-up|5|||
13118896|NCT03029819|25931474|FG000|Overall Study|Removed due to disruptive behavior|0|||
13118897|NCT03029819|25931475|FG001|Overall Study|Removed due to disruptive behavior|1|||
13118898|NCT03029650|25931493|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
13118899|NCT03029650|25931494|FG001|Washout (1 Week)|Withdrawal by Subject|1|||
13118900|NCT03029650|25931493|FG000|Washout (1 Week)|Physician Decision|0|||
13118901|NCT03029650|25931494|FG001|Washout (1 Week)|Physician Decision|1|||
13118902|NCT03029624|25931503|FG000|Overall Study|Adverse Event|1|||
13118903|NCT03029624|25931503|FG000|Overall Study|Withdrawal by Subject|1|||
13118904|NCT03029624|25931503|FG000|Overall Study|Lack of Efficacy|1|||
13118905|NCT03029624|25931503|FG000|Overall Study|MRI need|2|||
13118906|NCT03029585|25931520|FG000|Overall Study|Death|1|||
13118907|NCT03029585|25931521|FG001|Overall Study|Death|1|||
13118908|NCT03029585|25931520|FG000|Overall Study|Withdrawal by Subject|1|||
13118909|NCT03029585|25931521|FG001|Overall Study|Withdrawal by Subject|0|||
13118910|NCT03029247|25931635|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3|||
13118911|NCT03029247|25931636|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0|||
13118912|NCT03029247|25931635|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
13118913|NCT03029247|25931636|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
13118914|NCT03029247|25931635|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7|||
13118915|NCT03029247|25931636|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4|||
13118916|NCT03029247|25931635|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
13275207|NCT03091192|26437956|FG000|Overall Study|Study terminated by sponsor|21|||
13275208|NCT03091192|26437957|FG001|Overall Study|Study terminated by sponsor|14|||
13275209|NCT03091192|26437956|FG000|Overall Study|Death|9|||
13275210|NCT03091192|26437957|FG001|Overall Study|Death|13|||
13275211|NCT03091192|26437956|FG000|Overall Study|Withdrawal by Subject|2|||
13275212|NCT03091192|26437957|FG001|Overall Study|Withdrawal by Subject|0|||
13275213|NCT03091192|26437956|FG000|Overall Study|Lost to Follow-up|1|||
13275214|NCT03091192|26437957|FG001|Overall Study|Lost to Follow-up|0|||
13275215|NCT03064763|26437964|FG000|Overall Study|Ongoing in study|10|||
13275216|NCT03064763|26437964|FG000|Overall Study|Death|8|||
13275217|NCT03049449|26438024|FG000|Overall Study|Did not receive treatment.|0|||
13275218|NCT03049449|26438025|FG001|Overall Study|Did not receive treatment.|0|||
13275219|NCT03049449|26438026|FG002|Overall Study|Did not receive treatment.|0|||
13275220|NCT03049449|26438027|FG003|Overall Study|Did not receive treatment.|0|||
13275221|NCT03049449|26438028|FG004|Overall Study|Did not receive treatment.|0|||
13275222|NCT03049449|26438029|FG005|Overall Study|Did not receive treatment.|0|||
13275223|NCT03049449|26438030|FG006|Overall Study|Did not receive treatment.|0|||
13275224|NCT03049449|26438031|FG007|Overall Study|Did not receive treatment.|0|||
13275225|NCT03049449|26438032|FG008|Overall Study|Did not receive treatment.|1|||
13275226|NCT03049449|26438033|FG009|Overall Study|Did not receive treatment.|0|||
13275227|NCT03049449|26438024|FG000|Overall Study|Enrolled and removed from study with no treatment|0|||
13275228|NCT03049449|26438025|FG001|Overall Study|Enrolled and removed from study with no treatment|0|||
13275229|NCT03049449|26438026|FG002|Overall Study|Enrolled and removed from study with no treatment|1|||
13275230|NCT03049449|26438027|FG003|Overall Study|Enrolled and removed from study with no treatment|1|||
13275231|NCT03049449|26438028|FG004|Overall Study|Enrolled and removed from study with no treatment|0|||
13275232|NCT03049449|26438029|FG005|Overall Study|Enrolled and removed from study with no treatment|0|||
13275233|NCT03049449|26438030|FG006|Overall Study|Enrolled and removed from study with no treatment|0|||
13275234|NCT03049449|26438031|FG007|Overall Study|Enrolled and removed from study with no treatment|0|||
13275235|NCT03049449|26438032|FG008|Overall Study|Enrolled and removed from study with no treatment|0|||
13275236|NCT03049449|26438033|FG009|Overall Study|Enrolled and removed from study with no treatment|0|||
13275237|NCT03049449|26438024|FG000|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
13275238|NCT03049449|26438025|FG001|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
13118917|NCT03029247|25931636|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
13118918|NCT03029208|25931714|FG000|Overall Study|Withdrawal by Subject|2|||
13118919|NCT03029208|25931715|FG001|Overall Study|Withdrawal by Subject|3|||
13118920|NCT03029208|25931714|FG000|Overall Study|Lost to Follow-up|0|||
13118921|NCT03029208|25931715|FG001|Overall Study|Lost to Follow-up|1|||
13275239|NCT03049449|26438026|FG002|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
13291205|NCT00157755|26482699|FG002|Overall Study|Study completion|0|||
13118922|NCT03029143|25931738|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8|||
13118923|NCT03029143|25931739|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
13118924|NCT03029143|25931740|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
13118925|NCT03029143|25931738|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12|||
13118926|NCT03029143|25931739|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
13118927|NCT03029143|25931740|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
13118928|NCT03029143|25931738|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1|||
13118929|NCT03029143|25931739|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
13118930|NCT03029143|25931740|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
13118931|NCT03029143|25931738|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6|||
13118932|NCT03029143|25931739|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
13118933|NCT03029143|25931740|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
13118934|NCT03029143|25931738|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142|||
13118935|NCT03029143|25931739|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
13118936|NCT03029143|25931740|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
13118937|NCT03029143|25931738|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0|||
13118938|NCT03029143|25931739|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3|||
13118939|NCT03029143|25931740|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9|||
13118940|NCT03029143|25931738|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0|||
13118941|NCT03029143|25931739|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1|||
13118942|NCT03029143|25931740|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3|||
13118943|NCT03029143|25931738|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0|||
13118944|NCT03029143|25931739|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1|||
13118945|NCT03029143|25931740|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3|||
13118946|NCT03029143|25931738|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0|||
13118947|NCT03029143|25931739|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10|||
13118948|NCT03029143|25931740|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1|||
13118949|NCT03029143|25931738|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0|||
13118950|NCT03029143|25931739|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6|||
13118951|NCT03029143|25931740|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7|||
13118952|NCT03029143|25931738|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0|||
13118953|NCT03029143|25931739|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2|||
13118954|NCT03029143|25931740|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1|||
13118955|NCT03028870|25931831|FG000|Overall Study|Adverse Event|7|||
13118956|NCT03028870|25931832|FG001|Overall Study|Adverse Event|4|||
13118957|NCT03028870|25931833|FG002|Overall Study|Adverse Event|3|||
13118958|NCT03028870|25931834|FG003|Overall Study|Adverse Event|3|||
13118959|NCT03028870|25931831|FG000|Overall Study|Withdrawal by Subject|1|||
13118960|NCT03028870|25931832|FG001|Overall Study|Withdrawal by Subject|1|||
13275240|NCT03049449|26438027|FG003|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
13275241|NCT03049449|26438028|FG004|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
13275242|NCT03049449|26438029|FG005|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
13275243|NCT03049449|26438030|FG006|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
13275244|NCT03049449|26438031|FG007|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
13275245|NCT03049449|26438032|FG008|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
13275246|NCT03049449|26438033|FG009|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
13275247|NCT03006926|26438058|FG000|Overall Study|Death|0|||
13275248|NCT03006926|26438059|FG001|Overall Study|Death|33|||
13275249|NCT03006926|26438058|FG000|Overall Study|Ongoing Survival Follow-up|0|||
13275250|NCT03006926|26438059|FG001|Overall Study|Ongoing Survival Follow-up|26|||
13275251|NCT03006926|26438058|FG000|Overall Study|Ongoing-on Treatment|0|||
13275252|NCT03006926|26438059|FG001|Overall Study|Ongoing-on Treatment|36|||
13275253|NCT03006926|26438058|FG000|Overall Study|Lost to Follow-up|0|||
13275254|NCT03006926|26438059|FG001|Overall Study|Lost to Follow-up|1|||
13275255|NCT03006926|26438058|FG000|Overall Study|Withdrawal by Subject|0|||
13275256|NCT03006926|26438059|FG001|Overall Study|Withdrawal by Subject|2|||
13275257|NCT02989857|26438130|FG000|Randomization Phase|Not Treated|3|||
13275258|NCT02989857|26438131|FG001|Randomization Phase|Not Treated|2|||
13275259|NCT02989857|26438132|FG002|Randomization Phase|Not Treated|0|||
13275260|NCT02915783|26438161|FG000|Overall Study|Death|21|||
13275261|NCT02915783|26438161|FG000|Overall Study|Lost to Follow-up|1|||
13275262|NCT02915783|26438161|FG000|Overall Study|Withdrawal by Subject|2|||
13275263|NCT02546986|26438272|FG000|Treatment Period|Progressive Disease|20|||
13118961|NCT03028870|25931833|FG002|Overall Study|Withdrawal by Subject|1|||
13118962|NCT03028870|25931834|FG003|Overall Study|Withdrawal by Subject|2|||
13118963|NCT03028870|25931831|FG000|Overall Study|Lost to Follow-up|1|||
13275264|NCT02546986|26438273|FG001|Treatment Period|Progressive Disease|22|||
13275265|NCT02546986|26438272|FG000|Treatment Period|Adverse Event|14|||
13275266|NCT02546986|26438273|FG001|Treatment Period|Adverse Event|6|||
13275267|NCT02546986|26438272|FG000|Treatment Period|Symptomatic Deterioration|4|||
13275268|NCT02546986|26438273|FG001|Treatment Period|Symptomatic Deterioration|3|||
13275269|NCT02546986|26438272|FG000|Treatment Period|Death|3|||
13275270|NCT02546986|26438273|FG001|Treatment Period|Death|4|||
13275271|NCT02546986|26438272|FG000|Treatment Period|Physician Decision|1|||
13275272|NCT02546986|26438273|FG001|Treatment Period|Physician Decision|2|||
13275273|NCT02546986|26438272|FG000|Treatment Period|Protocol Violation|1|||
13275274|NCT02546986|26438273|FG001|Treatment Period|Protocol Violation|0|||
13275275|NCT02546986|26438272|FG000|Treatment Period|Withdrawal by Subject|1|||
13275276|NCT02546986|26438273|FG001|Treatment Period|Withdrawal by Subject|1|||
13275277|NCT02546986|26438272|FG000|Treatment Period|Non-compliance with Study Drug|0|||
13275278|NCT02546986|26438273|FG001|Treatment Period|Non-compliance with Study Drug|1|||
13275279|NCT02546986|26438272|FG000|Treatment Period|Study Terminated by Sponsor|0|||
13275280|NCT02546986|26438273|FG001|Treatment Period|Study Terminated by Sponsor|1|||
13275281|NCT02546986|26438272|FG000|Treatment Period|Miscellaneous|7|||
13275282|NCT02546986|26438273|FG001|Treatment Period|Miscellaneous|9|||
13275283|NCT02546986|26438272|FG000|Survival Follow-Up Phase|Missing Status|3|||
13275284|NCT02546986|26438273|FG001|Survival Follow-Up Phase|Missing Status|5|||
13275285|NCT02546986|26438272|FG000|Survival Follow-Up Phase|Death|18|||
13275286|NCT02546986|26438273|FG001|Survival Follow-Up Phase|Death|12|||
13275287|NCT02546986|26438272|FG000|Survival Follow-Up Phase|Alive|13|||
13275288|NCT02546986|26438273|FG001|Survival Follow-Up Phase|Alive|16|||
13275289|NCT02546986|26438272|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
13275290|NCT02546986|26438273|FG001|Survival Follow-Up Phase|Lost to Follow-up|2|||
13275291|NCT02519348|26438412|FG000|Overall Study|Death|31|||
13275292|NCT02519348|26438413|FG001|Overall Study|Death|74|||
13275293|NCT02519348|26438414|FG002|Overall Study|Death|47|||
13275294|NCT02519348|26438415|FG003|Overall Study|Death|54|||
13275295|NCT02519348|26438416|FG004|Overall Study|Death|63|||
13275296|NCT02519348|26438417|FG005|Overall Study|Death|18|||
13275297|NCT02519348|26438418|FG006|Overall Study|Death|2|||
13275298|NCT02519348|26438419|FG007|Overall Study|Death|5|||
13275299|NCT02519348|26438420|FG008|Overall Study|Death|5|||
13275300|NCT02519348|26438412|FG000|Overall Study|Withdrawal by Subject|4|||
13275301|NCT02519348|26438413|FG001|Overall Study|Withdrawal by Subject|7|||
13275302|NCT02519348|26438414|FG002|Overall Study|Withdrawal by Subject|4|||
13275303|NCT02519348|26438415|FG003|Overall Study|Withdrawal by Subject|3|||
13275304|NCT02519348|26438416|FG004|Overall Study|Withdrawal by Subject|3|||
13275305|NCT02519348|26438417|FG005|Overall Study|Withdrawal by Subject|2|||
13275306|NCT02519348|26438418|FG006|Overall Study|Withdrawal by Subject|0|||
13275307|NCT02519348|26438419|FG007|Overall Study|Withdrawal by Subject|0|||
13275308|NCT02519348|26438420|FG008|Overall Study|Withdrawal by Subject|1|||
13275309|NCT02519348|26438412|FG000|Overall Study|Lost to Follow-up|0|||
13275310|NCT02519348|26438413|FG001|Overall Study|Lost to Follow-up|0|||
13275311|NCT02519348|26438414|FG002|Overall Study|Lost to Follow-up|1|||
13275312|NCT02519348|26438415|FG003|Overall Study|Lost to Follow-up|0|||
13275313|NCT02519348|26438416|FG004|Overall Study|Lost to Follow-up|2|||
13275314|NCT02519348|26438417|FG005|Overall Study|Lost to Follow-up|1|||
13275315|NCT02519348|26438418|FG006|Overall Study|Lost to Follow-up|1|||
13275316|NCT02519348|26438419|FG007|Overall Study|Lost to Follow-up|0|||
13275317|NCT02519348|26438420|FG008|Overall Study|Lost to Follow-up|0|||
13275318|NCT02519348|26438412|FG000|Overall Study|Other|0|||
13275319|NCT02519348|26438413|FG001|Overall Study|Other|3|||
13275320|NCT02519348|26438414|FG002|Overall Study|Other|0|||
13275321|NCT02519348|26438415|FG003|Overall Study|Other|0|||
13275322|NCT02519348|26438416|FG004|Overall Study|Other|1|||
13275323|NCT02519348|26438417|FG005|Overall Study|Other|0|||
13275324|NCT02519348|26438418|FG006|Overall Study|Other|0|||
13275325|NCT02519348|26438419|FG007|Overall Study|Other|0|||
13275326|NCT02519348|26438420|FG008|Overall Study|Other|0|||
13275327|NCT02519348|26438412|FG000|Overall Study|Ongoing at the time of data cut-off date|5|||
13275328|NCT02519348|26438413|FG001|Overall Study|Ongoing at the time of data cut-off date|20|||
13275329|NCT02519348|26438414|FG002|Overall Study|Ongoing at the time of data cut-off date|23|||
13275330|NCT02519348|26438415|FG003|Overall Study|Ongoing at the time of data cut-off date|12|||
13275331|NCT02519348|26438416|FG004|Overall Study|Ongoing at the time of data cut-off date|15|||
13275332|NCT02519348|26438417|FG005|Overall Study|Ongoing at the time of data cut-off date|26|||
13275333|NCT02519348|26438418|FG006|Overall Study|Ongoing at the time of data cut-off date|0|||
13275334|NCT02519348|26438419|FG007|Overall Study|Ongoing at the time of data cut-off date|0|||
13275335|NCT02519348|26438420|FG008|Overall Study|Ongoing at the time of data cut-off date|0|||
13291206|NCT00157755|26482700|FG003|Overall Study|Study completion|0|||
13291207|NCT00157755|26482701|FG004|Overall Study|Study completion|1|||
13291208|NCT00157755|26482702|FG005|Overall Study|Study completion|2|||
13291209|NCT00157248|26482819|FG000|Overall Study|Adverse Event|36|||
13291210|NCT00157248|26482820|FG001|Overall Study|Adverse Event|25|||
13291211|NCT00157248|26482821|FG002|Overall Study|Adverse Event|13|||
13275336|NCT02511106|26438452|FG000|Overall Study|Lost to Follow-up|1|||
13275337|NCT02511106|26438453|FG001|Overall Study|Lost to Follow-up|2|||
13275338|NCT02511106|26438452|FG000|Overall Study|Withdrawal by Subject|19|||
13275339|NCT02511106|26438453|FG001|Overall Study|Withdrawal by Subject|14|||
13275340|NCT02511106|26438452|FG000|Overall Study|Ongoing study at data cut-off|309|||
13275341|NCT02511106|26438453|FG001|Overall Study|Ongoing study at data cut-off|307|||
13275342|NCT02511106|26438452|FG000|Overall Study|Without specified reason|1|||
13275343|NCT02511106|26438453|FG001|Overall Study|Without specified reason|0|||
13275344|NCT02511106|26438452|FG000|Overall Study|Missing|1|||
13275345|NCT02511106|26438453|FG001|Overall Study|Missing|0|||
13275346|NCT02421939|26438508|FG000|Overall Study|Progressive disease|70|||
13275347|NCT02421939|26438509|FG001|Overall Study|Progressive disease|16|||
13275348|NCT02421939|26438508|FG000|Overall Study|Lack of Efficacy|21|||
13275349|NCT02421939|26438509|FG001|Overall Study|Lack of Efficacy|31|||
13275350|NCT02421939|26438508|FG000|Overall Study|Death|36|||
13275351|NCT02421939|26438509|FG001|Overall Study|Death|10|||
13275352|NCT02421939|26438508|FG000|Overall Study|Disease relapse|33|||
13275353|NCT02421939|26438509|FG001|Overall Study|Disease relapse|2|||
13275354|NCT02421939|26438508|FG000|Overall Study|Adverse Event|28|||
13275355|NCT02421939|26438509|FG001|Overall Study|Adverse Event|5|||
13275356|NCT02421939|26438508|FG000|Overall Study|Withdrawal by Subject|5|||
13275357|NCT02421939|26438509|FG001|Overall Study|Withdrawal by Subject|24|||
13275358|NCT02421939|26438508|FG000|Overall Study|Physician Decision|11|||
13275359|NCT02421939|26438509|FG001|Overall Study|Physician Decision|11|||
13275360|NCT02421939|26438508|FG000|Overall Study|Completed 1 or 2 chemo cycles with CRs|0|||
13275361|NCT02421939|26438509|FG001|Overall Study|Completed 1 or 2 chemo cycles with CRs|19|||
13275362|NCT02421939|26438508|FG000|Overall Study|Miscellaneous|4|||
13275363|NCT02421939|26438509|FG001|Overall Study|Miscellaneous|5|||
13275364|NCT02421939|26438508|FG000|Overall Study|Protocol deviation|1|||
13275365|NCT02421939|26438509|FG001|Overall Study|Protocol deviation|1|||
13275366|NCT02367040|26438538|FG000|Overall Study|Lost to Follow-up|1|||
13275367|NCT02367040|26438539|FG001|Overall Study|Lost to Follow-up|1|||
13275368|NCT02367040|26438538|FG000|Overall Study|Lack of Efficacy|1|||
13275369|NCT02367040|26438539|FG001|Overall Study|Lack of Efficacy|0|||
13275370|NCT02367040|26438538|FG000|Overall Study|Additional primary malignancy|0|||
13275371|NCT02367040|26438539|FG001|Overall Study|Additional primary malignancy|1|||
13275372|NCT02367040|26438538|FG000|Overall Study|AE not associated with clinical disease progression|104|||
13275373|NCT02367040|26438539|FG001|Overall Study|AE not associated with clinical disease progression|9|||
13275374|NCT02367040|26438538|FG000|Overall Study|AE associated with clinical disease progression|1|||
13275375|NCT02367040|26438539|FG001|Overall Study|AE associated with clinical disease progression|3|||
13275376|NCT02367040|26438538|FG000|Overall Study|Physician Decision|2|||
13275377|NCT02367040|26438539|FG001|Overall Study|Physician Decision|8|||
13275378|NCT02367040|26438538|FG000|Overall Study|Non-compliance with study drug|1|||
13275379|NCT02367040|26438539|FG001|Overall Study|Non-compliance with study drug|0|||
13275380|NCT02367040|26438538|FG000|Overall Study|Failure to meet continuation criteria|1|||
13275381|NCT02367040|26438539|FG001|Overall Study|Failure to meet continuation criteria|0|||
13275382|NCT02367040|26438538|FG000|Overall Study|Switching to other therapy|2|||
13275383|NCT02367040|26438539|FG001|Overall Study|Switching to other therapy|0|||
13275384|NCT02367040|26438538|FG000|Overall Study|Withdrawal by Subject|41|||
13275385|NCT02367040|26438539|FG001|Overall Study|Withdrawal by Subject|14|||
13275386|NCT02367040|26438538|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1|||
13275387|NCT02367040|26438539|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
13275388|NCT02367040|26438538|FG000|Overall Study|Patient decision|35|||
13275389|NCT02367040|26438539|FG001|Overall Study|Patient decision|11|||
13275390|NCT02367040|26438538|FG000|Overall Study|Required procedure failed|1|||
13275391|NCT02367040|26438539|FG001|Overall Study|Required procedure failed|0|||
13275392|NCT02367040|26438538|FG000|Overall Study|Randomized by mistake with study treatment|1|||
13275393|NCT02367040|26438539|FG001|Overall Study|Randomized by mistake with study treatment|0|||
13275394|NCT02367040|26438538|FG000|Overall Study|Protocol Violation|1|||
13275395|NCT02367040|26438539|FG001|Overall Study|Protocol Violation|0|||
13275396|NCT02367040|26438538|FG000|Overall Study|Progressive disease - radiological progression|39|||
13275397|NCT02367040|26438539|FG001|Overall Study|Progressive disease - radiological progression|67|||
13275398|NCT02367040|26438538|FG000|Overall Study|Progressive disease - clinical progression|2|||
13275399|NCT02367040|26438539|FG001|Overall Study|Progressive disease - clinical progression|6|||
13275400|NCT02367040|26438538|FG000|Overall Study|Drug not administered|3|||
13275401|NCT02367040|26438539|FG001|Overall Study|Drug not administered|2|||
13275402|NCT02312258|26438552|FG000|Overall Study|Adverse Event|15|||
13275403|NCT02312258|26438553|FG001|Overall Study|Adverse Event|47|||
13275404|NCT02312258|26438552|FG000|Overall Study|Lost to Follow-up|0|||
13275405|NCT02312258|26438553|FG001|Overall Study|Lost to Follow-up|1|||
13275406|NCT02312258|26438552|FG000|Overall Study|Progressive Disease|174|||
13275407|NCT02312258|26438553|FG001|Overall Study|Progressive Disease|188|||
13275408|NCT02312258|26438552|FG000|Overall Study|Withdrawal by Subject|8|||
13275409|NCT02312258|26438553|FG001|Overall Study|Withdrawal by Subject|9|||
13118964|NCT03028870|25931832|FG001|Overall Study|Lost to Follow-up|0|||
13275410|NCT02312258|26438552|FG000|Overall Study|Reason not Specified|11|||
13275411|NCT02312258|26438553|FG001|Overall Study|Reason not Specified|31|||
13275412|NCT02312258|26438552|FG000|Overall Study|Participants Ongoing Treatment|43|||
13275413|NCT02312258|26438553|FG001|Overall Study|Participants Ongoing Treatment|83|||
13275414|NCT02294461|26438614|FG000|Double-blind Period (up to 29.4 Months)|Death|6|||
13275415|NCT02294461|26438615|FG001|Double-blind Period (up to 29.4 Months)|Death|4|||
13275416|NCT02294461|26438614|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30|||
13275417|NCT02294461|26438615|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66|||
13118965|NCT03028870|25931833|FG002|Overall Study|Lost to Follow-up|0|||
13118966|NCT03028870|25931834|FG003|Overall Study|Lost to Follow-up|0|||
13118967|NCT03028870|25931831|FG000|Overall Study|Lack of Efficacy|3|||
13118968|NCT03028870|25931832|FG001|Overall Study|Lack of Efficacy|0|||
13118969|NCT03028870|25931833|FG002|Overall Study|Lack of Efficacy|0|||
13118970|NCT03028870|25931834|FG003|Overall Study|Lack of Efficacy|0|||
13118971|NCT03028870|25931831|FG000|Overall Study|Administrative|5|||
13118972|NCT03028870|25931832|FG001|Overall Study|Administrative|5|||
13118973|NCT03028870|25931833|FG002|Overall Study|Administrative|12|||
13118974|NCT03028870|25931834|FG003|Overall Study|Administrative|4|||
13275418|NCT02294461|26438614|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27|||
13275419|NCT02294461|26438615|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54|||
13275420|NCT02294461|26438614|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
13275421|NCT02294461|26438615|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2|||
13275422|NCT02294461|26438614|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1|||
13275423|NCT02294461|26438615|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
13275424|NCT02294461|26438614|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38|||
13275425|NCT02294461|26438615|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51|||
13275426|NCT02294461|26438614|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16|||
13275427|NCT02294461|26438615|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15|||
13275428|NCT02294461|26438614|FG000|Open-label Period (up to 54.3 Months)|Ongoing|19|||
13275429|NCT02294461|26438615|FG001|Open-label Period (up to 54.3 Months)|Ongoing|9|||
13275430|NCT02294461|26438614|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|16|||
13275431|NCT02294461|26438615|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|12|||
13275432|NCT02294461|26438614|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|18|||
13275433|NCT02294461|26438615|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|9|||
13275434|NCT02294461|26438614|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2|||
13275435|NCT02294461|26438615|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
13275436|NCT02294461|26438614|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|3|||
13275437|NCT02294461|26438615|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|1|||
13275438|NCT02294461|26438614|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|15|||
13275439|NCT02294461|26438615|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|9|||
13275440|NCT02294461|26438614|FG000|Open-label Period (up to 54.3 Months)|Death|6|||
13275441|NCT02294461|26438615|FG001|Open-label Period (up to 54.3 Months)|Death|5|||
13275442|NCT02294461|26438614|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
13275443|NCT02294461|26438615|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
13275444|NCT02277444|26438642|FG000|Overall Study|Adverse Event|10|||
13275445|NCT02277444|26438642|FG000|Overall Study|Withdrawal by Subject|3|||
13275446|NCT02277444|26438642|FG000|Overall Study|Other|1|||
13275447|NCT02277444|26438642|FG000|Overall Study|Enrolled and not Treated|3|||
13275448|NCT02277444|26438642|FG000|Overall Study|Ongoing|113|||
13275449|NCT02252172|26438661|FG000|Overall Study|Lost to Follow-up|3|||
13275450|NCT02252172|26438662|FG001|Overall Study|Lost to Follow-up|1|||
13275451|NCT02252172|26438661|FG000|Overall Study|Ongoing|276|||
13275452|NCT02252172|26438662|FG001|Overall Study|Ongoing|298|||
13275453|NCT02197234|26438695|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1|||
13275454|NCT02197234|26438695|FG000|Part A: Day 3-30 (AZD9291 Alone)|Adverse Event|1|||
13275455|NCT02197234|26438695|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1|||
13275456|NCT02197234|26438695|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1|||
13275457|NCT02197234|26438695|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1|||
13275458|NCT02197234|26438695|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6|||
13275459|NCT02197234|26438695|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22|||
13275460|NCT02195479|26438738|FG000|Overall Study|Lost to Follow-up|3|||
13275461|NCT02195479|26438739|FG001|Overall Study|Lost to Follow-up|0|||
13275462|NCT02195479|26438738|FG000|Overall Study|Death|48|||
13275463|NCT02195479|26438739|FG001|Overall Study|Death|45|||
13275464|NCT02195479|26438738|FG000|Overall Study|Physician Decision|1|||
13275465|NCT02195479|26438739|FG001|Overall Study|Physician Decision|0|||
13275466|NCT02195479|26438738|FG000|Overall Study|Withdrawal by Subject|11|||
13118975|NCT03028415|25931878|FG000|Overall Study|Lost to Follow-up|6|||
13118976|NCT03028415|25931879|FG001|Overall Study|Lost to Follow-up|3|||
13118977|NCT03028415|25931878|FG000|Overall Study|Withdrawal by Subject|1|||
13118978|NCT03028415|25931879|FG001|Overall Study|Withdrawal by Subject|0|||
13275467|NCT02195479|26438739|FG001|Overall Study|Withdrawal by Subject|6|||
13275468|NCT02195479|26438738|FG000|Overall Study|Other|2|||
13275469|NCT02195479|26438739|FG001|Overall Study|Other|2|||
13275470|NCT02195479|26438738|FG000|Overall Study|Ongoing|291|||
13275471|NCT02195479|26438739|FG001|Overall Study|Ongoing|297|||
13275472|NCT02163733|26438782|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
13275473|NCT02163733|26438783|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
13275474|NCT02163733|26438784|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5|||
13275475|NCT02163733|26438782|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
13275476|NCT02163733|26438783|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
13275477|NCT02163733|26438784|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19|||
13275478|NCT02157883|26438815|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1|||
13275479|NCT02157883|26438815|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3|||
13275480|NCT02157883|26438815|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15|||
13275481|NCT02157883|26438815|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1|||
13275482|NCT02157883|26438815|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3|||
13275483|NCT02136134|26438838|FG000|Overall Study|Death|35|||
13275484|NCT02136134|26438839|FG001|Overall Study|Death|29|||
13275485|NCT02136134|26438838|FG000|Overall Study|Withdrawal by Subject|14|||
13275486|NCT02136134|26438839|FG001|Overall Study|Withdrawal by Subject|4|||
13275487|NCT02136134|26438838|FG000|Overall Study|Other|3|||
13275488|NCT02136134|26438839|FG001|Overall Study|Other|3|||
13275489|NCT02136134|26438838|FG000|Overall Study|Ongoing|185|||
13275490|NCT02136134|26438839|FG001|Overall Study|Ongoing|207|||
13275491|NCT02136134|26438838|FG000|Overall Study|Subjects randomized but not treated|10|||
13275492|NCT02136134|26438839|FG001|Overall Study|Subjects randomized but not treated|8|||
13275493|NCT02076009|26438866|FG000|Overall Study|Death|44|||
13275494|NCT02076009|26438867|FG001|Overall Study|Death|30|||
13275495|NCT02076009|26438866|FG000|Overall Study|Withdrawal by Subject|9|||
13275496|NCT02076009|26438867|FG001|Overall Study|Withdrawal by Subject|3|||
13275497|NCT02076009|26438866|FG000|Overall Study|Lost to Follow-up|1|||
13275498|NCT02076009|26438867|FG001|Overall Study|Lost to Follow-up|1|||
13275499|NCT02076009|26438866|FG000|Overall Study|Progressive disease|1|||
13275500|NCT02076009|26438867|FG001|Overall Study|Progressive disease|0|||
13275501|NCT02076009|26438866|FG000|Overall Study|Ongoing|226|||
13275502|NCT02076009|26438867|FG001|Overall Study|Ongoing|249|||
13275503|NCT02076009|26438866|FG000|Overall Study|Subjects randomized but not treated|2|||
13275504|NCT02076009|26438867|FG001|Overall Study|Subjects randomized but not treated|3|||
13275505|NCT01993719|26438927|FG000|First Drug Administration|Not treated|1|||
13275506|NCT01993719|26438928|FG001|First Drug Administration|Not treated|0|||
13275507|NCT01993719|26438929|FG002|First Drug Administration|Not treated|0|||
13275508|NCT01993719|26438930|FG003|First Drug Administration|Not treated|0|||
13275509|NCT01993719|26438931|FG004|First Drug Administration|Not treated|0|||
13275510|NCT01892722|26438944|FG000|Overall Study|Protocol deviation|0|||
13275511|NCT01892722|26438945|FG001|Overall Study|Protocol deviation|1|||
13275512|NCT01892722|26438944|FG000|Overall Study|Administrative problems|0|||
13275513|NCT01892722|26438945|FG001|Overall Study|Administrative problems|1|||
13275514|NCT01892722|26438944|FG000|Overall Study|Patient/guardian decision|0|||
13275515|NCT01892722|26438945|FG001|Overall Study|Patient/guardian decision|2|||
13275516|NCT01892722|26438944|FG000|Overall Study|Physician Decision|1|||
13275517|NCT01892722|26438945|FG001|Overall Study|Physician Decision|2|||
13275518|NCT01892722|26438944|FG000|Overall Study|Adverse Event|3|||
13275519|NCT01892722|26438945|FG001|Overall Study|Adverse Event|2|||
13275520|NCT01892722|26438944|FG000|Overall Study|Lack of Efficacy|0|||
13275521|NCT01892722|26438945|FG001|Overall Study|Lack of Efficacy|7|||
13275522|NCT01892722|26438944|FG000|Overall Study|Withdrawal by Subject|3|||
13275523|NCT01892722|26438945|FG001|Overall Study|Withdrawal by Subject|5|||
13275524|NCT01847274|26439076|FG000|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|22|||
13275525|NCT01847274|26439077|FG001|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|8|||
13275526|NCT01847274|26439078|FG002|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|31|||
13275527|NCT01847274|26439079|FG003|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|13|||
13275528|NCT01847274|26439080|FG004|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
13275529|NCT01847274|26439081|FG005|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
13275530|NCT01847274|26439082|FG006|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
13275531|NCT01847274|26439076|FG000|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|20|||
13275532|NCT01847274|26439077|FG001|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|11|||
13275533|NCT01847274|26439078|FG002|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|29|||
13275534|NCT01847274|26439079|FG003|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|14|||
13275535|NCT01847274|26439080|FG004|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
13275536|NCT01847274|26439081|FG005|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
13275537|NCT01847274|26439082|FG006|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
13275538|NCT01847274|26439076|FG000|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|7|||
13275539|NCT01847274|26439077|FG001|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|2|||
13275540|NCT01847274|26439078|FG002|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|5|||
13275541|NCT01847274|26439079|FG003|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|1|||
13275542|NCT01847274|26439080|FG004|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
13275543|NCT01847274|26439081|FG005|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
13275544|NCT01847274|26439082|FG006|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
13275545|NCT01847274|26439076|FG000|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
13275546|NCT01847274|26439077|FG001|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
13275547|NCT01847274|26439078|FG002|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
13275548|NCT01847274|26439079|FG003|Main Study (Upto 7years 7months 6 Days)|Disease progression|2|||
13275549|NCT01847274|26439080|FG004|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
13275550|NCT01847274|26439081|FG005|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
13275551|NCT01847274|26439082|FG006|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
13275552|NCT01847274|26439076|FG000|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
13275553|NCT01847274|26439077|FG001|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
13275554|NCT01847274|26439078|FG002|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|15|||
13275555|NCT01847274|26439079|FG003|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|14|||
13275556|NCT01847274|26439080|FG004|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
13275557|NCT01847274|26439081|FG005|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
13275558|NCT01847274|26439082|FG006|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
13275559|NCT01847274|26439076|FG000|Main Study (Upto 7years 7months 6 Days)|Death|72|||
13275560|NCT01847274|26439077|FG001|Main Study (Upto 7years 7months 6 Days)|Death|29|||
13275561|NCT01847274|26439078|FG002|Main Study (Upto 7years 7months 6 Days)|Death|146|||
13275562|NCT01847274|26439079|FG003|Main Study (Upto 7years 7months 6 Days)|Death|68|||
13275563|NCT01847274|26439080|FG004|Main Study (Upto 7years 7months 6 Days)|Death|0|||
13275564|NCT01847274|26439081|FG005|Main Study (Upto 7years 7months 6 Days)|Death|0|||
13275565|NCT01847274|26439082|FG006|Main Study (Upto 7years 7months 6 Days)|Death|0|||
13275566|NCT01847274|26439076|FG000|Main Study (Upto 7years 7months 6 Days)|Other reasons|5|||
13275567|NCT01847274|26439077|FG001|Main Study (Upto 7years 7months 6 Days)|Other reasons|3|||
13275568|NCT01847274|26439078|FG002|Main Study (Upto 7years 7months 6 Days)|Other reasons|8|||
13275569|NCT01847274|26439079|FG003|Main Study (Upto 7years 7months 6 Days)|Other reasons|4|||
13275570|NCT01847274|26439080|FG004|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
13275571|NCT01847274|26439081|FG005|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
13275572|NCT01847274|26439082|FG006|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
13275573|NCT01847274|26439076|FG000|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
13275574|NCT01847274|26439077|FG001|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
13275575|NCT01847274|26439078|FG002|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
13275576|NCT01847274|26439079|FG003|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
13275577|NCT01847274|26439080|FG004|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
13275578|NCT01847274|26439081|FG005|FE Sub-study, Period1 (Day1)|Adverse Event|1|||
13275579|NCT01847274|26439082|FG006|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
13275580|NCT01847274|26439076|FG000|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
13275581|NCT01847274|26439077|FG001|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
13275582|NCT01847274|26439078|FG002|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
13275583|NCT01847274|26439079|FG003|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
13275584|NCT01847274|26439080|FG004|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|1|||
13275585|NCT01847274|26439081|FG005|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
13275586|NCT01847274|26439082|FG006|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
13275587|NCT01847274|26439076|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
13275588|NCT01847274|26439077|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
13275589|NCT01847274|26439078|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
13275590|NCT01847274|26439079|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
13275591|NCT01847274|26439080|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
13275592|NCT01847274|26439081|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
13275593|NCT01847274|26439082|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|4|||
13275594|NCT01847274|26439076|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
13275595|NCT01847274|26439077|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
13275596|NCT01847274|26439078|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
13275597|NCT01847274|26439079|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
13275598|NCT01847274|26439080|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
13275599|NCT01847274|26439081|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
13275600|NCT01847274|26439082|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|5|||
13275601|NCT01847274|26439076|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
13275602|NCT01847274|26439077|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
13275603|NCT01847274|26439078|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
13275604|NCT01847274|26439079|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
13275605|NCT01847274|26439080|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
13275606|NCT01847274|26439081|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
13275607|NCT01847274|26439082|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|17|||
13275608|NCT01757535|26439119|FG000|Overall Study|Disease Relapse|143|||
13275609|NCT01757535|26439120|FG001|Overall Study|Disease Relapse|180|||
13275610|NCT01757535|26439119|FG000|Overall Study|Adverse Event|29|||
13275611|NCT01757535|26439120|FG001|Overall Study|Adverse Event|11|||
13275612|NCT01757535|26439119|FG000|Overall Study|Withdrawal by Subject|9|||
13275613|NCT01757535|26439120|FG001|Overall Study|Withdrawal by Subject|13|||
13275614|NCT01757535|26439119|FG000|Overall Study|Miscellaneous|5|||
13275615|NCT01757535|26439120|FG001|Overall Study|Miscellaneous|2|||
13275616|NCT01757535|26439119|FG000|Overall Study|Physician Decision|6|||
13275617|NCT01757535|26439120|FG001|Overall Study|Physician Decision|0|||
13275618|NCT01757535|26439119|FG000|Overall Study|Death|1|||
13275619|NCT01757535|26439120|FG001|Overall Study|Death|2|||
13275620|NCT01660451|26439158|FG000|Overall Study|Protocol Violation|0|||
13275621|NCT01660451|26439159|FG001|Overall Study|Protocol Violation|1|||
13275622|NCT01660451|26439160|FG002|Overall Study|Protocol Violation|1|||
13275623|NCT01660451|26439158|FG000|Overall Study|Adverse Event (AE) without Clinical PD|11|||
13275624|NCT01660451|26439159|FG001|Overall Study|Adverse Event (AE) without Clinical PD|8|||
13275625|NCT01660451|26439160|FG002|Overall Study|Adverse Event (AE) without Clinical PD|26|||
13275626|NCT01660451|26439158|FG000|Overall Study|AE with Clinical PD|1|||
13275627|NCT01660451|26439159|FG001|Overall Study|AE with Clinical PD|3|||
13275628|NCT01660451|26439160|FG002|Overall Study|AE with Clinical PD|9|||
13275629|NCT01660451|26439158|FG000|Overall Study|Sponsor Decision|0|||
13275630|NCT01660451|26439159|FG001|Overall Study|Sponsor Decision|0|||
13275631|NCT01660451|26439160|FG002|Overall Study|Sponsor Decision|1|||
13275632|NCT01660451|26439158|FG000|Overall Study|Protocol Deviation|0|||
13275633|NCT01660451|26439159|FG001|Overall Study|Protocol Deviation|0|||
13275634|NCT01660451|26439160|FG002|Overall Study|Protocol Deviation|1|||
13275635|NCT01660451|26439158|FG000|Overall Study|Physician Decision|1|||
13275636|NCT01660451|26439159|FG001|Overall Study|Physician Decision|2|||
13275637|NCT01660451|26439160|FG002|Overall Study|Physician Decision|5|||
13275638|NCT01660451|26439158|FG000|Overall Study|Withdrawal by Subject|1|||
13275639|NCT01660451|26439159|FG001|Overall Study|Withdrawal by Subject|0|||
13275640|NCT01660451|26439160|FG002|Overall Study|Withdrawal by Subject|16|||
13275641|NCT01660451|26439158|FG000|Overall Study|Ongoing with treatment|3|||
13275642|NCT01660451|26439159|FG001|Overall Study|Ongoing with treatment|3|||
13275643|NCT01660451|26439160|FG002|Overall Study|Ongoing with treatment|46|||
13275644|NCT01625286|26439261|FG000|Overall Study|Adverse Event|0|||
13275645|NCT01625286|26439262|FG001|Overall Study|Adverse Event|0|||
13275646|NCT01625286|26439263|FG002|Overall Study|Adverse Event|0|||
13275647|NCT01625286|26439264|FG003|Overall Study|Adverse Event|0|||
13275648|NCT01625286|26439265|FG004|Overall Study|Adverse Event|1|||
13275649|NCT01625286|26439266|FG005|Overall Study|Adverse Event|2|||
13275650|NCT01625286|26439267|FG006|Overall Study|Adverse Event|1|||
13275651|NCT01625286|26439261|FG000|Overall Study|Death|0|||
13275652|NCT01625286|26439262|FG001|Overall Study|Death|0|||
13275653|NCT01625286|26439263|FG002|Overall Study|Death|1|||
13275654|NCT01625286|26439264|FG003|Overall Study|Death|1|||
13275655|NCT01625286|26439265|FG004|Overall Study|Death|0|||
13275656|NCT01625286|26439266|FG005|Overall Study|Death|11|||
13275657|NCT01625286|26439267|FG006|Overall Study|Death|16|||
13275658|NCT01625286|26439261|FG000|Overall Study|Withdrawal by Subject|0|||
13275659|NCT01625286|26439262|FG001|Overall Study|Withdrawal by Subject|1|||
13275660|NCT01625286|26439263|FG002|Overall Study|Withdrawal by Subject|0|||
13275661|NCT01625286|26439264|FG003|Overall Study|Withdrawal by Subject|1|||
13275662|NCT01625286|26439265|FG004|Overall Study|Withdrawal by Subject|0|||
13275663|NCT01625286|26439266|FG005|Overall Study|Withdrawal by Subject|0|||
13275664|NCT01625286|26439267|FG006|Overall Study|Withdrawal by Subject|1|||
13275665|NCT01625286|26439261|FG000|Overall Study|Any reason not specifically recorded|0|||
13275666|NCT01625286|26439262|FG001|Overall Study|Any reason not specifically recorded|0|||
13275667|NCT01625286|26439263|FG002|Overall Study|Any reason not specifically recorded|0|||
13275668|NCT01625286|26439264|FG003|Overall Study|Any reason not specifically recorded|0|||
13275669|NCT01625286|26439265|FG004|Overall Study|Any reason not specifically recorded|0|||
13275670|NCT01625286|26439266|FG005|Overall Study|Any reason not specifically recorded|1|||
13275671|NCT01625286|26439267|FG006|Overall Study|Any reason not specifically recorded|0|||
13275672|NCT01625286|26439261|FG000|Overall Study|Progressive disease|6|||
13275673|NCT01625286|26439262|FG001|Overall Study|Progressive disease|3|||
13275674|NCT01625286|26439263|FG002|Overall Study|Progressive disease|4|||
13275675|NCT01625286|26439264|FG003|Overall Study|Progressive disease|5|||
13275676|NCT01625286|26439265|FG004|Overall Study|Progressive disease|5|||
13275677|NCT01625286|26439266|FG005|Overall Study|Progressive disease|0|||
13275678|NCT01625286|26439267|FG006|Overall Study|Progressive disease|0|||
13275679|NCT01625286|26439261|FG000|Overall Study|Lost to Follow-up|0|||
13275680|NCT01625286|26439262|FG001|Overall Study|Lost to Follow-up|0|||
13275681|NCT01625286|26439263|FG002|Overall Study|Lost to Follow-up|0|||
13275682|NCT01625286|26439264|FG003|Overall Study|Lost to Follow-up|0|||
13275683|NCT01625286|26439265|FG004|Overall Study|Lost to Follow-up|0|||
13275684|NCT01625286|26439266|FG005|Overall Study|Lost to Follow-up|0|||
13275685|NCT01625286|26439267|FG006|Overall Study|Lost to Follow-up|1|||
13275686|NCT01615029|26439304|FG000|Overall Study|Adverse Event|0|||
13275687|NCT01615029|26439305|FG001|Overall Study|Adverse Event|0|||
13275688|NCT01615029|26439306|FG002|Overall Study|Adverse Event|0|||
13275689|NCT01615029|26439307|FG003|Overall Study|Adverse Event|0|||
13275690|NCT01615029|26439308|FG004|Overall Study|Adverse Event|1|||
13275691|NCT01615029|26439304|FG000|Overall Study|Death|0|||
13275692|NCT01615029|26439305|FG001|Overall Study|Death|0|||
13275693|NCT01615029|26439306|FG002|Overall Study|Death|0|||
13275694|NCT01615029|26439307|FG003|Overall Study|Death|0|||
13275695|NCT01615029|26439308|FG004|Overall Study|Death|1|||
13275696|NCT01615029|26439304|FG000|Overall Study|Lost to Follow-up|0|||
13275697|NCT01615029|26439305|FG001|Overall Study|Lost to Follow-up|0|||
13275698|NCT01615029|26439306|FG002|Overall Study|Lost to Follow-up|0|||
13275699|NCT01615029|26439307|FG003|Overall Study|Lost to Follow-up|0|||
13275700|NCT01615029|26439308|FG004|Overall Study|Lost to Follow-up|1|||
13275701|NCT01615029|26439304|FG000|Overall Study|Progressive disease|2|||
13275702|NCT01615029|26439305|FG001|Overall Study|Progressive disease|1|||
13275703|NCT01615029|26439306|FG002|Overall Study|Progressive disease|1|||
13275704|NCT01615029|26439307|FG003|Overall Study|Progressive disease|1|||
13275705|NCT01615029|26439308|FG004|Overall Study|Progressive disease|5|||
13275706|NCT01615029|26439304|FG000|Overall Study|Physician Decision|0|||
13275707|NCT01615029|26439305|FG001|Overall Study|Physician Decision|0|||
13275708|NCT01615029|26439306|FG002|Overall Study|Physician Decision|0|||
13275709|NCT01615029|26439307|FG003|Overall Study|Physician Decision|0|||
13275710|NCT01615029|26439308|FG004|Overall Study|Physician Decision|1|||
13275711|NCT01615029|26439304|FG000|Overall Study|Ongoing|1|||
13275712|NCT01615029|26439305|FG001|Overall Study|Ongoing|2|||
13275713|NCT01615029|26439306|FG002|Overall Study|Ongoing|3|||
13275714|NCT01615029|26439307|FG003|Overall Study|Ongoing|2|||
13275715|NCT01615029|26439308|FG004|Overall Study|Ongoing|23|||
13275716|NCT01217385|26439390|FG000|Overall Study|Withdrawal by Subject|3|||
13275717|NCT01217385|26439390|FG000|Overall Study|DOSI not performed/not eval|12|||
13275718|NCT01217385|26439390|FG000|Overall Study|Central Path not Available|1|||
13275719|NCT01217385|26439390|FG000|Overall Study|Normal Breast TOI not available|10|||
13275720|NCT01216683|26439472|FG000|Induction|Never started treatment|0|||
13275721|NCT01216683|26439473|FG001|Induction|Never started treatment|6|||
13275722|NCT01216683|26439474|FG002|Induction|Never started treatment|3|||
13275723|NCT01216683|26439472|FG000|Induction|Lack of Efficacy|4|||
13275724|NCT01216683|26439473|FG001|Induction|Lack of Efficacy|3|||
13275725|NCT01216683|26439474|FG002|Induction|Lack of Efficacy|7|||
13275726|NCT01216683|26439472|FG000|Induction|Adverse Event|0|||
13275727|NCT01216683|26439473|FG001|Induction|Adverse Event|5|||
13275728|NCT01216683|26439474|FG002|Induction|Adverse Event|5|||
13275729|NCT01216683|26439472|FG000|Induction|Death|0|||
13275730|NCT01216683|26439473|FG001|Induction|Death|0|||
13275731|NCT01216683|26439474|FG002|Induction|Death|2|||
13275732|NCT01216683|26439472|FG000|Induction|Withdrawal by Subject|0|||
13275733|NCT01216683|26439473|FG001|Induction|Withdrawal by Subject|4|||
13275734|NCT01216683|26439474|FG002|Induction|Withdrawal by Subject|2|||
13275735|NCT01216683|26439472|FG000|Induction|Other disease|0|||
13275736|NCT01216683|26439473|FG001|Induction|Other disease|1|||
13275737|NCT01216683|26439474|FG002|Induction|Other disease|2|||
13275738|NCT01216683|26439472|FG000|Continuation|Lack of Efficacy|3|||
13275739|NCT01216683|26439473|FG001|Continuation|Lack of Efficacy|2|||
13275740|NCT01216683|26439474|FG002|Continuation|Lack of Efficacy|7|||
13275741|NCT01216683|26439472|FG000|Continuation|Adverse Event|5|||
13275742|NCT01216683|26439473|FG001|Continuation|Adverse Event|3|||
13275743|NCT01216683|26439474|FG002|Continuation|Adverse Event|16|||
13275744|NCT01216683|26439472|FG000|Continuation|Death|1|||
13275745|NCT01216683|26439473|FG001|Continuation|Death|0|||
13275746|NCT01216683|26439474|FG002|Continuation|Death|2|||
13275747|NCT01216683|26439472|FG000|Continuation|Withdrawal by Subject|4|||
13118979|NCT03028415|25931878|FG000|Overall Study|Discontinued due to COVID-19|1|||
13118980|NCT03028415|25931879|FG001|Overall Study|Discontinued due to COVID-19|0|||
13118981|NCT03028142|25931903|FG000|Overall Study|Adverse Event|1|||
13118982|NCT03028142|25931904|FG001|Overall Study|Adverse Event|1|||
13275748|NCT01216683|26439473|FG001|Continuation|Withdrawal by Subject|5|||
13275749|NCT01216683|26439474|FG002|Continuation|Withdrawal by Subject|9|||
13275750|NCT01216683|26439472|FG000|Continuation|Other diseases|0|||
13275751|NCT01216683|26439473|FG001|Continuation|Other diseases|2|||
13275752|NCT01216683|26439474|FG002|Continuation|Other diseases|1|||
13275753|NCT01216683|26439472|FG000|Continuation|Physician Decision|1|||
13275754|NCT01216683|26439473|FG001|Continuation|Physician Decision|0|||
13275755|NCT01216683|26439474|FG002|Continuation|Physician Decision|1|||
13275756|NCT01216683|26439472|FG000|Continuation|Non-compliance|1|||
13275757|NCT01216683|26439473|FG001|Continuation|Non-compliance|0|||
13118983|NCT03028142|25931905|FG002|Overall Study|Adverse Event|0|||
13118984|NCT03028142|25931906|FG003|Overall Study|Adverse Event|0|||
13118985|NCT03028142|25931907|FG004|Overall Study|Adverse Event|0|||
13118986|NCT03028142|25931908|FG005|Overall Study|Adverse Event|1|||
13118987|NCT03028142|25931903|FG000|Overall Study|Withdrawal by Subject|0|||
13118988|NCT03028142|25931904|FG001|Overall Study|Withdrawal by Subject|0|||
13118989|NCT03028142|25931905|FG002|Overall Study|Withdrawal by Subject|0|||
13118990|NCT03028142|25931906|FG003|Overall Study|Withdrawal by Subject|0|||
13118991|NCT03028142|25931907|FG004|Overall Study|Withdrawal by Subject|1|||
13118992|NCT03028142|25931908|FG005|Overall Study|Withdrawal by Subject|0|||
13118993|NCT03028129|25931921|FG000|Overall Study|Adverse Event|13|||
13118994|NCT03028129|25931922|FG001|Overall Study|Adverse Event|2|||
13118995|NCT03028129|25931921|FG000|Overall Study|Lost to Follow-up|50|||
13118996|NCT03028129|25931922|FG001|Overall Study|Lost to Follow-up|38|||
13118997|NCT03028129|25931921|FG000|Overall Study|Physician Decision|0|||
13118998|NCT03028129|25931922|FG001|Overall Study|Physician Decision|1|||
13118999|NCT03028129|25931921|FG000|Overall Study|Protocol Violation|1|||
13275758|NCT01216683|26439474|FG002|Continuation|Non-compliance|1|||
13275759|NCT01216683|26439472|FG000|Continuation|Insurance change|0|||
13275760|NCT01216683|26439473|FG001|Continuation|Insurance change|1|||
13275761|NCT01216683|26439474|FG002|Continuation|Insurance change|0|||
13275762|NCT01216683|26439472|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
13275763|NCT01216683|26439473|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1|||
13275764|NCT01216683|26439474|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
13275765|NCT01216683|26439472|FG000|Continuation|Not reported|0|||
13275766|NCT01216683|26439473|FG001|Continuation|Not reported|0|||
13275767|NCT01216683|26439474|FG002|Continuation|Not reported|1|||
13119000|NCT03028129|25931922|FG001|Overall Study|Protocol Violation|1|||
13119001|NCT03028129|25931921|FG000|Overall Study|Withdrawal by Subject|62|||
13119002|NCT03028129|25931922|FG001|Overall Study|Withdrawal by Subject|45|||
13275768|NCT01216683|26439472|FG000|Continuation|Never started treatment|0|||
13275769|NCT01216683|26439473|FG001|Continuation|Never started treatment|1|||
13275770|NCT01216683|26439474|FG002|Continuation|Never started treatment|5|||
13275771|NCT01065454|26439597|FG000|Treatment|Adverse Event|7|||
13275772|NCT01065454|26439598|FG001|Treatment|Adverse Event|4|||
13275773|NCT01065454|26439599|FG002|Treatment|Adverse Event|3|||
13275774|NCT01065454|26439600|FG003|Treatment|Adverse Event|6|||
13275775|NCT01065454|26439597|FG000|Treatment|Death|1|||
13275776|NCT01065454|26439598|FG001|Treatment|Death|0|||
13275777|NCT01065454|26439599|FG002|Treatment|Death|0|||
13275778|NCT01065454|26439600|FG003|Treatment|Death|0|||
13275779|NCT01065454|26439597|FG000|Treatment|Non-compliance|1|||
13275780|NCT01065454|26439598|FG001|Treatment|Non-compliance|0|||
13275781|NCT01065454|26439599|FG002|Treatment|Non-compliance|0|||
13275782|NCT01065454|26439600|FG003|Treatment|Non-compliance|1|||
13275783|NCT01065454|26439597|FG000|Treatment|Protocol Decision|0|||
13275784|NCT01065454|26439598|FG001|Treatment|Protocol Decision|0|||
13275785|NCT01065454|26439599|FG002|Treatment|Protocol Decision|3|||
13275786|NCT01065454|26439600|FG003|Treatment|Protocol Decision|2|||
13275787|NCT01065454|26439597|FG000|Treatment|Protocol Violation|1|||
13275788|NCT01065454|26439598|FG001|Treatment|Protocol Violation|0|||
13275789|NCT01065454|26439599|FG002|Treatment|Protocol Violation|1|||
13275790|NCT01065454|26439600|FG003|Treatment|Protocol Violation|0|||
13275791|NCT01065454|26439597|FG000|Treatment|Withdrawal by Subject|3|||
13275792|NCT01065454|26439598|FG001|Treatment|Withdrawal by Subject|1|||
13275793|NCT01065454|26439599|FG002|Treatment|Withdrawal by Subject|2|||
13275794|NCT01065454|26439600|FG003|Treatment|Withdrawal by Subject|3|||
13275795|NCT01065454|26439597|FG000|Follow up|Adverse Event|1|||
13275796|NCT01065454|26439598|FG001|Follow up|Adverse Event|0|||
13275797|NCT01065454|26439599|FG002|Follow up|Adverse Event|0|||
13275798|NCT01065454|26439600|FG003|Follow up|Adverse Event|1|||
13275799|NCT01065454|26439597|FG000|Follow up|Death|0|||
13275800|NCT01065454|26439598|FG001|Follow up|Death|1|||
13275801|NCT01065454|26439599|FG002|Follow up|Death|1|||
13275802|NCT01065454|26439600|FG003|Follow up|Death|0|||
13275803|NCT01065454|26439597|FG000|Follow up|Lost to Follow-up|0|||
13275804|NCT01065454|26439598|FG001|Follow up|Lost to Follow-up|0|||
13275805|NCT01065454|26439599|FG002|Follow up|Lost to Follow-up|0|||
13275806|NCT01065454|26439600|FG003|Follow up|Lost to Follow-up|1|||
13275807|NCT01065454|26439597|FG000|Follow up|Progressive disease|0|||
13275808|NCT01065454|26439598|FG001|Follow up|Progressive disease|0|||
13275809|NCT01065454|26439599|FG002|Follow up|Progressive disease|0|||
13275810|NCT01065454|26439600|FG003|Follow up|Progressive disease|1|||
13275811|NCT01065454|26439597|FG000|Follow up|Withdrawal by Subject|1|||
13275812|NCT01065454|26439598|FG001|Follow up|Withdrawal by Subject|1|||
13119003|NCT03028012|25931946|FG000|Overall Study|Lost to Follow-up|2|||
13119004|NCT03028012|25931947|FG001|Overall Study|Lost to Follow-up|3|||
13119005|NCT03028012|25931948|FG002|Overall Study|Lost to Follow-up|3|||
13275813|NCT01065454|26439599|FG002|Follow up|Withdrawal by Subject|1|||
13275814|NCT01065454|26439600|FG003|Follow up|Withdrawal by Subject|0|||
13275815|NCT01065454|26439597|FG000|Follow up|study ongoing|37|||
13275816|NCT01065454|26439598|FG001|Follow up|study ongoing|22|||
13275817|NCT01065454|26439599|FG002|Follow up|study ongoing|15|||
13275818|NCT01065454|26439600|FG003|Follow up|study ongoing|41|||
13275819|NCT00980538|26439606|FG000|Overall Study|Lost to Follow-up|20|||
13275820|NCT00980538|26439606|FG000|Overall Study|Sponsor's Decision|4|||
13275821|NCT00980538|26439606|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34|||
13275822|NCT00980538|26439606|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12|||
13275823|NCT00980538|26439606|FG000|Overall Study|Switch to Commercially Available Medication|25|||
13119006|NCT03027557|25932059|FG000|Overall Study|Adverse Event|1|||
13119007|NCT03027557|25932060|FG001|Overall Study|Adverse Event|0|||
13119008|NCT03027557|25932061|FG002|Overall Study|Adverse Event|0|||
13119009|NCT03027466|25932092|FG000|Overall Study|Opting out of the app|1869|||
13119010|NCT03027466|25932093|FG001|Overall Study|Opting out of the app|1819|||
13119011|NCT03027466|25932094|FG002|Overall Study|Opting out of the app|1743|||
13119012|NCT03027466|25932095|FG003|Overall Study|Opting out of the app|1821|||
13119013|NCT03026530|25932110|FG000|Overall Study|Lost to Follow-up|19|||
13119014|NCT03026530|25932111|FG001|Overall Study|Lost to Follow-up|24|||
13119015|NCT03026530|25932110|FG000|Overall Study|Protocol Violation|2|||
13119016|NCT03026530|25932111|FG001|Overall Study|Protocol Violation|5|||
13119017|NCT03026283|25932135|FG000|CCTA Diagnosis|CCTA not performed as planned|9|||
13119018|NCT03026283|25932136|FG001|CCTA Diagnosis|CCTA not performed as planned|0|||
13119019|NCT03026283|25932137|FG002|CCTA Diagnosis|CCTA not performed as planned|0|||
13119020|NCT03026283|25932138|FG003|CCTA Diagnosis|CCTA not performed as planned|0|||
13119021|NCT03026283|25932139|FG004|CCTA Diagnosis|CCTA not performed as planned|0|||
13119022|NCT03026283|25932140|FG005|CCTA Diagnosis|CCTA not performed as planned|0|||
13119023|NCT03026283|25932141|FG006|CCTA Diagnosis|CCTA not performed as planned|0|||
13119024|NCT03026283|25932142|FG007|CCTA Diagnosis|CCTA not performed as planned|0|||
13275824|NCT00980538|26439606|FG000|Overall Study|Participant Non-Compliant|9|||
13275825|NCT00980538|26439606|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9|||
13275826|NCT00980538|26439606|FG000|Overall Study|Participant Ineligible to Continue the Trial|6|||
13275827|NCT00980538|26439606|FG000|Overall Study|Other|60|||
13275828|NCT00980538|26439606|FG000|Overall Study|Other|1|||
13291212|NCT00157248|26482822|FG003|Overall Study|Adverse Event|33|||
13291213|NCT00157248|26482819|FG000|Overall Study|Protocol Violation|4|||
13291214|NCT00157248|26482820|FG001|Overall Study|Protocol Violation|0|||
13291215|NCT00157248|26482821|FG002|Overall Study|Protocol Violation|2|||
13291216|NCT00157248|26482822|FG003|Overall Study|Protocol Violation|2|||
13291217|NCT00157248|26482819|FG000|Overall Study|Lost to Follow-up|0|||
13291218|NCT00157248|26482820|FG001|Overall Study|Lost to Follow-up|1|||
13291219|NCT00157248|26482821|FG002|Overall Study|Lost to Follow-up|0|||
13291220|NCT00157248|26482822|FG003|Overall Study|Lost to Follow-up|0|||
13291221|NCT00157248|26482819|FG000|Overall Study|Withdrawal by Subject|1|||
13291222|NCT00157248|26482820|FG001|Overall Study|Withdrawal by Subject|4|||
13291223|NCT00157248|26482821|FG002|Overall Study|Withdrawal by Subject|3|||
13291224|NCT00157248|26482822|FG003|Overall Study|Withdrawal by Subject|3|||
13291225|NCT00157248|26482819|FG000|Overall Study|site closures, subject moving|7|||
13291226|NCT00157248|26482820|FG001|Overall Study|site closures, subject moving|7|||
13291227|NCT00157248|26482821|FG002|Overall Study|site closures, subject moving|3|||
13291228|NCT00157248|26482822|FG003|Overall Study|site closures, subject moving|9|||
13291229|NCT00157196|26482830|FG000|Overall Study|Ongoing at data cut-off|9|||
13291230|NCT00156533|26482857|FG000|Overall Study|Withdrawn - Medication Expiration|0|||
13291231|NCT00156533|26482858|FG001|Overall Study|Withdrawn - Medication Expiration|2|||
13291232|NCT00156533|26482859|FG002|Overall Study|Withdrawn - Medication Expiration|1|||
13291233|NCT00156533|26482860|FG003|Overall Study|Withdrawn - Medication Expiration|0|||
13291234|NCT00156533|26482857|FG000|Overall Study|Withdrawal by Subject|1|||
13291235|NCT00156533|26482858|FG001|Overall Study|Withdrawal by Subject|0|||
13291236|NCT00156533|26482859|FG002|Overall Study|Withdrawal by Subject|0|||
13291237|NCT00156533|26482860|FG003|Overall Study|Withdrawal by Subject|1|||
13291238|NCT00156533|26482857|FG000|Overall Study|Failed Screening|1|||
13291239|NCT00156533|26482858|FG001|Overall Study|Failed Screening|0|||
13291240|NCT00156533|26482859|FG002|Overall Study|Failed Screening|1|||
13291241|NCT00156533|26482860|FG003|Overall Study|Failed Screening|1|||
13291242|NCT00156065|26482881|FG000|Overall Study|Enrolled But Never Received Treatment|1|||
13291243|NCT00156065|26482882|FG001|Overall Study|Enrolled But Never Received Treatment|1|||
13291244|NCT00156065|26482883|FG002|Overall Study|Enrolled But Never Received Treatment|0|||
13291245|NCT00156065|26482881|FG000|Overall Study|Adverse Event|8|||
13291246|NCT00156065|26482882|FG001|Overall Study|Adverse Event|11|||
13291247|NCT00156065|26482883|FG002|Overall Study|Adverse Event|4|||
13291248|NCT00156065|26482881|FG000|Overall Study|Lack of Efficacy|2|||
13291249|NCT00156065|26482882|FG001|Overall Study|Lack of Efficacy|9|||
13291250|NCT00156065|26482883|FG002|Overall Study|Lack of Efficacy|3|||
13291251|NCT00156065|26482881|FG000|Overall Study|Withdrawal by Subject|13|||
13291252|NCT00156065|26482882|FG001|Overall Study|Withdrawal by Subject|26|||
13291253|NCT00156065|26482883|FG002|Overall Study|Withdrawal by Subject|16|||
13291254|NCT00156065|26482881|FG000|Overall Study|Lost to Follow-up|5|||
13291255|NCT00156065|26482882|FG001|Overall Study|Lost to Follow-up|7|||
13275829|NCT00861705|26439659|FG000|Overall Study|Never Began Treatment|7|||
13275830|NCT00861705|26439660|FG001|Overall Study|Never Began Treatment|3|||
13275831|NCT00861705|26439661|FG002|Overall Study|Never Began Treatment|0|||
13275832|NCT00861705|26439662|FG003|Overall Study|Never Began Treatment|1|||
13275833|NCT00676715|26439705|FG000|Overall Study|Withdrawal by Subject|7|||
13275834|NCT00676715|26439706|FG001|Overall Study|Withdrawal by Subject|9|||
13275835|NCT00676715|26439707|FG002|Overall Study|Withdrawal by Subject|10|||
13275836|NCT00676715|26439708|FG003|Overall Study|Withdrawal by Subject|10|||
13275837|NCT00676715|26439705|FG000|Overall Study|Other|2|||
13203698|NCT01983254|26225473|FG001|Overall Study|too ill|8|||
13203699|NCT01983111|26225496|FG000|Overall Study|Withdrawal by Subject|8|||
13203700|NCT01983111|26225497|FG001|Overall Study|Withdrawal by Subject|6|||
13203701|NCT01983111|26225496|FG000|Overall Study|Adverse Event|4|||
13203702|NCT01983111|26225497|FG001|Overall Study|Adverse Event|0|||
13203703|NCT01983111|26225496|FG000|Overall Study|Protocol Violation|0|||
13203704|NCT01983111|26225497|FG001|Overall Study|Protocol Violation|1|||
13203705|NCT01982942|26225520|FG000|Overall Study|Adverse Event|10|||
13203706|NCT01982942|26225521|FG001|Overall Study|Adverse Event|5|||
13203707|NCT01982942|26225520|FG000|Overall Study|Lost to Follow-up|4|||
13203708|NCT01982942|26225521|FG001|Overall Study|Lost to Follow-up|3|||
13203709|NCT01982942|26225520|FG000|Overall Study|Multiple sclerosis progression|3|||
13203710|NCT01982942|26225521|FG001|Overall Study|Multiple sclerosis progression|2|||
13203711|NCT01982942|26225520|FG000|Overall Study|Wanted to try therapy not permitted|1|||
13203712|NCT01982942|26225521|FG001|Overall Study|Wanted to try therapy not permitted|0|||
13203713|NCT01982942|26225520|FG000|Overall Study|Subject declined future visits|0|||
13203714|NCT01982942|26225521|FG001|Overall Study|Subject declined future visits|1|||
13203715|NCT01982942|26225520|FG000|Overall Study|Left geographical area|2|||
13203716|NCT01982942|26225521|FG001|Overall Study|Left geographical area|0|||
13203717|NCT01982942|26225520|FG000|Overall Study|Too many pills|1|||
13203718|NCT01982942|26225521|FG001|Overall Study|Too many pills|0|||
13203719|NCT01982942|26225520|FG000|Overall Study|MS Relapse|0|||
13203720|NCT01982942|26225521|FG001|Overall Study|MS Relapse|1|||
13203721|NCT01982942|26225520|FG000|Overall Study|Chose to join a stem cell trial|0|||
13203722|NCT01982942|26225521|FG001|Overall Study|Chose to join a stem cell trial|1|||
13203723|NCT01982942|26225520|FG000|Overall Study|Subject bedridden, rapidly declining|0|||
13203724|NCT01982942|26225521|FG001|Overall Study|Subject bedridden, rapidly declining|1|||
13203725|NCT01982812|26225540|FG000|Overall Study|Death|1|||
13203726|NCT01982812|26225541|FG001|Overall Study|Death|5|||
13203727|NCT01982812|26225540|FG000|Overall Study|Adverse Event|0|||
13203728|NCT01982812|26225541|FG001|Overall Study|Adverse Event|5|||
13203729|NCT01982773|26225560|FG000|Overall Study|Withdrawal by Subject|1|||
13203730|NCT01982773|26225561|FG001|Overall Study|Withdrawal by Subject|3|||
13203731|NCT01982773|26225560|FG000|Overall Study|Lost to Follow-up|7|||
13203732|NCT01982773|26225561|FG001|Overall Study|Lost to Follow-up|1|||
13203733|NCT01982682|26225571|FG000|Overall Study|Physician Decision|1|||
13203734|NCT01982435|26225606|FG000|Overall Study|Adverse Event|1|||
13203735|NCT01982435|26225607|FG001|Overall Study|Adverse Event|0|||
13203736|NCT01982331|26225648|FG000|Received Vaccination 2|Adverse Event|1|||
13203737|NCT01982331|26225649|FG001|Received Vaccination 2|Adverse Event|2|||
13203738|NCT01982331|26225648|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
13203739|NCT01982331|26225649|FG001|Received Vaccination 2|Withdrawal by Subject|1|||
13203740|NCT01982331|26225648|FG000|Completed Study (Day 112)|Withdrawal by Subject|2|||
13203741|NCT01982331|26225649|FG001|Completed Study (Day 112)|Withdrawal by Subject|0|||
13203742|NCT01982292|26225674|FG000|Overall Study|Adverse Event|2|||
13203743|NCT01982292|26225675|FG001|Overall Study|Adverse Event|0|||
13203744|NCT01982292|26225674|FG000|Overall Study|Death|1|||
13203745|NCT01982292|26225675|FG001|Overall Study|Death|0|||
13203746|NCT01982292|26225674|FG000|Overall Study|Lost to Follow-up|2|||
13203747|NCT01982292|26225675|FG001|Overall Study|Lost to Follow-up|0|||
13203748|NCT01982292|26225674|FG000|Overall Study|Non-Compliance With Study Treatment|1|||
13203749|NCT01982292|26225675|FG001|Overall Study|Non-Compliance With Study Treatment|0|||
13203750|NCT01982292|26225674|FG000|Overall Study|Protocol Deviation|1|||
13203751|NCT01982292|26225675|FG001|Overall Study|Protocol Deviation|0|||
13203752|NCT01982292|26225674|FG000|Overall Study|Patient/Guardian Decision|3|||
13203753|NCT01982292|26225675|FG001|Overall Study|Patient/Guardian Decision|1|||
13203754|NCT01982292|26225674|FG000|Overall Study|Technical Problems|2|||
13203755|NCT01982292|26225675|FG001|Overall Study|Technical Problems|0|||
13203756|NCT01982253|26225696|FG000|Overall Study|Withdrawal by Subject|1|||
13203757|NCT01982253|26225697|FG001|Overall Study|Withdrawal by Subject|0|||
13203758|NCT01982253|26225698|FG002|Overall Study|Withdrawal by Subject|0|||
13203759|NCT01982253|26225696|FG000|Overall Study|Study terminated by sponsor|1|||
13203760|NCT01982253|26225697|FG001|Overall Study|Study terminated by sponsor|4|||
13203761|NCT01982253|26225698|FG002|Overall Study|Study terminated by sponsor|4|||
13203762|NCT01981954|26225745|FG000|Titration Period|Protocol Deviation|1|||
13203763|NCT01981954|26225745|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1|||
13203764|NCT01981616|26225764|FG000|Overall Study|Adverse Event|0|||
13203765|NCT01981616|26225765|FG001|Overall Study|Adverse Event|1|||
13275838|NCT00676715|26439706|FG001|Overall Study|Other|6|||
13275839|NCT00676715|26439707|FG002|Overall Study|Other|4|||
13275840|NCT00676715|26439708|FG003|Overall Study|Other|3|||
13275841|NCT00676715|26439705|FG000|Overall Study|Lost to Follow-up|1|||
13275842|NCT00676715|26439706|FG001|Overall Study|Lost to Follow-up|1|||
13275843|NCT00676715|26439707|FG002|Overall Study|Lost to Follow-up|7|||
13275844|NCT00676715|26439708|FG003|Overall Study|Lost to Follow-up|3|||
13275845|NCT00676715|26439705|FG000|Overall Study|Death|1|||
13275846|NCT00676715|26439706|FG001|Overall Study|Death|1|||
13275847|NCT00676715|26439707|FG002|Overall Study|Death|1|||
13275848|NCT00676715|26439708|FG003|Overall Study|Death|0|||
13275849|NCT00676715|26439705|FG000|Overall Study|Adverse Event|0|||
13275850|NCT00676715|26439706|FG001|Overall Study|Adverse Event|1|||
13275851|NCT00676715|26439707|FG002|Overall Study|Adverse Event|2|||
13275852|NCT00676715|26439708|FG003|Overall Study|Adverse Event|0|||
13275853|NCT00676715|26439705|FG000|Overall Study|Participants Ongoing|29|||
13275854|NCT00676715|26439706|FG001|Overall Study|Participants Ongoing|29|||
13275855|NCT00676715|26439707|FG002|Overall Study|Participants Ongoing|17|||
13275856|NCT00676715|26439708|FG003|Overall Study|Participants Ongoing|24|||
13275857|NCT00512317|26439723|FG000|Overall Study|Insufficient clinical response|36|||
13275858|NCT00512317|26439723|FG000|Overall Study|Withdrawal by Subject|23|||
13275859|NCT00512317|26439723|FG000|Overall Study|Sponsor closure of study|21|||
13275860|NCT00512317|26439723|FG000|Overall Study|<50% reduction in seizure frequency on or after Visit 7|18|||
13275861|NCT00512317|26439723|FG000|Overall Study|Adverse Event|13|||
13275862|NCT00512317|26439723|FG000|Overall Study|Discretion of the investigator or sponsor|2|||
13275863|NCT00512317|26439723|FG000|Overall Study|Lost to Follow-up|2|||
13275864|NCT00512317|26439723|FG000|Overall Study|Other|2|||
13275865|NCT00378482|26439734|FG000|Overall Study|Lost to Follow-up|1|||
13275866|NCT00378482|26439734|FG000|Overall Study|Lack of Efficacy|8|||
13275867|NCT00378482|26439734|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9|||
13275868|NCT00378482|26439734|FG000|Overall Study|Withdrawal by Subject|4|||
13275869|NCT00378482|26439734|FG000|Overall Study|Adverse Event|9|||
13275870|NCT00331773|26439769|FG000|Overall Study|Withdrawal by Subject|6|||
13275871|NCT00331773|26439770|FG001|Overall Study|Withdrawal by Subject|4|||
13275872|NCT00331773|26439769|FG000|Overall Study|Protocol Violation|10|||
13275873|NCT00331773|26439770|FG001|Overall Study|Protocol Violation|3|||
13275874|NCT00114517|26439816|FG000|Overall Study|Adverse Event|6|||
13275875|NCT00114517|26439817|FG001|Overall Study|Adverse Event|1|||
13119025|NCT03026283|25932135|FG000|CCTA Diagnosis|Withdrawal by Subject|5|||
13119026|NCT03026283|25932136|FG001|CCTA Diagnosis|Withdrawal by Subject|0|||
13119027|NCT03026283|25932137|FG002|CCTA Diagnosis|Withdrawal by Subject|0|||
13119028|NCT03026283|25932138|FG003|CCTA Diagnosis|Withdrawal by Subject|0|||
13119029|NCT03026283|25932139|FG004|CCTA Diagnosis|Withdrawal by Subject|0|||
13119030|NCT03026283|25932140|FG005|CCTA Diagnosis|Withdrawal by Subject|0|||
13119031|NCT03026283|25932141|FG006|CCTA Diagnosis|Withdrawal by Subject|0|||
13119032|NCT03026283|25932142|FG007|CCTA Diagnosis|Withdrawal by Subject|0|||
13119033|NCT03026283|25932135|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
13119034|NCT03026283|25932136|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3|||
13119035|NCT03026283|25932137|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
13119036|NCT03026283|25932138|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
13119037|NCT03026283|25932139|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
13119038|NCT03026283|25932140|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
13119039|NCT03026283|25932141|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
13119040|NCT03026283|25932142|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
13119041|NCT03026283|25932135|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
13119042|NCT03026283|25932136|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
13119043|NCT03026283|25932137|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15|||
13119044|NCT03026283|25932138|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
13119045|NCT03026283|25932139|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
13119046|NCT03026283|25932140|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
13119047|NCT03026283|25932141|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
13119048|NCT03026283|25932142|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
13119049|NCT03026283|25932135|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
13119050|NCT03026283|25932136|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
13119051|NCT03026283|25932137|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
13119052|NCT03026283|25932138|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8|||
13119053|NCT03026283|25932139|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11|||
13119054|NCT03026283|25932140|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
13119055|NCT03026283|25932141|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
13275876|NCT00114517|26439818|FG002|Overall Study|Adverse Event|6|||
13275877|NCT00114517|26439819|FG003|Overall Study|Adverse Event|3|||
13275878|NCT00114517|26439816|FG000|Overall Study|Lost to Follow-up|2|||
13275879|NCT00114517|26439817|FG001|Overall Study|Lost to Follow-up|2|||
13275880|NCT00114517|26439818|FG002|Overall Study|Lost to Follow-up|2|||
13275881|NCT00114517|26439819|FG003|Overall Study|Lost to Follow-up|1|||
13275882|NCT00114517|26439816|FG000|Overall Study|Too busy|3|||
13275883|NCT00114517|26439817|FG001|Overall Study|Too busy|1|||
13275884|NCT00114517|26439818|FG002|Overall Study|Too busy|1|||
13275885|NCT00114517|26439819|FG003|Overall Study|Too busy|2|||
13275886|NCT00114517|26439816|FG000|Overall Study|Moved from area|0|||
13275887|NCT00114517|26439817|FG001|Overall Study|Moved from area|3|||
13275888|NCT00114517|26439818|FG002|Overall Study|Moved from area|2|||
13275889|NCT00114517|26439819|FG003|Overall Study|Moved from area|1|||
13275890|NCT00114517|26439816|FG000|Overall Study|Did not want estradiol|1|||
13275891|NCT00114517|26439817|FG001|Overall Study|Did not want estradiol|1|||
13275892|NCT00114517|26439818|FG002|Overall Study|Did not want estradiol|0|||
13275893|NCT00114517|26439819|FG003|Overall Study|Did not want estradiol|0|||
13275894|NCT00114517|26439816|FG000|Overall Study|Armed-services duty|0|||
13275895|NCT00114517|26439817|FG001|Overall Study|Armed-services duty|1|||
13275896|NCT00114517|26439818|FG002|Overall Study|Armed-services duty|0|||
13275897|NCT00114517|26439819|FG003|Overall Study|Armed-services duty|1|||
13275898|NCT00114517|26439816|FG000|Overall Study|Competing family issue|0|||
13275899|NCT00114517|26439817|FG001|Overall Study|Competing family issue|1|||
13275900|NCT00114517|26439818|FG002|Overall Study|Competing family issue|0|||
13275901|NCT00114517|26439819|FG003|Overall Study|Competing family issue|1|||
13275902|NCT00114517|26439816|FG000|Overall Study|Physician Decision|0|||
13275903|NCT00114517|26439817|FG001|Overall Study|Physician Decision|1|||
13275904|NCT00114517|26439818|FG002|Overall Study|Physician Decision|0|||
13275905|NCT00114517|26439819|FG003|Overall Study|Physician Decision|0|||
13275906|NCT00114517|26439816|FG000|Overall Study|Lost interest|0|||
13275907|NCT00114517|26439817|FG001|Overall Study|Lost interest|0|||
13275908|NCT00114517|26439818|FG002|Overall Study|Lost interest|1|||
13275909|NCT00114517|26439819|FG003|Overall Study|Lost interest|0|||
13275910|NCT00114517|26439816|FG000|Overall Study|Weight increase|0|||
13275911|NCT00114517|26439817|FG001|Overall Study|Weight increase|0|||
13275912|NCT00114517|26439818|FG002|Overall Study|Weight increase|1|||
13275913|NCT00114517|26439819|FG003|Overall Study|Weight increase|0|||
13275914|NCT00114517|26439816|FG000|Overall Study|Concern about blood clots|0|||
13275915|NCT00114517|26439817|FG001|Overall Study|Concern about blood clots|0|||
13275916|NCT00114517|26439818|FG002|Overall Study|Concern about blood clots|1|||
13275917|NCT00114517|26439819|FG003|Overall Study|Concern about blood clots|0|||
13275918|NCT00114517|26439816|FG000|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
13275919|NCT00114517|26439817|FG001|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
13275920|NCT00114517|26439818|FG002|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
13275921|NCT00114517|26439819|FG003|Overall Study|Breast cancer diagnosis on baseline mammogram|1|||
13275922|NCT00033631|26439848|FG000|Overall Study|Protocol Violation|14|||
13275923|NCT00033631|26439849|FG001|Overall Study|Protocol Violation|11|||
13275924|NCT00033631|26439848|FG000|Overall Study|Withdrawal by Subject|4|||
13275925|NCT00033631|26439849|FG001|Overall Study|Withdrawal by Subject|4|||
13275926|NCT03084302|26439858|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9|||
13275927|NCT03084302|26439858|FG000|Overall Study|No valid objective monitor data|6|||
13275928|NCT03089853|26439887|FG000|Overall Study|Lost to Follow-up|2|||
13275929|NCT03089853|26439888|FG001|Overall Study|Lost to Follow-up|1|||
13275930|NCT03086967|26439945|FG000|Overall Study|Screen Failure|2|||
13275931|NCT03086967|26439946|FG001|Overall Study|Screen Failure|2|||
13275932|NCT03086343|26439963|FG000|Overall Study|Adverse Event|7|||
13275933|NCT03086343|26439964|FG001|Overall Study|Adverse Event|7|||
13275934|NCT03086343|26439963|FG000|Overall Study|Withdrawal by Subject|10|||
13275935|NCT03086343|26439964|FG001|Overall Study|Withdrawal by Subject|6|||
13275936|NCT03086343|26439963|FG000|Overall Study|Lost to Follow-up|3|||
13275937|NCT03086343|26439964|FG001|Overall Study|Lost to Follow-up|1|||
13275938|NCT03086343|26439963|FG000|Overall Study|Lack of Efficacy|4|||
13275939|NCT03086343|26439964|FG001|Overall Study|Lack of Efficacy|6|||
13275940|NCT03086343|26439963|FG000|Overall Study|Other, not specified|8|||
13275941|NCT03086343|26439964|FG001|Overall Study|Other, not specified|4|||
13275942|NCT03086343|26439963|FG000|Overall Study|Missing|0|||
13275943|NCT03086343|26439964|FG001|Overall Study|Missing|1|||
13275944|NCT03084367|26440044|FG000|Overall Study|Lost to Follow-up|32|||
13275945|NCT03084367|26440044|FG000|Overall Study|Withdrawal by Subject|4|||
13275946|NCT03084367|26440044|FG000|Overall Study|Other|1|||
13291256|NCT00156065|26482883|FG002|Overall Study|Lost to Follow-up|1|||
13291257|NCT00156065|26482881|FG000|Overall Study|Other|2|||
13291258|NCT00156065|26482882|FG001|Overall Study|Other|9|||
13291259|NCT00156065|26482883|FG002|Overall Study|Other|3|||
13291260|NCT00154375|26482899|FG000|Overall Study|Unsatisfactory therapeutic effect|25|||
13291261|NCT00154375|26482900|FG001|Overall Study|Unsatisfactory therapeutic effect|26|||
13291262|NCT00154375|26482899|FG000|Overall Study|Adverse Event|18|||
13291263|NCT00154375|26482900|FG001|Overall Study|Adverse Event|20|||
13291264|NCT00154375|26482899|FG000|Overall Study|Withdrawal by Subject|14|||
13291265|NCT00154375|26482900|FG001|Overall Study|Withdrawal by Subject|10|||
13275947|NCT02395120|26440116|FG000|Overall Study|Missed follow-up dental exam|57|||
13275948|NCT02395120|26440117|FG001|Overall Study|Missed follow-up dental exam|62|||
13275949|NCT02395120|26440118|FG002|Overall Study|Missed follow-up dental exam|6|||
13275950|NCT02395120|26440119|FG003|Overall Study|Missed follow-up dental exam|6|||
13275951|NCT02395120|26440120|FG004|Overall Study|Missed follow-up dental exam|51|||
13275952|NCT00639769|26440153|FG000|Overall Study|Death|2|||
13275953|NCT00639769|26440153|FG000|Overall Study|Adverse Event|7|||
13275954|NCT00639769|26440153|FG000|Overall Study|Lack of Efficacy|1|||
13275955|NCT00639769|26440153|FG000|Overall Study|Disease progression|26|||
13275956|NCT00639769|26440153|FG000|Overall Study|Withdrawal by Subject|4|||
13275957|NCT00639678|26440226|FG000|Overall Study|Withdrawal by Subject|3|||
13275958|NCT00639678|26440227|FG001|Overall Study|Withdrawal by Subject|0|||
13275959|NCT00639678|26440228|FG002|Overall Study|Withdrawal by Subject|4|||
13275960|NCT00639678|26440229|FG003|Overall Study|Withdrawal by Subject|0|||
13275961|NCT00639678|26440226|FG000|Overall Study|Lost to Follow-up|1|||
13275962|NCT00639678|26440227|FG001|Overall Study|Lost to Follow-up|0|||
13275963|NCT00639678|26440228|FG002|Overall Study|Lost to Follow-up|6|||
13275964|NCT00639678|26440229|FG003|Overall Study|Lost to Follow-up|0|||
13275965|NCT00639678|26440226|FG000|Overall Study|Adverse Event|0|||
13275966|NCT00639678|26440227|FG001|Overall Study|Adverse Event|1|||
13275967|NCT00639678|26440228|FG002|Overall Study|Adverse Event|0|||
13275968|NCT00639678|26440229|FG003|Overall Study|Adverse Event|0|||
13275969|NCT00639678|26440226|FG000|Overall Study|Lack of Compliance|0|||
13275970|NCT00639678|26440227|FG001|Overall Study|Lack of Compliance|0|||
13275971|NCT00639678|26440228|FG002|Overall Study|Lack of Compliance|1|||
13275972|NCT00639678|26440229|FG003|Overall Study|Lack of Compliance|0|||
13275973|NCT00639509|26440237|FG000|Overall Study|Death|1|||
13275974|NCT00639457|26440278|FG000|Overall Study|Withdrawal by Subject|2|||
13275975|NCT00639457|26440279|FG001|Overall Study|Withdrawal by Subject|3|||
13275976|NCT00639379|26440296|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2|||
13275977|NCT00639379|26440297|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0|||
13275978|NCT00639379|26440296|FG000|Period 1 - 2 Weeks|lens issue|3|||
13275979|NCT00639379|26440297|FG001|Period 1 - 2 Weeks|lens issue|0|||
13275980|NCT00639223|26440312|FG000|Overall Study|Lost to Follow-up|0|||
13275981|NCT00639223|26440313|FG001|Overall Study|Lost to Follow-up|2|||
13275982|NCT00639002|26440321|FG000|Overall Study|Death|1|||
13275983|NCT00639002|26440321|FG000|Overall Study|Adverse Event|1|||
13275984|NCT00639002|26440321|FG000|Overall Study|Protocol Violation|1|||
13275985|NCT00639002|26440321|FG000|Overall Study|Disease progression|3|||
13275986|NCT00639002|26440321|FG000|Overall Study|Physician Decision|6|||
13275987|NCT00639002|26440321|FG000|Overall Study|Lack of Efficacy|1|||
13275988|NCT00638989|26440369|FG000|Overall Study|Lost to Follow-up|0|||
13275989|NCT00638989|26440370|FG001|Overall Study|Lost to Follow-up|0|||
13275990|NCT00638989|26440371|FG002|Overall Study|Lost to Follow-up|1|||
13275991|NCT00638963|26440397|FG000|Overall Study|Withdrawal by Subject|1|||
13275992|NCT00638963|26440398|FG001|Overall Study|Withdrawal by Subject|0|||
13275993|NCT00638846|26440421|FG000|Overall Study|Adverse Event|0|||
13275994|NCT00638846|26440422|FG001|Overall Study|Adverse Event|1|||
13275995|NCT00638846|26440421|FG000|Overall Study|Lost to Follow-up|3|||
13275996|NCT00638846|26440422|FG001|Overall Study|Lost to Follow-up|2|||
13275997|NCT00638846|26440421|FG000|Overall Study|lens issue|1|||
13275998|NCT00638846|26440422|FG001|Overall Study|lens issue|3|||
13275999|NCT00638508|26440473|FG000|Overall Study|Physician Decision|5|||
13276000|NCT00638508|26440474|FG001|Overall Study|Physician Decision|2|||
13276001|NCT00638456|26440491|FG000|Overall Study|Withdrawal by Subject|6|||
13276002|NCT00638456|26440492|FG001|Overall Study|Withdrawal by Subject|2|||
13276003|NCT00638404|26440511|FG000|Overall Study|Physician Decision|8|||
13276004|NCT00638404|26440512|FG001|Overall Study|Physician Decision|0|||
13276005|NCT00638378|26440521|FG000|Overall Study|Death|2|||
13276006|NCT00638378|26440521|FG000|Overall Study|Adverse Event|1|||
13276007|NCT00638378|26440521|FG000|Overall Study|Disease progression|15|||
13276008|NCT00638378|26440521|FG000|Overall Study|Physician Decision|4|||
13276009|NCT00638235|26440947|FG000|Overall Study|Lost to Follow-up|31|||
13276010|NCT00638235|26440948|FG001|Overall Study|Lost to Follow-up|3|||
13276011|NCT00638235|26440949|FG002|Overall Study|Lost to Follow-up|18|||
13276012|NCT00638235|26440950|FG003|Overall Study|Lost to Follow-up|10|||
13276013|NCT00638235|26440951|FG004|Overall Study|Lost to Follow-up|13|||
13276014|NCT00638235|26440952|FG005|Overall Study|Lost to Follow-up|26|||
13276015|NCT00638235|26440953|FG006|Overall Study|Lost to Follow-up|0|||
13276016|NCT00638235|26440954|FG007|Overall Study|Lost to Follow-up|1|||
13276017|NCT00638235|26440955|FG008|Overall Study|Lost to Follow-up|18|||
13276018|NCT00638183|26440964|FG000|Overall Study|Adverse Event|23|||
13276019|NCT00638183|26440964|FG000|Overall Study|Lack of Efficacy|14|||
13119056|NCT03026283|25932142|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
13276020|NCT00638183|26440964|FG000|Overall Study|Physician Decision|9|||
13276021|NCT00638183|26440964|FG000|Overall Study|Lost to Follow-up|46|||
13276022|NCT00638183|26440964|FG000|Overall Study|Other reason not defined above|27|||
13276023|NCT00638157|26440979|FG000|Overall Study|Adverse Event|0|||
13276024|NCT00638157|26440980|FG001|Overall Study|Adverse Event|1|||
13276025|NCT00638157|26440979|FG000|Overall Study|Clinical (symptomatic) failure|1|||
13276026|NCT00638157|26440980|FG001|Overall Study|Clinical (symptomatic) failure|1|||
13276027|NCT00638157|26440979|FG000|Overall Study|Microbiological failure|1|||
13276028|NCT00638157|26440980|FG001|Overall Study|Microbiological failure|0|||
13276029|NCT00638157|26440979|FG000|Overall Study|Lost to Follow-up|1|||
13276030|NCT00638157|26440980|FG001|Overall Study|Lost to Follow-up|0|||
13276031|NCT00638157|26440979|FG000|Overall Study|Physician Decision|1|||
13276032|NCT00638157|26440980|FG001|Overall Study|Physician Decision|0|||
13276033|NCT00638157|26440979|FG000|Overall Study|Other|1|||
13276034|NCT00638157|26440980|FG001|Overall Study|Other|2|||
13276035|NCT00638157|26440979|FG000|Overall Study|Randomized, not treated|2|||
13276036|NCT00638157|26440980|FG001|Overall Study|Randomized, not treated|0|||
13276037|NCT00638027|26440997|FG000|Overall Study|Adverse Event|0|||
13276038|NCT00638027|26440998|FG001|Overall Study|Adverse Event|2|||
13119057|NCT03026283|25932135|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
13119058|NCT03026283|25932136|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
13119059|NCT03026283|25932137|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
13119060|NCT03026283|25932138|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9|||
13119061|NCT03026283|25932139|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
13119062|NCT03026283|25932140|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
13119063|NCT03026283|25932141|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
13119064|NCT03026283|25932142|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
13119065|NCT03026283|25932135|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
13119066|NCT03026283|25932136|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
13276039|NCT00637806|26441027|FG000|Double-blind Phase|Study Discontinued|2|||
13276040|NCT00637806|26441028|FG001|Double-blind Phase|Study Discontinued|0|||
13276041|NCT00637806|26441029|FG002|Double-blind Phase|Study Discontinued|1|||
13276042|NCT00637806|26441030|FG003|Double-blind Phase|Study Discontinued|0|||
13276043|NCT00637806|26441027|FG000|Extension Phase|Study Discontinued|0|||
13276044|NCT00637806|26441028|FG001|Extension Phase|Study Discontinued|0|||
13276045|NCT00637806|26441029|FG002|Extension Phase|Study Discontinued|0|||
13276046|NCT00637806|26441030|FG003|Extension Phase|Study Discontinued|1|||
13276047|NCT00637728|26441051|FG000|Double-blind Phase|Adverse Event|1|||
13276048|NCT00637728|26441052|FG001|Double-blind Phase|Adverse Event|0|||
13276049|NCT00637728|26441053|FG002|Double-blind Phase|Adverse Event|0|||
13276050|NCT00637728|26441051|FG000|Double-blind Phase|Non-compliance|2|||
13276051|NCT00637728|26441052|FG001|Double-blind Phase|Non-compliance|0|||
13276052|NCT00637728|26441053|FG002|Double-blind Phase|Non-compliance|0|||
13276053|NCT00637728|26441051|FG000|Double-blind Phase|Study Discontinued|1|||
13276054|NCT00637728|26441052|FG001|Double-blind Phase|Study Discontinued|1|||
13276055|NCT00637728|26441053|FG002|Double-blind Phase|Study Discontinued|0|||
13276056|NCT00637572|26441086|FG000|Overall Study|Adverse Event|1|||
13276057|NCT00637572|26441087|FG001|Overall Study|Adverse Event|2|||
13276058|NCT00637572|26441086|FG000|Overall Study|Death|0|||
13276059|NCT00637572|26441087|FG001|Overall Study|Death|1|||
13276060|NCT00637572|26441086|FG000|Overall Study|Lost to Follow-up|0|||
13276061|NCT00637572|26441087|FG001|Overall Study|Lost to Follow-up|1|||
13276062|NCT00637572|26441086|FG000|Overall Study|Physician Decision|1|||
13276063|NCT00637572|26441087|FG001|Overall Study|Physician Decision|1|||
13276064|NCT00637572|26441086|FG000|Overall Study|Withdrawal by Subject|0|||
13276065|NCT00637572|26441087|FG001|Overall Study|Withdrawal by Subject|2|||
13276066|NCT00637572|26441086|FG000|Overall Study|Illicit Drug Use|1|||
13276067|NCT00637572|26441087|FG001|Overall Study|Illicit Drug Use|0|||
13276068|NCT00637416|26441100|FG000|Overall Study|Lost to Follow-up|1|||
13276069|NCT00637416|26441101|FG001|Overall Study|Lost to Follow-up|1|||
13276070|NCT00637416|26441100|FG000|Overall Study|Unable to take study drug|0|||
13276071|NCT00637416|26441101|FG001|Overall Study|Unable to take study drug|1|||
13276072|NCT00637377|26441140|FG000|Overall Study|Adverse Event|2|||
13276073|NCT00637377|26441141|FG001|Overall Study|Adverse Event|6|||
13276074|NCT00637377|26441142|FG002|Overall Study|Adverse Event|8|||
13276075|NCT00637377|26441143|FG003|Overall Study|Adverse Event|9|||
13276076|NCT00637377|26441140|FG000|Overall Study|Death|1|||
13276077|NCT00637377|26441141|FG001|Overall Study|Death|3|||
13276078|NCT00637377|26441142|FG002|Overall Study|Death|2|||
13276079|NCT00637377|26441143|FG003|Overall Study|Death|1|||
13276080|NCT00637377|26441140|FG000|Overall Study|Lack of Efficacy|0|||
13276081|NCT00637377|26441141|FG001|Overall Study|Lack of Efficacy|0|||
13276082|NCT00637377|26441142|FG002|Overall Study|Lack of Efficacy|1|||
13276083|NCT00637377|26441143|FG003|Overall Study|Lack of Efficacy|1|||
13276084|NCT00637377|26441140|FG000|Overall Study|Lost to Follow-up|4|||
13276085|NCT00637377|26441141|FG001|Overall Study|Lost to Follow-up|1|||
13276086|NCT00637377|26441142|FG002|Overall Study|Lost to Follow-up|2|||
13276087|NCT00637377|26441143|FG003|Overall Study|Lost to Follow-up|2|||
13276088|NCT00637377|26441140|FG000|Overall Study|Protocol Violation|2|||
13276089|NCT00637377|26441141|FG001|Overall Study|Protocol Violation|1|||
13276090|NCT00637377|26441142|FG002|Overall Study|Protocol Violation|1|||
13276091|NCT00637377|26441143|FG003|Overall Study|Protocol Violation|0|||
13276092|NCT00637377|26441140|FG000|Overall Study|Withdrawal by Subject|11|||
13276093|NCT00637377|26441141|FG001|Overall Study|Withdrawal by Subject|15|||
13276094|NCT00637377|26441142|FG002|Overall Study|Withdrawal by Subject|13|||
13276095|NCT00637377|26441143|FG003|Overall Study|Withdrawal by Subject|11|||
13276096|NCT00637377|26441140|FG000|Overall Study|Other (no further information available)|7|||
13276097|NCT00637377|26441141|FG001|Overall Study|Other (no further information available)|6|||
13276098|NCT00637377|26441142|FG002|Overall Study|Other (no further information available)|10|||
13276099|NCT00637377|26441143|FG003|Overall Study|Other (no further information available)|5|||
13276100|NCT00637273|26441194|FG000|Overall Study|Adverse Event|11|||
13276101|NCT00637273|26441195|FG001|Overall Study|Adverse Event|5|||
13276102|NCT00637273|26441196|FG002|Overall Study|Adverse Event|7|||
13276103|NCT00637273|26441194|FG000|Overall Study|Lost to Follow-up|8|||
13276104|NCT00637273|26441195|FG001|Overall Study|Lost to Follow-up|9|||
13276105|NCT00637273|26441196|FG002|Overall Study|Lost to Follow-up|13|||
13276106|NCT00637273|26441194|FG000|Overall Study|Protocol Violation|2|||
13276107|NCT00637273|26441195|FG001|Overall Study|Protocol Violation|4|||
13276108|NCT00637273|26441196|FG002|Overall Study|Protocol Violation|1|||
13276109|NCT00637273|26441194|FG000|Overall Study|Withdrawal of Consent|18|||
13276110|NCT00637273|26441195|FG001|Overall Study|Withdrawal of Consent|6|||
13276111|NCT00637273|26441196|FG002|Overall Study|Withdrawal of Consent|18|||
13276112|NCT00637273|26441194|FG000|Overall Study|Investigator Decision|1|||
13276113|NCT00637273|26441195|FG001|Overall Study|Investigator Decision|3|||
13276114|NCT00637273|26441196|FG002|Overall Study|Investigator Decision|1|||
13276115|NCT00637273|26441194|FG000|Overall Study|Administrative|2|||
13276116|NCT00637273|26441195|FG001|Overall Study|Administrative|0|||
13276117|NCT00637273|26441196|FG002|Overall Study|Administrative|0|||
13276118|NCT00637273|26441194|FG000|Overall Study|Loss of Glucose Control|1|||
13276119|NCT00637273|26441195|FG001|Overall Study|Loss of Glucose Control|1|||
13276120|NCT00637273|26441196|FG002|Overall Study|Loss of Glucose Control|1|||
13276121|NCT00637195|26441237|FG000|Overall Study|Lost to Follow-up|1|||
13276122|NCT00637195|26441238|FG001|Overall Study|Lost to Follow-up|0|||
13276123|NCT00637195|26441237|FG000|Overall Study|Other|2|||
13276124|NCT00637195|26441238|FG001|Overall Study|Other|0|||
13276125|NCT00637195|26441237|FG000|Overall Study|Withdrawal by Subject|0|||
13276126|NCT00637195|26441238|FG001|Overall Study|Withdrawal by Subject|1|||
13276127|NCT00637156|26441285|FG000|Overall Study|Withdrawal by Subject|0|||
13276128|NCT00637156|26441286|FG001|Overall Study|Withdrawal by Subject|7|||
13276129|NCT00637156|26441285|FG000|Overall Study|Death|0|||
13276130|NCT00637156|26441286|FG001|Overall Study|Death|1|||
13276131|NCT00637156|26441285|FG000|Overall Study|Lost to Follow-up|10|||
13119067|NCT03026283|25932137|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
13119068|NCT03026283|25932138|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2|||
13119069|NCT03026283|25932139|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
13119070|NCT03026283|25932140|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7|||
13119071|NCT03026283|25932141|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
13119072|NCT03026283|25932142|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
13119073|NCT03026283|25932135|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
13119074|NCT03026283|25932136|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
13119075|NCT03026283|25932137|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
13119076|NCT03026283|25932138|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1|||
13119077|NCT03026283|25932139|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
13119078|NCT03026283|25932140|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
13119079|NCT03026283|25932141|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
13119080|NCT03026283|25932142|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
13119081|NCT03026283|25932135|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
13119082|NCT03026283|25932136|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
13119083|NCT03026283|25932137|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
13119084|NCT03026283|25932138|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
13119085|NCT03026283|25932139|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25|||
13119086|NCT03026283|25932140|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19|||
13119087|NCT03026283|25932141|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
13119088|NCT03026283|25932142|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
13119089|NCT03026257|25932175|FG000|Overall Study|Adverse Event|3|||
13119090|NCT03026257|25932176|FG001|Overall Study|Adverse Event|0|||
13119091|NCT03026257|25932177|FG002|Overall Study|Adverse Event|0|||
13119092|NCT03026257|25932178|FG003|Overall Study|Adverse Event|0|||
13119093|NCT03026257|25932179|FG004|Overall Study|Adverse Event|0|||
13119094|NCT03026257|25932180|FG005|Overall Study|Adverse Event|0|||
13119095|NCT03026257|25932175|FG000|Overall Study|Lost to Follow-up|1|||
13276132|NCT00637156|26441286|FG001|Overall Study|Lost to Follow-up|16|||
13276133|NCT00637000|26441333|FG000|Overall Study|Withdrawal by Subject|4|||
13276134|NCT00637000|26441334|FG001|Overall Study|Withdrawal by Subject|3|||
13276135|NCT00636987|26441344|FG000|Overall Study|Death|44|||
13119096|NCT03026257|25932176|FG001|Overall Study|Lost to Follow-up|0|||
13119097|NCT03026257|25932177|FG002|Overall Study|Lost to Follow-up|0|||
13119098|NCT03026257|25932178|FG003|Overall Study|Lost to Follow-up|0|||
13119099|NCT03026257|25932179|FG004|Overall Study|Lost to Follow-up|0|||
13119100|NCT03026257|25932180|FG005|Overall Study|Lost to Follow-up|0|||
13119101|NCT03026257|25932175|FG000|Overall Study|Protocol Violation|1|||
13119102|NCT03026257|25932176|FG001|Overall Study|Protocol Violation|0|||
13119103|NCT03026257|25932177|FG002|Overall Study|Protocol Violation|0|||
13119104|NCT03026257|25932178|FG003|Overall Study|Protocol Violation|1|||
13119105|NCT03026257|25932179|FG004|Overall Study|Protocol Violation|1|||
13119106|NCT03026257|25932180|FG005|Overall Study|Protocol Violation|0|||
13119107|NCT03026257|25932175|FG000|Overall Study|Withdrawal by Subject|1|||
13119108|NCT03026257|25932176|FG001|Overall Study|Withdrawal by Subject|1|||
13119109|NCT03026257|25932177|FG002|Overall Study|Withdrawal by Subject|0|||
13119110|NCT03026257|25932178|FG003|Overall Study|Withdrawal by Subject|0|||
13119111|NCT03026257|25932179|FG004|Overall Study|Withdrawal by Subject|0|||
13119112|NCT03026257|25932180|FG005|Overall Study|Withdrawal by Subject|0|||
13119113|NCT03026166|25932203|FG000|Overall Study|Death|22|||
13119114|NCT03026166|25932204|FG001|Overall Study|Death|7|||
13119115|NCT03026166|25932203|FG000|Overall Study|Physician Decision|2|||
13119116|NCT03026166|25932204|FG001|Overall Study|Physician Decision|0|||
13119117|NCT03026166|25932203|FG000|Overall Study|Withdrawal by Subject|1|||
13119118|NCT03026166|25932204|FG001|Overall Study|Withdrawal by Subject|2|||
13119119|NCT03026166|25932203|FG000|Overall Study|Lost to Follow-up|1|||
13119120|NCT03026166|25932204|FG001|Overall Study|Lost to Follow-up|0|||
13119121|NCT03026166|25932203|FG000|Overall Study|Study Terminated by Sponsor|3|||
13119122|NCT03026166|25932204|FG001|Overall Study|Study Terminated by Sponsor|3|||
13119123|NCT03026166|25932203|FG000|Overall Study|Other|1|||
13119124|NCT03026166|25932204|FG001|Overall Study|Other|0|||
13119125|NCT03026088|25932230|FG000|Overall Study|Study termination|20|||
13119126|NCT03026075|25932236|FG000|Overall Study|Physician Decision|1|||
13119127|NCT03025828|25932248|FG000|Overall Study|Lost to Follow-up|1|||
13119128|NCT03025217|25932255|FG000|Overall Study|Pregnancy|1|||
13119129|NCT03025217|25932255|FG000|Overall Study|Lost to Follow-up|1|||
13119130|NCT03025217|25932255|FG000|Overall Study|Not eligible, poor English|2|||
13119131|NCT03024970|25932334|FG000|First Intervention|Adverse Event|1|||
13119132|NCT03024970|25932335|FG001|First Intervention|Adverse Event|0|||
13119133|NCT03024970|25932334|FG000|Second Intervention|Lost to Follow-up|1|||
13119134|NCT03024970|25932335|FG001|Second Intervention|Lost to Follow-up|0|||
13119135|NCT03024606|25932348|FG000|Overall Study|Withdrawal by Subject|9|||
13119136|NCT03024606|25932349|FG001|Overall Study|Withdrawal by Subject|10|||
13119137|NCT03023878|25932364|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11|||
13119138|NCT03023878|25932364|FG000|Pre-Study Run-In Period|Death|1|||
13119139|NCT03023878|25932364|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5|||
13119140|NCT03023878|25932364|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2|||
13119141|NCT03023878|25932364|FG000|Treatment Period|Disease Progression|1|||
13119142|NCT03023878|25932364|FG000|Treatment Period|Withdrawal by Subject|1|||
13119143|NCT03023878|25932364|FG000|Treatment Period|Adverse Event|1|||
13119144|NCT03023878|25932364|FG000|Long Term Follow-Up Period|Death|2|||
13276136|NCT00636987|26441344|FG000|Overall Study|Explanted|13|||
13276137|NCT00636987|26441344|FG000|Overall Study|Lost to Follow-up|63|||
13276138|NCT00636987|26441344|FG000|Overall Study|5 year visit window not complete|69|||
13276139|NCT00636961|26441365|FG000|Period 1|Administrative problems|1|||
13276140|NCT00636961|26441366|FG001|Period 1|Administrative problems|1|||
13276141|NCT00636961|26441365|FG000|Period 2|Adverse Event|1|||
13276142|NCT00636961|26441366|FG001|Period 2|Adverse Event|0|||
13276143|NCT00636818|26441383|FG000|Overall Study|Adverse Event|1|||
13276144|NCT00636818|26441383|FG000|Overall Study|Lost to Follow-up|2|||
13276145|NCT00636818|26441383|FG000|Overall Study|Entry Criteria Exclusion|3|||
13276146|NCT00636818|26441383|FG000|Overall Study|Protocol Violation|1|||
13276147|NCT00636818|26441383|FG000|Overall Study|Withdrawal by Subject|4|||
13276148|NCT00636792|26441390|FG000|Overall Study|Adverse Event|16|||
13276149|NCT00636792|26441390|FG000|Overall Study|Physician Decision|7|||
13276150|NCT00636792|26441390|FG000|Overall Study|Progressive Disease|4|||
13276151|NCT00636792|26441390|FG000|Overall Study|Withdrawal by Subject|3|||
13276152|NCT00636792|26441390|FG000|Overall Study|Other|3|||
13276153|NCT00636636|26441411|FG000|Overall Study|Other reason|4|||
13276154|NCT00636636|26441412|FG001|Overall Study|Other reason|6|||
13276155|NCT00636636|26441411|FG000|Overall Study|Adverse Event|19|||
13276156|NCT00636636|26441412|FG001|Overall Study|Adverse Event|8|||
13119145|NCT03023826|25932385|FG000|Period 1|Withdrawal by Subject|0|||
13119146|NCT03023826|25932386|FG001|Period 1|Withdrawal by Subject|0|||
13119147|NCT03023826|25932387|FG002|Period 1|Withdrawal by Subject|0|||
13119148|NCT03023826|25932388|FG003|Period 1|Withdrawal by Subject|0|||
13276157|NCT00636636|26441411|FG000|Overall Study|Lack of Efficacy|7|||
13276158|NCT00636636|26441412|FG001|Overall Study|Lack of Efficacy|12|||
13119149|NCT03023826|25932389|FG004|Period 1|Withdrawal by Subject|1|||
13119150|NCT03023826|25932390|FG005|Period 1|Withdrawal by Subject|0|||
13133446|NCT02769312|25987786|FG001|Follow-up|Lost to Follow-up|1|||
13276159|NCT00636636|26441411|FG000|Overall Study|Protocol Violation|2|||
13276160|NCT00636636|26441412|FG001|Overall Study|Protocol Violation|2|||
13276161|NCT00636636|26441411|FG000|Overall Study|Lost to Follow-up|0|||
13276162|NCT00636636|26441412|FG001|Overall Study|Lost to Follow-up|1|||
13276163|NCT00636636|26441411|FG000|Overall Study|Death|0|||
13276164|NCT00636636|26441412|FG001|Overall Study|Death|1|||
13276165|NCT00636636|26441411|FG000|Overall Study|Withdrawal by Subject|4|||
13276166|NCT00636636|26441412|FG001|Overall Study|Withdrawal by Subject|9|||
13276167|NCT00636610|26441429|FG000|Overall Study|Adverse Event|4|||
13276168|NCT00636610|26441430|FG001|Overall Study|Adverse Event|4|||
13276169|NCT00636610|26441429|FG000|Overall Study|Death|6|||
13276170|NCT00636610|26441430|FG001|Overall Study|Death|3|||
13276171|NCT00636610|26441429|FG000|Overall Study|Physician decision to withdraw patient|15|||
13276172|NCT00636610|26441430|FG001|Overall Study|Physician decision to withdraw patient|9|||
13276173|NCT00636610|26441429|FG000|Overall Study|Subject decision to withdraw|15|||
13276174|NCT00636610|26441430|FG001|Overall Study|Subject decision to withdraw|11|||
13276175|NCT00636610|26441429|FG000|Overall Study|Disease progression - radiographic|41|||
13276176|NCT00636610|26441430|FG001|Overall Study|Disease progression - radiographic|51|||
13276177|NCT00636610|26441429|FG000|Overall Study|Disease progression - clinical|8|||
13276178|NCT00636610|26441430|FG001|Overall Study|Disease progression - clinical|3|||
13276179|NCT00636610|26441429|FG000|Overall Study|Reason for discontinuation not available|3|||
13276180|NCT00636610|26441430|FG001|Overall Study|Reason for discontinuation not available|2|||
13276181|NCT00636506|26441472|FG000|Overall Study|Lost to Follow-up|8|||
13276182|NCT00636506|26441472|FG000|Overall Study|Explanted|1|||
13276183|NCT00636506|26441472|FG000|Overall Study|Withdrawal by Subject|6|||
13276184|NCT00636506|26441472|FG000|Overall Study|Procedure aborted|1|||
13276185|NCT00636441|26441523|FG000|Overall Study|Adverse Event|0|||
13276186|NCT00636441|26441524|FG001|Overall Study|Adverse Event|1|||
13276187|NCT00636441|26441525|FG002|Overall Study|Adverse Event|1|||
13276188|NCT00636441|26441526|FG003|Overall Study|Adverse Event|0|||
13276189|NCT00636441|26441527|FG004|Overall Study|Adverse Event|0|||
13276190|NCT00636441|26441528|FG005|Overall Study|Adverse Event|1|||
13276191|NCT00636441|26441529|FG006|Overall Study|Adverse Event|0|||
13276192|NCT00636441|26441523|FG000|Overall Study|Late, ineligible|0|||
13276193|NCT00636441|26441524|FG001|Overall Study|Late, ineligible|0|||
13276194|NCT00636441|26441525|FG002|Overall Study|Late, ineligible|0|||
13276195|NCT00636441|26441526|FG003|Overall Study|Late, ineligible|0|||
13276196|NCT00636441|26441527|FG004|Overall Study|Late, ineligible|0|||
13276197|NCT00636441|26441528|FG005|Overall Study|Late, ineligible|0|||
13276198|NCT00636441|26441529|FG006|Overall Study|Late, ineligible|1|||
13276199|NCT00636441|26441523|FG000|Overall Study|Screen Failure|0|||
13276200|NCT00636441|26441524|FG001|Overall Study|Screen Failure|0|||
13276201|NCT00636441|26441525|FG002|Overall Study|Screen Failure|0|||
13276202|NCT00636441|26441526|FG003|Overall Study|Screen Failure|0|||
13276203|NCT00636441|26441527|FG004|Overall Study|Screen Failure|0|||
13276204|NCT00636441|26441528|FG005|Overall Study|Screen Failure|0|||
13276205|NCT00636441|26441529|FG006|Overall Study|Screen Failure|17|||
13276206|NCT00636363|26441553|FG000|Overall Study|Conjunctivitis|0|||
13276207|NCT00636363|26441554|FG001|Overall Study|Conjunctivitis|0|||
13276208|NCT00636363|26441555|FG002|Overall Study|Conjunctivitis|1|||
13276209|NCT00636363|26441553|FG000|Overall Study|Adverse Event|0|||
13276210|NCT00636363|26441554|FG001|Overall Study|Adverse Event|0|||
13276211|NCT00636363|26441555|FG002|Overall Study|Adverse Event|1|||
13276212|NCT00636363|26441553|FG000|Overall Study|Positive slit lamp finding|0|||
13276213|NCT00636363|26441554|FG001|Overall Study|Positive slit lamp finding|2|||
13276214|NCT00636363|26441555|FG002|Overall Study|Positive slit lamp finding|1|||
13276215|NCT00636363|26441553|FG000|Overall Study|Study related symptoms/complaints|8|||
13276216|NCT00636363|26441554|FG001|Overall Study|Study related symptoms/complaints|7|||
13276217|NCT00636363|26441555|FG002|Overall Study|Study related symptoms/complaints|4|||
13276218|NCT00636363|26441553|FG000|Overall Study|Met ineligibility criteria|0|||
13276219|NCT00636363|26441554|FG001|Overall Study|Met ineligibility criteria|0|||
13276220|NCT00636363|26441555|FG002|Overall Study|Met ineligibility criteria|3|||
13276221|NCT00636363|26441553|FG000|Overall Study|Missed > 1 visit|0|||
13276222|NCT00636363|26441554|FG001|Overall Study|Missed > 1 visit|1|||
13276223|NCT00636363|26441555|FG002|Overall Study|Missed > 1 visit|3|||
13276224|NCT00636363|26441553|FG000|Overall Study|Lack of motivation|1|||
13276225|NCT00636363|26441554|FG001|Overall Study|Lack of motivation|0|||
13276226|NCT00636363|26441555|FG002|Overall Study|Lack of motivation|1|||
13276227|NCT00636363|26441553|FG000|Overall Study|Protocol Violation|0|||
13276228|NCT00636363|26441554|FG001|Overall Study|Protocol Violation|3|||
13276229|NCT00636363|26441555|FG002|Overall Study|Protocol Violation|0|||
13276230|NCT00636363|26441553|FG000|Overall Study|Lost to Follow-up|3|||
13276231|NCT00636363|26441554|FG001|Overall Study|Lost to Follow-up|4|||
13276232|NCT00636363|26441555|FG002|Overall Study|Lost to Follow-up|2|||
13276233|NCT00636363|26441553|FG000|Overall Study|Withdrawal by Subject|1|||
13276234|NCT00636363|26441554|FG001|Overall Study|Withdrawal by Subject|3|||
13276235|NCT00636363|26441555|FG002|Overall Study|Withdrawal by Subject|2|||
13276236|NCT00636207|26441631|FG000|Overall Study|Adverse Event|1|||
13276237|NCT00636207|26441632|FG001|Overall Study|Adverse Event|0|||
13276238|NCT00636207|26441633|FG002|Overall Study|Adverse Event|0|||
13276239|NCT00636207|26441634|FG003|Overall Study|Adverse Event|0|||
13276240|NCT00636207|26441635|FG004|Overall Study|Adverse Event|0|||
13276241|NCT00636207|26441636|FG005|Overall Study|Adverse Event|0|||
13276242|NCT00636207|26441637|FG006|Overall Study|Adverse Event|0|||
13276243|NCT00636207|26441631|FG000|Overall Study|Withdrawal by Subject|0|||
13276244|NCT00636207|26441632|FG001|Overall Study|Withdrawal by Subject|1|||
13276245|NCT00636207|26441633|FG002|Overall Study|Withdrawal by Subject|0|||
13276246|NCT00636207|26441634|FG003|Overall Study|Withdrawal by Subject|0|||
13276247|NCT00636207|26441635|FG004|Overall Study|Withdrawal by Subject|1|||
13276248|NCT00636207|26441636|FG005|Overall Study|Withdrawal by Subject|0|||
13276249|NCT00636207|26441637|FG006|Overall Study|Withdrawal by Subject|0|||
13276250|NCT00636194|26441654|FG000|Overall Study|Study related symptoms and complaints|1|||
13276251|NCT00636194|26441655|FG001|Overall Study|Study related symptoms and complaints|0|||
13276252|NCT00636194|26441654|FG000|Overall Study|Protocol Violation|2|||
13276253|NCT00636194|26441655|FG001|Overall Study|Protocol Violation|0|||
13276254|NCT00636155|26441663|FG000|Overall Study|Adverse Event|8|||
13276255|NCT00636155|26441663|FG000|Overall Study|Lack of Efficacy|1|||
13276256|NCT00636155|26441663|FG000|Overall Study|Withdrawal by Subject|3|||
13276257|NCT00636155|26441663|FG000|Overall Study|Stem cell transplant|1|||
13276258|NCT00636155|26441663|FG000|Overall Study|Physician Decision|5|||
13276259|NCT00635804|26441785|FG000|Overall Study|Adverse Event|0|||
13276260|NCT00635804|26441786|FG001|Overall Study|Adverse Event|0|||
13276261|NCT00635804|26441787|FG002|Overall Study|Adverse Event|0|||
13276262|NCT00635804|26441788|FG003|Overall Study|Adverse Event|0|||
13276263|NCT00635804|26441789|FG004|Overall Study|Adverse Event|0|||
13276264|NCT00635804|26441790|FG005|Overall Study|Adverse Event|1|||
13276265|NCT00635804|26441791|FG006|Overall Study|Adverse Event|0|||
13276266|NCT00635804|26441792|FG007|Overall Study|Adverse Event|0|||
13276267|NCT00635804|26441785|FG000|Overall Study|Withdrawal by Subject|1|||
13276268|NCT00635804|26441786|FG001|Overall Study|Withdrawal by Subject|0|||
13276269|NCT00635804|26441787|FG002|Overall Study|Withdrawal by Subject|0|||
13276270|NCT00635804|26441788|FG003|Overall Study|Withdrawal by Subject|0|||
13276271|NCT00635804|26441789|FG004|Overall Study|Withdrawal by Subject|0|||
13276272|NCT00635804|26441790|FG005|Overall Study|Withdrawal by Subject|0|||
13276273|NCT00635804|26441791|FG006|Overall Study|Withdrawal by Subject|0|||
13276274|NCT00635804|26441792|FG007|Overall Study|Withdrawal by Subject|0|||
13276275|NCT00635778|26441865|FG000|Overall Study|Adverse Event|1|||
13276276|NCT00635778|26441866|FG001|Overall Study|Adverse Event|0|||
13276277|NCT00635778|26441867|FG002|Overall Study|Adverse Event|0|||
13276278|NCT00635778|26441868|FG003|Overall Study|Adverse Event|3|||
13276279|NCT00635778|26441869|FG004|Overall Study|Adverse Event|3|||
13276280|NCT00635778|26441870|FG005|Overall Study|Adverse Event|6|||
13276281|NCT00635778|26441871|FG006|Overall Study|Adverse Event|1|||
13276282|NCT00635778|26441865|FG000|Overall Study|Withdrawal by Subject|0|||
13276283|NCT00635778|26441866|FG001|Overall Study|Withdrawal by Subject|0|||
13276284|NCT00635778|26441867|FG002|Overall Study|Withdrawal by Subject|0|||
13276285|NCT00635778|26441868|FG003|Overall Study|Withdrawal by Subject|1|||
13276286|NCT00635778|26441869|FG004|Overall Study|Withdrawal by Subject|0|||
13276287|NCT00635778|26441870|FG005|Overall Study|Withdrawal by Subject|1|||
13276288|NCT00635778|26441871|FG006|Overall Study|Withdrawal by Subject|1|||
13486356|NCT03915860|27035920|FG000|Overall Study|Withdrawal by Subject|6|||
13276289|NCT00635778|26441865|FG000|Overall Study|Progressive disease|0|||
13276290|NCT00635778|26441866|FG001|Overall Study|Progressive disease|3|||
13276291|NCT00635778|26441867|FG002|Overall Study|Progressive disease|3|||
13276292|NCT00635778|26441868|FG003|Overall Study|Progressive disease|4|||
13276293|NCT00635778|26441869|FG004|Overall Study|Progressive disease|5|||
13276294|NCT00635778|26441870|FG005|Overall Study|Progressive disease|14|||
13276295|NCT00635778|26441871|FG006|Overall Study|Progressive disease|4|||
13276296|NCT00635661|26441877|FG000|Overall Study|Withdrawal by Subject|4|||
13276297|NCT00635648|26441886|FG000|Overall Study|Adverse Event|12|||
13276298|NCT00635648|26441886|FG000|Overall Study|Withdrawal by Subject|9|||
13276299|NCT00635648|26441886|FG000|Overall Study|Physician Decision|4|||
13276300|NCT00635648|26441886|FG000|Overall Study|Rapid progression of baseline disease|4|||
13276301|NCT00635648|26441886|FG000|Overall Study|Use of other antifungal agent needed|1|||
13276302|NCT00635648|26441886|FG000|Overall Study|No improvement after 7-10 days treatment|4|||
13276303|NCT00635648|26441886|FG000|Overall Study|Noncompliance with protocol|1|||
13486357|NCT03915860|27035920|FG000|Overall Study|Lost to Follow-up|2|||
13276304|NCT00635648|26441886|FG000|Overall Study|Other reason|2|||
13276305|NCT00635427|26441922|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
13276306|NCT00635427|26441923|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
13276307|NCT00635427|26441924|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1|||
13276308|NCT00635427|26441925|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
13276309|NCT00635427|26441926|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
13276310|NCT00635427|26441922|FG000|Overall Study|Death|0|||
13486358|NCT03915860|27035920|FG000|Overall Study|Other than specified|3|||
13486359|NCT03795233|27035943|FG000|Overall Study|Withdrawal by Subject|2|||
13119151|NCT03023813|25932432|FG000|Overall Study|Lost to Follow-up|1|||
13119152|NCT03023813|25932433|FG001|Overall Study|Lost to Follow-up|2|||
13119153|NCT03023813|25932434|FG002|Overall Study|Lost to Follow-up|0|||
13119154|NCT03023722|25932442|FG000|Overall Study|No follow-up assessment|4|||
13119155|NCT03023423|25932482|FG000|Overall Study|Death|5|||
13119156|NCT03023423|25932483|FG001|Overall Study|Death|12|||
13119157|NCT03023423|25932484|FG002|Overall Study|Death|20|||
13119158|NCT03023423|25932482|FG000|Overall Study|Other|0|||
13119159|NCT03023423|25932483|FG001|Overall Study|Other|2|||
13119160|NCT03023423|25932484|FG002|Overall Study|Other|2|||
13119161|NCT03023423|25932482|FG000|Overall Study|Ongoing|2|||
13119162|NCT03023423|25932483|FG001|Overall Study|Ongoing|32|||
13119163|NCT03023423|25932484|FG002|Overall Study|Ongoing|24|||
13119164|NCT03023397|25932520|FG000|Run-In|Failed screening allergen challenge|1|||
13119165|NCT03023397|25932521|FG001|Run-In|Failed screening allergen challenge|0|||
13119166|NCT03023397|25932522|FG002|Run-In|Failed screening allergen challenge|0|||
13119167|NCT03023397|25932520|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1|||
13119168|NCT03023397|25932521|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
13119169|NCT03023397|25932522|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
13119170|NCT03023137|25932555|FG000|Overall Study|Multiple pregnancy|2|||
13486360|NCT03795233|27035944|FG001|Overall Study|Withdrawal by Subject|1|||
13486361|NCT03795233|27035943|FG000|Overall Study|Lost to Follow-up|1|||
13486362|NCT03795233|27035944|FG001|Overall Study|Lost to Follow-up|0|||
13119171|NCT03023137|25932556|FG001|Overall Study|Multiple pregnancy|4|||
13119172|NCT03023137|25932555|FG000|Overall Study|Lost to Follow-up|1|||
13119173|NCT03023137|25932556|FG001|Overall Study|Lost to Follow-up|1|||
13276311|NCT00635427|26441923|FG001|Overall Study|Death|0|||
13119174|NCT03023137|25932555|FG000|Overall Study|Protocol Violation|0|||
13119175|NCT03023137|25932556|FG001|Overall Study|Protocol Violation|4|||
13119176|NCT03023137|25932555|FG000|Overall Study|Lost the baby in a car accident|1|||
13119177|NCT03023137|25932556|FG001|Overall Study|Lost the baby in a car accident|0|||
13119178|NCT03023046|25932568|FG000|Overall Study|Withdrawal by Subject|1|||
13119179|NCT03022981|25932654|FG000|Overall Study|Adverse Event|0|||
13119180|NCT03022981|25932655|FG001|Overall Study|Adverse Event|1|||
13119181|NCT03022981|25932656|FG002|Overall Study|Adverse Event|0|||
13119182|NCT03022981|25932654|FG000|Overall Study|Investigator's Discretion|0|||
13119183|NCT03022981|25932655|FG001|Overall Study|Investigator's Discretion|1|||
13119184|NCT03022981|25932656|FG002|Overall Study|Investigator's Discretion|2|||
13119185|NCT03022981|25932654|FG000|Overall Study|Lost to Follow-up|6|||
13119186|NCT03022981|25932655|FG001|Overall Study|Lost to Follow-up|2|||
13119187|NCT03022981|25932656|FG002|Overall Study|Lost to Follow-up|1|||
13119188|NCT03022981|25932654|FG000|Overall Study|Non-Compliance With Study Drug|0|||
13119189|NCT03022981|25932655|FG001|Overall Study|Non-Compliance With Study Drug|0|||
13119190|NCT03022981|25932656|FG002|Overall Study|Non-Compliance With Study Drug|2|||
13119191|NCT03022981|25932654|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0|||
13119192|NCT03022981|25932655|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0|||
13119193|NCT03022981|25932656|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1|||
13119194|NCT03022799|25932891|FG000|Overall Study|Adverse Event|0|||
13119195|NCT03022799|25932892|FG001|Overall Study|Adverse Event|0|||
13119196|NCT03022799|25932893|FG002|Overall Study|Adverse Event|0|||
13119197|NCT03022799|25932894|FG003|Overall Study|Adverse Event|0|||
13119198|NCT03022799|25932895|FG004|Overall Study|Adverse Event|0|||
13119199|NCT03022799|25932896|FG005|Overall Study|Adverse Event|0|||
13119200|NCT03022799|25932897|FG006|Overall Study|Adverse Event|0|||
13119201|NCT03022799|25932898|FG007|Overall Study|Adverse Event|0|||
13119202|NCT03022799|25932899|FG008|Overall Study|Adverse Event|0|||
13119203|NCT03022799|25932900|FG009|Overall Study|Adverse Event|1|||
13119204|NCT03022799|25932901|FG010|Overall Study|Adverse Event|1|||
13119205|NCT03022799|25932902|FG011|Overall Study|Adverse Event|0|||
13276312|NCT00635427|26441924|FG002|Overall Study|Death|0|||
13486363|NCT03795233|27035943|FG000|Overall Study|Death|1|||
13486364|NCT03795233|27035944|FG001|Overall Study|Death|0|||
13486365|NCT03786380|27035987|FG000|Overall Study|Adverse Event|1|||
13486366|NCT03786380|27035988|FG001|Overall Study|Adverse Event|0|||
13486367|NCT03786380|27035989|FG002|Overall Study|Adverse Event|0|||
13486368|NCT03786380|27035990|FG003|Overall Study|Adverse Event|3|||
13486369|NCT03786380|27035991|FG004|Overall Study|Adverse Event|1|||
13486370|NCT03786380|27035987|FG000|Overall Study|Lack of Efficacy|0|||
13486371|NCT03786380|27035988|FG001|Overall Study|Lack of Efficacy|0|||
13119206|NCT03022799|25932903|FG012|Overall Study|Adverse Event|0|||
13119207|NCT03022630|25932958|FG000|Overall Study|Death|9|||
13119208|NCT03022630|25932959|FG001|Overall Study|Death|7|||
13119209|NCT03022630|25932958|FG000|Overall Study|Withdrawal by Subject|0|||
13276313|NCT00635427|26441925|FG003|Overall Study|Death|1|||
13486372|NCT03786380|27035989|FG002|Overall Study|Lack of Efficacy|0|||
13486373|NCT03786380|27035990|FG003|Overall Study|Lack of Efficacy|0|||
13486374|NCT03786380|27035991|FG004|Overall Study|Lack of Efficacy|1|||
13276314|NCT00635427|26441926|FG004|Overall Study|Death|0|||
13276315|NCT00635427|26441922|FG000|Overall Study|Termination Of Study By Sponsor|12|||
13276316|NCT00635427|26441923|FG001|Overall Study|Termination Of Study By Sponsor|6|||
13276317|NCT00635427|26441924|FG002|Overall Study|Termination Of Study By Sponsor|10|||
13276318|NCT00635427|26441925|FG003|Overall Study|Termination Of Study By Sponsor|6|||
13276319|NCT00635427|26441926|FG004|Overall Study|Termination Of Study By Sponsor|6|||
13276320|NCT00635427|26441922|FG000|Overall Study|Withdrawal Of Consent|0|||
13276321|NCT00635427|26441923|FG001|Overall Study|Withdrawal Of Consent|0|||
13276322|NCT00635427|26441924|FG002|Overall Study|Withdrawal Of Consent|0|||
13276323|NCT00635427|26441925|FG003|Overall Study|Withdrawal Of Consent|2|||
13276324|NCT00635427|26441926|FG004|Overall Study|Withdrawal Of Consent|2|||
13276325|NCT00635349|26441951|FG000|Overall Study|Other|8|||
13276326|NCT00635349|26441952|FG001|Overall Study|Other|6|||
13276327|NCT00635349|26441951|FG000|Overall Study|Protocol Violation|18|||
13276328|NCT00635349|26441952|FG001|Overall Study|Protocol Violation|22|||
13276329|NCT00635349|26441951|FG000|Overall Study|Withdrawal by Subject|3|||
13276330|NCT00635349|26441952|FG001|Overall Study|Withdrawal by Subject|8|||
13276331|NCT00635349|26441951|FG000|Overall Study|Lost to Follow-up|4|||
13276332|NCT00635349|26441952|FG001|Overall Study|Lost to Follow-up|3|||
13276333|NCT00635349|26441951|FG000|Overall Study|Adverse Event|11|||
13276334|NCT00635349|26441952|FG001|Overall Study|Adverse Event|9|||
13276335|NCT00635102|26442053|FG000|Overall Study|Withdrawal by Subject|7|||
13119210|NCT03022630|25932959|FG001|Overall Study|Withdrawal by Subject|5|||
13119211|NCT03022578|25932973|FG000|Overall Study|Adverse Event|1|||
13119212|NCT03022578|25932973|FG000|Overall Study|Lack of Efficacy|2|||
13119213|NCT03022578|25932973|FG000|Overall Study|Withdrawal by Subject|1|||
13276336|NCT00635102|26442054|FG001|Overall Study|Withdrawal by Subject|8|||
13276337|NCT00635089|26442083|FG000|Overall Study|Adverse Event|7|||
13276338|NCT00635089|26442083|FG000|Overall Study|Lack of Efficacy|28|||
13276339|NCT00635089|26442083|FG000|Overall Study|Protocol Deviation|4|||
13276340|NCT00635089|26442083|FG000|Overall Study|Lost to Follow-up|8|||
13276341|NCT00635089|26442083|FG000|Overall Study|Other|31|||
13276342|NCT00635050|26442092|FG000|Overall Study|Withdrawal by Subject|1|||
13276343|NCT00635024|26442102|FG000|Overall Study|Adverse Event|1|||
13276344|NCT00634920|26442154|FG000|Period 1 - Pre-Randomization|Adverse Event|0|||
13276345|NCT00634920|26442155|FG001|Period 1 - Pre-Randomization|Adverse Event|0|||
13276346|NCT00634920|26442156|FG002|Period 1 - Pre-Randomization|Adverse Event|36|||
13276347|NCT00634920|26442154|FG000|Period 1 - Pre-Randomization|Wound healing problems|0|||
13276348|NCT00634920|26442155|FG001|Period 1 - Pre-Randomization|Wound healing problems|0|||
13276349|NCT00634920|26442156|FG002|Period 1 - Pre-Randomization|Wound healing problems|16|||
13276350|NCT00634920|26442154|FG000|Period 1 - Pre-Randomization|Rejections|0|||
13276351|NCT00634920|26442155|FG001|Period 1 - Pre-Randomization|Rejections|0|||
13276352|NCT00634920|26442156|FG002|Period 1 - Pre-Randomization|Rejections|55|||
13276353|NCT00634920|26442154|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
13276354|NCT00634920|26442155|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
13276355|NCT00634920|26442156|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21|||
13276356|NCT00634920|26442154|FG000|Period 1 - Pre-Randomization|Non-Compliance|0|||
13276357|NCT00634920|26442155|FG001|Period 1 - Pre-Randomization|Non-Compliance|0|||
13276358|NCT00634920|26442156|FG002|Period 1 - Pre-Randomization|Non-Compliance|3|||
13276359|NCT00634920|26442154|FG000|Period 1 - Pre-Randomization|Other issues|0|||
13276360|NCT00634920|26442155|FG001|Period 1 - Pre-Randomization|Other issues|0|||
13276361|NCT00634920|26442156|FG002|Period 1 - Pre-Randomization|Other issues|6|||
13276362|NCT00634920|26442154|FG000|Period 2 - Post-Randomization|Adverse Event|37|||
13276363|NCT00634920|26442155|FG001|Period 2 - Post-Randomization|Adverse Event|9|||
13276364|NCT00634920|26442156|FG002|Period 2 - Post-Randomization|Adverse Event|0|||
13276365|NCT00634920|26442154|FG000|Period 2 - Post-Randomization|Rejection|11|||
13276366|NCT00634920|26442155|FG001|Period 2 - Post-Randomization|Rejection|5|||
13276367|NCT00634920|26442156|FG002|Period 2 - Post-Randomization|Rejection|0|||
13276368|NCT00634920|26442154|FG000|Period 2 - Post-Randomization|Death|2|||
13276369|NCT00634920|26442155|FG001|Period 2 - Post-Randomization|Death|5|||
13276370|NCT00634920|26442156|FG002|Period 2 - Post-Randomization|Death|0|||
13276371|NCT00634920|26442154|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9|||
13276372|NCT00634920|26442155|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13|||
13276373|NCT00634920|26442156|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0|||
13276374|NCT00634920|26442154|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2|||
13276375|NCT00634920|26442155|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
13119214|NCT03022461|25932987|FG000|Overall Study|Death|3|||
13119215|NCT03022422|25933026|FG000|Overall Study|3 subjects consented but not vaccinated|0|||
13276376|NCT00634920|26442156|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
13276377|NCT00634907|26442185|FG000|Overall Study|Withdrawal by Subject|3|||
13276378|NCT00634907|26442186|FG001|Overall Study|Withdrawal by Subject|0|||
13276379|NCT00634907|26442185|FG000|Overall Study|Physician Decision|3|||
13276380|NCT00634907|26442186|FG001|Overall Study|Physician Decision|9|||
13276381|NCT00634907|26442185|FG000|Overall Study|Withdrawal by Subject|11|||
13276382|NCT00634907|26442186|FG001|Overall Study|Withdrawal by Subject|8|||
13276383|NCT00634842|26442205|FG000|Overall Study|Adverse Event|2|||
13276384|NCT00634842|26442206|FG001|Overall Study|Adverse Event|3|||
13276385|NCT00634842|26442205|FG000|Overall Study|Protocol Violation|8|||
13276386|NCT00634842|26442206|FG001|Overall Study|Protocol Violation|4|||
13276387|NCT00634842|26442205|FG000|Overall Study|Move to another state|1|||
13276388|NCT00634842|26442206|FG001|Overall Study|Move to another state|0|||
13276389|NCT00634842|26442205|FG000|Overall Study|Inclusion criteria were not met|1|||
13276390|NCT00634842|26442206|FG001|Overall Study|Inclusion criteria were not met|0|||
13276391|NCT00634842|26442205|FG000|Overall Study|Lost to Follow-up|1|||
13276392|NCT00634842|26442206|FG001|Overall Study|Lost to Follow-up|2|||
13276393|NCT00634842|26442205|FG000|Overall Study|Physician Decision|1|||
13276394|NCT00634842|26442206|FG001|Overall Study|Physician Decision|0|||
13276395|NCT00634842|26442205|FG000|Overall Study|Withdrawal by Subject|1|||
13276396|NCT00634842|26442206|FG001|Overall Study|Withdrawal by Subject|3|||
13276397|NCT00634842|26442205|FG000|Overall Study|Lack of time and intolerance to drug|0|||
13276398|NCT00634842|26442206|FG001|Overall Study|Lack of time and intolerance to drug|1|||
13276399|NCT00634842|26442205|FG000|Overall Study|Discontinued due to injection|0|||
13276400|NCT00634842|26442206|FG001|Overall Study|Discontinued due to injection|2|||
13276401|NCT00634842|26442205|FG000|Overall Study|No need of study drug to treat diabetes|0|||
13276402|NCT00634842|26442206|FG001|Overall Study|No need of study drug to treat diabetes|1|||
13276403|NCT00634842|26442205|FG000|Overall Study|No wish to keep taking Avandia|0|||
13276404|NCT00634842|26442206|FG001|Overall Study|No wish to keep taking Avandia|1|||
13276405|NCT00634842|26442205|FG000|Overall Study|Subject off study drug for too long|0|||
13276406|NCT00634842|26442206|FG001|Overall Study|Subject off study drug for too long|1|||
13276407|NCT00634803|26442230|FG000|Overall Study|Lost to Follow-up|6|||
13276408|NCT00634803|26442231|FG001|Overall Study|Lost to Follow-up|7|||
13276409|NCT00634803|26442232|FG002|Overall Study|Lost to Follow-up|7|||
13276410|NCT00634751|26442263|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1|||
13276411|NCT00634751|26442264|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0|||
13276412|NCT00634751|26442265|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0|||
13276413|NCT00634751|26442266|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0|||
13276414|NCT00634751|26442263|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
13276415|NCT00634751|26442264|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1|||
13276416|NCT00634751|26442265|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
13276417|NCT00634751|26442266|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
13276418|NCT00634751|26442263|FG000|Pancreatic and Bilial Tract Cancer|Death|0|||
13276419|NCT00634751|26442264|FG001|Pancreatic and Bilial Tract Cancer|Death|0|||
13276420|NCT00634751|26442265|FG002|Pancreatic and Bilial Tract Cancer|Death|1|||
13276421|NCT00634751|26442266|FG003|Pancreatic and Bilial Tract Cancer|Death|1|||
13276422|NCT00634569|26442285|FG000|Overall Study|Withdrawal by Subject|0|||
13276423|NCT00634569|26442286|FG001|Overall Study|Withdrawal by Subject|4|||
13276424|NCT00634569|26442285|FG000|Overall Study|Physician Decision|0|||
13276425|NCT00634569|26442286|FG001|Overall Study|Physician Decision|1|||
13276426|NCT00634543|26442309|FG000|Overall Study|Other|1|||
13276427|NCT00634543|26442310|FG001|Overall Study|Other|2|||
13276428|NCT00634543|26442309|FG000|Overall Study|Protocol Violation|3|||
13276429|NCT00634543|26442310|FG001|Overall Study|Protocol Violation|3|||
13276430|NCT00634543|26442309|FG000|Overall Study|Adverse Event|11|||
13276431|NCT00634543|26442310|FG001|Overall Study|Adverse Event|11|||
13276432|NCT00634543|26442309|FG000|Overall Study|Withdrawal by Subject|4|||
13276433|NCT00634543|26442310|FG001|Overall Study|Withdrawal by Subject|4|||
13276434|NCT00634543|26442309|FG000|Overall Study|Lost to Follow-up|0|||
13276435|NCT00634543|26442310|FG001|Overall Study|Lost to Follow-up|1|||
13276436|NCT00634504|26442323|FG000|Overall Study|Protocol Violation|1|||
13276437|NCT00634504|26442324|FG001|Overall Study|Protocol Violation|0|||
13276438|NCT00634244|26442345|FG000|Overall Study|Never started treatment|0|||
13119216|NCT03022422|25933027|FG001|Overall Study|3 subjects consented but not vaccinated|0|||
13119217|NCT03022422|25933028|FG002|Overall Study|3 subjects consented but not vaccinated|3|||
13119218|NCT03022422|25933029|FG003|Overall Study|3 subjects consented but not vaccinated|0|||
13119219|NCT03022422|25933030|FG004|Overall Study|3 subjects consented but not vaccinated|0|||
13119220|NCT03022422|25933031|FG005|Overall Study|3 subjects consented but not vaccinated|0|||
13119221|NCT03022370|25933116|FG000|Overall Study|Death|6|||
13119222|NCT03022370|25933117|FG001|Overall Study|Death|12|||
13119223|NCT03022370|25933116|FG000|Overall Study|Lost to Follow-up|174|||
13276439|NCT00634244|26442346|FG001|Overall Study|Never started treatment|1|||
13276440|NCT00634244|26442347|FG002|Overall Study|Never started treatment|0|||
13276441|NCT00634244|26442345|FG000|Overall Study|Death|1|||
13276442|NCT00634244|26442346|FG001|Overall Study|Death|6|||
13276443|NCT00634244|26442347|FG002|Overall Study|Death|0|||
13276444|NCT00634244|26442345|FG000|Overall Study|Adverse Event|0|||
13276445|NCT00634244|26442346|FG001|Overall Study|Adverse Event|2|||
13276446|NCT00634244|26442347|FG002|Overall Study|Adverse Event|0|||
13276447|NCT00634244|26442345|FG000|Overall Study|Withdrawal by Subject|0|||
13119224|NCT03022370|25933117|FG001|Overall Study|Lost to Follow-up|109|||
13119225|NCT03022084|25933130|FG000|Overall Study|Lost to Follow-up|2|||
13276448|NCT00634244|26442346|FG001|Overall Study|Withdrawal by Subject|1|||
13276449|NCT00634244|26442347|FG002|Overall Study|Withdrawal by Subject|0|||
13276450|NCT00634244|26442345|FG000|Overall Study|Physician Decision|0|||
13276451|NCT00634244|26442346|FG001|Overall Study|Physician Decision|1|||
13276452|NCT00634244|26442347|FG002|Overall Study|Physician Decision|0|||
13276453|NCT00634244|26442345|FG000|Overall Study|Disease progression/relapse|0|||
13276454|NCT00634244|26442346|FG001|Overall Study|Disease progression/relapse|1|||
13276455|NCT00634244|26442347|FG002|Overall Study|Disease progression/relapse|0|||
13276456|NCT00634244|26442345|FG000|Overall Study|Other complicating disease|0|||
13276457|NCT00634244|26442346|FG001|Overall Study|Other complicating disease|1|||
13276458|NCT00634244|26442347|FG002|Overall Study|Other complicating disease|0|||
13276459|NCT00634179|26442356|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1|||
13276460|NCT00634114|26442380|FG000|Overall Study|Adverse Event|6|||
13276461|NCT00634114|26442381|FG001|Overall Study|Adverse Event|8|||
13276462|NCT00634114|26442382|FG002|Overall Study|Adverse Event|3|||
13276463|NCT00634114|26442380|FG000|Overall Study|Withdrawal by Subject|9|||
13276464|NCT00634114|26442381|FG001|Overall Study|Withdrawal by Subject|6|||
13276465|NCT00634114|26442382|FG002|Overall Study|Withdrawal by Subject|11|||
13276466|NCT00634114|26442380|FG000|Overall Study|Lost to Follow-up|0|||
13276467|NCT00634114|26442381|FG001|Overall Study|Lost to Follow-up|0|||
13276468|NCT00634114|26442382|FG002|Overall Study|Lost to Follow-up|1|||
13276469|NCT00634114|26442380|FG000|Overall Study|Protocol Violation|3|||
13276470|NCT00634114|26442381|FG001|Overall Study|Protocol Violation|3|||
13276471|NCT00634114|26442382|FG002|Overall Study|Protocol Violation|1|||
13276472|NCT00634114|26442380|FG000|Overall Study|Pregnancy|1|||
13276473|NCT00634114|26442381|FG001|Overall Study|Pregnancy|0|||
13276474|NCT00634114|26442382|FG002|Overall Study|Pregnancy|0|||
13276475|NCT00634114|26442380|FG000|Overall Study|Incorrect enrolment|0|||
13276476|NCT00634114|26442381|FG001|Overall Study|Incorrect enrolment|1|||
13276477|NCT00634114|26442382|FG002|Overall Study|Incorrect enrolment|0|||
13276478|NCT00634114|26442380|FG000|Overall Study|Recurrence of reflux esophagitis|5|||
13276479|NCT00634114|26442381|FG001|Overall Study|Recurrence of reflux esophagitis|15|||
13276480|NCT00634114|26442382|FG002|Overall Study|Recurrence of reflux esophagitis|21|||
13276481|NCT00634114|26442380|FG000|Overall Study|Difficult to continue|3|||
13276482|NCT00634114|26442381|FG001|Overall Study|Difficult to continue|1|||
13276483|NCT00634114|26442382|FG002|Overall Study|Difficult to continue|1|||
13276484|NCT00634114|26442380|FG000|Overall Study|Other reason|1|||
13276485|NCT00634114|26442381|FG001|Overall Study|Other reason|1|||
13276486|NCT00634114|26442382|FG002|Overall Study|Other reason|1|||
13276487|NCT00634101|26442419|FG000|Overall Study|Study Terminated|3|||
13276488|NCT00634101|26442420|FG001|Overall Study|Study Terminated|3|||
13276489|NCT00634101|26442419|FG000|Overall Study|Lost to Follow-up|2|||
13276490|NCT00634101|26442420|FG001|Overall Study|Lost to Follow-up|0|||
13276491|NCT00634088|26442484|FG000|Time Period 1: Dose Level 1|Disease progression|2|||
13276492|NCT00634088|26442485|FG001|Time Period 1: Dose Level 1|Disease progression|0|||
13276493|NCT00634088|26442486|FG002|Time Period 1: Dose Level 1|Disease progression|0|||
13276494|NCT00634088|26442487|FG003|Time Period 1: Dose Level 1|Disease progression|0|||
13276495|NCT00634088|26442484|FG000|Time Period 1: Dose Level 1|Physician Decision|1|||
13276496|NCT00634088|26442485|FG001|Time Period 1: Dose Level 1|Physician Decision|0|||
13276497|NCT00634088|26442486|FG002|Time Period 1: Dose Level 1|Physician Decision|0|||
13276498|NCT00634088|26442487|FG003|Time Period 1: Dose Level 1|Physician Decision|0|||
13276499|NCT00634088|26442484|FG000|Time Period 1: Dose Level 1|Adverse Event|3|||
13276500|NCT00634088|26442485|FG001|Time Period 1: Dose Level 1|Adverse Event|0|||
13276501|NCT00634088|26442486|FG002|Time Period 1: Dose Level 1|Adverse Event|0|||
13276502|NCT00634088|26442487|FG003|Time Period 1: Dose Level 1|Adverse Event|0|||
13276503|NCT00634088|26442484|FG000|Time Period 2: Dose Level 2|Adverse Event|0|||
13276504|NCT00634088|26442485|FG001|Time Period 2: Dose Level 2|Adverse Event|2|||
13276505|NCT00634088|26442486|FG002|Time Period 2: Dose Level 2|Adverse Event|0|||
13276506|NCT00634088|26442487|FG003|Time Period 2: Dose Level 2|Adverse Event|0|||
13276507|NCT00634088|26442484|FG000|Time Period 2: Dose Level 2|Progressive disease|0|||
13276508|NCT00634088|26442485|FG001|Time Period 2: Dose Level 2|Progressive disease|1|||
13276509|NCT00634088|26442486|FG002|Time Period 2: Dose Level 2|Progressive disease|0|||
13276510|NCT00634088|26442487|FG003|Time Period 2: Dose Level 2|Progressive disease|0|||
13276511|NCT00634088|26442484|FG000|Time Period 3: Dose Level 3|Progressive disease|0|||
13276512|NCT00634088|26442485|FG001|Time Period 3: Dose Level 3|Progressive disease|0|||
13276513|NCT00634088|26442486|FG002|Time Period 3: Dose Level 3|Progressive disease|1|||
13276514|NCT00634088|26442487|FG003|Time Period 3: Dose Level 3|Progressive disease|0|||
13276515|NCT00634049|26442566|FG000|Overall Study|Never received study drug|1|||
13276516|NCT00634049|26442566|FG000|Overall Study|Died prior to receiving study drug|1|||
13276517|NCT00634049|26442566|FG000|Overall Study|Screening failure|1|||
13276518|NCT00634036|26442585|FG000|Overall Study|Lost to Follow-up|1|||
13276519|NCT00634036|26442586|FG001|Overall Study|Lost to Follow-up|1|||
13276520|NCT00634036|26442585|FG000|Overall Study|Withdrawal by Subject|1|||
13276521|NCT00634036|26442586|FG001|Overall Study|Withdrawal by Subject|1|||
13276522|NCT00634010|26442599|FG000|Overall Study|Adverse Event|2|||
13276523|NCT00634010|26442600|FG001|Overall Study|Adverse Event|5|||
13276524|NCT00634010|26442599|FG000|Overall Study|Withdrawal by Subject|5|||
13276525|NCT00634010|26442600|FG001|Overall Study|Withdrawal by Subject|6|||
13276526|NCT00634010|26442599|FG000|Overall Study|Physician Decision|1|||
13276527|NCT00634010|26442600|FG001|Overall Study|Physician Decision|1|||
13276528|NCT00634010|26442599|FG000|Overall Study|Disease Progression|1|||
13276529|NCT00634010|26442600|FG001|Overall Study|Disease Progression|1|||
13276530|NCT00634010|26442599|FG000|Overall Study|Non-Compliant|1|||
13276531|NCT00634010|26442600|FG001|Overall Study|Non-Compliant|1|||
13276532|NCT00633984|26442615|FG000|Overall Study|Lost to Follow-up|0|||
13276533|NCT00633984|26442616|FG001|Overall Study|Lost to Follow-up|6|||
13276534|NCT00633984|26442615|FG000|Overall Study|Withdrawal by Subject|8|||
13276535|NCT00633984|26442616|FG001|Overall Study|Withdrawal by Subject|7|||
13276536|NCT00633984|26442615|FG000|Overall Study|Hospitalized|1|||
13276537|NCT00633984|26442616|FG001|Overall Study|Hospitalized|0|||
13276538|NCT00633945|26442631|FG000|Overall Study|Physician Decision|2|||
13276539|NCT00633932|26442652|FG000|Overall Study|Adverse Event|1|||
13276540|NCT00633932|26442653|FG001|Overall Study|Adverse Event|3|||
13276541|NCT00633932|26442654|FG002|Overall Study|Adverse Event|4|||
13276542|NCT00633932|26442652|FG000|Overall Study|Withdrawal by Subject|3|||
13276543|NCT00633932|26442653|FG001|Overall Study|Withdrawal by Subject|9|||
13276544|NCT00633932|26442654|FG002|Overall Study|Withdrawal by Subject|1|||
13276545|NCT00633932|26442652|FG000|Overall Study|Lost to Follow-up|1|||
13119226|NCT03022084|25933131|FG001|Overall Study|Lost to Follow-up|3|||
13276546|NCT00633932|26442653|FG001|Overall Study|Lost to Follow-up|0|||
13119227|NCT03022045|25933152|FG000|Overall Study|Adverse Event|0|||
13276547|NCT00633932|26442654|FG002|Overall Study|Lost to Follow-up|2|||
13276548|NCT00633932|26442652|FG000|Overall Study|Protocol Violation|5|||
13276549|NCT00633932|26442653|FG001|Overall Study|Protocol Violation|2|||
13276550|NCT00633932|26442654|FG002|Overall Study|Protocol Violation|3|||
13276551|NCT00633932|26442652|FG000|Overall Study|Physician Decision|0|||
13276552|NCT00633932|26442653|FG001|Overall Study|Physician Decision|0|||
13276553|NCT00633932|26442654|FG002|Overall Study|Physician Decision|1|||
13276554|NCT00633932|26442652|FG000|Overall Study|Doctor's judgement|1|||
13276555|NCT00633932|26442653|FG001|Overall Study|Doctor's judgement|0|||
13276556|NCT00633932|26442654|FG002|Overall Study|Doctor's judgement|0|||
13276557|NCT00633932|26442652|FG000|Overall Study|Moved Away|1|||
13276558|NCT00633932|26442653|FG001|Overall Study|Moved Away|0|||
13276559|NCT00633932|26442654|FG002|Overall Study|Moved Away|0|||
13276560|NCT00633750|26442662|FG000|Overall Study|Adverse Event|2|||
13276561|NCT00633750|26442662|FG000|Overall Study|Withdrawal by Subject|3|||
13276562|NCT00633477|26442683|FG000|Overall Study|Death|1|||
13276563|NCT00633477|26442684|FG001|Overall Study|Death|0|||
13276564|NCT00633477|26442683|FG000|Overall Study|Randomized but not treated|1|||
13276565|NCT00633477|26442684|FG001|Overall Study|Randomized but not treated|0|||
13276566|NCT00633464|26442711|FG000|Overall Study|Never Treated (Not met study criteria)|0|||
13276567|NCT00633464|26442712|FG001|Overall Study|Never Treated (Not met study criteria)|1|||
13276568|NCT00633464|26442711|FG000|Overall Study|Never Treated (Randomized in error)|0|||
13276569|NCT00633464|26442712|FG001|Overall Study|Never Treated (Randomized in error)|1|||
13276570|NCT00633360|26442727|FG000|Overall Study|Lost to Follow-up|1|||
13276571|NCT00633360|26442728|FG001|Overall Study|Lost to Follow-up|1|||
13276572|NCT00633360|26442727|FG000|Overall Study|Adverse Event|3|||
13276573|NCT00633360|26442728|FG001|Overall Study|Adverse Event|1|||
13276574|NCT00633360|26442727|FG000|Overall Study|Protocol Violation|0|||
13276575|NCT00633360|26442728|FG001|Overall Study|Protocol Violation|1|||
13276576|NCT00633243|26442741|FG000|Overall Study|Withdrawal by Subject|0|||
13276577|NCT00633243|26442742|FG001|Overall Study|Withdrawal by Subject|1|||
13276578|NCT00633243|26442741|FG000|Overall Study|incarceration|0|||
13276579|NCT00633243|26442742|FG001|Overall Study|incarceration|2|||
13276580|NCT00633243|26442741|FG000|Overall Study|Homeless--no refrigeration for meds|0|||
13276581|NCT00633243|26442742|FG001|Overall Study|Homeless--no refrigeration for meds|1|||
13276582|NCT00633243|26442741|FG000|Overall Study|Not comfortable with self-injecting|0|||
13276583|NCT00633243|26442742|FG001|Overall Study|Not comfortable with self-injecting|1|||
13276584|NCT00633243|26442741|FG000|Overall Study|Mental Health--Depression|0|||
13276585|NCT00633243|26442742|FG001|Overall Study|Mental Health--Depression|1|||
13276586|NCT00633243|26442741|FG000|Overall Study|Couldn't tolerate side-effects|1|||
13276587|NCT00633243|26442742|FG001|Overall Study|Couldn't tolerate side-effects|1|||
13276588|NCT00633217|26442759|FG000|Overall Study|Adverse Event|5|||
13276589|NCT00633217|26442760|FG001|Overall Study|Adverse Event|9|||
13276590|NCT00633217|26442759|FG000|Overall Study|Lack of Efficacy|0|||
13276591|NCT00633217|26442760|FG001|Overall Study|Lack of Efficacy|2|||
13276592|NCT00633217|26442759|FG000|Overall Study|Protocol Violation|3|||
13276593|NCT00633217|26442760|FG001|Overall Study|Protocol Violation|7|||
13276594|NCT00633217|26442759|FG000|Overall Study|Lost to Follow-up|2|||
13276595|NCT00633217|26442760|FG001|Overall Study|Lost to Follow-up|2|||
13276596|NCT00633217|26442759|FG000|Overall Study|Investigator Discretion|2|||
13276597|NCT00633217|26442760|FG001|Overall Study|Investigator Discretion|0|||
13276598|NCT00633217|26442759|FG000|Overall Study|Withdrew Consent|3|||
13276599|NCT00633217|26442760|FG001|Overall Study|Withdrew Consent|3|||
13276600|NCT00633152|26442775|FG000|Overall Study|Adverse Event|1|||
13276601|NCT00633152|26442776|FG001|Overall Study|Adverse Event|0|||
13276602|NCT00633152|26442775|FG000|Overall Study|Randomized, did not receive study drug|5|||
13276603|NCT00633152|26442776|FG001|Overall Study|Randomized, did not receive study drug|2|||
13276604|NCT00633152|26442775|FG000|Overall Study|Withdrawal by Subject|1|||
13276605|NCT00633152|26442776|FG001|Overall Study|Withdrawal by Subject|1|||
13276606|NCT00633152|26442775|FG000|Overall Study|Lost to Follow-up|4|||
13276607|NCT00633152|26442776|FG001|Overall Study|Lost to Follow-up|1|||
13276608|NCT00633152|26442775|FG000|Overall Study|Miscellaneous Other|3|||
13276609|NCT00633152|26442776|FG001|Overall Study|Miscellaneous Other|2|||
13276610|NCT00633126|26442783|FG000|Overall Study|Did not receive full dose|1|||
13276611|NCT00633074|26442818|FG000|Overall Study|Adverse Event|1|||
13276612|NCT00633074|26442819|FG001|Overall Study|Adverse Event|0|||
13276613|NCT00633061|26442834|FG000|Overall Study|Study closed|86|||
13276614|NCT00633061|26442835|FG001|Overall Study|Study closed|0|||
13276615|NCT00633022|26442880|FG000|Overall Study|Adverse Event|1|||
13276616|NCT00633022|26442881|FG001|Overall Study|Adverse Event|0|||
13276617|NCT00633022|26442882|FG002|Overall Study|Adverse Event|5|||
13276618|NCT00633022|26442880|FG000|Overall Study|Physician Decision|0|||
13276619|NCT00633022|26442881|FG001|Overall Study|Physician Decision|1|||
13276620|NCT00633022|26442882|FG002|Overall Study|Physician Decision|0|||
13276621|NCT00632931|26442905|FG000|Part 1, Period 1|Protocol Violation|1|||
13276622|NCT00632931|26442906|FG001|Part 1, Period 1|Protocol Violation|0|||
13276623|NCT00632931|26442907|FG002|Part 1, Period 1|Protocol Violation|0|||
13276624|NCT00632931|26442905|FG000|Part 1, Period 1|Withdrawal by Subject|1|||
13276625|NCT00632931|26442906|FG001|Part 1, Period 1|Withdrawal by Subject|0|||
13276626|NCT00632931|26442907|FG002|Part 1, Period 1|Withdrawal by Subject|0|||
13276627|NCT00632931|26442905|FG000|Part 2|Adverse Event|0|||
13276628|NCT00632931|26442906|FG001|Part 2|Adverse Event|0|||
13276629|NCT00632931|26442907|FG002|Part 2|Adverse Event|3|||
13276630|NCT00632931|26442905|FG000|Part 2|Death|0|||
13276631|NCT00632931|26442906|FG001|Part 2|Death|0|||
13276632|NCT00632931|26442907|FG002|Part 2|Death|1|||
13276633|NCT00632931|26442905|FG000|Part 2|Lack of Efficacy|0|||
13276634|NCT00632931|26442906|FG001|Part 2|Lack of Efficacy|0|||
13276635|NCT00632931|26442907|FG002|Part 2|Lack of Efficacy|17|||
13276636|NCT00632931|26442905|FG000|Part 2|Withdrawal by Subject|0|||
13276637|NCT00632931|26442906|FG001|Part 2|Withdrawal by Subject|0|||
13276638|NCT00632931|26442907|FG002|Part 2|Withdrawal by Subject|3|||
13276639|NCT00632827|26442916|FG000|Overall Study|Excluded after GVD (Not evaluable)|2|||
13276640|NCT00632827|26442916|FG000|Overall Study|Death|2|||
13276641|NCT00632827|26442916|FG000|Overall Study|Adverse Event|5|||
13276642|NCT00632827|26442916|FG000|Overall Study|Lost to Follow-up|1|||
13276643|NCT00632749|26443253|FG000|Overall Study|Progressive disease|3|||
13276644|NCT00632749|26443254|FG001|Overall Study|Progressive disease|2|||
13276645|NCT00632749|26443255|FG002|Overall Study|Progressive disease|2|||
13276646|NCT00632749|26443256|FG003|Overall Study|Progressive disease|2|||
13276647|NCT00632749|26443257|FG004|Overall Study|Progressive disease|4|||
13276648|NCT00632749|26443258|FG005|Overall Study|Progressive disease|4|||
13276649|NCT00632749|26443259|FG006|Overall Study|Progressive disease|3|||
13276650|NCT00632749|26443260|FG007|Overall Study|Progressive disease|2|||
13276651|NCT00632749|26443261|FG008|Overall Study|Progressive disease|3|||
13276652|NCT00632749|26443262|FG009|Overall Study|Progressive disease|2|||
13276653|NCT00632749|26443263|FG010|Overall Study|Progressive disease|4|||
13276654|NCT00632749|26443264|FG011|Overall Study|Progressive disease|3|||
13276655|NCT00632749|26443265|FG012|Overall Study|Progressive disease|2|||
13276656|NCT00632749|26443266|FG013|Overall Study|Progressive disease|4|||
13276657|NCT00632749|26443253|FG000|Overall Study|Other Adverse event|1|||
13119228|NCT03022045|25933153|FG001|Overall Study|Adverse Event|1|||
13119229|NCT03022045|25933152|FG000|Overall Study|Withdrawal by Subject|1|||
13119230|NCT03022045|25933153|FG001|Overall Study|Withdrawal by Subject|1|||
13119231|NCT03021668|25933172|FG000|Overall Study|Physician Decision|0|||
13119232|NCT03021668|25933173|FG001|Overall Study|Physician Decision|1|||
13119233|NCT03021642|25933214|FG000|Washout Period (21 Days)|Adverse Event|1|||
13119234|NCT03021642|25933215|FG001|Washout Period (21 Days)|Adverse Event|1|||
13203766|NCT01981616|26225764|FG000|Overall Study|Protocol Violation|1|||
13203767|NCT01981616|26225765|FG001|Overall Study|Protocol Violation|0|||
13203768|NCT01981473|26225814|FG000|Overall Study|Incorrect diagnosis of RA|0|||
13203769|NCT01981473|26225815|FG001|Overall Study|Incorrect diagnosis of RA|0|||
13203770|NCT01981473|26225816|FG002|Overall Study|Incorrect diagnosis of RA|1|||
13203771|NCT01981473|26225814|FG000|Overall Study|Received treatment for < 6 months|0|||
13203772|NCT01981473|26225815|FG001|Overall Study|Received treatment for < 6 months|0|||
13203773|NCT01981473|26225816|FG002|Overall Study|Received treatment for < 6 months|1|||
13203774|NCT01981473|26225814|FG000|Overall Study|Received treatment for >24 months|2|||
13203775|NCT01981473|26225815|FG001|Overall Study|Received treatment for >24 months|0|||
13203776|NCT01981473|26225816|FG002|Overall Study|Received treatment for >24 months|6|||
13276658|NCT00632749|26443254|FG001|Overall Study|Other Adverse event|1|||
13276659|NCT00632749|26443255|FG002|Overall Study|Other Adverse event|1|||
13276660|NCT00632749|26443256|FG003|Overall Study|Other Adverse event|1|||
13276661|NCT00632749|26443257|FG004|Overall Study|Other Adverse event|2|||
13119235|NCT03021564|25933246|FG000|Overall Study|Death|84|||
13119236|NCT03021564|25933247|FG001|Overall Study|Death|466|||
13119237|NCT03021564|25933246|FG000|Overall Study|Lost to Follow-up|0|||
13119238|NCT03021564|25933247|FG001|Overall Study|Lost to Follow-up|2|||
13119239|NCT03021551|25933253|FG000|Overall Study|Equipment Issues|2|||
13119240|NCT03021551|25933253|FG000|Overall Study|Protocol Violation|1|||
13119241|NCT03021499|25933292|FG000|Overall Study|Adverse Event|1|||
13119242|NCT03021499|25933293|FG001|Overall Study|Adverse Event|0|||
13119243|NCT03021499|25933292|FG000|Overall Study|Death|1|||
13119244|NCT03021499|25933293|FG001|Overall Study|Death|5|||
13119245|NCT03021499|25933292|FG000|Overall Study|Lack of Efficacy|0|||
13119246|NCT03021499|25933293|FG001|Overall Study|Lack of Efficacy|1|||
13119247|NCT03021499|25933292|FG000|Overall Study|Lost to Follow-up|1|||
13119248|NCT03021499|25933293|FG001|Overall Study|Lost to Follow-up|3|||
13119249|NCT03021499|25933292|FG000|Overall Study|Physician Decision|2|||
13119250|NCT03021499|25933293|FG001|Overall Study|Physician Decision|3|||
13119251|NCT03021499|25933292|FG000|Overall Study|Pregnancy|1|||
13119252|NCT03021499|25933293|FG001|Overall Study|Pregnancy|0|||
13119253|NCT03021499|25933292|FG000|Overall Study|Withdrawal by Subject|7|||
13119254|NCT03021499|25933293|FG001|Overall Study|Withdrawal by Subject|14|||
13276662|NCT00632749|26443258|FG005|Overall Study|Other Adverse event|4|||
13276663|NCT00632749|26443259|FG006|Overall Study|Other Adverse event|1|||
13276664|NCT00632749|26443260|FG007|Overall Study|Other Adverse event|2|||
13276665|NCT00632749|26443261|FG008|Overall Study|Other Adverse event|2|||
13276666|NCT00632749|26443262|FG009|Overall Study|Other Adverse event|0|||
13276667|NCT00632749|26443263|FG010|Overall Study|Other Adverse event|1|||
13276668|NCT00632749|26443264|FG011|Overall Study|Other Adverse event|0|||
13276669|NCT00632749|26443265|FG012|Overall Study|Other Adverse event|1|||
13276670|NCT00632749|26443266|FG013|Overall Study|Other Adverse event|0|||
13276671|NCT00632749|26443253|FG000|Overall Study|Refuse to continue medication|0|||
13276672|NCT00632749|26443254|FG001|Overall Study|Refuse to continue medication|0|||
13276673|NCT00632749|26443255|FG002|Overall Study|Refuse to continue medication|0|||
13276674|NCT00632749|26443256|FG003|Overall Study|Refuse to continue medication|1|||
13276675|NCT00632749|26443257|FG004|Overall Study|Refuse to continue medication|0|||
13276676|NCT00632749|26443258|FG005|Overall Study|Refuse to continue medication|0|||
13276677|NCT00632749|26443259|FG006|Overall Study|Refuse to continue medication|0|||
13276678|NCT00632749|26443260|FG007|Overall Study|Refuse to continue medication|0|||
13276679|NCT00632749|26443261|FG008|Overall Study|Refuse to continue medication|0|||
13486375|NCT03786380|27035987|FG000|Overall Study|Withdrawal by Subject|1|||
13119255|NCT03021499|25933292|FG000|Overall Study|Prohibited medication required|1|||
13119256|NCT03021499|25933293|FG001|Overall Study|Prohibited medication required|0|||
13119257|NCT03021499|25933292|FG000|Overall Study|Protocol non-compliance|1|||
13119258|NCT03021499|25933293|FG001|Overall Study|Protocol non-compliance|1|||
13203777|NCT01981356|26225848|FG000|Overall Study|Lost to Follow-up|4|||
13203778|NCT01981356|26225849|FG001|Overall Study|Lost to Follow-up|1|||
13203779|NCT01981356|26225848|FG000|Overall Study|Withdrawal by Subject|1|||
13203780|NCT01981356|26225849|FG001|Overall Study|Withdrawal by Subject|1|||
13203781|NCT01981356|26225848|FG000|Overall Study|Protocol Violation|2|||
13203782|NCT01981356|26225849|FG001|Overall Study|Protocol Violation|0|||
13203783|NCT01981187|26225868|FG000|Overall Study|Participant/guardian decision|2|||
13203784|NCT01981187|26225868|FG000|Overall Study|Physician Decision|1|||
13203785|NCT01981187|26225868|FG000|Overall Study|Disease progression|2|||
13203786|NCT01981187|26225868|FG000|Overall Study|Adverse Event|7|||
13203787|NCT01981122|26225881|FG000|Overall Study|Withdrawal by Subject|0|||
13203788|NCT01981122|26225882|FG001|Overall Study|Withdrawal by Subject|2|||
13203789|NCT01981122|26225881|FG000|Overall Study|Protocol Violation|0|||
13203790|NCT01981122|26225882|FG001|Overall Study|Protocol Violation|1|||
13203791|NCT01981122|26225881|FG000|Overall Study|Lost to Follow-up|0|||
13203792|NCT01981122|26225882|FG001|Overall Study|Lost to Follow-up|1|||
13203793|NCT01981122|26225881|FG000|Overall Study|Investigator Or Dendreon Discretion|0|||
13203794|NCT01981122|26225882|FG001|Overall Study|Investigator Or Dendreon Discretion|1|||
13203795|NCT01981122|26225881|FG000|Overall Study|Death|14|||
13203796|NCT01981122|26225882|FG001|Overall Study|Death|15|||
13203797|NCT01981109|26225889|FG000|Overall Study|Death|36|||
13203798|NCT01981109|26225889|FG000|Overall Study|Withdrawal by Subject|40|||
13203799|NCT01981109|26225889|FG000|Overall Study|Lost to Follow-up|9|||
13203800|NCT01981109|26225889|FG000|Overall Study|No Discontinuation Documentation|37|||
13203801|NCT01981109|26225889|FG000|Overall Study|Study Termination|100|||
13203802|NCT01981109|26225889|FG000|Overall Study|No data available|2|||
13203803|NCT01981096|26225906|FG000|Overall Study|Parent illness|1|||
13203804|NCT01981096|26225907|FG001|Overall Study|Parent illness|0|||
13203805|NCT01981096|26225906|FG000|Overall Study|Withdrawal by Subject|0|||
13203806|NCT01981096|26225907|FG001|Overall Study|Withdrawal by Subject|1|||
13203807|NCT01981096|26225906|FG000|Overall Study|Lost to Follow-up|2|||
13203808|NCT01981096|26225907|FG001|Overall Study|Lost to Follow-up|0|||
13203809|NCT01980992|26225931|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0|||
13203810|NCT01980992|26225932|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3|||
13203811|NCT01980992|26225931|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
13276680|NCT00632749|26443262|FG009|Overall Study|Refuse to continue medication|1|||
13276681|NCT00632749|26443263|FG010|Overall Study|Refuse to continue medication|0|||
13276682|NCT00632749|26443264|FG011|Overall Study|Refuse to continue medication|0|||
13276683|NCT00632749|26443265|FG012|Overall Study|Refuse to continue medication|0|||
13276684|NCT00632749|26443266|FG013|Overall Study|Refuse to continue medication|0|||
13276685|NCT00632749|26443253|FG000|Overall Study|Reason other than those specified above|0|||
13276686|NCT00632749|26443254|FG001|Overall Study|Reason other than those specified above|2|||
13276687|NCT00632749|26443255|FG002|Overall Study|Reason other than those specified above|0|||
13276688|NCT00632749|26443256|FG003|Overall Study|Reason other than those specified above|0|||
13276689|NCT00632749|26443257|FG004|Overall Study|Reason other than those specified above|1|||
13276690|NCT00632749|26443258|FG005|Overall Study|Reason other than those specified above|0|||
13276691|NCT00632749|26443259|FG006|Overall Study|Reason other than those specified above|1|||
13276692|NCT00632749|26443260|FG007|Overall Study|Reason other than those specified above|0|||
13276693|NCT00632749|26443261|FG008|Overall Study|Reason other than those specified above|0|||
13276694|NCT00632749|26443262|FG009|Overall Study|Reason other than those specified above|0|||
13276695|NCT00632749|26443263|FG010|Overall Study|Reason other than those specified above|2|||
13276696|NCT00632749|26443264|FG011|Overall Study|Reason other than those specified above|1|||
13276697|NCT00632749|26443265|FG012|Overall Study|Reason other than those specified above|0|||
13276698|NCT00632749|26443266|FG013|Overall Study|Reason other than those specified above|2|||
13276699|NCT00632736|26443273|FG000|Overall Study|Adverse Event|104|||
13276700|NCT00632736|26443273|FG000|Overall Study|Lost to Follow-up|15|||
13276701|NCT00632736|26443273|FG000|Overall Study|Protocol Violation|14|||
13276702|NCT00632736|26443273|FG000|Overall Study|Withdrawal by Subject|99|||
13276703|NCT00632736|26443273|FG000|Overall Study|Lack of Efficacy|5|||
13276704|NCT00632736|26443273|FG000|Overall Study|Sponsor terminated study|5|||
13276705|NCT00632736|26443273|FG000|Overall Study|Non-compliance|10|||
13276706|NCT00632736|26443273|FG000|Overall Study|Other|16|||
13276707|NCT00632541|26443282|FG000|Overall Study|Adverse Event|7|||
13276708|NCT00632502|26443314|FG000|Overall Study|Adverse Event|0|||
13276709|NCT00632502|26443315|FG001|Overall Study|Adverse Event|1|||
13276710|NCT00632502|26443314|FG000|Overall Study|Randomized not treated|3|||
13276711|NCT00632502|26443315|FG001|Overall Study|Randomized not treated|0|||
13276712|NCT00632463|26443339|FG000|Overall Study|Adverse Event|0|||
13276713|NCT00632463|26443340|FG001|Overall Study|Adverse Event|1|||
13276714|NCT00632463|26443341|FG002|Overall Study|Adverse Event|0|||
13276715|NCT00632424|26443371|FG000|Overall Study|Disease Progression|17|||
13276716|NCT00632424|26443371|FG000|Overall Study|Study Drug Toxicity|1|||
13276717|NCT00632359|26443379|FG000|Overall Study|Withdrawal by Subject|2|||
13276718|NCT00632229|26443394|FG000|Overall Study|Adverse Event|6|||
13276719|NCT00632229|26443395|FG001|Overall Study|Adverse Event|0|||
13276720|NCT00632229|26443394|FG000|Overall Study|Lost to Follow-up|0|||
13276721|NCT00632229|26443395|FG001|Overall Study|Lost to Follow-up|3|||
13276722|NCT00632229|26443394|FG000|Overall Study|Lack of Efficacy|0|||
13276723|NCT00632229|26443395|FG001|Overall Study|Lack of Efficacy|2|||
13276724|NCT00632229|26443394|FG000|Overall Study|Undisclosed reasons within the first wee|0|||
13276725|NCT00632229|26443395|FG001|Overall Study|Undisclosed reasons within the first wee|1|||
13276726|NCT00632203|26443420|FG000|Overall Study|Did not start study treatment|1|||
13276727|NCT00632203|26443421|FG001|Overall Study|Did not start study treatment|0|||
13276728|NCT00632099|26443434|FG000|Overall Study|Lost to Follow-up|3|||
13276729|NCT00632099|26443435|FG001|Overall Study|Lost to Follow-up|3|||
13276730|NCT00632021|26443450|FG000|Overall Study|Withdrawal/death|4|||
13276731|NCT00632021|26443451|FG001|Overall Study|Withdrawal/death|7|||
13276732|NCT00631969|26443502|FG000|Overall Study|Adverse Event|3|||
13276733|NCT00631969|26443503|FG001|Overall Study|Adverse Event|1|||
13276734|NCT00631969|26443502|FG000|Overall Study|Lack of Efficacy|2|||
13276735|NCT00631969|26443503|FG001|Overall Study|Lack of Efficacy|8|||
13276736|NCT00631969|26443502|FG000|Overall Study|Lost to Follow-up|2|||
13276737|NCT00631969|26443503|FG001|Overall Study|Lost to Follow-up|1|||
13276738|NCT00631969|26443502|FG000|Overall Study|Protocol Violation|1|||
13276739|NCT00631969|26443503|FG001|Overall Study|Protocol Violation|1|||
13276740|NCT00631969|26443502|FG000|Overall Study|Consent Withdrawn|5|||
13276741|NCT00631969|26443503|FG001|Overall Study|Consent Withdrawn|7|||
13276742|NCT00631969|26443502|FG000|Overall Study|Noncompliant With Study Medication|0|||
13276743|NCT00631969|26443503|FG001|Overall Study|Noncompliant With Study Medication|1|||
13276744|NCT00631969|26443502|FG000|Overall Study|No Drug Exposure|2|||
13276745|NCT00631969|26443503|FG001|Overall Study|No Drug Exposure|2|||
13276746|NCT00631657|26443538|FG000|6-Month Treatment Period|Adverse Event|47|||
13276747|NCT00631657|26443539|FG001|6-Month Treatment Period|Adverse Event|0|||
13276748|NCT00631657|26443540|FG002|6-Month Treatment Period|Adverse Event|7|||
13276749|NCT00631657|26443538|FG000|6-Month Treatment Period|Withdrawal by Subject|14|||
13276750|NCT00631657|26443539|FG001|6-Month Treatment Period|Withdrawal by Subject|0|||
13276751|NCT00631657|26443540|FG002|6-Month Treatment Period|Withdrawal by Subject|5|||
13276752|NCT00631657|26443538|FG000|6-Month Treatment Period|Lack of Efficacy|34|||
13276753|NCT00631657|26443539|FG001|6-Month Treatment Period|Lack of Efficacy|0|||
13276754|NCT00631657|26443540|FG002|6-Month Treatment Period|Lack of Efficacy|25|||
13276755|NCT00631657|26443538|FG000|6-Month Treatment Period|Lost to Follow-up|7|||
13276756|NCT00631657|26443539|FG001|6-Month Treatment Period|Lost to Follow-up|0|||
13276757|NCT00631657|26443540|FG002|6-Month Treatment Period|Lost to Follow-up|2|||
13276758|NCT00631657|26443538|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21|||
13276759|NCT00631657|26443539|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0|||
13276760|NCT00631657|26443540|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6|||
13276761|NCT00631657|26443538|FG000|6-Month Treatment Period|Other|16|||
13276762|NCT00631657|26443539|FG001|6-Month Treatment Period|Other|0|||
13276763|NCT00631657|26443540|FG002|6-Month Treatment Period|Other|4|||
13276764|NCT00631657|26443538|FG000|6-Month Treatment Period|Not Treated|2|||
13276765|NCT00631657|26443539|FG001|6-Month Treatment Period|Not Treated|0|||
13276766|NCT00631657|26443540|FG002|6-Month Treatment Period|Not Treated|1|||
13276767|NCT00631657|26443538|FG000|7-Day Discontinuation Period|Not Treated|1|||
13119259|NCT03021499|25933292|FG000|Overall Study|None of the above|0|||
13119260|NCT03021499|25933293|FG001|Overall Study|None of the above|4|||
13119261|NCT03021499|25933292|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1|||
13119262|NCT03021499|25933293|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0|||
13119263|NCT03021486|25933341|FG000|Overall Study|Withdrawal by Subject|1|||
13119264|NCT03021486|25933342|FG001|Overall Study|Withdrawal by Subject|1|||
13119265|NCT03021486|25933343|FG002|Overall Study|Withdrawal by Subject|3|||
13119266|NCT03021486|25933341|FG000|Overall Study|Did not develop an RASS score of at least >= 1|7|||
13119267|NCT03021486|25933342|FG001|Overall Study|Did not develop an RASS score of at least >= 1|5|||
13119268|NCT03021486|25933343|FG002|Overall Study|Did not develop an RASS score of at least >= 1|6|||
13119269|NCT03021304|25933350|FG000|Overall Study|Lack of Efficacy|1|||
13119270|NCT03021265|25933358|FG000|Overall Study|Adverse Event|29|||
13119271|NCT03021265|25933358|FG000|Overall Study|Lack of Efficacy|3|||
13119272|NCT03021265|25933358|FG000|Overall Study|Improved|17|||
13119273|NCT03021265|25933358|FG000|Overall Study|Lost to Follow-up|67|||
13119274|NCT03021265|25933358|FG000|Overall Study|No reason given|2|||
13119275|NCT03021265|25933358|FG000|Overall Study|No visit since the first visit|4|||
13119276|NCT03021187|25933524|FG000|Overall Study|Death|0|||
13119277|NCT03021187|25933525|FG001|Overall Study|Death|0|||
13119278|NCT03021187|25933526|FG002|Overall Study|Death|3|||
13119279|NCT03021187|25933527|FG003|Overall Study|Death|0|||
13119280|NCT03021187|25933524|FG000|Overall Study|Withdrawal by Subject|0|||
13276768|NCT00631657|26443539|FG001|7-Day Discontinuation Period|Not Treated|1|||
13276769|NCT00631657|26443540|FG002|7-Day Discontinuation Period|Not Treated|1|||
13276770|NCT00631657|26443538|FG000|7-Day Discontinuation Period|Other|1|||
13276771|NCT00631657|26443539|FG001|7-Day Discontinuation Period|Other|0|||
13119281|NCT03021187|25933525|FG001|Overall Study|Withdrawal by Subject|6|||
13119282|NCT03021187|25933526|FG002|Overall Study|Withdrawal by Subject|2|||
13119283|NCT03021187|25933527|FG003|Overall Study|Withdrawal by Subject|5|||
13119284|NCT03021187|25933524|FG000|Overall Study|Lost to Follow-up|10|||
13119285|NCT03021187|25933525|FG001|Overall Study|Lost to Follow-up|3|||
13119286|NCT03021187|25933526|FG002|Overall Study|Lost to Follow-up|1|||
13119287|NCT03021187|25933527|FG003|Overall Study|Lost to Follow-up|4|||
13119288|NCT03021018|25933566|FG000|Overall Study|Adverse Event|1|||
13119289|NCT03021018|25933567|FG001|Overall Study|Adverse Event|0|||
13119290|NCT03021018|25933568|FG002|Overall Study|Adverse Event|0|||
13119291|NCT03021018|25933566|FG000|Overall Study|Fall with subsequent nasal fracture|1|||
13119292|NCT03021018|25933567|FG001|Overall Study|Fall with subsequent nasal fracture|0|||
13119293|NCT03021018|25933568|FG002|Overall Study|Fall with subsequent nasal fracture|0|||
13203812|NCT01980992|26225932|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
13203813|NCT01980992|26225931|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1|||
13203814|NCT01980992|26225932|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0|||
13203815|NCT01980992|26225931|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2|||
13203816|NCT01980992|26225932|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0|||
13203817|NCT01980992|26225931|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1|||
13203818|NCT01980992|26225932|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0|||
13203819|NCT01980992|26225931|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0|||
13203820|NCT01980992|26225932|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1|||
13203821|NCT01980940|26226009|FG000|Overall Study|Protocol Violation|0|||
13203822|NCT01980940|26226010|FG001|Overall Study|Protocol Violation|0|||
13203823|NCT01980940|26226011|FG002|Overall Study|Protocol Violation|0|||
13276772|NCT00631657|26443540|FG002|7-Day Discontinuation Period|Other|0|||
13276773|NCT00631488|26443570|FG000|Overall Study|Adverse Event|1|||
13276774|NCT00631488|26443571|FG001|Overall Study|Adverse Event|0|||
13276775|NCT00631488|26443572|FG002|Overall Study|Adverse Event|0|||
13276776|NCT00631488|26443570|FG000|Overall Study|Lost to Follow-up|2|||
13276777|NCT00631488|26443571|FG001|Overall Study|Lost to Follow-up|2|||
13276778|NCT00631488|26443572|FG002|Overall Study|Lost to Follow-up|0|||
13276779|NCT00631488|26443570|FG000|Overall Study|Physician Decision|1|||
13276780|NCT00631488|26443571|FG001|Overall Study|Physician Decision|0|||
13119294|NCT03021005|25933581|FG000|Overall Study|Lost to Follow-up|39|||
13119295|NCT03021005|25933582|FG001|Overall Study|Lost to Follow-up|26|||
13119296|NCT03020992|25933619|FG000|Overall Study|Adverse Event|5|||
13119297|NCT03020992|25933619|FG000|Overall Study|Withdrawal by Subject|1|||
13119298|NCT03020966|25933636|FG000|Overall Study|Withdrawal by Subject|2|||
13276781|NCT00631488|26443572|FG002|Overall Study|Physician Decision|1|||
13276782|NCT00631488|26443570|FG000|Overall Study|Protocol Violation|0|||
13276783|NCT00631488|26443571|FG001|Overall Study|Protocol Violation|0|||
13276784|NCT00631488|26443572|FG002|Overall Study|Protocol Violation|1|||
13276785|NCT00631475|26443582|FG000|Overall Study|Death|18|||
13276786|NCT00631475|26443582|FG000|Overall Study|Adverse Event|14|||
13276787|NCT00631475|26443582|FG000|Overall Study|Withdrew consent|5|||
13276788|NCT00631475|26443582|FG000|Overall Study|Preparation for lung transplant|8|||
13276789|NCT00631189|26443637|FG000|Initial Phase|Protocol Violation|347|||
13276790|NCT00631189|26443638|FG001|Initial Phase|Protocol Violation|0|||
13276791|NCT00631189|26443639|FG002|Initial Phase|Protocol Violation|0|||
13276792|NCT00631189|26443640|FG003|Initial Phase|Protocol Violation|0|||
13276793|NCT00631189|26443637|FG000|Initial Phase|Withdrawal by Subject|4|||
13276794|NCT00631189|26443638|FG001|Initial Phase|Withdrawal by Subject|0|||
13119299|NCT03020966|25933637|FG001|Overall Study|Withdrawal by Subject|0|||
13119300|NCT03020914|25933658|FG000|Overall Study|Surgery Cancelled|1|||
13119301|NCT03020914|25933659|FG001|Overall Study|Surgery Cancelled|0|||
13276795|NCT00631189|26443639|FG002|Initial Phase|Withdrawal by Subject|0|||
13276796|NCT00631189|26443640|FG003|Initial Phase|Withdrawal by Subject|0|||
13276797|NCT00631189|26443637|FG000|Treatment Phase|Withdrawal by Subject|0|||
13276798|NCT00631189|26443638|FG001|Treatment Phase|Withdrawal by Subject|2|||
13276799|NCT00631189|26443639|FG002|Treatment Phase|Withdrawal by Subject|1|||
13276800|NCT00631189|26443640|FG003|Treatment Phase|Withdrawal by Subject|1|||
13276801|NCT00631189|26443637|FG000|Treatment Phase|Protocol Violation|0|||
13276802|NCT00631189|26443638|FG001|Treatment Phase|Protocol Violation|1|||
13276803|NCT00631189|26443639|FG002|Treatment Phase|Protocol Violation|6|||
13276804|NCT00631189|26443640|FG003|Treatment Phase|Protocol Violation|2|||
13276805|NCT00631189|26443637|FG000|Treatment Phase|Adverse Event|0|||
13276806|NCT00631189|26443638|FG001|Treatment Phase|Adverse Event|3|||
13276807|NCT00631189|26443639|FG002|Treatment Phase|Adverse Event|2|||
13276808|NCT00631189|26443640|FG003|Treatment Phase|Adverse Event|4|||
13276809|NCT00631189|26443637|FG000|Treatment Phase|Lost to Follow-up|0|||
13276810|NCT00631189|26443638|FG001|Treatment Phase|Lost to Follow-up|1|||
13276811|NCT00631189|26443639|FG002|Treatment Phase|Lost to Follow-up|0|||
13276812|NCT00631189|26443640|FG003|Treatment Phase|Lost to Follow-up|0|||
13276813|NCT00631189|26443637|FG000|Treatment Phase|Pregnancy|0|||
13276814|NCT00631189|26443638|FG001|Treatment Phase|Pregnancy|0|||
13276815|NCT00631189|26443639|FG002|Treatment Phase|Pregnancy|1|||
13276816|NCT00631189|26443640|FG003|Treatment Phase|Pregnancy|0|||
13276817|NCT00631189|26443637|FG000|Treatment Phase|patient did not take pravastatin|0|||
13276818|NCT00631189|26443638|FG001|Treatment Phase|patient did not take pravastatin|0|||
13276819|NCT00631189|26443639|FG002|Treatment Phase|patient did not take pravastatin|1|||
13276820|NCT00631189|26443640|FG003|Treatment Phase|patient did not take pravastatin|0|||
13276821|NCT00631163|26443660|FG000|Number of Participants in Year 1|Adverse Event|12|||
13276822|NCT00631163|26443660|FG000|Number of Participants in Year 1|Withdrawal by Subject|8|||
13276823|NCT00631163|26443660|FG000|Number of Participants in Year 1|Death|6|||
13276824|NCT00631163|26443660|FG000|Number of Participants in Year 1|Lost to Follow-up|1|||
13276825|NCT00631163|26443660|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1|||
13276826|NCT00631163|26443660|FG000|Number of Participants in Year 1|Administrative problems|6|||
13276827|NCT00631163|26443660|FG000|Number of Participants in Year 2|Withdrawal by Subject|2|||
13276828|NCT00631163|26443660|FG000|Number of Participants in Year 2|Adverse Event|1|||
13276829|NCT00631163|26443660|FG000|Number of Participants in Year 2|Protocol Violation|1|||
13276830|NCT00631163|26443660|FG000|Number of Participants in Year 2|Abnormal laboratory value|1|||
13276831|NCT00631137|26443685|FG000|Overall Study|Withdrawal by Subject|1|||
13276832|NCT00631137|26443686|FG001|Overall Study|Withdrawal by Subject|0|||
13276833|NCT00631020|26443697|FG000|Overall Study|Lost to Follow-up|7|||
13276834|NCT00631020|26443697|FG000|Overall Study|Incarcerated|1|||
13276835|NCT00631007|26443736|FG000|Overall Study|Adverse Event|0|||
13276836|NCT00631007|26443737|FG001|Overall Study|Adverse Event|2|||
13276837|NCT00631007|26443738|FG002|Overall Study|Adverse Event|0|||
13276838|NCT00631007|26443739|FG003|Overall Study|Adverse Event|2|||
13276839|NCT00631007|26443740|FG004|Overall Study|Adverse Event|3|||
13276840|NCT00631007|26443741|FG005|Overall Study|Adverse Event|2|||
13276841|NCT00631007|26443736|FG000|Overall Study|Lost to Follow-up|2|||
13276842|NCT00631007|26443737|FG001|Overall Study|Lost to Follow-up|1|||
13276843|NCT00631007|26443738|FG002|Overall Study|Lost to Follow-up|2|||
13276844|NCT00631007|26443739|FG003|Overall Study|Lost to Follow-up|4|||
13119302|NCT03020888|25933672|FG000|Overall Study|Physician Decision|4|||
13276845|NCT00631007|26443740|FG004|Overall Study|Lost to Follow-up|5|||
13276846|NCT00631007|26443741|FG005|Overall Study|Lost to Follow-up|3|||
13276847|NCT00631007|26443736|FG000|Overall Study|Physician Decision|1|||
13276848|NCT00631007|26443737|FG001|Overall Study|Physician Decision|0|||
13276849|NCT00631007|26443738|FG002|Overall Study|Physician Decision|1|||
13276850|NCT00631007|26443739|FG003|Overall Study|Physician Decision|0|||
13276851|NCT00631007|26443740|FG004|Overall Study|Physician Decision|0|||
13276852|NCT00631007|26443741|FG005|Overall Study|Physician Decision|2|||
13276853|NCT00631007|26443736|FG000|Overall Study|Persistent Hyperglycemia|2|||
13276854|NCT00631007|26443737|FG001|Overall Study|Persistent Hyperglycemia|2|||
13276855|NCT00631007|26443738|FG002|Overall Study|Persistent Hyperglycemia|5|||
13276856|NCT00631007|26443739|FG003|Overall Study|Persistent Hyperglycemia|1|||
13276857|NCT00631007|26443740|FG004|Overall Study|Persistent Hyperglycemia|2|||
13276858|NCT00631007|26443741|FG005|Overall Study|Persistent Hyperglycemia|5|||
13276859|NCT00631007|26443736|FG000|Overall Study|Withdrawal by Subject|4|||
13276860|NCT00631007|26443737|FG001|Overall Study|Withdrawal by Subject|5|||
13276861|NCT00631007|26443738|FG002|Overall Study|Withdrawal by Subject|2|||
13276862|NCT00631007|26443739|FG003|Overall Study|Withdrawal by Subject|2|||
13276863|NCT00631007|26443740|FG004|Overall Study|Withdrawal by Subject|1|||
13276864|NCT00631007|26443741|FG005|Overall Study|Withdrawal by Subject|3|||
13276865|NCT00631007|26443736|FG000|Overall Study|Other|2|||
13276866|NCT00631007|26443737|FG001|Overall Study|Other|1|||
13276867|NCT00631007|26443738|FG002|Overall Study|Other|0|||
13276868|NCT00631007|26443739|FG003|Overall Study|Other|0|||
13276869|NCT00631007|26443740|FG004|Overall Study|Other|1|||
13276870|NCT00631007|26443741|FG005|Overall Study|Other|0|||
13276871|NCT00630994|26443751|FG000|Overall Study|Adverse Event|1|||
13276872|NCT00630994|26443751|FG000|Overall Study|Disease Progression|1|||
13276873|NCT00630994|26443751|FG000|Overall Study|Lack of Efficacy|1|||
13276874|NCT00630994|26443751|FG000|Overall Study|Other|1|||
13276875|NCT00630877|26443779|FG000|Overall Study|Adverse Event|11|||
13276876|NCT00630877|26443780|FG001|Overall Study|Adverse Event|8|||
13276877|NCT00630877|26443781|FG002|Overall Study|Adverse Event|7|||
13276878|NCT00630877|26443779|FG000|Overall Study|Withdrawal by Subject|3|||
13276879|NCT00630877|26443780|FG001|Overall Study|Withdrawal by Subject|4|||
13276880|NCT00630877|26443781|FG002|Overall Study|Withdrawal by Subject|0|||
13276881|NCT00630877|26443779|FG000|Overall Study|Lost to Follow-up|2|||
13276882|NCT00630877|26443780|FG001|Overall Study|Lost to Follow-up|0|||
13276883|NCT00630877|26443781|FG002|Overall Study|Lost to Follow-up|0|||
13276884|NCT00630877|26443779|FG000|Overall Study|Noncompliance|2|||
13276885|NCT00630877|26443780|FG001|Overall Study|Noncompliance|3|||
13276886|NCT00630877|26443781|FG002|Overall Study|Noncompliance|1|||
13276887|NCT00630877|26443779|FG000|Overall Study|Protocol violation|1|||
13276888|NCT00630877|26443780|FG001|Overall Study|Protocol violation|0|||
13276889|NCT00630877|26443781|FG002|Overall Study|Protocol violation|1|||
13276890|NCT00630877|26443779|FG000|Overall Study|Personal reasons|0|||
13276891|NCT00630877|26443780|FG001|Overall Study|Personal reasons|0|||
13276892|NCT00630877|26443781|FG002|Overall Study|Personal reasons|1|||
13276893|NCT00630864|26443820|FG000|Part 1 (up to Week 6)|Adverse Event|1|||
13276894|NCT00630864|26443820|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2|||
13276895|NCT00630838|26443835|FG000|Overall Study|Death|0|||
13276896|NCT00630838|26443836|FG001|Overall Study|Death|1|||
13276897|NCT00630838|26443835|FG000|Overall Study|Lost to Follow-up|0|||
13276898|NCT00630838|26443836|FG001|Overall Study|Lost to Follow-up|1|||
13276899|NCT00630825|26443918|FG000|Overall Study|Adverse Event|4|||
13276900|NCT00630825|26443919|FG001|Overall Study|Adverse Event|4|||
13276901|NCT00630825|26443920|FG002|Overall Study|Adverse Event|3|||
13276902|NCT00630825|26443921|FG003|Overall Study|Adverse Event|1|||
13276903|NCT00630825|26443918|FG000|Overall Study|Entry Criteria Not Met|1|||
13276904|NCT00630825|26443919|FG001|Overall Study|Entry Criteria Not Met|0|||
13276905|NCT00630825|26443920|FG002|Overall Study|Entry Criteria Not Met|2|||
13276906|NCT00630825|26443921|FG003|Overall Study|Entry Criteria Not Met|1|||
13276907|NCT00630825|26443918|FG000|Overall Study|Lost to Follow-up|1|||
13276908|NCT00630825|26443919|FG001|Overall Study|Lost to Follow-up|1|||
13276909|NCT00630825|26443920|FG002|Overall Study|Lost to Follow-up|1|||
13276910|NCT00630825|26443921|FG003|Overall Study|Lost to Follow-up|1|||
13276911|NCT00630825|26443918|FG000|Overall Study|Physician Decision|1|||
13276912|NCT00630825|26443919|FG001|Overall Study|Physician Decision|0|||
13276913|NCT00630825|26443920|FG002|Overall Study|Physician Decision|0|||
13276914|NCT00630825|26443921|FG003|Overall Study|Physician Decision|0|||
13276915|NCT00630825|26443918|FG000|Overall Study|Withdrawal by Subject|2|||
13276916|NCT00630825|26443919|FG001|Overall Study|Withdrawal by Subject|2|||
13276917|NCT00630825|26443920|FG002|Overall Study|Withdrawal by Subject|2|||
13276918|NCT00630825|26443921|FG003|Overall Study|Withdrawal by Subject|3|||
13276919|NCT00630786|26443950|FG000|Overall Study|Physician Decision|0|||
13276920|NCT00630786|26443951|FG001|Overall Study|Physician Decision|0|||
13276921|NCT00630786|26443952|FG002|Overall Study|Physician Decision|1|||
13276922|NCT00630786|26443950|FG000|Overall Study|Withdrawal by Subject|0|||
13276923|NCT00630786|26443951|FG001|Overall Study|Withdrawal by Subject|1|||
13276924|NCT00630786|26443952|FG002|Overall Study|Withdrawal by Subject|1|||
13276925|NCT00630786|26443950|FG000|Overall Study|Lost to Follow-up|0|||
13276926|NCT00630786|26443951|FG001|Overall Study|Lost to Follow-up|1|||
13276927|NCT00630786|26443952|FG002|Overall Study|Lost to Follow-up|0|||
13276928|NCT00630786|26443950|FG000|Overall Study|Other|1|||
13276929|NCT00630786|26443951|FG001|Overall Study|Other|0|||
13276930|NCT00630786|26443952|FG002|Overall Study|Other|0|||
13276931|NCT00630539|26444019|FG000|Overall Study|Adverse Event|1|||
13276932|NCT00630539|26444020|FG001|Overall Study|Adverse Event|3|||
13276933|NCT00630539|26444021|FG002|Overall Study|Adverse Event|1|||
13276934|NCT00630539|26444022|FG003|Overall Study|Adverse Event|2|||
13276935|NCT00630539|26444019|FG000|Overall Study|Withdrawal by Subject|0|||
13276936|NCT00630539|26444020|FG001|Overall Study|Withdrawal by Subject|1|||
13276937|NCT00630539|26444021|FG002|Overall Study|Withdrawal by Subject|0|||
13276938|NCT00630539|26444022|FG003|Overall Study|Withdrawal by Subject|1|||
13276939|NCT00630396|26444030|FG000|Overall Study|Death|4|||
13276940|NCT00630396|26444030|FG000|Overall Study|Lost to Follow-up|3|||
13276941|NCT00630344|26444041|FG000|Overall Study|Adverse Event|5|||
13276942|NCT00630344|26444041|FG000|Overall Study|Progressive Disease|19|||
13276943|NCT00630344|26444041|FG000|Overall Study|Physician Decision|9|||
13276944|NCT00630344|26444041|FG000|Overall Study|Withdrawal by Subject|1|||
13276945|NCT00630344|26444041|FG000|Overall Study|Intercurrent Illness|1|||
13276946|NCT00630344|26444041|FG000|Overall Study|Other|1|||
13291266|NCT00154375|26482899|FG000|Overall Study|Death|5|||
13291267|NCT00154375|26482900|FG001|Overall Study|Death|13|||
13291268|NCT00154375|26482899|FG000|Overall Study|Study drug no longer required|5|||
13291269|NCT00154375|26482900|FG001|Overall Study|Study drug no longer required|3|||
13291270|NCT00154375|26482899|FG000|Overall Study|Lost to Follow-up|2|||
13291271|NCT00154375|26482900|FG001|Overall Study|Lost to Follow-up|1|||
13291272|NCT00154375|26482899|FG000|Overall Study|Abnormal laboratory value(s)|0|||
13291273|NCT00154375|26482900|FG001|Overall Study|Abnormal laboratory value(s)|2|||
13291274|NCT00154375|26482899|FG000|Overall Study|Protocol Violation|0|||
13291275|NCT00154375|26482900|FG001|Overall Study|Protocol Violation|1|||
13291276|NCT00154375|26482899|FG000|Overall Study|Suspected progression of disease|44|||
13291277|NCT00154375|26482900|FG001|Overall Study|Suspected progression of disease|30|||
13291278|NCT00154297|26482923|FG000|Overall Study|Death|5|||
13291279|NCT00154297|26482924|FG001|Overall Study|Death|2|||
13291280|NCT00154297|26482923|FG000|Overall Study|Withdrawal by Subject|0|||
13291281|NCT00154297|26482924|FG001|Overall Study|Withdrawal by Subject|5|||
13291282|NCT00154297|26482923|FG000|Overall Study|Lost to Follow-up|3|||
13291283|NCT00154297|26482924|FG001|Overall Study|Lost to Follow-up|0|||
13291284|NCT00154284|26482943|FG000|Overall Study|Adverse Event|6|||
13291285|NCT00154284|26482944|FG001|Overall Study|Adverse Event|9|||
13291286|NCT00154284|26482943|FG000|Overall Study|Abnormal laboratory value(s)|0|||
13291287|NCT00154284|26482944|FG001|Overall Study|Abnormal laboratory value(s)|1|||
13291288|NCT00154284|26482943|FG000|Overall Study|Lack of Efficacy|1|||
13291289|NCT00154284|26482944|FG001|Overall Study|Lack of Efficacy|2|||
13291290|NCT00154284|26482943|FG000|Overall Study|Protocol Violation|0|||
13291291|NCT00154284|26482944|FG001|Overall Study|Protocol Violation|1|||
13291292|NCT00154102|26482985|FG000|Overall Study|investigational study phase ongoing|7|||
13291293|NCT00154102|26482986|FG001|Overall Study|investigational study phase ongoing|2|||
13291294|NCT00154063|26483049|FG000|Overall Study|Adverse Event|4|||
13291295|NCT00154063|26483050|FG001|Overall Study|Adverse Event|8|||
13291296|NCT00154063|26483049|FG000|Overall Study|Protocol Violation|1|||
13291297|NCT00154063|26483050|FG001|Overall Study|Protocol Violation|1|||
13291298|NCT00154063|26483049|FG000|Overall Study|Investigator or Sponsor Request|0|||
13291299|NCT00154063|26483050|FG001|Overall Study|Investigator or Sponsor Request|1|||
13291300|NCT00154063|26483049|FG000|Overall Study|Withdrawal by Subject|4|||
13291301|NCT00154063|26483050|FG001|Overall Study|Withdrawal by Subject|9|||
13291302|NCT00154063|26483049|FG000|Overall Study|Other|3|||
13291303|NCT00154063|26483050|FG001|Overall Study|Other|3|||
13291304|NCT00153920|26483061|FG000|Overall Study|Adverse Event|9|||
13291305|NCT00153920|26483061|FG000|Overall Study|Progressive Disease|9|||
13291306|NCT00153920|26483061|FG000|Overall Study|Physician Decision|3|||
13291307|NCT00153920|26483061|FG000|Overall Study|Lack of Response|3|||
13291308|NCT00153920|26483061|FG000|Overall Study|Death|2|||
13291309|NCT00153920|26483061|FG000|Overall Study|Withdrawal by Subject|1|||
13291310|NCT00153920|26483061|FG000|Overall Study|Non-Protocol Therapy|1|||
13291311|NCT00153920|26483061|FG000|Overall Study|Withdrawal of Consent before Trt|1|||
13291312|NCT00153920|26483061|FG000|Overall Study|Progressive Disease before Trt|1|||
13291313|NCT00153179|26483080|FG000|Study Visit Day 2|Withdrawal by Subject|1|||
13291314|NCT00153179|26483081|FG001|Study Visit Day 2|Withdrawal by Subject|0|||
13291315|NCT00153179|26483082|FG002|Study Visit Day 2|Withdrawal by Subject|2|||
13291316|NCT00153179|26483083|FG003|Study Visit Day 2|Withdrawal by Subject|2|||
13291317|NCT00152971|26483125|FG000|Overall Study|Adverse Event|12|||
13291318|NCT00152971|26483126|FG001|Overall Study|Adverse Event|10|||
13291319|NCT00152971|26483127|FG002|Overall Study|Adverse Event|9|||
13291320|NCT00152971|26483125|FG000|Overall Study|Protocol Violation|10|||
13291321|NCT00152971|26483126|FG001|Overall Study|Protocol Violation|11|||
13291322|NCT00152971|26483127|FG002|Overall Study|Protocol Violation|8|||
13291323|NCT00152971|26483125|FG000|Overall Study|Lost to Follow-up|17|||
13291324|NCT00152971|26483126|FG001|Overall Study|Lost to Follow-up|14|||
13291325|NCT00152971|26483127|FG002|Overall Study|Lost to Follow-up|13|||
13291326|NCT00152971|26483125|FG000|Overall Study|Withdrawal by Subject|9|||
13291327|NCT00152971|26483126|FG001|Overall Study|Withdrawal by Subject|8|||
13276947|NCT00630331|26444092|FG000|Overall Study|Death|2|||
13276948|NCT00630331|26444093|FG001|Overall Study|Death|1|||
13276949|NCT00630331|26444094|FG002|Overall Study|Death|1|||
13276950|NCT00630331|26444092|FG000|Overall Study|Adverse Event|1|||
13276951|NCT00630331|26444093|FG001|Overall Study|Adverse Event|0|||
13276952|NCT00630331|26444094|FG002|Overall Study|Adverse Event|0|||
13276953|NCT00630331|26444092|FG000|Overall Study|Withdrawal by Subject|12|||
13276954|NCT00630331|26444093|FG001|Overall Study|Withdrawal by Subject|7|||
13276955|NCT00630331|26444094|FG002|Overall Study|Withdrawal by Subject|5|||
13276956|NCT00630331|26444092|FG000|Overall Study|Lost to Follow-up|175|||
13276957|NCT00630331|26444093|FG001|Overall Study|Lost to Follow-up|143|||
13276958|NCT00630331|26444094|FG002|Overall Study|Lost to Follow-up|170|||
13276959|NCT00630331|26444092|FG000|Overall Study|Inappropriate enrollment|3|||
13276960|NCT00630331|26444093|FG001|Overall Study|Inappropriate enrollment|6|||
13276961|NCT00630331|26444094|FG002|Overall Study|Inappropriate enrollment|3|||
13276962|NCT00630331|26444092|FG000|Overall Study|Unable to classify|9|||
13276963|NCT00630331|26444093|FG001|Overall Study|Unable to classify|4|||
13276964|NCT00630331|26444094|FG002|Overall Study|Unable to classify|3|||
13276965|NCT00630331|26444092|FG000|Overall Study|Protocol Violation|4|||
13276966|NCT00630331|26444093|FG001|Overall Study|Protocol Violation|5|||
13276967|NCT00630331|26444094|FG002|Overall Study|Protocol Violation|6|||
13276968|NCT00630305|26444118|FG000|Overall Study|Withdrawal by Subject|1|||
13276969|NCT00630305|26444118|FG000|Overall Study|Inability to insert contact lens|1|||
13276970|NCT00630058|26444141|FG000|Overall Study|Adverse Event|1|||
13276971|NCT00630058|26444142|FG001|Overall Study|Adverse Event|1|||
13276972|NCT00630058|26444141|FG000|Overall Study|Withdrawal by Subject|0|||
13276973|NCT00630058|26444142|FG001|Overall Study|Withdrawal by Subject|1|||
13276974|NCT00630058|26444141|FG000|Overall Study|stopping criteria|3|||
13276975|NCT00630058|26444142|FG001|Overall Study|stopping criteria|2|||
13276976|NCT00635882|26444223|FG000|Overall Study|Protocol Violation|1|||
13276977|NCT00635882|26444224|FG001|Overall Study|Protocol Violation|0|||
13276978|NCT00635882|26444225|FG002|Overall Study|Protocol Violation|0|||
13276979|NCT00635882|26444226|FG003|Overall Study|Protocol Violation|0|||
13276980|NCT00635882|26444227|FG004|Overall Study|Protocol Violation|0|||
13276981|NCT00635882|26444228|FG005|Overall Study|Protocol Violation|0|||
13276982|NCT00630032|26444251|FG000|Overall Study|Death|55|||
13276983|NCT00630032|26444252|FG001|Overall Study|Death|49|||
13276984|NCT00630032|26444251|FG000|Overall Study|Withdrawal by Subject|3|||
13276985|NCT00630032|26444252|FG001|Overall Study|Withdrawal by Subject|2|||
13276986|NCT00630032|26444251|FG000|Overall Study|Lost to Follow-up|18|||
13276987|NCT00630032|26444252|FG001|Overall Study|Lost to Follow-up|31|||
13276988|NCT00630032|26444251|FG000|Overall Study|Protocol Violation|1|||
13276989|NCT00630032|26444252|FG001|Overall Study|Protocol Violation|0|||
13276990|NCT00630032|26444251|FG000|Overall Study|Patient has moved|1|||
13276991|NCT00630032|26444252|FG001|Overall Study|Patient has moved|1|||
13276992|NCT00630032|26444251|FG000|Overall Study|Disease progression|1|||
13276993|NCT00630032|26444252|FG001|Overall Study|Disease progression|1|||
13276994|NCT00630032|26444251|FG000|Overall Study|End of monitoring in US centers|11|||
13276995|NCT00630032|26444252|FG001|Overall Study|End of monitoring in US centers|11|||
13291328|NCT00152971|26483127|FG002|Overall Study|Withdrawal by Subject|14|||
13291329|NCT00152971|26483125|FG000|Overall Study|Other|3|||
13291330|NCT00152971|26483126|FG001|Overall Study|Other|5|||
13291331|NCT00152971|26483127|FG002|Overall Study|Other|5|||
13291332|NCT00152971|26483125|FG000|Treatment|Adverse Event|49|||
13291333|NCT00152971|26483126|FG001|Treatment|Adverse Event|40|||
13291334|NCT00152971|26483127|FG002|Treatment|Adverse Event|54|||
13291335|NCT00152971|26483125|FG000|Treatment|Protocol Violation|8|||
13291336|NCT00152971|26483126|FG001|Treatment|Protocol Violation|6|||
13291337|NCT00152971|26483127|FG002|Treatment|Protocol Violation|10|||
13291338|NCT00152971|26483125|FG000|Treatment|Lost to Follow-up|1|||
13291339|NCT00152971|26483126|FG001|Treatment|Lost to Follow-up|2|||
13291340|NCT00152971|26483127|FG002|Treatment|Lost to Follow-up|1|||
13291341|NCT00152971|26483125|FG000|Treatment|Withdrawal by Subject|4|||
13291342|NCT00152971|26483126|FG001|Treatment|Withdrawal by Subject|4|||
13291343|NCT00152971|26483127|FG002|Treatment|Withdrawal by Subject|5|||
13291344|NCT00152971|26483125|FG000|Treatment|Other|9|||
13291345|NCT00152971|26483126|FG001|Treatment|Other|11|||
13291346|NCT00152971|26483127|FG002|Treatment|Other|10|||
13291347|NCT00152763|26483256|FG000|Overall Study|Death|4|||
13291348|NCT00152763|26483257|FG001|Overall Study|Death|1|||
13291349|NCT00152763|26483258|FG002|Overall Study|Death|2|||
13291350|NCT00152763|26483259|FG003|Overall Study|Death|1|||
13291351|NCT00152763|26483256|FG000|Overall Study|Lost to Follow-up|6|||
13291352|NCT00152763|26483257|FG001|Overall Study|Lost to Follow-up|4|||
13291353|NCT00152763|26483258|FG002|Overall Study|Lost to Follow-up|2|||
13291354|NCT00152763|26483259|FG003|Overall Study|Lost to Follow-up|13|||
13291355|NCT00152477|26483299|FG000|Chemotherapy Period|Adverse Event|9|||
13291356|NCT00152477|26483300|FG001|Chemotherapy Period|Adverse Event|4|||
13291357|NCT00152477|26483301|FG002|Chemotherapy Period|Adverse Event|5|||
13291358|NCT00152477|26483299|FG000|Chemotherapy Period|Death|1|||
13291359|NCT00152477|26483300|FG001|Chemotherapy Period|Death|3|||
13291360|NCT00152477|26483301|FG002|Chemotherapy Period|Death|3|||
13276996|NCT01925794|26444489|FG000|180 Days|Death|2|||
13276997|NCT01925794|26444489|FG000|180 Days|Withdrawal by Subject|2|||
13276998|NCT01925794|26444489|FG000|270 Days|Death|2|||
13276999|NCT01925794|26444489|FG000|270 Days|Protocol Violation|3|||
13277000|NCT01921218|26444510|FG000|Overall Study|Death|2|||
13277001|NCT01921218|26444511|FG001|Overall Study|Death|1|||
13277002|NCT01921218|26444510|FG000|Overall Study|Withdrawal by Subject|0|||
13277003|NCT01921218|26444511|FG001|Overall Study|Withdrawal by Subject|2|||
13277004|NCT01921218|26444510|FG000|Overall Study|Kidney transplant|1|||
13277005|NCT01921218|26444511|FG001|Overall Study|Kidney transplant|1|||
13277006|NCT01926197|26444534|FG000|Overall Study|Withdrawn to receive chemotherapy|1|||
13277007|NCT01926197|26444535|FG001|Overall Study|Withdrawn to receive chemotherapy|0|||
13277008|NCT01926197|26444534|FG000|Overall Study|Withdrawn due to non-coverage by insurance|0|||
13277009|NCT01926197|26444535|FG001|Overall Study|Withdrawn due to non-coverage by insurance|1|||
13291361|NCT00152477|26483299|FG000|Chemotherapy Period|Lack of Efficacy|4|||
13291362|NCT00152477|26483300|FG001|Chemotherapy Period|Lack of Efficacy|5|||
13291363|NCT00152477|26483301|FG002|Chemotherapy Period|Lack of Efficacy|6|||
13291364|NCT00152477|26483299|FG000|Chemotherapy Period|Lost to Follow-up|1|||
13291365|NCT00152477|26483300|FG001|Chemotherapy Period|Lost to Follow-up|0|||
13291366|NCT00152477|26483301|FG002|Chemotherapy Period|Lost to Follow-up|1|||
13291367|NCT00152477|26483299|FG000|Chemotherapy Period|Protocol Violation|1|||
13291368|NCT00152477|26483300|FG001|Chemotherapy Period|Protocol Violation|1|||
13291369|NCT00152477|26483301|FG002|Chemotherapy Period|Protocol Violation|0|||
13291370|NCT00152477|26483299|FG000|Chemotherapy Period|Withdrawal by Subject|5|||
13291371|NCT00152477|26483300|FG001|Chemotherapy Period|Withdrawal by Subject|1|||
13291372|NCT00152477|26483301|FG002|Chemotherapy Period|Withdrawal by Subject|0|||
13291373|NCT00152477|26483299|FG000|Chemotherapy Period|Progression of Disease|6|||
13291374|NCT00152477|26483300|FG001|Chemotherapy Period|Progression of Disease|8|||
13291375|NCT00152477|26483301|FG002|Chemotherapy Period|Progression of Disease|4|||
13291376|NCT00152477|26483299|FG000|Chemotherapy Period|Investigator decision|0|||
13291377|NCT00152477|26483300|FG001|Chemotherapy Period|Investigator decision|0|||
13291378|NCT00152477|26483301|FG002|Chemotherapy Period|Investigator decision|1|||
13291379|NCT00152477|26483299|FG000|Chemotherapy Period|Patient condition worsened|1|||
13291380|NCT00152477|26483300|FG001|Chemotherapy Period|Patient condition worsened|0|||
13291381|NCT00152477|26483301|FG002|Chemotherapy Period|Patient condition worsened|0|||
13291382|NCT00152477|26483299|FG000|Monotherapy Period|Adverse Event|1|||
13291383|NCT00152477|26483300|FG001|Monotherapy Period|Adverse Event|0|||
13291384|NCT00152477|26483301|FG002|Monotherapy Period|Adverse Event|5|||
13291385|NCT00152477|26483299|FG000|Monotherapy Period|Death|2|||
13291386|NCT00152477|26483300|FG001|Monotherapy Period|Death|0|||
13291387|NCT00152477|26483301|FG002|Monotherapy Period|Death|1|||
13291388|NCT00152477|26483299|FG000|Monotherapy Period|Lack of Efficacy|7|||
13291389|NCT00152477|26483300|FG001|Monotherapy Period|Lack of Efficacy|16|||
13291390|NCT00152477|26483301|FG002|Monotherapy Period|Lack of Efficacy|10|||
13291391|NCT00152477|26483299|FG000|Monotherapy Period|Protocol Violation|0|||
13291392|NCT00152477|26483300|FG001|Monotherapy Period|Protocol Violation|1|||
13291393|NCT00152477|26483301|FG002|Monotherapy Period|Protocol Violation|0|||
13291394|NCT00152477|26483299|FG000|Monotherapy Period|Withdrawal by Subject|0|||
13291395|NCT00152477|26483300|FG001|Monotherapy Period|Withdrawal by Subject|0|||
13291396|NCT00152477|26483301|FG002|Monotherapy Period|Withdrawal by Subject|4|||
13291397|NCT00152477|26483299|FG000|Monotherapy Period|Progression of Disease|5|||
13291398|NCT00152477|26483300|FG001|Monotherapy Period|Progression of Disease|11|||
13291399|NCT00152477|26483301|FG002|Monotherapy Period|Progression of Disease|12|||
13291400|NCT00152477|26483299|FG000|Monotherapy Period|Patient decision|0|||
13291401|NCT00152477|26483300|FG001|Monotherapy Period|Patient decision|1|||
13291402|NCT00152477|26483301|FG002|Monotherapy Period|Patient decision|1|||
13291403|NCT00152477|26483299|FG000|Monotherapy Period|Study personel decision|0|||
13291404|NCT00152477|26483300|FG001|Monotherapy Period|Study personel decision|0|||
13291405|NCT00152477|26483301|FG002|Monotherapy Period|Study personel decision|1|||
13291406|NCT00152464|26483332|FG000|Overall Study|Adverse Event|3|||
13291407|NCT00152464|26483333|FG001|Overall Study|Adverse Event|6|||
13291408|NCT00152464|26483332|FG000|Overall Study|Lost to Follow-up|8|||
13291409|NCT00152464|26483333|FG001|Overall Study|Lost to Follow-up|4|||
13291410|NCT00152464|26483332|FG000|Overall Study|Protocol Violation|3|||
13291411|NCT00152464|26483333|FG001|Overall Study|Protocol Violation|1|||
13291412|NCT00152464|26483332|FG000|Overall Study|Withdrawal by Subject|21|||
13291413|NCT00152464|26483333|FG001|Overall Study|Withdrawal by Subject|22|||
13291414|NCT00152464|26483332|FG000|Overall Study|Atopic dermatitis poorly controlled|0|||
13119303|NCT03020888|25933672|FG000|Overall Study|Withdrawal by Subject|6|||
13119304|NCT03020888|25933672|FG000|Overall Study|Insurance coverage|2|||
13119305|NCT03020888|25933672|FG000|Overall Study|Lost to Follow-up|1|||
13291415|NCT00152464|26483333|FG001|Overall Study|Atopic dermatitis poorly controlled|1|||
13291416|NCT00152464|26483332|FG000|Overall Study|Eczema deterioration|0|||
13291417|NCT00152464|26483333|FG001|Overall Study|Eczema deterioration|1|||
13291418|NCT00152464|26483332|FG000|Overall Study|Parent decision|1|||
13291419|NCT00152464|26483333|FG001|Overall Study|Parent decision|1|||
13119306|NCT03020745|25934037|FG000|Part 2 (Up to 169 Days)|Adverse Event|0|||
13119307|NCT03020745|25934038|FG001|Part 2 (Up to 169 Days)|Adverse Event|0|||
13119308|NCT03020745|25934039|FG002|Part 2 (Up to 169 Days)|Adverse Event|0|||
13119309|NCT03020745|25934040|FG003|Part 2 (Up to 169 Days)|Adverse Event|0|||
13119310|NCT03020745|25934041|FG004|Part 2 (Up to 169 Days)|Adverse Event|0|||
13119311|NCT03020745|25934042|FG005|Part 2 (Up to 169 Days)|Adverse Event|0|||
13119312|NCT03020745|25934043|FG006|Part 2 (Up to 169 Days)|Adverse Event|0|||
13119313|NCT03020745|25934044|FG007|Part 2 (Up to 169 Days)|Adverse Event|0|||
13119314|NCT03020745|25934045|FG008|Part 2 (Up to 169 Days)|Adverse Event|1|||
13119315|NCT03020745|25934046|FG009|Part 2 (Up to 169 Days)|Adverse Event|0|||
13119316|NCT03020745|25934037|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
13119317|NCT03020745|25934038|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
13119318|NCT03020745|25934039|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
13119319|NCT03020745|25934040|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
13119320|NCT03020745|25934041|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
13119321|NCT03020745|25934042|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
13119322|NCT03020745|25934043|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
13119323|NCT03020745|25934044|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1|||
13119324|NCT03020745|25934045|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
13119325|NCT03020745|25934046|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
13277010|NCT00989963|26444583|FG000|Overall Study|Adverse Event|1|||
13277011|NCT00989963|26444584|FG001|Overall Study|Adverse Event|1|||
13277012|NCT00989963|26444585|FG002|Overall Study|Adverse Event|1|||
13277013|NCT00989950|26444608|FG000|Randomized Phase|Protocol Violation|1|||
13277014|NCT00989950|26444609|FG001|Randomized Phase|Protocol Violation|0|||
13277015|NCT00989950|26444610|FG002|Randomized Phase|Protocol Violation|0|||
13277016|NCT00989950|26444611|FG003|Randomized Phase|Protocol Violation|0|||
13277017|NCT00989950|26444608|FG000|Randomized Phase|Adverse Event|0|||
13277018|NCT00989950|26444609|FG001|Randomized Phase|Adverse Event|1|||
13277019|NCT00989950|26444610|FG002|Randomized Phase|Adverse Event|0|||
13277020|NCT00989950|26444611|FG003|Randomized Phase|Adverse Event|0|||
13277021|NCT00989781|26444637|FG000|Ovarian Response to hCG|Lost to Follow-up|3|||
13277022|NCT00989781|26444638|FG001|Ovarian Response to hCG|Lost to Follow-up|2|||
13277023|NCT00989664|26444668|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1|||
13277024|NCT00989664|26444668|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2|||
13277025|NCT00989664|26444668|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49|||
13277026|NCT00989664|26444668|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
13277027|NCT00989664|26444668|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7|||
13277028|NCT00989664|26444668|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1|||
13277029|NCT00989664|26444668|FG000|Long-Term Follow-Up|Death|3|||
13277030|NCT00989573|26444695|FG000|Overall Study|Adverse Event|8|||
13277031|NCT00989573|26444696|FG001|Overall Study|Adverse Event|12|||
13277032|NCT00989573|26444697|FG002|Overall Study|Adverse Event|4|||
13277033|NCT00989573|26444695|FG000|Overall Study|Physician Decision|0|||
13277034|NCT00989573|26444696|FG001|Overall Study|Physician Decision|2|||
13277035|NCT00989573|26444697|FG002|Overall Study|Physician Decision|0|||
13277036|NCT00989573|26444695|FG000|Overall Study|Protocol Violation|1|||
13277037|NCT00989573|26444696|FG001|Overall Study|Protocol Violation|1|||
13277038|NCT00989573|26444697|FG002|Overall Study|Protocol Violation|1|||
13277039|NCT00989573|26444695|FG000|Overall Study|Withdrawal by Subject|4|||
13277040|NCT00989573|26444696|FG001|Overall Study|Withdrawal by Subject|7|||
13277041|NCT00989573|26444697|FG002|Overall Study|Withdrawal by Subject|3|||
13277042|NCT00989261|26444732|FG000|Overall Study|Still in follow up|12|||
13277043|NCT00989261|26444733|FG001|Overall Study|Still in follow up|21|||
13277044|NCT00989261|26444732|FG000|Overall Study|Withdrawal by Subject|0|||
13277045|NCT00989261|26444733|FG001|Overall Study|Withdrawal by Subject|1|||
13277046|NCT00989261|26444732|FG000|Overall Study|Lost to Follow-up|3|||
13277047|NCT00989261|26444733|FG001|Overall Study|Lost to Follow-up|0|||
13277048|NCT00989235|26444785|FG000|Overall Study|Death|0|||
13277049|NCT00989235|26444786|FG001|Overall Study|Death|1|||
13277050|NCT00989235|26444785|FG000|Overall Study|Adverse Event|0|||
13277051|NCT00989235|26444786|FG001|Overall Study|Adverse Event|1|||
13277052|NCT00989235|26444785|FG000|Overall Study|Lack of Efficacy|1|||
13277053|NCT00989235|26444786|FG001|Overall Study|Lack of Efficacy|0|||
13277054|NCT00989235|26444785|FG000|Overall Study|Withdrawal of Consent|1|||
13277055|NCT00989235|26444786|FG001|Overall Study|Withdrawal of Consent|1|||
13277056|NCT00989235|26444785|FG000|Overall Study|Desire to Become Pregnant|1|||
13277057|NCT00989235|26444786|FG001|Overall Study|Desire to Become Pregnant|0|||
13277058|NCT00989235|26444785|FG000|Overall Study|Randomized by Mistake|0|||
13277059|NCT00989235|26444786|FG001|Overall Study|Randomized by Mistake|2|||
13119326|NCT03020745|25934037|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
13119327|NCT03020745|25934038|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
13277060|NCT00989235|26444785|FG000|Overall Study|Lost to Follow-up|0|||
13277061|NCT00989235|26444786|FG001|Overall Study|Lost to Follow-up|1|||
13277062|NCT00989196|26444808|FG000|Treatment Period|Lost to Follow-up|1|||
13277063|NCT00989196|26444809|FG001|Treatment Period|Lost to Follow-up|0|||
13277064|NCT00989092|26444849|FG000|Overall Study|Physician Decision|9|||
13277065|NCT00989092|26444850|FG001|Overall Study|Physician Decision|6|||
13277066|NCT00989092|26444849|FG000|Overall Study|Adverse Event|20|||
13277067|NCT00989092|26444850|FG001|Overall Study|Adverse Event|1|||
13277068|NCT00989092|26444849|FG000|Overall Study|Chemotherapy initiated|12|||
13277069|NCT00989092|26444850|FG001|Overall Study|Chemotherapy initiated|4|||
13277070|NCT00989092|26444849|FG000|Overall Study|Withdrawal by Subject|17|||
13277071|NCT00989092|26444850|FG001|Overall Study|Withdrawal by Subject|9|||
13277072|NCT00989092|26444849|FG000|Overall Study|Death|14|||
13277073|NCT00989092|26444850|FG001|Overall Study|Death|2|||
13277074|NCT00989092|26444849|FG000|Overall Study|Ineligibility determined|3|||
13277075|NCT00989092|26444850|FG001|Overall Study|Ineligibility determined|3|||
13277076|NCT00989092|26444849|FG000|Overall Study|Lost to Follow-up|6|||
13277077|NCT00989092|26444850|FG001|Overall Study|Lost to Follow-up|2|||
13277078|NCT00989092|26444849|FG000|Overall Study|Other|3|||
13277079|NCT00989092|26444850|FG001|Overall Study|Other|1|||
13277080|NCT00989092|26444849|FG000|Overall Study|Protocol deviation|2|||
13277081|NCT00989092|26444850|FG001|Overall Study|Protocol deviation|0|||
13277082|NCT00989092|26444849|FG000|Overall Study|Erythropoietin therapy initiated|2|||
13277083|NCT00989092|26444850|FG001|Overall Study|Erythropoietin therapy initiated|0|||
13277084|NCT00989092|26444849|FG000|Overall Study|Did not receive study drug|2|||
13277085|NCT00989092|26444850|FG001|Overall Study|Did not receive study drug|0|||
13277086|NCT00988884|26444879|FG000|Overall Study|Adverse Event|0|||
13277087|NCT00988884|26444880|FG001|Overall Study|Adverse Event|1|||
13277088|NCT00988884|26444879|FG000|Overall Study|Lost to Follow-up|20|||
13277089|NCT00988884|26444880|FG001|Overall Study|Lost to Follow-up|16|||
13277090|NCT00988884|26444879|FG000|Overall Study|Protocol Violation|0|||
13277091|NCT00988884|26444880|FG001|Overall Study|Protocol Violation|1|||
13277092|NCT00988884|26444879|FG000|Overall Study|Withdrawal by Subject|15|||
13277093|NCT00988884|26444880|FG001|Overall Study|Withdrawal by Subject|18|||
13119328|NCT03020745|25934039|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
13119329|NCT03020745|25934040|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
13277094|NCT00988858|26444894|FG000|Overall Study|Adverse Event|7|||
13277095|NCT00988858|26444894|FG000|Overall Study|Death|1|||
13277096|NCT00988858|26444894|FG000|Overall Study|Physician Decision|1|||
13277097|NCT00988858|26444894|FG000|Overall Study|Sponsor Decision|1|||
13277098|NCT00988559|26444921|FG000|Overall Study|Withdrawal by Subject|1|||
13277099|NCT00988559|26444922|FG001|Overall Study|Withdrawal by Subject|1|||
13277100|NCT00988559|26444923|FG002|Overall Study|Withdrawal by Subject|0|||
13277101|NCT00988559|26444924|FG003|Overall Study|Withdrawal by Subject|1|||
13277102|NCT00988559|26444921|FG000|Overall Study|Pregnancy|0|||
13277103|NCT00988559|26444922|FG001|Overall Study|Pregnancy|1|||
13277104|NCT00988559|26444923|FG002|Overall Study|Pregnancy|1|||
13277105|NCT00988559|26444924|FG003|Overall Study|Pregnancy|0|||
13277106|NCT00988559|26444921|FG000|Overall Study|Lost to Follow-up|0|||
13277107|NCT00988559|26444922|FG001|Overall Study|Lost to Follow-up|0|||
13277108|NCT00988559|26444923|FG002|Overall Study|Lost to Follow-up|1|||
13277109|NCT00988559|26444924|FG003|Overall Study|Lost to Follow-up|0|||
13119330|NCT03020745|25934041|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
13119331|NCT03020745|25934042|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
13119332|NCT03020745|25934043|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
13119333|NCT03020745|25934044|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
13119334|NCT03020745|25934045|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
13119335|NCT03020745|25934046|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
13119336|NCT03020745|25934037|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
13119337|NCT03020745|25934038|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
13119338|NCT03020745|25934039|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
13119339|NCT03020745|25934040|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
13119340|NCT03020745|25934041|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
13119341|NCT03020745|25934042|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
13119342|NCT03020745|25934043|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
13119343|NCT03020745|25934044|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
13119344|NCT03020745|25934045|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2|||
13119345|NCT03020745|25934046|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
13119346|NCT03020641|25934065|FG000|Overall Study|Lost to Follow-up|0|||
13119347|NCT03020641|25934066|FG001|Overall Study|Lost to Follow-up|1|||
13119348|NCT03020641|25934065|FG000|Overall Study|Converted to open surgery|2|||
13119349|NCT03020641|25934066|FG001|Overall Study|Converted to open surgery|1|||
13119350|NCT03020641|25934065|FG000|Overall Study|for surgery not performed|0|||
13119351|NCT03020641|25934066|FG001|Overall Study|for surgery not performed|1|||
13277110|NCT00988533|26444938|FG000|Overall Study|Lost to Follow-up|3|||
13277111|NCT00988351|26444959|FG000|Overall Study|Withdrawal by Subject|8|||
13277112|NCT00988351|26444960|FG001|Overall Study|Withdrawal by Subject|0|||
13277113|NCT00988351|26444959|FG000|Overall Study|Lost to Follow-up|6|||
13277114|NCT00988351|26444960|FG001|Overall Study|Lost to Follow-up|9|||
13119352|NCT03020615|25934174|FG000|Overall Study|Physician Decision|3|||
13119353|NCT03020615|25934175|FG001|Overall Study|Physician Decision|1|||
13119354|NCT03020615|25934176|FG002|Overall Study|Physician Decision|2|||
13119355|NCT03020615|25934174|FG000|Overall Study|Parent/guardian/patient choice|3|||
13119356|NCT03020615|25934175|FG001|Overall Study|Parent/guardian/patient choice|0|||
13119357|NCT03020615|25934176|FG002|Overall Study|Parent/guardian/patient choice|4|||
13119358|NCT03020615|25934174|FG000|Overall Study|Screen failure|0|||
13119359|NCT03020615|25934175|FG001|Overall Study|Screen failure|0|||
13119360|NCT03020615|25934176|FG002|Overall Study|Screen failure|1|||
13119361|NCT03020615|25934174|FG000|Overall Study|Death|1|||
13119362|NCT03020615|25934175|FG001|Overall Study|Death|0|||
13119363|NCT03020615|25934176|FG002|Overall Study|Death|0|||
13119364|NCT03020615|25934174|FG000|Overall Study|Lost to Follow-up|0|||
13119365|NCT03020615|25934175|FG001|Overall Study|Lost to Follow-up|1|||
13277115|NCT00988351|26444959|FG000|Overall Study|not using CPAP|5|||
13277116|NCT00988351|26444960|FG001|Overall Study|not using CPAP|3|||
13277117|NCT00988169|26444966|FG000|Overall Study|Withdrawal by Subject|1|||
13277118|NCT00988117|26444975|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1|||
13119366|NCT03020615|25934176|FG002|Overall Study|Lost to Follow-up|0|||
13277119|NCT00988117|26444975|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2|||
13119367|NCT03020576|25934203|FG000|Overall Study|Withdrawal by Subject|1|||
13119368|NCT03020576|25934204|FG001|Overall Study|Withdrawal by Subject|2|||
13119369|NCT03020407|25934225|FG000|Overall Study|Withdrawal by Subject|2|||
13119370|NCT03020407|25934226|FG001|Overall Study|Withdrawal by Subject|1|||
13277120|NCT00988091|26445001|FG000|Double-blind Period|Withdrawal by Subject|15|||
13277121|NCT00988091|26445002|FG001|Double-blind Period|Withdrawal by Subject|13|||
13277122|NCT00988091|26445001|FG000|Double-blind Period|Lost to Follow-up|12|||
13277123|NCT00988091|26445002|FG001|Double-blind Period|Lost to Follow-up|14|||
13277124|NCT00988091|26445001|FG000|Double-blind Period|Other|8|||
13277125|NCT00988091|26445002|FG001|Double-blind Period|Other|8|||
13277126|NCT00988091|26445001|FG000|Double-blind Period|Adverse Event|6|||
13277127|NCT00988091|26445002|FG001|Double-blind Period|Adverse Event|9|||
13277128|NCT00988091|26445001|FG000|Double-blind Period|Use of exclusionary medication|2|||
13277129|NCT00988091|26445002|FG001|Double-blind Period|Use of exclusionary medication|3|||
13277130|NCT00988091|26445001|FG000|Open-label Period|Adverse Event|4|||
13277131|NCT00988091|26445002|FG001|Open-label Period|Adverse Event|7|||
13277132|NCT00988091|26445001|FG000|Open-label Period|Use of exclusionary medication|1|||
13277133|NCT00988091|26445002|FG001|Open-label Period|Use of exclusionary medication|1|||
13277134|NCT00988091|26445001|FG000|Open-label Period|Protocol Violation|1|||
13277135|NCT00988091|26445002|FG001|Open-label Period|Protocol Violation|1|||
13277136|NCT00988091|26445001|FG000|Open-label Period|Withdrawal by Subject|10|||
13277137|NCT00988091|26445002|FG001|Open-label Period|Withdrawal by Subject|16|||
13277138|NCT00988091|26445001|FG000|Open-label Period|Lost to Follow-up|3|||
13277139|NCT00988091|26445002|FG001|Open-label Period|Lost to Follow-up|5|||
13277140|NCT00988091|26445001|FG000|Open-label Period|Other|2|||
13277141|NCT00988091|26445002|FG001|Open-label Period|Other|3|||
13277142|NCT00988065|26445032|FG000|Overall Study|Adverse Event|4|||
13277143|NCT00988065|26445033|FG001|Overall Study|Adverse Event|10|||
13277144|NCT00988065|26445034|FG002|Overall Study|Adverse Event|2|||
13277145|NCT00988065|26445032|FG000|Overall Study|Lost to Follow-up|1|||
13277146|NCT00988065|26445033|FG001|Overall Study|Lost to Follow-up|2|||
13277147|NCT00988065|26445034|FG002|Overall Study|Lost to Follow-up|2|||
13277148|NCT00988065|26445032|FG000|Overall Study|Subject withdrew consent|3|||
13277149|NCT00988065|26445033|FG001|Overall Study|Subject withdrew consent|5|||
13277150|NCT00988065|26445034|FG002|Overall Study|Subject withdrew consent|2|||
13277151|NCT00988065|26445032|FG000|Overall Study|Noncompliance with protocol|5|||
13277152|NCT00988065|26445033|FG001|Overall Study|Noncompliance with protocol|6|||
13277153|NCT00988065|26445034|FG002|Overall Study|Noncompliance with protocol|9|||
13277154|NCT00987935|26445115|FG000|Overall Study|Progressive disease|3|||
13277155|NCT00987935|26445116|FG001|Overall Study|Progressive disease|2|||
13277156|NCT00987935|26445117|FG002|Overall Study|Progressive disease|3|||
13277157|NCT00987935|26445118|FG003|Overall Study|Progressive disease|2|||
13277158|NCT00987935|26445119|FG004|Overall Study|Progressive disease|5|||
13277159|NCT00987935|26445120|FG005|Overall Study|Progressive disease|3|||
13277160|NCT00987935|26445121|FG006|Overall Study|Progressive disease|9|||
13277161|NCT00987935|26445122|FG007|Overall Study|Progressive disease|48|||
13277162|NCT00987935|26445123|FG008|Overall Study|Progressive disease|23|||
13277163|NCT00987935|26445115|FG000|Overall Study|Adverse Event|0|||
13277164|NCT00987935|26445116|FG001|Overall Study|Adverse Event|1|||
13277165|NCT00987935|26445117|FG002|Overall Study|Adverse Event|0|||
13277166|NCT00987935|26445118|FG003|Overall Study|Adverse Event|1|||
13277167|NCT00987935|26445119|FG004|Overall Study|Adverse Event|1|||
13277168|NCT00987935|26445120|FG005|Overall Study|Adverse Event|0|||
13277169|NCT00987935|26445121|FG006|Overall Study|Adverse Event|2|||
13119371|NCT03020407|25934225|FG000|Overall Study|Lost to Follow-up|2|||
13277170|NCT00987935|26445122|FG007|Overall Study|Adverse Event|10|||
13277171|NCT00987935|26445123|FG008|Overall Study|Adverse Event|6|||
13277172|NCT00987935|26445115|FG000|Overall Study|Refused to continue taking trial med.|1|||
13277173|NCT00987935|26445116|FG001|Overall Study|Refused to continue taking trial med.|0|||
13277174|NCT00987935|26445117|FG002|Overall Study|Refused to continue taking trial med.|0|||
13277175|NCT00987935|26445118|FG003|Overall Study|Refused to continue taking trial med.|0|||
13277176|NCT00987935|26445119|FG004|Overall Study|Refused to continue taking trial med.|1|||
13277177|NCT00987935|26445120|FG005|Overall Study|Refused to continue taking trial med.|0|||
13277178|NCT00987935|26445121|FG006|Overall Study|Refused to continue taking trial med.|4|||
13277179|NCT00987935|26445122|FG007|Overall Study|Refused to continue taking trial med.|4|||
13277180|NCT00987935|26445123|FG008|Overall Study|Refused to continue taking trial med.|2|||
13277181|NCT00987935|26445115|FG000|Overall Study|Reason other than those specified above|0|||
13277182|NCT00987935|26445116|FG001|Overall Study|Reason other than those specified above|0|||
13277183|NCT00987935|26445117|FG002|Overall Study|Reason other than those specified above|0|||
13277184|NCT00987935|26445118|FG003|Overall Study|Reason other than those specified above|0|||
13277185|NCT00987935|26445119|FG004|Overall Study|Reason other than those specified above|0|||
13277186|NCT00987935|26445120|FG005|Overall Study|Reason other than those specified above|0|||
13277187|NCT00987935|26445121|FG006|Overall Study|Reason other than those specified above|0|||
13277188|NCT00987935|26445122|FG007|Overall Study|Reason other than those specified above|0|||
13277189|NCT00987935|26445123|FG008|Overall Study|Reason other than those specified above|1|||
13277190|NCT00987831|26445142|FG000|Overall Study|Never flared in 12 months|1|||
13277191|NCT00987831|26445143|FG001|Overall Study|Never flared in 12 months|0|||
13277192|NCT00987831|26445144|FG002|Overall Study|Never flared in 12 months|0|||
13277193|NCT00987831|26445142|FG000|Overall Study|Lost to Follow-up|0|||
13277194|NCT00987831|26445143|FG001|Overall Study|Lost to Follow-up|3|||
13277195|NCT00987831|26445144|FG002|Overall Study|Lost to Follow-up|0|||
13277196|NCT00987623|26445157|FG000|Overall Study|Lost to Follow-up|2|||
13277197|NCT00987623|26445158|FG001|Overall Study|Lost to Follow-up|1|||
13277198|NCT00987623|26445157|FG000|Overall Study|Time/job conflict|2|||
13277199|NCT00987623|26445158|FG001|Overall Study|Time/job conflict|0|||
13277200|NCT00987623|26445157|FG000|Overall Study|Discomfort|1|||
13277201|NCT00987623|26445158|FG001|Overall Study|Discomfort|0|||
13277202|NCT00987623|26445157|FG000|Overall Study|Biomicroscopy|0|||
13277203|NCT00987623|26445158|FG001|Overall Study|Biomicroscopy|1|||
13277204|NCT00987623|26445157|FG000|Overall Study|Influenza|0|||
13277205|NCT00987623|26445158|FG001|Overall Study|Influenza|1|||
13277206|NCT00987467|26445165|FG000|Overall Study|Lost to Follow-up|2|||
13277207|NCT00987402|26445178|FG000|Overall Study|Insufficient data entry|86|||
13277208|NCT00987402|26445179|FG001|Overall Study|Insufficient data entry|98|||
13277209|NCT00986986|26445196|FG000|Overall Study|Lost to Follow-up|0|||
13277210|NCT00986986|26445197|FG001|Overall Study|Lost to Follow-up|1|||
13277211|NCT00986973|26445209|FG000|Overall Study|Withdrawn by study team|1|||
13277212|NCT00986921|26445226|FG000|Overall Study|Physician Decision|1|||
13277213|NCT00986921|26445227|FG001|Overall Study|Physician Decision|0|||
13277214|NCT00986674|26445251|FG000|Overall Study|Lack of Efficacy|28|||
13277215|NCT00986674|26445252|FG001|Overall Study|Lack of Efficacy|25|||
13277216|NCT00986674|26445253|FG002|Overall Study|Lack of Efficacy|23|||
13277217|NCT00986674|26445251|FG000|Overall Study|Adverse Event|4|||
13277218|NCT00986674|26445252|FG001|Overall Study|Adverse Event|8|||
13277219|NCT00986674|26445253|FG002|Overall Study|Adverse Event|9|||
13277220|NCT00986674|26445251|FG000|Overall Study|Death|5|||
13277221|NCT00986674|26445252|FG001|Overall Study|Death|0|||
13277222|NCT00986674|26445253|FG002|Overall Study|Death|4|||
13277223|NCT00986674|26445251|FG000|Overall Study|Withdrawal by Subject|6|||
13277224|NCT00986674|26445252|FG001|Overall Study|Withdrawal by Subject|2|||
13277225|NCT00986674|26445253|FG002|Overall Study|Withdrawal by Subject|1|||
13277226|NCT00986674|26445251|FG000|Overall Study|alternative therapy|0|||
13277227|NCT00986674|26445252|FG001|Overall Study|alternative therapy|0|||
13277228|NCT00986674|26445253|FG002|Overall Study|alternative therapy|1|||
13277229|NCT00986674|26445251|FG000|Overall Study|not start protocol therapy|4|||
13277230|NCT00986674|26445252|FG001|Overall Study|not start protocol therapy|3|||
13277231|NCT00986674|26445253|FG002|Overall Study|not start protocol therapy|1|||
13277232|NCT00986674|26445251|FG000|Overall Study|unknown/not specify|0|||
13277233|NCT00986674|26445252|FG001|Overall Study|unknown/not specify|7|||
13277234|NCT00986674|26445253|FG002|Overall Study|unknown/not specify|9|||
13277235|NCT00986570|26445259|FG000|Overall Study|Lost to Follow-up|6|||
13277236|NCT00986570|26445259|FG000|Overall Study|Potential bias for objective assessment|1|||
13277237|NCT00986440|26445282|FG000|Overall Study|Progressive disease|27|||
13277238|NCT00986440|26445283|FG001|Overall Study|Progressive disease|37|||
13277239|NCT00986440|26445282|FG000|Overall Study|Serious adverse event or adverse event|9|||
13277240|NCT00986440|26445283|FG001|Overall Study|Serious adverse event or adverse event|2|||
13277241|NCT00986440|26445282|FG000|Overall Study|Withdrawal by Subject|1|||
13277242|NCT00986440|26445283|FG001|Overall Study|Withdrawal by Subject|2|||
13277243|NCT00986440|26445282|FG000|Overall Study|Screen failure (not dosed)|4|||
13277244|NCT00986440|26445283|FG001|Overall Study|Screen failure (not dosed)|2|||
13277245|NCT00986427|26445304|FG000|Overall Study|Lost to Follow-up|2|||
13277246|NCT00986427|26445305|FG001|Overall Study|Lost to Follow-up|0|||
13277247|NCT00986427|26445304|FG000|Overall Study|Lack of Efficacy|1|||
13277248|NCT00986427|26445305|FG001|Overall Study|Lack of Efficacy|0|||
13277249|NCT00986427|26445304|FG000|Overall Study|Withdrawal by Subject|1|||
13277250|NCT00986427|26445305|FG001|Overall Study|Withdrawal by Subject|0|||
13277251|NCT00986362|26445318|FG000|Overall Study|Death|2|||
13277252|NCT00986362|26445319|FG001|Overall Study|Death|0|||
13277253|NCT00986362|26445318|FG000|Overall Study|Lost to Follow-up|0|||
13277254|NCT00986362|26445319|FG001|Overall Study|Lost to Follow-up|1|||
13277255|NCT00986349|26445334|FG000|Overall Study|Unsuccessful implant procedure|3|||
13277256|NCT00986349|26445334|FG000|Overall Study|Adverse Event|2|||
13277257|NCT00986349|26445334|FG000|Overall Study|Physician Decision|1|||
13277258|NCT00986349|26445334|FG000|Overall Study|device migration|1|||
13277259|NCT00986258|26445364|FG000|Observation Period|Not eligible to be dosed|11|||
13277260|NCT00986258|26445364|FG000|Titration and Optimal Dose Period|Adverse Event|15|||
13277261|NCT00986258|26445364|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3|||
13277262|NCT00986258|26445364|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3|||
13277263|NCT00986258|26445364|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
13277264|NCT00986258|26445364|FG000|Titration and Optimal Dose Period|Other|1|||
13277265|NCT00986258|26445364|FG000|Maintenance Period|Adverse Event|5|||
13277266|NCT00986258|26445364|FG000|Maintenance Period|Lack of Efficacy|2|||
13277267|NCT00986258|26445364|FG000|Maintenance Period|Withdrawal by Subject|2|||
13277268|NCT00986180|26445447|FG000|Overall Study|Adverse Event|21|||
13277269|NCT00986180|26445448|FG001|Overall Study|Adverse Event|23|||
13277270|NCT00986180|26445447|FG000|Overall Study|Lack of Efficacy|4|||
13277271|NCT00986180|26445448|FG001|Overall Study|Lack of Efficacy|3|||
13277272|NCT00986180|26445447|FG000|Overall Study|Lost to Follow-up|5|||
13277273|NCT00986180|26445448|FG001|Overall Study|Lost to Follow-up|7|||
13277274|NCT00986180|26445447|FG000|Overall Study|Physician Decision|1|||
13277275|NCT00986180|26445448|FG001|Overall Study|Physician Decision|3|||
13277276|NCT00986180|26445447|FG000|Overall Study|Protocol Violation|2|||
13277277|NCT00986180|26445448|FG001|Overall Study|Protocol Violation|0|||
13277278|NCT00986180|26445447|FG000|Overall Study|Withdrawal by Subject|1|||
13277279|NCT00986180|26445448|FG001|Overall Study|Withdrawal by Subject|9|||
13277280|NCT00986180|26445447|FG000|Overall Study|Miscellanies|10|||
13277281|NCT00986180|26445448|FG001|Overall Study|Miscellanies|11|||
13277282|NCT00986102|26445507|FG000|Overall Study|Lost to Follow-up|0|||
13277283|NCT00986102|26445508|FG001|Overall Study|Lost to Follow-up|1|||
13277284|NCT00986102|26445509|FG002|Overall Study|Lost to Follow-up|0|||
13277285|NCT00986102|26445510|FG003|Overall Study|Lost to Follow-up|1|||
13277286|NCT00986102|26445507|FG000|Overall Study|Withdrawal by Subject|1|||
13277287|NCT00986102|26445508|FG001|Overall Study|Withdrawal by Subject|1|||
13277288|NCT00986102|26445509|FG002|Overall Study|Withdrawal by Subject|0|||
13277289|NCT00986102|26445510|FG003|Overall Study|Withdrawal by Subject|0|||
13277290|NCT00985959|26445543|FG000|Overall Study|Adverse Event|0|||
13277291|NCT00985959|26445544|FG001|Overall Study|Adverse Event|0|||
13277292|NCT00985959|26445545|FG002|Overall Study|Adverse Event|19|||
13277293|NCT00985959|26445543|FG000|Overall Study|Withdrawal by Subject|0|||
13277294|NCT00985959|26445544|FG001|Overall Study|Withdrawal by Subject|0|||
13277295|NCT00985959|26445545|FG002|Overall Study|Withdrawal by Subject|8|||
13277296|NCT00985959|26445543|FG000|Overall Study|Progressive disease|1|||
13277297|NCT00985959|26445544|FG001|Overall Study|Progressive disease|2|||
13277298|NCT00985959|26445545|FG002|Overall Study|Progressive disease|8|||
13277299|NCT00985959|26445543|FG000|Overall Study|Unrecovered toxicity|0|||
13277300|NCT00985959|26445544|FG001|Overall Study|Unrecovered toxicity|0|||
13277301|NCT00985959|26445545|FG002|Overall Study|Unrecovered toxicity|7|||
13277302|NCT00985959|26445543|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
13277303|NCT00985959|26445544|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0|||
13277304|NCT00985959|26445545|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
13277305|NCT00985959|26445543|FG000|Overall Study|Complete response observed over 2 cycles|0|||
13277306|NCT00985959|26445544|FG001|Overall Study|Complete response observed over 2 cycles|1|||
13277307|NCT00985959|26445545|FG002|Overall Study|Complete response observed over 2 cycles|4|||
13277308|NCT00985959|26445543|FG000|Overall Study|Other|0|||
13277309|NCT00985959|26445544|FG001|Overall Study|Other|0|||
13277310|NCT00985959|26445545|FG002|Overall Study|Other|11|||
13277311|NCT00985946|26445555|FG000|Overall Study|Lost to Follow-up|6|||
13277312|NCT00985946|26445555|FG000|Overall Study|Withdrawal by Subject|1|||
13277313|NCT00985790|26445598|FG000|Overall Study|Withdrawal by Subject|1|||
13277314|NCT00985790|26445599|FG001|Overall Study|Withdrawal by Subject|1|||
13277315|NCT00985790|26445598|FG000|Overall Study|Lost to Follow-up|6|||
13277316|NCT00985790|26445599|FG001|Overall Study|Lost to Follow-up|7|||
13277317|NCT00985751|26445676|FG000|Overall Study|Adverse Event|0|||
13277318|NCT00985751|26445677|FG001|Overall Study|Adverse Event|0|||
13277319|NCT00985751|26445678|FG002|Overall Study|Adverse Event|0|||
13277320|NCT00985751|26445679|FG003|Overall Study|Adverse Event|0|||
13277321|NCT00985751|26445680|FG004|Overall Study|Adverse Event|1|||
13277322|NCT00985738|26445693|FG000|Overall Study|Study closed prematurely|8|||
13277323|NCT00985738|26445694|FG001|Overall Study|Study closed prematurely|8|||
13277324|NCT00985725|26445735|FG000|Overall Study|Adverse Event|4|||
13277325|NCT00985725|26445736|FG001|Overall Study|Adverse Event|1|||
13277326|NCT00985725|26445735|FG000|Overall Study|Protocol Violation|1|||
13119372|NCT03020407|25934226|FG001|Overall Study|Lost to Follow-up|3|||
13119373|NCT03020407|25934225|FG000|Overall Study|Protocol Violation|0|||
13119374|NCT03020407|25934226|FG001|Overall Study|Protocol Violation|1|||
13119375|NCT03020069|25934245|FG000|Overall Study|Lost to Follow-up|0|||
13119376|NCT03020069|25934246|FG001|Overall Study|Lost to Follow-up|1|||
13119377|NCT03019965|25934261|FG000|Overall Study|Withdrawal by Subject|1|||
13119378|NCT03019965|25934262|FG001|Overall Study|Withdrawal by Subject|0|||
13119379|NCT03019965|25934261|FG000|Overall Study|Protocol Violation|1|||
13119380|NCT03019965|25934262|FG001|Overall Study|Protocol Violation|3|||
13119381|NCT03019965|25934261|FG000|Overall Study|viral or fungal infection|3|||
13119382|NCT03019965|25934262|FG001|Overall Study|viral or fungal infection|4|||
13119383|NCT03019965|25934261|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4|||
13119384|NCT03019965|25934262|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5|||
13119385|NCT03019965|25934261|FG000|Overall Study|Physician Decision|1|||
13119386|NCT03019965|25934262|FG001|Overall Study|Physician Decision|1|||
13119387|NCT03019627|25934285|FG000|Overall Study|Adverse Event|8|||
13119388|NCT03019627|25934286|FG001|Overall Study|Adverse Event|0|||
13119389|NCT03019627|25934285|FG000|Overall Study|Unrelated to adverse event|1|||
13119390|NCT03019627|25934286|FG001|Overall Study|Unrelated to adverse event|3|||
13119391|NCT03019627|25934285|FG000|Overall Study|Lost to Follow-up|2|||
13277327|NCT00985725|26445736|FG001|Overall Study|Protocol Violation|3|||
13277328|NCT00985725|26445735|FG000|Overall Study|Withdrawal by Subject|4|||
13277329|NCT00985725|26445736|FG001|Overall Study|Withdrawal by Subject|4|||
13277330|NCT00985725|26445735|FG000|Overall Study|Lost to Follow-up|1|||
13277331|NCT00985725|26445736|FG001|Overall Study|Lost to Follow-up|1|||
13277332|NCT00985725|26445735|FG000|Overall Study|Lack of Efficacy|0|||
13277333|NCT00985725|26445736|FG001|Overall Study|Lack of Efficacy|1|||
13277334|NCT00985725|26445735|FG000|Overall Study|Non-compliance|1|||
13277335|NCT00985725|26445736|FG001|Overall Study|Non-compliance|2|||
13277336|NCT00985725|26445735|FG000|Overall Study|Out-of-window visits|0|||
13277337|NCT00985725|26445736|FG001|Overall Study|Out-of-window visits|1|||
13277338|NCT00985712|26445757|FG000|Overall Study|Adverse Event|0|||
13277339|NCT00985712|26445758|FG001|Overall Study|Adverse Event|1|||
13277340|NCT00985712|26445757|FG000|Overall Study|Lost to Follow-up|2|||
13277341|NCT00985712|26445758|FG001|Overall Study|Lost to Follow-up|2|||
13277342|NCT00985712|26445757|FG000|Overall Study|Protocol Violation|0|||
13277343|NCT00985712|26445758|FG001|Overall Study|Protocol Violation|1|||
13277344|NCT00985712|26445757|FG000|Overall Study|Withdrawal by Subject|4|||
13277345|NCT00985712|26445758|FG001|Overall Study|Withdrawal by Subject|1|||
13277346|NCT00985712|26445757|FG000|Overall Study|Sponsor decision|0|||
13277347|NCT00985712|26445758|FG001|Overall Study|Sponsor decision|2|||
13277348|NCT00985686|26445779|FG000|Overall Study|Lost to Follow-up|1|||
13119392|NCT03019627|25934286|FG001|Overall Study|Lost to Follow-up|1|||
13119393|NCT03019627|25934285|FG000|Overall Study|not compliance|2|||
13119394|NCT03019627|25934286|FG001|Overall Study|not compliance|2|||
13119395|NCT03019627|25934285|FG000|Overall Study|Other|2|||
13119396|NCT03019627|25934286|FG001|Overall Study|Other|2|||
13119397|NCT03019549|25934299|FG000|Washout|DId not meet genotype criteria|11|||
13119398|NCT03019549|25934299|FG000|Period 2|Adverse Event|2|||
13119399|NCT03019549|25934299|FG000|Period 2|Physician Decision|2|||
13119400|NCT03019549|25934299|FG000|Period 2|Withdrawal by Subject|1|||
13119401|NCT03019458|25934318|FG000|Overall Study|Death|0|||
13119402|NCT03019458|25934319|FG001|Overall Study|Death|1|||
13119403|NCT03019289|25934382|FG000|Overall Study|Adverse Event|1|||
13119404|NCT03019289|25934383|FG001|Overall Study|Adverse Event|0|||
13119405|NCT03019289|25934384|FG002|Overall Study|Adverse Event|0|||
13119406|NCT03019289|25934385|FG003|Overall Study|Adverse Event|0|||
13119407|NCT03019289|25934386|FG004|Overall Study|Adverse Event|0|||
13119408|NCT03019289|25934387|FG005|Overall Study|Adverse Event|0|||
13119409|NCT03019289|25934388|FG006|Overall Study|Adverse Event|0|||
13119410|NCT03019289|25934389|FG007|Overall Study|Adverse Event|0|||
13119411|NCT03019289|25934390|FG008|Overall Study|Adverse Event|1|||
13119412|NCT03019289|25934382|FG000|Overall Study|Other|1|||
13119413|NCT03019289|25934383|FG001|Overall Study|Other|0|||
13119414|NCT03019289|25934384|FG002|Overall Study|Other|0|||
13119415|NCT03019289|25934385|FG003|Overall Study|Other|0|||
13119416|NCT03019289|25934386|FG004|Overall Study|Other|0|||
13119417|NCT03019289|25934387|FG005|Overall Study|Other|0|||
13119418|NCT03019289|25934388|FG006|Overall Study|Other|0|||
13119419|NCT03019289|25934389|FG007|Overall Study|Other|0|||
13119420|NCT03019289|25934390|FG008|Overall Study|Other|0|||
13119421|NCT03018938|25934433|FG000|Overall Study|Death|0|||
13119422|NCT03018938|25934434|FG001|Overall Study|Death|1|||
13119423|NCT03018938|25934433|FG000|Overall Study|Lost to Follow-up|21|||
13119424|NCT03018938|25934434|FG001|Overall Study|Lost to Follow-up|32|||
13119425|NCT03018938|25934433|FG000|Overall Study|Withdrawal by Subject|38|||
13119426|NCT03018938|25934434|FG001|Overall Study|Withdrawal by Subject|45|||
13119427|NCT03018938|25934433|FG000|Overall Study|Physician Decision|3|||
13119428|NCT03018938|25934434|FG001|Overall Study|Physician Decision|2|||
13277349|NCT00985686|26445780|FG001|Overall Study|Lost to Follow-up|1|||
13119429|NCT03018938|25934433|FG000|Overall Study|Sponsor Decision|0|||
13119430|NCT03018938|25934434|FG001|Overall Study|Sponsor Decision|1|||
13119431|NCT03018938|25934433|FG000|Overall Study|Screen failure-After randomization|4|||
13119432|NCT03018938|25934434|FG001|Overall Study|Screen failure-After randomization|2|||
13119433|NCT03018938|25934433|FG000|Overall Study|Not recorded|0|||
13119434|NCT03018938|25934434|FG001|Overall Study|Not recorded|2|||
13119435|NCT03018691|25934478|FG000|Overall Study|Adverse Event|1|||
13119436|NCT03018691|25934479|FG001|Overall Study|Adverse Event|1|||
13119437|NCT03018691|25934480|FG002|Overall Study|Adverse Event|4|||
13119438|NCT03018691|25934478|FG000|Overall Study|Lack of Efficacy|0|||
13119439|NCT03018691|25934479|FG001|Overall Study|Lack of Efficacy|0|||
13119440|NCT03018691|25934480|FG002|Overall Study|Lack of Efficacy|1|||
13119441|NCT03018691|25934478|FG000|Overall Study|Withdrawal by Subject|0|||
13119442|NCT03018691|25934479|FG001|Overall Study|Withdrawal by Subject|0|||
13119443|NCT03018691|25934480|FG002|Overall Study|Withdrawal by Subject|1|||
13119444|NCT03018691|25934478|FG000|Overall Study|Withdrawal by parent/guardian|1|||
13119445|NCT03018691|25934479|FG001|Overall Study|Withdrawal by parent/guardian|0|||
13119446|NCT03018691|25934480|FG002|Overall Study|Withdrawal by parent/guardian|1|||
13119447|NCT03018340|25934537|FG000|Overall Study|Adverse Event|1|||
13119448|NCT03018340|25934538|FG001|Overall Study|Adverse Event|2|||
13119449|NCT03018340|25934537|FG000|Overall Study|Withdrawal by Subject|0|||
13119450|NCT03018340|25934538|FG001|Overall Study|Withdrawal by Subject|8|||
13119451|NCT03018340|25934537|FG000|Overall Study|Lack of Efficacy|0|||
13119452|NCT03018340|25934538|FG001|Overall Study|Lack of Efficacy|1|||
13119453|NCT03018340|25934537|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
13119454|NCT03018340|25934538|FG001|Overall Study|Non-compliance with study drug/procedure|4|||
13119455|NCT03018340|25934537|FG000|Overall Study|Lost to Follow-up|1|||
13119456|NCT03018340|25934538|FG001|Overall Study|Lost to Follow-up|7|||
13277350|NCT00985686|26445781|FG002|Overall Study|Lost to Follow-up|0|||
13277351|NCT00985686|26445782|FG003|Overall Study|Lost to Follow-up|2|||
13277352|NCT00985673|26446052|FG000|Overall Study|Lost to Follow-up|6|||
13277353|NCT00985673|26446053|FG001|Overall Study|Lost to Follow-up|7|||
13277354|NCT00985673|26446054|FG002|Overall Study|Lost to Follow-up|6|||
13277355|NCT00985673|26446055|FG003|Overall Study|Lost to Follow-up|10|||
13277356|NCT00985673|26446056|FG004|Overall Study|Lost to Follow-up|5|||
13277357|NCT00985673|26446057|FG005|Overall Study|Lost to Follow-up|3|||
13277358|NCT00985673|26446052|FG000|Overall Study|Withdrawal by Subject|0|||
13277359|NCT00985673|26446053|FG001|Overall Study|Withdrawal by Subject|4|||
13277360|NCT00985673|26446054|FG002|Overall Study|Withdrawal by Subject|5|||
13277361|NCT00985673|26446055|FG003|Overall Study|Withdrawal by Subject|2|||
13277362|NCT00985673|26446056|FG004|Overall Study|Withdrawal by Subject|2|||
13277363|NCT00985673|26446057|FG005|Overall Study|Withdrawal by Subject|3|||
13277364|NCT00985673|26446052|FG000|Overall Study|Other|1|||
13277365|NCT00985673|26446053|FG001|Overall Study|Other|0|||
13277366|NCT00985673|26446054|FG002|Overall Study|Other|1|||
13277367|NCT00985673|26446055|FG003|Overall Study|Other|0|||
13277368|NCT00985673|26446056|FG004|Overall Study|Other|1|||
13277369|NCT00985673|26446057|FG005|Overall Study|Other|0|||
13277370|NCT00985504|26446090|FG000|Acute Treatment Period|Adverse Event|3|||
13277371|NCT00985504|26446091|FG001|Acute Treatment Period|Adverse Event|4|||
13277372|NCT00985504|26446090|FG000|Acute Treatment Period|Entry Criteria Not Met|1|||
13277373|NCT00985504|26446091|FG001|Acute Treatment Period|Entry Criteria Not Met|2|||
13277374|NCT00985504|26446090|FG000|Acute Treatment Period|Protocol Violation|2|||
13277375|NCT00985504|26446091|FG001|Acute Treatment Period|Protocol Violation|0|||
13277376|NCT00985504|26446090|FG000|Acute Treatment Period|Sponsor Decision|0|||
13277377|NCT00985504|26446091|FG001|Acute Treatment Period|Sponsor Decision|1|||
13277378|NCT00985504|26446090|FG000|Acute Treatment Period|Withdrawal by Subject|9|||
13277379|NCT00985504|26446091|FG001|Acute Treatment Period|Withdrawal by Subject|5|||
13277380|NCT00985504|26446090|FG000|Optimization Period|Adverse Event|7|||
13277381|NCT00985504|26446091|FG001|Optimization Period|Adverse Event|9|||
13277382|NCT00985504|26446090|FG000|Optimization Period|Death|0|||
13277383|NCT00985504|26446091|FG001|Optimization Period|Death|1|||
13277384|NCT00985504|26446090|FG000|Optimization Period|Lack of Efficacy|5|||
13277385|NCT00985504|26446091|FG001|Optimization Period|Lack of Efficacy|3|||
13277386|NCT00985504|26446090|FG000|Optimization Period|Lost to Follow-up|0|||
13277387|NCT00985504|26446091|FG001|Optimization Period|Lost to Follow-up|1|||
13277388|NCT00985504|26446090|FG000|Optimization Period|Physician Decision|1|||
13277389|NCT00985504|26446091|FG001|Optimization Period|Physician Decision|0|||
13277390|NCT00985504|26446090|FG000|Optimization Period|Protocol Violation|3|||
13277391|NCT00985504|26446091|FG001|Optimization Period|Protocol Violation|1|||
13277392|NCT00985504|26446090|FG000|Optimization Period|Withdrawal by Subject|10|||
13119457|NCT03018340|25934537|FG000|Overall Study|Protocol Violation|3|||
13119458|NCT03018340|25934538|FG001|Overall Study|Protocol Violation|7|||
13277393|NCT00985504|26446091|FG001|Optimization Period|Withdrawal by Subject|8|||
13277394|NCT00985491|26446098|FG000|Overall Study|Adverse Event|8|||
13277395|NCT00985491|26446098|FG000|Overall Study|device migration|7|||
13277396|NCT00985491|26446098|FG000|Overall Study|Withdrawal by Subject|1|||
13277397|NCT00985491|26446098|FG000|Overall Study|implant failure|3|||
13277398|NCT00985465|26446128|FG000|Overall Study|Withdrawal by Subject|1|||
13277399|NCT00985465|26446129|FG001|Overall Study|Withdrawal by Subject|2|||
13277400|NCT00985465|26446128|FG000|Overall Study|Considered to be part of the other group|0|||
13277401|NCT00985465|26446129|FG001|Overall Study|Considered to be part of the other group|1|||
13277402|NCT00985439|26446152|FG000|Overall Study|Adverse Event|0|||
13277403|NCT00985439|26446153|FG001|Overall Study|Adverse Event|0|||
13277404|NCT00985439|26446154|FG002|Overall Study|Adverse Event|1|||
13277405|NCT00985439|26446155|FG003|Overall Study|Adverse Event|0|||
13277406|NCT00985426|26446178|FG000|Overall Study|Adverse Event|0|||
13277407|NCT00985426|26446179|FG001|Overall Study|Adverse Event|1|||
13277408|NCT00985426|26446178|FG000|Overall Study|Subject Non-Compliance|3|||
13277409|NCT00985426|26446179|FG001|Overall Study|Subject Non-Compliance|3|||
13277410|NCT00985426|26446178|FG000|Overall Study|Withdrawal by Subject|12|||
13277411|NCT00985426|26446179|FG001|Overall Study|Withdrawal by Subject|16|||
13277412|NCT00985426|26446178|FG000|Overall Study|Lost to Follow-up|8|||
13277413|NCT00985426|26446179|FG001|Overall Study|Lost to Follow-up|10|||
13277414|NCT00985426|26446178|FG000|Overall Study|Death|7|||
13277415|NCT00985426|26446179|FG001|Overall Study|Death|3|||
13277416|NCT00985426|26446178|FG000|Overall Study|Protocol Violation|2|||
13277417|NCT00985426|26446179|FG001|Overall Study|Protocol Violation|0|||
13277418|NCT00985426|26446178|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
13277419|NCT00985426|26446179|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
13277420|NCT00985231|26446194|FG000|Overall Study|ineligible|1|||
13277421|NCT00985231|26446195|FG001|Overall Study|ineligible|0|||
13277422|NCT00985231|26446194|FG000|Overall Study|Protocol Violation|1|||
13277423|NCT00985231|26446195|FG001|Overall Study|Protocol Violation|0|||
13277424|NCT00985231|26446194|FG000|Overall Study|Withdrawal by Subject|1|||
13277425|NCT00985231|26446195|FG001|Overall Study|Withdrawal by Subject|0|||
13277426|NCT00985231|26446194|FG000|Overall Study|Lost to Follow-up|0|||
13277427|NCT00985231|26446195|FG001|Overall Study|Lost to Follow-up|1|||
13277428|NCT00985231|26446194|FG000|Overall Study|Study related symptoms & complaints|0|||
13277429|NCT00985231|26446195|FG001|Overall Study|Study related symptoms & complaints|2|||
13277430|NCT00985192|26446206|FG000|Overall Study|Withdrawal by Subject|1|||
13277431|NCT00985192|26446206|FG000|Overall Study|Disease Progression|1|||
13277432|NCT00985192|26446206|FG000|Overall Study|Determined to be Ineligible During Trial|2|||
13277433|NCT00985166|26446232|FG000|Overall Study|Lost to Follow-up|3|||
13277434|NCT00985166|26446233|FG001|Overall Study|Lost to Follow-up|2|||
13277435|NCT00985166|26446234|FG002|Overall Study|Lost to Follow-up|2|||
13277436|NCT00985166|26446232|FG000|Overall Study|Withdrawal by Subject|3|||
13277437|NCT00985166|26446233|FG001|Overall Study|Withdrawal by Subject|2|||
13277438|NCT00985166|26446234|FG002|Overall Study|Withdrawal by Subject|0|||
13277439|NCT00985166|26446232|FG000|Overall Study|Test not done|2|||
13277440|NCT00985166|26446233|FG001|Overall Study|Test not done|0|||
13277441|NCT00985166|26446234|FG002|Overall Study|Test not done|4|||
13277442|NCT00985166|26446232|FG000|Overall Study|Other|1|||
13277443|NCT00985166|26446233|FG001|Overall Study|Other|0|||
13277444|NCT00985166|26446234|FG002|Overall Study|Other|1|||
13277445|NCT00985153|26446289|FG000|Overall Study|Lost to Follow-up|16|||
13277446|NCT00985153|26446290|FG001|Overall Study|Lost to Follow-up|19|||
13277447|NCT00985153|26446291|FG002|Overall Study|Lost to Follow-up|17|||
13277448|NCT00985153|26446292|FG003|Overall Study|Lost to Follow-up|20|||
13277449|NCT00985153|26446289|FG000|Overall Study|Protocol Violation|3|||
13277450|NCT00985153|26446290|FG001|Overall Study|Protocol Violation|2|||
13277451|NCT00985153|26446291|FG002|Overall Study|Protocol Violation|4|||
13277452|NCT00985153|26446292|FG003|Overall Study|Protocol Violation|3|||
13277453|NCT00985153|26446289|FG000|Overall Study|Withdrawal by Subject|6|||
13277454|NCT00985153|26446290|FG001|Overall Study|Withdrawal by Subject|11|||
13277455|NCT00985153|26446291|FG002|Overall Study|Withdrawal by Subject|11|||
13277456|NCT00985153|26446292|FG003|Overall Study|Withdrawal by Subject|10|||
13277457|NCT00985153|26446289|FG000|Overall Study|Missed One or More Bleeds|7|||
13277458|NCT00985153|26446290|FG001|Overall Study|Missed One or More Bleeds|7|||
13277459|NCT00985153|26446291|FG002|Overall Study|Missed One or More Bleeds|8|||
13277460|NCT00985153|26446292|FG003|Overall Study|Missed One or More Bleeds|10|||
13277461|NCT00985153|26446289|FG000|Overall Study|Incomplete Safety Follow-up|3|||
13277462|NCT00985153|26446290|FG001|Overall Study|Incomplete Safety Follow-up|5|||
13277463|NCT00985153|26446291|FG002|Overall Study|Incomplete Safety Follow-up|4|||
13277464|NCT00985153|26446292|FG003|Overall Study|Incomplete Safety Follow-up|4|||
13277465|NCT00985114|26446305|FG000|Overall Study|Adverse Event|1|||
13277466|NCT00985114|26446306|FG001|Overall Study|Adverse Event|0|||
13277467|NCT00985114|26446305|FG000|Overall Study|Withdrawal by Subject|0|||
13277468|NCT00985114|26446306|FG001|Overall Study|Withdrawal by Subject|2|||
13277469|NCT00985088|26446587|FG000|Overall Study|Serious Adverse Event|1|||
13277470|NCT00985088|26446588|FG001|Overall Study|Serious Adverse Event|1|||
13277471|NCT00985088|26446589|FG002|Overall Study|Serious Adverse Event|0|||
13277472|NCT00985088|26446590|FG003|Overall Study|Serious Adverse Event|0|||
13277473|NCT00985088|26446591|FG004|Overall Study|Serious Adverse Event|0|||
13277474|NCT00985088|26446592|FG005|Overall Study|Serious Adverse Event|0|||
13277475|NCT00985088|26446593|FG006|Overall Study|Serious Adverse Event|0|||
13277476|NCT00985088|26446594|FG007|Overall Study|Serious Adverse Event|1|||
13277477|NCT00985088|26446587|FG000|Overall Study|Adverse Event|0|||
13277478|NCT00985088|26446588|FG001|Overall Study|Adverse Event|0|||
13277479|NCT00985088|26446589|FG002|Overall Study|Adverse Event|1|||
13277480|NCT00985088|26446590|FG003|Overall Study|Adverse Event|0|||
13277481|NCT00985088|26446591|FG004|Overall Study|Adverse Event|0|||
13277482|NCT00985088|26446592|FG005|Overall Study|Adverse Event|0|||
13277483|NCT00985088|26446593|FG006|Overall Study|Adverse Event|0|||
13277484|NCT00985088|26446594|FG007|Overall Study|Adverse Event|0|||
13277485|NCT00985088|26446587|FG000|Overall Study|Withdrawal by Subject|4|||
13277486|NCT00985088|26446588|FG001|Overall Study|Withdrawal by Subject|0|||
13277487|NCT00985088|26446589|FG002|Overall Study|Withdrawal by Subject|0|||
13277488|NCT00985088|26446590|FG003|Overall Study|Withdrawal by Subject|1|||
13277489|NCT00985088|26446591|FG004|Overall Study|Withdrawal by Subject|3|||
13277490|NCT00985088|26446592|FG005|Overall Study|Withdrawal by Subject|2|||
13277491|NCT00985088|26446593|FG006|Overall Study|Withdrawal by Subject|1|||
13277492|NCT00985088|26446594|FG007|Overall Study|Withdrawal by Subject|2|||
13277493|NCT00985088|26446587|FG000|Overall Study|Migrated/moved from study area|0|||
13277494|NCT00985088|26446588|FG001|Overall Study|Migrated/moved from study area|0|||
13277495|NCT00985088|26446589|FG002|Overall Study|Migrated/moved from study area|1|||
13277496|NCT00985088|26446590|FG003|Overall Study|Migrated/moved from study area|0|||
13277497|NCT00985088|26446591|FG004|Overall Study|Migrated/moved from study area|0|||
13277498|NCT00985088|26446592|FG005|Overall Study|Migrated/moved from study area|0|||
13277499|NCT00985088|26446593|FG006|Overall Study|Migrated/moved from study area|0|||
13277500|NCT00985088|26446594|FG007|Overall Study|Migrated/moved from study area|1|||
13277501|NCT00985088|26446587|FG000|Overall Study|Lost to Follow-up|6|||
13277502|NCT00985088|26446588|FG001|Overall Study|Lost to Follow-up|1|||
13277503|NCT00985088|26446589|FG002|Overall Study|Lost to Follow-up|2|||
13277504|NCT00985088|26446590|FG003|Overall Study|Lost to Follow-up|6|||
13277505|NCT00985088|26446591|FG004|Overall Study|Lost to Follow-up|6|||
13277506|NCT00985088|26446592|FG005|Overall Study|Lost to Follow-up|5|||
13277507|NCT00985088|26446593|FG006|Overall Study|Lost to Follow-up|3|||
13277508|NCT00985088|26446594|FG007|Overall Study|Lost to Follow-up|2|||
13277509|NCT00984867|26446619|FG000|Overall Study|Adverse Event|3|||
13277510|NCT00984867|26446620|FG001|Overall Study|Adverse Event|7|||
13277511|NCT00984867|26446619|FG000|Overall Study|Death|1|||
13277512|NCT00984867|26446620|FG001|Overall Study|Death|0|||
13277513|NCT00984867|26446619|FG000|Overall Study|Withdrawal by Subject|13|||
13277514|NCT00984867|26446620|FG001|Overall Study|Withdrawal by Subject|4|||
13277515|NCT00984867|26446619|FG000|Overall Study|Lost to Follow-up|3|||
13277516|NCT00984867|26446620|FG001|Overall Study|Lost to Follow-up|4|||
13277517|NCT00984867|26446619|FG000|Overall Study|Poor/non-compliance|0|||
13277518|NCT00984867|26446620|FG001|Overall Study|Poor/non-compliance|1|||
13277519|NCT00984867|26446619|FG000|Overall Study|Subject no longer meets study criteria|1|||
13277520|NCT00984867|26446620|FG001|Overall Study|Subject no longer meets study criteria|1|||
13277521|NCT00984867|26446619|FG000|Overall Study|site closing|1|||
13277522|NCT00984867|26446620|FG001|Overall Study|site closing|0|||
13277523|NCT00984867|26446619|FG000|Overall Study|lack of efficacy and subject compliance|1|||
13277524|NCT00984867|26446620|FG001|Overall Study|lack of efficacy and subject compliance|0|||
13277525|NCT00984594|26446641|FG000|Overall Study|Lost to Follow-up|1|||
13277526|NCT00984594|26446642|FG001|Overall Study|Lost to Follow-up|0|||
13277527|NCT00984594|26446641|FG000|Overall Study|Withdrawal by Subject|0|||
13277528|NCT00984594|26446642|FG001|Overall Study|Withdrawal by Subject|1|||
13277529|NCT00984568|26446657|FG000|Overall Study|Withdrawal by Subject|1|||
13277530|NCT00984568|26446658|FG001|Overall Study|Withdrawal by Subject|2|||
13277531|NCT00984568|26446657|FG000|Overall Study|Lack of Efficacy|2|||
13277532|NCT00984568|26446658|FG001|Overall Study|Lack of Efficacy|0|||
13277533|NCT00984568|26446657|FG000|Overall Study|Adverse Event|2|||
13277534|NCT00984568|26446658|FG001|Overall Study|Adverse Event|0|||
13277535|NCT00984568|26446657|FG000|Overall Study|Did Not Meet Randomization Criteria|1|||
13277536|NCT00984568|26446658|FG001|Overall Study|Did Not Meet Randomization Criteria|0|||
13277537|NCT00984568|26446657|FG000|Overall Study|Lost to Follow-up|0|||
13277538|NCT00984568|26446658|FG001|Overall Study|Lost to Follow-up|1|||
13277539|NCT00984568|26446657|FG000|Overall Study|Opportunistic Infection|1|||
13277540|NCT00984568|26446658|FG001|Overall Study|Opportunistic Infection|0|||
13277541|NCT00984568|26446657|FG000|Overall Study|Unknown Reason|1|||
13277542|NCT00984568|26446658|FG001|Overall Study|Unknown Reason|3|||
13277543|NCT00984542|26446668|FG000|Overall Study|disease progression|19|||
13277544|NCT00984542|26446668|FG000|Overall Study|toxicity|7|||
13277545|NCT00984542|26446668|FG000|Overall Study|Death|7|||
13277546|NCT00984542|26446668|FG000|Overall Study|complicating disease|3|||
13277547|NCT00984542|26446668|FG000|Overall Study|Withdrawal by Subject|3|||
13277548|NCT00984542|26446668|FG000|Overall Study|clinical deterioration|2|||
13277549|NCT00984256|26446695|FG000|Overall Study|Withdrawal by Subject|0|||
13277550|NCT00984256|26446696|FG001|Overall Study|Withdrawal by Subject|1|||
13277551|NCT00984204|26446704|FG000|Overall Study|Death|1|||
13277552|NCT00984204|26446704|FG000|Overall Study|Lost to Follow-up|4|||
13277553|NCT00984204|26446704|FG000|Overall Study|Lack of Efficacy|10|||
13277554|NCT00984061|26446717|FG000|Clarithromycin Alone|Protocol Violation|1|||
13277555|NCT00984022|26446734|FG000|Overall Study|Lost to Follow-up|10|||
13277556|NCT00984022|26446735|FG001|Overall Study|Lost to Follow-up|14|||
13277557|NCT00984009|26446748|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1|||
13277558|NCT00983957|26446784|FG000|Overall Study|Adverse Event|1|||
13277559|NCT00983957|26446784|FG000|Overall Study|Personal Reasons|1|||
13277560|NCT00983931|26446796|FG000|14 Day Washout Period|Physician Decision|1|||
13277561|NCT00983918|26446819|FG000|Overall Study|conversion to open cholecystectomy|0|||
13277562|NCT00983918|26446820|FG001|Overall Study|conversion to open cholecystectomy|2|||
13277563|NCT00983918|26446821|FG002|Overall Study|conversion to open cholecystectomy|2|||
13277564|NCT00983918|26446822|FG003|Overall Study|conversion to open cholecystectomy|2|||
13277565|NCT00983905|26446835|FG000|Theophylline Alone|Adverse Event|1|||
13277566|NCT00983905|26446835|FG000|Colchicine Alone|Adverse Event|2|||
13277567|NCT00983892|26446848|FG000|Overall Study|Withdrawal by Subject|10|||
13277568|NCT00983892|26446849|FG001|Overall Study|Withdrawal by Subject|12|||
13277569|NCT00983853|26446896|FG000|Overall Study|Lost to Follow-up|1|||
13277570|NCT00983853|26446897|FG001|Overall Study|Lost to Follow-up|1|||
13277571|NCT00983853|26446898|FG002|Overall Study|Lost to Follow-up|2|||
13277572|NCT00983853|26446899|FG003|Overall Study|Lost to Follow-up|2|||
13277573|NCT00983853|26446900|FG004|Overall Study|Lost to Follow-up|2|||
13277574|NCT00983853|26446901|FG005|Overall Study|Lost to Follow-up|1|||
13277575|NCT00983853|26446896|FG000|Overall Study|Withdrawal by Subject|0|||
13277576|NCT00983853|26446897|FG001|Overall Study|Withdrawal by Subject|0|||
13277577|NCT00983853|26446898|FG002|Overall Study|Withdrawal by Subject|1|||
13277578|NCT00983853|26446899|FG003|Overall Study|Withdrawal by Subject|0|||
13277579|NCT00983853|26446900|FG004|Overall Study|Withdrawal by Subject|1|||
13277580|NCT00983853|26446901|FG005|Overall Study|Withdrawal by Subject|0|||
13277581|NCT00983853|26446896|FG000|Overall Study|Unable to come to study follow-up visits|0|||
13277582|NCT00983853|26446897|FG001|Overall Study|Unable to come to study follow-up visits|1|||
13277583|NCT00983853|26446898|FG002|Overall Study|Unable to come to study follow-up visits|0|||
13277584|NCT00983853|26446899|FG003|Overall Study|Unable to come to study follow-up visits|0|||
13277585|NCT00983853|26446900|FG004|Overall Study|Unable to come to study follow-up visits|0|||
13277586|NCT00983853|26446901|FG005|Overall Study|Unable to come to study follow-up visits|0|||
13277587|NCT00983827|26446907|FG000|Overall Study|Withdrawal by Subject|1|||
13277588|NCT00983749|26446922|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1|||
13277589|NCT00983749|26446923|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3|||
13277590|NCT00983580|26446946|FG000|Overall Study|Cancel Prior to treatment|1|||
13277591|NCT00983580|26446947|FG001|Overall Study|Cancel Prior to treatment|3|||
13277592|NCT00983580|26446946|FG000|Overall Study|Protocol Violation|1|||
13277593|NCT00983580|26446947|FG001|Overall Study|Protocol Violation|1|||
13277594|NCT00983580|26446946|FG000|Overall Study|Ineligible|3|||
13277595|NCT00983580|26446947|FG001|Overall Study|Ineligible|0|||
13277596|NCT00983528|26446954|FG000|Overall Study|Death|4|||
13277597|NCT00983528|26446954|FG000|Overall Study|Lost to Follow-up|1|||
13277598|NCT00983528|26446954|FG000|Overall Study|Study Terminated|1|||
13277599|NCT00983515|26446967|FG000|Ritonavir Alone|liver panel out of range|6|||
13277600|NCT00983515|26446967|FG000|Colchicine With Ritonavir|Lost to Follow-up|1|||
13277601|NCT00983372|26446980|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
13277602|NCT00983372|26446980|FG000|Diltiazem ER Alone|missed diltiazem dose|2|||
13277603|NCT00983372|26446980|FG000|Diltiazem ER Alone|Adverse Event|1|||
13277604|NCT00983294|26446993|FG000|14 Day Washout Period|Withdrawal by Subject|2|||
13277605|NCT00983294|26446993|FG000|Colchicine With Azithromycin|Adverse Event|1|||
13277606|NCT00983073|26447016|FG000|Titration and Optimal Dose Period|Adverse Event|19|||
13277607|NCT00983073|26447016|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11|||
13277608|NCT00983073|26447016|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5|||
13277609|NCT00983073|26447016|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
13277610|NCT00983073|26447016|FG000|Titration and Optimal Dose Period|Other reason|4|||
13277611|NCT00983073|26447016|FG000|Maintenance Period|Adverse Event|5|||
13277612|NCT00983073|26447016|FG000|Maintenance Period|Withdrawal by Subject|2|||
13277613|NCT00983073|26447016|FG000|Maintenance Period|Lack of Efficacy|2|||
13277614|NCT00983073|26447016|FG000|Maintenance Period|Other Reason|7|||
13277615|NCT00982930|26447036|FG000|Overall Study|Adverse Event|1|||
13277616|NCT00982930|26447036|FG000|Overall Study|Withdrawal by Subject|1|||
13277617|NCT00982930|26447036|FG000|Overall Study|Administrative Problems|2|||
13277618|NCT00982878|26447043|FG000|Overall Study|Physician Decision|1|||
13277619|NCT00982735|26447051|FG000|Overall Study|Lost to Follow-up|6|||
13277620|NCT00982735|26447051|FG000|Overall Study|Patient ineligible for trial|224|||
13277621|NCT00982488|26447079|FG000|Overall Study|Administrative reason by sponsor|81|||
13277622|NCT00982488|26447080|FG001|Overall Study|Administrative reason by sponsor|3|||
13277623|NCT00982488|26447081|FG002|Overall Study|Administrative reason by sponsor|11|||
13277624|NCT00982488|26447082|FG003|Overall Study|Administrative reason by sponsor|0|||
13277625|NCT00982488|26447083|FG004|Overall Study|Administrative reason by sponsor|0|||
13277626|NCT00982488|26447079|FG000|Overall Study|Adverse event unrelated to study drug|5|||
13277627|NCT00982488|26447080|FG001|Overall Study|Adverse event unrelated to study drug|1|||
13277628|NCT00982488|26447081|FG002|Overall Study|Adverse event unrelated to study drug|0|||
13277629|NCT00982488|26447082|FG003|Overall Study|Adverse event unrelated to study drug|0|||
13277630|NCT00982488|26447083|FG004|Overall Study|Adverse event unrelated to study drug|0|||
13277631|NCT00982488|26447079|FG000|Overall Study|Death|11|||
13277632|NCT00982488|26447080|FG001|Overall Study|Death|0|||
13277633|NCT00982488|26447081|FG002|Overall Study|Death|2|||
13277634|NCT00982488|26447082|FG003|Overall Study|Death|0|||
13277635|NCT00982488|26447083|FG004|Overall Study|Death|0|||
13277636|NCT00982488|26447079|FG000|Overall Study|Disease progression|30|||
13277637|NCT00982488|26447080|FG001|Overall Study|Disease progression|5|||
13277638|NCT00982488|26447081|FG002|Overall Study|Disease progression|10|||
13277639|NCT00982488|26447082|FG003|Overall Study|Disease progression|1|||
13277640|NCT00982488|26447083|FG004|Overall Study|Disease progression|1|||
13277641|NCT00982488|26447079|FG000|Overall Study|Lost to Follow-up|1|||
13277642|NCT00982488|26447080|FG001|Overall Study|Lost to Follow-up|0|||
13277643|NCT00982488|26447081|FG002|Overall Study|Lost to Follow-up|0|||
13277644|NCT00982488|26447082|FG003|Overall Study|Lost to Follow-up|0|||
13277645|NCT00982488|26447083|FG004|Overall Study|Lost to Follow-up|0|||
13277646|NCT00982488|26447079|FG000|Overall Study|Maximum clinical benefit|1|||
13277647|NCT00982488|26447080|FG001|Overall Study|Maximum clinical benefit|1|||
13277648|NCT00982488|26447081|FG002|Overall Study|Maximum clinical benefit|1|||
13277649|NCT00982488|26447082|FG003|Overall Study|Maximum clinical benefit|0|||
13277650|NCT00982488|26447083|FG004|Overall Study|Maximum clinical benefit|0|||
13277651|NCT00982488|26447079|FG000|Overall Study|Other|15|||
13277652|NCT00982488|26447080|FG001|Overall Study|Other|1|||
13277653|NCT00982488|26447081|FG002|Overall Study|Other|3|||
13277654|NCT00982488|26447082|FG003|Overall Study|Other|1|||
13277655|NCT00982488|26447083|FG004|Overall Study|Other|0|||
13277656|NCT00982488|26447079|FG000|Overall Study|Poor compliance/noncompliance|0|||
13277657|NCT00982488|26447080|FG001|Overall Study|Poor compliance/noncompliance|1|||
13277658|NCT00982488|26447081|FG002|Overall Study|Poor compliance/noncompliance|0|||
13277659|NCT00982488|26447082|FG003|Overall Study|Poor compliance/noncompliance|0|||
13277660|NCT00982488|26447083|FG004|Overall Study|Poor compliance/noncompliance|0|||
13277661|NCT00982488|26447079|FG000|Overall Study|Stem cell transplant|2|||
13277662|NCT00982488|26447080|FG001|Overall Study|Stem cell transplant|0|||
13277663|NCT00982488|26447081|FG002|Overall Study|Stem cell transplant|0|||
13277664|NCT00982488|26447082|FG003|Overall Study|Stem cell transplant|1|||
13277665|NCT00982488|26447083|FG004|Overall Study|Stem cell transplant|0|||
13277666|NCT00982488|26447079|FG000|Overall Study|Study drug toxicity|34|||
13277667|NCT00982488|26447080|FG001|Overall Study|Study drug toxicity|1|||
13277668|NCT00982488|26447081|FG002|Overall Study|Study drug toxicity|6|||
13277669|NCT00982488|26447082|FG003|Overall Study|Study drug toxicity|0|||
13277670|NCT00982488|26447083|FG004|Overall Study|Study drug toxicity|0|||
13277671|NCT00982488|26447079|FG000|Overall Study|Withdrawal by Subject|5|||
13277672|NCT00982488|26447080|FG001|Overall Study|Withdrawal by Subject|1|||
13277673|NCT00982488|26447081|FG002|Overall Study|Withdrawal by Subject|1|||
13277674|NCT00982488|26447082|FG003|Overall Study|Withdrawal by Subject|0|||
13277675|NCT00982488|26447083|FG004|Overall Study|Withdrawal by Subject|0|||
13277676|NCT00982410|26447112|FG000|3-month Follow-up Assessment|Could not reach to schedule|8|||
13277677|NCT00982410|26447113|FG001|3-month Follow-up Assessment|Could not reach to schedule|9|||
13277678|NCT00982410|26447112|FG000|3-month Follow-up Assessment|Scheduled, no-show|1|||
13277679|NCT00982410|26447113|FG001|3-month Follow-up Assessment|Scheduled, no-show|2|||
13277680|NCT00982410|26447112|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0|||
13277681|NCT00982410|26447113|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2|||
13277682|NCT00982410|26447112|FG000|6-month Follow-up Assessment|Could not reach to schedule|5|||
13277683|NCT00982410|26447113|FG001|6-month Follow-up Assessment|Could not reach to schedule|7|||
13277684|NCT00982410|26447112|FG000|6-month Follow-up Assessment|participant no transportation|1|||
13277685|NCT00982410|26447113|FG001|6-month Follow-up Assessment|participant no transportation|0|||
13277686|NCT00982410|26447112|FG000|6-month Follow-up Assessment|incarceration|0|||
13277687|NCT00982410|26447113|FG001|6-month Follow-up Assessment|incarceration|2|||
13277688|NCT00982410|26447112|FG000|6-month Follow-up Assessment|patent surgery|0|||
13277689|NCT00982410|26447113|FG001|6-month Follow-up Assessment|patent surgery|1|||
13277690|NCT00982410|26447112|FG000|6-month Follow-up Assessment|scheduled, no-show|0|||
13277691|NCT00982410|26447113|FG001|6-month Follow-up Assessment|scheduled, no-show|1|||
13277692|NCT00982410|26447112|FG000|12-month Follow-up Assessment|Death|0|||
13277693|NCT00982410|26447113|FG001|12-month Follow-up Assessment|Death|2|||
13277694|NCT00982410|26447112|FG000|12-month Follow-up Assessment|could not reach to schedule|6|||
13277695|NCT00982410|26447113|FG001|12-month Follow-up Assessment|could not reach to schedule|5|||
13277696|NCT00982410|26447112|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0|||
13277697|NCT00982410|26447113|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1|||
13277698|NCT00982410|26447112|FG000|12-month Follow-up Assessment|incarceration|2|||
13277699|NCT00982410|26447113|FG001|12-month Follow-up Assessment|incarceration|1|||
13277700|NCT00982410|26447112|FG000|12-month Follow-up Assessment|scheduled, no-show|1|||
13277701|NCT00982410|26447113|FG001|12-month Follow-up Assessment|scheduled, no-show|0|||
13277702|NCT00982280|26447138|FG000|Observation Period|Not eligible to be dosed|19|||
13277703|NCT00982280|26447138|FG000|Titration and Optimal Dose Period|Adverse Event|5|||
13277704|NCT00982280|26447138|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2|||
13277705|NCT00982280|26447138|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1|||
13119459|NCT03018340|25934537|FG000|Overall Study|Not further specified|0|||
13119460|NCT03018340|25934538|FG001|Overall Study|Not further specified|1|||
13119461|NCT03018249|25934557|FG000|Overall Study|Withdrawal by Subject|2|||
13277706|NCT00982280|26447138|FG000|Maintenance Period|Adverse Event|1|||
13291420|NCT00152464|26483332|FG000|Overall Study|Investigator decision|1|||
13291421|NCT00152464|26483333|FG001|Overall Study|Investigator decision|0|||
13291422|NCT00152464|26483332|FG000|Overall Study|Lack of Efficacy|1|||
13291423|NCT00152464|26483333|FG001|Overall Study|Lack of Efficacy|0|||
13291424|NCT00152464|26483332|FG000|Overall Study|Eczema poorly controlled|1|||
13291425|NCT00152464|26483333|FG001|Overall Study|Eczema poorly controlled|0|||
13291426|NCT00152464|26483332|FG000|Overall Study|Patient relocated|1|||
13291427|NCT00152464|26483333|FG001|Overall Study|Patient relocated|0|||
13291428|NCT00152009|26483376|FG000|Overall Study|Adverse Event|9|||
13291429|NCT00152009|26483377|FG001|Overall Study|Adverse Event|13|||
13291430|NCT00152009|26483378|FG002|Overall Study|Adverse Event|20|||
13291431|NCT00152009|26483379|FG003|Overall Study|Adverse Event|1|||
13291432|NCT00152009|26483376|FG000|Overall Study|Protocol Violation|3|||
13291433|NCT00152009|26483377|FG001|Overall Study|Protocol Violation|0|||
13291434|NCT00152009|26483378|FG002|Overall Study|Protocol Violation|0|||
13291435|NCT00152009|26483379|FG003|Overall Study|Protocol Violation|1|||
13291436|NCT00152009|26483376|FG000|Overall Study|Withdrawal by Subject|2|||
13119462|NCT03018249|25934558|FG001|Overall Study|Withdrawal by Subject|2|||
13119463|NCT03018106|25934573|FG000|Overall Study|Lost to Follow-up|0|||
13119464|NCT03018106|25934574|FG001|Overall Study|Lost to Follow-up|1|||
13119465|NCT03018028|25934835|FG000|Overall Study|Withdrawal by Subject|3|||
13119466|NCT03018028|25934836|FG001|Overall Study|Withdrawal by Subject|0|||
13119467|NCT03018028|25934837|FG002|Overall Study|Withdrawal by Subject|1|||
13119468|NCT03018028|25934838|FG003|Overall Study|Withdrawal by Subject|2|||
13291437|NCT00152009|26483377|FG001|Overall Study|Withdrawal by Subject|3|||
13291438|NCT00152009|26483378|FG002|Overall Study|Withdrawal by Subject|4|||
13291439|NCT00152009|26483379|FG003|Overall Study|Withdrawal by Subject|9|||
13291440|NCT00152009|26483376|FG000|Overall Study|Lost to Follow-up|2|||
13291441|NCT00152009|26483377|FG001|Overall Study|Lost to Follow-up|4|||
13291442|NCT00152009|26483378|FG002|Overall Study|Lost to Follow-up|3|||
13291443|NCT00152009|26483379|FG003|Overall Study|Lost to Follow-up|3|||
13291444|NCT00152009|26483376|FG000|Overall Study|Lack of Efficacy|8|||
13291445|NCT00152009|26483377|FG001|Overall Study|Lack of Efficacy|6|||
13291446|NCT00152009|26483378|FG002|Overall Study|Lack of Efficacy|7|||
13291447|NCT00152009|26483379|FG003|Overall Study|Lack of Efficacy|15|||
13291448|NCT00152009|26483376|FG000|Overall Study|ECG abnormalities|2|||
13291449|NCT00152009|26483377|FG001|Overall Study|ECG abnormalities|2|||
13291450|NCT00152009|26483378|FG002|Overall Study|ECG abnormalities|2|||
13291451|NCT00152009|26483379|FG003|Overall Study|ECG abnormalities|1|||
13291452|NCT00152009|26483376|FG000|Overall Study|Sponsor's decision|3|||
13291453|NCT00152009|26483377|FG001|Overall Study|Sponsor's decision|3|||
13291454|NCT00152009|26483378|FG002|Overall Study|Sponsor's decision|1|||
13291455|NCT00152009|26483379|FG003|Overall Study|Sponsor's decision|3|||
13291456|NCT00151996|26483400|FG000|Overall Study|Adverse Event|3|||
13291457|NCT00151996|26483401|FG001|Overall Study|Adverse Event|2|||
13291458|NCT00151996|26483400|FG000|Overall Study|Withdrawal by Subject|1|||
13291459|NCT00151996|26483401|FG001|Overall Study|Withdrawal by Subject|1|||
13119469|NCT03018028|25934839|FG004|Overall Study|Withdrawal by Subject|0|||
13119470|NCT03017846|25934849|FG000|Overall Study|Lost to Follow-up|3|||
13119471|NCT03017846|25934849|FG000|Overall Study|Adverse Event|2|||
13119472|NCT03017742|25934861|FG000|Overall Study|Protocol Violation|36|||
13119473|NCT03017742|25934861|FG000|Overall Study|Withdrawal by Subject|37|||
13119474|NCT03017612|25934871|FG000|Overall Study|Adverse Event|2|||
13119475|NCT03017235|25934928|FG000|Overall Study|Withdrawal by Subject|4|||
13119476|NCT03017235|25934929|FG001|Overall Study|Withdrawal by Subject|3|||
13291460|NCT00151996|26483400|FG000|Overall Study|Protocol Violation|1|||
13291461|NCT00151996|26483401|FG001|Overall Study|Protocol Violation|2|||
13291462|NCT00151996|26483400|FG000|Overall Study|Sponsor's decision|0|||
13291463|NCT00151996|26483401|FG001|Overall Study|Sponsor's decision|2|||
13291464|NCT00151892|26483422|FG000|Overall Study|Lack of Efficacy|50|||
13291465|NCT00151892|26483423|FG001|Overall Study|Lack of Efficacy|57|||
13291466|NCT00151892|26483422|FG000|Overall Study|Patient request|10|||
13291467|NCT00151892|26483423|FG001|Overall Study|Patient request|7|||
13119477|NCT03017235|25934928|FG000|Overall Study|Lost to Follow-up|2|||
13119478|NCT03017235|25934929|FG001|Overall Study|Lost to Follow-up|7|||
13119479|NCT03017235|25934928|FG000|Overall Study|Adverse Event|0|||
13119480|NCT03017235|25934929|FG001|Overall Study|Adverse Event|1|||
13119481|NCT03017235|25934928|FG000|Overall Study|Protocol Violation|2|||
13119482|NCT03017235|25934929|FG001|Overall Study|Protocol Violation|1|||
13119483|NCT03017235|25934928|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4|||
13119484|NCT03017235|25934929|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2|||
13119485|NCT03017079|25934952|FG000|Overall Study|Physician Decision|1|||
13119486|NCT03017079|25934953|FG001|Overall Study|Physician Decision|1|||
13119487|NCT03017079|25934952|FG000|Overall Study|Death|3|||
13119488|NCT03017079|25934953|FG001|Overall Study|Death|2|||
13119489|NCT03017079|25934952|FG000|Overall Study|Lack of Efficacy|2|||
13119490|NCT03017079|25934953|FG001|Overall Study|Lack of Efficacy|2|||
13119491|NCT03017079|25934952|FG000|Overall Study|Protocol Violation|0|||
13119492|NCT03017079|25934953|FG001|Overall Study|Protocol Violation|1|||
13119493|NCT03016598|25934986|FG000|Overall Study|Lost to Follow-up|0|||
13277707|NCT00982137|26447181|FG000|Overall Study|Lost to Follow-up|0|||
13277708|NCT00982137|26447182|FG001|Overall Study|Lost to Follow-up|0|||
13277709|NCT00982137|26447183|FG002|Overall Study|Lost to Follow-up|0|||
13277710|NCT00982137|26447184|FG003|Overall Study|Lost to Follow-up|1|||
13277711|NCT00982137|26447181|FG000|Overall Study|Withdrawal by Subject|0|||
13277712|NCT00982137|26447182|FG001|Overall Study|Withdrawal by Subject|1|||
13277713|NCT00982137|26447183|FG002|Overall Study|Withdrawal by Subject|0|||
13277714|NCT00982137|26447184|FG003|Overall Study|Withdrawal by Subject|0|||
13277715|NCT00982020|26447211|FG000|Overall Study|Adverse Event|19|||
13277716|NCT00982020|26447212|FG001|Overall Study|Adverse Event|15|||
13277717|NCT00982020|26447211|FG000|Overall Study|Withdrawal by Subject|11|||
13277718|NCT00982020|26447212|FG001|Overall Study|Withdrawal by Subject|14|||
13277719|NCT00982020|26447211|FG000|Overall Study|Lost to Follow-up|5|||
13277720|NCT00982020|26447212|FG001|Overall Study|Lost to Follow-up|11|||
13277721|NCT00982020|26447211|FG000|Overall Study|Lack of Efficacy|10|||
13277722|NCT00982020|26447212|FG001|Overall Study|Lack of Efficacy|4|||
13277723|NCT00982020|26447211|FG000|Overall Study|Parent/Caregiver Decision|5|||
13277724|NCT00982020|26447212|FG001|Overall Study|Parent/Caregiver Decision|5|||
13277725|NCT00982020|26447211|FG000|Overall Study|Treatment Non-compliance|3|||
13277726|NCT00982020|26447212|FG001|Overall Study|Treatment Non-compliance|6|||
13277727|NCT00982020|26447211|FG000|Overall Study|Physician Decision|2|||
13277728|NCT00982020|26447212|FG001|Overall Study|Physician Decision|5|||
13277729|NCT00982020|26447211|FG000|Overall Study|Entry Criteria Not Met|2|||
13277730|NCT00982020|26447212|FG001|Overall Study|Entry Criteria Not Met|1|||
13277731|NCT00982020|26447211|FG000|Overall Study|Protocol Violation|0|||
13277732|NCT00982020|26447212|FG001|Overall Study|Protocol Violation|2|||
13277733|NCT00982020|26447211|FG000|Overall Study|Clinical Relapse|0|||
13277734|NCT00982020|26447212|FG001|Overall Study|Clinical Relapse|1|||
13277735|NCT00981799|26447239|FG000|Overall Study|Adverse Event|1|||
13277736|NCT00981799|26447240|FG001|Overall Study|Adverse Event|1|||
13277737|NCT00981799|26447241|FG002|Overall Study|Adverse Event|0|||
13277738|NCT00981799|26447242|FG003|Overall Study|Adverse Event|0|||
13277739|NCT00981747|26447262|FG000|Losartan|Withdrawal by Subject|1|||
13277740|NCT00981747|26447262|FG000|Losartan|Death|1|||
13277741|NCT00981747|26447262|FG000|Placebo Oral Tablet|Withdrawal by Subject|1|||
13277742|NCT00981682|26447268|FG000|Overall Study|Adverse Event|48|||
13277743|NCT00981682|26447268|FG000|Overall Study|Withdrawal by Subject|52|||
13277744|NCT00981682|26447268|FG000|Overall Study|Lost to Follow-up|14|||
13277745|NCT00981682|26447268|FG000|Overall Study|Lack of Efficacy|13|||
13277746|NCT00981682|26447268|FG000|Overall Study|Protocol Violation|6|||
13277747|NCT00981682|26447268|FG000|Overall Study|administrative|9|||
13277748|NCT00981578|26447276|FG000|Overall Study|Death|1|||
13277749|NCT00981578|26447276|FG000|Overall Study|Withdrawal by Subject|2|||
13277750|NCT00981461|26447289|FG000|Overall Study|Lost to Follow-up|5|||
13277751|NCT00981461|26447290|FG001|Overall Study|Lost to Follow-up|2|||
13277752|NCT00981292|26447326|FG000|Day 1|Protocol Violation|1|||
13277753|NCT00981292|26447327|FG001|Day 1|Protocol Violation|0|||
13277754|NCT00981292|26447328|FG002|Day 1|Protocol Violation|0|||
13277755|NCT00981292|26447329|FG003|Day 1|Protocol Violation|0|||
13277756|NCT00981292|26447330|FG004|Day 1|Protocol Violation|0|||
13277757|NCT00981292|26447331|FG005|Day 1|Protocol Violation|2|||
13277758|NCT00981292|26447326|FG000|Day 2|Protocol Violation|2|||
13277759|NCT00981292|26447327|FG001|Day 2|Protocol Violation|0|||
13277760|NCT00981292|26447328|FG002|Day 2|Protocol Violation|0|||
13277761|NCT00981292|26447329|FG003|Day 2|Protocol Violation|0|||
13277762|NCT00981292|26447330|FG004|Day 2|Protocol Violation|0|||
13277763|NCT00981292|26447331|FG005|Day 2|Protocol Violation|0|||
13277764|NCT00981292|26447326|FG000|Day 3|Protocol Violation|0|||
13277765|NCT00981292|26447327|FG001|Day 3|Protocol Violation|0|||
13277766|NCT00981292|26447328|FG002|Day 3|Protocol Violation|0|||
13277767|NCT00981292|26447329|FG003|Day 3|Protocol Violation|0|||
13277768|NCT00981292|26447330|FG004|Day 3|Protocol Violation|0|||
13277769|NCT00981292|26447331|FG005|Day 3|Protocol Violation|1|||
13277770|NCT00981175|26447363|FG000|Primary Dose Vaccination|Adverse Event|1|||
13277771|NCT00981175|26447364|FG001|Primary Dose Vaccination|Adverse Event|0|||
13119494|NCT03016598|25934987|FG001|Overall Study|Lost to Follow-up|2|||
13119495|NCT03016403|25935026|FG000|Baseline|Death|5|||
13119496|NCT03016403|25935027|FG001|Baseline|Death|8|||
13277772|NCT00981175|26447363|FG000|Primary Dose Vaccination|Protocol Violation|0|||
13277773|NCT00981175|26447364|FG001|Primary Dose Vaccination|Protocol Violation|1|||
13277774|NCT00981175|26447363|FG000|Primary Dose Vaccination|Lost to Follow-up|2|||
13277775|NCT00981175|26447364|FG001|Primary Dose Vaccination|Lost to Follow-up|1|||
13277776|NCT00981175|26447363|FG000|Booster Dose Vaccination|Lost to Follow-up|2|||
13277777|NCT00981175|26447364|FG001|Booster Dose Vaccination|Lost to Follow-up|3|||
13277778|NCT00981149|26447379|FG000|Overall Study|Lost to Follow-up|1|||
13119497|NCT03016403|25935028|FG002|Baseline|Death|1|||
13277779|NCT00981149|26447380|FG001|Overall Study|Lost to Follow-up|2|||
13277780|NCT00981149|26447379|FG000|Overall Study|Withdrawal by Subject|1|||
13277781|NCT00981149|26447380|FG001|Overall Study|Withdrawal by Subject|1|||
13277782|NCT00981084|26447401|FG000|Post Intervention (Data Analysis)|poor effort|1|||
13277783|NCT00981084|26447402|FG001|Post Intervention (Data Analysis)|poor effort|1|||
13277784|NCT00981084|26447401|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1|||
13277785|NCT00981084|26447402|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0|||
13277786|NCT00981019|26447408|FG000|Overall Study|Did not respond|65|||
13277787|NCT00981019|26447408|FG000|Overall Study|Did not match target population|94|||
13277788|NCT00981019|26447408|FG000|Overall Study|Inadvertent exclusion|239|||
13277789|NCT00981019|26447408|FG000|Overall Study|Hit the survey after closure|79|||
13277790|NCT00980798|26447423|FG000|Overall Study|Adverse Event|7|||
13119498|NCT03016403|25935029|FG003|Baseline|Death|0|||
13277791|NCT00980798|26447424|FG001|Overall Study|Adverse Event|36|||
13277792|NCT00980798|26447423|FG000|Overall Study|Lack of Efficacy|16|||
13277793|NCT00980798|26447424|FG001|Overall Study|Lack of Efficacy|5|||
13277794|NCT00980798|26447423|FG000|Overall Study|Lost to Follow-up|0|||
13277795|NCT00980798|26447424|FG001|Overall Study|Lost to Follow-up|1|||
13277796|NCT00980798|26447423|FG000|Overall Study|Physician Decision|2|||
13277797|NCT00980798|26447424|FG001|Overall Study|Physician Decision|1|||
13277798|NCT00980798|26447423|FG000|Overall Study|Withdrawal by Subject|8|||
13277799|NCT00980798|26447424|FG001|Overall Study|Withdrawal by Subject|11|||
13277800|NCT00980798|26447423|FG000|Overall Study|Other|0|||
13277801|NCT00980798|26447424|FG001|Overall Study|Other|1|||
13277802|NCT00980655|26447477|FG000|Overall Study|Adverse Event|13|||
13277803|NCT00980655|26447478|FG001|Overall Study|Adverse Event|31|||
13277804|NCT00980655|26447477|FG000|Overall Study|Death|0|||
13277805|NCT00980655|26447478|FG001|Overall Study|Death|7|||
13277806|NCT00980655|26447477|FG000|Overall Study|Protocol Violation|2|||
13277807|NCT00980655|26447478|FG001|Overall Study|Protocol Violation|7|||
13277808|NCT00980655|26447477|FG000|Overall Study|Withdrawal by Subject|0|||
13277809|NCT00980655|26447478|FG001|Overall Study|Withdrawal by Subject|4|||
13277810|NCT00980655|26447477|FG000|Overall Study|Lost to Follow-up|0|||
13277811|NCT00980655|26447478|FG001|Overall Study|Lost to Follow-up|1|||
13277812|NCT00980655|26447477|FG000|Overall Study|Parent/legal guardian request|1|||
13291468|NCT00151892|26483422|FG000|Overall Study|Lost to Follow-up|5|||
13119499|NCT03016403|25935026|FG000|Baseline|Withdrawal by Subject|2|||
13119500|NCT03016403|25935027|FG001|Baseline|Withdrawal by Subject|8|||
13119501|NCT03016403|25935028|FG002|Baseline|Withdrawal by Subject|4|||
13119502|NCT03016403|25935029|FG003|Baseline|Withdrawal by Subject|10|||
13119503|NCT03016403|25935026|FG000|Baseline|Lost to Follow-up|9|||
13119504|NCT03016403|25935027|FG001|Baseline|Lost to Follow-up|11|||
13119505|NCT03016403|25935028|FG002|Baseline|Lost to Follow-up|6|||
13119506|NCT03016403|25935029|FG003|Baseline|Lost to Follow-up|24|||
13119507|NCT03016403|25935026|FG000|6-week Follow-up|Death|1|||
13119508|NCT03016403|25935027|FG001|6-week Follow-up|Death|4|||
13119509|NCT03016403|25935028|FG002|6-week Follow-up|Death|0|||
13119510|NCT03016403|25935029|FG003|6-week Follow-up|Death|0|||
13119511|NCT03016403|25935026|FG000|6-week Follow-up|Lost to Follow-up|2|||
13119512|NCT03016403|25935027|FG001|6-week Follow-up|Lost to Follow-up|7|||
13119513|NCT03016403|25935028|FG002|6-week Follow-up|Lost to Follow-up|4|||
13119514|NCT03016403|25935029|FG003|6-week Follow-up|Lost to Follow-up|8|||
13119515|NCT03016403|25935026|FG000|6-week Follow-up|Withdrawal by Subject|0|||
13119516|NCT03016403|25935027|FG001|6-week Follow-up|Withdrawal by Subject|2|||
13119517|NCT03016403|25935028|FG002|6-week Follow-up|Withdrawal by Subject|0|||
13119518|NCT03016403|25935029|FG003|6-week Follow-up|Withdrawal by Subject|1|||
13119519|NCT03016403|25935026|FG000|3-month Follow-up and 6-month Follow-up|Death|6|||
13119520|NCT03016403|25935027|FG001|3-month Follow-up and 6-month Follow-up|Death|4|||
13119521|NCT03016403|25935028|FG002|3-month Follow-up and 6-month Follow-up|Death|0|||
13119522|NCT03016403|25935029|FG003|3-month Follow-up and 6-month Follow-up|Death|0|||
13119523|NCT03016403|25935026|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
13119524|NCT03016403|25935027|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7|||
13119525|NCT03016403|25935028|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8|||
13119526|NCT03016403|25935029|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
13119527|NCT03016403|25935026|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
13119528|NCT03016403|25935027|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
13119529|NCT03016403|25935028|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
13119530|NCT03016403|25935029|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1|||
13119531|NCT03016325|25935277|FG000|Treatment Period|Participant withdrew consent|0|||
13119532|NCT03016325|25935278|FG001|Treatment Period|Participant withdrew consent|1|||
13119533|NCT03016325|25935279|FG002|Treatment Period|Participant withdrew consent|0|||
13119534|NCT03016325|25935280|FG003|Treatment Period|Participant withdrew consent|0|||
13119535|NCT03016325|25935281|FG004|Treatment Period|Participant withdrew consent|0|||
13119536|NCT03016325|25935282|FG005|Treatment Period|Participant withdrew consent|0|||
13119537|NCT03016325|25935283|FG006|Treatment Period|Participant withdrew consent|0|||
13277813|NCT00980655|26447478|FG001|Overall Study|Parent/legal guardian request|0|||
13277814|NCT00980655|26447477|FG000|Overall Study|Other|0|||
13277815|NCT00980655|26447478|FG001|Overall Study|Other|1|||
13277816|NCT00980343|26447502|FG000|Overall Study|no tumor at surgery - treatment effect|1|||
13277817|NCT00980343|26447503|FG001|Overall Study|no tumor at surgery - treatment effect|3|||
13119538|NCT03016325|25935284|FG007|Treatment Period|Participant withdrew consent|0|||
13119539|NCT03016325|25935277|FG000|Treatment Period|Death|0|||
13277818|NCT00980330|26447623|FG000|Overall Study|Adverse Event|0|||
13277819|NCT00980330|26447624|FG001|Overall Study|Adverse Event|0|||
13119540|NCT03016325|25935278|FG001|Treatment Period|Death|0|||
13119541|NCT03016325|25935279|FG002|Treatment Period|Death|0|||
13119542|NCT03016325|25935280|FG003|Treatment Period|Death|0|||
13119543|NCT03016325|25935281|FG004|Treatment Period|Death|2|||
13119544|NCT03016325|25935282|FG005|Treatment Period|Death|0|||
13277820|NCT00980330|26447625|FG002|Overall Study|Adverse Event|0|||
13277821|NCT00980330|26447626|FG003|Overall Study|Adverse Event|1|||
13277822|NCT00980330|26447627|FG004|Overall Study|Adverse Event|0|||
13277823|NCT00980330|26447628|FG005|Overall Study|Adverse Event|0|||
13277824|NCT00980330|26447629|FG006|Overall Study|Adverse Event|0|||
13277825|NCT00980330|26447623|FG000|Overall Study|Lost to Follow-up|1|||
13277826|NCT00980330|26447624|FG001|Overall Study|Lost to Follow-up|1|||
13277827|NCT00980330|26447625|FG002|Overall Study|Lost to Follow-up|4|||
13277828|NCT00980330|26447626|FG003|Overall Study|Lost to Follow-up|2|||
13277829|NCT00980330|26447627|FG004|Overall Study|Lost to Follow-up|1|||
13277830|NCT00980330|26447628|FG005|Overall Study|Lost to Follow-up|1|||
13277831|NCT00980330|26447629|FG006|Overall Study|Lost to Follow-up|2|||
13277832|NCT00980330|26447623|FG000|Overall Study|Withdrawal by Subject|2|||
13277833|NCT00980330|26447624|FG001|Overall Study|Withdrawal by Subject|4|||
13277834|NCT00980330|26447625|FG002|Overall Study|Withdrawal by Subject|4|||
13277835|NCT00980330|26447626|FG003|Overall Study|Withdrawal by Subject|1|||
13203824|NCT01980940|26226012|FG003|Overall Study|Protocol Violation|0|||
13203825|NCT01980940|26226013|FG004|Overall Study|Protocol Violation|0|||
13203826|NCT01980940|26226014|FG005|Overall Study|Protocol Violation|2|||
13203827|NCT01980940|26226015|FG006|Overall Study|Protocol Violation|0|||
13203828|NCT01980940|26226016|FG007|Overall Study|Protocol Violation|0|||
13203829|NCT01980888|26226039|FG000|Overall Study|Study Terminated by Sponsor|116|||
13203830|NCT01980888|26226040|FG001|Overall Study|Study Terminated by Sponsor|122|||
13203831|NCT01980888|26226039|FG000|Overall Study|Withdrew Consent|17|||
13203832|NCT01980888|26226040|FG001|Overall Study|Withdrew Consent|6|||
13203833|NCT01980888|26226039|FG000|Overall Study|Investigator's Discretion|8|||
13203834|NCT01980888|26226040|FG001|Overall Study|Investigator's Discretion|3|||
13203835|NCT01980888|26226039|FG000|Overall Study|Non-Compliance with Study Drug|3|||
13203836|NCT01980888|26226040|FG001|Overall Study|Non-Compliance with Study Drug|2|||
13203837|NCT01980875|26226073|FG000|Overall Study|Withdrew Consent|1|||
13203838|NCT01980875|26226074|FG001|Overall Study|Withdrew Consent|1|||
13203839|NCT01980875|26226075|FG002|Overall Study|Withdrew Consent|1|||
13203840|NCT01980875|26226073|FG000|Overall Study|Study Terminated by Sponsor|7|||
13203841|NCT01980875|26226074|FG001|Overall Study|Study Terminated by Sponsor|24|||
13203842|NCT01980875|26226075|FG002|Overall Study|Study Terminated by Sponsor|22|||
13203843|NCT01980875|26226073|FG000|Overall Study|Lost to Follow-up|0|||
13203844|NCT01980875|26226074|FG001|Overall Study|Lost to Follow-up|0|||
13203845|NCT01980875|26226075|FG002|Overall Study|Lost to Follow-up|1|||
13203846|NCT01980706|26226108|FG000|Overall Study|Withdrawal by Subject|9|||
13203847|NCT01980706|26226109|FG001|Overall Study|Withdrawal by Subject|6|||
13203848|NCT01980706|26226110|FG002|Overall Study|Withdrawal by Subject|2|||
13203849|NCT01980706|26226108|FG000|Overall Study|Adverse Event|1|||
13203850|NCT01980706|26226109|FG001|Overall Study|Adverse Event|2|||
13203851|NCT01980706|26226110|FG002|Overall Study|Adverse Event|5|||
13203852|NCT01980706|26226108|FG000|Overall Study|Lost to Follow-up|3|||
13203853|NCT01980706|26226109|FG001|Overall Study|Lost to Follow-up|4|||
13203854|NCT01980706|26226110|FG002|Overall Study|Lost to Follow-up|3|||
13203855|NCT01980706|26226108|FG000|Overall Study|miscellaneous|4|||
13203856|NCT01980706|26226109|FG001|Overall Study|miscellaneous|5|||
13119545|NCT03016325|25935283|FG006|Treatment Period|Death|0|||
13119546|NCT03016325|25935284|FG007|Treatment Period|Death|0|||
13119547|NCT03016325|25935277|FG000|Treatment Period|Participant refuses assessments|0|||
13203857|NCT01980706|26226110|FG002|Overall Study|miscellaneous|3|||
13203858|NCT01980628|26226117|FG000|Overall Study|Adverse Event|12|||
13203859|NCT01980628|26226117|FG000|Overall Study|Physician Decision|5|||
13203860|NCT01980628|26226117|FG000|Overall Study|Withdrawal by Subject|4|||
13203861|NCT01980628|26226117|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42|||
13203862|NCT01980095|26226132|FG000|Overall Study|Lost to Follow-up|6|||
13277836|NCT00980330|26447627|FG004|Overall Study|Withdrawal by Subject|3|||
13277837|NCT00980330|26447628|FG005|Overall Study|Withdrawal by Subject|2|||
13277838|NCT00980330|26447629|FG006|Overall Study|Withdrawal by Subject|5|||
13277839|NCT00980330|26447623|FG000|Overall Study|(not specified)|2|||
13277840|NCT00980330|26447624|FG001|Overall Study|(not specified)|0|||
13277841|NCT00980330|26447625|FG002|Overall Study|(not specified)|0|||
13277842|NCT00980330|26447626|FG003|Overall Study|(not specified)|1|||
13277843|NCT00980330|26447627|FG004|Overall Study|(not specified)|1|||
13277844|NCT00980330|26447628|FG005|Overall Study|(not specified)|1|||
13277845|NCT00980330|26447629|FG006|Overall Study|(not specified)|0|||
13277846|NCT00980174|26447652|FG000|Overall Study|Withdrawal by Subject|1|||
13277847|NCT00980174|26447653|FG001|Overall Study|Withdrawal by Subject|4|||
13277848|NCT00980174|26447652|FG000|Overall Study|Adverse Event|0|||
13277849|NCT00980174|26447653|FG001|Overall Study|Adverse Event|3|||
13277850|NCT00980174|26447652|FG000|Overall Study|Ineligibility determined|2|||
13277851|NCT00980174|26447653|FG001|Overall Study|Ineligibility determined|1|||
13277852|NCT00980174|26447652|FG000|Overall Study|Death|1|||
13277853|NCT00980174|26447653|FG001|Overall Study|Death|1|||
13277854|NCT00980174|26447652|FG000|Overall Study|Other|0|||
13277855|NCT00980174|26447653|FG001|Overall Study|Other|1|||
13277856|NCT00980148|26447666|FG000|Overall Study|Discharged from facility|89|||
13277857|NCT00980148|26447667|FG001|Overall Study|Discharged from facility|96|||
13277858|NCT00980148|26447666|FG000|Overall Study|Received other antichlamydia treatment|20|||
13277859|NCT00980148|26447667|FG001|Overall Study|Received other antichlamydia treatment|14|||
13277860|NCT00980148|26447666|FG000|Overall Study|Negative for chlamydia at enrollment|12|||
13277861|NCT00980148|26447667|FG001|Overall Study|Negative for chlamydia at enrollment|9|||
13277862|NCT00980148|26447666|FG000|Overall Study|Various other reasons|8|||
13277863|NCT00980148|26447667|FG001|Overall Study|Various other reasons|9|||
13277864|NCT00980057|26447694|FG000|Overall Study|Death|13|||
13277865|NCT00980057|26447695|FG001|Overall Study|Death|3|||
13277866|NCT00980057|26447694|FG000|Overall Study|Adverse Event|0|||
13277867|NCT00980057|26447695|FG001|Overall Study|Adverse Event|1|||
13277868|NCT00980057|26447694|FG000|Overall Study|Physician Decision|4|||
13277869|NCT00980057|26447695|FG001|Overall Study|Physician Decision|0|||
13277870|NCT00980057|26447694|FG000|Overall Study|Lost to Follow-up|1|||
13277871|NCT00980057|26447695|FG001|Overall Study|Lost to Follow-up|0|||
13277872|NCT00980057|26447694|FG000|Overall Study|Withdrawal by Subject|1|||
13277873|NCT00980057|26447695|FG001|Overall Study|Withdrawal by Subject|1|||
13277874|NCT00980044|26447722|FG000|Overall Study|Withdrawal by Subject|5|||
13277875|NCT00980044|26447723|FG001|Overall Study|Withdrawal by Subject|7|||
13277876|NCT00980044|26447724|FG002|Overall Study|Withdrawal by Subject|3|||
13277877|NCT00980044|26447722|FG000|Overall Study|Protocol Violation|0|||
13277878|NCT00980044|26447723|FG001|Overall Study|Protocol Violation|0|||
13277879|NCT00980044|26447724|FG002|Overall Study|Protocol Violation|2|||
13277880|NCT00980018|26447738|FG000|Overall Study|Adverse Event|8|||
13277881|NCT00980018|26447738|FG000|Overall Study|Patient withdrew consent|3|||
13277882|NCT00980018|26447738|FG000|Overall Study|Lost to Follow-up|1|||
13277883|NCT00980005|26447785|FG000|Overall Study|Withdrawal by Subject|6|||
13277884|NCT00980005|26447786|FG001|Overall Study|Withdrawal by Subject|17|||
13277885|NCT00980005|26447785|FG000|Overall Study|Lost to Follow-up|37|||
13277886|NCT00980005|26447786|FG001|Overall Study|Lost to Follow-up|43|||
13277887|NCT00980005|26447785|FG000|Overall Study|Other|4|||
13277888|NCT00980005|26447786|FG001|Overall Study|Other|3|||
13277889|NCT00988247|26447809|FG000|Overall Study|Adverse Event|17|||
13277890|NCT00988247|26447810|FG001|Overall Study|Adverse Event|3|||
13277891|NCT00988247|26447809|FG000|Overall Study|Withdrawal by Subject|44|||
13277892|NCT00988247|26447810|FG001|Overall Study|Withdrawal by Subject|13|||
13277893|NCT00988247|26447809|FG000|Overall Study|Pregnancy|1|||
13277894|NCT00988247|26447810|FG001|Overall Study|Pregnancy|2|||
13277895|NCT00988247|26447809|FG000|Overall Study|Lost to Follow-up|11|||
13277896|NCT00988247|26447810|FG001|Overall Study|Lost to Follow-up|2|||
13277897|NCT00988247|26447809|FG000|Overall Study|Protocol Violation|4|||
13277898|NCT00988247|26447810|FG001|Overall Study|Protocol Violation|5|||
13277899|NCT00988247|26447809|FG000|Overall Study|Sponsor requested withdrawal|3|||
13277900|NCT00988247|26447810|FG001|Overall Study|Sponsor requested withdrawal|1|||
13277901|NCT00988247|26447809|FG000|Overall Study|Other|3|||
13277902|NCT00988247|26447810|FG001|Overall Study|Other|0|||
13277903|NCT00983437|26447831|FG000|Overall Study|Adverse Event|9|||
13277904|NCT00983437|26447831|FG000|Overall Study|Lack of Efficacy|1|||
13277905|NCT00983437|26447831|FG000|Overall Study|Withdrawal by Subject|8|||
13277906|NCT00983437|26447831|FG000|Overall Study|Noncompliance to Study Procedures|1|||
13277907|NCT00983437|26447831|FG000|Overall Study|Lost to Follow-up|2|||
13277908|NCT00983437|26447831|FG000|Overall Study|Other Reason|26|||
13277909|NCT00984659|26447869|FG000|2-week Run-in Period|Adverse Event|8|||
13277910|NCT00984659|26447870|FG001|2-week Run-in Period|Adverse Event|0|||
13277911|NCT00984659|26447871|FG002|2-week Run-in Period|Adverse Event|0|||
13277912|NCT00984659|26447872|FG003|2-week Run-in Period|Adverse Event|0|||
13277913|NCT00984659|26447869|FG000|2-week Run-in Period|Protocol Violation|5|||
13291469|NCT00151892|26483423|FG001|Overall Study|Lost to Follow-up|10|||
13277914|NCT00984659|26447870|FG001|2-week Run-in Period|Protocol Violation|0|||
13277915|NCT00984659|26447871|FG002|2-week Run-in Period|Protocol Violation|0|||
13277916|NCT00984659|26447872|FG003|2-week Run-in Period|Protocol Violation|0|||
13277917|NCT00984659|26447869|FG000|2-week Run-in Period|Study Closed/Terminated|2|||
13277918|NCT00984659|26447870|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
13277919|NCT00984659|26447871|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
13277920|NCT00984659|26447872|FG003|2-week Run-in Period|Study Closed/Terminated|0|||
13277921|NCT00984659|26447869|FG000|2-week Run-in Period|Lost to Follow-up|3|||
13277922|NCT00984659|26447870|FG001|2-week Run-in Period|Lost to Follow-up|0|||
13277923|NCT00984659|26447871|FG002|2-week Run-in Period|Lost to Follow-up|0|||
13277924|NCT00984659|26447872|FG003|2-week Run-in Period|Lost to Follow-up|0|||
13277925|NCT00984659|26447869|FG000|2-week Run-in Period|Physician Decision|10|||
13277926|NCT00984659|26447870|FG001|2-week Run-in Period|Physician Decision|0|||
13277927|NCT00984659|26447871|FG002|2-week Run-in Period|Physician Decision|0|||
13277928|NCT00984659|26447872|FG003|2-week Run-in Period|Physician Decision|0|||
13277929|NCT00984659|26447869|FG000|2-week Run-in Period|Withdrawal by Subject|10|||
13277930|NCT00984659|26447870|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
13277931|NCT00984659|26447871|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
13277932|NCT00984659|26447872|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
13277933|NCT00984659|26447869|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14|||
13277934|NCT00984659|26447870|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
13277935|NCT00984659|26447871|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
13277936|NCT00984659|26447872|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
13277937|NCT00984659|26447869|FG000|6-week Double-blind Treatment Period|Adverse Event|0|||
13277938|NCT00984659|26447870|FG001|6-week Double-blind Treatment Period|Adverse Event|3|||
13277939|NCT00984659|26447871|FG002|6-week Double-blind Treatment Period|Adverse Event|3|||
13277940|NCT00984659|26447872|FG003|6-week Double-blind Treatment Period|Adverse Event|7|||
13277941|NCT00984659|26447869|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
13277942|NCT00984659|26447870|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2|||
13277943|NCT00984659|26447871|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
13277944|NCT00984659|26447872|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1|||
13277945|NCT00984659|26447869|FG000|6-week Double-blind Treatment Period|Protocol Violation|0|||
13277946|NCT00984659|26447870|FG001|6-week Double-blind Treatment Period|Protocol Violation|0|||
13277947|NCT00984659|26447871|FG002|6-week Double-blind Treatment Period|Protocol Violation|0|||
13277948|NCT00984659|26447872|FG003|6-week Double-blind Treatment Period|Protocol Violation|4|||
13277949|NCT00984659|26447869|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
13277950|NCT00984659|26447870|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
13277951|NCT00984659|26447871|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1|||
13277952|NCT00984659|26447872|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
13277953|NCT00984659|26447869|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0|||
13277954|NCT00984659|26447870|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
13277955|NCT00984659|26447871|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7|||
13277956|NCT00984659|26447872|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
13277957|NCT00982319|26447887|FG000|Overall Study|Surgery date change|1|||
13277958|NCT00982319|26447888|FG001|Overall Study|Surgery date change|0|||
13277959|NCT00982319|26447887|FG000|Overall Study|Preop values out of acceptable range|1|||
13277960|NCT00982319|26447888|FG001|Overall Study|Preop values out of acceptable range|1|||
13277961|NCT00982319|26447887|FG000|Overall Study|Pregnancy|0|||
13277962|NCT00982319|26447888|FG001|Overall Study|Pregnancy|1|||
13277963|NCT00981526|26447911|FG000|Overall Study|Withdrawal by Subject|0|||
13277964|NCT00981526|26447912|FG001|Overall Study|Withdrawal by Subject|2|||
13277965|NCT00981526|26447911|FG000|Overall Study|Physician Decision|4|||
13277966|NCT00981526|26447912|FG001|Overall Study|Physician Decision|4|||
13277967|NCT00983619|26448252|FG000|Overall Study|Lost to Follow-up|0|||
13277968|NCT00983619|26448253|FG001|Overall Study|Lost to Follow-up|1|||
13277969|NCT00983619|26448254|FG002|Overall Study|Lost to Follow-up|0|||
13277970|NCT00983619|26448255|FG003|Overall Study|Lost to Follow-up|0|||
13277971|NCT00983619|26448256|FG004|Overall Study|Lost to Follow-up|0|||
13277972|NCT00983619|26448257|FG005|Overall Study|Lost to Follow-up|2|||
13277973|NCT00983619|26448258|FG006|Overall Study|Lost to Follow-up|0|||
13277974|NCT00983619|26448259|FG007|Overall Study|Lost to Follow-up|0|||
13277975|NCT00983619|26448260|FG008|Overall Study|Lost to Follow-up|0|||
13203863|NCT01980095|26226133|FG001|Overall Study|Lost to Follow-up|7|||
13203864|NCT01980095|26226132|FG000|Overall Study|Withdrawal by Subject|2|||
13203865|NCT01980095|26226133|FG001|Overall Study|Withdrawal by Subject|3|||
13203866|NCT01980095|26226132|FG000|Overall Study|Poor compliance|5|||
13203867|NCT01980095|26226133|FG001|Overall Study|Poor compliance|0|||
13203868|NCT01980095|26226132|FG000|Overall Study|Safety issue|0|||
13203869|NCT01980095|26226133|FG001|Overall Study|Safety issue|1|||
13203870|NCT01980095|26226132|FG000|Overall Study|Study drug discontinued|1|||
13203871|NCT01980095|26226133|FG001|Overall Study|Study drug discontinued|0|||
13203872|NCT01980095|26226132|FG000|Overall Study|Randomized by mistake|1|||
13203873|NCT01980095|26226133|FG001|Overall Study|Randomized by mistake|0|||
13119548|NCT03016325|25935278|FG001|Treatment Period|Participant refuses assessments|0|||
13203874|NCT01980056|26226155|FG000|Overall Study|Death|1|||
13277976|NCT00983619|26448261|FG009|Overall Study|Lost to Follow-up|0|||
13277977|NCT00983619|26448262|FG010|Overall Study|Lost to Follow-up|0|||
13277978|NCT00983619|26448263|FG011|Overall Study|Lost to Follow-up|2|||
13277979|NCT00983619|26448252|FG000|Overall Study|Withdrawal by Subject|2|||
13277980|NCT00983619|26448253|FG001|Overall Study|Withdrawal by Subject|1|||
13277981|NCT00983619|26448254|FG002|Overall Study|Withdrawal by Subject|1|||
13277982|NCT00983619|26448255|FG003|Overall Study|Withdrawal by Subject|3|||
13277983|NCT00983619|26448256|FG004|Overall Study|Withdrawal by Subject|1|||
13277984|NCT00983619|26448257|FG005|Overall Study|Withdrawal by Subject|23|||
13277985|NCT00983619|26448258|FG006|Overall Study|Withdrawal by Subject|0|||
13277986|NCT00983619|26448259|FG007|Overall Study|Withdrawal by Subject|0|||
13277987|NCT00983619|26448260|FG008|Overall Study|Withdrawal by Subject|0|||
13277988|NCT00983619|26448261|FG009|Overall Study|Withdrawal by Subject|0|||
13277989|NCT00983619|26448262|FG010|Overall Study|Withdrawal by Subject|1|||
13277990|NCT00983619|26448263|FG011|Overall Study|Withdrawal by Subject|1|||
13277991|NCT00983619|26448252|FG000|Overall Study|Death|0|||
13277992|NCT00983619|26448253|FG001|Overall Study|Death|2|||
13277993|NCT00983619|26448254|FG002|Overall Study|Death|2|||
13277994|NCT00983619|26448255|FG003|Overall Study|Death|1|||
13277995|NCT00983619|26448256|FG004|Overall Study|Death|2|||
13277996|NCT00983619|26448257|FG005|Overall Study|Death|30|||
13277997|NCT00983619|26448258|FG006|Overall Study|Death|1|||
13277998|NCT00983619|26448259|FG007|Overall Study|Death|0|||
13277999|NCT00983619|26448260|FG008|Overall Study|Death|1|||
13278000|NCT00983619|26448261|FG009|Overall Study|Death|2|||
13278001|NCT00983619|26448262|FG010|Overall Study|Death|9|||
13278002|NCT00983619|26448263|FG011|Overall Study|Death|8|||
13278003|NCT00983619|26448252|FG000|Overall Study|Other|1|||
13278004|NCT00983619|26448253|FG001|Overall Study|Other|0|||
13278005|NCT00983619|26448254|FG002|Overall Study|Other|0|||
13278006|NCT00983619|26448255|FG003|Overall Study|Other|1|||
13278007|NCT00983619|26448256|FG004|Overall Study|Other|0|||
13278008|NCT00983619|26448257|FG005|Overall Study|Other|12|||
13278009|NCT00983619|26448258|FG006|Overall Study|Other|2|||
13278010|NCT00983619|26448259|FG007|Overall Study|Other|2|||
13278011|NCT00983619|26448260|FG008|Overall Study|Other|0|||
13278012|NCT00983619|26448261|FG009|Overall Study|Other|1|||
13278013|NCT00983619|26448262|FG010|Overall Study|Other|1|||
13278014|NCT00983619|26448263|FG011|Overall Study|Other|0|||
13278015|NCT00981656|26448276|FG000|Overall Study|Protocol Violation|1|||
13119549|NCT03016325|25935279|FG002|Treatment Period|Participant refuses assessments|1|||
13119550|NCT03016325|25935280|FG003|Treatment Period|Participant refuses assessments|0|||
13119551|NCT03016325|25935281|FG004|Treatment Period|Participant refuses assessments|0|||
13119552|NCT03016325|25935282|FG005|Treatment Period|Participant refuses assessments|0|||
13119553|NCT03016325|25935283|FG006|Treatment Period|Participant refuses assessments|0|||
13119554|NCT03016325|25935284|FG007|Treatment Period|Participant refuses assessments|0|||
13119555|NCT03016325|25935277|FG000|32-Day Follow-Up Period|Death|2|||
13119556|NCT03016325|25935278|FG001|32-Day Follow-Up Period|Death|0|||
13119557|NCT03016325|25935279|FG002|32-Day Follow-Up Period|Death|5|||
13119558|NCT03016325|25935280|FG003|32-Day Follow-Up Period|Death|6|||
13119559|NCT03016325|25935281|FG004|32-Day Follow-Up Period|Death|3|||
13119560|NCT03016325|25935282|FG005|32-Day Follow-Up Period|Death|0|||
13119561|NCT03016325|25935283|FG006|32-Day Follow-Up Period|Death|0|||
13119562|NCT03016325|25935284|FG007|32-Day Follow-Up Period|Death|0|||
13119563|NCT03016325|25935277|FG000|32-Day Follow-Up Period|Lost to Follow-up|1|||
13119564|NCT03016325|25935278|FG001|32-Day Follow-Up Period|Lost to Follow-up|0|||
13119565|NCT03016325|25935279|FG002|32-Day Follow-Up Period|Lost to Follow-up|1|||
13119566|NCT03016325|25935280|FG003|32-Day Follow-Up Period|Lost to Follow-up|1|||
13119567|NCT03016325|25935281|FG004|32-Day Follow-Up Period|Lost to Follow-up|0|||
13119568|NCT03016325|25935282|FG005|32-Day Follow-Up Period|Lost to Follow-up|0|||
13119569|NCT03016325|25935283|FG006|32-Day Follow-Up Period|Lost to Follow-up|0|||
13203875|NCT01980056|26226156|FG001|Overall Study|Death|1|||
13203876|NCT01980056|26226157|FG002|Overall Study|Death|0|||
13203877|NCT01980017|26226173|FG000|Overall Study|Lost to Follow-up|30|||
13203878|NCT01980017|26226174|FG001|Overall Study|Lost to Follow-up|21|||
13203879|NCT01980017|26226173|FG000|Overall Study|Death|0|||
13203880|NCT01980017|26226174|FG001|Overall Study|Death|1|||
13203881|NCT01979952|26226209|FG000|Overall Study|Adverse Event|4|||
13203882|NCT01979952|26226210|FG001|Overall Study|Adverse Event|5|||
13203883|NCT01979952|26226209|FG000|Overall Study|Protocol Violation|1|||
13203884|NCT01979952|26226210|FG001|Overall Study|Protocol Violation|0|||
13203885|NCT01979952|26226209|FG000|Overall Study|Withdrawal by Subject|2|||
13203886|NCT01979952|26226210|FG001|Overall Study|Withdrawal by Subject|1|||
13203887|NCT01979952|26226209|FG000|Overall Study|Other than specified above|1|||
13203888|NCT01979952|26226210|FG001|Overall Study|Other than specified above|0|||
13203889|NCT01979835|26226217|FG000|Primary Outcome SA Measurment|failed insertion|18|||
13203890|NCT01979835|26226217|FG000|Follow-up|Lost to Follow-up|32|||
13119570|NCT03016325|25935284|FG007|32-Day Follow-Up Period|Lost to Follow-up|0|||
13119571|NCT03016325|25935277|FG000|32-Day Follow-Up Period|Poor/non-compliance|1|||
13119572|NCT03016325|25935278|FG001|32-Day Follow-Up Period|Poor/non-compliance|0|||
13119573|NCT03016325|25935279|FG002|32-Day Follow-Up Period|Poor/non-compliance|0|||
13119574|NCT03016325|25935280|FG003|32-Day Follow-Up Period|Poor/non-compliance|1|||
13119575|NCT03016325|25935281|FG004|32-Day Follow-Up Period|Poor/non-compliance|1|||
13119576|NCT03016325|25935282|FG005|32-Day Follow-Up Period|Poor/non-compliance|0|||
13119577|NCT03016325|25935283|FG006|32-Day Follow-Up Period|Poor/non-compliance|0|||
13119578|NCT03016325|25935284|FG007|32-Day Follow-Up Period|Poor/non-compliance|0|||
13119579|NCT03016325|25935277|FG000|32-Day Follow-Up Period|Participant refused to visit|0|||
13119580|NCT03016325|25935278|FG001|32-Day Follow-Up Period|Participant refused to visit|1|||
13278016|NCT00981656|26448276|FG000|Overall Study|Did not start protocol treatment|2|||
13278017|NCT00988052|26448297|FG000|Overall Study|Missing|1|||
13278018|NCT00988052|26448298|FG001|Overall Study|Missing|0|||
13278019|NCT00988052|26448297|FG000|Overall Study|Teva requested subject withdrawal|3|||
13278020|NCT00988052|26448298|FG001|Overall Study|Teva requested subject withdrawal|1|||
13278021|NCT00988052|26448297|FG000|Overall Study|Death|1|||
13278022|NCT00988052|26448298|FG001|Overall Study|Death|3|||
13278023|NCT00988052|26448297|FG000|Overall Study|Protocol Violation|6|||
13278024|NCT00988052|26448298|FG001|Overall Study|Protocol Violation|5|||
13278025|NCT00988052|26448297|FG000|Overall Study|Pregnancy|6|||
13278026|NCT00988052|26448298|FG001|Overall Study|Pregnancy|6|||
13278027|NCT00988052|26448297|FG000|Overall Study|Lack of Efficacy|8|||
13278028|NCT00988052|26448298|FG001|Overall Study|Lack of Efficacy|7|||
13278029|NCT00988052|26448297|FG000|Overall Study|Lost to Follow-up|6|||
13278030|NCT00988052|26448298|FG001|Overall Study|Lost to Follow-up|11|||
13278031|NCT00988052|26448297|FG000|Overall Study|Physician Decision|27|||
13278032|NCT00988052|26448298|FG001|Overall Study|Physician Decision|28|||
13278033|NCT00988052|26448297|FG000|Overall Study|Adverse Event|35|||
13278034|NCT00988052|26448298|FG001|Overall Study|Adverse Event|28|||
13278035|NCT00988052|26448297|FG000|Overall Study|Withdrawal by Subject|90|||
13278036|NCT00988052|26448298|FG001|Overall Study|Withdrawal by Subject|91|||
13278037|NCT00988052|26448297|FG000|Overall Study|Study terminated by sponsor|240|||
13278038|NCT00988052|26448298|FG001|Overall Study|Study terminated by sponsor|236|||
13291470|NCT00151892|26483422|FG000|Overall Study|Adverse Event|6|||
13291471|NCT00151892|26483423|FG001|Overall Study|Adverse Event|3|||
13291472|NCT00151892|26483422|FG000|Overall Study|Protocol Violation|3|||
13291473|NCT00151892|26483423|FG001|Overall Study|Protocol Violation|3|||
13291474|NCT00151892|26483422|FG000|Overall Study|Non-compliance|0|||
13291475|NCT00151892|26483423|FG001|Overall Study|Non-compliance|1|||
13291476|NCT00151892|26483422|FG000|Overall Study|Pregnancy|0|||
13291477|NCT00151892|26483423|FG001|Overall Study|Pregnancy|1|||
13291478|NCT00151892|26483422|FG000|Overall Study|Did not return for a visit|1|||
13291479|NCT00151892|26483423|FG001|Overall Study|Did not return for a visit|0|||
13291480|NCT00151892|26483422|FG000|Overall Study|Used prohibited corticosteroids|1|||
13119581|NCT03016325|25935279|FG002|32-Day Follow-Up Period|Participant refused to visit|2|||
13119582|NCT03016325|25935280|FG003|32-Day Follow-Up Period|Participant refused to visit|0|||
13119583|NCT03016325|25935281|FG004|32-Day Follow-Up Period|Participant refused to visit|2|||
13119584|NCT03016325|25935282|FG005|32-Day Follow-Up Period|Participant refused to visit|0|||
13119585|NCT03016325|25935283|FG006|32-Day Follow-Up Period|Participant refused to visit|0|||
13119586|NCT03016325|25935284|FG007|32-Day Follow-Up Period|Participant refused to visit|0|||
13119587|NCT03016325|25935277|FG000|32-Day Follow-Up Period|Participant withdrew consent|0|||
13119588|NCT03016325|25935278|FG001|32-Day Follow-Up Period|Participant withdrew consent|0|||
13291481|NCT00151892|26483423|FG001|Overall Study|Used prohibited corticosteroids|0|||
13291482|NCT00151892|26483422|FG000|Overall Study|Lack of study medication at center|0|||
13291483|NCT00151892|26483423|FG001|Overall Study|Lack of study medication at center|1|||
13291484|NCT00151775|26483487|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1|||
13291485|NCT00151775|26483488|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2|||
13291486|NCT00151775|26483489|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
13119589|NCT03016325|25935279|FG002|32-Day Follow-Up Period|Participant withdrew consent|0|||
13119590|NCT03016325|25935280|FG003|32-Day Follow-Up Period|Participant withdrew consent|0|||
13119591|NCT03016325|25935281|FG004|32-Day Follow-Up Period|Participant withdrew consent|2|||
13119592|NCT03016325|25935282|FG005|32-Day Follow-Up Period|Participant withdrew consent|0|||
13119593|NCT03016325|25935283|FG006|32-Day Follow-Up Period|Participant withdrew consent|1|||
13119594|NCT03016325|25935284|FG007|32-Day Follow-Up Period|Participant withdrew consent|0|||
13119595|NCT03016325|25935277|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
13119596|NCT03016325|25935278|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
13119597|NCT03016325|25935279|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1|||
13119598|NCT03016325|25935280|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
13119599|NCT03016325|25935281|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
13119600|NCT03016325|25935282|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
13291487|NCT00151775|26483490|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
13119601|NCT03016325|25935283|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
13119602|NCT03016325|25935284|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
13119603|NCT03016325|25935277|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
13119604|NCT03016325|25935278|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1|||
13119605|NCT03016325|25935279|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
13119606|NCT03016325|25935280|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
13119607|NCT03016325|25935281|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
13278039|NCT04553406|26448329|FG000|Overall Study|Study Discontinuation|0|||
13278040|NCT04553406|26448330|FG001|Overall Study|Study Discontinuation|1|||
13278041|NCT04126213|26448598|FG000|Overall Study|Lost to Follow-up|9|||
13278042|NCT04126213|26448599|FG001|Overall Study|Lost to Follow-up|1|||
13278043|NCT04126213|26448600|FG002|Overall Study|Lost to Follow-up|5|||
13278044|NCT04126213|26448601|FG003|Overall Study|Lost to Follow-up|10|||
13278045|NCT04126213|26448602|FG004|Overall Study|Lost to Follow-up|4|||
13278046|NCT04126213|26448603|FG005|Overall Study|Lost to Follow-up|7|||
13278047|NCT04126213|26448598|FG000|Overall Study|Withdrawal by Subject|3|||
13278048|NCT04126213|26448599|FG001|Overall Study|Withdrawal by Subject|2|||
13278049|NCT04126213|26448600|FG002|Overall Study|Withdrawal by Subject|1|||
13278050|NCT04126213|26448601|FG003|Overall Study|Withdrawal by Subject|1|||
13278051|NCT04126213|26448602|FG004|Overall Study|Withdrawal by Subject|1|||
13278052|NCT04126213|26448603|FG005|Overall Study|Withdrawal by Subject|1|||
13278053|NCT04126213|26448598|FG000|Overall Study|Other|0|||
13278054|NCT04126213|26448599|FG001|Overall Study|Other|0|||
13278055|NCT04126213|26448600|FG002|Overall Study|Other|2|||
13278056|NCT04126213|26448601|FG003|Overall Study|Other|2|||
13278057|NCT04126213|26448602|FG004|Overall Study|Other|0|||
13278058|NCT04126213|26448603|FG005|Overall Study|Other|1|||
13278059|NCT04126213|26448598|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
13278060|NCT04126213|26448599|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
13278061|NCT04126213|26448600|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
13278062|NCT04126213|26448601|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
13278063|NCT04126213|26448602|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
13278064|NCT04126213|26448603|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
13278065|NCT04128319|26448635|FG000|Overall Study|Death|3|||
13278066|NCT04129944|26448674|FG000|Overall Study|Death|0|||
13278067|NCT04129944|26448675|FG001|Overall Study|Death|0|||
13278068|NCT04129944|26448676|FG002|Overall Study|Death|0|||
13278069|NCT04129944|26448677|FG003|Overall Study|Death|1|||
13278070|NCT04129944|26448674|FG000|Overall Study|Lost to Follow-up|1|||
13278071|NCT04129944|26448675|FG001|Overall Study|Lost to Follow-up|0|||
13278072|NCT04129944|26448676|FG002|Overall Study|Lost to Follow-up|0|||
13278073|NCT04129944|26448677|FG003|Overall Study|Lost to Follow-up|0|||
13278074|NCT04129944|26448674|FG000|Overall Study|Withdrawal by Subject|1|||
13278075|NCT04129944|26448675|FG001|Overall Study|Withdrawal by Subject|0|||
13278076|NCT04129944|26448676|FG002|Overall Study|Withdrawal by Subject|1|||
13278077|NCT04129944|26448677|FG003|Overall Study|Withdrawal by Subject|2|||
13278078|NCT04126083|26448683|FG000|Overall Study|Withdrawal by Subject|1|||
13278079|NCT04126733|26448732|FG000|Treatment Period|Other Reason|1|||
13278080|NCT04126733|26448732|FG000|Treatment Period|Death|1|||
13278081|NCT04126733|26448732|FG000|Treatment Period|Physician Decision|3|||
13278082|NCT04126733|26448732|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7|||
13278083|NCT04126733|26448732|FG000|Treatment Period|Adverse Event|7|||
13278084|NCT04126733|26448732|FG000|Treatment Period|Progressive Disease - Radiological Progression|44|||
13278085|NCT04126733|26448732|FG000|Treatment Period|Ongoing with Study Treatment|7|||
13278086|NCT04126733|26448732|FG000|Active Follow-up Period|Death|13|||
13278087|NCT04126733|26448732|FG000|Active Follow-up Period|Other Reason|1|||
13278088|NCT04126733|26448732|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4|||
13278089|NCT04126733|26448732|FG000|Active Follow-up Period|Withdrawal by Subject|2|||
13278090|NCT04126733|26448732|FG000|Long-term Follow-up Period|Withdrawal by Subject|1|||
13278091|NCT04126733|26448732|FG000|Long-term Follow-up Period|Death|5|||
13278092|NCT03829332|26448763|FG000|Overall Study|Death|145|||
13278093|NCT03829332|26448764|FG001|Overall Study|Death|135|||
13278094|NCT03829332|26448763|FG000|Overall Study|Withdrawal by Subject|10|||
13278095|NCT03829332|26448764|FG001|Overall Study|Withdrawal by Subject|4|||
13278096|NCT03829332|26448763|FG000|Overall Study|Ongoing in Study|154|||
13278097|NCT03829332|26448764|FG001|Overall Study|Ongoing in Study|175|||
13278098|NCT03822832|26448818|FG000|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
13278099|NCT03822832|26448819|FG001|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
13278100|NCT03822832|26448818|FG000|Period 1 - Double Blind Period|Lost to Follow-up|1|||
13278101|NCT03822832|26448819|FG001|Period 1 - Double Blind Period|Lost to Follow-up|1|||
13278102|NCT03822832|26448818|FG000|Period 1 - Double Blind Period|Protocol Violation|1|||
13278103|NCT03822832|26448819|FG001|Period 1 - Double Blind Period|Protocol Violation|1|||
13278104|NCT03822832|26448818|FG000|Period 1 - Double Blind Period|Lack of Efficacy|2|||
13278105|NCT03822832|26448819|FG001|Period 1 - Double Blind Period|Lack of Efficacy|1|||
13278106|NCT03822832|26448818|FG000|Period 1 - Double Blind Period|Adverse Event|3|||
13278107|NCT03822832|26448819|FG001|Period 1 - Double Blind Period|Adverse Event|5|||
13278108|NCT03822832|26448818|FG000|Re-allocation|Not re-allocated to open label period|2|||
13278109|NCT03822832|26448819|FG001|Re-allocation|Not re-allocated to open label period|6|||
13278110|NCT03822832|26448818|FG000|Period 2 - Open Label Period|Lost to Follow-up|1|||
13278111|NCT03822832|26448819|FG001|Period 2 - Open Label Period|Lost to Follow-up|0|||
13278112|NCT03822832|26448818|FG000|Period 2 - Open Label Period|Adverse Event|0|||
13278113|NCT03822832|26448819|FG001|Period 2 - Open Label Period|Adverse Event|3|||
13291488|NCT00151775|26483491|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
13291489|NCT00151775|26483492|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
13291490|NCT00151775|26483493|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
13291491|NCT00151775|26483494|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
13291492|NCT00151775|26483495|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
13291493|NCT00151775|26483496|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
13291494|NCT00151775|26483497|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
13291495|NCT00151775|26483498|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
13291496|NCT00151775|26483487|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
13291497|NCT00151775|26483488|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
13291498|NCT00151775|26483489|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
13291499|NCT00151775|26483490|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
13291500|NCT00151775|26483491|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
13291501|NCT00151775|26483492|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
13291502|NCT00151775|26483493|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
13291503|NCT00151775|26483494|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
13291504|NCT00151775|26483495|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
13291505|NCT00151775|26483496|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
13291506|NCT00151775|26483497|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
13291507|NCT00151775|26483498|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
13291508|NCT00151775|26483487|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
13291509|NCT00151775|26483488|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4|||
13291510|NCT00151775|26483489|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
13291511|NCT00151775|26483490|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
13291512|NCT00151775|26483491|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
13291513|NCT00151775|26483492|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
13291514|NCT00151775|26483493|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
13291515|NCT00151775|26483494|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
13291516|NCT00151775|26483495|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
13291517|NCT00151775|26483496|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
13291518|NCT00151775|26483497|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
13291519|NCT00151775|26483498|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
13291520|NCT00151775|26483487|FG000|Period 2 - Double-Blind Dose Response|Other|0|||
13291521|NCT00151775|26483488|FG001|Period 2 - Double-Blind Dose Response|Other|0|||
13291522|NCT00151775|26483489|FG002|Period 2 - Double-Blind Dose Response|Other|0|||
13291523|NCT00151775|26483490|FG003|Period 2 - Double-Blind Dose Response|Other|0|||
13291524|NCT00151775|26483491|FG004|Period 2 - Double-Blind Dose Response|Other|0|||
13291525|NCT00151775|26483492|FG005|Period 2 - Double-Blind Dose Response|Other|0|||
13291526|NCT00151775|26483493|FG006|Period 2 - Double-Blind Dose Response|Other|1|||
13291527|NCT00151775|26483494|FG007|Period 2 - Double-Blind Dose Response|Other|0|||
13119608|NCT03016325|25935282|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
13119609|NCT03016325|25935283|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
13119610|NCT03016325|25935284|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
13119611|NCT03016325|25935277|FG000|182-Day Follow-Up Period|Death|3|||
13119612|NCT03016325|25935278|FG001|182-Day Follow-Up Period|Death|3|||
13119613|NCT03016325|25935279|FG002|182-Day Follow-Up Period|Death|11|||
13119614|NCT03016325|25935280|FG003|182-Day Follow-Up Period|Death|12|||
13119615|NCT03016325|25935281|FG004|182-Day Follow-Up Period|Death|9|||
13119616|NCT03016325|25935282|FG005|182-Day Follow-Up Period|Death|0|||
13119617|NCT03016325|25935283|FG006|182-Day Follow-Up Period|Death|0|||
13119618|NCT03016325|25935284|FG007|182-Day Follow-Up Period|Death|1|||
13119619|NCT03016325|25935277|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1|||
13119620|NCT03016325|25935278|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0|||
13119621|NCT03016325|25935279|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0|||
13119622|NCT03016325|25935280|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0|||
13119623|NCT03016325|25935281|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0|||
13119624|NCT03016325|25935282|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0|||
13119625|NCT03016325|25935283|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0|||
13119626|NCT03016325|25935284|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0|||
13119627|NCT03016325|25935277|FG000|182-Day Follow-Up Period|Participant withdrew consent|0|||
13119628|NCT03016325|25935278|FG001|182-Day Follow-Up Period|Participant withdrew consent|0|||
13119629|NCT03016325|25935279|FG002|182-Day Follow-Up Period|Participant withdrew consent|0|||
13119630|NCT03016325|25935280|FG003|182-Day Follow-Up Period|Participant withdrew consent|0|||
13119631|NCT03016325|25935281|FG004|182-Day Follow-Up Period|Participant withdrew consent|1|||
13278114|NCT01458340|26448873|FG000|Overall Study|Adverse Event|5|||
13278115|NCT01458340|26448874|FG001|Overall Study|Adverse Event|4|||
13278116|NCT01458340|26448875|FG002|Overall Study|Adverse Event|2|||
13278117|NCT01458340|26448873|FG000|Overall Study|Lost to Follow-up|3|||
13278118|NCT01458340|26448874|FG001|Overall Study|Lost to Follow-up|3|||
13278119|NCT01458340|26448875|FG002|Overall Study|Lost to Follow-up|10|||
13278120|NCT01458340|26448873|FG000|Overall Study|Miscellaneous|0|||
13278121|NCT01458340|26448874|FG001|Overall Study|Miscellaneous|1|||
13278122|NCT01458340|26448875|FG002|Overall Study|Miscellaneous|0|||
13278123|NCT01458340|26448873|FG000|Overall Study|Physician Decision|1|||
13278124|NCT01458340|26448874|FG001|Overall Study|Physician Decision|1|||
13278125|NCT01458340|26448875|FG002|Overall Study|Physician Decision|2|||
13278126|NCT01458340|26448873|FG000|Overall Study|Protocol Violation|6|||
13278127|NCT01458340|26448874|FG001|Overall Study|Protocol Violation|6|||
13278128|NCT01458340|26448875|FG002|Overall Study|Protocol Violation|5|||
13278129|NCT01458340|26448873|FG000|Overall Study|Withdrawal by Subject|12|||
13278130|NCT01458340|26448874|FG001|Overall Study|Withdrawal by Subject|6|||
13278131|NCT01458340|26448875|FG002|Overall Study|Withdrawal by Subject|4|||
13278132|NCT01453946|26448883|FG000|Overall Study|Did not receive drug for the taper phase|1|||
13278133|NCT01453946|26448883|FG000|Overall Study|Protocol Violation|2|||
13278134|NCT01453946|26448883|FG000|Overall Study|Lack of Efficacy|3|||
13278135|NCT01453946|26448883|FG000|Overall Study|Adverse Event|3|||
13278136|NCT01455597|26448916|FG000|Overall Study|Adverse Event|7|||
13278137|NCT01455597|26448917|FG001|Overall Study|Adverse Event|0|||
13278138|NCT01455597|26448918|FG002|Overall Study|Adverse Event|5|||
13278139|NCT01455597|26448919|FG003|Overall Study|Adverse Event|1|||
13278140|NCT01455597|26448916|FG000|Overall Study|Lack of Efficacy|0|||
13278141|NCT01455597|26448917|FG001|Overall Study|Lack of Efficacy|1|||
13278142|NCT01455597|26448918|FG002|Overall Study|Lack of Efficacy|2|||
13278143|NCT01455597|26448919|FG003|Overall Study|Lack of Efficacy|0|||
13278144|NCT01455597|26448916|FG000|Overall Study|Lost to Follow-up|3|||
13278145|NCT01455597|26448917|FG001|Overall Study|Lost to Follow-up|0|||
13278146|NCT01455597|26448918|FG002|Overall Study|Lost to Follow-up|2|||
13278147|NCT01455597|26448919|FG003|Overall Study|Lost to Follow-up|1|||
13278148|NCT01455597|26448916|FG000|Overall Study|Withdrew Consent|6|||
13278149|NCT01455597|26448917|FG001|Overall Study|Withdrew Consent|5|||
13278150|NCT01455597|26448918|FG002|Overall Study|Withdrew Consent|8|||
13278151|NCT01455597|26448919|FG003|Overall Study|Withdrew Consent|5|||
13278152|NCT01455597|26448916|FG000|Overall Study|Reason not Specified|1|||
13278153|NCT01455597|26448917|FG001|Overall Study|Reason not Specified|2|||
13278154|NCT01455597|26448918|FG002|Overall Study|Reason not Specified|3|||
13278155|NCT01455597|26448919|FG003|Overall Study|Reason not Specified|3|||
13278156|NCT01459497|26448946|FG000|Overall Study|Inability to meet trial constraints.|1|||
13278157|NCT01459497|26448947|FG001|Overall Study|Inability to meet trial constraints.|0|||
13278158|NCT01459497|26448946|FG000|Overall Study|Physician Decision|1|||
13278159|NCT01459497|26448947|FG001|Overall Study|Physician Decision|1|||
13278160|NCT01459497|26448946|FG000|Overall Study|Hospitalization.|0|||
13278161|NCT01459497|26448947|FG001|Overall Study|Hospitalization.|3|||
13278162|NCT01459497|26448946|FG000|Overall Study|Disease progression.|0|||
13278163|NCT01459497|26448947|FG001|Overall Study|Disease progression.|1|||
13278164|NCT01899144|26448988|FG000|Treatment Period 2|Other|1|||
13278165|NCT01899144|26448988|FG000|Treatment Period 3|Other|2|||
13278166|NCT01899144|26448988|FG000|Treatment Period 5|Other|1|||
13278167|NCT01898494|26449027|FG000|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
13278168|NCT01898494|26449028|FG001|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
13278169|NCT01898494|26449029|FG002|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
13278170|NCT01898494|26449030|FG003|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
13278171|NCT01898494|26449031|FG004|Step 1 (Arm S - Transoral Surgery)|Physician Decision|2|||
13278172|NCT01898494|26449027|FG000|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
13278173|NCT01898494|26449028|FG001|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
13278174|NCT01898494|26449029|FG002|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
13278175|NCT01898494|26449030|FG003|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
13278176|NCT01898494|26449031|FG004|Step 1 (Arm S - Transoral Surgery)|Adverse Event|1|||
13278177|NCT01898494|26449027|FG000|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
13278178|NCT01898494|26449028|FG001|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
13278179|NCT01898494|26449029|FG002|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
13278180|NCT01898494|26449030|FG003|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
13278181|NCT01898494|26449031|FG004|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|7|||
13278182|NCT01898494|26449027|FG000|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
13278183|NCT01898494|26449028|FG001|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
13278184|NCT01898494|26449029|FG002|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
13278185|NCT01898494|26449030|FG003|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
13278186|NCT01898494|26449031|FG004|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|9|||
13278187|NCT01898494|26449027|FG000|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
13278188|NCT01898494|26449028|FG001|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
13278189|NCT01898494|26449029|FG002|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
13278190|NCT01898494|26449030|FG003|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
13278191|NCT01898494|26449031|FG004|Step 1 (Arm S - Transoral Surgery)|Disease progression|2|||
13278192|NCT01898494|26449027|FG000|Step 1 (Arm S - Transoral Surgery)|Death|0|||
13278193|NCT01898494|26449028|FG001|Step 1 (Arm S - Transoral Surgery)|Death|0|||
13278194|NCT01898494|26449029|FG002|Step 1 (Arm S - Transoral Surgery)|Death|0|||
13278195|NCT01898494|26449030|FG003|Step 1 (Arm S - Transoral Surgery)|Death|0|||
13278196|NCT01898494|26449031|FG004|Step 1 (Arm S - Transoral Surgery)|Death|1|||
13278197|NCT01898494|26449027|FG000|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
13278198|NCT01898494|26449028|FG001|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
13278199|NCT01898494|26449029|FG002|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
13278200|NCT01898494|26449030|FG003|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
13278201|NCT01898494|26449031|FG004|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|1|||
13278202|NCT01898494|26449027|FG000|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
13278203|NCT01898494|26449028|FG001|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
13278204|NCT01898494|26449029|FG002|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
13278205|NCT01898494|26449030|FG003|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
13278206|NCT01898494|26449031|FG004|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|1|||
13278207|NCT01898494|26449027|FG000|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
13278208|NCT01898494|26449028|FG001|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
13278209|NCT01898494|26449029|FG002|Step 2 (Adjuvant Treatment)|Adverse Event|2|||
13278210|NCT01898494|26449030|FG003|Step 2 (Adjuvant Treatment)|Adverse Event|3|||
13278211|NCT01898494|26449031|FG004|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
13278212|NCT01898494|26449027|FG000|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
13278213|NCT01898494|26449028|FG001|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
13278214|NCT01898494|26449029|FG002|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|6|||
13278215|NCT01898494|26449030|FG003|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|3|||
13278216|NCT01898494|26449031|FG004|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
13278217|NCT01898494|26449027|FG000|Step 2 (Adjuvant Treatment)|Death|0|||
13278218|NCT01898494|26449028|FG001|Step 2 (Adjuvant Treatment)|Death|0|||
13278219|NCT01898494|26449029|FG002|Step 2 (Adjuvant Treatment)|Death|0|||
13278220|NCT01898494|26449030|FG003|Step 2 (Adjuvant Treatment)|Death|1|||
13278221|NCT01898494|26449031|FG004|Step 2 (Adjuvant Treatment)|Death|0|||
13278222|NCT01898494|26449027|FG000|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
13278223|NCT01898494|26449028|FG001|Step 2 (Adjuvant Treatment)|Physician Decision|1|||
13278224|NCT01898494|26449029|FG002|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
13119632|NCT03016325|25935282|FG005|182-Day Follow-Up Period|Participant withdrew consent|0|||
13119633|NCT03016325|25935283|FG006|182-Day Follow-Up Period|Participant withdrew consent|1|||
13119634|NCT03016325|25935284|FG007|182-Day Follow-Up Period|Participant withdrew consent|0|||
13119635|NCT03016325|25935277|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0|||
13119636|NCT03016325|25935278|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0|||
13119637|NCT03016325|25935279|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0|||
13119638|NCT03016325|25935280|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0|||
13119639|NCT03016325|25935281|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1|||
13119640|NCT03016325|25935282|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0|||
13119641|NCT03016325|25935283|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0|||
13119642|NCT03016325|25935284|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0|||
13119643|NCT03016325|25935277|FG000|182-Day Follow-Up Period|Alive, per civil unit|0|||
13119644|NCT03016325|25935278|FG001|182-Day Follow-Up Period|Alive, per civil unit|0|||
13119645|NCT03016325|25935279|FG002|182-Day Follow-Up Period|Alive, per civil unit|0|||
13119646|NCT03016325|25935280|FG003|182-Day Follow-Up Period|Alive, per civil unit|0|||
13119647|NCT03016325|25935281|FG004|182-Day Follow-Up Period|Alive, per civil unit|1|||
13119648|NCT03016325|25935282|FG005|182-Day Follow-Up Period|Alive, per civil unit|0|||
13119649|NCT03016325|25935283|FG006|182-Day Follow-Up Period|Alive, per civil unit|0|||
13119650|NCT03016325|25935284|FG007|182-Day Follow-Up Period|Alive, per civil unit|0|||
13119651|NCT03016325|25935277|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0|||
13119652|NCT03016325|25935278|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0|||
13119653|NCT03016325|25935279|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0|||
13119654|NCT03016325|25935280|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1|||
13119655|NCT03016325|25935281|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0|||
13119656|NCT03016325|25935282|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0|||
13278225|NCT01898494|26449030|FG003|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
13278226|NCT01898494|26449031|FG004|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
13278227|NCT01898494|26449027|FG000|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
13119657|NCT03016325|25935283|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0|||
13119658|NCT03016325|25935284|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0|||
13119659|NCT03016325|25935277|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
13119660|NCT03016325|25935278|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1|||
13119661|NCT03016325|25935279|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
13119662|NCT03016325|25935280|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
13278228|NCT01898494|26449028|FG001|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
13278229|NCT01898494|26449029|FG002|Step 2 (Adjuvant Treatment)|Alternative therapy|1|||
13278230|NCT01898494|26449030|FG003|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
13278231|NCT01898494|26449031|FG004|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
13278232|NCT01898494|26449027|FG000|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
13278233|NCT01898494|26449028|FG001|Step 2 (Adjuvant Treatment)|Never started treatment|6|||
13278234|NCT01898494|26449029|FG002|Step 2 (Adjuvant Treatment)|Never started treatment|5|||
13278235|NCT01898494|26449030|FG003|Step 2 (Adjuvant Treatment)|Never started treatment|4|||
13278236|NCT01898494|26449031|FG004|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
13278237|NCT01891643|26449056|FG000|Overall Study|Adverse event unrelated to study drug|2|||
13278238|NCT01891643|26449057|FG001|Overall Study|Adverse event unrelated to study drug|5|||
13278239|NCT01891643|26449056|FG000|Overall Study|Disease Progression|4|||
13278240|NCT01891643|26449057|FG001|Overall Study|Disease Progression|3|||
13278241|NCT01891643|26449056|FG000|Overall Study|Study Drug Toxicity|3|||
13278242|NCT01891643|26449057|FG001|Overall Study|Study Drug Toxicity|0|||
13278243|NCT01891643|26449056|FG000|Overall Study|Maximum Clinical Benefit|0|||
13278244|NCT01891643|26449057|FG001|Overall Study|Maximum Clinical Benefit|1|||
13278245|NCT01891643|26449056|FG000|Overall Study|Poor/Non-compliance|0|||
13278246|NCT01891643|26449057|FG001|Overall Study|Poor/Non-compliance|1|||
13278247|NCT01891643|26449056|FG000|Overall Study|Participant request to discontinue|1|||
13278248|NCT01891643|26449057|FG001|Overall Study|Participant request to discontinue|0|||
13291528|NCT00151775|26483495|FG008|Period 2 - Double-Blind Dose Response|Other|0|||
13291529|NCT00151775|26483496|FG009|Period 2 - Double-Blind Dose Response|Other|0|||
13291530|NCT00151775|26483497|FG010|Period 2 - Double-Blind Dose Response|Other|0|||
13291531|NCT00151775|26483498|FG011|Period 2 - Double-Blind Dose Response|Other|0|||
13291532|NCT00151775|26483487|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0|||
13291533|NCT00151775|26483488|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0|||
13291534|NCT00151775|26483489|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0|||
13291535|NCT00151775|26483490|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0|||
13291536|NCT00151775|26483491|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0|||
13291537|NCT00151775|26483492|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1|||
13291538|NCT00151775|26483493|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0|||
13291539|NCT00151775|26483494|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0|||
13291540|NCT00151775|26483495|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0|||
13291541|NCT00151775|26483496|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0|||
13291542|NCT00151775|26483497|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0|||
13291543|NCT00151775|26483498|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0|||
13291544|NCT00151775|26483487|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
13291545|NCT00151775|26483488|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
13291546|NCT00151775|26483489|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
13291547|NCT00151775|26483490|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
13291548|NCT00151775|26483491|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
13291549|NCT00151775|26483492|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1|||
13291550|NCT00151775|26483493|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
13291551|NCT00151775|26483494|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
13291552|NCT00151775|26483495|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
13291553|NCT00151775|26483496|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
13291554|NCT00151775|26483497|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
13291555|NCT00151775|26483498|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
13291556|NCT00151775|26483487|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
13291557|NCT00151775|26483488|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
13291558|NCT00151775|26483489|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
13291559|NCT00151775|26483490|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
13291560|NCT00151775|26483491|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
13291561|NCT00151775|26483492|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
13291562|NCT00151775|26483493|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1|||
13291563|NCT00151775|26483494|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
13291564|NCT00151775|26483495|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
13291565|NCT00151775|26483496|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
13291566|NCT00151775|26483497|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
13278249|NCT01798004|26449063|FG000|Overall Study|Death|2|||
13278250|NCT01798004|26449063|FG000|Overall Study|Lack of Efficacy|8|||
13278251|NCT01798004|26449063|FG000|Overall Study|Physician Decision|25|||
13278252|NCT01798004|26449063|FG000|Overall Study|Withdrawal by Subject|4|||
13278253|NCT01798004|26449063|FG000|Overall Study|Ineligible|4|||
13278254|NCT01798004|26449063|FG000|Overall Study|Patient/parent refusal|7|||
13278255|NCT01798004|26449063|FG000|Overall Study|Initiation of other non-protocol therapy|5|||
13278256|NCT01798004|26449063|FG000|Overall Study|Enrollment another COG therapeutic trial|32|||
13278257|NCT01796301|26449104|FG000|Overall Study|Withdrawal by Subject|15|||
13278258|NCT01796301|26449105|FG001|Overall Study|Withdrawal by Subject|15|||
13278259|NCT01796301|26449104|FG000|Overall Study|Lost to Follow-up|3|||
13278260|NCT01796301|26449105|FG001|Overall Study|Lost to Follow-up|3|||
13278261|NCT01796301|26449104|FG000|Overall Study|Death|0|||
13278262|NCT01796301|26449105|FG001|Overall Study|Death|1|||
13278263|NCT01796301|26449104|FG000|Overall Study|Decision by Sponsor|0|||
13278264|NCT01796301|26449105|FG001|Overall Study|Decision by Sponsor|1|||
13278265|NCT02999633|26449115|FG000|Overall Study|Adverse Event|2|||
13278266|NCT02999633|26449115|FG000|Overall Study|Progressive disease|12|||
13278267|NCT02992418|26449156|FG000|Overall Study|Withdrawal by Subject|11|||
13278268|NCT02992418|26449157|FG001|Overall Study|Withdrawal by Subject|12|||
13278269|NCT02992418|26449156|FG000|Overall Study|Non-compliance with the protocol|308|||
13278270|NCT02992418|26449157|FG001|Overall Study|Non-compliance with the protocol|308|||
13278271|NCT02992418|26449156|FG000|Overall Study|Lost to Follow-up|27|||
13278272|NCT02992418|26449157|FG001|Overall Study|Lost to Follow-up|22|||
13278273|NCT02992743|26449212|FG000|Overall Study|Withdrawal by Subject|1|||
13278274|NCT02992743|26449213|FG001|Overall Study|Withdrawal by Subject|1|||
13278275|NCT02992743|26449212|FG000|Overall Study|Death-Prior to T-Cell Infusion|1|||
13278276|NCT02992743|26449213|FG001|Overall Study|Death-Prior to T-Cell Infusion|0|||
13278277|NCT02992743|26449212|FG000|Overall Study|Did Not Meet Inclusion/Exclusion|1|||
13278278|NCT02992743|26449213|FG001|Overall Study|Did Not Meet Inclusion/Exclusion|0|||
13278279|NCT02992743|26449212|FG000|Overall Study|No measurable disease|1|||
13278280|NCT02992743|26449213|FG001|Overall Study|No measurable disease|0|||
13278281|NCT02992743|26449212|FG000|Overall Study|In Follow-up|0|||
13278282|NCT02992743|26449213|FG001|Overall Study|In Follow-up|1|||
13278283|NCT02992743|26449212|FG000|Overall Study|On Study Treatment|0|||
13278284|NCT02992743|26449213|FG001|Overall Study|On Study Treatment|1|||
13278285|NCT02999854|26449302|FG000|Active Study Phase (up to 18 Months)|Screen failures|7|||
13278286|NCT02999854|26449303|FG001|Active Study Phase (up to 18 Months)|Screen failures|2|||
13278287|NCT02999854|26449302|FG000|Active Study Phase (up to 18 Months)|Discontinued before HSCT|8|||
13278288|NCT02999854|26449303|FG001|Active Study Phase (up to 18 Months)|Discontinued before HSCT|2|||
13278289|NCT02999854|26449302|FG000|Active Study Phase (up to 18 Months)|Death|7|||
13278290|NCT02999854|26449303|FG001|Active Study Phase (up to 18 Months)|Death|5|||
13278291|NCT02999854|26449302|FG000|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|1|||
13278292|NCT02999854|26449303|FG001|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|0|||
13278293|NCT02999854|26449302|FG000|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|1|||
13278294|NCT02999854|26449303|FG001|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|0|||
13278295|NCT02999854|26449302|FG000|Long Term Safety FU (up to 24 Months)|Death|1|||
13278296|NCT02999854|26449303|FG001|Long Term Safety FU (up to 24 Months)|Death|1|||
13278297|NCT02999854|26449302|FG000|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
13278298|NCT02999854|26449303|FG001|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
13278299|NCT02999854|26449302|FG000|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
13278300|NCT02999854|26449303|FG001|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
13278301|NCT02993263|26449309|FG000|Overall Study|Equipment Software failed and results were lost.|323|||
13278302|NCT01279681|26449345|FG000|Overall Study|Disease Progression|9|||
13278303|NCT01279681|26449346|FG001|Overall Study|Disease Progression|6|||
13278304|NCT01279681|26449345|FG000|Overall Study|Withdrawal by Subject|3|||
13278305|NCT01279681|26449346|FG001|Overall Study|Withdrawal by Subject|4|||
13278306|NCT01279681|26449345|FG000|Overall Study|Adverse Event|2|||
13278307|NCT01279681|26449346|FG001|Overall Study|Adverse Event|3|||
13278308|NCT01279681|26449345|FG000|Overall Study|Death|0|||
13278309|NCT01279681|26449346|FG001|Overall Study|Death|1|||
13278310|NCT01279681|26449345|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
13278311|NCT01279681|26449346|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
13278312|NCT01279681|26449345|FG000|Overall Study|Physician Decision|1|||
13278313|NCT01279681|26449346|FG001|Overall Study|Physician Decision|0|||
13278314|NCT01279681|26449345|FG000|Overall Study|Other Reason|0|||
13278315|NCT01279681|26449346|FG001|Overall Study|Other Reason|2|||
13278316|NCT01279616|26449352|FG000|Overall Study|donor could not be located|5|||
13278317|NCT01279616|26449352|FG000|Overall Study|no signs of sickle cell disease|2|||
13278318|NCT01279486|26449358|FG000|Overall Study|Lost to Follow-up|1|||
13278319|NCT01279343|26449389|FG000|Overall Study|Did not receive treatment|2|||
13278320|NCT01279343|26449390|FG001|Overall Study|Did not receive treatment|6|||
13278321|NCT01279070|26449413|FG000|Overall Study|Withdrawal by Subject|2|||
13307958|NCT01281306|26530320|FG002|Overall Study|Adverse Event|2|||
13278322|NCT01279070|26449414|FG001|Overall Study|Withdrawal by Subject|3|||
13278323|NCT01279070|26449413|FG000|Overall Study|Acute exacerbation|3|||
13278324|NCT01279070|26449414|FG001|Overall Study|Acute exacerbation|1|||
13278325|NCT01279057|26449449|FG000|Overall Study|Adverse Event|1|||
13278326|NCT01279057|26449450|FG001|Overall Study|Adverse Event|0|||
13278327|NCT01279057|26449451|FG002|Overall Study|Adverse Event|1|||
13278328|NCT01279057|26449449|FG000|Overall Study|Insufficient therapeutic response|0|||
13119663|NCT03016325|25935281|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
13278329|NCT01279057|26449450|FG001|Overall Study|Insufficient therapeutic response|0|||
13278330|NCT01279057|26449451|FG002|Overall Study|Insufficient therapeutic response|1|||
13278331|NCT01279057|26449449|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
13278332|NCT01279057|26449450|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
13278333|NCT01279057|26449451|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
13278334|NCT01279057|26449449|FG000|Overall Study|Withdrew consent|2|||
13278335|NCT01279057|26449450|FG001|Overall Study|Withdrew consent|0|||
13278336|NCT01279057|26449451|FG002|Overall Study|Withdrew consent|1|||
13278337|NCT01279057|26449449|FG000|Overall Study|Pregnancy|0|||
13278338|NCT01279057|26449450|FG001|Overall Study|Pregnancy|1|||
13278339|NCT01279057|26449451|FG002|Overall Study|Pregnancy|0|||
13278340|NCT01279057|26449449|FG000|Overall Study|Other|3|||
13278341|NCT01279057|26449450|FG001|Overall Study|Other|3|||
13278342|NCT01279057|26449451|FG002|Overall Study|Other|0|||
13278343|NCT01279044|26449479|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0|||
13278344|NCT01279044|26449480|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3|||
13278345|NCT01279044|26449481|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2|||
13278346|NCT01279044|26449479|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
13278347|NCT01279044|26449480|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8|||
13278348|NCT01279044|26449481|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
13278349|NCT01279044|26449479|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0|||
13119664|NCT03016325|25935282|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
13119665|NCT03016325|25935283|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
13119666|NCT03016325|25935284|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
13119667|NCT03016325|25935277|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
13119668|NCT03016325|25935278|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
13119669|NCT03016325|25935279|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
13119670|NCT03016325|25935280|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
13119671|NCT03016325|25935281|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
13119672|NCT03016325|25935282|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5|||
13119673|NCT03016325|25935283|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3|||
13119674|NCT03016325|25935284|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4|||
13119675|NCT03016078|25935297|FG000|Overall Study|Protocol Violation|1|||
13119676|NCT03016078|25935297|FG000|Overall Study|Protocol Violation|1|||
13119677|NCT03015532|25935356|FG000|Overall Study|Adverse Event|0|||
13119678|NCT03015532|25935357|FG001|Overall Study|Adverse Event|0|||
13119679|NCT03015532|25935358|FG002|Overall Study|Adverse Event|0|||
13119680|NCT03015532|25935359|FG003|Overall Study|Adverse Event|0|||
13119681|NCT03015532|25935360|FG004|Overall Study|Adverse Event|0|||
13119682|NCT03015532|25935361|FG005|Overall Study|Adverse Event|2|||
13278350|NCT01279044|26449480|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0|||
13278351|NCT01279044|26449481|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1|||
13278352|NCT01278862|26449496|FG000|Overall Study|Lost to Follow-up|1|||
13278353|NCT01278862|26449497|FG001|Overall Study|Lost to Follow-up|1|||
13278354|NCT01278797|26449510|FG000|Period 1|Adverse Event|0|||
13278355|NCT01278797|26449511|FG001|Period 1|Adverse Event|1|||
13278356|NCT01278797|26449510|FG000|Period 1|Protocol Violation|1|||
13278357|NCT01278797|26449511|FG001|Period 1|Protocol Violation|0|||
13278358|NCT01278745|26449552|FG000|Overall Study|Death|2|||
13278359|NCT01278745|26449553|FG001|Overall Study|Death|5|||
13278360|NCT01278745|26449554|FG002|Overall Study|Death|7|||
13278361|NCT01278745|26449555|FG003|Overall Study|Death|0|||
13278362|NCT01278745|26449552|FG000|Overall Study|Physician Decision|1|||
13278363|NCT01278745|26449553|FG001|Overall Study|Physician Decision|0|||
13278364|NCT01278745|26449554|FG002|Overall Study|Physician Decision|0|||
13278365|NCT01278745|26449555|FG003|Overall Study|Physician Decision|9|||
13278366|NCT01278745|26449552|FG000|Overall Study|Withdrawal by Subject|1|||
13278367|NCT01278745|26449553|FG001|Overall Study|Withdrawal by Subject|1|||
13278368|NCT01278745|26449554|FG002|Overall Study|Withdrawal by Subject|5|||
13278369|NCT01278745|26449555|FG003|Overall Study|Withdrawal by Subject|1|||
13278370|NCT01278745|26449552|FG000|Overall Study|Sponsor Decision|1|||
13278371|NCT01278745|26449553|FG001|Overall Study|Sponsor Decision|0|||
13278372|NCT01278745|26449554|FG002|Overall Study|Sponsor Decision|62|||
13278373|NCT01278745|26449555|FG003|Overall Study|Sponsor Decision|6|||
13278374|NCT01278745|26449552|FG000|Overall Study|Ineligible|0|||
13278375|NCT01278745|26449553|FG001|Overall Study|Ineligible|0|||
13278376|NCT01278745|26449554|FG002|Overall Study|Ineligible|42|||
13278377|NCT01278745|26449555|FG003|Overall Study|Ineligible|61|||
13278378|NCT01278745|26449552|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0|||
13278379|NCT01278745|26449553|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0|||
13278380|NCT01278745|26449554|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5|||
13278381|NCT01278745|26449555|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1|||
13278382|NCT01278615|26449567|FG000|Overall Study|Withdrawal by Subject|2|||
13278383|NCT01278407|26449592|FG000|Confirmatory Phase|Adverse Event|5|||
13278384|NCT01278407|26449593|FG001|Confirmatory Phase|Adverse Event|10|||
13278385|NCT01278407|26449594|FG002|Confirmatory Phase|Adverse Event|1|||
13278386|NCT01278407|26449595|FG003|Confirmatory Phase|Adverse Event|0|||
13278387|NCT01278407|26449596|FG004|Confirmatory Phase|Adverse Event|0|||
13278388|NCT01278407|26449592|FG000|Confirmatory Phase|Participant's Choice|3|||
13278389|NCT01278407|26449593|FG001|Confirmatory Phase|Participant's Choice|5|||
13278390|NCT01278407|26449594|FG002|Confirmatory Phase|Participant's Choice|3|||
13278391|NCT01278407|26449595|FG003|Confirmatory Phase|Participant's Choice|0|||
13278392|NCT01278407|26449596|FG004|Confirmatory Phase|Participant's Choice|0|||
13278393|NCT01278407|26449592|FG000|Confirmatory Phase|Other|1|||
13278394|NCT01278407|26449593|FG001|Confirmatory Phase|Other|1|||
13278395|NCT01278407|26449594|FG002|Confirmatory Phase|Other|2|||
13278396|NCT01278407|26449595|FG003|Confirmatory Phase|Other|0|||
13278397|NCT01278407|26449596|FG004|Confirmatory Phase|Other|0|||
13278398|NCT01278407|26449592|FG000|Extension Phase|Adverse Event|0|||
13278399|NCT01278407|26449593|FG001|Extension Phase|Adverse Event|0|||
13278400|NCT01278407|26449594|FG002|Extension Phase|Adverse Event|0|||
13278401|NCT01278407|26449595|FG003|Extension Phase|Adverse Event|7|||
13278402|NCT01278407|26449596|FG004|Extension Phase|Adverse Event|16|||
13278403|NCT01278407|26449592|FG000|Extension Phase|Participant's Choice|0|||
13278404|NCT01278407|26449593|FG001|Extension Phase|Participant's Choice|0|||
13278405|NCT01278407|26449594|FG002|Extension Phase|Participant's Choice|0|||
13278406|NCT01278407|26449595|FG003|Extension Phase|Participant's Choice|4|||
13278407|NCT01278407|26449596|FG004|Extension Phase|Participant's Choice|11|||
13278408|NCT01278407|26449592|FG000|Extension Phase|Other|0|||
13278409|NCT01278407|26449593|FG001|Extension Phase|Other|0|||
13278410|NCT01278407|26449594|FG002|Extension Phase|Other|0|||
13278411|NCT01278407|26449595|FG003|Extension Phase|Other|1|||
13278412|NCT01278407|26449596|FG004|Extension Phase|Other|3|||
13278413|NCT01278394|26449608|FG000|Overall Study|Lost to Follow-up|1|||
13278414|NCT01278342|26449632|FG000|Overall Study|Physician Decision|0|||
13278415|NCT01278342|26449633|FG001|Overall Study|Physician Decision|1|||
13278416|NCT01278342|26449634|FG002|Overall Study|Physician Decision|0|||
13278417|NCT01278342|26449632|FG000|Overall Study|Lost to Follow-up|1|||
13278418|NCT01278342|26449633|FG001|Overall Study|Lost to Follow-up|0|||
13278419|NCT01278342|26449634|FG002|Overall Study|Lost to Follow-up|0|||
13278420|NCT01278342|26449632|FG000|Overall Study|Administrative problems|2|||
13278421|NCT01278342|26449633|FG001|Overall Study|Administrative problems|0|||
13278422|NCT01278342|26449634|FG002|Overall Study|Administrative problems|0|||
13278423|NCT01278342|26449632|FG000|Overall Study|Other|1|||
13278424|NCT01278342|26449633|FG001|Overall Study|Other|0|||
13278425|NCT01278342|26449634|FG002|Overall Study|Other|0|||
13278426|NCT01278173|26449641|FG000|Overall Study|Lack of Efficacy|13|||
13278427|NCT01278173|26449641|FG000|Overall Study|Adverse Event|8|||
13278428|NCT01278173|26449641|FG000|Overall Study|Administrative or other reason|4|||
13278429|NCT01278173|26449641|FG000|Overall Study|Protocol Violation|1|||
13278430|NCT01278173|26449641|FG000|Overall Study|Withdrawal by Subject|1|||
13278431|NCT01278160|26449662|FG000|Overall Study|Adverse Event|1|||
13278432|NCT01278160|26449663|FG001|Overall Study|Adverse Event|1|||
13278433|NCT01278160|26449662|FG000|Overall Study|Lost to Follow-up|0|||
13278434|NCT01278160|26449663|FG001|Overall Study|Lost to Follow-up|1|||
13278435|NCT01278160|26449662|FG000|Overall Study|Withdrawal by Subject|3|||
13278436|NCT01278160|26449663|FG001|Overall Study|Withdrawal by Subject|2|||
13278437|NCT01278160|26449662|FG000|Overall Study|Unclassified|1|||
13278438|NCT01278160|26449663|FG001|Overall Study|Unclassified|2|||
13278439|NCT01278030|26449676|FG000|Overall Study|Withdrawal by Subject|8|||
13278440|NCT01278030|26449677|FG001|Overall Study|Withdrawal by Subject|4|||
13278441|NCT01277887|26449694|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1|||
13278442|NCT01277887|26449695|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0|||
13278443|NCT01277887|26449694|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2|||
13278444|NCT01277887|26449695|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0|||
13278445|NCT01277887|26449694|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3|||
13278446|NCT01277887|26449695|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5|||
13278447|NCT01277861|26449712|FG000|Overall Study|Physician Decision|2|||
13278448|NCT01277861|26449713|FG001|Overall Study|Physician Decision|2|||
13278449|NCT01277822|26449740|FG000|Overall Study|Adverse Event|2|||
13278450|NCT01277822|26449741|FG001|Overall Study|Adverse Event|1|||
13278451|NCT01277822|26449740|FG000|Overall Study|Withdrawal by Subject|6|||
13278452|NCT01277822|26449741|FG001|Overall Study|Withdrawal by Subject|7|||
13278453|NCT01277822|26449740|FG000|Overall Study|Physician Decision|1|||
13278454|NCT01277822|26449741|FG001|Overall Study|Physician Decision|1|||
13278455|NCT01277822|26449740|FG000|Overall Study|Protocol Violation|1|||
13278456|NCT01277822|26449741|FG001|Overall Study|Protocol Violation|0|||
13278457|NCT01277822|26449740|FG000|Overall Study|Lost to Follow-up|2|||
13278458|NCT01277822|26449741|FG001|Overall Study|Lost to Follow-up|1|||
13278459|NCT01277822|26449740|FG000|Overall Study|Contraindicated medication used|2|||
13278460|NCT01277822|26449741|FG001|Overall Study|Contraindicated medication used|1|||
13278461|NCT01277822|26449740|FG000|Overall Study|Participant moved|1|||
13278462|NCT01277822|26449741|FG001|Overall Study|Participant moved|0|||
13278463|NCT01277757|26449750|FG000|Overall Study|Disease Progression|1|||
13278464|NCT01277757|26449750|FG000|Overall Study|Withdrawal by Subject|1|||
13278465|NCT01277718|26449764|FG000|Period 2 - Second Intervention|Protocol Violation|0|||
13278466|NCT01277718|26449765|FG001|Period 2 - Second Intervention|Protocol Violation|1|||
13278467|NCT01277718|26449764|FG000|Period 2 - Second Intervention|Physician Decision|0|||
13278468|NCT01277718|26449765|FG001|Period 2 - Second Intervention|Physician Decision|2|||
13278469|NCT01277666|26449804|FG000|Overall Study|Adverse Event|26|||
13278470|NCT01277666|26449805|FG001|Overall Study|Adverse Event|25|||
13278471|NCT01277666|26449806|FG002|Overall Study|Adverse Event|20|||
13278472|NCT01277666|26449804|FG000|Overall Study|Lack of Efficacy|8|||
13278473|NCT01277666|26449805|FG001|Overall Study|Lack of Efficacy|20|||
13278474|NCT01277666|26449806|FG002|Overall Study|Lack of Efficacy|12|||
13278475|NCT01277666|26449804|FG000|Overall Study|Protocol Violation|2|||
13278476|NCT01277666|26449805|FG001|Overall Study|Protocol Violation|3|||
13278477|NCT01277666|26449806|FG002|Overall Study|Protocol Violation|2|||
13278478|NCT01277666|26449804|FG000|Overall Study|Protocol Defined Stopping criteria|1|||
13278479|NCT01277666|26449805|FG001|Overall Study|Protocol Defined Stopping criteria|2|||
13278480|NCT01277666|26449806|FG002|Overall Study|Protocol Defined Stopping criteria|6|||
13278481|NCT01277666|26449804|FG000|Overall Study|Lost to Follow-up|1|||
13278482|NCT01277666|26449805|FG001|Overall Study|Lost to Follow-up|1|||
13278483|NCT01277666|26449806|FG002|Overall Study|Lost to Follow-up|2|||
13278484|NCT01277666|26449804|FG000|Overall Study|Withdrawal by Subject|7|||
13278485|NCT01277666|26449805|FG001|Overall Study|Withdrawal by Subject|8|||
13278486|NCT01277666|26449806|FG002|Overall Study|Withdrawal by Subject|6|||
13278487|NCT01277666|26449804|FG000|Overall Study|Death|0|||
13278488|NCT01277666|26449805|FG001|Overall Study|Death|0|||
13278489|NCT01277666|26449806|FG002|Overall Study|Death|1|||
13119683|NCT03015532|25935362|FG006|Overall Study|Adverse Event|1|||
13119684|NCT03015532|25935363|FG007|Overall Study|Adverse Event|0|||
13119685|NCT03015532|25935356|FG000|Overall Study|Withdrawal by Subject|0|||
13119686|NCT03015532|25935357|FG001|Overall Study|Withdrawal by Subject|0|||
13119687|NCT03015532|25935358|FG002|Overall Study|Withdrawal by Subject|0|||
13119688|NCT03015532|25935359|FG003|Overall Study|Withdrawal by Subject|0|||
13119689|NCT03015532|25935360|FG004|Overall Study|Withdrawal by Subject|0|||
13119690|NCT03015532|25935361|FG005|Overall Study|Withdrawal by Subject|0|||
13278490|NCT01277549|26449827|FG000|Overall Study|Failed to meet eligibility criteria|13|||
13278491|NCT01277549|26449828|FG001|Overall Study|Failed to meet eligibility criteria|9|||
13278492|NCT01277549|26449827|FG000|Overall Study|Withdrawal by Subject|1|||
13278493|NCT01277549|26449828|FG001|Overall Study|Withdrawal by Subject|3|||
13278494|NCT01277549|26449827|FG000|Overall Study|Protocol Violation|10|||
13278495|NCT01277549|26449828|FG001|Overall Study|Protocol Violation|1|||
13278496|NCT01277549|26449827|FG000|Overall Study|Physician Decision|2|||
13278497|NCT01277549|26449828|FG001|Overall Study|Physician Decision|1|||
13278498|NCT01277302|26449868|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
13278499|NCT01277302|26449869|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
13278500|NCT01277302|26449870|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8|||
13278501|NCT01277302|26449868|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
13278502|NCT01277302|26449869|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
13278503|NCT01277302|26449870|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2|||
13278504|NCT01277302|26449868|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
13278505|NCT01277302|26449869|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
13278506|NCT01277302|26449870|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1|||
13278507|NCT01277302|26449868|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
13278508|NCT01277302|26449869|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
13278509|NCT01277302|26449870|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1|||
13278510|NCT01277302|26449868|FG000|8-Month Alternate Dose Regimen Period|Death|0|||
13278511|NCT01277302|26449869|FG001|8-Month Alternate Dose Regimen Period|Death|1|||
13278512|NCT01277302|26449870|FG002|8-Month Alternate Dose Regimen Period|Death|0|||
13278513|NCT01277302|26449868|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
13278514|NCT01277302|26449869|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
13278515|NCT01277302|26449870|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3|||
13278516|NCT01277302|26449868|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3|||
13119691|NCT03015532|25935362|FG006|Overall Study|Withdrawal by Subject|1|||
13119692|NCT03015532|25935363|FG007|Overall Study|Withdrawal by Subject|0|||
13278517|NCT01277302|26449869|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0|||
13278518|NCT01277302|26449870|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1|||
13278519|NCT01277302|26449868|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0|||
13278520|NCT01277302|26449869|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2|||
13278521|NCT01277302|26449870|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1|||
13278522|NCT01277302|26449868|FG000|8-Month Alternate Dose Regimen Period|Relocation|1|||
13278523|NCT01277302|26449869|FG001|8-Month Alternate Dose Regimen Period|Relocation|0|||
13278524|NCT01277302|26449870|FG002|8-Month Alternate Dose Regimen Period|Relocation|1|||
13278525|NCT01277042|26449899|FG000|Overall Study|Adverse Event|4|||
13278526|NCT01277042|26449900|FG001|Overall Study|Adverse Event|3|||
13278527|NCT01277042|26449899|FG000|Overall Study|Lost to Follow-up|2|||
13278528|NCT01277042|26449900|FG001|Overall Study|Lost to Follow-up|2|||
13278529|NCT01277042|26449899|FG000|Overall Study|Withdrawal by Subject|2|||
13278530|NCT01277042|26449900|FG001|Overall Study|Withdrawal by Subject|0|||
13278531|NCT01276847|26449918|FG000|Overall Study|Withdrawal by Subject|1|||
13278532|NCT01276847|26449919|FG001|Overall Study|Withdrawal by Subject|0|||
13278533|NCT01276847|26449920|FG002|Overall Study|Withdrawal by Subject|0|||
13278534|NCT01276821|26449945|FG000|Overall Study|Protocol Violation|0|||
13119693|NCT03015363|25935372|FG000|Overall Study|Physician Decision|14|||
13119694|NCT03015363|25935372|FG000|Overall Study|Withdrawal by Subject|3|||
13119695|NCT03015220|25935523|FG000|Overall Study|Withdrawal by Subject|3|||
13119696|NCT03015220|25935524|FG001|Overall Study|Withdrawal by Subject|2|||
13119697|NCT03015220|25935525|FG002|Overall Study|Withdrawal by Subject|2|||
13119698|NCT03015220|25935526|FG003|Overall Study|Withdrawal by Subject|2|||
13119699|NCT03015220|25935523|FG000|Overall Study|Lost to Follow-up|0|||
13119700|NCT03015220|25935524|FG001|Overall Study|Lost to Follow-up|0|||
13119701|NCT03015220|25935525|FG002|Overall Study|Lost to Follow-up|1|||
13119702|NCT03015220|25935526|FG003|Overall Study|Lost to Follow-up|0|||
13119703|NCT03015181|25935659|FG000|Overall Study|Enrolled, but product never administered|1|||
13119704|NCT03015181|25935660|FG001|Overall Study|Enrolled, but product never administered|0|||
13119705|NCT03015181|25935661|FG002|Overall Study|Enrolled, but product never administered|0|||
13119706|NCT03015181|25935662|FG003|Overall Study|Enrolled, but product never administered|0|||
13119707|NCT03015181|25935663|FG004|Overall Study|Enrolled, but product never administered|0|||
13119708|NCT03015181|25935664|FG005|Overall Study|Enrolled, but product never administered|0|||
13119709|NCT03015181|25935665|FG006|Overall Study|Enrolled, but product never administered|0|||
13119710|NCT03015181|25935659|FG000|Overall Study|Withdrawal by Subject|0|||
13119711|NCT03015181|25935660|FG001|Overall Study|Withdrawal by Subject|0|||
13119712|NCT03015181|25935661|FG002|Overall Study|Withdrawal by Subject|0|||
13119713|NCT03015181|25935662|FG003|Overall Study|Withdrawal by Subject|0|||
13119714|NCT03015181|25935663|FG004|Overall Study|Withdrawal by Subject|0|||
13119715|NCT03015181|25935664|FG005|Overall Study|Withdrawal by Subject|1|||
13119716|NCT03015181|25935665|FG006|Overall Study|Withdrawal by Subject|0|||
13119717|NCT03015181|25935659|FG000|Overall Study|Physician Decision|0|||
13119718|NCT03015181|25935660|FG001|Overall Study|Physician Decision|0|||
13278535|NCT01276821|26449946|FG001|Overall Study|Protocol Violation|1|||
13278536|NCT01276756|26449967|FG000|Overall Study|Lost to Follow-up|2|||
13278537|NCT01276756|26449968|FG001|Overall Study|Lost to Follow-up|0|||
13278538|NCT01276756|26449967|FG000|Overall Study|Adverse Event|3|||
13278539|NCT01276756|26449968|FG001|Overall Study|Adverse Event|2|||
13278540|NCT01276457|26449987|FG000|Core Study|Adverse Event|6|||
13278541|NCT01276457|26449988|FG001|Core Study|Adverse Event|3|||
13278542|NCT01276457|26449987|FG000|Core Study|Lost to Follow-up|1|||
13278543|NCT01276457|26449988|FG001|Core Study|Lost to Follow-up|2|||
13278544|NCT01276457|26449987|FG000|Core Study|Administrative problems|1|||
13278545|NCT01276457|26449988|FG001|Core Study|Administrative problems|1|||
13278546|NCT01276457|26449987|FG000|Core Study|Death|2|||
13278547|NCT01276457|26449988|FG001|Core Study|Death|2|||
13278548|NCT01276457|26449987|FG000|Core Study|Lack of Efficacy|3|||
13278549|NCT01276457|26449988|FG001|Core Study|Lack of Efficacy|12|||
13278550|NCT01276457|26449987|FG000|Extension Study|Lost to Follow-up|3|||
13278551|NCT01276457|26449988|FG001|Extension Study|Lost to Follow-up|0|||
13278552|NCT01276457|26449987|FG000|Extension Study|Death|0|||
13278553|NCT01276457|26449988|FG001|Extension Study|Death|1|||
13278554|NCT01276457|26449987|FG000|Extension Study|Lack of Efficacy|3|||
13278555|NCT01276457|26449988|FG001|Extension Study|Lack of Efficacy|1|||
13278556|NCT01276353|26450005|FG000|Double-blind|Adverse Event|2|||
13278557|NCT01276353|26450006|FG001|Double-blind|Adverse Event|0|||
13278558|NCT01276353|26450005|FG000|Double-blind|Withdrawal by Subject|1|||
13278559|NCT01276353|26450006|FG001|Double-blind|Withdrawal by Subject|0|||
13278560|NCT01276353|26450005|FG000|Extension|Adverse Event|2|||
13278561|NCT01276353|26450006|FG001|Extension|Adverse Event|5|||
13278562|NCT01276353|26450005|FG000|Extension|Withdrawal by Subject|1|||
13278563|NCT01276353|26450006|FG001|Extension|Withdrawal by Subject|2|||
13278564|NCT01276353|26450005|FG000|Extension|Withdrawal of study drug 4 days in a row|3|||
13278565|NCT01276353|26450006|FG001|Extension|Withdrawal of study drug 4 days in a row|1|||
13119719|NCT03015181|25935661|FG002|Overall Study|Physician Decision|0|||
13278566|NCT01276353|26450005|FG000|Extension|Physician Decision|1|||
13278567|NCT01276353|26450006|FG001|Extension|Physician Decision|0|||
13278568|NCT01276353|26450005|FG000|Extension|Prohibited concomitant medications|0|||
13278569|NCT01276353|26450006|FG001|Extension|Prohibited concomitant medications|1|||
13278570|NCT01276327|26450035|FG000|Overall Study|Adverse Event|1|||
13278571|NCT01276327|26450036|FG001|Overall Study|Adverse Event|3|||
13278572|NCT01276327|26450035|FG000|Overall Study|Withdrawal by Subject|1|||
13278573|NCT01276327|26450036|FG001|Overall Study|Withdrawal by Subject|0|||
13278574|NCT01276288|26450165|FG000|Overall Study|Adverse Event|1|||
13278575|NCT01276288|26450166|FG001|Overall Study|Adverse Event|1|||
13278576|NCT01276288|26450167|FG002|Overall Study|Adverse Event|0|||
13278577|NCT01276288|26450168|FG003|Overall Study|Adverse Event|0|||
13278578|NCT01276288|26450165|FG000|Overall Study|not treated|1|||
13278579|NCT01276288|26450166|FG001|Overall Study|not treated|0|||
13278580|NCT01276288|26450167|FG002|Overall Study|not treated|0|||
13278581|NCT01276288|26450168|FG003|Overall Study|not treated|0|||
13278582|NCT01276236|26450181|FG000|Overall Study|Lack of Efficacy|2|||
13278583|NCT01276236|26450181|FG000|Overall Study|Withdrawal by Subject|4|||
13278584|NCT01276223|26450198|FG000|Overall Study|Adverse Event|7|||
13278585|NCT01276223|26450199|FG001|Overall Study|Adverse Event|4|||
13278586|NCT01276223|26450200|FG002|Overall Study|Adverse Event|1|||
13278587|NCT01276223|26450198|FG000|Overall Study|Lost to Follow-up|0|||
13278588|NCT01276223|26450199|FG001|Overall Study|Lost to Follow-up|0|||
13278589|NCT01276223|26450200|FG002|Overall Study|Lost to Follow-up|1|||
13278590|NCT01276223|26450198|FG000|Overall Study|Other|0|||
13278591|NCT01276223|26450199|FG001|Overall Study|Other|0|||
13278592|NCT01276223|26450200|FG002|Overall Study|Other|1|||
13278593|NCT01276223|26450198|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3|||
13278594|NCT01276223|26450199|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
13278595|NCT01276223|26450200|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
13278596|NCT01276223|26450198|FG000|Overall Study|Protocol Violation|1|||
13278597|NCT01276223|26450199|FG001|Overall Study|Protocol Violation|0|||
13278598|NCT01276223|26450200|FG002|Overall Study|Protocol Violation|0|||
13278599|NCT01276106|26450223|FG000|Overall Study|Adverse Event|3|||
13278600|NCT01276106|26450224|FG001|Overall Study|Adverse Event|3|||
13278601|NCT01276106|26450225|FG002|Overall Study|Adverse Event|11|||
13278602|NCT01276106|26450226|FG003|Overall Study|Adverse Event|3|||
13278603|NCT01276106|26450223|FG000|Overall Study|Withdrawal by Subject|6|||
13278604|NCT01276106|26450224|FG001|Overall Study|Withdrawal by Subject|3|||
13278605|NCT01276106|26450225|FG002|Overall Study|Withdrawal by Subject|1|||
13278606|NCT01276106|26450226|FG003|Overall Study|Withdrawal by Subject|6|||
13278607|NCT01276106|26450223|FG000|Overall Study|Lack of Efficacy|0|||
13278608|NCT01276106|26450224|FG001|Overall Study|Lack of Efficacy|1|||
13119720|NCT03015181|25935662|FG003|Overall Study|Physician Decision|0|||
13119721|NCT03015181|25935663|FG004|Overall Study|Physician Decision|0|||
13119722|NCT03015181|25935664|FG005|Overall Study|Physician Decision|0|||
13119723|NCT03015181|25935665|FG006|Overall Study|Physician Decision|1|||
13119724|NCT03015116|25935693|FG000|Overall Study|Lost to Follow-up|3|||
13278609|NCT01276106|26450225|FG002|Overall Study|Lack of Efficacy|0|||
13278610|NCT01276106|26450226|FG003|Overall Study|Lack of Efficacy|1|||
13278611|NCT01276106|26450223|FG000|Overall Study|Lost to Follow-up|2|||
13278612|NCT01276106|26450224|FG001|Overall Study|Lost to Follow-up|1|||
13278613|NCT01276106|26450225|FG002|Overall Study|Lost to Follow-up|1|||
13278614|NCT01276106|26450226|FG003|Overall Study|Lost to Follow-up|0|||
13278615|NCT01276106|26450223|FG000|Overall Study|Physician Decision|0|||
13278616|NCT01276106|26450224|FG001|Overall Study|Physician Decision|0|||
13278617|NCT01276106|26450225|FG002|Overall Study|Physician Decision|1|||
13278618|NCT01276106|26450226|FG003|Overall Study|Physician Decision|1|||
13278619|NCT01276106|26450223|FG000|Overall Study|Protocol Violation|1|||
13278620|NCT01276106|26450224|FG001|Overall Study|Protocol Violation|1|||
13278621|NCT01276106|26450225|FG002|Overall Study|Protocol Violation|0|||
13278622|NCT01276106|26450226|FG003|Overall Study|Protocol Violation|2|||
13278623|NCT01276106|26450223|FG000|Overall Study|Insufficient therapeutic effects|0|||
13278624|NCT01276106|26450224|FG001|Overall Study|Insufficient therapeutic effects|0|||
13278625|NCT01276106|26450225|FG002|Overall Study|Insufficient therapeutic effects|2|||
13278626|NCT01276106|26450226|FG003|Overall Study|Insufficient therapeutic effects|0|||
13278627|NCT01276054|26450239|FG000|Overall Study|No one to oversee trial after P.I. left|2|||
13278628|NCT01276054|26450240|FG001|Overall Study|No one to oversee trial after P.I. left|2|||
13278629|NCT01275833|26450253|FG000|Overall Study|Study terminated|1|||
13278630|NCT01275833|26450254|FG001|Overall Study|Study terminated|1|||
13278631|NCT01275755|26450267|FG000|Double-blind Treatment Period|Adverse Event|0|||
13278632|NCT01275755|26450268|FG001|Double-blind Treatment Period|Adverse Event|2|||
13278633|NCT01275755|26450267|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
13278634|NCT01275755|26450268|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
13278635|NCT01275755|26450267|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
13278636|NCT01275755|26450268|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
13278637|NCT01275755|26450267|FG000|Run-out Placebo Period|Lost to Follow-up|1|||
13278638|NCT01275755|26450268|FG001|Run-out Placebo Period|Lost to Follow-up|0|||
13278639|NCT01275430|26450278|FG000|Overall Study|Adverse Event|1|||
13278640|NCT01275430|26450278|FG000|Overall Study|No Contrast Injection|6|||
13278641|NCT01275430|26450278|FG000|Overall Study|Device Malfunction|1|||
13278642|NCT01275430|26450278|FG000|Overall Study|Inability to achieve maximum p-wave|1|||
13278643|NCT01275222|26450353|FG000|Phase l by Treatment|Adverse Event|1|||
13278644|NCT01275222|26450354|FG001|Phase l by Treatment|Adverse Event|4|||
13278645|NCT01275222|26450355|FG002|Phase l by Treatment|Adverse Event|2|||
13278646|NCT01275222|26450356|FG003|Phase l by Treatment|Adverse Event|3|||
13278647|NCT01275222|26450357|FG004|Phase l by Treatment|Adverse Event|0|||
13278648|NCT01275222|26450358|FG005|Phase l by Treatment|Adverse Event|0|||
13278649|NCT01275222|26450353|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0|||
13278650|NCT01275222|26450354|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0|||
13278651|NCT01275222|26450355|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1|||
13278652|NCT01275222|26450356|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0|||
13278653|NCT01275222|26450357|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0|||
13278654|NCT01275222|26450358|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0|||
13278655|NCT01275222|26450353|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0|||
13278656|NCT01275222|26450354|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0|||
13278657|NCT01275222|26450355|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0|||
13278658|NCT01275222|26450356|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1|||
13278659|NCT01275222|26450357|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0|||
13278660|NCT01275222|26450358|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0|||
13278661|NCT01275222|26450353|FG000|Phase l by Treatment|Disease progression|12|||
13278662|NCT01275222|26450354|FG001|Phase l by Treatment|Disease progression|8|||
13278663|NCT01275222|26450355|FG002|Phase l by Treatment|Disease progression|2|||
13278664|NCT01275222|26450356|FG003|Phase l by Treatment|Disease progression|5|||
13278665|NCT01275222|26450357|FG004|Phase l by Treatment|Disease progression|0|||
13278666|NCT01275222|26450358|FG005|Phase l by Treatment|Disease progression|0|||
13278667|NCT01275222|26450353|FG000|Phase l by Treatment|Withdrawal by Subject|0|||
13278668|NCT01275222|26450354|FG001|Phase l by Treatment|Withdrawal by Subject|0|||
13278669|NCT01275222|26450355|FG002|Phase l by Treatment|Withdrawal by Subject|0|||
13278670|NCT01275222|26450356|FG003|Phase l by Treatment|Withdrawal by Subject|1|||
13278671|NCT01275222|26450357|FG004|Phase l by Treatment|Withdrawal by Subject|0|||
13278672|NCT01275222|26450358|FG005|Phase l by Treatment|Withdrawal by Subject|0|||
13278673|NCT01275222|26450353|FG000|Phase l by Treatment|Death|0|||
13278674|NCT01275222|26450354|FG001|Phase l by Treatment|Death|1|||
13278675|NCT01275222|26450355|FG002|Phase l by Treatment|Death|0|||
13278676|NCT01275222|26450356|FG003|Phase l by Treatment|Death|1|||
13278677|NCT01275222|26450357|FG004|Phase l by Treatment|Death|0|||
13278678|NCT01275222|26450358|FG005|Phase l by Treatment|Death|0|||
13278679|NCT01275222|26450353|FG000|Phase ll by Stratum|Adverse Event|0|||
13278680|NCT01275222|26450354|FG001|Phase ll by Stratum|Adverse Event|0|||
13278681|NCT01275222|26450355|FG002|Phase ll by Stratum|Adverse Event|0|||
13278682|NCT01275222|26450356|FG003|Phase ll by Stratum|Adverse Event|0|||
13278683|NCT01275222|26450357|FG004|Phase ll by Stratum|Adverse Event|2|||
13278684|NCT01275222|26450358|FG005|Phase ll by Stratum|Adverse Event|10|||
13278685|NCT01275222|26450353|FG000|Phase ll by Stratum|Abnormal laboratory values|0|||
13278686|NCT01275222|26450354|FG001|Phase ll by Stratum|Abnormal laboratory values|0|||
13278687|NCT01275222|26450355|FG002|Phase ll by Stratum|Abnormal laboratory values|0|||
13278688|NCT01275222|26450356|FG003|Phase ll by Stratum|Abnormal laboratory values|0|||
13278689|NCT01275222|26450357|FG004|Phase ll by Stratum|Abnormal laboratory values|0|||
13278690|NCT01275222|26450358|FG005|Phase ll by Stratum|Abnormal laboratory values|1|||
13278691|NCT01275222|26450353|FG000|Phase ll by Stratum|Disease progression|0|||
13278692|NCT01275222|26450354|FG001|Phase ll by Stratum|Disease progression|0|||
13278693|NCT01275222|26450355|FG002|Phase ll by Stratum|Disease progression|0|||
13278694|NCT01275222|26450356|FG003|Phase ll by Stratum|Disease progression|0|||
13278695|NCT01275222|26450357|FG004|Phase ll by Stratum|Disease progression|23|||
13278696|NCT01275222|26450358|FG005|Phase ll by Stratum|Disease progression|31|||
13278697|NCT01275222|26450353|FG000|Phase ll by Stratum|Withdrawal by Subject|0|||
13278698|NCT01275222|26450354|FG001|Phase ll by Stratum|Withdrawal by Subject|0|||
13278699|NCT01275222|26450355|FG002|Phase ll by Stratum|Withdrawal by Subject|0|||
13278700|NCT01275222|26450356|FG003|Phase ll by Stratum|Withdrawal by Subject|0|||
13278701|NCT01275222|26450357|FG004|Phase ll by Stratum|Withdrawal by Subject|2|||
13278702|NCT01275222|26450358|FG005|Phase ll by Stratum|Withdrawal by Subject|3|||
13278703|NCT01275222|26450353|FG000|Phase ll by Stratum|Death|0|||
13278704|NCT01275222|26450354|FG001|Phase ll by Stratum|Death|0|||
13278705|NCT01275222|26450355|FG002|Phase ll by Stratum|Death|0|||
13278706|NCT01275222|26450356|FG003|Phase ll by Stratum|Death|0|||
13278707|NCT01275222|26450357|FG004|Phase ll by Stratum|Death|1|||
13278708|NCT01275222|26450358|FG005|Phase ll by Stratum|Death|1|||
13278709|NCT01275196|26450404|FG000|Overall Study|Adverse Event|3|||
13278710|NCT01275196|26450405|FG001|Overall Study|Adverse Event|5|||
13278711|NCT01275196|26450404|FG000|Overall Study|Withdrawal by Subject|4|||
13278712|NCT01275196|26450405|FG001|Overall Study|Withdrawal by Subject|5|||
13278713|NCT01275196|26450404|FG000|Overall Study|Lost to Follow-up|1|||
13278714|NCT01275196|26450405|FG001|Overall Study|Lost to Follow-up|0|||
13278715|NCT01275196|26450404|FG000|Overall Study|Disease Progression|6|||
13278716|NCT01275196|26450405|FG001|Overall Study|Disease Progression|5|||
13278717|NCT01275196|26450404|FG000|Overall Study|Protocol Violation|1|||
13278718|NCT01275196|26450405|FG001|Overall Study|Protocol Violation|0|||
13278719|NCT01275196|26450404|FG000|Overall Study|Suboptimal response/treatment failure|5|||
13278720|NCT01275196|26450405|FG001|Overall Study|Suboptimal response/treatment failure|6|||
13278721|NCT01275170|26450648|FG000|Part 1: Period 1|Equipment malfunction before study drug|1|||
13278722|NCT01275170|26450649|FG001|Part 1: Period 1|Equipment malfunction before study drug|0|||
13278723|NCT01275170|26450650|FG002|Part 1: Period 1|Equipment malfunction before study drug|0|||
13278724|NCT01275170|26450651|FG003|Part 1: Period 1|Equipment malfunction before study drug|0|||
13278725|NCT01275170|26450652|FG004|Part 1: Period 1|Equipment malfunction before study drug|0|||
13278726|NCT01275170|26450653|FG005|Part 1: Period 1|Equipment malfunction before study drug|0|||
13278727|NCT01275170|26450654|FG006|Part 1: Period 1|Equipment malfunction before study drug|0|||
13278728|NCT01275170|26450655|FG007|Part 1: Period 1|Equipment malfunction before study drug|0|||
13278729|NCT01275144|26450712|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1|||
13278730|NCT01275144|26450713|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0|||
13278731|NCT01275131|26450760|FG000|Period 1|Withdrawal by Subject|1|||
13278732|NCT01275131|26450761|FG001|Period 1|Withdrawal by Subject|0|||
13278733|NCT01275131|26450762|FG002|Period 1|Withdrawal by Subject|3|||
13278734|NCT01275131|26450763|FG003|Period 1|Withdrawal by Subject|2|||
13278735|NCT01275131|26450760|FG000|Period 1|Physician Decision|1|||
13278736|NCT01275131|26450761|FG001|Period 1|Physician Decision|0|||
13278737|NCT01275131|26450762|FG002|Period 1|Physician Decision|0|||
13278738|NCT01275131|26450763|FG003|Period 1|Physician Decision|0|||
13278739|NCT01275131|26450760|FG000|Period 2 (Crossover)|Adverse Event|0|||
13278740|NCT01275131|26450761|FG001|Period 2 (Crossover)|Adverse Event|1|||
13278741|NCT01275131|26450762|FG002|Period 2 (Crossover)|Adverse Event|0|||
13278742|NCT01275131|26450763|FG003|Period 2 (Crossover)|Adverse Event|0|||
13278743|NCT01275131|26450760|FG000|Period 2 (Crossover)|Withdrawal by Subject|1|||
13278744|NCT01275131|26450761|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
13278745|NCT01275131|26450762|FG002|Period 2 (Crossover)|Withdrawal by Subject|1|||
13278746|NCT01275131|26450763|FG003|Period 2 (Crossover)|Withdrawal by Subject|2|||
13278747|NCT01275066|26450787|FG000|Overall Study|Withdrawal by Subject|0|||
13278748|NCT01275066|26450788|FG001|Overall Study|Withdrawal by Subject|0|||
13278749|NCT01275066|26450789|FG002|Overall Study|Withdrawal by Subject|1|||
13278750|NCT01275066|26450787|FG000|Overall Study|Not Diagnosed w/ Disease|1|||
13278751|NCT01275066|26450788|FG001|Overall Study|Not Diagnosed w/ Disease|0|||
13278752|NCT01275066|26450789|FG002|Overall Study|Not Diagnosed w/ Disease|0|||
13278753|NCT01274715|26450796|FG000|Overall Study|Lost to Follow-up|1|||
13278754|NCT01274715|26450796|FG000|Overall Study|After consent, met exclusion criteria.|1|||
13278755|NCT01274715|26450796|FG000|Overall Study|After consent, met exclusion criteria.|1|||
13278756|NCT01274715|26450796|FG000|Overall Study|After consent, met exclusion criteria.|1|||
13278757|NCT01274559|26450853|FG000|Overall Study|Adverse Event|57|||
13278758|NCT01274559|26450854|FG001|Overall Study|Adverse Event|13|||
13278759|NCT01274559|26450853|FG000|Overall Study|Death|1|||
13278760|NCT01274559|26450854|FG001|Overall Study|Death|1|||
13278761|NCT01274559|26450853|FG000|Overall Study|Lost to Follow-up|3|||
13278762|NCT01274559|26450854|FG001|Overall Study|Lost to Follow-up|3|||
13278763|NCT01274559|26450853|FG000|Overall Study|Non-compliance with Study Drug|2|||
13278764|NCT01274559|26450854|FG001|Overall Study|Non-compliance with Study Drug|4|||
13278765|NCT01274559|26450853|FG000|Overall Study|Physician Decision|2|||
13278766|NCT01274559|26450854|FG001|Overall Study|Physician Decision|1|||
13278767|NCT01274559|26450853|FG000|Overall Study|Protocol Violation|28|||
13278768|NCT01274559|26450854|FG001|Overall Study|Protocol Violation|23|||
13278769|NCT01274559|26450853|FG000|Overall Study|Study Terminated by Sponsor|79|||
13278770|NCT01274559|26450854|FG001|Overall Study|Study Terminated by Sponsor|87|||
13278771|NCT01274559|26450853|FG000|Overall Study|Withdrawal by Subject|25|||
13278772|NCT01274559|26450854|FG001|Overall Study|Withdrawal by Subject|13|||
13278773|NCT01274533|26450861|FG000|Overall Study|Withdrawal by Subject|1|||
13278774|NCT01274533|26450861|FG000|Overall Study|Non-compliance|1|||
13278775|NCT01274533|26450861|FG000|Overall Study|Disease progression|2|||
13278776|NCT01274429|26450868|FG000|Overall Study|Study closed do to lack of funding|5|||
13278777|NCT01274182|26450915|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
13278778|NCT01274182|26450916|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
13278779|NCT01274182|26450917|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
13278780|NCT01274182|26450915|FG000|Overall Study|Adverse Event|4|||
13278781|NCT01274182|26450916|FG001|Overall Study|Adverse Event|5|||
13278782|NCT01274182|26450917|FG002|Overall Study|Adverse Event|3|||
13278783|NCT01274182|26450915|FG000|Overall Study|Withdrawal by Subject|5|||
13278784|NCT01274182|26450916|FG001|Overall Study|Withdrawal by Subject|5|||
13307959|NCT01281306|26530321|FG003|Overall Study|Adverse Event|3|||
13307960|NCT01281306|26530322|FG004|Overall Study|Adverse Event|5|||
13307961|NCT01281306|26530323|FG005|Overall Study|Adverse Event|3|||
13307962|NCT01281306|26530324|FG006|Overall Study|Adverse Event|3|||
13307963|NCT01281306|26530318|FG000|Overall Study|Randomized in error|1|||
13119725|NCT03015116|25935694|FG001|Overall Study|Lost to Follow-up|0|||
13278785|NCT01274182|26450917|FG002|Overall Study|Withdrawal by Subject|3|||
13278786|NCT01274182|26450915|FG000|Overall Study|Lost to Follow-up|2|||
13278787|NCT01274182|26450916|FG001|Overall Study|Lost to Follow-up|3|||
13278788|NCT01274182|26450917|FG002|Overall Study|Lost to Follow-up|1|||
13278789|NCT01274182|26450915|FG000|Overall Study|Protocol Violation|3|||
13278790|NCT01274182|26450916|FG001|Overall Study|Protocol Violation|2|||
13278791|NCT01274182|26450917|FG002|Overall Study|Protocol Violation|0|||
13278792|NCT01274182|26450915|FG000|Overall Study|Death|1|||
13278793|NCT01274182|26450916|FG001|Overall Study|Death|0|||
13278794|NCT01274182|26450917|FG002|Overall Study|Death|1|||
13278795|NCT01273883|26450932|FG000|First Intervention|Adverse Event|2|||
13278796|NCT01273883|26450933|FG001|First Intervention|Adverse Event|1|||
13278797|NCT01273883|26450932|FG000|Second Intervention|Lost to Follow-up|1|||
13278798|NCT01273883|26450933|FG001|Second Intervention|Lost to Follow-up|1|||
13278799|NCT01273883|26450932|FG000|Second Intervention|Lack of Efficacy|1|||
13278800|NCT01273883|26450933|FG001|Second Intervention|Lack of Efficacy|0|||
13278801|NCT01273805|26450956|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10|||
13278802|NCT01273805|26450957|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10|||
13278803|NCT01273623|26450966|FG000|Overall Study|did not meet IVUS criteria|29|||
13278804|NCT01273597|26450980|FG000|Overall Study|Adverse Event|5|||
13278805|NCT01273597|26450980|FG000|Overall Study|Underwent Kidney Transplantation|2|||
13278806|NCT01273597|26450980|FG000|Overall Study|Reason Not Reported|1|||
13278807|NCT01273519|26451023|FG000|Overall Study|Adverse Event|3|||
13278808|NCT01273519|26451024|FG001|Overall Study|Adverse Event|0|||
13278809|NCT01273519|26451025|FG002|Overall Study|Adverse Event|0|||
13278810|NCT01273519|26451023|FG000|Overall Study|Lost to Follow-up|2|||
13278811|NCT01273519|26451024|FG001|Overall Study|Lost to Follow-up|1|||
13278812|NCT01273519|26451025|FG002|Overall Study|Lost to Follow-up|3|||
13278813|NCT01273519|26451023|FG000|Overall Study|Lack of Efficacy|8|||
13278814|NCT01273519|26451024|FG001|Overall Study|Lack of Efficacy|3|||
13278815|NCT01273519|26451025|FG002|Overall Study|Lack of Efficacy|4|||
13278816|NCT01273519|26451023|FG000|Overall Study|Other|6|||
13278817|NCT01273519|26451024|FG001|Overall Study|Other|1|||
13278818|NCT01273519|26451025|FG002|Overall Study|Other|1|||
13278819|NCT01273181|26451052|FG000|Phase I, Dose 1|Study termination|1|||
13278820|NCT01273181|26451053|FG001|Phase I, Dose 1|Study termination|0|||
13278821|NCT01273181|26451054|FG002|Phase I, Dose 1|Study termination|0|||
13278822|NCT01273181|26451055|FG003|Phase I, Dose 1|Study termination|0|||
13278823|NCT01273181|26451052|FG000|Phase I, Dose 2|Death during treatment|0|||
13278824|NCT01273181|26451053|FG001|Phase I, Dose 2|Death during treatment|1|||
13278825|NCT01273181|26451054|FG002|Phase I, Dose 2|Death during treatment|0|||
13278826|NCT01273181|26451055|FG003|Phase I, Dose 2|Death during treatment|0|||
13278827|NCT01273181|26451052|FG000|Phase 2, Dose 1|Study termination|0|||
13278828|NCT01273181|26451053|FG001|Phase 2, Dose 1|Study termination|0|||
13278829|NCT01273181|26451054|FG002|Phase 2, Dose 1|Study termination|1|||
13278830|NCT01273181|26451055|FG003|Phase 2, Dose 1|Study termination|0|||
13278831|NCT01273181|26451052|FG000|Phase 2, Dose 2|Death during treatment|0|||
13278832|NCT01273181|26451053|FG001|Phase 2, Dose 2|Death during treatment|0|||
13278833|NCT01273181|26451054|FG002|Phase 2, Dose 2|Death during treatment|0|||
13278834|NCT01273181|26451055|FG003|Phase 2, Dose 2|Death during treatment|1|||
13278835|NCT01273064|26451088|FG000|Overall Study|Adverse Event|5|||
13278836|NCT01273064|26451089|FG001|Overall Study|Adverse Event|1|||
13278837|NCT01273064|26451090|FG002|Overall Study|Adverse Event|3|||
13278838|NCT01273064|26451091|FG003|Overall Study|Adverse Event|2|||
13278839|NCT01273064|26451092|FG004|Overall Study|Adverse Event|1|||
13278840|NCT01273064|26451088|FG000|Overall Study|Withdrawal by Subject|4|||
13278841|NCT01273064|26451089|FG001|Overall Study|Withdrawal by Subject|2|||
13278842|NCT01273064|26451090|FG002|Overall Study|Withdrawal by Subject|2|||
13278843|NCT01273064|26451091|FG003|Overall Study|Withdrawal by Subject|2|||
13278844|NCT01273064|26451092|FG004|Overall Study|Withdrawal by Subject|0|||
13278845|NCT01273064|26451088|FG000|Overall Study|Study Termination|13|||
13278846|NCT01273064|26451089|FG001|Overall Study|Study Termination|27|||
13278847|NCT01273064|26451090|FG002|Overall Study|Study Termination|26|||
13278848|NCT01273064|26451091|FG003|Overall Study|Study Termination|16|||
13278849|NCT01273064|26451092|FG004|Overall Study|Study Termination|8|||
13278850|NCT01273064|26451088|FG000|Overall Study|Lost to Follow-up|1|||
13278851|NCT01273064|26451089|FG001|Overall Study|Lost to Follow-up|0|||
13278852|NCT01273064|26451090|FG002|Overall Study|Lost to Follow-up|0|||
13278853|NCT01273064|26451091|FG003|Overall Study|Lost to Follow-up|0|||
13278854|NCT01273064|26451092|FG004|Overall Study|Lost to Follow-up|0|||
13278855|NCT01273064|26451088|FG000|Overall Study|Physician Decision|0|||
13278856|NCT01273064|26451089|FG001|Overall Study|Physician Decision|0|||
13278857|NCT01273064|26451090|FG002|Overall Study|Physician Decision|0|||
13278858|NCT01273064|26451091|FG003|Overall Study|Physician Decision|0|||
13278859|NCT01273064|26451092|FG004|Overall Study|Physician Decision|1|||
13278860|NCT01273038|26451105|FG000|Second Intervention (14 Days)|Adverse Event|0|||
13278861|NCT01273038|26451106|FG001|Second Intervention (14 Days)|Adverse Event|1|||
13278862|NCT01273038|26451105|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
13278863|NCT01273038|26451106|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
13278864|NCT01272947|26451121|FG000|Overall Study|Abnormal Laboratory Value|2|||
13278865|NCT01272947|26451122|FG001|Overall Study|Abnormal Laboratory Value|2|||
13278866|NCT01272934|26451137|FG000|Overall Study|Adverse Event|0|||
13278867|NCT01272934|26451138|FG001|Overall Study|Adverse Event|1|||
13278868|NCT01272934|26451137|FG000|Overall Study|Abnormal Laboratory Value|0|||
13278869|NCT01272934|26451138|FG001|Overall Study|Abnormal Laboratory Value|1|||
13278870|NCT01272921|26451153|FG000|Overall Study|Protocol Violation|2|||
13278871|NCT01272921|26451154|FG001|Overall Study|Protocol Violation|1|||
13278872|NCT01272908|26451190|FG000|Initial Treatment Period|Adverse Event|1|||
13278873|NCT01272908|26451190|FG000|Initial Treatment Period|Lack of Efficacy|5|||
13278874|NCT01272908|26451190|FG000|Initial Treatment Period|Protocol Violation|1|||
13278875|NCT01272908|26451190|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
13278876|NCT01272908|26451190|FG000|Re-Treatment Period|Adverse Event|2|||
13278877|NCT01272908|26451190|FG000|Re-Treatment Period|Lack of Efficacy|3|||
13278878|NCT01272908|26451190|FG000|Re-Treatment Period|Withdrawal by Subject|1|||
13278879|NCT01272869|26451203|FG000|Period 2 (14 Days)|Adverse Event|1|||
13278880|NCT01272869|26451204|FG001|Period 2 (14 Days)|Adverse Event|0|||
13278881|NCT01272661|26451237|FG000|Overall Study|lost to followup/case closed/ no birth|126|||
13278882|NCT01272661|26451238|FG001|Overall Study|lost to followup/case closed/ no birth|209|||
13278883|NCT01272661|26451239|FG002|Overall Study|lost to followup/case closed/ no birth|72|||
13278884|NCT01272635|26451264|FG000|Overall Study|Lost to Follow-up|31|||
13278885|NCT01272635|26451265|FG001|Overall Study|Lost to Follow-up|20|||
13278886|NCT01272635|26451266|FG002|Overall Study|Lost to Follow-up|31|||
13278887|NCT01272635|26451267|FG003|Overall Study|Lost to Follow-up|23|||
13278888|NCT01272232|26451318|FG000|Weeks 0-56|Adverse Event|39|||
13278889|NCT01272232|26451319|FG001|Weeks 0-56|Adverse Event|18|||
13278890|NCT01272232|26451320|FG002|Weeks 0-56|Adverse Event|7|||
13278891|NCT01272232|26451318|FG000|Weeks 0-56|Lack of Efficacy|0|||
13278892|NCT01272232|26451319|FG001|Weeks 0-56|Lack of Efficacy|0|||
13278893|NCT01272232|26451320|FG002|Weeks 0-56|Lack of Efficacy|3|||
13278894|NCT01272232|26451318|FG000|Weeks 0-56|Protocol Violation|12|||
13278895|NCT01272232|26451319|FG001|Weeks 0-56|Protocol Violation|8|||
13278896|NCT01272232|26451320|FG002|Weeks 0-56|Protocol Violation|13|||
13278897|NCT01272232|26451318|FG000|Weeks 0-56|Withdrawal criteria|32|||
13278898|NCT01272232|26451319|FG001|Weeks 0-56|Withdrawal criteria|14|||
13278899|NCT01272232|26451320|FG002|Weeks 0-56|Withdrawal criteria|37|||
13278900|NCT01272232|26451318|FG000|Weeks 0-56|Unclassified|16|||
13278901|NCT01272232|26451319|FG001|Weeks 0-56|Unclassified|7|||
13278902|NCT01272232|26451320|FG002|Weeks 0-56|Unclassified|12|||
13278903|NCT01272232|26451318|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
13278904|NCT01272232|26451319|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
13278905|NCT01272232|26451320|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0|||
13278906|NCT01272232|26451318|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1|||
13278907|NCT01272232|26451319|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
13278908|NCT01272232|26451320|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
13278909|NCT01272232|26451318|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
13278910|NCT01272232|26451319|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0|||
13278911|NCT01272232|26451320|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
13278912|NCT01272232|26451318|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9|||
13278913|NCT01272232|26451319|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7|||
13278914|NCT01272232|26451320|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4|||
13278915|NCT01272232|26451318|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
13278916|NCT01272232|26451319|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
13278917|NCT01272232|26451320|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0|||
13278918|NCT01272219|26451367|FG000|Main Period: Week 0 to Week 56|Adverse Event|86|||
13278919|NCT01272219|26451368|FG001|Main Period: Week 0 to Week 56|Adverse Event|0|||
13278920|NCT01272219|26451369|FG002|Main Period: Week 0 to Week 56|Adverse Event|0|||
13278921|NCT01272219|26451370|FG003|Main Period: Week 0 to Week 56|Adverse Event|16|||
13278922|NCT01272219|26451371|FG004|Main Period: Week 0 to Week 56|Adverse Event|152|||
13278923|NCT01272219|26451372|FG005|Main Period: Week 0 to Week 56|Adverse Event|29|||
13278924|NCT01272219|26451367|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11|||
13278925|NCT01272219|26451368|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
13278926|NCT01272219|26451369|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
13278927|NCT01272219|26451370|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14|||
13278928|NCT01272219|26451371|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12|||
13278929|NCT01272219|26451372|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22|||
13278930|NCT01272219|26451367|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25|||
13278931|NCT01272219|26451368|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0|||
13278932|NCT01272219|26451369|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0|||
13278933|NCT01272219|26451370|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18|||
13278934|NCT01272219|26451371|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40|||
13278935|NCT01272219|26451372|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20|||
13278936|NCT01272219|26451367|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122|||
13278937|NCT01272219|26451368|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
13278938|NCT01272219|26451369|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
13278939|NCT01272219|26451370|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114|||
13278940|NCT01272219|26451371|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172|||
13278941|NCT01272219|26451372|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147|||
13278942|NCT01272219|26451367|FG000|Main Period: Week 0 to Week 56|Unclassified|36|||
13278943|NCT01272219|26451368|FG001|Main Period: Week 0 to Week 56|Unclassified|0|||
13278944|NCT01272219|26451369|FG002|Main Period: Week 0 to Week 56|Unclassified|0|||
13278945|NCT01272219|26451370|FG003|Main Period: Week 0 to Week 56|Unclassified|29|||
13278946|NCT01272219|26451371|FG004|Main Period: Week 0 to Week 56|Unclassified|42|||
13278947|NCT01272219|26451372|FG005|Main Period: Week 0 to Week 56|Unclassified|34|||
13278948|NCT01272219|26451367|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
13278949|NCT01272219|26451368|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
13278950|NCT01272219|26451369|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
13278951|NCT01272219|26451370|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2|||
13278952|NCT01272219|26451371|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
13278953|NCT01272219|26451372|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
13278954|NCT01272219|26451367|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
13278955|NCT01272219|26451368|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
13278956|NCT01272219|26451369|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
13278957|NCT01272219|26451370|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1|||
13278958|NCT01272219|26451371|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
13278959|NCT01272219|26451372|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
13278960|NCT01272219|26451367|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
13278961|NCT01272219|26451368|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1|||
13278962|NCT01272219|26451369|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
13278963|NCT01272219|26451370|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3|||
13278964|NCT01272219|26451371|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
13278965|NCT01272219|26451372|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
13278966|NCT01272219|26451367|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
13278967|NCT01272219|26451368|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6|||
13278968|NCT01272219|26451369|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4|||
13278969|NCT01272219|26451370|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7|||
13278970|NCT01272219|26451371|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
13278971|NCT01272219|26451372|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
13278972|NCT01272219|26451367|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
13278973|NCT01272219|26451368|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1|||
13278974|NCT01272219|26451369|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
13278975|NCT01272219|26451370|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
13278976|NCT01272219|26451371|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
13278977|NCT01272219|26451372|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
13278978|NCT01272219|26451367|FG000|Main + Extension Period: Week 0-172|Adverse Event|0|||
13278979|NCT01272219|26451368|FG001|Main + Extension Period: Week 0-172|Adverse Event|0|||
13278980|NCT01272219|26451369|FG002|Main + Extension Period: Week 0-172|Adverse Event|0|||
13278981|NCT01272219|26451370|FG003|Main + Extension Period: Week 0-172|Adverse Event|0|||
13278982|NCT01272219|26451371|FG004|Main + Extension Period: Week 0-172|Adverse Event|191|||
13278983|NCT01272219|26451372|FG005|Main + Extension Period: Week 0-172|Adverse Event|43|||
13278984|NCT01272219|26451367|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
13278985|NCT01272219|26451368|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
13278986|NCT01272219|26451369|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
13278987|NCT01272219|26451370|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
13278988|NCT01272219|26451371|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29|||
13278989|NCT01272219|26451372|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36|||
13278990|NCT01272219|26451367|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0|||
13278991|NCT01272219|26451368|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0|||
13278992|NCT01272219|26451369|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0|||
13278993|NCT01272219|26451370|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0|||
13278994|NCT01272219|26451371|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76|||
13278995|NCT01272219|26451372|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36|||
13278996|NCT01272219|26451367|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
13278997|NCT01272219|26451368|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
13278998|NCT01272219|26451369|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
13278999|NCT01272219|26451370|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
13307964|NCT01281306|26530319|FG001|Overall Study|Randomized in error|0|||
13279000|NCT01272219|26451371|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364|||
13279001|NCT01272219|26451372|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256|||
13279002|NCT01272219|26451367|FG000|Main + Extension Period: Week 0-172|Missing reason|0|||
13279003|NCT01272219|26451368|FG001|Main + Extension Period: Week 0-172|Missing reason|0|||
13279004|NCT01272219|26451369|FG002|Main + Extension Period: Week 0-172|Missing reason|0|||
13279005|NCT01272219|26451370|FG003|Main + Extension Period: Week 0-172|Missing reason|0|||
13279006|NCT01272219|26451371|FG004|Main + Extension Period: Week 0-172|Missing reason|1|||
13279007|NCT01272219|26451372|FG005|Main + Extension Period: Week 0-172|Missing reason|0|||
13279008|NCT01272219|26451367|FG000|Main + Extension Period: Week 0-172|Unclassified|0|||
13279009|NCT01272219|26451368|FG001|Main + Extension Period: Week 0-172|Unclassified|0|||
13279010|NCT01272219|26451369|FG002|Main + Extension Period: Week 0-172|Unclassified|0|||
13279011|NCT01272219|26451370|FG003|Main + Extension Period: Week 0-172|Unclassified|0|||
13279012|NCT01272219|26451371|FG004|Main + Extension Period: Week 0-172|Unclassified|61|||
13279013|NCT01272219|26451372|FG005|Main + Extension Period: Week 0-172|Unclassified|51|||
13279014|NCT01272180|26451425|FG000|Overall Study|Adverse Event|0|||
13279015|NCT01272180|26451426|FG001|Overall Study|Adverse Event|0|||
13279016|NCT01272180|26451427|FG002|Overall Study|Adverse Event|1|||
13279017|NCT01272180|26451428|FG003|Overall Study|Adverse Event|0|||
13279018|NCT01272180|26451425|FG000|Overall Study|Withdrawal by Subject|2|||
13279019|NCT01272180|26451426|FG001|Overall Study|Withdrawal by Subject|6|||
13279020|NCT01272180|26451427|FG002|Overall Study|Withdrawal by Subject|3|||
13279021|NCT01272180|26451428|FG003|Overall Study|Withdrawal by Subject|2|||
13279022|NCT01272180|26451425|FG000|Overall Study|Lost to Follow-up|15|||
13279023|NCT01272180|26451426|FG001|Overall Study|Lost to Follow-up|14|||
13279024|NCT01272180|26451427|FG002|Overall Study|Lost to Follow-up|8|||
13279025|NCT01272180|26451428|FG003|Overall Study|Lost to Follow-up|10|||
13279026|NCT01272180|26451425|FG000|Overall Study|Inappropriate enrollment|0|||
13279027|NCT01272180|26451426|FG001|Overall Study|Inappropriate enrollment|0|||
13279028|NCT01272180|26451427|FG002|Overall Study|Inappropriate enrollment|1|||
13279029|NCT01272180|26451428|FG003|Overall Study|Inappropriate enrollment|1|||
13279030|NCT01272180|26451425|FG000|Overall Study|Protocol Violation|0|||
13279031|NCT01272180|26451426|FG001|Overall Study|Protocol Violation|1|||
13279032|NCT01272180|26451427|FG002|Overall Study|Protocol Violation|0|||
13279033|NCT01272180|26451428|FG003|Overall Study|Protocol Violation|1|||
13279034|NCT01272011|26451449|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0|||
13279035|NCT01272011|26451450|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2|||
13279036|NCT01272011|26451451|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0|||
13279037|NCT01271712|26451479|FG000|Double Blind Treatment|Death|2|||
13279038|NCT01271712|26451480|FG001|Double Blind Treatment|Death|0|||
13279039|NCT01271712|26451479|FG000|Double Blind Treatment|Lack of Efficacy|1|||
13279040|NCT01271712|26451480|FG001|Double Blind Treatment|Lack of Efficacy|0|||
13279041|NCT01271712|26451479|FG000|Double Blind Treatment|Adverse Event|9|||
13279042|NCT01271712|26451480|FG001|Double Blind Treatment|Adverse Event|4|||
13279043|NCT01271712|26451479|FG000|Double Blind Treatment|Progressive disease|23|||
13279044|NCT01271712|26451480|FG001|Double Blind Treatment|Progressive disease|3|||
13279045|NCT01271712|26451479|FG000|Double Blind Treatment|Withdrawal by Subject|4|||
13279046|NCT01271712|26451480|FG001|Double Blind Treatment|Withdrawal by Subject|1|||
13279047|NCT01271712|26451479|FG000|Double Blind Treatment|Non compliance with study drug|2|||
13279048|NCT01271712|26451480|FG001|Double Blind Treatment|Non compliance with study drug|0|||
13279049|NCT01271712|26451479|FG000|Double Blind Treatment|receive no study drug|1|||
13279050|NCT01271712|26451480|FG001|Double Blind Treatment|receive no study drug|0|||
13279051|NCT01271712|26451479|FG000|Open Label Treatment|Death|6|||
13279052|NCT01271712|26451480|FG001|Open Label Treatment|Death|5|||
13279053|NCT01271712|26451479|FG000|Open Label Treatment|Withdrawal by Subject|6|||
13279054|NCT01271712|26451480|FG001|Open Label Treatment|Withdrawal by Subject|11|||
13279055|NCT01271712|26451479|FG000|Open Label Treatment|Physician Decision|2|||
13279056|NCT01271712|26451480|FG001|Open Label Treatment|Physician Decision|0|||
13279057|NCT01271712|26451479|FG000|Open Label Treatment|Adverse Event|14|||
13279058|NCT01271712|26451480|FG001|Open Label Treatment|Adverse Event|8|||
13279059|NCT01271712|26451479|FG000|Open Label Treatment|Progressive disease|59|||
13279060|NCT01271712|26451480|FG001|Open Label Treatment|Progressive disease|32|||
13279061|NCT01271712|26451479|FG000|Open Label Treatment|transferred to rollover study|1|||
13279062|NCT01271712|26451480|FG001|Open Label Treatment|transferred to rollover study|0|||
13279063|NCT01271712|26451479|FG000|Open Label Treatment|Non-compliance with study drug|1|||
13279064|NCT01271712|26451480|FG001|Open Label Treatment|Non-compliance with study drug|0|||
13279065|NCT01271712|26451479|FG000|Open Label Treatment|Protocol Violation|0|||
13279066|NCT01271712|26451480|FG001|Open Label Treatment|Protocol Violation|1|||
13279067|NCT01271712|26451479|FG000|Open Label Treatment|Switching to other therapy|2|||
13279068|NCT01271712|26451480|FG001|Open Label Treatment|Switching to other therapy|1|||
13279069|NCT01271712|26451479|FG000|Safety Follow-up|Death|11|||
13279070|NCT01271712|26451480|FG001|Safety Follow-up|Death|7|||
13279071|NCT01271712|26451479|FG000|Safety Follow-up|Withdrawal by Subject|4|||
13279072|NCT01271712|26451480|FG001|Safety Follow-up|Withdrawal by Subject|2|||
13279073|NCT01271712|26451479|FG000|Safety Follow-up|Protocol Violation|1|||
13279074|NCT01271712|26451480|FG001|Safety Follow-up|Protocol Violation|1|||
13279075|NCT01271712|26451479|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3|||
13279076|NCT01271712|26451480|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4|||
13279077|NCT01271712|26451479|FG000|Safety Follow-up|No follow-up|1|||
13279078|NCT01271712|26451480|FG001|Safety Follow-up|No follow-up|1|||
13279079|NCT01271712|26451479|FG000|Safety Follow-up|Progressive disease|1|||
13279080|NCT01271712|26451480|FG001|Safety Follow-up|Progressive disease|0|||
13279081|NCT01271712|26451479|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15|||
13279082|NCT01271712|26451480|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6|||
13279083|NCT01271504|26451545|FG000|Overall Study|Death|7|||
13279084|NCT01271504|26451546|FG001|Overall Study|Death|6|||
13279085|NCT01271504|26451547|FG002|Overall Study|Death|32|||
13279086|NCT01271504|26451548|FG003|Overall Study|Death|32|||
13279087|NCT01271504|26451545|FG000|Overall Study|Lost to Follow-up|0|||
13279088|NCT01271504|26451546|FG001|Overall Study|Lost to Follow-up|1|||
13119726|NCT03015116|25935695|FG002|Overall Study|Lost to Follow-up|2|||
13119727|NCT03015116|25935693|FG000|Overall Study|Withdrawal by Subject|3|||
13119728|NCT03015116|25935694|FG001|Overall Study|Withdrawal by Subject|1|||
13119729|NCT03015116|25935695|FG002|Overall Study|Withdrawal by Subject|0|||
13119730|NCT03015116|25935693|FG000|Overall Study|Subject has New Medical Status|1|||
13279089|NCT01271504|26451547|FG002|Overall Study|Lost to Follow-up|3|||
13279090|NCT01271504|26451548|FG003|Overall Study|Lost to Follow-up|1|||
13279091|NCT01271504|26451545|FG000|Overall Study|Protocol Violation|0|||
13279092|NCT01271504|26451546|FG001|Overall Study|Protocol Violation|0|||
13279093|NCT01271504|26451547|FG002|Overall Study|Protocol Violation|0|||
13279094|NCT01271504|26451548|FG003|Overall Study|Protocol Violation|2|||
13279095|NCT01271504|26451545|FG000|Overall Study|Administrative Reasons|0|||
13279096|NCT01271504|26451546|FG001|Overall Study|Administrative Reasons|0|||
13279097|NCT01271504|26451547|FG002|Overall Study|Administrative Reasons|6|||
13279098|NCT01271504|26451548|FG003|Overall Study|Administrative Reasons|5|||
13279099|NCT01271504|26451545|FG000|Overall Study|Withdrawal by Subject|0|||
13279100|NCT01271504|26451546|FG001|Overall Study|Withdrawal by Subject|0|||
13279101|NCT01271504|26451547|FG002|Overall Study|Withdrawal by Subject|1|||
13279102|NCT01271504|26451548|FG003|Overall Study|Withdrawal by Subject|3|||
13279103|NCT01271504|26451545|FG000|Overall Study|Other|0|||
13279104|NCT01271504|26451546|FG001|Overall Study|Other|1|||
13279105|NCT01271504|26451547|FG002|Overall Study|Other|2|||
13279106|NCT01271504|26451548|FG003|Overall Study|Other|0|||
13279107|NCT01271010|26451563|FG000|Overall Study|Reason not specified|11|||
13279108|NCT01271010|26451563|FG000|Overall Study|Start of new CLL therapy|1|||
13279109|NCT01271010|26451563|FG000|Overall Study|Protocol Violation|1|||
13279110|NCT01271010|26451563|FG000|Overall Study|Death|2|||
13279111|NCT01271010|26451563|FG000|Overall Study|Progression and relapse of disease|1|||
13279112|NCT01271010|26451563|FG000|Overall Study|Withdrawal by Subject|18|||
13279113|NCT01271010|26451563|FG000|Overall Study|Disease progression|27|||
13279114|NCT01270971|26451582|FG000|Overall Study|Withdrawal by Subject|24|||
13279115|NCT01270971|26451583|FG001|Overall Study|Withdrawal by Subject|11|||
13279116|NCT01270971|26451582|FG000|Overall Study|Lost to Follow-up|18|||
13279117|NCT01270971|26451583|FG001|Overall Study|Lost to Follow-up|5|||
13279118|NCT01270971|26451582|FG000|Overall Study|Adverse Event|1|||
13279119|NCT01270971|26451583|FG001|Overall Study|Adverse Event|2|||
13279120|NCT01270971|26451582|FG000|Overall Study|Non compliance|2|||
13279121|NCT01270971|26451583|FG001|Overall Study|Non compliance|2|||
13279122|NCT01270971|26451582|FG000|Overall Study|Non-specific|7|||
13279123|NCT01270971|26451583|FG001|Overall Study|Non-specific|3|||
13279124|NCT01270958|26451609|FG000|Overall Study|Lost to Follow-up|2|||
13279125|NCT01270958|26451609|FG000|Overall Study|Did not meet inclusion criteria for age|2|||
13279126|NCT01270880|26451620|FG000|Overall Study|Never rec'd treatment, but registered.|1|||
13279127|NCT01270841|26451655|FG000|Overall Study|Adverse Event|0|||
13279128|NCT01270841|26451656|FG001|Overall Study|Adverse Event|1|||
13279129|NCT01270841|26451657|FG002|Overall Study|Adverse Event|0|||
13279130|NCT01270841|26451658|FG003|Overall Study|Adverse Event|3|||
13279131|NCT01270841|26451655|FG000|Overall Study|Withdrawal by Subject|3|||
13279132|NCT01270841|26451656|FG001|Overall Study|Withdrawal by Subject|2|||
13279133|NCT01270841|26451657|FG002|Overall Study|Withdrawal by Subject|3|||
13279134|NCT01270841|26451658|FG003|Overall Study|Withdrawal by Subject|3|||
13279135|NCT01270841|26451655|FG000|Overall Study|Lost to Follow-up|3|||
13279136|NCT01270841|26451656|FG001|Overall Study|Lost to Follow-up|1|||
13279137|NCT01270841|26451657|FG002|Overall Study|Lost to Follow-up|4|||
13279138|NCT01270841|26451658|FG003|Overall Study|Lost to Follow-up|2|||
13279139|NCT01270841|26451655|FG000|Overall Study|Physician Decision|0|||
13279140|NCT01270841|26451656|FG001|Overall Study|Physician Decision|1|||
13279141|NCT01270841|26451657|FG002|Overall Study|Physician Decision|0|||
13279142|NCT01270841|26451658|FG003|Overall Study|Physician Decision|0|||
13279143|NCT01270841|26451655|FG000|Overall Study|Did not qualify|6|||
13279144|NCT01270841|26451656|FG001|Overall Study|Did not qualify|3|||
13279145|NCT01270841|26451657|FG002|Overall Study|Did not qualify|4|||
13279146|NCT01270841|26451658|FG003|Overall Study|Did not qualify|5|||
13279147|NCT01270841|26451655|FG000|Overall Study|Protocol Violation|1|||
13279148|NCT01270841|26451656|FG001|Overall Study|Protocol Violation|5|||
13279149|NCT01270841|26451657|FG002|Overall Study|Protocol Violation|0|||
13279150|NCT01270841|26451658|FG003|Overall Study|Protocol Violation|0|||
13279151|NCT01270841|26451655|FG000|Overall Study|Enrolled in error|0|||
13279152|NCT01270841|26451656|FG001|Overall Study|Enrolled in error|1|||
13279153|NCT01270841|26451657|FG002|Overall Study|Enrolled in error|0|||
13279154|NCT01270841|26451658|FG003|Overall Study|Enrolled in error|0|||
13279155|NCT01270802|26451673|FG000|Overall Study|Withdrawal by Subject|1|||
13279156|NCT01270802|26451674|FG001|Overall Study|Withdrawal by Subject|0|||
13279157|NCT01270802|26451673|FG000|Overall Study|Adverse Event|1|||
13279158|NCT01270802|26451674|FG001|Overall Study|Adverse Event|0|||
13279159|NCT01270802|26451673|FG000|Overall Study|Lost to Follow-up|0|||
13279160|NCT01270802|26451674|FG001|Overall Study|Lost to Follow-up|1|||
13279161|NCT01270620|26451731|FG000|Overall Study|Withdrawal by Subject|1|||
13279162|NCT01270620|26451732|FG001|Overall Study|Withdrawal by Subject|3|||
13279163|NCT01270503|26451739|FG000|Overall Study|Lost to Follow-up|1|||
13279164|NCT01270464|26451796|FG000|Overall Study|Protocol Violation|4|||
13279165|NCT01270464|26451797|FG001|Overall Study|Protocol Violation|3|||
13279166|NCT01270464|26451798|FG002|Overall Study|Protocol Violation|2|||
13279167|NCT01270464|26451796|FG000|Overall Study|Lack of Efficacy|2|||
13279168|NCT01270464|26451797|FG001|Overall Study|Lack of Efficacy|3|||
13279169|NCT01270464|26451798|FG002|Overall Study|Lack of Efficacy|1|||
13279170|NCT01270464|26451796|FG000|Overall Study|Adverse Event|9|||
13279171|NCT01270464|26451797|FG001|Overall Study|Adverse Event|1|||
13279172|NCT01270464|26451798|FG002|Overall Study|Adverse Event|7|||
13279173|NCT01270464|26451796|FG000|Overall Study|Withdrawal by Subject|2|||
13279174|NCT01270464|26451797|FG001|Overall Study|Withdrawal by Subject|1|||
13279175|NCT01270464|26451798|FG002|Overall Study|Withdrawal by Subject|4|||
13279176|NCT01270464|26451796|FG000|Overall Study|Lost to Follow-up|2|||
13279177|NCT01270464|26451797|FG001|Overall Study|Lost to Follow-up|3|||
13279178|NCT01270464|26451798|FG002|Overall Study|Lost to Follow-up|1|||
13279179|NCT01270464|26451796|FG000|Overall Study|Other|1|||
13279180|NCT01270464|26451797|FG001|Overall Study|Other|1|||
13279181|NCT01270464|26451798|FG002|Overall Study|Other|3|||
13279182|NCT01270256|26451811|FG000|Overall Study|Withdrawal by Subject|1|||
13279183|NCT01270256|26451812|FG001|Overall Study|Withdrawal by Subject|0|||
13279184|NCT01270139|26451880|FG000|Overall Study|Adverse Event|8|||
13279185|NCT01270139|26451881|FG001|Overall Study|Adverse Event|17|||
13279186|NCT01270139|26451882|FG002|Overall Study|Adverse Event|18|||
13279187|NCT01270139|26451880|FG000|Overall Study|Lost to Follow-up|10|||
13279188|NCT01270139|26451881|FG001|Overall Study|Lost to Follow-up|9|||
13279189|NCT01270139|26451882|FG002|Overall Study|Lost to Follow-up|2|||
13291567|NCT00151775|26483498|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
13291568|NCT00151775|26483487|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
13291569|NCT00151775|26483488|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
13291570|NCT00151775|26483489|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
13291571|NCT00151775|26483490|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
13291572|NCT00151775|26483491|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
13291573|NCT00151775|26483492|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1|||
13119731|NCT03015116|25935694|FG001|Overall Study|Subject has New Medical Status|0|||
13291574|NCT00151775|26483493|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
13291575|NCT00151775|26483494|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
13291576|NCT00151775|26483495|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
13291577|NCT00151775|26483496|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
13291578|NCT00151775|26483497|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
13291579|NCT00151775|26483498|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
13291580|NCT00151775|26483487|FG000|Period 3: Double-blind, Withdrawal|Other|0|||
13291581|NCT00151775|26483488|FG001|Period 3: Double-blind, Withdrawal|Other|0|||
13291582|NCT00151775|26483489|FG002|Period 3: Double-blind, Withdrawal|Other|1|||
13291583|NCT00151775|26483490|FG003|Period 3: Double-blind, Withdrawal|Other|0|||
13291584|NCT00151775|26483491|FG004|Period 3: Double-blind, Withdrawal|Other|0|||
13291585|NCT00151775|26483492|FG005|Period 3: Double-blind, Withdrawal|Other|0|||
13291586|NCT00151775|26483493|FG006|Period 3: Double-blind, Withdrawal|Other|0|||
13291587|NCT00151775|26483494|FG007|Period 3: Double-blind, Withdrawal|Other|1|||
13291588|NCT00151775|26483495|FG008|Period 3: Double-blind, Withdrawal|Other|0|||
13291589|NCT00151775|26483496|FG009|Period 3: Double-blind, Withdrawal|Other|0|||
13119732|NCT03015116|25935695|FG002|Overall Study|Subject has New Medical Status|0|||
13119733|NCT03015116|25935693|FG000|Overall Study|Physician Decision|0|||
13119734|NCT03015116|25935694|FG001|Overall Study|Physician Decision|1|||
13119735|NCT03015116|25935695|FG002|Overall Study|Physician Decision|0|||
13291590|NCT00151775|26483497|FG010|Period 3: Double-blind, Withdrawal|Other|0|||
13291591|NCT00151775|26483498|FG011|Period 3: Double-blind, Withdrawal|Other|0|||
13291592|NCT00151775|26483487|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
13291593|NCT00151775|26483488|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
13279190|NCT01277211|26451909|FG000|Overall Study|Adverse Event|60|||
13279191|NCT01277211|26451910|FG001|Overall Study|Adverse Event|22|||
13279192|NCT01277211|26451909|FG000|Overall Study|Pregnancy|9|||
13279193|NCT01277211|26451910|FG001|Overall Study|Pregnancy|4|||
13279194|NCT01277211|26451909|FG000|Overall Study|Lost to Follow-up|14|||
13279195|NCT01277211|26451910|FG001|Overall Study|Lost to Follow-up|9|||
13279196|NCT01277211|26451909|FG000|Overall Study|Did not wish to continue|17|||
13279197|NCT01277211|26451910|FG001|Overall Study|Did not wish to continue|0|||
13279198|NCT01277211|26451909|FG000|Overall Study|Withdrew Consent|9|||
13279199|NCT01277211|26451910|FG001|Overall Study|Withdrew Consent|9|||
13279200|NCT01277211|26451909|FG000|Overall Study|Non-compliance with protocol|13|||
13279201|NCT01277211|26451910|FG001|Overall Study|Non-compliance with protocol|4|||
13279202|NCT01277211|26451909|FG000|Overall Study|Did not meet protocol eligibility|1|||
13279203|NCT01277211|26451910|FG001|Overall Study|Did not meet protocol eligibility|0|||
13279204|NCT01277211|26451909|FG000|Overall Study|Administrative|3|||
13279205|NCT01277211|26451910|FG001|Overall Study|Administrative|0|||
13279206|NCT01277211|26451909|FG000|Overall Study|Pregnancy wish|0|||
13279207|NCT01277211|26451910|FG001|Overall Study|Pregnancy wish|2|||
13279208|NCT01277211|26451909|FG000|Overall Study|Discontinued prior to treatment|24|||
13279209|NCT01277211|26451910|FG001|Overall Study|Discontinued prior to treatment|13|||
13279210|NCT01279954|26451928|FG000|Overall Study|Lack of Efficacy|3|||
13279211|NCT01279954|26451929|FG001|Overall Study|Lack of Efficacy|4|||
13279212|NCT01277744|26451936|FG000|Overall Study|Physician Decision|2|||
13279213|NCT01276379|26451954|FG000|Overall Study|Screening failure|40|||
13279214|NCT01276041|26451963|FG000|Overall Study|Adverse Event|2|||
13279215|NCT01276041|26451963|FG000|Overall Study|Protocol Violation|1|||
13279216|NCT01275339|26451986|FG000|Overall Study|Referred for surgery for AS symptoms|1|||
13279217|NCT01275339|26451987|FG001|Overall Study|Referred for surgery for AS symptoms|0|||
13279218|NCT01275339|26451988|FG002|Overall Study|Referred for surgery for AS symptoms|0|||
13279219|NCT01275339|26451989|FG003|Overall Study|Referred for surgery for AS symptoms|0|||
13279220|NCT01275339|26451986|FG000|Overall Study|Withdrawal by Subject|0|||
13279221|NCT01275339|26451987|FG001|Overall Study|Withdrawal by Subject|0|||
13279222|NCT01275339|26451988|FG002|Overall Study|Withdrawal by Subject|1|||
13279223|NCT01275339|26451989|FG003|Overall Study|Withdrawal by Subject|0|||
13279224|NCT01271803|26452161|FG000|Overall Study|Progressive disease|0|||
13279225|NCT01271803|26452162|FG001|Overall Study|Progressive disease|0|||
13279226|NCT01271803|26452163|FG002|Overall Study|Progressive disease|2|||
13279227|NCT01271803|26452161|FG000|Overall Study|Death|53|||
13279228|NCT01271803|26452162|FG001|Overall Study|Death|34|||
13279229|NCT01271803|26452163|FG002|Overall Study|Death|0|||
13279230|NCT01271803|26452161|FG000|Overall Study|Withdrawal by Subject|1|||
13279231|NCT01271803|26452162|FG001|Overall Study|Withdrawal by Subject|5|||
13279232|NCT01271803|26452163|FG002|Overall Study|Withdrawal by Subject|0|||
13279233|NCT01271803|26452161|FG000|Overall Study|Lost to Follow-up|1|||
13279234|NCT01271803|26452162|FG001|Overall Study|Lost to Follow-up|0|||
13279235|NCT01271803|26452163|FG002|Overall Study|Lost to Follow-up|0|||
13279236|NCT01271725|26452193|FG000|Part A|Progressive disease according to RECIST|8|||
13279237|NCT01271725|26452194|FG001|Part A|Progressive disease according to RECIST|0|||
13279238|NCT01271725|26452193|FG000|Part A|Clinical signs/symptoms of progression|2|||
13279239|NCT01271725|26452194|FG001|Part A|Clinical signs/symptoms of progression|0|||
13279240|NCT01271725|26452193|FG000|Part A|Other Adverse Event|8|||
13279241|NCT01271725|26452194|FG001|Part A|Other Adverse Event|0|||
13279242|NCT01271725|26452193|FG000|Part A|Lost to Follow-up|1|||
13279243|NCT01271725|26452194|FG001|Part A|Lost to Follow-up|0|||
13279244|NCT01271725|26452193|FG000|Part A|Withdrawal by Subject|12|||
13279245|NCT01271725|26452194|FG001|Part A|Withdrawal by Subject|0|||
13279246|NCT01271725|26452193|FG000|Part A|Other than specified|3|||
13279247|NCT01271725|26452194|FG001|Part A|Other than specified|0|||
13279248|NCT01271725|26452193|FG000|Part A|Protocol Violation|1|||
13279249|NCT01271725|26452194|FG001|Part A|Protocol Violation|0|||
13279250|NCT01271725|26452193|FG000|Part B|Other than specified|0|||
13279251|NCT01271725|26452194|FG001|Part B|Other than specified|2|||
13279252|NCT01271725|26452193|FG000|Part B|Clinical signs/symptoms of progression|0|||
13279253|NCT01271725|26452194|FG001|Part B|Clinical signs/symptoms of progression|2|||
13279254|NCT01271725|26452193|FG000|Part B|Other Adverse Event|0|||
13279255|NCT01271725|26452194|FG001|Part B|Other Adverse Event|1|||
13279256|NCT01271725|26452193|FG000|Part B|Protocol Violation|0|||
13279257|NCT01271725|26452194|FG001|Part B|Protocol Violation|1|||
13279258|NCT01271725|26452193|FG000|Part B|Withdrawal by Subject|0|||
13279259|NCT01271725|26452194|FG001|Part B|Withdrawal by Subject|6|||
13279260|NCT01270321|26452215|FG000|Overall Study|Death|3|||
13279261|NCT01270321|26452216|FG001|Overall Study|Death|1|||
13279262|NCT01270321|26452217|FG002|Overall Study|Death|4|||
13279263|NCT01270321|26452215|FG000|Overall Study|Adverse Event|7|||
13279264|NCT01270321|26452216|FG001|Overall Study|Adverse Event|9|||
13279265|NCT01270321|26452217|FG002|Overall Study|Adverse Event|5|||
13279266|NCT00249834|26452289|FG000|Overall Study|Ovarian stimulation failed|1|||
13279267|NCT00249834|26452290|FG001|Overall Study|Ovarian stimulation failed|0|||
13307965|NCT01281306|26530320|FG002|Overall Study|Randomized in error|0|||
13279268|NCT00249834|26452291|FG002|Overall Study|Ovarian stimulation failed|0|||
13279269|NCT00249834|26452292|FG003|Overall Study|Ovarian stimulation failed|0|||
13279270|NCT00249834|26452293|FG004|Overall Study|Ovarian stimulation failed|0|||
13279271|NCT00249834|26452294|FG005|Overall Study|Ovarian stimulation failed|0|||
13279272|NCT00249834|26452295|FG006|Overall Study|Ovarian stimulation failed|0|||
13279273|NCT00249834|26452296|FG007|Overall Study|Ovarian stimulation failed|0|||
13279274|NCT00249834|26452289|FG000|Overall Study|Failure of down-regulation|0|||
13279275|NCT00249834|26452290|FG001|Overall Study|Failure of down-regulation|0|||
13279276|NCT00249834|26452291|FG002|Overall Study|Failure of down-regulation|0|||
13279277|NCT00249834|26452292|FG003|Overall Study|Failure of down-regulation|0|||
13279278|NCT00249834|26452293|FG004|Overall Study|Failure of down-regulation|0|||
13279279|NCT00249834|26452294|FG005|Overall Study|Failure of down-regulation|0|||
13279280|NCT00249834|26452295|FG006|Overall Study|Failure of down-regulation|1|||
13279281|NCT00249834|26452296|FG007|Overall Study|Failure of down-regulation|0|||
13279282|NCT00249834|26452289|FG000|Overall Study|Protocol Violation|0|||
13279283|NCT00249834|26452290|FG001|Overall Study|Protocol Violation|19|||
13279284|NCT00249834|26452291|FG002|Overall Study|Protocol Violation|14|||
13279285|NCT00249834|26452292|FG003|Overall Study|Protocol Violation|8|||
13279286|NCT00249834|26452293|FG004|Overall Study|Protocol Violation|5|||
13279287|NCT00249834|26452294|FG005|Overall Study|Protocol Violation|2|||
13279288|NCT00249834|26452295|FG006|Overall Study|Protocol Violation|0|||
13279289|NCT00249834|26452296|FG007|Overall Study|Protocol Violation|0|||
13279290|NCT00249821|26452323|FG000|Overall Study|Technical problem|0|||
13279291|NCT00249821|26452324|FG001|Overall Study|Technical problem|1|||
13279292|NCT00249795|26452349|FG000|Overall Study|Not treated|16|||
13279293|NCT00249795|26452350|FG001|Overall Study|Not treated|14|||
13279294|NCT00249795|26452349|FG000|Overall Study|Symptomatic hypotension|127|||
13279295|NCT00249795|26452350|FG001|Overall Study|Symptomatic hypotension|64|||
13119736|NCT03014674|25935767|FG000|Overall Study|Withdrawal by Subject|1|||
13119737|NCT03014674|25935768|FG001|Overall Study|Withdrawal by Subject|0|||
13119738|NCT03014674|25935769|FG002|Overall Study|Withdrawal by Subject|0|||
13119739|NCT03014479|25935822|FG000|Overall Study|Adverse Event|0|||
13119740|NCT03014479|25935823|FG001|Overall Study|Adverse Event|1|||
13119741|NCT03014479|25935822|FG000|Overall Study|Voluntary Withdrawal|0|||
13119742|NCT03014479|25935823|FG001|Overall Study|Voluntary Withdrawal|2|||
13119743|NCT03014479|25935822|FG000|Overall Study|Unacceptable Inability of Site Visit|0|||
13119744|NCT03014479|25935823|FG001|Overall Study|Unacceptable Inability of Site Visit|1|||
13119745|NCT03014453|25935829|FG000|Overall Study|Lost to Follow-up|12|||
13119746|NCT03014453|25935829|FG000|Overall Study|Discontinued GER|3|||
13119747|NCT03014453|25935829|FG000|Overall Study|Excluded|19|||
13119748|NCT03014453|25935829|FG000|Overall Study|Refused to take part in|37|||
13119749|NCT03014206|25935835|FG000|Overall Study|Registration Violation|12|||
13119750|NCT03014180|25935846|FG000|Overall Study|Protocol Violation|2|||
13119751|NCT03014011|25935855|FG000|First Intervention|Withdrawal by Subject|1|||
13119752|NCT03014011|25935856|FG001|First Intervention|Withdrawal by Subject|0|||
13119753|NCT03014011|25935855|FG000|Washout|Withdrawal by Subject|1|||
13119754|NCT03014011|25935856|FG001|Washout|Withdrawal by Subject|0|||
13119755|NCT03013985|25935895|FG000|Overall Study|Protocol Violation|2|||
13119756|NCT03013985|25935896|FG001|Overall Study|Protocol Violation|2|||
13119757|NCT03013985|25935895|FG000|Overall Study|Withdrawal by Subject|14|||
13119758|NCT03013985|25935896|FG001|Overall Study|Withdrawal by Subject|17|||
13119759|NCT03012841|25935907|FG000|Overall Study|Protocol Violation|0|||
13119760|NCT03012841|25935908|FG001|Overall Study|Protocol Violation|10|||
13119761|NCT03012841|25935907|FG000|Overall Study|Lost to Follow-up|6|||
13119762|NCT03012841|25935908|FG001|Overall Study|Lost to Follow-up|1|||
13119763|NCT03012841|25935907|FG000|Overall Study|Withdrawal by Subject|6|||
13119764|NCT03012841|25935908|FG001|Overall Study|Withdrawal by Subject|0|||
13119765|NCT03012841|25935907|FG000|Overall Study|Unable to complete 12 month visit|6|||
13119766|NCT03012841|25935908|FG001|Overall Study|Unable to complete 12 month visit|0|||
13119767|NCT03012841|25935907|FG000|Overall Study|Subject relocation|1|||
13119768|NCT03012841|25935908|FG001|Overall Study|Subject relocation|0|||
13119769|NCT03012841|25935907|FG000|Overall Study|Seasonal winter travel|1|||
13119770|NCT03012841|25935908|FG001|Overall Study|Seasonal winter travel|0|||
13119771|NCT03012841|25935907|FG000|Overall Study|Physician Decision|0|||
13119772|NCT03012841|25935908|FG001|Overall Study|Physician Decision|2|||
13119773|NCT03012841|25935907|FG000|Overall Study|No ablation performed|0|||
13119774|NCT03012841|25935908|FG001|Overall Study|No ablation performed|2|||
13119775|NCT03012841|25935907|FG000|Overall Study|Study reached n=165 treated subject cap|0|||
13279296|NCT00249795|26452349|FG000|Overall Study|Other Serious Adverse Event|84|||
13279297|NCT00249795|26452350|FG001|Overall Study|Other Serious Adverse Event|93|||
13119776|NCT03012841|25935908|FG001|Overall Study|Study reached n=165 treated subject cap|5|||
13119777|NCT03012841|25935907|FG000|Overall Study|Insurance change|0|||
13119778|NCT03012841|25935908|FG001|Overall Study|Insurance change|1|||
13279298|NCT00249795|26452349|FG000|Overall Study|Qualifying condition not present|26|||
13279299|NCT00249795|26452350|FG001|Overall Study|Qualifying condition not present|29|||
13279300|NCT00249795|26452349|FG000|Overall Study|Withdrawal by Subject|678|||
13279301|NCT00249795|26452350|FG001|Overall Study|Withdrawal by Subject|742|||
13279302|NCT00249795|26452349|FG000|Overall Study|Thromboembolic / outcome event|39|||
13279303|NCT00249795|26452350|FG001|Overall Study|Thromboembolic / outcome event|45|||
13279304|NCT00249795|26452349|FG000|Overall Study|Oral anticoagulant required|2|||
13279305|NCT00249795|26452350|FG001|Overall Study|Oral anticoagulant required|0|||
13279306|NCT00249795|26452349|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7|||
13279307|NCT00249795|26452350|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3|||
13279308|NCT00249795|26452349|FG000|Overall Study|Non-compliance|71|||
13279309|NCT00249795|26452350|FG001|Overall Study|Non-compliance|69|||
13279310|NCT00249795|26452349|FG000|Overall Study|Study drug intolerance|3|||
13279311|NCT00249795|26452350|FG001|Overall Study|Study drug intolerance|3|||
13279312|NCT00249795|26452349|FG000|Overall Study|Other adverse events (non-serious)|188|||
13279313|NCT00249795|26452350|FG001|Overall Study|Other adverse events (non-serious)|159|||
13279314|NCT00249795|26452349|FG000|Overall Study|Physician withdrew consent|71|||
13279315|NCT00249795|26452350|FG001|Overall Study|Physician withdrew consent|63|||
13279316|NCT00249795|26452349|FG000|Overall Study|Surgery / procedure|4|||
13279317|NCT00249795|26452350|FG001|Overall Study|Surgery / procedure|5|||
13279318|NCT00249795|26452349|FG000|Overall Study|Angiotensin II receptor blocker required|35|||
13279319|NCT00249795|26452350|FG001|Overall Study|Angiotensin II receptor blocker required|58|||
13279320|NCT00249795|26452349|FG000|Overall Study|Lightheadedness / dizziness|15|||
13279321|NCT00249795|26452350|FG001|Overall Study|Lightheadedness / dizziness|11|||
13279322|NCT00249795|26452349|FG000|Overall Study|Hypotension (non-symptomatic)|5|||
13279323|NCT00249795|26452350|FG001|Overall Study|Hypotension (non-symptomatic)|5|||
13279324|NCT00249795|26452349|FG000|Overall Study|Other contraindicated medication|1|||
13279325|NCT00249795|26452350|FG001|Overall Study|Other contraindicated medication|1|||
13119779|NCT03012828|25935960|FG000|Overall Study|Lost to Follow-up|1|||
13119780|NCT03012828|25935961|FG001|Overall Study|Lost to Follow-up|0|||
13119781|NCT03012828|25935962|FG002|Overall Study|Lost to Follow-up|1|||
13119782|NCT03012828|25935963|FG003|Overall Study|Lost to Follow-up|0|||
13119783|NCT03012828|25935964|FG004|Overall Study|Lost to Follow-up|1|||
13119784|NCT03012828|25935965|FG005|Overall Study|Lost to Follow-up|0|||
13119785|NCT03012828|25935960|FG000|Overall Study|Withdrawal by Subject|0|||
13119786|NCT03012828|25935961|FG001|Overall Study|Withdrawal by Subject|0|||
13119787|NCT03012828|25935962|FG002|Overall Study|Withdrawal by Subject|1|||
13119788|NCT03012828|25935963|FG003|Overall Study|Withdrawal by Subject|0|||
13119789|NCT03012828|25935964|FG004|Overall Study|Withdrawal by Subject|0|||
13119790|NCT03012828|25935965|FG005|Overall Study|Withdrawal by Subject|1|||
13119791|NCT03012828|25935960|FG000|Overall Study|Non-compliance with protocol|0|||
13119792|NCT03012828|25935961|FG001|Overall Study|Non-compliance with protocol|0|||
13119793|NCT03012828|25935962|FG002|Overall Study|Non-compliance with protocol|0|||
13119794|NCT03012828|25935963|FG003|Overall Study|Non-compliance with protocol|0|||
13119795|NCT03012828|25935964|FG004|Overall Study|Non-compliance with protocol|1|||
13119796|NCT03012828|25935965|FG005|Overall Study|Non-compliance with protocol|0|||
13119797|NCT03012828|25935960|FG000|Overall Study|Delay to last visit would delay DBL|0|||
13119798|NCT03012828|25935961|FG001|Overall Study|Delay to last visit would delay DBL|0|||
13119799|NCT03012828|25935962|FG002|Overall Study|Delay to last visit would delay DBL|0|||
13119800|NCT03012828|25935963|FG003|Overall Study|Delay to last visit would delay DBL|0|||
13119801|NCT03012828|25935964|FG004|Overall Study|Delay to last visit would delay DBL|0|||
13119802|NCT03012828|25935965|FG005|Overall Study|Delay to last visit would delay DBL|1|||
13119803|NCT03012334|25936043|FG000|Period 1|Withdrawal by Subject|0|||
13119804|NCT03012334|25936044|FG001|Period 1|Withdrawal by Subject|0|||
13119805|NCT03012334|25936045|FG002|Period 1|Withdrawal by Subject|0|||
13119806|NCT03012334|25936046|FG003|Period 1|Withdrawal by Subject|0|||
13119807|NCT03012334|25936047|FG004|Period 1|Withdrawal by Subject|0|||
13119808|NCT03012334|25936048|FG005|Period 1|Withdrawal by Subject|0|||
13119809|NCT03012334|25936049|FG006|Period 1|Withdrawal by Subject|0|||
13119810|NCT03012334|25936050|FG007|Period 1|Withdrawal by Subject|0|||
13119811|NCT03012334|25936051|FG008|Period 1|Withdrawal by Subject|0|||
13119812|NCT03012334|25936052|FG009|Period 1|Withdrawal by Subject|1|||
13119813|NCT03012334|25936043|FG000|Period 2|Withdrawal by Subject|0|||
13119814|NCT03012334|25936044|FG001|Period 2|Withdrawal by Subject|1|||
13119815|NCT03012334|25936045|FG002|Period 2|Withdrawal by Subject|0|||
13119816|NCT03012334|25936046|FG003|Period 2|Withdrawal by Subject|0|||
13119817|NCT03012334|25936047|FG004|Period 2|Withdrawal by Subject|0|||
13119818|NCT03012334|25936048|FG005|Period 2|Withdrawal by Subject|0|||
13119819|NCT03012334|25936049|FG006|Period 2|Withdrawal by Subject|0|||
13119820|NCT03012334|25936050|FG007|Period 2|Withdrawal by Subject|0|||
13119821|NCT03012334|25936051|FG008|Period 2|Withdrawal by Subject|0|||
13119822|NCT03012334|25936052|FG009|Period 2|Withdrawal by Subject|0|||
13119823|NCT03012334|25936043|FG000|Period 2|Protocol Violation|0|||
13279326|NCT00249795|26452349|FG000|Overall Study|Event related to cardiac condition|17|||
13119824|NCT03012334|25936044|FG001|Period 2|Protocol Violation|0|||
13119825|NCT03012334|25936045|FG002|Period 2|Protocol Violation|1|||
13119826|NCT03012334|25936046|FG003|Period 2|Protocol Violation|0|||
13279327|NCT00249795|26452350|FG001|Overall Study|Event related to cardiac condition|16|||
13279328|NCT00249795|26452349|FG000|Overall Study|Patient not wish to continue after May08|4|||
13279329|NCT00249795|26452350|FG001|Overall Study|Patient not wish to continue after May08|6|||
13279330|NCT00249795|26452349|FG000|Overall Study|Site not agree to continue after May08|1|||
13279331|NCT00249795|26452350|FG001|Overall Study|Site not agree to continue after May08|1|||
13279332|NCT00249795|26452349|FG000|Overall Study|Lost to Follow-up|0|||
13279333|NCT00249795|26452350|FG001|Overall Study|Lost to Follow-up|2|||
13279334|NCT00249795|26452349|FG000|Overall Study|Missing|0|||
13279335|NCT00249795|26452350|FG001|Overall Study|Missing|1|||
13279336|NCT00249769|26452386|FG000|Overall Study|Withdrawal by Subject|1|||
13279337|NCT00249769|26452387|FG001|Overall Study|Withdrawal by Subject|10|||
13279338|NCT00249769|26452388|FG002|Overall Study|Withdrawal by Subject|6|||
13279339|NCT00249769|26452386|FG000|Overall Study|Migration from Study Area|1|||
13279340|NCT00249769|26452387|FG001|Overall Study|Migration from Study Area|3|||
13279341|NCT00249769|26452388|FG002|Overall Study|Migration from Study Area|14|||
13279342|NCT00249769|26452386|FG000|Overall Study|Miscellaneous|0|||
13279343|NCT00249769|26452387|FG001|Overall Study|Miscellaneous|2|||
13279344|NCT00249769|26452388|FG002|Overall Study|Miscellaneous|2|||
13279345|NCT00249769|26452386|FG000|Overall Study|Adverse Event|0|||
13279346|NCT00249769|26452387|FG001|Overall Study|Adverse Event|0|||
13279347|NCT00249769|26452388|FG002|Overall Study|Adverse Event|1|||
13279348|NCT00249769|26452386|FG000|Overall Study|Physician Decision|0|||
13279349|NCT00249769|26452387|FG001|Overall Study|Physician Decision|0|||
13279350|NCT00249769|26452388|FG002|Overall Study|Physician Decision|2|||
13279351|NCT00249769|26452386|FG000|Overall Study|Lost to Follow-up|0|||
13279352|NCT00249769|26452387|FG001|Overall Study|Lost to Follow-up|0|||
13279353|NCT00249769|26452388|FG002|Overall Study|Lost to Follow-up|3|||
13279354|NCT00249613|26452404|FG000|12 Month Follow-up|Death|1|||
13279355|NCT00249613|26452405|FG001|12 Month Follow-up|Death|1|||
13279356|NCT00249613|26452404|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
13279357|NCT00249613|26452405|FG001|12 Month Follow-up|Withdrawal by Subject|6|||
13279358|NCT00249613|26452404|FG000|12 Month Follow-up|Lost to Follow-up|10|||
13279359|NCT00249613|26452405|FG001|12 Month Follow-up|Lost to Follow-up|8|||
13279360|NCT00249444|26452420|FG000|Overall Study|Lost to Follow-up|2|||
13279361|NCT00249444|26452421|FG001|Overall Study|Lost to Follow-up|2|||
13279362|NCT00249444|26452420|FG000|Overall Study|non-compliant|9|||
13279363|NCT00249444|26452421|FG001|Overall Study|non-compliant|11|||
13279364|NCT00249444|26452420|FG000|Overall Study|Adverse Event|1|||
13279365|NCT00249444|26452421|FG001|Overall Study|Adverse Event|1|||
13279366|NCT00249444|26452420|FG000|Overall Study|life event|0|||
13279367|NCT00249444|26452421|FG001|Overall Study|life event|1|||
13279368|NCT00249288|26452459|FG000|Overall Study|Lost to Follow-up|3|||
13279369|NCT00249288|26452460|FG001|Overall Study|Lost to Follow-up|3|||
13279370|NCT00249288|26452459|FG000|Overall Study|Withdrawal by Subject|2|||
13279371|NCT00249288|26452460|FG001|Overall Study|Withdrawal by Subject|2|||
13279372|NCT00249002|26452478|FG000|Overall Study|Adverse Event|2|||
13279373|NCT00249002|26452478|FG000|Overall Study|Study cancellation|3|||
13279374|NCT00249002|26452478|FG000|Overall Study|Other|2|||
13279375|NCT00248833|26452504|FG000|Overall Study|Adverse Event|2|||
13279376|NCT00248833|26452505|FG001|Overall Study|Adverse Event|0|||
13279377|NCT00248833|26452506|FG002|Overall Study|Adverse Event|0|||
13279378|NCT00248833|26452504|FG000|Overall Study|Withdrawal by Subject|0|||
13279379|NCT00248833|26452505|FG001|Overall Study|Withdrawal by Subject|1|||
13279380|NCT00248833|26452506|FG002|Overall Study|Withdrawal by Subject|1|||
13279381|NCT00248833|26452504|FG000|Overall Study|Lost to Follow-up|1|||
13279382|NCT00248833|26452505|FG001|Overall Study|Lost to Follow-up|1|||
13279383|NCT00248833|26452506|FG002|Overall Study|Lost to Follow-up|1|||
13279384|NCT00248833|26452504|FG000|Overall Study|Other|0|||
13279385|NCT00248833|26452505|FG001|Overall Study|Other|1|||
13279386|NCT00248833|26452506|FG002|Overall Study|Other|0|||
13279387|NCT00248794|26452536|FG000|Overall Study|Lost to Follow-up|6|||
13279388|NCT00248794|26452537|FG001|Overall Study|Lost to Follow-up|8|||
13279389|NCT00248794|26452538|FG002|Overall Study|Lost to Follow-up|3|||
13279390|NCT00248651|26452565|FG000|Overall Study|Withdrawal by Subject|28|||
13279391|NCT00248651|26452566|FG001|Overall Study|Withdrawal by Subject|40|||
13279392|NCT00248651|26452567|FG002|Overall Study|Withdrawal by Subject|32|||
13279393|NCT00248495|26452578|FG000|Overall Study|Withdrawal by Subject|1|||
13279394|NCT00248170|26452605|FG000|Overall Study|Withdrawal by Subject|71|||
13279395|NCT00248170|26452606|FG001|Overall Study|Withdrawal by Subject|79|||
13279396|NCT00248170|26452605|FG000|Overall Study|Protocol Violation|35|||
13279397|NCT00248170|26452606|FG001|Overall Study|Protocol Violation|30|||
13279398|NCT00248170|26452605|FG000|Overall Study|Lost to Follow-up|28|||
13279399|NCT00248170|26452606|FG001|Overall Study|Lost to Follow-up|35|||
13279400|NCT00248170|26452605|FG000|Overall Study|Disease progression|196|||
13279401|NCT00248170|26452606|FG001|Overall Study|Disease progression|216|||
13279402|NCT00248170|26452605|FG000|Overall Study|Death|28|||
13279403|NCT00248170|26452606|FG001|Overall Study|Death|47|||
13279404|NCT00248170|26452605|FG000|Overall Study|Adverse Event|311|||
13279405|NCT00248170|26452606|FG001|Overall Study|Adverse Event|296|||
13279406|NCT00248170|26452605|FG000|Overall Study|Administrative problems|22|||
13279407|NCT00248170|26452606|FG001|Overall Study|Administrative problems|25|||
13307966|NCT01281306|26530321|FG003|Overall Study|Randomized in error|1|||
13279408|NCT00248170|26452605|FG000|Overall Study|Abnormal test procedure(s) result|49|||
13279409|NCT00248170|26452606|FG001|Overall Study|Abnormal test procedure(s) result|61|||
13279410|NCT00248170|26452605|FG000|Overall Study|Abnormal laboratory values|4|||
13279411|NCT00248170|26452606|FG001|Overall Study|Abnormal laboratory values|0|||
13279412|NCT00248170|26452605|FG000|Overall Study|Protocol deviation|17|||
13279413|NCT00248170|26452606|FG001|Overall Study|Protocol deviation|19|||
13279414|NCT00248040|26452663|FG000|Overall Study|transplantectomy|2|||
13279415|NCT00248040|26452664|FG001|Overall Study|transplantectomy|1|||
13279416|NCT00248040|26452665|FG002|Overall Study|transplantectomy|3|||
13279417|NCT00248040|26452663|FG000|Overall Study|transplant cancelled post treat start|1|||
13279418|NCT00248040|26452664|FG001|Overall Study|transplant cancelled post treat start|0|||
13279419|NCT00248040|26452665|FG002|Overall Study|transplant cancelled post treat start|0|||
13279420|NCT00248040|26452663|FG000|Overall Study|Death|0|||
13279421|NCT00248040|26452664|FG001|Overall Study|Death|0|||
13279422|NCT00248040|26452665|FG002|Overall Study|Death|1|||
13279423|NCT00247962|26452680|FG000|Overall Study|Adverse Event|15|||
13279424|NCT00247962|26452681|FG001|Overall Study|Adverse Event|12|||
13279425|NCT00247962|26452680|FG000|Overall Study|Lost to Follow-up|3|||
13279426|NCT00247962|26452681|FG001|Overall Study|Lost to Follow-up|1|||
13279427|NCT00247962|26452680|FG000|Overall Study|Physician Decision|0|||
13279428|NCT00247962|26452681|FG001|Overall Study|Physician Decision|1|||
13279429|NCT00247962|26452680|FG000|Overall Study|Protocol Violation|1|||
13279430|NCT00247962|26452681|FG001|Overall Study|Protocol Violation|1|||
13279431|NCT00247962|26452680|FG000|Overall Study|Withdrawal by Subject|3|||
13279432|NCT00247962|26452681|FG001|Overall Study|Withdrawal by Subject|2|||
13279433|NCT00247962|26452680|FG000|Overall Study|Lack of Efficacy|4|||
13279434|NCT00247962|26452681|FG001|Overall Study|Lack of Efficacy|2|||
13279435|NCT00247611|26452704|FG000|Baselined|Completed baseline, never placed on ARVs|8|||
13279436|NCT00247611|26452705|FG001|Baselined|Completed baseline, never placed on ARVs|5|||
13279437|NCT00247611|26452704|FG000|Baselined|Completed baseline only|9|||
13279438|NCT00247611|26452705|FG001|Baselined|Completed baseline only|8|||
13279439|NCT00247416|26452724|FG000|Overall Study|3 patients were found to be ineligible|1|||
13279440|NCT00247416|26452725|FG001|Overall Study|3 patients were found to be ineligible|2|||
13279441|NCT00247273|26452776|FG000|Overall Study|Adverse Event|85|||
13279442|NCT00247273|26452777|FG001|Overall Study|Adverse Event|80|||
13279443|NCT00247273|26452776|FG000|Overall Study|Physician Decision|6|||
13279444|NCT00247273|26452777|FG001|Overall Study|Physician Decision|3|||
13279445|NCT00247273|26452776|FG000|Overall Study|Lost to Follow-up|7|||
13279446|NCT00247273|26452777|FG001|Overall Study|Lost to Follow-up|7|||
13279447|NCT00247273|26452776|FG000|Overall Study|Withdrawal by Subject|46|||
13279448|NCT00247273|26452777|FG001|Overall Study|Withdrawal by Subject|47|||
13279449|NCT00247273|26452776|FG000|Overall Study|Did not take any study drug|2|||
13279450|NCT00247273|26452777|FG001|Overall Study|Did not take any study drug|0|||
13279451|NCT00246753|26452785|FG000|Overall Study|Withdrawal by Subject|2|||
13279452|NCT00246753|26452785|FG000|Overall Study|Physician Decision|2|||
13279453|NCT00246753|26452785|FG000|Overall Study|Adverse Event|2|||
13279454|NCT00246753|26452785|FG000|Overall Study|Unacceptable toxicity|2|||
13279455|NCT00246740|26452814|FG000|Initial Enrollment|Death|1|||
13279456|NCT00246740|26452815|FG001|Initial Enrollment|Death|0|||
13279457|NCT00246740|26452814|FG000|Initial Enrollment|Additional surgery scheduled|0|||
13279458|NCT00246740|26452815|FG001|Initial Enrollment|Additional surgery scheduled|2|||
13279459|NCT00246740|26452814|FG000|Initial Enrollment|Surgery schedule change|4|||
13279460|NCT00246740|26452815|FG001|Initial Enrollment|Surgery schedule change|4|||
13279461|NCT00246740|26452814|FG000|Initial Enrollment|Other|1|||
13279462|NCT00246740|26452815|FG001|Initial Enrollment|Other|2|||
13279463|NCT00246376|26452873|FG000|Overall Study|Dropped/withdrew during dietary run-in|11|||
13279464|NCT00246376|26452874|FG001|Overall Study|Dropped/withdrew during dietary run-in|5|||
13279465|NCT00246376|26452875|FG002|Overall Study|Dropped/withdrew during dietary run-in|4|||
13279466|NCT00246376|26452876|FG003|Overall Study|Dropped/withdrew during dietary run-in|7|||
13279467|NCT00246376|26452877|FG004|Overall Study|Dropped/withdrew during dietary run-in|3|||
13279468|NCT00246376|26452873|FG000|Overall Study|Adverse Event|2|||
13279469|NCT00246376|26452874|FG001|Overall Study|Adverse Event|3|||
13279470|NCT00246376|26452875|FG002|Overall Study|Adverse Event|1|||
13279471|NCT00246376|26452876|FG003|Overall Study|Adverse Event|3|||
13279472|NCT00246376|26452877|FG004|Overall Study|Adverse Event|1|||
13279473|NCT00246376|26452873|FG000|Overall Study|Lost to Follow-up|2|||
13279474|NCT00246376|26452874|FG001|Overall Study|Lost to Follow-up|11|||
13279475|NCT00246376|26452875|FG002|Overall Study|Lost to Follow-up|11|||
13279476|NCT00246376|26452876|FG003|Overall Study|Lost to Follow-up|16|||
13279477|NCT00246376|26452877|FG004|Overall Study|Lost to Follow-up|13|||
13279478|NCT00246259|26452918|FG000|Overall Study|Other|3|||
13279479|NCT00246259|26452919|FG001|Overall Study|Other|3|||
13279480|NCT00246259|26452918|FG000|Overall Study|Not stable by Week 18|2|||
13279481|NCT00246259|26452919|FG001|Overall Study|Not stable by Week 18|1|||
13279482|NCT00246259|26452918|FG000|Overall Study|Participant non-compliant|4|||
13279483|NCT00246259|26452919|FG001|Overall Study|Participant non-compliant|9|||
13279484|NCT00246259|26452918|FG000|Overall Study|Lack of Efficacy|2|||
13279485|NCT00246259|26452919|FG001|Overall Study|Lack of Efficacy|2|||
13279486|NCT00246259|26452918|FG000|Overall Study|Investigator withdrew participant|2|||
13279487|NCT00246259|26452919|FG001|Overall Study|Investigator withdrew participant|0|||
13279488|NCT00246259|26452918|FG000|Overall Study|Adverse Event|5|||
13279489|NCT00246259|26452919|FG001|Overall Study|Adverse Event|0|||
13279490|NCT00246259|26452918|FG000|Overall Study|Lost to Follow-up|3|||
13279491|NCT00246259|26452919|FG001|Overall Study|Lost to Follow-up|4|||
13279492|NCT00246259|26452918|FG000|Overall Study|Withdrawal by Subject|5|||
13279493|NCT00246259|26452919|FG001|Overall Study|Withdrawal by Subject|1|||
13279494|NCT00246259|26452918|FG000|Overall Study|randomly assigned, not eligible for ITT|2|||
13279495|NCT00246259|26452919|FG001|Overall Study|randomly assigned, not eligible for ITT|6|||
13279496|NCT00246129|26452948|FG000|Overall Study|Lost to Follow-up|1|||
13279497|NCT00246129|26452949|FG001|Overall Study|Lost to Follow-up|0|||
13279498|NCT00246129|26452948|FG000|Overall Study|Death|2|||
13279499|NCT00246129|26452949|FG001|Overall Study|Death|1|||
13279500|NCT00246129|26452948|FG000|Overall Study|suffered primary non-function|1|||
13279501|NCT00246129|26452949|FG001|Overall Study|suffered primary non-function|0|||
13279502|NCT00246129|26452948|FG000|Overall Study|grafts failed|3|||
13279503|NCT00246129|26452949|FG001|Overall Study|grafts failed|1|||
13279504|NCT00246090|26452956|FG000|Overall Study|Adverse Event|25|||
13279505|NCT00246090|26452956|FG000|Overall Study|Withdrawal by Subject|7|||
13279506|NCT00246090|26452956|FG000|Overall Study|Progressive Disease|212|||
13279507|NCT00246090|26452956|FG000|Overall Study|Clinical Progression|30|||
13279508|NCT00246090|26452956|FG000|Overall Study|Physician Decision|11|||
13279509|NCT00246090|26452956|FG000|Overall Study|Not Otherwise Specified|10|||
13279510|NCT00246025|26453019|FG000|Overall Study|Adverse Event|7|||
13279511|NCT00246025|26453020|FG001|Overall Study|Adverse Event|9|||
13279512|NCT00246025|26453021|FG002|Overall Study|Adverse Event|9|||
13279513|NCT00246025|26453022|FG003|Overall Study|Adverse Event|10|||
13279514|NCT00246025|26453019|FG000|Overall Study|Withdrawal by Subject|3|||
13279515|NCT00246025|26453020|FG001|Overall Study|Withdrawal by Subject|0|||
13279516|NCT00246025|26453021|FG002|Overall Study|Withdrawal by Subject|1|||
13279517|NCT00246025|26453022|FG003|Overall Study|Withdrawal by Subject|2|||
13279518|NCT00246025|26453019|FG000|Overall Study|unsuitable medical history was found|0|||
13279519|NCT00246025|26453020|FG001|Overall Study|unsuitable medical history was found|0|||
13279520|NCT00246025|26453021|FG002|Overall Study|unsuitable medical history was found|0|||
13279521|NCT00246025|26453022|FG003|Overall Study|unsuitable medical history was found|1|||
13279522|NCT00246012|26453143|FG000|Overall Study|Adverse Event|0|||
13279523|NCT00246012|26453144|FG001|Overall Study|Adverse Event|0|||
13279524|NCT00246012|26453145|FG002|Overall Study|Adverse Event|0|||
13279525|NCT00246012|26453146|FG003|Overall Study|Adverse Event|0|||
13279526|NCT00246012|26453147|FG004|Overall Study|Adverse Event|0|||
13279527|NCT00246012|26453148|FG005|Overall Study|Adverse Event|1|||
13279528|NCT00246012|26453149|FG006|Overall Study|Adverse Event|0|||
13279529|NCT00246012|26453150|FG007|Overall Study|Adverse Event|0|||
13279530|NCT00246012|26453151|FG008|Overall Study|Adverse Event|2|||
13279531|NCT00246012|26453143|FG000|Overall Study|Withdrawal by Subject|0|||
13279532|NCT00246012|26453144|FG001|Overall Study|Withdrawal by Subject|0|||
13279533|NCT00246012|26453145|FG002|Overall Study|Withdrawal by Subject|0|||
13279534|NCT00246012|26453146|FG003|Overall Study|Withdrawal by Subject|0|||
13279535|NCT00246012|26453147|FG004|Overall Study|Withdrawal by Subject|0|||
13279536|NCT00246012|26453148|FG005|Overall Study|Withdrawal by Subject|1|||
13279537|NCT00246012|26453149|FG006|Overall Study|Withdrawal by Subject|0|||
13279538|NCT00246012|26453150|FG007|Overall Study|Withdrawal by Subject|0|||
13279539|NCT00246012|26453151|FG008|Overall Study|Withdrawal by Subject|0|||
13279540|NCT00246012|26453143|FG000|Overall Study|Disease progression|3|||
13279541|NCT00246012|26453144|FG001|Overall Study|Disease progression|1|||
13279542|NCT00246012|26453145|FG002|Overall Study|Disease progression|2|||
13279543|NCT00246012|26453146|FG003|Overall Study|Disease progression|3|||
13279544|NCT00246012|26453147|FG004|Overall Study|Disease progression|3|||
13279545|NCT00246012|26453148|FG005|Overall Study|Disease progression|25|||
13279546|NCT00246012|26453149|FG006|Overall Study|Disease progression|30|||
13279547|NCT00246012|26453150|FG007|Overall Study|Disease progression|27|||
13279548|NCT00246012|26453151|FG008|Overall Study|Disease progression|26|||
13279549|NCT00246012|26453143|FG000|Overall Study|Other|0|||
13279550|NCT00246012|26453144|FG001|Overall Study|Other|0|||
13279551|NCT00246012|26453145|FG002|Overall Study|Other|0|||
13279552|NCT00246012|26453146|FG003|Overall Study|Other|0|||
13279553|NCT00246012|26453147|FG004|Overall Study|Other|0|||
13279554|NCT00246012|26453148|FG005|Overall Study|Other|0|||
13279555|NCT00246012|26453149|FG006|Overall Study|Other|0|||
13279556|NCT00246012|26453150|FG007|Overall Study|Other|1|||
13279557|NCT00246012|26453151|FG008|Overall Study|Other|0|||
13279558|NCT00246012|26453143|FG000|Overall Study|Randomly assigned but not treated|0|||
13279559|NCT00246012|26453144|FG001|Overall Study|Randomly assigned but not treated|0|||
13279560|NCT00246012|26453145|FG002|Overall Study|Randomly assigned but not treated|0|||
13279561|NCT00246012|26453146|FG003|Overall Study|Randomly assigned but not treated|0|||
13279562|NCT00246012|26453147|FG004|Overall Study|Randomly assigned but not treated|0|||
13279563|NCT00246012|26453148|FG005|Overall Study|Randomly assigned but not treated|1|||
13279564|NCT00246012|26453149|FG006|Overall Study|Randomly assigned but not treated|1|||
13279565|NCT00246012|26453150|FG007|Overall Study|Randomly assigned but not treated|0|||
13279566|NCT00246012|26453151|FG008|Overall Study|Randomly assigned but not treated|0|||
13279567|NCT00245856|26453161|FG000|Period Two|Withdrawal by Subject|0|||
13279568|NCT00245856|26453162|FG001|Period Two|Withdrawal by Subject|1|||
13279569|NCT00245765|26453210|FG000|Overall Study|Adverse Event|1|||
13279570|NCT00245765|26453211|FG001|Overall Study|Adverse Event|1|||
13279571|NCT00245765|26453212|FG002|Overall Study|Adverse Event|0|||
13279572|NCT00245765|26453210|FG000|Overall Study|Lack of Efficacy|14|||
13279573|NCT00245765|26453211|FG001|Overall Study|Lack of Efficacy|7|||
13279574|NCT00245765|26453212|FG002|Overall Study|Lack of Efficacy|0|||
13279575|NCT00245765|26453210|FG000|Overall Study|Lost to Follow-up|1|||
13279576|NCT00245765|26453211|FG001|Overall Study|Lost to Follow-up|2|||
13279577|NCT00245765|26453212|FG002|Overall Study|Lost to Follow-up|0|||
13279578|NCT00245765|26453210|FG000|Overall Study|Withdrawal by Subject|1|||
13279579|NCT00245765|26453211|FG001|Overall Study|Withdrawal by Subject|0|||
13279580|NCT00245765|26453212|FG002|Overall Study|Withdrawal by Subject|3|||
13279581|NCT00245765|26453210|FG000|Overall Study|Other reason|2|||
13279582|NCT00245765|26453211|FG001|Overall Study|Other reason|0|||
13279583|NCT00245765|26453212|FG002|Overall Study|Other reason|1|||
13279584|NCT00245765|26453210|FG000|Overall Study|Other|13|||
13279585|NCT00245765|26453211|FG001|Overall Study|Other|4|||
13279586|NCT00245765|26453212|FG002|Overall Study|Other|4|||
13279587|NCT00245583|26453239|FG000|Overall Study|Lost to Follow-up|1|||
13279588|NCT00245583|26453240|FG001|Overall Study|Lost to Follow-up|5|||
13279589|NCT00245583|26453239|FG000|Overall Study|Adverse Event|2|||
13279590|NCT00245583|26453240|FG001|Overall Study|Adverse Event|1|||
13279591|NCT00245583|26453239|FG000|Overall Study|Lack of Efficacy|1|||
13279592|NCT00245583|26453240|FG001|Overall Study|Lack of Efficacy|0|||
13279593|NCT00245583|26453239|FG000|Overall Study|Withdrawal by Subject|2|||
13279594|NCT00245583|26453240|FG001|Overall Study|Withdrawal by Subject|3|||
13279595|NCT00245466|26453264|FG000|Overall Study|Adverse Event|2|||
13279596|NCT00245466|26453265|FG001|Overall Study|Adverse Event|8|||
13279597|NCT00245466|26453266|FG002|Overall Study|Adverse Event|4|||
13279598|NCT00245466|26453264|FG000|Overall Study|Low prostate specific antigen suppr|16|||
13279599|NCT00245466|26453265|FG001|Overall Study|Low prostate specific antigen suppr|14|||
13119827|NCT03012334|25936047|FG004|Period 2|Protocol Violation|0|||
13279600|NCT00245466|26453266|FG002|Overall Study|Low prostate specific antigen suppr|5|||
13279601|NCT00245466|26453264|FG000|Overall Study|Insufficient testosterone suppr|12|||
13279602|NCT00245466|26453265|FG001|Overall Study|Insufficient testosterone suppr|12|||
13279603|NCT00245466|26453266|FG002|Overall Study|Insufficient testosterone suppr|21|||
13279604|NCT00245466|26453264|FG000|Overall Study|Insufficient PSA and testosterone suppr|0|||
13279605|NCT00245466|26453265|FG001|Overall Study|Insufficient PSA and testosterone suppr|0|||
13279606|NCT00245466|26453266|FG002|Overall Study|Insufficient PSA and testosterone suppr|3|||
13279607|NCT00245466|26453264|FG000|Overall Study|Withdrawal by Subject|2|||
13279608|NCT00245466|26453265|FG001|Overall Study|Withdrawal by Subject|2|||
13279609|NCT00245466|26453266|FG002|Overall Study|Withdrawal by Subject|1|||
13279610|NCT00245466|26453264|FG000|Overall Study|Lost to Follow-up|3|||
13119828|NCT03012334|25936048|FG005|Period 2|Protocol Violation|0|||
13119829|NCT03012334|25936049|FG006|Period 2|Protocol Violation|0|||
13119830|NCT03012334|25936050|FG007|Period 2|Protocol Violation|1|||
13119831|NCT03012334|25936051|FG008|Period 2|Protocol Violation|0|||
13119832|NCT03012334|25936052|FG009|Period 2|Protocol Violation|0|||
13119833|NCT03012334|25936043|FG000|Period 4|Non-Compliance|0|||
13119834|NCT03012334|25936044|FG001|Period 4|Non-Compliance|0|||
13119835|NCT03012334|25936045|FG002|Period 4|Non-Compliance|0|||
13119836|NCT03012334|25936046|FG003|Period 4|Non-Compliance|0|||
13119837|NCT03012334|25936047|FG004|Period 4|Non-Compliance|0|||
13119838|NCT03012334|25936048|FG005|Period 4|Non-Compliance|0|||
13119839|NCT03012334|25936049|FG006|Period 4|Non-Compliance|1|||
13279611|NCT00245466|26453265|FG001|Overall Study|Lost to Follow-up|0|||
13279612|NCT00245466|26453266|FG002|Overall Study|Lost to Follow-up|0|||
13279613|NCT00245466|26453264|FG000|Overall Study|Disease progression|0|||
13279614|NCT00245466|26453265|FG001|Overall Study|Disease progression|3|||
13279615|NCT00245466|26453266|FG002|Overall Study|Disease progression|1|||
13279616|NCT00245466|26453264|FG000|Overall Study|Protocol Violation|1|||
13279617|NCT00245466|26453265|FG001|Overall Study|Protocol Violation|2|||
13279618|NCT00245466|26453266|FG002|Overall Study|Protocol Violation|2|||
13279619|NCT00245466|26453264|FG000|Overall Study|Death|0|||
13279620|NCT00245466|26453265|FG001|Overall Study|Death|2|||
13119840|NCT03012334|25936050|FG007|Period 4|Non-Compliance|0|||
13119841|NCT03012334|25936051|FG008|Period 4|Non-Compliance|0|||
13119842|NCT03012334|25936052|FG009|Period 4|Non-Compliance|0|||
13119843|NCT03012334|25936043|FG000|Period 4|Adverse Event|0|||
13119844|NCT03012334|25936044|FG001|Period 4|Adverse Event|0|||
13119845|NCT03012334|25936045|FG002|Period 4|Adverse Event|0|||
13119846|NCT03012334|25936046|FG003|Period 4|Adverse Event|0|||
13119847|NCT03012334|25936047|FG004|Period 4|Adverse Event|0|||
13279621|NCT00245466|26453266|FG002|Overall Study|Death|0|||
13279622|NCT00245466|26453264|FG000|Overall Study|Administrative reasons|0|||
13279623|NCT00245466|26453265|FG001|Overall Study|Administrative reasons|1|||
13279624|NCT00245466|26453266|FG002|Overall Study|Administrative reasons|0|||
13279625|NCT00245102|26453299|FG000|Overall Study|Not Treated|1|||
13279626|NCT00245102|26453300|FG001|Overall Study|Not Treated|0|||
13279627|NCT00245102|26453301|FG002|Overall Study|Not Treated|1|||
13279628|NCT00245102|26453302|FG003|Overall Study|Not Treated|0|||
13279629|NCT00245102|26453303|FG004|Overall Study|Not Treated|0|||
13279630|NCT00245102|26453304|FG005|Overall Study|Not Treated|0|||
13279631|NCT00245102|26453299|FG000|Overall Study|Protocol Violation|1|||
13279632|NCT00245102|26453300|FG001|Overall Study|Protocol Violation|0|||
13279633|NCT00245102|26453301|FG002|Overall Study|Protocol Violation|0|||
13279634|NCT00245102|26453302|FG003|Overall Study|Protocol Violation|0|||
13279635|NCT00245102|26453303|FG004|Overall Study|Protocol Violation|0|||
13279636|NCT00245102|26453304|FG005|Overall Study|Protocol Violation|0|||
13279637|NCT00245102|26453299|FG000|Overall Study|Death|0|||
13279638|NCT00245102|26453300|FG001|Overall Study|Death|0|||
13279639|NCT00245102|26453301|FG002|Overall Study|Death|0|||
13279640|NCT00245102|26453302|FG003|Overall Study|Death|1|||
13279641|NCT00245102|26453303|FG004|Overall Study|Death|0|||
13279642|NCT00245102|26453304|FG005|Overall Study|Death|0|||
13279643|NCT00245102|26453299|FG000|Overall Study|Adverse Event|4|||
13279644|NCT00245102|26453300|FG001|Overall Study|Adverse Event|2|||
13279645|NCT00245102|26453301|FG002|Overall Study|Adverse Event|5|||
13307967|NCT01281306|26530322|FG004|Overall Study|Randomized in error|0|||
13307968|NCT01281306|26530323|FG005|Overall Study|Randomized in error|0|||
13307969|NCT01281306|26530324|FG006|Overall Study|Randomized in error|0|||
13307970|NCT01281202|26530339|FG000|Overall Study|Adverse Event|2|||
13307971|NCT01281202|26530340|FG001|Overall Study|Adverse Event|0|||
13307972|NCT01281202|26530339|FG000|Overall Study|Withdrawal by Subject|2|||
13307973|NCT01281202|26530340|FG001|Overall Study|Withdrawal by Subject|2|||
13307974|NCT01281202|26530339|FG000|Overall Study|Protocol Violation|11|||
13307975|NCT01281202|26530340|FG001|Overall Study|Protocol Violation|10|||
13307976|NCT01281202|26530339|FG000|Overall Study|Administrative|2|||
13307977|NCT01281202|26530340|FG001|Overall Study|Administrative|8|||
13307978|NCT01281202|26530339|FG000|Overall Study|Lost to Follow-up|11|||
13307979|NCT01281202|26530340|FG001|Overall Study|Lost to Follow-up|13|||
13307980|NCT01281202|26530339|FG000|Overall Study|Incarceration|0|||
13307981|NCT01281202|26530340|FG001|Overall Study|Incarceration|3|||
13307982|NCT01281189|26530363|FG000|Overall Study|Adverse Event|7|||
13307983|NCT01281189|26530364|FG001|Overall Study|Adverse Event|9|||
13307984|NCT01281189|26530363|FG000|Overall Study|Lost to Follow-up|6|||
13307985|NCT01281189|26530364|FG001|Overall Study|Lost to Follow-up|4|||
13307986|NCT01281189|26530363|FG000|Overall Study|Withdrawal by Subject|21|||
13307987|NCT01281189|26530364|FG001|Overall Study|Withdrawal by Subject|24|||
13307988|NCT01281189|26530363|FG000|Overall Study|Physician Decision|2|||
13307989|NCT01281189|26530364|FG001|Overall Study|Physician Decision|3|||
13307990|NCT01281189|26530363|FG000|Overall Study|Death|103|||
13307991|NCT01281189|26530364|FG001|Overall Study|Death|91|||
13307992|NCT01281189|26530363|FG000|Overall Study|Other|8|||
13307993|NCT01281189|26530364|FG001|Overall Study|Other|12|||
13307994|NCT01281137|26530395|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0|||
13307995|NCT01281137|26530396|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1|||
13307996|NCT01281137|26530395|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4|||
13307997|NCT01281137|26530396|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9|||
13307998|NCT01281137|26530395|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0|||
13307999|NCT01281137|26530396|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5|||
13308000|NCT01281137|26530395|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1|||
13308001|NCT01281137|26530396|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0|||
13308002|NCT01281137|26530395|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1|||
13308003|NCT01281137|26530396|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2|||
13308004|NCT01281124|26530404|FG000|Overall Study|Death|1|||
13308005|NCT01280981|26530415|FG000|Overall Study|Withdrawal by Subject|11|||
13308006|NCT01280981|26530415|FG000|Overall Study|Protocol Violation|2|||
13279646|NCT00245102|26453302|FG003|Overall Study|Adverse Event|1|||
13279647|NCT00245102|26453303|FG004|Overall Study|Adverse Event|0|||
13279648|NCT00245102|26453304|FG005|Overall Study|Adverse Event|2|||
13279649|NCT00245102|26453299|FG000|Overall Study|Decline in performance|0|||
13279650|NCT00245102|26453300|FG001|Overall Study|Decline in performance|2|||
13279651|NCT00245102|26453301|FG002|Overall Study|Decline in performance|0|||
13279652|NCT00245102|26453302|FG003|Overall Study|Decline in performance|1|||
13279653|NCT00245102|26453303|FG004|Overall Study|Decline in performance|0|||
13279654|NCT00245102|26453304|FG005|Overall Study|Decline in performance|2|||
13279655|NCT00245102|26453299|FG000|Overall Study|Participant needed surgery|0|||
13279656|NCT00245102|26453300|FG001|Overall Study|Participant needed surgery|0|||
13279657|NCT00245102|26453301|FG002|Overall Study|Participant needed surgery|1|||
13279658|NCT00245102|26453302|FG003|Overall Study|Participant needed surgery|0|||
13279659|NCT00245102|26453303|FG004|Overall Study|Participant needed surgery|0|||
13279660|NCT00245102|26453304|FG005|Overall Study|Participant needed surgery|0|||
13279661|NCT00245102|26453299|FG000|Overall Study|Clinical progression|1|||
13279662|NCT00245102|26453300|FG001|Overall Study|Clinical progression|0|||
13279663|NCT00245102|26453301|FG002|Overall Study|Clinical progression|0|||
13279664|NCT00245102|26453302|FG003|Overall Study|Clinical progression|0|||
13279665|NCT00245102|26453303|FG004|Overall Study|Clinical progression|0|||
13279666|NCT00245102|26453304|FG005|Overall Study|Clinical progression|0|||
13279667|NCT00245063|26453317|FG000|Overall Study|Adverse Event|6|||
13279668|NCT00245063|26453318|FG001|Overall Study|Adverse Event|5|||
13279669|NCT00245063|26453317|FG000|Overall Study|Death|1|||
13279670|NCT00245063|26453318|FG001|Overall Study|Death|0|||
13279671|NCT00245050|26453333|FG000|Overall Study|Adverse Event|3|||
13279672|NCT00245050|26453334|FG001|Overall Study|Adverse Event|2|||
13279673|NCT00245011|26453345|FG000|Overall Study|Lack of Efficacy|1|||
13279674|NCT00244933|26453351|FG000|Overall Study|Not response evaluable|2|||
13279675|NCT00244881|26453359|FG000|Overall Study|Withdrawal by Subject|3|||
13119848|NCT03012334|25936048|FG005|Period 4|Adverse Event|0|||
13279676|NCT00244855|26453374|FG000|Overall Study|Withdrawal by Subject|0|||
13279677|NCT00244855|26453375|FG001|Overall Study|Withdrawal by Subject|1|||
13279678|NCT00244764|26453384|FG000|Overall Study|Adverse Event|37|||
13279679|NCT00244764|26453384|FG000|Overall Study|Lost to Follow-up|23|||
13279680|NCT00244764|26453384|FG000|Overall Study|Withdrawal by Subject|12|||
13279681|NCT00244764|26453384|FG000|Overall Study|Disease Progression|13|||
13279682|NCT00244764|26453384|FG000|Overall Study|Protocol Violation|2|||
13279683|NCT00244764|26453384|FG000|Overall Study|Death|1|||
13279684|NCT00244764|26453384|FG000|Overall Study|Off Study Medication for >21 Days|1|||
13279685|NCT00244764|26453384|FG000|Overall Study|Declining Performance Status|1|||
13279686|NCT00244764|26453384|FG000|Overall Study|Participant was Hospitalized until Death|1|||
13279687|NCT00244764|26453384|FG000|Overall Study|Primary Investigator Discretion|2|||
13279688|NCT00244764|26453384|FG000|Overall Study|Sponsor Terminated Study|2|||
13279689|NCT00244764|26453384|FG000|Overall Study|Developed Secondary Malignancy|1|||
13279690|NCT00244751|26453491|FG000|Overall Study|Adverse Event|7|||
13279691|NCT00244751|26453492|FG001|Overall Study|Adverse Event|7|||
13279692|NCT00244751|26453493|FG002|Overall Study|Adverse Event|5|||
13279693|NCT00244751|26453491|FG000|Overall Study|Lost to Follow-up|0|||
13279694|NCT00244751|26453492|FG001|Overall Study|Lost to Follow-up|1|||
13279695|NCT00244751|26453493|FG002|Overall Study|Lost to Follow-up|0|||
13279696|NCT00244751|26453491|FG000|Overall Study|Protocol Violation|1|||
13279697|NCT00244751|26453492|FG001|Overall Study|Protocol Violation|0|||
13279698|NCT00244751|26453493|FG002|Overall Study|Protocol Violation|1|||
13279699|NCT00244751|26453491|FG000|Overall Study|Withdrawal by Subject|7|||
13279700|NCT00244751|26453492|FG001|Overall Study|Withdrawal by Subject|5|||
13279701|NCT00244751|26453493|FG002|Overall Study|Withdrawal by Subject|3|||
13279702|NCT00244751|26453491|FG000|Overall Study|Elevated liver enzymes|1|||
13279703|NCT00244751|26453492|FG001|Overall Study|Elevated liver enzymes|0|||
13279704|NCT00244751|26453493|FG002|Overall Study|Elevated liver enzymes|0|||
13279705|NCT00244751|26453491|FG000|Overall Study|Lack of compliance with protocol|0|||
13279706|NCT00244751|26453492|FG001|Overall Study|Lack of compliance with protocol|1|||
13279707|NCT00244751|26453493|FG002|Overall Study|Lack of compliance with protocol|0|||
13279708|NCT00244751|26453491|FG000|Overall Study|Safety reasons|0|||
13279709|NCT00244751|26453492|FG001|Overall Study|Safety reasons|1|||
13279710|NCT00244751|26453493|FG002|Overall Study|Safety reasons|0|||
13279711|NCT00244751|26453491|FG000|Overall Study|Participant randomized by mistake|0|||
13279712|NCT00244751|26453492|FG001|Overall Study|Participant randomized by mistake|0|||
13279713|NCT00244751|26453493|FG002|Overall Study|Participant randomized by mistake|1|||
13279714|NCT00244725|26453560|FG000|Overall Study|Lost to Follow-up|3|||
13279715|NCT00244725|26453561|FG001|Overall Study|Lost to Follow-up|4|||
13279716|NCT00244725|26453562|FG002|Overall Study|Lost to Follow-up|9|||
13279717|NCT00244725|26453563|FG003|Overall Study|Lost to Follow-up|2|||
13279718|NCT00244725|26453560|FG000|Overall Study|Withdrawal by Subject|9|||
13279719|NCT00244725|26453561|FG001|Overall Study|Withdrawal by Subject|7|||
13279720|NCT00244725|26453562|FG002|Overall Study|Withdrawal by Subject|7|||
13279721|NCT00244725|26453563|FG003|Overall Study|Withdrawal by Subject|8|||
13279722|NCT00244725|26453560|FG000|Overall Study|Not meet treatment eligibility criteria|1|||
13279723|NCT00244725|26453561|FG001|Overall Study|Not meet treatment eligibility criteria|2|||
13279724|NCT00244725|26453562|FG002|Overall Study|Not meet treatment eligibility criteria|0|||
13279725|NCT00244725|26453563|FG003|Overall Study|Not meet treatment eligibility criteria|0|||
13279726|NCT00244725|26453560|FG000|Overall Study|Physician Decision|3|||
13279727|NCT00244725|26453561|FG001|Overall Study|Physician Decision|0|||
13279728|NCT00244725|26453562|FG002|Overall Study|Physician Decision|1|||
13279729|NCT00244725|26453563|FG003|Overall Study|Physician Decision|2|||
13279730|NCT00244725|26453560|FG000|Overall Study|Adverse Events|3|||
13279731|NCT00244725|26453561|FG001|Overall Study|Adverse Events|1|||
13279732|NCT00244725|26453562|FG002|Overall Study|Adverse Events|4|||
13279733|NCT00244725|26453563|FG003|Overall Study|Adverse Events|4|||
13279734|NCT00244725|26453560|FG000|Overall Study|Withdrwal by participant|1|||
13279735|NCT00244725|26453561|FG001|Overall Study|Withdrwal by participant|0|||
13279736|NCT00244725|26453562|FG002|Overall Study|Withdrwal by participant|0|||
13279737|NCT00244725|26453563|FG003|Overall Study|Withdrwal by participant|1|||
13279738|NCT00244725|26453560|FG000|Overall Study|Liver function test abnormality|2|||
13279739|NCT00244725|26453561|FG001|Overall Study|Liver function test abnormality|0|||
13279740|NCT00244725|26453562|FG002|Overall Study|Liver function test abnormality|0|||
13279741|NCT00244725|26453563|FG003|Overall Study|Liver function test abnormality|1|||
13279742|NCT00244725|26453560|FG000|Overall Study|Sponsor withdrew the participant|1|||
13279743|NCT00244725|26453561|FG001|Overall Study|Sponsor withdrew the participant|0|||
13279744|NCT00244725|26453562|FG002|Overall Study|Sponsor withdrew the participant|0|||
13279745|NCT00244725|26453563|FG003|Overall Study|Sponsor withdrew the participant|1|||
13279746|NCT00244725|26453560|FG000|Overall Study|Mediciation Error|0|||
13279747|NCT00244725|26453561|FG001|Overall Study|Mediciation Error|1|||
13279748|NCT00244725|26453562|FG002|Overall Study|Mediciation Error|0|||
13279749|NCT00244725|26453563|FG003|Overall Study|Mediciation Error|0|||
13279750|NCT00244725|26453560|FG000|Overall Study|Rehab Refused to allow participantion|0|||
13279751|NCT00244725|26453561|FG001|Overall Study|Rehab Refused to allow participantion|1|||
13279752|NCT00244725|26453562|FG002|Overall Study|Rehab Refused to allow participantion|0|||
13279753|NCT00244725|26453563|FG003|Overall Study|Rehab Refused to allow participantion|0|||
13279754|NCT00244725|26453560|FG000|Overall Study|Headache|0|||
13279755|NCT00244725|26453561|FG001|Overall Study|Headache|1|||
13279756|NCT00244725|26453562|FG002|Overall Study|Headache|0|||
13279757|NCT00244725|26453563|FG003|Overall Study|Headache|0|||
13279758|NCT00244725|26453560|FG000|Overall Study|Received prohibited medication|0|||
13279759|NCT00244725|26453561|FG001|Overall Study|Received prohibited medication|1|||
13279760|NCT00244725|26453562|FG002|Overall Study|Received prohibited medication|0|||
13279761|NCT00244725|26453563|FG003|Overall Study|Received prohibited medication|1|||
13279762|NCT00244725|26453560|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
13279763|NCT00244725|26453561|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1|||
13279764|NCT00244725|26453562|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
13279765|NCT00244725|26453563|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
13279766|NCT00244725|26453560|FG000|Overall Study|Administrative reason|0|||
13279767|NCT00244725|26453561|FG001|Overall Study|Administrative reason|0|||
13279768|NCT00244725|26453562|FG002|Overall Study|Administrative reason|1|||
13279769|NCT00244725|26453563|FG003|Overall Study|Administrative reason|0|||
13279770|NCT00244725|26453560|FG000|Overall Study|Vomit|0|||
13279771|NCT00244725|26453561|FG001|Overall Study|Vomit|0|||
13279772|NCT00244725|26453562|FG002|Overall Study|Vomit|1|||
13279773|NCT00244725|26453563|FG003|Overall Study|Vomit|0|||
13279774|NCT00244725|26453560|FG000|Overall Study|Failed to follow-up|0|||
13279775|NCT00244725|26453561|FG001|Overall Study|Failed to follow-up|0|||
13279776|NCT00244725|26453562|FG002|Overall Study|Failed to follow-up|1|||
13279777|NCT00244725|26453563|FG003|Overall Study|Failed to follow-up|1|||
13279778|NCT00244712|26453602|FG000|Overall Study|Adverse Event|20|||
13279779|NCT00244712|26453603|FG001|Overall Study|Adverse Event|21|||
13279780|NCT00244712|26453602|FG000|Overall Study|Protocol-Defined Virologic Failure|8|||
13279781|NCT00244712|26453603|FG001|Overall Study|Protocol-Defined Virologic Failure|6|||
13279782|NCT00244712|26453602|FG000|Overall Study|Lack of Compliance|10|||
13279783|NCT00244712|26453603|FG001|Overall Study|Lack of Compliance|11|||
13279784|NCT00244712|26453602|FG000|Overall Study|Lost to Follow-up|45|||
13279785|NCT00244712|26453603|FG001|Overall Study|Lost to Follow-up|52|||
13279786|NCT00244712|26453602|FG000|Overall Study|Withdrawal by Subject|13|||
13279787|NCT00244712|26453603|FG001|Overall Study|Withdrawal by Subject|23|||
13279788|NCT00244712|26453602|FG000|Overall Study|Protocol Violation, disease progression|13|||
13279789|NCT00244712|26453603|FG001|Overall Study|Protocol Violation, disease progression|11|||
13279790|NCT00244621|26453630|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
13279791|NCT00244621|26453631|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
13279792|NCT00244621|26453632|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
13279793|NCT00244621|26453630|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
13279794|NCT00244621|26453631|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
13279795|NCT00244621|26453632|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
13279796|NCT00244621|26453630|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
13279797|NCT00244621|26453631|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
13279798|NCT00244621|26453632|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
13279799|NCT00244621|26453630|FG000|Double-blind Treatment Period|Multiple Reasons|2|||
13279800|NCT00244621|26453631|FG001|Double-blind Treatment Period|Multiple Reasons|1|||
13279801|NCT00244621|26453632|FG002|Double-blind Treatment Period|Multiple Reasons|1|||
13279802|NCT00244621|26453630|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
13279803|NCT00244621|26453631|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
13279804|NCT00244621|26453632|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
13279805|NCT00244621|26453630|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
13279806|NCT00244621|26453631|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
13279807|NCT00244621|26453632|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
13279808|NCT00244621|26453630|FG000|Open-label Treatment Period|Adverse Event|0|||
13279809|NCT00244621|26453631|FG001|Open-label Treatment Period|Adverse Event|0|||
13279810|NCT00244621|26453632|FG002|Open-label Treatment Period|Adverse Event|1|||
13279811|NCT00244621|26453630|FG000|Open-label Treatment Period|Moved abroad|0|||
13279812|NCT00244621|26453631|FG001|Open-label Treatment Period|Moved abroad|0|||
13279813|NCT00244621|26453632|FG002|Open-label Treatment Period|Moved abroad|1|||
13279814|NCT00244374|26453654|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105|||
13279815|NCT00244374|26453655|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
13279816|NCT00244374|26453656|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
13279817|NCT00244374|26453657|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
13279818|NCT00244374|26453658|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
13279819|NCT00244374|26453654|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17|||
13279820|NCT00244374|26453655|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
13279821|NCT00244374|26453656|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
13279822|NCT00244374|26453657|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
13279823|NCT00244374|26453658|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
13279824|NCT00244374|26453654|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14|||
13279825|NCT00244374|26453655|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
13279826|NCT00244374|26453656|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
13279827|NCT00244374|26453657|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
13279828|NCT00244374|26453658|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
13279829|NCT00244374|26453654|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1|||
13279830|NCT00244374|26453655|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
13279831|NCT00244374|26453656|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
13279832|NCT00244374|26453657|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
13279833|NCT00244374|26453658|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
13279834|NCT00244374|26453654|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172|||
13279835|NCT00244374|26453655|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
13279836|NCT00244374|26453656|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
13279837|NCT00244374|26453657|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
13279838|NCT00244374|26453658|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
13279839|NCT00244374|26453654|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51|||
13279840|NCT00244374|26453655|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
13279841|NCT00244374|26453656|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
13279842|NCT00244374|26453657|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
13279843|NCT00244374|26453658|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
13279844|NCT00244374|26453654|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34|||
13279845|NCT00244374|26453655|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
13279846|NCT00244374|26453656|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
13279847|NCT00244374|26453657|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
13279848|NCT00244374|26453658|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
13279849|NCT00244374|26453654|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4|||
13279850|NCT00244374|26453655|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
13279851|NCT00244374|26453656|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
13119849|NCT03012334|25936049|FG006|Period 4|Adverse Event|0|||
13279852|NCT00244374|26453657|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
13279853|NCT00244374|26453658|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
13279854|NCT00244374|26453654|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12|||
13119850|NCT03012334|25936050|FG007|Period 4|Adverse Event|0|||
13119851|NCT03012334|25936051|FG008|Period 4|Adverse Event|1|||
13119852|NCT03012334|25936052|FG009|Period 4|Adverse Event|0|||
13119853|NCT03012061|25936085|FG000|Overall Study|Withdrawal by Subject|1|||
13119854|NCT03012061|25936086|FG001|Overall Study|Withdrawal by Subject|5|||
13119855|NCT03012061|25936087|FG002|Overall Study|Withdrawal by Subject|4|||
13119856|NCT03012061|25936085|FG000|Overall Study|Investigator Site Closed|1|||
13119857|NCT03012061|25936086|FG001|Overall Study|Investigator Site Closed|2|||
13279855|NCT00244374|26453655|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
13279856|NCT00244374|26453656|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
13279857|NCT00244374|26453657|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
13279858|NCT00244374|26453658|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
13279859|NCT00243932|26453676|FG000|Stage 1: Dose Selection|Lost to Follow-up|2|||
13279860|NCT00243932|26453677|FG001|Stage 1: Dose Selection|Lost to Follow-up|0|||
13279861|NCT00243932|26453678|FG002|Stage 1: Dose Selection|Lost to Follow-up|0|||
13279862|NCT00243841|26453711|FG000|Overall Study|Physician Decision|0|||
13279863|NCT00243841|26453712|FG001|Overall Study|Physician Decision|0|||
13279864|NCT00243841|26453713|FG002|Overall Study|Physician Decision|1|||
13279865|NCT00243841|26453714|FG003|Overall Study|Physician Decision|0|||
13279866|NCT00243841|26453715|FG004|Overall Study|Physician Decision|0|||
13279867|NCT00243841|26453716|FG005|Overall Study|Physician Decision|2|||
13279868|NCT00243659|26453731|FG000|Overall Study|Withdrawal by Subject|1|||
13279869|NCT00243659|26453732|FG001|Overall Study|Withdrawal by Subject|1|||
13279870|NCT00243659|26453731|FG000|Overall Study|Protocol Violation|1|||
13279871|NCT00243659|26453732|FG001|Overall Study|Protocol Violation|2|||
13279872|NCT00243412|26453765|FG000|Overall Study|Death|0|||
13279873|NCT00243412|26453766|FG001|Overall Study|Death|1|||
13279874|NCT00243412|26453765|FG000|Overall Study|Adverse Event|4|||
13279875|NCT00243412|26453766|FG001|Overall Study|Adverse Event|2|||
13279876|NCT00243412|26453765|FG000|Overall Study|Lost to Follow-up|0|||
13279877|NCT00243412|26453766|FG001|Overall Study|Lost to Follow-up|1|||
13279878|NCT00243412|26453765|FG000|Overall Study|Physician Decision|1|||
13279879|NCT00243412|26453766|FG001|Overall Study|Physician Decision|1|||
13279880|NCT00243412|26453765|FG000|Overall Study|Withdrawal by Subject|4|||
13279881|NCT00243412|26453766|FG001|Overall Study|Withdrawal by Subject|5|||
13279882|NCT00243412|26453765|FG000|Overall Study|Other|1|||
13279883|NCT00243412|26453766|FG001|Overall Study|Other|1|||
13279884|NCT00243386|26453835|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1|||
13279885|NCT00243386|26453836|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
13279886|NCT00243386|26453837|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
13279887|NCT00243386|26453835|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1|||
13279888|NCT00243386|26453836|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
13279889|NCT00243386|26453837|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
13279890|NCT00243386|26453835|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2|||
13279891|NCT00243386|26453836|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
13279892|NCT00243386|26453837|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
13279893|NCT00243386|26453835|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1|||
13279894|NCT00243386|26453836|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
13279895|NCT00243386|26453837|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
13279896|NCT00243386|26453835|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1|||
13279897|NCT00243386|26453836|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
13279898|NCT00243386|26453837|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
13279899|NCT00243386|26453835|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1|||
13279900|NCT00243386|26453836|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
13279901|NCT00243386|26453837|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
13279902|NCT00243386|26453835|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
13279903|NCT00243386|26453836|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2|||
13279904|NCT00243386|26453837|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
13279905|NCT00243386|26453835|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
13279906|NCT00243386|26453836|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1|||
13279907|NCT00243386|26453837|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
13279908|NCT00243347|26453844|FG000|Overall Study|Lack of Efficacy|4|||
13279909|NCT00243347|26453844|FG000|Overall Study|Adverse Event|2|||
13279910|NCT00243347|26453844|FG000|Overall Study|Death|1|||
13279911|NCT00243347|26453844|FG000|Overall Study|Withdrawal by Subject|5|||
13279912|NCT00243347|26453844|FG000|Overall Study|Condition worsened|7|||
13279913|NCT00243269|26453871|FG000|Overall Study|Protocol Violation|2|||
13279914|NCT00243269|26453872|FG001|Overall Study|Protocol Violation|1|||
13279915|NCT00243269|26453873|FG002|Overall Study|Protocol Violation|0|||
13279916|NCT00243269|26453874|FG003|Overall Study|Protocol Violation|1|||
13279917|NCT00243269|26453871|FG000|Overall Study|Lost to Follow-up|1|||
13279918|NCT00243269|26453872|FG001|Overall Study|Lost to Follow-up|0|||
13279919|NCT00243269|26453873|FG002|Overall Study|Lost to Follow-up|1|||
13279920|NCT00243269|26453874|FG003|Overall Study|Lost to Follow-up|3|||
13279921|NCT00243230|26453960|FG000|Double-Blind Period|Adverse Event|0|||
13279922|NCT00243230|26453961|FG001|Double-Blind Period|Adverse Event|2|||
13279923|NCT00243230|26453962|FG002|Double-Blind Period|Adverse Event|2|||
13279924|NCT00243230|26453963|FG003|Double-Blind Period|Adverse Event|0|||
13279925|NCT00243230|26453960|FG000|Double-Blind Period|Withdrawal by Subject|1|||
13279926|NCT00243230|26453961|FG001|Double-Blind Period|Withdrawal by Subject|0|||
13279927|NCT00243230|26453962|FG002|Double-Blind Period|Withdrawal by Subject|0|||
13279928|NCT00243230|26453963|FG003|Double-Blind Period|Withdrawal by Subject|0|||
13279929|NCT00243230|26453960|FG000|Double-Blind Period|Protocol Violation|0|||
13279930|NCT00243230|26453961|FG001|Double-Blind Period|Protocol Violation|0|||
13279931|NCT00243230|26453962|FG002|Double-Blind Period|Protocol Violation|1|||
13279932|NCT00243230|26453963|FG003|Double-Blind Period|Protocol Violation|0|||
13279933|NCT00243230|26453960|FG000|Double-Blind Period|Randomized but Not Treated|0|||
13279934|NCT00243230|26453961|FG001|Double-Blind Period|Randomized but Not Treated|0|||
13279935|NCT00243230|26453962|FG002|Double-Blind Period|Randomized but Not Treated|2|||
13279936|NCT00243230|26453963|FG003|Double-Blind Period|Randomized but Not Treated|0|||
13279937|NCT00243230|26453960|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5|||
13279938|NCT00243230|26453961|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3|||
13279939|NCT00243230|26453962|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14|||
13279940|NCT00243230|26453963|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0|||
13279941|NCT00243230|26453960|FG000|Open Label Period|Adverse Event|0|||
13279942|NCT00243230|26453961|FG001|Open Label Period|Adverse Event|0|||
13279943|NCT00243230|26453962|FG002|Open Label Period|Adverse Event|0|||
13279944|NCT00243230|26453963|FG003|Open Label Period|Adverse Event|2|||
13279945|NCT00243230|26453960|FG000|Open Label Period|Treatment Failure - Virologic Failure|0|||
13279946|NCT00243230|26453961|FG001|Open Label Period|Treatment Failure - Virologic Failure|0|||
13279947|NCT00243230|26453962|FG002|Open Label Period|Treatment Failure - Virologic Failure|0|||
13279948|NCT00243230|26453963|FG003|Open Label Period|Treatment Failure - Virologic Failure|13|||
13279949|NCT00243230|26453960|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0|||
13279950|NCT00243230|26453961|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0|||
13279951|NCT00243230|26453962|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0|||
13279952|NCT00243230|26453963|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1|||
13279953|NCT00243230|26453960|FG000|Open Label Period|Lost to Follow-up|0|||
13279954|NCT00243230|26453961|FG001|Open Label Period|Lost to Follow-up|0|||
13279955|NCT00243230|26453962|FG002|Open Label Period|Lost to Follow-up|0|||
13279956|NCT00243230|26453963|FG003|Open Label Period|Lost to Follow-up|2|||
13279957|NCT00243230|26453960|FG000|Open Label Period|Withdrawal by Subject|0|||
13279958|NCT00243230|26453961|FG001|Open Label Period|Withdrawal by Subject|0|||
13279959|NCT00243230|26453962|FG002|Open Label Period|Withdrawal by Subject|0|||
13279960|NCT00243230|26453963|FG003|Open Label Period|Withdrawal by Subject|2|||
13279961|NCT00243230|26453960|FG000|Open Label Period|Protocol Violation|0|||
13279962|NCT00243230|26453961|FG001|Open Label Period|Protocol Violation|0|||
13279963|NCT00243230|26453962|FG002|Open Label Period|Protocol Violation|0|||
13279964|NCT00243230|26453963|FG003|Open Label Period|Protocol Violation|2|||
13279965|NCT00243230|26453960|FG000|Open Label Period|Administrative Reason|0|||
13279966|NCT00243230|26453961|FG001|Open Label Period|Administrative Reason|0|||
13279967|NCT00243230|26453962|FG002|Open Label Period|Administrative Reason|0|||
13279968|NCT00243230|26453963|FG003|Open Label Period|Administrative Reason|63|||
13279969|NCT00243074|26453975|FG000|Overall Study|Ineligible|6|||
13279970|NCT00243074|26453975|FG000|Overall Study|Adverse Event|6|||
13279971|NCT00243074|26453975|FG000|Overall Study|Withdrawal by Subject|2|||
13279972|NCT00243074|26453975|FG000|Overall Study|Lack of Efficacy|36|||
13279973|NCT00243074|26453975|FG000|Overall Study|Death|2|||
13279974|NCT00243074|26453975|FG000|Overall Study|not protocol specified|1|||
13279975|NCT00243074|26453975|FG000|Overall Study|Did not receive any treatment|1|||
13279976|NCT00243022|26454002|FG000|Overall Study|Withdrawal by Subject|1|||
13279977|NCT00243022|26454003|FG001|Overall Study|Withdrawal by Subject|0|||
13279978|NCT00243022|26454002|FG000|Overall Study|Death|1|||
13279979|NCT00243022|26454003|FG001|Overall Study|Death|0|||
13279980|NCT00243022|26454002|FG000|Overall Study|Difficult Travel Distance|0|||
13279981|NCT00243022|26454003|FG001|Overall Study|Difficult Travel Distance|1|||
13279982|NCT00242658|26454018|FG000|Overall Study|Lost to Follow-up|22|||
13279983|NCT00242658|26454019|FG001|Overall Study|Lost to Follow-up|19|||
13279984|NCT00242580|26454052|FG000|Overall Study|Adverse Event|3|||
13279985|NCT00242580|26454053|FG001|Overall Study|Adverse Event|0|||
13279986|NCT00242580|26454054|FG002|Overall Study|Adverse Event|2|||
13279987|NCT00242580|26454052|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
13279988|NCT00242580|26454053|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
13279989|NCT00242580|26454054|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
13279990|NCT00242580|26454052|FG000|Overall Study|Protocol Violation|0|||
13279991|NCT00242580|26454053|FG001|Overall Study|Protocol Violation|0|||
13279992|NCT00242580|26454054|FG002|Overall Study|Protocol Violation|1|||
13279993|NCT00242580|26454052|FG000|Overall Study|Subject withdrew consent|2|||
13279994|NCT00242580|26454053|FG001|Overall Study|Subject withdrew consent|2|||
13279995|NCT00242580|26454054|FG002|Overall Study|Subject withdrew consent|5|||
13279996|NCT00242580|26454052|FG000|Overall Study|Lost to Follow-up|0|||
13279997|NCT00242580|26454053|FG001|Overall Study|Lost to Follow-up|3|||
13279998|NCT00242580|26454054|FG002|Overall Study|Lost to Follow-up|0|||
13279999|NCT00242580|26454052|FG000|Overall Study|Death|1|||
13280000|NCT00242580|26454053|FG001|Overall Study|Death|2|||
13280001|NCT00242580|26454054|FG002|Overall Study|Death|1|||
13280002|NCT00242567|26454077|FG000|Overall Study|Adverse Event|70|||
13280003|NCT00242567|26454078|FG001|Overall Study|Adverse Event|43|||
13280004|NCT00242567|26454077|FG000|Overall Study|Disease Progression|17|||
13280005|NCT00242567|26454078|FG001|Overall Study|Disease Progression|22|||
13280006|NCT00242567|26454077|FG000|Overall Study|Symptomatic deterioration|9|||
13280007|NCT00242567|26454078|FG001|Overall Study|Symptomatic deterioration|3|||
13280008|NCT00242567|26454077|FG000|Overall Study|Lack of Efficacy|2|||
13280009|NCT00242567|26454078|FG001|Overall Study|Lack of Efficacy|2|||
13280010|NCT00242567|26454077|FG000|Overall Study|Lost to Follow-up|9|||
13280011|NCT00242567|26454078|FG001|Overall Study|Lost to Follow-up|19|||
13280012|NCT00242567|26454077|FG000|Overall Study|Withdrawal by Subject|33|||
13280013|NCT00242567|26454078|FG001|Overall Study|Withdrawal by Subject|28|||
13280014|NCT00242567|26454077|FG000|Overall Study|Protocol Violation|12|||
13280015|NCT00242567|26454078|FG001|Overall Study|Protocol Violation|12|||
13280016|NCT00242567|26454077|FG000|Overall Study|Use of an inhibitor of bone resorption|0|||
13280017|NCT00242567|26454078|FG001|Overall Study|Use of an inhibitor of bone resorption|2|||
13280018|NCT00242567|26454077|FG000|Overall Study|Other|14|||
13280019|NCT00242567|26454078|FG001|Overall Study|Other|9|||
13280020|NCT00241644|26454173|FG000|First Efficacy Period (Year 1)|Adverse Event|46|||
13280021|NCT00241644|26454174|FG001|First Efficacy Period (Year 1)|Adverse Event|45|||
13280022|NCT00241644|26454175|FG002|First Efficacy Period (Year 1)|Adverse Event|45|||
13280023|NCT00241644|26454176|FG003|First Efficacy Period (Year 1)|Adverse Event|91|||
13280024|NCT00241644|26454173|FG000|First Efficacy Period (Year 1)|Protocol Violation|3|||
13280025|NCT00241644|26454174|FG001|First Efficacy Period (Year 1)|Protocol Violation|5|||
13280026|NCT00241644|26454175|FG002|First Efficacy Period (Year 1)|Protocol Violation|4|||
13280027|NCT00241644|26454176|FG003|First Efficacy Period (Year 1)|Protocol Violation|8|||
13280028|NCT00241644|26454173|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59|||
13280029|NCT00241644|26454174|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74|||
13280030|NCT00241644|26454175|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81|||
13280031|NCT00241644|26454176|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133|||
13280032|NCT00241644|26454173|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
13280033|NCT00241644|26454174|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142|||
13280034|NCT00241644|26454175|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
13280035|NCT00241644|26454176|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258|||
13280036|NCT00241644|26454173|FG000|First Efficacy Period (Year 1)|Non-compliance|2|||
13280037|NCT00241644|26454174|FG001|First Efficacy Period (Year 1)|Non-compliance|1|||
13280038|NCT00241644|26454175|FG002|First Efficacy Period (Year 1)|Non-compliance|2|||
13280039|NCT00241644|26454176|FG003|First Efficacy Period (Year 1)|Non-compliance|3|||
13280040|NCT00241644|26454173|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1|||
13280041|NCT00241644|26454174|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0|||
13280042|NCT00241644|26454175|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0|||
13280043|NCT00241644|26454176|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1|||
13280044|NCT00241644|26454173|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
13280045|NCT00241644|26454174|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
13280046|NCT00241644|26454175|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1|||
13280047|NCT00241644|26454176|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
13280048|NCT00241644|26454173|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
13280049|NCT00241644|26454174|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
13280050|NCT00241644|26454175|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
13280051|NCT00241644|26454176|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
13280052|NCT00241644|26454173|FG000|Second Efficacy Period (Year 2)|Adverse Event|11|||
13280053|NCT00241644|26454174|FG001|Second Efficacy Period (Year 2)|Adverse Event|9|||
13280054|NCT00241644|26454175|FG002|Second Efficacy Period (Year 2)|Adverse Event|12|||
13280055|NCT00241644|26454176|FG003|Second Efficacy Period (Year 2)|Adverse Event|20|||
13280056|NCT00241644|26454173|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2|||
13280057|NCT00241644|26454174|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1|||
13280058|NCT00241644|26454175|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2|||
13280059|NCT00241644|26454176|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3|||
13280060|NCT00241644|26454173|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4|||
13280061|NCT00241644|26454174|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3|||
13280062|NCT00241644|26454175|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2|||
13280063|NCT00241644|26454176|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7|||
13280064|NCT00241644|26454173|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
13280065|NCT00241644|26454174|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
13280066|NCT00241644|26454175|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46|||
13280067|NCT00241644|26454176|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86|||
13280068|NCT00241644|26454173|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
13280069|NCT00241644|26454174|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
13280070|NCT00241644|26454175|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
13280071|NCT00241644|26454176|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
13280072|NCT00241631|26454193|FG000|Run in (2 Weeks)|Physician Decision|3|||
13280073|NCT00241631|26454194|FG001|Run in (2 Weeks)|Physician Decision|3|||
13280074|NCT00241631|26454193|FG000|Phase 1 (4 Weeks)|sore throat|1|||
13280075|NCT00241631|26454194|FG001|Phase 1 (4 Weeks)|sore throat|0|||
13119858|NCT03012061|25936087|FG002|Overall Study|Investigator Site Closed|0|||
13119859|NCT03012061|25936085|FG000|Overall Study|Lost to Follow-up|2|||
13119860|NCT03012061|25936086|FG001|Overall Study|Lost to Follow-up|1|||
13119861|NCT03012061|25936087|FG002|Overall Study|Lost to Follow-up|0|||
13119862|NCT03012061|25936085|FG000|Overall Study|Study closed/ Terminated|0|||
13119863|NCT03012061|25936086|FG001|Overall Study|Study closed/ Terminated|0|||
13119864|NCT03012061|25936087|FG002|Overall Study|Study closed/ Terminated|1|||
13119865|NCT03012061|25936085|FG000|Overall Study|Met Protocol Withdrawal Criterion|0|||
13119866|NCT03012061|25936086|FG001|Overall Study|Met Protocol Withdrawal Criterion|0|||
13119867|NCT03012061|25936087|FG002|Overall Study|Met Protocol Withdrawal Criterion|1|||
13119868|NCT03012061|25936085|FG000|Overall Study|Protocol Violation|0|||
13119869|NCT03012061|25936086|FG001|Overall Study|Protocol Violation|0|||
13119870|NCT03012061|25936087|FG002|Overall Study|Protocol Violation|2|||
13119871|NCT03012061|25936085|FG000|Overall Study|Lack of Efficacy|0|||
13119872|NCT03012061|25936086|FG001|Overall Study|Lack of Efficacy|1|||
13119873|NCT03012061|25936087|FG002|Overall Study|Lack of Efficacy|0|||
13119874|NCT03012061|25936085|FG000|Overall Study|Adverse Event|2|||
13119875|NCT03012061|25936086|FG001|Overall Study|Adverse Event|0|||
13119876|NCT03012061|25936087|FG002|Overall Study|Adverse Event|0|||
13119877|NCT03011892|25936179|FG000|Double Blind (DB) Period|Adverse Event|0|||
13119878|NCT03011892|25936180|FG001|Double Blind (DB) Period|Adverse Event|1|||
13119879|NCT03011892|25936181|FG002|Double Blind (DB) Period|Adverse Event|1|||
13119880|NCT03011892|25936182|FG003|Double Blind (DB) Period|Adverse Event|0|||
13119881|NCT03011892|25936183|FG004|Double Blind (DB) Period|Adverse Event|0|||
13119882|NCT03011892|25936184|FG005|Double Blind (DB) Period|Adverse Event|0|||
13119883|NCT03011892|25936185|FG006|Double Blind (DB) Period|Adverse Event|0|||
13119884|NCT03011892|25936186|FG007|Double Blind (DB) Period|Adverse Event|0|||
13119885|NCT03011892|25936187|FG008|Double Blind (DB) Period|Adverse Event|0|||
13119886|NCT03011892|25936188|FG009|Double Blind (DB) Period|Adverse Event|0|||
13119887|NCT03011892|25936189|FG010|Double Blind (DB) Period|Adverse Event|0|||
13119888|NCT03011892|25936190|FG011|Double Blind (DB) Period|Adverse Event|0|||
13119889|NCT03011892|25936179|FG000|Double Blind (DB) Period|Lack of Efficacy|1|||
13119890|NCT03011892|25936180|FG001|Double Blind (DB) Period|Lack of Efficacy|0|||
13119891|NCT03011892|25936181|FG002|Double Blind (DB) Period|Lack of Efficacy|0|||
13119892|NCT03011892|25936182|FG003|Double Blind (DB) Period|Lack of Efficacy|0|||
13119893|NCT03011892|25936183|FG004|Double Blind (DB) Period|Lack of Efficacy|0|||
13119894|NCT03011892|25936184|FG005|Double Blind (DB) Period|Lack of Efficacy|0|||
13119895|NCT03011892|25936185|FG006|Double Blind (DB) Period|Lack of Efficacy|0|||
13119896|NCT03011892|25936186|FG007|Double Blind (DB) Period|Lack of Efficacy|0|||
13119897|NCT03011892|25936187|FG008|Double Blind (DB) Period|Lack of Efficacy|0|||
13119898|NCT03011892|25936188|FG009|Double Blind (DB) Period|Lack of Efficacy|0|||
13119899|NCT03011892|25936189|FG010|Double Blind (DB) Period|Lack of Efficacy|0|||
13119900|NCT03011892|25936190|FG011|Double Blind (DB) Period|Lack of Efficacy|0|||
13119901|NCT03011892|25936179|FG000|Double Blind (DB) Period|Lost to Follow-up|0|||
13119902|NCT03011892|25936180|FG001|Double Blind (DB) Period|Lost to Follow-up|3|||
13119903|NCT03011892|25936181|FG002|Double Blind (DB) Period|Lost to Follow-up|2|||
13119904|NCT03011892|25936182|FG003|Double Blind (DB) Period|Lost to Follow-up|5|||
13119905|NCT03011892|25936183|FG004|Double Blind (DB) Period|Lost to Follow-up|0|||
13119906|NCT03011892|25936184|FG005|Double Blind (DB) Period|Lost to Follow-up|2|||
13119907|NCT03011892|25936185|FG006|Double Blind (DB) Period|Lost to Follow-up|0|||
13119908|NCT03011892|25936186|FG007|Double Blind (DB) Period|Lost to Follow-up|0|||
13119909|NCT03011892|25936187|FG008|Double Blind (DB) Period|Lost to Follow-up|0|||
13280076|NCT00241631|26454193|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
13280077|NCT00241631|26454194|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
13280078|NCT00241631|26454193|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3|||
13280079|NCT00241631|26454194|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0|||
13280080|NCT00241631|26454193|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0|||
13280081|NCT00241631|26454194|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1|||
13280082|NCT00241358|26454235|FG000|Overall Study|Determined to be not ineligible|0|||
13280083|NCT00241358|26454236|FG001|Overall Study|Determined to be not ineligible|1|||
13280084|NCT00241358|26454237|FG002|Overall Study|Determined to be not ineligible|1|||
13280085|NCT00241280|26454252|FG000|Overall Study|Adverse Event|2|||
13280086|NCT00241280|26454253|FG001|Overall Study|Adverse Event|6|||
13280087|NCT00241280|26454252|FG000|Overall Study|Discomfort|11|||
13280088|NCT00241280|26454253|FG001|Overall Study|Discomfort|16|||
13280089|NCT00241280|26454252|FG000|Overall Study|Pregnancy|1|||
13280090|NCT00241280|26454253|FG001|Overall Study|Pregnancy|5|||
13119910|NCT03011892|25936188|FG009|Double Blind (DB) Period|Lost to Follow-up|0|||
13119911|NCT03011892|25936189|FG010|Double Blind (DB) Period|Lost to Follow-up|0|||
13119912|NCT03011892|25936190|FG011|Double Blind (DB) Period|Lost to Follow-up|0|||
13280091|NCT00241280|26454252|FG000|Overall Study|Lost to Follow-up|5|||
13280092|NCT00241280|26454253|FG001|Overall Study|Lost to Follow-up|8|||
13280093|NCT00241280|26454252|FG000|Overall Study|Withdrawal by Subject|7|||
13280094|NCT00241280|26454253|FG001|Overall Study|Withdrawal by Subject|4|||
13280095|NCT00241280|26454252|FG000|Overall Study|Protocol Violation|4|||
13280096|NCT00241280|26454253|FG001|Overall Study|Protocol Violation|10|||
13280097|NCT00241280|26454252|FG000|Overall Study|Relocation|4|||
13280098|NCT00241280|26454253|FG001|Overall Study|Relocation|4|||
13280099|NCT00241280|26454252|FG000|Overall Study|Unsatisfactory Physiological Response|1|||
13280100|NCT00241280|26454253|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
13280101|NCT00241280|26454252|FG000|Overall Study|Unsatisfactory Visual Response|1|||
13119913|NCT03011892|25936179|FG000|Double Blind (DB) Period|Other|1|||
13119914|NCT03011892|25936180|FG001|Double Blind (DB) Period|Other|1|||
13119915|NCT03011892|25936181|FG002|Double Blind (DB) Period|Other|1|||
13119916|NCT03011892|25936182|FG003|Double Blind (DB) Period|Other|0|||
13119917|NCT03011892|25936183|FG004|Double Blind (DB) Period|Other|1|||
13119918|NCT03011892|25936184|FG005|Double Blind (DB) Period|Other|0|||
13280102|NCT00241280|26454253|FG001|Overall Study|Unsatisfactory Visual Response|1|||
13280103|NCT00241280|26454252|FG000|Overall Study|Diabetic|1|||
13280104|NCT00241280|26454253|FG001|Overall Study|Diabetic|0|||
13280105|NCT00241280|26454252|FG000|Overall Study|Subject Ineligible/Dispensed|9|||
13280106|NCT00241280|26454253|FG001|Overall Study|Subject Ineligible/Dispensed|6|||
13280107|NCT00241280|26454252|FG000|Overall Study|Dispensed incorrect test article|1|||
13280108|NCT00241280|26454253|FG001|Overall Study|Dispensed incorrect test article|2|||
13280109|NCT00241280|26454252|FG000|Overall Study|Unacceptable Fit|0|||
13280110|NCT00241280|26454253|FG001|Overall Study|Unacceptable Fit|1|||
13280111|NCT00241280|26454252|FG000|Overall Study|Scheduling Conflict|0|||
13280112|NCT00241280|26454253|FG001|Overall Study|Scheduling Conflict|2|||
13280113|NCT00241280|26454252|FG000|Overall Study|History of Ocular Surgery|0|||
13280114|NCT00241280|26454253|FG001|Overall Study|History of Ocular Surgery|1|||
13280115|NCT00241280|26454252|FG000|Overall Study|Coating on Lens|1|||
13280116|NCT00241280|26454253|FG001|Overall Study|Coating on Lens|0|||
13280117|NCT00241280|26454252|FG000|Overall Study|Excessive Dryness|0|||
13280118|NCT00241280|26454253|FG001|Overall Study|Excessive Dryness|1|||
13280119|NCT00240331|26454278|FG000|Overall Study|Withdrawal by Subject|125|||
13280120|NCT00240331|26454279|FG001|Overall Study|Withdrawal by Subject|132|||
13280121|NCT00240331|26454278|FG000|Overall Study|Option selected by investigator|1|||
13280122|NCT00240331|26454279|FG001|Overall Study|Option selected by investigator|2|||
13280123|NCT00240097|26454291|FG000|Part I|Adverse Event|1|||
13280124|NCT00240097|26454291|FG000|Part I|Death|1|||
13280125|NCT00240097|26454291|FG000|Part I|histology|1|||
13280126|NCT00240097|26454291|FG000|Part I|unevaluable|1|||
13280127|NCT00240097|26454291|FG000|Part II|did not continue from Part I|23|||
13291594|NCT00151775|26483489|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
13291595|NCT00151775|26483490|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
13291596|NCT00151775|26483491|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
13291597|NCT00151775|26483492|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
13291598|NCT00151775|26483493|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1|||
13291599|NCT00151775|26483494|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
13291600|NCT00151775|26483495|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
13291601|NCT00151775|26483496|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
13291602|NCT00151775|26483497|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
13291603|NCT00151775|26483498|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
13291604|NCT00151775|26483487|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
13291605|NCT00151775|26483488|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
13291606|NCT00151775|26483489|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1|||
13291607|NCT00151775|26483490|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
13291608|NCT00151775|26483491|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
13291609|NCT00151775|26483492|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
13291610|NCT00151775|26483493|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
13291611|NCT00151775|26483494|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
13291612|NCT00151775|26483495|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
13291613|NCT00151775|26483496|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
13291614|NCT00151775|26483497|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
13291615|NCT00151775|26483498|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
13291616|NCT00151775|26483487|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
13291617|NCT00151775|26483488|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
13291618|NCT00151775|26483489|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1|||
13291619|NCT00151775|26483490|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
13291620|NCT00151775|26483491|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
13291621|NCT00151775|26483492|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
13119919|NCT03011892|25936185|FG006|Double Blind (DB) Period|Other|0|||
13119920|NCT03011892|25936186|FG007|Double Blind (DB) Period|Other|0|||
13280128|NCT00240071|26454298|FG000|Overall Study|Withdrawal by Subject|3|||
13280129|NCT00245037|26454354|FG000|Overall Study|Death|17|||
13280130|NCT00241839|26454373|FG000|Overall Study|Withdrawal by Subject|18|||
13280131|NCT00241839|26454374|FG001|Overall Study|Withdrawal by Subject|17|||
13280132|NCT00241839|26454373|FG000|Overall Study|Adverse Event|1|||
13280133|NCT00241839|26454374|FG001|Overall Study|Adverse Event|1|||
13280134|NCT00248287|26454393|FG000|Overall Study|Adverse Event|11|||
13280135|NCT00248287|26454394|FG001|Overall Study|Adverse Event|10|||
13280136|NCT00248287|26454393|FG000|Overall Study|Death|1|||
13280137|NCT00248287|26454394|FG001|Overall Study|Death|0|||
13280138|NCT00248287|26454393|FG000|Overall Study|Lost to Follow-up|0|||
13280139|NCT00248287|26454394|FG001|Overall Study|Lost to Follow-up|1|||
13280140|NCT00248287|26454393|FG000|Overall Study|Investigator Request|4|||
13280141|NCT00248287|26454394|FG001|Overall Study|Investigator Request|3|||
13280142|NCT00248287|26454393|FG000|Overall Study|Patient Request|5|||
13280143|NCT00248287|26454394|FG001|Overall Study|Patient Request|3|||
13280144|NCT00248287|26454393|FG000|Overall Study|Other|3|||
13280145|NCT00248287|26454394|FG001|Overall Study|Other|2|||
13291622|NCT00151775|26483493|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
13291623|NCT00151775|26483494|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
13291624|NCT00151775|26483495|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
13291625|NCT00151775|26483496|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
13291626|NCT00151775|26483497|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
13291627|NCT00151775|26483498|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
13291628|NCT00151775|26483487|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
13291629|NCT00151775|26483488|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
13291630|NCT00151775|26483489|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
13291631|NCT00151775|26483490|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
13291632|NCT00151775|26483491|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
13291633|NCT00151775|26483492|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
13291634|NCT00151775|26483493|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
13291635|NCT00151775|26483494|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
13291636|NCT00151775|26483495|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
13291637|NCT00151775|26483496|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
13291638|NCT00151775|26483497|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
13291639|NCT00151775|26483498|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1|||
13291640|NCT00151775|26483487|FG000|Period 4: Open Label|Increased blood pressure|0|||
13291641|NCT00151775|26483488|FG001|Period 4: Open Label|Increased blood pressure|0|||
13291642|NCT00151775|26483489|FG002|Period 4: Open Label|Increased blood pressure|0|||
13291643|NCT00151775|26483490|FG003|Period 4: Open Label|Increased blood pressure|0|||
13291644|NCT00151775|26483491|FG004|Period 4: Open Label|Increased blood pressure|1|||
13291645|NCT00151775|26483492|FG005|Period 4: Open Label|Increased blood pressure|0|||
13291646|NCT00151775|26483493|FG006|Period 4: Open Label|Increased blood pressure|0|||
13291647|NCT00151775|26483494|FG007|Period 4: Open Label|Increased blood pressure|0|||
13291648|NCT00151775|26483495|FG008|Period 4: Open Label|Increased blood pressure|0|||
13291649|NCT00151775|26483496|FG009|Period 4: Open Label|Increased blood pressure|1|||
13291650|NCT00151775|26483497|FG010|Period 4: Open Label|Increased blood pressure|0|||
13291651|NCT00151775|26483498|FG011|Period 4: Open Label|Increased blood pressure|0|||
13291652|NCT00151775|26483487|FG000|Period 4: Open Label|Withdrawal by Subject|0|||
13291653|NCT00151775|26483488|FG001|Period 4: Open Label|Withdrawal by Subject|0|||
13291654|NCT00151775|26483489|FG002|Period 4: Open Label|Withdrawal by Subject|0|||
13291655|NCT00151775|26483490|FG003|Period 4: Open Label|Withdrawal by Subject|0|||
13291656|NCT00151775|26483491|FG004|Period 4: Open Label|Withdrawal by Subject|5|||
13291657|NCT00151775|26483492|FG005|Period 4: Open Label|Withdrawal by Subject|0|||
13291658|NCT00151775|26483493|FG006|Period 4: Open Label|Withdrawal by Subject|0|||
13291659|NCT00151775|26483494|FG007|Period 4: Open Label|Withdrawal by Subject|0|||
13291660|NCT00151775|26483495|FG008|Period 4: Open Label|Withdrawal by Subject|0|||
13291661|NCT00151775|26483496|FG009|Period 4: Open Label|Withdrawal by Subject|2|||
13291662|NCT00151775|26483497|FG010|Period 4: Open Label|Withdrawal by Subject|0|||
13291663|NCT00151775|26483498|FG011|Period 4: Open Label|Withdrawal by Subject|0|||
13291664|NCT00151775|26483487|FG000|Period 4: Open Label|Adverse Event|0|||
13291665|NCT00151775|26483488|FG001|Period 4: Open Label|Adverse Event|0|||
13119921|NCT03011892|25936187|FG008|Double Blind (DB) Period|Other|0|||
13291666|NCT00151775|26483489|FG002|Period 4: Open Label|Adverse Event|0|||
13291667|NCT00151775|26483490|FG003|Period 4: Open Label|Adverse Event|0|||
13291668|NCT00151775|26483491|FG004|Period 4: Open Label|Adverse Event|1|||
13119922|NCT03011892|25936188|FG009|Double Blind (DB) Period|Other|0|||
13291669|NCT00151775|26483492|FG005|Period 4: Open Label|Adverse Event|0|||
13291670|NCT00151775|26483493|FG006|Period 4: Open Label|Adverse Event|0|||
13291671|NCT00151775|26483494|FG007|Period 4: Open Label|Adverse Event|0|||
13291672|NCT00151775|26483495|FG008|Period 4: Open Label|Adverse Event|0|||
13291673|NCT00151775|26483496|FG009|Period 4: Open Label|Adverse Event|2|||
13280146|NCT03809663|26454454|FG000|Overall Study|Decision by sponsor|24|||
13280147|NCT03809663|26454455|FG001|Overall Study|Decision by sponsor|18|||
13280148|NCT03809663|26454456|FG002|Overall Study|Decision by sponsor|20|||
13280149|NCT03809663|26454457|FG003|Overall Study|Decision by sponsor|20|||
13280150|NCT03809663|26454458|FG004|Overall Study|Decision by sponsor|0|||
13280151|NCT03809663|26454459|FG005|Overall Study|Decision by sponsor|0|||
13280152|NCT03809663|26454454|FG000|Overall Study|Withdrawal by Subject|26|||
13280153|NCT03809663|26454455|FG001|Overall Study|Withdrawal by Subject|22|||
13280154|NCT03809663|26454456|FG002|Overall Study|Withdrawal by Subject|27|||
13280155|NCT03809663|26454457|FG003|Overall Study|Withdrawal by Subject|26|||
13280156|NCT03809663|26454458|FG004|Overall Study|Withdrawal by Subject|0|||
13280157|NCT03809663|26454459|FG005|Overall Study|Withdrawal by Subject|0|||
13280158|NCT03809663|26454454|FG000|Overall Study|Lost to Follow-up|1|||
13280159|NCT03809663|26454455|FG001|Overall Study|Lost to Follow-up|4|||
13280160|NCT03809663|26454456|FG002|Overall Study|Lost to Follow-up|1|||
13280161|NCT03809663|26454457|FG003|Overall Study|Lost to Follow-up|1|||
13280162|NCT03809663|26454458|FG004|Overall Study|Lost to Follow-up|0|||
13280163|NCT03809663|26454459|FG005|Overall Study|Lost to Follow-up|0|||
13280164|NCT03804684|26454530|FG000|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|3|||
13280165|NCT03804684|26454531|FG001|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|18|||
13280166|NCT03807349|26454545|FG000|Overall Study|Early Study Termination|9|||
13280167|NCT03805750|26454566|FG000|Second Intervention - 4 Weeks|Adverse Event|0|||
13280168|NCT03805750|26454567|FG001|Second Intervention - 4 Weeks|Adverse Event|2|||
13280169|NCT03804268|26454604|FG000|Overall Study|Adverse Event|2|||
13280170|NCT03804268|26454605|FG001|Overall Study|Adverse Event|2|||
13280171|NCT03804268|26454604|FG000|Overall Study|Withdrawal by Subject|2|||
13280172|NCT03804268|26454605|FG001|Overall Study|Withdrawal by Subject|0|||
13280173|NCT03804268|26454604|FG000|Overall Study|Lost to Follow-up|1|||
13280174|NCT03804268|26454605|FG001|Overall Study|Lost to Follow-up|0|||
13280175|NCT03804268|26454604|FG000|Overall Study|Physician Decision|2|||
13280176|NCT03804268|26454605|FG001|Overall Study|Physician Decision|0|||
13280177|NCT03802825|26454626|FG000|Overall Study|Lost to follow-up for intervention|12|||
13280178|NCT03802825|26454627|FG001|Overall Study|Lost to follow-up for intervention|3|||
13280179|NCT03802825|26454626|FG000|Overall Study|Received only 1 component of intervention|0|||
13280180|NCT03802825|26454627|FG001|Overall Study|Received only 1 component of intervention|13|||
13280181|NCT03808909|26454660|FG000|Overall Study|Lost to Follow-up|3|||
13280182|NCT03808909|26454661|FG001|Overall Study|Lost to Follow-up|0|||
13280183|NCT03802565|26454689|FG000|Overall Study|Adverse Event|0|||
13280184|NCT03802565|26454690|FG001|Overall Study|Adverse Event|1|||
13280185|NCT03802565|26454691|FG002|Overall Study|Adverse Event|2|||
13280186|NCT03802565|26454692|FG003|Overall Study|Adverse Event|1|||
13280187|NCT03802565|26454693|FG004|Overall Study|Adverse Event|1|||
13280188|NCT03802565|26454689|FG000|Overall Study|Withdrawal by Subject|2|||
13280189|NCT03802565|26454690|FG001|Overall Study|Withdrawal by Subject|2|||
13280190|NCT03802565|26454691|FG002|Overall Study|Withdrawal by Subject|2|||
13280191|NCT03802565|26454692|FG003|Overall Study|Withdrawal by Subject|0|||
13280192|NCT03802565|26454693|FG004|Overall Study|Withdrawal by Subject|1|||
13280193|NCT03802565|26454689|FG000|Overall Study|Protocol Violation|2|||
13280194|NCT03802565|26454690|FG001|Overall Study|Protocol Violation|1|||
13280195|NCT03802565|26454691|FG002|Overall Study|Protocol Violation|4|||
13280196|NCT03802565|26454692|FG003|Overall Study|Protocol Violation|5|||
13280197|NCT03802565|26454693|FG004|Overall Study|Protocol Violation|1|||
13280198|NCT03802565|26454689|FG000|Overall Study|Lost to Follow-up|0|||
13308007|NCT01280981|26530415|FG000|Overall Study|Lack of Efficacy|13|||
13119923|NCT03011892|25936189|FG010|Double Blind (DB) Period|Other|0|||
13119924|NCT03011892|25936190|FG011|Double Blind (DB) Period|Other|0|||
13119925|NCT03011892|25936179|FG000|Double Blind (DB) Period|Physician Decision|1|||
13119926|NCT03011892|25936180|FG001|Double Blind (DB) Period|Physician Decision|0|||
13119927|NCT03011892|25936181|FG002|Double Blind (DB) Period|Physician Decision|1|||
13119928|NCT03011892|25936182|FG003|Double Blind (DB) Period|Physician Decision|0|||
13119929|NCT03011892|25936183|FG004|Double Blind (DB) Period|Physician Decision|0|||
13119930|NCT03011892|25936184|FG005|Double Blind (DB) Period|Physician Decision|0|||
13280199|NCT03802565|26454690|FG001|Overall Study|Lost to Follow-up|0|||
13280200|NCT03802565|26454691|FG002|Overall Study|Lost to Follow-up|1|||
13280201|NCT03802565|26454692|FG003|Overall Study|Lost to Follow-up|0|||
13280202|NCT03802565|26454693|FG004|Overall Study|Lost to Follow-up|0|||
13280203|NCT03802565|26454689|FG000|Overall Study|Subjects Related to Each Other|1|||
13280204|NCT03802565|26454690|FG001|Overall Study|Subjects Related to Each Other|0|||
13280205|NCT03802565|26454691|FG002|Overall Study|Subjects Related to Each Other|0|||
13280206|NCT03802565|26454692|FG003|Overall Study|Subjects Related to Each Other|2|||
13280207|NCT03802565|26454693|FG004|Overall Study|Subjects Related to Each Other|1|||
13280208|NCT03802565|26454689|FG000|Overall Study|Elevated Enzymes|0|||
13280209|NCT03802565|26454690|FG001|Overall Study|Elevated Enzymes|0|||
13119931|NCT03011892|25936185|FG006|Double Blind (DB) Period|Physician Decision|0|||
13119932|NCT03011892|25936186|FG007|Double Blind (DB) Period|Physician Decision|0|||
13280210|NCT03802565|26454691|FG002|Overall Study|Elevated Enzymes|0|||
13280211|NCT03802565|26454692|FG003|Overall Study|Elevated Enzymes|0|||
13280212|NCT03802565|26454693|FG004|Overall Study|Elevated Enzymes|2|||
13280213|NCT03802513|26454699|FG000|Overall Study|Lost to Follow-up|1|||
13291674|NCT00151775|26483497|FG010|Period 4: Open Label|Adverse Event|0|||
13291675|NCT00151775|26483498|FG011|Period 4: Open Label|Adverse Event|0|||
13291676|NCT00151775|26483487|FG000|Period 4: Open Label|Lost to Follow-up|0|||
13291677|NCT00151775|26483488|FG001|Period 4: Open Label|Lost to Follow-up|0|||
13291678|NCT00151775|26483489|FG002|Period 4: Open Label|Lost to Follow-up|0|||
13291679|NCT00151775|26483490|FG003|Period 4: Open Label|Lost to Follow-up|0|||
13291680|NCT00151775|26483491|FG004|Period 4: Open Label|Lost to Follow-up|17|||
13291681|NCT00151775|26483492|FG005|Period 4: Open Label|Lost to Follow-up|0|||
13291682|NCT00151775|26483493|FG006|Period 4: Open Label|Lost to Follow-up|0|||
13291683|NCT00151775|26483494|FG007|Period 4: Open Label|Lost to Follow-up|0|||
13291684|NCT00151775|26483495|FG008|Period 4: Open Label|Lost to Follow-up|0|||
13291685|NCT00151775|26483496|FG009|Period 4: Open Label|Lost to Follow-up|7|||
13291686|NCT00151775|26483497|FG010|Period 4: Open Label|Lost to Follow-up|0|||
13291687|NCT00151775|26483498|FG011|Period 4: Open Label|Lost to Follow-up|0|||
13291688|NCT00151775|26483487|FG000|Period 4: Open Label|Non-compliance with protocol|0|||
13291689|NCT00151775|26483488|FG001|Period 4: Open Label|Non-compliance with protocol|0|||
13291690|NCT00151775|26483489|FG002|Period 4: Open Label|Non-compliance with protocol|0|||
13291691|NCT00151775|26483490|FG003|Period 4: Open Label|Non-compliance with protocol|0|||
13291692|NCT00151775|26483491|FG004|Period 4: Open Label|Non-compliance with protocol|4|||
13291693|NCT00151775|26483492|FG005|Period 4: Open Label|Non-compliance with protocol|0|||
13291694|NCT00151775|26483493|FG006|Period 4: Open Label|Non-compliance with protocol|0|||
13291695|NCT00151775|26483494|FG007|Period 4: Open Label|Non-compliance with protocol|0|||
13291696|NCT00151775|26483495|FG008|Period 4: Open Label|Non-compliance with protocol|0|||
13291697|NCT00151775|26483496|FG009|Period 4: Open Label|Non-compliance with protocol|4|||
13291698|NCT00151775|26483497|FG010|Period 4: Open Label|Non-compliance with protocol|0|||
13291699|NCT00151775|26483498|FG011|Period 4: Open Label|Non-compliance with protocol|0|||
13291700|NCT00151775|26483487|FG000|Period 4: Open Label|Other|0|||
13291701|NCT00151775|26483488|FG001|Period 4: Open Label|Other|0|||
13291702|NCT00151775|26483489|FG002|Period 4: Open Label|Other|0|||
13291703|NCT00151775|26483490|FG003|Period 4: Open Label|Other|0|||
13291704|NCT00151775|26483491|FG004|Period 4: Open Label|Other|1|||
13291705|NCT00151775|26483492|FG005|Period 4: Open Label|Other|0|||
13291706|NCT00151775|26483493|FG006|Period 4: Open Label|Other|0|||
13291707|NCT00151775|26483494|FG007|Period 4: Open Label|Other|0|||
13291708|NCT00151775|26483495|FG008|Period 4: Open Label|Other|0|||
13291709|NCT00151775|26483496|FG009|Period 4: Open Label|Other|3|||
13291710|NCT00151775|26483497|FG010|Period 4: Open Label|Other|0|||
13291711|NCT00151775|26483498|FG011|Period 4: Open Label|Other|0|||
13291712|NCT00151775|26483487|FG000|Period 4: Open Label|Physician Decision|0|||
13291713|NCT00151775|26483488|FG001|Period 4: Open Label|Physician Decision|0|||
13291714|NCT00151775|26483489|FG002|Period 4: Open Label|Physician Decision|0|||
13291715|NCT00151775|26483490|FG003|Period 4: Open Label|Physician Decision|0|||
13291716|NCT00151775|26483491|FG004|Period 4: Open Label|Physician Decision|0|||
13291717|NCT00151775|26483492|FG005|Period 4: Open Label|Physician Decision|0|||
13291718|NCT00151775|26483493|FG006|Period 4: Open Label|Physician Decision|0|||
13291719|NCT00151775|26483494|FG007|Period 4: Open Label|Physician Decision|0|||
13291720|NCT00151775|26483495|FG008|Period 4: Open Label|Physician Decision|0|||
13291721|NCT00151775|26483496|FG009|Period 4: Open Label|Physician Decision|2|||
13291722|NCT00151775|26483497|FG010|Period 4: Open Label|Physician Decision|0|||
13291723|NCT00151775|26483498|FG011|Period 4: Open Label|Physician Decision|0|||
13291724|NCT00151775|26483487|FG000|Period 4: Open Label|Protocol Violation|0|||
13291725|NCT00151775|26483488|FG001|Period 4: Open Label|Protocol Violation|0|||
13291726|NCT00151775|26483489|FG002|Period 4: Open Label|Protocol Violation|0|||
13291727|NCT00151775|26483490|FG003|Period 4: Open Label|Protocol Violation|0|||
13291728|NCT00151775|26483491|FG004|Period 4: Open Label|Protocol Violation|1|||
13291729|NCT00151775|26483492|FG005|Period 4: Open Label|Protocol Violation|0|||
13291730|NCT00151775|26483493|FG006|Period 4: Open Label|Protocol Violation|0|||
13291731|NCT00151775|26483494|FG007|Period 4: Open Label|Protocol Violation|0|||
13291732|NCT00151775|26483495|FG008|Period 4: Open Label|Protocol Violation|0|||
13291733|NCT00151775|26483496|FG009|Period 4: Open Label|Protocol Violation|0|||
13291734|NCT00151775|26483497|FG010|Period 4: Open Label|Protocol Violation|0|||
13291735|NCT00151775|26483498|FG011|Period 4: Open Label|Protocol Violation|0|||
13291736|NCT00151411|26483515|FG000|Overall Study|Lost to Follow-up|15|||
13291737|NCT00151411|26483516|FG001|Overall Study|Lost to Follow-up|19|||
13291738|NCT00151411|26483515|FG000|Overall Study|Withdrawal by Subject|12|||
13291739|NCT00151411|26483516|FG001|Overall Study|Withdrawal by Subject|20|||
13119933|NCT03011892|25936187|FG008|Double Blind (DB) Period|Physician Decision|0|||
13119934|NCT03011892|25936188|FG009|Double Blind (DB) Period|Physician Decision|0|||
13119935|NCT03011892|25936189|FG010|Double Blind (DB) Period|Physician Decision|0|||
13119936|NCT03011892|25936190|FG011|Double Blind (DB) Period|Physician Decision|0|||
13291740|NCT00151411|26483515|FG000|Overall Study|Adverse Event|6|||
13119937|NCT03011892|25936179|FG000|Double Blind (DB) Period|Pregnancy|0|||
13119938|NCT03011892|25936180|FG001|Double Blind (DB) Period|Pregnancy|0|||
13119939|NCT03011892|25936181|FG002|Double Blind (DB) Period|Pregnancy|0|||
13119940|NCT03011892|25936182|FG003|Double Blind (DB) Period|Pregnancy|0|||
13119941|NCT03011892|25936183|FG004|Double Blind (DB) Period|Pregnancy|1|||
13119942|NCT03011892|25936184|FG005|Double Blind (DB) Period|Pregnancy|0|||
13119943|NCT03011892|25936185|FG006|Double Blind (DB) Period|Pregnancy|0|||
13119944|NCT03011892|25936186|FG007|Double Blind (DB) Period|Pregnancy|0|||
13119945|NCT03011892|25936187|FG008|Double Blind (DB) Period|Pregnancy|0|||
13119946|NCT03011892|25936188|FG009|Double Blind (DB) Period|Pregnancy|0|||
13119947|NCT03011892|25936189|FG010|Double Blind (DB) Period|Pregnancy|0|||
13119948|NCT03011892|25936190|FG011|Double Blind (DB) Period|Pregnancy|0|||
13119949|NCT03011892|25936179|FG000|Double Blind (DB) Period|Protocol Violation|1|||
13119950|NCT03011892|25936180|FG001|Double Blind (DB) Period|Protocol Violation|0|||
13119951|NCT03011892|25936181|FG002|Double Blind (DB) Period|Protocol Violation|0|||
13119952|NCT03011892|25936182|FG003|Double Blind (DB) Period|Protocol Violation|0|||
13119953|NCT03011892|25936183|FG004|Double Blind (DB) Period|Protocol Violation|0|||
13119954|NCT03011892|25936184|FG005|Double Blind (DB) Period|Protocol Violation|0|||
13119955|NCT03011892|25936185|FG006|Double Blind (DB) Period|Protocol Violation|0|||
13119956|NCT03011892|25936186|FG007|Double Blind (DB) Period|Protocol Violation|0|||
13119957|NCT03011892|25936187|FG008|Double Blind (DB) Period|Protocol Violation|0|||
13119958|NCT03011892|25936188|FG009|Double Blind (DB) Period|Protocol Violation|0|||
13119959|NCT03011892|25936189|FG010|Double Blind (DB) Period|Protocol Violation|0|||
13119960|NCT03011892|25936190|FG011|Double Blind (DB) Period|Protocol Violation|0|||
13119961|NCT03011892|25936179|FG000|Double Blind (DB) Period|Withdrawal by Subject|7|||
13119962|NCT03011892|25936180|FG001|Double Blind (DB) Period|Withdrawal by Subject|5|||
13119963|NCT03011892|25936181|FG002|Double Blind (DB) Period|Withdrawal by Subject|1|||
13119964|NCT03011892|25936182|FG003|Double Blind (DB) Period|Withdrawal by Subject|2|||
13119965|NCT03011892|25936183|FG004|Double Blind (DB) Period|Withdrawal by Subject|4|||
13119966|NCT03011892|25936184|FG005|Double Blind (DB) Period|Withdrawal by Subject|3|||
13119967|NCT03011892|25936185|FG006|Double Blind (DB) Period|Withdrawal by Subject|0|||
13119968|NCT03011892|25936186|FG007|Double Blind (DB) Period|Withdrawal by Subject|0|||
13119969|NCT03011892|25936187|FG008|Double Blind (DB) Period|Withdrawal by Subject|0|||
13119970|NCT03011892|25936188|FG009|Double Blind (DB) Period|Withdrawal by Subject|0|||
13119971|NCT03011892|25936189|FG010|Double Blind (DB) Period|Withdrawal by Subject|0|||
13119972|NCT03011892|25936190|FG011|Double Blind (DB) Period|Withdrawal by Subject|0|||
13119973|NCT03011892|25936179|FG000|Double Blind (DB) Period|Randomized but not treated|0|||
13119974|NCT03011892|25936180|FG001|Double Blind (DB) Period|Randomized but not treated|0|||
13119975|NCT03011892|25936181|FG002|Double Blind (DB) Period|Randomized but not treated|0|||
13119976|NCT03011892|25936182|FG003|Double Blind (DB) Period|Randomized but not treated|0|||
13119977|NCT03011892|25936183|FG004|Double Blind (DB) Period|Randomized but not treated|1|||
13119978|NCT03011892|25936184|FG005|Double Blind (DB) Period|Randomized but not treated|0|||
13119979|NCT03011892|25936185|FG006|Double Blind (DB) Period|Randomized but not treated|0|||
13119980|NCT03011892|25936186|FG007|Double Blind (DB) Period|Randomized but not treated|0|||
13119981|NCT03011892|25936187|FG008|Double Blind (DB) Period|Randomized but not treated|0|||
13119982|NCT03011892|25936188|FG009|Double Blind (DB) Period|Randomized but not treated|0|||
13119983|NCT03011892|25936189|FG010|Double Blind (DB) Period|Randomized but not treated|0|||
13119984|NCT03011892|25936190|FG011|Double Blind (DB) Period|Randomized but not treated|0|||
13119985|NCT03011892|25936179|FG000|Open Label (OL) Period|Lost to Follow-up|0|||
13119986|NCT03011892|25936180|FG001|Open Label (OL) Period|Lost to Follow-up|0|||
13119987|NCT03011892|25936181|FG002|Open Label (OL) Period|Lost to Follow-up|0|||
13119988|NCT03011892|25936182|FG003|Open Label (OL) Period|Lost to Follow-up|0|||
13119989|NCT03011892|25936183|FG004|Open Label (OL) Period|Lost to Follow-up|0|||
13119990|NCT03011892|25936184|FG005|Open Label (OL) Period|Lost to Follow-up|0|||
13119991|NCT03011892|25936185|FG006|Open Label (OL) Period|Lost to Follow-up|4|||
13119992|NCT03011892|25936186|FG007|Open Label (OL) Period|Lost to Follow-up|2|||
13119993|NCT03011892|25936187|FG008|Open Label (OL) Period|Lost to Follow-up|1|||
13119994|NCT03011892|25936188|FG009|Open Label (OL) Period|Lost to Follow-up|0|||
13119995|NCT03011892|25936189|FG010|Open Label (OL) Period|Lost to Follow-up|1|||
13119996|NCT03011892|25936190|FG011|Open Label (OL) Period|Lost to Follow-up|1|||
13119997|NCT03011892|25936179|FG000|Open Label (OL) Period|Withdrawal by Subject|0|||
13119998|NCT03011892|25936180|FG001|Open Label (OL) Period|Withdrawal by Subject|0|||
13119999|NCT03011892|25936181|FG002|Open Label (OL) Period|Withdrawal by Subject|0|||
13120000|NCT03011892|25936182|FG003|Open Label (OL) Period|Withdrawal by Subject|0|||
13120001|NCT03011892|25936183|FG004|Open Label (OL) Period|Withdrawal by Subject|0|||
13120002|NCT03011892|25936184|FG005|Open Label (OL) Period|Withdrawal by Subject|0|||
13280214|NCT03213158|26454748|FG000|Overall Study|Withdrawal by Subject|1|||
13120003|NCT03011892|25936185|FG006|Open Label (OL) Period|Withdrawal by Subject|3|||
13120004|NCT03011892|25936186|FG007|Open Label (OL) Period|Withdrawal by Subject|0|||
13120005|NCT03011892|25936187|FG008|Open Label (OL) Period|Withdrawal by Subject|1|||
13120006|NCT03011892|25936188|FG009|Open Label (OL) Period|Withdrawal by Subject|0|||
13120007|NCT03011892|25936189|FG010|Open Label (OL) Period|Withdrawal by Subject|1|||
13120008|NCT03011892|25936190|FG011|Open Label (OL) Period|Withdrawal by Subject|2|||
13120009|NCT03011892|25936179|FG000|Open Label (OL) Period|Reason not specified|0|||
13120010|NCT03011892|25936180|FG001|Open Label (OL) Period|Reason not specified|0|||
13120011|NCT03011892|25936181|FG002|Open Label (OL) Period|Reason not specified|0|||
13120012|NCT03011892|25936182|FG003|Open Label (OL) Period|Reason not specified|0|||
13120013|NCT03011892|25936183|FG004|Open Label (OL) Period|Reason not specified|0|||
13120014|NCT03011892|25936184|FG005|Open Label (OL) Period|Reason not specified|0|||
13120015|NCT03011892|25936185|FG006|Open Label (OL) Period|Reason not specified|0|||
13120016|NCT03011892|25936186|FG007|Open Label (OL) Period|Reason not specified|1|||
13120017|NCT03011892|25936187|FG008|Open Label (OL) Period|Reason not specified|0|||
13120018|NCT03011892|25936188|FG009|Open Label (OL) Period|Reason not specified|0|||
13120019|NCT03011892|25936189|FG010|Open Label (OL) Period|Reason not specified|0|||
13120020|NCT03011892|25936190|FG011|Open Label (OL) Period|Reason not specified|0|||
13120021|NCT03011840|25936205|FG000|Overall Study|Not received PIL in post PIL phase|0|||
13120022|NCT03011840|25936206|FG001|Overall Study|Not received PIL in post PIL phase|21|||
13120023|NCT03011333|25936251|FG000|Overall Study|Lost to Follow-up|0|||
13120024|NCT03011333|25936252|FG001|Overall Study|Lost to Follow-up|1|||
13120025|NCT03011333|25936253|FG002|Overall Study|Lost to Follow-up|0|||
13120026|NCT03011333|25936254|FG003|Overall Study|Lost to Follow-up|1|||
13120027|NCT03011333|25936255|FG004|Overall Study|Lost to Follow-up|4|||
13120028|NCT03011333|25936256|FG005|Overall Study|Lost to Follow-up|4|||
13120029|NCT03011333|25936257|FG006|Overall Study|Lost to Follow-up|5|||
13120030|NCT03011099|25936288|FG000|Overall Study|Withdrawal by Subject|0|||
13120031|NCT03011099|25936289|FG001|Overall Study|Withdrawal by Subject|2|||
13120032|NCT03010527|25936325|FG000|Overall Study|Death|0|||
13120033|NCT03010527|25936326|FG001|Overall Study|Death|0|||
13120034|NCT03010527|25936327|FG002|Overall Study|Death|1|||
13120035|NCT03010527|25936325|FG000|Overall Study|Adverse Event|0|||
13120036|NCT03010527|25936326|FG001|Overall Study|Adverse Event|4|||
13120037|NCT03010527|25936327|FG002|Overall Study|Adverse Event|2|||
13120038|NCT03010527|25936325|FG000|Overall Study|Protocol Violation|0|||
13120039|NCT03010527|25936326|FG001|Overall Study|Protocol Violation|1|||
13280215|NCT03213158|26454748|FG000|Overall Study|Physician Decision|2|||
13280216|NCT03219034|26454773|FG000|Overall Study|Lost to Follow-up|9|||
13280217|NCT03219034|26454774|FG001|Overall Study|Lost to Follow-up|13|||
13280218|NCT03219034|26454773|FG000|Overall Study|Additional dental work needed|1|||
13280219|NCT03219034|26454774|FG001|Overall Study|Additional dental work needed|0|||
13280220|NCT03219034|26454773|FG000|Overall Study|UPPP Surgery|1|||
13280221|NCT03219034|26454774|FG001|Overall Study|UPPP Surgery|0|||
13280222|NCT03219034|26454773|FG000|Overall Study|Dental sensitivity|0|||
13280223|NCT03219034|26454774|FG001|Overall Study|Dental sensitivity|1|||
13280224|NCT03219034|26454773|FG000|Overall Study|Death in family|0|||
13280225|NCT03219034|26454774|FG001|Overall Study|Death in family|1|||
13280226|NCT03217136|26454817|FG000|Overall Study|Lost to Follow-up|2|||
13280227|NCT03217136|26454818|FG001|Overall Study|Lost to Follow-up|1|||
13280228|NCT03217136|26454817|FG000|Overall Study|Site Randomized Participant in Error|0|||
13280229|NCT03217136|26454818|FG001|Overall Study|Site Randomized Participant in Error|1|||
13280230|NCT03217136|26454817|FG000|Overall Study|Did Not Meet Criteria after Randomization|0|||
13280231|NCT03217136|26454818|FG001|Overall Study|Did Not Meet Criteria after Randomization|1|||
13280232|NCT03217136|26454817|FG000|Overall Study|Dispensing Error|1|||
13280233|NCT03217136|26454818|FG001|Overall Study|Dispensing Error|0|||
13280234|NCT03217136|26454817|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
13280235|NCT03217136|26454818|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
13280236|NCT03219567|26454832|FG000|Overall Study|Withdrawal by Subject|0|||
13280237|NCT03219567|26454833|FG001|Overall Study|Withdrawal by Subject|1|||
13280238|NCT03219164|26454851|FG000|Overall Study|Study Terminated by Sponsor|16|||
13280239|NCT03219164|26454852|FG001|Overall Study|Study Terminated by Sponsor|12|||
13280240|NCT03219164|26454851|FG000|Overall Study|Withdrew Consent by Parent/Guardian|5|||
13280241|NCT03219164|26454852|FG001|Overall Study|Withdrew Consent by Parent/Guardian|4|||
13120040|NCT03010527|25936327|FG002|Overall Study|Protocol Violation|0|||
13120041|NCT03010527|25936325|FG000|Overall Study|Lost to Follow-up|0|||
13120042|NCT03010527|25936326|FG001|Overall Study|Lost to Follow-up|2|||
13120043|NCT03010527|25936327|FG002|Overall Study|Lost to Follow-up|1|||
13120044|NCT03010527|25936325|FG000|Overall Study|Withdrawal by Subject|0|||
13120045|NCT03010527|25936326|FG001|Overall Study|Withdrawal by Subject|3|||
13120046|NCT03010527|25936327|FG002|Overall Study|Withdrawal by Subject|4|||
13120047|NCT03010527|25936325|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0|||
13120048|NCT03010527|25936326|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4|||
13120049|NCT03010527|25936327|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6|||
13120050|NCT03010527|25936325|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0|||
13120051|NCT03010527|25936326|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4|||
13120052|NCT03010527|25936327|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2|||
13120053|NCT03010527|25936325|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
13280242|NCT03219164|26454851|FG000|Overall Study|Lost to Follow-up|1|||
13280243|NCT03219164|26454852|FG001|Overall Study|Lost to Follow-up|1|||
13280244|NCT03219164|26454851|FG000|Overall Study|Adverse Event|1|||
13280245|NCT03219164|26454852|FG001|Overall Study|Adverse Event|0|||
13280246|NCT03219164|26454851|FG000|Overall Study|Non-Compliance with Study Drug|1|||
13280247|NCT03219164|26454852|FG001|Overall Study|Non-Compliance with Study Drug|0|||
13280248|NCT03219164|26454851|FG000|Overall Study|Protocol Violation|0|||
13280249|NCT03219164|26454852|FG001|Overall Study|Protocol Violation|1|||
13280250|NCT03219164|26454851|FG000|Overall Study|Withdrew Assent|1|||
13280251|NCT03219164|26454852|FG001|Overall Study|Withdrew Assent|0|||
13291741|NCT00151411|26483516|FG001|Overall Study|Adverse Event|0|||
13291742|NCT00151411|26483515|FG000|Overall Study|Pregnancy|0|||
13291743|NCT00151411|26483516|FG001|Overall Study|Pregnancy|4|||
13291744|NCT00151372|26483531|FG000|Overall Study|Death|12|||
13291745|NCT00151372|26483532|FG001|Overall Study|Death|11|||
13291746|NCT00151372|26483531|FG000|Overall Study|Lost to Follow-up|5|||
13291747|NCT00151372|26483532|FG001|Overall Study|Lost to Follow-up|5|||
13291748|NCT00151372|26483531|FG000|Overall Study|Too sick medically to continue|5|||
13291749|NCT00151372|26483532|FG001|Overall Study|Too sick medically to continue|6|||
13291750|NCT00151372|26483531|FG000|Overall Study|Withdrawal by Subject|7|||
13291751|NCT00151372|26483532|FG001|Overall Study|Withdrawal by Subject|7|||
13291752|NCT00151281|26483541|FG000|Overall Study|Not evaluable|3|||
13291753|NCT00150813|26483547|FG000|Overall Study|Adverse Event|1|||
13291754|NCT00150813|26483547|FG000|Overall Study|Lack of Efficacy|1|||
13291755|NCT00150813|26483547|FG000|Overall Study|Lost to Follow-up|5|||
13291756|NCT00150813|26483547|FG000|Overall Study|Withdrawal by Subject|5|||
13291757|NCT00150813|26483547|FG000|Overall Study|Remission|3|||
13291758|NCT00150813|26483547|FG000|Overall Study|Planned pregancy|1|||
13291759|NCT00150813|26483547|FG000|Overall Study|Switch to commercially available LEV|2|||
13292345|NCT00706654|26485248|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21|||
13292346|NCT00706654|26485249|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
13292347|NCT00706654|26485250|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
13292348|NCT00706654|26485251|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0|||
13292349|NCT00706654|26485248|FG000|Oral Stabilization Phase|Withdrew consent|55|||
13292350|NCT00706654|26485249|FG001|Oral Stabilization Phase|Withdrew consent|0|||
13292351|NCT00706654|26485250|FG002|Oral Stabilization Phase|Withdrew consent|0|||
13292352|NCT00706654|26485251|FG003|Oral Stabilization Phase|Withdrew consent|0|||
13292353|NCT00706654|26485248|FG000|Oral Stabilization Phase|Protocol Deviation|2|||
13292354|NCT00706654|26485249|FG001|Oral Stabilization Phase|Protocol Deviation|0|||
13292355|NCT00706654|26485250|FG002|Oral Stabilization Phase|Protocol Deviation|0|||
13292356|NCT00706654|26485251|FG003|Oral Stabilization Phase|Protocol Deviation|0|||
13292357|NCT00706654|26485248|FG000|Oral Stabilization Phase|Adverse Event|21|||
13292358|NCT00706654|26485249|FG001|Oral Stabilization Phase|Adverse Event|0|||
13292359|NCT00706654|26485250|FG002|Oral Stabilization Phase|Adverse Event|0|||
13292360|NCT00706654|26485251|FG003|Oral Stabilization Phase|Adverse Event|0|||
13292361|NCT00706654|26485248|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20|||
13292362|NCT00706654|26485249|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
13292363|NCT00706654|26485250|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
13292364|NCT00706654|26485251|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
13292365|NCT00706654|26485248|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10|||
13292366|NCT00706654|26485249|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
13292367|NCT00706654|26485250|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
13292368|NCT00706654|26485251|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
13292369|NCT00706654|26485248|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
13292370|NCT00706654|26485249|FG001|Depot Maintenance Phase|Lost to Follow-up|4|||
13292371|NCT00706654|26485250|FG002|Depot Maintenance Phase|Lost to Follow-up|10|||
13292372|NCT00706654|26485251|FG003|Depot Maintenance Phase|Lost to Follow-up|6|||
13292373|NCT00706654|26485248|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
13292374|NCT00706654|26485249|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4|||
13292375|NCT00706654|26485250|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6|||
13292376|NCT00706654|26485251|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5|||
13292377|NCT00706654|26485248|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
13120054|NCT03010527|25936326|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1|||
13120055|NCT03010527|25936327|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
13120056|NCT03010501|25936348|FG000|Study Week 1|Withdrawal by Subject|2|||
13120057|NCT03010501|25936349|FG001|Study Week 1|Withdrawal by Subject|1|||
13120058|NCT03010501|25936350|FG002|Study Week 1|Withdrawal by Subject|0|||
13120059|NCT03010501|25936351|FG003|Study Week 1|Withdrawal by Subject|2|||
13120060|NCT03010501|25936352|FG004|Study Week 1|Withdrawal by Subject|0|||
13120061|NCT03010501|25936353|FG005|Study Week 1|Withdrawal by Subject|0|||
13120062|NCT03010501|25936348|FG000|Study Week 3|Withdrawal by Subject|0|||
13120063|NCT03010501|25936349|FG001|Study Week 3|Withdrawal by Subject|0|||
13120064|NCT03010501|25936350|FG002|Study Week 3|Withdrawal by Subject|0|||
13120065|NCT03010501|25936351|FG003|Study Week 3|Withdrawal by Subject|1|||
13120066|NCT03010501|25936352|FG004|Study Week 3|Withdrawal by Subject|0|||
13120067|NCT03010501|25936353|FG005|Study Week 3|Withdrawal by Subject|0|||
13120068|NCT03010462|25936374|FG000|Overall Study|Withdrawal by Subject|3|||
13120069|NCT03010462|25936375|FG001|Overall Study|Withdrawal by Subject|1|||
13120070|NCT03010423|25936388|FG000|Overall Study|Study termination|8|||
13120071|NCT03010254|25936420|FG000|Overall Study|Adverse Event|0|||
13120072|NCT03010254|25936421|FG001|Overall Study|Adverse Event|1|||
13120073|NCT03010254|25936420|FG000|Overall Study|Lost to Follow-up|4|||
13120074|NCT03010254|25936421|FG001|Overall Study|Lost to Follow-up|0|||
13120075|NCT03010254|25936420|FG000|Overall Study|Withdrawal by Subject|1|||
13120076|NCT03010254|25936421|FG001|Overall Study|Withdrawal by Subject|1|||
13120077|NCT03010254|25936420|FG000|Overall Study|Other|2|||
13120078|NCT03010254|25936421|FG001|Overall Study|Other|3|||
13280252|NCT01838200|26454869|FG000|Overall Study|Adverse Event|0|||
13280253|NCT01838200|26454870|FG001|Overall Study|Adverse Event|2|||
13280254|NCT01838200|26454869|FG000|Overall Study|Progressive disease|3|||
13280255|NCT01838200|26454870|FG001|Overall Study|Progressive disease|0|||
13280256|NCT01839331|26454913|FG000|Overall Study|Early Termination|3|||
13280257|NCT01839331|26454914|FG001|Overall Study|Early Termination|0|||
13280258|NCT01839331|26454915|FG002|Overall Study|Early Termination|1|||
13280259|NCT01839331|26454916|FG003|Overall Study|Early Termination|2|||
13280260|NCT01839331|26454913|FG000|Overall Study|Protocol Violation|1|||
13280261|NCT01839331|26454914|FG001|Overall Study|Protocol Violation|6|||
13280262|NCT01839331|26454915|FG002|Overall Study|Protocol Violation|4|||
13280263|NCT01839331|26454916|FG003|Overall Study|Protocol Violation|3|||
13280264|NCT01727336|26455025|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
13280265|NCT01727336|26455026|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1|||
13280266|NCT01727336|26455027|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5|||
13280267|NCT01727336|26455028|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
13280268|NCT01727336|26455029|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
13280269|NCT01727336|26455030|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
13280270|NCT01727336|26455025|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
13280271|NCT01727336|26455026|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1|||
13280272|NCT01727336|26455027|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
13280273|NCT01727336|26455028|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
13280274|NCT01727336|26455029|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
13280275|NCT01727336|26455030|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
13280276|NCT01727336|26455025|FG000|Part 2 Blinded|Death|0|||
13280277|NCT01727336|26455026|FG001|Part 2 Blinded|Death|0|||
13280278|NCT01727336|26455027|FG002|Part 2 Blinded|Death|0|||
13280279|NCT01727336|26455028|FG003|Part 2 Blinded|Death|0|||
13280280|NCT01727336|26455029|FG004|Part 2 Blinded|Death|20|||
13280281|NCT01727336|26455030|FG005|Part 2 Blinded|Death|16|||
13280282|NCT01727336|26455025|FG000|Part 2 Blinded|Lack of Efficacy|0|||
13280283|NCT01727336|26455026|FG001|Part 2 Blinded|Lack of Efficacy|0|||
13280284|NCT01727336|26455027|FG002|Part 2 Blinded|Lack of Efficacy|0|||
13280285|NCT01727336|26455028|FG003|Part 2 Blinded|Lack of Efficacy|0|||
13280286|NCT01727336|26455029|FG004|Part 2 Blinded|Lack of Efficacy|42|||
13280287|NCT01727336|26455030|FG005|Part 2 Blinded|Lack of Efficacy|44|||
13280288|NCT01727336|26455025|FG000|Part 2 Blinded|Lost to Follow-up|0|||
13280289|NCT01727336|26455026|FG001|Part 2 Blinded|Lost to Follow-up|0|||
13280290|NCT01727336|26455027|FG002|Part 2 Blinded|Lost to Follow-up|0|||
13280291|NCT01727336|26455028|FG003|Part 2 Blinded|Lost to Follow-up|0|||
13280292|NCT01727336|26455029|FG004|Part 2 Blinded|Lost to Follow-up|0|||
13280293|NCT01727336|26455030|FG005|Part 2 Blinded|Lost to Follow-up|1|||
13280294|NCT01727336|26455025|FG000|Part 2 Blinded|Withdrawal by Subject|0|||
13280295|NCT01727336|26455026|FG001|Part 2 Blinded|Withdrawal by Subject|0|||
13280296|NCT01727336|26455027|FG002|Part 2 Blinded|Withdrawal by Subject|0|||
13280297|NCT01727336|26455028|FG003|Part 2 Blinded|Withdrawal by Subject|0|||
13280298|NCT01727336|26455029|FG004|Part 2 Blinded|Withdrawal by Subject|0|||
13280299|NCT01727336|26455030|FG005|Part 2 Blinded|Withdrawal by Subject|4|||
13280300|NCT01727336|26455025|FG000|Part 2 Blinded|use of prohibited medications|0|||
13308008|NCT01280981|26530415|FG000|Overall Study|Lost to Follow-up|3|||
13120079|NCT03009344|25936452|FG000|Overall Study|Lack of Efficacy|5|||
13120080|NCT03009344|25936452|FG000|Overall Study|Withdrawal by Subject|1|||
13120081|NCT03009344|25936452|FG000|Overall Study|Adverse Event|1|||
13120082|NCT03008915|25936467|FG000|Treatment 1|Withdrawal by Subject|0|||
13120083|NCT03008915|25936468|FG001|Treatment 1|Withdrawal by Subject|1|||
13120084|NCT03008460|25936505|FG000|Overall Study|Protocol deviation|0|||
13120085|NCT03008460|25936506|FG001|Overall Study|Protocol deviation|2|||
13120086|NCT03008460|25936505|FG000|Overall Study|Study drug not dispensed|0|||
13120087|NCT03008460|25936506|FG001|Overall Study|Study drug not dispensed|1|||
13120088|NCT03008460|25936505|FG000|Overall Study|Adverse Event|0|||
13280301|NCT01727336|26455026|FG001|Part 2 Blinded|use of prohibited medications|0|||
13280302|NCT01727336|26455027|FG002|Part 2 Blinded|use of prohibited medications|0|||
13308009|NCT01280981|26530415|FG000|Overall Study|Adverse Event|6|||
13120089|NCT03008460|25936506|FG001|Overall Study|Adverse Event|1|||
13120090|NCT03008460|25936505|FG000|Overall Study|Withdrawal by Subject|5|||
13120091|NCT03008460|25936506|FG001|Overall Study|Withdrawal by Subject|6|||
13120092|NCT03008460|25936505|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1|||
13120093|NCT03008460|25936506|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0|||
13120094|NCT03008460|25936505|FG000|Overall Study|End of study visit outside permitted time window|0|||
13120095|NCT03008460|25936506|FG001|Overall Study|End of study visit outside permitted time window|1|||
13120096|NCT03008460|25936505|FG000|Overall Study|Lost to Follow-up|1|||
13120097|NCT03008460|25936506|FG001|Overall Study|Lost to Follow-up|3|||
13120098|NCT03008070|25936605|FG000|Overall Study|Adverse Event|3|||
13120099|NCT03008070|25936606|FG001|Overall Study|Adverse Event|3|||
13120100|NCT03008070|25936607|FG002|Overall Study|Adverse Event|3|||
13120101|NCT03008070|25936605|FG000|Overall Study|Lost to Follow-up|1|||
13120102|NCT03008070|25936606|FG001|Overall Study|Lost to Follow-up|1|||
13120103|NCT03008070|25936607|FG002|Overall Study|Lost to Follow-up|0|||
13120104|NCT03008070|25936605|FG000|Overall Study|Non compliance|0|||
13120105|NCT03008070|25936606|FG001|Overall Study|Non compliance|1|||
13120106|NCT03008070|25936607|FG002|Overall Study|Non compliance|1|||
13120107|NCT03008070|25936605|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
13120108|NCT03008070|25936606|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1|||
13120109|NCT03008070|25936607|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
13120110|NCT03008070|25936605|FG000|Overall Study|Withdrawal by Subject|2|||
13120111|NCT03008070|25936606|FG001|Overall Study|Withdrawal by Subject|0|||
13120112|NCT03008070|25936607|FG002|Overall Study|Withdrawal by Subject|1|||
13120113|NCT03008070|25936605|FG000|Overall Study|Use of prohibited drug|0|||
13120114|NCT03008070|25936606|FG001|Overall Study|Use of prohibited drug|0|||
13120115|NCT03008070|25936607|FG002|Overall Study|Use of prohibited drug|2|||
13120116|NCT03008005|25936628|FG000|Overall Study|Physician Decision|1|||
13120117|NCT03008005|25936629|FG001|Overall Study|Physician Decision|0|||
13120118|NCT03008005|25936630|FG002|Overall Study|Physician Decision|0|||
13120119|NCT03008005|25936628|FG000|Overall Study|Withdrawal by Subject|1|||
13120120|NCT03008005|25936629|FG001|Overall Study|Withdrawal by Subject|0|||
13120121|NCT03008005|25936630|FG002|Overall Study|Withdrawal by Subject|0|||
13120122|NCT03008005|25936628|FG000|Overall Study|Ineligible|0|||
13120123|NCT03008005|25936629|FG001|Overall Study|Ineligible|1|||
13120124|NCT03008005|25936630|FG002|Overall Study|Ineligible|0|||
13120125|NCT03007979|25936636|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1|||
13120126|NCT03007966|25936673|FG000|Overall Study|Did not meeting inclusion/exclusion|1|||
13120127|NCT03007966|25936674|FG001|Overall Study|Did not meeting inclusion/exclusion|0|||
13120128|NCT03007953|25936689|FG000|Overall Study|Withdrawal by Subject|5|||
13120129|NCT03007953|25936690|FG001|Overall Study|Withdrawal by Subject|2|||
13120130|NCT03007953|25936689|FG000|Overall Study|Death|5|||
13120131|NCT03007953|25936690|FG001|Overall Study|Death|7|||
13280303|NCT01727336|26455028|FG003|Part 2 Blinded|use of prohibited medications|0|||
13280304|NCT01727336|26455029|FG004|Part 2 Blinded|use of prohibited medications|1|||
13280305|NCT01727336|26455030|FG005|Part 2 Blinded|use of prohibited medications|3|||
13280306|NCT01049984|26455053|FG000|Overall Study|Withdrawal by Subject|1|||
13280307|NCT01049984|26455054|FG001|Overall Study|Withdrawal by Subject|5|||
13280308|NCT01049984|26455053|FG000|Overall Study|Protocol Violation|3|||
13280309|NCT01049984|26455054|FG001|Overall Study|Protocol Violation|4|||
13120132|NCT03007953|25936689|FG000|Overall Study|Lost to Follow-up|3|||
13120133|NCT03007953|25936690|FG001|Overall Study|Lost to Follow-up|2|||
13120134|NCT03007953|25936689|FG000|Overall Study|Enrolled in Hospice|3|||
13120135|NCT03007953|25936690|FG001|Overall Study|Enrolled in Hospice|2|||
13120136|NCT03007888|25936734|FG000|First Intervention (14 Days)|Adverse Event|1|||
13120137|NCT03007888|25936735|FG001|First Intervention (14 Days)|Adverse Event|0|||
13120138|NCT03007472|25936743|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2|||
13120139|NCT03007472|25936743|FG000|Overall Study|Death|2|||
13120140|NCT03007472|25936743|FG000|Overall Study|Loss to Follow Up|1|||
13120141|NCT03006887|25936771|FG000|Overall Study|Adverse Event|1|||
13120142|NCT03006848|25936784|FG000|Overall Study|Adverse Event|1|||
13120143|NCT03006848|25936784|FG000|Overall Study|Physician Decision|1|||
13120144|NCT03006848|25936784|FG000|Overall Study|Lack of Efficacy|16|||
13280310|NCT01049984|26455053|FG000|Overall Study|Lost to Follow-up|2|||
13120145|NCT03006562|25936809|FG000|Overall Study|Lost to Follow-up|0|||
13120146|NCT03006562|25936810|FG001|Overall Study|Lost to Follow-up|1|||
13120147|NCT03006458|25936851|FG000|First Intervention|Unsatisfied Vision|0|||
13120148|NCT03006458|25936852|FG001|First Intervention|Unsatisfied Vision|3|||
13120149|NCT03006393|25936869|FG000|Overall Study|Withdrawal by Subject|1|||
13120150|NCT03006393|25936870|FG001|Overall Study|Withdrawal by Subject|1|||
13120151|NCT03006393|25936869|FG000|Overall Study|Pregnancy|0|||
13120152|NCT03006393|25936870|FG001|Overall Study|Pregnancy|1|||
13120153|NCT03006393|25936869|FG000|Overall Study|Lost to Follow-up|0|||
13120154|NCT03006393|25936870|FG001|Overall Study|Lost to Follow-up|1|||
13280311|NCT01049984|26455054|FG001|Overall Study|Lost to Follow-up|1|||
13280312|NCT01049984|26455053|FG000|Overall Study|Adverse Event|13|||
13280313|NCT01049984|26455054|FG001|Overall Study|Adverse Event|7|||
13120155|NCT03006341|25936925|FG000|Overall Study|Not linked in the EMR|25069|||
13120156|NCT03006341|25936926|FG001|Overall Study|Not linked in the EMR|67505|||
13120157|NCT03006341|25936927|FG002|Overall Study|Not linked in the EMR|30993|||
13120158|NCT03006341|25936928|FG003|Overall Study|Not linked in the EMR|10685|||
13120159|NCT03005288|25936965|FG000|Overall Study|Withdrawal by Subject|7|||
13120160|NCT03005288|25936966|FG001|Overall Study|Withdrawal by Subject|5|||
13120161|NCT03005288|25936965|FG000|Overall Study|Lost to Follow-up|0|||
13120162|NCT03005288|25936966|FG001|Overall Study|Lost to Follow-up|1|||
13120163|NCT03005288|25936965|FG000|Overall Study|Adverse Event|5|||
13120164|NCT03005288|25936966|FG001|Overall Study|Adverse Event|0|||
13120165|NCT03005288|25936965|FG000|Overall Study|Protocol deviation|0|||
13120166|NCT03005288|25936966|FG001|Overall Study|Protocol deviation|1|||
13120167|NCT03005288|25936965|FG000|Overall Study|Physician Decision|0|||
13120168|NCT03005288|25936966|FG001|Overall Study|Physician Decision|1|||
13120169|NCT03005106|25936975|FG000|Overall Study|Lost to Follow-up|16|||
13120170|NCT03005106|25936975|FG000|Overall Study|Adverse Event|1|||
13120171|NCT03005106|25936975|FG000|Overall Study|Physician Decision|1|||
13120172|NCT03005106|25936975|FG000|Overall Study|Death|2|||
13133447|NCT02769247|25987837|FG000|Overall Study|Withdrawal by Subject|1|||
13133448|NCT02769247|25987838|FG001|Overall Study|Withdrawal by Subject|0|||
13133449|NCT02769247|25987839|FG002|Overall Study|Withdrawal by Subject|0|||
13133450|NCT02769247|25987840|FG003|Overall Study|Withdrawal by Subject|1|||
13133451|NCT02769247|25987837|FG000|Overall Study|Protocol Violation|0|||
13133452|NCT02769247|25987838|FG001|Overall Study|Protocol Violation|0|||
13133453|NCT02769247|25987839|FG002|Overall Study|Protocol Violation|1|||
13133454|NCT02769247|25987840|FG003|Overall Study|Protocol Violation|0|||
13133455|NCT02769247|25987837|FG000|Overall Study|Physician Decision|1|||
13133456|NCT02769247|25987838|FG001|Overall Study|Physician Decision|0|||
13133457|NCT02769247|25987839|FG002|Overall Study|Physician Decision|0|||
13133458|NCT02769247|25987840|FG003|Overall Study|Physician Decision|0|||
13133459|NCT02769065|25988341|FG000|Overall Study|Voluntary Withdrawal|1|||
13133460|NCT02769065|25988342|FG001|Overall Study|Voluntary Withdrawal|0|||
13280314|NCT01049984|26455053|FG000|Overall Study|Treatment failure|0|||
13280315|NCT01049984|26455054|FG001|Overall Study|Treatment failure|2|||
13280316|NCT01049919|26455075|FG000|Overall Study|Met study endpoint (major amputation, death)|36|||
13280317|NCT01049919|26455076|FG001|Overall Study|Met study endpoint (major amputation, death)|16|||
13280318|NCT01049919|26455075|FG000|Overall Study|Withdrawal by Subject|5|||
13280319|NCT01049919|26455076|FG001|Overall Study|Withdrawal by Subject|0|||
13280320|NCT01049919|26455075|FG000|Overall Study|Lost to Follow-up|6|||
13280321|NCT01049919|26455076|FG001|Overall Study|Lost to Follow-up|1|||
13280322|NCT01049919|26455075|FG000|Overall Study|Physician Decision|2|||
13280323|NCT01049919|26455076|FG001|Overall Study|Physician Decision|0|||
13280324|NCT01049919|26455075|FG000|Overall Study|Received 2nd treatment via compassionate use|1|||
13280325|NCT01049919|26455076|FG001|Overall Study|Received 2nd treatment via compassionate use|0|||
13280326|NCT01049919|26455075|FG000|Overall Study|Early study termination by sponsor.|2|||
13280327|NCT01049919|26455076|FG001|Overall Study|Early study termination by sponsor.|0|||
13280328|NCT01049581|26455092|FG000|Overall Study|Lost to Follow-up|2|||
13280329|NCT01049581|26455093|FG001|Overall Study|Lost to Follow-up|1|||
13280330|NCT01049373|26455114|FG000|Overall Study|Protocol Violation|9|||
13280331|NCT01049373|26455115|FG001|Overall Study|Protocol Violation|9|||
13280332|NCT01049373|26455114|FG000|Overall Study|Withdrawal by Subject|8|||
13280333|NCT01049373|26455115|FG001|Overall Study|Withdrawal by Subject|5|||
13280334|NCT01049373|26455114|FG000|Overall Study|Adverse Event|3|||
13280335|NCT01049373|26455115|FG001|Overall Study|Adverse Event|3|||
13280336|NCT01049373|26455114|FG000|Overall Study|Lost to Follow-up|9|||
13280337|NCT01049373|26455115|FG001|Overall Study|Lost to Follow-up|4|||
13280338|NCT01049373|26455114|FG000|Overall Study|no evaluable study values|9|||
13133461|NCT02769065|25988343|FG002|Overall Study|Voluntary Withdrawal|0|||
13280339|NCT01049373|26455115|FG001|Overall Study|no evaluable study values|21|||
13280340|NCT01049373|26455114|FG000|Overall Study|Other|1|||
13280341|NCT01049373|26455115|FG001|Overall Study|Other|1|||
13280342|NCT01049373|26455114|FG000|Overall Study|Non-cooperation|0|||
13280343|NCT01049373|26455115|FG001|Overall Study|Non-cooperation|1|||
13280344|NCT01049360|26455158|FG000|Period 1|Adverse Event|0|||
13280345|NCT01049360|26455159|FG001|Period 1|Adverse Event|1|||
13280346|NCT01049360|26455160|FG002|Period 1|Adverse Event|0|||
13280347|NCT01049360|26455161|FG003|Period 1|Adverse Event|1|||
13280348|NCT01049360|26455162|FG004|Period 1|Adverse Event|0|||
13280349|NCT01049360|26455163|FG005|Period 1|Adverse Event|0|||
13280350|NCT01049360|26455164|FG006|Period 1|Adverse Event|0|||
13280351|NCT01049360|26455165|FG007|Period 1|Adverse Event|1|||
13280352|NCT01049360|26455166|FG008|Period 1|Adverse Event|0|||
13280353|NCT01049360|26455167|FG009|Period 1|Adverse Event|0|||
13280354|NCT01049360|26455168|FG010|Period 1|Adverse Event|0|||
13280355|NCT01049360|26455169|FG011|Period 1|Adverse Event|0|||
13133462|NCT02769065|25988344|FG003|Overall Study|Voluntary Withdrawal|0|||
13133463|NCT02769065|25988345|FG004|Overall Study|Voluntary Withdrawal|0|||
13280356|NCT01049360|26455170|FG012|Period 1|Adverse Event|1|||
13133464|NCT02769065|25988346|FG005|Overall Study|Voluntary Withdrawal|0|||
13280357|NCT01049360|26455171|FG013|Period 1|Adverse Event|1|||
13280358|NCT01049360|26455172|FG014|Period 1|Adverse Event|0|||
13280359|NCT01049360|26455173|FG015|Period 1|Adverse Event|0|||
13280360|NCT01049360|26455174|FG016|Period 1|Adverse Event|1|||
13280361|NCT01049360|26455175|FG017|Period 1|Adverse Event|0|||
13280362|NCT01049360|26455176|FG018|Period 1|Adverse Event|1|||
13280363|NCT01049360|26455177|FG019|Period 1|Adverse Event|0|||
13280364|NCT01049360|26455158|FG000|Period 1|Did not meet inc/exc criteria|0|||
13280365|NCT01049360|26455159|FG001|Period 1|Did not meet inc/exc criteria|0|||
13280366|NCT01049360|26455160|FG002|Period 1|Did not meet inc/exc criteria|0|||
13280367|NCT01049360|26455161|FG003|Period 1|Did not meet inc/exc criteria|0|||
13280368|NCT01049360|26455162|FG004|Period 1|Did not meet inc/exc criteria|0|||
13280369|NCT01049360|26455163|FG005|Period 1|Did not meet inc/exc criteria|0|||
13280370|NCT01049360|26455164|FG006|Period 1|Did not meet inc/exc criteria|0|||
13280371|NCT01049360|26455165|FG007|Period 1|Did not meet inc/exc criteria|1|||
13280372|NCT01049360|26455166|FG008|Period 1|Did not meet inc/exc criteria|1|||
13280373|NCT01049360|26455167|FG009|Period 1|Did not meet inc/exc criteria|0|||
13280374|NCT01049360|26455168|FG010|Period 1|Did not meet inc/exc criteria|0|||
13280375|NCT01049360|26455169|FG011|Period 1|Did not meet inc/exc criteria|0|||
13280376|NCT01049360|26455170|FG012|Period 1|Did not meet inc/exc criteria|0|||
13280377|NCT01049360|26455171|FG013|Period 1|Did not meet inc/exc criteria|0|||
13280378|NCT01049360|26455172|FG014|Period 1|Did not meet inc/exc criteria|0|||
13280379|NCT01049360|26455173|FG015|Period 1|Did not meet inc/exc criteria|0|||
13280380|NCT01049360|26455174|FG016|Period 1|Did not meet inc/exc criteria|0|||
13280381|NCT01049360|26455175|FG017|Period 1|Did not meet inc/exc criteria|0|||
13280382|NCT01049360|26455176|FG018|Period 1|Did not meet inc/exc criteria|0|||
13280383|NCT01049360|26455177|FG019|Period 1|Did not meet inc/exc criteria|0|||
13280384|NCT01049360|26455158|FG000|Period 1|Withdrawal by Subject|0|||
13280385|NCT01049360|26455159|FG001|Period 1|Withdrawal by Subject|0|||
13280386|NCT01049360|26455160|FG002|Period 1|Withdrawal by Subject|0|||
13280387|NCT01049360|26455161|FG003|Period 1|Withdrawal by Subject|0|||
13280388|NCT01049360|26455162|FG004|Period 1|Withdrawal by Subject|0|||
13280389|NCT01049360|26455163|FG005|Period 1|Withdrawal by Subject|0|||
13280390|NCT01049360|26455164|FG006|Period 1|Withdrawal by Subject|0|||
13280391|NCT01049360|26455165|FG007|Period 1|Withdrawal by Subject|0|||
13280392|NCT01049360|26455166|FG008|Period 1|Withdrawal by Subject|1|||
13280393|NCT01049360|26455167|FG009|Period 1|Withdrawal by Subject|0|||
13280394|NCT01049360|26455168|FG010|Period 1|Withdrawal by Subject|1|||
13280395|NCT01049360|26455169|FG011|Period 1|Withdrawal by Subject|0|||
13280396|NCT01049360|26455170|FG012|Period 1|Withdrawal by Subject|1|||
13280397|NCT01049360|26455171|FG013|Period 1|Withdrawal by Subject|0|||
13280398|NCT01049360|26455172|FG014|Period 1|Withdrawal by Subject|0|||
13280399|NCT01049360|26455173|FG015|Period 1|Withdrawal by Subject|0|||
13280400|NCT01049360|26455174|FG016|Period 1|Withdrawal by Subject|0|||
13280401|NCT01049360|26455175|FG017|Period 1|Withdrawal by Subject|0|||
13280402|NCT01049360|26455176|FG018|Period 1|Withdrawal by Subject|0|||
13280403|NCT01049360|26455177|FG019|Period 1|Withdrawal by Subject|0|||
13280404|NCT01049360|26455158|FG000|Period 2|Protocol Violation|0|||
13280405|NCT01049360|26455159|FG001|Period 2|Protocol Violation|0|||
13280406|NCT01049360|26455160|FG002|Period 2|Protocol Violation|0|||
13120173|NCT03005067|25936994|FG000|Overall Study|Withdrawal by Subject|3|||
13120174|NCT03005067|25936995|FG001|Overall Study|Withdrawal by Subject|2|||
13120175|NCT03005067|25936994|FG000|Overall Study|Adverse Event|4|||
13120176|NCT03005067|25936995|FG001|Overall Study|Adverse Event|3|||
13120177|NCT03005067|25936994|FG000|Overall Study|Other (reason not specified)|3|||
13120178|NCT03005067|25936995|FG001|Overall Study|Other (reason not specified)|1|||
13120179|NCT03005067|25936994|FG000|Overall Study|Protocol Violation|0|||
13120180|NCT03005067|25936995|FG001|Overall Study|Protocol Violation|1|||
13120181|NCT03004924|25937055|FG000|Overall Study|Adverse Event|6|||
13120182|NCT03004924|25937056|FG001|Overall Study|Adverse Event|5|||
13120183|NCT03004924|25937057|FG002|Overall Study|Adverse Event|10|||
13120184|NCT03004924|25937055|FG000|Overall Study|Protocol Violation|4|||
13120185|NCT03004924|25937056|FG001|Overall Study|Protocol Violation|0|||
13120186|NCT03004924|25937057|FG002|Overall Study|Protocol Violation|1|||
13280407|NCT01049360|26455161|FG003|Period 2|Protocol Violation|1|||
13280408|NCT01049360|26455162|FG004|Period 2|Protocol Violation|0|||
13280409|NCT01049360|26455163|FG005|Period 2|Protocol Violation|0|||
13120187|NCT03004924|25937055|FG000|Overall Study|Withdrawal by Subject|5|||
13280410|NCT01049360|26455164|FG006|Period 2|Protocol Violation|0|||
13280411|NCT01049360|26455165|FG007|Period 2|Protocol Violation|0|||
13280412|NCT01049360|26455166|FG008|Period 2|Protocol Violation|0|||
13280413|NCT01049360|26455167|FG009|Period 2|Protocol Violation|0|||
13280414|NCT01049360|26455168|FG010|Period 2|Protocol Violation|0|||
13280415|NCT01049360|26455169|FG011|Period 2|Protocol Violation|0|||
13280416|NCT01049360|26455170|FG012|Period 2|Protocol Violation|0|||
13280417|NCT01049360|26455171|FG013|Period 2|Protocol Violation|0|||
13280418|NCT01049360|26455172|FG014|Period 2|Protocol Violation|1|||
13280419|NCT01049360|26455173|FG015|Period 2|Protocol Violation|1|||
13280420|NCT01049360|26455174|FG016|Period 2|Protocol Violation|0|||
13280421|NCT01049360|26455175|FG017|Period 2|Protocol Violation|0|||
13280422|NCT01049360|26455176|FG018|Period 2|Protocol Violation|0|||
13280423|NCT01049360|26455177|FG019|Period 2|Protocol Violation|0|||
13120188|NCT03004924|25937056|FG001|Overall Study|Withdrawal by Subject|3|||
13120189|NCT03004924|25937057|FG002|Overall Study|Withdrawal by Subject|5|||
13120190|NCT03004924|25937055|FG000|Overall Study|Lost to Follow-up|6|||
13120191|NCT03004924|25937056|FG001|Overall Study|Lost to Follow-up|1|||
13120192|NCT03004924|25937057|FG002|Overall Study|Lost to Follow-up|4|||
13120193|NCT03004924|25937055|FG000|Overall Study|Lack of Efficacy|2|||
13120194|NCT03004924|25937056|FG001|Overall Study|Lack of Efficacy|4|||
13120195|NCT03004924|25937057|FG002|Overall Study|Lack of Efficacy|2|||
13120196|NCT03004924|25937055|FG000|Overall Study|Physician Decision|1|||
13120197|NCT03004924|25937056|FG001|Overall Study|Physician Decision|0|||
13120198|NCT03004924|25937057|FG002|Overall Study|Physician Decision|1|||
13120199|NCT03004924|25937055|FG000|Overall Study|Withdrawal by parent/guardian|1|||
13120200|NCT03004924|25937056|FG001|Overall Study|Withdrawal by parent/guardian|0|||
13120201|NCT03004924|25937057|FG002|Overall Study|Withdrawal by parent/guardian|2|||
13120202|NCT03004924|25937055|FG000|Overall Study|Screen Failure|1|||
13120203|NCT03004924|25937056|FG001|Overall Study|Screen Failure|0|||
13120204|NCT03004924|25937057|FG002|Overall Study|Screen Failure|0|||
13120205|NCT03004924|25937055|FG000|Overall Study|Pregnancy|0|||
13120206|NCT03004924|25937056|FG001|Overall Study|Pregnancy|1|||
13120207|NCT03004924|25937057|FG002|Overall Study|Pregnancy|0|||
13120208|NCT03004924|25937055|FG000|Overall Study|Terminated by Sponsor|0|||
13120209|NCT03004924|25937056|FG001|Overall Study|Terminated by Sponsor|0|||
13120210|NCT03004924|25937057|FG002|Overall Study|Terminated by Sponsor|1|||
13120211|NCT03004924|25937055|FG000|Overall Study|Missed Study Visit|0|||
13120212|NCT03004924|25937056|FG001|Overall Study|Missed Study Visit|0|||
13120213|NCT03004924|25937057|FG002|Overall Study|Missed Study Visit|2|||
13120214|NCT03004924|25937055|FG000|Overall Study|HSV1 Positive|1|||
13120215|NCT03004924|25937056|FG001|Overall Study|HSV1 Positive|0|||
13120216|NCT03004924|25937057|FG002|Overall Study|HSV1 Positive|0|||
13120217|NCT03004469|25937099|FG000|Overall Study|Adverse Event|6|||
13120218|NCT03004469|25937100|FG001|Overall Study|Adverse Event|4|||
13120219|NCT03004469|25937101|FG002|Overall Study|Adverse Event|6|||
13120220|NCT03004469|25937099|FG000|Overall Study|Lack of Efficacy|1|||
13120221|NCT03004469|25937100|FG001|Overall Study|Lack of Efficacy|0|||
13120222|NCT03004469|25937101|FG002|Overall Study|Lack of Efficacy|1|||
13120223|NCT03004469|25937099|FG000|Overall Study|Lost to Follow-up|23|||
13280424|NCT01049360|26455158|FG000|Period 2|Adverse Event|0|||
13280425|NCT01049360|26455159|FG001|Period 2|Adverse Event|1|||
13280426|NCT01049360|26455160|FG002|Period 2|Adverse Event|0|||
13280427|NCT01049360|26455161|FG003|Period 2|Adverse Event|0|||
13280428|NCT01049360|26455162|FG004|Period 2|Adverse Event|0|||
13280429|NCT01049360|26455163|FG005|Period 2|Adverse Event|0|||
13280430|NCT01049360|26455164|FG006|Period 2|Adverse Event|0|||
13280431|NCT01049360|26455165|FG007|Period 2|Adverse Event|0|||
13280432|NCT01049360|26455166|FG008|Period 2|Adverse Event|1|||
13280433|NCT01049360|26455167|FG009|Period 2|Adverse Event|0|||
13280434|NCT01049360|26455168|FG010|Period 2|Adverse Event|0|||
13280435|NCT01049360|26455169|FG011|Period 2|Adverse Event|0|||
13280436|NCT01049360|26455170|FG012|Period 2|Adverse Event|0|||
13280437|NCT01049360|26455171|FG013|Period 2|Adverse Event|0|||
13280438|NCT01049360|26455172|FG014|Period 2|Adverse Event|0|||
13280439|NCT01049360|26455173|FG015|Period 2|Adverse Event|0|||
13280440|NCT01049360|26455174|FG016|Period 2|Adverse Event|0|||
13280441|NCT01049360|26455175|FG017|Period 2|Adverse Event|0|||
13280442|NCT01049360|26455176|FG018|Period 2|Adverse Event|0|||
13280443|NCT01049360|26455177|FG019|Period 2|Adverse Event|1|||
13280444|NCT01049360|26455158|FG000|Period 2|Withdrawal by Subject|0|||
13280445|NCT01049360|26455159|FG001|Period 2|Withdrawal by Subject|0|||
13120224|NCT03004469|25937100|FG001|Overall Study|Lost to Follow-up|14|||
13280446|NCT01049360|26455160|FG002|Period 2|Withdrawal by Subject|0|||
13280447|NCT01049360|26455161|FG003|Period 2|Withdrawal by Subject|1|||
13280448|NCT01049360|26455162|FG004|Period 2|Withdrawal by Subject|0|||
13280449|NCT01049360|26455163|FG005|Period 2|Withdrawal by Subject|0|||
13280450|NCT01049360|26455164|FG006|Period 2|Withdrawal by Subject|0|||
13280451|NCT01049360|26455165|FG007|Period 2|Withdrawal by Subject|0|||
13120225|NCT03004469|25937101|FG002|Overall Study|Lost to Follow-up|6|||
13120226|NCT03004469|25937099|FG000|Overall Study|Non-Compliance with Study Drug|2|||
13120227|NCT03004469|25937100|FG001|Overall Study|Non-Compliance with Study Drug|0|||
13120228|NCT03004469|25937101|FG002|Overall Study|Non-Compliance with Study Drug|0|||
13120229|NCT03004469|25937099|FG000|Overall Study|Protocol Violation|0|||
13280452|NCT01049360|26455166|FG008|Period 2|Withdrawal by Subject|0|||
13280453|NCT01049360|26455167|FG009|Period 2|Withdrawal by Subject|0|||
13280454|NCT01049360|26455168|FG010|Period 2|Withdrawal by Subject|0|||
13280455|NCT01049360|26455169|FG011|Period 2|Withdrawal by Subject|0|||
13120230|NCT03004469|25937100|FG001|Overall Study|Protocol Violation|0|||
13120231|NCT03004469|25937101|FG002|Overall Study|Protocol Violation|1|||
13120232|NCT03004469|25937099|FG000|Overall Study|Withdrawal by Subject|29|||
13280456|NCT01049360|26455170|FG012|Period 2|Withdrawal by Subject|0|||
13280457|NCT01049360|26455171|FG013|Period 2|Withdrawal by Subject|0|||
13280458|NCT01049360|26455172|FG014|Period 2|Withdrawal by Subject|1|||
13280459|NCT01049360|26455173|FG015|Period 2|Withdrawal by Subject|0|||
13280460|NCT01049360|26455174|FG016|Period 2|Withdrawal by Subject|0|||
13280461|NCT01049360|26455175|FG017|Period 2|Withdrawal by Subject|0|||
13280462|NCT01049360|26455176|FG018|Period 2|Withdrawal by Subject|0|||
13280463|NCT01049360|26455177|FG019|Period 2|Withdrawal by Subject|1|||
13280464|NCT01049360|26455158|FG000|Period 2|Lack of Efficacy|0|||
13280465|NCT01049360|26455159|FG001|Period 2|Lack of Efficacy|0|||
13280466|NCT01049360|26455160|FG002|Period 2|Lack of Efficacy|0|||
13280467|NCT01049360|26455161|FG003|Period 2|Lack of Efficacy|0|||
13280468|NCT01049360|26455162|FG004|Period 2|Lack of Efficacy|0|||
13280469|NCT01049360|26455163|FG005|Period 2|Lack of Efficacy|1|||
13280470|NCT01049360|26455164|FG006|Period 2|Lack of Efficacy|0|||
13280471|NCT01049360|26455165|FG007|Period 2|Lack of Efficacy|0|||
13280472|NCT01049360|26455166|FG008|Period 2|Lack of Efficacy|0|||
13280473|NCT01049360|26455167|FG009|Period 2|Lack of Efficacy|0|||
13280474|NCT01049360|26455168|FG010|Period 2|Lack of Efficacy|0|||
13280475|NCT01049360|26455169|FG011|Period 2|Lack of Efficacy|0|||
13280476|NCT01049360|26455170|FG012|Period 2|Lack of Efficacy|0|||
13280477|NCT01049360|26455171|FG013|Period 2|Lack of Efficacy|0|||
13280478|NCT01049360|26455172|FG014|Period 2|Lack of Efficacy|0|||
13280479|NCT01049360|26455173|FG015|Period 2|Lack of Efficacy|0|||
13280480|NCT01049360|26455174|FG016|Period 2|Lack of Efficacy|0|||
13280481|NCT01049360|26455175|FG017|Period 2|Lack of Efficacy|0|||
13280482|NCT01049360|26455176|FG018|Period 2|Lack of Efficacy|0|||
13280483|NCT01049360|26455177|FG019|Period 2|Lack of Efficacy|0|||
13280484|NCT01049360|26455158|FG000|Period 4|Protocol Violation|0|||
13280485|NCT01049360|26455159|FG001|Period 4|Protocol Violation|0|||
13280486|NCT01049360|26455160|FG002|Period 4|Protocol Violation|0|||
13280487|NCT01049360|26455161|FG003|Period 4|Protocol Violation|0|||
13280488|NCT01049360|26455162|FG004|Period 4|Protocol Violation|0|||
13280489|NCT01049360|26455163|FG005|Period 4|Protocol Violation|0|||
13280490|NCT01049360|26455164|FG006|Period 4|Protocol Violation|0|||
13280491|NCT01049360|26455165|FG007|Period 4|Protocol Violation|0|||
13280492|NCT01049360|26455166|FG008|Period 4|Protocol Violation|0|||
13280493|NCT01049360|26455167|FG009|Period 4|Protocol Violation|0|||
13280494|NCT01049360|26455168|FG010|Period 4|Protocol Violation|0|||
13280495|NCT01049360|26455169|FG011|Period 4|Protocol Violation|0|||
13280496|NCT01049360|26455170|FG012|Period 4|Protocol Violation|0|||
13280497|NCT01049360|26455171|FG013|Period 4|Protocol Violation|0|||
13280498|NCT01049360|26455172|FG014|Period 4|Protocol Violation|0|||
13280499|NCT01049360|26455173|FG015|Period 4|Protocol Violation|0|||
13280500|NCT01049360|26455174|FG016|Period 4|Protocol Violation|0|||
13280501|NCT01049360|26455175|FG017|Period 4|Protocol Violation|1|||
13280502|NCT01049360|26455176|FG018|Period 4|Protocol Violation|0|||
13280503|NCT01049360|26455177|FG019|Period 4|Protocol Violation|0|||
13280504|NCT01049360|26455158|FG000|Period 4|Withdrawal by Subject|0|||
13280505|NCT01049360|26455159|FG001|Period 4|Withdrawal by Subject|0|||
13280506|NCT01049360|26455160|FG002|Period 4|Withdrawal by Subject|0|||
13280507|NCT01049360|26455161|FG003|Period 4|Withdrawal by Subject|1|||
13280508|NCT01049360|26455162|FG004|Period 4|Withdrawal by Subject|0|||
13280509|NCT01049360|26455163|FG005|Period 4|Withdrawal by Subject|0|||
13280510|NCT01049360|26455164|FG006|Period 4|Withdrawal by Subject|0|||
13280511|NCT01049360|26455165|FG007|Period 4|Withdrawal by Subject|0|||
13280512|NCT01049360|26455166|FG008|Period 4|Withdrawal by Subject|0|||
13280513|NCT01049360|26455167|FG009|Period 4|Withdrawal by Subject|0|||
13280514|NCT01049360|26455168|FG010|Period 4|Withdrawal by Subject|0|||
13280515|NCT01049360|26455169|FG011|Period 4|Withdrawal by Subject|0|||
13280516|NCT01049360|26455170|FG012|Period 4|Withdrawal by Subject|0|||
13120233|NCT03004469|25937100|FG001|Overall Study|Withdrawal by Subject|27|||
13120234|NCT03004469|25937101|FG002|Overall Study|Withdrawal by Subject|10|||
13120235|NCT03004469|25937099|FG000|Overall Study|Other unspecified reason|0|||
13120236|NCT03004469|25937100|FG001|Overall Study|Other unspecified reason|4|||
13120237|NCT03004469|25937101|FG002|Overall Study|Other unspecified reason|1|||
13120238|NCT03003676|25937116|FG000|Overall Study|Lack of Efficacy|5|||
13120239|NCT03003676|25937117|FG001|Overall Study|Lack of Efficacy|7|||
13120240|NCT03003676|25937116|FG000|Overall Study|Withdrawal by Subject|0|||
13120241|NCT03003676|25937117|FG001|Overall Study|Withdrawal by Subject|1|||
13120242|NCT03003676|25937116|FG000|Overall Study|Hepatitis B infection|1|||
13120243|NCT03003676|25937117|FG001|Overall Study|Hepatitis B infection|0|||
13120244|NCT03003520|25937142|FG000|Induction|Ongoing|1|||
13280517|NCT01049360|26455171|FG013|Period 4|Withdrawal by Subject|0|||
13280518|NCT01049360|26455172|FG014|Period 4|Withdrawal by Subject|0|||
13280519|NCT01049360|26455173|FG015|Period 4|Withdrawal by Subject|0|||
13280520|NCT01049360|26455174|FG016|Period 4|Withdrawal by Subject|0|||
13280521|NCT01049360|26455175|FG017|Period 4|Withdrawal by Subject|0|||
13120245|NCT03003520|25937143|FG001|Induction|Ongoing|0|||
13120246|NCT03003520|25937142|FG000|Induction|Adverse Event|4|||
13280522|NCT01049360|26455176|FG018|Period 4|Withdrawal by Subject|0|||
13280523|NCT01049360|26455177|FG019|Period 4|Withdrawal by Subject|0|||
13280524|NCT01049334|26455220|FG000|Overall Study|Withdrawal by Subject|5|||
13280525|NCT01049334|26455221|FG001|Overall Study|Withdrawal by Subject|3|||
13280526|NCT01049334|26455220|FG000|Overall Study|Adverse Event|2|||
13280527|NCT01049334|26455221|FG001|Overall Study|Adverse Event|3|||
13280528|NCT01049334|26455220|FG000|Overall Study|Physician Decision|2|||
13120247|NCT03003520|25937143|FG001|Induction|Adverse Event|0|||
13120248|NCT03003520|25937142|FG000|Induction|Death|1|||
13120249|NCT03003520|25937143|FG001|Induction|Death|0|||
13120250|NCT03003520|25937142|FG000|Induction|Palliative care|1|||
13120251|NCT03003520|25937143|FG001|Induction|Palliative care|0|||
13120252|NCT03003520|25937142|FG000|Induction|Physician Decision|2|||
13120253|NCT03003520|25937143|FG001|Induction|Physician Decision|0|||
13120254|NCT03003520|25937142|FG000|Induction|Withdrawal by Subject|3|||
13120255|NCT03003520|25937143|FG001|Induction|Withdrawal by Subject|0|||
13120256|NCT03003520|25937142|FG000|Induction|Progressive disease|1|||
13120257|NCT03003520|25937143|FG001|Induction|Progressive disease|0|||
13120258|NCT03003520|25937142|FG000|Consolidation|Ongoing|18|||
13120259|NCT03003520|25937143|FG001|Consolidation|Ongoing|0|||
13120260|NCT03003520|25937142|FG000|Consolidation|Adverse Event|2|||
13120261|NCT03003520|25937143|FG001|Consolidation|Adverse Event|0|||
13120262|NCT03003520|25937142|FG000|Consolidation|Progressive disease|3|||
13120263|NCT03003520|25937143|FG001|Consolidation|Progressive disease|1|||
13280529|NCT01049334|26455221|FG001|Overall Study|Physician Decision|0|||
13280530|NCT01049334|26455220|FG000|Overall Study|Protocol Violation|0|||
13280531|NCT01049334|26455221|FG001|Overall Study|Protocol Violation|1|||
13280532|NCT01049308|26455230|FG000|Pill Counts|Withdrawal by Subject|83|||
13280533|NCT01049035|26455409|FG000|Overall Study|Serious adverse event|0|||
13280534|NCT01049035|26455410|FG001|Overall Study|Serious adverse event|1|||
13280535|NCT01049035|26455411|FG002|Overall Study|Serious adverse event|1|||
13280536|NCT01049035|26455412|FG003|Overall Study|Serious adverse event|2|||
13280537|NCT01049035|26455413|FG004|Overall Study|Serious adverse event|0|||
13280538|NCT01049035|26455414|FG005|Overall Study|Serious adverse event|0|||
13280539|NCT01049035|26455415|FG006|Overall Study|Serious adverse event|0|||
13280540|NCT01049035|26455409|FG000|Overall Study|Other adverse event (AE)|0|||
13280541|NCT01049035|26455410|FG001|Overall Study|Other adverse event (AE)|0|||
13280542|NCT01049035|26455411|FG002|Overall Study|Other adverse event (AE)|0|||
13280543|NCT01049035|26455412|FG003|Overall Study|Other adverse event (AE)|1|||
13280544|NCT01049035|26455413|FG004|Overall Study|Other adverse event (AE)|0|||
13280545|NCT01049035|26455414|FG005|Overall Study|Other adverse event (AE)|0|||
13280546|NCT01049035|26455415|FG006|Overall Study|Other adverse event (AE)|0|||
13280547|NCT01049035|26455409|FG000|Overall Study|Non-compliance with the protocol|12|||
13280548|NCT01049035|26455410|FG001|Overall Study|Non-compliance with the protocol|6|||
13280549|NCT01049035|26455411|FG002|Overall Study|Non-compliance with the protocol|14|||
13120264|NCT03003520|25937142|FG000|Consolidation|Withdrawal by Subject|1|||
13280550|NCT01049035|26455412|FG003|Overall Study|Non-compliance with the protocol|5|||
13120265|NCT03003520|25937143|FG001|Consolidation|Withdrawal by Subject|0|||
13120266|NCT03003520|25937142|FG000|Follow-up|Death|1|||
13120267|NCT03003520|25937143|FG001|Follow-up|Death|1|||
13120268|NCT03003520|25937142|FG000|Follow-up|Ongoing|12|||
13120269|NCT03003520|25937143|FG001|Follow-up|Ongoing|2|||
13120270|NCT03003520|25937142|FG000|Follow-up|Withdrawal by Subject|1|||
13120271|NCT03003520|25937143|FG001|Follow-up|Withdrawal by Subject|0|||
13120272|NCT03003494|25937154|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28|||
13120273|NCT03003390|25937186|FG000|Overall Study|Physician Decision|2|||
13120274|NCT03003390|25937187|FG001|Overall Study|Physician Decision|0|||
13120275|NCT03003390|25937186|FG000|Overall Study|Parent refused intervention|2|||
13120276|NCT03003390|25937187|FG001|Overall Study|Parent refused intervention|0|||
13120277|NCT03003000|25937223|FG000|Overall Study|Adverse Event|1|||
13120278|NCT03003000|25937224|FG001|Overall Study|Adverse Event|2|||
13120279|NCT03003000|25937225|FG002|Overall Study|Adverse Event|3|||
13120280|NCT03003000|25937223|FG000|Overall Study|Lack of Efficacy|1|||
13120281|NCT03003000|25937224|FG001|Overall Study|Lack of Efficacy|0|||
13120282|NCT03003000|25937225|FG002|Overall Study|Lack of Efficacy|0|||
13120283|NCT03003000|25937223|FG000|Overall Study|Non-compliant with protocol|0|||
13120284|NCT03003000|25937224|FG001|Overall Study|Non-compliant with protocol|1|||
13120285|NCT03003000|25937225|FG002|Overall Study|Non-compliant with protocol|1|||
13120286|NCT03003000|25937223|FG000|Overall Study|Refused to continue medication|2|||
13120287|NCT03003000|25937224|FG001|Overall Study|Refused to continue medication|0|||
13120288|NCT03003000|25937225|FG002|Overall Study|Refused to continue medication|0|||
13120289|NCT03003000|25937223|FG000|Overall Study|Other than listed|1|||
13120290|NCT03003000|25937224|FG001|Overall Study|Other than listed|1|||
13120291|NCT03003000|25937225|FG002|Overall Study|Other than listed|1|||
13120292|NCT03002818|25937239|FG000|Overall Study|Decision of the investigator|1|||
13120293|NCT03002623|25937260|FG000|Overall Study|Lost to Follow-up|1|||
13120294|NCT03002623|25937261|FG001|Overall Study|Lost to Follow-up|0|||
13120295|NCT03002623|25937260|FG000|Overall Study|Physician Decision|1|||
13120296|NCT03002623|25937261|FG001|Overall Study|Physician Decision|1|||
13120297|NCT03002610|25937288|FG000|Overall Study|Withdrawal by Subject|6|||
13120298|NCT03002610|25937289|FG001|Overall Study|Withdrawal by Subject|25|||
13120299|NCT03002610|25937290|FG002|Overall Study|Withdrawal by Subject|13|||
13120300|NCT03002311|25937305|FG000|Overall Study|Lost to Follow-up|13|||
13280551|NCT01049035|26455413|FG004|Overall Study|Non-compliance with the protocol|3|||
13280552|NCT01049035|26455414|FG005|Overall Study|Non-compliance with the protocol|4|||
13120301|NCT03002311|25937306|FG001|Overall Study|Lost to Follow-up|26|||
13120302|NCT03002311|25937305|FG000|Overall Study|Referral provider called to schedule app|3|||
13120303|NCT03002311|25937306|FG001|Overall Study|Referral provider called to schedule app|3|||
13120304|NCT03002311|25937305|FG000|Overall Study|Physician Decision|3|||
13120305|NCT03002311|25937306|FG001|Overall Study|Physician Decision|1|||
13120306|NCT03002194|25937314|FG000|Overall Study|Lost to Follow-up|6|||
13120307|NCT03002194|25937314|FG000|Overall Study|Adverse Event|1|||
13120308|NCT03002194|25937314|FG000|Overall Study|Lack of Efficacy|1|||
13120309|NCT03002194|25937314|FG000|Overall Study|Withdrawal by Subject|2|||
13120310|NCT03002077|25937322|FG000|Overall Study|Non-compliance with Study Drug|4|||
13120311|NCT03002077|25937322|FG000|Overall Study|Non-compliance w/Background ADT|1|||
13120312|NCT03002077|25937322|FG000|Overall Study|Study Terminated by Sponsor|257|||
13120313|NCT03002077|25937322|FG000|Overall Study|Site Terminated by Sponsor|5|||
13120314|NCT03002077|25937322|FG000|Overall Study|Miscellaneous Reasons|10|||
13120315|NCT03002077|25937322|FG000|Overall Study|Adverse Event|23|||
13120316|NCT03002077|25937322|FG000|Overall Study|Lack of Efficacy|20|||
13280553|NCT01049035|26455415|FG006|Overall Study|Non-compliance with the protocol|10|||
13280554|NCT01049035|26455409|FG000|Overall Study|Lost to Follow-up|5|||
13120317|NCT03002077|25937322|FG000|Overall Study|Withdrawal by Subject|72|||
13120318|NCT03002077|25937322|FG000|Overall Study|Lost to Follow-up|21|||
13120319|NCT03002077|25937322|FG000|Overall Study|Pregnancy|4|||
13280555|NCT01049035|26455410|FG001|Overall Study|Lost to Follow-up|4|||
13280556|NCT01049035|26455411|FG002|Overall Study|Lost to Follow-up|4|||
13280557|NCT01049035|26455412|FG003|Overall Study|Lost to Follow-up|1|||
13280558|NCT01049035|26455413|FG004|Overall Study|Lost to Follow-up|0|||
13280559|NCT01049035|26455414|FG005|Overall Study|Lost to Follow-up|3|||
13280560|NCT01049035|26455415|FG006|Overall Study|Lost to Follow-up|3|||
13280561|NCT01049035|26455409|FG000|Overall Study|Voluntary withdrawal not due to an AE|16|||
13280562|NCT01049035|26455410|FG001|Overall Study|Voluntary withdrawal not due to an AE|10|||
13280563|NCT01049035|26455411|FG002|Overall Study|Voluntary withdrawal not due to an AE|8|||
13280564|NCT01049035|26455412|FG003|Overall Study|Voluntary withdrawal not due to an AE|2|||
13280565|NCT01049035|26455413|FG004|Overall Study|Voluntary withdrawal not due to an AE|1|||
13280566|NCT01049035|26455414|FG005|Overall Study|Voluntary withdrawal not due to an AE|5|||
13280567|NCT01049035|26455415|FG006|Overall Study|Voluntary withdrawal not due to an AE|2|||
13280568|NCT01049009|26455430|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
13280569|NCT01049009|26455431|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
13280570|NCT01049009|26455430|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
13120320|NCT03002077|25937322|FG000|Overall Study|Protocol Violation|21|||
13120321|NCT03002038|25937339|FG000|Overall Study|Adverse Event|3|||
13120322|NCT03002038|25937340|FG001|Overall Study|Adverse Event|1|||
13120323|NCT03002038|25937339|FG000|Overall Study|Withdrawal by Subject|8|||
13120324|NCT03002038|25937340|FG001|Overall Study|Withdrawal by Subject|4|||
13120325|NCT03002038|25937339|FG000|Overall Study|Immigration to another region|0|||
13120326|NCT03002038|25937340|FG001|Overall Study|Immigration to another region|2|||
13120327|NCT03001557|25937635|FG000|Core Phase|Randomized but not treated|0|||
13120328|NCT03001557|25937636|FG001|Core Phase|Randomized but not treated|0|||
13120329|NCT03001557|25937637|FG002|Core Phase|Randomized but not treated|1|||
13120330|NCT03001557|25937638|FG003|Core Phase|Randomized but not treated|0|||
13120331|NCT03001557|25937639|FG004|Core Phase|Randomized but not treated|0|||
13120332|NCT03001557|25937640|FG005|Core Phase|Randomized but not treated|0|||
13120333|NCT03001557|25937641|FG006|Core Phase|Randomized but not treated|0|||
13120334|NCT03001557|25937642|FG007|Core Phase|Randomized but not treated|0|||
13120335|NCT03001557|25937635|FG000|Extension Phase|Adverse Event|0|||
13120336|NCT03001557|25937636|FG001|Extension Phase|Adverse Event|0|||
13120337|NCT03001557|25937637|FG002|Extension Phase|Adverse Event|0|||
13120338|NCT03001557|25937638|FG003|Extension Phase|Adverse Event|0|||
13120339|NCT03001557|25937639|FG004|Extension Phase|Adverse Event|0|||
13120340|NCT03001557|25937640|FG005|Extension Phase|Adverse Event|2|||
13120341|NCT03001557|25937641|FG006|Extension Phase|Adverse Event|0|||
13120342|NCT03001557|25937642|FG007|Extension Phase|Adverse Event|0|||
13120343|NCT03001557|25937635|FG000|Extension Phase|Withdrawal by Subject|0|||
13120344|NCT03001557|25937636|FG001|Extension Phase|Withdrawal by Subject|0|||
13120345|NCT03001557|25937637|FG002|Extension Phase|Withdrawal by Subject|0|||
13120346|NCT03001557|25937638|FG003|Extension Phase|Withdrawal by Subject|0|||
13120347|NCT03001557|25937639|FG004|Extension Phase|Withdrawal by Subject|0|||
13120348|NCT03001557|25937640|FG005|Extension Phase|Withdrawal by Subject|1|||
13120349|NCT03001557|25937641|FG006|Extension Phase|Withdrawal by Subject|5|||
13120350|NCT03001557|25937642|FG007|Extension Phase|Withdrawal by Subject|2|||
13120351|NCT03001557|25937635|FG000|Extension Phase|Lost to Follow-up|0|||
13120352|NCT03001557|25937636|FG001|Extension Phase|Lost to Follow-up|0|||
13120353|NCT03001557|25937637|FG002|Extension Phase|Lost to Follow-up|0|||
13280571|NCT01049009|26455431|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
13120354|NCT03001557|25937638|FG003|Extension Phase|Lost to Follow-up|0|||
13120355|NCT03001557|25937639|FG004|Extension Phase|Lost to Follow-up|0|||
13120356|NCT03001557|25937640|FG005|Extension Phase|Lost to Follow-up|0|||
13120357|NCT03001557|25937641|FG006|Extension Phase|Lost to Follow-up|2|||
13120358|NCT03001557|25937642|FG007|Extension Phase|Lost to Follow-up|1|||
13120359|NCT03001557|25937635|FG000|Extension Phase|Administrative Reason|0|||
13120360|NCT03001557|25937636|FG001|Extension Phase|Administrative Reason|0|||
13120361|NCT03001557|25937637|FG002|Extension Phase|Administrative Reason|0|||
13120362|NCT03001557|25937638|FG003|Extension Phase|Administrative Reason|0|||
13120363|NCT03001557|25937639|FG004|Extension Phase|Administrative Reason|0|||
13120364|NCT03001557|25937640|FG005|Extension Phase|Administrative Reason|1|||
13120365|NCT03001557|25937641|FG006|Extension Phase|Administrative Reason|3|||
13120366|NCT03001557|25937642|FG007|Extension Phase|Administrative Reason|3|||
13280572|NCT01049009|26455430|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
13280573|NCT01049009|26455431|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3|||
13280574|NCT01049009|26455430|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8|||
13280575|NCT01049009|26455431|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7|||
13280576|NCT01048944|26455458|FG000|Overall Study|Protocol Violation|8|||
13280577|NCT01048944|26455459|FG001|Overall Study|Protocol Violation|10|||
13280578|NCT01048944|26455460|FG002|Overall Study|Protocol Violation|10|||
13280579|NCT01048944|26455461|FG003|Overall Study|Protocol Violation|2|||
13280580|NCT01048866|26455510|FG000|Overall Study|Adverse Event|1|||
13280581|NCT01048866|26455511|FG001|Overall Study|Adverse Event|0|||
13280582|NCT01048866|26455510|FG000|Overall Study|Protocol Violation|1|||
13120367|NCT03001557|25937635|FG000|Extension Phase|Loss of caregiver|0|||
13120368|NCT03001557|25937636|FG001|Extension Phase|Loss of caregiver|0|||
13120369|NCT03001557|25937637|FG002|Extension Phase|Loss of caregiver|0|||
13120370|NCT03001557|25937638|FG003|Extension Phase|Loss of caregiver|0|||
13120371|NCT03001557|25937639|FG004|Extension Phase|Loss of caregiver|0|||
13120372|NCT03001557|25937640|FG005|Extension Phase|Loss of caregiver|0|||
13120373|NCT03001557|25937641|FG006|Extension Phase|Loss of caregiver|1|||
13120374|NCT03001557|25937642|FG007|Extension Phase|Loss of caregiver|0|||
13120375|NCT03001557|25937635|FG000|Extension Phase|Others|0|||
13120376|NCT03001557|25937636|FG001|Extension Phase|Others|0|||
13120377|NCT03001557|25937637|FG002|Extension Phase|Others|0|||
13280583|NCT01048866|26455511|FG001|Overall Study|Protocol Violation|0|||
13280584|NCT01048866|26455510|FG000|Overall Study|Physician Decision|1|||
13280585|NCT01048866|26455511|FG001|Overall Study|Physician Decision|0|||
13280586|NCT01048866|26455510|FG000|Overall Study|Withdrawal by Subject|0|||
13280587|NCT01048866|26455511|FG001|Overall Study|Withdrawal by Subject|2|||
13280588|NCT01048866|26455510|FG000|Overall Study|Lost to Follow-up|0|||
13280589|NCT01048866|26455511|FG001|Overall Study|Lost to Follow-up|2|||
13280590|NCT01048866|26455510|FG000|Overall Study|Other|1|||
13280591|NCT01048866|26455511|FG001|Overall Study|Other|1|||
13280592|NCT01048788|26455529|FG000|Overall Study|Adverse Event|5|||
13280593|NCT01048788|26455530|FG001|Overall Study|Adverse Event|1|||
13280594|NCT01048788|26455531|FG002|Overall Study|Adverse Event|1|||
13280595|NCT01048788|26455529|FG000|Overall Study|Lack of Efficacy|0|||
13280596|NCT01048788|26455530|FG001|Overall Study|Lack of Efficacy|0|||
13280597|NCT01048788|26455531|FG002|Overall Study|Lack of Efficacy|1|||
13280598|NCT01048788|26455529|FG000|Overall Study|Withdrawal by Subject|0|||
13280599|NCT01048788|26455530|FG001|Overall Study|Withdrawal by Subject|1|||
13280600|NCT01048788|26455531|FG002|Overall Study|Withdrawal by Subject|0|||
13291760|NCT00150618|26483595|FG000|Overall Study|Adverse Event|2|||
13291761|NCT00150618|26483596|FG001|Overall Study|Adverse Event|2|||
13291762|NCT00150618|26483597|FG002|Overall Study|Adverse Event|6|||
13291763|NCT00150618|26483598|FG003|Overall Study|Adverse Event|9|||
13120378|NCT03001557|25937638|FG003|Extension Phase|Others|0|||
13120379|NCT03001557|25937639|FG004|Extension Phase|Others|0|||
13120380|NCT03001557|25937640|FG005|Extension Phase|Others|1|||
13120381|NCT03001557|25937641|FG006|Extension Phase|Others|3|||
13120382|NCT03001557|25937642|FG007|Extension Phase|Others|0|||
13291764|NCT00150618|26483599|FG004|Overall Study|Adverse Event|5|||
13291765|NCT00150618|26483595|FG000|Overall Study|Withdrawal by Subject|6|||
13291766|NCT00150618|26483596|FG001|Overall Study|Withdrawal by Subject|8|||
13291767|NCT00150618|26483597|FG002|Overall Study|Withdrawal by Subject|8|||
13291768|NCT00150618|26483598|FG003|Overall Study|Withdrawal by Subject|4|||
13291769|NCT00150618|26483599|FG004|Overall Study|Withdrawal by Subject|5|||
13291770|NCT00150618|26483595|FG000|Overall Study|Lost to Follow-up|4|||
13291771|NCT00150618|26483596|FG001|Overall Study|Lost to Follow-up|1|||
13291772|NCT00150618|26483597|FG002|Overall Study|Lost to Follow-up|5|||
13120383|NCT03001219|25937708|FG000|Proof of Concept|Study Termination by Sponsor|0|||
13291773|NCT00150618|26483598|FG003|Overall Study|Lost to Follow-up|8|||
13291774|NCT00150618|26483599|FG004|Overall Study|Lost to Follow-up|4|||
13291775|NCT00150618|26483595|FG000|Overall Study|Protocol Violation|1|||
13291776|NCT00150618|26483596|FG001|Overall Study|Protocol Violation|0|||
13291777|NCT00150618|26483597|FG002|Overall Study|Protocol Violation|0|||
13291778|NCT00150618|26483598|FG003|Overall Study|Protocol Violation|0|||
13291779|NCT00150618|26483599|FG004|Overall Study|Protocol Violation|1|||
13291780|NCT00150618|26483595|FG000|Overall Study|Lack of Efficacy|1|||
13291781|NCT00150618|26483596|FG001|Overall Study|Lack of Efficacy|4|||
13120384|NCT03001219|25937709|FG001|Proof of Concept|Study Termination by Sponsor|1|||
13120385|NCT03001219|25937708|FG000|Proof of Concept|Withdrawal by Subject|0|||
13120386|NCT03001219|25937709|FG001|Proof of Concept|Withdrawal by Subject|4|||
13280601|NCT01048671|26455562|FG000|Overall Study|Protocol Violation|0|||
13280602|NCT01048671|26455563|FG001|Overall Study|Protocol Violation|1|||
13280603|NCT01048671|26455564|FG002|Overall Study|Protocol Violation|1|||
13280604|NCT01048502|26455588|FG000|Overall Study|Lost to Follow-up|2|||
13280605|NCT01048502|26455589|FG001|Overall Study|Lost to Follow-up|0|||
13280606|NCT01048502|26455590|FG002|Overall Study|Lost to Follow-up|0|||
13120387|NCT03001219|25937708|FG000|Proof of Concept|Protocol Deviation|0|||
13120388|NCT03001219|25937709|FG001|Proof of Concept|Protocol Deviation|1|||
13120389|NCT03001219|25937708|FG000|Proof of Concept|Adverse Event|1|||
13120390|NCT03001219|25937709|FG001|Proof of Concept|Adverse Event|1|||
13120391|NCT03001219|25937708|FG000|Proof of Concept|Physician Decision|1|||
13120392|NCT03001219|25937709|FG001|Proof of Concept|Physician Decision|0|||
13120393|NCT03001219|25937708|FG000|Extension Period Analysis|Study Termination by Sponsor|0|||
13120394|NCT03001219|25937709|FG001|Extension Period Analysis|Study Termination by Sponsor|36|||
13120395|NCT03001219|25937708|FG000|Extension Period Analysis|Participant Non-Compliance|0|||
13120396|NCT03001219|25937709|FG001|Extension Period Analysis|Participant Non-Compliance|1|||
13120397|NCT03001219|25937708|FG000|Extension Period Analysis|Physician Decision|0|||
13120398|NCT03001219|25937709|FG001|Extension Period Analysis|Physician Decision|1|||
13120399|NCT03001219|25937708|FG000|Extension Period Analysis|Adverse Event|1|||
13120400|NCT03001219|25937709|FG001|Extension Period Analysis|Adverse Event|1|||
13280607|NCT01048502|26455591|FG003|Overall Study|Lost to Follow-up|0|||
13280608|NCT01048502|26455588|FG000|Overall Study|Adverse Event|1|||
13280609|NCT01048502|26455589|FG001|Overall Study|Adverse Event|0|||
13308010|NCT01280981|26530415|FG000|Overall Study|Irregular or discontinued menses|3|||
13308011|NCT01280981|26530415|FG000|Overall Study|Failed to return|45|||
13308012|NCT01280981|26530415|FG000|Overall Study|Non-compliance with protocol|3|||
13308013|NCT01280981|26530415|FG000|Overall Study|Withdrawal of consent|3|||
13308014|NCT01280981|26530415|FG000|Overall Study|Elective surgery|2|||
13308015|NCT01280981|26530415|FG000|Overall Study|Study site closure|1|||
13308016|NCT01280968|26530438|FG000|Overall Study|Lost to Follow-up|8|||
13308017|NCT01280968|26530439|FG001|Overall Study|Lost to Follow-up|2|||
13308018|NCT01280968|26530438|FG000|Overall Study|Unable to Follow Experimental Protocol|2|||
13308019|NCT01280968|26530439|FG001|Overall Study|Unable to Follow Experimental Protocol|0|||
13308020|NCT01280968|26530438|FG000|Overall Study|Commuting Problems|2|||
13308021|NCT01280968|26530439|FG001|Overall Study|Commuting Problems|0|||
13308022|NCT01280968|26530438|FG000|Overall Study|Anxiety|2|||
13308023|NCT01280968|26530439|FG001|Overall Study|Anxiety|0|||
13308024|NCT01280968|26530438|FG000|Overall Study|Adverse Event|1|||
13308025|NCT01280968|26530439|FG001|Overall Study|Adverse Event|0|||
13308026|NCT01280968|26530438|FG000|Overall Study|Scheduling Conflicts|1|||
13308027|NCT01280968|26530439|FG001|Overall Study|Scheduling Conflicts|1|||
13308028|NCT01280968|26530438|FG000|Overall Study|Pre-existing Neurological Condition|1|||
13308029|NCT01280968|26530439|FG001|Overall Study|Pre-existing Neurological Condition|0|||
13308030|NCT01280968|26530438|FG000|Overall Study|Unable to Smoke in Supine Position|1|||
13308031|NCT01280968|26530439|FG001|Overall Study|Unable to Smoke in Supine Position|0|||
13308032|NCT01280955|26530472|FG000|Overall Study|Death|2|||
13308033|NCT01280955|26530472|FG000|Overall Study|Withdrawal by Subject|1|||
13308034|NCT01280903|26530543|FG000|Overall Study|Lost to Follow-up|23|||
13308035|NCT01280903|26530544|FG001|Overall Study|Lost to Follow-up|16|||
13308036|NCT01280812|26530577|FG000|Overall Study|Withdrawal by Subject|2|||
13308037|NCT01280812|26530578|FG001|Overall Study|Withdrawal by Subject|1|||
13308038|NCT01280812|26530579|FG002|Overall Study|Withdrawal by Subject|0|||
13308039|NCT01280812|26530577|FG000|Overall Study|Lost to Follow-up|1|||
13308040|NCT01280812|26530578|FG001|Overall Study|Lost to Follow-up|1|||
13308041|NCT01280812|26530579|FG002|Overall Study|Lost to Follow-up|1|||
13308042|NCT01280721|26530596|FG000|Overall Study|Adverse Event|4|||
13308043|NCT01280721|26530596|FG000|Overall Study|Physician Decision|3|||
13308044|NCT01280721|26530596|FG000|Overall Study|Withdrawal by Subject|6|||
13120401|NCT03001219|25937708|FG000|Extension Period Analysis|Protocol Deviation|0|||
13120402|NCT03001219|25937709|FG001|Extension Period Analysis|Protocol Deviation|1|||
13120403|NCT03001219|25937708|FG000|Extension Period Analysis|Withdrawal by Subject|4|||
13120404|NCT03001219|25937709|FG001|Extension Period Analysis|Withdrawal by Subject|5|||
13120405|NCT03001076|25937748|FG000|Overall Study|Withdrawal by patient|2|||
13120406|NCT03001076|25937749|FG001|Overall Study|Withdrawal by patient|0|||
13120407|NCT03001076|25937748|FG000|Overall Study|Other|1|||
13120408|NCT03001076|25937749|FG001|Overall Study|Other|0|||
13120409|NCT03001076|25937748|FG000|Overall Study|Adverse Event|3|||
13120410|NCT03001076|25937749|FG001|Overall Study|Adverse Event|3|||
13120411|NCT03001076|25937748|FG000|Overall Study|Sponsor decision|1|||
13120412|NCT03001076|25937749|FG001|Overall Study|Sponsor decision|0|||
13308045|NCT01280721|26530596|FG000|Overall Study|eGFR under the withdrawal criteria|7|||
13120413|NCT03001076|25937748|FG000|Overall Study|Lost to Follow-up|0|||
13120414|NCT03001076|25937749|FG001|Overall Study|Lost to Follow-up|2|||
13120415|NCT03000686|25937824|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0|||
13120416|NCT03000686|25937825|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1|||
13308046|NCT01280721|26530596|FG000|Overall Study|No tolerability for the lowest dose|2|||
13120417|NCT03000686|25937826|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0|||
13120418|NCT03000686|25937827|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0|||
13120419|NCT03000673|25937920|FG000|Overall Study|Withdrawal by Subject|1|||
13120420|NCT03000673|25937921|FG001|Overall Study|Withdrawal by Subject|0|||
13120421|NCT03000673|25937922|FG002|Overall Study|Withdrawal by Subject|0|||
13120422|NCT03000673|25937923|FG003|Overall Study|Withdrawal by Subject|0|||
13120423|NCT03000452|25937941|FG000|Treatment Period|Death|1|||
13120424|NCT03000452|25937941|FG000|Treatment Period|Progressive Disease (PD)|14|||
13120425|NCT03000452|25937941|FG000|Treatment Period|Physician Decision|1|||
13120426|NCT03000452|25937941|FG000|Treatment Period|Miscellaneous|2|||
13120427|NCT03000452|25937941|FG000|Follow-Up Period|Study Terminated by Sponsor|1|||
13120428|NCT03000452|25937941|FG000|Follow-Up Period|Death|3|||
13120429|NCT03000452|25937941|FG000|Follow-Up Period|Withdrawal by Subject|3|||
13120430|NCT03000348|25938052|FG000|Overall Study|Adverse Event|1|||
13120431|NCT03000348|25938053|FG001|Overall Study|Adverse Event|1|||
13120432|NCT03000348|25938054|FG002|Overall Study|Adverse Event|1|||
13120433|NCT03000348|25938055|FG003|Overall Study|Adverse Event|1|||
13120434|NCT03000348|25938056|FG004|Overall Study|Adverse Event|1|||
13120435|NCT03000348|25938057|FG005|Overall Study|Adverse Event|1|||
13120436|NCT03000348|25938052|FG000|Overall Study|Lost to Follow-up|0|||
13120437|NCT03000348|25938053|FG001|Overall Study|Lost to Follow-up|0|||
13120438|NCT03000348|25938054|FG002|Overall Study|Lost to Follow-up|1|||
13120439|NCT03000348|25938055|FG003|Overall Study|Lost to Follow-up|0|||
13120440|NCT03000348|25938056|FG004|Overall Study|Lost to Follow-up|0|||
13120441|NCT03000348|25938057|FG005|Overall Study|Lost to Follow-up|0|||
13120442|NCT03000348|25938052|FG000|Overall Study|Withdrawal by Subject|0|||
13120443|NCT03000348|25938053|FG001|Overall Study|Withdrawal by Subject|1|||
13120444|NCT03000348|25938054|FG002|Overall Study|Withdrawal by Subject|0|||
13120445|NCT03000348|25938055|FG003|Overall Study|Withdrawal by Subject|0|||
13120446|NCT03000348|25938056|FG004|Overall Study|Withdrawal by Subject|0|||
13120447|NCT03000348|25938057|FG005|Overall Study|Withdrawal by Subject|0|||
13120448|NCT03000348|25938052|FG000|Overall Study|Consent|0|||
13120449|NCT03000348|25938053|FG001|Overall Study|Consent|0|||
13120450|NCT03000348|25938054|FG002|Overall Study|Consent|0|||
13120451|NCT03000348|25938055|FG003|Overall Study|Consent|0|||
13120452|NCT03000348|25938056|FG004|Overall Study|Consent|1|||
13120453|NCT03000348|25938057|FG005|Overall Study|Consent|0|||
13120454|NCT03000348|25938052|FG000|Overall Study|Failure to expectorate sputum|1|||
13120455|NCT03000348|25938053|FG001|Overall Study|Failure to expectorate sputum|0|||
13120456|NCT03000348|25938054|FG002|Overall Study|Failure to expectorate sputum|1|||
13120457|NCT03000348|25938055|FG003|Overall Study|Failure to expectorate sputum|0|||
13120458|NCT03000348|25938056|FG004|Overall Study|Failure to expectorate sputum|1|||
13120459|NCT03000348|25938057|FG005|Overall Study|Failure to expectorate sputum|0|||
13120460|NCT03000348|25938052|FG000|Overall Study|No gram negative|1|||
13120461|NCT03000348|25938053|FG001|Overall Study|No gram negative|2|||
13120462|NCT03000348|25938054|FG002|Overall Study|No gram negative|1|||
13120463|NCT03000348|25938055|FG003|Overall Study|No gram negative|1|||
13120464|NCT03000348|25938056|FG004|Overall Study|No gram negative|1|||
13120465|NCT03000348|25938057|FG005|Overall Study|No gram negative|1|||
13120466|NCT03000348|25938052|FG000|Overall Study|Patient had no transport|0|||
13120467|NCT03000348|25938053|FG001|Overall Study|Patient had no transport|0|||
13120468|NCT03000348|25938054|FG002|Overall Study|Patient had no transport|0|||
13120469|NCT03000348|25938055|FG003|Overall Study|Patient had no transport|1|||
13120470|NCT03000348|25938056|FG004|Overall Study|Patient had no transport|0|||
13120471|NCT03000348|25938057|FG005|Overall Study|Patient had no transport|0|||
13120472|NCT03000348|25938052|FG000|Overall Study|Dosing|0|||
13120473|NCT03000348|25938053|FG001|Overall Study|Dosing|0|||
13120474|NCT03000348|25938054|FG002|Overall Study|Dosing|0|||
13120475|NCT03000348|25938055|FG003|Overall Study|Dosing|0|||
13120476|NCT03000348|25938056|FG004|Overall Study|Dosing|1|||
13120477|NCT03000348|25938057|FG005|Overall Study|Dosing|0|||
13120478|NCT03000179|25938067|FG000|Overall Study|Lost to Follow-up|2|||
13120479|NCT03000075|25938125|FG000|Part A|Adverse Event|4|||
13120480|NCT03000075|25938126|FG001|Part A|Adverse Event|0|||
13120481|NCT03000075|25938127|FG002|Part A|Adverse Event|0|||
13120482|NCT03000075|25938128|FG003|Part A|Adverse Event|0|||
13120483|NCT03000075|25938129|FG004|Part A|Adverse Event|0|||
13120484|NCT03000075|25938130|FG005|Part A|Adverse Event|0|||
13120485|NCT03000075|25938131|FG006|Part A|Adverse Event|0|||
13120486|NCT03000075|25938125|FG000|Part B|Not dosed due to AE|0|||
13120487|NCT03000075|25938126|FG001|Part B|Not dosed due to AE|0|||
13120488|NCT03000075|25938127|FG002|Part B|Not dosed due to AE|0|||
13120489|NCT03000075|25938128|FG003|Part B|Not dosed due to AE|0|||
13120490|NCT03000075|25938129|FG004|Part B|Not dosed due to AE|0|||
13120491|NCT03000075|25938130|FG005|Part B|Not dosed due to AE|2|||
13120492|NCT03000075|25938131|FG006|Part B|Not dosed due to AE|1|||
13120493|NCT03000075|25938125|FG000|Part B|Adverse Event|0|||
13120494|NCT03000075|25938126|FG001|Part B|Adverse Event|0|||
13120495|NCT03000075|25938127|FG002|Part B|Adverse Event|0|||
13120496|NCT03000075|25938128|FG003|Part B|Adverse Event|0|||
13120497|NCT03000075|25938129|FG004|Part B|Adverse Event|1|||
13120498|NCT03000075|25938130|FG005|Part B|Adverse Event|0|||
13120499|NCT03000075|25938131|FG006|Part B|Adverse Event|0|||
13120500|NCT02999984|25938146|FG000|Overall Study|Treatment Failure|1|||
13120501|NCT02999672|25938169|FG000|Overall Study|Death|0|||
13120502|NCT02999672|25938170|FG001|Overall Study|Death|1|||
13120503|NCT02999672|25938169|FG000|Overall Study|Study Terminated by Sponsor|0|||
13120504|NCT02999672|25938170|FG001|Overall Study|Study Terminated by Sponsor|1|||
13120505|NCT02999672|25938169|FG000|Overall Study|Progressive Disease|9|||
13280610|NCT01048502|26455590|FG002|Overall Study|Adverse Event|0|||
13280611|NCT01048502|26455591|FG003|Overall Study|Adverse Event|0|||
13120506|NCT02999672|25938170|FG001|Overall Study|Progressive Disease|5|||
13120507|NCT02999672|25938169|FG000|Overall Study|Adverse Event|4|||
13120508|NCT02999672|25938170|FG001|Overall Study|Adverse Event|0|||
13120509|NCT02999191|25938191|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0|||
13120510|NCT02999191|25938192|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1|||
13120511|NCT02999191|25938193|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0|||
13120512|NCT02999178|25938244|FG000|Overall Study|Adverse Event|85|||
13120513|NCT02999178|25938245|FG001|Overall Study|Adverse Event|62|||
13120514|NCT02999178|25938244|FG000|Overall Study|Protocol Violation|1|||
13120515|NCT02999178|25938245|FG001|Overall Study|Protocol Violation|2|||
13120516|NCT02999178|25938244|FG000|Overall Study|Lost to Follow-up|0|||
13120517|NCT02999178|25938245|FG001|Overall Study|Lost to Follow-up|2|||
13120518|NCT02999178|25938244|FG000|Overall Study|Withdrawal by Subject|21|||
13120519|NCT02999178|25938245|FG001|Overall Study|Withdrawal by Subject|21|||
13120520|NCT02999178|25938244|FG000|Overall Study|Other reason not defined above|7|||
13120521|NCT02999178|25938245|FG001|Overall Study|Other reason not defined above|13|||
13120522|NCT02999100|25938426|FG000|Part 1 (up to 15 Days)|Adverse Event|0|||
13120523|NCT02999100|25938427|FG001|Part 1 (up to 15 Days)|Adverse Event|1|||
13120524|NCT02999100|25938428|FG002|Part 1 (up to 15 Days)|Adverse Event|0|||
13120525|NCT02999100|25938429|FG003|Part 1 (up to 15 Days)|Adverse Event|0|||
13120526|NCT02999100|25938430|FG004|Part 1 (up to 15 Days)|Adverse Event|0|||
13120527|NCT02999100|25938431|FG005|Part 1 (up to 15 Days)|Adverse Event|0|||
13280612|NCT01048502|26455588|FG000|Overall Study|Withdrawal by Subject|1|||
13280613|NCT01048502|26455589|FG001|Overall Study|Withdrawal by Subject|4|||
13280614|NCT01048502|26455590|FG002|Overall Study|Withdrawal by Subject|5|||
13280615|NCT01048502|26455591|FG003|Overall Study|Withdrawal by Subject|3|||
13280616|NCT01048502|26455588|FG000|Overall Study|Physician Decision|0|||
13120528|NCT02999100|25938426|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
13120529|NCT02999100|25938427|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
13120530|NCT02999100|25938428|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
13120531|NCT02999100|25938429|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
13120532|NCT02999100|25938430|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
13120533|NCT02999100|25938431|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1|||
13120534|NCT02999100|25938426|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
13120535|NCT02999100|25938427|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
13120536|NCT02999100|25938428|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1|||
13120537|NCT02999100|25938429|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
13120538|NCT02999100|25938430|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
13120539|NCT02999100|25938431|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
13120540|NCT02998996|25938468|FG000|Overall Study|Lost to Follow-up|0|||
13120541|NCT02998996|25938469|FG001|Overall Study|Lost to Follow-up|0|||
13120542|NCT02998996|25938470|FG002|Overall Study|Lost to Follow-up|1|||
13120543|NCT02998996|25938471|FG003|Overall Study|Lost to Follow-up|0|||
13120544|NCT02998996|25938472|FG004|Overall Study|Lost to Follow-up|0|||
13120545|NCT02998996|25938473|FG005|Overall Study|Lost to Follow-up|0|||
13120546|NCT02998996|25938468|FG000|Overall Study|Pregnancy|0|||
13120547|NCT02998996|25938469|FG001|Overall Study|Pregnancy|1|||
13120548|NCT02998996|25938470|FG002|Overall Study|Pregnancy|0|||
13120549|NCT02998996|25938471|FG003|Overall Study|Pregnancy|0|||
13120550|NCT02998996|25938472|FG004|Overall Study|Pregnancy|0|||
13120551|NCT02998996|25938473|FG005|Overall Study|Pregnancy|0|||
13120552|NCT02998996|25938468|FG000|Overall Study|Family reasons|0|||
13120553|NCT02998996|25938469|FG001|Overall Study|Family reasons|0|||
13120554|NCT02998996|25938470|FG002|Overall Study|Family reasons|0|||
13120555|NCT02998996|25938471|FG003|Overall Study|Family reasons|0|||
13120556|NCT02998996|25938472|FG004|Overall Study|Family reasons|1|||
13120557|NCT02998996|25938473|FG005|Overall Study|Family reasons|0|||
13120558|NCT02998840|25938512|FG000|Overall Study|Lost to Follow-up|1|||
13120559|NCT02998840|25938513|FG001|Overall Study|Lost to Follow-up|1|||
13120560|NCT02998840|25938514|FG002|Overall Study|Lost to Follow-up|2|||
13120561|NCT02998840|25938515|FG003|Overall Study|Lost to Follow-up|3|||
13120562|NCT02998840|25938512|FG000|Overall Study|Withdrawal by Subject|1|||
13120563|NCT02998840|25938513|FG001|Overall Study|Withdrawal by Subject|1|||
13120564|NCT02998840|25938514|FG002|Overall Study|Withdrawal by Subject|0|||
13120565|NCT02998840|25938515|FG003|Overall Study|Withdrawal by Subject|1|||
13280617|NCT01048502|26455589|FG001|Overall Study|Physician Decision|3|||
13120566|NCT02998840|25938512|FG000|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|2|||
13120567|NCT02998840|25938513|FG001|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
13120568|NCT02998840|25938514|FG002|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|0|||
13120569|NCT02998840|25938515|FG003|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
13120570|NCT02998671|25938574|FG000|Period 1|Study Terminated By Sponsor|2|||
13120571|NCT02998671|25938575|FG001|Period 1|Study Terminated By Sponsor|1|||
13120572|NCT02998671|25938576|FG002|Period 1|Study Terminated By Sponsor|0|||
13120573|NCT02998671|25938577|FG003|Period 1|Study Terminated By Sponsor|0|||
13120574|NCT02998671|25938578|FG004|Period 1|Study Terminated By Sponsor|1|||
13120575|NCT02998671|25938574|FG000|Period 1|Withdrawal by Subject|1|||
13120576|NCT02998671|25938575|FG001|Period 1|Withdrawal by Subject|2|||
13120577|NCT02998671|25938576|FG002|Period 1|Withdrawal by Subject|0|||
13120578|NCT02998671|25938577|FG003|Period 1|Withdrawal by Subject|0|||
13120579|NCT02998671|25938578|FG004|Period 1|Withdrawal by Subject|2|||
13120580|NCT02998671|25938574|FG000|Period 1|Pregnancy|1|||
13120581|NCT02998671|25938575|FG001|Period 1|Pregnancy|0|||
13120582|NCT02998671|25938576|FG002|Period 1|Pregnancy|0|||
13120583|NCT02998671|25938577|FG003|Period 1|Pregnancy|0|||
13120584|NCT02998671|25938578|FG004|Period 1|Pregnancy|0|||
13120585|NCT02998671|25938574|FG000|Period 1|Adverse Event|0|||
13120586|NCT02998671|25938575|FG001|Period 1|Adverse Event|0|||
13120587|NCT02998671|25938576|FG002|Period 1|Adverse Event|0|||
13120588|NCT02998671|25938577|FG003|Period 1|Adverse Event|0|||
13120589|NCT02998671|25938578|FG004|Period 1|Adverse Event|1|||
13120590|NCT02998671|25938574|FG000|Period 2|Adverse Event|0|||
13120591|NCT02998671|25938575|FG001|Period 2|Adverse Event|1|||
13120592|NCT02998671|25938576|FG002|Period 2|Adverse Event|0|||
13120593|NCT02998671|25938577|FG003|Period 2|Adverse Event|0|||
13120594|NCT02998671|25938578|FG004|Period 2|Adverse Event|0|||
13120595|NCT02998671|25938574|FG000|Period 2|Study Terminated By Sponsor|3|||
13120596|NCT02998671|25938575|FG001|Period 2|Study Terminated By Sponsor|5|||
13120597|NCT02998671|25938576|FG002|Period 2|Study Terminated By Sponsor|1|||
13120598|NCT02998671|25938577|FG003|Period 2|Study Terminated By Sponsor|3|||
13120599|NCT02998671|25938578|FG004|Period 2|Study Terminated By Sponsor|0|||
13120600|NCT02998671|25938574|FG000|Period 2|Withdrawal by Subject|0|||
13120601|NCT02998671|25938575|FG001|Period 2|Withdrawal by Subject|1|||
13120602|NCT02998671|25938576|FG002|Period 2|Withdrawal by Subject|0|||
13120603|NCT02998671|25938577|FG003|Period 2|Withdrawal by Subject|0|||
13120604|NCT02998671|25938578|FG004|Period 2|Withdrawal by Subject|0|||
13120605|NCT02998671|25938574|FG000|Period 2|Lost to Follow-up|0|||
13120606|NCT02998671|25938575|FG001|Period 2|Lost to Follow-up|0|||
13120607|NCT02998671|25938576|FG002|Period 2|Lost to Follow-up|0|||
13120608|NCT02998671|25938577|FG003|Period 2|Lost to Follow-up|1|||
13120609|NCT02998671|25938578|FG004|Period 2|Lost to Follow-up|0|||
13120610|NCT02998554|25938613|FG000|Overall Study|Adverse Event|8|||
13120611|NCT02998554|25938614|FG001|Overall Study|Adverse Event|3|||
13120612|NCT02998554|25938613|FG000|Overall Study|Protocol deviation|1|||
13120613|NCT02998554|25938614|FG001|Overall Study|Protocol deviation|0|||
13120614|NCT02998554|25938613|FG000|Overall Study|Withdrawal by Subject|2|||
13120615|NCT02998554|25938614|FG001|Overall Study|Withdrawal by Subject|6|||
13120616|NCT02998554|25938613|FG000|Overall Study|Lost to Follow-up|0|||
13120617|NCT02998554|25938614|FG001|Overall Study|Lost to Follow-up|1|||
13120618|NCT02998554|25938613|FG000|Overall Study|Lack of Efficacy|0|||
13120619|NCT02998554|25938614|FG001|Overall Study|Lack of Efficacy|1|||
13120620|NCT02998541|25938677|FG000|Overall Study|Adverse Event|4|||
13120621|NCT02998541|25938678|FG001|Overall Study|Adverse Event|5|||
13120622|NCT02998541|25938679|FG002|Overall Study|Adverse Event|1|||
13120623|NCT02998541|25938677|FG000|Overall Study|Protocol Violation|1|||
13280618|NCT01048502|26455590|FG002|Overall Study|Physician Decision|0|||
13120624|NCT02998541|25938678|FG001|Overall Study|Protocol Violation|0|||
13120625|NCT02998541|25938679|FG002|Overall Study|Protocol Violation|0|||
13120626|NCT02998541|25938677|FG000|Overall Study|Withdrawal by Subject|3|||
13120627|NCT02998541|25938678|FG001|Overall Study|Withdrawal by Subject|1|||
13120628|NCT02998541|25938679|FG002|Overall Study|Withdrawal by Subject|0|||
13120629|NCT02998541|25938677|FG000|Overall Study|Lost to Follow-up|0|||
13120630|NCT02998541|25938678|FG001|Overall Study|Lost to Follow-up|3|||
13120631|NCT02998541|25938679|FG002|Overall Study|Lost to Follow-up|1|||
13120632|NCT02998541|25938677|FG000|Overall Study|Physician Decision|0|||
13120633|NCT02998541|25938678|FG001|Overall Study|Physician Decision|0|||
13120634|NCT02998541|25938679|FG002|Overall Study|Physician Decision|3|||
13120635|NCT02998541|25938677|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
13120636|NCT02998541|25938678|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
13120637|NCT02998541|25938679|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
13120638|NCT02998151|25938713|FG000|Overall Study|Withdrawal by Subject|3|||
13120639|NCT02998151|25938713|FG000|Overall Study|Participant declined to re-enroll for baclofen|8|||
13120640|NCT02998151|25938713|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13|||
13120641|NCT02998021|25938744|FG000|Overall Study|Withdrawal by Subject|3|||
13280619|NCT01048502|26455591|FG003|Overall Study|Physician Decision|1|||
13120642|NCT02998021|25938745|FG001|Overall Study|Withdrawal by Subject|1|||
13120643|NCT02998021|25938744|FG000|Overall Study|unsafe home|0|||
13120644|NCT02998021|25938745|FG001|Overall Study|unsafe home|1|||
13120645|NCT02997176|25938892|FG000|Overall Study|Adverse Event|0|||
13120646|NCT02997176|25938893|FG001|Overall Study|Adverse Event|0|||
13280620|NCT01048333|26455618|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
13280621|NCT01048333|26455619|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1|||
13280622|NCT01048333|26455620|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
13280623|NCT01048333|26455621|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
13280624|NCT01048333|26455622|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
13280625|NCT01048333|26455623|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
13280626|NCT01048242|26455636|FG000|Overall Study|See study flow chart|4|||
13280627|NCT01048242|26455637|FG001|Overall Study|See study flow chart|2|||
13280628|NCT01047683|26455670|FG000|Overall Study|Adverse Event|3|||
13280629|NCT01047683|26455671|FG001|Overall Study|Adverse Event|1|||
13280630|NCT01047683|26455672|FG002|Overall Study|Adverse Event|0|||
13280631|NCT01047683|26455670|FG000|Overall Study|Withdrew Consent|1|||
13280632|NCT01047683|26455671|FG001|Overall Study|Withdrew Consent|4|||
13280633|NCT01047683|26455672|FG002|Overall Study|Withdrew Consent|2|||
13280634|NCT01047683|26455670|FG000|Overall Study|Lost to Follow-up|0|||
13280635|NCT01047683|26455671|FG001|Overall Study|Lost to Follow-up|1|||
13280636|NCT01047683|26455672|FG002|Overall Study|Lost to Follow-up|0|||
13280637|NCT01047683|26455670|FG000|Overall Study|Triglycerides >2000 mg/dL|1|||
13280638|NCT01047683|26455671|FG001|Overall Study|Triglycerides >2000 mg/dL|0|||
13280639|NCT01047683|26455672|FG002|Overall Study|Triglycerides >2000 mg/dL|1|||
13280640|NCT01047553|26455761|FG000|Overall Study|Adverse Event|10|||
13280641|NCT01047553|26455762|FG001|Overall Study|Adverse Event|5|||
13280642|NCT01047553|26455761|FG000|Overall Study|Withdrawal by Subject|4|||
13280643|NCT01047553|26455762|FG001|Overall Study|Withdrawal by Subject|2|||
13280644|NCT01047553|26455761|FG000|Overall Study|Development of Study-Specific Withdrawal|1|||
13280645|NCT01047553|26455762|FG001|Overall Study|Development of Study-Specific Withdrawal|1|||
13280646|NCT01047553|26455761|FG000|Overall Study|Lost to Follow-up|1|||
13280647|NCT01047553|26455762|FG001|Overall Study|Lost to Follow-up|0|||
13280648|NCT01047553|26455761|FG000|Overall Study|Sever Non-Compliance to Protocol|1|||
13280649|NCT01047553|26455762|FG001|Overall Study|Sever Non-Compliance to Protocol|0|||
13280650|NCT01047553|26455761|FG000|Overall Study|PI's decision|0|||
13280651|NCT01047553|26455762|FG001|Overall Study|PI's decision|1|||
13280652|NCT01047436|26455785|FG000|Overall Study|Protocol Violation|1|||
13280653|NCT01047436|26455786|FG001|Overall Study|Protocol Violation|0|||
13280654|NCT01047345|26455814|FG000|Base Study|Adverse Event|3|||
13280655|NCT01047345|26455815|FG001|Base Study|Adverse Event|0|||
13280656|NCT01047345|26455816|FG002|Base Study|Adverse Event|0|||
13280657|NCT01047345|26455814|FG000|Base Study|Lost to Follow-up|4|||
13280658|NCT01047345|26455815|FG001|Base Study|Lost to Follow-up|1|||
13280659|NCT01047345|26455816|FG002|Base Study|Lost to Follow-up|0|||
13280660|NCT01047345|26455814|FG000|Base Study|Protocol Violation|3|||
13280661|NCT01047345|26455815|FG001|Base Study|Protocol Violation|1|||
13280662|NCT01047345|26455816|FG002|Base Study|Protocol Violation|0|||
13280663|NCT01047345|26455814|FG000|Base Study|Withdrawal by Subject|12|||
13280664|NCT01047345|26455815|FG001|Base Study|Withdrawal by Subject|4|||
13280665|NCT01047345|26455816|FG002|Base Study|Withdrawal by Subject|0|||
13120647|NCT02997176|25938894|FG002|Overall Study|Adverse Event|0|||
13120648|NCT02997176|25938895|FG003|Overall Study|Adverse Event|8|||
13120649|NCT02997176|25938892|FG000|Overall Study|Progressive Disease|1|||
13280666|NCT01047345|26455814|FG000|Extension|Withdrawal by Subject|0|||
13280667|NCT01047345|26455815|FG001|Extension|Withdrawal by Subject|0|||
13280668|NCT01047345|26455816|FG002|Extension|Withdrawal by Subject|1|||
13280669|NCT01047345|26455814|FG000|Extension|Lost to Follow-up|0|||
13120650|NCT02997176|25938893|FG001|Overall Study|Progressive Disease|0|||
13120651|NCT02997176|25938894|FG002|Overall Study|Progressive Disease|1|||
13120652|NCT02997176|25938895|FG003|Overall Study|Progressive Disease|1|||
13120653|NCT02997176|25938892|FG000|Overall Study|Death|0|||
13120654|NCT02997176|25938893|FG001|Overall Study|Death|0|||
13280670|NCT01047345|26455815|FG001|Extension|Lost to Follow-up|0|||
13280671|NCT01047345|26455816|FG002|Extension|Lost to Follow-up|5|||
13280672|NCT01047332|26455835|FG000|Overall Study|SEMS Obstruction|11|||
13280673|NCT01047332|26455836|FG001|Overall Study|SEMS Obstruction|20|||
13280674|NCT01047332|26455835|FG000|Overall Study|Died Unobstructed|38|||
13280675|NCT01047332|26455836|FG001|Overall Study|Died Unobstructed|41|||
13280676|NCT01047332|26455835|FG000|Overall Study|Lost to Follow-up|8|||
13280677|NCT01047332|26455836|FG001|Overall Study|Lost to Follow-up|3|||
13280678|NCT01047306|26455917|FG000|Overall Study|Withdrawal by Subject|2|||
13280679|NCT01047306|26455918|FG001|Overall Study|Withdrawal by Subject|0|||
13280680|NCT01047306|26455917|FG000|Overall Study|Lost to Follow-up|1|||
13280681|NCT01047306|26455918|FG001|Overall Study|Lost to Follow-up|0|||
13280682|NCT01047293|26455930|FG000|Overall Study|DLT criteria not fulfilled|1|||
13280683|NCT01047293|26455931|FG001|Overall Study|DLT criteria not fulfilled|1|||
13280684|NCT01047293|26455932|FG002|Overall Study|DLT criteria not fulfilled|0|||
13280685|NCT01047293|26455933|FG003|Overall Study|DLT criteria not fulfilled|0|||
13280686|NCT01047007|26455957|FG000|Overall Study|Adverse Event|0|||
13280687|NCT01047007|26455958|FG001|Overall Study|Adverse Event|2|||
13280688|NCT01047007|26455959|FG002|Overall Study|Adverse Event|1|||
13280689|NCT01047007|26455960|FG003|Overall Study|Adverse Event|0|||
13280690|NCT01047007|26455957|FG000|Overall Study|Progressive Disease|2|||
13280691|NCT01047007|26455958|FG001|Overall Study|Progressive Disease|4|||
13280692|NCT01047007|26455959|FG002|Overall Study|Progressive Disease|1|||
13280693|NCT01047007|26455960|FG003|Overall Study|Progressive Disease|0|||
13280694|NCT01046877|26455976|FG000|Overall Study|Exited voluntarily before tube extrusion|7|||
13280695|NCT01046877|26455976|FG000|Overall Study|Exited voluntarily after tube extrusion|11|||
13280696|NCT01046695|26455993|FG000|Overall Study|Subject had a pacemaker|0|||
13280697|NCT01046695|26455994|FG001|Overall Study|Subject had a pacemaker|1|||
13280698|NCT01046695|26455993|FG000|Overall Study|TENS interfered with the cardiac monitor|0|||
13280699|NCT01046695|26455994|FG001|Overall Study|TENS interfered with the cardiac monitor|1|||
13280700|NCT01046682|26456007|FG000|Overall Study|Adverse Event|2|||
13280701|NCT01046682|26456008|FG001|Overall Study|Adverse Event|0|||
13280702|NCT01046643|26456039|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0|||
13280703|NCT01046643|26456040|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1|||
13280704|NCT01046643|26456041|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0|||
13280705|NCT01046643|26456042|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0|||
13280706|NCT01046565|26456053|FG000|Overall Study|Adverse Event|2|||
13280707|NCT01046565|26456053|FG000|Overall Study|Withdrawal by Subject|7|||
13280708|NCT01046396|26456064|FG000|Overall Study|Withdrawal by Subject|5|||
13280709|NCT01046253|26456081|FG000|Second Intervention|Adverse Event|0|||
13280710|NCT01046253|26456082|FG001|Second Intervention|Adverse Event|1|||
13280711|NCT01046253|26456081|FG000|Second Intervention|Protocol Violation|0|||
13280712|NCT01046253|26456082|FG001|Second Intervention|Protocol Violation|1|||
13280713|NCT01046110|26456097|FG000|Overall Study|Adverse Event|9|||
13280714|NCT01046110|26456098|FG001|Overall Study|Adverse Event|2|||
13280715|NCT01046110|26456097|FG000|Overall Study|Lack of Efficacy|0|||
13280716|NCT01046110|26456098|FG001|Overall Study|Lack of Efficacy|1|||
13280717|NCT01046110|26456097|FG000|Overall Study|Protocol Violation|7|||
13280718|NCT01046110|26456098|FG001|Overall Study|Protocol Violation|12|||
13280719|NCT01046110|26456097|FG000|Overall Study|Withdrawal Criteria|3|||
13280720|NCT01046110|26456098|FG001|Overall Study|Withdrawal Criteria|5|||
13280721|NCT01046110|26456097|FG000|Overall Study|Unclassified|36|||
13280722|NCT01046110|26456098|FG001|Overall Study|Unclassified|35|||
13280723|NCT01046084|26456115|FG000|Third Washout of 7 Days|Withdrawal by Subject|2|||
13280724|NCT01046084|26456116|FG001|Third Washout of 7 Days|Withdrawal by Subject|0|||
13280725|NCT01045967|26456133|FG000|Second Intervention|Protocol Violation|0|||
13280726|NCT01045967|26456134|FG001|Second Intervention|Protocol Violation|1|||
13280727|NCT01045798|26456147|FG000|Overall Study|Changed to Open-Label Caspofungin|1|||
13280728|NCT01045798|26456148|FG001|Overall Study|Changed to Open-Label Caspofungin|0|||
13280729|NCT01045798|26456147|FG000|Overall Study|Invasive Fungal Infection at Baseline|0|||
13280730|NCT01045798|26456148|FG001|Overall Study|Invasive Fungal Infection at Baseline|1|||
13280731|NCT01045798|26456147|FG000|Overall Study|Changed to Other Antifungal Therapy|1|||
13280732|NCT01045798|26456148|FG001|Overall Study|Changed to Other Antifungal Therapy|2|||
13280733|NCT01045798|26456147|FG000|Overall Study|Received Systemic Antifungal Prestudy|0|||
13280734|NCT01045798|26456148|FG001|Overall Study|Received Systemic Antifungal Prestudy|1|||
13280735|NCT01045694|26456156|FG000|Overall Study|Withdrawal by Subject|2|||
13280736|NCT01045421|26456260|FG000|Phase 1|Progressive Disease|0|||
13280737|NCT01045421|26456261|FG001|Phase 1|Progressive Disease|0|||
13280738|NCT01045421|26456262|FG002|Phase 1|Progressive Disease|0|||
13280739|NCT01045421|26456263|FG003|Phase 1|Progressive Disease|0|||
13280740|NCT01045421|26456264|FG004|Phase 1|Progressive Disease|1|||
13120655|NCT02997176|25938894|FG002|Overall Study|Death|1|||
13120656|NCT02997176|25938895|FG003|Overall Study|Death|1|||
13280741|NCT01045421|26456265|FG005|Phase 1|Progressive Disease|0|||
13280742|NCT01045421|26456266|FG006|Phase 1|Progressive Disease|0|||
13280743|NCT01045421|26456267|FG007|Phase 1|Progressive Disease|0|||
13280744|NCT01045421|26456268|FG008|Phase 1|Progressive Disease|0|||
13120657|NCT02997176|25938892|FG000|Overall Study|Withdrawal by Subject|0|||
13120658|NCT02997176|25938893|FG001|Overall Study|Withdrawal by Subject|2|||
13120659|NCT02997176|25938894|FG002|Overall Study|Withdrawal by Subject|0|||
13120660|NCT02997176|25938895|FG003|Overall Study|Withdrawal by Subject|1|||
13120661|NCT02997163|25939038|FG000|Overall Study|Adverse Event|1|||
13120662|NCT02997163|25939039|FG001|Overall Study|Adverse Event|0|||
13120663|NCT02997163|25939040|FG002|Overall Study|Adverse Event|0|||
13120664|NCT02997163|25939041|FG003|Overall Study|Adverse Event|1|||
13120665|NCT02996968|25939054|FG000|Overall Study|Withdrawal by Subject|1|||
13280745|NCT01045421|26456269|FG009|Phase 1|Progressive Disease|0|||
13280746|NCT01045421|26456270|FG010|Phase 1|Progressive Disease|0|||
13280747|NCT01045421|26456260|FG000|Phase 1|Withdrawal by Subject|0|||
13280748|NCT01045421|26456261|FG001|Phase 1|Withdrawal by Subject|0|||
13280749|NCT01045421|26456262|FG002|Phase 1|Withdrawal by Subject|0|||
13280750|NCT01045421|26456263|FG003|Phase 1|Withdrawal by Subject|1|||
13280751|NCT01045421|26456264|FG004|Phase 1|Withdrawal by Subject|0|||
13280752|NCT01045421|26456265|FG005|Phase 1|Withdrawal by Subject|0|||
13280753|NCT01045421|26456266|FG006|Phase 1|Withdrawal by Subject|0|||
13280754|NCT01045421|26456267|FG007|Phase 1|Withdrawal by Subject|0|||
13280755|NCT01045421|26456268|FG008|Phase 1|Withdrawal by Subject|0|||
13280756|NCT01045421|26456269|FG009|Phase 1|Withdrawal by Subject|0|||
13280757|NCT01045421|26456270|FG010|Phase 1|Withdrawal by Subject|0|||
13280758|NCT01045421|26456260|FG000|Phase 2|Progressive Disease|0|||
13280759|NCT01045421|26456261|FG001|Phase 2|Progressive Disease|0|||
13280760|NCT01045421|26456262|FG002|Phase 2|Progressive Disease|0|||
13280761|NCT01045421|26456263|FG003|Phase 2|Progressive Disease|0|||
13280762|NCT01045421|26456264|FG004|Phase 2|Progressive Disease|0|||
13280763|NCT01045421|26456265|FG005|Phase 2|Progressive Disease|0|||
13280764|NCT01045421|26456266|FG006|Phase 2|Progressive Disease|0|||
13280765|NCT01045421|26456267|FG007|Phase 2|Progressive Disease|1|||
13280766|NCT01045421|26456268|FG008|Phase 2|Progressive Disease|1|||
13280767|NCT01045421|26456269|FG009|Phase 2|Progressive Disease|1|||
13280768|NCT01045421|26456270|FG010|Phase 2|Progressive Disease|1|||
13280769|NCT01045421|26456260|FG000|Phase 2|Death|0|||
13280770|NCT01045421|26456261|FG001|Phase 2|Death|0|||
13280771|NCT01045421|26456262|FG002|Phase 2|Death|0|||
13280772|NCT01045421|26456263|FG003|Phase 2|Death|0|||
13280773|NCT01045421|26456264|FG004|Phase 2|Death|0|||
13280774|NCT01045421|26456265|FG005|Phase 2|Death|0|||
13280775|NCT01045421|26456266|FG006|Phase 2|Death|0|||
13280776|NCT01045421|26456267|FG007|Phase 2|Death|1|||
13280777|NCT01045421|26456268|FG008|Phase 2|Death|1|||
13280778|NCT01045421|26456269|FG009|Phase 2|Death|2|||
13280779|NCT01045421|26456270|FG010|Phase 2|Death|0|||
13280780|NCT01045421|26456260|FG000|Phase 2|Other|0|||
13280781|NCT01045421|26456261|FG001|Phase 2|Other|0|||
13280782|NCT01045421|26456262|FG002|Phase 2|Other|0|||
13280783|NCT01045421|26456263|FG003|Phase 2|Other|0|||
13280784|NCT01045421|26456264|FG004|Phase 2|Other|0|||
13280785|NCT01045421|26456265|FG005|Phase 2|Other|0|||
13280786|NCT01045421|26456266|FG006|Phase 2|Other|0|||
13280787|NCT01045421|26456267|FG007|Phase 2|Other|3|||
13280788|NCT01045421|26456268|FG008|Phase 2|Other|0|||
13280789|NCT01045421|26456269|FG009|Phase 2|Other|0|||
13280790|NCT01045421|26456270|FG010|Phase 2|Other|1|||
13280791|NCT01045161|26456300|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8|||
13280792|NCT01045161|26456301|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12|||
13280793|NCT01045161|26456302|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6|||
13280794|NCT01045161|26456300|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4|||
13280795|NCT01045161|26456301|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3|||
13280796|NCT01045161|26456302|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8|||
13280797|NCT01045161|26456300|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6|||
13280798|NCT01045161|26456301|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3|||
13280799|NCT01045161|26456302|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2|||
13280800|NCT01045161|26456300|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4|||
13280801|NCT01045161|26456301|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1|||
13280802|NCT01045161|26456302|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6|||
13120666|NCT02996968|25939055|FG001|Overall Study|Withdrawal by Subject|0|||
13280803|NCT01045161|26456300|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
13280804|NCT01045161|26456301|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
13120667|NCT02996682|25939084|FG000|Overall Study|Death|0|||
13120668|NCT02996682|25939085|FG001|Overall Study|Death|3|||
13120669|NCT02996500|25939287|FG000|Overall Study|Adverse Event|1|||
13120670|NCT02996500|25939288|FG001|Overall Study|Adverse Event|1|||
13120671|NCT02996500|25939289|FG002|Overall Study|Adverse Event|4|||
13120672|NCT02996500|25939290|FG003|Overall Study|Adverse Event|3|||
13120673|NCT02996500|25939291|FG004|Overall Study|Adverse Event|1|||
13120674|NCT02996500|25939292|FG005|Overall Study|Adverse Event|2|||
13120675|NCT02996500|25939287|FG000|Overall Study|Lack of Efficacy|0|||
13120676|NCT02996500|25939288|FG001|Overall Study|Lack of Efficacy|0|||
13120677|NCT02996500|25939289|FG002|Overall Study|Lack of Efficacy|0|||
13120678|NCT02996500|25939290|FG003|Overall Study|Lack of Efficacy|0|||
13120679|NCT02996500|25939291|FG004|Overall Study|Lack of Efficacy|2|||
13120680|NCT02996500|25939292|FG005|Overall Study|Lack of Efficacy|0|||
13120681|NCT02996500|25939287|FG000|Overall Study|Lost to Follow-up|1|||
13120682|NCT02996500|25939288|FG001|Overall Study|Lost to Follow-up|0|||
13120683|NCT02996500|25939289|FG002|Overall Study|Lost to Follow-up|0|||
13280805|NCT01045161|26456302|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
13280806|NCT01045161|26456300|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
13280807|NCT01045161|26456301|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4|||
13280808|NCT01045161|26456302|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
13280809|NCT01045161|26456300|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
13280810|NCT01045161|26456301|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
13280811|NCT01045161|26456302|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2|||
13120684|NCT02996500|25939290|FG003|Overall Study|Lost to Follow-up|0|||
13120685|NCT02996500|25939291|FG004|Overall Study|Lost to Follow-up|0|||
13120686|NCT02996500|25939292|FG005|Overall Study|Lost to Follow-up|1|||
13120687|NCT02996500|25939287|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
13120688|NCT02996500|25939288|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
13120689|NCT02996500|25939289|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
13120690|NCT02996500|25939290|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
13120691|NCT02996500|25939291|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
13120692|NCT02996500|25939292|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
13280812|NCT01045161|26456300|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10|||
13280813|NCT01045161|26456301|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7|||
13280814|NCT01045161|26456302|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9|||
13280815|NCT01045161|26456300|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
13280816|NCT01045161|26456301|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
13280817|NCT01045161|26456302|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7|||
13280818|NCT01045161|26456300|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3|||
13280819|NCT01045161|26456301|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
13280820|NCT01045161|26456302|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
13280821|NCT01045161|26456300|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
13280822|NCT01045161|26456301|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5|||
13280823|NCT01045161|26456302|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
13280824|NCT01045161|26456300|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4|||
13280825|NCT01045161|26456301|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2|||
13280826|NCT01045161|26456302|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1|||
13280827|NCT01045161|26456300|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
13280828|NCT01045161|26456301|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6|||
13280829|NCT01045161|26456302|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
13280830|NCT01045161|26456300|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5|||
13280831|NCT01045161|26456301|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1|||
13280832|NCT01045161|26456302|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6|||
13280833|NCT01044745|26456311|FG000|Overall Study|Ineiligible|2|||
13280834|NCT01044732|26456326|FG000|Overall Study|Lost to Follow-up|2|||
13280835|NCT01044732|26456327|FG001|Overall Study|Lost to Follow-up|1|||
13280836|NCT01044732|26456326|FG000|Overall Study|Physician Decision|5|||
13280837|NCT01044732|26456327|FG001|Overall Study|Physician Decision|3|||
13280838|NCT01044732|26456326|FG000|Overall Study|Protocol Violation|11|||
13280839|NCT01044732|26456327|FG001|Overall Study|Protocol Violation|12|||
13280840|NCT01044732|26456326|FG000|Overall Study|Withdrawal by Subject|0|||
13280841|NCT01044732|26456327|FG001|Overall Study|Withdrawal by Subject|1|||
13280842|NCT01044732|26456326|FG000|Overall Study|Inadequate bowel preparation|11|||
13280843|NCT01044732|26456327|FG001|Overall Study|Inadequate bowel preparation|17|||
13280844|NCT01044732|26456326|FG000|Overall Study|Inability to reach cecum|5|||
13280845|NCT01044732|26456327|FG001|Overall Study|Inability to reach cecum|2|||
13280846|NCT01044732|26456326|FG000|Overall Study|Technical error or malfunction|15|||
13280847|NCT01044732|26456327|FG001|Overall Study|Technical error or malfunction|14|||
13280848|NCT01044498|26456358|FG000|Overall Study|Withdrew consent|1|||
13280849|NCT01044498|26456359|FG001|Overall Study|Withdrew consent|1|||
13280850|NCT01044498|26456358|FG000|Overall Study|Adverse Event|1|||
13280851|NCT01044498|26456359|FG001|Overall Study|Adverse Event|1|||
13280852|NCT01044498|26456358|FG000|Overall Study|Other|1|||
13280853|NCT01044498|26456359|FG001|Overall Study|Other|0|||
13280854|NCT01044459|26456374|FG000|Overall Study|Withdrawal by Subject|21|||
13280855|NCT01044459|26456375|FG001|Overall Study|Withdrawal by Subject|28|||
13308047|NCT01280656|26530650|FG000|Overall Study|Adverse Event|1|||
13120693|NCT02996500|25939287|FG000|Overall Study|Non-Compliance With Study Drug|0|||
13120694|NCT02996500|25939288|FG001|Overall Study|Non-Compliance With Study Drug|0|||
13120695|NCT02996500|25939289|FG002|Overall Study|Non-Compliance With Study Drug|0|||
13120696|NCT02996500|25939290|FG003|Overall Study|Non-Compliance With Study Drug|0|||
13120697|NCT02996500|25939291|FG004|Overall Study|Non-Compliance With Study Drug|0|||
13120698|NCT02996500|25939292|FG005|Overall Study|Non-Compliance With Study Drug|1|||
13120699|NCT02996500|25939287|FG000|Overall Study|Progressive Disease|1|||
13120700|NCT02996500|25939288|FG001|Overall Study|Progressive Disease|0|||
13120701|NCT02996500|25939289|FG002|Overall Study|Progressive Disease|0|||
13120702|NCT02996500|25939290|FG003|Overall Study|Progressive Disease|0|||
13120703|NCT02996500|25939291|FG004|Overall Study|Progressive Disease|0|||
13120704|NCT02996500|25939292|FG005|Overall Study|Progressive Disease|0|||
13120705|NCT02996500|25939287|FG000|Overall Study|Other|2|||
13120706|NCT02996500|25939288|FG001|Overall Study|Other|0|||
13120707|NCT02996500|25939289|FG002|Overall Study|Other|2|||
13120708|NCT02996500|25939290|FG003|Overall Study|Other|0|||
13120709|NCT02996500|25939291|FG004|Overall Study|Other|0|||
13120710|NCT02996500|25939292|FG005|Overall Study|Other|0|||
13120711|NCT02996500|25939287|FG000|Overall Study|Protocol Violation|0|||
13120712|NCT02996500|25939288|FG001|Overall Study|Protocol Violation|0|||
13280856|NCT01044459|26456374|FG000|Overall Study|Terminated by Sponsor|22|||
13280857|NCT01044459|26456375|FG001|Overall Study|Terminated by Sponsor|21|||
13280858|NCT01044459|26456374|FG000|Overall Study|Adverse Event|22|||
13280859|NCT01044459|26456375|FG001|Overall Study|Adverse Event|20|||
13280860|NCT01044459|26456374|FG000|Overall Study|Lack of Efficacy|23|||
13280861|NCT01044459|26456375|FG001|Overall Study|Lack of Efficacy|12|||
13280862|NCT01044459|26456374|FG000|Overall Study|Protocol Violation|11|||
13280863|NCT01044459|26456375|FG001|Overall Study|Protocol Violation|16|||
13280864|NCT01044459|26456374|FG000|Overall Study|Other Reason|7|||
13280865|NCT01044459|26456375|FG001|Overall Study|Other Reason|14|||
13280866|NCT01044459|26456374|FG000|Overall Study|COPD exacerbation|9|||
13280867|NCT01044459|26456375|FG001|Overall Study|COPD exacerbation|8|||
13280868|NCT01044459|26456374|FG000|Overall Study|Lost to Follow-up|18|||
13280869|NCT01044459|26456375|FG001|Overall Study|Lost to Follow-up|12|||
13280870|NCT01044433|26456385|FG000|Overall Study|Lost to Follow-up|3|||
13280871|NCT01044433|26456385|FG000|Overall Study|Withdrawal by Subject|3|||
13308048|NCT01280656|26530651|FG001|Overall Study|Adverse Event|14|||
13120713|NCT02996500|25939289|FG002|Overall Study|Protocol Violation|0|||
13120714|NCT02996500|25939290|FG003|Overall Study|Protocol Violation|1|||
13120715|NCT02996500|25939291|FG004|Overall Study|Protocol Violation|0|||
13120716|NCT02996500|25939292|FG005|Overall Study|Protocol Violation|0|||
13120717|NCT02996500|25939287|FG000|Overall Study|Withdrawal by Subject|3|||
13120718|NCT02996500|25939288|FG001|Overall Study|Withdrawal by Subject|0|||
13120719|NCT02996500|25939289|FG002|Overall Study|Withdrawal by Subject|3|||
13120720|NCT02996500|25939290|FG003|Overall Study|Withdrawal by Subject|0|||
13120721|NCT02996500|25939291|FG004|Overall Study|Withdrawal by Subject|2|||
13120722|NCT02996500|25939292|FG005|Overall Study|Withdrawal by Subject|0|||
13120723|NCT02996448|25939300|FG000|Overall Study|Study terminated due to adverse effects|3|||
13120724|NCT02996097|25939310|FG000|Overall Study|Lost to Follow-up|11|||
13120725|NCT02996097|25939311|FG001|Overall Study|Lost to Follow-up|11|||
13120726|NCT02995980|25939322|FG000|Overall Study|Lost to Follow-up|14|||
13120727|NCT02994940|25939341|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6|||
13120728|NCT02994940|25939342|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0|||
13120729|NCT02994940|25939341|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1|||
13120730|NCT02994940|25939342|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0|||
13120731|NCT02994940|25939341|FG000|Overall Study|Did not receive study medications: red dye allergy|0|||
13120732|NCT02994940|25939342|FG001|Overall Study|Did not receive study medications: red dye allergy|1|||
13120733|NCT02994654|25939351|FG000|Overall Study|Lost to Follow-up|1|||
13120734|NCT02994394|25939382|FG000|Period 1 (Days 1 to 3)|Adverse Event|0|||
13120735|NCT02994394|25939383|FG001|Period 1 (Days 1 to 3)|Adverse Event|0|||
13120736|NCT02994394|25939384|FG002|Period 1 (Days 1 to 3)|Adverse Event|1|||
13120737|NCT02994394|25939385|FG003|Period 1 (Days 1 to 3)|Adverse Event|0|||
13120738|NCT02994394|25939386|FG004|Period 1 (Days 1 to 3)|Adverse Event|0|||
13120739|NCT02994394|25939387|FG005|Period 1 (Days 1 to 3)|Adverse Event|0|||
13120740|NCT02994394|25939382|FG000|Period 2 (Days 4 to 6)|Adverse Event|0|||
13120741|NCT02994394|25939383|FG001|Period 2 (Days 4 to 6)|Adverse Event|1|||
13120742|NCT02994394|25939384|FG002|Period 2 (Days 4 to 6)|Adverse Event|0|||
13120743|NCT02994394|25939385|FG003|Period 2 (Days 4 to 6)|Adverse Event|0|||
13120744|NCT02994394|25939386|FG004|Period 2 (Days 4 to 6)|Adverse Event|1|||
13120745|NCT02994394|25939387|FG005|Period 2 (Days 4 to 6)|Adverse Event|0|||
13120746|NCT02994108|25939426|FG000|Intervention Messages|Withdrawal by Subject|2|||
13120747|NCT02994108|25939427|FG001|Intervention Messages|Withdrawal by Subject|0|||
13120748|NCT02994108|25939426|FG000|Phase 1 Assessment|Lost to Follow-up|5|||
13280872|NCT01044303|26456394|FG000|Overall Study|Lost to Follow-up|2|||
13280873|NCT01044290|26456427|FG000|Follow-up 1|Death|3|||
13280874|NCT01044290|26456428|FG001|Follow-up 1|Death|3|||
13280875|NCT01044290|26456429|FG002|Follow-up 1|Death|1|||
13280876|NCT01044290|26456427|FG000|Follow-up 1|Withdrawal by Subject|2|||
13280877|NCT01044290|26456428|FG001|Follow-up 1|Withdrawal by Subject|2|||
13280878|NCT01044290|26456429|FG002|Follow-up 1|Withdrawal by Subject|0|||
13280879|NCT01044290|26456427|FG000|Follow-Up 2|Death|0|||
13280880|NCT01044290|26456428|FG001|Follow-Up 2|Death|1|||
13280881|NCT01044290|26456429|FG002|Follow-Up 2|Death|1|||
13280882|NCT01044290|26456427|FG000|Follow-Up 2|Withdrawal by Subject|0|||
13280883|NCT01044290|26456428|FG001|Follow-Up 2|Withdrawal by Subject|1|||
13280884|NCT01044290|26456429|FG002|Follow-Up 2|Withdrawal by Subject|1|||
13280885|NCT01043874|26456438|FG000|Overall Study|Adverse Event|3|||
13280886|NCT01043874|26456438|FG000|Overall Study|Withdrawal by Subject|1|||
13280887|NCT01043874|26456438|FG000|Overall Study|Lack of Efficacy|1|||
13280888|NCT01043874|26456438|FG000|Overall Study|Administrative Problems|1|||
13280889|NCT01043185|26456476|FG000|Period 6 - Third Washout Period|Protocol Violation|0|||
13280890|NCT01043185|26456477|FG001|Period 6 - Third Washout Period|Protocol Violation|0|||
13280891|NCT01043185|26456478|FG002|Period 6 - Third Washout Period|Protocol Violation|0|||
13280892|NCT01043185|26456479|FG003|Period 6 - Third Washout Period|Protocol Violation|0|||
13280893|NCT01043185|26456480|FG004|Period 6 - Third Washout Period|Protocol Violation|0|||
13280894|NCT01043185|26456481|FG005|Period 6 - Third Washout Period|Protocol Violation|0|||
13280895|NCT01043185|26456482|FG006|Period 6 - Third Washout Period|Protocol Violation|0|||
13280896|NCT01043185|26456483|FG007|Period 6 - Third Washout Period|Protocol Violation|0|||
13280897|NCT01043185|26456484|FG008|Period 6 - Third Washout Period|Protocol Violation|1|||
13280898|NCT01043185|26456485|FG009|Period 6 - Third Washout Period|Protocol Violation|0|||
13280899|NCT01042977|26456510|FG000|Overall Study|Adverse Event|4|||
13280900|NCT01042977|26456511|FG001|Overall Study|Adverse Event|12|||
13280901|NCT01042977|26456510|FG000|Overall Study|Death|2|||
13280902|NCT01042977|26456511|FG001|Overall Study|Death|1|||
13280903|NCT01042977|26456510|FG000|Overall Study|Withdrawal by Subject|8|||
13280904|NCT01042977|26456511|FG001|Overall Study|Withdrawal by Subject|16|||
13280905|NCT01042977|26456510|FG000|Overall Study|Lost to Follow-up|0|||
13280906|NCT01042977|26456511|FG001|Overall Study|Lost to Follow-up|2|||
13280907|NCT01042977|26456510|FG000|Overall Study|Poor/non-compliance|3|||
13280908|NCT01042977|26456511|FG001|Overall Study|Poor/non-compliance|4|||
13280909|NCT01042977|26456510|FG000|Overall Study|Subject no longer meets study criteria|15|||
13280910|NCT01042977|26456511|FG001|Overall Study|Subject no longer meets study criteria|13|||
13280911|NCT01042977|26456510|FG000|Overall Study|Incorrect enrollment|6|||
13280912|NCT01042977|26456511|FG001|Overall Study|Incorrect enrollment|4|||
13280913|NCT01042977|26456510|FG000|Overall Study|Safety|0|||
13280914|NCT01042977|26456511|FG001|Overall Study|Safety|2|||
13280915|NCT01042977|26456510|FG000|Overall Study|Administrative reason by sponsor|0|||
13280916|NCT01042977|26456511|FG001|Overall Study|Administrative reason by sponsor|1|||
13280917|NCT01042977|26456510|FG000|Overall Study|Various|3|||
13280918|NCT01042977|26456511|FG001|Overall Study|Various|0|||
13280919|NCT01042938|26456530|FG000|Overall Study|Withdrawal by Subject|1|||
13280920|NCT01042938|26456531|FG001|Overall Study|Withdrawal by Subject|1|||
13280921|NCT01042938|26456530|FG000|Overall Study|Protocol Violation|1|||
13280922|NCT01042938|26456531|FG001|Overall Study|Protocol Violation|1|||
13280923|NCT01042938|26456530|FG000|Overall Study|Ineligible: RTOG study conflict|1|||
13280924|NCT01042938|26456531|FG001|Overall Study|Ineligible: RTOG study conflict|0|||
13280925|NCT01042678|26456567|FG000|Overall Study|Physician Decision|1|||
13280926|NCT01042678|26456568|FG001|Overall Study|Physician Decision|0|||
13280927|NCT01042678|26456569|FG002|Overall Study|Physician Decision|0|||
13280928|NCT01042678|26456570|FG003|Overall Study|Physician Decision|0|||
13280929|NCT01042678|26456571|FG004|Overall Study|Physician Decision|0|||
13280930|NCT01042678|26456572|FG005|Overall Study|Physician Decision|0|||
13280931|NCT01042600|26456599|FG000|Overall Study|Ineligible|1|||
13280932|NCT01042600|26456600|FG001|Overall Study|Ineligible|0|||
13280933|NCT01042535|26456610|FG000|Overall Study|disease progression prior to treatment|3|||
13280934|NCT01042535|26456610|FG000|Overall Study|disease progression during treatment|3|||
13280935|NCT01042535|26456610|FG000|Overall Study|complications from other disease|2|||
13280936|NCT01042158|26456619|FG000|Overall Study|Physician Decision|1|||
13280937|NCT01042093|26456650|FG000|Overall Study|Protocol Violation|2|||
13280938|NCT01042093|26456651|FG001|Overall Study|Protocol Violation|2|||
13280939|NCT01042093|26456652|FG002|Overall Study|Protocol Violation|2|||
13280940|NCT01042093|26456653|FG003|Overall Study|Protocol Violation|3|||
13280941|NCT01042093|26456650|FG000|Overall Study|Withdrawal by Subject|0|||
13280942|NCT01042093|26456651|FG001|Overall Study|Withdrawal by Subject|0|||
13280943|NCT01042093|26456652|FG002|Overall Study|Withdrawal by Subject|0|||
13280944|NCT01042093|26456653|FG003|Overall Study|Withdrawal by Subject|1|||
13280945|NCT01041976|26456668|FG000|Overall Study|Withdrawal by Subject|3|||
13280946|NCT01041976|26456669|FG001|Overall Study|Withdrawal by Subject|0|||
13120749|NCT02994108|25939427|FG001|Phase 1 Assessment|Lost to Follow-up|3|||
13280947|NCT01041976|26456668|FG000|Overall Study|Incarceration|2|||
13120750|NCT02994108|25939426|FG000|Phase 2 Assessment|Lost to Follow-up|8|||
13120751|NCT02994108|25939427|FG001|Phase 2 Assessment|Lost to Follow-up|7|||
13120752|NCT02994108|25939426|FG000|Phase 2 Assessment|Withdrawal by Subject|1|||
13120753|NCT02994108|25939427|FG001|Phase 2 Assessment|Withdrawal by Subject|0|||
13120754|NCT02994056|25939463|FG000|Overall Study|Death|8|||
13120755|NCT02994056|25939463|FG000|Overall Study|Withdrew Consent|1|||
13120756|NCT02993926|25939497|FG000|Enantone Treatment Phase|Adverse Event|1|||
13120757|NCT02993926|25939498|FG001|Enantone Treatment Phase|Adverse Event|0|||
13120758|NCT02993926|25939499|FG002|Enantone Treatment Phase|Adverse Event|0|||
13120759|NCT02993926|25939497|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26|||
13120760|NCT02993926|25939498|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
13120761|NCT02993926|25939499|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
13120762|NCT02993926|25939497|FG000|Enantone Treatment Phase|Investigator Judgment|1|||
13120763|NCT02993926|25939498|FG001|Enantone Treatment Phase|Investigator Judgment|0|||
13120764|NCT02993926|25939499|FG002|Enantone Treatment Phase|Investigator Judgment|0|||
13120765|NCT02993926|25939497|FG000|Enantone Treatment Phase|Reason Not Specified|4|||
13120766|NCT02993926|25939498|FG001|Enantone Treatment Phase|Reason Not Specified|0|||
13120767|NCT02993926|25939499|FG002|Enantone Treatment Phase|Reason Not Specified|0|||
13120768|NCT02993822|25939626|FG000|Overall Study|Lack of Efficacy|1|||
13120769|NCT02993822|25939627|FG001|Overall Study|Lack of Efficacy|1|||
13120770|NCT02993822|25939628|FG002|Overall Study|Lack of Efficacy|0|||
13120771|NCT02993822|25939629|FG003|Overall Study|Lack of Efficacy|0|||
13120772|NCT02993822|25939626|FG000|Overall Study|Protocol Violation|1|||
13120773|NCT02993822|25939627|FG001|Overall Study|Protocol Violation|0|||
13120774|NCT02993822|25939628|FG002|Overall Study|Protocol Violation|0|||
13120775|NCT02993822|25939629|FG003|Overall Study|Protocol Violation|0|||
13120776|NCT02993822|25939626|FG000|Overall Study|Unable to attend follow-up due to illness|0|||
13120777|NCT02993822|25939627|FG001|Overall Study|Unable to attend follow-up due to illness|0|||
13120778|NCT02993822|25939628|FG002|Overall Study|Unable to attend follow-up due to illness|0|||
13120779|NCT02993822|25939629|FG003|Overall Study|Unable to attend follow-up due to illness|1|||
13120780|NCT02993822|25939626|FG000|Overall Study|Adverse Event|3|||
13120781|NCT02993822|25939627|FG001|Overall Study|Adverse Event|1|||
13120782|NCT02993822|25939628|FG002|Overall Study|Adverse Event|7|||
13120783|NCT02993822|25939629|FG003|Overall Study|Adverse Event|0|||
13120784|NCT02993822|25939626|FG000|Overall Study|Withdrawal by Subject|4|||
13120785|NCT02993822|25939627|FG001|Overall Study|Withdrawal by Subject|2|||
13120786|NCT02993822|25939628|FG002|Overall Study|Withdrawal by Subject|2|||
13120787|NCT02993822|25939629|FG003|Overall Study|Withdrawal by Subject|3|||
13120788|NCT02993822|25939626|FG000|Overall Study|Lost to Follow-up|1|||
13120789|NCT02993822|25939627|FG001|Overall Study|Lost to Follow-up|0|||
13120790|NCT02993822|25939628|FG002|Overall Study|Lost to Follow-up|1|||
13120791|NCT02993822|25939629|FG003|Overall Study|Lost to Follow-up|0|||
13120792|NCT02993783|25939666|FG000|Overall Study|Reason not Specified|6|||
13120793|NCT02993783|25939667|FG001|Overall Study|Reason not Specified|9|||
13120794|NCT02993731|25939698|FG000|Overall Study|Study Termination|101|||
13120795|NCT02993731|25939699|FG001|Overall Study|Study Termination|105|||
13120796|NCT02993471|25939735|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1|||
13120797|NCT02993471|25939735|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1|||
13120798|NCT02993250|25939762|FG000|Overall Study|Lost to Follow-up|0|||
13120799|NCT02993250|25939763|FG001|Overall Study|Lost to Follow-up|1|||
13120800|NCT02993224|25939782|FG000|Core Phase - Period 1|Adverse Event|4|||
13120801|NCT02993224|25939782|FG000|Core Phase - Period 1|Withdrawal by Subject|1|||
13120802|NCT02993224|25939782|FG000|Core Phase - Period 1|Lost to Follow-up|3|||
13120803|NCT02993224|25939782|FG000|Core Phase- Period 2|Adverse Event|1|||
13120804|NCT02993224|25939782|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2|||
13203891|NCT01979614|26226244|FG000|Overall Study|Adverse Event|1|||
13203892|NCT01979614|26226245|FG001|Overall Study|Adverse Event|1|||
13203893|NCT01979523|26226273|FG000|Overall Study|Withdrawal by Subject|1|||
13203894|NCT01979523|26226274|FG001|Overall Study|Withdrawal by Subject|0|||
13203895|NCT01979185|26226291|FG000|Period 2|Other|0|||
13203896|NCT01979185|26226292|FG001|Period 2|Other|1|||
13203897|NCT01979016|26226331|FG000|Overall Study|Withdrawal by Subject|2|||
13203898|NCT01979016|26226332|FG001|Overall Study|Withdrawal by Subject|0|||
13203899|NCT01979016|26226331|FG000|Overall Study|Adverse Event|0|||
13203900|NCT01979016|26226332|FG001|Overall Study|Adverse Event|1|||
13203901|NCT01978912|26226391|FG000|Overall Study|Adverse Event|0|||
13203902|NCT01978912|26226392|FG001|Overall Study|Adverse Event|1|||
13203903|NCT01978912|26226393|FG002|Overall Study|Adverse Event|0|||
13203904|NCT01978912|26226394|FG003|Overall Study|Adverse Event|0|||
13203905|NCT01978912|26226391|FG000|Overall Study|Lost to Follow-up|1|||
13203906|NCT01978912|26226392|FG001|Overall Study|Lost to Follow-up|1|||
13203907|NCT01978912|26226393|FG002|Overall Study|Lost to Follow-up|0|||
13203908|NCT01978912|26226394|FG003|Overall Study|Lost to Follow-up|1|||
13203909|NCT01978912|26226391|FG000|Overall Study|Withdrawal by Subject|1|||
13203910|NCT01978912|26226392|FG001|Overall Study|Withdrawal by Subject|0|||
13203911|NCT01978912|26226393|FG002|Overall Study|Withdrawal by Subject|2|||
13203912|NCT01978912|26226394|FG003|Overall Study|Withdrawal by Subject|2|||
13203913|NCT01978912|26226391|FG000|Overall Study|Lumbar Surgery|1|||
13203914|NCT01978912|26226392|FG001|Overall Study|Lumbar Surgery|0|||
13203915|NCT01978912|26226393|FG002|Overall Study|Lumbar Surgery|1|||
13203916|NCT01978912|26226394|FG003|Overall Study|Lumbar Surgery|0|||
13203917|NCT01978912|26226391|FG000|Overall Study|Intradiscal Steroid Injection|0|||
13203918|NCT01978912|26226392|FG001|Overall Study|Intradiscal Steroid Injection|1|||
13203919|NCT01978912|26226393|FG002|Overall Study|Intradiscal Steroid Injection|0|||
13203920|NCT01978912|26226394|FG003|Overall Study|Intradiscal Steroid Injection|0|||
13203921|NCT01978262|26226401|FG000|Overall Study|Withdrawal by Subject|9|||
13203922|NCT01978262|26226401|FG000|Overall Study|Lost to Follow-up|2|||
13203923|NCT01978236|26226422|FG000|Overall Study|Discontinued due to study close|2|||
13203924|NCT01978184|26226455|FG000|Overall Study|Progressive disease|5|||
13203925|NCT01978184|26226456|FG001|Overall Study|Progressive disease|5|||
13203926|NCT01978184|26226455|FG000|Overall Study|Other than PDA|2|||
13203927|NCT01978184|26226456|FG001|Overall Study|Other than PDA|2|||
13203928|NCT01978184|26226455|FG000|Overall Study|Physician Decision|0|||
13203929|NCT01978184|26226456|FG001|Overall Study|Physician Decision|3|||
13203930|NCT01978184|26226455|FG000|Overall Study|Noncompliance|1|||
13203931|NCT01978184|26226456|FG001|Overall Study|Noncompliance|2|||
13203932|NCT01978184|26226455|FG000|Overall Study|Death|1|||
13120805|NCT02993224|25939782|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1|||
13120806|NCT02993224|25939782|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1|||
13120807|NCT02993224|25939782|FG000|Extension Phase|Adverse Event|3|||
13120808|NCT02993224|25939782|FG000|Extension Phase|Withdrawal by Subject|3|||
13120809|NCT02993224|25939782|FG000|Extension Phase|Lost to Follow-up|2|||
13120810|NCT02993224|25939782|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27|||
13120811|NCT02992899|25939839|FG000|Overall Study|Withdrawal by Subject|1|||
13120812|NCT02992899|25939840|FG001|Overall Study|Withdrawal by Subject|0|||
13120813|NCT02992899|25939839|FG000|Overall Study|Lost to Follow-up|1|||
13120814|NCT02992899|25939840|FG001|Overall Study|Lost to Follow-up|3|||
13120815|NCT02992691|25939859|FG000|Overall Study|Adverse Event|2|||
13120816|NCT02992691|25939859|FG000|Overall Study|Withdrawal by Subject|1|||
13120817|NCT02992288|25939934|FG000|Overall Study|Adverse Event|8|||
13120818|NCT02992288|25939935|FG001|Overall Study|Adverse Event|2|||
13120819|NCT02992288|25939936|FG002|Overall Study|Adverse Event|2|||
13120820|NCT02992288|25939937|FG003|Overall Study|Adverse Event|2|||
13120821|NCT02992288|25939938|FG004|Overall Study|Adverse Event|2|||
13120822|NCT02992288|25939939|FG005|Overall Study|Adverse Event|7|||
13120823|NCT02992288|25939934|FG000|Overall Study|Non-compliance with study drug|0|||
13120824|NCT02992288|25939935|FG001|Overall Study|Non-compliance with study drug|1|||
13120825|NCT02992288|25939936|FG002|Overall Study|Non-compliance with study drug|1|||
13120826|NCT02992288|25939937|FG003|Overall Study|Non-compliance with study drug|0|||
13120827|NCT02992288|25939938|FG004|Overall Study|Non-compliance with study drug|1|||
13120828|NCT02992288|25939939|FG005|Overall Study|Non-compliance with study drug|0|||
13120829|NCT02992288|25939934|FG000|Overall Study|Physician Decision|3|||
13120830|NCT02992288|25939935|FG001|Overall Study|Physician Decision|0|||
13120831|NCT02992288|25939936|FG002|Overall Study|Physician Decision|1|||
13120832|NCT02992288|25939937|FG003|Overall Study|Physician Decision|0|||
13120833|NCT02992288|25939938|FG004|Overall Study|Physician Decision|0|||
13120834|NCT02992288|25939939|FG005|Overall Study|Physician Decision|1|||
13120835|NCT02992288|25939934|FG000|Overall Study|Death|2|||
13120836|NCT02992288|25939935|FG001|Overall Study|Death|0|||
13120837|NCT02992288|25939936|FG002|Overall Study|Death|2|||
13120838|NCT02992288|25939937|FG003|Overall Study|Death|1|||
13120839|NCT02992288|25939938|FG004|Overall Study|Death|2|||
13120840|NCT02992288|25939939|FG005|Overall Study|Death|0|||
13120841|NCT02992288|25939934|FG000|Overall Study|Lost to Follow-up|0|||
13120842|NCT02992288|25939935|FG001|Overall Study|Lost to Follow-up|0|||
13120843|NCT02992288|25939936|FG002|Overall Study|Lost to Follow-up|0|||
13120844|NCT02992288|25939937|FG003|Overall Study|Lost to Follow-up|1|||
13120845|NCT02992288|25939938|FG004|Overall Study|Lost to Follow-up|0|||
13120846|NCT02992288|25939939|FG005|Overall Study|Lost to Follow-up|0|||
13120847|NCT02992288|25939934|FG000|Overall Study|Protocol Violation|0|||
13120848|NCT02992288|25939935|FG001|Overall Study|Protocol Violation|0|||
13120849|NCT02992288|25939936|FG002|Overall Study|Protocol Violation|0|||
13120850|NCT02992288|25939937|FG003|Overall Study|Protocol Violation|0|||
13280948|NCT01041976|26456669|FG001|Overall Study|Incarceration|0|||
13280949|NCT01041976|26456668|FG000|Overall Study|Death|0|||
13280950|NCT01041976|26456669|FG001|Overall Study|Death|4|||
13280951|NCT01041859|26456692|FG000|Open-Label Titration|Adverse Event|69|||
13280952|NCT01041859|26456693|FG001|Open-Label Titration|Adverse Event|0|||
13280953|NCT01041859|26456694|FG002|Open-Label Titration|Adverse Event|0|||
13120851|NCT02992288|25939938|FG004|Overall Study|Protocol Violation|0|||
13120852|NCT02992288|25939939|FG005|Overall Study|Protocol Violation|1|||
13120853|NCT02992288|25939934|FG000|Overall Study|Withdrawal by Subject|4|||
13120854|NCT02992288|25939935|FG001|Overall Study|Withdrawal by Subject|2|||
13120855|NCT02992288|25939936|FG002|Overall Study|Withdrawal by Subject|1|||
13120856|NCT02992288|25939937|FG003|Overall Study|Withdrawal by Subject|5|||
13120857|NCT02992288|25939938|FG004|Overall Study|Withdrawal by Subject|3|||
13120858|NCT02992288|25939939|FG005|Overall Study|Withdrawal by Subject|4|||
13120859|NCT02992132|25939960|FG000|Overall Study|Adverse Event|4|||
13120860|NCT02992132|25939961|FG001|Overall Study|Adverse Event|1|||
13120861|NCT02992132|25939962|FG002|Overall Study|Adverse Event|3|||
13120862|NCT02992132|25939960|FG000|Overall Study|Lack of Efficacy|2|||
13120863|NCT02992132|25939961|FG001|Overall Study|Lack of Efficacy|0|||
13120864|NCT02992132|25939962|FG002|Overall Study|Lack of Efficacy|0|||
13120865|NCT02992132|25939960|FG000|Overall Study|Non-compliance with study drug|2|||
13120866|NCT02992132|25939961|FG001|Overall Study|Non-compliance with study drug|0|||
13120867|NCT02992132|25939962|FG002|Overall Study|Non-compliance with study drug|0|||
13120868|NCT02992132|25939960|FG000|Overall Study|Progressive disease|1|||
13120869|NCT02992132|25939961|FG001|Overall Study|Progressive disease|0|||
13120870|NCT02992132|25939962|FG002|Overall Study|Progressive disease|0|||
13120871|NCT02992132|25939960|FG000|Overall Study|Protocol Violation|2|||
13120872|NCT02992132|25939961|FG001|Overall Study|Protocol Violation|2|||
13120873|NCT02992132|25939962|FG002|Overall Study|Protocol Violation|0|||
13120874|NCT02992132|25939960|FG000|Overall Study|Caregiver withdrew consent|2|||
13120875|NCT02992132|25939961|FG001|Overall Study|Caregiver withdrew consent|3|||
13120876|NCT02992132|25939962|FG002|Overall Study|Caregiver withdrew consent|2|||
13120877|NCT02992132|25939960|FG000|Overall Study|Withdrawal by Subject|0|||
13120878|NCT02992132|25939961|FG001|Overall Study|Withdrawal by Subject|2|||
13120879|NCT02992132|25939962|FG002|Overall Study|Withdrawal by Subject|1|||
13120880|NCT02992132|25939960|FG000|Overall Study|Physician Decision|0|||
13120881|NCT02992132|25939961|FG001|Overall Study|Physician Decision|0|||
13120882|NCT02992132|25939962|FG002|Overall Study|Physician Decision|1|||
13120883|NCT02991859|25940257|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
13120884|NCT02991859|25940258|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
13120885|NCT02991859|25940259|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
13120886|NCT02991859|25940260|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
13120887|NCT02991859|25940261|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
13120888|NCT02991859|25940262|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
13120889|NCT02991859|25940263|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
13120890|NCT02991859|25940264|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
13120891|NCT02991859|25940265|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
13120892|NCT02991859|25940266|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
13120893|NCT02991859|25940267|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
13120894|NCT02991859|25940268|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
13120895|NCT02991859|25940269|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
13120896|NCT02991859|25940270|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
13120897|NCT02991859|25940271|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
13120898|NCT02991859|25940272|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
13120899|NCT02991859|25940273|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
13120900|NCT02991859|25940257|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
13120901|NCT02991859|25940258|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
13120902|NCT02991859|25940259|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
13120903|NCT02991859|25940260|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
13120904|NCT02991859|25940261|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
13120905|NCT02991859|25940262|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
13120906|NCT02991859|25940263|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
13120907|NCT02991859|25940264|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
13120908|NCT02991859|25940265|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
13120909|NCT02991859|25940266|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
13120910|NCT02991859|25940267|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
13120911|NCT02991859|25940268|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
13120912|NCT02991859|25940269|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
13120913|NCT02991859|25940270|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
13120914|NCT02991859|25940271|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
13120915|NCT02991859|25940272|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
13120916|NCT02991859|25940273|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
13120917|NCT02991859|25940257|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
13120918|NCT02991859|25940258|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
13120919|NCT02991859|25940259|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
13120920|NCT02991859|25940260|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
13120921|NCT02991859|25940261|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
13120922|NCT02991859|25940262|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1|||
13120923|NCT02991859|25940263|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
13120924|NCT02991859|25940264|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
13120925|NCT02991859|25940265|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
13120926|NCT02991859|25940266|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
13120927|NCT02991859|25940267|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
13120928|NCT02991859|25940268|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
13120929|NCT02991859|25940269|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
13120930|NCT02991859|25940270|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
13120931|NCT02991859|25940271|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
13120932|NCT02991859|25940272|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
13120933|NCT02991859|25940273|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
13120934|NCT02991859|25940257|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0|||
13120935|NCT02991859|25940258|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0|||
13120936|NCT02991859|25940259|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0|||
13120937|NCT02991859|25940260|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0|||
13120938|NCT02991859|25940261|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0|||
13120939|NCT02991859|25940262|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0|||
13120940|NCT02991859|25940263|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0|||
13120941|NCT02991859|25940264|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0|||
13120942|NCT02991859|25940265|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0|||
13120943|NCT02991859|25940266|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1|||
13120944|NCT02991859|25940267|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0|||
13120945|NCT02991859|25940268|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0|||
13120946|NCT02991859|25940269|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0|||
13120947|NCT02991859|25940270|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0|||
13120948|NCT02991859|25940271|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0|||
13120949|NCT02991859|25940272|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0|||
13120950|NCT02991859|25940273|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0|||
13120951|NCT02991859|25940257|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
13120952|NCT02991859|25940258|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
13120953|NCT02991859|25940259|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
13120954|NCT02991859|25940260|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
13120955|NCT02991859|25940261|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
13120956|NCT02991859|25940262|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
13120957|NCT02991859|25940263|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
13120958|NCT02991859|25940264|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
13120959|NCT02991859|25940265|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1|||
13120960|NCT02991859|25940266|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
13120961|NCT02991859|25940267|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
13120962|NCT02991859|25940268|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
13120963|NCT02991859|25940269|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
13120964|NCT02991859|25940270|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
13120965|NCT02991859|25940271|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
13120966|NCT02991859|25940272|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
13120967|NCT02991859|25940273|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
13120968|NCT02991482|25940296|FG000|Overall Study|Disease progression|56|||
13120969|NCT02991482|25940297|FG001|Overall Study|Disease progression|47|||
13120970|NCT02991482|25940296|FG000|Overall Study|Death|4|||
13120971|NCT02991482|25940297|FG001|Overall Study|Death|4|||
13120972|NCT02991482|25940296|FG000|Overall Study|Adverse Event|1|||
13120973|NCT02991482|25940297|FG001|Overall Study|Adverse Event|6|||
13120974|NCT02991482|25940296|FG000|Overall Study|Patient decision|1|||
13120975|NCT02991482|25940297|FG001|Overall Study|Patient decision|1|||
13120976|NCT02991482|25940296|FG000|Overall Study|Physician Decision|0|||
13120977|NCT02991482|25940297|FG001|Overall Study|Physician Decision|6|||
13120978|NCT02991482|25940296|FG000|Overall Study|Clinical deterioration|1|||
13120979|NCT02991482|25940297|FG001|Overall Study|Clinical deterioration|0|||
13120980|NCT02991482|25940296|FG000|Overall Study|Patient feeling too unwell|1|||
13120981|NCT02991482|25940297|FG001|Overall Study|Patient feeling too unwell|0|||
13120982|NCT02991482|25940296|FG000|Overall Study|Worsening of performance status|0|||
13120983|NCT02991482|25940297|FG001|Overall Study|Worsening of performance status|1|||
13280954|NCT01041859|26456692|FG000|Open-Label Titration|Lack of Efficacy|3|||
13280955|NCT01041859|26456693|FG001|Open-Label Titration|Lack of Efficacy|0|||
13280956|NCT01041859|26456694|FG002|Open-Label Titration|Lack of Efficacy|0|||
13280957|NCT01041859|26456692|FG000|Open-Label Titration|Lost to Follow-up|1|||
13280958|NCT01041859|26456693|FG001|Open-Label Titration|Lost to Follow-up|0|||
13280959|NCT01041859|26456694|FG002|Open-Label Titration|Lost to Follow-up|0|||
13280960|NCT01041859|26456692|FG000|Open-Label Titration|Physician Decision|1|||
13280961|NCT01041859|26456693|FG001|Open-Label Titration|Physician Decision|0|||
13280962|NCT01041859|26456694|FG002|Open-Label Titration|Physician Decision|0|||
13280963|NCT01041859|26456692|FG000|Open-Label Titration|Protocol Violation|1|||
13280964|NCT01041859|26456693|FG001|Open-Label Titration|Protocol Violation|0|||
13280965|NCT01041859|26456694|FG002|Open-Label Titration|Protocol Violation|0|||
13280966|NCT01041859|26456692|FG000|Open-Label Titration|Other|7|||
13280967|NCT01041859|26456693|FG001|Open-Label Titration|Other|0|||
13280968|NCT01041859|26456694|FG002|Open-Label Titration|Other|0|||
13280969|NCT01041859|26456692|FG000|Open-Label Titration|Noncompliance With Study Drug|8|||
13280970|NCT01041859|26456693|FG001|Open-Label Titration|Noncompliance With Study Drug|0|||
13280971|NCT01041859|26456694|FG002|Open-Label Titration|Noncompliance With Study Drug|0|||
13280972|NCT01041859|26456692|FG000|Open-Label Titration|Withdrawal by Subject|11|||
13280973|NCT01041859|26456693|FG001|Open-Label Titration|Withdrawal by Subject|0|||
13280974|NCT01041859|26456694|FG002|Open-Label Titration|Withdrawal by Subject|0|||
13280975|NCT01041859|26456692|FG000|Double-Blind Maintenance|Adverse Event|0|||
13280976|NCT01041859|26456693|FG001|Double-Blind Maintenance|Adverse Event|23|||
13280977|NCT01041859|26456694|FG002|Double-Blind Maintenance|Adverse Event|13|||
13280978|NCT01041859|26456692|FG000|Double-Blind Maintenance|Lack of Efficacy|0|||
13280979|NCT01041859|26456693|FG001|Double-Blind Maintenance|Lack of Efficacy|3|||
13280980|NCT01041859|26456694|FG002|Double-Blind Maintenance|Lack of Efficacy|11|||
13280981|NCT01041859|26456692|FG000|Double-Blind Maintenance|Lost to Follow-up|0|||
13120984|NCT02991482|25940296|FG000|Overall Study|Death prior to study drug initiation|1|||
13120985|NCT02991482|25940297|FG001|Overall Study|Death prior to study drug initiation|0|||
13203933|NCT01978184|26226456|FG001|Overall Study|Death|0|||
13120986|NCT02991482|25940296|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0|||
13120987|NCT02991482|25940297|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1|||
13120988|NCT02991430|25940342|FG000|Treatment Period 1|Adverse Event|1|||
13120989|NCT02991430|25940343|FG001|Treatment Period 1|Adverse Event|0|||
13120990|NCT02991430|25940344|FG002|Treatment Period 1|Adverse Event|2|||
13120991|NCT02991430|25940342|FG000|Treatment Period 1|Withdrawal by Subject|0|||
13120992|NCT02991430|25940343|FG001|Treatment Period 1|Withdrawal by Subject|4|||
13120993|NCT02991430|25940344|FG002|Treatment Period 1|Withdrawal by Subject|0|||
13120994|NCT02991430|25940342|FG000|Treatment Period 2|Study Termination|6|||
13120995|NCT02991430|25940343|FG001|Treatment Period 2|Study Termination|3|||
13120996|NCT02991430|25940344|FG002|Treatment Period 2|Study Termination|3|||
13120997|NCT02991430|25940342|FG000|Treatment Period 2|Lost to Follow-up|0|||
13120998|NCT02991430|25940343|FG001|Treatment Period 2|Lost to Follow-up|0|||
13120999|NCT02991430|25940344|FG002|Treatment Period 2|Lost to Follow-up|1|||
13121000|NCT02991430|25940342|FG000|Post-treatment Observation Period|Study Termination|3|||
13121001|NCT02991430|25940343|FG001|Post-treatment Observation Period|Study Termination|6|||
13121002|NCT02991430|25940344|FG002|Post-treatment Observation Period|Study Termination|5|||
13121003|NCT02991118|25940395|FG000|Overall Study|Death|3|||
13121004|NCT02991118|25940396|FG001|Overall Study|Death|8|||
13121005|NCT02991118|25940395|FG000|Overall Study|Protocol Violation|0|||
13121006|NCT02991118|25940396|FG001|Overall Study|Protocol Violation|3|||
13121007|NCT02991118|25940395|FG000|Overall Study|Physician Decision|0|||
13121008|NCT02991118|25940396|FG001|Overall Study|Physician Decision|1|||
13121009|NCT02991118|25940395|FG000|Overall Study|Moved out of the country|0|||
13121010|NCT02991118|25940396|FG001|Overall Study|Moved out of the country|1|||
13121011|NCT02991118|25940395|FG000|Overall Study|Adverse Event|2|||
13121012|NCT02991118|25940396|FG001|Overall Study|Adverse Event|2|||
13121013|NCT02991118|25940395|FG000|Overall Study|Withdrawal by Subject|1|||
13121014|NCT02991118|25940396|FG001|Overall Study|Withdrawal by Subject|7|||
13121015|NCT02991118|25940395|FG000|Overall Study|Could not attend study visits|0|||
13121016|NCT02991118|25940396|FG001|Overall Study|Could not attend study visits|1|||
13121017|NCT02991118|25940395|FG000|Overall Study|Lost to Follow-up|1|||
13121018|NCT02991118|25940396|FG001|Overall Study|Lost to Follow-up|9|||
13121019|NCT02991040|25940411|FG000|Overall Study|Withdrawal by Subject|2|||
13121020|NCT02991040|25940411|FG000|Overall Study|Lost to Follow-up|2|||
13121021|NCT02990910|25940426|FG000|Overall Study|Lack of Efficacy|6|||
13121022|NCT02990910|25940427|FG001|Overall Study|Lack of Efficacy|10|||
13121023|NCT02990338|25940480|FG000|Overall Study|Adverse Event|19|||
13121024|NCT02990338|25940481|FG001|Overall Study|Adverse Event|11|||
13121025|NCT02990338|25940480|FG000|Overall Study|Progressive disease|88|||
13121026|NCT02990338|25940481|FG001|Overall Study|Progressive disease|66|||
13121027|NCT02990338|25940480|FG000|Overall Study|Poor compliance to protocol|0|||
13121028|NCT02990338|25940481|FG001|Overall Study|Poor compliance to protocol|1|||
13121029|NCT02990338|25940480|FG000|Overall Study|Withdrawal by Subject|6|||
13121030|NCT02990338|25940481|FG001|Overall Study|Withdrawal by Subject|5|||
13121031|NCT02990338|25940480|FG000|Overall Study|Other|1|||
13280982|NCT01041859|26456693|FG001|Double-Blind Maintenance|Lost to Follow-up|1|||
13280983|NCT01041859|26456694|FG002|Double-Blind Maintenance|Lost to Follow-up|0|||
13280984|NCT01041859|26456692|FG000|Double-Blind Maintenance|Physician Decision|0|||
13280985|NCT01041859|26456693|FG001|Double-Blind Maintenance|Physician Decision|2|||
13308049|NCT01280656|26530652|FG002|Overall Study|Adverse Event|13|||
13280986|NCT01041859|26456694|FG002|Double-Blind Maintenance|Physician Decision|1|||
13280987|NCT01041859|26456692|FG000|Double-Blind Maintenance|Protocol Violation|0|||
13280988|NCT01041859|26456693|FG001|Double-Blind Maintenance|Protocol Violation|1|||
13280989|NCT01041859|26456694|FG002|Double-Blind Maintenance|Protocol Violation|3|||
13280990|NCT01041859|26456692|FG000|Double-Blind Maintenance|Other|0|||
13280991|NCT01041859|26456693|FG001|Double-Blind Maintenance|Other|6|||
13280992|NCT01041859|26456694|FG002|Double-Blind Maintenance|Other|2|||
13280993|NCT01041859|26456692|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0|||
13280994|NCT01041859|26456693|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2|||
13280995|NCT01041859|26456694|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6|||
13280996|NCT01041859|26456692|FG000|Double-Blind Maintenance|Withdrawal by Subject|0|||
13280997|NCT01041859|26456693|FG001|Double-Blind Maintenance|Withdrawal by Subject|8|||
13291782|NCT00150618|26483597|FG002|Overall Study|Lack of Efficacy|7|||
13121032|NCT02990338|25940481|FG001|Overall Study|Other|4|||
13121033|NCT02990338|25940480|FG000|Overall Study|Randomized but not treated|4|||
13121034|NCT02990338|25940481|FG001|Overall Study|Randomized but not treated|2|||
13121035|NCT02990000|25940506|FG000|Overall Study|Failed to provide data beyond baseline|36|||
13121036|NCT02990000|25940507|FG001|Overall Study|Failed to provide data beyond baseline|34|||
13121037|NCT02989805|25940526|FG000|Overall Study|invalid consent|6|||
13121038|NCT02989805|25940527|FG001|Overall Study|invalid consent|4|||
13121039|NCT02989649|25940541|FG000|Overall Study|Patient/Investigator's Decision to Stop|403|||
13121040|NCT02989649|25940541|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1|||
13121041|NCT02989649|25940541|FG000|Overall Study|Lost For Observation During Study|3|||
13121042|NCT02989649|25940541|FG000|Overall Study|Reason Not Specified|13|||
13121043|NCT02989610|25940549|FG000|Overall Study|Withdrawal/Other reasons|39|||
13121044|NCT02989389|25940644|FG000|Period 1|Lost to Follow-up|0|||
13121045|NCT02989389|25940645|FG001|Period 1|Lost to Follow-up|1|||
13121046|NCT02989389|25940646|FG002|Period 1|Lost to Follow-up|0|||
13121047|NCT02989389|25940647|FG003|Period 1|Lost to Follow-up|0|||
13121048|NCT02989389|25940648|FG004|Period 1|Lost to Follow-up|0|||
13121049|NCT02989389|25940649|FG005|Period 1|Lost to Follow-up|0|||
13121050|NCT02989389|25940650|FG006|Period 1|Lost to Follow-up|0|||
13121051|NCT02989389|25940651|FG007|Period 1|Lost to Follow-up|0|||
13121052|NCT02989389|25940652|FG008|Period 1|Lost to Follow-up|0|||
13121053|NCT02989389|25940653|FG009|Period 1|Lost to Follow-up|0|||
13121054|NCT02989389|25940644|FG000|Period 1|Physician Decision|0|||
13121055|NCT02989389|25940645|FG001|Period 1|Physician Decision|0|||
13121056|NCT02989389|25940646|FG002|Period 1|Physician Decision|0|||
13121057|NCT02989389|25940647|FG003|Period 1|Physician Decision|0|||
13121058|NCT02989389|25940648|FG004|Period 1|Physician Decision|0|||
13121059|NCT02989389|25940649|FG005|Period 1|Physician Decision|0|||
13121060|NCT02989389|25940650|FG006|Period 1|Physician Decision|0|||
13121061|NCT02989389|25940651|FG007|Period 1|Physician Decision|0|||
13121062|NCT02989389|25940652|FG008|Period 1|Physician Decision|1|||
13121063|NCT02989389|25940653|FG009|Period 1|Physician Decision|0|||
13121064|NCT02989194|25940728|FG000|Overall Study|Study on hold for safety and participant was withdrawn|1|||
13121065|NCT02989194|25940729|FG001|Overall Study|Study on hold for safety and participant was withdrawn|0|||
13121066|NCT02989194|25940730|FG002|Overall Study|Study on hold for safety and participant was withdrawn|0|||
13121067|NCT02989194|25940728|FG000|Overall Study|Lost to Follow-up|0|||
13121068|NCT02989194|25940729|FG001|Overall Study|Lost to Follow-up|1|||
13121069|NCT02989194|25940730|FG002|Overall Study|Lost to Follow-up|0|||
13121070|NCT02989194|25940728|FG000|Overall Study|Withdrawal by Subject|0|||
13121071|NCT02989194|25940729|FG001|Overall Study|Withdrawal by Subject|1|||
13121072|NCT02989194|25940730|FG002|Overall Study|Withdrawal by Subject|0|||
13121073|NCT02989168|25940757|FG000|Overall Study|Withdrawal by Subject|2|||
13121074|NCT02989168|25940758|FG001|Overall Study|Withdrawal by Subject|0|||
13121075|NCT02989168|25940757|FG000|Overall Study|Physician Decision|0|||
13121076|NCT02989168|25940758|FG001|Overall Study|Physician Decision|1|||
13121077|NCT02989168|25940757|FG000|Overall Study|Adverse Event|1|||
13121078|NCT02989168|25940758|FG001|Overall Study|Adverse Event|2|||
13121079|NCT02989168|25940757|FG000|Overall Study|Sponsor stopped study.|1|||
13121080|NCT02989168|25940758|FG001|Overall Study|Sponsor stopped study.|0|||
13121081|NCT02988713|25940764|FG000|Overall Study|Withdrawal by Subject|1|||
13121082|NCT02988713|25940764|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2|||
13121091|NCT02988622|25940826|FG000|Overall Study|Lost to Follow-up|17|||
13121092|NCT02988219|25940841|FG000|Overall Study|Lack of Efficacy|1|||
13121093|NCT02988219|25940842|FG001|Overall Study|Lack of Efficacy|1|||
13121094|NCT02988219|25940841|FG000|Overall Study|Withdrawal by Subject|0|||
13121095|NCT02988219|25940842|FG001|Overall Study|Withdrawal by Subject|2|||
13121096|NCT02988115|25940863|FG000|Overall Study|Adverse Event|6|||
13121097|NCT02988115|25940864|FG001|Overall Study|Adverse Event|1|||
13121098|NCT02988115|25940863|FG000|Overall Study|Sponsor Decision|5|||
13121099|NCT02988115|25940864|FG001|Overall Study|Sponsor Decision|2|||
13121100|NCT02988115|25940863|FG000|Overall Study|Withdrawal by Subject|1|||
13121101|NCT02988115|25940864|FG001|Overall Study|Withdrawal by Subject|1|||
13121102|NCT02988115|25940863|FG000|Overall Study|Withdrawn by Mistake|1|||
13121103|NCT02988115|25940864|FG001|Overall Study|Withdrawn by Mistake|0|||
13280998|NCT01041859|26456694|FG002|Double-Blind Maintenance|Withdrawal by Subject|9|||
13280999|NCT01041638|26456702|FG000|Overall Study|Adverse Event|4|||
13281000|NCT01041638|26456702|FG000|Overall Study|Death|1|||
13281001|NCT01041638|26456702|FG000|Overall Study|Lack of Efficacy|7|||
13281002|NCT01041638|26456702|FG000|Overall Study|Physician Decision|4|||
13281003|NCT01041638|26456702|FG000|Overall Study|Withdrawal by Subject|11|||
13281004|NCT01041573|26456745|FG000|Overall Study|Withdrawal by Subject|2|||
13281005|NCT01041573|26456746|FG001|Overall Study|Withdrawal by Subject|5|||
13121104|NCT02988115|25940863|FG000|Overall Study|Lost to Follow-up|1|||
13121105|NCT02988115|25940864|FG001|Overall Study|Lost to Follow-up|0|||
13121106|NCT02987972|25940903|FG000|Overall Study|Adverse Event|1|||
13121107|NCT02987972|25940904|FG001|Overall Study|Adverse Event|1|||
13281006|NCT01041573|26456747|FG002|Overall Study|Withdrawal by Subject|2|||
13121108|NCT02987972|25940905|FG002|Overall Study|Adverse Event|0|||
13121109|NCT02987972|25940903|FG000|Overall Study|Death|1|||
13121110|NCT02987972|25940904|FG001|Overall Study|Death|0|||
13281007|NCT01041573|26456748|FG003|Overall Study|Withdrawal by Subject|0|||
13281008|NCT01041573|26456745|FG000|Overall Study|Death|1|||
13281009|NCT01041573|26456746|FG001|Overall Study|Death|0|||
13281010|NCT01041573|26456747|FG002|Overall Study|Death|0|||
13281011|NCT01041573|26456748|FG003|Overall Study|Death|0|||
13281012|NCT01041573|26456745|FG000|Overall Study|Lost to Follow-up|0|||
13281013|NCT01041573|26456746|FG001|Overall Study|Lost to Follow-up|1|||
13281014|NCT01041573|26456747|FG002|Overall Study|Lost to Follow-up|2|||
13281015|NCT01041573|26456748|FG003|Overall Study|Lost to Follow-up|1|||
13281016|NCT01041573|26456745|FG000|Overall Study|Adverse Event|0|||
13281017|NCT01041573|26456746|FG001|Overall Study|Adverse Event|2|||
13281018|NCT01041573|26456747|FG002|Overall Study|Adverse Event|0|||
13281019|NCT01041573|26456748|FG003|Overall Study|Adverse Event|0|||
13281020|NCT01041573|26456745|FG000|Overall Study|relocation|1|||
13281021|NCT01041573|26456746|FG001|Overall Study|relocation|4|||
13281022|NCT01041573|26456747|FG002|Overall Study|relocation|3|||
13281023|NCT01041573|26456748|FG003|Overall Study|relocation|1|||
13281024|NCT01041573|26456745|FG000|Overall Study|further blood extraction|0|||
13281025|NCT01041573|26456746|FG001|Overall Study|further blood extraction|1|||
13281026|NCT01041573|26456747|FG002|Overall Study|further blood extraction|0|||
13281027|NCT01041573|26456748|FG003|Overall Study|further blood extraction|0|||
13281028|NCT01041573|26456745|FG000|Overall Study|positive to anti-HCV|1|||
13281029|NCT01041573|26456746|FG001|Overall Study|positive to anti-HCV|0|||
13281030|NCT01041573|26456747|FG002|Overall Study|positive to anti-HCV|0|||
13281031|NCT01041573|26456748|FG003|Overall Study|positive to anti-HCV|0|||
13281032|NCT01041495|26456765|FG000|Overall Study|Withdrawal by Subject|2|||
13281033|NCT01041495|26456766|FG001|Overall Study|Withdrawal by Subject|5|||
13281034|NCT01041495|26456765|FG000|Overall Study|Adverse Event|2|||
13281035|NCT01041495|26456766|FG001|Overall Study|Adverse Event|1|||
13281036|NCT01041495|26456765|FG000|Overall Study|Lost to Follow-up|0|||
13281037|NCT01041495|26456766|FG001|Overall Study|Lost to Follow-up|1|||
13281038|NCT01041417|26456809|FG000|Overall Study|Adverse Event|5|||
13281039|NCT01041417|26456810|FG001|Overall Study|Adverse Event|2|||
13281040|NCT01041417|26456809|FG000|Overall Study|Lost to Follow-up|1|||
13281041|NCT01041417|26456810|FG001|Overall Study|Lost to Follow-up|1|||
13281042|NCT01041417|26456809|FG000|Overall Study|Death|1|||
13281043|NCT01041417|26456810|FG001|Overall Study|Death|0|||
13281044|NCT01041287|26456827|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
13281045|NCT01041287|26456828|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
13281046|NCT01041287|26456827|FG000|Treatment Period 2 (3 Months)|Adverse Event|0|||
13281047|NCT01041287|26456828|FG001|Treatment Period 2 (3 Months)|Adverse Event|2|||
13281048|NCT01040871|26456853|FG000|Overall Study|Adverse Event|6|||
13281049|NCT01040871|26456854|FG001|Overall Study|Adverse Event|2|||
13281050|NCT01040871|26456853|FG000|Overall Study|Withdrawal by Subject|2|||
13281051|NCT01040871|26456854|FG001|Overall Study|Withdrawal by Subject|0|||
13281052|NCT01040871|26456853|FG000|Overall Study|Death|1|||
13281053|NCT01040871|26456854|FG001|Overall Study|Death|3|||
13281054|NCT01040871|26456853|FG000|Overall Study|Lack of Efficacy|1|||
13281055|NCT01040871|26456854|FG001|Overall Study|Lack of Efficacy|1|||
13281056|NCT01040871|26456853|FG000|Overall Study|drug supply issue|1|||
13281057|NCT01040871|26456854|FG001|Overall Study|drug supply issue|0|||
13281058|NCT01040871|26456853|FG000|Overall Study|Randomized and Not Treated|2|||
13281059|NCT01040871|26456854|FG001|Overall Study|Randomized and Not Treated|1|||
13121111|NCT02987972|25940905|FG002|Overall Study|Death|0|||
13121112|NCT02987972|25940903|FG000|Overall Study|Lack of Efficacy|9|||
13121113|NCT02987972|25940904|FG001|Overall Study|Lack of Efficacy|12|||
13121114|NCT02987972|25940905|FG002|Overall Study|Lack of Efficacy|12|||
13121115|NCT02987972|25940903|FG000|Overall Study|Lost to Follow-up|7|||
13121116|NCT02987972|25940904|FG001|Overall Study|Lost to Follow-up|8|||
13121117|NCT02987972|25940905|FG002|Overall Study|Lost to Follow-up|4|||
13121118|NCT02987972|25940903|FG000|Overall Study|Physician Decision|1|||
13121119|NCT02987972|25940904|FG001|Overall Study|Physician Decision|6|||
13121120|NCT02987972|25940905|FG002|Overall Study|Physician Decision|0|||
13121121|NCT02987972|25940903|FG000|Overall Study|Protocol Violation|2|||
13121122|NCT02987972|25940904|FG001|Overall Study|Protocol Violation|1|||
13121123|NCT02987972|25940905|FG002|Overall Study|Protocol Violation|5|||
13121124|NCT02987972|25940903|FG000|Overall Study|Withdrawal by Subject|22|||
13121125|NCT02987972|25940904|FG001|Overall Study|Withdrawal by Subject|17|||
13121126|NCT02987972|25940905|FG002|Overall Study|Withdrawal by Subject|21|||
13121127|NCT02987660|25940922|FG000|Overall Study|Study terminated by sponsor|10|||
13121128|NCT02987660|25940923|FG001|Overall Study|Study terminated by sponsor|10|||
13121129|NCT02987205|25940933|FG000|Overall Study|Adverse Event|1|||
13121130|NCT02987205|25940933|FG000|Overall Study|Withdrawal by Subject|3|||
13121131|NCT02986854|25941016|FG000|Overall Study|Withdrawal by Subject|0|||
13121132|NCT02986854|25941017|FG001|Overall Study|Withdrawal by Subject|1|||
13121133|NCT02986854|25941018|FG002|Overall Study|Withdrawal by Subject|1|||
13121134|NCT02986854|25941016|FG000|Overall Study|Lost to Follow-up|3|||
13281060|NCT01040845|26456874|FG000|Overall Study|Withdrawal by Subject|1|||
13281061|NCT01040845|26456875|FG001|Overall Study|Withdrawal by Subject|1|||
13281062|NCT01040845|26456874|FG000|Overall Study|Physician Decision|1|||
13121135|NCT02986854|25941017|FG001|Overall Study|Lost to Follow-up|11|||
13121136|NCT02986854|25941018|FG002|Overall Study|Lost to Follow-up|2|||
13121137|NCT02986373|25941055|FG000|Overall Study|Adverse Event|4|||
13121138|NCT02986373|25941055|FG000|Overall Study|Lost to Follow-up|1|||
13121139|NCT02986373|25941055|FG000|Overall Study|Withdrawal by Subject|10|||
13121140|NCT02986373|25941055|FG000|Overall Study|Other|24|||
13121141|NCT02986139|25941074|FG000|Overall Study|Sponsor Decision|1|||
13121142|NCT02986139|25941075|FG001|Overall Study|Sponsor Decision|2|||
13121143|NCT02986139|25941074|FG000|Overall Study|Withdrawal by Subject|0|||
13121144|NCT02986139|25941075|FG001|Overall Study|Withdrawal by Subject|1|||
13121145|NCT02986139|25941074|FG000|Overall Study|Lost to Follow-up|0|||
13121146|NCT02986139|25941075|FG001|Overall Study|Lost to Follow-up|1|||
13121147|NCT02986074|25941113|FG000|First Trial Period|Adverse Event|1|||
13121148|NCT02986074|25941114|FG001|First Trial Period|Adverse Event|0|||
13121149|NCT02986074|25941115|FG002|First Trial Period|Adverse Event|0|||
13121150|NCT02986074|25941116|FG003|First Trial Period|Adverse Event|0|||
13281063|NCT01040845|26456875|FG001|Overall Study|Physician Decision|0|||
13281064|NCT01040728|26456950|FG000|Overall Study|Adverse Event|4|||
13281065|NCT01040728|26456951|FG001|Overall Study|Adverse Event|8|||
13281066|NCT01040728|26456952|FG002|Overall Study|Adverse Event|0|||
13281067|NCT01040728|26456953|FG003|Overall Study|Adverse Event|4|||
13281068|NCT01040728|26456950|FG000|Overall Study|Withdrawal by Subject|0|||
13281069|NCT01040728|26456951|FG001|Overall Study|Withdrawal by Subject|1|||
13281070|NCT01040728|26456952|FG002|Overall Study|Withdrawal by Subject|1|||
13281071|NCT01040728|26456953|FG003|Overall Study|Withdrawal by Subject|0|||
13281072|NCT01040728|26456950|FG000|Overall Study|Protocol Violation|0|||
13281073|NCT01040728|26456951|FG001|Overall Study|Protocol Violation|0|||
13281074|NCT01040728|26456952|FG002|Overall Study|Protocol Violation|0|||
13281075|NCT01040728|26456953|FG003|Overall Study|Protocol Violation|1|||
13281076|NCT01040728|26456950|FG000|Overall Study|Lack of Efficacy|0|||
13281077|NCT01040728|26456951|FG001|Overall Study|Lack of Efficacy|1|||
13281078|NCT01040728|26456952|FG002|Overall Study|Lack of Efficacy|0|||
13281079|NCT01040728|26456953|FG003|Overall Study|Lack of Efficacy|1|||
13281080|NCT01040728|26456950|FG000|Overall Study|Other reasons not listed above|0|||
13281081|NCT01040728|26456951|FG001|Overall Study|Other reasons not listed above|1|||
13281082|NCT01040728|26456952|FG002|Overall Study|Other reasons not listed above|0|||
13281083|NCT01040728|26456953|FG003|Overall Study|Other reasons not listed above|0|||
13281084|NCT01040689|26457028|FG000|Overall Study|Adverse Event|0|||
13281085|NCT01040689|26457029|FG001|Overall Study|Adverse Event|0|||
13281086|NCT01040689|26457030|FG002|Overall Study|Adverse Event|2|||
13281087|NCT01040689|26457031|FG003|Overall Study|Adverse Event|4|||
13281088|NCT01040689|26457028|FG000|Overall Study|Lack of Efficacy|0|||
13281089|NCT01040689|26457029|FG001|Overall Study|Lack of Efficacy|0|||
13281090|NCT01040689|26457030|FG002|Overall Study|Lack of Efficacy|1|||
13281091|NCT01040689|26457031|FG003|Overall Study|Lack of Efficacy|0|||
13281092|NCT01040689|26457028|FG000|Overall Study|Lost to Follow-up|1|||
13281093|NCT01040689|26457029|FG001|Overall Study|Lost to Follow-up|0|||
13281094|NCT01040689|26457030|FG002|Overall Study|Lost to Follow-up|0|||
13281095|NCT01040689|26457031|FG003|Overall Study|Lost to Follow-up|0|||
13281096|NCT01040689|26457028|FG000|Overall Study|Withdrawal by Subject|2|||
13281097|NCT01040689|26457029|FG001|Overall Study|Withdrawal by Subject|1|||
13281098|NCT01040689|26457030|FG002|Overall Study|Withdrawal by Subject|1|||
13281099|NCT01040689|26457031|FG003|Overall Study|Withdrawal by Subject|0|||
13281100|NCT01040689|26457028|FG000|Overall Study|Other reasons not listed above|0|||
13281101|NCT01040689|26457029|FG001|Overall Study|Other reasons not listed above|1|||
13281102|NCT01040689|26457030|FG002|Overall Study|Other reasons not listed above|0|||
13281103|NCT01040689|26457031|FG003|Overall Study|Other reasons not listed above|0|||
13281104|NCT01040351|26457046|FG000|Overall Study|poor ovarian response|1|||
13281105|NCT01040351|26457047|FG001|Overall Study|poor ovarian response|2|||
13281106|NCT01040260|26457060|FG000|Overall Study|Withdrawal by Subject|12|||
13281107|NCT01040260|26457061|FG001|Overall Study|Withdrawal by Subject|6|||
13281108|NCT01040260|26457060|FG000|Overall Study|Lost to Follow-up|3|||
13281109|NCT01040260|26457061|FG001|Overall Study|Lost to Follow-up|5|||
13281110|NCT01040169|26457076|FG000|Overall Study|Lost to Follow-up|3|||
13281111|NCT01040169|26457077|FG001|Overall Study|Lost to Follow-up|8|||
13281112|NCT01047540|26457105|FG000|Overall Study|Protocol Violation|1|||
13281113|NCT01047540|26457106|FG001|Overall Study|Protocol Violation|0|||
13281114|NCT01047540|26457107|FG002|Overall Study|Protocol Violation|0|||
13281115|NCT01047540|26457108|FG003|Overall Study|Protocol Violation|0|||
13281116|NCT01047540|26457109|FG004|Overall Study|Protocol Violation|0|||
13121151|NCT02986074|25941113|FG000|Follow up Period|system explant|0|||
13121152|NCT02986074|25941114|FG001|Follow up Period|system explant|0|||
13281117|NCT01047540|26457105|FG000|Overall Study|Lost to Follow-up|1|||
13281118|NCT01047540|26457106|FG001|Overall Study|Lost to Follow-up|0|||
13281119|NCT01047540|26457107|FG002|Overall Study|Lost to Follow-up|0|||
13281120|NCT01047540|26457108|FG003|Overall Study|Lost to Follow-up|0|||
13121153|NCT02986074|25941115|FG002|Follow up Period|system explant|1|||
13121154|NCT02986074|25941116|FG003|Follow up Period|system explant|2|||
13281121|NCT01047540|26457109|FG004|Overall Study|Lost to Follow-up|0|||
13281122|NCT01047540|26457105|FG000|Overall Study|Withdrawal by Subject|1|||
13281123|NCT01047540|26457106|FG001|Overall Study|Withdrawal by Subject|0|||
13281124|NCT01047540|26457107|FG002|Overall Study|Withdrawal by Subject|3|||
13281125|NCT01047540|26457108|FG003|Overall Study|Withdrawal by Subject|0|||
13281126|NCT01047540|26457109|FG004|Overall Study|Withdrawal by Subject|1|||
13281127|NCT01047540|26457105|FG000|Overall Study|Pregnancy|1|||
13121155|NCT02986074|25941113|FG000|Follow up Period|Physician Decision|0|||
13121156|NCT02986074|25941114|FG001|Follow up Period|Physician Decision|0|||
13121157|NCT02986074|25941115|FG002|Follow up Period|Physician Decision|0|||
13121158|NCT02986074|25941116|FG003|Follow up Period|Physician Decision|1|||
13121159|NCT02985996|25941244|FG000|Overall Study|Withdrawal by Subject|0|||
13121160|NCT02985996|25941245|FG001|Overall Study|Withdrawal by Subject|0|||
13121161|NCT02985996|25941246|FG002|Overall Study|Withdrawal by Subject|1|||
13121162|NCT02985996|25941247|FG003|Overall Study|Withdrawal by Subject|0|||
13121163|NCT02985996|25941248|FG004|Overall Study|Withdrawal by Subject|0|||
13121164|NCT02985996|25941244|FG000|Overall Study|Protocol Violation|0|||
13121165|NCT02985996|25941245|FG001|Overall Study|Protocol Violation|1|||
13121166|NCT02985996|25941246|FG002|Overall Study|Protocol Violation|0|||
13121167|NCT02985996|25941247|FG003|Overall Study|Protocol Violation|0|||
13121168|NCT02985996|25941248|FG004|Overall Study|Protocol Violation|0|||
13121169|NCT02985879|25941324|FG000|Overall Study|Adverse Event|7|||
13121170|NCT02985879|25941325|FG001|Overall Study|Adverse Event|9|||
13281128|NCT01047540|26457106|FG001|Overall Study|Pregnancy|0|||
13281129|NCT01047540|26457107|FG002|Overall Study|Pregnancy|0|||
13281130|NCT01047540|26457108|FG003|Overall Study|Pregnancy|0|||
13281131|NCT01047540|26457109|FG004|Overall Study|Pregnancy|0|||
13281132|NCT01047540|26457105|FG000|Overall Study|Adverse Event|1|||
13281133|NCT01047540|26457106|FG001|Overall Study|Adverse Event|0|||
13281134|NCT01047540|26457107|FG002|Overall Study|Adverse Event|0|||
13281135|NCT01047540|26457108|FG003|Overall Study|Adverse Event|0|||
13281136|NCT01047540|26457109|FG004|Overall Study|Adverse Event|0|||
13281137|NCT01045460|26457142|FG000|Overall Study|Physician Decision|3|||
13281138|NCT01045460|26457143|FG001|Overall Study|Physician Decision|2|||
13281139|NCT01045460|26457142|FG000|Overall Study|Lost to Follow-up|0|||
13281140|NCT01045460|26457143|FG001|Overall Study|Lost to Follow-up|1|||
13281141|NCT01045460|26457142|FG000|Overall Study|Lack of Efficacy|3|||
13281142|NCT01045460|26457143|FG001|Overall Study|Lack of Efficacy|0|||
13281143|NCT01047319|26457173|FG000|Overall Study|Teva requested participant withdrawal|3|||
13281144|NCT01047319|26457174|FG001|Overall Study|Teva requested participant withdrawal|0|||
13281145|NCT01047319|26457175|FG002|Overall Study|Teva requested participant withdrawal|1|||
13281146|NCT01047319|26457173|FG000|Overall Study|Protocol Violation|3|||
13281147|NCT01047319|26457174|FG001|Overall Study|Protocol Violation|2|||
13281148|NCT01047319|26457175|FG002|Overall Study|Protocol Violation|4|||
13281149|NCT01047319|26457173|FG000|Overall Study|Lack of Efficacy|4|||
13281150|NCT01047319|26457174|FG001|Overall Study|Lack of Efficacy|3|||
13281151|NCT01047319|26457175|FG002|Overall Study|Lack of Efficacy|3|||
13281152|NCT01047319|26457173|FG000|Overall Study|Death|5|||
13281153|NCT01047319|26457174|FG001|Overall Study|Death|1|||
13281154|NCT01047319|26457175|FG002|Overall Study|Death|5|||
13281155|NCT01047319|26457173|FG000|Overall Study|Pregnancy|13|||
13281156|NCT01047319|26457174|FG001|Overall Study|Pregnancy|8|||
13281157|NCT01047319|26457175|FG002|Overall Study|Pregnancy|8|||
13281158|NCT01047319|26457173|FG000|Overall Study|Physician Decision|12|||
13281159|NCT01047319|26457174|FG001|Overall Study|Physician Decision|9|||
13281160|NCT01047319|26457175|FG002|Overall Study|Physician Decision|10|||
13281161|NCT01047319|26457173|FG000|Overall Study|Lost to Follow-up|14|||
13281162|NCT01047319|26457174|FG001|Overall Study|Lost to Follow-up|10|||
13281163|NCT01047319|26457175|FG002|Overall Study|Lost to Follow-up|10|||
13281164|NCT01047319|26457173|FG000|Overall Study|Adverse Event|16|||
13281165|NCT01047319|26457174|FG001|Overall Study|Adverse Event|27|||
13121171|NCT02985879|25941326|FG002|Overall Study|Adverse Event|7|||
13121172|NCT02985879|25941324|FG000|Overall Study|Withdrew consent|6|||
13121173|NCT02985879|25941325|FG001|Overall Study|Withdrew consent|8|||
13121174|NCT02985879|25941326|FG002|Overall Study|Withdrew consent|10|||
13121175|NCT02985879|25941324|FG000|Overall Study|Lost to Follow-up|1|||
13121176|NCT02985879|25941325|FG001|Overall Study|Lost to Follow-up|0|||
13121177|NCT02985879|25941326|FG002|Overall Study|Lost to Follow-up|2|||
13121178|NCT02985879|25941324|FG000|Overall Study|Other, not specified|62|||
13121179|NCT02985879|25941325|FG001|Overall Study|Other, not specified|58|||
13121180|NCT02985879|25941326|FG002|Overall Study|Other, not specified|58|||
13121181|NCT02985684|25941339|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5|||
13121182|NCT02985684|25941339|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5|||
13281166|NCT01047319|26457175|FG002|Overall Study|Adverse Event|21|||
13281167|NCT01047319|26457173|FG000|Overall Study|Withdrawal by Subject|77|||
13281168|NCT01047319|26457174|FG001|Overall Study|Withdrawal by Subject|75|||
13281169|NCT01047319|26457175|FG002|Overall Study|Withdrawal by Subject|87|||
13281170|NCT01047319|26457173|FG000|Overall Study|Study terminated by Sponsor|198|||
13281171|NCT01047319|26457174|FG001|Overall Study|Study terminated by Sponsor|215|||
13281172|NCT01047319|26457175|FG002|Overall Study|Study terminated by Sponsor|203|||
13121183|NCT02985684|25941339|FG000|6-Month Closure Success Evaluation|Device Removal|3|||
13121184|NCT02985541|25941350|FG000|Overall Study|Withdrawal by Subject|33|||
13121185|NCT02985541|25941350|FG000|Overall Study|Lost to Follow-up|26|||
13121186|NCT02985541|25941350|FG000|Overall Study|Adverse Event|27|||
13281173|NCT01042522|26457244|FG000|Overall Study|Adverse Event|1|||
13281174|NCT01042522|26457245|FG001|Overall Study|Adverse Event|2|||
13281175|NCT01042522|26457244|FG000|Overall Study|Disease Progression|5|||
13281176|NCT01042522|26457245|FG001|Overall Study|Disease Progression|0|||
13281177|NCT01042522|26457244|FG000|Overall Study|Death|1|||
13281178|NCT01042522|26457245|FG001|Overall Study|Death|0|||
13281179|NCT01042522|26457244|FG000|Overall Study|Patient Refused|0|||
13281180|NCT01042522|26457245|FG001|Overall Study|Patient Refused|3|||
13281181|NCT01042522|26457244|FG000|Overall Study|Withdrawal by Subject|1|||
13281182|NCT01042522|26457245|FG001|Overall Study|Withdrawal by Subject|1|||
13291783|NCT00150618|26483598|FG003|Overall Study|Lack of Efficacy|4|||
13291784|NCT00150618|26483599|FG004|Overall Study|Lack of Efficacy|6|||
13291785|NCT00150618|26483595|FG000|Overall Study|No study meds|0|||
13291786|NCT00150618|26483596|FG001|Overall Study|No study meds|0|||
13291787|NCT00150618|26483597|FG002|Overall Study|No study meds|0|||
13291788|NCT00150618|26483598|FG003|Overall Study|No study meds|0|||
13291789|NCT00150618|26483599|FG004|Overall Study|No study meds|2|||
13291790|NCT00150618|26483595|FG000|Overall Study|Physician Decision|0|||
13291791|NCT00150618|26483596|FG001|Overall Study|Physician Decision|2|||
13291792|NCT00150618|26483597|FG002|Overall Study|Physician Decision|0|||
13291793|NCT00150618|26483598|FG003|Overall Study|Physician Decision|0|||
13291794|NCT00150618|26483599|FG004|Overall Study|Physician Decision|1|||
13291795|NCT00150618|26483595|FG000|Overall Study|Lack of compliance|2|||
13291796|NCT00150618|26483596|FG001|Overall Study|Lack of compliance|1|||
13291797|NCT00150618|26483597|FG002|Overall Study|Lack of compliance|1|||
13291798|NCT00150618|26483598|FG003|Overall Study|Lack of compliance|0|||
13291799|NCT00150618|26483599|FG004|Overall Study|Lack of compliance|1|||
13291800|NCT00150618|26483595|FG000|Overall Study|Abnormal ECG|1|||
13291801|NCT00150618|26483596|FG001|Overall Study|Abnormal ECG|0|||
13291802|NCT00150618|26483597|FG002|Overall Study|Abnormal ECG|0|||
13291803|NCT00150618|26483598|FG003|Overall Study|Abnormal ECG|0|||
13291804|NCT00150618|26483599|FG004|Overall Study|Abnormal ECG|0|||
13291805|NCT00150618|26483595|FG000|Overall Study|Sponsor's decision|0|||
13291806|NCT00150618|26483596|FG001|Overall Study|Sponsor's decision|0|||
13291807|NCT00150618|26483597|FG002|Overall Study|Sponsor's decision|0|||
13291808|NCT00150618|26483598|FG003|Overall Study|Sponsor's decision|1|||
13291809|NCT00150618|26483599|FG004|Overall Study|Sponsor's decision|0|||
13291810|NCT00150462|26483741|FG000|Overall Study|Disease Progression or Relapse|3|||
13291811|NCT00150462|26483742|FG001|Overall Study|Disease Progression or Relapse|1|||
13291812|NCT00150462|26483743|FG002|Overall Study|Disease Progression or Relapse|2|||
13121187|NCT02985541|25941350|FG000|Overall Study|Physician Decision|2|||
13121188|NCT02985541|25941350|FG000|Overall Study|Pregnancy|2|||
13291813|NCT00150462|26483744|FG003|Overall Study|Disease Progression or Relapse|1|||
13291814|NCT00150462|26483745|FG004|Overall Study|Disease Progression or Relapse|2|||
13291815|NCT00150462|26483746|FG005|Overall Study|Disease Progression or Relapse|2|||
13291816|NCT00150462|26483747|FG006|Overall Study|Disease Progression or Relapse|3|||
13291817|NCT00150462|26483748|FG007|Overall Study|Disease Progression or Relapse|5|||
13291818|NCT00150462|26483749|FG008|Overall Study|Disease Progression or Relapse|5|||
13291819|NCT00150462|26483750|FG009|Overall Study|Disease Progression or Relapse|3|||
13291820|NCT00150462|26483751|FG010|Overall Study|Disease Progression or Relapse|2|||
13291821|NCT00150462|26483741|FG000|Overall Study|Withdrawal by Subject|0|||
13291822|NCT00150462|26483742|FG001|Overall Study|Withdrawal by Subject|1|||
13291823|NCT00150462|26483743|FG002|Overall Study|Withdrawal by Subject|1|||
13291824|NCT00150462|26483744|FG003|Overall Study|Withdrawal by Subject|0|||
13291825|NCT00150462|26483745|FG004|Overall Study|Withdrawal by Subject|1|||
13291826|NCT00150462|26483746|FG005|Overall Study|Withdrawal by Subject|2|||
13291827|NCT00150462|26483747|FG006|Overall Study|Withdrawal by Subject|0|||
13291828|NCT00150462|26483748|FG007|Overall Study|Withdrawal by Subject|1|||
13291829|NCT00150462|26483749|FG008|Overall Study|Withdrawal by Subject|0|||
13291830|NCT00150462|26483750|FG009|Overall Study|Withdrawal by Subject|1|||
13291831|NCT00150462|26483751|FG010|Overall Study|Withdrawal by Subject|0|||
13291832|NCT00150462|26483741|FG000|Overall Study|Death|0|||
13291833|NCT00150462|26483742|FG001|Overall Study|Death|1|||
13291834|NCT00150462|26483743|FG002|Overall Study|Death|0|||
13291835|NCT00150462|26483744|FG003|Overall Study|Death|0|||
13291836|NCT00150462|26483745|FG004|Overall Study|Death|0|||
13291837|NCT00150462|26483746|FG005|Overall Study|Death|0|||
13291838|NCT00150462|26483747|FG006|Overall Study|Death|0|||
13291839|NCT00150462|26483748|FG007|Overall Study|Death|0|||
13121189|NCT02985541|25941350|FG000|Overall Study|Wish for pregnancy|44|||
13121190|NCT02985541|25941350|FG000|Overall Study|Other reason|5|||
13121191|NCT02985541|25941350|FG000|Overall Study|Not valid for analysis|2|||
13291840|NCT00150462|26483749|FG008|Overall Study|Death|1|||
13291841|NCT00150462|26483750|FG009|Overall Study|Death|0|||
13291842|NCT00150462|26483751|FG010|Overall Study|Death|0|||
13281183|NCT03408444|26457272|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
13281184|NCT03408444|26457273|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
13281185|NCT03408444|26457274|FG002|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
13281186|NCT03408444|26457275|FG003|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
13281187|NCT03408444|26457272|FG000|Overall Study|Lens Discomfort|0|||
13281188|NCT03408444|26457273|FG001|Overall Study|Lens Discomfort|1|||
13281189|NCT03408444|26457274|FG002|Overall Study|Lens Discomfort|0|||
13281190|NCT03408444|26457275|FG003|Overall Study|Lens Discomfort|0|||
13281191|NCT03408444|26457272|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
13281192|NCT03408444|26457273|FG001|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
13281193|NCT03408444|26457274|FG002|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
13281194|NCT03408444|26457275|FG003|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
13281195|NCT03408444|26457272|FG000|Overall Study|Withdrawal by Subject|0|||
13281196|NCT03408444|26457273|FG001|Overall Study|Withdrawal by Subject|2|||
13281197|NCT03408444|26457274|FG002|Overall Study|Withdrawal by Subject|3|||
13281198|NCT03408444|26457275|FG003|Overall Study|Withdrawal by Subject|0|||
13281199|NCT03408444|26457272|FG000|Overall Study|Lost to Follow-up|0|||
13281200|NCT03408444|26457273|FG001|Overall Study|Lost to Follow-up|0|||
13281201|NCT03408444|26457274|FG002|Overall Study|Lost to Follow-up|1|||
13281202|NCT03408444|26457275|FG003|Overall Study|Lost to Follow-up|0|||
13281203|NCT03408444|26457272|FG000|Overall Study|Adverse Event|0|||
13281204|NCT03408444|26457273|FG001|Overall Study|Adverse Event|0|||
13281205|NCT03408444|26457274|FG002|Overall Study|Adverse Event|0|||
13281206|NCT03408444|26457275|FG003|Overall Study|Adverse Event|1|||
13281207|NCT03408444|26457272|FG000|Overall Study|Lens Handling Difficulties|0|||
13281208|NCT03408444|26457273|FG001|Overall Study|Lens Handling Difficulties|0|||
13281209|NCT03408444|26457274|FG002|Overall Study|Lens Handling Difficulties|1|||
13281210|NCT03408444|26457275|FG003|Overall Study|Lens Handling Difficulties|0|||
13281211|NCT03408444|26457272|FG000|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
13281212|NCT03408444|26457273|FG001|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
13281213|NCT03408444|26457274|FG002|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
13281214|NCT03408444|26457275|FG003|Overall Study|Subject Decided to Not Wear Contact Lenses|3|||
13281215|NCT03409796|26457332|FG000|Overall Study|Adverse Event|2|||
13281216|NCT03409796|26457333|FG001|Overall Study|Adverse Event|0|||
13281217|NCT03409796|26457332|FG000|Overall Study|Other|0|||
13281218|NCT03409796|26457333|FG001|Overall Study|Other|1|||
13281219|NCT03400943|26457410|FG000|Treatment Period 1|Adverse Event|0|||
13281220|NCT03400943|26457411|FG001|Treatment Period 1|Adverse Event|0|||
13281221|NCT03400943|26457412|FG002|Treatment Period 1|Adverse Event|0|||
13281222|NCT03400943|26457413|FG003|Treatment Period 1|Adverse Event|1|||
13281223|NCT03400943|26457410|FG000|Treatment Period 1|Lost to Follow-up|1|||
13281224|NCT03400943|26457411|FG001|Treatment Period 1|Lost to Follow-up|0|||
13281225|NCT03400943|26457412|FG002|Treatment Period 1|Lost to Follow-up|0|||
13281226|NCT03400943|26457413|FG003|Treatment Period 1|Lost to Follow-up|0|||
13281227|NCT03400943|26457410|FG000|Treatment Period 1|Protocol Violation|0|||
13281228|NCT03400943|26457411|FG001|Treatment Period 1|Protocol Violation|1|||
13281229|NCT03400943|26457412|FG002|Treatment Period 1|Protocol Violation|1|||
13281230|NCT03400943|26457413|FG003|Treatment Period 1|Protocol Violation|0|||
13281231|NCT03400943|26457410|FG000|Treatment Period 1|Study terminated by sponsor|2|||
13281232|NCT03400943|26457411|FG001|Treatment Period 1|Study terminated by sponsor|0|||
13281233|NCT03400943|26457412|FG002|Treatment Period 1|Study terminated by sponsor|0|||
13281234|NCT03400943|26457413|FG003|Treatment Period 1|Study terminated by sponsor|1|||
13281235|NCT03400943|26457410|FG000|Treatment Period 1|Withdrawal by Subject|0|||
13281236|NCT03400943|26457411|FG001|Treatment Period 1|Withdrawal by Subject|0|||
13281237|NCT03400943|26457412|FG002|Treatment Period 1|Withdrawal by Subject|3|||
13281238|NCT03400943|26457413|FG003|Treatment Period 1|Withdrawal by Subject|1|||
13281239|NCT03400943|26457410|FG000|Treatment Period 1|Other|2|||
13281240|NCT03400943|26457411|FG001|Treatment Period 1|Other|1|||
13281241|NCT03400943|26457412|FG002|Treatment Period 1|Other|2|||
13281242|NCT03400943|26457413|FG003|Treatment Period 1|Other|2|||
13281243|NCT03400943|26457410|FG000|Post-treatment Period 1|Adverse Event|2|||
13281244|NCT03400943|26457411|FG001|Post-treatment Period 1|Adverse Event|0|||
13281245|NCT03400943|26457412|FG002|Post-treatment Period 1|Adverse Event|0|||
13281246|NCT03400943|26457413|FG003|Post-treatment Period 1|Adverse Event|0|||
13281247|NCT03400943|26457410|FG000|Post-treatment Period 1|Protocol Violation|1|||
13281248|NCT03400943|26457411|FG001|Post-treatment Period 1|Protocol Violation|0|||
13281249|NCT03400943|26457412|FG002|Post-treatment Period 1|Protocol Violation|0|||
13281250|NCT03400943|26457413|FG003|Post-treatment Period 1|Protocol Violation|0|||
13281251|NCT03400943|26457410|FG000|Post-treatment Period 1|Study terminated by sponsor|5|||
13281252|NCT03400943|26457411|FG001|Post-treatment Period 1|Study terminated by sponsor|0|||
13281253|NCT03400943|26457412|FG002|Post-treatment Period 1|Study terminated by sponsor|5|||
13281254|NCT03400943|26457413|FG003|Post-treatment Period 1|Study terminated by sponsor|6|||
13281255|NCT03400943|26457410|FG000|Post-treatment Period 1|Withdrawal by Subject|1|||
13281256|NCT03400943|26457411|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
13281257|NCT03400943|26457412|FG002|Post-treatment Period 1|Withdrawal by Subject|2|||
13281258|NCT03400943|26457413|FG003|Post-treatment Period 1|Withdrawal by Subject|2|||
13281259|NCT03400943|26457410|FG000|Post-treatment Period 1|Other|2|||
13281260|NCT03400943|26457411|FG001|Post-treatment Period 1|Other|0|||
13281261|NCT03400943|26457412|FG002|Post-treatment Period 1|Other|4|||
13281262|NCT03400943|26457413|FG003|Post-treatment Period 1|Other|5|||
13281263|NCT03400943|26457410|FG000|Treatment Period 2|Study terminated by sponsor|0|||
13281264|NCT03400943|26457411|FG001|Treatment Period 2|Study terminated by sponsor|1|||
13281265|NCT03400943|26457412|FG002|Treatment Period 2|Study terminated by sponsor|0|||
13281266|NCT03400943|26457413|FG003|Treatment Period 2|Study terminated by sponsor|0|||
13281267|NCT03400943|26457410|FG000|Treatment Period 2|Withdrawal by Subject|0|||
13281268|NCT03400943|26457411|FG001|Treatment Period 2|Withdrawal by Subject|1|||
13281269|NCT03400943|26457412|FG002|Treatment Period 2|Withdrawal by Subject|0|||
13281270|NCT03400943|26457413|FG003|Treatment Period 2|Withdrawal by Subject|0|||
13281271|NCT03400943|26457410|FG000|Treatment Period 2|Other|1|||
13281272|NCT03400943|26457411|FG001|Treatment Period 2|Other|6|||
13281273|NCT03400943|26457412|FG002|Treatment Period 2|Other|0|||
13281274|NCT03400943|26457413|FG003|Treatment Period 2|Other|0|||
13281275|NCT03400943|26457410|FG000|Follow-up Period|Withdrawal by Subject|1|||
13281276|NCT03400943|26457411|FG001|Follow-up Period|Withdrawal by Subject|0|||
13281277|NCT03400943|26457412|FG002|Follow-up Period|Withdrawal by Subject|0|||
13281278|NCT03400943|26457413|FG003|Follow-up Period|Withdrawal by Subject|0|||
13281279|NCT03400956|26457452|FG000|Treatment Period 1|Adverse Event|0|||
13281280|NCT03400956|26457453|FG001|Treatment Period 1|Adverse Event|1|||
13281281|NCT03400956|26457454|FG002|Treatment Period 1|Adverse Event|0|||
13281282|NCT03400956|26457452|FG000|Treatment Period 1|Lost to Follow-up|0|||
13281283|NCT03400956|26457453|FG001|Treatment Period 1|Lost to Follow-up|0|||
13281284|NCT03400956|26457454|FG002|Treatment Period 1|Lost to Follow-up|1|||
13281285|NCT03400956|26457452|FG000|Treatment Period 1|Protocol Violation|0|||
13281286|NCT03400956|26457453|FG001|Treatment Period 1|Protocol Violation|2|||
13281287|NCT03400956|26457454|FG002|Treatment Period 1|Protocol Violation|0|||
13281288|NCT03400956|26457452|FG000|Treatment Period 1|Study terminated by sponsor|3|||
13281289|NCT03400956|26457453|FG001|Treatment Period 1|Study terminated by sponsor|1|||
13281290|NCT03400956|26457454|FG002|Treatment Period 1|Study terminated by sponsor|1|||
13281291|NCT03400956|26457452|FG000|Treatment Period 1|Withdrawal by Subject|0|||
13281292|NCT03400956|26457453|FG001|Treatment Period 1|Withdrawal by Subject|2|||
13281293|NCT03400956|26457454|FG002|Treatment Period 1|Withdrawal by Subject|4|||
13281294|NCT03400956|26457452|FG000|Treatment Period 1|Other|1|||
13281295|NCT03400956|26457453|FG001|Treatment Period 1|Other|2|||
13281296|NCT03400956|26457454|FG002|Treatment Period 1|Other|3|||
13281297|NCT03400956|26457452|FG000|Post-treatment Period 1|Adverse Event|0|||
13281298|NCT03400956|26457453|FG001|Post-treatment Period 1|Adverse Event|0|||
13281299|NCT03400956|26457454|FG002|Post-treatment Period 1|Adverse Event|1|||
13281300|NCT03400956|26457452|FG000|Post-treatment Period 1|Physician Decision|2|||
13281301|NCT03400956|26457453|FG001|Post-treatment Period 1|Physician Decision|3|||
13281302|NCT03400956|26457454|FG002|Post-treatment Period 1|Physician Decision|0|||
13281303|NCT03400956|26457452|FG000|Post-treatment Period 1|Study terminated by sponsor|11|||
13281304|NCT03400956|26457453|FG001|Post-treatment Period 1|Study terminated by sponsor|10|||
13281305|NCT03400956|26457454|FG002|Post-treatment Period 1|Study terminated by sponsor|11|||
13281306|NCT03400956|26457452|FG000|Post-treatment Period 1|Withdrawal by Subject|5|||
13281307|NCT03400956|26457453|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
13281308|NCT03400956|26457454|FG002|Post-treatment Period 1|Withdrawal by Subject|0|||
13281309|NCT03400956|26457452|FG000|Post-treatment Period 1|Other|4|||
13281310|NCT03400956|26457453|FG001|Post-treatment Period 1|Other|3|||
13281311|NCT03400956|26457454|FG002|Post-treatment Period 1|Other|4|||
13281312|NCT03400956|26457452|FG000|Treatment Period 2|Adverse Event|2|||
13281313|NCT03400956|26457453|FG001|Treatment Period 2|Adverse Event|1|||
13281314|NCT03400956|26457454|FG002|Treatment Period 2|Adverse Event|1|||
13281315|NCT03400956|26457452|FG000|Treatment Period 2|Lost to Follow-up|1|||
13281316|NCT03400956|26457453|FG001|Treatment Period 2|Lost to Follow-up|1|||
13281317|NCT03400956|26457454|FG002|Treatment Period 2|Lost to Follow-up|0|||
13281318|NCT03400956|26457452|FG000|Treatment Period 2|Withdrawal by Subject|0|||
13281319|NCT03400956|26457453|FG001|Treatment Period 2|Withdrawal by Subject|0|||
13281320|NCT03400956|26457454|FG002|Treatment Period 2|Withdrawal by Subject|3|||
13281321|NCT03400956|26457452|FG000|Treatment Period 2|Other|1|||
13281322|NCT03400956|26457453|FG001|Treatment Period 2|Other|1|||
13281323|NCT03400956|26457454|FG002|Treatment Period 2|Other|0|||
13281324|NCT03400956|26457452|FG000|Follow-up Period|Withdrawal by Subject|0|||
13281325|NCT03400956|26457453|FG001|Follow-up Period|Withdrawal by Subject|0|||
13281326|NCT03400956|26457454|FG002|Follow-up Period|Withdrawal by Subject|1|||
13281327|NCT03400956|26457452|FG000|Follow-up Period|Other|0|||
13281328|NCT03400956|26457453|FG001|Follow-up Period|Other|0|||
13281329|NCT03400956|26457454|FG002|Follow-up Period|Other|1|||
13281330|NCT00019604|26457469|FG000|Overall Study|Death|1|||
13281331|NCT00019604|26457469|FG000|Overall Study|Progressive disease|23|||
13281332|NCT00019604|26457469|FG000|Overall Study|Refused treatment|1|||
13281333|NCT00019604|26457469|FG000|Overall Study|Carcinoid tumor, not treatable|1|||
13281334|NCT00019604|26457469|FG000|Overall Study|Going to have liver transplant|1|||
13281335|NCT00019604|26457469|FG000|Overall Study|Move to a different study|1|||
13281336|NCT00019604|26457469|FG000|Overall Study|Non compliant on systemic CH|1|||
13281337|NCT00019604|26457469|FG000|Overall Study|Non compliant|1|||
13281338|NCT00019604|26457469|FG000|Overall Study|Resectable disease|1|||
13281339|NCT00019604|26457469|FG000|Overall Study|Started new chemo regimen|1|||
13281340|NCT00019604|26457469|FG000|Overall Study|Pt going to immunotherapy study|1|||
13281341|NCT00019604|26457469|FG000|Overall Study|Too much disease|1|||
13281342|NCT00019604|26457469|FG000|Overall Study|Unable to evaluate|1|||
13281343|NCT00019604|26457469|FG000|Overall Study|Details for other not available|4|||
13281344|NCT00016354|26457482|FG000|Overall Study|Lack of Efficacy|0|||
13281345|NCT00016354|26457483|FG001|Overall Study|Lack of Efficacy|0|||
13281346|NCT00016354|26457484|FG002|Overall Study|Lack of Efficacy|0|||
13281347|NCT00016354|26457485|FG003|Overall Study|Lack of Efficacy|0|||
13281348|NCT00016354|26457486|FG004|Overall Study|Lack of Efficacy|0|||
13281349|NCT00016354|26457487|FG005|Overall Study|Lack of Efficacy|0|||
13281350|NCT00016354|26457488|FG006|Overall Study|Lack of Efficacy|0|||
13281351|NCT00016354|26457489|FG007|Overall Study|Lack of Efficacy|1|||
13281352|NCT00014911|26457500|FG000|Overall Study|Adverse Event|1|||
13281353|NCT00014911|26457500|FG000|Overall Study|Lost to Follow-up|1|||
13281354|NCT00014911|26457500|FG000|Overall Study|Withdrawal by Subject|6|||
13281355|NCT00014911|26457500|FG000|Overall Study|Unknown Reasons|2|||
13281356|NCT00014911|26457500|FG000|Overall Study|Immunosuppression-related Side Effects|1|||
13281357|NCT00014495|26457520|FG000|Overall Study|Death|0|||
13281358|NCT00014495|26457521|FG001|Overall Study|Death|0|||
13281359|NCT00014495|26457522|FG002|Overall Study|Death|1|||
13281360|NCT00014495|26457523|FG003|Overall Study|Death|0|||
13281361|NCT00014495|26457520|FG000|Overall Study|Clinical deterioration|0|||
13281362|NCT00014495|26457521|FG001|Overall Study|Clinical deterioration|0|||
13281363|NCT00014495|26457522|FG002|Overall Study|Clinical deterioration|0|||
13281364|NCT00014495|26457523|FG003|Overall Study|Clinical deterioration|1|||
13281365|NCT00013611|26457546|FG000|Overall Study|Lost to Follow-up|91|||
13281366|NCT00013611|26457547|FG001|Overall Study|Lost to Follow-up|100|||
13281367|NCT00012012|26457560|FG000|Overall Study|Protocol Violation|1|||
13281368|NCT00012012|26457561|FG001|Overall Study|Protocol Violation|1|||
13281369|NCT00012012|26457560|FG000|Overall Study|Withdrawal by Subject|0|||
13281370|NCT00012012|26457561|FG001|Overall Study|Withdrawal by Subject|2|||
13281371|NCT00010374|26457569|FG000|Overall Study|False positive phrenic nerve test|1|||
13281372|NCT00010257|26457584|FG000|Overall Study|Withdrawal by Subject|1|||
13281373|NCT00010257|26457585|FG001|Overall Study|Withdrawal by Subject|0|||
13291843|NCT00150462|26483741|FG000|Overall Study|Adverse Event|0|||
13291844|NCT00150462|26483742|FG001|Overall Study|Adverse Event|0|||
13291845|NCT00150462|26483743|FG002|Overall Study|Adverse Event|0|||
13291846|NCT00150462|26483744|FG003|Overall Study|Adverse Event|1|||
13291847|NCT00150462|26483745|FG004|Overall Study|Adverse Event|0|||
13291848|NCT00150462|26483746|FG005|Overall Study|Adverse Event|0|||
13291849|NCT00150462|26483747|FG006|Overall Study|Adverse Event|0|||
13291850|NCT00150462|26483748|FG007|Overall Study|Adverse Event|2|||
13291851|NCT00150462|26483749|FG008|Overall Study|Adverse Event|0|||
13291852|NCT00150462|26483750|FG009|Overall Study|Adverse Event|1|||
13291853|NCT00150462|26483751|FG010|Overall Study|Adverse Event|0|||
13291854|NCT00150462|26483741|FG000|Overall Study|Physician Decision|0|||
13291855|NCT00150462|26483742|FG001|Overall Study|Physician Decision|0|||
13291856|NCT00150462|26483743|FG002|Overall Study|Physician Decision|1|||
13291857|NCT00150462|26483744|FG003|Overall Study|Physician Decision|1|||
13291858|NCT00150462|26483745|FG004|Overall Study|Physician Decision|0|||
13291859|NCT00150462|26483746|FG005|Overall Study|Physician Decision|0|||
13291860|NCT00150462|26483747|FG006|Overall Study|Physician Decision|0|||
13291861|NCT00150462|26483748|FG007|Overall Study|Physician Decision|0|||
13291862|NCT00150462|26483749|FG008|Overall Study|Physician Decision|0|||
13291863|NCT00150462|26483750|FG009|Overall Study|Physician Decision|0|||
13291864|NCT00150462|26483751|FG010|Overall Study|Physician Decision|0|||
13291865|NCT00150462|26483741|FG000|Overall Study|Other|0|||
13291866|NCT00150462|26483742|FG001|Overall Study|Other|0|||
13291867|NCT00150462|26483743|FG002|Overall Study|Other|0|||
13291868|NCT00150462|26483744|FG003|Overall Study|Other|0|||
13291869|NCT00150462|26483745|FG004|Overall Study|Other|0|||
13291870|NCT00150462|26483746|FG005|Overall Study|Other|0|||
13291871|NCT00150462|26483747|FG006|Overall Study|Other|0|||
13291872|NCT00150462|26483748|FG007|Overall Study|Other|0|||
13291873|NCT00150462|26483749|FG008|Overall Study|Other|0|||
13291874|NCT00150462|26483750|FG009|Overall Study|Other|1|||
13291875|NCT00150462|26483751|FG010|Overall Study|Other|1|||
13291876|NCT00150176|26483767|FG000|Overall Study|Adverse Event|16|||
13291877|NCT00150176|26483768|FG001|Overall Study|Adverse Event|53|||
13291878|NCT00150176|26483767|FG000|Overall Study|Relapse/Impending relapse, non-AE|10|||
13291879|NCT00150176|26483768|FG001|Overall Study|Relapse/Impending relapse, non-AE|39|||
13291880|NCT00150176|26483767|FG000|Overall Study|Withdrawal by Subject|19|||
13291881|NCT00150176|26483768|FG001|Overall Study|Withdrawal by Subject|12|||
13291882|NCT00150176|26483767|FG000|Overall Study|Lost to Follow-up|3|||
13281374|NCT02245672|26457612|FG000|Overall Study|Adverse Event|4|||
13281375|NCT02245672|26457613|FG001|Overall Study|Adverse Event|4|||
13281376|NCT02245672|26457614|FG002|Overall Study|Adverse Event|4|||
13281377|NCT02245672|26457612|FG000|Overall Study|Lost to Follow-up|3|||
13281378|NCT02245672|26457613|FG001|Overall Study|Lost to Follow-up|5|||
13281379|NCT02245672|26457614|FG002|Overall Study|Lost to Follow-up|1|||
13281380|NCT02245672|26457612|FG000|Overall Study|Withdrawal by Subject|6|||
13281381|NCT02245672|26457613|FG001|Overall Study|Withdrawal by Subject|3|||
13281382|NCT02245672|26457614|FG002|Overall Study|Withdrawal by Subject|0|||
13281383|NCT02245672|26457612|FG000|Overall Study|Randomized in error (not treated)|0|||
13281384|NCT02245672|26457613|FG001|Overall Study|Randomized in error (not treated)|1|||
13281385|NCT02245672|26457614|FG002|Overall Study|Randomized in error (not treated)|0|||
13281386|NCT02243306|26457679|FG000|Overall Study|Adverse Event|0|||
13281387|NCT02243306|26457680|FG001|Overall Study|Adverse Event|1|||
13281388|NCT02243306|26457679|FG000|Overall Study|Other: Reached stopping criteria|0|||
13281389|NCT02243306|26457680|FG001|Overall Study|Other: Reached stopping criteria|1|||
13281390|NCT02243306|26457679|FG000|Overall Study|Physician Decision|0|||
13281391|NCT02243306|26457680|FG001|Overall Study|Physician Decision|1|||
13281392|NCT02240485|26457767|FG000|3 Months Post-admission|Lost to Follow-up|1|||
13281393|NCT02240485|26457768|FG001|3 Months Post-admission|Lost to Follow-up|5|||
13281394|NCT02240485|26457767|FG000|3 Months Post-admission|Withdrawal by Subject|2|||
13281395|NCT02240485|26457768|FG001|3 Months Post-admission|Withdrawal by Subject|1|||
13281396|NCT02240485|26457767|FG000|9 Months Post-admission|Lost to Follow-up|3|||
13281397|NCT02240485|26457768|FG001|9 Months Post-admission|Lost to Follow-up|1|||
13281398|NCT02240485|26457767|FG000|9 Months Post-admission|Withdrawal by Subject|0|||
13281399|NCT02240485|26457768|FG001|9 Months Post-admission|Withdrawal by Subject|3|||
13281400|NCT02240485|26457767|FG000|18 Months Post-admission|Lost to Follow-up|1|||
13281401|NCT02240485|26457768|FG001|18 Months Post-admission|Lost to Follow-up|1|||
13281402|NCT02240485|26457767|FG000|18 Months Post-admission|Withdrawal by Subject|2|||
13281403|NCT02240485|26457768|FG001|18 Months Post-admission|Withdrawal by Subject|4|||
13281404|NCT02240069|26457817|FG000|Overall Study|Withdrawal by Subject|5|||
13281405|NCT02240069|26457818|FG001|Overall Study|Withdrawal by Subject|5|||
13281406|NCT02240069|26457819|FG002|Overall Study|Withdrawal by Subject|2|||
13281407|NCT02246530|26457838|FG000|Overall Study|Lost to Follow-up|4|||
13281408|NCT02246530|26457839|FG001|Overall Study|Lost to Follow-up|0|||
13291883|NCT00150176|26483768|FG001|Overall Study|Lost to Follow-up|3|||
13291884|NCT00150176|26483767|FG000|Overall Study|OTHER|11|||
13291885|NCT00150176|26483768|FG001|Overall Study|OTHER|13|||
13291886|NCT00157014|26483859|FG000|Overall Study|Death|4|||
13291887|NCT00157014|26483860|FG001|Overall Study|Death|2|||
13291888|NCT00157014|26483861|FG002|Overall Study|Death|1|||
13291889|NCT00157014|26483862|FG003|Overall Study|Death|1|||
13291890|NCT00157014|26483859|FG000|Overall Study|Physician Decision|0|||
13291891|NCT00157014|26483860|FG001|Overall Study|Physician Decision|1|||
13291892|NCT00157014|26483861|FG002|Overall Study|Physician Decision|0|||
13291893|NCT00157014|26483862|FG003|Overall Study|Physician Decision|0|||
13291894|NCT00157014|26483859|FG000|Overall Study|Medications withdrawn on family request|0|||
13291895|NCT00157014|26483860|FG001|Overall Study|Medications withdrawn on family request|1|||
13291896|NCT00157014|26483861|FG002|Overall Study|Medications withdrawn on family request|0|||
13291897|NCT00157014|26483862|FG003|Overall Study|Medications withdrawn on family request|0|||
13291898|NCT00157014|26483859|FG000|Overall Study|Patient withdrawn by investigator|1|||
13291899|NCT00157014|26483860|FG001|Overall Study|Patient withdrawn by investigator|0|||
13291900|NCT00157014|26483861|FG002|Overall Study|Patient withdrawn by investigator|0|||
13291901|NCT00157014|26483862|FG003|Overall Study|Patient withdrawn by investigator|0|||
13291902|NCT00157014|26483859|FG000|Overall Study|Patient unable to return in nursing home|1|||
13291903|NCT00157014|26483860|FG001|Overall Study|Patient unable to return in nursing home|0|||
13291904|NCT00157014|26483861|FG002|Overall Study|Patient unable to return in nursing home|0|||
13291905|NCT00157014|26483862|FG003|Overall Study|Patient unable to return in nursing home|0|||
13291906|NCT00157014|26483859|FG000|Overall Study|Patient would not receive transplant|0|||
13291907|NCT00157014|26483860|FG001|Overall Study|Patient would not receive transplant|1|||
13291908|NCT00157014|26483861|FG002|Overall Study|Patient would not receive transplant|0|||
13291909|NCT00157014|26483862|FG003|Overall Study|Patient would not receive transplant|0|||
13291910|NCT00157014|26483859|FG000|Overall Study|Withdrawal by Subject|1|||
13291911|NCT00157014|26483860|FG001|Overall Study|Withdrawal by Subject|0|||
13291912|NCT00157014|26483861|FG002|Overall Study|Withdrawal by Subject|0|||
13291913|NCT00157014|26483862|FG003|Overall Study|Withdrawal by Subject|0|||
13291914|NCT02440425|26483881|FG000|Overall Study|Death likely due to disease progression|1|||
13291915|NCT02440425|26483881|FG000|Overall Study|Withdrawal by Subject|2|||
13291916|NCT02440425|26483881|FG000|Overall Study|Adverse Event|1|||
13291917|NCT02440425|26483881|FG000|Overall Study|Adverse Event/Ineligible|1|||
13291918|NCT00709995|26483904|FG000|Overall Study|Adverse Event|4|||
13291919|NCT00709995|26483905|FG001|Overall Study|Adverse Event|2|||
13291920|NCT00709995|26483904|FG000|Overall Study|Withdrawal by Subject|1|||
13291921|NCT00709995|26483905|FG001|Overall Study|Withdrawal by Subject|3|||
13281409|NCT00559988|26457891|FG000|Overall Study|Death|147|||
13281410|NCT00559988|26457892|FG001|Overall Study|Death|140|||
13281411|NCT00559988|26457891|FG000|Overall Study|Withdrawal by Subject|152|||
13281412|NCT00559988|26457892|FG001|Overall Study|Withdrawal by Subject|139|||
13281413|NCT00559988|26457891|FG000|Overall Study|Lost to Follow-up|42|||
13281414|NCT00559988|26457892|FG001|Overall Study|Lost to Follow-up|56|||
13281415|NCT00559988|26457891|FG000|Overall Study|ICD device explanted|10|||
13281416|NCT00559988|26457892|FG001|Overall Study|ICD device explanted|17|||
13281417|NCT00559962|26457937|FG000|Overall Study|Adverse Event|1|||
13121192|NCT02985515|25941367|FG000|Olfaction Testing|Lost to Follow-up|0|||
13121193|NCT02985515|25941368|FG001|Olfaction Testing|Lost to Follow-up|5|||
13121194|NCT02985515|25941367|FG000|Olfaction Testing|Protocol Violation|0|||
13121195|NCT02985515|25941368|FG001|Olfaction Testing|Protocol Violation|3|||
13121196|NCT02985450|25941377|FG000|Overall Study|Lost to Follow-up|7|||
13121197|NCT02985398|25941395|FG000|Overall Study|Adverse Event|1|||
13121198|NCT02985398|25941395|FG000|Overall Study|Lost to Follow-up|4|||
13121199|NCT02985398|25941395|FG000|Overall Study|Withdrawal by Subject|8|||
13121200|NCT02985398|25941395|FG000|Overall Study|Study Burden|9|||
13281418|NCT00559962|26457938|FG001|Overall Study|Adverse Event|7|||
13281419|NCT00559962|26457939|FG002|Overall Study|Adverse Event|8|||
13281420|NCT00559962|26457940|FG003|Overall Study|Adverse Event|5|||
13281421|NCT00559962|26457941|FG004|Overall Study|Adverse Event|11|||
13281422|NCT00559962|26457942|FG005|Overall Study|Adverse Event|4|||
13281423|NCT00559962|26457943|FG006|Overall Study|Adverse Event|4|||
13281424|NCT00559962|26457944|FG007|Overall Study|Adverse Event|2|||
13281425|NCT00559962|26457937|FG000|Overall Study|Lost to Follow-up|0|||
13281426|NCT00559962|26457938|FG001|Overall Study|Lost to Follow-up|1|||
13281427|NCT00559962|26457939|FG002|Overall Study|Lost to Follow-up|0|||
13281428|NCT00559962|26457940|FG003|Overall Study|Lost to Follow-up|0|||
13281429|NCT00559962|26457941|FG004|Overall Study|Lost to Follow-up|0|||
13281430|NCT00559962|26457942|FG005|Overall Study|Lost to Follow-up|0|||
13281431|NCT00559962|26457943|FG006|Overall Study|Lost to Follow-up|0|||
13281432|NCT00559962|26457944|FG007|Overall Study|Lost to Follow-up|0|||
13281433|NCT00559962|26457937|FG000|Overall Study|Withdrawal by Subject|1|||
13281434|NCT00559962|26457938|FG001|Overall Study|Withdrawal by Subject|1|||
13281435|NCT00559962|26457939|FG002|Overall Study|Withdrawal by Subject|2|||
13281436|NCT00559962|26457940|FG003|Overall Study|Withdrawal by Subject|0|||
13281437|NCT00559962|26457941|FG004|Overall Study|Withdrawal by Subject|3|||
13281438|NCT00559962|26457942|FG005|Overall Study|Withdrawal by Subject|1|||
13281439|NCT00559962|26457943|FG006|Overall Study|Withdrawal by Subject|0|||
13281440|NCT00559962|26457944|FG007|Overall Study|Withdrawal by Subject|2|||
13281441|NCT00559962|26457937|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
13281442|NCT00559962|26457938|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
13281443|NCT00559962|26457939|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
13281444|NCT00559962|26457940|FG003|Overall Study|Inclusion/exclusion criteria not met|0|||
13281445|NCT00559962|26457941|FG004|Overall Study|Inclusion/exclusion criteria not met|0|||
13281446|NCT00559962|26457942|FG005|Overall Study|Inclusion/exclusion criteria not met|0|||
13281447|NCT00559962|26457943|FG006|Overall Study|Inclusion/exclusion criteria not met|1|||
13281448|NCT00559962|26457944|FG007|Overall Study|Inclusion/exclusion criteria not met|0|||
13281449|NCT00559949|26457953|FG000|Overall Study|Progressive Disease during cycle 1|1|||
13281450|NCT00559949|26457953|FG000|Overall Study|Adverse Event|1|||
13281451|NCT00559949|26457953|FG000|Overall Study|Withdrawal by Subject|4|||
13281452|NCT00559949|26457953|FG000|Overall Study|No disease evaluation per protocol|1|||
13281453|NCT00559845|26457964|FG000|Overall Study|Withdrew Consent|1|||
13281454|NCT00559845|26457964|FG000|Overall Study|Disease Progression|1|||
13281455|NCT00559845|26457964|FG000|Overall Study|Adverse Event|3|||
13281456|NCT00559845|26457964|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1|||
13281457|NCT00559845|26457964|FG000|Overall Study|Premature Surgery-Investigator Decision|1|||
13281458|NCT00559754|26457990|FG000|Overall Study|Disease progression|1|||
13281459|NCT00559754|26457990|FG000|Overall Study|Adverse Event|5|||
13281460|NCT00559754|26457990|FG000|Overall Study|Protocol Violation|1|||
13281461|NCT00559754|26457990|FG000|Overall Study|Investigator criteria|2|||
13281462|NCT00559754|26457990|FG000|Overall Study|Withdrawal by Subject|2|||
13281463|NCT00559637|26458003|FG000|Overall Study|Adverse Event|22|||
13281464|NCT00559637|26458003|FG000|Overall Study|Withdrawal by Subject|4|||
13281465|NCT00559637|26458003|FG000|Overall Study|Protocol Violation|6|||
13281466|NCT00559637|26458003|FG000|Overall Study|Withdrawal criteria fulfilled|4|||
13281467|NCT00559637|26458003|FG000|Overall Study|Failure to return|6|||
13308050|NCT01280656|26530650|FG000|Overall Study|Lack of Efficacy|1|||
13308051|NCT01280656|26530651|FG001|Overall Study|Lack of Efficacy|22|||
13121201|NCT02985021|25941401|FG000|Overall Study|Inability to comply with study procedures|1|||
13121202|NCT02984995|25941453|FG000|Overall Study|Required stem cell transplant|13|||
13281468|NCT00559637|26458003|FG000|Overall Study|Insufficient response|3|||
13281469|NCT00559637|26458003|FG000|Overall Study|Started requiring dialysis after month 7|2|||
13281470|NCT00559637|26458003|FG000|Overall Study|Suspected lung cancer|1|||
13308052|NCT01280656|26530652|FG002|Overall Study|Lack of Efficacy|38|||
13308053|NCT01280656|26530650|FG000|Overall Study|Treatment shortening (RGT)|0|||
13308054|NCT01280656|26530651|FG001|Overall Study|Treatment shortening (RGT)|4|||
13308055|NCT01280656|26530652|FG002|Overall Study|Treatment shortening (RGT)|5|||
13308056|NCT01280656|26530650|FG000|Overall Study|Other|1|||
13308057|NCT01280656|26530651|FG001|Overall Study|Other|7|||
13308058|NCT01280656|26530652|FG002|Overall Study|Other|7|||
13308059|NCT01280617|26530667|FG000|Overall Study|Adverse Event|0|||
13308060|NCT01280617|26530668|FG001|Overall Study|Adverse Event|1|||
13308061|NCT01280591|26530771|FG000|Overall Study|Withdrawal by Subject|0|||
13308062|NCT01280591|26530772|FG001|Overall Study|Withdrawal by Subject|0|||
13308063|NCT01280591|26530773|FG002|Overall Study|Withdrawal by Subject|0|||
13308064|NCT01280591|26530774|FG003|Overall Study|Withdrawal by Subject|2|||
13308065|NCT01280591|26530771|FG000|Overall Study|Does not meet exclusion #27 criteria|0|||
13308066|NCT01280591|26530772|FG001|Overall Study|Does not meet exclusion #27 criteria|0|||
13308067|NCT01280591|26530773|FG002|Overall Study|Does not meet exclusion #27 criteria|0|||
13308068|NCT01280591|26530774|FG003|Overall Study|Does not meet exclusion #27 criteria|1|||
13308069|NCT01280357|26530783|FG000|Overall Study|Excluded no internal monitoring|14|||
13308070|NCT01280357|26530783|FG000|Overall Study|IInsufficient data/No data supplied|12|||
13308071|NCT01280266|26530812|FG000|First Intervention (Week 1-4)|Adverse Event|1|||
13308072|NCT01280266|26530813|FG001|First Intervention (Week 1-4)|Adverse Event|0|||
13308073|NCT01280266|26530812|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0|||
13308074|NCT01280266|26530813|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2|||
13308075|NCT01279850|26530829|FG000|Overall Study|Protocol Violation|50|||
13308076|NCT01279850|26530829|FG000|Overall Study|No Drug Administration Information|7|||
13308077|NCT01279850|26530829|FG000|Overall Study|No Visit After Treatment|34|||
13308078|NCT01279447|26530842|FG000|Overall Study|Lost to Follow-up|3|||
13308079|NCT01279447|26530843|FG001|Overall Study|Lost to Follow-up|1|||
13308080|NCT01279200|26530858|FG000|Overall Study|Withdrawal by Subject|1|||
13308081|NCT01279200|26530859|FG001|Overall Study|Withdrawal by Subject|3|||
13308082|NCT01279200|26530858|FG000|Overall Study|Patient withdrawal due to high cost|0|||
13308083|NCT01279200|26530859|FG001|Overall Study|Patient withdrawal due to high cost|1|||
13308084|NCT01279200|26530858|FG000|Overall Study|Inconvenience of ultrasound visit|0|||
13308085|NCT01279200|26530859|FG001|Overall Study|Inconvenience of ultrasound visit|1|||
13308086|NCT01279200|26530858|FG000|Overall Study|ultrasound screening failure|0|||
13308087|NCT01279200|26530859|FG001|Overall Study|ultrasound screening failure|1|||
13308088|NCT01279200|26530858|FG000|Overall Study|Lost to Follow-up|0|||
13308089|NCT01279200|26530859|FG001|Overall Study|Lost to Follow-up|1|||
13308090|NCT01279200|26530858|FG000|Overall Study|Adverse Event|1|||
13308091|NCT01279200|26530859|FG001|Overall Study|Adverse Event|0|||
13308092|NCT01277601|26530961|FG000|Overall Study|Adverse Event|5|||
13308093|NCT01277601|26530962|FG001|Overall Study|Adverse Event|3|||
13281471|NCT00559637|26458003|FG000|Overall Study|Participation in another study|1|||
13281472|NCT00559637|26458003|FG000|Overall Study|Delayed administration of C.E.R.A|1|||
13281473|NCT00559637|26458003|FG000|Overall Study|Change of center|1|||
13281474|NCT00559637|26458003|FG000|Overall Study|Change of home|1|||
13281475|NCT00559637|26458003|FG000|Overall Study|Inclusion or exclusion criteria violated|2|||
13281476|NCT00559585|26458070|FG000|Double Blind ST Period Main Study|Adverse Event|17|||
13281477|NCT00559585|26458071|FG001|Double Blind ST Period Main Study|Adverse Event|25|||
13281478|NCT00559585|26458070|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11|||
13281479|NCT00559585|26458071|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5|||
13281480|NCT00559585|26458070|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0|||
13281481|NCT00559585|26458071|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6|||
13281482|NCT00559585|26458070|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1|||
13281483|NCT00559585|26458071|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0|||
13281484|NCT00559585|26458070|FG000|Double Blind ST Period Main Study|Death|1|||
13281485|NCT00559585|26458071|FG001|Double Blind ST Period Main Study|Death|1|||
13281486|NCT00559585|26458070|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2|||
13281487|NCT00559585|26458071|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1|||
13281488|NCT00559585|26458070|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6|||
13281489|NCT00559585|26458071|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1|||
13281490|NCT00559585|26458070|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3|||
13281491|NCT00559585|26458071|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0|||
13281492|NCT00559585|26458070|FG000|Double Blind ST Period Main Study|Missed Doses|0|||
13281493|NCT00559585|26458071|FG001|Double Blind ST Period Main Study|Missed Doses|1|||
13281494|NCT00559585|26458070|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0|||
13281495|NCT00559585|26458071|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1|||
13281496|NCT00559585|26458070|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0|||
13308094|NCT01277601|26530963|FG002|Overall Study|Adverse Event|0|||
13308095|NCT01277601|26530964|FG003|Overall Study|Adverse Event|7|||
13308096|NCT01277601|26530961|FG000|Overall Study|Withdrawal by Subject|18|||
13308097|NCT01277601|26530962|FG001|Overall Study|Withdrawal by Subject|21|||
13308098|NCT01277601|26530963|FG002|Overall Study|Withdrawal by Subject|8|||
13281497|NCT00559585|26458071|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1|||
13281498|NCT00559585|26458070|FG000|Double Blind ST Period Main Study|Early Discontinuation|0|||
13281499|NCT00559585|26458071|FG001|Double Blind ST Period Main Study|Early Discontinuation|1|||
13281500|NCT00559585|26458070|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1|||
13281501|NCT00559585|26458071|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0|||
13281502|NCT00559585|26458070|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0|||
13281503|NCT00559585|26458071|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1|||
13281504|NCT00559585|26458070|FG000|Double Blind ST Period Main Study|Investigator Decision|0|||
13281505|NCT00559585|26458071|FG001|Double Blind ST Period Main Study|Investigator Decision|1|||
13281506|NCT00559585|26458070|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1|||
13281507|NCT00559585|26458071|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0|||
13281508|NCT00559585|26458070|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
13281509|NCT00559585|26458071|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
13281510|NCT00559585|26458070|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100|||
13281511|NCT00559585|26458071|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0|||
13281512|NCT00559585|26458070|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81|||
13281513|NCT00559585|26458071|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0|||
13281514|NCT00559585|26458070|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16|||
13281515|NCT00559585|26458071|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0|||
13281516|NCT00559585|26458070|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32|||
13281517|NCT00559585|26458071|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0|||
13281518|NCT00559585|26458070|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9|||
13281519|NCT00559585|26458071|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0|||
13281520|NCT00559585|26458070|FG000|Open Label LT Period Main + Sub-Study|Death|20|||
13281521|NCT00559585|26458071|FG001|Open Label LT Period Main + Sub-Study|Death|0|||
13281522|NCT00559585|26458070|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1|||
13281523|NCT00559585|26458071|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0|||
13281524|NCT00559585|26458070|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89|||
13281525|NCT00559585|26458071|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0|||
13281526|NCT00559585|26458070|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8|||
13281527|NCT00559585|26458071|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0|||
13281528|NCT00559585|26458070|FG000|Open Label LT Period Main + Sub-Study|non-specified|71|||
13281529|NCT00559585|26458071|FG001|Open Label LT Period Main + Sub-Study|non-specified|0|||
13281530|NCT00559585|26458070|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1|||
13121203|NCT02984995|25941454|FG001|Overall Study|Required stem cell transplant|2|||
13121204|NCT02984995|25941453|FG000|Overall Study|Progressive disease|11|||
13121205|NCT02984995|25941454|FG001|Overall Study|Progressive disease|1|||
13121206|NCT02984995|25941453|FG000|Overall Study|Adverse Event|1|||
13281531|NCT00559585|26458071|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0|||
13281532|NCT00559507|26458079|FG000|Overall Study|Not treated, patient ineligible|3|||
13281533|NCT00559377|26458089|FG000|Overall Study|Withdrawal by Subject|9|||
13281534|NCT00559364|26458106|FG000|Overall Study|Inclusion/exclusion criteria failure|1|||
13281535|NCT00559364|26458107|FG001|Overall Study|Inclusion/exclusion criteria failure|0|||
13281536|NCT00559273|26458134|FG000|Correction Period (20 Weeks)|Death|3|||
13281537|NCT00559273|26458135|FG001|Correction Period (20 Weeks)|Death|4|||
13121207|NCT02984995|25941454|FG001|Overall Study|Adverse Event|0|||
13281538|NCT00559273|26458134|FG000|Correction Period (20 Weeks)|Adverse Event|2|||
13281539|NCT00559273|26458135|FG001|Correction Period (20 Weeks)|Adverse Event|1|||
13281540|NCT00559273|26458134|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2|||
13281541|NCT00559273|26458135|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6|||
13281542|NCT00559273|26458134|FG000|Correction Period (20 Weeks)|Participant treated by another center|0|||
13281543|NCT00559273|26458135|FG001|Correction Period (20 Weeks)|Participant treated by another center|1|||
13281544|NCT00559273|26458134|FG000|Correction Period (20 Weeks)|Did not received study treatment|2|||
13281545|NCT00559273|26458135|FG001|Correction Period (20 Weeks)|Did not received study treatment|0|||
13281546|NCT00559273|26458134|FG000|Evaluation Period (8 Weeks)|Death|1|||
13281547|NCT00559273|26458135|FG001|Evaluation Period (8 Weeks)|Death|3|||
13281548|NCT00559273|26458134|FG000|Evaluation Period (8 Weeks)|Adverse Event|0|||
13281549|NCT00559273|26458135|FG001|Evaluation Period (8 Weeks)|Adverse Event|1|||
13281550|NCT00559273|26458134|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2|||
13281551|NCT00559273|26458135|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0|||
13281552|NCT00559273|26458134|FG000|Evaluation Period (8 Weeks)|Physician Decision|0|||
13281553|NCT00559273|26458135|FG001|Evaluation Period (8 Weeks)|Physician Decision|1|||
13281554|NCT00559104|26458152|FG000|Overall Study|Lack of Efficacy|9|||
13281555|NCT00559104|26458153|FG001|Overall Study|Lack of Efficacy|0|||
13281556|NCT00558896|26458205|FG000|Overall Study|Adverse Event|1|||
13281557|NCT00558896|26458206|FG001|Overall Study|Adverse Event|1|||
13121208|NCT02984982|25941513|FG000|Overall Study|Adverse Event|2|||
13281558|NCT00558896|26458207|FG002|Overall Study|Adverse Event|1|||
13281559|NCT00558896|26458208|FG003|Overall Study|Adverse Event|3|||
13281560|NCT00558896|26458209|FG004|Overall Study|Adverse Event|4|||
13281561|NCT00558896|26458210|FG005|Overall Study|Adverse Event|10|||
13281562|NCT00558896|26458211|FG006|Overall Study|Adverse Event|3|||
13281563|NCT00558896|26458205|FG000|Overall Study|Death|3|||
13281564|NCT00558896|26458206|FG001|Overall Study|Death|0|||
13281565|NCT00558896|26458207|FG002|Overall Study|Death|2|||
13281566|NCT00558896|26458208|FG003|Overall Study|Death|3|||
13281567|NCT00558896|26458209|FG004|Overall Study|Death|2|||
13281568|NCT00558896|26458210|FG005|Overall Study|Death|2|||
13281569|NCT00558896|26458211|FG006|Overall Study|Death|6|||
13281570|NCT00558896|26458205|FG000|Overall Study|Withdrawal by Subject|2|||
13281571|NCT00558896|26458206|FG001|Overall Study|Withdrawal by Subject|1|||
13281572|NCT00558896|26458207|FG002|Overall Study|Withdrawal by Subject|1|||
13281573|NCT00558896|26458208|FG003|Overall Study|Withdrawal by Subject|1|||
13281574|NCT00558896|26458209|FG004|Overall Study|Withdrawal by Subject|1|||
13281575|NCT00558896|26458210|FG005|Overall Study|Withdrawal by Subject|5|||
13281576|NCT00558896|26458211|FG006|Overall Study|Withdrawal by Subject|5|||
13281577|NCT00558896|26458205|FG000|Overall Study|Alternative Treatment|2|||
13281578|NCT00558896|26458206|FG001|Overall Study|Alternative Treatment|2|||
13281579|NCT00558896|26458207|FG002|Overall Study|Alternative Treatment|0|||
13281580|NCT00558896|26458208|FG003|Overall Study|Alternative Treatment|2|||
13281581|NCT00558896|26458209|FG004|Overall Study|Alternative Treatment|6|||
13281582|NCT00558896|26458210|FG005|Overall Study|Alternative Treatment|7|||
13281583|NCT00558896|26458211|FG006|Overall Study|Alternative Treatment|1|||
13281584|NCT00558896|26458205|FG000|Overall Study|Physician discretion|3|||
13281585|NCT00558896|26458206|FG001|Overall Study|Physician discretion|2|||
13281586|NCT00558896|26458207|FG002|Overall Study|Physician discretion|1|||
13281587|NCT00558896|26458208|FG003|Overall Study|Physician discretion|2|||
13281588|NCT00558896|26458209|FG004|Overall Study|Physician discretion|1|||
13281589|NCT00558896|26458210|FG005|Overall Study|Physician discretion|3|||
13281590|NCT00558896|26458211|FG006|Overall Study|Physician discretion|3|||
13281591|NCT00558896|26458205|FG000|Overall Study|Continues on treatment|10|||
13281592|NCT00558896|26458206|FG001|Overall Study|Continues on treatment|1|||
13281593|NCT00558896|26458207|FG002|Overall Study|Continues on treatment|0|||
13281594|NCT00558896|26458208|FG003|Overall Study|Continues on treatment|1|||
13281595|NCT00558896|26458209|FG004|Overall Study|Continues on treatment|9|||
13281596|NCT00558896|26458210|FG005|Overall Study|Continues on treatment|25|||
13281597|NCT00558896|26458211|FG006|Overall Study|Continues on treatment|6|||
13281598|NCT00558831|26458219|FG000|Overall Study|Lost to Follow-up|1|||
13281599|NCT00558753|26458236|FG000|Overall Study|Lost to Follow-up|5|||
13281600|NCT00558753|26458237|FG001|Overall Study|Lost to Follow-up|7|||
13281601|NCT00558636|26458262|FG000|Treatment|Adverse Event|9|||
13281602|NCT00558636|26458263|FG001|Treatment|Adverse Event|2|||
13281603|NCT00558636|26458262|FG000|Treatment|Withdrawal by Subject|2|||
13281604|NCT00558636|26458263|FG001|Treatment|Withdrawal by Subject|0|||
13281605|NCT00558636|26458262|FG000|Treatment|Premature termination of the study|35|||
13281606|NCT00558636|26458263|FG001|Treatment|Premature termination of the study|37|||
13281607|NCT00558636|26458262|FG000|Treatment|Disease progression|1|||
13281608|NCT00558636|26458263|FG001|Treatment|Disease progression|5|||
13281609|NCT00558636|26458262|FG000|Follow-up|Premature termination of the study|12|||
13281610|NCT00558636|26458263|FG001|Follow-up|Premature termination of the study|7|||
13281611|NCT00558558|26458269|FG000|Overall Study|Unable to swallow|1|||
13281612|NCT00558558|26458269|FG000|Overall Study|Withdrawal by Subject|1|||
13281613|NCT00558558|26458269|FG000|Overall Study|Lack of Efficacy|4|||
13281614|NCT00558519|26458279|FG000|Overall Study|Ph+|20|||
13281615|NCT00558519|26458279|FG000|Overall Study|Ineligible|1|||
13281616|NCT00558519|26458279|FG000|Overall Study|Insufficient data|1|||
13281617|NCT00558519|26458279|FG000|Overall Study|Never received treatment|1|||
13281618|NCT00558467|26458342|FG000|Overall Study|Adverse Event|1|||
13281619|NCT00558467|26458343|FG001|Overall Study|Adverse Event|2|||
13281620|NCT00558467|26458342|FG000|Overall Study|Lack of Efficacy|0|||
13281621|NCT00558467|26458343|FG001|Overall Study|Lack of Efficacy|1|||
13281622|NCT00558467|26458342|FG000|Overall Study|Patient moving out of state|0|||
13121209|NCT02984982|25941514|FG001|Overall Study|Adverse Event|5|||
13281623|NCT00558467|26458343|FG001|Overall Study|Patient moving out of state|1|||
13281624|NCT00558428|26458394|FG000|Overall Study|Adverse Event|6|||
13281625|NCT00558428|26458395|FG001|Overall Study|Adverse Event|22|||
13281626|NCT00558428|26458396|FG002|Overall Study|Adverse Event|3|||
13281627|NCT00558428|26458397|FG003|Overall Study|Adverse Event|4|||
13281628|NCT00558428|26458394|FG000|Overall Study|Lost to Follow-up|0|||
13281629|NCT00558428|26458395|FG001|Overall Study|Lost to Follow-up|1|||
13281630|NCT00558428|26458396|FG002|Overall Study|Lost to Follow-up|0|||
13281631|NCT00558428|26458397|FG003|Overall Study|Lost to Follow-up|0|||
13281632|NCT00558428|26458394|FG000|Overall Study|Lack of Efficacy|0|||
13281633|NCT00558428|26458395|FG001|Overall Study|Lack of Efficacy|0|||
13281634|NCT00558428|26458396|FG002|Overall Study|Lack of Efficacy|1|||
13281635|NCT00558428|26458397|FG003|Overall Study|Lack of Efficacy|2|||
13281636|NCT00558428|26458394|FG000|Overall Study|Non compliant with protocol|1|||
13281637|NCT00558428|26458395|FG001|Overall Study|Non compliant with protocol|0|||
13281638|NCT00558428|26458396|FG002|Overall Study|Non compliant with protocol|0|||
13281639|NCT00558428|26458397|FG003|Overall Study|Non compliant with protocol|3|||
13281640|NCT00558428|26458394|FG000|Overall Study|Consent withdrawn|2|||
13281641|NCT00558428|26458395|FG001|Overall Study|Consent withdrawn|1|||
13281642|NCT00558428|26458396|FG002|Overall Study|Consent withdrawn|0|||
13281643|NCT00558428|26458397|FG003|Overall Study|Consent withdrawn|1|||
13281644|NCT00558428|26458394|FG000|Overall Study|Other|3|||
13281645|NCT00558428|26458395|FG001|Overall Study|Other|0|||
13281646|NCT00558428|26458396|FG002|Overall Study|Other|0|||
13281647|NCT00558428|26458397|FG003|Overall Study|Other|1|||
13281648|NCT00558285|26458455|FG000|Overall Study|Adverse Event|1|||
13281649|NCT00558285|26458456|FG001|Overall Study|Adverse Event|1|||
13281650|NCT00558285|26458457|FG002|Overall Study|Adverse Event|4|||
13281651|NCT00558285|26458458|FG003|Overall Study|Adverse Event|1|||
13281652|NCT00558285|26458459|FG004|Overall Study|Adverse Event|2|||
13281653|NCT00558285|26458455|FG000|Overall Study|Abnormal test procedure result(s)|1|||
13281654|NCT00558285|26458456|FG001|Overall Study|Abnormal test procedure result(s)|0|||
13281655|NCT00558285|26458457|FG002|Overall Study|Abnormal test procedure result(s)|0|||
13281656|NCT00558285|26458458|FG003|Overall Study|Abnormal test procedure result(s)|0|||
13281657|NCT00558285|26458459|FG004|Overall Study|Abnormal test procedure result(s)|0|||
13281658|NCT00558285|26458455|FG000|Overall Study|Subject withdrew consent|2|||
13281659|NCT00558285|26458456|FG001|Overall Study|Subject withdrew consent|0|||
13281660|NCT00558285|26458457|FG002|Overall Study|Subject withdrew consent|1|||
13281661|NCT00558285|26458458|FG003|Overall Study|Subject withdrew consent|1|||
13281662|NCT00558285|26458459|FG004|Overall Study|Subject withdrew consent|1|||
13281663|NCT00558285|26458455|FG000|Overall Study|Lost to Follow-up|1|||
13281664|NCT00558285|26458456|FG001|Overall Study|Lost to Follow-up|1|||
13281665|NCT00558285|26458457|FG002|Overall Study|Lost to Follow-up|0|||
13281666|NCT00558285|26458458|FG003|Overall Study|Lost to Follow-up|0|||
13281667|NCT00558285|26458459|FG004|Overall Study|Lost to Follow-up|0|||
13281668|NCT00558285|26458455|FG000|Overall Study|Administrative problems|0|||
13281669|NCT00558285|26458456|FG001|Overall Study|Administrative problems|0|||
13281670|NCT00558285|26458457|FG002|Overall Study|Administrative problems|0|||
13281671|NCT00558285|26458458|FG003|Overall Study|Administrative problems|1|||
13281672|NCT00558285|26458459|FG004|Overall Study|Administrative problems|1|||
13281673|NCT00558285|26458455|FG000|Overall Study|Protocol deviation|1|||
13281674|NCT00558285|26458456|FG001|Overall Study|Protocol deviation|1|||
13281675|NCT00558285|26458457|FG002|Overall Study|Protocol deviation|0|||
13281676|NCT00558285|26458458|FG003|Overall Study|Protocol deviation|1|||
13281677|NCT00558285|26458459|FG004|Overall Study|Protocol deviation|0|||
13281678|NCT00558272|26458504|FG000|Overall Study|Adverse Event|10|||
13281679|NCT00558272|26458505|FG001|Overall Study|Adverse Event|0|||
13281680|NCT00558272|26458504|FG000|Overall Study|Death|1|||
13281681|NCT00558272|26458505|FG001|Overall Study|Death|0|||
13281682|NCT00558272|26458504|FG000|Overall Study|Dev. of study specific discon. criteria|1|||
13281683|NCT00558272|26458505|FG001|Overall Study|Dev. of study specific discon. criteria|0|||
13281684|NCT00558272|26458504|FG000|Overall Study|AZ study team decision|0|||
13281685|NCT00558272|26458505|FG001|Overall Study|AZ study team decision|1|||
13281686|NCT00558272|26458504|FG000|Overall Study|Incorrectly enrolled|1|||
13281687|NCT00558272|26458505|FG001|Overall Study|Incorrectly enrolled|0|||
13281688|NCT00558272|26458504|FG000|Overall Study|Withdrawal by Subject|0|||
13281689|NCT00558272|26458505|FG001|Overall Study|Withdrawal by Subject|1|||
13281690|NCT00558259|26458532|FG000|Overall Study|Adverse Event|50|||
13281691|NCT00558259|26458533|FG001|Overall Study|Adverse Event|81|||
13281692|NCT00558259|26458532|FG000|Overall Study|Protocol Violation|9|||
13281693|NCT00558259|26458533|FG001|Overall Study|Protocol Violation|5|||
13121210|NCT02984982|25941513|FG000|Overall Study|Poor Compliance to Protocol|4|||
13121211|NCT02984982|25941514|FG001|Overall Study|Poor Compliance to Protocol|4|||
13121212|NCT02984982|25941513|FG000|Overall Study|Withdrawal by Subject|2|||
13121213|NCT02984982|25941514|FG001|Overall Study|Withdrawal by Subject|0|||
13121214|NCT02984982|25941513|FG000|Overall Study|Randomized but not treated|0|||
13281694|NCT00558259|26458532|FG000|Overall Study|Withdrawal by Subject|12|||
13281695|NCT00558259|26458533|FG001|Overall Study|Withdrawal by Subject|13|||
13281696|NCT00558103|26458578|FG000|Randomized Treatment Phase|Lost to Follow-up|2|||
13281697|NCT00558103|26458579|FG001|Randomized Treatment Phase|Lost to Follow-up|2|||
13281698|NCT00558103|26458580|FG002|Randomized Treatment Phase|Lost to Follow-up|2|||
13281699|NCT00558103|26458581|FG003|Randomized Treatment Phase|Lost to Follow-up|1|||
13281700|NCT00558103|26458582|FG004|Randomized Treatment Phase|Lost to Follow-up|3|||
13121215|NCT02984982|25941514|FG001|Overall Study|Randomized but not treated|1|||
13281701|NCT00558103|26458583|FG005|Randomized Treatment Phase|Lost to Follow-up|0|||
13281702|NCT00558103|26458578|FG000|Randomized Treatment Phase|Withdrawal by Subject|2|||
13281703|NCT00558103|26458579|FG001|Randomized Treatment Phase|Withdrawal by Subject|2|||
13281704|NCT00558103|26458580|FG002|Randomized Treatment Phase|Withdrawal by Subject|0|||
13281705|NCT00558103|26458581|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
13121216|NCT02984943|25941559|FG000|Overall Study|Withdrawal by Subject|3|||
13121217|NCT02984943|25941559|FG000|Overall Study|Physician Decision|1|||
13121218|NCT02984683|25941588|FG000|Overall Study|Adverse Event|3|||
13121219|NCT02984683|25941589|FG001|Overall Study|Adverse Event|3|||
13121220|NCT02984683|25941588|FG000|Overall Study|Withdrawal by Subject|1|||
13121221|NCT02984683|25941589|FG001|Overall Study|Withdrawal by Subject|0|||
13121222|NCT02984683|25941588|FG000|Overall Study|Disease progression|7|||
13281706|NCT00558103|26458582|FG004|Randomized Treatment Phase|Withdrawal by Subject|1|||
13281707|NCT00558103|26458583|FG005|Randomized Treatment Phase|Withdrawal by Subject|0|||
13281708|NCT00558103|26458578|FG000|Randomized Treatment Phase|Disease Progression|1|||
13281709|NCT00558103|26458579|FG001|Randomized Treatment Phase|Disease Progression|0|||
13281710|NCT00558103|26458580|FG002|Randomized Treatment Phase|Disease Progression|1|||
13281711|NCT00558103|26458581|FG003|Randomized Treatment Phase|Disease Progression|0|||
13281712|NCT00558103|26458582|FG004|Randomized Treatment Phase|Disease Progression|0|||
13281713|NCT00558103|26458583|FG005|Randomized Treatment Phase|Disease Progression|0|||
13281714|NCT00558103|26458578|FG000|Randomized Treatment Phase|Adverse Event|0|||
13281715|NCT00558103|26458579|FG001|Randomized Treatment Phase|Adverse Event|0|||
13281716|NCT00558103|26458580|FG002|Randomized Treatment Phase|Adverse Event|0|||
13281717|NCT00558103|26458581|FG003|Randomized Treatment Phase|Adverse Event|1|||
13281718|NCT00558103|26458582|FG004|Randomized Treatment Phase|Adverse Event|1|||
13281719|NCT00558103|26458583|FG005|Randomized Treatment Phase|Adverse Event|0|||
13281720|NCT00558103|26458578|FG000|Monotherapy Extension Phase|Protocol Violation|0|||
13281721|NCT00558103|26458579|FG001|Monotherapy Extension Phase|Protocol Violation|0|||
13281722|NCT00558103|26458580|FG002|Monotherapy Extension Phase|Protocol Violation|0|||
13281723|NCT00558103|26458581|FG003|Monotherapy Extension Phase|Protocol Violation|0|||
13281724|NCT00558103|26458582|FG004|Monotherapy Extension Phase|Protocol Violation|0|||
13281725|NCT00558103|26458583|FG005|Monotherapy Extension Phase|Protocol Violation|1|||
13281726|NCT00558103|26458578|FG000|Monotherapy Extension Phase|Disease Progression|0|||
13281727|NCT00558103|26458579|FG001|Monotherapy Extension Phase|Disease Progression|0|||
13281728|NCT00558103|26458580|FG002|Monotherapy Extension Phase|Disease Progression|0|||
13281729|NCT00558103|26458581|FG003|Monotherapy Extension Phase|Disease Progression|0|||
13281730|NCT00558103|26458582|FG004|Monotherapy Extension Phase|Disease Progression|0|||
13281731|NCT00558103|26458583|FG005|Monotherapy Extension Phase|Disease Progression|8|||
13281732|NCT00558064|26458610|FG000|Overall Study|Adverse Event|3|||
13281733|NCT00558064|26458611|FG001|Overall Study|Adverse Event|2|||
13281734|NCT00558064|26458610|FG000|Overall Study|Lack of Efficacy|0|||
13281735|NCT00558064|26458611|FG001|Overall Study|Lack of Efficacy|1|||
13281736|NCT00558064|26458610|FG000|Overall Study|Protocol Violation|1|||
13281737|NCT00558064|26458611|FG001|Overall Study|Protocol Violation|0|||
13281738|NCT00558064|26458610|FG000|Overall Study|Lost to Follow-up|0|||
13281739|NCT00558064|26458611|FG001|Overall Study|Lost to Follow-up|1|||
13281740|NCT00558064|26458610|FG000|Overall Study|Withdrawal by Subject|0|||
13281741|NCT00558064|26458611|FG001|Overall Study|Withdrawal by Subject|1|||
13281742|NCT00558064|26458610|FG000|Overall Study|No visit within allowance period|1|||
13281743|NCT00558064|26458611|FG001|Overall Study|No visit within allowance period|0|||
13281744|NCT00558025|26458640|FG000|Overall Study|Adverse Event|1|||
13281745|NCT00558025|26458641|FG001|Overall Study|Adverse Event|1|||
13281746|NCT00558025|26458640|FG000|Overall Study|Withdrawal by Subject|2|||
13281747|NCT00558025|26458641|FG001|Overall Study|Withdrawal by Subject|2|||
13281748|NCT00558025|26458640|FG000|Overall Study|Protocol Violation|1|||
13281749|NCT00558025|26458641|FG001|Overall Study|Protocol Violation|0|||
13281750|NCT00557830|26458671|FG000|Screening Treatment Phase|Withdrawal by Subject|1|||
13281751|NCT00557830|26458672|FG001|Screening Treatment Phase|Withdrawal by Subject|0|||
13281752|NCT00557830|26458673|FG002|Screening Treatment Phase|Withdrawal by Subject|0|||
13281753|NCT00557830|26458671|FG000|Screening Treatment Phase|Adverse Event|2|||
13281754|NCT00557830|26458672|FG001|Screening Treatment Phase|Adverse Event|0|||
13281755|NCT00557830|26458673|FG002|Screening Treatment Phase|Adverse Event|0|||
13281756|NCT00557830|26458671|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3|||
13281757|NCT00557830|26458672|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0|||
13281758|NCT00557830|26458673|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0|||
13281759|NCT00557622|26458700|FG000|4-Week Run-in Phase|Withdrawal by Subject|1|||
13281760|NCT00557622|26458701|FG001|4-Week Run-in Phase|Withdrawal by Subject|0|||
13281761|NCT00557622|26458700|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1|||
13281762|NCT00557622|26458701|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0|||
13281763|NCT00557622|26458700|FG000|12-Week Treatment Phase|Lost to Follow-up|0|||
13121223|NCT02984683|25941589|FG001|Overall Study|Disease progression|9|||
13121224|NCT02984267|25941620|FG000|Overall Study|Protocol Violation|1|||
13121225|NCT02984267|25941621|FG001|Overall Study|Protocol Violation|0|||
13121226|NCT02984267|25941620|FG000|Overall Study|Withdrawal by Subject|0|||
13281764|NCT00557622|26458701|FG001|12-Week Treatment Phase|Lost to Follow-up|1|||
13281765|NCT00557492|26458715|FG000|Overall Study|Change in health insurance|1|||
13281766|NCT00557466|26458784|FG000|Overall Study|Adverse Event|3|||
13281767|NCT00557466|26458785|FG001|Overall Study|Adverse Event|1|||
13281768|NCT00557466|26458786|FG002|Overall Study|Adverse Event|4|||
13281769|NCT00557466|26458787|FG003|Overall Study|Adverse Event|1|||
13281770|NCT00557466|26458788|FG004|Overall Study|Adverse Event|2|||
13281771|NCT00557466|26458789|FG005|Overall Study|Adverse Event|4|||
13281772|NCT00557466|26458784|FG000|Overall Study|Abnormal laboratory value(s)|1|||
13281773|NCT00557466|26458785|FG001|Overall Study|Abnormal laboratory value(s)|2|||
13281774|NCT00557466|26458786|FG002|Overall Study|Abnormal laboratory value(s)|0|||
13281775|NCT00557466|26458787|FG003|Overall Study|Abnormal laboratory value(s)|0|||
13281776|NCT00557466|26458788|FG004|Overall Study|Abnormal laboratory value(s)|0|||
13281777|NCT00557466|26458789|FG005|Overall Study|Abnormal laboratory value(s)|0|||
13281778|NCT00557466|26458784|FG000|Overall Study|Protocol deviation|0|||
13281779|NCT00557466|26458785|FG001|Overall Study|Protocol deviation|1|||
13281780|NCT00557466|26458786|FG002|Overall Study|Protocol deviation|0|||
13281781|NCT00557466|26458787|FG003|Overall Study|Protocol deviation|2|||
13281782|NCT00557466|26458788|FG004|Overall Study|Protocol deviation|0|||
13281783|NCT00557466|26458789|FG005|Overall Study|Protocol deviation|0|||
13281784|NCT00557466|26458784|FG000|Overall Study|Subject withdrew consent|0|||
13281785|NCT00557466|26458785|FG001|Overall Study|Subject withdrew consent|0|||
13281786|NCT00557466|26458786|FG002|Overall Study|Subject withdrew consent|0|||
13281787|NCT00557466|26458787|FG003|Overall Study|Subject withdrew consent|0|||
13281788|NCT00557466|26458788|FG004|Overall Study|Subject withdrew consent|1|||
13281789|NCT00557466|26458789|FG005|Overall Study|Subject withdrew consent|2|||
13281790|NCT00557466|26458784|FG000|Overall Study|Administrative problems|0|||
13281791|NCT00557466|26458785|FG001|Overall Study|Administrative problems|1|||
13281792|NCT00557466|26458786|FG002|Overall Study|Administrative problems|1|||
13281793|NCT00557466|26458787|FG003|Overall Study|Administrative problems|0|||
13281794|NCT00557466|26458788|FG004|Overall Study|Administrative problems|0|||
13281795|NCT00557466|26458789|FG005|Overall Study|Administrative problems|0|||
13281796|NCT00557466|26458784|FG000|Overall Study|Abnormal test procedure results|0|||
13281797|NCT00557466|26458785|FG001|Overall Study|Abnormal test procedure results|0|||
13281798|NCT00557466|26458786|FG002|Overall Study|Abnormal test procedure results|1|||
13281799|NCT00557466|26458787|FG003|Overall Study|Abnormal test procedure results|0|||
13281800|NCT00557466|26458788|FG004|Overall Study|Abnormal test procedure results|0|||
13281801|NCT00557466|26458789|FG005|Overall Study|Abnormal test procedure results|0|||
13281802|NCT00557466|26458784|FG000|Overall Study|Lost to Follow-up|0|||
13281803|NCT00557466|26458785|FG001|Overall Study|Lost to Follow-up|0|||
13281804|NCT00557466|26458786|FG002|Overall Study|Lost to Follow-up|0|||
13281805|NCT00557466|26458787|FG003|Overall Study|Lost to Follow-up|1|||
13281806|NCT00557466|26458788|FG004|Overall Study|Lost to Follow-up|0|||
13281807|NCT00557466|26458789|FG005|Overall Study|Lost to Follow-up|0|||
13281808|NCT00557440|26458819|FG000|Treatment Period 1|Adverse Event|0|||
13281809|NCT00557440|26458820|FG001|Treatment Period 1|Adverse Event|0|||
13281810|NCT00557440|26458821|FG002|Treatment Period 1|Adverse Event|1|||
13281811|NCT00557323|26458828|FG000|Overall Study|Death|3|||
13281812|NCT00557323|26458828|FG000|Overall Study|Withdrawal by Subject|2|||
13281813|NCT00557323|26458828|FG000|Overall Study|Administrative change|2|||
13281814|NCT00557310|26458850|FG000|Main Study (0 - 18 Months)|Adverse Event|4|||
13281815|NCT00557310|26458850|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1|||
13281816|NCT00557310|26458850|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1|||
13281817|NCT00557310|26458850|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1|||
13281818|NCT00557310|26458850|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2|||
13281819|NCT00557310|26458850|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1|||
13281820|NCT00557245|26458898|FG000|Overall Study|Lost to Follow-up|7|||
13281821|NCT00557245|26458899|FG001|Overall Study|Lost to Follow-up|8|||
13281822|NCT00557245|26458900|FG002|Overall Study|Lost to Follow-up|10|||
13281823|NCT00557245|26458898|FG000|Overall Study|Ineligible|5|||
13281824|NCT00557245|26458899|FG001|Overall Study|Ineligible|4|||
13281825|NCT00557245|26458900|FG002|Overall Study|Ineligible|2|||
13281826|NCT00556894|26458918|FG000|Overall Study|Adverse Event|2|||
13281827|NCT00556894|26458919|FG001|Overall Study|Adverse Event|3|||
13281828|NCT00556894|26458920|FG002|Overall Study|Adverse Event|3|||
13281829|NCT00556894|26458918|FG000|Overall Study|Death|1|||
13281830|NCT00556894|26458919|FG001|Overall Study|Death|0|||
13281831|NCT00556894|26458920|FG002|Overall Study|Death|0|||
13281832|NCT00556894|26458918|FG000|Overall Study|regulatory decision in Bulgaria|10|||
13281833|NCT00556894|26458919|FG001|Overall Study|regulatory decision in Bulgaria|14|||
13281834|NCT00556894|26458920|FG002|Overall Study|regulatory decision in Bulgaria|13|||
13281835|NCT00556894|26458918|FG000|Overall Study|Change in therapy|2|||
13281836|NCT00556894|26458919|FG001|Overall Study|Change in therapy|1|||
13281837|NCT00556894|26458920|FG002|Overall Study|Change in therapy|2|||
13281838|NCT00556894|26458918|FG000|Overall Study|Withdrawal by Subject|1|||
13281839|NCT00556894|26458919|FG001|Overall Study|Withdrawal by Subject|1|||
13281840|NCT00556894|26458920|FG002|Overall Study|Withdrawal by Subject|1|||
13281841|NCT00556712|26459003|FG000|Overall Study|Adverse Event|7|||
13281842|NCT00556712|26459004|FG001|Overall Study|Adverse Event|19|||
13281843|NCT00556712|26459003|FG000|Overall Study|Death|5|||
13281844|NCT00556712|26459004|FG001|Overall Study|Death|10|||
13281845|NCT00556712|26459003|FG000|Overall Study|Progressive Disease|383|||
13281846|NCT00556712|26459004|FG001|Overall Study|Progressive Disease|320|||
13281847|NCT00556712|26459003|FG000|Overall Study|Protocol Violation|3|||
13281848|NCT00556712|26459004|FG001|Overall Study|Protocol Violation|2|||
13281849|NCT00556712|26459003|FG000|Overall Study|Refused Treatment|17|||
13281850|NCT00556712|26459004|FG001|Overall Study|Refused Treatment|16|||
13281851|NCT00556712|26459003|FG000|Overall Study|Failure to Return|2|||
13281852|NCT00556712|26459004|FG001|Overall Study|Failure to Return|3|||
13281853|NCT00556712|26459003|FG000|Overall Study|Other|2|||
13281854|NCT00556712|26459004|FG001|Overall Study|Other|2|||
13281855|NCT00556712|26459003|FG000|Overall Study|Ongoing at Data Cutoff|32|||
13281856|NCT00556712|26459004|FG001|Overall Study|Ongoing at Data Cutoff|66|||
13281857|NCT00556673|26459047|FG000|Overall Study|Protocol deviation|3|||
13281858|NCT00556673|26459048|FG001|Overall Study|Protocol deviation|2|||
13281859|NCT00556426|26459058|FG000|Overall Study|Withdrawal by Subject|3|||
13281860|NCT00556426|26459058|FG000|Overall Study|Death|6|||
13281861|NCT00556322|26459113|FG000|Overall Study|Insufficient therapeutic response|158|||
13281862|NCT00556322|26459114|FG001|Overall Study|Insufficient therapeutic response|168|||
13281863|NCT00556322|26459113|FG000|Overall Study|Adverse Event|7|||
13121227|NCT02984267|25941621|FG001|Overall Study|Withdrawal by Subject|1|||
13121228|NCT02983799|25941683|FG000|Overall Study|Withdrawn from study before data cut-off|28|||
13121229|NCT02983799|25941684|FG001|Overall Study|Withdrawn from study before data cut-off|12|||
13121230|NCT02983799|25941685|FG002|Overall Study|Withdrawn from study before data cut-off|23|||
13121231|NCT02983799|25941686|FG003|Overall Study|Withdrawn from study before data cut-off|25|||
13121232|NCT02983799|25941687|FG004|Overall Study|Withdrawn from study before data cut-off|1|||
13121233|NCT02983799|25941683|FG000|Overall Study|Death|20|||
13121234|NCT02983799|25941684|FG001|Overall Study|Death|5|||
13121235|NCT02983799|25941685|FG002|Overall Study|Death|23|||
13121236|NCT02983799|25941686|FG003|Overall Study|Death|47|||
13121237|NCT02983799|25941687|FG004|Overall Study|Death|7|||
13121238|NCT02983799|25941683|FG000|Overall Study|Withdrawal by Subject|1|||
13121239|NCT02983799|25941684|FG001|Overall Study|Withdrawal by Subject|0|||
13121240|NCT02983799|25941685|FG002|Overall Study|Withdrawal by Subject|3|||
13121241|NCT02983799|25941686|FG003|Overall Study|Withdrawal by Subject|4|||
13281864|NCT00556322|26459114|FG001|Overall Study|Adverse Event|4|||
13281865|NCT00556322|26459113|FG000|Overall Study|Other|4|||
13281866|NCT00556322|26459114|FG001|Overall Study|Other|1|||
13281867|NCT00556322|26459113|FG000|Overall Study|Lost to Follow-up|5|||
13281868|NCT00556322|26459114|FG001|Overall Study|Lost to Follow-up|3|||
13281869|NCT00556322|26459113|FG000|Overall Study|Withdrawal by Subject|19|||
13281870|NCT00556322|26459114|FG001|Overall Study|Withdrawal by Subject|7|||
13281871|NCT00556322|26459113|FG000|Overall Study|Protocol Violation|5|||
13281872|NCT00556322|26459114|FG001|Overall Study|Protocol Violation|1|||
13281873|NCT00556322|26459113|FG000|Overall Study|Ongoing at data cutoff|3|||
13281874|NCT00556322|26459114|FG001|Overall Study|Ongoing at data cutoff|5|||
13281875|NCT00556322|26459113|FG000|Overall Study|Death|20|||
13281876|NCT00556322|26459114|FG001|Overall Study|Death|14|||
13281877|NCT00556166|26459121|FG000|Overall Study|Withdrawal by Subject|1|||
13281878|NCT00556075|26459154|FG000|Overall Study|Lost to Follow-up|3|||
13281879|NCT00556075|26459155|FG001|Overall Study|Lost to Follow-up|0|||
13281880|NCT00556075|26459156|FG002|Overall Study|Lost to Follow-up|3|||
13281881|NCT00556075|26459154|FG000|Overall Study|Withdrawal by Subject|3|||
13281882|NCT00556075|26459155|FG001|Overall Study|Withdrawal by Subject|3|||
13281883|NCT00556075|26459156|FG002|Overall Study|Withdrawal by Subject|0|||
13281884|NCT00556075|26459154|FG000|Overall Study|Protocol Violation|1|||
13281885|NCT00556075|26459155|FG001|Overall Study|Protocol Violation|1|||
13281886|NCT00556075|26459156|FG002|Overall Study|Protocol Violation|3|||
13281887|NCT00556075|26459154|FG000|Overall Study|Not eligible|1|||
13281888|NCT00556075|26459155|FG001|Overall Study|Not eligible|1|||
13281889|NCT00556075|26459156|FG002|Overall Study|Not eligible|2|||
13281890|NCT00556075|26459154|FG000|Overall Study|Adverse Event|1|||
13281891|NCT00556075|26459155|FG001|Overall Study|Adverse Event|2|||
13281892|NCT00556075|26459156|FG002|Overall Study|Adverse Event|0|||
13281893|NCT00556075|26459154|FG000|Overall Study|Personal issues|4|||
13281894|NCT00556075|26459155|FG001|Overall Study|Personal issues|1|||
13281895|NCT00556075|26459156|FG002|Overall Study|Personal issues|0|||
13281896|NCT00556075|26459154|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
13281897|NCT00556075|26459155|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1|||
13281898|NCT00556075|26459156|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
13281899|NCT00555568|26459186|FG000|Overall Study|Lost to Follow-up|26|||
13281900|NCT00555568|26459187|FG001|Overall Study|Lost to Follow-up|16|||
13281901|NCT00555568|26459188|FG002|Overall Study|Lost to Follow-up|16|||
13281902|NCT00555477|26459200|FG000|Overall Study|Adverse Event|0|||
13281903|NCT00555477|26459201|FG001|Overall Study|Adverse Event|9|||
13121242|NCT02983799|25941687|FG004|Overall Study|Withdrawal by Subject|1|||
13121243|NCT02983799|25941683|FG000|Overall Study|Protocol Violation|0|||
13281904|NCT00555477|26459200|FG000|Overall Study|Withdrawal by Subject|1|||
13281905|NCT00555477|26459201|FG001|Overall Study|Withdrawal by Subject|2|||
13281906|NCT00555477|26459200|FG000|Overall Study|Physician Decision|1|||
13281907|NCT00555477|26459201|FG001|Overall Study|Physician Decision|2|||
13281908|NCT00555438|26459211|FG000|10 Days Post-operative|Death|4|||
13281909|NCT00555438|26459211|FG000|Between 10 Days and 30 Days Postoperativ|Death|5|||
13281910|NCT00555425|26459236|FG000|Overall Study|Missed Medication > 1 wk|34|||
13121244|NCT02983799|25941684|FG001|Overall Study|Protocol Violation|1|||
13281911|NCT00555425|26459237|FG001|Overall Study|Missed Medication > 1 wk|15|||
13281912|NCT00555425|26459236|FG000|Overall Study|Missed 3 physician management visits|1|||
13121245|NCT02983799|25941685|FG002|Overall Study|Protocol Violation|0|||
13121246|NCT02983799|25941686|FG003|Overall Study|Protocol Violation|0|||
13121247|NCT02983799|25941687|FG004|Overall Study|Protocol Violation|1|||
13121248|NCT02983799|25941683|FG000|Overall Study|Lost to Follow-up|1|||
13281913|NCT00555425|26459237|FG001|Overall Study|Missed 3 physician management visits|0|||
13121249|NCT02983799|25941684|FG001|Overall Study|Lost to Follow-up|0|||
13281914|NCT00555425|26459236|FG000|Overall Study|Met criteria for protective transfer|16|||
13281915|NCT00555425|26459237|FG001|Overall Study|Met criteria for protective transfer|3|||
13281916|NCT00555425|26459236|FG000|Overall Study|Became pregnant and transferred care|0|||
13281917|NCT00555425|26459237|FG001|Overall Study|Became pregnant and transferred care|1|||
13281918|NCT00555061|26459246|FG000|Overall Study|Adverse Event|3|||
13281919|NCT00555061|26459246|FG000|Overall Study|Protocol Violation|1|||
13281920|NCT00555061|26459246|FG000|Overall Study|Lost to Follow-up|2|||
13281921|NCT00555061|26459246|FG000|Overall Study|Withdrawal by Subject|2|||
13121250|NCT02983799|25941685|FG002|Overall Study|Lost to Follow-up|1|||
13121251|NCT02983799|25941686|FG003|Overall Study|Lost to Follow-up|0|||
13121252|NCT02983799|25941687|FG004|Overall Study|Lost to Follow-up|0|||
13133465|NCT02769065|25988347|FG006|Overall Study|Voluntary Withdrawal|0|||
13133466|NCT02769065|25988348|FG007|Overall Study|Voluntary Withdrawal|0|||
13133467|NCT02769065|25988349|FG008|Overall Study|Voluntary Withdrawal|0|||
13133468|NCT02769065|25988350|FG009|Overall Study|Voluntary Withdrawal|0|||
13133469|NCT02769065|25988351|FG010|Overall Study|Voluntary Withdrawal|0|||
13133470|NCT02769065|25988352|FG011|Overall Study|Voluntary Withdrawal|0|||
13133471|NCT02769065|25988353|FG012|Overall Study|Voluntary Withdrawal|0|||
13281922|NCT00555061|26459246|FG000|Overall Study|Participant enrolled, but never treated|1|||
13281923|NCT00554840|26459269|FG000|Overall Study|Physician Decision|0|||
13281924|NCT00554840|26459270|FG001|Overall Study|Physician Decision|1|||
13281925|NCT00554619|26459284|FG000|Overall Study|Adverse Event|1|||
13281926|NCT00554619|26459284|FG000|Overall Study|Physician Decision|1|||
13281927|NCT00554619|26459284|FG000|Overall Study|Liver Function Test Abnormality|1|||
13281928|NCT00554606|26459315|FG000|Overall Study|Adverse Event|3|||
13281929|NCT00554606|26459315|FG000|Overall Study|Abnormal laboratory values|1|||
13281930|NCT00554606|26459315|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
13281931|NCT00554606|26459315|FG000|Overall Study|Subject withdrew consent|2|||
13281932|NCT00554606|26459315|FG000|Overall Study|Lost to Follow-up|2|||
13281933|NCT00554606|26459315|FG000|Overall Study|Administrative problems|60|||
13281934|NCT00554606|26459315|FG000|Overall Study|Death|1|||
13281935|NCT00554606|26459315|FG000|Overall Study|Protocol deviation|2|||
13281936|NCT00554229|26459344|FG000|Overall Study|Lost to Follow-up|3|||
13281937|NCT00554229|26459345|FG001|Overall Study|Lost to Follow-up|6|||
13281938|NCT00554229|26459344|FG000|Overall Study|Withdrawal by Subject|29|||
13281939|NCT00554229|26459345|FG001|Overall Study|Withdrawal by Subject|37|||
13281940|NCT00554229|26459344|FG000|Overall Study|Adverse Event|71|||
13281941|NCT00554229|26459345|FG001|Overall Study|Adverse Event|39|||
13281942|NCT00554229|26459344|FG000|Overall Study|Protocol Violation|3|||
13281943|NCT00554229|26459345|FG001|Overall Study|Protocol Violation|3|||
13281944|NCT00554229|26459344|FG000|Overall Study|Reason not otherwise captured, eg; death|119|||
13281945|NCT00554229|26459345|FG001|Overall Study|Reason not otherwise captured, eg; death|140|||
13281946|NCT00554229|26459344|FG000|Overall Study|Randomised but no treatment received|1|||
13281947|NCT00554229|26459345|FG001|Overall Study|Randomised but no treatment received|0|||
13281948|NCT00554216|26459366|FG000|Overall Study|Lost to Follow-up|92|||
13281949|NCT00554216|26459367|FG001|Overall Study|Lost to Follow-up|31|||
13281950|NCT00554216|26459368|FG002|Overall Study|Lost to Follow-up|63|||
13281951|NCT00554216|26459366|FG000|Overall Study|Adverse Event|16|||
13281952|NCT00554216|26459367|FG001|Overall Study|Adverse Event|16|||
13281953|NCT00554216|26459368|FG002|Overall Study|Adverse Event|36|||
13281954|NCT00554216|26459366|FG000|Overall Study|Withdrawal by Subject|92|||
13281955|NCT00554216|26459367|FG001|Overall Study|Withdrawal by Subject|31|||
13281956|NCT00554216|26459368|FG002|Overall Study|Withdrawal by Subject|43|||
13281957|NCT00554216|26459366|FG000|Overall Study|Non compliance|10|||
13281958|NCT00554216|26459367|FG001|Overall Study|Non compliance|4|||
13281959|NCT00554216|26459368|FG002|Overall Study|Non compliance|5|||
13281960|NCT00554216|26459366|FG000|Overall Study|Pregnancy|2|||
13281961|NCT00554216|26459367|FG001|Overall Study|Pregnancy|1|||
13133472|NCT02769065|25988354|FG013|Overall Study|Voluntary Withdrawal|0|||
13133473|NCT02769065|25988355|FG014|Overall Study|Voluntary Withdrawal|0|||
13133474|NCT02769065|25988356|FG015|Overall Study|Voluntary Withdrawal|0|||
13133475|NCT02769065|25988357|FG016|Overall Study|Voluntary Withdrawal|0|||
13133476|NCT02769065|25988358|FG017|Overall Study|Voluntary Withdrawal|0|||
13281962|NCT00554216|26459368|FG002|Overall Study|Pregnancy|14|||
13281963|NCT00554216|26459366|FG000|Overall Study|Restricted med|3|||
13281964|NCT00554216|26459367|FG001|Overall Study|Restricted med|1|||
13281965|NCT00554216|26459368|FG002|Overall Study|Restricted med|1|||
13281966|NCT00554216|26459366|FG000|Overall Study|Other|12|||
13281967|NCT00554216|26459367|FG001|Overall Study|Other|7|||
13281968|NCT00554216|26459368|FG002|Overall Study|Other|10|||
13281969|NCT00554216|26459366|FG000|Overall Study|Lack of Efficacy|15|||
13281970|NCT00554216|26459367|FG001|Overall Study|Lack of Efficacy|3|||
13281971|NCT00554216|26459368|FG002|Overall Study|Lack of Efficacy|0|||
13281972|NCT00554099|26459407|FG000|Treatment Period (12 Weeks)|Adverse Event|3|||
13281973|NCT00554099|26459408|FG001|Treatment Period (12 Weeks)|Adverse Event|5|||
13281974|NCT00554099|26459409|FG002|Treatment Period (12 Weeks)|Adverse Event|1|||
13281975|NCT00554099|26459407|FG000|Treatment Period (12 Weeks)|Physician Decision|3|||
13281976|NCT00554099|26459408|FG001|Treatment Period (12 Weeks)|Physician Decision|0|||
13281977|NCT00554099|26459409|FG002|Treatment Period (12 Weeks)|Physician Decision|0|||
13281978|NCT00554099|26459407|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1|||
13281979|NCT00554099|26459408|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0|||
13281980|NCT00554099|26459409|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2|||
13281981|NCT00554099|26459407|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1|||
13281982|NCT00554099|26459408|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2|||
13281983|NCT00554099|26459409|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0|||
13281984|NCT00554099|26459407|FG000|Treatment Period (12 Weeks)|Protocol Violation|0|||
13281985|NCT00554099|26459408|FG001|Treatment Period (12 Weeks)|Protocol Violation|0|||
13281986|NCT00554099|26459409|FG002|Treatment Period (12 Weeks)|Protocol Violation|2|||
13281987|NCT00554099|26459407|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
13281988|NCT00554099|26459408|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
13281989|NCT00554099|26459409|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
13281990|NCT00554099|26459407|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1|||
13281991|NCT00554099|26459408|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2|||
13281992|NCT00554099|26459409|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0|||
13281993|NCT00554099|26459407|FG000|Non-Treatment Phase (9 Months)|Relapse|2|||
13281994|NCT00554099|26459408|FG001|Non-Treatment Phase (9 Months)|Relapse|1|||
13281995|NCT00554099|26459409|FG002|Non-Treatment Phase (9 Months)|Relapse|1|||
13281996|NCT00554099|26459407|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4|||
13281997|NCT00554099|26459408|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
13281998|NCT00554099|26459409|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
13281999|NCT00553644|26459418|FG000|Overall Study|Adverse Event|17|||
13282000|NCT00553644|26459418|FG000|Overall Study|Withdrawal by Subject|4|||
13282001|NCT00553644|26459418|FG000|Overall Study|Physician Decision|1|||
13282002|NCT00553644|26459418|FG000|Overall Study|Alternative therapy|6|||
13282003|NCT00553631|26459445|FG000|Overall Study|Withdrawal by Subject|0|||
13282004|NCT00553631|26459446|FG001|Overall Study|Withdrawal by Subject|1|||
13282005|NCT00553631|26459445|FG000|Overall Study|Lost to Follow-up|1|||
13282006|NCT00553631|26459446|FG001|Overall Study|Lost to Follow-up|0|||
13282007|NCT00553514|26459499|FG000|Overall Study|Protocol deviation|0|||
13282008|NCT00553514|26459500|FG001|Overall Study|Protocol deviation|0|||
13282009|NCT00553514|26459501|FG002|Overall Study|Protocol deviation|0|||
13282010|NCT00553514|26459502|FG003|Overall Study|Protocol deviation|1|||
13282011|NCT00553514|26459503|FG004|Overall Study|Protocol deviation|0|||
13282012|NCT00553514|26459499|FG000|Overall Study|Lack of ovarian response|4|||
13282013|NCT00553514|26459500|FG001|Overall Study|Lack of ovarian response|5|||
13282014|NCT00553514|26459501|FG002|Overall Study|Lack of ovarian response|5|||
13282015|NCT00553514|26459502|FG003|Overall Study|Lack of ovarian response|5|||
13282016|NCT00553514|26459503|FG004|Overall Study|Lack of ovarian response|6|||
13282017|NCT00553514|26459499|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
13282018|NCT00553514|26459500|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
13282019|NCT00553514|26459501|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
13282020|NCT00553514|26459502|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
13282021|NCT00553514|26459503|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
13282022|NCT00553514|26459499|FG000|Overall Study|Risk of multiple pregnancy|0|||
13282023|NCT00553514|26459500|FG001|Overall Study|Risk of multiple pregnancy|2|||
13282024|NCT00553514|26459501|FG002|Overall Study|Risk of multiple pregnancy|0|||
13282025|NCT00553514|26459502|FG003|Overall Study|Risk of multiple pregnancy|1|||
13282026|NCT00553514|26459503|FG004|Overall Study|Risk of multiple pregnancy|0|||
13282027|NCT00553514|26459499|FG000|Overall Study|Other|1|||
13282028|NCT00553514|26459500|FG001|Overall Study|Other|1|||
13282029|NCT00553514|26459501|FG002|Overall Study|Other|0|||
13282030|NCT00553514|26459502|FG003|Overall Study|Other|0|||
13282031|NCT00553514|26459503|FG004|Overall Study|Other|1|||
13282032|NCT00553501|26459511|FG000|Overall Study|Adverse Event|2|||
13282033|NCT00553501|26459511|FG000|Overall Study|Death|1|||
13282034|NCT00553501|26459511|FG000|Overall Study|Progression|1|||
13282035|NCT00553462|26459519|FG000|Overall Study|Adverse Event|4|||
13282036|NCT00553462|26459519|FG000|Overall Study|Progression|4|||
13282037|NCT00553462|26459519|FG000|Overall Study|Withdrawal by Subject|5|||
13282038|NCT00553462|26459519|FG000|Overall Study|Physician Decision|1|||
13282039|NCT00553436|26459527|FG000|Overall Study|Conversion to another procedure|1|||
13282040|NCT00553332|26459538|FG000|Overall Study|ineligible, incorrect diagnosis|1|||
13282041|NCT00553319|26459559|FG000|Overall Study|Lost to Follow-up|10|||
13282042|NCT00553319|26459560|FG001|Overall Study|Lost to Follow-up|9|||
13282043|NCT00553319|26459561|FG002|Overall Study|Lost to Follow-up|5|||
13282044|NCT00553319|26459559|FG000|Overall Study|wanted treatment elsewhere|2|||
13282045|NCT00553319|26459560|FG001|Overall Study|wanted treatment elsewhere|1|||
13282046|NCT00553319|26459561|FG002|Overall Study|wanted treatment elsewhere|1|||
13282047|NCT00553319|26459559|FG000|Overall Study|non-compliance|0|||
13282048|NCT00553319|26459560|FG001|Overall Study|non-compliance|0|||
13282049|NCT00553319|26459561|FG002|Overall Study|non-compliance|2|||
13282050|NCT00553319|26459559|FG000|Overall Study|incarceration|1|||
13282051|NCT00553319|26459560|FG001|Overall Study|incarceration|0|||
13282052|NCT00553319|26459561|FG002|Overall Study|incarceration|0|||
13282053|NCT00553319|26459559|FG000|Overall Study|moved|1|||
13282054|NCT00553319|26459560|FG001|Overall Study|moved|0|||
13282055|NCT00553319|26459561|FG002|Overall Study|moved|1|||
13282056|NCT00553267|26459606|FG000|Overall Study|Adverse Event|8|||
13282057|NCT00553267|26459607|FG001|Overall Study|Adverse Event|10|||
13282058|NCT00553267|26459608|FG002|Overall Study|Adverse Event|5|||
13282059|NCT00553267|26459606|FG000|Overall Study|Non compliant with protocol|3|||
13282060|NCT00553267|26459607|FG001|Overall Study|Non compliant with protocol|3|||
13282061|NCT00553267|26459608|FG002|Overall Study|Non compliant with protocol|2|||
13282062|NCT00553267|26459606|FG000|Overall Study|Lost to Follow-up|0|||
13282063|NCT00553267|26459607|FG001|Overall Study|Lost to Follow-up|0|||
13121253|NCT02983604|25941738|FG000|Overall Study|Enrolled but not Treated|0|||
13282064|NCT00553267|26459608|FG002|Overall Study|Lost to Follow-up|1|||
13282065|NCT00553267|26459606|FG000|Overall Study|Consent withdrawn|2|||
13282066|NCT00553267|26459607|FG001|Overall Study|Consent withdrawn|3|||
13121254|NCT02983604|25941739|FG001|Overall Study|Enrolled but not Treated|0|||
13121255|NCT02983604|25941740|FG002|Overall Study|Enrolled but not Treated|1|||
13121256|NCT02983604|25941741|FG003|Overall Study|Enrolled but not Treated|0|||
13121257|NCT02983305|25941756|FG000|Overall Study|incomplete data|2|||
13121258|NCT02983305|25941757|FG001|Overall Study|incomplete data|0|||
13121259|NCT02983227|25941822|FG000|Overall Study|Adverse Event|21|||
13121260|NCT02983227|25941823|FG001|Overall Study|Adverse Event|3|||
13282067|NCT00553267|26459608|FG002|Overall Study|Consent withdrawn|1|||
13282068|NCT00553267|26459606|FG000|Overall Study|Specified category|1|||
13282069|NCT00553267|26459607|FG001|Overall Study|Specified category|2|||
13282070|NCT00553267|26459608|FG002|Overall Study|Specified category|1|||
13282071|NCT00553202|26459618|FG000|Overall Study|Death|16|||
13282072|NCT00553202|26459618|FG000|Overall Study|Lost to Follow-up|1|||
13282073|NCT00553202|26459618|FG000|Overall Study|Physician Decision|28|||
13282074|NCT00553202|26459618|FG000|Overall Study|Withdrawal by Subject|1|||
13121261|NCT02983227|25941822|FG000|Overall Study|Death|3|||
13121262|NCT02983227|25941823|FG001|Overall Study|Death|0|||
13121263|NCT02983227|25941822|FG000|Overall Study|Lack of Efficacy|8|||
13121264|NCT02983227|25941823|FG001|Overall Study|Lack of Efficacy|1|||
13121265|NCT02983227|25941822|FG000|Overall Study|Lost to Follow-up|3|||
13121266|NCT02983227|25941823|FG001|Overall Study|Lost to Follow-up|0|||
13121267|NCT02983227|25941822|FG000|Overall Study|Multiple Reasons|2|||
13121268|NCT02983227|25941823|FG001|Overall Study|Multiple Reasons|1|||
13121269|NCT02983227|25941822|FG000|Overall Study|Physician Decision|3|||
13121270|NCT02983227|25941823|FG001|Overall Study|Physician Decision|1|||
13121271|NCT02983227|25941822|FG000|Overall Study|Withdrawal by Subject|19|||
13121272|NCT02983227|25941823|FG001|Overall Study|Withdrawal by Subject|8|||
13121273|NCT02982863|25941896|FG000|Overall Study|Not eligible patients|809|||
13121274|NCT02982863|25941897|FG001|Overall Study|Not eligible patients|4261|||
13121275|NCT02982863|25941898|FG002|Overall Study|Not eligible patients|1852|||
13282075|NCT00553202|26459618|FG000|Overall Study|No donor identified|16|||
13282076|NCT00553202|26459618|FG000|Overall Study|Fails to meet organ function|6|||
13282077|NCT00553150|26459639|FG000|Overall Study|Withdrawal by Subject|0|||
13282078|NCT00553150|26459640|FG001|Overall Study|Withdrawal by Subject|0|||
13282079|NCT00553150|26459641|FG002|Overall Study|Withdrawal by Subject|0|||
13121276|NCT02982863|25941899|FG003|Overall Study|Not eligible patients|1400|||
13121277|NCT02982863|25941900|FG004|Overall Study|Not eligible patients|492|||
13121278|NCT02982772|25941931|FG000|Intervention|Lost to Follow-up|19|||
13121279|NCT02982772|25941932|FG001|Intervention|Lost to Follow-up|13|||
13121280|NCT02982772|25941931|FG000|1M Follow-Up|Lost to Follow-up|21|||
13121281|NCT02982772|25941932|FG001|1M Follow-Up|Lost to Follow-up|18|||
13121282|NCT02982772|25941931|FG000|3M Follow-Up|Lost to Follow-up|17|||
13121283|NCT02982772|25941932|FG001|3M Follow-Up|Lost to Follow-up|11|||
13121284|NCT02982772|25941931|FG000|6M Follow-Up|Lost to Follow-up|11|||
13121285|NCT02982772|25941932|FG001|6M Follow-Up|Lost to Follow-up|9|||
13282080|NCT00553150|26459642|FG003|Overall Study|Withdrawal by Subject|2|||
13282081|NCT00553150|26459639|FG000|Overall Study|Protocol Violation|0|||
13282082|NCT00553150|26459640|FG001|Overall Study|Protocol Violation|0|||
13121286|NCT02982772|25941931|FG000|12M Follow-Up|Lost to Follow-up|11|||
13121287|NCT02982772|25941932|FG001|12M Follow-Up|Lost to Follow-up|5|||
13121288|NCT02982720|25941942|FG000|Overall Study|Adverse Event|3|||
13121289|NCT02982720|25941942|FG000|Overall Study|Death|1|||
13121290|NCT02982590|25941961|FG000|Overall Study|Lost to Follow-up|0|||
13121291|NCT02982590|25941962|FG001|Overall Study|Lost to Follow-up|1|||
13121292|NCT02982590|25941961|FG000|Overall Study|Death|4|||
13121293|NCT02982590|25941962|FG001|Overall Study|Death|0|||
13121294|NCT02982239|25941983|FG000|Overall Study|Lost to Follow-up|3|||
13121295|NCT02982239|25941984|FG001|Overall Study|Lost to Follow-up|2|||
13121296|NCT02982213|25942005|FG000|Overall Study|Did not complete follow up questionnaire|5|||
13121297|NCT02982213|25942006|FG001|Overall Study|Did not complete follow up questionnaire|1|||
13121298|NCT02982187|25942067|FG000|Overall Study|Withdrawal by Subject|0|||
13121299|NCT02982187|25942068|FG001|Overall Study|Withdrawal by Subject|0|||
13121300|NCT02982187|25942069|FG002|Overall Study|Withdrawal by Subject|0|||
13121301|NCT02982187|25942070|FG003|Overall Study|Withdrawal by Subject|0|||
13121302|NCT02982187|25942071|FG004|Overall Study|Withdrawal by Subject|0|||
13121303|NCT02982187|25942072|FG005|Overall Study|Withdrawal by Subject|0|||
13121304|NCT02982187|25942073|FG006|Overall Study|Withdrawal by Subject|1|||
13121305|NCT02982187|25942074|FG007|Overall Study|Withdrawal by Subject|0|||
13121306|NCT02982018|25942095|FG000|Overall Study|Incorrect Lens Dispensed|1|||
13121307|NCT02982018|25942096|FG001|Overall Study|Incorrect Lens Dispensed|0|||
13121308|NCT02982018|25942095|FG000|Overall Study|Protocol Violation|1|||
13121309|NCT02982018|25942096|FG001|Overall Study|Protocol Violation|1|||
13121310|NCT02982018|25942095|FG000|Overall Study|Adverse Event|1|||
13121311|NCT02982018|25942096|FG001|Overall Study|Adverse Event|1|||
13282083|NCT00553150|26459641|FG002|Overall Study|Protocol Violation|0|||
13282084|NCT00553150|26459642|FG003|Overall Study|Protocol Violation|1|||
13282085|NCT00553150|26459639|FG000|Overall Study|Ineligible|0|||
13282086|NCT00553150|26459640|FG001|Overall Study|Ineligible|0|||
13282087|NCT00553150|26459641|FG002|Overall Study|Ineligible|0|||
13282088|NCT00553150|26459642|FG003|Overall Study|Ineligible|1|||
13282089|NCT00553059|26459667|FG000|Overall Study|Deemed ineligible|1|||
13282090|NCT00553059|26459668|FG001|Overall Study|Deemed ineligible|1|||
13282091|NCT00553059|26459667|FG000|Overall Study|Drug supply not available|0|||
13282092|NCT00553059|26459668|FG001|Overall Study|Drug supply not available|1|||
13282093|NCT00552929|26459751|FG000|Overall Study|Lost to Follow-up|0|||
13282094|NCT00552929|26459752|FG001|Overall Study|Lost to Follow-up|0|||
13282095|NCT00552929|26459753|FG002|Overall Study|Lost to Follow-up|0|||
13282096|NCT00552929|26459754|FG003|Overall Study|Lost to Follow-up|0|||
13282097|NCT00552929|26459755|FG004|Overall Study|Lost to Follow-up|0|||
13282098|NCT00552929|26459756|FG005|Overall Study|Lost to Follow-up|0|||
13282099|NCT00552929|26459757|FG006|Overall Study|Lost to Follow-up|0|||
13282100|NCT00552929|26459758|FG007|Overall Study|Lost to Follow-up|0|||
13282101|NCT00552929|26459759|FG008|Overall Study|Lost to Follow-up|1|||
13282102|NCT00552929|26459760|FG009|Overall Study|Lost to Follow-up|0|||
13282103|NCT00552929|26459751|FG000|Overall Study|Not Eligible|0|||
13282104|NCT00552929|26459752|FG001|Overall Study|Not Eligible|0|||
13282105|NCT00552929|26459753|FG002|Overall Study|Not Eligible|0|||
13282106|NCT00552929|26459754|FG003|Overall Study|Not Eligible|0|||
13282107|NCT00552929|26459755|FG004|Overall Study|Not Eligible|0|||
13282108|NCT00552929|26459756|FG005|Overall Study|Not Eligible|1|||
13282109|NCT00552929|26459757|FG006|Overall Study|Not Eligible|0|||
13282110|NCT00552929|26459758|FG007|Overall Study|Not Eligible|0|||
13282111|NCT00552929|26459759|FG008|Overall Study|Not Eligible|0|||
13282112|NCT00552929|26459760|FG009|Overall Study|Not Eligible|0|||
13282113|NCT00552617|26459833|FG000|Overall Study|Not Treated|0|||
13282114|NCT00552617|26459834|FG001|Overall Study|Not Treated|0|||
13282115|NCT00552617|26459835|FG002|Overall Study|Not Treated|1|||
13282116|NCT00552617|26459836|FG003|Overall Study|Not Treated|0|||
13282117|NCT00552617|26459837|FG004|Overall Study|Not Treated|0|||
13282118|NCT00552617|26459838|FG005|Overall Study|Not Treated|0|||
13282119|NCT00552617|26459839|FG006|Overall Study|Not Treated|0|||
13282120|NCT00552617|26459840|FG007|Overall Study|Not Treated|0|||
13282121|NCT00552617|26459841|FG008|Overall Study|Not Treated|0|||
13282122|NCT00552617|26459842|FG009|Overall Study|Not Treated|1|||
13282123|NCT00552617|26459833|FG000|Overall Study|Lost to Follow-up|0|||
13282124|NCT00552617|26459834|FG001|Overall Study|Lost to Follow-up|0|||
13282125|NCT00552617|26459835|FG002|Overall Study|Lost to Follow-up|0|||
13282126|NCT00552617|26459836|FG003|Overall Study|Lost to Follow-up|1|||
13121312|NCT02982018|25942095|FG000|Overall Study|Lens Discomfort|2|||
13121313|NCT02982018|25942096|FG001|Overall Study|Lens Discomfort|0|||
13121314|NCT02982018|25942095|FG000|Overall Study|Withdrawal by Subject|0|||
13121315|NCT02982018|25942096|FG001|Overall Study|Withdrawal by Subject|1|||
13121316|NCT02981953|25942129|FG000|Overall Study|Death|9|||
13121317|NCT02981953|25942129|FG000|Overall Study|Withdrawal by Subject|1|||
13121318|NCT02981953|25942129|FG000|Overall Study|Withdrawal to non-compliance|1|||
13121319|NCT02981602|25942325|FG000|Overall Study|Adverse Event|0|||
13282127|NCT00552617|26459837|FG004|Overall Study|Lost to Follow-up|0|||
13282128|NCT00552617|26459838|FG005|Overall Study|Lost to Follow-up|2|||
13282129|NCT00552617|26459839|FG006|Overall Study|Lost to Follow-up|0|||
13282130|NCT00552617|26459840|FG007|Overall Study|Lost to Follow-up|0|||
13282131|NCT00552617|26459841|FG008|Overall Study|Lost to Follow-up|2|||
13282132|NCT00552617|26459842|FG009|Overall Study|Lost to Follow-up|0|||
13282133|NCT00552578|26459859|FG000|Overall Study|Lost to Follow-up|1|||
13282134|NCT00552578|26459860|FG001|Overall Study|Lost to Follow-up|1|||
13282135|NCT00552396|26459919|FG000|Overall Study|protocol withdrawal criteria|3|||
13282136|NCT00552396|26459920|FG001|Overall Study|protocol withdrawal criteria|3|||
13282137|NCT00552396|26459921|FG002|Overall Study|protocol withdrawal criteria|3|||
13282138|NCT00552396|26459922|FG003|Overall Study|protocol withdrawal criteria|6|||
13282139|NCT00552396|26459923|FG004|Overall Study|protocol withdrawal criteria|3|||
13282140|NCT00552396|26459924|FG005|Overall Study|protocol withdrawal criteria|3|||
13282141|NCT00552396|26459925|FG006|Overall Study|protocol withdrawal criteria|9|||
13282142|NCT00552344|26459936|FG000|Overall Study|Lack of Efficacy|55|||
13282143|NCT00552344|26459936|FG000|Overall Study|Loss of efficacy|75|||
13282144|NCT00552344|26459936|FG000|Overall Study|Lost to Follow-up|8|||
13282145|NCT00552344|26459936|FG000|Overall Study|Withdrawal by Subject|48|||
13282146|NCT00552344|26459936|FG000|Overall Study|SAE, non-fatal|6|||
13282147|NCT00552344|26459936|FG000|Overall Study|AE, non-serious non-fatal|38|||
13282148|NCT00552344|26459936|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62|||
13282149|NCT00552344|26459936|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1|||
13121320|NCT02981602|25942326|FG001|Overall Study|Adverse Event|0|||
13121321|NCT02981602|25942327|FG002|Overall Study|Adverse Event|0|||
13121322|NCT02981602|25942328|FG003|Overall Study|Adverse Event|1|||
13121323|NCT02981602|25942329|FG004|Overall Study|Adverse Event|0|||
13121324|NCT02981524|25942339|FG000|Overall Study|Progressive Disease|14|||
13121325|NCT02981524|25942339|FG000|Overall Study|Death (unrelated)|1|||
13121326|NCT02981524|25942339|FG000|Overall Study|Treatment Related Toxicity|1|||
13121327|NCT02981524|25942339|FG000|Overall Study|Withdrawal by Subject|1|||
13121328|NCT02981472|25942394|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
13121329|NCT02981472|25942395|FG001|Pre-Treatment Period|Participant withdrew consent|1|||
13121330|NCT02981472|25942394|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
13121331|NCT02981472|25942395|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
13282150|NCT00552344|26459936|FG000|Overall Study|Other Reason|22|||
13282151|NCT00552305|26459946|FG000|Overall Study|Adverse Event|43|||
13121332|NCT02981472|25942394|FG000|Treatment Period|Adverse Event|6|||
13282152|NCT00552305|26459946|FG000|Overall Study|Lack of Efficacy|120|||
13282153|NCT00552305|26459946|FG000|Overall Study|Lost to Follow-up|4|||
13282154|NCT00552305|26459946|FG000|Overall Study|Protocol Violation|3|||
13282155|NCT00552305|26459946|FG000|Overall Study|Withdrawal by Subject|44|||
13282156|NCT00552305|26459946|FG000|Overall Study|Lack of efficacy/withdrew consent|1|||
13282157|NCT00552305|26459946|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3|||
13282158|NCT00552305|26459946|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2|||
13282159|NCT00552305|26459946|FG000|Overall Study|Unsatisfactory compliance|11|||
13282160|NCT00552305|26459946|FG000|Overall Study|Poor compliance/lost to follow-up|1|||
13282161|NCT00552305|26459946|FG000|Overall Study|AE/Other: prohibited drug required|1|||
13282162|NCT00552305|26459946|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1|||
13282163|NCT00552305|26459946|FG000|Overall Study|Other: Site closed|4|||
13282164|NCT00552305|26459946|FG000|Overall Study|Other: Personal problems|1|||
13282165|NCT00552305|26459946|FG000|Overall Study|Other: Unable to attend visits|1|||
13282166|NCT00552305|26459946|FG000|Overall Study|Other: Subject underwent surgery|4|||
13282167|NCT00552305|26459946|FG000|Overall Study|Other: Subject became pregnant|1|||
13282168|NCT00552305|26459946|FG000|Overall Study|Other: Health problems, not drug related|1|||
13282169|NCT00552305|26459946|FG000|Overall Study|Other: Subject moved from area|2|||
13282170|NCT00552305|26459946|FG000|Overall Study|Other: Subject incarcerated|1|||
13282171|NCT00552305|26459946|FG000|Overall Study|Other: Subject went to rehab|1|||
13282172|NCT00552279|26459977|FG000|Overall Study|Adverse Event|0|||
13282173|NCT00552279|26459978|FG001|Overall Study|Adverse Event|1|||
13282174|NCT00552279|26459977|FG000|Overall Study|Withdrawal by Subject|12|||
13282175|NCT00552279|26459978|FG001|Overall Study|Withdrawal by Subject|1|||
13282176|NCT00552279|26459977|FG000|Overall Study|Lost to Follow-up|1|||
13282177|NCT00552279|26459978|FG001|Overall Study|Lost to Follow-up|0|||
13282178|NCT00552279|26459977|FG000|Overall Study|Other|1|||
13282179|NCT00552279|26459978|FG001|Overall Study|Other|1|||
13282180|NCT00552240|26460085|FG000|Overall Study|Adverse Event|9|||
13282181|NCT00552240|26460086|FG001|Overall Study|Adverse Event|9|||
13282182|NCT00552240|26460085|FG000|Overall Study|Protocol Violation|1|||
13282183|NCT00552240|26460086|FG001|Overall Study|Protocol Violation|1|||
13282184|NCT00552240|26460085|FG000|Overall Study|Lost to Follow-up|5|||
13121333|NCT02981472|25942395|FG001|Treatment Period|Adverse Event|1|||
13121334|NCT02981472|25942394|FG000|Treatment Period|Participant withdrew consent|1|||
13121335|NCT02981472|25942395|FG001|Treatment Period|Participant withdrew consent|0|||
13121336|NCT02981472|25942394|FG000|Treatment Period|Lost to Follow-up|0|||
13282185|NCT00552240|26460086|FG001|Overall Study|Lost to Follow-up|6|||
13282186|NCT00552240|26460085|FG000|Overall Study|Withdrawal by Subject|2|||
13282187|NCT00552240|26460086|FG001|Overall Study|Withdrawal by Subject|2|||
13282188|NCT00552240|26460085|FG000|Overall Study|Lack of Efficacy|6|||
13282189|NCT00552240|26460086|FG001|Overall Study|Lack of Efficacy|0|||
13282190|NCT00552240|26460085|FG000|Overall Study|Other|1|||
13282191|NCT00552240|26460086|FG001|Overall Study|Other|0|||
13282192|NCT00552188|26460101|FG000|Overall Study|Adverse Event|0|||
13282193|NCT00552188|26460102|FG001|Overall Study|Adverse Event|2|||
13282194|NCT00552188|26460101|FG000|Overall Study|Lost to Follow-up|2|||
13282195|NCT00552188|26460102|FG001|Overall Study|Lost to Follow-up|1|||
13282196|NCT00552188|26460101|FG000|Overall Study|Withdrawal of consent|0|||
13282197|NCT00552188|26460102|FG001|Overall Study|Withdrawal of consent|1|||
13282198|NCT00552188|26460101|FG000|Overall Study|Subject returned to home country|0|||
13282199|NCT00552188|26460102|FG001|Overall Study|Subject returned to home country|1|||
13282200|NCT00552175|26460147|FG000|Overall Study|Lack of Efficacy|2|||
13282201|NCT00552175|26460148|FG001|Overall Study|Lack of Efficacy|0|||
13282202|NCT00552175|26460149|FG002|Overall Study|Lack of Efficacy|1|||
13282203|NCT00552175|26460147|FG000|Overall Study|Adverse Event|9|||
13282204|NCT00552175|26460148|FG001|Overall Study|Adverse Event|9|||
13282205|NCT00552175|26460149|FG002|Overall Study|Adverse Event|10|||
13282206|NCT00552175|26460147|FG000|Overall Study|Withdrawal by Subject|2|||
13282207|NCT00552175|26460148|FG001|Overall Study|Withdrawal by Subject|2|||
13282208|NCT00552175|26460149|FG002|Overall Study|Withdrawal by Subject|1|||
13282209|NCT00552175|26460147|FG000|Overall Study|Lost to Follow-up|0|||
13282210|NCT00552175|26460148|FG001|Overall Study|Lost to Follow-up|0|||
13282211|NCT00552175|26460149|FG002|Overall Study|Lost to Follow-up|1|||
13121337|NCT02981472|25942395|FG001|Treatment Period|Lost to Follow-up|1|||
13282212|NCT00552175|26460147|FG000|Overall Study|Entry Criteria Not Met|1|||
13282213|NCT00552175|26460148|FG001|Overall Study|Entry Criteria Not Met|1|||
13282214|NCT00552175|26460149|FG002|Overall Study|Entry Criteria Not Met|0|||
13282215|NCT00552175|26460147|FG000|Overall Study|Reason Not Specified|3|||
13282216|NCT00552175|26460148|FG001|Overall Study|Reason Not Specified|1|||
13282217|NCT00552175|26460149|FG002|Overall Study|Reason Not Specified|1|||
13282218|NCT00552110|26460182|FG000|Overall Study|Serious or Life-Threatening AE|0|||
13282219|NCT00552110|26460183|FG001|Overall Study|Serious or Life-Threatening AE|0|||
13282220|NCT00552110|26460184|FG002|Overall Study|Serious or Life-Threatening AE|1|||
13282221|NCT00552110|26460185|FG003|Overall Study|Serious or Life-Threatening AE|0|||
13282222|NCT00552110|26460186|FG004|Overall Study|Serious or Life-Threatening AE|0|||
13282223|NCT00552110|26460182|FG000|Overall Study|Lack of Efficacy|1|||
13282224|NCT00552110|26460183|FG001|Overall Study|Lack of Efficacy|0|||
13282225|NCT00552110|26460184|FG002|Overall Study|Lack of Efficacy|0|||
13282226|NCT00552110|26460185|FG003|Overall Study|Lack of Efficacy|1|||
13282227|NCT00552110|26460186|FG004|Overall Study|Lack of Efficacy|4|||
13282228|NCT00552110|26460182|FG000|Overall Study|Withdrawal by Subject|0|||
13282229|NCT00552110|26460183|FG001|Overall Study|Withdrawal by Subject|2|||
13282230|NCT00552110|26460184|FG002|Overall Study|Withdrawal by Subject|0|||
13282231|NCT00552110|26460185|FG003|Overall Study|Withdrawal by Subject|3|||
13282232|NCT00552110|26460186|FG004|Overall Study|Withdrawal by Subject|2|||
13282233|NCT00552110|26460182|FG000|Overall Study|Lost to Follow-up|0|||
13282234|NCT00552110|26460183|FG001|Overall Study|Lost to Follow-up|0|||
13282235|NCT00552110|26460184|FG002|Overall Study|Lost to Follow-up|0|||
13282236|NCT00552110|26460185|FG003|Overall Study|Lost to Follow-up|1|||
13282237|NCT00552110|26460186|FG004|Overall Study|Lost to Follow-up|1|||
13282238|NCT00552110|26460182|FG000|Overall Study|Failed to Comply With Study Requirements|1|||
13282239|NCT00552110|26460183|FG001|Overall Study|Failed to Comply With Study Requirements|1|||
13282240|NCT00552110|26460184|FG002|Overall Study|Failed to Comply With Study Requirements|1|||
13282241|NCT00552110|26460185|FG003|Overall Study|Failed to Comply With Study Requirements|0|||
13282242|NCT00552110|26460186|FG004|Overall Study|Failed to Comply With Study Requirements|1|||
13282243|NCT00552110|26460182|FG000|Overall Study|Withdrawn per Sponsor|0|||
13282244|NCT00552110|26460183|FG001|Overall Study|Withdrawn per Sponsor|1|||
13282245|NCT00552110|26460184|FG002|Overall Study|Withdrawn per Sponsor|0|||
13282246|NCT00552110|26460185|FG003|Overall Study|Withdrawn per Sponsor|0|||
13282247|NCT00552110|26460186|FG004|Overall Study|Withdrawn per Sponsor|1|||
13282248|NCT00552110|26460182|FG000|Overall Study|Use of Prohibited Medication|1|||
13282249|NCT00552110|26460183|FG001|Overall Study|Use of Prohibited Medication|1|||
13282250|NCT00552110|26460184|FG002|Overall Study|Use of Prohibited Medication|0|||
13282251|NCT00552110|26460185|FG003|Overall Study|Use of Prohibited Medication|0|||
13282252|NCT00552110|26460186|FG004|Overall Study|Use of Prohibited Medication|0|||
13282253|NCT00552110|26460182|FG000|Overall Study|Delay of Study due to Relabeling|0|||
13282254|NCT00552110|26460183|FG001|Overall Study|Delay of Study due to Relabeling|0|||
13282255|NCT00552110|26460184|FG002|Overall Study|Delay of Study due to Relabeling|0|||
13282256|NCT00552110|26460185|FG003|Overall Study|Delay of Study due to Relabeling|1|||
13282257|NCT00552110|26460186|FG004|Overall Study|Delay of Study due to Relabeling|0|||
13282258|NCT00552110|26460182|FG000|Overall Study|Increased Blood Pressure at Visit 2|0|||
13282259|NCT00552110|26460183|FG001|Overall Study|Increased Blood Pressure at Visit 2|0|||
13282260|NCT00552110|26460184|FG002|Overall Study|Increased Blood Pressure at Visit 2|0|||
13282261|NCT00552110|26460185|FG003|Overall Study|Increased Blood Pressure at Visit 2|1|||
13282262|NCT00552110|26460186|FG004|Overall Study|Increased Blood Pressure at Visit 2|0|||
13282263|NCT00552110|26460182|FG000|Overall Study|Nonserious Adverse Event (AE)|1|||
13282264|NCT00552110|26460183|FG001|Overall Study|Nonserious Adverse Event (AE)|0|||
13282265|NCT00552110|26460184|FG002|Overall Study|Nonserious Adverse Event (AE)|0|||
13282266|NCT00552110|26460185|FG003|Overall Study|Nonserious Adverse Event (AE)|1|||
13121338|NCT02981342|25942449|FG000|Overall Study|Adverse Event|0|||
13121339|NCT02981342|25942450|FG001|Overall Study|Adverse Event|0|||
13121340|NCT02981342|25942451|FG002|Overall Study|Adverse Event|0|||
13121341|NCT02981342|25942452|FG003|Overall Study|Adverse Event|1|||
13121342|NCT02981342|25942449|FG000|Overall Study|Death|0|||
13121343|NCT02981342|25942450|FG001|Overall Study|Death|9|||
13121344|NCT02981342|25942451|FG002|Overall Study|Death|9|||
13121345|NCT02981342|25942452|FG003|Overall Study|Death|4|||
13282267|NCT00552110|26460186|FG004|Overall Study|Nonserious Adverse Event (AE)|0|||
13282268|NCT00552084|26460199|FG000|Overall Study|Adverse Event|2|||
13282269|NCT00552084|26460200|FG001|Overall Study|Adverse Event|3|||
13282270|NCT00552084|26460199|FG000|Overall Study|Withdrawal by Subject|4|||
13282271|NCT00552084|26460200|FG001|Overall Study|Withdrawal by Subject|5|||
13121346|NCT02981342|25942449|FG000|Overall Study|Withdrawal by Subject|0|||
13121347|NCT02981342|25942450|FG001|Overall Study|Withdrawal by Subject|0|||
13282272|NCT00552084|26460199|FG000|Overall Study|Protocol Violation|1|||
13282273|NCT00552084|26460200|FG001|Overall Study|Protocol Violation|0|||
13121348|NCT02981342|25942451|FG002|Overall Study|Withdrawal by Subject|3|||
13282274|NCT00552084|26460199|FG000|Overall Study|change in anti-arrythmic drug|1|||
13282275|NCT00552084|26460200|FG001|Overall Study|change in anti-arrythmic drug|1|||
13282276|NCT00552071|26460215|FG000|Overall Study|Adverse Event|1|||
13282277|NCT00552071|26460216|FG001|Overall Study|Adverse Event|0|||
13282278|NCT00552071|26460215|FG000|Overall Study|Lack of Efficacy|1|||
13282279|NCT00552071|26460216|FG001|Overall Study|Lack of Efficacy|0|||
13282280|NCT00552071|26460215|FG000|Overall Study|Physician Decision|1|||
13282281|NCT00552071|26460216|FG001|Overall Study|Physician Decision|0|||
13282282|NCT00552071|26460215|FG000|Overall Study|Pregnancy|1|||
13282283|NCT00552071|26460216|FG001|Overall Study|Pregnancy|0|||
13282284|NCT00552071|26460215|FG000|Overall Study|Death|0|||
13282285|NCT00552071|26460216|FG001|Overall Study|Death|1|||
13282286|NCT00552071|26460215|FG000|Overall Study|Withdrawal by Subject|0|||
13282287|NCT00552071|26460216|FG001|Overall Study|Withdrawal by Subject|1|||
13282288|NCT00552058|26460261|FG000|Overall Study|Adverse Event|8|||
13282289|NCT00552058|26460262|FG001|Overall Study|Adverse Event|7|||
13282290|NCT00552058|26460261|FG000|Overall Study|Lack of Efficacy|1|||
13282291|NCT00552058|26460262|FG001|Overall Study|Lack of Efficacy|5|||
13282292|NCT00552058|26460261|FG000|Overall Study|Lost to Follow-up|1|||
13282293|NCT00552058|26460262|FG001|Overall Study|Lost to Follow-up|0|||
13282294|NCT00552058|26460261|FG000|Overall Study|Withdrawal by Subject|4|||
13282295|NCT00552058|26460262|FG001|Overall Study|Withdrawal by Subject|4|||
13282296|NCT00552058|26460261|FG000|Overall Study|Other: Protocol Violation|0|||
13282297|NCT00552058|26460262|FG001|Overall Study|Other: Protocol Violation|1|||
13282298|NCT00552058|26460261|FG000|Overall Study|Other: Non Compliance|1|||
13282299|NCT00552058|26460262|FG001|Overall Study|Other: Non Compliance|2|||
13282300|NCT00552058|26460261|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0|||
13282301|NCT00552058|26460262|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1|||
13282302|NCT00552058|26460261|FG000|Overall Study|Other: Low CDAI score, entry violation|0|||
13282303|NCT00552058|26460262|FG001|Overall Study|Other: Low CDAI score, entry violation|1|||
13282304|NCT00552058|26460261|FG000|Overall Study|Other: Positive Stool Result|0|||
13282305|NCT00552058|26460262|FG001|Overall Study|Other: Positive Stool Result|1|||
13282306|NCT00552058|26460261|FG000|Overall Study|Other: Randomized in error|0|||
13282307|NCT00552058|26460262|FG001|Overall Study|Other: Randomized in error|1|||
13282308|NCT00552058|26460261|FG000|Overall Study|Other: Sponsors Decision|0|||
13282309|NCT00552058|26460262|FG001|Overall Study|Other: Sponsors Decision|1|||
13282310|NCT00552058|26460261|FG000|Overall Study|Other: Early Roll Over|1|||
13282311|NCT00552058|26460262|FG001|Overall Study|Other: Early Roll Over|0|||
13282312|NCT00551759|26460268|FG000|Overall Study|Adverse Event|7|||
13282313|NCT00551759|26460268|FG000|Overall Study|Death|5|||
13282314|NCT00551759|26460268|FG000|Overall Study|Ineligible|1|||
13282315|NCT00551642|26460285|FG000|Treatment Period|Protocol Deviation|6|||
13282316|NCT00551642|26460286|FG001|Treatment Period|Protocol Deviation|11|||
13282317|NCT00551642|26460285|FG000|Treatment Period|Delivery device failure|1|||
13282318|NCT00551642|26460286|FG001|Treatment Period|Delivery device failure|3|||
13282319|NCT00551642|26460285|FG000|Treatment Period|Physician Decision|0|||
13282320|NCT00551642|26460286|FG001|Treatment Period|Physician Decision|1|||
13282321|NCT00551642|26460285|FG000|Treatment Period|Death|33|||
13282322|NCT00551642|26460286|FG001|Treatment Period|Death|31|||
13282323|NCT00551642|26460285|FG000|Treatment Period|Inclusion/Exclusion criteria|4|||
13282324|NCT00551642|26460286|FG001|Treatment Period|Inclusion/Exclusion criteria|4|||
13121349|NCT02981342|25942452|FG003|Overall Study|Withdrawal by Subject|1|||
13282325|NCT00551642|26460285|FG000|Treatment Period|Adverse Event|15|||
13121350|NCT02981342|25942449|FG000|Overall Study|Study closed by sponsor|0|||
13282326|NCT00551642|26460286|FG001|Treatment Period|Adverse Event|12|||
13282327|NCT00551642|26460285|FG000|Treatment Period|Withdrawal by Subject|2|||
13282328|NCT00551642|26460286|FG001|Treatment Period|Withdrawal by Subject|1|||
13282329|NCT00551525|26460297|FG000|Overall Study|Protocol Violation|5|||
13282330|NCT00551421|26460306|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1|||
13282331|NCT00551369|26460317|FG000|Overall Study|Protocol Violation|5|||
13282332|NCT00551369|26460317|FG000|Overall Study|Withdrawal by Subject|1|||
13121351|NCT02981342|25942450|FG001|Overall Study|Study closed by sponsor|0|||
13121352|NCT02981342|25942451|FG002|Overall Study|Study closed by sponsor|1|||
13121353|NCT02981342|25942452|FG003|Overall Study|Study closed by sponsor|1|||
13121354|NCT02981342|25942449|FG000|Overall Study|Randomized, Never Treated|0|||
13121355|NCT02981342|25942450|FG001|Overall Study|Randomized, Never Treated|1|||
13121356|NCT02981342|25942451|FG002|Overall Study|Randomized, Never Treated|0|||
13121357|NCT02981342|25942452|FG003|Overall Study|Randomized, Never Treated|7|||
13121358|NCT02981342|25942449|FG000|Overall Study|Lost to Follow-up|0|||
13121359|NCT02981342|25942450|FG001|Overall Study|Lost to Follow-up|1|||
13121360|NCT02981342|25942451|FG002|Overall Study|Lost to Follow-up|0|||
13121361|NCT02981342|25942452|FG003|Overall Study|Lost to Follow-up|0|||
13121362|NCT02981082|25942473|FG000|Overall Study|Withdrawal by Subject|2|||
13121363|NCT02981082|25942474|FG001|Overall Study|Withdrawal by Subject|0|||
13121364|NCT02981082|25942473|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1|||
13121365|NCT02981082|25942474|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0|||
13121366|NCT02981082|25942473|FG000|Overall Study|Adverse Event|0|||
13121367|NCT02981082|25942474|FG001|Overall Study|Adverse Event|1|||
13121368|NCT02980874|25942491|FG000|Overall Study|Adverse Event|2|||
13121369|NCT02980874|25942492|FG001|Overall Study|Adverse Event|7|||
13121370|NCT02980874|25942491|FG000|Overall Study|Withdrawal by Subject|7|||
13121371|NCT02980874|25942492|FG001|Overall Study|Withdrawal by Subject|2|||
13121372|NCT02980874|25942491|FG000|Overall Study|Lost to Follow-up|5|||
13121373|NCT02980874|25942492|FG001|Overall Study|Lost to Follow-up|5|||
13282333|NCT00551369|26460317|FG000|Overall Study|Not treated per protocol and re|1|||
13121374|NCT02980874|25942491|FG000|Overall Study|Includes premature discontinuation due to study termination.|88|||
13121375|NCT02980874|25942492|FG001|Overall Study|Includes premature discontinuation due to study termination.|88|||
13121376|NCT02980874|25942491|FG000|Overall Study|Unknown study completion status|1|||
13121377|NCT02980874|25942492|FG001|Overall Study|Unknown study completion status|0|||
13121378|NCT02980783|25942505|FG000|Overall Study|Lost to Follow-up|1|||
13121379|NCT02980705|25942521|FG000|Overall Study|Adverse Event|0|||
13121380|NCT02980705|25942522|FG001|Overall Study|Adverse Event|1|||
13121381|NCT02980705|25942521|FG000|Overall Study|Withdrawal by Subject|6|||
13121382|NCT02980705|25942522|FG001|Overall Study|Withdrawal by Subject|9|||
13121383|NCT02980705|25942521|FG000|Overall Study|withdrew participation|0|||
13121384|NCT02980705|25942522|FG001|Overall Study|withdrew participation|1|||
13121385|NCT02980705|25942521|FG000|Overall Study|Lost to Follow-up|2|||
13121386|NCT02980705|25942522|FG001|Overall Study|Lost to Follow-up|0|||
13121387|NCT02980601|25942617|FG000|Overall Study|Lost to Follow-up|2|||
13121388|NCT02980601|25942618|FG001|Overall Study|Lost to Follow-up|2|||
13121389|NCT02980601|25942617|FG000|Overall Study|Death|0|||
13121390|NCT02980601|25942618|FG001|Overall Study|Death|1|||
13121391|NCT02980601|25942617|FG000|Overall Study|Graft loss|1|||
13121392|NCT02980601|25942618|FG001|Overall Study|Graft loss|0|||
13121393|NCT02980601|25942617|FG000|Overall Study|Failed to sign consent|2|||
13121394|NCT02980601|25942618|FG001|Overall Study|Failed to sign consent|0|||
13121395|NCT02980523|25942676|FG000|Overall Study|Lost to Follow-up|1|||
13121396|NCT02980523|25942677|FG001|Overall Study|Lost to Follow-up|4|||
13121397|NCT02980523|25942678|FG002|Overall Study|Lost to Follow-up|1|||
13121398|NCT02980523|25942679|FG003|Overall Study|Lost to Follow-up|2|||
13121399|NCT02980523|25942680|FG004|Overall Study|Lost to Follow-up|1|||
13121400|NCT02980523|25942676|FG000|Overall Study|Excluded from analysis|1|||
13121401|NCT02980523|25942677|FG001|Overall Study|Excluded from analysis|3|||
13121402|NCT02980523|25942678|FG002|Overall Study|Excluded from analysis|1|||
13121403|NCT02980523|25942679|FG003|Overall Study|Excluded from analysis|1|||
13121404|NCT02980523|25942680|FG004|Overall Study|Excluded from analysis|1|||
13121405|NCT02980523|25942676|FG000|Overall Study|Lack of Efficacy|1|||
13121406|NCT02980523|25942677|FG001|Overall Study|Lack of Efficacy|4|||
13121407|NCT02980523|25942678|FG002|Overall Study|Lack of Efficacy|4|||
13121408|NCT02980523|25942679|FG003|Overall Study|Lack of Efficacy|5|||
13121409|NCT02980523|25942680|FG004|Overall Study|Lack of Efficacy|8|||
13121410|NCT02980523|25942676|FG000|Overall Study|Did not receive intervention|0|||
13282334|NCT00551291|26460325|FG000|Overall Study|Physician Decision|1|||
13282335|NCT00551213|26460348|FG000|Overall Study|Adverse Event|6|||
13282336|NCT00551213|26460349|FG001|Overall Study|Adverse Event|3|||
13282337|NCT00551213|26460348|FG000|Overall Study|Progressive Disease|41|||
13282338|NCT00551213|26460349|FG001|Overall Study|Progressive Disease|12|||
13121411|NCT02980523|25942677|FG001|Overall Study|Did not receive intervention|0|||
13121412|NCT02980523|25942678|FG002|Overall Study|Did not receive intervention|0|||
13282339|NCT00551213|26460348|FG000|Overall Study|Withdrawal by Subject|2|||
13282340|NCT00551213|26460349|FG001|Overall Study|Withdrawal by Subject|0|||
13282341|NCT00551213|26460348|FG000|Overall Study|Not Treated|1|||
13282342|NCT00551213|26460349|FG001|Overall Study|Not Treated|2|||
13282343|NCT00551161|26460355|FG000|Overall Study|Withdrawal by Subject|1|||
13282344|NCT00551031|26460398|FG000|Overall Study|Adverse Event|0|||
13282345|NCT00551031|26460399|FG001|Overall Study|Adverse Event|1|||
13282346|NCT00551031|26460400|FG002|Overall Study|Adverse Event|0|||
13282347|NCT00551031|26460401|FG003|Overall Study|Adverse Event|0|||
13282348|NCT00551031|26460402|FG004|Overall Study|Adverse Event|0|||
13282349|NCT00551031|26460398|FG000|Overall Study|Protocol Violation|1|||
13282350|NCT00551031|26460399|FG001|Overall Study|Protocol Violation|1|||
13282351|NCT00551031|26460400|FG002|Overall Study|Protocol Violation|0|||
13282352|NCT00551031|26460401|FG003|Overall Study|Protocol Violation|0|||
13282353|NCT00551031|26460402|FG004|Overall Study|Protocol Violation|0|||
13282354|NCT00551031|26460398|FG000|Overall Study|Lost to Follow-up|0|||
13282355|NCT00551031|26460399|FG001|Overall Study|Lost to Follow-up|1|||
13282356|NCT00551031|26460400|FG002|Overall Study|Lost to Follow-up|0|||
13282357|NCT00551031|26460401|FG003|Overall Study|Lost to Follow-up|1|||
13282358|NCT00551031|26460402|FG004|Overall Study|Lost to Follow-up|1|||
13282359|NCT00551031|26460398|FG000|Overall Study|Withdrawal by Subject|0|||
13282360|NCT00551031|26460399|FG001|Overall Study|Withdrawal by Subject|4|||
13282361|NCT00551031|26460400|FG002|Overall Study|Withdrawal by Subject|1|||
13282362|NCT00551031|26460401|FG003|Overall Study|Withdrawal by Subject|2|||
13282363|NCT00551031|26460402|FG004|Overall Study|Withdrawal by Subject|0|||
13282364|NCT00551031|26460398|FG000|Overall Study|Serious Adverse Event|0|||
13282365|NCT00551031|26460399|FG001|Overall Study|Serious Adverse Event|2|||
13282366|NCT00551031|26460400|FG002|Overall Study|Serious Adverse Event|1|||
13282367|NCT00551031|26460401|FG003|Overall Study|Serious Adverse Event|0|||
13282368|NCT00551031|26460402|FG004|Overall Study|Serious Adverse Event|0|||
13282369|NCT00551031|26460398|FG000|Overall Study|Did not receive vaccine|1|||
13282370|NCT00551031|26460399|FG001|Overall Study|Did not receive vaccine|2|||
13121413|NCT02980523|25942679|FG003|Overall Study|Did not receive intervention|1|||
13121414|NCT02980523|25942680|FG004|Overall Study|Did not receive intervention|0|||
13121415|NCT02980224|25942697|FG000|Overall Study|Adverse Event|4|||
13121416|NCT02980224|25942698|FG001|Overall Study|Adverse Event|1|||
13121417|NCT02980224|25942697|FG000|Overall Study|Withdrawal by Subject|0|||
13121418|NCT02980224|25942698|FG001|Overall Study|Withdrawal by Subject|2|||
13121419|NCT02980133|25942747|FG000|Overall Study|Other than specified|1|||
13121420|NCT02980133|25942748|FG001|Overall Study|Other than specified|1|||
13121421|NCT02980133|25942749|FG002|Overall Study|Other than specified|2|||
13121422|NCT02980133|25942750|FG003|Overall Study|Other than specified|2|||
13121423|NCT02980133|25942747|FG000|Overall Study|Lost to Follow-up|0|||
13121424|NCT02980133|25942748|FG001|Overall Study|Lost to Follow-up|0|||
13121425|NCT02980133|25942749|FG002|Overall Study|Lost to Follow-up|1|||
13121426|NCT02980133|25942750|FG003|Overall Study|Lost to Follow-up|3|||
13121427|NCT02980133|25942747|FG000|Overall Study|Protocol Violation|0|||
13121428|NCT02980133|25942748|FG001|Overall Study|Protocol Violation|1|||
13121429|NCT02980133|25942749|FG002|Overall Study|Protocol Violation|0|||
13121430|NCT02980133|25942750|FG003|Overall Study|Protocol Violation|0|||
13121431|NCT02980133|25942747|FG000|Overall Study|Withdrawal by parent/guardian|6|||
13121432|NCT02980133|25942748|FG001|Overall Study|Withdrawal by parent/guardian|3|||
13121433|NCT02980133|25942749|FG002|Overall Study|Withdrawal by parent/guardian|3|||
13121434|NCT02980133|25942750|FG003|Overall Study|Withdrawal by parent/guardian|1|||
13121435|NCT02980133|25942747|FG000|Overall Study|Withdrawal by Subject|0|||
13121436|NCT02980133|25942748|FG001|Overall Study|Withdrawal by Subject|0|||
13121437|NCT02980133|25942749|FG002|Overall Study|Withdrawal by Subject|1|||
13121438|NCT02980133|25942750|FG003|Overall Study|Withdrawal by Subject|0|||
13121439|NCT02980107|25942769|FG000|Overall Study|Withdrawal by Subject|51|||
13121440|NCT02980107|25942770|FG001|Overall Study|Withdrawal by Subject|62|||
13121441|NCT02980042|25942866|FG000|Overall Study|Lost to Follow-up|5|||
13121442|NCT02980042|25942867|FG001|Overall Study|Lost to Follow-up|0|||
13121443|NCT02980042|25942866|FG000|Overall Study|Insurance issues/treatment plan changes|2|||
13121444|NCT02980042|25942867|FG001|Overall Study|Insurance issues/treatment plan changes|0|||
13121445|NCT02979639|25942899|FG000|Overall Study|Withdrawal based on medical judgement|1|||
13121446|NCT02979639|25942899|FG000|Overall Study|Lost to Follow-up|8|||
13121447|NCT02979639|25942899|FG000|Overall Study|Withdrawal by Subject|3|||
13282371|NCT00551031|26460400|FG002|Overall Study|Did not receive vaccine|0|||
13121448|NCT02979639|25942899|FG000|Overall Study|Adverse Event|2|||
13121449|NCT02979613|25942964|FG000|Double-Blind Phase|Withdrew Consent|2|||
13121450|NCT02979613|25942965|FG001|Double-Blind Phase|Withdrew Consent|4|||
13121451|NCT02979613|25942964|FG000|Double-Blind Phase|Pregnancy|2|||
13121452|NCT02979613|25942965|FG001|Double-Blind Phase|Pregnancy|2|||
13121453|NCT02979613|25942964|FG000|Double-Blind Phase|Adverse Event|2|||
13282372|NCT00551031|26460401|FG003|Overall Study|Did not receive vaccine|0|||
13282373|NCT00551031|26460402|FG004|Overall Study|Did not receive vaccine|0|||
13282374|NCT00550953|26460429|FG000|Overall Study|Adverse Event|4|||
13282375|NCT00550953|26460430|FG001|Overall Study|Adverse Event|3|||
13121454|NCT02979613|25942965|FG001|Double-Blind Phase|Adverse Event|0|||
13121455|NCT02979613|25942964|FG000|Double-Blind Phase|Lost to Follow-up|1|||
13121456|NCT02979613|25942965|FG001|Double-Blind Phase|Lost to Follow-up|1|||
13282376|NCT00550953|26460429|FG000|Overall Study|Not able to visit the site|2|||
13282377|NCT00550953|26460430|FG001|Overall Study|Not able to visit the site|3|||
13282378|NCT00550836|26460451|FG000|Overall Study|Withdrawal by Subject|3|||
13282379|NCT00550836|26460452|FG001|Overall Study|Withdrawal by Subject|9|||
13282380|NCT00550771|26460471|FG000|Overall Study|Adverse Event|11|||
13282381|NCT00550771|26460472|FG001|Overall Study|Adverse Event|3|||
13282382|NCT00550771|26460471|FG000|Overall Study|Discontinued for study-related reasons|0|||
13282383|NCT00550771|26460472|FG001|Overall Study|Discontinued for study-related reasons|1|||
13282384|NCT00550771|26460471|FG000|Overall Study|Physician Decision|2|||
13282385|NCT00550771|26460472|FG001|Overall Study|Physician Decision|0|||
13282386|NCT00550771|26460471|FG000|Overall Study|Withdrawal by Subject|0|||
13282387|NCT00550771|26460472|FG001|Overall Study|Withdrawal by Subject|1|||
13282388|NCT00550771|26460471|FG000|Overall Study|Protocol Violation|4|||
13282389|NCT00550771|26460472|FG001|Overall Study|Protocol Violation|5|||
13282390|NCT00550732|26460485|FG000|Overall Study|Death|4|||
13282391|NCT00550732|26460485|FG000|Overall Study|Withdrawal by Subject|2|||
13282392|NCT00550732|26460485|FG000|Overall Study|Physician Decision|2|||
13282393|NCT00550732|26460485|FG000|Overall Study|Lost to Follow-up|1|||
13282394|NCT00550732|26460485|FG000|Overall Study|Palliative care|1|||
13282395|NCT00550732|26460485|FG000|Overall Study|Adverse Event|1|||
13282396|NCT00550680|26460496|FG000|Overall Study|Administrative Reasons|1|||
13282397|NCT00550680|26460496|FG000|Overall Study|Adverse Event|5|||
13282398|NCT00550680|26460496|FG000|Overall Study|Death|3|||
13282399|NCT00550680|26460496|FG000|Overall Study|Early Improvement|1|||
13121457|NCT02979613|25942964|FG000|Double-Blind Phase|Protocol Violation|1|||
13282400|NCT00550680|26460496|FG000|Overall Study|Lost to Follow-up|3|||
13282401|NCT00550680|26460496|FG000|Overall Study|Lack of Efficacy|1|||
13282402|NCT00550680|26460496|FG000|Overall Study|Other|10|||
13282403|NCT00550680|26460496|FG000|Overall Study|Protocol Violation|7|||
13282404|NCT00550680|26460496|FG000|Overall Study|Refused Treatment|19|||
13282405|NCT00550680|26460496|FG000|Overall Study|Screen Failure|6|||
13282406|NCT00550550|26460515|FG000|Overall Study|Adverse Event|13|||
13282407|NCT00550550|26460516|FG001|Overall Study|Adverse Event|5|||
13282408|NCT00550550|26460515|FG000|Overall Study|Treatment Failure|0|||
13282409|NCT00550550|26460516|FG001|Overall Study|Treatment Failure|1|||
13282410|NCT00550550|26460515|FG000|Overall Study|Lost to Follow-up|4|||
13282411|NCT00550550|26460516|FG001|Overall Study|Lost to Follow-up|0|||
13282412|NCT00550550|26460515|FG000|Overall Study|Withdrawal by Subject|10|||
13282413|NCT00550550|26460516|FG001|Overall Study|Withdrawal by Subject|8|||
13282414|NCT00550550|26460515|FG000|Overall Study|Protocol Violation|5|||
13282415|NCT00550550|26460516|FG001|Overall Study|Protocol Violation|14|||
13282416|NCT00550550|26460515|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
13282417|NCT00550550|26460516|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
13282418|NCT00550550|26460515|FG000|Overall Study|Randomized But Not Treated|1|||
13282419|NCT00550550|26460516|FG001|Overall Study|Randomized But Not Treated|0|||
13282420|NCT00550537|26460533|FG000|Overall Study|Death|18|||
13282421|NCT00550537|26460533|FG000|Overall Study|Adverse Event|20|||
13282422|NCT00550537|26460533|FG000|Overall Study|Disease progression before|46|||
13282423|NCT00550537|26460533|FG000|Overall Study|Withdrawal by Subject|7|||
13282424|NCT00550537|26460533|FG000|Overall Study|Change in treatment plan|4|||
13282425|NCT00550537|26460533|FG000|Overall Study|Other complicating ilness|3|||
13282426|NCT00550537|26460533|FG000|Overall Study|Declining performance status|2|||
13282427|NCT00550537|26460533|FG000|Overall Study|Treated closer to home|4|||
13282428|NCT00550420|26460556|FG000|Overall Study|Adverse Event|28|||
13282429|NCT00550420|26460556|FG000|Overall Study|Lost to Follow-up|8|||
13282430|NCT00550420|26460556|FG000|Overall Study|Protocol Violation|11|||
13282431|NCT00550420|26460556|FG000|Overall Study|Withdrawal by Subject|30|||
13282432|NCT00550420|26460556|FG000|Overall Study|Still in study at termination|206|||
13282433|NCT00550420|26460556|FG000|Overall Study|Missing|2|||
13282434|NCT00550420|26460556|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12|||
13282435|NCT00550420|26460556|FG000|Overall Study|Investigators opinion|1|||
13282436|NCT00550420|26460556|FG000|Overall Study|Lack of curative effect|1|||
13282437|NCT00550420|26460556|FG000|Overall Study|Unethical stop of enrollment|2|||
13282438|NCT00550420|26460556|FG000|Overall Study|Caregiver's decision to withdraw|1|||
13282439|NCT00550420|26460556|FG000|Overall Study|Out of Electrocardiogram criteria|1|||
13282440|NCT00550420|26460556|FG000|Overall Study|Exclusion criteria|1|||
13282441|NCT00550420|26460556|FG000|Overall Study|Prohibited medicine|1|||
13291922|NCT00709956|26483920|FG000|Overall Study|Withdrawal by Subject|1|||
13291923|NCT00709956|26483921|FG001|Overall Study|Withdrawal by Subject|1|||
13291924|NCT00709956|26483920|FG000|Overall Study|Inclusion/exclusion criteria violation|2|||
13291925|NCT00709956|26483921|FG001|Overall Study|Inclusion/exclusion criteria violation|3|||
13291926|NCT00709852|26484077|FG000|Period 1|Adverse Event|2|||
13121458|NCT02979613|25942965|FG001|Double-Blind Phase|Protocol Violation|1|||
13291927|NCT00709852|26484078|FG001|Period 1|Adverse Event|0|||
13282442|NCT00550173|26460595|FG000|Overall Study|Death|45|||
13282443|NCT00550173|26460596|FG001|Overall Study|Death|38|||
13282444|NCT00550173|26460597|FG002|Overall Study|Death|50|||
13282445|NCT00550173|26460595|FG000|Overall Study|Physician Decision|1|||
13282446|NCT00550173|26460596|FG001|Overall Study|Physician Decision|2|||
13282447|NCT00550173|26460597|FG002|Overall Study|Physician Decision|2|||
13282448|NCT00550173|26460595|FG000|Overall Study|Withdrawal by Subject|9|||
13282449|NCT00550173|26460596|FG001|Overall Study|Withdrawal by Subject|12|||
13282450|NCT00550173|26460597|FG002|Overall Study|Withdrawal by Subject|17|||
13282451|NCT00550173|26460595|FG000|Overall Study|Sponsor Decision|13|||
13282452|NCT00550173|26460596|FG001|Overall Study|Sponsor Decision|7|||
13282453|NCT00550173|26460597|FG002|Overall Study|Sponsor Decision|1|||
13282454|NCT00550173|26460595|FG000|Overall Study|Lost to Follow-up|4|||
13282455|NCT00550173|26460596|FG001|Overall Study|Lost to Follow-up|4|||
13282456|NCT00550173|26460597|FG002|Overall Study|Lost to Follow-up|3|||
13282457|NCT00550147|26460617|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4|||
13282458|NCT00550147|26460617|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2|||
13282459|NCT00550147|26460617|FG000|Quetiapine Addition Treatment Period|Adverse Event|3|||
13282460|NCT00550147|26460617|FG000|Quetiapine Addition Treatment Period|Noncompliance|2|||
13282461|NCT00550147|26460617|FG000|Quetiapine Addition Treatment Period|Moved out of state|1|||
13282462|NCT00550043|26460685|FG000|Overall Study|Adverse Event|0|||
13282463|NCT00550043|26460686|FG001|Overall Study|Adverse Event|0|||
13282464|NCT00550043|26460687|FG002|Overall Study|Adverse Event|0|||
13282465|NCT00550043|26460688|FG003|Overall Study|Adverse Event|1|||
13282466|NCT00550043|26460689|FG004|Overall Study|Adverse Event|1|||
13282467|NCT00550043|26460685|FG000|Overall Study|Subject Withdrew Consent|0|||
13282468|NCT00550043|26460686|FG001|Overall Study|Subject Withdrew Consent|2|||
13282469|NCT00550043|26460687|FG002|Overall Study|Subject Withdrew Consent|1|||
13282470|NCT00550043|26460688|FG003|Overall Study|Subject Withdrew Consent|0|||
13282471|NCT00550043|26460689|FG004|Overall Study|Subject Withdrew Consent|0|||
13282472|NCT00550043|26460685|FG000|Overall Study|Other Reasons- Unspecified|0|||
13282473|NCT00550043|26460686|FG001|Overall Study|Other Reasons- Unspecified|1|||
13282474|NCT00550043|26460687|FG002|Overall Study|Other Reasons- Unspecified|0|||
13282475|NCT00550043|26460688|FG003|Overall Study|Other Reasons- Unspecified|1|||
13282476|NCT00550043|26460689|FG004|Overall Study|Other Reasons- Unspecified|0|||
13282477|NCT00554190|26460716|FG000|Overall Study|Termination forms not completed|10|||
13282478|NCT00556374|26460741|FG000|Overall Study|Withdrawal by Subject|190|||
13282479|NCT00556374|26460742|FG001|Overall Study|Withdrawal by Subject|172|||
13282480|NCT00556374|26460741|FG000|Overall Study|Death|50|||
13282481|NCT00556374|26460742|FG001|Overall Study|Death|43|||
13282482|NCT00556374|26460741|FG000|Overall Study|Lost to Follow-up|7|||
13282483|NCT00556374|26460742|FG001|Overall Study|Lost to Follow-up|5|||
13282484|NCT00555321|26461060|FG000|Treatment Phase up to 12-months|Adverse Event|6|||
13282485|NCT00555321|26461061|FG001|Treatment Phase up to 12-months|Adverse Event|7|||
13282486|NCT00555321|26461062|FG002|Treatment Phase up to 12-months|Adverse Event|11|||
13282487|NCT00555321|26461063|FG003|Treatment Phase up to 12-months|Adverse Event|7|||
13282488|NCT00555321|26461064|FG004|Treatment Phase up to 12-months|Adverse Event|18|||
13282489|NCT00555321|26461060|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
13282490|NCT00555321|26461061|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
13282491|NCT00555321|26461062|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
13282492|NCT00555321|26461063|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
13282493|NCT00555321|26461064|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
13282494|NCT00555321|26461060|FG000|Treatment Phase up to 12-months|Death|2|||
13282495|NCT00555321|26461061|FG001|Treatment Phase up to 12-months|Death|1|||
13282496|NCT00555321|26461062|FG002|Treatment Phase up to 12-months|Death|4|||
13282497|NCT00555321|26461063|FG003|Treatment Phase up to 12-months|Death|0|||
13282498|NCT00555321|26461064|FG004|Treatment Phase up to 12-months|Death|0|||
13282499|NCT00555321|26461060|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9|||
13282500|NCT00555321|26461061|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8|||
13282501|NCT00555321|26461062|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5|||
13282502|NCT00555321|26461063|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0|||
13282503|NCT00555321|26461064|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0|||
13282504|NCT00555321|26461060|FG000|Treatment Phase up to 12-months|Other Reason|1|||
13282505|NCT00555321|26461061|FG001|Treatment Phase up to 12-months|Other Reason|3|||
13282506|NCT00555321|26461062|FG002|Treatment Phase up to 12-months|Other Reason|2|||
13282507|NCT00555321|26461063|FG003|Treatment Phase up to 12-months|Other Reason|0|||
13282508|NCT00555321|26461064|FG004|Treatment Phase up to 12-months|Other Reason|0|||
13282509|NCT00555321|26461060|FG000|Treatment Phase up to 12-months|Never treated|2|||
13282510|NCT00555321|26461061|FG001|Treatment Phase up to 12-months|Never treated|3|||
13282511|NCT00555321|26461062|FG002|Treatment Phase up to 12-months|Never treated|1|||
13282512|NCT00555321|26461063|FG003|Treatment Phase up to 12-months|Never treated|0|||
13282513|NCT00555321|26461064|FG004|Treatment Phase up to 12-months|Never treated|4|||
13282514|NCT00555321|26461060|FG000|Long-term Extension Phase|Adverse Event|2|||
13282515|NCT00555321|26461061|FG001|Long-term Extension Phase|Adverse Event|5|||
13282516|NCT00555321|26461062|FG002|Long-term Extension Phase|Adverse Event|2|||
13282517|NCT00555321|26461063|FG003|Long-term Extension Phase|Adverse Event|1|||
13282518|NCT00555321|26461064|FG004|Long-term Extension Phase|Adverse Event|0|||
13282519|NCT00555321|26461060|FG000|Long-term Extension Phase|Withdrawal by Subject|2|||
13282520|NCT00555321|26461061|FG001|Long-term Extension Phase|Withdrawal by Subject|1|||
13282521|NCT00555321|26461062|FG002|Long-term Extension Phase|Withdrawal by Subject|2|||
13282522|NCT00555321|26461063|FG003|Long-term Extension Phase|Withdrawal by Subject|3|||
13282523|NCT00555321|26461064|FG004|Long-term Extension Phase|Withdrawal by Subject|2|||
13282524|NCT00555321|26461060|FG000|Long-term Extension Phase|Administrative reason by sponsor|23|||
13282525|NCT00555321|26461061|FG001|Long-term Extension Phase|Administrative reason by sponsor|21|||
13282526|NCT00555321|26461062|FG002|Long-term Extension Phase|Administrative reason by sponsor|18|||
13282527|NCT00555321|26461063|FG003|Long-term Extension Phase|Administrative reason by sponsor|31|||
13282528|NCT00555321|26461064|FG004|Long-term Extension Phase|Administrative reason by sponsor|23|||
13282529|NCT00555321|26461060|FG000|Long-term Extension Phase|Death|2|||
13282530|NCT00555321|26461061|FG001|Long-term Extension Phase|Death|0|||
13282531|NCT00555321|26461062|FG002|Long-term Extension Phase|Death|0|||
13282532|NCT00555321|26461063|FG003|Long-term Extension Phase|Death|3|||
13282533|NCT00555321|26461064|FG004|Long-term Extension Phase|Death|0|||
13282534|NCT00555321|26461060|FG000|Long-term Extension Phase|Participant did not meet study criteria|0|||
13282535|NCT00555321|26461061|FG001|Long-term Extension Phase|Participant did not meet study criteria|0|||
13282536|NCT00555321|26461062|FG002|Long-term Extension Phase|Participant did not meet study criteria|0|||
13282537|NCT00555321|26461063|FG003|Long-term Extension Phase|Participant did not meet study criteria|0|||
13282538|NCT00555321|26461064|FG004|Long-term Extension Phase|Participant did not meet study criteria|1|||
13282539|NCT00555321|26461060|FG000|Long-term Extension Phase|Other Reason|1|||
13282540|NCT00555321|26461061|FG001|Long-term Extension Phase|Other Reason|0|||
13282541|NCT00555321|26461062|FG002|Long-term Extension Phase|Other Reason|2|||
13282542|NCT00555321|26461063|FG003|Long-term Extension Phase|Other Reason|0|||
13282543|NCT00555321|26461064|FG004|Long-term Extension Phase|Other Reason|0|||
13282544|NCT00552032|26461115|FG000|Overall Study|Withdrawal by Subject|2|||
13282545|NCT00552032|26461116|FG001|Overall Study|Withdrawal by Subject|2|||
13282546|NCT00552032|26461115|FG000|Overall Study|Protocol Violation|7|||
13282547|NCT00552032|26461116|FG001|Overall Study|Protocol Violation|12|||
13282548|NCT00552032|26461115|FG000|Overall Study|Lost to Follow-up|8|||
13282549|NCT00552032|26461116|FG001|Overall Study|Lost to Follow-up|5|||
13282550|NCT00550459|26461185|FG000|Overall Study|Adverse Event|0|||
13282551|NCT00550459|26461186|FG001|Overall Study|Adverse Event|2|||
13282552|NCT00550459|26461185|FG000|Overall Study|Withdrawal by Subject|1|||
13282553|NCT00550459|26461186|FG001|Overall Study|Withdrawal by Subject|1|||
13282554|NCT00557193|26461231|FG000|Induction|Adverse Event|2|||
13282555|NCT00557193|26461232|FG001|Induction|Adverse Event|0|||
13282556|NCT00557193|26461233|FG002|Induction|Adverse Event|0|||
13282557|NCT00557193|26461234|FG003|Induction|Adverse Event|0|||
13282558|NCT00557193|26461235|FG004|Induction|Adverse Event|0|||
13282559|NCT00557193|26461236|FG005|Induction|Adverse Event|0|||
13282560|NCT00557193|26461231|FG000|Induction|Death|6|||
13282561|NCT00557193|26461232|FG001|Induction|Death|0|||
13282562|NCT00557193|26461233|FG002|Induction|Death|0|||
13282563|NCT00557193|26461234|FG003|Induction|Death|0|||
13282564|NCT00557193|26461235|FG004|Induction|Death|0|||
13282565|NCT00557193|26461236|FG005|Induction|Death|0|||
13282566|NCT00557193|26461231|FG000|Induction|Physician Decision|3|||
13282567|NCT00557193|26461232|FG001|Induction|Physician Decision|0|||
13282568|NCT00557193|26461233|FG002|Induction|Physician Decision|0|||
13282569|NCT00557193|26461234|FG003|Induction|Physician Decision|0|||
13282570|NCT00557193|26461235|FG004|Induction|Physician Decision|0|||
13282571|NCT00557193|26461236|FG005|Induction|Physician Decision|0|||
13282572|NCT00557193|26461231|FG000|Induction|Withdrawal by Subject|1|||
13282573|NCT00557193|26461232|FG001|Induction|Withdrawal by Subject|0|||
13282574|NCT00557193|26461233|FG002|Induction|Withdrawal by Subject|0|||
13282575|NCT00557193|26461234|FG003|Induction|Withdrawal by Subject|0|||
13282576|NCT00557193|26461235|FG004|Induction|Withdrawal by Subject|0|||
13282577|NCT00557193|26461236|FG005|Induction|Withdrawal by Subject|0|||
13282578|NCT00557193|26461231|FG000|Induction|Refusal of Further Protocol Therapy|2|||
13282579|NCT00557193|26461232|FG001|Induction|Refusal of Further Protocol Therapy|0|||
13282580|NCT00557193|26461233|FG002|Induction|Refusal of Further Protocol Therapy|0|||
13282581|NCT00557193|26461234|FG003|Induction|Refusal of Further Protocol Therapy|0|||
13282582|NCT00557193|26461235|FG004|Induction|Refusal of Further Protocol Therapy|0|||
13282583|NCT00557193|26461236|FG005|Induction|Refusal of Further Protocol Therapy|0|||
13282584|NCT00557193|26461231|FG000|Induction|Ineligible|8|||
13282585|NCT00557193|26461232|FG001|Induction|Ineligible|0|||
13282586|NCT00557193|26461233|FG002|Induction|Ineligible|0|||
13282587|NCT00557193|26461234|FG003|Induction|Ineligible|0|||
13282588|NCT00557193|26461235|FG004|Induction|Ineligible|0|||
13282589|NCT00557193|26461236|FG005|Induction|Ineligible|0|||
13282590|NCT00557193|26461231|FG000|Induction|Inevaluable for post Induction|2|||
13282591|NCT00557193|26461232|FG001|Induction|Inevaluable for post Induction|0|||
13282592|NCT00557193|26461233|FG002|Induction|Inevaluable for post Induction|0|||
13282593|NCT00557193|26461234|FG003|Induction|Inevaluable for post Induction|0|||
13282594|NCT00557193|26461235|FG004|Induction|Inevaluable for post Induction|0|||
13282595|NCT00557193|26461236|FG005|Induction|Inevaluable for post Induction|0|||
13282596|NCT00557193|26461231|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2|||
13282597|NCT00557193|26461232|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0|||
13282598|NCT00557193|26461233|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0|||
13282599|NCT00557193|26461234|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0|||
13282600|NCT00557193|26461235|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0|||
13282601|NCT00557193|26461236|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0|||
13282602|NCT00557193|26461231|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
13282603|NCT00557193|26461232|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
13282604|NCT00557193|26461233|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
13282605|NCT00557193|26461234|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
13282606|NCT00557193|26461235|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
13282607|NCT00557193|26461236|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3|||
13282608|NCT00557193|26461231|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
13282609|NCT00557193|26461232|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
13282610|NCT00557193|26461233|FG002|Post Induction Therapy by Tx Assignment|Death|2|||
13282611|NCT00557193|26461234|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
13282612|NCT00557193|26461235|FG004|Post Induction Therapy by Tx Assignment|Death|2|||
13282613|NCT00557193|26461236|FG005|Post Induction Therapy by Tx Assignment|Death|2|||
13282614|NCT00557193|26461231|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
13282615|NCT00557193|26461232|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3|||
13282616|NCT00557193|26461233|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5|||
13282617|NCT00557193|26461234|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1|||
13282618|NCT00557193|26461235|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
13282619|NCT00557193|26461236|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
13282620|NCT00557193|26461231|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
13282621|NCT00557193|26461232|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1|||
13282622|NCT00557193|26461233|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
13282623|NCT00557193|26461234|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
13282624|NCT00557193|26461235|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
13282625|NCT00557193|26461236|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5|||
13282626|NCT00557193|26461231|FG000|Post Induction Therapy by Tx Assignment|Relapse|0|||
13282627|NCT00557193|26461232|FG001|Post Induction Therapy by Tx Assignment|Relapse|5|||
13282628|NCT00557193|26461233|FG002|Post Induction Therapy by Tx Assignment|Relapse|16|||
13282629|NCT00557193|26461234|FG003|Post Induction Therapy by Tx Assignment|Relapse|3|||
13282630|NCT00557193|26461235|FG004|Post Induction Therapy by Tx Assignment|Relapse|1|||
13282631|NCT00557193|26461236|FG005|Post Induction Therapy by Tx Assignment|Relapse|20|||
13282632|NCT00557193|26461231|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
13282633|NCT00557193|26461232|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
13282634|NCT00557193|26461233|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1|||
13282635|NCT00557193|26461234|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
13282636|NCT00557193|26461235|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
13282637|NCT00557193|26461236|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
13282638|NCT00557193|26461231|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
13282639|NCT00557193|26461232|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
13282640|NCT00557193|26461233|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2|||
13282641|NCT00557193|26461234|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
13282642|NCT00557193|26461235|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
13282643|NCT00557193|26461236|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
13282644|NCT00557193|26461231|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
13282645|NCT00557193|26461232|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
13282646|NCT00557193|26461233|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4|||
13282647|NCT00557193|26461234|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
13282648|NCT00557193|26461235|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
13282649|NCT00557193|26461236|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5|||
13282650|NCT00555971|26461251|FG000|Overall Study|Adverse Event|1|||
13282651|NCT00555971|26461252|FG001|Overall Study|Adverse Event|1|||
13291928|NCT00709852|26484077|FG000|Period 1|Withdrawal by Subject|4|||
13291929|NCT00709852|26484078|FG001|Period 1|Withdrawal by Subject|2|||
13291930|NCT00709852|26484077|FG000|Period 1|Protocol Violation|1|||
13291931|NCT00709852|26484078|FG001|Period 1|Protocol Violation|0|||
13291932|NCT00709852|26484077|FG000|Period 1|Defective scanner|0|||
13291933|NCT00709852|26484078|FG001|Period 1|Defective scanner|1|||
13282652|NCT03028740|26461289|FG000|Overall Study|Did not Receive Study Drug|4|||
13282653|NCT03028740|26461290|FG001|Overall Study|Did not Receive Study Drug|5|||
13282654|NCT03028740|26461289|FG000|Overall Study|Adverse Event|8|||
13121459|NCT02979613|25942964|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
13121460|NCT02979613|25942965|FG001|Double-Blind Phase|Randomized but Never Treated|0|||
13121461|NCT02979613|25942964|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2|||
13121462|NCT02979613|25942965|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4|||
13121463|NCT02979613|25942964|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1|||
13121464|NCT02979613|25942965|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
13121465|NCT02979613|25942964|FG000|Open-Label Extension (OLE) Phase|Death|0|||
13121466|NCT02979613|25942965|FG001|Open-Label Extension (OLE) Phase|Death|1|||
13121467|NCT02979613|25942964|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0|||
13121468|NCT02979613|25942965|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1|||
13121469|NCT02979431|25943028|FG000|Overall Study|Parent/guardian withdrew consent|2|||
13121470|NCT02979431|25943029|FG001|Overall Study|Parent/guardian withdrew consent|1|||
13121471|NCT02979431|25943030|FG002|Overall Study|Parent/guardian withdrew consent|1|||
13121472|NCT02979431|25943031|FG003|Overall Study|Parent/guardian withdrew consent|1|||
13121473|NCT02979431|25943028|FG000|Overall Study|Randomized but received no study drug|1|||
13121474|NCT02979431|25943029|FG001|Overall Study|Randomized but received no study drug|1|||
13121475|NCT02979431|25943030|FG002|Overall Study|Randomized but received no study drug|0|||
13121476|NCT02979431|25943031|FG003|Overall Study|Randomized but received no study drug|0|||
13121477|NCT02979431|25943028|FG000|Overall Study|Adverse Event|0|||
13121478|NCT02979431|25943029|FG001|Overall Study|Adverse Event|0|||
13121479|NCT02979431|25943030|FG002|Overall Study|Adverse Event|1|||
13121480|NCT02979431|25943031|FG003|Overall Study|Adverse Event|0|||
13121481|NCT02979431|25943028|FG000|Overall Study|Subject left country after Day14|1|||
13121482|NCT02979431|25943029|FG001|Overall Study|Subject left country after Day14|0|||
13121483|NCT02979431|25943030|FG002|Overall Study|Subject left country after Day14|0|||
13121484|NCT02979431|25943031|FG003|Overall Study|Subject left country after Day14|0|||
13282655|NCT03028740|26461290|FG001|Overall Study|Adverse Event|26|||
13282656|NCT03028740|26461289|FG000|Overall Study|Lack of Efficacy|0|||
13121485|NCT02979249|25943038|FG000|Overall Study|Lost to Follow-up|2|||
13121486|NCT02979249|25943038|FG000|Overall Study|Withdrawal by Subject|4|||
13121487|NCT02979197|25943074|FG000|Overall Study|Adverse Event|4|||
13121488|NCT02979197|25943075|FG001|Overall Study|Adverse Event|2|||
13121489|NCT02979197|25943076|FG002|Overall Study|Adverse Event|0|||
13282657|NCT03028740|26461290|FG001|Overall Study|Lack of Efficacy|1|||
13282658|NCT03028740|26461289|FG000|Overall Study|Withdrawal by Subject|48|||
13282659|NCT03028740|26461290|FG001|Overall Study|Withdrawal by Subject|101|||
13282660|NCT03028740|26461289|FG000|Overall Study|Lost to Follow-up|30|||
13282661|NCT03028740|26461290|FG001|Overall Study|Lost to Follow-up|54|||
13282662|NCT03028740|26461289|FG000|Overall Study|Physician Decision|4|||
13282663|NCT03028740|26461290|FG001|Overall Study|Physician Decision|11|||
13282664|NCT03028740|26461289|FG000|Overall Study|Protocol Violation|4|||
13282665|NCT03028740|26461290|FG001|Overall Study|Protocol Violation|8|||
13282666|NCT03028740|26461289|FG000|Overall Study|Non-compliance with Study Drug|0|||
13282667|NCT03028740|26461290|FG001|Overall Study|Non-compliance with Study Drug|2|||
13282668|NCT03028740|26461289|FG000|Overall Study|Study Terminated by Sponsor|467|||
13282669|NCT03028740|26461290|FG001|Overall Study|Study Terminated by Sponsor|917|||
13282670|NCT03028740|26461289|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27|||
13282671|NCT03028740|26461290|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55|||
13282672|NCT03028740|26461289|FG000|Overall Study|Reason not Specified|1|||
13282673|NCT03028740|26461290|FG001|Overall Study|Reason not Specified|5|||
13282674|NCT03029780|26461317|FG000|Overall Study|Disease Progression|20|||
13282675|NCT03029780|26461318|FG001|Overall Study|Disease Progression|22|||
13282676|NCT03029780|26461317|FG000|Overall Study|Study Drug Toxicity|15|||
13282677|NCT03029780|26461318|FG001|Overall Study|Study Drug Toxicity|11|||
13282678|NCT03029780|26461317|FG000|Overall Study|Adverse Event Unrelated to Study Drug|2|||
13282679|NCT03029780|26461318|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
13282680|NCT03029780|26461317|FG000|Overall Study|Participant request to discontinue study treatment|4|||
13282681|NCT03029780|26461318|FG001|Overall Study|Participant request to discontinue study treatment|1|||
13282682|NCT03029780|26461317|FG000|Overall Study|Maximum clinical benefit|1|||
13282683|NCT03029780|26461318|FG001|Overall Study|Maximum clinical benefit|0|||
13282684|NCT03029780|26461317|FG000|Overall Study|Participant no longer meets study criteria|0|||
13282685|NCT03029780|26461318|FG001|Overall Study|Participant no longer meets study criteria|1|||
13282686|NCT03029780|26461317|FG000|Overall Study|Other reasons|6|||
13282687|NCT03029780|26461318|FG001|Overall Study|Other reasons|6|||
13282688|NCT03029780|26461317|FG000|Overall Study|Not reported|1|||
13282689|NCT03029780|26461318|FG001|Overall Study|Not reported|1|||
13282690|NCT03029780|26461317|FG000|Overall Study|Death|2|||
13282691|NCT03029780|26461318|FG001|Overall Study|Death|6|||
13282692|NCT03029234|26461345|FG000|Overall Study|Sponsor Decision|1|||
13282693|NCT03029234|26461345|FG000|Overall Study|Withdrawal by Subject|5|||
13282694|NCT03029234|26461345|FG000|Overall Study|Death|91|||
13282695|NCT03029234|26461345|FG000|Overall Study|Lost to Follow-up|2|||
13291934|NCT00709852|26484077|FG000|Period 1|Lost to Follow-up|1|||
13291935|NCT00709852|26484078|FG001|Period 1|Lost to Follow-up|0|||
13291936|NCT00709852|26484077|FG000|Period 2|Protocol Violation|4|||
13291937|NCT00709852|26484078|FG001|Period 2|Protocol Violation|1|||
13291938|NCT00709852|26484077|FG000|Period 2|Adverse Event|1|||
13291939|NCT00709852|26484078|FG001|Period 2|Adverse Event|1|||
13291940|NCT00709852|26484077|FG000|Period 2|Lost to Follow-up|1|||
13291941|NCT00709852|26484078|FG001|Period 2|Lost to Follow-up|0|||
13291942|NCT00709852|26484077|FG000|Period 2|No 72-hour follow-up|3|||
13291943|NCT00709852|26484078|FG001|Period 2|No 72-hour follow-up|0|||
13291944|NCT00709761|26484089|FG000|Overall Study|Withdrawal by Subject|8|||
13291945|NCT00709761|26484089|FG000|Overall Study|study closed/terminated|17|||
13291946|NCT00709761|26484089|FG000|Overall Study|Lost to Follow-up|2|||
13291947|NCT00709735|26484104|FG000|Overall Study|Lost to Follow-up|1|||
13121490|NCT02979197|25943074|FG000|Overall Study|Protocol Violation|0|||
13121491|NCT02979197|25943075|FG001|Overall Study|Protocol Violation|1|||
13121492|NCT02979197|25943076|FG002|Overall Study|Protocol Violation|0|||
13121493|NCT02979197|25943074|FG000|Overall Study|Subject unable to commit to study dates|0|||
13121494|NCT02979197|25943075|FG001|Overall Study|Subject unable to commit to study dates|1|||
13121495|NCT02979197|25943076|FG002|Overall Study|Subject unable to commit to study dates|0|||
13121496|NCT02978833|25943099|FG000|Overall Study|Study terminated|1|||
13121497|NCT02978833|25943100|FG001|Overall Study|Study terminated|1|||
13121498|NCT02978417|25943141|FG000|Overall Study|Lost to Follow-up|2|||
13121499|NCT02978417|25943142|FG001|Overall Study|Lost to Follow-up|2|||
13121500|NCT02978326|25943203|FG000|Part B (Up to 45 Days)|Adverse Event|0|||
13121501|NCT02978326|25943204|FG001|Part B (Up to 45 Days)|Adverse Event|0|||
13121502|NCT02978326|25943205|FG002|Part B (Up to 45 Days)|Adverse Event|1|||
13291948|NCT00709735|26484105|FG001|Overall Study|Lost to Follow-up|1|||
13291949|NCT00709735|26484104|FG000|Overall Study|Relapse into Opioid Abuse|0|||
13291950|NCT00709735|26484105|FG001|Overall Study|Relapse into Opioid Abuse|1|||
13291951|NCT00709735|26484104|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2|||
13291952|NCT00709735|26484105|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0|||
13291953|NCT00709722|26484113|FG000|Overall Study|Adverse Event|1|||
13291954|NCT00709618|26484125|FG000|Overall Study|Withdrawal by Subject|4|||
13291955|NCT00709618|26484125|FG000|Overall Study|Lost to Follow-up|1|||
13291956|NCT00709618|26484125|FG000|Overall Study|Study Closed/Terminated|25|||
13291957|NCT00709592|26484154|FG000|Overall Study|Unable to proceed to transplant|0|||
13121503|NCT02978326|25943203|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0|||
13121504|NCT02978326|25943204|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3|||
13121505|NCT02978326|25943205|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0|||
13121506|NCT02978326|25943203|FG000|Part B (Up to 45 Days)|Non-compliance|0|||
13121507|NCT02978326|25943204|FG001|Part B (Up to 45 Days)|Non-compliance|2|||
13121508|NCT02978326|25943205|FG002|Part B (Up to 45 Days)|Non-compliance|0|||
13121509|NCT02978326|25943203|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0|||
13121510|NCT02978326|25943204|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2|||
13121511|NCT02978326|25943205|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3|||
13291958|NCT00709592|26484155|FG001|Overall Study|Unable to proceed to transplant|1|||
13291959|NCT00709319|26484165|FG000|Overall Study|Death|4|||
13291960|NCT00709319|26484165|FG000|Overall Study|Withdrawal by Subject|2|||
13291961|NCT00709228|26484171|FG000|Overall Study|Not treated|14|||
13291962|NCT00709228|26484171|FG000|Overall Study|Eligibility criteria not met|281|||
13291963|NCT00709228|26484171|FG000|Overall Study|Adverse events|2|||
13291964|NCT00709228|26484171|FG000|Overall Study|Discontinued treatment|14|||
13291965|NCT00709228|26484171|FG000|Overall Study|Did not enter follow-up|4|||
13291966|NCT00709228|26484171|FG000|Overall Study|Discontinued follow-up|5|||
13291967|NCT00709228|26484171|FG000|Overall Study|Disease progression|1|||
13291968|NCT00709228|26484171|FG000|Overall Study|Lost to Follow-up|6|||
13291969|NCT00709228|26484171|FG000|Overall Study|Non-compliance|5|||
13291970|NCT00709202|26484204|FG000|Overall Study|Withdrawal by Subject|6|||
13291971|NCT00709202|26484205|FG001|Overall Study|Withdrawal by Subject|6|||
13291972|NCT00709124|26484246|FG000|Overall Study|Death|3|||
13291973|NCT00709124|26484247|FG001|Overall Study|Death|1|||
13291974|NCT00709124|26484246|FG000|Overall Study|encephalopathy; can't do assessment|1|||
13291975|NCT00709124|26484247|FG001|Overall Study|encephalopathy; can't do assessment|0|||
13291976|NCT00709098|26484276|FG000|Double-blind Period|Withdrawal of consent|3|||
13291977|NCT00709098|26484277|FG001|Double-blind Period|Withdrawal of consent|3|||
13291978|NCT00709098|26484278|FG002|Double-blind Period|Withdrawal of consent|0|||
13291979|NCT00709098|26484276|FG000|Double-blind Period|Administrative reason|1|||
13121512|NCT02977572|25943234|FG000|Overall Study|Exclusion criterion|2|||
13291980|NCT00709098|26484277|FG001|Double-blind Period|Administrative reason|3|||
13291981|NCT00709098|26484278|FG002|Double-blind Period|Administrative reason|0|||
13291982|NCT00709098|26484276|FG000|Double-blind Period|Death|1|||
13291983|NCT00709098|26484277|FG001|Double-blind Period|Death|1|||
13291984|NCT00709098|26484278|FG002|Double-blind Period|Death|0|||
13291985|NCT00709098|26484276|FG000|Double-blind Period|Lost to Follow-up|1|||
13291986|NCT00709098|26484277|FG001|Double-blind Period|Lost to Follow-up|1|||
13282696|NCT04278872|26461545|FG000|Overall Study|Adverse Event|1|||
13282697|NCT04278872|26461546|FG001|Overall Study|Adverse Event|0|||
13282698|NCT04278872|26461545|FG000|Overall Study|Protocol Violation|0|||
13282699|NCT04278872|26461546|FG001|Overall Study|Protocol Violation|1|||
13282700|NCT04278872|26461545|FG000|Overall Study|Study Termination|2|||
13282701|NCT04278872|26461546|FG001|Overall Study|Study Termination|0|||
13282702|NCT03838484|26461609|FG000|Overall Study|Lost to Follow-up|0|||
13282703|NCT03838484|26461610|FG001|Overall Study|Lost to Follow-up|1|||
13282704|NCT03838484|26461611|FG002|Overall Study|Lost to Follow-up|0|||
13282705|NCT03838484|26461612|FG003|Overall Study|Lost to Follow-up|0|||
13282706|NCT01059903|26461740|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
13282707|NCT01059903|26461741|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
13282708|NCT01059825|26461946|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
13282709|NCT01059825|26461947|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
13282710|NCT01059825|26461948|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
13282711|NCT01059825|26461949|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
13282712|NCT01059825|26461950|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
13282713|NCT01059825|26461951|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
13282714|NCT01059825|26461952|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3|||
13282715|NCT01059825|26461946|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
13282716|NCT01059825|26461947|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
13282717|NCT01059825|26461948|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
13282718|NCT01059825|26461949|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
13282719|NCT01059825|26461950|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
13282720|NCT01059825|26461951|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
13121513|NCT02977572|25943235|FG001|Overall Study|Exclusion criterion|2|||
13121514|NCT02977507|25943261|FG000|Overall Study|Protocol Deviation|1|||
13121515|NCT02977507|25943262|FG001|Overall Study|Protocol Deviation|0|||
13282721|NCT01059825|26461952|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14|||
13282722|NCT01059825|26461946|FG000|Enrolled, Run-in Period|Lost to Follow-up|0|||
13282723|NCT01059825|26461947|FG001|Enrolled, Run-in Period|Lost to Follow-up|0|||
13282724|NCT01059825|26461948|FG002|Enrolled, Run-in Period|Lost to Follow-up|0|||
13282725|NCT01059825|26461949|FG003|Enrolled, Run-in Period|Lost to Follow-up|0|||
13308099|NCT01277601|26530964|FG003|Overall Study|Withdrawal by Subject|17|||
13308100|NCT01277601|26530961|FG000|Overall Study|Lost to Follow-up|7|||
13308101|NCT01277601|26530962|FG001|Overall Study|Lost to Follow-up|9|||
13308102|NCT01277601|26530963|FG002|Overall Study|Lost to Follow-up|4|||
13308103|NCT01277601|26530964|FG003|Overall Study|Lost to Follow-up|2|||
13308104|NCT01277601|26530961|FG000|Overall Study|Physician Decision|3|||
13308105|NCT01277601|26530962|FG001|Overall Study|Physician Decision|5|||
13308106|NCT01277601|26530963|FG002|Overall Study|Physician Decision|1|||
13308107|NCT01277601|26530964|FG003|Overall Study|Physician Decision|6|||
13308108|NCT01277601|26530961|FG000|Overall Study|Pregnancy|2|||
13308109|NCT01277601|26530962|FG001|Overall Study|Pregnancy|2|||
13308110|NCT01277601|26530963|FG002|Overall Study|Pregnancy|4|||
13308111|NCT01277601|26530964|FG003|Overall Study|Pregnancy|1|||
13308112|NCT01277601|26530961|FG000|Overall Study|Noncompliance with Study Drug|1|||
13308113|NCT01277601|26530962|FG001|Overall Study|Noncompliance with Study Drug|3|||
13308114|NCT01277601|26530963|FG002|Overall Study|Noncompliance with Study Drug|2|||
13308115|NCT01277601|26530964|FG003|Overall Study|Noncompliance with Study Drug|0|||
13308116|NCT01277601|26530961|FG000|Overall Study|Subject Never Dosed with Study Drug|1|||
13308117|NCT01277601|26530962|FG001|Overall Study|Subject Never Dosed with Study Drug|2|||
13308118|NCT01277601|26530963|FG002|Overall Study|Subject Never Dosed with Study Drug|3|||
13308119|NCT01277601|26530964|FG003|Overall Study|Subject Never Dosed with Study Drug|1|||
13308120|NCT01277601|26530961|FG000|Overall Study|Protocol Violation|0|||
13308121|NCT01277601|26530962|FG001|Overall Study|Protocol Violation|2|||
13308122|NCT01277601|26530963|FG002|Overall Study|Protocol Violation|5|||
13308123|NCT01277601|26530964|FG003|Overall Study|Protocol Violation|0|||
13308124|NCT01277601|26530961|FG000|Overall Study|Subject Terminated from Study by Sponsor|0|||
13308125|NCT01277601|26530962|FG001|Overall Study|Subject Terminated from Study by Sponsor|1|||
13308126|NCT01277601|26530963|FG002|Overall Study|Subject Terminated from Study by Sponsor|0|||
13308127|NCT01277601|26530964|FG003|Overall Study|Subject Terminated from Study by Sponsor|2|||
13308128|NCT01277523|26531024|FG000|Overall Study|Adverse Event|1|||
13308129|NCT01277523|26531025|FG001|Overall Study|Adverse Event|0|||
13308130|NCT01277523|26531026|FG002|Overall Study|Adverse Event|0|||
13308131|NCT01277523|26531024|FG000|Overall Study|Protocol Violation|2|||
13308132|NCT01277523|26531025|FG001|Overall Study|Protocol Violation|0|||
13308133|NCT01277523|26531026|FG002|Overall Study|Protocol Violation|0|||
13308134|NCT01277523|26531024|FG000|Overall Study|Other Reason not Defined|0|||
13308135|NCT01277523|26531025|FG001|Overall Study|Other Reason not Defined|1|||
13308136|NCT01277523|26531026|FG002|Overall Study|Other Reason not Defined|0|||
13308137|NCT01277510|26531055|FG000|Double-blind Phase|Non-compliance|0|||
13308138|NCT01277510|26531056|FG001|Double-blind Phase|Non-compliance|1|||
13308139|NCT01277510|26531055|FG000|Double-blind Phase|Adverse Event|1|||
13308140|NCT01277510|26531056|FG001|Double-blind Phase|Adverse Event|0|||
13308141|NCT01277510|26531055|FG000|Double-blind Phase|Withdrawal by Subject|2|||
13308142|NCT01277510|26531056|FG001|Double-blind Phase|Withdrawal by Subject|0|||
13308143|NCT01277510|26531055|FG000|Double-blind Phase|Administrative decision|7|||
13308144|NCT01277510|26531056|FG001|Double-blind Phase|Administrative decision|9|||
13308145|NCT01277510|26531055|FG000|Double-blind Phase|Death|0|||
13308146|NCT01277510|26531056|FG001|Double-blind Phase|Death|1|||
13308147|NCT01277510|26531055|FG000|Double-blind Phase|Protocol-specified criteria|2|||
13308148|NCT01277510|26531056|FG001|Double-blind Phase|Protocol-specified criteria|6|||
13308149|NCT01277510|26531055|FG000|Double-blind Phase|Other|1|||
13308150|NCT01277510|26531056|FG001|Double-blind Phase|Other|1|||
13308151|NCT01277510|26531055|FG000|Open-label Phase|Administrative decision|4|||
13121516|NCT02977507|25943261|FG000|Overall Study|Lost to Follow-up|1|||
13121517|NCT02977507|25943262|FG001|Overall Study|Lost to Follow-up|0|||
13121518|NCT02976519|25943308|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
13121519|NCT02976519|25943309|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1|||
13121520|NCT02976519|25943310|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
13121521|NCT02976519|25943311|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
13121522|NCT02976519|25943312|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
13308152|NCT01277510|26531056|FG001|Open-label Phase|Administrative decision|3|||
13308153|NCT01277510|26531055|FG000|Open-label Phase|Protocol-specified criteria|1|||
13308154|NCT01277510|26531056|FG001|Open-label Phase|Protocol-specified criteria|0|||
13121523|NCT02976519|25943313|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
13121524|NCT02976519|25943314|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
13121525|NCT02976519|25943308|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
13121526|NCT02976519|25943309|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
13121527|NCT02976519|25943310|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
13121528|NCT02976519|25943311|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1|||
13121529|NCT02976519|25943312|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
13121530|NCT02976519|25943313|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
13121531|NCT02976519|25943314|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
13282726|NCT01059825|26461950|FG004|Enrolled, Run-in Period|Lost to Follow-up|0|||
13282727|NCT01059825|26461951|FG005|Enrolled, Run-in Period|Lost to Follow-up|0|||
13282728|NCT01059825|26461952|FG006|Enrolled, Run-in Period|Lost to Follow-up|5|||
13282729|NCT01059825|26461946|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0|||
13282730|NCT01059825|26461947|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0|||
13282731|NCT01059825|26461948|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0|||
13282732|NCT01059825|26461949|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0|||
13282733|NCT01059825|26461950|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0|||
13282734|NCT01059825|26461951|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0|||
13282735|NCT01059825|26461952|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13|||
13282736|NCT01059825|26461946|FG000|Enrolled, Run-in Period|Other reason not specified|0|||
13282737|NCT01059825|26461947|FG001|Enrolled, Run-in Period|Other reason not specified|0|||
13282738|NCT01059825|26461948|FG002|Enrolled, Run-in Period|Other reason not specified|0|||
13282739|NCT01059825|26461949|FG003|Enrolled, Run-in Period|Other reason not specified|0|||
13282740|NCT01059825|26461950|FG004|Enrolled, Run-in Period|Other reason not specified|0|||
13282741|NCT01059825|26461951|FG005|Enrolled, Run-in Period|Other reason not specified|0|||
13282742|NCT01059825|26461952|FG006|Enrolled, Run-in Period|Other reason not specified|7|||
13282743|NCT01059825|26461946|FG000|Enrolled, Run-in Period|Protocol Violation|0|||
13282744|NCT01059825|26461947|FG001|Enrolled, Run-in Period|Protocol Violation|0|||
13282745|NCT01059825|26461948|FG002|Enrolled, Run-in Period|Protocol Violation|0|||
13282746|NCT01059825|26461949|FG003|Enrolled, Run-in Period|Protocol Violation|0|||
13282747|NCT01059825|26461950|FG004|Enrolled, Run-in Period|Protocol Violation|0|||
13282748|NCT01059825|26461951|FG005|Enrolled, Run-in Period|Protocol Violation|0|||
13282749|NCT01059825|26461952|FG006|Enrolled, Run-in Period|Protocol Violation|5|||
13282750|NCT01059825|26461946|FG000|Treatment Period|Lost to Follow-up|2|||
13282751|NCT01059825|26461947|FG001|Treatment Period|Lost to Follow-up|1|||
13282752|NCT01059825|26461948|FG002|Treatment Period|Lost to Follow-up|0|||
13282753|NCT01059825|26461949|FG003|Treatment Period|Lost to Follow-up|1|||
13282754|NCT01059825|26461950|FG004|Treatment Period|Lost to Follow-up|2|||
13282755|NCT01059825|26461951|FG005|Treatment Period|Lost to Follow-up|0|||
13282756|NCT01059825|26461952|FG006|Treatment Period|Lost to Follow-up|0|||
13282757|NCT01059825|26461946|FG000|Treatment Period|Withdrawal by Subject|3|||
13282758|NCT01059825|26461947|FG001|Treatment Period|Withdrawal by Subject|0|||
13282759|NCT01059825|26461948|FG002|Treatment Period|Withdrawal by Subject|1|||
13282760|NCT01059825|26461949|FG003|Treatment Period|Withdrawal by Subject|5|||
13282761|NCT01059825|26461950|FG004|Treatment Period|Withdrawal by Subject|4|||
13282762|NCT01059825|26461951|FG005|Treatment Period|Withdrawal by Subject|1|||
13308155|NCT01277510|26531055|FG000|Open-label Phase|Never received investigational product|2|||
13308156|NCT01277510|26531056|FG001|Open-label Phase|Never received investigational product|0|||
13308157|NCT01276639|26531263|FG000|Week 0 to 16|Death|1|||
13282763|NCT01059825|26461952|FG006|Treatment Period|Withdrawal by Subject|0|||
13282764|NCT01059825|26461946|FG000|Treatment Period|Other reason not specified|1|||
13282765|NCT01059825|26461947|FG001|Treatment Period|Other reason not specified|2|||
13282766|NCT01059825|26461948|FG002|Treatment Period|Other reason not specified|1|||
13282767|NCT01059825|26461949|FG003|Treatment Period|Other reason not specified|2|||
13282768|NCT01059825|26461950|FG004|Treatment Period|Other reason not specified|0|||
13282769|NCT01059825|26461951|FG005|Treatment Period|Other reason not specified|0|||
13282770|NCT01059825|26461952|FG006|Treatment Period|Other reason not specified|0|||
13282771|NCT01059825|26461946|FG000|Treatment Period|Protocol Violation|0|||
13282772|NCT01059825|26461947|FG001|Treatment Period|Protocol Violation|0|||
13282773|NCT01059825|26461948|FG002|Treatment Period|Protocol Violation|1|||
13282774|NCT01059825|26461949|FG003|Treatment Period|Protocol Violation|1|||
13282775|NCT01059825|26461950|FG004|Treatment Period|Protocol Violation|1|||
13282776|NCT01059825|26461951|FG005|Treatment Period|Protocol Violation|1|||
13282777|NCT01059825|26461952|FG006|Treatment Period|Protocol Violation|0|||
13282778|NCT01059825|26461946|FG000|Treatment Period|Adverse event related to study drug|1|||
13282779|NCT01059825|26461947|FG001|Treatment Period|Adverse event related to study drug|0|||
13282780|NCT01059825|26461948|FG002|Treatment Period|Adverse event related to study drug|1|||
13121532|NCT02976519|25943308|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0|||
13121533|NCT02976519|25943309|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0|||
13282781|NCT01059825|26461949|FG003|Treatment Period|Adverse event related to study drug|1|||
13282782|NCT01059825|26461950|FG004|Treatment Period|Adverse event related to study drug|0|||
13282783|NCT01059825|26461951|FG005|Treatment Period|Adverse event related to study drug|0|||
13282784|NCT01059825|26461952|FG006|Treatment Period|Adverse event related to study drug|0|||
13282785|NCT01059825|26461946|FG000|Treatment Period|Insufficient clinical response|3|||
13282786|NCT01059825|26461947|FG001|Treatment Period|Insufficient clinical response|0|||
13282787|NCT01059825|26461948|FG002|Treatment Period|Insufficient clinical response|0|||
13282788|NCT01059825|26461949|FG003|Treatment Period|Insufficient clinical response|0|||
13282789|NCT01059825|26461950|FG004|Treatment Period|Insufficient clinical response|0|||
13282790|NCT01059825|26461951|FG005|Treatment Period|Insufficient clinical response|0|||
13282791|NCT01059825|26461952|FG006|Treatment Period|Insufficient clinical response|0|||
13282792|NCT01059825|26461946|FG000|Treatment Period|Adverse event not related to study drug|0|||
13282793|NCT01059825|26461947|FG001|Treatment Period|Adverse event not related to study drug|1|||
13282794|NCT01059825|26461948|FG002|Treatment Period|Adverse event not related to study drug|2|||
13282795|NCT01059825|26461949|FG003|Treatment Period|Adverse event not related to study drug|1|||
13282796|NCT01059825|26461950|FG004|Treatment Period|Adverse event not related to study drug|1|||
13282797|NCT01059825|26461951|FG005|Treatment Period|Adverse event not related to study drug|1|||
13282798|NCT01059825|26461952|FG006|Treatment Period|Adverse event not related to study drug|0|||
13282799|NCT01059773|26461989|FG000|Overall Study|Adverse Event|2|||
13282800|NCT01059773|26461990|FG001|Overall Study|Adverse Event|2|||
13282801|NCT01059773|26461989|FG000|Overall Study|Withdrawal by Subject|1|||
13282802|NCT01059773|26461990|FG001|Overall Study|Withdrawal by Subject|5|||
13282803|NCT01059773|26461989|FG000|Overall Study|Lost to Follow-up|1|||
13282804|NCT01059773|26461990|FG001|Overall Study|Lost to Follow-up|1|||
13282805|NCT01059773|26461989|FG000|Overall Study|Pregnancy|1|||
13282806|NCT01059773|26461990|FG001|Overall Study|Pregnancy|1|||
13282807|NCT01059773|26461989|FG000|Overall Study|Protocol Violation|6|||
13282808|NCT01059773|26461990|FG001|Overall Study|Protocol Violation|2|||
13282809|NCT01059773|26461989|FG000|Overall Study|Physician Decision|5|||
13282810|NCT01059773|26461990|FG001|Overall Study|Physician Decision|4|||
13282811|NCT01059773|26461989|FG000|Overall Study|Lack of Efficacy|3|||
13282812|NCT01059773|26461990|FG001|Overall Study|Lack of Efficacy|3|||
13282813|NCT01059773|26461989|FG000|Overall Study|Death|0|||
13282814|NCT01059773|26461990|FG001|Overall Study|Death|1|||
13282815|NCT01059773|26461989|FG000|Overall Study|Malignancy including squamous cell skin|0|||
13282816|NCT01059773|26461990|FG001|Overall Study|Malignancy including squamous cell skin|1|||
13282817|NCT01059773|26461989|FG000|Overall Study|Ineligible follow TB screening criteria|0|||
13282818|NCT01059773|26461990|FG001|Overall Study|Ineligible follow TB screening criteria|1|||
13282819|NCT01059773|26461989|FG000|Overall Study|Other|1|||
13282820|NCT01059773|26461990|FG001|Overall Study|Other|3|||
13282821|NCT01059643|26462005|FG000|Overall Study|Adverse Event|3|||
13282822|NCT01059643|26462005|FG000|Overall Study|Withdrawal by Subject|2|||
13282823|NCT01059643|26462005|FG000|Overall Study|Physician Decision|1|||
13282824|NCT01059617|26462186|FG000|Overall Study|Other|7|||
13282825|NCT01059617|26462187|FG001|Overall Study|Other|1|||
13282826|NCT01059617|26462188|FG002|Overall Study|Other|8|||
13282827|NCT01059617|26462189|FG003|Overall Study|Other|6|||
13282828|NCT01059565|26462230|FG000|24-Week Randomized Phase|Randomized but not treated|1|||
13282829|NCT01059565|26462231|FG001|24-Week Randomized Phase|Randomized but not treated|0|||
13282830|NCT01059565|26462230|FG000|24-Week Randomized Phase|Adverse Event|5|||
13282831|NCT01059565|26462231|FG001|24-Week Randomized Phase|Adverse Event|0|||
13282832|NCT01059565|26462230|FG000|24-Week Randomized Phase|Withdrawal by Subject|3|||
13282833|NCT01059565|26462231|FG001|24-Week Randomized Phase|Withdrawal by Subject|1|||
13282834|NCT01059565|26462230|FG000|24-Week Randomized Phase|Lost to Follow-up|0|||
13282835|NCT01059565|26462231|FG001|24-Week Randomized Phase|Lost to Follow-up|1|||
13282836|NCT01059565|26462230|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1|||
13282837|NCT01059565|26462231|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5|||
13282838|NCT01059565|26462230|FG000|24-Week Open-Label Phase|Adverse Event|2|||
13282839|NCT01059565|26462231|FG001|24-Week Open-Label Phase|Adverse Event|0|||
13282840|NCT01059565|26462230|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
13282841|NCT01059565|26462231|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
13282842|NCT01059565|26462230|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1|||
13282843|NCT01059565|26462231|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0|||
13282844|NCT01059565|26462230|FG000|24-Week Open-Label Phase|Subject noncompliance|1|||
13282845|NCT01059565|26462231|FG001|24-Week Open-Label Phase|Subject noncompliance|0|||
13282846|NCT01059565|26462230|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0|||
13282847|NCT01059565|26462231|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1|||
13282848|NCT01059565|26462230|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0|||
13282849|NCT01059565|26462231|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1|||
13282850|NCT01059526|26462246|FG000|Overall Study|Patient enrolled but not treated|20|||
13282851|NCT01059526|26462247|FG001|Overall Study|Patient enrolled but not treated|17|||
13282852|NCT01059526|26462246|FG000|Overall Study|Adverse Event|2|||
13282853|NCT01059526|26462247|FG001|Overall Study|Adverse Event|2|||
13282854|NCT01059526|26462246|FG000|Overall Study|Protocol Violation|0|||
13282855|NCT01059526|26462247|FG001|Overall Study|Protocol Violation|1|||
13282856|NCT01059526|26462246|FG000|Overall Study|Withdrawal by Subject|3|||
13282857|NCT01059526|26462247|FG001|Overall Study|Withdrawal by Subject|1|||
13282858|NCT01059526|26462246|FG000|Overall Study|Lost to Follow-up|4|||
13282859|NCT01059526|26462247|FG001|Overall Study|Lost to Follow-up|1|||
13282860|NCT01059526|26462246|FG000|Overall Study|Patient found to be dermatographic|1|||
13282861|NCT01059526|26462247|FG001|Overall Study|Patient found to be dermatographic|0|||
13282862|NCT01059344|26462272|FG000|Overall Study|Adverse Event|12|||
13282863|NCT01059344|26462273|FG001|Overall Study|Adverse Event|30|||
13282864|NCT01059344|26462272|FG000|Overall Study|Withdrawal by Subject|6|||
13282865|NCT01059344|26462273|FG001|Overall Study|Withdrawal by Subject|9|||
13282866|NCT01059344|26462272|FG000|Overall Study|Lost to Follow-up|1|||
13282867|NCT01059344|26462273|FG001|Overall Study|Lost to Follow-up|1|||
13282868|NCT01059344|26462272|FG000|Overall Study|Other|3|||
13282869|NCT01059344|26462273|FG001|Overall Study|Other|6|||
13282870|NCT01059318|26462290|FG000|Core Study (26 Week)|Adverse Event|3|||
13282871|NCT01059318|26462290|FG000|Core Study (26 Week)|Withdrawal by Subject|1|||
13282872|NCT01059318|26462290|FG000|Extension (36 Week)|Adverse Event|3|||
13282873|NCT01059071|26462307|FG000|Overall Study|Lack of Efficacy|1|||
13282874|NCT01059071|26462308|FG001|Overall Study|Lack of Efficacy|4|||
13282875|NCT01059071|26462309|FG002|Overall Study|Lack of Efficacy|2|||
13282876|NCT01059071|26462310|FG003|Overall Study|Lack of Efficacy|3|||
13282877|NCT01059071|26462307|FG000|Overall Study|Withdrawal by Subject|1|||
13282878|NCT01059071|26462308|FG001|Overall Study|Withdrawal by Subject|0|||
13282879|NCT01059071|26462309|FG002|Overall Study|Withdrawal by Subject|0|||
13282880|NCT01059071|26462310|FG003|Overall Study|Withdrawal by Subject|2|||
13282881|NCT01059071|26462307|FG000|Overall Study|Physician Decision|0|||
13282882|NCT01059071|26462308|FG001|Overall Study|Physician Decision|0|||
13282883|NCT01059071|26462309|FG002|Overall Study|Physician Decision|0|||
13282884|NCT01059071|26462310|FG003|Overall Study|Physician Decision|1|||
13282885|NCT01058863|26462330|FG000|Overall Study|Lost to Follow-up|1|||
13282886|NCT01058863|26462330|FG000|Overall Study|Withdrawal by Subject|1|||
13282887|NCT01058863|26462330|FG000|Overall Study|Sponsor requested withdrawal|1|||
13282888|NCT01058863|26462330|FG000|Overall Study|Randomized in error|1|||
13291987|NCT00709098|26484278|FG002|Double-blind Period|Lost to Follow-up|0|||
13291988|NCT00709098|26484276|FG000|Open-label Period|Withdrawal of consent|0|||
13291989|NCT00709098|26484277|FG001|Open-label Period|Withdrawal of consent|0|||
13291990|NCT00709098|26484278|FG002|Open-label Period|Withdrawal of consent|7|||
13291991|NCT00709098|26484276|FG000|Open-label Period|Administrative reason|0|||
13291992|NCT00709098|26484277|FG001|Open-label Period|Administrative reason|0|||
13291993|NCT00709098|26484278|FG002|Open-label Period|Administrative reason|5|||
13291994|NCT00709098|26484276|FG000|Open-label Period|Death|0|||
13291995|NCT00709098|26484277|FG001|Open-label Period|Death|0|||
13291996|NCT00709098|26484278|FG002|Open-label Period|Death|1|||
13291997|NCT00709098|26484276|FG000|Open-label Period|Lost to Follow-up|0|||
13291998|NCT00709098|26484277|FG001|Open-label Period|Lost to Follow-up|0|||
13291999|NCT00709098|26484278|FG002|Open-label Period|Lost to Follow-up|1|||
13292000|NCT00709059|26484284|FG000|Overall Study|Lost to Follow-up|34|||
13292001|NCT00709059|26484284|FG000|Overall Study|Withdrawal by Subject|19|||
13292002|NCT00709059|26484284|FG000|Overall Study|Physician Decision|7|||
13292003|NCT00709059|26484284|FG000|Overall Study|Disease complication|3|||
13292004|NCT00709059|26484284|FG000|Overall Study|Side effects|20|||
13292005|NCT00709059|26484284|FG000|Overall Study|Serious side effects|11|||
13292006|NCT00708916|26484295|FG000|Overall Study|Subject Noncompliance|2|||
13282889|NCT01058655|26462357|FG000|Overall Study|Withdrawal by Subject|1|||
13282890|NCT01058655|26462358|FG001|Overall Study|Withdrawal by Subject|0|||
13282891|NCT01058655|26462359|FG002|Overall Study|Withdrawal by Subject|3|||
13282892|NCT01058655|26462360|FG003|Overall Study|Withdrawal by Subject|4|||
13282893|NCT01058655|26462357|FG000|Overall Study|Prolonged Treatment Delay|0|||
13282894|NCT01058655|26462358|FG001|Overall Study|Prolonged Treatment Delay|0|||
13282895|NCT01058655|26462359|FG002|Overall Study|Prolonged Treatment Delay|0|||
13282896|NCT01058655|26462360|FG003|Overall Study|Prolonged Treatment Delay|2|||
13282897|NCT01058655|26462357|FG000|Overall Study|Symptomatic Deterioration|0|||
13282898|NCT01058655|26462358|FG001|Overall Study|Symptomatic Deterioration|0|||
13282899|NCT01058655|26462359|FG002|Overall Study|Symptomatic Deterioration|0|||
13282900|NCT01058655|26462360|FG003|Overall Study|Symptomatic Deterioration|1|||
13282901|NCT01058655|26462357|FG000|Overall Study|Clinical Progression (non-RECIST)|1|||
13121534|NCT02976519|25943310|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0|||
13121535|NCT02976519|25943311|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0|||
13121536|NCT02976519|25943312|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0|||
13121537|NCT02976519|25943313|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0|||
13121538|NCT02976519|25943314|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1|||
13121539|NCT02976519|25943308|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
13121540|NCT02976519|25943309|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
13121541|NCT02976519|25943310|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
13121542|NCT02976519|25943311|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
13121543|NCT02976519|25943312|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
13121544|NCT02976519|25943313|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
13121545|NCT02976519|25943314|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1|||
13121546|NCT02976519|25943308|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
13121547|NCT02976519|25943309|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
13121548|NCT02976519|25943310|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
13121549|NCT02976519|25943311|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
13121550|NCT02976519|25943312|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
13121551|NCT02976519|25943313|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
13121552|NCT02976519|25943314|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1|||
13121553|NCT02976103|25943372|FG000|Overall Study|Withdrawal by Subject|1|||
13121554|NCT02976103|25943373|FG001|Overall Study|Withdrawal by Subject|0|||
13121555|NCT02976103|25943372|FG000|Overall Study|Lost to Follow-up|12|||
13121556|NCT02976103|25943373|FG001|Overall Study|Lost to Follow-up|8|||
13282902|NCT01058655|26462358|FG001|Overall Study|Clinical Progression (non-RECIST)|0|||
13282903|NCT01058655|26462359|FG002|Overall Study|Clinical Progression (non-RECIST)|0|||
13282904|NCT01058655|26462360|FG003|Overall Study|Clinical Progression (non-RECIST)|7|||
13282905|NCT01058655|26462357|FG000|Overall Study|Death|0|||
13282906|NCT01058655|26462358|FG001|Overall Study|Death|1|||
13282907|NCT01058655|26462359|FG002|Overall Study|Death|1|||
13282908|NCT01058655|26462360|FG003|Overall Study|Death|0|||
13282909|NCT01058655|26462357|FG000|Overall Study|Disease Progression|1|||
13282910|NCT01058655|26462358|FG001|Overall Study|Disease Progression|2|||
13282911|NCT01058655|26462359|FG002|Overall Study|Disease Progression|4|||
13282912|NCT01058655|26462360|FG003|Overall Study|Disease Progression|24|||
13282913|NCT01058655|26462357|FG000|Overall Study|Other|0|||
13282914|NCT01058655|26462358|FG001|Overall Study|Other|0|||
13282915|NCT01058655|26462359|FG002|Overall Study|Other|0|||
13282916|NCT01058655|26462360|FG003|Overall Study|Other|4|||
13282917|NCT01058642|26462381|FG000|Treatment Period 1|Adverse Event|0|||
13282918|NCT01058642|26462382|FG001|Treatment Period 1|Adverse Event|1|||
13282919|NCT01058642|26462383|FG002|Treatment Period 1|Adverse Event|1|||
13282920|NCT01058642|26462384|FG003|Treatment Period 1|Adverse Event|0|||
13282921|NCT01058642|26462381|FG000|Treatment Period 1|Physician Decision|0|||
13282922|NCT01058642|26462382|FG001|Treatment Period 1|Physician Decision|0|||
13282923|NCT01058642|26462383|FG002|Treatment Period 1|Physician Decision|1|||
13282924|NCT01058642|26462384|FG003|Treatment Period 1|Physician Decision|0|||
13282925|NCT01058642|26462381|FG000|Treatment Period 1|Withdrawal by Subject|1|||
13282926|NCT01058642|26462382|FG001|Treatment Period 1|Withdrawal by Subject|0|||
13282927|NCT01058642|26462383|FG002|Treatment Period 1|Withdrawal by Subject|0|||
13282928|NCT01058642|26462384|FG003|Treatment Period 1|Withdrawal by Subject|0|||
13282929|NCT01058642|26462381|FG000|Treatment Period 1|Lack of Efficacy|0|||
13282930|NCT01058642|26462382|FG001|Treatment Period 1|Lack of Efficacy|0|||
13282931|NCT01058642|26462383|FG002|Treatment Period 1|Lack of Efficacy|0|||
13282932|NCT01058642|26462384|FG003|Treatment Period 1|Lack of Efficacy|1|||
13282933|NCT01058642|26462381|FG000|Treatment Period 1|Protocol Violation|0|||
13282934|NCT01058642|26462382|FG001|Treatment Period 1|Protocol Violation|0|||
13121557|NCT02975973|25943408|FG000|Overall Study|Adverse Event|1|||
13121558|NCT02975973|25943409|FG001|Overall Study|Adverse Event|1|||
13282935|NCT01058642|26462383|FG002|Treatment Period 1|Protocol Violation|0|||
13282936|NCT01058642|26462384|FG003|Treatment Period 1|Protocol Violation|1|||
13282937|NCT01058642|26462381|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1|||
13282938|NCT01058642|26462382|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0|||
13282939|NCT01058642|26462383|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0|||
13282940|NCT01058642|26462384|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0|||
13282941|NCT01058421|26462413|FG000|1 Month Outcomes|Death|10|||
13282942|NCT01058421|26462414|FG001|1 Month Outcomes|Death|6|||
13282943|NCT01058421|26462413|FG000|1 Month Outcomes|Lost to Follow-up|8|||
13282944|NCT01058421|26462414|FG001|1 Month Outcomes|Lost to Follow-up|7|||
13282945|NCT01058421|26462413|FG000|1 Month Outcomes|Remained in Hospital|5|||
13282946|NCT01058421|26462414|FG001|1 Month Outcomes|Remained in Hospital|12|||
13282947|NCT01058421|26462413|FG000|1 Month Outcomes|Remained in Other Facility|16|||
13282948|NCT01058421|26462414|FG001|1 Month Outcomes|Remained in Other Facility|17|||
13282949|NCT01058421|26462413|FG000|3 Month Outcomes|Death|3|||
13282950|NCT01058421|26462414|FG001|3 Month Outcomes|Death|5|||
13282951|NCT01058421|26462413|FG000|3 Month Outcomes|Lost to Follow-up|12|||
13282952|NCT01058421|26462414|FG001|3 Month Outcomes|Lost to Follow-up|11|||
13282953|NCT01058421|26462413|FG000|3 Month Outcomes|Remained in Hospital|0|||
13282954|NCT01058421|26462414|FG001|3 Month Outcomes|Remained in Hospital|2|||
13282955|NCT01058421|26462413|FG000|3 Month Outcomes|Remained in Other Facility|5|||
13282956|NCT01058421|26462414|FG001|3 Month Outcomes|Remained in Other Facility|8|||
13282957|NCT01058421|26462413|FG000|6 Month Outcomes|Death|2|||
13282958|NCT01058421|26462414|FG001|6 Month Outcomes|Death|2|||
13282959|NCT01058421|26462413|FG000|6 Month Outcomes|Lost to Follow-up|16|||
13282960|NCT01058421|26462414|FG001|6 Month Outcomes|Lost to Follow-up|21|||
13121559|NCT02975973|25943410|FG002|Overall Study|Adverse Event|1|||
13121560|NCT02975973|25943411|FG003|Overall Study|Adverse Event|0|||
13121561|NCT02975700|25943431|FG000|Overall Study|Adverse Event|1|||
13121562|NCT02975700|25943431|FG000|Overall Study|Progressive disease|3|||
13121563|NCT02975700|25943431|FG000|Overall Study|Failed screening criteria|2|||
13121564|NCT02975349|25943579|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
13121565|NCT02975349|25943580|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
13121566|NCT02975349|25943581|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
13121567|NCT02975349|25943582|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
13121568|NCT02975349|25943583|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
13121569|NCT02975349|25943584|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
13121570|NCT02975349|25943579|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1|||
13121571|NCT02975349|25943580|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
13121572|NCT02975349|25943581|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
13121573|NCT02975349|25943582|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
13121574|NCT02975349|25943583|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
13121575|NCT02975349|25943584|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
13121576|NCT02975349|25943579|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4|||
13121577|NCT02975349|25943580|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0|||
13121578|NCT02975349|25943581|FG002|Active Treatment Period (24 Weeks)|Adverse Event|1|||
13121579|NCT02975349|25943582|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2|||
13121580|NCT02975349|25943583|FG004|Active Treatment Period (24 Weeks)|Adverse Event|6|||
13121581|NCT02975349|25943584|FG005|Active Treatment Period (24 Weeks)|Adverse Event|2|||
13121582|NCT02975349|25943579|FG000|Active Treatment Period (24 Weeks)|Un-specified|0|||
13121583|NCT02975349|25943580|FG001|Active Treatment Period (24 Weeks)|Un-specified|0|||
13121584|NCT02975349|25943581|FG002|Active Treatment Period (24 Weeks)|Un-specified|1|||
13121585|NCT02975349|25943582|FG003|Active Treatment Period (24 Weeks)|Un-specified|0|||
13121586|NCT02975349|25943583|FG004|Active Treatment Period (24 Weeks)|Un-specified|0|||
13121587|NCT02975349|25943584|FG005|Active Treatment Period (24 Weeks)|Un-specified|0|||
13121588|NCT02975349|25943579|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
13121589|NCT02975349|25943580|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
13121590|NCT02975349|25943581|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
13121591|NCT02975349|25943582|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|2|||
13121592|NCT02975349|25943583|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
13121593|NCT02975349|25943584|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
13121594|NCT02975349|25943579|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
13121595|NCT02975349|25943580|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5|||
13121596|NCT02975349|25943581|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2|||
13121597|NCT02975349|25943582|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
13121598|NCT02975349|25943583|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
13121599|NCT02975349|25943584|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
13121600|NCT02975349|25943579|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
13121601|NCT02975349|25943580|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
13121602|NCT02975349|25943581|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1|||
13282961|NCT01058421|26462413|FG000|6 Month Outcomes|Remained in Other Facility|1|||
13282962|NCT01058421|26462414|FG001|6 Month Outcomes|Remained in Other Facility|3|||
13282963|NCT01058395|26462430|FG000|Overall Study|Death|2|||
13282964|NCT01058395|26462431|FG001|Overall Study|Death|1|||
13282965|NCT01058395|26462430|FG000|Overall Study|Lost to Follow-up|1|||
13282966|NCT01058395|26462431|FG001|Overall Study|Lost to Follow-up|0|||
13282967|NCT01058369|26462437|FG000|Overall Study|Adverse Event|1|||
13282968|NCT01058369|26462437|FG000|Overall Study|Early termination study|1|||
13282969|NCT01058356|26462444|FG000|Overall Study|Adverse Event|5|||
13282970|NCT01058356|26462444|FG000|Overall Study|Administration of contraindicated drugs|12|||
13282971|NCT01058356|26462444|FG000|Overall Study|Withdrawal by Subject|21|||
13282972|NCT01058356|26462444|FG000|Overall Study|Lost to Follow-up|4|||
13282973|NCT01058304|26462459|FG000|Overall Study|Withdrawal by Subject|8|||
13282974|NCT01058304|26462460|FG001|Overall Study|Withdrawal by Subject|5|||
13282975|NCT01058304|26462459|FG000|Overall Study|Lost to Follow-up|13|||
13282976|NCT01058304|26462460|FG001|Overall Study|Lost to Follow-up|16|||
13282977|NCT01058304|26462459|FG000|Overall Study|Developed exclusion criterion|6|||
13282978|NCT01058304|26462460|FG001|Overall Study|Developed exclusion criterion|12|||
13282979|NCT01058265|26462475|FG000|Overall Study|Lost to Follow-up|11|||
13282980|NCT01058265|26462476|FG001|Overall Study|Lost to Follow-up|12|||
13282981|NCT01058005|26462494|FG000|Overall Study|Adverse Event|0|||
13282982|NCT01058005|26462495|FG001|Overall Study|Adverse Event|2|||
13282983|NCT01058005|26462496|FG002|Overall Study|Adverse Event|1|||
13282984|NCT01058005|26462494|FG000|Overall Study|Physician Decision|2|||
13282985|NCT01058005|26462495|FG001|Overall Study|Physician Decision|2|||
13282986|NCT01058005|26462496|FG002|Overall Study|Physician Decision|0|||
13121603|NCT02975349|25943582|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
13121604|NCT02975349|25943583|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
13121605|NCT02975349|25943584|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
13121606|NCT02975349|25943579|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
13121607|NCT02975349|25943580|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1|||
13121608|NCT02975349|25943581|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
13121609|NCT02975349|25943582|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
13121610|NCT02975349|25943583|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
13121611|NCT02975349|25943584|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
13121612|NCT02975349|25943579|FG000|Blinded Extension Period (24 Weeks)|Un-specified|0|||
13121613|NCT02975349|25943580|FG001|Blinded Extension Period (24 Weeks)|Un-specified|0|||
13121614|NCT02975349|25943581|FG002|Blinded Extension Period (24 Weeks)|Un-specified|0|||
13121615|NCT02975349|25943582|FG003|Blinded Extension Period (24 Weeks)|Un-specified|1|||
13121616|NCT02975349|25943583|FG004|Blinded Extension Period (24 Weeks)|Un-specified|0|||
13121617|NCT02975349|25943584|FG005|Blinded Extension Period (24 Weeks)|Un-specified|0|||
13121618|NCT02975336|25943835|FG000|DBPC (52 Weeks)|Adverse Event|16|||
13121619|NCT02975336|25943836|FG001|DBPC (52 Weeks)|Adverse Event|17|||
13121620|NCT02975336|25943837|FG002|DBPC (52 Weeks)|Adverse Event|13|||
13121621|NCT02975336|25943838|FG003|DBPC (52 Weeks)|Adverse Event|18|||
13121622|NCT02975336|25943839|FG004|DBPC (52 Weeks)|Adverse Event|0|||
13121623|NCT02975336|25943840|FG005|DBPC (52 Weeks)|Adverse Event|0|||
13121624|NCT02975336|25943841|FG006|DBPC (52 Weeks)|Adverse Event|0|||
13121625|NCT02975336|25943842|FG007|DBPC (52 Weeks)|Adverse Event|0|||
13121626|NCT02975336|25943835|FG000|DBPC (52 Weeks)|Lost to Follow-up|2|||
13121627|NCT02975336|25943836|FG001|DBPC (52 Weeks)|Lost to Follow-up|1|||
13121628|NCT02975336|25943837|FG002|DBPC (52 Weeks)|Lost to Follow-up|2|||
13121629|NCT02975336|25943838|FG003|DBPC (52 Weeks)|Lost to Follow-up|4|||
13121630|NCT02975336|25943839|FG004|DBPC (52 Weeks)|Lost to Follow-up|0|||
13121631|NCT02975336|25943840|FG005|DBPC (52 Weeks)|Lost to Follow-up|0|||
13121632|NCT02975336|25943841|FG006|DBPC (52 Weeks)|Lost to Follow-up|0|||
13121633|NCT02975336|25943842|FG007|DBPC (52 Weeks)|Lost to Follow-up|0|||
13121634|NCT02975336|25943835|FG000|DBPC (52 Weeks)|Protocol Violation|4|||
13282987|NCT01058005|26462494|FG000|Overall Study|Withdrawal by Subject|4|||
13282988|NCT01058005|26462495|FG001|Overall Study|Withdrawal by Subject|5|||
13282989|NCT01058005|26462496|FG002|Overall Study|Withdrawal by Subject|11|||
13282990|NCT01058005|26462494|FG000|Overall Study|Withdrawn Due to Study Termination|27|||
13282991|NCT01058005|26462495|FG001|Overall Study|Withdrawn Due to Study Termination|13|||
13282992|NCT01058005|26462496|FG002|Overall Study|Withdrawn Due to Study Termination|7|||
13282993|NCT01058005|26462494|FG000|Overall Study|Reason Missing|5|||
13282994|NCT01058005|26462495|FG001|Overall Study|Reason Missing|3|||
13282995|NCT01058005|26462496|FG002|Overall Study|Reason Missing|1|||
13282996|NCT01057433|26462502|FG000|Overall Study|Adverse Event|1|||
13282997|NCT01057394|26462509|FG000|Overall Study|Not eligible|0|||
13282998|NCT01057394|26462510|FG001|Overall Study|Not eligible|2|||
13282999|NCT01057251|26462525|FG000|Overall Study|Did not meet InclusionExclusion criteria|4|||
13283000|NCT01057251|26462526|FG001|Overall Study|Did not meet InclusionExclusion criteria|2|||
13283001|NCT01057251|26462525|FG000|Overall Study|Adverse Event|4|||
13283002|NCT01057251|26462526|FG001|Overall Study|Adverse Event|2|||
13283003|NCT01057251|26462525|FG000|Overall Study|Lack of Efficacy|2|||
13283004|NCT01057251|26462526|FG001|Overall Study|Lack of Efficacy|11|||
13121635|NCT02975336|25943836|FG001|DBPC (52 Weeks)|Protocol Violation|1|||
13121636|NCT02975336|25943837|FG002|DBPC (52 Weeks)|Protocol Violation|3|||
13283005|NCT01057251|26462525|FG000|Overall Study|Protocol Violation|6|||
13283006|NCT01057251|26462526|FG001|Overall Study|Protocol Violation|2|||
13283007|NCT01057251|26462525|FG000|Overall Study|Withdrawal by Subject|4|||
13283008|NCT01057251|26462526|FG001|Overall Study|Withdrawal by Subject|5|||
13283009|NCT01057251|26462525|FG000|Overall Study|Lost to Follow-up|7|||
13121637|NCT02975336|25943838|FG003|DBPC (52 Weeks)|Protocol Violation|1|||
13121638|NCT02975336|25943839|FG004|DBPC (52 Weeks)|Protocol Violation|0|||
13121639|NCT02975336|25943840|FG005|DBPC (52 Weeks)|Protocol Violation|0|||
13121640|NCT02975336|25943841|FG006|DBPC (52 Weeks)|Protocol Violation|0|||
13121641|NCT02975336|25943842|FG007|DBPC (52 Weeks)|Protocol Violation|0|||
13121642|NCT02975336|25943835|FG000|DBPC (52 Weeks)|Lack of Efficacy|4|||
13121643|NCT02975336|25943836|FG001|DBPC (52 Weeks)|Lack of Efficacy|4|||
13121644|NCT02975336|25943837|FG002|DBPC (52 Weeks)|Lack of Efficacy|2|||
13121645|NCT02975336|25943838|FG003|DBPC (52 Weeks)|Lack of Efficacy|3|||
13121646|NCT02975336|25943839|FG004|DBPC (52 Weeks)|Lack of Efficacy|0|||
13121647|NCT02975336|25943840|FG005|DBPC (52 Weeks)|Lack of Efficacy|0|||
13283010|NCT01057251|26462526|FG001|Overall Study|Lost to Follow-up|6|||
13283011|NCT01057251|26462525|FG000|Overall Study|Other Reason|1|||
13283012|NCT01057251|26462526|FG001|Overall Study|Other Reason|1|||
13283013|NCT01056822|26462582|FG000|Overall Study|Adverse Event|0|||
13283014|NCT01056822|26462583|FG001|Overall Study|Adverse Event|1|||
13283015|NCT01056822|26462582|FG000|Overall Study|Protocol Violation|6|||
13283016|NCT01056822|26462583|FG001|Overall Study|Protocol Violation|5|||
13121648|NCT02975336|25943841|FG006|DBPC (52 Weeks)|Lack of Efficacy|0|||
13121649|NCT02975336|25943842|FG007|DBPC (52 Weeks)|Lack of Efficacy|0|||
13121650|NCT02975336|25943835|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1|||
13121651|NCT02975336|25943836|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0|||
13283017|NCT01056822|26462582|FG000|Overall Study|Withdrawal by Subject|1|||
13121652|NCT02975336|25943837|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1|||
13121653|NCT02975336|25943838|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3|||
13121654|NCT02975336|25943839|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0|||
13121655|NCT02975336|25943840|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0|||
13121656|NCT02975336|25943841|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0|||
13121657|NCT02975336|25943842|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0|||
13283018|NCT01056822|26462583|FG001|Overall Study|Withdrawal by Subject|1|||
13121658|NCT02975336|25943835|FG000|DBPC (52 Weeks)|Premature termination of the study|5|||
13121659|NCT02975336|25943836|FG001|DBPC (52 Weeks)|Premature termination of the study|6|||
13121660|NCT02975336|25943837|FG002|DBPC (52 Weeks)|Premature termination of the study|6|||
13121661|NCT02975336|25943838|FG003|DBPC (52 Weeks)|Premature termination of the study|4|||
13121662|NCT02975336|25943839|FG004|DBPC (52 Weeks)|Premature termination of the study|0|||
13121663|NCT02975336|25943840|FG005|DBPC (52 Weeks)|Premature termination of the study|0|||
13121664|NCT02975336|25943841|FG006|DBPC (52 Weeks)|Premature termination of the study|0|||
13121665|NCT02975336|25943842|FG007|DBPC (52 Weeks)|Premature termination of the study|0|||
13121666|NCT02975336|25943835|FG000|LTE (104 Weeks)|Adverse Event|0|||
13121667|NCT02975336|25943836|FG001|LTE (104 Weeks)|Adverse Event|0|||
13121668|NCT02975336|25943837|FG002|LTE (104 Weeks)|Adverse Event|0|||
13121669|NCT02975336|25943838|FG003|LTE (104 Weeks)|Adverse Event|0|||
13121670|NCT02975336|25943839|FG004|LTE (104 Weeks)|Adverse Event|7|||
13121671|NCT02975336|25943840|FG005|LTE (104 Weeks)|Adverse Event|4|||
13283019|NCT01056822|26462582|FG000|Overall Study|Lost to Follow-up|1|||
13283020|NCT01056822|26462583|FG001|Overall Study|Lost to Follow-up|0|||
13283021|NCT01056653|26462607|FG000|Overall Study|Lost to Follow-up|0|||
13121672|NCT02975336|25943841|FG006|LTE (104 Weeks)|Adverse Event|2|||
13121673|NCT02975336|25943842|FG007|LTE (104 Weeks)|Adverse Event|0|||
13121674|NCT02975336|25943835|FG000|LTE (104 Weeks)|Lost to Follow-up|0|||
13121675|NCT02975336|25943836|FG001|LTE (104 Weeks)|Lost to Follow-up|0|||
13121676|NCT02975336|25943837|FG002|LTE (104 Weeks)|Lost to Follow-up|0|||
13121677|NCT02975336|25943838|FG003|LTE (104 Weeks)|Lost to Follow-up|0|||
13121678|NCT02975336|25943839|FG004|LTE (104 Weeks)|Lost to Follow-up|0|||
13121679|NCT02975336|25943840|FG005|LTE (104 Weeks)|Lost to Follow-up|1|||
13121680|NCT02975336|25943841|FG006|LTE (104 Weeks)|Lost to Follow-up|0|||
13121681|NCT02975336|25943842|FG007|LTE (104 Weeks)|Lost to Follow-up|0|||
13121682|NCT02975336|25943835|FG000|LTE (104 Weeks)|Lack of Efficacy|0|||
13121683|NCT02975336|25943836|FG001|LTE (104 Weeks)|Lack of Efficacy|0|||
13121684|NCT02975336|25943837|FG002|LTE (104 Weeks)|Lack of Efficacy|0|||
13121685|NCT02975336|25943838|FG003|LTE (104 Weeks)|Lack of Efficacy|0|||
13121686|NCT02975336|25943839|FG004|LTE (104 Weeks)|Lack of Efficacy|0|||
13121687|NCT02975336|25943840|FG005|LTE (104 Weeks)|Lack of Efficacy|1|||
13121688|NCT02975336|25943841|FG006|LTE (104 Weeks)|Lack of Efficacy|2|||
13121689|NCT02975336|25943842|FG007|LTE (104 Weeks)|Lack of Efficacy|0|||
13121690|NCT02975336|25943835|FG000|LTE (104 Weeks)|Other|0|||
13283022|NCT01056653|26462608|FG001|Overall Study|Lost to Follow-up|0|||
13283023|NCT01056653|26462609|FG002|Overall Study|Lost to Follow-up|2|||
13283024|NCT01056640|26462622|FG000|Overall Study|Withdrawal by Subject|11|||
13283025|NCT01056640|26462623|FG001|Overall Study|Withdrawal by Subject|8|||
13283026|NCT01056640|26462622|FG000|Overall Study|Death|15|||
13121691|NCT02975336|25943836|FG001|LTE (104 Weeks)|Other|0|||
13283027|NCT01056640|26462623|FG001|Overall Study|Death|4|||
13121692|NCT02975336|25943837|FG002|LTE (104 Weeks)|Other|0|||
13121693|NCT02975336|25943838|FG003|LTE (104 Weeks)|Other|0|||
13121694|NCT02975336|25943839|FG004|LTE (104 Weeks)|Other|55|||
13121695|NCT02975336|25943840|FG005|LTE (104 Weeks)|Other|63|||
13121696|NCT02975336|25943841|FG006|LTE (104 Weeks)|Other|76|||
13121697|NCT02975336|25943842|FG007|LTE (104 Weeks)|Other|72|||
13121698|NCT02975206|25943866|FG000|Overall Study|Withdrawal by Subject|14|||
13121699|NCT02975206|25943867|FG001|Overall Study|Withdrawal by Subject|11|||
13121700|NCT02975206|25943868|FG002|Overall Study|Withdrawal by Subject|11|||
13121701|NCT02975206|25943866|FG000|Overall Study|Other (e.g., lost to follow up)|13|||
13121702|NCT02975206|25943867|FG001|Overall Study|Other (e.g., lost to follow up)|6|||
13121703|NCT02975206|25943868|FG002|Overall Study|Other (e.g., lost to follow up)|6|||
13121704|NCT02974868|25943997|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
13121705|NCT02974868|25943998|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
13121706|NCT02974868|25943999|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2|||
13121707|NCT02974868|25944000|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4|||
13121708|NCT02974868|25943997|FG000|Initial 24-Week Treatment Period (TP)|others|3|||
13121709|NCT02974868|25943998|FG001|Initial 24-Week Treatment Period (TP)|others|8|||
13283028|NCT01056536|26462644|FG000|Overall Study|Lost to Follow-up|202|||
13283029|NCT01056536|26462645|FG001|Overall Study|Lost to Follow-up|116|||
13283030|NCT01056536|26462646|FG002|Overall Study|Lost to Follow-up|248|||
13283031|NCT01056523|26462662|FG000|Overall Study|Death|1|||
13283032|NCT01056523|26462663|FG001|Overall Study|Death|0|||
13283033|NCT01056523|26462664|FG002|Overall Study|Death|2|||
13283034|NCT01056523|26462665|FG003|Overall Study|Death|3|||
13283035|NCT01056523|26462666|FG004|Overall Study|Death|0|||
13283036|NCT01056523|26462667|FG005|Overall Study|Death|0|||
13283037|NCT01056523|26462668|FG006|Overall Study|Death|1|||
13283038|NCT01056510|26462719|FG000|Overall Study|Dropout Before Start of Treatment|1|||
13283039|NCT01056510|26462720|FG001|Overall Study|Dropout Before Start of Treatment|1|||
13283040|NCT01056510|26462719|FG000|Overall Study|Withdrawal by Subject|4|||
13283041|NCT01056510|26462720|FG001|Overall Study|Withdrawal by Subject|2|||
13283042|NCT01056510|26462719|FG000|Overall Study|Death|29|||
13121710|NCT02974868|25943999|FG002|Initial 24-Week Treatment Period (TP)|others|1|||
13121711|NCT02974868|25944000|FG003|Initial 24-Week Treatment Period (TP)|others|8|||
13121712|NCT02974868|25943997|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2|||
13121713|NCT02974868|25943998|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1|||
13121714|NCT02974868|25943999|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11|||
13121715|NCT02974868|25944000|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6|||
13121716|NCT02974868|25943997|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2|||
13121717|NCT02974868|25943998|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1|||
13121718|NCT02974868|25943999|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3|||
13121719|NCT02974868|25944000|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0|||
13121720|NCT02974855|25944199|FG000|Overall Study|Adverse Event|0|||
13121721|NCT02974855|25944200|FG001|Overall Study|Adverse Event|1|||
13121722|NCT02974855|25944201|FG002|Overall Study|Adverse Event|0|||
13121723|NCT02974855|25944202|FG003|Overall Study|Adverse Event|1|||
13121724|NCT02974842|25944208|FG000|Overall Study|Withdrawal by Subject|4|||
13121725|NCT02974842|25944208|FG000|Overall Study|Screen failures|4|||
13121726|NCT02974634|25944223|FG000|Overall Study|Advanced disease|12|||
13121727|NCT02974634|25944224|FG001|Overall Study|Advanced disease|3|||
13121728|NCT02974634|25944223|FG000|Overall Study|Noncompliance|3|||
13283043|NCT01056510|26462720|FG001|Overall Study|Death|34|||
13121729|NCT02974634|25944224|FG001|Overall Study|Noncompliance|7|||
13283044|NCT01056510|26462719|FG000|Overall Study|Noncompliance|1|||
13283045|NCT01056510|26462720|FG001|Overall Study|Noncompliance|3|||
13283046|NCT01056510|26462719|FG000|Overall Study|Physician Decision|4|||
13283047|NCT01056510|26462720|FG001|Overall Study|Physician Decision|5|||
13283048|NCT01056510|26462719|FG000|Overall Study|Lost to Follow-up|5|||
13121730|NCT02974634|25944223|FG000|Overall Study|intervention technology related issues|5|||
13121731|NCT02974634|25944224|FG001|Overall Study|intervention technology related issues|0|||
13121732|NCT02974634|25944223|FG000|Overall Study|Death|8|||
13121733|NCT02974634|25944224|FG001|Overall Study|Death|11|||
13121734|NCT02974543|25944251|FG000|Overall Study|Withdrawal by Subject|1|||
13283049|NCT01056510|26462720|FG001|Overall Study|Lost to Follow-up|6|||
13283050|NCT01056510|26462719|FG000|Overall Study|Other|10|||
13283051|NCT01056510|26462720|FG001|Overall Study|Other|12|||
13283052|NCT01056510|26462719|FG000|Overall Study|Missing|0|||
13283053|NCT01056510|26462720|FG001|Overall Study|Missing|1|||
13283054|NCT01056484|26462741|FG000|Randomized Controlled Trial|Withdrawal by Subject|6|||
13283055|NCT01056484|26462742|FG001|Randomized Controlled Trial|Withdrawal by Subject|1|||
13308158|NCT01276639|26531264|FG001|Week 0 to 16|Death|0|||
13121735|NCT02974543|25944252|FG001|Overall Study|Withdrawal by Subject|0|||
13121736|NCT02974153|25944348|FG000|Overall Study|Adverse Event|6|||
13121737|NCT02974153|25944349|FG001|Overall Study|Adverse Event|0|||
13283056|NCT01056484|26462741|FG000|Randomized Controlled Trial|Physician Decision|1|||
13283057|NCT01056484|26462742|FG001|Randomized Controlled Trial|Physician Decision|0|||
13283058|NCT01056484|26462741|FG000|Follow up - Non-randomized|Withdrawal by Subject|0|||
13283059|NCT01056484|26462742|FG001|Follow up - Non-randomized|Withdrawal by Subject|2|||
13283060|NCT01056380|26462771|FG000|Overall Study|Lost to Follow-up|2|||
13308159|NCT01276639|26531265|FG002|Week 0 to 16|Death|0|||
13283061|NCT01056380|26462772|FG001|Overall Study|Lost to Follow-up|3|||
13283062|NCT01056276|26462793|FG000|Treatment Period-Cycles 1-8|Toxicity|2|||
13283063|NCT01056276|26462794|FG001|Treatment Period-Cycles 1-8|Toxicity|1|||
13283064|NCT01056276|26462793|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1|||
13283065|NCT01056276|26462794|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2|||
13283066|NCT01056276|26462793|FG000|Treatment Period-Cycles 1-8|Disease Progression|2|||
13283067|NCT01056276|26462794|FG001|Treatment Period-Cycles 1-8|Disease Progression|2|||
13283068|NCT01056276|26462793|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1|||
13283069|NCT01056276|26462794|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2|||
13283070|NCT01056276|26462793|FG000|Treatment Period-Cycles 1-8|Physician Decision|3|||
13283071|NCT01056276|26462794|FG001|Treatment Period-Cycles 1-8|Physician Decision|0|||
13283072|NCT01056276|26462793|FG000|Treatment Period-Cycles 1-8|Death|3|||
13283073|NCT01056276|26462794|FG001|Treatment Period-Cycles 1-8|Death|1|||
13283074|NCT01056276|26462793|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1|||
13283075|NCT01056276|26462794|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0|||
13283076|NCT01056276|26462793|FG000|Maintenance Therapy|Toxicity|0|||
13283077|NCT01056276|26462794|FG001|Maintenance Therapy|Toxicity|2|||
13283078|NCT01056276|26462793|FG000|Maintenance Therapy|Progressive Disease|0|||
13283079|NCT01056276|26462794|FG001|Maintenance Therapy|Progressive Disease|9|||
13283080|NCT01056276|26462793|FG000|Maintenance Therapy|Physician Decision|0|||
13283081|NCT01056276|26462794|FG001|Maintenance Therapy|Physician Decision|1|||
13283082|NCT01056276|26462793|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
13283083|NCT01056276|26462794|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
13121738|NCT02974153|25944350|FG002|Overall Study|Adverse Event|1|||
13121739|NCT02974153|25944348|FG000|Overall Study|Lack of Efficacy|6|||
13121740|NCT02974153|25944349|FG001|Overall Study|Lack of Efficacy|5|||
13121741|NCT02974153|25944350|FG002|Overall Study|Lack of Efficacy|10|||
13121742|NCT02974153|25944348|FG000|Overall Study|Lost to Follow-up|9|||
13121743|NCT02974153|25944349|FG001|Overall Study|Lost to Follow-up|10|||
13121744|NCT02974153|25944350|FG002|Overall Study|Lost to Follow-up|17|||
13121745|NCT02974153|25944348|FG000|Overall Study|Physician Decision|0|||
13121746|NCT02974153|25944349|FG001|Overall Study|Physician Decision|2|||
13121747|NCT02974153|25944350|FG002|Overall Study|Physician Decision|1|||
13121748|NCT02974153|25944348|FG000|Overall Study|Withdrawal by Subject|9|||
13121749|NCT02974153|25944349|FG001|Overall Study|Withdrawal by Subject|16|||
13121750|NCT02974153|25944350|FG002|Overall Study|Withdrawal by Subject|11|||
13121751|NCT02974153|25944348|FG000|Overall Study|Study Burden|8|||
13121752|NCT02974153|25944349|FG001|Overall Study|Study Burden|7|||
13121753|NCT02974153|25944350|FG002|Overall Study|Study Burden|3|||
13121754|NCT02974153|25944348|FG000|Overall Study|Other|14|||
13121755|NCT02974153|25944349|FG001|Overall Study|Other|8|||
13283084|NCT01056276|26462793|FG000|Maintenance Therapy|Intercurrent Illness|0|||
13203934|NCT01978184|26226455|FG000|Overall Study|Withdrew- toxicities or physical decline|4|||
13203935|NCT01978184|26226456|FG001|Overall Study|Withdrew- toxicities or physical decline|8|||
13203936|NCT01978145|26226475|FG000|Treatment Period 1|Adverse Event|1|||
13203937|NCT01978145|26226476|FG001|Treatment Period 1|Adverse Event|9|||
13203938|NCT01978145|26226475|FG000|Treatment Period 1|Physician Decision|1|||
13203939|NCT01978145|26226476|FG001|Treatment Period 1|Physician Decision|0|||
13203940|NCT01978145|26226475|FG000|Treatment Period 1|Withdrawal by Subject|5|||
13203941|NCT01978145|26226476|FG001|Treatment Period 1|Withdrawal by Subject|4|||
13203942|NCT01978145|26226475|FG000|Treatment Period 1|Par. reached defined stopping criteria|2|||
13203943|NCT01978145|26226476|FG001|Treatment Period 1|Par. reached defined stopping criteria|3|||
13203944|NCT01978145|26226475|FG000|Washout Period 1|Adverse Event|0|||
13203945|NCT01978145|26226476|FG001|Washout Period 1|Adverse Event|1|||
13203946|NCT01978145|26226475|FG000|Washout Period 1|Withdrawal by Subject|1|||
13203947|NCT01978145|26226476|FG001|Washout Period 1|Withdrawal by Subject|1|||
13283085|NCT01056276|26462794|FG001|Maintenance Therapy|Intercurrent Illness|1|||
13283086|NCT01056276|26462793|FG000|Maintenance Therapy|Continuing maintenance therapy|0|||
13283087|NCT01056276|26462794|FG001|Maintenance Therapy|Continuing maintenance therapy|14|||
13283088|NCT01055886|26462811|FG000|Overall Study|Withdrawal by Subject|4|||
13283089|NCT01055886|26462812|FG001|Overall Study|Withdrawal by Subject|9|||
13283090|NCT01055886|26462811|FG000|Overall Study|Lost to Follow-up|1|||
13283091|NCT01055886|26462812|FG001|Overall Study|Lost to Follow-up|1|||
13283092|NCT01055886|26462811|FG000|Overall Study|Withdrawal by PI|0|||
13283093|NCT01055886|26462812|FG001|Overall Study|Withdrawal by PI|1|||
13283094|NCT01055834|26462831|FG000|Treatment Period I|Adverse Event|1|||
13283095|NCT01055834|26462832|FG001|Treatment Period I|Adverse Event|0|||
13283096|NCT01055639|26462861|FG000|Overall Study|Adverse Event|0|||
13283097|NCT01055639|26462862|FG001|Overall Study|Adverse Event|1|||
13283098|NCT01055639|26462861|FG000|Overall Study|Lack of Efficacy|0|||
13283099|NCT01055639|26462862|FG001|Overall Study|Lack of Efficacy|1|||
13121756|NCT02974153|25944350|FG002|Overall Study|Other|7|||
13121757|NCT02974140|25944365|FG000|Overall Study|Adverse Event|2|||
13283100|NCT01055639|26462861|FG000|Overall Study|Lost to Follow-up|8|||
13283101|NCT01055639|26462862|FG001|Overall Study|Lost to Follow-up|11|||
13121758|NCT02974140|25944365|FG000|Overall Study|Lost to Follow-up|1|||
13121759|NCT02974140|25944365|FG000|Overall Study|Study Terminated by Sponsor|36|||
13283102|NCT01055639|26462861|FG000|Overall Study|Protocol Violation|5|||
13283103|NCT01055639|26462862|FG001|Overall Study|Protocol Violation|5|||
13283104|NCT01055639|26462861|FG000|Overall Study|Withdrawal by Subject|8|||
13283105|NCT01055639|26462862|FG001|Overall Study|Withdrawal by Subject|11|||
13283106|NCT01055613|26462877|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
13283107|NCT01055613|26462878|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
13283108|NCT01055613|26462877|FG000|Overall Study|Unacceptable lens fit|1|||
13283109|NCT01055613|26462878|FG001|Overall Study|Unacceptable lens fit|0|||
13283110|NCT01055613|26462877|FG000|Overall Study|Discomfort|2|||
13283111|NCT01055613|26462878|FG001|Overall Study|Discomfort|1|||
13283112|NCT01055613|26462877|FG000|Overall Study|Lost to Follow-up|1|||
13283113|NCT01055613|26462878|FG001|Overall Study|Lost to Follow-up|1|||
13283114|NCT01055613|26462877|FG000|Overall Study|Protocol Violation|1|||
13283115|NCT01055613|26462878|FG001|Overall Study|Protocol Violation|1|||
13283116|NCT01055613|26462877|FG000|Overall Study|Subject Disinterest|1|||
13283117|NCT01055613|26462878|FG001|Overall Study|Subject Disinterest|1|||
13121760|NCT02974114|25944416|FG000|Overall Study|Other (Not specified)|0|||
13283118|NCT01055457|26462941|FG000|Overall Study|Lost to Follow-up|0|||
13283119|NCT01055457|26462942|FG001|Overall Study|Lost to Follow-up|1|||
13283120|NCT01055457|26462943|FG002|Overall Study|Lost to Follow-up|0|||
13283121|NCT01055457|26462944|FG003|Overall Study|Lost to Follow-up|0|||
13121761|NCT02974114|25944417|FG001|Overall Study|Other (Not specified)|1|||
13121762|NCT02974114|25944418|FG002|Overall Study|Other (Not specified)|2|||
13121763|NCT02974088|25944431|FG000|Overall Study|Lost to Follow-up|0|||
13283122|NCT01055457|26462945|FG004|Overall Study|Lost to Follow-up|0|||
13283123|NCT01055457|26462946|FG005|Overall Study|Lost to Follow-up|1|||
13283124|NCT01055457|26462947|FG006|Overall Study|Lost to Follow-up|0|||
13283125|NCT01055457|26462948|FG007|Overall Study|Lost to Follow-up|0|||
13283126|NCT01055457|26462949|FG008|Overall Study|Lost to Follow-up|0|||
13283127|NCT01055457|26462950|FG009|Overall Study|Lost to Follow-up|0|||
13283128|NCT01055457|26462941|FG000|Overall Study|Protocol Violation|0|||
13283129|NCT01055457|26462942|FG001|Overall Study|Protocol Violation|0|||
13283130|NCT01055457|26462943|FG002|Overall Study|Protocol Violation|1|||
13283131|NCT01055457|26462944|FG003|Overall Study|Protocol Violation|1|||
13121764|NCT02974088|25944432|FG001|Overall Study|Lost to Follow-up|2|||
13121765|NCT02974088|25944431|FG000|Overall Study|Adverse Event|0|||
13121766|NCT02974088|25944432|FG001|Overall Study|Adverse Event|1|||
13121767|NCT02974010|25944455|FG000|Overall Study|Lost to Follow-up|3|||
13121768|NCT02974010|25944456|FG001|Overall Study|Lost to Follow-up|1|||
13121769|NCT02974010|25944457|FG002|Overall Study|Lost to Follow-up|0|||
13121770|NCT02974010|25944458|FG003|Overall Study|Lost to Follow-up|0|||
13121771|NCT02974010|25944455|FG000|Overall Study|Withdrawal by Subject|2|||
13121772|NCT02974010|25944456|FG001|Overall Study|Withdrawal by Subject|1|||
13121773|NCT02974010|25944457|FG002|Overall Study|Withdrawal by Subject|0|||
13121774|NCT02974010|25944458|FG003|Overall Study|Withdrawal by Subject|0|||
13121775|NCT02974010|25944455|FG000|Overall Study|Adverse Event|0|||
13121776|NCT02974010|25944456|FG001|Overall Study|Adverse Event|1|||
13121777|NCT02974010|25944457|FG002|Overall Study|Adverse Event|0|||
13121778|NCT02974010|25944458|FG003|Overall Study|Adverse Event|0|||
13283132|NCT01055457|26462945|FG004|Overall Study|Protocol Violation|1|||
13283133|NCT01055457|26462946|FG005|Overall Study|Protocol Violation|2|||
13283134|NCT01055457|26462947|FG006|Overall Study|Protocol Violation|1|||
13283135|NCT01055457|26462948|FG007|Overall Study|Protocol Violation|0|||
13283136|NCT01055457|26462949|FG008|Overall Study|Protocol Violation|0|||
13283137|NCT01055457|26462950|FG009|Overall Study|Protocol Violation|1|||
13283138|NCT01055457|26462941|FG000|Overall Study|Subject Disinterest|0|||
13283139|NCT01055457|26462942|FG001|Overall Study|Subject Disinterest|0|||
13283140|NCT01055457|26462943|FG002|Overall Study|Subject Disinterest|0|||
13283141|NCT01055457|26462944|FG003|Overall Study|Subject Disinterest|0|||
13283142|NCT01055457|26462945|FG004|Overall Study|Subject Disinterest|0|||
13283143|NCT01055457|26462946|FG005|Overall Study|Subject Disinterest|0|||
13283144|NCT01055457|26462947|FG006|Overall Study|Subject Disinterest|0|||
13283145|NCT01055457|26462948|FG007|Overall Study|Subject Disinterest|1|||
13283146|NCT01055457|26462949|FG008|Overall Study|Subject Disinterest|0|||
13283147|NCT01055457|26462950|FG009|Overall Study|Subject Disinterest|0|||
13283148|NCT01055457|26462941|FG000|Overall Study|Subject Ineligible|1|||
13283149|NCT01055457|26462942|FG001|Overall Study|Subject Ineligible|0|||
13283150|NCT01055457|26462943|FG002|Overall Study|Subject Ineligible|1|||
13283151|NCT01055457|26462944|FG003|Overall Study|Subject Ineligible|0|||
13283152|NCT01055457|26462945|FG004|Overall Study|Subject Ineligible|1|||
13283153|NCT01055457|26462946|FG005|Overall Study|Subject Ineligible|0|||
13283154|NCT01055457|26462947|FG006|Overall Study|Subject Ineligible|0|||
13283155|NCT01055457|26462948|FG007|Overall Study|Subject Ineligible|0|||
13283156|NCT01055457|26462949|FG008|Overall Study|Subject Ineligible|0|||
13283157|NCT01055457|26462950|FG009|Overall Study|Subject Ineligible|0|||
13283158|NCT01055457|26462941|FG000|Overall Study|Discomfort|0|||
13121779|NCT02974010|25944455|FG000|Overall Study|Completed day 42 but did not return for day 70|1|||
13121780|NCT02974010|25944456|FG001|Overall Study|Completed day 42 but did not return for day 70|0|||
13283159|NCT01055457|26462942|FG001|Overall Study|Discomfort|0|||
13283160|NCT01055457|26462943|FG002|Overall Study|Discomfort|0|||
13283161|NCT01055457|26462944|FG003|Overall Study|Discomfort|0|||
13283162|NCT01055457|26462945|FG004|Overall Study|Discomfort|1|||
13283163|NCT01055457|26462946|FG005|Overall Study|Discomfort|0|||
13283164|NCT01055457|26462947|FG006|Overall Study|Discomfort|0|||
13283165|NCT01055457|26462948|FG007|Overall Study|Discomfort|0|||
13283166|NCT01055457|26462949|FG008|Overall Study|Discomfort|0|||
13283167|NCT01055457|26462950|FG009|Overall Study|Discomfort|0|||
13283168|NCT01055457|26462941|FG000|Overall Study|Pregnancy|0|||
13121781|NCT02974010|25944457|FG002|Overall Study|Completed day 42 but did not return for day 70|1|||
13121782|NCT02974010|25944458|FG003|Overall Study|Completed day 42 but did not return for day 70|0|||
13121783|NCT02974010|25944455|FG000|Overall Study|Lack of Efficacy|0|||
13121784|NCT02974010|25944456|FG001|Overall Study|Lack of Efficacy|0|||
13121785|NCT02974010|25944457|FG002|Overall Study|Lack of Efficacy|1|||
13283169|NCT01055457|26462942|FG001|Overall Study|Pregnancy|0|||
13283170|NCT01055457|26462943|FG002|Overall Study|Pregnancy|0|||
13283171|NCT01055457|26462944|FG003|Overall Study|Pregnancy|1|||
13283172|NCT01055457|26462945|FG004|Overall Study|Pregnancy|0|||
13283173|NCT01055457|26462946|FG005|Overall Study|Pregnancy|0|||
13283174|NCT01055457|26462947|FG006|Overall Study|Pregnancy|0|||
13283175|NCT01055457|26462948|FG007|Overall Study|Pregnancy|0|||
13283176|NCT01055457|26462949|FG008|Overall Study|Pregnancy|0|||
13283177|NCT01055457|26462950|FG009|Overall Study|Pregnancy|0|||
13283178|NCT01055457|26462941|FG000|Overall Study|Adverse Event|0|||
13283179|NCT01055457|26462942|FG001|Overall Study|Adverse Event|0|||
13283180|NCT01055457|26462943|FG002|Overall Study|Adverse Event|0|||
13283181|NCT01055457|26462944|FG003|Overall Study|Adverse Event|1|||
13283182|NCT01055457|26462945|FG004|Overall Study|Adverse Event|0|||
13283183|NCT01055457|26462946|FG005|Overall Study|Adverse Event|0|||
13283184|NCT01055457|26462947|FG006|Overall Study|Adverse Event|0|||
13283185|NCT01055457|26462948|FG007|Overall Study|Adverse Event|0|||
13283186|NCT01055457|26462949|FG008|Overall Study|Adverse Event|0|||
13283187|NCT01055457|26462950|FG009|Overall Study|Adverse Event|0|||
13283188|NCT01055314|26462969|FG000|Overall Study|Adverse Event|7|||
13283189|NCT01055314|26462970|FG001|Overall Study|Adverse Event|4|||
13283190|NCT01055314|26462969|FG000|Overall Study|Death|2|||
13283191|NCT01055314|26462970|FG001|Overall Study|Death|1|||
13283192|NCT01055314|26462969|FG000|Overall Study|Lack of Efficacy|11|||
13283193|NCT01055314|26462970|FG001|Overall Study|Lack of Efficacy|19|||
13283194|NCT01055314|26462969|FG000|Overall Study|Physician Decision|10|||
13283195|NCT01055314|26462970|FG001|Overall Study|Physician Decision|5|||
13283196|NCT01055314|26462969|FG000|Overall Study|Withdrawal by Subject|1|||
13283197|NCT01055314|26462970|FG001|Overall Study|Withdrawal by Subject|0|||
13283198|NCT01055314|26462969|FG000|Overall Study|Ineligible|3|||
13283199|NCT01055314|26462970|FG001|Overall Study|Ineligible|5|||
13283200|NCT01055314|26462969|FG000|Overall Study|Refusal of further protocol therapy|10|||
13283201|NCT01055314|26462970|FG001|Overall Study|Refusal of further protocol therapy|4|||
13283202|NCT01055314|26462969|FG000|Overall Study|No treatment|1|||
13283203|NCT01055314|26462970|FG001|Overall Study|No treatment|0|||
13283204|NCT01055197|26462991|FG000|Overall Study|Protocol Violation|7|||
13283205|NCT01055197|26462992|FG001|Overall Study|Protocol Violation|2|||
13283206|NCT01055197|26462991|FG000|Overall Study|Withdrawal by Subject|2|||
13283207|NCT01055197|26462992|FG001|Overall Study|Withdrawal by Subject|0|||
13283208|NCT01055132|26463006|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1|||
13283209|NCT01055132|26463007|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0|||
13283210|NCT01055132|26463006|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0|||
13283211|NCT01055132|26463007|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1|||
13283212|NCT01055028|26463028|FG000|Screening|Screen Failure|1|||
13283213|NCT01055028|26463029|FG001|Screening|Screen Failure|1|||
13283214|NCT01055028|26463028|FG000|Treatment Cycles 1 to 3|Adverse Event|0|||
13283215|NCT01055028|26463029|FG001|Treatment Cycles 1 to 3|Adverse Event|1|||
13283216|NCT01055028|26463028|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
13283217|NCT01055028|26463029|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
13283218|NCT01055028|26463028|FG000|Inter-treatment Period|Did not start Cycle 4|0|||
13283219|NCT01055028|26463029|FG001|Inter-treatment Period|Did not start Cycle 4|3|||
13283220|NCT01054976|26463039|FG000|Overall Study|Adverse Event|16|||
13283221|NCT01054976|26463039|FG000|Overall Study|Uncooperative participations to study|7|||
13283222|NCT01054976|26463039|FG000|Overall Study|Withdrawal by Subject|4|||
13283223|NCT01054976|26463039|FG000|Overall Study|Other|8|||
13283224|NCT01054885|26463097|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246|||
13283225|NCT01054885|26463098|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
13283226|NCT01054885|26463099|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
13283227|NCT01054885|26463100|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
13283228|NCT01054885|26463101|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
13283229|NCT01054885|26463102|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
13283230|NCT01054885|26463103|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
13283231|NCT01054885|26463097|FG000|2-week, Single-blind Run-In Period|Physician Decision|6|||
13283232|NCT01054885|26463098|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
13283233|NCT01054885|26463099|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
13283234|NCT01054885|26463100|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
13283235|NCT01054885|26463101|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
13283236|NCT01054885|26463102|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
13283237|NCT01054885|26463103|FG006|2-week, Single-blind Run-In Period|Physician Decision|0|||
13283238|NCT01054885|26463097|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23|||
13283239|NCT01054885|26463098|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
13121786|NCT02974010|25944458|FG003|Overall Study|Lack of Efficacy|0|||
13121787|NCT02973802|25944474|FG000|Overall Study|Lost to Follow-up|1|||
13283240|NCT01054885|26463099|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
13283241|NCT01054885|26463100|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
13283242|NCT01054885|26463101|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
13283243|NCT01054885|26463102|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
13283244|NCT01054885|26463103|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
13283245|NCT01054885|26463097|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
13283246|NCT01054885|26463098|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
13283247|NCT01054885|26463099|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
13283248|NCT01054885|26463100|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
13283249|NCT01054885|26463101|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
13283250|NCT01054885|26463102|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
13283251|NCT01054885|26463103|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
13283252|NCT01054885|26463097|FG000|2-week, Single-blind Run-In Period|Adverse Event|7|||
13283253|NCT01054885|26463098|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
13283254|NCT01054885|26463099|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
13283255|NCT01054885|26463100|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
13283256|NCT01054885|26463101|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
13283257|NCT01054885|26463102|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
13283258|NCT01054885|26463103|FG006|2-week, Single-blind Run-In Period|Adverse Event|0|||
13283259|NCT01054885|26463097|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68|||
13283260|NCT01054885|26463098|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
13283261|NCT01054885|26463099|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
13283262|NCT01054885|26463100|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
13283263|NCT01054885|26463101|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
13283264|NCT01054885|26463102|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
13283265|NCT01054885|26463103|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
13283266|NCT01054885|26463097|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
13283267|NCT01054885|26463098|FG001|24-week, Double-blind Treatment Period|Adverse Event|18|||
13283268|NCT01054885|26463099|FG002|24-week, Double-blind Treatment Period|Adverse Event|12|||
13283269|NCT01054885|26463100|FG003|24-week, Double-blind Treatment Period|Adverse Event|15|||
13283270|NCT01054885|26463101|FG004|24-week, Double-blind Treatment Period|Adverse Event|15|||
13283271|NCT01054885|26463102|FG005|24-week, Double-blind Treatment Period|Adverse Event|17|||
13283272|NCT01054885|26463103|FG006|24-week, Double-blind Treatment Period|Adverse Event|19|||
13283273|NCT01054885|26463097|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
13283274|NCT01054885|26463098|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
13283275|NCT01054885|26463099|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
13283276|NCT01054885|26463100|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
13283277|NCT01054885|26463101|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
13283278|NCT01054885|26463102|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
13283279|NCT01054885|26463103|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
13283280|NCT01054885|26463097|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
13283281|NCT01054885|26463098|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
13283282|NCT01054885|26463099|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2|||
13283283|NCT01054885|26463100|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5|||
13283284|NCT01054885|26463101|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11|||
13283285|NCT01054885|26463102|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
13283286|NCT01054885|26463103|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
13283287|NCT01054885|26463097|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
13283288|NCT01054885|26463098|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7|||
13283289|NCT01054885|26463099|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7|||
13283290|NCT01054885|26463100|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
13283291|NCT01054885|26463101|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3|||
13283292|NCT01054885|26463102|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8|||
13283293|NCT01054885|26463103|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4|||
13283294|NCT01054885|26463097|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0|||
13283295|NCT01054885|26463098|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
13283296|NCT01054885|26463099|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
13283297|NCT01054885|26463100|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
13283298|NCT01054885|26463101|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
13283299|NCT01054885|26463102|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15|||
13121788|NCT02973802|25944474|FG000|Overall Study|Withdrawal by Subject|1|||
13121789|NCT02973477|25944494|FG000|First Intervention|Lost to Follow-up|0|||
13121790|NCT02973477|25944495|FG001|First Intervention|Lost to Follow-up|2|||
13121791|NCT02973477|25944494|FG000|Washout|Withdrawal by Subject|1|||
13121792|NCT02973477|25944495|FG001|Washout|Withdrawal by Subject|0|||
13121793|NCT02973477|25944494|FG000|Second Intervention|Lost to Follow-up|1|||
13121794|NCT02973477|25944495|FG001|Second Intervention|Lost to Follow-up|0|||
13121795|NCT02973425|25944520|FG000|Overall Study|Lost to Follow-up|49|||
13121796|NCT02973425|25944521|FG001|Overall Study|Lost to Follow-up|53|||
13283300|NCT01054885|26463103|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
13283301|NCT01054885|26463097|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
13283302|NCT01054885|26463098|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
13283303|NCT01054885|26463099|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
13283304|NCT01054885|26463100|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
13283305|NCT01054885|26463101|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
13283306|NCT01054885|26463102|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
13283307|NCT01054885|26463103|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
13283308|NCT01054885|26463097|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
13283309|NCT01054885|26463098|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
13283310|NCT01054885|26463099|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
13283311|NCT01054885|26463100|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
13283312|NCT01054885|26463101|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
13283313|NCT01054885|26463102|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
13283314|NCT01054885|26463103|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
13283315|NCT01054885|26463097|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
13283316|NCT01054885|26463098|FG001|24-week, Double-blind Treatment Period|Physician Decision|4|||
13283317|NCT01054885|26463099|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
13283318|NCT01054885|26463100|FG003|24-week, Double-blind Treatment Period|Physician Decision|6|||
13283319|NCT01054885|26463101|FG004|24-week, Double-blind Treatment Period|Physician Decision|3|||
13283320|NCT01054885|26463102|FG005|24-week, Double-blind Treatment Period|Physician Decision|1|||
13283321|NCT01054885|26463103|FG006|24-week, Double-blind Treatment Period|Physician Decision|1|||
13283322|NCT01054885|26463097|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
13283323|NCT01054885|26463098|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8|||
13283324|NCT01054885|26463099|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
13283325|NCT01054885|26463100|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
13283326|NCT01054885|26463101|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
13283327|NCT01054885|26463102|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
13283328|NCT01054885|26463103|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2|||
13283329|NCT01054846|26463117|FG000|Overall Study|Lost to Follow-up|76|||
13283330|NCT01054846|26463118|FG001|Overall Study|Lost to Follow-up|17|||
13283331|NCT01054729|26463192|FG000|Overall Study|Randomized but Not Treated|0|||
13283332|NCT01054729|26463193|FG001|Overall Study|Randomized but Not Treated|1|||
13283333|NCT01054729|26463194|FG002|Overall Study|Randomized but Not Treated|0|||
13283334|NCT01054729|26463195|FG003|Overall Study|Randomized but Not Treated|0|||
13283335|NCT01054729|26463192|FG000|Overall Study|Adverse Event|1|||
13283336|NCT01054729|26463193|FG001|Overall Study|Adverse Event|1|||
13283337|NCT01054729|26463194|FG002|Overall Study|Adverse Event|2|||
13283338|NCT01054729|26463195|FG003|Overall Study|Adverse Event|1|||
13283339|NCT01054729|26463192|FG000|Overall Study|Withdrawal by Subject|1|||
13283340|NCT01054729|26463193|FG001|Overall Study|Withdrawal by Subject|0|||
13283341|NCT01054729|26463194|FG002|Overall Study|Withdrawal by Subject|1|||
13283342|NCT01054729|26463195|FG003|Overall Study|Withdrawal by Subject|0|||
13283343|NCT01054729|26463192|FG000|Overall Study|Lost to Follow-up|0|||
13283344|NCT01054729|26463193|FG001|Overall Study|Lost to Follow-up|1|||
13283345|NCT01054729|26463194|FG002|Overall Study|Lost to Follow-up|0|||
13283346|NCT01054729|26463195|FG003|Overall Study|Lost to Follow-up|0|||
13283347|NCT01054729|26463192|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
13283348|NCT01054729|26463193|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1|||
13283349|NCT01054729|26463194|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
13283350|NCT01054729|26463195|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
13121797|NCT02973100|25944570|FG000|Overall Study|Adverse Event|1|||
13121798|NCT02973100|25944571|FG001|Overall Study|Adverse Event|2|||
13283351|NCT01054729|26463192|FG000|Overall Study|Non-responder|1|||
13283352|NCT01054729|26463193|FG001|Overall Study|Non-responder|0|||
13283353|NCT01054729|26463194|FG002|Overall Study|Non-responder|1|||
13283354|NCT01054729|26463195|FG003|Overall Study|Non-responder|1|||
13283355|NCT01054729|26463192|FG000|Overall Study|PEG/RBV Non-responder|1|||
13283356|NCT01054729|26463193|FG001|Overall Study|PEG/RBV Non-responder|0|||
13283357|NCT01054729|26463194|FG002|Overall Study|PEG/RBV Non-responder|1|||
13283358|NCT01054729|26463195|FG003|Overall Study|PEG/RBV Non-responder|0|||
13283359|NCT01054729|26463192|FG000|Overall Study|Personal/Obligations|0|||
13283360|NCT01054729|26463193|FG001|Overall Study|Personal/Obligations|1|||
13283361|NCT01054729|26463194|FG002|Overall Study|Personal/Obligations|0|||
13283362|NCT01054729|26463195|FG003|Overall Study|Personal/Obligations|0|||
13283363|NCT01054729|26463192|FG000|Overall Study|Subject moved|0|||
13283364|NCT01054729|26463193|FG001|Overall Study|Subject moved|0|||
13283365|NCT01054729|26463194|FG002|Overall Study|Subject moved|1|||
13283366|NCT01054729|26463195|FG003|Overall Study|Subject moved|0|||
13283367|NCT01054729|26463192|FG000|Overall Study|Lack of Efficacy|0|||
13283368|NCT01054729|26463193|FG001|Overall Study|Lack of Efficacy|0|||
13283369|NCT01054729|26463194|FG002|Overall Study|Lack of Efficacy|0|||
13283370|NCT01054729|26463195|FG003|Overall Study|Lack of Efficacy|1|||
13283371|NCT01054573|26463252|FG000|Overall Study|Adverse Event|1|||
13283372|NCT01054573|26463253|FG001|Overall Study|Adverse Event|0|||
13283373|NCT01054573|26463254|FG002|Overall Study|Adverse Event|1|||
13283374|NCT01054573|26463255|FG003|Overall Study|Adverse Event|1|||
13283375|NCT01054573|26463252|FG000|Overall Study|Lost to Follow-up|0|||
13283376|NCT01054573|26463253|FG001|Overall Study|Lost to Follow-up|2|||
13283377|NCT01054573|26463254|FG002|Overall Study|Lost to Follow-up|0|||
13283378|NCT01054573|26463255|FG003|Overall Study|Lost to Follow-up|0|||
13283379|NCT01054573|26463252|FG000|Overall Study|Withdrawal by Subject|0|||
13283380|NCT01054573|26463253|FG001|Overall Study|Withdrawal by Subject|2|||
13283381|NCT01054573|26463254|FG002|Overall Study|Withdrawal by Subject|2|||
13283382|NCT01054573|26463255|FG003|Overall Study|Withdrawal by Subject|1|||
13283383|NCT01054560|26463284|FG000|Overall Study|Death|10|||
13283384|NCT01054560|26463285|FG001|Overall Study|Death|21|||
13283385|NCT01054560|26463284|FG000|Overall Study|Lost to Follow-up|2|||
13283386|NCT01054560|26463285|FG001|Overall Study|Lost to Follow-up|5|||
13283387|NCT01054560|26463284|FG000|Overall Study|Withdrawal by Subject|0|||
13283388|NCT01054560|26463285|FG001|Overall Study|Withdrawal by Subject|2|||
13283389|NCT01054560|26463284|FG000|Overall Study|Physician Decision|1|||
13283390|NCT01054560|26463285|FG001|Overall Study|Physician Decision|0|||
13283391|NCT01054456|26463305|FG000|Overall Study|Other|1|||
13283392|NCT01054443|26463362|FG000|Overall Study|Withdrawal by Subject|0|||
13283393|NCT01054443|26463363|FG001|Overall Study|Withdrawal by Subject|0|||
13283394|NCT01054443|26463364|FG002|Overall Study|Withdrawal by Subject|0|||
13283395|NCT01054443|26463365|FG003|Overall Study|Withdrawal by Subject|1|||
13283396|NCT01054300|26463424|FG000|Period 1|Adverse Event|1|||
13283397|NCT01054300|26463425|FG001|Period 1|Adverse Event|0|||
13283398|NCT01054300|26463426|FG002|Period 1|Adverse Event|0|||
13283399|NCT01054300|26463427|FG003|Period 1|Adverse Event|0|||
13283400|NCT01054300|26463424|FG000|Period 2|Withdrawal by Subject|0|||
13283401|NCT01054300|26463425|FG001|Period 2|Withdrawal by Subject|0|||
13283402|NCT01054300|26463426|FG002|Period 2|Withdrawal by Subject|1|||
13283403|NCT01054300|26463427|FG003|Period 2|Withdrawal by Subject|0|||
13283404|NCT01054170|26463486|FG000|Overall Study|Protocol Violation|1|||
13283405|NCT01054170|26463487|FG001|Overall Study|Protocol Violation|0|||
13283406|NCT01054170|26463486|FG000|Overall Study|Withdrawal by Subject|3|||
13283407|NCT01054170|26463487|FG001|Overall Study|Withdrawal by Subject|2|||
13283408|NCT01054170|26463486|FG000|Overall Study|Adverse Event|0|||
13283409|NCT01054170|26463487|FG001|Overall Study|Adverse Event|4|||
13283410|NCT01053988|26463536|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220|||
13283411|NCT01053988|26463537|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
13283412|NCT01053988|26463538|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
13283413|NCT01053988|26463539|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
13283414|NCT01053988|26463540|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
13283415|NCT01053988|26463541|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
13283416|NCT01053988|26463536|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98|||
13283417|NCT01053988|26463537|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
13283418|NCT01053988|26463538|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
13283419|NCT01053988|26463539|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
13283420|NCT01053988|26463540|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
13283421|NCT01053988|26463541|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
13283422|NCT01053988|26463536|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30|||
13283423|NCT01053988|26463537|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
13283424|NCT01053988|26463538|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
13283425|NCT01053988|26463539|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
13283426|NCT01053988|26463540|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
13283427|NCT01053988|26463541|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
13283428|NCT01053988|26463536|FG000|2-week, Single-blind Run-In Period|Adverse Event|6|||
13283429|NCT01053988|26463537|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
13283430|NCT01053988|26463538|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
13283431|NCT01053988|26463539|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
13283432|NCT01053988|26463540|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
13283433|NCT01053988|26463541|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
13283434|NCT01053988|26463536|FG000|2-week, Single-blind Run-In Period|Physician Decision|5|||
13283435|NCT01053988|26463537|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
13283436|NCT01053988|26463538|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
13283437|NCT01053988|26463539|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
13283438|NCT01053988|26463540|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
13283439|NCT01053988|26463541|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
13283440|NCT01053988|26463536|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
13283441|NCT01053988|26463537|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
13283442|NCT01053988|26463538|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
13283443|NCT01053988|26463539|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
13283444|NCT01053988|26463540|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
13283445|NCT01053988|26463541|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
13283446|NCT01053988|26463536|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
13283447|NCT01053988|26463537|FG001|24-week, Double-blind Treatment Period|Adverse Event|15|||
13283448|NCT01053988|26463538|FG002|24-week, Double-blind Treatment Period|Adverse Event|23|||
13283449|NCT01053988|26463539|FG003|24-week, Double-blind Treatment Period|Adverse Event|24|||
13283450|NCT01053988|26463540|FG004|24-week, Double-blind Treatment Period|Adverse Event|17|||
13283451|NCT01053988|26463541|FG005|24-week, Double-blind Treatment Period|Adverse Event|14|||
13283452|NCT01053988|26463536|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
13283453|NCT01053988|26463537|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
13283454|NCT01053988|26463538|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
13283455|NCT01053988|26463539|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
13283456|NCT01053988|26463540|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
13283457|NCT01053988|26463541|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
13283458|NCT01053988|26463536|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
13283459|NCT01053988|26463537|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17|||
13283460|NCT01053988|26463538|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16|||
13283461|NCT01053988|26463539|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
13283462|NCT01053988|26463540|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9|||
13283463|NCT01053988|26463541|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
13283464|NCT01053988|26463536|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
13283465|NCT01053988|26463537|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3|||
13283466|NCT01053988|26463538|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4|||
13283467|NCT01053988|26463539|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
13283468|NCT01053988|26463540|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
13283469|NCT01053988|26463541|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4|||
13283470|NCT01053988|26463536|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
13283471|NCT01053988|26463537|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
13283472|NCT01053988|26463538|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5|||
13283473|NCT01053988|26463539|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8|||
13283474|NCT01053988|26463540|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
13283475|NCT01053988|26463541|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
13283476|NCT01053988|26463536|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
13283477|NCT01053988|26463537|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4|||
13283478|NCT01053988|26463538|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
13283479|NCT01053988|26463539|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
13283480|NCT01053988|26463540|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
13283481|NCT01053988|26463541|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
13283482|NCT01053988|26463536|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
13283483|NCT01053988|26463537|FG001|24-week, Double-blind Treatment Period|Physician Decision|5|||
13283484|NCT01053988|26463538|FG002|24-week, Double-blind Treatment Period|Physician Decision|2|||
13283485|NCT01053988|26463539|FG003|24-week, Double-blind Treatment Period|Physician Decision|5|||
13283486|NCT01053988|26463540|FG004|24-week, Double-blind Treatment Period|Physician Decision|5|||
13283487|NCT01053988|26463541|FG005|24-week, Double-blind Treatment Period|Physician Decision|4|||
13283488|NCT01053988|26463536|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
13283489|NCT01053988|26463537|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11|||
13283490|NCT01053988|26463538|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
13283491|NCT01053988|26463539|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
13283492|NCT01053988|26463540|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10|||
13283493|NCT01053988|26463541|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
13283494|NCT01053962|26463589|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
13283495|NCT01053962|26463590|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
13283496|NCT01053962|26463591|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
13283497|NCT01053962|26463592|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1|||
13283498|NCT01053962|26463593|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2|||
13283499|NCT01053962|26463589|FG000|Pretreatment Period|Venipuncture Failure|0|||
13283500|NCT01053962|26463590|FG001|Pretreatment Period|Venipuncture Failure|0|||
13283501|NCT01053962|26463591|FG002|Pretreatment Period|Venipuncture Failure|1|||
13283502|NCT01053962|26463592|FG003|Pretreatment Period|Venipuncture Failure|0|||
13283503|NCT01053962|26463593|FG004|Pretreatment Period|Venipuncture Failure|0|||
13283504|NCT01053962|26463589|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0|||
13283505|NCT01053962|26463590|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1|||
13283506|NCT01053962|26463591|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0|||
13283507|NCT01053962|26463592|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0|||
13283508|NCT01053962|26463593|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0|||
13283509|NCT01053962|26463589|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0|||
13283510|NCT01053962|26463590|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0|||
13283511|NCT01053962|26463591|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0|||
13283512|NCT01053962|26463592|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1|||
13121799|NCT02973100|25944572|FG002|Overall Study|Adverse Event|1|||
13121800|NCT02973100|25944573|FG003|Overall Study|Adverse Event|2|||
13121801|NCT02973100|25944570|FG000|Overall Study|Lost to Follow-up|3|||
13283513|NCT01053962|26463593|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0|||
13283514|NCT01053962|26463589|FG000|Treatment Period|Lack of Efficacy|0|||
13283515|NCT01053962|26463590|FG001|Treatment Period|Lack of Efficacy|0|||
13283516|NCT01053962|26463591|FG002|Treatment Period|Lack of Efficacy|0|||
13283517|NCT01053962|26463592|FG003|Treatment Period|Lack of Efficacy|0|||
13283518|NCT01053962|26463593|FG004|Treatment Period|Lack of Efficacy|1|||
13283519|NCT01053962|26463589|FG000|Treatment Period|Adverse Event|0|||
13121802|NCT02973100|25944571|FG001|Overall Study|Lost to Follow-up|1|||
13121803|NCT02973100|25944572|FG002|Overall Study|Lost to Follow-up|1|||
13121804|NCT02973100|25944573|FG003|Overall Study|Lost to Follow-up|0|||
13121805|NCT02973100|25944570|FG000|Overall Study|Withdrawal by Subject|3|||
13121806|NCT02973100|25944571|FG001|Overall Study|Withdrawal by Subject|5|||
13121807|NCT02973100|25944572|FG002|Overall Study|Withdrawal by Subject|1|||
13121808|NCT02973100|25944573|FG003|Overall Study|Withdrawal by Subject|4|||
13121809|NCT02973100|25944570|FG000|Overall Study|Notification of change in address|0|||
13121810|NCT02973100|25944571|FG001|Overall Study|Notification of change in address|0|||
13121811|NCT02973100|25944572|FG002|Overall Study|Notification of change in address|0|||
13121812|NCT02973100|25944573|FG003|Overall Study|Notification of change in address|1|||
13121813|NCT02973100|25944570|FG000|Overall Study|Failed to attend Safety followup period|0|||
13121814|NCT02973100|25944571|FG001|Overall Study|Failed to attend Safety followup period|0|||
13121815|NCT02973100|25944572|FG002|Overall Study|Failed to attend Safety followup period|1|||
13121816|NCT02973100|25944573|FG003|Overall Study|Failed to attend Safety followup period|0|||
13121817|NCT02973087|25944682|FG000|Overall Study|Withdrawal by Subject|2|||
13121818|NCT02973087|25944683|FG001|Overall Study|Withdrawal by Subject|1|||
13121819|NCT02973087|25944682|FG000|Overall Study|Adverse Event|1|||
13121820|NCT02973087|25944683|FG001|Overall Study|Adverse Event|0|||
13121821|NCT02973087|25944682|FG000|Overall Study|other|1|||
13121822|NCT02973087|25944683|FG001|Overall Study|other|1|||
13121823|NCT02973048|25944738|FG000|Overall Study|Epidural catheter insertion failure|1|||
13121824|NCT02973048|25944739|FG001|Overall Study|Epidural catheter insertion failure|0|||
13121825|NCT02973048|25944738|FG000|Overall Study|Withdrawal by Subject|0|||
13121826|NCT02973048|25944739|FG001|Overall Study|Withdrawal by Subject|3|||
13121827|NCT02972658|25944782|FG000|Overall Study|Adverse Event|0|||
13121828|NCT02972658|25944783|FG001|Overall Study|Adverse Event|3|||
13121829|NCT02972658|25944784|FG002|Overall Study|Adverse Event|0|||
13121830|NCT02972658|25944785|FG003|Overall Study|Adverse Event|2|||
13121831|NCT02972658|25944782|FG000|Overall Study|Other-determined by Investigator|1|||
13121832|NCT02972658|25944783|FG001|Overall Study|Other-determined by Investigator|1|||
13283520|NCT01053962|26463590|FG001|Treatment Period|Adverse Event|0|||
13283521|NCT01053962|26463591|FG002|Treatment Period|Adverse Event|0|||
13283522|NCT01053962|26463592|FG003|Treatment Period|Adverse Event|0|||
13121833|NCT02972658|25944784|FG002|Overall Study|Other-determined by Investigator|0|||
13121834|NCT02972658|25944785|FG003|Overall Study|Other-determined by Investigator|0|||
13121835|NCT02972658|25944782|FG000|Overall Study|Death|0|||
13121836|NCT02972658|25944783|FG001|Overall Study|Death|0|||
13121837|NCT02972658|25944784|FG002|Overall Study|Death|0|||
13283523|NCT01053962|26463593|FG004|Treatment Period|Adverse Event|1|||
13283524|NCT01053962|26463589|FG000|Treatment Period|Withdrawal by Subject|0|||
13283525|NCT01053962|26463590|FG001|Treatment Period|Withdrawal by Subject|0|||
13283526|NCT01053962|26463591|FG002|Treatment Period|Withdrawal by Subject|0|||
13283527|NCT01053962|26463592|FG003|Treatment Period|Withdrawal by Subject|0|||
13283528|NCT01053962|26463593|FG004|Treatment Period|Withdrawal by Subject|1|||
13283529|NCT01053962|26463589|FG000|Treatment Period|Noncompliance with protocol|1|||
13283530|NCT01053962|26463590|FG001|Treatment Period|Noncompliance with protocol|0|||
13283531|NCT01053962|26463591|FG002|Treatment Period|Noncompliance with protocol|0|||
13121838|NCT02972658|25944785|FG003|Overall Study|Death|1|||
13121839|NCT02972658|25944782|FG000|Overall Study|Lost to Follow-up|0|||
13121840|NCT02972658|25944783|FG001|Overall Study|Lost to Follow-up|1|||
13121841|NCT02972658|25944784|FG002|Overall Study|Lost to Follow-up|1|||
13121842|NCT02972658|25944785|FG003|Overall Study|Lost to Follow-up|2|||
13283532|NCT01053962|26463592|FG003|Treatment Period|Noncompliance with protocol|0|||
13283533|NCT01053962|26463593|FG004|Treatment Period|Noncompliance with protocol|0|||
13283534|NCT01053741|26463606|FG000|2nd Study Intervention|Physician Decision|0|||
13283535|NCT01053741|26463607|FG001|2nd Study Intervention|Physician Decision|1|||
13283536|NCT01053247|26463625|FG000|Overall Study|Withdrawal by Subject|9|||
13283537|NCT01053247|26463626|FG001|Overall Study|Withdrawal by Subject|4|||
13283538|NCT01053247|26463627|FG002|Overall Study|Withdrawal by Subject|15|||
13283539|NCT01053247|26463625|FG000|Overall Study|Lack of Efficacy|1|||
13283540|NCT01053247|26463626|FG001|Overall Study|Lack of Efficacy|0|||
13283541|NCT01053247|26463627|FG002|Overall Study|Lack of Efficacy|1|||
13283542|NCT01053247|26463625|FG000|Overall Study|Protocol Violation|2|||
13283543|NCT01053247|26463626|FG001|Overall Study|Protocol Violation|1|||
13283544|NCT01053247|26463627|FG002|Overall Study|Protocol Violation|2|||
13283545|NCT01053247|26463625|FG000|Overall Study|Lost to Follow-up|8|||
13283546|NCT01053247|26463626|FG001|Overall Study|Lost to Follow-up|5|||
13283547|NCT01053247|26463627|FG002|Overall Study|Lost to Follow-up|7|||
13283548|NCT01053247|26463625|FG000|Overall Study|Adverse Event|0|||
13283549|NCT01053247|26463626|FG001|Overall Study|Adverse Event|9|||
13283550|NCT01053247|26463627|FG002|Overall Study|Adverse Event|3|||
13283551|NCT01053221|26463648|FG000|Overall Study|The study was closed prematurely|5|||
13283552|NCT01053221|26463649|FG001|Overall Study|The study was closed prematurely|9|||
13283553|NCT01052779|26463664|FG000|Overall Study|Adverse Event|1|||
13283554|NCT01052779|26463665|FG001|Overall Study|Adverse Event|4|||
13283555|NCT01052779|26463664|FG000|Overall Study|Withdrawal by Subject|1|||
13283556|NCT01052779|26463665|FG001|Overall Study|Withdrawal by Subject|2|||
13283557|NCT01052779|26463664|FG000|Overall Study|Other-Protocol Violation|1|||
13283558|NCT01052779|26463665|FG001|Overall Study|Other-Protocol Violation|1|||
13283559|NCT01052779|26463664|FG000|Overall Study|Other-Surgery|0|||
13283560|NCT01052779|26463665|FG001|Overall Study|Other-Surgery|2|||
13283561|NCT01052779|26463664|FG000|Overall Study|Other-Missed Week 5 Visit|2|||
13283562|NCT01052779|26463665|FG001|Overall Study|Other-Missed Week 5 Visit|0|||
13283563|NCT01052662|26463689|FG000|Overall Study|Lost to Follow-up|15|||
13283564|NCT01052662|26463690|FG001|Overall Study|Lost to Follow-up|13|||
13283565|NCT01052662|26463691|FG002|Overall Study|Lost to Follow-up|18|||
13283566|NCT01052662|26463689|FG000|Overall Study|Withdrawal by Subject|3|||
13283567|NCT01052662|26463690|FG001|Overall Study|Withdrawal by Subject|2|||
13283568|NCT01052662|26463691|FG002|Overall Study|Withdrawal by Subject|1|||
13283569|NCT01052662|26463689|FG000|Overall Study|Pharmacy issue|1|||
13283570|NCT01052662|26463690|FG001|Overall Study|Pharmacy issue|3|||
13283571|NCT01052662|26463691|FG002|Overall Study|Pharmacy issue|3|||
13283572|NCT01052662|26463689|FG000|Overall Study|Adverse Event|1|||
13283573|NCT01052662|26463690|FG001|Overall Study|Adverse Event|1|||
13283574|NCT01052662|26463691|FG002|Overall Study|Adverse Event|0|||
13283575|NCT01052662|26463689|FG000|Overall Study|Legal Problem|2|||
13283576|NCT01052662|26463690|FG001|Overall Study|Legal Problem|0|||
13283577|NCT01052662|26463691|FG002|Overall Study|Legal Problem|0|||
13283578|NCT01052662|26463689|FG000|Overall Study|Administrative|0|||
13283579|NCT01052662|26463690|FG001|Overall Study|Administrative|3|||
13283580|NCT01052662|26463691|FG002|Overall Study|Administrative|0|||
13283581|NCT01052493|26463720|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1|||
13283582|NCT01052493|26463721|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
13283583|NCT01052493|26463722|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
13283584|NCT01052116|26463735|FG000|Overall Study|Lost to Follow-up|11|||
13283585|NCT01052116|26463736|FG001|Overall Study|Lost to Follow-up|17|||
13283586|NCT01052116|26463735|FG000|Overall Study|Withdrawal by Subject|3|||
13283587|NCT01052116|26463736|FG001|Overall Study|Withdrawal by Subject|6|||
13283588|NCT01052116|26463735|FG000|Overall Study|Spirometry not performed|0|||
13283589|NCT01052116|26463736|FG001|Overall Study|Spirometry not performed|4|||
13283590|NCT01052103|26463797|FG000|Overall Study|Adverse Event|10|||
13283591|NCT01052103|26463798|FG001|Overall Study|Adverse Event|6|||
13283592|NCT01052103|26463797|FG000|Overall Study|Entry Criteria Not Met|3|||
13121843|NCT02972658|25944782|FG000|Overall Study|Progressive Disease|0|||
13121844|NCT02972658|25944783|FG001|Overall Study|Progressive Disease|1|||
13292007|NCT00708916|26484295|FG000|Overall Study|Adverse Event|2|||
13283593|NCT01052103|26463798|FG001|Overall Study|Entry Criteria Not Met|1|||
13283594|NCT01052103|26463797|FG000|Overall Study|Lost to Follow-up|3|||
13283595|NCT01052103|26463798|FG001|Overall Study|Lost to Follow-up|5|||
13283596|NCT01052103|26463797|FG000|Overall Study|Protocol Violation|10|||
13283597|NCT01052103|26463798|FG001|Overall Study|Protocol Violation|4|||
13283598|NCT01052103|26463797|FG000|Overall Study|Scheduling conflict|2|||
13283599|NCT01052103|26463798|FG001|Overall Study|Scheduling conflict|1|||
13283600|NCT01052103|26463797|FG000|Overall Study|Sponsor Decision|2|||
13283601|NCT01052103|26463798|FG001|Overall Study|Sponsor Decision|0|||
13283602|NCT01052103|26463797|FG000|Overall Study|Withdrawal by Subject|3|||
13283603|NCT01052103|26463798|FG001|Overall Study|Withdrawal by Subject|6|||
13283604|NCT01052103|26463797|FG000|Overall Study|Perceived Lack of Efficacy|1|||
13283605|NCT01052103|26463798|FG001|Overall Study|Perceived Lack of Efficacy|0|||
13283606|NCT01052077|26463831|FG000|Phase A|Lost to Follow-up|22|||
13283607|NCT01052077|26463832|FG001|Phase A|Lost to Follow-up|0|||
13283608|NCT01052077|26463833|FG002|Phase A|Lost to Follow-up|0|||
13283609|NCT01052077|26463834|FG003|Phase A|Lost to Follow-up|0|||
13283610|NCT01052077|26463831|FG000|Phase A|Adverse Event|32|||
13283611|NCT01052077|26463832|FG001|Phase A|Adverse Event|0|||
13283612|NCT01052077|26463833|FG002|Phase A|Adverse Event|0|||
13283613|NCT01052077|26463834|FG003|Phase A|Adverse Event|0|||
13283614|NCT01052077|26463831|FG000|Phase A|Met Withdrawal Criteria|26|||
13283615|NCT01052077|26463832|FG001|Phase A|Met Withdrawal Criteria|0|||
13283616|NCT01052077|26463833|FG002|Phase A|Met Withdrawal Criteria|0|||
13283617|NCT01052077|26463834|FG003|Phase A|Met Withdrawal Criteria|0|||
13283618|NCT01052077|26463831|FG000|Phase A|Physician Decision|10|||
13283619|NCT01052077|26463832|FG001|Phase A|Physician Decision|0|||
13283620|NCT01052077|26463833|FG002|Phase A|Physician Decision|0|||
13283621|NCT01052077|26463834|FG003|Phase A|Physician Decision|0|||
13283622|NCT01052077|26463831|FG000|Phase A|Withdrawal by Subject|29|||
13283623|NCT01052077|26463832|FG001|Phase A|Withdrawal by Subject|0|||
13283624|NCT01052077|26463833|FG002|Phase A|Withdrawal by Subject|0|||
13283625|NCT01052077|26463834|FG003|Phase A|Withdrawal by Subject|0|||
13283626|NCT01052077|26463831|FG000|Phase A|Protocol Deviation|27|||
13283627|NCT01052077|26463832|FG001|Phase A|Protocol Deviation|0|||
13283628|NCT01052077|26463833|FG002|Phase A|Protocol Deviation|0|||
13283629|NCT01052077|26463834|FG003|Phase A|Protocol Deviation|0|||
13283630|NCT01052077|26463831|FG000|Phase B|Lost to Follow-up|0|||
13283631|NCT01052077|26463832|FG001|Phase B|Lost to Follow-up|2|||
13283632|NCT01052077|26463833|FG002|Phase B|Lost to Follow-up|3|||
13283633|NCT01052077|26463834|FG003|Phase B|Lost to Follow-up|0|||
13283634|NCT01052077|26463831|FG000|Phase B|Adverse Event|0|||
13283635|NCT01052077|26463832|FG001|Phase B|Adverse Event|9|||
13283636|NCT01052077|26463833|FG002|Phase B|Adverse Event|2|||
13283637|NCT01052077|26463834|FG003|Phase B|Adverse Event|0|||
13283638|NCT01052077|26463831|FG000|Phase B|Met Withdrawal Criteria|0|||
13283639|NCT01052077|26463832|FG001|Phase B|Met Withdrawal Criteria|2|||
13283640|NCT01052077|26463833|FG002|Phase B|Met Withdrawal Criteria|1|||
13283641|NCT01052077|26463834|FG003|Phase B|Met Withdrawal Criteria|0|||
13283642|NCT01052077|26463831|FG000|Phase B|Physician Decision|0|||
13283643|NCT01052077|26463832|FG001|Phase B|Physician Decision|1|||
13283644|NCT01052077|26463833|FG002|Phase B|Physician Decision|1|||
13283645|NCT01052077|26463834|FG003|Phase B|Physician Decision|0|||
13283646|NCT01052077|26463831|FG000|Phase B|Withdrawal by Subject|0|||
13283647|NCT01052077|26463832|FG001|Phase B|Withdrawal by Subject|0|||
13283648|NCT01052077|26463833|FG002|Phase B|Withdrawal by Subject|5|||
13283649|NCT01052077|26463834|FG003|Phase B|Withdrawal by Subject|0|||
13283650|NCT01052077|26463831|FG000|Phase B|Protocol Deviation|0|||
13283651|NCT01052077|26463832|FG001|Phase B|Protocol Deviation|3|||
13283652|NCT01052077|26463833|FG002|Phase B|Protocol Deviation|4|||
13283653|NCT01052077|26463834|FG003|Phase B|Protocol Deviation|0|||
13283654|NCT01052077|26463831|FG000|Phase B|Lack of Efficacy|0|||
13283655|NCT01052077|26463832|FG001|Phase B|Lack of Efficacy|1|||
13283656|NCT01052077|26463833|FG002|Phase B|Lack of Efficacy|0|||
13308160|NCT01276639|26531266|FG003|Week 0 to 16|Death|0|||
13283657|NCT01052077|26463834|FG003|Phase B|Lack of Efficacy|0|||
13283658|NCT01052077|26463831|FG000|Phase A+|Lost to Follow-up|0|||
13283659|NCT01052077|26463832|FG001|Phase A+|Lost to Follow-up|0|||
13283660|NCT01052077|26463833|FG002|Phase A+|Lost to Follow-up|0|||
13283661|NCT01052077|26463834|FG003|Phase A+|Lost to Follow-up|8|||
13283662|NCT01052077|26463831|FG000|Phase A+|Adverse Event|0|||
13283663|NCT01052077|26463832|FG001|Phase A+|Adverse Event|0|||
13283664|NCT01052077|26463833|FG002|Phase A+|Adverse Event|0|||
13283665|NCT01052077|26463834|FG003|Phase A+|Adverse Event|4|||
13283666|NCT01052077|26463831|FG000|Phase A+|Met Withdrawal Criteria|0|||
13283667|NCT01052077|26463832|FG001|Phase A+|Met Withdrawal Criteria|0|||
13283668|NCT01052077|26463833|FG002|Phase A+|Met Withdrawal Criteria|0|||
13283669|NCT01052077|26463834|FG003|Phase A+|Met Withdrawal Criteria|2|||
13283670|NCT01052077|26463831|FG000|Phase A+|Withdrawal by Subject|0|||
13283671|NCT01052077|26463832|FG001|Phase A+|Withdrawal by Subject|0|||
13283672|NCT01052077|26463833|FG002|Phase A+|Withdrawal by Subject|0|||
13283673|NCT01052077|26463834|FG003|Phase A+|Withdrawal by Subject|7|||
13308161|NCT01276639|26531267|FG004|Week 0 to 16|Death|0|||
13283674|NCT01052038|26463864|FG000|Overall Study|Lost to Follow-up|2|||
13283675|NCT01052038|26463865|FG001|Overall Study|Lost to Follow-up|3|||
13283676|NCT01052038|26463866|FG002|Overall Study|Lost to Follow-up|1|||
13283677|NCT01052038|26463864|FG000|Overall Study|Protocol Violation|2|||
13283678|NCT01052038|26463865|FG001|Overall Study|Protocol Violation|3|||
13283679|NCT01052038|26463866|FG002|Overall Study|Protocol Violation|3|||
13283680|NCT01052012|26463947|FG000|Overall Study|Not treated|2|||
13283681|NCT01052012|26463948|FG001|Overall Study|Not treated|5|||
13283682|NCT01052012|26463949|FG002|Overall Study|Not treated|0|||
13283683|NCT01052012|26463950|FG003|Overall Study|Not treated|0|||
13283684|NCT01052012|26463951|FG004|Overall Study|Not treated|11|||
13283685|NCT01052012|26463952|FG005|Overall Study|Not treated|8|||
13283686|NCT01052012|26463947|FG000|Overall Study|Adverse Event|1|||
13283687|NCT01052012|26463948|FG001|Overall Study|Adverse Event|0|||
13283688|NCT01052012|26463949|FG002|Overall Study|Adverse Event|0|||
13283689|NCT01052012|26463950|FG003|Overall Study|Adverse Event|1|||
13283690|NCT01052012|26463951|FG004|Overall Study|Adverse Event|0|||
13283691|NCT01052012|26463952|FG005|Overall Study|Adverse Event|0|||
13283692|NCT01052012|26463947|FG000|Overall Study|Lost to Follow-up|0|||
13283693|NCT01052012|26463948|FG001|Overall Study|Lost to Follow-up|0|||
13283694|NCT01052012|26463949|FG002|Overall Study|Lost to Follow-up|0|||
13283695|NCT01052012|26463950|FG003|Overall Study|Lost to Follow-up|0|||
13121845|NCT02972658|25944784|FG002|Overall Study|Progressive Disease|0|||
13121846|NCT02972658|25944785|FG003|Overall Study|Progressive Disease|1|||
13121847|NCT02972658|25944782|FG000|Overall Study|Withdrawal by Subject|4|||
13121848|NCT02972658|25944783|FG001|Overall Study|Withdrawal by Subject|4|||
13121849|NCT02972658|25944784|FG002|Overall Study|Withdrawal by Subject|1|||
13121850|NCT02972658|25944785|FG003|Overall Study|Withdrawal by Subject|6|||
13121851|NCT02972658|25944782|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
13121852|NCT02972658|25944783|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
13121853|NCT02972658|25944784|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
13121854|NCT02972658|25944785|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0|||
13121855|NCT02972658|25944782|FG000|Overall Study|Sponsor Decision|70|||
13121856|NCT02972658|25944783|FG001|Overall Study|Sponsor Decision|127|||
13121857|NCT02972658|25944784|FG002|Overall Study|Sponsor Decision|72|||
13121858|NCT02972658|25944785|FG003|Overall Study|Sponsor Decision|119|||
13121859|NCT02972632|25944798|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
13121860|NCT02972632|25944798|FG000|Overall Study|Lost to Follow-up|4|||
13121861|NCT02972632|25944798|FG000|Overall Study|Voluntary Withdrawal|10|||
13121862|NCT02972515|25944807|FG000|Overall Study|Lost to Follow-up|78|||
13121863|NCT02972502|25944824|FG000|Overall Study|Lost to Follow-up|3|||
13121864|NCT02972502|25944825|FG001|Overall Study|Lost to Follow-up|1|||
13121865|NCT02972502|25944824|FG000|Overall Study|Withdrawal by Subject|1|||
13121866|NCT02972502|25944825|FG001|Overall Study|Withdrawal by Subject|1|||
13121867|NCT02972359|25944838|FG000|Overall Study|Incl. criteria not met/Exclusion met|2|||
13121868|NCT02972359|25944838|FG000|Overall Study|Lack of Efficacy|1|||
13121869|NCT02972359|25944838|FG000|Overall Study|Adverse Event|4|||
13121870|NCT02972359|25944838|FG000|Overall Study|Death|1|||
13121871|NCT02972359|25944838|FG000|Overall Study|Withdrawal by Subject|30|||
13121872|NCT02972359|25944838|FG000|Overall Study|Protocol Violation|1|||
13121873|NCT02972359|25944838|FG000|Overall Study|Lost to Follow-up|26|||
13121874|NCT02972359|25944838|FG000|Overall Study|Other reasons|5|||
13121875|NCT02972359|25944838|FG000|Overall Study|Missing|1|||
13121876|NCT02972242|25944867|FG000|Overall Study|Withdrawal by Subject|1|||
13121877|NCT02972242|25944868|FG001|Overall Study|Withdrawal by Subject|0|||
13121878|NCT02971800|25944876|FG000|Overall Study|Protocol Violation|1|||
13121879|NCT02971800|25944876|FG000|Overall Study|Withdrawal by Subject|1|||
13121880|NCT02971800|25944876|FG000|Overall Study|Exclusion criteria prior intervention|1|||
13121881|NCT02971800|25944876|FG000|Overall Study|Number evaluable participant already reached|4|||
13121882|NCT02971683|25944905|FG000|Overall Study|Other reasons|0|||
13121883|NCT02971683|25944906|FG001|Overall Study|Other reasons|1|||
13121884|NCT02971683|25944905|FG000|Overall Study|Poor/Non-Compliance|0|||
13121885|NCT02971683|25944906|FG001|Overall Study|Poor/Non-Compliance|1|||
13121886|NCT02971683|25944905|FG000|Overall Study|Lost to Follow-up|1|||
13121887|NCT02971683|25944906|FG001|Overall Study|Lost to Follow-up|0|||
13121888|NCT02971683|25944905|FG000|Overall Study|Participant withdrew consent|1|||
13121889|NCT02971683|25944906|FG001|Overall Study|Participant withdrew consent|1|||
13121890|NCT02971683|25944905|FG000|Overall Study|Participant request to discontinue study treatment|1|||
13121891|NCT02971683|25944906|FG001|Overall Study|Participant request to discontinue study treatment|1|||
13121892|NCT02971683|25944905|FG000|Overall Study|Adverse Event|1|||
13283696|NCT01052012|26463951|FG004|Overall Study|Lost to Follow-up|1|||
13283697|NCT01052012|26463952|FG005|Overall Study|Lost to Follow-up|0|||
13283698|NCT01052012|26463947|FG000|Overall Study|Withdrawal by Subject|1|||
13283699|NCT01052012|26463948|FG001|Overall Study|Withdrawal by Subject|1|||
13283700|NCT01052012|26463949|FG002|Overall Study|Withdrawal by Subject|0|||
13283701|NCT01052012|26463950|FG003|Overall Study|Withdrawal by Subject|0|||
13283702|NCT01052012|26463951|FG004|Overall Study|Withdrawal by Subject|3|||
13283703|NCT01052012|26463952|FG005|Overall Study|Withdrawal by Subject|1|||
13121893|NCT02971683|25944906|FG001|Overall Study|Adverse Event|2|||
13121894|NCT02971683|25944905|FG000|Overall Study|Lack of Efficacy|2|||
13121895|NCT02971683|25944906|FG001|Overall Study|Lack of Efficacy|2|||
13121896|NCT02971670|25944937|FG000|Overall Study|Withdrawal by Subject|4|||
13121897|NCT02971670|25944938|FG001|Overall Study|Withdrawal by Subject|1|||
13121898|NCT02971670|25944939|FG002|Overall Study|Withdrawal by Subject|1|||
13121899|NCT02971670|25944940|FG003|Overall Study|Withdrawal by Subject|2|||
13121900|NCT02971605|25944957|FG000|Overall Study|Withdrawal by Subject|1|||
13121901|NCT02971228|25945005|FG000|Overall Study|Withdrawal by Subject|1|||
13121902|NCT02971228|25945006|FG001|Overall Study|Withdrawal by Subject|1|||
13121903|NCT02971228|25945007|FG002|Overall Study|Withdrawal by Subject|0|||
13121904|NCT02971228|25945008|FG003|Overall Study|Withdrawal by Subject|0|||
13121905|NCT02971228|25945009|FG004|Overall Study|Withdrawal by Subject|0|||
13121906|NCT02971228|25945005|FG000|Overall Study|Logistical challenges|0|||
13121907|NCT02971228|25945006|FG001|Overall Study|Logistical challenges|1|||
13121908|NCT02971228|25945007|FG002|Overall Study|Logistical challenges|0|||
13283704|NCT01052012|26463947|FG000|Overall Study|Physician Decision|0|||
13283705|NCT01052012|26463948|FG001|Overall Study|Physician Decision|0|||
13283706|NCT01052012|26463949|FG002|Overall Study|Physician Decision|0|||
13283707|NCT01052012|26463950|FG003|Overall Study|Physician Decision|0|||
13283708|NCT01052012|26463951|FG004|Overall Study|Physician Decision|0|||
13283709|NCT01052012|26463952|FG005|Overall Study|Physician Decision|1|||
13283710|NCT01052012|26463947|FG000|Overall Study|Other|0|||
13283711|NCT01052012|26463948|FG001|Overall Study|Other|0|||
13283712|NCT01052012|26463949|FG002|Overall Study|Other|0|||
13283713|NCT01052012|26463950|FG003|Overall Study|Other|0|||
13283714|NCT01052012|26463951|FG004|Overall Study|Other|1|||
13283715|NCT01052012|26463952|FG005|Overall Study|Other|0|||
13283716|NCT01051986|26463973|FG000|Overall Study|Death|1|||
13283717|NCT01051986|26463974|FG001|Overall Study|Death|0|||
13283718|NCT01051986|26463973|FG000|Overall Study|Withdrawal by Subject|2|||
13283719|NCT01051986|26463974|FG001|Overall Study|Withdrawal by Subject|1|||
13283720|NCT01051986|26463973|FG000|Overall Study|Protocol Violation|2|||
13283721|NCT01051986|26463974|FG001|Overall Study|Protocol Violation|3|||
13283722|NCT01051960|26463984|FG000|Overall Study|Adverse Event|1|||
13283723|NCT01051921|26463991|FG000|Overall Study|Physician Decision|9|||
13283724|NCT01051921|26463991|FG000|Overall Study|Adverse Event|8|||
13283725|NCT01051921|26463991|FG000|Overall Study|Withdrawal by Subject|7|||
13283726|NCT01051921|26463991|FG000|Overall Study|Lost to Follow-up|4|||
13283727|NCT01051921|26463991|FG000|Overall Study|virological failure|1|||
13283728|NCT01051921|26463991|FG000|Overall Study|patient moved|1|||
13283729|NCT01051856|26464006|FG000|Overall Study|Withdrawal by Subject|1|||
13283730|NCT01051856|26464007|FG001|Overall Study|Withdrawal by Subject|0|||
13283731|NCT01051817|26464024|FG000|Overall Study|Adverse Event|0|||
13283732|NCT01051817|26464025|FG001|Overall Study|Adverse Event|2|||
13283733|NCT01051817|26464024|FG000|Overall Study|Abnormal Test Proceedure reults|0|||
13283734|NCT01051817|26464025|FG001|Overall Study|Abnormal Test Proceedure reults|1|||
13283735|NCT01051817|26464024|FG000|Overall Study|Withdrawal by Subject|3|||
13283736|NCT01051817|26464025|FG001|Overall Study|Withdrawal by Subject|5|||
13283737|NCT01051817|26464024|FG000|Overall Study|Protocol Violation|0|||
13283738|NCT01051817|26464025|FG001|Overall Study|Protocol Violation|1|||
13283739|NCT01051791|26464034|FG000|Overall Study|Failed screening|3|||
13283740|NCT01051791|26464034|FG000|Overall Study|Withdrawal by Subject|1|||
13283741|NCT01051739|26464047|FG000|Overall Study|Death|3|||
13283742|NCT01051739|26464048|FG001|Overall Study|Death|3|||
13308162|NCT01276639|26531263|FG000|Week 0 to 16|Adverse Event|11|||
13308163|NCT01276639|26531264|FG001|Week 0 to 16|Adverse Event|8|||
13308164|NCT01276639|26531265|FG002|Week 0 to 16|Adverse Event|11|||
13308165|NCT01276639|26531266|FG003|Week 0 to 16|Adverse Event|0|||
13308166|NCT01276639|26531267|FG004|Week 0 to 16|Adverse Event|0|||
13308167|NCT01276639|26531263|FG000|Week 0 to 16|Lack of Efficacy|20|||
13308168|NCT01276639|26531264|FG001|Week 0 to 16|Lack of Efficacy|15|||
13308169|NCT01276639|26531265|FG002|Week 0 to 16|Lack of Efficacy|25|||
13308170|NCT01276639|26531266|FG003|Week 0 to 16|Lack of Efficacy|0|||
13308171|NCT01276639|26531267|FG004|Week 0 to 16|Lack of Efficacy|0|||
13308172|NCT01276639|26531263|FG000|Week 0 to 16|Lost to Follow-up|3|||
13283743|NCT01051739|26464047|FG000|Overall Study|Withdrawal by Subject|25|||
13283744|NCT01051739|26464048|FG001|Overall Study|Withdrawal by Subject|10|||
13283745|NCT01051661|26464246|FG000|Overall Study|Adverse Event|1|||
13283746|NCT01051661|26464247|FG001|Overall Study|Adverse Event|1|||
13283747|NCT01051661|26464248|FG002|Overall Study|Adverse Event|1|||
13283748|NCT01051661|26464249|FG003|Overall Study|Adverse Event|1|||
13283749|NCT01051661|26464250|FG004|Overall Study|Adverse Event|0|||
13283750|NCT01051661|26464251|FG005|Overall Study|Adverse Event|0|||
13283751|NCT01051661|26464246|FG000|Overall Study|Lost to Follow-up|13|||
13283752|NCT01051661|26464247|FG001|Overall Study|Lost to Follow-up|22|||
13283753|NCT01051661|26464248|FG002|Overall Study|Lost to Follow-up|15|||
13308173|NCT01276639|26531264|FG001|Week 0 to 16|Lost to Follow-up|5|||
13308174|NCT01276639|26531265|FG002|Week 0 to 16|Lost to Follow-up|3|||
13308175|NCT01276639|26531266|FG003|Week 0 to 16|Lost to Follow-up|0|||
13308176|NCT01276639|26531267|FG004|Week 0 to 16|Lost to Follow-up|0|||
13308177|NCT01276639|26531263|FG000|Week 0 to 16|Withdrawal by Subject|8|||
13308178|NCT01276639|26531264|FG001|Week 0 to 16|Withdrawal by Subject|5|||
13308179|NCT01276639|26531265|FG002|Week 0 to 16|Withdrawal by Subject|4|||
13308180|NCT01276639|26531266|FG003|Week 0 to 16|Withdrawal by Subject|0|||
13308181|NCT01276639|26531267|FG004|Week 0 to 16|Withdrawal by Subject|0|||
13308182|NCT01276639|26531263|FG000|Week 0 to 16|Other|7|||
13121909|NCT02971228|25945008|FG003|Overall Study|Logistical challenges|0|||
13121910|NCT02971228|25945009|FG004|Overall Study|Logistical challenges|0|||
13121911|NCT02971202|25945033|FG000|Overall Study|Pregnancy|1|||
13121912|NCT02971202|25945034|FG001|Overall Study|Pregnancy|0|||
13121913|NCT02971202|25945035|FG002|Overall Study|Pregnancy|0|||
13121914|NCT02971202|25945033|FG000|Overall Study|screen fail after consent|1|||
13121915|NCT02971202|25945034|FG001|Overall Study|screen fail after consent|0|||
13121916|NCT02971202|25945035|FG002|Overall Study|screen fail after consent|1|||
13121917|NCT02971163|25945062|FG000|Overall Study|Lost to Follow-up|4|||
13121918|NCT02971163|25945063|FG001|Overall Study|Lost to Follow-up|2|||
13283754|NCT01051661|26464249|FG003|Overall Study|Lost to Follow-up|17|||
13283755|NCT01051661|26464250|FG004|Overall Study|Lost to Follow-up|10|||
13283756|NCT01051661|26464251|FG005|Overall Study|Lost to Follow-up|24|||
13283757|NCT01051661|26464246|FG000|Overall Study|Migrated/moved from study area|1|||
13283758|NCT01051661|26464247|FG001|Overall Study|Migrated/moved from study area|6|||
13283759|NCT01051661|26464248|FG002|Overall Study|Migrated/moved from study area|6|||
13283760|NCT01051661|26464249|FG003|Overall Study|Migrated/moved from study area|8|||
13283761|NCT01051661|26464250|FG004|Overall Study|Migrated/moved from study area|7|||
13283762|NCT01051661|26464251|FG005|Overall Study|Migrated/moved from study area|3|||
13283763|NCT01051661|26464246|FG000|Overall Study|Refused blood sampling|0|||
13283764|NCT01051661|26464247|FG001|Overall Study|Refused blood sampling|0|||
13283765|NCT01051661|26464248|FG002|Overall Study|Refused blood sampling|0|||
13283766|NCT01051661|26464249|FG003|Overall Study|Refused blood sampling|0|||
13283767|NCT01051661|26464250|FG004|Overall Study|Refused blood sampling|0|||
13283768|NCT01051661|26464251|FG005|Overall Study|Refused blood sampling|1|||
13283769|NCT01051661|26464246|FG000|Overall Study|Data not reliable|1|||
13283770|NCT01051661|26464247|FG001|Overall Study|Data not reliable|0|||
13283771|NCT01051661|26464248|FG002|Overall Study|Data not reliable|0|||
13283772|NCT01051661|26464249|FG003|Overall Study|Data not reliable|0|||
13283773|NCT01051661|26464250|FG004|Overall Study|Data not reliable|0|||
13283774|NCT01051661|26464251|FG005|Overall Study|Data not reliable|1|||
13283775|NCT01051661|26464246|FG000|Overall Study|Unable to attend visit(s)|2|||
13283776|NCT01051661|26464247|FG001|Overall Study|Unable to attend visit(s)|4|||
13283777|NCT01051661|26464248|FG002|Overall Study|Unable to attend visit(s)|2|||
13283778|NCT01051661|26464249|FG003|Overall Study|Unable to attend visit(s)|1|||
13283779|NCT01051661|26464250|FG004|Overall Study|Unable to attend visit(s)|3|||
13283780|NCT01051661|26464251|FG005|Overall Study|Unable to attend visit(s)|2|||
13283781|NCT01051661|26464246|FG000|Overall Study|Consent not received from both parents|0|||
13283782|NCT01051661|26464247|FG001|Overall Study|Consent not received from both parents|0|||
13283783|NCT01051661|26464248|FG002|Overall Study|Consent not received from both parents|0|||
13283784|NCT01051661|26464249|FG003|Overall Study|Consent not received from both parents|0|||
13283785|NCT01051661|26464250|FG004|Overall Study|Consent not received from both parents|0|||
13283786|NCT01051661|26464251|FG005|Overall Study|Consent not received from both parents|1|||
13283787|NCT01051661|26464246|FG000|Overall Study|Failure to comply with protocol|0|||
13283788|NCT01051661|26464247|FG001|Overall Study|Failure to comply with protocol|0|||
13283789|NCT01051661|26464248|FG002|Overall Study|Failure to comply with protocol|2|||
13283790|NCT01051661|26464249|FG003|Overall Study|Failure to comply with protocol|0|||
13283791|NCT01051661|26464250|FG004|Overall Study|Failure to comply with protocol|0|||
13283792|NCT01051661|26464251|FG005|Overall Study|Failure to comply with protocol|0|||
13283793|NCT01051661|26464246|FG000|Overall Study|Subject lost legal representation|0|||
13283794|NCT01051661|26464247|FG001|Overall Study|Subject lost legal representation|0|||
13283795|NCT01051661|26464248|FG002|Overall Study|Subject lost legal representation|0|||
13283796|NCT01051661|26464249|FG003|Overall Study|Subject lost legal representation|0|||
13283797|NCT01051661|26464250|FG004|Overall Study|Subject lost legal representation|1|||
13283798|NCT01051661|26464251|FG005|Overall Study|Subject lost legal representation|0|||
13283799|NCT01051661|26464246|FG000|Overall Study|Protocol Violation|0|||
13283800|NCT01051661|26464247|FG001|Overall Study|Protocol Violation|0|||
13283801|NCT01051661|26464248|FG002|Overall Study|Protocol Violation|0|||
13283802|NCT01051661|26464249|FG003|Overall Study|Protocol Violation|1|||
13283803|NCT01051661|26464250|FG004|Overall Study|Protocol Violation|2|||
13283804|NCT01051661|26464251|FG005|Overall Study|Protocol Violation|1|||
13283805|NCT01051661|26464246|FG000|Overall Study|Withdrawal by Subject|16|||
13283806|NCT01051661|26464247|FG001|Overall Study|Withdrawal by Subject|30|||
13283807|NCT01051661|26464248|FG002|Overall Study|Withdrawal by Subject|13|||
13283808|NCT01051661|26464249|FG003|Overall Study|Withdrawal by Subject|28|||
13283809|NCT01051661|26464250|FG004|Overall Study|Withdrawal by Subject|12|||
13121919|NCT02971007|25945090|FG000|Overall Study|Adverse Event|1|||
13308183|NCT01276639|26531264|FG001|Week 0 to 16|Other|7|||
13283810|NCT01051661|26464251|FG005|Overall Study|Withdrawal by Subject|34|||
13283811|NCT01051466|26464290|FG000|Overall Study|Adverse Event|1|||
13283812|NCT01051466|26464291|FG001|Overall Study|Adverse Event|0|||
13283813|NCT01051466|26464290|FG000|Overall Study|Lost to Follow-up|1|||
13283814|NCT01051466|26464291|FG001|Overall Study|Lost to Follow-up|1|||
13283815|NCT01051466|26464290|FG000|Overall Study|Withdrawal by Subject|5|||
13283816|NCT01051466|26464291|FG001|Overall Study|Withdrawal by Subject|1|||
13283817|NCT01051466|26464290|FG000|Overall Study|Entry Criteria Not Met|0|||
13283818|NCT01051466|26464291|FG001|Overall Study|Entry Criteria Not Met|3|||
13283819|NCT01051466|26464290|FG000|Overall Study|Physician Decision|1|||
13121920|NCT02971007|25945091|FG001|Overall Study|Adverse Event|0|||
13121921|NCT02971007|25945092|FG002|Overall Study|Adverse Event|0|||
13121922|NCT02971007|25945090|FG000|Overall Study|Lost to Follow-up|0|||
13121923|NCT02971007|25945091|FG001|Overall Study|Lost to Follow-up|1|||
13121924|NCT02971007|25945092|FG002|Overall Study|Lost to Follow-up|1|||
13121925|NCT02971007|25945090|FG000|Overall Study|Withdrawal by Subject|0|||
13283820|NCT01051466|26464291|FG001|Overall Study|Physician Decision|0|||
13283821|NCT01051349|26464320|FG000|Overall Study|Adverse Event|88|||
13283822|NCT01051349|26464320|FG000|Overall Study|Consent Withdrawn|54|||
13283823|NCT01051349|26464320|FG000|Overall Study|Investigator Decision|6|||
13283824|NCT01051349|26464320|FG000|Overall Study|Lost to Follow-up|6|||
13283825|NCT01051349|26464320|FG000|Overall Study|Subject non-compliance|7|||
13283826|NCT01051349|26464320|FG000|Overall Study|Reason not Specified|12|||
13283827|NCT01051323|26464348|FG000|Overall Study|Discontinuation of treatment|103|||
13283828|NCT01051323|26464348|FG000|Overall Study|Transplantation|28|||
13283829|NCT01051323|26464348|FG000|Overall Study|Dialysis dependency|22|||
13121926|NCT02971007|25945091|FG001|Overall Study|Withdrawal by Subject|1|||
13121927|NCT02971007|25945092|FG002|Overall Study|Withdrawal by Subject|0|||
13121928|NCT02971007|25945090|FG000|Overall Study|Patient had yeast at Day 5 visit|1|||
13121929|NCT02971007|25945091|FG001|Overall Study|Patient had yeast at Day 5 visit|0|||
13121930|NCT02971007|25945092|FG002|Overall Study|Patient had yeast at Day 5 visit|0|||
13283830|NCT01051323|26464348|FG000|Overall Study|Withdrawal by Subject|13|||
13283831|NCT01051323|26464348|FG000|Overall Study|Lost to Follow-up|31|||
13283832|NCT01051323|26464348|FG000|Overall Study|Death|129|||
13283833|NCT01051323|26464348|FG000|Overall Study|Hospitalization|28|||
13283834|NCT01051323|26464348|FG000|Overall Study|Other|148|||
13283835|NCT01051323|26464348|FG000|Overall Study|Missing|37|||
13283836|NCT01051063|26464370|FG000|Overall Study|Death|2|||
13283837|NCT01051063|26464371|FG001|Overall Study|Death|2|||
13283838|NCT01051063|26464370|FG000|Overall Study|Withdrawal by Subject|1|||
13283839|NCT01051063|26464371|FG001|Overall Study|Withdrawal by Subject|1|||
13283840|NCT01051063|26464370|FG000|Overall Study|Termination of the study|5|||
13283841|NCT01051063|26464371|FG001|Overall Study|Termination of the study|0|||
13283842|NCT01051063|26464370|FG000|Overall Study|Moved from the study site area|1|||
13283843|NCT01051063|26464371|FG001|Overall Study|Moved from the study site area|0|||
13283844|NCT01051063|26464370|FG000|Overall Study|Other|1|||
13283845|NCT01051063|26464371|FG001|Overall Study|Other|0|||
13283846|NCT01051063|26464370|FG000|Overall Study|Lost to Follow-up|0|||
13283847|NCT01051063|26464371|FG001|Overall Study|Lost to Follow-up|1|||
13283848|NCT01050998|26464711|FG000|Overall Study|Adverse Event|1|||
13283849|NCT01050998|26464712|FG001|Overall Study|Adverse Event|0|||
13283850|NCT01050998|26464713|FG002|Overall Study|Adverse Event|1|||
13283851|NCT01050998|26464714|FG003|Overall Study|Adverse Event|0|||
13283852|NCT01050998|26464715|FG004|Overall Study|Adverse Event|2|||
13283853|NCT01050998|26464711|FG000|Overall Study|Withdrawal by Subject|0|||
13283854|NCT01050998|26464712|FG001|Overall Study|Withdrawal by Subject|0|||
13283855|NCT01050998|26464713|FG002|Overall Study|Withdrawal by Subject|0|||
13283856|NCT01050998|26464714|FG003|Overall Study|Withdrawal by Subject|1|||
13283857|NCT01050998|26464715|FG004|Overall Study|Withdrawal by Subject|3|||
13283858|NCT01050998|26464711|FG000|Overall Study|Other|3|||
13283859|NCT01050998|26464712|FG001|Overall Study|Other|2|||
13283860|NCT01050998|26464713|FG002|Overall Study|Other|1|||
13283861|NCT01050998|26464714|FG003|Overall Study|Other|1|||
13283862|NCT01050998|26464715|FG004|Overall Study|Other|5|||
13283863|NCT01050998|26464711|FG000|Overall Study|Data integrity issues|0|||
13283864|NCT01050998|26464712|FG001|Overall Study|Data integrity issues|0|||
13283865|NCT01050998|26464713|FG002|Overall Study|Data integrity issues|1|||
13283866|NCT01050998|26464714|FG003|Overall Study|Data integrity issues|1|||
13283867|NCT01050998|26464715|FG004|Overall Study|Data integrity issues|4|||
13283868|NCT01050816|26464723|FG000|Overall Study|Lost to Follow-up|2|||
13283869|NCT01050816|26464723|FG000|Overall Study|patient's refusal|2|||
13283870|NCT01050790|26464735|FG000|Overall Study|Adverse Event|1|||
13121931|NCT02971007|25945090|FG000|Overall Study|Patient discontinued study drug|0|||
13121932|NCT02971007|25945091|FG001|Overall Study|Patient discontinued study drug|1|||
13283871|NCT01050764|26464746|FG000|Overall Study|Death, before HSCT|1|||
13283872|NCT01050764|26464746|FG000|Overall Study|Donor mobilization failure, death|1|||
13283873|NCT01050764|26464746|FG000|Overall Study|Death after HSCT, before T-cell infusion|1|||
13283874|NCT01050673|26464775|FG000|Overall Study|Physician Decision|4|||
13283875|NCT01050673|26464776|FG001|Overall Study|Physician Decision|5|||
13283876|NCT01050569|26464803|FG000|Overall Study|Lost to Follow-up|20|||
13121933|NCT02971007|25945092|FG002|Overall Study|Patient discontinued study drug|0|||
13283877|NCT01050569|26464804|FG001|Overall Study|Lost to Follow-up|14|||
13283878|NCT01050569|26464805|FG002|Overall Study|Lost to Follow-up|16|||
13283879|NCT01050569|26464803|FG000|Overall Study|Withdrawal by Subject|9|||
13283880|NCT01050569|26464804|FG001|Overall Study|Withdrawal by Subject|3|||
13283881|NCT01050569|26464805|FG002|Overall Study|Withdrawal by Subject|11|||
13283882|NCT01050569|26464803|FG000|Overall Study|Lack of Efficacy|5|||
13283883|NCT01050569|26464804|FG001|Overall Study|Lack of Efficacy|4|||
13283884|NCT01050569|26464805|FG002|Overall Study|Lack of Efficacy|3|||
13283885|NCT01050569|26464803|FG000|Overall Study|Adverse Event|1|||
13121934|NCT02970942|25945459|FG000|Overall Study|Death|0|||
13121935|NCT02970942|25945460|FG001|Overall Study|Death|1|||
13121936|NCT02970942|25945461|FG002|Overall Study|Death|0|||
13121937|NCT02970942|25945462|FG003|Overall Study|Death|0|||
13283886|NCT01050569|26464804|FG001|Overall Study|Adverse Event|0|||
13283887|NCT01050569|26464805|FG002|Overall Study|Adverse Event|0|||
13283888|NCT01050569|26464803|FG000|Overall Study|Physician Decision|3|||
13283889|NCT01050569|26464804|FG001|Overall Study|Physician Decision|3|||
13283890|NCT01050569|26464805|FG002|Overall Study|Physician Decision|3|||
13283891|NCT01050543|26464818|FG000|Overall Study|Withdrawal by Subject|0|||
13283892|NCT01050543|26464819|FG001|Overall Study|Withdrawal by Subject|2|||
13283893|NCT01050543|26464818|FG000|Overall Study|Protocol Violation|0|||
13283894|NCT01050543|26464819|FG001|Overall Study|Protocol Violation|1|||
13283895|NCT01050543|26464818|FG000|Overall Study|Administrative|4|||
13283896|NCT01050543|26464819|FG001|Overall Study|Administrative|1|||
13283897|NCT01050530|26464834|FG000|Overall Study|Adverse Event|6|||
13283898|NCT01050530|26464835|FG001|Overall Study|Adverse Event|3|||
13283899|NCT01050530|26464834|FG000|Overall Study|Lack of Efficacy|1|||
13283900|NCT01050530|26464835|FG001|Overall Study|Lack of Efficacy|4|||
13283901|NCT01050530|26464834|FG000|Overall Study|Withdrawal by Subject|0|||
13283902|NCT01050530|26464835|FG001|Overall Study|Withdrawal by Subject|3|||
13283903|NCT01050530|26464834|FG000|Overall Study|Protocol Violation|1|||
13283904|NCT01050530|26464835|FG001|Overall Study|Protocol Violation|0|||
13283905|NCT01050257|26464880|FG000|Overall Study|Adverse Event|4|||
13283906|NCT01050257|26464881|FG001|Overall Study|Adverse Event|4|||
13283907|NCT01050257|26464882|FG002|Overall Study|Adverse Event|2|||
13283908|NCT01050257|26464880|FG000|Overall Study|Admin/Other (did not switch to oral)|6|||
13283909|NCT01050257|26464881|FG001|Overall Study|Admin/Other (did not switch to oral)|2|||
13283910|NCT01050257|26464882|FG002|Overall Study|Admin/Other (did not switch to oral)|2|||
13283911|NCT01050257|26464880|FG000|Overall Study|Withdrawal by Subject|0|||
13283912|NCT01050257|26464881|FG001|Overall Study|Withdrawal by Subject|3|||
13283913|NCT01050257|26464882|FG002|Overall Study|Withdrawal by Subject|0|||
13283914|NCT01050257|26464880|FG000|Overall Study|No reason specified|0|||
13283915|NCT01050257|26464881|FG001|Overall Study|No reason specified|0|||
13283916|NCT01050257|26464882|FG002|Overall Study|No reason specified|2|||
13283917|NCT01050257|26464880|FG000|Overall Study|Refused treatment/ Did not Cooperate|1|||
13283918|NCT01050257|26464881|FG001|Overall Study|Refused treatment/ Did not Cooperate|1|||
13283919|NCT01050257|26464882|FG002|Overall Study|Refused treatment/ Did not Cooperate|0|||
13283920|NCT01050257|26464880|FG000|Overall Study|Violation criteria|0|||
13283921|NCT01050257|26464881|FG001|Overall Study|Violation criteria|1|||
13283922|NCT01050257|26464882|FG002|Overall Study|Violation criteria|0|||
13283923|NCT01050257|26464880|FG000|Overall Study|Failure to return|0|||
13283924|NCT01050257|26464881|FG001|Overall Study|Failure to return|2|||
13283925|NCT01050257|26464882|FG002|Overall Study|Failure to return|0|||
13283926|NCT01050257|26464880|FG000|Overall Study|Death|0|||
13283927|NCT01050257|26464881|FG001|Overall Study|Death|0|||
13283928|NCT01050257|26464882|FG002|Overall Study|Death|1|||
13283929|NCT01050218|26464888|FG000|Overall Study|Adverse Event|37|||
13283930|NCT01050218|26464888|FG000|Overall Study|Lack of Efficacy|8|||
13283931|NCT01050218|26464888|FG000|Overall Study|Protocol Violation|3|||
13283932|NCT01050218|26464888|FG000|Overall Study|Withdrawal by Subject|18|||
13283933|NCT01050218|26464888|FG000|Overall Study|Discontinued by sponsor|18|||
13283934|NCT01050218|26464888|FG000|Overall Study|Compliance|2|||
13283935|NCT01050218|26464888|FG000|Overall Study|Failed to return|7|||
13283936|NCT01050218|26464888|FG000|Overall Study|Serious Adverse Event|1|||
13283937|NCT01050218|26464888|FG000|Overall Study|Family emergency|1|||
13283938|NCT01050205|26464923|FG000|Overall Study|Lost to Follow-up|7|||
13283939|NCT01050205|26464924|FG001|Overall Study|Lost to Follow-up|1|||
13283940|NCT01050205|26464923|FG000|Overall Study|Withdrawal by Subject|1|||
13283941|NCT01050205|26464924|FG001|Overall Study|Withdrawal by Subject|1|||
13283942|NCT01050205|26464923|FG000|Overall Study|Relocated from area|1|||
13283943|NCT01050205|26464924|FG001|Overall Study|Relocated from area|2|||
13283944|NCT01050205|26464923|FG000|Overall Study|Discontinued Intervention|2|||
13283945|NCT01050205|26464924|FG001|Overall Study|Discontinued Intervention|0|||
13283946|NCT01050062|26464951|FG000|Overall Study|Adverse Event|75|||
13283947|NCT01050062|26464952|FG001|Overall Study|Adverse Event|22|||
13283948|NCT01050062|26464951|FG000|Overall Study|Lost to Follow-up|83|||
13283949|NCT01050062|26464952|FG001|Overall Study|Lost to Follow-up|35|||
13283950|NCT01050062|26464951|FG000|Overall Study|Lack of Efficacy|22|||
13283951|NCT01050062|26464952|FG001|Overall Study|Lack of Efficacy|35|||
13283952|NCT01050062|26464951|FG000|Overall Study|Physician Decision|74|||
13121938|NCT02970942|25945459|FG000|Overall Study|Lost to Follow-up|1|||
13121939|NCT02970942|25945460|FG001|Overall Study|Lost to Follow-up|0|||
13121940|NCT02970942|25945461|FG002|Overall Study|Lost to Follow-up|2|||
13121941|NCT02970942|25945462|FG003|Overall Study|Lost to Follow-up|1|||
13121942|NCT02970942|25945459|FG000|Overall Study|Withdrawal by Subject|3|||
13121943|NCT02970942|25945460|FG001|Overall Study|Withdrawal by Subject|5|||
13121944|NCT02970942|25945461|FG002|Overall Study|Withdrawal by Subject|3|||
13121945|NCT02970942|25945462|FG003|Overall Study|Withdrawal by Subject|2|||
13121946|NCT02970929|25945480|FG000|Overall Study|Adverse Event|18|||
13121947|NCT02970929|25945480|FG000|Overall Study|Lack of Efficacy|8|||
13121948|NCT02970929|25945480|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1|||
13133477|NCT02769065|25988359|FG018|Overall Study|Voluntary Withdrawal|0|||
13283953|NCT01050062|26464952|FG001|Overall Study|Physician Decision|9|||
13283954|NCT01050062|26464951|FG000|Overall Study|Others|17|||
13283955|NCT01050062|26464952|FG001|Overall Study|Others|11|||
13283956|NCT01059448|26465007|FG000|Overall Study|Adverse Event|1|||
13283957|NCT01059448|26465008|FG001|Overall Study|Adverse Event|3|||
13283958|NCT01059448|26465009|FG002|Overall Study|Adverse Event|0|||
13283959|NCT01059448|26465010|FG003|Overall Study|Adverse Event|1|||
13283960|NCT01059448|26465007|FG000|Overall Study|Withdrawal by Subject|2|||
13283961|NCT01059448|26465008|FG001|Overall Study|Withdrawal by Subject|0|||
13283962|NCT01059448|26465009|FG002|Overall Study|Withdrawal by Subject|2|||
13283963|NCT01059448|26465010|FG003|Overall Study|Withdrawal by Subject|4|||
13283964|NCT01059448|26465007|FG000|Overall Study|Disease Progression|2|||
13283965|NCT01059448|26465008|FG001|Overall Study|Disease Progression|1|||
13283966|NCT01059448|26465009|FG002|Overall Study|Disease Progression|4|||
13283967|NCT01059448|26465010|FG003|Overall Study|Disease Progression|2|||
13283968|NCT01059448|26465007|FG000|Overall Study|Administrative Decision|43|||
13283969|NCT01059448|26465008|FG001|Overall Study|Administrative Decision|49|||
13283970|NCT01059448|26465009|FG002|Overall Study|Administrative Decision|45|||
13283971|NCT01059448|26465010|FG003|Overall Study|Administrative Decision|46|||
13283972|NCT01059448|26465007|FG000|Overall Study|Lost to Follow-up|0|||
13283973|NCT01059448|26465008|FG001|Overall Study|Lost to Follow-up|0|||
13283974|NCT01059448|26465009|FG002|Overall Study|Lost to Follow-up|2|||
13283975|NCT01059448|26465010|FG003|Overall Study|Lost to Follow-up|0|||
13283976|NCT01059448|26465007|FG000|Overall Study|Death|0|||
13283977|NCT01059448|26465008|FG001|Overall Study|Death|1|||
13283978|NCT01059448|26465009|FG002|Overall Study|Death|0|||
13283979|NCT01059448|26465010|FG003|Overall Study|Death|0|||
13283980|NCT01059448|26465007|FG000|Overall Study|Other|1|||
13283981|NCT01059448|26465008|FG001|Overall Study|Other|1|||
13283982|NCT01059448|26465009|FG002|Overall Study|Other|0|||
13283983|NCT01059448|26465010|FG003|Overall Study|Other|1|||
13283984|NCT01058707|26465195|FG000|Overall Study|Disease Progression|15|||
13283985|NCT01058707|26465196|FG001|Overall Study|Disease Progression|20|||
13283986|NCT01058707|26465197|FG002|Overall Study|Disease Progression|20|||
13283987|NCT01058707|26465198|FG003|Overall Study|Disease Progression|15|||
13283988|NCT01058707|26465199|FG004|Overall Study|Disease Progression|23|||
13283989|NCT01058707|26465200|FG005|Overall Study|Disease Progression|10|||
13283990|NCT01058707|26465201|FG006|Overall Study|Disease Progression|12|||
13283991|NCT01058707|26465195|FG000|Overall Study|Adverse Event|11|||
13283992|NCT01058707|26465196|FG001|Overall Study|Adverse Event|4|||
13283993|NCT01058707|26465197|FG002|Overall Study|Adverse Event|7|||
13283994|NCT01058707|26465198|FG003|Overall Study|Adverse Event|6|||
13283995|NCT01058707|26465199|FG004|Overall Study|Adverse Event|7|||
13283996|NCT01058707|26465200|FG005|Overall Study|Adverse Event|3|||
13283997|NCT01058707|26465201|FG006|Overall Study|Adverse Event|1|||
13283998|NCT01058707|26465195|FG000|Overall Study|Subject Decision|5|||
13283999|NCT01058707|26465196|FG001|Overall Study|Subject Decision|3|||
13284000|NCT01058707|26465197|FG002|Overall Study|Subject Decision|3|||
13284001|NCT01058707|26465198|FG003|Overall Study|Subject Decision|1|||
13284002|NCT01058707|26465199|FG004|Overall Study|Subject Decision|2|||
13284003|NCT01058707|26465200|FG005|Overall Study|Subject Decision|3|||
13284004|NCT01058707|26465201|FG006|Overall Study|Subject Decision|6|||
13284005|NCT01058707|26465195|FG000|Overall Study|Lost to Follow-up|0|||
13284006|NCT01058707|26465196|FG001|Overall Study|Lost to Follow-up|0|||
13284007|NCT01058707|26465197|FG002|Overall Study|Lost to Follow-up|1|||
13284008|NCT01058707|26465198|FG003|Overall Study|Lost to Follow-up|0|||
13284009|NCT01058707|26465199|FG004|Overall Study|Lost to Follow-up|0|||
13284010|NCT01058707|26465200|FG005|Overall Study|Lost to Follow-up|0|||
13284011|NCT01058707|26465201|FG006|Overall Study|Lost to Follow-up|0|||
13284012|NCT01058707|26465195|FG000|Overall Study|Reason Not Specified|0|||
13284013|NCT01058707|26465196|FG001|Overall Study|Reason Not Specified|3|||
13284014|NCT01058707|26465197|FG002|Overall Study|Reason Not Specified|2|||
13284015|NCT01058707|26465198|FG003|Overall Study|Reason Not Specified|0|||
13284016|NCT01058707|26465199|FG004|Overall Study|Reason Not Specified|7|||
13284017|NCT01058707|26465200|FG005|Overall Study|Reason Not Specified|1|||
13284018|NCT01058707|26465201|FG006|Overall Study|Reason Not Specified|7|||
13284019|NCT01054144|26465212|FG000|Overall Study|Death|2|||
13121949|NCT02970929|25945480|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1|||
13121950|NCT02970929|25945480|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1|||
13121951|NCT02970929|25945480|FG000|Overall Study|LOST TO FOLLOWUP|6|||
13121952|NCT02970929|25945480|FG000|Overall Study|MOVED OUT OF STATE|1|||
13121953|NCT02970929|25945480|FG000|Overall Study|Withdrawal by Subject|16|||
13121954|NCT02970669|25945505|FG000|Double-blind Period|Adverse Event|4|||
13121955|NCT02970669|25945506|FG001|Double-blind Period|Adverse Event|0|||
13121956|NCT02970669|25945505|FG000|Double-blind Period|Death|1|||
13121957|NCT02970669|25945506|FG001|Double-blind Period|Death|0|||
13121958|NCT02970669|25945505|FG000|Double-blind Period|Study terminated by sponsor|1|||
13284020|NCT01051557|26465251|FG000|Overall Study|Physician Decision|1|||
13284021|NCT01051557|26465252|FG001|Overall Study|Physician Decision|0|||
13284022|NCT01051557|26465253|FG002|Overall Study|Physician Decision|0|||
13284023|NCT01051557|26465254|FG003|Overall Study|Physician Decision|0|||
13284024|NCT01051557|26465255|FG004|Overall Study|Physician Decision|0|||
13284025|NCT01051557|26465256|FG005|Overall Study|Physician Decision|0|||
13284026|NCT01051557|26465257|FG006|Overall Study|Physician Decision|0|||
13284027|NCT01051557|26465251|FG000|Overall Study|disease progression|3|||
13284028|NCT01051557|26465252|FG001|Overall Study|disease progression|3|||
13284029|NCT01051557|26465253|FG002|Overall Study|disease progression|5|||
13284030|NCT01051557|26465254|FG003|Overall Study|disease progression|2|||
13284031|NCT01051557|26465255|FG004|Overall Study|disease progression|4|||
13284032|NCT01051557|26465256|FG005|Overall Study|disease progression|3|||
13284033|NCT01051557|26465257|FG006|Overall Study|disease progression|1|||
13284034|NCT01051557|26465251|FG000|Overall Study|Withdrawal by Subject|0|||
13284035|NCT01051557|26465252|FG001|Overall Study|Withdrawal by Subject|0|||
13284036|NCT01051557|26465253|FG002|Overall Study|Withdrawal by Subject|1|||
13284037|NCT01051557|26465254|FG003|Overall Study|Withdrawal by Subject|0|||
13284038|NCT01051557|26465255|FG004|Overall Study|Withdrawal by Subject|2|||
13284039|NCT01051557|26465256|FG005|Overall Study|Withdrawal by Subject|0|||
13284040|NCT01051557|26465257|FG006|Overall Study|Withdrawal by Subject|1|||
13284041|NCT01051557|26465251|FG000|Overall Study|Adverse Event|0|||
13284042|NCT01051557|26465252|FG001|Overall Study|Adverse Event|0|||
13284043|NCT01051557|26465253|FG002|Overall Study|Adverse Event|0|||
13284044|NCT01051557|26465254|FG003|Overall Study|Adverse Event|1|||
13284045|NCT01051557|26465255|FG004|Overall Study|Adverse Event|1|||
13284046|NCT01051557|26465256|FG005|Overall Study|Adverse Event|3|||
13284047|NCT01051557|26465257|FG006|Overall Study|Adverse Event|4|||
13292008|NCT00708734|26484301|FG000|Overall Study|scheduling conflict|2|||
13292009|NCT00708734|26484301|FG000|Overall Study|moved|1|||
13292010|NCT00708734|26484301|FG000|Overall Study|leg injury|1|||
13292011|NCT00708734|26484301|FG000|Overall Study|knee replacement|1|||
13292012|NCT00708734|26484301|FG000|Overall Study|vertigo|1|||
13292013|NCT00708734|26484301|FG000|Overall Study|leg fracture|1|||
13292014|NCT00708643|26484324|FG000|Overall Study|Adverse Event|0|||
13292015|NCT00708643|26484325|FG001|Overall Study|Adverse Event|1|||
13292016|NCT00708552|26484486|FG000|Overall Study|Adverse Event|10|||
13292017|NCT00708552|26484487|FG001|Overall Study|Adverse Event|3|||
13292018|NCT00708552|26484488|FG002|Overall Study|Adverse Event|4|||
13292019|NCT00708552|26484489|FG003|Overall Study|Adverse Event|6|||
13292020|NCT00708552|26484486|FG000|Overall Study|Lack of Efficacy|0|||
13292021|NCT00708552|26484487|FG001|Overall Study|Lack of Efficacy|4|||
13292022|NCT00708552|26484488|FG002|Overall Study|Lack of Efficacy|1|||
13292023|NCT00708552|26484489|FG003|Overall Study|Lack of Efficacy|0|||
13292024|NCT00708552|26484486|FG000|Overall Study|Protocol Violation|0|||
13292025|NCT00708552|26484487|FG001|Overall Study|Protocol Violation|0|||
13292026|NCT00708552|26484488|FG002|Overall Study|Protocol Violation|2|||
13292027|NCT00708552|26484489|FG003|Overall Study|Protocol Violation|4|||
13292028|NCT00708552|26484486|FG000|Overall Study|Lost to Follow-up|4|||
13292029|NCT00708552|26484487|FG001|Overall Study|Lost to Follow-up|2|||
13292030|NCT00708552|26484488|FG002|Overall Study|Lost to Follow-up|0|||
13292031|NCT00708552|26484489|FG003|Overall Study|Lost to Follow-up|1|||
13292032|NCT00708552|26484486|FG000|Overall Study|Physician Decision|1|||
13292033|NCT00708552|26484487|FG001|Overall Study|Physician Decision|2|||
13292034|NCT00708552|26484488|FG002|Overall Study|Physician Decision|0|||
13292035|NCT00708552|26484489|FG003|Overall Study|Physician Decision|0|||
13292036|NCT00708552|26484486|FG000|Overall Study|Withdrawal by Subject|12|||
13292037|NCT00708552|26484487|FG001|Overall Study|Withdrawal by Subject|7|||
13292038|NCT00708552|26484488|FG002|Overall Study|Withdrawal by Subject|8|||
13292039|NCT00708552|26484489|FG003|Overall Study|Withdrawal by Subject|10|||
13292040|NCT00708500|26484516|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
13292041|NCT00708500|26484517|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3|||
13292042|NCT00708500|26484518|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
13308184|NCT01276639|26531265|FG002|Week 0 to 16|Other|2|||
13292043|NCT00708500|26484516|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1|||
13284048|NCT03277261|26465284|FG000|Overall Study|Adverse Event|17|||
13284049|NCT03277261|26465285|FG001|Overall Study|Adverse Event|1|||
13284050|NCT03277261|26465284|FG000|Overall Study|Participant Withdrawal of Consent|6|||
13284051|NCT03277261|26465285|FG001|Overall Study|Participant Withdrawal of Consent|15|||
13284052|NCT03277261|26465284|FG000|Overall Study|Investigator / Sponsor Decision|4|||
13284053|NCT03277261|26465285|FG001|Overall Study|Investigator / Sponsor Decision|2|||
13284054|NCT03277261|26465284|FG000|Overall Study|Pregnancy|2|||
13284055|NCT03277261|26465285|FG001|Overall Study|Pregnancy|0|||
13284056|NCT03277261|26465284|FG000|Overall Study|Lost to Follow-up|2|||
13284057|NCT03277261|26465285|FG001|Overall Study|Lost to Follow-up|2|||
13284058|NCT03277261|26465284|FG000|Overall Study|Lack of Efficacy|2|||
13284059|NCT03277261|26465285|FG001|Overall Study|Lack of Efficacy|2|||
13284060|NCT03277261|26465284|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
13284061|NCT03277261|26465285|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
13284062|NCT03277248|26465312|FG000|Overall Study|Adverse Event|3|||
13284063|NCT03277248|26465313|FG001|Overall Study|Adverse Event|1|||
13284064|NCT03277248|26465312|FG000|Overall Study|Subject Withdrawal of Consent|6|||
13284065|NCT03277248|26465313|FG001|Overall Study|Subject Withdrawal of Consent|23|||
13284066|NCT03277248|26465312|FG000|Overall Study|Investigator/Sponsor Decision|2|||
13284067|NCT03277248|26465313|FG001|Overall Study|Investigator/Sponsor Decision|2|||
13284068|NCT03277248|26465312|FG000|Overall Study|Pregnancy|4|||
13284069|NCT03277248|26465313|FG001|Overall Study|Pregnancy|1|||
13284070|NCT03277248|26465312|FG000|Overall Study|Lost to Follow-up|0|||
13284071|NCT03277248|26465313|FG001|Overall Study|Lost to Follow-up|2|||
13284072|NCT03277248|26465312|FG000|Overall Study|Lack of Efficacy|0|||
13284073|NCT03277248|26465313|FG001|Overall Study|Lack of Efficacy|2|||
13284074|NCT03277248|26465312|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
13284075|NCT03277248|26465313|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
13284076|NCT03276780|26465348|FG000|Overall Study|Withdrawal by Subject|5|||
13284077|NCT03276780|26465349|FG001|Overall Study|Withdrawal by Subject|3|||
13284078|NCT03276780|26465348|FG000|Overall Study|Lost to Follow-up|3|||
13284079|NCT03276780|26465349|FG001|Overall Study|Lost to Follow-up|5|||
13284080|NCT03276780|26465348|FG000|Overall Study|Moved out of state|1|||
13284081|NCT03276780|26465349|FG001|Overall Study|Moved out of state|1|||
13284082|NCT03276780|26465348|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1|||
13284083|NCT03276780|26465349|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0|||
13284084|NCT03276780|26465348|FG000|Overall Study|No show to appointments after baseline through Week 5|8|||
13284085|NCT03276780|26465349|FG001|Overall Study|No show to appointments after baseline through Week 5|1|||
13284086|NCT03277690|26465392|FG000|Dose Titration and Maintenance|Protocol Violation|3|||
13284087|NCT03277690|26465393|FG001|Dose Titration and Maintenance|Protocol Violation|0|||
13284088|NCT03277690|26465392|FG000|Dose Titration and Maintenance|Physician Decision|1|||
13284089|NCT03277690|26465393|FG001|Dose Titration and Maintenance|Physician Decision|0|||
13284090|NCT03277690|26465392|FG000|Dose Titration and Maintenance|Sponsor decision - Randomization closed|4|||
13284091|NCT03277690|26465393|FG001|Dose Titration and Maintenance|Sponsor decision - Randomization closed|0|||
13284092|NCT03277690|26465392|FG000|Dose Titration and Maintenance|Lack of Efficacy|9|||
13284093|NCT03277690|26465393|FG001|Dose Titration and Maintenance|Lack of Efficacy|0|||
13284094|NCT03277690|26465392|FG000|Dose Titration and Maintenance|Adverse Event|15|||
13284095|NCT03277690|26465393|FG001|Dose Titration and Maintenance|Adverse Event|0|||
13284096|NCT03277690|26465392|FG000|Dose Titration and Maintenance|Withdrawal by Subject|8|||
13284097|NCT03277690|26465393|FG001|Dose Titration and Maintenance|Withdrawal by Subject|0|||
13284098|NCT03277690|26465392|FG000|Randomized Withdrawal|Withdrawal by Subject|1|||
13284099|NCT03277690|26465393|FG001|Randomized Withdrawal|Withdrawal by Subject|0|||
13284100|NCT03271047|26465462|FG000|Phase 1b: Dose Finding Period|Death|8|||
13284101|NCT03271047|26465463|FG001|Phase 1b: Dose Finding Period|Death|8|||
13284102|NCT03271047|26465464|FG002|Phase 1b: Dose Finding Period|Death|0|||
13284103|NCT03271047|26465465|FG003|Phase 1b: Dose Finding Period|Death|0|||
13284104|NCT03271047|26465462|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1|||
13284105|NCT03271047|26465463|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
13284106|NCT03271047|26465464|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
13284107|NCT03271047|26465465|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
13284108|NCT03271047|26465462|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
13284109|NCT03271047|26465463|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2|||
13284110|NCT03271047|26465464|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
13284111|NCT03271047|26465465|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
13284112|NCT03271047|26465462|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
13284113|NCT03271047|26465463|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
13284114|NCT03271047|26465464|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
13284115|NCT03271047|26465465|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
13284116|NCT03271047|26465462|FG000|Randomized Phase 2 Period|Other|0|||
13284117|NCT03271047|26465463|FG001|Randomized Phase 2 Period|Other|0|||
13284118|NCT03271047|26465464|FG002|Randomized Phase 2 Period|Other|0|||
13284119|NCT03271047|26465465|FG003|Randomized Phase 2 Period|Other|1|||
13284120|NCT03271047|26465462|FG000|Randomized Phase 2 Period|Death|0|||
13284121|NCT03271047|26465463|FG001|Randomized Phase 2 Period|Death|0|||
13284122|NCT03271047|26465464|FG002|Randomized Phase 2 Period|Death|20|||
13284123|NCT03271047|26465465|FG003|Randomized Phase 2 Period|Death|21|||
13284124|NCT03271047|26465462|FG000|Randomized Phase 2 Period|Lost to Follow-up|0|||
13284125|NCT03271047|26465463|FG001|Randomized Phase 2 Period|Lost to Follow-up|0|||
13284126|NCT03271047|26465464|FG002|Randomized Phase 2 Period|Lost to Follow-up|2|||
13284127|NCT03271047|26465465|FG003|Randomized Phase 2 Period|Lost to Follow-up|1|||
13284128|NCT03271047|26465462|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0|||
13284129|NCT03271047|26465463|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0|||
13284130|NCT03271047|26465464|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5|||
13284131|NCT03271047|26465465|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0|||
13284132|NCT03271047|26465462|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
13284133|NCT03271047|26465463|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
13284134|NCT03271047|26465464|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
13284135|NCT03271047|26465465|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4|||
13284136|NCT03276936|26465490|FG000|Overall Study|Adverse Event|4|||
13284137|NCT03276936|26465491|FG001|Overall Study|Adverse Event|2|||
13284138|NCT03276936|26465490|FG000|Overall Study|Lost to Follow-up|16|||
13284139|NCT03276936|26465491|FG001|Overall Study|Lost to Follow-up|13|||
13284140|NCT03276936|26465490|FG000|Overall Study|Withdrawal by Subject|30|||
13284141|NCT03276936|26465491|FG001|Overall Study|Withdrawal by Subject|20|||
13284142|NCT03276936|26465490|FG000|Overall Study|Not mentioned|6|||
13284143|NCT03276936|26465491|FG001|Overall Study|Not mentioned|3|||
13284144|NCT03271021|26465516|FG000|Overall Study|Adverse Event|3|||
13284145|NCT03271021|26465517|FG001|Overall Study|Adverse Event|2|||
13284146|NCT03271021|26465516|FG000|Overall Study|Withdrawal by Subject|36|||
13284147|NCT03271021|26465517|FG001|Overall Study|Withdrawal by Subject|53|||
13284148|NCT03271021|26465516|FG000|Overall Study|Lost to Follow-up|34|||
13284149|NCT03271021|26465517|FG001|Overall Study|Lost to Follow-up|39|||
13284150|NCT03271021|26465516|FG000|Overall Study|Protocol Violation|6|||
13284151|NCT03271021|26465517|FG001|Overall Study|Protocol Violation|4|||
13284152|NCT03271021|26465516|FG000|Overall Study|Abnormal Lab Results|1|||
13284153|NCT03271021|26465517|FG001|Overall Study|Abnormal Lab Results|0|||
13284154|NCT03271021|26465516|FG000|Overall Study|Miscellaneous|9|||
13284155|NCT03271021|26465517|FG001|Overall Study|Miscellaneous|8|||
13292044|NCT00708500|26484517|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
13292045|NCT00708500|26484518|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
13292046|NCT00708500|26484516|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
13292047|NCT00708500|26484517|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1|||
13292048|NCT00708500|26484518|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
13292049|NCT00708500|26484516|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
13292050|NCT00708500|26484517|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2|||
13292051|NCT00708500|26484518|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
13292052|NCT00708500|26484516|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
13292053|NCT00708500|26484517|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
13292054|NCT00708500|26484518|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1|||
13292055|NCT00708500|26484516|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1|||
13292056|NCT00708500|26484517|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10|||
13292057|NCT00708500|26484518|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19|||
13292058|NCT00708500|26484516|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49|||
13292059|NCT00708500|26484517|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36|||
13292060|NCT00708500|26484518|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29|||
13292061|NCT00708500|26484516|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
13292062|NCT00708500|26484517|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1|||
13292063|NCT00708500|26484518|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
13292064|NCT00708500|26484516|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3|||
13292065|NCT00708500|26484517|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1|||
13292066|NCT00708500|26484518|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4|||
13292067|NCT00708500|26484516|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2|||
13292068|NCT00708500|26484517|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0|||
13292069|NCT00708500|26484518|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1|||
13292070|NCT00708500|26484516|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0|||
13292071|NCT00708500|26484517|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2|||
13292072|NCT00708500|26484518|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1|||
13292073|NCT00708500|26484516|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0|||
13292074|NCT00708500|26484517|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
13308185|NCT01276639|26531266|FG003|Week 0 to 16|Other|0|||
13284156|NCT01249833|26465559|FG000|Overall Study|Lost to Follow-up|0|||
13284157|NCT01249833|26465560|FG001|Overall Study|Lost to Follow-up|1|||
13284158|NCT01249664|26465617|FG000|Overall Study|Withdrawal by Subject|5|||
13284159|NCT01249664|26465618|FG001|Overall Study|Withdrawal by Subject|0|||
13284160|NCT01249664|26465617|FG000|Overall Study|Adverse Event|1|||
13284161|NCT01249664|26465618|FG001|Overall Study|Adverse Event|0|||
13284162|NCT01249651|26465627|FG000|Overall Study|Withdrawal by Subject|4|||
13284163|NCT01249651|26465627|FG000|Overall Study|Adverse Event|1|||
13284164|NCT01249651|26465627|FG000|Overall Study|Protocol Violation|1|||
13284165|NCT01249651|26465627|FG000|Overall Study|Sponsor Decision|1|||
13284166|NCT01249417|26465651|FG000|Randomised Population|Study treatment not received|0|||
13284167|NCT01249417|26465652|FG001|Randomised Population|Study treatment not received|0|||
13284168|NCT01249417|26465653|FG002|Randomised Population|Study treatment not received|2|||
13284169|NCT01249417|26465651|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1|||
13284170|NCT01249417|26465652|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1|||
13284171|NCT01249417|26465653|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2|||
13284172|NCT01249417|26465651|FG000|Treatment Phase - ITT Population|Other|0|||
13284173|NCT01249417|26465652|FG001|Treatment Phase - ITT Population|Other|0|||
13284174|NCT01249417|26465653|FG002|Treatment Phase - ITT Population|Other|1|||
13284175|NCT01249417|26465651|FG000|Treatment Phase - ITT Population|Adverse Event|0|||
13284176|NCT01249417|26465652|FG001|Treatment Phase - ITT Population|Adverse Event|0|||
13284177|NCT01249417|26465653|FG002|Treatment Phase - ITT Population|Adverse Event|1|||
13284178|NCT01249417|26465651|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
13284179|NCT01249417|26465652|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3|||
13284180|NCT01249417|26465653|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
13284181|NCT01249417|26465651|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0|||
13284182|NCT01249417|26465652|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1|||
13284183|NCT01249417|26465653|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1|||
13284184|NCT01249404|26465740|FG000|Overall Study|Study treatment not received|0|||
13284185|NCT01249404|26465741|FG001|Overall Study|Study treatment not received|1|||
13284186|NCT01249404|26465742|FG002|Overall Study|Study treatment not received|2|||
13284187|NCT01249404|26465740|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2|||
13284188|NCT01249404|26465741|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0|||
13284189|NCT01249404|26465742|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2|||
13284190|NCT01249404|26465740|FG000|Overall Study|Adverse Event|2|||
13284191|NCT01249404|26465741|FG001|Overall Study|Adverse Event|2|||
13284192|NCT01249404|26465742|FG002|Overall Study|Adverse Event|2|||
13284193|NCT01249404|26465740|FG000|Overall Study|Withdrawal by Subject|2|||
13284194|NCT01249404|26465741|FG001|Overall Study|Withdrawal by Subject|2|||
13284195|NCT01249404|26465742|FG002|Overall Study|Withdrawal by Subject|0|||
13284196|NCT01249404|26465740|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
13284197|NCT01249404|26465741|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2|||
13284198|NCT01249404|26465742|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
13284199|NCT01249404|26465740|FG000|Overall Study|Non compliance to visit schedule|0|||
13284200|NCT01249404|26465741|FG001|Overall Study|Non compliance to visit schedule|1|||
13284201|NCT01249404|26465742|FG002|Overall Study|Non compliance to visit schedule|0|||
13284202|NCT01249365|26465750|FG000|Overall Study|Lost to Follow-up|1|||
13284203|NCT01249274|26465781|FG000|Overall Study|Lost to Follow-up|3|||
13284204|NCT01249274|26465782|FG001|Overall Study|Lost to Follow-up|4|||
13284205|NCT01249274|26465781|FG000|Overall Study|Received inpatient substance treatment|1|||
13284206|NCT01249274|26465782|FG001|Overall Study|Received inpatient substance treatment|2|||
13284207|NCT01249261|26465817|FG000|Overall Study|Withdrawal by Subject|1|||
13284208|NCT01249261|26465818|FG001|Overall Study|Withdrawal by Subject|0|||
13284209|NCT01249157|26465824|FG000|Overall Study|Withdrawal by Subject|1|||
13284210|NCT01249131|26465851|FG000|Washout Period of 10 Days|Adverse Event|0|||
13284211|NCT01249131|26465852|FG001|Washout Period of 10 Days|Adverse Event|0|||
13284212|NCT01249131|26465853|FG002|Washout Period of 10 Days|Adverse Event|0|||
13284213|NCT01249131|26465854|FG003|Washout Period of 10 Days|Adverse Event|0|||
13284214|NCT01249131|26465855|FG004|Washout Period of 10 Days|Adverse Event|1|||
13284215|NCT01249131|26465856|FG005|Washout Period of 10 Days|Adverse Event|0|||
13284216|NCT01249118|26465894|FG000|First Washout Period|Physician Decision|0|||
13284217|NCT01249118|26465895|FG001|First Washout Period|Physician Decision|1|||
13284218|NCT01249118|26465896|FG002|First Washout Period|Physician Decision|0|||
13284219|NCT01249092|26465904|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1|||
13284220|NCT01249092|26465904|FG000|Overall Study|Unable to tolerate expected SE -nausea|1|||
13284221|NCT01248949|26466032|FG000|Overall Study|Lost to Follow-up|2|||
13284222|NCT01248949|26466033|FG001|Overall Study|Lost to Follow-up|2|||
13284223|NCT01248949|26466034|FG002|Overall Study|Lost to Follow-up|2|||
13284224|NCT01248949|26466035|FG003|Overall Study|Lost to Follow-up|1|||
13284225|NCT01248949|26466036|FG004|Overall Study|Lost to Follow-up|0|||
13284226|NCT01248949|26466032|FG000|Overall Study|Withdrawal by Subject|5|||
13284227|NCT01248949|26466033|FG001|Overall Study|Withdrawal by Subject|3|||
13284228|NCT01248949|26466034|FG002|Overall Study|Withdrawal by Subject|11|||
13284229|NCT01248949|26466035|FG003|Overall Study|Withdrawal by Subject|3|||
13284230|NCT01248949|26466036|FG004|Overall Study|Withdrawal by Subject|1|||
13284231|NCT01248949|26466032|FG000|Overall Study|Death|22|||
13284232|NCT01248949|26466033|FG001|Overall Study|Death|7|||
13284233|NCT01248949|26466034|FG002|Overall Study|Death|21|||
13284234|NCT01248949|26466035|FG003|Overall Study|Death|6|||
13284235|NCT01248949|26466036|FG004|Overall Study|Death|2|||
13284236|NCT01248949|26466032|FG000|Overall Study|Alternative Therapy|1|||
13284237|NCT01248949|26466033|FG001|Overall Study|Alternative Therapy|0|||
13284238|NCT01248949|26466034|FG002|Overall Study|Alternative Therapy|0|||
13284239|NCT01248949|26466035|FG003|Overall Study|Alternative Therapy|0|||
13284240|NCT01248949|26466036|FG004|Overall Study|Alternative Therapy|0|||
13284241|NCT01248949|26466032|FG000|Overall Study|Alternative Therapy.|1|||
13284242|NCT01248949|26466033|FG001|Overall Study|Alternative Therapy.|0|||
13284243|NCT01248949|26466034|FG002|Overall Study|Alternative Therapy.|0|||
13284244|NCT01248949|26466035|FG003|Overall Study|Alternative Therapy.|0|||
13284245|NCT01248949|26466036|FG004|Overall Study|Alternative Therapy.|0|||
13284246|NCT01248949|26466032|FG000|Overall Study|Palliative Radiation To Brain Metastases|1|||
13284247|NCT01248949|26466033|FG001|Overall Study|Palliative Radiation To Brain Metastases|0|||
13284248|NCT01248949|26466034|FG002|Overall Study|Palliative Radiation To Brain Metastases|0|||
13284249|NCT01248949|26466035|FG003|Overall Study|Palliative Radiation To Brain Metastases|0|||
13284250|NCT01248949|26466036|FG004|Overall Study|Palliative Radiation To Brain Metastases|0|||
13284251|NCT01248949|26466032|FG000|Overall Study|Entered Hospice And Refused Follow Up|0|||
13284252|NCT01248949|26466033|FG001|Overall Study|Entered Hospice And Refused Follow Up|0|||
13284253|NCT01248949|26466034|FG002|Overall Study|Entered Hospice And Refused Follow Up|0|||
13284254|NCT01248949|26466035|FG003|Overall Study|Entered Hospice And Refused Follow Up|0|||
13284255|NCT01248949|26466036|FG004|Overall Study|Entered Hospice And Refused Follow Up|1|||
13284256|NCT01248949|26466032|FG000|Overall Study|Participant Went To Hospice|0|||
13284257|NCT01248949|26466033|FG001|Overall Study|Participant Went To Hospice|0|||
13284258|NCT01248949|26466034|FG002|Overall Study|Participant Went To Hospice|1|||
13284259|NCT01248949|26466035|FG003|Overall Study|Participant Went To Hospice|0|||
13284260|NCT01248949|26466036|FG004|Overall Study|Participant Went To Hospice|0|||
13284261|NCT01248949|26466032|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1|||
13284262|NCT01248949|26466033|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
13284263|NCT01248949|26466034|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
13284264|NCT01248949|26466035|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
13284265|NCT01248949|26466036|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
13284266|NCT01248949|26466032|FG000|Overall Study|Pi Decision Due To Declining Status|0|||
13284267|NCT01248949|26466033|FG001|Overall Study|Pi Decision Due To Declining Status|0|||
13284268|NCT01248949|26466034|FG002|Overall Study|Pi Decision Due To Declining Status|1|||
13284269|NCT01248949|26466035|FG003|Overall Study|Pi Decision Due To Declining Status|0|||
13284270|NCT01248949|26466036|FG004|Overall Study|Pi Decision Due To Declining Status|0|||
13284271|NCT01248949|26466032|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0|||
13284272|NCT01248949|26466033|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1|||
13284273|NCT01248949|26466034|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0|||
13284274|NCT01248949|26466035|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0|||
13284275|NCT01248949|26466036|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0|||
13284276|NCT01248949|26466032|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
13284277|NCT01248949|26466033|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
13284278|NCT01248949|26466034|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1|||
13284279|NCT01248949|26466035|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
13284280|NCT01248949|26466036|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
13284281|NCT01248936|26466048|FG000|Overall Study|Sponsor Decision|259|||
13284282|NCT01248936|26466048|FG000|Overall Study|Progression of Disease|50|||
13284283|NCT01248936|26466048|FG000|Overall Study|Death|26|||
13284284|NCT01248936|26466048|FG000|Overall Study|Withdrawal of Consent|20|||
13284285|NCT01248936|26466048|FG000|Overall Study|Adverse Event|8|||
13284286|NCT01248936|26466048|FG000|Overall Study|Lost to Follow-up|7|||
13284287|NCT01248936|26466048|FG000|Overall Study|Refused Treatment|1|||
13284288|NCT01248936|26466048|FG000|Overall Study|Other reason|3|||
13284289|NCT01248884|26466114|FG000|Overall Study|Withdrawal by Subject|1|||
13284290|NCT01248884|26466115|FG001|Overall Study|Withdrawal by Subject|3|||
13284291|NCT01248884|26466116|FG002|Overall Study|Withdrawal by Subject|1|||
13284292|NCT01248884|26466114|FG000|Overall Study|Adverse Event|1|||
13284293|NCT01248884|26466115|FG001|Overall Study|Adverse Event|0|||
13284294|NCT01248884|26466116|FG002|Overall Study|Adverse Event|0|||
13284295|NCT01248793|26466135|FG000|Overall Study|Lost to Follow-up|0|||
13284296|NCT01248793|26466136|FG001|Overall Study|Lost to Follow-up|1|||
13284297|NCT01248793|26466135|FG000|Overall Study|Adverse Event|1|||
13284298|NCT01248793|26466136|FG001|Overall Study|Adverse Event|1|||
13284299|NCT01248793|26466135|FG000|Overall Study|Protocol Violation|0|||
13284300|NCT01248793|26466136|FG001|Overall Study|Protocol Violation|1|||
13284301|NCT01248793|26466135|FG000|Overall Study|Withdrawal by Subject|3|||
13284302|NCT01248793|26466136|FG001|Overall Study|Withdrawal by Subject|3|||
13284303|NCT01248780|26466155|FG000|Overall Study|Lack of Efficacy|2|||
13284304|NCT01248780|26466156|FG001|Overall Study|Lack of Efficacy|0|||
13284305|NCT01248780|26466155|FG000|Overall Study|Lost to Follow-up|0|||
13284306|NCT01248780|26466156|FG001|Overall Study|Lost to Follow-up|1|||
13284307|NCT01248780|26466155|FG000|Overall Study|Death|0|||
13284308|NCT01248780|26466156|FG001|Overall Study|Death|1|||
13284309|NCT01248780|26466155|FG000|Overall Study|Adverse Event|2|||
13284310|NCT01248780|26466156|FG001|Overall Study|Adverse Event|7|||
13284311|NCT01248780|26466155|FG000|Overall Study|Protocol Violation|1|||
13284312|NCT01248780|26466156|FG001|Overall Study|Protocol Violation|1|||
13284313|NCT01248780|26466155|FG000|Overall Study|Withdrawal by Subject|4|||
13284314|NCT01248780|26466156|FG001|Overall Study|Withdrawal by Subject|4|||
13284315|NCT01248780|26466155|FG000|Overall Study|Not treated|0|||
13284316|NCT01248780|26466156|FG001|Overall Study|Not treated|1|||
13284317|NCT01248728|26466177|FG000|Overall Study|Adverse Event|1|||
13284318|NCT01248728|26466178|FG001|Overall Study|Adverse Event|1|||
13284319|NCT01248728|26466177|FG000|Overall Study|Withdrawal by Subject|2|||
13284320|NCT01248728|26466178|FG001|Overall Study|Withdrawal by Subject|1|||
13284321|NCT01248728|26466177|FG000|Overall Study|Lack of Efficacy|1|||
13284322|NCT01248728|26466178|FG001|Overall Study|Lack of Efficacy|0|||
13284323|NCT01248715|26466203|FG000|Overall Study|Not influenza positive|501|||
13284324|NCT01248715|26466204|FG001|Overall Study|Not influenza positive|510|||
13284325|NCT01248468|26466231|FG000|Overall Study|Administrative problem|1|||
13284326|NCT01248468|26466232|FG001|Overall Study|Administrative problem|0|||
13284327|NCT01248468|26466233|FG002|Overall Study|Administrative problem|0|||
13284328|NCT01248468|26466231|FG000|Overall Study|Lost to Follow-up|9|||
13284329|NCT01248468|26466232|FG001|Overall Study|Lost to Follow-up|12|||
13284330|NCT01248468|26466233|FG002|Overall Study|Lost to Follow-up|4|||
13284331|NCT01248468|26466231|FG000|Overall Study|Pregnancy|1|||
13284332|NCT01248468|26466232|FG001|Overall Study|Pregnancy|0|||
13284333|NCT01248468|26466233|FG002|Overall Study|Pregnancy|0|||
13284334|NCT01248468|26466231|FG000|Overall Study|Withdrawal by Subject|4|||
13284335|NCT01248468|26466232|FG001|Overall Study|Withdrawal by Subject|2|||
13284336|NCT01248468|26466233|FG002|Overall Study|Withdrawal by Subject|0|||
13284337|NCT01248364|26466292|FG000|Overall Study|Adverse Event|0|||
13284338|NCT01248364|26466293|FG001|Overall Study|Adverse Event|1|||
13284339|NCT01248364|26466294|FG002|Overall Study|Adverse Event|0|||
13284340|NCT01248364|26466295|FG003|Overall Study|Adverse Event|0|||
13284341|NCT01248130|26466310|FG000|Overall Study|Protocol Violation|1|||
13284342|NCT01248130|26466311|FG001|Overall Study|Protocol Violation|0|||
13284343|NCT01248130|26466310|FG000|Overall Study|Ineligible|1|||
13284344|NCT01248130|26466311|FG001|Overall Study|Ineligible|0|||
13284345|NCT01248013|26466317|FG000|Overall Study|Withdrawal by Subject|14|||
13284346|NCT01247922|26466325|FG000|Overall Study|Disease progression|4|||
13284347|NCT01247350|26466397|FG000|Overall Study|Adverse Event|0|||
13284348|NCT01247350|26466398|FG001|Overall Study|Adverse Event|0|||
13284349|NCT01247350|26466399|FG002|Overall Study|Adverse Event|1|||
13284350|NCT01247350|26466400|FG003|Overall Study|Adverse Event|0|||
13284351|NCT01247350|26466401|FG004|Overall Study|Adverse Event|0|||
13284352|NCT01247350|26466397|FG000|Overall Study|Withdrawal by Subject|0|||
13284353|NCT01247350|26466398|FG001|Overall Study|Withdrawal by Subject|0|||
13284354|NCT01247350|26466399|FG002|Overall Study|Withdrawal by Subject|0|||
13284355|NCT01247350|26466400|FG003|Overall Study|Withdrawal by Subject|1|||
13284356|NCT01247350|26466401|FG004|Overall Study|Withdrawal by Subject|0|||
13284357|NCT01247350|26466397|FG000|Overall Study|Entry criteria not met|0|||
13284358|NCT01247350|26466398|FG001|Overall Study|Entry criteria not met|0|||
13284359|NCT01247350|26466399|FG002|Overall Study|Entry criteria not met|0|||
13284360|NCT01247350|26466400|FG003|Overall Study|Entry criteria not met|0|||
13284361|NCT01247350|26466401|FG004|Overall Study|Entry criteria not met|1|||
13284362|NCT01246999|26466447|FG000|Overall Study|Lost to Follow-up|0|||
13284363|NCT01246999|26466448|FG001|Overall Study|Lost to Follow-up|1|||
13284364|NCT01246999|26466449|FG002|Overall Study|Lost to Follow-up|0|||
13284365|NCT01246999|26466450|FG003|Overall Study|Lost to Follow-up|0|||
13284366|NCT01246999|26466447|FG000|Overall Study|Withdrawal by Subject|0|||
13284367|NCT01246999|26466448|FG001|Overall Study|Withdrawal by Subject|0|||
13284368|NCT01246999|26466449|FG002|Overall Study|Withdrawal by Subject|0|||
13284369|NCT01246999|26466450|FG003|Overall Study|Withdrawal by Subject|2|||
13284370|NCT01246973|26466465|FG000|Overall Study|Other|38|||
13284371|NCT01246973|26466466|FG001|Overall Study|Other|25|||
13284372|NCT01246973|26466465|FG000|Overall Study|Adverse Event|16|||
13284373|NCT01246973|26466466|FG001|Overall Study|Adverse Event|9|||
13284374|NCT01246973|26466465|FG000|Overall Study|Withdrawal by Subject|7|||
13284375|NCT01246973|26466466|FG001|Overall Study|Withdrawal by Subject|13|||
13284376|NCT01246466|26466479|FG000|Overall Study|Death|1|||
13284377|NCT01246466|26466479|FG000|Overall Study|Withdrawal by Subject|1|||
13284378|NCT01246206|26466492|FG000|Overall Study|Patient did not receive study regiments.|1|||
13284379|NCT01246011|26466513|FG000|Overall Study|If needed warfarin clinically, withdrawn|0|||
13284380|NCT01246011|26466514|FG001|Overall Study|If needed warfarin clinically, withdrawn|0|||
13284381|NCT01246011|26466515|FG002|Overall Study|If needed warfarin clinically, withdrawn|3|||
13284382|NCT01246011|26466513|FG000|Overall Study|Withdrawal by Subject|0|||
13284383|NCT01246011|26466514|FG001|Overall Study|Withdrawal by Subject|0|||
13284384|NCT01246011|26466515|FG002|Overall Study|Withdrawal by Subject|1|||
13284385|NCT01245764|26466562|FG000|Study Phase A|Other|3|||
13284386|NCT01245764|26466563|FG001|Study Phase A|Other|2|||
13284387|NCT01245764|26466564|FG002|Study Phase A|Other|3|||
13284388|NCT01245764|26466565|FG003|Study Phase A|Other|1|||
13284389|NCT01245764|26466562|FG000|Study Phase A|Protocol Violation|6|||
13284390|NCT01245764|26466563|FG001|Study Phase A|Protocol Violation|3|||
13284391|NCT01245764|26466564|FG002|Study Phase A|Protocol Violation|2|||
13284392|NCT01245764|26466565|FG003|Study Phase A|Protocol Violation|2|||
13284393|NCT01245764|26466562|FG000|Study Phase A|Lost to Follow-up|0|||
13284394|NCT01245764|26466563|FG001|Study Phase A|Lost to Follow-up|0|||
13284395|NCT01245764|26466564|FG002|Study Phase A|Lost to Follow-up|5|||
13284396|NCT01245764|26466565|FG003|Study Phase A|Lost to Follow-up|0|||
13284397|NCT01245751|26466591|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2|||
13284398|NCT01245751|26466592|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1|||
13284399|NCT01245751|26466593|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
13284400|NCT01245751|26466594|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
13284401|NCT01245751|26466591|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
13284402|NCT01245751|26466592|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
13284403|NCT01245751|26466593|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
13284404|NCT01245751|26466594|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2|||
13284405|NCT01245751|26466591|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
13284406|NCT01245751|26466592|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4|||
13284407|NCT01245751|26466593|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
13284408|NCT01245751|26466594|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
13284409|NCT01245673|26466600|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1|||
13284410|NCT01245283|26466642|FG000|Overall Study|Lost to Follow-up|14|||
13284411|NCT01245283|26466643|FG001|Overall Study|Lost to Follow-up|11|||
13284412|NCT01245283|26466644|FG002|Overall Study|Lost to Follow-up|11|||
13284413|NCT01245140|26466705|FG000|Overall Study|Adverse Event|1|||
13284414|NCT01245140|26466706|FG001|Overall Study|Adverse Event|3|||
13284415|NCT01245140|26466705|FG000|Overall Study|Lack of Efficacy|2|||
13284416|NCT01245140|26466706|FG001|Overall Study|Lack of Efficacy|4|||
13284417|NCT01245140|26466705|FG000|Overall Study|Protocol Violation|0|||
13284418|NCT01245140|26466706|FG001|Overall Study|Protocol Violation|1|||
13284419|NCT01245140|26466705|FG000|Overall Study|Withdrawal by Subject|0|||
13284420|NCT01245140|26466706|FG001|Overall Study|Withdrawal by Subject|1|||
13284421|NCT01245140|26466705|FG000|Overall Study|Refused Treatment/Did Not Coopera|0|||
13284422|NCT01245140|26466706|FG001|Overall Study|Refused Treatment/Did Not Coopera|1|||
13284423|NCT01245101|26466721|FG000|Period 1 (Treatment)|Withdrawal by Subject|2|||
13284424|NCT01245101|26466722|FG001|Period 1 (Treatment)|Withdrawal by Subject|0|||
13284425|NCT01245101|26466721|FG000|Period 2 (Washout)|Withdrawal by Subject|1|||
13284426|NCT01245101|26466722|FG001|Period 2 (Washout)|Withdrawal by Subject|0|||
13284427|NCT01245101|26466721|FG000|Period 3 (Treatment)|Withdrawal by Subject|1|||
13284428|NCT01245101|26466722|FG001|Period 3 (Treatment)|Withdrawal by Subject|0|||
13284429|NCT01245062|26466766|FG000|Randomization and Crossover Phase|Lost to Follow-up|4|||
13284430|NCT01245062|26466767|FG001|Randomization and Crossover Phase|Lost to Follow-up|2|||
13284431|NCT01245062|26466768|FG002|Randomization and Crossover Phase|Lost to Follow-up|0|||
13284432|NCT01245062|26466766|FG000|Randomization and Crossover Phase|Physician Decision|2|||
13284433|NCT01245062|26466767|FG001|Randomization and Crossover Phase|Physician Decision|4|||
13284434|NCT01245062|26466768|FG002|Randomization and Crossover Phase|Physician Decision|0|||
13284435|NCT01245062|26466766|FG000|Randomization and Crossover Phase|Withdrew Consent|12|||
13284436|NCT01245062|26466767|FG001|Randomization and Crossover Phase|Withdrew Consent|11|||
13284437|NCT01245062|26466768|FG002|Randomization and Crossover Phase|Withdrew Consent|0|||
13284438|NCT01245062|26466766|FG000|Randomization and Crossover Phase|Study closed/ terminated|23|||
13284439|NCT01245062|26466767|FG001|Randomization and Crossover Phase|Study closed/ terminated|14|||
13284440|NCT01245062|26466768|FG002|Randomization and Crossover Phase|Study closed/ terminated|0|||
13284441|NCT01245062|26466766|FG000|Cross-over Phase|Lost to Follow-up|0|||
13284442|NCT01245062|26466767|FG001|Cross-over Phase|Lost to Follow-up|0|||
13284443|NCT01245062|26466768|FG002|Cross-over Phase|Lost to Follow-up|1|||
13284444|NCT01245062|26466766|FG000|Cross-over Phase|Physician Decision|0|||
13284445|NCT01245062|26466767|FG001|Cross-over Phase|Physician Decision|0|||
13284446|NCT01245062|26466768|FG002|Cross-over Phase|Physician Decision|1|||
13284447|NCT01245062|26466766|FG000|Cross-over Phase|Withdrew Consent|0|||
13284448|NCT01245062|26466767|FG001|Cross-over Phase|Withdrew Consent|0|||
13284449|NCT01245062|26466768|FG002|Cross-over Phase|Withdrew Consent|4|||
13284450|NCT01245062|26466766|FG000|Cross-over Phase|Study closed/ terminated|0|||
13284451|NCT01245062|26466767|FG001|Cross-over Phase|Study closed/ terminated|0|||
13284452|NCT01245062|26466768|FG002|Cross-over Phase|Study closed/ terminated|11|||
13284453|NCT01245049|26466825|FG000|Overall Study|Migrated/moved from study area|0|||
13284454|NCT01245049|26466826|FG001|Overall Study|Migrated/moved from study area|1|||
13284455|NCT01245049|26466825|FG000|Overall Study|Withdrawal by Subject|0|||
13284456|NCT01245049|26466826|FG001|Overall Study|Withdrawal by Subject|1|||
13284457|NCT01245049|26466825|FG000|Overall Study|Lost to Follow-up|1|||
13284458|NCT01245049|26466826|FG001|Overall Study|Lost to Follow-up|2|||
13284459|NCT01244984|26466910|FG000|Overall Study|Adverse Event|2|||
13284460|NCT01244984|26466911|FG001|Overall Study|Adverse Event|11|||
13284461|NCT01244984|26466912|FG002|Overall Study|Adverse Event|2|||
13284462|NCT01244984|26466910|FG000|Overall Study|Protocol Violation|1|||
13284463|NCT01244984|26466911|FG001|Overall Study|Protocol Violation|0|||
13284464|NCT01244984|26466912|FG002|Overall Study|Protocol Violation|0|||
13284465|NCT01244984|26466910|FG000|Overall Study|Protocol Defined Stopping Criteria|1|||
13284466|NCT01244984|26466911|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
13284467|NCT01244984|26466912|FG002|Overall Study|Protocol Defined Stopping Criteria|0|||
13284468|NCT01244984|26466910|FG000|Overall Study|Withdrawal by Subject|1|||
13284469|NCT01244984|26466911|FG001|Overall Study|Withdrawal by Subject|2|||
13284470|NCT01244984|26466912|FG002|Overall Study|Withdrawal by Subject|2|||
13284471|NCT01244893|26466927|FG000|Baseline|Protocol Violation|0|||
13284472|NCT01244893|26466928|FG001|Baseline|Protocol Violation|1|||
13284473|NCT01244893|26466927|FG000|1-Week Follow Up|Lost to Follow-up|1|||
13284474|NCT01244893|26466928|FG001|1-Week Follow Up|Lost to Follow-up|0|||
13284475|NCT01244815|26467015|FG000|Overall Study|Not Treated|0|||
13284476|NCT01244815|26467016|FG001|Overall Study|Not Treated|1|||
13284477|NCT01244815|26467017|FG002|Overall Study|Not Treated|0|||
13284478|NCT01244815|26467018|FG003|Overall Study|Not Treated|0|||
13284479|NCT01244815|26467015|FG000|Overall Study|Adverse Event|4|||
13284480|NCT01244815|26467016|FG001|Overall Study|Adverse Event|7|||
13284481|NCT01244815|26467017|FG002|Overall Study|Adverse Event|5|||
13284482|NCT01244815|26467018|FG003|Overall Study|Adverse Event|5|||
13284483|NCT01244815|26467015|FG000|Overall Study|Treatment Failure|0|||
13284484|NCT01244815|26467016|FG001|Overall Study|Treatment Failure|0|||
13284485|NCT01244815|26467017|FG002|Overall Study|Treatment Failure|0|||
13284486|NCT01244815|26467018|FG003|Overall Study|Treatment Failure|1|||
13284487|NCT01244815|26467015|FG000|Overall Study|Lost to Follow-up|3|||
13284488|NCT01244815|26467016|FG001|Overall Study|Lost to Follow-up|2|||
13284489|NCT01244815|26467017|FG002|Overall Study|Lost to Follow-up|3|||
13284490|NCT01244815|26467018|FG003|Overall Study|Lost to Follow-up|2|||
13284491|NCT01244815|26467015|FG000|Overall Study|Withdrawal by Subject|0|||
13284492|NCT01244815|26467016|FG001|Overall Study|Withdrawal by Subject|2|||
13284493|NCT01244815|26467017|FG002|Overall Study|Withdrawal by Subject|0|||
13284494|NCT01244815|26467018|FG003|Overall Study|Withdrawal by Subject|3|||
13284495|NCT01244815|26467015|FG000|Overall Study|Protocol Violation|7|||
13284496|NCT01244815|26467016|FG001|Overall Study|Protocol Violation|4|||
13284497|NCT01244815|26467017|FG002|Overall Study|Protocol Violation|3|||
13284498|NCT01244815|26467018|FG003|Overall Study|Protocol Violation|1|||
13284499|NCT01244815|26467015|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
13284500|NCT01244815|26467016|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
13284501|NCT01244815|26467017|FG002|Overall Study|Did Not Meet Protocol Eligibility|0|||
13284502|NCT01244815|26467018|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
13292075|NCT00708500|26484518|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
13292076|NCT00708500|26484516|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
13292077|NCT00708500|26484517|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1|||
13292078|NCT00708500|26484518|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
13292079|NCT00708500|26484516|FG000|FOLLOWUP|Adverse Event|0|||
13292080|NCT00708500|26484517|FG001|FOLLOWUP|Adverse Event|1|||
13292081|NCT00708500|26484518|FG002|FOLLOWUP|Adverse Event|0|||
13292082|NCT00708500|26484516|FG000|FOLLOWUP|Lost to Follow-up|1|||
13292083|NCT00708500|26484517|FG001|FOLLOWUP|Lost to Follow-up|6|||
13292084|NCT00708500|26484518|FG002|FOLLOWUP|Lost to Follow-up|4|||
13292085|NCT00708500|26484516|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3|||
13292086|NCT00708500|26484517|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4|||
13292087|NCT00708500|26484518|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5|||
13292088|NCT00708500|26484516|FG000|FOLLOWUP|Subject withdrew consent|31|||
13292089|NCT00708500|26484517|FG001|FOLLOWUP|Subject withdrew consent|4|||
13292090|NCT00708500|26484518|FG002|FOLLOWUP|Subject withdrew consent|5|||
13292091|NCT00708500|26484516|FG000|FOLLOWUP|Non-compliance with protocol|5|||
13292092|NCT00708500|26484517|FG001|FOLLOWUP|Non-compliance with protocol|0|||
13292093|NCT00708500|26484518|FG002|FOLLOWUP|Non-compliance with protocol|1|||
13292094|NCT00708461|26484531|FG000|Overall Study|Lost to Follow-up|18|||
13292095|NCT00708461|26484532|FG001|Overall Study|Lost to Follow-up|11|||
13292096|NCT00708461|26484531|FG000|Overall Study|Withdrawal by Subject|8|||
13292097|NCT00708461|26484532|FG001|Overall Study|Withdrawal by Subject|9|||
13292098|NCT00708461|26484531|FG000|Overall Study|left workforce|115|||
13292099|NCT00708461|26484532|FG001|Overall Study|left workforce|180|||
13292100|NCT00708435|26484564|FG000|Overall Study|Death / Serious Adverse Event|10|||
13292101|NCT00708435|26484565|FG001|Overall Study|Death / Serious Adverse Event|5|||
13292102|NCT00708435|26484564|FG000|Overall Study|Lost to Follow-up|9|||
13292103|NCT00708435|26484565|FG001|Overall Study|Lost to Follow-up|4|||
13284503|NCT01244516|26467041|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4|||
13284504|NCT01244516|26467042|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5|||
13284505|NCT01244516|26467043|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2|||
13284506|NCT01244516|26467041|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
13284507|NCT01244516|26467042|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1|||
13284508|NCT01244516|26467043|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
13284509|NCT01244516|26467041|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
13284510|NCT01244516|26467042|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
13284511|NCT01244516|26467043|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1|||
13284512|NCT01244516|26467041|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2|||
13284513|NCT01244516|26467042|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
13284514|NCT01244516|26467043|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
13284515|NCT01244516|26467041|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
13284516|NCT01244516|26467042|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0|||
13284517|NCT01244516|26467043|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
13284518|NCT01244516|26467041|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
13284519|NCT01244516|26467042|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1|||
13284520|NCT01244516|26467043|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
13284521|NCT01244516|26467041|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
13284522|NCT01244516|26467042|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
13284523|NCT01244516|26467043|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1|||
13284524|NCT01244490|26467106|FG000|Overall Study|Lack of Efficacy|14|||
13284525|NCT01244490|26467107|FG001|Overall Study|Lack of Efficacy|5|||
13284526|NCT01244490|26467108|FG002|Overall Study|Lack of Efficacy|5|||
13284527|NCT01244490|26467106|FG000|Overall Study|Withdrawal by Subject|4|||
13284528|NCT01244490|26467107|FG001|Overall Study|Withdrawal by Subject|4|||
13284529|NCT01244490|26467108|FG002|Overall Study|Withdrawal by Subject|9|||
13284530|NCT01244490|26467106|FG000|Overall Study|Adverse Event|1|||
13284531|NCT01244490|26467107|FG001|Overall Study|Adverse Event|9|||
13284532|NCT01244490|26467108|FG002|Overall Study|Adverse Event|5|||
13284533|NCT01244490|26467106|FG000|Overall Study|Lost to Follow-up|0|||
13284534|NCT01244490|26467107|FG001|Overall Study|Lost to Follow-up|6|||
13284535|NCT01244490|26467108|FG002|Overall Study|Lost to Follow-up|3|||
13284536|NCT01244490|26467106|FG000|Overall Study|Other|0|||
13284537|NCT01244490|26467107|FG001|Overall Study|Other|0|||
13284538|NCT01244490|26467108|FG002|Overall Study|Other|1|||
13284539|NCT01244425|26467135|FG000|Overall Study|Withdrawal by Subject|2|||
13284540|NCT01244425|26467136|FG001|Overall Study|Withdrawal by Subject|2|||
13284541|NCT01244425|26467135|FG000|Overall Study|Adverse Event|1|||
13284542|NCT01244425|26467136|FG001|Overall Study|Adverse Event|1|||
13284543|NCT01244191|26467163|FG000|Overall Study|Progressive disease|295|||
13284544|NCT01244191|26467164|FG001|Overall Study|Progressive disease|350|||
13284545|NCT01244191|26467163|FG000|Overall Study|Clinical disease progression|54|||
13284546|NCT01244191|26467164|FG001|Overall Study|Clinical disease progression|36|||
13284547|NCT01244191|26467163|FG000|Overall Study|Adverse Event|65|||
13284548|NCT01244191|26467164|FG001|Overall Study|Adverse Event|48|||
13284549|NCT01244191|26467163|FG000|Overall Study|Death|22|||
13284550|NCT01244191|26467164|FG001|Overall Study|Death|29|||
13284551|NCT01244191|26467163|FG000|Overall Study|Lost to Follow-up|0|||
13284552|NCT01244191|26467164|FG001|Overall Study|Lost to Follow-up|2|||
13284553|NCT01244191|26467163|FG000|Overall Study|Protocol Violation|1|||
13284554|NCT01244191|26467164|FG001|Overall Study|Protocol Violation|2|||
13284555|NCT01244191|26467163|FG000|Overall Study|Withdrawal by Subject|31|||
13284556|NCT01244191|26467164|FG001|Overall Study|Withdrawal by Subject|23|||
13284557|NCT01244191|26467163|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12|||
13284558|NCT01244191|26467164|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8|||
13284559|NCT01244126|26467185|FG000|Overall Study|Protocol Violation|3|||
13284560|NCT01244126|26467186|FG001|Overall Study|Protocol Violation|3|||
13284561|NCT01244126|26467187|FG002|Overall Study|Protocol Violation|9|||
13284562|NCT01244035|26467222|FG000|Part 1: Period 1|Adverse Event|0|||
13284563|NCT01244035|26467223|FG001|Part 1: Period 1|Adverse Event|0|||
13284564|NCT01244035|26467224|FG002|Part 1: Period 1|Adverse Event|0|||
13284565|NCT01244035|26467225|FG003|Part 1: Period 1|Adverse Event|0|||
13284566|NCT01244035|26467226|FG004|Part 1: Period 1|Adverse Event|0|||
13284567|NCT01244035|26467227|FG005|Part 1: Period 1|Adverse Event|1|||
13284568|NCT01244035|26467222|FG000|Part 1: Period 1|Withdrawal by Subject|0|||
13284569|NCT01244035|26467223|FG001|Part 1: Period 1|Withdrawal by Subject|2|||
13284570|NCT01244035|26467224|FG002|Part 1: Period 1|Withdrawal by Subject|0|||
13284571|NCT01244035|26467225|FG003|Part 1: Period 1|Withdrawal by Subject|0|||
13284572|NCT01244035|26467226|FG004|Part 1: Period 1|Withdrawal by Subject|0|||
13284573|NCT01244035|26467227|FG005|Part 1: Period 1|Withdrawal by Subject|0|||
13284574|NCT01244035|26467222|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
13284575|NCT01244035|26467223|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
13284576|NCT01244035|26467224|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2|||
13284577|NCT01244035|26467225|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
13284578|NCT01244035|26467226|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
13284579|NCT01244035|26467227|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
13284580|NCT01244035|26467222|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
13284581|NCT01244035|26467223|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
13284582|NCT01244035|26467224|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1|||
13284583|NCT01244035|26467225|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
13284584|NCT01244035|26467226|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
13284585|NCT01244035|26467227|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
13284586|NCT01244035|26467222|FG000|Part 1: Period 3|Adverse Event|0|||
13284587|NCT01244035|26467223|FG001|Part 1: Period 3|Adverse Event|0|||
13284588|NCT01244035|26467224|FG002|Part 1: Period 3|Adverse Event|0|||
13284589|NCT01244035|26467225|FG003|Part 1: Period 3|Adverse Event|0|||
13284590|NCT01244035|26467226|FG004|Part 1: Period 3|Adverse Event|0|||
13284591|NCT01244035|26467227|FG005|Part 1: Period 3|Adverse Event|1|||
13284592|NCT01244035|26467222|FG000|Part 1: Period 3|Withdrawal by Subject|0|||
13284593|NCT01244035|26467223|FG001|Part 1: Period 3|Withdrawal by Subject|0|||
13284594|NCT01244035|26467224|FG002|Part 1: Period 3|Withdrawal by Subject|0|||
13284595|NCT01244035|26467225|FG003|Part 1: Period 3|Withdrawal by Subject|0|||
13284596|NCT01244035|26467226|FG004|Part 1: Period 3|Withdrawal by Subject|1|||
13284597|NCT01244035|26467227|FG005|Part 1: Period 3|Withdrawal by Subject|0|||
13284598|NCT01244035|26467222|FG000|Part 1: Period 3|Protocol Deviation|0|||
13284599|NCT01244035|26467223|FG001|Part 1: Period 3|Protocol Deviation|1|||
13284600|NCT01244035|26467224|FG002|Part 1: Period 3|Protocol Deviation|0|||
13284601|NCT01244035|26467225|FG003|Part 1: Period 3|Protocol Deviation|0|||
13284602|NCT01244035|26467226|FG004|Part 1: Period 3|Protocol Deviation|0|||
13284603|NCT01244035|26467227|FG005|Part 1: Period 3|Protocol Deviation|0|||
13284604|NCT01243944|26467260|FG000|Overall Study|Adverse Event|15|||
13284605|NCT01243944|26467261|FG001|Overall Study|Adverse Event|13|||
13284606|NCT01243944|26467260|FG000|Overall Study|Lost to Follow-up|2|||
13284607|NCT01243944|26467261|FG001|Overall Study|Lost to Follow-up|1|||
13284608|NCT01243944|26467260|FG000|Overall Study|Physician Decision|2|||
13284609|NCT01243944|26467261|FG001|Overall Study|Physician Decision|7|||
13284610|NCT01243944|26467260|FG000|Overall Study|Disease progression|12|||
13284611|NCT01243944|26467261|FG001|Overall Study|Disease progression|11|||
13284612|NCT01243944|26467260|FG000|Overall Study|Protocol deviation|1|||
13284613|NCT01243944|26467261|FG001|Overall Study|Protocol deviation|1|||
13284614|NCT01243944|26467260|FG000|Overall Study|Participant decision|10|||
13284615|NCT01243944|26467261|FG001|Overall Study|Participant decision|15|||
13284616|NCT01243944|26467260|FG000|Overall Study|Death|2|||
13284617|NCT01243944|26467261|FG001|Overall Study|Death|3|||
13284618|NCT01243944|26467260|FG000|Overall Study|Non-compliance with study treatment|1|||
13284619|NCT01243944|26467261|FG001|Overall Study|Non-compliance with study treatment|0|||
13284620|NCT01243892|26467278|FG000|Overall Study|Did not meet eligibility criteria|2|||
13284621|NCT01243892|26467279|FG001|Overall Study|Did not meet eligibility criteria|0|||
13284622|NCT01243775|26467288|FG000|Overall Study|Withdrawal by Subject|2|||
13284623|NCT01243762|26467329|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
13284624|NCT01243762|26467330|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2|||
13284625|NCT01243762|26467331|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
13284626|NCT01243762|26467332|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
13284627|NCT01243762|26467333|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
13284628|NCT01243762|26467334|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
13284629|NCT01243762|26467335|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
13284630|NCT01243762|26467329|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
13284631|NCT01243762|26467330|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
13284632|NCT01243762|26467331|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
13284633|NCT01243762|26467332|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
13284634|NCT01243762|26467333|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
13284635|NCT01243762|26467334|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
13284636|NCT01243762|26467335|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
13284637|NCT01243762|26467329|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
13284638|NCT01243762|26467330|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
13284639|NCT01243762|26467331|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
13284640|NCT01243762|26467332|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
13284641|NCT01243762|26467333|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
13284642|NCT01243762|26467334|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
13284643|NCT01243762|26467335|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0|||
13284644|NCT01243762|26467329|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
13284645|NCT01243762|26467330|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3|||
13308186|NCT01276639|26531267|FG004|Week 0 to 16|Other|0|||
13308187|NCT01276639|26531263|FG000|Week 0 to 16|Randomized, But Not Treated|0|||
13284646|NCT01243762|26467331|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
13284647|NCT01243762|26467332|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
13284648|NCT01243762|26467333|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
13308188|NCT01276639|26531264|FG001|Week 0 to 16|Randomized, But Not Treated|1|||
13284649|NCT01243762|26467334|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
13284650|NCT01243762|26467335|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
13284651|NCT01243762|26467329|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
13284652|NCT01243762|26467330|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1|||
13284653|NCT01243762|26467331|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
13284654|NCT01243762|26467332|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
13284655|NCT01243762|26467333|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
13284656|NCT01243762|26467334|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
13284657|NCT01243762|26467335|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3|||
13284658|NCT01243762|26467329|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
13284659|NCT01243762|26467330|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
13284660|NCT01243762|26467331|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
13284661|NCT01243762|26467332|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
13284662|NCT01243762|26467333|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2|||
13284663|NCT01243762|26467334|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
13284664|NCT01243762|26467335|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
13284665|NCT01243762|26467329|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
13284666|NCT01243762|26467330|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
13284667|NCT01243762|26467331|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
13284668|NCT01243762|26467332|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
13284669|NCT01243762|26467333|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
13284670|NCT01243762|26467334|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
13284671|NCT01243762|26467335|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
13284672|NCT01243762|26467329|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
13284673|NCT01243762|26467330|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
13284674|NCT01243762|26467331|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
13284675|NCT01243762|26467332|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
13284676|NCT01243762|26467333|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
13284677|NCT01243762|26467334|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
13284678|NCT01243762|26467335|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
13284679|NCT01243411|26467349|FG000|Overall Study|Withdrawal by Subject|18|||
13284680|NCT01243411|26467349|FG000|Overall Study|Lost to Follow-up|10|||
13284681|NCT01243411|26467349|FG000|Overall Study|Adverse Event|5|||
13284682|NCT01243411|26467349|FG000|Overall Study|Other|8|||
13284683|NCT01243268|26467359|FG000|Overall Study|Lost to Follow-up|4|||
13284684|NCT01243268|26467359|FG000|Overall Study|Protocol Violation|51|||
13284685|NCT01243268|26467359|FG000|Overall Study|Deviation with contract date|7|||
13284686|NCT01243268|26467359|FG000|Overall Study|Duplicate subject|2|||
13284687|NCT01243242|26467378|FG000|Overall Study|Adverse Event|1|||
13284688|NCT01243242|26467379|FG001|Overall Study|Adverse Event|1|||
13284689|NCT01243242|26467378|FG000|Overall Study|Withdrawal by Subject|1|||
13284690|NCT01243242|26467379|FG001|Overall Study|Withdrawal by Subject|1|||
13284691|NCT01243242|26467378|FG000|Overall Study|Physician Decision|0|||
13284692|NCT01243242|26467379|FG001|Overall Study|Physician Decision|1|||
13284693|NCT01243242|26467378|FG000|Overall Study|sponsor decision|0|||
13284694|NCT01243242|26467379|FG001|Overall Study|sponsor decision|1|||
13284695|NCT01243242|26467378|FG000|Overall Study|non compliance|1|||
13284696|NCT01243242|26467379|FG001|Overall Study|non compliance|0|||
13284697|NCT01243177|26467402|FG000|Overall Study|Lack of Efficacy|47|||
13284698|NCT01243177|26467403|FG001|Overall Study|Lack of Efficacy|31|||
13284699|NCT01243177|26467402|FG000|Overall Study|Protocol Violation|11|||
13284700|NCT01243177|26467403|FG001|Overall Study|Protocol Violation|10|||
13284701|NCT01243177|26467402|FG000|Overall Study|Lost to Follow-up|15|||
13284702|NCT01243177|26467403|FG001|Overall Study|Lost to Follow-up|18|||
13284703|NCT01243177|26467402|FG000|Overall Study|Withdrawal by Subject|46|||
13284704|NCT01243177|26467403|FG001|Overall Study|Withdrawal by Subject|38|||
13284705|NCT01243177|26467402|FG000|Overall Study|AE, serious fatal|0|||
13284706|NCT01243177|26467403|FG001|Overall Study|AE, serious fatal|1|||
13284707|NCT01243177|26467402|FG000|Overall Study|SAE, non-fatal|7|||
13284708|NCT01243177|26467403|FG001|Overall Study|SAE, non-fatal|9|||
13284709|NCT01243177|26467402|FG000|Overall Study|AE, non-serious non-fatal|40|||
13284710|NCT01243177|26467403|FG001|Overall Study|AE, non-serious non-fatal|58|||
13284711|NCT01243177|26467402|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1|||
13284712|NCT01243177|26467403|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0|||
13284713|NCT01243177|26467402|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
13284714|NCT01243177|26467403|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
13284715|NCT01243177|26467402|FG000|Overall Study|Other Reason|11|||
13284716|NCT01243177|26467403|FG001|Overall Study|Other Reason|12|||
13284717|NCT01242813|26467425|FG000|Overall Study|Lost to Follow-up|2|||
13284718|NCT01242748|26467452|FG000|Overall Study|Adverse Event|10|||
13284719|NCT01242748|26467453|FG001|Overall Study|Adverse Event|5|||
13284720|NCT01242748|26467452|FG000|Overall Study|Lost to Follow-up|6|||
13284721|NCT01242748|26467453|FG001|Overall Study|Lost to Follow-up|2|||
13284722|NCT01242748|26467452|FG000|Overall Study|Physician Decision|3|||
13284723|NCT01242748|26467453|FG001|Overall Study|Physician Decision|2|||
13284724|NCT01242748|26467452|FG000|Overall Study|Protocol Violation|1|||
13284725|NCT01242748|26467453|FG001|Overall Study|Protocol Violation|0|||
13284726|NCT01242748|26467452|FG000|Overall Study|Withdrawal by Subject|10|||
13284727|NCT01242748|26467453|FG001|Overall Study|Withdrawal by Subject|2|||
13284728|NCT01242748|26467452|FG000|Overall Study|Miscellaneous reasons|8|||
13284729|NCT01242748|26467453|FG001|Overall Study|Miscellaneous reasons|3|||
13284730|NCT01242514|26467480|FG000|Overall Study|e.g., project closure|1042|||
13284731|NCT01242514|26467481|FG001|Overall Study|e.g., project closure|305|||
13284732|NCT01242514|26467482|FG002|Overall Study|e.g., project closure|171|||
13284733|NCT01242514|26467480|FG000|Overall Study|Subject decision|33|||
13284734|NCT01242514|26467481|FG001|Overall Study|Subject decision|8|||
13284735|NCT01242514|26467482|FG002|Overall Study|Subject decision|2|||
13284736|NCT01242514|26467480|FG000|Overall Study|Severe non-compliance to protocol|5|||
13284737|NCT01242514|26467481|FG001|Overall Study|Severe non-compliance to protocol|2|||
13284738|NCT01242514|26467482|FG002|Overall Study|Severe non-compliance to protocol|1|||
13284739|NCT01242514|26467480|FG000|Overall Study|Lack of therapeutic response|99|||
13284740|NCT01242514|26467481|FG001|Overall Study|Lack of therapeutic response|16|||
13284741|NCT01242514|26467482|FG002|Overall Study|Lack of therapeutic response|10|||
13284742|NCT01242514|26467480|FG000|Overall Study|Dev. of study specific discont. criteria|21|||
13284743|NCT01242514|26467481|FG001|Overall Study|Dev. of study specific discont. criteria|3|||
13284744|NCT01242514|26467482|FG002|Overall Study|Dev. of study specific discont. criteria|5|||
13284745|NCT01242514|26467480|FG000|Overall Study|Lost to Follow-up|14|||
13284746|NCT01242514|26467481|FG001|Overall Study|Lost to Follow-up|5|||
13284747|NCT01242514|26467482|FG002|Overall Study|Lost to Follow-up|4|||
13284748|NCT01242514|26467480|FG000|Overall Study|Adverse Event|129|||
13284749|NCT01242514|26467481|FG001|Overall Study|Adverse Event|18|||
13284750|NCT01242514|26467482|FG002|Overall Study|Adverse Event|19|||
13284751|NCT01242371|26467495|FG000|Overall Study|Withdrawal by Subject|2|||
13284752|NCT01242371|26467496|FG001|Overall Study|Withdrawal by Subject|2|||
13284753|NCT01242371|26467495|FG000|Overall Study|Protocol Violation|0|||
13284754|NCT01242371|26467496|FG001|Overall Study|Protocol Violation|3|||
13284755|NCT01242176|26467509|FG000|Washout Period of 7 Days|Adverse Event|0|||
13284756|NCT01242176|26467510|FG001|Washout Period of 7 Days|Adverse Event|2|||
13284757|NCT01242176|26467509|FG000|Washout Period of 7 Days|Non-compliant with protocol|1|||
13284758|NCT01242176|26467510|FG001|Washout Period of 7 Days|Non-compliant with protocol|0|||
13284759|NCT01242111|26467521|FG000|Overall Study|Adverse Event|1|||
13284760|NCT01242111|26467521|FG000|Overall Study|Withdrawal by Subject|1|||
13284761|NCT01242111|26467521|FG000|Overall Study|Did not consent to MOR-100 follow-up|1|||
13284762|NCT01242085|26467539|FG000|Overall Study|Withdrawal by Subject|4|||
13284763|NCT01242085|26467540|FG001|Overall Study|Withdrawal by Subject|2|||
13284764|NCT01242085|26467541|FG002|Overall Study|Withdrawal by Subject|0|||
13284765|NCT01242085|26467539|FG000|Overall Study|medically unable to have surgery|4|||
13284766|NCT01242085|26467540|FG001|Overall Study|medically unable to have surgery|5|||
13284767|NCT01242085|26467541|FG002|Overall Study|medically unable to have surgery|0|||
13284768|NCT01242020|26467556|FG000|Overall Study|Withdrawal by Subject|2|||
13284769|NCT01242020|26467557|FG001|Overall Study|Withdrawal by Subject|0|||
13284770|NCT01242020|26467556|FG000|Overall Study|Failed screening|1|||
13284771|NCT01242020|26467557|FG001|Overall Study|Failed screening|0|||
13284772|NCT01241786|26467566|FG000|Overall Study|Lack of Efficacy|5|||
13284773|NCT01241604|26467611|FG000|Screening Period|Screen Failure|3|||
13284774|NCT01241604|26467612|FG001|Screening Period|Screen Failure|0|||
13284775|NCT01241604|26467613|FG002|Screening Period|Screen Failure|0|||
13284776|NCT01241461|26467636|FG000|Overall Study|Progressive Disease|3|||
13284777|NCT01241461|26467637|FG001|Overall Study|Progressive Disease|6|||
13284778|NCT01241318|26467659|FG000|Overall Study|Woman: false pregnancies|27|||
13284779|NCT01241318|26467660|FG001|Overall Study|Woman: false pregnancies|15|||
13284780|NCT01241318|26467659|FG000|Overall Study|Woman: miscarriage/abortion|46|||
13284781|NCT01241318|26467660|FG001|Overall Study|Woman: miscarriage/abortion|38|||
13284782|NCT01241318|26467659|FG000|Overall Study|Withdrawal by Subject|175|||
13284783|NCT01241318|26467660|FG001|Overall Study|Withdrawal by Subject|46|||
13284784|NCT01241318|26467659|FG000|Overall Study|Lost to Follow-up|740|||
13284785|NCT01241318|26467660|FG001|Overall Study|Lost to Follow-up|455|||
13284786|NCT01241318|26467659|FG000|Overall Study|Death|2|||
13284787|NCT01241318|26467660|FG001|Overall Study|Death|4|||
13284788|NCT01241318|26467659|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60|||
13284789|NCT01241318|26467660|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38|||
13284790|NCT01241318|26467659|FG000|Overall Study|Woman: Stillborn infant|129|||
13284791|NCT01241318|26467660|FG001|Overall Study|Woman: Stillborn infant|146|||
13284792|NCT01241292|26467689|FG000|Overall Study|Administrative Reason by Sponsor|1|||
13284793|NCT01241292|26467690|FG001|Overall Study|Administrative Reason by Sponsor|0|||
13284794|NCT01241292|26467689|FG000|Overall Study|Disease Progression|2|||
13284795|NCT01241292|26467690|FG001|Overall Study|Disease Progression|0|||
13284796|NCT01241292|26467689|FG000|Overall Study|Study Drug Toxicity|0|||
13284797|NCT01241292|26467690|FG001|Overall Study|Study Drug Toxicity|1|||
13284798|NCT01241292|26467689|FG000|Overall Study|Participant Discontinued Treatment|0|||
13284799|NCT01241292|26467690|FG001|Overall Study|Participant Discontinued Treatment|2|||
13284800|NCT01241279|26467705|FG000|Overall Study|Lost to Follow-up|0|||
13284801|NCT01241279|26467706|FG001|Overall Study|Lost to Follow-up|1|||
13284802|NCT01241240|26467723|FG000|Overall Study|Adverse Event|5|||
13284803|NCT01241240|26467724|FG001|Overall Study|Adverse Event|4|||
13284804|NCT01241240|26467723|FG000|Overall Study|Lost to Follow-up|2|||
13284805|NCT01241240|26467724|FG001|Overall Study|Lost to Follow-up|4|||
13284806|NCT01241240|26467723|FG000|Overall Study|Personal Reasons|1|||
13284807|NCT01241240|26467724|FG001|Overall Study|Personal Reasons|1|||
13284808|NCT01240863|26467791|FG000|Open-label Titration Period|Adverse Event|47|||
13284809|NCT01240863|26467792|FG001|Open-label Titration Period|Adverse Event|0|||
13284810|NCT01240863|26467793|FG002|Open-label Titration Period|Adverse Event|0|||
13284811|NCT01240863|26467791|FG000|Open-label Titration Period|Lack of Efficacy|19|||
13284812|NCT01240863|26467792|FG001|Open-label Titration Period|Lack of Efficacy|0|||
13284813|NCT01240863|26467793|FG002|Open-label Titration Period|Lack of Efficacy|0|||
13284814|NCT01240863|26467791|FG000|Open-label Titration Period|Withdrawal by Subject|9|||
13284815|NCT01240863|26467792|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
13284816|NCT01240863|26467793|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
13284817|NCT01240863|26467791|FG000|Open-label Titration Period|Protocol Violation|7|||
13284818|NCT01240863|26467792|FG001|Open-label Titration Period|Protocol Violation|0|||
13284819|NCT01240863|26467793|FG002|Open-label Titration Period|Protocol Violation|0|||
13284820|NCT01240863|26467791|FG000|Open-label Titration Period|Noncompliance to study drug admin|3|||
13284821|NCT01240863|26467792|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
13284822|NCT01240863|26467793|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
13284823|NCT01240863|26467791|FG000|Open-label Titration Period|Noncompliance to study procedures|3|||
13284824|NCT01240863|26467792|FG001|Open-label Titration Period|Noncompliance to study procedures|0|||
13284825|NCT01240863|26467793|FG002|Open-label Titration Period|Noncompliance to study procedures|0|||
13284826|NCT01240863|26467791|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
13284827|NCT01240863|26467792|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
13284828|NCT01240863|26467793|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
13284829|NCT01240863|26467791|FG000|Open-label Titration Period|Other|7|||
13284830|NCT01240863|26467792|FG001|Open-label Titration Period|Other|0|||
13284831|NCT01240863|26467793|FG002|Open-label Titration Period|Other|0|||
13284832|NCT01240863|26467791|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
13284833|NCT01240863|26467792|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4|||
13284834|NCT01240863|26467793|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10|||
13284835|NCT01240863|26467791|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
13284836|NCT01240863|26467792|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
13284837|NCT01240863|26467793|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
13284838|NCT01240863|26467791|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
13284839|NCT01240863|26467792|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
13284840|NCT01240863|26467793|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
13284841|NCT01240863|26467791|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
13284842|NCT01240863|26467792|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
13284843|NCT01240863|26467793|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14|||
13284844|NCT01240863|26467791|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
13284845|NCT01240863|26467792|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9|||
13284846|NCT01240863|26467793|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11|||
13284847|NCT01240863|26467791|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0|||
13284848|NCT01240863|26467792|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
13284849|NCT01240863|26467793|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
13284850|NCT01240863|26467791|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
13284851|NCT01240863|26467792|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
13284852|NCT01240863|26467793|FG002|Double-blind Treatment Period (12 Weeks)|Other|5|||
13284853|NCT01240863|26467791|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
13284854|NCT01240863|26467792|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1|||
13284855|NCT01240863|26467793|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
13284856|NCT01240811|26467817|FG000|Overall Study|Physician Decision|0|||
13284857|NCT01240811|26467818|FG001|Overall Study|Physician Decision|1|||
13284858|NCT01240811|26467819|FG002|Overall Study|Physician Decision|0|||
13284859|NCT01240811|26467817|FG000|Overall Study|Withdrawal by Subject|0|||
13284860|NCT01240811|26467818|FG001|Overall Study|Withdrawal by Subject|0|||
13284861|NCT01240811|26467819|FG002|Overall Study|Withdrawal by Subject|1|||
13284862|NCT01240746|26467879|FG000|Overall Study|Adverse Event|2|||
13284863|NCT01240746|26467880|FG001|Overall Study|Adverse Event|0|||
13284864|NCT01240746|26467881|FG002|Overall Study|Adverse Event|10|||
13284865|NCT01240746|26467879|FG000|Overall Study|Lost to Follow-up|23|||
13284866|NCT01240746|26467880|FG001|Overall Study|Lost to Follow-up|20|||
13284867|NCT01240746|26467881|FG002|Overall Study|Lost to Follow-up|102|||
13284868|NCT01240746|26467879|FG000|Overall Study|Protocol Violation|24|||
13284869|NCT01240746|26467880|FG001|Overall Study|Protocol Violation|15|||
13284870|NCT01240746|26467881|FG002|Overall Study|Protocol Violation|72|||
13284871|NCT01240746|26467879|FG000|Overall Study|Withdrawal by Subject|10|||
13284872|NCT01240746|26467880|FG001|Overall Study|Withdrawal by Subject|13|||
13284873|NCT01240746|26467881|FG002|Overall Study|Withdrawal by Subject|59|||
13284874|NCT01240590|26467923|FG000|Phase I|Refused further treatment|0|||
13284875|NCT01240590|26467924|FG001|Phase I|Refused further treatment|0|||
13284876|NCT01240590|26467925|FG002|Phase I|Refused further treatment|3|||
13284877|NCT01240590|26467926|FG003|Phase I|Refused further treatment|0|||
13284878|NCT01240590|26467927|FG004|Phase I|Refused further treatment|0|||
13284879|NCT01240590|26467923|FG000|Phase II|Refused further treatment|0|||
13308189|NCT01276639|26531265|FG002|Week 0 to 16|Randomized, But Not Treated|0|||
13308190|NCT01276639|26531266|FG003|Week 0 to 16|Randomized, But Not Treated|0|||
13308191|NCT01276639|26531267|FG004|Week 0 to 16|Randomized, But Not Treated|0|||
13308192|NCT01276639|26531263|FG000|Week 16 to 52|Death|1|||
13308193|NCT01276639|26531264|FG001|Week 16 to 52|Death|0|||
13308194|NCT01276639|26531265|FG002|Week 16 to 52|Death|0|||
13308195|NCT01276639|26531266|FG003|Week 16 to 52|Death|0|||
13308196|NCT01276639|26531267|FG004|Week 16 to 52|Death|0|||
13308197|NCT01276639|26531263|FG000|Week 16 to 52|Adverse Event|10|||
13308198|NCT01276639|26531264|FG001|Week 16 to 52|Adverse Event|13|||
13308199|NCT01276639|26531265|FG002|Week 16 to 52|Adverse Event|0|||
13308200|NCT01276639|26531266|FG003|Week 16 to 52|Adverse Event|1|||
13308201|NCT01276639|26531267|FG004|Week 16 to 52|Adverse Event|3|||
13308202|NCT01276639|26531263|FG000|Week 16 to 52|Lack of Efficacy|99|||
13308203|NCT01276639|26531264|FG001|Week 16 to 52|Lack of Efficacy|71|||
13308204|NCT01276639|26531265|FG002|Week 16 to 52|Lack of Efficacy|0|||
13308205|NCT01276639|26531266|FG003|Week 16 to 52|Lack of Efficacy|14|||
13308206|NCT01276639|26531267|FG004|Week 16 to 52|Lack of Efficacy|13|||
13308207|NCT01276639|26531263|FG000|Week 16 to 52|Lost to Follow-up|3|||
13308208|NCT01276639|26531264|FG001|Week 16 to 52|Lost to Follow-up|1|||
13308209|NCT01276639|26531265|FG002|Week 16 to 52|Lost to Follow-up|0|||
13308210|NCT01276639|26531266|FG003|Week 16 to 52|Lost to Follow-up|0|||
13308211|NCT01276639|26531267|FG004|Week 16 to 52|Lost to Follow-up|1|||
13308212|NCT01276639|26531263|FG000|Week 16 to 52|Withdrawal by Subject|4|||
13308213|NCT01276639|26531264|FG001|Week 16 to 52|Withdrawal by Subject|4|||
13308214|NCT01276639|26531265|FG002|Week 16 to 52|Withdrawal by Subject|0|||
13308215|NCT01276639|26531266|FG003|Week 16 to 52|Withdrawal by Subject|0|||
13308216|NCT01276639|26531267|FG004|Week 16 to 52|Withdrawal by Subject|1|||
13308217|NCT01276639|26531263|FG000|Week 16 to 52|Other|10|||
13308218|NCT01276639|26531264|FG001|Week 16 to 52|Other|12|||
13308219|NCT01276639|26531265|FG002|Week 16 to 52|Other|0|||
13308220|NCT01276639|26531266|FG003|Week 16 to 52|Other|1|||
13308221|NCT01276639|26531267|FG004|Week 16 to 52|Other|3|||
13308222|NCT01276509|26531331|FG000|Overall Study|Adverse Event|9|||
13308223|NCT01276509|26531332|FG001|Overall Study|Adverse Event|8|||
13308224|NCT01276509|26531333|FG002|Overall Study|Adverse Event|4|||
13308225|NCT01276509|26531334|FG003|Overall Study|Adverse Event|3|||
13308226|NCT01276509|26531331|FG000|Overall Study|Lack of Efficacy|2|||
13308227|NCT01276509|26531332|FG001|Overall Study|Lack of Efficacy|1|||
13308228|NCT01276509|26531333|FG002|Overall Study|Lack of Efficacy|1|||
13308229|NCT01276509|26531334|FG003|Overall Study|Lack of Efficacy|2|||
13308230|NCT01276509|26531331|FG000|Overall Study|Pregnancy|1|||
13308231|NCT01276509|26531332|FG001|Overall Study|Pregnancy|0|||
13308232|NCT01276509|26531333|FG002|Overall Study|Pregnancy|0|||
13308233|NCT01276509|26531334|FG003|Overall Study|Pregnancy|0|||
13308234|NCT01276509|26531331|FG000|Overall Study|Withdrawal by Subject|1|||
13308235|NCT01276509|26531332|FG001|Overall Study|Withdrawal by Subject|2|||
13308236|NCT01276509|26531333|FG002|Overall Study|Withdrawal by Subject|0|||
13308237|NCT01276509|26531334|FG003|Overall Study|Withdrawal by Subject|0|||
13308238|NCT01276509|26531331|FG000|Overall Study|Other|0|||
13308239|NCT01276509|26531332|FG001|Overall Study|Other|1|||
13308240|NCT01276509|26531333|FG002|Overall Study|Other|0|||
13308241|NCT01276509|26531334|FG003|Overall Study|Other|0|||
13308242|NCT01275625|26531350|FG000|Overall Study|Death|1|||
13308243|NCT01275625|26531350|FG000|Overall Study|Lack of Efficacy|2|||
13308244|NCT01275625|26531350|FG000|Overall Study|Lost to Follow-up|1|||
13284880|NCT01240590|26467924|FG001|Phase II|Refused further treatment|0|||
13284881|NCT01240590|26467925|FG002|Phase II|Refused further treatment|0|||
13308245|NCT01275625|26531350|FG000|Overall Study|Withdrawal by Subject|3|||
13308246|NCT01275625|26531350|FG000|Overall Study|Protocol Violation|1|||
13308247|NCT01275625|26531350|FG000|Overall Study|Adverse Event|4|||
13284882|NCT01240590|26467926|FG003|Phase II|Refused further treatment|2|||
13308248|NCT01275625|26531350|FG000|Overall Study|Other|1|||
13308249|NCT01274637|26531373|FG000|Overall Study|Withdrawal by Subject|0|||
13308250|NCT01274637|26531374|FG001|Overall Study|Withdrawal by Subject|1|||
13308251|NCT01274637|26531373|FG000|Overall Study|Lost to Follow-up|0|||
13308252|NCT01274637|26531374|FG001|Overall Study|Lost to Follow-up|1|||
13308253|NCT01274351|26531385|FG000|Overall Study|Lost to Follow-up|1|||
13308254|NCT01274351|26531385|FG000|Overall Study|patient not compliant with the protocol|1|||
13308255|NCT01274351|26531385|FG000|Overall Study|Pregnancy|1|||
13308256|NCT01274351|26531385|FG000|Overall Study|Death|2|||
13308257|NCT01274351|26531385|FG000|Overall Study|Withdrawal by Subject|3|||
13308258|NCT01274351|26531385|FG000|Overall Study|Adverse Event|8|||
13308259|NCT01274351|26531385|FG000|Overall Study|progression of disease|3|||
13308260|NCT01274351|26531385|FG000|Overall Study|hospitalization|1|||
13308261|NCT01274338|26531429|FG000|Overall Study|Lack of Efficacy|72|||
13284883|NCT01240590|26467927|FG004|Phase II|Refused further treatment|1|||
13284884|NCT01240382|26467942|FG000|Overall Study|Adverse Event|2|||
13284885|NCT01240382|26467943|FG001|Overall Study|Adverse Event|1|||
13284886|NCT01240382|26467942|FG000|Overall Study|Lack of Efficacy|0|||
13284887|NCT01240382|26467943|FG001|Overall Study|Lack of Efficacy|2|||
13284888|NCT01240382|26467942|FG000|Overall Study|Fear of adverse events|0|||
13284889|NCT01240382|26467943|FG001|Overall Study|Fear of adverse events|1|||
13284890|NCT01240200|26467966|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
13284891|NCT01240200|26467967|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1|||
13284892|NCT01240135|26467982|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
13284893|NCT01240135|26467983|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
13284894|NCT01240135|26467982|FG000|Period Two, 14 Days of Wear|Adverse Event|0|||
13284895|NCT01240135|26467983|FG001|Period Two, 14 Days of Wear|Adverse Event|1|||
13284896|NCT01244828|26467997|FG000|Overall Study|Adverse Event|37|||
13284897|NCT01244828|26467997|FG000|Overall Study|Withdrawal by Subject|31|||
13284898|NCT01244828|26467997|FG000|Overall Study|Lack of Efficacy|7|||
13284899|NCT01244828|26467997|FG000|Overall Study|Lost to Follow-up|2|||
13284900|NCT01244828|26467997|FG000|Overall Study|Other reason (not specified)|1|||
13284901|NCT01248962|26468015|FG000|Overall Study|Withdrawal by Subject|1|||
13284902|NCT01248962|26468016|FG001|Overall Study|Withdrawal by Subject|1|||
13284903|NCT01248962|26468015|FG000|Overall Study|Adverse Event|2|||
13284904|NCT01248962|26468016|FG001|Overall Study|Adverse Event|1|||
13284905|NCT01248962|26468015|FG000|Overall Study|Complete Response after 4 Cycles|1|||
13284906|NCT01248962|26468016|FG001|Overall Study|Complete Response after 4 Cycles|0|||
13284907|NCT01248962|26468015|FG000|Overall Study|Complete Response after 3 Cycles|0|||
13284908|NCT01248962|26468016|FG001|Overall Study|Complete Response after 3 Cycles|1|||
13284909|NCT01248962|26468015|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12|||
13284910|NCT01248962|26468016|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13|||
13284911|NCT01248455|26468023|FG000|Overall Study|switched to alternate treatment|1|||
13284912|NCT01247090|26468041|FG000|Overall Study|Physician Decision|1|||
13284913|NCT01247090|26468042|FG001|Overall Study|Physician Decision|0|||
13284914|NCT01247090|26468043|FG002|Overall Study|Physician Decision|0|||
13284915|NCT01247090|26468041|FG000|Overall Study|Withdrawal by Subject|0|||
13284916|NCT01247090|26468042|FG001|Overall Study|Withdrawal by Subject|1|||
13284917|NCT01247090|26468043|FG002|Overall Study|Withdrawal by Subject|0|||
13284918|NCT01247701|26468055|FG000|Overall Study|Death|2|||
13284919|NCT01247701|26468055|FG000|Overall Study|Relapsed|8|||
13284920|NCT01248247|26468082|FG000|Overall Study|Adverse Event|2|||
13284921|NCT01248247|26468083|FG001|Overall Study|Adverse Event|4|||
13284922|NCT01248247|26468084|FG002|Overall Study|Adverse Event|4|||
13284923|NCT01248247|26468085|FG003|Overall Study|Adverse Event|2|||
13284924|NCT01248247|26468082|FG000|Overall Study|Death|0|||
13284925|NCT01248247|26468083|FG001|Overall Study|Death|1|||
13284926|NCT01248247|26468084|FG002|Overall Study|Death|4|||
13284927|NCT01248247|26468085|FG003|Overall Study|Death|7|||
13284928|NCT01248247|26468082|FG000|Overall Study|Lost to Follow-up|0|||
13284929|NCT01248247|26468083|FG001|Overall Study|Lost to Follow-up|1|||
13284930|NCT01248247|26468084|FG002|Overall Study|Lost to Follow-up|1|||
13284931|NCT01248247|26468085|FG003|Overall Study|Lost to Follow-up|0|||
13284932|NCT01248247|26468082|FG000|Overall Study|Alternative treatment|0|||
13284933|NCT01248247|26468083|FG001|Overall Study|Alternative treatment|1|||
13284934|NCT01248247|26468084|FG002|Overall Study|Alternative treatment|0|||
13284935|NCT01248247|26468085|FG003|Overall Study|Alternative treatment|0|||
13284936|NCT01248247|26468082|FG000|Overall Study|Other|2|||
13284937|NCT01248247|26468083|FG001|Overall Study|Other|8|||
13284938|NCT01248247|26468084|FG002|Overall Study|Other|8|||
13284939|NCT01248247|26468085|FG003|Overall Study|Other|5|||
13284940|NCT01248247|26468082|FG000|Overall Study|Progression|18|||
13284941|NCT01248247|26468083|FG001|Overall Study|Progression|27|||
13284942|NCT01248247|26468084|FG002|Overall Study|Progression|56|||
13284943|NCT01248247|26468085|FG003|Overall Study|Progression|44|||
13284944|NCT01248247|26468082|FG000|Overall Study|Refuse further treatment|0|||
13284945|NCT01248247|26468083|FG001|Overall Study|Refuse further treatment|0|||
13284946|NCT01248247|26468084|FG002|Overall Study|Refuse further treatment|1|||
13284947|NCT01248247|26468085|FG003|Overall Study|Refuse further treatment|2|||
13284948|NCT01248247|26468082|FG000|Overall Study|Complicating disease|0|||
13284949|NCT01248247|26468083|FG001|Overall Study|Complicating disease|0|||
13284950|NCT01248247|26468084|FG002|Overall Study|Complicating disease|1|||
13308262|NCT01274338|26531430|FG001|Overall Study|Lack of Efficacy|108|||
13308263|NCT01274338|26531431|FG002|Overall Study|Lack of Efficacy|116|||
13284951|NCT01248247|26468085|FG003|Overall Study|Complicating disease|1|||
13292104|NCT00708435|26484564|FG000|Overall Study|Withdrawal by Subject|3|||
13292105|NCT00708435|26484565|FG001|Overall Study|Withdrawal by Subject|7|||
13292106|NCT00708435|26484564|FG000|Overall Study|Adverse Event|1|||
13292107|NCT00708435|26484565|FG001|Overall Study|Adverse Event|0|||
13292108|NCT00708435|26484564|FG000|Overall Study|Protocol Violation|0|||
13292109|NCT00708435|26484565|FG001|Overall Study|Protocol Violation|1|||
13292110|NCT00708435|26484564|FG000|Overall Study|Intervention by primary care physician|1|||
13292111|NCT00708435|26484565|FG001|Overall Study|Intervention by primary care physician|0|||
13292112|NCT00708435|26484564|FG000|Overall Study|Refused hospitalization|1|||
13292113|NCT00708435|26484565|FG001|Overall Study|Refused hospitalization|0|||
13292114|NCT00708422|26484580|FG000|Overall Study|Adverse Event|3|||
13292115|NCT00708422|26484581|FG001|Overall Study|Adverse Event|1|||
13292116|NCT00708422|26484580|FG000|Overall Study|Withdrawal by Subject|1|||
13292117|NCT00708422|26484581|FG001|Overall Study|Withdrawal by Subject|0|||
13292118|NCT00708227|26484624|FG000|Overall Study|Physician Decision|0|||
13292119|NCT00708227|26484625|FG001|Overall Study|Physician Decision|3|||
13292120|NCT00708227|26484626|FG002|Overall Study|Physician Decision|1|||
13292121|NCT00708227|26484627|FG003|Overall Study|Physician Decision|2|||
13292122|NCT00708227|26484624|FG000|Overall Study|Withdrawal by Subject|1|||
13292123|NCT00708227|26484625|FG001|Overall Study|Withdrawal by Subject|2|||
13292124|NCT00708227|26484626|FG002|Overall Study|Withdrawal by Subject|0|||
13292125|NCT00708227|26484627|FG003|Overall Study|Withdrawal by Subject|1|||
13292126|NCT00708214|26484678|FG000|Overall Study|Other Adverse Event|3|||
13292127|NCT00708214|26484679|FG001|Overall Study|Other Adverse Event|6|||
13292128|NCT00708214|26484680|FG002|Overall Study|Other Adverse Event|2|||
13292129|NCT00708214|26484678|FG000|Overall Study|Other|0|||
13292130|NCT00708214|26484679|FG001|Overall Study|Other|1|||
13292131|NCT00708214|26484680|FG002|Overall Study|Other|1|||
13292132|NCT00708214|26484678|FG000|Overall Study|Progressive Disease|4|||
13292133|NCT00708214|26484679|FG001|Overall Study|Progressive Disease|6|||
13292134|NCT00708214|26484680|FG002|Overall Study|Progressive Disease|5|||
13292135|NCT00708201|26484709|FG000|Overall Study|Adverse Event|4|||
13292136|NCT00708201|26484710|FG001|Overall Study|Adverse Event|4|||
13292137|NCT00708201|26484709|FG000|Overall Study|Withdrawal by Subject|1|||
13292138|NCT00708201|26484710|FG001|Overall Study|Withdrawal by Subject|1|||
13292139|NCT00708201|26484709|FG000|Overall Study|Lost to Follow-up|2|||
13292140|NCT00708201|26484710|FG001|Overall Study|Lost to Follow-up|0|||
13292141|NCT00708201|26484709|FG000|Overall Study|Protocol Violation|0|||
13292142|NCT00708201|26484710|FG001|Overall Study|Protocol Violation|1|||
13292143|NCT00708162|26484758|FG000|Randomized Phase|Randomized but Not Treated|7|||
13292144|NCT00708162|26484759|FG001|Randomized Phase|Randomized but Not Treated|5|||
13292145|NCT00708162|26484758|FG000|Randomized Phase|Participant Noncompliance|40|||
13292146|NCT00708162|26484759|FG001|Randomized Phase|Participant Noncompliance|32|||
13292147|NCT00708162|26484758|FG000|Randomized Phase|Lost to Follow-up|34|||
13292148|NCT00708162|26484759|FG001|Randomized Phase|Lost to Follow-up|34|||
13292149|NCT00708162|26484758|FG000|Randomized Phase|Withdrew Consent|31|||
13292150|NCT00708162|26484759|FG001|Randomized Phase|Withdrew Consent|22|||
13292151|NCT00708162|26484758|FG000|Randomized Phase|Lack of Efficacy|14|||
13292152|NCT00708162|26484759|FG001|Randomized Phase|Lack of Efficacy|19|||
13292153|NCT00708162|26484758|FG000|Randomized Phase|Protocol Violation|10|||
13292154|NCT00708162|26484759|FG001|Randomized Phase|Protocol Violation|11|||
13292155|NCT00708162|26484758|FG000|Randomized Phase|Adverse Event|8|||
13292156|NCT00708162|26484759|FG001|Randomized Phase|Adverse Event|12|||
13292157|NCT00708162|26484758|FG000|Randomized Phase|Investigator's Discretion|7|||
13292158|NCT00708162|26484759|FG001|Randomized Phase|Investigator's Discretion|10|||
13292159|NCT00708162|26484758|FG000|Randomized Phase|Death|2|||
13292160|NCT00708162|26484759|FG001|Randomized Phase|Death|9|||
13292161|NCT00708162|26484758|FG000|Randomized Phase|Pregnancy|3|||
13292162|NCT00708162|26484759|FG001|Randomized Phase|Pregnancy|0|||
13292163|NCT00708162|26484758|FG000|Open-Label Phase|Lost to Follow-up|10|||
13292164|NCT00708162|26484759|FG001|Open-Label Phase|Lost to Follow-up|8|||
13292165|NCT00708162|26484758|FG000|Open-Label Phase|Withdrew Consent|12|||
13292166|NCT00708162|26484759|FG001|Open-Label Phase|Withdrew Consent|6|||
13292167|NCT00708162|26484758|FG000|Open-Label Phase|Participant Noncompliance|7|||
13292168|NCT00708162|26484759|FG001|Open-Label Phase|Participant Noncompliance|7|||
13292169|NCT00708162|26484758|FG000|Open-Label Phase|Lack of Efficacy|7|||
13292170|NCT00708162|26484759|FG001|Open-Label Phase|Lack of Efficacy|4|||
13292171|NCT00708162|26484758|FG000|Open-Label Phase|Investigator's Discretion|3|||
13292172|NCT00708162|26484759|FG001|Open-Label Phase|Investigator's Discretion|2|||
13292173|NCT00708162|26484758|FG000|Open-Label Phase|Death|3|||
13292174|NCT00708162|26484759|FG001|Open-Label Phase|Death|1|||
13292175|NCT00708162|26484758|FG000|Open-Label Phase|Adverse Event|1|||
13292176|NCT00708162|26484759|FG001|Open-Label Phase|Adverse Event|2|||
13292177|NCT00708162|26484758|FG000|Open-Label Phase|Other|1|||
13292178|NCT00708162|26484759|FG001|Open-Label Phase|Other|0|||
13292179|NCT00708032|26484780|FG000|Overall Study|Adverse Event|0|||
13292180|NCT00708032|26484781|FG001|Overall Study|Adverse Event|2|||
13284952|NCT04518462|26468109|FG000|Overall Study|Withdrawal by Subject|0|||
13284953|NCT04518462|26468110|FG001|Overall Study|Withdrawal by Subject|0|||
13284954|NCT04518462|26468111|FG002|Overall Study|Withdrawal by Subject|1|||
13284955|NCT04518462|26468109|FG000|Overall Study|Physician Decision|1|||
13284956|NCT04518462|26468110|FG001|Overall Study|Physician Decision|1|||
13284957|NCT04518462|26468111|FG002|Overall Study|Physician Decision|0|||
13284987|NCT03456700|26468265|FG000|Overall Study|Withdrawal by Subject|1|||
13284988|NCT03452397|26468292|FG000|Overall Study|Adverse Event|1|||
13284989|NCT03452397|26468293|FG001|Overall Study|Adverse Event|0|||
13284990|NCT03452397|26468294|FG002|Overall Study|Adverse Event|0|||
13284991|NCT03452397|26468295|FG003|Overall Study|Adverse Event|0|||
13284992|NCT03452397|26468292|FG000|Overall Study|Administrative reason|0|||
13284993|NCT03452397|26468293|FG001|Overall Study|Administrative reason|0|||
13284994|NCT03452397|26468294|FG002|Overall Study|Administrative reason|1|||
13284995|NCT03452397|26468295|FG003|Overall Study|Administrative reason|1|||
13284996|NCT03452397|26468292|FG000|Overall Study|Withdrawal by Subject|0|||
13284997|NCT03452397|26468293|FG001|Overall Study|Withdrawal by Subject|0|||
13284998|NCT03452397|26468294|FG002|Overall Study|Withdrawal by Subject|1|||
13284999|NCT03452397|26468295|FG003|Overall Study|Withdrawal by Subject|0|||
13285000|NCT03450629|26468323|FG000|Overall Study|Adverse Event|15|||
13285001|NCT03450629|26468324|FG001|Overall Study|Adverse Event|14|||
13285002|NCT03450629|26468323|FG000|Overall Study|Physician Decision|2|||
13285003|NCT03450629|26468324|FG001|Overall Study|Physician Decision|2|||
13285004|NCT03450629|26468323|FG000|Overall Study|Lack of Efficacy|2|||
13285005|NCT03450629|26468324|FG001|Overall Study|Lack of Efficacy|0|||
13285006|NCT03450629|26468323|FG000|Overall Study|Lost to Follow-up|4|||
13285007|NCT03450629|26468324|FG001|Overall Study|Lost to Follow-up|2|||
13285008|NCT03450629|26468323|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
13285009|NCT03450629|26468324|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
13285010|NCT03450629|26468323|FG000|Overall Study|Non-Compliance With Study Drug|2|||
13285011|NCT03450629|26468324|FG001|Overall Study|Non-Compliance With Study Drug|1|||
13285012|NCT03450629|26468323|FG000|Overall Study|Protocol Violation|11|||
13285013|NCT03450629|26468324|FG001|Overall Study|Protocol Violation|8|||
13285014|NCT03450629|26468323|FG000|Overall Study|Withdrawal by Subject|12|||
13285015|NCT03450629|26468324|FG001|Overall Study|Withdrawal by Subject|6|||
13285016|NCT00199888|26468376|FG000|Overall Study|Lost to Follow-up|1|||
13285017|NCT00199875|26468414|FG000|Overall Study|Withdrawal by Subject|0|||
13285018|NCT00199875|26468415|FG001|Overall Study|Withdrawal by Subject|0|||
13285019|NCT00199875|26468416|FG002|Overall Study|Withdrawal by Subject|0|||
13285020|NCT00199875|26468417|FG003|Overall Study|Withdrawal by Subject|0|||
13285021|NCT00199875|26468418|FG004|Overall Study|Withdrawal by Subject|1|||
13285022|NCT00199849|26468448|FG000|Overall Study|Unrelated illness or complication|0|||
13285023|NCT00199849|26468449|FG001|Overall Study|Unrelated illness or complication|1|||
13285024|NCT00199849|26468450|FG002|Overall Study|Unrelated illness or complication|0|||
13285025|NCT00199849|26468448|FG000|Overall Study|Progressive disease requiring intervention|0|||
13285026|NCT00199849|26468449|FG001|Overall Study|Progressive disease requiring intervention|0|||
13285027|NCT00199849|26468450|FG002|Overall Study|Progressive disease requiring intervention|1|||
13285028|NCT00199849|26468448|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0|||
13285029|NCT00199849|26468449|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0|||
13285030|NCT00199849|26468450|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1|||
13285031|NCT00199836|26468460|FG000|Overall Study|Progressive Disease|5|||
13285032|NCT00199836|26468460|FG000|Overall Study|Death|1|||
13285033|NCT00199797|26468468|FG000|Overall Study|Progressive Disease|1|||
13285034|NCT00199797|26468468|FG000|Overall Study|Adverse Event|1|||
13285035|NCT00199797|26468468|FG000|Overall Study|Physician Decision|1|||
13285036|NCT00199381|26468474|FG000|Overall Study|Withdrawal by Subject|38|||
13285037|NCT00199381|26468474|FG000|Overall Study|Adverse Event|73|||
13285038|NCT00199381|26468474|FG000|Overall Study|Protocol Violation|6|||
13285039|NCT00199381|26468474|FG000|Overall Study|Lack of Efficacy|27|||
13285040|NCT00199381|26468474|FG000|Overall Study|Not including due to early termination|37|||
13285041|NCT00199381|26468474|FG000|Overall Study|Study termination by Sponsor|323|||
13285042|NCT00198822|26468501|FG000|Overall Study|Lost to Follow-up|14|||
13285043|NCT00198822|26468502|FG001|Overall Study|Lost to Follow-up|20|||
13285044|NCT00198822|26468503|FG002|Overall Study|Lost to Follow-up|21|||
13285045|NCT00198133|26468520|FG000|Overall Study|Disease progression|2|||
13285046|NCT00198133|26468521|FG001|Overall Study|Disease progression|5|||
13285047|NCT00198133|26468520|FG000|Overall Study|Adverse Event|1|||
13285048|NCT00198133|26468521|FG001|Overall Study|Adverse Event|3|||
13285049|NCT00198133|26468520|FG000|Overall Study|Withdrawal by Subject|1|||
13285050|NCT00198133|26468521|FG001|Overall Study|Withdrawal by Subject|0|||
13285051|NCT00198133|26468520|FG000|Overall Study|Physician Decision|1|||
13285052|NCT00198133|26468521|FG001|Overall Study|Physician Decision|0|||
13285053|NCT00198029|26468528|FG000|Overall Study|Withdrawal by Subject|4|||
13285054|NCT00197496|26468548|FG000|Baseline to Discharge|not interested|1|||
13285055|NCT00197496|26468549|FG001|Baseline to Discharge|not interested|0|||
13285056|NCT00197496|26468548|FG000|Baseline to Discharge|MRSA|1|||
13284958|NCT02598583|26468162|FG000|Extension Period|Withdrawal by Subject|1|||
13284959|NCT02598583|26468163|FG001|Extension Period|Withdrawal by Subject|0|||
13284960|NCT02596035|26468200|FG000|Overall Study|Disease Progression|64|||
13284961|NCT02596035|26468201|FG001|Overall Study|Disease Progression|32|||
13284962|NCT02596035|26468202|FG002|Overall Study|Disease Progression|1|||
13284963|NCT02596035|26468200|FG000|Overall Study|study drug toxicity|12|||
13284964|NCT02596035|26468201|FG001|Overall Study|study drug toxicity|3|||
13284965|NCT02596035|26468202|FG002|Overall Study|study drug toxicity|0|||
13284966|NCT02596035|26468200|FG000|Overall Study|AE unrelated to study drug|5|||
13284967|NCT02596035|26468201|FG001|Overall Study|AE unrelated to study drug|2|||
13284968|NCT02596035|26468202|FG002|Overall Study|AE unrelated to study drug|0|||
13284969|NCT02596035|26468200|FG000|Overall Study|participant request to discontinue study treatment|2|||
13284970|NCT02596035|26468201|FG001|Overall Study|participant request to discontinue study treatment|0|||
13284971|NCT02596035|26468202|FG002|Overall Study|participant request to discontinue study treatment|0|||
13284972|NCT02596035|26468200|FG000|Overall Study|participant withdrew consent|2|||
13284973|NCT02596035|26468201|FG001|Overall Study|participant withdrew consent|2|||
13284974|NCT02596035|26468202|FG002|Overall Study|participant withdrew consent|0|||
13284975|NCT02596035|26468200|FG000|Overall Study|Poor/Non Comlpiance|0|||
13284976|NCT02596035|26468201|FG001|Overall Study|Poor/Non Comlpiance|1|||
13284977|NCT02596035|26468202|FG002|Overall Study|Poor/Non Comlpiance|0|||
13284978|NCT02596035|26468200|FG000|Overall Study|participant no longer meets study criteria|1|||
13284979|NCT02596035|26468201|FG001|Overall Study|participant no longer meets study criteria|0|||
13284980|NCT02596035|26468202|FG002|Overall Study|participant no longer meets study criteria|0|||
13284981|NCT02596035|26468200|FG000|Overall Study|other reasons|11|||
13284982|NCT02596035|26468201|FG001|Overall Study|other reasons|4|||
13284983|NCT02596035|26468202|FG002|Overall Study|other reasons|0|||
13284984|NCT02595372|26468213|FG000|Overall Study|Adverse Event|6|||
13284985|NCT02595372|26468213|FG000|Overall Study|Physician Decision|2|||
13284986|NCT02595372|26468213|FG000|Overall Study|Disease Progression|1|||
13285057|NCT00197496|26468549|FG001|Baseline to Discharge|MRSA|0|||
13285058|NCT00197496|26468548|FG000|Baseline to Discharge|Physician Decision|0|||
13285059|NCT00197496|26468549|FG001|Baseline to Discharge|Physician Decision|1|||
13285060|NCT00197496|26468548|FG000|Baseline to Discharge|Protocol Violation|0|||
13285061|NCT00197496|26468549|FG001|Baseline to Discharge|Protocol Violation|1|||
13285062|NCT00197496|26468548|FG000|Follow-up|Lost to Follow-up|2|||
13285063|NCT00197496|26468549|FG001|Follow-up|Lost to Follow-up|1|||
13285064|NCT00197236|26468606|FG000|Overall Study|Adverse Event|1|||
13285065|NCT00197236|26468607|FG001|Overall Study|Adverse Event|0|||
13285066|NCT00197236|26468608|FG002|Overall Study|Adverse Event|1|||
13285067|NCT00197236|26468606|FG000|Overall Study|Lost to Follow-up|5|||
13285068|NCT00197236|26468607|FG001|Overall Study|Lost to Follow-up|14|||
13285069|NCT00197236|26468608|FG002|Overall Study|Lost to Follow-up|6|||
13285070|NCT00197236|26468606|FG000|Overall Study|Protocol Violation|0|||
13285071|NCT00197236|26468607|FG001|Overall Study|Protocol Violation|0|||
13285072|NCT00197236|26468608|FG002|Overall Study|Protocol Violation|1|||
13285073|NCT00197236|26468606|FG000|Overall Study|Withdrawal by Subject|7|||
13285074|NCT00197236|26468607|FG001|Overall Study|Withdrawal by Subject|3|||
13285075|NCT00197236|26468608|FG002|Overall Study|Withdrawal by Subject|11|||
13285076|NCT00197236|26468606|FG000|Overall Study|Study drug/medication expiration|1|||
13285077|NCT00197236|26468607|FG001|Overall Study|Study drug/medication expiration|0|||
13285078|NCT00197236|26468608|FG002|Overall Study|Study drug/medication expiration|3|||
13285079|NCT00197236|26468606|FG000|Overall Study|Returned out of specified time window|0|||
13285080|NCT00197236|26468607|FG001|Overall Study|Returned out of specified time window|0|||
13285081|NCT00197236|26468608|FG002|Overall Study|Returned out of specified time window|1|||
13285082|NCT00197145|26468671|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
13285083|NCT00197145|26468672|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
13285084|NCT00197145|26468671|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10|||
13285085|NCT00197145|26468672|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8|||
13285086|NCT00197145|26468671|FG000|Period 1: Randomized Treatment Phase|Other|2|||
13285087|NCT00197145|26468672|FG001|Period 1: Randomized Treatment Phase|Other|2|||
13285088|NCT00197145|26468671|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1|||
13285089|NCT00197145|26468672|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0|||
13285090|NCT00197145|26468671|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3|||
13285091|NCT00197145|26468672|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0|||
13285092|NCT00197145|26468671|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2|||
13285093|NCT00197145|26468672|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0|||
13285094|NCT00197145|26468671|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3|||
13285095|NCT00197145|26468672|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0|||
13285096|NCT00197145|26468671|FG000|Period 2 : Open Label Phase|Other|1|||
13285097|NCT00197145|26468672|FG001|Period 2 : Open Label Phase|Other|0|||
13285098|NCT00197106|26468714|FG000|4-Week Run-In Period|Did not meet entry criteria|99|||
13285099|NCT00197106|26468715|FG001|4-Week Run-In Period|Did not meet entry criteria|0|||
13292181|NCT00708032|26484780|FG000|Overall Study|Lost to Follow-up|1|||
13285100|NCT00197106|26468716|FG002|4-Week Run-In Period|Did not meet entry criteria|0|||
13285101|NCT00197106|26468714|FG000|Overall Treatment Period|Lack of Efficacy|0|||
13285102|NCT00197106|26468715|FG001|Overall Treatment Period|Lack of Efficacy|1|||
13285103|NCT00197106|26468716|FG002|Overall Treatment Period|Lack of Efficacy|0|||
13285104|NCT00197106|26468714|FG000|Overall Treatment Period|Lost to Follow-up|0|||
13285105|NCT00197106|26468715|FG001|Overall Treatment Period|Lost to Follow-up|0|||
13285106|NCT00197106|26468716|FG002|Overall Treatment Period|Lost to Follow-up|2|||
13285107|NCT00197106|26468714|FG000|Overall Treatment Period|Protocol Violation|0|||
13285108|NCT00197106|26468715|FG001|Overall Treatment Period|Protocol Violation|0|||
13285109|NCT00197106|26468716|FG002|Overall Treatment Period|Protocol Violation|2|||
13285110|NCT00197106|26468714|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
13285111|NCT00197106|26468715|FG001|Overall Treatment Period|Withdrawal by Subject|0|||
13285112|NCT00197106|26468716|FG002|Overall Treatment Period|Withdrawal by Subject|2|||
13285113|NCT00197054|26468834|FG000|Overall Study|Withdrawal by Subject|9|||
13285114|NCT00197054|26468835|FG001|Overall Study|Withdrawal by Subject|3|||
13285115|NCT00197054|26468836|FG002|Overall Study|Withdrawal by Subject|3|||
13285116|NCT00197054|26468834|FG000|Overall Study|Moved from area|7|||
13285117|NCT00197054|26468835|FG001|Overall Study|Moved from area|14|||
13285118|NCT00197054|26468836|FG002|Overall Study|Moved from area|9|||
13285119|NCT00197054|26468834|FG000|Overall Study|Lost to Follow-up|1|||
13285120|NCT00197054|26468835|FG001|Overall Study|Lost to Follow-up|4|||
13285121|NCT00197054|26468836|FG002|Overall Study|Lost to Follow-up|0|||
13285122|NCT00197015|26468902|FG000|Overall Study|Adverse Event|3|||
13285123|NCT00197015|26468903|FG001|Overall Study|Adverse Event|0|||
13285124|NCT00197015|26468904|FG002|Overall Study|Adverse Event|1|||
13285125|NCT00197015|26468902|FG000|Overall Study|Protocol Violation|0|||
13285126|NCT00197015|26468903|FG001|Overall Study|Protocol Violation|3|||
13285127|NCT00197015|26468904|FG002|Overall Study|Protocol Violation|3|||
13285128|NCT00197015|26468902|FG000|Overall Study|Withdrawal by Subject|17|||
13285129|NCT00197015|26468903|FG001|Overall Study|Withdrawal by Subject|37|||
13285130|NCT00197015|26468904|FG002|Overall Study|Withdrawal by Subject|34|||
13285131|NCT00197015|26468902|FG000|Overall Study|Lost to Follow-up|28|||
13285132|NCT00197015|26468903|FG001|Overall Study|Lost to Follow-up|46|||
13285133|NCT00197015|26468904|FG002|Overall Study|Lost to Follow-up|37|||
13285134|NCT00197015|26468902|FG000|Overall Study|Other|2|||
13285135|NCT00197015|26468903|FG001|Overall Study|Other|3|||
13285136|NCT00197015|26468904|FG002|Overall Study|Other|2|||
13285137|NCT00197002|26468951|FG000|Overall Study|Adverse Event|0|||
13285138|NCT00197002|26468952|FG001|Overall Study|Adverse Event|1|||
13285139|NCT00197002|26468953|FG002|Overall Study|Adverse Event|0|||
13285140|NCT00197002|26468951|FG000|Overall Study|Protocol Violation|1|||
13285141|NCT00197002|26468952|FG001|Overall Study|Protocol Violation|0|||
13285142|NCT00197002|26468953|FG002|Overall Study|Protocol Violation|2|||
13285143|NCT00197002|26468951|FG000|Overall Study|Withdrawal by Subject|9|||
13285144|NCT00197002|26468952|FG001|Overall Study|Withdrawal by Subject|5|||
13285145|NCT00197002|26468953|FG002|Overall Study|Withdrawal by Subject|7|||
13285146|NCT00197002|26468951|FG000|Overall Study|Migrated/moved from study area|3|||
13285147|NCT00197002|26468952|FG001|Overall Study|Migrated/moved from study area|5|||
13285148|NCT00197002|26468953|FG002|Overall Study|Migrated/moved from study area|1|||
13285149|NCT00197002|26468951|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
13285150|NCT00197002|26468952|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
13285151|NCT00197002|26468953|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5|||
13285152|NCT00197002|26468951|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2|||
13285153|NCT00197002|26468952|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2|||
13285154|NCT00197002|26468953|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1|||
13285155|NCT00197002|26468951|FG000|Overall Study|Others|3|||
13285156|NCT00197002|26468952|FG001|Overall Study|Others|1|||
13285157|NCT00197002|26468953|FG002|Overall Study|Others|1|||
13285158|NCT00196976|26469189|FG000|Primary Study|Migrated from study area|0|||
13285159|NCT00196976|26469190|FG001|Primary Study|Migrated from study area|0|||
13285160|NCT00196976|26469191|FG002|Primary Study|Migrated from study area|0|||
13285161|NCT00196976|26469192|FG003|Primary Study|Migrated from study area|0|||
13285162|NCT00196976|26469193|FG004|Primary Study|Migrated from study area|0|||
13285163|NCT00196976|26469194|FG005|Primary Study|Migrated from study area|0|||
13285164|NCT00196976|26469195|FG006|Primary Study|Migrated from study area|0|||
13285165|NCT00196976|26469196|FG007|Primary Study|Migrated from study area|1|||
13285166|NCT00196976|26469197|FG008|Primary Study|Migrated from study area|0|||
13285167|NCT00196976|26469198|FG009|Primary Study|Migrated from study area|0|||
13285168|NCT00196976|26469199|FG010|Primary Study|Migrated from study area|0|||
13285169|NCT00196976|26469200|FG011|Primary Study|Migrated from study area|0|||
13285170|NCT00196976|26469201|FG012|Primary Study|Migrated from study area|0|||
13285171|NCT00196976|26469202|FG013|Primary Study|Migrated from study area|0|||
13285172|NCT00196976|26469189|FG000|Primary Study|Protocol Violation|0|||
13285173|NCT00196976|26469190|FG001|Primary Study|Protocol Violation|1|||
13285174|NCT00196976|26469191|FG002|Primary Study|Protocol Violation|1|||
13285175|NCT00196976|26469192|FG003|Primary Study|Protocol Violation|0|||
13285176|NCT00196976|26469193|FG004|Primary Study|Protocol Violation|0|||
13285177|NCT00196976|26469194|FG005|Primary Study|Protocol Violation|0|||
13285178|NCT00196976|26469195|FG006|Primary Study|Protocol Violation|0|||
13285179|NCT00196976|26469196|FG007|Primary Study|Protocol Violation|0|||
13285180|NCT00196976|26469197|FG008|Primary Study|Protocol Violation|0|||
13285181|NCT00196976|26469198|FG009|Primary Study|Protocol Violation|0|||
13285182|NCT00196976|26469199|FG010|Primary Study|Protocol Violation|0|||
13285183|NCT00196976|26469200|FG011|Primary Study|Protocol Violation|0|||
13285184|NCT00196976|26469201|FG012|Primary Study|Protocol Violation|0|||
13285185|NCT00196976|26469202|FG013|Primary Study|Protocol Violation|0|||
13285186|NCT00196976|26469189|FG000|Primary Study|Withdrawal by Subject|1|||
13285187|NCT00196976|26469190|FG001|Primary Study|Withdrawal by Subject|0|||
13285188|NCT00196976|26469191|FG002|Primary Study|Withdrawal by Subject|1|||
13285189|NCT00196976|26469192|FG003|Primary Study|Withdrawal by Subject|1|||
13285190|NCT00196976|26469193|FG004|Primary Study|Withdrawal by Subject|2|||
13285191|NCT00196976|26469194|FG005|Primary Study|Withdrawal by Subject|1|||
13285192|NCT00196976|26469195|FG006|Primary Study|Withdrawal by Subject|0|||
13285193|NCT00196976|26469196|FG007|Primary Study|Withdrawal by Subject|0|||
13285194|NCT00196976|26469197|FG008|Primary Study|Withdrawal by Subject|0|||
13285195|NCT00196976|26469198|FG009|Primary Study|Withdrawal by Subject|1|||
13285196|NCT00196976|26469199|FG010|Primary Study|Withdrawal by Subject|0|||
13285197|NCT00196976|26469200|FG011|Primary Study|Withdrawal by Subject|0|||
13285198|NCT00196976|26469201|FG012|Primary Study|Withdrawal by Subject|0|||
13285199|NCT00196976|26469202|FG013|Primary Study|Withdrawal by Subject|0|||
13285200|NCT00196976|26469189|FG000|Primary Study|Lost to Follow-up|0|||
13285201|NCT00196976|26469190|FG001|Primary Study|Lost to Follow-up|0|||
13285202|NCT00196976|26469191|FG002|Primary Study|Lost to Follow-up|0|||
13285203|NCT00196976|26469192|FG003|Primary Study|Lost to Follow-up|0|||
13285204|NCT00196976|26469193|FG004|Primary Study|Lost to Follow-up|1|||
13285205|NCT00196976|26469194|FG005|Primary Study|Lost to Follow-up|1|||
13285206|NCT00196976|26469195|FG006|Primary Study|Lost to Follow-up|0|||
13285207|NCT00196976|26469196|FG007|Primary Study|Lost to Follow-up|2|||
13285208|NCT00196976|26469197|FG008|Primary Study|Lost to Follow-up|0|||
13285209|NCT00196976|26469198|FG009|Primary Study|Lost to Follow-up|0|||
13285210|NCT00196976|26469199|FG010|Primary Study|Lost to Follow-up|0|||
13285211|NCT00196976|26469200|FG011|Primary Study|Lost to Follow-up|0|||
13285212|NCT00196976|26469201|FG012|Primary Study|Lost to Follow-up|0|||
13285213|NCT00196976|26469202|FG013|Primary Study|Lost to Follow-up|0|||
13285214|NCT00196976|26469189|FG000|Primary Study|Other|0|||
13285215|NCT00196976|26469190|FG001|Primary Study|Other|0|||
13285216|NCT00196976|26469191|FG002|Primary Study|Other|2|||
13285217|NCT00196976|26469192|FG003|Primary Study|Other|0|||
13285218|NCT00196976|26469193|FG004|Primary Study|Other|0|||
13285219|NCT00196976|26469194|FG005|Primary Study|Other|0|||
13285220|NCT00196976|26469195|FG006|Primary Study|Other|0|||
13285221|NCT00196976|26469196|FG007|Primary Study|Other|0|||
13285222|NCT00196976|26469197|FG008|Primary Study|Other|0|||
13285223|NCT00196976|26469198|FG009|Primary Study|Other|0|||
13285224|NCT00196976|26469199|FG010|Primary Study|Other|0|||
13285225|NCT00196976|26469200|FG011|Primary Study|Other|0|||
13285226|NCT00196976|26469201|FG012|Primary Study|Other|0|||
13285227|NCT00196976|26469202|FG013|Primary Study|Other|0|||
13285228|NCT00196976|26469189|FG000|Booster Study|Withdrawal by Subject|0|||
13285229|NCT00196976|26469190|FG001|Booster Study|Withdrawal by Subject|0|||
13285230|NCT00196976|26469191|FG002|Booster Study|Withdrawal by Subject|0|||
13285231|NCT00196976|26469192|FG003|Booster Study|Withdrawal by Subject|0|||
13285232|NCT00196976|26469193|FG004|Booster Study|Withdrawal by Subject|0|||
13285233|NCT00196976|26469194|FG005|Booster Study|Withdrawal by Subject|0|||
13285234|NCT00196976|26469195|FG006|Booster Study|Withdrawal by Subject|0|||
13285235|NCT00196976|26469196|FG007|Booster Study|Withdrawal by Subject|0|||
13285236|NCT00196976|26469197|FG008|Booster Study|Withdrawal by Subject|0|||
13285237|NCT00196976|26469198|FG009|Booster Study|Withdrawal by Subject|0|||
13285238|NCT00196976|26469199|FG010|Booster Study|Withdrawal by Subject|1|||
13285239|NCT00196976|26469200|FG011|Booster Study|Withdrawal by Subject|0|||
13285240|NCT00196976|26469201|FG012|Booster Study|Withdrawal by Subject|0|||
13285241|NCT00196976|26469202|FG013|Booster Study|Withdrawal by Subject|0|||
13285242|NCT00196976|26469189|FG000|Booster Study|Lost to Follow-up|0|||
13285243|NCT00196976|26469190|FG001|Booster Study|Lost to Follow-up|0|||
13285244|NCT00196976|26469191|FG002|Booster Study|Lost to Follow-up|0|||
13285245|NCT00196976|26469192|FG003|Booster Study|Lost to Follow-up|0|||
13285246|NCT00196976|26469193|FG004|Booster Study|Lost to Follow-up|0|||
13285247|NCT00196976|26469194|FG005|Booster Study|Lost to Follow-up|0|||
13285248|NCT00196976|26469195|FG006|Booster Study|Lost to Follow-up|0|||
13285249|NCT00196976|26469196|FG007|Booster Study|Lost to Follow-up|0|||
13285250|NCT00196976|26469197|FG008|Booster Study|Lost to Follow-up|0|||
13285251|NCT00196976|26469198|FG009|Booster Study|Lost to Follow-up|0|||
13285252|NCT00196976|26469199|FG010|Booster Study|Lost to Follow-up|1|||
13285253|NCT00196976|26469200|FG011|Booster Study|Lost to Follow-up|2|||
13285254|NCT00196976|26469201|FG012|Booster Study|Lost to Follow-up|0|||
13285255|NCT00196976|26469202|FG013|Booster Study|Lost to Follow-up|0|||
13285256|NCT00196326|26469210|FG000|Overall Study|Did not meet protocol requirements|64|||
13285257|NCT00196326|26469210|FG000|Overall Study|Non-compliance with the protocol|81|||
13285258|NCT00196326|26469210|FG000|Overall Study|Physician Decision|3|||
13285259|NCT00196326|26469210|FG000|Overall Study|Withdrawal by Subject|225|||
13285260|NCT00196326|26469210|FG000|Overall Study|Adverse Event|253|||
13285261|NCT00196326|26469210|FG000|Overall Study|Pregnancy|34|||
13285262|NCT00196326|26469210|FG000|Overall Study|Lost to Follow-up|304|||
13285263|NCT00196326|26469210|FG000|Overall Study|Other|22|||
13285264|NCT00196313|26469231|FG000|Overall Study|Protocol Violation|2|||
13285265|NCT00196313|26469232|FG001|Overall Study|Protocol Violation|3|||
13285266|NCT00196313|26469231|FG000|Overall Study|Withdrawal by Subject|3|||
13285267|NCT00196313|26469232|FG001|Overall Study|Withdrawal by Subject|1|||
13285268|NCT00196313|26469231|FG000|Overall Study|Adverse Event|3|||
13285269|NCT00196313|26469232|FG001|Overall Study|Adverse Event|1|||
13285270|NCT00196313|26469231|FG000|Overall Study|Subject Pregnant|1|||
13285271|NCT00196313|26469232|FG001|Overall Study|Subject Pregnant|1|||
13285272|NCT00196313|26469231|FG000|Overall Study|Lost to Follow-up|2|||
13285273|NCT00196313|26469232|FG001|Overall Study|Lost to Follow-up|2|||
13285274|NCT00196196|26469239|FG000|Overall Study|Withdrawal by Subject|2|||
13285275|NCT00196196|26469239|FG000|Overall Study|Did not have required condition (hydroce|5|||
13285276|NCT00196105|26469269|FG000|Overall Study|Lost to Follow-up|4|||
13285277|NCT00196105|26469270|FG001|Overall Study|Lost to Follow-up|5|||
13285278|NCT00196105|26469271|FG002|Overall Study|Lost to Follow-up|7|||
13285279|NCT00195715|26469301|FG000|Overall Study|Adverse Event|122|||
13285280|NCT00195715|26469301|FG000|Overall Study|Withdrawal by Subject|58|||
13285281|NCT00195715|26469301|FG000|Overall Study|Lost to Follow-up|27|||
13285282|NCT00195715|26469301|FG000|Overall Study|Protocol Violation|13|||
13285283|NCT00195715|26469301|FG000|Overall Study|Lack of Efficacy|93|||
13285284|NCT00195715|26469301|FG000|Overall Study|Pregnancy|14|||
13285285|NCT00195715|26469301|FG000|Overall Study|Investigative site closure|8|||
13285286|NCT00195715|26469301|FG000|Overall Study|Subject moved/relocated|7|||
13285287|NCT00195715|26469301|FG000|Overall Study|Subject non-compliance|6|||
13285288|NCT00195715|26469301|FG000|Overall Study|Subject started commercial Humira|5|||
13285289|NCT00195715|26469301|FG000|Overall Study|Subject choice|3|||
13285290|NCT00195715|26469301|FG000|Overall Study|Loss of response/no improvement|3|||
13285291|NCT00195715|26469301|FG000|Overall Study|Sponsor stopped study|1|||
13285292|NCT00195715|26469301|FG000|Overall Study|Administrative reasons|2|||
13285293|NCT00195715|26469301|FG000|Overall Study|Investigator's decision|2|||
13285294|NCT00195715|26469301|FG000|Overall Study|Subject wants to get pregnant|4|||
13285295|NCT00195715|26469301|FG000|Overall Study|Use of prohibited medication|2|||
13285296|NCT00195715|26469301|FG000|Overall Study|Planned surgery|2|||
13285297|NCT00195715|26469301|FG000|Overall Study|Increased infection rate|1|||
13285298|NCT00195715|26469301|FG000|Overall Study|Ineligible|1|||
13285299|NCT00195715|26469301|FG000|Overall Study|Colonic stricture|1|||
13285300|NCT00195715|26469301|FG000|Overall Study|Sponsor discontinued trial|1|||
13285301|NCT00195715|26469301|FG000|Overall Study|Sponsor discretion - trial ended early|1|||
13285302|NCT00195676|26469314|FG000|Period O - Open-label Treatment|Adverse Event|82|||
13285303|NCT00195676|26469314|FG000|Period O - Open-label Treatment|Death|6|||
13285304|NCT00195676|26469314|FG000|Period O - Open-label Treatment|Lack of Efficacy|198|||
13285305|NCT00195676|26469314|FG000|Period O - Open-label Treatment|Lost to Follow-up|91|||
13285306|NCT00195676|26469314|FG000|Period O - Open-label Treatment|Protocol Violation|12|||
13285307|NCT00195676|26469314|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147|||
13285308|NCT00195676|26469314|FG000|Period O - Open-label Treatment|Administrative reasons|2|||
13285309|NCT00195676|26469314|FG000|Period O - Open-label Treatment|Other reasons|68|||
13285310|NCT00195676|26469314|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4|||
13285311|NCT00195676|26469314|FG000|Period W (Withdrawal) - No Treatment|Death|2|||
13285312|NCT00195676|26469314|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11|||
13285313|NCT00195676|26469314|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46|||
13285314|NCT00195676|26469314|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397|||
13285315|NCT00195676|26469314|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129|||
13285316|NCT00195676|26469314|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1|||
13285317|NCT00195676|26469314|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18|||
13285318|NCT00195676|26469314|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4|||
13285319|NCT00195676|26469314|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5|||
13285320|NCT00195676|26469314|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11|||
13285321|NCT00195676|26469314|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9|||
13285322|NCT00195676|26469314|FG000|Period R - Retreatment 16 Weeks|Other reasons|6|||
13285323|NCT00195663|26469418|FG000|2-year Double-blind Treatment Period|Adverse Event|21|||
13285324|NCT00195663|26469419|FG001|2-year Double-blind Treatment Period|Adverse Event|27|||
13285325|NCT00195663|26469420|FG002|2-year Double-blind Treatment Period|Adverse Event|32|||
13285326|NCT00195663|26469418|FG000|2-year Double-blind Treatment Period|Death|0|||
13285327|NCT00195663|26469419|FG001|2-year Double-blind Treatment Period|Death|2|||
13285328|NCT00195663|26469420|FG002|2-year Double-blind Treatment Period|Death|0|||
13292182|NCT00708032|26484781|FG001|Overall Study|Lost to Follow-up|2|||
13285329|NCT00195663|26469418|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
13285330|NCT00195663|26469419|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
13285331|NCT00195663|26469420|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1|||
13285332|NCT00195663|26469418|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15|||
13285333|NCT00195663|26469419|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18|||
13285334|NCT00195663|26469420|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12|||
13285335|NCT00195663|26469418|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47|||
13285336|NCT00195663|26469419|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52|||
13285337|NCT00195663|26469420|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13|||
13285338|NCT00195663|26469418|FG000|2-year Double-blind Treatment Period|Protocol Violation|6|||
13285339|NCT00195663|26469419|FG001|2-year Double-blind Treatment Period|Protocol Violation|6|||
13285340|NCT00195663|26469420|FG002|2-year Double-blind Treatment Period|Protocol Violation|4|||
13285341|NCT00195663|26469418|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0|||
13285342|NCT00195663|26469419|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1|||
13285343|NCT00195663|26469420|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0|||
13285344|NCT00195663|26469418|FG000|2-year Double-blind Treatment Period|Recovery|1|||
13285345|NCT00195663|26469419|FG001|2-year Double-blind Treatment Period|Recovery|0|||
13285346|NCT00195663|26469420|FG002|2-year Double-blind Treatment Period|Recovery|1|||
13285347|NCT00195663|26469418|FG000|2-year Double-blind Treatment Period|Administrative reasons|3|||
13285348|NCT00195663|26469419|FG001|2-year Double-blind Treatment Period|Administrative reasons|2|||
13285349|NCT00195663|26469420|FG002|2-year Double-blind Treatment Period|Administrative reasons|9|||
13285350|NCT00195663|26469418|FG000|Open-Label Extension Period|Adverse Event|21|||
13285351|NCT00195663|26469419|FG001|Open-Label Extension Period|Adverse Event|32|||
13285352|NCT00195663|26469420|FG002|Open-Label Extension Period|Adverse Event|36|||
13285353|NCT00195663|26469418|FG000|Open-Label Extension Period|Lost to Follow-up|9|||
13285354|NCT00195663|26469419|FG001|Open-Label Extension Period|Lost to Follow-up|2|||
13285355|NCT00195663|26469420|FG002|Open-Label Extension Period|Lost to Follow-up|6|||
13285356|NCT00195663|26469418|FG000|Open-Label Extension Period|Recovery|0|||
13285357|NCT00195663|26469419|FG001|Open-Label Extension Period|Recovery|2|||
13285358|NCT00195663|26469420|FG002|Open-Label Extension Period|Recovery|2|||
13285359|NCT00195663|26469418|FG000|Open-Label Extension Period|Protocol Violation|3|||
13285360|NCT00195663|26469419|FG001|Open-Label Extension Period|Protocol Violation|4|||
13285361|NCT00195663|26469420|FG002|Open-Label Extension Period|Protocol Violation|4|||
13285362|NCT00195663|26469418|FG000|Open-Label Extension Period|Death|2|||
13285363|NCT00195663|26469419|FG001|Open-Label Extension Period|Death|2|||
13285364|NCT00195663|26469420|FG002|Open-Label Extension Period|Death|2|||
13285365|NCT00195663|26469418|FG000|Open-Label Extension Period|Withdrawal by Subject|16|||
13285366|NCT00195663|26469419|FG001|Open-Label Extension Period|Withdrawal by Subject|15|||
13285367|NCT00195663|26469420|FG002|Open-Label Extension Period|Withdrawal by Subject|22|||
13285368|NCT00195663|26469418|FG000|Open-Label Extension Period|Lack of Efficacy|14|||
13285369|NCT00195663|26469419|FG001|Open-Label Extension Period|Lack of Efficacy|6|||
13285370|NCT00195663|26469420|FG002|Open-Label Extension Period|Lack of Efficacy|12|||
13285371|NCT00195663|26469418|FG000|Open-Label Extension Period|Administrative reasons|11|||
13285372|NCT00195663|26469419|FG001|Open-Label Extension Period|Administrative reasons|11|||
13285373|NCT00195663|26469420|FG002|Open-Label Extension Period|Administrative reasons|13|||
13285374|NCT00195650|26469436|FG000|Overall Study|Adverse Event|194|||
13285375|NCT00195650|26469436|FG000|Overall Study|Lack of Efficacy|99|||
13285376|NCT00195650|26469436|FG000|Overall Study|Withdrawal by Subject|67|||
13285377|NCT00195650|26469436|FG000|Overall Study|Lost to Follow-up|44|||
13285378|NCT00195650|26469436|FG000|Overall Study|Death|23|||
13285379|NCT00195650|26469436|FG000|Overall Study|Protocol Violation|15|||
13285380|NCT00195650|26469436|FG000|Overall Study|Administrative reasons|83|||
13285381|NCT00195507|26469455|FG000|Overall Study|Adverse Event|24|||
13285382|NCT00195507|26469456|FG001|Overall Study|Adverse Event|13|||
13285383|NCT00195507|26469455|FG000|Overall Study|Death|0|||
13285384|NCT00195507|26469456|FG001|Overall Study|Death|1|||
13285385|NCT00195507|26469455|FG000|Overall Study|Failed to Return|4|||
13285386|NCT00195507|26469456|FG001|Overall Study|Failed to Return|3|||
13285387|NCT00195507|26469455|FG000|Overall Study|Physician Decision|1|||
13285388|NCT00195507|26469456|FG001|Overall Study|Physician Decision|2|||
13285389|NCT00195507|26469455|FG000|Overall Study|Lost to Follow-up|3|||
13285390|NCT00195507|26469456|FG001|Overall Study|Lost to Follow-up|2|||
13285391|NCT00195507|26469455|FG000|Overall Study|Protocol Violation|5|||
13285392|NCT00195507|26469456|FG001|Overall Study|Protocol Violation|4|||
13285393|NCT00195507|26469455|FG000|Overall Study|Lack of Efficacy|40|||
13285394|NCT00195507|26469456|FG001|Overall Study|Lack of Efficacy|67|||
13285395|NCT00195507|26469455|FG000|Overall Study|Withdrawal by Subject|16|||
13285396|NCT00195507|26469456|FG001|Overall Study|Withdrawal by Subject|23|||
13285397|NCT00195507|26469455|FG000|Overall Study|Protocol Deviation|6|||
13285398|NCT00195507|26469456|FG001|Overall Study|Protocol Deviation|3|||
13285399|NCT00195494|26469485|FG000|Year 1|Adverse Event|0|||
13285400|NCT00195494|26469486|FG001|Year 1|Adverse Event|0|||
13285401|NCT00195494|26469487|FG002|Year 1|Adverse Event|0|||
13285402|NCT00195494|26469488|FG003|Year 1|Adverse Event|0|||
13285403|NCT00195494|26469489|FG004|Year 1|Adverse Event|34|||
13285404|NCT00195494|26469490|FG005|Year 1|Adverse Event|27|||
13285405|NCT00195494|26469485|FG000|Year 1|System Toxicity|0|||
13285406|NCT00195494|26469486|FG001|Year 1|System Toxicity|0|||
13285407|NCT00195494|26469487|FG002|Year 1|System Toxicity|0|||
13285408|NCT00195494|26469488|FG003|Year 1|System Toxicity|0|||
13285409|NCT00195494|26469489|FG004|Year 1|System Toxicity|0|||
13285410|NCT00195494|26469490|FG005|Year 1|System Toxicity|1|||
13285411|NCT00195494|26469485|FG000|Year 1|Lack of Efficacy|0|||
13285412|NCT00195494|26469486|FG001|Year 1|Lack of Efficacy|0|||
13285413|NCT00195494|26469487|FG002|Year 1|Lack of Efficacy|0|||
13285414|NCT00195494|26469488|FG003|Year 1|Lack of Efficacy|0|||
13285415|NCT00195494|26469489|FG004|Year 1|Lack of Efficacy|24|||
13285416|NCT00195494|26469490|FG005|Year 1|Lack of Efficacy|9|||
13285417|NCT00195494|26469485|FG000|Year 1|Compliance|0|||
13285418|NCT00195494|26469486|FG001|Year 1|Compliance|0|||
13285419|NCT00195494|26469487|FG002|Year 1|Compliance|0|||
13285420|NCT00195494|26469488|FG003|Year 1|Compliance|0|||
13285421|NCT00195494|26469489|FG004|Year 1|Compliance|5|||
13285422|NCT00195494|26469490|FG005|Year 1|Compliance|1|||
13285423|NCT00195494|26469485|FG000|Year 1|Lost to Follow-up|0|||
13285424|NCT00195494|26469486|FG001|Year 1|Lost to Follow-up|0|||
13285425|NCT00195494|26469487|FG002|Year 1|Lost to Follow-up|0|||
13285426|NCT00195494|26469488|FG003|Year 1|Lost to Follow-up|0|||
13285427|NCT00195494|26469489|FG004|Year 1|Lost to Follow-up|1|||
13285428|NCT00195494|26469490|FG005|Year 1|Lost to Follow-up|0|||
13285429|NCT00195494|26469485|FG000|Year 1|Missed >4 consecutive doses|0|||
13285430|NCT00195494|26469486|FG001|Year 1|Missed >4 consecutive doses|0|||
13285431|NCT00195494|26469487|FG002|Year 1|Missed >4 consecutive doses|0|||
13285432|NCT00195494|26469488|FG003|Year 1|Missed >4 consecutive doses|0|||
13285433|NCT00195494|26469489|FG004|Year 1|Missed >4 consecutive doses|3|||
13285434|NCT00195494|26469490|FG005|Year 1|Missed >4 consecutive doses|2|||
13285435|NCT00195494|26469485|FG000|Year 1|Protocol deviation|0|||
13285436|NCT00195494|26469486|FG001|Year 1|Protocol deviation|0|||
13285437|NCT00195494|26469487|FG002|Year 1|Protocol deviation|0|||
13285438|NCT00195494|26469488|FG003|Year 1|Protocol deviation|0|||
13285439|NCT00195494|26469489|FG004|Year 1|Protocol deviation|2|||
13285440|NCT00195494|26469490|FG005|Year 1|Protocol deviation|3|||
13285441|NCT00195494|26469485|FG000|Year 1|Physician Decision|0|||
13285442|NCT00195494|26469486|FG001|Year 1|Physician Decision|0|||
13285443|NCT00195494|26469487|FG002|Year 1|Physician Decision|0|||
13285444|NCT00195494|26469488|FG003|Year 1|Physician Decision|0|||
13285445|NCT00195494|26469489|FG004|Year 1|Physician Decision|1|||
13285446|NCT00195494|26469490|FG005|Year 1|Physician Decision|0|||
13285447|NCT00195494|26469485|FG000|Year 1|Withdrawal by Subject|0|||
13285448|NCT00195494|26469486|FG001|Year 1|Withdrawal by Subject|0|||
13285449|NCT00195494|26469487|FG002|Year 1|Withdrawal by Subject|0|||
13285450|NCT00195494|26469488|FG003|Year 1|Withdrawal by Subject|0|||
13285451|NCT00195494|26469489|FG004|Year 1|Withdrawal by Subject|8|||
13285452|NCT00195494|26469490|FG005|Year 1|Withdrawal by Subject|9|||
13285453|NCT00195494|26469485|FG000|Year 1|Protocol Violation|0|||
13285454|NCT00195494|26469486|FG001|Year 1|Protocol Violation|0|||
13285455|NCT00195494|26469487|FG002|Year 1|Protocol Violation|0|||
13285456|NCT00195494|26469488|FG003|Year 1|Protocol Violation|0|||
13285457|NCT00195494|26469489|FG004|Year 1|Protocol Violation|1|||
13285458|NCT00195494|26469490|FG005|Year 1|Protocol Violation|1|||
13285459|NCT00195494|26469485|FG000|Year 2|Adverse Event|3|||
13285460|NCT00195494|26469486|FG001|Year 2|Adverse Event|7|||
13285461|NCT00195494|26469487|FG002|Year 2|Adverse Event|5|||
13285462|NCT00195494|26469488|FG003|Year 2|Adverse Event|9|||
13285463|NCT00195494|26469489|FG004|Year 2|Adverse Event|0|||
13285464|NCT00195494|26469490|FG005|Year 2|Adverse Event|0|||
13285465|NCT00195494|26469485|FG000|Year 2|Lack of Efficacy|0|||
13285466|NCT00195494|26469486|FG001|Year 2|Lack of Efficacy|1|||
13285467|NCT00195494|26469487|FG002|Year 2|Lack of Efficacy|7|||
13285468|NCT00195494|26469488|FG003|Year 2|Lack of Efficacy|7|||
13285469|NCT00195494|26469489|FG004|Year 2|Lack of Efficacy|0|||
13285470|NCT00195494|26469490|FG005|Year 2|Lack of Efficacy|0|||
13285471|NCT00195494|26469485|FG000|Year 2|Compliance|1|||
13285472|NCT00195494|26469486|FG001|Year 2|Compliance|0|||
13285473|NCT00195494|26469487|FG002|Year 2|Compliance|0|||
13285474|NCT00195494|26469488|FG003|Year 2|Compliance|2|||
13285475|NCT00195494|26469489|FG004|Year 2|Compliance|0|||
13285476|NCT00195494|26469490|FG005|Year 2|Compliance|0|||
13285477|NCT00195494|26469485|FG000|Year 2|Lost to Follow-up|0|||
13285478|NCT00195494|26469486|FG001|Year 2|Lost to Follow-up|0|||
13285479|NCT00195494|26469487|FG002|Year 2|Lost to Follow-up|1|||
13285480|NCT00195494|26469488|FG003|Year 2|Lost to Follow-up|1|||
13285481|NCT00195494|26469489|FG004|Year 2|Lost to Follow-up|0|||
13285482|NCT00195494|26469490|FG005|Year 2|Lost to Follow-up|0|||
13285483|NCT00195494|26469485|FG000|Year 2|Missed >4 consecutive doses|1|||
13285484|NCT00195494|26469486|FG001|Year 2|Missed >4 consecutive doses|1|||
13285485|NCT00195494|26469487|FG002|Year 2|Missed >4 consecutive doses|1|||
13285486|NCT00195494|26469488|FG003|Year 2|Missed >4 consecutive doses|0|||
13285487|NCT00195494|26469489|FG004|Year 2|Missed >4 consecutive doses|0|||
13285488|NCT00195494|26469490|FG005|Year 2|Missed >4 consecutive doses|0|||
13285489|NCT00195494|26469485|FG000|Year 2|Protocol deviation|0|||
13285490|NCT00195494|26469486|FG001|Year 2|Protocol deviation|1|||
13285491|NCT00195494|26469487|FG002|Year 2|Protocol deviation|0|||
13285492|NCT00195494|26469488|FG003|Year 2|Protocol deviation|0|||
13285493|NCT00195494|26469489|FG004|Year 2|Protocol deviation|0|||
13285494|NCT00195494|26469490|FG005|Year 2|Protocol deviation|0|||
13285495|NCT00195494|26469485|FG000|Year 2|Physician Decision|1|||
13285496|NCT00195494|26469486|FG001|Year 2|Physician Decision|1|||
13285497|NCT00195494|26469487|FG002|Year 2|Physician Decision|0|||
13285498|NCT00195494|26469488|FG003|Year 2|Physician Decision|0|||
13285499|NCT00195494|26469489|FG004|Year 2|Physician Decision|0|||
13285500|NCT00195494|26469490|FG005|Year 2|Physician Decision|0|||
13285501|NCT00195494|26469485|FG000|Year 2|Withdrawal by Subject|1|||
13285502|NCT00195494|26469486|FG001|Year 2|Withdrawal by Subject|5|||
13285503|NCT00195494|26469487|FG002|Year 2|Withdrawal by Subject|4|||
13285504|NCT00195494|26469488|FG003|Year 2|Withdrawal by Subject|3|||
13285505|NCT00195494|26469489|FG004|Year 2|Withdrawal by Subject|0|||
13285506|NCT00195494|26469490|FG005|Year 2|Withdrawal by Subject|0|||
13285507|NCT00195494|26469485|FG000|Year 2|System toxicity|0|||
13285508|NCT00195494|26469486|FG001|Year 2|System toxicity|0|||
13285509|NCT00195494|26469487|FG002|Year 2|System toxicity|0|||
13285510|NCT00195494|26469488|FG003|Year 2|System toxicity|1|||
13285511|NCT00195494|26469489|FG004|Year 2|System toxicity|0|||
13285512|NCT00195494|26469490|FG005|Year 2|System toxicity|0|||
13285513|NCT00195429|26469505|FG000|Overall Study|Adverse Event|2|||
13285514|NCT00195429|26469506|FG001|Overall Study|Adverse Event|4|||
13285515|NCT00195429|26469505|FG000|Overall Study|Lack of Efficacy|2|||
13285516|NCT00195429|26469506|FG001|Overall Study|Lack of Efficacy|1|||
13285517|NCT00195429|26469505|FG000|Overall Study|Lost to Follow-up|1|||
13285518|NCT00195429|26469506|FG001|Overall Study|Lost to Follow-up|0|||
13285519|NCT00195351|26469523|FG000|Overall Study|Lost to Follow-up|9|||
13285520|NCT00195351|26469524|FG001|Overall Study|Lost to Follow-up|9|||
13285521|NCT00195351|26469523|FG000|Overall Study|Withdrawal by Subject|6|||
13285522|NCT00195351|26469524|FG001|Overall Study|Withdrawal by Subject|3|||
13285523|NCT00195351|26469523|FG000|Overall Study|Protocol Deviation|3|||
13285524|NCT00195351|26469524|FG001|Overall Study|Protocol Deviation|2|||
13285525|NCT00195351|26469523|FG000|Overall Study|Death|3|||
13285526|NCT00195351|26469524|FG001|Overall Study|Death|1|||
13285527|NCT00195351|26469523|FG000|Overall Study|Lack of Efficacy|0|||
13285528|NCT00195351|26469524|FG001|Overall Study|Lack of Efficacy|1|||
13285529|NCT00195273|26469543|FG000|Overall Study|Adverse Event|9|||
13285530|NCT00195273|26469544|FG001|Overall Study|Adverse Event|9|||
13285531|NCT00195273|26469543|FG000|Overall Study|Protocol deviation|0|||
13285532|NCT00195273|26469544|FG001|Overall Study|Protocol deviation|1|||
13285533|NCT00195273|26469543|FG000|Overall Study|Lack of Efficacy|3|||
13285534|NCT00195273|26469544|FG001|Overall Study|Lack of Efficacy|1|||
13285535|NCT00195273|26469543|FG000|Overall Study|Procedural complications|9|||
13285536|NCT00195273|26469544|FG001|Overall Study|Procedural complications|3|||
13285537|NCT00194987|26469563|FG000|Overall Study|Withdrawal by Subject|0|||
13285538|NCT00194987|26469564|FG001|Overall Study|Withdrawal by Subject|3|||
13285539|NCT00194792|26469576|FG000|Overall Study|Withdrawal by Subject|1|||
13285540|NCT00194675|26469599|FG000|Overall Study|Lost to Follow-up|1|||
13285541|NCT00194675|26469600|FG001|Overall Study|Lost to Follow-up|1|||
13285542|NCT00194675|26469599|FG000|Overall Study|lack of interest|1|||
13285543|NCT00194675|26469600|FG001|Overall Study|lack of interest|1|||
13285544|NCT00194675|26469599|FG000|Overall Study|"withdrew due to edgy feeling"|1|||
13285545|NCT00194675|26469600|FG001|Overall Study|"withdrew due to edgy feeling"|0|||
13285546|NCT00194675|26469599|FG000|Overall Study|Protocol Violation|1|||
13285547|NCT00194675|26469600|FG001|Overall Study|Protocol Violation|0|||
13285548|NCT00194675|26469599|FG000|Overall Study|Death|1|||
13285549|NCT00194675|26469600|FG001|Overall Study|Death|0|||
13285550|NCT00194077|26469613|FG000|Overall Study|Lack of Efficacy|22|||
13285551|NCT00194077|26469614|FG001|Overall Study|Lack of Efficacy|29|||
13285552|NCT00194077|26469613|FG000|Overall Study|Study nonadherence|1|||
13285553|NCT00194077|26469614|FG001|Overall Study|Study nonadherence|0|||
13285554|NCT00194077|26469613|FG000|Overall Study|Withdrawal by Subject|1|||
13285555|NCT00194077|26469614|FG001|Overall Study|Withdrawal by Subject|1|||
13285556|NCT00194012|26469657|FG000|Randomized Phase|Lack of Efficacy|8|||
13285557|NCT00194012|26469658|FG001|Randomized Phase|Lack of Efficacy|18|||
13285558|NCT00194012|26469657|FG000|Randomized Phase|Study nonadherence|2|||
13285559|NCT00194012|26469658|FG001|Randomized Phase|Study nonadherence|1|||
13285560|NCT00194012|26469657|FG000|Randomized Phase|Withdrawal by Subject|3|||
13285561|NCT00194012|26469658|FG001|Randomized Phase|Withdrawal by Subject|3|||
13285562|NCT00194012|26469657|FG000|Randomized Phase|Adverse Event|2|||
13285563|NCT00194012|26469658|FG001|Randomized Phase|Adverse Event|1|||
13285564|NCT00194012|26469657|FG000|Randomized Phase|Participant reported having a rash|1|||
13285565|NCT00194012|26469658|FG001|Randomized Phase|Participant reported having a rash|0|||
13285566|NCT00194012|26469657|FG000|Randomized Phase|Emesis and enuresis|0|||
13285567|NCT00194012|26469658|FG001|Randomized Phase|Emesis and enuresis|1|||
13285568|NCT00194012|26469657|FG000|Randomized Phase|Oral/nasal twitching|0|||
13285569|NCT00194012|26469658|FG001|Randomized Phase|Oral/nasal twitching|1|||
13285570|NCT00194012|26469657|FG000|Open Label Extension (OLE)|Weight Gain|1|||
13285571|NCT00194012|26469658|FG001|Open Label Extension (OLE)|Weight Gain|0|||
13285572|NCT00194012|26469657|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0|||
13285573|NCT00194012|26469658|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1|||
13285574|NCT00194012|26469657|FG000|Open Label Extension (OLE)|Lost to Follow-up|3|||
13285575|NCT00194012|26469658|FG001|Open Label Extension (OLE)|Lost to Follow-up|5|||
13285576|NCT00194012|26469657|FG000|Open Label Extension (OLE)|Lack of Efficacy|1|||
13285577|NCT00194012|26469658|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
13285578|NCT00193609|26469665|FG000|Overall Study|Lack of Efficacy|2|||
13285579|NCT00193609|26469665|FG000|Overall Study|Adverse Event|2|||
13285580|NCT00193479|26469671|FG000|Induction Chemotherapy|Adverse Event|2|||
13285581|NCT00193479|26469671|FG000|Induction Chemotherapy|Disease Progression|1|||
13285582|NCT00193479|26469671|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2|||
13285583|NCT00193479|26469671|FG000|Maintenance Rituximab|Withdrawal by Subject|2|||
13285584|NCT00193206|26469680|FG000|Preoperative Therapy|Lack of Efficacy|2|||
13285585|NCT00193206|26469680|FG000|Preoperative Therapy|Adverse Event|2|||
13285586|NCT00193206|26469680|FG000|Preoperative Therapy|Withdrawal by Subject|2|||
13285587|NCT00193206|26469680|FG000|Preoperative Therapy|False Positive Pregnancy Test|1|||
13285588|NCT00193206|26469680|FG000|Postoperative Therapy|Withdrawal by Subject|7|||
13285589|NCT00193206|26469680|FG000|Postoperative Therapy|Physician Decision|3|||
13285590|NCT00193206|26469680|FG000|Postoperative Therapy|Intercurrent Illness|2|||
13285591|NCT00193206|26469680|FG000|Postoperative Therapy|Lack of Efficacy|1|||
13285592|NCT00193206|26469680|FG000|Postoperative Therapy|Protocol Violation|1|||
13285593|NCT00193180|26469688|FG000|Overall Study|Lack of Efficacy|1|||
13285594|NCT00193180|26469688|FG000|Overall Study|Adverse Event|8|||
13285595|NCT00193180|26469688|FG000|Overall Study|Protocol Violation|1|||
13285596|NCT00193063|26469696|FG000|Overall Study|Lack of Efficacy|3|||
13285597|NCT00193063|26469696|FG000|Overall Study|Adverse Event|1|||
13285598|NCT00193050|26469704|FG000|Neoadjuvant Treatment|Lack of Efficacy|2|||
13285599|NCT00193050|26469704|FG000|Neoadjuvant Treatment|Intercurrent Illness|3|||
13285600|NCT00193050|26469704|FG000|Neoadjuvant Treatment|Physician Decision|2|||
13285601|NCT00193050|26469704|FG000|Neoadjuvant Treatment|Adverse Event|2|||
13285602|NCT00193050|26469704|FG000|Adjuvant|Physician Decision|5|||
13285603|NCT00193050|26469704|FG000|Adjuvant|Intercurrent Hospitalization|3|||
13285604|NCT00193050|26469704|FG000|Adjuvant|Lack of Efficacy|2|||
13285605|NCT00192647|26469727|FG000|Overall Study|Death|1|||
13285606|NCT00192647|26469728|FG001|Overall Study|Death|1|||
13285607|NCT00192647|26469727|FG000|Overall Study|Adverse Event|35|||
13285608|NCT00192647|26469728|FG001|Overall Study|Adverse Event|29|||
13285609|NCT00192647|26469727|FG000|Overall Study|Laboratory Test Abnormality|4|||
13285610|NCT00192647|26469728|FG001|Overall Study|Laboratory Test Abnormality|2|||
13285611|NCT00192647|26469727|FG000|Overall Study|Insufficient Therapeutic Response|53|||
13285612|NCT00192647|26469728|FG001|Overall Study|Insufficient Therapeutic Response|83|||
13285613|NCT00192647|26469727|FG000|Overall Study|Entry Criteria Violation|6|||
13285614|NCT00192647|26469728|FG001|Overall Study|Entry Criteria Violation|6|||
13285615|NCT00192647|26469727|FG000|Overall Study|Protocol Violation|3|||
13285616|NCT00192647|26469728|FG001|Overall Study|Protocol Violation|1|||
13285617|NCT00192647|26469727|FG000|Overall Study|Refused Treatment/Did not Cooperate|10|||
13285618|NCT00192647|26469728|FG001|Overall Study|Refused Treatment/Did not Cooperate|8|||
13285619|NCT00192647|26469727|FG000|Overall Study|Failure to Return|11|||
13285620|NCT00192647|26469728|FG001|Overall Study|Failure to Return|13|||
13285621|NCT00192647|26469727|FG000|Overall Study|Other/Administrative|5|||
13285622|NCT00192647|26469728|FG001|Overall Study|Other/Administrative|3|||
13285623|NCT00192504|26469771|FG000|Overall Study|Lost to Follow-up|1|||
13285624|NCT00192504|26469772|FG001|Overall Study|Lost to Follow-up|0|||
13285625|NCT00192504|26469773|FG002|Overall Study|Lost to Follow-up|0|||
13285626|NCT00192504|26469774|FG003|Overall Study|Lost to Follow-up|0|||
13285627|NCT00192504|26469771|FG000|Overall Study|Dosing window missed|0|||
13285628|NCT00192504|26469772|FG001|Overall Study|Dosing window missed|0|||
13285629|NCT00192504|26469773|FG002|Overall Study|Dosing window missed|1|||
13285630|NCT00192504|26469774|FG003|Overall Study|Dosing window missed|0|||
13285631|NCT00192296|26469841|FG000|Overall Study|Withdrawal by Subject|0|||
13285632|NCT00192296|26469842|FG001|Overall Study|Withdrawal by Subject|1|||
13285633|NCT00192296|26469843|FG002|Overall Study|Withdrawal by Subject|0|||
13285634|NCT00192296|26469844|FG003|Overall Study|Withdrawal by Subject|0|||
13285635|NCT00192114|26469861|FG000|Overall Study|Objective Tumor Progression|19|||
13285636|NCT00192114|26469861|FG000|Overall Study|Adverse Event|2|||
13285637|NCT00192114|26469861|FG000|Overall Study|Clinical Progression|2|||
13285638|NCT00192114|26469861|FG000|Overall Study|Death|1|||
13285639|NCT00192075|26469893|FG000|Overall Study|Disease Progression|23|||
13285640|NCT00192075|26469894|FG001|Overall Study|Disease Progression|6|||
13285641|NCT00192075|26469893|FG000|Overall Study|Adverse Event|1|||
13285642|NCT00192075|26469894|FG001|Overall Study|Adverse Event|3|||
13285643|NCT00192075|26469893|FG000|Overall Study|Death|0|||
13285644|NCT00192075|26469894|FG001|Overall Study|Death|1|||
13285645|NCT00192075|26469893|FG000|Overall Study|Lack of Efficacy|0|||
13285646|NCT00192075|26469894|FG001|Overall Study|Lack of Efficacy|0|||
13285647|NCT00192075|26469893|FG000|Overall Study|Physician Decision|3|||
13285648|NCT00192075|26469894|FG001|Overall Study|Physician Decision|0|||
13285649|NCT00192075|26469893|FG000|Overall Study|Withdrawal by Subject|5|||
13285650|NCT00192075|26469894|FG001|Overall Study|Withdrawal by Subject|5|||
13285651|NCT00192075|26469893|FG000|Overall Study|Patient Non-Compliance|0|||
13285652|NCT00192075|26469894|FG001|Overall Study|Patient Non-Compliance|1|||
13285653|NCT00192075|26469893|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2|||
13285654|NCT00192075|26469894|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1|||
13285655|NCT00192075|26469893|FG000|Overall Study|Other|5|||
13285656|NCT00192075|26469894|FG001|Overall Study|Other|2|||
13285657|NCT00192036|26469904|FG000|Overall Study|Protocol Violation|3|||
13285658|NCT00192036|26469904|FG000|Overall Study|Adverse Event|6|||
13285659|NCT00192036|26469904|FG000|Overall Study|Patient/Physician Perception|1|||
13285660|NCT00192036|26469904|FG000|Overall Study|Objective Tumor Progression|4|||
13285661|NCT00192036|26469904|FG000|Overall Study|Clinical Disease Progression|1|||
13285662|NCT00192036|26469904|FG000|Overall Study|Death|1|||
13285663|NCT00192036|26469904|FG000|Overall Study|Unknown or Not Specified|5|||
13285664|NCT00192023|26469933|FG000|Period III - Double-Blind|Adverse Event|3|||
13285665|NCT00192023|26469934|FG001|Period III - Double-Blind|Adverse Event|0|||
13285666|NCT00192023|26469933|FG000|Period III - Double-Blind|Physician Decision|2|||
13285667|NCT00192023|26469934|FG001|Period III - Double-Blind|Physician Decision|0|||
13285668|NCT00192023|26469933|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2|||
13285669|NCT00192023|26469934|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0|||
13285670|NCT00192023|26469933|FG000|Period IV - Optional Open-Label|Adverse Event|6|||
13285671|NCT00192023|26469934|FG001|Period IV - Optional Open-Label|Adverse Event|0|||
13285672|NCT00192023|26469933|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7|||
13285673|NCT00192023|26469934|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0|||
13285674|NCT00192023|26469933|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46|||
13285675|NCT00192023|26469934|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0|||
13285676|NCT00192023|26469933|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2|||
13285677|NCT00192023|26469934|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0|||
13285678|NCT00192023|26469933|FG000|Period IV - Optional Open-Label|Protocol Violation|1|||
13285679|NCT00192023|26469934|FG001|Period IV - Optional Open-Label|Protocol Violation|0|||
13285680|NCT00192023|26469933|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4|||
13285681|NCT00192023|26469934|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0|||
13285682|NCT00192023|26469933|FG000|Period IV - Optional Open-Label|Physician Decision|9|||
13285683|NCT00192023|26469934|FG001|Period IV - Optional Open-Label|Physician Decision|0|||
13285684|NCT00191984|26469944|FG000|Overall Study|Disease Progression|21|||
13285685|NCT00191984|26469944|FG000|Overall Study|Adverse Event|4|||
13285686|NCT00191984|26469944|FG000|Overall Study|Death|2|||
13285687|NCT00191984|26469944|FG000|Overall Study|Entry Criteria Exclusion|1|||
13285688|NCT00191984|26469944|FG000|Overall Study|Withdrawal by Subject|7|||
13285689|NCT00191984|26469944|FG000|Overall Study|Physician Decision|4|||
13285690|NCT00191906|26469997|FG000|Study Period II|Adverse Event|0|||
13285691|NCT00191906|26469998|FG001|Study Period II|Adverse Event|1|||
13285692|NCT00191906|26469999|FG002|Study Period II|Adverse Event|0|||
13285693|NCT00191906|26470000|FG003|Study Period II|Adverse Event|0|||
13285694|NCT00191906|26469997|FG000|Study Period II|Withdrawal by Subject|0|||
13285695|NCT00191906|26469998|FG001|Study Period II|Withdrawal by Subject|3|||
13285696|NCT00191906|26469999|FG002|Study Period II|Withdrawal by Subject|0|||
13285697|NCT00191906|26470000|FG003|Study Period II|Withdrawal by Subject|0|||
13285698|NCT00191906|26469997|FG000|Study Period II|Parent/Caregiver Decision|0|||
13285699|NCT00191906|26469998|FG001|Study Period II|Parent/Caregiver Decision|1|||
13285700|NCT00191906|26469999|FG002|Study Period II|Parent/Caregiver Decision|0|||
13285701|NCT00191906|26470000|FG003|Study Period II|Parent/Caregiver Decision|0|||
13285702|NCT00191906|26469997|FG000|Study Period II|Entry Criteria Exclusion|0|||
13285703|NCT00191906|26469998|FG001|Study Period II|Entry Criteria Exclusion|0|||
13285704|NCT00191906|26469999|FG002|Study Period II|Entry Criteria Exclusion|1|||
13285705|NCT00191906|26470000|FG003|Study Period II|Entry Criteria Exclusion|0|||
13285706|NCT00191906|26469997|FG000|Study Period III|Adverse Event|1|||
13285707|NCT00191906|26469998|FG001|Study Period III|Adverse Event|0|||
13285708|NCT00191906|26469999|FG002|Study Period III|Adverse Event|0|||
13285709|NCT00191906|26470000|FG003|Study Period III|Adverse Event|0|||
13285710|NCT00191906|26469997|FG000|Study Period III|Lost to Follow-up|0|||
13285711|NCT00191906|26469998|FG001|Study Period III|Lost to Follow-up|1|||
13285712|NCT00191906|26469999|FG002|Study Period III|Lost to Follow-up|0|||
13285713|NCT00191906|26470000|FG003|Study Period III|Lost to Follow-up|0|||
13285714|NCT00191906|26469997|FG000|Study Period III|Parent/Caregiver Decision|1|||
13285715|NCT00191906|26469998|FG001|Study Period III|Parent/Caregiver Decision|0|||
13285716|NCT00191906|26469999|FG002|Study Period III|Parent/Caregiver Decision|0|||
13285717|NCT00191906|26470000|FG003|Study Period III|Parent/Caregiver Decision|0|||
13285718|NCT00191906|26469997|FG000|Study Period III|Lack of Efficacy|3|||
13285719|NCT00191906|26469998|FG001|Study Period III|Lack of Efficacy|3|||
13285720|NCT00191906|26469999|FG002|Study Period III|Lack of Efficacy|0|||
13285721|NCT00191906|26470000|FG003|Study Period III|Lack of Efficacy|0|||
13285722|NCT00191854|26470030|FG000|Overall Study|Death|26|||
13285723|NCT00191854|26470031|FG001|Overall Study|Death|23|||
13285724|NCT00191854|26470032|FG002|Overall Study|Death|29|||
13285725|NCT00191854|26470030|FG000|Overall Study|Lost to Follow-up|7|||
13285726|NCT00191854|26470031|FG001|Overall Study|Lost to Follow-up|5|||
13285727|NCT00191854|26470032|FG002|Overall Study|Lost to Follow-up|5|||
13285728|NCT00191854|26470030|FG000|Overall Study|Withdrawal by Subject|4|||
13285729|NCT00191854|26470031|FG001|Overall Study|Withdrawal by Subject|2|||
13285730|NCT00191854|26470032|FG002|Overall Study|Withdrawal by Subject|3|||
13285731|NCT00191854|26470030|FG000|Overall Study|Sponsor Decision|0|||
13285732|NCT00191854|26470031|FG001|Overall Study|Sponsor Decision|0|||
13285733|NCT00191854|26470032|FG002|Overall Study|Sponsor Decision|1|||
13285734|NCT00191854|26470030|FG000|Overall Study|Screen Failure|0|||
13285735|NCT00191854|26470031|FG001|Overall Study|Screen Failure|0|||
13285736|NCT00191854|26470032|FG002|Overall Study|Screen Failure|1|||
13285737|NCT00191815|26470046|FG000|Overall Study|Adverse Event|2|||
13285738|NCT00191815|26470046|FG000|Overall Study|Disease progression or relapse|24|||
13285739|NCT00191815|26470046|FG000|Overall Study|Death|2|||
13285740|NCT00191815|26470046|FG000|Overall Study|Protocol Violation|3|||
13285741|NCT00191815|26470046|FG000|Overall Study|Physician Decision|2|||
13285742|NCT00191815|26470046|FG000|Overall Study|Withdrawal by Subject|7|||
13285743|NCT00191789|26470060|FG000|Overall Study|Adverse Event|5|||
13285744|NCT00191789|26470060|FG000|Overall Study|Patient: Satisfactory Response|5|||
13285745|NCT00191789|26470060|FG000|Overall Study|Patient/Physician: Satisfactory Response|4|||
13285746|NCT00191789|26470060|FG000|Overall Study|Withdrawal by Subject|4|||
13285747|NCT00191789|26470060|FG000|Overall Study|Death - Possibly Study Drug Related|4|||
13285748|NCT00191789|26470060|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2|||
13285749|NCT00191789|26470060|FG000|Overall Study|Death - Not Study-Drug Related|1|||
13285750|NCT00191724|26470103|FG000|Overall Study|Adverse Event|0|||
13285751|NCT00191724|26470104|FG001|Overall Study|Adverse Event|0|||
13285752|NCT00191724|26470105|FG002|Overall Study|Adverse Event|1|||
13285753|NCT00191724|26470106|FG003|Overall Study|Adverse Event|0|||
13285754|NCT00191724|26470107|FG004|Overall Study|Adverse Event|0|||
13285755|NCT00191724|26470103|FG000|Overall Study|Lost to Follow-up|1|||
13285756|NCT00191724|26470104|FG001|Overall Study|Lost to Follow-up|1|||
13285757|NCT00191724|26470105|FG002|Overall Study|Lost to Follow-up|0|||
13285758|NCT00191724|26470106|FG003|Overall Study|Lost to Follow-up|2|||
13285759|NCT00191724|26470107|FG004|Overall Study|Lost to Follow-up|3|||
13285760|NCT00191724|26470103|FG000|Overall Study|Withdrawal by Subject|0|||
13285761|NCT00191724|26470104|FG001|Overall Study|Withdrawal by Subject|0|||
13285762|NCT00191724|26470105|FG002|Overall Study|Withdrawal by Subject|0|||
13285763|NCT00191724|26470106|FG003|Overall Study|Withdrawal by Subject|1|||
13285764|NCT00191724|26470107|FG004|Overall Study|Withdrawal by Subject|0|||
13285765|NCT00191646|26470132|FG000|Overall Study|Toxicity|26|||
13285766|NCT00191646|26470133|FG001|Overall Study|Toxicity|37|||
13285767|NCT00191646|26470132|FG000|Overall Study|Disease Progression|5|||
13285768|NCT00191646|26470133|FG001|Overall Study|Disease Progression|6|||
13285769|NCT00191646|26470132|FG000|Overall Study|Physician Decision|20|||
13285770|NCT00191646|26470133|FG001|Overall Study|Physician Decision|11|||
13285771|NCT00191646|26470132|FG000|Overall Study|Withdrawal by Subject|58|||
13285772|NCT00191646|26470133|FG001|Overall Study|Withdrawal by Subject|39|||
13285773|NCT00191646|26470132|FG000|Overall Study|Protocol Violation|5|||
13285774|NCT00191646|26470133|FG001|Overall Study|Protocol Violation|7|||
13285775|NCT00191646|26470132|FG000|Overall Study|Death|6|||
13285776|NCT00191646|26470133|FG001|Overall Study|Death|8|||
13285777|NCT00191646|26470132|FG000|Overall Study|Other|33|||
13285778|NCT00191646|26470133|FG001|Overall Study|Other|34|||
13285779|NCT00191646|26470132|FG000|Overall Study|Missing Data|18|||
13285780|NCT00191646|26470133|FG001|Overall Study|Missing Data|11|||
13285781|NCT00191451|26470163|FG000|Overall Study|Withdrawal by Subject|2|||
13285782|NCT00191451|26470164|FG001|Overall Study|Withdrawal by Subject|3|||
13285783|NCT00191451|26470165|FG002|Overall Study|Withdrawal by Subject|5|||
13285784|NCT00191451|26470163|FG000|Overall Study|Physician Decision|2|||
13285785|NCT00191451|26470164|FG001|Overall Study|Physician Decision|9|||
13285786|NCT00191451|26470165|FG002|Overall Study|Physician Decision|6|||
13285787|NCT00191451|26470163|FG000|Overall Study|Sponsor Decision|1|||
13285788|NCT00191451|26470164|FG001|Overall Study|Sponsor Decision|0|||
13285789|NCT00191451|26470165|FG002|Overall Study|Sponsor Decision|0|||
13285790|NCT00191451|26470163|FG000|Overall Study|Ineligible|0|||
13285791|NCT00191451|26470164|FG001|Overall Study|Ineligible|1|||
13285792|NCT00191451|26470165|FG002|Overall Study|Ineligible|0|||
13285793|NCT00191451|26470163|FG000|Overall Study|Reason Not Specified|2|||
13285794|NCT00191451|26470164|FG001|Overall Study|Reason Not Specified|1|||
13285795|NCT00191451|26470165|FG002|Overall Study|Reason Not Specified|3|||
13285796|NCT00191386|26470174|FG000|Overall Study|Adverse Event|16|||
13285797|NCT00191386|26470174|FG000|Overall Study|Lost to Follow-up|1|||
13285798|NCT00191386|26470174|FG000|Overall Study|Entry Criteria Exclusion|3|||
13285799|NCT00191386|26470174|FG000|Overall Study|Protocol Violation|18|||
13285800|NCT00191386|26470174|FG000|Overall Study|Withdrawal by Subject|96|||
13285801|NCT00191386|26470174|FG000|Overall Study|Physician Decision|11|||
13285802|NCT00191386|26470174|FG000|Overall Study|Lack of Efficacy|15|||
13285803|NCT00191334|26470184|FG000|Overall Study|Adverse Event|4|||
13285804|NCT00191334|26470184|FG000|Overall Study|Disease Progression or Relapse|8|||
13285805|NCT00191334|26470184|FG000|Overall Study|Physician Decision|1|||
13285806|NCT00191334|26470184|FG000|Overall Study|Withdrawal by Subject|4|||
13285807|NCT00191308|26470194|FG000|Overall Study|Adverse Event|1|||
13285808|NCT00191282|26470259|FG000|Overall Study|Adverse Event|5|||
13285809|NCT00191282|26470260|FG001|Overall Study|Adverse Event|6|||
13285810|NCT00191282|26470259|FG000|Overall Study|Death|51|||
13285811|NCT00191282|26470260|FG001|Overall Study|Death|51|||
13285812|NCT00191282|26470259|FG000|Overall Study|Lack of Efficacy|11|||
13285813|NCT00191282|26470260|FG001|Overall Study|Lack of Efficacy|6|||
13285814|NCT00191282|26470259|FG000|Overall Study|Noncompliance|14|||
13285815|NCT00191282|26470260|FG001|Overall Study|Noncompliance|17|||
13285816|NCT00191282|26470259|FG000|Overall Study|Patient moved|11|||
13285817|NCT00191282|26470260|FG001|Overall Study|Patient moved|14|||
13285818|NCT00191282|26470259|FG000|Overall Study|Withdrawal by Subject|59|||
13285819|NCT00191282|26470260|FG001|Overall Study|Withdrawal by Subject|44|||
13285820|NCT00191282|26470259|FG000|Overall Study|Physician Decision|18|||
13285821|NCT00191282|26470260|FG001|Overall Study|Physician Decision|15|||
13285822|NCT00191282|26470259|FG000|Overall Study|Protocol entry criteria not met|14|||
13285823|NCT00191282|26470260|FG001|Overall Study|Protocol entry criteria not met|9|||
13285824|NCT00191282|26470259|FG000|Overall Study|Protocol Violation|9|||
13285825|NCT00191282|26470260|FG001|Overall Study|Protocol Violation|12|||
13285826|NCT00191282|26470259|FG000|Overall Study|Severity of outcome|2|||
13285827|NCT00191282|26470260|FG001|Overall Study|Severity of outcome|5|||
13285828|NCT00191282|26470259|FG000|Overall Study|Sponsor's decision|2|||
13285829|NCT00191282|26470260|FG001|Overall Study|Sponsor's decision|2|||
13285830|NCT00191282|26470259|FG000|Overall Study|Lost to Follow-up|24|||
13285831|NCT00191282|26470260|FG001|Overall Study|Lost to Follow-up|31|||
13285832|NCT00191269|26470281|FG000|Overall Study|Protocol Violation|0|||
13285833|NCT00191269|26470282|FG001|Overall Study|Protocol Violation|2|||
13285834|NCT00191269|26470281|FG000|Overall Study|Adverse Event|1|||
13285835|NCT00191269|26470282|FG001|Overall Study|Adverse Event|4|||
13285836|NCT00191269|26470281|FG000|Overall Study|Progression of Disease|4|||
13285837|NCT00191269|26470282|FG001|Overall Study|Progression of Disease|42|||
13285838|NCT00191269|26470281|FG000|Overall Study|Lack of Efficacy|1|||
13285839|NCT00191269|26470282|FG001|Overall Study|Lack of Efficacy|5|||
13285840|NCT00191269|26470281|FG000|Overall Study|Withdrawal by Subject|0|||
13285841|NCT00191269|26470282|FG001|Overall Study|Withdrawal by Subject|1|||
13285842|NCT00191269|26470281|FG000|Overall Study|Pathologic Aggrevation|0|||
13285843|NCT00191269|26470282|FG001|Overall Study|Pathologic Aggrevation|1|||
13285844|NCT00191269|26470281|FG000|Overall Study|Physician Decision|0|||
13285845|NCT00191269|26470282|FG001|Overall Study|Physician Decision|3|||
13285846|NCT00191191|26470303|FG000|Overall Study|Entry Criteria Exclusion|2|||
13285847|NCT00191191|26470304|FG001|Overall Study|Entry Criteria Exclusion|0|||
13285848|NCT00191191|26470303|FG000|Overall Study|Treated with Another Systemic Agent|1|||
13285849|NCT00191191|26470304|FG001|Overall Study|Treated with Another Systemic Agent|1|||
13285850|NCT00191191|26470303|FG000|Overall Study|Adverse Event|11|||
13285851|NCT00191191|26470304|FG001|Overall Study|Adverse Event|21|||
13285852|NCT00191191|26470303|FG000|Overall Study|Progressive Disease|84|||
13285853|NCT00191191|26470304|FG001|Overall Study|Progressive Disease|72|||
13285854|NCT00191191|26470303|FG000|Overall Study|Toxicity After Dose Reduction|7|||
13285855|NCT00191191|26470304|FG001|Overall Study|Toxicity After Dose Reduction|8|||
13285856|NCT00191191|26470303|FG000|Overall Study|Family/Caregiver Decision|5|||
13285857|NCT00191191|26470304|FG001|Overall Study|Family/Caregiver Decision|7|||
13285858|NCT00191191|26470303|FG000|Overall Study|Lost to Follow-up|1|||
13285859|NCT00191191|26470304|FG001|Overall Study|Lost to Follow-up|0|||
13285860|NCT00191191|26470303|FG000|Overall Study|Physician Decision|3|||
13285861|NCT00191191|26470304|FG001|Overall Study|Physician Decision|2|||
13285862|NCT00191191|26470303|FG000|Overall Study|Good Clinical Practice Violation|0|||
13285863|NCT00191191|26470304|FG001|Overall Study|Good Clinical Practice Violation|1|||
13285864|NCT00191165|26470321|FG000|Overall Study|Adverse Event|2|||
13285865|NCT00191165|26470322|FG001|Overall Study|Adverse Event|0|||
13285866|NCT00191165|26470321|FG000|Overall Study|Protocol Violation|0|||
13285867|NCT00191165|26470322|FG001|Overall Study|Protocol Violation|1|||
13285868|NCT00191165|26470321|FG000|Overall Study|Participant Moved Away|0|||
13285869|NCT00191165|26470322|FG001|Overall Study|Participant Moved Away|1|||
13292183|NCT00708032|26484780|FG000|Overall Study|Pregnancy|0|||
13292184|NCT00708032|26484781|FG001|Overall Study|Pregnancy|1|||
13292185|NCT00708032|26484780|FG000|Overall Study|Poor vision|0|||
13292186|NCT00708032|26484781|FG001|Overall Study|Poor vision|6|||
13292187|NCT00708032|26484780|FG000|Overall Study|Visit out of range at month 12|4|||
13292188|NCT00708032|26484781|FG001|Overall Study|Visit out of range at month 12|1|||
13292189|NCT00708032|26484780|FG000|Overall Study|Did not meet protocol criteria|1|||
13292190|NCT00708032|26484781|FG001|Overall Study|Did not meet protocol criteria|2|||
13285870|NCT00191152|26470359|FG000|Initial Treatment|Adverse Event|43|||
13285871|NCT00191152|26470360|FG001|Initial Treatment|Adverse Event|67|||
13285872|NCT00191152|26470359|FG000|Initial Treatment|Physician Decision|40|||
13285873|NCT00191152|26470360|FG001|Initial Treatment|Physician Decision|31|||
13285874|NCT00191152|26470359|FG000|Initial Treatment|Withdrawal by Subject|40|||
13285875|NCT00191152|26470360|FG001|Initial Treatment|Withdrawal by Subject|28|||
13285876|NCT00191152|26470359|FG000|Initial Treatment|Lost to Follow-up|0|||
13285877|NCT00191152|26470360|FG001|Initial Treatment|Lost to Follow-up|6|||
13285878|NCT00191152|26470359|FG000|Initial Treatment|Other|18|||
13285879|NCT00191152|26470360|FG001|Initial Treatment|Other|21|||
13285880|NCT00191152|26470359|FG000|Crossover Treatment|Adverse Event|8|||
13285881|NCT00191152|26470360|FG001|Crossover Treatment|Adverse Event|8|||
13285882|NCT00191152|26470359|FG000|Crossover Treatment|Physician Decision|7|||
13285883|NCT00191152|26470360|FG001|Crossover Treatment|Physician Decision|7|||
13285884|NCT00191152|26470359|FG000|Crossover Treatment|Withdrawal by Subject|6|||
13285885|NCT00191152|26470360|FG001|Crossover Treatment|Withdrawal by Subject|9|||
13285886|NCT00191152|26470359|FG000|Crossover Treatment|Lost to Follow-up|2|||
13285887|NCT00191152|26470360|FG001|Crossover Treatment|Lost to Follow-up|1|||
13285888|NCT00191152|26470359|FG000|Crossover Treatment|Other|4|||
13285889|NCT00191152|26470360|FG001|Crossover Treatment|Other|3|||
13285890|NCT00191139|26470381|FG000|Overall Study|Adverse Event|2|||
13285891|NCT00191139|26470382|FG001|Overall Study|Adverse Event|6|||
13285892|NCT00191139|26470381|FG000|Overall Study|Death|2|||
13285893|NCT00191139|26470382|FG001|Overall Study|Death|0|||
13285894|NCT00191139|26470381|FG000|Overall Study|Withdrawal by Subject|0|||
13285895|NCT00191139|26470382|FG001|Overall Study|Withdrawal by Subject|3|||
13285896|NCT00191139|26470381|FG000|Overall Study|Disease Progression|0|||
13285897|NCT00191139|26470382|FG001|Overall Study|Disease Progression|1|||
13285898|NCT00191139|26470381|FG000|Overall Study|Other|1|||
13285899|NCT00191139|26470382|FG001|Overall Study|Other|2|||
13285900|NCT00190983|26470391|FG000|Overall Study|Inevaluable (never treated)|2|||
13285901|NCT00190775|26470467|FG000|Overall Study|Adverse Event|57|||
13285902|NCT00190775|26470468|FG001|Overall Study|Adverse Event|22|||
13285903|NCT00190775|26470467|FG000|Overall Study|Satisfactory Response|1|||
13285904|NCT00190775|26470468|FG001|Overall Study|Satisfactory Response|0|||
13285905|NCT00190775|26470467|FG000|Overall Study|Lack of Efficacy|28|||
13285906|NCT00190775|26470468|FG001|Overall Study|Lack of Efficacy|32|||
13285907|NCT00190775|26470467|FG000|Overall Study|Lost to Follow-up|31|||
13285908|NCT00190775|26470468|FG001|Overall Study|Lost to Follow-up|23|||
13285909|NCT00190775|26470467|FG000|Overall Study|Participant Moved|0|||
13285910|NCT00190775|26470468|FG001|Overall Study|Participant Moved|1|||
13285911|NCT00190775|26470467|FG000|Overall Study|Withdrawal by Subject|24|||
13285912|NCT00190775|26470468|FG001|Overall Study|Withdrawal by Subject|13|||
13285913|NCT00190775|26470467|FG000|Overall Study|Sponsor Decision|1|||
13285914|NCT00190775|26470468|FG001|Overall Study|Sponsor Decision|0|||
13285915|NCT00190775|26470467|FG000|Overall Study|Physician Decision|3|||
13285916|NCT00190775|26470468|FG001|Overall Study|Physician Decision|0|||
13285917|NCT00190775|26470467|FG000|Overall Study|Noncompliance|3|||
13285918|NCT00190775|26470468|FG001|Overall Study|Noncompliance|5|||
13285919|NCT00190775|26470467|FG000|Overall Study|Protocol Violation|0|||
13285920|NCT00190775|26470468|FG001|Overall Study|Protocol Violation|1|||
13285921|NCT00190775|26470467|FG000|Overall Study|Exclusion Criteria Met|1|||
13285922|NCT00190775|26470468|FG001|Overall Study|Exclusion Criteria Met|3|||
13285923|NCT00190749|26470539|FG000|Overall Study|Lost to Follow-up|8|||
13285924|NCT00190749|26470540|FG001|Overall Study|Lost to Follow-up|11|||
13285925|NCT00190749|26470539|FG000|Overall Study|Withdrawal by Subject|10|||
13285926|NCT00190749|26470540|FG001|Overall Study|Withdrawal by Subject|6|||
13285927|NCT00190749|26470539|FG000|Overall Study|Protocol Violation|5|||
13285928|NCT00190749|26470540|FG001|Overall Study|Protocol Violation|4|||
13285929|NCT00190749|26470539|FG000|Overall Study|Adverse Event|0|||
13285930|NCT00190749|26470540|FG001|Overall Study|Adverse Event|5|||
13285931|NCT00190749|26470539|FG000|Overall Study|Lack of Efficacy|2|||
13285932|NCT00190749|26470540|FG001|Overall Study|Lack of Efficacy|3|||
13285933|NCT00190749|26470539|FG000|Overall Study|Reason Not Specified|0|||
13285934|NCT00190749|26470540|FG001|Overall Study|Reason Not Specified|2|||
13285935|NCT00190749|26470539|FG000|Overall Study|Sponsor Decision|1|||
13285936|NCT00190749|26470540|FG001|Overall Study|Sponsor Decision|0|||
13285937|NCT00190684|26470561|FG000|Overall Study|Adverse Event|86|||
13285938|NCT00190684|26470561|FG000|Overall Study|Satisfactory response|80|||
13285939|NCT00190684|26470561|FG000|Overall Study|Lack of efficacy|204|||
13285940|NCT00190684|26470561|FG000|Overall Study|Lost to Follow-up|232|||
13285941|NCT00190684|26470561|FG000|Overall Study|Patient moved|60|||
13486376|NCT03786380|27035988|FG001|Overall Study|Withdrawal by Subject|2|||
13285942|NCT00190684|26470561|FG000|Overall Study|Patient Decision|432|||
13285943|NCT00190684|26470561|FG000|Overall Study|Clinical relapse|67|||
13285944|NCT00190684|26470561|FG000|Overall Study|Sponsor's decision|17|||
13285945|NCT00190684|26470561|FG000|Overall Study|Physician Decision|84|||
13285946|NCT00190684|26470561|FG000|Overall Study|Protocol Violation|123|||
13285947|NCT00190684|26470561|FG000|Overall Study|Study Period III Completed|103|||
13486377|NCT03786380|27035989|FG002|Overall Study|Withdrawal by Subject|2|||
13285948|NCT00190684|26470561|FG000|Overall Study|Study Period V Completed|1|||
13285949|NCT00190671|26470586|FG000|Overall Study|Satisfactory Response|4|||
13285950|NCT00190671|26470587|FG001|Overall Study|Satisfactory Response|7|||
13285951|NCT00190671|26470586|FG000|Overall Study|Lack of Efficacy|19|||
13285952|NCT00190671|26470587|FG001|Overall Study|Lack of Efficacy|24|||
13285953|NCT00190671|26470586|FG000|Overall Study|Death from Study Disease|1|||
13285954|NCT00190671|26470587|FG001|Overall Study|Death from Study Disease|1|||
13285955|NCT00190671|26470586|FG000|Overall Study|Adverse Event|3|||
13285956|NCT00190671|26470587|FG001|Overall Study|Adverse Event|2|||
13285957|NCT00190671|26470586|FG000|Overall Study|Clinical Relapse|0|||
13285958|NCT00190671|26470587|FG001|Overall Study|Clinical Relapse|1|||
13285959|NCT00190671|26470586|FG000|Overall Study|Death from Study-Drug Toxicity|0|||
13285960|NCT00190671|26470587|FG001|Overall Study|Death from Study-Drug Toxicity|2|||
13285961|NCT00190671|26470586|FG000|Overall Study|Death from Other Causes|0|||
13285962|NCT00190671|26470587|FG001|Overall Study|Death from Other Causes|2|||
13285963|NCT00190671|26470586|FG000|Overall Study|Protocol Violation|0|||
13285964|NCT00190671|26470587|FG001|Overall Study|Protocol Violation|1|||
13285965|NCT00190671|26470586|FG000|Overall Study|Withdrawal by Subject|0|||
13285966|NCT00190671|26470587|FG001|Overall Study|Withdrawal by Subject|2|||
13285967|NCT00199901|26470616|FG000|Overall Study|Protocol Violation|2|||
13285968|NCT00199901|26470617|FG001|Overall Study|Protocol Violation|0|||
13285969|NCT00199901|26470616|FG000|Overall Study|Withdrawal by Subject|1|||
13285970|NCT00199901|26470617|FG001|Overall Study|Withdrawal by Subject|0|||
13285971|NCT00199901|26470616|FG000|Overall Study|Progressive Disease|24|||
13285972|NCT00199901|26470617|FG001|Overall Study|Progressive Disease|24|||
13285973|NCT00198107|26470684|FG000|Double-Blind Period|Adverse Event|1|||
13285974|NCT00198107|26470685|FG001|Double-Blind Period|Adverse Event|1|||
13285975|NCT00198107|26470686|FG002|Double-Blind Period|Adverse Event|0|||
13285976|NCT00198107|26470684|FG000|Double-Blind Period|Lack of Efficacy|2|||
13285977|NCT00198107|26470685|FG001|Double-Blind Period|Lack of Efficacy|0|||
13285978|NCT00198107|26470686|FG002|Double-Blind Period|Lack of Efficacy|0|||
13285979|NCT00198107|26470684|FG000|Double-Blind Period|Lost to Follow-up|2|||
13285980|NCT00198107|26470685|FG001|Double-Blind Period|Lost to Follow-up|1|||
13285981|NCT00198107|26470686|FG002|Double-Blind Period|Lost to Follow-up|0|||
13285982|NCT00198107|26470684|FG000|Double-Blind Period|Physician Decision|1|||
13285983|NCT00198107|26470685|FG001|Double-Blind Period|Physician Decision|0|||
13285984|NCT00198107|26470686|FG002|Double-Blind Period|Physician Decision|0|||
13285985|NCT00198107|26470684|FG000|Double-Blind Period|Withdrawal by Subject|0|||
13285986|NCT00198107|26470685|FG001|Double-Blind Period|Withdrawal by Subject|1|||
13285987|NCT00198107|26470686|FG002|Double-Blind Period|Withdrawal by Subject|0|||
13285988|NCT00198107|26470684|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
13285989|NCT00198107|26470685|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
13285990|NCT00198107|26470686|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2|||
13285991|NCT00179959|26470699|FG000|Overall Study|Lost to Follow-up|3|||
13285992|NCT00179959|26470700|FG001|Overall Study|Lost to Follow-up|1|||
13285993|NCT00179959|26470699|FG000|Overall Study|Withdrawal by Subject|3|||
13285994|NCT00179959|26470700|FG001|Overall Study|Withdrawal by Subject|2|||
13285995|NCT00179673|26470710|FG000|Overall Study|Adverse Event|7|||
13285996|NCT00179673|26470710|FG000|Overall Study|Lack of Efficacy|15|||
13285997|NCT00179673|26470710|FG000|Overall Study|Withdrawal by Subject|3|||
13285998|NCT00179673|26470710|FG000|Overall Study|Death|4|||
13285999|NCT00179673|26470710|FG000|Overall Study|Other Observations and options|14|||
13286000|NCT00179660|26470721|FG000|Overall Study|Adverse Event|7|||
13286001|NCT00179660|26470721|FG000|Overall Study|Lack of therapeutic effect|28|||
13286002|NCT00179660|26470721|FG000|Overall Study|Withdrawal by Subject|2|||
13286003|NCT00179660|26470721|FG000|Overall Study|Lost to Follow-up|1|||
13286004|NCT00179660|26470721|FG000|Overall Study|Death|3|||
13286005|NCT00179660|26470721|FG000|Overall Study|Other - Unspecified|9|||
13286006|NCT00179647|26470727|FG000|Overall Study|Adverse Event|294|||
13286007|NCT00179647|26470727|FG000|Overall Study|Lack of Efficacy|478|||
13286008|NCT00179647|26470727|FG000|Overall Study|Withdrawal by Subject|83|||
13286009|NCT00179647|26470727|FG000|Overall Study|Lost to Follow-up|4|||
13286010|NCT00179647|26470727|FG000|Overall Study|Death|94|||
13286011|NCT00179647|26470727|FG000|Overall Study|Other|960|||
13286012|NCT00179517|26470756|FG000|Overall Study|Withdrawal by Subject|2|||
13286013|NCT00179517|26470757|FG001|Overall Study|Withdrawal by Subject|1|||
13286014|NCT00179413|26470774|FG000|Overall Study|Adverse Event|38|||
13286015|NCT00179413|26470775|FG001|Overall Study|Adverse Event|20|||
13286016|NCT00179413|26470774|FG000|Overall Study|Withdrawal by Subject|87|||
13286017|NCT00179413|26470775|FG001|Overall Study|Withdrawal by Subject|95|||
13286018|NCT00179010|26470790|FG000|Overall Study|Muscle probe defective|1|||
13286019|NCT00179010|26470791|FG001|Overall Study|Muscle probe defective|1|||
13286020|NCT00179010|26470790|FG000|Overall Study|Failure to place arterial line|0|||
13286021|NCT00179010|26470791|FG001|Overall Study|Failure to place arterial line|1|||
13286022|NCT00178633|26470801|FG000|Overall Study|Lost to Follow-up|6|||
13286023|NCT00178464|26470808|FG000|Overall Study|Withdrawal by Subject|1|||
13286024|NCT00178464|26470808|FG000|Overall Study|Physician Decision|1|||
13286025|NCT00178399|26470817|FG000|Overall Study|Physician Decision|4|||
13286026|NCT00178399|26470817|FG000|Overall Study|Withdrawal by Subject|8|||
13286027|NCT00178399|26470817|FG000|Overall Study|Lost to Follow-up|1|||
13286028|NCT00178256|26470829|FG000|Overall Study|Adverse Event|2|||
13286029|NCT00178256|26470830|FG001|Overall Study|Adverse Event|0|||
13286030|NCT00178256|26470831|FG002|Overall Study|Adverse Event|0|||
13286031|NCT00178256|26470832|FG003|Overall Study|Adverse Event|0|||
13308264|NCT01274338|26531432|FG003|Overall Study|Lack of Efficacy|0|||
13308265|NCT01274338|26531433|FG004|Overall Study|Lack of Efficacy|0|||
13308266|NCT01274338|26531434|FG005|Overall Study|Lack of Efficacy|0|||
13308267|NCT01274338|26531429|FG000|Overall Study|Adverse Event|272|||
13308268|NCT01274338|26531430|FG001|Overall Study|Adverse Event|105|||
13308269|NCT01274338|26531431|FG002|Overall Study|Adverse Event|180|||
13308270|NCT01274338|26531432|FG003|Overall Study|Adverse Event|1|||
13308271|NCT01274338|26531433|FG004|Overall Study|Adverse Event|0|||
13308272|NCT01274338|26531434|FG005|Overall Study|Adverse Event|0|||
13308273|NCT01274338|26531429|FG000|Overall Study|Death|8|||
13308274|NCT01274338|26531430|FG001|Overall Study|Death|1|||
13308275|NCT01274338|26531431|FG002|Overall Study|Death|0|||
13308276|NCT01274338|26531432|FG003|Overall Study|Death|0|||
13308277|NCT01274338|26531433|FG004|Overall Study|Death|0|||
13308278|NCT01274338|26531434|FG005|Overall Study|Death|0|||
13308279|NCT01274338|26531429|FG000|Overall Study|Withdrawal by Subject|27|||
13308280|NCT01274338|26531430|FG001|Overall Study|Withdrawal by Subject|99|||
13308281|NCT01274338|26531431|FG002|Overall Study|Withdrawal by Subject|17|||
13308282|NCT01274338|26531432|FG003|Overall Study|Withdrawal by Subject|0|||
13308283|NCT01274338|26531433|FG004|Overall Study|Withdrawal by Subject|0|||
13308284|NCT01274338|26531434|FG005|Overall Study|Withdrawal by Subject|0|||
13308285|NCT01274338|26531429|FG000|Overall Study|Did not start treatment|8|||
13308286|NCT01274338|26531430|FG001|Overall Study|Did not start treatment|116|||
13308287|NCT01274338|26531431|FG002|Overall Study|Did not start treatment|7|||
13308288|NCT01274338|26531432|FG003|Overall Study|Did not start treatment|0|||
13308289|NCT01274338|26531433|FG004|Overall Study|Did not start treatment|0|||
13308290|NCT01274338|26531434|FG005|Overall Study|Did not start treatment|0|||
13308291|NCT01274338|26531429|FG000|Overall Study|Alternative therapy|0|||
13308292|NCT01274338|26531430|FG001|Overall Study|Alternative therapy|1|||
13308293|NCT01274338|26531431|FG002|Overall Study|Alternative therapy|0|||
13308294|NCT01274338|26531432|FG003|Overall Study|Alternative therapy|0|||
13308295|NCT01274338|26531433|FG004|Overall Study|Alternative therapy|0|||
13308296|NCT01274338|26531434|FG005|Overall Study|Alternative therapy|0|||
13308297|NCT01274338|26531429|FG000|Overall Study|Other complicating diseases|0|||
13308298|NCT01274338|26531430|FG001|Overall Study|Other complicating diseases|3|||
13308299|NCT01274338|26531431|FG002|Overall Study|Other complicating diseases|1|||
13308300|NCT01274338|26531432|FG003|Overall Study|Other complicating diseases|0|||
13308301|NCT01274338|26531433|FG004|Overall Study|Other complicating diseases|0|||
13308302|NCT01274338|26531434|FG005|Overall Study|Other complicating diseases|0|||
13308303|NCT01274338|26531429|FG000|Overall Study|Treatment arm was suspended due to toxicity|4|||
13308304|NCT01274338|26531430|FG001|Overall Study|Treatment arm was suspended due to toxicity|0|||
13308305|NCT01274338|26531431|FG002|Overall Study|Treatment arm was suspended due to toxicity|0|||
13308306|NCT01274338|26531432|FG003|Overall Study|Treatment arm was suspended due to toxicity|0|||
13308307|NCT01274338|26531433|FG004|Overall Study|Treatment arm was suspended due to toxicity|0|||
13308308|NCT01274338|26531434|FG005|Overall Study|Treatment arm was suspended due to toxicity|0|||
13308309|NCT01274338|26531429|FG000|Overall Study|Pregnancy|0|||
13308310|NCT01274338|26531430|FG001|Overall Study|Pregnancy|0|||
13308311|NCT01274338|26531431|FG002|Overall Study|Pregnancy|1|||
13308312|NCT01274338|26531432|FG003|Overall Study|Pregnancy|0|||
13308313|NCT01274338|26531433|FG004|Overall Study|Pregnancy|0|||
13286032|NCT00178256|26470829|FG000|Overall Study|Death|0|||
13286033|NCT00178256|26470830|FG001|Overall Study|Death|1|||
13286034|NCT00178256|26470831|FG002|Overall Study|Death|0|||
13286035|NCT00178256|26470832|FG003|Overall Study|Death|1|||
13286036|NCT00178256|26470829|FG000|Overall Study|Cancer progression|2|||
13286037|NCT00178256|26470830|FG001|Overall Study|Cancer progression|0|||
13286038|NCT00178256|26470831|FG002|Overall Study|Cancer progression|0|||
13286039|NCT00178256|26470832|FG003|Overall Study|Cancer progression|1|||
13286040|NCT00178126|26470845|FG000|Overall Study|Lost to Follow-up|21|||
13286041|NCT00178126|26470846|FG001|Overall Study|Lost to Follow-up|21|||
13286042|NCT00178126|26470845|FG000|Overall Study|did not receive intervention|4|||
13308314|NCT01274338|26531434|FG005|Overall Study|Pregnancy|0|||
13308315|NCT01274338|26531429|FG000|Overall Study|Reason not reported|12|||
13308316|NCT01274338|26531430|FG001|Overall Study|Reason not reported|21|||
13308317|NCT01274338|26531431|FG002|Overall Study|Reason not reported|3|||
13308318|NCT01274338|26531432|FG003|Overall Study|Reason not reported|0|||
13308319|NCT01274338|26531433|FG004|Overall Study|Reason not reported|1|||
13308320|NCT01274338|26531434|FG005|Overall Study|Reason not reported|0|||
13308321|NCT01273818|26531452|FG000|Overall Study|Physician Decision|13|||
13308322|NCT01273818|26531453|FG001|Overall Study|Physician Decision|2|||
13308323|NCT01273818|26531454|FG002|Overall Study|Physician Decision|9|||
13286043|NCT00178126|26470846|FG001|Overall Study|did not receive intervention|6|||
13308324|NCT01273155|26531542|FG000|Overall Study|Off study trmt prior to end of C1/PD|2|||
13308325|NCT01273155|26531543|FG001|Overall Study|Off study trmt prior to end of C1/PD|3|||
13308326|NCT01273155|26531544|FG002|Overall Study|Off study trmt prior to end of C1/PD|8|||
13308327|NCT01273155|26531545|FG003|Overall Study|Off study trmt prior to end of C1/PD|0|||
13286044|NCT00177307|26470855|FG000|Overall Study|Withdrawal by Subject|1|||
13286045|NCT00177294|26470868|FG000|Overall Study|Withdrawal by Subject|7|||
13286046|NCT00177294|26470869|FG001|Overall Study|Withdrawal by Subject|5|||
13286047|NCT00177216|26470893|FG000|Overall Study|Withdrawal by Subject|6|||
13286048|NCT00177216|26470894|FG001|Overall Study|Withdrawal by Subject|3|||
13286049|NCT00177216|26470895|FG002|Overall Study|Withdrawal by Subject|1|||
13286050|NCT00177164|26470914|FG000|Overall Study|Protocol Violation|0|||
13286051|NCT00177164|26470915|FG001|Overall Study|Protocol Violation|7|||
13286052|NCT00177164|26470914|FG000|Overall Study|Lost to Follow-up|4|||
13286053|NCT00177164|26470915|FG001|Overall Study|Lost to Follow-up|5|||
13286054|NCT00177164|26470914|FG000|Overall Study|increase in alcohol and drug use|1|||
13286055|NCT00177164|26470915|FG001|Overall Study|increase in alcohol and drug use|2|||
13286056|NCT00177164|26470914|FG000|Overall Study|Adverse Event|1|||
13286057|NCT00177164|26470915|FG001|Overall Study|Adverse Event|0|||
13286058|NCT00177164|26470914|FG000|Overall Study|discharge from hospital|1|||
13286059|NCT00177164|26470915|FG001|Overall Study|discharge from hospital|0|||
13286060|NCT00177164|26470914|FG000|Overall Study|Lack of Efficacy|2|||
13286061|NCT00177164|26470915|FG001|Overall Study|Lack of Efficacy|1|||
13286062|NCT00177164|26470914|FG000|Overall Study|Pregnancy|0|||
13286063|NCT00177164|26470915|FG001|Overall Study|Pregnancy|1|||
13286064|NCT00176644|26470925|FG000|Overall Study|Withdrawal by Subject|1|||
13286065|NCT00176605|26470932|FG000|Overall Study|Withdrawal by Subject|2|||
13286066|NCT00176488|26470940|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1|||
13286067|NCT00176462|26470954|FG000|Induction (4 Weeks)|Withdrawal by Subject|0|||
13286068|NCT00176462|26470955|FG001|Induction (4 Weeks)|Withdrawal by Subject|2|||
13286069|NCT00176462|26470954|FG000|Induction (4 Weeks)|Death|1|||
13286070|NCT00176462|26470955|FG001|Induction (4 Weeks)|Death|2|||
13286071|NCT00176462|26470954|FG000|Induction (4 Weeks)|Lack of Efficacy|0|||
13286072|NCT00176462|26470955|FG001|Induction (4 Weeks)|Lack of Efficacy|1|||
13286073|NCT00176462|26470954|FG000|Consolidation (12 Weeks)|Patient moved to another state|0|||
13286074|NCT00176462|26470955|FG001|Consolidation (12 Weeks)|Patient moved to another state|1|||
13286075|NCT00176462|26470954|FG000|Consolidation (12 Weeks)|Adverse Event|0|||
13286076|NCT00176462|26470955|FG001|Consolidation (12 Weeks)|Adverse Event|1|||
13286077|NCT00176462|26470954|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0|||
13286078|NCT00176462|26470955|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2|||
13286079|NCT00176462|26470954|FG000|Consolidation (12 Weeks)|Not documented|0|||
13286080|NCT00176462|26470955|FG001|Consolidation (12 Weeks)|Not documented|1|||
13286081|NCT00176462|26470954|FG000|Intensive Continuation (8X8-week Cycles)|Death|1|||
13286082|NCT00176462|26470955|FG001|Intensive Continuation (8X8-week Cycles)|Death|0|||
13286083|NCT00176462|26470954|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0|||
13286084|NCT00176462|26470955|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3|||
13286085|NCT00176254|26470965|FG000|Overall Study|Lost to Follow-up|1|||
13286086|NCT00175825|26471028|FG000|Overall Study|Adverse Event|3|||
13286087|NCT00175825|26471029|FG001|Overall Study|Adverse Event|2|||
13286088|NCT00175825|26471030|FG002|Overall Study|Adverse Event|1|||
13286089|NCT00175825|26471031|FG003|Overall Study|Adverse Event|1|||
13286090|NCT00175825|26471028|FG000|Overall Study|Lost to Follow-up|1|||
13286091|NCT00175825|26471029|FG001|Overall Study|Lost to Follow-up|2|||
13286092|NCT00175825|26471030|FG002|Overall Study|Lost to Follow-up|0|||
13286093|NCT00175825|26471031|FG003|Overall Study|Lost to Follow-up|0|||
13286094|NCT00175825|26471028|FG000|Overall Study|Withdrawal by Subject|1|||
13286095|NCT00175825|26471029|FG001|Overall Study|Withdrawal by Subject|0|||
13286096|NCT00175825|26471030|FG002|Overall Study|Withdrawal by Subject|0|||
13286097|NCT00175825|26471031|FG003|Overall Study|Withdrawal by Subject|0|||
13286098|NCT00175019|26471085|FG000|Overall Study|Adverse Event|54|||
13286099|NCT00175019|26471086|FG001|Overall Study|Adverse Event|22|||
13286100|NCT00175019|26471087|FG002|Overall Study|Adverse Event|2|||
13286101|NCT00175019|26471085|FG000|Overall Study|Protocol Violation|6|||
13286102|NCT00175019|26471086|FG001|Overall Study|Protocol Violation|3|||
13286103|NCT00175019|26471087|FG002|Overall Study|Protocol Violation|3|||
13286104|NCT00175019|26471085|FG000|Overall Study|Lost to Follow-up|42|||
13286105|NCT00175019|26471086|FG001|Overall Study|Lost to Follow-up|39|||
13286106|NCT00175019|26471087|FG002|Overall Study|Lost to Follow-up|9|||
13286107|NCT00175019|26471085|FG000|Overall Study|Did not continue under Amendment 4|1|||
13286108|NCT00175019|26471086|FG001|Overall Study|Did not continue under Amendment 4|1|||
13286109|NCT00175019|26471087|FG002|Overall Study|Did not continue under Amendment 4|2|||
13286110|NCT00175019|26471085|FG000|Overall Study|Personal Reason(s)|39|||
13286111|NCT00175019|26471086|FG001|Overall Study|Personal Reason(s)|31|||
13286112|NCT00175019|26471087|FG002|Overall Study|Personal Reason(s)|8|||
13286113|NCT00175019|26471085|FG000|Overall Study|Therapeutic Failure|10|||
13286114|NCT00175019|26471086|FG001|Overall Study|Therapeutic Failure|38|||
13286115|NCT00175019|26471087|FG002|Overall Study|Therapeutic Failure|22|||
13286116|NCT00175019|26471085|FG000|Overall Study|Gout Flare|2|||
13286117|NCT00175019|26471086|FG001|Overall Study|Gout Flare|3|||
13286118|NCT00175019|26471087|FG002|Overall Study|Gout Flare|0|||
13286119|NCT00175019|26471085|FG000|Overall Study|Reason Not Specified|40|||
13286120|NCT00175019|26471086|FG001|Overall Study|Reason Not Specified|34|||
13286121|NCT00175019|26471087|FG002|Overall Study|Reason Not Specified|11|||
13286122|NCT00174967|26471146|FG000|Overall Study|Adverse Event|1|||
13286123|NCT00174967|26471147|FG001|Overall Study|Adverse Event|2|||
13286124|NCT00174967|26471148|FG002|Overall Study|Adverse Event|2|||
13286125|NCT00174967|26471149|FG003|Overall Study|Adverse Event|1|||
13286126|NCT00174967|26471146|FG000|Overall Study|Gout Flare|0|||
13286127|NCT00174967|26471147|FG001|Overall Study|Gout Flare|0|||
13286128|NCT00174967|26471148|FG002|Overall Study|Gout Flare|0|||
13286129|NCT00174967|26471149|FG003|Overall Study|Gout Flare|1|||
13286130|NCT00174967|26471146|FG000|Overall Study|Other|0|||
13286131|NCT00174967|26471147|FG001|Overall Study|Other|1|||
13286132|NCT00174967|26471148|FG002|Overall Study|Other|0|||
13286133|NCT00174967|26471149|FG003|Overall Study|Other|0|||
13286134|NCT00174954|26471156|FG000|Overall Study|Adverse Event|2|||
13286135|NCT00174954|26471156|FG000|Overall Study|No tophi found in MRI|1|||
13286136|NCT00174954|26471156|FG000|Overall Study|Physician Decision|1|||
13286137|NCT00174941|26471237|FG000|Overall Study|Adverse Event|1|||
13286138|NCT00174941|26471238|FG001|Overall Study|Adverse Event|10|||
13286139|NCT00174941|26471239|FG002|Overall Study|Adverse Event|2|||
13286140|NCT00174941|26471240|FG003|Overall Study|Adverse Event|13|||
13286141|NCT00174941|26471237|FG000|Overall Study|Protocol Violation|0|||
13286142|NCT00174941|26471238|FG001|Overall Study|Protocol Violation|1|||
13286143|NCT00174941|26471239|FG002|Overall Study|Protocol Violation|0|||
13286144|NCT00174941|26471240|FG003|Overall Study|Protocol Violation|1|||
13286145|NCT00174941|26471237|FG000|Overall Study|Lost to Follow-up|0|||
13286146|NCT00174941|26471238|FG001|Overall Study|Lost to Follow-up|3|||
13286147|NCT00174941|26471239|FG002|Overall Study|Lost to Follow-up|2|||
13286148|NCT00174941|26471240|FG003|Overall Study|Lost to Follow-up|5|||
13286149|NCT00174941|26471237|FG000|Overall Study|Personal Reason(s)|0|||
13286150|NCT00174941|26471238|FG001|Overall Study|Personal Reason(s)|14|||
13286151|NCT00174941|26471239|FG002|Overall Study|Personal Reason(s)|8|||
13286152|NCT00174941|26471240|FG003|Overall Study|Personal Reason(s)|22|||
13286153|NCT00174941|26471237|FG000|Overall Study|Gout Flare|0|||
13286154|NCT00174941|26471238|FG001|Overall Study|Gout Flare|4|||
13286155|NCT00174941|26471239|FG002|Overall Study|Gout Flare|4|||
13286156|NCT00174941|26471240|FG003|Overall Study|Gout Flare|8|||
13286157|NCT00174941|26471237|FG000|Overall Study|Reason Not Specified|1|||
13286158|NCT00174941|26471238|FG001|Overall Study|Reason Not Specified|6|||
13286159|NCT00174941|26471239|FG002|Overall Study|Reason Not Specified|2|||
13286160|NCT00174941|26471240|FG003|Overall Study|Reason Not Specified|9|||
13286161|NCT00174915|26471313|FG000|Overall Study|Lost to Follow-up|19|||
13286162|NCT00174915|26471314|FG001|Overall Study|Lost to Follow-up|17|||
13286163|NCT00174915|26471315|FG002|Overall Study|Lost to Follow-up|9|||
13286164|NCT00174915|26471316|FG003|Overall Study|Lost to Follow-up|17|||
13286165|NCT00174915|26471317|FG004|Overall Study|Lost to Follow-up|10|||
13286166|NCT00174915|26471313|FG000|Overall Study|Adverse Event|18|||
13286167|NCT00174915|26471314|FG001|Overall Study|Adverse Event|16|||
13286168|NCT00174915|26471315|FG002|Overall Study|Adverse Event|11|||
13286169|NCT00174915|26471316|FG003|Overall Study|Adverse Event|18|||
13286170|NCT00174915|26471317|FG004|Overall Study|Adverse Event|5|||
13286171|NCT00174915|26471313|FG000|Overall Study|Personal Reason(s)|16|||
13286172|NCT00174915|26471314|FG001|Overall Study|Personal Reason(s)|16|||
13286173|NCT00174915|26471315|FG002|Overall Study|Personal Reason(s)|9|||
13286174|NCT00174915|26471316|FG003|Overall Study|Personal Reason(s)|9|||
13286175|NCT00174915|26471317|FG004|Overall Study|Personal Reason(s)|9|||
13286176|NCT00174915|26471313|FG000|Overall Study|Other|15|||
13286177|NCT00174915|26471314|FG001|Overall Study|Other|8|||
13286178|NCT00174915|26471315|FG002|Overall Study|Other|6|||
13286179|NCT00174915|26471316|FG003|Overall Study|Other|5|||
13286180|NCT00174915|26471317|FG004|Overall Study|Other|3|||
13286181|NCT00174915|26471313|FG000|Overall Study|Gout Flare|13|||
13286182|NCT00174915|26471314|FG001|Overall Study|Gout Flare|6|||
13286183|NCT00174915|26471315|FG002|Overall Study|Gout Flare|8|||
13286184|NCT00174915|26471316|FG003|Overall Study|Gout Flare|1|||
13286185|NCT00174915|26471317|FG004|Overall Study|Gout Flare|0|||
13286186|NCT00174915|26471313|FG000|Overall Study|Protocol Violation|6|||
13286187|NCT00174915|26471314|FG001|Overall Study|Protocol Violation|3|||
13286188|NCT00174915|26471315|FG002|Overall Study|Protocol Violation|3|||
13286189|NCT00174915|26471316|FG003|Overall Study|Protocol Violation|6|||
13286190|NCT00174915|26471317|FG004|Overall Study|Protocol Violation|3|||
13286191|NCT00174915|26471313|FG000|Overall Study|Therapeutic Failure|6|||
13286192|NCT00174915|26471314|FG001|Overall Study|Therapeutic Failure|3|||
13286193|NCT00174915|26471315|FG002|Overall Study|Therapeutic Failure|2|||
13286194|NCT00174915|26471316|FG003|Overall Study|Therapeutic Failure|1|||
13286195|NCT00174915|26471317|FG004|Overall Study|Therapeutic Failure|3|||
13286196|NCT00174265|26471332|FG000|Overall Study|Adverse Event|7|||
13286197|NCT00174265|26471333|FG001|Overall Study|Adverse Event|4|||
13286198|NCT00174265|26471332|FG000|Overall Study|Lack of Efficacy|2|||
13286199|NCT00174265|26471333|FG001|Overall Study|Lack of Efficacy|2|||
13286200|NCT00174265|26471332|FG000|Overall Study|Withdrawal by Subject|3|||
13286201|NCT00174265|26471333|FG001|Overall Study|Withdrawal by Subject|5|||
13286202|NCT00174265|26471332|FG000|Overall Study|Lost to Follow-up|1|||
13308328|NCT01273155|26531546|FG004|Overall Study|Off study trmt prior to end of C1/PD|0|||
13286203|NCT00174265|26471333|FG001|Overall Study|Lost to Follow-up|0|||
13286204|NCT00174265|26471332|FG000|Overall Study|Other (Not specified)|16|||
13286205|NCT00174265|26471333|FG001|Overall Study|Other (Not specified)|10|||
13286206|NCT00172185|26471360|FG000|Overall Study|Adverse Event|0|||
13286207|NCT00172185|26471361|FG001|Overall Study|Adverse Event|1|||
13286208|NCT00172185|26471362|FG002|Overall Study|Adverse Event|3|||
13286209|NCT00172185|26471363|FG003|Overall Study|Adverse Event|4|||
13286210|NCT00172185|26471360|FG000|Overall Study|Physician Decision|0|||
13286211|NCT00172185|26471361|FG001|Overall Study|Physician Decision|0|||
13286212|NCT00172185|26471362|FG002|Overall Study|Physician Decision|1|||
13286213|NCT00172185|26471363|FG003|Overall Study|Physician Decision|0|||
13286214|NCT00172185|26471360|FG000|Overall Study|SPONSOR Decision|0|||
13286215|NCT00172185|26471361|FG001|Overall Study|SPONSOR Decision|1|||
13286216|NCT00172185|26471362|FG002|Overall Study|SPONSOR Decision|0|||
13286217|NCT00172185|26471363|FG003|Overall Study|SPONSOR Decision|0|||
13286218|NCT00172185|26471360|FG000|Overall Study|Withdrawal by Subject|0|||
13286219|NCT00172185|26471361|FG001|Overall Study|Withdrawal by Subject|0|||
13286220|NCT00172185|26471362|FG002|Overall Study|Withdrawal by Subject|1|||
13286221|NCT00172185|26471363|FG003|Overall Study|Withdrawal by Subject|0|||
13286222|NCT00172042|26471390|FG000|Overall Study|Adverse Event|27|||
13286223|NCT00172042|26471391|FG001|Overall Study|Adverse Event|13|||
13286224|NCT00172042|26471390|FG000|Overall Study|Abnormal laboratory value(s)|5|||
13286225|NCT00172042|26471391|FG001|Overall Study|Abnormal laboratory value(s)|1|||
13286226|NCT00172042|26471390|FG000|Overall Study|Abnormal test procedure(s)|0|||
13286227|NCT00172042|26471391|FG001|Overall Study|Abnormal test procedure(s)|3|||
13286228|NCT00172042|26471390|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
13286229|NCT00172042|26471391|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
13286230|NCT00172042|26471390|FG000|Overall Study|Patient no longer requires study drug|10|||
13286231|NCT00172042|26471391|FG001|Overall Study|Patient no longer requires study drug|8|||
13286232|NCT00172042|26471390|FG000|Overall Study|Protocol Violation|8|||
13286233|NCT00172042|26471391|FG001|Overall Study|Protocol Violation|7|||
13286234|NCT00172042|26471390|FG000|Overall Study|Withdrawal by Subject|37|||
13286235|NCT00172042|26471391|FG001|Overall Study|Withdrawal by Subject|25|||
13286236|NCT00172042|26471390|FG000|Overall Study|Lost to Follow-up|3|||
13286237|NCT00172042|26471391|FG001|Overall Study|Lost to Follow-up|5|||
13286238|NCT00172042|26471390|FG000|Overall Study|Administrative problems|13|||
13286239|NCT00172042|26471391|FG001|Overall Study|Administrative problems|10|||
13286240|NCT00172042|26471390|FG000|Overall Study|Death|42|||
13286241|NCT00172042|26471391|FG001|Overall Study|Death|42|||
13286242|NCT00171951|26471405|FG000|Overall Study|Adverse Event|1|||
13286243|NCT00171951|26471405|FG000|Overall Study|Abnormal Laboratory Values|2|||
13286244|NCT00171951|26471405|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
13286245|NCT00171951|26471405|FG000|Overall Study|Participants Withdrew Consent|3|||
13286246|NCT00171951|26471405|FG000|Overall Study|New Cancer Therapy|5|||
13286247|NCT00171951|26471405|FG000|Overall Study|Reason not Specified|2|||
13286248|NCT00171925|26471422|FG000|Overall Study|Adverse Event|10|||
13286249|NCT00171925|26471423|FG001|Overall Study|Adverse Event|6|||
13286250|NCT00171925|26471422|FG000|Overall Study|Protocol Violation|1|||
13286251|NCT00171925|26471423|FG001|Overall Study|Protocol Violation|1|||
13286252|NCT00171925|26471422|FG000|Overall Study|Withdrawal by Subject|6|||
13286253|NCT00171925|26471423|FG001|Overall Study|Withdrawal by Subject|9|||
13286254|NCT00171925|26471422|FG000|Overall Study|Lost to Follow-up|2|||
13286255|NCT00171925|26471423|FG001|Overall Study|Lost to Follow-up|2|||
13286256|NCT00171925|26471422|FG000|Overall Study|Administrative problems|10|||
13286257|NCT00171925|26471423|FG001|Overall Study|Administrative problems|11|||
13286258|NCT00171925|26471422|FG000|Overall Study|Death|1|||
13286259|NCT00171925|26471423|FG001|Overall Study|Death|2|||
13286260|NCT00171873|26471436|FG000|Overall Study|Withdrawal by Subject|4|||
13286261|NCT00171873|26471437|FG001|Overall Study|Withdrawal by Subject|2|||
13286262|NCT00171873|26471436|FG000|Overall Study|Adverse Event|5|||
13286263|NCT00171873|26471437|FG001|Overall Study|Adverse Event|0|||
13286264|NCT00171873|26471436|FG000|Overall Study|Switched to Octreotide|0|||
13286265|NCT00171873|26471437|FG001|Overall Study|Switched to Octreotide|1|||
13286266|NCT00171834|26471497|FG000|Overall Study|Adverse Event|2|||
13286267|NCT00171834|26471498|FG001|Overall Study|Adverse Event|1|||
13286268|NCT00171834|26471499|FG002|Overall Study|Adverse Event|3|||
13286269|NCT00171834|26471500|FG003|Overall Study|Adverse Event|2|||
13286270|NCT00171834|26471501|FG004|Overall Study|Adverse Event|2|||
13286271|NCT00171834|26471502|FG005|Overall Study|Adverse Event|15|||
13286272|NCT00171834|26471503|FG006|Overall Study|Adverse Event|1|||
13286273|NCT00171834|26471497|FG000|Overall Study|Withdrawal by Subject|0|||
13286274|NCT00171834|26471498|FG001|Overall Study|Withdrawal by Subject|2|||
13286275|NCT00171834|26471499|FG002|Overall Study|Withdrawal by Subject|0|||
13286276|NCT00171834|26471500|FG003|Overall Study|Withdrawal by Subject|1|||
13286277|NCT00171834|26471501|FG004|Overall Study|Withdrawal by Subject|1|||
13286278|NCT00171834|26471502|FG005|Overall Study|Withdrawal by Subject|1|||
13286279|NCT00171834|26471503|FG006|Overall Study|Withdrawal by Subject|0|||
13286280|NCT00171834|26471497|FG000|Overall Study|Death from study indication|0|||
13286281|NCT00171834|26471498|FG001|Overall Study|Death from study indication|1|||
13286282|NCT00171834|26471499|FG002|Overall Study|Death from study indication|0|||
13286283|NCT00171834|26471500|FG003|Overall Study|Death from study indication|0|||
13286284|NCT00171834|26471501|FG004|Overall Study|Death from study indication|1|||
13286285|NCT00171834|26471502|FG005|Overall Study|Death from study indication|0|||
13286286|NCT00171834|26471503|FG006|Overall Study|Death from study indication|0|||
13286287|NCT00171834|26471497|FG000|Overall Study|Disease Progression|4|||
13286288|NCT00171834|26471498|FG001|Overall Study|Disease Progression|8|||
13286289|NCT00171834|26471499|FG002|Overall Study|Disease Progression|8|||
13286290|NCT00171834|26471500|FG003|Overall Study|Disease Progression|9|||
13286291|NCT00171834|26471501|FG004|Overall Study|Disease Progression|2|||
13286292|NCT00171834|26471502|FG005|Overall Study|Disease Progression|18|||
13286293|NCT00171834|26471503|FG006|Overall Study|Disease Progression|3|||
13286294|NCT00171834|26471497|FG000|Overall Study|Treatment Duration Completed|0|||
13286295|NCT00171834|26471498|FG001|Overall Study|Treatment Duration Completed|0|||
13286296|NCT00171834|26471499|FG002|Overall Study|Treatment Duration Completed|1|||
13286297|NCT00171834|26471500|FG003|Overall Study|Treatment Duration Completed|0|||
13286298|NCT00171834|26471501|FG004|Overall Study|Treatment Duration Completed|2|||
13286299|NCT00171834|26471502|FG005|Overall Study|Treatment Duration Completed|1|||
13286300|NCT00171834|26471503|FG006|Overall Study|Treatment Duration Completed|0|||
13286301|NCT00171704|26471530|FG000|Overall Study|Adverse Event|24|||
13286302|NCT00171704|26471531|FG001|Overall Study|Adverse Event|33|||
13286303|NCT00171704|26471530|FG000|Overall Study|Disease Progression|14|||
13286304|NCT00171704|26471531|FG001|Overall Study|Disease Progression|9|||
13286305|NCT00171704|26471530|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1|||
13286306|NCT00171704|26471531|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0|||
13286307|NCT00171704|26471530|FG000|Overall Study|Administrative Problems|2|||
13286308|NCT00171704|26471531|FG001|Overall Study|Administrative Problems|1|||
13286309|NCT00171704|26471530|FG000|Overall Study|Death|2|||
13286310|NCT00171704|26471531|FG001|Overall Study|Death|2|||
13286311|NCT00171704|26471530|FG000|Overall Study|Withdrawal by Subject|1|||
13286312|NCT00171704|26471531|FG001|Overall Study|Withdrawal by Subject|3|||
13286313|NCT00171704|26471530|FG000|Overall Study|Protocol Violation|0|||
13286314|NCT00171704|26471531|FG001|Overall Study|Protocol Violation|1|||
13292191|NCT00708032|26484780|FG000|Overall Study|Protocol Violation|4|||
13292192|NCT00708032|26484781|FG001|Overall Study|Protocol Violation|1|||
13292193|NCT00708032|26484780|FG000|Overall Study|Withdrawal by Subject|0|||
13292194|NCT00708032|26484781|FG001|Overall Study|Withdrawal by Subject|1|||
13292195|NCT00707993|26484830|FG000|Overall Study|Adverse Event|16|||
13292196|NCT00707993|26484831|FG001|Overall Study|Adverse Event|20|||
13292197|NCT00707993|26484830|FG000|Overall Study|Protocol Violation|4|||
13292198|NCT00707993|26484831|FG001|Overall Study|Protocol Violation|7|||
13292199|NCT00707993|26484830|FG000|Overall Study|Lost to Follow-up|0|||
13292200|NCT00707993|26484831|FG001|Overall Study|Lost to Follow-up|4|||
13292201|NCT00707993|26484830|FG000|Overall Study|Withdrawal by Subject|12|||
13292202|NCT00707993|26484831|FG001|Overall Study|Withdrawal by Subject|16|||
13292203|NCT00707993|26484830|FG000|Overall Study|Hyperglycemic Rescue|55|||
13292204|NCT00707993|26484831|FG001|Overall Study|Hyperglycemic Rescue|47|||
13292205|NCT00707993|26484830|FG000|Overall Study|Other|2|||
13292206|NCT00707993|26484831|FG001|Overall Study|Other|0|||
13292207|NCT00707980|26484848|FG000|Overall Study|Adverse Event|49|||
13292208|NCT00707980|26484848|FG000|Overall Study|Lack of Efficacy|35|||
13292209|NCT00707980|26484848|FG000|Overall Study|Non-Compliance with Study Drug|28|||
13292210|NCT00707980|26484848|FG000|Overall Study|Protocol Deviations|19|||
13292211|NCT00707980|26484848|FG000|Overall Study|Withdrawal of Consent|81|||
13292212|NCT00707980|26484848|FG000|Overall Study|Lost to Follow-up|59|||
13292213|NCT00707980|26484848|FG000|Overall Study|Other|39|||
13292214|NCT00707954|26484876|FG000|Overall Study|Physician Decision|0|||
13292215|NCT00707954|26484877|FG001|Overall Study|Physician Decision|0|||
13292216|NCT00707954|26484878|FG002|Overall Study|Physician Decision|0|||
13292217|NCT00707954|26484879|FG003|Overall Study|Physician Decision|0|||
13292218|NCT00707954|26484880|FG004|Overall Study|Physician Decision|1|||
13292219|NCT00707577|26484893|FG000|Overall Study|Withdrawal by Subject|3|||
13292220|NCT00707577|26484894|FG001|Overall Study|Withdrawal by Subject|2|||
13292221|NCT00707577|26484893|FG000|Overall Study|Lost to Follow-up|34|||
13292222|NCT00707577|26484894|FG001|Overall Study|Lost to Follow-up|25|||
13292223|NCT00707577|26484893|FG000|Overall Study|Left employment|13|||
13292224|NCT00707577|26484894|FG001|Overall Study|Left employment|10|||
13292225|NCT00707577|26484893|FG000|Overall Study|Pregnancy|4|||
13292226|NCT00707577|26484894|FG001|Overall Study|Pregnancy|1|||
13292227|NCT00707486|26484905|FG000|Overall Study|Withdrawal by Subject|1|||
13292228|NCT00707434|26484911|FG000|Overall Study|Adverse Event|1|||
13292229|NCT00707174|26484924|FG000|Overall Study|Adverse Event|1|||
13286315|NCT00171340|26471552|FG000|Overall Study|Adverse Event|46|||
13286316|NCT00171340|26471553|FG001|Overall Study|Adverse Event|42|||
13286317|NCT00171340|26471552|FG000|Overall Study|Lack of Efficacy|29|||
13286318|NCT00171340|26471553|FG001|Overall Study|Lack of Efficacy|41|||
13286319|NCT00171340|26471552|FG000|Overall Study|Protocol Violation|7|||
13286320|NCT00171340|26471553|FG001|Overall Study|Protocol Violation|8|||
13286321|NCT00171340|26471552|FG000|Overall Study|Withdrawal by Subject|22|||
13286322|NCT00171340|26471553|FG001|Overall Study|Withdrawal by Subject|19|||
13286323|NCT00171340|26471552|FG000|Overall Study|Lost to Follow-up|0|||
13286324|NCT00171340|26471553|FG001|Overall Study|Lost to Follow-up|5|||
13286325|NCT00171340|26471552|FG000|Overall Study|Abnormal Laboratory Results|2|||
13286326|NCT00171340|26471553|FG001|Overall Study|Abnormal Laboratory Results|0|||
13286327|NCT00171340|26471552|FG000|Overall Study|Abnormal Test Procedure Results|6|||
13286328|NCT00171340|26471553|FG001|Overall Study|Abnormal Test Procedure Results|11|||
13286329|NCT00171340|26471552|FG000|Overall Study|No Longer Required Study Drug|1|||
13286330|NCT00171340|26471553|FG001|Overall Study|No Longer Required Study Drug|1|||
13286331|NCT00171340|26471552|FG000|Overall Study|Administrative Problems|5|||
13286332|NCT00171340|26471553|FG001|Overall Study|Administrative Problems|2|||
13286333|NCT00171340|26471552|FG000|Overall Study|Death|6|||
13286334|NCT00171340|26471553|FG001|Overall Study|Death|6|||
13286335|NCT00171314|26471574|FG000|Overall Study|Adverse Event|44|||
13286336|NCT00171314|26471575|FG001|Overall Study|Adverse Event|41|||
13286337|NCT00171314|26471574|FG000|Overall Study|Lack of Efficacy|19|||
13286338|NCT00171314|26471575|FG001|Overall Study|Lack of Efficacy|14|||
13286339|NCT00171314|26471574|FG000|Overall Study|Withdrawal by Subject|9|||
13286340|NCT00171314|26471575|FG001|Overall Study|Withdrawal by Subject|6|||
13286341|NCT00171314|26471574|FG000|Overall Study|Abnormal Test Procedure Results|9|||
13286342|NCT00171314|26471575|FG001|Overall Study|Abnormal Test Procedure Results|3|||
13286343|NCT00171314|26471574|FG000|Overall Study|Protocol Violation|3|||
13286344|NCT00171314|26471575|FG001|Overall Study|Protocol Violation|7|||
13286345|NCT00171314|26471574|FG000|Overall Study|Administrative Problems|4|||
13286346|NCT00171314|26471575|FG001|Overall Study|Administrative Problems|3|||
13286347|NCT00171314|26471574|FG000|Overall Study|Lost to Follow-up|1|||
13286348|NCT00171314|26471575|FG001|Overall Study|Lost to Follow-up|3|||
13286349|NCT00171314|26471574|FG000|Overall Study|Death|2|||
13286350|NCT00171314|26471575|FG001|Overall Study|Death|1|||
13286351|NCT00171301|26471593|FG000|Overall Study|Death|1|||
13286352|NCT00171301|26471594|FG001|Overall Study|Death|2|||
13286353|NCT00171301|26471593|FG000|Overall Study|Adverse Event|1|||
13286354|NCT00171301|26471594|FG001|Overall Study|Adverse Event|2|||
13286355|NCT00171301|26471593|FG000|Overall Study|Lost to Follow-up|6|||
13286356|NCT00171301|26471594|FG001|Overall Study|Lost to Follow-up|2|||
13286357|NCT00171301|26471593|FG000|Overall Study|Protocol Violation|0|||
13286358|NCT00171301|26471594|FG001|Overall Study|Protocol Violation|2|||
13286359|NCT00171301|26471593|FG000|Overall Study|Withdrawal by Subject|0|||
13286360|NCT00171301|26471594|FG001|Overall Study|Withdrawal by Subject|1|||
13286361|NCT00171249|26471621|FG000|Overall Study|Withdrawal by Subject|2|||
13286362|NCT00171249|26471622|FG001|Overall Study|Withdrawal by Subject|0|||
13286363|NCT00171249|26471623|FG002|Overall Study|Withdrawal by Subject|0|||
13286364|NCT00171249|26471624|FG003|Overall Study|Withdrawal by Subject|6|||
13286365|NCT00171249|26471625|FG004|Overall Study|Withdrawal by Subject|0|||
13286366|NCT00171249|26471626|FG005|Overall Study|Withdrawal by Subject|0|||
13286367|NCT00171249|26471627|FG006|Overall Study|Withdrawal by Subject|0|||
13286368|NCT00171249|26471621|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44|||
13286369|NCT00171249|26471622|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
13286370|NCT00171249|26471623|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5|||
13286371|NCT00171249|26471624|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70|||
13286372|NCT00171249|26471625|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3|||
13286373|NCT00171249|26471626|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31|||
13286374|NCT00171249|26471627|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1|||
13286375|NCT00171249|26471621|FG000|Overall Study|Death|7|||
13286376|NCT00171249|26471622|FG001|Overall Study|Death|1|||
13286377|NCT00171249|26471623|FG002|Overall Study|Death|0|||
13286378|NCT00171249|26471624|FG003|Overall Study|Death|4|||
13286379|NCT00171249|26471625|FG004|Overall Study|Death|0|||
13286380|NCT00171249|26471626|FG005|Overall Study|Death|3|||
13286381|NCT00171249|26471627|FG006|Overall Study|Death|1|||
13286382|NCT00171249|26471621|FG000|Overall Study|Other|10|||
13286383|NCT00171249|26471622|FG001|Overall Study|Other|0|||
13286384|NCT00171249|26471623|FG002|Overall Study|Other|0|||
13286385|NCT00171249|26471624|FG003|Overall Study|Other|43|||
13286386|NCT00171249|26471625|FG004|Overall Study|Other|0|||
13286387|NCT00171249|26471626|FG005|Overall Study|Other|2|||
13286388|NCT00171249|26471627|FG006|Overall Study|Other|0|||
13286389|NCT00171249|26471621|FG000|Overall Study|No Longer Requires Study Drug|4|||
13286390|NCT00171249|26471622|FG001|Overall Study|No Longer Requires Study Drug|0|||
13286391|NCT00171249|26471623|FG002|Overall Study|No Longer Requires Study Drug|0|||
13286392|NCT00171249|26471624|FG003|Overall Study|No Longer Requires Study Drug|3|||
13292230|NCT00707174|26484925|FG001|Overall Study|Adverse Event|6|||
13286393|NCT00171249|26471625|FG004|Overall Study|No Longer Requires Study Drug|0|||
13286394|NCT00171249|26471626|FG005|Overall Study|No Longer Requires Study Drug|5|||
13286395|NCT00171249|26471627|FG006|Overall Study|No Longer Requires Study Drug|0|||
13286396|NCT00171249|26471621|FG000|Overall Study|Administrative Problems|1|||
13286397|NCT00171249|26471622|FG001|Overall Study|Administrative Problems|0|||
13286398|NCT00171249|26471623|FG002|Overall Study|Administrative Problems|0|||
13286399|NCT00171249|26471624|FG003|Overall Study|Administrative Problems|2|||
13286400|NCT00171249|26471625|FG004|Overall Study|Administrative Problems|0|||
13286401|NCT00171249|26471626|FG005|Overall Study|Administrative Problems|0|||
13286402|NCT00171249|26471627|FG006|Overall Study|Administrative Problems|0|||
13286403|NCT00171249|26471621|FG000|Overall Study|Adverse Event|3|||
13286404|NCT00171249|26471622|FG001|Overall Study|Adverse Event|1|||
13286405|NCT00171249|26471623|FG002|Overall Study|Adverse Event|0|||
13286406|NCT00171249|26471624|FG003|Overall Study|Adverse Event|15|||
13286407|NCT00171249|26471625|FG004|Overall Study|Adverse Event|0|||
13286408|NCT00171249|26471626|FG005|Overall Study|Adverse Event|2|||
13286409|NCT00171249|26471627|FG006|Overall Study|Adverse Event|0|||
13286410|NCT00171249|26471621|FG000|Overall Study|Lost to Follow-up|5|||
13286411|NCT00171249|26471622|FG001|Overall Study|Lost to Follow-up|0|||
13286412|NCT00171249|26471623|FG002|Overall Study|Lost to Follow-up|0|||
13286413|NCT00171249|26471624|FG003|Overall Study|Lost to Follow-up|9|||
13286414|NCT00171249|26471625|FG004|Overall Study|Lost to Follow-up|0|||
13286415|NCT00171249|26471626|FG005|Overall Study|Lost to Follow-up|0|||
13286416|NCT00171249|26471627|FG006|Overall Study|Lost to Follow-up|0|||
13286417|NCT00171223|26471661|FG000|Overall Study|Adverse Event (Non-fatal)|6|||
13286418|NCT00171223|26471662|FG001|Overall Study|Adverse Event (Non-fatal)|5|||
13286419|NCT00171223|26471663|FG002|Overall Study|Adverse Event (Non-fatal)|19|||
13286420|NCT00171223|26471661|FG000|Overall Study|Abnormal Laboratory Value (s)|4|||
13286421|NCT00171223|26471662|FG001|Overall Study|Abnormal Laboratory Value (s)|2|||
13286422|NCT00171223|26471663|FG002|Overall Study|Abnormal Laboratory Value (s)|3|||
13286423|NCT00171223|26471661|FG000|Overall Study|Abnormal Procedure|1|||
13286424|NCT00171223|26471662|FG001|Overall Study|Abnormal Procedure|0|||
13286425|NCT00171223|26471663|FG002|Overall Study|Abnormal Procedure|0|||
13286426|NCT00171223|26471661|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57|||
13286427|NCT00171223|26471662|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43|||
13286428|NCT00171223|26471663|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52|||
13286429|NCT00171223|26471661|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
13286430|NCT00171223|26471662|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4|||
13286431|NCT00171223|26471663|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
13286432|NCT00171223|26471661|FG000|Overall Study|Protocol Violation|2|||
13286433|NCT00171223|26471662|FG001|Overall Study|Protocol Violation|2|||
13286434|NCT00171223|26471663|FG002|Overall Study|Protocol Violation|3|||
13286435|NCT00171223|26471661|FG000|Overall Study|Participant Withdrew Consent|12|||
13286436|NCT00171223|26471662|FG001|Overall Study|Participant Withdrew Consent|21|||
13286437|NCT00171223|26471663|FG002|Overall Study|Participant Withdrew Consent|15|||
13286438|NCT00171223|26471661|FG000|Overall Study|Lost to Follow-up|5|||
13286439|NCT00171223|26471662|FG001|Overall Study|Lost to Follow-up|2|||
13286440|NCT00171223|26471663|FG002|Overall Study|Lost to Follow-up|3|||
13286441|NCT00171223|26471661|FG000|Overall Study|Administrative Problems|4|||
13286442|NCT00171223|26471662|FG001|Overall Study|Administrative Problems|7|||
13286443|NCT00171223|26471663|FG002|Overall Study|Administrative Problems|6|||
13286444|NCT00171223|26471661|FG000|Overall Study|Adverse Event (Serious Fatal)|6|||
13286445|NCT00171223|26471662|FG001|Overall Study|Adverse Event (Serious Fatal)|8|||
13286446|NCT00171223|26471663|FG002|Overall Study|Adverse Event (Serious Fatal)|9|||
13286447|NCT00171223|26471661|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41|||
13286448|NCT00171223|26471662|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47|||
13286449|NCT00171223|26471663|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58|||
13286450|NCT00171210|26471698|FG000|Overall Study|Adverse Event|16|||
13286451|NCT00171210|26471699|FG001|Overall Study|Adverse Event|27|||
13286452|NCT00171210|26471698|FG000|Overall Study|Abnormal laboratory value(s)|6|||
13286453|NCT00171210|26471699|FG001|Overall Study|Abnormal laboratory value(s)|3|||
13286454|NCT00171210|26471698|FG000|Overall Study|Abnormal test procedure result(s)|0|||
13286455|NCT00171210|26471699|FG001|Overall Study|Abnormal test procedure result(s)|1|||
13286456|NCT00171210|26471698|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
13286457|NCT00171210|26471699|FG001|Overall Study|Unsatisfactory therapeutic effect|15|||
13286458|NCT00171210|26471698|FG000|Overall Study|Protocol Violation|0|||
13286459|NCT00171210|26471699|FG001|Overall Study|Protocol Violation|2|||
13286460|NCT00171210|26471698|FG000|Overall Study|Withdrawal by Subject|32|||
13286461|NCT00171210|26471699|FG001|Overall Study|Withdrawal by Subject|30|||
13286462|NCT00171210|26471698|FG000|Overall Study|Lost to Follow-up|1|||
13286463|NCT00171210|26471699|FG001|Overall Study|Lost to Follow-up|0|||
13286464|NCT00171210|26471698|FG000|Overall Study|Administrative problems|1|||
13286465|NCT00171210|26471699|FG001|Overall Study|Administrative problems|1|||
13286466|NCT00171210|26471698|FG000|Overall Study|Death|2|||
13286467|NCT00171210|26471699|FG001|Overall Study|Death|3|||
13286468|NCT00171210|26471698|FG000|Overall Study|Stopped at end of core|0|||
13286469|NCT00171210|26471699|FG001|Overall Study|Stopped at end of core|32|||
13286470|NCT00171210|26471698|FG000|Overall Study|Stopped at end of extension 1|0|||
13286471|NCT00171210|26471699|FG001|Overall Study|Stopped at end of extension 1|1|||
13286472|NCT00171158|26471706|FG000|Core Study|Death|27|||
13286473|NCT00171158|26471706|FG000|Core Study|Unsatisfactory therapeutic effect|163|||
13286474|NCT00171158|26471706|FG000|Core Study|Protocol Violation|4|||
13286475|NCT00171158|26471706|FG000|Core Study|Administrative problems|1|||
13286476|NCT00171158|26471706|FG000|Core Study|Adverse event, non-fatal|21|||
13286477|NCT00171158|26471706|FG000|Core Study|Consent withdrawn by subject|6|||
13286478|NCT00171158|26471706|FG000|Core Study|No longer required drug (BMT)|14|||
13286479|NCT00171158|26471706|FG000|Core Study|Abnormal Laboratory Values|2|||
13286480|NCT00171158|26471706|FG000|Core Study|Lost to Follow-up|1|||
13286481|NCT00171158|26471706|FG000|E2 Extension|Other|7|||
13286482|NCT00171054|26471743|FG000|Overall Study|Protocol Violation|1|||
13286483|NCT00171054|26471744|FG001|Overall Study|Protocol Violation|2|||
13286484|NCT00171054|26471743|FG000|Overall Study|Patient withdrew consent|1|||
13286485|NCT00171054|26471744|FG001|Overall Study|Patient withdrew consent|0|||
13286486|NCT00171054|26471743|FG000|Overall Study|Lost to Follow-up|0|||
13286487|NCT00171054|26471744|FG001|Overall Study|Lost to Follow-up|1|||
13286488|NCT00171054|26471743|FG000|Overall Study|Adverse Event|8|||
13286489|NCT00171054|26471744|FG001|Overall Study|Adverse Event|8|||
13286490|NCT00171054|26471743|FG000|Overall Study|Condition no longer required study drug|0|||
13286491|NCT00171054|26471744|FG001|Overall Study|Condition no longer required study drug|1|||
13286492|NCT00170846|26471768|FG000|Overall Study|Subject withdrew Informed Consent|5|||
13286493|NCT00170846|26471769|FG001|Overall Study|Subject withdrew Informed Consent|12|||
13286494|NCT00170846|26471770|FG002|Overall Study|Subject withdrew Informed Consent|8|||
13286495|NCT00170846|26471768|FG000|Overall Study|Lost to Follow-up|6|||
13286496|NCT00170846|26471769|FG001|Overall Study|Lost to Follow-up|3|||
13286497|NCT00170846|26471770|FG002|Overall Study|Lost to Follow-up|2|||
13286498|NCT00170846|26471768|FG000|Overall Study|Death|0|||
13286499|NCT00170846|26471769|FG001|Overall Study|Death|3|||
13286500|NCT00170846|26471770|FG002|Overall Study|Death|3|||
13286501|NCT00170846|26471768|FG000|Overall Study|Reason Missing|0|||
13286502|NCT00170846|26471769|FG001|Overall Study|Reason Missing|1|||
13286503|NCT00170846|26471770|FG002|Overall Study|Reason Missing|0|||
13286504|NCT00479882|26471913|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96|||
13286505|NCT00479882|26471914|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99|||
13286506|NCT00479882|26471915|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98|||
13286507|NCT00479882|26471916|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87|||
13286508|NCT00479882|26471913|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0|||
13286509|NCT00479882|26471914|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
13286510|NCT00479882|26471915|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
13286511|NCT00479882|26471916|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
13286512|NCT00479882|26471913|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12|||
13286513|NCT00479882|26471914|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
13286514|NCT00479882|26471915|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
13286515|NCT00479882|26471916|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11|||
13286516|NCT00479882|26471913|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4|||
13286517|NCT00479882|26471914|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6|||
13286518|NCT00479882|26471915|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9|||
13286519|NCT00479882|26471916|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5|||
13286520|NCT00479882|26471913|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0|||
13286521|NCT00479882|26471914|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4|||
13286522|NCT00479882|26471915|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2|||
13286523|NCT00479882|26471916|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1|||
13286524|NCT00479882|26471913|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24|||
13286525|NCT00479882|26471914|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33|||
13286526|NCT00479882|26471915|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30|||
13286527|NCT00479882|26471916|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25|||
13286528|NCT00479882|26471913|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2|||
13286529|NCT00479882|26471914|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
13286530|NCT00479882|26471915|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5|||
13286531|NCT00479882|26471916|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
13286532|NCT00479882|26471913|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
13286533|NCT00479882|26471914|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13|||
13286534|NCT00479882|26471915|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
13286535|NCT00479882|26471916|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10|||
13286536|NCT00479882|26471913|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3|||
13286537|NCT00479882|26471914|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1|||
13286538|NCT00479882|26471915|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
13286539|NCT00479882|26471916|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
13286540|NCT00479882|26471913|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
13286541|NCT00479882|26471914|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2|||
13286542|NCT00479882|26471915|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
13286543|NCT00479882|26471916|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
13286544|NCT00479882|26471913|FG000|Crossover: Period III (Weeks 13-20)|Other|5|||
13286545|NCT00479882|26471914|FG001|Crossover: Period III (Weeks 13-20)|Other|0|||
13286546|NCT00479882|26471915|FG002|Crossover: Period III (Weeks 13-20)|Other|2|||
13286547|NCT00479882|26471916|FG003|Crossover: Period III (Weeks 13-20)|Other|2|||
13286548|NCT00479882|26471913|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
13286549|NCT00479882|26471914|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2|||
13286550|NCT00479882|26471915|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
13286551|NCT00479882|26471916|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0|||
13286552|NCT00479882|26471913|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
13286553|NCT00479882|26471914|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
13286554|NCT00479882|26471915|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1|||
13286555|NCT00479882|26471916|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
13286556|NCT00479882|26471913|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
13286557|NCT00479882|26471914|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
13286558|NCT00479882|26471915|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1|||
13286559|NCT00479882|26471916|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
13286560|NCT00479856|26471927|FG000|Overall Study|Adverse Event|1|||
13286561|NCT00479856|26471927|FG000|Overall Study|Withdrawal by Subject|1|||
13286562|NCT00479856|26471927|FG000|Overall Study|Physician Decision|1|||
13286563|NCT00479765|26471933|FG000|Overall Study|study terminated|4|||
13286564|NCT00479687|26471948|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
13286565|NCT00479687|26471949|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2|||
13286566|NCT00479687|26471950|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
13286567|NCT00479687|26471948|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0|||
13286568|NCT00479687|26471949|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1|||
13286569|NCT00479687|26471950|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0|||
13286570|NCT00479687|26471948|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4|||
13286571|NCT00479687|26471949|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5|||
13286572|NCT00479687|26471950|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0|||
13286573|NCT00479687|26471948|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2|||
13286574|NCT00479687|26471949|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
13286575|NCT00479687|26471950|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
13286576|NCT00479687|26471948|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19|||
13286577|NCT00479687|26471949|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11|||
13286578|NCT00479687|26471950|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0|||
13286579|NCT00479687|26471948|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
13286580|NCT00479687|26471949|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
13286581|NCT00479687|26471950|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4|||
13286582|NCT00479687|26471948|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
13286583|NCT00479687|26471949|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
13121959|NCT02970669|25945506|FG001|Double-blind Period|Study terminated by sponsor|2|||
13121960|NCT02970669|25945505|FG000|Double-blind Period|Physician Decision|0|||
13121961|NCT02970669|25945506|FG001|Double-blind Period|Physician Decision|2|||
13121962|NCT02970669|25945505|FG000|Double-blind Period|Withdrawal by Subject|2|||
13286584|NCT00479687|26471950|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3|||
13286585|NCT00479687|26471948|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
13286586|NCT00479687|26471949|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
13286587|NCT00479687|26471950|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1|||
13286588|NCT00479687|26471948|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
13286589|NCT00479687|26471949|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
13286590|NCT00479687|26471950|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1|||
13121963|NCT02970669|25945506|FG001|Double-blind Period|Withdrawal by Subject|2|||
13121964|NCT02970669|25945505|FG000|Open-label Period|Withdrawal by Subject|2|||
13286591|NCT00479674|26471960|FG000|Overall Study|Adverse Event|18|||
13286592|NCT00479674|26471960|FG000|Overall Study|Withdrawal by Subject|6|||
13286593|NCT00479674|26471960|FG000|Overall Study|Physician Decision|14|||
13286594|NCT00479674|26471960|FG000|Overall Study|none provided|3|||
13286595|NCT00479466|26472005|FG000|Overall Study|Adverse Event|5|||
13286596|NCT00479466|26472006|FG001|Overall Study|Adverse Event|1|||
13286597|NCT00479466|26472007|FG002|Overall Study|Adverse Event|0|||
13286598|NCT00479466|26472008|FG003|Overall Study|Adverse Event|1|||
13286599|NCT00479466|26472009|FG004|Overall Study|Adverse Event|2|||
13286600|NCT00479466|26472010|FG005|Overall Study|Adverse Event|0|||
13286601|NCT00479466|26472005|FG000|Overall Study|Hyperglycemia|0|||
13286602|NCT00479466|26472006|FG001|Overall Study|Hyperglycemia|0|||
13286603|NCT00479466|26472007|FG002|Overall Study|Hyperglycemia|0|||
13286604|NCT00479466|26472008|FG003|Overall Study|Hyperglycemia|0|||
13286605|NCT00479466|26472009|FG004|Overall Study|Hyperglycemia|0|||
13286606|NCT00479466|26472010|FG005|Overall Study|Hyperglycemia|1|||
13286607|NCT00479466|26472005|FG000|Overall Study|Lack of Efficacy|2|||
13286608|NCT00479466|26472006|FG001|Overall Study|Lack of Efficacy|0|||
13286609|NCT00479466|26472007|FG002|Overall Study|Lack of Efficacy|1|||
13286610|NCT00479466|26472008|FG003|Overall Study|Lack of Efficacy|0|||
13286611|NCT00479466|26472009|FG004|Overall Study|Lack of Efficacy|0|||
13286612|NCT00479466|26472010|FG005|Overall Study|Lack of Efficacy|0|||
13286613|NCT00479466|26472005|FG000|Overall Study|Lost to Follow-up|0|||
13286614|NCT00479466|26472006|FG001|Overall Study|Lost to Follow-up|1|||
13286615|NCT00479466|26472007|FG002|Overall Study|Lost to Follow-up|1|||
13286616|NCT00479466|26472008|FG003|Overall Study|Lost to Follow-up|0|||
13286617|NCT00479466|26472009|FG004|Overall Study|Lost to Follow-up|2|||
13286618|NCT00479466|26472010|FG005|Overall Study|Lost to Follow-up|2|||
13286619|NCT00479466|26472005|FG000|Overall Study|Physician Decision|2|||
13286620|NCT00479466|26472006|FG001|Overall Study|Physician Decision|1|||
13286621|NCT00479466|26472007|FG002|Overall Study|Physician Decision|1|||
13286622|NCT00479466|26472008|FG003|Overall Study|Physician Decision|0|||
13286623|NCT00479466|26472009|FG004|Overall Study|Physician Decision|0|||
13286624|NCT00479466|26472010|FG005|Overall Study|Physician Decision|0|||
13286625|NCT00479466|26472005|FG000|Overall Study|Pregnancy|0|||
13286626|NCT00479466|26472006|FG001|Overall Study|Pregnancy|0|||
13286627|NCT00479466|26472007|FG002|Overall Study|Pregnancy|0|||
13286628|NCT00479466|26472008|FG003|Overall Study|Pregnancy|0|||
13286629|NCT00479466|26472009|FG004|Overall Study|Pregnancy|1|||
13286630|NCT00479466|26472010|FG005|Overall Study|Pregnancy|0|||
13286631|NCT00479466|26472005|FG000|Overall Study|Protocol Violation|1|||
13286632|NCT00479466|26472006|FG001|Overall Study|Protocol Violation|0|||
13286633|NCT00479466|26472007|FG002|Overall Study|Protocol Violation|0|||
13286634|NCT00479466|26472008|FG003|Overall Study|Protocol Violation|0|||
13286635|NCT00479466|26472009|FG004|Overall Study|Protocol Violation|0|||
13286636|NCT00479466|26472010|FG005|Overall Study|Protocol Violation|0|||
13286637|NCT00479466|26472005|FG000|Overall Study|Withdrawal by Subject|3|||
13286638|NCT00479466|26472006|FG001|Overall Study|Withdrawal by Subject|5|||
13286639|NCT00479466|26472007|FG002|Overall Study|Withdrawal by Subject|0|||
13286640|NCT00479466|26472008|FG003|Overall Study|Withdrawal by Subject|2|||
13286641|NCT00479466|26472009|FG004|Overall Study|Withdrawal by Subject|3|||
13286642|NCT00479466|26472010|FG005|Overall Study|Withdrawal by Subject|1|||
13286643|NCT00479401|26472073|FG000|Overall Study|Adverse Event|24|||
13286644|NCT00479401|26472074|FG001|Overall Study|Adverse Event|20|||
13286645|NCT00479401|26472075|FG002|Overall Study|Adverse Event|4|||
13286646|NCT00479401|26472073|FG000|Overall Study|Lack of Efficacy|2|||
13286647|NCT00479401|26472074|FG001|Overall Study|Lack of Efficacy|2|||
13286648|NCT00479401|26472075|FG002|Overall Study|Lack of Efficacy|4|||
13286649|NCT00479401|26472073|FG000|Overall Study|Protocol Violation|2|||
13286650|NCT00479401|26472074|FG001|Overall Study|Protocol Violation|1|||
13286651|NCT00479401|26472075|FG002|Overall Study|Protocol Violation|1|||
13286652|NCT00479401|26472073|FG000|Overall Study|Lost to Follow-up|1|||
13286653|NCT00479401|26472074|FG001|Overall Study|Lost to Follow-up|1|||
13286654|NCT00479401|26472075|FG002|Overall Study|Lost to Follow-up|1|||
13286655|NCT00479401|26472073|FG000|Overall Study|Withdrawal by Subject|16|||
13286656|NCT00479401|26472074|FG001|Overall Study|Withdrawal by Subject|10|||
13286657|NCT00479401|26472075|FG002|Overall Study|Withdrawal by Subject|2|||
13286658|NCT00479401|26472073|FG000|Overall Study|Exclusion criteria, relocation|4|||
13286659|NCT00479401|26472074|FG001|Overall Study|Exclusion criteria, relocation|3|||
13286660|NCT00479401|26472075|FG002|Overall Study|Exclusion criteria, relocation|0|||
13286661|NCT00479388|26472092|FG000|Overall Study|Adverse Event|90|||
13286662|NCT00479388|26472093|FG001|Overall Study|Adverse Event|45|||
13286663|NCT00479388|26472092|FG000|Overall Study|Lost to Follow-up|0|||
13286664|NCT00479388|26472093|FG001|Overall Study|Lost to Follow-up|2|||
13286665|NCT00479388|26472092|FG000|Overall Study|Protocol Violation|10|||
13286666|NCT00479388|26472093|FG001|Overall Study|Protocol Violation|9|||
13286667|NCT00479388|26472092|FG000|Overall Study|Withdrawal by Subject|32|||
13286668|NCT00479388|26472093|FG001|Overall Study|Withdrawal by Subject|17|||
13286669|NCT00479336|26472120|FG000|Overall Study|Adverse Event|1|||
13286670|NCT00479336|26472121|FG001|Overall Study|Adverse Event|1|||
13286671|NCT00479336|26472122|FG002|Overall Study|Adverse Event|1|||
13286672|NCT00479336|26472123|FG003|Overall Study|Adverse Event|3|||
13286673|NCT00479336|26472120|FG000|Overall Study|Lack of Efficacy|1|||
13286674|NCT00479336|26472121|FG001|Overall Study|Lack of Efficacy|0|||
13286675|NCT00479336|26472122|FG002|Overall Study|Lack of Efficacy|0|||
13286676|NCT00479336|26472123|FG003|Overall Study|Lack of Efficacy|0|||
13286677|NCT00479336|26472120|FG000|Overall Study|Protocol Violation|0|||
13286678|NCT00479336|26472121|FG001|Overall Study|Protocol Violation|1|||
13286679|NCT00479336|26472122|FG002|Overall Study|Protocol Violation|0|||
13286680|NCT00479336|26472123|FG003|Overall Study|Protocol Violation|0|||
13286681|NCT00479336|26472120|FG000|Overall Study|Withdrawal by Subject|1|||
13286682|NCT00479336|26472121|FG001|Overall Study|Withdrawal by Subject|2|||
13286683|NCT00479336|26472122|FG002|Overall Study|Withdrawal by Subject|0|||
13286684|NCT00479336|26472123|FG003|Overall Study|Withdrawal by Subject|0|||
13286685|NCT00479336|26472120|FG000|Overall Study|Physician Decision|0|||
13286686|NCT00479336|26472121|FG001|Overall Study|Physician Decision|1|||
13286687|NCT00479336|26472122|FG002|Overall Study|Physician Decision|0|||
13286688|NCT00479336|26472123|FG003|Overall Study|Physician Decision|2|||
13286689|NCT00479336|26472120|FG000|Overall Study|Resolution of all hepatic edema findings|1|||
13286690|NCT00479336|26472121|FG001|Overall Study|Resolution of all hepatic edema findings|1|||
13286691|NCT00479336|26472122|FG002|Overall Study|Resolution of all hepatic edema findings|0|||
13286692|NCT00479336|26472123|FG003|Overall Study|Resolution of all hepatic edema findings|0|||
13286693|NCT00479232|26472152|FG000|Overall Study|Adverse Event|0|||
13286694|NCT00479232|26472153|FG001|Overall Study|Adverse Event|0|||
13286695|NCT00479232|26472154|FG002|Overall Study|Adverse Event|5|||
13286696|NCT00479232|26472155|FG003|Overall Study|Adverse Event|0|||
13286697|NCT00479232|26472156|FG004|Overall Study|Adverse Event|0|||
13286698|NCT00479232|26472157|FG005|Overall Study|Adverse Event|10|||
13286699|NCT00479232|26472152|FG000|Overall Study|Deviation from Protocol|0|||
13286700|NCT00479232|26472153|FG001|Overall Study|Deviation from Protocol|0|||
13286701|NCT00479232|26472154|FG002|Overall Study|Deviation from Protocol|1|||
13286702|NCT00479232|26472155|FG003|Overall Study|Deviation from Protocol|0|||
13286703|NCT00479232|26472156|FG004|Overall Study|Deviation from Protocol|0|||
13286704|NCT00479232|26472157|FG005|Overall Study|Deviation from Protocol|0|||
13286705|NCT00479232|26472152|FG000|Overall Study|Lack of Efficacy|0|||
13286706|NCT00479232|26472153|FG001|Overall Study|Lack of Efficacy|0|||
13286707|NCT00479232|26472154|FG002|Overall Study|Lack of Efficacy|2|||
13286708|NCT00479232|26472155|FG003|Overall Study|Lack of Efficacy|0|||
13286709|NCT00479232|26472156|FG004|Overall Study|Lack of Efficacy|0|||
13286710|NCT00479232|26472157|FG005|Overall Study|Lack of Efficacy|4|||
13286711|NCT00479232|26472152|FG000|Overall Study|Physician Decision|0|||
13286712|NCT00479232|26472153|FG001|Overall Study|Physician Decision|0|||
13286713|NCT00479232|26472154|FG002|Overall Study|Physician Decision|2|||
13286714|NCT00479232|26472155|FG003|Overall Study|Physician Decision|0|||
13286715|NCT00479232|26472156|FG004|Overall Study|Physician Decision|0|||
13286716|NCT00479232|26472157|FG005|Overall Study|Physician Decision|1|||
13286717|NCT00479232|26472152|FG000|Overall Study|Progressive Disease|3|||
13286718|NCT00479232|26472153|FG001|Overall Study|Progressive Disease|1|||
13286719|NCT00479232|26472154|FG002|Overall Study|Progressive Disease|12|||
13286720|NCT00479232|26472155|FG003|Overall Study|Progressive Disease|3|||
13286721|NCT00479232|26472156|FG004|Overall Study|Progressive Disease|3|||
13286722|NCT00479232|26472157|FG005|Overall Study|Progressive Disease|12|||
13286723|NCT00479232|26472152|FG000|Overall Study|Withdrew Consent|0|||
13286724|NCT00479232|26472153|FG001|Overall Study|Withdrew Consent|2|||
13286725|NCT00479232|26472154|FG002|Overall Study|Withdrew Consent|6|||
13286726|NCT00479232|26472155|FG003|Overall Study|Withdrew Consent|0|||
13286727|NCT00479232|26472156|FG004|Overall Study|Withdrew Consent|1|||
13286728|NCT00479232|26472157|FG005|Overall Study|Withdrew Consent|3|||
13286729|NCT00478881|26472188|FG000|Overall Study|Adverse Event|31|||
13286730|NCT00478881|26472189|FG001|Overall Study|Adverse Event|12|||
13286731|NCT00478881|26472188|FG000|Overall Study|Lack of Efficacy|0|||
13286732|NCT00478881|26472189|FG001|Overall Study|Lack of Efficacy|3|||
13286733|NCT00478881|26472188|FG000|Overall Study|Lost to Follow-up|0|||
13286734|NCT00478881|26472189|FG001|Overall Study|Lost to Follow-up|1|||
13286735|NCT00478881|26472188|FG000|Overall Study|Protocol Violation|2|||
13286736|NCT00478881|26472189|FG001|Overall Study|Protocol Violation|2|||
13286737|NCT00478881|26472188|FG000|Overall Study|Withdrawal by Subject|6|||
13286738|NCT00478881|26472189|FG001|Overall Study|Withdrawal by Subject|2|||
13286739|NCT00478881|26472188|FG000|Overall Study|Non-Compliance with Study Medication|0|||
13286740|NCT00478881|26472189|FG001|Overall Study|Non-Compliance with Study Medication|2|||
13286741|NCT00478777|26472198|FG000|Overall Study|Adverse Event|29|||
13286742|NCT00478777|26472198|FG000|Overall Study|Lack of Efficacy|23|||
13286743|NCT00478777|26472198|FG000|Overall Study|Withdrawal by Subject|4|||
13286744|NCT00478777|26472198|FG000|Overall Study|Death|3|||
13286745|NCT00478777|26472198|FG000|Overall Study|Protocol Violation|3|||
13286746|NCT00478777|26472198|FG000|Overall Study|Lost to Follow-up|3|||
13286747|NCT00478777|26472198|FG000|Overall Study|Physician Decision|1|||
13286748|NCT00478777|26472198|FG000|Overall Study|Intolerance of therapy|1|||
13286749|NCT00478777|26472198|FG000|Overall Study|Lack of compliance|1|||
13286750|NCT00478777|26472198|FG000|Overall Study|Lymphocytes infusion|1|||
13286751|NCT00478777|26472198|FG000|Overall Study|End of therapy|2|||
13286752|NCT00478777|26472198|FG000|Overall Study|Not treated with lenalidomide|6|||
13286753|NCT00478647|26472208|FG000|Overall Study|Adverse Event|1|||
13286754|NCT00478647|26472208|FG000|Overall Study|Withdrawal by Subject|1|||
13286755|NCT00478608|26472218|FG000|Overall Study|Adverse Event|1|||
13286756|NCT00478608|26472218|FG000|Overall Study|Serious Adverse Event|14|||
13286757|NCT00478608|26472218|FG000|Overall Study|Withdrawal by Subject|2|||
13286758|NCT00478608|26472218|FG000|Overall Study|Protocol Violation|3|||
13286759|NCT00478257|26472231|FG000|Overall Study|Withdrawal by Subject|8|||
13286760|NCT00478257|26472232|FG001|Overall Study|Withdrawal by Subject|3|||
13286761|NCT00478244|26472247|FG000|Overall Study|Did not receive transplant|1|||
13286762|NCT00478205|26472266|FG000|Overall Study|Adverse Event|182|||
13286763|NCT00478205|26472267|FG001|Overall Study|Adverse Event|39|||
13286764|NCT00478205|26472266|FG000|Overall Study|Medication Non-compliance|9|||
13286765|NCT00478205|26472267|FG001|Overall Study|Medication Non-compliance|4|||
13286766|NCT00478205|26472266|FG000|Overall Study|Protocol Violation|15|||
13286767|NCT00478205|26472267|FG001|Overall Study|Protocol Violation|5|||
13286768|NCT00478205|26472266|FG000|Overall Study|Request of Investigator or Sponsor|4|||
13286769|NCT00478205|26472267|FG001|Overall Study|Request of Investigator or Sponsor|5|||
13286770|NCT00478205|26472266|FG000|Overall Study|Withdrawal by Subject|61|||
13286771|NCT00478205|26472267|FG001|Overall Study|Withdrawal by Subject|22|||
13286772|NCT00478205|26472266|FG000|Overall Study|Lack of Efficacy|1|||
13286773|NCT00478205|26472267|FG001|Overall Study|Lack of Efficacy|0|||
13286774|NCT00478205|26472266|FG000|Overall Study|Other|24|||
13286775|NCT00478205|26472267|FG001|Overall Study|Other|12|||
13286776|NCT00478140|26472276|FG000|Overall Study|Clinical Disease Progression|1|||
13286777|NCT00478023|26472309|FG000|Overall Study|Adverse Event|11|||
13286778|NCT00478023|26472310|FG001|Overall Study|Adverse Event|7|||
13286779|NCT00478023|26472311|FG002|Overall Study|Adverse Event|8|||
13286780|NCT00478023|26472312|FG003|Overall Study|Adverse Event|14|||
13286781|NCT00478023|26472313|FG004|Overall Study|Adverse Event|6|||
13286782|NCT00478023|26472309|FG000|Overall Study|Death|1|||
13286783|NCT00478023|26472310|FG001|Overall Study|Death|0|||
13286784|NCT00478023|26472311|FG002|Overall Study|Death|0|||
13286785|NCT00478023|26472312|FG003|Overall Study|Death|0|||
13286786|NCT00478023|26472313|FG004|Overall Study|Death|0|||
13286787|NCT00478023|26472309|FG000|Overall Study|Lack of Efficacy|11|||
13286788|NCT00478023|26472310|FG001|Overall Study|Lack of Efficacy|10|||
13286789|NCT00478023|26472311|FG002|Overall Study|Lack of Efficacy|4|||
13286790|NCT00478023|26472312|FG003|Overall Study|Lack of Efficacy|5|||
13286791|NCT00478023|26472313|FG004|Overall Study|Lack of Efficacy|41|||
13286792|NCT00478023|26472309|FG000|Overall Study|Lost to Follow-up|3|||
13286793|NCT00478023|26472310|FG001|Overall Study|Lost to Follow-up|1|||
13286794|NCT00478023|26472311|FG002|Overall Study|Lost to Follow-up|1|||
13286795|NCT00478023|26472312|FG003|Overall Study|Lost to Follow-up|1|||
13286796|NCT00478023|26472313|FG004|Overall Study|Lost to Follow-up|0|||
13286797|NCT00478023|26472309|FG000|Overall Study|Withdrawal by Subject|2|||
13286798|NCT00478023|26472310|FG001|Overall Study|Withdrawal by Subject|3|||
13286799|NCT00478023|26472311|FG002|Overall Study|Withdrawal by Subject|2|||
13286800|NCT00478023|26472312|FG003|Overall Study|Withdrawal by Subject|4|||
13286801|NCT00478023|26472313|FG004|Overall Study|Withdrawal by Subject|5|||
13286802|NCT00478023|26472309|FG000|Overall Study|Lack of pain, Technical difficulties|7|||
13286803|NCT00478023|26472310|FG001|Overall Study|Lack of pain, Technical difficulties|3|||
13286804|NCT00478023|26472311|FG002|Overall Study|Lack of pain, Technical difficulties|5|||
13286805|NCT00478023|26472312|FG003|Overall Study|Lack of pain, Technical difficulties|6|||
13286806|NCT00478023|26472313|FG004|Overall Study|Lack of pain, Technical difficulties|3|||
13286807|NCT00477971|26472332|FG000|Overall Study|Disease progression|6|||
13286808|NCT00477971|26472333|FG001|Overall Study|Disease progression|0|||
13286809|NCT00477971|26472332|FG000|Overall Study|Withdrawal by Subject|3|||
13286810|NCT00477971|26472333|FG001|Overall Study|Withdrawal by Subject|1|||
13286811|NCT00477971|26472332|FG000|Overall Study|Adverse Event|3|||
13286812|NCT00477971|26472333|FG001|Overall Study|Adverse Event|0|||
13286813|NCT00477971|26472332|FG000|Overall Study|Death|2|||
13286814|NCT00477971|26472333|FG001|Overall Study|Death|4|||
13286815|NCT00477971|26472332|FG000|Overall Study|Alternative treatment|3|||
13286816|NCT00477971|26472333|FG001|Overall Study|Alternative treatment|1|||
13308329|NCT01273155|26531547|FG005|Overall Study|Off study trmt prior to end of C1/PD|2|||
13308330|NCT01273155|26531548|FG006|Overall Study|Off study trmt prior to end of C1/PD|3|||
13308331|NCT01273155|26531542|FG000|Overall Study|Change in liver function/no longer eval.|0|||
13308332|NCT01273155|26531543|FG001|Overall Study|Change in liver function/no longer eval.|1|||
13308333|NCT01273155|26531544|FG002|Overall Study|Change in liver function/no longer eval.|0|||
13308334|NCT01273155|26531545|FG003|Overall Study|Change in liver function/no longer eval.|0|||
13308335|NCT01273155|26531546|FG004|Overall Study|Change in liver function/no longer eval.|1|||
13308336|NCT01273155|26531547|FG005|Overall Study|Change in liver function/no longer eval.|0|||
13308337|NCT01273155|26531548|FG006|Overall Study|Change in liver function/no longer eval.|0|||
13308338|NCT01273155|26531542|FG000|Overall Study|Off study prior to C1/due to toxicity|0|||
13308339|NCT01273155|26531543|FG001|Overall Study|Off study prior to C1/due to toxicity|0|||
13308340|NCT01273155|26531544|FG002|Overall Study|Off study prior to C1/due to toxicity|2|||
13308341|NCT01273155|26531545|FG003|Overall Study|Off study prior to C1/due to toxicity|0|||
13308342|NCT01273155|26531546|FG004|Overall Study|Off study prior to C1/due to toxicity|0|||
13308343|NCT01273155|26531547|FG005|Overall Study|Off study prior to C1/due to toxicity|0|||
13286817|NCT00477750|26472343|FG000|Overall Study|Currently Receiving Treatment|11|||
13308344|NCT01273155|26531548|FG006|Overall Study|Off study prior to C1/due to toxicity|1|||
13308345|NCT01273155|26531542|FG000|Overall Study|Died during Cycle 1|0|||
13308346|NCT01273155|26531543|FG001|Overall Study|Died during Cycle 1|0|||
13308347|NCT01273155|26531544|FG002|Overall Study|Died during Cycle 1|1|||
13308348|NCT01273155|26531545|FG003|Overall Study|Died during Cycle 1|1|||
13308349|NCT01273155|26531546|FG004|Overall Study|Died during Cycle 1|0|||
13308350|NCT01273155|26531547|FG005|Overall Study|Died during Cycle 1|2|||
13308351|NCT01273155|26531548|FG006|Overall Study|Died during Cycle 1|2|||
13308352|NCT01273155|26531542|FG000|Overall Study|Withdrew during C1/refused further trmt|0|||
13308353|NCT01273155|26531543|FG001|Overall Study|Withdrew during C1/refused further trmt|0|||
13308354|NCT01273155|26531544|FG002|Overall Study|Withdrew during C1/refused further trmt|1|||
13308355|NCT01273155|26531545|FG003|Overall Study|Withdrew during C1/refused further trmt|0|||
13308356|NCT01273155|26531546|FG004|Overall Study|Withdrew during C1/refused further trmt|1|||
13308357|NCT01273155|26531547|FG005|Overall Study|Withdrew during C1/refused further trmt|1|||
13308358|NCT01273155|26531548|FG006|Overall Study|Withdrew during C1/refused further trmt|0|||
13308359|NCT01272804|26531722|FG000|Overall Study|Adverse Event|1|||
13308360|NCT01272804|26531723|FG001|Overall Study|Adverse Event|0|||
13308361|NCT01272804|26531724|FG002|Overall Study|Adverse Event|0|||
13308362|NCT01272804|26531725|FG003|Overall Study|Adverse Event|0|||
13308363|NCT01272804|26531726|FG004|Overall Study|Adverse Event|2|||
13308364|NCT01272804|26531727|FG005|Overall Study|Adverse Event|1|||
13308365|NCT01272193|26531750|FG000|Overall Study|Adverse Event|1|||
13308366|NCT01272193|26531751|FG001|Overall Study|Adverse Event|1|||
13308367|NCT01272193|26531750|FG000|Overall Study|Lack of Efficacy|0|||
13308368|NCT01272193|26531751|FG001|Overall Study|Lack of Efficacy|3|||
13308369|NCT01272193|26531750|FG000|Overall Study|Withdrawal Criteria|1|||
13308370|NCT01272193|26531751|FG001|Overall Study|Withdrawal Criteria|1|||
13308371|NCT01272193|26531750|FG000|Overall Study|Unclassified|8|||
13308372|NCT01272193|26531751|FG001|Overall Study|Unclassified|7|||
13308373|NCT01271933|26531852|FG000|Single-Blind Phase|Lack of Efficacy|37|||
13308374|NCT01271933|26531853|FG001|Single-Blind Phase|Lack of Efficacy|0|||
13308375|NCT01271933|26531854|FG002|Single-Blind Phase|Lack of Efficacy|0|||
13308376|NCT01271933|26531852|FG000|Single-Blind Phase|Lost to Follow-up|10|||
13308377|NCT01271933|26531853|FG001|Single-Blind Phase|Lost to Follow-up|0|||
13308378|NCT01271933|26531854|FG002|Single-Blind Phase|Lost to Follow-up|0|||
13308379|NCT01271933|26531852|FG000|Single-Blind Phase|Withdrawal by Subject|15|||
13308380|NCT01271933|26531853|FG001|Single-Blind Phase|Withdrawal by Subject|0|||
13308381|NCT01271933|26531854|FG002|Single-Blind Phase|Withdrawal by Subject|0|||
13308382|NCT01271933|26531852|FG000|Single-Blind Phase|Protocol Violation|3|||
13308383|NCT01271933|26531853|FG001|Single-Blind Phase|Protocol Violation|0|||
13308384|NCT01271933|26531854|FG002|Single-Blind Phase|Protocol Violation|0|||
13308385|NCT01271933|26531852|FG000|Single-Blind Phase|Adverse Event|52|||
13308386|NCT01271933|26531853|FG001|Single-Blind Phase|Adverse Event|0|||
13308387|NCT01271933|26531854|FG002|Single-Blind Phase|Adverse Event|0|||
13308388|NCT01271933|26531852|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1|||
13308389|NCT01271933|26531853|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
13308390|NCT01271933|26531854|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
13308391|NCT01271933|26531852|FG000|Single-Blind Phase|(Protocol non-compliance)|2|||
13308392|NCT01271933|26531853|FG001|Single-Blind Phase|(Protocol non-compliance)|0|||
13308393|NCT01271933|26531854|FG002|Single-Blind Phase|(Protocol non-compliance)|0|||
13308394|NCT01271933|26531852|FG000|Single-Blind Phase|(Participant request-personal reason)|1|||
13308395|NCT01271933|26531853|FG001|Single-Blind Phase|(Participant request-personal reason)|0|||
13308396|NCT01271933|26531854|FG002|Single-Blind Phase|(Participant request-personal reason)|0|||
13308397|NCT01271933|26531852|FG000|Double-Blind Phase|Randomized but not treated|0|||
13308398|NCT01271933|26531853|FG001|Double-Blind Phase|Randomized but not treated|0|||
13308399|NCT01271933|26531854|FG002|Double-Blind Phase|Randomized but not treated|1|||
13308400|NCT01271933|26531852|FG000|Double-Blind Phase|Lack of Efficacy|0|||
13308401|NCT01271933|26531853|FG001|Double-Blind Phase|Lack of Efficacy|6|||
13308402|NCT01271933|26531854|FG002|Double-Blind Phase|Lack of Efficacy|9|||
13308403|NCT01271933|26531852|FG000|Double-Blind Phase|Lost to Follow-up|0|||
13308404|NCT01271933|26531853|FG001|Double-Blind Phase|Lost to Follow-up|1|||
13308405|NCT01271933|26531854|FG002|Double-Blind Phase|Lost to Follow-up|1|||
13308406|NCT01271933|26531852|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
13308407|NCT01271933|26531853|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
13308408|NCT01271933|26531854|FG002|Double-Blind Phase|Withdrawal by Subject|1|||
13308409|NCT01271933|26531852|FG000|Double-Blind Phase|Adverse Event|0|||
13308410|NCT01271933|26531853|FG001|Double-Blind Phase|Adverse Event|3|||
13308411|NCT01271933|26531854|FG002|Double-Blind Phase|Adverse Event|0|||
13308412|NCT01271933|26531852|FG000|Double-Blind Phase|Participant request-personal reason|0|||
13308413|NCT01271933|26531853|FG001|Double-Blind Phase|Participant request-personal reason|1|||
13308414|NCT01271933|26531854|FG002|Double-Blind Phase|Participant request-personal reason|0|||
13308415|NCT01270828|26531902|FG000|Pregabalin CR SB|Reason Unspecified|0|||
13308416|NCT01270828|26531903|FG001|Pregabalin CR SB|Reason Unspecified|0|||
13308417|NCT01270828|26531904|FG002|Pregabalin CR SB|Reason Unspecified|8|||
13308418|NCT01270828|26531902|FG000|Pregabalin CR SB|Enrolled but not treated|0|||
13308419|NCT01270828|26531903|FG001|Pregabalin CR SB|Enrolled but not treated|0|||
13308420|NCT01270828|26531904|FG002|Pregabalin CR SB|Enrolled but not treated|5|||
13308421|NCT01270828|26531902|FG000|Pregabalin CR SB|Related adverse event|0|||
13308422|NCT01270828|26531903|FG001|Pregabalin CR SB|Related adverse event|0|||
13308423|NCT01270828|26531904|FG002|Pregabalin CR SB|Related adverse event|46|||
13308424|NCT01270828|26531902|FG000|Pregabalin CR SB|Lack of Efficacy|0|||
13308425|NCT01270828|26531903|FG001|Pregabalin CR SB|Lack of Efficacy|0|||
13308426|NCT01270828|26531904|FG002|Pregabalin CR SB|Lack of Efficacy|32|||
13308427|NCT01270828|26531902|FG000|Pregabalin CR SB|Withdrawal by Subject|0|||
13308428|NCT01270828|26531903|FG001|Pregabalin CR SB|Withdrawal by Subject|0|||
13308429|NCT01270828|26531904|FG002|Pregabalin CR SB|Withdrawal by Subject|29|||
13308430|NCT01270828|26531902|FG000|Pregabalin CR SB|Lost to Follow-up|0|||
13308431|NCT01270828|26531903|FG001|Pregabalin CR SB|Lost to Follow-up|0|||
13308432|NCT01270828|26531904|FG002|Pregabalin CR SB|Lost to Follow-up|10|||
13308433|NCT01270828|26531902|FG000|Pregabalin CR SB|Unrelated AE|0|||
13308434|NCT01270828|26531903|FG001|Pregabalin CR SB|Unrelated AE|0|||
13308435|NCT01270828|26531904|FG002|Pregabalin CR SB|Unrelated AE|8|||
13308436|NCT01270828|26531902|FG000|Pregabalin CR SB|Protocol Violation|0|||
13308437|NCT01270828|26531903|FG001|Pregabalin CR SB|Protocol Violation|0|||
13308438|NCT01270828|26531904|FG002|Pregabalin CR SB|Protocol Violation|8|||
13308439|NCT01270828|26531902|FG000|Double Blind Phase|Death|0|||
13308440|NCT01270828|26531903|FG001|Double Blind Phase|Death|1|||
13308441|NCT01270828|26531904|FG002|Double Blind Phase|Death|0|||
13308442|NCT01270828|26531902|FG000|Double Blind Phase|Protocol Violation|0|||
13308443|NCT01270828|26531903|FG001|Double Blind Phase|Protocol Violation|1|||
13308444|NCT01270828|26531904|FG002|Double Blind Phase|Protocol Violation|0|||
13308445|NCT01270828|26531902|FG000|Double Blind Phase|Protocol and GCP non-compliance|4|||
13308446|NCT01270828|26531903|FG001|Double Blind Phase|Protocol and GCP non-compliance|3|||
13308447|NCT01270828|26531904|FG002|Double Blind Phase|Protocol and GCP non-compliance|0|||
13308448|NCT01270828|26531902|FG000|Double Blind Phase|Reason Unspecified|7|||
13308449|NCT01270828|26531903|FG001|Double Blind Phase|Reason Unspecified|4|||
13308450|NCT01270828|26531904|FG002|Double Blind Phase|Reason Unspecified|0|||
13308451|NCT01270828|26531902|FG000|Double Blind Phase|Withdrawal by Subject|6|||
13308452|NCT01270828|26531903|FG001|Double Blind Phase|Withdrawal by Subject|15|||
13308453|NCT01270828|26531904|FG002|Double Blind Phase|Withdrawal by Subject|0|||
13308454|NCT01270828|26531902|FG000|Double Blind Phase|Lost to Follow-up|1|||
13308455|NCT01270828|26531903|FG001|Double Blind Phase|Lost to Follow-up|2|||
13308456|NCT01270828|26531904|FG002|Double Blind Phase|Lost to Follow-up|0|||
13308457|NCT01270828|26531902|FG000|Double Blind Phase|Lack of Efficacy|2|||
13308458|NCT01270828|26531903|FG001|Double Blind Phase|Lack of Efficacy|11|||
13308459|NCT01270828|26531904|FG002|Double Blind Phase|Lack of Efficacy|0|||
13308460|NCT01270828|26531902|FG000|Double Blind Phase|Adverse event not related to study drug|1|||
13308461|NCT01270828|26531903|FG001|Double Blind Phase|Adverse event not related to study drug|1|||
13308462|NCT01270828|26531904|FG002|Double Blind Phase|Adverse event not related to study drug|0|||
13308463|NCT01270828|26531902|FG000|Double Blind Phase|Adverse event related to study drug|5|||
13308464|NCT01270828|26531903|FG001|Double Blind Phase|Adverse event related to study drug|7|||
13308465|NCT01270828|26531904|FG002|Double Blind Phase|Adverse event related to study drug|0|||
13308466|NCT01269918|26531943|FG000|Overall Study|Did not receive study drug|0|||
13308467|NCT01269918|26531944|FG001|Overall Study|Did not receive study drug|3|||
13308468|NCT01269385|26531963|FG000|Overall Study|Adverse Event|1|||
13308469|NCT01269385|26531964|FG001|Overall Study|Adverse Event|1|||
13308470|NCT01269385|26531965|FG002|Overall Study|Adverse Event|0|||
13308471|NCT01269385|26531966|FG003|Overall Study|Adverse Event|0|||
13308472|NCT01269346|26531976|FG000|Treatment Phase|Disease progression|3|||
13308473|NCT01269346|26531976|FG000|Treatment Phase|Adverse Event|3|||
13308474|NCT01269346|26531976|FG000|Treatment Phase|Withdrawal by Subject|1|||
13308475|NCT01269346|26531976|FG000|Treatment Phase|Other|2|||
13308476|NCT01269346|26531976|FG000|Extension Phase|Adverse Event|6|||
13308477|NCT01269346|26531976|FG000|Extension Phase|Withdrawal by Subject|4|||
13308478|NCT01269346|26531976|FG000|Extension Phase|Disease progression|22|||
13308479|NCT01269346|26531976|FG000|Extension Phase|Physician decision or participant choice|9|||
13308480|NCT01269346|26531976|FG000|Extension Phase|Clinical progression|1|||
13308481|NCT01269346|26531976|FG000|Extension Phase|Started a prohibited con med|1|||
13308482|NCT01269125|26532006|FG000|Overall Study|Adverse Event|3|||
13308483|NCT01269125|26532007|FG001|Overall Study|Adverse Event|5|||
13308484|NCT01269125|26532008|FG002|Overall Study|Adverse Event|0|||
13308485|NCT01269125|26532006|FG000|Overall Study|Lost to Follow-up|4|||
13308486|NCT01269125|26532007|FG001|Overall Study|Lost to Follow-up|0|||
13308487|NCT01269125|26532008|FG002|Overall Study|Lost to Follow-up|0|||
13308488|NCT01268891|26532027|FG000|Overall Study|Adverse Event|3|||
13308489|NCT01268891|26532028|FG001|Overall Study|Adverse Event|7|||
13308490|NCT01268891|26532027|FG000|Overall Study|Lack of Efficacy|1|||
13308491|NCT01268891|26532028|FG001|Overall Study|Lack of Efficacy|0|||
13308492|NCT01268891|26532027|FG000|Overall Study|Withdrawal of Consent|3|||
13308493|NCT01268891|26532028|FG001|Overall Study|Withdrawal of Consent|1|||
13308494|NCT01268891|26532027|FG000|Overall Study|Administrative or other reason(s)|1|||
13308495|NCT01268891|26532028|FG001|Overall Study|Administrative or other reason(s)|0|||
13308496|NCT01268683|26532053|FG000|Overall Study|Lost to Follow-up|1|||
13308497|NCT01268683|26532053|FG000|Overall Study|Death|1|||
13308498|NCT01268566|26532073|FG000|Overall Study|Lost to Follow-up|1|||
13308499|NCT01268566|26532073|FG000|Overall Study|Withdrawal by Subject|12|||
13308500|NCT01268566|26532073|FG000|Overall Study|Death|30|||
13308501|NCT01268514|26532084|FG000|Overall Study|Adverse Event|20|||
13308502|NCT01268514|26532084|FG000|Overall Study|Death|8|||
13308503|NCT01268514|26532084|FG000|Overall Study|Lost to Follow-up|5|||
13308504|NCT01268514|26532084|FG000|Overall Study|Withdrawal by Subject|3|||
13308505|NCT01268514|26532084|FG000|Overall Study|Withdrawal by Surgeon|5|||
13308506|NCT01268501|26532090|FG000|Overall Study|Lost to Follow-up|1|||
13308507|NCT01268501|26532090|FG000|Overall Study|Withdrawal by Subject|3|||
13308508|NCT01268501|26532090|FG000|Overall Study|Unacceptable Subjective Vision|3|||
13308509|NCT01268501|26532090|FG000|Overall Study|Handling Difficulties|2|||
13308510|NCT01268488|26532099|FG000|Overall Study|Adverse Event|3|||
13308511|NCT01268488|26532099|FG000|Overall Study|Physician Decision|2|||
13308512|NCT01268306|26532105|FG000|Overall Study|Lost to Follow-up|1|||
13308513|NCT01268293|26532112|FG000|Overall Study|Disease progression|7|||
13308514|NCT01268293|26532112|FG000|Overall Study|Adverse Event|1|||
13308515|NCT01268293|26532112|FG000|Overall Study|Subject choice|1|||
13308516|NCT01268267|26532121|FG000|Overall Study|Protocol Violation|1|||
13308517|NCT01268150|26532131|FG000|Treatment Phase|Progression of disease|18|||
13308518|NCT01268150|26532131|FG000|Treatment Phase|Adverse Event|3|||
13308519|NCT01268150|26532131|FG000|Treatment Phase|Withdrawal by Subject|3|||
13308520|NCT01268150|26532131|FG000|Treatment Phase|Other|4|||
13308521|NCT01268150|26532131|FG000|Extension Phase|Adverse Event|3|||
13308522|NCT01268150|26532131|FG000|Extension Phase|Disease progression|18|||
13308523|NCT01268150|26532131|FG000|Extension Phase|Other|6|||
13308524|NCT01268098|26532146|FG000|Overall Study|Adverse Event|1|||
13308525|NCT01268098|26532147|FG001|Overall Study|Adverse Event|0|||
13308526|NCT01268059|26532217|FG000|Overall Study|Lost to Follow-up|0|||
13308527|NCT01268059|26532218|FG001|Overall Study|Lost to Follow-up|1|||
13308528|NCT01268059|26532219|FG002|Overall Study|Lost to Follow-up|0|||
13308529|NCT01268059|26532220|FG003|Overall Study|Lost to Follow-up|0|||
13308530|NCT01268059|26532217|FG000|Overall Study|Withdrawal by Subject|7|||
13308531|NCT01268059|26532218|FG001|Overall Study|Withdrawal by Subject|4|||
13308532|NCT01268059|26532219|FG002|Overall Study|Withdrawal by Subject|0|||
13308533|NCT01268059|26532220|FG003|Overall Study|Withdrawal by Subject|0|||
13308534|NCT01268059|26532217|FG000|Overall Study|Death|20|||
13308535|NCT01268059|26532218|FG001|Overall Study|Death|30|||
13308536|NCT01268059|26532219|FG002|Overall Study|Death|3|||
13308537|NCT01268059|26532220|FG003|Overall Study|Death|5|||
13308538|NCT01268059|26532217|FG000|Overall Study|Progression of disease|1|||
13308539|NCT01268059|26532218|FG001|Overall Study|Progression of disease|0|||
13308540|NCT01268059|26532219|FG002|Overall Study|Progression of disease|0|||
13308541|NCT01268059|26532220|FG003|Overall Study|Progression of disease|0|||
13308542|NCT01268046|26532243|FG000|Overall Study|Withdrawal by Subject|1|||
13308543|NCT01268046|26532244|FG001|Overall Study|Withdrawal by Subject|0|||
13308544|NCT01268046|26532245|FG002|Overall Study|Withdrawal by Subject|0|||
13308545|NCT01268046|26532246|FG003|Overall Study|Withdrawal by Subject|1|||
13308546|NCT01268046|26532243|FG000|Overall Study|Lost to Follow-up|0|||
13308547|NCT01268046|26532244|FG001|Overall Study|Lost to Follow-up|0|||
13308548|NCT01268046|26532245|FG002|Overall Study|Lost to Follow-up|1|||
13308549|NCT01268046|26532246|FG003|Overall Study|Lost to Follow-up|0|||
13308550|NCT01267994|26532253|FG000|Overall Study|Adverse Event|2|||
13308551|NCT01267955|26532259|FG000|Stage 1 (6 Months)|Death|3|||
13308552|NCT01267955|26532259|FG000|Stage 2 (6 Months)|Death|5|||
13308553|NCT01267955|26532259|FG000|Stage 2 (6 Months)|Protocol Violation|1|||
13121965|NCT02970669|25945506|FG001|Open-label Period|Withdrawal by Subject|2|||
13308554|NCT01267825|26532276|FG000|Overall Study|study terminated. no data collected.|1|||
13308555|NCT01267825|26532277|FG001|Overall Study|study terminated. no data collected.|0|||
13308556|NCT01267266|26532293|FG000|Enrollment Phase|Withdrawal by Subject|2|||
13308557|NCT01267266|26532294|FG001|Enrollment Phase|Withdrawal by Subject|0|||
13308558|NCT01267266|26532293|FG000|Lead-in Phase|Lack of Efficacy|20|||
13308559|NCT01267266|26532294|FG001|Lead-in Phase|Lack of Efficacy|0|||
13308560|NCT01267266|26532293|FG000|Lead-in Phase|Adverse Event|2|||
13308561|NCT01267266|26532294|FG001|Lead-in Phase|Adverse Event|0|||
13308562|NCT01267266|26532293|FG000|Lead-in Phase|Withdrawal by Subject|1|||
13308563|NCT01267266|26532294|FG001|Lead-in Phase|Withdrawal by Subject|0|||
13308564|NCT01267253|26532304|FG000|Overall Study|Ineligible - required test not done|1|||
13308565|NCT01267253|26532304|FG000|Overall Study|Inevaluable-never received study treatme|2|||
13308566|NCT01267201|26532328|FG000|First Intervention Period|Withdrawal by Subject|1|||
13308567|NCT01267201|26532329|FG001|First Intervention Period|Withdrawal by Subject|0|||
13308568|NCT01267201|26532330|FG002|First Intervention Period|Withdrawal by Subject|0|||
13308569|NCT01267201|26532331|FG003|First Intervention Period|Withdrawal by Subject|0|||
13308570|NCT01267201|26532332|FG004|First Intervention Period|Withdrawal by Subject|0|||
13308571|NCT01267201|26532333|FG005|First Intervention Period|Withdrawal by Subject|0|||
13308572|NCT01267201|26532328|FG000|Second Intervention Period|Withdrawal by Subject|0|||
13308573|NCT01267201|26532329|FG001|Second Intervention Period|Withdrawal by Subject|1|||
13308574|NCT01267201|26532330|FG002|Second Intervention Period|Withdrawal by Subject|0|||
13308575|NCT01267201|26532331|FG003|Second Intervention Period|Withdrawal by Subject|0|||
13308576|NCT01267201|26532332|FG004|Second Intervention Period|Withdrawal by Subject|0|||
13308577|NCT01267201|26532333|FG005|Second Intervention Period|Withdrawal by Subject|0|||
13308578|NCT01267175|26532340|FG000|Overall Study|Withdrawal by Subject|1|||
13308579|NCT01267175|26532340|FG000|Overall Study|Lost to Follow-up|1|||
13308580|NCT01266993|26532415|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5|||
13308581|NCT01266993|26532416|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1|||
13308582|NCT01266993|26532415|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0|||
13308583|NCT01266993|26532416|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1|||
13308584|NCT01266967|26532470|FG000|Overall Study|Death|69|||
13308585|NCT01266967|26532471|FG001|Overall Study|Death|61|||
13308586|NCT01266967|26532470|FG000|Overall Study|Study Closed/Terminated|15|||
13308587|NCT01266967|26532471|FG001|Overall Study|Study Closed/Terminated|17|||
13308588|NCT01266967|26532470|FG000|Overall Study|Lost to Follow-up|2|||
13308589|NCT01266967|26532471|FG001|Overall Study|Lost to Follow-up|1|||
13308590|NCT01266967|26532470|FG000|Overall Study|Physician Decision|0|||
13308591|NCT01266967|26532471|FG001|Overall Study|Physician Decision|1|||
13308592|NCT01266967|26532470|FG000|Overall Study|Withdrawal by Subject|3|||
13308593|NCT01266967|26532471|FG001|Overall Study|Withdrawal by Subject|3|||
13308594|NCT01266902|26532499|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2|||
13308595|NCT01266902|26532500|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3|||
13308596|NCT01266902|26532501|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0|||
13308597|NCT01266902|26532499|FG000|Period 1 (Main Study)|Lost to Follow-up|5|||
13308598|NCT01266902|26532500|FG001|Period 1 (Main Study)|Lost to Follow-up|12|||
13308599|NCT01266902|26532501|FG002|Period 1 (Main Study)|Lost to Follow-up|0|||
13308600|NCT01266902|26532499|FG000|Period 1 (Main Study)|Lack of Efficacy|4|||
13308601|NCT01266902|26532500|FG001|Period 1 (Main Study)|Lack of Efficacy|2|||
13308602|NCT01266902|26532501|FG002|Period 1 (Main Study)|Lack of Efficacy|0|||
13308603|NCT01266902|26532499|FG000|Period 1 (Main Study)|Adverse Event|3|||
13308604|NCT01266902|26532500|FG001|Period 1 (Main Study)|Adverse Event|11|||
13308605|NCT01266902|26532501|FG002|Period 1 (Main Study)|Adverse Event|0|||
13308606|NCT01266902|26532499|FG000|Period 1 (Main Study)|Withdrawal by Subject|2|||
13308607|NCT01266902|26532500|FG001|Period 1 (Main Study)|Withdrawal by Subject|12|||
13308608|NCT01266902|26532501|FG002|Period 1 (Main Study)|Withdrawal by Subject|0|||
13308609|NCT01266902|26532499|FG000|Period 1 (Main Study)|Subject non-compliant|3|||
13308610|NCT01266902|26532500|FG001|Period 1 (Main Study)|Subject non-compliant|7|||
13308611|NCT01266902|26532501|FG002|Period 1 (Main Study)|Subject non-compliant|0|||
13308612|NCT01266902|26532499|FG000|Period 1 (Main Study)|Continued RPV treatment|11|||
13308613|NCT01266902|26532500|FG001|Period 1 (Main Study)|Continued RPV treatment|34|||
13308614|NCT01266902|26532501|FG002|Period 1 (Main Study)|Continued RPV treatment|0|||
13308615|NCT01266902|26532499|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
13308616|NCT01266902|26532500|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
13308617|NCT01266902|26532501|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1|||
13308618|NCT01266902|26532499|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
13308619|NCT01266902|26532500|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
13308620|NCT01266902|26532501|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1|||
13308621|NCT01266902|26532499|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
13308622|NCT01266902|26532500|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
13308623|NCT01266902|26532501|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6|||
13308624|NCT01266876|26532619|FG000|Overall Study|Adverse Event|0|||
13308625|NCT01266876|26532620|FG001|Overall Study|Adverse Event|0|||
13308626|NCT01266876|26532621|FG002|Overall Study|Adverse Event|0|||
13308627|NCT01266876|26532622|FG003|Overall Study|Adverse Event|1|||
13308628|NCT01266876|26532623|FG004|Overall Study|Adverse Event|0|||
13308629|NCT01266850|26532691|FG000|Overall Study|Lost to Follow-up|19|||
13308630|NCT01266850|26532692|FG001|Overall Study|Lost to Follow-up|19|||
13308631|NCT01266850|26532693|FG002|Overall Study|Lost to Follow-up|13|||
13308632|NCT01266850|26532694|FG003|Overall Study|Lost to Follow-up|13|||
13308633|NCT01266850|26532695|FG004|Overall Study|Lost to Follow-up|12|||
13308634|NCT01266850|26532691|FG000|Overall Study|Withdrawal by Subject|8|||
13308635|NCT01266850|26532692|FG001|Overall Study|Withdrawal by Subject|9|||
13308636|NCT01266850|26532693|FG002|Overall Study|Withdrawal by Subject|6|||
13308637|NCT01266850|26532694|FG003|Overall Study|Withdrawal by Subject|9|||
13308638|NCT01266850|26532695|FG004|Overall Study|Withdrawal by Subject|12|||
13308639|NCT01266850|26532691|FG000|Overall Study|Physician Decision|3|||
13308640|NCT01266850|26532692|FG001|Overall Study|Physician Decision|6|||
13308641|NCT01266850|26532693|FG002|Overall Study|Physician Decision|4|||
13308642|NCT01266850|26532694|FG003|Overall Study|Physician Decision|4|||
13308643|NCT01266850|26532695|FG004|Overall Study|Physician Decision|3|||
13308644|NCT01266850|26532691|FG000|Overall Study|Protocol Violation|0|||
13308645|NCT01266850|26532692|FG001|Overall Study|Protocol Violation|1|||
13308646|NCT01266850|26532693|FG002|Overall Study|Protocol Violation|0|||
13308647|NCT01266850|26532694|FG003|Overall Study|Protocol Violation|1|||
13308648|NCT01266850|26532695|FG004|Overall Study|Protocol Violation|2|||
13308649|NCT01266850|26532691|FG000|Overall Study|Adverse Event|0|||
13308650|NCT01266850|26532692|FG001|Overall Study|Adverse Event|0|||
13308651|NCT01266850|26532693|FG002|Overall Study|Adverse Event|0|||
13308652|NCT01266850|26532694|FG003|Overall Study|Adverse Event|0|||
13308653|NCT01266850|26532695|FG004|Overall Study|Adverse Event|1|||
13308654|NCT01266850|26532691|FG000|Overall Study|Site Closure|0|||
13308655|NCT01266850|26532692|FG001|Overall Study|Site Closure|1|||
13308656|NCT01266850|26532693|FG002|Overall Study|Site Closure|1|||
13308657|NCT01266850|26532694|FG003|Overall Study|Site Closure|1|||
13308658|NCT01266850|26532695|FG004|Overall Study|Site Closure|0|||
13372872|NCT00806260|26722172|FG001|Period 2|Need to take concomitant medication|0|||
13372873|NCT00806260|26722173|FG002|Period 2|Need to take concomitant medication|0|||
13121966|NCT02970669|25945505|FG000|Open-label Period|Adverse Event|1|||
13121967|NCT02970669|25945506|FG001|Open-label Period|Adverse Event|0|||
13121968|NCT02970669|25945505|FG000|Open-label Period|Physician Decision|1|||
13121969|NCT02970669|25945506|FG001|Open-label Period|Physician Decision|0|||
13121970|NCT02970305|25945543|FG000|Overall Study|Adverse Event|10|||
13121971|NCT02970305|25945544|FG001|Overall Study|Adverse Event|6|||
13121972|NCT02970305|25945543|FG000|Overall Study|Lack of Efficacy|1|||
13121973|NCT02970305|25945544|FG001|Overall Study|Lack of Efficacy|1|||
13121974|NCT02970305|25945543|FG000|Overall Study|Noncompliance with study drug|2|||
13121975|NCT02970305|25945544|FG001|Overall Study|Noncompliance with study drug|4|||
13121976|NCT02970305|25945543|FG000|Overall Study|Protocol Violation|2|||
13121977|NCT02970305|25945544|FG001|Overall Study|Protocol Violation|2|||
13121978|NCT02970305|25945543|FG000|Overall Study|Withdrawal by Subject|12|||
13121979|NCT02970305|25945544|FG001|Overall Study|Withdrawal by Subject|11|||
13121980|NCT02970305|25945543|FG000|Overall Study|Not further specified|1|||
13121981|NCT02970305|25945544|FG001|Overall Study|Not further specified|2|||
13121982|NCT02970305|25945543|FG000|Overall Study|Lost to Follow-up|1|||
13121983|NCT02970305|25945544|FG001|Overall Study|Lost to Follow-up|2|||
13121984|NCT02970292|25945573|FG000|Overall Study|Physician Decision|1|||
13121985|NCT02970292|25945574|FG001|Overall Study|Physician Decision|1|||
13121986|NCT02970292|25945573|FG000|Overall Study|Withdrawal by Subject|11|||
13121987|NCT02970292|25945574|FG001|Overall Study|Withdrawal by Subject|5|||
13121988|NCT02970292|25945573|FG000|Overall Study|Noncompliance with study drug|2|||
13121989|NCT02970292|25945574|FG001|Overall Study|Noncompliance with study drug|2|||
13121990|NCT02970292|25945573|FG000|Overall Study|Adverse Event|5|||
13121991|NCT02970292|25945574|FG001|Overall Study|Adverse Event|0|||
13121992|NCT02970292|25945573|FG000|Overall Study|Lack of Efficacy|1|||
13121993|NCT02970292|25945574|FG001|Overall Study|Lack of Efficacy|0|||
13372874|NCT00806260|26722174|FG003|Period 2|Need to take concomitant medication|0|||
13372875|NCT00806260|26722175|FG004|Period 2|Need to take concomitant medication|0|||
13372876|NCT00806260|26722176|FG005|Period 2|Need to take concomitant medication|0|||
13372877|NCT00806260|26722171|FG000|Period 2|sponsor request|0|||
13372878|NCT00806260|26722172|FG001|Period 2|sponsor request|0|||
13372879|NCT00806260|26722173|FG002|Period 2|sponsor request|1|||
13372880|NCT00806260|26722174|FG003|Period 2|sponsor request|1|||
13372881|NCT00806260|26722175|FG004|Period 2|sponsor request|0|||
13372882|NCT00806260|26722176|FG005|Period 2|sponsor request|0|||
13372883|NCT00806260|26722171|FG000|Period 3|Protocol Violation|0|||
13372884|NCT00806260|26722172|FG001|Period 3|Protocol Violation|1|||
13372885|NCT00806260|26722173|FG002|Period 3|Protocol Violation|1|||
13372886|NCT00806260|26722174|FG003|Period 3|Protocol Violation|0|||
13372887|NCT00806260|26722175|FG004|Period 3|Protocol Violation|0|||
13372888|NCT00806260|26722176|FG005|Period 3|Protocol Violation|0|||
13372889|NCT00806260|26722171|FG000|Period 3|Pregnancy|1|||
13372890|NCT00806260|26722172|FG001|Period 3|Pregnancy|0|||
13372891|NCT00806260|26722173|FG002|Period 3|Pregnancy|0|||
13372892|NCT00806260|26722174|FG003|Period 3|Pregnancy|0|||
13372893|NCT00806260|26722175|FG004|Period 3|Pregnancy|0|||
13372894|NCT00806260|26722176|FG005|Period 3|Pregnancy|0|||
13372895|NCT00806195|26722201|FG000|Overall Study|Death|6|||
13121994|NCT02970292|25945573|FG000|Overall Study|Lost to Follow-up|1|||
13121995|NCT02970292|25945574|FG001|Overall Study|Lost to Follow-up|0|||
13121996|NCT02970292|25945573|FG000|Overall Study|Protocol Violation|2|||
13372896|NCT00806195|26722202|FG001|Overall Study|Death|0|||
13372897|NCT00806195|26722203|FG002|Overall Study|Death|1|||
13372898|NCT00806195|26722204|FG003|Overall Study|Death|0|||
13372899|NCT00806195|26722201|FG000|Overall Study|Adverse Event|25|||
13372900|NCT00806195|26722202|FG001|Overall Study|Adverse Event|5|||
13372901|NCT00806195|26722203|FG002|Overall Study|Adverse Event|11|||
13372902|NCT00806195|26722204|FG003|Overall Study|Adverse Event|2|||
13372903|NCT00806195|26722201|FG000|Overall Study|Withdrawal by Subject|119|||
13372904|NCT00806195|26722202|FG001|Overall Study|Withdrawal by Subject|31|||
13121997|NCT02970292|25945574|FG001|Overall Study|Protocol Violation|0|||
13121998|NCT02970292|25945573|FG000|Overall Study|Other|1|||
13121999|NCT02970292|25945574|FG001|Overall Study|Other|0|||
13308659|NCT01266824|26532714|FG000|Overall Study|Study terminated prior to completion|2|||
13308660|NCT01266824|26532715|FG001|Overall Study|Study terminated prior to completion|3|||
13308661|NCT01266642|26532730|FG000|Overall Study|Protocol Violation|0|||
13308662|NCT01266642|26532731|FG001|Overall Study|Protocol Violation|1|||
13308663|NCT01266603|26532739|FG000|Overall Study|Adverse Event|1|||
13308664|NCT01266603|26532739|FG000|Overall Study|Lack of Efficacy|14|||
13308665|NCT01266603|26532739|FG000|Overall Study|Withdrawal by Subject|1|||
13308666|NCT01266603|26532739|FG000|Overall Study|Failed screening; MAGE-A3 negative|26|||
13308667|NCT01266590|26532752|FG000|Overall Study|Adverse Event|3|||
13308668|NCT01266590|26532752|FG000|Overall Study|Lost to Follow-up|1|||
13308669|NCT01266590|26532752|FG000|Overall Study|Withdrawal by Subject|1|||
13308670|NCT01266590|26532752|FG000|Overall Study|Physician Decision|1|||
13308671|NCT01266460|26532763|FG000|Overall Study|Adverse Event|3|||
13308672|NCT01266460|26532763|FG000|Overall Study|Withdrawal by Subject|5|||
13308673|NCT01266460|26532763|FG000|Overall Study|Disease Progression|18|||
13308674|NCT01266460|26532763|FG000|Overall Study|Not otherwise specified|8|||
13308675|NCT01266317|26532770|FG000|Overall Study|Withdrawal by Subject|2|||
13308676|NCT01266291|26532777|FG000|Overall Study|Adverse Event|1|||
13308677|NCT01266265|26532790|FG000|Overall Study|Death|95|||
13308678|NCT01266265|26532791|FG001|Overall Study|Death|73|||
13308679|NCT01266265|26532790|FG000|Overall Study|Lost to Follow-up|23|||
13308680|NCT01266265|26532791|FG001|Overall Study|Lost to Follow-up|28|||
13308681|NCT01266265|26532790|FG000|Overall Study|Withdrawal by Subject|13|||
13308682|NCT01266265|26532791|FG001|Overall Study|Withdrawal by Subject|11|||
13308683|NCT01266265|26532790|FG000|Overall Study|Respiratory-related adverse event|2|||
13308684|NCT01266265|26532791|FG001|Overall Study|Respiratory-related adverse event|1|||
13308685|NCT01266265|26532790|FG000|Overall Study|Transferred care to another provider|22|||
13308686|NCT01266265|26532791|FG001|Overall Study|Transferred care to another provider|28|||
13308687|NCT01266265|26532790|FG000|Overall Study|Stopped/changed PAH medication(s)|16|||
13308688|NCT01266265|26532791|FG001|Overall Study|Stopped/changed PAH medication(s)|9|||
13308689|NCT01266265|26532790|FG000|Overall Study|Enrolled in another clinical study|15|||
13308690|NCT01266265|26532791|FG001|Overall Study|Enrolled in another clinical study|26|||
13308691|NCT01266265|26532790|FG000|Overall Study|Non-compliance|8|||
13308692|NCT01266265|26532791|FG001|Overall Study|Non-compliance|5|||
13308693|NCT01266265|26532790|FG000|Overall Study|Lung transplant|6|||
13308694|NCT01266265|26532791|FG001|Overall Study|Lung transplant|5|||
13308695|NCT01266265|26532790|FG000|Overall Study|Site closed early|4|||
13308696|NCT01266265|26532791|FG001|Overall Study|Site closed early|3|||
13308697|NCT01266265|26532790|FG000|Overall Study|Clinical worsening|1|||
13308698|NCT01266265|26532791|FG001|Overall Study|Clinical worsening|1|||
13308699|NCT01266161|26532828|FG000|Overall Study|Ineligible|1|||
13308700|NCT01266161|26532829|FG001|Overall Study|Ineligible|0|||
13308701|NCT01266161|26532828|FG000|Overall Study|Lack of Efficacy|0|||
13308702|NCT01266161|26532829|FG001|Overall Study|Lack of Efficacy|1|||
13308703|NCT01266161|26532828|FG000|Overall Study|Vomited within 4 hours of dosing|3|||
13308704|NCT01266161|26532829|FG001|Overall Study|Vomited within 4 hours of dosing|0|||
13308705|NCT01266148|26532862|FG000|Overall Study|Adverse Event|2|||
13308706|NCT01266148|26532863|FG001|Overall Study|Adverse Event|0|||
13308707|NCT01266148|26532862|FG000|Overall Study|Ongoing rejection|1|||
13308708|NCT01266148|26532863|FG001|Overall Study|Ongoing rejection|0|||
13308709|NCT01266148|26532862|FG000|Overall Study|2 2R rejections|1|||
13308710|NCT01266148|26532863|FG001|Overall Study|2 2R rejections|0|||
13308711|NCT01266148|26532862|FG000|Overall Study|Death|2|||
13308712|NCT01266148|26532863|FG001|Overall Study|Death|3|||
13308713|NCT01266148|26532862|FG000|Overall Study|missing mGFR value + AE|1|||
13308714|NCT01266148|26532863|FG001|Overall Study|missing mGFR value + AE|0|||
13308715|NCT01266122|26532878|FG000|Overall Study|Lost to Follow-up|6|||
13308716|NCT01266122|26532879|FG001|Overall Study|Lost to Follow-up|6|||
13308717|NCT01266070|26532886|FG000|Overall Study|Adverse Event|3|||
13308718|NCT01266070|26532886|FG000|Overall Study|Protocol Violation|1|||
13308719|NCT01266018|26532900|FG000|Overall Study|Physician Decision|1|||
13308720|NCT01266018|26532901|FG001|Overall Study|Physician Decision|0|||
13308721|NCT01266018|26532900|FG000|Overall Study|Progressive disease|0|||
13308722|NCT01266018|26532901|FG001|Overall Study|Progressive disease|1|||
13308723|NCT01265992|26532916|FG000|Overall Study|Lost to Follow-up|1|||
13308724|NCT01265992|26532916|FG000|Overall Study|Withdrawal by Subject|1|||
13308725|NCT01265992|26532916|FG000|Overall Study|Adverse Event|1|||
13308726|NCT01265992|26532916|FG000|Overall Study|Administrative reasons|2|||
13308727|NCT01265992|26532916|FG000|Overall Study|Stopped treatment|3|||
13308728|NCT01265992|26532916|FG000|Overall Study|Did not receive treatment|1|||
13308729|NCT01265953|26532935|FG000|Overall Study|Non compliance|5|||
13308730|NCT01265953|26532936|FG001|Overall Study|Non compliance|3|||
13308731|NCT01265875|26532946|FG000|Overall Study|Uncooperative/unreliable|1|||
13308732|NCT01265849|26533008|FG000|Overall Study|Randomized//Treatment not initiated|1|||
13308733|NCT01265849|26533009|FG001|Overall Study|Randomized//Treatment not initiated|4|||
13308734|NCT01265849|26533010|FG002|Overall Study|Randomized//Treatment not initiated|0|||
13308735|NCT01265849|26533008|FG000|Overall Study|Physician Decision|1|||
13308736|NCT01265849|26533009|FG001|Overall Study|Physician Decision|2|||
13308737|NCT01265849|26533010|FG002|Overall Study|Physician Decision|0|||
13308738|NCT01265849|26533008|FG000|Overall Study|Lost to Follow-up|18|||
13308739|NCT01265849|26533009|FG001|Overall Study|Lost to Follow-up|15|||
13308740|NCT01265849|26533010|FG002|Overall Study|Lost to Follow-up|5|||
13308741|NCT01265849|26533008|FG000|Overall Study|Not otherwise specified|1|||
13308742|NCT01265849|26533009|FG001|Overall Study|Not otherwise specified|6|||
13308743|NCT01265849|26533010|FG002|Overall Study|Not otherwise specified|1|||
13308744|NCT01265849|26533008|FG000|Overall Study|Withdrawal by Subject|25|||
13308745|NCT01265849|26533009|FG001|Overall Study|Withdrawal by Subject|34|||
13308746|NCT01265849|26533010|FG002|Overall Study|Withdrawal by Subject|13|||
13308747|NCT01265823|26533039|FG000|Overall Study|Unsatisfactory Response Efficacy|1|||
13308748|NCT01265823|26533039|FG000|Overall Study|Failure to Return|4|||
13308749|NCT01265823|26533039|FG000|Overall Study|Protocol Violation|1|||
13308750|NCT01265823|26533039|FG000|Overall Study|Participant Request|1|||
13308751|NCT01265797|26533074|FG000|Run-in Month|Withdrawal by Subject|0|||
13308752|NCT01265797|26533075|FG001|Run-in Month|Withdrawal by Subject|4|||
13308753|NCT01265797|26533074|FG000|Run-in Month|1st seizure during run-in month|0|||
13308754|NCT01265797|26533075|FG001|Run-in Month|1st seizure during run-in month|1|||
13308755|NCT01265797|26533074|FG000|Blinded Month|Lack of Efficacy|5|||
13308756|NCT01265797|26533075|FG001|Blinded Month|Lack of Efficacy|0|||
13308757|NCT01265797|26533074|FG000|Blinded Month|Lost to Follow-up|1|||
13308758|NCT01265797|26533075|FG001|Blinded Month|Lost to Follow-up|0|||
13308759|NCT01265797|26533074|FG000|Blinded Month|Protocol Violation|2|||
13308760|NCT01265797|26533075|FG001|Blinded Month|Protocol Violation|1|||
13308761|NCT01265797|26533074|FG000|Blinded Month|Adverse Event|2|||
13308762|NCT01265797|26533075|FG001|Blinded Month|Adverse Event|0|||
13308763|NCT01265797|26533074|FG000|Blinded Month|Diary data incomplete|0|||
13308764|NCT01265797|26533075|FG001|Blinded Month|Diary data incomplete|1|||
13308765|NCT01265797|26533074|FG000|Open Label Month|Lost to Follow-up|0|||
13308766|NCT01265797|26533075|FG001|Open Label Month|Lost to Follow-up|1|||
13308767|NCT01265719|26533114|FG000|Overall Study|Does not meet entrance criteria|0|||
13308768|NCT01265719|26533115|FG001|Overall Study|Does not meet entrance criteria|3|||
13308769|NCT01265719|26533114|FG000|Overall Study|Other reasons|2|||
13308770|NCT01265719|26533115|FG001|Overall Study|Other reasons|0|||
13308771|NCT01265719|26533114|FG000|Overall Study|Withdrawal by Subject|8|||
13308772|NCT01265719|26533115|FG001|Overall Study|Withdrawal by Subject|3|||
13308773|NCT01265719|26533114|FG000|Overall Study|Lost to Follow-up|2|||
13308774|NCT01265719|26533115|FG001|Overall Study|Lost to Follow-up|7|||
13308775|NCT01265719|26533114|FG000|Overall Study|Adverse Event|2|||
13308776|NCT01265719|26533115|FG001|Overall Study|Adverse Event|0|||
13308777|NCT01265615|26533174|FG000|Overall Study|Protocol Violation|2|||
13308778|NCT01265615|26533175|FG001|Overall Study|Protocol Violation|2|||
13308779|NCT01265615|26533176|FG002|Overall Study|Protocol Violation|4|||
13308780|NCT01265615|26533177|FG003|Overall Study|Protocol Violation|3|||
13308781|NCT01265563|26533215|FG000|Overall Study|Withdrawal by Subject|0|||
13308782|NCT01265563|26533216|FG001|Overall Study|Withdrawal by Subject|1|||
13308783|NCT01265563|26533217|FG002|Overall Study|Withdrawal by Subject|1|||
13308784|NCT01265563|26533218|FG003|Overall Study|Withdrawal by Subject|0|||
13308785|NCT01265563|26533219|FG004|Overall Study|Withdrawal by Subject|2|||
13308786|NCT01265550|26533322|FG000|Pre Randomization|Withdrawal by Subject|0|||
13308787|NCT01265550|26533323|FG001|Pre Randomization|Withdrawal by Subject|0|||
13308788|NCT01265550|26533324|FG002|Pre Randomization|Withdrawal by Subject|0|||
13308789|NCT01265550|26533325|FG003|Pre Randomization|Withdrawal by Subject|70|||
13308790|NCT01265550|26533322|FG000|Pre Randomization|Technical Exclusions|0|||
13308791|NCT01265550|26533323|FG001|Pre Randomization|Technical Exclusions|0|||
13308792|NCT01265550|26533324|FG002|Pre Randomization|Technical Exclusions|0|||
13308793|NCT01265550|26533325|FG003|Pre Randomization|Technical Exclusions|54|||
13308794|NCT01265550|26533322|FG000|Pre Randomization|GERD, PPI-Responsive|0|||
13308795|NCT01265550|26533323|FG001|Pre Randomization|GERD, PPI-Responsive|0|||
13308796|NCT01265550|26533324|FG002|Pre Randomization|GERD, PPI-Responsive|0|||
13308797|NCT01265550|26533325|FG003|Pre Randomization|GERD, PPI-Responsive|42|||
13308798|NCT01265550|26533322|FG000|Pre Randomization|Non-GERD organic disorders|0|||
13308799|NCT01265550|26533323|FG001|Pre Randomization|Non-GERD organic disorders|0|||
13308800|NCT01265550|26533324|FG002|Pre Randomization|Non-GERD organic disorders|0|||
13308801|NCT01265550|26533325|FG003|Pre Randomization|Non-GERD organic disorders|23|||
13308802|NCT01265550|26533322|FG000|Pre Randomization|Functional heartburn|0|||
13308803|NCT01265550|26533323|FG001|Pre Randomization|Functional heartburn|0|||
13308804|NCT01265550|26533324|FG002|Pre Randomization|Functional heartburn|0|||
13308805|NCT01265550|26533325|FG003|Pre Randomization|Functional heartburn|99|||
13308806|NCT01265511|26533344|FG000|Overall Study|Lack of Efficacy|2|||
13308807|NCT01265511|26533345|FG001|Overall Study|Lack of Efficacy|1|||
13122000|NCT02969863|25945595|FG000|Overall Study|Physician Decision|1|||
13308808|NCT01265511|26533344|FG000|Overall Study|Met stopping rules|0|||
13308809|NCT01265511|26533345|FG001|Overall Study|Met stopping rules|2|||
13308810|NCT01265498|26533452|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31|||
13308811|NCT01265498|26533453|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33|||
13308812|NCT01265420|26533459|FG000|Overall Study|Lost to Follow-up|1|||
13308813|NCT01265394|26533466|FG000|Overall Study|Subjects withdrawn|37|||
13308814|NCT01265056|26533483|FG000|Initial Study Period|Withdrawal by Subject|1|||
13308815|NCT01265056|26533484|FG001|Initial Study Period|Withdrawal by Subject|1|||
13308816|NCT01265056|26533483|FG000|Initial Study Period|Withdrawal by Subject|1|||
13308817|NCT01265056|26533484|FG001|Initial Study Period|Withdrawal by Subject|1|||
13308818|NCT01265056|26533483|FG000|Follow up|Lost to Follow-up|7|||
13308819|NCT01265056|26533484|FG001|Follow up|Lost to Follow-up|3|||
13308820|NCT01264965|26533491|FG000|Overall Study|Withdrawal by Subject|10|||
13308821|NCT01264939|26533524|FG000|Overall Study|Adverse Event|1|||
13308822|NCT01264939|26533525|FG001|Overall Study|Adverse Event|3|||
13308823|NCT01264939|26533524|FG000|Overall Study|Lost to Follow-up|0|||
13308824|NCT01264939|26533525|FG001|Overall Study|Lost to Follow-up|3|||
13308825|NCT01264939|26533524|FG000|Overall Study|Physician Decision|1|||
13308826|NCT01264939|26533525|FG001|Overall Study|Physician Decision|1|||
13308827|NCT01264939|26533524|FG000|Overall Study|Patient/Guardian Decision|8|||
13308828|NCT01264939|26533525|FG001|Overall Study|Patient/Guardian Decision|10|||
13308829|NCT01264939|26533524|FG000|Overall Study|Disease Progression|8|||
13308830|NCT01264939|26533525|FG001|Overall Study|Disease Progression|11|||
13308831|NCT01264887|26533538|FG000|Overall Study|Adverse Event|5|||
13308832|NCT01264887|26533538|FG000|Overall Study|Death|7|||
13308833|NCT01264887|26533538|FG000|Overall Study|Lack of Efficacy|5|||
13308834|NCT01264887|26533538|FG000|Overall Study|Physician Decision|4|||
13308835|NCT01264887|26533538|FG000|Overall Study|Withdrawal by Subject|6|||
13308836|NCT01264887|26533538|FG000|Overall Study|Sponsor Decision Administrative Reasons|2|||
13308837|NCT01264887|26533538|FG000|Overall Study|Other|2|||
13308838|NCT01264835|26533544|FG000|Overall Study|Lost to Follow-up|1|||
13308839|NCT01264770|26533647|FG000|Overall Study|Not reported|0|||
13308840|NCT01264770|26533648|FG001|Overall Study|Not reported|0|||
13308841|NCT01264770|26533649|FG002|Overall Study|Not reported|1|||
13308842|NCT01264770|26533650|FG003|Overall Study|Not reported|0|||
13308843|NCT01264770|26533651|FG004|Overall Study|Not reported|0|||
13308844|NCT01264770|26533652|FG005|Overall Study|Not reported|0|||
13308845|NCT01264770|26533647|FG000|Overall Study|e.g., change in circumstances|8|||
13308846|NCT01264770|26533648|FG001|Overall Study|e.g., change in circumstances|3|||
13308847|NCT01264770|26533649|FG002|Overall Study|e.g., change in circumstances|3|||
13308848|NCT01264770|26533650|FG003|Overall Study|e.g., change in circumstances|3|||
13308849|NCT01264770|26533651|FG004|Overall Study|e.g., change in circumstances|4|||
13308850|NCT01264770|26533652|FG005|Overall Study|e.g., change in circumstances|4|||
13308851|NCT01264770|26533647|FG000|Overall Study|Severe non-compliance to protocol|0|||
13308852|NCT01264770|26533648|FG001|Overall Study|Severe non-compliance to protocol|0|||
13308853|NCT01264770|26533649|FG002|Overall Study|Severe non-compliance to protocol|1|||
13308854|NCT01264770|26533650|FG003|Overall Study|Severe non-compliance to protocol|1|||
13308855|NCT01264770|26533651|FG004|Overall Study|Severe non-compliance to protocol|0|||
13308856|NCT01264770|26533652|FG005|Overall Study|Severe non-compliance to protocol|0|||
13308857|NCT01264770|26533647|FG000|Overall Study|Lack of therapeutic response|1|||
13308858|NCT01264770|26533648|FG001|Overall Study|Lack of therapeutic response|0|||
13308859|NCT01264770|26533649|FG002|Overall Study|Lack of therapeutic response|2|||
13308860|NCT01264770|26533650|FG003|Overall Study|Lack of therapeutic response|1|||
13308861|NCT01264770|26533651|FG004|Overall Study|Lack of therapeutic response|1|||
13308862|NCT01264770|26533652|FG005|Overall Study|Lack of therapeutic response|0|||
13308863|NCT01264770|26533647|FG000|Overall Study|Dev. of study specific discont. criteria|2|||
13308864|NCT01264770|26533648|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
13308865|NCT01264770|26533649|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
13308866|NCT01264770|26533650|FG003|Overall Study|Dev. of study specific discont. criteria|0|||
13308867|NCT01264770|26533651|FG004|Overall Study|Dev. of study specific discont. criteria|1|||
13308868|NCT01264770|26533652|FG005|Overall Study|Dev. of study specific discont. criteria|1|||
13308869|NCT01264770|26533647|FG000|Overall Study|Lost to Follow-up|0|||
13308870|NCT01264770|26533648|FG001|Overall Study|Lost to Follow-up|0|||
13308871|NCT01264770|26533649|FG002|Overall Study|Lost to Follow-up|1|||
13308872|NCT01264770|26533650|FG003|Overall Study|Lost to Follow-up|1|||
13308873|NCT01264770|26533651|FG004|Overall Study|Lost to Follow-up|0|||
13308874|NCT01264770|26533652|FG005|Overall Study|Lost to Follow-up|0|||
13308875|NCT01264770|26533647|FG000|Overall Study|Adverse Event|7|||
13308876|NCT01264770|26533648|FG001|Overall Study|Adverse Event|7|||
13308877|NCT01264770|26533649|FG002|Overall Study|Adverse Event|8|||
13308878|NCT01264770|26533650|FG003|Overall Study|Adverse Event|0|||
13308879|NCT01264770|26533651|FG004|Overall Study|Adverse Event|2|||
13308880|NCT01264770|26533652|FG005|Overall Study|Adverse Event|1|||
13308881|NCT01264718|26533671|FG000|Overall Study|Lost to Follow-up|3|||
13308882|NCT01264718|26533672|FG001|Overall Study|Lost to Follow-up|2|||
13308883|NCT01264718|26533671|FG000|Overall Study|Withdrawal by Subject|9|||
13308884|NCT01264718|26533672|FG001|Overall Study|Withdrawal by Subject|15|||
13308885|NCT01264718|26533671|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37|||
13308886|NCT01264718|26533672|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26|||
13308887|NCT01264679|26533680|FG000|Overall Study|Participation in Another Clinical Trial|1|||
13308888|NCT01264679|26533680|FG000|Overall Study|Physician Decision|1|||
13308889|NCT01264679|26533680|FG000|Overall Study|Sponsor's Suspension of Dosing|2|||
13308890|NCT01264679|26533680|FG000|Overall Study|Withdrawal by Subject|1|||
13308891|NCT01264419|26533687|FG000|Overall Study|Lost to Follow-up|3|||
13308892|NCT01264380|26533712|FG000|Period C|Disease Progression|0|||
13308893|NCT01264380|26533713|FG001|Period C|Disease Progression|0|||
13308894|NCT01264380|26533714|FG002|Period C|Disease Progression|4|||
13308895|NCT01264380|26533712|FG000|Period C|Death|0|||
13308896|NCT01264380|26533713|FG001|Period C|Death|0|||
13308897|NCT01264380|26533714|FG002|Period C|Death|2|||
13308898|NCT01264380|26533712|FG000|Period C|Follow-up for survival status|0|||
13308899|NCT01264380|26533713|FG001|Period C|Follow-up for survival status|0|||
13308900|NCT01264380|26533714|FG002|Period C|Follow-up for survival status|6|||
13308901|NCT01264380|26533712|FG000|Period C|Withdrawal by Subject|0|||
13308902|NCT01264380|26533713|FG001|Period C|Withdrawal by Subject|0|||
13308903|NCT01264380|26533714|FG002|Period C|Withdrawal by Subject|1|||
13308904|NCT01264380|26533712|FG000|Period C|Adverse Event|0|||
13308905|NCT01264380|26533713|FG001|Period C|Adverse Event|0|||
13308906|NCT01264380|26533714|FG002|Period C|Adverse Event|1|||
13308907|NCT01264081|26533721|FG000|Participants Screened|Screening failures|30|||
13308908|NCT01264081|26533721|FG000|Started Treatment|Withdrawal by Subject|1|||
13308909|NCT01264081|26533721|FG000|Started Treatment|Not complete cycle 1 due to death|1|||
13308910|NCT01264016|26533729|FG000|Overall Study|Withdrawal by Subject|1|||
13308911|NCT01264016|26533729|FG000|Overall Study|Felt faint at sight of blood|1|||
13308912|NCT01263925|26533768|FG000|Overall Study|Protocol Violation|1|||
13308913|NCT01263925|26533769|FG001|Overall Study|Protocol Violation|0|||
13308914|NCT01263925|26533768|FG000|Overall Study|Lack of Efficacy|0|||
13308915|NCT01263925|26533769|FG001|Overall Study|Lack of Efficacy|1|||
13308916|NCT01263925|26533768|FG000|Overall Study|Adverse Event|23|||
13308917|NCT01263925|26533769|FG001|Overall Study|Adverse Event|22|||
13308918|NCT01263925|26533768|FG000|Overall Study|Unsatisfactory Compliance of Subject|8|||
13308919|NCT01263925|26533769|FG001|Overall Study|Unsatisfactory Compliance of Subject|5|||
13308920|NCT01263925|26533768|FG000|Overall Study|Withdrawal by Subject|6|||
13308921|NCT01263925|26533769|FG001|Overall Study|Withdrawal by Subject|8|||
13308922|NCT01263925|26533768|FG000|Overall Study|Other|4|||
13308923|NCT01263925|26533769|FG001|Overall Study|Other|4|||
13308924|NCT01263925|26533768|FG000|Overall Study|Lost to Follow-up|3|||
13308925|NCT01263925|26533769|FG001|Overall Study|Lost to Follow-up|1|||
13308926|NCT01263925|26533768|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
13308927|NCT01263925|26533769|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
13308928|NCT01263925|26533768|FG000|Overall Study|AE/ Unsatisfactory Compliance|2|||
13308929|NCT01263925|26533769|FG001|Overall Study|AE/ Unsatisfactory Compliance|2|||
13308930|NCT01263925|26533768|FG000|Overall Study|AE/ Withdrawal|1|||
13308931|NCT01263925|26533769|FG001|Overall Study|AE/ Withdrawal|4|||
13308932|NCT01263925|26533768|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
13308933|NCT01263925|26533769|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
13308934|NCT01263925|26533768|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1|||
13308935|NCT01263925|26533769|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2|||
13308936|NCT01263925|26533768|FG000|Overall Study|Withdrawal/ Not specified|0|||
13308937|NCT01263925|26533769|FG001|Overall Study|Withdrawal/ Not specified|1|||
13308938|NCT01263873|26533786|FG000|Overall Study|One provider unable to complete numbers|1|||
13308939|NCT01263873|26533787|FG001|Overall Study|One provider unable to complete numbers|1|||
13308940|NCT01263782|26533814|FG000|Overall Study|Death|0|||
13308941|NCT01263782|26533815|FG001|Overall Study|Death|0|||
13308942|NCT01263782|26533816|FG002|Overall Study|Death|1|||
13308943|NCT01263782|26533817|FG003|Overall Study|Death|0|||
13308944|NCT01263782|26533814|FG000|Overall Study|Progressive disease|0|||
13308945|NCT01263782|26533815|FG001|Overall Study|Progressive disease|0|||
13308946|NCT01263782|26533816|FG002|Overall Study|Progressive disease|0|||
13308947|NCT01263782|26533817|FG003|Overall Study|Progressive disease|1|||
13308948|NCT01263782|26533814|FG000|Overall Study|Too early|0|||
13308949|NCT01263782|26533815|FG001|Overall Study|Too early|0|||
13308950|NCT01263782|26533816|FG002|Overall Study|Too early|1|||
13308951|NCT01263782|26533817|FG003|Overall Study|Too early|0|||
13308952|NCT01263782|26533814|FG000|Overall Study|Inevaluable|0|||
13308953|NCT01263782|26533815|FG001|Overall Study|Inevaluable|0|||
13308954|NCT01263782|26533816|FG002|Overall Study|Inevaluable|1|||
13308955|NCT01263782|26533817|FG003|Overall Study|Inevaluable|0|||
13308956|NCT01263769|26533823|FG000|Overall Study|Non-Compliant with treatment|1|||
13308957|NCT01263704|26533834|FG000|Overall Study|Progressive disease|18|||
13308958|NCT01263704|26533834|FG000|Overall Study|Adverse Event|3|||
13308959|NCT01263704|26533834|FG000|Overall Study|Death|2|||
13308960|NCT01263704|26533834|FG000|Overall Study|Patient withdrew consent|2|||
13308961|NCT01263704|26533834|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
13308962|NCT01263704|26533834|FG000|Overall Study|Lost to Follow-up|1|||
13308963|NCT01263704|26533834|FG000|Overall Study|Colon metastases|1|||
13308964|NCT01263704|26533834|FG000|Overall Study|Principal Investigator (PI) decision|1|||
13308965|NCT01263691|26533963|FG000|Overall Study|Lost to Follow-up|1|||
13308966|NCT01263691|26533964|FG001|Overall Study|Lost to Follow-up|0|||
13308967|NCT01263691|26533965|FG002|Overall Study|Lost to Follow-up|1|||
13308968|NCT01263691|26533966|FG003|Overall Study|Lost to Follow-up|1|||
13308969|NCT01263691|26533967|FG004|Overall Study|Lost to Follow-up|0|||
13308970|NCT01263691|26533968|FG005|Overall Study|Lost to Follow-up|0|||
13308971|NCT01263691|26533963|FG000|Overall Study|Withdrawal by Subject|1|||
13308972|NCT01263691|26533964|FG001|Overall Study|Withdrawal by Subject|0|||
13308973|NCT01263691|26533965|FG002|Overall Study|Withdrawal by Subject|0|||
13308974|NCT01263691|26533966|FG003|Overall Study|Withdrawal by Subject|0|||
13308975|NCT01263691|26533967|FG004|Overall Study|Withdrawal by Subject|0|||
13308976|NCT01263691|26533968|FG005|Overall Study|Withdrawal by Subject|0|||
13308977|NCT01263691|26533963|FG000|Overall Study|Adverse Event|1|||
13308978|NCT01263691|26533964|FG001|Overall Study|Adverse Event|0|||
13308979|NCT01263691|26533965|FG002|Overall Study|Adverse Event|0|||
13308980|NCT01263691|26533966|FG003|Overall Study|Adverse Event|0|||
13308981|NCT01263691|26533967|FG004|Overall Study|Adverse Event|0|||
13308982|NCT01263691|26533968|FG005|Overall Study|Adverse Event|0|||
13308983|NCT01263665|26533975|FG000|Overall Study|Withdrew Consent|1|||
13308984|NCT01263665|26533975|FG000|Overall Study|Lost to Follow-up|3|||
13308985|NCT01263665|26533975|FG000|Overall Study|Death|2|||
13308986|NCT01263665|26533975|FG000|Overall Study|Amputation above the ankle|1|||
13308987|NCT01263665|26533975|FG000|Overall Study|Surgical Bypass|2|||
13308988|NCT01263639|26533988|FG000|Overall Study|Lost to Follow-up|66|||
13308989|NCT01263639|26533989|FG001|Overall Study|Lost to Follow-up|70|||
13308990|NCT01263639|26533988|FG000|Overall Study|Exclusion =Admission greater than 7 days|7|||
13308991|NCT01263639|26533989|FG001|Overall Study|Exclusion =Admission greater than 7 days|9|||
13308992|NCT01263561|26534006|FG000|Overall Study|Death|1|||
13308993|NCT01263561|26534007|FG001|Overall Study|Death|2|||
13308994|NCT01263509|26534140|FG000|Entered - Long-Term Extension Study|Adverse Event|5|||
13308995|NCT01263509|26534141|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
13308996|NCT01263509|26534142|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
13308997|NCT01263509|26534143|FG003|Entered - Long-Term Extension Study|Adverse Event|1|||
13308998|NCT01263509|26534140|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
13308999|NCT01263509|26534141|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
13309000|NCT01263509|26534142|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
13309001|NCT01263509|26534143|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
13309002|NCT01263509|26534140|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
13309003|NCT01263509|26534141|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
13309004|NCT01263509|26534142|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
13309005|NCT01263509|26534143|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
13309006|NCT01263509|26534140|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1|||
13309007|NCT01263509|26534141|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1|||
13309008|NCT01263509|26534142|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
13309009|NCT01263509|26534143|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
13309010|NCT01263509|26534140|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
13309011|NCT01263509|26534141|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
13309012|NCT01263509|26534142|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
13309013|NCT01263509|26534143|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1|||
13309014|NCT01263496|26534455|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1|||
13309015|NCT01263496|26534456|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
13309016|NCT01263496|26534457|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
13309017|NCT01263496|26534458|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
13309018|NCT01263496|26534459|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
13309019|NCT01263496|26534460|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
13309020|NCT01263496|26534461|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
13309021|NCT01263496|26534462|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
13309022|NCT01263496|26534463|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
13309023|NCT01263496|26534455|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
13309024|NCT01263496|26534456|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
13309025|NCT01263496|26534457|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
13309026|NCT01263496|26534458|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
13309027|NCT01263496|26534459|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2|||
13309028|NCT01263496|26534460|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
13309029|NCT01263496|26534461|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
13309030|NCT01263496|26534462|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
13309031|NCT01263496|26534463|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0|||
13309032|NCT01263496|26534455|FG000|Entered - Long-Term Extension Study|Adverse Event|0|||
13309033|NCT01263496|26534456|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
13309034|NCT01263496|26534457|FG002|Entered - Long-Term Extension Study|Adverse Event|6|||
13309035|NCT01263496|26534458|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
13309036|NCT01263496|26534459|FG004|Entered - Long-Term Extension Study|Adverse Event|1|||
13309037|NCT01263496|26534460|FG005|Entered - Long-Term Extension Study|Adverse Event|0|||
13309038|NCT01263496|26534461|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
13309039|NCT01263496|26534462|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
13309040|NCT01263496|26534463|FG008|Entered - Long-Term Extension Study|Adverse Event|1|||
13309041|NCT01263496|26534455|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
13309042|NCT01263496|26534456|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2|||
13309043|NCT01263496|26534457|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
13309044|NCT01263496|26534458|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
13309045|NCT01263496|26534459|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
13309046|NCT01263496|26534460|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
13309047|NCT01263496|26534461|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
13309048|NCT01263496|26534462|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
13309049|NCT01263496|26534463|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
13309050|NCT01263496|26534455|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
13309051|NCT01263496|26534456|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
13309052|NCT01263496|26534457|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
13309053|NCT01263496|26534458|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
13309054|NCT01263496|26534459|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4|||
13309055|NCT01263496|26534460|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
13309056|NCT01263496|26534461|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
13309057|NCT01263496|26534462|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
13309058|NCT01263496|26534463|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
13309059|NCT01263496|26534455|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8|||
13309060|NCT01263496|26534456|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
13309061|NCT01263496|26534457|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
13309062|NCT01263496|26534458|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
13309063|NCT01263496|26534459|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
13309064|NCT01263496|26534460|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
13309065|NCT01263496|26534461|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
13309066|NCT01263496|26534462|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
13309067|NCT01263496|26534463|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
13309068|NCT01263496|26534455|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0|||
13309069|NCT01263496|26534456|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0|||
13309070|NCT01263496|26534457|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
13309071|NCT01263496|26534458|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
13309072|NCT01263496|26534459|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0|||
13309073|NCT01263496|26534460|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0|||
13309074|NCT01263496|26534461|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0|||
13309075|NCT01263496|26534462|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1|||
13309076|NCT01263496|26534463|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0|||
13309077|NCT01263483|26534529|FG000|Overall Study|Adverse Event|4|||
13309078|NCT01263483|26534530|FG001|Overall Study|Adverse Event|0|||
13309079|NCT01263483|26534531|FG002|Overall Study|Adverse Event|3|||
13309080|NCT01263483|26534529|FG000|Overall Study|Withdrawal by Subject|1|||
13309081|NCT01263483|26534530|FG001|Overall Study|Withdrawal by Subject|0|||
13309082|NCT01263483|26534531|FG002|Overall Study|Withdrawal by Subject|0|||
13309083|NCT01263483|26534529|FG000|Overall Study|Lack of Efficacy|2|||
13309084|NCT01263483|26534530|FG001|Overall Study|Lack of Efficacy|0|||
13309085|NCT01263483|26534531|FG002|Overall Study|Lack of Efficacy|0|||
13309086|NCT01263483|26534529|FG000|Overall Study|Protocol Violation|0|||
13309087|NCT01263483|26534530|FG001|Overall Study|Protocol Violation|1|||
13309088|NCT01263483|26534531|FG002|Overall Study|Protocol Violation|1|||
13309089|NCT01263483|26534529|FG000|Overall Study|Participant Unavailability|0|||
13309090|NCT01263483|26534530|FG001|Overall Study|Participant Unavailability|1|||
13309091|NCT01263483|26534531|FG002|Overall Study|Participant Unavailability|1|||
13309092|NCT01263470|26534660|FG000|Overall Study|Adverse Event|2|||
13309093|NCT01263470|26534661|FG001|Overall Study|Adverse Event|2|||
13309094|NCT01263470|26534662|FG002|Overall Study|Adverse Event|1|||
13309095|NCT01263470|26534663|FG003|Overall Study|Adverse Event|1|||
13309096|NCT01263470|26534664|FG004|Overall Study|Adverse Event|2|||
13309097|NCT01263470|26534665|FG005|Overall Study|Adverse Event|2|||
13309098|NCT01263470|26534660|FG000|Overall Study|Protocol Violation|0|||
13309099|NCT01263470|26534661|FG001|Overall Study|Protocol Violation|1|||
13309100|NCT01263470|26534662|FG002|Overall Study|Protocol Violation|0|||
13309101|NCT01263470|26534663|FG003|Overall Study|Protocol Violation|0|||
13309102|NCT01263470|26534664|FG004|Overall Study|Protocol Violation|0|||
13309103|NCT01263470|26534665|FG005|Overall Study|Protocol Violation|1|||
13309104|NCT01263470|26534660|FG000|Overall Study|Withdrawal by Subject|0|||
13309105|NCT01263470|26534661|FG001|Overall Study|Withdrawal by Subject|1|||
13309106|NCT01263470|26534662|FG002|Overall Study|Withdrawal by Subject|1|||
13309107|NCT01263470|26534663|FG003|Overall Study|Withdrawal by Subject|2|||
13309108|NCT01263470|26534664|FG004|Overall Study|Withdrawal by Subject|0|||
13309109|NCT01263470|26534665|FG005|Overall Study|Withdrawal by Subject|2|||
13309110|NCT01263470|26534660|FG000|Overall Study|Lack of Efficacy|0|||
13309111|NCT01263470|26534661|FG001|Overall Study|Lack of Efficacy|0|||
13309112|NCT01263470|26534662|FG002|Overall Study|Lack of Efficacy|2|||
13309113|NCT01263470|26534663|FG003|Overall Study|Lack of Efficacy|0|||
13309114|NCT01263470|26534664|FG004|Overall Study|Lack of Efficacy|0|||
13309115|NCT01263470|26534665|FG005|Overall Study|Lack of Efficacy|0|||
13309116|NCT01263470|26534660|FG000|Overall Study|Participant Unavailability|0|||
13309117|NCT01263470|26534661|FG001|Overall Study|Participant Unavailability|1|||
13309118|NCT01263470|26534662|FG002|Overall Study|Participant Unavailability|0|||
13309119|NCT01263470|26534663|FG003|Overall Study|Participant Unavailability|0|||
13309120|NCT01263470|26534664|FG004|Overall Study|Participant Unavailability|0|||
13309121|NCT01263470|26534665|FG005|Overall Study|Participant Unavailability|0|||
13309122|NCT01263470|26534660|FG000|Overall Study|Study Drug Non-compliance|0|||
13309123|NCT01263470|26534661|FG001|Overall Study|Study Drug Non-compliance|0|||
13309124|NCT01263470|26534662|FG002|Overall Study|Study Drug Non-compliance|0|||
13309125|NCT01263470|26534663|FG003|Overall Study|Study Drug Non-compliance|0|||
13309126|NCT01263470|26534664|FG004|Overall Study|Study Drug Non-compliance|1|||
13309127|NCT01263470|26534665|FG005|Overall Study|Study Drug Non-compliance|0|||
13309128|NCT01263444|26534674|FG000|Overall Study|Adverse Event|8|||
13309129|NCT01263444|26534674|FG000|Overall Study|Withdrawal by Subject|1|||
13309130|NCT01263444|26534674|FG000|Overall Study|Protocol Violation|1|||
13309131|NCT01263223|26534698|FG000|Period 2|Withdrawal by Subject|0|||
13309132|NCT01263223|26534699|FG001|Period 2|Withdrawal by Subject|1|||
13309133|NCT01263223|26534698|FG000|7-day Follow-up|Withdrawal by Subject|0|||
13309134|NCT01263223|26534699|FG001|7-day Follow-up|Withdrawal by Subject|1|||
13309135|NCT01263223|26534698|FG000|7-day Follow-up|Lost to Follow-up|1|||
13309136|NCT01263223|26534699|FG001|7-day Follow-up|Lost to Follow-up|0|||
13309137|NCT01263197|26534736|FG000|First Intervention (Period 1)|Adverse Event|0|||
13309138|NCT01263197|26534737|FG001|First Intervention (Period 1)|Adverse Event|0|||
13309139|NCT01263197|26534738|FG002|First Intervention (Period 1)|Adverse Event|0|||
13309140|NCT01263197|26534739|FG003|First Intervention (Period 1)|Adverse Event|0|||
13309141|NCT01263197|26534740|FG004|First Intervention (Period 1)|Adverse Event|0|||
13309142|NCT01263197|26534741|FG005|First Intervention (Period 1)|Adverse Event|1|||
13309143|NCT01263197|26534736|FG000|Washout Period 1|Protocol Violation|0|||
13309144|NCT01263197|26534737|FG001|Washout Period 1|Protocol Violation|0|||
13309145|NCT01263197|26534738|FG002|Washout Period 1|Protocol Violation|0|||
13309146|NCT01263197|26534739|FG003|Washout Period 1|Protocol Violation|0|||
13309147|NCT01263197|26534740|FG004|Washout Period 1|Protocol Violation|1|||
13309148|NCT01263197|26534741|FG005|Washout Period 1|Protocol Violation|0|||
13309149|NCT01263197|26534736|FG000|Washout Period 2|Physician Decision|0|||
13309150|NCT01263197|26534737|FG001|Washout Period 2|Physician Decision|0|||
13309151|NCT01263197|26534738|FG002|Washout Period 2|Physician Decision|0|||
13309152|NCT01263197|26534739|FG003|Washout Period 2|Physician Decision|0|||
13309153|NCT01263197|26534740|FG004|Washout Period 2|Physician Decision|0|||
13309154|NCT01263197|26534741|FG005|Washout Period 2|Physician Decision|1|||
13309155|NCT01263197|26534736|FG000|Washout Period 2|Protocol Violation|0|||
13309156|NCT01263197|26534737|FG001|Washout Period 2|Protocol Violation|0|||
13309157|NCT01263197|26534738|FG002|Washout Period 2|Protocol Violation|0|||
13309158|NCT01263197|26534739|FG003|Washout Period 2|Protocol Violation|1|||
13309159|NCT01263197|26534740|FG004|Washout Period 2|Protocol Violation|0|||
13309160|NCT01263197|26534741|FG005|Washout Period 2|Protocol Violation|0|||
13309161|NCT01263197|26534736|FG000|Third Intervention (Period 3)|Adverse Event|0|||
13309162|NCT01263197|26534737|FG001|Third Intervention (Period 3)|Adverse Event|1|||
13309163|NCT01263197|26534738|FG002|Third Intervention (Period 3)|Adverse Event|0|||
13309164|NCT01263197|26534739|FG003|Third Intervention (Period 3)|Adverse Event|0|||
13309165|NCT01263197|26534740|FG004|Third Intervention (Period 3)|Adverse Event|0|||
13309166|NCT01263197|26534741|FG005|Third Intervention (Period 3)|Adverse Event|0|||
13309167|NCT01263119|26534764|FG000|Period 1|Protocol Violation|2|||
13309168|NCT01263119|26534764|FG000|Period 2|Adverse Event|2|||
13309169|NCT01263106|26534780|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1|||
13309170|NCT01263106|26534781|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
13309171|NCT01263093|26534803|FG000|Washout|Physician Decision|1|||
13309172|NCT01263093|26534804|FG001|Washout|Physician Decision|0|||
13309173|NCT01263093|26534803|FG000|Period 2|Adverse Event|1|||
13309174|NCT01263093|26534804|FG001|Period 2|Adverse Event|0|||
13309175|NCT01263054|26534829|FG000|Overall Study|Death|1|||
13309176|NCT01263054|26534830|FG001|Overall Study|Death|0|||
13309177|NCT01263054|26534829|FG000|Overall Study|Lost to Follow-up|2|||
13309178|NCT01263054|26534830|FG001|Overall Study|Lost to Follow-up|2|||
13309179|NCT01263054|26534829|FG000|Overall Study|Withdrawal by Subject|1|||
13309180|NCT01263054|26534830|FG001|Overall Study|Withdrawal by Subject|3|||
13309181|NCT01263054|26534829|FG000|Overall Study|Qualification Violation|1|||
13309182|NCT01263054|26534830|FG001|Overall Study|Qualification Violation|0|||
13309183|NCT01263054|26534829|FG000|Overall Study|Other|0|||
13309184|NCT01263054|26534830|FG001|Overall Study|Other|1|||
13309185|NCT01263028|26534840|FG000|Overall Study|Withdrawal by Subject|1|||
13309186|NCT01263028|26534840|FG000|Overall Study|Adverse Event|1|||
13309187|NCT01263028|26534840|FG000|Overall Study|Study terminated due to low enrollment.|4|||
13309188|NCT01263015|26534873|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13|||
13309189|NCT01263015|26534874|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48|||
13309190|NCT01263015|26534873|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18|||
13309191|NCT01263015|26534874|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14|||
13309192|NCT01263015|26534873|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14|||
13309193|NCT01263015|26534874|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12|||
13309194|NCT01263015|26534873|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17|||
13309195|NCT01263015|26534874|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18|||
13309196|NCT01263015|26534873|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9|||
13309197|NCT01263015|26534874|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15|||
13309198|NCT01263015|26534873|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1|||
13309199|NCT01263015|26534874|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2|||
13309200|NCT01263015|26534873|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3|||
13309201|NCT01263015|26534874|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10|||
13309202|NCT01263015|26534873|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7|||
13309203|NCT01263015|26534874|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2|||
13309204|NCT01263015|26534873|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3|||
13309205|NCT01263015|26534874|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2|||
13309206|NCT01263015|26534873|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
13309207|NCT01263015|26534874|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
13309208|NCT01263015|26534873|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0|||
13309209|NCT01263015|26534874|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2|||
13309210|NCT01263015|26534873|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3|||
13309211|NCT01263015|26534874|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7|||
13309212|NCT01262989|26534887|FG000|Period 1|Lost to Follow-up|1|||
13309213|NCT01262989|26534888|FG001|Period 1|Lost to Follow-up|1|||
13309214|NCT01262989|26534887|FG000|Period 1|Intercurrent disease|0|||
13309215|NCT01262989|26534888|FG001|Period 1|Intercurrent disease|1|||
13309216|NCT01262989|26534887|FG000|Period 1|Positive answer for exclusion criteria|0|||
13309217|NCT01262989|26534888|FG001|Period 1|Positive answer for exclusion criteria|1|||
13309218|NCT01262989|26534887|FG000|Period 2|Intercurrent disease|0|||
13309219|NCT01262989|26534888|FG001|Period 2|Intercurrent disease|1|||
13309220|NCT01262976|26535059|FG000|Up to Month 2|Serious Adverse Event|0|||
13309221|NCT01262976|26535060|FG001|Up to Month 2|Serious Adverse Event|0|||
13309222|NCT01262976|26535061|FG002|Up to Month 2|Serious Adverse Event|1|||
13309223|NCT01262976|26535062|FG003|Up to Month 2|Serious Adverse Event|0|||
13309224|NCT01262976|26535063|FG004|Up to Month 2|Serious Adverse Event|0|||
13309225|NCT01262976|26535064|FG005|Up to Month 2|Serious Adverse Event|0|||
13309226|NCT01262976|26535059|FG000|Up to Month 2|Withdrawal by Subject|1|||
13309227|NCT01262976|26535060|FG001|Up to Month 2|Withdrawal by Subject|0|||
13309228|NCT01262976|26535061|FG002|Up to Month 2|Withdrawal by Subject|0|||
13309229|NCT01262976|26535062|FG003|Up to Month 2|Withdrawal by Subject|0|||
13309230|NCT01262976|26535063|FG004|Up to Month 2|Withdrawal by Subject|0|||
13309231|NCT01262976|26535064|FG005|Up to Month 2|Withdrawal by Subject|0|||
13309232|NCT01262976|26535059|FG000|Up to Month 2|Migrated/moved from study area|0|||
13309233|NCT01262976|26535060|FG001|Up to Month 2|Migrated/moved from study area|1|||
13309234|NCT01262976|26535061|FG002|Up to Month 2|Migrated/moved from study area|0|||
13309235|NCT01262976|26535062|FG003|Up to Month 2|Migrated/moved from study area|0|||
13309236|NCT01262976|26535063|FG004|Up to Month 2|Migrated/moved from study area|1|||
13309237|NCT01262976|26535064|FG005|Up to Month 2|Migrated/moved from study area|1|||
13309238|NCT01262976|26535059|FG000|Up to Month 2|Lost to Follow-up|1|||
13309239|NCT01262976|26535060|FG001|Up to Month 2|Lost to Follow-up|0|||
13309240|NCT01262976|26535061|FG002|Up to Month 2|Lost to Follow-up|0|||
13309241|NCT01262976|26535062|FG003|Up to Month 2|Lost to Follow-up|1|||
13309242|NCT01262976|26535063|FG004|Up to Month 2|Lost to Follow-up|1|||
13309243|NCT01262976|26535064|FG005|Up to Month 2|Lost to Follow-up|1|||
13309244|NCT01262976|26535059|FG000|Up to Month 2|Other|1|||
13309245|NCT01262976|26535060|FG001|Up to Month 2|Other|0|||
13309246|NCT01262976|26535061|FG002|Up to Month 2|Other|0|||
13309247|NCT01262976|26535062|FG003|Up to Month 2|Other|1|||
13309248|NCT01262976|26535063|FG004|Up to Month 2|Other|0|||
13309249|NCT01262976|26535064|FG005|Up to Month 2|Other|2|||
13309250|NCT01262976|26535059|FG000|Up to Month 7|Serious Adverse Event|0|||
13309251|NCT01262976|26535060|FG001|Up to Month 7|Serious Adverse Event|0|||
13309252|NCT01262976|26535061|FG002|Up to Month 7|Serious Adverse Event|2|||
13309253|NCT01262976|26535062|FG003|Up to Month 7|Serious Adverse Event|0|||
13309254|NCT01262976|26535063|FG004|Up to Month 7|Serious Adverse Event|0|||
13309255|NCT01262976|26535064|FG005|Up to Month 7|Serious Adverse Event|0|||
13309256|NCT01262976|26535059|FG000|Up to Month 7|Withdrawal by Subject|1|||
13309257|NCT01262976|26535060|FG001|Up to Month 7|Withdrawal by Subject|0|||
13309258|NCT01262976|26535061|FG002|Up to Month 7|Withdrawal by Subject|0|||
13309259|NCT01262976|26535062|FG003|Up to Month 7|Withdrawal by Subject|0|||
13309260|NCT01262976|26535063|FG004|Up to Month 7|Withdrawal by Subject|0|||
13309261|NCT01262976|26535064|FG005|Up to Month 7|Withdrawal by Subject|0|||
13309262|NCT01262976|26535059|FG000|Up to Month 7|Migrated/moved from study area|0|||
13309263|NCT01262976|26535060|FG001|Up to Month 7|Migrated/moved from study area|0|||
13309264|NCT01262976|26535061|FG002|Up to Month 7|Migrated/moved from study area|1|||
13309265|NCT01262976|26535062|FG003|Up to Month 7|Migrated/moved from study area|3|||
13309266|NCT01262976|26535063|FG004|Up to Month 7|Migrated/moved from study area|1|||
13309267|NCT01262976|26535064|FG005|Up to Month 7|Migrated/moved from study area|1|||
13309268|NCT01262976|26535059|FG000|Up to Month 7|Lost to Follow-up|1|||
13309269|NCT01262976|26535060|FG001|Up to Month 7|Lost to Follow-up|0|||
13309270|NCT01262976|26535061|FG002|Up to Month 7|Lost to Follow-up|1|||
13309271|NCT01262976|26535062|FG003|Up to Month 7|Lost to Follow-up|3|||
13309272|NCT01262976|26535063|FG004|Up to Month 7|Lost to Follow-up|1|||
13309273|NCT01262976|26535064|FG005|Up to Month 7|Lost to Follow-up|3|||
13309274|NCT01262976|26535059|FG000|Up to Month 7|Other|3|||
13309275|NCT01262976|26535060|FG001|Up to Month 7|Other|0|||
13309276|NCT01262976|26535061|FG002|Up to Month 7|Other|2|||
13309277|NCT01262976|26535062|FG003|Up to Month 7|Other|0|||
13309278|NCT01262976|26535063|FG004|Up to Month 7|Other|0|||
13309279|NCT01262976|26535064|FG005|Up to Month 7|Other|0|||
13309280|NCT01262976|26535059|FG000|Up to Year 1|Serious Adverse Event|0|||
13309281|NCT01262976|26535060|FG001|Up to Year 1|Serious Adverse Event|0|||
13309282|NCT01262976|26535061|FG002|Up to Year 1|Serious Adverse Event|2|||
13309283|NCT01262976|26535062|FG003|Up to Year 1|Serious Adverse Event|0|||
13309284|NCT01262976|26535063|FG004|Up to Year 1|Serious Adverse Event|0|||
13309285|NCT01262976|26535064|FG005|Up to Year 1|Serious Adverse Event|0|||
13309286|NCT01262976|26535059|FG000|Up to Year 1|Withdrawal by Subject|1|||
13309287|NCT01262976|26535060|FG001|Up to Year 1|Withdrawal by Subject|0|||
13309288|NCT01262976|26535061|FG002|Up to Year 1|Withdrawal by Subject|0|||
13309289|NCT01262976|26535062|FG003|Up to Year 1|Withdrawal by Subject|0|||
13309290|NCT01262976|26535063|FG004|Up to Year 1|Withdrawal by Subject|0|||
13309291|NCT01262976|26535064|FG005|Up to Year 1|Withdrawal by Subject|0|||
13309292|NCT01262976|26535059|FG000|Up to Year 1|Migrated/moved from study area|1|||
13309293|NCT01262976|26535060|FG001|Up to Year 1|Migrated/moved from study area|0|||
13309294|NCT01262976|26535061|FG002|Up to Year 1|Migrated/moved from study area|0|||
13309295|NCT01262976|26535062|FG003|Up to Year 1|Migrated/moved from study area|3|||
13309296|NCT01262976|26535063|FG004|Up to Year 1|Migrated/moved from study area|3|||
13309297|NCT01262976|26535064|FG005|Up to Year 1|Migrated/moved from study area|2|||
13309298|NCT01262976|26535059|FG000|Up to Year 1|Lost to Follow-up|4|||
13309299|NCT01262976|26535060|FG001|Up to Year 1|Lost to Follow-up|0|||
13309300|NCT01262976|26535061|FG002|Up to Year 1|Lost to Follow-up|0|||
13309301|NCT01262976|26535062|FG003|Up to Year 1|Lost to Follow-up|1|||
13309302|NCT01262976|26535063|FG004|Up to Year 1|Lost to Follow-up|6|||
13309303|NCT01262976|26535064|FG005|Up to Year 1|Lost to Follow-up|5|||
13309304|NCT01262976|26535059|FG000|Up to Year 1|Other|3|||
13309305|NCT01262976|26535060|FG001|Up to Year 1|Other|1|||
13309306|NCT01262976|26535061|FG002|Up to Year 1|Other|0|||
13309307|NCT01262976|26535062|FG003|Up to Year 1|Other|0|||
13309308|NCT01262976|26535063|FG004|Up to Year 1|Other|2|||
13309309|NCT01262976|26535064|FG005|Up to Year 1|Other|1|||
13309310|NCT01262976|26535059|FG000|Up to Year 1|Subjects with unknown completion status|0|||
13309311|NCT01262976|26535060|FG001|Up to Year 1|Subjects with unknown completion status|0|||
13309312|NCT01262976|26535061|FG002|Up to Year 1|Subjects with unknown completion status|1|||
13309313|NCT01262976|26535062|FG003|Up to Year 1|Subjects with unknown completion status|0|||
13309314|NCT01262976|26535063|FG004|Up to Year 1|Subjects with unknown completion status|0|||
13309315|NCT01262976|26535064|FG005|Up to Year 1|Subjects with unknown completion status|1|||
13309316|NCT01262976|26535059|FG000|Up to Year 2|Serious Adverse Event|0|||
13309317|NCT01262976|26535060|FG001|Up to Year 2|Serious Adverse Event|0|||
13309318|NCT01262976|26535061|FG002|Up to Year 2|Serious Adverse Event|2|||
13309319|NCT01262976|26535062|FG003|Up to Year 2|Serious Adverse Event|0|||
13309320|NCT01262976|26535063|FG004|Up to Year 2|Serious Adverse Event|0|||
13309321|NCT01262976|26535064|FG005|Up to Year 2|Serious Adverse Event|0|||
13309322|NCT01262976|26535059|FG000|Up to Year 2|Withdrawal by Subject|1|||
13309323|NCT01262976|26535060|FG001|Up to Year 2|Withdrawal by Subject|0|||
13309324|NCT01262976|26535061|FG002|Up to Year 2|Withdrawal by Subject|0|||
13309325|NCT01262976|26535062|FG003|Up to Year 2|Withdrawal by Subject|0|||
13309326|NCT01262976|26535063|FG004|Up to Year 2|Withdrawal by Subject|0|||
13309327|NCT01262976|26535064|FG005|Up to Year 2|Withdrawal by Subject|0|||
13309328|NCT01262976|26535059|FG000|Up to Year 2|Migrated/moved from study area|0|||
13309329|NCT01262976|26535060|FG001|Up to Year 2|Migrated/moved from study area|0|||
13309330|NCT01262976|26535061|FG002|Up to Year 2|Migrated/moved from study area|0|||
13309331|NCT01262976|26535062|FG003|Up to Year 2|Migrated/moved from study area|2|||
13309332|NCT01262976|26535063|FG004|Up to Year 2|Migrated/moved from study area|1|||
13309333|NCT01262976|26535064|FG005|Up to Year 2|Migrated/moved from study area|2|||
13309334|NCT01262976|26535059|FG000|Up to Year 2|Lost to Follow-up|1|||
13309335|NCT01262976|26535060|FG001|Up to Year 2|Lost to Follow-up|1|||
13309336|NCT01262976|26535061|FG002|Up to Year 2|Lost to Follow-up|2|||
13309337|NCT01262976|26535062|FG003|Up to Year 2|Lost to Follow-up|2|||
13309338|NCT01262976|26535063|FG004|Up to Year 2|Lost to Follow-up|3|||
13309339|NCT01262976|26535064|FG005|Up to Year 2|Lost to Follow-up|3|||
13309340|NCT01262976|26535059|FG000|Up to Year 2|Subjects with unknown completion status|0|||
13309341|NCT01262976|26535060|FG001|Up to Year 2|Subjects with unknown completion status|0|||
13309342|NCT01262976|26535061|FG002|Up to Year 2|Subjects with unknown completion status|1|||
13309343|NCT01262976|26535062|FG003|Up to Year 2|Subjects with unknown completion status|0|||
13309344|NCT01262976|26535063|FG004|Up to Year 2|Subjects with unknown completion status|0|||
13309345|NCT01262976|26535064|FG005|Up to Year 2|Subjects with unknown completion status|0|||
13309346|NCT01262976|26535059|FG000|Up to Year 2|Other|3|||
13309347|NCT01262976|26535060|FG001|Up to Year 2|Other|0|||
13309348|NCT01262976|26535061|FG002|Up to Year 2|Other|0|||
13309349|NCT01262976|26535062|FG003|Up to Year 2|Other|0|||
13309350|NCT01262976|26535063|FG004|Up to Year 2|Other|0|||
13309351|NCT01262976|26535064|FG005|Up to Year 2|Other|0|||
13309352|NCT01262976|26535059|FG000|Up to Year 3|Serious Adverse Event|0|||
13309353|NCT01262976|26535060|FG001|Up to Year 3|Serious Adverse Event|0|||
13309354|NCT01262976|26535061|FG002|Up to Year 3|Serious Adverse Event|2|||
13309355|NCT01262976|26535062|FG003|Up to Year 3|Serious Adverse Event|0|||
13309356|NCT01262976|26535063|FG004|Up to Year 3|Serious Adverse Event|0|||
13309357|NCT01262976|26535064|FG005|Up to Year 3|Serious Adverse Event|0|||
13309358|NCT01262976|26535059|FG000|Up to Year 3|Withdrawal by Subject|1|||
13309359|NCT01262976|26535060|FG001|Up to Year 3|Withdrawal by Subject|0|||
13309360|NCT01262976|26535061|FG002|Up to Year 3|Withdrawal by Subject|0|||
13309361|NCT01262976|26535062|FG003|Up to Year 3|Withdrawal by Subject|0|||
13309362|NCT01262976|26535063|FG004|Up to Year 3|Withdrawal by Subject|0|||
13309363|NCT01262976|26535064|FG005|Up to Year 3|Withdrawal by Subject|0|||
13309364|NCT01262976|26535059|FG000|Up to Year 3|Migrated/moved from study area|0|||
13309365|NCT01262976|26535060|FG001|Up to Year 3|Migrated/moved from study area|0|||
13309366|NCT01262976|26535061|FG002|Up to Year 3|Migrated/moved from study area|0|||
13309367|NCT01262976|26535062|FG003|Up to Year 3|Migrated/moved from study area|2|||
13309368|NCT01262976|26535063|FG004|Up to Year 3|Migrated/moved from study area|1|||
13309369|NCT01262976|26535064|FG005|Up to Year 3|Migrated/moved from study area|1|||
13309370|NCT01262976|26535059|FG000|Up to Year 3|Lost to Follow-up|2|||
13309371|NCT01262976|26535060|FG001|Up to Year 3|Lost to Follow-up|2|||
13309372|NCT01262976|26535061|FG002|Up to Year 3|Lost to Follow-up|4|||
13309373|NCT01262976|26535062|FG003|Up to Year 3|Lost to Follow-up|3|||
13309374|NCT01262976|26535063|FG004|Up to Year 3|Lost to Follow-up|1|||
13309375|NCT01262976|26535064|FG005|Up to Year 3|Lost to Follow-up|3|||
13309376|NCT01262976|26535059|FG000|Up to Year 3|Subjects with unknown completion status|0|||
13309377|NCT01262976|26535060|FG001|Up to Year 3|Subjects with unknown completion status|0|||
13309378|NCT01262976|26535061|FG002|Up to Year 3|Subjects with unknown completion status|1|||
13309379|NCT01262976|26535062|FG003|Up to Year 3|Subjects with unknown completion status|0|||
13309380|NCT01262976|26535063|FG004|Up to Year 3|Subjects with unknown completion status|0|||
13309381|NCT01262976|26535064|FG005|Up to Year 3|Subjects with unknown completion status|0|||
13309382|NCT01262976|26535059|FG000|Up to Year 3|Other|3|||
13309383|NCT01262976|26535060|FG001|Up to Year 3|Other|0|||
13309384|NCT01262976|26535061|FG002|Up to Year 3|Other|0|||
13309385|NCT01262976|26535062|FG003|Up to Year 3|Other|0|||
13309386|NCT01262976|26535063|FG004|Up to Year 3|Other|0|||
13309387|NCT01262976|26535064|FG005|Up to Year 3|Other|0|||
13309388|NCT01262898|26535197|FG000|Overall Study|Protocol Violation|1|||
13309389|NCT01262898|26535198|FG001|Overall Study|Protocol Violation|1|||
13309390|NCT01262898|26535199|FG002|Overall Study|Protocol Violation|0|||
13309391|NCT01262898|26535200|FG003|Overall Study|Protocol Violation|0|||
13309392|NCT01262898|26535197|FG000|Overall Study|Lost to Follow-up|1|||
13309393|NCT01262898|26535198|FG001|Overall Study|Lost to Follow-up|0|||
13309394|NCT01262898|26535199|FG002|Overall Study|Lost to Follow-up|0|||
13309395|NCT01262898|26535200|FG003|Overall Study|Lost to Follow-up|0|||
13309396|NCT01262898|26535197|FG000|Overall Study|Withdrawal by Subject|1|||
13309397|NCT01262898|26535198|FG001|Overall Study|Withdrawal by Subject|1|||
13309398|NCT01262898|26535199|FG002|Overall Study|Withdrawal by Subject|0|||
13309399|NCT01262898|26535200|FG003|Overall Study|Withdrawal by Subject|0|||
13309400|NCT01262872|26535490|FG000|Step 2|Death|0|||
13309401|NCT01262872|26535491|FG001|Step 2|Death|0|||
13309402|NCT01262872|26535492|FG002|Step 2|Death|0|||
13309403|NCT01262872|26535493|FG003|Step 2|Death|1|||
13309404|NCT01262872|26535494|FG004|Step 2|Death|0|||
13309405|NCT01262872|26535495|FG005|Step 2|Death|2|||
13309406|NCT01262872|26535496|FG006|Step 2|Death|2|||
13309407|NCT01262872|26535497|FG007|Step 2|Death|1|||
13309408|NCT01262872|26535490|FG000|Step 2|Protocol Violation|0|||
13309409|NCT01262872|26535491|FG001|Step 2|Protocol Violation|0|||
13309410|NCT01262872|26535492|FG002|Step 2|Protocol Violation|1|||
13309411|NCT01262872|26535493|FG003|Step 2|Protocol Violation|0|||
13309412|NCT01262872|26535494|FG004|Step 2|Protocol Violation|0|||
13309413|NCT01262872|26535495|FG005|Step 2|Protocol Violation|0|||
13309414|NCT01262872|26535496|FG006|Step 2|Protocol Violation|3|||
13309415|NCT01262872|26535497|FG007|Step 2|Protocol Violation|1|||
13309416|NCT01262872|26535490|FG000|Step 2|Withdrawal by Subject|0|||
13309417|NCT01262872|26535491|FG001|Step 2|Withdrawal by Subject|0|||
13309418|NCT01262872|26535492|FG002|Step 2|Withdrawal by Subject|4|||
13309419|NCT01262872|26535493|FG003|Step 2|Withdrawal by Subject|6|||
13309420|NCT01262872|26535494|FG004|Step 2|Withdrawal by Subject|3|||
13309421|NCT01262872|26535495|FG005|Step 2|Withdrawal by Subject|1|||
13309422|NCT01262872|26535496|FG006|Step 2|Withdrawal by Subject|2|||
13309423|NCT01262872|26535497|FG007|Step 2|Withdrawal by Subject|1|||
13309424|NCT01262872|26535490|FG000|Step 2|Migrated/moved from study area|0|||
13309425|NCT01262872|26535491|FG001|Step 2|Migrated/moved from study area|0|||
13309426|NCT01262872|26535492|FG002|Step 2|Migrated/moved from study area|4|||
13309427|NCT01262872|26535493|FG003|Step 2|Migrated/moved from study area|3|||
13309428|NCT01262872|26535494|FG004|Step 2|Migrated/moved from study area|2|||
13309429|NCT01262872|26535495|FG005|Step 2|Migrated/moved from study area|6|||
13309430|NCT01262872|26535496|FG006|Step 2|Migrated/moved from study area|2|||
13309431|NCT01262872|26535497|FG007|Step 2|Migrated/moved from study area|3|||
13309432|NCT01262820|26535506|FG000|Overall Study|Adverse Event|5|||
13309433|NCT01262820|26535506|FG000|Overall Study|Lack of Efficacy|9|||
13309434|NCT01262820|26535506|FG000|Overall Study|Drug held for 21+ days|1|||
13309435|NCT01262677|26535605|FG000|Overall Study|Does not meet entrance criteria|0|||
13309436|NCT01262677|26535606|FG001|Overall Study|Does not meet entrance criteria|2|||
13309437|NCT01262677|26535607|FG002|Overall Study|Does not meet entrance criteria|0|||
13309438|NCT01262677|26535605|FG000|Overall Study|Insufficient clinical response|0|||
13309439|NCT01262677|26535606|FG001|Overall Study|Insufficient clinical response|0|||
13309440|NCT01262677|26535607|FG002|Overall Study|Insufficient clinical response|1|||
13309441|NCT01262677|26535605|FG000|Overall Study|Lost to Follow-up|1|||
13309442|NCT01262677|26535606|FG001|Overall Study|Lost to Follow-up|0|||
13309443|NCT01262677|26535607|FG002|Overall Study|Lost to Follow-up|2|||
13309444|NCT01262677|26535605|FG000|Overall Study|No longer willing to participate|3|||
13309445|NCT01262677|26535606|FG001|Overall Study|No longer willing to participate|3|||
13309446|NCT01262677|26535607|FG002|Overall Study|No longer willing to participate|2|||
13309447|NCT01262677|26535605|FG000|Overall Study|Reason not provided|2|||
13309448|NCT01262677|26535606|FG001|Overall Study|Reason not provided|1|||
13309449|NCT01262677|26535607|FG002|Overall Study|Reason not provided|3|||
13309450|NCT01262677|26535605|FG000|Overall Study|Protocol Violation|0|||
13309451|NCT01262677|26535606|FG001|Overall Study|Protocol Violation|1|||
13309452|NCT01262677|26535607|FG002|Overall Study|Protocol Violation|1|||
13309453|NCT01262677|26535605|FG000|Overall Study|Adverse Event (AE) related to study drug|3|||
13309454|NCT01262677|26535606|FG001|Overall Study|Adverse Event (AE) related to study drug|8|||
13309455|NCT01262677|26535607|FG002|Overall Study|Adverse Event (AE) related to study drug|3|||
13309456|NCT01262651|26535640|FG000|Overall Study|Adverse Event|40|||
13309457|NCT01262651|26535641|FG001|Overall Study|Adverse Event|35|||
13309458|NCT01262651|26535640|FG000|Overall Study|Withdrawal by Subject|15|||
13309459|NCT01262651|26535641|FG001|Overall Study|Withdrawal by Subject|11|||
13309460|NCT01262651|26535640|FG000|Overall Study|Withdrawal by Investigator|2|||
13309461|NCT01262651|26535641|FG001|Overall Study|Withdrawal by Investigator|2|||
13309462|NCT01262651|26535640|FG000|Overall Study|Met Withdrawal Criteria|1|||
13309463|NCT01262651|26535641|FG001|Overall Study|Met Withdrawal Criteria|0|||
13309464|NCT01262638|26535732|FG000|Overall Study|Adverse Event|3|||
13309465|NCT01262638|26535733|FG001|Overall Study|Adverse Event|4|||
13309466|NCT01262638|26535734|FG002|Overall Study|Adverse Event|3|||
13309467|NCT01262638|26535735|FG003|Overall Study|Adverse Event|4|||
13309468|NCT01262638|26535732|FG000|Overall Study|Protocol Violation|1|||
13309469|NCT01262638|26535733|FG001|Overall Study|Protocol Violation|0|||
13309470|NCT01262638|26535734|FG002|Overall Study|Protocol Violation|0|||
13309471|NCT01262638|26535735|FG003|Overall Study|Protocol Violation|1|||
13309472|NCT01262638|26535732|FG000|Overall Study|Withdrawal by Subject|2|||
13309473|NCT01262638|26535733|FG001|Overall Study|Withdrawal by Subject|1|||
13309474|NCT01262638|26535734|FG002|Overall Study|Withdrawal by Subject|0|||
13309475|NCT01262638|26535735|FG003|Overall Study|Withdrawal by Subject|1|||
13309476|NCT01262638|26535732|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
13309477|NCT01262638|26535733|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
13309478|NCT01262638|26535734|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
13309479|NCT01262638|26535735|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
13309480|NCT01262638|26535732|FG000|Overall Study|Lost to Follow-up|1|||
13309481|NCT01262638|26535733|FG001|Overall Study|Lost to Follow-up|1|||
13309482|NCT01262638|26535734|FG002|Overall Study|Lost to Follow-up|1|||
13309483|NCT01262638|26535735|FG003|Overall Study|Lost to Follow-up|1|||
13309484|NCT01262638|26535732|FG000|Overall Study|Participant Went Out of Town|0|||
13309485|NCT01262638|26535733|FG001|Overall Study|Participant Went Out of Town|0|||
13309486|NCT01262638|26535734|FG002|Overall Study|Participant Went Out of Town|1|||
13309487|NCT01262638|26535735|FG003|Overall Study|Participant Went Out of Town|0|||
13309488|NCT01262573|26535750|FG000|Overall Study|Withdrawal by Subject|0|||
13309489|NCT01262573|26535751|FG001|Overall Study|Withdrawal by Subject|1|||
13309490|NCT01262560|26535796|FG000|Overall Study|Protocol Violation|0|||
13309491|NCT01262560|26535797|FG001|Overall Study|Protocol Violation|1|||
13309492|NCT01262560|26535798|FG002|Overall Study|Protocol Violation|2|||
13309493|NCT01262456|26535849|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6|||
13309494|NCT01262456|26535850|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8|||
13309495|NCT01262456|26535851|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9|||
13309496|NCT01262456|26535849|FG000|3-Month Double-Blind Period|Lost to Follow-up|4|||
13309497|NCT01262456|26535850|FG001|3-Month Double-Blind Period|Lost to Follow-up|5|||
13309498|NCT01262456|26535851|FG002|3-Month Double-Blind Period|Lost to Follow-up|3|||
13309499|NCT01262456|26535849|FG000|3-Month Double-Blind Period|Adverse Event|6|||
13309500|NCT01262456|26535850|FG001|3-Month Double-Blind Period|Adverse Event|4|||
13309501|NCT01262456|26535851|FG002|3-Month Double-Blind Period|Adverse Event|8|||
13309502|NCT01262456|26535849|FG000|3-Month Double-Blind Period|Protocol Violation|3|||
13309503|NCT01262456|26535850|FG001|3-Month Double-Blind Period|Protocol Violation|6|||
13309504|NCT01262456|26535851|FG002|3-Month Double-Blind Period|Protocol Violation|6|||
13309505|NCT01262456|26535849|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
13309506|NCT01262456|26535850|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
13309507|NCT01262456|26535851|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
13309508|NCT01262456|26535849|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
13309509|NCT01262456|26535850|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1|||
13309510|NCT01262456|26535851|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
13309511|NCT01262456|26535849|FG000|1-Month Open-Label Extension Period|Adverse Event|2|||
13309512|NCT01262456|26535850|FG001|1-Month Open-Label Extension Period|Adverse Event|0|||
13309513|NCT01262456|26535851|FG002|1-Month Open-Label Extension Period|Adverse Event|2|||
13309514|NCT01262456|26535849|FG000|1-Month Open-Label Extension Period|Protocol Violation|1|||
13309515|NCT01262456|26535850|FG001|1-Month Open-Label Extension Period|Protocol Violation|0|||
13309516|NCT01262456|26535851|FG002|1-Month Open-Label Extension Period|Protocol Violation|2|||
13309517|NCT01262456|26535849|FG000|1-Month Open-Label Extension Period|Other Reason|0|||
13309518|NCT01262456|26535850|FG001|1-Month Open-Label Extension Period|Other Reason|1|||
13309519|NCT01262456|26535851|FG002|1-Month Open-Label Extension Period|Other Reason|0|||
13309520|NCT01262365|26535884|FG000|Overall Study|Lack of Efficacy|35|||
13309521|NCT01262365|26535885|FG001|Overall Study|Lack of Efficacy|30|||
13309522|NCT01262365|26535886|FG002|Overall Study|Lack of Efficacy|47|||
13309523|NCT01262365|26535884|FG000|Overall Study|Protocol Violation|3|||
13309524|NCT01262365|26535885|FG001|Overall Study|Protocol Violation|1|||
13309525|NCT01262365|26535886|FG002|Overall Study|Protocol Violation|1|||
13309526|NCT01262365|26535884|FG000|Overall Study|Lost to Follow-up|3|||
13309527|NCT01262365|26535885|FG001|Overall Study|Lost to Follow-up|7|||
13309528|NCT01262365|26535886|FG002|Overall Study|Lost to Follow-up|6|||
13309529|NCT01262365|26535884|FG000|Overall Study|Withdrawal by Subject|17|||
13309530|NCT01262365|26535885|FG001|Overall Study|Withdrawal by Subject|22|||
13309531|NCT01262365|26535886|FG002|Overall Study|Withdrawal by Subject|22|||
13309532|NCT01262365|26535884|FG000|Overall Study|Death|1|||
13309533|NCT01262365|26535885|FG001|Overall Study|Death|2|||
13309534|NCT01262365|26535886|FG002|Overall Study|Death|1|||
13309535|NCT01262365|26535884|FG000|Overall Study|Adverse Event|26|||
13309536|NCT01262365|26535885|FG001|Overall Study|Adverse Event|16|||
13309537|NCT01262365|26535886|FG002|Overall Study|Adverse Event|11|||
13309538|NCT01262365|26535884|FG000|Overall Study|sponsor decision|1|||
13309539|NCT01262365|26535885|FG001|Overall Study|sponsor decision|1|||
13309540|NCT01262365|26535886|FG002|Overall Study|sponsor decision|0|||
13309541|NCT01262365|26535884|FG000|Overall Study|Randomization error|1|||
13309542|NCT01262365|26535885|FG001|Overall Study|Randomization error|0|||
13309543|NCT01262365|26535886|FG002|Overall Study|Randomization error|2|||
13309544|NCT01262365|26535884|FG000|Overall Study|Non-compliance|1|||
13309545|NCT01262365|26535885|FG001|Overall Study|Non-compliance|0|||
13309546|NCT01262365|26535886|FG002|Overall Study|Non-compliance|2|||
13309547|NCT01262365|26535884|FG000|Overall Study|Suspected pregnancy|1|||
13309548|NCT01262365|26535885|FG001|Overall Study|Suspected pregnancy|0|||
13309549|NCT01262365|26535886|FG002|Overall Study|Suspected pregnancy|0|||
13309550|NCT01262365|26535884|FG000|Overall Study|Patient pregnant|1|||
13309551|NCT01262365|26535885|FG001|Overall Study|Patient pregnant|0|||
13309552|NCT01262365|26535886|FG002|Overall Study|Patient pregnant|1|||
13309553|NCT01262365|26535884|FG000|Overall Study|Toxicity related to study drug|0|||
13309554|NCT01262365|26535885|FG001|Overall Study|Toxicity related to study drug|1|||
13309555|NCT01262365|26535886|FG002|Overall Study|Toxicity related to study drug|0|||
13309556|NCT01262365|26535884|FG000|Overall Study|Cannot tolerate the protocol|0|||
13309557|NCT01262365|26535885|FG001|Overall Study|Cannot tolerate the protocol|1|||
13309558|NCT01262365|26535886|FG002|Overall Study|Cannot tolerate the protocol|0|||
13309559|NCT01262365|26535884|FG000|Overall Study|Patient unavailable|0|||
13309560|NCT01262365|26535885|FG001|Overall Study|Patient unavailable|0|||
13309561|NCT01262365|26535886|FG002|Overall Study|Patient unavailable|1|||
13309562|NCT01262352|26535905|FG000|Period 1|Illness after randomization|1|||
13309563|NCT01262352|26535906|FG001|Period 1|Illness after randomization|0|||
13309564|NCT01262352|26535905|FG000|Washout|Adverse Event|1|||
13309565|NCT01262352|26535906|FG001|Washout|Adverse Event|1|||
13309566|NCT01262352|26535905|FG000|Washout|Extended Washout|0|||
13309567|NCT01262352|26535906|FG001|Washout|Extended Washout|1|||
13309568|NCT01262287|26535923|FG000|Overall Study|Lost to Follow-up|2|||
13309569|NCT01262287|26535924|FG001|Overall Study|Lost to Follow-up|1|||
13309570|NCT01262092|26535937|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2|||
13309571|NCT01262092|26535938|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1|||
13309572|NCT01262092|26535937|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1|||
13309573|NCT01262092|26535938|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0|||
13309574|NCT01262092|26535937|FG000|Buprenorphine Taper|noncompliance - missed medication|1|||
13309575|NCT01262092|26535938|FG001|Buprenorphine Taper|noncompliance - missed medication|1|||
13309576|NCT01262092|26535937|FG000|Gabapentin Taper|noncompliance - missed medications|1|||
13309577|NCT01262092|26535938|FG001|Gabapentin Taper|noncompliance - missed medications|0|||
13309578|NCT01262027|26535945|FG000|Overall Study|Adverse Event|1|||
13309579|NCT01262027|26535945|FG000|Overall Study|Withdrawal by Subject|3|||
13309580|NCT01262027|26535945|FG000|Overall Study|Protocol Violation|1|||
13309581|NCT01261975|26535966|FG000|Overall Study|Surgical complication|1|||
13309582|NCT01261793|26535999|FG000|Overall Study|Lack of Efficacy|44|||
13309583|NCT01261793|26536000|FG001|Overall Study|Lack of Efficacy|37|||
13309584|NCT01261793|26536001|FG002|Overall Study|Lack of Efficacy|32|||
13309585|NCT01261793|26535999|FG000|Overall Study|Protocol Violation|3|||
13309586|NCT01261793|26536000|FG001|Overall Study|Protocol Violation|5|||
13309587|NCT01261793|26536001|FG002|Overall Study|Protocol Violation|6|||
13309588|NCT01261793|26535999|FG000|Overall Study|Lost to Follow-up|10|||
13309589|NCT01261793|26536000|FG001|Overall Study|Lost to Follow-up|3|||
13309590|NCT01261793|26536001|FG002|Overall Study|Lost to Follow-up|7|||
13309591|NCT01261793|26535999|FG000|Overall Study|Withdrawal by Subject|12|||
13309592|NCT01261793|26536000|FG001|Overall Study|Withdrawal by Subject|14|||
13309593|NCT01261793|26536001|FG002|Overall Study|Withdrawal by Subject|14|||
13309594|NCT01261793|26535999|FG000|Overall Study|Death|3|||
13309595|NCT01261793|26536000|FG001|Overall Study|Death|1|||
13309596|NCT01261793|26536001|FG002|Overall Study|Death|0|||
13309597|NCT01261793|26535999|FG000|Overall Study|Adverse Event|9|||
13309598|NCT01261793|26536000|FG001|Overall Study|Adverse Event|24|||
13309599|NCT01261793|26536001|FG002|Overall Study|Adverse Event|19|||
13309600|NCT01261793|26535999|FG000|Overall Study|Patient non-availability|1|||
13309601|NCT01261793|26536000|FG001|Overall Study|Patient non-availability|1|||
13309602|NCT01261793|26536001|FG002|Overall Study|Patient non-availability|1|||
13309603|NCT01261793|26535999|FG000|Overall Study|Suspected pregnancy|1|||
13309604|NCT01261793|26536000|FG001|Overall Study|Suspected pregnancy|1|||
13309605|NCT01261793|26536001|FG002|Overall Study|Suspected pregnancy|0|||
13309606|NCT01261793|26535999|FG000|Overall Study|Patient non-compliance|1|||
13309607|NCT01261793|26536000|FG001|Overall Study|Patient non-compliance|0|||
13309608|NCT01261793|26536001|FG002|Overall Study|Patient non-compliance|1|||
13309609|NCT01261793|26535999|FG000|Overall Study|Patient pregnant|1|||
13309610|NCT01261793|26536000|FG001|Overall Study|Patient pregnant|0|||
13309611|NCT01261793|26536001|FG002|Overall Study|Patient pregnant|0|||
13309612|NCT01261793|26535999|FG000|Overall Study|Outside the study area|0|||
13309613|NCT01261793|26536000|FG001|Overall Study|Outside the study area|2|||
13309614|NCT01261793|26536001|FG002|Overall Study|Outside the study area|1|||
13309615|NCT01261793|26535999|FG000|Overall Study|Lack of efficacy & patient not available|0|||
13309616|NCT01261793|26536000|FG001|Overall Study|Lack of efficacy & patient not available|1|||
13309617|NCT01261793|26536001|FG002|Overall Study|Lack of efficacy & patient not available|0|||
13309618|NCT01261793|26535999|FG000|Overall Study|Patient withdrew after cardiology visit|0|||
13309619|NCT01261793|26536000|FG001|Overall Study|Patient withdrew after cardiology visit|1|||
13309620|NCT01261793|26536001|FG002|Overall Study|Patient withdrew after cardiology visit|0|||
13309621|NCT01261793|26535999|FG000|Overall Study|Randomization error|0|||
13309622|NCT01261793|26536000|FG001|Overall Study|Randomization error|1|||
13309623|NCT01261793|26536001|FG002|Overall Study|Randomization error|0|||
13309624|NCT01261793|26535999|FG000|Overall Study|Patient unable to start IV line|0|||
13309625|NCT01261793|26536000|FG001|Overall Study|Patient unable to start IV line|0|||
13309626|NCT01261793|26536001|FG002|Overall Study|Patient unable to start IV line|1|||
13309627|NCT01261780|26536016|FG000|Overall Study|Withdrawal by Subject|1|||
13309628|NCT01261780|26536017|FG001|Overall Study|Withdrawal by Subject|0|||
13309629|NCT01261780|26536016|FG000|Overall Study|Event not related to subject|1|||
13309630|NCT01261780|26536017|FG001|Overall Study|Event not related to subject|2|||
13309631|NCT01261624|26536041|FG000|Week 0 to Week 12|Disease Progression|1|||
13309632|NCT01261624|26536042|FG001|Week 0 to Week 12|Disease Progression|1|||
13309633|NCT01261624|26536041|FG000|Week 0 to Week 12|Insufficient Response|0|||
13309634|NCT01261624|26536042|FG001|Week 0 to Week 12|Insufficient Response|2|||
13309635|NCT01261624|26536041|FG000|Week 13 to Week 24|Insufficient Response|0|||
13309636|NCT01261624|26536042|FG001|Week 13 to Week 24|Insufficient Response|1|||
13309637|NCT01261611|26536088|FG000|Treatment Cycle 1|Withdrawal by Subject|3|||
13309638|NCT01261611|26536089|FG001|Treatment Cycle 1|Withdrawal by Subject|2|||
13309639|NCT01261611|26536090|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
13309640|NCT01261611|26536088|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
13309641|NCT01261611|26536089|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
13309642|NCT01261611|26536090|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
13309643|NCT01261611|26536088|FG000|Treatment Cycle 1|Adverse Event|0|||
13309644|NCT01261611|26536089|FG001|Treatment Cycle 1|Adverse Event|1|||
13309645|NCT01261611|26536090|FG002|Treatment Cycle 1|Adverse Event|0|||
13309646|NCT01261611|26536088|FG000|Treatment Cycle 1|Protocol Violation|0|||
13309647|NCT01261611|26536089|FG001|Treatment Cycle 1|Protocol Violation|0|||
13309648|NCT01261611|26536090|FG002|Treatment Cycle 1|Protocol Violation|2|||
13309649|NCT01261611|26536088|FG000|Treatment Cycle 2|Completed study|4|||
13309650|NCT01261611|26536089|FG001|Treatment Cycle 2|Completed study|0|||
13309651|NCT01261611|26536090|FG002|Treatment Cycle 2|Completed study|0|||
13309652|NCT01261611|26536088|FG000|Treatment Cycle 2|Withdrawal by Subject|4|||
13309653|NCT01261611|26536089|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
13309654|NCT01261611|26536090|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
13309655|NCT01261611|26536088|FG000|Treatment Cycle 2|Adverse Event|1|||
13309656|NCT01261611|26536089|FG001|Treatment Cycle 2|Adverse Event|0|||
13309657|NCT01261611|26536090|FG002|Treatment Cycle 2|Adverse Event|0|||
13309658|NCT01261611|26536088|FG000|Treatment Cycle 2|Protocol Violation|2|||
13309659|NCT01261611|26536089|FG001|Treatment Cycle 2|Protocol Violation|0|||
13309660|NCT01261611|26536090|FG002|Treatment Cycle 2|Protocol Violation|0|||
13309661|NCT01261611|26536088|FG000|Treatment Cycle 2|Not otherwise specified|2|||
13309662|NCT01261611|26536089|FG001|Treatment Cycle 2|Not otherwise specified|0|||
13309663|NCT01261611|26536090|FG002|Treatment Cycle 2|Not otherwise specified|0|||
13309664|NCT01261611|26536088|FG000|Treatment Cycle 3|Completed study|24|||
13309665|NCT01261611|26536089|FG001|Treatment Cycle 3|Completed study|0|||
13309666|NCT01261611|26536090|FG002|Treatment Cycle 3|Completed study|0|||
13309667|NCT01261611|26536088|FG000|Treatment Cycle 3|Withdrawal by Subject|4|||
13309668|NCT01261611|26536089|FG001|Treatment Cycle 3|Withdrawal by Subject|0|||
13309669|NCT01261611|26536090|FG002|Treatment Cycle 3|Withdrawal by Subject|0|||
13309670|NCT01261611|26536088|FG000|Treatment Cycle 3|Adverse Event|1|||
13309671|NCT01261611|26536089|FG001|Treatment Cycle 3|Adverse Event|0|||
13309672|NCT01261611|26536090|FG002|Treatment Cycle 3|Adverse Event|0|||
13309673|NCT01261611|26536088|FG000|Treatment Cycle 3|Lost to Follow-up|1|||
13309674|NCT01261611|26536089|FG001|Treatment Cycle 3|Lost to Follow-up|0|||
13309675|NCT01261611|26536090|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
13309676|NCT01261611|26536088|FG000|Treatment Cycle 4|Completed study|87|||
13309677|NCT01261611|26536089|FG001|Treatment Cycle 4|Completed study|0|||
13309678|NCT01261611|26536090|FG002|Treatment Cycle 4|Completed study|0|||
13309679|NCT01261611|26536088|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
13309680|NCT01261611|26536089|FG001|Treatment Cycle 4|Withdrawal by Subject|0|||
13309681|NCT01261611|26536090|FG002|Treatment Cycle 4|Withdrawal by Subject|0|||
13309682|NCT01261611|26536088|FG000|Treatment Cycle 4|Adverse Event|1|||
13309683|NCT01261611|26536089|FG001|Treatment Cycle 4|Adverse Event|0|||
13309684|NCT01261611|26536090|FG002|Treatment Cycle 4|Adverse Event|0|||
13309685|NCT01261611|26536088|FG000|Treatment Cycle 4|Lost to Follow-up|2|||
13309686|NCT01261611|26536089|FG001|Treatment Cycle 4|Lost to Follow-up|0|||
13309687|NCT01261611|26536090|FG002|Treatment Cycle 4|Lost to Follow-up|0|||
13309688|NCT01261611|26536088|FG000|Treatment Cycle 4|Not otherwise specified|3|||
13309689|NCT01261611|26536089|FG001|Treatment Cycle 4|Not otherwise specified|0|||
13309690|NCT01261611|26536090|FG002|Treatment Cycle 4|Not otherwise specified|0|||
13309691|NCT01261611|26536088|FG000|Treatment Cycle 5|Withdrawal by Subject|1|||
13309692|NCT01261611|26536089|FG001|Treatment Cycle 5|Withdrawal by Subject|0|||
13309693|NCT01261611|26536090|FG002|Treatment Cycle 5|Withdrawal by Subject|0|||
13309694|NCT01261611|26536088|FG000|Treatment Cycle 5|Adverse Event|1|||
13309695|NCT01261611|26536089|FG001|Treatment Cycle 5|Adverse Event|0|||
13309696|NCT01261611|26536090|FG002|Treatment Cycle 5|Adverse Event|0|||
13309697|NCT01261611|26536088|FG000|Treatment Cycle 5|Lost to Follow-up|1|||
13309698|NCT01261611|26536089|FG001|Treatment Cycle 5|Lost to Follow-up|0|||
13309699|NCT01261611|26536090|FG002|Treatment Cycle 5|Lost to Follow-up|0|||
13309700|NCT01261390|26536265|FG000|Overall Study|Significant Concurrent Illness|1|||
13309701|NCT01261390|26536266|FG001|Overall Study|Significant Concurrent Illness|0|||
13309702|NCT01261390|26536267|FG002|Overall Study|Significant Concurrent Illness|1|||
13309703|NCT01261390|26536268|FG003|Overall Study|Significant Concurrent Illness|0|||
13309704|NCT01261390|26536265|FG000|Overall Study|Dissatisfaction with Treatment|2|||
13309705|NCT01261390|26536266|FG001|Overall Study|Dissatisfaction with Treatment|1|||
13309706|NCT01261390|26536267|FG002|Overall Study|Dissatisfaction with Treatment|1|||
13309707|NCT01261390|26536268|FG003|Overall Study|Dissatisfaction with Treatment|2|||
13309708|NCT01261390|26536265|FG000|Overall Study|Relocation|0|||
13309709|NCT01261390|26536266|FG001|Overall Study|Relocation|1|||
13309710|NCT01261390|26536267|FG002|Overall Study|Relocation|0|||
13309711|NCT01261390|26536268|FG003|Overall Study|Relocation|0|||
13309712|NCT01261390|26536265|FG000|Overall Study|Loss of Interest in the Study|3|||
13309713|NCT01261390|26536266|FG001|Overall Study|Loss of Interest in the Study|1|||
13309714|NCT01261390|26536267|FG002|Overall Study|Loss of Interest in the Study|0|||
13309715|NCT01261390|26536268|FG003|Overall Study|Loss of Interest in the Study|0|||
13309716|NCT01261390|26536265|FG000|Overall Study|Lost to Follow-up|1|||
13309717|NCT01261390|26536266|FG001|Overall Study|Lost to Follow-up|6|||
13309718|NCT01261390|26536267|FG002|Overall Study|Lost to Follow-up|5|||
13309719|NCT01261390|26536268|FG003|Overall Study|Lost to Follow-up|6|||
13309720|NCT01261338|26536283|FG000|Overall Study|Withdrawal by Subject|3|||
13309721|NCT01261338|26536284|FG001|Overall Study|Withdrawal by Subject|2|||
13309722|NCT01261325|26536326|FG000|Overall Study|Lack of Efficacy|1|||
13309723|NCT01261325|26536327|FG001|Overall Study|Lack of Efficacy|1|||
13309724|NCT01261325|26536328|FG002|Overall Study|Lack of Efficacy|0|||
13309725|NCT01261325|26536326|FG000|Overall Study|Withdrawal by Subject|2|||
13309726|NCT01261325|26536327|FG001|Overall Study|Withdrawal by Subject|2|||
13309727|NCT01261325|26536328|FG002|Overall Study|Withdrawal by Subject|4|||
13309728|NCT01261325|26536326|FG000|Overall Study|SAE, non-fatal|1|||
13309729|NCT01261325|26536327|FG001|Overall Study|SAE, non-fatal|5|||
13309730|NCT01261325|26536328|FG002|Overall Study|SAE, non-fatal|1|||
13309731|NCT01261325|26536326|FG000|Overall Study|AE, non-serious non-fatal|9|||
13309732|NCT01261325|26536327|FG001|Overall Study|AE, non-serious non-fatal|15|||
13309733|NCT01261325|26536328|FG002|Overall Study|AE, non-serious non-fatal|13|||
13309734|NCT01261325|26536326|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
13309735|NCT01261325|26536327|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
13309736|NCT01261325|26536328|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
13309737|NCT01261325|26536326|FG000|Overall Study|Non Compliance|2|||
13309738|NCT01261325|26536327|FG001|Overall Study|Non Compliance|0|||
13309739|NCT01261325|26536328|FG002|Overall Study|Non Compliance|0|||
13309740|NCT01261325|26536326|FG000|Overall Study|Patient Randomized by Mistake|0|||
13309741|NCT01261325|26536327|FG001|Overall Study|Patient Randomized by Mistake|1|||
13309742|NCT01261325|26536328|FG002|Overall Study|Patient Randomized by Mistake|0|||
13309743|NCT01261325|26536326|FG000|Overall Study|Erroneously Randomized|1|||
13309744|NCT01261325|26536327|FG001|Overall Study|Erroneously Randomized|0|||
13309745|NCT01261325|26536328|FG002|Overall Study|Erroneously Randomized|0|||
13309746|NCT01261325|26536326|FG000|Overall Study|Screen Failure|1|||
13309747|NCT01261325|26536327|FG001|Overall Study|Screen Failure|0|||
13309748|NCT01261325|26536328|FG002|Overall Study|Screen Failure|0|||
13309749|NCT01261325|26536326|FG000|Overall Study|Randomized in Error|0|||
13309750|NCT01261325|26536327|FG001|Overall Study|Randomized in Error|0|||
13309751|NCT01261325|26536328|FG002|Overall Study|Randomized in Error|1|||
13309752|NCT01261325|26536326|FG000|Overall Study|Protocol Violation|0|||
13309753|NCT01261325|26536327|FG001|Overall Study|Protocol Violation|3|||
13309754|NCT01261325|26536328|FG002|Overall Study|Protocol Violation|1|||
13309755|NCT01261325|26536326|FG000|Overall Study|Lost to Follow-up|0|||
13309756|NCT01261325|26536327|FG001|Overall Study|Lost to Follow-up|1|||
13309757|NCT01261325|26536328|FG002|Overall Study|Lost to Follow-up|3|||
13309758|NCT01261325|26536326|FG000|Overall Study|AE, serious fatal|0|||
13309759|NCT01261325|26536327|FG001|Overall Study|AE, serious fatal|0|||
13309760|NCT01261325|26536328|FG002|Overall Study|AE, serious fatal|2|||
13309761|NCT01261000|26536334|FG000|Overall Study|Screen failure|1|||
13309762|NCT01260948|26536349|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
13309763|NCT01260948|26536350|FG001|Washout of 28 Days|Withdrawal by Subject|3|||
13309764|NCT01260948|26536349|FG000|Second Intervention|Emesis|0|||
13309765|NCT01260948|26536350|FG001|Second Intervention|Emesis|1|||
13309766|NCT01260922|26536365|FG000|First Intervention|Withdrawal by Subject|0|||
13309767|NCT01260922|26536366|FG001|First Intervention|Withdrawal by Subject|1|||
13309768|NCT01260922|26536365|FG000|Washout of 28 Days|Withdrawal by Subject|4|||
13309769|NCT01260922|26536366|FG001|Washout of 28 Days|Withdrawal by Subject|2|||
13309770|NCT01260922|26536365|FG000|Second Intervention|Emesis|0|||
13309771|NCT01260922|26536366|FG001|Second Intervention|Emesis|2|||
13309772|NCT01260896|26536389|FG000|First Intervention|Withdrawn Due to Emesis|2|||
13309773|NCT01260896|26536390|FG001|First Intervention|Withdrawn Due to Emesis|0|||
13309774|NCT01260701|26536399|FG000|Overall Study|Adverse Event|9|||
13309775|NCT01260701|26536399|FG000|Overall Study|Withdrawal by Subject|2|||
13309776|NCT01260701|26536399|FG000|Overall Study|Progression|53|||
13309777|NCT01260701|26536399|FG000|Overall Study|Death|2|||
13309778|NCT01260701|26536399|FG000|Overall Study|Not protocol specified|3|||
13309779|NCT01260701|26536399|FG000|Overall Study|Under review|1|||
13309780|NCT01260701|26536399|FG000|Overall Study|Ineligible|4|||
13309781|NCT01260701|26536399|FG000|Overall Study|Did not begin protocol therapy|1|||
13309782|NCT01260584|26536446|FG000|Period 1|Protocol Violation|0|||
13309783|NCT01260584|26536447|FG001|Period 1|Protocol Violation|0|||
13309784|NCT01260584|26536448|FG002|Period 1|Protocol Violation|1|||
13309785|NCT01260584|26536449|FG003|Period 1|Protocol Violation|1|||
13309786|NCT01260584|26536446|FG000|Period 1|Adverse Event|0|||
13309787|NCT01260584|26536447|FG001|Period 1|Adverse Event|0|||
13309788|NCT01260584|26536448|FG002|Period 1|Adverse Event|1|||
13309789|NCT01260584|26536449|FG003|Period 1|Adverse Event|0|||
13309790|NCT01260584|26536446|FG000|Period 2|Protocol Violation|0|||
13309791|NCT01260584|26536447|FG001|Period 2|Protocol Violation|2|||
13309792|NCT01260584|26536448|FG002|Period 2|Protocol Violation|3|||
13309793|NCT01260584|26536449|FG003|Period 2|Protocol Violation|1|||
13309794|NCT01260584|26536446|FG000|Period 2|Adverse Event|1|||
13309795|NCT01260584|26536447|FG001|Period 2|Adverse Event|0|||
13309796|NCT01260584|26536448|FG002|Period 2|Adverse Event|2|||
13309797|NCT01260584|26536449|FG003|Period 2|Adverse Event|0|||
13309798|NCT01260584|26536446|FG000|Period 2|Withdrawal by Subject|0|||
13309799|NCT01260584|26536447|FG001|Period 2|Withdrawal by Subject|1|||
13309800|NCT01260584|26536448|FG002|Period 2|Withdrawal by Subject|0|||
13309801|NCT01260584|26536449|FG003|Period 2|Withdrawal by Subject|0|||
13309802|NCT01260467|26536457|FG000|Overall Study|Withdrawal by Subject|2|||
13309803|NCT01260350|26536710|FG000|Overall Study|Lack of Efficacy|0|||
13309804|NCT01260350|26536711|FG001|Overall Study|Lack of Efficacy|0|||
13309805|NCT01260350|26536712|FG002|Overall Study|Lack of Efficacy|0|||
13309806|NCT01260350|26536713|FG003|Overall Study|Lack of Efficacy|0|||
13309807|NCT01260350|26536714|FG004|Overall Study|Lack of Efficacy|0|||
13309808|NCT01260350|26536715|FG005|Overall Study|Lack of Efficacy|0|||
13309809|NCT01260350|26536716|FG006|Overall Study|Lack of Efficacy|0|||
13309810|NCT01260350|26536717|FG007|Overall Study|Lack of Efficacy|0|||
13309811|NCT01260350|26536718|FG008|Overall Study|Lack of Efficacy|0|||
13309812|NCT01260350|26536719|FG009|Overall Study|Lack of Efficacy|0|||
13309813|NCT01260350|26536720|FG010|Overall Study|Lack of Efficacy|0|||
13309814|NCT01260350|26536721|FG011|Overall Study|Lack of Efficacy|0|||
13309815|NCT01260350|26536722|FG012|Overall Study|Lack of Efficacy|0|||
13309816|NCT01260350|26536723|FG013|Overall Study|Lack of Efficacy|0|||
13309817|NCT01260350|26536724|FG014|Overall Study|Lack of Efficacy|0|||
13309818|NCT01260350|26536725|FG015|Overall Study|Lack of Efficacy|0|||
13309819|NCT01260350|26536726|FG016|Overall Study|Lack of Efficacy|0|||
13309820|NCT01260350|26536727|FG017|Overall Study|Lack of Efficacy|1|||
13309821|NCT01260350|26536728|FG018|Overall Study|Lack of Efficacy|0|||
13309822|NCT01260350|26536729|FG019|Overall Study|Lack of Efficacy|0|||
13309823|NCT01260350|26536730|FG020|Overall Study|Lack of Efficacy|3|||
13309824|NCT01260350|26536731|FG021|Overall Study|Lack of Efficacy|0|||
13309825|NCT01260350|26536710|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
13309826|NCT01260350|26536711|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
13309827|NCT01260350|26536712|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
13309828|NCT01260350|26536713|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
13309829|NCT01260350|26536714|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
13309830|NCT01260350|26536715|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
13309831|NCT01260350|26536716|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
13309832|NCT01260350|26536717|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
13309833|NCT01260350|26536718|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1|||
13309834|NCT01260350|26536719|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
13309835|NCT01260350|26536720|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
13309836|NCT01260350|26536721|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
13309837|NCT01260350|26536722|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
13309838|NCT01260350|26536723|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
13309839|NCT01260350|26536724|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
13309840|NCT01260350|26536725|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
13309841|NCT01260350|26536726|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
13309842|NCT01260350|26536727|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
13309843|NCT01260350|26536728|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
13309844|NCT01260350|26536729|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
13309845|NCT01260350|26536730|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
13309846|NCT01260350|26536731|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
13309847|NCT01260311|26536741|FG000|Overall Study|Adverse Event|11|||
13309848|NCT01260311|26536741|FG000|Overall Study|Lack of Efficacy|4|||
13309849|NCT01260311|26536741|FG000|Overall Study|Lost to Follow-up|25|||
13309850|NCT01260311|26536741|FG000|Overall Study|Withdrawal by Subject|6|||
13309851|NCT01260311|26536741|FG000|Overall Study|Financial Constraints|77|||
13309852|NCT01260311|26536741|FG000|Overall Study|Gone to Province|2|||
13309853|NCT01260311|26536741|FG000|Overall Study|Medication Stopped|1|||
13309854|NCT01260311|26536741|FG000|Overall Study|Fesoterodine Started Before Enrollment|1|||
13309855|NCT01260194|26536755|FG000|Overall Study|Withdrawal of Consent|1|||
13309856|NCT01260181|26536766|FG000|Overall Study|Decision of Investigator|1|||
13309857|NCT01260142|26536835|FG000|Treatment Period 1|Study on hold|1|||
13309858|NCT01260142|26536836|FG001|Treatment Period 1|Study on hold|1|||
13309859|NCT01260142|26536837|FG002|Treatment Period 1|Study on hold|0|||
13309860|NCT01260142|26536838|FG003|Treatment Period 1|Study on hold|0|||
13309861|NCT01260142|26536839|FG004|Treatment Period 1|Study on hold|1|||
13309862|NCT01260142|26536840|FG005|Treatment Period 1|Study on hold|2|||
13309863|NCT01260142|26536835|FG000|Treatment Period 1|Unexplained elevated sys. BP|0|||
13309864|NCT01260142|26536836|FG001|Treatment Period 1|Unexplained elevated sys. BP|0|||
13309865|NCT01260142|26536837|FG002|Treatment Period 1|Unexplained elevated sys. BP|0|||
13309866|NCT01260142|26536838|FG003|Treatment Period 1|Unexplained elevated sys. BP|0|||
13122001|NCT02969863|25945596|FG001|Overall Study|Physician Decision|0|||
13122002|NCT02969863|25945597|FG002|Overall Study|Physician Decision|0|||
13122003|NCT02969863|25945598|FG003|Overall Study|Physician Decision|0|||
13122004|NCT02969863|25945599|FG004|Overall Study|Physician Decision|0|||
13122005|NCT02969863|25945600|FG005|Overall Study|Physician Decision|0|||
13122006|NCT02969707|25945645|FG000|Overall Study|Adverse Event|1|||
13122007|NCT02969707|25945646|FG001|Overall Study|Adverse Event|2|||
13122008|NCT02969707|25945645|FG000|Overall Study|Lost to Follow-up|3|||
13122009|NCT02969707|25945646|FG001|Overall Study|Lost to Follow-up|0|||
13122010|NCT02969707|25945645|FG000|Overall Study|Physician Decision|0|||
13122011|NCT02969707|25945646|FG001|Overall Study|Physician Decision|1|||
13122012|NCT02969707|25945645|FG000|Overall Study|Protocol Violation|1|||
13122013|NCT02969707|25945646|FG001|Overall Study|Protocol Violation|1|||
13122014|NCT02969707|25945645|FG000|Overall Study|Withdrawal by Subject|3|||
13122015|NCT02969707|25945646|FG001|Overall Study|Withdrawal by Subject|4|||
13122016|NCT02969655|25945686|FG000|Overall Study|Withdrawal by Subject|3|||
13122017|NCT02969655|25945687|FG001|Overall Study|Withdrawal by Subject|2|||
13122018|NCT02969655|25945686|FG000|Overall Study|Physician Decision|4|||
13122019|NCT02969655|25945687|FG001|Overall Study|Physician Decision|3|||
13122020|NCT02969655|25945686|FG000|Overall Study|Protocol-specified withdrawal criteria|4|||
13122021|NCT02969655|25945687|FG001|Overall Study|Protocol-specified withdrawal criteria|2|||
13122022|NCT02969655|25945686|FG000|Overall Study|Adverse Event|10|||
13122023|NCT02969655|25945687|FG001|Overall Study|Adverse Event|8|||
13122024|NCT02969590|25945713|FG000|Screening Period|Hormones not suppressed post Lupron|1|||
13122025|NCT02969590|25945714|FG001|Screening Period|Hormones not suppressed post Lupron|0|||
13122026|NCT02969590|25945715|FG002|Screening Period|Hormones not suppressed post Lupron|0|||
13122027|NCT02969525|25945876|FG000|Double-Blind Period|Adverse Event|0|||
13122028|NCT02969525|25945877|FG001|Double-Blind Period|Adverse Event|0|||
13122029|NCT02969525|25945878|FG002|Double-Blind Period|Adverse Event|1|||
13122030|NCT02969525|25945879|FG003|Double-Blind Period|Adverse Event|1|||
13122031|NCT02969525|25945880|FG004|Double-Blind Period|Adverse Event|0|||
13122032|NCT02969525|25945881|FG005|Double-Blind Period|Adverse Event|0|||
13122033|NCT02969525|25945882|FG006|Double-Blind Period|Adverse Event|0|||
13122034|NCT02969525|25945883|FG007|Double-Blind Period|Adverse Event|0|||
13122035|NCT02969525|25945884|FG008|Double-Blind Period|Adverse Event|0|||
13122036|NCT02969525|25945885|FG009|Double-Blind Period|Adverse Event|0|||
13122037|NCT02969525|25945886|FG010|Double-Blind Period|Adverse Event|0|||
13122038|NCT02969525|25945887|FG011|Double-Blind Period|Adverse Event|0|||
13122039|NCT02969525|25945876|FG000|Double-Blind Period|LOW EGFR|0|||
13122040|NCT02969525|25945877|FG001|Double-Blind Period|LOW EGFR|0|||
13122041|NCT02969525|25945878|FG002|Double-Blind Period|LOW EGFR|0|||
13122042|NCT02969525|25945879|FG003|Double-Blind Period|LOW EGFR|1|||
13122043|NCT02969525|25945880|FG004|Double-Blind Period|LOW EGFR|0|||
13122044|NCT02969525|25945881|FG005|Double-Blind Period|LOW EGFR|0|||
13122045|NCT02969525|25945882|FG006|Double-Blind Period|LOW EGFR|0|||
13122046|NCT02969525|25945883|FG007|Double-Blind Period|LOW EGFR|0|||
13122047|NCT02969525|25945884|FG008|Double-Blind Period|LOW EGFR|0|||
13122048|NCT02969525|25945885|FG009|Double-Blind Period|LOW EGFR|0|||
13122049|NCT02969525|25945886|FG010|Double-Blind Period|LOW EGFR|0|||
13122050|NCT02969525|25945887|FG011|Double-Blind Period|LOW EGFR|0|||
13122051|NCT02969525|25945876|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2|||
13122052|NCT02969525|25945877|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0|||
13122053|NCT02969525|25945878|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0|||
13122054|NCT02969525|25945879|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2|||
13122055|NCT02969525|25945880|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0|||
13203948|NCT01978145|26226475|FG000|Washout Period 1|Par. reached defined stopping criteria|0|||
13203949|NCT01978145|26226476|FG001|Washout Period 1|Par. reached defined stopping criteria|1|||
13203950|NCT01978145|26226475|FG000|Treatment Period 2|Adverse Event|3|||
13203951|NCT01978145|26226476|FG001|Treatment Period 2|Adverse Event|3|||
13203952|NCT01978145|26226475|FG000|Treatment Period 2|Protocol Violation|0|||
13203953|NCT01978145|26226476|FG001|Treatment Period 2|Protocol Violation|1|||
13203954|NCT01978145|26226475|FG000|Treatment Period 2|Lost to Follow-up|1|||
13286818|NCT00477672|26472364|FG000|Overall Study|Adverse Event|3|||
13286819|NCT00477672|26472365|FG001|Overall Study|Adverse Event|5|||
13286820|NCT00477672|26472366|FG002|Overall Study|Adverse Event|6|||
13286821|NCT00477672|26472364|FG000|Overall Study|Death|0|||
13286822|NCT00477672|26472365|FG001|Overall Study|Death|1|||
13286823|NCT00477672|26472366|FG002|Overall Study|Death|0|||
13286824|NCT00477672|26472364|FG000|Overall Study|Disease progression|0|||
13286825|NCT00477672|26472365|FG001|Overall Study|Disease progression|1|||
13286826|NCT00477672|26472366|FG002|Overall Study|Disease progression|0|||
13286827|NCT00477672|26472364|FG000|Overall Study|Physician Decision|1|||
13286828|NCT00477672|26472365|FG001|Overall Study|Physician Decision|0|||
13286829|NCT00477672|26472366|FG002|Overall Study|Physician Decision|0|||
13286830|NCT00477672|26472364|FG000|Overall Study|Protocol noncompliance|0|||
13286831|NCT00477672|26472365|FG001|Overall Study|Protocol noncompliance|2|||
13286832|NCT00477672|26472366|FG002|Overall Study|Protocol noncompliance|0|||
13203955|NCT01978145|26226476|FG001|Treatment Period 2|Lost to Follow-up|1|||
13203956|NCT01978145|26226475|FG000|Treatment Period 2|Withdrawal by Subject|7|||
13203957|NCT01978145|26226476|FG001|Treatment Period 2|Withdrawal by Subject|4|||
13203958|NCT01978145|26226475|FG000|Treatment Period 2|Par. reached defined stopping criteria|8|||
13203959|NCT01978145|26226476|FG001|Treatment Period 2|Par. reached defined stopping criteria|5|||
13203960|NCT01978119|26226503|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1|||
13203961|NCT01978119|26226504|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0|||
13203962|NCT01978119|26226503|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
13309867|NCT01260142|26536839|FG004|Treatment Period 1|Unexplained elevated sys. BP|1|||
13309868|NCT01260142|26536840|FG005|Treatment Period 1|Unexplained elevated sys. BP|0|||
13309869|NCT01260142|26536835|FG000|Treatment Period 1|Withdrawal by Subject|0|||
13309870|NCT01260142|26536836|FG001|Treatment Period 1|Withdrawal by Subject|0|||
13309871|NCT01260142|26536837|FG002|Treatment Period 1|Withdrawal by Subject|0|||
13309872|NCT01260142|26536838|FG003|Treatment Period 1|Withdrawal by Subject|0|||
13309873|NCT01260142|26536839|FG004|Treatment Period 1|Withdrawal by Subject|0|||
13309874|NCT01260142|26536840|FG005|Treatment Period 1|Withdrawal by Subject|1|||
13309875|NCT01259869|26536846|FG000|Overall Study|Duplicated registration|1|||
13309876|NCT01259856|26536873|FG000|Overall Study|Adverse Event|12|||
13309877|NCT01259856|26536874|FG001|Overall Study|Adverse Event|9|||
13309878|NCT01259856|26536873|FG000|Overall Study|Death|0|||
13309879|NCT01259856|26536874|FG001|Overall Study|Death|1|||
13309880|NCT01259856|26536873|FG000|Overall Study|Lack of Efficacy|3|||
13309881|NCT01259856|26536874|FG001|Overall Study|Lack of Efficacy|1|||
13309882|NCT01259856|26536873|FG000|Overall Study|Lost to Follow-up|1|||
13309883|NCT01259856|26536874|FG001|Overall Study|Lost to Follow-up|1|||
13309884|NCT01259856|26536873|FG000|Overall Study|Physician Decision|2|||
13309885|NCT01259856|26536874|FG001|Overall Study|Physician Decision|1|||
13309886|NCT01259856|26536873|FG000|Overall Study|Withdrawal by Subject|9|||
13309887|NCT01259856|26536874|FG001|Overall Study|Withdrawal by Subject|10|||
13309888|NCT01259856|26536873|FG000|Overall Study|Treatment never started|0|||
13309889|NCT01259856|26536874|FG001|Overall Study|Treatment never started|6|||
13309890|NCT01259856|26536873|FG000|Overall Study|Study closure by sponsor|40|||
13309891|NCT01259856|26536874|FG001|Overall Study|Study closure by sponsor|41|||
13309892|NCT01259856|26536873|FG000|Overall Study|Patient developed other disease|0|||
13309893|NCT01259856|26536874|FG001|Overall Study|Patient developed other disease|1|||
13309894|NCT01259856|26536873|FG000|Overall Study|Transfer to another study|0|||
13309895|NCT01259856|26536874|FG001|Overall Study|Transfer to another study|1|||
13309896|NCT01259856|26536873|FG000|Overall Study|Unknown/missing|2|||
13309897|NCT01259856|26536874|FG001|Overall Study|Unknown/missing|2|||
13309898|NCT01259726|26536917|FG000|Overall Study|Death|1|||
13309899|NCT01259726|26536918|FG001|Overall Study|Death|0|||
13309900|NCT01259726|26536919|FG002|Overall Study|Death|0|||
13309901|NCT01259726|26536920|FG003|Overall Study|Death|0|||
13309902|NCT01259726|26536917|FG000|Overall Study|Physician Decision|2|||
13309903|NCT01259726|26536918|FG001|Overall Study|Physician Decision|0|||
13309904|NCT01259726|26536919|FG002|Overall Study|Physician Decision|1|||
13309905|NCT01259726|26536920|FG003|Overall Study|Physician Decision|1|||
13309906|NCT01259726|26536917|FG000|Overall Study|Withdrawal by Subject|1|||
13309907|NCT01259726|26536918|FG001|Overall Study|Withdrawal by Subject|3|||
13309908|NCT01259726|26536919|FG002|Overall Study|Withdrawal by Subject|2|||
13309909|NCT01259726|26536920|FG003|Overall Study|Withdrawal by Subject|1|||
13309910|NCT01259726|26536917|FG000|Overall Study|Lost to Follow-up|1|||
13309911|NCT01259726|26536918|FG001|Overall Study|Lost to Follow-up|1|||
13309912|NCT01259726|26536919|FG002|Overall Study|Lost to Follow-up|1|||
13309913|NCT01259726|26536920|FG003|Overall Study|Lost to Follow-up|3|||
13372905|NCT00806195|26722203|FG002|Overall Study|Withdrawal by Subject|76|||
13372906|NCT00806195|26722204|FG003|Overall Study|Withdrawal by Subject|35|||
13372907|NCT00806195|26722201|FG000|Overall Study|Lost to Follow-up|217|||
13372908|NCT00806195|26722202|FG001|Overall Study|Lost to Follow-up|66|||
13372909|NCT00806195|26722203|FG002|Overall Study|Lost to Follow-up|90|||
13372910|NCT00806195|26722204|FG003|Overall Study|Lost to Follow-up|34|||
13372911|NCT00806195|26722201|FG000|Overall Study|Inappropriate Enrollment|0|||
13372912|NCT00806195|26722202|FG001|Overall Study|Inappropriate Enrollment|1|||
13372913|NCT00806195|26722203|FG002|Overall Study|Inappropriate Enrollment|0|||
13372914|NCT00806195|26722204|FG003|Overall Study|Inappropriate Enrollment|0|||
13372915|NCT00806195|26722201|FG000|Overall Study|Administrative Reason|113|||
13372916|NCT00806195|26722202|FG001|Overall Study|Administrative Reason|35|||
13372917|NCT00806195|26722203|FG002|Overall Study|Administrative Reason|66|||
13372918|NCT00806195|26722204|FG003|Overall Study|Administrative Reason|26|||
13372919|NCT00806195|26722201|FG000|Overall Study|Protocol Violation|34|||
13372920|NCT00806195|26722202|FG001|Overall Study|Protocol Violation|24|||
13372921|NCT00806195|26722203|FG002|Overall Study|Protocol Violation|26|||
13372922|NCT00806195|26722204|FG003|Overall Study|Protocol Violation|9|||
13372923|NCT00806156|26722292|FG000|Overall Study|Death|35|||
13372924|NCT00806156|26722293|FG001|Overall Study|Death|95|||
13372925|NCT00806156|26722292|FG000|Overall Study|Did not meet eligibility criteria|1|||
13372926|NCT00806156|26722293|FG001|Overall Study|Did not meet eligibility criteria|0|||
13309914|NCT01259713|26536949|FG000|Overall Study|Adverse Event|54|||
13309915|NCT01259713|26536950|FG001|Overall Study|Adverse Event|23|||
13309916|NCT01259713|26536949|FG000|Overall Study|Death Not Related to IFI|8|||
13309917|NCT01259713|26536950|FG001|Overall Study|Death Not Related to IFI|1|||
13309918|NCT01259713|26536949|FG000|Overall Study|Investigators Discretion|14|||
13309919|NCT01259713|26536950|FG001|Overall Study|Investigators Discretion|6|||
13309920|NCT01259713|26536949|FG000|Overall Study|Lack of Efficacy|2|||
13309921|NCT01259713|26536950|FG001|Overall Study|Lack of Efficacy|0|||
13309922|NCT01259713|26536949|FG000|Overall Study|Protocol Violation|5|||
13309923|NCT01259713|26536950|FG001|Overall Study|Protocol Violation|4|||
13309924|NCT01259713|26536949|FG000|Overall Study|Subject Withdrew Consent|12|||
13309925|NCT01259713|26536950|FG001|Overall Study|Subject Withdrew Consent|7|||
13309926|NCT01259492|26537010|FG000|Period 1 (9 Weeks)|Adverse Event|13|||
13309927|NCT01259492|26537011|FG001|Period 1 (9 Weeks)|Adverse Event|18|||
13309928|NCT01259492|26537012|FG002|Period 1 (9 Weeks)|Adverse Event|26|||
13309929|NCT01259492|26537013|FG003|Period 1 (9 Weeks)|Adverse Event|3|||
13309930|NCT01259492|26537010|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2|||
13309931|NCT01259492|26537011|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2|||
13309932|NCT01259492|26537012|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4|||
13309933|NCT01259492|26537013|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11|||
13309934|NCT01259492|26537010|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5|||
13309935|NCT01259492|26537011|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8|||
13309936|NCT01259492|26537012|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6|||
13309937|NCT01259492|26537013|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7|||
13309938|NCT01259492|26537010|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4|||
13309939|NCT01259492|26537011|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6|||
13309940|NCT01259492|26537012|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3|||
13309941|NCT01259492|26537013|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4|||
13309942|NCT01259492|26537010|FG000|Period 1 (9 Weeks)|Administrative Problems|0|||
13309943|NCT01259492|26537011|FG001|Period 1 (9 Weeks)|Administrative Problems|1|||
13309944|NCT01259492|26537012|FG002|Period 1 (9 Weeks)|Administrative Problems|1|||
13309945|NCT01259492|26537013|FG003|Period 1 (9 Weeks)|Administrative Problems|2|||
13309946|NCT01259492|26537010|FG000|Period 1 (9 Weeks)|Protocol Violation|5|||
13309947|NCT01259492|26537011|FG001|Period 1 (9 Weeks)|Protocol Violation|6|||
13309948|NCT01259492|26537012|FG002|Period 1 (9 Weeks)|Protocol Violation|3|||
13309949|NCT01259492|26537013|FG003|Period 1 (9 Weeks)|Protocol Violation|1|||
13309950|NCT01259492|26537010|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3|||
13309951|NCT01259492|26537011|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4|||
13309952|NCT01259492|26537012|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7|||
13309953|NCT01259492|26537013|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8|||
13309954|NCT01259492|26537010|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
13309955|NCT01259492|26537011|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
13309956|NCT01259492|26537012|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
13309957|NCT01259492|26537013|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
13309958|NCT01259492|26537010|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6|||
13309959|NCT01259492|26537011|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2|||
13309960|NCT01259492|26537012|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8|||
13309961|NCT01259492|26537013|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4|||
13309962|NCT01259492|26537010|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
13309963|NCT01259492|26537011|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
13309964|NCT01259492|26537012|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1|||
13309965|NCT01259492|26537013|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
13309966|NCT01259492|26537010|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
13309967|NCT01259492|26537011|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2|||
13309968|NCT01259492|26537012|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1|||
13309969|NCT01259492|26537013|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
13309970|NCT01259492|26537010|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
13309971|NCT01259492|26537011|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11|||
13309972|NCT01259492|26537012|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6|||
13309973|NCT01259492|26537013|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
13309974|NCT01259492|26537010|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
13309975|NCT01259492|26537011|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
13309976|NCT01259492|26537012|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
13309977|NCT01259492|26537013|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1|||
13309978|NCT01259492|26537010|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
13309979|NCT01259492|26537011|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
13309980|NCT01259492|26537012|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1|||
13309981|NCT01259492|26537013|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
13309982|NCT01259492|26537010|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28|||
13309983|NCT01259492|26537011|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42|||
13309984|NCT01259492|26537012|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29|||
13309985|NCT01259492|26537013|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62|||
13309986|NCT01259492|26537010|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1|||
13309987|NCT01259492|26537011|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
13309988|NCT01259492|26537012|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
13309989|NCT01259492|26537013|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
13309990|NCT01259492|26537010|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12|||
13309991|NCT01259492|26537011|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6|||
13309992|NCT01259492|26537012|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4|||
13309993|NCT01259492|26537013|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3|||
13309994|NCT01259492|26537010|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
13309995|NCT01259492|26537011|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4|||
13309996|NCT01259492|26537012|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6|||
13309997|NCT01259492|26537013|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
13309998|NCT01259492|26537010|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
13309999|NCT01259492|26537011|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
13310000|NCT01259492|26537012|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1|||
13310001|NCT01259492|26537013|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
13310002|NCT01259492|26537010|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5|||
13310003|NCT01259492|26537011|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6|||
13310004|NCT01259492|26537012|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3|||
13310005|NCT01259492|26537013|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7|||
13310006|NCT01259466|26537028|FG000|Overall Study|Withdrawal by Subject|1|||
13310007|NCT01259466|26537029|FG001|Overall Study|Withdrawal by Subject|9|||
13310008|NCT01259401|26537044|FG000|4-month Follow-up|Death|0|||
13310009|NCT01259401|26537045|FG001|4-month Follow-up|Death|1|||
13310010|NCT01259401|26537044|FG000|4-month Follow-up|Lost to Follow-up|0|||
13310011|NCT01259401|26537045|FG001|4-month Follow-up|Lost to Follow-up|1|||
13310012|NCT01259388|26537062|FG000|Overall Study|Adverse Event|3|||
13310013|NCT01259388|26537063|FG001|Overall Study|Adverse Event|0|||
13310014|NCT01259388|26537062|FG000|Overall Study|Withdrawal by Subject|1|||
13310015|NCT01259388|26537063|FG001|Overall Study|Withdrawal by Subject|1|||
13310016|NCT01259388|26537062|FG000|Overall Study|Physician Decision|1|||
13310017|NCT01259388|26537063|FG001|Overall Study|Physician Decision|0|||
13310018|NCT01259375|26537074|FG000|Overall Study|Adverse Event|1|||
13372927|NCT00806156|26722292|FG000|Overall Study|Study terminated by Sponsor|2|||
13372928|NCT00806156|26722293|FG001|Overall Study|Study terminated by Sponsor|40|||
13372929|NCT00806156|26722292|FG000|Overall Study|Consent withdrawn by subject|1|||
13372930|NCT00806156|26722293|FG001|Overall Study|Consent withdrawn by subject|3|||
13372931|NCT00806156|26722292|FG000|Overall Study|Lost to Follow-up|0|||
13372932|NCT00806156|26722293|FG001|Overall Study|Lost to Follow-up|1|||
13372933|NCT00806026|26722407|FG000|Overall Study|Death|0|||
13372934|NCT00806026|26722408|FG001|Overall Study|Death|0|||
13372935|NCT00806026|26722409|FG002|Overall Study|Death|0|||
13372936|NCT00806026|26722410|FG003|Overall Study|Death|1|||
13372937|NCT00806026|26722411|FG004|Overall Study|Death|0|||
13372938|NCT00806026|26722412|FG005|Overall Study|Death|0|||
13372939|NCT00806026|26722407|FG000|Overall Study|Did not meet entrance criteria|4|||
13372940|NCT00806026|26722408|FG001|Overall Study|Did not meet entrance criteria|1|||
13372941|NCT00806026|26722409|FG002|Overall Study|Did not meet entrance criteria|2|||
13372942|NCT00806026|26722410|FG003|Overall Study|Did not meet entrance criteria|1|||
13372943|NCT00806026|26722411|FG004|Overall Study|Did not meet entrance criteria|0|||
13372944|NCT00806026|26722412|FG005|Overall Study|Did not meet entrance criteria|0|||
13372945|NCT00806026|26722407|FG000|Overall Study|Lack of Efficacy|5|||
13372946|NCT00806026|26722408|FG001|Overall Study|Lack of Efficacy|18|||
13372947|NCT00806026|26722409|FG002|Overall Study|Lack of Efficacy|13|||
13372948|NCT00806026|26722410|FG003|Overall Study|Lack of Efficacy|4|||
13372949|NCT00806026|26722411|FG004|Overall Study|Lack of Efficacy|8|||
13372950|NCT00806026|26722412|FG005|Overall Study|Lack of Efficacy|7|||
13372951|NCT00806026|26722407|FG000|Overall Study|Lost to Follow-up|8|||
13372952|NCT00806026|26722408|FG001|Overall Study|Lost to Follow-up|15|||
13372953|NCT00806026|26722409|FG002|Overall Study|Lost to Follow-up|8|||
13372954|NCT00806026|26722410|FG003|Overall Study|Lost to Follow-up|2|||
13372955|NCT00806026|26722411|FG004|Overall Study|Lost to Follow-up|6|||
13372956|NCT00806026|26722412|FG005|Overall Study|Lost to Follow-up|6|||
13372957|NCT00806026|26722407|FG000|Overall Study|Withdrawal by Subject|14|||
13372958|NCT00806026|26722408|FG001|Overall Study|Withdrawal by Subject|17|||
13372959|NCT00806026|26722409|FG002|Overall Study|Withdrawal by Subject|9|||
13372960|NCT00806026|26722410|FG003|Overall Study|Withdrawal by Subject|2|||
13372961|NCT00806026|26722411|FG004|Overall Study|Withdrawal by Subject|5|||
13372962|NCT00806026|26722412|FG005|Overall Study|Withdrawal by Subject|3|||
13372963|NCT00806026|26722407|FG000|Overall Study|Other|3|||
13372964|NCT00806026|26722408|FG001|Overall Study|Other|6|||
13372965|NCT00806026|26722409|FG002|Overall Study|Other|8|||
13310019|NCT03932812|26537105|FG000|Overall Study|Lost to Follow-up|12|||
13310020|NCT03932812|26537106|FG001|Overall Study|Lost to Follow-up|14|||
13310021|NCT03932812|26537105|FG000|Overall Study|Death of care partner (person living with dementia)|5|||
13310022|NCT03932812|26537106|FG001|Overall Study|Death of care partner (person living with dementia)|1|||
13310023|NCT03694522|26537127|FG000|Overall Study|Withdrawal by Subject|8|||
13310024|NCT03694522|26537128|FG001|Overall Study|Withdrawal by Subject|10|||
13310025|NCT03694522|26537127|FG000|Overall Study|Physician Decision|53|||
13310026|NCT03694522|26537128|FG001|Overall Study|Physician Decision|54|||
13310027|NCT03694522|26537127|FG000|Overall Study|Other|1|||
13310028|NCT03694522|26537128|FG001|Overall Study|Other|1|||
13310029|NCT03694522|26537127|FG000|Overall Study|Lost to Follow-up|0|||
13310030|NCT03694522|26537128|FG001|Overall Study|Lost to Follow-up|1|||
13310031|NCT03456726|26537157|FG000|Overall Study|Disease Progression|6|||
13310032|NCT03456726|26537158|FG001|Overall Study|Disease Progression|1|||
13310033|NCT03456726|26537157|FG000|Overall Study|Adverse Event|4|||
13310034|NCT03456726|26537158|FG001|Overall Study|Adverse Event|2|||
13310035|NCT03456726|26537157|FG000|Overall Study|Withdrawal by Subject|1|||
13310036|NCT03456726|26537158|FG001|Overall Study|Withdrawal by Subject|0|||
13310037|NCT03456726|26537157|FG000|Overall Study|Discontinued from study due to switch to commercial tazemetostat|6|||
13310038|NCT03456726|26537158|FG001|Overall Study|Discontinued from study due to switch to commercial tazemetostat|0|||
13310039|NCT03391882|26537192|FG000|Study Overall|Adverse Event|3|||
13310040|NCT03391882|26537193|FG001|Study Overall|Adverse Event|6|||
13310041|NCT03391882|26537194|FG002|Study Overall|Adverse Event|1|||
13310042|NCT03391882|26537195|FG003|Study Overall|Adverse Event|1|||
13310043|NCT03391882|26537196|FG004|Study Overall|Adverse Event|3|||
13310044|NCT03391882|26537197|FG005|Study Overall|Adverse Event|1|||
13310045|NCT03391882|26537192|FG000|Study Overall|Lack of Efficacy|13|||
13310046|NCT03391882|26537193|FG001|Study Overall|Lack of Efficacy|9|||
13310047|NCT03391882|26537194|FG002|Study Overall|Lack of Efficacy|0|||
13310048|NCT03391882|26537195|FG003|Study Overall|Lack of Efficacy|0|||
13310049|NCT03391882|26537196|FG004|Study Overall|Lack of Efficacy|0|||
13310050|NCT03391882|26537197|FG005|Study Overall|Lack of Efficacy|0|||
13310051|NCT03391882|26537192|FG000|Study Overall|Withdrawal by Subject|3|||
13310052|NCT03391882|26537193|FG001|Study Overall|Withdrawal by Subject|3|||
13310053|NCT03391882|26537194|FG002|Study Overall|Withdrawal by Subject|2|||
13310054|NCT03391882|26537195|FG003|Study Overall|Withdrawal by Subject|2|||
13310055|NCT03391882|26537196|FG004|Study Overall|Withdrawal by Subject|1|||
13310056|NCT03391882|26537197|FG005|Study Overall|Withdrawal by Subject|3|||
13310057|NCT03391882|26537192|FG000|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
13310058|NCT03391882|26537193|FG001|Study Overall|EARLY TERM AT SPONSOR REQUEST|1|||
13310059|NCT03391882|26537194|FG002|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
13310060|NCT03391882|26537195|FG003|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
13310061|NCT03391882|26537196|FG004|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
13310062|NCT03391882|26537197|FG005|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
13310063|NCT03391882|26537192|FG000|Study Overall|Protocol Violation|1|||
13310064|NCT03391882|26537193|FG001|Study Overall|Protocol Violation|0|||
13310065|NCT03391882|26537194|FG002|Study Overall|Protocol Violation|0|||
13310066|NCT03391882|26537195|FG003|Study Overall|Protocol Violation|0|||
13310067|NCT03391882|26537196|FG004|Study Overall|Protocol Violation|0|||
13310068|NCT03391882|26537197|FG005|Study Overall|Protocol Violation|0|||
13310069|NCT03391882|26537192|FG000|Part A - Titration Phase|Adverse Event|3|||
13310070|NCT03391882|26537193|FG001|Part A - Titration Phase|Adverse Event|6|||
13310071|NCT03391882|26537194|FG002|Part A - Titration Phase|Adverse Event|0|||
13310072|NCT03391882|26537195|FG003|Part A - Titration Phase|Adverse Event|0|||
13310073|NCT03391882|26537196|FG004|Part A - Titration Phase|Adverse Event|0|||
13310074|NCT03391882|26537197|FG005|Part A - Titration Phase|Adverse Event|0|||
13310075|NCT03391882|26537192|FG000|Part A - Titration Phase|Lack of Efficacy|12|||
13310076|NCT03391882|26537193|FG001|Part A - Titration Phase|Lack of Efficacy|6|||
13310077|NCT03391882|26537194|FG002|Part A - Titration Phase|Lack of Efficacy|0|||
13310078|NCT03391882|26537195|FG003|Part A - Titration Phase|Lack of Efficacy|0|||
13310079|NCT03391882|26537196|FG004|Part A - Titration Phase|Lack of Efficacy|0|||
13310080|NCT03391882|26537197|FG005|Part A - Titration Phase|Lack of Efficacy|0|||
13310081|NCT03391882|26537192|FG000|Part A - Titration Phase|Withdrawal by Subject|3|||
13310082|NCT03391882|26537193|FG001|Part A - Titration Phase|Withdrawal by Subject|3|||
13310083|NCT03391882|26537194|FG002|Part A - Titration Phase|Withdrawal by Subject|0|||
13310084|NCT03391882|26537195|FG003|Part A - Titration Phase|Withdrawal by Subject|0|||
13310085|NCT03391882|26537196|FG004|Part A - Titration Phase|Withdrawal by Subject|0|||
13310086|NCT03391882|26537197|FG005|Part A - Titration Phase|Withdrawal by Subject|0|||
13310087|NCT03391882|26537192|FG000|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
13310088|NCT03391882|26537193|FG001|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|1|||
13310089|NCT03391882|26537194|FG002|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
13310090|NCT03391882|26537195|FG003|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
13310091|NCT03391882|26537196|FG004|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
13310092|NCT03391882|26537197|FG005|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
13310093|NCT03391882|26537192|FG000|Post Part A / Pre Part B|Lack of Efficacy|1|||
13310094|NCT03391882|26537193|FG001|Post Part A / Pre Part B|Lack of Efficacy|3|||
13310095|NCT03391882|26537194|FG002|Post Part A / Pre Part B|Lack of Efficacy|0|||
13310096|NCT03391882|26537195|FG003|Post Part A / Pre Part B|Lack of Efficacy|0|||
13310097|NCT03391882|26537196|FG004|Post Part A / Pre Part B|Lack of Efficacy|0|||
13310098|NCT03391882|26537197|FG005|Post Part A / Pre Part B|Lack of Efficacy|0|||
13310099|NCT03391882|26537192|FG000|Post Part A / Pre Part B|Protocol Violation|1|||
13310100|NCT03391882|26537193|FG001|Post Part A / Pre Part B|Protocol Violation|0|||
13310101|NCT03391882|26537194|FG002|Post Part A / Pre Part B|Protocol Violation|0|||
13310102|NCT03391882|26537195|FG003|Post Part A / Pre Part B|Protocol Violation|0|||
13310103|NCT03391882|26537196|FG004|Post Part A / Pre Part B|Protocol Violation|0|||
13310104|NCT03391882|26537197|FG005|Post Part A / Pre Part B|Protocol Violation|0|||
13310105|NCT03391882|26537192|FG000|Part B - Treatment Phase|Adverse Event|0|||
13310106|NCT03391882|26537193|FG001|Part B - Treatment Phase|Adverse Event|0|||
13310107|NCT03391882|26537194|FG002|Part B - Treatment Phase|Adverse Event|1|||
13310108|NCT03391882|26537195|FG003|Part B - Treatment Phase|Adverse Event|1|||
13310109|NCT03391882|26537196|FG004|Part B - Treatment Phase|Adverse Event|3|||
13310110|NCT03391882|26537197|FG005|Part B - Treatment Phase|Adverse Event|1|||
13310111|NCT03391882|26537192|FG000|Part B - Treatment Phase|Withdrawal by Subject|0|||
13310112|NCT03391882|26537193|FG001|Part B - Treatment Phase|Withdrawal by Subject|0|||
13310113|NCT03391882|26537194|FG002|Part B - Treatment Phase|Withdrawal by Subject|2|||
13310114|NCT03391882|26537195|FG003|Part B - Treatment Phase|Withdrawal by Subject|2|||
13310115|NCT03391882|26537196|FG004|Part B - Treatment Phase|Withdrawal by Subject|1|||
13310116|NCT03391882|26537197|FG005|Part B - Treatment Phase|Withdrawal by Subject|3|||
13310117|NCT03181932|26537234|FG000|Period 1 (Double-blind Period)|Adverse Event|5|||
13310118|NCT03181932|26537235|FG001|Period 1 (Double-blind Period)|Adverse Event|1|||
13310119|NCT03181932|26537234|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0|||
13310120|NCT03181932|26537235|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1|||
13310121|NCT03181932|26537234|FG000|Period 1 (Double-blind Period)|Protocol Violation|1|||
13310122|NCT03181932|26537235|FG001|Period 1 (Double-blind Period)|Protocol Violation|2|||
13310123|NCT03181932|26537234|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5|||
13310124|NCT03181932|26537235|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9|||
13310125|NCT03181932|26537234|FG000|Period 2 (Open-label Period)|Adverse Event|1|||
13310126|NCT03181932|26537235|FG001|Period 2 (Open-label Period)|Adverse Event|6|||
13310127|NCT03181932|26537234|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0|||
13310128|NCT03181932|26537235|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1|||
13310129|NCT03181932|26537234|FG000|Period 2 (Open-label Period)|Protocol Violation|3|||
13310130|NCT03181932|26537235|FG001|Period 2 (Open-label Period)|Protocol Violation|1|||
13310131|NCT03181932|26537234|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2|||
13310132|NCT03181932|26537235|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5|||
13310133|NCT03181932|26537234|FG000|Period 2 (Open-label Period)|Reason missing|2|||
13310134|NCT03181932|26537235|FG001|Period 2 (Open-label Period)|Reason missing|0|||
13310135|NCT02864862|26537316|FG000|Overall Study|Lost to Follow-up|1|||
13310136|NCT02864862|26537317|FG001|Overall Study|Lost to Follow-up|0|||
13310137|NCT02864862|26537318|FG002|Overall Study|Lost to Follow-up|1|||
13310138|NCT02864862|26537316|FG000|Overall Study|Protocol Violation|0|||
13310139|NCT02864862|26537317|FG001|Overall Study|Protocol Violation|0|||
13310140|NCT02864862|26537318|FG002|Overall Study|Protocol Violation|1|||
13310141|NCT02702180|26537361|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
13310142|NCT02702180|26537362|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
13310143|NCT02702180|26537363|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
13310144|NCT02702180|26537361|FG000|Double-blind Treatment Period|Adverse Event|0|||
13310145|NCT02702180|26537362|FG001|Double-blind Treatment Period|Adverse Event|0|||
13310146|NCT02702180|26537363|FG002|Double-blind Treatment Period|Adverse Event|1|||
13310147|NCT02702180|26537361|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
13310148|NCT02702180|26537362|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
13310149|NCT02702180|26537363|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
13310150|NCT02702180|26537361|FG000|Double-blind Treatment Period|Protocol Violation|0|||
13310151|NCT02702180|26537362|FG001|Double-blind Treatment Period|Protocol Violation|0|||
13310152|NCT02702180|26537363|FG002|Double-blind Treatment Period|Protocol Violation|2|||
13310153|NCT02702180|26537361|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
13310154|NCT02702180|26537362|FG001|Open-label Treatment Period|Withdrawal by Subject|1|||
13310155|NCT02702180|26537363|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
13310156|NCT02702180|26537361|FG000|Open-label Treatment Period|Withdrawn in error|0|||
13310157|NCT02702180|26537362|FG001|Open-label Treatment Period|Withdrawn in error|0|||
13310158|NCT02702180|26537363|FG002|Open-label Treatment Period|Withdrawn in error|1|||
13310159|NCT02438722|26537386|FG000|Overall Study|Adverse Event|12|||
13310160|NCT02438722|26537387|FG001|Overall Study|Adverse Event|9|||
13310161|NCT02438722|26537386|FG000|Overall Study|Refusal unrelated to AE|2|||
13310162|NCT02438722|26537387|FG001|Overall Study|Refusal unrelated to AE|5|||
13310163|NCT02438722|26537386|FG000|Overall Study|Disease progression/relapse|46|||
13310164|NCT02438722|26537387|FG001|Overall Study|Disease progression/relapse|51|||
13310165|NCT02438722|26537386|FG000|Overall Study|Death|0|||
13310166|NCT02438722|26537387|FG001|Overall Study|Death|3|||
13310167|NCT02438722|26537386|FG000|Overall Study|Physician Decision|2|||
13310168|NCT02438722|26537387|FG001|Overall Study|Physician Decision|2|||
13310169|NCT02438722|26537386|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1|||
13310170|NCT02438722|26537387|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0|||
13310171|NCT02438722|26537386|FG000|Overall Study|Withdrawal by Subject|0|||
13310172|NCT02438722|26537387|FG001|Overall Study|Withdrawal by Subject|1|||
13310173|NCT02438722|26537386|FG000|Overall Study|On protocol treatment|15|||
13310174|NCT02438722|26537387|FG001|Overall Study|On protocol treatment|14|||
13310175|NCT02438722|26537386|FG000|Overall Study|Did not receive protocol treatment|5|||
13310176|NCT02438722|26537387|FG001|Overall Study|Did not receive protocol treatment|0|||
13310177|NCT01940471|26537410|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
13310178|NCT01940471|26537411|FG001|Double-Blind Phase|Randomized but Never Treated|1|||
13310179|NCT01940471|26537410|FG000|Double-Blind Phase|Withdrew Consent|13|||
13310180|NCT01940471|26537411|FG001|Double-Blind Phase|Withdrew Consent|7|||
13310181|NCT01940471|26537410|FG000|Double-Blind Phase|Adverse Event|1|||
13310182|NCT01940471|26537411|FG001|Double-Blind Phase|Adverse Event|2|||
13310183|NCT01940471|26537410|FG000|Double-Blind Phase|Lost to Follow-up|3|||
13310184|NCT01940471|26537411|FG001|Double-Blind Phase|Lost to Follow-up|2|||
13310185|NCT01940471|26537410|FG000|Double-Blind Phase|Pregnancy|2|||
13310186|NCT01940471|26537411|FG001|Double-Blind Phase|Pregnancy|1|||
13310187|NCT01940471|26537410|FG000|Double-Blind Phase|Investigator's Discretion|5|||
13310188|NCT01940471|26537411|FG001|Double-Blind Phase|Investigator's Discretion|0|||
13310189|NCT01940471|26537410|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
13310190|NCT01940471|26537411|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
13310191|NCT01940471|26537410|FG000|Double-Blind Phase|Protocol-Specified Criteria|1|||
13310192|NCT01940471|26537411|FG001|Double-Blind Phase|Protocol-Specified Criteria|0|||
13310193|NCT01940471|26537410|FG000|Double-Blind Phase|Death|1|||
13310194|NCT01940471|26537411|FG001|Double-Blind Phase|Death|0|||
13310195|NCT01940471|26537410|FG000|Double-Blind Phase|Lack of Efficacy|1|||
13310196|NCT01940471|26537411|FG001|Double-Blind Phase|Lack of Efficacy|0|||
13310197|NCT01940471|26537410|FG000|Double-Blind Phase|Protocol Violation|0|||
13310198|NCT01940471|26537411|FG001|Double-Blind Phase|Protocol Violation|1|||
13310199|NCT01940471|26537410|FG000|Double-Blind Phase|Still in Double-Blind Phase|539|||
13310200|NCT01940471|26537411|FG001|Double-Blind Phase|Still in Double-Blind Phase|270|||
13310201|NCT01940471|26537410|FG000|Open-Label Extension|Still in Open-Label Extension Phase|14|||
13310202|NCT01940471|26537411|FG001|Open-Label Extension|Still in Open-Label Extension Phase|8|||
13310203|NCT01598298|26537428|FG000|Overall Study|Not eligible|5|||
13310204|NCT01598298|26537429|FG001|Overall Study|Not eligible|5|||
13310205|NCT01598298|26537428|FG000|Overall Study|Adverse Event|21|||
13310206|NCT01598298|26537429|FG001|Overall Study|Adverse Event|19|||
13310207|NCT01598298|26537428|FG000|Overall Study|Progression/relapse|0|||
13310208|NCT01598298|26537429|FG001|Overall Study|Progression/relapse|2|||
13310209|NCT01598298|26537428|FG000|Overall Study|Withdrawal by Subject|10|||
13310210|NCT01598298|26537429|FG001|Overall Study|Withdrawal by Subject|15|||
13310211|NCT01598298|26537428|FG000|Overall Study|Other reason (not protocol specified)|4|||
13310212|NCT01598298|26537429|FG001|Overall Study|Other reason (not protocol specified)|0|||
13310213|NCT01321073|26537449|FG000|Overall Study|Did not attempt implant|4|||
13310214|NCT01321073|26537449|FG000|Overall Study|Death|3|||
13310215|NCT01313923|26537455|FG000|Overall Study|Physician Decision|3|||
13310216|NCT01313884|26537462|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1|||
13310217|NCT01135459|26537495|FG000|Overall Study|Adverse Event|8|||
13310218|NCT01135459|26537496|FG001|Overall Study|Adverse Event|10|||
13310219|NCT01135459|26537495|FG000|Overall Study|Lack of Efficacy|3|||
13310220|NCT01135459|26537496|FG001|Overall Study|Lack of Efficacy|1|||
13310221|NCT01135459|26537495|FG000|Overall Study|Withdrawal by Subject|2|||
13310222|NCT01135459|26537496|FG001|Overall Study|Withdrawal by Subject|3|||
13310223|NCT01135459|26537495|FG000|Overall Study|Protocol Violation|5|||
13310224|NCT01135459|26537496|FG001|Overall Study|Protocol Violation|3|||
13310225|NCT01135459|26537495|FG000|Overall Study|Lost to Follow-up|2|||
13310226|NCT01135459|26537496|FG001|Overall Study|Lost to Follow-up|1|||
13310227|NCT01135459|26537495|FG000|Overall Study|Non-compliance to study procedures|0|||
13310228|NCT01135459|26537496|FG001|Overall Study|Non-compliance to study procedures|1|||
13310229|NCT01135459|26537495|FG000|Overall Study|Other than specified|1|||
13310230|NCT01135459|26537496|FG001|Overall Study|Other than specified|1|||
13310231|NCT01063517|26537541|FG000|Overall Study|Consent withdrawal|1|||
13310232|NCT01063517|26537542|FG001|Overall Study|Consent withdrawal|0|||
13310233|NCT01063517|26537541|FG000|Overall Study|Study reached data cut-off|19|||
13310234|NCT01063517|26537542|FG001|Overall Study|Study reached data cut-off|7|||
13310235|NCT01063517|26537541|FG000|Overall Study|Lost to Follow-up|4|||
13310236|NCT01063517|26537542|FG001|Overall Study|Lost to Follow-up|3|||
13310237|NCT01063517|26537541|FG000|Overall Study|Withdrawal by Subject|1|||
13310238|NCT01063517|26537542|FG001|Overall Study|Withdrawal by Subject|2|||
13310239|NCT01063517|26537541|FG000|Overall Study|Death|33|||
13310240|NCT01063517|26537542|FG001|Overall Study|Death|48|||
13310241|NCT00946712|26537563|FG000|Overall Study|Adverse Event|118|||
13310242|NCT00946712|26537564|FG001|Overall Study|Adverse Event|124|||
13310243|NCT00946712|26537563|FG000|Overall Study|Disease progression|308|||
13310244|NCT00946712|26537564|FG001|Overall Study|Disease progression|404|||
13310245|NCT00946712|26537563|FG000|Overall Study|Death|21|||
13310246|NCT00946712|26537564|FG001|Overall Study|Death|22|||
13310247|NCT00946712|26537563|FG000|Overall Study|No treatment given|25|||
13310248|NCT00946712|26537564|FG001|Overall Study|No treatment given|29|||
13310249|NCT00946712|26537563|FG000|Overall Study|Other reasons|61|||
13310250|NCT00946712|26537564|FG001|Overall Study|Other reasons|73|||
13310251|NCT00946712|26537563|FG000|Overall Study|On Treatment|0|||
13310252|NCT00946712|26537564|FG001|Overall Study|On Treatment|4|||
13310253|NCT00946712|26537563|FG000|Overall Study|Ineligible|14|||
13310254|NCT00946712|26537564|FG001|Overall Study|Ineligible|6|||
13310255|NCT01259297|26537617|FG000|Double Blind Randomized Period|Death|1|||
13310256|NCT01259297|26537618|FG001|Double Blind Randomized Period|Death|1|||
13310257|NCT01259297|26537619|FG002|Double Blind Randomized Period|Death|1|||
13310258|NCT01259297|26537620|FG003|Double Blind Randomized Period|Death|2|||
13310259|NCT01259297|26537621|FG004|Double Blind Randomized Period|Death|1|||
13310260|NCT01259297|26537622|FG005|Double Blind Randomized Period|Death|5|||
13310261|NCT01259297|26537623|FG006|Double Blind Randomized Period|Death|2|||
13310262|NCT01259297|26537624|FG007|Double Blind Randomized Period|Death|1|||
13310263|NCT01259297|26537617|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
13310264|NCT01259297|26537618|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
13310265|NCT01259297|26537619|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0|||
13310266|NCT01259297|26537620|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
13310267|NCT01259297|26537621|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
13310268|NCT01259297|26537622|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
13310269|NCT01259297|26537623|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
13310270|NCT01259297|26537624|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
13310271|NCT01259297|26537617|FG000|Double Blind Randomized Period|Other reasons|0|||
13310272|NCT01259297|26537618|FG001|Double Blind Randomized Period|Other reasons|1|||
13310273|NCT01259297|26537619|FG002|Double Blind Randomized Period|Other reasons|0|||
13310274|NCT01259297|26537620|FG003|Double Blind Randomized Period|Other reasons|0|||
13310275|NCT01259297|26537621|FG004|Double Blind Randomized Period|Other reasons|1|||
13310276|NCT01259297|26537622|FG005|Double Blind Randomized Period|Other reasons|2|||
13310277|NCT01259297|26537623|FG006|Double Blind Randomized Period|Other reasons|3|||
13310278|NCT01259297|26537624|FG007|Double Blind Randomized Period|Other reasons|1|||
13310279|NCT01259284|26537642|FG000|Overall Study|Study Termination|2|||
13310280|NCT01259284|26537643|FG001|Overall Study|Study Termination|0|||
13310281|NCT01259284|26537644|FG002|Overall Study|Study Termination|0|||
13310282|NCT01259245|26537675|FG000|Overall Study|Withdrawal by Subject|27|||
13310283|NCT01259245|26537676|FG001|Overall Study|Withdrawal by Subject|24|||
13310284|NCT01259245|26537675|FG000|Overall Study|Death|1|||
13310285|NCT01259245|26537676|FG001|Overall Study|Death|2|||
13310286|NCT01259115|26537710|FG000|Period 1|Adverse Event|1|||
13310287|NCT01259115|26537711|FG001|Period 1|Adverse Event|0|||
13310288|NCT01259115|26537710|FG000|Period 1|Protocol Violation|2|||
13310289|NCT01259115|26537711|FG001|Period 1|Protocol Violation|0|||
13310290|NCT01259115|26537710|FG000|Period 1|Lost to Follow-up|0|||
13310291|NCT01259115|26537711|FG001|Period 1|Lost to Follow-up|1|||
13310292|NCT01259115|26537710|FG000|Period 2|Adverse Event|1|||
13310293|NCT01259115|26537711|FG001|Period 2|Adverse Event|0|||
13310294|NCT01259102|26537784|FG000|Overall Study|Adverse Event|1|||
13310295|NCT01259102|26537785|FG001|Overall Study|Adverse Event|0|||
13310296|NCT01259102|26537786|FG002|Overall Study|Adverse Event|1|||
13310297|NCT01259102|26537787|FG003|Overall Study|Adverse Event|1|||
13310298|NCT01259102|26537788|FG004|Overall Study|Adverse Event|0|||
13310299|NCT01259102|26537784|FG000|Overall Study|Other|0|||
13310300|NCT01259102|26537785|FG001|Overall Study|Other|0|||
13310301|NCT01259102|26537786|FG002|Overall Study|Other|1|||
13310302|NCT01259102|26537787|FG003|Overall Study|Other|1|||
13310303|NCT01259102|26537788|FG004|Overall Study|Other|1|||
13310304|NCT01259089|26537814|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0|||
13310305|NCT01259089|26537815|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0|||
13310306|NCT01259089|26537816|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0|||
13310307|NCT01259089|26537817|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0|||
13310308|NCT01259089|26537818|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0|||
13310309|NCT01259089|26537819|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1|||
13310310|NCT01259089|26537814|FG000|Reached First Response at 4 Weeks|Adverse Event|0|||
13310311|NCT01259089|26537815|FG001|Reached First Response at 4 Weeks|Adverse Event|0|||
13310312|NCT01259089|26537816|FG002|Reached First Response at 4 Weeks|Adverse Event|0|||
13310313|NCT01259089|26537817|FG003|Reached First Response at 4 Weeks|Adverse Event|0|||
13310314|NCT01259089|26537818|FG004|Reached First Response at 4 Weeks|Adverse Event|0|||
13310315|NCT01259089|26537819|FG005|Reached First Response at 4 Weeks|Adverse Event|1|||
13310316|NCT01259089|26537814|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
13310317|NCT01259089|26537815|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
13310318|NCT01259089|26537816|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
13310319|NCT01259089|26537817|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
13310320|NCT01259089|26537818|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
13310321|NCT01259089|26537819|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1|||
13310322|NCT01259089|26537814|FG000|Confirmed Response at 8 Weeks|Adverse Event|0|||
13310323|NCT01259089|26537815|FG001|Confirmed Response at 8 Weeks|Adverse Event|0|||
13310324|NCT01259089|26537816|FG002|Confirmed Response at 8 Weeks|Adverse Event|0|||
13310325|NCT01259089|26537817|FG003|Confirmed Response at 8 Weeks|Adverse Event|0|||
13310326|NCT01259089|26537818|FG004|Confirmed Response at 8 Weeks|Adverse Event|1|||
13310327|NCT01259089|26537819|FG005|Confirmed Response at 8 Weeks|Adverse Event|2|||
13310328|NCT01259089|26537814|FG000|Confirmed Response at 8 Weeks|Progressive disease|0|||
13310329|NCT01259089|26537815|FG001|Confirmed Response at 8 Weeks|Progressive disease|0|||
13310330|NCT01259089|26537816|FG002|Confirmed Response at 8 Weeks|Progressive disease|1|||
13310331|NCT01259089|26537817|FG003|Confirmed Response at 8 Weeks|Progressive disease|1|||
13310332|NCT01259089|26537818|FG004|Confirmed Response at 8 Weeks|Progressive disease|3|||
13310333|NCT01259089|26537819|FG005|Confirmed Response at 8 Weeks|Progressive disease|7|||
13310334|NCT01259089|26537814|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1|||
13310335|NCT01259089|26537815|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
13310336|NCT01259089|26537816|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
13310337|NCT01259089|26537817|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
13310338|NCT01259089|26537818|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
13310339|NCT01259089|26537819|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
13310340|NCT01259089|26537814|FG000|Continued Treatment After 8 Weeks|Adverse Event|0|||
13310341|NCT01259089|26537815|FG001|Continued Treatment After 8 Weeks|Adverse Event|0|||
13310342|NCT01259089|26537816|FG002|Continued Treatment After 8 Weeks|Adverse Event|0|||
13310343|NCT01259089|26537817|FG003|Continued Treatment After 8 Weeks|Adverse Event|0|||
13310344|NCT01259089|26537818|FG004|Continued Treatment After 8 Weeks|Adverse Event|2|||
13310345|NCT01259089|26537819|FG005|Continued Treatment After 8 Weeks|Adverse Event|1|||
13310346|NCT01259089|26537814|FG000|Continued Treatment After 8 Weeks|Progressive disease|1|||
13310347|NCT01259089|26537815|FG001|Continued Treatment After 8 Weeks|Progressive disease|1|||
13310348|NCT01259089|26537816|FG002|Continued Treatment After 8 Weeks|Progressive disease|1|||
13310349|NCT01259089|26537817|FG003|Continued Treatment After 8 Weeks|Progressive disease|1|||
13310350|NCT01259089|26537818|FG004|Continued Treatment After 8 Weeks|Progressive disease|0|||
13310351|NCT01259089|26537819|FG005|Continued Treatment After 8 Weeks|Progressive disease|0|||
13310352|NCT01259089|26537814|FG000|Survival Follow up for Two Years|Death|3|||
13310353|NCT01259089|26537815|FG001|Survival Follow up for Two Years|Death|2|||
13310354|NCT01259089|26537816|FG002|Survival Follow up for Two Years|Death|2|||
13310355|NCT01259089|26537817|FG003|Survival Follow up for Two Years|Death|3|||
13310356|NCT01259089|26537818|FG004|Survival Follow up for Two Years|Death|6|||
13310357|NCT01259089|26537819|FG005|Survival Follow up for Two Years|Death|13|||
13310358|NCT01259089|26537814|FG000|Survival Follow up for Two Years|Lost to Follow-up|0|||
13310359|NCT01259089|26537815|FG001|Survival Follow up for Two Years|Lost to Follow-up|0|||
13310360|NCT01259089|26537816|FG002|Survival Follow up for Two Years|Lost to Follow-up|0|||
13310361|NCT01259089|26537817|FG003|Survival Follow up for Two Years|Lost to Follow-up|0|||
13310362|NCT01259089|26537818|FG004|Survival Follow up for Two Years|Lost to Follow-up|0|||
13310363|NCT01259089|26537819|FG005|Survival Follow up for Two Years|Lost to Follow-up|2|||
13310364|NCT01259089|26537814|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0|||
13310365|NCT01259089|26537815|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0|||
13310366|NCT01259089|26537816|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0|||
13310367|NCT01259089|26537817|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0|||
13310368|NCT01259089|26537818|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0|||
13310369|NCT01259089|26537819|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4|||
13310370|NCT01259024|26537828|FG000|Overall Study|Physician Decision|1|||
13310371|NCT01258998|26537841|FG000|Overall Study|Ineligible|1|||
13310372|NCT01258738|26537984|FG000|Double-blind Period|Did not meet inclusion criteria|3|||
13310373|NCT01258738|26537985|FG001|Double-blind Period|Did not meet inclusion criteria|3|||
13310374|NCT01258738|26537984|FG000|Double-blind Period|Withdrawal by Subject|2|||
13310375|NCT01258738|26537985|FG001|Double-blind Period|Withdrawal by Subject|2|||
13310376|NCT01258738|26537984|FG000|Double-blind Period|Protocol Violation|1|||
13310377|NCT01258738|26537985|FG001|Double-blind Period|Protocol Violation|1|||
13310378|NCT01258738|26537984|FG000|Double-blind Period|Adverse Event|3|||
13310379|NCT01258738|26537985|FG001|Double-blind Period|Adverse Event|1|||
13310380|NCT01258738|26537984|FG000|Open-label Period|Did not meet inclusion criteria|0|||
13310381|NCT01258738|26537985|FG001|Open-label Period|Did not meet inclusion criteria|1|||
13310382|NCT01258738|26537984|FG000|Open-label Period|Insufficient clinical response|5|||
13310383|NCT01258738|26537985|FG001|Open-label Period|Insufficient clinical response|3|||
13310384|NCT01258738|26537984|FG000|Open-label Period|Lost to Follow-up|0|||
13310385|NCT01258738|26537985|FG001|Open-label Period|Lost to Follow-up|2|||
13310386|NCT01258738|26537984|FG000|Open-label Period|Withdrawal by Subject|5|||
13310387|NCT01258738|26537985|FG001|Open-label Period|Withdrawal by Subject|6|||
13310388|NCT01258738|26537984|FG000|Open-label Period|Protocol Violation|2|||
13310389|NCT01258738|26537985|FG001|Open-label Period|Protocol Violation|2|||
13310390|NCT01258738|26537984|FG000|Open-label Period|Adverse Event|4|||
13310391|NCT01258738|26537985|FG001|Open-label Period|Adverse Event|5|||
13310392|NCT01258738|26537984|FG000|Open-label Period|Other Reasons|0|||
13310393|NCT01258738|26537985|FG001|Open-label Period|Other Reasons|1|||
13310394|NCT01258738|26537984|FG000|Open-label Period|Withdrawn due to pregnancy|1|||
13310395|NCT01258738|26537985|FG001|Open-label Period|Withdrawn due to pregnancy|1|||
13310396|NCT01258660|26538009|FG000|Overall Study|Adverse Event|2|||
13310397|NCT01258660|26538010|FG001|Overall Study|Adverse Event|4|||
13310398|NCT01258660|26538009|FG000|Overall Study|Withdrawal by Subject|3|||
13310399|NCT01258660|26538010|FG001|Overall Study|Withdrawal by Subject|0|||
13310400|NCT01258660|26538009|FG000|Overall Study|due to relocation|2|||
13310401|NCT01258660|26538010|FG001|Overall Study|due to relocation|0|||
13310402|NCT01258660|26538009|FG000|Overall Study|Protocol Violation|0|||
13310403|NCT01258660|26538010|FG001|Overall Study|Protocol Violation|1|||
13310404|NCT01258660|26538009|FG000|Overall Study|Invalid for primary analysis data set|4|||
13310405|NCT01258660|26538010|FG001|Overall Study|Invalid for primary analysis data set|6|||
13310406|NCT01258608|26538063|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1|||
13310407|NCT01258608|26538064|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0|||
13310408|NCT01258608|26538063|FG000|Overall Study|Clinical progression|1|||
13310409|NCT01258608|26538064|FG001|Overall Study|Clinical progression|0|||
13310410|NCT01258608|26538063|FG000|Overall Study|Sponsor decision|0|||
13310411|NCT01258608|26538064|FG001|Overall Study|Sponsor decision|1|||
13310412|NCT01258608|26538063|FG000|Overall Study|Physician Decision|6|||
13310413|NCT01258608|26538064|FG001|Overall Study|Physician Decision|1|||
13310414|NCT01258608|26538063|FG000|Overall Study|Lost to Follow-up|0|||
13310415|NCT01258608|26538064|FG001|Overall Study|Lost to Follow-up|1|||
13310416|NCT01258608|26538063|FG000|Overall Study|Lack of compliance|1|||
13310417|NCT01258608|26538064|FG001|Overall Study|Lack of compliance|0|||
13310418|NCT01258608|26538063|FG000|Overall Study|Lack of Efficacy|0|||
13310419|NCT01258608|26538064|FG001|Overall Study|Lack of Efficacy|1|||
13310420|NCT01258608|26538063|FG000|Overall Study|Adverse Event|6|||
13310421|NCT01258608|26538064|FG001|Overall Study|Adverse Event|10|||
13310422|NCT01258608|26538063|FG000|Overall Study|Withdrawal by Subject|6|||
13310423|NCT01258608|26538064|FG001|Overall Study|Withdrawal by Subject|5|||
13310424|NCT01258595|26538085|FG000|Overall Study|Lost to Follow-up|1|||
13310425|NCT01258595|26538086|FG001|Overall Study|Lost to Follow-up|0|||
13310426|NCT01258595|26538085|FG000|Overall Study|Withdrawal by Subject|0|||
13310427|NCT01258595|26538086|FG001|Overall Study|Withdrawal by Subject|1|||
13310428|NCT01258348|26538117|FG000|Overall Study|Adverse Event|1|||
13310429|NCT01258348|26538118|FG001|Overall Study|Adverse Event|1|||
13310430|NCT01258348|26538119|FG002|Overall Study|Adverse Event|3|||
13310431|NCT01258348|26538120|FG003|Overall Study|Adverse Event|2|||
13310432|NCT01258348|26538121|FG004|Overall Study|Adverse Event|4|||
13310433|NCT01258348|26538117|FG000|Overall Study|Progressive Disease|0|||
13310434|NCT01258348|26538118|FG001|Overall Study|Progressive Disease|3|||
13310435|NCT01258348|26538119|FG002|Overall Study|Progressive Disease|0|||
13310436|NCT01258348|26538120|FG003|Overall Study|Progressive Disease|2|||
13310437|NCT01258348|26538121|FG004|Overall Study|Progressive Disease|2|||
13310438|NCT01258348|26538117|FG000|Overall Study|Physician Decision|0|||
13310439|NCT01258348|26538118|FG001|Overall Study|Physician Decision|0|||
13310440|NCT01258348|26538119|FG002|Overall Study|Physician Decision|0|||
13310441|NCT01258348|26538120|FG003|Overall Study|Physician Decision|2|||
13310442|NCT01258348|26538121|FG004|Overall Study|Physician Decision|0|||
13310443|NCT01258348|26538117|FG000|Overall Study|Withdrawal by Subject|0|||
13310444|NCT01258348|26538118|FG001|Overall Study|Withdrawal by Subject|1|||
13310445|NCT01258348|26538119|FG002|Overall Study|Withdrawal by Subject|0|||
13310446|NCT01258348|26538120|FG003|Overall Study|Withdrawal by Subject|0|||
13310447|NCT01258348|26538121|FG004|Overall Study|Withdrawal by Subject|0|||
13310448|NCT01258101|26538184|FG000|Overall Study|Adverse Event|5|||
13310449|NCT01258101|26538185|FG001|Overall Study|Adverse Event|6|||
13310450|NCT01258101|26538186|FG002|Overall Study|Adverse Event|0|||
13310451|NCT01258101|26538187|FG003|Overall Study|Adverse Event|0|||
13310452|NCT01258101|26538184|FG000|Overall Study|Extra exclusion criterion amended|2|||
13310453|NCT01258101|26538185|FG001|Overall Study|Extra exclusion criterion amended|1|||
13310454|NCT01258101|26538186|FG002|Overall Study|Extra exclusion criterion amended|1|||
13310455|NCT01258101|26538187|FG003|Overall Study|Extra exclusion criterion amended|1|||
13310456|NCT01258101|26538184|FG000|Overall Study|Informed consent has been withdrawn|2|||
13310457|NCT01258101|26538185|FG001|Overall Study|Informed consent has been withdrawn|2|||
13310458|NCT01258101|26538186|FG002|Overall Study|Informed consent has been withdrawn|1|||
13310459|NCT01258101|26538187|FG003|Overall Study|Informed consent has been withdrawn|1|||
13310460|NCT01258101|26538184|FG000|Overall Study|Patient is not able to attend visits|8|||
13310461|NCT01258101|26538185|FG001|Overall Study|Patient is not able to attend visits|9|||
13310462|NCT01258101|26538186|FG002|Overall Study|Patient is not able to attend visits|7|||
13310463|NCT01258101|26538187|FG003|Overall Study|Patient is not able to attend visits|6|||
13310464|NCT01258101|26538184|FG000|Overall Study|Patient´s compliance|4|||
13310465|NCT01258101|26538185|FG001|Overall Study|Patient´s compliance|3|||
13310466|NCT01258101|26538186|FG002|Overall Study|Patient´s compliance|1|||
13310467|NCT01258101|26538187|FG003|Overall Study|Patient´s compliance|2|||
13310468|NCT01258101|26538184|FG000|Overall Study|Lost to Follow-up|5|||
13310469|NCT01258101|26538185|FG001|Overall Study|Lost to Follow-up|5|||
13310470|NCT01258101|26538186|FG002|Overall Study|Lost to Follow-up|0|||
13310471|NCT01258101|26538187|FG003|Overall Study|Lost to Follow-up|6|||
13310472|NCT01258101|26538184|FG000|Overall Study|PCR positive at week 24|0|||
13310473|NCT01258101|26538185|FG001|Overall Study|PCR positive at week 24|0|||
13310474|NCT01258101|26538186|FG002|Overall Study|PCR positive at week 24|0|||
13310475|NCT01258101|26538187|FG003|Overall Study|PCR positive at week 24|1|||
13310476|NCT01258101|26538184|FG000|Overall Study|Other reason|7|||
13310477|NCT01258101|26538185|FG001|Overall Study|Other reason|8|||
13310478|NCT01258101|26538186|FG002|Overall Study|Other reason|1|||
13310479|NCT01258101|26538187|FG003|Overall Study|Other reason|8|||
13310480|NCT01258075|26538212|FG000|Overall Study|Adverse Event|8|||
13310481|NCT01258075|26538213|FG001|Overall Study|Adverse Event|3|||
13310482|NCT01258075|26538212|FG000|Overall Study|Lost to Follow-up|11|||
13310483|NCT01258075|26538213|FG001|Overall Study|Lost to Follow-up|6|||
13310484|NCT01258075|26538212|FG000|Overall Study|Withdrawal by Subject|10|||
13310485|NCT01258075|26538213|FG001|Overall Study|Withdrawal by Subject|7|||
13310486|NCT01258075|26538212|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1|||
13122056|NCT02969525|25945881|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0|||
13122057|NCT02969525|25945882|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0|||
13122058|NCT02969525|25945883|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0|||
13122059|NCT02969525|25945884|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0|||
13122060|NCT02969525|25945885|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0|||
13122061|NCT02969525|25945886|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0|||
13122062|NCT02969525|25945887|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0|||
13310487|NCT01258075|26538213|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2|||
13310488|NCT01258075|26538212|FG000|Overall Study|Other|12|||
13310489|NCT01258075|26538213|FG001|Overall Study|Other|5|||
13310490|NCT01257737|26538238|FG000|Overall Study|Lost to Follow-up|1|||
13310491|NCT01257737|26538239|FG001|Overall Study|Lost to Follow-up|2|||
13310492|NCT01257737|26538238|FG000|Overall Study|Liver transplant|1|||
13310493|NCT01257737|26538239|FG001|Overall Study|Liver transplant|0|||
13310494|NCT01257737|26538238|FG000|Overall Study|Relocation out of the country|0|||
13310495|NCT01257737|26538239|FG001|Overall Study|Relocation out of the country|1|||
13310496|NCT01257737|26538238|FG000|Overall Study|Withdrew from study|0|||
13310497|NCT01257737|26538239|FG001|Overall Study|Withdrew from study|1|||
13310498|NCT01257698|26538252|FG000|Overall Study|Protocol Violation|4|||
13310499|NCT01257698|26538253|FG001|Overall Study|Protocol Violation|0|||
13310500|NCT01257581|26538301|FG000|Overall Study|Early Termination|3|||
13310501|NCT01257581|26538302|FG001|Overall Study|Early Termination|1|||
13310502|NCT01257581|26538303|FG002|Overall Study|Early Termination|2|||
13310503|NCT01257581|26538301|FG000|Overall Study|Death|2|||
13310504|NCT01257581|26538302|FG001|Overall Study|Death|2|||
13310505|NCT01257581|26538303|FG002|Overall Study|Death|4|||
13122063|NCT02969525|25945876|FG000|Dose-Blind Period|Adverse Event|0|||
13122064|NCT02969525|25945877|FG001|Dose-Blind Period|Adverse Event|0|||
13310506|NCT01257568|26538317|FG000|Overall Study|Lost to Follow-up|2|||
13310507|NCT01257568|26538317|FG000|Overall Study|Withdrawal by Subject|6|||
13310508|NCT01257568|26538317|FG000|Overall Study|Terminated|1|||
13310509|NCT01257568|26538317|FG000|Overall Study|Component Revision|24|||
13310510|NCT01257542|26538342|FG000|Overall Study|Protocol Violation|3|||
13310511|NCT01257542|26538343|FG001|Overall Study|Protocol Violation|5|||
13310512|NCT01257542|26538342|FG000|Overall Study|Withdrawal by Subject|0|||
13310513|NCT01257542|26538343|FG001|Overall Study|Withdrawal by Subject|2|||
13310514|NCT01257503|26538364|FG000|Overall Study|Lost to Follow-up|7|||
13310515|NCT01257503|26538365|FG001|Overall Study|Lost to Follow-up|10|||
13310516|NCT01257503|26538364|FG000|Overall Study|Over 5 years old at enrollment|0|||
13310517|NCT01257503|26538365|FG001|Overall Study|Over 5 years old at enrollment|1|||
13310518|NCT01257503|26538364|FG000|Overall Study|strep culture positive at enrollment|1|||
13310519|NCT01257503|26538365|FG001|Overall Study|strep culture positive at enrollment|0|||
13310520|NCT01257425|26538390|FG000|Overall Study|Lack of Efficacy|3|||
13310521|NCT01257425|26538391|FG001|Overall Study|Lack of Efficacy|3|||
13310522|NCT01257425|26538390|FG000|Overall Study|Adverse Event|1|||
13310523|NCT01257425|26538391|FG001|Overall Study|Adverse Event|1|||
13310524|NCT01257425|26538390|FG000|Overall Study|Protocol Violation|1|||
13310525|NCT01257425|26538391|FG001|Overall Study|Protocol Violation|1|||
13310526|NCT01257425|26538390|FG000|Overall Study|Withdrawal by Subject|0|||
13310527|NCT01257425|26538391|FG001|Overall Study|Withdrawal by Subject|1|||
13310528|NCT01257425|26538390|FG000|Overall Study|Death|1|||
13310529|NCT01257425|26538391|FG001|Overall Study|Death|0|||
13310530|NCT01257230|26538454|FG000|Overall Study|Not Treated|0|||
13310531|NCT01257230|26538455|FG001|Overall Study|Not Treated|0|||
13310532|NCT01257230|26538456|FG002|Overall Study|Not Treated|1|||
13310533|NCT01257230|26538454|FG000|Overall Study|Adverse Event|2|||
13310534|NCT01257230|26538455|FG001|Overall Study|Adverse Event|0|||
13310535|NCT01257230|26538456|FG002|Overall Study|Adverse Event|0|||
13310536|NCT01257230|26538454|FG000|Overall Study|Lack of Efficacy|0|||
13310537|NCT01257230|26538455|FG001|Overall Study|Lack of Efficacy|1|||
13310538|NCT01257230|26538456|FG002|Overall Study|Lack of Efficacy|0|||
13310539|NCT01257230|26538454|FG000|Overall Study|Protocol Violation|3|||
13310540|NCT01257230|26538455|FG001|Overall Study|Protocol Violation|0|||
13310541|NCT01257230|26538456|FG002|Overall Study|Protocol Violation|1|||
13310542|NCT01257230|26538454|FG000|Overall Study|Withdrawal by Subject|0|||
13310543|NCT01257230|26538455|FG001|Overall Study|Withdrawal by Subject|4|||
13310544|NCT01257230|26538456|FG002|Overall Study|Withdrawal by Subject|1|||
13310545|NCT01257230|26538454|FG000|Overall Study|Other reason not defined above|1|||
13310546|NCT01257230|26538455|FG001|Overall Study|Other reason not defined above|5|||
13310547|NCT01257230|26538456|FG002|Overall Study|Other reason not defined above|3|||
13310548|NCT01257204|26538510|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
13310549|NCT01257204|26538511|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
13310550|NCT01257204|26538512|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3|||
13310551|NCT01257204|26538510|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
13310552|NCT01257204|26538511|FG001|Treatment Period (up to Week 24)|Adverse Event|1|||
13310553|NCT01257204|26538512|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
13310554|NCT01257204|26538510|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
13310555|NCT01257204|26538511|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0|||
13310556|NCT01257204|26538512|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
13310557|NCT01257204|26538510|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
13310558|NCT01257204|26538511|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
13310559|NCT01257204|26538512|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
13310560|NCT01257204|26538510|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
13310561|NCT01257204|26538511|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
13310562|NCT01257204|26538512|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1|||
13310563|NCT01257204|26538510|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1|||
13310564|NCT01257204|26538511|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
13310565|NCT01257204|26538512|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
13310566|NCT01257204|26538510|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0|||
13310567|NCT01257204|26538511|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2|||
13310568|NCT01257204|26538512|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1|||
13310569|NCT01257204|26538510|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1|||
13310570|NCT01257204|26538511|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
13310571|NCT01257204|26538512|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
13310572|NCT01257204|26538510|FG000|Follow-up Period (up to Week 48)|Other|0|||
13310573|NCT01257204|26538511|FG001|Follow-up Period (up to Week 48)|Other|0|||
13310574|NCT01257204|26538512|FG002|Follow-up Period (up to Week 48)|Other|5|||
13310575|NCT01256879|26538524|FG000|Overall Study|Withdrawal by Subject|1|||
13310576|NCT01256788|26538542|FG000|Overall Study|Lost to Follow-up|5|||
13310577|NCT01256788|26538543|FG001|Overall Study|Lost to Follow-up|8|||
13310578|NCT01256788|26538544|FG002|Overall Study|Lost to Follow-up|3|||
13310579|NCT01256684|26538586|FG000|Overall Study|Adverse Event|1|||
13310580|NCT01256684|26538587|FG001|Overall Study|Adverse Event|4|||
13310581|NCT01256684|26538588|FG002|Overall Study|Adverse Event|2|||
13310582|NCT01256684|26538586|FG000|Overall Study|Withdrawal by Subject|4|||
13310583|NCT01256684|26538587|FG001|Overall Study|Withdrawal by Subject|0|||
13310584|NCT01256684|26538588|FG002|Overall Study|Withdrawal by Subject|2|||
13310585|NCT01256684|26538586|FG000|Overall Study|Physician Decision|0|||
13310586|NCT01256684|26538587|FG001|Overall Study|Physician Decision|1|||
13310587|NCT01256684|26538588|FG002|Overall Study|Physician Decision|0|||
13310588|NCT01256684|26538586|FG000|Overall Study|Lack of Efficacy|0|||
13310589|NCT01256684|26538587|FG001|Overall Study|Lack of Efficacy|1|||
13310590|NCT01256684|26538588|FG002|Overall Study|Lack of Efficacy|1|||
13310591|NCT01256684|26538586|FG000|Overall Study|Entry criteria not met/non-compliance|4|||
13310592|NCT01256684|26538587|FG001|Overall Study|Entry criteria not met/non-compliance|7|||
13310593|NCT01256684|26538588|FG002|Overall Study|Entry criteria not met/non-compliance|6|||
13372966|NCT00806026|26722410|FG003|Overall Study|Other|2|||
13372967|NCT00806026|26722411|FG004|Overall Study|Other|0|||
13372968|NCT00806026|26722412|FG005|Overall Study|Other|4|||
13372969|NCT00806026|26722407|FG000|Overall Study|Protocol Violation|6|||
13372970|NCT00806026|26722408|FG001|Overall Study|Protocol Violation|9|||
13372971|NCT00806026|26722409|FG002|Overall Study|Protocol Violation|9|||
13310594|NCT01256671|26538601|FG000|Overall Study|Adverse Event|29|||
13310595|NCT01256671|26538601|FG000|Overall Study|Lost to Follow-up|16|||
13310596|NCT01256671|26538601|FG000|Overall Study|Withdrawal by Subject|31|||
13310597|NCT01256671|26538601|FG000|Overall Study|Physician Decision|3|||
13310598|NCT01256671|26538601|FG000|Overall Study|Lack of Efficacy|4|||
13310599|NCT01256671|26538601|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12|||
13310600|NCT01256658|26538658|FG000|Period 1|Lost to Follow-up|837|||
13310601|NCT01256658|26538659|FG001|Period 1|Lost to Follow-up|661|||
13310602|NCT01256658|26538658|FG000|Period 1|Withdrawal by Subject|35|||
13310603|NCT01256658|26538659|FG001|Period 1|Withdrawal by Subject|43|||
13310604|NCT01256658|26538658|FG000|Period 1|Death|48|||
13310605|NCT01256658|26538659|FG001|Period 1|Death|44|||
13310606|NCT01256593|26538675|FG000|Overall Study|Protocol Violation|26|||
13310607|NCT01256593|26538675|FG000|Overall Study|No Drug Administration Information|2|||
13310608|NCT01256593|26538675|FG000|Overall Study|No Visit After Treatment|186|||
13310609|NCT01256567|26538687|FG000|Overall Study|Withdrawal by Subject|1|||
13310610|NCT01256502|26538699|FG000|Overall Study|Had scaffold removed|4|||
13310611|NCT01256502|26538699|FG000|Overall Study|Personal reasons|5|||
13310612|NCT01256502|26538699|FG000|Overall Study|Protocol deviation|1|||
13310613|NCT01256476|26538712|FG000|Overall Study|Adverse Event|2|||
13310614|NCT01256476|26538713|FG001|Overall Study|Adverse Event|1|||
13310615|NCT01256476|26538712|FG000|Overall Study|Withdrawal by Subject|2|||
13310616|NCT01256476|26538713|FG001|Overall Study|Withdrawal by Subject|1|||
13310617|NCT01256476|26538712|FG000|Overall Study|Lost to Follow-up|1|||
13310618|NCT01256476|26538713|FG001|Overall Study|Lost to Follow-up|2|||
13310619|NCT01256476|26538712|FG000|Overall Study|Persistent ALT or AST elevation|1|||
13310620|NCT01256476|26538713|FG001|Overall Study|Persistent ALT or AST elevation|0|||
13310621|NCT01256476|26538712|FG000|Overall Study|Physician Decision|0|||
13310622|NCT01256476|26538713|FG001|Overall Study|Physician Decision|1|||
13310623|NCT01256476|26538712|FG000|Overall Study|Subject non-compliance|0|||
13310624|NCT01256476|26538713|FG001|Overall Study|Subject non-compliance|1|||
13310625|NCT01256476|26538712|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0|||
13310626|NCT01256476|26538713|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1|||
13310627|NCT01256450|26538746|FG000|Open-label Titration|Adverse Event|39|||
13310628|NCT01256450|26538747|FG001|Open-label Titration|Adverse Event|0|||
13310629|NCT01256450|26538748|FG002|Open-label Titration|Adverse Event|0|||
13310630|NCT01256450|26538746|FG000|Open-label Titration|Lost to Follow-up|7|||
13310631|NCT01256450|26538747|FG001|Open-label Titration|Lost to Follow-up|0|||
13310632|NCT01256450|26538748|FG002|Open-label Titration|Lost to Follow-up|0|||
13310633|NCT01256450|26538746|FG000|Open-label Titration|Lack of analgesic effect|30|||
13310634|NCT01256450|26538747|FG001|Open-label Titration|Lack of analgesic effect|0|||
13310635|NCT01256450|26538748|FG002|Open-label Titration|Lack of analgesic effect|0|||
13310636|NCT01256450|26538746|FG000|Open-label Titration|Non-compliance|9|||
13310637|NCT01256450|26538747|FG001|Open-label Titration|Non-compliance|0|||
13310638|NCT01256450|26538748|FG002|Open-label Titration|Non-compliance|0|||
13310639|NCT01256450|26538746|FG000|Open-label Titration|Screen failure|1|||
13310640|NCT01256450|26538747|FG001|Open-label Titration|Screen failure|0|||
13310641|NCT01256450|26538748|FG002|Open-label Titration|Screen failure|0|||
13310642|NCT01256450|26538746|FG000|Open-label Titration|Other|13|||
13310643|NCT01256450|26538747|FG001|Open-label Titration|Other|0|||
13310644|NCT01256450|26538748|FG002|Open-label Titration|Other|0|||
13310645|NCT01256450|26538746|FG000|Double-blind Treatment|Adverse Event|0|||
13310646|NCT01256450|26538747|FG001|Double-blind Treatment|Adverse Event|8|||
13310647|NCT01256450|26538748|FG002|Double-blind Treatment|Adverse Event|6|||
13310648|NCT01256450|26538746|FG000|Double-blind Treatment|Lost to Follow-up|0|||
13310649|NCT01256450|26538747|FG001|Double-blind Treatment|Lost to Follow-up|1|||
13310650|NCT01256450|26538748|FG002|Double-blind Treatment|Lost to Follow-up|7|||
13310651|NCT01256450|26538746|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
13310652|NCT01256450|26538747|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
13310653|NCT01256450|26538748|FG002|Double-blind Treatment|Withdrawal by Subject|1|||
13310654|NCT01256450|26538746|FG000|Double-blind Treatment|Lack of analgesic effect|0|||
13310655|NCT01256450|26538747|FG001|Double-blind Treatment|Lack of analgesic effect|5|||
13310656|NCT01256450|26538748|FG002|Double-blind Treatment|Lack of analgesic effect|6|||
13310657|NCT01256450|26538746|FG000|Double-blind Treatment|Non-compliance|0|||
13310658|NCT01256450|26538747|FG001|Double-blind Treatment|Non-compliance|5|||
13310659|NCT01256450|26538748|FG002|Double-blind Treatment|Non-compliance|4|||
13310660|NCT01256450|26538746|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0|||
13310661|NCT01256450|26538747|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0|||
13310662|NCT01256450|26538748|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1|||
13310663|NCT01256450|26538746|FG000|Double-blind Treatment|Other|0|||
13310664|NCT01256450|26538747|FG001|Double-blind Treatment|Other|9|||
13310665|NCT01256450|26538748|FG002|Double-blind Treatment|Other|12|||
13310666|NCT01256411|26538787|FG000|Extension by Maximum Treatment|Protocol deviation|0|||
13310667|NCT01256411|26538788|FG001|Extension by Maximum Treatment|Protocol deviation|0|||
13310668|NCT01256411|26538789|FG002|Extension by Maximum Treatment|Protocol deviation|1|||
13122065|NCT02969525|25945878|FG002|Dose-Blind Period|Adverse Event|0|||
13310669|NCT01256411|26538790|FG003|Extension by Maximum Treatment|Protocol deviation|0|||
13310670|NCT01256411|26538791|FG004|Extension by Maximum Treatment|Protocol deviation|0|||
13310671|NCT01256411|26538792|FG005|Extension by Maximum Treatment|Protocol deviation|0|||
13310672|NCT01256411|26538787|FG000|Extension by Maximum Treatment|Lost to Follow-up|1|||
13310673|NCT01256411|26538788|FG001|Extension by Maximum Treatment|Lost to Follow-up|2|||
13310674|NCT01256411|26538789|FG002|Extension by Maximum Treatment|Lost to Follow-up|0|||
13310675|NCT01256411|26538790|FG003|Extension by Maximum Treatment|Lost to Follow-up|0|||
13310676|NCT01256411|26538791|FG004|Extension by Maximum Treatment|Lost to Follow-up|0|||
13310677|NCT01256411|26538792|FG005|Extension by Maximum Treatment|Lost to Follow-up|0|||
13310678|NCT01256411|26538787|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1|||
13122066|NCT02969525|25945879|FG003|Dose-Blind Period|Adverse Event|0|||
13122067|NCT02969525|25945880|FG004|Dose-Blind Period|Adverse Event|0|||
13122068|NCT02969525|25945881|FG005|Dose-Blind Period|Adverse Event|0|||
13122069|NCT02969525|25945882|FG006|Dose-Blind Period|Adverse Event|0|||
13122070|NCT02969525|25945883|FG007|Dose-Blind Period|Adverse Event|0|||
13122071|NCT02969525|25945884|FG008|Dose-Blind Period|Adverse Event|0|||
13122072|NCT02969525|25945885|FG009|Dose-Blind Period|Adverse Event|1|||
13122073|NCT02969525|25945886|FG010|Dose-Blind Period|Adverse Event|1|||
13122074|NCT02969525|25945887|FG011|Dose-Blind Period|Adverse Event|1|||
13122075|NCT02969525|25945876|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
13122076|NCT02969525|25945877|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
13122077|NCT02969525|25945878|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
13122078|NCT02969525|25945879|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
13122079|NCT02969525|25945880|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
13122080|NCT02969525|25945881|FG005|Dose-Blind Period|Withdrawal by Subject|0|||
13122081|NCT02969525|25945882|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
13122082|NCT02969525|25945883|FG007|Dose-Blind Period|Withdrawal by Subject|0|||
13122083|NCT02969525|25945884|FG008|Dose-Blind Period|Withdrawal by Subject|1|||
13122084|NCT02969525|25945885|FG009|Dose-Blind Period|Withdrawal by Subject|2|||
13122085|NCT02969525|25945886|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
13310679|NCT01256411|26538788|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6|||
13310680|NCT01256411|26538789|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1|||
13310681|NCT01256411|26538790|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0|||
13310682|NCT01256411|26538791|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0|||
13310683|NCT01256411|26538792|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0|||
13310684|NCT01256411|26538787|FG000|Extension by Maximum Treatment|Lack of Efficacy|1|||
13310685|NCT01256411|26538788|FG001|Extension by Maximum Treatment|Lack of Efficacy|0|||
13310686|NCT01256411|26538789|FG002|Extension by Maximum Treatment|Lack of Efficacy|1|||
13310687|NCT01256411|26538790|FG003|Extension by Maximum Treatment|Lack of Efficacy|0|||
13310688|NCT01256411|26538791|FG004|Extension by Maximum Treatment|Lack of Efficacy|0|||
13310689|NCT01256411|26538792|FG005|Extension by Maximum Treatment|Lack of Efficacy|0|||
13310690|NCT01256411|26538787|FG000|Extension by Maximum Treatment|Adverse Event|4|||
13310691|NCT01256411|26538788|FG001|Extension by Maximum Treatment|Adverse Event|2|||
13310692|NCT01256411|26538789|FG002|Extension by Maximum Treatment|Adverse Event|1|||
13310693|NCT01256411|26538790|FG003|Extension by Maximum Treatment|Adverse Event|0|||
13310694|NCT01256411|26538791|FG004|Extension by Maximum Treatment|Adverse Event|0|||
13310695|NCT01256411|26538792|FG005|Extension by Maximum Treatment|Adverse Event|0|||
13310696|NCT01256411|26538787|FG000|Extension by Mono or Combination Therapy|Adverse Event|0|||
13310697|NCT01256411|26538788|FG001|Extension by Mono or Combination Therapy|Adverse Event|0|||
13310698|NCT01256411|26538789|FG002|Extension by Mono or Combination Therapy|Adverse Event|0|||
13310699|NCT01256411|26538790|FG003|Extension by Mono or Combination Therapy|Adverse Event|0|||
13310700|NCT01256411|26538791|FG004|Extension by Mono or Combination Therapy|Adverse Event|6|||
13310701|NCT01256411|26538792|FG005|Extension by Mono or Combination Therapy|Adverse Event|1|||
13310702|NCT01256411|26538787|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0|||
13310703|NCT01256411|26538788|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0|||
13310704|NCT01256411|26538789|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0|||
13310705|NCT01256411|26538790|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0|||
13310706|NCT01256411|26538791|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0|||
13310707|NCT01256411|26538792|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1|||
13310708|NCT01256411|26538787|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
13310709|NCT01256411|26538788|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
13310710|NCT01256411|26538789|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
13310711|NCT01256411|26538790|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
13310712|NCT01256411|26538791|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3|||
13310713|NCT01256411|26538792|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
13310714|NCT01256411|26538787|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
13310715|NCT01256411|26538788|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
13310716|NCT01256411|26538789|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
13310717|NCT01256411|26538790|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
13310718|NCT01256411|26538791|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7|||
13310719|NCT01256411|26538792|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1|||
13310720|NCT01256411|26538787|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
13310721|NCT01256411|26538788|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
13310722|NCT01256411|26538789|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
13310723|NCT01256411|26538790|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
13310724|NCT01256411|26538791|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
13310725|NCT01256411|26538792|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
13310726|NCT01256398|26538798|FG000|Overall Study|Withdrawal by Subject|1|||
13310727|NCT01256385|26538825|FG000|Overall Study|Physician Decision|1|||
13310728|NCT01256385|26538826|FG001|Overall Study|Physician Decision|1|||
13310729|NCT01256385|26538825|FG000|Overall Study|Withdrawal by Subject|2|||
13310730|NCT01256385|26538826|FG001|Overall Study|Withdrawal by Subject|2|||
13310731|NCT01256294|26538845|FG000|Overall Study|Adverse Event|1|||
13310732|NCT01256294|26538846|FG001|Overall Study|Adverse Event|0|||
13310733|NCT01256294|26538845|FG000|Overall Study|Withdrawal by Subject|1|||
13310734|NCT01256294|26538846|FG001|Overall Study|Withdrawal by Subject|1|||
13310735|NCT01256294|26538845|FG000|Overall Study|Protocol deviation|2|||
13310736|NCT01256294|26538846|FG001|Overall Study|Protocol deviation|1|||
13310737|NCT01256190|26538867|FG000|Overall Study|Lost to Follow-up|2|||
13310738|NCT01256190|26538868|FG001|Overall Study|Lost to Follow-up|0|||
13310739|NCT01256177|26538897|FG000|Overall Study|Withdrawal by Subject|23|||
13310740|NCT01256177|26538898|FG001|Overall Study|Withdrawal by Subject|22|||
13310741|NCT01256177|26538897|FG000|Overall Study|Lost to Follow-up|2|||
13310742|NCT01256177|26538898|FG001|Overall Study|Lost to Follow-up|2|||
13310743|NCT01256177|26538897|FG000|Overall Study|Adverse Event|8|||
13310744|NCT01256177|26538898|FG001|Overall Study|Adverse Event|9|||
13310745|NCT01256177|26538897|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
13310746|NCT01256177|26538898|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
13310747|NCT01256177|26538897|FG000|Overall Study|Condition under Investigation Worsened|1|||
13310748|NCT01256177|26538898|FG001|Overall Study|Condition under Investigation Worsened|0|||
13310749|NCT01256177|26538897|FG000|Overall Study|Lack of Efficacy|11|||
13310750|NCT01256177|26538898|FG001|Overall Study|Lack of Efficacy|2|||
13310751|NCT01256177|26538897|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1|||
13310752|NCT01256177|26538898|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0|||
13310753|NCT01256060|26538910|FG000|Overall Study|Lost to Follow-up|0|||
13310754|NCT01256060|26538911|FG001|Overall Study|Lost to Follow-up|1|||
13310755|NCT01256060|26538912|FG002|Overall Study|Lost to Follow-up|0|||
13310756|NCT01256060|26538913|FG003|Overall Study|Lost to Follow-up|0|||
13310757|NCT01256008|26538943|FG000|Overall Study|Lost to Follow-up|6|||
13310758|NCT01256008|26538944|FG001|Overall Study|Lost to Follow-up|4|||
13310759|NCT01256008|26538945|FG002|Overall Study|Lost to Follow-up|11|||
13310760|NCT01256008|26538943|FG000|Overall Study|Withdrawal by Subject|2|||
13310761|NCT01256008|26538944|FG001|Overall Study|Withdrawal by Subject|3|||
13310762|NCT01256008|26538945|FG002|Overall Study|Withdrawal by Subject|10|||
13310763|NCT01255904|26538958|FG000|Overall Study|Physician Decision|1|||
13310764|NCT01255904|26538959|FG001|Overall Study|Physician Decision|4|||
13310765|NCT01255787|26538998|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
13310766|NCT01255787|26538999|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2|||
13310767|NCT01255787|26539000|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
13310768|NCT01255787|26539001|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
13310769|NCT01255787|26538998|FG000|Overall Study|Major Protocol Deviation|1|||
13310770|NCT01255787|26538999|FG001|Overall Study|Major Protocol Deviation|1|||
13310771|NCT01255787|26539000|FG002|Overall Study|Major Protocol Deviation|0|||
13310772|NCT01255787|26539001|FG003|Overall Study|Major Protocol Deviation|4|||
13310773|NCT01255787|26538998|FG000|Overall Study|Lost to Follow-up|1|||
13310774|NCT01255787|26538999|FG001|Overall Study|Lost to Follow-up|2|||
13310775|NCT01255787|26539000|FG002|Overall Study|Lost to Follow-up|4|||
13310776|NCT01255787|26539001|FG003|Overall Study|Lost to Follow-up|2|||
13310777|NCT01255787|26538998|FG000|Overall Study|Withdrawal of Consent|3|||
13310778|NCT01255787|26538999|FG001|Overall Study|Withdrawal of Consent|9|||
13310779|NCT01255787|26539000|FG002|Overall Study|Withdrawal of Consent|3|||
13310780|NCT01255787|26539001|FG003|Overall Study|Withdrawal of Consent|4|||
13310781|NCT01255787|26538998|FG000|Overall Study|Pregnancy|0|||
13310782|NCT01255787|26538999|FG001|Overall Study|Pregnancy|0|||
13310783|NCT01255787|26539000|FG002|Overall Study|Pregnancy|0|||
13310784|NCT01255787|26539001|FG003|Overall Study|Pregnancy|1|||
13310785|NCT01255787|26538998|FG000|Overall Study|Lack of Efficacy|2|||
13310786|NCT01255787|26538999|FG001|Overall Study|Lack of Efficacy|2|||
13310787|NCT01255787|26539000|FG002|Overall Study|Lack of Efficacy|2|||
13310788|NCT01255787|26539001|FG003|Overall Study|Lack of Efficacy|2|||
13310789|NCT01255787|26538998|FG000|Overall Study|Noncompliance with Study Drug|3|||
13310790|NCT01255787|26538999|FG001|Overall Study|Noncompliance with Study Drug|1|||
13310791|NCT01255787|26539000|FG002|Overall Study|Noncompliance with Study Drug|0|||
13310792|NCT01255787|26539001|FG003|Overall Study|Noncompliance with Study Drug|0|||
13310793|NCT01255761|26539090|FG000|Overall Study|Adverse Event|29|||
13310794|NCT01255761|26539091|FG001|Overall Study|Adverse Event|43|||
13310795|NCT01255761|26539090|FG000|Overall Study|Lack of Efficacy|86|||
13310796|NCT01255761|26539091|FG001|Overall Study|Lack of Efficacy|74|||
13310797|NCT01255761|26539090|FG000|Overall Study|Protocol Violation|9|||
13310798|NCT01255761|26539091|FG001|Overall Study|Protocol Violation|5|||
13310799|NCT01255761|26539090|FG000|Overall Study|Lost to Follow-up|10|||
13310800|NCT01255761|26539091|FG001|Overall Study|Lost to Follow-up|8|||
13310801|NCT01255761|26539090|FG000|Overall Study|Withdrawal by Subject|11|||
13310802|NCT01255761|26539091|FG001|Overall Study|Withdrawal by Subject|27|||
13310803|NCT01255761|26539090|FG000|Overall Study|Other Reasons|37|||
13310804|NCT01255761|26539091|FG001|Overall Study|Other Reasons|18|||
13310805|NCT01255722|26539124|FG000|Overall Study|Adverse Event|0|||
13310806|NCT01255722|26539125|FG001|Overall Study|Adverse Event|1|||
13310807|NCT01255722|26539126|FG002|Overall Study|Adverse Event|1|||
13310808|NCT01255722|26539124|FG000|Overall Study|asymptomatic patient|1|||
13310809|NCT01255722|26539125|FG001|Overall Study|asymptomatic patient|0|||
13310810|NCT01255722|26539126|FG002|Overall Study|asymptomatic patient|0|||
13310811|NCT01255722|26539124|FG000|Overall Study|beta-blocker contraindicated|2|||
13310812|NCT01255722|26539125|FG001|Overall Study|beta-blocker contraindicated|0|||
13310813|NCT01255722|26539126|FG002|Overall Study|beta-blocker contraindicated|0|||
13310814|NCT01255670|26539141|FG000|Overall Study|Adverse Event|10|||
13310815|NCT01255670|26539142|FG001|Overall Study|Adverse Event|10|||
13310816|NCT01255670|26539141|FG000|Overall Study|Lost to Follow-up|16|||
13310817|NCT01255670|26539142|FG001|Overall Study|Lost to Follow-up|10|||
13310818|NCT01255631|26539165|FG000|Overall Study|poor enrollment, no data analyzed|9|||
13310819|NCT01255631|26539166|FG001|Overall Study|poor enrollment, no data analyzed|6|||
13310820|NCT01255592|26539229|FG000|Overall Study|Adverse Event|5|||
13310821|NCT01255592|26539230|FG001|Overall Study|Adverse Event|0|||
13310822|NCT01255592|26539229|FG000|Overall Study|Withdrawal by Subject|1|||
13310823|NCT01255592|26539230|FG001|Overall Study|Withdrawal by Subject|0|||
13310824|NCT01255592|26539229|FG000|Overall Study|Other|0|||
13310825|NCT01255592|26539230|FG001|Overall Study|Other|1|||
13310826|NCT01255436|26539249|FG000|Overall Study|Lost to Follow-up|178|||
13310827|NCT01255436|26539250|FG001|Overall Study|Lost to Follow-up|191|||
13310828|NCT01255436|26539249|FG000|Overall Study|Death, stroke, or MI|4|||
13310829|NCT01255436|26539250|FG001|Overall Study|Death, stroke, or MI|3|||
13310830|NCT01255423|26539271|FG000|Overall Study|Abnormal Laboratory value|3|||
13310831|NCT01255423|26539272|FG001|Overall Study|Abnormal Laboratory value|2|||
13310832|NCT01255423|26539271|FG000|Overall Study|Use of prohibited medications|0|||
13310833|NCT01255423|26539272|FG001|Overall Study|Use of prohibited medications|1|||
13310834|NCT01255306|26539288|FG000|Overall Study|Physician Decision|1|||
13310835|NCT01255306|26539289|FG001|Overall Study|Physician Decision|1|||
13310836|NCT01255163|26539318|FG000|Overall Study|Withdrawal by Subject|1|||
13310837|NCT01255163|26539319|FG001|Overall Study|Withdrawal by Subject|0|||
13310838|NCT01255163|26539318|FG000|Overall Study|Lost to Follow-up|2|||
13310839|NCT01255163|26539319|FG001|Overall Study|Lost to Follow-up|0|||
13310840|NCT01255163|26539318|FG000|Overall Study|Adverse Event|0|||
13310841|NCT01255163|26539319|FG001|Overall Study|Adverse Event|2|||
13310842|NCT01255163|26539318|FG000|Overall Study|AstraZeneca stopped support of the study|1|||
13310843|NCT01255163|26539319|FG001|Overall Study|AstraZeneca stopped support of the study|3|||
13310844|NCT01254890|26539332|FG000|Overall Study|Ineligible|0|||
13310845|NCT01254890|26539333|FG001|Overall Study|Ineligible|3|||
13310846|NCT01254890|26539332|FG000|Overall Study|Withdrawal by Subject|1|||
13310847|NCT01254890|26539333|FG001|Overall Study|Withdrawal by Subject|2|||
13310848|NCT01254890|26539332|FG000|Overall Study|Disease Progression|0|||
13310849|NCT01254890|26539333|FG001|Overall Study|Disease Progression|5|||
13310850|NCT01254747|26539384|FG000|Overall Study|Unacceptable subjective vision|0|||
13310851|NCT01254747|26539385|FG001|Overall Study|Unacceptable subjective vision|0|||
13310852|NCT01254747|26539386|FG002|Overall Study|Unacceptable subjective vision|0|||
13310853|NCT01254747|26539387|FG003|Overall Study|Unacceptable subjective vision|2|||
13310854|NCT01254747|26539384|FG000|Overall Study|Difficult removal handling|0|||
13310855|NCT01254747|26539385|FG001|Overall Study|Difficult removal handling|0|||
13310856|NCT01254747|26539386|FG002|Overall Study|Difficult removal handling|1|||
13310857|NCT01254747|26539387|FG003|Overall Study|Difficult removal handling|0|||
13310858|NCT01254747|26539384|FG000|Overall Study|Symptoms and problems|0|||
13310859|NCT01254747|26539385|FG001|Overall Study|Symptoms and problems|2|||
13310860|NCT01254747|26539386|FG002|Overall Study|Symptoms and problems|1|||
13310861|NCT01254747|26539387|FG003|Overall Study|Symptoms and problems|0|||
13310862|NCT01254747|26539384|FG000|Overall Study|Lost to Follow-up|0|||
13310863|NCT01254747|26539385|FG001|Overall Study|Lost to Follow-up|0|||
13310864|NCT01254747|26539386|FG002|Overall Study|Lost to Follow-up|1|||
13310865|NCT01254747|26539387|FG003|Overall Study|Lost to Follow-up|0|||
13310866|NCT01254747|26539384|FG000|Overall Study|Biomicroscopy|0|||
13310867|NCT01254747|26539385|FG001|Overall Study|Biomicroscopy|0|||
13310868|NCT01254747|26539386|FG002|Overall Study|Biomicroscopy|1|||
13310869|NCT01254747|26539387|FG003|Overall Study|Biomicroscopy|0|||
13310870|NCT01254747|26539384|FG000|Overall Study|Discomfort|0|||
13310871|NCT01254747|26539385|FG001|Overall Study|Discomfort|4|||
13310872|NCT01254747|26539386|FG002|Overall Study|Discomfort|0|||
13310873|NCT01254747|26539387|FG003|Overall Study|Discomfort|0|||
13310874|NCT01254721|26539402|FG000|Overall Study|Lost to Follow-up|0|||
13310875|NCT01254721|26539403|FG001|Overall Study|Lost to Follow-up|4|||
13310876|NCT01254721|26539402|FG000|Overall Study|Lack of Efficacy|4|||
13310877|NCT01254721|26539403|FG001|Overall Study|Lack of Efficacy|2|||
13310878|NCT01254721|26539402|FG000|Overall Study|Death|0|||
13310879|NCT01254721|26539403|FG001|Overall Study|Death|1|||
13310880|NCT01254721|26539402|FG000|Overall Study|technical problum|1|||
13310881|NCT01254721|26539403|FG001|Overall Study|technical problum|0|||
13310882|NCT01254721|26539402|FG000|Overall Study|Adverse Event|2|||
13310883|NCT01254721|26539403|FG001|Overall Study|Adverse Event|3|||
13310884|NCT01254721|26539402|FG000|Overall Study|Withdrawal by Subject|8|||
13310885|NCT01254721|26539403|FG001|Overall Study|Withdrawal by Subject|11|||
13310886|NCT01254721|26539402|FG000|Overall Study|Wrongly randomization|0|||
13310887|NCT01254721|26539403|FG001|Overall Study|Wrongly randomization|1|||
13310888|NCT01254669|26539418|FG000|Overall Study|Withdrawal by Subject|0|||
13310889|NCT01254669|26539419|FG001|Overall Study|Withdrawal by Subject|1|||
13310890|NCT01254669|26539418|FG000|Overall Study|time constraint|2|||
13310891|NCT01254669|26539419|FG001|Overall Study|time constraint|2|||
13310892|NCT01254669|26539418|FG000|Overall Study|called to clinic during intervention|1|||
13310893|NCT01254669|26539419|FG001|Overall Study|called to clinic during intervention|1|||
13310894|NCT01254656|26539455|FG000|Overall Study|Discontinued due to termination of study|40|||
13310895|NCT01254656|26539456|FG001|Overall Study|Discontinued due to termination of study|39|||
13310896|NCT01254656|26539457|FG002|Overall Study|Discontinued due to termination of study|13|||
13310897|NCT01254656|26539455|FG000|Overall Study|Lack of Efficacy|3|||
13310898|NCT01254656|26539456|FG001|Overall Study|Lack of Efficacy|0|||
13310899|NCT01254656|26539457|FG002|Overall Study|Lack of Efficacy|0|||
13310900|NCT01254656|26539455|FG000|Overall Study|Lost to Follow-up|1|||
13310901|NCT01254656|26539456|FG001|Overall Study|Lost to Follow-up|0|||
13310902|NCT01254656|26539457|FG002|Overall Study|Lost to Follow-up|2|||
13310903|NCT01254656|26539455|FG000|Overall Study|Withdrawal by Subject|2|||
13310904|NCT01254656|26539456|FG001|Overall Study|Withdrawal by Subject|2|||
13310905|NCT01254656|26539457|FG002|Overall Study|Withdrawal by Subject|1|||
13310906|NCT01254656|26539455|FG000|Overall Study|Pregnancy|0|||
13310907|NCT01254656|26539456|FG001|Overall Study|Pregnancy|0|||
13310908|NCT01254656|26539457|FG002|Overall Study|Pregnancy|2|||
13310909|NCT01254656|26539455|FG000|Overall Study|Adverse Event|1|||
13310910|NCT01254656|26539456|FG001|Overall Study|Adverse Event|1|||
13310911|NCT01254656|26539457|FG002|Overall Study|Adverse Event|0|||
13310912|NCT01254656|26539455|FG000|Overall Study|Death|0|||
13310913|NCT01254656|26539456|FG001|Overall Study|Death|1|||
13310914|NCT01254656|26539457|FG002|Overall Study|Death|0|||
13310915|NCT01254643|26539467|FG000|Overall Study|Withdrawal by Subject|1|||
13310916|NCT01254630|26539498|FG000|Overall Study|Adverse Event|36|||
13310917|NCT01254630|26539499|FG001|Overall Study|Adverse Event|15|||
13310918|NCT01254630|26539500|FG002|Overall Study|Adverse Event|40|||
13310919|NCT01254630|26539501|FG003|Overall Study|Adverse Event|8|||
13310920|NCT01254630|26539498|FG000|Overall Study|Death|461|||
13310921|NCT01254630|26539499|FG001|Overall Study|Death|151|||
13310922|NCT01254630|26539500|FG002|Overall Study|Death|478|||
13310923|NCT01254630|26539501|FG003|Overall Study|Death|139|||
13310924|NCT01254630|26539498|FG000|Overall Study|Lost to Follow-up|80|||
13310925|NCT01254630|26539499|FG001|Overall Study|Lost to Follow-up|26|||
13310926|NCT01254630|26539500|FG002|Overall Study|Lost to Follow-up|89|||
13310927|NCT01254630|26539501|FG003|Overall Study|Lost to Follow-up|32|||
13310928|NCT01254630|26539498|FG000|Overall Study|Physician Decision|24|||
13310929|NCT01254630|26539499|FG001|Overall Study|Physician Decision|8|||
13310930|NCT01254630|26539500|FG002|Overall Study|Physician Decision|16|||
13310931|NCT01254630|26539501|FG003|Overall Study|Physician Decision|7|||
13310932|NCT01254630|26539498|FG000|Overall Study|Withdrawal by Subject|201|||
13310933|NCT01254630|26539499|FG001|Overall Study|Withdrawal by Subject|94|||
13310934|NCT01254630|26539500|FG002|Overall Study|Withdrawal by Subject|188|||
13310935|NCT01254630|26539501|FG003|Overall Study|Withdrawal by Subject|89|||
13310936|NCT01254630|26539498|FG000|Overall Study|Study terminated by sponsor|0|||
13310937|NCT01254630|26539499|FG001|Overall Study|Study terminated by sponsor|994|||
13310938|NCT01254630|26539500|FG002|Overall Study|Study terminated by sponsor|0|||
13310939|NCT01254630|26539501|FG003|Overall Study|Study terminated by sponsor|1010|||
13310940|NCT01254630|26539498|FG000|Overall Study|Status not recorded|0|||
13310941|NCT01254630|26539499|FG001|Overall Study|Status not recorded|0|||
13310942|NCT01254630|26539500|FG002|Overall Study|Status not recorded|1|||
13310943|NCT01254630|26539501|FG003|Overall Study|Status not recorded|0|||
13310944|NCT01254604|26539520|FG000|Overall Study|Lost to Follow-up|1|||
13310945|NCT01254604|26539521|FG001|Overall Study|Lost to Follow-up|1|||
13310946|NCT01254604|26539520|FG000|Overall Study|Protocol Violation|2|||
13310947|NCT01254604|26539521|FG001|Overall Study|Protocol Violation|2|||
13310948|NCT01254604|26539520|FG000|Overall Study|Withdrawal by Subject|2|||
13310949|NCT01254604|26539521|FG001|Overall Study|Withdrawal by Subject|4|||
13310950|NCT01254604|26539520|FG000|Overall Study|Adverse Event|3|||
13310951|NCT01254604|26539521|FG001|Overall Study|Adverse Event|2|||
13310952|NCT01254565|26539590|FG000|Overall Study|Non-compliance to Study Procedures|0|||
13310953|NCT01254565|26539591|FG001|Overall Study|Non-compliance to Study Procedures|0|||
13310954|NCT01254565|26539592|FG002|Overall Study|Non-compliance to Study Procedures|0|||
13310955|NCT01254565|26539593|FG003|Overall Study|Non-compliance to Study Procedures|0|||
13310956|NCT01254565|26539594|FG004|Overall Study|Non-compliance to Study Procedures|1|||
13310957|NCT01254565|26539595|FG005|Overall Study|Non-compliance to Study Procedures|0|||
13310958|NCT01254565|26539590|FG000|Overall Study|Did not Receive Treatment|1|||
13310959|NCT01254565|26539591|FG001|Overall Study|Did not Receive Treatment|1|||
13310960|NCT01254565|26539592|FG002|Overall Study|Did not Receive Treatment|0|||
13310961|NCT01254565|26539593|FG003|Overall Study|Did not Receive Treatment|0|||
13310962|NCT01254565|26539594|FG004|Overall Study|Did not Receive Treatment|3|||
13310963|NCT01254565|26539595|FG005|Overall Study|Did not Receive Treatment|4|||
13310964|NCT01254565|26539590|FG000|Overall Study|Other|0|||
13310965|NCT01254565|26539591|FG001|Overall Study|Other|0|||
13310966|NCT01254565|26539592|FG002|Overall Study|Other|0|||
13310967|NCT01254565|26539593|FG003|Overall Study|Other|1|||
13310968|NCT01254565|26539594|FG004|Overall Study|Other|0|||
13310969|NCT01254565|26539595|FG005|Overall Study|Other|0|||
13310970|NCT01254409|26539660|FG000|Overall Study|Adverse Event|0|||
13310971|NCT01254409|26539661|FG001|Overall Study|Adverse Event|1|||
13310972|NCT01254409|26539662|FG002|Overall Study|Adverse Event|0|||
13310973|NCT01254409|26539663|FG003|Overall Study|Adverse Event|0|||
13310974|NCT01254344|26539678|FG000|Overall Study|Adverse Event|2|||
13310975|NCT01254344|26539679|FG001|Overall Study|Adverse Event|5|||
13310976|NCT01254344|26539678|FG000|Overall Study|Physician Decision|7|||
13310977|NCT01254344|26539679|FG001|Overall Study|Physician Decision|4|||
13310978|NCT01254344|26539678|FG000|Overall Study|Protocol Violation|1|||
13310979|NCT01254344|26539679|FG001|Overall Study|Protocol Violation|4|||
13310980|NCT01254344|26539678|FG000|Overall Study|Withdrawal by Subject|3|||
13310981|NCT01254344|26539679|FG001|Overall Study|Withdrawal by Subject|6|||
13310982|NCT01254331|26539699|FG000|Initial Phase|Adverse Event|3|||
13310983|NCT01254331|26539699|FG000|Initial Phase|Withdrawal by Subject|1|||
13310984|NCT01254331|26539699|FG000|Initial Phase|Pregnancy|1|||
13310985|NCT01254331|26539699|FG000|Extension Phase|Lack of Efficacy|1|||
13310986|NCT01254331|26539699|FG000|Extension Phase|Lost to Follow-up|3|||
13310987|NCT01254318|26539707|FG000|Overall Study|Lost to Follow-up|5|||
13310988|NCT01254318|26539707|FG000|Overall Study|Death|47|||
13310989|NCT01254305|26539731|FG000|Overall Study|Adverse Event|6|||
13310990|NCT01254305|26539732|FG001|Overall Study|Adverse Event|3|||
13310991|NCT01254305|26539733|FG002|Overall Study|Adverse Event|2|||
13310992|NCT01254305|26539731|FG000|Overall Study|Lack of Efficacy|1|||
13310993|NCT01254305|26539732|FG001|Overall Study|Lack of Efficacy|0|||
13310994|NCT01254305|26539733|FG002|Overall Study|Lack of Efficacy|1|||
13310995|NCT01254305|26539731|FG000|Overall Study|Protocol Violation|1|||
13310996|NCT01254305|26539732|FG001|Overall Study|Protocol Violation|7|||
13310997|NCT01254305|26539733|FG002|Overall Study|Protocol Violation|3|||
13310998|NCT01254305|26539731|FG000|Overall Study|Withdrawal by Subject|4|||
13310999|NCT01254305|26539732|FG001|Overall Study|Withdrawal by Subject|2|||
13311000|NCT01254305|26539733|FG002|Overall Study|Withdrawal by Subject|4|||
13311001|NCT01254305|26539731|FG000|Overall Study|Lost to Follow-up|10|||
13311002|NCT01254305|26539732|FG001|Overall Study|Lost to Follow-up|6|||
13311003|NCT01254305|26539733|FG002|Overall Study|Lost to Follow-up|5|||
13311004|NCT01254305|26539731|FG000|Overall Study|Other Reasons|0|||
13311005|NCT01254305|26539732|FG001|Overall Study|Other Reasons|0|||
13311006|NCT01254305|26539733|FG002|Overall Study|Other Reasons|2|||
13311007|NCT01254292|26539800|FG000|Comparative Phase|Adverse Event|25|||
13311008|NCT01254292|26539801|FG001|Comparative Phase|Adverse Event|25|||
13311009|NCT01254292|26539800|FG000|Comparative Phase|Lost to Follow-up|3|||
13311010|NCT01254292|26539801|FG001|Comparative Phase|Lost to Follow-up|21|||
13311011|NCT01254292|26539800|FG000|Comparative Phase|Pregnancy|2|||
13311012|NCT01254292|26539801|FG001|Comparative Phase|Pregnancy|6|||
13311013|NCT01254292|26539800|FG000|Comparative Phase|Withdrawal by Subject|20|||
13311014|NCT01254292|26539801|FG001|Comparative Phase|Withdrawal by Subject|21|||
13311015|NCT01254292|26539800|FG000|Comparative Phase|Protocol Violation|1|||
13311016|NCT01254292|26539801|FG001|Comparative Phase|Protocol Violation|2|||
13311017|NCT01254292|26539800|FG000|Comparative Phase|Wish for pregnancy|4|||
13311018|NCT01254292|26539801|FG001|Comparative Phase|Wish for pregnancy|6|||
13311019|NCT01254292|26539800|FG000|LCS12 Extension Phase|Wish for pregnancy|14|||
13311020|NCT01254292|26539801|FG001|LCS12 Extension Phase|Wish for pregnancy|0|||
13311021|NCT01254292|26539800|FG000|LCS12 Extension Phase|Adverse Event|9|||
13311022|NCT01254292|26539801|FG001|LCS12 Extension Phase|Adverse Event|0|||
13311023|NCT01254292|26539800|FG000|LCS12 Extension Phase|Withdrawal by Subject|7|||
13311024|NCT01254292|26539801|FG001|LCS12 Extension Phase|Withdrawal by Subject|0|||
13311025|NCT01254292|26539800|FG000|LCS12 Extension Phase|Other unknown|4|||
13311026|NCT01254292|26539801|FG001|LCS12 Extension Phase|Other unknown|0|||
13311027|NCT01254292|26539800|FG000|LCS12 Extension Phase|Pregnancy|2|||
13311028|NCT01254292|26539801|FG001|LCS12 Extension Phase|Pregnancy|0|||
13311029|NCT01254292|26539800|FG000|LCS12 Extension Phase|Lost to Follow-up|1|||
13311030|NCT01254292|26539801|FG001|LCS12 Extension Phase|Lost to Follow-up|0|||
13311031|NCT01254227|26539813|FG000|Overall Study|Withdrawal by Subject|6|||
13311032|NCT01254227|26539813|FG000|Overall Study|Lost to Follow-up|6|||
13311033|NCT01254227|26539813|FG000|Overall Study|Adverse Event|5|||
13311034|NCT01254227|26539813|FG000|Overall Study|Abnormal test procedure result|5|||
13311035|NCT01254227|26539813|FG000|Overall Study|Administrative problems|2|||
13311036|NCT01254227|26539813|FG000|Overall Study|Death|1|||
13311037|NCT01254227|26539813|FG000|Overall Study|Protocol deviation|1|||
13311038|NCT01254188|26539826|FG000|Overall Study|Disease Progression|6|||
13311039|NCT01254188|26539826|FG000|Overall Study|Protocol Violation|6|||
13311040|NCT01254188|26539826|FG000|Overall Study|Pregnancy|2|||
13311041|NCT01254188|26539826|FG000|Overall Study|Death|4|||
13311042|NCT01254188|26539826|FG000|Overall Study|Lost to Follow-up|5|||
13311043|NCT01254188|26539826|FG000|Overall Study|Withdrawal by Subject|7|||
13311044|NCT01254188|26539826|FG000|Overall Study|Adverse Event|43|||
13311045|NCT01254188|26539826|FG000|Overall Study|per investigator discretion|20|||
13311046|NCT01254045|26539844|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1|||
13311047|NCT01254045|26539845|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
13311048|NCT01254045|26539846|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
13311049|NCT01254045|26539847|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
13311050|NCT01254045|26539848|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
13311051|NCT01254045|26539849|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
13311052|NCT01254019|26539907|FG000|Overall Study|Adverse Event|0|||
13311053|NCT01254019|26539908|FG001|Overall Study|Adverse Event|2|||
13311054|NCT01254019|26539907|FG000|Overall Study|Protocol Violation|1|||
13311055|NCT01254019|26539908|FG001|Overall Study|Protocol Violation|0|||
13311056|NCT01254019|26539907|FG000|Overall Study|Withdrawal by Subject|0|||
13311057|NCT01254019|26539908|FG001|Overall Study|Withdrawal by Subject|2|||
13311058|NCT01253811|26539929|FG000|Overall Study|Withdrawal criteria|1|||
13311059|NCT01253577|26539939|FG000|Overall Study|Lost to Follow-up|3|||
13311060|NCT01253564|26539958|FG000|Overall Study|Disease Progression|22|||
13311061|NCT01253564|26539958|FG000|Overall Study|Withdrawal by Subject|1|||
13311062|NCT01253564|26539958|FG000|Overall Study|Serious Adverse Event|1|||
13311063|NCT01253447|26539966|FG000|Overall Study|Adverse Event|2|||
13311064|NCT01253421|26540026|FG000|Assessment and Scheduling|Found to be Ineligible|74|||
13311065|NCT01253421|26540027|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
13311066|NCT01253421|26540028|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
13311067|NCT01253421|26540029|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
13311068|NCT01253421|26540030|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
13311069|NCT01253421|26540026|FG000|Assessment and Scheduling|Lost to Follow-up|17|||
13311070|NCT01253421|26540027|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
13311071|NCT01253421|26540028|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
13311072|NCT01253421|26540029|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
13311073|NCT01253421|26540030|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
13311074|NCT01253421|26540026|FG000|Assessment and Scheduling|Withdrawal by Subject|7|||
13311075|NCT01253421|26540027|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
13311076|NCT01253421|26540028|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
13311077|NCT01253421|26540029|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
13311078|NCT01253421|26540030|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
13311079|NCT01253421|26540026|FG000|Assessment and Scheduling|Physician Decision|1|||
13311080|NCT01253421|26540027|FG001|Assessment and Scheduling|Physician Decision|0|||
13311081|NCT01253421|26540028|FG002|Assessment and Scheduling|Physician Decision|0|||
13311082|NCT01253421|26540029|FG003|Assessment and Scheduling|Physician Decision|0|||
13311083|NCT01253421|26540030|FG004|Assessment and Scheduling|Physician Decision|0|||
13311084|NCT01253421|26540026|FG000|Drug+Scanning Visit|Physician Decision|0|||
13311085|NCT01253421|26540027|FG001|Drug+Scanning Visit|Physician Decision|0|||
13311086|NCT01253421|26540028|FG002|Drug+Scanning Visit|Physician Decision|0|||
13311087|NCT01253421|26540029|FG003|Drug+Scanning Visit|Physician Decision|0|||
13311088|NCT01253421|26540030|FG004|Drug+Scanning Visit|Physician Decision|1|||
13311089|NCT01253408|26540063|FG000|Overall Study|Adverse Event|0|||
13311090|NCT01253408|26540064|FG001|Overall Study|Adverse Event|1|||
13311091|NCT01253408|26540065|FG002|Overall Study|Adverse Event|0|||
13311092|NCT01253369|26540072|FG000|Overall Study|Adverse Event|4|||
13311093|NCT01253369|26540072|FG000|Overall Study|Withdrawal by Subject|2|||
13311094|NCT01253369|26540072|FG000|Overall Study|Death|1|||
13311095|NCT01253369|26540072|FG000|Overall Study|Progressive disease|23|||
13311096|NCT01253369|26540072|FG000|Overall Study|Not Evaluable|3|||
13311097|NCT01253317|26540082|FG000|Overall Study|Adverse Event|2|||
13311098|NCT01253304|26540129|FG000|Overall Study|Adverse Event|0|||
13311099|NCT01253304|26540130|FG001|Overall Study|Adverse Event|0|||
13311100|NCT01253304|26540131|FG002|Overall Study|Adverse Event|0|||
13311101|NCT01253304|26540132|FG003|Overall Study|Adverse Event|1|||
13311102|NCT01253291|26540167|FG000|Overall Study|Withdrawal by Subject|1|||
13311103|NCT01253291|26540168|FG001|Overall Study|Withdrawal by Subject|1|||
13311104|NCT01253291|26540169|FG002|Overall Study|Withdrawal by Subject|0|||
13311105|NCT01253291|26540170|FG003|Overall Study|Withdrawal by Subject|0|||
13311106|NCT01253291|26540171|FG004|Overall Study|Withdrawal by Subject|0|||
13311107|NCT01253291|26540167|FG000|Overall Study|Adverse Event|0|||
13311108|NCT01253291|26540168|FG001|Overall Study|Adverse Event|1|||
13311109|NCT01253291|26540169|FG002|Overall Study|Adverse Event|0|||
13311110|NCT01253291|26540170|FG003|Overall Study|Adverse Event|0|||
13311111|NCT01253291|26540171|FG004|Overall Study|Adverse Event|0|||
13311112|NCT01253291|26540167|FG000|Overall Study|Lack of Efficacy|1|||
13311113|NCT01253291|26540168|FG001|Overall Study|Lack of Efficacy|0|||
13311114|NCT01253291|26540169|FG002|Overall Study|Lack of Efficacy|0|||
13311115|NCT01253291|26540170|FG003|Overall Study|Lack of Efficacy|0|||
13311116|NCT01253291|26540171|FG004|Overall Study|Lack of Efficacy|0|||
13311117|NCT01253291|26540167|FG000|Overall Study|Physician Decision|2|||
13311118|NCT01253291|26540168|FG001|Overall Study|Physician Decision|0|||
13311119|NCT01253291|26540169|FG002|Overall Study|Physician Decision|0|||
13311120|NCT01253291|26540170|FG003|Overall Study|Physician Decision|0|||
13311121|NCT01253291|26540171|FG004|Overall Study|Physician Decision|2|||
13311122|NCT01253265|26540231|FG000|Overall Study|Met Predefined Discontinuation Criteria|1|||
13311123|NCT01253265|26540232|FG001|Overall Study|Met Predefined Discontinuation Criteria|0|||
13311124|NCT01253265|26540233|FG002|Overall Study|Met Predefined Discontinuation Criteria|0|||
13311125|NCT01253265|26540234|FG003|Overall Study|Met Predefined Discontinuation Criteria|0|||
13311126|NCT01253265|26540235|FG004|Overall Study|Met Predefined Discontinuation Criteria|0|||
13311127|NCT01253265|26540231|FG000|Overall Study|Withdrawal by Subject|0|||
13311128|NCT01253265|26540232|FG001|Overall Study|Withdrawal by Subject|0|||
13311129|NCT01253265|26540233|FG002|Overall Study|Withdrawal by Subject|0|||
13311130|NCT01253265|26540234|FG003|Overall Study|Withdrawal by Subject|0|||
13311131|NCT01253265|26540235|FG004|Overall Study|Withdrawal by Subject|1|||
13311132|NCT01253226|26540306|FG000|Overall Study|Adverse Event|0|||
13311133|NCT01253226|26540307|FG001|Overall Study|Adverse Event|0|||
13311134|NCT01253226|26540308|FG002|Overall Study|Adverse Event|1|||
13311135|NCT01253226|26540309|FG003|Overall Study|Adverse Event|0|||
13311136|NCT01253226|26540310|FG004|Overall Study|Adverse Event|0|||
13311137|NCT01253226|26540306|FG000|Overall Study|Death|0|||
13311138|NCT01253226|26540307|FG001|Overall Study|Death|1|||
13311139|NCT01253226|26540308|FG002|Overall Study|Death|0|||
13311140|NCT01253226|26540309|FG003|Overall Study|Death|0|||
13311141|NCT01253226|26540310|FG004|Overall Study|Death|0|||
13311142|NCT01253226|26540306|FG000|Overall Study|Physician Decision|0|||
13311143|NCT01253226|26540307|FG001|Overall Study|Physician Decision|0|||
13311144|NCT01253226|26540308|FG002|Overall Study|Physician Decision|0|||
13311145|NCT01253226|26540309|FG003|Overall Study|Physician Decision|0|||
13311146|NCT01253226|26540310|FG004|Overall Study|Physician Decision|2|||
13311147|NCT01253226|26540306|FG000|Overall Study|Withdrawal by Subject|0|||
13311148|NCT01253226|26540307|FG001|Overall Study|Withdrawal by Subject|0|||
13311149|NCT01253226|26540308|FG002|Overall Study|Withdrawal by Subject|0|||
13311150|NCT01253226|26540309|FG003|Overall Study|Withdrawal by Subject|1|||
13311151|NCT01253226|26540310|FG004|Overall Study|Withdrawal by Subject|0|||
13311152|NCT01253200|26540341|FG000|Overall Study|Death|1|||
13311153|NCT01253200|26540342|FG001|Overall Study|Death|0|||
13311154|NCT01253200|26540343|FG002|Overall Study|Death|0|||
13311155|NCT01253200|26540344|FG003|Overall Study|Death|0|||
13311156|NCT01253200|26540345|FG004|Overall Study|Death|0|||
13311157|NCT01253200|26540341|FG000|Overall Study|Lost to Follow-up|1|||
13311158|NCT01253200|26540342|FG001|Overall Study|Lost to Follow-up|1|||
13311159|NCT01253200|26540343|FG002|Overall Study|Lost to Follow-up|0|||
13311160|NCT01253200|26540344|FG003|Overall Study|Lost to Follow-up|0|||
13311161|NCT01253200|26540345|FG004|Overall Study|Lost to Follow-up|0|||
13311162|NCT01253200|26540341|FG000|Overall Study|Withdrawal by Subject|2|||
13311163|NCT01253200|26540342|FG001|Overall Study|Withdrawal by Subject|0|||
13311164|NCT01253200|26540343|FG002|Overall Study|Withdrawal by Subject|0|||
13311165|NCT01253200|26540344|FG003|Overall Study|Withdrawal by Subject|0|||
13311166|NCT01253200|26540345|FG004|Overall Study|Withdrawal by Subject|0|||
13311167|NCT01253200|26540341|FG000|Overall Study|Protocol Violation|1|||
13311168|NCT01253200|26540342|FG001|Overall Study|Protocol Violation|4|||
13311169|NCT01253200|26540343|FG002|Overall Study|Protocol Violation|0|||
13311170|NCT01253200|26540344|FG003|Overall Study|Protocol Violation|0|||
13311171|NCT01253200|26540345|FG004|Overall Study|Protocol Violation|5|||
13311172|NCT01253200|26540341|FG000|Overall Study|intents|10|||
13311173|NCT01253200|26540342|FG001|Overall Study|intents|10|||
13311174|NCT01253200|26540343|FG002|Overall Study|intents|1|||
13311175|NCT01253200|26540344|FG003|Overall Study|intents|3|||
13311176|NCT01253200|26540345|FG004|Overall Study|intents|0|||
13311177|NCT01253200|26540341|FG000|Overall Study|Attempts|6|||
13311178|NCT01253200|26540342|FG001|Overall Study|Attempts|4|||
13311179|NCT01253200|26540343|FG002|Overall Study|Attempts|1|||
13311180|NCT01253200|26540344|FG003|Overall Study|Attempts|2|||
13311181|NCT01253200|26540345|FG004|Overall Study|Attempts|0|||
13311182|NCT01253187|26540381|FG000|Period 2|Withdrawal by Subject|0|||
13311183|NCT01253187|26540382|FG001|Period 2|Withdrawal by Subject|0|||
13311184|NCT01253187|26540383|FG002|Period 2|Withdrawal by Subject|0|||
13311185|NCT01253187|26540384|FG003|Period 2|Withdrawal by Subject|0|||
13311186|NCT01253187|26540385|FG004|Period 2|Withdrawal by Subject|1|||
13311187|NCT01253187|26540386|FG005|Period 2|Withdrawal by Subject|0|||
13311188|NCT01253187|26540381|FG000|Period 3|Pregnancy|1|||
13311189|NCT01253187|26540382|FG001|Period 3|Pregnancy|0|||
13311190|NCT01253187|26540383|FG002|Period 3|Pregnancy|0|||
13311191|NCT01253187|26540384|FG003|Period 3|Pregnancy|0|||
13311192|NCT01253187|26540385|FG004|Period 3|Pregnancy|0|||
13311193|NCT01253187|26540386|FG005|Period 3|Pregnancy|0|||
13311194|NCT01253187|26540381|FG000|Period 3|difficulty with blood sampling|0|||
13311195|NCT01253187|26540382|FG001|Period 3|difficulty with blood sampling|1|||
13311196|NCT01253187|26540383|FG002|Period 3|difficulty with blood sampling|0|||
13311197|NCT01253187|26540384|FG003|Period 3|difficulty with blood sampling|0|||
13311198|NCT01253187|26540385|FG004|Period 3|difficulty with blood sampling|0|||
13311199|NCT01253187|26540386|FG005|Period 3|difficulty with blood sampling|0|||
13311200|NCT01253187|26540381|FG000|Period 3|non-compliance|0|||
13311201|NCT01253187|26540382|FG001|Period 3|non-compliance|0|||
13311202|NCT01253187|26540383|FG002|Period 3|non-compliance|0|||
13311203|NCT01253187|26540384|FG003|Period 3|non-compliance|0|||
13311204|NCT01253187|26540385|FG004|Period 3|non-compliance|1|||
13311205|NCT01253187|26540386|FG005|Period 3|non-compliance|0|||
13311206|NCT01253174|26540422|FG000|Period 1|Randomized but not treated|0|||
13311207|NCT01253174|26540423|FG001|Period 1|Randomized but not treated|1|||
13311208|NCT01253174|26540424|FG002|Period 1|Randomized but not treated|1|||
13311209|NCT01253174|26540425|FG003|Period 1|Randomized but not treated|0|||
13311210|NCT01253174|26540426|FG004|Period 1|Randomized but not treated|1|||
13311211|NCT01253174|26540427|FG005|Period 1|Randomized but not treated|0|||
13311212|NCT01253174|26540422|FG000|Period 2|Adverse Event|0|||
13311213|NCT01253174|26540423|FG001|Period 2|Adverse Event|0|||
13311214|NCT01253174|26540424|FG002|Period 2|Adverse Event|1|||
13311215|NCT01253174|26540425|FG003|Period 2|Adverse Event|0|||
13311216|NCT01253174|26540426|FG004|Period 2|Adverse Event|0|||
13311217|NCT01253174|26540427|FG005|Period 2|Adverse Event|0|||
13311218|NCT01253174|26540422|FG000|Period 3|Withdrawal by Subject|0|||
13311219|NCT01253174|26540423|FG001|Period 3|Withdrawal by Subject|1|||
13311220|NCT01253174|26540424|FG002|Period 3|Withdrawal by Subject|0|||
13311221|NCT01253174|26540425|FG003|Period 3|Withdrawal by Subject|0|||
13311222|NCT01253174|26540426|FG004|Period 3|Withdrawal by Subject|1|||
13311223|NCT01253174|26540427|FG005|Period 3|Withdrawal by Subject|0|||
13311224|NCT01253174|26540422|FG000|Period 3|Pregnancy|0|||
13311225|NCT01253174|26540423|FG001|Period 3|Pregnancy|0|||
13311226|NCT01253174|26540424|FG002|Period 3|Pregnancy|1|||
13311227|NCT01253174|26540425|FG003|Period 3|Pregnancy|0|||
13311228|NCT01253174|26540426|FG004|Period 3|Pregnancy|0|||
13311229|NCT01253174|26540427|FG005|Period 3|Pregnancy|0|||
13311230|NCT01253161|26540435|FG000|Overall Study|Adverse Event|1|||
13311231|NCT01253135|26540445|FG000|Original Protocol|Protocol Amendment|15|||
13311232|NCT01253135|26540445|FG000|Amended Protocol|Non-compliance|1|||
13311233|NCT01253044|26540460|FG000|Overall Study|Lost to Follow-up|38|||
13311234|NCT01253044|26540461|FG001|Overall Study|Lost to Follow-up|29|||
13311235|NCT01253018|26540480|FG000|Overall Study|Lost to Follow-up|1|||
13311236|NCT01253018|26540481|FG001|Overall Study|Lost to Follow-up|1|||
13311237|NCT01253018|26540480|FG000|Overall Study|Robot Repair Issues|2|||
13311238|NCT01253018|26540481|FG001|Overall Study|Robot Repair Issues|0|||
13311239|NCT01253018|26540480|FG000|Overall Study|Withdrawal by Subject|1|||
13311240|NCT01253018|26540481|FG001|Overall Study|Withdrawal by Subject|1|||
13311241|NCT01252966|26540502|FG000|Overall Study|Lost to Follow-up|16|||
13311242|NCT01252966|26540503|FG001|Overall Study|Lost to Follow-up|10|||
13311243|NCT01252966|26540502|FG000|Overall Study|Withdrawal by Subject|7|||
13311244|NCT01252966|26540503|FG001|Overall Study|Withdrawal by Subject|3|||
13311245|NCT01252953|26540522|FG000|Overall Study|Withdrawal by Subject|16|||
13311246|NCT01252953|26540523|FG001|Overall Study|Withdrawal by Subject|17|||
13311247|NCT01252953|26540522|FG000|Overall Study|Lost to Follow-up|22|||
13311248|NCT01252953|26540523|FG001|Overall Study|Lost to Follow-up|21|||
13311249|NCT01252940|26540559|FG000|Main Study Phase|Randomized but not treated|4|||
13311250|NCT01252940|26540560|FG001|Main Study Phase|Randomized but not treated|2|||
13311251|NCT01252940|26540559|FG000|Main Study Phase|Adverse Event|3|||
13311252|NCT01252940|26540560|FG001|Main Study Phase|Adverse Event|1|||
13311253|NCT01252940|26540559|FG000|Main Study Phase|Lack of Efficacy|1|||
13311254|NCT01252940|26540560|FG001|Main Study Phase|Lack of Efficacy|0|||
13311255|NCT01252940|26540559|FG000|Main Study Phase|Lost to Follow-up|6|||
13311256|NCT01252940|26540560|FG001|Main Study Phase|Lost to Follow-up|1|||
13311257|NCT01252940|26540559|FG000|Main Study Phase|Physician Decision|1|||
13311258|NCT01252940|26540560|FG001|Main Study Phase|Physician Decision|0|||
13311259|NCT01252940|26540559|FG000|Main Study Phase|Protocol Violation|4|||
13311260|NCT01252940|26540560|FG001|Main Study Phase|Protocol Violation|2|||
13311261|NCT01252940|26540559|FG000|Main Study Phase|Withdrawal by Subject|6|||
13311262|NCT01252940|26540560|FG001|Main Study Phase|Withdrawal by Subject|5|||
13311263|NCT01252940|26540559|FG000|Main Study Phase|Subject Non-compliance|1|||
13372972|NCT00806026|26722410|FG003|Overall Study|Protocol Violation|0|||
13311264|NCT01252940|26540560|FG001|Main Study Phase|Subject Non-compliance|1|||
13311265|NCT01252940|26540559|FG000|Extension Phase|Adverse Event|2|||
13311266|NCT01252940|26540560|FG001|Extension Phase|Adverse Event|1|||
13311267|NCT01252940|26540559|FG000|Extension Phase|Lack of Efficacy|1|||
13311268|NCT01252940|26540560|FG001|Extension Phase|Lack of Efficacy|0|||
13311269|NCT01252940|26540559|FG000|Extension Phase|Lost to Follow-up|5|||
13311270|NCT01252940|26540560|FG001|Extension Phase|Lost to Follow-up|0|||
13311271|NCT01252940|26540559|FG000|Extension Phase|Physician Decision|0|||
13311272|NCT01252940|26540560|FG001|Extension Phase|Physician Decision|1|||
13311273|NCT01252940|26540559|FG000|Extension Phase|Subject Non-compliance|1|||
13311274|NCT01252940|26540560|FG001|Extension Phase|Subject Non-compliance|0|||
13311275|NCT01252940|26540559|FG000|Extension Phase|Withdrawal by Subject|1|||
13311276|NCT01252940|26540560|FG001|Extension Phase|Withdrawal by Subject|1|||
13311277|NCT01252810|26540577|FG000|Overall Study|Withdrawal by Subject|4|||
13311278|NCT01252810|26540578|FG001|Overall Study|Withdrawal by Subject|1|||
13311279|NCT01252810|26540577|FG000|Overall Study|Lost to Follow-up|0|||
13311280|NCT01252810|26540578|FG001|Overall Study|Lost to Follow-up|1|||
13311281|NCT01252810|26540577|FG000|Overall Study|Physician Decision|2|||
13311282|NCT01252810|26540578|FG001|Overall Study|Physician Decision|1|||
13311283|NCT01252810|26540577|FG000|Overall Study|Various reasons|8|||
13311284|NCT01252810|26540578|FG001|Overall Study|Various reasons|0|||
13311285|NCT01252667|26540659|FG000|Overall Study|Transplant aborted post-conditioning|0|||
13311286|NCT01252667|26540660|FG001|Overall Study|Transplant aborted post-conditioning|0|||
13311287|NCT01252667|26540661|FG002|Overall Study|Transplant aborted post-conditioning|0|||
13311288|NCT01252667|26540662|FG003|Overall Study|Transplant aborted post-conditioning|0|||
13311289|NCT01252667|26540663|FG004|Overall Study|Transplant aborted post-conditioning|0|||
13311290|NCT01252667|26540664|FG005|Overall Study|Transplant aborted post-conditioning|1|||
13311291|NCT01252563|26540703|FG000|Overall Study|Contract Deviation|41|||
13311292|NCT01252563|26540703|FG000|Overall Study|Centralized Registration Deviation|30|||
13311293|NCT01252563|26540703|FG000|Overall Study|Lost to Follow-up|161|||
13311294|NCT01252563|26540703|FG000|Overall Study|No visit after first day of treatment|194|||
13311295|NCT01252563|26540703|FG000|Overall Study|No drug administration|6|||
13311296|NCT01252355|26540751|FG000|Overall Study|Adverse Event|9|||
13311297|NCT01252355|26540752|FG001|Overall Study|Adverse Event|17|||
13311298|NCT01252355|26540753|FG002|Overall Study|Adverse Event|22|||
13311299|NCT01252355|26540751|FG000|Overall Study|Lack of Efficacy|6|||
13311300|NCT01252355|26540752|FG001|Overall Study|Lack of Efficacy|4|||
13311301|NCT01252355|26540753|FG002|Overall Study|Lack of Efficacy|2|||
13311302|NCT01252355|26540751|FG000|Overall Study|Lost to Follow-up|0|||
13311303|NCT01252355|26540752|FG001|Overall Study|Lost to Follow-up|0|||
13311304|NCT01252355|26540753|FG002|Overall Study|Lost to Follow-up|1|||
13311305|NCT01252355|26540751|FG000|Overall Study|Poor Compliance to Protocol|1|||
13311306|NCT01252355|26540752|FG001|Overall Study|Poor Compliance to Protocol|1|||
13311307|NCT01252355|26540753|FG002|Overall Study|Poor Compliance to Protocol|1|||
13311308|NCT01252355|26540751|FG000|Overall Study|Progressive Disease|2|||
13311309|NCT01252355|26540752|FG001|Overall Study|Progressive Disease|0|||
13311310|NCT01252355|26540753|FG002|Overall Study|Progressive Disease|0|||
13311311|NCT01252355|26540751|FG000|Overall Study|Sponsor Early Termination of Study|149|||
13311312|NCT01252355|26540752|FG001|Overall Study|Sponsor Early Termination of Study|149|||
13311313|NCT01252355|26540753|FG002|Overall Study|Sponsor Early Termination of Study|146|||
13311314|NCT01252355|26540751|FG000|Overall Study|Randomized but not Treated|2|||
13311315|NCT01252355|26540752|FG001|Overall Study|Randomized but not Treated|0|||
13311316|NCT01252355|26540753|FG002|Overall Study|Randomized but not Treated|0|||
13311317|NCT01252355|26540751|FG000|Overall Study|Other Than Above|8|||
13311318|NCT01252355|26540752|FG001|Overall Study|Other Than Above|7|||
13311319|NCT01252355|26540753|FG002|Overall Study|Other Than Above|7|||
13311320|NCT01252290|26540763|FG000|Overall Study|Withdrawal by Subject|1|||
13311321|NCT01252251|26540774|FG000|Overall Study|Withdrawal by Subject|1|||
13311322|NCT01252238|26540798|FG000|Overall Study|Sponsor terminated study|4|||
13311323|NCT01252238|26540799|FG001|Overall Study|Sponsor terminated study|4|||
13311324|NCT01252238|26540800|FG002|Overall Study|Sponsor terminated study|4|||
13311325|NCT01252186|26540878|FG000|Overall Study|Adverse Event|9|||
13311326|NCT01252186|26540879|FG001|Overall Study|Adverse Event|6|||
13311327|NCT01252186|26540880|FG002|Overall Study|Adverse Event|8|||
13311328|NCT01252186|26540878|FG000|Overall Study|Withdrawal by Subject|2|||
13311329|NCT01252186|26540879|FG001|Overall Study|Withdrawal by Subject|5|||
13311330|NCT01252186|26540880|FG002|Overall Study|Withdrawal by Subject|2|||
13311331|NCT01252186|26540878|FG000|Overall Study|Physician Decision|0|||
13311332|NCT01252186|26540879|FG001|Overall Study|Physician Decision|0|||
13311333|NCT01252186|26540880|FG002|Overall Study|Physician Decision|1|||
13311334|NCT01252186|26540878|FG000|Overall Study|Non-compliance|0|||
13311335|NCT01252186|26540879|FG001|Overall Study|Non-compliance|3|||
13311336|NCT01252186|26540880|FG002|Overall Study|Non-compliance|4|||
13311337|NCT01252186|26540878|FG000|Overall Study|Protocol Violation|0|||
13311338|NCT01252186|26540879|FG001|Overall Study|Protocol Violation|0|||
13311339|NCT01252186|26540880|FG002|Overall Study|Protocol Violation|1|||
13311340|NCT01252186|26540878|FG000|Overall Study|Pregnancy|2|||
13311341|NCT01252186|26540879|FG001|Overall Study|Pregnancy|2|||
13311342|NCT01252186|26540880|FG002|Overall Study|Pregnancy|0|||
13311343|NCT01252186|26540878|FG000|Overall Study|Sponsor Request|2|||
13311344|NCT01252186|26540879|FG001|Overall Study|Sponsor Request|1|||
13311345|NCT01252186|26540880|FG002|Overall Study|Sponsor Request|0|||
13311346|NCT01252186|26540878|FG000|Overall Study|Lost to Follow-up|10|||
13311347|NCT01252186|26540879|FG001|Overall Study|Lost to Follow-up|10|||
13311348|NCT01252186|26540880|FG002|Overall Study|Lost to Follow-up|11|||
13311349|NCT01252186|26540878|FG000|Overall Study|Other - Miscellaneous Reasons|5|||
13311350|NCT01252186|26540879|FG001|Overall Study|Other - Miscellaneous Reasons|5|||
13311351|NCT01252186|26540880|FG002|Overall Study|Other - Miscellaneous Reasons|7|||
13311352|NCT01252134|26540904|FG000|Period 1, 8 Hours|Personal Reasons|0|||
13311353|NCT01252134|26540905|FG001|Period 1, 8 Hours|Personal Reasons|1|||
13311354|NCT01252134|26540906|FG002|Period 1, 8 Hours|Personal Reasons|1|||
13311355|NCT01252134|26540907|FG003|Period 1, 8 Hours|Personal Reasons|0|||
13311356|NCT01252134|26540908|FG004|Period 1, 8 Hours|Personal Reasons|0|||
13311357|NCT01252134|26540909|FG005|Period 1, 8 Hours|Personal Reasons|0|||
13311358|NCT01252095|26540922|FG000|Overall Study|Disease progression|1|||
13311359|NCT01252095|26540923|FG001|Overall Study|Disease progression|0|||
13311360|NCT01251965|26540945|FG000|Overall Study|Participant/physician decision|1|||
13311361|NCT01251965|26540946|FG001|Overall Study|Participant/physician decision|2|||
13311362|NCT01251965|26540947|FG002|Overall Study|Participant/physician decision|0|||
13311363|NCT01251965|26540945|FG000|Overall Study|Death|0|||
13311364|NCT01251965|26540946|FG001|Overall Study|Death|0|||
13311365|NCT01251965|26540947|FG002|Overall Study|Death|11|||
13311366|NCT01251952|26540953|FG000|Overall Study|Adverse Event|1|||
13311367|NCT01251887|26541016|FG000|Overall Study|Scheduling conflict|1|||
13311368|NCT01251887|26541017|FG001|Overall Study|Scheduling conflict|2|||
13311369|NCT01251887|26541018|FG002|Overall Study|Scheduling conflict|2|||
13311370|NCT01251887|26541016|FG000|Overall Study|Physician Decision|0|||
13311371|NCT01251887|26541017|FG001|Overall Study|Physician Decision|1|||
13311372|NCT01251887|26541018|FG002|Overall Study|Physician Decision|0|||
13311373|NCT01251861|26541051|FG000|Overall Study|Disease progression|6|||
13311374|NCT01251861|26541052|FG001|Overall Study|Disease progression|6|||
13311375|NCT01251861|26541051|FG000|Overall Study|Adverse Event|2|||
13311376|NCT01251861|26541052|FG001|Overall Study|Adverse Event|17|||
13311377|NCT01251861|26541051|FG000|Overall Study|Withdrawal by Subject|2|||
13311378|NCT01251861|26541052|FG001|Overall Study|Withdrawal by Subject|2|||
13311379|NCT01251861|26541051|FG000|Overall Study|Alternative therapy|1|||
13311380|NCT01251861|26541052|FG001|Overall Study|Alternative therapy|0|||
13311381|NCT01251861|26541051|FG000|Overall Study|Other complicating disease|0|||
13311382|NCT01251861|26541052|FG001|Overall Study|Other complicating disease|1|||
13311383|NCT01251861|26541051|FG000|Overall Study|Physician Decision|1|||
13311384|NCT01251861|26541052|FG001|Overall Study|Physician Decision|0|||
13311385|NCT01251861|26541051|FG000|Overall Study|Continued treatment beyond 18 cycles|1|||
13311386|NCT01251861|26541052|FG001|Overall Study|Continued treatment beyond 18 cycles|0|||
13311387|NCT01251861|26541051|FG000|Overall Study|Other|1|||
13311388|NCT01251861|26541052|FG001|Overall Study|Other|0|||
13311389|NCT01251861|26541051|FG000|Overall Study|Never started therapy|4|||
13311390|NCT01251861|26541052|FG001|Overall Study|Never started therapy|1|||
13311391|NCT01251861|26541051|FG000|Overall Study|Potential interaction of drugs|0|||
13311392|NCT01251861|26541052|FG001|Overall Study|Potential interaction of drugs|1|||
13311393|NCT01251770|26541067|FG000|Overall Study|Protocol Violation|13|||
13311394|NCT01251770|26541068|FG001|Overall Study|Protocol Violation|7|||
13311395|NCT01251744|26541124|FG000|Overall Study|Lost to Follow-up|1|||
13311396|NCT01251744|26541125|FG001|Overall Study|Lost to Follow-up|0|||
13311397|NCT01251653|26541278|FG000|Overall Study|Progressive Disease|1|||
13311398|NCT01251653|26541279|FG001|Overall Study|Progressive Disease|7|||
13311399|NCT01251653|26541280|FG002|Overall Study|Progressive Disease|16|||
13311400|NCT01251653|26541281|FG003|Overall Study|Progressive Disease|4|||
13311401|NCT01251653|26541282|FG004|Overall Study|Progressive Disease|0|||
13311402|NCT01251653|26541283|FG005|Overall Study|Progressive Disease|17|||
13311403|NCT01251653|26541284|FG006|Overall Study|Progressive Disease|14|||
13311404|NCT01251653|26541285|FG007|Overall Study|Progressive Disease|7|||
13311405|NCT01251653|26541286|FG008|Overall Study|Progressive Disease|5|||
13311406|NCT01251653|26541278|FG000|Overall Study|Dose-limiting toxicity|0|||
13311407|NCT01251653|26541279|FG001|Overall Study|Dose-limiting toxicity|1|||
13311408|NCT01251653|26541280|FG002|Overall Study|Dose-limiting toxicity|1|||
13311409|NCT01251653|26541281|FG003|Overall Study|Dose-limiting toxicity|1|||
13311410|NCT01251653|26541282|FG004|Overall Study|Dose-limiting toxicity|0|||
13311411|NCT01251653|26541283|FG005|Overall Study|Dose-limiting toxicity|0|||
13311412|NCT01251653|26541284|FG006|Overall Study|Dose-limiting toxicity|2|||
13311413|NCT01251653|26541285|FG007|Overall Study|Dose-limiting toxicity|0|||
13311414|NCT01251653|26541286|FG008|Overall Study|Dose-limiting toxicity|0|||
13311415|NCT01251653|26541278|FG000|Overall Study|Adverse Event|1|||
13311416|NCT01251653|26541279|FG001|Overall Study|Adverse Event|0|||
13311417|NCT01251653|26541280|FG002|Overall Study|Adverse Event|2|||
13311418|NCT01251653|26541281|FG003|Overall Study|Adverse Event|1|||
13311419|NCT01251653|26541282|FG004|Overall Study|Adverse Event|1|||
13311420|NCT01251653|26541283|FG005|Overall Study|Adverse Event|0|||
13311421|NCT01251653|26541284|FG006|Overall Study|Adverse Event|2|||
13311422|NCT01251653|26541285|FG007|Overall Study|Adverse Event|2|||
13311423|NCT01251653|26541286|FG008|Overall Study|Adverse Event|1|||
13311424|NCT01251653|26541278|FG000|Overall Study|Withdrawal by Subject|1|||
13311425|NCT01251653|26541279|FG001|Overall Study|Withdrawal by Subject|0|||
13311426|NCT01251653|26541280|FG002|Overall Study|Withdrawal by Subject|1|||
13311427|NCT01251653|26541281|FG003|Overall Study|Withdrawal by Subject|0|||
13311428|NCT01251653|26541282|FG004|Overall Study|Withdrawal by Subject|1|||
13311429|NCT01251653|26541283|FG005|Overall Study|Withdrawal by Subject|1|||
13311430|NCT01251653|26541284|FG006|Overall Study|Withdrawal by Subject|0|||
13311431|NCT01251653|26541285|FG007|Overall Study|Withdrawal by Subject|1|||
13311432|NCT01251653|26541286|FG008|Overall Study|Withdrawal by Subject|0|||
13311433|NCT01251653|26541278|FG000|Overall Study|Other reason not mentioned above|0|||
13311434|NCT01251653|26541279|FG001|Overall Study|Other reason not mentioned above|0|||
13311435|NCT01251653|26541280|FG002|Overall Study|Other reason not mentioned above|0|||
13311436|NCT01251653|26541281|FG003|Overall Study|Other reason not mentioned above|0|||
13311437|NCT01251653|26541282|FG004|Overall Study|Other reason not mentioned above|0|||
13311438|NCT01251653|26541283|FG005|Overall Study|Other reason not mentioned above|0|||
13311439|NCT01251653|26541284|FG006|Overall Study|Other reason not mentioned above|0|||
13311440|NCT01251653|26541285|FG007|Overall Study|Other reason not mentioned above|2|||
13311441|NCT01251653|26541286|FG008|Overall Study|Other reason not mentioned above|0|||
13311442|NCT01251614|26541368|FG000|Overall Study|Adverse Event|1|||
13311443|NCT01251614|26541369|FG001|Overall Study|Adverse Event|0|||
13311444|NCT01251614|26541370|FG002|Overall Study|Adverse Event|1|||
13311445|NCT01251614|26541368|FG000|Overall Study|Lack of Efficacy|1|||
13311446|NCT01251614|26541369|FG001|Overall Study|Lack of Efficacy|9|||
13311447|NCT01251614|26541370|FG002|Overall Study|Lack of Efficacy|4|||
13311448|NCT01251614|26541368|FG000|Overall Study|Clearing of Psoriatic Lesions|1|||
13311449|NCT01251614|26541369|FG001|Overall Study|Clearing of Psoriatic Lesions|0|||
13311450|NCT01251614|26541370|FG002|Overall Study|Clearing of Psoriatic Lesions|0|||
13311451|NCT01251614|26541368|FG000|Overall Study|Pregnancy|0|||
13311452|NCT01251614|26541369|FG001|Overall Study|Pregnancy|0|||
13311453|NCT01251614|26541370|FG002|Overall Study|Pregnancy|2|||
13311454|NCT01251614|26541368|FG000|Overall Study|Loss of Disease Control|0|||
13311455|NCT01251614|26541369|FG001|Overall Study|Loss of Disease Control|1|||
13311456|NCT01251614|26541370|FG002|Overall Study|Loss of Disease Control|0|||
13311457|NCT01251614|26541368|FG000|Overall Study|Withdrawal by Subject|0|||
13311458|NCT01251614|26541369|FG001|Overall Study|Withdrawal by Subject|2|||
13311459|NCT01251614|26541370|FG002|Overall Study|Withdrawal by Subject|1|||
13311460|NCT01251614|26541368|FG000|Overall Study|Lost to Follow-up|0|||
13311461|NCT01251614|26541369|FG001|Overall Study|Lost to Follow-up|1|||
13311462|NCT01251614|26541370|FG002|Overall Study|Lost to Follow-up|0|||
13311463|NCT01251380|26541396|FG000|Overall Study|Other (Not otherwise specified)|12|||
13311464|NCT01251380|26541396|FG000|Overall Study|Withdrawal by Subject|6|||
13311465|NCT01251380|26541396|FG000|Overall Study|Lack of Efficacy|1|||
13311466|NCT01251380|26541396|FG000|Overall Study|Adverse Event|1|||
13311467|NCT01251380|26541396|FG000|Overall Study|Lost to Follow-up|2|||
13311468|NCT01251367|26541433|FG000|Overall Study|Protocol Violation|1|||
13311469|NCT01251367|26541433|FG000|Overall Study|Lack of Efficacy|2|||
13311470|NCT01251367|26541433|FG000|Overall Study|Adverse Event|19|||
13311471|NCT01251367|26541433|FG000|Overall Study|Withdrawal by Subject|36|||
13311472|NCT01251367|26541433|FG000|Overall Study|Lost to Follow-up|5|||
13311473|NCT01251367|26541433|FG000|Overall Study|Subject Required Alternative Treatment|7|||
13311474|NCT01251367|26541433|FG000|Overall Study|No Study Drug Available|1|||
13311475|NCT01251367|26541433|FG000|Overall Study|Subject had Personal or Medical Issues|4|||
13311476|NCT01251367|26541433|FG000|Overall Study|End of Study Visit Performed in Error|1|||
13311477|NCT01251354|26541445|FG000|Overall Study|Adverse Event|1|||
13311478|NCT01251354|26541445|FG000|Overall Study|Investigator's Decision|1|||
13311479|NCT01251354|26541445|FG000|Overall Study|Disease Progression|4|||
13311480|NCT01251276|26541468|FG000|Overall Study|Protocol Violation|1|||
13311481|NCT01251276|26541469|FG001|Overall Study|Protocol Violation|0|||
13311482|NCT01251276|26541468|FG000|Overall Study|Lost to Follow-up|0|||
13311483|NCT01251276|26541469|FG001|Overall Study|Lost to Follow-up|1|||
13311484|NCT01251146|26541496|FG000|Overall Study|Lost to Follow-up|3|||
13311485|NCT01251146|26541497|FG001|Overall Study|Lost to Follow-up|10|||
13311486|NCT01251120|26541524|FG000|Overall Study|Lack of Efficacy|0|||
13311487|NCT01251120|26541525|FG001|Overall Study|Lack of Efficacy|1|||
13311488|NCT01250925|26541573|FG000|Overall Study|Lost to Follow-up|1|||
13311489|NCT01250925|26541574|FG001|Overall Study|Lost to Follow-up|1|||
13311490|NCT01250925|26541575|FG002|Overall Study|Lost to Follow-up|0|||
13311491|NCT01250925|26541573|FG000|Overall Study|Withdrawal by Subject|2|||
13311492|NCT01250925|26541574|FG001|Overall Study|Withdrawal by Subject|0|||
13311493|NCT01250925|26541575|FG002|Overall Study|Withdrawal by Subject|0|||
13311494|NCT01250925|26541573|FG000|Overall Study|Protocol Violation|2|||
13311495|NCT01250925|26541574|FG001|Overall Study|Protocol Violation|0|||
13311496|NCT01250925|26541575|FG002|Overall Study|Protocol Violation|0|||
13311497|NCT01250925|26541573|FG000|Overall Study|Physician Decision|0|||
13311498|NCT01250925|26541574|FG001|Overall Study|Physician Decision|2|||
13311499|NCT01250925|26541575|FG002|Overall Study|Physician Decision|1|||
13311500|NCT01250925|26541573|FG000|Overall Study|Adverse Event|0|||
13311501|NCT01250925|26541574|FG001|Overall Study|Adverse Event|0|||
13311502|NCT01250925|26541575|FG002|Overall Study|Adverse Event|1|||
13311503|NCT01250873|26541588|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2|||
13311504|NCT01250873|26541588|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1|||
13311505|NCT01250769|26541631|FG000|Overall Study|Withdrawal by Subject|0|||
13311506|NCT01250769|26541632|FG001|Overall Study|Withdrawal by Subject|1|||
13311507|NCT01250769|26541633|FG002|Overall Study|Withdrawal by Subject|1|||
13311508|NCT01250769|26541634|FG003|Overall Study|Withdrawal by Subject|0|||
13311509|NCT01250769|26541631|FG000|Overall Study|Adverse Event|0|||
13311510|NCT01250769|26541632|FG001|Overall Study|Adverse Event|0|||
13311511|NCT01250769|26541633|FG002|Overall Study|Adverse Event|1|||
13311512|NCT01250769|26541634|FG003|Overall Study|Adverse Event|0|||
13311513|NCT01250756|26541691|FG000|Infant Series|Withdrawal by Subject|4|||
13311514|NCT01250756|26541692|FG001|Infant Series|Withdrawal by Subject|5|||
13311515|NCT01250756|26541691|FG000|Infant Series|Randomized, Not Vaccinated|2|||
13311516|NCT01250756|26541692|FG001|Infant Series|Randomized, Not Vaccinated|2|||
13311517|NCT01250756|26541691|FG000|Infant Series|Other|22|||
13311518|NCT01250756|26541692|FG001|Infant Series|Other|0|||
13311519|NCT01250756|26541691|FG000|After Infant Series|Adverse Event|5|||
13311520|NCT01250756|26541692|FG001|After Infant Series|Adverse Event|2|||
13311521|NCT01250756|26541691|FG000|After Infant Series|Withdrawal by Subject|4|||
13311522|NCT01250756|26541692|FG001|After Infant Series|Withdrawal by Subject|1|||
13311523|NCT01250756|26541691|FG000|After Infant Series|Other|2|||
13311524|NCT01250756|26541692|FG001|After Infant Series|Other|1|||
13311525|NCT01250756|26541691|FG000|Toddler Dose|Adverse Event|0|||
13311526|NCT01250756|26541692|FG001|Toddler Dose|Adverse Event|1|||
13311527|NCT01250756|26541691|FG000|After Toddler Dose|Adverse Event|0|||
13311528|NCT01250756|26541692|FG001|After Toddler Dose|Adverse Event|1|||
13311529|NCT01250509|26541711|FG000|Overall Study|Lost to Follow-up|5|||
13311530|NCT01250509|26541712|FG001|Overall Study|Lost to Follow-up|2|||
13311531|NCT01250418|26541725|FG000|Overall Study|monitor data failure|1|||
13311532|NCT01250418|26541726|FG001|Overall Study|monitor data failure|1|||
13311533|NCT01250379|26541791|FG000|Overall Study|Death|141|||
13311534|NCT01250379|26541792|FG001|Overall Study|Death|148|||
13311535|NCT01250379|26541791|FG000|Overall Study|Withdrawal by Subject|32|||
13311536|NCT01250379|26541792|FG001|Overall Study|Withdrawal by Subject|20|||
13311537|NCT01250379|26541791|FG000|Overall Study|Physician Decision|11|||
13311538|NCT01250379|26541792|FG001|Overall Study|Physician Decision|3|||
13311539|NCT01250379|26541791|FG000|Overall Study|Protocol Violation|2|||
13311540|NCT01250379|26541792|FG001|Overall Study|Protocol Violation|8|||
13311541|NCT01250379|26541791|FG000|Overall Study|Lost to Follow-up|9|||
13311542|NCT01250379|26541792|FG001|Overall Study|Lost to Follow-up|6|||
13311543|NCT01250379|26541791|FG000|Overall Study|Adverse Event|5|||
13311544|NCT01250379|26541792|FG001|Overall Study|Adverse Event|4|||
13311545|NCT01250379|26541791|FG000|Overall Study|Other|0|||
13311546|NCT01250379|26541792|FG001|Overall Study|Other|4|||
13311547|NCT01250379|26541791|FG000|Overall Study|Participant noncompliance|2|||
13311548|NCT01250379|26541792|FG001|Overall Study|Participant noncompliance|0|||
13311549|NCT01250171|26541831|FG000|Overall Study|Administrative reasons|1|||
13311550|NCT01250171|26541832|FG001|Overall Study|Administrative reasons|0|||
13311551|NCT01250171|26541833|FG002|Overall Study|Administrative reasons|0|||
13311552|NCT01250145|26541860|FG000|Overall Study|Adverse Event|2|||
13311553|NCT01250145|26541861|FG001|Overall Study|Adverse Event|1|||
13311554|NCT01250145|26541860|FG000|Overall Study|Withdrawal by Subject|0|||
13311555|NCT01250145|26541861|FG001|Overall Study|Withdrawal by Subject|4|||
13372973|NCT00806026|26722411|FG004|Overall Study|Protocol Violation|2|||
13372974|NCT00806026|26722412|FG005|Overall Study|Protocol Violation|3|||
13372975|NCT00806026|26722407|FG000|Overall Study|Adverse Event|52|||
13372976|NCT00806026|26722408|FG001|Overall Study|Adverse Event|35|||
13372977|NCT00806026|26722409|FG002|Overall Study|Adverse Event|44|||
13372978|NCT00806026|26722410|FG003|Overall Study|Adverse Event|17|||
13372979|NCT00806026|26722411|FG004|Overall Study|Adverse Event|9|||
13372980|NCT00806026|26722412|FG005|Overall Study|Adverse Event|9|||
13372981|NCT00805935|26722477|FG000|Overall Study|Stimulation Failure|1|||
13372982|NCT00805935|26722478|FG001|Overall Study|Stimulation Failure|5|||
13372983|NCT00805935|26722479|FG002|Overall Study|Stimulation Failure|2|||
13372984|NCT00805935|26722480|FG003|Overall Study|Stimulation Failure|2|||
13372985|NCT00805935|26722477|FG000|Overall Study|Cycle cancelled|0|||
13372986|NCT00805935|26722478|FG001|Overall Study|Cycle cancelled|0|||
13372987|NCT00805935|26722479|FG002|Overall Study|Cycle cancelled|2|||
13372988|NCT00805935|26722480|FG003|Overall Study|Cycle cancelled|0|||
13372989|NCT00805935|26722477|FG000|Overall Study|Cycle cancellation for risk of OHSS|1|||
13372990|NCT00805935|26722478|FG001|Overall Study|Cycle cancellation for risk of OHSS|0|||
13372991|NCT00805935|26722479|FG002|Overall Study|Cycle cancellation for risk of OHSS|1|||
13311556|NCT01250119|26541879|FG000|Diagnostic Phase|Failed to Produce a Test Results|69|||
13311557|NCT01250119|26541880|FG001|Diagnostic Phase|Failed to Produce a Test Results|0|||
13311558|NCT01250119|26541879|FG000|Diagnostic Phase|Participants Not Tested|44|||
13311559|NCT01250119|26541880|FG001|Diagnostic Phase|Participants Not Tested|0|||
13311560|NCT01250119|26541879|FG000|Treatment Phase|Progressive Disease|0|||
13311561|NCT01250119|26541880|FG001|Treatment Phase|Progressive Disease|32|||
13311562|NCT01250119|26541879|FG000|Treatment Phase|Death|0|||
13311563|NCT01250119|26541880|FG001|Treatment Phase|Death|2|||
13311564|NCT01250119|26541879|FG000|Treatment Phase|Withdrawal by Subject|0|||
13311565|NCT01250119|26541880|FG001|Treatment Phase|Withdrawal by Subject|1|||
13311566|NCT01250119|26541879|FG000|Treatment Phase|Adverse Event|0|||
13311567|NCT01250119|26541880|FG001|Treatment Phase|Adverse Event|2|||
13311568|NCT01250119|26541879|FG000|Treatment Phase|Unknown reason|0|||
13311569|NCT01250119|26541880|FG001|Treatment Phase|Unknown reason|4|||
13311570|NCT01250054|26541889|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1|||
13311571|NCT01250054|26541890|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0|||
13311572|NCT01250002|26541905|FG000|Overall Study|Change to open surgical procedure|4|||
13311573|NCT01250002|26541906|FG001|Overall Study|Change to open surgical procedure|3|||
13311574|NCT01248065|26541923|FG000|Overall Study|Lost to Follow-up|3|||
13311575|NCT01248065|26541924|FG001|Overall Study|Lost to Follow-up|5|||
13311576|NCT01248065|26541923|FG000|Overall Study|Withdrawal by Subject|14|||
13311577|NCT01248065|26541924|FG001|Overall Study|Withdrawal by Subject|11|||
13311578|NCT01248065|26541923|FG000|Overall Study|Adverse Event|3|||
13311579|NCT01248065|26541924|FG001|Overall Study|Adverse Event|0|||
13311580|NCT01248065|26541923|FG000|Overall Study|Third treatment failure event|3|||
13311581|NCT01248065|26541924|FG001|Overall Study|Third treatment failure event|1|||
13311582|NCT01248065|26541923|FG000|Overall Study|Other|3|||
13311583|NCT01248065|26541924|FG001|Overall Study|Other|5|||
13311584|NCT01246986|26542004|FG000|Overall Study|Lost to Follow-up|0|||
13311585|NCT01246986|26542005|FG001|Overall Study|Lost to Follow-up|1|||
13311586|NCT01246986|26542006|FG002|Overall Study|Lost to Follow-up|3|||
13311587|NCT01246986|26542007|FG003|Overall Study|Lost to Follow-up|0|||
13311588|NCT01246986|26542008|FG004|Overall Study|Lost to Follow-up|0|||
13311589|NCT01246986|26542009|FG005|Overall Study|Lost to Follow-up|1|||
13311590|NCT01246986|26542010|FG006|Overall Study|Lost to Follow-up|0|||
13311591|NCT01246986|26542004|FG000|Overall Study|Withdrawal by Subject|3|||
13311592|NCT01246986|26542005|FG001|Overall Study|Withdrawal by Subject|4|||
13311593|NCT01246986|26542006|FG002|Overall Study|Withdrawal by Subject|3|||
13311594|NCT01246986|26542007|FG003|Overall Study|Withdrawal by Subject|0|||
13311595|NCT01246986|26542008|FG004|Overall Study|Withdrawal by Subject|4|||
13311596|NCT01246986|26542009|FG005|Overall Study|Withdrawal by Subject|0|||
13311597|NCT01246986|26542010|FG006|Overall Study|Withdrawal by Subject|0|||
13311598|NCT01246960|26542035|FG000|Overall Study|Lost to Follow-up|3|||
13311599|NCT01246960|26542036|FG001|Overall Study|Lost to Follow-up|1|||
13311600|NCT01246960|26542035|FG000|Overall Study|Withdrawal (by participant or physician)|3|||
13311601|NCT01246960|26542036|FG001|Overall Study|Withdrawal (by participant or physician)|3|||
13311602|NCT01246583|26542133|FG000|Overall Study|Lost to Follow-up|0|||
13311603|NCT01246583|26542134|FG001|Overall Study|Lost to Follow-up|0|||
13311604|NCT01246583|26542135|FG002|Overall Study|Lost to Follow-up|0|||
13311605|NCT01246583|26542136|FG003|Overall Study|Lost to Follow-up|1|||
13311606|NCT01246583|26542133|FG000|Overall Study|Protocol Violation|0|||
13311607|NCT01246583|26542134|FG001|Overall Study|Protocol Violation|0|||
13311608|NCT01246583|26542135|FG002|Overall Study|Protocol Violation|1|||
13311609|NCT01246583|26542136|FG003|Overall Study|Protocol Violation|0|||
13311610|NCT01246583|26542133|FG000|Overall Study|Withdrawal by Subject|1|||
13311611|NCT01246583|26542134|FG001|Overall Study|Withdrawal by Subject|0|||
13311612|NCT01246583|26542135|FG002|Overall Study|Withdrawal by Subject|0|||
13311613|NCT01246583|26542136|FG003|Overall Study|Withdrawal by Subject|0|||
13311614|NCT01245387|26542187|FG000|Overall Study|Lost to Follow-up|106|||
13311615|NCT01245387|26542187|FG000|Overall Study|Lack of Efficacy|195|||
13311616|NCT01245387|26542187|FG000|Overall Study|Adverse Event|9|||
13311617|NCT01245387|26542187|FG000|Overall Study|Death|3|||
13311618|NCT01245387|26542187|FG000|Overall Study|Other|131|||
13311619|NCT01245387|26542187|FG000|Overall Study|Missing discontinuation status|369|||
13311620|NCT01245374|26542209|FG000|Overall Study|Protocol Violation|1|||
13311621|NCT01245374|26542209|FG000|Overall Study|Withdrawal by Subject|3|||
13311622|NCT01244906|26542220|FG000|Overall Study|Death|2|||
13311623|NCT01244906|26542220|FG000|Overall Study|Progression of disease post treatment|6|||
13311624|NCT01244763|26542367|FG000|Overall Study|Adverse Event|1|||
13311625|NCT01244763|26542368|FG001|Overall Study|Adverse Event|0|||
13311626|NCT01244763|26542369|FG002|Overall Study|Adverse Event|0|||
13311627|NCT01244763|26542370|FG003|Overall Study|Adverse Event|0|||
13311628|NCT01244763|26542371|FG004|Overall Study|Adverse Event|0|||
13311629|NCT01244763|26542372|FG005|Overall Study|Adverse Event|1|||
13311630|NCT01244763|26542367|FG000|Overall Study|Death|1|||
13311631|NCT01244763|26542368|FG001|Overall Study|Death|0|||
13311632|NCT01244763|26542369|FG002|Overall Study|Death|1|||
13311633|NCT01244763|26542370|FG003|Overall Study|Death|0|||
13311634|NCT01244763|26542371|FG004|Overall Study|Death|2|||
13311635|NCT01244763|26542372|FG005|Overall Study|Death|0|||
13311636|NCT01244763|26542367|FG000|Overall Study|Physician Decision|0|||
13311637|NCT01244763|26542368|FG001|Overall Study|Physician Decision|0|||
13311638|NCT01244763|26542369|FG002|Overall Study|Physician Decision|1|||
13311639|NCT01244763|26542370|FG003|Overall Study|Physician Decision|0|||
13311640|NCT01244763|26542371|FG004|Overall Study|Physician Decision|0|||
13311641|NCT01244763|26542372|FG005|Overall Study|Physician Decision|0|||
13311642|NCT01244763|26542367|FG000|Overall Study|Withdrawal by Subject|1|||
13311643|NCT01244763|26542368|FG001|Overall Study|Withdrawal by Subject|2|||
13311644|NCT01244763|26542369|FG002|Overall Study|Withdrawal by Subject|0|||
13311645|NCT01244763|26542370|FG003|Overall Study|Withdrawal by Subject|1|||
13311646|NCT01244763|26542371|FG004|Overall Study|Withdrawal by Subject|1|||
13311647|NCT01244763|26542372|FG005|Overall Study|Withdrawal by Subject|2|||
13311648|NCT01244763|26542367|FG000|Overall Study|Lost to Follow-up|0|||
13311649|NCT01244763|26542368|FG001|Overall Study|Lost to Follow-up|1|||
13311650|NCT01244763|26542369|FG002|Overall Study|Lost to Follow-up|0|||
13311651|NCT01244763|26542370|FG003|Overall Study|Lost to Follow-up|0|||
13311652|NCT01244763|26542371|FG004|Overall Study|Lost to Follow-up|0|||
13311653|NCT01244763|26542372|FG005|Overall Study|Lost to Follow-up|0|||
13311654|NCT01244763|26542367|FG000|Overall Study|Enrolled into the Extension Study|0|||
13311655|NCT01244763|26542368|FG001|Overall Study|Enrolled into the Extension Study|0|||
13311656|NCT01244763|26542369|FG002|Overall Study|Enrolled into the Extension Study|0|||
13311657|NCT01244763|26542370|FG003|Overall Study|Enrolled into the Extension Study|0|||
13311658|NCT01244763|26542371|FG004|Overall Study|Enrolled into the Extension Study|0|||
13311659|NCT01244763|26542372|FG005|Overall Study|Enrolled into the Extension Study|1|||
13311660|NCT01244620|26542411|FG000|Overall Study|Study terminated|4|||
13311661|NCT01244620|26542412|FG001|Overall Study|Study terminated|4|||
13311662|NCT01244620|26542413|FG002|Overall Study|Study terminated|4|||
13311663|NCT01244620|26542414|FG003|Overall Study|Study terminated|4|||
13311664|NCT01244061|26542433|FG000|Overall Study|Death|1|||
13311665|NCT01244061|26542434|FG001|Overall Study|Death|0|||
13311666|NCT01244061|26542433|FG000|Overall Study|Did not meet entrance criteria|1|||
13311667|NCT01244061|26542434|FG001|Overall Study|Did not meet entrance criteria|0|||
13311668|NCT01244061|26542433|FG000|Overall Study|Lack of Efficacy|1|||
13311669|NCT01244061|26542434|FG001|Overall Study|Lack of Efficacy|3|||
13311670|NCT01244061|26542433|FG000|Overall Study|Lost to Follow-up|34|||
13311671|NCT01244061|26542434|FG001|Overall Study|Lost to Follow-up|30|||
13311672|NCT01244061|26542433|FG000|Overall Study|Withdrawal by Subject|29|||
13311673|NCT01244061|26542434|FG001|Overall Study|Withdrawal by Subject|46|||
13311674|NCT01244061|26542433|FG000|Overall Study|Other|8|||
13311675|NCT01244061|26542434|FG001|Overall Study|Other|19|||
13311676|NCT01244061|26542433|FG000|Overall Study|Protocol Violation|1|||
13311677|NCT01244061|26542434|FG001|Overall Study|Protocol Violation|1|||
13311678|NCT01244061|26542433|FG000|Overall Study|Adverse Event|5|||
13311679|NCT01244061|26542434|FG001|Overall Study|Adverse Event|2|||
13311680|NCT01244061|26542433|FG000|Overall Study|Randomized but not treated|2|||
13311681|NCT01244061|26542434|FG001|Overall Study|Randomized but not treated|2|||
13311682|NCT01243671|26542449|FG000|Overall Study|Adverse Event|3|||
13311683|NCT01243671|26542449|FG000|Overall Study|Anti-adalimumab antibody positive|1|||
13311684|NCT01243671|26542449|FG000|Overall Study|Other|1|||
13311685|NCT01243424|26542498|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49|||
13311686|NCT01243424|26542499|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37|||
13311687|NCT01243424|26542498|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14|||
13311688|NCT01243424|26542499|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12|||
13311689|NCT01243424|26542498|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15|||
13311690|NCT01243424|26542499|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22|||
13311691|NCT01243424|26542498|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0|||
13311692|NCT01243424|26542499|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1|||
13311693|NCT01243424|26542498|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38|||
13311694|NCT01243424|26542499|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35|||
13311695|NCT01243424|26542498|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
13311696|NCT01243424|26542499|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
13311697|NCT01243424|26542498|FG000|Discontinuation From Study (Treated Set)|Not treated|5|||
13311698|NCT01243424|26542499|FG001|Discontinuation From Study (Treated Set)|Not treated|4|||
13311699|NCT01243424|26542498|FG000|Discontinuation From Treatment|Not treated|5|||
13311700|NCT01243424|26542499|FG001|Discontinuation From Treatment|Not treated|4|||
13311701|NCT01243424|26542498|FG000|Discontinuation From Treatment|Adverse Event|457|||
13311702|NCT01243424|26542499|FG001|Discontinuation From Treatment|Adverse Event|523|||
13311703|NCT01243424|26542498|FG000|Discontinuation From Treatment|Lack of Efficacy|61|||
13311704|NCT01243424|26542499|FG001|Discontinuation From Treatment|Lack of Efficacy|41|||
13311705|NCT01243424|26542498|FG000|Discontinuation From Treatment|Protocol Violation|46|||
13311706|NCT01243424|26542499|FG001|Discontinuation From Treatment|Protocol Violation|47|||
13311707|NCT01243424|26542498|FG000|Discontinuation From Treatment|Lost to Follow-up|24|||
13311708|NCT01243424|26542499|FG001|Discontinuation From Treatment|Lost to Follow-up|28|||
13311709|NCT01243424|26542498|FG000|Discontinuation From Treatment|Withdrawal by Subject|309|||
13311710|NCT01243424|26542499|FG001|Discontinuation From Treatment|Withdrawal by Subject|328|||
13311711|NCT01243424|26542498|FG000|Discontinuation From Treatment|Other than listed above|230|||
13311712|NCT01243424|26542499|FG001|Discontinuation From Treatment|Other than listed above|211|||
13311713|NCT01243151|26542754|FG000|Overall Study|Adverse Event|0|||
13311714|NCT01243151|26542755|FG001|Overall Study|Adverse Event|1|||
13311715|NCT01243151|26542756|FG002|Overall Study|Adverse Event|0|||
13311716|NCT01243151|26542757|FG003|Overall Study|Adverse Event|0|||
13311717|NCT01243151|26542758|FG004|Overall Study|Adverse Event|0|||
13311718|NCT01243151|26542754|FG000|Overall Study|Protocol Violation|0|||
13311719|NCT01243151|26542755|FG001|Overall Study|Protocol Violation|0|||
13311720|NCT01243151|26542756|FG002|Overall Study|Protocol Violation|1|||
13311721|NCT01243151|26542757|FG003|Overall Study|Protocol Violation|0|||
13311722|NCT01243151|26542758|FG004|Overall Study|Protocol Violation|0|||
13311723|NCT01243151|26542754|FG000|Overall Study|Other|0|||
13311724|NCT01243151|26542755|FG001|Overall Study|Other|0|||
13311725|NCT01243151|26542756|FG002|Overall Study|Other|0|||
13311726|NCT01243151|26542757|FG003|Overall Study|Other|1|||
13311727|NCT01243151|26542758|FG004|Overall Study|Other|0|||
13311728|NCT01243151|26542754|FG000|Overall Study|Randomized but not treated|0|||
13311729|NCT01243151|26542755|FG001|Overall Study|Randomized but not treated|0|||
13311730|NCT01243151|26542756|FG002|Overall Study|Randomized but not treated|0|||
13311731|NCT01243151|26542757|FG003|Overall Study|Randomized but not treated|1|||
13311732|NCT01243151|26542758|FG004|Overall Study|Randomized but not treated|0|||
13311733|NCT01241760|26542784|FG000|Overall Study|Adverse Event|1|||
13311734|NCT01241760|26542785|FG001|Overall Study|Adverse Event|0|||
13311735|NCT01241760|26542784|FG000|Overall Study|Lost to Follow-up|18|||
13311736|NCT01241760|26542785|FG001|Overall Study|Lost to Follow-up|22|||
13311737|NCT01241760|26542784|FG000|Overall Study|Withdrawal by Subject|13|||
13311738|NCT01241760|26542785|FG001|Overall Study|Withdrawal by Subject|13|||
13311739|NCT01241760|26542784|FG000|Overall Study|Switch To Commercially Available Medicat|1|||
13311740|NCT01241760|26542785|FG001|Overall Study|Switch To Commercially Available Medicat|4|||
13311741|NCT01241760|26542784|FG000|Overall Study|Other|1|||
13311742|NCT01241760|26542785|FG001|Overall Study|Other|1|||
13311743|NCT01241591|26542988|FG000|Overall Study|Lack of Efficacy|5|||
13311744|NCT01241591|26542989|FG001|Overall Study|Lack of Efficacy|2|||
13311745|NCT01241591|26542990|FG002|Overall Study|Lack of Efficacy|2|||
13311746|NCT01241591|26542991|FG003|Overall Study|Lack of Efficacy|3|||
13311747|NCT01241591|26542988|FG000|Overall Study|Protocol Violation|5|||
13311748|NCT01241591|26542989|FG001|Overall Study|Protocol Violation|2|||
13311749|NCT01241591|26542990|FG002|Overall Study|Protocol Violation|3|||
13311750|NCT01241591|26542991|FG003|Overall Study|Protocol Violation|0|||
13311751|NCT01241591|26542988|FG000|Overall Study|Lost to Follow-up|1|||
13311752|NCT01241591|26542989|FG001|Overall Study|Lost to Follow-up|2|||
13311753|NCT01241591|26542990|FG002|Overall Study|Lost to Follow-up|2|||
13311754|NCT01241591|26542991|FG003|Overall Study|Lost to Follow-up|2|||
13311755|NCT01241591|26542988|FG000|Overall Study|Screen Failure|3|||
13311756|NCT01241591|26542989|FG001|Overall Study|Screen Failure|2|||
13311757|NCT01241591|26542990|FG002|Overall Study|Screen Failure|1|||
13311758|NCT01241591|26542991|FG003|Overall Study|Screen Failure|0|||
13311759|NCT01241591|26542988|FG000|Overall Study|Withdrawal by Subject|6|||
13311760|NCT01241591|26542989|FG001|Overall Study|Withdrawal by Subject|4|||
13311761|NCT01241591|26542990|FG002|Overall Study|Withdrawal by Subject|2|||
13311762|NCT01241591|26542991|FG003|Overall Study|Withdrawal by Subject|2|||
13311763|NCT01241591|26542988|FG000|Overall Study|Other|0|||
13311764|NCT01241591|26542989|FG001|Overall Study|Other|1|||
13311765|NCT01241591|26542990|FG002|Overall Study|Other|0|||
13311766|NCT01241591|26542991|FG003|Overall Study|Other|1|||
13311767|NCT01241591|26542988|FG000|Overall Study|Adverse Event|3|||
13311768|NCT01241591|26542989|FG001|Overall Study|Adverse Event|11|||
13311769|NCT01241591|26542990|FG002|Overall Study|Adverse Event|12|||
13311770|NCT01241591|26542991|FG003|Overall Study|Adverse Event|4|||
13311771|NCT01241552|26543070|FG000|Overall Study|Lack of Efficacy|1|||
13311772|NCT01241552|26543071|FG001|Overall Study|Lack of Efficacy|0|||
13311773|NCT01241552|26543072|FG002|Overall Study|Lack of Efficacy|0|||
13311774|NCT01241552|26543073|FG003|Overall Study|Lack of Efficacy|0|||
13311775|NCT01241552|26543070|FG000|Overall Study|Death|26|||
13311776|NCT01241552|26543071|FG001|Overall Study|Death|30|||
13311777|NCT01241552|26543072|FG002|Overall Study|Death|20|||
13311778|NCT01241552|26543073|FG003|Overall Study|Death|25|||
13311779|NCT01241552|26543070|FG000|Overall Study|Adverse Event|1|||
13311780|NCT01241552|26543071|FG001|Overall Study|Adverse Event|1|||
13311781|NCT01241552|26543072|FG002|Overall Study|Adverse Event|0|||
13311782|NCT01241552|26543073|FG003|Overall Study|Adverse Event|0|||
13311783|NCT01241552|26543070|FG000|Overall Study|Technical Problems|2|||
13311784|NCT01241552|26543071|FG001|Overall Study|Technical Problems|0|||
13311785|NCT01241552|26543072|FG002|Overall Study|Technical Problems|2|||
13311786|NCT01241552|26543073|FG003|Overall Study|Technical Problems|2|||
13311787|NCT01241552|26543070|FG000|Overall Study|Progressive Disease|0|||
13311788|NCT01241552|26543071|FG001|Overall Study|Progressive Disease|0|||
13311789|NCT01241552|26543072|FG002|Overall Study|Progressive Disease|1|||
13311790|NCT01241552|26543073|FG003|Overall Study|Progressive Disease|2|||
13311791|NCT01241552|26543070|FG000|Overall Study|Protocol Violation|0|||
13311792|NCT01241552|26543071|FG001|Overall Study|Protocol Violation|2|||
13311793|NCT01241552|26543072|FG002|Overall Study|Protocol Violation|6|||
13311794|NCT01241552|26543073|FG003|Overall Study|Protocol Violation|1|||
13311795|NCT01241552|26543070|FG000|Overall Study|Withdrawal by Subject|7|||
13311796|NCT01241552|26543071|FG001|Overall Study|Withdrawal by Subject|15|||
13311797|NCT01241552|26543072|FG002|Overall Study|Withdrawal by Subject|14|||
13311798|NCT01241552|26543073|FG003|Overall Study|Withdrawal by Subject|15|||
13311799|NCT01241552|26543070|FG000|Overall Study|Physician Decision|2|||
13311800|NCT01241552|26543071|FG001|Overall Study|Physician Decision|4|||
13311801|NCT01241552|26543072|FG002|Overall Study|Physician Decision|2|||
13311802|NCT01241552|26543073|FG003|Overall Study|Physician Decision|3|||
13311803|NCT01241552|26543070|FG000|Overall Study|Lost to Follow-up|2|||
13311804|NCT01241552|26543071|FG001|Overall Study|Lost to Follow-up|11|||
13311805|NCT01241552|26543072|FG002|Overall Study|Lost to Follow-up|15|||
13311806|NCT01241552|26543073|FG003|Overall Study|Lost to Follow-up|16|||
13311807|NCT01241448|26543150|FG000|Overall Study|Adverse Event|1|||
13311808|NCT01241448|26543151|FG001|Overall Study|Adverse Event|0|||
13311809|NCT01241448|26543152|FG002|Overall Study|Adverse Event|2|||
13311810|NCT01241448|26543153|FG003|Overall Study|Adverse Event|2|||
13311811|NCT01241448|26543150|FG000|Overall Study|Lost to Follow-up|2|||
13311812|NCT01241448|26543151|FG001|Overall Study|Lost to Follow-up|1|||
13311813|NCT01241448|26543152|FG002|Overall Study|Lost to Follow-up|1|||
13311814|NCT01241448|26543153|FG003|Overall Study|Lost to Follow-up|1|||
13311815|NCT01241448|26543150|FG000|Overall Study|Physician Decision|0|||
13311816|NCT01241448|26543151|FG001|Overall Study|Physician Decision|2|||
13311817|NCT01241448|26543152|FG002|Overall Study|Physician Decision|0|||
13311818|NCT01241448|26543153|FG003|Overall Study|Physician Decision|0|||
13311819|NCT01241448|26543150|FG000|Overall Study|Protocol Violation|10|||
13311820|NCT01241448|26543151|FG001|Overall Study|Protocol Violation|5|||
13311821|NCT01241448|26543152|FG002|Overall Study|Protocol Violation|3|||
13311822|NCT01241448|26543153|FG003|Overall Study|Protocol Violation|6|||
13311823|NCT01241448|26543150|FG000|Overall Study|Sponsor Decision|17|||
13311824|NCT01241448|26543151|FG001|Overall Study|Sponsor Decision|14|||
13311825|NCT01241448|26543152|FG002|Overall Study|Sponsor Decision|12|||
13311826|NCT01241448|26543153|FG003|Overall Study|Sponsor Decision|6|||
13311827|NCT01241448|26543150|FG000|Overall Study|Withdrawal by Subject|4|||
13311828|NCT01241448|26543151|FG001|Overall Study|Withdrawal by Subject|5|||
13311829|NCT01241448|26543152|FG002|Overall Study|Withdrawal by Subject|3|||
13311830|NCT01241448|26543153|FG003|Overall Study|Withdrawal by Subject|6|||
13311831|NCT01241448|26543150|FG000|Overall Study|Excluded due to data integrity issues|3|||
13311832|NCT01241448|26543151|FG001|Overall Study|Excluded due to data integrity issues|2|||
13311833|NCT01241448|26543152|FG002|Overall Study|Excluded due to data integrity issues|2|||
13311834|NCT01241448|26543153|FG003|Overall Study|Excluded due to data integrity issues|2|||
13311835|NCT01240915|26543358|FG000|Overall Study|Adverse Event|0|||
13311836|NCT01240915|26543359|FG001|Overall Study|Adverse Event|0|||
13311837|NCT01240915|26543360|FG002|Overall Study|Adverse Event|0|||
13311838|NCT01240915|26543361|FG003|Overall Study|Adverse Event|1|||
13311839|NCT01240915|26543362|FG004|Overall Study|Adverse Event|0|||
13311840|NCT01240915|26543363|FG005|Overall Study|Adverse Event|2|||
13311841|NCT01240915|26543364|FG006|Overall Study|Adverse Event|0|||
13311842|NCT01240915|26543365|FG007|Overall Study|Adverse Event|0|||
13311843|NCT01240915|26543366|FG008|Overall Study|Adverse Event|1|||
13311844|NCT01240915|26543358|FG000|Overall Study|Lost to Follow-up|0|||
13311845|NCT01240915|26543359|FG001|Overall Study|Lost to Follow-up|0|||
13311846|NCT01240915|26543360|FG002|Overall Study|Lost to Follow-up|0|||
13311847|NCT01240915|26543361|FG003|Overall Study|Lost to Follow-up|0|||
13311848|NCT01240915|26543362|FG004|Overall Study|Lost to Follow-up|1|||
13311849|NCT01240915|26543363|FG005|Overall Study|Lost to Follow-up|1|||
13311850|NCT01240915|26543364|FG006|Overall Study|Lost to Follow-up|0|||
13311851|NCT01240915|26543365|FG007|Overall Study|Lost to Follow-up|1|||
13311852|NCT01240915|26543366|FG008|Overall Study|Lost to Follow-up|1|||
13311853|NCT01240915|26543358|FG000|Overall Study|Withdrawal by Subject|2|||
13311854|NCT01240915|26543359|FG001|Overall Study|Withdrawal by Subject|1|||
13311855|NCT01240915|26543360|FG002|Overall Study|Withdrawal by Subject|0|||
13311856|NCT01240915|26543361|FG003|Overall Study|Withdrawal by Subject|2|||
13311857|NCT01240915|26543362|FG004|Overall Study|Withdrawal by Subject|0|||
13311858|NCT01240915|26543363|FG005|Overall Study|Withdrawal by Subject|4|||
13311859|NCT01240915|26543364|FG006|Overall Study|Withdrawal by Subject|2|||
13311860|NCT01240915|26543365|FG007|Overall Study|Withdrawal by Subject|3|||
13311861|NCT01240915|26543366|FG008|Overall Study|Withdrawal by Subject|3|||
13311862|NCT01240915|26543358|FG000|Overall Study|Other|0|||
13311863|NCT01240915|26543359|FG001|Overall Study|Other|0|||
13311864|NCT01240915|26543360|FG002|Overall Study|Other|0|||
13311865|NCT01240915|26543361|FG003|Overall Study|Other|0|||
13311866|NCT01240915|26543362|FG004|Overall Study|Other|2|||
13311867|NCT01240915|26543363|FG005|Overall Study|Other|0|||
13311868|NCT01240915|26543364|FG006|Overall Study|Other|0|||
13311869|NCT01240915|26543365|FG007|Overall Study|Other|0|||
13311870|NCT01240915|26543366|FG008|Overall Study|Other|0|||
13311871|NCT01240915|26543358|FG000|Overall Study|Insufficient Clinical Response|0|||
13311872|NCT01240915|26543359|FG001|Overall Study|Insufficient Clinical Response|0|||
13311873|NCT01240915|26543360|FG002|Overall Study|Insufficient Clinical Response|0|||
13311874|NCT01240915|26543361|FG003|Overall Study|Insufficient Clinical Response|0|||
13311875|NCT01240915|26543362|FG004|Overall Study|Insufficient Clinical Response|1|||
13311876|NCT01240915|26543363|FG005|Overall Study|Insufficient Clinical Response|3|||
13311877|NCT01240915|26543364|FG006|Overall Study|Insufficient Clinical Response|6|||
13311878|NCT01240915|26543365|FG007|Overall Study|Insufficient Clinical Response|0|||
13311879|NCT01240915|26543366|FG008|Overall Study|Insufficient Clinical Response|3|||
13311880|NCT01240785|26543401|FG000|Overall Study|Lost to Follow-up|1|||
13311881|NCT01240785|26543402|FG001|Overall Study|Lost to Follow-up|0|||
13311882|NCT01240785|26543401|FG000|Overall Study|Protocol Violation|0|||
13311883|NCT01240785|26543402|FG001|Overall Study|Protocol Violation|3|||
13311884|NCT01240551|26543417|FG000|Overall Study|Refused further treatment|3|||
13311885|NCT01240551|26543418|FG001|Overall Study|Refused further treatment|2|||
13311886|NCT01240551|26543417|FG000|Overall Study|Lost to Follow-up|1|||
13311887|NCT01240551|26543418|FG001|Overall Study|Lost to Follow-up|1|||
13311888|NCT01240356|26543436|FG000|Overall Study|Withdrawal by Subject|2|||
13311889|NCT01240356|26543437|FG001|Overall Study|Withdrawal by Subject|0|||
13311890|NCT01240356|26543436|FG000|Overall Study|MRI contraindication|1|||
13311891|NCT01240356|26543437|FG001|Overall Study|MRI contraindication|0|||
13311892|NCT01239992|26543446|FG000|Overall Study|Withdrawal by Subject|2|||
13311893|NCT01239745|26543459|FG000|Overall Study|Study terminated by sponsor|45|||
13311894|NCT01239745|26543459|FG000|Overall Study|Adverse Event|1|||
13311895|NCT01239732|26543472|FG000|Overall Study|Termination of study per protocol|667|||
13311896|NCT01239732|26543472|FG000|Overall Study|Death|226|||
13311897|NCT01239732|26543472|FG000|Overall Study|Withdrawal by Subject|87|||
13311898|NCT01239732|26543472|FG000|Overall Study|Adverse Event|6|||
13311899|NCT01239732|26543472|FG000|Overall Study|Protocol Violation|3|||
13311900|NCT01239732|26543472|FG000|Overall Study|Participant non compliance|5|||
13311901|NCT01239732|26543472|FG000|Overall Study|Study termination by sponsor|2|||
13311902|NCT01239732|26543472|FG000|Overall Study|Investigator's decision|4|||
13311903|NCT01239732|26543472|FG000|Overall Study|Treatment failure|2|||
13311904|NCT01239732|26543472|FG000|Overall Study|Other|19|||
13311905|NCT01239680|26543485|FG000|Overall Study|Withdrawal by Subject|2|||
13311906|NCT01239680|26543486|FG001|Overall Study|Withdrawal by Subject|0|||
13311907|NCT01239472|26543501|FG000|Overall Study|Withdrawal by Subject|5|||
13311908|NCT01239472|26543502|FG001|Overall Study|Withdrawal by Subject|1|||
13311909|NCT01239472|26543501|FG000|Overall Study|Adverse Event|0|||
13311910|NCT01239472|26543502|FG001|Overall Study|Adverse Event|1|||
13311911|NCT01239472|26543501|FG000|Overall Study|Lack of Efficacy|0|||
13311912|NCT01239472|26543502|FG001|Overall Study|Lack of Efficacy|1|||
13311913|NCT01239394|26543511|FG000|Overall Study|Adverse Event|1|||
13311914|NCT01239381|26543523|FG000|Overall Study|Protocol Violation|1|||
13311915|NCT01239381|26543523|FG000|Overall Study|Withdrawal by Subject|1|||
13311916|NCT01239342|26543546|FG000|Overall Study|Adverse Event|1|||
13311917|NCT01239342|26543547|FG001|Overall Study|Adverse Event|0|||
13311918|NCT01239342|26543546|FG000|Overall Study|Withdrawal by Subject|1|||
13311919|NCT01239342|26543547|FG001|Overall Study|Withdrawal by Subject|5|||
13311920|NCT01239342|26543546|FG000|Overall Study|Reason Unknown|1|||
13311921|NCT01239342|26543547|FG001|Overall Study|Reason Unknown|1|||
13311922|NCT01239316|26543557|FG000|Overall Study|Progression/Relapse|11|||
13311923|NCT01239316|26543557|FG000|Overall Study|Adverse Event|1|||
13311924|NCT01239160|26543575|FG000|Overall Study|Lost to Follow-up|3|||
13311925|NCT01239160|26543576|FG001|Overall Study|Lost to Follow-up|5|||
13311926|NCT01239160|26543577|FG002|Overall Study|Lost to Follow-up|0|||
13311927|NCT01239160|26543575|FG000|Overall Study|Withdrawal by Subject|17|||
13311928|NCT01239160|26543576|FG001|Overall Study|Withdrawal by Subject|6|||
13311929|NCT01239160|26543577|FG002|Overall Study|Withdrawal by Subject|2|||
13311930|NCT01239160|26543575|FG000|Overall Study|Physician Decision|5|||
13311931|NCT01239160|26543576|FG001|Overall Study|Physician Decision|7|||
13311932|NCT01239160|26543577|FG002|Overall Study|Physician Decision|2|||
13311933|NCT01239160|26543575|FG000|Overall Study|Early Termination Due to Study Closure|0|||
13311934|NCT01239160|26543576|FG001|Overall Study|Early Termination Due to Study Closure|1|||
13311935|NCT01239160|26543577|FG002|Overall Study|Early Termination Due to Study Closure|6|||
13311936|NCT01239121|26543601|FG000|Overall Study|Withdrawal by Subject|2|||
13311937|NCT01239121|26543602|FG001|Overall Study|Withdrawal by Subject|4|||
13311938|NCT01239121|26543603|FG002|Overall Study|Withdrawal by Subject|0|||
13311939|NCT01239043|26543628|FG000|Overall Study|Protocol Violation|2|||
13311940|NCT01239043|26543629|FG001|Overall Study|Protocol Violation|1|||
13311941|NCT01238991|26543747|FG000|Overall Study|Adverse Event|1|||
13311942|NCT01238991|26543748|FG001|Overall Study|Adverse Event|0|||
13311943|NCT01238991|26543749|FG002|Overall Study|Adverse Event|3|||
13311944|NCT01238991|26543750|FG003|Overall Study|Adverse Event|1|||
13311945|NCT01238991|26543751|FG004|Overall Study|Adverse Event|1|||
13311946|NCT01238991|26543752|FG005|Overall Study|Adverse Event|0|||
13311947|NCT01238991|26543753|FG006|Overall Study|Adverse Event|1|||
13311948|NCT01238991|26543754|FG007|Overall Study|Adverse Event|1|||
13311949|NCT01238991|26543755|FG008|Overall Study|Adverse Event|0|||
13311950|NCT01238991|26543756|FG009|Overall Study|Adverse Event|0|||
13311951|NCT01238991|26543747|FG000|Overall Study|Death|0|||
13311952|NCT01238991|26543748|FG001|Overall Study|Death|0|||
13311953|NCT01238991|26543749|FG002|Overall Study|Death|0|||
13311954|NCT01238991|26543750|FG003|Overall Study|Death|1|||
13311955|NCT01238991|26543751|FG004|Overall Study|Death|0|||
13311956|NCT01238991|26543752|FG005|Overall Study|Death|0|||
13311957|NCT01238991|26543753|FG006|Overall Study|Death|0|||
13311958|NCT01238991|26543754|FG007|Overall Study|Death|0|||
13311959|NCT01238991|26543755|FG008|Overall Study|Death|0|||
13311960|NCT01238991|26543756|FG009|Overall Study|Death|0|||
13311961|NCT01238991|26543747|FG000|Overall Study|Lack of Efficacy|0|||
13311962|NCT01238991|26543748|FG001|Overall Study|Lack of Efficacy|0|||
13311963|NCT01238991|26543749|FG002|Overall Study|Lack of Efficacy|1|||
13311964|NCT01238991|26543750|FG003|Overall Study|Lack of Efficacy|0|||
13311965|NCT01238991|26543751|FG004|Overall Study|Lack of Efficacy|0|||
13311966|NCT01238991|26543752|FG005|Overall Study|Lack of Efficacy|0|||
13311967|NCT01238991|26543753|FG006|Overall Study|Lack of Efficacy|0|||
13311968|NCT01238991|26543754|FG007|Overall Study|Lack of Efficacy|0|||
13311969|NCT01238991|26543755|FG008|Overall Study|Lack of Efficacy|1|||
13311970|NCT01238991|26543756|FG009|Overall Study|Lack of Efficacy|0|||
13311971|NCT01238991|26543747|FG000|Overall Study|Withdrawal by Subject|0|||
13311972|NCT01238991|26543748|FG001|Overall Study|Withdrawal by Subject|0|||
13311973|NCT01238991|26543749|FG002|Overall Study|Withdrawal by Subject|1|||
13311974|NCT01238991|26543750|FG003|Overall Study|Withdrawal by Subject|0|||
13311975|NCT01238991|26543751|FG004|Overall Study|Withdrawal by Subject|0|||
13311976|NCT01238991|26543752|FG005|Overall Study|Withdrawal by Subject|0|||
13311977|NCT01238991|26543753|FG006|Overall Study|Withdrawal by Subject|0|||
13311978|NCT01238991|26543754|FG007|Overall Study|Withdrawal by Subject|0|||
13311979|NCT01238991|26543755|FG008|Overall Study|Withdrawal by Subject|0|||
13311980|NCT01238991|26543756|FG009|Overall Study|Withdrawal by Subject|0|||
13311981|NCT01238991|26543747|FG000|Overall Study|Study Terminated by Sponsor|0|||
13311982|NCT01238991|26543748|FG001|Overall Study|Study Terminated by Sponsor|0|||
13311983|NCT01238991|26543749|FG002|Overall Study|Study Terminated by Sponsor|0|||
13311984|NCT01238991|26543750|FG003|Overall Study|Study Terminated by Sponsor|0|||
13311985|NCT01238991|26543751|FG004|Overall Study|Study Terminated by Sponsor|1|||
13311986|NCT01238991|26543752|FG005|Overall Study|Study Terminated by Sponsor|0|||
13311987|NCT01238991|26543753|FG006|Overall Study|Study Terminated by Sponsor|7|||
13311988|NCT01238991|26543754|FG007|Overall Study|Study Terminated by Sponsor|4|||
13311989|NCT01238991|26543755|FG008|Overall Study|Study Terminated by Sponsor|2|||
13311990|NCT01238991|26543756|FG009|Overall Study|Study Terminated by Sponsor|2|||
13311991|NCT01238991|26543747|FG000|Overall Study|Caregiver's request|0|||
13311992|NCT01238991|26543748|FG001|Overall Study|Caregiver's request|0|||
13311993|NCT01238991|26543749|FG002|Overall Study|Caregiver's request|0|||
13311994|NCT01238991|26543750|FG003|Overall Study|Caregiver's request|0|||
13311995|NCT01238991|26543751|FG004|Overall Study|Caregiver's request|0|||
13311996|NCT01238991|26543752|FG005|Overall Study|Caregiver's request|0|||
13311997|NCT01238991|26543753|FG006|Overall Study|Caregiver's request|0|||
13311998|NCT01238991|26543754|FG007|Overall Study|Caregiver's request|0|||
13311999|NCT01238991|26543755|FG008|Overall Study|Caregiver's request|1|||
13312000|NCT01238991|26543756|FG009|Overall Study|Caregiver's request|0|||
13312001|NCT01238991|26543747|FG000|Overall Study|Admission to a nursing home|1|||
13312002|NCT01238991|26543748|FG001|Overall Study|Admission to a nursing home|0|||
13312003|NCT01238991|26543749|FG002|Overall Study|Admission to a nursing home|1|||
13312004|NCT01238991|26543750|FG003|Overall Study|Admission to a nursing home|0|||
13312005|NCT01238991|26543751|FG004|Overall Study|Admission to a nursing home|0|||
13312006|NCT01238991|26543752|FG005|Overall Study|Admission to a nursing home|0|||
13312007|NCT01238991|26543753|FG006|Overall Study|Admission to a nursing home|0|||
13312008|NCT01238991|26543754|FG007|Overall Study|Admission to a nursing home|0|||
13312009|NCT01238991|26543755|FG008|Overall Study|Admission to a nursing home|0|||
13312010|NCT01238991|26543756|FG009|Overall Study|Admission to a nursing home|0|||
13312011|NCT01238900|26543766|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4|||
13312012|NCT01238900|26543766|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1|||
13312013|NCT01238861|26543863|FG000|Overall Study|Lost to Follow-up|4|||
13312014|NCT01238861|26543864|FG001|Overall Study|Lost to Follow-up|2|||
13312015|NCT01238861|26543865|FG002|Overall Study|Lost to Follow-up|3|||
13312016|NCT01238861|26543866|FG003|Overall Study|Lost to Follow-up|1|||
13312017|NCT01238861|26543867|FG004|Overall Study|Lost to Follow-up|1|||
13312018|NCT01238861|26543868|FG005|Overall Study|Lost to Follow-up|2|||
13312019|NCT01238861|26543863|FG000|Overall Study|Unplanned surgery|1|||
13312020|NCT01238861|26543864|FG001|Overall Study|Unplanned surgery|0|||
13312021|NCT01238861|26543865|FG002|Overall Study|Unplanned surgery|0|||
13312022|NCT01238861|26543866|FG003|Overall Study|Unplanned surgery|0|||
13312023|NCT01238861|26543867|FG004|Overall Study|Unplanned surgery|0|||
13312024|NCT01238861|26543868|FG005|Overall Study|Unplanned surgery|0|||
13312025|NCT01238861|26543863|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0|||
13312026|NCT01238861|26543864|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0|||
13312027|NCT01238861|26543865|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1|||
13312028|NCT01238861|26543866|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0|||
13312029|NCT01238861|26543867|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1|||
13312030|NCT01238861|26543868|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1|||
13312031|NCT01238861|26543863|FG000|Overall Study|Incorrect enrollment/randomization|0|||
13312032|NCT01238861|26543864|FG001|Overall Study|Incorrect enrollment/randomization|0|||
13312033|NCT01238861|26543865|FG002|Overall Study|Incorrect enrollment/randomization|1|||
13312034|NCT01238861|26543866|FG003|Overall Study|Incorrect enrollment/randomization|0|||
13312035|NCT01238861|26543867|FG004|Overall Study|Incorrect enrollment/randomization|1|||
13312036|NCT01238861|26543868|FG005|Overall Study|Incorrect enrollment/randomization|0|||
13312037|NCT01238861|26543863|FG000|Overall Study|Subject traveled to Argentina by 1 year|0|||
13312038|NCT01238861|26543864|FG001|Overall Study|Subject traveled to Argentina by 1 year|0|||
13312039|NCT01238861|26543865|FG002|Overall Study|Subject traveled to Argentina by 1 year|1|||
13312040|NCT01238861|26543866|FG003|Overall Study|Subject traveled to Argentina by 1 year|0|||
13312041|NCT01238861|26543867|FG004|Overall Study|Subject traveled to Argentina by 1 year|0|||
13312042|NCT01238861|26543868|FG005|Overall Study|Subject traveled to Argentina by 1 year|0|||
13312043|NCT01238861|26543863|FG000|Overall Study|Subject moved out of state/area|0|||
13312044|NCT01238861|26543864|FG001|Overall Study|Subject moved out of state/area|0|||
13312045|NCT01238861|26543865|FG002|Overall Study|Subject moved out of state/area|1|||
13312046|NCT01238861|26543866|FG003|Overall Study|Subject moved out of state/area|1|||
13312047|NCT01238861|26543867|FG004|Overall Study|Subject moved out of state/area|0|||
13312048|NCT01238861|26543868|FG005|Overall Study|Subject moved out of state/area|0|||
13312049|NCT01238861|26543863|FG000|Overall Study|Strongyloides stercoralis antibodies +|0|||
13312050|NCT01238861|26543864|FG001|Overall Study|Strongyloides stercoralis antibodies +|0|||
13312051|NCT01238861|26543865|FG002|Overall Study|Strongyloides stercoralis antibodies +|0|||
13312052|NCT01238861|26543866|FG003|Overall Study|Strongyloides stercoralis antibodies +|1|||
13312053|NCT01238861|26543867|FG004|Overall Study|Strongyloides stercoralis antibodies +|0|||
13312054|NCT01238861|26543868|FG005|Overall Study|Strongyloides stercoralis antibodies +|0|||
13312055|NCT01238861|26543863|FG000|Overall Study|Personal problems|0|||
13312056|NCT01238861|26543864|FG001|Overall Study|Personal problems|0|||
13312057|NCT01238861|26543865|FG002|Overall Study|Personal problems|0|||
13312058|NCT01238861|26543866|FG003|Overall Study|Personal problems|1|||
13312059|NCT01238861|26543867|FG004|Overall Study|Personal problems|0|||
13312060|NCT01238861|26543868|FG005|Overall Study|Personal problems|0|||
13312061|NCT01238861|26543863|FG000|Overall Study|Unable to continue visits|0|||
13312062|NCT01238861|26543864|FG001|Overall Study|Unable to continue visits|0|||
13312063|NCT01238861|26543865|FG002|Overall Study|Unable to continue visits|0|||
13312064|NCT01238861|26543866|FG003|Overall Study|Unable to continue visits|1|||
13312065|NCT01238861|26543867|FG004|Overall Study|Unable to continue visits|0|||
13312066|NCT01238861|26543868|FG005|Overall Study|Unable to continue visits|1|||
13312067|NCT01238861|26543863|FG000|Overall Study|Serious adverse event|0|||
13312068|NCT01238861|26543864|FG001|Overall Study|Serious adverse event|0|||
13312069|NCT01238861|26543865|FG002|Overall Study|Serious adverse event|0|||
13312070|NCT01238861|26543866|FG003|Overall Study|Serious adverse event|0|||
13312071|NCT01238861|26543867|FG004|Overall Study|Serious adverse event|0|||
13312072|NCT01238861|26543868|FG005|Overall Study|Serious adverse event|1|||
13312073|NCT01238861|26543863|FG000|Overall Study|Lack of compliance|0|||
13312074|NCT01238861|26543864|FG001|Overall Study|Lack of compliance|0|||
13312075|NCT01238861|26543865|FG002|Overall Study|Lack of compliance|0|||
13312076|NCT01238861|26543866|FG003|Overall Study|Lack of compliance|0|||
13312077|NCT01238861|26543867|FG004|Overall Study|Lack of compliance|0|||
13312078|NCT01238861|26543868|FG005|Overall Study|Lack of compliance|1|||
13312079|NCT01238861|26543863|FG000|Overall Study|Adverse Event|0|||
13312080|NCT01238861|26543864|FG001|Overall Study|Adverse Event|1|||
13312081|NCT01238861|26543865|FG002|Overall Study|Adverse Event|0|||
13312082|NCT01238861|26543866|FG003|Overall Study|Adverse Event|0|||
13312083|NCT01238861|26543867|FG004|Overall Study|Adverse Event|0|||
13312084|NCT01238861|26543868|FG005|Overall Study|Adverse Event|0|||
13312085|NCT01238861|26543863|FG000|Overall Study|Withdrawal by Subject|6|||
13312086|NCT01238861|26543864|FG001|Overall Study|Withdrawal by Subject|5|||
13312087|NCT01238861|26543865|FG002|Overall Study|Withdrawal by Subject|4|||
13312088|NCT01238861|26543866|FG003|Overall Study|Withdrawal by Subject|8|||
13312089|NCT01238861|26543867|FG004|Overall Study|Withdrawal by Subject|10|||
13312090|NCT01238861|26543868|FG005|Overall Study|Withdrawal by Subject|9|||
13312091|NCT01238848|26543883|FG000|Overall Study|Physician Decision|13|||
13312092|NCT01238848|26543884|FG001|Overall Study|Physician Decision|5|||
13312093|NCT01238835|26543891|FG000|Overall Study|Death|124|||
13312094|NCT01238835|26543891|FG000|Overall Study|Withdrawal by Subject|9|||
13312095|NCT01238835|26543891|FG000|Overall Study|Lost to Follow-up|1|||
13312096|NCT01238835|26543891|FG000|Overall Study|Site early discontinuation|2|||
13312097|NCT01238822|26543903|FG000|Overall Study|COULD NOT SWALLOW PILLS|3|||
13312098|NCT01238588|26543916|FG000|Overall Study|Withdrawal by Subject|1|||
13312099|NCT01238588|26543916|FG000|Overall Study|Physician Decision|2|||
13312100|NCT01238575|26543959|FG000|Overall Study|Lack of Efficacy|2|||
13312101|NCT01238575|26543960|FG001|Overall Study|Lack of Efficacy|4|||
13312102|NCT01238575|26543959|FG000|Overall Study|Adverse Event|2|||
13312103|NCT01238575|26543960|FG001|Overall Study|Adverse Event|0|||
13312104|NCT01238211|26543966|FG000|Overall Study|Continues active treatment|31|||
13312105|NCT01238211|26543966|FG000|Overall Study|Adverse Event|7|||
13312106|NCT01238211|26543966|FG000|Overall Study|Death|4|||
13312107|NCT01238211|26543966|FG000|Overall Study|Relapse/Progression|2|||
13312108|NCT01238211|26543966|FG000|Overall Study|Withdrawal by Subject|7|||
13312109|NCT01238211|26543966|FG000|Overall Study|Non-protocol treatment|4|||
13312110|NCT01238211|26543966|FG000|Overall Study|Investigator/Patient Decision|3|||
13312111|NCT01238172|26543985|FG000|Overall Study|Ineligible: based on Eligibility Review|2|||
13312112|NCT01238172|26543986|FG001|Overall Study|Ineligible: based on Eligibility Review|5|||
13312113|NCT01238172|26543985|FG000|Overall Study|Ineligible: based on Central Path Review|9|||
13312114|NCT01238172|26543986|FG001|Overall Study|Ineligible: based on Central Path Review|19|||
13312115|NCT01238120|26544013|FG000|Overall Study|Withdrawal by Subject|4|||
13312116|NCT01238120|26544014|FG001|Overall Study|Withdrawal by Subject|1|||
13312117|NCT01238120|26544015|FG002|Overall Study|Withdrawal by Subject|2|||
13312118|NCT01238120|26544016|FG003|Overall Study|Withdrawal by Subject|5|||
13312119|NCT01238120|26544013|FG000|Overall Study|Lost to Follow-up|2|||
13312120|NCT01238120|26544014|FG001|Overall Study|Lost to Follow-up|0|||
13312121|NCT01238120|26544015|FG002|Overall Study|Lost to Follow-up|1|||
13312122|NCT01238120|26544016|FG003|Overall Study|Lost to Follow-up|1|||
13312123|NCT01238120|26544013|FG000|Overall Study|Withdrawn due to Medical Problem|2|||
13312124|NCT01238120|26544014|FG001|Overall Study|Withdrawn due to Medical Problem|0|||
13312125|NCT01238120|26544015|FG002|Overall Study|Withdrawn due to Medical Problem|1|||
13312126|NCT01238120|26544016|FG003|Overall Study|Withdrawn due to Medical Problem|0|||
13312127|NCT01237951|26544025|FG000|Overall Study|Death|1|||
13312128|NCT01237899|26544087|FG000|Washout Period of at Least 7 Days|Adverse Event|0|||
13312129|NCT01237899|26544088|FG001|Washout Period of at Least 7 Days|Adverse Event|0|||
13312130|NCT01237899|26544089|FG002|Washout Period of at Least 7 Days|Adverse Event|1|||
13312131|NCT01237899|26544090|FG003|Washout Period of at Least 7 Days|Adverse Event|0|||
13312132|NCT01237899|26544091|FG004|Washout Period of at Least 7 Days|Adverse Event|0|||
13312133|NCT01237899|26544092|FG005|Washout Period of at Least 7 Days|Adverse Event|0|||
13312134|NCT01237899|26544093|FG006|Washout Period of at Least 7 Days|Adverse Event|0|||
13312135|NCT01237899|26544094|FG007|Washout Period of at Least 7 Days|Adverse Event|0|||
13312136|NCT01237899|26544095|FG008|Washout Period of at Least 7 Days|Adverse Event|0|||
13312137|NCT01237899|26544096|FG009|Washout Period of at Least 7 Days|Adverse Event|0|||
13312138|NCT01237899|26544097|FG010|Washout Period of at Least 7 Days|Adverse Event|0|||
13312139|NCT01237678|26544126|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5|||
13312140|NCT01237678|26544127|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
13312141|NCT01237678|26544128|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
13312142|NCT01237678|26544126|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24|||
13312143|NCT01237678|26544127|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
13312144|NCT01237678|26544128|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
13312145|NCT01237678|26544126|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3|||
13312146|NCT01237678|26544127|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
13312147|NCT01237678|26544128|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
13312148|NCT01237678|26544126|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1|||
13312149|NCT01237678|26544127|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
13312150|NCT01237678|26544128|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
13312151|NCT01237678|26544126|FG000|Phase II|Adverse Event|0|||
13312152|NCT01237678|26544127|FG001|Phase II|Adverse Event|39|||
13312153|NCT01237678|26544128|FG002|Phase II|Adverse Event|9|||
13312154|NCT01237678|26544126|FG000|Phase II|Death|0|||
13312155|NCT01237678|26544127|FG001|Phase II|Death|0|||
13312156|NCT01237678|26544128|FG002|Phase II|Death|2|||
13312157|NCT01237678|26544126|FG000|Phase II|Lack of Efficacy|0|||
13312158|NCT01237678|26544127|FG001|Phase II|Lack of Efficacy|25|||
13312159|NCT01237678|26544128|FG002|Phase II|Lack of Efficacy|3|||
13312160|NCT01237678|26544126|FG000|Phase II|Withdrawal by Subject|0|||
13312161|NCT01237678|26544127|FG001|Phase II|Withdrawal by Subject|1|||
13312162|NCT01237678|26544128|FG002|Phase II|Withdrawal by Subject|5|||
13312163|NCT01237678|26544126|FG000|Phase II|Completed Cycles 4-6|0|||
13312164|NCT01237678|26544127|FG001|Phase II|Completed Cycles 4-6|11|||
13312165|NCT01237678|26544128|FG002|Phase II|Completed Cycles 4-6|21|||
13312166|NCT01237678|26544126|FG000|Phase II|Sponsor Decision/Study Closed|0|||
13122086|NCT02969525|25945887|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
13312167|NCT01237678|26544127|FG001|Phase II|Sponsor Decision/Study Closed|18|||
13312168|NCT01237678|26544128|FG002|Phase II|Sponsor Decision/Study Closed|7|||
13312169|NCT01237678|26544126|FG000|Phase II|Randomized but were not treated|0|||
13312170|NCT01237678|26544127|FG001|Phase II|Randomized but were not treated|4|||
13312171|NCT01237678|26544128|FG002|Phase II|Randomized but were not treated|3|||
13312172|NCT01237587|26544182|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5|||
13312173|NCT01237587|26544183|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1|||
13312174|NCT01237587|26544182|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1|||
13312175|NCT01237587|26544183|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3|||
13312176|NCT01237587|26544182|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2|||
13312177|NCT01237587|26544183|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3|||
13312178|NCT01237587|26544182|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2|||
13312179|NCT01237587|26544183|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4|||
13312180|NCT01237587|26544182|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4|||
13312181|NCT01237587|26544183|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3|||
13312182|NCT01237587|26544182|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3|||
13312183|NCT01237587|26544183|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4|||
13312184|NCT01237587|26544182|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4|||
13312185|NCT01237587|26544183|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3|||
13312186|NCT01237587|26544182|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5|||
13312187|NCT01237587|26544183|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5|||
13312188|NCT01237587|26544182|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2|||
13312189|NCT01237587|26544183|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4|||
13312190|NCT01237587|26544182|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2|||
13312191|NCT01237587|26544183|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4|||
13312192|NCT01237587|26544182|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0|||
13312193|NCT01237587|26544183|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5|||
13312194|NCT01237587|26544182|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1|||
13312195|NCT01237587|26544183|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0|||
13312196|NCT01237587|26544182|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4|||
13312197|NCT01237587|26544183|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4|||
13312198|NCT01237587|26544182|FG000|Taper Phase|Adverse Event|0|||
13312199|NCT01237587|26544183|FG001|Taper Phase|Adverse Event|2|||
13312200|NCT01237587|26544182|FG000|Taper Phase|Protocol Violation|2|||
13312201|NCT01237587|26544183|FG001|Taper Phase|Protocol Violation|0|||
13312202|NCT01237587|26544182|FG000|Taper Phase|Lack of Efficacy|2|||
13312203|NCT01237587|26544183|FG001|Taper Phase|Lack of Efficacy|5|||
13312204|NCT01237587|26544182|FG000|Taper Phase|Parent/Guardian Decision|0|||
13312205|NCT01237587|26544183|FG001|Taper Phase|Parent/Guardian Decision|2|||
13312206|NCT01237587|26544182|FG000|Taper Phase|Sponsor Decision|1|||
13312207|NCT01237587|26544183|FG001|Taper Phase|Sponsor Decision|0|||
13312208|NCT01237587|26544182|FG000|Taper Phase|Withdrawal by Subject|0|||
13312209|NCT01237587|26544183|FG001|Taper Phase|Withdrawal by Subject|1|||
13312210|NCT01237340|26544197|FG000|Overall Study|Adverse Event|3|||
13312211|NCT01237340|26544197|FG000|Overall Study|Withdrawal by Subject|1|||
13312212|NCT01237340|26544197|FG000|Overall Study|Early termination of the trial|36|||
13312213|NCT01237327|26544218|FG000|Overall Study|Protocol Violation: Core Study|1|||
13312214|NCT01237327|26544219|FG001|Overall Study|Protocol Violation: Core Study|0|||
13312215|NCT01237327|26544218|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3|||
13312216|NCT01237327|26544219|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2|||
13312217|NCT01237327|26544218|FG000|Overall Study|Progression of Disease: Core Study|18|||
13312218|NCT01237327|26544219|FG001|Overall Study|Progression of Disease: Core Study|22|||
13312219|NCT01237327|26544218|FG000|Overall Study|Progression of Disease: Extension Study|15|||
13312220|NCT01237327|26544219|FG001|Overall Study|Progression of Disease: Extension Study|13|||
13312221|NCT01237327|26544218|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1|||
13312222|NCT01237327|26544219|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0|||
13312223|NCT01237327|26544218|FG000|Overall Study|Withdrawal by Subject|1|||
13312224|NCT01237327|26544219|FG001|Overall Study|Withdrawal by Subject|3|||
13312225|NCT01237327|26544218|FG000|Overall Study|Lost to Follow-up|3|||
13312226|NCT01237327|26544219|FG001|Overall Study|Lost to Follow-up|0|||
13312227|NCT01237223|26544277|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29|||
13312228|NCT01237223|26544278|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
13312229|NCT01237223|26544279|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
13312230|NCT01237223|26544280|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
13312231|NCT01237223|26544281|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
13312232|NCT01237223|26544282|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
13312233|NCT01237223|26544277|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25|||
13312234|NCT01237223|26544278|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
13312235|NCT01237223|26544279|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
13312236|NCT01237223|26544280|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
13312237|NCT01237223|26544281|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
13312238|NCT01237223|26544282|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
13312239|NCT01237223|26544277|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308|||
13312240|NCT01237223|26544278|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
13312241|NCT01237223|26544279|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
13312242|NCT01237223|26544280|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
13312243|NCT01237223|26544281|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
13312244|NCT01237223|26544282|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
13312245|NCT01237223|26544277|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28|||
13312246|NCT01237223|26544278|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
13312247|NCT01237223|26544279|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
13312248|NCT01237223|26544280|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
13312249|NCT01237223|26544281|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
13312250|NCT01237223|26544282|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
13312251|NCT01237223|26544277|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8|||
13312252|NCT01237223|26544278|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
13312253|NCT01237223|26544279|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
13312254|NCT01237223|26544280|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
13312255|NCT01237223|26544281|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
13312256|NCT01237223|26544282|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
13312257|NCT01237223|26544277|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12|||
13312258|NCT01237223|26544278|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4|||
13312259|NCT01237223|26544279|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3|||
13312260|NCT01237223|26544280|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
13312261|NCT01237223|26544281|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
13312262|NCT01237223|26544282|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1|||
13312263|NCT01237223|26544277|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20|||
13312264|NCT01237223|26544278|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6|||
13312265|NCT01237223|26544279|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7|||
13312266|NCT01237223|26544280|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
13312267|NCT01237223|26544281|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0|||
13312268|NCT01237223|26544282|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
13312269|NCT01237223|26544277|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
13312270|NCT01237223|26544278|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
13312271|NCT01237223|26544279|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
13312272|NCT01237223|26544280|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0|||
13312273|NCT01237223|26544281|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
13312274|NCT01237223|26544282|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
13312275|NCT01237223|26544277|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
13312276|NCT01237223|26544278|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
13312277|NCT01237223|26544279|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
13312278|NCT01237223|26544280|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
13312279|NCT01237223|26544281|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
13312280|NCT01237223|26544282|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1|||
13312281|NCT01237223|26544277|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0|||
13312282|NCT01237223|26544278|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
13312283|NCT01237223|26544279|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
13312284|NCT01237223|26544280|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2|||
13312285|NCT01237223|26544281|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
13312286|NCT01237223|26544282|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
13312287|NCT01237054|26544305|FG000|Overall Study|imaging 10C0096|1|||
13312288|NCT01236755|26544312|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8|||
13312289|NCT01236755|26544312|FG000|Spectacles Wearing Phase|Lost to Follow-up|9|||
13312290|NCT01236755|26544312|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5|||
13312291|NCT01236755|26544312|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3|||
13312292|NCT01236573|26544382|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
13312293|NCT01236573|26544383|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
13312294|NCT01236573|26544384|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
13312295|NCT01236573|26544385|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
13312296|NCT01236573|26544386|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
13312297|NCT01236573|26544387|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
13312298|NCT01236573|26544388|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
13312299|NCT01236573|26544389|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
13312300|NCT01236573|26544390|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
13312301|NCT01236573|26544391|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
13312302|NCT01236573|26544392|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
13312303|NCT01236573|26544382|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
13312304|NCT01236573|26544383|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
13312305|NCT01236573|26544384|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
13312306|NCT01236573|26544385|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
13312307|NCT01236573|26544386|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
13312308|NCT01236573|26544387|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
13312309|NCT01236573|26544388|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
13312310|NCT01236573|26544389|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
13312311|NCT01236573|26544390|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1|||
13312312|NCT01236573|26544391|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
13312313|NCT01236573|26544392|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
13312314|NCT01236573|26544382|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
13312315|NCT01236573|26544383|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
13312316|NCT01236573|26544384|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
13312317|NCT01236573|26544385|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
13312318|NCT01236573|26544386|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
13312319|NCT01236573|26544387|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
13312320|NCT01236573|26544388|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
13312321|NCT01236573|26544389|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
13312322|NCT01236573|26544390|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
13312323|NCT01236573|26544391|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
13312324|NCT01236573|26544392|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1|||
13312325|NCT01236560|26544430|FG000|Overall Study|Adverse Event|0|||
13312326|NCT01236560|26544431|FG001|Overall Study|Adverse Event|2|||
13312327|NCT01236560|26544432|FG002|Overall Study|Adverse Event|1|||
13312328|NCT01236560|26544433|FG003|Overall Study|Adverse Event|3|||
13312329|NCT01236560|26544434|FG004|Overall Study|Adverse Event|0|||
13312330|NCT01236560|26544435|FG005|Overall Study|Adverse Event|0|||
13312331|NCT01236560|26544430|FG000|Overall Study|Death|0|||
13312332|NCT01236560|26544431|FG001|Overall Study|Death|1|||
13312333|NCT01236560|26544432|FG002|Overall Study|Death|0|||
13312334|NCT01236560|26544433|FG003|Overall Study|Death|1|||
13312335|NCT01236560|26544434|FG004|Overall Study|Death|0|||
13312336|NCT01236560|26544435|FG005|Overall Study|Death|0|||
13312337|NCT01236560|26544430|FG000|Overall Study|Lost to Follow-up|0|||
13312338|NCT01236560|26544431|FG001|Overall Study|Lost to Follow-up|1|||
13312339|NCT01236560|26544432|FG002|Overall Study|Lost to Follow-up|1|||
13312340|NCT01236560|26544433|FG003|Overall Study|Lost to Follow-up|0|||
13312341|NCT01236560|26544434|FG004|Overall Study|Lost to Follow-up|0|||
13312342|NCT01236560|26544435|FG005|Overall Study|Lost to Follow-up|0|||
13312343|NCT01236560|26544430|FG000|Overall Study|Physician Decision|0|||
13312344|NCT01236560|26544431|FG001|Overall Study|Physician Decision|1|||
13312345|NCT01236560|26544432|FG002|Overall Study|Physician Decision|8|||
13312346|NCT01236560|26544433|FG003|Overall Study|Physician Decision|0|||
13312347|NCT01236560|26544434|FG004|Overall Study|Physician Decision|0|||
13312348|NCT01236560|26544435|FG005|Overall Study|Physician Decision|0|||
13312349|NCT01236560|26544430|FG000|Overall Study|Withdrawal by Subject|0|||
13312350|NCT01236560|26544431|FG001|Overall Study|Withdrawal by Subject|0|||
13312351|NCT01236560|26544432|FG002|Overall Study|Withdrawal by Subject|1|||
13312352|NCT01236560|26544433|FG003|Overall Study|Withdrawal by Subject|2|||
13312353|NCT01236560|26544434|FG004|Overall Study|Withdrawal by Subject|0|||
13312354|NCT01236560|26544435|FG005|Overall Study|Withdrawal by Subject|0|||
13312355|NCT01236560|26544430|FG000|Overall Study|Progressive disease|5|||
13312356|NCT01236560|26544431|FG001|Overall Study|Progressive disease|19|||
13312357|NCT01236560|26544432|FG002|Overall Study|Progressive disease|9|||
13312358|NCT01236560|26544433|FG003|Overall Study|Progressive disease|16|||
13312359|NCT01236560|26544434|FG004|Overall Study|Progressive disease|0|||
13312360|NCT01236560|26544435|FG005|Overall Study|Progressive disease|0|||
13312361|NCT01236534|26544450|FG000|Overall Study|Adverse Event|3|||
13312362|NCT01236534|26544451|FG001|Overall Study|Adverse Event|0|||
13312363|NCT01236365|26544480|FG000|Overall Study|Lost to Follow-up|0|||
13312364|NCT01236365|26544481|FG001|Overall Study|Lost to Follow-up|2|||
13312365|NCT01236365|26544480|FG000|Overall Study|Moved Out of State|1|||
13312366|NCT01236365|26544481|FG001|Overall Study|Moved Out of State|0|||
13312367|NCT01236365|26544480|FG000|Overall Study|Dropped at Randomization due to high LFT|1|||
13312368|NCT01236365|26544481|FG001|Overall Study|Dropped at Randomization due to high LFT|0|||
13312369|NCT01236352|26544682|FG000|Overall Study|Death|0|||
13312370|NCT01236352|26544683|FG001|Overall Study|Death|0|||
13312371|NCT01236352|26544684|FG002|Overall Study|Death|0|||
13312372|NCT01236352|26544685|FG003|Overall Study|Death|0|||
13312373|NCT01236352|26544686|FG004|Overall Study|Death|0|||
13312374|NCT01236352|26544687|FG005|Overall Study|Death|0|||
13312375|NCT01236352|26544688|FG006|Overall Study|Death|0|||
13312376|NCT01236352|26544689|FG007|Overall Study|Death|1|||
13312377|NCT01236352|26544690|FG008|Overall Study|Death|0|||
13312378|NCT01236352|26544691|FG009|Overall Study|Death|0|||
13312379|NCT01236352|26544692|FG010|Overall Study|Death|0|||
13312380|NCT01236352|26544682|FG000|Overall Study|Withdrawal by Subject|0|||
13312381|NCT01236352|26544683|FG001|Overall Study|Withdrawal by Subject|0|||
13312382|NCT01236352|26544684|FG002|Overall Study|Withdrawal by Subject|0|||
13312383|NCT01236352|26544685|FG003|Overall Study|Withdrawal by Subject|0|||
13312384|NCT01236352|26544686|FG004|Overall Study|Withdrawal by Subject|0|||
13312385|NCT01236352|26544687|FG005|Overall Study|Withdrawal by Subject|0|||
13312386|NCT01236352|26544688|FG006|Overall Study|Withdrawal by Subject|0|||
13312387|NCT01236352|26544689|FG007|Overall Study|Withdrawal by Subject|0|||
13312388|NCT01236352|26544690|FG008|Overall Study|Withdrawal by Subject|0|||
13312389|NCT01236352|26544691|FG009|Overall Study|Withdrawal by Subject|2|||
13312390|NCT01236352|26544692|FG010|Overall Study|Withdrawal by Subject|1|||
13312391|NCT01236352|26544682|FG000|Overall Study|Adverse Event|0|||
13312392|NCT01236352|26544683|FG001|Overall Study|Adverse Event|0|||
13312393|NCT01236352|26544684|FG002|Overall Study|Adverse Event|0|||
13312394|NCT01236352|26544685|FG003|Overall Study|Adverse Event|0|||
13312395|NCT01236352|26544686|FG004|Overall Study|Adverse Event|0|||
13312396|NCT01236352|26544687|FG005|Overall Study|Adverse Event|0|||
13312397|NCT01236352|26544688|FG006|Overall Study|Adverse Event|2|||
13312398|NCT01236352|26544689|FG007|Overall Study|Adverse Event|0|||
13312399|NCT01236352|26544690|FG008|Overall Study|Adverse Event|0|||
13312400|NCT01236352|26544691|FG009|Overall Study|Adverse Event|4|||
13312401|NCT01236352|26544692|FG010|Overall Study|Adverse Event|1|||
13312402|NCT01236352|26544682|FG000|Overall Study|Study drug toxicity|0|||
13312403|NCT01236352|26544683|FG001|Overall Study|Study drug toxicity|0|||
13312404|NCT01236352|26544684|FG002|Overall Study|Study drug toxicity|0|||
13312405|NCT01236352|26544685|FG003|Overall Study|Study drug toxicity|0|||
13312406|NCT01236352|26544686|FG004|Overall Study|Study drug toxicity|0|||
13312407|NCT01236352|26544687|FG005|Overall Study|Study drug toxicity|1|||
13312408|NCT01236352|26544688|FG006|Overall Study|Study drug toxicity|1|||
13312409|NCT01236352|26544689|FG007|Overall Study|Study drug toxicity|0|||
13312410|NCT01236352|26544690|FG008|Overall Study|Study drug toxicity|0|||
13312411|NCT01236352|26544691|FG009|Overall Study|Study drug toxicity|2|||
13312412|NCT01236352|26544692|FG010|Overall Study|Study drug toxicity|2|||
13312413|NCT01236352|26544682|FG000|Overall Study|Disease progression|1|||
13312414|NCT01236352|26544683|FG001|Overall Study|Disease progression|2|||
13312415|NCT01236352|26544684|FG002|Overall Study|Disease progression|1|||
13312416|NCT01236352|26544685|FG003|Overall Study|Disease progression|2|||
13312417|NCT01236352|26544686|FG004|Overall Study|Disease progression|2|||
13312418|NCT01236352|26544687|FG005|Overall Study|Disease progression|2|||
13312419|NCT01236352|26544688|FG006|Overall Study|Disease progression|1|||
13312420|NCT01236352|26544689|FG007|Overall Study|Disease progression|3|||
13312421|NCT01236352|26544690|FG008|Overall Study|Disease progression|2|||
13312422|NCT01236352|26544691|FG009|Overall Study|Disease progression|2|||
13312423|NCT01236352|26544692|FG010|Overall Study|Disease progression|2|||
13312424|NCT01236352|26544682|FG000|Overall Study|Poor/Non-compliance|1|||
13312425|NCT01236352|26544683|FG001|Overall Study|Poor/Non-compliance|0|||
13312426|NCT01236352|26544684|FG002|Overall Study|Poor/Non-compliance|0|||
13312427|NCT01236352|26544685|FG003|Overall Study|Poor/Non-compliance|0|||
13122087|NCT02969525|25945876|FG000|Dose-Blind Period|Non-cooperating patient|0|||
13312428|NCT01236352|26544686|FG004|Overall Study|Poor/Non-compliance|0|||
13312429|NCT01236352|26544687|FG005|Overall Study|Poor/Non-compliance|0|||
13312430|NCT01236352|26544688|FG006|Overall Study|Poor/Non-compliance|0|||
13312431|NCT01236352|26544689|FG007|Overall Study|Poor/Non-compliance|0|||
13312432|NCT01236352|26544690|FG008|Overall Study|Poor/Non-compliance|0|||
13312433|NCT01236352|26544691|FG009|Overall Study|Poor/Non-compliance|0|||
13312434|NCT01236352|26544692|FG010|Overall Study|Poor/Non-compliance|0|||
13312435|NCT01236352|26544682|FG000|Overall Study|Maximum clinical benefit|1|||
13312436|NCT01236352|26544683|FG001|Overall Study|Maximum clinical benefit|1|||
13312437|NCT01236352|26544684|FG002|Overall Study|Maximum clinical benefit|1|||
13312438|NCT01236352|26544685|FG003|Overall Study|Maximum clinical benefit|0|||
13312439|NCT01236352|26544686|FG004|Overall Study|Maximum clinical benefit|2|||
13312440|NCT01236352|26544687|FG005|Overall Study|Maximum clinical benefit|0|||
13312441|NCT01236352|26544688|FG006|Overall Study|Maximum clinical benefit|3|||
13312442|NCT01236352|26544689|FG007|Overall Study|Maximum clinical benefit|1|||
13312443|NCT01236352|26544690|FG008|Overall Study|Maximum clinical benefit|1|||
13312444|NCT01236352|26544691|FG009|Overall Study|Maximum clinical benefit|4|||
13312445|NCT01236352|26544692|FG010|Overall Study|Maximum clinical benefit|2|||
13312446|NCT01236352|26544682|FG000|Overall Study|Subject request to discontinue treatment|0|||
13312447|NCT01236352|26544683|FG001|Overall Study|Subject request to discontinue treatment|0|||
13312448|NCT01236352|26544684|FG002|Overall Study|Subject request to discontinue treatment|1|||
13312449|NCT01236352|26544685|FG003|Overall Study|Subject request to discontinue treatment|1|||
13312450|NCT01236352|26544686|FG004|Overall Study|Subject request to discontinue treatment|0|||
13312451|NCT01236352|26544687|FG005|Overall Study|Subject request to discontinue treatment|1|||
13312452|NCT01236352|26544688|FG006|Overall Study|Subject request to discontinue treatment|0|||
13312453|NCT01236352|26544689|FG007|Overall Study|Subject request to discontinue treatment|0|||
13312454|NCT01236352|26544690|FG008|Overall Study|Subject request to discontinue treatment|0|||
13312455|NCT01236352|26544691|FG009|Overall Study|Subject request to discontinue treatment|1|||
13312456|NCT01236352|26544692|FG010|Overall Study|Subject request to discontinue treatment|4|||
13312457|NCT01236352|26544682|FG000|Overall Study|Subject to receive drug via EAP|1|||
13312458|NCT01236352|26544683|FG001|Overall Study|Subject to receive drug via EAP|1|||
13312459|NCT01236352|26544684|FG002|Overall Study|Subject to receive drug via EAP|1|||
13312460|NCT01236352|26544685|FG003|Overall Study|Subject to receive drug via EAP|0|||
13312461|NCT01236352|26544686|FG004|Overall Study|Subject to receive drug via EAP|0|||
13312462|NCT01236352|26544687|FG005|Overall Study|Subject to receive drug via EAP|0|||
13312463|NCT01236352|26544688|FG006|Overall Study|Subject to receive drug via EAP|0|||
13312464|NCT01236352|26544689|FG007|Overall Study|Subject to receive drug via EAP|2|||
13312465|NCT01236352|26544690|FG008|Overall Study|Subject to receive drug via EAP|0|||
13312466|NCT01236352|26544691|FG009|Overall Study|Subject to receive drug via EAP|4|||
13312467|NCT01236352|26544692|FG010|Overall Study|Subject to receive drug via EAP|0|||
13312468|NCT01236352|26544682|FG000|Overall Study|Patient moving to allogeneic transplant|0|||
13312469|NCT01236352|26544683|FG001|Overall Study|Patient moving to allogeneic transplant|0|||
13312470|NCT01236352|26544684|FG002|Overall Study|Patient moving to allogeneic transplant|0|||
13312471|NCT01236352|26544685|FG003|Overall Study|Patient moving to allogeneic transplant|0|||
13312472|NCT01236352|26544686|FG004|Overall Study|Patient moving to allogeneic transplant|0|||
13312473|NCT01236352|26544687|FG005|Overall Study|Patient moving to allogeneic transplant|0|||
13312474|NCT01236352|26544688|FG006|Overall Study|Patient moving to allogeneic transplant|1|||
13312475|NCT01236352|26544689|FG007|Overall Study|Patient moving to allogeneic transplant|0|||
13312476|NCT01236352|26544690|FG008|Overall Study|Patient moving to allogeneic transplant|0|||
13312477|NCT01236352|26544691|FG009|Overall Study|Patient moving to allogeneic transplant|0|||
13312478|NCT01236352|26544692|FG010|Overall Study|Patient moving to allogeneic transplant|0|||
13312479|NCT01236352|26544682|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0|||
13312480|NCT01236352|26544683|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0|||
13312481|NCT01236352|26544684|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0|||
13312482|NCT01236352|26544685|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0|||
13312483|NCT01236352|26544686|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0|||
13312484|NCT01236352|26544687|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0|||
13312485|NCT01236352|26544688|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0|||
13312486|NCT01236352|26544689|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0|||
13312487|NCT01236352|26544690|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0|||
13312488|NCT01236352|26544691|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0|||
13312489|NCT01236352|26544692|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1|||
13312490|NCT01236352|26544682|FG000|Overall Study|Lack of response to drug|0|||
13312491|NCT01236352|26544683|FG001|Overall Study|Lack of response to drug|0|||
13312492|NCT01236352|26544684|FG002|Overall Study|Lack of response to drug|0|||
13312493|NCT01236352|26544685|FG003|Overall Study|Lack of response to drug|0|||
13122088|NCT02969525|25945877|FG001|Dose-Blind Period|Non-cooperating patient|0|||
13122089|NCT02969525|25945878|FG002|Dose-Blind Period|Non-cooperating patient|0|||
13122090|NCT02969525|25945879|FG003|Dose-Blind Period|Non-cooperating patient|0|||
13122091|NCT02969525|25945880|FG004|Dose-Blind Period|Non-cooperating patient|0|||
13122092|NCT02969525|25945881|FG005|Dose-Blind Period|Non-cooperating patient|0|||
13122093|NCT02969525|25945882|FG006|Dose-Blind Period|Non-cooperating patient|0|||
13122094|NCT02969525|25945883|FG007|Dose-Blind Period|Non-cooperating patient|0|||
13122095|NCT02969525|25945884|FG008|Dose-Blind Period|Non-cooperating patient|0|||
13122096|NCT02969525|25945885|FG009|Dose-Blind Period|Non-cooperating patient|0|||
13122097|NCT02969525|25945886|FG010|Dose-Blind Period|Non-cooperating patient|0|||
13122098|NCT02969525|25945887|FG011|Dose-Blind Period|Non-cooperating patient|1|||
13312494|NCT01236352|26544686|FG004|Overall Study|Lack of response to drug|0|||
13312495|NCT01236352|26544687|FG005|Overall Study|Lack of response to drug|0|||
13312496|NCT01236352|26544688|FG006|Overall Study|Lack of response to drug|0|||
13312497|NCT01236352|26544689|FG007|Overall Study|Lack of response to drug|0|||
13312498|NCT01236352|26544690|FG008|Overall Study|Lack of response to drug|0|||
13312499|NCT01236352|26544691|FG009|Overall Study|Lack of response to drug|1|||
13312500|NCT01236352|26544692|FG010|Overall Study|Lack of response to drug|1|||
13312501|NCT01236352|26544682|FG000|Overall Study|Patient transferred to IST|0|||
13312502|NCT01236352|26544683|FG001|Overall Study|Patient transferred to IST|0|||
13312503|NCT01236352|26544684|FG002|Overall Study|Patient transferred to IST|0|||
13312504|NCT01236352|26544685|FG003|Overall Study|Patient transferred to IST|0|||
13312505|NCT01236352|26544686|FG004|Overall Study|Patient transferred to IST|0|||
13312506|NCT01236352|26544687|FG005|Overall Study|Patient transferred to IST|0|||
13312507|NCT01236352|26544688|FG006|Overall Study|Patient transferred to IST|0|||
13122099|NCT02969525|25945876|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
13312508|NCT01236352|26544689|FG007|Overall Study|Patient transferred to IST|0|||
13312509|NCT01236352|26544690|FG008|Overall Study|Patient transferred to IST|0|||
13312510|NCT01236352|26544691|FG009|Overall Study|Patient transferred to IST|2|||
13312511|NCT01236352|26544692|FG010|Overall Study|Patient transferred to IST|6|||
13312512|NCT01236339|26544717|FG000|Overall Study|Termination of study by sponsor|11|||
13312513|NCT01236339|26544718|FG001|Overall Study|Termination of study by sponsor|13|||
13312514|NCT01236118|26544736|FG000|Overall Study|Adverse Event|2|||
13312515|NCT01236118|26544737|FG001|Overall Study|Adverse Event|0|||
13312516|NCT01236118|26544738|FG002|Overall Study|Adverse Event|2|||
13312517|NCT01236118|26544736|FG000|Overall Study|Physician Decision|0|||
13312518|NCT01236118|26544737|FG001|Overall Study|Physician Decision|1|||
13312519|NCT01236118|26544738|FG002|Overall Study|Physician Decision|0|||
13312520|NCT01236118|26544736|FG000|Overall Study|Withdrawal by Subject|0|||
13312521|NCT01236118|26544737|FG001|Overall Study|Withdrawal by Subject|0|||
13312522|NCT01236118|26544738|FG002|Overall Study|Withdrawal by Subject|1|||
13312523|NCT01236001|26544775|FG000|Overall Study|Adverse Event|5|||
13312524|NCT01236001|26544776|FG001|Overall Study|Adverse Event|14|||
13312525|NCT01236001|26544775|FG000|Overall Study|Lack of Efficacy|6|||
13312526|NCT01236001|26544776|FG001|Overall Study|Lack of Efficacy|6|||
13312527|NCT01236001|26544775|FG000|Overall Study|Lost to Follow-up|6|||
13312528|NCT01236001|26544776|FG001|Overall Study|Lost to Follow-up|1|||
13312529|NCT01236001|26544775|FG000|Overall Study|Incompliance|1|||
13312530|NCT01236001|26544776|FG001|Overall Study|Incompliance|0|||
13312531|NCT01236001|26544775|FG000|Overall Study|Planned Visit After End of Study|0|||
13312532|NCT01236001|26544776|FG001|Overall Study|Planned Visit After End of Study|1|||
13312533|NCT01235975|26544815|FG000|Overall Study|Serious Adverse Event|0|||
13312534|NCT01235975|26544816|FG001|Overall Study|Serious Adverse Event|1|||
13312535|NCT01235975|26544815|FG000|Overall Study|Withdrawal by Subject|8|||
13312536|NCT01235975|26544816|FG001|Overall Study|Withdrawal by Subject|2|||
13312537|NCT01235975|26544815|FG000|Overall Study|Migrated/moved from study area|2|||
13312538|NCT01235975|26544816|FG001|Overall Study|Migrated/moved from study area|1|||
13312539|NCT01235975|26544815|FG000|Overall Study|Lost to Follow-up|7|||
13312540|NCT01235975|26544816|FG001|Overall Study|Lost to Follow-up|3|||
13312541|NCT01235949|26545107|FG000|Primary Phase|Migrated/moved from study area|1|||
13312542|NCT01235949|26545108|FG001|Primary Phase|Migrated/moved from study area|1|||
13312543|NCT01235949|26545109|FG002|Primary Phase|Migrated/moved from study area|0|||
13312544|NCT01235949|26545110|FG003|Primary Phase|Migrated/moved from study area|0|||
13312545|NCT01235949|26545111|FG004|Primary Phase|Migrated/moved from study area|1|||
13312546|NCT01235949|26545112|FG005|Primary Phase|Migrated/moved from study area|2|||
13312547|NCT01235949|26545113|FG006|Primary Phase|Migrated/moved from study area|0|||
13312548|NCT01235949|26545114|FG007|Primary Phase|Migrated/moved from study area|0|||
13312549|NCT01235949|26545115|FG008|Primary Phase|Migrated/moved from study area|0|||
13312550|NCT01235949|26545116|FG009|Primary Phase|Migrated/moved from study area|0|||
13312551|NCT01235949|26545117|FG010|Primary Phase|Migrated/moved from study area|0|||
13312552|NCT01235949|26545118|FG011|Primary Phase|Migrated/moved from study area|0|||
13312553|NCT01235949|26545119|FG012|Primary Phase|Migrated/moved from study area|0|||
13312554|NCT01235949|26545120|FG013|Primary Phase|Migrated/moved from study area|0|||
13312555|NCT01235949|26545121|FG014|Primary Phase|Migrated/moved from study area|0|||
13312556|NCT01235949|26545122|FG015|Primary Phase|Migrated/moved from study area|0|||
13312557|NCT01235949|26545123|FG016|Primary Phase|Migrated/moved from study area|0|||
13312558|NCT01235949|26545124|FG017|Primary Phase|Migrated/moved from study area|0|||
13312559|NCT01235949|26545107|FG000|Primary Phase|Adverse Event|0|||
13312560|NCT01235949|26545108|FG001|Primary Phase|Adverse Event|0|||
13312561|NCT01235949|26545109|FG002|Primary Phase|Adverse Event|0|||
13312562|NCT01235949|26545110|FG003|Primary Phase|Adverse Event|1|||
13312563|NCT01235949|26545111|FG004|Primary Phase|Adverse Event|0|||
13312564|NCT01235949|26545112|FG005|Primary Phase|Adverse Event|0|||
13312565|NCT01235949|26545113|FG006|Primary Phase|Adverse Event|0|||
13312566|NCT01235949|26545114|FG007|Primary Phase|Adverse Event|0|||
13312567|NCT01235949|26545115|FG008|Primary Phase|Adverse Event|0|||
13312568|NCT01235949|26545116|FG009|Primary Phase|Adverse Event|0|||
13312569|NCT01235949|26545117|FG010|Primary Phase|Adverse Event|0|||
13312570|NCT01235949|26545118|FG011|Primary Phase|Adverse Event|0|||
13312571|NCT01235949|26545119|FG012|Primary Phase|Adverse Event|0|||
13312572|NCT01235949|26545120|FG013|Primary Phase|Adverse Event|0|||
13312573|NCT01235949|26545121|FG014|Primary Phase|Adverse Event|0|||
13312574|NCT01235949|26545122|FG015|Primary Phase|Adverse Event|0|||
13312575|NCT01235949|26545123|FG016|Primary Phase|Adverse Event|0|||
13312576|NCT01235949|26545124|FG017|Primary Phase|Adverse Event|0|||
13312577|NCT01235949|26545107|FG000|Primary Phase|Withdrawal by Subject|3|||
13312578|NCT01235949|26545108|FG001|Primary Phase|Withdrawal by Subject|2|||
13312579|NCT01235949|26545109|FG002|Primary Phase|Withdrawal by Subject|2|||
13312580|NCT01235949|26545110|FG003|Primary Phase|Withdrawal by Subject|0|||
13312581|NCT01235949|26545111|FG004|Primary Phase|Withdrawal by Subject|0|||
13312582|NCT01235949|26545112|FG005|Primary Phase|Withdrawal by Subject|3|||
13312583|NCT01235949|26545113|FG006|Primary Phase|Withdrawal by Subject|0|||
13312584|NCT01235949|26545114|FG007|Primary Phase|Withdrawal by Subject|0|||
13312585|NCT01235949|26545115|FG008|Primary Phase|Withdrawal by Subject|0|||
13312586|NCT01235949|26545116|FG009|Primary Phase|Withdrawal by Subject|0|||
13312587|NCT01235949|26545117|FG010|Primary Phase|Withdrawal by Subject|0|||
13312588|NCT01235949|26545118|FG011|Primary Phase|Withdrawal by Subject|0|||
13312589|NCT01235949|26545119|FG012|Primary Phase|Withdrawal by Subject|0|||
13312590|NCT01235949|26545120|FG013|Primary Phase|Withdrawal by Subject|0|||
13312591|NCT01235949|26545121|FG014|Primary Phase|Withdrawal by Subject|0|||
13312592|NCT01235949|26545122|FG015|Primary Phase|Withdrawal by Subject|0|||
13312593|NCT01235949|26545123|FG016|Primary Phase|Withdrawal by Subject|0|||
13312594|NCT01235949|26545124|FG017|Primary Phase|Withdrawal by Subject|0|||
13312595|NCT01235949|26545107|FG000|Primary Phase|Lost to Follow-up|0|||
13312596|NCT01235949|26545108|FG001|Primary Phase|Lost to Follow-up|0|||
13312597|NCT01235949|26545109|FG002|Primary Phase|Lost to Follow-up|1|||
13312598|NCT01235949|26545110|FG003|Primary Phase|Lost to Follow-up|1|||
13312599|NCT01235949|26545111|FG004|Primary Phase|Lost to Follow-up|0|||
13312600|NCT01235949|26545112|FG005|Primary Phase|Lost to Follow-up|2|||
13312601|NCT01235949|26545113|FG006|Primary Phase|Lost to Follow-up|0|||
13312602|NCT01235949|26545114|FG007|Primary Phase|Lost to Follow-up|0|||
13312603|NCT01235949|26545115|FG008|Primary Phase|Lost to Follow-up|0|||
13312604|NCT01235949|26545116|FG009|Primary Phase|Lost to Follow-up|0|||
13312605|NCT01235949|26545117|FG010|Primary Phase|Lost to Follow-up|0|||
13312606|NCT01235949|26545118|FG011|Primary Phase|Lost to Follow-up|0|||
13312607|NCT01235949|26545119|FG012|Primary Phase|Lost to Follow-up|0|||
13312608|NCT01235949|26545120|FG013|Primary Phase|Lost to Follow-up|0|||
13312609|NCT01235949|26545121|FG014|Primary Phase|Lost to Follow-up|0|||
13312610|NCT01235949|26545122|FG015|Primary Phase|Lost to Follow-up|0|||
13312611|NCT01235949|26545123|FG016|Primary Phase|Lost to Follow-up|0|||
13312612|NCT01235949|26545124|FG017|Primary Phase|Lost to Follow-up|0|||
13312613|NCT01235949|26545107|FG000|Booster Phase|Migrated/moved from study area|0|||
13312614|NCT01235949|26545108|FG001|Booster Phase|Migrated/moved from study area|0|||
13312615|NCT01235949|26545109|FG002|Booster Phase|Migrated/moved from study area|0|||
13312616|NCT01235949|26545110|FG003|Booster Phase|Migrated/moved from study area|0|||
13312617|NCT01235949|26545111|FG004|Booster Phase|Migrated/moved from study area|0|||
13312618|NCT01235949|26545112|FG005|Booster Phase|Migrated/moved from study area|0|||
13312619|NCT01235949|26545113|FG006|Booster Phase|Migrated/moved from study area|0|||
13312620|NCT01235949|26545114|FG007|Booster Phase|Migrated/moved from study area|0|||
13312621|NCT01235949|26545115|FG008|Booster Phase|Migrated/moved from study area|0|||
13312622|NCT01235949|26545116|FG009|Booster Phase|Migrated/moved from study area|0|||
13312623|NCT01235949|26545117|FG010|Booster Phase|Migrated/moved from study area|0|||
13312624|NCT01235949|26545118|FG011|Booster Phase|Migrated/moved from study area|1|||
13312625|NCT01235949|26545119|FG012|Booster Phase|Migrated/moved from study area|1|||
13312626|NCT01235949|26545120|FG013|Booster Phase|Migrated/moved from study area|0|||
13312627|NCT01235949|26545121|FG014|Booster Phase|Migrated/moved from study area|0|||
13312628|NCT01235949|26545122|FG015|Booster Phase|Migrated/moved from study area|0|||
13312629|NCT01235949|26545123|FG016|Booster Phase|Migrated/moved from study area|0|||
13312630|NCT01235949|26545124|FG017|Booster Phase|Migrated/moved from study area|1|||
13312631|NCT01235949|26545107|FG000|Booster Phase|Adverse Event|0|||
13312632|NCT01235949|26545108|FG001|Booster Phase|Adverse Event|0|||
13312633|NCT01235949|26545109|FG002|Booster Phase|Adverse Event|0|||
13312634|NCT01235949|26545110|FG003|Booster Phase|Adverse Event|0|||
13312635|NCT01235949|26545111|FG004|Booster Phase|Adverse Event|0|||
13312636|NCT01235949|26545112|FG005|Booster Phase|Adverse Event|0|||
13312637|NCT01235949|26545113|FG006|Booster Phase|Adverse Event|0|||
13312638|NCT01235949|26545114|FG007|Booster Phase|Adverse Event|0|||
13312639|NCT01235949|26545115|FG008|Booster Phase|Adverse Event|0|||
13312640|NCT01235949|26545116|FG009|Booster Phase|Adverse Event|0|||
13312641|NCT01235949|26545117|FG010|Booster Phase|Adverse Event|0|||
13312642|NCT01235949|26545118|FG011|Booster Phase|Adverse Event|0|||
13312643|NCT01235949|26545119|FG012|Booster Phase|Adverse Event|0|||
13312644|NCT01235949|26545120|FG013|Booster Phase|Adverse Event|0|||
13312645|NCT01235949|26545121|FG014|Booster Phase|Adverse Event|0|||
13312646|NCT01235949|26545122|FG015|Booster Phase|Adverse Event|1|||
13312647|NCT01235949|26545123|FG016|Booster Phase|Adverse Event|0|||
13312648|NCT01235949|26545124|FG017|Booster Phase|Adverse Event|0|||
13312649|NCT01235949|26545107|FG000|Booster Phase|Withdrawal by Subject|0|||
13312650|NCT01235949|26545108|FG001|Booster Phase|Withdrawal by Subject|0|||
13312651|NCT01235949|26545109|FG002|Booster Phase|Withdrawal by Subject|0|||
13312652|NCT01235949|26545110|FG003|Booster Phase|Withdrawal by Subject|0|||
13312653|NCT01235949|26545111|FG004|Booster Phase|Withdrawal by Subject|0|||
13312654|NCT01235949|26545112|FG005|Booster Phase|Withdrawal by Subject|0|||
13312655|NCT01235949|26545113|FG006|Booster Phase|Withdrawal by Subject|0|||
13312656|NCT01235949|26545114|FG007|Booster Phase|Withdrawal by Subject|1|||
13312657|NCT01235949|26545115|FG008|Booster Phase|Withdrawal by Subject|1|||
13312658|NCT01235949|26545116|FG009|Booster Phase|Withdrawal by Subject|0|||
13122100|NCT02969525|25945877|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
13312659|NCT01235949|26545117|FG010|Booster Phase|Withdrawal by Subject|1|||
13312660|NCT01235949|26545118|FG011|Booster Phase|Withdrawal by Subject|1|||
13312661|NCT01235949|26545119|FG012|Booster Phase|Withdrawal by Subject|2|||
13312662|NCT01235949|26545120|FG013|Booster Phase|Withdrawal by Subject|0|||
13312663|NCT01235949|26545121|FG014|Booster Phase|Withdrawal by Subject|2|||
13312664|NCT01235949|26545122|FG015|Booster Phase|Withdrawal by Subject|0|||
13312665|NCT01235949|26545123|FG016|Booster Phase|Withdrawal by Subject|0|||
13312666|NCT01235949|26545124|FG017|Booster Phase|Withdrawal by Subject|0|||
13312667|NCT01235949|26545107|FG000|Booster Phase|Lost to Follow-up|0|||
13312668|NCT01235949|26545108|FG001|Booster Phase|Lost to Follow-up|0|||
13312669|NCT01235949|26545109|FG002|Booster Phase|Lost to Follow-up|0|||
13312670|NCT01235949|26545110|FG003|Booster Phase|Lost to Follow-up|0|||
13312671|NCT01235949|26545111|FG004|Booster Phase|Lost to Follow-up|0|||
13312672|NCT01235949|26545112|FG005|Booster Phase|Lost to Follow-up|0|||
13312673|NCT01235949|26545113|FG006|Booster Phase|Lost to Follow-up|0|||
13312674|NCT01235949|26545114|FG007|Booster Phase|Lost to Follow-up|0|||
13312675|NCT01235949|26545115|FG008|Booster Phase|Lost to Follow-up|1|||
13312676|NCT01235949|26545116|FG009|Booster Phase|Lost to Follow-up|1|||
13312677|NCT01235949|26545117|FG010|Booster Phase|Lost to Follow-up|1|||
13312678|NCT01235949|26545118|FG011|Booster Phase|Lost to Follow-up|1|||
13312679|NCT01235949|26545119|FG012|Booster Phase|Lost to Follow-up|0|||
13312680|NCT01235949|26545120|FG013|Booster Phase|Lost to Follow-up|0|||
13312681|NCT01235949|26545121|FG014|Booster Phase|Lost to Follow-up|0|||
13312682|NCT01235949|26545122|FG015|Booster Phase|Lost to Follow-up|0|||
13312683|NCT01235949|26545123|FG016|Booster Phase|Lost to Follow-up|0|||
13312684|NCT01235949|26545124|FG017|Booster Phase|Lost to Follow-up|1|||
13312685|NCT01235793|26545131|FG000|Overall Study|Death|6|||
13312686|NCT01235741|26545168|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9|||
13312687|NCT01235741|26545169|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
13312688|NCT01235741|26545170|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
13312689|NCT01235741|26545168|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121|||
13312690|NCT01235741|26545169|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
13312691|NCT01235741|26545170|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
13312692|NCT01235741|26545168|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1|||
13312693|NCT01235741|26545169|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
13312694|NCT01235741|26545170|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
13312695|NCT01235741|26545168|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1|||
13312696|NCT01235741|26545169|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
13312697|NCT01235741|26545170|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
13312698|NCT01235741|26545168|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5|||
13312699|NCT01235741|26545169|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
13312700|NCT01235741|26545170|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
13312701|NCT01235741|26545168|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4|||
13312702|NCT01235741|26545169|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
13312703|NCT01235741|26545170|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
13312704|NCT01235741|26545168|FG000|Randomized to Treatment|Withdrawal by Subject|0|||
13312705|NCT01235741|26545169|FG001|Randomized to Treatment|Withdrawal by Subject|0|||
13312706|NCT01235741|26545170|FG002|Randomized to Treatment|Withdrawal by Subject|1|||
13312707|NCT01235741|26545168|FG000|Randomized to Treatment|Adverse Event|0|||
13312708|NCT01235741|26545169|FG001|Randomized to Treatment|Adverse Event|1|||
13312709|NCT01235741|26545170|FG002|Randomized to Treatment|Adverse Event|1|||
13312710|NCT01235741|26545168|FG000|Randomized to Treatment|Sponsor terminated study|0|||
13312711|NCT01235741|26545169|FG001|Randomized to Treatment|Sponsor terminated study|35|||
13312712|NCT01235741|26545170|FG002|Randomized to Treatment|Sponsor terminated study|34|||
13312713|NCT01235741|26545168|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0|||
13312714|NCT01235741|26545169|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3|||
13312715|NCT01235741|26545170|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6|||
13312716|NCT01235741|26545168|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0|||
13312717|NCT01235741|26545169|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5|||
13312718|NCT01235741|26545170|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1|||
13312719|NCT01235741|26545168|FG000|Follow-Up Post Treatment up to Month 6|Other|0|||
13312720|NCT01235741|26545169|FG001|Follow-Up Post Treatment up to Month 6|Other|1|||
13312721|NCT01235741|26545170|FG002|Follow-Up Post Treatment up to Month 6|Other|0|||
13312722|NCT01235728|26545187|FG000|Overall Study|Protocol Violation|0|||
13312723|NCT01235728|26545188|FG001|Overall Study|Protocol Violation|0|||
13312724|NCT01235728|26545189|FG002|Overall Study|Protocol Violation|0|||
13312725|NCT01235728|26545190|FG003|Overall Study|Protocol Violation|1|||
13312726|NCT01235728|26545191|FG004|Overall Study|Protocol Violation|0|||
13312727|NCT01235728|26545192|FG005|Overall Study|Protocol Violation|0|||
13312728|NCT01235728|26545193|FG006|Overall Study|Protocol Violation|0|||
13122101|NCT02969525|25945878|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
13312729|NCT01235728|26545194|FG007|Overall Study|Protocol Violation|0|||
13312730|NCT01235715|26545239|FG000|Overall Study|Physician Decision|0|||
13312731|NCT01235715|26545240|FG001|Overall Study|Physician Decision|2|||
13312732|NCT01235689|26545317|FG000|Overall Study|Adverse Event|12|||
13312733|NCT01235689|26545318|FG001|Overall Study|Adverse Event|16|||
13312734|NCT01235689|26545317|FG000|Overall Study|Lack of Efficacy|12|||
13312735|NCT01235689|26545318|FG001|Overall Study|Lack of Efficacy|5|||
13312736|NCT01235689|26545317|FG000|Overall Study|Withdrawal by Subject|3|||
13312737|NCT01235689|26545318|FG001|Overall Study|Withdrawal by Subject|4|||
13312738|NCT01235689|26545317|FG000|Overall Study|Lost to Follow-up|1|||
13312739|NCT01235689|26545318|FG001|Overall Study|Lost to Follow-up|2|||
13312740|NCT01235689|26545317|FG000|Overall Study|Miscellaneous|1|||
13312741|NCT01235689|26545318|FG001|Overall Study|Miscellaneous|5|||
13312742|NCT01235598|26545368|FG000|Overall Study|Adverse Event|0|||
13312743|NCT01235598|26545369|FG001|Overall Study|Adverse Event|3|||
13312744|NCT01235598|26545368|FG000|Overall Study|Lack of Efficacy|0|||
13312745|NCT01235598|26545369|FG001|Overall Study|Lack of Efficacy|1|||
13312746|NCT01235598|26545368|FG000|Overall Study|Withdrawal by Subject|1|||
13312747|NCT01235598|26545369|FG001|Overall Study|Withdrawal by Subject|0|||
13312748|NCT01235546|26545400|FG000|Overall Study|Staff error, medication not administered|1|||
13312749|NCT01235546|26545401|FG001|Overall Study|Staff error, medication not administered|0|||
13312750|NCT01235546|26545400|FG000|Overall Study|Protocol Violation|1|||
13312751|NCT01235546|26545401|FG001|Overall Study|Protocol Violation|1|||
13312752|NCT01235507|26545415|FG000|Overall Study|Adverse Event|1|||
13312753|NCT01235507|26545415|FG000|Overall Study|Withdrawal by Subject|1|||
13312754|NCT01235442|26545440|FG000|Overall Study|Lost to Follow-up|12|||
13312755|NCT01235442|26545441|FG001|Overall Study|Lost to Follow-up|10|||
13312756|NCT01235442|26545440|FG000|Overall Study|Death|0|||
13312757|NCT01235442|26545441|FG001|Overall Study|Death|2|||
13312758|NCT01235442|26545440|FG000|Overall Study|Pregnancy|1|||
13312759|NCT01235442|26545441|FG001|Overall Study|Pregnancy|1|||
13312760|NCT01235442|26545440|FG000|Overall Study|Ineligibility determined|5|||
13312761|NCT01235442|26545441|FG001|Overall Study|Ineligibility determined|4|||
13312762|NCT01235442|26545440|FG000|Overall Study|Protocol Violation|3|||
13312763|NCT01235442|26545441|FG001|Overall Study|Protocol Violation|3|||
13312764|NCT01235442|26545440|FG000|Overall Study|Adverse Event|4|||
13312765|NCT01235442|26545441|FG001|Overall Study|Adverse Event|6|||
13312766|NCT01235442|26545440|FG000|Overall Study|Withdrawal by Subject|15|||
13312767|NCT01235442|26545441|FG001|Overall Study|Withdrawal by Subject|9|||
13312768|NCT01235442|26545440|FG000|Overall Study|Lack of Efficacy|1|||
13312769|NCT01235442|26545441|FG001|Overall Study|Lack of Efficacy|3|||
13312770|NCT01235442|26545440|FG000|Overall Study|Noncompliance|1|||
13312771|NCT01235442|26545441|FG001|Overall Study|Noncompliance|2|||
13312772|NCT01235442|26545440|FG000|Overall Study|Administrative decision|1|||
13312773|NCT01235442|26545441|FG001|Overall Study|Administrative decision|2|||
13312774|NCT01235442|26545440|FG000|Overall Study|Other unspecified|1|||
13312775|NCT01235442|26545441|FG001|Overall Study|Other unspecified|2|||
13312776|NCT01235403|26545449|FG000|Overall Study|Adverse Event|14|||
13312777|NCT01235403|26545449|FG000|Overall Study|Lost to Follow-up|2|||
13312778|NCT01235403|26545449|FG000|Overall Study|Withdrawal by Subject|4|||
13312779|NCT01235403|26545449|FG000|Overall Study|Lack of Efficacy|2|||
13312780|NCT01235403|26545449|FG000|Overall Study|Other reasons for premature termination|4|||
13312781|NCT01235351|26545466|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10|||
13312782|NCT01235351|26545467|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4|||
13312783|NCT01235338|26545516|FG000|Overall Study|Adverse Event|3|||
13312784|NCT01235338|26545517|FG001|Overall Study|Adverse Event|2|||
13312785|NCT01235338|26545516|FG000|Overall Study|Protocol Violation|1|||
13312786|NCT01235338|26545517|FG001|Overall Study|Protocol Violation|1|||
13312787|NCT01235338|26545516|FG000|Overall Study|Withdrawal by Subject|5|||
13312788|NCT01235338|26545517|FG001|Overall Study|Withdrawal by Subject|0|||
13312789|NCT01235338|26545516|FG000|Overall Study|Exclusion criteria violations|1|||
13312790|NCT01235338|26545517|FG001|Overall Study|Exclusion criteria violations|1|||
13312791|NCT01235338|26545516|FG000|Overall Study|Positive drug screen|0|||
13312792|NCT01235338|26545517|FG001|Overall Study|Positive drug screen|1|||
13312793|NCT01235338|26545516|FG000|Overall Study|Prohibited meds|1|||
13312794|NCT01235338|26545517|FG001|Overall Study|Prohibited meds|0|||
13312795|NCT01234883|26545530|FG000|Overall Study|Early treatment release|8|||
13312796|NCT01234883|26545531|FG001|Overall Study|Early treatment release|10|||
13312797|NCT01234883|26545530|FG000|Overall Study|Parent/guardian withdrew consent|1|||
13312798|NCT01234883|26545531|FG001|Overall Study|Parent/guardian withdrew consent|2|||
13312799|NCT01234883|26545530|FG000|Overall Study|Technical difficulties with IV infusion|0|||
13312800|NCT01234883|26545531|FG001|Overall Study|Technical difficulties with IV infusion|1|||
13312801|NCT01234883|26545530|FG000|Overall Study|Inclusion/exclusion failure|1|||
13312802|NCT01234883|26545531|FG001|Overall Study|Inclusion/exclusion failure|0|||
13312803|NCT01234675|26545564|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
13312804|NCT01234675|26545565|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
13312805|NCT01234675|26545564|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
13312806|NCT01234675|26545565|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
13312807|NCT01234649|26545620|FG000|Overall Study|Withdrawal by Subject|32|||
13312808|NCT01234649|26545621|FG001|Overall Study|Withdrawal by Subject|26|||
13312809|NCT01234649|26545620|FG000|Overall Study|Pregnancy|6|||
13312810|NCT01234649|26545621|FG001|Overall Study|Pregnancy|6|||
13312811|NCT01234649|26545620|FG000|Overall Study|intolerant to side effects|4|||
13312812|NCT01234649|26545621|FG001|Overall Study|intolerant to side effects|3|||
13312813|NCT01234649|26545620|FG000|Overall Study|Allergic reaction|1|||
13312814|NCT01234649|26545621|FG001|Overall Study|Allergic reaction|0|||
13312815|NCT01234649|26545620|FG000|Overall Study|Lack of Efficacy|0|||
13312816|NCT01234649|26545621|FG001|Overall Study|Lack of Efficacy|3|||
13312817|NCT01234480|26545630|FG000|Overall Study|Pregnancy|88|||
13312818|NCT01234480|26545630|FG000|Overall Study|>36/Normal History|50|||
13312819|NCT01234480|26545630|FG000|Overall Study|Age|3|||
13312820|NCT01234480|26545630|FG000|Overall Study|HPV Vaccine History|28|||
13312821|NCT01234480|26545630|FG000|Overall Study|HPV Vaccine after Enrollment|17|||
13312822|NCT01234480|26545630|FG000|Overall Study|Hysterectomy|2|||
13312823|NCT01234480|26545630|FG000|Overall Study|Hysterectomy post enrollment|1|||
13312824|NCT01234480|26545630|FG000|Overall Study|Inclusion/Exclusion Violation|3|||
13312825|NCT01234480|26545630|FG000|Overall Study|Informed Consent Form Violation|30|||
13312826|NCT01234480|26545630|FG000|Overall Study|Incorrect Visit|3|||
13312827|NCT01234480|26545630|FG000|Overall Study|No Florida Lab License|20|||
13312828|NCT01234480|26545630|FG000|Overall Study|Out of Window|42|||
13312829|NCT01234480|26545630|FG000|Overall Study|Sample Processing/Storage|92|||
13312830|NCT01234480|26545630|FG000|Overall Study|Site Amendment prohibited colposcopy|11|||
13312831|NCT01234480|26545630|FG000|Overall Study|Site/Subject non-compliance|44|||
13312832|NCT01234480|26545630|FG000|Overall Study|Missing Sample|9|||
13312833|NCT01234467|26545641|FG000|Overall Study|Adverse Event|3|||
13312834|NCT01234467|26545641|FG000|Overall Study|Death|2|||
13312835|NCT01234467|26545641|FG000|Overall Study|Withdrawal by Subject|2|||
13312836|NCT01234467|26545641|FG000|Overall Study|Disease Progression|2|||
13312837|NCT01234467|26545641|FG000|Overall Study|Clinical deterioration|1|||
13312838|NCT01234467|26545641|FG000|Overall Study|Physician Decision|1|||
13312839|NCT01234467|26545641|FG000|Overall Study|Other complicating disease (stroke)|1|||
13312840|NCT01234402|26545690|FG000|Overall Study|Lost to Follow-up|0|||
13312841|NCT01234402|26545691|FG001|Overall Study|Lost to Follow-up|1|||
13312842|NCT01234402|26545692|FG002|Overall Study|Lost to Follow-up|3|||
13312843|NCT01234402|26545690|FG000|Overall Study|Withdrawal by Subject|1|||
13312844|NCT01234402|26545691|FG001|Overall Study|Withdrawal by Subject|3|||
13312845|NCT01234402|26545692|FG002|Overall Study|Withdrawal by Subject|4|||
13312846|NCT01234402|26545690|FG000|Overall Study|Never treated: Death|0|||
13312847|NCT01234402|26545691|FG001|Overall Study|Never treated: Death|0|||
13312848|NCT01234402|26545692|FG002|Overall Study|Never treated: Death|1|||
13312849|NCT01234402|26545690|FG000|Overall Study|Never treated: Withdrawal By Subject|0|||
13312850|NCT01234402|26545691|FG001|Overall Study|Never treated: Withdrawal By Subject|1|||
13312851|NCT01234402|26545692|FG002|Overall Study|Never treated: Withdrawal By Subject|0|||
13312852|NCT01234402|26545690|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0|||
13312853|NCT01234402|26545691|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1|||
13312854|NCT01234402|26545692|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0|||
13312855|NCT01234350|26545723|FG000|Overall Study|Adverse Event|277|||
13312856|NCT01234350|26545724|FG001|Overall Study|Adverse Event|92|||
13312857|NCT01234350|26545723|FG000|Overall Study|Withdrawal by Subject|61|||
13312858|NCT01234350|26545724|FG001|Overall Study|Withdrawal by Subject|36|||
13312859|NCT01234350|26545723|FG000|Overall Study|Lost to Follow-up|115|||
13312860|NCT01234350|26545724|FG001|Overall Study|Lost to Follow-up|47|||
13312861|NCT01234350|26545723|FG000|Overall Study|Covers a diverse set of reasons|234|||
13312862|NCT01234350|26545724|FG001|Overall Study|Covers a diverse set of reasons|92|||
13312863|NCT01234337|26545759|FG000|Overall Study|Adverse Event|58|||
13312864|NCT01234337|26545760|FG001|Overall Study|Adverse Event|21|||
13312865|NCT01234337|26545759|FG000|Overall Study|Disease progression/recurrence/relapse|181|||
13312866|NCT01234337|26545760|FG001|Overall Study|Disease progression/recurrence/relapse|223|||
13312867|NCT01234337|26545759|FG000|Overall Study|Investi. decision not protocol driven|5|||
13312868|NCT01234337|26545760|FG001|Overall Study|Investi. decision not protocol driven|6|||
13312869|NCT01234337|26545759|FG000|Overall Study|Non-compliant with study medication|3|||
13312870|NCT01234337|26545760|FG001|Overall Study|Non-compliant with study medication|2|||
13312871|NCT01234337|26545759|FG000|Overall Study|Randomized but not treated|6|||
13312872|NCT01234337|26545760|FG001|Overall Study|Randomized but not treated|4|||
13312873|NCT01234337|26545759|FG000|Overall Study|Lost to Follow-up|0|||
13312874|NCT01234337|26545760|FG001|Overall Study|Lost to Follow-up|1|||
13312875|NCT01234337|26545759|FG000|Overall Study|Protocol Violation|2|||
13312876|NCT01234337|26545760|FG001|Overall Study|Protocol Violation|3|||
13312877|NCT01234337|26545759|FG000|Overall Study|Withdrawal by Subject|11|||
13312878|NCT01234337|26545760|FG001|Overall Study|Withdrawal by Subject|9|||
13312879|NCT01234337|26545759|FG000|Overall Study|Death|0|||
13312880|NCT01234337|26545760|FG001|Overall Study|Death|1|||
13312881|NCT01234337|26545759|FG000|Overall Study|Switch to commercial drug|0|||
13312882|NCT01234337|26545760|FG001|Overall Study|Switch to commercial drug|1|||
13312883|NCT01233999|26545766|FG000|Overall Study|Withdrawal by Subject|1|||
13312884|NCT01233999|26545766|FG000|Overall Study|Lost to Follow-up|1|||
13312885|NCT01233869|26545865|FG000|Initial Treatment Period (24 Months)|Death|1|||
13312886|NCT01233869|26545866|FG001|Initial Treatment Period (24 Months)|Death|0|||
13312887|NCT01233869|26545867|FG002|Initial Treatment Period (24 Months)|Death|0|||
13312888|NCT01233869|26545868|FG003|Initial Treatment Period (24 Months)|Death|0|||
13312889|NCT01233869|26545865|FG000|Initial Treatment Period (24 Months)|Adverse Event|9|||
13312890|NCT01233869|26545866|FG001|Initial Treatment Period (24 Months)|Adverse Event|17|||
13312891|NCT01233869|26545867|FG002|Initial Treatment Period (24 Months)|Adverse Event|0|||
13312892|NCT01233869|26545868|FG003|Initial Treatment Period (24 Months)|Adverse Event|3|||
13312893|NCT01233869|26545865|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14|||
13312894|NCT01233869|26545866|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11|||
13312895|NCT01233869|26545867|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2|||
13312896|NCT01233869|26545868|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19|||
13312897|NCT01233869|26545865|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
13312898|NCT01233869|26545866|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
13312899|NCT01233869|26545867|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
13312900|NCT01233869|26545868|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1|||
13312901|NCT01233869|26545865|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10|||
13312902|NCT01233869|26545866|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3|||
13312903|NCT01233869|26545867|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5|||
13312904|NCT01233869|26545868|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11|||
13312905|NCT01233869|26545865|FG000|Extended Treatment Period (46 Months)|Other|3|||
13312906|NCT01233869|26545866|FG001|Extended Treatment Period (46 Months)|Other|0|||
13312907|NCT01233869|26545867|FG002|Extended Treatment Period (46 Months)|Other|0|||
13312908|NCT01233869|26545868|FG003|Extended Treatment Period (46 Months)|Other|3|||
13312909|NCT01233869|26545865|FG000|Extended Treatment Period (46 Months)|Adverse Event|1|||
13312910|NCT01233869|26545866|FG001|Extended Treatment Period (46 Months)|Adverse Event|0|||
13312911|NCT01233869|26545867|FG002|Extended Treatment Period (46 Months)|Adverse Event|0|||
13312912|NCT01233869|26545868|FG003|Extended Treatment Period (46 Months)|Adverse Event|1|||
13312913|NCT01233817|26545874|FG000|Overall Study|Lost to Follow-up|1|||
13312914|NCT01233817|26545874|FG000|Overall Study|Withdrawal by Subject|2|||
13312915|NCT01233687|26545884|FG000|Phase II AMG 102 + Erlotinib|Death|1|||
13312916|NCT01233687|26545884|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2|||
13312917|NCT01233687|26545884|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1|||
13312918|NCT01233609|26545915|FG000|Overall Study|Death|1|||
13312919|NCT01233609|26545916|FG001|Overall Study|Death|0|||
13312920|NCT01233609|26545915|FG000|Overall Study|Lost to Follow-up|3|||
13312921|NCT01233609|26545916|FG001|Overall Study|Lost to Follow-up|1|||
13312922|NCT01233609|26545915|FG000|Overall Study|Adverse Event|2|||
13312923|NCT01233609|26545916|FG001|Overall Study|Adverse Event|1|||
13312924|NCT01233609|26545915|FG000|Overall Study|Withdrawal by Subject|3|||
13312925|NCT01233609|26545916|FG001|Overall Study|Withdrawal by Subject|0|||
13312926|NCT01233284|26546000|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1|||
13312927|NCT01233284|26546001|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0|||
13312928|NCT01233284|26546002|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0|||
13312929|NCT01233284|26546003|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
13312930|NCT01233284|26546004|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
13312931|NCT01233284|26546000|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
13312932|NCT01233284|26546001|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
13312933|NCT01233284|26546002|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
13312934|NCT01233284|26546003|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
13312935|NCT01233284|26546004|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
13312936|NCT01233284|26546000|FG000|Period 1 (4 Weeks)|Other|0|||
13312937|NCT01233284|26546001|FG001|Period 1 (4 Weeks)|Other|0|||
13312938|NCT01233284|26546002|FG002|Period 1 (4 Weeks)|Other|1|||
13312939|NCT01233284|26546003|FG003|Period 1 (4 Weeks)|Other|0|||
13312940|NCT01233284|26546004|FG004|Period 1 (4 Weeks)|Other|0|||
13312941|NCT01233284|26546000|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
13312942|NCT01233284|26546001|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
13312943|NCT01233284|26546002|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1|||
13312944|NCT01233284|26546003|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
13312945|NCT01233284|26546004|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
13312946|NCT01233284|26546000|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
13312947|NCT01233284|26546001|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
13312948|NCT01233284|26546002|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
13312949|NCT01233284|26546003|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
13312950|NCT01233284|26546004|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
13312951|NCT01233284|26546000|FG000|Period 3 (4 Weeks)|Other|0|||
13312952|NCT01233284|26546001|FG001|Period 3 (4 Weeks)|Other|0|||
13312953|NCT01233284|26546002|FG002|Period 3 (4 Weeks)|Other|0|||
13312954|NCT01233284|26546003|FG003|Period 3 (4 Weeks)|Other|1|||
13312955|NCT01233284|26546004|FG004|Period 3 (4 Weeks)|Other|0|||
13312956|NCT01233284|26546000|FG000|Period 4 (4 Weeks)|Adverse Event|0|||
13312957|NCT01233284|26546001|FG001|Period 4 (4 Weeks)|Adverse Event|1|||
13312958|NCT01233284|26546002|FG002|Period 4 (4 Weeks)|Adverse Event|0|||
13312959|NCT01233284|26546003|FG003|Period 4 (4 Weeks)|Adverse Event|0|||
13312960|NCT01233284|26546004|FG004|Period 4 (4 Weeks)|Adverse Event|0|||
13312961|NCT01233284|26546000|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0|||
13312962|NCT01233284|26546001|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0|||
13312963|NCT01233284|26546002|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0|||
13312964|NCT01233284|26546003|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1|||
13312965|NCT01233284|26546004|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0|||
13312966|NCT01233258|26546034|FG000|First Intervention (6 Months)|Withdrawal by Subject|0|||
13312967|NCT01233258|26546035|FG001|First Intervention (6 Months)|Withdrawal by Subject|0|||
13312968|NCT01233258|26546036|FG002|First Intervention (6 Months)|Withdrawal by Subject|0|||
13312969|NCT01233258|26546037|FG003|First Intervention (6 Months)|Withdrawal by Subject|1|||
13312970|NCT01233258|26546038|FG004|First Intervention (6 Months)|Withdrawal by Subject|0|||
13312971|NCT01233258|26546039|FG005|First Intervention (6 Months)|Withdrawal by Subject|1|||
13312972|NCT01233258|26546034|FG000|First Intervention (6 Months)|Protocol Violation|0|||
13312973|NCT01233258|26546035|FG001|First Intervention (6 Months)|Protocol Violation|0|||
13312974|NCT01233258|26546036|FG002|First Intervention (6 Months)|Protocol Violation|1|||
13312975|NCT01233258|26546037|FG003|First Intervention (6 Months)|Protocol Violation|0|||
13312976|NCT01233258|26546038|FG004|First Intervention (6 Months)|Protocol Violation|0|||
13312977|NCT01233258|26546039|FG005|First Intervention (6 Months)|Protocol Violation|0|||
13312978|NCT01233258|26546034|FG000|First Intervention (6 Months)|Non-compliance with study medication|1|||
13312979|NCT01233258|26546035|FG001|First Intervention (6 Months)|Non-compliance with study medication|0|||
13312980|NCT01233258|26546036|FG002|First Intervention (6 Months)|Non-compliance with study medication|0|||
13312981|NCT01233258|26546037|FG003|First Intervention (6 Months)|Non-compliance with study medication|0|||
13312982|NCT01233258|26546038|FG004|First Intervention (6 Months)|Non-compliance with study medication|0|||
13312983|NCT01233258|26546039|FG005|First Intervention (6 Months)|Non-compliance with study medication|0|||
13312984|NCT01233232|26546102|FG000|Overall Study|Voluntary Discontinuation by Subject|1|||
13312985|NCT01233232|26546103|FG001|Overall Study|Voluntary Discontinuation by Subject|0|||
13312986|NCT01233232|26546104|FG002|Overall Study|Voluntary Discontinuation by Subject|0|||
13312987|NCT01233076|26546113|FG000|Period 2, One Week|Lost to Follow-up|1|||
13312988|NCT01233076|26546114|FG001|Period 2, One Week|Lost to Follow-up|0|||
13312989|NCT01233050|26546137|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8|||
13312990|NCT01233050|26546138|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6|||
13312991|NCT01232894|26546151|FG000|Overall Study|Lost to Follow-up|0|||
13312992|NCT01232894|26546152|FG001|Overall Study|Lost to Follow-up|1|||
13312993|NCT01232894|26546151|FG000|Overall Study|Death|1|||
13312994|NCT01232894|26546152|FG001|Overall Study|Death|0|||
13312995|NCT01232894|26546151|FG000|Overall Study|Protocol Violation|1|||
13312996|NCT01232894|26546152|FG001|Overall Study|Protocol Violation|1|||
13312997|NCT01232894|26546151|FG000|Overall Study|Withdrawal by Subject|8|||
13312998|NCT01232894|26546152|FG001|Overall Study|Withdrawal by Subject|5|||
13312999|NCT01232894|26546151|FG000|Overall Study|Physician Decision|2|||
13313000|NCT01232894|26546152|FG001|Overall Study|Physician Decision|1|||
13313001|NCT01232868|26546167|FG000|Overall Study|Lost to Follow-up|2|||
13313002|NCT01232868|26546168|FG001|Overall Study|Lost to Follow-up|4|||
13313003|NCT01232790|26546225|FG000|Randomization|Withdrawal by Subject|2|||
13313004|NCT01232790|26546226|FG001|Randomization|Withdrawal by Subject|0|||
13313005|NCT01232790|26546225|FG000|Randomization|Protocol Violation|0|||
13313006|NCT01232790|26546226|FG001|Randomization|Protocol Violation|1|||
13313007|NCT01232790|26546225|FG000|Randomization|Physician Decision|0|||
13313008|NCT01232790|26546226|FG001|Randomization|Physician Decision|1|||
13313009|NCT01232790|26546225|FG000|Initial Assessment|Withdrawal by Subject|0|||
13313010|NCT01232790|26546226|FG001|Initial Assessment|Withdrawal by Subject|1|||
13313011|NCT01232790|26546225|FG000|First Crossover|Withdrawal by Subject|1|||
13313012|NCT01232790|26546226|FG001|First Crossover|Withdrawal by Subject|0|||
13313013|NCT01232790|26546225|FG000|Second Crossover|Withdrawal by Subject|1|||
13313014|NCT01232790|26546226|FG001|Second Crossover|Withdrawal by Subject|2|||
13313015|NCT01232738|26546242|FG000|Overall Study|Death|3|||
13313016|NCT01232738|26546242|FG000|Overall Study|Physician Decision|2|||
13313017|NCT01232738|26546242|FG000|Overall Study|Lost to Follow-up|1|||
13313018|NCT01232738|26546242|FG000|Overall Study|Withdrawal by Subject|2|||
13313019|NCT01232738|26546242|FG000|Overall Study|Adverse Event|5|||
13372992|NCT00805935|26722480|FG003|Overall Study|Cycle cancellation for risk of OHSS|0|||
13372993|NCT00805935|26722477|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
13372994|NCT00805935|26722478|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
13372995|NCT00805935|26722479|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
13372996|NCT00805935|26722480|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1|||
13372997|NCT00805935|26722477|FG000|Overall Study|Lost to Follow-up|1|||
13372998|NCT00805935|26722478|FG001|Overall Study|Lost to Follow-up|0|||
13372999|NCT00805935|26722479|FG002|Overall Study|Lost to Follow-up|0|||
13313020|NCT01232569|26546292|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
13313021|NCT01232569|26546293|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
13313022|NCT01232569|26546294|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
13313023|NCT01232569|26546295|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
13313024|NCT01232569|26546292|FG000|Double-blind Treatment Period|Escape|2|||
13313025|NCT01232569|26546293|FG001|Double-blind Treatment Period|Escape|2|||
13313026|NCT01232569|26546294|FG002|Double-blind Treatment Period|Escape|0|||
13313027|NCT01232569|26546295|FG003|Double-blind Treatment Period|Escape|0|||
13313028|NCT01232569|26546292|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
13313029|NCT01232569|26546293|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
13313030|NCT01232569|26546294|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
13313031|NCT01232569|26546295|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
13313032|NCT01232569|26546292|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
13313033|NCT01232569|26546293|FG001|Double-blind Treatment Period|Lack of Efficacy|2|||
13313034|NCT01232569|26546294|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
13313035|NCT01232569|26546295|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
13313036|NCT01232569|26546292|FG000|Double-blind Treatment Period|Physician Decision|1|||
13313037|NCT01232569|26546293|FG001|Double-blind Treatment Period|Physician Decision|0|||
13313038|NCT01232569|26546294|FG002|Double-blind Treatment Period|Physician Decision|0|||
13313039|NCT01232569|26546295|FG003|Double-blind Treatment Period|Physician Decision|0|||
13313040|NCT01232569|26546292|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9|||
13313041|NCT01232569|26546293|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3|||
13313042|NCT01232569|26546294|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
13313043|NCT01232569|26546295|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
13313044|NCT01232569|26546292|FG000|Double-blind Treatment Period|Death|2|||
13313045|NCT01232569|26546293|FG001|Double-blind Treatment Period|Death|0|||
13313046|NCT01232569|26546294|FG002|Double-blind Treatment Period|Death|0|||
13313047|NCT01232569|26546295|FG003|Double-blind Treatment Period|Death|0|||
13313048|NCT01232556|26546322|FG000|Overall Study|Withdrawal by Subject|21|||
13313049|NCT01232556|26546323|FG001|Overall Study|Withdrawal by Subject|17|||
13313050|NCT01232556|26546322|FG000|Overall Study|Death|97|||
13313051|NCT01232556|26546323|FG001|Overall Study|Death|97|||
13313052|NCT01232556|26546322|FG000|Overall Study|Lost to Follow-up|0|||
13313053|NCT01232556|26546323|FG001|Overall Study|Lost to Follow-up|2|||
13313054|NCT01232556|26546322|FG000|Overall Study|Terminated by Sponsor|35|||
13313055|NCT01232556|26546323|FG001|Overall Study|Terminated by Sponsor|51|||
13313056|NCT01232556|26546322|FG000|Overall Study|Other|6|||
13313057|NCT01232556|26546323|FG001|Overall Study|Other|4|||
13313058|NCT01232491|26546348|FG000|Overall Study|Adverse Event|13|||
13313059|NCT01232491|26546349|FG001|Overall Study|Adverse Event|8|||
13313060|NCT01232491|26546348|FG000|Overall Study|Lack of Efficacy|1|||
13313061|NCT01232491|26546349|FG001|Overall Study|Lack of Efficacy|5|||
13313062|NCT01232491|26546348|FG000|Overall Study|Protocol Violation|13|||
13313063|NCT01232491|26546349|FG001|Overall Study|Protocol Violation|11|||
13313064|NCT01232491|26546348|FG000|Overall Study|Withdrawal Criteria|12|||
13313065|NCT01232491|26546349|FG001|Overall Study|Withdrawal Criteria|21|||
13313066|NCT01232491|26546348|FG000|Overall Study|Other|21|||
13313067|NCT01232491|26546349|FG001|Overall Study|Other|18|||
13313068|NCT01232452|26546380|FG000|Overall Study|Adverse Event|17|||
13313069|NCT01232452|26546381|FG001|Overall Study|Adverse Event|15|||
13313070|NCT01232452|26546380|FG000|Overall Study|Withdrawal by Subject|11|||
13313071|NCT01232452|26546381|FG001|Overall Study|Withdrawal by Subject|8|||
13313072|NCT01232452|26546380|FG000|Overall Study|Physician Decision|8|||
13313073|NCT01232452|26546381|FG001|Overall Study|Physician Decision|12|||
13313074|NCT01232452|26546380|FG000|Overall Study|Protocol entry criterion not met|0|||
13313075|NCT01232452|26546381|FG001|Overall Study|Protocol entry criterion not met|2|||
13313076|NCT01232452|26546380|FG000|Overall Study|Sponsor Decision|3|||
13313077|NCT01232452|26546381|FG001|Overall Study|Sponsor Decision|1|||
13313078|NCT01232452|26546380|FG000|Overall Study|Protocol Violation|0|||
13313079|NCT01232452|26546381|FG001|Overall Study|Protocol Violation|1|||
13313080|NCT01232296|26546403|FG000|Overall Study|Adverse Event|24|||
13313081|NCT01232296|26546404|FG001|Overall Study|Adverse Event|12|||
13313082|NCT01232296|26546403|FG000|Overall Study|Physician Decision|1|||
13313083|NCT01232296|26546404|FG001|Overall Study|Physician Decision|1|||
13313084|NCT01232296|26546403|FG000|Overall Study|Progressive disease|43|||
13313085|NCT01232296|26546404|FG001|Overall Study|Progressive disease|61|||
13313086|NCT01232296|26546403|FG000|Overall Study|Study terminated by sponsor|0|||
13313087|NCT01232296|26546404|FG001|Overall Study|Study terminated by sponsor|1|||
13313088|NCT01232296|26546403|FG000|Overall Study|Technical problems|3|||
13313089|NCT01232296|26546404|FG001|Overall Study|Technical problems|0|||
13313090|NCT01232296|26546403|FG000|Overall Study|Subject/guardian decision|10|||
13313091|NCT01232296|26546404|FG001|Overall Study|Subject/guardian decision|2|||
13313092|NCT01232296|26546403|FG000|Overall Study|Death|1|||
13313093|NCT01232296|26546404|FG001|Overall Study|Death|6|||
13313094|NCT01232283|26546451|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12|||
13373000|NCT00805935|26722480|FG003|Overall Study|Lost to Follow-up|0|||
13313095|NCT01232283|26546452|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8|||
13313096|NCT01232283|26546453|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
13313097|NCT01232283|26546454|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
13313098|NCT01232283|26546455|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
13313099|NCT01232283|26546456|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
13313100|NCT01232283|26546457|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
13313101|NCT01232283|26546458|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
13313102|NCT01232283|26546459|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
13313103|NCT01232283|26546460|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
13313104|NCT01232283|26546451|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3|||
13313105|NCT01232283|26546452|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2|||
13313106|NCT01232283|26546453|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
13313107|NCT01232283|26546454|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
13313108|NCT01232283|26546455|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
13313109|NCT01232283|26546456|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
13313110|NCT01232283|26546457|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
13313111|NCT01232283|26546458|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
13313112|NCT01232283|26546459|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
13313113|NCT01232283|26546460|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
13313114|NCT01232283|26546451|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1|||
13313115|NCT01232283|26546452|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
13313116|NCT01232283|26546453|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
13313117|NCT01232283|26546454|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
13313118|NCT01232283|26546455|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
13313119|NCT01232283|26546456|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
13313120|NCT01232283|26546457|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
13313121|NCT01232283|26546458|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
13313122|NCT01232283|26546459|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
13313123|NCT01232283|26546460|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
13313124|NCT01232283|26546451|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9|||
13313125|NCT01232283|26546452|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7|||
13313126|NCT01232283|26546453|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
13313127|NCT01232283|26546454|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
13313128|NCT01232283|26546455|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
13313129|NCT01232283|26546456|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
13313130|NCT01232283|26546457|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
13313131|NCT01232283|26546458|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
13313132|NCT01232283|26546459|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
13313133|NCT01232283|26546460|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
13313134|NCT01232283|26546451|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
13313135|NCT01232283|26546452|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
13313136|NCT01232283|26546453|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
13313137|NCT01232283|26546454|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
13313138|NCT01232283|26546455|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
13313139|NCT01232283|26546456|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
13313140|NCT01232283|26546457|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
13313141|NCT01232283|26546458|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
13313142|NCT01232283|26546459|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
13313143|NCT01232283|26546460|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
13313144|NCT01232283|26546451|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3|||
13313145|NCT01232283|26546452|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2|||
13313146|NCT01232283|26546453|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
13313147|NCT01232283|26546454|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
13313148|NCT01232283|26546455|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
13313149|NCT01232283|26546456|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
13313150|NCT01232283|26546457|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
13313151|NCT01232283|26546458|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
13313152|NCT01232283|26546459|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
13313153|NCT01232283|26546460|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
13313154|NCT01232283|26546451|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2|||
13313155|NCT01232283|26546452|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1|||
13313156|NCT01232283|26546453|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
13313157|NCT01232283|26546454|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
13313158|NCT01232283|26546455|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
13313159|NCT01232283|26546456|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
13313160|NCT01232283|26546457|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
13313161|NCT01232283|26546458|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
13313162|NCT01232283|26546459|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
13313163|NCT01232283|26546460|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
13313164|NCT01232283|26546451|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
13313165|NCT01232283|26546452|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
13313166|NCT01232283|26546453|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8|||
13313167|NCT01232283|26546454|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2|||
13313168|NCT01232283|26546455|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
13313169|NCT01232283|26546456|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
13313170|NCT01232283|26546457|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
13313171|NCT01232283|26546458|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
13313172|NCT01232283|26546459|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
13313173|NCT01232283|26546460|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
13313174|NCT01232283|26546451|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
13313175|NCT01232283|26546452|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
13313176|NCT01232283|26546453|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19|||
13313177|NCT01232283|26546454|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3|||
13313178|NCT01232283|26546455|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
13313179|NCT01232283|26546456|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
13313180|NCT01232283|26546457|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
13313181|NCT01232283|26546458|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
13313182|NCT01232283|26546459|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
13313183|NCT01232283|26546460|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
13313184|NCT01232283|26546451|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
13313185|NCT01232283|26546452|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
13313186|NCT01232283|26546453|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1|||
13313187|NCT01232283|26546454|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
13313188|NCT01232283|26546455|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
13313189|NCT01232283|26546456|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
13313190|NCT01232283|26546457|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
13313191|NCT01232283|26546458|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
13313192|NCT01232283|26546459|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
13313193|NCT01232283|26546460|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
13313194|NCT01232283|26546451|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
13313195|NCT01232283|26546452|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
13313196|NCT01232283|26546453|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7|||
13313197|NCT01232283|26546454|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1|||
13313198|NCT01232283|26546455|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
13313199|NCT01232283|26546456|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
13313200|NCT01232283|26546457|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
13313201|NCT01232283|26546458|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
13313202|NCT01232283|26546459|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
13313203|NCT01232283|26546460|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
13313204|NCT01232283|26546451|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
13313205|NCT01232283|26546452|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
13313206|NCT01232283|26546453|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3|||
13313207|NCT01232283|26546454|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2|||
13313208|NCT01232283|26546455|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
13313209|NCT01232283|26546456|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
13313210|NCT01232283|26546457|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
13313211|NCT01232283|26546458|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
13313212|NCT01232283|26546459|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
13313213|NCT01232283|26546460|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
13313214|NCT01232283|26546451|FG000|Maintenance Phase (Weeks16-32)|Other|0|||
13313215|NCT01232283|26546452|FG001|Maintenance Phase (Weeks16-32)|Other|0|||
13313216|NCT01232283|26546453|FG002|Maintenance Phase (Weeks16-32)|Other|2|||
13313217|NCT01232283|26546454|FG003|Maintenance Phase (Weeks16-32)|Other|0|||
13313218|NCT01232283|26546455|FG004|Maintenance Phase (Weeks16-32)|Other|0|||
13313219|NCT01232283|26546456|FG005|Maintenance Phase (Weeks16-32)|Other|0|||
13313220|NCT01232283|26546457|FG006|Maintenance Phase (Weeks16-32)|Other|0|||
13313221|NCT01232283|26546458|FG007|Maintenance Phase (Weeks16-32)|Other|0|||
13313222|NCT01232283|26546459|FG008|Maintenance Phase (Weeks16-32)|Other|0|||
13313223|NCT01232283|26546460|FG009|Maintenance Phase (Weeks16-32)|Other|0|||
13313224|NCT01232283|26546451|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
13313225|NCT01232283|26546452|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
13313226|NCT01232283|26546453|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
13313227|NCT01232283|26546454|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
13313228|NCT01232283|26546455|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2|||
13313229|NCT01232283|26546456|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
13313230|NCT01232283|26546457|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
13313231|NCT01232283|26546458|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
13313232|NCT01232283|26546459|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
13313233|NCT01232283|26546460|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
13313234|NCT01232283|26546451|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
13313235|NCT01232283|26546452|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
13313236|NCT01232283|26546453|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
13313237|NCT01232283|26546454|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
13313238|NCT01232283|26546455|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4|||
13313239|NCT01232283|26546456|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
13313240|NCT01232283|26546457|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13|||
13313241|NCT01232283|26546458|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5|||
13313242|NCT01232283|26546459|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
13313243|NCT01232283|26546460|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
13313244|NCT01232283|26546451|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
13313245|NCT01232283|26546452|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
13313246|NCT01232283|26546453|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
13313247|NCT01232283|26546454|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
13313248|NCT01232283|26546455|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
13313249|NCT01232283|26546456|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
13313250|NCT01232283|26546457|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
13313251|NCT01232283|26546458|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4|||
13313252|NCT01232283|26546459|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
13313253|NCT01232283|26546460|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
13313254|NCT01232283|26546451|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
13313255|NCT01232283|26546452|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
13313256|NCT01232283|26546453|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
13313257|NCT01232283|26546454|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
13313258|NCT01232283|26546455|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1|||
13313259|NCT01232283|26546456|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
13313260|NCT01232283|26546457|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
13313261|NCT01232283|26546458|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
13313262|NCT01232283|26546459|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
13313263|NCT01232283|26546460|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
13313264|NCT01232283|26546451|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
13313265|NCT01232283|26546452|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
13313266|NCT01232283|26546453|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
13313267|NCT01232283|26546454|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
13313268|NCT01232283|26546455|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2|||
13313269|NCT01232283|26546456|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
13313270|NCT01232283|26546457|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
13313271|NCT01232283|26546458|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
13313272|NCT01232283|26546459|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
13313273|NCT01232283|26546460|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
13313274|NCT01232283|26546451|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
13313275|NCT01232283|26546452|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
13313276|NCT01232283|26546453|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
13313277|NCT01232283|26546454|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
13313278|NCT01232283|26546455|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
13313279|NCT01232283|26546456|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
13313280|NCT01232283|26546457|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
13313281|NCT01232283|26546458|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1|||
13313282|NCT01232283|26546459|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
13313283|NCT01232283|26546460|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
13313284|NCT01232283|26546451|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
13313285|NCT01232283|26546452|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
13313286|NCT01232283|26546453|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
13313287|NCT01232283|26546454|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
13313288|NCT01232283|26546455|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
13313289|NCT01232283|26546456|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1|||
13313290|NCT01232283|26546457|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
13313291|NCT01232283|26546458|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
13313292|NCT01232283|26546459|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
13313293|NCT01232283|26546460|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
13313294|NCT01232283|26546451|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
13313295|NCT01232283|26546452|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
13313296|NCT01232283|26546453|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
13313297|NCT01232283|26546454|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
13313298|NCT01232283|26546455|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
13313299|NCT01232283|26546456|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
13313300|NCT01232283|26546457|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
13313301|NCT01232283|26546458|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
13313302|NCT01232283|26546459|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11|||
13313303|NCT01232283|26546460|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6|||
13313304|NCT01232283|26546451|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
13313305|NCT01232283|26546452|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
13313306|NCT01232283|26546453|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
13313307|NCT01232283|26546454|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
13313308|NCT01232283|26546455|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
13313309|NCT01232283|26546456|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
13313310|NCT01232283|26546457|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
13313311|NCT01232283|26546458|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
13313312|NCT01232283|26546459|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46|||
13313313|NCT01232283|26546460|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30|||
13313314|NCT01232283|26546451|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
13313315|NCT01232283|26546452|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
13313316|NCT01232283|26546453|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
13313317|NCT01232283|26546454|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
13313318|NCT01232283|26546455|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
13313319|NCT01232283|26546456|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
13313320|NCT01232283|26546457|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
13313321|NCT01232283|26546458|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
13313322|NCT01232283|26546459|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3|||
13313323|NCT01232283|26546460|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2|||
13313324|NCT01232283|26546451|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
13313325|NCT01232283|26546452|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
13313326|NCT01232283|26546453|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
13313327|NCT01232283|26546454|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
13313328|NCT01232283|26546455|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
13313329|NCT01232283|26546456|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
13313330|NCT01232283|26546457|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
13313331|NCT01232283|26546458|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
13313332|NCT01232283|26546459|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30|||
13313333|NCT01232283|26546460|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14|||
13313334|NCT01232283|26546451|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
13313335|NCT01232283|26546452|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
13313336|NCT01232283|26546453|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
13313337|NCT01232283|26546454|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
13313338|NCT01232283|26546455|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
13313339|NCT01232283|26546456|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
13313340|NCT01232283|26546457|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
13313341|NCT01232283|26546458|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
13313342|NCT01232283|26546459|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9|||
13313343|NCT01232283|26546460|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6|||
13313344|NCT01232283|26546451|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
13313345|NCT01232283|26546452|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
13313346|NCT01232283|26546453|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
13313347|NCT01232283|26546454|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
13313348|NCT01232283|26546455|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
13313349|NCT01232283|26546456|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
13313350|NCT01232283|26546457|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
13313351|NCT01232283|26546458|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
13313352|NCT01232283|26546459|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1|||
13313353|NCT01232283|26546460|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
13313354|NCT01232283|26546451|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
13313355|NCT01232283|26546452|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
13313356|NCT01232283|26546453|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
13313357|NCT01232283|26546454|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
13313358|NCT01232283|26546455|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
13313359|NCT01232283|26546456|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
13313360|NCT01232283|26546457|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
13313361|NCT01232283|26546458|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
13313362|NCT01232283|26546459|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1|||
13313363|NCT01232283|26546460|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
13313364|NCT01232283|26546451|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
13313365|NCT01232283|26546452|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
13313366|NCT01232283|26546453|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
13313367|NCT01232283|26546454|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
13313368|NCT01232283|26546455|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
13313369|NCT01232283|26546456|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
13313370|NCT01232283|26546457|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
13313371|NCT01232283|26546458|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
13313372|NCT01232283|26546459|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7|||
13313373|NCT01232283|26546460|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3|||
13313374|NCT01232127|26546486|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1|||
13313375|NCT01232127|26546487|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0|||
13313376|NCT01232127|26546488|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0|||
13313377|NCT01231984|26546518|FG000|Study Period 1|Withdrawal by Subject|0|||
13313378|NCT01231984|26546519|FG001|Study Period 1|Withdrawal by Subject|0|||
13313379|NCT01231984|26546520|FG002|Study Period 1|Withdrawal by Subject|0|||
13313380|NCT01231984|26546521|FG003|Study Period 1|Withdrawal by Subject|1|||
13313381|NCT01231984|26546518|FG000|Study Period 1|Lost to Follow-up|1|||
13313382|NCT01231984|26546519|FG001|Study Period 1|Lost to Follow-up|1|||
13313383|NCT01231984|26546520|FG002|Study Period 1|Lost to Follow-up|1|||
13313384|NCT01231984|26546521|FG003|Study Period 1|Lost to Follow-up|0|||
13313385|NCT01231984|26546518|FG000|Study Period 1|Did not continue to meet I/E Criteria|2|||
13313386|NCT01231984|26546519|FG001|Study Period 1|Did not continue to meet I/E Criteria|2|||
13313387|NCT01231984|26546520|FG002|Study Period 1|Did not continue to meet I/E Criteria|2|||
13313388|NCT01231984|26546521|FG003|Study Period 1|Did not continue to meet I/E Criteria|2|||
13313389|NCT01231984|26546518|FG000|Study Period 1|Screen Failure|0|||
13313390|NCT01231984|26546519|FG001|Study Period 1|Screen Failure|0|||
13313391|NCT01231984|26546520|FG002|Study Period 1|Screen Failure|0|||
13313392|NCT01231984|26546521|FG003|Study Period 1|Screen Failure|1|||
13313393|NCT01231984|26546518|FG000|Study Period 1|Non-compliance with study requirements|5|||
13313394|NCT01231984|26546519|FG001|Study Period 1|Non-compliance with study requirements|0|||
13313395|NCT01231984|26546520|FG002|Study Period 1|Non-compliance with study requirements|2|||
13313396|NCT01231984|26546521|FG003|Study Period 1|Non-compliance with study requirements|1|||
13313397|NCT01231984|26546518|FG000|Study Period 1|Protocol Violation|3|||
13313398|NCT01231984|26546519|FG001|Study Period 1|Protocol Violation|4|||
13313399|NCT01231984|26546520|FG002|Study Period 1|Protocol Violation|2|||
13313400|NCT01231984|26546521|FG003|Study Period 1|Protocol Violation|3|||
13313401|NCT01231984|26546518|FG000|Study Period 1|Adverse Event|1|||
13313402|NCT01231984|26546519|FG001|Study Period 1|Adverse Event|0|||
13313403|NCT01231984|26546520|FG002|Study Period 1|Adverse Event|0|||
13313404|NCT01231984|26546521|FG003|Study Period 1|Adverse Event|0|||
13313405|NCT01231984|26546518|FG000|Study Period 1|Other|0|||
13313406|NCT01231984|26546519|FG001|Study Period 1|Other|0|||
13313407|NCT01231984|26546520|FG002|Study Period 1|Other|0|||
13313408|NCT01231984|26546521|FG003|Study Period 1|Other|1|||
13313409|NCT01231984|26546518|FG000|Study Period 2|Withdrawal by Subject|1|||
13313410|NCT01231984|26546519|FG001|Study Period 2|Withdrawal by Subject|1|||
13313411|NCT01231984|26546520|FG002|Study Period 2|Withdrawal by Subject|0|||
13313412|NCT01231984|26546521|FG003|Study Period 2|Withdrawal by Subject|0|||
13313413|NCT01231984|26546518|FG000|Study Period 2|Lost to Follow-up|1|||
13313414|NCT01231984|26546519|FG001|Study Period 2|Lost to Follow-up|0|||
13313415|NCT01231984|26546520|FG002|Study Period 2|Lost to Follow-up|0|||
13313416|NCT01231984|26546521|FG003|Study Period 2|Lost to Follow-up|3|||
13313417|NCT01231984|26546518|FG000|Study Period 2|Did not continue to meet I/E Criteria|1|||
13313418|NCT01231984|26546519|FG001|Study Period 2|Did not continue to meet I/E Criteria|1|||
13313419|NCT01231984|26546520|FG002|Study Period 2|Did not continue to meet I/E Criteria|0|||
13313420|NCT01231984|26546521|FG003|Study Period 2|Did not continue to meet I/E Criteria|1|||
13313421|NCT01231659|26546532|FG000|Overall Study|Adverse Event|9|||
13313422|NCT01231659|26546532|FG000|Overall Study|Disease Progression|48|||
13313423|NCT01231659|26546532|FG000|Overall Study|Death|2|||
13313424|NCT01231659|26546532|FG000|Overall Study|Patient refused to complete study visit|1|||
13313425|NCT01231659|26546532|FG000|Overall Study|Other protocol defined criteria|12|||
13313426|NCT01231620|26546643|FG000|Overall Study|Physician Decision|3|||
13313427|NCT01231620|26546644|FG001|Overall Study|Physician Decision|5|||
13313428|NCT01231620|26546645|FG002|Overall Study|Physician Decision|10|||
13313429|NCT01231620|26546643|FG000|Overall Study|Death|12|||
13313430|NCT01231620|26546644|FG001|Overall Study|Death|14|||
13313431|NCT01231620|26546645|FG002|Overall Study|Death|11|||
13313432|NCT01231620|26546643|FG000|Overall Study|Adverse Event|2|||
13313433|NCT01231620|26546644|FG001|Overall Study|Adverse Event|2|||
13313434|NCT01231620|26546645|FG002|Overall Study|Adverse Event|1|||
13313435|NCT01231620|26546643|FG000|Overall Study|Withdrawal by Subject|6|||
13313436|NCT01231620|26546644|FG001|Overall Study|Withdrawal by Subject|6|||
13313437|NCT01231620|26546645|FG002|Overall Study|Withdrawal by Subject|8|||
13313438|NCT01231620|26546643|FG000|Overall Study|Lost to Follow-up|3|||
13313439|NCT01231620|26546644|FG001|Overall Study|Lost to Follow-up|4|||
13313440|NCT01231620|26546645|FG002|Overall Study|Lost to Follow-up|9|||
13313441|NCT01231607|26546751|FG000|Overall Study|Adverse Event|0|||
13313442|NCT01231607|26546752|FG001|Overall Study|Adverse Event|8|||
13313443|NCT01231607|26546753|FG002|Overall Study|Adverse Event|4|||
13313444|NCT01231607|26546754|FG003|Overall Study|Adverse Event|4|||
13313445|NCT01231607|26546755|FG004|Overall Study|Adverse Event|5|||
13313446|NCT01231607|26546751|FG000|Overall Study|Lost to Follow-up|13|||
13313447|NCT01231607|26546752|FG001|Overall Study|Lost to Follow-up|11|||
13313448|NCT01231607|26546753|FG002|Overall Study|Lost to Follow-up|10|||
13313449|NCT01231607|26546754|FG003|Overall Study|Lost to Follow-up|10|||
13313450|NCT01231607|26546755|FG004|Overall Study|Lost to Follow-up|4|||
13313451|NCT01231607|26546751|FG000|Overall Study|Physician Decision|4|||
13313452|NCT01231607|26546752|FG001|Overall Study|Physician Decision|4|||
13313453|NCT01231607|26546753|FG002|Overall Study|Physician Decision|3|||
13313454|NCT01231607|26546754|FG003|Overall Study|Physician Decision|5|||
13313455|NCT01231607|26546755|FG004|Overall Study|Physician Decision|4|||
13313456|NCT01231607|26546751|FG000|Overall Study|Protocol Violation|3|||
13313457|NCT01231607|26546752|FG001|Overall Study|Protocol Violation|2|||
13313458|NCT01231607|26546753|FG002|Overall Study|Protocol Violation|0|||
13313459|NCT01231607|26546754|FG003|Overall Study|Protocol Violation|2|||
13313460|NCT01231607|26546755|FG004|Overall Study|Protocol Violation|2|||
13313461|NCT01231607|26546751|FG000|Overall Study|Withdrawal by Subject|9|||
13313462|NCT01231607|26546752|FG001|Overall Study|Withdrawal by Subject|9|||
13313463|NCT01231607|26546753|FG002|Overall Study|Withdrawal by Subject|14|||
13313464|NCT01231607|26546754|FG003|Overall Study|Withdrawal by Subject|17|||
13313465|NCT01231607|26546755|FG004|Overall Study|Withdrawal by Subject|9|||
13313466|NCT01231581|26546780|FG000|Overall Study|Lost to Follow-up|2|||
13313467|NCT01231581|26546781|FG001|Overall Study|Lost to Follow-up|2|||
13313468|NCT01231581|26546780|FG000|Overall Study|Withdrawal by Subject|6|||
13313469|NCT01231581|26546781|FG001|Overall Study|Withdrawal by Subject|9|||
13313470|NCT01231581|26546780|FG000|Overall Study|Study Closed/Terminated|6|||
13313471|NCT01231581|26546781|FG001|Overall Study|Study Closed/Terminated|5|||
13313472|NCT01231581|26546780|FG000|Overall Study|Death|65|||
13313473|NCT01231581|26546781|FG001|Overall Study|Death|64|||
13313474|NCT01231581|26546780|FG000|Overall Study|Ongoing|1|||
13313475|NCT01231581|26546781|FG001|Overall Study|Ongoing|0|||
13313476|NCT01231555|26546820|FG000|Overall Study|Study terminated|8|||
13313477|NCT01231555|26546821|FG001|Overall Study|Study terminated|5|||
13313478|NCT01231555|26546822|FG002|Overall Study|Study terminated|8|||
13313479|NCT01231555|26546820|FG000|Overall Study|Withdrawal by Subject|0|||
13313480|NCT01231555|26546821|FG001|Overall Study|Withdrawal by Subject|2|||
13313481|NCT01231555|26546822|FG002|Overall Study|Withdrawal by Subject|0|||
13313482|NCT01231516|26546862|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4|||
13313483|NCT01231516|26546863|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11|||
13313484|NCT01231516|26546862|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20|||
13313485|NCT01231516|26546863|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42|||
13313486|NCT01231516|26546862|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9|||
13313487|NCT01231516|26546863|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6|||
13313488|NCT01231516|26546862|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5|||
13313489|NCT01231516|26546863|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3|||
13313490|NCT01231516|26546862|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5|||
13313491|NCT01231516|26546863|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10|||
13313492|NCT01231516|26546862|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
13313493|NCT01231516|26546863|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
13313494|NCT01231516|26546862|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11|||
13313495|NCT01231516|26546863|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5|||
13313496|NCT01231516|26546862|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3|||
13313497|NCT01231516|26546863|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1|||
13313498|NCT01231516|26546862|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3|||
13313499|NCT01231516|26546863|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2|||
13313500|NCT01231516|26546862|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5|||
13313501|NCT01231516|26546863|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0|||
13313502|NCT01231516|26546862|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27|||
13313503|NCT01231516|26546863|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11|||
13313504|NCT01231516|26546862|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10|||
13313505|NCT01231516|26546863|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0|||
13313506|NCT01231516|26546862|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6|||
13313507|NCT01231516|26546863|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3|||
13313508|NCT01231516|26546862|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2|||
13313509|NCT01231516|26546863|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0|||
13313510|NCT01231516|26546862|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6|||
13313511|NCT01231516|26546863|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1|||
13313512|NCT01231516|26546862|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12|||
13313513|NCT01231516|26546863|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2|||
13313514|NCT01231503|26547126|FG000|Overall Study|Adverse Event|0|||
13313515|NCT01231503|26547127|FG001|Overall Study|Adverse Event|0|||
13313516|NCT01231503|26547128|FG002|Overall Study|Adverse Event|0|||
13313517|NCT01231503|26547129|FG003|Overall Study|Adverse Event|0|||
13313518|NCT01231503|26547130|FG004|Overall Study|Adverse Event|0|||
13313519|NCT01231503|26547131|FG005|Overall Study|Adverse Event|1|||
13313520|NCT01231503|26547132|FG006|Overall Study|Adverse Event|0|||
13313521|NCT01231503|26547133|FG007|Overall Study|Adverse Event|0|||
13313522|NCT01231503|26547126|FG000|Overall Study|Adverse event, serious fatal|0|||
13313523|NCT01231503|26547127|FG001|Overall Study|Adverse event, serious fatal|0|||
13313524|NCT01231503|26547128|FG002|Overall Study|Adverse event, serious fatal|1|||
13313525|NCT01231503|26547129|FG003|Overall Study|Adverse event, serious fatal|1|||
13313526|NCT01231503|26547130|FG004|Overall Study|Adverse event, serious fatal|0|||
13313527|NCT01231503|26547131|FG005|Overall Study|Adverse event, serious fatal|1|||
13313528|NCT01231503|26547132|FG006|Overall Study|Adverse event, serious fatal|0|||
13313529|NCT01231503|26547133|FG007|Overall Study|Adverse event, serious fatal|0|||
13313530|NCT01231503|26547126|FG000|Overall Study|Withdrawal by Subject|6|||
13313531|NCT01231503|26547127|FG001|Overall Study|Withdrawal by Subject|3|||
13313532|NCT01231503|26547128|FG002|Overall Study|Withdrawal by Subject|3|||
13313533|NCT01231503|26547129|FG003|Overall Study|Withdrawal by Subject|1|||
13313534|NCT01231503|26547130|FG004|Overall Study|Withdrawal by Subject|3|||
13313535|NCT01231503|26547131|FG005|Overall Study|Withdrawal by Subject|5|||
13313536|NCT01231503|26547132|FG006|Overall Study|Withdrawal by Subject|1|||
13313537|NCT01231503|26547133|FG007|Overall Study|Withdrawal by Subject|2|||
13313538|NCT01231503|26547126|FG000|Overall Study|Lost to Follow-up|8|||
13313539|NCT01231503|26547127|FG001|Overall Study|Lost to Follow-up|10|||
13313540|NCT01231503|26547128|FG002|Overall Study|Lost to Follow-up|8|||
13313541|NCT01231503|26547129|FG003|Overall Study|Lost to Follow-up|5|||
13313542|NCT01231503|26547130|FG004|Overall Study|Lost to Follow-up|7|||
13313543|NCT01231503|26547131|FG005|Overall Study|Lost to Follow-up|9|||
13313544|NCT01231503|26547132|FG006|Overall Study|Lost to Follow-up|6|||
13313545|NCT01231503|26547133|FG007|Overall Study|Lost to Follow-up|6|||
13313546|NCT01231503|26547126|FG000|Overall Study|Protocol Violation|0|||
13313547|NCT01231503|26547127|FG001|Overall Study|Protocol Violation|0|||
13313548|NCT01231503|26547128|FG002|Overall Study|Protocol Violation|0|||
13313549|NCT01231503|26547129|FG003|Overall Study|Protocol Violation|1|||
13313550|NCT01231503|26547130|FG004|Overall Study|Protocol Violation|0|||
13313551|NCT01231503|26547131|FG005|Overall Study|Protocol Violation|0|||
13313552|NCT01231503|26547132|FG006|Overall Study|Protocol Violation|0|||
13313553|NCT01231503|26547133|FG007|Overall Study|Protocol Violation|0|||
13313554|NCT01231464|26547150|FG000|Overall Study|Adverse Event|0|||
13313555|NCT01231464|26547151|FG001|Overall Study|Adverse Event|1|||
13313556|NCT01231464|26547150|FG000|Overall Study|Protocol Violation|1|||
13313557|NCT01231464|26547151|FG001|Overall Study|Protocol Violation|2|||
13313558|NCT01231464|26547150|FG000|Overall Study|Lost to Follow-up|1|||
13313559|NCT01231464|26547151|FG001|Overall Study|Lost to Follow-up|2|||
13313560|NCT01231464|26547150|FG000|Overall Study|Withdrawal by Subject|3|||
13313561|NCT01231464|26547151|FG001|Overall Study|Withdrawal by Subject|2|||
13313562|NCT01231373|26547182|FG000|Overall Study|Withdrew consent prior to randomization|2|||
13313563|NCT01231373|26547183|FG001|Overall Study|Withdrew consent prior to randomization|1|||
13313564|NCT01231373|26547184|FG002|Overall Study|Withdrew consent prior to randomization|0|||
13313565|NCT01231373|26547185|FG003|Overall Study|Withdrew consent prior to randomization|0|||
13313566|NCT01231373|26547182|FG000|Overall Study|Lost to Follow-up|0|||
13313567|NCT01231373|26547183|FG001|Overall Study|Lost to Follow-up|0|||
13313568|NCT01231373|26547184|FG002|Overall Study|Lost to Follow-up|0|||
13313569|NCT01231373|26547185|FG003|Overall Study|Lost to Follow-up|1|||
13313570|NCT01231373|26547182|FG000|Overall Study|Withdrew Consent|1|||
13313571|NCT01231373|26547183|FG001|Overall Study|Withdrew Consent|0|||
13313572|NCT01231373|26547184|FG002|Overall Study|Withdrew Consent|0|||
13313573|NCT01231373|26547185|FG003|Overall Study|Withdrew Consent|0|||
13313574|NCT01231321|26547198|FG000|Overall Study|Adverse Event|3|||
13313575|NCT01231321|26547198|FG000|Overall Study|Lack of Efficacy|2|||
13313576|NCT01230892|26547211|FG000|Overall Study|Withdrawal by Subject|1|||
13313577|NCT01230892|26547212|FG001|Overall Study|Withdrawal by Subject|1|||
13313578|NCT01230892|26547211|FG000|Overall Study|Lost to Follow-up|2|||
13313579|NCT01230892|26547212|FG001|Overall Study|Lost to Follow-up|0|||
13313580|NCT01230827|26547239|FG000|Overall Study|Lost to Follow-up|0|||
13313581|NCT01230827|26547240|FG001|Overall Study|Lost to Follow-up|0|||
13313582|NCT01230827|26547241|FG002|Overall Study|Lost to Follow-up|1|||
13313583|NCT01230827|26547242|FG003|Overall Study|Lost to Follow-up|3|||
13313584|NCT01230827|26547239|FG000|Overall Study|Withdrawal by Subject|1|||
13313585|NCT01230827|26547240|FG001|Overall Study|Withdrawal by Subject|0|||
13313586|NCT01230827|26547241|FG002|Overall Study|Withdrawal by Subject|3|||
13313587|NCT01230827|26547242|FG003|Overall Study|Withdrawal by Subject|2|||
13313588|NCT01230827|26547239|FG000|Overall Study|Lack of Efficacy|14|||
13313589|NCT01230827|26547240|FG001|Overall Study|Lack of Efficacy|1|||
13313590|NCT01230827|26547241|FG002|Overall Study|Lack of Efficacy|2|||
13313591|NCT01230827|26547242|FG003|Overall Study|Lack of Efficacy|3|||
13313592|NCT01230827|26547239|FG000|Overall Study|Adverse Event|4|||
13313593|NCT01230827|26547240|FG001|Overall Study|Adverse Event|2|||
13313594|NCT01230827|26547241|FG002|Overall Study|Adverse Event|3|||
13313595|NCT01230827|26547242|FG003|Overall Study|Adverse Event|7|||
13313596|NCT01230827|26547239|FG000|Overall Study|Recovery|0|||
13313597|NCT01230827|26547240|FG001|Overall Study|Recovery|6|||
13313598|NCT01230827|26547241|FG002|Overall Study|Recovery|0|||
13313599|NCT01230827|26547242|FG003|Overall Study|Recovery|0|||
13313600|NCT01230827|26547239|FG000|Overall Study|Study terminated by Sponsor|0|||
13313601|NCT01230827|26547240|FG001|Overall Study|Study terminated by Sponsor|2|||
13313602|NCT01230827|26547241|FG002|Overall Study|Study terminated by Sponsor|56|||
13313603|NCT01230827|26547242|FG003|Overall Study|Study terminated by Sponsor|63|||
13313604|NCT01230814|26547261|FG000|Overall Study|Lost to Follow-up|11|||
13313605|NCT01230814|26547262|FG001|Overall Study|Lost to Follow-up|3|||
13313606|NCT01230814|26547261|FG000|Overall Study|Discontinued (not due to adverse event)|2|||
13313607|NCT01230814|26547262|FG001|Overall Study|Discontinued (not due to adverse event)|1|||
13313608|NCT01230788|26547272|FG000|Overall Study|Prescribed exclusion drug|1|||
13313609|NCT01230749|26547320|FG000|Overall Study|Adverse Event|0|||
13313610|NCT01230749|26547321|FG001|Overall Study|Adverse Event|0|||
13313611|NCT01230749|26547322|FG002|Overall Study|Adverse Event|0|||
13313612|NCT01230749|26547323|FG003|Overall Study|Adverse Event|1|||
13313613|NCT01230749|26547320|FG000|Overall Study|Physician Decision|0|||
13313614|NCT01230749|26547321|FG001|Overall Study|Physician Decision|0|||
13313615|NCT01230749|26547322|FG002|Overall Study|Physician Decision|1|||
13313616|NCT01230749|26547323|FG003|Overall Study|Physician Decision|0|||
13313617|NCT01230749|26547320|FG000|Overall Study|Withdrawal by Subject|0|||
13313618|NCT01230749|26547321|FG001|Overall Study|Withdrawal by Subject|1|||
13313619|NCT01230749|26547322|FG002|Overall Study|Withdrawal by Subject|0|||
13313620|NCT01230749|26547323|FG003|Overall Study|Withdrawal by Subject|0|||
13313621|NCT01230749|26547320|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0|||
13313622|NCT01230749|26547321|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1|||
13313623|NCT01230749|26547322|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1|||
13313624|NCT01230749|26547323|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1|||
13313625|NCT01230710|26547333|FG000|Overall Study|Disease Progression|41|||
13313626|NCT01230710|26547333|FG000|Overall Study|Lost to Follow-up|3|||
13313627|NCT01230710|26547333|FG000|Overall Study|Death|4|||
13313628|NCT01230710|26547333|FG000|Overall Study|Withdrawal of Consent|1|||
13313629|NCT01230554|26547342|FG000|Overall Study|Lost to Follow-up|2|||
13313630|NCT01230554|26547342|FG000|Overall Study|Inability to maintain visit schedule|1|||
13313631|NCT01230489|26547348|FG000|Overall Study|Death|2|||
13313632|NCT01230489|26547348|FG000|Overall Study|Adverse Event|2|||
13313633|NCT01230489|26547348|FG000|Overall Study|Treatment modality changed|1|||
13313634|NCT01230307|26547367|FG000|Overall Study|LVAD Placement|0|||
13313635|NCT01230307|26547368|FG001|Overall Study|LVAD Placement|2|||
13313636|NCT01230060|26547374|FG000|Overall Study|Withdrawal by Subject|1|||
13313637|NCT01229735|26547395|FG000|Overall Study|Lack of Efficacy|8|||
13313638|NCT01229735|26547396|FG001|Overall Study|Lack of Efficacy|8|||
13313639|NCT01229735|26547395|FG000|Overall Study|Protocol Violation|13|||
13313640|NCT01229735|26547396|FG001|Overall Study|Protocol Violation|8|||
13313641|NCT01229735|26547395|FG000|Overall Study|Lost to Follow-up|0|||
13313642|NCT01229735|26547396|FG001|Overall Study|Lost to Follow-up|2|||
13313643|NCT01229735|26547395|FG000|Overall Study|Withdrawal by Subject|18|||
13313644|NCT01229735|26547396|FG001|Overall Study|Withdrawal by Subject|17|||
13313645|NCT01229735|26547395|FG000|Overall Study|Other Reason|13|||
13313646|NCT01229735|26547396|FG001|Overall Study|Other Reason|10|||
13313647|NCT01229735|26547395|FG000|Overall Study|SAE, non-fatal|0|||
13313648|NCT01229735|26547396|FG001|Overall Study|SAE, non-fatal|4|||
13313649|NCT01229735|26547395|FG000|Overall Study|AE, non-serious non-fatal|13|||
13313650|NCT01229735|26547396|FG001|Overall Study|AE, non-serious non-fatal|17|||
13313651|NCT01229735|26547395|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
13313652|NCT01229735|26547396|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
13313653|NCT01229449|26547469|FG000|Overall Study|Withdrawal by Subject|0|||
13313654|NCT01229449|26547470|FG001|Overall Study|Withdrawal by Subject|3|||
13313655|NCT01229449|26547471|FG002|Overall Study|Withdrawal by Subject|0|||
13313656|NCT01229449|26547472|FG003|Overall Study|Withdrawal by Subject|1|||
13313657|NCT01229449|26547473|FG004|Overall Study|Withdrawal by Subject|1|||
13313658|NCT01229449|26547469|FG000|Overall Study|Lost to Follow-up|1|||
13313659|NCT01229449|26547470|FG001|Overall Study|Lost to Follow-up|1|||
13313660|NCT01229449|26547471|FG002|Overall Study|Lost to Follow-up|1|||
13313661|NCT01229449|26547472|FG003|Overall Study|Lost to Follow-up|0|||
13313662|NCT01229449|26547473|FG004|Overall Study|Lost to Follow-up|0|||
13313663|NCT01229449|26547469|FG000|Overall Study|Physician Decision|0|||
13313664|NCT01229449|26547470|FG001|Overall Study|Physician Decision|0|||
13313665|NCT01229449|26547471|FG002|Overall Study|Physician Decision|1|||
13313666|NCT01229449|26547472|FG003|Overall Study|Physician Decision|0|||
13313667|NCT01229449|26547473|FG004|Overall Study|Physician Decision|0|||
13313668|NCT01229436|26547513|FG000|Overall Study|Withdrawal by Subject|2|||
13313669|NCT01229436|26547513|FG000|Overall Study|Lost to Follow-up|3|||
13313670|NCT01229397|26547534|FG000|Overall Study|Withdrawal by Subject|3|||
13313671|NCT01229397|26547535|FG001|Overall Study|Withdrawal by Subject|3|||
13313672|NCT01229397|26547534|FG000|Overall Study|Lost to Follow-up|7|||
13313673|NCT01229397|26547535|FG001|Overall Study|Lost to Follow-up|6|||
13313674|NCT01229397|26547534|FG000|Overall Study|Migrated/moved from study area|1|||
13313675|NCT01229397|26547535|FG001|Overall Study|Migrated/moved from study area|0|||
13313676|NCT01229371|26547570|FG000|Overall Study|Withdrawal by Subject|0|||
13313677|NCT01229371|26547571|FG001|Overall Study|Withdrawal by Subject|1|||
13313678|NCT01229371|26547572|FG002|Overall Study|Withdrawal by Subject|0|||
13313679|NCT01229371|26547573|FG003|Overall Study|Withdrawal by Subject|0|||
13313680|NCT01229267|26547605|FG000|Overall Study|Adverse Event|4|||
13313681|NCT01229267|26547606|FG001|Overall Study|Adverse Event|6|||
13313682|NCT01229267|26547607|FG002|Overall Study|Adverse Event|3|||
13313683|NCT01229267|26547608|FG003|Overall Study|Adverse Event|2|||
13313684|NCT01229267|26547609|FG004|Overall Study|Adverse Event|10|||
13313685|NCT01229267|26547605|FG000|Overall Study|Death|40|||
13313686|NCT01229267|26547606|FG001|Overall Study|Death|37|||
13313687|NCT01229267|26547607|FG002|Overall Study|Death|35|||
13313688|NCT01229267|26547608|FG003|Overall Study|Death|13|||
13313689|NCT01229267|26547609|FG004|Overall Study|Death|103|||
13313690|NCT01229267|26547605|FG000|Overall Study|Withdrawal by Subject|23|||
13313691|NCT01229267|26547606|FG001|Overall Study|Withdrawal by Subject|22|||
13313692|NCT01229267|26547607|FG002|Overall Study|Withdrawal by Subject|32|||
13313693|NCT01229267|26547608|FG003|Overall Study|Withdrawal by Subject|14|||
13313694|NCT01229267|26547609|FG004|Overall Study|Withdrawal by Subject|59|||
13313695|NCT01229267|26547605|FG000|Overall Study|Protocol Violation|0|||
13313696|NCT01229267|26547606|FG001|Overall Study|Protocol Violation|1|||
13313697|NCT01229267|26547607|FG002|Overall Study|Protocol Violation|0|||
13313698|NCT01229267|26547608|FG003|Overall Study|Protocol Violation|0|||
13313699|NCT01229267|26547609|FG004|Overall Study|Protocol Violation|0|||
13313700|NCT01229267|26547605|FG000|Overall Study|Progressive disease|0|||
13313701|NCT01229267|26547606|FG001|Overall Study|Progressive disease|0|||
13313702|NCT01229267|26547607|FG002|Overall Study|Progressive disease|0|||
13313703|NCT01229267|26547608|FG003|Overall Study|Progressive disease|0|||
13313704|NCT01229267|26547609|FG004|Overall Study|Progressive disease|1|||
13313705|NCT01229267|26547605|FG000|Overall Study|Physician Decision|8|||
13313706|NCT01229267|26547606|FG001|Overall Study|Physician Decision|11|||
13313707|NCT01229267|26547607|FG002|Overall Study|Physician Decision|8|||
13313708|NCT01229267|26547608|FG003|Overall Study|Physician Decision|3|||
13313709|NCT01229267|26547609|FG004|Overall Study|Physician Decision|25|||
13313710|NCT01229267|26547605|FG000|Overall Study|Lost to Follow-up|6|||
13313711|NCT01229267|26547606|FG001|Overall Study|Lost to Follow-up|5|||
13313712|NCT01229267|26547607|FG002|Overall Study|Lost to Follow-up|8|||
13313713|NCT01229267|26547608|FG003|Overall Study|Lost to Follow-up|3|||
13313714|NCT01229267|26547609|FG004|Overall Study|Lost to Follow-up|22|||
13313715|NCT01229254|26547628|FG000|Overall Study|Not Continuing Into Safety Extension|3|||
13313716|NCT01229254|26547629|FG001|Overall Study|Not Continuing Into Safety Extension|1|||
13313717|NCT01229254|26547630|FG002|Overall Study|Not Continuing Into Safety Extension|1|||
13313718|NCT01229254|26547628|FG000|Overall Study|Adverse Event|4|||
13313719|NCT01229254|26547629|FG001|Overall Study|Adverse Event|5|||
13313720|NCT01229254|26547630|FG002|Overall Study|Adverse Event|3|||
13313721|NCT01229254|26547628|FG000|Overall Study|Lost to Follow-up|3|||
13313722|NCT01229254|26547629|FG001|Overall Study|Lost to Follow-up|0|||
13313723|NCT01229254|26547630|FG002|Overall Study|Lost to Follow-up|1|||
13313724|NCT01229254|26547628|FG000|Overall Study|Physician Decision|0|||
13313725|NCT01229254|26547629|FG001|Overall Study|Physician Decision|3|||
13313726|NCT01229254|26547630|FG002|Overall Study|Physician Decision|0|||
13313727|NCT01229254|26547628|FG000|Overall Study|Protocol Violation|4|||
13313728|NCT01229254|26547629|FG001|Overall Study|Protocol Violation|6|||
13313729|NCT01229254|26547630|FG002|Overall Study|Protocol Violation|5|||
13313730|NCT01229254|26547628|FG000|Overall Study|Withdrawal by Subject|1|||
13313731|NCT01229254|26547629|FG001|Overall Study|Withdrawal by Subject|0|||
13313732|NCT01229254|26547630|FG002|Overall Study|Withdrawal by Subject|1|||
13313733|NCT01229254|26547628|FG000|Overall Study|Non-compliance with Study Drug|0|||
13313734|NCT01229254|26547629|FG001|Overall Study|Non-compliance with Study Drug|1|||
13313735|NCT01229254|26547630|FG002|Overall Study|Non-compliance with Study Drug|1|||
13313736|NCT01229176|26547705|FG000|Overall Study|Withdrawal by Subject|0|||
13313737|NCT01229176|26547706|FG001|Overall Study|Withdrawal by Subject|0|||
13313738|NCT01229176|26547707|FG002|Overall Study|Withdrawal by Subject|0|||
13313739|NCT01229176|26547708|FG003|Overall Study|Withdrawal by Subject|1|||
13313740|NCT01229176|26547709|FG004|Overall Study|Withdrawal by Subject|1|||
13313741|NCT01229176|26547710|FG005|Overall Study|Withdrawal by Subject|1|||
13313742|NCT01229176|26547711|FG006|Overall Study|Withdrawal by Subject|0|||
13313743|NCT01229176|26547712|FG007|Overall Study|Withdrawal by Subject|1|||
13313744|NCT01229176|26547705|FG000|Overall Study|Lost to Follow-up|0|||
13313745|NCT01229176|26547706|FG001|Overall Study|Lost to Follow-up|3|||
13313746|NCT01229176|26547707|FG002|Overall Study|Lost to Follow-up|0|||
13313747|NCT01229176|26547708|FG003|Overall Study|Lost to Follow-up|0|||
13313748|NCT01229176|26547709|FG004|Overall Study|Lost to Follow-up|1|||
13313749|NCT01229176|26547710|FG005|Overall Study|Lost to Follow-up|1|||
13313750|NCT01229176|26547711|FG006|Overall Study|Lost to Follow-up|0|||
13313751|NCT01229176|26547712|FG007|Overall Study|Lost to Follow-up|2|||
13313752|NCT01229150|26547782|FG000|Overall Study|Toxicity|2|||
13313753|NCT01229150|26547783|FG001|Overall Study|Toxicity|2|||
13313754|NCT01229150|26547784|FG002|Overall Study|Toxicity|0|||
13313755|NCT01229150|26547785|FG003|Overall Study|Toxicity|0|||
13313756|NCT01229111|26547795|FG000|Overall Study|Death|1|||
13122102|NCT02969525|25945879|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
13122103|NCT02969525|25945880|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
13122104|NCT02969525|25945881|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
13122105|NCT02969525|25945882|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
13122106|NCT02969525|25945883|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
13122107|NCT02969525|25945884|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
13122108|NCT02969525|25945885|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
13122109|NCT02969525|25945886|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1|||
13313757|NCT01228747|26547816|FG000|Overall Study|Adverse Event|8|||
13313758|NCT01228747|26547817|FG001|Overall Study|Adverse Event|4|||
13313759|NCT01228747|26547816|FG000|Overall Study|Lack of Efficacy|40|||
13313760|NCT01228747|26547817|FG001|Overall Study|Lack of Efficacy|27|||
13313761|NCT01228747|26547816|FG000|Overall Study|Protocol Violation|6|||
13313762|NCT01228747|26547817|FG001|Overall Study|Protocol Violation|5|||
13313763|NCT01228747|26547816|FG000|Overall Study|Lost to Follow-up|4|||
13313764|NCT01228747|26547817|FG001|Overall Study|Lost to Follow-up|3|||
13313765|NCT01228747|26547816|FG000|Overall Study|Withdrawal by Subject|5|||
13313766|NCT01228747|26547817|FG001|Overall Study|Withdrawal by Subject|1|||
13313767|NCT01228747|26547816|FG000|Overall Study|Other Reason|2|||
13313768|NCT01228747|26547817|FG001|Overall Study|Other Reason|5|||
13313769|NCT01228734|26547838|FG000|Overall Study|Randomized, but not treated|0|||
13313770|NCT01228734|26547839|FG001|Overall Study|Randomized, but not treated|4|||
13313771|NCT01228591|26547858|FG000|Baseline|Lack of Efficacy|1|||
13313772|NCT01228591|26547859|FG001|Baseline|Lack of Efficacy|2|||
13313773|NCT01228318|26547880|FG000|Overall Study|Clinic no show to receive intervention|1|||
13313774|NCT01228318|26547881|FG001|Overall Study|Clinic no show to receive intervention|0|||
13313775|NCT01228318|26547880|FG000|Overall Study|Unable to contact|2|||
13313776|NCT01228318|26547881|FG001|Overall Study|Unable to contact|5|||
13313777|NCT01228318|26547880|FG000|Overall Study|Moved|0|||
13313778|NCT01228318|26547881|FG001|Overall Study|Moved|2|||
13313779|NCT01228318|26547880|FG000|Overall Study|Incarcerated|1|||
13313780|NCT01228318|26547881|FG001|Overall Study|Incarcerated|0|||
13313781|NCT01228175|26547894|FG000|Overall Study|Lost to Follow-up|64|||
13313782|NCT01228175|26547895|FG001|Overall Study|Lost to Follow-up|50|||
13313783|NCT01228175|26547894|FG000|Overall Study|Withdrawal by Subject|1|||
13313784|NCT01228175|26547895|FG001|Overall Study|Withdrawal by Subject|2|||
13313785|NCT01228175|26547894|FG000|Overall Study|Physician Decision|1|||
13313786|NCT01228175|26547895|FG001|Overall Study|Physician Decision|1|||
13313787|NCT01228071|26547903|FG000|Overall Study|Protocol Violation|1|||
13313788|NCT01228071|26547903|FG000|Overall Study|Withdrawal by Subject|1|||
13313789|NCT01228019|26547920|FG000|Overall Study|Dose Violation|70|||
13313790|NCT01228019|26547920|FG000|Overall Study|Duplicate enrollment|1|||
13313791|NCT01228019|26547920|FG000|Overall Study|Missing pre-treatment data|72|||
13313792|NCT01228019|26547920|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152|||
13313793|NCT01228019|26547920|FG000|Overall Study|Violation of Entry Criterion|9|||
13313794|NCT01227967|26547961|FG000|Overall Study|Protocol Violation|3|||
13313795|NCT01227967|26547962|FG001|Overall Study|Protocol Violation|1|||
13313796|NCT01227967|26547961|FG000|Overall Study|Death|0|||
13313797|NCT01227967|26547962|FG001|Overall Study|Death|1|||
13313798|NCT01227967|26547961|FG000|Overall Study|Lost to Follow-up|8|||
13313799|NCT01227967|26547962|FG001|Overall Study|Lost to Follow-up|3|||
13313800|NCT01227967|26547961|FG000|Overall Study|Withdrawal by Subject|4|||
13313801|NCT01227967|26547962|FG001|Overall Study|Withdrawal by Subject|3|||
13313802|NCT01227967|26547961|FG000|Overall Study|Physician Decision|0|||
13313803|NCT01227967|26547962|FG001|Overall Study|Physician Decision|1|||
13313804|NCT01227967|26547961|FG000|Overall Study|Never Started Treatment|0|||
13313805|NCT01227967|26547962|FG001|Overall Study|Never Started Treatment|4|||
13313806|NCT01227967|26547961|FG000|Overall Study|Taking Additional Antiviral Drug|1|||
13313807|NCT01227967|26547962|FG001|Overall Study|Taking Additional Antiviral Drug|0|||
13313808|NCT01227954|26547976|FG000|Overall Study|Protocol Violation|6|||
13313809|NCT01227954|26547976|FG000|Overall Study|No protocol treatment|7|||
13313810|NCT01227928|26548017|FG000|Overall Study|Lost to Follow-up|4|||
13313811|NCT01227928|26548018|FG001|Overall Study|Lost to Follow-up|2|||
13313812|NCT01227928|26548017|FG000|Overall Study|Withdrawal by Subject|4|||
13313813|NCT01227928|26548018|FG001|Overall Study|Withdrawal by Subject|3|||
13313814|NCT01227928|26548017|FG000|Overall Study|Death|14|||
13313815|NCT01227928|26548018|FG001|Overall Study|Death|12|||
13313816|NCT01227902|26548122|FG000|Overall Study|Adverse Event|12|||
13313817|NCT01227902|26548123|FG001|Overall Study|Adverse Event|8|||
13313818|NCT01227902|26548124|FG002|Overall Study|Adverse Event|11|||
13313819|NCT01227902|26548125|FG003|Overall Study|Adverse Event|4|||
13313820|NCT01227902|26548122|FG000|Overall Study|Lack of Efficacy|1|||
13313821|NCT01227902|26548123|FG001|Overall Study|Lack of Efficacy|2|||
13313822|NCT01227902|26548124|FG002|Overall Study|Lack of Efficacy|2|||
13313823|NCT01227902|26548125|FG003|Overall Study|Lack of Efficacy|1|||
13313824|NCT01227902|26548122|FG000|Overall Study|Protocol Violation|1|||
13313825|NCT01227902|26548123|FG001|Overall Study|Protocol Violation|0|||
13313826|NCT01227902|26548124|FG002|Overall Study|Protocol Violation|0|||
13313827|NCT01227902|26548125|FG003|Overall Study|Protocol Violation|0|||
13313828|NCT01227902|26548122|FG000|Overall Study|Lost to Follow-up|0|||
13313829|NCT01227902|26548123|FG001|Overall Study|Lost to Follow-up|0|||
13313830|NCT01227902|26548124|FG002|Overall Study|Lost to Follow-up|1|||
13313831|NCT01227902|26548125|FG003|Overall Study|Lost to Follow-up|2|||
13313832|NCT01227902|26548122|FG000|Overall Study|Physician Decision|0|||
13313833|NCT01227902|26548123|FG001|Overall Study|Physician Decision|1|||
13313834|NCT01227902|26548124|FG002|Overall Study|Physician Decision|1|||
13313835|NCT01227902|26548125|FG003|Overall Study|Physician Decision|0|||
13313836|NCT01227902|26548122|FG000|Overall Study|Withdrawal by Subject|4|||
13313837|NCT01227902|26548123|FG001|Overall Study|Withdrawal by Subject|2|||
13313838|NCT01227902|26548124|FG002|Overall Study|Withdrawal by Subject|4|||
13313839|NCT01227902|26548125|FG003|Overall Study|Withdrawal by Subject|3|||
13313840|NCT01227889|26548157|FG000|Randomized Phase (RP)|Adverse Event|13|||
13313841|NCT01227889|26548158|FG001|Randomized Phase (RP)|Adverse Event|0|||
13313842|NCT01227889|26548157|FG000|Randomized Phase (RP)|Physician Decision|13|||
13313843|NCT01227889|26548158|FG001|Randomized Phase (RP)|Physician Decision|5|||
13313844|NCT01227889|26548157|FG000|Randomized Phase (RP)|Progressive Disease|135|||
13313845|NCT01227889|26548158|FG001|Randomized Phase (RP)|Progressive Disease|52|||
13313846|NCT01227889|26548157|FG000|Randomized Phase (RP)|Study terminated by sponsor|10|||
13313847|NCT01227889|26548158|FG001|Randomized Phase (RP)|Study terminated by sponsor|0|||
13313848|NCT01227889|26548157|FG000|Randomized Phase (RP)|Missing|1|||
13313849|NCT01227889|26548158|FG001|Randomized Phase (RP)|Missing|3|||
13313850|NCT01227889|26548157|FG000|Randomized Phase (RP)|Withdrawal by Subject|15|||
13313851|NCT01227889|26548158|FG001|Randomized Phase (RP)|Withdrawal by Subject|3|||
13313852|NCT01227889|26548157|FG000|Crossover Phase|Adverse Event|0|||
13313853|NCT01227889|26548158|FG001|Crossover Phase|Adverse Event|1|||
13313854|NCT01227889|26548157|FG000|Crossover Phase|Physician Decision|0|||
13313855|NCT01227889|26548158|FG001|Crossover Phase|Physician Decision|3|||
13313856|NCT01227889|26548157|FG000|Crossover Phase|Progressive Disease|0|||
13313857|NCT01227889|26548158|FG001|Crossover Phase|Progressive Disease|31|||
13313858|NCT01227889|26548157|FG000|Crossover Phase|Study Terminated By Sponsor|0|||
13313859|NCT01227889|26548158|FG001|Crossover Phase|Study Terminated By Sponsor|1|||
13313860|NCT01227889|26548157|FG000|Crossover Phase|Withdrawal by Subject|0|||
13313861|NCT01227889|26548158|FG001|Crossover Phase|Withdrawal by Subject|1|||
13313862|NCT01227824|26548195|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12|||
13313863|NCT01227824|26548196|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7|||
13313864|NCT01227824|26548197|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0|||
13313865|NCT01227824|26548195|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22|||
13313866|NCT01227824|26548196|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25|||
13313867|NCT01227824|26548197|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0|||
13313868|NCT01227824|26548195|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18|||
13313869|NCT01227824|26548196|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16|||
13313870|NCT01227824|26548197|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0|||
13313871|NCT01227824|26548195|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6|||
13313872|NCT01227824|26548196|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3|||
13313873|NCT01227824|26548197|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0|||
13313874|NCT01227824|26548195|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6|||
13313875|NCT01227824|26548196|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4|||
13313876|NCT01227824|26548197|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0|||
13313877|NCT01227824|26548195|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22|||
13313878|NCT01227824|26548196|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10|||
13313879|NCT01227824|26548197|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0|||
13313880|NCT01227824|26548195|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18|||
13313881|NCT01227824|26548196|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14|||
13313882|NCT01227824|26548197|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0|||
13313883|NCT01227824|26548195|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3|||
13313884|NCT01227824|26548196|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
13313885|NCT01227824|26548197|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
13313886|NCT01227824|26548195|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
13313887|NCT01227824|26548196|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
13313888|NCT01227824|26548197|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4|||
13313889|NCT01227824|26548195|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
13313890|NCT01227824|26548196|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
13313891|NCT01227824|26548197|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5|||
13313892|NCT01227824|26548195|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
13313893|NCT01227824|26548196|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
13313894|NCT01227824|26548197|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5|||
13313895|NCT01227824|26548195|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
13313896|NCT01227824|26548196|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
13313897|NCT01227824|26548197|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4|||
13313898|NCT01227824|26548195|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
13313899|NCT01227824|26548196|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
13313900|NCT01227824|26548197|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15|||
13313901|NCT01227824|26548195|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
13313902|NCT01227824|26548196|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
13313903|NCT01227824|26548197|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8|||
13313904|NCT01227824|26548195|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
13313905|NCT01227824|26548196|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
13313906|NCT01227824|26548197|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3|||
13313907|NCT01227707|26548215|FG000|Overall Study|Adverse Event|10|||
13313908|NCT01227707|26548215|FG000|Overall Study|Progression of disease|3|||
13313909|NCT01227707|26548215|FG000|Overall Study|Withdrawal by Subject|1|||
13313910|NCT01227707|26548215|FG000|Overall Study|Patient non-compliance|3|||
13313911|NCT01227707|26548215|FG000|Overall Study|Medical decision|6|||
13313912|NCT01227707|26548215|FG000|Overall Study|Death|1|||
13313913|NCT01227668|26548236|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12|||
13313914|NCT01227668|26548237|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0|||
13313915|NCT01227668|26548236|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7|||
13313916|NCT01227668|26548237|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0|||
13313917|NCT01227668|26548236|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8|||
13313918|NCT01227668|26548237|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0|||
13313919|NCT01227668|26548236|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11|||
13313920|NCT01227668|26548237|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0|||
13313921|NCT01227668|26548236|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7|||
13313922|NCT01227668|26548237|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0|||
13313923|NCT01227668|26548236|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25|||
13313924|NCT01227668|26548237|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0|||
13313925|NCT01227668|26548236|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2|||
13313926|NCT01227668|26548237|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0|||
13313927|NCT01227668|26548236|FG000|Phase 2 (Randomization Phase)|Adverse Event|0|||
13313928|NCT01227668|26548237|FG001|Phase 2 (Randomization Phase)|Adverse Event|1|||
13313929|NCT01227668|26548236|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5|||
13313930|NCT01227668|26548237|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0|||
13313931|NCT01227668|26548236|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1|||
13313932|NCT01227668|26548237|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0|||
13313933|NCT01227668|26548236|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13|||
13313934|NCT01227668|26548237|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23|||
13313935|NCT01227668|26548236|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0|||
13313936|NCT01227668|26548237|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1|||
13313937|NCT01227629|26548504|FG000|Overall Study|Adverse Event|2|||
13313938|NCT01227629|26548505|FG001|Overall Study|Adverse Event|2|||
13313939|NCT01227629|26548506|FG002|Overall Study|Adverse Event|1|||
13313940|NCT01227629|26548507|FG003|Overall Study|Adverse Event|6|||
13313941|NCT01227629|26548508|FG004|Overall Study|Adverse Event|1|||
13313942|NCT01227629|26548509|FG005|Overall Study|Adverse Event|1|||
13313943|NCT01227629|26548510|FG006|Overall Study|Adverse Event|6|||
13313944|NCT01227629|26548511|FG007|Overall Study|Adverse Event|6|||
13313945|NCT01227629|26548512|FG008|Overall Study|Adverse Event|4|||
13313946|NCT01227629|26548513|FG009|Overall Study|Adverse Event|0|||
13313947|NCT01227629|26548504|FG000|Overall Study|Protocol Violation|0|||
13313948|NCT01227629|26548505|FG001|Overall Study|Protocol Violation|0|||
13313949|NCT01227629|26548506|FG002|Overall Study|Protocol Violation|0|||
13313950|NCT01227629|26548507|FG003|Overall Study|Protocol Violation|1|||
13313951|NCT01227629|26548508|FG004|Overall Study|Protocol Violation|0|||
13313952|NCT01227629|26548509|FG005|Overall Study|Protocol Violation|0|||
13313953|NCT01227629|26548510|FG006|Overall Study|Protocol Violation|0|||
13313954|NCT01227629|26548511|FG007|Overall Study|Protocol Violation|0|||
13313955|NCT01227629|26548512|FG008|Overall Study|Protocol Violation|0|||
13313956|NCT01227629|26548513|FG009|Overall Study|Protocol Violation|0|||
13313957|NCT01227629|26548504|FG000|Overall Study|Lost to Follow-up|0|||
13313958|NCT01227629|26548505|FG001|Overall Study|Lost to Follow-up|0|||
13313959|NCT01227629|26548506|FG002|Overall Study|Lost to Follow-up|0|||
13313960|NCT01227629|26548507|FG003|Overall Study|Lost to Follow-up|0|||
13313961|NCT01227629|26548508|FG004|Overall Study|Lost to Follow-up|1|||
13313962|NCT01227629|26548509|FG005|Overall Study|Lost to Follow-up|0|||
13313963|NCT01227629|26548510|FG006|Overall Study|Lost to Follow-up|0|||
13313964|NCT01227629|26548511|FG007|Overall Study|Lost to Follow-up|0|||
13313965|NCT01227629|26548512|FG008|Overall Study|Lost to Follow-up|0|||
13313966|NCT01227629|26548513|FG009|Overall Study|Lost to Follow-up|0|||
13313967|NCT01227629|26548504|FG000|Overall Study|Withdrawal by Subject|0|||
13313968|NCT01227629|26548505|FG001|Overall Study|Withdrawal by Subject|0|||
13313969|NCT01227629|26548506|FG002|Overall Study|Withdrawal by Subject|0|||
13313970|NCT01227629|26548507|FG003|Overall Study|Withdrawal by Subject|0|||
13313971|NCT01227629|26548508|FG004|Overall Study|Withdrawal by Subject|0|||
13313972|NCT01227629|26548509|FG005|Overall Study|Withdrawal by Subject|0|||
13313973|NCT01227629|26548510|FG006|Overall Study|Withdrawal by Subject|2|||
13313974|NCT01227629|26548511|FG007|Overall Study|Withdrawal by Subject|0|||
13313975|NCT01227629|26548512|FG008|Overall Study|Withdrawal by Subject|0|||
13313976|NCT01227629|26548513|FG009|Overall Study|Withdrawal by Subject|1|||
13313977|NCT01227629|26548504|FG000|Overall Study|Other|0|||
13313978|NCT01227629|26548505|FG001|Overall Study|Other|0|||
13313979|NCT01227629|26548506|FG002|Overall Study|Other|0|||
13313980|NCT01227629|26548507|FG003|Overall Study|Other|1|||
13313981|NCT01227629|26548508|FG004|Overall Study|Other|0|||
13313982|NCT01227629|26548509|FG005|Overall Study|Other|0|||
13313983|NCT01227629|26548510|FG006|Overall Study|Other|0|||
13313984|NCT01227629|26548511|FG007|Overall Study|Other|0|||
13313985|NCT01227629|26548512|FG008|Overall Study|Other|2|||
13313986|NCT01227629|26548513|FG009|Overall Study|Other|1|||
13313987|NCT01227577|26548527|FG000|Overall Study|Protocol deviation|3|||
13313988|NCT01227577|26548527|FG000|Overall Study|Death|3|||
13313989|NCT01227577|26548527|FG000|Overall Study|Administrative problems|2|||
13313990|NCT01227577|26548527|FG000|Overall Study|Lost to Follow-up|1|||
13313991|NCT01227577|26548527|FG000|Overall Study|Withdrawal by Subject|4|||
13313992|NCT01227577|26548527|FG000|Overall Study|Lack of Efficacy|5|||
13313993|NCT01227577|26548527|FG000|Overall Study|Adverse Event|17|||
13313994|NCT01227564|26548668|FG000|Overall Study|No Longer Willing to Participate|4|||
13313995|NCT01227564|26548669|FG001|Overall Study|No Longer Willing to Participate|2|||
13313996|NCT01227564|26548670|FG002|Overall Study|No Longer Willing to Participate|5|||
13313997|NCT01227564|26548668|FG000|Overall Study|Participant moved to another town|0|||
13313998|NCT01227564|26548669|FG001|Overall Study|Participant moved to another town|0|||
13313999|NCT01227564|26548670|FG002|Overall Study|Participant moved to another town|1|||
13314000|NCT01227512|26548697|FG000|Overall Study|Physician Decision|6|||
13314001|NCT01227512|26548698|FG001|Overall Study|Physician Decision|6|||
13314002|NCT01227512|26548697|FG000|Overall Study|Adverse Event|4|||
13314003|NCT01227512|26548698|FG001|Overall Study|Adverse Event|3|||
13314004|NCT01227512|26548697|FG000|Overall Study|Withdrawal by Subject|3|||
13314005|NCT01227512|26548698|FG001|Overall Study|Withdrawal by Subject|0|||
13314006|NCT01227512|26548697|FG000|Overall Study|Participant met withdrawal criteria|0|||
13314007|NCT01227512|26548698|FG001|Overall Study|Participant met withdrawal criteria|1|||
13314008|NCT01227421|26548758|FG000|Overall Study|Lost to Follow-up|6|||
13314009|NCT01227421|26548759|FG001|Overall Study|Lost to Follow-up|7|||
13314010|NCT01227421|26548760|FG002|Overall Study|Lost to Follow-up|5|||
13314011|NCT01227421|26548758|FG000|Overall Study|Adverse Event|2|||
13314012|NCT01227421|26548759|FG001|Overall Study|Adverse Event|7|||
13314013|NCT01227421|26548760|FG002|Overall Study|Adverse Event|2|||
13314014|NCT01227421|26548758|FG000|Overall Study|Withdrawal by Subject|1|||
13314015|NCT01227421|26548759|FG001|Overall Study|Withdrawal by Subject|2|||
13314016|NCT01227421|26548760|FG002|Overall Study|Withdrawal by Subject|1|||
13314017|NCT01227421|26548758|FG000|Overall Study|Protocol Violation|1|||
13314018|NCT01227421|26548759|FG001|Overall Study|Protocol Violation|1|||
13314019|NCT01227421|26548760|FG002|Overall Study|Protocol Violation|2|||
13314020|NCT01227421|26548758|FG000|Overall Study|Randomized in error|1|||
13314021|NCT01227421|26548759|FG001|Overall Study|Randomized in error|1|||
13314022|NCT01227421|26548760|FG002|Overall Study|Randomized in error|0|||
13314023|NCT01227395|26548795|FG000|Overall Study|Protocol Violation|0|||
13314024|NCT01227395|26548796|FG001|Overall Study|Protocol Violation|1|||
13314025|NCT01227278|26548827|FG000|Overall Study|Withdrawal by Subject|4|||
13314026|NCT01227278|26548828|FG001|Overall Study|Withdrawal by Subject|4|||
13314027|NCT01227278|26548827|FG000|Overall Study|Death|0|||
13314028|NCT01227278|26548828|FG001|Overall Study|Death|2|||
13314029|NCT01227278|26548827|FG000|Overall Study|Other|1|||
13314030|NCT01227278|26548828|FG001|Overall Study|Other|2|||
13314031|NCT01227265|26548864|FG000|Overall Study|Did Not Receive Treatment|1|||
13314032|NCT01227265|26548865|FG001|Overall Study|Did Not Receive Treatment|2|||
13314033|NCT01227265|26548866|FG002|Overall Study|Did Not Receive Treatment|0|||
13314034|NCT01227265|26548864|FG000|Overall Study|Administrative|1|||
13314035|NCT01227265|26548865|FG001|Overall Study|Administrative|0|||
13314036|NCT01227265|26548866|FG002|Overall Study|Administrative|2|||
13314037|NCT01227265|26548864|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
13314038|NCT01227265|26548865|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
13314039|NCT01227265|26548866|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
13314040|NCT01227265|26548864|FG000|Overall Study|Protocol Violation|2|||
13314041|NCT01227265|26548865|FG001|Overall Study|Protocol Violation|1|||
13314042|NCT01227265|26548866|FG002|Overall Study|Protocol Violation|0|||
13314043|NCT01227265|26548864|FG000|Overall Study|Withdrawal by Subject|7|||
13314044|NCT01227265|26548865|FG001|Overall Study|Withdrawal by Subject|7|||
13314045|NCT01227265|26548866|FG002|Overall Study|Withdrawal by Subject|3|||
13314046|NCT01227265|26548864|FG000|Overall Study|Lost to Follow-up|2|||
13314047|NCT01227265|26548865|FG001|Overall Study|Lost to Follow-up|0|||
13314048|NCT01227265|26548866|FG002|Overall Study|Lost to Follow-up|3|||
13314049|NCT01227265|26548864|FG000|Overall Study|Adverse Event|6|||
13314050|NCT01227265|26548865|FG001|Overall Study|Adverse Event|10|||
13314051|NCT01227265|26548866|FG002|Overall Study|Adverse Event|5|||
13314052|NCT01227252|26548906|FG000|Overall Study|Sponsor Decision|0|||
13314053|NCT01227252|26548907|FG001|Overall Study|Sponsor Decision|1|||
13314054|NCT01227252|26548908|FG002|Overall Study|Sponsor Decision|0|||
13314055|NCT01227252|26548909|FG003|Overall Study|Sponsor Decision|0|||
13314056|NCT01227252|26548906|FG000|Overall Study|Lost to Follow-up|0|||
13314057|NCT01227252|26548907|FG001|Overall Study|Lost to Follow-up|1|||
13314058|NCT01227252|26548908|FG002|Overall Study|Lost to Follow-up|0|||
13314059|NCT01227252|26548909|FG003|Overall Study|Lost to Follow-up|0|||
13314060|NCT01227252|26548906|FG000|Overall Study|Withdrawal by Subject|0|||
13314061|NCT01227252|26548907|FG001|Overall Study|Withdrawal by Subject|1|||
13314062|NCT01227252|26548908|FG002|Overall Study|Withdrawal by Subject|0|||
13314063|NCT01227252|26548909|FG003|Overall Study|Withdrawal by Subject|0|||
13314064|NCT01227044|26548924|FG000|Overall Study|Lost to Follow-up|5|||
13314065|NCT01227044|26548925|FG001|Overall Study|Lost to Follow-up|7|||
13314066|NCT01227044|26548924|FG000|Overall Study|Discontinued Intervention|1|||
13314067|NCT01227044|26548925|FG001|Overall Study|Discontinued Intervention|2|||
13314068|NCT01227018|26548935|FG000|Overall Study|Disease progression|9|||
13314069|NCT01227018|26548935|FG000|Overall Study|Toxicity|2|||
13314070|NCT01227018|26548935|FG000|Overall Study|Withdrew after beginning treatment|4|||
13314071|NCT01226745|26549028|FG000|Overall Study|Did not complete schedule of assessments|8|||
13314072|NCT01226745|26549029|FG001|Overall Study|Did not complete schedule of assessments|3|||
13314073|NCT01226745|26549030|FG002|Overall Study|Did not complete schedule of assessments|6|||
13314074|NCT01226745|26549031|FG003|Overall Study|Did not complete schedule of assessments|0|||
13314075|NCT01226745|26549032|FG004|Overall Study|Did not complete schedule of assessments|0|||
13314076|NCT01226745|26549033|FG005|Overall Study|Did not complete schedule of assessments|1|||
13314077|NCT01226745|26549028|FG000|Overall Study|Lost to Follow-up|2|||
13314078|NCT01226745|26549029|FG001|Overall Study|Lost to Follow-up|6|||
13314079|NCT01226745|26549030|FG002|Overall Study|Lost to Follow-up|6|||
13314080|NCT01226745|26549031|FG003|Overall Study|Lost to Follow-up|1|||
13314081|NCT01226745|26549032|FG004|Overall Study|Lost to Follow-up|1|||
13314082|NCT01226745|26549033|FG005|Overall Study|Lost to Follow-up|2|||
13314083|NCT01226745|26549028|FG000|Overall Study|Death|1|||
13314084|NCT01226745|26549029|FG001|Overall Study|Death|0|||
13314085|NCT01226745|26549030|FG002|Overall Study|Death|0|||
13314086|NCT01226745|26549031|FG003|Overall Study|Death|0|||
13314087|NCT01226745|26549032|FG004|Overall Study|Death|0|||
13314088|NCT01226745|26549033|FG005|Overall Study|Death|1|||
13314089|NCT01226745|26549028|FG000|Overall Study|Other|6|||
13314090|NCT01226745|26549029|FG001|Overall Study|Other|7|||
13314091|NCT01226745|26549030|FG002|Overall Study|Other|8|||
13314092|NCT01226745|26549031|FG003|Overall Study|Other|4|||
13314093|NCT01226745|26549032|FG004|Overall Study|Other|3|||
13314094|NCT01226745|26549033|FG005|Overall Study|Other|1|||
13314095|NCT01226511|26549076|FG000|Acute Treatment Period|Adverse Event|7|||
13314096|NCT01226511|26549077|FG001|Acute Treatment Period|Adverse Event|6|||
13314097|NCT01226511|26549076|FG000|Acute Treatment Period|Lack of Efficacy|2|||
13314098|NCT01226511|26549077|FG001|Acute Treatment Period|Lack of Efficacy|1|||
13314099|NCT01226511|26549076|FG000|Acute Treatment Period|Lost to Follow-up|3|||
13314100|NCT01226511|26549077|FG001|Acute Treatment Period|Lost to Follow-up|6|||
13314101|NCT01226511|26549076|FG000|Acute Treatment Period|Parent/caregiver decision|5|||
13314102|NCT01226511|26549077|FG001|Acute Treatment Period|Parent/caregiver decision|7|||
13314103|NCT01226511|26549076|FG000|Acute Treatment Period|Protocol Violation|5|||
13314104|NCT01226511|26549077|FG001|Acute Treatment Period|Protocol Violation|5|||
13314105|NCT01226511|26549076|FG000|Acute Treatment Period|Withdrawal by Subject|10|||
13314106|NCT01226511|26549077|FG001|Acute Treatment Period|Withdrawal by Subject|6|||
13314107|NCT01226511|26549076|FG000|Extension Treatment Period|Adverse Event|8|||
13314108|NCT01226511|26549077|FG001|Extension Treatment Period|Adverse Event|8|||
13314109|NCT01226511|26549076|FG000|Extension Treatment Period|Lack of Efficacy|3|||
13314110|NCT01226511|26549077|FG001|Extension Treatment Period|Lack of Efficacy|2|||
13314111|NCT01226511|26549076|FG000|Extension Treatment Period|Lost to Follow-up|4|||
13314112|NCT01226511|26549077|FG001|Extension Treatment Period|Lost to Follow-up|3|||
13314113|NCT01226511|26549076|FG000|Extension Treatment Period|Protocol Violation|2|||
13314114|NCT01226511|26549077|FG001|Extension Treatment Period|Protocol Violation|2|||
13314115|NCT01226511|26549076|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
13314116|NCT01226511|26549077|FG001|Extension Treatment Period|Withdrawal by Subject|3|||
13314117|NCT01226511|26549076|FG000|Extension Treatment Period|Parent/Caregiver Decision|8|||
13314118|NCT01226511|26549077|FG001|Extension Treatment Period|Parent/Caregiver Decision|8|||
13314119|NCT01226511|26549076|FG000|Extension Treatment Period|Sponsor Decision|1|||
13314120|NCT01226511|26549077|FG001|Extension Treatment Period|Sponsor Decision|1|||
13314121|NCT01226511|26549076|FG000|Taper Period|Adverse Event|1|||
13314122|NCT01226511|26549077|FG001|Taper Period|Adverse Event|0|||
13314123|NCT01226511|26549076|FG000|Taper Period|Lost to Follow-up|2|||
13314124|NCT01226511|26549077|FG001|Taper Period|Lost to Follow-up|2|||
13314125|NCT01226511|26549076|FG000|Taper Period|Protocol Violation|1|||
13314126|NCT01226511|26549077|FG001|Taper Period|Protocol Violation|0|||
13314127|NCT01226511|26549076|FG000|Taper Period|Parent/Caregiver Decision|1|||
13314128|NCT01226511|26549077|FG001|Taper Period|Parent/Caregiver Decision|1|||
13314129|NCT01226472|26549084|FG000|Overall Study|Progressive Disease|1|||
13314130|NCT01226459|26549101|FG000|Overall Study|Adverse Event|2|||
13314131|NCT01226459|26549102|FG001|Overall Study|Adverse Event|8|||
13314132|NCT01226459|26549101|FG000|Overall Study|Protocol Violation|4|||
13314133|NCT01226459|26549102|FG001|Overall Study|Protocol Violation|3|||
13314134|NCT01226459|26549101|FG000|Overall Study|Withdrawal by Subject|10|||
13314135|NCT01226459|26549102|FG001|Overall Study|Withdrawal by Subject|13|||
13314136|NCT01226459|26549101|FG000|Overall Study|Lost to Follow-up|4|||
13314137|NCT01226459|26549102|FG001|Overall Study|Lost to Follow-up|8|||
13314138|NCT01226459|26549101|FG000|Overall Study|Pregnancy|1|||
13314139|NCT01226459|26549102|FG001|Overall Study|Pregnancy|0|||
13314140|NCT01226121|26549123|FG000|Overall Study|Lost to Follow-up|2|||
13314141|NCT01226121|26549124|FG001|Overall Study|Lost to Follow-up|0|||
13314142|NCT01226121|26549125|FG002|Overall Study|Lost to Follow-up|1|||
13314143|NCT01226095|26549150|FG000|Overall Study|Poor compliance|1|||
13314144|NCT01226043|26549197|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1|||
13314145|NCT01226043|26549198|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2|||
13314146|NCT01226043|26549199|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0|||
13314147|NCT01226043|26549200|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0|||
13314148|NCT01226043|26549197|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
13314149|NCT01226043|26549198|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1|||
13314150|NCT01226043|26549199|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
13314151|NCT01226043|26549200|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
13314152|NCT01226043|26549197|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
13314153|NCT01226043|26549198|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
13314154|NCT01226043|26549199|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
13314155|NCT01226043|26549200|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
13314156|NCT01226043|26549197|FG000|4-week Crossover Phase - Period 1|Physician Decision|0|||
13314157|NCT01226043|26549198|FG001|4-week Crossover Phase - Period 1|Physician Decision|6|||
13314158|NCT01226043|26549199|FG002|4-week Crossover Phase - Period 1|Physician Decision|0|||
13314159|NCT01226043|26549200|FG003|4-week Crossover Phase - Period 1|Physician Decision|0|||
13314160|NCT01226043|26549197|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
13314161|NCT01226043|26549198|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1|||
13314162|NCT01226043|26549199|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
13314163|NCT01226043|26549200|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
13314164|NCT01226043|26549197|FG000|4-week Crossover Phase - Period 2|Physician Decision|4|||
13314165|NCT01226043|26549198|FG001|4-week Crossover Phase - Period 2|Physician Decision|5|||
13314166|NCT01226043|26549199|FG002|4-week Crossover Phase - Period 2|Physician Decision|0|||
13314167|NCT01226043|26549200|FG003|4-week Crossover Phase - Period 2|Physician Decision|0|||
13314168|NCT01226043|26549197|FG000|6-week Re-randomization Phase|Adverse Event|0|||
13314169|NCT01226043|26549198|FG001|6-week Re-randomization Phase|Adverse Event|0|||
13314170|NCT01226043|26549199|FG002|6-week Re-randomization Phase|Adverse Event|1|||
13314171|NCT01226043|26549200|FG003|6-week Re-randomization Phase|Adverse Event|1|||
13314172|NCT01226043|26549197|FG000|6-week Re-randomization Phase|Protocol Violation|0|||
13314173|NCT01226043|26549198|FG001|6-week Re-randomization Phase|Protocol Violation|0|||
13314174|NCT01226043|26549199|FG002|6-week Re-randomization Phase|Protocol Violation|1|||
13314175|NCT01226043|26549200|FG003|6-week Re-randomization Phase|Protocol Violation|1|||
13314176|NCT01226043|26549197|FG000|6-week Re-randomization Phase|Lost to Follow-up|0|||
13314177|NCT01226043|26549198|FG001|6-week Re-randomization Phase|Lost to Follow-up|0|||
13314178|NCT01226043|26549199|FG002|6-week Re-randomization Phase|Lost to Follow-up|1|||
13314179|NCT01226043|26549200|FG003|6-week Re-randomization Phase|Lost to Follow-up|3|||
13314180|NCT01226043|26549197|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0|||
13314181|NCT01226043|26549198|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0|||
13314182|NCT01226043|26549199|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1|||
13314183|NCT01226043|26549200|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3|||
13314184|NCT01226043|26549197|FG000|6-week Re-randomization Phase|Physician Decision|0|||
13314185|NCT01226043|26549198|FG001|6-week Re-randomization Phase|Physician Decision|0|||
13314186|NCT01226043|26549199|FG002|6-week Re-randomization Phase|Physician Decision|3|||
13314187|NCT01226043|26549200|FG003|6-week Re-randomization Phase|Physician Decision|2|||
13314188|NCT01226043|26549197|FG000|6-week Re-randomization Phase|completed in error|0|||
13314189|NCT01226043|26549198|FG001|6-week Re-randomization Phase|completed in error|0|||
13314190|NCT01226043|26549199|FG002|6-week Re-randomization Phase|completed in error|0|||
13314191|NCT01226043|26549200|FG003|6-week Re-randomization Phase|completed in error|1|||
13314192|NCT01226043|26549197|FG000|30-week Observational Phase|Adverse Event|0|||
13314193|NCT01226043|26549198|FG001|30-week Observational Phase|Adverse Event|0|||
13314194|NCT01226043|26549199|FG002|30-week Observational Phase|Adverse Event|1|||
13314195|NCT01226043|26549200|FG003|30-week Observational Phase|Adverse Event|1|||
13314196|NCT01226043|26549197|FG000|30-week Observational Phase|Protocol Violation|0|||
13314197|NCT01226043|26549198|FG001|30-week Observational Phase|Protocol Violation|0|||
13314198|NCT01226043|26549199|FG002|30-week Observational Phase|Protocol Violation|0|||
13314199|NCT01226043|26549200|FG003|30-week Observational Phase|Protocol Violation|1|||
13314200|NCT01226043|26549197|FG000|30-week Observational Phase|Lost to Follow-up|0|||
13314201|NCT01226043|26549198|FG001|30-week Observational Phase|Lost to Follow-up|0|||
13314202|NCT01226043|26549199|FG002|30-week Observational Phase|Lost to Follow-up|2|||
13314203|NCT01226043|26549200|FG003|30-week Observational Phase|Lost to Follow-up|2|||
13314204|NCT01226043|26549197|FG000|30-week Observational Phase|Withdrawal by Subject|0|||
13314205|NCT01226043|26549198|FG001|30-week Observational Phase|Withdrawal by Subject|0|||
13314206|NCT01226043|26549199|FG002|30-week Observational Phase|Withdrawal by Subject|1|||
13314207|NCT01226043|26549200|FG003|30-week Observational Phase|Withdrawal by Subject|7|||
13314208|NCT01226043|26549197|FG000|30-week Observational Phase|Physician Decision|0|||
13314209|NCT01226043|26549198|FG001|30-week Observational Phase|Physician Decision|0|||
13314210|NCT01226043|26549199|FG002|30-week Observational Phase|Physician Decision|2|||
13314211|NCT01226043|26549200|FG003|30-week Observational Phase|Physician Decision|2|||
13314212|NCT01225991|26549210|FG000|Overall Study|Withdrawal by Subject|6|||
13314213|NCT01225952|26549303|FG000|Overall Study|Lost to Follow-up|1|||
13314214|NCT01225952|26549304|FG001|Overall Study|Lost to Follow-up|0|||
13314215|NCT01225952|26549305|FG002|Overall Study|Lost to Follow-up|0|||
13314216|NCT01225952|26549303|FG000|Overall Study|Study Eye Explanted|0|||
13314217|NCT01225952|26549304|FG001|Overall Study|Study Eye Explanted|0|||
13314218|NCT01225952|26549305|FG002|Overall Study|Study Eye Explanted|1|||
13314219|NCT01225952|26549303|FG000|Overall Study|Withdrawal by Subject|4|||
13314220|NCT01225952|26549304|FG001|Overall Study|Withdrawal by Subject|4|||
13314221|NCT01225952|26549305|FG002|Overall Study|Withdrawal by Subject|5|||
13314222|NCT01225952|26549303|FG000|Overall Study|Surgical complications|1|||
13314223|NCT01225952|26549304|FG001|Overall Study|Surgical complications|0|||
13314224|NCT01225952|26549305|FG002|Overall Study|Surgical complications|0|||
13314225|NCT01225887|26549315|FG000|Overall Study|Ineligible:required test not done|2|||
13314226|NCT01225887|26549315|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1|||
13314227|NCT01225887|26549315|FG000|Overall Study|Ineligible:inadequate pathology|2|||
13314228|NCT01225835|26549365|FG000|Overall Study|Completed protocol|2|||
13314229|NCT01225835|26549366|FG001|Overall Study|Completed protocol|1|||
13314230|NCT01225835|26549365|FG000|Overall Study|Did not meet hCG criterion|2|||
13314231|NCT01225835|26549366|FG001|Overall Study|Did not meet hCG criterion|0|||
13314232|NCT01225835|26549365|FG000|Overall Study|Adverse Event|2|||
13314233|NCT01225835|26549366|FG001|Overall Study|Adverse Event|1|||
13314234|NCT01225835|26549365|FG000|Overall Study|Other|1|||
13314235|NCT01225835|26549366|FG001|Overall Study|Other|1|||
13314236|NCT01225822|26549444|FG000|Overall Study|Adverse Event|13|||
13314237|NCT01225822|26549445|FG001|Overall Study|Adverse Event|31|||
13314238|NCT01225822|26549446|FG002|Overall Study|Adverse Event|18|||
13314239|NCT01225822|26549447|FG003|Overall Study|Adverse Event|23|||
13314240|NCT01225822|26549448|FG004|Overall Study|Adverse Event|14|||
13314241|NCT01225822|26549444|FG000|Overall Study|Protocol Violation|6|||
13314242|NCT01225822|26549445|FG001|Overall Study|Protocol Violation|8|||
13314243|NCT01225822|26549446|FG002|Overall Study|Protocol Violation|6|||
13314244|NCT01225822|26549447|FG003|Overall Study|Protocol Violation|7|||
13314245|NCT01225822|26549448|FG004|Overall Study|Protocol Violation|4|||
13314246|NCT01225822|26549444|FG000|Overall Study|Lost to Follow-up|0|||
13314247|NCT01225822|26549445|FG001|Overall Study|Lost to Follow-up|0|||
13314248|NCT01225822|26549446|FG002|Overall Study|Lost to Follow-up|0|||
13314249|NCT01225822|26549447|FG003|Overall Study|Lost to Follow-up|1|||
13314250|NCT01225822|26549448|FG004|Overall Study|Lost to Follow-up|0|||
13314251|NCT01225822|26549444|FG000|Overall Study|Withdrawal by Subject|6|||
13314252|NCT01225822|26549445|FG001|Overall Study|Withdrawal by Subject|7|||
13314253|NCT01225822|26549446|FG002|Overall Study|Withdrawal by Subject|7|||
13314254|NCT01225822|26549447|FG003|Overall Study|Withdrawal by Subject|11|||
13314255|NCT01225822|26549448|FG004|Overall Study|Withdrawal by Subject|6|||
13314256|NCT01225822|26549444|FG000|Overall Study|Other|13|||
13314257|NCT01225822|26549445|FG001|Overall Study|Other|10|||
13314258|NCT01225822|26549446|FG002|Overall Study|Other|7|||
13314259|NCT01225822|26549447|FG003|Overall Study|Other|10|||
13314260|NCT01225822|26549448|FG004|Overall Study|Other|7|||
13314261|NCT01225731|26549564|FG000|Part 1|Did not meet eligibility criteria|1|||
13314262|NCT01225731|26549565|FG001|Part 1|Did not meet eligibility criteria|0|||
13314263|NCT01225731|26549566|FG002|Part 1|Did not meet eligibility criteria|0|||
13314264|NCT01225731|26549567|FG003|Part 1|Did not meet eligibility criteria|0|||
13314265|NCT01225731|26549568|FG004|Part 1|Did not meet eligibility criteria|1|||
13314266|NCT01225731|26549569|FG005|Part 1|Did not meet eligibility criteria|0|||
13314267|NCT01225731|26549570|FG006|Part 1|Did not meet eligibility criteria|0|||
13314268|NCT01225731|26549571|FG007|Part 1|Did not meet eligibility criteria|0|||
13314269|NCT01225731|26549572|FG008|Part 1|Did not meet eligibility criteria|0|||
13314270|NCT01225731|26549573|FG009|Part 1|Did not meet eligibility criteria|0|||
13314271|NCT01225731|26549574|FG010|Part 1|Did not meet eligibility criteria|0|||
13314272|NCT01225731|26549575|FG011|Part 1|Did not meet eligibility criteria|0|||
13314273|NCT01225731|26549576|FG012|Part 1|Did not meet eligibility criteria|0|||
13314274|NCT01225731|26549564|FG000|Part 1|Adverse Event|1|||
13314275|NCT01225731|26549565|FG001|Part 1|Adverse Event|2|||
13314276|NCT01225731|26549566|FG002|Part 1|Adverse Event|1|||
13314277|NCT01225731|26549567|FG003|Part 1|Adverse Event|1|||
13314278|NCT01225731|26549568|FG004|Part 1|Adverse Event|1|||
13314279|NCT01225731|26549569|FG005|Part 1|Adverse Event|0|||
13314280|NCT01225731|26549570|FG006|Part 1|Adverse Event|0|||
13314281|NCT01225731|26549571|FG007|Part 1|Adverse Event|0|||
13314282|NCT01225731|26549572|FG008|Part 1|Adverse Event|0|||
13314283|NCT01225731|26549573|FG009|Part 1|Adverse Event|0|||
13314284|NCT01225731|26549574|FG010|Part 1|Adverse Event|0|||
13314285|NCT01225731|26549575|FG011|Part 1|Adverse Event|0|||
13314286|NCT01225731|26549576|FG012|Part 1|Adverse Event|0|||
13314287|NCT01225731|26549564|FG000|Part 1|Withdrawal by Subject|0|||
13314288|NCT01225731|26549565|FG001|Part 1|Withdrawal by Subject|3|||
13314289|NCT01225731|26549566|FG002|Part 1|Withdrawal by Subject|0|||
13314290|NCT01225731|26549567|FG003|Part 1|Withdrawal by Subject|0|||
13314291|NCT01225731|26549568|FG004|Part 1|Withdrawal by Subject|4|||
13314292|NCT01225731|26549569|FG005|Part 1|Withdrawal by Subject|0|||
13314293|NCT01225731|26549570|FG006|Part 1|Withdrawal by Subject|0|||
13314294|NCT01225731|26549571|FG007|Part 1|Withdrawal by Subject|0|||
13314295|NCT01225731|26549572|FG008|Part 1|Withdrawal by Subject|0|||
13314296|NCT01225731|26549573|FG009|Part 1|Withdrawal by Subject|0|||
13314297|NCT01225731|26549574|FG010|Part 1|Withdrawal by Subject|0|||
13314298|NCT01225731|26549575|FG011|Part 1|Withdrawal by Subject|0|||
13314299|NCT01225731|26549576|FG012|Part 1|Withdrawal by Subject|0|||
13314300|NCT01225731|26549564|FG000|Part 1|Protocol Violation|0|||
13314301|NCT01225731|26549565|FG001|Part 1|Protocol Violation|0|||
13314302|NCT01225731|26549566|FG002|Part 1|Protocol Violation|0|||
13314303|NCT01225731|26549567|FG003|Part 1|Protocol Violation|1|||
13314304|NCT01225731|26549568|FG004|Part 1|Protocol Violation|0|||
13314305|NCT01225731|26549569|FG005|Part 1|Protocol Violation|0|||
13314306|NCT01225731|26549570|FG006|Part 1|Protocol Violation|0|||
13314307|NCT01225731|26549571|FG007|Part 1|Protocol Violation|0|||
13314308|NCT01225731|26549572|FG008|Part 1|Protocol Violation|0|||
13314309|NCT01225731|26549573|FG009|Part 1|Protocol Violation|0|||
13314310|NCT01225731|26549574|FG010|Part 1|Protocol Violation|0|||
13314311|NCT01225731|26549575|FG011|Part 1|Protocol Violation|0|||
13314312|NCT01225731|26549576|FG012|Part 1|Protocol Violation|0|||
13314313|NCT01225731|26549564|FG000|Part 2|Protocol Violation|0|||
13314314|NCT01225731|26549565|FG001|Part 2|Protocol Violation|0|||
13314315|NCT01225731|26549566|FG002|Part 2|Protocol Violation|0|||
13314316|NCT01225731|26549567|FG003|Part 2|Protocol Violation|0|||
13314317|NCT01225731|26549568|FG004|Part 2|Protocol Violation|0|||
13314318|NCT01225731|26549569|FG005|Part 2|Protocol Violation|1|||
13314319|NCT01225731|26549570|FG006|Part 2|Protocol Violation|0|||
13314320|NCT01225731|26549571|FG007|Part 2|Protocol Violation|0|||
13314321|NCT01225731|26549572|FG008|Part 2|Protocol Violation|1|||
13314322|NCT01225731|26549573|FG009|Part 2|Protocol Violation|0|||
13314323|NCT01225731|26549574|FG010|Part 2|Protocol Violation|0|||
13314324|NCT01225731|26549575|FG011|Part 2|Protocol Violation|0|||
13314325|NCT01225731|26549576|FG012|Part 2|Protocol Violation|0|||
13314326|NCT01225731|26549564|FG000|Part 2|Adverse Event|0|||
13314327|NCT01225731|26549565|FG001|Part 2|Adverse Event|0|||
13314328|NCT01225731|26549566|FG002|Part 2|Adverse Event|0|||
13314329|NCT01225731|26549567|FG003|Part 2|Adverse Event|0|||
13314330|NCT01225731|26549568|FG004|Part 2|Adverse Event|0|||
13314331|NCT01225731|26549569|FG005|Part 2|Adverse Event|0|||
13314332|NCT01225731|26549570|FG006|Part 2|Adverse Event|4|||
13314333|NCT01225731|26549571|FG007|Part 2|Adverse Event|4|||
13314334|NCT01225731|26549572|FG008|Part 2|Adverse Event|2|||
13314335|NCT01225731|26549573|FG009|Part 2|Adverse Event|0|||
13314336|NCT01225731|26549574|FG010|Part 2|Adverse Event|0|||
13314337|NCT01225731|26549575|FG011|Part 2|Adverse Event|0|||
13314338|NCT01225731|26549576|FG012|Part 2|Adverse Event|0|||
13314339|NCT01225731|26549564|FG000|Part 2|Lack of Efficacy|0|||
13314340|NCT01225731|26549565|FG001|Part 2|Lack of Efficacy|0|||
13314341|NCT01225731|26549566|FG002|Part 2|Lack of Efficacy|0|||
13314342|NCT01225731|26549567|FG003|Part 2|Lack of Efficacy|0|||
13314343|NCT01225731|26549568|FG004|Part 2|Lack of Efficacy|0|||
13314344|NCT01225731|26549569|FG005|Part 2|Lack of Efficacy|1|||
13314345|NCT01225731|26549570|FG006|Part 2|Lack of Efficacy|0|||
13314346|NCT01225731|26549571|FG007|Part 2|Lack of Efficacy|12|||
13314347|NCT01225731|26549572|FG008|Part 2|Lack of Efficacy|3|||
13314348|NCT01225731|26549573|FG009|Part 2|Lack of Efficacy|0|||
13314349|NCT01225731|26549574|FG010|Part 2|Lack of Efficacy|0|||
13314350|NCT01225731|26549575|FG011|Part 2|Lack of Efficacy|0|||
13314351|NCT01225731|26549576|FG012|Part 2|Lack of Efficacy|0|||
13314352|NCT01225731|26549564|FG000|Part 2|Pregnancy|0|||
13314353|NCT01225731|26549565|FG001|Part 2|Pregnancy|0|||
13314354|NCT01225731|26549566|FG002|Part 2|Pregnancy|0|||
13314355|NCT01225731|26549567|FG003|Part 2|Pregnancy|0|||
13314356|NCT01225731|26549568|FG004|Part 2|Pregnancy|0|||
13314357|NCT01225731|26549569|FG005|Part 2|Pregnancy|0|||
13314358|NCT01225731|26549570|FG006|Part 2|Pregnancy|1|||
13314359|NCT01225731|26549571|FG007|Part 2|Pregnancy|0|||
13314360|NCT01225731|26549572|FG008|Part 2|Pregnancy|1|||
13314361|NCT01225731|26549573|FG009|Part 2|Pregnancy|0|||
13314362|NCT01225731|26549574|FG010|Part 2|Pregnancy|0|||
13314363|NCT01225731|26549575|FG011|Part 2|Pregnancy|0|||
13314364|NCT01225731|26549576|FG012|Part 2|Pregnancy|0|||
13314365|NCT01225731|26549564|FG000|Part 2|Lost to Follow-up|0|||
13314366|NCT01225731|26549565|FG001|Part 2|Lost to Follow-up|0|||
13314367|NCT01225731|26549566|FG002|Part 2|Lost to Follow-up|0|||
13314368|NCT01225731|26549567|FG003|Part 2|Lost to Follow-up|0|||
13314369|NCT01225731|26549568|FG004|Part 2|Lost to Follow-up|0|||
13314370|NCT01225731|26549569|FG005|Part 2|Lost to Follow-up|0|||
13314371|NCT01225731|26549570|FG006|Part 2|Lost to Follow-up|0|||
13314372|NCT01225731|26549571|FG007|Part 2|Lost to Follow-up|3|||
13314373|NCT01225731|26549572|FG008|Part 2|Lost to Follow-up|1|||
13314374|NCT01225731|26549573|FG009|Part 2|Lost to Follow-up|0|||
13314375|NCT01225731|26549574|FG010|Part 2|Lost to Follow-up|0|||
13314376|NCT01225731|26549575|FG011|Part 2|Lost to Follow-up|0|||
13314377|NCT01225731|26549576|FG012|Part 2|Lost to Follow-up|0|||
13314378|NCT01225731|26549564|FG000|Part 2|Physician Decision|0|||
13314379|NCT01225731|26549565|FG001|Part 2|Physician Decision|0|||
13314380|NCT01225731|26549566|FG002|Part 2|Physician Decision|0|||
13314381|NCT01225731|26549567|FG003|Part 2|Physician Decision|0|||
13314382|NCT01225731|26549568|FG004|Part 2|Physician Decision|0|||
13314383|NCT01225731|26549569|FG005|Part 2|Physician Decision|0|||
13314384|NCT01225731|26549570|FG006|Part 2|Physician Decision|0|||
13314385|NCT01225731|26549571|FG007|Part 2|Physician Decision|2|||
13314386|NCT01225731|26549572|FG008|Part 2|Physician Decision|2|||
13314387|NCT01225731|26549573|FG009|Part 2|Physician Decision|0|||
13314388|NCT01225731|26549574|FG010|Part 2|Physician Decision|0|||
13314389|NCT01225731|26549575|FG011|Part 2|Physician Decision|0|||
13314390|NCT01225731|26549576|FG012|Part 2|Physician Decision|0|||
13314391|NCT01225731|26549564|FG000|Part 2|Withdrawal by Subject|0|||
13314392|NCT01225731|26549565|FG001|Part 2|Withdrawal by Subject|0|||
13314393|NCT01225731|26549566|FG002|Part 2|Withdrawal by Subject|0|||
13314394|NCT01225731|26549567|FG003|Part 2|Withdrawal by Subject|0|||
13314395|NCT01225731|26549568|FG004|Part 2|Withdrawal by Subject|0|||
13314396|NCT01225731|26549569|FG005|Part 2|Withdrawal by Subject|1|||
13314397|NCT01225731|26549570|FG006|Part 2|Withdrawal by Subject|3|||
13314398|NCT01225731|26549571|FG007|Part 2|Withdrawal by Subject|4|||
13314399|NCT01225731|26549572|FG008|Part 2|Withdrawal by Subject|1|||
13314400|NCT01225731|26549573|FG009|Part 2|Withdrawal by Subject|0|||
13314401|NCT01225731|26549574|FG010|Part 2|Withdrawal by Subject|0|||
13314402|NCT01225731|26549575|FG011|Part 2|Withdrawal by Subject|0|||
13314403|NCT01225731|26549576|FG012|Part 2|Withdrawal by Subject|0|||
13314404|NCT01225731|26549564|FG000|Part 3|Adverse Event|0|||
13314405|NCT01225731|26549565|FG001|Part 3|Adverse Event|0|||
13314406|NCT01225731|26549566|FG002|Part 3|Adverse Event|0|||
13314407|NCT01225731|26549567|FG003|Part 3|Adverse Event|0|||
13314408|NCT01225731|26549568|FG004|Part 3|Adverse Event|0|||
13314409|NCT01225731|26549569|FG005|Part 3|Adverse Event|0|||
13314410|NCT01225731|26549570|FG006|Part 3|Adverse Event|0|||
13314411|NCT01225731|26549571|FG007|Part 3|Adverse Event|0|||
13314412|NCT01225731|26549572|FG008|Part 3|Adverse Event|0|||
13314413|NCT01225731|26549573|FG009|Part 3|Adverse Event|0|||
13314414|NCT01225731|26549574|FG010|Part 3|Adverse Event|1|||
13314415|NCT01225731|26549575|FG011|Part 3|Adverse Event|1|||
13314416|NCT01225731|26549576|FG012|Part 3|Adverse Event|0|||
13314417|NCT01225731|26549564|FG000|Part 3|Lost to Follow-up|0|||
13314418|NCT01225731|26549565|FG001|Part 3|Lost to Follow-up|0|||
13314419|NCT01225731|26549566|FG002|Part 3|Lost to Follow-up|0|||
13314420|NCT01225731|26549567|FG003|Part 3|Lost to Follow-up|0|||
13314421|NCT01225731|26549568|FG004|Part 3|Lost to Follow-up|0|||
13314422|NCT01225731|26549569|FG005|Part 3|Lost to Follow-up|0|||
13314423|NCT01225731|26549570|FG006|Part 3|Lost to Follow-up|0|||
13314424|NCT01225731|26549571|FG007|Part 3|Lost to Follow-up|0|||
13314425|NCT01225731|26549572|FG008|Part 3|Lost to Follow-up|0|||
13314426|NCT01225731|26549573|FG009|Part 3|Lost to Follow-up|0|||
13314427|NCT01225731|26549574|FG010|Part 3|Lost to Follow-up|1|||
13314428|NCT01225731|26549575|FG011|Part 3|Lost to Follow-up|2|||
13314429|NCT01225731|26549576|FG012|Part 3|Lost to Follow-up|1|||
13314430|NCT01225731|26549564|FG000|Part 3|Physician Decision|0|||
13314431|NCT01225731|26549565|FG001|Part 3|Physician Decision|0|||
13314432|NCT01225731|26549566|FG002|Part 3|Physician Decision|0|||
13314433|NCT01225731|26549567|FG003|Part 3|Physician Decision|0|||
13314434|NCT01225731|26549568|FG004|Part 3|Physician Decision|0|||
13314435|NCT01225731|26549569|FG005|Part 3|Physician Decision|0|||
13314436|NCT01225731|26549570|FG006|Part 3|Physician Decision|0|||
13314437|NCT01225731|26549571|FG007|Part 3|Physician Decision|0|||
13314438|NCT01225731|26549572|FG008|Part 3|Physician Decision|0|||
13314439|NCT01225731|26549573|FG009|Part 3|Physician Decision|0|||
13314440|NCT01225731|26549574|FG010|Part 3|Physician Decision|0|||
13314441|NCT01225731|26549575|FG011|Part 3|Physician Decision|1|||
13314442|NCT01225731|26549576|FG012|Part 3|Physician Decision|2|||
13314443|NCT01225731|26549564|FG000|Part 3|Withdrawal by Subject|0|||
13314444|NCT01225731|26549565|FG001|Part 3|Withdrawal by Subject|0|||
13314445|NCT01225731|26549566|FG002|Part 3|Withdrawal by Subject|0|||
13314446|NCT01225731|26549567|FG003|Part 3|Withdrawal by Subject|0|||
13314447|NCT01225731|26549568|FG004|Part 3|Withdrawal by Subject|0|||
13314448|NCT01225731|26549569|FG005|Part 3|Withdrawal by Subject|0|||
13314449|NCT01225731|26549570|FG006|Part 3|Withdrawal by Subject|0|||
13314450|NCT01225731|26549571|FG007|Part 3|Withdrawal by Subject|0|||
13314451|NCT01225731|26549572|FG008|Part 3|Withdrawal by Subject|0|||
13314452|NCT01225731|26549573|FG009|Part 3|Withdrawal by Subject|0|||
13314453|NCT01225731|26549574|FG010|Part 3|Withdrawal by Subject|4|||
13314454|NCT01225731|26549575|FG011|Part 3|Withdrawal by Subject|6|||
13314455|NCT01225731|26549576|FG012|Part 3|Withdrawal by Subject|4|||
13314456|NCT01225562|26549603|FG000|Overall Study|Withdrawal by Subject|52|||
13314457|NCT01225562|26549604|FG001|Overall Study|Withdrawal by Subject|50|||
13314458|NCT01225562|26549605|FG002|Overall Study|Withdrawal by Subject|52|||
13314459|NCT01225562|26549603|FG000|Overall Study|Lost to Follow-up|3|||
13314460|NCT01225562|26549604|FG001|Overall Study|Lost to Follow-up|6|||
13314461|NCT01225562|26549605|FG002|Overall Study|Lost to Follow-up|1|||
13314462|NCT01225549|26549658|FG000|Period 4 - Washout|Disallowed medication|0|||
13314463|NCT01225549|26549659|FG001|Period 4 - Washout|Disallowed medication|1|||
13314464|NCT01225549|26549660|FG002|Period 4 - Washout|Disallowed medication|0|||
13314465|NCT01225549|26549661|FG003|Period 4 - Washout|Disallowed medication|0|||
13314466|NCT01225549|26549662|FG004|Period 4 - Washout|Disallowed medication|0|||
13314467|NCT01225549|26549663|FG005|Period 4 - Washout|Disallowed medication|0|||
13314468|NCT01225549|26549664|FG006|Period 4 - Washout|Disallowed medication|0|||
13314469|NCT01225549|26549665|FG007|Period 4 - Washout|Disallowed medication|0|||
13314470|NCT01225549|26549666|FG008|Period 4 - Washout|Disallowed medication|0|||
13314471|NCT01225549|26549667|FG009|Period 4 - Washout|Disallowed medication|0|||
13314472|NCT01225549|26549658|FG000|Period 6 - Washout|Disallowed medication|0|||
13314473|NCT01225549|26549659|FG001|Period 6 - Washout|Disallowed medication|0|||
13314474|NCT01225549|26549660|FG002|Period 6 - Washout|Disallowed medication|0|||
13314475|NCT01225549|26549661|FG003|Period 6 - Washout|Disallowed medication|1|||
13314476|NCT01225549|26549662|FG004|Period 6 - Washout|Disallowed medication|0|||
13314477|NCT01225549|26549663|FG005|Period 6 - Washout|Disallowed medication|0|||
13314478|NCT01225549|26549664|FG006|Period 6 - Washout|Disallowed medication|0|||
13314479|NCT01225549|26549665|FG007|Period 6 - Washout|Disallowed medication|0|||
13314480|NCT01225549|26549666|FG008|Period 6 - Washout|Disallowed medication|0|||
13314481|NCT01225549|26549667|FG009|Period 6 - Washout|Disallowed medication|0|||
13314482|NCT01225211|26549799|FG000|Overall Study|Adverse Event|0|||
13314483|NCT01225211|26549800|FG001|Overall Study|Adverse Event|0|||
13314484|NCT01225211|26549801|FG002|Overall Study|Adverse Event|1|||
13314485|NCT01225211|26549802|FG003|Overall Study|Adverse Event|0|||
13314486|NCT01225211|26549803|FG004|Overall Study|Adverse Event|0|||
13314487|NCT01225211|26549804|FG005|Overall Study|Adverse Event|0|||
13314488|NCT01225211|26549805|FG006|Overall Study|Adverse Event|0|||
13314489|NCT01225211|26549806|FG007|Overall Study|Adverse Event|0|||
13314490|NCT01225211|26549807|FG008|Overall Study|Adverse Event|0|||
13314491|NCT01225211|26549808|FG009|Overall Study|Adverse Event|1|||
13314492|NCT01225211|26549799|FG000|Overall Study|Withdrawal by Subject|0|||
13314493|NCT01225211|26549800|FG001|Overall Study|Withdrawal by Subject|0|||
13314494|NCT01225211|26549801|FG002|Overall Study|Withdrawal by Subject|0|||
13314495|NCT01225211|26549802|FG003|Overall Study|Withdrawal by Subject|0|||
13314496|NCT01225211|26549803|FG004|Overall Study|Withdrawal by Subject|0|||
13314497|NCT01225211|26549804|FG005|Overall Study|Withdrawal by Subject|0|||
13314498|NCT01225211|26549805|FG006|Overall Study|Withdrawal by Subject|1|||
13314499|NCT01225211|26549806|FG007|Overall Study|Withdrawal by Subject|0|||
13314500|NCT01225211|26549807|FG008|Overall Study|Withdrawal by Subject|1|||
13314501|NCT01225211|26549808|FG009|Overall Study|Withdrawal by Subject|3|||
13314502|NCT01225211|26549799|FG000|Overall Study|Other|0|||
13314503|NCT01225211|26549800|FG001|Overall Study|Other|0|||
13314504|NCT01225211|26549801|FG002|Overall Study|Other|0|||
13314505|NCT01225211|26549802|FG003|Overall Study|Other|0|||
13314506|NCT01225211|26549803|FG004|Overall Study|Other|0|||
13314507|NCT01225211|26549804|FG005|Overall Study|Other|0|||
13314508|NCT01225211|26549805|FG006|Overall Study|Other|0|||
13314509|NCT01225211|26549806|FG007|Overall Study|Other|0|||
13314510|NCT01225211|26549807|FG008|Overall Study|Other|0|||
13314511|NCT01225211|26549808|FG009|Overall Study|Other|1|||
13314512|NCT01225172|26549835|FG000|Overall Study|Subject decision to stop|1|||
13314513|NCT01225172|26549836|FG001|Overall Study|Subject decision to stop|0|||
13314514|NCT01225172|26549835|FG000|Overall Study|Subject request to discontinue treatment|3|||
13314515|NCT01225172|26549836|FG001|Overall Study|Subject request to discontinue treatment|1|||
13314516|NCT01225172|26549835|FG000|Overall Study|Subject no longer meets study criteria|1|||
13314517|NCT01225172|26549836|FG001|Overall Study|Subject no longer meets study criteria|0|||
13314518|NCT01225172|26549835|FG000|Overall Study|Withdrawal by Subject|1|||
13314519|NCT01225172|26549836|FG001|Overall Study|Withdrawal by Subject|0|||
13314520|NCT01225159|26549851|FG000|Overall Study|Change operation|1|||
13314521|NCT01225159|26549852|FG001|Overall Study|Change operation|0|||
13314522|NCT01225146|26549875|FG000|Overall Study|Sponsor discontinued making 2mg drug|0|||
13314523|NCT01225146|26549876|FG001|Overall Study|Sponsor discontinued making 2mg drug|2|||
13314524|NCT01224925|26549891|FG000|Overall Study|Lost to Follow-up|3|||
13314525|NCT01224925|26549892|FG001|Overall Study|Lost to Follow-up|2|||
13314526|NCT01224821|26549913|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
13314527|NCT01224821|26549913|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38|||
13314528|NCT01224821|26549913|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3|||
13314529|NCT01224821|26549913|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
13314530|NCT01224821|26549913|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1|||
13314531|NCT01224821|26549913|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1|||
13314532|NCT01224821|26549913|FG000|Long-Term Follow-Up|Death|2|||
13314533|NCT01224821|26549913|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9|||
13314534|NCT01224782|26549924|FG000|Overall Study|Lost to Follow-up|177|||
13314535|NCT01224782|26549924|FG000|Overall Study|Withdrawal by Subject|16|||
13314536|NCT01224782|26549924|FG000|Overall Study|Death|14|||
13314537|NCT01224782|26549924|FG000|Overall Study|Improvement|13|||
13314538|NCT01224782|26549924|FG000|Overall Study|Adverse Event|12|||
13314539|NCT01224782|26549924|FG000|Overall Study|Adverse Reaction|11|||
13314540|NCT01224782|26549924|FG000|Overall Study|Noncompliance|10|||
13314541|NCT01224782|26549924|FG000|Overall Study|Other|4|||
13314542|NCT01224782|26549924|FG000|Overall Study|Start of Dialysis|3|||
13314543|NCT01224782|26549924|FG000|Overall Study|Change of Treatment|1|||
13314544|NCT01224782|26549924|FG000|Overall Study|Financial Reasons|1|||
13314545|NCT01224782|26549924|FG000|Overall Study|Deterioration|1|||
13314546|NCT01224782|26549924|FG000|Overall Study|Transplantation|1|||
13314547|NCT01224639|26550055|FG000|Overall Study|Withdrawal by Subject|0|||
13314548|NCT01224639|26550056|FG001|Overall Study|Withdrawal by Subject|0|||
13314549|NCT01224639|26550057|FG002|Overall Study|Withdrawal by Subject|0|||
13314550|NCT01224639|26550058|FG003|Overall Study|Withdrawal by Subject|0|||
13314551|NCT01224639|26550059|FG004|Overall Study|Withdrawal by Subject|2|||
13314552|NCT01224639|26550060|FG005|Overall Study|Withdrawal by Subject|0|||
13314553|NCT01224639|26550061|FG006|Overall Study|Withdrawal by Subject|1|||
13314554|NCT01224639|26550062|FG007|Overall Study|Withdrawal by Subject|1|||
13314555|NCT01224639|26550055|FG000|Overall Study|Adverse Event|0|||
13314556|NCT01224639|26550056|FG001|Overall Study|Adverse Event|0|||
13314557|NCT01224639|26550057|FG002|Overall Study|Adverse Event|0|||
13314558|NCT01224639|26550058|FG003|Overall Study|Adverse Event|0|||
13314559|NCT01224639|26550059|FG004|Overall Study|Adverse Event|0|||
13314560|NCT01224639|26550060|FG005|Overall Study|Adverse Event|0|||
13314561|NCT01224639|26550061|FG006|Overall Study|Adverse Event|0|||
13314562|NCT01224639|26550062|FG007|Overall Study|Adverse Event|1|||
13314563|NCT01224431|26550077|FG000|Overall Study|not randomized|0|||
13314564|NCT01224431|26550078|FG001|Overall Study|not randomized|4|||
13314565|NCT01224431|26550077|FG000|Overall Study|no video record|0|||
13314566|NCT01224431|26550078|FG001|Overall Study|no video record|1|||
13314567|NCT01224171|26550105|FG000|Overall Study|Adverse Event|8|||
13314568|NCT01224171|26550106|FG001|Overall Study|Adverse Event|4|||
13314569|NCT01224171|26550105|FG000|Overall Study|Protocol Violation|0|||
13314570|NCT01224171|26550106|FG001|Overall Study|Protocol Violation|1|||
13314571|NCT01224171|26550105|FG000|Overall Study|Lack of Efficacy|5|||
13314572|NCT01224171|26550106|FG001|Overall Study|Lack of Efficacy|1|||
13314573|NCT01224171|26550105|FG000|Overall Study|Withdrawal of Consent|2|||
13314574|NCT01224171|26550106|FG001|Overall Study|Withdrawal of Consent|4|||
13314575|NCT01224171|26550105|FG000|Overall Study|Lost to Follow-up|0|||
13314576|NCT01224171|26550106|FG001|Overall Study|Lost to Follow-up|3|||
13314577|NCT01224158|26550129|FG000|Overall Study|Withdrawal by Subject|1|||
13314578|NCT01224158|26550130|FG001|Overall Study|Withdrawal by Subject|0|||
13314579|NCT01223937|26550159|FG000|Overall Study|Withdrawal by Subject|3|||
13314580|NCT01223937|26550160|FG001|Overall Study|Withdrawal by Subject|2|||
13314581|NCT01223937|26550159|FG000|Overall Study|Lost to Follow-up|1|||
13314582|NCT01223937|26550160|FG001|Overall Study|Lost to Follow-up|4|||
13314583|NCT01223937|26550159|FG000|Overall Study|Adverse Event|1|||
13314584|NCT01223937|26550160|FG001|Overall Study|Adverse Event|4|||
13314585|NCT01223937|26550159|FG000|Overall Study|Protocol Violation|8|||
13314586|NCT01223937|26550160|FG001|Overall Study|Protocol Violation|7|||
13314587|NCT01223937|26550159|FG000|Overall Study|Other|4|||
13314588|NCT01223937|26550160|FG001|Overall Study|Other|1|||
13314589|NCT01223404|26550190|FG000|First Intervention (1 Day)|Adverse Event|0|||
13314590|NCT01223404|26550191|FG001|First Intervention (1 Day)|Adverse Event|0|||
13314591|NCT01223404|26550192|FG002|First Intervention (1 Day)|Adverse Event|0|||
13314592|NCT01223404|26550193|FG003|First Intervention (1 Day)|Adverse Event|1|||
13314593|NCT01223404|26550194|FG004|First Intervention (1 Day)|Adverse Event|0|||
13314594|NCT01223404|26550195|FG005|First Intervention (1 Day)|Adverse Event|0|||
13314595|NCT01223404|26550190|FG000|Second Intervention (1 Day)|Adverse Event|1|||
13314596|NCT01223404|26550191|FG001|Second Intervention (1 Day)|Adverse Event|0|||
13314597|NCT01223404|26550192|FG002|Second Intervention (1 Day)|Adverse Event|0|||
13314598|NCT01223404|26550193|FG003|Second Intervention (1 Day)|Adverse Event|0|||
13314599|NCT01223404|26550194|FG004|Second Intervention (1 Day)|Adverse Event|0|||
13314600|NCT01223404|26550195|FG005|Second Intervention (1 Day)|Adverse Event|0|||
13314601|NCT01223404|26550190|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0|||
13314602|NCT01223404|26550191|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0|||
13314603|NCT01223404|26550192|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0|||
13314604|NCT01223404|26550193|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1|||
13314605|NCT01223404|26550194|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0|||
13314606|NCT01223404|26550195|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0|||
13314607|NCT01223365|26550238|FG000|Open-label Titration Period|Enrolled but not treated|1|||
13314608|NCT01223365|26550238|FG000|Open-label Titration Period|Adverse Event|23|||
13314609|NCT01223365|26550238|FG000|Open-label Titration Period|Lack of Efficacy|3|||
13314610|NCT01223365|26550238|FG000|Open-label Titration Period|Withdrawal by Subject|5|||
13314611|NCT01223365|26550238|FG000|Open-label Titration Period|Protocol Violation|1|||
13314612|NCT01223365|26550238|FG000|Open-label Titration Period|Lost to Follow-up|2|||
13314613|NCT01223365|26550238|FG000|Open-label Titration Period|Noncompliance with study drug admin|1|||
13314614|NCT01223365|26550238|FG000|Open-label Titration Period|Noncompliance with study procedures|2|||
13314615|NCT01223365|26550238|FG000|Open-label Titration Period|Starting physical therapy|1|||
13314616|NCT01223365|26550238|FG000|Open-label Treatment Period|Adverse Event|39|||
13314617|NCT01223365|26550238|FG000|Open-label Treatment Period|Lack of Efficacy|2|||
13314618|NCT01223365|26550238|FG000|Open-label Treatment Period|Withdrawal by Subject|19|||
13314619|NCT01223365|26550238|FG000|Open-label Treatment Period|Protocol Violation|15|||
13314620|NCT01223365|26550238|FG000|Open-label Treatment Period|Lost to Follow-up|7|||
13314621|NCT01223365|26550238|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7|||
13314622|NCT01223365|26550238|FG000|Open-label Treatment Period|Noncompliance with study procedures|6|||
13314623|NCT01223365|26550238|FG000|Open-label Treatment Period|Moved out of area|2|||
13314624|NCT01223365|26550238|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1|||
13314625|NCT01223365|26550238|FG000|Open-label Treatment Period|"Out of window"|1|||
13314626|NCT01223365|26550238|FG000|Open-label Treatment Period|Starting physical therapy|1|||
13314627|NCT01223365|26550238|FG000|Open-label Treatment Period|Physician Decision|2|||
13314628|NCT01223235|26550246|FG000|Overall Study|Withdrawal by Subject|1|||
13314629|NCT01223196|26550263|FG000|Overall Study|Lost to Follow-up|2|||
13314630|NCT01223196|26550264|FG001|Overall Study|Lost to Follow-up|0|||
13314631|NCT01223196|26550263|FG000|Overall Study|Physician Decision|1|||
13314632|NCT01223196|26550264|FG001|Overall Study|Physician Decision|0|||
13314633|NCT01223196|26550263|FG000|Overall Study|Withdrawal by Subject|1|||
13314634|NCT01223196|26550264|FG001|Overall Study|Withdrawal by Subject|0|||
13314635|NCT01223183|26550279|FG000|Imaging Day 1|Physician Decision|0|||
13314636|NCT01223183|26550280|FG001|Imaging Day 1|Physician Decision|1|||
13314637|NCT01223183|26550279|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1|||
13314638|NCT01223183|26550280|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0|||
13314639|NCT01223183|26550279|FG000|Washout Period (5-24 Days)|Physician Decision|1|||
13314640|NCT01223183|26550280|FG001|Washout Period (5-24 Days)|Physician Decision|0|||
13314641|NCT01223027|26550308|FG000|Overall Study|Adverse Event|20|||
13314642|NCT01223027|26550309|FG001|Overall Study|Adverse Event|10|||
13314643|NCT01223027|26550308|FG000|Overall Study|Death|42|||
13314644|NCT01223027|26550309|FG001|Overall Study|Death|42|||
13314645|NCT01223027|26550308|FG000|Overall Study|Lost to Follow-up|2|||
13314646|NCT01223027|26550309|FG001|Overall Study|Lost to Follow-up|1|||
13314647|NCT01223027|26550308|FG000|Overall Study|Physician Decision|4|||
13314648|NCT01223027|26550309|FG001|Overall Study|Physician Decision|8|||
13314649|NCT01223027|26550308|FG000|Overall Study|Progressive Disease|167|||
13314650|NCT01223027|26550309|FG001|Overall Study|Progressive Disease|183|||
13314651|NCT01223027|26550308|FG000|Overall Study|Protocol Violation|2|||
13314652|NCT01223027|26550309|FG001|Overall Study|Protocol Violation|1|||
13314653|NCT01223027|26550308|FG000|Overall Study|Subject/guardian decicion|18|||
13314654|NCT01223027|26550309|FG001|Overall Study|Subject/guardian decicion|16|||
13314655|NCT01223027|26550308|FG000|Overall Study|New therapy for study indication|17|||
13314656|NCT01223027|26550309|FG001|Overall Study|New therapy for study indication|8|||
13314657|NCT01223027|26550308|FG000|Overall Study|Study terminated by sponsor|2|||
13314658|NCT01223027|26550309|FG001|Overall Study|Study terminated by sponsor|8|||
13314659|NCT01222767|26550325|FG000|Overall Study|Progressive disease|13|||
13314660|NCT01222767|26550325|FG000|Overall Study|Adverse Event|2|||
13314661|NCT01222767|26550325|FG000|Overall Study|Surgical resection|1|||
13314662|NCT01222767|26550325|FG000|Overall Study|Never treated|1|||
13314663|NCT01222715|26550342|FG000|Overall Study|Adverse Event|0|||
13314664|NCT01222715|26550343|FG001|Overall Study|Adverse Event|4|||
13314665|NCT01222715|26550342|FG000|Overall Study|Death|0|||
13314666|NCT01222715|26550343|FG001|Overall Study|Death|1|||
13314667|NCT01222715|26550342|FG000|Overall Study|Lack of Efficacy|22|||
13314668|NCT01222715|26550343|FG001|Overall Study|Lack of Efficacy|14|||
13314669|NCT01222715|26550342|FG000|Overall Study|Physician Decision|12|||
13314670|NCT01222715|26550343|FG001|Overall Study|Physician Decision|2|||
13314671|NCT01222715|26550342|FG000|Overall Study|Refusal of further protocol therapy|0|||
13314672|NCT01222715|26550343|FG001|Overall Study|Refusal of further protocol therapy|4|||
13314673|NCT01222715|26550342|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1|||
13314674|NCT01222715|26550343|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1|||
13314675|NCT01222715|26550342|FG000|Overall Study|Ineligible|0|||
13314676|NCT01222715|26550343|FG001|Overall Study|Ineligible|1|||
13314677|NCT01222715|26550342|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1|||
13314678|NCT01222715|26550343|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0|||
13314679|NCT01222533|26550482|FG000|Overall Study|Adverse Event|5|||
13314680|NCT01222533|26550482|FG000|Overall Study|Withdrawal by Subject|5|||
13314681|NCT01222533|26550482|FG000|Overall Study|Other|4|||
13373001|NCT00805935|26722477|FG000|Overall Study|No positive serum pregnancy|8|||
13373002|NCT00805935|26722478|FG001|Overall Study|No positive serum pregnancy|7|||
13373003|NCT00805935|26722479|FG002|Overall Study|No positive serum pregnancy|6|||
13373004|NCT00805935|26722480|FG003|Overall Study|No positive serum pregnancy|5|||
13373005|NCT00805935|26722477|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0|||
13373006|NCT00805935|26722478|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
13373007|NCT00805935|26722479|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0|||
13373008|NCT00805935|26722480|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1|||
13373009|NCT00805935|26722477|FG000|Overall Study|Pregnancy loss/miscarriage|2|||
13373010|NCT00805935|26722478|FG001|Overall Study|Pregnancy loss/miscarriage|0|||
13373011|NCT00805935|26722479|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
13373012|NCT00805935|26722480|FG003|Overall Study|Pregnancy loss/miscarriage|0|||
13373013|NCT00805935|26722477|FG000|Overall Study|Biochemical pregnancy|0|||
13373014|NCT00805935|26722478|FG001|Overall Study|Biochemical pregnancy|1|||
13373015|NCT00805935|26722479|FG002|Overall Study|Biochemical pregnancy|0|||
13373016|NCT00805935|26722480|FG003|Overall Study|Biochemical pregnancy|0|||
13373017|NCT00805935|26722477|FG000|Overall Study|Chemical pregnancy|0|||
13373018|NCT00805935|26722478|FG001|Overall Study|Chemical pregnancy|5|||
13373019|NCT00805935|26722479|FG002|Overall Study|Chemical pregnancy|3|||
13373020|NCT00805935|26722480|FG003|Overall Study|Chemical pregnancy|2|||
13373021|NCT00805935|26722477|FG000|Overall Study|Ectopic pregnancy|0|||
13373022|NCT00805935|26722478|FG001|Overall Study|Ectopic pregnancy|0|||
13373023|NCT00805935|26722479|FG002|Overall Study|Ectopic pregnancy|1|||
13373024|NCT00805935|26722480|FG003|Overall Study|Ectopic pregnancy|0|||
13373025|NCT00805935|26722477|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0|||
13373026|NCT00805935|26722478|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1|||
13373027|NCT00805935|26722479|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0|||
13373028|NCT00805935|26722480|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0|||
13373029|NCT00805792|26722490|FG000|Overall Study|Death|3|||
13122110|NCT02969525|25945887|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
13122111|NCT02969408|25945897|FG000|Overall Study|Adverse Event|2|||
13122112|NCT02969408|25945897|FG000|Overall Study|Withdrawal by Subject|8|||
13122113|NCT02969408|25945897|FG000|Overall Study|Lost to Follow-up|4|||
13122114|NCT02969408|25945897|FG000|Overall Study|Protocol Violation|1|||
13122115|NCT02969408|25945897|FG000|Overall Study|Other than specified|1|||
13373030|NCT00805792|26722490|FG000|Overall Study|Lost to Follow-up|2|||
13373031|NCT00805766|26722504|FG000|Screening Period|Adverse Event|1|||
13373032|NCT00805766|26722504|FG000|Screening Period|Lack of Efficacy|2|||
13373033|NCT00805766|26722504|FG000|Screening Period|Pregnancy|1|||
13373034|NCT00805766|26722504|FG000|Screening Period|Responder|2|||
13373035|NCT00805766|26722504|FG000|Increased Dose Period|Adverse Event|4|||
13373036|NCT00805766|26722504|FG000|Increased Dose Period|Lack of Efficacy|7|||
13373037|NCT00805766|26722504|FG000|Increased Dose Period|Pregnancy|1|||
13373038|NCT00805766|26722504|FG000|Increased Dose Period|Withdrawal by Subject|1|||
13373039|NCT00805740|26722533|FG000|Overall Study|Death|7|||
13122116|NCT02969382|25945932|FG000|Overall Study|Adverse Event|8|||
13122117|NCT02969382|25945933|FG001|Overall Study|Adverse Event|10|||
13122118|NCT02969382|25945932|FG000|Overall Study|Lack of Efficacy|4|||
13122119|NCT02969382|25945933|FG001|Overall Study|Lack of Efficacy|5|||
13122120|NCT02969382|25945932|FG000|Overall Study|Death|0|||
13314682|NCT01222520|26550507|FG000|Open-label run-in Period|Withdrawal by Subject|0|||
13314683|NCT01222520|26550508|FG001|Open-label run-in Period|Withdrawal by Subject|2|||
13314684|NCT01222520|26550507|FG000|Open-label run-in Period|Blood pressure criteria not met|0|||
13314685|NCT01222520|26550508|FG001|Open-label run-in Period|Blood pressure criteria not met|18|||
13314686|NCT01222520|26550507|FG000|Open-label run-in Period|Number of patients fulfilled|0|||
13314687|NCT01222520|26550508|FG001|Open-label run-in Period|Number of patients fulfilled|3|||
13314688|NCT01222520|26550507|FG000|Double-blind Period|Adverse Event|0|||
13314689|NCT01222520|26550508|FG001|Double-blind Period|Adverse Event|1|||
13314690|NCT01222520|26550507|FG000|Double-blind Period|Lack of Efficacy|0|||
13314691|NCT01222520|26550508|FG001|Double-blind Period|Lack of Efficacy|1|||
13314692|NCT01222520|26550507|FG000|Double-blind Period|Study medication stolen|1|||
13314693|NCT01222520|26550508|FG001|Double-blind Period|Study medication stolen|0|||
13314694|NCT01222507|26550514|FG000|Overall Study|Physician Decision|1|||
13314695|NCT01222507|26550514|FG000|Overall Study|Withdrawal by Subject|1|||
13314696|NCT01222416|26550529|FG000|Overall Study|ineligible;metastasis|3|||
13314697|NCT01222416|26550530|FG001|Overall Study|ineligible;metastasis|0|||
13314698|NCT01222416|26550529|FG000|Overall Study|Adverse Event|4|||
13314699|NCT01222416|26550530|FG001|Overall Study|Adverse Event|0|||
13314700|NCT01222416|26550529|FG000|Overall Study|Withdrawal by Subject|5|||
13314701|NCT01222416|26550530|FG001|Overall Study|Withdrawal by Subject|0|||
13314702|NCT01222416|26550529|FG000|Overall Study|scheduling|6|||
13314703|NCT01222416|26550530|FG001|Overall Study|scheduling|0|||
13314704|NCT01222416|26550529|FG000|Overall Study|missed view/scan|1|||
13314705|NCT01222416|26550530|FG001|Overall Study|missed view/scan|0|||
13314706|NCT01222416|26550529|FG000|Overall Study|Death|1|||
13314707|NCT01222416|26550530|FG001|Overall Study|Death|0|||
13122121|NCT02969382|25945933|FG001|Overall Study|Death|1|||
13314708|NCT01222403|26550547|FG000|Overall Study|Inappropriate enrollment|0|||
13314709|NCT01222403|26550548|FG001|Overall Study|Inappropriate enrollment|2|||
13314710|NCT01222247|26550617|FG000|Overall Study|Lost to Follow-up|2|||
13314711|NCT01222247|26550618|FG001|Overall Study|Lost to Follow-up|2|||
13314712|NCT01222104|26550634|FG000|Overall Study|Lost to Follow-up|37|||
13314713|NCT01222104|26550634|FG000|Overall Study|Death|10|||
13314714|NCT01222078|26550670|FG000|Overall Study|Early termination of the study|1|||
13314715|NCT01221948|26550683|FG000|Overall Study|Physician Decision|5|||
13314716|NCT01221948|26550683|FG000|Overall Study|Withdrawal by Subject|2|||
13314717|NCT01221948|26550683|FG000|Overall Study|not disclosed|2|||
13314718|NCT01221948|26550683|FG000|Overall Study|Death|1|||
13314719|NCT01221948|26550683|FG000|Overall Study|Protocol Violation|4|||
13314720|NCT01221753|26550690|FG000|Overall Study|Adverse Event|1|||
13314721|NCT01221727|26550716|FG000|Overall Study|Physician Decision|2|||
13314722|NCT01221727|26550717|FG001|Overall Study|Physician Decision|0|||
13314723|NCT01221727|26550716|FG000|Overall Study|Withdrawal by Subject|1|||
13314724|NCT01221727|26550717|FG001|Overall Study|Withdrawal by Subject|1|||
13314725|NCT01221623|26550746|FG000|Overall Study|Withdrawal by Subject|19|||
13314726|NCT01221623|26550747|FG001|Overall Study|Withdrawal by Subject|8|||
13314727|NCT01221623|26550746|FG000|Overall Study|Lost to Follow-up|7|||
13314728|NCT01221623|26550747|FG001|Overall Study|Lost to Follow-up|1|||
13314729|NCT01221623|26550746|FG000|Overall Study|Adverse Event|6|||
13314730|NCT01221623|26550747|FG001|Overall Study|Adverse Event|3|||
13314731|NCT01221623|26550746|FG000|Overall Study|Death|1|||
13314732|NCT01221623|26550747|FG001|Overall Study|Death|0|||
13314733|NCT01221623|26550746|FG000|Overall Study|Other|5|||
13314734|NCT01221623|26550747|FG001|Overall Study|Other|2|||
13314735|NCT01221597|26550776|FG000|Overall Study|Adverse Event|4|||
13314736|NCT01221597|26550777|FG001|Overall Study|Adverse Event|1|||
13314737|NCT01221597|26550776|FG000|Overall Study|Withdrawal by Subject|20|||
13314738|NCT01221597|26550777|FG001|Overall Study|Withdrawal by Subject|6|||
13314739|NCT01221597|26550776|FG000|Overall Study|Lost to Follow-up|6|||
13314740|NCT01221597|26550777|FG001|Overall Study|Lost to Follow-up|5|||
13314741|NCT01221597|26550776|FG000|Overall Study|Protocol Violation|1|||
13314742|NCT01221597|26550777|FG001|Overall Study|Protocol Violation|0|||
13314743|NCT01221597|26550776|FG000|Overall Study|Other|3|||
13314744|NCT01221597|26550777|FG001|Overall Study|Other|4|||
13314745|NCT01221597|26550776|FG000|Overall Study|Death|2|||
13314746|NCT01221597|26550777|FG001|Overall Study|Death|0|||
13314747|NCT01221363|26550792|FG000|Overall Study|Pregnancy|1|||
13314748|NCT01221363|26550793|FG001|Overall Study|Pregnancy|0|||
13314749|NCT01221363|26550792|FG000|Overall Study|Withdrawal by Subject|11|||
13314750|NCT01221363|26550793|FG001|Overall Study|Withdrawal by Subject|5|||
13314751|NCT01221350|26550840|FG000|Overall Study|Discontinued intervention (GERD)|1|||
13314752|NCT01221350|26550841|FG001|Overall Study|Discontinued intervention (GERD)|0|||
13122122|NCT02969382|25945932|FG000|Overall Study|PROTOCOL DEVIATION|0|||
13314753|NCT01221350|26550840|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0|||
13314754|NCT01221350|26550841|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1|||
13314755|NCT01221350|26550840|FG000|Overall Study|Withdrawal by Subject|4|||
13314756|NCT01221350|26550841|FG001|Overall Study|Withdrawal by Subject|2|||
13314757|NCT01221285|26550852|FG000|Overall Study|Withdrawal by Subject|1|||
13314758|NCT01221272|26550870|FG000|Period 1|Adverse Event|2|||
13314759|NCT01221272|26550871|FG001|Period 1|Adverse Event|0|||
13314760|NCT01221272|26550870|FG000|Period 1|Consent Withdrawal|0|||
13314761|NCT01221272|26550871|FG001|Period 1|Consent Withdrawal|1|||
13314762|NCT01221272|26550870|FG000|Period 1|Significant Dosing Noncompliance|0|||
13314763|NCT01221272|26550871|FG001|Period 1|Significant Dosing Noncompliance|1|||
13314764|NCT01221272|26550870|FG000|Period 2|Adverse Event|0|||
13314765|NCT01221272|26550871|FG001|Period 2|Adverse Event|2|||
13314766|NCT01221233|26550884|FG000|Overall Study|Withdrawal by Subject|3|||
13314767|NCT01221233|26550885|FG001|Overall Study|Withdrawal by Subject|1|||
13314768|NCT01221181|26550891|FG000|Overall Study|Lost to Follow-up|1|||
13314769|NCT01221090|26550930|FG000|Overall Study|Non-Compliant or Unable to Contact|15|||
13314770|NCT01221090|26550931|FG001|Overall Study|Non-Compliant or Unable to Contact|12|||
13314771|NCT01221090|26550932|FG002|Overall Study|Non-Compliant or Unable to Contact|15|||
13314772|NCT01221090|26550933|FG003|Overall Study|Non-Compliant or Unable to Contact|20|||
13314773|NCT01221090|26550930|FG000|Overall Study|Withdrawal by Subject|0|||
13314774|NCT01221090|26550931|FG001|Overall Study|Withdrawal by Subject|22|||
13314775|NCT01221090|26550932|FG002|Overall Study|Withdrawal by Subject|27|||
13314776|NCT01221090|26550933|FG003|Overall Study|Withdrawal by Subject|2|||
13314777|NCT01220856|26550988|FG000|Overall Study|graft loss|3|||
13314778|NCT01220856|26550989|FG001|Overall Study|graft loss|3|||
13314779|NCT01220856|26550988|FG000|Overall Study|Lost to Follow-up|1|||
13314780|NCT01220856|26550989|FG001|Overall Study|Lost to Follow-up|0|||
13314781|NCT01220609|26551003|FG000|Overall Study|Ineligible-Wrong primary cancer site|1|||
13314782|NCT01220609|26551003|FG000|Overall Study|Ineligible- Wrong cell type|1|||
13314783|NCT01220609|26551003|FG000|Overall Study|Ineligible-Never treated|1|||
13314784|NCT01220557|26551016|FG000|Overall Study|Lost to Follow-up|5|||
13314785|NCT01220557|26551017|FG001|Overall Study|Lost to Follow-up|3|||
13314786|NCT01220557|26551016|FG000|Overall Study|attended less than 6 lessons|1|||
13314787|NCT01220557|26551017|FG001|Overall Study|attended less than 6 lessons|2|||
13314788|NCT01220414|26551033|FG000|Overall Study|Withdrawal by Subject|1|||
13314789|NCT01220414|26551034|FG001|Overall Study|Withdrawal by Subject|0|||
13314790|NCT01220414|26551035|FG002|Overall Study|Withdrawal by Subject|0|||
13314791|NCT01220414|26551036|FG003|Overall Study|Withdrawal by Subject|1|||
13314792|NCT01220401|26551045|FG000|Overall Study|Withdrawal by Subject|2|||
13314793|NCT01220401|26551045|FG000|Overall Study|Protocol Violation|1|||
13314794|NCT01220297|26551065|FG000|Overall Study|Death|2|||
13314795|NCT01220297|26551065|FG000|Overall Study|Lost to Follow-up|1|||
13314796|NCT01220180|26551096|FG000|Overall Study|Lost to Follow-up|76|||
13314797|NCT01220180|26551096|FG000|Overall Study|Other|72|||
13314798|NCT01220180|26551096|FG000|Overall Study|Adverse Event|35|||
13314799|NCT01220180|26551096|FG000|Overall Study|Lack of Efficacy|22|||
13314800|NCT01220180|26551096|FG000|Overall Study|Death|1|||
13314801|NCT01220180|26551096|FG000|Overall Study|Randomized but not treated|1|||
13314802|NCT01220167|26551112|FG000|Period 3|Urine positive for substance abuse|0|||
13314803|NCT01220167|26551113|FG001|Period 3|Urine positive for substance abuse|1|||
13314804|NCT01220167|26551114|FG002|Period 3|Urine positive for substance abuse|0|||
13314805|NCT01220128|26551341|FG000|Overall Study|Progressive disease|0|||
13314806|NCT01220128|26551342|FG001|Overall Study|Progressive disease|0|||
13314807|NCT01220128|26551343|FG002|Overall Study|Progressive disease|2|||
13314808|NCT01220128|26551344|FG003|Overall Study|Progressive disease|0|||
13314809|NCT01220128|26551345|FG004|Overall Study|Progressive disease|0|||
13314810|NCT01220128|26551346|FG005|Overall Study|Progressive disease|0|||
13314811|NCT01220128|26551347|FG006|Overall Study|Progressive disease|0|||
13314812|NCT01220128|26551341|FG000|Overall Study|Sponsor study termination|0|||
13314813|NCT01220128|26551342|FG001|Overall Study|Sponsor study termination|1|||
13314814|NCT01220128|26551343|FG002|Overall Study|Sponsor study termination|0|||
13314815|NCT01220128|26551344|FG003|Overall Study|Sponsor study termination|0|||
13314816|NCT01220128|26551345|FG004|Overall Study|Sponsor study termination|0|||
13314817|NCT01220128|26551346|FG005|Overall Study|Sponsor study termination|0|||
13314818|NCT01220128|26551347|FG006|Overall Study|Sponsor study termination|1|||
13314819|NCT01220128|26551341|FG000|Overall Study|Adverse event, serious fatal|2|||
13314820|NCT01220128|26551342|FG001|Overall Study|Adverse event, serious fatal|0|||
13314821|NCT01220128|26551343|FG002|Overall Study|Adverse event, serious fatal|0|||
13314822|NCT01220128|26551344|FG003|Overall Study|Adverse event, serious fatal|0|||
13314823|NCT01220128|26551345|FG004|Overall Study|Adverse event, serious fatal|0|||
13314824|NCT01220128|26551346|FG005|Overall Study|Adverse event, serious fatal|0|||
13314825|NCT01220128|26551347|FG006|Overall Study|Adverse event, serious fatal|1|||
13314826|NCT01220128|26551341|FG000|Overall Study|Adverse event, non-fatal|1|||
13314827|NCT01220128|26551342|FG001|Overall Study|Adverse event, non-fatal|0|||
13314828|NCT01220128|26551343|FG002|Overall Study|Adverse event, non-fatal|0|||
13314829|NCT01220128|26551344|FG003|Overall Study|Adverse event, non-fatal|0|||
13314830|NCT01220128|26551345|FG004|Overall Study|Adverse event, non-fatal|0|||
13314831|NCT01220128|26551346|FG005|Overall Study|Adverse event, non-fatal|0|||
13314832|NCT01220128|26551347|FG006|Overall Study|Adverse event, non-fatal|3|||
13314833|NCT01220128|26551341|FG000|Overall Study|Other|0|||
13314834|NCT01220128|26551342|FG001|Overall Study|Other|0|||
13314835|NCT01220128|26551343|FG002|Overall Study|Other|1|||
13314836|NCT01220128|26551344|FG003|Overall Study|Other|0|||
13314837|NCT01220128|26551345|FG004|Overall Study|Other|0|||
13314838|NCT01220128|26551346|FG005|Overall Study|Other|0|||
13314839|NCT01220128|26551347|FG006|Overall Study|Other|0|||
13314840|NCT01220128|26551341|FG000|Overall Study|Consent withdrawn by subject|1|||
13314841|NCT01220128|26551342|FG001|Overall Study|Consent withdrawn by subject|0|||
13314842|NCT01220128|26551343|FG002|Overall Study|Consent withdrawn by subject|0|||
13314843|NCT01220128|26551344|FG003|Overall Study|Consent withdrawn by subject|0|||
13314844|NCT01220128|26551345|FG004|Overall Study|Consent withdrawn by subject|0|||
13314845|NCT01220128|26551346|FG005|Overall Study|Consent withdrawn by subject|0|||
13314846|NCT01220128|26551347|FG006|Overall Study|Consent withdrawn by subject|0|||
13314847|NCT01220024|26551370|FG000|Overall Study|Lost to Follow-up|1|||
13314848|NCT01220024|26551371|FG001|Overall Study|Lost to Follow-up|1|||
13314849|NCT01219985|26551379|FG000|Overall Study|Physician Decision|20|||
13314850|NCT01219959|26551434|FG000|Overall Study|Adverse Event|6|||
13314851|NCT01219959|26551435|FG001|Overall Study|Adverse Event|14|||
13314852|NCT01219959|26551434|FG000|Overall Study|Physician Decision|0|||
13314853|NCT01219959|26551435|FG001|Overall Study|Physician Decision|4|||
13314854|NCT01219959|26551434|FG000|Overall Study|Withdrawal by Subject|0|||
13314855|NCT01219959|26551435|FG001|Overall Study|Withdrawal by Subject|2|||
13314856|NCT01219959|26551434|FG000|Overall Study|Renal Transplantation|0|||
13314857|NCT01219959|26551435|FG001|Overall Study|Renal Transplantation|3|||
13314858|NCT01219959|26551434|FG000|Overall Study|Other|1|||
13314859|NCT01219959|26551435|FG001|Overall Study|Other|0|||
13314860|NCT01219933|26551474|FG000|Overall Study|Adverse Event|8|||
13314861|NCT01219933|26551474|FG000|Overall Study|No LDA reached|5|||
13314862|NCT01219933|26551474|FG000|Overall Study|No LDA maintained|7|||
13314863|NCT01219933|26551474|FG000|Overall Study|Lost to Follow-up|3|||
13314864|NCT01219933|26551474|FG000|Overall Study|GC free|1|||
13314865|NCT01219933|26551474|FG000|Overall Study|Withdrawal by Subject|5|||
13314866|NCT01219933|26551474|FG000|Overall Study|Protocol Violation|8|||
13122123|NCT02969382|25945933|FG001|Overall Study|PROTOCOL DEVIATION|1|||
13122124|NCT02969382|25945932|FG000|Overall Study|Withdrawal by Subject|14|||
13122125|NCT02969382|25945933|FG001|Overall Study|Withdrawal by Subject|9|||
13122126|NCT02969356|25945953|FG000|Overall Study|Adverse Event|7|||
13122127|NCT02969356|25945953|FG000|Overall Study|Consent withdrawn|2|||
13314867|NCT01219933|26551474|FG000|Overall Study|Lack of Efficacy|1|||
13314868|NCT01218867|26551554|FG000|Overall Study|Death during treatment|0|||
13314869|NCT01218867|26551555|FG001|Overall Study|Death during treatment|0|||
13314870|NCT01218867|26551556|FG002|Overall Study|Death during treatment|0|||
13314871|NCT01218867|26551557|FG003|Overall Study|Death during treatment|0|||
13314872|NCT01218867|26551558|FG004|Overall Study|Death during treatment|0|||
13314873|NCT01218867|26551559|FG005|Overall Study|Death during treatment|0|||
13314874|NCT01218867|26551560|FG006|Overall Study|Death during treatment|1|||
13314875|NCT01218867|26551561|FG007|Overall Study|Death during treatment|0|||
13314876|NCT01218867|26551562|FG008|Overall Study|Death during treatment|0|||
13314877|NCT01218867|26551563|FG009|Overall Study|Death during treatment|0|||
13314878|NCT01218867|26551564|FG010|Overall Study|Death during treatment|0|||
13314879|NCT01218802|26551579|FG000|Overall Study|Lost to Follow-up|5|||
13314880|NCT01218802|26551580|FG001|Overall Study|Lost to Follow-up|6|||
13314881|NCT01218802|26551579|FG000|Overall Study|Withdrawal by Subject|3|||
13314882|NCT01218802|26551580|FG001|Overall Study|Withdrawal by Subject|10|||
13314883|NCT01218802|26551579|FG000|Overall Study|Adverse Event|0|||
13314884|NCT01218802|26551580|FG001|Overall Study|Adverse Event|2|||
13314885|NCT01218802|26551579|FG000|Overall Study|Incarcerated|2|||
13314886|NCT01218802|26551580|FG001|Overall Study|Incarcerated|0|||
13314887|NCT01218659|26551599|FG000|18-Month Randomized Period|Withdrawal by Subject|2|||
13314888|NCT01218659|26551600|FG001|18-Month Randomized Period|Withdrawal by Subject|3|||
13314889|NCT01218659|26551601|FG002|18-Month Randomized Period|Withdrawal by Subject|0|||
13314890|NCT01218659|26551599|FG000|18-Month Randomized Period|Did not receive study drug|0|||
13314891|NCT01218659|26551600|FG001|18-Month Randomized Period|Did not receive study drug|3|||
13314892|NCT01218659|26551601|FG002|18-Month Randomized Period|Did not receive study drug|0|||
13314893|NCT01218659|26551599|FG000|12-Month OLE|Withdrawal by Subject|0|||
13314894|NCT01218659|26551600|FG001|12-Month OLE|Withdrawal by Subject|0|||
13314895|NCT01218659|26551601|FG002|12-Month OLE|Withdrawal by Subject|2|||
13122128|NCT02969356|25945953|FG000|Overall Study|Lost to Follow-up|3|||
13314896|NCT01218659|26551599|FG000|12-Month OLE|Physician Decision|0|||
13314897|NCT01218659|26551600|FG001|12-Month OLE|Physician Decision|0|||
13314898|NCT01218659|26551601|FG002|12-Month OLE|Physician Decision|1|||
13314899|NCT01218659|26551599|FG000|12-Month OLE|Lost to Follow-up|0|||
13314900|NCT01218659|26551600|FG001|12-Month OLE|Lost to Follow-up|0|||
13314901|NCT01218659|26551601|FG002|12-Month OLE|Lost to Follow-up|1|||
13314902|NCT01218659|26551599|FG000|12-Month OLE|Pregnancy|0|||
13314903|NCT01218659|26551600|FG001|12-Month OLE|Pregnancy|0|||
13314904|NCT01218659|26551601|FG002|12-Month OLE|Pregnancy|1|||
13314905|NCT01218659|26551599|FG000|12-Month OLE|Lack of Efficacy|0|||
13314906|NCT01218659|26551600|FG001|12-Month OLE|Lack of Efficacy|0|||
13314907|NCT01218659|26551601|FG002|12-Month OLE|Lack of Efficacy|1|||
13314908|NCT01218659|26551599|FG000|12-Month OLE|Declined to participate in the OLE|0|||
13314909|NCT01218659|26551600|FG001|12-Month OLE|Declined to participate in the OLE|0|||
13314910|NCT01218659|26551601|FG002|12-Month OLE|Declined to participate in the OLE|4|||
13314911|NCT01218646|26551652|FG000|Overall Study|Adverse Event|0|||
13122129|NCT02969356|25945953|FG000|Overall Study|Did not need to be reinjected|6|||
13122130|NCT02969356|25945953|FG000|Overall Study|Personal reasons|5|||
13122131|NCT02969187|25945970|FG000|Overall Study|Physician Decision|12|||
13122132|NCT02969187|25945971|FG001|Overall Study|Physician Decision|13|||
13122133|NCT02969044|25946018|FG000|Overall Study|Withdrawal by Subject|2|||
13122134|NCT02969044|25946019|FG001|Overall Study|Withdrawal by Subject|6|||
13122135|NCT02969044|25946018|FG000|Overall Study|Adverse Event|3|||
13122136|NCT02969044|25946019|FG001|Overall Study|Adverse Event|0|||
13314912|NCT01218646|26551653|FG001|Overall Study|Adverse Event|0|||
13314913|NCT01218646|26551654|FG002|Overall Study|Adverse Event|1|||
13314914|NCT01218646|26551655|FG003|Overall Study|Adverse Event|0|||
13314915|NCT01218646|26551652|FG000|Overall Study|Lost to Follow-up|1|||
13314916|NCT01218646|26551653|FG001|Overall Study|Lost to Follow-up|0|||
13314917|NCT01218646|26551654|FG002|Overall Study|Lost to Follow-up|0|||
13314918|NCT01218646|26551655|FG003|Overall Study|Lost to Follow-up|0|||
13314919|NCT01218646|26551652|FG000|Overall Study|Protocol Violation|0|||
13314920|NCT01218646|26551653|FG001|Overall Study|Protocol Violation|0|||
13314921|NCT01218646|26551654|FG002|Overall Study|Protocol Violation|1|||
13314922|NCT01218646|26551655|FG003|Overall Study|Protocol Violation|1|||
13314923|NCT01218594|26551661|FG000|Overall Study|Death|1|||
13314924|NCT01218594|26551661|FG000|Overall Study|Withdrawal by Subject|3|||
13314925|NCT01218594|26551661|FG000|Overall Study|Adverse Event|2|||
13314926|NCT01218594|26551661|FG000|Overall Study|Physician Decision|6|||
13314927|NCT01218516|26551688|FG000|Combination Therapy (up to 4.5 Months)|Death|2|||
13314928|NCT01218516|26551689|FG001|Combination Therapy (up to 4.5 Months)|Death|1|||
13314929|NCT01218516|26551690|FG002|Combination Therapy (up to 4.5 Months)|Death|0|||
13314930|NCT01218516|26551691|FG003|Combination Therapy (up to 4.5 Months)|Death|0|||
13314931|NCT01218516|26551688|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
13314932|NCT01218516|26551689|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3|||
13314933|NCT01218516|26551690|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
13314934|NCT01218516|26551691|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
13314935|NCT01218516|26551688|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
13314936|NCT01218516|26551689|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
13314937|NCT01218516|26551690|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
13314938|NCT01218516|26551691|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
13314939|NCT01218516|26551688|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2|||
13314940|NCT01218516|26551689|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
13314941|NCT01218516|26551690|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
13314942|NCT01218516|26551691|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
13314943|NCT01218516|26551688|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17|||
13314944|NCT01218516|26551689|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15|||
13314945|NCT01218516|26551690|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
13314946|NCT01218516|26551691|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
13314947|NCT01218516|26551688|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
13314948|NCT01218516|26551689|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1|||
13314949|NCT01218516|26551690|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
13314950|NCT01218516|26551691|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
13314951|NCT01218516|26551688|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
13314952|NCT01218516|26551689|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1|||
13314953|NCT01218516|26551690|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
13314954|NCT01218516|26551691|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
13314955|NCT01218516|26551688|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
13314956|NCT01218516|26551689|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3|||
13122137|NCT02969018|25946161|FG000|Overall Study|Adverse Event|2|||
13122138|NCT02969018|25946162|FG001|Overall Study|Adverse Event|4|||
13314957|NCT01218516|26551690|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
13314958|NCT01218516|26551691|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
13314959|NCT01218516|26551688|FG000|Combination Therapy (up to 4.5 Months)|Other|3|||
13122139|NCT02969018|25946163|FG002|Overall Study|Adverse Event|1|||
13314960|NCT01218516|26551689|FG001|Combination Therapy (up to 4.5 Months)|Other|4|||
13314961|NCT01218516|26551690|FG002|Combination Therapy (up to 4.5 Months)|Other|0|||
13314962|NCT01218516|26551691|FG003|Combination Therapy (up to 4.5 Months)|Other|0|||
13314963|NCT01218516|26551688|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
13314964|NCT01218516|26551689|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1|||
13314965|NCT01218516|26551690|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
13314966|NCT01218516|26551691|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
13314967|NCT01218516|26551688|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2|||
13314968|NCT01218516|26551689|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3|||
13314969|NCT01218516|26551690|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
13314970|NCT01218516|26551691|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
13314971|NCT01218516|26551688|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
13314972|NCT01218516|26551689|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
13314973|NCT01218516|26551690|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
13314974|NCT01218516|26551691|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
13314975|NCT01218477|26551721|FG000|Overall Study|Disease progression|2|||
13314976|NCT01218477|26551722|FG001|Overall Study|Disease progression|3|||
13314977|NCT01218477|26551723|FG002|Overall Study|Disease progression|6|||
13314978|NCT01218477|26551724|FG003|Overall Study|Disease progression|2|||
13314979|NCT01218477|26551721|FG000|Overall Study|Study drug toxicity|0|||
13314980|NCT01218477|26551722|FG001|Overall Study|Study drug toxicity|2|||
13314981|NCT01218477|26551723|FG002|Overall Study|Study drug toxicity|5|||
13314982|NCT01218477|26551724|FG003|Overall Study|Study drug toxicity|0|||
13314983|NCT01218477|26551721|FG000|Overall Study|No longer meets study criteria|1|||
13314984|NCT01218477|26551722|FG001|Overall Study|No longer meets study criteria|0|||
13314985|NCT01218477|26551723|FG002|Overall Study|No longer meets study criteria|0|||
13314986|NCT01218477|26551724|FG003|Overall Study|No longer meets study criteria|0|||
13314987|NCT01218477|26551721|FG000|Overall Study|Withdrawal by Subject|0|||
13314988|NCT01218477|26551722|FG001|Overall Study|Withdrawal by Subject|0|||
13314989|NCT01218477|26551723|FG002|Overall Study|Withdrawal by Subject|1|||
13314990|NCT01218477|26551724|FG003|Overall Study|Withdrawal by Subject|0|||
13314991|NCT01218477|26551721|FG000|Overall Study|Prepared for cell transplantation|0|||
13314992|NCT01218477|26551722|FG001|Overall Study|Prepared for cell transplantation|1|||
13314993|NCT01218477|26551723|FG002|Overall Study|Prepared for cell transplantation|1|||
13314994|NCT01218477|26551724|FG003|Overall Study|Prepared for cell transplantation|0|||
13314995|NCT01218477|26551721|FG000|Overall Study|Administrative reason by sponsor|0|||
13314996|NCT01218477|26551722|FG001|Overall Study|Administrative reason by sponsor|0|||
13314997|NCT01218477|26551723|FG002|Overall Study|Administrative reason by sponsor|1|||
13314998|NCT01218477|26551724|FG003|Overall Study|Administrative reason by sponsor|0|||
13314999|NCT01218477|26551721|FG000|Overall Study|Maximum clinical benefit|0|||
13315000|NCT01218477|26551722|FG001|Overall Study|Maximum clinical benefit|2|||
13315001|NCT01218477|26551723|FG002|Overall Study|Maximum clinical benefit|0|||
13315002|NCT01218477|26551724|FG003|Overall Study|Maximum clinical benefit|0|||
13315003|NCT01218438|26552031|FG000|Epoch 1|Physician Decision|2|||
13315004|NCT01218438|26552031|FG000|Epoch 1|Adverse Event|1|||
13315005|NCT01218438|26552031|FG000|Epoch 3|Withdrawal by Subject|3|||
13315006|NCT01218438|26552031|FG000|Epoch 3|Adverse Event|1|||
13315007|NCT01218438|26552031|FG000|Epoch 4|Physician Decision|1|||
13315008|NCT01218438|26552031|FG000|Epoch 4|Withdrawal by Subject|2|||
13315009|NCT01218308|26552080|FG000|Overall Study|Adverse Event|1|||
13315010|NCT01218308|26552081|FG001|Overall Study|Adverse Event|2|||
13315011|NCT01218308|26552080|FG000|Overall Study|Protocol Violation|0|||
13315012|NCT01218308|26552081|FG001|Overall Study|Protocol Violation|2|||
13315013|NCT01218308|26552080|FG000|Overall Study|Withdrawal by Subject|61|||
13315014|NCT01218308|26552081|FG001|Overall Study|Withdrawal by Subject|64|||
13315015|NCT01218308|26552080|FG000|Overall Study|Lost to Follow-up|27|||
13315016|NCT01218308|26552081|FG001|Overall Study|Lost to Follow-up|31|||
13315017|NCT01218308|26552080|FG000|Overall Study|Other|14|||
13315018|NCT01218308|26552081|FG001|Overall Study|Other|21|||
13315019|NCT01218243|26552102|FG000|Overall Study|Lack of Efficacy|1|||
13315020|NCT01218243|26552103|FG001|Overall Study|Lack of Efficacy|1|||
13315021|NCT01218243|26552102|FG000|Overall Study|Lost to Follow-up|3|||
13315022|NCT01218243|26552103|FG001|Overall Study|Lost to Follow-up|3|||
13315023|NCT01218243|26552102|FG000|Overall Study|Protocol Violation|5|||
13315024|NCT01218243|26552103|FG001|Overall Study|Protocol Violation|10|||
13315025|NCT01218204|26552372|FG000|Part B Washout|Adverse Event|0|||
13315026|NCT01218204|26552373|FG001|Part B Washout|Adverse Event|1|||
13315027|NCT01218204|26552374|FG002|Part B Washout|Adverse Event|0|||
13315028|NCT01218204|26552375|FG003|Part B Washout|Adverse Event|0|||
13315029|NCT01218204|26552372|FG000|Part B Washout|Lost to Follow-up|0|||
13315030|NCT01218204|26552373|FG001|Part B Washout|Lost to Follow-up|2|||
13315031|NCT01218204|26552374|FG002|Part B Washout|Lost to Follow-up|0|||
13315032|NCT01218204|26552375|FG003|Part B Washout|Lost to Follow-up|0|||
13315033|NCT01218204|26552372|FG000|Part B Washout|Physician Decision|0|||
13315034|NCT01218204|26552373|FG001|Part B Washout|Physician Decision|14|||
13315035|NCT01218204|26552374|FG002|Part B Washout|Physician Decision|0|||
13315036|NCT01218204|26552375|FG003|Part B Washout|Physician Decision|0|||
13315037|NCT01218204|26552372|FG000|Part B Washout|Withdrawal by Subject|0|||
13315038|NCT01218204|26552373|FG001|Part B Washout|Withdrawal by Subject|14|||
13315039|NCT01218204|26552374|FG002|Part B Washout|Withdrawal by Subject|0|||
13315040|NCT01218204|26552375|FG003|Part B Washout|Withdrawal by Subject|0|||
13315041|NCT01218204|26552372|FG000|Part B Washout|Reached defined stopping criteria|0|||
13315042|NCT01218204|26552373|FG001|Part B Washout|Reached defined stopping criteria|2|||
13315043|NCT01218204|26552374|FG002|Part B Washout|Reached defined stopping criteria|0|||
13315044|NCT01218204|26552375|FG003|Part B Washout|Reached defined stopping criteria|0|||
13315045|NCT01218204|26552372|FG000|Part B Washout|Did not meet continuation criteria|0|||
13315046|NCT01218204|26552373|FG001|Part B Washout|Did not meet continuation criteria|112|||
13315047|NCT01218204|26552374|FG002|Part B Washout|Did not meet continuation criteria|0|||
13315048|NCT01218204|26552375|FG003|Part B Washout|Did not meet continuation criteria|0|||
13315049|NCT01218204|26552372|FG000|Part B Run-in|Adverse Event|0|||
13315050|NCT01218204|26552373|FG001|Part B Run-in|Adverse Event|0|||
13315051|NCT01218204|26552374|FG002|Part B Run-in|Adverse Event|1|||
13315052|NCT01218204|26552375|FG003|Part B Run-in|Adverse Event|0|||
13315053|NCT01218204|26552372|FG000|Part B Run-in|Protocol Violation|0|||
13315054|NCT01218204|26552373|FG001|Part B Run-in|Protocol Violation|0|||
13315055|NCT01218204|26552374|FG002|Part B Run-in|Protocol Violation|2|||
13315056|NCT01218204|26552375|FG003|Part B Run-in|Protocol Violation|0|||
13315057|NCT01218204|26552372|FG000|Part B Run-in|Withdrawal by Subject|0|||
13315058|NCT01218204|26552373|FG001|Part B Run-in|Withdrawal by Subject|0|||
13315059|NCT01218204|26552374|FG002|Part B Run-in|Withdrawal by Subject|3|||
13315060|NCT01218204|26552375|FG003|Part B Run-in|Withdrawal by Subject|0|||
13315061|NCT01218204|26552372|FG000|Part B Pooled Treatment Arm|Adverse Event|0|||
13315062|NCT01218204|26552373|FG001|Part B Pooled Treatment Arm|Adverse Event|0|||
13315063|NCT01218204|26552374|FG002|Part B Pooled Treatment Arm|Adverse Event|0|||
13315064|NCT01218204|26552375|FG003|Part B Pooled Treatment Arm|Adverse Event|2|||
13315065|NCT01218204|26552372|FG000|Part B Pooled Treatment Arm|Protocol Violation|0|||
13315066|NCT01218204|26552373|FG001|Part B Pooled Treatment Arm|Protocol Violation|0|||
13315067|NCT01218204|26552374|FG002|Part B Pooled Treatment Arm|Protocol Violation|0|||
13315068|NCT01218204|26552375|FG003|Part B Pooled Treatment Arm|Protocol Violation|1|||
13315069|NCT01218126|26552426|FG000|Overall Study|Adverse Event|8|||
13315070|NCT01218126|26552427|FG001|Overall Study|Adverse Event|10|||
13315071|NCT01218126|26552428|FG002|Overall Study|Adverse Event|12|||
13315072|NCT01218126|26552429|FG003|Overall Study|Adverse Event|16|||
13315073|NCT01218126|26552426|FG000|Overall Study|Lack of Efficacy|7|||
13315074|NCT01218126|26552427|FG001|Overall Study|Lack of Efficacy|2|||
13315075|NCT01218126|26552428|FG002|Overall Study|Lack of Efficacy|2|||
13315076|NCT01218126|26552429|FG003|Overall Study|Lack of Efficacy|6|||
13315077|NCT01218126|26552426|FG000|Overall Study|Protocol Violation|5|||
13315078|NCT01218126|26552427|FG001|Overall Study|Protocol Violation|2|||
13315079|NCT01218126|26552428|FG002|Overall Study|Protocol Violation|2|||
13315080|NCT01218126|26552429|FG003|Overall Study|Protocol Violation|3|||
13315081|NCT01218126|26552426|FG000|Overall Study|Protocol-defined stopping criteria|1|||
13315082|NCT01218126|26552427|FG001|Overall Study|Protocol-defined stopping criteria|1|||
13315083|NCT01218126|26552428|FG002|Overall Study|Protocol-defined stopping criteria|0|||
13315084|NCT01218126|26552429|FG003|Overall Study|Protocol-defined stopping criteria|0|||
13315085|NCT01218126|26552426|FG000|Overall Study|Lost to Follow-up|0|||
13315086|NCT01218126|26552427|FG001|Overall Study|Lost to Follow-up|0|||
13315087|NCT01218126|26552428|FG002|Overall Study|Lost to Follow-up|0|||
13315088|NCT01218126|26552429|FG003|Overall Study|Lost to Follow-up|2|||
13315089|NCT01218126|26552426|FG000|Overall Study|Physician Decision|1|||
13315090|NCT01218126|26552427|FG001|Overall Study|Physician Decision|2|||
13315091|NCT01218126|26552428|FG002|Overall Study|Physician Decision|4|||
13315092|NCT01218126|26552429|FG003|Overall Study|Physician Decision|2|||
13315093|NCT01218126|26552426|FG000|Overall Study|Withdrawal by Subject|2|||
13315094|NCT01218126|26552427|FG001|Overall Study|Withdrawal by Subject|5|||
13315095|NCT01218126|26552428|FG002|Overall Study|Withdrawal by Subject|4|||
13315096|NCT01218126|26552429|FG003|Overall Study|Withdrawal by Subject|6|||
13315097|NCT01218113|26552616|FG000|Overall Study|Withdrawal by Subject|1|||
13315098|NCT01218113|26552617|FG001|Overall Study|Withdrawal by Subject|0|||
13315099|NCT01218113|26552618|FG002|Overall Study|Withdrawal by Subject|1|||
13315100|NCT01218113|26552616|FG000|Overall Study|Lost to Follow-up|4|||
13315101|NCT01218113|26552617|FG001|Overall Study|Lost to Follow-up|1|||
13315102|NCT01218113|26552618|FG002|Overall Study|Lost to Follow-up|4|||
13315103|NCT01218113|26552616|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0|||
13315104|NCT01218113|26552617|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0|||
13315105|NCT01218113|26552618|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1|||
13315106|NCT01218100|26552645|FG000|Overall Study|Did not meet InclusionExclusion criteria|1|||
13315107|NCT01218100|26552646|FG001|Overall Study|Did not meet InclusionExclusion criteria|1|||
13315108|NCT01218100|26552647|FG002|Overall Study|Did not meet InclusionExclusion criteria|1|||
13373040|NCT00805740|26722534|FG001|Overall Study|Death|4|||
13315109|NCT01218100|26552648|FG003|Overall Study|Did not meet InclusionExclusion criteria|2|||
13315110|NCT01218100|26552645|FG000|Overall Study|Adverse Event|4|||
13315111|NCT01218100|26552646|FG001|Overall Study|Adverse Event|6|||
13315112|NCT01218100|26552647|FG002|Overall Study|Adverse Event|6|||
13315113|NCT01218100|26552648|FG003|Overall Study|Adverse Event|7|||
13315114|NCT01218100|26552645|FG000|Overall Study|Lack of Efficacy|9|||
13315115|NCT01218100|26552646|FG001|Overall Study|Lack of Efficacy|6|||
13315116|NCT01218100|26552647|FG002|Overall Study|Lack of Efficacy|5|||
13315117|NCT01218100|26552648|FG003|Overall Study|Lack of Efficacy|12|||
13315118|NCT01218100|26552645|FG000|Overall Study|Protocol Violation|0|||
13315119|NCT01218100|26552646|FG001|Overall Study|Protocol Violation|0|||
13315120|NCT01218100|26552647|FG002|Overall Study|Protocol Violation|1|||
13315121|NCT01218100|26552648|FG003|Overall Study|Protocol Violation|1|||
13315122|NCT01218100|26552645|FG000|Overall Study|Withdrawal by Subject|5|||
13315123|NCT01218100|26552646|FG001|Overall Study|Withdrawal by Subject|2|||
13315124|NCT01218100|26552647|FG002|Overall Study|Withdrawal by Subject|6|||
13315125|NCT01218100|26552648|FG003|Overall Study|Withdrawal by Subject|7|||
13315126|NCT01218100|26552645|FG000|Overall Study|Lost to Follow-up|3|||
13315127|NCT01218100|26552646|FG001|Overall Study|Lost to Follow-up|8|||
13315128|NCT01218100|26552647|FG002|Overall Study|Lost to Follow-up|2|||
13315129|NCT01218100|26552648|FG003|Overall Study|Lost to Follow-up|1|||
13315130|NCT01218100|26552645|FG000|Overall Study|Other Reason|2|||
13315131|NCT01218100|26552646|FG001|Overall Study|Other Reason|2|||
13315132|NCT01218100|26552647|FG002|Overall Study|Other Reason|6|||
13315133|NCT01218100|26552648|FG003|Overall Study|Other Reason|4|||
13315134|NCT01218087|26552663|FG000|Overall Study|Death|2|||
13315135|NCT01218087|26552664|FG001|Overall Study|Death|1|||
13315136|NCT01218087|26552663|FG000|Overall Study|Withdrawal by Subject|5|||
13315137|NCT01218087|26552664|FG001|Overall Study|Withdrawal by Subject|0|||
13315138|NCT01218087|26552663|FG000|Overall Study|Transferred|8|||
13315139|NCT01218087|26552664|FG001|Overall Study|Transferred|5|||
13315140|NCT01218009|26552689|FG000|Overall Study|Protocol Violation|2|||
13315141|NCT01218009|26552690|FG001|Overall Study|Protocol Violation|1|||
13315142|NCT01218009|26552689|FG000|Overall Study|Withdrawal by Subject|3|||
13315143|NCT01218009|26552690|FG001|Overall Study|Withdrawal by Subject|1|||
13315144|NCT01218009|26552689|FG000|Overall Study|Sponsor terminated study|161|||
13315145|NCT01218009|26552690|FG001|Overall Study|Sponsor terminated study|163|||
13315146|NCT01217957|26552762|FG000|Phase 1|Withdrawal by Patient|1|||
13315147|NCT01217957|26552763|FG001|Phase 1|Withdrawal by Patient|0|||
13315148|NCT01217957|26552764|FG002|Phase 1|Withdrawal by Patient|1|||
13315149|NCT01217957|26552765|FG003|Phase 1|Withdrawal by Patient|1|||
13315150|NCT01217957|26552766|FG004|Phase 1|Withdrawal by Patient|0|||
13315151|NCT01217957|26552762|FG000|Phase 2|Withdrawal by Patient|0|||
13315152|NCT01217957|26552763|FG001|Phase 2|Withdrawal by Patient|0|||
13315153|NCT01217957|26552764|FG002|Phase 2|Withdrawal by Patient|0|||
13315154|NCT01217957|26552765|FG003|Phase 2|Withdrawal by Patient|0|||
13315155|NCT01217957|26552766|FG004|Phase 2|Withdrawal by Patient|1|||
13315156|NCT01217944|26552815|FG000|Overall Study|Protocol Violation|1|||
13315157|NCT01217944|26552816|FG001|Overall Study|Protocol Violation|1|||
13315158|NCT01217944|26552817|FG002|Overall Study|Protocol Violation|0|||
13315159|NCT01217944|26552815|FG000|Overall Study|Lost to Follow-up|3|||
13315160|NCT01217944|26552816|FG001|Overall Study|Lost to Follow-up|1|||
13315161|NCT01217944|26552817|FG002|Overall Study|Lost to Follow-up|0|||
13315162|NCT01217944|26552815|FG000|Overall Study|Withdrawal by Subject|1|||
13315163|NCT01217944|26552816|FG001|Overall Study|Withdrawal by Subject|2|||
13315164|NCT01217944|26552817|FG002|Overall Study|Withdrawal by Subject|0|||
13315165|NCT01217944|26552815|FG000|Overall Study|Lack of Efficacy|1|||
13315166|NCT01217944|26552816|FG001|Overall Study|Lack of Efficacy|0|||
13315167|NCT01217944|26552817|FG002|Overall Study|Lack of Efficacy|0|||
13315168|NCT01217892|26552856|FG000|Overall Study|Adverse Event|1|||
13315169|NCT01217892|26552857|FG001|Overall Study|Adverse Event|1|||
13315170|NCT01217892|26552858|FG002|Overall Study|Adverse Event|1|||
13315171|NCT01217892|26552859|FG003|Overall Study|Adverse Event|0|||
13315172|NCT01217892|26552856|FG000|Overall Study|Withdrawal by Subject|0|||
13315173|NCT01217892|26552857|FG001|Overall Study|Withdrawal by Subject|2|||
13315174|NCT01217892|26552858|FG002|Overall Study|Withdrawal by Subject|1|||
13315175|NCT01217892|26552859|FG003|Overall Study|Withdrawal by Subject|0|||
13315176|NCT01217892|26552856|FG000|Overall Study|Lab value|1|||
13315177|NCT01217892|26552857|FG001|Overall Study|Lab value|0|||
13315178|NCT01217892|26552858|FG002|Overall Study|Lab value|1|||
13315179|NCT01217892|26552859|FG003|Overall Study|Lab value|0|||
13315180|NCT01217892|26552856|FG000|Overall Study|Subject no longer meets study criteria|5|||
13315181|NCT01217892|26552857|FG001|Overall Study|Subject no longer meets study criteria|2|||
13315182|NCT01217892|26552858|FG002|Overall Study|Subject no longer meets study criteria|4|||
13315183|NCT01217892|26552859|FG003|Overall Study|Subject no longer meets study criteria|8|||
13315184|NCT01217892|26552856|FG000|Overall Study|Incorrect enrollment|0|||
13315185|NCT01217892|26552857|FG001|Overall Study|Incorrect enrollment|1|||
13315186|NCT01217892|26552858|FG002|Overall Study|Incorrect enrollment|1|||
13315187|NCT01217892|26552859|FG003|Overall Study|Incorrect enrollment|0|||
13315188|NCT01217892|26552856|FG000|Overall Study|Poor/Non-Compliance|0|||
13315189|NCT01217892|26552857|FG001|Overall Study|Poor/Non-Compliance|0|||
13315190|NCT01217892|26552858|FG002|Overall Study|Poor/Non-Compliance|1|||
13315191|NCT01217892|26552859|FG003|Overall Study|Poor/Non-Compliance|0|||
13315192|NCT01217814|26552893|FG000|Overall Study|Adverse Event|1|||
13315193|NCT01217814|26552894|FG001|Overall Study|Adverse Event|1|||
13315194|NCT01217814|26552895|FG002|Overall Study|Adverse Event|0|||
13315195|NCT01217814|26552893|FG000|Overall Study|Lack of Efficacy|0|||
13315196|NCT01217814|26552894|FG001|Overall Study|Lack of Efficacy|0|||
13315197|NCT01217814|26552895|FG002|Overall Study|Lack of Efficacy|1|||
13315198|NCT01217801|26552908|FG000|Period 1|Protocol Violation|1|||
13315199|NCT01217801|26552909|FG001|Period 1|Protocol Violation|1|||
13315200|NCT01217801|26552908|FG000|Period 1|Withdrawal by Subject|0|||
13315201|NCT01217801|26552909|FG001|Period 1|Withdrawal by Subject|1|||
13315202|NCT01217606|26552926|FG000|Initial Treatment Phase|Other Reasons|0|||
13315203|NCT01217606|26552927|FG001|Initial Treatment Phase|Other Reasons|2|||
13315204|NCT01217606|26552926|FG000|Initial Treatment Phase|Protocol Violation|3|||
13315205|NCT01217606|26552927|FG001|Initial Treatment Phase|Protocol Violation|2|||
13315206|NCT01217606|26552926|FG000|Initial Treatment Phase|Personal Reasons|0|||
13315207|NCT01217606|26552927|FG001|Initial Treatment Phase|Personal Reasons|2|||
13315208|NCT01217606|26552926|FG000|Initial Treatment Phase|Lack of Efficacy|1|||
13315209|NCT01217606|26552927|FG001|Initial Treatment Phase|Lack of Efficacy|0|||
13315210|NCT01217606|26552926|FG000|Initial Treatment Phase|Adverse Event|10|||
13315211|NCT01217606|26552927|FG001|Initial Treatment Phase|Adverse Event|6|||
13315212|NCT01217606|26552926|FG000|9-Month Masked Extension|Adverse Event|3|||
13315213|NCT01217606|26552927|FG001|9-Month Masked Extension|Adverse Event|6|||
13315214|NCT01217606|26552926|FG000|9-Month Masked Extension|Other Reasons|4|||
13315215|NCT01217606|26552927|FG001|9-Month Masked Extension|Other Reasons|4|||
13315216|NCT01217606|26552926|FG000|9-Month Masked Extension|Personal Reasons|2|||
13315217|NCT01217606|26552927|FG001|9-Month Masked Extension|Personal Reasons|1|||
13315218|NCT01217606|26552926|FG000|9-Month Masked Extension|Lost to Follow-up|1|||
13315219|NCT01217606|26552927|FG001|9-Month Masked Extension|Lost to Follow-up|0|||
13315220|NCT01217606|26552926|FG000|9-Month Masked Extension|Pregnancy|1|||
13315221|NCT01217606|26552927|FG001|9-Month Masked Extension|Pregnancy|0|||
13315222|NCT01217606|26552926|FG000|9-Month Masked Extension|Lack of Efficacy|2|||
13315223|NCT01217606|26552927|FG001|9-Month Masked Extension|Lack of Efficacy|0|||
13315224|NCT01217476|26552942|FG000|Overall Study|Adverse Event|6|||
13315225|NCT01217476|26552943|FG001|Overall Study|Adverse Event|1|||
13315226|NCT01217476|26552942|FG000|Overall Study|Physician Decision|0|||
13315227|NCT01217476|26552943|FG001|Overall Study|Physician Decision|1|||
13315228|NCT01217476|26552942|FG000|Overall Study|Withdrawal by Subject|3|||
13315229|NCT01217476|26552943|FG001|Overall Study|Withdrawal by Subject|3|||
13315230|NCT01217476|26552942|FG000|Overall Study|Surgery on the Target Limb|0|||
13315231|NCT01217476|26552943|FG001|Overall Study|Surgery on the Target Limb|2|||
13315232|NCT01217476|26552942|FG000|Overall Study|Protocol Deviation|1|||
13315233|NCT01217476|26552943|FG001|Overall Study|Protocol Deviation|0|||
13315234|NCT01217476|26552942|FG000|Overall Study|Other|2|||
13315235|NCT01217476|26552943|FG001|Overall Study|Other|0|||
13315236|NCT01217463|26552958|FG000|Overall Study|Adverse Event|8|||
13315237|NCT01217463|26552959|FG001|Overall Study|Adverse Event|5|||
13315238|NCT01217463|26552958|FG000|Overall Study|Physician Decision|0|||
13315239|NCT01217463|26552959|FG001|Overall Study|Physician Decision|1|||
13315240|NCT01217463|26552958|FG000|Overall Study|Withdrawal by Subject|3|||
13315241|NCT01217463|26552959|FG001|Overall Study|Withdrawal by Subject|0|||
13315242|NCT01217463|26552958|FG000|Overall Study|Surgery on the Target Limb|0|||
13315243|NCT01217463|26552959|FG001|Overall Study|Surgery on the Target Limb|1|||
13315244|NCT01217463|26552958|FG000|Overall Study|Patient Non-compliant|1|||
13315245|NCT01217463|26552959|FG001|Overall Study|Patient Non-compliant|0|||
13315246|NCT01217463|26552958|FG000|Overall Study|Other|1|||
13315247|NCT01217463|26552959|FG001|Overall Study|Other|1|||
13315248|NCT01217437|26552976|FG000|Overall Study|Adverse Event|0|||
13315249|NCT01217437|26552977|FG001|Overall Study|Adverse Event|8|||
13315250|NCT01217437|26552976|FG000|Overall Study|Death|5|||
13315251|NCT01217437|26552977|FG001|Overall Study|Death|0|||
13315252|NCT01217437|26552976|FG000|Overall Study|Lack of Efficacy|29|||
13315253|NCT01217437|26552977|FG001|Overall Study|Lack of Efficacy|25|||
13315254|NCT01217437|26552976|FG000|Overall Study|Physician Decision|8|||
13315255|NCT01217437|26552977|FG001|Overall Study|Physician Decision|5|||
13315256|NCT01217437|26552976|FG000|Overall Study|Withdrawal by Subject|0|||
13315257|NCT01217437|26552977|FG001|Overall Study|Withdrawal by Subject|2|||
13315258|NCT01217437|26552976|FG000|Overall Study|Ineligible|1|||
13315259|NCT01217437|26552977|FG001|Overall Study|Ineligible|1|||
13315260|NCT01217307|26552990|FG000|Overall Study|Withdrawal by Subject|0|||
13315261|NCT01217307|26552991|FG001|Overall Study|Withdrawal by Subject|1|||
13315262|NCT01217229|26553000|FG000|Overall Study|Adverse Event|1|||
13315263|NCT01217229|26553000|FG000|Overall Study|Disease progression, deterioration|2|||
13315264|NCT01217229|26553000|FG000|Overall Study|Disease progression, Cheson criteria|14|||
13315265|NCT01217229|26553000|FG000|Overall Study|Protocol Violation|1|||
13315266|NCT01217229|26553000|FG000|Overall Study|Disease progression not confirmed|2|||
13315267|NCT01217190|26553017|FG000|Second Dosing|Withdrawal by Subject|0|||
13315268|NCT01217190|26553018|FG001|Second Dosing|Withdrawal by Subject|2|||
13315269|NCT01217112|26553261|FG000|Overall Study|Adverse Event|0|||
13315270|NCT01217112|26553262|FG001|Overall Study|Adverse Event|2|||
13315271|NCT01217112|26553263|FG002|Overall Study|Adverse Event|0|||
13315272|NCT01217112|26553264|FG003|Overall Study|Adverse Event|2|||
13315273|NCT01217112|26553265|FG004|Overall Study|Adverse Event|0|||
13315274|NCT01217112|26553261|FG000|Overall Study|Withdrawal by Subject|0|||
13315275|NCT01217112|26553262|FG001|Overall Study|Withdrawal by Subject|0|||
13315276|NCT01217112|26553263|FG002|Overall Study|Withdrawal by Subject|1|||
13315277|NCT01217112|26553264|FG003|Overall Study|Withdrawal by Subject|0|||
13315278|NCT01217112|26553265|FG004|Overall Study|Withdrawal by Subject|0|||
13315279|NCT01217112|26553261|FG000|Overall Study|Physician Decision|0|||
13315280|NCT01217112|26553262|FG001|Overall Study|Physician Decision|0|||
13315281|NCT01217112|26553263|FG002|Overall Study|Physician Decision|0|||
13315282|NCT01217112|26553264|FG003|Overall Study|Physician Decision|0|||
13315283|NCT01217112|26553265|FG004|Overall Study|Physician Decision|1|||
13315284|NCT01217073|26553354|FG000|Base Period|Adverse Event|1|||
13315285|NCT01217073|26553355|FG001|Base Period|Adverse Event|0|||
13315286|NCT01217073|26553356|FG002|Base Period|Adverse Event|1|||
13315287|NCT01217073|26553357|FG003|Base Period|Adverse Event|0|||
13315288|NCT01217073|26553358|FG004|Base Period|Adverse Event|4|||
13315289|NCT01217073|26553359|FG005|Base Period|Adverse Event|1|||
13315290|NCT01217073|26553360|FG006|Base Period|Adverse Event|0|||
13315291|NCT01217073|26553361|FG007|Base Period|Adverse Event|0|||
13315292|NCT01217073|26553354|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1|||
13315293|NCT01217073|26553355|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0|||
13315294|NCT01217073|26553356|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0|||
13315295|NCT01217073|26553357|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0|||
13315296|NCT01217073|26553358|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0|||
13315297|NCT01217073|26553359|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0|||
13315298|NCT01217073|26553360|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0|||
13315299|NCT01217073|26553361|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0|||
13315300|NCT01217073|26553354|FG000|Base Period|Excluded medication|0|||
13315301|NCT01217073|26553355|FG001|Base Period|Excluded medication|0|||
13315302|NCT01217073|26553356|FG002|Base Period|Excluded medication|0|||
13315303|NCT01217073|26553357|FG003|Base Period|Excluded medication|0|||
13315304|NCT01217073|26553358|FG004|Base Period|Excluded medication|1|||
13315305|NCT01217073|26553359|FG005|Base Period|Excluded medication|0|||
13315306|NCT01217073|26553360|FG006|Base Period|Excluded medication|0|||
13315307|NCT01217073|26553361|FG007|Base Period|Excluded medication|0|||
13315308|NCT01217073|26553354|FG000|Base Period|Lack of Efficacy|0|||
13315309|NCT01217073|26553355|FG001|Base Period|Lack of Efficacy|0|||
13315310|NCT01217073|26553356|FG002|Base Period|Lack of Efficacy|0|||
13315311|NCT01217073|26553357|FG003|Base Period|Lack of Efficacy|0|||
13315312|NCT01217073|26553358|FG004|Base Period|Lack of Efficacy|0|||
13315313|NCT01217073|26553359|FG005|Base Period|Lack of Efficacy|1|||
13315314|NCT01217073|26553360|FG006|Base Period|Lack of Efficacy|0|||
13315315|NCT01217073|26553361|FG007|Base Period|Lack of Efficacy|0|||
13315316|NCT01217073|26553354|FG000|Base Period|Lost to Follow-up|0|||
13315317|NCT01217073|26553355|FG001|Base Period|Lost to Follow-up|0|||
13315318|NCT01217073|26553356|FG002|Base Period|Lost to Follow-up|1|||
13315319|NCT01217073|26553357|FG003|Base Period|Lost to Follow-up|1|||
13315320|NCT01217073|26553358|FG004|Base Period|Lost to Follow-up|3|||
13315321|NCT01217073|26553359|FG005|Base Period|Lost to Follow-up|0|||
13315322|NCT01217073|26553360|FG006|Base Period|Lost to Follow-up|0|||
13315323|NCT01217073|26553361|FG007|Base Period|Lost to Follow-up|0|||
13315324|NCT01217073|26553354|FG000|Base Period|Physician Decision|0|||
13315325|NCT01217073|26553355|FG001|Base Period|Physician Decision|0|||
13315326|NCT01217073|26553356|FG002|Base Period|Physician Decision|0|||
13315327|NCT01217073|26553357|FG003|Base Period|Physician Decision|0|||
13315328|NCT01217073|26553358|FG004|Base Period|Physician Decision|1|||
13315329|NCT01217073|26553359|FG005|Base Period|Physician Decision|0|||
13315330|NCT01217073|26553360|FG006|Base Period|Physician Decision|0|||
13315331|NCT01217073|26553361|FG007|Base Period|Physician Decision|0|||
13315332|NCT01217073|26553354|FG000|Base Period|Protocol Violation|1|||
13315333|NCT01217073|26553355|FG001|Base Period|Protocol Violation|0|||
13315334|NCT01217073|26553356|FG002|Base Period|Protocol Violation|0|||
13315335|NCT01217073|26553357|FG003|Base Period|Protocol Violation|0|||
13315336|NCT01217073|26553358|FG004|Base Period|Protocol Violation|1|||
13315337|NCT01217073|26553359|FG005|Base Period|Protocol Violation|2|||
13315338|NCT01217073|26553360|FG006|Base Period|Protocol Violation|0|||
13315339|NCT01217073|26553361|FG007|Base Period|Protocol Violation|0|||
13315340|NCT01217073|26553354|FG000|Base Period|Withdrawal by Subject|4|||
13315341|NCT01217073|26553355|FG001|Base Period|Withdrawal by Subject|5|||
13122140|NCT02969018|25946164|FG003|Overall Study|Adverse Event|2|||
13315342|NCT01217073|26553356|FG002|Base Period|Withdrawal by Subject|5|||
13315343|NCT01217073|26553357|FG003|Base Period|Withdrawal by Subject|1|||
13315344|NCT01217073|26553358|FG004|Base Period|Withdrawal by Subject|5|||
13315345|NCT01217073|26553359|FG005|Base Period|Withdrawal by Subject|5|||
13315346|NCT01217073|26553360|FG006|Base Period|Withdrawal by Subject|0|||
13315347|NCT01217073|26553361|FG007|Base Period|Withdrawal by Subject|0|||
13315348|NCT01217073|26553354|FG000|Extension Period|Adverse Event|0|||
13315349|NCT01217073|26553355|FG001|Extension Period|Adverse Event|0|||
13315350|NCT01217073|26553356|FG002|Extension Period|Adverse Event|0|||
13315351|NCT01217073|26553357|FG003|Extension Period|Adverse Event|0|||
13315352|NCT01217073|26553358|FG004|Extension Period|Adverse Event|0|||
13315353|NCT01217073|26553359|FG005|Extension Period|Adverse Event|0|||
13315354|NCT01217073|26553360|FG006|Extension Period|Adverse Event|19|||
13315355|NCT01217073|26553361|FG007|Extension Period|Adverse Event|5|||
13315356|NCT01217073|26553354|FG000|Extension Period|ALT/AST|0|||
13315357|NCT01217073|26553355|FG001|Extension Period|ALT/AST|0|||
13315358|NCT01217073|26553356|FG002|Extension Period|ALT/AST|0|||
13315359|NCT01217073|26553357|FG003|Extension Period|ALT/AST|0|||
13315360|NCT01217073|26553358|FG004|Extension Period|ALT/AST|0|||
13315361|NCT01217073|26553359|FG005|Extension Period|ALT/AST|0|||
13315362|NCT01217073|26553360|FG006|Extension Period|ALT/AST|2|||
13315363|NCT01217073|26553361|FG007|Extension Period|ALT/AST|0|||
13315364|NCT01217073|26553354|FG000|Extension Period|Contraindication to study medication|0|||
13315365|NCT01217073|26553355|FG001|Extension Period|Contraindication to study medication|0|||
13315366|NCT01217073|26553356|FG002|Extension Period|Contraindication to study medication|0|||
13315367|NCT01217073|26553357|FG003|Extension Period|Contraindication to study medication|0|||
13315368|NCT01217073|26553358|FG004|Extension Period|Contraindication to study medication|0|||
13315369|NCT01217073|26553359|FG005|Extension Period|Contraindication to study medication|0|||
13315370|NCT01217073|26553360|FG006|Extension Period|Contraindication to study medication|1|||
13315371|NCT01217073|26553361|FG007|Extension Period|Contraindication to study medication|0|||
13315372|NCT01217073|26553354|FG000|Extension Period|Creatinine/eGFR|0|||
13315373|NCT01217073|26553355|FG001|Extension Period|Creatinine/eGFR|0|||
13315374|NCT01217073|26553356|FG002|Extension Period|Creatinine/eGFR|0|||
13315375|NCT01217073|26553357|FG003|Extension Period|Creatinine/eGFR|0|||
13315376|NCT01217073|26553358|FG004|Extension Period|Creatinine/eGFR|0|||
13315377|NCT01217073|26553359|FG005|Extension Period|Creatinine/eGFR|0|||
13315378|NCT01217073|26553360|FG006|Extension Period|Creatinine/eGFR|11|||
13315379|NCT01217073|26553361|FG007|Extension Period|Creatinine/eGFR|1|||
13315380|NCT01217073|26553354|FG000|Extension Period|Death|0|||
13315381|NCT01217073|26553355|FG001|Extension Period|Death|0|||
13315382|NCT01217073|26553356|FG002|Extension Period|Death|0|||
13315383|NCT01217073|26553357|FG003|Extension Period|Death|0|||
13315384|NCT01217073|26553358|FG004|Extension Period|Death|0|||
13315385|NCT01217073|26553359|FG005|Extension Period|Death|0|||
13315386|NCT01217073|26553360|FG006|Extension Period|Death|1|||
13315387|NCT01217073|26553361|FG007|Extension Period|Death|0|||
13315388|NCT01217073|26553354|FG000|Extension Period|Excluded medication|0|||
13315389|NCT01217073|26553355|FG001|Extension Period|Excluded medication|0|||
13315390|NCT01217073|26553356|FG002|Extension Period|Excluded medication|0|||
13315391|NCT01217073|26553357|FG003|Extension Period|Excluded medication|0|||
13315392|NCT01217073|26553358|FG004|Extension Period|Excluded medication|0|||
13315393|NCT01217073|26553359|FG005|Extension Period|Excluded medication|0|||
13315394|NCT01217073|26553360|FG006|Extension Period|Excluded medication|2|||
13315395|NCT01217073|26553361|FG007|Extension Period|Excluded medication|0|||
13315396|NCT01217073|26553354|FG000|Extension Period|Lack of Efficacy|0|||
13315397|NCT01217073|26553355|FG001|Extension Period|Lack of Efficacy|0|||
13315398|NCT01217073|26553356|FG002|Extension Period|Lack of Efficacy|0|||
13315399|NCT01217073|26553357|FG003|Extension Period|Lack of Efficacy|0|||
13315400|NCT01217073|26553358|FG004|Extension Period|Lack of Efficacy|0|||
13315401|NCT01217073|26553359|FG005|Extension Period|Lack of Efficacy|0|||
13315402|NCT01217073|26553360|FG006|Extension Period|Lack of Efficacy|3|||
13315403|NCT01217073|26553361|FG007|Extension Period|Lack of Efficacy|0|||
13315404|NCT01217073|26553354|FG000|Extension Period|Lost to Follow-up|0|||
13315405|NCT01217073|26553355|FG001|Extension Period|Lost to Follow-up|0|||
13315406|NCT01217073|26553356|FG002|Extension Period|Lost to Follow-up|0|||
13315407|NCT01217073|26553357|FG003|Extension Period|Lost to Follow-up|0|||
13315408|NCT01217073|26553358|FG004|Extension Period|Lost to Follow-up|0|||
13315409|NCT01217073|26553359|FG005|Extension Period|Lost to Follow-up|0|||
13315410|NCT01217073|26553360|FG006|Extension Period|Lost to Follow-up|9|||
13315411|NCT01217073|26553361|FG007|Extension Period|Lost to Follow-up|1|||
13315412|NCT01217073|26553354|FG000|Extension Period|Non-compliance with study drug|0|||
13315413|NCT01217073|26553355|FG001|Extension Period|Non-compliance with study drug|0|||
13315414|NCT01217073|26553356|FG002|Extension Period|Non-compliance with study drug|0|||
13315415|NCT01217073|26553357|FG003|Extension Period|Non-compliance with study drug|0|||
13315416|NCT01217073|26553358|FG004|Extension Period|Non-compliance with study drug|0|||
13315417|NCT01217073|26553359|FG005|Extension Period|Non-compliance with study drug|0|||
13315418|NCT01217073|26553360|FG006|Extension Period|Non-compliance with study drug|0|||
13315419|NCT01217073|26553361|FG007|Extension Period|Non-compliance with study drug|1|||
13315420|NCT01217073|26553354|FG000|Extension Period|Physician Decision|0|||
13315421|NCT01217073|26553355|FG001|Extension Period|Physician Decision|0|||
13315422|NCT01217073|26553356|FG002|Extension Period|Physician Decision|0|||
13315423|NCT01217073|26553357|FG003|Extension Period|Physician Decision|0|||
13315424|NCT01217073|26553358|FG004|Extension Period|Physician Decision|0|||
13315425|NCT01217073|26553359|FG005|Extension Period|Physician Decision|0|||
13315426|NCT01217073|26553360|FG006|Extension Period|Physician Decision|4|||
13315427|NCT01217073|26553361|FG007|Extension Period|Physician Decision|1|||
13315428|NCT01217073|26553354|FG000|Extension Period|Protocol Violation|0|||
13315429|NCT01217073|26553355|FG001|Extension Period|Protocol Violation|0|||
13315430|NCT01217073|26553356|FG002|Extension Period|Protocol Violation|0|||
13315431|NCT01217073|26553357|FG003|Extension Period|Protocol Violation|0|||
13315432|NCT01217073|26553358|FG004|Extension Period|Protocol Violation|0|||
13315433|NCT01217073|26553359|FG005|Extension Period|Protocol Violation|0|||
13315434|NCT01217073|26553360|FG006|Extension Period|Protocol Violation|2|||
13315435|NCT01217073|26553361|FG007|Extension Period|Protocol Violation|1|||
13315436|NCT01217073|26553354|FG000|Extension Period|Site discontinued study participation|0|||
13315437|NCT01217073|26553355|FG001|Extension Period|Site discontinued study participation|0|||
13315438|NCT01217073|26553356|FG002|Extension Period|Site discontinued study participation|0|||
13315439|NCT01217073|26553357|FG003|Extension Period|Site discontinued study participation|0|||
13315440|NCT01217073|26553358|FG004|Extension Period|Site discontinued study participation|0|||
13315441|NCT01217073|26553359|FG005|Extension Period|Site discontinued study participation|0|||
13315442|NCT01217073|26553360|FG006|Extension Period|Site discontinued study participation|7|||
13315443|NCT01217073|26553361|FG007|Extension Period|Site discontinued study participation|2|||
13315444|NCT01217073|26553354|FG000|Extension Period|Withdrawal by Subject|0|||
13315445|NCT01217073|26553355|FG001|Extension Period|Withdrawal by Subject|0|||
13315446|NCT01217073|26553356|FG002|Extension Period|Withdrawal by Subject|0|||
13315447|NCT01217073|26553357|FG003|Extension Period|Withdrawal by Subject|0|||
13315448|NCT01217073|26553358|FG004|Extension Period|Withdrawal by Subject|0|||
13315449|NCT01217073|26553359|FG005|Extension Period|Withdrawal by Subject|0|||
13315450|NCT01217073|26553360|FG006|Extension Period|Withdrawal by Subject|30|||
13315451|NCT01217073|26553361|FG007|Extension Period|Withdrawal by Subject|8|||
13315452|NCT01217060|26553368|FG000|Overall Study|Withdrawal by Subject|1|||
13315453|NCT01217047|26553421|FG000|Overall Study|Lost to Follow-up|0|||
13315454|NCT01217047|26553422|FG001|Overall Study|Lost to Follow-up|1|||
13315455|NCT01217047|26553423|FG002|Overall Study|Lost to Follow-up|0|||
13315456|NCT01216332|26553448|FG000|Overall Study|Withdrawal by Subject|4|||
13315457|NCT01216332|26553449|FG001|Overall Study|Withdrawal by Subject|0|||
13315458|NCT01216319|26553456|FG000|Overall Study|Lost to Follow-up|2|||
13315459|NCT01216319|26553456|FG000|Overall Study|Unanticipated chemo for breast cancer|2|||
13315460|NCT01216202|26553471|FG000|Overall Study|Withdrawal by Subject|8|||
13315461|NCT01216202|26553472|FG001|Overall Study|Withdrawal by Subject|0|||
13315462|NCT01216202|26553471|FG000|Overall Study|Death|0|||
13315463|NCT01216202|26553472|FG001|Overall Study|Death|2|||
13315464|NCT01216202|26553471|FG000|Overall Study|Lost to Follow-up|14|||
13315465|NCT01216202|26553472|FG001|Overall Study|Lost to Follow-up|0|||
13315466|NCT01216189|26553487|FG000|Overall Study|Lost to Follow-up|21|||
13315467|NCT01216189|26553488|FG001|Overall Study|Lost to Follow-up|3|||
13315468|NCT01216189|26553487|FG000|Overall Study|Death|4|||
13315469|NCT01216189|26553488|FG001|Overall Study|Death|2|||
13315470|NCT01216176|26553518|FG000|Overall Study|Adverse Event|0|||
13315471|NCT01216176|26553519|FG001|Overall Study|Adverse Event|8|||
13315472|NCT01216176|26553520|FG002|Overall Study|Adverse Event|0|||
13315473|NCT01216176|26553518|FG000|Overall Study|Physician Decision|0|||
13315474|NCT01216176|26553519|FG001|Overall Study|Physician Decision|0|||
13315475|NCT01216176|26553520|FG002|Overall Study|Physician Decision|1|||
13315476|NCT01216163|26553580|FG000|Overall Study|Withdrawal by Subject|1|||
13315477|NCT01216163|26553581|FG001|Overall Study|Withdrawal by Subject|1|||
13315478|NCT01216163|26553582|FG002|Overall Study|Withdrawal by Subject|0|||
13315479|NCT01216072|26553615|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40|||
13315480|NCT01216072|26553616|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4|||
13315481|NCT01216072|26553615|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2|||
13315482|NCT01216072|26553616|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0|||
13315483|NCT01216072|26553615|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3|||
13315484|NCT01216072|26553616|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0|||
13315485|NCT01216072|26553615|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3|||
13315486|NCT01216072|26553616|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4|||
13315487|NCT01216072|26553615|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12|||
13315488|NCT01216072|26553616|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22|||
13315489|NCT01216072|26553615|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5|||
13315490|NCT01216072|26553616|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0|||
13315491|NCT01216072|26553615|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11|||
13315492|NCT01216072|26553616|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4|||
13315493|NCT01216072|26553615|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0|||
13315494|NCT01216072|26553616|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10|||
13373041|NCT00805740|26722533|FG000|Overall Study|Withdrawal by Subject|1|||
13315495|NCT01216072|26553615|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0|||
13315496|NCT01216072|26553616|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1|||
13315497|NCT01216072|26553615|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0|||
13315498|NCT01216072|26553616|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3|||
13315499|NCT01215981|26553631|FG000|Overall Study|Physician Decision|0|||
13315500|NCT01215981|26553632|FG001|Overall Study|Physician Decision|1|||
13315501|NCT01215981|26553631|FG000|Overall Study|Protocol Violation|1|||
13315502|NCT01215981|26553632|FG001|Overall Study|Protocol Violation|0|||
13315503|NCT01215981|26553631|FG000|Overall Study|Withdrawal by Subject|1|||
13315504|NCT01215981|26553632|FG001|Overall Study|Withdrawal by Subject|0|||
13315505|NCT01215968|26553655|FG000|Overall Study|Adverse Event|0|||
13315506|NCT01215968|26553656|FG001|Overall Study|Adverse Event|2|||
13315507|NCT01215968|26553655|FG000|Overall Study|Protocol Violation|2|||
13315508|NCT01215968|26553656|FG001|Overall Study|Protocol Violation|4|||
13315509|NCT01215968|26553655|FG000|Overall Study|Not received study drug|0|||
13315510|NCT01215968|26553656|FG001|Overall Study|Not received study drug|1|||
13315511|NCT01215955|26553735|FG000|Overall Study|Adverse Event|1|||
13315512|NCT01215955|26553736|FG001|Overall Study|Adverse Event|4|||
13315513|NCT01215955|26553737|FG002|Overall Study|Adverse Event|2|||
13315514|NCT01215955|26553738|FG003|Overall Study|Adverse Event|3|||
13315515|NCT01215955|26553735|FG000|Overall Study|Death|2|||
13315516|NCT01215955|26553736|FG001|Overall Study|Death|0|||
13315517|NCT01215955|26553737|FG002|Overall Study|Death|1|||
13315518|NCT01215955|26553738|FG003|Overall Study|Death|3|||
13315519|NCT01215955|26553735|FG000|Overall Study|Entry Criteria Not Met|1|||
13315520|NCT01215955|26553736|FG001|Overall Study|Entry Criteria Not Met|3|||
13315521|NCT01215955|26553737|FG002|Overall Study|Entry Criteria Not Met|4|||
13315522|NCT01215955|26553738|FG003|Overall Study|Entry Criteria Not Met|7|||
13315523|NCT01215955|26553735|FG000|Overall Study|Lack of Efficacy|1|||
13315524|NCT01215955|26553736|FG001|Overall Study|Lack of Efficacy|2|||
13315525|NCT01215955|26553737|FG002|Overall Study|Lack of Efficacy|1|||
13315526|NCT01215955|26553738|FG003|Overall Study|Lack of Efficacy|0|||
13315527|NCT01215955|26553735|FG000|Overall Study|Lost to Follow-up|4|||
13315528|NCT01215955|26553736|FG001|Overall Study|Lost to Follow-up|4|||
13315529|NCT01215955|26553737|FG002|Overall Study|Lost to Follow-up|8|||
13315530|NCT01215955|26553738|FG003|Overall Study|Lost to Follow-up|9|||
13315531|NCT01215955|26553735|FG000|Overall Study|Physician Decision|4|||
13315532|NCT01215955|26553736|FG001|Overall Study|Physician Decision|10|||
13315533|NCT01215955|26553737|FG002|Overall Study|Physician Decision|8|||
13315534|NCT01215955|26553738|FG003|Overall Study|Physician Decision|11|||
13315535|NCT01215955|26553735|FG000|Overall Study|Protocol Violation|17|||
13315536|NCT01215955|26553736|FG001|Overall Study|Protocol Violation|13|||
13315537|NCT01215955|26553737|FG002|Overall Study|Protocol Violation|8|||
13315538|NCT01215955|26553738|FG003|Overall Study|Protocol Violation|8|||
13315539|NCT01215955|26553735|FG000|Overall Study|Sponsor Decision|1|||
13315540|NCT01215955|26553736|FG001|Overall Study|Sponsor Decision|2|||
13315541|NCT01215955|26553737|FG002|Overall Study|Sponsor Decision|0|||
13315542|NCT01215955|26553738|FG003|Overall Study|Sponsor Decision|1|||
13315543|NCT01215955|26553735|FG000|Overall Study|Withdrawal by Subject|14|||
13315544|NCT01215955|26553736|FG001|Overall Study|Withdrawal by Subject|15|||
13315545|NCT01215955|26553737|FG002|Overall Study|Withdrawal by Subject|13|||
13315546|NCT01215955|26553738|FG003|Overall Study|Withdrawal by Subject|9|||
13315547|NCT01215955|26553735|FG000|Overall Study|Quality Issues|0|||
13315548|NCT01215955|26553736|FG001|Overall Study|Quality Issues|0|||
13315549|NCT01215955|26553737|FG002|Overall Study|Quality Issues|3|||
13315550|NCT01215955|26553738|FG003|Overall Study|Quality Issues|2|||
13315551|NCT01215942|26553860|FG000|Treatment Period|Adverse Event|15|||
13315552|NCT01215942|26553861|FG001|Treatment Period|Adverse Event|26|||
13315553|NCT01215942|26553860|FG000|Treatment Period|Death|2|||
13315554|NCT01215942|26553861|FG001|Treatment Period|Death|4|||
13315555|NCT01215942|26553860|FG000|Treatment Period|Lack of Efficacy|23|||
13315556|NCT01215942|26553861|FG001|Treatment Period|Lack of Efficacy|62|||
13315557|NCT01215942|26553860|FG000|Treatment Period|Lost to Follow-up|3|||
13315558|NCT01215942|26553861|FG001|Treatment Period|Lost to Follow-up|4|||
13315559|NCT01215942|26553860|FG000|Treatment Period|Withdrawal by Subject|17|||
13315560|NCT01215942|26553861|FG001|Treatment Period|Withdrawal by Subject|40|||
13315561|NCT01215942|26553860|FG000|Treatment Period|Physician Decision|5|||
13315562|NCT01215942|26553861|FG001|Treatment Period|Physician Decision|5|||
13315563|NCT01215942|26553860|FG000|Treatment Period|Protocol Violation|0|||
13315564|NCT01215942|26553861|FG001|Treatment Period|Protocol Violation|1|||
13315565|NCT01215942|26553860|FG000|Treatment Period|Sponsor Decision|349|||
13315566|NCT01215942|26553861|FG001|Treatment Period|Sponsor Decision|530|||
13315567|NCT01215942|26553860|FG000|Post-Treatment Follow-Up Period|Death|0|||
13315568|NCT01215942|26553861|FG001|Post-Treatment Follow-Up Period|Death|1|||
13315569|NCT01215942|26553860|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
13315570|NCT01215942|26553861|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
13315571|NCT01215942|26553860|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43|||
13315572|NCT01215942|26553861|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69|||
13315573|NCT01215942|26553860|FG000|Post-Treatment Follow-Up Period|Physician Decision|1|||
13315574|NCT01215942|26553861|FG001|Post-Treatment Follow-Up Period|Physician Decision|2|||
13315575|NCT01215942|26553860|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28|||
13315576|NCT01215942|26553861|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61|||
13315577|NCT01215916|26553917|FG000|Overall Study|Progressive Disease|0|||
13315578|NCT01215916|26553918|FG001|Overall Study|Progressive Disease|2|||
13315579|NCT01215916|26553919|FG002|Overall Study|Progressive Disease|1|||
13315580|NCT01215916|26553920|FG003|Overall Study|Progressive Disease|2|||
13315581|NCT01215916|26553921|FG004|Overall Study|Progressive Disease|5|||
13315582|NCT01215916|26553922|FG005|Overall Study|Progressive Disease|4|||
13315583|NCT01215916|26553923|FG006|Overall Study|Progressive Disease|5|||
13315584|NCT01215916|26553924|FG007|Overall Study|Progressive Disease|3|||
13315585|NCT01215916|26553925|FG008|Overall Study|Progressive Disease|1|||
13315586|NCT01215916|26553917|FG000|Overall Study|Adverse Event|1|||
13315587|NCT01215916|26553918|FG001|Overall Study|Adverse Event|1|||
13315588|NCT01215916|26553919|FG002|Overall Study|Adverse Event|0|||
13315589|NCT01215916|26553920|FG003|Overall Study|Adverse Event|1|||
13315590|NCT01215916|26553921|FG004|Overall Study|Adverse Event|0|||
13315591|NCT01215916|26553922|FG005|Overall Study|Adverse Event|0|||
13315592|NCT01215916|26553923|FG006|Overall Study|Adverse Event|3|||
13315593|NCT01215916|26553924|FG007|Overall Study|Adverse Event|0|||
13315594|NCT01215916|26553925|FG008|Overall Study|Adverse Event|0|||
13315595|NCT01215916|26553917|FG000|Overall Study|Withdrawal by Subject|0|||
13315596|NCT01215916|26553918|FG001|Overall Study|Withdrawal by Subject|1|||
13315597|NCT01215916|26553919|FG002|Overall Study|Withdrawal by Subject|1|||
13315598|NCT01215916|26553920|FG003|Overall Study|Withdrawal by Subject|2|||
13315599|NCT01215916|26553921|FG004|Overall Study|Withdrawal by Subject|0|||
13315600|NCT01215916|26553922|FG005|Overall Study|Withdrawal by Subject|0|||
13315601|NCT01215916|26553923|FG006|Overall Study|Withdrawal by Subject|1|||
13315602|NCT01215916|26553924|FG007|Overall Study|Withdrawal by Subject|0|||
13315603|NCT01215916|26553925|FG008|Overall Study|Withdrawal by Subject|0|||
13315604|NCT01215916|26553917|FG000|Overall Study|Death|0|||
13315605|NCT01215916|26553918|FG001|Overall Study|Death|1|||
13315606|NCT01215916|26553919|FG002|Overall Study|Death|0|||
13315607|NCT01215916|26553920|FG003|Overall Study|Death|0|||
13315608|NCT01215916|26553921|FG004|Overall Study|Death|1|||
13315609|NCT01215916|26553922|FG005|Overall Study|Death|0|||
13315610|NCT01215916|26553923|FG006|Overall Study|Death|0|||
13315611|NCT01215916|26553924|FG007|Overall Study|Death|0|||
13315612|NCT01215916|26553925|FG008|Overall Study|Death|1|||
13315613|NCT01215916|26553917|FG000|Overall Study|Physician Decision|0|||
13315614|NCT01215916|26553918|FG001|Overall Study|Physician Decision|0|||
13315615|NCT01215916|26553919|FG002|Overall Study|Physician Decision|1|||
13315616|NCT01215916|26553920|FG003|Overall Study|Physician Decision|1|||
13315617|NCT01215916|26553921|FG004|Overall Study|Physician Decision|0|||
13315618|NCT01215916|26553922|FG005|Overall Study|Physician Decision|0|||
13315619|NCT01215916|26553923|FG006|Overall Study|Physician Decision|0|||
13315620|NCT01215916|26553924|FG007|Overall Study|Physician Decision|0|||
13315621|NCT01215916|26553925|FG008|Overall Study|Physician Decision|0|||
13315622|NCT01215851|26553982|FG000|Treatment Period|Adverse Event|1|||
13315623|NCT01215851|26553983|FG001|Treatment Period|Adverse Event|1|||
13315624|NCT01215851|26553984|FG002|Treatment Period|Adverse Event|1|||
13315625|NCT01215851|26553985|FG003|Treatment Period|Adverse Event|3|||
13315626|NCT01215851|26553986|FG004|Treatment Period|Adverse Event|0|||
13315627|NCT01215851|26553987|FG005|Treatment Period|Adverse Event|1|||
13315628|NCT01215851|26553982|FG000|Follow up Period|Lost to Follow-up|0|||
13315629|NCT01215851|26553983|FG001|Follow up Period|Lost to Follow-up|0|||
13315630|NCT01215851|26553984|FG002|Follow up Period|Lost to Follow-up|0|||
13315631|NCT01215851|26553985|FG003|Follow up Period|Lost to Follow-up|0|||
13315632|NCT01215851|26553986|FG004|Follow up Period|Lost to Follow-up|0|||
13315633|NCT01215851|26553987|FG005|Follow up Period|Lost to Follow-up|1|||
13315634|NCT01215734|26554002|FG000|Overall Study|Death|0|||
13315635|NCT01215734|26554003|FG001|Overall Study|Death|1|||
13315636|NCT01215721|26554009|FG000|Overall Study|Adverse Event|2|||
13315637|NCT01215513|26554018|FG000|Overall Study|Not completed CS42|9|||
13315638|NCT01215513|26554018|FG000|Overall Study|Not enrolled from CS42 to CS42A|21|||
13315639|NCT01215513|26554018|FG000|Overall Study|Adverse event (CS42A)|2|||
13315640|NCT01215513|26554018|FG000|Overall Study|Physician decision (CS42A)|6|||
13315641|NCT01215513|26554018|FG000|Overall Study|Withdrawal by subject (CS42A)|5|||
13315642|NCT01215513|26554018|FG000|Overall Study|Miscellaneous reasons (CS42A)|2|||
13315643|NCT01215435|26554035|FG000|Overall Study|Adverse Event|1|||
13315644|NCT01215435|26554036|FG001|Overall Study|Adverse Event|0|||
13315645|NCT01215435|26554035|FG000|Overall Study|Protocol Violation|2|||
13315646|NCT01215435|26554036|FG001|Overall Study|Protocol Violation|0|||
13315647|NCT01215435|26554035|FG000|Overall Study|Withdrawal Criteria|8|||
13315648|NCT01215435|26554036|FG001|Overall Study|Withdrawal Criteria|11|||
13315649|NCT01215435|26554035|FG000|Overall Study|Lost to Follow-up|3|||
13315650|NCT01215435|26554036|FG001|Overall Study|Lost to Follow-up|0|||
13315651|NCT01215435|26554035|FG000|Overall Study|Unclassified|5|||
13315652|NCT01215435|26554036|FG001|Overall Study|Unclassified|5|||
13315653|NCT01215422|26554071|FG000|Overall Study|Relocation|1|||
13315654|NCT01215422|26554072|FG001|Overall Study|Relocation|0|||
13315655|NCT01215422|26554073|FG002|Overall Study|Relocation|0|||
13315656|NCT01215422|26554074|FG003|Overall Study|Relocation|0|||
13315657|NCT01215422|26554071|FG000|Overall Study|Failed intubations|0|||
13315658|NCT01215422|26554072|FG001|Overall Study|Failed intubations|0|||
13315659|NCT01215422|26554073|FG002|Overall Study|Failed intubations|3|||
13315660|NCT01215422|26554074|FG003|Overall Study|Failed intubations|8|||
13315661|NCT01215422|26554071|FG000|Overall Study|Did not complete all intubations|7|||
13315662|NCT01215422|26554072|FG001|Overall Study|Did not complete all intubations|0|||
13315663|NCT01215422|26554073|FG002|Overall Study|Did not complete all intubations|0|||
13315664|NCT01215422|26554074|FG003|Overall Study|Did not complete all intubations|0|||
13315665|NCT01215357|26554080|FG000|Overall Study|Withdrawal by Subject|3|||
13315666|NCT01215357|26554080|FG000|Overall Study|Protocol Violation|9|||
13315667|NCT01215253|26554115|FG000|Overall Study|Withdrawal by Subject|57|||
13315668|NCT01215253|26554116|FG001|Overall Study|Withdrawal by Subject|35|||
13315669|NCT01215253|26554115|FG000|Overall Study|Physician Decision|9|||
13315670|NCT01215253|26554116|FG001|Overall Study|Physician Decision|12|||
13315671|NCT01215253|26554115|FG000|Overall Study|Lost to Follow-up|6|||
13315672|NCT01215253|26554116|FG001|Overall Study|Lost to Follow-up|4|||
13315673|NCT01215253|26554115|FG000|Overall Study|Other|14|||
13315674|NCT01215253|26554116|FG001|Overall Study|Other|12|||
13315675|NCT01215227|26554179|FG000|Overall Study|Adverse Event|11|||
13315676|NCT01215227|26554180|FG001|Overall Study|Adverse Event|11|||
13315677|NCT01215227|26554181|FG002|Overall Study|Adverse Event|4|||
13315678|NCT01215227|26554182|FG003|Overall Study|Adverse Event|8|||
13315679|NCT01215227|26554183|FG004|Overall Study|Adverse Event|7|||
13315680|NCT01215227|26554184|FG005|Overall Study|Adverse Event|6|||
13315681|NCT01215227|26554179|FG000|Overall Study|Treatment Failure|8|||
13315682|NCT01215227|26554180|FG001|Overall Study|Treatment Failure|4|||
13315683|NCT01215227|26554181|FG002|Overall Study|Treatment Failure|1|||
13315684|NCT01215227|26554182|FG003|Overall Study|Treatment Failure|5|||
13315685|NCT01215227|26554183|FG004|Overall Study|Treatment Failure|1|||
13315686|NCT01215227|26554184|FG005|Overall Study|Treatment Failure|1|||
13315687|NCT01215227|26554179|FG000|Overall Study|Lost to Follow-up|1|||
13315688|NCT01215227|26554180|FG001|Overall Study|Lost to Follow-up|4|||
13315689|NCT01215227|26554181|FG002|Overall Study|Lost to Follow-up|1|||
13315690|NCT01215227|26554182|FG003|Overall Study|Lost to Follow-up|1|||
13315691|NCT01215227|26554183|FG004|Overall Study|Lost to Follow-up|1|||
13315692|NCT01215227|26554184|FG005|Overall Study|Lost to Follow-up|2|||
13315693|NCT01215227|26554179|FG000|Overall Study|Subject Withdrew Consent|16|||
13315694|NCT01215227|26554180|FG001|Overall Study|Subject Withdrew Consent|20|||
13315695|NCT01215227|26554181|FG002|Overall Study|Subject Withdrew Consent|7|||
13315696|NCT01215227|26554182|FG003|Overall Study|Subject Withdrew Consent|10|||
13315697|NCT01215227|26554183|FG004|Overall Study|Subject Withdrew Consent|11|||
13315698|NCT01215227|26554184|FG005|Overall Study|Subject Withdrew Consent|8|||
13315699|NCT01215227|26554179|FG000|Overall Study|Non-Compliance With Protocol|2|||
13315700|NCT01215227|26554180|FG001|Overall Study|Non-Compliance With Protocol|6|||
13315701|NCT01215227|26554181|FG002|Overall Study|Non-Compliance With Protocol|1|||
13315702|NCT01215227|26554182|FG003|Overall Study|Non-Compliance With Protocol|0|||
13315703|NCT01215227|26554183|FG004|Overall Study|Non-Compliance With Protocol|0|||
13315704|NCT01215227|26554184|FG005|Overall Study|Non-Compliance With Protocol|0|||
13315705|NCT01215227|26554179|FG000|Overall Study|Administrative|83|||
13315706|NCT01215227|26554180|FG001|Overall Study|Administrative|73|||
13315707|NCT01215227|26554181|FG002|Overall Study|Administrative|42|||
13315708|NCT01215227|26554182|FG003|Overall Study|Administrative|24|||
13315709|NCT01215227|26554183|FG004|Overall Study|Administrative|28|||
13315710|NCT01215227|26554184|FG005|Overall Study|Administrative|40|||
13315711|NCT01215227|26554179|FG000|Overall Study|Missing Status|0|||
13315712|NCT01215227|26554180|FG001|Overall Study|Missing Status|1|||
13315713|NCT01215227|26554181|FG002|Overall Study|Missing Status|0|||
13315714|NCT01215227|26554182|FG003|Overall Study|Missing Status|0|||
13315715|NCT01215227|26554183|FG004|Overall Study|Missing Status|0|||
13315716|NCT01215227|26554184|FG005|Overall Study|Missing Status|0|||
13315717|NCT01215227|26554179|FG000|Overall Study|Randomized but not treated|0|||
13315718|NCT01215227|26554180|FG001|Overall Study|Randomized but not treated|0|||
13315719|NCT01215227|26554181|FG002|Overall Study|Randomized but not treated|1|||
13315720|NCT01215227|26554182|FG003|Overall Study|Randomized but not treated|1|||
13315721|NCT01215227|26554183|FG004|Overall Study|Randomized but not treated|0|||
13315722|NCT01215227|26554184|FG005|Overall Study|Randomized but not treated|1|||
13315723|NCT01215188|26554241|FG000|Overall Study|Lost to Follow-up|22|||
13315724|NCT01215188|26554242|FG001|Overall Study|Lost to Follow-up|22|||
13315725|NCT01215188|26554243|FG002|Overall Study|Lost to Follow-up|16|||
13315726|NCT01215188|26554241|FG000|Overall Study|Adverse Event|1|||
13315727|NCT01215188|26554242|FG001|Overall Study|Adverse Event|1|||
13315728|NCT01215188|26554243|FG002|Overall Study|Adverse Event|3|||
13315729|NCT01215188|26554241|FG000|Overall Study|Physician Decision|2|||
13315730|NCT01215188|26554242|FG001|Overall Study|Physician Decision|1|||
13315731|NCT01215188|26554243|FG002|Overall Study|Physician Decision|0|||
13315732|NCT01215188|26554241|FG000|Overall Study|Lack of Efficacy|0|||
13315733|NCT01215188|26554242|FG001|Overall Study|Lack of Efficacy|0|||
13315734|NCT01215188|26554243|FG002|Overall Study|Lack of Efficacy|1|||
13315735|NCT01215188|26554241|FG000|Overall Study|Protocol Violation|1|||
13315736|NCT01215188|26554242|FG001|Overall Study|Protocol Violation|1|||
13315737|NCT01215188|26554243|FG002|Overall Study|Protocol Violation|1|||
13315738|NCT01215188|26554241|FG000|Overall Study|Withdrawal by Subject|32|||
13315739|NCT01215188|26554242|FG001|Overall Study|Withdrawal by Subject|34|||
13315740|NCT01215188|26554243|FG002|Overall Study|Withdrawal by Subject|31|||
13315741|NCT01215175|26554301|FG000|Overall Study|Lost to Follow-up|0|||
13315742|NCT01215175|26554302|FG001|Overall Study|Lost to Follow-up|1|||
13315743|NCT01215175|26554303|FG002|Overall Study|Lost to Follow-up|0|||
13315744|NCT01215175|26554304|FG003|Overall Study|Lost to Follow-up|1|||
13315745|NCT01215175|26554305|FG004|Overall Study|Lost to Follow-up|0|||
13315746|NCT01215097|26554344|FG000|Overall Study|Adverse Event|1|||
13315747|NCT01215097|26554345|FG001|Overall Study|Adverse Event|3|||
13315748|NCT01215097|26554344|FG000|Overall Study|Protocol Violation|0|||
13315749|NCT01215097|26554345|FG001|Overall Study|Protocol Violation|2|||
13315750|NCT01215097|26554344|FG000|Overall Study|Lost to Follow-up|2|||
13315751|NCT01215097|26554345|FG001|Overall Study|Lost to Follow-up|0|||
13315752|NCT01215097|26554344|FG000|Overall Study|Withdrawal by Subject|6|||
13315753|NCT01215097|26554345|FG001|Overall Study|Withdrawal by Subject|3|||
13315754|NCT01215097|26554344|FG000|Overall Study|Lack of Efficacy|0|||
13315755|NCT01215097|26554345|FG001|Overall Study|Lack of Efficacy|3|||
13315756|NCT01215097|26554344|FG000|Overall Study|patient's refusal to come|2|||
13315757|NCT01215097|26554345|FG001|Overall Study|patient's refusal to come|2|||
13315758|NCT01215097|26554344|FG000|Overall Study|patient's private reason|1|||
13315759|NCT01215097|26554345|FG001|Overall Study|patient's private reason|1|||
13315760|NCT01215032|26554355|FG000|Overall Study|Adverse Event|3|||
13315761|NCT01215032|26554355|FG000|Overall Study|Lack of Efficacy|17|||
13315762|NCT01214915|26554365|FG000|Overall Study|Adverse Event|8|||
13315763|NCT01214915|26554365|FG000|Overall Study|Lack of Efficacy|3|||
13315764|NCT01214850|26554456|FG000|Overall Study|Withdrawal by Subject|38|||
13315765|NCT01214850|26554457|FG001|Overall Study|Withdrawal by Subject|31|||
13315766|NCT01214850|26554458|FG002|Overall Study|Withdrawal by Subject|28|||
13315767|NCT01214850|26554456|FG000|Overall Study|Lost to Follow-up|124|||
13315768|NCT01214850|26554457|FG001|Overall Study|Lost to Follow-up|98|||
13315769|NCT01214850|26554458|FG002|Overall Study|Lost to Follow-up|123|||
13315770|NCT01214850|26554456|FG000|Overall Study|Protocol Violation|5|||
13315771|NCT01214850|26554457|FG001|Overall Study|Protocol Violation|5|||
13315772|NCT01214850|26554458|FG002|Overall Study|Protocol Violation|6|||
13315773|NCT01214850|26554456|FG000|Overall Study|Adverse event or death|11|||
13315774|NCT01214850|26554457|FG001|Overall Study|Adverse event or death|8|||
13315775|NCT01214850|26554458|FG002|Overall Study|Adverse event or death|3|||
13315776|NCT01214850|26554456|FG000|Overall Study|Inappropriate enrollment|2|||
13315777|NCT01214850|26554457|FG001|Overall Study|Inappropriate enrollment|1|||
13315778|NCT01214850|26554458|FG002|Overall Study|Inappropriate enrollment|0|||
13315779|NCT01214850|26554456|FG000|Overall Study|Administrative reason|1|||
13315780|NCT01214850|26554457|FG001|Overall Study|Administrative reason|0|||
13315781|NCT01214850|26554458|FG002|Overall Study|Administrative reason|0|||
13315782|NCT01214850|26554456|FG000|Overall Study|Unable to classify|2|||
13315783|NCT01214850|26554457|FG001|Overall Study|Unable to classify|1|||
13315784|NCT01214850|26554458|FG002|Overall Study|Unable to classify|1|||
13315785|NCT01214837|26554505|FG000|Overall Study|Death|0|||
13315786|NCT01214837|26554506|FG001|Overall Study|Death|0|||
13315787|NCT01214837|26554507|FG002|Overall Study|Death|1|||
13315788|NCT01214837|26554505|FG000|Overall Study|Adverse Event|1|||
13315789|NCT01214837|26554506|FG001|Overall Study|Adverse Event|2|||
13315790|NCT01214837|26554507|FG002|Overall Study|Adverse Event|1|||
13315791|NCT01214837|26554505|FG000|Overall Study|Withdrawal by Subject|27|||
13315792|NCT01214837|26554506|FG001|Overall Study|Withdrawal by Subject|36|||
13315793|NCT01214837|26554507|FG002|Overall Study|Withdrawal by Subject|28|||
13315794|NCT01214837|26554505|FG000|Overall Study|Lost to Follow-up|20|||
13315795|NCT01214837|26554506|FG001|Overall Study|Lost to Follow-up|15|||
13315796|NCT01214837|26554507|FG002|Overall Study|Lost to Follow-up|21|||
13315797|NCT01214837|26554505|FG000|Overall Study|Inappropriate Enrolment|0|||
13315798|NCT01214837|26554506|FG001|Overall Study|Inappropriate Enrolment|1|||
13315799|NCT01214837|26554507|FG002|Overall Study|Inappropriate Enrolment|2|||
13315800|NCT01214837|26554505|FG000|Overall Study|Administrative Reason|2|||
13315801|NCT01214837|26554506|FG001|Overall Study|Administrative Reason|6|||
13315802|NCT01214837|26554507|FG002|Overall Study|Administrative Reason|4|||
13315803|NCT01214837|26554505|FG000|Overall Study|Protocol Violation|3|||
13315804|NCT01214837|26554506|FG001|Overall Study|Protocol Violation|1|||
13315805|NCT01214837|26554507|FG002|Overall Study|Protocol Violation|5|||
13315806|NCT01214837|26554505|FG000|Overall Study|Unable to Classify|1|||
13315807|NCT01214837|26554506|FG001|Overall Study|Unable to Classify|3|||
13315808|NCT01214837|26554507|FG002|Overall Study|Unable to Classify|0|||
13315809|NCT01214720|26554531|FG000|Overall Study|Alive and still on treatment|34|||
13315810|NCT01214720|26554532|FG001|Overall Study|Alive and still on treatment|18|||
13315811|NCT01214720|26554531|FG000|Overall Study|Alive and in follow-up|45|||
13315812|NCT01214720|26554532|FG001|Overall Study|Alive and in follow-up|48|||
13315813|NCT01214720|26554531|FG000|Overall Study|Lost to Follow-up|6|||
13315814|NCT01214720|26554532|FG001|Overall Study|Lost to Follow-up|2|||
13315815|NCT01214668|26554585|FG000|Overall Study|Adverse Event|0|||
13315816|NCT01214668|26554586|FG001|Overall Study|Adverse Event|1|||
13315817|NCT01214668|26554587|FG002|Overall Study|Adverse Event|0|||
13315818|NCT01214668|26554588|FG003|Overall Study|Adverse Event|2|||
13315819|NCT01214668|26554589|FG004|Overall Study|Adverse Event|1|||
13315820|NCT01214668|26554590|FG005|Overall Study|Adverse Event|1|||
13315821|NCT01214668|26554585|FG000|Overall Study|Death|0|||
13315822|NCT01214668|26554586|FG001|Overall Study|Death|0|||
13315823|NCT01214668|26554587|FG002|Overall Study|Death|1|||
13315824|NCT01214668|26554588|FG003|Overall Study|Death|0|||
13315825|NCT01214668|26554589|FG004|Overall Study|Death|0|||
13315826|NCT01214668|26554590|FG005|Overall Study|Death|0|||
13315827|NCT01214668|26554585|FG000|Overall Study|Progressive Disease|4|||
13315828|NCT01214668|26554586|FG001|Overall Study|Progressive Disease|2|||
13315829|NCT01214668|26554587|FG002|Overall Study|Progressive Disease|5|||
13315830|NCT01214668|26554588|FG003|Overall Study|Progressive Disease|4|||
13315831|NCT01214668|26554589|FG004|Overall Study|Progressive Disease|4|||
13315832|NCT01214668|26554590|FG005|Overall Study|Progressive Disease|5|||
13315833|NCT01214668|26554585|FG000|Overall Study|Withdrawal by Subject|0|||
13315834|NCT01214668|26554586|FG001|Overall Study|Withdrawal by Subject|0|||
13315835|NCT01214668|26554587|FG002|Overall Study|Withdrawal by Subject|0|||
13315836|NCT01214668|26554588|FG003|Overall Study|Withdrawal by Subject|0|||
13315837|NCT01214668|26554589|FG004|Overall Study|Withdrawal by Subject|1|||
13315838|NCT01214668|26554590|FG005|Overall Study|Withdrawal by Subject|0|||
13315839|NCT01214655|26554661|FG000|Part A|Progressive Disease|7|||
13315840|NCT01214655|26554662|FG001|Part A|Progressive Disease|0|||
13315841|NCT01214655|26554663|FG002|Part A|Progressive Disease|0|||
13315842|NCT01214655|26554661|FG000|Part A|Physician Decision|1|||
13315843|NCT01214655|26554662|FG001|Part A|Physician Decision|0|||
13315844|NCT01214655|26554663|FG002|Part A|Physician Decision|0|||
13315845|NCT01214655|26554661|FG000|Part B|Progressive disease|0|||
13315846|NCT01214655|26554662|FG001|Part B|Progressive disease|10|||
13315847|NCT01214655|26554663|FG002|Part B|Progressive disease|0|||
13315848|NCT01214655|26554661|FG000|Part B|Death|0|||
13315849|NCT01214655|26554662|FG001|Part B|Death|1|||
13315850|NCT01214655|26554663|FG002|Part B|Death|0|||
13315851|NCT01214655|26554661|FG000|Part B|Withdrawal by Subject|0|||
13315852|NCT01214655|26554662|FG001|Part B|Withdrawal by Subject|2|||
13315853|NCT01214655|26554663|FG002|Part B|Withdrawal by Subject|0|||
13315854|NCT01214655|26554661|FG000|Part C|Progressive Disease|0|||
13315855|NCT01214655|26554662|FG001|Part C|Progressive Disease|0|||
13315856|NCT01214655|26554663|FG002|Part C|Progressive Disease|5|||
13315857|NCT01214655|26554661|FG000|Part C|Death|0|||
13315858|NCT01214655|26554662|FG001|Part C|Death|0|||
13315859|NCT01214655|26554663|FG002|Part C|Death|1|||
13315860|NCT01214655|26554661|FG000|Part C|Physician Decision|0|||
13315861|NCT01214655|26554662|FG001|Part C|Physician Decision|0|||
13315862|NCT01214655|26554663|FG002|Part C|Physician Decision|1|||
13315863|NCT01214642|26554769|FG000|Overall Study|Progressive Disease|3|||
13315864|NCT01214642|26554770|FG001|Overall Study|Progressive Disease|2|||
13315865|NCT01214642|26554771|FG002|Overall Study|Progressive Disease|3|||
13315866|NCT01214642|26554772|FG003|Overall Study|Progressive Disease|5|||
13315867|NCT01214642|26554773|FG004|Overall Study|Progressive Disease|5|||
13315868|NCT01214642|26554774|FG005|Overall Study|Progressive Disease|3|||
13315869|NCT01214642|26554775|FG006|Overall Study|Progressive Disease|5|||
13315870|NCT01214642|26554776|FG007|Overall Study|Progressive Disease|3|||
13315871|NCT01214642|26554777|FG008|Overall Study|Progressive Disease|10|||
13315872|NCT01214642|26554778|FG009|Overall Study|Progressive Disease|2|||
13315873|NCT01214642|26554779|FG010|Overall Study|Progressive Disease|1|||
13315874|NCT01214642|26554780|FG011|Overall Study|Progressive Disease|4|||
13315875|NCT01214642|26554769|FG000|Overall Study|Adverse Event|0|||
13315876|NCT01214642|26554770|FG001|Overall Study|Adverse Event|1|||
13315877|NCT01214642|26554771|FG002|Overall Study|Adverse Event|0|||
13315878|NCT01214642|26554772|FG003|Overall Study|Adverse Event|0|||
13315879|NCT01214642|26554773|FG004|Overall Study|Adverse Event|0|||
13315880|NCT01214642|26554774|FG005|Overall Study|Adverse Event|0|||
13315881|NCT01214642|26554775|FG006|Overall Study|Adverse Event|1|||
13315882|NCT01214642|26554776|FG007|Overall Study|Adverse Event|0|||
13315883|NCT01214642|26554777|FG008|Overall Study|Adverse Event|0|||
13315884|NCT01214642|26554778|FG009|Overall Study|Adverse Event|1|||
13315885|NCT01214642|26554779|FG010|Overall Study|Adverse Event|1|||
13315886|NCT01214642|26554780|FG011|Overall Study|Adverse Event|0|||
13315887|NCT01214642|26554769|FG000|Overall Study|Death|0|||
13315888|NCT01214642|26554770|FG001|Overall Study|Death|0|||
13315889|NCT01214642|26554771|FG002|Overall Study|Death|1|||
13315890|NCT01214642|26554772|FG003|Overall Study|Death|0|||
13315891|NCT01214642|26554773|FG004|Overall Study|Death|0|||
13315892|NCT01214642|26554774|FG005|Overall Study|Death|0|||
13315893|NCT01214642|26554775|FG006|Overall Study|Death|0|||
13315894|NCT01214642|26554776|FG007|Overall Study|Death|0|||
13315895|NCT01214642|26554777|FG008|Overall Study|Death|0|||
13315896|NCT01214642|26554778|FG009|Overall Study|Death|0|||
13315897|NCT01214642|26554779|FG010|Overall Study|Death|1|||
13315898|NCT01214642|26554780|FG011|Overall Study|Death|0|||
13315899|NCT01214642|26554769|FG000|Overall Study|Withdrawal by Subject|0|||
13315900|NCT01214642|26554770|FG001|Overall Study|Withdrawal by Subject|0|||
13315901|NCT01214642|26554771|FG002|Overall Study|Withdrawal by Subject|1|||
13315902|NCT01214642|26554772|FG003|Overall Study|Withdrawal by Subject|0|||
13315903|NCT01214642|26554773|FG004|Overall Study|Withdrawal by Subject|0|||
13315904|NCT01214642|26554774|FG005|Overall Study|Withdrawal by Subject|0|||
13315905|NCT01214642|26554775|FG006|Overall Study|Withdrawal by Subject|0|||
13315906|NCT01214642|26554776|FG007|Overall Study|Withdrawal by Subject|0|||
13315907|NCT01214642|26554777|FG008|Overall Study|Withdrawal by Subject|3|||
13315908|NCT01214642|26554778|FG009|Overall Study|Withdrawal by Subject|1|||
13315909|NCT01214642|26554779|FG010|Overall Study|Withdrawal by Subject|1|||
13315910|NCT01214642|26554780|FG011|Overall Study|Withdrawal by Subject|0|||
13315911|NCT01214642|26554769|FG000|Overall Study|Physician Decision|0|||
13315912|NCT01214642|26554770|FG001|Overall Study|Physician Decision|0|||
13315913|NCT01214642|26554771|FG002|Overall Study|Physician Decision|1|||
13315914|NCT01214642|26554772|FG003|Overall Study|Physician Decision|1|||
13315915|NCT01214642|26554773|FG004|Overall Study|Physician Decision|1|||
13315916|NCT01214642|26554774|FG005|Overall Study|Physician Decision|0|||
13315917|NCT01214642|26554775|FG006|Overall Study|Physician Decision|0|||
13315918|NCT01214642|26554776|FG007|Overall Study|Physician Decision|0|||
13315919|NCT01214642|26554777|FG008|Overall Study|Physician Decision|0|||
13315920|NCT01214642|26554778|FG009|Overall Study|Physician Decision|0|||
13315921|NCT01214642|26554779|FG010|Overall Study|Physician Decision|0|||
13315922|NCT01214642|26554780|FG011|Overall Study|Physician Decision|2|||
13315923|NCT01214629|26554875|FG000|Overall Study|Progressive Disease|1|||
13315924|NCT01214629|26554876|FG001|Overall Study|Progressive Disease|1|||
13315925|NCT01214629|26554877|FG002|Overall Study|Progressive Disease|0|||
13315926|NCT01214629|26554878|FG003|Overall Study|Progressive Disease|1|||
13315927|NCT01214629|26554879|FG004|Overall Study|Progressive Disease|2|||
13315928|NCT01214629|26554880|FG005|Overall Study|Progressive Disease|3|||
13315929|NCT01214629|26554881|FG006|Overall Study|Progressive Disease|1|||
13315930|NCT01214629|26554882|FG007|Overall Study|Progressive Disease|1|||
13315931|NCT01214629|26554883|FG008|Overall Study|Progressive Disease|1|||
13315932|NCT01214629|26554884|FG009|Overall Study|Progressive Disease|5|||
13315933|NCT01214629|26554885|FG010|Overall Study|Progressive Disease|1|||
13315934|NCT01214629|26554875|FG000|Overall Study|Adverse Event|0|||
13315935|NCT01214629|26554876|FG001|Overall Study|Adverse Event|0|||
13315936|NCT01214629|26554877|FG002|Overall Study|Adverse Event|0|||
13315937|NCT01214629|26554878|FG003|Overall Study|Adverse Event|1|||
13315938|NCT01214629|26554879|FG004|Overall Study|Adverse Event|0|||
13315939|NCT01214629|26554880|FG005|Overall Study|Adverse Event|1|||
13315940|NCT01214629|26554881|FG006|Overall Study|Adverse Event|0|||
13315941|NCT01214629|26554882|FG007|Overall Study|Adverse Event|0|||
13315942|NCT01214629|26554883|FG008|Overall Study|Adverse Event|0|||
13315943|NCT01214629|26554884|FG009|Overall Study|Adverse Event|1|||
13315944|NCT01214629|26554885|FG010|Overall Study|Adverse Event|0|||
13315945|NCT01214629|26554875|FG000|Overall Study|Physician Decision|0|||
13315946|NCT01214629|26554876|FG001|Overall Study|Physician Decision|0|||
13315947|NCT01214629|26554877|FG002|Overall Study|Physician Decision|0|||
13315948|NCT01214629|26554878|FG003|Overall Study|Physician Decision|0|||
13315949|NCT01214629|26554879|FG004|Overall Study|Physician Decision|0|||
13315950|NCT01214629|26554880|FG005|Overall Study|Physician Decision|0|||
13315951|NCT01214629|26554881|FG006|Overall Study|Physician Decision|0|||
13315952|NCT01214629|26554882|FG007|Overall Study|Physician Decision|0|||
13315953|NCT01214629|26554883|FG008|Overall Study|Physician Decision|0|||
13315954|NCT01214629|26554884|FG009|Overall Study|Physician Decision|0|||
13315955|NCT01214629|26554885|FG010|Overall Study|Physician Decision|1|||
13315956|NCT01214629|26554875|FG000|Overall Study|Withdrawal by Subject|0|||
13315957|NCT01214629|26554876|FG001|Overall Study|Withdrawal by Subject|0|||
13315958|NCT01214629|26554877|FG002|Overall Study|Withdrawal by Subject|0|||
13315959|NCT01214629|26554878|FG003|Overall Study|Withdrawal by Subject|0|||
13315960|NCT01214629|26554879|FG004|Overall Study|Withdrawal by Subject|0|||
13315961|NCT01214629|26554880|FG005|Overall Study|Withdrawal by Subject|0|||
13315962|NCT01214629|26554881|FG006|Overall Study|Withdrawal by Subject|0|||
13315963|NCT01214629|26554882|FG007|Overall Study|Withdrawal by Subject|0|||
13315964|NCT01214629|26554883|FG008|Overall Study|Withdrawal by Subject|0|||
13315965|NCT01214629|26554884|FG009|Overall Study|Withdrawal by Subject|1|||
13315966|NCT01214629|26554885|FG010|Overall Study|Withdrawal by Subject|0|||
13315967|NCT01214616|26554932|FG000|Overall Study|Progressive disease|2|||
13315968|NCT01214616|26554933|FG001|Overall Study|Progressive disease|2|||
13315969|NCT01214616|26554934|FG002|Overall Study|Progressive disease|2|||
13315970|NCT01214616|26554935|FG003|Overall Study|Progressive disease|4|||
13315971|NCT01214616|26554932|FG000|Overall Study|Dose limiting toxicity|0|||
13315972|NCT01214616|26554933|FG001|Overall Study|Dose limiting toxicity|2|||
13315973|NCT01214616|26554934|FG002|Overall Study|Dose limiting toxicity|0|||
13315974|NCT01214616|26554935|FG003|Overall Study|Dose limiting toxicity|0|||
13315975|NCT01214616|26554932|FG000|Overall Study|Other adverse events|0|||
13315976|NCT01214616|26554933|FG001|Overall Study|Other adverse events|1|||
13315977|NCT01214616|26554934|FG002|Overall Study|Other adverse events|1|||
13315978|NCT01214616|26554935|FG003|Overall Study|Other adverse events|1|||
13315979|NCT01214616|26554932|FG000|Overall Study|Withdrawal by Subject|1|||
13315980|NCT01214616|26554933|FG001|Overall Study|Withdrawal by Subject|0|||
13315981|NCT01214616|26554934|FG002|Overall Study|Withdrawal by Subject|0|||
13315982|NCT01214616|26554935|FG003|Overall Study|Withdrawal by Subject|1|||
13315983|NCT01214603|26554966|FG000|Overall Study|Adverse Event|0|||
13315984|NCT01214603|26554967|FG001|Overall Study|Adverse Event|0|||
13315985|NCT01214603|26554968|FG002|Overall Study|Adverse Event|1|||
13315986|NCT01214603|26554966|FG000|Overall Study|Death|1|||
13315987|NCT01214603|26554967|FG001|Overall Study|Death|0|||
13315988|NCT01214603|26554968|FG002|Overall Study|Death|0|||
13315989|NCT01214603|26554966|FG000|Overall Study|Progressive Disease|4|||
13315990|NCT01214603|26554967|FG001|Overall Study|Progressive Disease|1|||
13315991|NCT01214603|26554968|FG002|Overall Study|Progressive Disease|3|||
13315992|NCT01214434|26554991|FG000|Overall Study|Withdrawal by Subject|1|||
13315993|NCT01214434|26554992|FG001|Overall Study|Withdrawal by Subject|0|||
13315994|NCT01214434|26554991|FG000|Overall Study|Lost to Follow-up|2|||
13315995|NCT01214434|26554992|FG001|Overall Study|Lost to Follow-up|2|||
13315996|NCT01214434|26554991|FG000|Overall Study|Site error|1|||
13315997|NCT01214434|26554992|FG001|Overall Study|Site error|0|||
13373042|NCT00805740|26722534|FG001|Overall Study|Withdrawal by Subject|0|||
13373043|NCT00805740|26722533|FG000|Overall Study|Lost to Follow-up|1|||
13373044|NCT00805740|26722534|FG001|Overall Study|Lost to Follow-up|0|||
13373045|NCT00805740|26722533|FG000|Overall Study|Randomized, but not treated|2|||
13373046|NCT00805740|26722534|FG001|Overall Study|Randomized, but not treated|0|||
13373047|NCT00805675|26722576|FG000|Overall Study|Adverse Event|0|||
13373048|NCT00805675|26722577|FG001|Overall Study|Adverse Event|0|||
13373049|NCT00805675|26722578|FG002|Overall Study|Adverse Event|1|||
13373050|NCT00805545|26722591|FG000|Overall Study|Protocol Violation|3|||
13373051|NCT00805545|26722592|FG001|Overall Study|Protocol Violation|2|||
13373052|NCT00805545|26722591|FG000|Overall Study|Protocol Violation|3|||
13373053|NCT00805545|26722592|FG001|Overall Study|Protocol Violation|1|||
13373054|NCT00805532|26722613|FG000|Overall Study|invalid data|0|||
13373055|NCT00805532|26722614|FG001|Overall Study|invalid data|1|||
13373056|NCT00805480|26722652|FG000|Overall Study|Withdrawal by Subject|13|||
13373057|NCT00805480|26722653|FG001|Overall Study|Withdrawal by Subject|5|||
13373058|NCT00805480|26722654|FG002|Overall Study|Withdrawal by Subject|11|||
13373059|NCT00805480|26722655|FG003|Overall Study|Withdrawal by Subject|5|||
13373060|NCT00805480|26722652|FG000|Overall Study|Lost to Follow-up|1|||
13373061|NCT00805480|26722653|FG001|Overall Study|Lost to Follow-up|2|||
13373062|NCT00805480|26722654|FG002|Overall Study|Lost to Follow-up|0|||
13373063|NCT00805480|26722655|FG003|Overall Study|Lost to Follow-up|0|||
13373064|NCT00805480|26722652|FG000|Overall Study|Adverse Event|0|||
13373065|NCT00805480|26722653|FG001|Overall Study|Adverse Event|0|||
13373066|NCT00805480|26722654|FG002|Overall Study|Adverse Event|1|||
13373067|NCT00805480|26722655|FG003|Overall Study|Adverse Event|0|||
13373068|NCT00805467|26722686|FG000|Overall Study|Lack of Efficacy|0|||
13373069|NCT00805467|26722687|FG001|Overall Study|Lack of Efficacy|8|||
13373070|NCT00805467|26722688|FG002|Overall Study|Lack of Efficacy|13|||
13373071|NCT00805467|26722689|FG003|Overall Study|Lack of Efficacy|86|||
13373072|NCT00805467|26722686|FG000|Overall Study|Lost to Follow-up|0|||
13373073|NCT00805467|26722687|FG001|Overall Study|Lost to Follow-up|1|||
13373074|NCT00805467|26722688|FG002|Overall Study|Lost to Follow-up|7|||
13373075|NCT00805467|26722689|FG003|Overall Study|Lost to Follow-up|21|||
13373076|NCT00805467|26722686|FG000|Overall Study|Withdrawal by Subject|0|||
13373077|NCT00805467|26722687|FG001|Overall Study|Withdrawal by Subject|6|||
13373078|NCT00805467|26722688|FG002|Overall Study|Withdrawal by Subject|45|||
13373079|NCT00805467|26722689|FG003|Overall Study|Withdrawal by Subject|50|||
13373080|NCT00805467|26722686|FG000|Overall Study|Protocol Violation|0|||
13373081|NCT00805467|26722687|FG001|Overall Study|Protocol Violation|3|||
13373082|NCT00805467|26722688|FG002|Overall Study|Protocol Violation|0|||
13373083|NCT00805467|26722689|FG003|Overall Study|Protocol Violation|5|||
13373084|NCT00805467|26722686|FG000|Overall Study|Adverse Event|0|||
13373085|NCT00805467|26722687|FG001|Overall Study|Adverse Event|13|||
13373086|NCT00805467|26722688|FG002|Overall Study|Adverse Event|26|||
13373087|NCT00805467|26722689|FG003|Overall Study|Adverse Event|57|||
13373088|NCT00805467|26722686|FG000|Overall Study|Death|0|||
13373089|NCT00805467|26722687|FG001|Overall Study|Death|2|||
13122141|NCT02969018|25946165|FG004|Overall Study|Adverse Event|0|||
13373090|NCT00805467|26722688|FG002|Overall Study|Death|7|||
13373091|NCT00805467|26722689|FG003|Overall Study|Death|5|||
13373092|NCT00805467|26722686|FG000|Overall Study|Physician Decision|0|||
13373093|NCT00805467|26722687|FG001|Overall Study|Physician Decision|1|||
13373094|NCT00805467|26722688|FG002|Overall Study|Physician Decision|2|||
13373095|NCT00805467|26722689|FG003|Overall Study|Physician Decision|6|||
13315998|NCT01214421|26555023|FG000|Overall Study|Lost to Follow-up|7|||
13315999|NCT01214421|26555024|FG001|Overall Study|Lost to Follow-up|3|||
13316000|NCT01214421|26555025|FG002|Overall Study|Lost to Follow-up|7|||
13316001|NCT01214421|26555026|FG003|Overall Study|Lost to Follow-up|3|||
13316002|NCT01214421|26555023|FG000|Overall Study|Adverse Event|16|||
13316003|NCT01214421|26555024|FG001|Overall Study|Adverse Event|35|||
13316004|NCT01214421|26555025|FG002|Overall Study|Adverse Event|14|||
13316005|NCT01214421|26555026|FG003|Overall Study|Adverse Event|3|||
13316006|NCT01214421|26555023|FG000|Overall Study|Sponsor Discontinued Site|1|||
13316007|NCT01214421|26555024|FG001|Overall Study|Sponsor Discontinued Site|2|||
13316008|NCT01214421|26555025|FG002|Overall Study|Sponsor Discontinued Site|0|||
13316009|NCT01214421|26555026|FG003|Overall Study|Sponsor Discontinued Site|0|||
13316010|NCT01214421|26555023|FG000|Overall Study|Withdrawal Criteria Met|3|||
13316011|NCT01214421|26555024|FG001|Overall Study|Withdrawal Criteria Met|0|||
13316012|NCT01214421|26555025|FG002|Overall Study|Withdrawal Criteria Met|2|||
13316013|NCT01214421|26555026|FG003|Overall Study|Withdrawal Criteria Met|1|||
13316014|NCT01214421|26555023|FG000|Overall Study|Physician Decision|2|||
13316015|NCT01214421|26555024|FG001|Overall Study|Physician Decision|0|||
13316016|NCT01214421|26555025|FG002|Overall Study|Physician Decision|4|||
13316017|NCT01214421|26555026|FG003|Overall Study|Physician Decision|0|||
13316018|NCT01214421|26555023|FG000|Overall Study|Withdrawal by Subject|21|||
13316019|NCT01214421|26555024|FG001|Overall Study|Withdrawal by Subject|18|||
13316020|NCT01214421|26555025|FG002|Overall Study|Withdrawal by Subject|11|||
13316021|NCT01214421|26555026|FG003|Overall Study|Withdrawal by Subject|2|||
13316022|NCT01214395|26555033|FG000|Overall Study|All patients had infection|5|||
13316023|NCT01214252|26555041|FG000|Overall Study|Not eligible per protocol|82|||
13316024|NCT01214239|26555080|FG000|Overall Study|Adverse Event|3|||
13316025|NCT01214239|26555081|FG001|Overall Study|Adverse Event|4|||
13316026|NCT01214239|26555080|FG000|Overall Study|Protocol Violation|2|||
13316027|NCT01214239|26555081|FG001|Overall Study|Protocol Violation|1|||
13316028|NCT01214239|26555080|FG000|Overall Study|Lost to Follow-up|1|||
13316029|NCT01214239|26555081|FG001|Overall Study|Lost to Follow-up|1|||
13316030|NCT01214239|26555080|FG000|Overall Study|Withdrawal by Subject|4|||
13316031|NCT01214239|26555081|FG001|Overall Study|Withdrawal by Subject|9|||
13316032|NCT01214239|26555080|FG000|Overall Study|Lack of Efficacy|1|||
13316033|NCT01214239|26555081|FG001|Overall Study|Lack of Efficacy|2|||
13316034|NCT01214239|26555080|FG000|Overall Study|patient's private reason|1|||
13316035|NCT01214239|26555081|FG001|Overall Study|patient's private reason|1|||
13316036|NCT01214200|26555095|FG000|Overall Study|Did not meet inclusion/exclusion|9|||
13316037|NCT01214200|26555095|FG000|Overall Study|Withdrawal by Subject|2|||
13316038|NCT01214187|26555116|FG000|Overall Study|Adverse Event|6|||
13316039|NCT01214187|26555117|FG001|Overall Study|Adverse Event|2|||
13316040|NCT01214187|26555116|FG000|Overall Study|Death|1|||
13316041|NCT01214187|26555117|FG001|Overall Study|Death|1|||
13316042|NCT01214187|26555116|FG000|Overall Study|Withdrawal by Subject|0|||
13316043|NCT01214187|26555117|FG001|Overall Study|Withdrawal by Subject|3|||
13316044|NCT01214174|26555135|FG000|Overall Study|Withdrawal by Subject|0|||
13316045|NCT01214174|26555136|FG001|Overall Study|Withdrawal by Subject|0|||
13316046|NCT01214174|26555137|FG002|Overall Study|Withdrawal by Subject|1|||
13316047|NCT01214044|26555149|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5|||
13316048|NCT01214044|26555149|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3|||
13316049|NCT01214044|26555149|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4|||
13316050|NCT01214044|26555149|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3|||
13316051|NCT01214044|26555149|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3|||
13316052|NCT01214044|26555149|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1|||
13316053|NCT01213966|26555172|FG000|Overall Study|Protocol Violation|1|||
13316054|NCT01213966|26555173|FG001|Overall Study|Protocol Violation|0|||
13316055|NCT01213966|26555174|FG002|Overall Study|Protocol Violation|3|||
13316056|NCT01213966|26555175|FG003|Overall Study|Protocol Violation|1|||
13316057|NCT01213836|26555200|FG000|Period 1, First Intervention|Adverse Event|2|||
13316058|NCT01213836|26555201|FG001|Period 1, First Intervention|Adverse Event|1|||
13316059|NCT01213836|26555200|FG000|Period 1, First Intervention|Protocol Violation|0|||
13316060|NCT01213836|26555201|FG001|Period 1, First Intervention|Protocol Violation|1|||
13316061|NCT01213836|26555200|FG000|Period 1, First Intervention|Withdrawal by Subject|1|||
13316062|NCT01213836|26555201|FG001|Period 1, First Intervention|Withdrawal by Subject|1|||
13316063|NCT01213524|26555221|FG000|Baseline|Withdrawal by Subject|5|||
13316064|NCT01213524|26555221|FG000|Baseline|high breath alcohol levels|1|||
13316065|NCT01213524|26555221|FG000|Baseline|Physician Decision|1|||
13316066|NCT01213524|26555221|FG000|Session 2|Withdrawal by Subject|5|||
13316067|NCT01213524|26555221|FG000|Session 3|Withdrawal by Subject|4|||
13316068|NCT01213524|26555221|FG000|Session 4|Physician Decision|1|||
13316069|NCT01213524|26555221|FG000|Session 4|Withdrawal by Subject|2|||
13316070|NCT01213472|26555244|FG000|Overall Study|Recurrence/Progressive disease|25|||
13316071|NCT01213472|26555244|FG000|Overall Study|Withdrawal by Subject|1|||
13316072|NCT01213472|26555244|FG000|Overall Study|Physician Decision|1|||
13316073|NCT01213264|26555271|FG000|Overall Study|Adverse Event|1|||
13316074|NCT01213264|26555272|FG001|Overall Study|Adverse Event|0|||
13316075|NCT01213264|26555273|FG002|Overall Study|Adverse Event|0|||
13316076|NCT01213264|26555271|FG000|Overall Study|Lost to Follow-up|1|||
13316077|NCT01213264|26555272|FG001|Overall Study|Lost to Follow-up|2|||
13316078|NCT01213264|26555273|FG002|Overall Study|Lost to Follow-up|6|||
13316079|NCT01213251|26555304|FG000|Overall Study|Death|2|||
13316080|NCT01213251|26555305|FG001|Overall Study|Death|1|||
13316081|NCT01213251|26555306|FG002|Overall Study|Death|2|||
13316082|NCT01213251|26555304|FG000|Overall Study|Exit|3|||
13316083|NCT01213251|26555305|FG001|Overall Study|Exit|2|||
13316084|NCT01213251|26555306|FG002|Overall Study|Exit|8|||
13316085|NCT01213251|26555304|FG000|Overall Study|Protocol Violation|1|||
13316086|NCT01213251|26555305|FG001|Overall Study|Protocol Violation|1|||
13316087|NCT01213251|26555306|FG002|Overall Study|Protocol Violation|0|||
13316088|NCT01213251|26555304|FG000|Overall Study|Missed 18-Month Follow-up|0|||
13316089|NCT01213251|26555305|FG001|Overall Study|Missed 18-Month Follow-up|0|||
13316090|NCT01213251|26555306|FG002|Overall Study|Missed 18-Month Follow-up|1|||
13316091|NCT01213173|26555343|FG000|Overall Study|Protocol Violation|2|||
13316092|NCT01213173|26555344|FG001|Overall Study|Protocol Violation|0|||
13316093|NCT01213173|26555343|FG000|Overall Study|Adverse Event|4|||
13316094|NCT01213173|26555344|FG001|Overall Study|Adverse Event|8|||
13316095|NCT01213173|26555343|FG000|Overall Study|Withdrawal by Subject|5|||
13316096|NCT01213173|26555344|FG001|Overall Study|Withdrawal by Subject|5|||
13316097|NCT01213173|26555343|FG000|Overall Study|Incorrect Enrollment|1|||
13316098|NCT01213173|26555344|FG001|Overall Study|Incorrect Enrollment|3|||
13316099|NCT01213082|26555365|FG000|Overall Study|Lost to Follow-up|6|||
13316100|NCT01213082|26555366|FG001|Overall Study|Lost to Follow-up|7|||
13316101|NCT01213082|26555367|FG002|Overall Study|Lost to Follow-up|4|||
13316102|NCT01213082|26555365|FG000|Overall Study|Physician Decision|0|||
13316103|NCT01213082|26555366|FG001|Overall Study|Physician Decision|0|||
13316104|NCT01213082|26555367|FG002|Overall Study|Physician Decision|1|||
13316105|NCT01212991|26555403|FG000|Double-blind|Lost to Follow-up|8|||
13316106|NCT01212991|26555404|FG001|Double-blind|Lost to Follow-up|4|||
13316107|NCT01212991|26555405|FG002|Double-blind|Lost to Follow-up|0|||
13316108|NCT01212991|26555403|FG000|Double-blind|Death|699|||
13316109|NCT01212991|26555404|FG001|Double-blind|Death|550|||
13316110|NCT01212991|26555405|FG002|Double-blind|Death|0|||
13316111|NCT01212991|26555403|FG000|Double-blind|Withdrawal by Subject|16|||
13316112|NCT01212991|26555404|FG001|Double-blind|Withdrawal by Subject|19|||
13316113|NCT01212991|26555405|FG002|Double-blind|Withdrawal by Subject|0|||
13316114|NCT01212991|26555403|FG000|Double-blind|Other|7|||
13316115|NCT01212991|26555404|FG001|Double-blind|Other|0|||
13316116|NCT01212991|26555405|FG002|Double-blind|Other|0|||
13316117|NCT01212991|26555403|FG000|Double-blind|Sponsor decision|142|||
13316118|NCT01212991|26555404|FG001|Double-blind|Sponsor decision|38|||
13316119|NCT01212991|26555405|FG002|Double-blind|Sponsor decision|0|||
13316120|NCT01212991|26555403|FG000|Open-label|Death|0|||
13316121|NCT01212991|26555404|FG001|Open-label|Death|0|||
13316122|NCT01212991|26555405|FG002|Open-label|Death|166|||
13316123|NCT01212991|26555403|FG000|Open-label|Lost to Follow-up|0|||
13316124|NCT01212991|26555404|FG001|Open-label|Lost to Follow-up|0|||
13316125|NCT01212991|26555405|FG002|Open-label|Lost to Follow-up|5|||
13316126|NCT01212991|26555403|FG000|Open-label|Withdrawal by Subject|0|||
13316127|NCT01212991|26555404|FG001|Open-label|Withdrawal by Subject|0|||
13316128|NCT01212991|26555405|FG002|Open-label|Withdrawal by Subject|7|||
13316129|NCT01212991|26555403|FG000|Open-label|Sponsor decision|0|||
13316130|NCT01212991|26555404|FG001|Open-label|Sponsor decision|0|||
13316131|NCT01212991|26555405|FG002|Open-label|Sponsor decision|53|||
13316132|NCT01212991|26555403|FG000|Open-label|Other|0|||
13316133|NCT01212991|26555404|FG001|Open-label|Other|0|||
13316134|NCT01212991|26555405|FG002|Open-label|Other|3|||
13316135|NCT01212770|26555615|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
13316136|NCT01212770|26555616|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
13316137|NCT01212770|26555617|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8|||
13316138|NCT01212770|26555618|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
13316139|NCT01212770|26555619|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
13316140|NCT01212770|26555620|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
13316141|NCT01212770|26555621|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
13316142|NCT01212770|26555622|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
13316143|NCT01212770|26555623|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
13316144|NCT01212770|26555615|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
13316145|NCT01212770|26555616|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5|||
13316146|NCT01212770|26555617|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7|||
13316147|NCT01212770|26555618|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
13316148|NCT01212770|26555619|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
13316149|NCT01212770|26555620|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
13316150|NCT01212770|26555621|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
13316151|NCT01212770|26555622|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
13316152|NCT01212770|26555623|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
13316153|NCT01212770|26555615|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
13316154|NCT01212770|26555616|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
13316155|NCT01212770|26555617|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
13316156|NCT01212770|26555618|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
13316157|NCT01212770|26555619|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
13316158|NCT01212770|26555620|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
13316159|NCT01212770|26555621|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
13316160|NCT01212770|26555622|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
13316161|NCT01212770|26555623|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
13316162|NCT01212770|26555615|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
13316163|NCT01212770|26555616|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
13316164|NCT01212770|26555617|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3|||
13316165|NCT01212770|26555618|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
13316166|NCT01212770|26555619|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
13316167|NCT01212770|26555620|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
13316168|NCT01212770|26555621|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
13316169|NCT01212770|26555622|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
13316170|NCT01212770|26555623|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
13316171|NCT01212770|26555615|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
13316172|NCT01212770|26555616|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
13316173|NCT01212770|26555617|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
13316174|NCT01212770|26555618|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
13316175|NCT01212770|26555619|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
13316176|NCT01212770|26555620|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
13316177|NCT01212770|26555621|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
13316178|NCT01212770|26555622|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
13316179|NCT01212770|26555623|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
13316180|NCT01212770|26555615|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3|||
13316181|NCT01212770|26555616|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1|||
13316182|NCT01212770|26555617|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2|||
13316183|NCT01212770|26555618|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
13316184|NCT01212770|26555619|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
13316185|NCT01212770|26555620|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
13316186|NCT01212770|26555621|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
13316187|NCT01212770|26555622|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
13316188|NCT01212770|26555623|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
13316189|NCT01212770|26555615|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
13316190|NCT01212770|26555616|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6|||
13316191|NCT01212770|26555617|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
13316192|NCT01212770|26555618|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
13316193|NCT01212770|26555619|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
13316194|NCT01212770|26555620|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
13316195|NCT01212770|26555621|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1|||
13316196|NCT01212770|26555622|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
13316197|NCT01212770|26555623|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
13316198|NCT01212770|26555615|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
13316199|NCT01212770|26555616|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7|||
13316200|NCT01212770|26555617|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5|||
13316201|NCT01212770|26555618|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4|||
13316202|NCT01212770|26555619|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1|||
13316203|NCT01212770|26555620|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2|||
13316204|NCT01212770|26555621|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
13316205|NCT01212770|26555622|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
13316206|NCT01212770|26555623|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
13316207|NCT01212770|26555615|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
13316208|NCT01212770|26555616|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6|||
13316209|NCT01212770|26555617|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
13316210|NCT01212770|26555618|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
13316211|NCT01212770|26555619|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
13316212|NCT01212770|26555620|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
13316213|NCT01212770|26555621|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
13316214|NCT01212770|26555622|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
13316215|NCT01212770|26555623|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
13316216|NCT01212770|26555615|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
13316217|NCT01212770|26555616|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
13316218|NCT01212770|26555617|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1|||
13316219|NCT01212770|26555618|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
13316220|NCT01212770|26555619|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
13316221|NCT01212770|26555620|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
13316222|NCT01212770|26555621|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
13316223|NCT01212770|26555622|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
13316224|NCT01212770|26555623|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
13316225|NCT01212770|26555615|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
13316226|NCT01212770|26555616|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
13316227|NCT01212770|26555617|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
13316228|NCT01212770|26555618|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1|||
13316229|NCT01212770|26555619|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
13316230|NCT01212770|26555620|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
13316231|NCT01212770|26555621|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
13316232|NCT01212770|26555622|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
13316233|NCT01212770|26555623|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
13316234|NCT01212770|26555615|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
13316235|NCT01212770|26555616|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
13316236|NCT01212770|26555617|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
13316237|NCT01212770|26555618|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
13316238|NCT01212770|26555619|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
13316239|NCT01212770|26555620|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
13316240|NCT01212770|26555621|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
13316241|NCT01212770|26555622|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
13316242|NCT01212770|26555623|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
13316243|NCT01212770|26555615|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
13316244|NCT01212770|26555616|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3|||
13316245|NCT01212770|26555617|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3|||
13316246|NCT01212770|26555618|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
13316247|NCT01212770|26555619|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
13316248|NCT01212770|26555620|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
13316249|NCT01212770|26555621|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
13316250|NCT01212770|26555622|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0|||
13316251|NCT01212770|26555623|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2|||
13316252|NCT01212770|26555615|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
13316253|NCT01212770|26555616|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
13316254|NCT01212770|26555617|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
13316255|NCT01212770|26555618|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
13316256|NCT01212770|26555619|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
13316257|NCT01212770|26555620|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
13316258|NCT01212770|26555621|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
13316259|NCT01212770|26555622|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
13316260|NCT01212770|26555623|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
13316261|NCT01212770|26555615|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
13316262|NCT01212770|26555616|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1|||
13316263|NCT01212770|26555617|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
13316264|NCT01212770|26555618|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
13316265|NCT01212770|26555619|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
13316266|NCT01212770|26555620|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
13316267|NCT01212770|26555621|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
13316268|NCT01212770|26555622|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
13316269|NCT01212770|26555623|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
13316270|NCT01212770|26555615|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
13316271|NCT01212770|26555616|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9|||
13316272|NCT01212770|26555617|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
13316273|NCT01212770|26555618|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
13316274|NCT01212770|26555619|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
13316275|NCT01212770|26555620|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
13316276|NCT01212770|26555621|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
13316277|NCT01212770|26555622|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
13316278|NCT01212770|26555623|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
13316279|NCT01212770|26555615|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
13316280|NCT01212770|26555616|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2|||
13316281|NCT01212770|26555617|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
13316282|NCT01212770|26555618|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
13316283|NCT01212770|26555619|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
13316284|NCT01212770|26555620|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
13316285|NCT01212770|26555621|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
13316286|NCT01212770|26555622|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
13316287|NCT01212770|26555623|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
13316288|NCT01212770|26555615|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
13316289|NCT01212770|26555616|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2|||
13316290|NCT01212770|26555617|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
13316291|NCT01212770|26555618|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
13316292|NCT01212770|26555619|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
13316293|NCT01212770|26555620|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
13316294|NCT01212770|26555621|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
13316295|NCT01212770|26555622|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
13316296|NCT01212770|26555623|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
13316297|NCT01212770|26555615|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
13316298|NCT01212770|26555616|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2|||
13316299|NCT01212770|26555617|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
13316300|NCT01212770|26555618|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
13316301|NCT01212770|26555619|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
13316302|NCT01212770|26555620|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
13316303|NCT01212770|26555621|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
13316304|NCT01212770|26555622|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2|||
13316305|NCT01212770|26555623|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1|||
13316306|NCT01212770|26555615|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
13316307|NCT01212770|26555616|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3|||
13316308|NCT01212770|26555617|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
13316309|NCT01212770|26555618|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
13316310|NCT01212770|26555619|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
13316311|NCT01212770|26555620|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
13316312|NCT01212770|26555621|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
13316313|NCT01212770|26555622|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
13316314|NCT01212770|26555623|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
13316315|NCT01212770|26555615|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
13316316|NCT01212770|26555616|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3|||
13316317|NCT01212770|26555617|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
13316318|NCT01212770|26555618|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
13316319|NCT01212770|26555619|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
13316320|NCT01212770|26555620|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
13316321|NCT01212770|26555621|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
13316322|NCT01212770|26555622|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
13316323|NCT01212770|26555623|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
13316324|NCT01212770|26555615|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
13316325|NCT01212770|26555616|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
13316326|NCT01212770|26555617|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
13316327|NCT01212770|26555618|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
13316328|NCT01212770|26555619|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
13316329|NCT01212770|26555620|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
13316330|NCT01212770|26555621|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
13316331|NCT01212770|26555622|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
13316332|NCT01212770|26555623|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
13316333|NCT01212770|26555615|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
13316334|NCT01212770|26555616|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
13316335|NCT01212770|26555617|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
13316336|NCT01212770|26555618|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
13316337|NCT01212770|26555619|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
13316338|NCT01212770|26555620|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
13316339|NCT01212770|26555621|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
13316340|NCT01212770|26555622|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1|||
13316341|NCT01212770|26555623|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
13316342|NCT01212770|26555615|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
13316343|NCT01212770|26555616|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2|||
13316344|NCT01212770|26555617|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
13316345|NCT01212770|26555618|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
13316346|NCT01212770|26555619|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
13316347|NCT01212770|26555620|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
13316348|NCT01212770|26555621|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
13316349|NCT01212770|26555622|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
13316350|NCT01212770|26555623|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
13316351|NCT01212770|26555615|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
13316352|NCT01212770|26555616|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1|||
13316353|NCT01212770|26555617|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1|||
13316354|NCT01212770|26555618|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
13316355|NCT01212770|26555619|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
13316356|NCT01212770|26555620|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
13316357|NCT01212770|26555621|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
13316358|NCT01212770|26555622|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
13316359|NCT01212770|26555623|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1|||
13316360|NCT01212770|26555615|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
13316361|NCT01212770|26555616|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
13316362|NCT01212770|26555617|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5|||
13316363|NCT01212770|26555618|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
13316364|NCT01212770|26555619|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
13316365|NCT01212770|26555620|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
13316366|NCT01212770|26555621|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
13316367|NCT01212770|26555622|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2|||
13316368|NCT01212770|26555623|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
13316369|NCT01212770|26555615|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
13316370|NCT01212770|26555616|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
13316371|NCT01212770|26555617|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
13316372|NCT01212770|26555618|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
13316373|NCT01212770|26555619|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
13316374|NCT01212770|26555620|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
13316375|NCT01212770|26555621|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
13316376|NCT01212770|26555622|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
13316377|NCT01212770|26555623|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
13316378|NCT01212770|26555615|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
13316379|NCT01212770|26555616|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2|||
13316380|NCT01212770|26555617|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3|||
13316381|NCT01212770|26555618|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
13316382|NCT01212770|26555619|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
13316383|NCT01212770|26555620|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
13316384|NCT01212770|26555621|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
13316385|NCT01212770|26555622|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
13316386|NCT01212770|26555623|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
13316387|NCT01212770|26555615|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
13316388|NCT01212770|26555616|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
13316389|NCT01212770|26555617|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
13316390|NCT01212770|26555618|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
13316391|NCT01212770|26555619|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
13316392|NCT01212770|26555620|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
13316393|NCT01212770|26555621|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
13316394|NCT01212770|26555622|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
13316395|NCT01212770|26555623|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
13316396|NCT01212770|26555615|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
13316397|NCT01212770|26555616|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
13316398|NCT01212770|26555617|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
13316399|NCT01212770|26555618|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
13316400|NCT01212770|26555619|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
13316401|NCT01212770|26555620|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
13316402|NCT01212770|26555621|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
13316403|NCT01212770|26555622|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
13316404|NCT01212770|26555623|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
13316405|NCT01212770|26555615|FG000|Long-term Safety Phase (Year 5)|Missing|0|||
13316406|NCT01212770|26555616|FG001|Long-term Safety Phase (Year 5)|Missing|0|||
13316407|NCT01212770|26555617|FG002|Long-term Safety Phase (Year 5)|Missing|1|||
13316408|NCT01212770|26555618|FG003|Long-term Safety Phase (Year 5)|Missing|0|||
13316409|NCT01212770|26555619|FG004|Long-term Safety Phase (Year 5)|Missing|0|||
13316410|NCT01212770|26555620|FG005|Long-term Safety Phase (Year 5)|Missing|0|||
13316411|NCT01212770|26555621|FG006|Long-term Safety Phase (Year 5)|Missing|0|||
13316412|NCT01212770|26555622|FG007|Long-term Safety Phase (Year 5)|Missing|0|||
13316413|NCT01212770|26555623|FG008|Long-term Safety Phase (Year 5)|Missing|0|||
13316414|NCT01212770|26555615|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
13316415|NCT01212770|26555616|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
13316416|NCT01212770|26555617|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3|||
13316417|NCT01212770|26555618|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
13316418|NCT01212770|26555619|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
13316419|NCT01212770|26555620|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
13316420|NCT01212770|26555621|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
13316421|NCT01212770|26555622|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
13316422|NCT01212770|26555623|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
13316423|NCT01212770|26555615|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
13316424|NCT01212770|26555616|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0|||
13316425|NCT01212770|26555617|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2|||
13316426|NCT01212770|26555618|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
13316427|NCT01212770|26555619|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
13316428|NCT01212770|26555620|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
13316429|NCT01212770|26555621|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
13316430|NCT01212770|26555622|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
13316431|NCT01212770|26555623|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
13316432|NCT01212770|26555615|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
13316433|NCT01212770|26555616|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
13316434|NCT01212770|26555617|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4|||
13316435|NCT01212770|26555618|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
13316436|NCT01212770|26555619|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
13316437|NCT01212770|26555620|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
13316438|NCT01212770|26555621|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
13316439|NCT01212770|26555622|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
13316440|NCT01212770|26555623|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
13316441|NCT01212770|26555615|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
13316442|NCT01212770|26555616|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
13316443|NCT01212770|26555617|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
13316444|NCT01212770|26555618|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
13316445|NCT01212770|26555619|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
13316446|NCT01212770|26555620|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
13316447|NCT01212770|26555621|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
13316448|NCT01212770|26555622|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
13316449|NCT01212770|26555623|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
13316450|NCT01212770|26555615|FG000|Long-term Safety Phase (Year 5)|Death|0|||
13316451|NCT01212770|26555616|FG001|Long-term Safety Phase (Year 5)|Death|0|||
13316452|NCT01212770|26555617|FG002|Long-term Safety Phase (Year 5)|Death|0|||
13316453|NCT01212770|26555618|FG003|Long-term Safety Phase (Year 5)|Death|0|||
13316454|NCT01212770|26555619|FG004|Long-term Safety Phase (Year 5)|Death|0|||
13316455|NCT01212770|26555620|FG005|Long-term Safety Phase (Year 5)|Death|0|||
13316456|NCT01212770|26555621|FG006|Long-term Safety Phase (Year 5)|Death|0|||
13316457|NCT01212770|26555622|FG007|Long-term Safety Phase (Year 5)|Death|1|||
13316458|NCT01212770|26555623|FG008|Long-term Safety Phase (Year 5)|Death|0|||
13316459|NCT01212757|26555823|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
13316460|NCT01212757|26555824|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
13316461|NCT01212757|26555825|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
13316462|NCT01212757|26555826|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
13316463|NCT01212757|26555827|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
13316464|NCT01212757|26555828|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
13316465|NCT01212757|26555829|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
13316466|NCT01212757|26555830|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
13316467|NCT01212757|26555831|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
13316468|NCT01212757|26555823|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
13316469|NCT01212757|26555824|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
13316470|NCT01212757|26555825|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
13316471|NCT01212757|26555826|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
13316472|NCT01212757|26555827|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
13316473|NCT01212757|26555828|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
13316474|NCT01212757|26555829|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
13316475|NCT01212757|26555830|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
13316476|NCT01212757|26555831|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
13316477|NCT01212757|26555823|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7|||
13316478|NCT01212757|26555824|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9|||
13316479|NCT01212757|26555825|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
13316480|NCT01212757|26555826|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
13316481|NCT01212757|26555827|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
13316482|NCT01212757|26555828|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
13316483|NCT01212757|26555829|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
13316484|NCT01212757|26555830|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
13316485|NCT01212757|26555831|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
13316486|NCT01212757|26555823|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3|||
13316487|NCT01212757|26555824|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
13316488|NCT01212757|26555825|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
13316489|NCT01212757|26555826|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
13316490|NCT01212757|26555827|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
13316491|NCT01212757|26555828|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
13316492|NCT01212757|26555829|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
13316493|NCT01212757|26555830|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
13316494|NCT01212757|26555831|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
13316495|NCT01212757|26555823|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
13316496|NCT01212757|26555824|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
13316497|NCT01212757|26555825|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
13316498|NCT01212757|26555826|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
13316499|NCT01212757|26555827|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
13316500|NCT01212757|26555828|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
13316501|NCT01212757|26555829|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
13316502|NCT01212757|26555830|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
13316503|NCT01212757|26555831|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
13316504|NCT01212757|26555823|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
13316505|NCT01212757|26555824|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
13316506|NCT01212757|26555825|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
13316507|NCT01212757|26555826|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
13316508|NCT01212757|26555827|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
13316509|NCT01212757|26555828|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
13316510|NCT01212757|26555829|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
13316511|NCT01212757|26555830|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
13316512|NCT01212757|26555831|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
13316513|NCT01212757|26555823|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
13316514|NCT01212757|26555824|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
13316515|NCT01212757|26555825|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
13316516|NCT01212757|26555826|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
13316517|NCT01212757|26555827|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
13316518|NCT01212757|26555828|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
13316519|NCT01212757|26555829|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
13316520|NCT01212757|26555830|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
13316521|NCT01212757|26555831|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
13316522|NCT01212757|26555823|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
13316523|NCT01212757|26555824|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
13316524|NCT01212757|26555825|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3|||
13316525|NCT01212757|26555826|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1|||
13316526|NCT01212757|26555827|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
13316527|NCT01212757|26555828|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
13316528|NCT01212757|26555829|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
13316529|NCT01212757|26555830|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
13316530|NCT01212757|26555831|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
13316531|NCT01212757|26555823|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
13316532|NCT01212757|26555824|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5|||
13316533|NCT01212757|26555825|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7|||
13316534|NCT01212757|26555826|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4|||
13316535|NCT01212757|26555827|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
13316536|NCT01212757|26555828|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2|||
13316537|NCT01212757|26555829|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
13316538|NCT01212757|26555830|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
13316539|NCT01212757|26555831|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
13316540|NCT01212757|26555823|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
13316541|NCT01212757|26555824|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
13316542|NCT01212757|26555825|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2|||
13316543|NCT01212757|26555826|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
13316544|NCT01212757|26555827|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
13316545|NCT01212757|26555828|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
13316546|NCT01212757|26555829|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
13316547|NCT01212757|26555830|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
13316548|NCT01212757|26555831|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
13316549|NCT01212757|26555823|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
13316550|NCT01212757|26555824|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
13316551|NCT01212757|26555825|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7|||
13316552|NCT01212757|26555826|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
13316553|NCT01212757|26555827|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1|||
13316554|NCT01212757|26555828|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
13316555|NCT01212757|26555829|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
13316556|NCT01212757|26555830|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
13316557|NCT01212757|26555831|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
13316558|NCT01212757|26555823|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
13316559|NCT01212757|26555824|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
13316560|NCT01212757|26555825|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
13316561|NCT01212757|26555826|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
13316562|NCT01212757|26555827|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
13316563|NCT01212757|26555828|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
13316564|NCT01212757|26555829|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
13316565|NCT01212757|26555830|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
13316566|NCT01212757|26555831|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
13316567|NCT01212757|26555823|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
13316568|NCT01212757|26555824|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
13316569|NCT01212757|26555825|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
13316570|NCT01212757|26555826|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
13316571|NCT01212757|26555827|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
13316572|NCT01212757|26555828|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
13316573|NCT01212757|26555829|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
13316574|NCT01212757|26555830|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
13316575|NCT01212757|26555831|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
13316576|NCT01212757|26555823|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
13316577|NCT01212757|26555824|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
13316578|NCT01212757|26555825|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
13316579|NCT01212757|26555826|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
13316580|NCT01212757|26555827|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
13316581|NCT01212757|26555828|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
13316582|NCT01212757|26555829|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
13316583|NCT01212757|26555830|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
13316584|NCT01212757|26555831|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1|||
13316585|NCT01212757|26555823|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
13316586|NCT01212757|26555824|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
13316587|NCT01212757|26555825|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
13316588|NCT01212757|26555826|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
13316589|NCT01212757|26555827|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
13316590|NCT01212757|26555828|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
13316591|NCT01212757|26555829|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
13316592|NCT01212757|26555830|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
13316593|NCT01212757|26555831|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
13316594|NCT01212757|26555823|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
13316595|NCT01212757|26555824|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
13316596|NCT01212757|26555825|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2|||
13316597|NCT01212757|26555826|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
13316598|NCT01212757|26555827|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
13316599|NCT01212757|26555828|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
13316600|NCT01212757|26555829|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
13316601|NCT01212757|26555830|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
13316602|NCT01212757|26555831|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
13316603|NCT01212757|26555823|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
13316604|NCT01212757|26555824|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7|||
13316605|NCT01212757|26555825|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9|||
13316606|NCT01212757|26555826|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
13316607|NCT01212757|26555827|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
13316608|NCT01212757|26555828|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
13316609|NCT01212757|26555829|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
13316610|NCT01212757|26555830|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4|||
13316611|NCT01212757|26555831|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6|||
13316612|NCT01212757|26555823|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
13316613|NCT01212757|26555824|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
13316614|NCT01212757|26555825|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2|||
13316615|NCT01212757|26555826|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
13316616|NCT01212757|26555827|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
13316617|NCT01212757|26555828|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
13316618|NCT01212757|26555829|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
13316619|NCT01212757|26555830|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
13316620|NCT01212757|26555831|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
13316621|NCT01212757|26555823|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
13316622|NCT01212757|26555824|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4|||
13316623|NCT01212757|26555825|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1|||
13316624|NCT01212757|26555826|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
13316625|NCT01212757|26555827|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
13316626|NCT01212757|26555828|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
13316627|NCT01212757|26555829|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
13316628|NCT01212757|26555830|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2|||
13316629|NCT01212757|26555831|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
13316630|NCT01212757|26555823|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
13316631|NCT01212757|26555824|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8|||
13316632|NCT01212757|26555825|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5|||
13316633|NCT01212757|26555826|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
13316634|NCT01212757|26555827|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
13316635|NCT01212757|26555828|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
13316636|NCT01212757|26555829|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
13316637|NCT01212757|26555830|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3|||
13316638|NCT01212757|26555831|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1|||
13316639|NCT01212757|26555823|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
13316640|NCT01212757|26555824|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
13316641|NCT01212757|26555825|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1|||
13316642|NCT01212757|26555826|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
13316643|NCT01212757|26555827|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
13316644|NCT01212757|26555828|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
13316645|NCT01212757|26555829|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
13316646|NCT01212757|26555830|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
13316647|NCT01212757|26555831|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
13316648|NCT01212757|26555823|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
13316649|NCT01212757|26555824|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5|||
13316650|NCT01212757|26555825|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
13316651|NCT01212757|26555826|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
13316652|NCT01212757|26555827|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
13316653|NCT01212757|26555828|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
13316654|NCT01212757|26555829|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
13316655|NCT01212757|26555830|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
13316656|NCT01212757|26555831|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
13316657|NCT01212757|26555823|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
13316658|NCT01212757|26555824|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
13316659|NCT01212757|26555825|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
13316660|NCT01212757|26555826|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
13316661|NCT01212757|26555827|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
13316662|NCT01212757|26555828|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
13316663|NCT01212757|26555829|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
13316664|NCT01212757|26555830|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
13316665|NCT01212757|26555831|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1|||
13316666|NCT01212757|26555823|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
13316667|NCT01212757|26555824|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1|||
13316668|NCT01212757|26555825|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
13316669|NCT01212757|26555826|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
13316670|NCT01212757|26555827|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
13316671|NCT01212757|26555828|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
13316672|NCT01212757|26555829|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
13316673|NCT01212757|26555830|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
13316674|NCT01212757|26555831|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
13316675|NCT01212757|26555823|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
13316676|NCT01212757|26555824|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
13316677|NCT01212757|26555825|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3|||
13316678|NCT01212757|26555826|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
13316679|NCT01212757|26555827|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
13316680|NCT01212757|26555828|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
13316681|NCT01212757|26555829|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
13316682|NCT01212757|26555830|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
13316683|NCT01212757|26555831|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2|||
13316684|NCT01212757|26555823|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
13316685|NCT01212757|26555824|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2|||
13373096|NCT00805467|26722686|FG000|Overall Study|Not reported|0|||
13316686|NCT01212757|26555825|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
13316687|NCT01212757|26555826|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
13316688|NCT01212757|26555827|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
13316689|NCT01212757|26555828|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
13316690|NCT01212757|26555829|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
13316691|NCT01212757|26555830|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
13316692|NCT01212757|26555831|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1|||
13316693|NCT01212757|26555823|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
13316694|NCT01212757|26555824|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
13316695|NCT01212757|26555825|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2|||
13316696|NCT01212757|26555826|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
13316697|NCT01212757|26555827|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
13316698|NCT01212757|26555828|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
13316699|NCT01212757|26555829|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
13316700|NCT01212757|26555830|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
13316701|NCT01212757|26555831|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
13316702|NCT01212757|26555823|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
13316703|NCT01212757|26555824|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
13316704|NCT01212757|26555825|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
13316705|NCT01212757|26555826|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
13316706|NCT01212757|26555827|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
13316707|NCT01212757|26555828|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
13316708|NCT01212757|26555829|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
13316709|NCT01212757|26555830|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
13316710|NCT01212757|26555831|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
13316711|NCT01212757|26555823|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
13316712|NCT01212757|26555824|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4|||
13316713|NCT01212757|26555825|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2|||
13316714|NCT01212757|26555826|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
13316715|NCT01212757|26555827|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
13316716|NCT01212757|26555828|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
13316717|NCT01212757|26555829|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
13316718|NCT01212757|26555830|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1|||
13316719|NCT01212757|26555831|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3|||
13316720|NCT01212757|26555823|FG000|Long-Term Safety Phase (Year 4)|Death|0|||
13316721|NCT01212757|26555824|FG001|Long-Term Safety Phase (Year 4)|Death|0|||
13316722|NCT01212757|26555825|FG002|Long-Term Safety Phase (Year 4)|Death|1|||
13316723|NCT01212757|26555826|FG003|Long-Term Safety Phase (Year 4)|Death|0|||
13316724|NCT01212757|26555827|FG004|Long-Term Safety Phase (Year 4)|Death|0|||
13316725|NCT01212757|26555828|FG005|Long-Term Safety Phase (Year 4)|Death|0|||
13316726|NCT01212757|26555829|FG006|Long-Term Safety Phase (Year 4)|Death|0|||
13316727|NCT01212757|26555830|FG007|Long-Term Safety Phase (Year 4)|Death|0|||
13316728|NCT01212757|26555831|FG008|Long-Term Safety Phase (Year 4)|Death|1|||
13316729|NCT01212757|26555823|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
13316730|NCT01212757|26555824|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
13316731|NCT01212757|26555825|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
13316732|NCT01212757|26555826|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
13316733|NCT01212757|26555827|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
13316734|NCT01212757|26555828|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
13316735|NCT01212757|26555829|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
13316736|NCT01212757|26555830|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1|||
13316737|NCT01212757|26555831|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
13316738|NCT01212757|26555823|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
13316739|NCT01212757|26555824|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
13316740|NCT01212757|26555825|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
13316741|NCT01212757|26555826|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
13316742|NCT01212757|26555827|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
13316743|NCT01212757|26555828|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
13316744|NCT01212757|26555829|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
13316745|NCT01212757|26555830|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
13316746|NCT01212757|26555831|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
13316747|NCT01212757|26555823|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
13316748|NCT01212757|26555824|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
13316749|NCT01212757|26555825|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
13316750|NCT01212757|26555826|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
13316751|NCT01212757|26555827|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
13316752|NCT01212757|26555828|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
13316753|NCT01212757|26555829|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
13122142|NCT02969018|25946166|FG005|Overall Study|Adverse Event|1|||
13316754|NCT01212757|26555830|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
13316755|NCT01212757|26555831|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
13316756|NCT01212757|26555823|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
13316757|NCT01212757|26555824|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
13316758|NCT01212757|26555825|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
13316759|NCT01212757|26555826|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
13316760|NCT01212757|26555827|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
13316761|NCT01212757|26555828|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
13316762|NCT01212757|26555829|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
13316763|NCT01212757|26555830|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
13316764|NCT01212757|26555831|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
13316765|NCT01212757|26555823|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
13316766|NCT01212757|26555824|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1|||
13316767|NCT01212757|26555825|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
13316768|NCT01212757|26555826|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
13316769|NCT01212757|26555827|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
13316770|NCT01212757|26555828|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
13316771|NCT01212757|26555829|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
13316772|NCT01212757|26555830|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
13316773|NCT01212757|26555831|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
13316774|NCT01212757|26555823|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
13316775|NCT01212757|26555824|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
13316776|NCT01212757|26555825|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
13316777|NCT01212757|26555826|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
13316778|NCT01212757|26555827|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
13316779|NCT01212757|26555828|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
13316780|NCT01212757|26555829|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
13316781|NCT01212757|26555830|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
13316782|NCT01212757|26555831|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
13316783|NCT01212744|26555846|FG000|Overall Study|Withdrawal by Subject|1|||
13316784|NCT01212588|26555887|FG000|Overall Study|Physician Decision|0|||
13316785|NCT01212588|26555888|FG001|Overall Study|Physician Decision|1|||
13316786|NCT01212588|26555887|FG000|Overall Study|Protocol Violation|1|||
13316787|NCT01212588|26555888|FG001|Overall Study|Protocol Violation|1|||
13316788|NCT01212185|26555903|FG000|Overall Study|Protocol Violation|2|||
13316789|NCT01212185|26555904|FG001|Overall Study|Protocol Violation|1|||
13316790|NCT01212159|26555921|FG000|Overall Study|Withdrawal by Subject|12|||
13316791|NCT01212159|26555922|FG001|Overall Study|Withdrawal by Subject|12|||
13316792|NCT01212094|26555963|FG000|Year 1: Baseline Monitoring|Study terminated|7|||
13316793|NCT01212094|26555964|FG001|Year 1: Baseline Monitoring|Study terminated|0|||
13316794|NCT01212094|26555965|FG002|Year 1: Baseline Monitoring|Study terminated|0|||
13316795|NCT01212094|26555963|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7|||
13316796|NCT01212094|26555964|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
13316797|NCT01212094|26555965|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
13316798|NCT01212094|26555963|FG000|Year 1: Baseline Monitoring|Started on DMT|2|||
13316799|NCT01212094|26555964|FG001|Year 1: Baseline Monitoring|Started on DMT|0|||
13316800|NCT01212094|26555965|FG002|Year 1: Baseline Monitoring|Started on DMT|0|||
13316801|NCT01212094|26555963|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0|||
13316802|NCT01212094|26555964|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4|||
13316803|NCT01212094|26555965|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7|||
13316804|NCT01212094|26555963|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
13316805|NCT01212094|26555964|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
13316806|NCT01212094|26555965|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3|||
13316807|NCT01212094|26555963|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
13316808|NCT01212094|26555964|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
13316809|NCT01212094|26555965|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1|||
13316810|NCT01211769|26555996|FG000|Overall Study|Lost to Follow-up|7|||
13316811|NCT01211769|26555997|FG001|Overall Study|Lost to Follow-up|9|||
13316812|NCT01211769|26555998|FG002|Overall Study|Lost to Follow-up|5|||
13316813|NCT01211769|26555999|FG003|Overall Study|Lost to Follow-up|9|||
13316814|NCT01211769|26555996|FG000|Overall Study|Physician Decision|2|||
13316815|NCT01211769|26555997|FG001|Overall Study|Physician Decision|0|||
13316816|NCT01211769|26555998|FG002|Overall Study|Physician Decision|2|||
13316817|NCT01211769|26555999|FG003|Overall Study|Physician Decision|1|||
13316818|NCT01211769|26555996|FG000|Overall Study|Adverse Event|0|||
13316819|NCT01211769|26555997|FG001|Overall Study|Adverse Event|1|||
13316820|NCT01211769|26555998|FG002|Overall Study|Adverse Event|1|||
13316821|NCT01211769|26555999|FG003|Overall Study|Adverse Event|1|||
13316822|NCT01211665|26556030|FG000|Overall Study|Withdrawal by Subject|1|||
13316823|NCT01211665|26556031|FG001|Overall Study|Withdrawal by Subject|0|||
13316824|NCT01211665|26556030|FG000|Overall Study|Death|1|||
13316825|NCT01211665|26556031|FG001|Overall Study|Death|0|||
13316826|NCT01211613|26556052|FG000|Overall Study|Lost to Follow-up|2|||
13316827|NCT01211613|26556053|FG001|Overall Study|Lost to Follow-up|2|||
13316828|NCT01211613|26556054|FG002|Overall Study|Lost to Follow-up|2|||
13316829|NCT01211613|26556052|FG000|Overall Study|Withdrawal by Subject|1|||
13316830|NCT01211613|26556053|FG001|Overall Study|Withdrawal by Subject|0|||
13316831|NCT01211613|26556054|FG002|Overall Study|Withdrawal by Subject|0|||
13316832|NCT01211535|26556067|FG000|Overall Study|Adverse Event|0|||
13316833|NCT01211535|26556068|FG001|Overall Study|Adverse Event|1|||
13316834|NCT01211522|26556113|FG000|Overall Study|Withdrawal by Subject|3|||
13316835|NCT01211522|26556114|FG001|Overall Study|Withdrawal by Subject|7|||
13316836|NCT01211522|26556115|FG002|Overall Study|Withdrawal by Subject|5|||
13316837|NCT01211483|26556172|FG000|Phase 1b|Death|6|||
13316838|NCT01211483|26556173|FG001|Phase 1b|Death|0|||
13316839|NCT01211483|26556174|FG002|Phase 1b|Death|0|||
13316840|NCT01211483|26556175|FG003|Phase 1b|Death|0|||
13316841|NCT01211483|26556172|FG000|Phase 1b|Withdrawal by Subject|1|||
13316842|NCT01211483|26556173|FG001|Phase 1b|Withdrawal by Subject|0|||
13316843|NCT01211483|26556174|FG002|Phase 1b|Withdrawal by Subject|0|||
13316844|NCT01211483|26556175|FG003|Phase 1b|Withdrawal by Subject|0|||
13316845|NCT01211483|26556172|FG000|Phase 2|Lost to Follow-up|0|||
13316846|NCT01211483|26556173|FG001|Phase 2|Lost to Follow-up|1|||
13316847|NCT01211483|26556174|FG002|Phase 2|Lost to Follow-up|1|||
13316848|NCT01211483|26556175|FG003|Phase 2|Lost to Follow-up|2|||
13316849|NCT01211483|26556172|FG000|Phase 2|Death|0|||
13316850|NCT01211483|26556173|FG001|Phase 2|Death|64|||
13316851|NCT01211483|26556174|FG002|Phase 2|Death|53|||
13316852|NCT01211483|26556175|FG003|Phase 2|Death|53|||
13316853|NCT01211483|26556172|FG000|Phase 2|Withdrawal by Subject|0|||
13316854|NCT01211483|26556173|FG001|Phase 2|Withdrawal by Subject|1|||
13316855|NCT01211483|26556174|FG002|Phase 2|Withdrawal by Subject|10|||
13316856|NCT01211483|26556175|FG003|Phase 2|Withdrawal by Subject|5|||
13316857|NCT01211483|26556172|FG000|Phase 2|Study terminated by Sponsor|0|||
13316858|NCT01211483|26556173|FG001|Phase 2|Study terminated by Sponsor|6|||
13316859|NCT01211483|26556174|FG002|Phase 2|Study terminated by Sponsor|8|||
13316860|NCT01211483|26556175|FG003|Phase 2|Study terminated by Sponsor|11|||
13316861|NCT01211288|26556198|FG000|Overall Study|Lost to Follow-up|1|||
13316862|NCT01211288|26556199|FG001|Overall Study|Lost to Follow-up|1|||
13316863|NCT01211262|26556246|FG000|Overall Study|Progressive Disease|18|||
13316864|NCT01211262|26556247|FG001|Overall Study|Progressive Disease|9|||
13316865|NCT01211262|26556246|FG000|Overall Study|Adverse Event|4|||
13316866|NCT01211262|26556247|FG001|Overall Study|Adverse Event|0|||
13316867|NCT01211262|26556246|FG000|Overall Study|Withdrawal of Consent|1|||
13316868|NCT01211262|26556247|FG001|Overall Study|Withdrawal of Consent|0|||
13316869|NCT01211262|26556246|FG000|Overall Study|Other|0|||
13316870|NCT01211262|26556247|FG001|Overall Study|Other|1|||
13316871|NCT01211197|26556298|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
13316872|NCT01211197|26556299|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
13316873|NCT01211197|26556300|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
13316874|NCT01211197|26556301|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
13316875|NCT01211197|26556302|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
13316876|NCT01211197|26556303|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
13316877|NCT01211197|26556298|FG000|Washout Period 2 (7 Days)|Adverse Event|1|||
13316878|NCT01211197|26556299|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
13316879|NCT01211197|26556300|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
13316880|NCT01211197|26556301|FG003|Washout Period 2 (7 Days)|Adverse Event|0|||
13316881|NCT01211197|26556302|FG004|Washout Period 2 (7 Days)|Adverse Event|0|||
13316882|NCT01211197|26556303|FG005|Washout Period 2 (7 Days)|Adverse Event|0|||
13316883|NCT01211184|26556324|FG000|Overall Study|Withdrawal by Subject|0|||
13316884|NCT01211184|26556325|FG001|Overall Study|Withdrawal by Subject|2|||
13316885|NCT01211184|26556326|FG002|Overall Study|Withdrawal by Subject|1|||
13316886|NCT01211145|26556369|FG000|Overall Study|Reason not specified|3|||
13316887|NCT01211145|26556370|FG001|Overall Study|Reason not specified|2|||
13316888|NCT01211145|26556371|FG002|Overall Study|Reason not specified|2|||
13316889|NCT01211145|26556372|FG003|Overall Study|Reason not specified|1|||
13316890|NCT01211145|26556369|FG000|Overall Study|Lost to Follow-up|3|||
13316891|NCT01211145|26556370|FG001|Overall Study|Lost to Follow-up|2|||
13316892|NCT01211145|26556371|FG002|Overall Study|Lost to Follow-up|1|||
13316893|NCT01211145|26556372|FG003|Overall Study|Lost to Follow-up|2|||
13316894|NCT01211145|26556369|FG000|Overall Study|Study-specific withdrawal criteria|1|||
13316895|NCT01211145|26556370|FG001|Overall Study|Study-specific withdrawal criteria|0|||
13316896|NCT01211145|26556371|FG002|Overall Study|Study-specific withdrawal criteria|0|||
13316897|NCT01211145|26556372|FG003|Overall Study|Study-specific withdrawal criteria|0|||
13316898|NCT01211145|26556369|FG000|Overall Study|Severe noncompliance to protocol|1|||
13316899|NCT01211145|26556370|FG001|Overall Study|Severe noncompliance to protocol|0|||
13316900|NCT01211145|26556371|FG002|Overall Study|Severe noncompliance to protocol|0|||
13316901|NCT01211145|26556372|FG003|Overall Study|Severe noncompliance to protocol|0|||
13316902|NCT01211145|26556369|FG000|Overall Study|Eligibility criteria not fulfilled|16|||
13373097|NCT00805467|26722687|FG001|Overall Study|Not reported|0|||
13316903|NCT01211145|26556370|FG001|Overall Study|Eligibility criteria not fulfilled|12|||
13316904|NCT01211145|26556371|FG002|Overall Study|Eligibility criteria not fulfilled|10|||
13316905|NCT01211145|26556372|FG003|Overall Study|Eligibility criteria not fulfilled|15|||
13316906|NCT01211145|26556369|FG000|Overall Study|Patient decision|2|||
13316907|NCT01211145|26556370|FG001|Overall Study|Patient decision|1|||
13316908|NCT01211145|26556371|FG002|Overall Study|Patient decision|0|||
13316909|NCT01211145|26556372|FG003|Overall Study|Patient decision|2|||
13316910|NCT01210807|26556387|FG000|Overall Study|Lost to Follow-up|1|||
13316911|NCT01210807|26556388|FG001|Overall Study|Lost to Follow-up|2|||
13316912|NCT01210807|26556387|FG000|Overall Study|Not implanted bilaterally|2|||
13316913|NCT01210807|26556388|FG001|Overall Study|Not implanted bilaterally|1|||
13316914|NCT01210690|26556403|FG000|Overall Study|Adverse Event|7|||
13316915|NCT01210690|26556403|FG000|Overall Study|Lack of Efficacy|12|||
13316916|NCT01210690|26556403|FG000|Overall Study|Lost to Follow-up|3|||
13316917|NCT01210690|26556403|FG000|Overall Study|Disease Remission|1|||
13316918|NCT01210690|26556403|FG000|Overall Study|Withdrawal by Subject|1|||
13316919|NCT01210690|26556403|FG000|Overall Study|Patient refused to swallow|1|||
13316920|NCT01210690|26556403|FG000|Overall Study|Patient could not take glucose|1|||
13316921|NCT01210664|26556434|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
13316922|NCT01210664|26556435|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
13316923|NCT01210664|26556436|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1|||
13316924|NCT01210664|26556437|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
13316925|NCT01210664|26556434|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
13316926|NCT01210664|26556435|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
13316927|NCT01210664|26556436|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1|||
13316928|NCT01210664|26556437|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
13316929|NCT01210664|26556434|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
13316930|NCT01210664|26556435|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
13316931|NCT01210664|26556436|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
13316932|NCT01210664|26556437|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1|||
13316933|NCT01210651|26556458|FG000|Overall Study|Lost to Follow-up|1|||
13316934|NCT01210651|26556459|FG001|Overall Study|Lost to Follow-up|1|||
13316935|NCT01210651|26556458|FG000|Overall Study|schedule conflicts|1|||
13316936|NCT01210651|26556459|FG001|Overall Study|schedule conflicts|5|||
13316937|NCT01210651|26556458|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0|||
13316938|NCT01210651|26556459|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1|||
13316939|NCT01210651|26556458|FG000|Overall Study|Withdrawal by Subject|1|||
13316940|NCT01210651|26556459|FG001|Overall Study|Withdrawal by Subject|1|||
13316941|NCT01210651|26556458|FG000|Overall Study|Injury outside study|2|||
13316942|NCT01210651|26556459|FG001|Overall Study|Injury outside study|0|||
13316943|NCT01210495|26556534|FG000|Overall Study|Participant Refused Further Follow-Up|1|||
13316944|NCT01210495|26556535|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
13316945|NCT01210495|26556536|FG002|Overall Study|Participant Refused Further Follow-Up|11|||
13316946|NCT01210495|26556537|FG003|Overall Study|Participant Refused Further Follow-Up|2|||
13316947|NCT01210495|26556534|FG000|Overall Study|Death|14|||
13316948|NCT01210495|26556535|FG001|Overall Study|Death|7|||
13316949|NCT01210495|26556536|FG002|Overall Study|Death|112|||
13316950|NCT01210495|26556537|FG003|Overall Study|Death|54|||
13316951|NCT01210495|26556534|FG000|Overall Study|Study Terminated by Sponsor|0|||
13316952|NCT01210495|26556535|FG001|Overall Study|Study Terminated by Sponsor|0|||
13316953|NCT01210495|26556536|FG002|Overall Study|Study Terminated by Sponsor|4|||
13316954|NCT01210495|26556537|FG003|Overall Study|Study Terminated by Sponsor|11|||
13316955|NCT01210495|26556534|FG000|Overall Study|Lost to Follow-up|0|||
13316956|NCT01210495|26556535|FG001|Overall Study|Lost to Follow-up|0|||
13316957|NCT01210495|26556536|FG002|Overall Study|Lost to Follow-up|1|||
13316958|NCT01210495|26556537|FG003|Overall Study|Lost to Follow-up|1|||
13316959|NCT01210495|26556534|FG000|Overall Study|Other unspecified|0|||
13316960|NCT01210495|26556535|FG001|Overall Study|Other unspecified|0|||
13316961|NCT01210495|26556536|FG002|Overall Study|Other unspecified|6|||
13316962|NCT01210495|26556537|FG003|Overall Study|Other unspecified|0|||
13316963|NCT01210443|26556547|FG000|Overall Study|Study terminated by sponsor|2|||
13316964|NCT01210352|26556766|FG000|Overall Study|Adverse Event|0|||
13316965|NCT01210352|26556767|FG001|Overall Study|Adverse Event|0|||
13316966|NCT01210352|26556768|FG002|Overall Study|Adverse Event|0|||
13316967|NCT01210352|26556769|FG003|Overall Study|Adverse Event|0|||
13316968|NCT01210352|26556770|FG004|Overall Study|Adverse Event|0|||
13316969|NCT01210352|26556771|FG005|Overall Study|Adverse Event|0|||
13316970|NCT01210352|26556772|FG006|Overall Study|Adverse Event|0|||
13316971|NCT01210352|26556773|FG007|Overall Study|Adverse Event|2|||
13316972|NCT01210352|26556774|FG008|Overall Study|Adverse Event|1|||
13316973|NCT01210352|26556766|FG000|Overall Study|Lack of Efficacy|0|||
13316974|NCT01210352|26556767|FG001|Overall Study|Lack of Efficacy|0|||
13316975|NCT01210352|26556768|FG002|Overall Study|Lack of Efficacy|0|||
13316976|NCT01210352|26556769|FG003|Overall Study|Lack of Efficacy|0|||
13316977|NCT01210352|26556770|FG004|Overall Study|Lack of Efficacy|0|||
13316978|NCT01210352|26556771|FG005|Overall Study|Lack of Efficacy|0|||
13316979|NCT01210352|26556772|FG006|Overall Study|Lack of Efficacy|1|||
13316980|NCT01210352|26556773|FG007|Overall Study|Lack of Efficacy|0|||
13316981|NCT01210352|26556774|FG008|Overall Study|Lack of Efficacy|0|||
13316982|NCT01210352|26556766|FG000|Overall Study|Physician Decision|0|||
13316983|NCT01210352|26556767|FG001|Overall Study|Physician Decision|0|||
13316984|NCT01210352|26556768|FG002|Overall Study|Physician Decision|0|||
13316985|NCT01210352|26556769|FG003|Overall Study|Physician Decision|0|||
13316986|NCT01210352|26556770|FG004|Overall Study|Physician Decision|0|||
13316987|NCT01210352|26556771|FG005|Overall Study|Physician Decision|0|||
13316988|NCT01210352|26556772|FG006|Overall Study|Physician Decision|0|||
13316989|NCT01210352|26556773|FG007|Overall Study|Physician Decision|1|||
13316990|NCT01210352|26556774|FG008|Overall Study|Physician Decision|2|||
13316991|NCT01210352|26556766|FG000|Overall Study|Withdrawal by Subject|0|||
13316992|NCT01210352|26556767|FG001|Overall Study|Withdrawal by Subject|0|||
13316993|NCT01210352|26556768|FG002|Overall Study|Withdrawal by Subject|1|||
13316994|NCT01210352|26556769|FG003|Overall Study|Withdrawal by Subject|0|||
13316995|NCT01210352|26556770|FG004|Overall Study|Withdrawal by Subject|0|||
13316996|NCT01210352|26556771|FG005|Overall Study|Withdrawal by Subject|0|||
13316997|NCT01210352|26556772|FG006|Overall Study|Withdrawal by Subject|1|||
13316998|NCT01210352|26556773|FG007|Overall Study|Withdrawal by Subject|0|||
13316999|NCT01210352|26556774|FG008|Overall Study|Withdrawal by Subject|1|||
13317000|NCT01210352|26556766|FG000|Overall Study|Patient Discharged Early|0|||
13317001|NCT01210352|26556767|FG001|Overall Study|Patient Discharged Early|0|||
13317002|NCT01210352|26556768|FG002|Overall Study|Patient Discharged Early|1|||
13317003|NCT01210352|26556769|FG003|Overall Study|Patient Discharged Early|0|||
13317004|NCT01210352|26556770|FG004|Overall Study|Patient Discharged Early|0|||
13317005|NCT01210352|26556771|FG005|Overall Study|Patient Discharged Early|0|||
13317006|NCT01210352|26556772|FG006|Overall Study|Patient Discharged Early|0|||
13317007|NCT01210352|26556773|FG007|Overall Study|Patient Discharged Early|0|||
13317008|NCT01210352|26556774|FG008|Overall Study|Patient Discharged Early|0|||
13317009|NCT01210222|26556789|FG000|Overall Study|Ineligible|2|||
13317010|NCT01210222|26556789|FG000|Overall Study|Never treated|1|||
13317011|NCT01210144|26556816|FG000|Overall Study|Lack of ovarian response|1|||
13317012|NCT01210144|26556817|FG001|Overall Study|Lack of ovarian response|0|||
13317013|NCT01210144|26556816|FG000|Overall Study|No fertilization|1|||
13317014|NCT01210144|26556817|FG001|Overall Study|No fertilization|0|||
13317015|NCT01210144|26556816|FG000|Overall Study|No transfer|1|||
13317016|NCT01210144|26556817|FG001|Overall Study|No transfer|0|||
13317017|NCT01210118|26556836|FG000|Overall Study|Lost to Follow-up|1|||
13317018|NCT01210118|26556837|FG001|Overall Study|Lost to Follow-up|1|||
13317019|NCT01210118|26556836|FG000|Overall Study|Protocol Violation|1|||
13317020|NCT01210118|26556837|FG001|Overall Study|Protocol Violation|1|||
13317021|NCT01210118|26556836|FG000|Overall Study|Spontaneous abortion|1|||
13317022|NCT01210118|26556837|FG001|Overall Study|Spontaneous abortion|3|||
13317023|NCT01210001|26556867|FG000|Overall Study|Not treated|1|||
13317024|NCT01210001|26556868|FG001|Overall Study|Not treated|0|||
13317025|NCT01210001|26556869|FG002|Overall Study|Not treated|0|||
13317026|NCT01210001|26556867|FG000|Overall Study|Adverse Event|4|||
13317027|NCT01210001|26556868|FG001|Overall Study|Adverse Event|2|||
13317028|NCT01210001|26556869|FG002|Overall Study|Adverse Event|5|||
13317029|NCT01210001|26556867|FG000|Overall Study|Non compliant with protocol|2|||
13317030|NCT01210001|26556868|FG001|Overall Study|Non compliant with protocol|2|||
13317031|NCT01210001|26556869|FG002|Overall Study|Non compliant with protocol|3|||
13317032|NCT01210001|26556867|FG000|Overall Study|Lost to Follow-up|4|||
13317033|NCT01210001|26556868|FG001|Overall Study|Lost to Follow-up|3|||
13317034|NCT01210001|26556869|FG002|Overall Study|Lost to Follow-up|2|||
13317035|NCT01210001|26556867|FG000|Overall Study|Patient refusal to continue,not due toAE|6|||
13317036|NCT01210001|26556868|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
13317037|NCT01210001|26556869|FG002|Overall Study|Patient refusal to continue,not due toAE|1|||
13317038|NCT01210001|26556867|FG000|Overall Study|Other reason not defined above|2|||
13317039|NCT01210001|26556868|FG001|Overall Study|Other reason not defined above|2|||
13317040|NCT01210001|26556869|FG002|Overall Study|Other reason not defined above|1|||
13317041|NCT01209949|26556877|FG000|Overall Study|Lost to Follow-up|3|||
13317042|NCT01209832|26556894|FG000|Period 1|Sponsor Decision and was not dosed|1|||
13317043|NCT01209832|26556894|FG000|Period 2|Sponsor Decision|1|||
13317044|NCT01209780|26556934|FG000|Overall Study|Adverse Event|0|||
13317045|NCT01209780|26556935|FG001|Overall Study|Adverse Event|1|||
13317046|NCT01209780|26556936|FG002|Overall Study|Adverse Event|0|||
13317047|NCT01209780|26556937|FG003|Overall Study|Adverse Event|0|||
13317048|NCT01209780|26556938|FG004|Overall Study|Adverse Event|0|||
13317049|NCT01209780|26556934|FG000|Overall Study|Withdrawal by Subject|9|||
13317050|NCT01209780|26556935|FG001|Overall Study|Withdrawal by Subject|2|||
13317051|NCT01209780|26556936|FG002|Overall Study|Withdrawal by Subject|1|||
13317052|NCT01209780|26556937|FG003|Overall Study|Withdrawal by Subject|1|||
13317053|NCT01209780|26556938|FG004|Overall Study|Withdrawal by Subject|0|||
13317054|NCT01209780|26556934|FG000|Overall Study|Lost to Follow-up|17|||
13317055|NCT01209780|26556935|FG001|Overall Study|Lost to Follow-up|12|||
13317056|NCT01209780|26556936|FG002|Overall Study|Lost to Follow-up|3|||
13317057|NCT01209780|26556937|FG003|Overall Study|Lost to Follow-up|9|||
13317058|NCT01209780|26556938|FG004|Overall Study|Lost to Follow-up|4|||
13317059|NCT01209780|26556934|FG000|Overall Study|Protocol Violation|0|||
13317060|NCT01209780|26556935|FG001|Overall Study|Protocol Violation|1|||
13317061|NCT01209780|26556936|FG002|Overall Study|Protocol Violation|0|||
13317062|NCT01209780|26556937|FG003|Overall Study|Protocol Violation|0|||
13317063|NCT01209780|26556938|FG004|Overall Study|Protocol Violation|0|||
13317064|NCT01209780|26556934|FG000|Overall Study|Inappropriate enrollment|0|||
13317065|NCT01209780|26556935|FG001|Overall Study|Inappropriate enrollment|2|||
13317066|NCT01209780|26556936|FG002|Overall Study|Inappropriate enrollment|0|||
13317067|NCT01209780|26556937|FG003|Overall Study|Inappropriate enrollment|0|||
13317068|NCT01209780|26556938|FG004|Overall Study|Inappropriate enrollment|1|||
13317069|NCT01209689|26556951|FG000|Overall Study|Insufficient Therapeutic Response|7|||
13317070|NCT01209689|26556952|FG001|Overall Study|Insufficient Therapeutic Response|2|||
13317071|NCT01209689|26556951|FG000|Overall Study|Refused Treatment|8|||
13317072|NCT01209689|26556952|FG001|Overall Study|Refused Treatment|3|||
13317073|NCT01209689|26556951|FG000|Overall Study|Adverse Event|4|||
13317074|NCT01209689|26556952|FG001|Overall Study|Adverse Event|0|||
13317075|NCT01209689|26556951|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
13317076|NCT01209689|26556952|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
13317077|NCT01209689|26556951|FG000|Overall Study|Failure to Return|3|||
13317078|NCT01209689|26556952|FG001|Overall Study|Failure to Return|0|||
13317079|NCT01209689|26556951|FG000|Overall Study|Sponsor's Decision to Stop the Study|68|||
13317080|NCT01209689|26556952|FG001|Overall Study|Sponsor's Decision to Stop the Study|17|||
13317081|NCT01209624|26556985|FG000|Overall Study|Death|2|||
13317082|NCT01209624|26556985|FG000|Overall Study|Adverse Event|13|||
13317083|NCT01209624|26556985|FG000|Overall Study|Lack of Efficacy|17|||
13317084|NCT01209624|26556985|FG000|Overall Study|Lost to Follow-up|290|||
13317085|NCT01209624|26556985|FG000|Overall Study|Other|4|||
13317086|NCT01209598|26557000|FG000|Overall Study|Withdrawal by Subject|1|||
13317087|NCT01209598|26557001|FG001|Overall Study|Withdrawal by Subject|0|||
13317088|NCT01209520|26557008|FG000|Overall Study|Withdrawal by Subject|3|||
13317089|NCT01209325|26557062|FG000|Overall Study|Lost to Follow-up|24|||
13317090|NCT01209325|26557062|FG000|Overall Study|Adverse Event|1|||
13317091|NCT01209325|26557062|FG000|Overall Study|Relocated|3|||
13317092|NCT01209325|26557062|FG000|Overall Study|Refusal after starting therapy|8|||
13317093|NCT01209325|26557062|FG000|Overall Study|Protocol Violation|4|||
13317094|NCT01209325|26557062|FG000|Overall Study|Refusal prior to therapy|1|||
13317095|NCT01209325|26557062|FG000|Overall Study|Incarceration|2|||
13317096|NCT01209286|26557123|FG000|Overall Study|Adverse Event|4|||
13317097|NCT01209286|26557124|FG001|Overall Study|Adverse Event|3|||
13317098|NCT01209286|26557125|FG002|Overall Study|Adverse Event|1|||
13317099|NCT01209286|26557123|FG000|Overall Study|Hematological Relapse After Remission|0|||
13317100|NCT01209286|26557124|FG001|Overall Study|Hematological Relapse After Remission|1|||
13317101|NCT01209286|26557125|FG002|Overall Study|Hematological Relapse After Remission|1|||
13317102|NCT01209286|26557123|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1|||
13317103|NCT01209286|26557124|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3|||
13317104|NCT01209286|26557125|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1|||
13317105|NCT01209286|26557123|FG000|Overall Study|Physician Decision|0|||
13317106|NCT01209286|26557124|FG001|Overall Study|Physician Decision|2|||
13317107|NCT01209286|26557125|FG002|Overall Study|Physician Decision|0|||
13317108|NCT01209286|26557123|FG000|Overall Study|Other|0|||
13317109|NCT01209286|26557124|FG001|Overall Study|Other|1|||
13317110|NCT01209286|26557125|FG002|Overall Study|Other|0|||
13317111|NCT01209143|26557140|FG000|Overall Study|Adverse Event|2|||
13317112|NCT01209143|26557141|FG001|Overall Study|Adverse Event|1|||
13317113|NCT01209143|26557140|FG000|Overall Study|Death|0|||
13317114|NCT01209143|26557141|FG001|Overall Study|Death|1|||
13317115|NCT01209143|26557140|FG000|Overall Study|Physician Decision|3|||
13317116|NCT01209143|26557141|FG001|Overall Study|Physician Decision|1|||
13317117|NCT01209143|26557140|FG000|Overall Study|Lost to Follow-up|1|||
13317118|NCT01209143|26557141|FG001|Overall Study|Lost to Follow-up|0|||
13317119|NCT01209143|26557140|FG000|Overall Study|Withdrawal by Subject|2|||
13317120|NCT01209143|26557141|FG001|Overall Study|Withdrawal by Subject|1|||
13317121|NCT01209143|26557140|FG000|Overall Study|Disease progression|11|||
13317122|NCT01209143|26557141|FG001|Overall Study|Disease progression|16|||
13317123|NCT01209078|26557223|FG000|Overall Study|Adverse Event|5|||
13317124|NCT01209078|26557224|FG001|Overall Study|Adverse Event|0|||
13317125|NCT01209078|26557223|FG000|Overall Study|Lost to Follow-up|4|||
13317126|NCT01209078|26557224|FG001|Overall Study|Lost to Follow-up|0|||
13317127|NCT01209078|26557223|FG000|Overall Study|Physician Decision|5|||
13317128|NCT01209078|26557224|FG001|Overall Study|Physician Decision|2|||
13317129|NCT01209078|26557223|FG000|Overall Study|Withdrawal by Subject|2|||
13317130|NCT01209078|26557224|FG001|Overall Study|Withdrawal by Subject|1|||
13317131|NCT01208961|26557236|FG000|High-Fat Period III|Protocol Violation|1|||
13317132|NCT01208961|26557237|FG001|High-Fat Period III|Protocol Violation|0|||
13317133|NCT01208870|26557260|FG000|Overall Study|Lost to Follow-up|2|||
13317134|NCT01208870|26557261|FG001|Overall Study|Lost to Follow-up|8|||
13317135|NCT01208415|26557267|FG000|Overall Study|Death|1|||
13317136|NCT01208415|26557267|FG000|Overall Study|Lost to Follow-up|2|||
13317137|NCT01208415|26557267|FG000|Overall Study|Withdrawal by Subject|3|||
13317138|NCT01208415|26557267|FG000|Overall Study|Device not placed|1|||
13317139|NCT01208415|26557267|FG000|Overall Study|Still be eligible for follow-up|33|||
13317140|NCT01208402|26557290|FG000|Overall Study|Withdrawal by Subject|1|||
13317141|NCT01208402|26557291|FG001|Overall Study|Withdrawal by Subject|0|||
13317142|NCT01208337|26557301|FG000|Overall Study|Death|3|||
13317143|NCT01208324|26557324|FG000|Post-randomization of Patch|Withdrawal by Subject|1|||
13317144|NCT01208324|26557325|FG001|Post-randomization of Patch|Withdrawal by Subject|0|||
13317145|NCT01208324|26557326|FG002|Post-randomization of Patch|Withdrawal by Subject|0|||
13317146|NCT01208324|26557327|FG003|Post-randomization of Patch|Withdrawal by Subject|0|||
13317147|NCT01208233|26557457|FG000|Overall Study|Adverse Event|0|||
13317148|NCT01208233|26557458|FG001|Overall Study|Adverse Event|1|||
13317149|NCT01208233|26557459|FG002|Overall Study|Adverse Event|2|||
13317150|NCT01208233|26557460|FG003|Overall Study|Adverse Event|0|||
13317151|NCT01208233|26557461|FG004|Overall Study|Adverse Event|3|||
13317152|NCT01208233|26557462|FG005|Overall Study|Adverse Event|5|||
13317153|NCT01208233|26557457|FG000|Overall Study|Death|0|||
13317154|NCT01208233|26557458|FG001|Overall Study|Death|0|||
13317155|NCT01208233|26557459|FG002|Overall Study|Death|0|||
13317156|NCT01208233|26557460|FG003|Overall Study|Death|0|||
13317157|NCT01208233|26557461|FG004|Overall Study|Death|3|||
13317158|NCT01208233|26557462|FG005|Overall Study|Death|5|||
13317159|NCT01208233|26557457|FG000|Overall Study|Did not meet entrance criteria|2|||
13317160|NCT01208233|26557458|FG001|Overall Study|Did not meet entrance criteria|1|||
13317161|NCT01208233|26557459|FG002|Overall Study|Did not meet entrance criteria|1|||
13317162|NCT01208233|26557460|FG003|Overall Study|Did not meet entrance criteria|0|||
13317163|NCT01208233|26557461|FG004|Overall Study|Did not meet entrance criteria|1|||
13317164|NCT01208233|26557462|FG005|Overall Study|Did not meet entrance criteria|0|||
13317165|NCT01208233|26557457|FG000|Overall Study|Medication error without adverse event|0|||
13317166|NCT01208233|26557458|FG001|Overall Study|Medication error without adverse event|0|||
13317167|NCT01208233|26557459|FG002|Overall Study|Medication error without adverse event|0|||
13317168|NCT01208233|26557460|FG003|Overall Study|Medication error without adverse event|0|||
13317169|NCT01208233|26557461|FG004|Overall Study|Medication error without adverse event|0|||
13317170|NCT01208233|26557462|FG005|Overall Study|Medication error without adverse event|1|||
13317171|NCT01208233|26557457|FG000|Overall Study|Study terminated by sponsor|0|||
13317172|NCT01208233|26557458|FG001|Overall Study|Study terminated by sponsor|0|||
13317173|NCT01208233|26557459|FG002|Overall Study|Study terminated by sponsor|0|||
13317174|NCT01208233|26557460|FG003|Overall Study|Study terminated by sponsor|0|||
13317175|NCT01208233|26557461|FG004|Overall Study|Study terminated by sponsor|10|||
13317176|NCT01208233|26557462|FG005|Overall Study|Study terminated by sponsor|7|||
13317177|NCT01208233|26557457|FG000|Overall Study|Protocol Violation|0|||
13317178|NCT01208233|26557458|FG001|Overall Study|Protocol Violation|0|||
13317179|NCT01208233|26557459|FG002|Overall Study|Protocol Violation|0|||
13317180|NCT01208233|26557460|FG003|Overall Study|Protocol Violation|0|||
13317181|NCT01208233|26557461|FG004|Overall Study|Protocol Violation|3|||
13317182|NCT01208233|26557462|FG005|Overall Study|Protocol Violation|0|||
13317183|NCT01208233|26557457|FG000|Overall Study|Other|2|||
13317184|NCT01208233|26557458|FG001|Overall Study|Other|1|||
13317185|NCT01208233|26557459|FG002|Overall Study|Other|0|||
13317186|NCT01208233|26557460|FG003|Overall Study|Other|0|||
13317187|NCT01208233|26557461|FG004|Overall Study|Other|0|||
13317188|NCT01208233|26557462|FG005|Overall Study|Other|1|||
13317189|NCT01208233|26557457|FG000|Overall Study|Withdrawal by Subject|1|||
13317190|NCT01208233|26557458|FG001|Overall Study|Withdrawal by Subject|0|||
13317191|NCT01208233|26557459|FG002|Overall Study|Withdrawal by Subject|1|||
13317192|NCT01208233|26557460|FG003|Overall Study|Withdrawal by Subject|1|||
13317193|NCT01208233|26557461|FG004|Overall Study|Withdrawal by Subject|4|||
13317194|NCT01208233|26557462|FG005|Overall Study|Withdrawal by Subject|2|||
13317195|NCT01208207|26557500|FG000|Part I|Adverse Event|19|||
13317196|NCT01208207|26557501|FG001|Part I|Adverse Event|2|||
13317197|NCT01208207|26557502|FG002|Part I|Adverse Event|6|||
13317198|NCT01208207|26557503|FG003|Part I|Adverse Event|0|||
13317199|NCT01208207|26557504|FG004|Part I|Adverse Event|0|||
13317200|NCT01208207|26557505|FG005|Part I|Adverse Event|0|||
13317201|NCT01208207|26557506|FG006|Part I|Adverse Event|0|||
13317202|NCT01208207|26557500|FG000|Part I|Lack of Efficacy|21|||
13317203|NCT01208207|26557501|FG001|Part I|Lack of Efficacy|3|||
13317204|NCT01208207|26557502|FG002|Part I|Lack of Efficacy|2|||
13317205|NCT01208207|26557503|FG003|Part I|Lack of Efficacy|0|||
13317206|NCT01208207|26557504|FG004|Part I|Lack of Efficacy|0|||
13317207|NCT01208207|26557505|FG005|Part I|Lack of Efficacy|0|||
13317208|NCT01208207|26557506|FG006|Part I|Lack of Efficacy|0|||
13317209|NCT01208207|26557500|FG000|Part I|Lost to Follow-up|6|||
13317210|NCT01208207|26557501|FG001|Part I|Lost to Follow-up|1|||
13317211|NCT01208207|26557502|FG002|Part I|Lost to Follow-up|0|||
13317212|NCT01208207|26557503|FG003|Part I|Lost to Follow-up|0|||
13317213|NCT01208207|26557504|FG004|Part I|Lost to Follow-up|0|||
13317214|NCT01208207|26557505|FG005|Part I|Lost to Follow-up|0|||
13317215|NCT01208207|26557506|FG006|Part I|Lost to Follow-up|0|||
13317216|NCT01208207|26557500|FG000|Part I|Non-Compliance With Study Drug|1|||
13317217|NCT01208207|26557501|FG001|Part I|Non-Compliance With Study Drug|0|||
13317218|NCT01208207|26557502|FG002|Part I|Non-Compliance With Study Drug|1|||
13317219|NCT01208207|26557503|FG003|Part I|Non-Compliance With Study Drug|0|||
13317220|NCT01208207|26557504|FG004|Part I|Non-Compliance With Study Drug|0|||
13317221|NCT01208207|26557505|FG005|Part I|Non-Compliance With Study Drug|0|||
13317222|NCT01208207|26557506|FG006|Part I|Non-Compliance With Study Drug|0|||
13317223|NCT01208207|26557500|FG000|Part I|Physician Decision|0|||
13317224|NCT01208207|26557501|FG001|Part I|Physician Decision|1|||
13317225|NCT01208207|26557502|FG002|Part I|Physician Decision|0|||
13317226|NCT01208207|26557503|FG003|Part I|Physician Decision|0|||
13317227|NCT01208207|26557504|FG004|Part I|Physician Decision|0|||
13317228|NCT01208207|26557505|FG005|Part I|Physician Decision|0|||
13317229|NCT01208207|26557506|FG006|Part I|Physician Decision|0|||
13317230|NCT01208207|26557500|FG000|Part I|Progressive Disease|1|||
13317231|NCT01208207|26557501|FG001|Part I|Progressive Disease|0|||
13317232|NCT01208207|26557502|FG002|Part I|Progressive Disease|0|||
13317233|NCT01208207|26557503|FG003|Part I|Progressive Disease|0|||
13317234|NCT01208207|26557504|FG004|Part I|Progressive Disease|0|||
13317235|NCT01208207|26557505|FG005|Part I|Progressive Disease|0|||
13317236|NCT01208207|26557506|FG006|Part I|Progressive Disease|0|||
13317237|NCT01208207|26557500|FG000|Part I|Protocol Violation|8|||
13317238|NCT01208207|26557501|FG001|Part I|Protocol Violation|0|||
13317239|NCT01208207|26557502|FG002|Part I|Protocol Violation|2|||
13317240|NCT01208207|26557503|FG003|Part I|Protocol Violation|0|||
13317241|NCT01208207|26557504|FG004|Part I|Protocol Violation|0|||
13317242|NCT01208207|26557505|FG005|Part I|Protocol Violation|0|||
13317243|NCT01208207|26557506|FG006|Part I|Protocol Violation|0|||
13317244|NCT01208207|26557500|FG000|Part I|Withdrawal by Subject|14|||
13317245|NCT01208207|26557501|FG001|Part I|Withdrawal by Subject|4|||
13317246|NCT01208207|26557502|FG002|Part I|Withdrawal by Subject|4|||
13317247|NCT01208207|26557503|FG003|Part I|Withdrawal by Subject|0|||
13317248|NCT01208207|26557504|FG004|Part I|Withdrawal by Subject|0|||
13317249|NCT01208207|26557505|FG005|Part I|Withdrawal by Subject|0|||
13317250|NCT01208207|26557506|FG006|Part I|Withdrawal by Subject|0|||
13317251|NCT01208207|26557500|FG000|Part II|Withdrawal by Subject|0|||
13317252|NCT01208207|26557501|FG001|Part II|Withdrawal by Subject|0|||
13317253|NCT01208207|26557502|FG002|Part II|Withdrawal by Subject|0|||
13317254|NCT01208207|26557503|FG003|Part II|Withdrawal by Subject|10|||
13317255|NCT01208207|26557504|FG004|Part II|Withdrawal by Subject|9|||
13317256|NCT01208207|26557505|FG005|Part II|Withdrawal by Subject|3|||
13317257|NCT01208207|26557506|FG006|Part II|Withdrawal by Subject|5|||
13317258|NCT01208207|26557500|FG000|Part II|Adverse Event|0|||
13317259|NCT01208207|26557501|FG001|Part II|Adverse Event|0|||
13317260|NCT01208207|26557502|FG002|Part II|Adverse Event|0|||
13317261|NCT01208207|26557503|FG003|Part II|Adverse Event|5|||
13317262|NCT01208207|26557504|FG004|Part II|Adverse Event|9|||
13317263|NCT01208207|26557505|FG005|Part II|Adverse Event|4|||
13317264|NCT01208207|26557506|FG006|Part II|Adverse Event|2|||
13317265|NCT01208207|26557500|FG000|Part II|Lack of Efficacy|0|||
13317266|NCT01208207|26557501|FG001|Part II|Lack of Efficacy|0|||
13317267|NCT01208207|26557502|FG002|Part II|Lack of Efficacy|0|||
13317268|NCT01208207|26557503|FG003|Part II|Lack of Efficacy|6|||
13317269|NCT01208207|26557504|FG004|Part II|Lack of Efficacy|4|||
13317270|NCT01208207|26557505|FG005|Part II|Lack of Efficacy|3|||
13317271|NCT01208207|26557506|FG006|Part II|Lack of Efficacy|3|||
13317272|NCT01208207|26557500|FG000|Part II|Lost to Follow-up|0|||
13317273|NCT01208207|26557501|FG001|Part II|Lost to Follow-up|0|||
13317274|NCT01208207|26557502|FG002|Part II|Lost to Follow-up|0|||
13317275|NCT01208207|26557503|FG003|Part II|Lost to Follow-up|4|||
13317276|NCT01208207|26557504|FG004|Part II|Lost to Follow-up|0|||
13317277|NCT01208207|26557505|FG005|Part II|Lost to Follow-up|2|||
13317278|NCT01208207|26557506|FG006|Part II|Lost to Follow-up|1|||
13317279|NCT01208207|26557500|FG000|Part II|Non-Compliance With Study Drug|0|||
13317280|NCT01208207|26557501|FG001|Part II|Non-Compliance With Study Drug|0|||
13317281|NCT01208207|26557502|FG002|Part II|Non-Compliance With Study Drug|0|||
13317282|NCT01208207|26557503|FG003|Part II|Non-Compliance With Study Drug|4|||
13317283|NCT01208207|26557504|FG004|Part II|Non-Compliance With Study Drug|1|||
13317284|NCT01208207|26557505|FG005|Part II|Non-Compliance With Study Drug|1|||
13317285|NCT01208207|26557506|FG006|Part II|Non-Compliance With Study Drug|0|||
13317286|NCT01208207|26557500|FG000|Part II|Physician Decision|0|||
13317287|NCT01208207|26557501|FG001|Part II|Physician Decision|0|||
13317288|NCT01208207|26557502|FG002|Part II|Physician Decision|0|||
13317289|NCT01208207|26557503|FG003|Part II|Physician Decision|1|||
13317290|NCT01208207|26557504|FG004|Part II|Physician Decision|0|||
13317291|NCT01208207|26557505|FG005|Part II|Physician Decision|2|||
13317292|NCT01208207|26557506|FG006|Part II|Physician Decision|0|||
13317293|NCT01208207|26557500|FG000|Part II|Protocol Violation|0|||
13317294|NCT01208207|26557501|FG001|Part II|Protocol Violation|0|||
13317295|NCT01208207|26557502|FG002|Part II|Protocol Violation|0|||
13317296|NCT01208207|26557503|FG003|Part II|Protocol Violation|1|||
13317297|NCT01208207|26557504|FG004|Part II|Protocol Violation|0|||
13317298|NCT01208207|26557505|FG005|Part II|Protocol Violation|0|||
13317299|NCT01208207|26557506|FG006|Part II|Protocol Violation|0|||
13317300|NCT01208207|26557500|FG000|Part II|Technical Problems|0|||
13317301|NCT01208207|26557501|FG001|Part II|Technical Problems|0|||
13317302|NCT01208207|26557502|FG002|Part II|Technical Problems|0|||
13317303|NCT01208207|26557503|FG003|Part II|Technical Problems|1|||
13317304|NCT01208207|26557504|FG004|Part II|Technical Problems|0|||
13317305|NCT01208207|26557505|FG005|Part II|Technical Problems|1|||
13317306|NCT01208207|26557506|FG006|Part II|Technical Problems|0|||
13317307|NCT01208181|26557547|FG000|Part 1|Withdrawal by Subject|11|||
13317308|NCT01208181|26557548|FG001|Part 1|Withdrawal by Subject|10|||
13317309|NCT01208181|26557549|FG002|Part 1|Withdrawal by Subject|0|||
13317310|NCT01208181|26557550|FG003|Part 1|Withdrawal by Subject|0|||
13317311|NCT01208181|26557551|FG004|Part 1|Withdrawal by Subject|0|||
13317312|NCT01208181|26557547|FG000|Part 1|Technical problem|5|||
13317313|NCT01208181|26557548|FG001|Part 1|Technical problem|0|||
13317314|NCT01208181|26557549|FG002|Part 1|Technical problem|0|||
13317315|NCT01208181|26557550|FG003|Part 1|Technical problem|0|||
13317316|NCT01208181|26557551|FG004|Part 1|Technical problem|0|||
13317317|NCT01208181|26557547|FG000|Part 1|Protocol Violation|10|||
13317318|NCT01208181|26557548|FG001|Part 1|Protocol Violation|5|||
13317319|NCT01208181|26557549|FG002|Part 1|Protocol Violation|0|||
13317320|NCT01208181|26557550|FG003|Part 1|Protocol Violation|0|||
13317321|NCT01208181|26557551|FG004|Part 1|Protocol Violation|0|||
13317322|NCT01208181|26557547|FG000|Part 1|Physician Decision|4|||
13317323|NCT01208181|26557548|FG001|Part 1|Physician Decision|0|||
13317324|NCT01208181|26557549|FG002|Part 1|Physician Decision|0|||
13317325|NCT01208181|26557550|FG003|Part 1|Physician Decision|0|||
13317326|NCT01208181|26557551|FG004|Part 1|Physician Decision|0|||
13317327|NCT01208181|26557547|FG000|Part 1|Non-compliance with study drug|1|||
13317328|NCT01208181|26557548|FG001|Part 1|Non-compliance with study drug|1|||
13317329|NCT01208181|26557549|FG002|Part 1|Non-compliance with study drug|0|||
13317330|NCT01208181|26557550|FG003|Part 1|Non-compliance with study drug|0|||
13317331|NCT01208181|26557551|FG004|Part 1|Non-compliance with study drug|0|||
13317332|NCT01208181|26557547|FG000|Part 1|Lost to Follow-up|5|||
13317333|NCT01208181|26557548|FG001|Part 1|Lost to Follow-up|3|||
13317334|NCT01208181|26557549|FG002|Part 1|Lost to Follow-up|0|||
13317335|NCT01208181|26557550|FG003|Part 1|Lost to Follow-up|0|||
13317336|NCT01208181|26557551|FG004|Part 1|Lost to Follow-up|1|||
13317337|NCT01208181|26557547|FG000|Part 1|Lack of Efficacy|37|||
13317338|NCT01208181|26557548|FG001|Part 1|Lack of Efficacy|12|||
13317339|NCT01208181|26557549|FG002|Part 1|Lack of Efficacy|0|||
13317340|NCT01208181|26557550|FG003|Part 1|Lack of Efficacy|0|||
13317341|NCT01208181|26557551|FG004|Part 1|Lack of Efficacy|17|||
13317342|NCT01208181|26557547|FG000|Part 1|Adverse Event|26|||
13317343|NCT01208181|26557548|FG001|Part 1|Adverse Event|24|||
13317344|NCT01208181|26557549|FG002|Part 1|Adverse Event|0|||
13317345|NCT01208181|26557550|FG003|Part 1|Adverse Event|0|||
13317346|NCT01208181|26557551|FG004|Part 1|Adverse Event|4|||
13317347|NCT01208181|26557547|FG000|Part 2|Adverse Event|0|||
13317348|NCT01208181|26557548|FG001|Part 2|Adverse Event|0|||
13317349|NCT01208181|26557549|FG002|Part 2|Adverse Event|6|||
13317350|NCT01208181|26557550|FG003|Part 2|Adverse Event|7|||
13317351|NCT01208181|26557551|FG004|Part 2|Adverse Event|0|||
13317352|NCT01208181|26557547|FG000|Part 2|Withdrawal by Subject|0|||
13317353|NCT01208181|26557548|FG001|Part 2|Withdrawal by Subject|0|||
13317354|NCT01208181|26557549|FG002|Part 2|Withdrawal by Subject|1|||
13317355|NCT01208181|26557550|FG003|Part 2|Withdrawal by Subject|1|||
13317356|NCT01208181|26557551|FG004|Part 2|Withdrawal by Subject|0|||
13317357|NCT01208181|26557547|FG000|Part 2|Protocol Violation|0|||
13317358|NCT01208181|26557548|FG001|Part 2|Protocol Violation|0|||
13317359|NCT01208181|26557549|FG002|Part 2|Protocol Violation|1|||
13317360|NCT01208181|26557550|FG003|Part 2|Protocol Violation|0|||
13317361|NCT01208181|26557551|FG004|Part 2|Protocol Violation|0|||
13317362|NCT01208181|26557547|FG000|Part 2|Physician Decision|0|||
13317363|NCT01208181|26557548|FG001|Part 2|Physician Decision|0|||
13317364|NCT01208181|26557549|FG002|Part 2|Physician Decision|1|||
13317365|NCT01208181|26557550|FG003|Part 2|Physician Decision|2|||
13317366|NCT01208181|26557551|FG004|Part 2|Physician Decision|0|||
13317367|NCT01208181|26557547|FG000|Part 2|Non-compliance with study drug|0|||
13317368|NCT01208181|26557548|FG001|Part 2|Non-compliance with study drug|0|||
13317369|NCT01208181|26557549|FG002|Part 2|Non-compliance with study drug|1|||
13317370|NCT01208181|26557550|FG003|Part 2|Non-compliance with study drug|1|||
13317371|NCT01208181|26557551|FG004|Part 2|Non-compliance with study drug|0|||
13317372|NCT01208181|26557547|FG000|Part 2|Lost to Follow-up|0|||
13317373|NCT01208181|26557548|FG001|Part 2|Lost to Follow-up|0|||
13317374|NCT01208181|26557549|FG002|Part 2|Lost to Follow-up|1|||
13317375|NCT01208181|26557550|FG003|Part 2|Lost to Follow-up|2|||
13317376|NCT01208181|26557551|FG004|Part 2|Lost to Follow-up|0|||
13317377|NCT01208181|26557547|FG000|Part 2|Lack of Efficacy|0|||
13317378|NCT01208181|26557548|FG001|Part 2|Lack of Efficacy|0|||
13317379|NCT01208181|26557549|FG002|Part 2|Lack of Efficacy|5|||
13317380|NCT01208181|26557550|FG003|Part 2|Lack of Efficacy|7|||
13317381|NCT01208181|26557551|FG004|Part 2|Lack of Efficacy|0|||
13317382|NCT01208103|26557561|FG000|Overall Study|Adverse Event|1|||
13317383|NCT01208103|26557561|FG000|Overall Study|Withdrawal by Subject|1|||
13317384|NCT01208051|26557624|FG000|Total Enrollment|Withdrawal by Subject|0|||
13317385|NCT01208051|26557625|FG001|Total Enrollment|Withdrawal by Subject|1|||
13317386|NCT01208051|26557626|FG002|Total Enrollment|Withdrawal by Subject|0|||
13317387|NCT01208051|26557627|FG003|Total Enrollment|Withdrawal by Subject|0|||
13317388|NCT01208051|26557628|FG004|Total Enrollment|Withdrawal by Subject|2|||
13317389|NCT01208051|26557624|FG000|Total Enrollment|Brain metastases|0|||
13317390|NCT01208051|26557625|FG001|Total Enrollment|Brain metastases|0|||
13317391|NCT01208051|26557626|FG002|Total Enrollment|Brain metastases|1|||
13317392|NCT01208051|26557627|FG003|Total Enrollment|Brain metastases|0|||
13317393|NCT01208051|26557628|FG004|Total Enrollment|Brain metastases|0|||
13317394|NCT01208038|26557637|FG000|Overall Study|Withdrawal by Subject|1|||
13317395|NCT01207687|26557669|FG000|Overall Study|Adverse Event|1|||
13317396|NCT01207687|26557669|FG000|Overall Study|Withdrawal by Subject|1|||
13317397|NCT01207596|26557681|FG000|Overall Study|Physician Decision|4|||
13317398|NCT01207596|26557681|FG000|Overall Study|Lack of Efficacy|1|||
13317399|NCT01207596|26557681|FG000|Overall Study|Adverse Event|3|||
13317400|NCT01207596|26557681|FG000|Overall Study|Withdrawal by Subject|1|||
13317401|NCT01207583|26557729|FG000|Overall Study|Withdrawal by Subject|0|||
13317402|NCT01207583|26557730|FG001|Overall Study|Withdrawal by Subject|3|||
13317403|NCT01207583|26557731|FG002|Overall Study|Withdrawal by Subject|1|||
13317404|NCT01207583|26557729|FG000|Overall Study|Participant failed to return|1|||
13317405|NCT01207583|26557730|FG001|Overall Study|Participant failed to return|0|||
13317406|NCT01207583|26557731|FG002|Overall Study|Participant failed to return|0|||
13317407|NCT01207583|26557729|FG000|Overall Study|Lost to Follow-up|0|||
13317408|NCT01207583|26557730|FG001|Overall Study|Lost to Follow-up|2|||
13317409|NCT01207583|26557731|FG002|Overall Study|Lost to Follow-up|0|||
13317410|NCT01207453|26557757|FG000|First Intervention|Adverse Event|2|||
13317411|NCT01207453|26557758|FG001|First Intervention|Adverse Event|1|||
13317412|NCT01207453|26557757|FG000|Washout|Adverse Event|1|||
13317413|NCT01207453|26557758|FG001|Washout|Adverse Event|0|||
13317414|NCT01207453|26557757|FG000|Washout|Lost to Follow-up|1|||
13317415|NCT01207453|26557758|FG001|Washout|Lost to Follow-up|0|||
13317416|NCT01207453|26557757|FG000|2nd Intervention|Adverse Event|1|||
13317417|NCT01207453|26557758|FG001|2nd Intervention|Adverse Event|2|||
13317418|NCT01207453|26557757|FG000|2nd Intervention|Lost to Follow-up|1|||
13317419|NCT01207453|26557758|FG001|2nd Intervention|Lost to Follow-up|0|||
13317420|NCT01207440|26557844|FG000|Overall Study|Adverse Event|46|||
13317421|NCT01207440|26557845|FG001|Overall Study|Adverse Event|11|||
13317422|NCT01207440|26557846|FG002|Overall Study|Adverse Event|7|||
13317423|NCT01207440|26557847|FG003|Overall Study|Adverse Event|2|||
13317424|NCT01207440|26557848|FG004|Overall Study|Adverse Event|6|||
13317425|NCT01207440|26557849|FG005|Overall Study|Adverse Event|6|||
13317426|NCT01207440|26557850|FG006|Overall Study|Adverse Event|2|||
13317427|NCT01207440|26557844|FG000|Overall Study|Death|6|||
13317428|NCT01207440|26557845|FG001|Overall Study|Death|3|||
13317429|NCT01207440|26557846|FG002|Overall Study|Death|2|||
13317430|NCT01207440|26557847|FG003|Overall Study|Death|2|||
13317431|NCT01207440|26557848|FG004|Overall Study|Death|7|||
13317432|NCT01207440|26557849|FG005|Overall Study|Death|5|||
13317433|NCT01207440|26557850|FG006|Overall Study|Death|1|||
13317434|NCT01207440|26557844|FG000|Overall Study|Lack of Efficacy|13|||
13317435|NCT01207440|26557845|FG001|Overall Study|Lack of Efficacy|2|||
13317436|NCT01207440|26557846|FG002|Overall Study|Lack of Efficacy|5|||
13317437|NCT01207440|26557847|FG003|Overall Study|Lack of Efficacy|1|||
13317438|NCT01207440|26557848|FG004|Overall Study|Lack of Efficacy|2|||
13317439|NCT01207440|26557849|FG005|Overall Study|Lack of Efficacy|3|||
13317440|NCT01207440|26557850|FG006|Overall Study|Lack of Efficacy|0|||
13317441|NCT01207440|26557844|FG000|Overall Study|Lost to Follow-up|0|||
13317442|NCT01207440|26557845|FG001|Overall Study|Lost to Follow-up|0|||
13317443|NCT01207440|26557846|FG002|Overall Study|Lost to Follow-up|2|||
13317444|NCT01207440|26557847|FG003|Overall Study|Lost to Follow-up|1|||
13317445|NCT01207440|26557848|FG004|Overall Study|Lost to Follow-up|0|||
13317446|NCT01207440|26557849|FG005|Overall Study|Lost to Follow-up|0|||
13317447|NCT01207440|26557850|FG006|Overall Study|Lost to Follow-up|0|||
13317448|NCT01207440|26557844|FG000|Overall Study|Non-compliance with Study Drug|3|||
13317449|NCT01207440|26557845|FG001|Overall Study|Non-compliance with Study Drug|0|||
13317450|NCT01207440|26557846|FG002|Overall Study|Non-compliance with Study Drug|1|||
13317451|NCT01207440|26557847|FG003|Overall Study|Non-compliance with Study Drug|0|||
13317452|NCT01207440|26557848|FG004|Overall Study|Non-compliance with Study Drug|0|||
13317453|NCT01207440|26557849|FG005|Overall Study|Non-compliance with Study Drug|0|||
13317454|NCT01207440|26557850|FG006|Overall Study|Non-compliance with Study Drug|0|||
13317455|NCT01207440|26557844|FG000|Overall Study|Physician Decision|6|||
13317456|NCT01207440|26557845|FG001|Overall Study|Physician Decision|5|||
13317457|NCT01207440|26557846|FG002|Overall Study|Physician Decision|5|||
13317458|NCT01207440|26557847|FG003|Overall Study|Physician Decision|0|||
13317459|NCT01207440|26557848|FG004|Overall Study|Physician Decision|1|||
13317460|NCT01207440|26557849|FG005|Overall Study|Physician Decision|0|||
13317461|NCT01207440|26557850|FG006|Overall Study|Physician Decision|0|||
13317462|NCT01207440|26557844|FG000|Overall Study|Progressive Disease|19|||
13317463|NCT01207440|26557845|FG001|Overall Study|Progressive Disease|10|||
13317464|NCT01207440|26557846|FG002|Overall Study|Progressive Disease|19|||
13317465|NCT01207440|26557847|FG003|Overall Study|Progressive Disease|7|||
13317466|NCT01207440|26557848|FG004|Overall Study|Progressive Disease|23|||
13317467|NCT01207440|26557849|FG005|Overall Study|Progressive Disease|27|||
13317468|NCT01207440|26557850|FG006|Overall Study|Progressive Disease|0|||
13317469|NCT01207440|26557844|FG000|Overall Study|Protocol Violation|2|||
13317470|NCT01207440|26557845|FG001|Overall Study|Protocol Violation|0|||
13317471|NCT01207440|26557846|FG002|Overall Study|Protocol Violation|0|||
13317472|NCT01207440|26557847|FG003|Overall Study|Protocol Violation|0|||
13317473|NCT01207440|26557848|FG004|Overall Study|Protocol Violation|0|||
13317474|NCT01207440|26557849|FG005|Overall Study|Protocol Violation|0|||
13317475|NCT01207440|26557850|FG006|Overall Study|Protocol Violation|0|||
13317476|NCT01207440|26557844|FG000|Overall Study|Site Terminated by Sponsor|69|||
13317477|NCT01207440|26557845|FG001|Overall Study|Site Terminated by Sponsor|19|||
13317478|NCT01207440|26557846|FG002|Overall Study|Site Terminated by Sponsor|12|||
13317479|NCT01207440|26557847|FG003|Overall Study|Site Terminated by Sponsor|2|||
13317480|NCT01207440|26557848|FG004|Overall Study|Site Terminated by Sponsor|3|||
13317481|NCT01207440|26557849|FG005|Overall Study|Site Terminated by Sponsor|0|||
13317482|NCT01207440|26557850|FG006|Overall Study|Site Terminated by Sponsor|2|||
13317483|NCT01207440|26557844|FG000|Overall Study|Withdrawal by Subject|29|||
13317484|NCT01207440|26557845|FG001|Overall Study|Withdrawal by Subject|4|||
13317485|NCT01207440|26557846|FG002|Overall Study|Withdrawal by Subject|5|||
13317486|NCT01207440|26557847|FG003|Overall Study|Withdrawal by Subject|3|||
13317487|NCT01207440|26557848|FG004|Overall Study|Withdrawal by Subject|2|||
13317488|NCT01207440|26557849|FG005|Overall Study|Withdrawal by Subject|2|||
13317489|NCT01207440|26557850|FG006|Overall Study|Withdrawal by Subject|0|||
13317490|NCT01207440|26557844|FG000|Overall Study|Reason Not Specified|10|||
13317491|NCT01207440|26557845|FG001|Overall Study|Reason Not Specified|10|||
13317492|NCT01207440|26557846|FG002|Overall Study|Reason Not Specified|7|||
13317493|NCT01207440|26557847|FG003|Overall Study|Reason Not Specified|0|||
13317494|NCT01207440|26557848|FG004|Overall Study|Reason Not Specified|4|||
13317495|NCT01207440|26557849|FG005|Overall Study|Reason Not Specified|3|||
13317496|NCT01207440|26557850|FG006|Overall Study|Reason Not Specified|0|||
13317497|NCT01207427|26557868|FG000|Double-blind Treatment Period|Adverse Event|0|||
13317498|NCT01207427|26557869|FG001|Double-blind Treatment Period|Adverse Event|1|||
13317499|NCT01207427|26557870|FG002|Double-blind Treatment Period|Adverse Event|0|||
13317500|NCT01207427|26557868|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
13317501|NCT01207427|26557869|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
13317502|NCT01207427|26557870|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
13317503|NCT01207427|26557868|FG000|Double-blind Treatment Period|Protocol Violation|2|||
13317504|NCT01207427|26557869|FG001|Double-blind Treatment Period|Protocol Violation|1|||
13317505|NCT01207427|26557870|FG002|Double-blind Treatment Period|Protocol Violation|1|||
13317506|NCT01207427|26557868|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
13317507|NCT01207427|26557869|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
13317508|NCT01207427|26557870|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
13317509|NCT01207414|26557893|FG000|Overall Study|Adverse Event|25|||
13317510|NCT01207414|26557894|FG001|Overall Study|Adverse Event|39|||
13317511|NCT01207414|26557893|FG000|Overall Study|Abnormal test procedure results|0|||
13317512|NCT01207414|26557894|FG001|Overall Study|Abnormal test procedure results|1|||
13317513|NCT01207414|26557893|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
13317514|NCT01207414|26557894|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
13317515|NCT01207414|26557893|FG000|Overall Study|Patient withdrew consent|14|||
13317516|NCT01207414|26557894|FG001|Overall Study|Patient withdrew consent|11|||
13317517|NCT01207414|26557893|FG000|Overall Study|Lost to Follow-up|15|||
13317518|NCT01207414|26557894|FG001|Overall Study|Lost to Follow-up|17|||
13317519|NCT01207414|26557893|FG000|Overall Study|Administrative problems|1|||
13317520|NCT01207414|26557894|FG001|Overall Study|Administrative problems|1|||
13317521|NCT01207414|26557893|FG000|Overall Study|Protocol deviation|12|||
13317522|NCT01207414|26557894|FG001|Overall Study|Protocol deviation|9|||
13317523|NCT01207414|26557893|FG000|Overall Study|Randomized in error|1|||
13317524|NCT01207414|26557894|FG001|Overall Study|Randomized in error|0|||
13317525|NCT01207388|26557918|FG000|Overall Study|Death|67|||
13317526|NCT01207388|26557918|FG000|Overall Study|Withdrawal by Subject|1|||
13317527|NCT01207219|26557948|FG000|Overall Study|changed diagnosis during study period|5|||
13317528|NCT01207219|26557949|FG001|Overall Study|changed diagnosis during study period|3|||
13317529|NCT01207219|26557950|FG002|Overall Study|changed diagnosis during study period|1|||
13317530|NCT01207219|26557948|FG000|Overall Study|Lost to Follow-up|6|||
13317531|NCT01207219|26557949|FG001|Overall Study|Lost to Follow-up|8|||
13317532|NCT01207219|26557950|FG002|Overall Study|Lost to Follow-up|6|||
13317533|NCT01207102|26557957|FG000|Overall Study|Withdrawal by Subject|5|||
13317534|NCT01207102|26557957|FG000|Overall Study|Adverse Event|2|||
13122143|NCT02969018|25946167|FG006|Overall Study|Adverse Event|2|||
13317535|NCT01207102|26557957|FG000|Overall Study|progression|2|||
13317536|NCT01207102|26557957|FG000|Overall Study|Withdrawal by Treating Physician|1|||
13317537|NCT01206816|26558025|FG000|Overall Study|Protocol Violation|0|||
13317538|NCT01206816|26558026|FG001|Overall Study|Protocol Violation|0|||
13317539|NCT01206816|26558027|FG002|Overall Study|Protocol Violation|1|||
13317540|NCT01206816|26558028|FG003|Overall Study|Protocol Violation|0|||
13317541|NCT01206816|26558029|FG004|Overall Study|Protocol Violation|0|||
13317542|NCT01206816|26558030|FG005|Overall Study|Protocol Violation|0|||
13317543|NCT01206816|26558031|FG006|Overall Study|Protocol Violation|0|||
13317544|NCT01206816|26558025|FG000|Overall Study|Withdrawal by Subject|0|||
13317545|NCT01206816|26558026|FG001|Overall Study|Withdrawal by Subject|0|||
13317546|NCT01206816|26558027|FG002|Overall Study|Withdrawal by Subject|1|||
13317547|NCT01206816|26558028|FG003|Overall Study|Withdrawal by Subject|0|||
13317548|NCT01206816|26558029|FG004|Overall Study|Withdrawal by Subject|0|||
13317549|NCT01206816|26558030|FG005|Overall Study|Withdrawal by Subject|0|||
13317550|NCT01206816|26558031|FG006|Overall Study|Withdrawal by Subject|0|||
13317551|NCT01206816|26558025|FG000|Overall Study|Progressive disease|3|||
13317552|NCT01206816|26558026|FG001|Overall Study|Progressive disease|3|||
13317553|NCT01206816|26558027|FG002|Overall Study|Progressive disease|13|||
13317554|NCT01206816|26558028|FG003|Overall Study|Progressive disease|3|||
13317555|NCT01206816|26558029|FG004|Overall Study|Progressive disease|3|||
13317556|NCT01206816|26558030|FG005|Overall Study|Progressive disease|16|||
13317557|NCT01206816|26558031|FG006|Overall Study|Progressive disease|3|||
13317558|NCT01206816|26558025|FG000|Overall Study|Other AE|0|||
13317559|NCT01206816|26558026|FG001|Overall Study|Other AE|0|||
13317560|NCT01206816|26558027|FG002|Overall Study|Other AE|4|||
13317561|NCT01206816|26558028|FG003|Overall Study|Other AE|0|||
13317562|NCT01206816|26558029|FG004|Overall Study|Other AE|0|||
13317563|NCT01206816|26558030|FG005|Overall Study|Other AE|3|||
13317564|NCT01206816|26558031|FG006|Overall Study|Other AE|2|||
13317565|NCT01206816|26558025|FG000|Overall Study|other than stated above|0|||
13317566|NCT01206816|26558026|FG001|Overall Study|other than stated above|0|||
13317567|NCT01206816|26558027|FG002|Overall Study|other than stated above|1|||
13317568|NCT01206816|26558028|FG003|Overall Study|other than stated above|0|||
13317569|NCT01206816|26558029|FG004|Overall Study|other than stated above|0|||
13317570|NCT01206816|26558030|FG005|Overall Study|other than stated above|0|||
13317571|NCT01206816|26558031|FG006|Overall Study|other than stated above|1|||
13317572|NCT01206777|26558039|FG000|Overall Study|Death|1|||
13317573|NCT01206777|26558039|FG000|Overall Study|Adverse Event|1|||
13317574|NCT01206764|26558049|FG000|Overall Study|Adverse Event|20|||
13317575|NCT01206764|26558049|FG000|Overall Study|Abnormal laboratory value|2|||
13317576|NCT01206764|26558049|FG000|Overall Study|Abnormal test procedure result|1|||
13317577|NCT01206764|26558049|FG000|Overall Study|Patient withdrew consent|5|||
13317578|NCT01206764|26558049|FG000|Overall Study|Lost to Follow-up|6|||
13317579|NCT01206764|26558049|FG000|Overall Study|Death|11|||
13317580|NCT01206764|26558049|FG000|Overall Study|New cancer therapy|2|||
13317581|NCT01206764|26558049|FG000|Overall Study|Disease progression|88|||
13317582|NCT01206764|26558049|FG000|Overall Study|Protocol deviation|3|||
13317583|NCT01206582|26558082|FG000|Overall Study|Withdrew prior to study|1|||
13317584|NCT01206582|26558083|FG001|Overall Study|Withdrew prior to study|0|||
13317585|NCT01206582|26558082|FG000|Overall Study|Discontinued intervention before week 8|1|||
13317586|NCT01206582|26558083|FG001|Overall Study|Discontinued intervention before week 8|2|||
13317587|NCT01206517|26558131|FG000|Overall Study|Withdrawal by Subject|0|||
13317588|NCT01206517|26558132|FG001|Overall Study|Withdrawal by Subject|0|||
13317589|NCT01206517|26558133|FG002|Overall Study|Withdrawal by Subject|2|||
13317590|NCT01206517|26558134|FG003|Overall Study|Withdrawal by Subject|0|||
13317591|NCT01206517|26558135|FG004|Overall Study|Withdrawal by Subject|1|||
13317592|NCT01206517|26558136|FG005|Overall Study|Withdrawal by Subject|0|||
13317593|NCT01206439|26558142|FG000|Overall Study|subject did not meet inclusion criteria|1|||
13317594|NCT01206322|26558165|FG000|Overall Study|Adverse Event|0|||
13317595|NCT01206322|26558166|FG001|Overall Study|Adverse Event|0|||
13317596|NCT01206322|26558167|FG002|Overall Study|Adverse Event|0|||
13317597|NCT01206322|26558168|FG003|Overall Study|Adverse Event|1|||
13317598|NCT01206166|26558239|FG000|Overall Study|No evaluable data|2|||
13317599|NCT01206166|26558240|FG001|Overall Study|No evaluable data|3|||
13317600|NCT01206140|26558257|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1|||
13317601|NCT01206140|26558258|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0|||
13317602|NCT01206101|26558281|FG000|Overall Study|Adverse Event|1|||
13317603|NCT01206101|26558282|FG001|Overall Study|Adverse Event|0|||
13317604|NCT01206101|26558281|FG000|Overall Study|Physician Decision|0|||
13317605|NCT01206101|26558282|FG001|Overall Study|Physician Decision|1|||
13317606|NCT01206101|26558281|FG000|Overall Study|Unclassified|1|||
13317607|NCT01206101|26558282|FG001|Overall Study|Unclassified|0|||
13317608|NCT01205776|26558477|FG000|Overall Study|Lost to Follow-up|53|||
13317609|NCT01205776|26558478|FG001|Overall Study|Lost to Follow-up|61|||
13317610|NCT01205776|26558477|FG000|Overall Study|Withdrawal by Subject|11|||
13317611|NCT01205776|26558478|FG001|Overall Study|Withdrawal by Subject|34|||
13317612|NCT01205685|26558487|FG000|Overall Study|Disease Progression|10|||
13317613|NCT01205685|26558487|FG000|Overall Study|Withdrawal by Subject|1|||
13317614|NCT01205581|26558570|FG000|Overall Study|Withdrawal by Subject|1|||
13317615|NCT01205581|26558571|FG001|Overall Study|Withdrawal by Subject|0|||
13317616|NCT01205581|26558572|FG002|Overall Study|Withdrawal by Subject|0|||
13317617|NCT01205581|26558573|FG003|Overall Study|Withdrawal by Subject|0|||
13317618|NCT01205581|26558574|FG004|Overall Study|Withdrawal by Subject|0|||
13317619|NCT01205581|26558575|FG005|Overall Study|Withdrawal by Subject|0|||
13317620|NCT01205529|26558581|FG000|Overall Study|Procedure Cancelled|4|||
13317621|NCT01205529|26558581|FG000|Overall Study|Withdrawal by Subject|2|||
13317622|NCT01205529|26558581|FG000|Overall Study|Physician Decision|4|||
13317623|NCT01205529|26558581|FG000|Overall Study|Unstable post op|15|||
13317624|NCT01205529|26558581|FG000|Overall Study|No longer met criteria|30|||
13317625|NCT01205451|26558630|FG000|Overall Study|Lost to Follow-up|1|||
13317626|NCT01205451|26558631|FG001|Overall Study|Lost to Follow-up|1|||
13317627|NCT01205451|26558630|FG000|Overall Study|Withdrawal by Subject|5|||
13317628|NCT01205451|26558631|FG001|Overall Study|Withdrawal by Subject|9|||
13317629|NCT01205438|26558691|FG000|Overall Study|Adverse Event|19|||
13317630|NCT01205438|26558692|FG001|Overall Study|Adverse Event|17|||
13317631|NCT01205438|26558693|FG002|Overall Study|Adverse Event|24|||
13317632|NCT01205438|26558691|FG000|Overall Study|Death|1|||
13317633|NCT01205438|26558692|FG001|Overall Study|Death|1|||
13317634|NCT01205438|26558693|FG002|Overall Study|Death|3|||
13317635|NCT01205438|26558691|FG000|Overall Study|Entry Criteria Not Met|16|||
13317636|NCT01205438|26558692|FG001|Overall Study|Entry Criteria Not Met|15|||
13317637|NCT01205438|26558693|FG002|Overall Study|Entry Criteria Not Met|13|||
13317638|NCT01205438|26558691|FG000|Overall Study|Lack of Efficacy|14|||
13317639|NCT01205438|26558692|FG001|Overall Study|Lack of Efficacy|11|||
13317640|NCT01205438|26558693|FG002|Overall Study|Lack of Efficacy|14|||
13317641|NCT01205438|26558691|FG000|Overall Study|Lost to Follow-up|6|||
13317642|NCT01205438|26558692|FG001|Overall Study|Lost to Follow-up|7|||
13317643|NCT01205438|26558693|FG002|Overall Study|Lost to Follow-up|8|||
13317644|NCT01205438|26558691|FG000|Overall Study|Withdrawal by Subject|19|||
13317645|NCT01205438|26558692|FG001|Overall Study|Withdrawal by Subject|25|||
13317646|NCT01205438|26558693|FG002|Overall Study|Withdrawal by Subject|19|||
13317647|NCT01205438|26558691|FG000|Overall Study|Physician Decision|0|||
13317648|NCT01205438|26558692|FG001|Overall Study|Physician Decision|3|||
13317649|NCT01205438|26558693|FG002|Overall Study|Physician Decision|2|||
13317650|NCT01205438|26558691|FG000|Overall Study|Protocol Violation|2|||
13317651|NCT01205438|26558692|FG001|Overall Study|Protocol Violation|7|||
13317652|NCT01205438|26558693|FG002|Overall Study|Protocol Violation|4|||
13317653|NCT01205438|26558691|FG000|Overall Study|Sponsor Decision|0|||
13317654|NCT01205438|26558692|FG001|Overall Study|Sponsor Decision|1|||
13317655|NCT01205438|26558693|FG002|Overall Study|Sponsor Decision|1|||
13317656|NCT01205269|26558738|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
13317657|NCT01205269|26558739|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
13317658|NCT01205269|26558740|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
13317659|NCT01205269|26558741|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1|||
13317660|NCT01205269|26558742|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
13317661|NCT01205269|26558743|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
13317662|NCT01205230|26558793|FG000|Overall Study|Adverse Event|4|||
13317663|NCT01205230|26558794|FG001|Overall Study|Adverse Event|0|||
13317664|NCT01205230|26558793|FG000|Overall Study|Physician Decision|1|||
13317665|NCT01205230|26558794|FG001|Overall Study|Physician Decision|0|||
13317666|NCT01205165|26558809|FG000|Overall Study|Lost to Follow-up|2|||
13317667|NCT01205152|26558822|FG000|Overall Study|Death|1|||
13317668|NCT01205126|26558845|FG000|Titration Phase|Adverse Event|5|||
13317669|NCT01205126|26558846|FG001|Titration Phase|Adverse Event|3|||
13317670|NCT01205126|26558845|FG000|Titration Phase|Withdrawal by Subject|5|||
13317671|NCT01205126|26558846|FG001|Titration Phase|Withdrawal by Subject|5|||
13317672|NCT01205126|26558845|FG000|Titration Phase|Lost to Follow-up|2|||
13317673|NCT01205126|26558846|FG001|Titration Phase|Lost to Follow-up|2|||
13317674|NCT01205126|26558845|FG000|Titration Phase|No stable titration dose|1|||
13317675|NCT01205126|26558846|FG001|Titration Phase|No stable titration dose|0|||
13317676|NCT01205126|26558845|FG000|Titration Phase|More than maximum dosage required|2|||
13317677|NCT01205126|26558846|FG001|Titration Phase|More than maximum dosage required|3|||
13317678|NCT01205126|26558845|FG000|Titration Phase|Other|8|||
13317679|NCT01205126|26558846|FG001|Titration Phase|Other|6|||
13317680|NCT01205126|26558845|FG000|Between Titration & Maintenance Phase|Other|0|||
13317681|NCT01205126|26558846|FG001|Between Titration & Maintenance Phase|Other|4|||
13317682|NCT01205126|26558845|FG000|Maintenance Phase|Adverse Event|3|||
13317683|NCT01205126|26558846|FG001|Maintenance Phase|Adverse Event|7|||
13317684|NCT01205126|26558845|FG000|Maintenance Phase|Death|4|||
13317685|NCT01205126|26558846|FG001|Maintenance Phase|Death|4|||
13317686|NCT01205126|26558845|FG000|Maintenance Phase|More than the maximum dosage required|5|||
13317687|NCT01205126|26558846|FG001|Maintenance Phase|More than the maximum dosage required|5|||
13317688|NCT01205126|26558845|FG000|Maintenance Phase|Prohibited drugs used|1|||
13317689|NCT01205126|26558846|FG001|Maintenance Phase|Prohibited drugs used|0|||
13317690|NCT01205126|26558845|FG000|Maintenance Phase|Other|11|||
13317691|NCT01205126|26558846|FG001|Maintenance Phase|Other|8|||
13317692|NCT01205126|26558845|FG000|Maintenance Phase|Lost to Follow-up|5|||
13317693|NCT01205126|26558846|FG001|Maintenance Phase|Lost to Follow-up|5|||
13317694|NCT01205126|26558845|FG000|Maintenance Phase|Withdrawal by Subject|8|||
13317695|NCT01205126|26558846|FG001|Maintenance Phase|Withdrawal by Subject|11|||
13373098|NCT00805467|26722688|FG002|Overall Study|Not reported|3|||
13373099|NCT00805467|26722689|FG003|Overall Study|Not reported|7|||
13373100|NCT00805441|26722726|FG000|Overall Study|Adverse Event|5|||
13373101|NCT00805441|26722727|FG001|Overall Study|Adverse Event|2|||
13373102|NCT00805441|26722726|FG000|Overall Study|Lack of Efficacy|0|||
13373103|NCT00805441|26722727|FG001|Overall Study|Lack of Efficacy|2|||
13373104|NCT00805441|26722726|FG000|Overall Study|Protocol Violation|4|||
13373105|NCT00805441|26722727|FG001|Overall Study|Protocol Violation|8|||
13373106|NCT00805441|26722726|FG000|Overall Study|Lost to Follow-up|10|||
13373107|NCT00805441|26722727|FG001|Overall Study|Lost to Follow-up|13|||
13373108|NCT00805441|26722726|FG000|Overall Study|Withdrawal by Subject|15|||
13373109|NCT00805441|26722727|FG001|Overall Study|Withdrawal by Subject|9|||
13373110|NCT00805441|26722726|FG000|Overall Study|Physician Decision|0|||
13373111|NCT00805441|26722727|FG001|Overall Study|Physician Decision|1|||
13373112|NCT00805441|26722726|FG000|Overall Study|Acute Alcohol Withdrawal|0|||
13373113|NCT00805441|26722727|FG001|Overall Study|Acute Alcohol Withdrawal|1|||
13373114|NCT00805389|26722990|FG000|Overall Study|Adverse Event|0|||
13373115|NCT00805389|26722991|FG001|Overall Study|Adverse Event|0|||
13373116|NCT00805389|26722992|FG002|Overall Study|Adverse Event|1|||
13373117|NCT00805389|26722993|FG003|Overall Study|Adverse Event|2|||
13373118|NCT00805389|26722994|FG004|Overall Study|Adverse Event|0|||
13373119|NCT00805389|26722990|FG000|Overall Study|Lost to Follow-up|4|||
13373120|NCT00805389|26722991|FG001|Overall Study|Lost to Follow-up|3|||
13373121|NCT00805389|26722992|FG002|Overall Study|Lost to Follow-up|6|||
13373122|NCT00805389|26722993|FG003|Overall Study|Lost to Follow-up|10|||
13373123|NCT00805389|26722994|FG004|Overall Study|Lost to Follow-up|9|||
13373124|NCT00805389|26722990|FG000|Overall Study|Protocol Violation|0|||
13373125|NCT00805389|26722991|FG001|Overall Study|Protocol Violation|0|||
13373126|NCT00805389|26722992|FG002|Overall Study|Protocol Violation|1|||
13373127|NCT00805389|26722993|FG003|Overall Study|Protocol Violation|0|||
13373128|NCT00805389|26722994|FG004|Overall Study|Protocol Violation|0|||
13373129|NCT00805389|26722990|FG000|Overall Study|Withdrawal by Subject|3|||
13373130|NCT00805389|26722991|FG001|Overall Study|Withdrawal by Subject|2|||
13373131|NCT00805389|26722992|FG002|Overall Study|Withdrawal by Subject|4|||
13373132|NCT00805389|26722993|FG003|Overall Study|Withdrawal by Subject|5|||
13373133|NCT00805389|26722994|FG004|Overall Study|Withdrawal by Subject|4|||
13373134|NCT00805285|26723004|FG000|Overall Study|Lack of Efficacy|1|||
13373135|NCT00805207|26723088|FG000|Overall Study|Protocol Violation|0|||
13373136|NCT00805207|26723089|FG001|Overall Study|Protocol Violation|0|||
13373137|NCT00805207|26723090|FG002|Overall Study|Protocol Violation|1|||
13373138|NCT00805207|26723091|FG003|Overall Study|Protocol Violation|0|||
13373139|NCT00805207|26723092|FG004|Overall Study|Protocol Violation|0|||
13373140|NCT00805207|26723093|FG005|Overall Study|Protocol Violation|0|||
13373141|NCT00805207|26723094|FG006|Overall Study|Protocol Violation|0|||
13373142|NCT00805207|26723095|FG007|Overall Study|Protocol Violation|0|||
13373143|NCT00805207|26723096|FG008|Overall Study|Protocol Violation|0|||
13373144|NCT00805207|26723088|FG000|Overall Study|Physician Decision|0|||
13373145|NCT00805207|26723089|FG001|Overall Study|Physician Decision|1|||
13373146|NCT00805207|26723090|FG002|Overall Study|Physician Decision|0|||
13373147|NCT00805207|26723091|FG003|Overall Study|Physician Decision|0|||
13373148|NCT00805207|26723092|FG004|Overall Study|Physician Decision|0|||
13373149|NCT00805207|26723093|FG005|Overall Study|Physician Decision|1|||
13373150|NCT00805207|26723094|FG006|Overall Study|Physician Decision|0|||
13373151|NCT00805207|26723095|FG007|Overall Study|Physician Decision|0|||
13373152|NCT00805207|26723096|FG008|Overall Study|Physician Decision|0|||
13373153|NCT00805207|26723088|FG000|Overall Study|Withdrawal by Subject|0|||
13373154|NCT00805207|26723089|FG001|Overall Study|Withdrawal by Subject|1|||
13373155|NCT00805207|26723090|FG002|Overall Study|Withdrawal by Subject|0|||
13373156|NCT00805207|26723091|FG003|Overall Study|Withdrawal by Subject|0|||
13373157|NCT00805207|26723092|FG004|Overall Study|Withdrawal by Subject|1|||
13373158|NCT00805207|26723093|FG005|Overall Study|Withdrawal by Subject|2|||
13373159|NCT00805207|26723094|FG006|Overall Study|Withdrawal by Subject|0|||
13373160|NCT00805207|26723095|FG007|Overall Study|Withdrawal by Subject|0|||
13373161|NCT00805207|26723096|FG008|Overall Study|Withdrawal by Subject|0|||
13373162|NCT00805194|26723135|FG000|Overall Study|Progressive disease (modified RECIST)|404|||
13373163|NCT00805194|26723136|FG001|Overall Study|Progressive disease (modified RECIST)|435|||
13373164|NCT00805194|26723135|FG000|Overall Study|Worsening or AE of underlying disease|64|||
13373165|NCT00805194|26723136|FG001|Overall Study|Worsening or AE of underlying disease|70|||
13373166|NCT00805194|26723135|FG000|Overall Study|Other AE|84|||
13373167|NCT00805194|26723136|FG001|Overall Study|Other AE|73|||
13373168|NCT00805194|26723135|FG000|Overall Study|Protocol Violation|9|||
13373169|NCT00805194|26723136|FG001|Overall Study|Protocol Violation|9|||
13373170|NCT00805194|26723135|FG000|Overall Study|Lost to Follow-up|5|||
13373171|NCT00805194|26723136|FG001|Overall Study|Lost to Follow-up|5|||
13317696|NCT01205035|26558867|FG000|Overall Study|Withdrawal by Subject|1|||
13317697|NCT01205035|26558868|FG001|Overall Study|Withdrawal by Subject|0|||
13317698|NCT01205035|26558867|FG000|Overall Study|Physician Decision|1|||
13317699|NCT01205035|26558868|FG001|Overall Study|Physician Decision|0|||
13317700|NCT01204918|26558895|FG000|Overall Study|Withdrawal by Subject|4|||
13317701|NCT01204918|26558896|FG001|Overall Study|Withdrawal by Subject|10|||
13317702|NCT01204918|26558897|FG002|Overall Study|Withdrawal by Subject|5|||
13317703|NCT01204775|26558910|FG000|Overall Study|Poor/non-compliance|0|||
13317704|NCT01204775|26558911|FG001|Overall Study|Poor/non-compliance|1|||
13317705|NCT01204775|26558910|FG000|Overall Study|Withdrawal by Subject|1|||
13317706|NCT01204775|26558911|FG001|Overall Study|Withdrawal by Subject|0|||
13317707|NCT01204710|26558952|FG000|Randomization Treatment|Lost to Follow-up|1|||
13317708|NCT01204710|26558953|FG001|Randomization Treatment|Lost to Follow-up|0|||
13317709|NCT01204710|26558952|FG000|Randomization Treatment|Withdrawal by Subject|6|||
13317710|NCT01204710|26558953|FG001|Randomization Treatment|Withdrawal by Subject|5|||
13317711|NCT01204710|26558952|FG000|Randomization Treatment|Physician Decision|3|||
13317712|NCT01204710|26558953|FG001|Randomization Treatment|Physician Decision|2|||
13317713|NCT01204710|26558952|FG000|Randomization Treatment|Entry criteria not met|0|||
13317714|NCT01204710|26558953|FG001|Randomization Treatment|Entry criteria not met|1|||
13317715|NCT01204710|26558952|FG000|Randomization Treatment|Adverse Event|4|||
13317716|NCT01204710|26558953|FG001|Randomization Treatment|Adverse Event|2|||
13317717|NCT01204710|26558952|FG000|Randomization Treatment|Sponsor Decision|0|||
13317718|NCT01204710|26558953|FG001|Randomization Treatment|Sponsor Decision|1|||
13317719|NCT01204710|26558952|FG000|Randomization Treatment|Worsening of General condition|0|||
13317720|NCT01204710|26558953|FG001|Randomization Treatment|Worsening of General condition|1|||
13317721|NCT01204710|26558952|FG000|Randomization Treatment|Moved and Followed for Survival|0|||
13317722|NCT01204710|26558953|FG001|Randomization Treatment|Moved and Followed for Survival|1|||
13317723|NCT01204710|26558952|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0|||
13317724|NCT01204710|26558953|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1|||
13317725|NCT01204710|26558952|FG000|Optional Olaratumab Monotherapy|Physician Decision|0|||
13317726|NCT01204710|26558953|FG001|Optional Olaratumab Monotherapy|Physician Decision|1|||
13317727|NCT01204710|26558952|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0|||
13317728|NCT01204710|26558953|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1|||
13317729|NCT01204697|26558976|FG000|Overall Study|Death|26|||
13317730|NCT01204697|26558977|FG001|Overall Study|Death|27|||
13317731|NCT01204697|26558976|FG000|Overall Study|Lost to Follow-up|3|||
13317732|NCT01204697|26558977|FG001|Overall Study|Lost to Follow-up|4|||
13317733|NCT01204697|26558976|FG000|Overall Study|Withdrawal by Subject|2|||
13317734|NCT01204697|26558977|FG001|Overall Study|Withdrawal by Subject|4|||
13317735|NCT01204697|26558976|FG000|Overall Study|Randomized, but not treated|0|||
13317736|NCT01204697|26558977|FG001|Overall Study|Randomized, but not treated|1|||
13317737|NCT01204671|26559051|FG000|Overall Study|Adverse Event|4|||
13317738|NCT01204671|26559052|FG001|Overall Study|Adverse Event|3|||
13317739|NCT01204671|26559053|FG002|Overall Study|Adverse Event|3|||
13317740|NCT01204671|26559054|FG003|Overall Study|Adverse Event|3|||
13317741|NCT01204671|26559055|FG004|Overall Study|Adverse Event|1|||
13317742|NCT01204671|26559051|FG000|Overall Study|Withdrawal by Subject|2|||
13317743|NCT01204671|26559052|FG001|Overall Study|Withdrawal by Subject|3|||
13317744|NCT01204671|26559053|FG002|Overall Study|Withdrawal by Subject|4|||
13317745|NCT01204671|26559054|FG003|Overall Study|Withdrawal by Subject|5|||
13317746|NCT01204671|26559055|FG004|Overall Study|Withdrawal by Subject|3|||
13317747|NCT01204671|26559051|FG000|Overall Study|Lost to Follow-up|7|||
13317748|NCT01204671|26559052|FG001|Overall Study|Lost to Follow-up|8|||
13317749|NCT01204671|26559053|FG002|Overall Study|Lost to Follow-up|6|||
13317750|NCT01204671|26559054|FG003|Overall Study|Lost to Follow-up|4|||
13317751|NCT01204671|26559055|FG004|Overall Study|Lost to Follow-up|0|||
13317752|NCT01204671|26559051|FG000|Overall Study|Unknown Completion Status|1|||
13317753|NCT01204671|26559052|FG001|Overall Study|Unknown Completion Status|1|||
13317754|NCT01204671|26559053|FG002|Overall Study|Unknown Completion Status|0|||
13317755|NCT01204671|26559054|FG003|Overall Study|Unknown Completion Status|0|||
13317756|NCT01204671|26559055|FG004|Overall Study|Unknown Completion Status|0|||
13317757|NCT01204671|26559051|FG000|Overall Study|Physician Decision|0|||
13317758|NCT01204671|26559052|FG001|Overall Study|Physician Decision|0|||
13317759|NCT01204671|26559053|FG002|Overall Study|Physician Decision|0|||
13317760|NCT01204671|26559054|FG003|Overall Study|Physician Decision|1|||
13317761|NCT01204671|26559055|FG004|Overall Study|Physician Decision|0|||
13317762|NCT01204658|26559186|FG000|Primary Phase|Adverse Event|0|||
13317763|NCT01204658|26559187|FG001|Primary Phase|Adverse Event|0|||
13317764|NCT01204658|26559188|FG002|Primary Phase|Adverse Event|1|||
13317765|NCT01204658|26559189|FG003|Primary Phase|Adverse Event|0|||
13317766|NCT01204398|26559201|FG000|Overall Study|Adverse Event|1|||
13317767|NCT01204294|26559246|FG000|Overall Study|Adverse Event|2|||
13317768|NCT01204294|26559247|FG001|Overall Study|Adverse Event|6|||
13317769|NCT01204294|26559248|FG002|Overall Study|Adverse Event|0|||
13317770|NCT01204294|26559249|FG003|Overall Study|Adverse Event|7|||
13317771|NCT01204294|26559250|FG004|Overall Study|Adverse Event|1|||
13317772|NCT01204294|26559251|FG005|Overall Study|Adverse Event|4|||
13317773|NCT01204294|26559252|FG006|Overall Study|Adverse Event|0|||
13317774|NCT01204294|26559246|FG000|Overall Study|Protocol Violation|1|||
13317775|NCT01204294|26559247|FG001|Overall Study|Protocol Violation|0|||
13317776|NCT01204294|26559248|FG002|Overall Study|Protocol Violation|2|||
13317777|NCT01204294|26559249|FG003|Overall Study|Protocol Violation|1|||
13317778|NCT01204294|26559250|FG004|Overall Study|Protocol Violation|0|||
13317779|NCT01204294|26559251|FG005|Overall Study|Protocol Violation|0|||
13317780|NCT01204294|26559252|FG006|Overall Study|Protocol Violation|0|||
13317781|NCT01204294|26559246|FG000|Overall Study|Withdrawal by Subject|0|||
13317782|NCT01204294|26559247|FG001|Overall Study|Withdrawal by Subject|2|||
13317783|NCT01204294|26559248|FG002|Overall Study|Withdrawal by Subject|2|||
13317784|NCT01204294|26559249|FG003|Overall Study|Withdrawal by Subject|1|||
13317785|NCT01204294|26559250|FG004|Overall Study|Withdrawal by Subject|1|||
13317786|NCT01204294|26559251|FG005|Overall Study|Withdrawal by Subject|1|||
13317787|NCT01204294|26559252|FG006|Overall Study|Withdrawal by Subject|2|||
13317788|NCT01204294|26559246|FG000|Overall Study|Lack of Efficacy|0|||
13317789|NCT01204294|26559247|FG001|Overall Study|Lack of Efficacy|0|||
13317790|NCT01204294|26559248|FG002|Overall Study|Lack of Efficacy|0|||
13317791|NCT01204294|26559249|FG003|Overall Study|Lack of Efficacy|2|||
13317792|NCT01204294|26559250|FG004|Overall Study|Lack of Efficacy|0|||
13317793|NCT01204294|26559251|FG005|Overall Study|Lack of Efficacy|0|||
13317794|NCT01204294|26559252|FG006|Overall Study|Lack of Efficacy|0|||
13317795|NCT01204294|26559246|FG000|Overall Study|Other (house moving)|0|||
13317796|NCT01204294|26559247|FG001|Overall Study|Other (house moving)|0|||
13317797|NCT01204294|26559248|FG002|Overall Study|Other (house moving)|1|||
13317798|NCT01204294|26559249|FG003|Overall Study|Other (house moving)|0|||
13317799|NCT01204294|26559250|FG004|Overall Study|Other (house moving)|0|||
13317800|NCT01204294|26559251|FG005|Overall Study|Other (house moving)|0|||
13317801|NCT01204294|26559252|FG006|Overall Study|Other (house moving)|0|||
13317802|NCT01203956|26559262|FG000|Second Two-week Period|Non-compliant: no evaluable results|5|||
13317803|NCT01203956|26559263|FG001|Second Two-week Period|Non-compliant: no evaluable results|6|||
13317804|NCT01203930|26559292|FG000|Overall Study|Disease Progression|0|||
13317805|NCT01203930|26559293|FG001|Overall Study|Disease Progression|4|||
13317806|NCT01203930|26559292|FG000|Overall Study|Death|3|||
13317807|NCT01203930|26559293|FG001|Overall Study|Death|1|||
13317808|NCT01203930|26559292|FG000|Overall Study|Withdrew Consent|1|||
13317809|NCT01203930|26559293|FG001|Overall Study|Withdrew Consent|10|||
13317810|NCT01203930|26559292|FG000|Overall Study|Investigator Request|0|||
13317811|NCT01203930|26559293|FG001|Overall Study|Investigator Request|8|||
13317812|NCT01203930|26559292|FG000|Overall Study|Study Terminated by Sponsor|0|||
13317813|NCT01203930|26559293|FG001|Overall Study|Study Terminated by Sponsor|12|||
13317814|NCT01203930|26559292|FG000|Overall Study|Poor tolerance of study drug|0|||
13122144|NCT02969018|25946168|FG007|Overall Study|Adverse Event|0|||
13317815|NCT01203930|26559293|FG001|Overall Study|Poor tolerance of study drug|1|||
13317816|NCT01203930|26559292|FG000|Overall Study|Adverse Event|17|||
13317817|NCT01203930|26559293|FG001|Overall Study|Adverse Event|5|||
13317818|NCT01203917|26559305|FG000|Overall Study|Death|29|||
13317819|NCT01203917|26559305|FG000|Overall Study|Lost to Follow-up|2|||
13317820|NCT01203917|26559305|FG000|Overall Study|Withdrawal by Subject|3|||
13317821|NCT01203917|26559305|FG000|Overall Study|Due to objective disease progression|1|||
13317822|NCT01203917|26559305|FG000|Overall Study|Due to EGFR M+I patient|1|||
13317823|NCT01203878|26559326|FG000|Overall Study|Withdrawal by Subject|0|||
13317824|NCT01203878|26559327|FG001|Overall Study|Withdrawal by Subject|0|||
13317825|NCT01203878|26559328|FG002|Overall Study|Withdrawal by Subject|1|||
13317826|NCT01203878|26559326|FG000|Overall Study|Adverse Event|0|||
13122145|NCT02969018|25946161|FG000|Overall Study|Lack of Efficacy|0|||
13122146|NCT02969018|25946162|FG001|Overall Study|Lack of Efficacy|1|||
13122147|NCT02969018|25946163|FG002|Overall Study|Lack of Efficacy|0|||
13317827|NCT01203878|26559327|FG001|Overall Study|Adverse Event|0|||
13317828|NCT01203878|26559328|FG002|Overall Study|Adverse Event|2|||
13317829|NCT01203852|26559337|FG000|Metoprolol 8 Weeks|Physician Decision|470|||
13317830|NCT01203852|26559337|FG000|Washout 2 Weeks|Physician Decision|46|||
13317831|NCT01203787|26559362|FG000|Overall Study|Death|12|||
13317832|NCT01203787|26559363|FG001|Overall Study|Death|10|||
13317833|NCT01203787|26559362|FG000|Overall Study|Withdrawal by Subject|6|||
13317834|NCT01203787|26559363|FG001|Overall Study|Withdrawal by Subject|2|||
13317835|NCT01203787|26559362|FG000|Overall Study|Lost to Follow-up|2|||
13317836|NCT01203787|26559363|FG001|Overall Study|Lost to Follow-up|0|||
13317837|NCT01203787|26559362|FG000|Overall Study|Adverse Event|11|||
13317838|NCT01203787|26559363|FG001|Overall Study|Adverse Event|15|||
13317839|NCT01203098|26559384|FG000|Overall Study|Adverse Event|3|||
13317840|NCT01203098|26559385|FG001|Overall Study|Adverse Event|1|||
13122148|NCT02969018|25946164|FG003|Overall Study|Lack of Efficacy|0|||
13317841|NCT01203098|26559386|FG002|Overall Study|Adverse Event|7|||
13317842|NCT01203098|26559384|FG000|Overall Study|Lost to Follow-up|0|||
13317843|NCT01203098|26559385|FG001|Overall Study|Lost to Follow-up|0|||
13317844|NCT01203098|26559386|FG002|Overall Study|Lost to Follow-up|1|||
13317845|NCT01203098|26559384|FG000|Overall Study|Physician Decision|2|||
13317846|NCT01203098|26559385|FG001|Overall Study|Physician Decision|2|||
13317847|NCT01203098|26559386|FG002|Overall Study|Physician Decision|0|||
13317848|NCT01203098|26559384|FG000|Overall Study|Withdrawal by Subject|1|||
13317849|NCT01203098|26559385|FG001|Overall Study|Withdrawal by Subject|1|||
13317850|NCT01203098|26559386|FG002|Overall Study|Withdrawal by Subject|3|||
13317851|NCT01203072|26559419|FG000|Overall Study|Adverse Event|5|||
13317852|NCT01203072|26559420|FG001|Overall Study|Adverse Event|3|||
13317853|NCT01203072|26559421|FG002|Overall Study|Adverse Event|2|||
13317854|NCT01203072|26559422|FG003|Overall Study|Adverse Event|4|||
13317855|NCT01203072|26559423|FG004|Overall Study|Adverse Event|2|||
13317856|NCT01203072|26559419|FG000|Overall Study|Lack of Efficacy|1|||
13317857|NCT01203072|26559420|FG001|Overall Study|Lack of Efficacy|0|||
13317858|NCT01203072|26559421|FG002|Overall Study|Lack of Efficacy|0|||
13317859|NCT01203072|26559422|FG003|Overall Study|Lack of Efficacy|0|||
13317860|NCT01203072|26559423|FG004|Overall Study|Lack of Efficacy|0|||
13317861|NCT01203072|26559419|FG000|Overall Study|Lost to Follow-up|0|||
13317862|NCT01203072|26559420|FG001|Overall Study|Lost to Follow-up|1|||
13317863|NCT01203072|26559421|FG002|Overall Study|Lost to Follow-up|0|||
13317864|NCT01203072|26559422|FG003|Overall Study|Lost to Follow-up|0|||
13317865|NCT01203072|26559423|FG004|Overall Study|Lost to Follow-up|0|||
13317866|NCT01203072|26559419|FG000|Overall Study|Protocol Violation|2|||
13317867|NCT01203072|26559420|FG001|Overall Study|Protocol Violation|0|||
13317868|NCT01203072|26559421|FG002|Overall Study|Protocol Violation|0|||
13317869|NCT01203072|26559422|FG003|Overall Study|Protocol Violation|0|||
13317870|NCT01203072|26559423|FG004|Overall Study|Protocol Violation|1|||
13317871|NCT01203072|26559419|FG000|Overall Study|Withdrawal by Subject|2|||
13317872|NCT01203072|26559420|FG001|Overall Study|Withdrawal by Subject|2|||
13317873|NCT01203072|26559421|FG002|Overall Study|Withdrawal by Subject|1|||
13317874|NCT01203072|26559422|FG003|Overall Study|Withdrawal by Subject|2|||
13317875|NCT01203072|26559423|FG004|Overall Study|Withdrawal by Subject|3|||
13317876|NCT01202955|26559440|FG000|Period 1: 10 Days|Withdrawal by Subject|0|||
13317877|NCT01202955|26559441|FG001|Period 1: 10 Days|Withdrawal by Subject|2|||
13317878|NCT01202903|26559472|FG000|Overall Study|Administrative Probelms|1|||
13317879|NCT01202903|26559473|FG001|Overall Study|Administrative Probelms|4|||
13317880|NCT01202903|26559472|FG000|Overall Study|Protocol Violation|0|||
13317881|NCT01202903|26559473|FG001|Overall Study|Protocol Violation|1|||
13317882|NCT01202903|26559472|FG000|Overall Study|Death|1|||
13317883|NCT01202903|26559473|FG001|Overall Study|Death|0|||
13317884|NCT01202903|26559472|FG000|Overall Study|Lost to Follow-up|1|||
13317885|NCT01202903|26559473|FG001|Overall Study|Lost to Follow-up|1|||
13317886|NCT01202903|26559472|FG000|Overall Study|Lack of Efficacy|1|||
13317887|NCT01202903|26559473|FG001|Overall Study|Lack of Efficacy|3|||
13317888|NCT01202903|26559472|FG000|Overall Study|Adverse Event|3|||
13317889|NCT01202903|26559473|FG001|Overall Study|Adverse Event|3|||
13317890|NCT01202903|26559472|FG000|Overall Study|Withdrawal by Subject|4|||
13317891|NCT01202903|26559473|FG001|Overall Study|Withdrawal by Subject|4|||
13317892|NCT01202877|26559494|FG000|Overall Study|Disease Progression|0|||
13317893|NCT01202877|26559495|FG001|Overall Study|Disease Progression|1|||
13317894|NCT01202877|26559496|FG002|Overall Study|Disease Progression|2|||
13317895|NCT01202877|26559494|FG000|Overall Study|Adverse Event|0|||
13317896|NCT01202877|26559495|FG001|Overall Study|Adverse Event|0|||
13317897|NCT01202877|26559496|FG002|Overall Study|Adverse Event|2|||
13317898|NCT01202877|26559494|FG000|Overall Study|Withdrawal by Subject|0|||
13317899|NCT01202877|26559495|FG001|Overall Study|Withdrawal by Subject|0|||
13317900|NCT01202877|26559496|FG002|Overall Study|Withdrawal by Subject|1|||
13317901|NCT01202877|26559494|FG000|Overall Study|Death|0|||
13317902|NCT01202877|26559495|FG001|Overall Study|Death|0|||
13317903|NCT01202877|26559496|FG002|Overall Study|Death|1|||
13317904|NCT01202773|26559580|FG000|Overall Study|Adverse Event|4|||
13317905|NCT01202773|26559581|FG001|Overall Study|Adverse Event|5|||
13317906|NCT01202773|26559582|FG002|Overall Study|Adverse Event|5|||
13317907|NCT01202773|26559580|FG000|Overall Study|Lack of Efficacy|5|||
13317908|NCT01202773|26559581|FG001|Overall Study|Lack of Efficacy|4|||
13317909|NCT01202773|26559582|FG002|Overall Study|Lack of Efficacy|9|||
13317910|NCT01202773|26559580|FG000|Overall Study|Entry Criteria Not Met|2|||
13317911|NCT01202773|26559581|FG001|Overall Study|Entry Criteria Not Met|0|||
13317912|NCT01202773|26559582|FG002|Overall Study|Entry Criteria Not Met|1|||
13317913|NCT01202773|26559580|FG000|Overall Study|Lost to Follow-up|1|||
13317914|NCT01202773|26559581|FG001|Overall Study|Lost to Follow-up|2|||
13317915|NCT01202773|26559582|FG002|Overall Study|Lost to Follow-up|2|||
13317916|NCT01202773|26559580|FG000|Overall Study|Withdrawal by Subject|13|||
13317917|NCT01202773|26559581|FG001|Overall Study|Withdrawal by Subject|6|||
13317918|NCT01202773|26559582|FG002|Overall Study|Withdrawal by Subject|5|||
13317919|NCT01202773|26559580|FG000|Overall Study|Physician Decision|2|||
13317920|NCT01202773|26559581|FG001|Overall Study|Physician Decision|0|||
13317921|NCT01202773|26559582|FG002|Overall Study|Physician Decision|0|||
13317922|NCT01202773|26559580|FG000|Overall Study|Protocol Violation|11|||
13317923|NCT01202773|26559581|FG001|Overall Study|Protocol Violation|6|||
13317924|NCT01202773|26559582|FG002|Overall Study|Protocol Violation|10|||
13317925|NCT01202773|26559580|FG000|Overall Study|Sponsor Decision|19|||
13317926|NCT01202773|26559581|FG001|Overall Study|Sponsor Decision|20|||
13317927|NCT01202773|26559582|FG002|Overall Study|Sponsor Decision|23|||
13317928|NCT01202760|26559660|FG000|Overall Study|Entry Criteria Not Met|0|||
13317929|NCT01202760|26559661|FG001|Overall Study|Entry Criteria Not Met|3|||
13317930|NCT01202760|26559662|FG002|Overall Study|Entry Criteria Not Met|1|||
13317931|NCT01202760|26559660|FG000|Overall Study|Adverse Event|11|||
13317932|NCT01202760|26559661|FG001|Overall Study|Adverse Event|9|||
13317933|NCT01202760|26559662|FG002|Overall Study|Adverse Event|10|||
13317934|NCT01202760|26559660|FG000|Overall Study|Death|2|||
13317935|NCT01202760|26559661|FG001|Overall Study|Death|1|||
13317936|NCT01202760|26559662|FG002|Overall Study|Death|0|||
13317937|NCT01202760|26559660|FG000|Overall Study|Lack of Efficacy|6|||
13317938|NCT01202760|26559661|FG001|Overall Study|Lack of Efficacy|8|||
13317939|NCT01202760|26559662|FG002|Overall Study|Lack of Efficacy|7|||
13317940|NCT01202760|26559660|FG000|Overall Study|Lost to Follow-up|0|||
13317941|NCT01202760|26559661|FG001|Overall Study|Lost to Follow-up|2|||
13317942|NCT01202760|26559662|FG002|Overall Study|Lost to Follow-up|1|||
13317943|NCT01202760|26559660|FG000|Overall Study|Parent / Caregiver Decision|0|||
13317944|NCT01202760|26559661|FG001|Overall Study|Parent / Caregiver Decision|1|||
13317945|NCT01202760|26559662|FG002|Overall Study|Parent / Caregiver Decision|0|||
13317946|NCT01202760|26559660|FG000|Overall Study|Withdrawal by Subject|17|||
13317947|NCT01202760|26559661|FG001|Overall Study|Withdrawal by Subject|18|||
13317948|NCT01202760|26559662|FG002|Overall Study|Withdrawal by Subject|14|||
13317949|NCT01202760|26559660|FG000|Overall Study|Physician Decision|0|||
13317950|NCT01202760|26559661|FG001|Overall Study|Physician Decision|1|||
13317951|NCT01202760|26559662|FG002|Overall Study|Physician Decision|0|||
13317952|NCT01202760|26559660|FG000|Overall Study|Protocol Violation|7|||
13317953|NCT01202760|26559661|FG001|Overall Study|Protocol Violation|5|||
13317954|NCT01202760|26559662|FG002|Overall Study|Protocol Violation|2|||
13317955|NCT01202760|26559660|FG000|Overall Study|Sponsor Decision|4|||
13317956|NCT01202760|26559661|FG001|Overall Study|Sponsor Decision|4|||
13317957|NCT01202760|26559662|FG002|Overall Study|Sponsor Decision|0|||
13317958|NCT01202747|26559668|FG000|Overall Study|Withdrawal by Subject|1|||
13317959|NCT01202591|26559701|FG000|Overall Study|Adverse Event|2|||
13317960|NCT01202591|26559702|FG001|Overall Study|Adverse Event|1|||
13317961|NCT01202591|26559703|FG002|Overall Study|Adverse Event|4|||
13317962|NCT01202591|26559704|FG003|Overall Study|Adverse Event|4|||
13317963|NCT01202591|26559705|FG004|Overall Study|Adverse Event|0|||
13317964|NCT01202591|26559706|FG005|Overall Study|Adverse Event|0|||
13317965|NCT01202591|26559701|FG000|Overall Study|Other reason as per investigator|3|||
13317966|NCT01202591|26559702|FG001|Overall Study|Other reason as per investigator|4|||
13317967|NCT01202591|26559703|FG002|Overall Study|Other reason as per investigator|7|||
13317968|NCT01202591|26559704|FG003|Overall Study|Other reason as per investigator|3|||
13317969|NCT01202591|26559705|FG004|Overall Study|Other reason as per investigator|1|||
13317970|NCT01202591|26559706|FG005|Overall Study|Other reason as per investigator|3|||
13317971|NCT01202591|26559701|FG000|Overall Study|Withdrawal by Subject|0|||
13317972|NCT01202591|26559702|FG001|Overall Study|Withdrawal by Subject|0|||
13317973|NCT01202591|26559703|FG002|Overall Study|Withdrawal by Subject|0|||
13317974|NCT01202591|26559704|FG003|Overall Study|Withdrawal by Subject|0|||
13317975|NCT01202591|26559705|FG004|Overall Study|Withdrawal by Subject|2|||
13317976|NCT01202591|26559706|FG005|Overall Study|Withdrawal by Subject|1|||
13317977|NCT01202591|26559701|FG000|Overall Study|Objective Disease Progression|0|||
13317978|NCT01202591|26559702|FG001|Overall Study|Objective Disease Progression|0|||
13317979|NCT01202591|26559703|FG002|Overall Study|Objective Disease Progression|0|||
13317980|NCT01202591|26559704|FG003|Overall Study|Objective Disease Progression|0|||
13317981|NCT01202591|26559705|FG004|Overall Study|Objective Disease Progression|2|||
13317982|NCT01202591|26559706|FG005|Overall Study|Objective Disease Progression|0|||
13317983|NCT01202409|26559713|FG000|Overall Study|Adverse Event|1|||
13317984|NCT01202409|26559713|FG000|Overall Study|Ineligible - KRAS mutants|7|||
13317985|NCT01202279|26559728|FG000|Overall Study|Adverse Event|8|||
13317986|NCT01202279|26559729|FG001|Overall Study|Adverse Event|6|||
13317987|NCT01202279|26559728|FG000|Overall Study|Withdrawal by Subject|13|||
13317988|NCT01202279|26559729|FG001|Overall Study|Withdrawal by Subject|10|||
13317989|NCT01202279|26559728|FG000|Overall Study|Physician Decision|0|||
13317990|NCT01202279|26559729|FG001|Overall Study|Physician Decision|1|||
13317991|NCT01202279|26559728|FG000|Overall Study|Lost to Follow-up|10|||
13317992|NCT01202279|26559729|FG001|Overall Study|Lost to Follow-up|7|||
13317993|NCT01202279|26559728|FG000|Overall Study|Protocol Violation|1|||
13317994|NCT01202279|26559729|FG001|Overall Study|Protocol Violation|1|||
13317995|NCT01202279|26559728|FG000|Overall Study|study compliance|5|||
13317996|NCT01202279|26559729|FG001|Overall Study|study compliance|2|||
13317997|NCT01202227|26559750|FG000|Overall Study|Adverse Event|16|||
13317998|NCT01202227|26559750|FG000|Overall Study|Withdrawal by Subject|2|||
13317999|NCT01202227|26559750|FG000|Overall Study|Lack of Efficacy|1|||
13318000|NCT01202188|26559872|FG000|Overall Study|Protocol deviation|14|||
13318001|NCT01202188|26559873|FG001|Overall Study|Protocol deviation|8|||
13318002|NCT01202188|26559874|FG002|Overall Study|Protocol deviation|12|||
13318003|NCT01202188|26559875|FG003|Overall Study|Protocol deviation|10|||
13318004|NCT01202188|26559876|FG004|Overall Study|Protocol deviation|11|||
13318005|NCT01202188|26559872|FG000|Overall Study|Subject withdrew consent|12|||
13318006|NCT01202188|26559873|FG001|Overall Study|Subject withdrew consent|13|||
13318007|NCT01202188|26559874|FG002|Overall Study|Subject withdrew consent|22|||
13318008|NCT01202188|26559875|FG003|Overall Study|Subject withdrew consent|11|||
13318009|NCT01202188|26559876|FG004|Overall Study|Subject withdrew consent|13|||
13318010|NCT01202188|26559872|FG000|Overall Study|Adverse Event|5|||
13318011|NCT01202188|26559873|FG001|Overall Study|Adverse Event|23|||
13318012|NCT01202188|26559874|FG002|Overall Study|Adverse Event|13|||
13318013|NCT01202188|26559875|FG003|Overall Study|Adverse Event|10|||
13318014|NCT01202188|26559876|FG004|Overall Study|Adverse Event|10|||
13318015|NCT01202188|26559872|FG000|Overall Study|Administrative problems|3|||
13318016|NCT01202188|26559873|FG001|Overall Study|Administrative problems|2|||
13318017|NCT01202188|26559874|FG002|Overall Study|Administrative problems|1|||
13318018|NCT01202188|26559875|FG003|Overall Study|Administrative problems|1|||
13318019|NCT01202188|26559876|FG004|Overall Study|Administrative problems|2|||
13318020|NCT01202188|26559872|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
13318021|NCT01202188|26559873|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
13318022|NCT01202188|26559874|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
13318023|NCT01202188|26559875|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
13318024|NCT01202188|26559876|FG004|Overall Study|Unsatisfactory therapeutic effect|8|||
13318025|NCT01202188|26559872|FG000|Overall Study|Lost to Follow-up|1|||
13318026|NCT01202188|26559873|FG001|Overall Study|Lost to Follow-up|1|||
13318027|NCT01202188|26559874|FG002|Overall Study|Lost to Follow-up|0|||
13318028|NCT01202188|26559875|FG003|Overall Study|Lost to Follow-up|4|||
13318029|NCT01202188|26559876|FG004|Overall Study|Lost to Follow-up|1|||
13318030|NCT01202188|26559872|FG000|Overall Study|Death|1|||
13318031|NCT01202188|26559873|FG001|Overall Study|Death|1|||
13318032|NCT01202188|26559874|FG002|Overall Study|Death|1|||
13318033|NCT01202188|26559875|FG003|Overall Study|Death|1|||
13318034|NCT01202188|26559876|FG004|Overall Study|Death|0|||
13318035|NCT01202188|26559872|FG000|Overall Study|Abnormal test procedure result (s)|0|||
13318036|NCT01202188|26559873|FG001|Overall Study|Abnormal test procedure result (s)|0|||
13318037|NCT01202188|26559874|FG002|Overall Study|Abnormal test procedure result (s)|2|||
13318038|NCT01202188|26559875|FG003|Overall Study|Abnormal test procedure result (s)|0|||
13318039|NCT01202188|26559876|FG004|Overall Study|Abnormal test procedure result (s)|0|||
13318040|NCT01202175|26559909|FG000|Overall Study|Lost to Follow-up|2|||
13318041|NCT01202175|26559909|FG000|Overall Study|Withdrawal by Subject|1|||
13318042|NCT01202175|26559909|FG000|Overall Study|Adverse Event|2|||
13318043|NCT01201967|26559938|FG000|Overall Study|Lost to Follow-up|6|||
13318044|NCT01201967|26559939|FG001|Overall Study|Lost to Follow-up|5|||
13318045|NCT01201915|26559960|FG000|Overall Study|Adverse Event|2|||
13318046|NCT01201915|26559961|FG001|Overall Study|Adverse Event|1|||
13318047|NCT01201915|26559962|FG002|Overall Study|Adverse Event|1|||
13318048|NCT01201915|26559960|FG000|Overall Study|Lost to Follow-up|0|||
13318049|NCT01201915|26559961|FG001|Overall Study|Lost to Follow-up|4|||
13318050|NCT01201915|26559962|FG002|Overall Study|Lost to Follow-up|0|||
13318051|NCT01201915|26559960|FG000|Overall Study|Physician Decision|3|||
13318052|NCT01201915|26559961|FG001|Overall Study|Physician Decision|0|||
13318053|NCT01201915|26559962|FG002|Overall Study|Physician Decision|0|||
13318054|NCT01201915|26559960|FG000|Overall Study|Subject Decision|3|||
13318055|NCT01201915|26559961|FG001|Overall Study|Subject Decision|3|||
13318056|NCT01201915|26559962|FG002|Overall Study|Subject Decision|5|||
13318057|NCT01201915|26559960|FG000|Overall Study|Target Lesion Progression|0|||
13318058|NCT01201915|26559961|FG001|Overall Study|Target Lesion Progression|3|||
13318059|NCT01201915|26559962|FG002|Overall Study|Target Lesion Progression|0|||
13318060|NCT01201850|26559972|FG000|Overall Study|Tumor progression|4|||
13318061|NCT01201811|26559994|FG000|Overall Study|Adverse Event|6|||
13318062|NCT01201811|26559994|FG000|Overall Study|Disease progression|3|||
13318063|NCT01201811|26559994|FG000|Overall Study|Withdrawal by Subject|3|||
13318064|NCT01201811|26559994|FG000|Overall Study|Death|4|||
13318065|NCT01201811|26559994|FG000|Overall Study|Treatment Failure|2|||
13318066|NCT01201811|26559994|FG000|Overall Study|Physician Decision|1|||
13318067|NCT01201798|26560025|FG000|Overall Study|Adverse Event|2|||
13318068|NCT01201798|26560026|FG001|Overall Study|Adverse Event|0|||
13318069|NCT01201798|26560025|FG000|Overall Study|Lost to Follow-up|3|||
13318070|NCT01201798|26560026|FG001|Overall Study|Lost to Follow-up|5|||
13318071|NCT01201798|26560025|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
13318072|NCT01201798|26560026|FG001|Overall Study|Decision Unrelated to an Adverse Event|1|||
13318073|NCT01201798|26560025|FG000|Overall Study|Noncompliance|1|||
13318074|NCT01201798|26560026|FG001|Overall Study|Noncompliance|0|||
13318075|NCT01201798|26560025|FG000|Overall Study|Protocol Violation|1|||
13318076|NCT01201798|26560026|FG001|Overall Study|Protocol Violation|1|||
13318077|NCT01201798|26560025|FG000|Overall Study|Treatment Failure|1|||
13318078|NCT01201798|26560026|FG001|Overall Study|Treatment Failure|8|||
13318079|NCT01201785|26560032|FG000|Overall Study|Lost to Follow-up|16|||
13318080|NCT01201759|26560051|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2|||
13318081|NCT01201759|26560052|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1|||
13318082|NCT01201759|26560051|FG000|Visit 3 - Washout|Adverse Event|0|||
13318083|NCT01201759|26560052|FG001|Visit 3 - Washout|Adverse Event|3|||
13318084|NCT01201759|26560051|FG000|Visit 3 - Washout|Lost to Follow-up|1|||
13318085|NCT01201759|26560052|FG001|Visit 3 - Washout|Lost to Follow-up|0|||
13318086|NCT01201759|26560051|FG000|Visit 4 Crossover|Lost to Follow-up|0|||
13318087|NCT01201759|26560052|FG001|Visit 4 Crossover|Lost to Follow-up|1|||
13318088|NCT01201356|26560068|FG000|Overall Study|Adverse Event|170|||
13318089|NCT01201356|26560068|FG000|Overall Study|Abnormal laboratory value(s)|51|||
13318090|NCT01201356|26560068|FG000|Overall Study|Abnormal test procedure result(s)|3|||
13318091|NCT01201356|26560068|FG000|Overall Study|Unsatisfactory therapeutic effect|112|||
13318092|NCT01201356|26560068|FG000|Overall Study|Condition no longer requires study drug|12|||
13318093|NCT01201356|26560068|FG000|Overall Study|Withdrawal by Subject|144|||
13318094|NCT01201356|26560068|FG000|Overall Study|Lost to Follow-up|50|||
13318095|NCT01201356|26560068|FG000|Overall Study|administrative problems|74|||
13318096|NCT01201356|26560068|FG000|Overall Study|Death|16|||
13318097|NCT01201356|26560068|FG000|Overall Study|Protocol Violation|12|||
13318098|NCT01201343|26560081|FG000|Overall Study|Adverse Event|6|||
13318099|NCT01201343|26560081|FG000|Overall Study|Withdrawal by Subject|5|||
13318100|NCT01201343|26560081|FG000|Overall Study|Lost to Follow-up|2|||
13318101|NCT01201343|26560081|FG000|Overall Study|Lack of Efficacy|2|||
13318102|NCT01201343|26560081|FG000|Overall Study|Participant wrongly included in trial|1|||
13318103|NCT01201343|26560081|FG000|Overall Study|Randomized, not treated|3|||
13318104|NCT01201317|26560111|FG000|Overall Study|Withdrawal by Subject|5|||
13318105|NCT01201317|26560112|FG001|Overall Study|Withdrawal by Subject|0|||
13318106|NCT01201317|26560113|FG002|Overall Study|Withdrawal by Subject|3|||
13318107|NCT01201317|26560111|FG000|Overall Study|Adverse Event|2|||
13318108|NCT01201317|26560112|FG001|Overall Study|Adverse Event|2|||
13318109|NCT01201317|26560113|FG002|Overall Study|Adverse Event|2|||
13318110|NCT01201317|26560111|FG000|Overall Study|Screen failure|1|||
13318111|NCT01201317|26560112|FG001|Overall Study|Screen failure|1|||
13318112|NCT01201317|26560113|FG002|Overall Study|Screen failure|0|||
13318113|NCT01201317|26560111|FG000|Overall Study|Protocol Violation|0|||
13318114|NCT01201317|26560112|FG001|Overall Study|Protocol Violation|1|||
13318115|NCT01201317|26560113|FG002|Overall Study|Protocol Violation|1|||
13318116|NCT01201317|26560111|FG000|Overall Study|Death|0|||
13318117|NCT01201317|26560112|FG001|Overall Study|Death|1|||
13318118|NCT01201317|26560113|FG002|Overall Study|Death|0|||
13318119|NCT01201317|26560111|FG000|Overall Study|Study-specific withdrawal criteria|0|||
13318120|NCT01201317|26560112|FG001|Overall Study|Study-specific withdrawal criteria|0|||
13318121|NCT01201317|26560113|FG002|Overall Study|Study-specific withdrawal criteria|1|||
13318122|NCT01201317|26560111|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0|||
13318123|NCT01201317|26560112|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1|||
13318124|NCT01201317|26560113|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0|||
13318125|NCT01201317|26560111|FG000|Overall Study|Decrease in renal function|0|||
13318126|NCT01201317|26560112|FG001|Overall Study|Decrease in renal function|1|||
13318127|NCT01201317|26560113|FG002|Overall Study|Decrease in renal function|0|||
13318128|NCT01201317|26560111|FG000|Overall Study|Lack of Efficacy|1|||
13318129|NCT01201317|26560112|FG001|Overall Study|Lack of Efficacy|0|||
13318130|NCT01201317|26560113|FG002|Overall Study|Lack of Efficacy|0|||
13318131|NCT01201317|26560111|FG000|Overall Study|Safety, possible history of tuberculosis|0|||
13318132|NCT01201317|26560112|FG001|Overall Study|Safety, possible history of tuberculosis|0|||
13318133|NCT01201317|26560113|FG002|Overall Study|Safety, possible history of tuberculosis|1|||
13318134|NCT01201265|26560127|FG000|Overall Study|Death|14|||
13318135|NCT01201265|26560127|FG000|Overall Study|Insufficient Therapeutic Response|3|||
13318136|NCT01201265|26560127|FG000|Overall Study|Lost to Follow-up|10|||
13318137|NCT01201265|26560127|FG000|Overall Study|Withdrawal by Subject|7|||
13318138|NCT01201265|26560127|FG000|Overall Study|Disease Progression|4|||
13318139|NCT01200992|26560142|FG000|Overall Study|Study terminated early|35|||
13318140|NCT01200992|26560143|FG001|Overall Study|Study terminated early|41|||
13318141|NCT01200992|26560142|FG000|Overall Study|Randomized but not treated|2|||
13318142|NCT01200992|26560143|FG001|Overall Study|Randomized but not treated|0|||
13318143|NCT01200810|26560170|FG000|Overall Study|Physician Decision|1|||
13318144|NCT01200810|26560171|FG001|Overall Study|Physician Decision|0|||
13318145|NCT01200810|26560170|FG000|Overall Study|Withdrawal by Subject|1|||
13318146|NCT01200810|26560171|FG001|Overall Study|Withdrawal by Subject|2|||
13318147|NCT01200810|26560170|FG000|Overall Study|Sponsor stopped making study drug|3|||
13318148|NCT01200810|26560171|FG001|Overall Study|Sponsor stopped making study drug|3|||
13318149|NCT01200797|26560181|FG000|Overall Study|symptomatic deterioration|2|||
13318150|NCT01200797|26560181|FG000|Overall Study|Adverse Event|4|||
13318151|NCT01200797|26560181|FG000|Overall Study|Disease Progression|13|||
13318152|NCT01200758|26560244|FG000|Stage I|Death|0|||
13318153|NCT01200758|26560245|FG001|Stage I|Death|1|||
13318154|NCT01200758|26560246|FG002|Stage I|Death|0|||
13318155|NCT01200758|26560247|FG003|Stage I|Death|0|||
13318156|NCT01200758|26560244|FG000|Stage I|Physician Decision|1|||
13318157|NCT01200758|26560245|FG001|Stage I|Physician Decision|1|||
13318158|NCT01200758|26560246|FG002|Stage I|Physician Decision|0|||
13318159|NCT01200758|26560247|FG003|Stage I|Physician Decision|0|||
13318160|NCT01200758|26560244|FG000|Stage I|Lack of Efficacy|2|||
13318161|NCT01200758|26560245|FG001|Stage I|Lack of Efficacy|1|||
13318162|NCT01200758|26560246|FG002|Stage I|Lack of Efficacy|0|||
13318163|NCT01200758|26560247|FG003|Stage I|Lack of Efficacy|0|||
13318164|NCT01200758|26560244|FG000|Stage I|Adverse Event|5|||
13318165|NCT01200758|26560245|FG001|Stage I|Adverse Event|5|||
13318166|NCT01200758|26560246|FG002|Stage I|Adverse Event|0|||
13318167|NCT01200758|26560247|FG003|Stage I|Adverse Event|0|||
13318168|NCT01200758|26560244|FG000|Stage I|Withdrawal by Subject|1|||
13318169|NCT01200758|26560245|FG001|Stage I|Withdrawal by Subject|2|||
13318170|NCT01200758|26560246|FG002|Stage I|Withdrawal by Subject|0|||
13318171|NCT01200758|26560247|FG003|Stage I|Withdrawal by Subject|0|||
13318172|NCT01200758|26560244|FG000|Stage I|Disease Progression|9|||
13318173|NCT01200758|26560245|FG001|Stage I|Disease Progression|7|||
13318174|NCT01200758|26560246|FG002|Stage I|Disease Progression|0|||
13318175|NCT01200758|26560247|FG003|Stage I|Disease Progression|0|||
13318176|NCT01200758|26560244|FG000|Stage 2|Disease Progression|0|||
13318177|NCT01200758|26560245|FG001|Stage 2|Disease Progression|0|||
13318178|NCT01200758|26560246|FG002|Stage 2|Disease Progression|16|||
13318179|NCT01200758|26560247|FG003|Stage 2|Disease Progression|21|||
13318180|NCT01200758|26560244|FG000|Stage 2|Lack of Efficacy|0|||
13318181|NCT01200758|26560245|FG001|Stage 2|Lack of Efficacy|0|||
13318182|NCT01200758|26560246|FG002|Stage 2|Lack of Efficacy|4|||
13318183|NCT01200758|26560247|FG003|Stage 2|Lack of Efficacy|2|||
13318184|NCT01200758|26560244|FG000|Stage 2|Physician Decision|0|||
13318185|NCT01200758|26560245|FG001|Stage 2|Physician Decision|0|||
13318186|NCT01200758|26560246|FG002|Stage 2|Physician Decision|5|||
13318187|NCT01200758|26560247|FG003|Stage 2|Physician Decision|7|||
13318188|NCT01200758|26560244|FG000|Stage 2|Adverse Event|0|||
13318189|NCT01200758|26560245|FG001|Stage 2|Adverse Event|0|||
13318190|NCT01200758|26560246|FG002|Stage 2|Adverse Event|5|||
13318191|NCT01200758|26560247|FG003|Stage 2|Adverse Event|9|||
13318192|NCT01200758|26560244|FG000|Stage 2|Withdrawal by Subject|0|||
13318193|NCT01200758|26560245|FG001|Stage 2|Withdrawal by Subject|0|||
13318194|NCT01200758|26560246|FG002|Stage 2|Withdrawal by Subject|4|||
13318195|NCT01200758|26560247|FG003|Stage 2|Withdrawal by Subject|1|||
13318196|NCT01200758|26560244|FG000|Stage 2|Lost to Follow-up|0|||
13318197|NCT01200758|26560245|FG001|Stage 2|Lost to Follow-up|0|||
13318198|NCT01200758|26560246|FG002|Stage 2|Lost to Follow-up|3|||
13318199|NCT01200758|26560247|FG003|Stage 2|Lost to Follow-up|1|||
13318200|NCT01200758|26560244|FG000|Stage 2|Protocol Violation|0|||
13318201|NCT01200758|26560245|FG001|Stage 2|Protocol Violation|0|||
13318202|NCT01200758|26560246|FG002|Stage 2|Protocol Violation|1|||
13318203|NCT01200758|26560247|FG003|Stage 2|Protocol Violation|4|||
13318204|NCT01200758|26560244|FG000|Stage 2|Death|0|||
13318205|NCT01200758|26560245|FG001|Stage 2|Death|0|||
13318206|NCT01200758|26560246|FG002|Stage 2|Death|3|||
13318207|NCT01200758|26560247|FG003|Stage 2|Death|5|||
13318208|NCT01200589|26560278|FG000|Overall Study|Withdrawal by Subject|13|||
13318209|NCT01200589|26560279|FG001|Overall Study|Withdrawal by Subject|11|||
13318210|NCT01200589|26560278|FG000|Overall Study|Physician Decision|2|||
13318211|NCT01200589|26560279|FG001|Overall Study|Physician Decision|2|||
13318212|NCT01200589|26560278|FG000|Overall Study|Lost to Follow-up|5|||
13318213|NCT01200589|26560279|FG001|Overall Study|Lost to Follow-up|4|||
13318214|NCT01200589|26560278|FG000|Overall Study|Study terminated|170|||
13318215|NCT01200589|26560279|FG001|Overall Study|Study terminated|172|||
13318216|NCT01200524|26560309|FG000|Overall Study|Withdrawal by Subject|1|||
13318217|NCT01200524|26560310|FG001|Overall Study|Withdrawal by Subject|1|||
13318218|NCT01200524|26560311|FG002|Overall Study|Withdrawal by Subject|3|||
13318219|NCT01200524|26560309|FG000|Overall Study|Adverse Event|1|||
13318220|NCT01200524|26560310|FG001|Overall Study|Adverse Event|0|||
13318221|NCT01200524|26560311|FG002|Overall Study|Adverse Event|0|||
13318222|NCT01200524|26560309|FG000|Overall Study|Non availability of study nurse|0|||
13318223|NCT01200524|26560310|FG001|Overall Study|Non availability of study nurse|0|||
13318224|NCT01200524|26560311|FG002|Overall Study|Non availability of study nurse|1|||
13318225|NCT01200511|26560321|FG000|Overall Study|Lost to Follow-up|3|||
13318226|NCT01200511|26560321|FG000|Overall Study|Withdrawal by Subject|1|||
13318227|NCT01200511|26560321|FG000|Overall Study|Adverse Event|1|||
13318228|NCT01200485|26560334|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1|||
13318229|NCT01200485|26560335|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
13318230|NCT01200485|26560336|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
13318231|NCT01200485|26560334|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2|||
13318232|NCT01200485|26560335|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
13318233|NCT01200485|26560336|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
13318234|NCT01200407|26560345|FG000|Overall Study|Lost to Follow-up|56|||
13318235|NCT01200407|26560345|FG000|Overall Study|Adverse Event|3|||
13318236|NCT01200407|26560345|FG000|Overall Study|Withdrawal by Subject|4|||
13318237|NCT01200407|26560345|FG000|Overall Study|Other|19|||
13318238|NCT01200394|26560387|FG000|Overall Study|Adverse Event|0|||
13318239|NCT01200394|26560388|FG001|Overall Study|Adverse Event|14|||
13318240|NCT01200394|26560387|FG000|Overall Study|Death|1|||
13318241|NCT01200394|26560388|FG001|Overall Study|Death|0|||
13318242|NCT01200394|26560387|FG000|Overall Study|Lost to Follow-up|0|||
13318243|NCT01200394|26560388|FG001|Overall Study|Lost to Follow-up|1|||
13318244|NCT01200394|26560387|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
13318245|NCT01200394|26560388|FG001|Overall Study|Did Not Meet Entrance Criteria|4|||
13318246|NCT01200394|26560387|FG000|Overall Study|Protocol Violation|0|||
13318247|NCT01200394|26560388|FG001|Overall Study|Protocol Violation|3|||
13318248|NCT01200394|26560387|FG000|Overall Study|Withdrawal by Subject|0|||
13318249|NCT01200394|26560388|FG001|Overall Study|Withdrawal by Subject|5|||
13318250|NCT01200394|26560387|FG000|Overall Study|Other|0|||
13318251|NCT01200394|26560388|FG001|Overall Study|Other|1|||
13318252|NCT01200368|26560462|FG000|Infant Series|Adverse Event|2|||
13318253|NCT01200368|26560463|FG001|Infant Series|Adverse Event|2|||
13318254|NCT01200368|26560464|FG002|Infant Series|Adverse Event|3|||
13318255|NCT01200368|26560462|FG000|Infant Series|Withdrawal by Subject|0|||
13318256|NCT01200368|26560463|FG001|Infant Series|Withdrawal by Subject|2|||
13318257|NCT01200368|26560464|FG002|Infant Series|Withdrawal by Subject|2|||
13318258|NCT01200368|26560462|FG000|Infant Series|Did not meet entrance criteria|0|||
13318259|NCT01200368|26560463|FG001|Infant Series|Did not meet entrance criteria|1|||
13318260|NCT01200368|26560464|FG002|Infant Series|Did not meet entrance criteria|0|||
13318261|NCT01200368|26560462|FG000|Infant Series|Randomized, not vaccinated|0|||
13318262|NCT01200368|26560463|FG001|Infant Series|Randomized, not vaccinated|1|||
13318263|NCT01200368|26560464|FG002|Infant Series|Randomized, not vaccinated|1|||
13318264|NCT01200368|26560462|FG000|Infant Series|Other|1|||
13318265|NCT01200368|26560463|FG001|Infant Series|Other|0|||
13318266|NCT01200368|26560464|FG002|Infant Series|Other|0|||
13318267|NCT01200368|26560462|FG000|After Infant Series|Adverse Event|6|||
13318268|NCT01200368|26560463|FG001|After Infant Series|Adverse Event|6|||
13318269|NCT01200368|26560464|FG002|After Infant Series|Adverse Event|3|||
13318270|NCT01200368|26560462|FG000|After Infant Series|Withdrawal by Subject|10|||
13318271|NCT01200368|26560463|FG001|After Infant Series|Withdrawal by Subject|8|||
13318272|NCT01200368|26560464|FG002|After Infant Series|Withdrawal by Subject|4|||
13318273|NCT01200368|26560462|FG000|After Infant Series|Lost to Follow-up|1|||
13318274|NCT01200368|26560463|FG001|After Infant Series|Lost to Follow-up|0|||
13318275|NCT01200368|26560464|FG002|After Infant Series|Lost to Follow-up|0|||
13318276|NCT01200368|26560462|FG000|After Infant Series|Other|1|||
13318277|NCT01200368|26560463|FG001|After Infant Series|Other|2|||
13318278|NCT01200368|26560464|FG002|After Infant Series|Other|2|||
13318279|NCT01200368|26560462|FG000|Toddler Dose|Adverse Event|0|||
13318280|NCT01200368|26560463|FG001|Toddler Dose|Adverse Event|3|||
13318281|NCT01200368|26560464|FG002|Toddler Dose|Adverse Event|1|||
13318282|NCT01200355|26560485|FG000|Overall Study|Death|7|||
13318283|NCT01200355|26560486|FG001|Overall Study|Death|2|||
13318284|NCT01200342|26560493|FG000|Overall Study|Disease Progression|1|||
13318285|NCT01200329|26560500|FG000|Overall Study|Lack of financial coverage|2|||
13318286|NCT01200329|26560500|FG000|Overall Study|Progressive disease|1|||
13318287|NCT01200290|26560513|FG000|Treatment Period|Adverse Event|1|||
13318288|NCT01200290|26560513|FG000|Post-Treatment Follow-Up Period|Death|2|||
13318289|NCT01200238|26560538|FG000|Overall Study|Adverse Event|2|||
13318290|NCT01200238|26560539|FG001|Overall Study|Adverse Event|1|||
13318291|NCT01200238|26560538|FG000|Overall Study|Progressive Disease|5|||
13318292|NCT01200238|26560539|FG001|Overall Study|Progressive Disease|8|||
13318293|NCT01200238|26560538|FG000|Overall Study|Withdrawal by Subject|0|||
13318294|NCT01200238|26560539|FG001|Overall Study|Withdrawal by Subject|1|||
13318295|NCT01200069|26560598|FG000|Overall Study|Withdrawal by Subject|0|||
13318296|NCT01200069|26560599|FG001|Overall Study|Withdrawal by Subject|1|||
13318297|NCT01199939|26560618|FG000|Overall Study|Adverse Event|4|||
13318298|NCT01199939|26560618|FG000|Overall Study|Protocol Violation|3|||
13318299|NCT01199939|26560618|FG000|Overall Study|Lost to Follow-up|2|||
13318300|NCT01199939|26560618|FG000|Overall Study|Reached a virologic endpoint|4|||
13318301|NCT01199861|26560643|FG000|Overall Study|Administrative problems|1|||
13318302|NCT01199861|26560644|FG001|Overall Study|Administrative problems|0|||
13318303|NCT01199861|26560643|FG000|Overall Study|Adverse Event|1|||
13318304|NCT01199861|26560644|FG001|Overall Study|Adverse Event|0|||
13122149|NCT02969018|25946165|FG004|Overall Study|Lack of Efficacy|1|||
13122150|NCT02969018|25946166|FG005|Overall Study|Lack of Efficacy|1|||
13318305|NCT01199822|26560687|FG000|Overall Study|Investigator discontinued therapy|0|||
13122151|NCT02969018|25946167|FG006|Overall Study|Lack of Efficacy|1|||
13122152|NCT02969018|25946168|FG007|Overall Study|Lack of Efficacy|1|||
13122153|NCT02969018|25946161|FG000|Overall Study|Lost to Follow-up|1|||
13122154|NCT02969018|25946162|FG001|Overall Study|Lost to Follow-up|2|||
13122155|NCT02969018|25946163|FG002|Overall Study|Lost to Follow-up|2|||
13122156|NCT02969018|25946164|FG003|Overall Study|Lost to Follow-up|0|||
13122157|NCT02969018|25946165|FG004|Overall Study|Lost to Follow-up|1|||
13122158|NCT02969018|25946166|FG005|Overall Study|Lost to Follow-up|1|||
13122159|NCT02969018|25946167|FG006|Overall Study|Lost to Follow-up|0|||
13122160|NCT02969018|25946168|FG007|Overall Study|Lost to Follow-up|1|||
13318306|NCT01199822|26560688|FG001|Overall Study|Investigator discontinued therapy|1|||
13318307|NCT01199822|26560689|FG002|Overall Study|Investigator discontinued therapy|0|||
13318308|NCT01199731|26560737|FG000|Overall Study|Adverse Event|0|||
13318309|NCT01199731|26560738|FG001|Overall Study|Adverse Event|1|||
13318310|NCT01199731|26560739|FG002|Overall Study|Adverse Event|0|||
13318311|NCT01199731|26560737|FG000|Overall Study|Study closed/terminated|7|||
13318312|NCT01199731|26560738|FG001|Overall Study|Study closed/terminated|9|||
13318313|NCT01199731|26560739|FG002|Overall Study|Study closed/terminated|7|||
13318314|NCT01199731|26560737|FG000|Overall Study|Lost to Follow-up|0|||
13318315|NCT01199731|26560738|FG001|Overall Study|Lost to Follow-up|0|||
13318316|NCT01199731|26560739|FG002|Overall Study|Lost to Follow-up|2|||
13318317|NCT01199731|26560737|FG000|Overall Study|Physician Decision|0|||
13318318|NCT01199731|26560738|FG001|Overall Study|Physician Decision|1|||
13318319|NCT01199731|26560739|FG002|Overall Study|Physician Decision|1|||
13318320|NCT01199731|26560737|FG000|Overall Study|Withdrawal by Subject|2|||
13318321|NCT01199731|26560738|FG001|Overall Study|Withdrawal by Subject|0|||
13318322|NCT01199731|26560739|FG002|Overall Study|Withdrawal by Subject|0|||
13318323|NCT01199705|26560771|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1|||
13318324|NCT01199601|26560788|FG000|Overall Study|Lost to Follow-up|47|||
13318325|NCT01199601|26560789|FG001|Overall Study|Lost to Follow-up|66|||
13318326|NCT01199601|26560788|FG000|Overall Study|Withdrawal by Subject|15|||
13318327|NCT01199601|26560789|FG001|Overall Study|Withdrawal by Subject|3|||
13318328|NCT01199601|26560788|FG000|Overall Study|Insecurity prevented staff interviewing.|7|||
13318329|NCT01199601|26560789|FG001|Overall Study|Insecurity prevented staff interviewing.|9|||
13318330|NCT01199575|26560796|FG000|Overall Study|Withdrawal by Subject|5|||
13318331|NCT01199471|26560807|FG000|Overall Study|Protocol Violation|4|||
13318332|NCT01199471|26560807|FG000|Overall Study|Withdrawal by Subject|1|||
13318333|NCT01199471|26560807|FG000|Overall Study|Physician Decision|1|||
13318334|NCT01199289|26560863|FG000|Overall Study|Ineligibility determined|2|||
13318335|NCT01199289|26560864|FG001|Overall Study|Ineligibility determined|1|||
13318336|NCT01199289|26560865|FG002|Overall Study|Ineligibility determined|0|||
13318337|NCT01199289|26560866|FG003|Overall Study|Ineligibility determined|0|||
13318338|NCT01199289|26560863|FG000|Overall Study|Protocol Violation|1|||
13318339|NCT01199289|26560864|FG001|Overall Study|Protocol Violation|0|||
13318340|NCT01199289|26560865|FG002|Overall Study|Protocol Violation|0|||
13318341|NCT01199289|26560866|FG003|Overall Study|Protocol Violation|1|||
13318342|NCT01199289|26560863|FG000|Overall Study|Noncompliance|1|||
13318343|NCT01199289|26560864|FG001|Overall Study|Noncompliance|0|||
13318344|NCT01199289|26560865|FG002|Overall Study|Noncompliance|2|||
13318345|NCT01199289|26560866|FG003|Overall Study|Noncompliance|0|||
13318346|NCT01199289|26560863|FG000|Overall Study|Adverse Event|0|||
13318347|NCT01199289|26560864|FG001|Overall Study|Adverse Event|3|||
13318348|NCT01199289|26560865|FG002|Overall Study|Adverse Event|1|||
13318349|NCT01199289|26560866|FG003|Overall Study|Adverse Event|4|||
13318350|NCT01199289|26560863|FG000|Overall Study|Full consent withdrawn|2|||
13318351|NCT01199289|26560864|FG001|Overall Study|Full consent withdrawn|2|||
13318352|NCT01199289|26560865|FG002|Overall Study|Full consent withdrawn|2|||
13318353|NCT01199289|26560866|FG003|Overall Study|Full consent withdrawn|3|||
13318354|NCT01199289|26560863|FG000|Overall Study|Administrative decision|0|||
13318355|NCT01199289|26560864|FG001|Overall Study|Administrative decision|0|||
13318356|NCT01199289|26560865|FG002|Overall Study|Administrative decision|0|||
13318357|NCT01199289|26560866|FG003|Overall Study|Administrative decision|1|||
13318358|NCT01199289|26560863|FG000|Overall Study|Lost to Follow-up|0|||
13318359|NCT01199289|26560864|FG001|Overall Study|Lost to Follow-up|0|||
13318360|NCT01199289|26560865|FG002|Overall Study|Lost to Follow-up|0|||
13318361|NCT01199289|26560866|FG003|Overall Study|Lost to Follow-up|1|||
13318362|NCT01199289|26560863|FG000|Overall Study|Protocol-specified criteria|3|||
13318363|NCT01199289|26560864|FG001|Overall Study|Protocol-specified criteria|0|||
13318364|NCT01199289|26560865|FG002|Overall Study|Protocol-specified criteria|0|||
13318365|NCT01199289|26560866|FG003|Overall Study|Protocol-specified criteria|1|||
13318366|NCT01199289|26560863|FG000|Overall Study|Pregnancy|0|||
13318367|NCT01199289|26560864|FG001|Overall Study|Pregnancy|1|||
13318368|NCT01199289|26560865|FG002|Overall Study|Pregnancy|0|||
13318369|NCT01199289|26560866|FG003|Overall Study|Pregnancy|1|||
13318370|NCT01199263|26560887|FG000|Overall Study|Ineligible|0|||
13318371|NCT01199263|26560888|FG001|Overall Study|Ineligible|2|||
13318372|NCT01199263|26560887|FG000|Overall Study|Never Treated|6|||
13486378|NCT03786380|27035990|FG003|Overall Study|Withdrawal by Subject|1|||
13122161|NCT02969018|25946161|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
13318373|NCT01199263|26560888|FG001|Overall Study|Never Treated|0|||
13318374|NCT01199198|26560903|FG000|Overall Study|Adverse Event|3|||
13318375|NCT01199198|26560904|FG001|Overall Study|Adverse Event|0|||
13318376|NCT01199198|26560903|FG000|Overall Study|Lost to Follow-up|1|||
13318377|NCT01199198|26560904|FG001|Overall Study|Lost to Follow-up|5|||
13318378|NCT01199198|26560903|FG000|Overall Study|Withdrawal by Subject|1|||
13318379|NCT01199198|26560904|FG001|Overall Study|Withdrawal by Subject|2|||
13318380|NCT01199198|26560903|FG000|Overall Study|ICU Transfer|1|||
13318381|NCT01199198|26560904|FG001|Overall Study|ICU Transfer|2|||
13318382|NCT01199198|26560903|FG000|Overall Study|Hospice-care transfer|1|||
13318383|NCT01199198|26560904|FG001|Overall Study|Hospice-care transfer|2|||
13318384|NCT01199068|26560945|FG000|Overall Study|Unacceptable toxicity|0|||
13318385|NCT01199068|26560946|FG001|Overall Study|Unacceptable toxicity|0|||
13318386|NCT01199068|26560947|FG002|Overall Study|Unacceptable toxicity|2|||
13318387|NCT01199068|26560945|FG000|Overall Study|Progressive disease|3|||
13318388|NCT01199068|26560946|FG001|Overall Study|Progressive disease|3|||
13318389|NCT01199068|26560947|FG002|Overall Study|Progressive disease|6|||
13318390|NCT01199068|26560945|FG000|Overall Study|Withdrawal by Subject|0|||
13318391|NCT01199068|26560946|FG001|Overall Study|Withdrawal by Subject|0|||
13318392|NCT01199068|26560947|FG002|Overall Study|Withdrawal by Subject|1|||
13318393|NCT01199055|26560982|FG000|Overall Study|Death|0|||
13318394|NCT01199055|26560983|FG001|Overall Study|Death|1|||
13318395|NCT01199055|26560984|FG002|Overall Study|Death|0|||
13318396|NCT01199055|26560982|FG000|Overall Study|Physician Decision|0|||
13318397|NCT01199055|26560983|FG001|Overall Study|Physician Decision|1|||
13318398|NCT01199055|26560984|FG002|Overall Study|Physician Decision|1|||
13318399|NCT01199055|26560982|FG000|Overall Study|Progressive disease|2|||
13318400|NCT01199055|26560983|FG001|Overall Study|Progressive disease|1|||
13318401|NCT01199055|26560984|FG002|Overall Study|Progressive disease|2|||
13318402|NCT01199055|26560982|FG000|Overall Study|Withdrawal by Subject|0|||
13318403|NCT01199055|26560983|FG001|Overall Study|Withdrawal by Subject|0|||
13318404|NCT01199055|26560984|FG002|Overall Study|Withdrawal by Subject|1|||
13318405|NCT01199042|26560995|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2|||
13318406|NCT01199042|26560995|FG000|At Home (3 Months)|Lost to Follow-up|1|||
13318407|NCT01199016|26561004|FG000|Overall Study|No longer meets eligibility criteria|4|||
13318408|NCT01199016|26561004|FG000|Overall Study|Entrance criteria|5|||
13318409|NCT01199016|26561004|FG000|Overall Study|Protocol Violation|9|||
13318410|NCT01199016|26561004|FG000|Overall Study|Other|13|||
13318411|NCT01199016|26561004|FG000|Overall Study|Withdrawal by Subject|21|||
13318412|NCT01199016|26561004|FG000|Overall Study|Lost to Follow-up|25|||
13318413|NCT01198977|26561021|FG000|Overall Study|Lost to Follow-up|1|||
13318414|NCT01198977|26561022|FG001|Overall Study|Lost to Follow-up|0|||
13318415|NCT01198873|26561043|FG000|Overall Study|Adverse Event|4|||
13318416|NCT01198873|26561044|FG001|Overall Study|Adverse Event|7|||
13318417|NCT01198873|26561043|FG000|Overall Study|Study closure|29|||
13318418|NCT01198873|26561044|FG001|Overall Study|Study closure|23|||
13318419|NCT01198873|26561043|FG000|Overall Study|Other than above|4|||
13318420|NCT01198873|26561044|FG001|Overall Study|Other than above|2|||
13318421|NCT01198795|26561050|FG000|Overall Study|Did not meet InclusionExclusion criteria|30|||
13318422|NCT01198795|26561050|FG000|Overall Study|Withdrawal by Subject|17|||
13318423|NCT01198795|26561050|FG000|Overall Study|Lost to Follow-up|15|||
13318424|NCT01198795|26561050|FG000|Overall Study|Adverse Event|9|||
13318425|NCT01198795|26561050|FG000|Overall Study|Lack of Efficacy|5|||
13318426|NCT01198795|26561050|FG000|Overall Study|Protocol Violation|2|||
13318427|NCT01198795|26561050|FG000|Overall Study|Other Reason|4|||
13318428|NCT01198756|26561159|FG000|Overall Study|Adverse Event|0|||
13318429|NCT01198756|26561160|FG001|Overall Study|Adverse Event|0|||
13318430|NCT01198756|26561161|FG002|Overall Study|Adverse Event|0|||
13318431|NCT01198756|26561162|FG003|Overall Study|Adverse Event|1|||
13318432|NCT01198756|26561159|FG000|Overall Study|Protocol Violation|0|||
13318433|NCT01198756|26561160|FG001|Overall Study|Protocol Violation|0|||
13318434|NCT01198756|26561161|FG002|Overall Study|Protocol Violation|0|||
13318435|NCT01198756|26561162|FG003|Overall Study|Protocol Violation|2|||
13122162|NCT02969018|25946162|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
13122163|NCT02969018|25946163|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
13122164|NCT02969018|25946164|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
13122165|NCT02969018|25946165|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
13122166|NCT02969018|25946166|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
13122167|NCT02969018|25946167|FG006|Overall Study|No Longer Meets Eligibility Criteria|1|||
13122168|NCT02969018|25946168|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
13122169|NCT02969018|25946161|FG000|Overall Study|Non-Compliance With Study Drug|1|||
13122170|NCT02969018|25946162|FG001|Overall Study|Non-Compliance With Study Drug|0|||
13122171|NCT02969018|25946163|FG002|Overall Study|Non-Compliance With Study Drug|0|||
13122172|NCT02969018|25946164|FG003|Overall Study|Non-Compliance With Study Drug|0|||
13122173|NCT02969018|25946165|FG004|Overall Study|Non-Compliance With Study Drug|0|||
13122174|NCT02969018|25946166|FG005|Overall Study|Non-Compliance With Study Drug|0|||
13318436|NCT01198756|26561159|FG000|Overall Study|Withdrawal by Subject|9|||
13318437|NCT01198756|26561160|FG001|Overall Study|Withdrawal by Subject|4|||
13318438|NCT01198756|26561161|FG002|Overall Study|Withdrawal by Subject|7|||
13318439|NCT01198756|26561162|FG003|Overall Study|Withdrawal by Subject|5|||
13318440|NCT01198756|26561159|FG000|Overall Study|Lost to Follow-up|29|||
13318441|NCT01198756|26561160|FG001|Overall Study|Lost to Follow-up|36|||
13318442|NCT01198756|26561161|FG002|Overall Study|Lost to Follow-up|23|||
13318443|NCT01198756|26561162|FG003|Overall Study|Lost to Follow-up|18|||
13318444|NCT01198600|26561189|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1|||
13122175|NCT02969018|25946167|FG006|Overall Study|Non-Compliance With Study Drug|0|||
13122176|NCT02969018|25946168|FG007|Overall Study|Non-Compliance With Study Drug|0|||
13122177|NCT02969018|25946161|FG000|Overall Study|Other|0|||
13122178|NCT02969018|25946162|FG001|Overall Study|Other|0|||
13122179|NCT02969018|25946163|FG002|Overall Study|Other|0|||
13122180|NCT02969018|25946164|FG003|Overall Study|Other|1|||
13318445|NCT01198600|26561190|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
13318446|NCT01198600|26561191|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
13318447|NCT01198600|26561192|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
13318448|NCT01198600|26561189|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1|||
13318449|NCT01198600|26561190|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
13318450|NCT01198600|26561191|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
13318451|NCT01198600|26561192|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
13122181|NCT02969018|25946165|FG004|Overall Study|Other|0|||
13122182|NCT02969018|25946166|FG005|Overall Study|Other|0|||
13122183|NCT02969018|25946167|FG006|Overall Study|Other|0|||
13318452|NCT01198600|26561189|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
13318453|NCT01198600|26561190|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1|||
13318454|NCT01198600|26561191|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
13318455|NCT01198600|26561192|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
13122184|NCT02969018|25946168|FG007|Overall Study|Other|2|||
13318456|NCT01198600|26561189|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
13318457|NCT01198600|26561190|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1|||
13318458|NCT01198600|26561191|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
13318459|NCT01198600|26561192|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
13318460|NCT01198600|26561189|FG000|Phase 2: 56 Days of Wear|Inconvenience|0|||
13318461|NCT01198600|26561190|FG001|Phase 2: 56 Days of Wear|Inconvenience|0|||
13318462|NCT01198600|26561191|FG002|Phase 2: 56 Days of Wear|Inconvenience|2|||
13318463|NCT01198600|26561192|FG003|Phase 2: 56 Days of Wear|Inconvenience|0|||
13318464|NCT01198600|26561189|FG000|Phase 2: 56 Days of Wear|Relocation|0|||
13318465|NCT01198600|26561190|FG001|Phase 2: 56 Days of Wear|Relocation|0|||
13318466|NCT01198600|26561191|FG002|Phase 2: 56 Days of Wear|Relocation|2|||
13318467|NCT01198600|26561192|FG003|Phase 2: 56 Days of Wear|Relocation|0|||
13318468|NCT01198600|26561189|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
13318469|NCT01198600|26561190|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
13318470|NCT01198600|26561191|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1|||
13318471|NCT01198600|26561192|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
13318472|NCT01198587|26561223|FG000|Overall Study|Lost to Follow-up|8|||
13318473|NCT01198587|26561224|FG001|Overall Study|Lost to Follow-up|0|||
13318474|NCT01198587|26561225|FG002|Overall Study|Lost to Follow-up|9|||
13318475|NCT01198587|26561226|FG003|Overall Study|Lost to Follow-up|0|||
13318476|NCT01198574|26561257|FG000|Overall Study|Resigned from schools|4|||
13318477|NCT01198574|26561258|FG001|Overall Study|Resigned from schools|1|||
13318478|NCT01198574|26561259|FG002|Overall Study|Resigned from schools|1|||
13318479|NCT01198574|26561260|FG003|Overall Study|Resigned from schools|4|||
13318480|NCT01198548|26561271|FG000|Overall Study|Disease Progression|9|||
13318481|NCT01198548|26561271|FG000|Overall Study|Administrative Decision|1|||
13318482|NCT01198509|26561307|FG000|Overall Study|Withdrawal by Subject|1|||
13318483|NCT01198509|26561308|FG001|Overall Study|Withdrawal by Subject|0|||
13318484|NCT01198509|26561309|FG002|Overall Study|Withdrawal by Subject|0|||
13318485|NCT01198509|26561310|FG003|Overall Study|Withdrawal by Subject|0|||
13318486|NCT01198509|26561311|FG004|Overall Study|Withdrawal by Subject|0|||
13318487|NCT01198509|26561312|FG005|Overall Study|Withdrawal by Subject|0|||
13318488|NCT01198470|26561321|FG000|Overall Study|Adverse Event|2|||
13318489|NCT01198275|26561334|FG000|Overall Study|Adverse Event|2|||
13318490|NCT01198275|26561335|FG001|Overall Study|Adverse Event|3|||
13318491|NCT01198275|26561334|FG000|Overall Study|spontaneous return to sinus rhythm|4|||
13318492|NCT01198275|26561335|FG001|Overall Study|spontaneous return to sinus rhythm|2|||
13318493|NCT01198145|26561362|FG000|Overall Study|Withdrawal by Subject|1|||
13318494|NCT01198145|26561363|FG001|Overall Study|Withdrawal by Subject|1|||
13318495|NCT01198132|26561394|FG000|Overall Study|Withdrawal by Subject|4|||
13318496|NCT01198132|26561395|FG001|Overall Study|Withdrawal by Subject|5|||
13318497|NCT01198132|26561394|FG000|Overall Study|Physician Decision|5|||
13318498|NCT01198132|26561395|FG001|Overall Study|Physician Decision|4|||
13318499|NCT01198132|26561394|FG000|Overall Study|Other Unspecified|3|||
13318500|NCT01198132|26561395|FG001|Overall Study|Other Unspecified|6|||
13318501|NCT01198132|26561394|FG000|Overall Study|Lack of Efficacy|2|||
13318502|NCT01198132|26561395|FG001|Overall Study|Lack of Efficacy|3|||
13318503|NCT01198132|26561394|FG000|Overall Study|Sign/symptoms of underlying disease|2|||
13122185|NCT02969018|25946161|FG000|Overall Study|Pregnancy|0|||
13318504|NCT01198132|26561395|FG001|Overall Study|Sign/symptoms of underlying disease|1|||
13318505|NCT01198132|26561394|FG000|Overall Study|Abnormal/clinically significant biologic|1|||
13318506|NCT01198132|26561395|FG001|Overall Study|Abnormal/clinically significant biologic|1|||
13318507|NCT01198132|26561394|FG000|Overall Study|Adverse Event|0|||
13318508|NCT01198132|26561395|FG001|Overall Study|Adverse Event|1|||
13318509|NCT01198132|26561394|FG000|Overall Study|Protocol Violation|1|||
13318510|NCT01198132|26561395|FG001|Overall Study|Protocol Violation|0|||
13318511|NCT01198028|26561406|FG000|Overall Study|Adverse Event|5|||
13318512|NCT01198028|26561406|FG000|Overall Study|Death|3|||
13318513|NCT01198028|26561406|FG000|Overall Study|Physician Decision|2|||
13318514|NCT01198002|26561528|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18|||
13318515|NCT01198002|26561529|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
13318516|NCT01198002|26561530|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
13318517|NCT01198002|26561528|FG000|Treatment Period 1 (Weeks 0-52)|Death|2|||
13318518|NCT01198002|26561529|FG001|Treatment Period 1 (Weeks 0-52)|Death|0|||
13122186|NCT02969018|25946162|FG001|Overall Study|Pregnancy|0|||
13122187|NCT02969018|25946163|FG002|Overall Study|Pregnancy|0|||
13122188|NCT02969018|25946164|FG003|Overall Study|Pregnancy|0|||
13318519|NCT01198002|26561530|FG002|Treatment Period 1 (Weeks 0-52)|Death|1|||
13318520|NCT01198002|26561528|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10|||
13318521|NCT01198002|26561529|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9|||
13318522|NCT01198002|26561530|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6|||
13318523|NCT01198002|26561528|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1|||
13318524|NCT01198002|26561529|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
13318525|NCT01198002|26561530|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
13318526|NCT01198002|26561528|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
13318527|NCT01198002|26561529|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2|||
13318528|NCT01198002|26561530|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
13318529|NCT01198002|26561528|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16|||
13318530|NCT01198002|26561529|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21|||
13318531|NCT01198002|26561530|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12|||
13318532|NCT01198002|26561528|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1|||
13318533|NCT01198002|26561529|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
13318534|NCT01198002|26561530|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
13318535|NCT01198002|26561528|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14|||
13318536|NCT01198002|26561529|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
13318537|NCT01198002|26561530|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
13318538|NCT01198002|26561528|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213|||
13318539|NCT01198002|26561529|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216|||
13318540|NCT01198002|26561530|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224|||
13318541|NCT01198002|26561528|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2|||
13318542|NCT01198002|26561529|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0|||
13318543|NCT01198002|26561530|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1|||
13318544|NCT01198002|26561528|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3|||
13318545|NCT01198002|26561529|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
13318546|NCT01198002|26561530|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
13318547|NCT01198002|26561528|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1|||
13318548|NCT01198002|26561529|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
13318549|NCT01198002|26561530|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
13318550|NCT01198002|26561528|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
13318551|NCT01198002|26561529|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2|||
13318552|NCT01198002|26561530|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
13318553|NCT01198002|26561528|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
13318554|NCT01198002|26561529|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0|||
13318555|NCT01198002|26561530|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
13318556|NCT01198002|26561528|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62|||
13318557|NCT01198002|26561529|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70|||
13318558|NCT01198002|26561530|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75|||
13318559|NCT01197950|26561548|FG000|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
13318560|NCT01197950|26561549|FG001|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
13318561|NCT01197950|26561550|FG002|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|18|||
13318562|NCT01197911|26561643|FG000|Overall Study|Adverse Event|0|||
13318563|NCT01197911|26561644|FG001|Overall Study|Adverse Event|0|||
13318564|NCT01197911|26561645|FG002|Overall Study|Adverse Event|1|||
13318565|NCT01197794|26561746|FG000|Overall Study|Adverse Event|3|||
13318566|NCT01197794|26561747|FG001|Overall Study|Adverse Event|2|||
13318567|NCT01197794|26561748|FG002|Overall Study|Adverse Event|4|||
13318568|NCT01197794|26561749|FG003|Overall Study|Adverse Event|4|||
13318569|NCT01197794|26561750|FG004|Overall Study|Adverse Event|4|||
13318570|NCT01197794|26561751|FG005|Overall Study|Adverse Event|2|||
13318571|NCT01197794|26561752|FG006|Overall Study|Adverse Event|3|||
13318572|NCT01197794|26561746|FG000|Overall Study|Protocol Violation|0|||
13318573|NCT01197794|26561747|FG001|Overall Study|Protocol Violation|0|||
13318574|NCT01197794|26561748|FG002|Overall Study|Protocol Violation|0|||
13318575|NCT01197794|26561749|FG003|Overall Study|Protocol Violation|0|||
13318576|NCT01197794|26561750|FG004|Overall Study|Protocol Violation|2|||
13318577|NCT01197794|26561751|FG005|Overall Study|Protocol Violation|0|||
13318578|NCT01197794|26561752|FG006|Overall Study|Protocol Violation|1|||
13318579|NCT01197794|26561746|FG000|Overall Study|Development of study withdrawal criteria|3|||
13318580|NCT01197794|26561747|FG001|Overall Study|Development of study withdrawal criteria|0|||
13318581|NCT01197794|26561748|FG002|Overall Study|Development of study withdrawal criteria|0|||
13318582|NCT01197794|26561749|FG003|Overall Study|Development of study withdrawal criteria|1|||
13318583|NCT01197794|26561750|FG004|Overall Study|Development of study withdrawal criteria|0|||
13318584|NCT01197794|26561751|FG005|Overall Study|Development of study withdrawal criteria|0|||
13318585|NCT01197794|26561752|FG006|Overall Study|Development of study withdrawal criteria|1|||
13318586|NCT01197794|26561746|FG000|Overall Study|Eligibility criteria not fulfilled|5|||
13318587|NCT01197794|26561747|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
13318588|NCT01197794|26561748|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
13318589|NCT01197794|26561749|FG003|Overall Study|Eligibility criteria not fulfilled|5|||
13318590|NCT01197794|26561750|FG004|Overall Study|Eligibility criteria not fulfilled|5|||
13318591|NCT01197794|26561751|FG005|Overall Study|Eligibility criteria not fulfilled|9|||
13318592|NCT01197794|26561752|FG006|Overall Study|Eligibility criteria not fulfilled|6|||
13318593|NCT01197794|26561746|FG000|Overall Study|Withdrawal by Subject|3|||
13318594|NCT01197794|26561747|FG001|Overall Study|Withdrawal by Subject|3|||
13318595|NCT01197794|26561748|FG002|Overall Study|Withdrawal by Subject|4|||
13318596|NCT01197794|26561749|FG003|Overall Study|Withdrawal by Subject|1|||
13318597|NCT01197794|26561750|FG004|Overall Study|Withdrawal by Subject|1|||
13318598|NCT01197794|26561751|FG005|Overall Study|Withdrawal by Subject|5|||
13318599|NCT01197794|26561752|FG006|Overall Study|Withdrawal by Subject|6|||
13318600|NCT01197794|26561746|FG000|Overall Study|Lost to Follow-up|1|||
13318601|NCT01197794|26561747|FG001|Overall Study|Lost to Follow-up|1|||
13318602|NCT01197794|26561748|FG002|Overall Study|Lost to Follow-up|0|||
13318603|NCT01197794|26561749|FG003|Overall Study|Lost to Follow-up|1|||
13318604|NCT01197794|26561750|FG004|Overall Study|Lost to Follow-up|0|||
13318605|NCT01197794|26561751|FG005|Overall Study|Lost to Follow-up|1|||
13318606|NCT01197794|26561752|FG006|Overall Study|Lost to Follow-up|0|||
13318607|NCT01197794|26561746|FG000|Overall Study|Other|1|||
13318608|NCT01197794|26561747|FG001|Overall Study|Other|1|||
13318609|NCT01197794|26561748|FG002|Overall Study|Other|3|||
13318610|NCT01197794|26561749|FG003|Overall Study|Other|0|||
13318611|NCT01197794|26561750|FG004|Overall Study|Other|2|||
13318612|NCT01197794|26561751|FG005|Overall Study|Other|2|||
13318613|NCT01197794|26561752|FG006|Overall Study|Other|4|||
13318614|NCT01197755|26561802|FG000|Overall Study|Adverse Event|8|||
13318615|NCT01197755|26561803|FG001|Overall Study|Adverse Event|10|||
13318616|NCT01197755|26561804|FG002|Overall Study|Adverse Event|10|||
13318617|NCT01197755|26561802|FG000|Overall Study|Study-specific discontinuation criteria|2|||
13318618|NCT01197755|26561803|FG001|Overall Study|Study-specific discontinuation criteria|1|||
13318619|NCT01197755|26561804|FG002|Overall Study|Study-specific discontinuation criteria|0|||
13318620|NCT01197755|26561802|FG000|Overall Study|Entered the long-term extension study|18|||
13318621|NCT01197755|26561803|FG001|Overall Study|Entered the long-term extension study|21|||
13318622|NCT01197755|26561804|FG002|Overall Study|Entered the long-term extension study|35|||
13318623|NCT01197755|26561802|FG000|Overall Study|Lack of therapeutic response|0|||
13318624|NCT01197755|26561803|FG001|Overall Study|Lack of therapeutic response|7|||
13318625|NCT01197755|26561804|FG002|Overall Study|Lack of therapeutic response|4|||
13318626|NCT01197755|26561802|FG000|Overall Study|Severe non-compliance to the protocol|2|||
13318627|NCT01197755|26561803|FG001|Overall Study|Severe non-compliance to the protocol|1|||
13318628|NCT01197755|26561804|FG002|Overall Study|Severe non-compliance to the protocol|2|||
13318629|NCT01197755|26561802|FG000|Overall Study|Withdrawal by Subject|1|||
13318630|NCT01197755|26561803|FG001|Overall Study|Withdrawal by Subject|0|||
13318631|NCT01197755|26561804|FG002|Overall Study|Withdrawal by Subject|0|||
13318632|NCT01197755|26561802|FG000|Overall Study|Lost to Follow-up|0|||
13318633|NCT01197755|26561803|FG001|Overall Study|Lost to Follow-up|0|||
13318634|NCT01197755|26561804|FG002|Overall Study|Lost to Follow-up|1|||
13318635|NCT01197755|26561802|FG000|Overall Study|eg, change in circumstances|7|||
13318636|NCT01197755|26561803|FG001|Overall Study|eg, change in circumstances|3|||
13318637|NCT01197755|26561804|FG002|Overall Study|eg, change in circumstances|2|||
13318638|NCT01197560|26561849|FG000|Overall Study|Adverse Event|6|||
13318639|NCT01197560|26561850|FG001|Overall Study|Adverse Event|8|||
13318640|NCT01197560|26561849|FG000|Overall Study|Death|3|||
13318641|NCT01197560|26561850|FG001|Overall Study|Death|5|||
13318642|NCT01197560|26561849|FG000|Overall Study|Withdrawal by Subject|1|||
13318643|NCT01197560|26561850|FG001|Overall Study|Withdrawal by Subject|1|||
13318644|NCT01197560|26561849|FG000|Overall Study|Disease progression|40|||
13318645|NCT01197560|26561850|FG001|Overall Study|Disease progression|35|||
13318646|NCT01197560|26561849|FG000|Overall Study|Miscellaneous|4|||
13318647|NCT01197560|26561850|FG001|Overall Study|Miscellaneous|3|||
13122189|NCT02969018|25946165|FG004|Overall Study|Pregnancy|0|||
13318648|NCT01197560|26561849|FG000|Overall Study|Missing|0|||
13318649|NCT01197560|26561850|FG001|Overall Study|Missing|1|||
13318650|NCT01197534|26561901|FG000|Overall Study|Not reported|16|||
13318651|NCT01197534|26561902|FG001|Overall Study|Not reported|10|||
13318652|NCT01197534|26561903|FG002|Overall Study|Not reported|16|||
13318653|NCT01197534|26561901|FG000|Overall Study|Enrolment in long term extension|57|||
13318654|NCT01197534|26561902|FG001|Overall Study|Enrolment in long term extension|66|||
13318655|NCT01197534|26561903|FG002|Overall Study|Enrolment in long term extension|119|||
13318656|NCT01197534|26561901|FG000|Overall Study|Severe non-compliance to protocol|3|||
13318657|NCT01197534|26561902|FG001|Overall Study|Severe non-compliance to protocol|4|||
13318658|NCT01197534|26561903|FG002|Overall Study|Severe non-compliance to protocol|1|||
13318659|NCT01197534|26561901|FG000|Overall Study|Lack of therapeutic response|9|||
13318660|NCT01197534|26561902|FG001|Overall Study|Lack of therapeutic response|4|||
13318661|NCT01197534|26561903|FG002|Overall Study|Lack of therapeutic response|9|||
13318662|NCT01197534|26561901|FG000|Overall Study|Dev. of study specific discont. criteria|13|||
13318663|NCT01197534|26561902|FG001|Overall Study|Dev. of study specific discont. criteria|6|||
13318664|NCT01197534|26561903|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
13318665|NCT01197534|26561901|FG000|Overall Study|Lost to Follow-up|1|||
13318666|NCT01197534|26561902|FG001|Overall Study|Lost to Follow-up|4|||
13318667|NCT01197534|26561903|FG002|Overall Study|Lost to Follow-up|2|||
13318668|NCT01197534|26561901|FG000|Overall Study|Adverse Event|35|||
13318669|NCT01197534|26561902|FG001|Overall Study|Adverse Event|36|||
13318670|NCT01197534|26561903|FG002|Overall Study|Adverse Event|24|||
13318671|NCT01197521|26561954|FG000|Overall Study|Not reported|24|||
13318672|NCT01197521|26561955|FG001|Overall Study|Not reported|25|||
13318673|NCT01197521|26561956|FG002|Overall Study|Not reported|21|||
13318674|NCT01197521|26561954|FG000|Overall Study|Enrolment in long term extension|42|||
13318675|NCT01197521|26561955|FG001|Overall Study|Enrolment in long term extension|36|||
13318676|NCT01197521|26561956|FG002|Overall Study|Enrolment in long term extension|87|||
13318677|NCT01197521|26561954|FG000|Overall Study|Severe non-compliance to protocol|1|||
13318678|NCT01197521|26561955|FG001|Overall Study|Severe non-compliance to protocol|3|||
13318679|NCT01197521|26561956|FG002|Overall Study|Severe non-compliance to protocol|3|||
13318680|NCT01197521|26561954|FG000|Overall Study|Lack of therapeutic response|2|||
13318681|NCT01197521|26561955|FG001|Overall Study|Lack of therapeutic response|3|||
13318682|NCT01197521|26561956|FG002|Overall Study|Lack of therapeutic response|4|||
13318683|NCT01197521|26561954|FG000|Overall Study|Dev. of study specific discont. criteria|6|||
13318684|NCT01197521|26561955|FG001|Overall Study|Dev. of study specific discont. criteria|16|||
13318685|NCT01197521|26561956|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
13318686|NCT01197521|26561954|FG000|Overall Study|Lost to Follow-up|3|||
13318687|NCT01197521|26561955|FG001|Overall Study|Lost to Follow-up|2|||
13318688|NCT01197521|26561956|FG002|Overall Study|Lost to Follow-up|2|||
13318689|NCT01197521|26561954|FG000|Overall Study|Adverse Event|25|||
13318690|NCT01197521|26561955|FG001|Overall Study|Adverse Event|28|||
13318691|NCT01197521|26561956|FG002|Overall Study|Adverse Event|24|||
13318692|NCT01197508|26562063|FG000|Overall Study|Withdrawal by Subject|8|||
13318693|NCT01197508|26562064|FG001|Overall Study|Withdrawal by Subject|7|||
13318694|NCT01197508|26562065|FG002|Overall Study|Withdrawal by Subject|15|||
13318695|NCT01197508|26562066|FG003|Overall Study|Withdrawal by Subject|4|||
13318696|NCT01197508|26562063|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
13318697|NCT01197508|26562064|FG001|Overall Study|Eligiblity criteria not fulfilled|0|||
13318698|NCT01197508|26562065|FG002|Overall Study|Eligiblity criteria not fulfilled|2|||
13318699|NCT01197508|26562066|FG003|Overall Study|Eligiblity criteria not fulfilled|0|||
13318700|NCT01197508|26562063|FG000|Overall Study|Adverse Event|10|||
13318701|NCT01197508|26562064|FG001|Overall Study|Adverse Event|13|||
13318702|NCT01197508|26562065|FG002|Overall Study|Adverse Event|23|||
13318703|NCT01197508|26562066|FG003|Overall Study|Adverse Event|3|||
13318704|NCT01197508|26562063|FG000|Overall Study|Severe non-compliance to protocol|0|||
13318705|NCT01197508|26562064|FG001|Overall Study|Severe non-compliance to protocol|3|||
13318706|NCT01197508|26562065|FG002|Overall Study|Severe non-compliance to protocol|1|||
13318707|NCT01197508|26562066|FG003|Overall Study|Severe non-compliance to protocol|3|||
13318708|NCT01197508|26562063|FG000|Overall Study|Condition under investigation worsened|1|||
13318709|NCT01197508|26562064|FG001|Overall Study|Condition under investigation worsened|1|||
13318710|NCT01197508|26562065|FG002|Overall Study|Condition under investigation worsened|1|||
13318711|NCT01197508|26562066|FG003|Overall Study|Condition under investigation worsened|1|||
13318712|NCT01197508|26562063|FG000|Overall Study|Lack of Efficacy|1|||
13318713|NCT01197508|26562064|FG001|Overall Study|Lack of Efficacy|2|||
13318714|NCT01197508|26562065|FG002|Overall Study|Lack of Efficacy|2|||
13318715|NCT01197508|26562066|FG003|Overall Study|Lack of Efficacy|1|||
13318716|NCT01197508|26562063|FG000|Overall Study|Study-specific withdrawal criteria|0|||
13318717|NCT01197508|26562064|FG001|Overall Study|Study-specific withdrawal criteria|0|||
13318718|NCT01197508|26562065|FG002|Overall Study|Study-specific withdrawal criteria|1|||
13318719|NCT01197508|26562066|FG003|Overall Study|Study-specific withdrawal criteria|2|||
13318720|NCT01197508|26562063|FG000|Overall Study|Lost to Follow-up|1|||
13318721|NCT01197508|26562064|FG001|Overall Study|Lost to Follow-up|1|||
13318722|NCT01197508|26562065|FG002|Overall Study|Lost to Follow-up|2|||
13318723|NCT01197508|26562066|FG003|Overall Study|Lost to Follow-up|0|||
13318724|NCT01197508|26562063|FG000|Overall Study|Other|2|||
13318725|NCT01197508|26562064|FG001|Overall Study|Other|3|||
13318726|NCT01197508|26562065|FG002|Overall Study|Other|2|||
13318727|NCT01197508|26562066|FG003|Overall Study|Other|2|||
13318728|NCT01197417|26562091|FG000|Overall Study|Physician Decision|3|||
13318729|NCT01197417|26562092|FG001|Overall Study|Physician Decision|2|||
13318730|NCT01197417|26562091|FG000|Overall Study|Withdrawal by Subject|2|||
13318731|NCT01197417|26562092|FG001|Overall Study|Withdrawal by Subject|4|||
13318732|NCT01197417|26562091|FG000|Overall Study|Site miscommunication|0|||
13318733|NCT01197417|26562092|FG001|Overall Study|Site miscommunication|1|||
13318734|NCT01197417|26562091|FG000|Overall Study|Subject transferred to intensive care|0|||
13318735|NCT01197417|26562092|FG001|Overall Study|Subject transferred to intensive care|1|||
13318736|NCT01197417|26562091|FG000|Overall Study|Not consented in time to receive drug|0|||
13318737|NCT01197417|26562092|FG001|Overall Study|Not consented in time to receive drug|1|||
13318738|NCT01197417|26562091|FG000|Overall Study|Hypotension|1|||
13318739|NCT01197417|26562092|FG001|Overall Study|Hypotension|2|||
13318740|NCT01197417|26562091|FG000|Overall Study|Found to be ineligible|2|||
13318741|NCT01197417|26562092|FG001|Overall Study|Found to be ineligible|5|||
13318742|NCT01197417|26562091|FG000|Overall Study|No 25-hour magnesium level|0|||
13318743|NCT01197417|26562092|FG001|Overall Study|No 25-hour magnesium level|2|||
13318744|NCT01197378|26562100|FG000|Overall Study|Adverse Event|3|||
13318745|NCT01197378|26562100|FG000|Overall Study|Withdrawal by Subject|1|||
13318746|NCT01197378|26562100|FG000|Overall Study|Physician Decision|1|||
13318747|NCT01197378|26562100|FG000|Overall Study|Other|2|||
13318748|NCT01197300|26562135|FG000|Overall Study|Lost to Follow-up|0|||
13318749|NCT01197300|26562136|FG001|Overall Study|Lost to Follow-up|1|||
13318750|NCT01197300|26562135|FG000|Overall Study|Protocol Violation|0|||
13318751|NCT01197300|26562136|FG001|Overall Study|Protocol Violation|1|||
13318752|NCT01196988|26562238|FG000|Overall Study|Adverse Event|1|||
13318753|NCT01196988|26562239|FG001|Overall Study|Adverse Event|2|||
13318754|NCT01196988|26562240|FG002|Overall Study|Adverse Event|0|||
13318755|NCT01196988|26562241|FG003|Overall Study|Adverse Event|0|||
13318756|NCT01196988|26562238|FG000|Overall Study|Withdrawal by Subject|5|||
13318757|NCT01196988|26562239|FG001|Overall Study|Withdrawal by Subject|1|||
13318758|NCT01196988|26562240|FG002|Overall Study|Withdrawal by Subject|4|||
13318759|NCT01196988|26562241|FG003|Overall Study|Withdrawal by Subject|0|||
13318760|NCT01196988|26562238|FG000|Overall Study|Lost to Follow-up|16|||
13318761|NCT01196988|26562239|FG001|Overall Study|Lost to Follow-up|29|||
13318762|NCT01196988|26562240|FG002|Overall Study|Lost to Follow-up|21|||
13318763|NCT01196988|26562241|FG003|Overall Study|Lost to Follow-up|1|||
13122190|NCT02969018|25946166|FG005|Overall Study|Pregnancy|1|||
13318764|NCT01196988|26562238|FG000|Overall Study|Other|2|||
13318765|NCT01196988|26562239|FG001|Overall Study|Other|0|||
13318766|NCT01196988|26562240|FG002|Overall Study|Other|0|||
13318767|NCT01196988|26562241|FG003|Overall Study|Other|0|||
13318768|NCT01196975|26562389|FG000|Overall Study|Adverse Event|2|||
13318769|NCT01196975|26562390|FG001|Overall Study|Adverse Event|2|||
13318770|NCT01196975|26562391|FG002|Overall Study|Adverse Event|0|||
13318771|NCT01196975|26562392|FG003|Overall Study|Adverse Event|0|||
13318772|NCT01196975|26562393|FG004|Overall Study|Adverse Event|2|||
13318773|NCT01196975|26562389|FG000|Overall Study|Withdrawal by Subject|2|||
13318774|NCT01196975|26562390|FG001|Overall Study|Withdrawal by Subject|1|||
13318775|NCT01196975|26562391|FG002|Overall Study|Withdrawal by Subject|0|||
13318776|NCT01196975|26562392|FG003|Overall Study|Withdrawal by Subject|1|||
13318777|NCT01196975|26562393|FG004|Overall Study|Withdrawal by Subject|0|||
13318778|NCT01196975|26562389|FG000|Overall Study|Lost to Follow-up|11|||
13318779|NCT01196975|26562390|FG001|Overall Study|Lost to Follow-up|6|||
13318780|NCT01196975|26562391|FG002|Overall Study|Lost to Follow-up|5|||
13318781|NCT01196975|26562392|FG003|Overall Study|Lost to Follow-up|5|||
13318782|NCT01196975|26562393|FG004|Overall Study|Lost to Follow-up|11|||
13373172|NCT00805194|26723135|FG000|Overall Study|Withdrawal by Subject|60|||
13373173|NCT00805194|26723136|FG001|Overall Study|Withdrawal by Subject|42|||
13373174|NCT00805194|26723135|FG000|Overall Study|Not treated|3|||
13373175|NCT00805194|26723136|FG001|Overall Study|Not treated|4|||
13373176|NCT00805194|26723135|FG000|Overall Study|Reasons other than stated above|20|||
13373177|NCT00805194|26723136|FG001|Overall Study|Reasons other than stated above|16|||
13373178|NCT00805142|26723167|FG000|Titration Period|Adverse Event|3|||
13373179|NCT00805142|26723168|FG001|Titration Period|Adverse Event|3|||
13373180|NCT00805142|26723167|FG000|Titration Period|Lack of Efficacy|1|||
13373181|NCT00805142|26723168|FG001|Titration Period|Lack of Efficacy|1|||
13373182|NCT00805142|26723167|FG000|Titration Period|Lost to Follow-up|0|||
13373183|NCT00805142|26723168|FG001|Titration Period|Lost to Follow-up|1|||
13373184|NCT00805142|26723167|FG000|Titration Period|Disease Progression|2|||
13373185|NCT00805142|26723168|FG001|Titration Period|Disease Progression|1|||
13373186|NCT00805142|26723167|FG000|Titration Period|Withdrawal of consent|0|||
13373187|NCT00805142|26723168|FG001|Titration Period|Withdrawal of consent|1|||
13373188|NCT00805142|26723167|FG000|Titration Period|Other|0|||
13318783|NCT01196741|26562414|FG000|Overall Study|Disease progression|34|||
13318784|NCT01196741|26562415|FG001|Overall Study|Disease progression|14|||
13122191|NCT02969018|25946167|FG006|Overall Study|Pregnancy|0|||
13122192|NCT02969018|25946168|FG007|Overall Study|Pregnancy|0|||
13122193|NCT02969018|25946161|FG000|Overall Study|Protocol Violation|0|||
13122194|NCT02969018|25946162|FG001|Overall Study|Protocol Violation|0|||
13122195|NCT02969018|25946163|FG002|Overall Study|Protocol Violation|1|||
13122196|NCT02969018|25946164|FG003|Overall Study|Protocol Violation|1|||
13122197|NCT02969018|25946165|FG004|Overall Study|Protocol Violation|0|||
13122198|NCT02969018|25946166|FG005|Overall Study|Protocol Violation|0|||
13122199|NCT02969018|25946167|FG006|Overall Study|Protocol Violation|0|||
13122200|NCT02969018|25946168|FG007|Overall Study|Protocol Violation|0|||
13122201|NCT02969018|25946161|FG000|Overall Study|Withdrawal by Subject|0|||
13122202|NCT02969018|25946162|FG001|Overall Study|Withdrawal by Subject|1|||
13318785|NCT01196741|26562414|FG000|Overall Study|Adverse Event|10|||
13318786|NCT01196741|26562415|FG001|Overall Study|Adverse Event|6|||
13318787|NCT01196741|26562414|FG000|Overall Study|Serious Adverse Event|3|||
13318788|NCT01196741|26562415|FG001|Overall Study|Serious Adverse Event|1|||
13318789|NCT01196741|26562414|FG000|Overall Study|Dose limiting Adverse Event|2|||
13318790|NCT01196741|26562415|FG001|Overall Study|Dose limiting Adverse Event|1|||
13318791|NCT01196741|26562414|FG000|Overall Study|Withdrawal by Subject|3|||
13318792|NCT01196741|26562415|FG001|Overall Study|Withdrawal by Subject|0|||
13318793|NCT01196741|26562414|FG000|Overall Study|Other reason|3|||
13318794|NCT01196741|26562415|FG001|Overall Study|Other reason|3|||
13318795|NCT01196741|26562414|FG000|Overall Study|Other|3|||
13318796|NCT01196741|26562415|FG001|Overall Study|Other|2|||
13318797|NCT01196741|26562414|FG000|Overall Study|Protocol Violation|2|||
13318798|NCT01196741|26562415|FG001|Overall Study|Protocol Violation|1|||
13318799|NCT01196429|26562438|FG000|Overall Study|Ineligible - inadequate pathology|1|||
13318800|NCT01196429|26562439|FG001|Overall Study|Ineligible - inadequate pathology|0|||
13318801|NCT01196429|26562438|FG000|Overall Study|Ineligible - wrong cell type|1|||
13318802|NCT01196429|26562439|FG001|Overall Study|Ineligible - wrong cell type|0|||
13318803|NCT01196429|26562438|FG000|Overall Study|Refused - Never Treated|1|||
13318804|NCT01196429|26562439|FG001|Overall Study|Refused - Never Treated|0|||
13318805|NCT01196416|26562455|FG000|Overall Study|Withdrawal by Subject|2|||
13318806|NCT01196390|26562478|FG000|Overall Study|Protocol Violation|4|||
13318807|NCT01196390|26562479|FG001|Overall Study|Protocol Violation|5|||
13318808|NCT01196104|26562526|FG000|Overall Study|Lost to Follow-up|1|||
13318809|NCT01196104|26562527|FG001|Overall Study|Lost to Follow-up|0|||
13318810|NCT01196104|26562526|FG000|Overall Study|Physician Decision|0|||
13318811|NCT01196104|26562527|FG001|Overall Study|Physician Decision|1|||
13318812|NCT01196104|26562526|FG000|Overall Study|Withdrawal by Subject|3|||
13318813|NCT01196104|26562527|FG001|Overall Study|Withdrawal by Subject|3|||
13318814|NCT01196104|26562526|FG000|Overall Study|Various|0|||
13318815|NCT01196104|26562527|FG001|Overall Study|Various|1|||
13318816|NCT01196091|26562587|FG000|Overall Study|Adverse Event|22|||
13318817|NCT01196091|26562588|FG001|Overall Study|Adverse Event|27|||
13318818|NCT01196091|26562589|FG002|Overall Study|Adverse Event|26|||
13318819|NCT01196091|26562587|FG000|Overall Study|Death|3|||
13318820|NCT01196091|26562588|FG001|Overall Study|Death|2|||
13318821|NCT01196091|26562589|FG002|Overall Study|Death|2|||
13318822|NCT01196091|26562587|FG000|Overall Study|Entry Criteria Not Met|11|||
13318823|NCT01196091|26562588|FG001|Overall Study|Entry Criteria Not Met|11|||
13318824|NCT01196091|26562589|FG002|Overall Study|Entry Criteria Not Met|10|||
13318825|NCT01196091|26562587|FG000|Overall Study|Lack of Efficacy|15|||
13318826|NCT01196091|26562588|FG001|Overall Study|Lack of Efficacy|12|||
13318827|NCT01196091|26562589|FG002|Overall Study|Lack of Efficacy|17|||
13122203|NCT02969018|25946163|FG002|Overall Study|Withdrawal by Subject|2|||
13122204|NCT02969018|25946164|FG003|Overall Study|Withdrawal by Subject|1|||
13318828|NCT01196091|26562587|FG000|Overall Study|Lost to Follow-up|5|||
13318829|NCT01196091|26562588|FG001|Overall Study|Lost to Follow-up|5|||
13318830|NCT01196091|26562589|FG002|Overall Study|Lost to Follow-up|6|||
13318831|NCT01196091|26562587|FG000|Overall Study|Parent/Caregiver Decision|0|||
13318832|NCT01196091|26562588|FG001|Overall Study|Parent/Caregiver Decision|0|||
13318833|NCT01196091|26562589|FG002|Overall Study|Parent/Caregiver Decision|1|||
13318834|NCT01196091|26562587|FG000|Overall Study|Withdrawal by Subject|16|||
13318835|NCT01196091|26562588|FG001|Overall Study|Withdrawal by Subject|19|||
13318836|NCT01196091|26562589|FG002|Overall Study|Withdrawal by Subject|22|||
13318837|NCT01196091|26562587|FG000|Overall Study|Physician Decision|3|||
13318838|NCT01196091|26562588|FG001|Overall Study|Physician Decision|3|||
13318839|NCT01196091|26562589|FG002|Overall Study|Physician Decision|4|||
13318840|NCT01196091|26562587|FG000|Overall Study|Protocol Violation|1|||
13318841|NCT01196091|26562588|FG001|Overall Study|Protocol Violation|3|||
13318842|NCT01196091|26562589|FG002|Overall Study|Protocol Violation|3|||
13318843|NCT01196091|26562587|FG000|Overall Study|Sponsor Decision|6|||
13318844|NCT01196091|26562588|FG001|Overall Study|Sponsor Decision|5|||
13318845|NCT01196091|26562589|FG002|Overall Study|Sponsor Decision|4|||
13318846|NCT01196091|26562587|FG000|Overall Study|Excluded Site|5|||
13318847|NCT01196091|26562588|FG001|Overall Study|Excluded Site|11|||
13318848|NCT01196091|26562589|FG002|Overall Study|Excluded Site|8|||
13318849|NCT01196091|26562587|FG000|Overall Study|Randomized, No Study Drug Received|1|||
13318850|NCT01196091|26562588|FG001|Overall Study|Randomized, No Study Drug Received|0|||
13318851|NCT01196091|26562589|FG002|Overall Study|Randomized, No Study Drug Received|1|||
13318852|NCT01196078|26562624|FG000|Overall Study|Withdrawal by Subject|3|||
13318853|NCT01196078|26562625|FG001|Overall Study|Withdrawal by Subject|5|||
13318854|NCT01196078|26562624|FG000|Overall Study|Adverse Event|4|||
13318855|NCT01196078|26562625|FG001|Overall Study|Adverse Event|4|||
13318856|NCT01196078|26562624|FG000|Overall Study|Protocol Violation|2|||
13122205|NCT02969018|25946165|FG004|Overall Study|Withdrawal by Subject|0|||
13122206|NCT02969018|25946166|FG005|Overall Study|Withdrawal by Subject|4|||
13318857|NCT01196078|26562625|FG001|Overall Study|Protocol Violation|1|||
13318858|NCT01196078|26562624|FG000|Overall Study|Lack of Efficacy|17|||
13318859|NCT01196078|26562625|FG001|Overall Study|Lack of Efficacy|23|||
13318860|NCT01196078|26562624|FG000|Overall Study|Lost to Follow-up|1|||
13318861|NCT01196078|26562625|FG001|Overall Study|Lost to Follow-up|0|||
13318862|NCT01196078|26562624|FG000|Overall Study|Death|6|||
13318863|NCT01196078|26562625|FG001|Overall Study|Death|4|||
13318864|NCT01196052|26562638|FG000|Overall Study|Adverse Event|9|||
13318865|NCT01196052|26562638|FG000|Overall Study|Lost to Follow-up|1|||
13318866|NCT01196052|26562638|FG000|Overall Study|Noncompliance to Protocol Requirements|2|||
13318867|NCT01196052|26562638|FG000|Overall Study|Reason not Specified|5|||
13318868|NCT01196052|26562638|FG000|Overall Study|Withdrawal by Subject|6|||
13318869|NCT01196026|26562888|FG000|Overall Study|Withdrawal by Subject|1|||
13318870|NCT01196026|26562889|FG001|Overall Study|Withdrawal by Subject|4|||
13318871|NCT01196026|26562890|FG002|Overall Study|Withdrawal by Subject|0|||
13318872|NCT01196026|26562891|FG003|Overall Study|Withdrawal by Subject|0|||
13318873|NCT01196026|26562892|FG004|Overall Study|Withdrawal by Subject|0|||
13318874|NCT01196026|26562893|FG005|Overall Study|Withdrawal by Subject|0|||
13318875|NCT01196026|26562888|FG000|Overall Study|Lost to Follow-up|0|||
13318876|NCT01196026|26562889|FG001|Overall Study|Lost to Follow-up|3|||
13318877|NCT01196026|26562890|FG002|Overall Study|Lost to Follow-up|0|||
13318878|NCT01196026|26562891|FG003|Overall Study|Lost to Follow-up|0|||
13318879|NCT01196026|26562892|FG004|Overall Study|Lost to Follow-up|1|||
13318880|NCT01196026|26562893|FG005|Overall Study|Lost to Follow-up|0|||
13318881|NCT01196026|26562888|FG000|Overall Study|Other|0|||
13318882|NCT01196026|26562889|FG001|Overall Study|Other|1|||
13318883|NCT01196026|26562890|FG002|Overall Study|Other|0|||
13318884|NCT01196026|26562891|FG003|Overall Study|Other|0|||
13318885|NCT01196026|26562892|FG004|Overall Study|Other|0|||
13318886|NCT01196026|26562893|FG005|Overall Study|Other|0|||
13318887|NCT01195948|26562935|FG000|Overall Study|Lost to Follow-up|0|||
13318888|NCT01195948|26562936|FG001|Overall Study|Lost to Follow-up|1|||
13318889|NCT01195948|26562937|FG002|Overall Study|Lost to Follow-up|2|||
13318890|NCT01195844|26562954|FG000|Overall Study|Fecal sample not collected|40|||
13318891|NCT01195831|26562975|FG000|Overall Study|Lost to Follow-up|2|||
13318892|NCT01195831|26562976|FG001|Overall Study|Lost to Follow-up|4|||
13318893|NCT01195831|26562975|FG000|Overall Study|Withdrawal by Subject|2|||
13318894|NCT01195831|26562976|FG001|Overall Study|Withdrawal by Subject|2|||
13318895|NCT01195831|26562975|FG000|Overall Study|Adverse Event|4|||
13318896|NCT01195831|26562976|FG001|Overall Study|Adverse Event|2|||
13318897|NCT01195831|26562975|FG000|Overall Study|Protocol Violation|0|||
13318898|NCT01195831|26562976|FG001|Overall Study|Protocol Violation|2|||
13318899|NCT01195675|26563008|FG000|Overall Study|Adverse Event|1|||
13318900|NCT01195675|26563008|FG000|Overall Study|Withdrawal by Subject|2|||
13318901|NCT01195662|26563046|FG000|Double Blind Treatment Period|Adverse Event|4|||
13318902|NCT01195662|26563047|FG001|Double Blind Treatment Period|Adverse Event|1|||
13318903|NCT01195662|26563048|FG002|Double Blind Treatment Period|Adverse Event|2|||
13318904|NCT01195662|26563046|FG000|Double Blind Treatment Period|Withdrawal by Subject|6|||
13318905|NCT01195662|26563047|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
13318906|NCT01195662|26563048|FG002|Double Blind Treatment Period|Withdrawal by Subject|4|||
13318907|NCT01195662|26563046|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
13318908|NCT01195662|26563047|FG001|Double Blind Treatment Period|Lost to Follow-up|2|||
13318909|NCT01195662|26563048|FG002|Double Blind Treatment Period|Lost to Follow-up|3|||
13318910|NCT01195662|26563046|FG000|Double Blind Treatment Period|Administrative reason|2|||
13318911|NCT01195662|26563047|FG001|Double Blind Treatment Period|Administrative reason|1|||
13318912|NCT01195662|26563048|FG002|Double Blind Treatment Period|Administrative reason|1|||
13318913|NCT01195662|26563046|FG000|Double Blind Treatment Period|Requested discontinue treatment|1|||
13318914|NCT01195662|26563047|FG001|Double Blind Treatment Period|Requested discontinue treatment|0|||
13318915|NCT01195662|26563048|FG002|Double Blind Treatment Period|Requested discontinue treatment|1|||
13318916|NCT01195662|26563046|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1|||
13318917|NCT01195662|26563047|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5|||
13318918|NCT01195662|26563048|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2|||
13318919|NCT01195662|26563046|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
13318920|NCT01195662|26563047|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
13318921|NCT01195662|26563048|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
13318922|NCT01195662|26563046|FG000|Double Blind Treatment Period|Non-specified|3|||
13318923|NCT01195662|26563047|FG001|Double Blind Treatment Period|Non-specified|0|||
13318924|NCT01195662|26563048|FG002|Double Blind Treatment Period|Non-specified|0|||
13122207|NCT02969018|25946167|FG006|Overall Study|Withdrawal by Subject|4|||
13122208|NCT02969018|25946168|FG007|Overall Study|Withdrawal by Subject|3|||
13318925|NCT01195662|26563046|FG000|Double Blind Treatment Period|Missing disposition information|0|||
13122209|NCT02968979|25946256|FG000|Overall Study|Protocol Violation|7|||
13122210|NCT02968979|25946256|FG000|Overall Study|Withdrawal by Subject|1|||
13122211|NCT02968576|25946264|FG000|Overall Study|Pregnancy|0|||
13122212|NCT02968576|25946265|FG001|Overall Study|Pregnancy|1|||
13122213|NCT02968433|25946280|FG000|Overall Study|Withdrawal by Subject|1|||
13122214|NCT02968173|25946294|FG000|Overall Study|Withdrawal by Subject|1|||
13122215|NCT02967679|25946315|FG000|Overall Study|Adverse Event|1|||
13318926|NCT01195662|26563047|FG001|Double Blind Treatment Period|Missing disposition information|1|||
13318927|NCT01195662|26563048|FG002|Double Blind Treatment Period|Missing disposition information|1|||
13318928|NCT01195662|26563046|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2|||
13318929|NCT01195662|26563047|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0|||
13318930|NCT01195662|26563048|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1|||
13318931|NCT01195662|26563046|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1|||
13318932|NCT01195662|26563047|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
13318933|NCT01195662|26563048|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
13318934|NCT01195636|26563079|FG000|First Intervention (3 Weeks)|Adverse Event|2|||
13318935|NCT01195636|26563080|FG001|First Intervention (3 Weeks)|Adverse Event|3|||
13318936|NCT01195636|26563079|FG000|First Intervention (3 Weeks)|Protocol Violation|1|||
13318937|NCT01195636|26563080|FG001|First Intervention (3 Weeks)|Protocol Violation|0|||
13318938|NCT01195636|26563079|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
13318939|NCT01195636|26563080|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
13318940|NCT01195636|26563079|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
13318941|NCT01195636|26563080|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0|||
13318942|NCT01195636|26563079|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
13318943|NCT01195636|26563080|FG001|Washout Period (2 Weeks)|Adverse Event|1|||
13318944|NCT01195636|26563079|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
13318945|NCT01195636|26563080|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
13318946|NCT01195636|26563079|FG000|Second Intervention (3 Weeks)|Adverse Event|1|||
13318947|NCT01195636|26563080|FG001|Second Intervention (3 Weeks)|Adverse Event|1|||
13318948|NCT01195636|26563079|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
13318949|NCT01195636|26563080|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
13318950|NCT01195623|26563095|FG000|Overall Study|Lost to Follow-up|35|||
13318951|NCT01195623|26563096|FG001|Overall Study|Lost to Follow-up|37|||
13318952|NCT01195545|26563105|FG000|Overall Study|Protocol Violation|4|||
13318953|NCT01195415|26563114|FG000|Overall Study|No repeat biopsy due to progression|2|||
13318954|NCT01195363|26563127|FG000|Overall Study|Lost to Follow-up|7|||
13122216|NCT02967562|25946332|FG000|Overall Study|Consent not obtained|1|||
13122217|NCT02967562|25946333|FG001|Overall Study|Consent not obtained|0|||
13122218|NCT02967562|25946332|FG000|Overall Study|High leak precluding analysis|1|||
13122219|NCT02967562|25946333|FG001|Overall Study|High leak precluding analysis|1|||
13122220|NCT02967055|25946341|FG000|Overall Study|Excluded|40|||
13122221|NCT02967055|25946341|FG000|Overall Study|Screen fail|3|||
13122222|NCT02967055|25946341|FG000|Overall Study|Lost to Follow-up|2|||
13122223|NCT02967055|25946341|FG000|Overall Study|Stopped due to side effects|3|||
13122224|NCT02967055|25946341|FG000|Overall Study|Stopped due to drug cost|1|||
13122225|NCT02966834|25946589|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
13122226|NCT02966834|25946590|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
13122227|NCT02966834|25946591|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
13122228|NCT02966834|25946592|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
13122229|NCT02966834|25946593|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1|||
13122230|NCT02966834|25946594|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
13122231|NCT02966834|25946589|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1|||
13122232|NCT02966834|25946590|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
13122233|NCT02966834|25946591|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
13122234|NCT02966834|25946592|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
13122235|NCT02966834|25946593|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
13122236|NCT02966834|25946594|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
13122237|NCT02966834|25946589|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
13122238|NCT02966834|25946590|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
13122239|NCT02966834|25946591|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4|||
13133478|NCT02769065|25988360|FG019|Overall Study|Voluntary Withdrawal|0|||
13318955|NCT01195363|26563128|FG001|Overall Study|Lost to Follow-up|4|||
13318956|NCT01195363|26563127|FG000|Overall Study|Adverse Event|3|||
13318957|NCT01195363|26563128|FG001|Overall Study|Adverse Event|1|||
13318958|NCT01195363|26563127|FG000|Overall Study|Lack of Efficacy|0|||
13318959|NCT01195363|26563128|FG001|Overall Study|Lack of Efficacy|4|||
13318960|NCT01195363|26563127|FG000|Overall Study|incarceration|1|||
13318961|NCT01195363|26563128|FG001|Overall Study|incarceration|0|||
13318962|NCT01195272|26563147|FG000|Overall Study|Adverse Event|1|||
13318963|NCT01195272|26563147|FG000|Overall Study|Lack of Efficacy|3|||
13318964|NCT01195103|26563165|FG000|Overall Study|Withdrawal by Subject|1|||
13318965|NCT01195103|26563166|FG001|Overall Study|Withdrawal by Subject|0|||
13318966|NCT01195103|26563167|FG002|Overall Study|Withdrawal by Subject|0|||
13122240|NCT02966834|25946592|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8|||
13133479|NCT02769065|25988361|FG020|Overall Study|Voluntary Withdrawal|0|||
13318967|NCT01195090|26563232|FG000|Overall Study|Adverse Event|1|||
13318968|NCT01195090|26563233|FG001|Overall Study|Adverse Event|2|||
13318969|NCT01195090|26563232|FG000|Overall Study|Lost to Follow-up|2|||
13318970|NCT01195090|26563233|FG001|Overall Study|Lost to Follow-up|2|||
13318971|NCT01195090|26563232|FG000|Overall Study|Protocol Violation|3|||
13318972|NCT01195090|26563233|FG001|Overall Study|Protocol Violation|4|||
13318973|NCT01194999|26563239|FG000|Overall Study|Lost to Follow-up|17|||
13318974|NCT01194973|26563256|FG000|Screening Period|Screen Failure|3|||
13318975|NCT01194973|26563256|FG000|26 Week Treatment Period|Adverse Event|1|||
13318976|NCT01194973|26563256|FG000|26 Week Treatment Period|Lack of Efficacy|1|||
13318977|NCT01194973|26563256|FG000|26 Week Treatment Period|Pregnancy|1|||
13318978|NCT01194869|26563264|FG000|Overall Study|Disease Progression|2|||
13318979|NCT01194869|26563264|FG000|Overall Study|Toxicity|2|||
13318980|NCT01194830|26563293|FG000|Overall Study|Adverse Event|3|||
13318981|NCT01194830|26563294|FG001|Overall Study|Adverse Event|2|||
13318982|NCT01194830|26563293|FG000|Overall Study|Protocol Violation|5|||
13318983|NCT01194830|26563294|FG001|Overall Study|Protocol Violation|4|||
13318984|NCT01194830|26563293|FG000|Overall Study|Lost to Follow-up|9|||
13318985|NCT01194830|26563294|FG001|Overall Study|Lost to Follow-up|7|||
13318986|NCT01194830|26563293|FG000|Overall Study|Withdrawal by Subject|2|||
13318987|NCT01194830|26563294|FG001|Overall Study|Withdrawal by Subject|1|||
13318988|NCT01194830|26563293|FG000|Overall Study|Lack of Efficacy|1|||
13318989|NCT01194830|26563294|FG001|Overall Study|Lack of Efficacy|1|||
13318990|NCT01194830|26563293|FG000|Overall Study|Non-compliance issues|4|||
13318991|NCT01194830|26563294|FG001|Overall Study|Non-compliance issues|4|||
13318992|NCT01194830|26563293|FG000|Overall Study|Other Reason|12|||
13318993|NCT01194830|26563294|FG001|Overall Study|Other Reason|8|||
13318994|NCT01194804|26563304|FG000|Overall Study|Withdrawal by Subject|1|||
13318995|NCT01194531|26563317|FG000|Overall Study|Withdrawal by Subject|1|||
13318996|NCT01194531|26563318|FG001|Overall Study|Withdrawal by Subject|0|||
13318997|NCT01194531|26563317|FG000|Overall Study|Protocol Violation|4|||
13318998|NCT01194531|26563318|FG001|Overall Study|Protocol Violation|1|||
13318999|NCT01194531|26563317|FG000|Overall Study|Physician Decision|0|||
13319000|NCT01194531|26563318|FG001|Overall Study|Physician Decision|2|||
13319001|NCT01194440|26563327|FG000|Baseline (First Dose)|Reason not specified|4|||
13319002|NCT01194440|26563327|FG000|Baseline (First Dose)|Lack of Efficacy|1|||
13319003|NCT01194440|26563327|FG000|Baseline (First Dose)|Change in therapy|1|||
13319004|NCT01194440|26563327|FG000|Baseline (First Dose)|Adverse Event|1|||
13319005|NCT01194440|26563327|FG000|6-months (2nd Dose)|Change in therapy|4|||
13319006|NCT01194414|26563396|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11|||
13319007|NCT01194414|26563397|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8|||
13319008|NCT01194414|26563398|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
13319009|NCT01194414|26563399|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
13319010|NCT01194414|26563396|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9|||
13319011|NCT01194414|26563397|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5|||
13319012|NCT01194414|26563398|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
13319013|NCT01194414|26563399|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
13319014|NCT01194414|26563396|FG000|24 Weeks Double Blind Period|Protocol Violation|5|||
13319015|NCT01194414|26563397|FG001|24 Weeks Double Blind Period|Protocol Violation|3|||
13319016|NCT01194414|26563398|FG002|24 Weeks Double Blind Period|Protocol Violation|0|||
13319017|NCT01194414|26563399|FG003|24 Weeks Double Blind Period|Protocol Violation|0|||
13319018|NCT01194414|26563396|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
13319019|NCT01194414|26563397|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5|||
13319020|NCT01194414|26563398|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
13319021|NCT01194414|26563399|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
13319022|NCT01194414|26563396|FG000|24 Weeks Double Blind Period|Pregnancy|2|||
13319023|NCT01194414|26563397|FG001|24 Weeks Double Blind Period|Pregnancy|2|||
13319024|NCT01194414|26563398|FG002|24 Weeks Double Blind Period|Pregnancy|0|||
13319025|NCT01194414|26563399|FG003|24 Weeks Double Blind Period|Pregnancy|0|||
13319026|NCT01194414|26563396|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2|||
13319027|NCT01194414|26563397|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1|||
13319028|NCT01194414|26563398|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0|||
13319029|NCT01194414|26563399|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0|||
13319030|NCT01194414|26563396|FG000|24 Weeks Double Blind Period|Other|0|||
13319031|NCT01194414|26563397|FG001|24 Weeks Double Blind Period|Other|1|||
13319032|NCT01194414|26563398|FG002|24 Weeks Double Blind Period|Other|0|||
13319033|NCT01194414|26563399|FG003|24 Weeks Double Blind Period|Other|0|||
13319034|NCT01194414|26563396|FG000|24 Weeks Double Blind Period|Adverse Event|28|||
13319035|NCT01194414|26563397|FG001|24 Weeks Double Blind Period|Adverse Event|40|||
13319036|NCT01194414|26563398|FG002|24 Weeks Double Blind Period|Adverse Event|0|||
13319037|NCT01194414|26563399|FG003|24 Weeks Double Blind Period|Adverse Event|0|||
13319038|NCT01194414|26563396|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2|||
13319039|NCT01194414|26563397|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1|||
13319040|NCT01194414|26563398|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
13319041|NCT01194414|26563399|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
13319042|NCT01194414|26563396|FG000|24 Weeks Double Blind Period|Death|0|||
13319043|NCT01194414|26563397|FG001|24 Weeks Double Blind Period|Death|1|||
13319044|NCT01194414|26563398|FG002|24 Weeks Double Blind Period|Death|0|||
13319045|NCT01194414|26563399|FG003|24 Weeks Double Blind Period|Death|0|||
13319046|NCT01194414|26563396|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3|||
13319047|NCT01194414|26563397|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5|||
13319048|NCT01194414|26563398|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0|||
13319049|NCT01194414|26563399|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0|||
13319050|NCT01194414|26563396|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20|||
13319051|NCT01194414|26563397|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14|||
13319052|NCT01194414|26563398|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1|||
13319053|NCT01194414|26563399|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6|||
13319054|NCT01194414|26563396|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9|||
13319055|NCT01194414|26563397|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11|||
13319056|NCT01194414|26563398|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2|||
13319057|NCT01194414|26563399|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3|||
13319058|NCT01194414|26563396|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4|||
13319059|NCT01194414|26563397|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3|||
13319060|NCT01194414|26563398|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2|||
13319061|NCT01194414|26563399|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1|||
13319062|NCT01194414|26563396|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3|||
13319063|NCT01194414|26563397|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5|||
13319064|NCT01194414|26563398|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
13319065|NCT01194414|26563399|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
13319066|NCT01194414|26563396|FG000|72 Weeks Open Label Extension|Pregnancy|1|||
13319067|NCT01194414|26563397|FG001|72 Weeks Open Label Extension|Pregnancy|3|||
13319068|NCT01194414|26563398|FG002|72 Weeks Open Label Extension|Pregnancy|1|||
13319069|NCT01194414|26563399|FG003|72 Weeks Open Label Extension|Pregnancy|1|||
13319070|NCT01194414|26563396|FG000|72 Weeks Open Label Extension|Other|2|||
13319071|NCT01194414|26563397|FG001|72 Weeks Open Label Extension|Other|1|||
13319072|NCT01194414|26563398|FG002|72 Weeks Open Label Extension|Other|0|||
13319073|NCT01194414|26563399|FG003|72 Weeks Open Label Extension|Other|0|||
13319074|NCT01194414|26563396|FG000|72 Weeks Open Label Extension|Protocol Violation|0|||
13319075|NCT01194414|26563397|FG001|72 Weeks Open Label Extension|Protocol Violation|0|||
13319076|NCT01194414|26563398|FG002|72 Weeks Open Label Extension|Protocol Violation|0|||
13319077|NCT01194414|26563399|FG003|72 Weeks Open Label Extension|Protocol Violation|1|||
13319078|NCT01194414|26563396|FG000|72 Weeks Open Label Extension|Adverse Event|35|||
13319079|NCT01194414|26563397|FG001|72 Weeks Open Label Extension|Adverse Event|21|||
13319080|NCT01194414|26563398|FG002|72 Weeks Open Label Extension|Adverse Event|2|||
13319081|NCT01194414|26563399|FG003|72 Weeks Open Label Extension|Adverse Event|12|||
13319082|NCT01194414|26563396|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
13319083|NCT01194414|26563397|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
13319084|NCT01194414|26563398|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
13319085|NCT01194414|26563399|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
13319086|NCT01194414|26563396|FG000|72 Weeks Open Label Extension|Death|1|||
13319087|NCT01194414|26563397|FG001|72 Weeks Open Label Extension|Death|2|||
13319088|NCT01194414|26563398|FG002|72 Weeks Open Label Extension|Death|0|||
13319089|NCT01194414|26563399|FG003|72 Weeks Open Label Extension|Death|2|||
13319090|NCT01194271|26563405|FG000|Overall Study|Withdrawal by Subject|1|||
13319091|NCT01194271|26563405|FG000|Overall Study|Ineligible, Screen Failure|1|||
13319092|NCT01194271|26563405|FG000|Overall Study|Death|1|||
13319093|NCT01194258|26563430|FG000|Titration Period|Withdrawal by Subject|6|||
13319094|NCT01194258|26563431|FG001|Titration Period|Withdrawal by Subject|0|||
13319095|NCT01194258|26563432|FG002|Titration Period|Withdrawal by Subject|0|||
13319096|NCT01194258|26563433|FG003|Titration Period|Withdrawal by Subject|0|||
13319097|NCT01194258|26563434|FG004|Titration Period|Withdrawal by Subject|0|||
13319098|NCT01194258|26563430|FG000|Titration Period|Lost to Follow-up|2|||
13319099|NCT01194258|26563431|FG001|Titration Period|Lost to Follow-up|0|||
13319100|NCT01194258|26563432|FG002|Titration Period|Lost to Follow-up|0|||
13319101|NCT01194258|26563433|FG003|Titration Period|Lost to Follow-up|0|||
13319102|NCT01194258|26563434|FG004|Titration Period|Lost to Follow-up|0|||
13319103|NCT01194258|26563430|FG000|Titration Period|Titration failure|3|||
13319104|NCT01194258|26563431|FG001|Titration Period|Titration failure|0|||
13319105|NCT01194258|26563432|FG002|Titration Period|Titration failure|0|||
13319106|NCT01194258|26563433|FG003|Titration Period|Titration failure|0|||
13319107|NCT01194258|26563434|FG004|Titration Period|Titration failure|0|||
13319108|NCT01194258|26563430|FG000|Period 1 (12 Weeks)|Death|0|||
13319109|NCT01194258|26563431|FG001|Period 1 (12 Weeks)|Death|0|||
13319110|NCT01194258|26563432|FG002|Period 1 (12 Weeks)|Death|0|||
13319111|NCT01194258|26563433|FG003|Period 1 (12 Weeks)|Death|0|||
13319112|NCT01194258|26563434|FG004|Period 1 (12 Weeks)|Death|1|||
13319113|NCT01194258|26563430|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
13319114|NCT01194258|26563431|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
13319115|NCT01194258|26563432|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0|||
13319116|NCT01194258|26563433|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
13319117|NCT01194258|26563434|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2|||
13319118|NCT01194258|26563430|FG000|Period 2 (12 Weeks)|Adverse Event|0|||
13319119|NCT01194258|26563431|FG001|Period 2 (12 Weeks)|Adverse Event|1|||
13319120|NCT01194258|26563432|FG002|Period 2 (12 Weeks)|Adverse Event|0|||
13319121|NCT01194258|26563433|FG003|Period 2 (12 Weeks)|Adverse Event|0|||
13319122|NCT01194258|26563434|FG004|Period 2 (12 Weeks)|Adverse Event|0|||
13319123|NCT01194258|26563430|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
13319124|NCT01194258|26563431|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
13319125|NCT01194258|26563432|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
13319126|NCT01194258|26563433|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
13319127|NCT01194258|26563434|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
13319128|NCT01194245|26563469|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5|||
13319129|NCT01194245|26563470|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
13319130|NCT01194245|26563471|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
13319131|NCT01194245|26563472|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
13319132|NCT01194245|26563473|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
13319133|NCT01194245|26563469|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3|||
13319134|NCT01194245|26563470|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
13319135|NCT01194245|26563471|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
13319136|NCT01194245|26563472|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
13319137|NCT01194245|26563473|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
13319138|NCT01194245|26563469|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3|||
13319139|NCT01194245|26563470|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
13319140|NCT01194245|26563471|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
13319141|NCT01194245|26563472|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
13319142|NCT01194245|26563473|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
13319143|NCT01194245|26563469|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7|||
13319144|NCT01194245|26563470|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
13319145|NCT01194245|26563471|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
13319146|NCT01194245|26563472|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
13319147|NCT01194245|26563473|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
13319148|NCT01194245|26563469|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
13319149|NCT01194245|26563470|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
13319150|NCT01194245|26563471|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
13319151|NCT01194245|26563472|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
13319152|NCT01194245|26563473|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
13319153|NCT01194245|26563469|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
13319154|NCT01194245|26563470|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
13319155|NCT01194245|26563471|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
13319156|NCT01194245|26563472|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
13319157|NCT01194245|26563473|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
13319158|NCT01194219|26563520|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23|||
13319159|NCT01194219|26563521|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5|||
13319160|NCT01194219|26563522|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
13319161|NCT01194219|26563523|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
13319162|NCT01194219|26563524|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
13319163|NCT01194219|26563525|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
13319164|NCT01194219|26563526|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
13319165|NCT01194219|26563527|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
13319166|NCT01194219|26563528|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
13319167|NCT01194219|26563529|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
13319168|NCT01194219|26563520|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2|||
13319169|NCT01194219|26563521|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7|||
13319170|NCT01194219|26563522|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
13319171|NCT01194219|26563523|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
13319172|NCT01194219|26563524|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
13319173|NCT01194219|26563525|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
13319174|NCT01194219|26563526|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
13319175|NCT01194219|26563527|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
13319176|NCT01194219|26563528|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
13319177|NCT01194219|26563529|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
13319178|NCT01194219|26563520|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7|||
13319179|NCT01194219|26563521|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
13319180|NCT01194219|26563522|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
13319181|NCT01194219|26563523|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
13319182|NCT01194219|26563524|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
13319183|NCT01194219|26563525|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
13319184|NCT01194219|26563526|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
13319185|NCT01194219|26563527|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
13319186|NCT01194219|26563528|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
13319187|NCT01194219|26563529|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
13319188|NCT01194219|26563520|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12|||
13319189|NCT01194219|26563521|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9|||
13319190|NCT01194219|26563522|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
13319191|NCT01194219|26563523|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
13319192|NCT01194219|26563524|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
13319193|NCT01194219|26563525|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
13319194|NCT01194219|26563526|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
13319195|NCT01194219|26563527|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
13319196|NCT01194219|26563528|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
13319197|NCT01194219|26563529|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
13319198|NCT01194219|26563520|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0|||
13319199|NCT01194219|26563521|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1|||
13319200|NCT01194219|26563522|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0|||
13319201|NCT01194219|26563523|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0|||
13319202|NCT01194219|26563524|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0|||
13319203|NCT01194219|26563525|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0|||
13319204|NCT01194219|26563526|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0|||
13319205|NCT01194219|26563527|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0|||
13319206|NCT01194219|26563528|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0|||
13319207|NCT01194219|26563529|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0|||
13319208|NCT01194219|26563520|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7|||
13319209|NCT01194219|26563521|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9|||
13319210|NCT01194219|26563522|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
13319211|NCT01194219|26563523|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
13319212|NCT01194219|26563524|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
13319213|NCT01194219|26563525|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
13319214|NCT01194219|26563526|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
13319215|NCT01194219|26563527|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
13319216|NCT01194219|26563528|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
13319217|NCT01194219|26563529|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
13319218|NCT01194219|26563520|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7|||
13319219|NCT01194219|26563521|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1|||
13319220|NCT01194219|26563522|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
13319221|NCT01194219|26563523|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
13319222|NCT01194219|26563524|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
13319223|NCT01194219|26563525|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
13319224|NCT01194219|26563526|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
13319225|NCT01194219|26563527|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
13319226|NCT01194219|26563528|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
13319227|NCT01194219|26563529|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
13319228|NCT01194219|26563520|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
13319229|NCT01194219|26563521|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
13319230|NCT01194219|26563522|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
13319231|NCT01194219|26563523|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
13319232|NCT01194219|26563524|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
13319233|NCT01194219|26563525|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
13373189|NCT00805142|26723168|FG001|Titration Period|Other|3|||
13319234|NCT01194219|26563526|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
13319235|NCT01194219|26563527|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
13319236|NCT01194219|26563528|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
13319237|NCT01194219|26563529|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
13319238|NCT01194219|26563520|FG000|Maintenance Phase Weeks16-32|Adverse Event|0|||
13319239|NCT01194219|26563521|FG001|Maintenance Phase Weeks16-32|Adverse Event|0|||
13319240|NCT01194219|26563522|FG002|Maintenance Phase Weeks16-32|Adverse Event|8|||
13319241|NCT01194219|26563523|FG003|Maintenance Phase Weeks16-32|Adverse Event|9|||
13319242|NCT01194219|26563524|FG004|Maintenance Phase Weeks16-32|Adverse Event|0|||
13319243|NCT01194219|26563525|FG005|Maintenance Phase Weeks16-32|Adverse Event|0|||
13319244|NCT01194219|26563526|FG006|Maintenance Phase Weeks16-32|Adverse Event|0|||
13319245|NCT01194219|26563527|FG007|Maintenance Phase Weeks16-32|Adverse Event|0|||
13319246|NCT01194219|26563528|FG008|Maintenance Phase Weeks16-32|Adverse Event|0|||
13319247|NCT01194219|26563529|FG009|Maintenance Phase Weeks16-32|Adverse Event|0|||
13319248|NCT01194219|26563520|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
13319249|NCT01194219|26563521|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
13319250|NCT01194219|26563522|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37|||
13319251|NCT01194219|26563523|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15|||
13319252|NCT01194219|26563524|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
13319253|NCT01194219|26563525|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
13319254|NCT01194219|26563526|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
13319255|NCT01194219|26563527|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
13319256|NCT01194219|26563528|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
13319257|NCT01194219|26563529|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
13319258|NCT01194219|26563520|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
13319259|NCT01194219|26563521|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
13319260|NCT01194219|26563522|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2|||
13319261|NCT01194219|26563523|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1|||
13319262|NCT01194219|26563524|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
13319263|NCT01194219|26563525|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
13319264|NCT01194219|26563526|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
13319265|NCT01194219|26563527|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
13319266|NCT01194219|26563528|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
13319267|NCT01194219|26563529|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
13319268|NCT01194219|26563520|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
13319269|NCT01194219|26563521|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
13319270|NCT01194219|26563522|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12|||
13319271|NCT01194219|26563523|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3|||
13319272|NCT01194219|26563524|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
13319273|NCT01194219|26563525|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
13319274|NCT01194219|26563526|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
13319275|NCT01194219|26563527|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
13319276|NCT01194219|26563528|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
13319277|NCT01194219|26563529|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
13319278|NCT01194219|26563520|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
13319279|NCT01194219|26563521|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
13319280|NCT01194219|26563522|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9|||
13319281|NCT01194219|26563523|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
13319282|NCT01194219|26563524|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
13319283|NCT01194219|26563525|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
13319284|NCT01194219|26563526|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
13319285|NCT01194219|26563527|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
13319286|NCT01194219|26563528|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
13319287|NCT01194219|26563529|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
13319288|NCT01194219|26563520|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0|||
13286833|NCT00477672|26472364|FG000|Overall Study|Consent withdrawn|2|||
13286834|NCT00477672|26472365|FG001|Overall Study|Consent withdrawn|5|||
13286835|NCT00477672|26472366|FG002|Overall Study|Consent withdrawn|10|||
13286836|NCT00477672|26472364|FG000|Overall Study|Discretion of Sponsor|1|||
13286837|NCT00477672|26472365|FG001|Overall Study|Discretion of Sponsor|2|||
13286838|NCT00477672|26472366|FG002|Overall Study|Discretion of Sponsor|0|||
13286839|NCT00477633|26472374|FG000|Overall Study|Did not receive treatment|23|||
13286840|NCT00477633|26472374|FG000|Overall Study|Adverse Event|143|||
13286841|NCT00477633|26472374|FG000|Overall Study|Pregnancy|23|||
13286842|NCT00477633|26472374|FG000|Overall Study|Lost to Follow-up|271|||
13286843|NCT00477633|26472374|FG000|Overall Study|Withdrawal by Subject|149|||
13286844|NCT00477633|26472374|FG000|Overall Study|Protocol Violation|25|||
13286845|NCT00477633|26472374|FG000|Overall Study|Various (Moving, Enrollment closed)|75|||
13286846|NCT00477607|26472391|FG000|Overall Study|Lost to Follow-up|7|||
13319289|NCT01194219|26563521|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0|||
13319290|NCT01194219|26563522|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0|||
13319291|NCT01194219|26563523|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1|||
13319292|NCT01194219|26563524|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0|||
13319293|NCT01194219|26563525|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0|||
13319294|NCT01194219|26563526|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0|||
13319295|NCT01194219|26563527|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0|||
13319296|NCT01194219|26563528|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0|||
13319297|NCT01194219|26563529|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0|||
13319298|NCT01194219|26563520|FG000|Maintenance Phase Weeks16-32|Other|0|||
13319299|NCT01194219|26563521|FG001|Maintenance Phase Weeks16-32|Other|0|||
13319300|NCT01194219|26563522|FG002|Maintenance Phase Weeks16-32|Other|2|||
13319301|NCT01194219|26563523|FG003|Maintenance Phase Weeks16-32|Other|1|||
13319302|NCT01194219|26563524|FG004|Maintenance Phase Weeks16-32|Other|0|||
13319303|NCT01194219|26563525|FG005|Maintenance Phase Weeks16-32|Other|0|||
13319304|NCT01194219|26563526|FG006|Maintenance Phase Weeks16-32|Other|0|||
13319305|NCT01194219|26563527|FG007|Maintenance Phase Weeks16-32|Other|0|||
13319306|NCT01194219|26563528|FG008|Maintenance Phase Weeks16-32|Other|0|||
13319307|NCT01194219|26563529|FG009|Maintenance Phase Weeks16-32|Other|0|||
13319308|NCT01194219|26563520|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
13319309|NCT01194219|26563521|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
13319310|NCT01194219|26563522|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
13319311|NCT01194219|26563523|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
13319312|NCT01194219|26563524|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
13319313|NCT01194219|26563525|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1|||
13319314|NCT01194219|26563526|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6|||
13319315|NCT01194219|26563527|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5|||
13319316|NCT01194219|26563528|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
13319317|NCT01194219|26563529|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
13319318|NCT01194219|26563520|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
13319319|NCT01194219|26563521|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
13319320|NCT01194219|26563522|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
13319321|NCT01194219|26563523|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
13319322|NCT01194219|26563524|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
13319323|NCT01194219|26563525|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
13319324|NCT01194219|26563526|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35|||
13319325|NCT01194219|26563527|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33|||
13319326|NCT01194219|26563528|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
13319327|NCT01194219|26563529|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
13319328|NCT01194219|26563520|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
13319329|NCT01194219|26563521|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
13319330|NCT01194219|26563522|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
13319331|NCT01194219|26563523|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
13319332|NCT01194219|26563524|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1|||
13319333|NCT01194219|26563525|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
13319334|NCT01194219|26563526|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2|||
13319335|NCT01194219|26563527|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
13319336|NCT01194219|26563528|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
13319337|NCT01194219|26563529|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
13319338|NCT01194219|26563520|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
13319339|NCT01194219|26563521|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
13319340|NCT01194219|26563522|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
13319341|NCT01194219|26563523|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
13319342|NCT01194219|26563524|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1|||
13319343|NCT01194219|26563525|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
13319344|NCT01194219|26563526|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12|||
13319345|NCT01194219|26563527|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6|||
13319346|NCT01194219|26563528|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
13319347|NCT01194219|26563529|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
13319348|NCT01194219|26563520|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
13319349|NCT01194219|26563521|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
13319350|NCT01194219|26563522|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
13319351|NCT01194219|26563523|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
13319352|NCT01194219|26563524|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1|||
13319353|NCT01194219|26563525|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2|||
13373190|NCT00805142|26723167|FG000|Maintenance Period|Adverse Event|0|||
13319354|NCT01194219|26563526|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5|||
13319355|NCT01194219|26563527|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
13319356|NCT01194219|26563528|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
13319357|NCT01194219|26563529|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
13319358|NCT01194219|26563520|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
13319359|NCT01194219|26563521|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
13319360|NCT01194219|26563522|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
13319361|NCT01194219|26563523|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
13319362|NCT01194219|26563524|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
13319363|NCT01194219|26563525|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
13319364|NCT01194219|26563526|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
13319365|NCT01194219|26563527|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1|||
13319366|NCT01194219|26563528|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
13319367|NCT01194219|26563529|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
13319368|NCT01194219|26563520|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
13319369|NCT01194219|26563521|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
13319370|NCT01194219|26563522|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
13319371|NCT01194219|26563523|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
13319372|NCT01194219|26563524|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
13319373|NCT01194219|26563525|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
13319374|NCT01194219|26563526|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1|||
13319375|NCT01194219|26563527|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
13319376|NCT01194219|26563528|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
13319377|NCT01194219|26563529|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
13319378|NCT01194219|26563520|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
13319379|NCT01194219|26563521|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
13319380|NCT01194219|26563522|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
13319381|NCT01194219|26563523|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
13319382|NCT01194219|26563524|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
13319383|NCT01194219|26563525|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
13319384|NCT01194219|26563526|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
13319385|NCT01194219|26563527|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
13319386|NCT01194219|26563528|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25|||
13319387|NCT01194219|26563529|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14|||
13319388|NCT01194219|26563520|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
13319389|NCT01194219|26563521|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
13319390|NCT01194219|26563522|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
13319391|NCT01194219|26563523|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
13319392|NCT01194219|26563524|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
13319393|NCT01194219|26563525|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
13319394|NCT01194219|26563526|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
13319395|NCT01194219|26563527|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
13319396|NCT01194219|26563528|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81|||
13319397|NCT01194219|26563529|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49|||
13319398|NCT01194219|26563520|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
13319399|NCT01194219|26563521|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
13319400|NCT01194219|26563522|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
13319401|NCT01194219|26563523|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
13319402|NCT01194219|26563524|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
13319403|NCT01194219|26563525|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
13319404|NCT01194219|26563526|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
13319405|NCT01194219|26563527|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
13319406|NCT01194219|26563528|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9|||
13319407|NCT01194219|26563529|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4|||
13319408|NCT01194219|26563520|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
13319409|NCT01194219|26563521|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
13319410|NCT01194219|26563522|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
13319411|NCT01194219|26563523|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
13319412|NCT01194219|26563524|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
13319413|NCT01194219|26563525|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
13319414|NCT01194219|26563526|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
13319415|NCT01194219|26563527|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
13319416|NCT01194219|26563528|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66|||
13319417|NCT01194219|26563529|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32|||
13319418|NCT01194219|26563520|FG000|Long-Term Extension Weeks 52 to 260|Death|0|||
13319419|NCT01194219|26563521|FG001|Long-Term Extension Weeks 52 to 260|Death|0|||
13319420|NCT01194219|26563522|FG002|Long-Term Extension Weeks 52 to 260|Death|0|||
13319421|NCT01194219|26563523|FG003|Long-Term Extension Weeks 52 to 260|Death|0|||
13319422|NCT01194219|26563524|FG004|Long-Term Extension Weeks 52 to 260|Death|0|||
13319423|NCT01194219|26563525|FG005|Long-Term Extension Weeks 52 to 260|Death|0|||
13319424|NCT01194219|26563526|FG006|Long-Term Extension Weeks 52 to 260|Death|0|||
13319425|NCT01194219|26563527|FG007|Long-Term Extension Weeks 52 to 260|Death|0|||
13319426|NCT01194219|26563528|FG008|Long-Term Extension Weeks 52 to 260|Death|1|||
13319427|NCT01194219|26563529|FG009|Long-Term Extension Weeks 52 to 260|Death|1|||
13319428|NCT01194219|26563520|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
13319429|NCT01194219|26563521|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
13319430|NCT01194219|26563522|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
13319431|NCT01194219|26563523|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
13319432|NCT01194219|26563524|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
13319433|NCT01194219|26563525|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
13319434|NCT01194219|26563526|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
13319435|NCT01194219|26563527|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
13319436|NCT01194219|26563528|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24|||
13319437|NCT01194219|26563529|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10|||
13319438|NCT01194219|26563520|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
13319439|NCT01194219|26563521|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
13319440|NCT01194219|26563522|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
13319441|NCT01194219|26563523|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
13319442|NCT01194219|26563524|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
13319443|NCT01194219|26563525|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
13319444|NCT01194219|26563526|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
13319445|NCT01194219|26563527|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
13319446|NCT01194219|26563528|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3|||
13319447|NCT01194219|26563529|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
13319448|NCT01194219|26563520|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
13319449|NCT01194219|26563521|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
13319450|NCT01194219|26563522|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
13319451|NCT01194219|26563523|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
13319452|NCT01194219|26563524|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
13319453|NCT01194219|26563525|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
13319454|NCT01194219|26563526|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
13319455|NCT01194219|26563527|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
13319456|NCT01194219|26563528|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11|||
13319457|NCT01194219|26563529|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2|||
13319458|NCT01194154|26563554|FG000|Overall Study|Adverse Event|12|||
13319459|NCT01194154|26563555|FG001|Overall Study|Adverse Event|7|||
13319460|NCT01194154|26563554|FG000|Overall Study|Lost to Follow-up|2|||
13319461|NCT01194154|26563555|FG001|Overall Study|Lost to Follow-up|3|||
13319462|NCT01194154|26563554|FG000|Overall Study|Protocol Violation|0|||
13319463|NCT01194154|26563555|FG001|Overall Study|Protocol Violation|1|||
13319464|NCT01194154|26563554|FG000|Overall Study|Withdrawal by Subject|5|||
13319465|NCT01194154|26563555|FG001|Overall Study|Withdrawal by Subject|6|||
13319466|NCT01194154|26563554|FG000|Overall Study|Blood pressure increase|5|||
13319467|NCT01194154|26563555|FG001|Overall Study|Blood pressure increase|3|||
13319468|NCT01194154|26563554|FG000|Overall Study|Hemoglobin decrease|0|||
13319469|NCT01194154|26563555|FG001|Overall Study|Hemoglobin decrease|1|||
13319470|NCT01194154|26563554|FG000|Overall Study|Hemoglobin increase|12|||
13319471|NCT01194154|26563555|FG001|Overall Study|Hemoglobin increase|3|||
13319472|NCT01194154|26563554|FG000|Overall Study|Skipping of CERA treatment at two visits|3|||
13319473|NCT01194154|26563555|FG001|Overall Study|Skipping of CERA treatment at two visits|0|||
13319474|NCT01194154|26563554|FG000|Overall Study|Treatment with prohibited medication|4|||
13319475|NCT01194154|26563555|FG001|Overall Study|Treatment with prohibited medication|5|||
13319476|NCT01194154|26563554|FG000|Overall Study|Other|4|||
13319477|NCT01194154|26563555|FG001|Overall Study|Other|0|||
13319478|NCT01194154|26563554|FG000|Overall Study|Did not receive study medication|2|||
13319479|NCT01194154|26563555|FG001|Overall Study|Did not receive study medication|4|||
13319480|NCT01193920|26563636|FG000|Overall Study|Withdrawal by Subject|1|||
13319481|NCT01193920|26563637|FG001|Overall Study|Withdrawal by Subject|0|||
13319482|NCT01193920|26563638|FG002|Overall Study|Withdrawal by Subject|5|||
13319483|NCT01193920|26563639|FG003|Overall Study|Withdrawal by Subject|1|||
13319484|NCT01193920|26563640|FG004|Overall Study|Withdrawal by Subject|3|||
13319485|NCT01193920|26563641|FG005|Overall Study|Withdrawal by Subject|1|||
13319486|NCT01193920|26563642|FG006|Overall Study|Withdrawal by Subject|3|||
13319487|NCT01193920|26563643|FG007|Overall Study|Withdrawal by Subject|0|||
13319488|NCT01193920|26563644|FG008|Overall Study|Withdrawal by Subject|1|||
13319489|NCT01193920|26563645|FG009|Overall Study|Withdrawal by Subject|0|||
13319490|NCT01193920|26563636|FG000|Overall Study|Lost to Follow-up|1|||
13319491|NCT01193920|26563637|FG001|Overall Study|Lost to Follow-up|0|||
13319492|NCT01193920|26563638|FG002|Overall Study|Lost to Follow-up|1|||
13319493|NCT01193920|26563639|FG003|Overall Study|Lost to Follow-up|1|||
13319494|NCT01193920|26563640|FG004|Overall Study|Lost to Follow-up|3|||
13319495|NCT01193920|26563641|FG005|Overall Study|Lost to Follow-up|3|||
13319496|NCT01193920|26563642|FG006|Overall Study|Lost to Follow-up|1|||
13319497|NCT01193920|26563643|FG007|Overall Study|Lost to Follow-up|0|||
13319498|NCT01193920|26563644|FG008|Overall Study|Lost to Follow-up|2|||
13319499|NCT01193920|26563645|FG009|Overall Study|Lost to Follow-up|3|||
13319500|NCT01193920|26563636|FG000|Overall Study|Protocol Violation|1|||
13319501|NCT01193920|26563637|FG001|Overall Study|Protocol Violation|0|||
13319502|NCT01193920|26563638|FG002|Overall Study|Protocol Violation|0|||
13319503|NCT01193920|26563639|FG003|Overall Study|Protocol Violation|0|||
13319504|NCT01193920|26563640|FG004|Overall Study|Protocol Violation|0|||
13319505|NCT01193920|26563641|FG005|Overall Study|Protocol Violation|0|||
13319506|NCT01193920|26563642|FG006|Overall Study|Protocol Violation|0|||
13319507|NCT01193920|26563643|FG007|Overall Study|Protocol Violation|0|||
13319508|NCT01193920|26563644|FG008|Overall Study|Protocol Violation|0|||
13319509|NCT01193920|26563645|FG009|Overall Study|Protocol Violation|0|||
13319510|NCT01193920|26563636|FG000|Overall Study|Death|0|||
13319511|NCT01193920|26563637|FG001|Overall Study|Death|0|||
13319512|NCT01193920|26563638|FG002|Overall Study|Death|0|||
13319513|NCT01193920|26563639|FG003|Overall Study|Death|1|||
13319514|NCT01193920|26563640|FG004|Overall Study|Death|0|||
13319515|NCT01193920|26563641|FG005|Overall Study|Death|0|||
13319516|NCT01193920|26563642|FG006|Overall Study|Death|2|||
13319517|NCT01193920|26563643|FG007|Overall Study|Death|3|||
13319518|NCT01193920|26563644|FG008|Overall Study|Death|2|||
13319519|NCT01193920|26563645|FG009|Overall Study|Death|4|||
13319520|NCT01193920|26563636|FG000|Overall Study|Unable to classify|0|||
13319521|NCT01193920|26563637|FG001|Overall Study|Unable to classify|0|||
13319522|NCT01193920|26563638|FG002|Overall Study|Unable to classify|0|||
13319523|NCT01193920|26563639|FG003|Overall Study|Unable to classify|1|||
13319524|NCT01193920|26563640|FG004|Overall Study|Unable to classify|0|||
13319525|NCT01193920|26563641|FG005|Overall Study|Unable to classify|0|||
13286847|NCT00477607|26472392|FG001|Overall Study|Lost to Follow-up|7|||
13286848|NCT00477490|26472496|FG000|Part I: 4 Week Efficacy|Adverse Event|1|||
13286849|NCT00477490|26472497|FG001|Part I: 4 Week Efficacy|Adverse Event|4|||
13286850|NCT00477490|26472498|FG002|Part I: 4 Week Efficacy|Adverse Event|0|||
13286851|NCT00477490|26472499|FG003|Part I: 4 Week Efficacy|Adverse Event|5|||
13286852|NCT00477490|26472500|FG004|Part I: 4 Week Efficacy|Adverse Event|6|||
13286853|NCT00477490|26472501|FG005|Part I: 4 Week Efficacy|Adverse Event|0|||
13286854|NCT00477490|26472502|FG006|Part I: 4 Week Efficacy|Adverse Event|0|||
13286855|NCT00477490|26472503|FG007|Part I: 4 Week Efficacy|Adverse Event|0|||
13319526|NCT01193920|26563642|FG006|Overall Study|Unable to classify|0|||
13319527|NCT01193920|26563643|FG007|Overall Study|Unable to classify|1|||
13319528|NCT01193920|26563644|FG008|Overall Study|Unable to classify|0|||
13319529|NCT01193920|26563645|FG009|Overall Study|Unable to classify|0|||
13319530|NCT01193686|26563666|FG000|Overall Study|Withdrawal by Subject|4|||
13319531|NCT01193686|26563667|FG001|Overall Study|Withdrawal by Subject|1|||
13319532|NCT01193686|26563666|FG000|Overall Study|Removed by Investigators; unable to matc|3|||
13319533|NCT01193686|26563667|FG001|Overall Study|Removed by Investigators; unable to matc|0|||
13319534|NCT01193660|26563715|FG000|Overall Study|Withdrawal by Subject|2|||
13319535|NCT01193660|26563716|FG001|Overall Study|Withdrawal by Subject|3|||
13319536|NCT01193660|26563717|FG002|Overall Study|Withdrawal by Subject|1|||
13319537|NCT01193660|26563715|FG000|Overall Study|Death|1|||
13319538|NCT01193660|26563716|FG001|Overall Study|Death|0|||
13319539|NCT01193660|26563717|FG002|Overall Study|Death|0|||
13319540|NCT01193660|26563715|FG000|Overall Study|Physician Decision|1|||
13319541|NCT01193660|26563716|FG001|Overall Study|Physician Decision|0|||
13319542|NCT01193660|26563717|FG002|Overall Study|Physician Decision|1|||
13319543|NCT01193608|26563969|FG000|Overall Study|Other|0|||
13319544|NCT01193608|26563970|FG001|Overall Study|Other|1|||
13319545|NCT01193608|26563971|FG002|Overall Study|Other|0|||
13319546|NCT01193608|26563972|FG003|Overall Study|Other|0|||
13319547|NCT01193608|26563973|FG004|Overall Study|Other|0|||
13319548|NCT01193608|26563974|FG005|Overall Study|Other|0|||
13319549|NCT01193608|26563969|FG000|Overall Study|Withdrawal by Subject|0|||
13319550|NCT01193608|26563970|FG001|Overall Study|Withdrawal by Subject|1|||
13319551|NCT01193608|26563971|FG002|Overall Study|Withdrawal by Subject|2|||
13319552|NCT01193608|26563972|FG003|Overall Study|Withdrawal by Subject|3|||
13319553|NCT01193608|26563973|FG004|Overall Study|Withdrawal by Subject|3|||
13319554|NCT01193608|26563974|FG005|Overall Study|Withdrawal by Subject|0|||
13319555|NCT01193608|26563969|FG000|Overall Study|Lost to Follow-up|0|||
13319556|NCT01193608|26563970|FG001|Overall Study|Lost to Follow-up|0|||
13319557|NCT01193608|26563971|FG002|Overall Study|Lost to Follow-up|0|||
13319558|NCT01193608|26563972|FG003|Overall Study|Lost to Follow-up|0|||
13319559|NCT01193608|26563973|FG004|Overall Study|Lost to Follow-up|1|||
13319560|NCT01193608|26563974|FG005|Overall Study|Lost to Follow-up|2|||
13319561|NCT01193608|26563969|FG000|Overall Study|Adverse Event|0|||
13319562|NCT01193608|26563970|FG001|Overall Study|Adverse Event|0|||
13319563|NCT01193608|26563971|FG002|Overall Study|Adverse Event|0|||
13319564|NCT01193608|26563972|FG003|Overall Study|Adverse Event|0|||
13319565|NCT01193608|26563973|FG004|Overall Study|Adverse Event|1|||
13319566|NCT01193608|26563974|FG005|Overall Study|Adverse Event|0|||
13319567|NCT01193582|26564015|FG000|Vaccination Series|Withdrawal by Subject|11|||
13319568|NCT01193582|26564016|FG001|Vaccination Series|Withdrawal by Subject|13|||
13319569|NCT01193582|26564017|FG002|Vaccination Series|Withdrawal by Subject|8|||
13319570|NCT01193582|26564018|FG003|Vaccination Series|Withdrawal by Subject|3|||
13319571|NCT01193582|26564015|FG000|12 Month Follow-up|Death|0|||
13319572|NCT01193582|26564016|FG001|12 Month Follow-up|Death|0|||
13319573|NCT01193582|26564017|FG002|12 Month Follow-up|Death|1|||
13319574|NCT01193582|26564018|FG003|12 Month Follow-up|Death|0|||
13319575|NCT01193582|26564015|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
13319576|NCT01193582|26564016|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
13319577|NCT01193582|26564017|FG002|12 Month Follow-up|Withdrawal by Subject|3|||
13319578|NCT01193582|26564018|FG003|12 Month Follow-up|Withdrawal by Subject|11|||
13319579|NCT01193556|26564033|FG000|Overall Study|Study termination|26|||
13319580|NCT01193556|26564034|FG001|Overall Study|Study termination|25|||
13319581|NCT01193530|26564047|FG000|Overall Study|Withdrawal by Subject|2|||
13319582|NCT01193530|26564048|FG001|Overall Study|Withdrawal by Subject|2|||
13319583|NCT01193530|26564047|FG000|Overall Study|Began Contraindicated Therapy|1|||
13319584|NCT01193530|26564048|FG001|Overall Study|Began Contraindicated Therapy|0|||
13319585|NCT01193530|26564047|FG000|Overall Study|Lost Light Box|0|||
13319586|NCT01193530|26564048|FG001|Overall Study|Lost Light Box|1|||
13319587|NCT01193530|26564047|FG000|Overall Study|Returned home - out of state|0|||
13319588|NCT01193530|26564048|FG001|Overall Study|Returned home - out of state|1|||
13319589|NCT01193530|26564047|FG000|Overall Study|Non-Compliance|0|||
13319590|NCT01193530|26564048|FG001|Overall Study|Non-Compliance|1|||
13319591|NCT01193517|26564067|FG000|Overall Study|Early Progression|1|||
13319592|NCT01193517|26564068|FG001|Overall Study|Early Progression|0|||
13319593|NCT01193517|26564069|FG002|Overall Study|Early Progression|0|||
13319594|NCT01193348|26564089|FG000|Screening Period|Screen Failure|5|||
13319595|NCT01193348|26564089|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1|||
13319596|NCT01193348|26564089|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1|||
13319597|NCT01193348|26564089|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1|||
13319598|NCT01193348|26564089|FG000|Extension Treatment Period|Physician Decision|1|||
13319599|NCT01193348|26564089|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2|||
13319600|NCT01193335|26564191|FG000|After Infant Series|Lost to Follow-up|1|||
13319601|NCT01193335|26564192|FG001|After Infant Series|Lost to Follow-up|2|||
13319602|NCT01193335|26564191|FG000|After Infant Series|No Longer Met Eligibility Criteria|0|||
13319603|NCT01193335|26564192|FG001|After Infant Series|No Longer Met Eligibility Criteria|1|||
13319604|NCT01193335|26564191|FG000|1-Year Follow-up|No Longer Willing to Participate|7|||
13319605|NCT01193335|26564192|FG001|1-Year Follow-up|No Longer Willing to Participate|9|||
13319606|NCT01193335|26564191|FG000|1-Year Follow-up|Lost to Follow-up|4|||
13319607|NCT01193335|26564192|FG001|1-Year Follow-up|Lost to Follow-up|0|||
13319608|NCT01193335|26564191|FG000|2-Year Follow-up|No Longer Willing to Participate|5|||
13319609|NCT01193335|26564192|FG001|2-Year Follow-up|No Longer Willing to Participate|6|||
13319610|NCT01193335|26564191|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
13319611|NCT01193335|26564192|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
13319612|NCT01193283|26564198|FG000|Overall Study|Death|1|||
13319613|NCT01193257|26564253|FG000|Overall Study|Death|202|||
13319614|NCT01193257|26564254|FG001|Overall Study|Death|391|||
13319615|NCT01193257|26564253|FG000|Overall Study|Study termination by sponsor|0|||
13319616|NCT01193257|26564254|FG001|Overall Study|Study termination by sponsor|3|||
13319617|NCT01193257|26564253|FG000|Overall Study|Withdrawal by Subject|26|||
13319618|NCT01193257|26564254|FG001|Overall Study|Withdrawal by Subject|86|||
13319619|NCT01193257|26564253|FG000|Overall Study|Lost to Follow-up|2|||
13319620|NCT01193257|26564254|FG001|Overall Study|Lost to Follow-up|3|||
13319621|NCT01193257|26564253|FG000|Overall Study|Unblinded due to futility|135|||
13319622|NCT01193257|26564254|FG001|Overall Study|Unblinded due to futility|251|||
13319623|NCT01193244|26564311|FG000|Overall Study|Withdrawal by Subject|79|||
13319624|NCT01193244|26564312|FG001|Overall Study|Withdrawal by Subject|97|||
13319625|NCT01193244|26564311|FG000|Overall Study|Other|303|||
13319626|NCT01193244|26564312|FG001|Overall Study|Other|278|||
13319627|NCT01193244|26564311|FG000|Overall Study|Lost to Follow-up|6|||
13319628|NCT01193244|26564312|FG001|Overall Study|Lost to Follow-up|15|||
13319629|NCT01193218|26564362|FG000|0-12 Weeks|Adverse Event|6|||
13319630|NCT01193218|26564363|FG001|0-12 Weeks|Adverse Event|0|||
13319631|NCT01193218|26564364|FG002|0-12 Weeks|Adverse Event|1|||
13319632|NCT01193218|26564365|FG003|0-12 Weeks|Adverse Event|0|||
13319633|NCT01193218|26564366|FG004|0-12 Weeks|Adverse Event|0|||
13319634|NCT01193218|26564367|FG005|0-12 Weeks|Adverse Event|2|||
13319635|NCT01193218|26564368|FG006|0-12 Weeks|Adverse Event|2|||
13319636|NCT01193218|26564369|FG007|0-12 Weeks|Adverse Event|0|||
13319637|NCT01193218|26564362|FG000|0-12 Weeks|Protocol Violation|0|||
13319638|NCT01193218|26564363|FG001|0-12 Weeks|Protocol Violation|0|||
13319639|NCT01193218|26564364|FG002|0-12 Weeks|Protocol Violation|0|||
13319640|NCT01193218|26564365|FG003|0-12 Weeks|Protocol Violation|0|||
13319641|NCT01193218|26564366|FG004|0-12 Weeks|Protocol Violation|1|||
13319642|NCT01193218|26564367|FG005|0-12 Weeks|Protocol Violation|1|||
13319643|NCT01193218|26564368|FG006|0-12 Weeks|Protocol Violation|0|||
13319644|NCT01193218|26564369|FG007|0-12 Weeks|Protocol Violation|0|||
13319645|NCT01193218|26564362|FG000|0-12 Weeks|Withdrawal by Subject|3|||
13319646|NCT01193218|26564363|FG001|0-12 Weeks|Withdrawal by Subject|0|||
13319647|NCT01193218|26564364|FG002|0-12 Weeks|Withdrawal by Subject|2|||
13319648|NCT01193218|26564365|FG003|0-12 Weeks|Withdrawal by Subject|0|||
13319649|NCT01193218|26564366|FG004|0-12 Weeks|Withdrawal by Subject|0|||
13319650|NCT01193218|26564367|FG005|0-12 Weeks|Withdrawal by Subject|0|||
13319651|NCT01193218|26564368|FG006|0-12 Weeks|Withdrawal by Subject|1|||
13319652|NCT01193218|26564369|FG007|0-12 Weeks|Withdrawal by Subject|0|||
13319653|NCT01193218|26564362|FG000|12-52 Weeks|Adverse Event|1|||
13319654|NCT01193218|26564363|FG001|12-52 Weeks|Adverse Event|0|||
13319655|NCT01193218|26564364|FG002|12-52 Weeks|Adverse Event|1|||
13319656|NCT01193218|26564365|FG003|12-52 Weeks|Adverse Event|2|||
13319657|NCT01193218|26564366|FG004|12-52 Weeks|Adverse Event|3|||
13319658|NCT01193218|26564367|FG005|12-52 Weeks|Adverse Event|3|||
13319659|NCT01193218|26564368|FG006|12-52 Weeks|Adverse Event|1|||
13319660|NCT01193218|26564369|FG007|12-52 Weeks|Adverse Event|2|||
13319661|NCT01193218|26564362|FG000|12-52 Weeks|Lack of Efficacy|0|||
13319662|NCT01193218|26564363|FG001|12-52 Weeks|Lack of Efficacy|0|||
13319663|NCT01193218|26564364|FG002|12-52 Weeks|Lack of Efficacy|0|||
13319664|NCT01193218|26564365|FG003|12-52 Weeks|Lack of Efficacy|0|||
13319665|NCT01193218|26564366|FG004|12-52 Weeks|Lack of Efficacy|0|||
13319666|NCT01193218|26564367|FG005|12-52 Weeks|Lack of Efficacy|0|||
13319667|NCT01193218|26564368|FG006|12-52 Weeks|Lack of Efficacy|1|||
13319668|NCT01193218|26564369|FG007|12-52 Weeks|Lack of Efficacy|0|||
13319669|NCT01193218|26564362|FG000|12-52 Weeks|Withdrawal by Subject|3|||
13319670|NCT01193218|26564363|FG001|12-52 Weeks|Withdrawal by Subject|0|||
13319671|NCT01193218|26564364|FG002|12-52 Weeks|Withdrawal by Subject|3|||
13319672|NCT01193218|26564365|FG003|12-52 Weeks|Withdrawal by Subject|0|||
13319673|NCT01193218|26564366|FG004|12-52 Weeks|Withdrawal by Subject|0|||
13122241|NCT02966834|25946593|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
13122242|NCT02966834|25946594|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5|||
13122243|NCT02966834|25946589|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
13122244|NCT02966834|25946590|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
13122245|NCT02966834|25946591|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
13122246|NCT02966834|25946592|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2|||
13122247|NCT02966834|25946593|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
13122248|NCT02966834|25946594|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
13122249|NCT02966834|25946589|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
13122250|NCT02966834|25946590|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
13122251|NCT02966834|25946591|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
13122252|NCT02966834|25946592|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2|||
13122253|NCT02966834|25946593|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
13319674|NCT01193218|26564367|FG005|12-52 Weeks|Withdrawal by Subject|2|||
13319675|NCT01193218|26564368|FG006|12-52 Weeks|Withdrawal by Subject|1|||
13319676|NCT01193218|26564369|FG007|12-52 Weeks|Withdrawal by Subject|2|||
13319677|NCT01193218|26564362|FG000|12-52 Weeks|Other reason than above|1|||
13319678|NCT01193218|26564363|FG001|12-52 Weeks|Other reason than above|0|||
13319679|NCT01193218|26564364|FG002|12-52 Weeks|Other reason than above|0|||
13319680|NCT01193218|26564365|FG003|12-52 Weeks|Other reason than above|1|||
13319681|NCT01193218|26564366|FG004|12-52 Weeks|Other reason than above|1|||
13319682|NCT01193218|26564367|FG005|12-52 Weeks|Other reason than above|0|||
13319683|NCT01193218|26564368|FG006|12-52 Weeks|Other reason than above|0|||
13319684|NCT01193218|26564369|FG007|12-52 Weeks|Other reason than above|0|||
13319685|NCT01193153|26564403|FG000|Open-label Lead in Period|Lost to Follow-up|32|||
13319686|NCT01193153|26564404|FG001|Open-label Lead in Period|Lost to Follow-up|0|||
13286856|NCT00477490|26472504|FG008|Part I: 4 Week Efficacy|Adverse Event|0|||
13286857|NCT00477490|26472496|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1|||
13286858|NCT00477490|26472497|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
13286859|NCT00477490|26472498|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
13286860|NCT00477490|26472499|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5|||
13286861|NCT00477490|26472500|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4|||
13286862|NCT00477490|26472501|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
13286863|NCT00477490|26472502|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
13286864|NCT00477490|26472503|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
13286865|NCT00477490|26472504|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
13286866|NCT00477490|26472496|FG000|Part I: 4 Week Efficacy|Protocol Violation|2|||
13286867|NCT00477490|26472497|FG001|Part I: 4 Week Efficacy|Protocol Violation|0|||
13286868|NCT00477490|26472498|FG002|Part I: 4 Week Efficacy|Protocol Violation|0|||
13286869|NCT00477490|26472499|FG003|Part I: 4 Week Efficacy|Protocol Violation|0|||
13319687|NCT01193153|26564403|FG000|Open-label Lead in Period|Pregnancy|1|||
13319688|NCT01193153|26564404|FG001|Open-label Lead in Period|Pregnancy|0|||
13319689|NCT01193153|26564403|FG000|Open-label Lead in Period|Withdrawal by Subject|69|||
13319690|NCT01193153|26564404|FG001|Open-label Lead in Period|Withdrawal by Subject|0|||
13319691|NCT01193153|26564403|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4|||
13319692|NCT01193153|26564404|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0|||
13319693|NCT01193153|26564403|FG000|Open-label Lead in Period|Other|14|||
13319694|NCT01193153|26564404|FG001|Open-label Lead in Period|Other|0|||
13319695|NCT01193153|26564403|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47|||
13319696|NCT01193153|26564404|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0|||
13319697|NCT01193153|26564403|FG000|Open-label Lead in Period|Adverse Event|41|||
13319698|NCT01193153|26564404|FG001|Open-label Lead in Period|Adverse Event|0|||
13319699|NCT01193153|26564403|FG000|Open-label Lead in Period|Death|1|||
13319700|NCT01193153|26564404|FG001|Open-label Lead in Period|Death|0|||
13319701|NCT01193153|26564403|FG000|Open-label Lead in Period|Lack of Efficacy|26|||
13319702|NCT01193153|26564404|FG001|Open-label Lead in Period|Lack of Efficacy|0|||
13319703|NCT01193153|26564403|FG000|Open-label Stabilization Period|Adverse Event|9|||
13319704|NCT01193153|26564404|FG001|Open-label Stabilization Period|Adverse Event|0|||
13319705|NCT01193153|26564403|FG000|Open-label Stabilization Period|Death|2|||
13319706|NCT01193153|26564404|FG001|Open-label Stabilization Period|Death|0|||
13319707|NCT01193153|26564403|FG000|Open-label Stabilization Period|Lost to Follow-up|10|||
13319708|NCT01193153|26564404|FG001|Open-label Stabilization Period|Lost to Follow-up|0|||
13319709|NCT01193153|26564403|FG000|Open-label Stabilization Period|Lack of Efficacy|5|||
13319710|NCT01193153|26564404|FG001|Open-label Stabilization Period|Lack of Efficacy|0|||
13319711|NCT01193153|26564403|FG000|Open-label Stabilization Period|Withdrawal by Subject|29|||
13319712|NCT01193153|26564404|FG001|Open-label Stabilization Period|Withdrawal by Subject|0|||
13319713|NCT01193153|26564403|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35|||
13319714|NCT01193153|26564404|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0|||
13319715|NCT01193153|26564403|FG000|Open-label Stabilization Period|Other|8|||
13319716|NCT01193153|26564404|FG001|Open-label Stabilization Period|Other|0|||
13319717|NCT01193153|26564403|FG000|Double Blind Relapse Prevention Period|Other|2|||
13319718|NCT01193153|26564404|FG001|Double Blind Relapse Prevention Period|Other|3|||
13319719|NCT01193153|26564403|FG000|Double Blind Relapse Prevention Period|Adverse Event|12|||
13319720|NCT01193153|26564404|FG001|Double Blind Relapse Prevention Period|Adverse Event|3|||
13319721|NCT01193153|26564403|FG000|Double Blind Relapse Prevention Period|Death|2|||
13319722|NCT01193153|26564404|FG001|Double Blind Relapse Prevention Period|Death|0|||
13319723|NCT01193153|26564403|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2|||
13319724|NCT01193153|26564404|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9|||
13319725|NCT01193153|26564403|FG000|Double Blind Relapse Prevention Period|Pregnancy|1|||
13319726|NCT01193153|26564404|FG001|Double Blind Relapse Prevention Period|Pregnancy|0|||
13319727|NCT01193153|26564403|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19|||
13319728|NCT01193153|26564404|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30|||
13319729|NCT01193153|26564403|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25|||
13319730|NCT01193153|26564404|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57|||
13319731|NCT01193153|26564403|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1|||
13319732|NCT01193153|26564404|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3|||
13319733|NCT01193127|26564719|FG000|Randomized|Surgery Cancelled|0|||
13319734|NCT01193127|26564720|FG001|Randomized|Surgery Cancelled|0|||
13319735|NCT01193127|26564721|FG002|Randomized|Surgery Cancelled|0|||
13319736|NCT01193127|26564722|FG003|Randomized|Surgery Cancelled|1|||
13319737|NCT01193127|26564719|FG000|Treated|Withdrawal by Subject|0|||
13319738|NCT01193127|26564720|FG001|Treated|Withdrawal by Subject|0|||
13319739|NCT01193127|26564721|FG002|Treated|Withdrawal by Subject|0|||
13319740|NCT01193127|26564722|FG003|Treated|Withdrawal by Subject|1|||
13319741|NCT01193101|26564791|FG000|Overall Study|Adverse Event|0|||
13319742|NCT01193101|26564792|FG001|Overall Study|Adverse Event|1|||
13319743|NCT01193101|26564793|FG002|Overall Study|Adverse Event|1|||
13319744|NCT01193101|26564794|FG003|Overall Study|Adverse Event|3|||
13319745|NCT01193101|26564791|FG000|Overall Study|Lack of Efficacy|3|||
13319746|NCT01193101|26564792|FG001|Overall Study|Lack of Efficacy|1|||
13319747|NCT01193101|26564793|FG002|Overall Study|Lack of Efficacy|0|||
13319748|NCT01193101|26564794|FG003|Overall Study|Lack of Efficacy|8|||
13319749|NCT01193101|26564791|FG000|Overall Study|Withdrawal by Subject|2|||
13319750|NCT01193101|26564792|FG001|Overall Study|Withdrawal by Subject|4|||
13319751|NCT01193101|26564793|FG002|Overall Study|Withdrawal by Subject|1|||
13319752|NCT01193101|26564794|FG003|Overall Study|Withdrawal by Subject|1|||
13319753|NCT01193101|26564791|FG000|Overall Study|Administrative problems|0|||
13319754|NCT01193101|26564792|FG001|Overall Study|Administrative problems|0|||
13319755|NCT01193101|26564793|FG002|Overall Study|Administrative problems|1|||
13319756|NCT01193101|26564794|FG003|Overall Study|Administrative problems|0|||
13319757|NCT01193101|26564791|FG000|Overall Study|Abnormal test procedure results|0|||
13319758|NCT01193101|26564792|FG001|Overall Study|Abnormal test procedure results|1|||
13319759|NCT01193101|26564793|FG002|Overall Study|Abnormal test procedure results|0|||
13319760|NCT01193101|26564794|FG003|Overall Study|Abnormal test procedure results|0|||
13319761|NCT01192815|26564807|FG000|Overall Study|Withdrawal by Subject|1|||
13319762|NCT01192815|26564807|FG000|Overall Study|Lack of Efficacy|1|||
13319763|NCT01192516|26564849|FG000|Overall Study|Lost to Follow-up|7|||
13319764|NCT01192516|26564850|FG001|Overall Study|Lost to Follow-up|10|||
13319765|NCT01192516|26564851|FG002|Overall Study|Lost to Follow-up|7|||
13319766|NCT01192516|26564849|FG000|Overall Study|Withdrawal by Subject|4|||
13319767|NCT01192516|26564850|FG001|Overall Study|Withdrawal by Subject|4|||
13319768|NCT01192516|26564851|FG002|Overall Study|Withdrawal by Subject|1|||
13319769|NCT01192516|26564849|FG000|Overall Study|started new treatment|5|||
13319770|NCT01192516|26564850|FG001|Overall Study|started new treatment|1|||
13319771|NCT01192516|26564851|FG002|Overall Study|started new treatment|0|||
13319772|NCT01192516|26564849|FG000|Overall Study|Unable to follow Actiwatch instructions|4|||
13319773|NCT01192516|26564850|FG001|Overall Study|Unable to follow Actiwatch instructions|2|||
13319774|NCT01192516|26564851|FG002|Overall Study|Unable to follow Actiwatch instructions|0|||
13319775|NCT01192412|26564866|FG000|Overall Study|Lost to Follow-up|2|||
13319776|NCT01192412|26564867|FG001|Overall Study|Lost to Follow-up|1|||
13319777|NCT01192412|26564866|FG000|Overall Study|Withdrawal by Subject|2|||
13319778|NCT01192412|26564867|FG001|Overall Study|Withdrawal by Subject|1|||
13319779|NCT01192399|26564879|FG000|Overall Study|Lack of Efficacy|2|||
13319780|NCT01192347|26564902|FG000|Overall Study|Death|3|||
13319781|NCT01192347|26564902|FG000|Overall Study|Lost to Follow-up|3|||
13319782|NCT01192347|26564902|FG000|Overall Study|Withdrawal by Subject|1|||
13319783|NCT01192347|26564902|FG000|Overall Study|Adverse Event|1|||
13319784|NCT01192347|26564902|FG000|Overall Study|Suspected serious adverse drug reaction|1|||
13319785|NCT01192347|26564902|FG000|Overall Study|Patient seen in different hospital|1|||
13319786|NCT01192347|26564902|FG000|Overall Study|Patient not visiting hospital regularly|1|||
13319787|NCT01192347|26564902|FG000|Overall Study|Patient did not show up for visits|1|||
13319788|NCT01192295|26564927|FG000|Overall Study|Adverse Event|3|||
13319789|NCT01192295|26564928|FG001|Overall Study|Adverse Event|7|||
13319790|NCT01192295|26564927|FG000|Overall Study|Withdrawal by Subject|3|||
13319791|NCT01192295|26564928|FG001|Overall Study|Withdrawal by Subject|4|||
13319792|NCT01192295|26564927|FG000|Overall Study|Lost to Follow-up|0|||
13319793|NCT01192295|26564928|FG001|Overall Study|Lost to Follow-up|1|||
13319794|NCT01192295|26564927|FG000|Overall Study|Lack of Efficacy|0|||
13319795|NCT01192295|26564928|FG001|Overall Study|Lack of Efficacy|5|||
13319796|NCT01192295|26564927|FG000|Overall Study|Administrative|4|||
13319797|NCT01192295|26564928|FG001|Overall Study|Administrative|6|||
13319798|NCT01192204|26564945|FG000|Overall Study|could not keep recall appointments|1|||
13319799|NCT01192204|26564946|FG001|Overall Study|could not keep recall appointments|0|||
13319800|NCT01192191|26564977|FG000|Overall Study|Adverse Event|7|||
13319801|NCT01192191|26564978|FG001|Overall Study|Adverse Event|12|||
13319802|NCT01192191|26564977|FG000|Overall Study|Participants Reached Stopping Criteria|3|||
13319803|NCT01192191|26564978|FG001|Overall Study|Participants Reached Stopping Criteria|2|||
13319804|NCT01192191|26564977|FG000|Overall Study|Lost to Follow-up|0|||
13319805|NCT01192191|26564978|FG001|Overall Study|Lost to Follow-up|1|||
13319806|NCT01192191|26564977|FG000|Overall Study|Withdrawal by Subject|1|||
13319807|NCT01192191|26564978|FG001|Overall Study|Withdrawal by Subject|6|||
13319808|NCT01192178|26565005|FG000|Overall Study|Withdrawal by Subject|6|||
13319809|NCT01192178|26565006|FG001|Overall Study|Withdrawal by Subject|10|||
13319810|NCT01192178|26565005|FG000|Overall Study|Protocol Violation|10|||
13319811|NCT01192178|26565006|FG001|Overall Study|Protocol Violation|3|||
13319812|NCT01192178|26565005|FG000|Overall Study|Physician Decision|2|||
13319813|NCT01192178|26565006|FG001|Overall Study|Physician Decision|4|||
13319814|NCT01192178|26565005|FG000|Overall Study|Lost to Follow-up|3|||
13319815|NCT01192178|26565006|FG001|Overall Study|Lost to Follow-up|3|||
13319816|NCT01192178|26565005|FG000|Overall Study|Adverse Event|2|||
13319817|NCT01192178|26565006|FG001|Overall Study|Adverse Event|1|||
13319818|NCT01192178|26565005|FG000|Overall Study|Lack of Efficacy|1|||
13319819|NCT01192178|26565006|FG001|Overall Study|Lack of Efficacy|2|||
13319820|NCT01192152|26565110|FG000|Period 1|left prematurely (while on treatment B)|0|||
13319821|NCT01192152|26565111|FG001|Period 1|left prematurely (while on treatment B)|1|||
13319822|NCT01192152|26565110|FG000|Period 3|family emergency|1|||
13319823|NCT01192152|26565111|FG001|Period 3|family emergency|0|||
13319824|NCT01192126|26565122|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1|||
13319825|NCT01192126|26565123|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0|||
13319826|NCT01192126|26565122|FG000|First Intervention (1 Week)|Lost to Follow-up|1|||
13319827|NCT01192126|26565123|FG001|First Intervention (1 Week)|Lost to Follow-up|1|||
13319828|NCT01192100|26565146|FG000|Overall Study|Withdrawal by Subject|0|||
13319829|NCT01192100|26565147|FG001|Overall Study|Withdrawal by Subject|0|||
13319830|NCT01192100|26565148|FG002|Overall Study|Withdrawal by Subject|0|||
13319831|NCT01192100|26565149|FG003|Overall Study|Withdrawal by Subject|0|||
13319832|NCT01192100|26565150|FG004|Overall Study|Withdrawal by Subject|1|||
13319833|NCT01192100|26565151|FG005|Overall Study|Withdrawal by Subject|0|||
13319834|NCT01192100|26565146|FG000|Overall Study|Protocol Violation|0|||
13319835|NCT01192100|26565147|FG001|Overall Study|Protocol Violation|0|||
13319836|NCT01192100|26565148|FG002|Overall Study|Protocol Violation|0|||
13319837|NCT01192100|26565149|FG003|Overall Study|Protocol Violation|1|||
13319838|NCT01192100|26565150|FG004|Overall Study|Protocol Violation|0|||
13319839|NCT01192100|26565151|FG005|Overall Study|Protocol Violation|0|||
13319840|NCT01192022|26565186|FG000|Overall Study|Withdrawal of Consent|3|||
13319841|NCT01192022|26565187|FG001|Overall Study|Withdrawal of Consent|1|||
13319842|NCT01192022|26565188|FG002|Overall Study|Withdrawal of Consent|0|||
13319843|NCT01192022|26565189|FG003|Overall Study|Withdrawal of Consent|0|||
13319844|NCT01192022|26565190|FG004|Overall Study|Withdrawal of Consent|0|||
13319845|NCT01192022|26565186|FG000|Overall Study|Lost to Follow-up|4|||
13319846|NCT01192022|26565187|FG001|Overall Study|Lost to Follow-up|2|||
13319847|NCT01192022|26565188|FG002|Overall Study|Lost to Follow-up|1|||
13319848|NCT01192022|26565189|FG003|Overall Study|Lost to Follow-up|1|||
13319849|NCT01192022|26565190|FG004|Overall Study|Lost to Follow-up|0|||
13319850|NCT01192022|26565186|FG000|Overall Study|Adverse Event|1|||
13319851|NCT01192022|26565187|FG001|Overall Study|Adverse Event|0|||
13319852|NCT01192022|26565188|FG002|Overall Study|Adverse Event|0|||
13319853|NCT01192022|26565189|FG003|Overall Study|Adverse Event|0|||
13319854|NCT01192022|26565190|FG004|Overall Study|Adverse Event|0|||
13319855|NCT01192022|26565186|FG000|Overall Study|Fatal Adverse Event|4|||
13319856|NCT01192022|26565187|FG001|Overall Study|Fatal Adverse Event|6|||
13319857|NCT01192022|26565188|FG002|Overall Study|Fatal Adverse Event|0|||
13319858|NCT01192022|26565189|FG003|Overall Study|Fatal Adverse Event|0|||
13319859|NCT01192022|26565190|FG004|Overall Study|Fatal Adverse Event|1|||
13319860|NCT01192022|26565186|FG000|Overall Study|Physician withdrew-patient hardship|1|||
13319861|NCT01192022|26565187|FG001|Overall Study|Physician withdrew-patient hardship|0|||
13319862|NCT01192022|26565188|FG002|Overall Study|Physician withdrew-patient hardship|0|||
13319863|NCT01192022|26565189|FG003|Overall Study|Physician withdrew-patient hardship|0|||
13319864|NCT01192022|26565190|FG004|Overall Study|Physician withdrew-patient hardship|0|||
13319865|NCT01192022|26565186|FG000|Overall Study|Patient too sick from chemotherapy|0|||
13319866|NCT01192022|26565187|FG001|Overall Study|Patient too sick from chemotherapy|1|||
13319867|NCT01192022|26565188|FG002|Overall Study|Patient too sick from chemotherapy|0|||
13319868|NCT01192022|26565189|FG003|Overall Study|Patient too sick from chemotherapy|0|||
13319869|NCT01192022|26565190|FG004|Overall Study|Patient too sick from chemotherapy|0|||
13319870|NCT01192022|26565186|FG000|Overall Study|Patient needed surgery|0|||
13319871|NCT01192022|26565187|FG001|Overall Study|Patient needed surgery|1|||
13319872|NCT01192022|26565188|FG002|Overall Study|Patient needed surgery|0|||
13319873|NCT01192022|26565189|FG003|Overall Study|Patient needed surgery|0|||
13319874|NCT01192022|26565190|FG004|Overall Study|Patient needed surgery|0|||
13319875|NCT01192022|26565186|FG000|Overall Study|Parents did not allow all follow up|0|||
13319876|NCT01192022|26565187|FG001|Overall Study|Parents did not allow all follow up|0|||
13319877|NCT01192022|26565188|FG002|Overall Study|Parents did not allow all follow up|0|||
13319878|NCT01192022|26565189|FG003|Overall Study|Parents did not allow all follow up|1|||
13319879|NCT01192022|26565190|FG004|Overall Study|Parents did not allow all follow up|0|||
13319880|NCT01191944|26565241|FG000|Overall Study|Adverse Event|11|||
13319881|NCT01191944|26565242|FG001|Overall Study|Adverse Event|12|||
13319882|NCT01191944|26565241|FG000|Overall Study|Protocol Violation|1|||
13319883|NCT01191944|26565242|FG001|Overall Study|Protocol Violation|2|||
13319884|NCT01191944|26565241|FG000|Overall Study|Withdrawal by Subject|4|||
13319885|NCT01191944|26565242|FG001|Overall Study|Withdrawal by Subject|2|||
13319886|NCT01191944|26565241|FG000|Overall Study|Other|1|||
13319887|NCT01191944|26565242|FG001|Overall Study|Other|3|||
13319888|NCT01191840|26565263|FG000|Overall Study|withdrew consent|2|||
13319889|NCT01191840|26565264|FG001|Overall Study|withdrew consent|1|||
13319890|NCT01191840|26565263|FG000|Overall Study|Subject discontinued treatment|1|||
13319891|NCT01191840|26565264|FG001|Overall Study|Subject discontinued treatment|2|||
13319892|NCT01191840|26565263|FG000|Overall Study|Lost to Follow-up|4|||
13319893|NCT01191840|26565264|FG001|Overall Study|Lost to Follow-up|6|||
13319894|NCT01191840|26565263|FG000|Overall Study|Non Staph Infection|4|||
13319895|NCT01191840|26565264|FG001|Overall Study|Non Staph Infection|3|||
13319896|NCT01191840|26565263|FG000|Overall Study|ineligible at enrollment|1|||
13319897|NCT01191840|26565264|FG001|Overall Study|ineligible at enrollment|0|||
13319898|NCT01191840|26565263|FG000|Overall Study|IRB approval lapse|0|||
13319899|NCT01191840|26565264|FG001|Overall Study|IRB approval lapse|2|||
13319900|NCT01191840|26565263|FG000|Overall Study|lab error speciation - non Staph infecti|0|||
13319901|NCT01191840|26565264|FG001|Overall Study|lab error speciation - non Staph infecti|1|||
13319902|NCT01191840|26565263|FG000|Overall Study|Withdrawal by Subject|2|||
13319903|NCT01191840|26565264|FG001|Overall Study|Withdrawal by Subject|0|||
13319904|NCT01191801|26565289|FG000|Overall Study|Death|36|||
13319905|NCT01191801|26565290|FG001|Overall Study|Death|12|||
13319906|NCT01191801|26565289|FG000|Overall Study|Lack of Efficacy|176|||
13319907|NCT01191801|26565290|FG001|Overall Study|Lack of Efficacy|258|||
13319908|NCT01191801|26565289|FG000|Overall Study|Adverse Event|9|||
13319909|NCT01191801|26565290|FG001|Overall Study|Adverse Event|8|||
13319910|NCT01191801|26565289|FG000|Overall Study|Protocol Violation|2|||
13319911|NCT01191801|26565290|FG001|Overall Study|Protocol Violation|4|||
13319912|NCT01191801|26565289|FG000|Overall Study|Physician Decision|47|||
13319913|NCT01191801|26565290|FG001|Overall Study|Physician Decision|24|||
13319914|NCT01191801|26565289|FG000|Overall Study|Withdrawal by Subject|1|||
13319915|NCT01191801|26565290|FG001|Overall Study|Withdrawal by Subject|4|||
13319916|NCT01191801|26565289|FG000|Overall Study|Not Provided|45|||
13319917|NCT01191801|26565290|FG001|Overall Study|Not Provided|27|||
13319918|NCT01191788|26565305|FG000|Overall Study|Lost to Follow-up|21|||
13319919|NCT01191788|26565306|FG001|Overall Study|Lost to Follow-up|22|||
13373191|NCT00805142|26723168|FG001|Maintenance Period|Adverse Event|1|||
13373192|NCT00805142|26723167|FG000|Maintenance Period|Other|0|||
13373193|NCT00805142|26723168|FG001|Maintenance Period|Other|1|||
13373194|NCT00805025|26723176|FG000|Overall Study|Screened but not enrolled/treated|42|||
13373195|NCT00805025|26723176|FG000|Overall Study|Adverse Event|4|||
13373196|NCT00805025|26723176|FG000|Overall Study|Withdrawal by Subject|2|||
13373197|NCT00805025|26723176|FG000|Overall Study|Physician Decision|1|||
13373198|NCT00804986|26723287|FG000|Overall Study|Adverse Event|0|||
13373199|NCT00804986|26723288|FG001|Overall Study|Adverse Event|1|||
13373200|NCT00804986|26723289|FG002|Overall Study|Adverse Event|2|||
13373201|NCT00804986|26723290|FG003|Overall Study|Adverse Event|1|||
13373202|NCT00804986|26723291|FG004|Overall Study|Adverse Event|3|||
13373203|NCT00804986|26723292|FG005|Overall Study|Adverse Event|0|||
13373204|NCT00804986|26723287|FG000|Overall Study|Lack of Efficacy|0|||
13373205|NCT00804986|26723288|FG001|Overall Study|Lack of Efficacy|0|||
13373206|NCT00804986|26723289|FG002|Overall Study|Lack of Efficacy|0|||
13373207|NCT00804986|26723290|FG003|Overall Study|Lack of Efficacy|1|||
13373208|NCT00804986|26723291|FG004|Overall Study|Lack of Efficacy|0|||
13373209|NCT00804986|26723292|FG005|Overall Study|Lack of Efficacy|3|||
13373210|NCT00804986|26723287|FG000|Overall Study|Lost to Follow-up|0|||
13373211|NCT00804986|26723288|FG001|Overall Study|Lost to Follow-up|0|||
13373212|NCT00804986|26723289|FG002|Overall Study|Lost to Follow-up|0|||
13373213|NCT00804986|26723290|FG003|Overall Study|Lost to Follow-up|1|||
13373214|NCT00804986|26723291|FG004|Overall Study|Lost to Follow-up|1|||
13373215|NCT00804986|26723292|FG005|Overall Study|Lost to Follow-up|3|||
13373216|NCT00804986|26723287|FG000|Overall Study|Protocol Violation|0|||
13373217|NCT00804986|26723288|FG001|Overall Study|Protocol Violation|1|||
13373218|NCT00804986|26723289|FG002|Overall Study|Protocol Violation|0|||
13373219|NCT00804986|26723290|FG003|Overall Study|Protocol Violation|1|||
13373220|NCT00804986|26723291|FG004|Overall Study|Protocol Violation|0|||
13373221|NCT00804986|26723292|FG005|Overall Study|Protocol Violation|0|||
13373222|NCT00804986|26723287|FG000|Overall Study|Withdrawal by Subject|0|||
13373223|NCT00804986|26723288|FG001|Overall Study|Withdrawal by Subject|3|||
13373224|NCT00804986|26723289|FG002|Overall Study|Withdrawal by Subject|0|||
13373225|NCT00804986|26723290|FG003|Overall Study|Withdrawal by Subject|3|||
13373226|NCT00804986|26723291|FG004|Overall Study|Withdrawal by Subject|5|||
13373227|NCT00804986|26723292|FG005|Overall Study|Withdrawal by Subject|3|||
13373228|NCT00804986|26723287|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
13373229|NCT00804986|26723288|FG001|Overall Study|Inclusion/Exclusion criteria not met|2|||
13373230|NCT00804986|26723289|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
13373231|NCT00804986|26723290|FG003|Overall Study|Inclusion/Exclusion criteria not met|1|||
13373232|NCT00804986|26723291|FG004|Overall Study|Inclusion/Exclusion criteria not met|0|||
13373233|NCT00804986|26723292|FG005|Overall Study|Inclusion/Exclusion criteria not met|1|||
13373234|NCT00804986|26723287|FG000|Overall Study|Sponsor Decision|0|||
13373235|NCT00804986|26723288|FG001|Overall Study|Sponsor Decision|1|||
13373236|NCT00804986|26723289|FG002|Overall Study|Sponsor Decision|0|||
13373237|NCT00804986|26723290|FG003|Overall Study|Sponsor Decision|0|||
13373238|NCT00804986|26723291|FG004|Overall Study|Sponsor Decision|0|||
13373239|NCT00804986|26723292|FG005|Overall Study|Sponsor Decision|0|||
13373240|NCT00804986|26723287|FG000|Overall Study|Physician Decision|1|||
13373241|NCT00804986|26723288|FG001|Overall Study|Physician Decision|0|||
13373242|NCT00804986|26723289|FG002|Overall Study|Physician Decision|0|||
13373243|NCT00804986|26723290|FG003|Overall Study|Physician Decision|0|||
13373244|NCT00804986|26723291|FG004|Overall Study|Physician Decision|0|||
13373245|NCT00804986|26723292|FG005|Overall Study|Physician Decision|0|||
13373246|NCT00804908|26723331|FG000|Overall Study|Other|115|||
13373247|NCT00804908|26723332|FG001|Overall Study|Other|116|||
13373248|NCT00804908|26723333|FG002|Overall Study|Other|114|||
13373249|NCT00804843|26723350|FG000|Overall Study|Protocol Violation|1|||
13373250|NCT00804843|26723351|FG001|Overall Study|Protocol Violation|0|||
13373251|NCT00804843|26723350|FG000|Overall Study|Adverse Event|8|||
13373252|NCT00804843|26723351|FG001|Overall Study|Adverse Event|5|||
13373253|NCT00804843|26723350|FG000|Overall Study|Withdrawal by Subject|1|||
13373254|NCT00804843|26723351|FG001|Overall Study|Withdrawal by Subject|2|||
13373255|NCT00804687|26723375|FG000|Period 3: Treatment Period|Positive Drug screen|0|||
13373256|NCT00804687|26723376|FG001|Period 3: Treatment Period|Positive Drug screen|0|||
13373257|NCT00804687|26723377|FG002|Period 3: Treatment Period|Positive Drug screen|0|||
13373258|NCT00804687|26723378|FG003|Period 3: Treatment Period|Positive Drug screen|1|||
13373259|NCT00804687|26723379|FG004|Period 3: Treatment Period|Positive Drug screen|0|||
13373260|NCT00804687|26723380|FG005|Period 3: Treatment Period|Positive Drug screen|0|||
13373261|NCT00804687|26723375|FG000|Period 5: Treatment Period|Withdrawal by Subject|0|||
13373262|NCT00804687|26723376|FG001|Period 5: Treatment Period|Withdrawal by Subject|0|||
13373263|NCT00804687|26723377|FG002|Period 5: Treatment Period|Withdrawal by Subject|0|||
13319920|NCT01188772|26565374|FG000|Overall Study|Randomized but Not Treated|0|||
13319921|NCT01188772|26565375|FG001|Overall Study|Randomized but Not Treated|1|||
13319922|NCT01188772|26565376|FG002|Overall Study|Randomized but Not Treated|0|||
13319923|NCT01188772|26565377|FG003|Overall Study|Randomized but Not Treated|0|||
13319924|NCT01188772|26565374|FG000|Overall Study|Adverse Event|0|||
13319925|NCT01188772|26565375|FG001|Overall Study|Adverse Event|1|||
13319926|NCT01188772|26565376|FG002|Overall Study|Adverse Event|2|||
13319927|NCT01188772|26565377|FG003|Overall Study|Adverse Event|0|||
13319928|NCT01188772|26565374|FG000|Overall Study|Lost to Follow-up|4|||
13319929|NCT01188772|26565375|FG001|Overall Study|Lost to Follow-up|1|||
13319930|NCT01188772|26565376|FG002|Overall Study|Lost to Follow-up|1|||
13319931|NCT01188772|26565377|FG003|Overall Study|Lost to Follow-up|1|||
13319932|NCT01188772|26565374|FG000|Overall Study|Non-responder|0|||
13319933|NCT01188772|26565375|FG001|Overall Study|Non-responder|0|||
13319934|NCT01188772|26565376|FG002|Overall Study|Non-responder|3|||
13319935|NCT01188772|26565377|FG003|Overall Study|Non-responder|0|||
13319936|NCT01188772|26565374|FG000|Overall Study|Physician Decision|0|||
13319937|NCT01188772|26565375|FG001|Overall Study|Physician Decision|0|||
13319938|NCT01188772|26565376|FG002|Overall Study|Physician Decision|1|||
13319939|NCT01188772|26565377|FG003|Overall Study|Physician Decision|0|||
13319940|NCT01188772|26565374|FG000|Overall Study|Terminated by Sponsor|0|||
13319941|NCT01188772|26565375|FG001|Overall Study|Terminated by Sponsor|0|||
13319942|NCT01188772|26565376|FG002|Overall Study|Terminated by Sponsor|1|||
13319943|NCT01188772|26565377|FG003|Overall Study|Terminated by Sponsor|0|||
13319944|NCT01188772|26565374|FG000|Overall Study|Treatment Failure|0|||
13319945|NCT01188772|26565375|FG001|Overall Study|Treatment Failure|0|||
13319946|NCT01188772|26565376|FG002|Overall Study|Treatment Failure|1|||
13319947|NCT01188772|26565377|FG003|Overall Study|Treatment Failure|0|||
13319948|NCT01188772|26565374|FG000|Overall Study|Virologic Failure|1|||
13319949|NCT01188772|26565375|FG001|Overall Study|Virologic Failure|0|||
13319950|NCT01188772|26565376|FG002|Overall Study|Virologic Failure|0|||
13319951|NCT01188772|26565377|FG003|Overall Study|Virologic Failure|0|||
13319952|NCT01188772|26565374|FG000|Overall Study|Withdrawal by Subject|0|||
13319953|NCT01188772|26565375|FG001|Overall Study|Withdrawal by Subject|0|||
13319954|NCT01188772|26565376|FG002|Overall Study|Withdrawal by Subject|2|||
13319955|NCT01188772|26565377|FG003|Overall Study|Withdrawal by Subject|0|||
13319956|NCT01188681|26565404|FG000|Overall Study|bladder cancer|0|||
13319957|NCT01188681|26565405|FG001|Overall Study|bladder cancer|0|||
13319958|NCT01188681|26565406|FG002|Overall Study|bladder cancer|1|||
13319959|NCT01188681|26565407|FG003|Overall Study|bladder cancer|0|||
13319960|NCT01188681|26565404|FG000|Overall Study|Withdrawal by Subject|0|||
13319961|NCT01188681|26565405|FG001|Overall Study|Withdrawal by Subject|0|||
13319962|NCT01188681|26565406|FG002|Overall Study|Withdrawal by Subject|0|||
13319963|NCT01188681|26565407|FG003|Overall Study|Withdrawal by Subject|1|||
13319964|NCT01188668|26565442|FG000|Period 1: ARIP Alone|Protocol Violation|2|||
13319965|NCT01188668|26565442|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2|||
13319966|NCT01188668|26565442|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1|||
13319967|NCT01188655|26565459|FG000|Overall Study|Lack of Efficacy|1|||
13319968|NCT01188655|26565459|FG000|Overall Study|Lost to Follow-up|1|||
13319969|NCT01188655|26565459|FG000|Overall Study|Other|11|||
13319970|NCT01188564|26565474|FG000|Double-blind Phase|randomized not treated|1|||
13319971|NCT01188564|26565475|FG001|Double-blind Phase|randomized not treated|0|||
13319972|NCT01188551|26565502|FG000|Overall Study|Pharmacy issues|1|||
13319973|NCT01188551|26565503|FG001|Overall Study|Pharmacy issues|0|||
13319974|NCT01188551|26565504|FG002|Overall Study|Pharmacy issues|0|||
13319975|NCT01188551|26565505|FG003|Overall Study|Pharmacy issues|0|||
13319976|NCT01188538|26565520|FG000|Overall Study|Lost to Follow-up|0|||
13319977|NCT01188538|26565521|FG001|Overall Study|Lost to Follow-up|1|||
13319978|NCT01188343|26565557|FG000|Overall Study|Not vaccinated|0|||
13319979|NCT01188343|26565558|FG001|Overall Study|Not vaccinated|2|||
13319980|NCT01188343|26565559|FG002|Overall Study|Not vaccinated|1|||
13319981|NCT01188343|26565557|FG000|Overall Study|Withdrawal by Subject|1|||
13319982|NCT01188343|26565558|FG001|Overall Study|Withdrawal by Subject|24|||
13319983|NCT01188343|26565559|FG002|Overall Study|Withdrawal by Subject|0|||
13319984|NCT01188226|26565600|FG000|Overall Study|Withdrawal by Subject|4|||
13319985|NCT01187953|26565615|FG000|Overall Study|Death|11|||
13319986|NCT01187953|26565616|FG001|Overall Study|Death|13|||
13319987|NCT01187953|26565615|FG000|Overall Study|Adverse Event|1|||
13319988|NCT01187953|26565616|FG001|Overall Study|Adverse Event|2|||
13319989|NCT01187953|26565615|FG000|Overall Study|Lost to Follow-up|0|||
13319990|NCT01187953|26565616|FG001|Overall Study|Lost to Follow-up|3|||
13319991|NCT01187953|26565615|FG000|Overall Study|Withdrawal by Subject|3|||
13319992|NCT01187953|26565616|FG001|Overall Study|Withdrawal by Subject|3|||
13319993|NCT01187901|26565639|FG000|Overall Study|Protocol Violation|1|||
13319994|NCT01187901|26565640|FG001|Overall Study|Protocol Violation|0|||
13319995|NCT01187901|26565639|FG000|Overall Study|Lost to Follow-up|1|||
13319996|NCT01187901|26565640|FG001|Overall Study|Lost to Follow-up|2|||
13319997|NCT01187901|26565639|FG000|Overall Study|Unrelated Health Reasons|1|||
13319998|NCT01187901|26565640|FG001|Overall Study|Unrelated Health Reasons|2|||
13319999|NCT01187901|26565639|FG000|Overall Study|Suspected Allergic Reaction|1|||
13320000|NCT01187901|26565640|FG001|Overall Study|Suspected Allergic Reaction|1|||
13320001|NCT01187901|26565639|FG000|Overall Study|Adverse Event|3|||
13320002|NCT01187901|26565640|FG001|Overall Study|Adverse Event|0|||
13320003|NCT01187901|26565639|FG000|Overall Study|No Endpoint due to Early Study Halt|2|||
13320004|NCT01187901|26565640|FG001|Overall Study|No Endpoint due to Early Study Halt|3|||
13320005|NCT01187901|26565639|FG000|Overall Study|Pregnancy|0|||
13320006|NCT01187901|26565640|FG001|Overall Study|Pregnancy|2|||
13320007|NCT01187550|26565663|FG000|Overall Study|Protocol Violation|3|||
13320008|NCT01187550|26565664|FG001|Overall Study|Protocol Violation|1|||
13320009|NCT01187550|26565663|FG000|Overall Study|Other|3|||
13320010|NCT01187550|26565664|FG001|Overall Study|Other|0|||
13320011|NCT01187550|26565663|FG000|Overall Study|Randomized but not treated|8|||
13320012|NCT01187550|26565664|FG001|Overall Study|Randomized but not treated|0|||
13320013|NCT01187446|26565685|FG000|Overall Study|Patient started non-protocol therapy|0|||
13320014|NCT01187446|26565686|FG001|Overall Study|Patient started non-protocol therapy|1|||
13320015|NCT01187407|26565770|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29|||
13320016|NCT01187407|26565771|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
13320017|NCT01187407|26565772|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
13320018|NCT01187407|26565773|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
13320019|NCT01187407|26565774|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
13320020|NCT01187407|26565770|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4|||
13320021|NCT01187407|26565771|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
13320022|NCT01187407|26565772|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
13320023|NCT01187407|26565773|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
13320024|NCT01187407|26565774|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
13320025|NCT01187407|26565770|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9|||
13320026|NCT01187407|26565771|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
13320027|NCT01187407|26565772|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
13320028|NCT01187407|26565773|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
13320029|NCT01187407|26565774|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
13320030|NCT01187407|26565770|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
13320031|NCT01187407|26565771|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
13320032|NCT01187407|26565772|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
13320033|NCT01187407|26565773|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
13320034|NCT01187407|26565774|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
13320035|NCT01187407|26565770|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13|||
13320036|NCT01187407|26565771|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
13320037|NCT01187407|26565772|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
13320038|NCT01187407|26565773|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
13320039|NCT01187407|26565774|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
13320040|NCT01187407|26565770|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29|||
13320041|NCT01187407|26565771|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
13320042|NCT01187407|26565772|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
13320043|NCT01187407|26565773|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
13320044|NCT01187407|26565774|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
13320045|NCT01187407|26565770|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4|||
13320046|NCT01187407|26565771|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
13320047|NCT01187407|26565772|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
13320048|NCT01187407|26565773|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
13320049|NCT01187407|26565774|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
13320050|NCT01187407|26565770|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
13320051|NCT01187407|26565771|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
13320052|NCT01187407|26565772|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6|||
13320053|NCT01187407|26565773|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5|||
13320054|NCT01187407|26565774|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12|||
13320055|NCT01187407|26565770|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
13320056|NCT01187407|26565771|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3|||
13320057|NCT01187407|26565772|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
13320058|NCT01187407|26565773|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5|||
13320059|NCT01187407|26565774|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13|||
13320060|NCT01187407|26565770|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
13320061|NCT01187407|26565771|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
13320062|NCT01187407|26565772|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
13320063|NCT01187407|26565773|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
13320064|NCT01187407|26565774|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
13320065|NCT01187407|26565770|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
13320066|NCT01187407|26565771|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
13320067|NCT01187407|26565772|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
13320068|NCT01187407|26565773|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
13320069|NCT01187407|26565774|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
13320070|NCT01187407|26565770|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
13320071|NCT01187407|26565771|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6|||
13320072|NCT01187407|26565772|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
13320073|NCT01187407|26565773|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3|||
13320074|NCT01187407|26565774|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10|||
13320075|NCT01187407|26565770|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
13320076|NCT01187407|26565771|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
13320077|NCT01187407|26565772|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
13320078|NCT01187407|26565773|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11|||
13320079|NCT01187407|26565774|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22|||
13320080|NCT01187407|26565770|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
13320081|NCT01187407|26565771|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
13320082|NCT01187407|26565772|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
13320083|NCT01187407|26565773|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
13320084|NCT01187407|26565774|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
13320085|NCT01187043|26565802|FG000|Overall Study|Adverse Event|0|||
13320086|NCT01187043|26565803|FG001|Overall Study|Adverse Event|0|||
13320087|NCT01187043|26565804|FG002|Overall Study|Adverse Event|0|||
13320088|NCT01187043|26565805|FG003|Overall Study|Adverse Event|0|||
13320089|NCT01187043|26565806|FG004|Overall Study|Adverse Event|1|||
13320090|NCT01187043|26565802|FG000|Overall Study|Unable to make scheduled visits|1|||
13320091|NCT01187043|26565803|FG001|Overall Study|Unable to make scheduled visits|0|||
13320092|NCT01187043|26565804|FG002|Overall Study|Unable to make scheduled visits|4|||
13320093|NCT01187043|26565805|FG003|Overall Study|Unable to make scheduled visits|0|||
13320094|NCT01187043|26565806|FG004|Overall Study|Unable to make scheduled visits|1|||
13320095|NCT01186978|26565815|FG000|Overall Study|Withdrawal by Subject|1|||
13320096|NCT01186939|26565821|FG000|Overall Study|Death|7|||
13320097|NCT01186939|26565821|FG000|Overall Study|Withdrawal by Subject|2|||
13320098|NCT01186939|26565821|FG000|Overall Study|No longer receiving clinical benefit|17|||
13320099|NCT01186939|26565821|FG000|Overall Study|Program closed|5|||
13320100|NCT01186939|26565821|FG000|Overall Study|Sponsor decision|4|||
13320101|NCT01186939|26565821|FG000|Overall Study|Started additional treatment|1|||
13320102|NCT01186939|26565821|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1|||
13320103|NCT01186939|26565821|FG000|Overall Study|Myocardial infarction|1|||
13320104|NCT01186939|26565821|FG000|Overall Study|Bone marrow transplant|1|||
13320105|NCT01186939|26565821|FG000|Overall Study|Transformation to AML|1|||
13320106|NCT01186809|26565827|FG000|Overall Study|Death|30|||
13320107|NCT01186796|26565848|FG000|Overall Study|Adverse Event|3|||
13320108|NCT01186796|26565849|FG001|Overall Study|Adverse Event|0|||
13320109|NCT01186796|26565848|FG000|Overall Study|Withdrawal by Subject|1|||
13320110|NCT01186796|26565849|FG001|Overall Study|Withdrawal by Subject|1|||
13320111|NCT01186796|26565848|FG000|Overall Study|Protocol Violation|0|||
13320112|NCT01186796|26565849|FG001|Overall Study|Protocol Violation|1|||
13320113|NCT01186770|26565880|FG000|Overall Study|Ineligibility|0|||
13320114|NCT01186770|26565881|FG001|Overall Study|Ineligibility|0|||
13320115|NCT01186770|26565882|FG002|Overall Study|Ineligibility|2|||
13320116|NCT01186770|26565883|FG003|Overall Study|Ineligibility|0|||
13320117|NCT01186770|26565880|FG000|Overall Study|Protocol Violation|7|||
13320118|NCT01186770|26565881|FG001|Overall Study|Protocol Violation|9|||
13320119|NCT01186770|26565882|FG002|Overall Study|Protocol Violation|12|||
13320120|NCT01186770|26565883|FG003|Overall Study|Protocol Violation|14|||
13320121|NCT01186770|26565880|FG000|Overall Study|Adverse Event|2|||
13320122|NCT01186770|26565881|FG001|Overall Study|Adverse Event|9|||
13320123|NCT01186770|26565882|FG002|Overall Study|Adverse Event|7|||
13320124|NCT01186770|26565883|FG003|Overall Study|Adverse Event|9|||
13320125|NCT01186770|26565880|FG000|Overall Study|Withdrawal by Subject|15|||
13320126|NCT01186770|26565881|FG001|Overall Study|Withdrawal by Subject|13|||
13320127|NCT01186770|26565882|FG002|Overall Study|Withdrawal by Subject|11|||
13320128|NCT01186770|26565883|FG003|Overall Study|Withdrawal by Subject|17|||
13320129|NCT01186770|26565880|FG000|Overall Study|Lost to Follow-up|10|||
13320130|NCT01186770|26565881|FG001|Overall Study|Lost to Follow-up|6|||
13320131|NCT01186770|26565882|FG002|Overall Study|Lost to Follow-up|14|||
13320132|NCT01186770|26565883|FG003|Overall Study|Lost to Follow-up|9|||
13320133|NCT01186770|26565880|FG000|Overall Study|Insufficient response to treatment|7|||
13320134|NCT01186770|26565881|FG001|Overall Study|Insufficient response to treatment|8|||
13320135|NCT01186770|26565882|FG002|Overall Study|Insufficient response to treatment|5|||
13320136|NCT01186770|26565883|FG003|Overall Study|Insufficient response to treatment|7|||
13320137|NCT01186770|26565880|FG000|Overall Study|Other than specified|0|||
13320138|NCT01186770|26565881|FG001|Overall Study|Other than specified|1|||
13320139|NCT01186770|26565882|FG002|Overall Study|Other than specified|1|||
13320140|NCT01186770|26565883|FG003|Overall Study|Other than specified|2|||
13320141|NCT01186744|26566318|FG000|Overall Study|Lack of Efficacy|156|||
13320142|NCT01186744|26566319|FG001|Overall Study|Lack of Efficacy|99|||
13320143|NCT01186744|26566320|FG002|Overall Study|Lack of Efficacy|0|||
13320144|NCT01186744|26566321|FG003|Overall Study|Lack of Efficacy|2|||
13320145|NCT01186744|26566322|FG004|Overall Study|Lack of Efficacy|2|||
13320146|NCT01186744|26566323|FG005|Overall Study|Lack of Efficacy|5|||
13320147|NCT01186744|26566318|FG000|Overall Study|Protocol Violation|1|||
13320148|NCT01186744|26566319|FG001|Overall Study|Protocol Violation|2|||
13320149|NCT01186744|26566320|FG002|Overall Study|Protocol Violation|0|||
13320150|NCT01186744|26566321|FG003|Overall Study|Protocol Violation|1|||
13320151|NCT01186744|26566322|FG004|Overall Study|Protocol Violation|1|||
13320152|NCT01186744|26566323|FG005|Overall Study|Protocol Violation|2|||
13320153|NCT01186744|26566318|FG000|Overall Study|Lost to Follow-up|15|||
13320154|NCT01186744|26566319|FG001|Overall Study|Lost to Follow-up|16|||
13320155|NCT01186744|26566320|FG002|Overall Study|Lost to Follow-up|2|||
13320156|NCT01186744|26566321|FG003|Overall Study|Lost to Follow-up|1|||
13320157|NCT01186744|26566322|FG004|Overall Study|Lost to Follow-up|1|||
13320158|NCT01186744|26566323|FG005|Overall Study|Lost to Follow-up|4|||
13320159|NCT01186744|26566318|FG000|Overall Study|Screen failure|1|||
13320160|NCT01186744|26566319|FG001|Overall Study|Screen failure|1|||
13320161|NCT01186744|26566320|FG002|Overall Study|Screen failure|0|||
13320162|NCT01186744|26566321|FG003|Overall Study|Screen failure|1|||
13320163|NCT01186744|26566322|FG004|Overall Study|Screen failure|0|||
13320164|NCT01186744|26566323|FG005|Overall Study|Screen failure|0|||
13320165|NCT01186744|26566318|FG000|Overall Study|Withdrawal by Subject|14|||
13320166|NCT01186744|26566319|FG001|Overall Study|Withdrawal by Subject|10|||
13320167|NCT01186744|26566320|FG002|Overall Study|Withdrawal by Subject|2|||
13320168|NCT01186744|26566321|FG003|Overall Study|Withdrawal by Subject|5|||
13320169|NCT01186744|26566322|FG004|Overall Study|Withdrawal by Subject|0|||
13320170|NCT01186744|26566323|FG005|Overall Study|Withdrawal by Subject|6|||
13320171|NCT01186744|26566318|FG000|Overall Study|Study terminated by Sponsor|1|||
13320172|NCT01186744|26566319|FG001|Overall Study|Study terminated by Sponsor|0|||
13320173|NCT01186744|26566320|FG002|Overall Study|Study terminated by Sponsor|0|||
13320174|NCT01186744|26566321|FG003|Overall Study|Study terminated by Sponsor|0|||
13320175|NCT01186744|26566322|FG004|Overall Study|Study terminated by Sponsor|0|||
13320176|NCT01186744|26566323|FG005|Overall Study|Study terminated by Sponsor|0|||
13320177|NCT01186744|26566318|FG000|Overall Study|Other|9|||
13320178|NCT01186744|26566319|FG001|Overall Study|Other|10|||
13320179|NCT01186744|26566320|FG002|Overall Study|Other|1|||
13320180|NCT01186744|26566321|FG003|Overall Study|Other|2|||
13320181|NCT01186744|26566322|FG004|Overall Study|Other|1|||
13320182|NCT01186744|26566323|FG005|Overall Study|Other|5|||
13320183|NCT01186744|26566318|FG000|Overall Study|Adverse Event|10|||
13320184|NCT01186744|26566319|FG001|Overall Study|Adverse Event|14|||
13320185|NCT01186744|26566320|FG002|Overall Study|Adverse Event|1|||
13320186|NCT01186744|26566321|FG003|Overall Study|Adverse Event|0|||
13320187|NCT01186744|26566322|FG004|Overall Study|Adverse Event|1|||
13320188|NCT01186744|26566323|FG005|Overall Study|Adverse Event|4|||
13320189|NCT01186744|26566318|FG000|Overall Study|Death|1|||
13320190|NCT01186744|26566319|FG001|Overall Study|Death|0|||
13320191|NCT01186744|26566320|FG002|Overall Study|Death|0|||
13320192|NCT01186744|26566321|FG003|Overall Study|Death|0|||
13320193|NCT01186744|26566322|FG004|Overall Study|Death|0|||
13320194|NCT01186744|26566323|FG005|Overall Study|Death|0|||
13320195|NCT01186692|26566333|FG000|Overall Study|Not Catheterized|11|||
13320196|NCT01186692|26566333|FG000|Overall Study|Futher testing contraindicated implant|19|||
13320197|NCT01186692|26566333|FG000|Overall Study|Adverse Event|2|||
13320198|NCT01186458|26566342|FG000|Overall Study|Adverse Event|1|||
13320199|NCT01186419|26566356|FG000|Overall Study|Withdrawal by Subject|5|||
13320200|NCT01186419|26566357|FG001|Overall Study|Withdrawal by Subject|3|||
13320201|NCT01186419|26566356|FG000|Overall Study|Adverse Event|1|||
13320202|NCT01186419|26566357|FG001|Overall Study|Adverse Event|2|||
13320203|NCT01186419|26566356|FG000|Overall Study|Physician Decision|0|||
13320204|NCT01186419|26566357|FG001|Overall Study|Physician Decision|3|||
13320205|NCT01186419|26566356|FG000|Overall Study|Other|1|||
13320206|NCT01186419|26566357|FG001|Overall Study|Other|1|||
13320207|NCT01186328|26566367|FG000|Overall Study|Death|1|||
13320208|NCT01186328|26566368|FG001|Overall Study|Death|0|||
13320209|NCT01186328|26566369|FG002|Overall Study|Death|0|||
13320210|NCT01185964|26566406|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1|||
13320211|NCT01185964|26566407|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6|||
13320212|NCT01185964|26566408|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2|||
13320213|NCT01185964|26566409|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0|||
13320214|NCT01185964|26566406|FG000|Phase 1b and Phase 2|Other Therapy Started|0|||
13320215|NCT01185964|26566407|FG001|Phase 1b and Phase 2|Other Therapy Started|3|||
13320216|NCT01185964|26566408|FG002|Phase 1b and Phase 2|Other Therapy Started|3|||
13320217|NCT01185964|26566409|FG003|Phase 1b and Phase 2|Other Therapy Started|0|||
13320218|NCT01185964|26566406|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
13320219|NCT01185964|26566407|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
13320220|NCT01185964|26566408|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1|||
13320221|NCT01185964|26566409|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
13320222|NCT01185964|26566406|FG000|Phase 1b and Phase 2|Adverse Event|1|||
13320223|NCT01185964|26566407|FG001|Phase 1b and Phase 2|Adverse Event|0|||
13320224|NCT01185964|26566408|FG002|Phase 1b and Phase 2|Adverse Event|2|||
13320225|NCT01185964|26566409|FG003|Phase 1b and Phase 2|Adverse Event|0|||
13320226|NCT01185964|26566406|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
13320227|NCT01185964|26566407|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
13320228|NCT01185964|26566408|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
13320229|NCT01185964|26566409|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
13320230|NCT01185964|26566406|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
13320231|NCT01185964|26566407|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
13320232|NCT01185964|26566408|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
13320233|NCT01185964|26566409|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2|||
13320234|NCT01185964|26566406|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
13320235|NCT01185964|26566407|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
13320236|NCT01185964|26566408|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
13320237|NCT01185964|26566409|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1|||
13320238|NCT01185964|26566406|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
13320239|NCT01185964|26566407|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
13320240|NCT01185964|26566408|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
13320241|NCT01185964|26566409|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2|||
13320242|NCT01185834|26566416|FG000|Overall Study|Lost to Follow-up|2|||
13320243|NCT01185834|26566416|FG000|Overall Study|Discomfort|4|||
13320244|NCT01185834|26566416|FG000|Overall Study|Biomicroscopy|4|||
13320245|NCT01185834|26566416|FG000|Overall Study|Time/Job Conflict|2|||
13320246|NCT01185834|26566416|FG000|Overall Study|Early exit - Site error|2|||
13320247|NCT01185821|26566481|FG000|Overall Study|Abnormal laboratory value(s)|1|||
13320248|NCT01185821|26566482|FG001|Overall Study|Abnormal laboratory value(s)|2|||
13320249|NCT01185821|26566483|FG002|Overall Study|Abnormal laboratory value(s)|1|||
13320250|NCT01185821|26566484|FG003|Overall Study|Abnormal laboratory value(s)|0|||
13320251|NCT01185821|26566485|FG004|Overall Study|Abnormal laboratory value(s)|0|||
13320252|NCT01185821|26566481|FG000|Overall Study|Protocol Violation|0|||
13320253|NCT01185821|26566482|FG001|Overall Study|Protocol Violation|0|||
13320254|NCT01185821|26566483|FG002|Overall Study|Protocol Violation|0|||
13320255|NCT01185821|26566484|FG003|Overall Study|Protocol Violation|1|||
13320256|NCT01185821|26566485|FG004|Overall Study|Protocol Violation|1|||
13320257|NCT01185821|26566481|FG000|Overall Study|Abnormal test procedure result|0|||
13320258|NCT01185821|26566482|FG001|Overall Study|Abnormal test procedure result|0|||
13320259|NCT01185821|26566483|FG002|Overall Study|Abnormal test procedure result|0|||
13320260|NCT01185821|26566484|FG003|Overall Study|Abnormal test procedure result|0|||
13320261|NCT01185821|26566485|FG004|Overall Study|Abnormal test procedure result|1|||
13320262|NCT01185821|26566481|FG000|Overall Study|Death|0|||
13320263|NCT01185821|26566482|FG001|Overall Study|Death|1|||
13320264|NCT01185821|26566483|FG002|Overall Study|Death|0|||
13320265|NCT01185821|26566484|FG003|Overall Study|Death|0|||
13320266|NCT01185821|26566485|FG004|Overall Study|Death|0|||
13320267|NCT01185821|26566481|FG000|Overall Study|Condition no longer required study drug|0|||
13320268|NCT01185821|26566482|FG001|Overall Study|Condition no longer required study drug|0|||
13320269|NCT01185821|26566483|FG002|Overall Study|Condition no longer required study drug|0|||
13320270|NCT01185821|26566484|FG003|Overall Study|Condition no longer required study drug|0|||
13320271|NCT01185821|26566485|FG004|Overall Study|Condition no longer required study drug|1|||
13320272|NCT01185821|26566481|FG000|Overall Study|Adverse Event|2|||
13320273|NCT01185821|26566482|FG001|Overall Study|Adverse Event|3|||
13320274|NCT01185821|26566483|FG002|Overall Study|Adverse Event|1|||
13320275|NCT01185821|26566484|FG003|Overall Study|Adverse Event|2|||
13320276|NCT01185821|26566485|FG004|Overall Study|Adverse Event|5|||
13320277|NCT01185821|26566481|FG000|Overall Study|Lack of Efficacy|0|||
13122254|NCT02966834|25946594|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
13122255|NCT02966834|25946589|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
13122256|NCT02966834|25946590|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
13122257|NCT02966834|25946591|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
13320278|NCT01185821|26566482|FG001|Overall Study|Lack of Efficacy|0|||
13320279|NCT01185821|26566483|FG002|Overall Study|Lack of Efficacy|3|||
13320280|NCT01185821|26566484|FG003|Overall Study|Lack of Efficacy|0|||
13320281|NCT01185821|26566485|FG004|Overall Study|Lack of Efficacy|9|||
13320282|NCT01185821|26566481|FG000|Overall Study|Withdrawal by Subject|3|||
13320283|NCT01185821|26566482|FG001|Overall Study|Withdrawal by Subject|2|||
13320284|NCT01185821|26566483|FG002|Overall Study|Withdrawal by Subject|2|||
13320285|NCT01185821|26566484|FG003|Overall Study|Withdrawal by Subject|1|||
13320286|NCT01185821|26566485|FG004|Overall Study|Withdrawal by Subject|3|||
13320287|NCT01185821|26566481|FG000|Overall Study|Lost to Follow-up|1|||
13320288|NCT01185821|26566482|FG001|Overall Study|Lost to Follow-up|1|||
13320289|NCT01185821|26566483|FG002|Overall Study|Lost to Follow-up|2|||
13320290|NCT01185821|26566484|FG003|Overall Study|Lost to Follow-up|1|||
13320291|NCT01185821|26566485|FG004|Overall Study|Lost to Follow-up|2|||
13320292|NCT01185821|26566481|FG000|Overall Study|Administrative problems|0|||
13320293|NCT01185821|26566482|FG001|Overall Study|Administrative problems|0|||
13320294|NCT01185821|26566483|FG002|Overall Study|Administrative problems|1|||
13320295|NCT01185821|26566484|FG003|Overall Study|Administrative problems|1|||
13320296|NCT01185821|26566485|FG004|Overall Study|Administrative problems|2|||
13320297|NCT01185782|26566518|FG000|Overall Study|Adverse Event|0|||
13320298|NCT01185782|26566519|FG001|Overall Study|Adverse Event|1|||
13320299|NCT01185782|26566518|FG000|Overall Study|Protocol Violation|1|||
13320300|NCT01185782|26566519|FG001|Overall Study|Protocol Violation|0|||
13320301|NCT01185782|26566518|FG000|Overall Study|Poor Response to Treatment|3|||
13320302|NCT01185782|26566519|FG001|Overall Study|Poor Response to Treatment|1|||
13320303|NCT01185782|26566518|FG000|Overall Study|Other|2|||
13320304|NCT01185782|26566519|FG001|Overall Study|Other|5|||
13320305|NCT01185782|26566518|FG000|Overall Study|Randomized but not treated|0|||
13320306|NCT01185782|26566519|FG001|Overall Study|Randomized but not treated|4|||
13320307|NCT01185704|26566560|FG000|Overall Study|Randomized but not treated|3|||
13320308|NCT01185704|26566561|FG001|Overall Study|Randomized but not treated|3|||
13320309|NCT01185704|26566560|FG000|Overall Study|Lack of ovarian response|5|||
13320310|NCT01185704|26566561|FG001|Overall Study|Lack of ovarian response|1|||
13320311|NCT01185704|26566560|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5|||
13320312|NCT01185704|26566561|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
13320313|NCT01185704|26566560|FG000|Overall Study|Ectopic pregnancy|0|||
13320314|NCT01185704|26566561|FG001|Overall Study|Ectopic pregnancy|1|||
13320315|NCT01185639|26566571|FG000|Overall Study|Progressed and didn't receive therapy|2|||
13320316|NCT01185600|26566598|FG000|Overall Study|Adverse Event|1|||
13320317|NCT01185600|26566599|FG001|Overall Study|Adverse Event|1|||
13320318|NCT01185600|26566598|FG000|Overall Study|Death|0|||
13320319|NCT01185600|26566599|FG001|Overall Study|Death|1|||
13320320|NCT01185600|26566598|FG000|Overall Study|Lost to Follow-up|0|||
13320321|NCT01185600|26566599|FG001|Overall Study|Lost to Follow-up|5|||
13320322|NCT01185600|26566598|FG000|Overall Study|Physician Decision|29|||
13320323|NCT01185600|26566599|FG001|Overall Study|Physician Decision|35|||
13320324|NCT01185600|26566598|FG000|Overall Study|Withdrawal by Subject|1|||
13320325|NCT01185600|26566599|FG001|Overall Study|Withdrawal by Subject|1|||
13320326|NCT01185600|26566598|FG000|Overall Study|Hold by DSMB|1|||
13320327|NCT01185600|26566599|FG001|Overall Study|Hold by DSMB|2|||
13320328|NCT01185561|26566618|FG000|Overall Study|Lost to Follow-up|0|||
13320329|NCT01185561|26566619|FG001|Overall Study|Lost to Follow-up|4|||
13320330|NCT01185561|26566618|FG000|Overall Study|Withdrawal by Subject|2|||
13320331|NCT01185561|26566619|FG001|Overall Study|Withdrawal by Subject|8|||
13320332|NCT01185548|26566634|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2|||
13320333|NCT01185522|26566660|FG000|Overall Study|Lack of Efficacy|28|||
13320334|NCT01185522|26566660|FG000|Overall Study|Lost to Follow-up|19|||
13320335|NCT01185522|26566660|FG000|Overall Study|Withdrawal by Subject|10|||
13320336|NCT01185522|26566660|FG000|Overall Study|Poor tolerance|39|||
13320337|NCT01185522|26566660|FG000|Overall Study|Other reasons|12|||
13320338|NCT01185509|26566678|FG000|Overall Study|Progression/Relapse|9|||
13320339|NCT01185509|26566679|FG001|Overall Study|Progression/Relapse|15|||
13320340|NCT01185509|26566678|FG000|Overall Study|Physician Decision|2|||
13320341|NCT01185509|26566679|FG001|Overall Study|Physician Decision|2|||
13320342|NCT01185509|26566678|FG000|Overall Study|Withdrawal by Subject|0|||
13320343|NCT01185509|26566679|FG001|Overall Study|Withdrawal by Subject|1|||
13320344|NCT01185509|26566678|FG000|Overall Study|Death|0|||
13320345|NCT01185509|26566679|FG001|Overall Study|Death|1|||
13320346|NCT01185509|26566678|FG000|Overall Study|Intercurrent Illness|0|||
13320347|NCT01185509|26566679|FG001|Overall Study|Intercurrent Illness|1|||
13320348|NCT01185366|26566700|FG000|First Line Therapy|Insurance Coverage Denied|1|||
13320349|NCT01185366|26566701|FG001|First Line Therapy|Insurance Coverage Denied|1|||
13320350|NCT01185366|26566700|FG000|First Line Therapy|Withdrawal by Subject|1|||
13320351|NCT01185366|26566701|FG001|First Line Therapy|Withdrawal by Subject|0|||
13320352|NCT01185366|26566700|FG000|First Line Therapy|Lack of Metastatic Site|1|||
13320353|NCT01185366|26566701|FG001|First Line Therapy|Lack of Metastatic Site|0|||
13320354|NCT01185366|26566700|FG000|Crossover to Second Line Therapy|Adverse Event|3|||
13320355|NCT01185366|26566701|FG001|Crossover to Second Line Therapy|Adverse Event|6|||
13320356|NCT01185366|26566700|FG000|Crossover to Second Line Therapy|Physician Decision|5|||
13320357|NCT01185366|26566701|FG001|Crossover to Second Line Therapy|Physician Decision|1|||
13320358|NCT01185366|26566700|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1|||
13320359|NCT01185366|26566701|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0|||
13320360|NCT01185366|26566700|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5|||
13320361|NCT01185366|26566701|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3|||
13320362|NCT01185353|26566880|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1|||
13320363|NCT01185353|26566881|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1|||
13320364|NCT01185353|26566882|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1|||
13320365|NCT01185353|26566883|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1|||
13320366|NCT01185353|26566884|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5|||
13320367|NCT01185353|26566885|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0|||
13320368|NCT01185353|26566886|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0|||
13320369|NCT01185353|26566887|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0|||
13320370|NCT01185353|26566888|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0|||
13320371|NCT01185353|26566889|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0|||
13320372|NCT01185353|26566880|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
13320373|NCT01185353|26566881|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
13320374|NCT01185353|26566882|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
13320375|NCT01185353|26566883|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
13320376|NCT01185353|26566884|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4|||
13320377|NCT01185353|26566885|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
13320378|NCT01185353|26566886|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
13320379|NCT01185353|26566887|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
13320380|NCT01185353|26566888|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
13320381|NCT01185353|26566889|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
13320382|NCT01185353|26566880|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2|||
13320383|NCT01185353|26566881|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
13320384|NCT01185353|26566882|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
13320385|NCT01185353|26566883|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
13320386|NCT01185353|26566884|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1|||
13320387|NCT01185353|26566885|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
13320388|NCT01185353|26566886|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
13320389|NCT01185353|26566887|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
13320390|NCT01185353|26566888|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
13320391|NCT01185353|26566889|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
13320392|NCT01185353|26566880|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0|||
13320393|NCT01185353|26566881|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0|||
13320394|NCT01185353|26566882|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1|||
13320395|NCT01185353|26566883|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0|||
13320396|NCT01185353|26566884|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2|||
13320397|NCT01185353|26566885|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0|||
13320398|NCT01185353|26566886|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0|||
13320399|NCT01185353|26566887|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0|||
13320400|NCT01185353|26566888|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0|||
13320401|NCT01185353|26566889|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0|||
13320402|NCT01185353|26566880|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
13320403|NCT01185353|26566881|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
13320404|NCT01185353|26566882|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
13320405|NCT01185353|26566883|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
13320406|NCT01185353|26566884|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1|||
13320407|NCT01185353|26566885|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
13320408|NCT01185353|26566886|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
13320409|NCT01185353|26566887|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
13320410|NCT01185353|26566888|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
13320411|NCT01185353|26566889|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
13320412|NCT01185353|26566880|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2|||
13320413|NCT01185353|26566881|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
13320414|NCT01185353|26566882|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
13320415|NCT01185353|26566883|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
13320416|NCT01185353|26566884|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3|||
13320417|NCT01185353|26566885|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
13320418|NCT01185353|26566886|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
13320419|NCT01185353|26566887|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
13320420|NCT01185353|26566888|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
13320421|NCT01185353|26566889|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
13320422|NCT01185353|26566880|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0|||
13320423|NCT01185353|26566881|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0|||
13320424|NCT01185353|26566882|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1|||
13320425|NCT01185353|26566883|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0|||
13320426|NCT01185353|26566884|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0|||
13320427|NCT01185353|26566885|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1|||
13320428|NCT01185353|26566886|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0|||
13320429|NCT01185353|26566887|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0|||
13320430|NCT01185353|26566888|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0|||
13320431|NCT01185353|26566889|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0|||
13320432|NCT01185353|26566880|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
13320433|NCT01185353|26566881|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
13320434|NCT01185353|26566882|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
13320435|NCT01185353|26566883|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
13320436|NCT01185353|26566884|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
13320437|NCT01185353|26566885|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
13320438|NCT01185353|26566886|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
13320439|NCT01185353|26566887|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
13320440|NCT01185353|26566888|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
13320441|NCT01185353|26566889|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
13320442|NCT01185353|26566880|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
13320443|NCT01185353|26566881|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
13320444|NCT01185353|26566882|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
13320445|NCT01185353|26566883|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
13320446|NCT01185353|26566884|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
13320447|NCT01185353|26566885|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
13320448|NCT01185353|26566886|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
13320449|NCT01185353|26566887|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
13320450|NCT01185353|26566888|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
13320451|NCT01185353|26566889|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
13320452|NCT01185353|26566880|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
13320453|NCT01185353|26566881|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
13320454|NCT01185353|26566882|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1|||
13320455|NCT01185353|26566883|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2|||
13320456|NCT01185353|26566884|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
13320457|NCT01185353|26566885|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3|||
13320458|NCT01185353|26566886|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4|||
13320459|NCT01185353|26566887|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
13320460|NCT01185353|26566888|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
13320461|NCT01185353|26566889|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
13320462|NCT01185353|26566880|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
13320463|NCT01185353|26566881|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
13320464|NCT01185353|26566882|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
13320465|NCT01185353|26566883|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
13320466|NCT01185353|26566884|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
13320467|NCT01185353|26566885|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
13122258|NCT02966834|25946592|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1|||
13122259|NCT02966834|25946593|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
13122260|NCT02966834|25946594|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
13122261|NCT02966795|25946610|FG000|Overall Study|Patient Left the Country|0|||
13122262|NCT02966795|25946611|FG001|Overall Study|Patient Left the Country|1|||
13122263|NCT02966509|25946642|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2|||
13320468|NCT01185353|26566886|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1|||
13320469|NCT01185353|26566887|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
13320470|NCT01185353|26566888|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
13320471|NCT01185353|26566889|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
13320472|NCT01185353|26566880|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0|||
13320473|NCT01185353|26566881|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0|||
13320474|NCT01185353|26566882|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0|||
13320475|NCT01185353|26566883|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0|||
13320476|NCT01185353|26566884|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0|||
13320477|NCT01185353|26566885|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0|||
13320478|NCT01185353|26566886|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0|||
13320479|NCT01185353|26566887|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8|||
13320480|NCT01185353|26566888|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2|||
13320481|NCT01185353|26566889|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2|||
13320482|NCT01185353|26566880|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
13320483|NCT01185353|26566881|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
13320484|NCT01185353|26566882|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
13320485|NCT01185353|26566883|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
13320486|NCT01185353|26566884|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
13320487|NCT01185353|26566885|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
13320488|NCT01185353|26566886|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
13320489|NCT01185353|26566887|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6|||
13320490|NCT01185353|26566888|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
13320491|NCT01185353|26566889|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
13320492|NCT01185353|26566880|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
13320493|NCT01185353|26566881|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
13320494|NCT01185353|26566882|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
13320495|NCT01185353|26566883|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
13122264|NCT02966509|25946643|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3|||
13122265|NCT02966509|25946642|FG000|Baseline Satisfaction Survey|Death|0|||
13122266|NCT02966509|25946643|FG001|Baseline Satisfaction Survey|Death|1|||
13122267|NCT02966509|25946642|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1|||
13122268|NCT02966509|25946643|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1|||
13122269|NCT02966509|25946642|FG000|Baseline Satisfaction Survey|Refused to Answer|1|||
13122270|NCT02966509|25946643|FG001|Baseline Satisfaction Survey|Refused to Answer|2|||
13122271|NCT02966509|25946642|FG000|6 Month Satisfaction Decision Survey|Death|22|||
13122272|NCT02966509|25946643|FG001|6 Month Satisfaction Decision Survey|Death|25|||
13320496|NCT01185353|26566884|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
13320497|NCT01185353|26566885|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
13320498|NCT01185353|26566886|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
13320499|NCT01185353|26566887|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2|||
13320500|NCT01185353|26566888|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
13320501|NCT01185353|26566889|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
13320502|NCT01185353|26566880|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
13320503|NCT01185353|26566881|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
13320504|NCT01185353|26566882|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
13320505|NCT01185353|26566883|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
13320506|NCT01185353|26566884|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
13320507|NCT01185353|26566885|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
13320508|NCT01185353|26566886|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
13320509|NCT01185353|26566887|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
13320510|NCT01185353|26566888|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2|||
13320511|NCT01185353|26566889|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
13320512|NCT01185353|26566880|FG000|Part C (Weeks 24 Through 76)|Death|0|||
13320513|NCT01185353|26566881|FG001|Part C (Weeks 24 Through 76)|Death|0|||
13320514|NCT01185353|26566882|FG002|Part C (Weeks 24 Through 76)|Death|0|||
13320515|NCT01185353|26566883|FG003|Part C (Weeks 24 Through 76)|Death|0|||
13320516|NCT01185353|26566884|FG004|Part C (Weeks 24 Through 76)|Death|0|||
13320517|NCT01185353|26566885|FG005|Part C (Weeks 24 Through 76)|Death|0|||
13320518|NCT01185353|26566886|FG006|Part C (Weeks 24 Through 76)|Death|0|||
13320519|NCT01185353|26566887|FG007|Part C (Weeks 24 Through 76)|Death|0|||
13320520|NCT01185353|26566888|FG008|Part C (Weeks 24 Through 76)|Death|0|||
13320521|NCT01185353|26566889|FG009|Part C (Weeks 24 Through 76)|Death|1|||
13320522|NCT01185353|26566880|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
13320523|NCT01185353|26566881|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
13320524|NCT01185353|26566882|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
13320525|NCT01185353|26566883|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
13320526|NCT01185353|26566884|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
13320527|NCT01185353|26566885|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
13320528|NCT01185353|26566886|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
13320529|NCT01185353|26566887|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
13320530|NCT01185353|26566888|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
13320531|NCT01185353|26566889|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1|||
13320532|NCT01185353|26566880|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0|||
13320533|NCT01185353|26566881|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0|||
13320534|NCT01185353|26566882|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0|||
13320535|NCT01185353|26566883|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0|||
13320536|NCT01185353|26566884|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0|||
13320537|NCT01185353|26566885|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0|||
13320538|NCT01185353|26566886|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0|||
13320539|NCT01185353|26566887|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0|||
13320540|NCT01185353|26566888|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0|||
13320541|NCT01185353|26566889|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1|||
13286870|NCT00477490|26472500|FG004|Part I: 4 Week Efficacy|Protocol Violation|1|||
13286871|NCT00477490|26472501|FG005|Part I: 4 Week Efficacy|Protocol Violation|0|||
13286872|NCT00477490|26472502|FG006|Part I: 4 Week Efficacy|Protocol Violation|0|||
13286873|NCT00477490|26472503|FG007|Part I: 4 Week Efficacy|Protocol Violation|0|||
13286874|NCT00477490|26472504|FG008|Part I: 4 Week Efficacy|Protocol Violation|0|||
13286875|NCT00477490|26472496|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
13286876|NCT00477490|26472497|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5|||
13286877|NCT00477490|26472498|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
13286878|NCT00477490|26472499|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4|||
13286879|NCT00477490|26472500|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9|||
13286880|NCT00477490|26472501|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
13286881|NCT00477490|26472502|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
13286882|NCT00477490|26472503|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
13286883|NCT00477490|26472504|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
13320542|NCT01185353|26566880|FG000|Part C (Weeks 24 Through 76)|Reason missing|0|||
13320543|NCT01185353|26566881|FG001|Part C (Weeks 24 Through 76)|Reason missing|0|||
13320544|NCT01185353|26566882|FG002|Part C (Weeks 24 Through 76)|Reason missing|0|||
13320545|NCT01185353|26566883|FG003|Part C (Weeks 24 Through 76)|Reason missing|0|||
13320546|NCT01185353|26566884|FG004|Part C (Weeks 24 Through 76)|Reason missing|0|||
13320547|NCT01185353|26566885|FG005|Part C (Weeks 24 Through 76)|Reason missing|0|||
13320548|NCT01185353|26566886|FG006|Part C (Weeks 24 Through 76)|Reason missing|0|||
13320549|NCT01185353|26566887|FG007|Part C (Weeks 24 Through 76)|Reason missing|0|||
13320550|NCT01185353|26566888|FG008|Part C (Weeks 24 Through 76)|Reason missing|1|||
13320551|NCT01185353|26566889|FG009|Part C (Weeks 24 Through 76)|Reason missing|0|||
13320552|NCT01185353|26566880|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
13320553|NCT01185353|26566881|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
13320554|NCT01185353|26566882|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
13320555|NCT01185353|26566883|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
13320556|NCT01185353|26566884|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
13320557|NCT01185353|26566885|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
13320558|NCT01185353|26566886|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
13320559|NCT01185353|26566887|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1|||
13320560|NCT01185353|26566888|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3|||
13320561|NCT01185353|26566889|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
13320562|NCT01185353|26566880|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
13320563|NCT01185353|26566881|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
13320564|NCT01185353|26566882|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
13320565|NCT01185353|26566883|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
13320566|NCT01185353|26566884|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
13320567|NCT01185353|26566885|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
13320568|NCT01185353|26566886|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
13320569|NCT01185353|26566887|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
13320570|NCT01185353|26566888|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2|||
13320571|NCT01185353|26566889|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
13320572|NCT01185353|26566880|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0|||
13320573|NCT01185353|26566881|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0|||
13320574|NCT01185353|26566882|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0|||
13320575|NCT01185353|26566883|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0|||
13320576|NCT01185353|26566884|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0|||
13320577|NCT01185353|26566885|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0|||
13320578|NCT01185353|26566886|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0|||
13320579|NCT01185353|26566887|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1|||
13320580|NCT01185353|26566888|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2|||
13320581|NCT01185353|26566889|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0|||
13320582|NCT01185340|26566948|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24|||
13320583|NCT01185340|26566949|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
13320584|NCT01185340|26566950|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
13320585|NCT01185340|26566951|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
13320586|NCT01185340|26566948|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6|||
13320587|NCT01185340|26566949|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
13320588|NCT01185340|26566950|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
13320589|NCT01185340|26566951|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
13320590|NCT01185340|26566948|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5|||
13320591|NCT01185340|26566949|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
13320592|NCT01185340|26566950|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
13320593|NCT01185340|26566951|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
13320594|NCT01185340|26566948|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
13320595|NCT01185340|26566949|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
13320596|NCT01185340|26566950|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
13320597|NCT01185340|26566951|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
13320598|NCT01185340|26566948|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16|||
13320599|NCT01185340|26566949|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
13320600|NCT01185340|26566950|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
13320601|NCT01185340|26566951|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
13320602|NCT01185340|26566948|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32|||
13320603|NCT01185340|26566949|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
13320604|NCT01185340|26566950|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
13320605|NCT01185340|26566951|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
13320606|NCT01185340|26566948|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3|||
13320607|NCT01185340|26566949|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
13320608|NCT01185340|26566950|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
13320609|NCT01185340|26566951|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
13320610|NCT01185340|26566948|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
13320611|NCT01185340|26566949|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
13320612|NCT01185340|26566950|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8|||
13320613|NCT01185340|26566951|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
13320614|NCT01185340|26566948|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
13320615|NCT01185340|26566949|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
13320616|NCT01185340|26566950|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7|||
13320617|NCT01185340|26566951|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
13320618|NCT01185340|26566948|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
13320619|NCT01185340|26566949|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4|||
13320620|NCT01185340|26566950|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
13320621|NCT01185340|26566951|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7|||
13320622|NCT01185340|26566948|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
13320623|NCT01185340|26566949|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
13320624|NCT01185340|26566950|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
13320625|NCT01185340|26566951|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
13320626|NCT01185340|26566948|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
13320627|NCT01185340|26566949|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
13320628|NCT01185340|26566950|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2|||
13320629|NCT01185340|26566951|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
13320630|NCT01185340|26566948|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
13320631|NCT01185340|26566949|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
13320632|NCT01185340|26566950|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
13320633|NCT01185340|26566951|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
13320634|NCT01185340|26566948|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
13320635|NCT01185340|26566949|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
13320636|NCT01185340|26566950|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3|||
13320637|NCT01185340|26566951|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
13320638|NCT01185301|26567022|FG000|Overall Study|Adverse Event|3|||
13320639|NCT01185301|26567023|FG001|Overall Study|Adverse Event|0|||
13320640|NCT01185301|26567024|FG002|Overall Study|Adverse Event|2|||
13320641|NCT01185301|26567025|FG003|Overall Study|Adverse Event|3|||
13320642|NCT01185301|26567022|FG000|Overall Study|Withdrawal by Subject|7|||
13320643|NCT01185301|26567023|FG001|Overall Study|Withdrawal by Subject|5|||
13320644|NCT01185301|26567024|FG002|Overall Study|Withdrawal by Subject|2|||
13320645|NCT01185301|26567025|FG003|Overall Study|Withdrawal by Subject|3|||
13320646|NCT01185301|26567022|FG000|Overall Study|Lost to Follow-up|2|||
13320647|NCT01185301|26567023|FG001|Overall Study|Lost to Follow-up|0|||
13320648|NCT01185301|26567024|FG002|Overall Study|Lost to Follow-up|0|||
13320649|NCT01185301|26567025|FG003|Overall Study|Lost to Follow-up|1|||
13320650|NCT01185301|26567022|FG000|Overall Study|Other Reason|3|||
13320651|NCT01185301|26567023|FG001|Overall Study|Other Reason|2|||
13320652|NCT01185301|26567024|FG002|Overall Study|Other Reason|2|||
13320653|NCT01185301|26567025|FG003|Overall Study|Other Reason|2|||
13320654|NCT01185288|26567050|FG000|Overall Study|Adverse Event|7|||
13320655|NCT01185288|26567051|FG001|Overall Study|Adverse Event|6|||
13320656|NCT01185288|26567050|FG000|Overall Study|Withdrawal by Subject|6|||
13320657|NCT01185288|26567051|FG001|Overall Study|Withdrawal by Subject|4|||
13320658|NCT01185288|26567050|FG000|Overall Study|Lost to Follow-up|2|||
13320659|NCT01185288|26567051|FG001|Overall Study|Lost to Follow-up|5|||
13320660|NCT01185288|26567050|FG000|Overall Study|Lack of Efficacy|2|||
13320661|NCT01185288|26567051|FG001|Overall Study|Lack of Efficacy|0|||
13320662|NCT01185288|26567050|FG000|Overall Study|Investigator discretion|1|||
13320663|NCT01185288|26567051|FG001|Overall Study|Investigator discretion|0|||
13320664|NCT01185288|26567050|FG000|Overall Study|Did not meet inclusion criteria|1|||
13320665|NCT01185288|26567051|FG001|Overall Study|Did not meet inclusion criteria|0|||
13320666|NCT01185288|26567050|FG000|Overall Study|Noncompliance|0|||
13320667|NCT01185288|26567051|FG001|Overall Study|Noncompliance|1|||
13320668|NCT01185249|26567058|FG000|Overall Study|Patients discharged or change in status|42|||
13320669|NCT01185171|26567067|FG000|Induction Chemotherapy|Withdrawal by Subject|1|||
13320670|NCT01185171|26567067|FG000|Induction Chemotherapy|Duodenal Ulcer|1|||
13320671|NCT01185171|26567067|FG000|Concurrent Chemo and Radiation Treatment|Death|3|||
13320672|NCT01185171|26567067|FG000|Maintenance|Elevated liver transaminases|3|||
13320673|NCT01185171|26567067|FG000|Maintenance|Rush|2|||
13320674|NCT01185171|26567067|FG000|Maintenance|Diarrhea|1|||
13320675|NCT01185171|26567067|FG000|Maintenance|Xerostomia|1|||
13320676|NCT01185171|26567067|FG000|Maintenance|Nausea|1|||
13320677|NCT01185171|26567067|FG000|Maintenance|Comorbid Illness|2|||
13320678|NCT01185171|26567067|FG000|Maintenance|Withdrawal by Subject|1|||
13320679|NCT01185171|26567067|FG000|Maintenance|Disease Recurrence|1|||
13320680|NCT01185080|26567124|FG000|Overall Study|Adverse Event|1|||
13320681|NCT01185080|26567125|FG001|Overall Study|Adverse Event|1|||
13320682|NCT01185080|26567126|FG002|Overall Study|Adverse Event|0|||
13320683|NCT01185080|26567124|FG000|Overall Study|Personal reasons|0|||
13320684|NCT01185080|26567125|FG001|Overall Study|Personal reasons|0|||
13320685|NCT01185080|26567126|FG002|Overall Study|Personal reasons|1|||
13320686|NCT01184989|26567134|FG000|Overall Study|Adverse Event|11|||
13320687|NCT01184989|26567134|FG000|Overall Study|Withdrawal by Subject|1|||
13320688|NCT01184872|26567155|FG000|Overall Study|Adverse Event|3|||
13320689|NCT01184872|26567156|FG001|Overall Study|Adverse Event|4|||
13320690|NCT01184872|26567155|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
13320691|NCT01184872|26567156|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
13320692|NCT01184872|26567155|FG000|Overall Study|Withdrawal by Subject|2|||
13320693|NCT01184872|26567156|FG001|Overall Study|Withdrawal by Subject|0|||
13320694|NCT01184872|26567155|FG000|Overall Study|Lost to Follow-up|0|||
13320695|NCT01184872|26567156|FG001|Overall Study|Lost to Follow-up|1|||
13320696|NCT01184872|26567155|FG000|Overall Study|Administrative problems|1|||
13320697|NCT01184872|26567156|FG001|Overall Study|Administrative problems|1|||
13320698|NCT01184872|26567155|FG000|Overall Study|Protocol deviation|1|||
13320699|NCT01184872|26567156|FG001|Overall Study|Protocol deviation|0|||
13320700|NCT01184859|26567264|FG000|Period 1: Single Dose|Insufficient urine production|0|||
13320701|NCT01184859|26567265|FG001|Period 1: Single Dose|Insufficient urine production|1|||
13320702|NCT01184859|26567266|FG002|Period 1: Single Dose|Insufficient urine production|0|||
13320703|NCT01184859|26567267|FG003|Period 1: Single Dose|Insufficient urine production|0|||
13320704|NCT01184859|26567268|FG004|Period 1: Single Dose|Insufficient urine production|0|||
13320705|NCT01184859|26567264|FG000|Period 1: Single Dose|Protocol Violation|0|||
13320706|NCT01184859|26567265|FG001|Period 1: Single Dose|Protocol Violation|1|||
13320707|NCT01184859|26567266|FG002|Period 1: Single Dose|Protocol Violation|0|||
13320708|NCT01184859|26567267|FG003|Period 1: Single Dose|Protocol Violation|0|||
13320709|NCT01184859|26567268|FG004|Period 1: Single Dose|Protocol Violation|0|||
13320710|NCT01184859|26567264|FG000|Period 1: Single Dose|Adverse Event|0|||
13320711|NCT01184859|26567265|FG001|Period 1: Single Dose|Adverse Event|0|||
13320712|NCT01184859|26567266|FG002|Period 1: Single Dose|Adverse Event|0|||
13320713|NCT01184859|26567267|FG003|Period 1: Single Dose|Adverse Event|0|||
13320714|NCT01184859|26567268|FG004|Period 1: Single Dose|Adverse Event|1|||
13320715|NCT01184859|26567264|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
13320716|NCT01184859|26567265|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
13320717|NCT01184859|26567266|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
13320718|NCT01184859|26567267|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
13320719|NCT01184859|26567268|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1|||
13320720|NCT01184859|26567264|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1|||
13320721|NCT01184859|26567265|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
13320722|NCT01184859|26567266|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
13320723|NCT01184859|26567267|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
13320724|NCT01184859|26567268|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
13320725|NCT01184846|26567288|FG000|Overall Study|Adverse Event|2|||
13320726|NCT01184846|26567288|FG000|Overall Study|Insufficient response|1|||
13320727|NCT01184508|26567320|FG000|Overall Study|Adverse Event|4|||
13320728|NCT01184508|26567321|FG001|Overall Study|Adverse Event|6|||
13320729|NCT01184508|26567320|FG000|Overall Study|Lack of Efficacy|1|||
13320730|NCT01184508|26567321|FG001|Overall Study|Lack of Efficacy|1|||
13320731|NCT01184508|26567320|FG000|Overall Study|Lost to Follow-up|1|||
13320732|NCT01184508|26567321|FG001|Overall Study|Lost to Follow-up|1|||
13320733|NCT01184508|26567320|FG000|Overall Study|Physician Decision|1|||
13320734|NCT01184508|26567321|FG001|Overall Study|Physician Decision|0|||
13320735|NCT01184508|26567320|FG000|Overall Study|Protocol Violation|3|||
13320736|NCT01184508|26567321|FG001|Overall Study|Protocol Violation|1|||
13320737|NCT01184508|26567320|FG000|Overall Study|Sponsor Decision|5|||
13320738|NCT01184508|26567321|FG001|Overall Study|Sponsor Decision|2|||
13320739|NCT01184508|26567320|FG000|Overall Study|Withdrawal by Subject|1|||
13320740|NCT01184508|26567321|FG001|Overall Study|Withdrawal by Subject|3|||
13320741|NCT01184508|26567320|FG000|Overall Study|Randomized, Not Treated|0|||
13320742|NCT01184508|26567321|FG001|Overall Study|Randomized, Not Treated|1|||
13320743|NCT01184326|26567345|FG000|Overall Study|Adverse Event|1|||
13320744|NCT01184326|26567346|FG001|Overall Study|Adverse Event|2|||
13320745|NCT01184326|26567347|FG002|Overall Study|Adverse Event|0|||
13320746|NCT01184326|26567345|FG000|Overall Study|Death|0|||
13320747|NCT01184326|26567346|FG001|Overall Study|Death|0|||
13320748|NCT01184326|26567347|FG002|Overall Study|Death|1|||
13320749|NCT01184326|26567345|FG000|Overall Study|Withdrawal by Subject|0|||
13320750|NCT01184326|26567346|FG001|Overall Study|Withdrawal by Subject|0|||
13320751|NCT01184326|26567347|FG002|Overall Study|Withdrawal by Subject|1|||
13320752|NCT01184326|26567345|FG000|Overall Study|Physician Decision|1|||
13320753|NCT01184326|26567346|FG001|Overall Study|Physician Decision|1|||
13320754|NCT01184326|26567347|FG002|Overall Study|Physician Decision|0|||
13320755|NCT01184326|26567345|FG000|Overall Study|Disease Progression|1|||
13320756|NCT01184326|26567346|FG001|Overall Study|Disease Progression|3|||
13320757|NCT01184326|26567347|FG002|Overall Study|Disease Progression|12|||
13320758|NCT01184118|26567355|FG000|Overall Study|Only asthma step 1 - screen fail|1|||
13320759|NCT01184118|26567355|FG000|Overall Study|No physiologic confirmation of asthma|8|||
13320760|NCT01184118|26567355|FG000|Overall Study|FEV1 <60% predicted|2|||
13320761|NCT01184118|26567355|FG000|Overall Study|Exclusionary medical condition|2|||
13320762|NCT01184118|26567355|FG000|Overall Study|Withdrawal by Subject|5|||
13320763|NCT01184079|26567372|FG000|Overall Study|Lost to Follow-up|14|||
13320764|NCT01184079|26567373|FG001|Overall Study|Lost to Follow-up|2|||
13320765|NCT01184053|26567382|FG000|Overall Study|progression while on treatment|3|||
13373264|NCT00804687|26723378|FG003|Period 5: Treatment Period|Withdrawal by Subject|0|||
13373265|NCT00804687|26723379|FG004|Period 5: Treatment Period|Withdrawal by Subject|1|||
13373266|NCT00804687|26723380|FG005|Period 5: Treatment Period|Withdrawal by Subject|0|||
13373267|NCT00804687|26723375|FG000|Period 5: Treatment Period|Positive drugs of abuse|0|||
13373268|NCT00804687|26723376|FG001|Period 5: Treatment Period|Positive drugs of abuse|0|||
13373269|NCT00804687|26723377|FG002|Period 5: Treatment Period|Positive drugs of abuse|1|||
13373270|NCT00804687|26723378|FG003|Period 5: Treatment Period|Positive drugs of abuse|0|||
13373271|NCT00804687|26723379|FG004|Period 5: Treatment Period|Positive drugs of abuse|0|||
13373272|NCT00804687|26723380|FG005|Period 5: Treatment Period|Positive drugs of abuse|0|||
13373273|NCT00804687|26723375|FG000|Period 5: Treatment Period|Positive drug test|1|||
13373274|NCT00804687|26723376|FG001|Period 5: Treatment Period|Positive drug test|0|||
13373275|NCT00804687|26723377|FG002|Period 5: Treatment Period|Positive drug test|0|||
13373276|NCT00804687|26723378|FG003|Period 5: Treatment Period|Positive drug test|0|||
13373277|NCT00804687|26723379|FG004|Period 5: Treatment Period|Positive drug test|0|||
13373278|NCT00804687|26723380|FG005|Period 5: Treatment Period|Positive drug test|0|||
13373279|NCT00804570|26723443|FG000|Overall Study|Adverse Event|14|||
13373280|NCT00804570|26723444|FG001|Overall Study|Adverse Event|7|||
13373281|NCT00804570|26723443|FG000|Overall Study|Lack of Efficacy|0|||
13373282|NCT00804570|26723444|FG001|Overall Study|Lack of Efficacy|1|||
13373283|NCT00804570|26723443|FG000|Overall Study|Lost to Follow-up|18|||
13373284|NCT00804570|26723444|FG001|Overall Study|Lost to Follow-up|21|||
13373285|NCT00804570|26723443|FG000|Overall Study|Entry criteria not met|5|||
13373286|NCT00804570|26723444|FG001|Overall Study|Entry criteria not met|5|||
13373287|NCT00804570|26723443|FG000|Overall Study|Protocol Violation|12|||
13373288|NCT00804570|26723444|FG001|Overall Study|Protocol Violation|16|||
13373289|NCT00804570|26723443|FG000|Overall Study|Physician Decision|1|||
13373290|NCT00804570|26723444|FG001|Overall Study|Physician Decision|2|||
13373291|NCT00804570|26723443|FG000|Overall Study|Sponsor decision|1|||
13373292|NCT00804570|26723444|FG001|Overall Study|Sponsor decision|4|||
13373293|NCT00804570|26723443|FG000|Overall Study|Withdrawal by Subject|21|||
13373294|NCT00804570|26723444|FG001|Overall Study|Withdrawal by Subject|38|||
13373295|NCT00804193|26723468|FG000|Overall Study|Lack of baseline fungus|32|||
13373296|NCT00804193|26723469|FG001|Overall Study|Lack of baseline fungus|31|||
13373297|NCT00804193|26723470|FG002|Overall Study|Lack of baseline fungus|19|||
13373298|NCT00804193|26723468|FG000|Overall Study|Adverse Event|0|||
13373299|NCT00804193|26723469|FG001|Overall Study|Adverse Event|0|||
13373300|NCT00804193|26723470|FG002|Overall Study|Adverse Event|2|||
13373301|NCT00804193|26723468|FG000|Overall Study|Lack of Efficacy|1|||
13373302|NCT00804193|26723469|FG001|Overall Study|Lack of Efficacy|1|||
13373303|NCT00804193|26723470|FG002|Overall Study|Lack of Efficacy|3|||
13373304|NCT00804193|26723468|FG000|Overall Study|Protocol Violation|0|||
13373305|NCT00804193|26723469|FG001|Overall Study|Protocol Violation|8|||
13373306|NCT00804193|26723470|FG002|Overall Study|Protocol Violation|2|||
13373307|NCT00804193|26723468|FG000|Overall Study|Lost to Follow-up|3|||
13373308|NCT00804193|26723469|FG001|Overall Study|Lost to Follow-up|3|||
13373309|NCT00804193|26723470|FG002|Overall Study|Lost to Follow-up|4|||
13373310|NCT00804193|26723468|FG000|Overall Study|Withdrawal by Subject|3|||
13373311|NCT00804193|26723469|FG001|Overall Study|Withdrawal by Subject|1|||
13373312|NCT00804193|26723470|FG002|Overall Study|Withdrawal by Subject|2|||
13373313|NCT00804141|26723477|FG000|Overall Study|Adverse Event|157|||
13373314|NCT00804141|26723477|FG000|Overall Study|Death|4|||
13373315|NCT00804141|26723477|FG000|Overall Study|Failed to return|96|||
13373316|NCT00804141|26723477|FG000|Overall Study|Investigator request|8|||
13373317|NCT00804141|26723477|FG000|Overall Study|Protocol Violation|85|||
13373318|NCT00804141|26723477|FG000|Overall Study|Withdrawal by Subject|131|||
13373319|NCT00804141|26723477|FG000|Overall Study|Lack of Efficacy|46|||
13373320|NCT00804141|26723477|FG000|Overall Study|Other than specified|30|||
13373321|NCT00804141|26723477|FG000|Overall Study|Enrolled but not treated|6|||
13373322|NCT00803738|26723494|FG000|Overall Study|Adverse Event|3|||
13373323|NCT00803738|26723495|FG001|Overall Study|Adverse Event|5|||
13373324|NCT00803738|26723494|FG000|Overall Study|Lost to Follow-up|4|||
13373325|NCT00803738|26723495|FG001|Overall Study|Lost to Follow-up|4|||
13373326|NCT00803738|26723494|FG000|Overall Study|Protocol Violation|18|||
13373327|NCT00803738|26723495|FG001|Overall Study|Protocol Violation|10|||
13373328|NCT00803738|26723494|FG000|Overall Study|Withdrawal by Subject|1|||
13373329|NCT00803738|26723495|FG001|Overall Study|Withdrawal by Subject|4|||
13373330|NCT00803738|26723494|FG000|Overall Study|Lack of Efficacy|10|||
13373331|NCT00803738|26723495|FG001|Overall Study|Lack of Efficacy|16|||
13320766|NCT01183975|26567389|FG000|Overall Study|Lost to Follow-up|73|||
13320767|NCT01183884|26567397|FG000|Overall Study|Progressive Disease|26|||
13320768|NCT01183884|26567397|FG000|Overall Study|Adverse Event|3|||
13320769|NCT01183884|26567397|FG000|Overall Study|Withdrawal by Subject|1|||
13320770|NCT01183884|26567397|FG000|Overall Study|Other Complicating Disease|3|||
13320771|NCT01183884|26567397|FG000|Overall Study|Not Treated|1|||
13320772|NCT01183884|26567397|FG000|Overall Study|Other|4|||
13320773|NCT01183858|26567424|FG000|Overall Study|Death not related to Progressive Disease|5|||
13320774|NCT01183858|26567425|FG001|Overall Study|Death not related to Progressive Disease|6|||
13320775|NCT01183858|26567424|FG000|Overall Study|Adverse Event|14|||
13320776|NCT01183858|26567425|FG001|Overall Study|Adverse Event|11|||
13320777|NCT01183858|26567424|FG000|Overall Study|Investigator's Decision|0|||
13320778|NCT01183858|26567425|FG001|Overall Study|Investigator's Decision|3|||
13320779|NCT01183858|26567424|FG000|Overall Study|Insufficient Therapeutic Response|2|||
13320780|NCT01183858|26567425|FG001|Overall Study|Insufficient Therapeutic Response|0|||
13320781|NCT01183858|26567424|FG000|Overall Study|Refused Treatment|1|||
13320782|NCT01183858|26567425|FG001|Overall Study|Refused Treatment|4|||
13320783|NCT01183858|26567424|FG000|Overall Study|Withdrew Consent|4|||
13320784|NCT01183858|26567425|FG001|Overall Study|Withdrew Consent|4|||
13320785|NCT01183858|26567424|FG000|Overall Study|Discontinued Smoking|3|||
13320786|NCT01183858|26567425|FG001|Overall Study|Discontinued Smoking|1|||
13320787|NCT01183858|26567424|FG000|Overall Study|Protocol Violation|1|||
13320788|NCT01183858|26567425|FG001|Overall Study|Protocol Violation|0|||
13320789|NCT01183858|26567424|FG000|Overall Study|Administrative/Other|6|||
13320790|NCT01183858|26567425|FG001|Overall Study|Administrative/Other|6|||
13320791|NCT01183858|26567424|FG000|Overall Study|Progressive Disease|112|||
13320792|NCT01183858|26567425|FG001|Overall Study|Progressive Disease|115|||
13320793|NCT01183858|26567424|FG000|Overall Study|Death related to Progressive Disease|4|||
13320794|NCT01183858|26567425|FG001|Overall Study|Death related to Progressive Disease|5|||
13320795|NCT01183858|26567424|FG000|Overall Study|Lost to Follow-up|1|||
13320796|NCT01183858|26567425|FG001|Overall Study|Lost to Follow-up|1|||
13320797|NCT01183780|26567449|FG000|Overall Study|Withdrawal by Subject|25|||
13320798|NCT01183780|26567450|FG001|Overall Study|Withdrawal by Subject|14|||
13320799|NCT01183780|26567449|FG000|Overall Study|Lost to Follow-up|6|||
13320800|NCT01183780|26567450|FG001|Overall Study|Lost to Follow-up|11|||
13320801|NCT01183468|26567471|FG000|Overall Study|Lost to Follow-up|2|||
13320802|NCT01183468|26567472|FG001|Overall Study|Lost to Follow-up|1|||
13320803|NCT01183468|26567473|FG002|Overall Study|Lost to Follow-up|0|||
13320804|NCT01183468|26567474|FG003|Overall Study|Lost to Follow-up|0|||
13320805|NCT01183468|26567471|FG000|Overall Study|Physician Decision|1|||
13320806|NCT01183468|26567472|FG001|Overall Study|Physician Decision|0|||
13320807|NCT01183468|26567473|FG002|Overall Study|Physician Decision|0|||
13320808|NCT01183468|26567474|FG003|Overall Study|Physician Decision|0|||
13320809|NCT01183468|26567471|FG000|Overall Study|Withdrawal by Subject|0|||
13320810|NCT01183468|26567472|FG001|Overall Study|Withdrawal by Subject|1|||
13320811|NCT01183468|26567473|FG002|Overall Study|Withdrawal by Subject|0|||
13320812|NCT01183468|26567474|FG003|Overall Study|Withdrawal by Subject|0|||
13320813|NCT01183390|26567489|FG000|First Intervention|Adverse Event|0|||
13320814|NCT01183390|26567490|FG001|First Intervention|Adverse Event|1|||
13320815|NCT01183260|26567505|FG000|Overall Study|Intraop screen failure|2|||
13320816|NCT01183260|26567506|FG001|Overall Study|Intraop screen failure|0|||
13320817|NCT01183260|26567505|FG000|Overall Study|Withdrawal by Subject|1|||
13320818|NCT01183260|26567506|FG001|Overall Study|Withdrawal by Subject|1|||
13320819|NCT01183260|26567505|FG000|Overall Study|Revised within 30 days|0|||
13320820|NCT01183260|26567506|FG001|Overall Study|Revised within 30 days|1|||
13320821|NCT01183260|26567505|FG000|Overall Study|Death|1|||
13320822|NCT01183260|26567506|FG001|Overall Study|Death|0|||
13320823|NCT01191762|26567519|FG000|Overall Study|Adverse Event|1|||
13320824|NCT01191762|26567520|FG001|Overall Study|Adverse Event|0|||
13320825|NCT01191268|26567623|FG000|Overall Study|Withdrawal by Subject|19|||
13320826|NCT01191268|26567624|FG001|Overall Study|Withdrawal by Subject|25|||
13320827|NCT01191268|26567625|FG002|Overall Study|Withdrawal by Subject|21|||
13320828|NCT01191268|26567623|FG000|Overall Study|Adverse Event|21|||
13320829|NCT01191268|26567624|FG001|Overall Study|Adverse Event|13|||
13320830|NCT01191268|26567625|FG002|Overall Study|Adverse Event|8|||
13320831|NCT01191268|26567623|FG000|Overall Study|Physician Decision|6|||
13320832|NCT01191268|26567624|FG001|Overall Study|Physician Decision|8|||
13320833|NCT01191268|26567625|FG002|Overall Study|Physician Decision|9|||
13320834|NCT01191268|26567623|FG000|Overall Study|Lost to Follow-up|8|||
13320835|NCT01191268|26567624|FG001|Overall Study|Lost to Follow-up|5|||
13320836|NCT01191268|26567625|FG002|Overall Study|Lost to Follow-up|9|||
13320837|NCT01191268|26567623|FG000|Overall Study|Entry Criteria Not Met|3|||
13320838|NCT01191268|26567624|FG001|Overall Study|Entry Criteria Not Met|1|||
13320839|NCT01191268|26567625|FG002|Overall Study|Entry Criteria Not Met|1|||
13320840|NCT01191268|26567623|FG000|Overall Study|Death|0|||
13320841|NCT01191268|26567624|FG001|Overall Study|Death|1|||
13320842|NCT01191268|26567625|FG002|Overall Study|Death|3|||
13320843|NCT01191268|26567623|FG000|Overall Study|Protocol Violation|1|||
13320844|NCT01191268|26567624|FG001|Overall Study|Protocol Violation|0|||
13320845|NCT01191268|26567625|FG002|Overall Study|Protocol Violation|1|||
13320846|NCT01191268|26567623|FG000|Overall Study|Sponsor Decision|0|||
13320847|NCT01191268|26567624|FG001|Overall Study|Sponsor Decision|2|||
13320848|NCT01191268|26567625|FG002|Overall Study|Sponsor Decision|0|||
13320849|NCT01191190|26567640|FG000|Overall Study|Withdrawal by Subject|1|||
13320850|NCT01191086|26567646|FG000|Overall Study|Adverse Event|20|||
13320851|NCT01191086|26567646|FG000|Overall Study|Lack of Efficacy|10|||
13320852|NCT01191086|26567646|FG000|Overall Study|Lost to Follow-up|4|||
13320853|NCT01191086|26567646|FG000|Overall Study|Physician Decision|2|||
13320854|NCT01191086|26567646|FG000|Overall Study|Withdrawal by Subject|24|||
13320855|NCT01191086|26567646|FG000|Overall Study|Discontinuation criterion met|1|||
13320856|NCT01191086|26567646|FG000|Overall Study|Other|1|||
13320857|NCT01191008|26567654|FG000|Overall Study|Protocol Violation|7|||
13320858|NCT01191008|26567654|FG000|Overall Study|Lost to Follow-up|8|||
13320859|NCT01190930|26567747|FG000|Induction|Adverse Event|17|||
13320860|NCT01190930|26567748|FG001|Induction|Adverse Event|0|||
13320861|NCT01190930|26567749|FG002|Induction|Adverse Event|0|||
13320862|NCT01190930|26567750|FG003|Induction|Adverse Event|0|||
13320863|NCT01190930|26567751|FG004|Induction|Adverse Event|0|||
13320864|NCT01190930|26567752|FG005|Induction|Adverse Event|0|||
13320865|NCT01190930|26567753|FG006|Induction|Adverse Event|0|||
13320866|NCT01190930|26567754|FG007|Induction|Adverse Event|0|||
13320867|NCT01190930|26567755|FG008|Induction|Adverse Event|0|||
13320868|NCT01190930|26567756|FG009|Induction|Adverse Event|0|||
13320869|NCT01190930|26567747|FG000|Induction|Death|34|||
13320870|NCT01190930|26567748|FG001|Induction|Death|0|||
13320871|NCT01190930|26567749|FG002|Induction|Death|0|||
13320872|NCT01190930|26567750|FG003|Induction|Death|0|||
13320873|NCT01190930|26567751|FG004|Induction|Death|0|||
13320874|NCT01190930|26567752|FG005|Induction|Death|0|||
13320875|NCT01190930|26567753|FG006|Induction|Death|0|||
13320876|NCT01190930|26567754|FG007|Induction|Death|0|||
13320877|NCT01190930|26567755|FG008|Induction|Death|0|||
13320878|NCT01190930|26567756|FG009|Induction|Death|0|||
13320879|NCT01190930|26567747|FG000|Induction|Lost to Follow-up|1|||
13320880|NCT01190930|26567748|FG001|Induction|Lost to Follow-up|0|||
13320881|NCT01190930|26567749|FG002|Induction|Lost to Follow-up|0|||
13320882|NCT01190930|26567750|FG003|Induction|Lost to Follow-up|0|||
13320883|NCT01190930|26567751|FG004|Induction|Lost to Follow-up|0|||
13320884|NCT01190930|26567752|FG005|Induction|Lost to Follow-up|0|||
13320885|NCT01190930|26567753|FG006|Induction|Lost to Follow-up|0|||
13320886|NCT01190930|26567754|FG007|Induction|Lost to Follow-up|0|||
13320887|NCT01190930|26567755|FG008|Induction|Lost to Follow-up|0|||
13320888|NCT01190930|26567756|FG009|Induction|Lost to Follow-up|0|||
13320889|NCT01190930|26567747|FG000|Induction|Physician Decision|125|||
13320890|NCT01190930|26567748|FG001|Induction|Physician Decision|3|||
13320891|NCT01190930|26567749|FG002|Induction|Physician Decision|0|||
13320892|NCT01190930|26567750|FG003|Induction|Physician Decision|0|||
13320893|NCT01190930|26567751|FG004|Induction|Physician Decision|0|||
13320894|NCT01190930|26567752|FG005|Induction|Physician Decision|0|||
13320895|NCT01190930|26567753|FG006|Induction|Physician Decision|0|||
13320896|NCT01190930|26567754|FG007|Induction|Physician Decision|0|||
13320897|NCT01190930|26567755|FG008|Induction|Physician Decision|0|||
13320898|NCT01190930|26567756|FG009|Induction|Physician Decision|0|||
13320899|NCT01190930|26567747|FG000|Induction|Withdrawal by Subject|9|||
13320900|NCT01190930|26567748|FG001|Induction|Withdrawal by Subject|0|||
13320901|NCT01190930|26567749|FG002|Induction|Withdrawal by Subject|0|||
13320902|NCT01190930|26567750|FG003|Induction|Withdrawal by Subject|0|||
13320903|NCT01190930|26567751|FG004|Induction|Withdrawal by Subject|0|||
13320904|NCT01190930|26567752|FG005|Induction|Withdrawal by Subject|0|||
13320905|NCT01190930|26567753|FG006|Induction|Withdrawal by Subject|0|||
13320906|NCT01190930|26567754|FG007|Induction|Withdrawal by Subject|0|||
13320907|NCT01190930|26567755|FG008|Induction|Withdrawal by Subject|0|||
13320908|NCT01190930|26567756|FG009|Induction|Withdrawal by Subject|0|||
13320909|NCT01190930|26567747|FG000|Induction|Refusal|235|||
13320910|NCT01190930|26567748|FG001|Induction|Refusal|0|||
13320911|NCT01190930|26567749|FG002|Induction|Refusal|0|||
13320912|NCT01190930|26567750|FG003|Induction|Refusal|0|||
13320913|NCT01190930|26567751|FG004|Induction|Refusal|0|||
13320914|NCT01190930|26567752|FG005|Induction|Refusal|0|||
13320915|NCT01190930|26567753|FG006|Induction|Refusal|0|||
13320916|NCT01190930|26567754|FG007|Induction|Refusal|0|||
13320917|NCT01190930|26567755|FG008|Induction|Refusal|0|||
13320918|NCT01190930|26567756|FG009|Induction|Refusal|0|||
13320919|NCT01190930|26567747|FG000|Induction|Inevaluable|23|||
13320920|NCT01190930|26567748|FG001|Induction|Inevaluable|1|||
13320921|NCT01190930|26567749|FG002|Induction|Inevaluable|0|||
13320922|NCT01190930|26567750|FG003|Induction|Inevaluable|0|||
13320923|NCT01190930|26567751|FG004|Induction|Inevaluable|0|||
13320924|NCT01190930|26567752|FG005|Induction|Inevaluable|0|||
13320925|NCT01190930|26567753|FG006|Induction|Inevaluable|0|||
13320926|NCT01190930|26567754|FG007|Induction|Inevaluable|0|||
13320927|NCT01190930|26567755|FG008|Induction|Inevaluable|0|||
13320928|NCT01190930|26567756|FG009|Induction|Inevaluable|0|||
13320929|NCT01190930|26567747|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61|||
13320930|NCT01190930|26567748|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
13320931|NCT01190930|26567749|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
13320932|NCT01190930|26567750|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
13320933|NCT01190930|26567751|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
13320934|NCT01190930|26567752|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
13320935|NCT01190930|26567753|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
13320936|NCT01190930|26567754|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
13320937|NCT01190930|26567755|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
13320938|NCT01190930|26567756|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
13320939|NCT01190930|26567747|FG000|Induction|High Risk Downs|80|||
13320940|NCT01190930|26567748|FG001|Induction|High Risk Downs|0|||
13320941|NCT01190930|26567749|FG002|Induction|High Risk Downs|0|||
13320942|NCT01190930|26567750|FG003|Induction|High Risk Downs|0|||
13320943|NCT01190930|26567751|FG004|Induction|High Risk Downs|0|||
13320944|NCT01190930|26567752|FG005|Induction|High Risk Downs|0|||
13320945|NCT01190930|26567753|FG006|Induction|High Risk Downs|0|||
13320946|NCT01190930|26567754|FG007|Induction|High Risk Downs|0|||
13320947|NCT01190930|26567755|FG008|Induction|High Risk Downs|0|||
13320948|NCT01190930|26567756|FG009|Induction|High Risk Downs|0|||
13320949|NCT01190930|26567747|FG000|Induction|Enrollment onto another COG Protocol|1|||
13320950|NCT01190930|26567748|FG001|Induction|Enrollment onto another COG Protocol|0|||
13320951|NCT01190930|26567749|FG002|Induction|Enrollment onto another COG Protocol|0|||
13320952|NCT01190930|26567750|FG003|Induction|Enrollment onto another COG Protocol|0|||
13320953|NCT01190930|26567751|FG004|Induction|Enrollment onto another COG Protocol|0|||
13320954|NCT01190930|26567752|FG005|Induction|Enrollment onto another COG Protocol|0|||
13320955|NCT01190930|26567753|FG006|Induction|Enrollment onto another COG Protocol|0|||
13320956|NCT01190930|26567754|FG007|Induction|Enrollment onto another COG Protocol|0|||
13320957|NCT01190930|26567755|FG008|Induction|Enrollment onto another COG Protocol|0|||
13320958|NCT01190930|26567756|FG009|Induction|Enrollment onto another COG Protocol|0|||
13320959|NCT01190930|26567747|FG000|Induction|Average Risk|1847|||
13320960|NCT01190930|26567748|FG001|Induction|Average Risk|0|||
13320961|NCT01190930|26567749|FG002|Induction|Average Risk|0|||
13320962|NCT01190930|26567750|FG003|Induction|Average Risk|0|||
13320963|NCT01190930|26567751|FG004|Induction|Average Risk|0|||
13320964|NCT01190930|26567752|FG005|Induction|Average Risk|0|||
13320965|NCT01190930|26567753|FG006|Induction|Average Risk|0|||
13320966|NCT01190930|26567754|FG007|Induction|Average Risk|0|||
13320967|NCT01190930|26567755|FG008|Induction|Average Risk|0|||
13320968|NCT01190930|26567756|FG009|Induction|Average Risk|0|||
13320969|NCT01190930|26567747|FG000|Induction|High Risk|1227|||
13320970|NCT01190930|26567748|FG001|Induction|High Risk|0|||
13320971|NCT01190930|26567749|FG002|Induction|High Risk|0|||
13320972|NCT01190930|26567750|FG003|Induction|High Risk|0|||
13320973|NCT01190930|26567751|FG004|Induction|High Risk|0|||
13320974|NCT01190930|26567752|FG005|Induction|High Risk|0|||
13320975|NCT01190930|26567753|FG006|Induction|High Risk|0|||
13320976|NCT01190930|26567754|FG007|Induction|High Risk|0|||
13320977|NCT01190930|26567755|FG008|Induction|High Risk|0|||
13320978|NCT01190930|26567756|FG009|Induction|High Risk|0|||
13320979|NCT01190930|26567747|FG000|Induction|Low Risk|443|||
13122273|NCT02966509|25946642|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2|||
13320980|NCT01190930|26567748|FG001|Induction|Low Risk|0|||
13320981|NCT01190930|26567749|FG002|Induction|Low Risk|0|||
13320982|NCT01190930|26567750|FG003|Induction|Low Risk|0|||
13320983|NCT01190930|26567751|FG004|Induction|Low Risk|0|||
13320984|NCT01190930|26567752|FG005|Induction|Low Risk|0|||
13320985|NCT01190930|26567753|FG006|Induction|Low Risk|0|||
13320986|NCT01190930|26567754|FG007|Induction|Low Risk|0|||
13320987|NCT01190930|26567755|FG008|Induction|Low Risk|0|||
13320988|NCT01190930|26567756|FG009|Induction|Low Risk|0|||
13320989|NCT01190930|26567747|FG000|Induction|Very High Risk|1012|||
13320990|NCT01190930|26567748|FG001|Induction|Very High Risk|0|||
13320991|NCT01190930|26567749|FG002|Induction|Very High Risk|0|||
13320992|NCT01190930|26567750|FG003|Induction|Very High Risk|0|||
13320993|NCT01190930|26567751|FG004|Induction|Very High Risk|0|||
13320994|NCT01190930|26567752|FG005|Induction|Very High Risk|0|||
13320995|NCT01190930|26567753|FG006|Induction|Very High Risk|0|||
13320996|NCT01190930|26567754|FG007|Induction|Very High Risk|0|||
13320997|NCT01190930|26567755|FG008|Induction|Very High Risk|0|||
13320998|NCT01190930|26567756|FG009|Induction|Very High Risk|0|||
13320999|NCT01190930|26567747|FG000|Induction|Philadelphia chromosome-positive|99|||
13321000|NCT01190930|26567748|FG001|Induction|Philadelphia chromosome-positive|0|||
13321001|NCT01190930|26567749|FG002|Induction|Philadelphia chromosome-positive|0|||
13321002|NCT01190930|26567750|FG003|Induction|Philadelphia chromosome-positive|0|||
13321003|NCT01190930|26567751|FG004|Induction|Philadelphia chromosome-positive|0|||
13321004|NCT01190930|26567752|FG005|Induction|Philadelphia chromosome-positive|0|||
13321005|NCT01190930|26567753|FG006|Induction|Philadelphia chromosome-positive|0|||
13321006|NCT01190930|26567754|FG007|Induction|Philadelphia chromosome-positive|0|||
13321007|NCT01190930|26567755|FG008|Induction|Philadelphia chromosome-positive|0|||
13321008|NCT01190930|26567756|FG009|Induction|Philadelphia chromosome-positive|0|||
13321009|NCT01190930|26567747|FG000|Induction|Incomplete Induction data|63|||
13321010|NCT01190930|26567748|FG001|Induction|Incomplete Induction data|0|||
13321011|NCT01190930|26567749|FG002|Induction|Incomplete Induction data|0|||
13321012|NCT01190930|26567750|FG003|Induction|Incomplete Induction data|0|||
13321013|NCT01190930|26567751|FG004|Induction|Incomplete Induction data|0|||
13321014|NCT01190930|26567752|FG005|Induction|Incomplete Induction data|0|||
13321015|NCT01190930|26567753|FG006|Induction|Incomplete Induction data|0|||
13321016|NCT01190930|26567754|FG007|Induction|Incomplete Induction data|0|||
13321017|NCT01190930|26567755|FG008|Induction|Incomplete Induction data|0|||
13321018|NCT01190930|26567756|FG009|Induction|Incomplete Induction data|0|||
13321019|NCT01190930|26567747|FG000|Induction|Progressive disease|0|||
13321020|NCT01190930|26567748|FG001|Induction|Progressive disease|1|||
13321021|NCT01190930|26567749|FG002|Induction|Progressive disease|0|||
13321022|NCT01190930|26567750|FG003|Induction|Progressive disease|0|||
13321023|NCT01190930|26567751|FG004|Induction|Progressive disease|0|||
13321024|NCT01190930|26567752|FG005|Induction|Progressive disease|0|||
13321025|NCT01190930|26567753|FG006|Induction|Progressive disease|0|||
13321026|NCT01190930|26567754|FG007|Induction|Progressive disease|0|||
13321027|NCT01190930|26567755|FG008|Induction|Progressive disease|0|||
13321028|NCT01190930|26567756|FG009|Induction|Progressive disease|0|||
13321029|NCT01190930|26567747|FG000|Induction|No treatment|3|||
13321030|NCT01190930|26567748|FG001|Induction|No treatment|0|||
13321031|NCT01190930|26567749|FG002|Induction|No treatment|0|||
13321032|NCT01190930|26567750|FG003|Induction|No treatment|0|||
13321033|NCT01190930|26567751|FG004|Induction|No treatment|0|||
13321034|NCT01190930|26567752|FG005|Induction|No treatment|0|||
13321035|NCT01190930|26567753|FG006|Induction|No treatment|0|||
13321036|NCT01190930|26567754|FG007|Induction|No treatment|0|||
13321037|NCT01190930|26567755|FG008|Induction|No treatment|0|||
13321038|NCT01190930|26567756|FG009|Induction|No treatment|0|||
13321039|NCT01190930|26567747|FG000|Induction|Ineligible|69|||
13321040|NCT01190930|26567748|FG001|Induction|Ineligible|4|||
13321041|NCT01190930|26567749|FG002|Induction|Ineligible|0|||
13321042|NCT01190930|26567750|FG003|Induction|Ineligible|0|||
13321043|NCT01190930|26567751|FG004|Induction|Ineligible|0|||
13321044|NCT01190930|26567752|FG005|Induction|Ineligible|0|||
13321045|NCT01190930|26567753|FG006|Induction|Ineligible|0|||
13321046|NCT01190930|26567754|FG007|Induction|Ineligible|0|||
13321047|NCT01190930|26567755|FG008|Induction|Ineligible|0|||
13321048|NCT01190930|26567756|FG009|Induction|Ineligible|0|||
13321049|NCT01190930|26567747|FG000|Post Induction Pre-Maintenance|Adverse Event|0|||
13321050|NCT01190930|26567748|FG001|Post Induction Pre-Maintenance|Adverse Event|0|||
13321051|NCT01190930|26567749|FG002|Post Induction Pre-Maintenance|Adverse Event|8|||
13321052|NCT01190930|26567750|FG003|Post Induction Pre-Maintenance|Adverse Event|0|||
13321053|NCT01190930|26567751|FG004|Post Induction Pre-Maintenance|Adverse Event|0|||
13321054|NCT01190930|26567752|FG005|Post Induction Pre-Maintenance|Adverse Event|0|||
13321055|NCT01190930|26567753|FG006|Post Induction Pre-Maintenance|Adverse Event|0|||
13321056|NCT01190930|26567754|FG007|Post Induction Pre-Maintenance|Adverse Event|0|||
13321057|NCT01190930|26567755|FG008|Post Induction Pre-Maintenance|Adverse Event|0|||
13321058|NCT01190930|26567756|FG009|Post Induction Pre-Maintenance|Adverse Event|0|||
13321059|NCT01190930|26567747|FG000|Post Induction Pre-Maintenance|Death|0|||
13321060|NCT01190930|26567748|FG001|Post Induction Pre-Maintenance|Death|0|||
13321061|NCT01190930|26567749|FG002|Post Induction Pre-Maintenance|Death|8|||
13321062|NCT01190930|26567750|FG003|Post Induction Pre-Maintenance|Death|4|||
13321063|NCT01190930|26567751|FG004|Post Induction Pre-Maintenance|Death|0|||
13321064|NCT01190930|26567752|FG005|Post Induction Pre-Maintenance|Death|0|||
13321065|NCT01190930|26567753|FG006|Post Induction Pre-Maintenance|Death|0|||
13321066|NCT01190930|26567754|FG007|Post Induction Pre-Maintenance|Death|0|||
13321067|NCT01190930|26567755|FG008|Post Induction Pre-Maintenance|Death|0|||
13321068|NCT01190930|26567756|FG009|Post Induction Pre-Maintenance|Death|0|||
13321069|NCT01190930|26567747|FG000|Post Induction Pre-Maintenance|Physician Decision|0|||
13321070|NCT01190930|26567748|FG001|Post Induction Pre-Maintenance|Physician Decision|2|||
13321071|NCT01190930|26567749|FG002|Post Induction Pre-Maintenance|Physician Decision|35|||
13321072|NCT01190930|26567750|FG003|Post Induction Pre-Maintenance|Physician Decision|7|||
13321073|NCT01190930|26567751|FG004|Post Induction Pre-Maintenance|Physician Decision|5|||
13321074|NCT01190930|26567752|FG005|Post Induction Pre-Maintenance|Physician Decision|3|||
13321075|NCT01190930|26567753|FG006|Post Induction Pre-Maintenance|Physician Decision|0|||
13321076|NCT01190930|26567754|FG007|Post Induction Pre-Maintenance|Physician Decision|0|||
13321077|NCT01190930|26567755|FG008|Post Induction Pre-Maintenance|Physician Decision|0|||
13321078|NCT01190930|26567756|FG009|Post Induction Pre-Maintenance|Physician Decision|0|||
13321079|NCT01190930|26567747|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
13321080|NCT01190930|26567748|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1|||
13321081|NCT01190930|26567749|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5|||
13321082|NCT01190930|26567750|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2|||
13321083|NCT01190930|26567751|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
13321084|NCT01190930|26567752|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
13321085|NCT01190930|26567753|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
13321086|NCT01190930|26567754|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
13321087|NCT01190930|26567755|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
13321088|NCT01190930|26567756|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
13321089|NCT01190930|26567747|FG000|Post Induction Pre-Maintenance|Refusal|0|||
13321090|NCT01190930|26567748|FG001|Post Induction Pre-Maintenance|Refusal|2|||
13321091|NCT01190930|26567749|FG002|Post Induction Pre-Maintenance|Refusal|694|||
13321092|NCT01190930|26567750|FG003|Post Induction Pre-Maintenance|Refusal|4|||
13321093|NCT01190930|26567751|FG004|Post Induction Pre-Maintenance|Refusal|0|||
13321094|NCT01190930|26567752|FG005|Post Induction Pre-Maintenance|Refusal|3|||
13321095|NCT01190930|26567753|FG006|Post Induction Pre-Maintenance|Refusal|0|||
13321096|NCT01190930|26567754|FG007|Post Induction Pre-Maintenance|Refusal|0|||
13321097|NCT01190930|26567755|FG008|Post Induction Pre-Maintenance|Refusal|0|||
13321098|NCT01190930|26567756|FG009|Post Induction Pre-Maintenance|Refusal|0|||
13321099|NCT01190930|26567747|FG000|Post Induction Pre-Maintenance|Inevaluable|0|||
13321100|NCT01190930|26567748|FG001|Post Induction Pre-Maintenance|Inevaluable|0|||
13321101|NCT01190930|26567749|FG002|Post Induction Pre-Maintenance|Inevaluable|6|||
13321102|NCT01190930|26567750|FG003|Post Induction Pre-Maintenance|Inevaluable|0|||
13321103|NCT01190930|26567751|FG004|Post Induction Pre-Maintenance|Inevaluable|0|||
13321104|NCT01190930|26567752|FG005|Post Induction Pre-Maintenance|Inevaluable|0|||
13321105|NCT01190930|26567753|FG006|Post Induction Pre-Maintenance|Inevaluable|0|||
13321106|NCT01190930|26567754|FG007|Post Induction Pre-Maintenance|Inevaluable|0|||
13321107|NCT01190930|26567755|FG008|Post Induction Pre-Maintenance|Inevaluable|0|||
13321108|NCT01190930|26567756|FG009|Post Induction Pre-Maintenance|Inevaluable|0|||
13321109|NCT01190930|26567747|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
13321110|NCT01190930|26567748|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1|||
13321111|NCT01190930|26567749|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
13122274|NCT02966509|25946643|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3|||
13122275|NCT02966509|25946642|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
13321112|NCT01190930|26567750|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
13321113|NCT01190930|26567751|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
13321114|NCT01190930|26567752|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
13321115|NCT01190930|26567753|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
13321116|NCT01190930|26567754|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
13321117|NCT01190930|26567755|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
13321118|NCT01190930|26567756|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
13321119|NCT01190930|26567747|FG000|Post Induction Pre-Maintenance|Progressive disease|0|||
13321120|NCT01190930|26567748|FG001|Post Induction Pre-Maintenance|Progressive disease|0|||
13321121|NCT01190930|26567749|FG002|Post Induction Pre-Maintenance|Progressive disease|1|||
13321122|NCT01190930|26567750|FG003|Post Induction Pre-Maintenance|Progressive disease|0|||
13321123|NCT01190930|26567751|FG004|Post Induction Pre-Maintenance|Progressive disease|0|||
13321124|NCT01190930|26567752|FG005|Post Induction Pre-Maintenance|Progressive disease|0|||
13321125|NCT01190930|26567753|FG006|Post Induction Pre-Maintenance|Progressive disease|0|||
13321126|NCT01190930|26567754|FG007|Post Induction Pre-Maintenance|Progressive disease|0|||
13321127|NCT01190930|26567755|FG008|Post Induction Pre-Maintenance|Progressive disease|0|||
13321128|NCT01190930|26567756|FG009|Post Induction Pre-Maintenance|Progressive disease|0|||
13321129|NCT01190930|26567747|FG000|Post Induction Pre-Maintenance|Relapse|0|||
13321130|NCT01190930|26567748|FG001|Post Induction Pre-Maintenance|Relapse|0|||
13321131|NCT01190930|26567749|FG002|Post Induction Pre-Maintenance|Relapse|1|||
13321132|NCT01190930|26567750|FG003|Post Induction Pre-Maintenance|Relapse|0|||
13321133|NCT01190930|26567751|FG004|Post Induction Pre-Maintenance|Relapse|0|||
13321134|NCT01190930|26567752|FG005|Post Induction Pre-Maintenance|Relapse|0|||
13321135|NCT01190930|26567753|FG006|Post Induction Pre-Maintenance|Relapse|0|||
13321136|NCT01190930|26567754|FG007|Post Induction Pre-Maintenance|Relapse|0|||
13321137|NCT01190930|26567755|FG008|Post Induction Pre-Maintenance|Relapse|0|||
13321138|NCT01190930|26567756|FG009|Post Induction Pre-Maintenance|Relapse|0|||
13321139|NCT01190930|26567747|FG000|Maintenance|Adverse Event|0|||
13321140|NCT01190930|26567748|FG001|Maintenance|Adverse Event|0|||
13321141|NCT01190930|26567749|FG002|Maintenance|Adverse Event|0|||
13321142|NCT01190930|26567750|FG003|Maintenance|Adverse Event|0|||
13321143|NCT01190930|26567751|FG004|Maintenance|Adverse Event|0|||
13321144|NCT01190930|26567752|FG005|Maintenance|Adverse Event|1|||
13321145|NCT01190930|26567753|FG006|Maintenance|Adverse Event|1|||
13321146|NCT01190930|26567754|FG007|Maintenance|Adverse Event|3|||
13321147|NCT01190930|26567755|FG008|Maintenance|Adverse Event|3|||
13321148|NCT01190930|26567756|FG009|Maintenance|Adverse Event|0|||
13321149|NCT01190930|26567747|FG000|Maintenance|Death|0|||
13321150|NCT01190930|26567748|FG001|Maintenance|Death|0|||
13321151|NCT01190930|26567749|FG002|Maintenance|Death|0|||
13321152|NCT01190930|26567750|FG003|Maintenance|Death|1|||
13321153|NCT01190930|26567751|FG004|Maintenance|Death|0|||
13321154|NCT01190930|26567752|FG005|Maintenance|Death|0|||
13321155|NCT01190930|26567753|FG006|Maintenance|Death|2|||
13321156|NCT01190930|26567754|FG007|Maintenance|Death|2|||
13321157|NCT01190930|26567755|FG008|Maintenance|Death|2|||
13321158|NCT01190930|26567756|FG009|Maintenance|Death|2|||
13321159|NCT01190930|26567747|FG000|Maintenance|Lost to Follow-up|0|||
13321160|NCT01190930|26567748|FG001|Maintenance|Lost to Follow-up|0|||
13321161|NCT01190930|26567749|FG002|Maintenance|Lost to Follow-up|0|||
13321162|NCT01190930|26567750|FG003|Maintenance|Lost to Follow-up|0|||
13321163|NCT01190930|26567751|FG004|Maintenance|Lost to Follow-up|0|||
13321164|NCT01190930|26567752|FG005|Maintenance|Lost to Follow-up|0|||
13321165|NCT01190930|26567753|FG006|Maintenance|Lost to Follow-up|1|||
13321166|NCT01190930|26567754|FG007|Maintenance|Lost to Follow-up|1|||
13321167|NCT01190930|26567755|FG008|Maintenance|Lost to Follow-up|1|||
13321168|NCT01190930|26567756|FG009|Maintenance|Lost to Follow-up|0|||
13321169|NCT01190930|26567747|FG000|Maintenance|Physician Decision|0|||
13321170|NCT01190930|26567748|FG001|Maintenance|Physician Decision|1|||
13321171|NCT01190930|26567749|FG002|Maintenance|Physician Decision|0|||
13321172|NCT01190930|26567750|FG003|Maintenance|Physician Decision|5|||
13321173|NCT01190930|26567751|FG004|Maintenance|Physician Decision|9|||
13321174|NCT01190930|26567752|FG005|Maintenance|Physician Decision|4|||
13321175|NCT01190930|26567753|FG006|Maintenance|Physician Decision|8|||
13321176|NCT01190930|26567754|FG007|Maintenance|Physician Decision|8|||
13321177|NCT01190930|26567755|FG008|Maintenance|Physician Decision|10|||
13321178|NCT01190930|26567756|FG009|Maintenance|Physician Decision|17|||
13321179|NCT01190930|26567747|FG000|Maintenance|Withdrawal by Subject|0|||
13321180|NCT01190930|26567748|FG001|Maintenance|Withdrawal by Subject|0|||
13321181|NCT01190930|26567749|FG002|Maintenance|Withdrawal by Subject|0|||
13321182|NCT01190930|26567750|FG003|Maintenance|Withdrawal by Subject|0|||
13321183|NCT01190930|26567751|FG004|Maintenance|Withdrawal by Subject|0|||
13321184|NCT01190930|26567752|FG005|Maintenance|Withdrawal by Subject|0|||
13321185|NCT01190930|26567753|FG006|Maintenance|Withdrawal by Subject|2|||
13321186|NCT01190930|26567754|FG007|Maintenance|Withdrawal by Subject|1|||
13321187|NCT01190930|26567755|FG008|Maintenance|Withdrawal by Subject|4|||
13321188|NCT01190930|26567756|FG009|Maintenance|Withdrawal by Subject|1|||
13321189|NCT01190930|26567747|FG000|Maintenance|Refusal|0|||
13321190|NCT01190930|26567748|FG001|Maintenance|Refusal|1|||
13321191|NCT01190930|26567749|FG002|Maintenance|Refusal|0|||
13321192|NCT01190930|26567750|FG003|Maintenance|Refusal|2|||
13321193|NCT01190930|26567751|FG004|Maintenance|Refusal|0|||
13321194|NCT01190930|26567752|FG005|Maintenance|Refusal|4|||
13321195|NCT01190930|26567753|FG006|Maintenance|Refusal|5|||
13321196|NCT01190930|26567754|FG007|Maintenance|Refusal|17|||
13321197|NCT01190930|26567755|FG008|Maintenance|Refusal|13|||
13321198|NCT01190930|26567756|FG009|Maintenance|Refusal|6|||
13321199|NCT01190930|26567747|FG000|Maintenance|second malignant neoplasm|0|||
13321200|NCT01190930|26567748|FG001|Maintenance|second malignant neoplasm|0|||
13321201|NCT01190930|26567749|FG002|Maintenance|second malignant neoplasm|0|||
13321202|NCT01190930|26567750|FG003|Maintenance|second malignant neoplasm|1|||
13321203|NCT01190930|26567751|FG004|Maintenance|second malignant neoplasm|0|||
13321204|NCT01190930|26567752|FG005|Maintenance|second malignant neoplasm|1|||
13321205|NCT01190930|26567753|FG006|Maintenance|second malignant neoplasm|0|||
13321206|NCT01190930|26567754|FG007|Maintenance|second malignant neoplasm|0|||
13321207|NCT01190930|26567755|FG008|Maintenance|second malignant neoplasm|1|||
13321208|NCT01190930|26567756|FG009|Maintenance|second malignant neoplasm|0|||
13321209|NCT01190930|26567747|FG000|Maintenance|Inevaluable|0|||
13321210|NCT01190930|26567748|FG001|Maintenance|Inevaluable|0|||
13321211|NCT01190930|26567749|FG002|Maintenance|Inevaluable|0|||
13321212|NCT01190930|26567750|FG003|Maintenance|Inevaluable|0|||
13321213|NCT01190930|26567751|FG004|Maintenance|Inevaluable|0|||
13321214|NCT01190930|26567752|FG005|Maintenance|Inevaluable|1|||
13321215|NCT01190930|26567753|FG006|Maintenance|Inevaluable|1|||
13321216|NCT01190930|26567754|FG007|Maintenance|Inevaluable|1|||
13321217|NCT01190930|26567755|FG008|Maintenance|Inevaluable|0|||
13321218|NCT01190930|26567756|FG009|Maintenance|Inevaluable|0|||
13321219|NCT01190930|26567747|FG000|Maintenance|Enrollment onto another COG Protocol|0|||
13321220|NCT01190930|26567748|FG001|Maintenance|Enrollment onto another COG Protocol|0|||
13321221|NCT01190930|26567749|FG002|Maintenance|Enrollment onto another COG Protocol|0|||
13321222|NCT01190930|26567750|FG003|Maintenance|Enrollment onto another COG Protocol|0|||
13321223|NCT01190930|26567751|FG004|Maintenance|Enrollment onto another COG Protocol|0|||
13321224|NCT01190930|26567752|FG005|Maintenance|Enrollment onto another COG Protocol|0|||
13321225|NCT01190930|26567753|FG006|Maintenance|Enrollment onto another COG Protocol|0|||
13321226|NCT01190930|26567754|FG007|Maintenance|Enrollment onto another COG Protocol|0|||
13321227|NCT01190930|26567755|FG008|Maintenance|Enrollment onto another COG Protocol|1|||
13321228|NCT01190930|26567756|FG009|Maintenance|Enrollment onto another COG Protocol|0|||
13321229|NCT01190930|26567747|FG000|Maintenance|Relapse|0|||
13321230|NCT01190930|26567748|FG001|Maintenance|Relapse|0|||
13321231|NCT01190930|26567749|FG002|Maintenance|Relapse|0|||
13321232|NCT01190930|26567750|FG003|Maintenance|Relapse|2|||
13321233|NCT01190930|26567751|FG004|Maintenance|Relapse|0|||
13321234|NCT01190930|26567752|FG005|Maintenance|Relapse|1|||
13321235|NCT01190930|26567753|FG006|Maintenance|Relapse|6|||
13321236|NCT01190930|26567754|FG007|Maintenance|Relapse|13|||
13321237|NCT01190930|26567755|FG008|Maintenance|Relapse|11|||
13321238|NCT01190930|26567756|FG009|Maintenance|Relapse|11|||
13321239|NCT01190930|26567747|FG000|Maintenance|Still on therapy|0|||
13321240|NCT01190930|26567748|FG001|Maintenance|Still on therapy|8|||
13321241|NCT01190930|26567749|FG002|Maintenance|Still on therapy|0|||
13321242|NCT01190930|26567750|FG003|Maintenance|Still on therapy|29|||
13321243|NCT01190930|26567751|FG004|Maintenance|Still on therapy|0|||
13321244|NCT01190930|26567752|FG005|Maintenance|Still on therapy|0|||
13321245|NCT01190930|26567753|FG006|Maintenance|Still on therapy|0|||
13321246|NCT01190930|26567754|FG007|Maintenance|Still on therapy|0|||
13321247|NCT01190930|26567755|FG008|Maintenance|Still on therapy|0|||
13321248|NCT01190930|26567756|FG009|Maintenance|Still on therapy|0|||
13321249|NCT01190891|26567771|FG000|Overall Study|Protocol Violation|1|||
13321250|NCT01190891|26567772|FG001|Overall Study|Protocol Violation|0|||
13321251|NCT01190891|26567771|FG000|Overall Study|Withdrawal by Subject|5|||
13122276|NCT02966509|25946643|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
13122277|NCT02966509|25946642|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0|||
13321252|NCT01190891|26567772|FG001|Overall Study|Withdrawal by Subject|0|||
13321253|NCT01190865|26567779|FG000|Overall Study|Withdrawal by Subject|1|||
13321254|NCT01190865|26567779|FG000|Overall Study|Non-compliance|2|||
13321255|NCT01190839|26567798|FG000|Overall Study|Adverse Event|32|||
13321256|NCT01190839|26567799|FG001|Overall Study|Adverse Event|41|||
13321257|NCT01190839|26567798|FG000|Overall Study|Protocol Violation|2|||
13321258|NCT01190839|26567799|FG001|Overall Study|Protocol Violation|2|||
13321259|NCT01190839|26567798|FG000|Overall Study|Lost to Follow-up|7|||
13321260|NCT01190839|26567799|FG001|Overall Study|Lost to Follow-up|1|||
13321261|NCT01190839|26567798|FG000|Overall Study|Death|1|||
13321262|NCT01190839|26567799|FG001|Overall Study|Death|0|||
13321263|NCT01190839|26567798|FG000|Overall Study|Trial stopped by Sponsor|71|||
13321264|NCT01190839|26567799|FG001|Overall Study|Trial stopped by Sponsor|68|||
13321265|NCT01190839|26567798|FG000|Overall Study|Undefined|35|||
13321266|NCT01190839|26567799|FG001|Overall Study|Undefined|31|||
13321267|NCT01190839|26567798|FG000|Overall Study|Randomized but not treated|2|||
13321268|NCT01190839|26567799|FG001|Overall Study|Randomized but not treated|4|||
13321269|NCT01190813|26567896|FG000|Overall Study|Lost to Follow-up|1|||
13321270|NCT01190813|26567897|FG001|Overall Study|Lost to Follow-up|2|||
13321271|NCT01190813|26567896|FG000|Overall Study|Withdrawal by Subject|2|||
13321272|NCT01190813|26567897|FG001|Overall Study|Withdrawal by Subject|1|||
13321273|NCT01190813|26567896|FG000|Overall Study|Refused study treatment after randomized|1|||
13321274|NCT01190813|26567897|FG001|Overall Study|Refused study treatment after randomized|0|||
13321275|NCT01190813|26567896|FG000|Overall Study|Adverse Event|0|||
13321276|NCT01190813|26567897|FG001|Overall Study|Adverse Event|1|||
13321277|NCT01190514|26567932|FG000|First Intervention (Period 1)|Adverse Event|1|||
13321278|NCT01190514|26567933|FG001|First Intervention (Period 1)|Adverse Event|0|||
13321279|NCT01190514|26567934|FG002|First Intervention (Period 1)|Adverse Event|0|||
13321280|NCT01190514|26567935|FG003|First Intervention (Period 1)|Adverse Event|0|||
13321281|NCT01190514|26567932|FG000|Third Intervention (Period 3)|Adverse Event|1|||
13321282|NCT01190514|26567933|FG001|Third Intervention (Period 3)|Adverse Event|0|||
13321283|NCT01190514|26567934|FG002|Third Intervention (Period 3)|Adverse Event|0|||
13321284|NCT01190514|26567935|FG003|Third Intervention (Period 3)|Adverse Event|0|||
13321285|NCT01190475|26567959|FG000|Overall Study|Withdrawal by Subject|0|||
13321286|NCT01190475|26567960|FG001|Overall Study|Withdrawal by Subject|0|||
13321287|NCT01190475|26567961|FG002|Overall Study|Withdrawal by Subject|1|||
13122278|NCT02966509|25946643|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2|||
13122279|NCT02966509|25946642|FG000|6 Month Satisfaction Survey|Death|36|||
13122280|NCT02966509|25946643|FG001|6 Month Satisfaction Survey|Death|33|||
13122281|NCT02966509|25946642|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2|||
13122282|NCT02966509|25946643|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3|||
13122283|NCT02966509|25946642|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1|||
13122284|NCT02966509|25946643|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1|||
13122285|NCT02966509|25946642|FG000|6 Month Satisfaction Survey|Refused to Answer|8|||
13122286|NCT02966509|25946643|FG001|6 Month Satisfaction Survey|Refused to Answer|11|||
13122287|NCT02966509|25946642|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69|||
13122288|NCT02966509|25946643|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75|||
13122289|NCT02966509|25946642|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45|||
13321288|NCT01190449|26567976|FG000|Overall Study|Ineligible|0|||
13321289|NCT01190449|26567977|FG001|Overall Study|Ineligible|4|||
13321290|NCT01190436|26567993|FG000|Overall Study|Lost to Follow-up|35|||
13321291|NCT01190436|26567993|FG000|Overall Study|Other|4|||
13321292|NCT01190410|26568017|FG000|Overall Study|Adverse Event|0|||
13321293|NCT01190410|26568018|FG001|Overall Study|Adverse Event|3|||
13321294|NCT01190410|26568017|FG000|Overall Study|Lack of Efficacy|0|||
13321295|NCT01190410|26568018|FG001|Overall Study|Lack of Efficacy|2|||
13321296|NCT01190410|26568017|FG000|Overall Study|Withdrawal by Subject|0|||
13321297|NCT01190410|26568018|FG001|Overall Study|Withdrawal by Subject|2|||
13321298|NCT01190410|26568017|FG000|Overall Study|Administrative decision|1|||
13321299|NCT01190410|26568018|FG001|Overall Study|Administrative decision|0|||
13486379|NCT03786380|27035991|FG004|Overall Study|Withdrawal by Subject|2|||
13486380|NCT03786380|27035987|FG000|Overall Study|Lost to Follow-up|3|||
13486381|NCT03786380|27035988|FG001|Overall Study|Lost to Follow-up|0|||
13486382|NCT03786380|27035989|FG002|Overall Study|Lost to Follow-up|1|||
13486383|NCT03786380|27035990|FG003|Overall Study|Lost to Follow-up|2|||
13486384|NCT03786380|27035991|FG004|Overall Study|Lost to Follow-up|0|||
13486385|NCT03786380|27035987|FG000|Overall Study|Physician Decision|0|||
13486386|NCT03786380|27035988|FG001|Overall Study|Physician Decision|0|||
13486387|NCT03786380|27035989|FG002|Overall Study|Physician Decision|1|||
13486388|NCT03786380|27035990|FG003|Overall Study|Physician Decision|0|||
13486389|NCT03786380|27035991|FG004|Overall Study|Physician Decision|0|||
13486390|NCT03786380|27035987|FG000|Overall Study|Study Terminated by the Sponsor|30|||
13486391|NCT03786380|27035988|FG001|Overall Study|Study Terminated by the Sponsor|20|||
13486392|NCT03786380|27035989|FG002|Overall Study|Study Terminated by the Sponsor|50|||
13486393|NCT03786380|27035990|FG003|Overall Study|Study Terminated by the Sponsor|57|||
13486394|NCT03786380|27035991|FG004|Overall Study|Study Terminated by the Sponsor|23|||
13486395|NCT03786380|27035987|FG000|Overall Study|Reason Not Specified|0|||
13321300|NCT01190410|26568017|FG000|Overall Study|PI discretion|0|||
13321301|NCT01190410|26568018|FG001|Overall Study|PI discretion|2|||
13321302|NCT01190267|26568033|FG000|Overall Study|Adverse Event|10|||
13321303|NCT01190267|26568034|FG001|Overall Study|Adverse Event|0|||
13321304|NCT01190267|26568033|FG000|Overall Study|Treatment Failure|8|||
13321305|NCT01190267|26568034|FG001|Overall Study|Treatment Failure|2|||
13321306|NCT01190267|26568033|FG000|Overall Study|Lost to Follow-up|2|||
13321307|NCT01190267|26568034|FG001|Overall Study|Lost to Follow-up|0|||
13321308|NCT01190267|26568033|FG000|Overall Study|Withdrawal by Subject|13|||
13321309|NCT01190267|26568034|FG001|Overall Study|Withdrawal by Subject|1|||
13321310|NCT01190267|26568033|FG000|Overall Study|Protocol Violation|8|||
13321311|NCT01190267|26568034|FG001|Overall Study|Protocol Violation|1|||
13321312|NCT01190254|26568106|FG000|Overall Study|Adverse Event|3|||
13321313|NCT01190254|26568107|FG001|Overall Study|Adverse Event|6|||
13321314|NCT01190254|26568108|FG002|Overall Study|Adverse Event|8|||
13321315|NCT01190254|26568106|FG000|Overall Study|Lack of Efficacy|7|||
13321316|NCT01190254|26568107|FG001|Overall Study|Lack of Efficacy|4|||
13321317|NCT01190254|26568108|FG002|Overall Study|Lack of Efficacy|5|||
13321318|NCT01190254|26568106|FG000|Overall Study|Lost to Follow-up|4|||
13321319|NCT01190254|26568107|FG001|Overall Study|Lost to Follow-up|2|||
13321320|NCT01190254|26568108|FG002|Overall Study|Lost to Follow-up|0|||
13321321|NCT01190254|26568106|FG000|Overall Study|Withdrawal by Subject|4|||
13321322|NCT01190254|26568107|FG001|Overall Study|Withdrawal by Subject|5|||
13321323|NCT01190254|26568108|FG002|Overall Study|Withdrawal by Subject|7|||
13321324|NCT01190254|26568106|FG000|Overall Study|Protocol Violation|2|||
13321325|NCT01190254|26568107|FG001|Overall Study|Protocol Violation|0|||
13321326|NCT01190254|26568108|FG002|Overall Study|Protocol Violation|2|||
13321327|NCT01190254|26568106|FG000|Overall Study|Did not meet protocol eligibility|1|||
13321328|NCT01190254|26568107|FG001|Overall Study|Did not meet protocol eligibility|0|||
13321329|NCT01190254|26568108|FG002|Overall Study|Did not meet protocol eligibility|0|||
13321330|NCT01190228|26568139|FG000|Overall Study|Protocol Violation|4|||
13321331|NCT01190228|26568140|FG001|Overall Study|Protocol Violation|0|||
13321332|NCT01190228|26568141|FG002|Overall Study|Protocol Violation|0|||
13321333|NCT01190228|26568139|FG000|Overall Study|Withdrawal by Subject|1|||
13321334|NCT01190228|26568140|FG001|Overall Study|Withdrawal by Subject|0|||
13321335|NCT01190228|26568141|FG002|Overall Study|Withdrawal by Subject|0|||
13321336|NCT01190215|26568216|FG000|Up to Month 6|Lost to Follow-up|2|||
13321337|NCT01190215|26568217|FG001|Up to Month 6|Lost to Follow-up|0|||
13321338|NCT01190189|26568226|FG000|Overall Study|Lost to Follow-up|4|||
13321339|NCT01190189|26568226|FG000|Overall Study|Withdrawal by Subject|1|||
13321340|NCT01190189|26568226|FG000|Overall Study|Migrated/moved from study area|1|||
13321341|NCT01190176|26568247|FG000|Overall Study|Withdrawal by Subject|1|||
13321342|NCT01190176|26568247|FG000|Overall Study|Lost to Follow-up|1|||
13321343|NCT01190150|26568278|FG000|First Treatment|Withdrawal by Subject|1|||
13321344|NCT01190150|26568279|FG001|First Treatment|Withdrawal by Subject|0|||
13321345|NCT01190150|26568278|FG000|Washout|Withdrawal by Subject|0|||
13321346|NCT01190150|26568279|FG001|Washout|Withdrawal by Subject|1|||
13321347|NCT01190150|26568278|FG000|Washout|Difficulty in adherence|0|||
13321348|NCT01190150|26568279|FG001|Washout|Difficulty in adherence|1|||
13321349|NCT01190124|26568325|FG000|Overall Study|Death|3|||
13321350|NCT01190124|26568326|FG001|Overall Study|Death|0|||
13321351|NCT01190124|26568327|FG002|Overall Study|Death|0|||
13321352|NCT01190124|26568325|FG000|Overall Study|Therapeutic Failure|12|||
13321353|NCT01190124|26568326|FG001|Overall Study|Therapeutic Failure|0|||
13321354|NCT01190124|26568327|FG002|Overall Study|Therapeutic Failure|1|||
13321355|NCT01190124|26568325|FG000|Overall Study|Lost to Follow-up|2|||
13321356|NCT01190124|26568326|FG001|Overall Study|Lost to Follow-up|0|||
13321357|NCT01190124|26568327|FG002|Overall Study|Lost to Follow-up|0|||
13486396|NCT03786380|27035988|FG001|Overall Study|Reason Not Specified|0|||
13486397|NCT03786380|27035989|FG002|Overall Study|Reason Not Specified|0|||
13486398|NCT03786380|27035990|FG003|Overall Study|Reason Not Specified|0|||
13321358|NCT01190098|26568354|FG000|Overall Study|Adverse Event|2|||
13321359|NCT01190098|26568355|FG001|Overall Study|Adverse Event|0|||
13321360|NCT01190098|26568354|FG000|Overall Study|Patient coomorbidity|0|||
13321361|NCT01190098|26568355|FG001|Overall Study|Patient coomorbidity|1|||
13321362|NCT01190098|26568354|FG000|Overall Study|Lack of transportation|1|||
13321363|NCT01190098|26568355|FG001|Overall Study|Lack of transportation|0|||
13321364|NCT01190098|26568354|FG000|Overall Study|Other|0|||
13321365|NCT01190098|26568355|FG001|Overall Study|Other|1|||
13321366|NCT01190020|26568374|FG000|Overall Study|Adverse Event|2|||
13321367|NCT01190020|26568375|FG001|Overall Study|Adverse Event|0|||
13321368|NCT01190020|26568374|FG000|Overall Study|Lost to Follow-up|2|||
13321369|NCT01190020|26568375|FG001|Overall Study|Lost to Follow-up|0|||
13321370|NCT01190020|26568374|FG000|Overall Study|Withdrawal by Subject|3|||
13321371|NCT01190020|26568375|FG001|Overall Study|Withdrawal by Subject|0|||
13321372|NCT01190007|26568392|FG000|Overall Study|Withdrawal by Subject|4|||
13321373|NCT01190007|26568392|FG000|Overall Study|Adverse Event|8|||
13321374|NCT01190007|26568392|FG000|Overall Study|Difficulty of visit for complications|1|||
13321375|NCT01190007|26568392|FG000|Overall Study|Participant was arrested|1|||
13321376|NCT01189890|26568419|FG000|Overall Study|Adverse Event|3|||
13321377|NCT01189890|26568420|FG001|Overall Study|Adverse Event|4|||
13321378|NCT01189890|26568419|FG000|Overall Study|Lack of Efficacy|7|||
13321379|NCT01189890|26568420|FG001|Overall Study|Lack of Efficacy|2|||
13321380|NCT01189890|26568419|FG000|Overall Study|Lost to Follow-up|1|||
13321381|NCT01189890|26568420|FG001|Overall Study|Lost to Follow-up|7|||
13321382|NCT01189890|26568419|FG000|Overall Study|Protocol Violation|1|||
13321383|NCT01189890|26568420|FG001|Overall Study|Protocol Violation|5|||
13321384|NCT01189890|26568419|FG000|Overall Study|Withdrawal by Subject|15|||
13321385|NCT01189890|26568420|FG001|Overall Study|Withdrawal by Subject|11|||
13321386|NCT01189890|26568419|FG000|Overall Study|Non Compliance|0|||
13321387|NCT01189890|26568420|FG001|Overall Study|Non Compliance|1|||
13321388|NCT01189890|26568419|FG000|Overall Study|Physician Decision|5|||
13321389|NCT01189890|26568420|FG001|Overall Study|Physician Decision|4|||
13321390|NCT01189890|26568419|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
13321391|NCT01189890|26568420|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
13321392|NCT01189812|26568433|FG000|Overall Study|Withdrawal by Subject|2|||
13321393|NCT01189812|26568434|FG001|Overall Study|Withdrawal by Subject|3|||
13321394|NCT01189812|26568433|FG000|Overall Study|Adverse Event|1|||
13321395|NCT01189812|26568434|FG001|Overall Study|Adverse Event|0|||
13321396|NCT01189812|26568433|FG000|Overall Study|Out of Window|4|||
13321397|NCT01189812|26568434|FG001|Overall Study|Out of Window|3|||
13321398|NCT01189812|26568433|FG000|Overall Study|Moved out of State|1|||
13321399|NCT01189812|26568434|FG001|Overall Study|Moved out of State|2|||
13321400|NCT01189604|26568500|FG000|Overall Study|Impossible to visit|0|||
13321401|NCT01189604|26568501|FG001|Overall Study|Impossible to visit|0|||
13321402|NCT01189604|26568502|FG002|Overall Study|Impossible to visit|0|||
13321403|NCT01189604|26568503|FG003|Overall Study|Impossible to visit|0|||
13321404|NCT01189604|26568504|FG004|Overall Study|Impossible to visit|0|||
13321405|NCT01189604|26568505|FG005|Overall Study|Impossible to visit|1|||
13321406|NCT01189604|26568506|FG006|Overall Study|Impossible to visit|0|||
13321407|NCT01189604|26568500|FG000|Overall Study|Adverse Event|0|||
13321408|NCT01189604|26568501|FG001|Overall Study|Adverse Event|1|||
13321409|NCT01189604|26568502|FG002|Overall Study|Adverse Event|0|||
13321410|NCT01189604|26568503|FG003|Overall Study|Adverse Event|0|||
13321411|NCT01189604|26568504|FG004|Overall Study|Adverse Event|2|||
13321412|NCT01189604|26568505|FG005|Overall Study|Adverse Event|0|||
13321413|NCT01189604|26568506|FG006|Overall Study|Adverse Event|1|||
13321414|NCT01189604|26568500|FG000|Overall Study|Withdrawal by Subject|1|||
13321415|NCT01189604|26568501|FG001|Overall Study|Withdrawal by Subject|0|||
13321416|NCT01189604|26568502|FG002|Overall Study|Withdrawal by Subject|0|||
13321417|NCT01189604|26568503|FG003|Overall Study|Withdrawal by Subject|0|||
13321418|NCT01189604|26568504|FG004|Overall Study|Withdrawal by Subject|0|||
13321419|NCT01189604|26568505|FG005|Overall Study|Withdrawal by Subject|0|||
13321420|NCT01189604|26568506|FG006|Overall Study|Withdrawal by Subject|0|||
13321421|NCT01189500|26568569|FG000|Period 1: TAMOX Alone|Adverse Event|1|||
13321422|NCT01189500|26568569|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1|||
13321423|NCT01189487|26568579|FG000|Overall Study|Lack of Efficacy|2|||
13321424|NCT01189487|26568579|FG000|Overall Study|Adverse Event|1|||
13321425|NCT01189461|26568588|FG000|Overall Study|Lack of Efficacy|13|||
13321426|NCT01189461|26568588|FG000|Overall Study|Lost to Follow-up|1|||
13321427|NCT01189461|26568588|FG000|Overall Study|Withdrawal by Subject|6|||
13321428|NCT01189461|26568588|FG000|Overall Study|Protocol Violation|1|||
13321429|NCT01189461|26568588|FG000|Overall Study|Adverse Event|2|||
13321430|NCT01189461|26568588|FG000|Overall Study|Did not meet entrance criteria|3|||
13321431|NCT01189461|26568588|FG000|Overall Study|Other|8|||
13321432|NCT01189435|26568594|FG000|Overall Study|Withdrawal by Subject|1|||
13321433|NCT01189435|26568594|FG000|Overall Study|Physician Decision|1|||
13321434|NCT01189266|26568631|FG000|Overall Study|Adverse Event|1|||
13321435|NCT01189266|26568632|FG001|Overall Study|Adverse Event|0|||
13321436|NCT01189266|26568633|FG002|Overall Study|Adverse Event|5|||
13321437|NCT01189266|26568631|FG000|Overall Study|Death|0|||
13321438|NCT01189266|26568632|FG001|Overall Study|Death|0|||
13122290|NCT02966509|25946643|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48|||
13133480|NCT02769065|25988362|FG021|Overall Study|Voluntary Withdrawal|0|||
13133481|NCT02769065|25988363|FG022|Overall Study|Voluntary Withdrawal|0|||
13133482|NCT02769065|25988364|FG023|Overall Study|Voluntary Withdrawal|0|||
13133483|NCT02769065|25988365|FG024|Overall Study|Voluntary Withdrawal|0|||
13133484|NCT02769065|25988366|FG025|Overall Study|Voluntary Withdrawal|0|||
13133485|NCT02769065|25988367|FG026|Overall Study|Voluntary Withdrawal|0|||
13133486|NCT02769065|25988368|FG027|Overall Study|Voluntary Withdrawal|0|||
13133487|NCT02769065|25988369|FG028|Overall Study|Voluntary Withdrawal|0|||
13133488|NCT02769065|25988370|FG029|Overall Study|Voluntary Withdrawal|0|||
13133489|NCT02769065|25988341|FG000|Overall Study|Reason Not Specified|0|||
13133490|NCT02769065|25988342|FG001|Overall Study|Reason Not Specified|0|||
13133491|NCT02769065|25988343|FG002|Overall Study|Reason Not Specified|0|||
13133492|NCT02769065|25988344|FG003|Overall Study|Reason Not Specified|0|||
13133493|NCT02769065|25988345|FG004|Overall Study|Reason Not Specified|0|||
13133494|NCT02769065|25988346|FG005|Overall Study|Reason Not Specified|0|||
13133495|NCT02769065|25988347|FG006|Overall Study|Reason Not Specified|1|||
13133496|NCT02769065|25988348|FG007|Overall Study|Reason Not Specified|0|||
13133497|NCT02769065|25988349|FG008|Overall Study|Reason Not Specified|0|||
13133498|NCT02769065|25988350|FG009|Overall Study|Reason Not Specified|0|||
13133499|NCT02769065|25988351|FG010|Overall Study|Reason Not Specified|0|||
13133500|NCT02769065|25988352|FG011|Overall Study|Reason Not Specified|0|||
13133501|NCT02769065|25988353|FG012|Overall Study|Reason Not Specified|0|||
13133502|NCT02769065|25988354|FG013|Overall Study|Reason Not Specified|0|||
13133503|NCT02769065|25988355|FG014|Overall Study|Reason Not Specified|0|||
13133504|NCT02769065|25988356|FG015|Overall Study|Reason Not Specified|0|||
13133505|NCT02769065|25988357|FG016|Overall Study|Reason Not Specified|0|||
13133506|NCT02769065|25988358|FG017|Overall Study|Reason Not Specified|0|||
13133507|NCT02769065|25988359|FG018|Overall Study|Reason Not Specified|0|||
13133508|NCT02769065|25988360|FG019|Overall Study|Reason Not Specified|0|||
13133509|NCT02769065|25988361|FG020|Overall Study|Reason Not Specified|0|||
13133510|NCT02769065|25988362|FG021|Overall Study|Reason Not Specified|0|||
13133511|NCT02769065|25988363|FG022|Overall Study|Reason Not Specified|0|||
13133512|NCT02769065|25988364|FG023|Overall Study|Reason Not Specified|0|||
13133513|NCT02769065|25988365|FG024|Overall Study|Reason Not Specified|0|||
13133514|NCT02769065|25988366|FG025|Overall Study|Reason Not Specified|0|||
13133515|NCT02769065|25988367|FG026|Overall Study|Reason Not Specified|0|||
13133516|NCT02769065|25988368|FG027|Overall Study|Reason Not Specified|0|||
13133517|NCT02769065|25988369|FG028|Overall Study|Reason Not Specified|0|||
13133518|NCT02769065|25988370|FG029|Overall Study|Reason Not Specified|0|||
13133519|NCT02769065|25988341|FG000|Overall Study|Pre-treatment Event/Adverse Event|0|||
13133520|NCT02769065|25988342|FG001|Overall Study|Pre-treatment Event/Adverse Event|0|||
13321439|NCT01189266|26568633|FG002|Overall Study|Death|5|||
13321440|NCT01189266|26568631|FG000|Overall Study|Lack of Efficacy|4|||
13321441|NCT01189266|26568632|FG001|Overall Study|Lack of Efficacy|5|||
13321442|NCT01189266|26568633|FG002|Overall Study|Lack of Efficacy|44|||
13321443|NCT01189266|26568631|FG000|Overall Study|Physician Decision|0|||
13321444|NCT01189266|26568632|FG001|Overall Study|Physician Decision|0|||
13321445|NCT01189266|26568633|FG002|Overall Study|Physician Decision|1|||
13321446|NCT01189266|26568631|FG000|Overall Study|Protocol Violation|0|||
13321447|NCT01189266|26568632|FG001|Overall Study|Protocol Violation|1|||
13321448|NCT01189266|26568633|FG002|Overall Study|Protocol Violation|1|||
13321449|NCT01189266|26568631|FG000|Overall Study|Withdrawal by Subject|0|||
13321450|NCT01189266|26568632|FG001|Overall Study|Withdrawal by Subject|0|||
13321451|NCT01189266|26568633|FG002|Overall Study|Withdrawal by Subject|1|||
13321452|NCT01189266|26568631|FG000|Overall Study|Patient refuses further therapy|1|||
13321453|NCT01189266|26568632|FG001|Overall Study|Patient refuses further therapy|0|||
13321454|NCT01189266|26568633|FG002|Overall Study|Patient refuses further therapy|7|||
13321455|NCT01189266|26568631|FG000|Overall Study|No treatment|0|||
13321456|NCT01189266|26568632|FG001|Overall Study|No treatment|0|||
13321457|NCT01189266|26568633|FG002|Overall Study|No treatment|1|||
13321458|NCT01189227|26568646|FG000|Overall Study|Study terminated due to low accrual|6|||
13321459|NCT01189227|26568647|FG001|Overall Study|Study terminated due to low accrual|3|||
13321460|NCT01189201|26568703|FG000|Overall Study|Adverse Event|1|||
13321461|NCT01189032|26568721|FG000|Overall Study|Adverse Event|1|||
13321462|NCT01189032|26568722|FG001|Overall Study|Adverse Event|3|||
13321463|NCT01189032|26568723|FG002|Overall Study|Adverse Event|4|||
13321464|NCT01189032|26568721|FG000|Overall Study|Lack of Efficacy|2|||
13321465|NCT01189032|26568722|FG001|Overall Study|Lack of Efficacy|3|||
13321466|NCT01189032|26568723|FG002|Overall Study|Lack of Efficacy|0|||
13321467|NCT01189032|26568721|FG000|Overall Study|Withdrawal by Subject|1|||
13321468|NCT01189032|26568722|FG001|Overall Study|Withdrawal by Subject|0|||
13321469|NCT01189032|26568723|FG002|Overall Study|Withdrawal by Subject|1|||
13321470|NCT01189032|26568721|FG000|Overall Study|Protocol Violation|1|||
13321471|NCT01189032|26568722|FG001|Overall Study|Protocol Violation|1|||
13321472|NCT01189032|26568723|FG002|Overall Study|Protocol Violation|1|||
13321473|NCT01188967|26568742|FG000|Overall Study|Withdrawal by Subject|1|||
13321474|NCT01188967|26568743|FG001|Overall Study|Withdrawal by Subject|1|||
13321475|NCT01188967|26568742|FG000|Overall Study|Physician Decision|1|||
13321476|NCT01188967|26568743|FG001|Overall Study|Physician Decision|1|||
13321477|NCT01188967|26568742|FG000|Overall Study|Lost to Follow-up|3|||
13321478|NCT01188967|26568743|FG001|Overall Study|Lost to Follow-up|2|||
13321479|NCT01188811|26568760|FG000|Overall Study|Withdrawal by Subject|0|||
13321480|NCT01188811|26568761|FG001|Overall Study|Withdrawal by Subject|2|||
13321481|NCT01188811|26568760|FG000|Overall Study|Adverse Event|6|||
13321482|NCT01188811|26568761|FG001|Overall Study|Adverse Event|0|||
13321483|NCT01188798|26568776|FG000|Overall Study|Death|0|||
13321484|NCT01188798|26568777|FG001|Overall Study|Death|1|||
13321485|NCT01188798|26568776|FG000|Overall Study|Required additional transplant|1|||
13321486|NCT01188798|26568777|FG001|Overall Study|Required additional transplant|1|||
13321487|NCT01188798|26568776|FG000|Overall Study|Protocol closure|1|||
13321488|NCT01188798|26568777|FG001|Overall Study|Protocol closure|1|||
13321489|NCT01183234|26568794|FG000|First Intervention|Adverse Event|1|||
13321490|NCT01183234|26568795|FG001|First Intervention|Adverse Event|0|||
13321491|NCT01183221|26568810|FG000|3 Weeks Wash Out|Lost to Follow-up|1|||
13321492|NCT01183221|26568811|FG001|3 Weeks Wash Out|Lost to Follow-up|1|||
13321493|NCT01183143|26568827|FG000|Overall Study|Protocol Violation|115|||
13321494|NCT01183143|26568827|FG000|Overall Study|Withdrawal by Subject|19|||
13321495|NCT01183143|26568827|FG000|Overall Study|Subject Questionnaires not returned|5|||
13321496|NCT01183143|26568827|FG000|Overall Study|Subjects enrolled, but not treated|11|||
13321497|NCT01183104|26568850|FG000|Overall Study|Adverse Event|8|||
13321498|NCT01183104|26568851|FG001|Overall Study|Adverse Event|6|||
13321499|NCT01183104|26568850|FG000|Overall Study|Death|0|||
13321500|NCT01183104|26568851|FG001|Overall Study|Death|1|||
13321501|NCT01183104|26568850|FG000|Overall Study|Lost to Follow-up|14|||
13321502|NCT01183104|26568851|FG001|Overall Study|Lost to Follow-up|7|||
13321503|NCT01183104|26568850|FG000|Overall Study|Physician Decision|5|||
13321504|NCT01183104|26568851|FG001|Overall Study|Physician Decision|8|||
13321505|NCT01183104|26568850|FG000|Overall Study|Withdrawal by Subject|6|||
13321506|NCT01183104|26568851|FG001|Overall Study|Withdrawal by Subject|11|||
13321507|NCT01183104|26568850|FG000|Overall Study|Nonparticipation in Extension Study|39|||
13321508|NCT01183104|26568851|FG001|Overall Study|Nonparticipation in Extension Study|50|||
13321509|NCT01183104|26568850|FG000|Overall Study|Did not receive study drug|5|||
13321510|NCT01183104|26568851|FG001|Overall Study|Did not receive study drug|9|||
13321511|NCT01183065|26568857|FG000|Overall Study|Patient no longer fits eligibility crite|1|||
13321512|NCT01183013|26568958|FG000|Overall Study|Adverse Event|6|||
13321513|NCT01183013|26568959|FG001|Overall Study|Adverse Event|8|||
13321514|NCT01183013|26568960|FG002|Overall Study|Adverse Event|5|||
13321515|NCT01183013|26568961|FG003|Overall Study|Adverse Event|5|||
13321516|NCT01183013|26568962|FG004|Overall Study|Adverse Event|10|||
13321517|NCT01183013|26568963|FG005|Overall Study|Adverse Event|10|||
13321518|NCT01183013|26568964|FG006|Overall Study|Adverse Event|6|||
13321519|NCT01183013|26568958|FG000|Overall Study|Lack of Efficacy|3|||
13321520|NCT01183013|26568959|FG001|Overall Study|Lack of Efficacy|2|||
13321521|NCT01183013|26568960|FG002|Overall Study|Lack of Efficacy|1|||
13321522|NCT01183013|26568961|FG003|Overall Study|Lack of Efficacy|2|||
13321523|NCT01183013|26568962|FG004|Overall Study|Lack of Efficacy|1|||
13321524|NCT01183013|26568963|FG005|Overall Study|Lack of Efficacy|2|||
13321525|NCT01183013|26568964|FG006|Overall Study|Lack of Efficacy|0|||
13122291|NCT02966353|25946654|FG000|Overall Study|Withdrawal by Subject|7|||
13122292|NCT02966353|25946654|FG000|Overall Study|Adverse Event|4|||
13122293|NCT02966353|25946654|FG000|Overall Study|Death|4|||
13321526|NCT01183013|26568958|FG000|Overall Study|Protocol Violation|5|||
13321527|NCT01183013|26568959|FG001|Overall Study|Protocol Violation|2|||
13321528|NCT01183013|26568960|FG002|Overall Study|Protocol Violation|4|||
13321529|NCT01183013|26568961|FG003|Overall Study|Protocol Violation|0|||
13321530|NCT01183013|26568962|FG004|Overall Study|Protocol Violation|4|||
13321531|NCT01183013|26568963|FG005|Overall Study|Protocol Violation|3|||
13321532|NCT01183013|26568964|FG006|Overall Study|Protocol Violation|3|||
13321533|NCT01183013|26568958|FG000|Overall Study|Lost to Follow-up|7|||
13321534|NCT01183013|26568959|FG001|Overall Study|Lost to Follow-up|3|||
13321535|NCT01183013|26568960|FG002|Overall Study|Lost to Follow-up|4|||
13321536|NCT01183013|26568961|FG003|Overall Study|Lost to Follow-up|3|||
13321537|NCT01183013|26568962|FG004|Overall Study|Lost to Follow-up|2|||
13321538|NCT01183013|26568963|FG005|Overall Study|Lost to Follow-up|6|||
13321539|NCT01183013|26568964|FG006|Overall Study|Lost to Follow-up|5|||
13321540|NCT01183013|26568958|FG000|Overall Study|Withdrawal by Subject|9|||
13321541|NCT01183013|26568959|FG001|Overall Study|Withdrawal by Subject|13|||
13321542|NCT01183013|26568960|FG002|Overall Study|Withdrawal by Subject|10|||
13321543|NCT01183013|26568961|FG003|Overall Study|Withdrawal by Subject|8|||
13321544|NCT01183013|26568962|FG004|Overall Study|Withdrawal by Subject|7|||
13321545|NCT01183013|26568963|FG005|Overall Study|Withdrawal by Subject|9|||
13321546|NCT01183013|26568964|FG006|Overall Study|Withdrawal by Subject|10|||
13321547|NCT01183013|26568958|FG000|Overall Study|Reasons other than stated above|15|||
13321548|NCT01183013|26568959|FG001|Overall Study|Reasons other than stated above|11|||
13321549|NCT01183013|26568960|FG002|Overall Study|Reasons other than stated above|17|||
13321550|NCT01183013|26568961|FG003|Overall Study|Reasons other than stated above|12|||
13321551|NCT01183013|26568962|FG004|Overall Study|Reasons other than stated above|12|||
13321552|NCT01183013|26568963|FG005|Overall Study|Reasons other than stated above|15|||
13321553|NCT01183013|26568964|FG006|Overall Study|Reasons other than stated above|13|||
13321554|NCT01182844|26568989|FG000|Overall Study|Withdrawal by Subject|0|||
13321555|NCT01182844|26568990|FG001|Overall Study|Withdrawal by Subject|2|||
13321556|NCT01182441|26569006|FG000|Overall Study|Patient Still in Follow-up|152|||
13321557|NCT01182441|26569007|FG001|Overall Study|Patient Still in Follow-up|72|||
13321558|NCT01182441|26569006|FG000|Overall Study|Death|37|||
13321559|NCT01182441|26569007|FG001|Overall Study|Death|25|||
13321560|NCT01182441|26569006|FG000|Overall Study|Implant Attempt Unsuccessful|13|||
13321561|NCT01182441|26569007|FG001|Overall Study|Implant Attempt Unsuccessful|0|||
13321562|NCT01182441|26569006|FG000|Overall Study|Lost to Follow-up|5|||
13321563|NCT01182441|26569007|FG001|Overall Study|Lost to Follow-up|8|||
13321564|NCT01182441|26569006|FG000|Overall Study|Withdrawal by Subject|6|||
13321565|NCT01182441|26569007|FG001|Overall Study|Withdrawal by Subject|13|||
13321566|NCT01182441|26569006|FG000|Overall Study|Implant Not Attempted|4|||
13321567|NCT01182441|26569007|FG001|Overall Study|Implant Not Attempted|0|||
13321568|NCT01182441|26569006|FG000|Overall Study|Adverse Event|2|||
13321569|NCT01182441|26569007|FG001|Overall Study|Adverse Event|0|||
13321570|NCT01182441|26569006|FG000|Overall Study|Physician Decision|1|||
13321571|NCT01182441|26569007|FG001|Overall Study|Physician Decision|1|||
13321572|NCT01182428|26569078|FG000|Overall Study|Physician Decision|1|||
13321573|NCT01182428|26569079|FG001|Overall Study|Physician Decision|0|||
13321574|NCT01182428|26569078|FG000|Overall Study|Lost to Follow-up|9|||
13321575|NCT01182428|26569079|FG001|Overall Study|Lost to Follow-up|1|||
13321576|NCT01182428|26569078|FG000|Overall Study|Withdrawal by Subject|1|||
13321577|NCT01182428|26569079|FG001|Overall Study|Withdrawal by Subject|0|||
13321578|NCT01182415|26569088|FG000|Overall Study|Lost to Follow-up|1|||
13321579|NCT01182350|26569114|FG000|Overall Study|Adverse Event|5|||
13321580|NCT01182350|26569115|FG001|Overall Study|Adverse Event|0|||
13321581|NCT01182350|26569116|FG002|Overall Study|Adverse Event|0|||
13321582|NCT01182350|26569117|FG003|Overall Study|Adverse Event|0|||
13321583|NCT01182350|26569118|FG004|Overall Study|Adverse Event|0|||
13321584|NCT01182350|26569114|FG000|Overall Study|Disease Progression|15|||
13321585|NCT01182350|26569115|FG001|Overall Study|Disease Progression|12|||
13321586|NCT01182350|26569116|FG002|Overall Study|Disease Progression|0|||
13321587|NCT01182350|26569117|FG003|Overall Study|Disease Progression|1|||
13321588|NCT01182350|26569118|FG004|Overall Study|Disease Progression|0|||
13321589|NCT01182350|26569114|FG000|Overall Study|Death|0|||
13321590|NCT01182350|26569115|FG001|Overall Study|Death|1|||
13321591|NCT01182350|26569116|FG002|Overall Study|Death|1|||
13321592|NCT01182350|26569117|FG003|Overall Study|Death|0|||
13321593|NCT01182350|26569118|FG004|Overall Study|Death|0|||
13321594|NCT01182350|26569114|FG000|Overall Study|Withdrawal by Subject|3|||
13321595|NCT01182350|26569115|FG001|Overall Study|Withdrawal by Subject|1|||
13321596|NCT01182350|26569116|FG002|Overall Study|Withdrawal by Subject|0|||
13321597|NCT01182350|26569117|FG003|Overall Study|Withdrawal by Subject|1|||
13321598|NCT01182350|26569118|FG004|Overall Study|Withdrawal by Subject|0|||
13321599|NCT01182350|26569114|FG000|Overall Study|Alternative Therapy|2|||
13321600|NCT01182350|26569115|FG001|Overall Study|Alternative Therapy|0|||
13321601|NCT01182350|26569116|FG002|Overall Study|Alternative Therapy|1|||
13321602|NCT01182350|26569117|FG003|Overall Study|Alternative Therapy|0|||
13321603|NCT01182350|26569118|FG004|Overall Study|Alternative Therapy|0|||
13321604|NCT01182350|26569114|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2|||
13321605|NCT01182350|26569115|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
13321606|NCT01182350|26569116|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
13321607|NCT01182350|26569117|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
13321608|NCT01182350|26569118|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
13321609|NCT01182350|26569114|FG000|Overall Study|Unevaluable for Biopsy|0|||
13321610|NCT01182350|26569115|FG001|Overall Study|Unevaluable for Biopsy|0|||
13321611|NCT01182350|26569116|FG002|Overall Study|Unevaluable for Biopsy|0|||
13321612|NCT01182350|26569117|FG003|Overall Study|Unevaluable for Biopsy|0|||
13321613|NCT01182350|26569118|FG004|Overall Study|Unevaluable for Biopsy|3|||
13321614|NCT01182337|26569143|FG000|Overall Study|Withdrawal by Subject|3|||
13321615|NCT01182337|26569144|FG001|Overall Study|Withdrawal by Subject|1|||
13321616|NCT01182337|26569143|FG000|Overall Study|Lost to Follow-up|0|||
13321617|NCT01182337|26569144|FG001|Overall Study|Lost to Follow-up|1|||
13321618|NCT01182298|26569150|FG000|Overall Study|Lack of Efficacy|4|||
13321619|NCT01182298|26569150|FG000|Overall Study|Withdrawal by Subject|2|||
13321620|NCT01182285|26569162|FG000|First Intervention Week 1-10|Disease progression|1|||
13321621|NCT01182285|26569163|FG001|First Intervention Week 1-10|Disease progression|0|||
13321622|NCT01182285|26569164|FG002|First Intervention Week 1-10|Disease progression|0|||
13321623|NCT01182285|26569162|FG000|First Intervention Week 1-10|Adverse Event|1|||
13321624|NCT01182285|26569163|FG001|First Intervention Week 1-10|Adverse Event|0|||
13321625|NCT01182285|26569164|FG002|First Intervention Week 1-10|Adverse Event|0|||
13321626|NCT01182285|26569162|FG000|First Intervention Week 1-10|Non-compliance|1|||
13321627|NCT01182285|26569163|FG001|First Intervention Week 1-10|Non-compliance|0|||
13321628|NCT01182285|26569164|FG002|First Intervention Week 1-10|Non-compliance|0|||
13321629|NCT01182285|26569162|FG000|Third Intervention Week 11-52|Disease Progression|0|||
13321630|NCT01182285|26569163|FG001|Third Intervention Week 11-52|Disease Progression|0|||
13321631|NCT01182285|26569164|FG002|Third Intervention Week 11-52|Disease Progression|6|||
13321632|NCT01182285|26569162|FG000|Third Intervention Week 11-52|Other|0|||
13321633|NCT01182285|26569163|FG001|Third Intervention Week 11-52|Other|0|||
13321634|NCT01182285|26569164|FG002|Third Intervention Week 11-52|Other|2|||
13321635|NCT01182207|26569187|FG000|First Intervention|Positive Hepatitis Results|0|||
13321636|NCT01182207|26569188|FG001|First Intervention|Positive Hepatitis Results|1|||
13321637|NCT01182207|26569187|FG000|Second Intervention|Emeses within 1 hour of dosing|1|||
13321638|NCT01182207|26569188|FG001|Second Intervention|Emeses within 1 hour of dosing|0|||
13321639|NCT01182194|26569211|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
13321640|NCT01182194|26569212|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
13321641|NCT01182181|26569227|FG000|First Intervention|Adverse Event|1|||
13321642|NCT01182181|26569228|FG001|First Intervention|Adverse Event|0|||
13321643|NCT01182181|26569227|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
13321644|NCT01182181|26569228|FG001|Washout of 21 Days|Withdrawal by Subject|1|||
13321645|NCT01181986|26569252|FG000|Phase 1|Lost to Follow-up|0|||
13321646|NCT01181986|26569253|FG001|Phase 1|Lost to Follow-up|1|||
13321647|NCT01181986|26569254|FG002|Phase 1|Lost to Follow-up|1|||
13321648|NCT01181986|26569252|FG000|Phase 1|Adverse Event|0|||
13321649|NCT01181986|26569253|FG001|Phase 1|Adverse Event|0|||
13321650|NCT01181986|26569254|FG002|Phase 1|Adverse Event|1|||
13321651|NCT01181986|26569252|FG000|Phase 1|Protocol Violation|1|||
13321652|NCT01181986|26569253|FG001|Phase 1|Protocol Violation|0|||
13321653|NCT01181986|26569254|FG002|Phase 1|Protocol Violation|0|||
13321654|NCT01181986|26569252|FG000|Phase 2|Adverse Event|0|||
13321655|NCT01181986|26569253|FG001|Phase 2|Adverse Event|3|||
13321656|NCT01181986|26569254|FG002|Phase 2|Adverse Event|0|||
13321657|NCT01181986|26569252|FG000|Phase 2|Medical condition|0|||
13321658|NCT01181986|26569253|FG001|Phase 2|Medical condition|1|||
13321659|NCT01181986|26569254|FG002|Phase 2|Medical condition|0|||
13321660|NCT01181921|26569260|FG000|Overall Study|Lost to Follow-up|1|||
13321661|NCT01181895|26569299|FG000|Overall Study|Adverse Event|3|||
13321662|NCT01181895|26569300|FG001|Overall Study|Adverse Event|1|||
13321663|NCT01181895|26569301|FG002|Overall Study|Adverse Event|1|||
13321664|NCT01181895|26569299|FG000|Overall Study|Lack of Efficacy|8|||
13321665|NCT01181895|26569300|FG001|Overall Study|Lack of Efficacy|9|||
13321666|NCT01181895|26569301|FG002|Overall Study|Lack of Efficacy|9|||
13321667|NCT01181895|26569299|FG000|Overall Study|Protocol Violation|2|||
13321668|NCT01181895|26569300|FG001|Overall Study|Protocol Violation|1|||
13321669|NCT01181895|26569301|FG002|Overall Study|Protocol Violation|0|||
13321670|NCT01181895|26569299|FG000|Overall Study|Lost to Follow-up|0|||
13321671|NCT01181895|26569300|FG001|Overall Study|Lost to Follow-up|1|||
13321672|NCT01181895|26569301|FG002|Overall Study|Lost to Follow-up|2|||
13321673|NCT01181895|26569299|FG000|Overall Study|Investigator Discretion|1|||
13321674|NCT01181895|26569300|FG001|Overall Study|Investigator Discretion|2|||
13321675|NCT01181895|26569301|FG002|Overall Study|Investigator Discretion|1|||
13321676|NCT01181895|26569299|FG000|Overall Study|Withdrawal by Subject|3|||
13321677|NCT01181895|26569300|FG001|Overall Study|Withdrawal by Subject|0|||
13321678|NCT01181895|26569301|FG002|Overall Study|Withdrawal by Subject|5|||
13321679|NCT01181726|26569354|FG000|First Intervention|Adverse Event|1|||
13321680|NCT01181726|26569355|FG001|First Intervention|Adverse Event|0|||
13321681|NCT01181609|26569368|FG000|Overall Study|Adverse Event|1|||
13321682|NCT01181609|26569368|FG000|Overall Study|Withdrawal by Subject|1|||
13321683|NCT01181609|26569368|FG000|Overall Study|Lost to Follow-up|1|||
13321684|NCT01181609|26569368|FG000|Overall Study|Death|50|||
13321685|NCT01181531|26569385|FG000|Overall Study|Other|17|||
13321686|NCT01181531|26569386|FG001|Overall Study|Other|12|||
13321687|NCT01181531|26569385|FG000|Overall Study|Partial consent by subject withdrawn|0|||
13321688|NCT01181531|26569386|FG001|Overall Study|Partial consent by subject withdrawn|1|||
13321689|NCT01181531|26569385|FG000|Overall Study|Physician Decision|3|||
13321690|NCT01181531|26569386|FG001|Overall Study|Physician Decision|1|||
13321691|NCT01181531|26569385|FG000|Overall Study|Noncompliance|2|||
13321692|NCT01181531|26569386|FG001|Overall Study|Noncompliance|2|||
13321693|NCT01181531|26569385|FG000|Overall Study|Ineligibility determined|1|||
13321694|NCT01181531|26569386|FG001|Overall Study|Ineligibility determined|2|||
13321695|NCT01181531|26569385|FG000|Overall Study|Protocol Specified Criteria|15|||
13321696|NCT01181531|26569386|FG001|Overall Study|Protocol Specified Criteria|8|||
13321697|NCT01181531|26569385|FG000|Overall Study|Pregnancy|0|||
13321698|NCT01181531|26569386|FG001|Overall Study|Pregnancy|1|||
13321699|NCT01181531|26569385|FG000|Overall Study|Withdrawal by Subject|8|||
13321700|NCT01181531|26569386|FG001|Overall Study|Withdrawal by Subject|7|||
13321701|NCT01181531|26569385|FG000|Overall Study|Protocol Violation|6|||
13321702|NCT01181531|26569386|FG001|Overall Study|Protocol Violation|6|||
13321703|NCT01181531|26569385|FG000|Overall Study|Death|9|||
13321704|NCT01181531|26569386|FG001|Overall Study|Death|12|||
13321705|NCT01181531|26569385|FG000|Overall Study|Adverse Event|0|||
13321706|NCT01181531|26569386|FG001|Overall Study|Adverse Event|1|||
13321707|NCT01181271|26569403|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6|||
13321708|NCT01181271|26569403|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4|||
13321709|NCT01181271|26569403|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2|||
13321710|NCT01181271|26569403|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1|||
13321711|NCT01181167|26569418|FG000|Overall Study|Adverse Event|11|||
13321712|NCT01181167|26569419|FG001|Overall Study|Adverse Event|21|||
13321713|NCT01181167|26569418|FG000|Overall Study|Lost to Follow-up|1|||
13321714|NCT01181167|26569419|FG001|Overall Study|Lost to Follow-up|0|||
13321715|NCT01181167|26569418|FG000|Overall Study|Physician Decision|2|||
13321716|NCT01181167|26569419|FG001|Overall Study|Physician Decision|3|||
13321717|NCT01181167|26569418|FG000|Overall Study|Protocol Violation|3|||
13321718|NCT01181167|26569419|FG001|Overall Study|Protocol Violation|0|||
13321719|NCT01181167|26569418|FG000|Overall Study|Withdrawal by Subject|6|||
13321720|NCT01181167|26569419|FG001|Overall Study|Withdrawal by Subject|8|||
13321721|NCT01181141|26569432|FG000|Overall Study|Adverse Event|2|||
13321722|NCT01181141|26569433|FG001|Overall Study|Adverse Event|1|||
13321723|NCT01181141|26569432|FG000|Overall Study|Lack of Efficacy|1|||
13321724|NCT01181141|26569433|FG001|Overall Study|Lack of Efficacy|0|||
13321725|NCT01181141|26569432|FG000|Overall Study|Lost to Follow-up|1|||
13321726|NCT01181141|26569433|FG001|Overall Study|Lost to Follow-up|1|||
13321727|NCT01181141|26569432|FG000|Overall Study|Physician Decision|2|||
13321728|NCT01181141|26569433|FG001|Overall Study|Physician Decision|0|||
13321729|NCT01181141|26569432|FG000|Overall Study|Protocol Violation|3|||
13321730|NCT01181141|26569433|FG001|Overall Study|Protocol Violation|1|||
13321731|NCT01181141|26569432|FG000|Overall Study|Withdrawal by Subject|3|||
13321732|NCT01181141|26569433|FG001|Overall Study|Withdrawal by Subject|1|||
13321733|NCT01181128|26569529|FG000|Overall Study|Withdrawal by Subject|2|||
13321734|NCT01181128|26569530|FG001|Overall Study|Withdrawal by Subject|2|||
13321735|NCT01181128|26569531|FG002|Overall Study|Withdrawal by Subject|0|||
13321736|NCT01181128|26569529|FG000|Overall Study|Death|1|||
13321737|NCT01181128|26569530|FG001|Overall Study|Death|0|||
13321738|NCT01181128|26569531|FG002|Overall Study|Death|0|||
13321739|NCT01181128|26569529|FG000|Overall Study|Physician Decision|2|||
13321740|NCT01181128|26569530|FG001|Overall Study|Physician Decision|0|||
13321741|NCT01181128|26569531|FG002|Overall Study|Physician Decision|0|||
13321742|NCT01181128|26569529|FG000|Overall Study|Adverse Event|0|||
13321743|NCT01181128|26569530|FG001|Overall Study|Adverse Event|2|||
13321744|NCT01181128|26569531|FG002|Overall Study|Adverse Event|0|||
13321745|NCT01181128|26569529|FG000|Overall Study|Other|1|||
13321746|NCT01181128|26569530|FG001|Overall Study|Other|1|||
13321747|NCT01181128|26569531|FG002|Overall Study|Other|1|||
13321748|NCT01181102|26569546|FG000|Overall Study|Adverse Event|28|||
13321749|NCT01181102|26569547|FG001|Overall Study|Adverse Event|26|||
13321750|NCT01181102|26569546|FG000|Overall Study|Lack of Efficacy|3|||
13321751|NCT01181102|26569547|FG001|Overall Study|Lack of Efficacy|1|||
13321752|NCT01181102|26569546|FG000|Overall Study|Lost to Follow-up|2|||
13321753|NCT01181102|26569547|FG001|Overall Study|Lost to Follow-up|0|||
13321754|NCT01181102|26569546|FG000|Overall Study|Physician Decision|3|||
13321755|NCT01181102|26569547|FG001|Overall Study|Physician Decision|1|||
13321756|NCT01181102|26569546|FG000|Overall Study|Protocol Violation|5|||
13321757|NCT01181102|26569547|FG001|Overall Study|Protocol Violation|6|||
13321758|NCT01181102|26569546|FG000|Overall Study|Withdrawal by Subject|10|||
13321759|NCT01181102|26569547|FG001|Overall Study|Withdrawal by Subject|12|||
13321760|NCT01181011|26569596|FG000|Overall Study|Adverse Event|2|||
13321761|NCT01181011|26569596|FG000|Overall Study|Lost to Follow-up|1|||
13321762|NCT01180998|26569620|FG000|Overall Study|Poor Vision|0|||
13321763|NCT01180998|26569621|FG001|Overall Study|Poor Vision|2|||
13321764|NCT01180998|26569622|FG002|Overall Study|Poor Vision|2|||
13321765|NCT01180998|26569620|FG000|Overall Study|Lost to Follow-up|0|||
13321766|NCT01180998|26569621|FG001|Overall Study|Lost to Follow-up|0|||
13321767|NCT01180998|26569622|FG002|Overall Study|Lost to Follow-up|1|||
13321768|NCT01180998|26569620|FG000|Overall Study|Protocol Violation|1|||
13321769|NCT01180998|26569621|FG001|Overall Study|Protocol Violation|2|||
13321770|NCT01180998|26569622|FG002|Overall Study|Protocol Violation|0|||
13321771|NCT01180998|26569620|FG000|Overall Study|Withdrawal by Subject|0|||
13321772|NCT01180998|26569621|FG001|Overall Study|Withdrawal by Subject|0|||
13321773|NCT01180998|26569622|FG002|Overall Study|Withdrawal by Subject|1|||
13321774|NCT01180998|26569620|FG000|Overall Study|Poor comfort|3|||
13321775|NCT01180998|26569621|FG001|Overall Study|Poor comfort|0|||
13321776|NCT01180998|26569622|FG002|Overall Study|Poor comfort|4|||
13321777|NCT01180998|26569620|FG000|Overall Study|Poor lens handling|0|||
13321778|NCT01180998|26569621|FG001|Overall Study|Poor lens handling|0|||
13122294|NCT02966353|25946654|FG000|Overall Study|Physician Decision|3|||
13321779|NCT01180998|26569622|FG002|Overall Study|Poor lens handling|2|||
13321780|NCT01180985|26569642|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1|||
13321781|NCT01180985|26569643|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0|||
13321782|NCT01180790|26569730|FG000|Overall Study|Adverse Event|1|||
13321783|NCT01180790|26569731|FG001|Overall Study|Adverse Event|1|||
13321784|NCT01180790|26569732|FG002|Overall Study|Adverse Event|2|||
13321785|NCT01180790|26569733|FG003|Overall Study|Adverse Event|0|||
13321786|NCT01180790|26569734|FG004|Overall Study|Adverse Event|1|||
13321787|NCT01180790|26569735|FG005|Overall Study|Adverse Event|3|||
13321788|NCT01180790|26569736|FG006|Overall Study|Adverse Event|0|||
13321789|NCT01180790|26569730|FG000|Overall Study|Withdrawal by Subject|3|||
13321790|NCT01180790|26569731|FG001|Overall Study|Withdrawal by Subject|0|||
13321791|NCT01180790|26569732|FG002|Overall Study|Withdrawal by Subject|5|||
13321792|NCT01180790|26569733|FG003|Overall Study|Withdrawal by Subject|0|||
13321793|NCT01180790|26569734|FG004|Overall Study|Withdrawal by Subject|2|||
13321794|NCT01180790|26569735|FG005|Overall Study|Withdrawal by Subject|1|||
13321795|NCT01180790|26569736|FG006|Overall Study|Withdrawal by Subject|0|||
13321796|NCT01180790|26569730|FG000|Overall Study|Lost to Follow-up|3|||
13321797|NCT01180790|26569731|FG001|Overall Study|Lost to Follow-up|1|||
13321798|NCT01180790|26569732|FG002|Overall Study|Lost to Follow-up|0|||
13321799|NCT01180790|26569733|FG003|Overall Study|Lost to Follow-up|2|||
13321800|NCT01180790|26569734|FG004|Overall Study|Lost to Follow-up|1|||
13321801|NCT01180790|26569735|FG005|Overall Study|Lost to Follow-up|0|||
13321802|NCT01180790|26569736|FG006|Overall Study|Lost to Follow-up|1|||
13321803|NCT01180790|26569730|FG000|Overall Study|Physician Decision|1|||
13321804|NCT01180790|26569731|FG001|Overall Study|Physician Decision|0|||
13321805|NCT01180790|26569732|FG002|Overall Study|Physician Decision|0|||
13321806|NCT01180790|26569733|FG003|Overall Study|Physician Decision|1|||
13321807|NCT01180790|26569734|FG004|Overall Study|Physician Decision|0|||
13321808|NCT01180790|26569735|FG005|Overall Study|Physician Decision|0|||
13321809|NCT01180790|26569736|FG006|Overall Study|Physician Decision|0|||
13321810|NCT01180790|26569730|FG000|Overall Study|Lack of Efficacy|1|||
13321811|NCT01180790|26569731|FG001|Overall Study|Lack of Efficacy|2|||
13321812|NCT01180790|26569732|FG002|Overall Study|Lack of Efficacy|5|||
13321813|NCT01180790|26569733|FG003|Overall Study|Lack of Efficacy|6|||
13321814|NCT01180790|26569734|FG004|Overall Study|Lack of Efficacy|1|||
13321815|NCT01180790|26569735|FG005|Overall Study|Lack of Efficacy|3|||
13321816|NCT01180790|26569736|FG006|Overall Study|Lack of Efficacy|0|||
13321817|NCT01180790|26569730|FG000|Overall Study|compliance|0|||
13321818|NCT01180790|26569731|FG001|Overall Study|compliance|1|||
13321819|NCT01180790|26569732|FG002|Overall Study|compliance|0|||
13321820|NCT01180790|26569733|FG003|Overall Study|compliance|0|||
13321821|NCT01180790|26569734|FG004|Overall Study|compliance|0|||
13321822|NCT01180790|26569735|FG005|Overall Study|compliance|0|||
13321823|NCT01180790|26569736|FG006|Overall Study|compliance|0|||
13321824|NCT01180790|26569730|FG000|Overall Study|Severe coronary atherosclerosis (death)|0|||
13321825|NCT01180790|26569731|FG001|Overall Study|Severe coronary atherosclerosis (death)|0|||
13321826|NCT01180790|26569732|FG002|Overall Study|Severe coronary atherosclerosis (death)|1|||
13321827|NCT01180790|26569733|FG003|Overall Study|Severe coronary atherosclerosis (death)|0|||
13321828|NCT01180790|26569734|FG004|Overall Study|Severe coronary atherosclerosis (death)|0|||
13321829|NCT01180790|26569735|FG005|Overall Study|Severe coronary atherosclerosis (death)|0|||
13321830|NCT01180790|26569736|FG006|Overall Study|Severe coronary atherosclerosis (death)|0|||
13321831|NCT01180777|26569750|FG000|Overall Study|Protocol Violation|6|||
13321832|NCT01180777|26569750|FG000|Overall Study|Poor lens fit|4|||
13321833|NCT01180777|26569750|FG000|Overall Study|Lost to Follow-up|1|||
13321834|NCT01180777|26569750|FG000|Overall Study|Adverse Event|1|||
13321835|NCT01180660|26569765|FG000|Overall Study|Changed to open surgery|1|||
13321836|NCT01180660|26569766|FG001|Overall Study|Changed to open surgery|0|||
13321837|NCT01180647|26569789|FG000|Overall Study|Lost to Follow-up|5|||
13321838|NCT01180647|26569790|FG001|Overall Study|Lost to Follow-up|6|||
13321839|NCT01180400|26569843|FG000|Overall Study|Withdrawal by Subject|5|||
13321840|NCT01180400|26569844|FG001|Overall Study|Withdrawal by Subject|6|||
13321841|NCT01180400|26569843|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
13321842|NCT01180400|26569844|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
13321843|NCT01180400|26569843|FG000|Overall Study|Adverse Event|12|||
13321844|NCT01180400|26569844|FG001|Overall Study|Adverse Event|10|||
13321845|NCT01180400|26569843|FG000|Overall Study|Severe non-compliance to protocol|1|||
13321846|NCT01180400|26569844|FG001|Overall Study|Severe non-compliance to protocol|2|||
13321847|NCT01180400|26569843|FG000|Overall Study|Condition under investigation worsened|2|||
13321848|NCT01180400|26569844|FG001|Overall Study|Condition under investigation worsened|1|||
13321849|NCT01180400|26569843|FG000|Overall Study|Lack of Efficacy|2|||
13321850|NCT01180400|26569844|FG001|Overall Study|Lack of Efficacy|0|||
13321851|NCT01180400|26569843|FG000|Overall Study|Study-specific withdrawal criteria|1|||
13321852|NCT01180400|26569844|FG001|Overall Study|Study-specific withdrawal criteria|2|||
13321853|NCT01180400|26569843|FG000|Overall Study|Lost to Follow-up|2|||
13321854|NCT01180400|26569844|FG001|Overall Study|Lost to Follow-up|3|||
13321855|NCT01180400|26569843|FG000|Overall Study|Other|0|||
13321856|NCT01180400|26569844|FG001|Overall Study|Other|1|||
13321857|NCT01180296|26569859|FG000|Overall Study|Protocol Violation|1|||
13321858|NCT01180296|26569860|FG001|Overall Study|Protocol Violation|2|||
13321859|NCT01180244|26569881|FG000|Overall Study|Lack of Efficacy|0|||
13321860|NCT01180244|26569882|FG001|Overall Study|Lack of Efficacy|7|||
13321861|NCT01180244|26569881|FG000|Overall Study|Physician Decision|3|||
13321862|NCT01180244|26569882|FG001|Overall Study|Physician Decision|0|||
13321863|NCT01180244|26569881|FG000|Overall Study|Adverse Event|1|||
13321864|NCT01180244|26569882|FG001|Overall Study|Adverse Event|0|||
13321865|NCT01180244|26569881|FG000|Overall Study|Withdrawal by Subject|0|||
13321866|NCT01180244|26569882|FG001|Overall Study|Withdrawal by Subject|1|||
13321867|NCT01180244|26569881|FG000|Overall Study|Protocol Violation|1|||
13321868|NCT01180244|26569882|FG001|Overall Study|Protocol Violation|0|||
13321869|NCT01180244|26569881|FG000|Overall Study|Lost to Follow-up|1|||
13321870|NCT01180244|26569882|FG001|Overall Study|Lost to Follow-up|0|||
13321871|NCT01180049|26569909|FG000|Overall Study|Other|9|||
13321872|NCT01180049|26569910|FG001|Overall Study|Other|7|||
13321873|NCT01180049|26569909|FG000|Overall Study|Lost to Follow-up|8|||
13321874|NCT01180049|26569910|FG001|Overall Study|Lost to Follow-up|6|||
13321875|NCT01180049|26569909|FG000|Overall Study|Death|36|||
13321876|NCT01180049|26569910|FG001|Overall Study|Death|35|||
13321877|NCT01179919|26569917|FG000|Overall Study|Protocol Violation|1|||
13321878|NCT01179919|26569917|FG000|Overall Study|Adverse Event|1|||
13321879|NCT01179737|26569939|FG000|Cohort 1 & Cohort 2|Adverse Event|3|||
13321880|NCT01179737|26569940|FG001|Cohort 1 & Cohort 2|Adverse Event|1|||
13321881|NCT01179737|26569941|FG002|Cohort 1 & Cohort 2|Adverse Event|1|||
13321882|NCT01179737|26569942|FG003|Cohort 1 & Cohort 2|Adverse Event|0|||
13321883|NCT01179737|26569939|FG000|Cohort 1 & Cohort 2|Withdrew consent|2|||
13321884|NCT01179737|26569940|FG001|Cohort 1 & Cohort 2|Withdrew consent|0|||
13321885|NCT01179737|26569941|FG002|Cohort 1 & Cohort 2|Withdrew consent|0|||
13321886|NCT01179737|26569942|FG003|Cohort 1 & Cohort 2|Withdrew consent|0|||
13321887|NCT01179737|26569939|FG000|Cohort 1 & Cohort 2|Administrative problems|0|||
13321888|NCT01179737|26569940|FG001|Cohort 1 & Cohort 2|Administrative problems|0|||
13321889|NCT01179737|26569941|FG002|Cohort 1 & Cohort 2|Administrative problems|2|||
13321890|NCT01179737|26569942|FG003|Cohort 1 & Cohort 2|Administrative problems|4|||
13321891|NCT01179737|26569939|FG000|Cohort 1 & Cohort 2|Death|0|||
13321892|NCT01179737|26569940|FG001|Cohort 1 & Cohort 2|Death|0|||
13321893|NCT01179737|26569941|FG002|Cohort 1 & Cohort 2|Death|1|||
13321894|NCT01179737|26569942|FG003|Cohort 1 & Cohort 2|Death|0|||
13321895|NCT01179737|26569939|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
13321896|NCT01179737|26569940|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1|||
13321897|NCT01179737|26569941|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
13321898|NCT01179737|26569942|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
13321899|NCT01179737|26569939|FG000|Cohort 1 & Cohort 2 Expansion|Death|1|||
13321900|NCT01179737|26569940|FG001|Cohort 1 & Cohort 2 Expansion|Death|0|||
13321901|NCT01179737|26569941|FG002|Cohort 1 & Cohort 2 Expansion|Death|0|||
13321902|NCT01179737|26569942|FG003|Cohort 1 & Cohort 2 Expansion|Death|0|||
13321903|NCT01179737|26569939|FG000|Extension|The study was terminated|3|||
13321904|NCT01179737|26569940|FG001|Extension|The study was terminated|0|||
13321905|NCT01179737|26569941|FG002|Extension|The study was terminated|0|||
13321906|NCT01179737|26569942|FG003|Extension|The study was terminated|0|||
13321907|NCT01179672|26569975|FG000|Overall Study|Adverse Event|17|||
13321908|NCT01179672|26569976|FG001|Overall Study|Adverse Event|8|||
13321909|NCT01179672|26569975|FG000|Overall Study|Withdrawal by Subject|10|||
13321910|NCT01179672|26569976|FG001|Overall Study|Withdrawal by Subject|12|||
13321911|NCT01179672|26569975|FG000|Overall Study|Entry Criteria Not Met|0|||
13321912|NCT01179672|26569976|FG001|Overall Study|Entry Criteria Not Met|2|||
13321913|NCT01179672|26569975|FG000|Overall Study|Lost to Follow-up|0|||
13321914|NCT01179672|26569976|FG001|Overall Study|Lost to Follow-up|1|||
13321915|NCT01179672|26569975|FG000|Overall Study|Protocol Violation|2|||
13321916|NCT01179672|26569976|FG001|Overall Study|Protocol Violation|2|||
13321917|NCT01179672|26569975|FG000|Overall Study|Physician Decision|1|||
13321918|NCT01179672|26569976|FG001|Overall Study|Physician Decision|1|||
13321919|NCT01179516|26570009|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
13321920|NCT01179516|26570010|FG001|Overall Study|Pretreatment Event or Adverse Event|8|||
13321921|NCT01179516|26570011|FG002|Overall Study|Pretreatment Event or Adverse Event|12|||
13321922|NCT01179516|26570009|FG000|Overall Study|Lack of Efficacy|4|||
13321923|NCT01179516|26570010|FG001|Overall Study|Lack of Efficacy|2|||
13321924|NCT01179516|26570011|FG002|Overall Study|Lack of Efficacy|0|||
13321925|NCT01179516|26570009|FG000|Overall Study|Noncompliance with Study Drug|2|||
13321926|NCT01179516|26570010|FG001|Overall Study|Noncompliance with Study Drug|0|||
13321927|NCT01179516|26570011|FG002|Overall Study|Noncompliance with Study Drug|1|||
13321928|NCT01179516|26570009|FG000|Overall Study|Protocol Deviations|4|||
13321929|NCT01179516|26570010|FG001|Overall Study|Protocol Deviations|3|||
13321930|NCT01179516|26570011|FG002|Overall Study|Protocol Deviations|3|||
13321931|NCT01179516|26570009|FG000|Overall Study|Withdrawal of Consent|2|||
13321932|NCT01179516|26570010|FG001|Overall Study|Withdrawal of Consent|6|||
13321933|NCT01179516|26570011|FG002|Overall Study|Withdrawal of Consent|10|||
13321934|NCT01179516|26570009|FG000|Overall Study|Lost to Follow-up|7|||
13321935|NCT01179516|26570010|FG001|Overall Study|Lost to Follow-up|7|||
13321936|NCT01179516|26570011|FG002|Overall Study|Lost to Follow-up|3|||
13321937|NCT01179516|26570009|FG000|Overall Study|Other|2|||
13321938|NCT01179516|26570010|FG001|Overall Study|Other|0|||
13321939|NCT01179516|26570011|FG002|Overall Study|Other|2|||
13321940|NCT01179477|26570018|FG000|Overall Study|Death|542|||
13321941|NCT01179477|26570018|FG000|Overall Study|Unsuccessful implant|80|||
13321942|NCT01179477|26570018|FG000|Overall Study|Non-death withdrawal|438|||
13321943|NCT01179477|26570018|FG000|Overall Study|Did not complete final visit|27|||
13321944|NCT01179399|26570024|FG000|Overall Study|Adverse Event|1|||
13321945|NCT01179399|26570024|FG000|Overall Study|Lack of Efficacy|30|||
13321946|NCT01179399|26570024|FG000|Overall Study|Withdrawal by Subject|1|||
13321947|NCT01179347|26570051|FG000|Double-blind Period (12 Weeks)|Adverse Event|2|||
13321948|NCT01179347|26570052|FG001|Double-blind Period (12 Weeks)|Adverse Event|6|||
13321949|NCT01179347|26570051|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2|||
13321950|NCT01179347|26570052|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0|||
13321951|NCT01179347|26570051|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
13321952|NCT01179347|26570052|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
13321953|NCT01179347|26570051|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1|||
13321954|NCT01179347|26570052|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2|||
13321955|NCT01179347|26570051|FG000|Double-blind Period (12 Weeks)|Other|2|||
13321956|NCT01179347|26570052|FG001|Double-blind Period (12 Weeks)|Other|4|||
13321957|NCT01179347|26570051|FG000|Open-label Period (12 Weeks)|Adverse Event|5|||
13321958|NCT01179347|26570052|FG001|Open-label Period (12 Weeks)|Adverse Event|9|||
13321959|NCT01179347|26570051|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0|||
13321960|NCT01179347|26570052|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2|||
13321961|NCT01179347|26570051|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1|||
13321962|NCT01179347|26570052|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0|||
13321963|NCT01179347|26570051|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
13321964|NCT01179347|26570052|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
13321965|NCT01179347|26570051|FG000|Open-label Period (12 Weeks)|Protocol Violation|1|||
13321966|NCT01179347|26570052|FG001|Open-label Period (12 Weeks)|Protocol Violation|0|||
13321967|NCT01179347|26570051|FG000|Open-label Period (12 Weeks)|Other|7|||
13321968|NCT01179347|26570052|FG001|Open-label Period (12 Weeks)|Other|4|||
13321969|NCT01179334|26570087|FG000|Treatment Period|Adverse Event|1|||
13321970|NCT01179334|26570088|FG001|Treatment Period|Adverse Event|0|||
13321971|NCT01179334|26570087|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6|||
13321972|NCT01179334|26570088|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2|||
13321973|NCT01179334|26570087|FG000|Long-term Extension (LTE) Period|Death|3|||
13321974|NCT01179334|26570088|FG001|Long-term Extension (LTE) Period|Death|0|||
13321975|NCT01179334|26570087|FG000|Long-term Extension (LTE) Period|Adverse Event|2|||
13321976|NCT01179334|26570088|FG001|Long-term Extension (LTE) Period|Adverse Event|4|||
13321977|NCT01179191|26570107|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47|||
13321978|NCT01179191|26570107|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19|||
13321979|NCT01179191|26570107|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30|||
13321980|NCT01179191|26570107|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162|||
13321981|NCT01179191|26570107|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13|||
13321982|NCT01179191|26570107|FG000|Titration Phase (up to 6 Weeks)|Other|62|||
13321983|NCT01179191|26570107|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10|||
13321984|NCT01179191|26570107|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9|||
13321985|NCT01179191|26570107|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3|||
13321986|NCT01179191|26570107|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29|||
13321987|NCT01179191|26570107|FG000|Maintenance Phase (8 Weeks)|Other|66|||
13321988|NCT01179048|26570130|FG000|Overall Study|Withdrawn - does not allow contact|4|||
13321989|NCT01179048|26570131|FG001|Overall Study|Withdrawn - does not allow contact|8|||
13321990|NCT01179048|26570130|FG000|Overall Study|Lost to Follow-up|8|||
13321991|NCT01179048|26570131|FG001|Overall Study|Lost to Follow-up|9|||
13321992|NCT01179048|26570130|FG000|Overall Study|Alive|127|||
13321993|NCT01179048|26570131|FG001|Overall Study|Alive|142|||
13321994|NCT01178853|26570144|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1|||
13321995|NCT01178853|26570145|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2|||
13321996|NCT01178853|26570144|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
13321997|NCT01178853|26570145|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
13321998|NCT01178853|26570144|FG000|Period 3 (Warfarin Titration)|Adverse Event|1|||
13321999|NCT01178853|26570145|FG001|Period 3 (Warfarin Titration)|Adverse Event|0|||
13322000|NCT01178853|26570144|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0|||
13322001|NCT01178853|26570145|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2|||
13322002|NCT01178853|26570144|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
13322003|NCT01178853|26570145|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
13322004|NCT01178762|26570151|FG000|Overall Study|Lost to Follow-up|15|||
13322005|NCT01178671|26570182|FG000|Overall Study|Adverse Event|4|||
13322006|NCT01178671|26570183|FG001|Overall Study|Adverse Event|6|||
13486399|NCT03786380|27035991|FG004|Overall Study|Reason Not Specified|1|||
13322007|NCT01178671|26570182|FG000|Overall Study|Protocol Violation|1|||
13322008|NCT01178671|26570183|FG001|Overall Study|Protocol Violation|1|||
13322009|NCT01178671|26570182|FG000|Overall Study|Lack of Efficacy|0|||
13322010|NCT01178671|26570183|FG001|Overall Study|Lack of Efficacy|1|||
13322011|NCT01178671|26570182|FG000|Overall Study|Lost to Follow-up|3|||
13322012|NCT01178671|26570183|FG001|Overall Study|Lost to Follow-up|1|||
13322013|NCT01178671|26570182|FG000|Overall Study|Physician Decision|4|||
13322014|NCT01178671|26570183|FG001|Overall Study|Physician Decision|6|||
13322015|NCT01178411|26570191|FG000|Overall Study|Adverse Event|5|||
13322016|NCT01178411|26570191|FG000|Overall Study|Withdrawal by Subject|4|||
13322017|NCT01178411|26570191|FG000|Overall Study|Protocol Violation|1|||
13322018|NCT01178411|26570191|FG000|Overall Study|Progressive disease per RECIST|32|||
13322019|NCT01178411|26570191|FG000|Overall Study|Progressive disease per clinician|9|||
13322020|NCT01178411|26570191|FG000|Overall Study|Physician Decision|6|||
13322021|NCT01178411|26570191|FG000|Overall Study|Death|1|||
13322022|NCT01178411|26570191|FG000|Overall Study|No reason provided|1|||
13322023|NCT01178411|26570191|FG000|Overall Study|Drug manufacturing ended|1|||
13373332|NCT00803738|26723494|FG000|Overall Study|Negative Baseline Culture of Candida|56|||
13373333|NCT00803738|26723495|FG001|Overall Study|Negative Baseline Culture of Candida|63|||
13373334|NCT00803738|26723494|FG000|Overall Study|Positive Results for STD or abnormal PAP|2|||
13373335|NCT00803738|26723495|FG001|Overall Study|Positive Results for STD or abnormal PAP|8|||
13373336|NCT00803712|26723566|FG000|Overall Study|Noncompliance|3|||
13373337|NCT00803712|26723567|FG001|Overall Study|Noncompliance|0|||
13373338|NCT00803712|26723566|FG000|Overall Study|Adverse Event|5|||
13373339|NCT00803712|26723567|FG001|Overall Study|Adverse Event|0|||
13373340|NCT00803712|26723566|FG000|Overall Study|Death|8|||
13373341|NCT00803712|26723567|FG001|Overall Study|Death|7|||
13373342|NCT00803712|26723566|FG000|Overall Study|Lost to Follow-up|3|||
13373343|NCT00803712|26723567|FG001|Overall Study|Lost to Follow-up|1|||
13373344|NCT00803712|26723566|FG000|Overall Study|Withdrawal by Subject|2|||
13373345|NCT00803712|26723567|FG001|Overall Study|Withdrawal by Subject|4|||
13373346|NCT00803712|26723566|FG000|Overall Study|"Other in electronic Case Report Form"|0|||
13373347|NCT00803712|26723567|FG001|Overall Study|"Other in electronic Case Report Form"|1|||
13373348|NCT00803712|26723566|FG000|Overall Study|Protocol criteria (other)|0|||
13373349|NCT00803712|26723567|FG001|Overall Study|Protocol criteria (other)|2|||
13373350|NCT00803712|26723566|FG000|Overall Study|Protocol criteria (renal transplant)|12|||
13373351|NCT00803712|26723567|FG001|Overall Study|Protocol criteria (renal transplant)|8|||
13373352|NCT00803712|26723566|FG000|Overall Study|Administrative decision|2|||
13373353|NCT00803712|26723567|FG001|Overall Study|Administrative decision|3|||
13373354|NCT00803712|26723566|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1|||
13373355|NCT00803712|26723567|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1|||
13373356|NCT00803634|26723600|FG000|Overall Study|Withdrew Consent|1|||
13373357|NCT00803634|26723601|FG001|Overall Study|Withdrew Consent|0|||
13373358|NCT00803634|26723600|FG000|Overall Study|Lost to Follow-up|2|||
13373359|NCT00803634|26723601|FG001|Overall Study|Lost to Follow-up|3|||
13373360|NCT00803634|26723600|FG000|Overall Study|Death|3|||
13373361|NCT00803634|26723601|FG001|Overall Study|Death|2|||
13373362|NCT00803595|26723622|FG000|Overall Study|Adverse Event|3|||
13373363|NCT00803595|26723623|FG001|Overall Study|Adverse Event|4|||
13373364|NCT00803595|26723624|FG002|Overall Study|Adverse Event|1|||
13373365|NCT00803595|26723622|FG000|Overall Study|Protocol Violation|7|||
13373366|NCT00803595|26723623|FG001|Overall Study|Protocol Violation|2|||
13373367|NCT00803595|26723624|FG002|Overall Study|Protocol Violation|12|||
13373368|NCT00803595|26723622|FG000|Overall Study|Withdrawal by Subject|5|||
13373369|NCT00803595|26723623|FG001|Overall Study|Withdrawal by Subject|2|||
13373370|NCT00803595|26723624|FG002|Overall Study|Withdrawal by Subject|3|||
13373371|NCT00803452|26723637|FG000|Overall Study|Adverse Event|0|||
13373372|NCT00803452|26723638|FG001|Overall Study|Adverse Event|2|||
13373373|NCT00803452|26723637|FG000|Overall Study|Lost to Follow-up|0|||
13373374|NCT00803452|26723638|FG001|Overall Study|Lost to Follow-up|3|||
13373375|NCT00803361|26723663|FG000|Overall Study|Adverse Event|13|||
13373376|NCT00803361|26723664|FG001|Overall Study|Adverse Event|3|||
13373377|NCT00803361|26723663|FG000|Overall Study|Lack of Efficacy|4|||
13373378|NCT00803361|26723664|FG001|Overall Study|Lack of Efficacy|13|||
13373379|NCT00803361|26723663|FG000|Overall Study|Lost to Follow-up|1|||
13373380|NCT00803361|26723664|FG001|Overall Study|Lost to Follow-up|2|||
13373381|NCT00803361|26723663|FG000|Overall Study|Physician Decision|1|||
13373382|NCT00803361|26723664|FG001|Overall Study|Physician Decision|0|||
13373383|NCT00803361|26723663|FG000|Overall Study|Protocol Violation|2|||
13373384|NCT00803361|26723664|FG001|Overall Study|Protocol Violation|4|||
13373385|NCT00803361|26723663|FG000|Overall Study|Withdrawal by Subject|5|||
13373386|NCT00803361|26723664|FG001|Overall Study|Withdrawal by Subject|6|||
13373387|NCT00803270|26723679|FG000|Overall Study|Lost to Follow-up|1|||
13373388|NCT00803270|26723680|FG001|Overall Study|Lost to Follow-up|2|||
13373389|NCT00803244|26723695|FG000|Overall Study|Adverse Event|1|||
13373390|NCT00803244|26723696|FG001|Overall Study|Adverse Event|2|||
13373391|NCT00803244|26723695|FG000|Overall Study|Withdrawal by Subject|2|||
13373392|NCT00803244|26723696|FG001|Overall Study|Withdrawal by Subject|3|||
13322024|NCT01178385|26570208|FG000|Overall Study|Withdrawal by Subject|2|||
13322025|NCT01178385|26570209|FG001|Overall Study|Withdrawal by Subject|0|||
13322026|NCT01178294|26570232|FG000|Overall Study|Adverse Event|4|||
13322027|NCT01178294|26570232|FG000|Overall Study|Lost to Follow-up|2|||
13322028|NCT01178294|26570232|FG000|Overall Study|Lack of Efficacy|1|||
13322029|NCT01178294|26570232|FG000|Overall Study|Death|1|||
13322030|NCT01178294|26570232|FG000|Overall Study|Development of inhibitors to OBI-1|1|||
13322031|NCT01178294|26570232|FG000|Overall Study|Subject status is terminal|1|||
13322032|NCT01178294|26570232|FG000|Overall Study|Completion status could not be verified|1|||
13322033|NCT01178138|26570255|FG000|Overall Study|Lost to Follow-up|8|||
13322034|NCT01178138|26570255|FG000|Overall Study|Withdrawal by Subject|7|||
13322035|NCT01178138|26570255|FG000|Overall Study|Physician Decision|8|||
13322036|NCT01178125|26570284|FG000|Overall Study|Lost to Follow-up|397|||
13322037|NCT01178125|26570284|FG000|Overall Study|Adverse Event|244|||
13322038|NCT01178125|26570284|FG000|Overall Study|Withdrawal by Subject|209|||
13322039|NCT01178125|26570284|FG000|Overall Study|Noncompliance|184|||
13322040|NCT01178125|26570284|FG000|Overall Study|Pregnancy|55|||
13322041|NCT01178125|26570284|FG000|Overall Study|Other Reason|39|||
13322042|NCT01178125|26570284|FG000|Overall Study|Sponsor Decision|28|||
13322043|NCT01178125|26570284|FG000|Overall Study|Protocol Violation|17|||
13322044|NCT01178125|26570284|FG000|Overall Study|Investigator Decision|5|||
13322045|NCT01178099|26570333|FG000|Overall Study|Physician Decision|0|||
13322046|NCT01178099|26570334|FG001|Overall Study|Physician Decision|1|||
13322047|NCT01178086|26570364|FG000|Overall Study|Participant refusal|7|||
13322048|NCT01178086|26570364|FG000|Overall Study|Physician Decision|44|||
13322049|NCT01178086|26570364|FG000|Overall Study|Switch to other CLL therapy|113|||
13322050|NCT01178086|26570364|FG000|Overall Study|Death|59|||
13322051|NCT01178086|26570364|FG000|Overall Study|Other unspecified|89|||
13322052|NCT01178086|26570364|FG000|Overall Study|Excluded from EAS|20|||
13322053|NCT01178073|26570403|FG000|Overall Study|Adverse Event|34|||
13322054|NCT01178073|26570404|FG001|Overall Study|Adverse Event|27|||
13322055|NCT01178073|26570405|FG002|Overall Study|Adverse Event|24|||
13322056|NCT01178073|26570403|FG000|Overall Study|Protocol Violation|1|||
13322057|NCT01178073|26570404|FG001|Overall Study|Protocol Violation|1|||
13322058|NCT01178073|26570405|FG002|Overall Study|Protocol Violation|1|||
13322059|NCT01178073|26570403|FG000|Overall Study|Lost to Follow-up|2|||
13322060|NCT01178073|26570404|FG001|Overall Study|Lost to Follow-up|0|||
13322061|NCT01178073|26570405|FG002|Overall Study|Lost to Follow-up|3|||
13322062|NCT01178073|26570403|FG000|Overall Study|Physician Decision|14|||
13322063|NCT01178073|26570404|FG001|Overall Study|Physician Decision|10|||
13322064|NCT01178073|26570405|FG002|Overall Study|Physician Decision|10|||
13322065|NCT01178073|26570403|FG000|Overall Study|Withdrawal by Subject|10|||
13322066|NCT01178073|26570404|FG001|Overall Study|Withdrawal by Subject|6|||
13322067|NCT01178073|26570405|FG002|Overall Study|Withdrawal by Subject|8|||
13322068|NCT01178073|26570403|FG000|Overall Study|Missing Completion Status|1|||
13322069|NCT01178073|26570404|FG001|Overall Study|Missing Completion Status|0|||
13322070|NCT01178073|26570405|FG002|Overall Study|Missing Completion Status|0|||
13322071|NCT01177969|26570420|FG000|Overall Study|Protocol Violation|2|||
13322072|NCT01177969|26570421|FG001|Overall Study|Protocol Violation|1|||
13322073|NCT01177969|26570420|FG000|Overall Study|Withdrawal by Subject|1|||
13322074|NCT01177969|26570421|FG001|Overall Study|Withdrawal by Subject|2|||
13322075|NCT01177943|26570436|FG000|First Intervention|Withdrawal by Subject|2|||
13322076|NCT01177943|26570437|FG001|First Intervention|Withdrawal by Subject|0|||
13322077|NCT01177813|26570480|FG000|Overall Study|Adverse Event|8|||
13322078|NCT01177813|26570481|FG001|Overall Study|Adverse Event|2|||
13322079|NCT01177813|26570482|FG002|Overall Study|Adverse Event|4|||
13322080|NCT01177813|26570483|FG003|Overall Study|Adverse Event|6|||
13322081|NCT01177813|26570484|FG004|Overall Study|Adverse Event|3|||
13322082|NCT01177813|26570480|FG000|Overall Study|Lack of Efficacy|1|||
13322083|NCT01177813|26570481|FG001|Overall Study|Lack of Efficacy|0|||
13322084|NCT01177813|26570482|FG002|Overall Study|Lack of Efficacy|0|||
13322085|NCT01177813|26570483|FG003|Overall Study|Lack of Efficacy|0|||
13322086|NCT01177813|26570484|FG004|Overall Study|Lack of Efficacy|0|||
13322087|NCT01177813|26570480|FG000|Overall Study|Protocol Violation|3|||
13322088|NCT01177813|26570481|FG001|Overall Study|Protocol Violation|2|||
13322089|NCT01177813|26570482|FG002|Overall Study|Protocol Violation|2|||
13322090|NCT01177813|26570483|FG003|Overall Study|Protocol Violation|0|||
13322091|NCT01177813|26570484|FG004|Overall Study|Protocol Violation|1|||
13322092|NCT01177813|26570480|FG000|Overall Study|Lost to Follow-up|12|||
13322093|NCT01177813|26570481|FG001|Overall Study|Lost to Follow-up|5|||
13322094|NCT01177813|26570482|FG002|Overall Study|Lost to Follow-up|6|||
13322095|NCT01177813|26570483|FG003|Overall Study|Lost to Follow-up|3|||
13322096|NCT01177813|26570484|FG004|Overall Study|Lost to Follow-up|0|||
13322097|NCT01177813|26570480|FG000|Overall Study|Withdrawal by Subject|12|||
13322098|NCT01177813|26570481|FG001|Overall Study|Withdrawal by Subject|7|||
13322099|NCT01177813|26570482|FG002|Overall Study|Withdrawal by Subject|6|||
13322100|NCT01177813|26570483|FG003|Overall Study|Withdrawal by Subject|5|||
13322101|NCT01177813|26570484|FG004|Overall Study|Withdrawal by Subject|3|||
13322102|NCT01177813|26570480|FG000|Overall Study|Other reason not defined above|5|||
13322103|NCT01177813|26570481|FG001|Overall Study|Other reason not defined above|2|||
13322104|NCT01177813|26570482|FG002|Overall Study|Other reason not defined above|2|||
13322105|NCT01177813|26570483|FG003|Overall Study|Other reason not defined above|3|||
13322106|NCT01177813|26570484|FG004|Overall Study|Other reason not defined above|2|||
13322107|NCT01177800|26570505|FG000|Overall Study|Adverse Event|9|||
13322108|NCT01177800|26570506|FG001|Overall Study|Adverse Event|3|||
13322109|NCT01177800|26570505|FG000|Overall Study|Protocol Violation|0|||
13322110|NCT01177800|26570506|FG001|Overall Study|Protocol Violation|1|||
13322111|NCT01177800|26570505|FG000|Overall Study|Physician Decision|1|||
13322112|NCT01177800|26570506|FG001|Overall Study|Physician Decision|0|||
13322113|NCT01177800|26570505|FG000|Overall Study|Withdrawal of informed consent|0|||
13322114|NCT01177800|26570506|FG001|Overall Study|Withdrawal of informed consent|1|||
13322115|NCT01177787|26570522|FG000|Cryolipolysis on Thigh|Protocol Violation|4|||
13322116|NCT01177787|26570522|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9|||
13322117|NCT01177787|26570522|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1|||
13322118|NCT01177722|26570561|FG000|Overall Study|Serious Adverse Event|0|||
13322119|NCT01177722|26570562|FG001|Overall Study|Serious Adverse Event|0|||
13322120|NCT01177722|26570563|FG002|Overall Study|Serious Adverse Event|1|||
13322121|NCT01177722|26570564|FG003|Overall Study|Serious Adverse Event|0|||
13322122|NCT01177722|26570561|FG000|Overall Study|Protocol Violation|0|||
13322123|NCT01177722|26570562|FG001|Overall Study|Protocol Violation|0|||
13322124|NCT01177722|26570563|FG002|Overall Study|Protocol Violation|1|||
13322125|NCT01177722|26570564|FG003|Overall Study|Protocol Violation|0|||
13322126|NCT01177722|26570561|FG000|Overall Study|Lost to Follow-up|3|||
13322127|NCT01177722|26570562|FG001|Overall Study|Lost to Follow-up|4|||
13322128|NCT01177722|26570563|FG002|Overall Study|Lost to Follow-up|3|||
13322129|NCT01177722|26570564|FG003|Overall Study|Lost to Follow-up|1|||
13322130|NCT01177722|26570561|FG000|Overall Study|Withdrawal by Subject|10|||
13322131|NCT01177722|26570562|FG001|Overall Study|Withdrawal by Subject|6|||
13322132|NCT01177722|26570563|FG002|Overall Study|Withdrawal by Subject|4|||
13322133|NCT01177722|26570564|FG003|Overall Study|Withdrawal by Subject|6|||
13322134|NCT01177670|26570571|FG000|Overall Study|Study Terminated|115|||
13322135|NCT01177670|26570571|FG000|Overall Study|Physician Decision|50|||
13322136|NCT01177670|26570571|FG000|Overall Study|Withdrawal by Subject|4|||
13322137|NCT01177553|26570584|FG000|Overall Study|babies not yet 6 months of age|1|||
13322138|NCT01177553|26570585|FG001|Overall Study|babies not yet 6 months of age|0|||
13322139|NCT01177540|26570612|FG000|Overall Study|Adverse Event|1|||
13322140|NCT01177540|26570613|FG001|Overall Study|Adverse Event|0|||
13322141|NCT01177410|26570634|FG000|Overall Study|Adverse Event|0|||
13322142|NCT01177410|26570635|FG001|Overall Study|Adverse Event|2|||
13322143|NCT01177410|26570636|FG002|Overall Study|Adverse Event|2|||
13322144|NCT01177410|26570634|FG000|Overall Study|Withdrawal by Subject|1|||
13322145|NCT01177410|26570635|FG001|Overall Study|Withdrawal by Subject|4|||
13322146|NCT01177410|26570636|FG002|Overall Study|Withdrawal by Subject|3|||
13322147|NCT01177410|26570634|FG000|Overall Study|Lost to Follow-up|0|||
13322148|NCT01177410|26570635|FG001|Overall Study|Lost to Follow-up|1|||
13322149|NCT01177410|26570636|FG002|Overall Study|Lost to Follow-up|0|||
13322150|NCT01177384|26570655|FG000|Overall Study|Adverse Event|6|||
13322151|NCT01177384|26570656|FG001|Overall Study|Adverse Event|4|||
13322152|NCT01177384|26570655|FG000|Overall Study|Lack of Efficacy|0|||
13322153|NCT01177384|26570656|FG001|Overall Study|Lack of Efficacy|1|||
13322154|NCT01177384|26570655|FG000|Overall Study|Lost to Follow-up|3|||
13322155|NCT01177384|26570656|FG001|Overall Study|Lost to Follow-up|4|||
13322156|NCT01177384|26570655|FG000|Overall Study|Physician Decision|0|||
13322157|NCT01177384|26570656|FG001|Overall Study|Physician Decision|3|||
13322158|NCT01177384|26570655|FG000|Overall Study|Protocol Violation|0|||
13322159|NCT01177384|26570656|FG001|Overall Study|Protocol Violation|2|||
13322160|NCT01177384|26570655|FG000|Overall Study|Withdrawal by Subject|5|||
13322161|NCT01177384|26570656|FG001|Overall Study|Withdrawal by Subject|12|||
13322162|NCT01177293|26570673|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0|||
13322163|NCT01177293|26570674|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1|||
13322164|NCT01177228|26570725|FG000|Overall Study|Positive tuberculosis test|0|||
13322165|NCT01177228|26570726|FG001|Overall Study|Positive tuberculosis test|1|||
13322166|NCT01177228|26570727|FG002|Overall Study|Positive tuberculosis test|0|||
13322167|NCT01177228|26570728|FG003|Overall Study|Positive tuberculosis test|0|||
13322168|NCT01177228|26570725|FG000|Overall Study|Worsening disease activity|1|||
13322169|NCT01177228|26570726|FG001|Overall Study|Worsening disease activity|0|||
13322170|NCT01177228|26570727|FG002|Overall Study|Worsening disease activity|0|||
13322171|NCT01177228|26570728|FG003|Overall Study|Worsening disease activity|0|||
13322172|NCT01177228|26570725|FG000|Overall Study|Withdrawal by Subject|0|||
13322173|NCT01177228|26570726|FG001|Overall Study|Withdrawal by Subject|1|||
13322174|NCT01177228|26570727|FG002|Overall Study|Withdrawal by Subject|0|||
13322175|NCT01177228|26570728|FG003|Overall Study|Withdrawal by Subject|0|||
13322176|NCT01177137|26570803|FG000|Overall Study|Withdrawal by Subject|10|||
13322177|NCT01177137|26570804|FG001|Overall Study|Withdrawal by Subject|10|||
13322178|NCT01177137|26570805|FG002|Overall Study|Withdrawal by Subject|2|||
13322179|NCT01177059|26570813|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30|||
13322180|NCT01177059|26570813|FG000|Overall Study|Withdrew consent|2|||
13322181|NCT01177059|26570813|FG000|Overall Study|Lost to Follow-up|18|||
13322182|NCT01177007|26570827|FG000|Overall Study|Lost to Follow-up|2|||
13322183|NCT01177007|26570827|FG000|Overall Study|Death|4|||
13322184|NCT01177007|26570827|FG000|Overall Study|Entered hospice care|5|||
13322185|NCT01177007|26570827|FG000|Overall Study|Required additional Y90 treatment|6|||
13322186|NCT01177007|26570827|FG000|Overall Study|Change in treatment modality|21|||
13322187|NCT01176968|26570866|FG000|Overall Study|Adverse Event|10|||
13322188|NCT01176968|26570867|FG001|Overall Study|Adverse Event|11|||
13322189|NCT01176968|26570866|FG000|Overall Study|Death|2|||
13322190|NCT01176968|26570867|FG001|Overall Study|Death|3|||
13322191|NCT01176968|26570866|FG000|Overall Study|Lack of Efficacy|0|||
13322192|NCT01176968|26570867|FG001|Overall Study|Lack of Efficacy|1|||
13322193|NCT01176968|26570866|FG000|Overall Study|Lost to Follow-up|16|||
13322194|NCT01176968|26570867|FG001|Overall Study|Lost to Follow-up|14|||
13322195|NCT01176968|26570866|FG000|Overall Study|Withdrawal by Subject|48|||
13322196|NCT01176968|26570867|FG001|Overall Study|Withdrawal by Subject|48|||
13322197|NCT01176968|26570866|FG000|Overall Study|Protocol Violation|2|||
13322198|NCT01176968|26570867|FG001|Overall Study|Protocol Violation|1|||
13322199|NCT01176968|26570866|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
13322200|NCT01176968|26570867|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
13322201|NCT01176968|26570866|FG000|Overall Study|Study terminated by sponsor|0|||
13322202|NCT01176968|26570867|FG001|Overall Study|Study terminated by sponsor|1|||
13322203|NCT01176968|26570866|FG000|Overall Study|Reason not defined|5|||
13322204|NCT01176968|26570867|FG001|Overall Study|Reason not defined|3|||
13322205|NCT01176916|26570879|FG000|Overall Study|Adverse Event|61|||
13322206|NCT01176916|26570879|FG000|Overall Study|Death|1|||
13322207|NCT01176916|26570879|FG000|Overall Study|Lost to Follow-up|15|||
13322208|NCT01176916|26570879|FG000|Overall Study|Objective progression or relapse|17|||
13322209|NCT01176916|26570879|FG000|Overall Study|Protocol Violation|24|||
13322210|NCT01176916|26570879|FG000|Overall Study|Withdrawal by Subject|37|||
13322211|NCT01176916|26570879|FG000|Overall Study|Other|6|||
13322212|NCT01176916|26570879|FG000|Overall Study|Withdrawal prior to Treatment|6|||
13322213|NCT01176773|26570890|FG000|Overall Study|Screen Failure|2|||
13322214|NCT01176773|26570890|FG000|Overall Study|Withdrew consent|1|||
13322215|NCT01176565|26570915|FG000|Overall Study|Lost to Follow-up|12|||
13322216|NCT01176565|26570916|FG001|Overall Study|Lost to Follow-up|16|||
13322217|NCT01176565|26570915|FG000|Overall Study|Withdrawal by Subject|7|||
13322218|NCT01176565|26570916|FG001|Overall Study|Withdrawal by Subject|1|||
13322219|NCT01176565|26570915|FG000|Overall Study|Not Analyzed (any other reason)|1|||
13322220|NCT01176565|26570916|FG001|Overall Study|Not Analyzed (any other reason)|2|||
13322221|NCT01176513|26570923|FG000|Overall Study|Withdrew subjects prior to dosing|3|||
13322222|NCT01176292|26570948|FG000|Overall Study|Lost to Follow-up|2|||
13322223|NCT01176292|26570949|FG001|Overall Study|Lost to Follow-up|4|||
13322224|NCT01176292|26570948|FG000|Overall Study|Adverse Event|1|||
13322225|NCT01176292|26570949|FG001|Overall Study|Adverse Event|1|||
13322226|NCT01176292|26570948|FG000|Overall Study|Physician Decision|0|||
13322227|NCT01176292|26570949|FG001|Overall Study|Physician Decision|2|||
13322228|NCT01176292|26570948|FG000|Overall Study|Has not scheduled one-year visit yet|2|||
13322229|NCT01176292|26570949|FG001|Overall Study|Has not scheduled one-year visit yet|2|||
13322230|NCT01176266|26570971|FG000|Overall Study|Death|6|||
13322231|NCT01176266|26570971|FG000|Overall Study|Withdrawal by Subject|3|||
13322232|NCT01176240|26571006|FG000|Study 306A|Lack of Efficacy|2|||
13322233|NCT01176240|26571007|FG001|Study 306A|Lack of Efficacy|1|||
13322234|NCT01176240|26571006|FG000|Study 306A|Protocol Violation|0|||
13322235|NCT01176240|26571007|FG001|Study 306A|Protocol Violation|1|||
13322236|NCT01176240|26571006|FG000|Study 306A|Withdrawal by Subject|0|||
13322237|NCT01176240|26571007|FG001|Study 306A|Withdrawal by Subject|1|||
13322238|NCT01176240|26571006|FG000|Study 306A|Stop due to diverse problems|1|||
13322239|NCT01176240|26571007|FG001|Study 306A|Stop due to diverse problems|0|||
13322240|NCT01176240|26571006|FG000|Study 306B|Lack of Efficacy|5|||
13322241|NCT01176240|26571007|FG001|Study 306B|Lack of Efficacy|3|||
13322242|NCT01176240|26571006|FG000|Study 306B|Adverse Event|10|||
13322243|NCT01176240|26571007|FG001|Study 306B|Adverse Event|5|||
13322244|NCT01176240|26571006|FG000|Study 306B|Protocol Violation|2|||
13322245|NCT01176240|26571007|FG001|Study 306B|Protocol Violation|3|||
13322246|NCT01176240|26571006|FG000|Study 306B|Withdrawal by Subject|4|||
13322247|NCT01176240|26571007|FG001|Study 306B|Withdrawal by Subject|1|||
13322248|NCT01176240|26571006|FG000|Study 306B|Physician Decision|2|||
13322249|NCT01176240|26571007|FG001|Study 306B|Physician Decision|1|||
13203963|NCT01978119|26226504|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
13322250|NCT01176240|26571006|FG000|Study 306B|Supine Hypertension|1|||
13322251|NCT01176240|26571007|FG001|Study 306B|Supine Hypertension|2|||
13322252|NCT01176240|26571006|FG000|Study 306B|Lost to Follow-up|0|||
13322253|NCT01176240|26571007|FG001|Study 306B|Lost to Follow-up|1|||
13322254|NCT01176240|26571006|FG000|Study 306B|withdrew prior to dosing|2|||
13322255|NCT01176240|26571007|FG001|Study 306B|withdrew prior to dosing|1|||
13322256|NCT01176058|26571036|FG000|Overall Study|Adverse Event|1|||
13322257|NCT01176058|26571037|FG001|Overall Study|Adverse Event|0|||
13322258|NCT01176058|26571036|FG000|Overall Study|Insufficient clinical response|2|||
13322259|NCT01176058|26571037|FG001|Overall Study|Insufficient clinical response|2|||
13322260|NCT01176058|26571036|FG000|Overall Study|Insufficient mycological response|0|||
13322261|NCT01176058|26571037|FG001|Overall Study|Insufficient mycological response|1|||
13322262|NCT01176058|26571036|FG000|Overall Study|Withdrawal by Subject|1|||
13322263|NCT01176058|26571037|FG001|Overall Study|Withdrawal by Subject|0|||
13322264|NCT01176032|26571102|FG000|Overall Study|Adverse Event|1|||
13322265|NCT01176032|26571103|FG001|Overall Study|Adverse Event|0|||
13322266|NCT01176032|26571102|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
13322267|NCT01176032|26571103|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
13322268|NCT01176032|26571102|FG000|Overall Study|Protocol Violation|1|||
13322269|NCT01176032|26571103|FG001|Overall Study|Protocol Violation|0|||
13322270|NCT01176032|26571102|FG000|Overall Study|Informed consent withdrawn|3|||
13322271|NCT01176032|26571103|FG001|Overall Study|Informed consent withdrawn|0|||
13322272|NCT01176032|26571102|FG000|Overall Study|Other|1|||
13322273|NCT01176032|26571103|FG001|Overall Study|Other|0|||
13322274|NCT01175824|26571142|FG000|Overall Study|Adverse Event|2|||
13322275|NCT01175824|26571143|FG001|Overall Study|Adverse Event|1|||
13322276|NCT01175824|26571142|FG000|Overall Study|Lack of Efficacy|2|||
13322277|NCT01175824|26571143|FG001|Overall Study|Lack of Efficacy|0|||
13322278|NCT01175824|26571142|FG000|Overall Study|Lost to Follow-up|0|||
13322279|NCT01175824|26571143|FG001|Overall Study|Lost to Follow-up|1|||
13322280|NCT01175824|26571142|FG000|Overall Study|Physician Decision|0|||
13322281|NCT01175824|26571143|FG001|Overall Study|Physician Decision|4|||
13322282|NCT01175824|26571142|FG000|Overall Study|Protocol Violation|2|||
13322283|NCT01175824|26571143|FG001|Overall Study|Protocol Violation|5|||
13322284|NCT01175824|26571142|FG000|Overall Study|Withdrawal by Subject|3|||
13322285|NCT01175824|26571143|FG001|Overall Study|Withdrawal by Subject|7|||
13322286|NCT01175824|26571142|FG000|Overall Study|Sponsor Decision|1|||
13322287|NCT01175824|26571143|FG001|Overall Study|Sponsor Decision|0|||
13322288|NCT01175824|26571142|FG000|Overall Study|Entry Criteria Not Met|6|||
13322289|NCT01175824|26571143|FG001|Overall Study|Entry Criteria Not Met|4|||
13322290|NCT01175811|26571174|FG000|Overall Study|Adverse Event|1|||
13322291|NCT01175811|26571175|FG001|Overall Study|Adverse Event|1|||
13322292|NCT01175811|26571174|FG000|Overall Study|Entry criteria not met|3|||
13322293|NCT01175811|26571175|FG001|Overall Study|Entry criteria not met|1|||
13322294|NCT01175811|26571174|FG000|Overall Study|Lack of Efficacy|1|||
13322295|NCT01175811|26571175|FG001|Overall Study|Lack of Efficacy|0|||
13322296|NCT01175811|26571174|FG000|Overall Study|Lost to Follow-up|3|||
13322297|NCT01175811|26571175|FG001|Overall Study|Lost to Follow-up|2|||
13322298|NCT01175811|26571174|FG000|Overall Study|Physician Decision|1|||
13322299|NCT01175811|26571175|FG001|Overall Study|Physician Decision|1|||
13322300|NCT01175811|26571174|FG000|Overall Study|Protocol Violation|1|||
13322301|NCT01175811|26571175|FG001|Overall Study|Protocol Violation|2|||
13322302|NCT01175811|26571174|FG000|Overall Study|Withdrawal by Subject|6|||
13322303|NCT01175811|26571175|FG001|Overall Study|Withdrawal by Subject|7|||
13322304|NCT01175707|26571216|FG000|Overall Study|Adverse Event|4|||
13322305|NCT01175707|26571217|FG001|Overall Study|Adverse Event|6|||
13322306|NCT01175668|26571232|FG000|Overall Study|Withdrawal by Subject|2|||
13322307|NCT01175668|26571233|FG001|Overall Study|Withdrawal by Subject|0|||
13322308|NCT01175590|26571272|FG000|Overall Study|Lost to Follow-up|1|||
13322309|NCT01175590|26571273|FG001|Overall Study|Lost to Follow-up|0|||
13322310|NCT01175590|26571272|FG000|Overall Study|Withdrawal by Subject|0|||
13322311|NCT01175590|26571273|FG001|Overall Study|Withdrawal by Subject|2|||
13322312|NCT01175590|26571272|FG000|Overall Study|Adverse Event|4|||
13322313|NCT01175590|26571273|FG001|Overall Study|Adverse Event|0|||
13322314|NCT01175590|26571272|FG000|Overall Study|Physician Decision|1|||
13322315|NCT01175590|26571273|FG001|Overall Study|Physician Decision|4|||
13322316|NCT01175590|26571272|FG000|Overall Study|Lack of Efficacy|1|||
13322317|NCT01175590|26571273|FG001|Overall Study|Lack of Efficacy|1|||
13322318|NCT01175590|26571272|FG000|Overall Study|Residual Bacterial Conjunctivitis|1|||
13322319|NCT01175590|26571273|FG001|Overall Study|Residual Bacterial Conjunctivitis|0|||
13322320|NCT01175590|26571272|FG000|Overall Study|Treated not as randomized|3|||
13322321|NCT01175590|26571273|FG001|Overall Study|Treated not as randomized|2|||
13322322|NCT01175590|26571272|FG000|Overall Study|Herpes Simplex Dermatitis|1|||
13322323|NCT01175590|26571273|FG001|Overall Study|Herpes Simplex Dermatitis|0|||
13322324|NCT01175590|26571272|FG000|Overall Study|Protocol Violation|0|||
13322325|NCT01175590|26571273|FG001|Overall Study|Protocol Violation|1|||
13322326|NCT01175473|26571304|FG000|Overall Study|Adverse Event|2|||
13322327|NCT01175473|26571305|FG001|Overall Study|Adverse Event|2|||
13322328|NCT01175382|26571392|FG000|Overall Study|Lost to Follow-up|4|||
13322329|NCT01175382|26571393|FG001|Overall Study|Lost to Follow-up|3|||
13322330|NCT01175382|26571394|FG002|Overall Study|Lost to Follow-up|1|||
13322331|NCT01175382|26571392|FG000|Overall Study|Physician Decision|0|||
13322332|NCT01175382|26571393|FG001|Overall Study|Physician Decision|1|||
13322333|NCT01175382|26571394|FG002|Overall Study|Physician Decision|0|||
13322334|NCT01175382|26571392|FG000|Overall Study|Withdrawal by Subject|0|||
13322335|NCT01175382|26571393|FG001|Overall Study|Withdrawal by Subject|0|||
13322336|NCT01175382|26571394|FG002|Overall Study|Withdrawal by Subject|1|||
13322337|NCT01175382|26571392|FG000|Overall Study|No longer having problem|1|||
13322338|NCT01175382|26571393|FG001|Overall Study|No longer having problem|0|||
13322339|NCT01175382|26571394|FG002|Overall Study|No longer having problem|1|||
13322340|NCT01175382|26571392|FG000|Overall Study|Unable/unwilling to attend visits|3|||
13322341|NCT01175382|26571393|FG001|Overall Study|Unable/unwilling to attend visits|1|||
13322342|NCT01175382|26571394|FG002|Overall Study|Unable/unwilling to attend visits|2|||
13322343|NCT01175382|26571392|FG000|Overall Study|Unwilling to follow protocol|0|||
13322344|NCT01175382|26571393|FG001|Overall Study|Unwilling to follow protocol|1|||
13322345|NCT01175382|26571394|FG002|Overall Study|Unwilling to follow protocol|0|||
13322346|NCT01175382|26571392|FG000|Overall Study|Unable to tolerate study meds|0|||
13322347|NCT01175382|26571393|FG001|Overall Study|Unable to tolerate study meds|1|||
13322348|NCT01175382|26571394|FG002|Overall Study|Unable to tolerate study meds|1|||
13322349|NCT01175213|26571450|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4|||
13322350|NCT01175213|26571451|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0|||
13322351|NCT01175213|26571450|FG000|IGSC, 10%/rHuPH20|Death|1|||
13322352|NCT01175213|26571451|FG001|IGSC, 10%/rHuPH20|Death|0|||
13322353|NCT01175213|26571450|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1|||
13322354|NCT01175213|26571451|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0|||
13322355|NCT01175213|26571450|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6|||
13322356|NCT01175213|26571451|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0|||
13322357|NCT01175213|26571450|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3|||
13322358|NCT01175213|26571451|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0|||
13322359|NCT01175213|26571450|FG000|Safety Follow-up|Adverse Event|1|||
13322360|NCT01175213|26571451|FG001|Safety Follow-up|Adverse Event|0|||
13322361|NCT01175135|26571546|FG000|Overall Study|Adverse Event|2|||
13322362|NCT01175135|26571547|FG001|Overall Study|Adverse Event|5|||
13322363|NCT01175135|26571548|FG002|Overall Study|Adverse Event|3|||
13322364|NCT01175135|26571549|FG003|Overall Study|Adverse Event|4|||
13322365|NCT01175135|26571546|FG000|Overall Study|Death|1|||
13322366|NCT01175135|26571547|FG001|Overall Study|Death|0|||
13322367|NCT01175135|26571548|FG002|Overall Study|Death|0|||
13322368|NCT01175135|26571549|FG003|Overall Study|Death|0|||
13322369|NCT01175135|26571546|FG000|Overall Study|Lack of Efficacy|4|||
13322370|NCT01175135|26571547|FG001|Overall Study|Lack of Efficacy|5|||
13322371|NCT01175135|26571548|FG002|Overall Study|Lack of Efficacy|0|||
13322372|NCT01175135|26571549|FG003|Overall Study|Lack of Efficacy|5|||
13322373|NCT01175135|26571546|FG000|Overall Study|Lost to Follow-up|1|||
13322374|NCT01175135|26571547|FG001|Overall Study|Lost to Follow-up|2|||
13322375|NCT01175135|26571548|FG002|Overall Study|Lost to Follow-up|0|||
13322376|NCT01175135|26571549|FG003|Overall Study|Lost to Follow-up|0|||
13322377|NCT01175135|26571546|FG000|Overall Study|Protocol Violation|1|||
13322378|NCT01175135|26571547|FG001|Overall Study|Protocol Violation|1|||
13322379|NCT01175135|26571548|FG002|Overall Study|Protocol Violation|0|||
13322380|NCT01175135|26571549|FG003|Overall Study|Protocol Violation|0|||
13322381|NCT01175135|26571546|FG000|Overall Study|Withdrawal by Subject|4|||
13322382|NCT01175135|26571547|FG001|Overall Study|Withdrawal by Subject|8|||
13322383|NCT01175135|26571548|FG002|Overall Study|Withdrawal by Subject|5|||
13322384|NCT01175135|26571549|FG003|Overall Study|Withdrawal by Subject|5|||
13322385|NCT01175135|26571546|FG000|Overall Study|Other|3|||
13322386|NCT01175135|26571547|FG001|Overall Study|Other|1|||
13322387|NCT01175135|26571548|FG002|Overall Study|Other|3|||
13322388|NCT01175135|26571549|FG003|Overall Study|Other|0|||
13322389|NCT01175135|26571546|FG000|Overall Study|Randomized But Not Treated|0|||
13322390|NCT01175135|26571547|FG001|Overall Study|Randomized But Not Treated|0|||
13322391|NCT01175135|26571548|FG002|Overall Study|Randomized But Not Treated|1|||
13322392|NCT01175135|26571549|FG003|Overall Study|Randomized But Not Treated|0|||
13322393|NCT01175083|26571650|FG000|Primary Epoch|Withdrawal by Subject|0|||
13322394|NCT01175083|26571651|FG001|Primary Epoch|Withdrawal by Subject|0|||
13322395|NCT01175083|26571652|FG002|Primary Epoch|Withdrawal by Subject|0|||
13322396|NCT01175083|26571653|FG003|Primary Epoch|Withdrawal by Subject|0|||
13322397|NCT01175083|26571654|FG004|Primary Epoch|Withdrawal by Subject|0|||
13322398|NCT01175083|26571655|FG005|Primary Epoch|Withdrawal by Subject|2|||
13322399|NCT01175083|26571650|FG000|Primary Epoch|Lost to Follow-up|0|||
13322400|NCT01175083|26571651|FG001|Primary Epoch|Lost to Follow-up|0|||
13322401|NCT01175083|26571652|FG002|Primary Epoch|Lost to Follow-up|0|||
13322402|NCT01175083|26571653|FG003|Primary Epoch|Lost to Follow-up|0|||
13322403|NCT01175083|26571654|FG004|Primary Epoch|Lost to Follow-up|0|||
13322404|NCT01175083|26571655|FG005|Primary Epoch|Lost to Follow-up|1|||
13322405|NCT01175083|26571650|FG000|Booster Epoch|Death|0|||
13322406|NCT01175083|26571651|FG001|Booster Epoch|Death|0|||
13322407|NCT01175083|26571652|FG002|Booster Epoch|Death|1|||
13322408|NCT01175083|26571653|FG003|Booster Epoch|Death|0|||
13322409|NCT01175083|26571654|FG004|Booster Epoch|Death|0|||
13322410|NCT01175083|26571655|FG005|Booster Epoch|Death|0|||
13322411|NCT01175083|26571650|FG000|Booster Epoch|Withdrawal by Subject|0|||
13322412|NCT01175083|26571651|FG001|Booster Epoch|Withdrawal by Subject|0|||
13322413|NCT01175083|26571652|FG002|Booster Epoch|Withdrawal by Subject|0|||
13322414|NCT01175083|26571653|FG003|Booster Epoch|Withdrawal by Subject|1|||
13322415|NCT01175083|26571654|FG004|Booster Epoch|Withdrawal by Subject|0|||
13322416|NCT01175083|26571655|FG005|Booster Epoch|Withdrawal by Subject|0|||
13322417|NCT01175018|26571698|FG000|Overall Study|Adverse Event|3|||
13322418|NCT01175018|26571699|FG001|Overall Study|Adverse Event|1|||
13322419|NCT01174784|26571706|FG000|Overall Study|Screen fails|4|||
13322420|NCT01174563|26571714|FG000|Overall Study|Progressive Disease|45|||
13322421|NCT01174563|26571714|FG000|Overall Study|Death|5|||
13322422|NCT01174563|26571714|FG000|Overall Study|Investigator's Discretion|5|||
13322423|NCT01174563|26571714|FG000|Overall Study|Participant Withdrew Consent|3|||
13322424|NCT01174563|26571714|FG000|Overall Study|Rash Adverse Event|1|||
13322425|NCT01174563|26571714|FG000|Overall Study|Sponsor's decision|1|||
13322426|NCT01174550|26571749|FG000|Overall Study|Death|75|||
13322427|NCT01174550|26571750|FG001|Overall Study|Death|74|||
13322428|NCT01174550|26571749|FG000|Overall Study|Lost to Follow-up|652|||
13322429|NCT01174550|26571750|FG001|Overall Study|Lost to Follow-up|510|||
13322430|NCT01174550|26571749|FG000|Overall Study|Withdrawal by Subject|543|||
13322431|NCT01174550|26571750|FG001|Overall Study|Withdrawal by Subject|289|||
13322432|NCT01174459|26571757|FG000|Overall Study|case report form (CRF) not collected|5|||
13322433|NCT01174446|26571949|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
13322434|NCT01174446|26571950|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
13322435|NCT01174446|26571951|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1|||
13322436|NCT01174446|26571952|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
13322437|NCT01174446|26571949|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
13322438|NCT01174446|26571950|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
13322439|NCT01174446|26571951|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1|||
13322440|NCT01174446|26571952|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
13322441|NCT01174446|26571949|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1|||
13322442|NCT01174446|26571950|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
13322443|NCT01174446|26571951|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
13322444|NCT01174446|26571952|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
13322445|NCT01174446|26571949|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
13322446|NCT01174446|26571950|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1|||
13322447|NCT01174446|26571951|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
13322448|NCT01174446|26571952|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
13322449|NCT01174368|26571960|FG000|Overall Study|Withdrawal by Subject|1|||
13322450|NCT01174342|26571966|FG000|Overall Study|Conversion to cesarean section|4|||
13322451|NCT01174264|26572008|FG000|Single Dose Pharmacokinetics|Early progressive disease|1|||
13322452|NCT01174264|26572009|FG001|Single Dose Pharmacokinetics|Early progressive disease|0|||
13322453|NCT01174264|26572010|FG002|Single Dose Pharmacokinetics|Early progressive disease|1|||
13322454|NCT01174264|26572008|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
13322455|NCT01174264|26572009|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
13322456|NCT01174264|26572010|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1|||
13322457|NCT01174264|26572008|FG000|Steady-state Pharmacokinetics|Not evaluable|6|||
13322458|NCT01174264|26572009|FG001|Steady-state Pharmacokinetics|Not evaluable|0|||
13322459|NCT01174264|26572010|FG002|Steady-state Pharmacokinetics|Not evaluable|2|||
13322460|NCT01174238|26572021|FG000|Overall Study|Lost to Follow-up|2|||
13322461|NCT01174186|26572035|FG000|Overall Study|Lost to Follow-up|0|||
13322462|NCT01174186|26572036|FG001|Overall Study|Lost to Follow-up|1|||
13322463|NCT01174186|26572035|FG000|Overall Study|Withdrawal by Subject|0|||
13322464|NCT01174186|26572036|FG001|Overall Study|Withdrawal by Subject|2|||
13322465|NCT01174173|26572047|FG000|Overall Study|drug-drug interaction|1|||
13322466|NCT01174160|26572060|FG000|Overall Study|Adverse Event|1|||
13322467|NCT01174160|26572061|FG001|Overall Study|Adverse Event|0|||
13322468|NCT01174160|26572060|FG000|Overall Study|Lost to Follow-up|1|||
13322469|NCT01174160|26572061|FG001|Overall Study|Lost to Follow-up|0|||
13322470|NCT01174160|26572060|FG000|Overall Study|Physician Decision|1|||
13322471|NCT01174160|26572061|FG001|Overall Study|Physician Decision|0|||
13322472|NCT01174160|26572060|FG000|Overall Study|Protocol Violation|4|||
13322473|NCT01174160|26572061|FG001|Overall Study|Protocol Violation|6|||
13322474|NCT01174160|26572060|FG000|Overall Study|Withdrawal by Subject|1|||
13322475|NCT01174160|26572061|FG001|Overall Study|Withdrawal by Subject|0|||
13322476|NCT01174043|26572069|FG000|Overall Study|Disease progression|5|||
13322477|NCT01174043|26572069|FG000|Overall Study|Adverse Event|3|||
13322478|NCT01174043|26572069|FG000|Overall Study|Death|1|||
13322479|NCT01174043|26572069|FG000|Overall Study|Withdrawal by Subject|2|||
13322480|NCT01174004|26572084|FG000|Overall Study|Adverse Event|2|||
13322481|NCT01174004|26572085|FG001|Overall Study|Adverse Event|10|||
13322482|NCT01174004|26572084|FG000|Overall Study|Withdrawal by Subject|2|||
13322483|NCT01174004|26572085|FG001|Overall Study|Withdrawal by Subject|3|||
13322484|NCT01174004|26572084|FG000|Overall Study|At Discretion of Sponsor|2|||
13322485|NCT01174004|26572085|FG001|Overall Study|At Discretion of Sponsor|2|||
13322486|NCT01174004|26572084|FG000|Overall Study|Protocol Violation|0|||
13322487|NCT01174004|26572085|FG001|Overall Study|Protocol Violation|1|||
13322488|NCT01174004|26572084|FG000|Overall Study|Physician Decision|1|||
13322489|NCT01174004|26572085|FG001|Overall Study|Physician Decision|0|||
13322490|NCT01173718|26572096|FG000|Overall Study|Death|17|||
13322491|NCT01173718|26572096|FG000|Overall Study|Abandonment of study graft|27|||
13322492|NCT01173692|26572109|FG000|Overall Study|Adverse Event|1|||
13322493|NCT01173692|26572110|FG001|Overall Study|Adverse Event|2|||
13322494|NCT01173692|26572109|FG000|Overall Study|Withdrawal by Subject|1|||
13322495|NCT01173692|26572110|FG001|Overall Study|Withdrawal by Subject|3|||
13322496|NCT01173679|26572118|FG000|Overall Study|Death|1|||
13322497|NCT01173653|26572131|FG000|Overall Study|Pts unwilling to provide follow-up|53|||
13322498|NCT01173653|26572132|FG001|Overall Study|Pts unwilling to provide follow-up|41|||
13322499|NCT01173601|26572221|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23|||
13322500|NCT01173601|26572222|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
13322501|NCT01173601|26572223|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
13322502|NCT01173601|26572224|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
13322503|NCT01173601|26572225|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
13322504|NCT01173601|26572221|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9|||
13322505|NCT01173601|26572222|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
13322506|NCT01173601|26572223|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
13322507|NCT01173601|26572224|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
13322508|NCT01173601|26572225|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
13322509|NCT01173601|26572221|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7|||
13322510|NCT01173601|26572222|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
13322511|NCT01173601|26572223|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
13322512|NCT01173601|26572224|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
13322513|NCT01173601|26572225|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
13322514|NCT01173601|26572221|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3|||
13322515|NCT01173601|26572222|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
13322516|NCT01173601|26572223|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
13322517|NCT01173601|26572224|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
13322518|NCT01173601|26572225|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
13322519|NCT01173601|26572221|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15|||
13322520|NCT01173601|26572222|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
13322521|NCT01173601|26572223|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
13322522|NCT01173601|26572224|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
13322523|NCT01173601|26572225|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
13322524|NCT01173601|26572221|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25|||
13322525|NCT01173601|26572222|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
13322526|NCT01173601|26572223|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
13322527|NCT01173601|26572224|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
13322528|NCT01173601|26572225|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
13322529|NCT01173601|26572221|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6|||
13322530|NCT01173601|26572222|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
13322531|NCT01173601|26572223|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
13322532|NCT01173601|26572224|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
13322533|NCT01173601|26572225|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
13322534|NCT01173601|26572221|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
13322535|NCT01173601|26572222|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10|||
13322536|NCT01173601|26572223|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15|||
13322537|NCT01173601|26572224|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7|||
13322538|NCT01173601|26572225|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14|||
13322539|NCT01173601|26572221|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
13322540|NCT01173601|26572222|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10|||
13322541|NCT01173601|26572223|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6|||
13322542|NCT01173601|26572224|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
13322543|NCT01173601|26572225|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9|||
13322544|NCT01173601|26572221|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
13322545|NCT01173601|26572222|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
13322546|NCT01173601|26572223|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
13322547|NCT01173601|26572224|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
13322548|NCT01173601|26572225|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
13322549|NCT01173601|26572221|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
13322550|NCT01173601|26572222|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
13322551|NCT01173601|26572223|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
13322552|NCT01173601|26572224|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
13322553|NCT01173601|26572225|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
13322554|NCT01173601|26572221|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
13322555|NCT01173601|26572222|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1|||
13322556|NCT01173601|26572223|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
13322557|NCT01173601|26572224|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4|||
13322558|NCT01173601|26572225|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
13322559|NCT01173601|26572221|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
13322560|NCT01173601|26572222|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
13322561|NCT01173601|26572223|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7|||
13322562|NCT01173601|26572224|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5|||
13322563|NCT01173601|26572225|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
13322564|NCT01173601|26572221|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
13322565|NCT01173601|26572222|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
13322566|NCT01173601|26572223|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
13322567|NCT01173601|26572224|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
13322568|NCT01173601|26572225|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6|||
13322569|NCT01173523|26572244|FG000|Overall Study|Clinical Progression|1|||
13322570|NCT01173523|26572245|FG001|Overall Study|Clinical Progression|1|||
13322571|NCT01173523|26572244|FG000|Overall Study|Progressive Disease|10|||
13322572|NCT01173523|26572245|FG001|Overall Study|Progressive Disease|8|||
13322573|NCT01173523|26572244|FG000|Overall Study|Other|2|||
13322574|NCT01173523|26572245|FG001|Overall Study|Other|3|||
13322575|NCT01173471|26572276|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
13322576|NCT01173471|26572277|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
13322577|NCT01173471|26572278|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
13322578|NCT01173471|26572279|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
13322579|NCT01173471|26572276|FG000|Overall Study|Condition under investigation worsened|2|||
13322580|NCT01173471|26572277|FG001|Overall Study|Condition under investigation worsened|0|||
13322581|NCT01173471|26572278|FG002|Overall Study|Condition under investigation worsened|0|||
13322582|NCT01173471|26572279|FG003|Overall Study|Condition under investigation worsened|0|||
13322583|NCT01173471|26572276|FG000|Overall Study|Lost to Follow-up|0|||
13322584|NCT01173471|26572277|FG001|Overall Study|Lost to Follow-up|0|||
13322585|NCT01173471|26572278|FG002|Overall Study|Lost to Follow-up|1|||
13322586|NCT01173471|26572279|FG003|Overall Study|Lost to Follow-up|0|||
13322587|NCT01173471|26572276|FG000|Overall Study|Reason given as Other|0|||
13322588|NCT01173471|26572277|FG001|Overall Study|Reason given as Other|0|||
13322589|NCT01173471|26572278|FG002|Overall Study|Reason given as Other|1|||
13322590|NCT01173471|26572279|FG003|Overall Study|Reason given as Other|0|||
13322591|NCT01173120|26572297|FG000|Overall Study|Lack of Efficacy|2|||
13322592|NCT01173120|26572297|FG000|Overall Study|Lost to Follow-up|1|||
13322593|NCT01173120|26572297|FG000|Overall Study|Participant Decision|2|||
13322594|NCT01173120|26572297|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33|||
13322595|NCT01173120|26572297|FG000|Overall Study|Switch-Participant Decision|12|||
13322596|NCT01173120|26572297|FG000|Overall Study|Switch-Difficulty With Device|12|||
13322597|NCT01173055|26572320|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
13322598|NCT01173055|26572321|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
13322599|NCT01173055|26572320|FG000|Period 2 - Day 64 to 112|Adverse Event|0|||
13322600|NCT01173055|26572321|FG001|Period 2 - Day 64 to 112|Adverse Event|1|||
13322601|NCT01172938|26572521|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11|||
13322602|NCT01172938|26572522|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8|||
13322603|NCT01172938|26572523|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10|||
13322604|NCT01172938|26572524|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
13322605|NCT01172938|26572525|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
13322606|NCT01172938|26572526|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
13322607|NCT01172938|26572527|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
13322608|NCT01172938|26572528|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
13322609|NCT01172938|26572529|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
13322610|NCT01172938|26572521|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
13322611|NCT01172938|26572522|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
13322612|NCT01172938|26572523|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
13322613|NCT01172938|26572524|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
13322614|NCT01172938|26572525|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
13322615|NCT01172938|26572526|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
13322616|NCT01172938|26572527|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
13322617|NCT01172938|26572528|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
13322618|NCT01172938|26572529|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
13322619|NCT01172938|26572521|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
13322620|NCT01172938|26572522|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
13322621|NCT01172938|26572523|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2|||
13322622|NCT01172938|26572524|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
13322623|NCT01172938|26572525|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
13322624|NCT01172938|26572526|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
13322625|NCT01172938|26572527|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
13322626|NCT01172938|26572528|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
13322627|NCT01172938|26572529|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
13322628|NCT01172938|26572521|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2|||
13322629|NCT01172938|26572522|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
13322630|NCT01172938|26572523|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
13322631|NCT01172938|26572524|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
13322632|NCT01172938|26572525|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
13322633|NCT01172938|26572526|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
13322634|NCT01172938|26572527|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
13322635|NCT01172938|26572528|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
13322636|NCT01172938|26572529|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
13322637|NCT01172938|26572521|FG000|Placebo-controlled Phase (Week 0-24)|Death|0|||
13322638|NCT01172938|26572522|FG001|Placebo-controlled Phase (Week 0-24)|Death|1|||
13322639|NCT01172938|26572523|FG002|Placebo-controlled Phase (Week 0-24)|Death|0|||
13322640|NCT01172938|26572524|FG003|Placebo-controlled Phase (Week 0-24)|Death|0|||
13322641|NCT01172938|26572525|FG004|Placebo-controlled Phase (Week 0-24)|Death|0|||
13322642|NCT01172938|26572526|FG005|Placebo-controlled Phase (Week 0-24)|Death|0|||
13322643|NCT01172938|26572527|FG006|Placebo-controlled Phase (Week 0-24)|Death|0|||
13322644|NCT01172938|26572528|FG007|Placebo-controlled Phase (Week 0-24)|Death|0|||
13322645|NCT01172938|26572529|FG008|Placebo-controlled Phase (Week 0-24)|Death|0|||
13322646|NCT01172938|26572521|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1|||
13322647|NCT01172938|26572522|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
13322648|NCT01172938|26572523|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
13322649|NCT01172938|26572524|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
13322650|NCT01172938|26572525|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
13322651|NCT01172938|26572526|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
13322652|NCT01172938|26572527|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
13322653|NCT01172938|26572528|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
13322654|NCT01172938|26572529|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
13322655|NCT01172938|26572521|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
13322656|NCT01172938|26572522|FG001|Placebo-controlled Phase (Week 0-24)|Other|2|||
13322657|NCT01172938|26572523|FG002|Placebo-controlled Phase (Week 0-24)|Other|1|||
13322658|NCT01172938|26572524|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
13322659|NCT01172938|26572525|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
13322660|NCT01172938|26572526|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
13322661|NCT01172938|26572527|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
13322662|NCT01172938|26572528|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
13322663|NCT01172938|26572529|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
13322664|NCT01172938|26572521|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
13322665|NCT01172938|26572522|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
13322666|NCT01172938|26572523|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5|||
13322667|NCT01172938|26572524|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
13322668|NCT01172938|26572525|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
13322669|NCT01172938|26572526|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
13322670|NCT01172938|26572527|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
13322671|NCT01172938|26572528|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
13322672|NCT01172938|26572529|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
13322673|NCT01172938|26572521|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
13322674|NCT01172938|26572522|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4|||
13322675|NCT01172938|26572523|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7|||
13322676|NCT01172938|26572524|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
13322677|NCT01172938|26572525|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1|||
13322678|NCT01172938|26572526|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
13322679|NCT01172938|26572527|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
13322680|NCT01172938|26572528|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
13322681|NCT01172938|26572529|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
13322682|NCT01172938|26572521|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
13322683|NCT01172938|26572522|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
13322684|NCT01172938|26572523|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1|||
13322685|NCT01172938|26572524|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
13322686|NCT01172938|26572525|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
13322687|NCT01172938|26572526|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
13322688|NCT01172938|26572527|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
13322689|NCT01172938|26572528|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
13322690|NCT01172938|26572529|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
13322691|NCT01172938|26572521|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
13322692|NCT01172938|26572522|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5|||
13322693|NCT01172938|26572523|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
13322694|NCT01172938|26572524|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
13322695|NCT01172938|26572525|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
13322696|NCT01172938|26572526|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9|||
13322697|NCT01172938|26572527|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
13322698|NCT01172938|26572528|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
13322699|NCT01172938|26572529|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
13322700|NCT01172938|26572521|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
13322701|NCT01172938|26572522|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
13322702|NCT01172938|26572523|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
13322703|NCT01172938|26572524|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
13322704|NCT01172938|26572525|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
13322705|NCT01172938|26572526|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
13322706|NCT01172938|26572527|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
13322707|NCT01172938|26572528|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
13322708|NCT01172938|26572529|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
13322709|NCT01172938|26572521|FG000|Active Treatment Phase (Weeks 25-52)|Other|0|||
13322710|NCT01172938|26572522|FG001|Active Treatment Phase (Weeks 25-52)|Other|0|||
13322711|NCT01172938|26572523|FG002|Active Treatment Phase (Weeks 25-52)|Other|0|||
13322712|NCT01172938|26572524|FG003|Active Treatment Phase (Weeks 25-52)|Other|0|||
13322713|NCT01172938|26572525|FG004|Active Treatment Phase (Weeks 25-52)|Other|0|||
13322714|NCT01172938|26572526|FG005|Active Treatment Phase (Weeks 25-52)|Other|1|||
13322715|NCT01172938|26572527|FG006|Active Treatment Phase (Weeks 25-52)|Other|1|||
13322716|NCT01172938|26572528|FG007|Active Treatment Phase (Weeks 25-52)|Other|0|||
13322717|NCT01172938|26572529|FG008|Active Treatment Phase (Weeks 25-52)|Other|0|||
13322718|NCT01172938|26572521|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
13322719|NCT01172938|26572522|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2|||
13322720|NCT01172938|26572523|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
13322721|NCT01172938|26572524|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
13322722|NCT01172938|26572525|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
13322723|NCT01172938|26572526|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
13322724|NCT01172938|26572527|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
13322725|NCT01172938|26572528|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3|||
13322726|NCT01172938|26572529|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
13322727|NCT01172938|26572521|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
13322728|NCT01172938|26572522|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7|||
13322729|NCT01172938|26572523|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8|||
13322730|NCT01172938|26572524|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
13322731|NCT01172938|26572525|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
13322732|NCT01172938|26572526|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
13322733|NCT01172938|26572527|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
13322734|NCT01172938|26572528|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4|||
13322735|NCT01172938|26572529|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
13322736|NCT01172938|26572521|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
13322737|NCT01172938|26572522|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
13322738|NCT01172938|26572523|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2|||
13322739|NCT01172938|26572524|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
13322740|NCT01172938|26572525|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
13322741|NCT01172938|26572526|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
13322742|NCT01172938|26572527|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
13322743|NCT01172938|26572528|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
13322744|NCT01172938|26572529|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
13322745|NCT01172938|26572521|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
13322746|NCT01172938|26572522|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10|||
13322747|NCT01172938|26572523|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8|||
13322748|NCT01172938|26572524|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
13322749|NCT01172938|26572525|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
13322750|NCT01172938|26572526|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
13322751|NCT01172938|26572527|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
13322752|NCT01172938|26572528|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5|||
13322753|NCT01172938|26572529|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2|||
13322754|NCT01172938|26572521|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0|||
13322755|NCT01172938|26572522|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0|||
13322756|NCT01172938|26572523|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1|||
13322757|NCT01172938|26572524|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0|||
13322758|NCT01172938|26572525|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0|||
13322759|NCT01172938|26572526|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0|||
13322760|NCT01172938|26572527|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0|||
13322761|NCT01172938|26572528|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0|||
13322762|NCT01172938|26572529|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0|||
13122295|NCT02966353|25946654|FG000|Overall Study|Progressive disease|2|||
13122296|NCT02966353|25946654|FG000|Overall Study|Protocol deviation|2|||
13122297|NCT02966340|25946665|FG000|Overall Study|Adverse Event|0|||
13322763|NCT01172938|26572521|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
13322764|NCT01172938|26572522|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
13322765|NCT01172938|26572523|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
13322766|NCT01172938|26572524|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
13322767|NCT01172938|26572525|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
13322768|NCT01172938|26572526|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
13322769|NCT01172938|26572527|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
13322770|NCT01172938|26572528|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3|||
13322771|NCT01172938|26572529|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
13322772|NCT01172938|26572521|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
13322773|NCT01172938|26572522|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2|||
13322774|NCT01172938|26572523|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
13322775|NCT01172938|26572524|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
13322776|NCT01172938|26572525|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
13322777|NCT01172938|26572526|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
13322778|NCT01172938|26572527|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
13322779|NCT01172938|26572528|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
13322780|NCT01172938|26572529|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1|||
13322781|NCT01172938|26572521|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
13322782|NCT01172938|26572522|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1|||
13322783|NCT01172938|26572523|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
13322784|NCT01172938|26572524|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
13322785|NCT01172938|26572525|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
13322786|NCT01172938|26572526|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
13322787|NCT01172938|26572527|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
13322788|NCT01172938|26572528|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
13322789|NCT01172938|26572529|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
13322790|NCT01172938|26572521|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
13322791|NCT01172938|26572522|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
13322792|NCT01172938|26572523|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
13322793|NCT01172938|26572524|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
13322794|NCT01172938|26572525|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
13322795|NCT01172938|26572526|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
13322796|NCT01172938|26572527|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
13322797|NCT01172938|26572528|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
13322798|NCT01172938|26572529|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1|||
13322799|NCT01172938|26572521|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
13322800|NCT01172938|26572522|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4|||
13322801|NCT01172938|26572523|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
13322802|NCT01172938|26572524|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
13322803|NCT01172938|26572525|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
13322804|NCT01172938|26572526|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
13322805|NCT01172938|26572527|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
13322806|NCT01172938|26572528|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
13322807|NCT01172938|26572529|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
13322808|NCT01172938|26572521|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
13322809|NCT01172938|26572522|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6|||
13322810|NCT01172938|26572523|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3|||
13322811|NCT01172938|26572524|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
13322812|NCT01172938|26572525|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
13322813|NCT01172938|26572526|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
13322814|NCT01172938|26572527|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
13322815|NCT01172938|26572528|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2|||
13322816|NCT01172938|26572529|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1|||
13322817|NCT01172938|26572521|FG000|Active-Treatment Phase Weeks (104-156)|Death|0|||
13322818|NCT01172938|26572522|FG001|Active-Treatment Phase Weeks (104-156)|Death|0|||
13322819|NCT01172938|26572523|FG002|Active-Treatment Phase Weeks (104-156)|Death|0|||
13322820|NCT01172938|26572524|FG003|Active-Treatment Phase Weeks (104-156)|Death|0|||
13322821|NCT01172938|26572525|FG004|Active-Treatment Phase Weeks (104-156)|Death|0|||
13322822|NCT01172938|26572526|FG005|Active-Treatment Phase Weeks (104-156)|Death|0|||
13322823|NCT01172938|26572527|FG006|Active-Treatment Phase Weeks (104-156)|Death|0|||
13322824|NCT01172938|26572528|FG007|Active-Treatment Phase Weeks (104-156)|Death|1|||
13322825|NCT01172938|26572529|FG008|Active-Treatment Phase Weeks (104-156)|Death|0|||
13322826|NCT01172938|26572521|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
13322827|NCT01172938|26572522|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1|||
13322828|NCT01172938|26572523|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
13322829|NCT01172938|26572524|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
13322830|NCT01172938|26572525|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
13322831|NCT01172938|26572526|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
13322832|NCT01172938|26572527|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
13322833|NCT01172938|26572528|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
13322834|NCT01172938|26572529|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
13322835|NCT01172938|26572521|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
13322836|NCT01172938|26572522|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
13322837|NCT01172938|26572523|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2|||
13322838|NCT01172938|26572524|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
13322839|NCT01172938|26572525|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
13322840|NCT01172938|26572526|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
13322841|NCT01172938|26572527|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
13322842|NCT01172938|26572528|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
13322843|NCT01172938|26572529|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
13322844|NCT01172938|26572521|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
13322845|NCT01172938|26572522|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4|||
13322846|NCT01172938|26572523|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1|||
13322847|NCT01172938|26572524|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
13322848|NCT01172938|26572525|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
13322849|NCT01172938|26572526|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
13322850|NCT01172938|26572527|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
13322851|NCT01172938|26572528|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3|||
13322852|NCT01172938|26572529|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
13322853|NCT01172938|26572521|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
13322854|NCT01172938|26572522|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
13322855|NCT01172938|26572523|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
13322856|NCT01172938|26572524|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
13322857|NCT01172938|26572525|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
13322858|NCT01172938|26572526|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
13322859|NCT01172938|26572527|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
13322860|NCT01172938|26572528|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3|||
13322861|NCT01172938|26572529|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2|||
13322862|NCT01172938|26572521|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
13322863|NCT01172938|26572522|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
13322864|NCT01172938|26572523|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
13322865|NCT01172938|26572524|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
13322866|NCT01172938|26572525|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
13322867|NCT01172938|26572526|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
13322868|NCT01172938|26572527|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
13322869|NCT01172938|26572528|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
13322870|NCT01172938|26572529|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
13322871|NCT01172938|26572521|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
13322872|NCT01172938|26572522|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
13322873|NCT01172938|26572523|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
13322874|NCT01172938|26572524|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
13322875|NCT01172938|26572525|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
13322876|NCT01172938|26572526|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
13322877|NCT01172938|26572527|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
13322878|NCT01172938|26572528|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
13322879|NCT01172938|26572529|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
13322880|NCT01172938|26572521|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
13322881|NCT01172938|26572522|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
13322882|NCT01172938|26572523|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
13322883|NCT01172938|26572524|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
13322884|NCT01172938|26572525|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
13322885|NCT01172938|26572526|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
13322886|NCT01172938|26572527|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
13322887|NCT01172938|26572528|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1|||
13322888|NCT01172938|26572529|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
13322889|NCT01172938|26572521|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
13322890|NCT01172938|26572522|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
13322891|NCT01172938|26572523|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
13322892|NCT01172938|26572524|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
13322893|NCT01172938|26572525|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
13322894|NCT01172938|26572526|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
13322895|NCT01172938|26572527|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
13322896|NCT01172938|26572528|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
13322897|NCT01172938|26572529|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
13322898|NCT01172938|26572521|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
13322899|NCT01172938|26572522|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
13322900|NCT01172938|26572523|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2|||
13322901|NCT01172938|26572524|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
13322902|NCT01172938|26572525|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
13322903|NCT01172938|26572526|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
13322904|NCT01172938|26572527|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
13322905|NCT01172938|26572528|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
13322906|NCT01172938|26572529|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
13322907|NCT01172938|26572521|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
13322908|NCT01172938|26572522|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
13322909|NCT01172938|26572523|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
13322910|NCT01172938|26572524|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
13322911|NCT01172938|26572525|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
13322912|NCT01172938|26572526|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
13322913|NCT01172938|26572527|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
13322914|NCT01172938|26572528|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
13322915|NCT01172938|26572529|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
13322916|NCT01172938|26572521|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
13322917|NCT01172938|26572522|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2|||
13322918|NCT01172938|26572523|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3|||
13322919|NCT01172938|26572524|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
13322920|NCT01172938|26572525|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
13322921|NCT01172938|26572526|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
13322922|NCT01172938|26572527|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
13322923|NCT01172938|26572528|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1|||
13322924|NCT01172938|26572529|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
13322925|NCT01172938|26572521|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0|||
13322926|NCT01172938|26572522|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0|||
13322927|NCT01172938|26572523|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1|||
13322928|NCT01172938|26572524|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0|||
13322929|NCT01172938|26572525|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0|||
13322930|NCT01172938|26572526|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0|||
13322931|NCT01172938|26572527|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0|||
13322932|NCT01172938|26572528|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0|||
13322933|NCT01172938|26572529|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0|||
13322934|NCT01172938|26572521|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
13322935|NCT01172938|26572522|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
13322936|NCT01172938|26572523|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1|||
13322937|NCT01172938|26572524|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
13322938|NCT01172938|26572525|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
13322939|NCT01172938|26572526|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
13322940|NCT01172938|26572527|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
13322941|NCT01172938|26572528|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
13322942|NCT01172938|26572529|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
13322943|NCT01172938|26572521|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
13322944|NCT01172938|26572522|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
13322945|NCT01172938|26572523|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
13322946|NCT01172938|26572524|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
13322947|NCT01172938|26572525|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
13322948|NCT01172938|26572526|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
13322949|NCT01172938|26572527|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
13322950|NCT01172938|26572528|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
13322951|NCT01172938|26572529|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1|||
13322952|NCT01172873|26572546|FG000|Overall Study|Withdrawal by Subject|3|||
13322953|NCT01172873|26572547|FG001|Overall Study|Withdrawal by Subject|2|||
13322954|NCT01172847|26572574|FG000|Overall Study|Withdrawal by Subject|3|||
13322955|NCT01172821|26572673|FG000|Overall Study|Adverse Event|5|||
13322956|NCT01172821|26572674|FG001|Overall Study|Adverse Event|2|||
13322957|NCT01172821|26572675|FG002|Overall Study|Adverse Event|2|||
13322958|NCT01172821|26572676|FG003|Overall Study|Adverse Event|7|||
13322959|NCT01172821|26572673|FG000|Overall Study|Protocol Violation|0|||
13322960|NCT01172821|26572674|FG001|Overall Study|Protocol Violation|2|||
13322961|NCT01172821|26572675|FG002|Overall Study|Protocol Violation|1|||
13322962|NCT01172821|26572676|FG003|Overall Study|Protocol Violation|2|||
13322963|NCT01172821|26572673|FG000|Overall Study|Lost to Follow-up|4|||
13322964|NCT01172821|26572674|FG001|Overall Study|Lost to Follow-up|1|||
13322965|NCT01172821|26572675|FG002|Overall Study|Lost to Follow-up|2|||
13322966|NCT01172821|26572676|FG003|Overall Study|Lost to Follow-up|2|||
13322967|NCT01172821|26572673|FG000|Overall Study|Withdrawal by Subject|2|||
13322968|NCT01172821|26572674|FG001|Overall Study|Withdrawal by Subject|3|||
13322969|NCT01172821|26572675|FG002|Overall Study|Withdrawal by Subject|3|||
13322970|NCT01172821|26572676|FG003|Overall Study|Withdrawal by Subject|3|||
13322971|NCT01172821|26572673|FG000|Overall Study|Other|3|||
13322972|NCT01172821|26572674|FG001|Overall Study|Other|4|||
13322973|NCT01172821|26572675|FG002|Overall Study|Other|5|||
13322974|NCT01172821|26572676|FG003|Overall Study|Other|3|||
13322975|NCT01172808|26572775|FG000|Overall Study|Adverse Event|8|||
13322976|NCT01172808|26572776|FG001|Overall Study|Adverse Event|4|||
13322977|NCT01172808|26572777|FG002|Overall Study|Adverse Event|8|||
13322978|NCT01172808|26572778|FG003|Overall Study|Adverse Event|3|||
13322979|NCT01172808|26572775|FG000|Overall Study|Lack of Efficacy|1|||
13322980|NCT01172808|26572776|FG001|Overall Study|Lack of Efficacy|0|||
13322981|NCT01172808|26572777|FG002|Overall Study|Lack of Efficacy|0|||
13322982|NCT01172808|26572778|FG003|Overall Study|Lack of Efficacy|0|||
13322983|NCT01172808|26572775|FG000|Overall Study|Protocol Violation|2|||
13322984|NCT01172808|26572776|FG001|Overall Study|Protocol Violation|2|||
13322985|NCT01172808|26572777|FG002|Overall Study|Protocol Violation|2|||
13322986|NCT01172808|26572778|FG003|Overall Study|Protocol Violation|0|||
13322987|NCT01172808|26572775|FG000|Overall Study|Lost to Follow-up|0|||
13322988|NCT01172808|26572776|FG001|Overall Study|Lost to Follow-up|1|||
13322989|NCT01172808|26572777|FG002|Overall Study|Lost to Follow-up|1|||
13322990|NCT01172808|26572778|FG003|Overall Study|Lost to Follow-up|3|||
13322991|NCT01172808|26572775|FG000|Overall Study|Withdrawal by Subject|4|||
13322992|NCT01172808|26572776|FG001|Overall Study|Withdrawal by Subject|1|||
13322993|NCT01172808|26572777|FG002|Overall Study|Withdrawal by Subject|3|||
13322994|NCT01172808|26572778|FG003|Overall Study|Withdrawal by Subject|2|||
13322995|NCT01172808|26572775|FG000|Overall Study|Other|6|||
13322996|NCT01172808|26572776|FG001|Overall Study|Other|5|||
13322997|NCT01172808|26572777|FG002|Overall Study|Other|9|||
13322998|NCT01172808|26572778|FG003|Overall Study|Other|7|||
13322999|NCT01172639|26572836|FG000|Overall Study|Death|1|||
13323000|NCT01172639|26572837|FG001|Overall Study|Death|1|||
13323001|NCT01172639|26572838|FG002|Overall Study|Death|0|||
13323002|NCT01172639|26572839|FG003|Overall Study|Death|0|||
13323003|NCT01172639|26572840|FG004|Overall Study|Death|0|||
13323004|NCT01172639|26572836|FG000|Overall Study|Lost to Follow-up|9|||
13323005|NCT01172639|26572837|FG001|Overall Study|Lost to Follow-up|7|||
13323006|NCT01172639|26572838|FG002|Overall Study|Lost to Follow-up|11|||
13323007|NCT01172639|26572839|FG003|Overall Study|Lost to Follow-up|6|||
13323008|NCT01172639|26572840|FG004|Overall Study|Lost to Follow-up|6|||
13323009|NCT01172639|26572836|FG000|Overall Study|Withdrawal by Subject|3|||
13323010|NCT01172639|26572837|FG001|Overall Study|Withdrawal by Subject|3|||
13323011|NCT01172639|26572838|FG002|Overall Study|Withdrawal by Subject|5|||
13323012|NCT01172639|26572839|FG003|Overall Study|Withdrawal by Subject|5|||
13323013|NCT01172639|26572840|FG004|Overall Study|Withdrawal by Subject|0|||
13323014|NCT01172535|26572857|FG000|Overall Study|Death|3|||
13323015|NCT01172535|26572857|FG000|Overall Study|Withdrawal by Subject|2|||
13323016|NCT01172535|26572857|FG000|Overall Study|Lost to Follow-up|1|||
13323017|NCT01172535|26572857|FG000|Overall Study|Ineligible at study entry|1|||
13323018|NCT01172535|26572857|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
13323019|NCT01172288|26572878|FG000|Overall Study|Adverse Event|1|||
13323020|NCT01172288|26572879|FG001|Overall Study|Adverse Event|0|||
13323021|NCT01172288|26572878|FG000|Overall Study|Protocol Violation|0|||
13323022|NCT01172288|26572879|FG001|Overall Study|Protocol Violation|1|||
13323023|NCT01172275|26572894|FG000|Overall Study|Lost to Follow-up|1|||
13323024|NCT01172275|26572895|FG001|Overall Study|Lost to Follow-up|0|||
13323025|NCT01172275|26572894|FG000|Overall Study|Protocol Violation|1|||
13323026|NCT01172275|26572895|FG001|Overall Study|Protocol Violation|0|||
13323027|NCT01171989|26572976|FG000|Overall Study|Lost to Follow-up|0|||
13323028|NCT01171989|26572977|FG001|Overall Study|Lost to Follow-up|0|||
13323029|NCT01171989|26572978|FG002|Overall Study|Lost to Follow-up|1|||
13323030|NCT01171976|26573023|FG000|Overall Study|Protocol Violation|0|||
13323031|NCT01171976|26573024|FG001|Overall Study|Protocol Violation|0|||
13323032|NCT01171976|26573025|FG002|Overall Study|Protocol Violation|1|||
13323033|NCT01171976|26573023|FG000|Overall Study|Death|2|||
13323034|NCT01171976|26573024|FG001|Overall Study|Death|4|||
13323035|NCT01171976|26573025|FG002|Overall Study|Death|1|||
13323036|NCT01171976|26573023|FG000|Overall Study|Lost to Follow-up|4|||
13323037|NCT01171976|26573024|FG001|Overall Study|Lost to Follow-up|0|||
13323038|NCT01171976|26573025|FG002|Overall Study|Lost to Follow-up|2|||
13323039|NCT01171976|26573023|FG000|Overall Study|Withdrawal by Subject|1|||
13323040|NCT01171976|26573024|FG001|Overall Study|Withdrawal by Subject|5|||
13323041|NCT01171976|26573025|FG002|Overall Study|Withdrawal by Subject|6|||
13323042|NCT01171976|26573023|FG000|Overall Study|Abnormal test result|1|||
13323043|NCT01171976|26573024|FG001|Overall Study|Abnormal test result|0|||
13323044|NCT01171976|26573025|FG002|Overall Study|Abnormal test result|0|||
13323045|NCT01171976|26573023|FG000|Overall Study|Adverse Event|6|||
13323046|NCT01171976|26573024|FG001|Overall Study|Adverse Event|2|||
13323047|NCT01171976|26573025|FG002|Overall Study|Adverse Event|5|||
13323048|NCT01171963|26573088|FG000|Overall Study|Adverse Event|10|||
13323049|NCT01171963|26573089|FG001|Overall Study|Adverse Event|15|||
13323050|NCT01171963|26573088|FG000|Overall Study|Lost to Follow-up|23|||
13323051|NCT01171963|26573089|FG001|Overall Study|Lost to Follow-up|24|||
13323052|NCT01171963|26573088|FG000|Overall Study|Other - diarrhoea|1|||
13323053|NCT01171963|26573089|FG001|Overall Study|Other - diarrhoea|0|||
13323054|NCT01171963|26573088|FG000|Overall Study|Withdrawal by Subject|114|||
13323055|NCT01171963|26573089|FG001|Overall Study|Withdrawal by Subject|129|||
13323056|NCT01171820|26573150|FG000|Overall Study|Death|3|||
13323057|NCT01171820|26573151|FG001|Overall Study|Death|3|||
13323058|NCT01171820|26573150|FG000|Overall Study|Lost to Follow-up|0|||
13323059|NCT01171820|26573151|FG001|Overall Study|Lost to Follow-up|1|||
13323060|NCT01171820|26573150|FG000|Overall Study|Withdrawal by Subject|2|||
13323061|NCT01171820|26573151|FG001|Overall Study|Withdrawal by Subject|0|||
13323062|NCT01171820|26573150|FG000|Overall Study|Physician Decision|0|||
13323063|NCT01171820|26573151|FG001|Overall Study|Physician Decision|1|||
13323064|NCT01171820|26573150|FG000|Overall Study|1-Year Missed Visit|1|||
13323065|NCT01171820|26573151|FG001|Overall Study|1-Year Missed Visit|1|||
13323066|NCT01171677|26573190|FG000|Overall Study|Withdrawal by Subject|0|||
13323067|NCT01171677|26573191|FG001|Overall Study|Withdrawal by Subject|3|||
13323068|NCT01171677|26573190|FG000|Overall Study|Adverse Event|1|||
13323069|NCT01171677|26573191|FG001|Overall Study|Adverse Event|0|||
13323070|NCT01171677|26573190|FG000|Overall Study|completed <70% IntenSati classes|5|||
13323071|NCT01171677|26573191|FG001|Overall Study|completed <70% IntenSati classes|0|||
13323072|NCT01171625|26573226|FG000|Overall Study|On-Protocol|67|||
13323073|NCT01171625|26573226|FG000|Overall Study|Death|38|||
13323074|NCT01171625|26573226|FG000|Overall Study|Withdrawal by Subject|31|||
13323075|NCT01171625|26573226|FG000|Overall Study|Explanted|10|||
13323076|NCT01171625|26573226|FG000|Overall Study|Lost to Follow-up|5|||
13323077|NCT01171625|26573226|FG000|Overall Study|Patient received valve-in-valve|3|||
13323078|NCT01171625|26573226|FG000|Overall Study|Other|1|||
13323079|NCT01171625|26573226|FG000|Overall Study|Consented but did not receive device|25|||
13323080|NCT01171612|26573236|FG000|Overall Study|Lost to Follow-up|51|||
13323081|NCT01171534|26573255|FG000|Overall Study|Lost to Follow-up|0|||
13323082|NCT01171534|26573256|FG001|Overall Study|Lost to Follow-up|2|||
13323083|NCT01171534|26573255|FG000|Overall Study|screen failure|0|||
13323084|NCT01171534|26573256|FG001|Overall Study|screen failure|1|||
13323085|NCT01171521|26573263|FG000|Overall Study|Lost to Follow-up|5|||
13323086|NCT01171521|26573263|FG000|Overall Study|screen failure|1|||
13323087|NCT01171183|26573278|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
13323088|NCT01171183|26573279|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
13323089|NCT01171183|26573278|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0|||
13323090|NCT01171183|26573279|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1|||
13323091|NCT01171183|26573278|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0|||
13323092|NCT01171183|26573279|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3|||
13323093|NCT01171183|26573278|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
13323094|NCT01171183|26573279|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
13323095|NCT01171183|26573278|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7|||
13323096|NCT01171183|26573279|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3|||
13323097|NCT01171183|26573278|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1|||
13323098|NCT01171183|26573279|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0|||
13323099|NCT01170962|26573333|FG000|Treatment Period|Lack of Efficacy|96|||
13323100|NCT01170962|26573334|FG001|Treatment Period|Lack of Efficacy|91|||
13323101|NCT01170962|26573335|FG002|Treatment Period|Lack of Efficacy|7|||
13323102|NCT01170962|26573333|FG000|Treatment Period|Adverse Event|11|||
13323103|NCT01170962|26573334|FG001|Treatment Period|Adverse Event|12|||
13323104|NCT01170962|26573335|FG002|Treatment Period|Adverse Event|3|||
13323105|NCT01170962|26573333|FG000|Treatment Period|Withdrawal by Subject|2|||
13323106|NCT01170962|26573334|FG001|Treatment Period|Withdrawal by Subject|1|||
13323107|NCT01170962|26573335|FG002|Treatment Period|Withdrawal by Subject|0|||
13323108|NCT01170962|26573333|FG000|Treatment Period|Lost to Follow-up|1|||
13323109|NCT01170962|26573334|FG001|Treatment Period|Lost to Follow-up|1|||
13323110|NCT01170962|26573335|FG002|Treatment Period|Lost to Follow-up|1|||
13323111|NCT01170962|26573333|FG000|Treatment Period|Participant no longer meets criteria|0|||
13323112|NCT01170962|26573334|FG001|Treatment Period|Participant no longer meets criteria|1|||
13323113|NCT01170962|26573335|FG002|Treatment Period|Participant no longer meets criteria|0|||
13323114|NCT01170962|26573333|FG000|Treatment Period|Request to discontinue treatment|7|||
13323115|NCT01170962|26573334|FG001|Treatment Period|Request to discontinue treatment|3|||
13323116|NCT01170962|26573335|FG002|Treatment Period|Request to discontinue treatment|1|||
13323117|NCT01170962|26573333|FG000|Treatment Period|Completed 24 Week treatment period only|10|||
13323118|NCT01170962|26573334|FG001|Treatment Period|Completed 24 Week treatment period only|2|||
13323119|NCT01170962|26573335|FG002|Treatment Period|Completed 24 Week treatment period only|0|||
13323120|NCT01170962|26573333|FG000|Follow up Period|Withdrawal by Subject|14|||
13323121|NCT01170962|26573334|FG001|Follow up Period|Withdrawal by Subject|10|||
13323122|NCT01170962|26573335|FG002|Follow up Period|Withdrawal by Subject|2|||
13323123|NCT01170962|26573333|FG000|Follow up Period|Lost to Follow-up|13|||
13323124|NCT01170962|26573334|FG001|Follow up Period|Lost to Follow-up|8|||
13323125|NCT01170962|26573335|FG002|Follow up Period|Lost to Follow-up|1|||
13323126|NCT01170962|26573333|FG000|Follow up Period|Death|2|||
13323127|NCT01170962|26573334|FG001|Follow up Period|Death|2|||
13323128|NCT01170962|26573335|FG002|Follow up Period|Death|0|||
13323129|NCT01170962|26573333|FG000|Follow up Period|Others|10|||
13323130|NCT01170962|26573334|FG001|Follow up Period|Others|7|||
13323131|NCT01170962|26573335|FG002|Follow up Period|Others|3|||
13323132|NCT01170663|26573370|FG000|Overall Study|Lost to Follow-up|3|||
13323133|NCT01170663|26573371|FG001|Overall Study|Lost to Follow-up|9|||
13323134|NCT01170663|26573370|FG000|Overall Study|Withdrawal of consent without follow-up|11|||
13323135|NCT01170663|26573371|FG001|Overall Study|Withdrawal of consent without follow-up|11|||
13323136|NCT01170598|26573388|FG000|Overall Study|Withdrawal by Subject|1|||
13323137|NCT01170598|26573388|FG000|Overall Study|Death|3|||
13323138|NCT01170598|26573388|FG000|Overall Study|Lost to Follow-up|1|||
13323139|NCT01170598|26573388|FG000|Overall Study|Refused|1|||
13323140|NCT01170364|26573401|FG000|Overall Study|Protocol Violation|4|||
13323141|NCT01170364|26573402|FG001|Overall Study|Protocol Violation|1|||
13323142|NCT01170273|26573415|FG000|Overall Study|Lost to Follow-up|6|||
13323143|NCT01170273|26573416|FG001|Overall Study|Lost to Follow-up|8|||
13323144|NCT01170273|26573415|FG000|Overall Study|Protocol Violation|1|||
13323145|NCT01170273|26573416|FG001|Overall Study|Protocol Violation|0|||
13323146|NCT01170273|26573415|FG000|Overall Study|Death|1|||
13323147|NCT01170273|26573416|FG001|Overall Study|Death|0|||
13323148|NCT01170273|26573415|FG000|Overall Study|Adverse Event|0|||
13323149|NCT01170273|26573416|FG001|Overall Study|Adverse Event|1|||
13323150|NCT01170221|26573443|FG000|Overall Study|Lost to Follow-up|22|||
13323151|NCT01170221|26573444|FG001|Overall Study|Lost to Follow-up|21|||
13323152|NCT01170221|26573443|FG000|Overall Study|Withdrawal by Subject|9|||
13323153|NCT01170221|26573444|FG001|Overall Study|Withdrawal by Subject|7|||
13323154|NCT01170221|26573443|FG000|Overall Study|Subject completed only screening and LFU|1|||
13323155|NCT01170221|26573444|FG001|Overall Study|Subject completed only screening and LFU|0|||
13323156|NCT01170221|26573443|FG000|Overall Study|Randomized but not treated|1|||
13323157|NCT01170221|26573444|FG001|Overall Study|Randomized but not treated|0|||
13323158|NCT01170208|26573471|FG000|Overall Study|Withdrawal by Subject|5|||
13323159|NCT01170208|26573472|FG001|Overall Study|Withdrawal by Subject|0|||
13323160|NCT01170208|26573473|FG002|Overall Study|Withdrawal by Subject|1|||
13323161|NCT01170208|26573471|FG000|Overall Study|Protocol Violation|1|||
13323162|NCT01170208|26573472|FG001|Overall Study|Protocol Violation|0|||
13323163|NCT01170208|26573473|FG002|Overall Study|Protocol Violation|1|||
13323164|NCT01170091|26573482|FG000|Overall Study|Missing efficacy evaluation|3|||
13323165|NCT01170091|26573482|FG000|Overall Study|Treatment duration is less than 4 weeks|21|||
13323166|NCT01170065|26573521|FG000|Overall Study|Adverse Event|17|||
13323167|NCT01170065|26573522|FG001|Overall Study|Adverse Event|50|||
13323168|NCT01170065|26573523|FG002|Overall Study|Adverse Event|10|||
13323169|NCT01170065|26573521|FG000|Overall Study|Lost to Follow-up|1|||
13323170|NCT01170065|26573522|FG001|Overall Study|Lost to Follow-up|4|||
13323171|NCT01170065|26573523|FG002|Overall Study|Lost to Follow-up|1|||
13323172|NCT01170065|26573521|FG000|Overall Study|Consent withdrawn, not due to AE|2|||
13323173|NCT01170065|26573522|FG001|Overall Study|Consent withdrawn, not due to AE|4|||
13323174|NCT01170065|26573523|FG002|Overall Study|Consent withdrawn, not due to AE|2|||
13323175|NCT01170065|26573521|FG000|Overall Study|Reason other than specified|3|||
13323176|NCT01170065|26573522|FG001|Overall Study|Reason other than specified|8|||
13323177|NCT01170065|26573523|FG002|Overall Study|Reason other than specified|3|||
13323178|NCT01170065|26573521|FG000|Overall Study|Ongoing after planned observation time|5|||
13323179|NCT01170065|26573522|FG001|Overall Study|Ongoing after planned observation time|26|||
13323180|NCT01170065|26573523|FG002|Overall Study|Ongoing after planned observation time|10|||
13323181|NCT01170039|26573542|FG000|Overall Study|Withdrawal by Subject|5|||
13323182|NCT01170039|26573543|FG001|Overall Study|Withdrawal by Subject|3|||
13323183|NCT01170039|26573542|FG000|Overall Study|Lack of funding, drug not available|3|||
13323184|NCT01170039|26573543|FG001|Overall Study|Lack of funding, drug not available|3|||
13323185|NCT01169987|26573609|FG000|Overall Study|Withdrawal by Subject|3|||
13323186|NCT01169987|26573609|FG000|Overall Study|Lost to Follow-up|24|||
13323187|NCT01169987|26573609|FG000|Overall Study|Other|4|||
13323188|NCT01169844|26573626|FG000|Overall Study|Adverse Event|0|||
13323189|NCT01169844|26573627|FG001|Overall Study|Adverse Event|1|||
13323190|NCT01169844|26573626|FG000|Overall Study|Patient withdrew consent|4|||
13323191|NCT01169844|26573627|FG001|Overall Study|Patient withdrew consent|0|||
13323192|NCT01169844|26573626|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
13323193|NCT01169844|26573627|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
13323194|NCT01169779|26573658|FG000|Overall Study|Adverse Event|3|||
13323195|NCT01169779|26573659|FG001|Overall Study|Adverse Event|11|||
13323196|NCT01169779|26573658|FG000|Overall Study|Lack of Efficacy|1|||
13323197|NCT01169779|26573659|FG001|Overall Study|Lack of Efficacy|0|||
13323198|NCT01169779|26573658|FG000|Overall Study|Protocol Violation|1|||
13323199|NCT01169779|26573659|FG001|Overall Study|Protocol Violation|1|||
13323200|NCT01169779|26573658|FG000|Overall Study|Withdrawal by Subject|3|||
13323201|NCT01169779|26573659|FG001|Overall Study|Withdrawal by Subject|2|||
13323202|NCT01169779|26573658|FG000|Overall Study|Familial and personal reasons|3|||
13323203|NCT01169779|26573659|FG001|Overall Study|Familial and personal reasons|3|||
13323204|NCT01169701|26573698|FG000|Overall Study|Lost to Follow-up|1|||
13323205|NCT01169701|26573699|FG001|Overall Study|Lost to Follow-up|1|||
13323206|NCT01169701|26573698|FG000|Overall Study|Withdrawal by Subject|1|||
13323207|NCT01169701|26573699|FG001|Overall Study|Withdrawal by Subject|3|||
13323208|NCT01169701|26573698|FG000|Overall Study|Adverse Event|1|||
13323209|NCT01169701|26573699|FG001|Overall Study|Adverse Event|2|||
13323210|NCT01169701|26573698|FG000|Overall Study|Exclusion criteria|2|||
13323211|NCT01169701|26573699|FG001|Overall Study|Exclusion criteria|0|||
13323212|NCT01169701|26573698|FG000|Overall Study|Death|0|||
13323213|NCT01169701|26573699|FG001|Overall Study|Death|1|||
13323214|NCT01169701|26573698|FG000|Overall Study|Administrative problems|0|||
13323215|NCT01169701|26573699|FG001|Overall Study|Administrative problems|1|||
13323216|NCT01169701|26573698|FG000|Overall Study|Serious adverse event|0|||
13323217|NCT01169701|26573699|FG001|Overall Study|Serious adverse event|1|||
13323218|NCT01169701|26573698|FG000|Overall Study|Sponsor decision|0|||
13323219|NCT01169701|26573699|FG001|Overall Study|Sponsor decision|1|||
13373393|NCT00803244|26723695|FG000|Overall Study|Any other reason not above-mentioned|4|||
13373394|NCT00803244|26723696|FG001|Overall Study|Any other reason not above-mentioned|10|||
13373395|NCT00803205|26723746|FG000|Overall Study|Adverse Event|7|||
13373396|NCT00803205|26723747|FG001|Overall Study|Adverse Event|2|||
13373397|NCT00803205|26723746|FG000|Overall Study|Lost to Follow-up|1|||
13373398|NCT00803205|26723747|FG001|Overall Study|Lost to Follow-up|0|||
13373399|NCT00803205|26723746|FG000|Overall Study|Withdrawal by Subject|9|||
13373400|NCT00803205|26723747|FG001|Overall Study|Withdrawal by Subject|9|||
13373401|NCT00803205|26723746|FG000|Overall Study|Physician Decision|1|||
13373402|NCT00803205|26723747|FG001|Overall Study|Physician Decision|0|||
13373403|NCT00803205|26723746|FG000|Overall Study|Protocol Violation|1|||
13373404|NCT00803205|26723747|FG001|Overall Study|Protocol Violation|1|||
13373405|NCT00803205|26723746|FG000|Overall Study|Medical Monitor Decision|1|||
13373406|NCT00803205|26723747|FG001|Overall Study|Medical Monitor Decision|0|||
13373407|NCT00803205|26723746|FG000|Overall Study|Acquired a Lung Infection|0|||
13373408|NCT00803205|26723747|FG001|Overall Study|Acquired a Lung Infection|1|||
13373409|NCT00803205|26723746|FG000|Overall Study|Sponsor Decision|0|||
13373410|NCT00803205|26723747|FG001|Overall Study|Sponsor Decision|1|||
13373411|NCT00803179|26723753|FG000|Overall Study|Lost to Follow-up|3|||
13373412|NCT00803101|26723778|FG000|Overall Study|Death / Serious Adverse Event|4|||
13373413|NCT00803101|26723779|FG001|Overall Study|Death / Serious Adverse Event|6|||
13373414|NCT00803101|26723778|FG000|Overall Study|Withdrawal by Subject|6|||
13373415|NCT00803101|26723779|FG001|Overall Study|Withdrawal by Subject|4|||
13373416|NCT00803101|26723778|FG000|Overall Study|Lost to Follow-up|2|||
13373417|NCT00803101|26723779|FG001|Overall Study|Lost to Follow-up|2|||
13373418|NCT00803101|26723778|FG000|Overall Study|Protocol Violation|1|||
13373419|NCT00803101|26723779|FG001|Overall Study|Protocol Violation|7|||
13373420|NCT00803101|26723778|FG000|Overall Study|Surgery finished outside protocol window|1|||
13373421|NCT00803101|26723779|FG001|Overall Study|Surgery finished outside protocol window|1|||
13373422|NCT00803101|26723778|FG000|Overall Study|Patient died outside SAE report period|1|||
13323220|NCT01169675|26573752|FG000|Overall Study|Progressive disease|13|||
13323221|NCT01169675|26573753|FG001|Overall Study|Progressive disease|2|||
13323222|NCT01169675|26573754|FG002|Overall Study|Progressive disease|5|||
13323223|NCT01169675|26573755|FG003|Overall Study|Progressive disease|15|||
13323224|NCT01169675|26573756|FG004|Overall Study|Progressive disease|1|||
13323225|NCT01169675|26573752|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1|||
13323226|NCT01169675|26573753|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
13323227|NCT01169675|26573754|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
13323228|NCT01169675|26573755|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
13323229|NCT01169675|26573756|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2|||
13323230|NCT01169675|26573752|FG000|Overall Study|Adverse Event|5|||
13323231|NCT01169675|26573753|FG001|Overall Study|Adverse Event|1|||
13323232|NCT01169675|26573754|FG002|Overall Study|Adverse Event|2|||
13323233|NCT01169675|26573755|FG003|Overall Study|Adverse Event|0|||
13323234|NCT01169675|26573756|FG004|Overall Study|Adverse Event|0|||
13323235|NCT01169675|26573752|FG000|Overall Study|Withdrawal by Subject|1|||
13323236|NCT01169675|26573753|FG001|Overall Study|Withdrawal by Subject|0|||
13323237|NCT01169675|26573754|FG002|Overall Study|Withdrawal by Subject|0|||
13323238|NCT01169675|26573755|FG003|Overall Study|Withdrawal by Subject|1|||
13323239|NCT01169675|26573756|FG004|Overall Study|Withdrawal by Subject|2|||
13323240|NCT01169675|26573752|FG000|Overall Study|Other Reason Not Defined Above|0|||
13323241|NCT01169675|26573753|FG001|Overall Study|Other Reason Not Defined Above|0|||
13323242|NCT01169675|26573754|FG002|Overall Study|Other Reason Not Defined Above|0|||
13323243|NCT01169675|26573755|FG003|Overall Study|Other Reason Not Defined Above|1|||
13323244|NCT01169675|26573756|FG004|Overall Study|Other Reason Not Defined Above|1|||
13323245|NCT01169649|26573762|FG000|Overall Study|Patient Not Treated|3|||
13323246|NCT01169636|26573792|FG000|Overall Study|Adverse Event|0|||
13323247|NCT01169636|26573793|FG001|Overall Study|Adverse Event|0|||
13323248|NCT01169636|26573794|FG002|Overall Study|Adverse Event|1|||
13323249|NCT01169636|26573795|FG003|Overall Study|Adverse Event|1|||
13323250|NCT01169636|26573796|FG004|Overall Study|Adverse Event|0|||
13323251|NCT01169636|26573792|FG000|Overall Study|Screen failure|0|||
13323252|NCT01169636|26573793|FG001|Overall Study|Screen failure|0|||
13323253|NCT01169636|26573794|FG002|Overall Study|Screen failure|2|||
13323254|NCT01169636|26573795|FG003|Overall Study|Screen failure|0|||
13323255|NCT01169636|26573796|FG004|Overall Study|Screen failure|0|||
13323256|NCT01169636|26573792|FG000|Overall Study|Withdrawal by Subject|0|||
13323257|NCT01169636|26573793|FG001|Overall Study|Withdrawal by Subject|0|||
13323258|NCT01169636|26573794|FG002|Overall Study|Withdrawal by Subject|0|||
13323259|NCT01169636|26573795|FG003|Overall Study|Withdrawal by Subject|0|||
13323260|NCT01169636|26573796|FG004|Overall Study|Withdrawal by Subject|3|||
13323261|NCT01169558|26573805|FG000|Overall Study|Disease progression|98|||
13323262|NCT01169558|26573805|FG000|Overall Study|Adverse Event|25|||
13323263|NCT01169558|26573805|FG000|Overall Study|Withdrawal of Consent|8|||
13323264|NCT01169558|26573805|FG000|Overall Study|Medical Decision|7|||
13323265|NCT01169558|26573805|FG000|Overall Study|Stable Disease|4|||
13323266|NCT01169558|26573805|FG000|Overall Study|Lost to Follow-up|4|||
13323267|NCT01169558|26573805|FG000|Overall Study|Need for Surgery|4|||
13323268|NCT01169558|26573805|FG000|Overall Study|Non-compliance|2|||
13323269|NCT01169558|26573805|FG000|Overall Study|Protocol Violation|2|||
13323270|NCT01169558|26573805|FG000|Overall Study|Partial response|2|||
13323271|NCT01169532|26573813|FG000|Overall Study|Withdrawal by Subject|1|||
13323272|NCT01169493|26573861|FG000|Period 1 (6 Months)|Withdrawal by Subject|0|||
13323273|NCT01169493|26573862|FG001|Period 1 (6 Months)|Withdrawal by Subject|1|||
13323274|NCT01169493|26573863|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
13323275|NCT01169493|26573864|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
13323276|NCT01169493|26573865|FG004|Period 1 (6 Months)|Withdrawal by Subject|0|||
13323277|NCT01169493|26573866|FG005|Period 1 (6 Months)|Withdrawal by Subject|3|||
13323278|NCT01169493|26573861|FG000|Period 3 (6 Months)|Adverse Event|0|||
13323279|NCT01169493|26573862|FG001|Period 3 (6 Months)|Adverse Event|1|||
13323280|NCT01169493|26573863|FG002|Period 3 (6 Months)|Adverse Event|0|||
13323281|NCT01169493|26573864|FG003|Period 3 (6 Months)|Adverse Event|0|||
13323282|NCT01169493|26573865|FG004|Period 3 (6 Months)|Adverse Event|0|||
13323283|NCT01169493|26573866|FG005|Period 3 (6 Months)|Adverse Event|0|||
13323284|NCT01169493|26573861|FG000|Period 3 (6 Months)|Physician Decision|0|||
13323285|NCT01169493|26573862|FG001|Period 3 (6 Months)|Physician Decision|1|||
13323286|NCT01169493|26573863|FG002|Period 3 (6 Months)|Physician Decision|1|||
13323287|NCT01169493|26573864|FG003|Period 3 (6 Months)|Physician Decision|0|||
13323288|NCT01169493|26573865|FG004|Period 3 (6 Months)|Physician Decision|0|||
13323289|NCT01169493|26573866|FG005|Period 3 (6 Months)|Physician Decision|0|||
13323290|NCT01169350|26573875|FG000|Overall Study|Physician Decision|3|||
13323291|NCT01169350|26573875|FG000|Overall Study|Lost to Follow-up|2|||
13323292|NCT01169337|26573902|FG000|Overall Study|Lack of Efficacy|5|||
13323293|NCT01169337|26573903|FG001|Overall Study|Lack of Efficacy|7|||
13323294|NCT01169337|26573904|FG002|Overall Study|Lack of Efficacy|0|||
13323295|NCT01169337|26573902|FG000|Overall Study|Adverse Event|12|||
13323296|NCT01169337|26573903|FG001|Overall Study|Adverse Event|18|||
13323297|NCT01169337|26573904|FG002|Overall Study|Adverse Event|0|||
13323298|NCT01169337|26573902|FG000|Overall Study|Death|2|||
13323299|NCT01169337|26573903|FG001|Overall Study|Death|0|||
13323300|NCT01169337|26573904|FG002|Overall Study|Death|0|||
13323301|NCT01169337|26573902|FG000|Overall Study|Withdrawal by Subject|11|||
13323302|NCT01169337|26573903|FG001|Overall Study|Withdrawal by Subject|11|||
13323303|NCT01169337|26573904|FG002|Overall Study|Withdrawal by Subject|6|||
13323304|NCT01169337|26573902|FG000|Overall Study|Noncompliance|2|||
13323305|NCT01169337|26573903|FG001|Overall Study|Noncompliance|0|||
13323306|NCT01169337|26573904|FG002|Overall Study|Noncompliance|0|||
13323307|NCT01169337|26573902|FG000|Overall Study|Other complicating disease|1|||
13323308|NCT01169337|26573903|FG001|Overall Study|Other complicating disease|1|||
13323309|NCT01169337|26573904|FG002|Overall Study|Other complicating disease|0|||
13323310|NCT01169337|26573902|FG000|Overall Study|Physician Decision|1|||
13323311|NCT01169337|26573903|FG001|Overall Study|Physician Decision|5|||
13323312|NCT01169337|26573904|FG002|Overall Study|Physician Decision|0|||
13323313|NCT01169337|26573902|FG000|Overall Study|Alternative therapy|0|||
13323314|NCT01169337|26573903|FG001|Overall Study|Alternative therapy|2|||
13323315|NCT01169337|26573904|FG002|Overall Study|Alternative therapy|0|||
13323316|NCT01169337|26573902|FG000|Overall Study|Changed hospital|0|||
13323317|NCT01169337|26573903|FG001|Overall Study|Changed hospital|1|||
13323318|NCT01169337|26573904|FG002|Overall Study|Changed hospital|0|||
13323319|NCT01169337|26573902|FG000|Overall Study|Never started treatment|0|||
13323320|NCT01169337|26573903|FG001|Overall Study|Never started treatment|2|||
13323321|NCT01169337|26573904|FG002|Overall Study|Never started treatment|0|||
13323322|NCT01169337|26573902|FG000|Overall Study|Reason not reported|1|||
13323323|NCT01169337|26573903|FG001|Overall Study|Reason not reported|0|||
13323324|NCT01169337|26573904|FG002|Overall Study|Reason not reported|0|||
13323325|NCT01169337|26573902|FG000|Overall Study|Continuing lenalidomide|9|||
13323326|NCT01169337|26573903|FG001|Overall Study|Continuing lenalidomide|43|||
13323327|NCT01169337|26573904|FG002|Overall Study|Continuing lenalidomide|0|||
13323328|NCT01169103|26573925|FG000|Overall Study|Lost to Follow-up|3|||
13323329|NCT01169103|26573926|FG001|Overall Study|Lost to Follow-up|3|||
13323330|NCT01169103|26573925|FG000|Overall Study|Withdrawal by Subject|3|||
13323331|NCT01169103|26573926|FG001|Overall Study|Withdrawal by Subject|1|||
13323332|NCT01169038|26573932|FG000|Overall Study|Death|1|||
13323333|NCT01169038|26573932|FG000|Overall Study|Adverse Event|5|||
13323334|NCT01169038|26573932|FG000|Overall Study|Required antibiotic administration|1|||
13323335|NCT01168999|26573987|FG000|Overall Study|Lost to Follow-up|2|||
13323336|NCT01168999|26573988|FG001|Overall Study|Lost to Follow-up|1|||
13323337|NCT01168999|26573989|FG002|Overall Study|Lost to Follow-up|0|||
13323338|NCT01168999|26573990|FG003|Overall Study|Lost to Follow-up|0|||
13323339|NCT01168973|26574018|FG000|Overall Study|Progressive Disease|341|||
13323340|NCT01168973|26574019|FG001|Overall Study|Progressive Disease|429|||
13323341|NCT01168973|26574018|FG000|Overall Study|Adverse Event|94|||
13323342|NCT01168973|26574019|FG001|Overall Study|Adverse Event|55|||
13323343|NCT01168973|26574018|FG000|Overall Study|Withdrawal by Subject|90|||
13323344|NCT01168973|26574019|FG001|Overall Study|Withdrawal by Subject|53|||
13323345|NCT01168973|26574018|FG000|Overall Study|Death|42|||
13323346|NCT01168973|26574019|FG001|Overall Study|Death|45|||
13323347|NCT01168973|26574018|FG000|Overall Study|Physician Decision|37|||
13323348|NCT01168973|26574019|FG001|Overall Study|Physician Decision|19|||
13323349|NCT01168973|26574018|FG000|Overall Study|Sponsor Decision|2|||
13323350|NCT01168973|26574019|FG001|Overall Study|Sponsor Decision|1|||
13323351|NCT01168973|26574018|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7|||
13323352|NCT01168973|26574019|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9|||
13323353|NCT01168856|26574083|FG000|Overall Study|Lost to Follow-up|4|||
13323354|NCT01168856|26574084|FG001|Overall Study|Lost to Follow-up|34|||
13323355|NCT01168856|26574083|FG000|Overall Study|Withdrawal by Subject|6|||
13323356|NCT01168856|26574084|FG001|Overall Study|Withdrawal by Subject|8|||
13323357|NCT01168856|26574083|FG000|Overall Study|Physician Decision|2|||
13323358|NCT01168856|26574084|FG001|Overall Study|Physician Decision|1|||
13323359|NCT01168856|26574083|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0|||
13323360|NCT01168856|26574084|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1|||
13323361|NCT01168856|26574083|FG000|Overall Study|Participant received anti-HCV treatment|1|||
13323362|NCT01168856|26574084|FG001|Overall Study|Participant received anti-HCV treatment|0|||
13323363|NCT01168856|26574083|FG000|Overall Study|Death|0|||
13323364|NCT01168856|26574084|FG001|Overall Study|Death|2|||
13323365|NCT01168856|26574083|FG000|Overall Study|Other|1|||
13323366|NCT01168856|26574084|FG001|Overall Study|Other|291|||
13323367|NCT01168856|26574083|FG000|Overall Study|Protocol Violation|4|||
13323368|NCT01168856|26574084|FG001|Overall Study|Protocol Violation|6|||
13323369|NCT01168596|26574135|FG000|Overall Study|Withdrawal by Subject|3|||
13323370|NCT01168596|26574136|FG001|Overall Study|Withdrawal by Subject|1|||
13323371|NCT01168427|26574143|FG000|Overall Study|Patient exited prior to implant|1|||
13323372|NCT01168401|26574410|FG000|Overall Study|Lost to Follow-up|1|||
13323373|NCT01168401|26574411|FG001|Overall Study|Lost to Follow-up|1|||
13323374|NCT01168401|26574412|FG002|Overall Study|Lost to Follow-up|2|||
13323375|NCT01168401|26574413|FG003|Overall Study|Lost to Follow-up|1|||
13323376|NCT01168401|26574414|FG004|Overall Study|Lost to Follow-up|0|||
13323377|NCT01168401|26574415|FG005|Overall Study|Lost to Follow-up|0|||
13323378|NCT01168401|26574416|FG006|Overall Study|Lost to Follow-up|0|||
13323379|NCT01168401|26574417|FG007|Overall Study|Lost to Follow-up|0|||
13323380|NCT01168401|26574418|FG008|Overall Study|Lost to Follow-up|0|||
13323381|NCT01168401|26574419|FG009|Overall Study|Lost to Follow-up|0|||
13323382|NCT01168401|26574420|FG010|Overall Study|Lost to Follow-up|0|||
13323383|NCT01168401|26574410|FG000|Overall Study|Withdrawal by Subject|0|||
13323384|NCT01168401|26574411|FG001|Overall Study|Withdrawal by Subject|0|||
13323385|NCT01168401|26574412|FG002|Overall Study|Withdrawal by Subject|0|||
13323386|NCT01168401|26574413|FG003|Overall Study|Withdrawal by Subject|1|||
13323387|NCT01168401|26574414|FG004|Overall Study|Withdrawal by Subject|0|||
13323388|NCT01168401|26574415|FG005|Overall Study|Withdrawal by Subject|0|||
13323389|NCT01168401|26574416|FG006|Overall Study|Withdrawal by Subject|0|||
13323390|NCT01168401|26574417|FG007|Overall Study|Withdrawal by Subject|0|||
13323391|NCT01168401|26574418|FG008|Overall Study|Withdrawal by Subject|0|||
13323392|NCT01168401|26574419|FG009|Overall Study|Withdrawal by Subject|0|||
13323393|NCT01168401|26574420|FG010|Overall Study|Withdrawal by Subject|0|||
13323394|NCT01168349|26574528|FG000|Overall Study|Death|157|||
13323395|NCT01168349|26574528|FG000|Overall Study|Lost to Follow-up|34|||
13323396|NCT01168349|26574528|FG000|Overall Study|Withdrawal by Subject|9|||
13323397|NCT01168349|26574528|FG000|Overall Study|Kidney transplantation|3|||
13323398|NCT01168349|26574528|FG000|Overall Study|Other|22|||
13323399|NCT01168349|26574528|FG000|Overall Study|Protocol Violation|76|||
13323400|NCT01168232|26574537|FG000|Overall Study|Ineligible-Second primary cancer site|1|||
13323401|NCT01168232|26574537|FG000|Overall Study|Ineligible- Wrong cell type|6|||
13323402|NCT01168232|26574537|FG000|Overall Study|Ineligible-Inadequate pathology|1|||
13323403|NCT01168219|26574545|FG000|Overall Study|off study before starting treatment|2|||
13323404|NCT01168219|26574545|FG000|Overall Study|withdrew before transplant|1|||
13323405|NCT01168219|26574545|FG000|Overall Study|ineligible due to CML|2|||
13323406|NCT01167907|26574568|FG000|Overall Study|Protocol Violation|1|||
13323407|NCT01167907|26574569|FG001|Overall Study|Protocol Violation|0|||
13323408|NCT01167907|26574568|FG000|Overall Study|saphenous catheter dislodged before comp|1|||
13323409|NCT01167907|26574569|FG001|Overall Study|saphenous catheter dislodged before comp|1|||
13323410|NCT01167881|26574600|FG000|Overall Study|Adverse Event|47|||
13323411|NCT01167881|26574601|FG001|Overall Study|Adverse Event|51|||
13323412|NCT01167881|26574600|FG000|Overall Study|Lack of Efficacy|4|||
13323413|NCT01167881|26574601|FG001|Overall Study|Lack of Efficacy|7|||
13323414|NCT01167881|26574600|FG000|Overall Study|Non compliant with protocol|9|||
13323415|NCT01167881|26574601|FG001|Overall Study|Non compliant with protocol|18|||
13323416|NCT01167881|26574600|FG000|Overall Study|Lost to Follow-up|19|||
13323417|NCT01167881|26574601|FG001|Overall Study|Lost to Follow-up|20|||
13323418|NCT01167881|26574600|FG000|Overall Study|Patient refusal to cont., not due to AE|45|||
13323419|NCT01167881|26574601|FG001|Overall Study|Patient refusal to cont., not due to AE|40|||
13323420|NCT01167881|26574600|FG000|Overall Study|Not treated|4|||
13323421|NCT01167881|26574601|FG001|Overall Study|Not treated|0|||
13323422|NCT01167881|26574600|FG000|Overall Study|Other not defined above|31|||
13323423|NCT01167881|26574601|FG001|Overall Study|Other not defined above|55|||
13323424|NCT01167634|26574624|FG000|Overall Study|Lost to Follow-up|1|||
13323425|NCT01167634|26574625|FG001|Overall Study|Lost to Follow-up|3|||
13323426|NCT01167634|26574626|FG002|Overall Study|Lost to Follow-up|3|||
13323427|NCT01167634|26574627|FG003|Overall Study|Lost to Follow-up|4|||
13323428|NCT01167634|26574624|FG000|Overall Study|Withdrawal by Subject|1|||
13323429|NCT01167634|26574625|FG001|Overall Study|Withdrawal by Subject|1|||
13323430|NCT01167634|26574626|FG002|Overall Study|Withdrawal by Subject|0|||
13323431|NCT01167634|26574627|FG003|Overall Study|Withdrawal by Subject|0|||
13323432|NCT01167582|26574664|FG000|Overall Study|Lost to Follow-up|0|||
13323433|NCT01167582|26574665|FG001|Overall Study|Lost to Follow-up|1|||
13323434|NCT01167426|26574673|FG000|Overall Study|Lost to Follow-up|6|||
13323435|NCT01167426|26574673|FG000|Overall Study|Protocol Violation|1|||
13323436|NCT01167426|26574673|FG000|Overall Study|Withdrawal by Subject|2|||
13323437|NCT01167426|26574673|FG000|Overall Study|Sponsor Decision|1|||
13323438|NCT01167257|26574702|FG000|Overall Study|Lost to Follow-up|2|||
13323439|NCT01167257|26574703|FG001|Overall Study|Lost to Follow-up|2|||
13323440|NCT01167257|26574702|FG000|Overall Study|Withdrew consent|1|||
13323441|NCT01167257|26574703|FG001|Overall Study|Withdrew consent|1|||
13323442|NCT01167192|26574720|FG000|Overall Study|Adverse Event|1|||
13323443|NCT01167192|26574720|FG000|Overall Study|Death|1|||
13323444|NCT01167192|26574720|FG000|Overall Study|Withdrawal by Subject|1|||
13323445|NCT01167192|26574720|FG000|Overall Study|Insurance denial|1|||
13323446|NCT01167179|26574735|FG000|Overall Study|disease recurrence|4|||
13323447|NCT01167179|26574736|FG001|Overall Study|disease recurrence|4|||
13323448|NCT01167179|26574735|FG000|Overall Study|Death|4|||
13323449|NCT01167179|26574736|FG001|Overall Study|Death|10|||
13323450|NCT01167179|26574735|FG000|Overall Study|Withdrawal by Subject|1|||
13323451|NCT01167179|26574736|FG001|Overall Study|Withdrawal by Subject|2|||
13323452|NCT01167179|26574735|FG000|Overall Study|diverse|6|||
13323453|NCT01167179|26574736|FG001|Overall Study|diverse|5|||
13323454|NCT01167153|26574761|FG000|Overall Study|Non-effective therapy|1|||
13323455|NCT01167153|26574762|FG001|Overall Study|Non-effective therapy|4|||
13323456|NCT01167153|26574761|FG000|Overall Study|AE including clinical laboratory AE|2|||
13323457|NCT01167153|26574762|FG001|Overall Study|AE including clinical laboratory AE|8|||
13323458|NCT01167153|26574761|FG000|Overall Study|Hypotension|1|||
13323459|NCT01167153|26574762|FG001|Overall Study|Hypotension|0|||
13323460|NCT01167153|26574761|FG000|Overall Study|Lost to Follow-up|7|||
13323461|NCT01167153|26574762|FG001|Overall Study|Lost to Follow-up|9|||
13323462|NCT01167153|26574761|FG000|Overall Study|Non-compliance to concomitant medication|0|||
13323463|NCT01167153|26574762|FG001|Overall Study|Non-compliance to concomitant medication|2|||
13323464|NCT01167153|26574761|FG000|Overall Study|Investigator initiation withdrawal,Other|1|||
13323465|NCT01167153|26574762|FG001|Overall Study|Investigator initiation withdrawal,Other|1|||
13323466|NCT01167153|26574761|FG000|Overall Study|Withdrawal consent|1|||
13323467|NCT01167153|26574762|FG001|Overall Study|Withdrawal consent|1|||
13323468|NCT01167153|26574761|FG000|Overall Study|Subject initiation withdrawal, Other|5|||
13323469|NCT01167153|26574762|FG001|Overall Study|Subject initiation withdrawal, Other|8|||
13323470|NCT01167140|26574770|FG000|Overall Study|Withdrawal by Subject|1|||
13323471|NCT01167023|26574796|FG000|Overall Study|Lost to Follow-up|0|||
13323472|NCT01167023|26574797|FG001|Overall Study|Lost to Follow-up|1|||
13323473|NCT01167023|26574798|FG002|Overall Study|Lost to Follow-up|1|||
13323474|NCT01167023|26574796|FG000|Overall Study|Screen Failure|0|||
13323475|NCT01167023|26574797|FG001|Overall Study|Screen Failure|1|||
13323476|NCT01167023|26574798|FG002|Overall Study|Screen Failure|0|||
13323477|NCT01167023|26574796|FG000|Overall Study|Sponsor Decision|0|||
13323478|NCT01167023|26574797|FG001|Overall Study|Sponsor Decision|1|||
13323479|NCT01167023|26574798|FG002|Overall Study|Sponsor Decision|0|||
13323480|NCT01167023|26574796|FG000|Overall Study|Withdrawal by Subject|0|||
13323481|NCT01167023|26574797|FG001|Overall Study|Withdrawal by Subject|0|||
13323482|NCT01167023|26574798|FG002|Overall Study|Withdrawal by Subject|1|||
13323483|NCT01166958|26574819|FG000|Overall Study|Withdrawal by Subject|1|||
13323484|NCT01166958|26574820|FG001|Overall Study|Withdrawal by Subject|0|||
13323485|NCT01166945|26574835|FG000|Randomized|diagnosed with Group A strep|4|||
13323486|NCT01166945|26574836|FG001|Randomized|diagnosed with Group A strep|4|||
13323487|NCT01166945|26574835|FG000|Day 10|NonCompliance/Lost to Follow Up|3|||
13323488|NCT01166945|26574836|FG001|Day 10|NonCompliance/Lost to Follow Up|2|||
13323489|NCT01166945|26574835|FG000|Day 15|NonCompliance/Lost to Follow Up|2|||
13323490|NCT01166945|26574836|FG001|Day 15|NonCompliance/Lost to Follow Up|1|||
13323491|NCT01166945|26574835|FG000|Day 30|Lost to Follow-up|4|||
13323492|NCT01166945|26574836|FG001|Day 30|Lost to Follow-up|3|||
13323493|NCT01166763|26574844|FG000|Overall Study|Withdrawal by Subject|3|||
13323494|NCT01166750|26574857|FG000|Overall Study|Lost to Follow-up|1|||
13323495|NCT01166750|26574858|FG001|Overall Study|Lost to Follow-up|0|||
13323496|NCT01166659|26574867|FG000|Overall Study|Subject Decision|8|||
13323497|NCT01166659|26574867|FG000|Overall Study|Investigator Decision|2|||
13323498|NCT01166659|26574867|FG000|Overall Study|Death|1|||
13323499|NCT01166659|26574867|FG000|Overall Study|Lost to Follow-up|1|||
13323500|NCT01166659|26574867|FG000|Overall Study|Study Closed at Site|1|||
13323501|NCT01166646|26574890|FG000|Overall Study|Protocol Violation|0|||
13323502|NCT01166646|26574891|FG001|Overall Study|Protocol Violation|1|||
13323503|NCT01166646|26574890|FG000|Overall Study|Adverse Event|1|||
13323504|NCT01166646|26574891|FG001|Overall Study|Adverse Event|0|||
13323505|NCT01166568|26574912|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
13323506|NCT01166568|26574913|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
13323507|NCT01166568|26574914|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1|||
13323508|NCT01166568|26574912|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7|||
13323509|NCT01166568|26574913|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
13323510|NCT01166568|26574914|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0|||
13323511|NCT01166568|26574912|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7|||
13323512|NCT01166568|26574913|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
13323513|NCT01166568|26574914|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
13323514|NCT01166438|26574935|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8|||
13323515|NCT01166438|26574936|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4|||
13323516|NCT01166438|26574935|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0|||
13323517|NCT01166438|26574936|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4|||
13323518|NCT01166438|26574935|FG000|Double-blind Phase: 1st 6 Months|Not treated|1|||
13323519|NCT01166438|26574936|FG001|Double-blind Phase: 1st 6 Months|Not treated|1|||
13323520|NCT01166438|26574935|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1|||
13323521|NCT01166438|26574936|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2|||
13323522|NCT01166438|26574935|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4|||
13323523|NCT01166438|26574936|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2|||
13323524|NCT01166438|26574935|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29|||
13323525|NCT01166438|26574936|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52|||
13323526|NCT01166386|26574951|FG000|Overall Study|Withdrawal by Subject|3|||
13323527|NCT01166386|26574952|FG001|Overall Study|Withdrawal by Subject|5|||
13323528|NCT01166373|26575063|FG000|Overall Study|Lost to Follow-up|3|||
13323529|NCT01166373|26575064|FG001|Overall Study|Lost to Follow-up|2|||
13323530|NCT01166373|26575065|FG002|Overall Study|Lost to Follow-up|2|||
13323531|NCT01166373|26575066|FG003|Overall Study|Lost to Follow-up|2|||
13323532|NCT01166373|26575063|FG000|Overall Study|Withdrawal by Subject|1|||
13323533|NCT01166373|26575064|FG001|Overall Study|Withdrawal by Subject|2|||
13323534|NCT01166373|26575065|FG002|Overall Study|Withdrawal by Subject|2|||
13323535|NCT01166373|26575066|FG003|Overall Study|Withdrawal by Subject|3|||
13323536|NCT01166373|26575063|FG000|Overall Study|Physician Decision|1|||
13323537|NCT01166373|26575064|FG001|Overall Study|Physician Decision|0|||
13323538|NCT01166373|26575065|FG002|Overall Study|Physician Decision|0|||
13323539|NCT01166373|26575066|FG003|Overall Study|Physician Decision|0|||
13323540|NCT01166282|26575096|FG000|Open-label Period|Adverse Event|0|||
13323541|NCT01166282|26575097|FG001|Open-label Period|Adverse Event|0|||
13323542|NCT01166282|26575098|FG002|Open-label Period|Adverse Event|6|||
13323543|NCT01166282|26575096|FG000|Open-label Period|Withdrawal by Subject|0|||
13323544|NCT01166282|26575097|FG001|Open-label Period|Withdrawal by Subject|0|||
13323545|NCT01166282|26575098|FG002|Open-label Period|Withdrawal by Subject|4|||
13323546|NCT01166282|26575096|FG000|Open-label Period|Lack of Efficacy|0|||
13323547|NCT01166282|26575097|FG001|Open-label Period|Lack of Efficacy|0|||
13323548|NCT01166282|26575098|FG002|Open-label Period|Lack of Efficacy|2|||
13323549|NCT01166282|26575096|FG000|Open-label Period|Remission|0|||
13323550|NCT01166282|26575097|FG001|Open-label Period|Remission|0|||
13323551|NCT01166282|26575098|FG002|Open-label Period|Remission|4|||
13323552|NCT01166282|26575096|FG000|Open-label Period|Irregular Compliance|0|||
13323553|NCT01166282|26575097|FG001|Open-label Period|Irregular Compliance|0|||
13323554|NCT01166282|26575098|FG002|Open-label Period|Irregular Compliance|1|||
13323555|NCT01166178|26575131|FG000|Overall Study|Withdrawal by Subject|1|||
13323556|NCT01166178|26575132|FG001|Overall Study|Withdrawal by Subject|0|||
13323557|NCT01166178|26575131|FG000|Overall Study|Study was terminated|20|||
13323558|NCT01166178|26575132|FG001|Overall Study|Study was terminated|8|||
13323559|NCT01165996|26575144|FG000|Overall Study|Death|1|||
13323560|NCT01165996|26575144|FG000|Overall Study|Physician Decision|1|||
13323561|NCT01165684|26575185|FG000|Overall Study|Adverse Event|1|||
13323562|NCT01165684|26575186|FG001|Overall Study|Adverse Event|1|||
13323563|NCT01165684|26575185|FG000|Overall Study|Lack of Efficacy|2|||
13323564|NCT01165684|26575186|FG001|Overall Study|Lack of Efficacy|1|||
13323565|NCT01165684|26575185|FG000|Overall Study|Protocol Violation|7|||
13323566|NCT01165684|26575186|FG001|Overall Study|Protocol Violation|15|||
13323567|NCT01165684|26575185|FG000|Overall Study|Withdrawal Criteria|2|||
13323568|NCT01165684|26575186|FG001|Overall Study|Withdrawal Criteria|13|||
13323569|NCT01165684|26575185|FG000|Overall Study|Unclassified|16|||
13323570|NCT01165684|26575186|FG001|Overall Study|Unclassified|22|||
13323571|NCT01165554|26575195|FG000|Overall Study|Withdrawal by Subject|23|||
13323572|NCT01165424|26575202|FG000|Overall Study|Clinical adverse experiences|1|||
13323573|NCT01165424|26575202|FG000|Overall Study|Laboratory adverse experiences|1|||
13323574|NCT01165424|26575202|FG000|Overall Study|Did not meet entry criteria|1|||
13323575|NCT01165424|26575202|FG000|Overall Study|Participant moved (relocated)|1|||
13323576|NCT01165320|26575218|FG000|Overall Study|Clinical adverse experience|2|||
13323577|NCT01165320|26575219|FG001|Overall Study|Clinical adverse experience|1|||
13323578|NCT01165320|26575220|FG002|Overall Study|Clinical adverse experience|0|||
13323579|NCT01165320|26575218|FG000|Overall Study|Laboratory adverse experience|1|||
13323580|NCT01165320|26575219|FG001|Overall Study|Laboratory adverse experience|0|||
13323581|NCT01165320|26575220|FG002|Overall Study|Laboratory adverse experience|0|||
13323582|NCT01165320|26575218|FG000|Overall Study|Lack of Efficacy|0|||
13323583|NCT01165320|26575219|FG001|Overall Study|Lack of Efficacy|2|||
13323584|NCT01165320|26575220|FG002|Overall Study|Lack of Efficacy|0|||
13323585|NCT01165320|26575218|FG000|Overall Study|Reason unknown|0|||
13323586|NCT01165320|26575219|FG001|Overall Study|Reason unknown|1|||
13323587|NCT01165320|26575220|FG002|Overall Study|Reason unknown|0|||
13323588|NCT01165307|26575255|FG000|Overall Study|Lost to Follow-up|11|||
13323589|NCT01165307|26575256|FG001|Overall Study|Lost to Follow-up|3|||
13323590|NCT01165307|26575255|FG000|Overall Study|Withdrawal by Subject|2|||
13323591|NCT01165307|26575256|FG001|Overall Study|Withdrawal by Subject|0|||
13323592|NCT01165307|26575255|FG000|Overall Study|Subject not available for contact|1|||
13323593|NCT01165307|26575256|FG001|Overall Study|Subject not available for contact|0|||
13323594|NCT01165281|26575281|FG000|Overall Study|Adverse Event|12|||
13323595|NCT01165281|26575282|FG001|Overall Study|Adverse Event|14|||
13323596|NCT01165281|26575281|FG000|Overall Study|Death|3|||
13323597|NCT01165281|26575282|FG001|Overall Study|Death|4|||
13323598|NCT01165281|26575281|FG000|Overall Study|Lack of Efficacy|4|||
13323599|NCT01165281|26575282|FG001|Overall Study|Lack of Efficacy|1|||
13323600|NCT01165281|26575281|FG000|Overall Study|Lost to Follow-up|0|||
13323601|NCT01165281|26575282|FG001|Overall Study|Lost to Follow-up|1|||
13323602|NCT01165281|26575281|FG000|Overall Study|Physician Decision|8|||
13323603|NCT01165281|26575282|FG001|Overall Study|Physician Decision|1|||
13323604|NCT01165281|26575281|FG000|Overall Study|Protocol Violation|6|||
13323605|NCT01165281|26575282|FG001|Overall Study|Protocol Violation|5|||
13323606|NCT01165281|26575281|FG000|Overall Study|Withdrawal by Subject|8|||
13323607|NCT01165281|26575282|FG001|Overall Study|Withdrawal by Subject|7|||
13323608|NCT01165281|26575281|FG000|Overall Study|Noncompliance with Study Drug|1|||
13323609|NCT01165281|26575282|FG001|Overall Study|Noncompliance with Study Drug|4|||
13323610|NCT01165281|26575281|FG000|Overall Study|Progressive Disease|10|||
13323611|NCT01165281|26575282|FG001|Overall Study|Progressive Disease|14|||
13323612|NCT01165281|26575281|FG000|Overall Study|Other|6|||
13323613|NCT01165281|26575282|FG001|Overall Study|Other|0|||
13323614|NCT01165242|26575324|FG000|Overall Study|Unreachable Subjects|1|||
13323615|NCT01165242|26575325|FG001|Overall Study|Unreachable Subjects|0|||
13323616|NCT01165242|26575326|FG002|Overall Study|Unreachable Subjects|0|||
13323617|NCT01165242|26575324|FG000|Overall Study|Incarcerated Subjects|0|||
13323618|NCT01165242|26575325|FG001|Overall Study|Incarcerated Subjects|1|||
13323619|NCT01165242|26575326|FG002|Overall Study|Incarcerated Subjects|0|||
13323620|NCT01165242|26575324|FG000|Overall Study|Visit 2 Declined by Subject|0|||
13323621|NCT01165242|26575325|FG001|Overall Study|Visit 2 Declined by Subject|0|||
13323622|NCT01165242|26575326|FG002|Overall Study|Visit 2 Declined by Subject|1|||
13323623|NCT01165242|26575324|FG000|Overall Study|Withdrawal by Subject|0|||
13323624|NCT01165242|26575325|FG001|Overall Study|Withdrawal by Subject|2|||
13323625|NCT01165242|26575326|FG002|Overall Study|Withdrawal by Subject|2|||
13323626|NCT01165242|26575324|FG000|Overall Study|Extended Holiday|0|||
13323627|NCT01165242|26575325|FG001|Overall Study|Extended Holiday|0|||
13323628|NCT01165242|26575326|FG002|Overall Study|Extended Holiday|1|||
13323629|NCT01165242|26575324|FG000|Overall Study|Lost to Follow-up|9|||
13323630|NCT01165242|26575325|FG001|Overall Study|Lost to Follow-up|7|||
13323631|NCT01165242|26575326|FG002|Overall Study|Lost to Follow-up|10|||
13323632|NCT01165229|26575465|FG000|Overall Study|Serious Adverse Event|456|||
13323633|NCT01165229|26575466|FG001|Overall Study|Serious Adverse Event|487|||
13323634|NCT01165229|26575465|FG000|Overall Study|Non-Serious Adverse Event|47|||
13323635|NCT01165229|26575466|FG001|Overall Study|Non-Serious Adverse Event|15|||
13323636|NCT01165229|26575465|FG000|Overall Study|Protocol Violation|6|||
13323637|NCT01165229|26575466|FG001|Overall Study|Protocol Violation|8|||
13323638|NCT01165229|26575465|FG000|Overall Study|Withdrawal by Subject|387|||
13323639|NCT01165229|26575466|FG001|Overall Study|Withdrawal by Subject|396|||
13323640|NCT01165229|26575465|FG000|Overall Study|Migrated/moved from study area|51|||
13323641|NCT01165229|26575466|FG001|Overall Study|Migrated/moved from study area|46|||
13323642|NCT01165229|26575465|FG000|Overall Study|Lost to Follow-up|123|||
13323643|NCT01165229|26575466|FG001|Overall Study|Lost to Follow-up|133|||
13323644|NCT01165229|26575465|FG000|Overall Study|Suspected HZ Episode|2|||
13323645|NCT01165229|26575466|FG001|Overall Study|Suspected HZ Episode|2|||
13323646|NCT01165229|26575465|FG000|Overall Study|No reason from the subject|108|||
13323647|NCT01165229|26575466|FG001|Overall Study|No reason from the subject|102|||
13323648|NCT01165229|26575465|FG000|Overall Study|Unknown completion status|0|||
13323649|NCT01165229|26575466|FG001|Overall Study|Unknown completion status|1|||
13323650|NCT01165216|26575493|FG000|Overall Study|Adverse Event|6|||
13323651|NCT01165216|26575494|FG001|Overall Study|Adverse Event|3|||
13323652|NCT01165216|26575493|FG000|Overall Study|Withdrawal by Subject|1|||
13323653|NCT01165216|26575494|FG001|Overall Study|Withdrawal by Subject|1|||
13323654|NCT01165216|26575493|FG000|Overall Study|Disease progression|1|||
13323655|NCT01165216|26575494|FG001|Overall Study|Disease progression|3|||
13323656|NCT01165203|26575589|FG000|Active Phase|Serious Adverse Event|1|||
13323657|NCT01165203|26575590|FG001|Active Phase|Serious Adverse Event|0|||
13323658|NCT01165203|26575589|FG000|Active Phase|Withdrawal by Subject|2|||
13323659|NCT01165203|26575590|FG001|Active Phase|Withdrawal by Subject|1|||
13323660|NCT01165203|26575589|FG000|Active Phase|Migrated/moved from study area|0|||
13323661|NCT01165203|26575590|FG001|Active Phase|Migrated/moved from study area|1|||
13323662|NCT01165203|26575589|FG000|Active Phase|Lost to Follow-up|2|||
13323663|NCT01165203|26575590|FG001|Active Phase|Lost to Follow-up|0|||
13323664|NCT01165203|26575589|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1|||
13323665|NCT01165203|26575590|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0|||
13323666|NCT01165203|26575589|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
13323667|NCT01165203|26575590|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
13323668|NCT01165203|26575589|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2|||
13323669|NCT01165203|26575590|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1|||
13323670|NCT01165203|26575589|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2|||
13323671|NCT01165203|26575590|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0|||
13323672|NCT01165203|26575589|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0|||
13323673|NCT01165203|26575590|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1|||
13323674|NCT01165177|26575723|FG000|Overall Study|Serious Adverse Event|227|||
13323675|NCT01165177|26575724|FG001|Overall Study|Serious Adverse Event|235|||
13323676|NCT01165177|26575723|FG000|Overall Study|Withdrawal by Subject|368|||
13323677|NCT01165177|26575724|FG001|Overall Study|Withdrawal by Subject|354|||
13323678|NCT01165177|26575723|FG000|Overall Study|Protocol Violation|19|||
13323679|NCT01165177|26575724|FG001|Overall Study|Protocol Violation|21|||
13323680|NCT01165177|26575723|FG000|Overall Study|Non-serious adverse event|30|||
13323681|NCT01165177|26575724|FG001|Overall Study|Non-serious adverse event|18|||
13323682|NCT01165177|26575723|FG000|Overall Study|Other unspecified reasons|47|||
13323683|NCT01165177|26575724|FG001|Overall Study|Other unspecified reasons|35|||
13323684|NCT01165177|26575723|FG000|Overall Study|Suspected HZ episode|0|||
13323685|NCT01165177|26575724|FG001|Overall Study|Suspected HZ episode|2|||
13323686|NCT01165177|26575723|FG000|Overall Study|Lost to Follow-up|183|||
13323687|NCT01165177|26575724|FG001|Overall Study|Lost to Follow-up|194|||
13323688|NCT01165177|26575723|FG000|Overall Study|Migrated/ moved from study area|48|||
13323689|NCT01165177|26575724|FG001|Overall Study|Migrated/ moved from study area|43|||
13323690|NCT01165138|26575794|FG000|Overall Study|Adverse Event|0|||
13323691|NCT01165138|26575795|FG001|Overall Study|Adverse Event|1|||
13323692|NCT01165138|26575796|FG002|Overall Study|Adverse Event|0|||
13323693|NCT01165138|26575797|FG003|Overall Study|Adverse Event|2|||
13323694|NCT01165138|26575794|FG000|Overall Study|Lack of Efficacy|0|||
13323695|NCT01165138|26575795|FG001|Overall Study|Lack of Efficacy|32|||
13323696|NCT01165138|26575796|FG002|Overall Study|Lack of Efficacy|6|||
13323697|NCT01165138|26575797|FG003|Overall Study|Lack of Efficacy|7|||
13323698|NCT01165138|26575794|FG000|Overall Study|Protocol Violation|0|||
13323699|NCT01165138|26575795|FG001|Overall Study|Protocol Violation|7|||
13323700|NCT01165138|26575796|FG002|Overall Study|Protocol Violation|0|||
13323701|NCT01165138|26575797|FG003|Overall Study|Protocol Violation|2|||
13323702|NCT01165138|26575794|FG000|Overall Study|Lost to Follow-up|0|||
13323703|NCT01165138|26575795|FG001|Overall Study|Lost to Follow-up|0|||
13323704|NCT01165138|26575796|FG002|Overall Study|Lost to Follow-up|1|||
13323705|NCT01165138|26575797|FG003|Overall Study|Lost to Follow-up|2|||
13323706|NCT01165138|26575794|FG000|Overall Study|Physician Decision|0|||
13323707|NCT01165138|26575795|FG001|Overall Study|Physician Decision|6|||
13323708|NCT01165138|26575796|FG002|Overall Study|Physician Decision|7|||
13323709|NCT01165138|26575797|FG003|Overall Study|Physician Decision|6|||
13323710|NCT01165138|26575794|FG000|Overall Study|Withdrawal by Subject|0|||
13323711|NCT01165138|26575795|FG001|Overall Study|Withdrawal by Subject|6|||
13323712|NCT01165138|26575796|FG002|Overall Study|Withdrawal by Subject|6|||
13323713|NCT01165138|26575797|FG003|Overall Study|Withdrawal by Subject|3|||
13323714|NCT01165021|26575807|FG000|Overall Study|Death|1|||
13323715|NCT01164956|26575819|FG000|Overall Study|Side Effects|1|||
13323716|NCT01164956|26575820|FG001|Overall Study|Side Effects|0|||
13323717|NCT01164956|26575821|FG002|Overall Study|Side Effects|1|||
13323718|NCT01164891|26575841|FG000|Overall Study|Disease Progression|5|||
13323719|NCT01164891|26575841|FG000|Overall Study|Adverse Event|1|||
13323720|NCT01164865|26575856|FG000|Overall Study|Lost to Follow-up|2|||
13323721|NCT01164865|26575857|FG001|Overall Study|Lost to Follow-up|1|||
13323722|NCT01164722|26575878|FG000|Overall Study|Adverse Event|0|||
13323723|NCT01164722|26575879|FG001|Overall Study|Adverse Event|1|||
13323724|NCT01164722|26575878|FG000|Overall Study|Withdrawal by Subject|3|||
13323725|NCT01164722|26575879|FG001|Overall Study|Withdrawal by Subject|4|||
13323726|NCT01164722|26575878|FG000|Overall Study|Lost to Follow-up|3|||
13323727|NCT01164722|26575879|FG001|Overall Study|Lost to Follow-up|6|||
13323728|NCT01164722|26575878|FG000|Overall Study|met protocol criteria for non-treatment|11|||
13323729|NCT01164722|26575879|FG001|Overall Study|met protocol criteria for non-treatment|1|||
13323730|NCT01164722|26575878|FG000|Overall Study|enrolled on other study, concomitant med|1|||
13323731|NCT01164722|26575879|FG001|Overall Study|enrolled on other study, concomitant med|3|||
13323732|NCT01164579|26575966|FG000|Overall Study|Lack of Efficacy|0|||
13323733|NCT01164579|26575967|FG001|Overall Study|Lack of Efficacy|0|||
13323734|NCT01164579|26575968|FG002|Overall Study|Lack of Efficacy|6|||
13323735|NCT01164579|26575966|FG000|Overall Study|Lost to Follow-up|1|||
13323736|NCT01164579|26575967|FG001|Overall Study|Lost to Follow-up|1|||
13323737|NCT01164579|26575968|FG002|Overall Study|Lost to Follow-up|0|||
13323738|NCT01164579|26575966|FG000|Overall Study|Withdrawal by Subject|2|||
13323739|NCT01164579|26575967|FG001|Overall Study|Withdrawal by Subject|5|||
13323740|NCT01164579|26575968|FG002|Overall Study|Withdrawal by Subject|3|||
13323741|NCT01164579|26575966|FG000|Overall Study|Protocol Violation|0|||
13323742|NCT01164579|26575967|FG001|Overall Study|Protocol Violation|1|||
13323743|NCT01164579|26575968|FG002|Overall Study|Protocol Violation|2|||
13323744|NCT01164579|26575966|FG000|Overall Study|Adverse Event|4|||
13323745|NCT01164579|26575967|FG001|Overall Study|Adverse Event|2|||
13323746|NCT01164579|26575968|FG002|Overall Study|Adverse Event|5|||
13323747|NCT01164579|26575966|FG000|Overall Study|Reason not specified|1|||
13323748|NCT01164579|26575967|FG001|Overall Study|Reason not specified|0|||
13323749|NCT01164579|26575968|FG002|Overall Study|Reason not specified|0|||
13323750|NCT01164501|26575993|FG000|Overall Study|Not treated|2|||
13323751|NCT01164501|26575994|FG001|Overall Study|Not treated|0|||
13323752|NCT01164501|26575995|FG002|Overall Study|Not treated|1|||
13323753|NCT01164501|26575993|FG000|Overall Study|Adverse Event|18|||
13323754|NCT01164501|26575994|FG001|Overall Study|Adverse Event|4|||
13323755|NCT01164501|26575995|FG002|Overall Study|Adverse Event|21|||
13323756|NCT01164501|26575993|FG000|Overall Study|Lack of Efficacy|0|||
13323757|NCT01164501|26575994|FG001|Overall Study|Lack of Efficacy|0|||
13323758|NCT01164501|26575995|FG002|Overall Study|Lack of Efficacy|1|||
13323759|NCT01164501|26575993|FG000|Overall Study|Non compliant with protocol|1|||
13323760|NCT01164501|26575994|FG001|Overall Study|Non compliant with protocol|1|||
13323761|NCT01164501|26575995|FG002|Overall Study|Non compliant with protocol|4|||
13323762|NCT01164501|26575993|FG000|Overall Study|Lost to Follow-up|3|||
13323763|NCT01164501|26575994|FG001|Overall Study|Lost to Follow-up|0|||
13323764|NCT01164501|26575995|FG002|Overall Study|Lost to Follow-up|3|||
13323765|NCT01164501|26575993|FG000|Overall Study|Patient refusal to continue,not due toAE|10|||
13323766|NCT01164501|26575994|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
13323767|NCT01164501|26575995|FG002|Overall Study|Patient refusal to continue,not due toAE|8|||
13323768|NCT01164501|26575993|FG000|Overall Study|Other reason not defined above|9|||
13323769|NCT01164501|26575994|FG001|Overall Study|Other reason not defined above|1|||
13323770|NCT01164501|26575995|FG002|Overall Study|Other reason not defined above|4|||
13323771|NCT01164475|26576026|FG000|Overall Study|Lack of Efficacy|1|||
13323772|NCT01164475|26576027|FG001|Overall Study|Lack of Efficacy|0|||
13323773|NCT01164475|26576026|FG000|Overall Study|Other|0|||
13323774|NCT01164475|26576027|FG001|Overall Study|Other|1|||
13323775|NCT01164475|26576026|FG000|Overall Study|Progressive disease|0|||
13323776|NCT01164475|26576027|FG001|Overall Study|Progressive disease|1|||
13323777|NCT01164475|26576026|FG000|Overall Study|Protocol Violation|1|||
13323778|NCT01164475|26576027|FG001|Overall Study|Protocol Violation|0|||
13323779|NCT01164007|26576043|FG000|Overall Study|Adverse Event|5|||
13323780|NCT01164007|26576043|FG000|Overall Study|Progression of Disease|30|||
13323781|NCT01164007|26576043|FG000|Overall Study|Protocol Violation|1|||
13323782|NCT01164007|26576043|FG000|Overall Study|Withdrawal by Subject|1|||
13323783|NCT01164007|26576043|FG000|Overall Study|Medical Decision|3|||
13323784|NCT01163916|26576089|FG000|Overall Study|Withdrawal by Subject|2|||
13323785|NCT01163916|26576090|FG001|Overall Study|Withdrawal by Subject|0|||
13323786|NCT01163916|26576091|FG002|Overall Study|Withdrawal by Subject|2|||
13323787|NCT01163916|26576089|FG000|Overall Study|Adverse Event|2|||
13323788|NCT01163916|26576090|FG001|Overall Study|Adverse Event|0|||
13323789|NCT01163916|26576091|FG002|Overall Study|Adverse Event|1|||
13323790|NCT01163916|26576089|FG000|Overall Study|Lack of Efficacy|2|||
13323791|NCT01163916|26576090|FG001|Overall Study|Lack of Efficacy|0|||
13323792|NCT01163916|26576091|FG002|Overall Study|Lack of Efficacy|1|||
13323793|NCT01163916|26576089|FG000|Overall Study|Other|24|||
13323794|NCT01163916|26576090|FG001|Overall Study|Other|4|||
13323795|NCT01163916|26576091|FG002|Overall Study|Other|16|||
13323796|NCT01163851|26576176|FG000|Overall Study|Site Closure|0|||
13323797|NCT01163851|26576177|FG001|Overall Study|Site Closure|1|||
13323798|NCT01163851|26576176|FG000|Overall Study|Enrolled but not treated|1|||
13323799|NCT01163851|26576177|FG001|Overall Study|Enrolled but not treated|0|||
13323800|NCT01163786|26576185|FG000|Treatment With Bortezomib|Withdrawal by Subject|1|||
13323801|NCT01163786|26576185|FG000|Treatment With Bortezomib|Adverse Event|2|||
13323802|NCT01163786|26576185|FG000|Completed Follow up (Visit 9 and 10)|Other|1|||
13323803|NCT01163747|26576210|FG000|Overall Study|Adverse Event|0|||
13323804|NCT01163747|26576211|FG001|Overall Study|Adverse Event|5|||
13323805|NCT01163747|26576210|FG000|Overall Study|Insufficient Therapeutic Response|0|||
13323806|NCT01163747|26576211|FG001|Overall Study|Insufficient Therapeutic Response|1|||
13323807|NCT01163747|26576210|FG000|Overall Study|Protocol Violation|0|||
13323808|NCT01163747|26576211|FG001|Overall Study|Protocol Violation|1|||
13323809|NCT01163747|26576210|FG000|Overall Study|Refused Treatment|6|||
13323810|NCT01163747|26576211|FG001|Overall Study|Refused Treatment|4|||
13323811|NCT01163721|26576228|FG000|Overall Study|Adverse Event|5|||
13323812|NCT01163721|26576229|FG001|Overall Study|Adverse Event|6|||
13323813|NCT01163721|26576228|FG000|Overall Study|Withdrawal by Subject|3|||
13323814|NCT01163721|26576229|FG001|Overall Study|Withdrawal by Subject|4|||
13323815|NCT01163721|26576228|FG000|Overall Study|Lost to Follow-up|0|||
13323816|NCT01163721|26576229|FG001|Overall Study|Lost to Follow-up|1|||
13323817|NCT01163721|26576228|FG000|Overall Study|Physician Decision|0|||
13323818|NCT01163721|26576229|FG001|Overall Study|Physician Decision|1|||
13323819|NCT01163617|26576258|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
13323820|NCT01163617|26576259|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1|||
13323821|NCT01163617|26576260|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
13323822|NCT01163617|26576261|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
13323823|NCT01163617|26576262|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
13323824|NCT01163617|26576263|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
13323825|NCT01163617|26576264|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
13323826|NCT01163617|26576265|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
13323827|NCT01163617|26576258|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
13323828|NCT01163617|26576259|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1|||
13323829|NCT01163617|26576260|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
13323830|NCT01163617|26576261|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
13323831|NCT01163617|26576262|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
13323832|NCT01163617|26576263|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
13323833|NCT01163617|26576264|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
13323834|NCT01163617|26576265|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
13323835|NCT01163617|26576258|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
13323836|NCT01163617|26576259|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
13323837|NCT01163617|26576260|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1|||
13323838|NCT01163617|26576261|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
13323839|NCT01163617|26576262|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
13323840|NCT01163617|26576263|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
13323841|NCT01163617|26576264|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
13323842|NCT01163617|26576265|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
13323843|NCT01163474|26576274|FG000|Overall Study|Withdrawal by Subject|1|||
13323844|NCT01163474|26576274|FG000|Overall Study|Tech barriers to videoteleconference vis|12|||
13323845|NCT01163474|26576274|FG000|Overall Study|Lost to Follow-up|3|||
13323846|NCT01163318|26576283|FG000|Overall Study|Off-Label Use of Adalimumab|8|||
13323847|NCT01163318|26576283|FG000|Overall Study|Did Not Continue Use of Adalimumab|26|||
13323848|NCT01163318|26576283|FG000|Overall Study|History/comorbidity of malignant tumor|3|||
13323849|NCT01163318|26576283|FG000|Overall Study|Participants Without Case Report Form|7|||
13323850|NCT01163318|26576283|FG000|Overall Study|Multiple Reasons Per Participant|224|||
13323851|NCT01163292|26576304|FG000|Overall Study|Lack of Efficacy|9|||
13323852|NCT01163292|26576305|FG001|Overall Study|Lack of Efficacy|0|||
13323853|NCT01163292|26576304|FG000|Overall Study|Adverse Event|6|||
13323854|NCT01163292|26576305|FG001|Overall Study|Adverse Event|0|||
13323855|NCT01163292|26576304|FG000|Overall Study|Initiation of biological therapy|0|||
13323856|NCT01163292|26576305|FG001|Overall Study|Initiation of biological therapy|15|||
13323857|NCT01163292|26576304|FG000|Overall Study|Sufficient response to adalimumab|8|||
13323858|NCT01163292|26576305|FG001|Overall Study|Sufficient response to adalimumab|0|||
13323859|NCT01163292|26576304|FG000|Overall Study|Refusal to receive adalimumab|7|||
13323860|NCT01163292|26576305|FG001|Overall Study|Refusal to receive adalimumab|0|||
13323861|NCT01163292|26576304|FG000|Overall Study|Economic reasons|6|||
13323862|NCT01163292|26576305|FG001|Overall Study|Economic reasons|0|||
13323863|NCT01163292|26576304|FG000|Overall Study|No further visits|5|||
13323864|NCT01163292|26576305|FG001|Overall Study|No further visits|7|||
13323865|NCT01163279|26576338|FG000|Overall Study|Withdrawal by Subject|2|||
13323866|NCT01163279|26576339|FG001|Overall Study|Withdrawal by Subject|0|||
13323867|NCT01163266|26576372|FG000|Overall Study|Pretreatment Event or Adverse Event|2|||
13323868|NCT01163266|26576373|FG001|Overall Study|Pretreatment Event or Adverse Event|9|||
13323869|NCT01163266|26576374|FG002|Overall Study|Pretreatment Event or Adverse Event|7|||
13323870|NCT01163266|26576372|FG000|Overall Study|Lack of Efficacy|1|||
13323871|NCT01163266|26576373|FG001|Overall Study|Lack of Efficacy|3|||
13323872|NCT01163266|26576374|FG002|Overall Study|Lack of Efficacy|1|||
13323873|NCT01163266|26576372|FG000|Overall Study|Noncompliance with Study Drug|0|||
13323874|NCT01163266|26576373|FG001|Overall Study|Noncompliance with Study Drug|2|||
13323875|NCT01163266|26576374|FG002|Overall Study|Noncompliance with Study Drug|0|||
13323876|NCT01163266|26576372|FG000|Overall Study|Protocol Deviations|2|||
13323877|NCT01163266|26576373|FG001|Overall Study|Protocol Deviations|2|||
13323878|NCT01163266|26576374|FG002|Overall Study|Protocol Deviations|5|||
13323879|NCT01163266|26576372|FG000|Overall Study|Withdrawal of Consent|5|||
13323880|NCT01163266|26576373|FG001|Overall Study|Withdrawal of Consent|7|||
13323881|NCT01163266|26576374|FG002|Overall Study|Withdrawal of Consent|3|||
13323882|NCT01163266|26576372|FG000|Overall Study|Lost to Follow-up|7|||
13323883|NCT01163266|26576373|FG001|Overall Study|Lost to Follow-up|7|||
13323884|NCT01163266|26576374|FG002|Overall Study|Lost to Follow-up|10|||
13323885|NCT01163266|26576372|FG000|Overall Study|Other|1|||
13323886|NCT01163266|26576373|FG001|Overall Study|Other|1|||
13323887|NCT01163266|26576374|FG002|Overall Study|Other|2|||
13323888|NCT01163253|26576541|FG000|Overall Study|Withdrawn Due to Pregnancy|12|||
13323889|NCT01163253|26576542|FG001|Overall Study|Withdrawn Due to Pregnancy|2|||
13323890|NCT01163253|26576541|FG000|Overall Study|Study Terminated by Sponsor|978|||
13323891|NCT01163253|26576542|FG001|Overall Study|Study Terminated by Sponsor|349|||
13323892|NCT01163253|26576541|FG000|Overall Study|Protocol Violation|43|||
13323893|NCT01163253|26576542|FG001|Overall Study|Protocol Violation|12|||
13323894|NCT01163253|26576541|FG000|Overall Study|Withdrawal by Subject|199|||
13323895|NCT01163253|26576542|FG001|Overall Study|Withdrawal by Subject|50|||
13323896|NCT01163253|26576541|FG000|Overall Study|Medication Error|1|||
13323897|NCT01163253|26576542|FG001|Overall Study|Medication Error|0|||
13323898|NCT01163253|26576541|FG000|Overall Study|Lost to Follow-up|125|||
13323899|NCT01163253|26576542|FG001|Overall Study|Lost to Follow-up|23|||
13323900|NCT01163253|26576541|FG000|Overall Study|Insufficient Clinical Response|423|||
13323901|NCT01163253|26576542|FG001|Overall Study|Insufficient Clinical Response|29|||
13323902|NCT01163253|26576541|FG000|Overall Study|Adverse Event|300|||
13323903|NCT01163253|26576542|FG001|Overall Study|Adverse Event|78|||
13323904|NCT01163253|26576541|FG000|Overall Study|Death|17|||
13323905|NCT01163253|26576542|FG001|Overall Study|Death|5|||
13323906|NCT01163253|26576541|FG000|Overall Study|Ongoing|13|||
13323907|NCT01163253|26576542|FG001|Overall Study|Ongoing|4|||
13323908|NCT01163253|26576541|FG000|Overall Study|Other Unspecified|170|||
13323909|NCT01163253|26576542|FG001|Overall Study|Other Unspecified|34|||
13323910|NCT01163149|26576594|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
13323911|NCT01163149|26576595|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
13323912|NCT01163149|26576596|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
13323913|NCT01163149|26576594|FG000|Extension Treatment Period|Adverse Event|0|||
13323914|NCT01163149|26576595|FG001|Extension Treatment Period|Adverse Event|1|||
13323915|NCT01163149|26576596|FG002|Extension Treatment Period|Adverse Event|0|||
13323916|NCT01163149|26576594|FG000|Extension Treatment Period|Noncompliance|0|||
13323917|NCT01163149|26576595|FG001|Extension Treatment Period|Noncompliance|0|||
13323918|NCT01163149|26576596|FG002|Extension Treatment Period|Noncompliance|1|||
13323919|NCT01163032|26576636|FG000|Randomization Phase|Withdrawal by Subject|2|||
13323920|NCT01163032|26576637|FG001|Randomization Phase|Withdrawal by Subject|3|||
13323921|NCT01163032|26576638|FG002|Randomization Phase|Withdrawal by Subject|0|||
13323922|NCT01163032|26576636|FG000|Randomization Phase|Adverse Event|3|||
13323923|NCT01163032|26576637|FG001|Randomization Phase|Adverse Event|3|||
13323924|NCT01163032|26576638|FG002|Randomization Phase|Adverse Event|0|||
13323925|NCT01163032|26576636|FG000|Randomization Phase|Protocol Violation|0|||
13323926|NCT01163032|26576637|FG001|Randomization Phase|Protocol Violation|1|||
13323927|NCT01163032|26576638|FG002|Randomization Phase|Protocol Violation|0|||
13323928|NCT01163032|26576636|FG000|Randomization Phase|Various*|5|||
13323929|NCT01163032|26576637|FG001|Randomization Phase|Various*|4|||
13323930|NCT01163032|26576638|FG002|Randomization Phase|Various*|0|||
13323931|NCT01163032|26576636|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
13323932|NCT01163032|26576637|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1|||
13323933|NCT01163032|26576638|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
13323934|NCT01163032|26576636|FG000|Open Label Extension Phase|Adverse Event|0|||
13323935|NCT01163032|26576637|FG001|Open Label Extension Phase|Adverse Event|0|||
13323936|NCT01163032|26576638|FG002|Open Label Extension Phase|Adverse Event|3|||
13323937|NCT01163032|26576636|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
13323938|NCT01163032|26576637|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
13323939|NCT01163032|26576638|FG002|Open Label Extension Phase|Withdrawal by Subject|3|||
13323940|NCT01163032|26576636|FG000|Open Label Extension Phase|Protocol Violation|0|||
13323941|NCT01163032|26576637|FG001|Open Label Extension Phase|Protocol Violation|0|||
13323942|NCT01163032|26576638|FG002|Open Label Extension Phase|Protocol Violation|1|||
13323943|NCT01163032|26576636|FG000|Open Label Extension Phase|Study Termination|0|||
13323944|NCT01163032|26576637|FG001|Open Label Extension Phase|Study Termination|0|||
13323945|NCT01163032|26576638|FG002|Open Label Extension Phase|Study Termination|7|||
13323946|NCT01163032|26576636|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
13323947|NCT01163032|26576637|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
13323948|NCT01163032|26576638|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2|||
13323949|NCT01162863|26576662|FG000|Overall Study|Lack of Efficacy|1|||
13323950|NCT01162863|26576663|FG001|Overall Study|Lack of Efficacy|0|||
13323951|NCT01162863|26576664|FG002|Overall Study|Lack of Efficacy|0|||
13323952|NCT01162863|26576662|FG000|Overall Study|Adverse Event|0|||
13323953|NCT01162863|26576663|FG001|Overall Study|Adverse Event|1|||
13323954|NCT01162863|26576664|FG002|Overall Study|Adverse Event|0|||
13323955|NCT01162499|26576687|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0|||
13323956|NCT01162499|26576688|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1|||
13323957|NCT01162486|26576735|FG000|Overall Study|low ANC|1|||
13323958|NCT01162486|26576736|FG001|Overall Study|low ANC|0|||
13323959|NCT01162486|26576737|FG002|Overall Study|low ANC|0|||
13323960|NCT01162486|26576738|FG003|Overall Study|low ANC|0|||
13323961|NCT01162486|26576739|FG004|Overall Study|low ANC|0|||
13323962|NCT01162486|26576735|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1|||
13323963|NCT01162486|26576736|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
13323964|NCT01162486|26576737|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
13323965|NCT01162486|26576738|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
13323966|NCT01162486|26576739|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
13323967|NCT01162486|26576735|FG000|Overall Study|elevated LFTs|0|||
13323968|NCT01162486|26576736|FG001|Overall Study|elevated LFTs|0|||
13323969|NCT01162486|26576737|FG002|Overall Study|elevated LFTs|1|||
13323970|NCT01162486|26576738|FG003|Overall Study|elevated LFTs|0|||
13323971|NCT01162486|26576739|FG004|Overall Study|elevated LFTs|0|||
13323972|NCT01162486|26576735|FG000|Overall Study|Pregnancy|0|||
13323973|NCT01162486|26576736|FG001|Overall Study|Pregnancy|0|||
13323974|NCT01162486|26576737|FG002|Overall Study|Pregnancy|0|||
13323975|NCT01162486|26576738|FG003|Overall Study|Pregnancy|1|||
13323976|NCT01162486|26576739|FG004|Overall Study|Pregnancy|0|||
13323977|NCT01162473|26576752|FG000|Overall Study|Adverse Event|2|||
13323978|NCT01162473|26576753|FG001|Overall Study|Adverse Event|1|||
13323979|NCT01162473|26576752|FG000|Overall Study|Withdrawal by Subject|0|||
13323980|NCT01162473|26576753|FG001|Overall Study|Withdrawal by Subject|4|||
13323981|NCT01162421|26576838|FG000|Overall Study|Did not receive study drug|2|||
13323982|NCT01162421|26576839|FG001|Overall Study|Did not receive study drug|1|||
13323983|NCT01162421|26576838|FG000|Overall Study|Adverse Event|2|||
13323984|NCT01162421|26576839|FG001|Overall Study|Adverse Event|5|||
13323985|NCT01162421|26576838|FG000|Overall Study|Lost to Follow-up|0|||
13323986|NCT01162421|26576839|FG001|Overall Study|Lost to Follow-up|2|||
13323987|NCT01162421|26576838|FG000|Overall Study|Lack of Efficacy|2|||
13323988|NCT01162421|26576839|FG001|Overall Study|Lack of Efficacy|2|||
13323989|NCT01162421|26576838|FG000|Overall Study|Other|2|||
13323990|NCT01162421|26576839|FG001|Overall Study|Other|3|||
13323991|NCT01162343|26576845|FG000|Overall Study|Left ED prior to psychiatrist assessment|80|||
13323992|NCT01162343|26576845|FG000|Overall Study|Refused psychiatrist assessment|12|||
13323993|NCT01162304|26576861|FG000|Overall Study|Beck scale to high|11|||
13323994|NCT01162239|26576904|FG000|Treatment Phase|Withdrawal by Subject|1|||
13323995|NCT01162239|26576905|FG001|Treatment Phase|Withdrawal by Subject|3|||
13323996|NCT01162239|26576906|FG002|Treatment Phase|Withdrawal by Subject|2|||
13323997|NCT01162239|26576907|FG003|Treatment Phase|Withdrawal by Subject|3|||
13323998|NCT01162239|26576904|FG000|Treatment Phase|Death|0|||
13323999|NCT01162239|26576905|FG001|Treatment Phase|Death|0|||
13324000|NCT01162239|26576906|FG002|Treatment Phase|Death|0|||
13324001|NCT01162239|26576907|FG003|Treatment Phase|Death|1|||
13324002|NCT01162239|26576904|FG000|Treatment Phase|Lost to Follow-up|5|||
13324003|NCT01162239|26576905|FG001|Treatment Phase|Lost to Follow-up|4|||
13324004|NCT01162239|26576906|FG002|Treatment Phase|Lost to Follow-up|2|||
13324005|NCT01162239|26576907|FG003|Treatment Phase|Lost to Follow-up|1|||
13324006|NCT01162239|26576904|FG000|Extended Follow-up|Lost to Follow-up|8|||
13324007|NCT01162239|26576905|FG001|Extended Follow-up|Lost to Follow-up|13|||
13324008|NCT01162239|26576906|FG002|Extended Follow-up|Lost to Follow-up|8|||
13324009|NCT01162239|26576907|FG003|Extended Follow-up|Lost to Follow-up|6|||
13324010|NCT01162135|26576913|FG000|Overall Study|Withdrawal by Subject|1|||
13324011|NCT01162135|26576913|FG000|Overall Study|Severe back pain|1|||
13324012|NCT01162135|26576913|FG000|Overall Study|Ineligible|1|||
13324013|NCT01162122|26576977|FG000|Overall Study|Withdrawal by Subject|52|||
13324014|NCT01162122|26576978|FG001|Overall Study|Withdrawal by Subject|43|||
13324015|NCT01162122|26576977|FG000|Overall Study|Lost to Follow-up|73|||
13324016|NCT01162122|26576978|FG001|Overall Study|Lost to Follow-up|91|||
13324017|NCT01162122|26576977|FG000|Overall Study|Adverse Event|3|||
13324018|NCT01162122|26576978|FG001|Overall Study|Adverse Event|2|||
13324019|NCT01162122|26576977|FG000|Overall Study|Death|51|||
13324020|NCT01162122|26576978|FG001|Overall Study|Death|46|||
13324021|NCT01162122|26576977|FG000|Overall Study|Protocol Violation|2|||
13324022|NCT01162122|26576978|FG001|Overall Study|Protocol Violation|2|||
13324023|NCT01162122|26576977|FG000|Overall Study|Inappropriate enrollment|5|||
13324024|NCT01162122|26576978|FG001|Overall Study|Inappropriate enrollment|4|||
13324025|NCT01162122|26576977|FG000|Overall Study|Administrative reason|1|||
13324026|NCT01162122|26576978|FG001|Overall Study|Administrative reason|1|||
13324027|NCT01162122|26576977|FG000|Overall Study|Unable to classify|3|||
13324028|NCT01162122|26576978|FG001|Overall Study|Unable to classify|7|||
13324029|NCT01162122|26576977|FG000|Overall Study|Missing primary reason|1|||
13324030|NCT01162122|26576978|FG001|Overall Study|Missing primary reason|0|||
13324031|NCT01161628|26576992|FG000|Overall Study|Death|6|||
13324032|NCT01161628|26576992|FG000|Overall Study|Lack of Efficacy|2|||
13324033|NCT01161537|26577010|FG000|Part B|Withdrawal by Subject|2|||
13324034|NCT01161524|26577055|FG000|Core Study (23 Weeks)|Adverse Event|3|||
13324035|NCT01161524|26577056|FG001|Core Study (23 Weeks)|Adverse Event|0|||
13324036|NCT01161524|26577057|FG002|Core Study (23 Weeks)|Adverse Event|0|||
13324037|NCT01161524|26577055|FG000|Core Study (23 Weeks)|Other|1|||
13324038|NCT01161524|26577056|FG001|Core Study (23 Weeks)|Other|0|||
13324039|NCT01161524|26577057|FG002|Core Study (23 Weeks)|Other|0|||
13324040|NCT01161524|26577055|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1|||
13324041|NCT01161524|26577056|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1|||
13324042|NCT01161524|26577057|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0|||
13324043|NCT01161524|26577055|FG000|Core Study (23 Weeks)|Lost to Follow-up|1|||
13324044|NCT01161524|26577056|FG001|Core Study (23 Weeks)|Lost to Follow-up|2|||
13324045|NCT01161524|26577057|FG002|Core Study (23 Weeks)|Lost to Follow-up|0|||
13324046|NCT01161524|26577055|FG000|Core Study (23 Weeks)|Subject Choice|3|||
13324047|NCT01161524|26577056|FG001|Core Study (23 Weeks)|Subject Choice|2|||
13324048|NCT01161524|26577057|FG002|Core Study (23 Weeks)|Subject Choice|0|||
13324049|NCT01161524|26577055|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
13324050|NCT01161524|26577056|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
13324051|NCT01161524|26577057|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8|||
13324052|NCT01161524|26577055|FG000|Extension Phase (Approximately 83 Weeks)|Other|0|||
13324053|NCT01161524|26577056|FG001|Extension Phase (Approximately 83 Weeks)|Other|0|||
13324054|NCT01161524|26577057|FG002|Extension Phase (Approximately 83 Weeks)|Other|6|||
13324055|NCT01161524|26577055|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
13324056|NCT01161524|26577056|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
13324057|NCT01161524|26577057|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1|||
13324058|NCT01161524|26577055|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
13324059|NCT01161524|26577056|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
13324060|NCT01161524|26577057|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5|||
13324061|NCT01161524|26577055|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
13324062|NCT01161524|26577056|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
13324063|NCT01161524|26577057|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4|||
13324064|NCT01161498|26577088|FG000|Overall Study|Disease Progression|0|||
13324065|NCT01161498|26577089|FG001|Overall Study|Disease Progression|1|||
13324066|NCT01161472|26577148|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1|||
13324067|NCT01161472|26577149|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
13324068|NCT01161472|26577150|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
13324069|NCT01161472|26577151|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
13324070|NCT01161446|26577170|FG000|Overall Study|Lost to Follow-up|18|||
13324071|NCT01161446|26577171|FG001|Overall Study|Lost to Follow-up|14|||
13324072|NCT01161446|26577170|FG000|Overall Study|Withdrawal by Subject|0|||
13324073|NCT01161446|26577171|FG001|Overall Study|Withdrawal by Subject|1|||
13324074|NCT01161407|26577188|FG000|Overall Study|Protocol Violation|3|||
13324075|NCT01161407|26577189|FG001|Overall Study|Protocol Violation|1|||
13324076|NCT01161173|26577200|FG000|Overall Study|Protocol Violation|13|||
13324077|NCT01161173|26577200|FG000|Overall Study|Lost to Follow-up|7|||
13324078|NCT01161173|26577200|FG000|Overall Study|Progressive Disease|82|||
13324079|NCT01161173|26577200|FG000|Overall Study|Withdrawal of Consent|5|||
13324080|NCT01161173|26577200|FG000|Overall Study|Unacceptable Toxicity|21|||
13324081|NCT01161173|26577200|FG000|Overall Study|Death|194|||
13324082|NCT01161173|26577200|FG000|Overall Study|End of Study|2|||
13324083|NCT01161173|26577200|FG000|Overall Study|Reasons Not Specified|23|||
13324084|NCT01161043|26577207|FG000|Overall Study|Withdrawal by Subject|3|||
13324085|NCT01160822|26577318|FG000|Overall Study|Adverse Event|0|||
13324086|NCT01160822|26577319|FG001|Overall Study|Adverse Event|0|||
13324087|NCT01160822|26577320|FG002|Overall Study|Adverse Event|0|||
13324088|NCT01160822|26577321|FG003|Overall Study|Adverse Event|0|||
13324089|NCT01160822|26577322|FG004|Overall Study|Adverse Event|1|||
13324090|NCT01160822|26577323|FG005|Overall Study|Adverse Event|2|||
13324091|NCT01160822|26577324|FG006|Overall Study|Adverse Event|5|||
13324092|NCT01160822|26577318|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
13324093|NCT01160822|26577319|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
13324094|NCT01160822|26577320|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
13324095|NCT01160822|26577321|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
13324096|NCT01160822|26577322|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
13324097|NCT01160822|26577323|FG005|Overall Study|Unsatisfactory therapeutic effect|5|||
13324098|NCT01160822|26577324|FG006|Overall Study|Unsatisfactory therapeutic effect|3|||
13324099|NCT01160822|26577318|FG000|Overall Study|Withdrawal by Subject|0|||
13324100|NCT01160822|26577319|FG001|Overall Study|Withdrawal by Subject|0|||
13324101|NCT01160822|26577320|FG002|Overall Study|Withdrawal by Subject|0|||
13324102|NCT01160822|26577321|FG003|Overall Study|Withdrawal by Subject|0|||
13324103|NCT01160822|26577322|FG004|Overall Study|Withdrawal by Subject|0|||
13324104|NCT01160822|26577323|FG005|Overall Study|Withdrawal by Subject|0|||
13324105|NCT01160822|26577324|FG006|Overall Study|Withdrawal by Subject|1|||
13324106|NCT01160822|26577318|FG000|Overall Study|Lost to Follow-up|0|||
13324107|NCT01160822|26577319|FG001|Overall Study|Lost to Follow-up|0|||
13324108|NCT01160822|26577320|FG002|Overall Study|Lost to Follow-up|0|||
13324109|NCT01160822|26577321|FG003|Overall Study|Lost to Follow-up|0|||
13324110|NCT01160822|26577322|FG004|Overall Study|Lost to Follow-up|1|||
13324111|NCT01160822|26577323|FG005|Overall Study|Lost to Follow-up|0|||
13324112|NCT01160822|26577324|FG006|Overall Study|Lost to Follow-up|0|||
13324113|NCT01160822|26577318|FG000|Overall Study|Administrative problems|0|||
13324114|NCT01160822|26577319|FG001|Overall Study|Administrative problems|0|||
13324115|NCT01160822|26577320|FG002|Overall Study|Administrative problems|0|||
13324116|NCT01160822|26577321|FG003|Overall Study|Administrative problems|0|||
13324117|NCT01160822|26577322|FG004|Overall Study|Administrative problems|1|||
13324118|NCT01160822|26577323|FG005|Overall Study|Administrative problems|0|||
13324119|NCT01160822|26577324|FG006|Overall Study|Administrative problems|0|||
13324120|NCT01160822|26577318|FG000|Overall Study|Protocol deviation|0|||
13324121|NCT01160822|26577319|FG001|Overall Study|Protocol deviation|0|||
13324122|NCT01160822|26577320|FG002|Overall Study|Protocol deviation|0|||
13324123|NCT01160822|26577321|FG003|Overall Study|Protocol deviation|0|||
13324124|NCT01160822|26577322|FG004|Overall Study|Protocol deviation|2|||
13324125|NCT01160822|26577323|FG005|Overall Study|Protocol deviation|0|||
13324126|NCT01160822|26577324|FG006|Overall Study|Protocol deviation|0|||
13324127|NCT01160770|26577335|FG000|Overall Study|Adverse Event|10|||
13324128|NCT01160770|26577335|FG000|Overall Study|Protocol Violation|2|||
13324129|NCT01160770|26577335|FG000|Overall Study|Subject/parent/caregiver request|33|||
13324130|NCT01160770|26577335|FG000|Overall Study|Physician Decision|1|||
13324131|NCT01160770|26577335|FG000|Overall Study|Lost to Follow-up|7|||
13324132|NCT01160770|26577335|FG000|Overall Study|Study termination or sponsor request|1|||
13324133|NCT01160770|26577335|FG000|Overall Study|Death|9|||
13324134|NCT01160770|26577335|FG000|Overall Study|Lack of Efficacy|15|||
13324135|NCT01160770|26577335|FG000|Overall Study|Other Reasons|1|||
13324136|NCT01160744|26577382|FG000|Overall Study|Withdrawal by Subject|11|||
13324137|NCT01160744|26577383|FG001|Overall Study|Withdrawal by Subject|5|||
13324138|NCT01160744|26577384|FG002|Overall Study|Withdrawal by Subject|6|||
13324139|NCT01160744|26577385|FG003|Overall Study|Withdrawal by Subject|4|||
13324140|NCT01160744|26577382|FG000|Overall Study|Not meet inclusion/exclusion criteria|0|||
13324141|NCT01160744|26577383|FG001|Overall Study|Not meet inclusion/exclusion criteria|0|||
13324142|NCT01160744|26577384|FG002|Overall Study|Not meet inclusion/exclusion criteria|1|||
13324143|NCT01160744|26577385|FG003|Overall Study|Not meet inclusion/exclusion criteria|0|||
13373423|NCT00803101|26723779|FG001|Overall Study|Patient died outside SAE report period|0|||
13373424|NCT00803101|26723778|FG000|Overall Study|Patient did not attend scheduled visit|2|||
13373425|NCT00803101|26723779|FG001|Overall Study|Patient did not attend scheduled visit|1|||
13373426|NCT00803101|26723778|FG000|Overall Study|Patient did not have surgery|1|||
13373427|NCT00803101|26723779|FG001|Overall Study|Patient did not have surgery|1|||
13373428|NCT00803049|26723822|FG000|Overall Study|Adverse Event|21|||
13373429|NCT00803049|26723823|FG001|Overall Study|Adverse Event|33|||
13373430|NCT00803049|26723824|FG002|Overall Study|Adverse Event|13|||
13373431|NCT00803049|26723825|FG003|Overall Study|Adverse Event|27|||
13373432|NCT00803049|26723822|FG000|Overall Study|Lack of Efficacy|10|||
13373433|NCT00803049|26723823|FG001|Overall Study|Lack of Efficacy|19|||
13373434|NCT00803049|26723824|FG002|Overall Study|Lack of Efficacy|6|||
13373435|NCT00803049|26723825|FG003|Overall Study|Lack of Efficacy|13|||
13373436|NCT00803049|26723822|FG000|Overall Study|Lost to Follow-up|0|||
13373437|NCT00803049|26723823|FG001|Overall Study|Lost to Follow-up|2|||
13373438|NCT00803049|26723824|FG002|Overall Study|Lost to Follow-up|0|||
13373439|NCT00803049|26723825|FG003|Overall Study|Lost to Follow-up|3|||
13373440|NCT00803049|26723822|FG000|Overall Study|Death|2|||
13373441|NCT00803049|26723823|FG001|Overall Study|Death|1|||
13373442|NCT00803049|26723824|FG002|Overall Study|Death|0|||
13373443|NCT00803049|26723825|FG003|Overall Study|Death|2|||
13373444|NCT00803049|26723822|FG000|Overall Study|Progressive Disease|6|||
13373445|NCT00803049|26723823|FG001|Overall Study|Progressive Disease|10|||
13373446|NCT00803049|26723824|FG002|Overall Study|Progressive Disease|6|||
13373447|NCT00803049|26723825|FG003|Overall Study|Progressive Disease|6|||
13373448|NCT00803049|26723822|FG000|Overall Study|Withdrawal by Subject|19|||
13373449|NCT00803049|26723823|FG001|Overall Study|Withdrawal by Subject|43|||
13373450|NCT00803049|26723824|FG002|Overall Study|Withdrawal by Subject|16|||
13373451|NCT00803049|26723825|FG003|Overall Study|Withdrawal by Subject|44|||
13373452|NCT00803049|26723822|FG000|Overall Study|Protocol Violation|0|||
13373453|NCT00803049|26723823|FG001|Overall Study|Protocol Violation|1|||
13373454|NCT00803049|26723824|FG002|Overall Study|Protocol Violation|1|||
13373455|NCT00803049|26723825|FG003|Overall Study|Protocol Violation|0|||
13373456|NCT00803049|26723822|FG000|Overall Study|Randomized and Not Treated|0|||
13373457|NCT00803049|26723823|FG001|Overall Study|Randomized and Not Treated|0|||
13373458|NCT00803049|26723824|FG002|Overall Study|Randomized and Not Treated|0|||
13373459|NCT00803049|26723825|FG003|Overall Study|Randomized and Not Treated|2|||
13373460|NCT00803049|26723822|FG000|Overall Study|Other than Specified Above|3|||
13373461|NCT00803049|26723823|FG001|Overall Study|Other than Specified Above|9|||
13373462|NCT00803049|26723824|FG002|Overall Study|Other than Specified Above|2|||
13373463|NCT00803049|26723825|FG003|Overall Study|Other than Specified Above|5|||
13373464|NCT00803023|26723848|FG000|Overall Study|Adverse Event|5|||
13373465|NCT00803023|26723849|FG001|Overall Study|Adverse Event|4|||
13373466|NCT00803023|26723850|FG002|Overall Study|Adverse Event|8|||
13373467|NCT00803023|26723851|FG003|Overall Study|Adverse Event|6|||
13373468|NCT00803023|26723848|FG000|Overall Study|Withdrawal by Subject|0|||
13373469|NCT00803023|26723849|FG001|Overall Study|Withdrawal by Subject|2|||
13373470|NCT00803023|26723850|FG002|Overall Study|Withdrawal by Subject|0|||
13373471|NCT00803023|26723851|FG003|Overall Study|Withdrawal by Subject|0|||
13373472|NCT00803023|26723848|FG000|Overall Study|Lost to Follow-up|0|||
13373473|NCT00803023|26723849|FG001|Overall Study|Lost to Follow-up|1|||
13373474|NCT00803023|26723850|FG002|Overall Study|Lost to Follow-up|2|||
13373475|NCT00803023|26723851|FG003|Overall Study|Lost to Follow-up|1|||
13373476|NCT00803023|26723848|FG000|Overall Study|Lack of Efficacy|0|||
13373477|NCT00803023|26723849|FG001|Overall Study|Lack of Efficacy|1|||
13373478|NCT00803023|26723850|FG002|Overall Study|Lack of Efficacy|1|||
13373479|NCT00803023|26723851|FG003|Overall Study|Lack of Efficacy|1|||
13373480|NCT00802945|26723874|FG000|Overall Study|Death|27|||
13373481|NCT00802945|26723875|FG001|Overall Study|Death|23|||
13373482|NCT00802945|26723874|FG000|Overall Study|Terminated by sponsor|8|||
13373483|NCT00802945|26723875|FG001|Overall Study|Terminated by sponsor|12|||
13373484|NCT00802893|26723882|FG000|Overall Study|study terminated|3|||
13375469|NCT00790790|26729933|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
13375470|NCT00790790|26729934|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3|||
13375471|NCT00790790|26729932|FG000|Study Period 2: Therapy Phase|Physician Decision|0|||
13375472|NCT00790790|26729933|FG001|Study Period 2: Therapy Phase|Physician Decision|1|||
13375473|NCT00790790|26729934|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
13324144|NCT01160640|26577406|FG000|Overall Study|Physician Decision|3|||
13324145|NCT01160640|26577407|FG001|Overall Study|Physician Decision|3|||
13324146|NCT01160640|26577406|FG000|Overall Study|Incarceration|1|||
13324147|NCT01160640|26577407|FG001|Overall Study|Incarceration|0|||
13324148|NCT01160640|26577406|FG000|Overall Study|Withdrawal by Subject|0|||
13324149|NCT01160640|26577407|FG001|Overall Study|Withdrawal by Subject|3|||
13324150|NCT01160614|26577462|FG000|Overall Study|Withdrawal by Subject|0|||
13324151|NCT01160614|26577463|FG001|Overall Study|Withdrawal by Subject|2|||
13324152|NCT01160484|26577475|FG000|Overall Study|Lack of Efficacy|9|||
13324153|NCT01160484|26577475|FG000|Overall Study|Adverse Event|6|||
13324154|NCT01160484|26577475|FG000|Overall Study|Withdrawal by Subject|2|||
13324155|NCT01160484|26577475|FG000|Overall Study|inclusion/exclusion criteria failure|1|||
13324156|NCT01160354|26577499|FG000|Overall Study|Death|0|||
13324157|NCT01160354|26577500|FG001|Overall Study|Death|1|||
13324158|NCT01160354|26577501|FG002|Overall Study|Death|1|||
13324159|NCT01160289|26577576|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8|||
13324160|NCT01160289|26577577|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0|||
13324161|NCT01160289|26577578|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0|||
13324162|NCT01160289|26577579|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0|||
13324163|NCT01160289|26577580|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0|||
13324164|NCT01160289|26577581|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0|||
13324165|NCT01160289|26577576|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308|||
13324166|NCT01160289|26577577|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
13324167|NCT01160289|26577578|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
13324168|NCT01160289|26577579|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
13324169|NCT01160289|26577580|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
13324170|NCT01160289|26577581|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
13324171|NCT01160289|26577576|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1|||
13324172|NCT01160289|26577577|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
13324173|NCT01160289|26577578|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
13324174|NCT01160289|26577579|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
13324175|NCT01160289|26577580|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
13324176|NCT01160289|26577581|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
13324177|NCT01160289|26577576|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9|||
13324178|NCT01160289|26577577|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
13324179|NCT01160289|26577578|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
13324180|NCT01160289|26577579|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
13324181|NCT01160289|26577580|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
13324182|NCT01160289|26577581|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
13324183|NCT01160289|26577576|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26|||
13324184|NCT01160289|26577577|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0|||
13324185|NCT01160289|26577578|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0|||
13324186|NCT01160289|26577579|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0|||
13324187|NCT01160289|26577580|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0|||
13324188|NCT01160289|26577581|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0|||
13324189|NCT01160289|26577576|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1|||
13324190|NCT01160289|26577577|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
13324191|NCT01160289|26577578|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
13324192|NCT01160289|26577579|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
13324193|NCT01160289|26577580|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
13324194|NCT01160289|26577581|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
13324195|NCT01160289|26577576|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67|||
13324196|NCT01160289|26577577|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
13324197|NCT01160289|26577578|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
13324198|NCT01160289|26577579|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
13324199|NCT01160289|26577580|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
13324200|NCT01160289|26577581|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
13324201|NCT01160289|26577576|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64|||
13324202|NCT01160289|26577577|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
13324203|NCT01160289|26577578|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
13324204|NCT01160289|26577579|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
13324205|NCT01160289|26577580|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
13324206|NCT01160289|26577581|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
13324207|NCT01160289|26577576|FG000|Post-Randomization Period|Adverse Event|0|||
13324208|NCT01160289|26577577|FG001|Post-Randomization Period|Adverse Event|4|||
13324209|NCT01160289|26577578|FG002|Post-Randomization Period|Adverse Event|4|||
13324210|NCT01160289|26577579|FG003|Post-Randomization Period|Adverse Event|2|||
13324211|NCT01160289|26577580|FG004|Post-Randomization Period|Adverse Event|0|||
13324212|NCT01160289|26577581|FG005|Post-Randomization Period|Adverse Event|0|||
13324213|NCT01160289|26577576|FG000|Post-Randomization Period|Death|0|||
13324214|NCT01160289|26577577|FG001|Post-Randomization Period|Death|0|||
13324215|NCT01160289|26577578|FG002|Post-Randomization Period|Death|0|||
13324216|NCT01160289|26577579|FG003|Post-Randomization Period|Death|1|||
13324217|NCT01160289|26577580|FG004|Post-Randomization Period|Death|0|||
13324218|NCT01160289|26577581|FG005|Post-Randomization Period|Death|0|||
13324219|NCT01160289|26577576|FG000|Post-Randomization Period|Lack of Efficacy|0|||
13324220|NCT01160289|26577577|FG001|Post-Randomization Period|Lack of Efficacy|1|||
13324221|NCT01160289|26577578|FG002|Post-Randomization Period|Lack of Efficacy|0|||
13324222|NCT01160289|26577579|FG003|Post-Randomization Period|Lack of Efficacy|3|||
13324223|NCT01160289|26577580|FG004|Post-Randomization Period|Lack of Efficacy|0|||
13324224|NCT01160289|26577581|FG005|Post-Randomization Period|Lack of Efficacy|0|||
13324225|NCT01160289|26577576|FG000|Post-Randomization Period|Lost to Follow-up|0|||
13324226|NCT01160289|26577577|FG001|Post-Randomization Period|Lost to Follow-up|3|||
13324227|NCT01160289|26577578|FG002|Post-Randomization Period|Lost to Follow-up|2|||
13324228|NCT01160289|26577579|FG003|Post-Randomization Period|Lost to Follow-up|5|||
13324229|NCT01160289|26577580|FG004|Post-Randomization Period|Lost to Follow-up|3|||
13324230|NCT01160289|26577581|FG005|Post-Randomization Period|Lost to Follow-up|4|||
13324231|NCT01160289|26577576|FG000|Post-Randomization Period|Physician Decision|0|||
13324232|NCT01160289|26577577|FG001|Post-Randomization Period|Physician Decision|0|||
13324233|NCT01160289|26577578|FG002|Post-Randomization Period|Physician Decision|1|||
13324234|NCT01160289|26577579|FG003|Post-Randomization Period|Physician Decision|0|||
13324235|NCT01160289|26577580|FG004|Post-Randomization Period|Physician Decision|0|||
13324236|NCT01160289|26577581|FG005|Post-Randomization Period|Physician Decision|0|||
13324237|NCT01160289|26577576|FG000|Post-Randomization Period|Protocol Violation|0|||
13324238|NCT01160289|26577577|FG001|Post-Randomization Period|Protocol Violation|4|||
13324239|NCT01160289|26577578|FG002|Post-Randomization Period|Protocol Violation|2|||
13324240|NCT01160289|26577579|FG003|Post-Randomization Period|Protocol Violation|0|||
13324241|NCT01160289|26577580|FG004|Post-Randomization Period|Protocol Violation|1|||
13324242|NCT01160289|26577581|FG005|Post-Randomization Period|Protocol Violation|3|||
13324243|NCT01160289|26577576|FG000|Post-Randomization Period|Withdrawal by Subject|0|||
13324244|NCT01160289|26577577|FG001|Post-Randomization Period|Withdrawal by Subject|5|||
13324245|NCT01160289|26577578|FG002|Post-Randomization Period|Withdrawal by Subject|13|||
13324246|NCT01160289|26577579|FG003|Post-Randomization Period|Withdrawal by Subject|8|||
13324247|NCT01160289|26577580|FG004|Post-Randomization Period|Withdrawal by Subject|5|||
13324248|NCT01160289|26577581|FG005|Post-Randomization Period|Withdrawal by Subject|7|||
13324249|NCT01160289|26577576|FG000|Post-Randomization Period|Entry Criteria Not Met|0|||
13324250|NCT01160289|26577577|FG001|Post-Randomization Period|Entry Criteria Not Met|2|||
13324251|NCT01160289|26577578|FG002|Post-Randomization Period|Entry Criteria Not Met|2|||
13324252|NCT01160289|26577579|FG003|Post-Randomization Period|Entry Criteria Not Met|2|||
13324253|NCT01160289|26577580|FG004|Post-Randomization Period|Entry Criteria Not Met|0|||
13324254|NCT01160289|26577581|FG005|Post-Randomization Period|Entry Criteria Not Met|0|||
13324255|NCT01160289|26577576|FG000|Post-Randomization Period|Sponsor Decision|0|||
13324256|NCT01160289|26577577|FG001|Post-Randomization Period|Sponsor Decision|1|||
13324257|NCT01160289|26577578|FG002|Post-Randomization Period|Sponsor Decision|0|||
13324258|NCT01160289|26577579|FG003|Post-Randomization Period|Sponsor Decision|0|||
13324259|NCT01160289|26577580|FG004|Post-Randomization Period|Sponsor Decision|0|||
13324260|NCT01160289|26577581|FG005|Post-Randomization Period|Sponsor Decision|0|||
13324261|NCT01160198|26577610|FG000|Overall Study|Withdrawal by Subject|2|||
13324262|NCT01160198|26577611|FG001|Overall Study|Withdrawal by Subject|1|||
13324263|NCT01160198|26577612|FG002|Overall Study|Withdrawal by Subject|0|||
13324264|NCT01160198|26577610|FG000|Overall Study|Adverse Event|0|||
13324265|NCT01160198|26577611|FG001|Overall Study|Adverse Event|1|||
13324266|NCT01160198|26577612|FG002|Overall Study|Adverse Event|0|||
13324267|NCT01160198|26577610|FG000|Overall Study|Lost to Follow-up|0|||
13324268|NCT01160198|26577611|FG001|Overall Study|Lost to Follow-up|1|||
13324269|NCT01160198|26577612|FG002|Overall Study|Lost to Follow-up|0|||
13324270|NCT01160198|26577610|FG000|Overall Study|Participant lost drug; withdrew consent|0|||
13324271|NCT01160198|26577611|FG001|Overall Study|Participant lost drug; withdrew consent|0|||
13324272|NCT01160198|26577612|FG002|Overall Study|Participant lost drug; withdrew consent|1|||
13324273|NCT01159938|26577684|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0|||
13324274|NCT01159938|26577685|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0|||
13324275|NCT01159938|26577686|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1|||
13324276|NCT01159938|26577687|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0|||
13324277|NCT01159938|26577688|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0|||
13324278|NCT01159912|26577721|FG000|Overall Study|Adverse Event|2|||
13324279|NCT01159912|26577722|FG001|Overall Study|Adverse Event|2|||
13324280|NCT01159912|26577723|FG002|Overall Study|Adverse Event|3|||
13324281|NCT01159912|26577721|FG000|Overall Study|Lack of Efficacy|23|||
13324282|NCT01159912|26577722|FG001|Overall Study|Lack of Efficacy|15|||
13324283|NCT01159912|26577723|FG002|Overall Study|Lack of Efficacy|14|||
13324284|NCT01159912|26577721|FG000|Overall Study|Protocol Violation|1|||
13324285|NCT01159912|26577722|FG001|Overall Study|Protocol Violation|2|||
13324286|NCT01159912|26577723|FG002|Overall Study|Protocol Violation|3|||
13324287|NCT01159912|26577721|FG000|Overall Study|Lost to Follow-up|4|||
13324288|NCT01159912|26577722|FG001|Overall Study|Lost to Follow-up|0|||
13324289|NCT01159912|26577723|FG002|Overall Study|Lost to Follow-up|0|||
13324290|NCT01159912|26577721|FG000|Overall Study|Physician Decision|0|||
13324291|NCT01159912|26577722|FG001|Overall Study|Physician Decision|0|||
13324292|NCT01159912|26577723|FG002|Overall Study|Physician Decision|3|||
13324293|NCT01159912|26577721|FG000|Overall Study|Withdrawal by Subject|10|||
13324294|NCT01159912|26577722|FG001|Overall Study|Withdrawal by Subject|3|||
13324295|NCT01159912|26577723|FG002|Overall Study|Withdrawal by Subject|3|||
13324296|NCT01159769|26577730|FG000|Overall Study|Adverse Event|1|||
13324297|NCT01159691|26577739|FG000|Overall Study|Lost to Follow-up|2|||
13324298|NCT01159691|26577739|FG000|Overall Study|Unknown reasons|1|||
13324299|NCT01159691|26577739|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6|||
13324300|NCT01159691|26577739|FG000|Overall Study|Discontinued Neupro due to other reasons|1|||
13324301|NCT01159691|26577739|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2|||
13324302|NCT01159691|26577739|FG000|Overall Study|Disc. Neupro other & unknown reasons|7|||
13324303|NCT01159691|26577739|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2|||
13324304|NCT01159691|26577739|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1|||
13324305|NCT01159665|26577778|FG000|Overall Study|Withdrawal by Subject|0|||
13324306|NCT01159665|26577779|FG001|Overall Study|Withdrawal by Subject|1|||
13324307|NCT01159665|26577780|FG002|Overall Study|Withdrawal by Subject|0|||
13324308|NCT01159665|26577781|FG003|Overall Study|Withdrawal by Subject|0|||
13324309|NCT01159665|26577782|FG004|Overall Study|Withdrawal by Subject|0|||
13324310|NCT01159665|26577783|FG005|Overall Study|Withdrawal by Subject|0|||
13324311|NCT01159600|26577850|FG000|Overall Study|Not treated|0|||
13324312|NCT01159600|26577851|FG001|Overall Study|Not treated|0|||
13324313|NCT01159600|26577852|FG002|Overall Study|Not treated|1|||
13324314|NCT01159600|26577853|FG003|Overall Study|Not treated|0|||
13324315|NCT01159600|26577854|FG004|Overall Study|Not treated|0|||
13324316|NCT01159600|26577855|FG005|Overall Study|Not treated|1|||
13324317|NCT01159600|26577856|FG006|Overall Study|Not treated|2|||
13324318|NCT01159600|26577857|FG007|Overall Study|Not treated|2|||
13324319|NCT01159600|26577850|FG000|Overall Study|Adverse Event|7|||
13324320|NCT01159600|26577851|FG001|Overall Study|Adverse Event|2|||
13324321|NCT01159600|26577852|FG002|Overall Study|Adverse Event|5|||
13324322|NCT01159600|26577853|FG003|Overall Study|Adverse Event|1|||
13324323|NCT01159600|26577854|FG004|Overall Study|Adverse Event|8|||
13324324|NCT01159600|26577855|FG005|Overall Study|Adverse Event|6|||
13324325|NCT01159600|26577856|FG006|Overall Study|Adverse Event|7|||
13324326|NCT01159600|26577857|FG007|Overall Study|Adverse Event|5|||
13324327|NCT01159600|26577850|FG000|Overall Study|Lack of Efficacy|0|||
13324328|NCT01159600|26577851|FG001|Overall Study|Lack of Efficacy|0|||
13324329|NCT01159600|26577852|FG002|Overall Study|Lack of Efficacy|0|||
13324330|NCT01159600|26577853|FG003|Overall Study|Lack of Efficacy|0|||
13324331|NCT01159600|26577854|FG004|Overall Study|Lack of Efficacy|2|||
13324332|NCT01159600|26577855|FG005|Overall Study|Lack of Efficacy|0|||
13324333|NCT01159600|26577856|FG006|Overall Study|Lack of Efficacy|0|||
13324334|NCT01159600|26577857|FG007|Overall Study|Lack of Efficacy|1|||
13324335|NCT01159600|26577850|FG000|Overall Study|Non compliant with protocol|2|||
13324336|NCT01159600|26577851|FG001|Overall Study|Non compliant with protocol|1|||
13324337|NCT01159600|26577852|FG002|Overall Study|Non compliant with protocol|0|||
13324338|NCT01159600|26577853|FG003|Overall Study|Non compliant with protocol|0|||
13324339|NCT01159600|26577854|FG004|Overall Study|Non compliant with protocol|2|||
13324340|NCT01159600|26577855|FG005|Overall Study|Non compliant with protocol|0|||
13324341|NCT01159600|26577856|FG006|Overall Study|Non compliant with protocol|2|||
13324342|NCT01159600|26577857|FG007|Overall Study|Non compliant with protocol|0|||
13324343|NCT01159600|26577850|FG000|Overall Study|Lost to Follow-up|2|||
13324344|NCT01159600|26577851|FG001|Overall Study|Lost to Follow-up|3|||
13324345|NCT01159600|26577852|FG002|Overall Study|Lost to Follow-up|4|||
13324346|NCT01159600|26577853|FG003|Overall Study|Lost to Follow-up|3|||
13324347|NCT01159600|26577854|FG004|Overall Study|Lost to Follow-up|3|||
13324348|NCT01159600|26577855|FG005|Overall Study|Lost to Follow-up|0|||
13324349|NCT01159600|26577856|FG006|Overall Study|Lost to Follow-up|3|||
13324350|NCT01159600|26577857|FG007|Overall Study|Lost to Follow-up|2|||
13324351|NCT01159600|26577850|FG000|Overall Study|Patient refusal to continue,not due toAE|7|||
13324352|NCT01159600|26577851|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
13324353|NCT01159600|26577852|FG002|Overall Study|Patient refusal to continue,not due toAE|4|||
13324354|NCT01159600|26577853|FG003|Overall Study|Patient refusal to continue,not due toAE|5|||
13324355|NCT01159600|26577854|FG004|Overall Study|Patient refusal to continue,not due toAE|4|||
13324356|NCT01159600|26577855|FG005|Overall Study|Patient refusal to continue,not due toAE|4|||
13324357|NCT01159600|26577856|FG006|Overall Study|Patient refusal to continue,not due toAE|2|||
13324358|NCT01159600|26577857|FG007|Overall Study|Patient refusal to continue,not due toAE|5|||
13324359|NCT01159600|26577850|FG000|Overall Study|Other reason not defined above|3|||
13324360|NCT01159600|26577851|FG001|Overall Study|Other reason not defined above|0|||
13324361|NCT01159600|26577852|FG002|Overall Study|Other reason not defined above|4|||
13324362|NCT01159600|26577853|FG003|Overall Study|Other reason not defined above|2|||
13324363|NCT01159600|26577854|FG004|Overall Study|Other reason not defined above|5|||
13324364|NCT01159600|26577855|FG005|Overall Study|Other reason not defined above|7|||
13324365|NCT01159600|26577856|FG006|Overall Study|Other reason not defined above|3|||
13324366|NCT01159600|26577857|FG007|Overall Study|Other reason not defined above|3|||
13324367|NCT01159574|26577865|FG000|Treatment Phase|non-evaluable/not included in analysis|1|||
13324368|NCT01159574|26577865|FG000|Treatment Phase|Adverse Event|3|||
13324369|NCT01159574|26577865|FG000|Treatment Phase|Death|6|||
13324370|NCT01159574|26577865|FG000|Treatment Phase|Physician Decision|2|||
13324371|NCT01159574|26577865|FG000|Treatment Phase|Withdrawal by Subject|7|||
13324372|NCT01159574|26577865|FG000|Treatment Phase|still on treatment|2|||
13324373|NCT01159574|26577865|FG000|Follow Up Phase|Lost to Follow-up|2|||
13324374|NCT01159574|26577865|FG000|Follow Up Phase|still being followed for overall surviva|18|||
13324375|NCT01159431|26577888|FG000|Overall Study|Adverse Event|1|||
13324376|NCT01159431|26577889|FG001|Overall Study|Adverse Event|2|||
13324377|NCT01159431|26577888|FG000|Overall Study|non-compliance|1|||
13324378|NCT01159431|26577889|FG001|Overall Study|non-compliance|1|||
13324379|NCT01159431|26577888|FG000|Overall Study|Lack of Efficacy|0|||
13324380|NCT01159431|26577889|FG001|Overall Study|Lack of Efficacy|3|||
13324381|NCT01159171|26577906|FG000|Overall Study|Adverse Event|11|||
13324382|NCT01159171|26577906|FG000|Overall Study|Progression of Disease|28|||
13324383|NCT01159171|26577906|FG000|Overall Study|Protocol Violation|1|||
13324384|NCT01159171|26577906|FG000|Overall Study|Need for Surgery|5|||
13324385|NCT01159171|26577906|FG000|Overall Study|Medical Decision|4|||
13324386|NCT01159171|26577906|FG000|Overall Study|Death|1|||
13324387|NCT01158950|26577915|FG000|1st Intervention (1 Day)|Physician Decision|1|||
13324388|NCT01158950|26577916|FG001|1st Intervention (1 Day)|Physician Decision|2|||
13324389|NCT01158924|26577937|FG000|Overall Study|Withdrawal by Subject|1|||
13324390|NCT01158924|26577938|FG001|Overall Study|Withdrawal by Subject|2|||
13324391|NCT01158924|26577937|FG000|Overall Study|Lost to Follow-up|0|||
13324392|NCT01158924|26577938|FG001|Overall Study|Lost to Follow-up|1|||
13324393|NCT01158534|26577948|FG000|Overall Study|Withdrawal by Subject|1|||
13324394|NCT01158534|26577948|FG000|Overall Study|Death|1|||
13324395|NCT01158534|26577948|FG000|Overall Study|Other|1|||
13324396|NCT01158404|26578013|FG000|Overall Study|Withdrawal by Subject|0|||
13324397|NCT01158404|26578014|FG001|Overall Study|Withdrawal by Subject|1|||
13324398|NCT01158404|26578015|FG002|Overall Study|Withdrawal by Subject|0|||
13324399|NCT01158404|26578016|FG003|Overall Study|Withdrawal by Subject|0|||
13324400|NCT01158404|26578017|FG004|Overall Study|Withdrawal by Subject|3|||
13324401|NCT01158404|26578018|FG005|Overall Study|Withdrawal by Subject|1|||
13324402|NCT01158404|26578019|FG006|Overall Study|Withdrawal by Subject|0|||
13324403|NCT01158404|26578020|FG007|Overall Study|Withdrawal by Subject|1|||
13324404|NCT01158404|26578013|FG000|Overall Study|Physician Decision|0|||
13324405|NCT01158404|26578014|FG001|Overall Study|Physician Decision|0|||
13324406|NCT01158404|26578015|FG002|Overall Study|Physician Decision|0|||
13324407|NCT01158404|26578016|FG003|Overall Study|Physician Decision|0|||
13324408|NCT01158404|26578017|FG004|Overall Study|Physician Decision|0|||
13324409|NCT01158404|26578018|FG005|Overall Study|Physician Decision|0|||
13324410|NCT01158404|26578019|FG006|Overall Study|Physician Decision|0|||
13324411|NCT01158404|26578020|FG007|Overall Study|Physician Decision|1|||
13324412|NCT01158404|26578013|FG000|Overall Study|Progressive Disease|0|||
13324413|NCT01158404|26578014|FG001|Overall Study|Progressive Disease|0|||
13324414|NCT01158404|26578015|FG002|Overall Study|Progressive Disease|0|||
13324415|NCT01158404|26578016|FG003|Overall Study|Progressive Disease|0|||
13324416|NCT01158404|26578017|FG004|Overall Study|Progressive Disease|0|||
13324417|NCT01158404|26578018|FG005|Overall Study|Progressive Disease|0|||
13324418|NCT01158404|26578019|FG006|Overall Study|Progressive Disease|1|||
13324419|NCT01158404|26578020|FG007|Overall Study|Progressive Disease|0|||
13324420|NCT01158378|26578039|FG000|Overall Study|Death|4|||
13324421|NCT01158378|26578040|FG001|Overall Study|Death|5|||
13324422|NCT01158378|26578039|FG000|Overall Study|Lost to Follow-up|2|||
13324423|NCT01158378|26578040|FG001|Overall Study|Lost to Follow-up|4|||
13324424|NCT01158378|26578039|FG000|Overall Study|Withdrawal by Subject|4|||
13324425|NCT01158378|26578040|FG001|Overall Study|Withdrawal by Subject|0|||
13324426|NCT01158261|26578046|FG000|Overall Study|Lost to Follow-up|9|||
13324427|NCT01158261|26578046|FG000|Overall Study|Death|7|||
13324428|NCT01158261|26578046|FG000|Overall Study|Withdrawal by Subject|1|||
13324429|NCT01158222|26578054|FG000|Overall Study|Not eligible for intermediate phase|17|||
13324430|NCT01158118|26578077|FG000|Overall Study|Screen failure|1|||
13324431|NCT01158118|26578078|FG001|Overall Study|Screen failure|0|||
13324432|NCT01158118|26578077|FG000|Overall Study|Donor match was a screen failure|0|||
13324433|NCT01158118|26578078|FG001|Overall Study|Donor match was a screen failure|1|||
13324434|NCT01158118|26578077|FG000|Overall Study|Suffered stroke prior to transplant|0|||
13324435|NCT01158118|26578078|FG001|Overall Study|Suffered stroke prior to transplant|1|||
13324436|NCT01158118|26578077|FG000|Overall Study|Death|0|||
13324437|NCT01158118|26578078|FG001|Overall Study|Death|1|||
13324438|NCT01157897|26578116|FG000|Overall Study|Lost to Follow-up|2|||
13324439|NCT01157897|26578117|FG001|Overall Study|Lost to Follow-up|0|||
13324440|NCT01157897|26578118|FG002|Overall Study|Lost to Follow-up|0|||
13324441|NCT01157897|26578119|FG003|Overall Study|Lost to Follow-up|1|||
13324442|NCT01157897|26578116|FG000|Overall Study|Relocated|0|||
13324443|NCT01157897|26578117|FG001|Overall Study|Relocated|2|||
13324444|NCT01157897|26578118|FG002|Overall Study|Relocated|0|||
13324445|NCT01157897|26578119|FG003|Overall Study|Relocated|0|||
13324446|NCT01157845|26578126|FG000|Overall Study|Lost to Follow-up|5|||
13324447|NCT01157845|26578126|FG000|Overall Study|Withdrawal by Subject|12|||
13324448|NCT01157845|26578126|FG000|Overall Study|Physician Decision|3|||
13324449|NCT01157845|26578126|FG000|Overall Study|Protocol Violation|13|||
13324450|NCT01157845|26578126|FG000|Overall Study|Study was ended|1|||
13324451|NCT01157845|26578126|FG000|Overall Study|Device malfunction|1|||
13324452|NCT01157676|26578179|FG000|Randomization|Death|1|||
13324453|NCT01157676|26578180|FG001|Randomization|Death|1|||
13324454|NCT01157676|26578179|FG000|Randomization|unresectable|2|||
13324455|NCT01157676|26578180|FG001|Randomization|unresectable|3|||
13324456|NCT01157676|26578179|FG000|Randomization|Withdrawal by Subject|17|||
13324457|NCT01157676|26578180|FG001|Randomization|Withdrawal by Subject|13|||
13324458|NCT01157676|26578179|FG000|Randomization|Physician Decision|1|||
13324459|NCT01157676|26578180|FG001|Randomization|Physician Decision|0|||
13324460|NCT01157676|26578179|FG000|Surgery|underwent open cystectomy|0|||
13324461|NCT01157676|26578180|FG001|Surgery|underwent open cystectomy|4|||
13324462|NCT01157676|26578179|FG000|Surgery|converted to open procedure|0|||
13324463|NCT01157676|26578180|FG001|Surgery|converted to open procedure|5|||
13324464|NCT01157676|26578179|FG000|Surgery|underwent robotic cystectomy|1|||
13324465|NCT01157676|26578180|FG001|Surgery|underwent robotic cystectomy|0|||
13324466|NCT01157377|26578218|FG000|Overall Study|Lost to Follow-up|0|||
13324467|NCT01157377|26578219|FG001|Overall Study|Lost to Follow-up|0|||
13324468|NCT01157377|26578220|FG002|Overall Study|Lost to Follow-up|1|||
13324469|NCT01157377|26578221|FG003|Overall Study|Lost to Follow-up|0|||
13324470|NCT01157377|26578222|FG004|Overall Study|Lost to Follow-up|1|||
13324471|NCT01157377|26578223|FG005|Overall Study|Lost to Follow-up|1|||
13324472|NCT01157377|26578224|FG006|Overall Study|Lost to Follow-up|0|||
13324473|NCT01157377|26578218|FG000|Overall Study|Personal Reasons|2|||
13324474|NCT01157377|26578219|FG001|Overall Study|Personal Reasons|1|||
13324475|NCT01157377|26578220|FG002|Overall Study|Personal Reasons|0|||
13324476|NCT01157377|26578221|FG003|Overall Study|Personal Reasons|1|||
13324477|NCT01157377|26578222|FG004|Overall Study|Personal Reasons|0|||
13324478|NCT01157377|26578223|FG005|Overall Study|Personal Reasons|0|||
13324479|NCT01157377|26578224|FG006|Overall Study|Personal Reasons|0|||
13324480|NCT01157377|26578218|FG000|Overall Study|Protocol Violation|0|||
13324481|NCT01157377|26578219|FG001|Overall Study|Protocol Violation|0|||
13324482|NCT01157377|26578220|FG002|Overall Study|Protocol Violation|0|||
13324483|NCT01157377|26578221|FG003|Overall Study|Protocol Violation|0|||
13324484|NCT01157377|26578222|FG004|Overall Study|Protocol Violation|0|||
13122298|NCT02966340|25946666|FG001|Overall Study|Adverse Event|1|||
13122299|NCT02966340|25946665|FG000|Overall Study|Lost to Follow-up|0|||
13122300|NCT02966340|25946666|FG001|Overall Study|Lost to Follow-up|1|||
13122301|NCT02966340|25946665|FG000|Overall Study|Withdrawal by Subject|1|||
13122302|NCT02966340|25946666|FG001|Overall Study|Withdrawal by Subject|0|||
13324485|NCT01157377|26578223|FG005|Overall Study|Protocol Violation|1|||
13324486|NCT01157377|26578224|FG006|Overall Study|Protocol Violation|0|||
13324487|NCT01157377|26578218|FG000|Overall Study|Lack of Efficacy|0|||
13324488|NCT01157377|26578219|FG001|Overall Study|Lack of Efficacy|0|||
13324489|NCT01157377|26578220|FG002|Overall Study|Lack of Efficacy|0|||
13324490|NCT01157377|26578221|FG003|Overall Study|Lack of Efficacy|0|||
13324491|NCT01157377|26578222|FG004|Overall Study|Lack of Efficacy|0|||
13324492|NCT01157377|26578223|FG005|Overall Study|Lack of Efficacy|0|||
13324493|NCT01157377|26578224|FG006|Overall Study|Lack of Efficacy|1|||
13324494|NCT01157377|26578218|FG000|Overall Study|Other Miscellaneous Reasons|0|||
13324495|NCT01157377|26578219|FG001|Overall Study|Other Miscellaneous Reasons|2|||
13324496|NCT01157377|26578220|FG002|Overall Study|Other Miscellaneous Reasons|0|||
13324497|NCT01157377|26578221|FG003|Overall Study|Other Miscellaneous Reasons|0|||
13324498|NCT01157377|26578222|FG004|Overall Study|Other Miscellaneous Reasons|1|||
13324499|NCT01157377|26578223|FG005|Overall Study|Other Miscellaneous Reasons|1|||
13324500|NCT01157377|26578224|FG006|Overall Study|Other Miscellaneous Reasons|1|||
13324501|NCT01157364|26578275|FG000|Overall Study|Other Reasons|1|||
13324502|NCT01157364|26578276|FG001|Overall Study|Other Reasons|1|||
13324503|NCT01157364|26578277|FG002|Overall Study|Other Reasons|2|||
13324504|NCT01157364|26578278|FG003|Overall Study|Other Reasons|1|||
13324505|NCT01157364|26578279|FG004|Overall Study|Other Reasons|0|||
13324506|NCT01157364|26578280|FG005|Overall Study|Other Reasons|0|||
13324507|NCT01157364|26578275|FG000|Overall Study|Personal Reasons|0|||
13324508|NCT01157364|26578276|FG001|Overall Study|Personal Reasons|2|||
13324509|NCT01157364|26578277|FG002|Overall Study|Personal Reasons|0|||
13324510|NCT01157364|26578278|FG003|Overall Study|Personal Reasons|0|||
13324511|NCT01157364|26578279|FG004|Overall Study|Personal Reasons|1|||
13324512|NCT01157364|26578280|FG005|Overall Study|Personal Reasons|1|||
13324513|NCT01157364|26578275|FG000|Overall Study|Lost to Follow-up|1|||
13324514|NCT01157364|26578276|FG001|Overall Study|Lost to Follow-up|0|||
13324515|NCT01157364|26578277|FG002|Overall Study|Lost to Follow-up|1|||
13324516|NCT01157364|26578278|FG003|Overall Study|Lost to Follow-up|0|||
13324517|NCT01157364|26578279|FG004|Overall Study|Lost to Follow-up|0|||
13324518|NCT01157364|26578280|FG005|Overall Study|Lost to Follow-up|0|||
13324519|NCT01157364|26578275|FG000|Overall Study|Lack of Efficacy|0|||
13324520|NCT01157364|26578276|FG001|Overall Study|Lack of Efficacy|0|||
13324521|NCT01157364|26578277|FG002|Overall Study|Lack of Efficacy|0|||
13324522|NCT01157364|26578278|FG003|Overall Study|Lack of Efficacy|1|||
13324523|NCT01157364|26578279|FG004|Overall Study|Lack of Efficacy|0|||
13324524|NCT01157364|26578280|FG005|Overall Study|Lack of Efficacy|0|||
13324525|NCT01157364|26578275|FG000|Overall Study|Adverse Event|0|||
13324526|NCT01157364|26578276|FG001|Overall Study|Adverse Event|1|||
13324527|NCT01157364|26578277|FG002|Overall Study|Adverse Event|1|||
13324528|NCT01157364|26578278|FG003|Overall Study|Adverse Event|0|||
13324529|NCT01157364|26578279|FG004|Overall Study|Adverse Event|1|||
13324530|NCT01157364|26578280|FG005|Overall Study|Adverse Event|0|||
13324531|NCT01157351|26578303|FG000|Overall Study|Adverse Event|5|||
13324532|NCT01157351|26578304|FG001|Overall Study|Adverse Event|4|||
13324533|NCT01157351|26578303|FG000|Overall Study|Death|1|||
13324534|NCT01157351|26578304|FG001|Overall Study|Death|0|||
13324535|NCT01157351|26578303|FG000|Overall Study|Lost to Follow-up|53|||
13324536|NCT01157351|26578304|FG001|Overall Study|Lost to Follow-up|55|||
13324537|NCT01157351|26578303|FG000|Overall Study|Withdrawal by Subject|37|||
13324538|NCT01157351|26578304|FG001|Overall Study|Withdrawal by Subject|27|||
13324539|NCT01157351|26578303|FG000|Overall Study|Physician Decision|5|||
13324540|NCT01157351|26578304|FG001|Overall Study|Physician Decision|4|||
13324541|NCT01157351|26578303|FG000|Overall Study|Protocol Violation|0|||
13324542|NCT01157351|26578304|FG001|Overall Study|Protocol Violation|1|||
13324543|NCT01157351|26578303|FG000|Overall Study|Other|32|||
13324544|NCT01157351|26578304|FG001|Overall Study|Other|36|||
13324545|NCT01157351|26578303|FG000|Overall Study|Noncompliance with Study Drug|0|||
13324546|NCT01157351|26578304|FG001|Overall Study|Noncompliance with Study Drug|3|||
13324547|NCT01157351|26578303|FG000|Overall Study|Randomized but not Treated|4|||
13324548|NCT01157351|26578304|FG001|Overall Study|Randomized but not Treated|2|||
13324549|NCT01157234|26578341|FG000|Overall Study|Withdrawal by Subject|1|||
13324550|NCT01157234|26578342|FG001|Overall Study|Withdrawal by Subject|0|||
13324551|NCT01157182|26578395|FG000|Washout of 28 Days|Adverse Event|2|||
13324552|NCT01157182|26578396|FG001|Washout of 28 Days|Adverse Event|0|||
13324553|NCT01157169|26578419|FG000|First Intervention|Emesis Within 4 hrs of Administration|4|||
13324554|NCT01157169|26578420|FG001|First Intervention|Emesis Within 4 hrs of Administration|2|||
13324555|NCT01157169|26578419|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0|||
13324556|NCT01157169|26578420|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1|||
13324557|NCT01157117|26578469|FG000|Overall Study|Dosing Symptoms|0|||
13324558|NCT01157117|26578470|FG001|Overall Study|Dosing Symptoms|4|||
13324559|NCT01157117|26578471|FG002|Overall Study|Dosing Symptoms|0|||
13324560|NCT01157117|26578469|FG000|Overall Study|Withdrawal by Subject|4|||
13324561|NCT01157117|26578470|FG001|Overall Study|Withdrawal by Subject|1|||
13324562|NCT01157117|26578471|FG002|Overall Study|Withdrawal by Subject|1|||
13324563|NCT01157117|26578469|FG000|Overall Study|Lack of Efficacy|1|||
13324564|NCT01157117|26578470|FG001|Overall Study|Lack of Efficacy|1|||
13324565|NCT01157117|26578471|FG002|Overall Study|Lack of Efficacy|0|||
13324566|NCT01157117|26578469|FG000|Overall Study|Lost to Follow-up|0|||
13324567|NCT01157117|26578470|FG001|Overall Study|Lost to Follow-up|0|||
13324568|NCT01157117|26578471|FG002|Overall Study|Lost to Follow-up|1|||
13324569|NCT01157117|26578469|FG000|Overall Study|Unknown (Pending Final Form Submission)|4|||
13324570|NCT01157117|26578470|FG001|Overall Study|Unknown (Pending Final Form Submission)|5|||
13324571|NCT01157117|26578471|FG002|Overall Study|Unknown (Pending Final Form Submission)|13|||
13324572|NCT01157078|26578526|FG000|Overall Study|Withdrawal by Subject|12|||
13324573|NCT01157078|26578527|FG001|Overall Study|Withdrawal by Subject|14|||
13324574|NCT01157078|26578526|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
13324575|NCT01157078|26578527|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
13324576|NCT01157078|26578526|FG000|Overall Study|Adverse Event|6|||
13324577|NCT01157078|26578527|FG001|Overall Study|Adverse Event|6|||
13324578|NCT01157078|26578526|FG000|Overall Study|Severe non-compliance to protocol|2|||
13324579|NCT01157078|26578527|FG001|Overall Study|Severe non-compliance to protocol|4|||
13324580|NCT01157078|26578526|FG000|Overall Study|Condition under investigation worsened|0|||
13324581|NCT01157078|26578527|FG001|Overall Study|Condition under investigation worsened|1|||
13324582|NCT01157078|26578526|FG000|Overall Study|Lack of Efficacy|2|||
13324583|NCT01157078|26578527|FG001|Overall Study|Lack of Efficacy|0|||
13324584|NCT01157078|26578526|FG000|Overall Study|Study-specific withdrawal criteria|2|||
13324585|NCT01157078|26578527|FG001|Overall Study|Study-specific withdrawal criteria|2|||
13324586|NCT01157078|26578526|FG000|Overall Study|Lost to Follow-up|7|||
13324587|NCT01157078|26578527|FG001|Overall Study|Lost to Follow-up|5|||
13324588|NCT01157078|26578526|FG000|Overall Study|Other|2|||
13324589|NCT01157078|26578527|FG001|Overall Study|Other|4|||
13324590|NCT01157065|26578542|FG000|Overall Study|Death|0|||
13324591|NCT01157065|26578543|FG001|Overall Study|Death|1|||
13324592|NCT01156844|26578575|FG000|Overall Study|Adverse Event|0|||
13324593|NCT01156844|26578576|FG001|Overall Study|Adverse Event|0|||
13324594|NCT01156844|26578577|FG002|Overall Study|Adverse Event|1|||
13324595|NCT01156844|26578578|FG003|Overall Study|Adverse Event|1|||
13324596|NCT01156844|26578575|FG000|Overall Study|Abnormal test procedure result(s)|0|||
13324597|NCT01156844|26578576|FG001|Overall Study|Abnormal test procedure result(s)|1|||
13324598|NCT01156844|26578577|FG002|Overall Study|Abnormal test procedure result(s)|2|||
13324599|NCT01156844|26578578|FG003|Overall Study|Abnormal test procedure result(s)|2|||
13324600|NCT01156844|26578575|FG000|Overall Study|Withdrawal by Subject|0|||
13324601|NCT01156844|26578576|FG001|Overall Study|Withdrawal by Subject|0|||
13324602|NCT01156844|26578577|FG002|Overall Study|Withdrawal by Subject|2|||
13324603|NCT01156844|26578578|FG003|Overall Study|Withdrawal by Subject|2|||
13324604|NCT01156844|26578575|FG000|Overall Study|Lost to Follow-up|0|||
13324605|NCT01156844|26578576|FG001|Overall Study|Lost to Follow-up|0|||
13324606|NCT01156844|26578577|FG002|Overall Study|Lost to Follow-up|1|||
13324607|NCT01156844|26578578|FG003|Overall Study|Lost to Follow-up|0|||
13324608|NCT01156844|26578575|FG000|Overall Study|Administrative problems|0|||
13324609|NCT01156844|26578576|FG001|Overall Study|Administrative problems|1|||
13324610|NCT01156844|26578577|FG002|Overall Study|Administrative problems|0|||
13324611|NCT01156844|26578578|FG003|Overall Study|Administrative problems|1|||
13324612|NCT01156844|26578575|FG000|Overall Study|Protocol deviation|2|||
13324613|NCT01156844|26578576|FG001|Overall Study|Protocol deviation|0|||
13324614|NCT01156844|26578577|FG002|Overall Study|Protocol deviation|0|||
13324615|NCT01156844|26578578|FG003|Overall Study|Protocol deviation|0|||
13324616|NCT01156792|26578645|FG000|Overall Study|Adverse Event|1|||
13324617|NCT01156792|26578645|FG000|Overall Study|Lack of Efficacy|36|||
13324618|NCT01156792|26578645|FG000|Overall Study|Protocol Violation|6|||
13324619|NCT01156792|26578645|FG000|Overall Study|Lost to Follow-up|3|||
13324620|NCT01156792|26578645|FG000|Overall Study|Physician Decision|3|||
13324621|NCT01156792|26578645|FG000|Overall Study|Withdrawal by Subject|9|||
13324622|NCT01156792|26578645|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11|||
13324623|NCT01156714|26578678|FG000|Overall Study|Withdrawal by Subject|9|||
13324624|NCT01156714|26578679|FG001|Overall Study|Withdrawal by Subject|4|||
13324625|NCT01156714|26578680|FG002|Overall Study|Withdrawal by Subject|3|||
13324626|NCT01156675|26578722|FG000|Overall Study|Death|5|||
13324627|NCT01156675|26578723|FG001|Overall Study|Death|3|||
13324628|NCT01156675|26578724|FG002|Overall Study|Death|0|||
13324629|NCT01156675|26578722|FG000|Overall Study|No data|29|||
13324630|NCT01156675|26578723|FG001|Overall Study|No data|22|||
13324631|NCT01156675|26578724|FG002|Overall Study|No data|2|||
13324632|NCT01156532|26578736|FG000|Overall Study|Family Reasons|1|||
13324633|NCT01156532|26578736|FG000|Overall Study|Lost to Follow-up|1|||
13324634|NCT01156480|26578769|FG000|Overall Study|change in diagnosis|0|||
13324635|NCT01156480|26578770|FG001|Overall Study|change in diagnosis|1|||
13324636|NCT01156376|26579001|FG000|Overall Study|Adverse Event|1|||
13324637|NCT01156376|26579002|FG001|Overall Study|Adverse Event|0|||
13324638|NCT01156376|26579003|FG002|Overall Study|Adverse Event|1|||
13324639|NCT01156376|26579001|FG000|Overall Study|Withdrawal by Subject|0|||
13324640|NCT01156376|26579002|FG001|Overall Study|Withdrawal by Subject|0|||
13324641|NCT01156376|26579003|FG002|Overall Study|Withdrawal by Subject|3|||
13324642|NCT01156363|26579025|FG000|Overall Study|Adverse Event|6|||
13324643|NCT01156363|26579025|FG000|Overall Study|Insufficient Therapeutic Response|5|||
13324644|NCT01156363|26579025|FG000|Overall Study|Failure to Return|1|||
13324645|NCT01156363|26579025|FG000|Overall Study|Refused Treatment|4|||
13324646|NCT01156363|26579025|FG000|Overall Study|Other|6|||
13324647|NCT01156311|26579056|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1|||
13324648|NCT01156311|26579057|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1|||
13324649|NCT01156311|26579058|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0|||
13324650|NCT01156311|26579059|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0|||
13324651|NCT01156311|26579056|FG000|2-Month Monotherapy Period|Physician Decision|0|||
13324652|NCT01156311|26579057|FG001|2-Month Monotherapy Period|Physician Decision|1|||
13324653|NCT01156311|26579058|FG002|2-Month Monotherapy Period|Physician Decision|0|||
13324654|NCT01156311|26579059|FG003|2-Month Monotherapy Period|Physician Decision|0|||
13324655|NCT01156311|26579056|FG000|2-Month Monotherapy Period|Other|1|||
13324656|NCT01156311|26579057|FG001|2-Month Monotherapy Period|Other|0|||
13324657|NCT01156311|26579058|FG002|2-Month Monotherapy Period|Other|0|||
13324658|NCT01156311|26579059|FG003|2-Month Monotherapy Period|Other|0|||
13324659|NCT01156311|26579056|FG000|6-month Add-on Therapy Period|Adverse Event|0|||
13324660|NCT01156311|26579057|FG001|6-month Add-on Therapy Period|Adverse Event|0|||
13324661|NCT01156311|26579058|FG002|6-month Add-on Therapy Period|Adverse Event|7|||
13324662|NCT01156311|26579059|FG003|6-month Add-on Therapy Period|Adverse Event|6|||
13324663|NCT01156311|26579056|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0|||
13324664|NCT01156311|26579057|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0|||
13324665|NCT01156311|26579058|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2|||
13324666|NCT01156311|26579059|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0|||
13324667|NCT01156311|26579056|FG000|6-month Add-on Therapy Period|Disease Activity|0|||
13324668|NCT01156311|26579057|FG001|6-month Add-on Therapy Period|Disease Activity|0|||
13324669|NCT01156311|26579058|FG002|6-month Add-on Therapy Period|Disease Activity|1|||
13324670|NCT01156311|26579059|FG003|6-month Add-on Therapy Period|Disease Activity|2|||
13324671|NCT01156311|26579056|FG000|6-month Add-on Therapy Period|Physician Decision|0|||
13324672|NCT01156311|26579057|FG001|6-month Add-on Therapy Period|Physician Decision|0|||
13324673|NCT01156311|26579058|FG002|6-month Add-on Therapy Period|Physician Decision|1|||
13324674|NCT01156311|26579059|FG003|6-month Add-on Therapy Period|Physician Decision|0|||
13324675|NCT01156311|26579056|FG000|6-month Add-on Therapy Period|Other|0|||
13324676|NCT01156311|26579057|FG001|6-month Add-on Therapy Period|Other|0|||
13324677|NCT01156311|26579058|FG002|6-month Add-on Therapy Period|Other|1|||
13324678|NCT01156311|26579059|FG003|6-month Add-on Therapy Period|Other|2|||
13324679|NCT01156142|26579082|FG000|Overall Study|Withdrawal by Subject|8|||
13324680|NCT01156142|26579083|FG001|Overall Study|Withdrawal by Subject|6|||
13324681|NCT01156142|26579082|FG000|Overall Study|Ineligible|0|||
13324682|NCT01156142|26579083|FG001|Overall Study|Ineligible|1|||
13324683|NCT01156116|26579102|FG000|Overall Study|Withdrawal by Subject|3|||
13324684|NCT01156116|26579103|FG001|Overall Study|Withdrawal by Subject|1|||
13324685|NCT01156116|26579102|FG000|Overall Study|CPAP intolerance|2|||
13324686|NCT01156116|26579103|FG001|Overall Study|CPAP intolerance|0|||
13324687|NCT01156051|26579122|FG000|Overall Study|Lost to Follow-up|1|||
13324688|NCT01156051|26579123|FG001|Overall Study|Lost to Follow-up|0|||
13324689|NCT01156051|26579122|FG000|Overall Study|patient not compliant with protocol|0|||
13286884|NCT00477490|26472496|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2|||
13286885|NCT00477490|26472497|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4|||
13286886|NCT00477490|26472498|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1|||
13286887|NCT00477490|26472499|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5|||
13286888|NCT00477490|26472500|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3|||
13286889|NCT00477490|26472501|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
13286890|NCT00477490|26472502|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
13286891|NCT00477490|26472503|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
13286892|NCT00477490|26472504|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
13286893|NCT00477490|26472496|FG000|Part I: 4 Week Efficacy|Other, not specified|2|||
13286894|NCT00477490|26472497|FG001|Part I: 4 Week Efficacy|Other, not specified|4|||
13286895|NCT00477490|26472498|FG002|Part I: 4 Week Efficacy|Other, not specified|0|||
13286896|NCT00477490|26472499|FG003|Part I: 4 Week Efficacy|Other, not specified|1|||
13324690|NCT01156051|26579123|FG001|Overall Study|patient not compliant with protocol|1|||
13324691|NCT01156012|26579136|FG000|Overall Study|Adverse Event|3|||
13324692|NCT01156012|26579137|FG001|Overall Study|Adverse Event|1|||
13324693|NCT01156012|26579136|FG000|Overall Study|Lost to Follow-up|1|||
13324694|NCT01156012|26579137|FG001|Overall Study|Lost to Follow-up|0|||
13324695|NCT01156012|26579136|FG000|Overall Study|Withdrawal by Subject|1|||
13324696|NCT01156012|26579137|FG001|Overall Study|Withdrawal by Subject|0|||
13324697|NCT01156012|26579136|FG000|Overall Study|use of commercial drug instead of study|0|||
13324698|NCT01156012|26579137|FG001|Overall Study|use of commercial drug instead of study|1|||
13324699|NCT01156012|26579136|FG000|Overall Study|Non respect of one of inclusion criteria|2|||
13324700|NCT01156012|26579137|FG001|Overall Study|Non respect of one of inclusion criteria|1|||
13324701|NCT01155869|26579152|FG000|Overall Study|Lost to Follow-up|3|||
13324702|NCT01155869|26579153|FG001|Overall Study|Lost to Follow-up|1|||
13324703|NCT01155726|26579180|FG000|Period 1, 3 Days (Masked)|Inconvenience|1|||
13324704|NCT01155726|26579181|FG001|Period 1, 3 Days (Masked)|Inconvenience|0|||
13324705|NCT01155726|26579182|FG002|Period 1, 3 Days (Masked)|Inconvenience|2|||
13324706|NCT01155726|26579183|FG003|Period 1, 3 Days (Masked)|Inconvenience|0|||
13324707|NCT01155661|26579211|FG000|Overall Study|Adverse Event|101|||
13324708|NCT01155661|26579211|FG000|Overall Study|Death|1|||
13324709|NCT01155661|26579211|FG000|Overall Study|Lack of Efficacy|32|||
13324710|NCT01155661|26579211|FG000|Overall Study|Lost to Follow-up|22|||
13324711|NCT01155661|26579211|FG000|Overall Study|Physician Decision|3|||
13324712|NCT01155661|26579211|FG000|Overall Study|Protocol Violation|35|||
13324713|NCT01155661|26579211|FG000|Overall Study|Withdrawal by Subject|73|||
13324714|NCT01155661|26579211|FG000|Overall Study|Sponsor Decision|13|||
13324715|NCT01155583|26579258|FG000|Phase I|Screen failure - did not start treatment|0|||
13324716|NCT01155583|26579259|FG001|Phase I|Screen failure - did not start treatment|0|||
13324717|NCT01155583|26579260|FG002|Phase I|Screen failure - did not start treatment|0|||
13324718|NCT01155583|26579261|FG003|Phase I|Screen failure - did not start treatment|0|||
13324719|NCT01155583|26579262|FG004|Phase I|Screen failure - did not start treatment|1|||
13324720|NCT01155583|26579263|FG005|Phase I|Screen failure - did not start treatment|0|||
13324721|NCT01155583|26579264|FG006|Phase I|Screen failure - did not start treatment|0|||
13324722|NCT01155583|26579265|FG007|Phase I|Screen failure - did not start treatment|2|||
13324723|NCT01155583|26579266|FG008|Phase I|Screen failure - did not start treatment|0|||
13324724|NCT01155583|26579258|FG000|Phase I|Withdrawal by Subject|0|||
13324725|NCT01155583|26579259|FG001|Phase I|Withdrawal by Subject|0|||
13324726|NCT01155583|26579260|FG002|Phase I|Withdrawal by Subject|0|||
13324727|NCT01155583|26579261|FG003|Phase I|Withdrawal by Subject|0|||
13324728|NCT01155583|26579262|FG004|Phase I|Withdrawal by Subject|0|||
13324729|NCT01155583|26579263|FG005|Phase I|Withdrawal by Subject|0|||
13324730|NCT01155583|26579264|FG006|Phase I|Withdrawal by Subject|0|||
13324731|NCT01155583|26579265|FG007|Phase I|Withdrawal by Subject|1|||
13324732|NCT01155583|26579266|FG008|Phase I|Withdrawal by Subject|0|||
13324733|NCT01155570|26579298|FG000|Overall Study|Adverse Event|39|||
13324734|NCT01155570|26579298|FG000|Overall Study|Lack of Efficacy|46|||
13324735|NCT01155570|26579298|FG000|Overall Study|Participant's Economic Reasons|17|||
13324736|NCT01155570|26579298|FG000|Overall Study|No Hospital Visits|7|||
13324737|NCT01155570|26579298|FG000|Overall Study|Adverse Event + Lack of Efficacy|2|||
13324738|NCT01155570|26579298|FG000|Overall Study|Adverse Event + Other Reasons|7|||
13324739|NCT01155570|26579298|FG000|Overall Study|Participant's Economic Reasons + Other|1|||
13324740|NCT01155570|26579298|FG000|Overall Study|Other Reasons|23|||
13324741|NCT01155531|26579329|FG000|Overall Study|Adverse Event|0|||
13324742|NCT01155531|26579330|FG001|Overall Study|Adverse Event|0|||
13324743|NCT01155531|26579331|FG002|Overall Study|Adverse Event|1|||
13324744|NCT01155531|26579332|FG003|Overall Study|Adverse Event|0|||
13324745|NCT01155531|26579329|FG000|Overall Study|Lost to Follow-up|0|||
13324746|NCT01155531|26579330|FG001|Overall Study|Lost to Follow-up|0|||
13324747|NCT01155531|26579331|FG002|Overall Study|Lost to Follow-up|0|||
13324748|NCT01155531|26579332|FG003|Overall Study|Lost to Follow-up|1|||
13324749|NCT01155531|26579329|FG000|Overall Study|Withdrawal by Subject|1|||
13324750|NCT01155531|26579330|FG001|Overall Study|Withdrawal by Subject|0|||
13324751|NCT01155531|26579331|FG002|Overall Study|Withdrawal by Subject|1|||
13324752|NCT01155531|26579332|FG003|Overall Study|Withdrawal by Subject|0|||
13324753|NCT01155479|26579395|FG000|Part I|Adverse Event|13|||
13324754|NCT01155479|26579396|FG001|Part I|Adverse Event|8|||
13324755|NCT01155479|26579397|FG002|Part I|Adverse Event|18|||
13324756|NCT01155479|26579398|FG003|Part I|Adverse Event|7|||
13324757|NCT01155479|26579399|FG004|Part I|Adverse Event|6|||
13324758|NCT01155479|26579395|FG000|Part I|Administrative|2|||
13324759|NCT01155479|26579396|FG001|Part I|Administrative|2|||
13324760|NCT01155479|26579397|FG002|Part I|Administrative|2|||
13324761|NCT01155479|26579398|FG003|Part I|Administrative|0|||
13324762|NCT01155479|26579399|FG004|Part I|Administrative|0|||
13324763|NCT01155479|26579395|FG000|Part I|Did Not Meet Protocol Eligibility|3|||
13324764|NCT01155479|26579396|FG001|Part I|Did Not Meet Protocol Eligibility|1|||
13324765|NCT01155479|26579397|FG002|Part I|Did Not Meet Protocol Eligibility|2|||
13324766|NCT01155479|26579398|FG003|Part I|Did Not Meet Protocol Eligibility|1|||
13324767|NCT01155479|26579399|FG004|Part I|Did Not Meet Protocol Eligibility|3|||
13324768|NCT01155479|26579395|FG000|Part I|Withdrawal by Subject|11|||
13324769|NCT01155479|26579396|FG001|Part I|Withdrawal by Subject|13|||
13324770|NCT01155479|26579397|FG002|Part I|Withdrawal by Subject|8|||
13324771|NCT01155479|26579398|FG003|Part I|Withdrawal by Subject|8|||
13324772|NCT01155479|26579399|FG004|Part I|Withdrawal by Subject|9|||
13324773|NCT01155479|26579395|FG000|Part I|Lost to Follow-up|0|||
13324774|NCT01155479|26579396|FG001|Part I|Lost to Follow-up|0|||
13324775|NCT01155479|26579397|FG002|Part I|Lost to Follow-up|1|||
13324776|NCT01155479|26579398|FG003|Part I|Lost to Follow-up|1|||
13324777|NCT01155479|26579399|FG004|Part I|Lost to Follow-up|0|||
13324778|NCT01155479|26579395|FG000|Part I|Treatment Failure|3|||
13324779|NCT01155479|26579396|FG001|Part I|Treatment Failure|0|||
13324780|NCT01155479|26579397|FG002|Part I|Treatment Failure|3|||
13324781|NCT01155479|26579398|FG003|Part I|Treatment Failure|1|||
13324782|NCT01155479|26579399|FG004|Part I|Treatment Failure|2|||
13324783|NCT01155479|26579395|FG000|Part I|Did Not Receive Treatment|4|||
13324784|NCT01155479|26579396|FG001|Part I|Did Not Receive Treatment|2|||
13324785|NCT01155479|26579397|FG002|Part I|Did Not Receive Treatment|2|||
13324786|NCT01155479|26579398|FG003|Part I|Did Not Receive Treatment|6|||
13324787|NCT01155479|26579399|FG004|Part I|Did Not Receive Treatment|1|||
13324788|NCT01155479|26579395|FG000|Part I|Non-Compliance with Protocol|2|||
13324789|NCT01155479|26579396|FG001|Part I|Non-Compliance with Protocol|1|||
13324790|NCT01155479|26579397|FG002|Part I|Non-Compliance with Protocol|3|||
13324791|NCT01155479|26579398|FG003|Part I|Non-Compliance with Protocol|3|||
13324792|NCT01155479|26579399|FG004|Part I|Non-Compliance with Protocol|2|||
13324793|NCT01155479|26579395|FG000|Part II|Adverse Event|7|||
13324794|NCT01155479|26579396|FG001|Part II|Adverse Event|6|||
13324795|NCT01155479|26579397|FG002|Part II|Adverse Event|8|||
13324796|NCT01155479|26579398|FG003|Part II|Adverse Event|3|||
13324797|NCT01155479|26579399|FG004|Part II|Adverse Event|4|||
13324798|NCT01155479|26579395|FG000|Part II|Administrative|43|||
13324799|NCT01155479|26579396|FG001|Part II|Administrative|49|||
13324800|NCT01155479|26579397|FG002|Part II|Administrative|36|||
13324801|NCT01155479|26579398|FG003|Part II|Administrative|38|||
13324802|NCT01155479|26579399|FG004|Part II|Administrative|46|||
13324803|NCT01155479|26579395|FG000|Part II|Withdrawal by Subject|8|||
13324804|NCT01155479|26579396|FG001|Part II|Withdrawal by Subject|4|||
13324805|NCT01155479|26579397|FG002|Part II|Withdrawal by Subject|12|||
13324806|NCT01155479|26579398|FG003|Part II|Withdrawal by Subject|7|||
13324807|NCT01155479|26579399|FG004|Part II|Withdrawal by Subject|3|||
13324808|NCT01155479|26579395|FG000|Part II|Lost to Follow-up|1|||
13324809|NCT01155479|26579396|FG001|Part II|Lost to Follow-up|0|||
13324810|NCT01155479|26579397|FG002|Part II|Lost to Follow-up|0|||
13324811|NCT01155479|26579398|FG003|Part II|Lost to Follow-up|0|||
13324812|NCT01155479|26579399|FG004|Part II|Lost to Follow-up|1|||
13324813|NCT01155479|26579395|FG000|Part II|Treatment Failure|0|||
13324814|NCT01155479|26579396|FG001|Part II|Treatment Failure|1|||
13324815|NCT01155479|26579397|FG002|Part II|Treatment Failure|2|||
13324816|NCT01155479|26579398|FG003|Part II|Treatment Failure|0|||
13324817|NCT01155479|26579399|FG004|Part II|Treatment Failure|1|||
13324818|NCT01155479|26579395|FG000|Part II|Non-Compliance with Protocol|0|||
13324819|NCT01155479|26579396|FG001|Part II|Non-Compliance with Protocol|1|||
13324820|NCT01155479|26579397|FG002|Part II|Non-Compliance with Protocol|0|||
13324821|NCT01155479|26579398|FG003|Part II|Non-Compliance with Protocol|2|||
13324822|NCT01155479|26579399|FG004|Part II|Non-Compliance with Protocol|0|||
13324823|NCT01155466|26579467|FG000|Overall Study|Adverse Event|13|||
13324824|NCT01155466|26579468|FG001|Overall Study|Adverse Event|15|||
13324825|NCT01155466|26579469|FG002|Overall Study|Adverse Event|6|||
13324826|NCT01155466|26579470|FG003|Overall Study|Adverse Event|17|||
13324827|NCT01155466|26579471|FG004|Overall Study|Adverse Event|18|||
13324828|NCT01155466|26579467|FG000|Overall Study|Lost to Follow-up|0|||
13324829|NCT01155466|26579468|FG001|Overall Study|Lost to Follow-up|0|||
13324830|NCT01155466|26579469|FG002|Overall Study|Lost to Follow-up|0|||
13324831|NCT01155466|26579470|FG003|Overall Study|Lost to Follow-up|0|||
13324832|NCT01155466|26579471|FG004|Overall Study|Lost to Follow-up|2|||
13324833|NCT01155466|26579467|FG000|Overall Study|Withdrawal by Subject|7|||
13324834|NCT01155466|26579468|FG001|Overall Study|Withdrawal by Subject|5|||
13324835|NCT01155466|26579469|FG002|Overall Study|Withdrawal by Subject|9|||
13286897|NCT00477490|26472500|FG004|Part I: 4 Week Efficacy|Other, not specified|1|||
13286898|NCT00477490|26472501|FG005|Part I: 4 Week Efficacy|Other, not specified|0|||
13286899|NCT00477490|26472502|FG006|Part I: 4 Week Efficacy|Other, not specified|0|||
13286900|NCT00477490|26472503|FG007|Part I: 4 Week Efficacy|Other, not specified|0|||
13286901|NCT00477490|26472504|FG008|Part I: 4 Week Efficacy|Other, not specified|0|||
13286902|NCT00477490|26472496|FG000|Part I: 4 Week Efficacy|Not Reported|1|||
13286903|NCT00477490|26472497|FG001|Part I: 4 Week Efficacy|Not Reported|2|||
13286904|NCT00477490|26472498|FG002|Part I: 4 Week Efficacy|Not Reported|3|||
13286905|NCT00477490|26472499|FG003|Part I: 4 Week Efficacy|Not Reported|0|||
13286906|NCT00477490|26472500|FG004|Part I: 4 Week Efficacy|Not Reported|1|||
13286907|NCT00477490|26472501|FG005|Part I: 4 Week Efficacy|Not Reported|0|||
13286908|NCT00477490|26472502|FG006|Part I: 4 Week Efficacy|Not Reported|0|||
13286909|NCT00477490|26472503|FG007|Part I: 4 Week Efficacy|Not Reported|0|||
13286910|NCT00477490|26472504|FG008|Part I: 4 Week Efficacy|Not Reported|0|||
13286911|NCT00477490|26472496|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0|||
13286912|NCT00477490|26472497|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15|||
13286913|NCT00477490|26472498|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
13286914|NCT00477490|26472499|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
13286915|NCT00477490|26472500|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10|||
13286916|NCT00477490|26472501|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4|||
13286917|NCT00477490|26472502|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
13286918|NCT00477490|26472503|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3|||
13286919|NCT00477490|26472504|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
13286920|NCT00477490|26472496|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0|||
13286921|NCT00477490|26472497|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2|||
13286922|NCT00477490|26472498|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3|||
13286923|NCT00477490|26472499|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
13286924|NCT00477490|26472500|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
13286925|NCT00477490|26472501|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
13286926|NCT00477490|26472502|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
13286927|NCT00477490|26472503|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
13286928|NCT00477490|26472504|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4|||
13286929|NCT00477490|26472496|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
13286930|NCT00477490|26472497|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3|||
13286931|NCT00477490|26472498|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2|||
13324836|NCT01155466|26579470|FG003|Overall Study|Withdrawal by Subject|4|||
13324837|NCT01155466|26579471|FG004|Overall Study|Withdrawal by Subject|4|||
13324838|NCT01155466|26579467|FG000|Overall Study|Protocol Violation|0|||
13324839|NCT01155466|26579468|FG001|Overall Study|Protocol Violation|0|||
13324840|NCT01155466|26579469|FG002|Overall Study|Protocol Violation|2|||
13324841|NCT01155466|26579470|FG003|Overall Study|Protocol Violation|0|||
13324842|NCT01155466|26579471|FG004|Overall Study|Protocol Violation|1|||
13324843|NCT01155466|26579467|FG000|Overall Study|Administrative|0|||
13324844|NCT01155466|26579468|FG001|Overall Study|Administrative|3|||
13324845|NCT01155466|26579469|FG002|Overall Study|Administrative|0|||
13324846|NCT01155466|26579470|FG003|Overall Study|Administrative|0|||
13324847|NCT01155466|26579471|FG004|Overall Study|Administrative|0|||
13324848|NCT01155466|26579467|FG000|Overall Study|Randomized not treated|2|||
13324849|NCT01155466|26579468|FG001|Overall Study|Randomized not treated|2|||
13286932|NCT00477490|26472499|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
13286933|NCT00477490|26472500|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5|||
13286934|NCT00477490|26472501|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
13286935|NCT00477490|26472502|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1|||
13286936|NCT00477490|26472503|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
13286937|NCT00477490|26472504|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
13286938|NCT00477490|26472496|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
13286939|NCT00477490|26472497|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
13286940|NCT00477490|26472498|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
13286941|NCT00477490|26472499|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
13286942|NCT00477490|26472500|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
13286943|NCT00477490|26472501|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
13286944|NCT00477490|26472502|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
13286945|NCT00477490|26472503|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
13286946|NCT00477490|26472504|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
13286947|NCT00477490|26472496|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
13286948|NCT00477490|26472497|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1|||
13286949|NCT00477490|26472498|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
13286950|NCT00477490|26472499|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
13286951|NCT00477490|26472500|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
13286952|NCT00477490|26472501|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
13286953|NCT00477490|26472502|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
13286954|NCT00477490|26472503|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
13286955|NCT00477490|26472504|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
13286956|NCT00477490|26472496|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
13286957|NCT00477490|26472497|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
13286958|NCT00477490|26472498|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
13286959|NCT00477490|26472499|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
13286960|NCT00477490|26472500|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
13286961|NCT00477490|26472501|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
13286962|NCT00477490|26472502|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
13286963|NCT00477490|26472503|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
13286964|NCT00477490|26472504|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
13286965|NCT00477490|26472496|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0|||
13286966|NCT00477490|26472497|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3|||
13286967|NCT00477490|26472498|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1|||
13286968|NCT00477490|26472499|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0|||
13286969|NCT00477490|26472500|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1|||
13286970|NCT00477490|26472501|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0|||
13286971|NCT00477490|26472502|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0|||
13286972|NCT00477490|26472503|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0|||
13286973|NCT00477490|26472504|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0|||
13286974|NCT00477464|26472529|FG000|Overall Study|Lost to Follow-up|1|||
13286975|NCT00477464|26472529|FG000|Overall Study|Death|36|||
13286976|NCT00477464|26472529|FG000|Overall Study|Completion of protocol-defined follow-up|14|||
13286977|NCT00477386|26472544|FG000|Overall Study|Adverse Event|4|||
13286978|NCT00477386|26472545|FG001|Overall Study|Adverse Event|8|||
13286979|NCT00477386|26472544|FG000|Overall Study|Disease progression, relapse|3|||
13286980|NCT00477386|26472545|FG001|Overall Study|Disease progression, relapse|4|||
13286981|NCT00477386|26472544|FG000|Overall Study|Disease progression, refractory|1|||
13286982|NCT00477386|26472545|FG001|Overall Study|Disease progression, refractory|3|||
13286983|NCT00477386|26472544|FG000|Overall Study|Other|1|||
13286984|NCT00477386|26472545|FG001|Overall Study|Other|2|||
13286985|NCT00477386|26472544|FG000|Overall Study|Physician Decision|1|||
13324850|NCT01155466|26579469|FG002|Overall Study|Randomized not treated|3|||
13324851|NCT01155466|26579470|FG003|Overall Study|Randomized not treated|0|||
13324852|NCT01155466|26579471|FG004|Overall Study|Randomized not treated|2|||
13324853|NCT01155388|26579486|FG000|Overall Study|Adverse Event|1|||
13324854|NCT01155388|26579487|FG001|Overall Study|Adverse Event|0|||
13324855|NCT01155323|26579506|FG000|First Intervention|exclusion criteria|1|||
13324856|NCT01155323|26579507|FG001|First Intervention|exclusion criteria|1|||
13324857|NCT01155323|26579506|FG000|Second Intervention|Lost to Follow-up|1|||
13324858|NCT01155323|26579507|FG001|Second Intervention|Lost to Follow-up|1|||
13324859|NCT01155284|26579522|FG000|Overall Study|Withdrawal by Subject|4|||
13324860|NCT01155284|26579523|FG001|Overall Study|Withdrawal by Subject|3|||
13324861|NCT01155284|26579522|FG000|Overall Study|Lost to Follow-up|1|||
13324862|NCT01155284|26579523|FG001|Overall Study|Lost to Follow-up|2|||
13324863|NCT01155284|26579522|FG000|Overall Study|Physician Decision|1|||
13324864|NCT01155284|26579523|FG001|Overall Study|Physician Decision|0|||
13324865|NCT01155284|26579522|FG000|Overall Study|Adverse Event|1|||
13324866|NCT01155284|26579523|FG001|Overall Study|Adverse Event|0|||
13324867|NCT01155219|26579536|FG000|Overall Study|Adverse Event|3|||
13324868|NCT01155219|26579537|FG001|Overall Study|Adverse Event|1|||
13286986|NCT00477386|26472545|FG001|Overall Study|Physician Decision|0|||
13286987|NCT00477386|26472544|FG000|Overall Study|Withdrawal by Subject|1|||
13286988|NCT00477386|26472545|FG001|Overall Study|Withdrawal by Subject|0|||
13286989|NCT00477334|26472576|FG000|Overall Study|Discontinued prior to taking study drug|106|||
13286990|NCT00477334|26472577|FG001|Overall Study|Discontinued prior to taking study drug|53|||
13286991|NCT00477334|26472576|FG000|Overall Study|Adverse Event|1|||
13286992|NCT00477334|26472577|FG001|Overall Study|Adverse Event|2|||
13286993|NCT00477334|26472576|FG000|Overall Study|Withdrawal by Subject|2|||
13286994|NCT00477334|26472577|FG001|Overall Study|Withdrawal by Subject|1|||
13286995|NCT00477334|26472576|FG000|Overall Study|Lost to Follow-up|15|||
13286996|NCT00477334|26472577|FG001|Overall Study|Lost to Follow-up|4|||
13286997|NCT00477334|26472576|FG000|Overall Study|Administrative Problems|39|||
13286998|NCT00477334|26472577|FG001|Overall Study|Administrative Problems|15|||
13286999|NCT00477334|26472576|FG000|Overall Study|Protocol Violation|7|||
13287000|NCT00477334|26472577|FG001|Overall Study|Protocol Violation|1|||
13287001|NCT00477295|26472610|FG000|Overall Study|Adverse Event|31|||
13287002|NCT00477295|26472611|FG001|Overall Study|Adverse Event|35|||
13287003|NCT00477295|26472610|FG000|Overall Study|Withdrawal by Subject|35|||
13287004|NCT00477295|26472611|FG001|Overall Study|Withdrawal by Subject|24|||
13287005|NCT00477295|26472610|FG000|Overall Study|Lack of Efficacy|23|||
13287006|NCT00477295|26472611|FG001|Overall Study|Lack of Efficacy|23|||
13287007|NCT00477295|26472610|FG000|Overall Study|Protocol Violation|3|||
13287008|NCT00477295|26472611|FG001|Overall Study|Protocol Violation|8|||
13287009|NCT00477295|26472610|FG000|Overall Study|Physician Decision|4|||
13287010|NCT00477295|26472611|FG001|Overall Study|Physician Decision|5|||
13324869|NCT01155219|26579536|FG000|Overall Study|non-medical reason|1|||
13324870|NCT01155219|26579537|FG001|Overall Study|non-medical reason|2|||
13324871|NCT01155167|26579554|FG000|Overall Study|Insufficient ultrasound data|2|||
13324872|NCT01155167|26579555|FG001|Overall Study|Insufficient ultrasound data|0|||
13324873|NCT01155167|26579554|FG000|Overall Study|Access site changed to femoral artery|1|||
13287011|NCT00477295|26472610|FG000|Overall Study|Lost to Follow-up|21|||
13287012|NCT00477295|26472611|FG001|Overall Study|Lost to Follow-up|11|||
13287013|NCT00477295|26472610|FG000|Overall Study|Other|4|||
13287014|NCT00477295|26472611|FG001|Overall Study|Other|3|||
13287015|NCT00477269|26472671|FG000|Core Study|Adverse Event|6|||
13287016|NCT00477269|26472672|FG001|Core Study|Adverse Event|4|||
13287017|NCT00477269|26472673|FG002|Core Study|Adverse Event|0|||
13287018|NCT00477269|26472671|FG000|Core Study|Death|3|||
13287019|NCT00477269|26472672|FG001|Core Study|Death|3|||
13287020|NCT00477269|26472673|FG002|Core Study|Death|0|||
13287021|NCT00477269|26472671|FG000|Core Study|Withdrawn Consent|0|||
13287022|NCT00477269|26472672|FG001|Core Study|Withdrawn Consent|1|||
13287023|NCT00477269|26472673|FG002|Core Study|Withdrawn Consent|0|||
13287024|NCT00477269|26472671|FG000|Open Label Extension|Adverse Event|0|||
13287025|NCT00477269|26472672|FG001|Open Label Extension|Adverse Event|0|||
13287026|NCT00477269|26472673|FG002|Open Label Extension|Adverse Event|4|||
13287027|NCT00477269|26472671|FG000|Open Label Extension|Abnormal laboratory values|0|||
13287028|NCT00477269|26472672|FG001|Open Label Extension|Abnormal laboratory values|0|||
13324874|NCT01155167|26579555|FG001|Overall Study|Access site changed to femoral artery|0|||
13324875|NCT01155141|26579569|FG000|Overall Study|Withdrawal by Subject|1|||
13324876|NCT01155141|26579569|FG000|Overall Study|Screen Failure|1|||
13324877|NCT01155063|26579581|FG000|Overall Study|Adverse Event|1|||
13287029|NCT00477269|26472673|FG002|Open Label Extension|Abnormal laboratory values|1|||
13287030|NCT00477269|26472671|FG000|Open Label Extension|unsatisfactory therapeutic effects|0|||
13287031|NCT00477269|26472672|FG001|Open Label Extension|unsatisfactory therapeutic effects|0|||
13287032|NCT00477269|26472673|FG002|Open Label Extension|unsatisfactory therapeutic effects|2|||
13287033|NCT00477269|26472671|FG000|Open Label Extension|Adminiatrative problems|0|||
13287034|NCT00477269|26472672|FG001|Open Label Extension|Adminiatrative problems|0|||
13287035|NCT00477269|26472673|FG002|Open Label Extension|Adminiatrative problems|2|||
13287036|NCT00477269|26472671|FG000|Open Label Extension|Death|0|||
13287037|NCT00477269|26472672|FG001|Open Label Extension|Death|0|||
13287038|NCT00477269|26472673|FG002|Open Label Extension|Death|4|||
13287039|NCT00477165|26472692|FG000|Overall Study|Adverse Event|7|||
13287040|NCT00477165|26472693|FG001|Overall Study|Adverse Event|2|||
13324878|NCT01155063|26579581|FG000|Overall Study|Withdrawal by Subject|1|||
13324879|NCT01155063|26579581|FG000|Overall Study|Study terminated by sponsor|87|||
13287041|NCT00477152|26472702|FG000|Overall Study|Parent withdrew consent|2|||
13287042|NCT00477152|26472702|FG000|Overall Study|Adverse Event|1|||
13287043|NCT00476996|26472743|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12|||
13287044|NCT00476996|26472744|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
13287045|NCT00476996|26472745|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
13324880|NCT01155050|26579632|FG000|Overall Study|Lost to Follow-up|15|||
13287046|NCT00476996|26472746|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0|||
13287047|NCT00476996|26472743|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1|||
13287048|NCT00476996|26472744|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3|||
13287049|NCT00476996|26472745|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
13287050|NCT00476996|26472746|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
13287051|NCT00476996|26472743|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24|||
13287052|NCT00476996|26472744|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20|||
13287053|NCT00476996|26472745|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21|||
13324881|NCT01155050|26579633|FG001|Overall Study|Lost to Follow-up|20|||
13324882|NCT01155050|26579634|FG002|Overall Study|Lost to Follow-up|19|||
13324883|NCT01155050|26579635|FG003|Overall Study|Lost to Follow-up|22|||
13324884|NCT01155024|26579646|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0|||
13324885|NCT01155024|26579647|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2|||
13324886|NCT01155024|26579646|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0|||
13287054|NCT00476996|26472746|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0|||
13287055|NCT00476996|26472743|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
13287056|NCT00476996|26472744|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2|||
13287057|NCT00476996|26472745|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
13287058|NCT00476996|26472746|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
13287059|NCT00476996|26472743|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
13287060|NCT00476996|26472744|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4|||
13287061|NCT00476996|26472745|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3|||
13287062|NCT00476996|26472746|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
13287063|NCT00476996|26472743|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22|||
13324887|NCT01155024|26579647|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2|||
13324888|NCT01155024|26579646|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0|||
13324889|NCT01155024|26579647|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2|||
13324890|NCT01155011|26579664|FG000|Baseline to 6 Months|Withdrawal by Subject|18|||
13324891|NCT01155011|26579665|FG001|Baseline to 6 Months|Withdrawal by Subject|19|||
13324892|NCT01155011|26579664|FG000|Baseline to 6 Months|investigator decision, moved|4|||
13324893|NCT01155011|26579665|FG001|Baseline to 6 Months|investigator decision, moved|5|||
13324894|NCT01155011|26579664|FG000|Baseline to 6 Months|Death|0|||
13324895|NCT01155011|26579665|FG001|Baseline to 6 Months|Death|1|||
13324896|NCT01155011|26579664|FG000|6 to 12 Months|Withdrawal by Subject|8|||
13324897|NCT01155011|26579665|FG001|6 to 12 Months|Withdrawal by Subject|5|||
13324898|NCT01155011|26579664|FG000|6 to 12 Months|Death|1|||
13324899|NCT01155011|26579665|FG001|6 to 12 Months|Death|5|||
13324900|NCT01154816|26579735|FG000|Overall Study|Withdrawal by Subject|1|||
13324901|NCT01154816|26579736|FG001|Overall Study|Withdrawal by Subject|0|||
13324902|NCT01154816|26579737|FG002|Overall Study|Withdrawal by Subject|0|||
13324903|NCT01154816|26579738|FG003|Overall Study|Withdrawal by Subject|1|||
13324904|NCT01154816|26579739|FG004|Overall Study|Withdrawal by Subject|0|||
13324905|NCT01154816|26579740|FG005|Overall Study|Withdrawal by Subject|0|||
13324906|NCT01154816|26579741|FG006|Overall Study|Withdrawal by Subject|0|||
13324907|NCT01154816|26579742|FG007|Overall Study|Withdrawal by Subject|0|||
13324908|NCT01154816|26579743|FG008|Overall Study|Withdrawal by Subject|1|||
13324909|NCT01154816|26579744|FG009|Overall Study|Withdrawal by Subject|3|||
13324910|NCT01154816|26579745|FG010|Overall Study|Withdrawal by Subject|0|||
13324911|NCT01154816|26579746|FG011|Overall Study|Withdrawal by Subject|0|||
13324912|NCT01154816|26579735|FG000|Overall Study|Progressive Disease|13|||
13324913|NCT01154816|26579736|FG001|Overall Study|Progressive Disease|8|||
13324914|NCT01154816|26579737|FG002|Overall Study|Progressive Disease|9|||
13324915|NCT01154816|26579738|FG003|Overall Study|Progressive Disease|9|||
13324916|NCT01154816|26579739|FG004|Overall Study|Progressive Disease|8|||
13324917|NCT01154816|26579740|FG005|Overall Study|Progressive Disease|8|||
13324918|NCT01154816|26579741|FG006|Overall Study|Progressive Disease|5|||
13324919|NCT01154816|26579742|FG007|Overall Study|Progressive Disease|6|||
13324920|NCT01154816|26579743|FG008|Overall Study|Progressive Disease|8|||
13324921|NCT01154816|26579744|FG009|Overall Study|Progressive Disease|6|||
13324922|NCT01154816|26579745|FG010|Overall Study|Progressive Disease|10|||
13324923|NCT01154816|26579746|FG011|Overall Study|Progressive Disease|3|||
13324924|NCT01154816|26579735|FG000|Overall Study|Physician Decision|1|||
13324925|NCT01154816|26579736|FG001|Overall Study|Physician Decision|0|||
13324926|NCT01154816|26579737|FG002|Overall Study|Physician Decision|1|||
13324927|NCT01154816|26579738|FG003|Overall Study|Physician Decision|0|||
13324928|NCT01154816|26579739|FG004|Overall Study|Physician Decision|2|||
13324929|NCT01154816|26579740|FG005|Overall Study|Physician Decision|0|||
13324930|NCT01154816|26579741|FG006|Overall Study|Physician Decision|0|||
13324931|NCT01154816|26579742|FG007|Overall Study|Physician Decision|0|||
13324932|NCT01154816|26579743|FG008|Overall Study|Physician Decision|0|||
13324933|NCT01154816|26579744|FG009|Overall Study|Physician Decision|1|||
13324934|NCT01154816|26579745|FG010|Overall Study|Physician Decision|1|||
13287064|NCT00476996|26472744|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5|||
13287065|NCT00476996|26472745|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6|||
13287066|NCT00476996|26472746|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0|||
13287067|NCT00476996|26472743|FG000|Blinded Treatment Phase (up to Week 48)|Death|2|||
13287068|NCT00476996|26472744|FG001|Blinded Treatment Phase (up to Week 48)|Death|1|||
13287069|NCT00476996|26472745|FG002|Blinded Treatment Phase (up to Week 48)|Death|1|||
13287070|NCT00476996|26472746|FG003|Blinded Treatment Phase (up to Week 48)|Death|0|||
13287071|NCT00476996|26472743|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11|||
13287072|NCT00476996|26472744|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13|||
13287073|NCT00476996|26472745|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7|||
13287074|NCT00476996|26472746|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0|||
13287075|NCT00476996|26472743|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
13287076|NCT00476996|26472744|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
13287077|NCT00476996|26472745|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
13287078|NCT00476996|26472746|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50|||
13287079|NCT00476996|26472743|FG000|OLE Phase (From Week 48)|Adverse Event|0|||
13287080|NCT00476996|26472744|FG001|OLE Phase (From Week 48)|Adverse Event|0|||
13287081|NCT00476996|26472745|FG002|OLE Phase (From Week 48)|Adverse Event|0|||
13287082|NCT00476996|26472746|FG003|OLE Phase (From Week 48)|Adverse Event|8|||
13287083|NCT00476996|26472743|FG000|OLE Phase (From Week 48)|Death|0|||
13287084|NCT00476996|26472744|FG001|OLE Phase (From Week 48)|Death|0|||
13287085|NCT00476996|26472745|FG002|OLE Phase (From Week 48)|Death|0|||
13287086|NCT00476996|26472746|FG003|OLE Phase (From Week 48)|Death|7|||
13287087|NCT00476996|26472743|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0|||
13287088|NCT00476996|26472744|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0|||
13287089|NCT00476996|26472745|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0|||
13287090|NCT00476996|26472746|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13|||
13287091|NCT00476996|26472743|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0|||
13287092|NCT00476996|26472744|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0|||
13287093|NCT00476996|26472745|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0|||
13287094|NCT00476996|26472746|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4|||
13287095|NCT00476996|26472743|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
13287096|NCT00476996|26472744|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
13287097|NCT00476996|26472745|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
13287098|NCT00476996|26472746|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4|||
13287099|NCT00476996|26472743|FG000|OLE Phase (From Week 48)|Early termination of the study|0|||
13287100|NCT00476996|26472744|FG001|OLE Phase (From Week 48)|Early termination of the study|0|||
13287101|NCT00476996|26472745|FG002|OLE Phase (From Week 48)|Early termination of the study|0|||
13287102|NCT00476996|26472746|FG003|OLE Phase (From Week 48)|Early termination of the study|578|||
13292231|NCT00707174|26484924|FG000|Overall Study|Withdrawal by Subject|4|||
13292232|NCT00707174|26484925|FG001|Overall Study|Withdrawal by Subject|1|||
13292233|NCT00707161|26484931|FG000|Overall Study|Physician Decision|6|||
13292234|NCT00707057|26484970|FG000|Overall Study|Withdrawal by Subject|8|||
13292235|NCT00707057|26484971|FG001|Overall Study|Withdrawal by Subject|3|||
13292236|NCT00707057|26484970|FG000|Overall Study|Dosed incorrectly|0|||
13292237|NCT00707057|26484971|FG001|Overall Study|Dosed incorrectly|1|||
13292238|NCT00706992|26485010|FG000|Overall Study|Study termination|5|||
13292239|NCT00706992|26485011|FG001|Overall Study|Study termination|5|||
13292240|NCT00706992|26485012|FG002|Overall Study|Study termination|6|||
13292241|NCT00706992|26485013|FG003|Overall Study|Study termination|2|||
13292242|NCT00706992|26485014|FG004|Overall Study|Study termination|3|||
13292243|NCT00706992|26485015|FG005|Overall Study|Study termination|2|||
13292244|NCT00706992|26485016|FG006|Overall Study|Study termination|3|||
13292245|NCT00706992|26485010|FG000|Overall Study|Disease progression before treatment|0|||
13292246|NCT00706992|26485011|FG001|Overall Study|Disease progression before treatment|0|||
13292247|NCT00706992|26485012|FG002|Overall Study|Disease progression before treatment|0|||
13292248|NCT00706992|26485013|FG003|Overall Study|Disease progression before treatment|0|||
13292249|NCT00706992|26485014|FG004|Overall Study|Disease progression before treatment|1|||
13292250|NCT00706992|26485015|FG005|Overall Study|Disease progression before treatment|0|||
13292251|NCT00706992|26485016|FG006|Overall Study|Disease progression before treatment|0|||
13292252|NCT00706966|26485051|FG000|Overall Study|Adverse Event|1|||
13292253|NCT00706914|26485081|FG000|Overall Study|Lack of Efficacy|0|||
13292254|NCT00706914|26485082|FG001|Overall Study|Lack of Efficacy|1|||
13292255|NCT00706914|26485083|FG002|Overall Study|Lack of Efficacy|0|||
13292256|NCT00706914|26485081|FG000|Overall Study|Lost to Follow-up|1|||
13292257|NCT00706914|26485082|FG001|Overall Study|Lost to Follow-up|0|||
13292258|NCT00706914|26485083|FG002|Overall Study|Lost to Follow-up|0|||
13292259|NCT00706914|26485081|FG000|Overall Study|Adverse Event|2|||
13292260|NCT00706914|26485082|FG001|Overall Study|Adverse Event|2|||
13292261|NCT00706914|26485083|FG002|Overall Study|Adverse Event|0|||
13292262|NCT00706914|26485081|FG000|Overall Study|Protocol Violation|3|||
13324935|NCT01154816|26579746|FG011|Overall Study|Physician Decision|1|||
13287103|NCT00476957|26472761|FG000|Overall Study|Lost to Follow-up|176|||
13287104|NCT00476957|26472762|FG001|Overall Study|Lost to Follow-up|193|||
13287105|NCT00476593|26472785|FG000|Overall Study|Lost to Follow-up|10|||
13287106|NCT00476593|26472786|FG001|Overall Study|Lost to Follow-up|2|||
13287107|NCT00476593|26472787|FG002|Overall Study|Lost to Follow-up|8|||
13287108|NCT00476593|26472788|FG003|Overall Study|Lost to Follow-up|22|||
13287109|NCT00476476|26472800|FG000|Overall Study|Adverse Event|2|||
13287110|NCT00476476|26472801|FG001|Overall Study|Adverse Event|7|||
13287111|NCT00476476|26472800|FG000|Overall Study|Progressive Disease|0|||
13287112|NCT00476476|26472801|FG001|Overall Study|Progressive Disease|17|||
13287113|NCT00476229|26472807|FG000|Overall Study|Progressive shortness of breath|1|||
13287114|NCT00476151|26472820|FG000|Overall Study|Adverse Event|0|||
13287115|NCT00476151|26472821|FG001|Overall Study|Adverse Event|2|||
13287116|NCT00476151|26472820|FG000|Overall Study|Protocol Violation|1|||
13287117|NCT00476151|26472821|FG001|Overall Study|Protocol Violation|3|||
13287118|NCT00476151|26472820|FG000|Overall Study|Withdrawal by Subject|2|||
13324936|NCT01154816|26579735|FG000|Overall Study|Adverse Event|5|||
13324937|NCT01154816|26579736|FG001|Overall Study|Adverse Event|2|||
13324938|NCT01154816|26579737|FG002|Overall Study|Adverse Event|0|||
13324939|NCT01154816|26579738|FG003|Overall Study|Adverse Event|0|||
13324940|NCT01154816|26579739|FG004|Overall Study|Adverse Event|0|||
13324941|NCT01154816|26579740|FG005|Overall Study|Adverse Event|0|||
13324942|NCT01154816|26579741|FG006|Overall Study|Adverse Event|1|||
13324943|NCT01154816|26579742|FG007|Overall Study|Adverse Event|1|||
13324944|NCT01154816|26579743|FG008|Overall Study|Adverse Event|0|||
13324945|NCT01154816|26579744|FG009|Overall Study|Adverse Event|0|||
13324946|NCT01154816|26579745|FG010|Overall Study|Adverse Event|0|||
13324947|NCT01154816|26579746|FG011|Overall Study|Adverse Event|0|||
13287119|NCT00476151|26472821|FG001|Overall Study|Withdrawal by Subject|0|||
13287120|NCT00476151|26472820|FG000|Overall Study|Physician Decision|0|||
13287121|NCT00476151|26472821|FG001|Overall Study|Physician Decision|2|||
13287122|NCT00476086|26472829|FG000|Overall Study|Alternative therapy|1|||
13287123|NCT00476086|26472829|FG000|Overall Study|Progressive Disease|4|||
13324948|NCT01154673|26579759|FG000|Overall Study|Lost to Follow-up|1|||
13324949|NCT01154673|26579760|FG001|Overall Study|Lost to Follow-up|0|||
13324950|NCT01154673|26579759|FG000|Overall Study|moved out of province|1|||
13324951|NCT01154673|26579760|FG001|Overall Study|moved out of province|0|||
13324952|NCT01154452|26579786|FG000|Phase Ib|Not Treated|1|||
13324953|NCT01154452|26579787|FG001|Phase Ib|Not Treated|0|||
13324954|NCT01154452|26579788|FG002|Phase Ib|Not Treated|0|||
13324955|NCT01154452|26579789|FG003|Phase Ib|Not Treated|0|||
13324956|NCT01154452|26579786|FG000|Phase Ib|Adverse Event|2|||
13324957|NCT01154452|26579787|FG001|Phase Ib|Adverse Event|1|||
13324958|NCT01154452|26579788|FG002|Phase Ib|Adverse Event|0|||
13324959|NCT01154452|26579789|FG003|Phase Ib|Adverse Event|0|||
13324960|NCT01154452|26579786|FG000|Phase II|Withdrawal by Subject|0|||
13324961|NCT01154452|26579787|FG001|Phase II|Withdrawal by Subject|0|||
13324962|NCT01154452|26579788|FG002|Phase II|Withdrawal by Subject|1|||
13324963|NCT01154452|26579789|FG003|Phase II|Withdrawal by Subject|2|||
13324964|NCT01154452|26579786|FG000|Phase II|Adverse Event|0|||
13324965|NCT01154452|26579787|FG001|Phase II|Adverse Event|0|||
13324966|NCT01154452|26579788|FG002|Phase II|Adverse Event|4|||
13324967|NCT01154452|26579789|FG003|Phase II|Adverse Event|4|||
13324968|NCT01154296|26579812|FG000|Randomization and Intervention|Decided to decline|1|||
13324969|NCT01154296|26579813|FG001|Randomization and Intervention|Decided to decline|1|||
13324970|NCT01154296|26579812|FG000|Randomization and Intervention|Declined by staff|1|||
13324971|NCT01154296|26579813|FG001|Randomization and Intervention|Declined by staff|0|||
13324972|NCT01154296|26579812|FG000|Randomization and Intervention|Did not return|1|||
13324973|NCT01154296|26579813|FG001|Randomization and Intervention|Did not return|0|||
13324974|NCT01154296|26579812|FG000|Randomization and Intervention|Left before test|0|||
13324975|NCT01154296|26579813|FG001|Randomization and Intervention|Left before test|1|||
13324976|NCT01154296|26579812|FG000|Randomization and Intervention|Left clinic early|2|||
13324977|NCT01154296|26579813|FG001|Randomization and Intervention|Left clinic early|0|||
13324978|NCT01154296|26579812|FG000|6-month Follow-up|Lost contact|269|||
13324979|NCT01154296|26579813|FG001|6-month Follow-up|Lost contact|275|||
13324980|NCT01154296|26579812|FG000|6-month Follow-up|Incarcerated|37|||
13324981|NCT01154296|26579813|FG001|6-month Follow-up|Incarcerated|32|||
13324982|NCT01154296|26579812|FG000|6-month Follow-up|Withdrew consent|14|||
13324983|NCT01154296|26579813|FG001|6-month Follow-up|Withdrew consent|15|||
13324984|NCT01154296|26579812|FG000|6-month Follow-up|Death|3|||
13324985|NCT01154296|26579813|FG001|6-month Follow-up|Death|2|||
13324986|NCT01154296|26579812|FG000|6-month Follow-up|Declined by Study Coordinator|5|||
13324987|NCT01154296|26579813|FG001|6-month Follow-up|Declined by Study Coordinator|4|||
13324988|NCT01154283|26579832|FG000|0-6 Weeks|Withdrawal by Subject|7|||
13324989|NCT01154283|26579833|FG001|0-6 Weeks|Withdrawal by Subject|2|||
13287124|NCT00476047|26472838|FG000|Overall Study|Lost to Follow-up|1|||
13287125|NCT00476008|26472869|FG000|Overall Study|Adverse Event|4|||
13287126|NCT00476008|26472870|FG001|Overall Study|Adverse Event|4|||
13324990|NCT01154283|26579832|FG000|0-6 Weeks|Death|0|||
13324991|NCT01154283|26579833|FG001|0-6 Weeks|Death|1|||
13287127|NCT00476008|26472869|FG000|Overall Study|Placebo concerns|2|||
13287128|NCT00476008|26472870|FG001|Overall Study|Placebo concerns|2|||
13287129|NCT00476008|26472869|FG000|Overall Study|Physician Decision: Medication Noncompli|2|||
13287130|NCT00476008|26472870|FG001|Overall Study|Physician Decision: Medication Noncompli|1|||
13287131|NCT00476008|26472869|FG000|Overall Study|Withdrawal by Subject|0|||
13287132|NCT00476008|26472870|FG001|Overall Study|Withdrawal by Subject|1|||
13287133|NCT00476008|26472869|FG000|Overall Study|Death|1|||
13287134|NCT00476008|26472870|FG001|Overall Study|Death|0|||
13287135|NCT00475865|26472908|FG000|Overall Study|Adverse Event|0|||
13287136|NCT00475865|26472909|FG001|Overall Study|Adverse Event|3|||
13287137|NCT00475865|26472910|FG002|Overall Study|Adverse Event|4|||
13287138|NCT00475865|26472908|FG000|Overall Study|Lack of Efficacy|1|||
13287139|NCT00475865|26472909|FG001|Overall Study|Lack of Efficacy|0|||
13287140|NCT00475865|26472910|FG002|Overall Study|Lack of Efficacy|0|||
13287141|NCT00475865|26472908|FG000|Overall Study|Progressive disease|0|||
13287142|NCT00475865|26472909|FG001|Overall Study|Progressive disease|1|||
13287143|NCT00475865|26472910|FG002|Overall Study|Progressive disease|2|||
13287144|NCT00475865|26472908|FG000|Overall Study|Participant did not wish to continue|1|||
13287145|NCT00475865|26472909|FG001|Overall Study|Participant did not wish to continue|0|||
13287146|NCT00475865|26472910|FG002|Overall Study|Participant did not wish to continue|0|||
13287147|NCT00475865|26472908|FG000|Overall Study|Other than above|0|||
13287148|NCT00475865|26472909|FG001|Overall Study|Other than above|1|||
13287149|NCT00475865|26472910|FG002|Overall Study|Other than above|0|||
13287150|NCT00475735|26472940|FG000|Treatment Period 1|Adverse Event|2|||
13287151|NCT00475735|26472941|FG001|Treatment Period 1|Adverse Event|0|||
13287152|NCT00475735|26472942|FG002|Treatment Period 1|Adverse Event|0|||
13287153|NCT00475735|26472943|FG003|Treatment Period 1|Adverse Event|0|||
13287154|NCT00475735|26472944|FG004|Treatment Period 1|Adverse Event|0|||
13287155|NCT00475735|26472945|FG005|Treatment Period 1|Adverse Event|0|||
13287156|NCT00475735|26472940|FG000|Treatment Period 1|Lack of Efficacy|1|||
13287157|NCT00475735|26472941|FG001|Treatment Period 1|Lack of Efficacy|0|||
13324992|NCT01154283|26579832|FG000|7-12 Weeks|Death|1|||
13324993|NCT01154283|26579833|FG001|7-12 Weeks|Death|0|||
13324994|NCT01154283|26579832|FG000|7-12 Weeks|Withdrawal by Subject|0|||
13324995|NCT01154283|26579833|FG001|7-12 Weeks|Withdrawal by Subject|1|||
13324996|NCT01154231|26579841|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1|||
13324997|NCT01154231|26579841|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1|||
13324998|NCT01154218|26579896|FG000|Third Intervention Period|Adverse Event|0|||
13324999|NCT01154218|26579897|FG001|Third Intervention Period|Adverse Event|1|||
13325000|NCT01154218|26579898|FG002|Third Intervention Period|Adverse Event|0|||
13325001|NCT01154218|26579899|FG003|Third Intervention Period|Adverse Event|0|||
13325002|NCT01154218|26579896|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
13325003|NCT01154218|26579897|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
13325004|NCT01154218|26579898|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
13325005|NCT01154218|26579899|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
13325006|NCT01154218|26579896|FG000|Fourth Intervention Period|Withdrawal by Subject|1|||
13325007|NCT01154218|26579897|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
13325008|NCT01154218|26579898|FG002|Fourth Intervention Period|Withdrawal by Subject|0|||
13325009|NCT01154218|26579899|FG003|Fourth Intervention Period|Withdrawal by Subject|0|||
13325010|NCT01154166|26579936|FG000|Overall Study|Adverse Event|14|||
13325011|NCT01154166|26579937|FG001|Overall Study|Adverse Event|9|||
13325012|NCT01154166|26579936|FG000|Overall Study|Lost to Follow-up|1|||
13325013|NCT01154166|26579937|FG001|Overall Study|Lost to Follow-up|1|||
13325014|NCT01154166|26579936|FG000|Overall Study|Protocol Violation|4|||
13325015|NCT01154166|26579937|FG001|Overall Study|Protocol Violation|1|||
13325016|NCT01154166|26579936|FG000|Overall Study|Withdrawal by Subject|10|||
13325017|NCT01154166|26579937|FG001|Overall Study|Withdrawal by Subject|1|||
13325018|NCT01154166|26579936|FG000|Overall Study|Lack of Efficacy|3|||
13325019|NCT01154166|26579937|FG001|Overall Study|Lack of Efficacy|0|||
13325020|NCT01154166|26579936|FG000|Overall Study|Disease Progression|1|||
13325021|NCT01154166|26579937|FG001|Overall Study|Disease Progression|0|||
13325022|NCT01154166|26579936|FG000|Overall Study|Poor Compliance|1|||
13325023|NCT01154166|26579937|FG001|Overall Study|Poor Compliance|0|||
13325024|NCT01154153|26579960|FG000|Overall Study|Poor compliance to protocol|2|||
13325025|NCT01154153|26579961|FG001|Overall Study|Poor compliance to protocol|0|||
13325026|NCT01154153|26579960|FG000|Overall Study|Unable to use labs|2|||
13325027|NCT01154153|26579961|FG001|Overall Study|Unable to use labs|3|||
13325028|NCT01154153|26579960|FG000|Overall Study|Withdrew consent|1|||
13325029|NCT01154153|26579961|FG001|Overall Study|Withdrew consent|0|||
13325030|NCT01154140|26580019|FG000|Overall Study|Death|71|||
13325031|NCT01154140|26580020|FG001|Overall Study|Death|81|||
13325032|NCT01154140|26580019|FG000|Overall Study|Lost to Follow-up|4|||
13325033|NCT01154140|26580020|FG001|Overall Study|Lost to Follow-up|5|||
13325034|NCT01154140|26580019|FG000|Overall Study|Withdrawal by Subject|12|||
13325035|NCT01154140|26580020|FG001|Overall Study|Withdrawal by Subject|13|||
13325036|NCT01154140|26580019|FG000|Overall Study|Other|3|||
13325037|NCT01154140|26580020|FG001|Overall Study|Other|1|||
13325038|NCT01154140|26580019|FG000|Overall Study|Randomized but not treated|1|||
13287158|NCT00475735|26472942|FG002|Treatment Period 1|Lack of Efficacy|0|||
13287159|NCT00475735|26472943|FG003|Treatment Period 1|Lack of Efficacy|0|||
13287160|NCT00475735|26472944|FG004|Treatment Period 1|Lack of Efficacy|0|||
13287161|NCT00475735|26472945|FG005|Treatment Period 1|Lack of Efficacy|0|||
13287162|NCT00475735|26472940|FG000|Treatment Period 1|Lost to Follow-up|0|||
13287163|NCT00475735|26472941|FG001|Treatment Period 1|Lost to Follow-up|0|||
13287164|NCT00475735|26472942|FG002|Treatment Period 1|Lost to Follow-up|0|||
13287165|NCT00475735|26472943|FG003|Treatment Period 1|Lost to Follow-up|0|||
13287166|NCT00475735|26472944|FG004|Treatment Period 1|Lost to Follow-up|0|||
13287167|NCT00475735|26472945|FG005|Treatment Period 1|Lost to Follow-up|1|||
13287168|NCT00475735|26472940|FG000|Treatment Period 1|Protocol Violation|0|||
13287169|NCT00475735|26472941|FG001|Treatment Period 1|Protocol Violation|0|||
13287170|NCT00475735|26472942|FG002|Treatment Period 1|Protocol Violation|0|||
13287171|NCT00475735|26472943|FG003|Treatment Period 1|Protocol Violation|1|||
13287172|NCT00475735|26472944|FG004|Treatment Period 1|Protocol Violation|0|||
13287173|NCT00475735|26472945|FG005|Treatment Period 1|Protocol Violation|0|||
13287174|NCT00475735|26472940|FG000|Treatment Period 1|Withdrawal by Subject|1|||
13287175|NCT00475735|26472941|FG001|Treatment Period 1|Withdrawal by Subject|1|||
13287176|NCT00475735|26472942|FG002|Treatment Period 1|Withdrawal by Subject|0|||
13287177|NCT00475735|26472943|FG003|Treatment Period 1|Withdrawal by Subject|0|||
13287178|NCT00475735|26472944|FG004|Treatment Period 1|Withdrawal by Subject|0|||
13287179|NCT00475735|26472945|FG005|Treatment Period 1|Withdrawal by Subject|0|||
13287180|NCT00475735|26472940|FG000|Treatment Period 1|DC due to AE but continuing|0|||
13287181|NCT00475735|26472941|FG001|Treatment Period 1|DC due to AE but continuing|0|||
13287182|NCT00475735|26472942|FG002|Treatment Period 1|DC due to AE but continuing|0|||
13325039|NCT01154140|26580020|FG001|Overall Study|Randomized but not treated|2|||
13325040|NCT01154127|26580049|FG000|Period 1 (21 Days)|Adverse Event|3|||
13325041|NCT01154127|26580050|FG001|Period 1 (21 Days)|Adverse Event|4|||
13325042|NCT01154127|26580049|FG000|Period 1 (21 Days)|Withdrawal by Subject|0|||
13325043|NCT01154127|26580050|FG001|Period 1 (21 Days)|Withdrawal by Subject|2|||
13325044|NCT01154127|26580049|FG000|Washout (14 - 28 Days)|Adverse Event|2|||
13325045|NCT01154127|26580050|FG001|Washout (14 - 28 Days)|Adverse Event|0|||
13325046|NCT01154127|26580049|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1|||
13325047|NCT01154127|26580050|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0|||
13325048|NCT01154127|26580049|FG000|Period 2 (21 Days)|Protocol Deviation|0|||
13325049|NCT01154127|26580050|FG001|Period 2 (21 Days)|Protocol Deviation|1|||
13325050|NCT01154101|26580118|FG000|Overall Study|Adverse Event|0|||
13325051|NCT01154101|26580119|FG001|Overall Study|Adverse Event|2|||
13325052|NCT01154101|26580120|FG002|Overall Study|Adverse Event|1|||
13325053|NCT01154101|26580121|FG003|Overall Study|Adverse Event|1|||
13325054|NCT01154101|26580122|FG004|Overall Study|Adverse Event|0|||
13325055|NCT01154101|26580118|FG000|Overall Study|Lost to Follow-up|0|||
13325056|NCT01154101|26580119|FG001|Overall Study|Lost to Follow-up|1|||
13325057|NCT01154101|26580120|FG002|Overall Study|Lost to Follow-up|0|||
13325058|NCT01154101|26580121|FG003|Overall Study|Lost to Follow-up|1|||
13325059|NCT01154101|26580122|FG004|Overall Study|Lost to Follow-up|0|||
13325060|NCT01154101|26580118|FG000|Overall Study|Withdrawal by Subject|0|||
13325061|NCT01154101|26580119|FG001|Overall Study|Withdrawal by Subject|1|||
13325062|NCT01154101|26580120|FG002|Overall Study|Withdrawal by Subject|2|||
13325063|NCT01154101|26580121|FG003|Overall Study|Withdrawal by Subject|0|||
13325064|NCT01154101|26580122|FG004|Overall Study|Withdrawal by Subject|1|||
13325065|NCT01154088|26580169|FG000|Overall Study|Lost to Follow-up|4|||
13325066|NCT01154088|26580170|FG001|Overall Study|Lost to Follow-up|6|||
13325067|NCT01154088|26580171|FG002|Overall Study|Lost to Follow-up|7|||
13325068|NCT01154036|26580308|FG000|Phase I|Physician Decision|0|||
13325069|NCT01154036|26580309|FG001|Phase I|Physician Decision|1|||
13325070|NCT01154036|26580310|FG002|Phase I|Physician Decision|0|||
13325071|NCT01154036|26580311|FG003|Phase I|Physician Decision|0|||
13325072|NCT01154036|26580312|FG004|Phase I|Physician Decision|0|||
13325073|NCT01154036|26580313|FG005|Phase I|Physician Decision|0|||
13325074|NCT01154036|26580314|FG006|Phase I|Physician Decision|0|||
13325075|NCT01154036|26580315|FG007|Phase I|Physician Decision|0|||
13325076|NCT01154036|26580308|FG000|Phase I|Lost to Follow-up|0|||
13325077|NCT01154036|26580309|FG001|Phase I|Lost to Follow-up|3|||
13325078|NCT01154036|26580310|FG002|Phase I|Lost to Follow-up|6|||
13325079|NCT01154036|26580311|FG003|Phase I|Lost to Follow-up|0|||
13325080|NCT01154036|26580312|FG004|Phase I|Lost to Follow-up|0|||
13325081|NCT01154036|26580313|FG005|Phase I|Lost to Follow-up|0|||
13325082|NCT01154036|26580314|FG006|Phase I|Lost to Follow-up|0|||
13325083|NCT01154036|26580315|FG007|Phase I|Lost to Follow-up|0|||
13325084|NCT01154036|26580308|FG000|Phase I|Protocol Violation|0|||
13325085|NCT01154036|26580309|FG001|Phase I|Protocol Violation|3|||
13287183|NCT00475735|26472943|FG003|Treatment Period 1|DC due to AE but continuing|1|||
13287184|NCT00475735|26472944|FG004|Treatment Period 1|DC due to AE but continuing|2|||
13287185|NCT00475735|26472945|FG005|Treatment Period 1|DC due to AE but continuing|2|||
13325086|NCT01154036|26580310|FG002|Phase I|Protocol Violation|9|||
13325087|NCT01154036|26580311|FG003|Phase I|Protocol Violation|0|||
13325088|NCT01154036|26580312|FG004|Phase I|Protocol Violation|0|||
13325089|NCT01154036|26580313|FG005|Phase I|Protocol Violation|0|||
13325090|NCT01154036|26580314|FG006|Phase I|Protocol Violation|0|||
13325091|NCT01154036|26580315|FG007|Phase I|Protocol Violation|0|||
13325092|NCT01154036|26580308|FG000|Phase I|Withdrawal by Subject|2|||
13325093|NCT01154036|26580309|FG001|Phase I|Withdrawal by Subject|10|||
13325094|NCT01154036|26580310|FG002|Phase I|Withdrawal by Subject|29|||
13325095|NCT01154036|26580311|FG003|Phase I|Withdrawal by Subject|0|||
13325096|NCT01154036|26580312|FG004|Phase I|Withdrawal by Subject|0|||
13325097|NCT01154036|26580313|FG005|Phase I|Withdrawal by Subject|0|||
13325098|NCT01154036|26580314|FG006|Phase I|Withdrawal by Subject|0|||
13325099|NCT01154036|26580315|FG007|Phase I|Withdrawal by Subject|0|||
13325100|NCT01154036|26580308|FG000|Phase I|Adverse Event|1|||
13325101|NCT01154036|26580309|FG001|Phase I|Adverse Event|11|||
13325102|NCT01154036|26580310|FG002|Phase I|Adverse Event|12|||
13325103|NCT01154036|26580311|FG003|Phase I|Adverse Event|0|||
13325104|NCT01154036|26580312|FG004|Phase I|Adverse Event|0|||
13287186|NCT00475735|26472940|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0|||
13287187|NCT00475735|26472941|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1|||
13287188|NCT00475735|26472942|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0|||
13287189|NCT00475735|26472943|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0|||
13287190|NCT00475735|26472944|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0|||
13287191|NCT00475735|26472945|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0|||
13287192|NCT00475735|26472940|FG000|Treatment Washout|Lost to Follow-up|0|||
13287193|NCT00475735|26472941|FG001|Treatment Washout|Lost to Follow-up|1|||
13287194|NCT00475735|26472942|FG002|Treatment Washout|Lost to Follow-up|0|||
13287195|NCT00475735|26472943|FG003|Treatment Washout|Lost to Follow-up|0|||
13287196|NCT00475735|26472944|FG004|Treatment Washout|Lost to Follow-up|0|||
13287197|NCT00475735|26472945|FG005|Treatment Washout|Lost to Follow-up|0|||
13287198|NCT00475735|26472940|FG000|Treatment Washout|Protocol Violation|0|||
13287199|NCT00475735|26472941|FG001|Treatment Washout|Protocol Violation|1|||
13287200|NCT00475735|26472942|FG002|Treatment Washout|Protocol Violation|0|||
13287201|NCT00475735|26472943|FG003|Treatment Washout|Protocol Violation|0|||
13287202|NCT00475735|26472944|FG004|Treatment Washout|Protocol Violation|0|||
13287203|NCT00475735|26472945|FG005|Treatment Washout|Protocol Violation|0|||
13287204|NCT00475735|26472940|FG000|Treatment Period 2|Adverse Event|0|||
13287205|NCT00475735|26472941|FG001|Treatment Period 2|Adverse Event|1|||
13287206|NCT00475735|26472942|FG002|Treatment Period 2|Adverse Event|0|||
13287207|NCT00475735|26472943|FG003|Treatment Period 2|Adverse Event|2|||
13287208|NCT00475735|26472944|FG004|Treatment Period 2|Adverse Event|0|||
13287209|NCT00475735|26472945|FG005|Treatment Period 2|Adverse Event|0|||
13287210|NCT00475735|26472940|FG000|Treatment Period 2|Lack of Efficacy|0|||
13287211|NCT00475735|26472941|FG001|Treatment Period 2|Lack of Efficacy|0|||
13287212|NCT00475735|26472942|FG002|Treatment Period 2|Lack of Efficacy|0|||
13325105|NCT01154036|26580313|FG005|Phase I|Adverse Event|0|||
13325106|NCT01154036|26580314|FG006|Phase I|Adverse Event|0|||
13325107|NCT01154036|26580315|FG007|Phase I|Adverse Event|0|||
13325108|NCT01154036|26580308|FG000|Phase II|Adverse Event|0|||
13325109|NCT01154036|26580309|FG001|Phase II|Adverse Event|0|||
13325110|NCT01154036|26580310|FG002|Phase II|Adverse Event|0|||
13325111|NCT01154036|26580311|FG003|Phase II|Adverse Event|0|||
13325112|NCT01154036|26580312|FG004|Phase II|Adverse Event|1|||
13325113|NCT01154036|26580313|FG005|Phase II|Adverse Event|1|||
13325114|NCT01154036|26580314|FG006|Phase II|Adverse Event|1|||
13287213|NCT00475735|26472943|FG003|Treatment Period 2|Lack of Efficacy|0|||
13287214|NCT00475735|26472944|FG004|Treatment Period 2|Lack of Efficacy|0|||
13287215|NCT00475735|26472945|FG005|Treatment Period 2|Lack of Efficacy|1|||
13287216|NCT00475735|26472940|FG000|Treatment Period 2|Withdrawal by Subject|0|||
13287217|NCT00475735|26472941|FG001|Treatment Period 2|Withdrawal by Subject|0|||
13287218|NCT00475735|26472942|FG002|Treatment Period 2|Withdrawal by Subject|0|||
13287219|NCT00475735|26472943|FG003|Treatment Period 2|Withdrawal by Subject|0|||
13287220|NCT00475735|26472944|FG004|Treatment Period 2|Withdrawal by Subject|1|||
13287221|NCT00475735|26472945|FG005|Treatment Period 2|Withdrawal by Subject|0|||
13287222|NCT00475709|26472953|FG000|Overall Study|Did not meet eligibility criteria|8|||
13287223|NCT00475709|26472953|FG000|Overall Study|Death|41|||
13287224|NCT00475709|26472953|FG000|Overall Study|Device Explant|6|||
13287225|NCT00475709|26472953|FG000|Overall Study|Lost to Follow-up|21|||
13287226|NCT00475670|26472984|FG000|Overall Study|Death|0|||
13287227|NCT00475670|26472985|FG001|Overall Study|Death|1|||
13287228|NCT00475670|26472984|FG000|Overall Study|Lack of Efficacy|3|||
13287229|NCT00475670|26472985|FG001|Overall Study|Lack of Efficacy|34|||
13287230|NCT00475670|26472984|FG000|Overall Study|Refused treatment|0|||
13287231|NCT00475670|26472985|FG001|Overall Study|Refused treatment|2|||
13287232|NCT00475670|26472984|FG000|Overall Study|Failure to Return|0|||
13287233|NCT00475670|26472985|FG001|Overall Study|Failure to Return|1|||
13287234|NCT00475670|26472984|FG000|Overall Study|Other|0|||
13325115|NCT01154036|26580315|FG007|Phase II|Adverse Event|1|||
13325116|NCT01154036|26580308|FG000|Phase II|Physician Decision|0|||
13325117|NCT01154036|26580309|FG001|Phase II|Physician Decision|0|||
13325118|NCT01154036|26580310|FG002|Phase II|Physician Decision|0|||
13287235|NCT00475670|26472985|FG001|Overall Study|Other|3|||
13287236|NCT00475657|26472995|FG000|Overall Study|Death|1|||
13287237|NCT00475657|26472995|FG000|Overall Study|Sponsor's Decision|3|||
13287238|NCT00475644|26473005|FG000|Overall Study|Protocol Violation|13|||
13287239|NCT00475423|26473028|FG000|Overall Study|Protocol Violation|5|||
13287240|NCT00475423|26473028|FG000|Overall Study|Adverse Event|4|||
13325119|NCT01154036|26580311|FG003|Phase II|Physician Decision|0|||
13325120|NCT01154036|26580312|FG004|Phase II|Physician Decision|0|||
13325121|NCT01154036|26580313|FG005|Phase II|Physician Decision|0|||
13325122|NCT01154036|26580314|FG006|Phase II|Physician Decision|1|||
13325123|NCT01154036|26580315|FG007|Phase II|Physician Decision|0|||
13287241|NCT00475423|26473028|FG000|Overall Study|Withdrawal by Subject|6|||
13287242|NCT00475423|26473028|FG000|Overall Study|Lack of Efficacy|8|||
13287243|NCT00475423|26473028|FG000|Overall Study|Death|1|||
13287244|NCT00475423|26473028|FG000|Overall Study|Reason not specified|1|||
13287245|NCT00475423|26473028|FG000|Overall Study|Lost to Follow-up|7|||
13287246|NCT00475306|26473055|FG000|Overall Study|Protocol Violation|1|||
13287247|NCT00475306|26473056|FG001|Overall Study|Protocol Violation|1|||
13287248|NCT00475306|26473057|FG002|Overall Study|Protocol Violation|0|||
13287249|NCT00475306|26473058|FG003|Overall Study|Protocol Violation|1|||
13287250|NCT00475228|26473075|FG000|Overall Study|Lost to Follow-up|17|||
13287251|NCT00475228|26473076|FG001|Overall Study|Lost to Follow-up|17|||
13287252|NCT00475033|26473131|FG000|Infant Series|Failed to return|3|||
13287253|NCT00475033|26473132|FG001|Infant Series|Failed to return|4|||
13287254|NCT00475033|26473131|FG000|Infant Series|Parent or legal guardian request|1|||
13287255|NCT00475033|26473132|FG001|Infant Series|Parent or legal guardian request|5|||
13287256|NCT00475033|26473131|FG000|Infant Series|Protocol Violation|1|||
13287257|NCT00475033|26473132|FG001|Infant Series|Protocol Violation|2|||
13287258|NCT00475033|26473131|FG000|Infant Series|Lost to Follow-up|2|||
13287259|NCT00475033|26473132|FG001|Infant Series|Lost to Follow-up|0|||
13287260|NCT00475033|26473131|FG000|Infant Series|Adverse Event|0|||
13287261|NCT00475033|26473132|FG001|Infant Series|Adverse Event|2|||
13287262|NCT00475033|26473131|FG000|After the Infant Series|Adverse Event|0|||
13287263|NCT00475033|26473132|FG001|After the Infant Series|Adverse Event|4|||
13287264|NCT00475033|26473131|FG000|After the Infant Series|Parent or legal guardian request|2|||
13287265|NCT00475033|26473132|FG001|After the Infant Series|Parent or legal guardian request|2|||
13287266|NCT00475033|26473131|FG000|After the Infant Series|Failed to return|2|||
13287267|NCT00475033|26473132|FG001|After the Infant Series|Failed to return|1|||
13287268|NCT00475033|26473131|FG000|After the Infant Series|Protocol Violation|1|||
13287269|NCT00475033|26473132|FG001|After the Infant Series|Protocol Violation|0|||
13287270|NCT00475033|26473131|FG000|After the Infant Series|Lost to Follow-up|1|||
13287271|NCT00475033|26473132|FG001|After the Infant Series|Lost to Follow-up|0|||
13287272|NCT00475033|26473131|FG000|After the Infant Series|Other|0|||
13287273|NCT00475033|26473132|FG001|After the Infant Series|Other|1|||
13287274|NCT00475033|26473131|FG000|Toddler Dose|Parent or legal guardian request|2|||
13287275|NCT00475033|26473132|FG001|Toddler Dose|Parent or legal guardian request|0|||
13287276|NCT00475033|26473131|FG000|Toddler Dose|Failed to return|1|||
13287277|NCT00475033|26473132|FG001|Toddler Dose|Failed to return|0|||
13287278|NCT00475033|26473131|FG000|Toddler Dose|Lost to Follow-up|1|||
13287279|NCT00475033|26473132|FG001|Toddler Dose|Lost to Follow-up|0|||
13287280|NCT00474994|26473138|FG000|Overall Study|Patient Not treated|1|||
13287281|NCT00474994|26473138|FG000|Overall Study|Patient evaluable for toxicity only|3|||
13287282|NCT00474994|26473138|FG000|Overall Study|Patient found to be ineligible|1|||
13287283|NCT00474968|26473155|FG000|Overall Study|Withdrawal by Subject|8|||
13287284|NCT00474968|26473156|FG001|Overall Study|Withdrawal by Subject|7|||
13287285|NCT00474968|26473155|FG000|Overall Study|Protocol Violation|9|||
13287286|NCT00474968|26473156|FG001|Overall Study|Protocol Violation|8|||
13287287|NCT00474968|26473155|FG000|Overall Study|Sample not collected|1|||
13287288|NCT00474968|26473156|FG001|Overall Study|Sample not collected|1|||
13287289|NCT00474955|26473169|FG000|Overall Study|Adverse Event|2|||
13287290|NCT00474955|26473169|FG000|Overall Study|Drug unavailability|1|||
13287291|NCT00474955|26473169|FG000|Overall Study|Personal reasons|5|||
13287292|NCT00474929|26473199|FG000|Overall Study|Withdrawal by Subject|0|||
13287293|NCT00474929|26473200|FG001|Overall Study|Withdrawal by Subject|1|||
13287294|NCT00474929|26473201|FG002|Overall Study|Withdrawal by Subject|0|||
13287295|NCT00474929|26473202|FG003|Overall Study|Withdrawal by Subject|0|||
13287296|NCT00474929|26473203|FG004|Overall Study|Withdrawal by Subject|0|||
13287297|NCT00474929|26473199|FG000|Overall Study|Unrelated medical condition|0|||
13287298|NCT00474929|26473200|FG001|Overall Study|Unrelated medical condition|0|||
13287299|NCT00474929|26473201|FG002|Overall Study|Unrelated medical condition|1|||
13287300|NCT00474929|26473202|FG003|Overall Study|Unrelated medical condition|0|||
13287301|NCT00474929|26473203|FG004|Overall Study|Unrelated medical condition|0|||
13287302|NCT00474929|26473199|FG000|Overall Study|Physician Decision|0|||
13287303|NCT00474929|26473200|FG001|Overall Study|Physician Decision|0|||
13287304|NCT00474929|26473201|FG002|Overall Study|Physician Decision|1|||
13287305|NCT00474929|26473202|FG003|Overall Study|Physician Decision|2|||
13287306|NCT00474929|26473203|FG004|Overall Study|Physician Decision|0|||
13287307|NCT00474903|26473224|FG000|Overall Study|Protocol Violation|1|||
13287308|NCT00474903|26473225|FG001|Overall Study|Protocol Violation|5|||
13287309|NCT00474903|26473226|FG002|Overall Study|Protocol Violation|2|||
13287310|NCT00474812|26473236|FG000|Overall Study|Withdrawal by Subject|5|||
13287311|NCT00474812|26473236|FG000|Overall Study|No Initiation of treatment|2|||
13287312|NCT00474708|26473251|FG000|Overall Study|Lack of Efficacy|11|||
13287313|NCT00474708|26473252|FG001|Overall Study|Lack of Efficacy|5|||
13287314|NCT00474708|26473251|FG000|Overall Study|Suicide ideation/behavior|0|||
13287315|NCT00474708|26473252|FG001|Overall Study|Suicide ideation/behavior|1|||
13287316|NCT00474708|26473251|FG000|Overall Study|Withdrawal by Subject|7|||
13287317|NCT00474708|26473252|FG001|Overall Study|Withdrawal by Subject|0|||
13287318|NCT00474708|26473251|FG000|Overall Study|Lack of compliance|12|||
13287319|NCT00474708|26473252|FG001|Overall Study|Lack of compliance|4|||
13325124|NCT01154036|26580308|FG000|Phase II|Lost to Follow-up|0|||
13325125|NCT01154036|26580309|FG001|Phase II|Lost to Follow-up|0|||
13287320|NCT00474708|26473251|FG000|Overall Study|Lost to Follow-up|18|||
13287321|NCT00474708|26473252|FG001|Overall Study|Lost to Follow-up|9|||
13287322|NCT00474708|26473251|FG000|Overall Study|Physician Decision|9|||
13287323|NCT00474708|26473252|FG001|Overall Study|Physician Decision|6|||
13287324|NCT00474487|26473285|FG000|Overall Study|Withdrawal by Subject|6|||
13287325|NCT00474487|26473286|FG001|Overall Study|Withdrawal by Subject|0|||
13287326|NCT00474487|26473287|FG002|Overall Study|Withdrawal by Subject|0|||
13287327|NCT00474487|26473288|FG003|Overall Study|Withdrawal by Subject|0|||
13287328|NCT00474487|26473285|FG000|Overall Study|Lost to Follow-up|20|||
13287329|NCT00474487|26473286|FG001|Overall Study|Lost to Follow-up|1|||
13287330|NCT00474487|26473287|FG002|Overall Study|Lost to Follow-up|7|||
13287331|NCT00474487|26473288|FG003|Overall Study|Lost to Follow-up|0|||
13287332|NCT00474487|26473285|FG000|Overall Study|Inappropriate enrollment|4|||
13287333|NCT00474487|26473286|FG001|Overall Study|Inappropriate enrollment|0|||
13287334|NCT00474487|26473287|FG002|Overall Study|Inappropriate enrollment|7|||
13287335|NCT00474487|26473288|FG003|Overall Study|Inappropriate enrollment|0|||
13287336|NCT00474487|26473285|FG000|Overall Study|Death|0|||
13287337|NCT00474487|26473286|FG001|Overall Study|Death|1|||
13287338|NCT00474487|26473287|FG002|Overall Study|Death|0|||
13287339|NCT00474487|26473288|FG003|Overall Study|Death|0|||
13287340|NCT00474383|26473302|FG000|Main Study|Adverse Event|11|||
13287341|NCT00474383|26473303|FG001|Main Study|Adverse Event|0|||
13287342|NCT00474383|26473302|FG000|Main Study|Symptomatic Deterioration|1|||
13287343|NCT00474383|26473303|FG001|Main Study|Symptomatic Deterioration|0|||
13287344|NCT00474383|26473302|FG000|Main Study|Progressive Disease|23|||
13287345|NCT00474383|26473303|FG001|Main Study|Progressive Disease|0|||
13287346|NCT00474383|26473302|FG000|Main Study|Other|1|||
13287347|NCT00474383|26473303|FG001|Main Study|Other|0|||
13287348|NCT00474383|26473302|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6|||
13287349|NCT00474383|26473303|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0|||
13287350|NCT00474383|26473302|FG000|Extension|Progressive Disease|0|||
13287351|NCT00474383|26473303|FG001|Extension|Progressive Disease|5|||
13287352|NCT00474266|26473418|FG000|Overall Study|Withdrawal by Subject|7|||
13287353|NCT00474266|26473419|FG001|Overall Study|Withdrawal by Subject|20|||
13287354|NCT00474266|26473420|FG002|Overall Study|Withdrawal by Subject|4|||
13287355|NCT00474266|26473421|FG003|Overall Study|Withdrawal by Subject|7|||
13287356|NCT00474253|26473446|FG000|Overall Study|Withdrew consent|2|||
13287357|NCT00474253|26473447|FG001|Overall Study|Withdrew consent|0|||
13287358|NCT00474253|26473446|FG000|Overall Study|Withdrew due to surgery-related issues|0|||
13287359|NCT00474253|26473447|FG001|Overall Study|Withdrew due to surgery-related issues|3|||
13287360|NCT00474253|26473446|FG000|Overall Study|Lost to Follow-up|1|||
13287361|NCT00474253|26473447|FG001|Overall Study|Lost to Follow-up|0|||
13287362|NCT00474253|26473446|FG000|Overall Study|Discharged prior to study completion|0|||
13287363|NCT00474253|26473447|FG001|Overall Study|Discharged prior to study completion|1|||
13287364|NCT00474240|26473486|FG000|Overall Study|Withdrawal by Subject|1|||
13287365|NCT00474240|26473487|FG001|Overall Study|Withdrawal by Subject|1|||
13287366|NCT00474240|26473488|FG002|Overall Study|Withdrawal by Subject|0|||
13287367|NCT00474240|26473489|FG003|Overall Study|Withdrawal by Subject|2|||
13287368|NCT00474240|26473490|FG004|Overall Study|Withdrawal by Subject|3|||
13325126|NCT01154036|26580310|FG002|Phase II|Lost to Follow-up|0|||
13287369|NCT00474240|26473491|FG005|Overall Study|Withdrawal by Subject|1|||
13287370|NCT00474240|26473486|FG000|Overall Study|Adverse Event|0|||
13287371|NCT00474240|26473487|FG001|Overall Study|Adverse Event|0|||
13287372|NCT00474240|26473488|FG002|Overall Study|Adverse Event|9|||
13287373|NCT00474240|26473489|FG003|Overall Study|Adverse Event|14|||
13287374|NCT00474240|26473490|FG004|Overall Study|Adverse Event|5|||
13287375|NCT00474240|26473491|FG005|Overall Study|Adverse Event|16|||
13287376|NCT00474240|26473486|FG000|Overall Study|Removed due to lab value|0|||
13287377|NCT00474240|26473487|FG001|Overall Study|Removed due to lab value|0|||
13287378|NCT00474240|26473488|FG002|Overall Study|Removed due to lab value|0|||
13287379|NCT00474240|26473489|FG003|Overall Study|Removed due to lab value|0|||
13287380|NCT00474240|26473490|FG004|Overall Study|Removed due to lab value|0|||
13287381|NCT00474240|26473491|FG005|Overall Study|Removed due to lab value|1|||
13325127|NCT01154036|26580311|FG003|Phase II|Lost to Follow-up|1|||
13287382|NCT00474058|26473510|FG000|Overall Study|Adverse Event|11|||
13287383|NCT00474058|26473511|FG001|Overall Study|Adverse Event|6|||
13287384|NCT00474058|26473510|FG000|Overall Study|Lack of Efficacy|0|||
13287385|NCT00474058|26473511|FG001|Overall Study|Lack of Efficacy|4|||
13287386|NCT00474058|26473510|FG000|Overall Study|Withdrawal by Subject|11|||
13287387|NCT00474058|26473511|FG001|Overall Study|Withdrawal by Subject|7|||
13287388|NCT00474058|26473510|FG000|Overall Study|Other|2|||
13287389|NCT00474058|26473511|FG001|Overall Study|Other|0|||
13287390|NCT00473889|26473528|FG000|Overall Study|Did not receive study medication|1|||
13287391|NCT00473889|26473529|FG001|Overall Study|Did not receive study medication|4|||
13287392|NCT00473889|26473528|FG000|Overall Study|Adverse Event|30|||
13287393|NCT00473889|26473529|FG001|Overall Study|Adverse Event|17|||
13287394|NCT00473889|26473528|FG000|Overall Study|Protocol Violation|4|||
13287395|NCT00473889|26473529|FG001|Overall Study|Protocol Violation|2|||
13287396|NCT00473889|26473528|FG000|Overall Study|Lack of Efficacy|28|||
13287397|NCT00473889|26473529|FG001|Overall Study|Lack of Efficacy|29|||
13287398|NCT00473889|26473528|FG000|Overall Study|Lost to Follow-up|2|||
13287399|NCT00473889|26473529|FG001|Overall Study|Lost to Follow-up|1|||
13287400|NCT00473889|26473528|FG000|Overall Study|Physician Decision|10|||
13287401|NCT00473889|26473529|FG001|Overall Study|Physician Decision|5|||
13287402|NCT00473889|26473528|FG000|Overall Study|Trial Terminated|3|||
13287403|NCT00473889|26473529|FG001|Overall Study|Trial Terminated|6|||
13287404|NCT00473889|26473528|FG000|Overall Study|Withdrawal by Subject|5|||
13287405|NCT00473889|26473529|FG001|Overall Study|Withdrawal by Subject|0|||
13287406|NCT00473824|26473542|FG000|Overall Study|Virologic Breakthrough|1|||
13287407|NCT00473824|26473543|FG001|Overall Study|Virologic Breakthrough|0|||
13287408|NCT00473824|26473542|FG000|Overall Study|Adverse Event|1|||
13287409|NCT00473824|26473543|FG001|Overall Study|Adverse Event|0|||
13287410|NCT00473824|26473542|FG000|Overall Study|Death|1|||
13287411|NCT00473824|26473543|FG001|Overall Study|Death|0|||
13287412|NCT00473824|26473542|FG000|Overall Study|Lost to Follow-up|1|||
13287413|NCT00473824|26473543|FG001|Overall Study|Lost to Follow-up|0|||
13287414|NCT00473824|26473542|FG000|Overall Study|Withdrawal by physician|1|||
13287415|NCT00473824|26473543|FG001|Overall Study|Withdrawal by physician|0|||
13287416|NCT00473746|26473604|FG000|Period 1 (Phase 1)|Adverse Event|1|||
13287417|NCT00473746|26473605|FG001|Period 1 (Phase 1)|Adverse Event|0|||
13287418|NCT00473746|26473606|FG002|Period 1 (Phase 1)|Adverse Event|0|||
13287419|NCT00473746|26473607|FG003|Period 1 (Phase 1)|Adverse Event|0|||
13287420|NCT00473746|26473608|FG004|Period 1 (Phase 1)|Adverse Event|0|||
13287421|NCT00473746|26473604|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0|||
13287422|NCT00473746|26473605|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1|||
13287423|NCT00473746|26473606|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0|||
13287424|NCT00473746|26473607|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0|||
13287425|NCT00473746|26473608|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0|||
13287426|NCT00473746|26473604|FG000|Period 1 (Phase 1)|Progressive Disease|5|||
13287427|NCT00473746|26473605|FG001|Period 1 (Phase 1)|Progressive Disease|6|||
13287428|NCT00473746|26473606|FG002|Period 1 (Phase 1)|Progressive Disease|6|||
13287429|NCT00473746|26473607|FG003|Period 1 (Phase 1)|Progressive Disease|10|||
13287430|NCT00473746|26473608|FG004|Period 1 (Phase 1)|Progressive Disease|0|||
13287431|NCT00473746|26473604|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
13287432|NCT00473746|26473605|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1|||
13287433|NCT00473746|26473606|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
13287434|NCT00473746|26473607|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
13287435|NCT00473746|26473608|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
13287436|NCT00473746|26473604|FG000|Period 1 (Phase 1)|Reason not specified|0|||
13287437|NCT00473746|26473605|FG001|Period 1 (Phase 1)|Reason not specified|1|||
13287438|NCT00473746|26473606|FG002|Period 1 (Phase 1)|Reason not specified|0|||
13287439|NCT00473746|26473607|FG003|Period 1 (Phase 1)|Reason not specified|0|||
13287440|NCT00473746|26473608|FG004|Period 1 (Phase 1)|Reason not specified|0|||
13287441|NCT00473746|26473604|FG000|Period 2 (Phase 2)|Adverse Event|0|||
13287442|NCT00473746|26473605|FG001|Period 2 (Phase 2)|Adverse Event|0|||
13287443|NCT00473746|26473606|FG002|Period 2 (Phase 2)|Adverse Event|0|||
13287444|NCT00473746|26473607|FG003|Period 2 (Phase 2)|Adverse Event|0|||
13287445|NCT00473746|26473608|FG004|Period 2 (Phase 2)|Adverse Event|3|||
13287446|NCT00473746|26473604|FG000|Period 2 (Phase 2)|Death|0|||
13287447|NCT00473746|26473605|FG001|Period 2 (Phase 2)|Death|0|||
13287448|NCT00473746|26473606|FG002|Period 2 (Phase 2)|Death|0|||
13287449|NCT00473746|26473607|FG003|Period 2 (Phase 2)|Death|0|||
13287450|NCT00473746|26473608|FG004|Period 2 (Phase 2)|Death|1|||
13287451|NCT00473746|26473604|FG000|Period 2 (Phase 2)|Progressive Disease|0|||
13325128|NCT01154036|26580312|FG004|Phase II|Lost to Follow-up|2|||
13287452|NCT00473746|26473605|FG001|Period 2 (Phase 2)|Progressive Disease|0|||
13287453|NCT00473746|26473606|FG002|Period 2 (Phase 2)|Progressive Disease|0|||
13287454|NCT00473746|26473607|FG003|Period 2 (Phase 2)|Progressive Disease|0|||
13287455|NCT00473746|26473608|FG004|Period 2 (Phase 2)|Progressive Disease|20|||
13287456|NCT00473746|26473604|FG000|Period 2 (Phase 2)|Reason not specified|0|||
13287457|NCT00473746|26473605|FG001|Period 2 (Phase 2)|Reason not specified|0|||
13287458|NCT00473746|26473606|FG002|Period 2 (Phase 2)|Reason not specified|0|||
13287459|NCT00473746|26473607|FG003|Period 2 (Phase 2)|Reason not specified|0|||
13287460|NCT00473746|26473608|FG004|Period 2 (Phase 2)|Reason not specified|3|||
13287461|NCT00473694|26473659|FG000|Overall Study|Adverse Event|0|||
13287462|NCT00473694|26473660|FG001|Overall Study|Adverse Event|1|||
13287463|NCT00473694|26473661|FG002|Overall Study|Adverse Event|0|||
13287464|NCT00473694|26473662|FG003|Overall Study|Adverse Event|0|||
13287465|NCT00473694|26473659|FG000|Overall Study|Participants did not receive treatment|11|||
13287466|NCT00473694|26473660|FG001|Overall Study|Participants did not receive treatment|3|||
13287467|NCT00473694|26473661|FG002|Overall Study|Participants did not receive treatment|5|||
13287468|NCT00473694|26473662|FG003|Overall Study|Participants did not receive treatment|6|||
13287469|NCT00473694|26473659|FG000|Overall Study|Lost to Follow-up|0|||
13287470|NCT00473694|26473660|FG001|Overall Study|Lost to Follow-up|0|||
13287471|NCT00473694|26473661|FG002|Overall Study|Lost to Follow-up|0|||
13287472|NCT00473694|26473662|FG003|Overall Study|Lost to Follow-up|1|||
13287473|NCT00473668|26473722|FG000|Overall Study|Withdrawal by Subject|0|||
13287474|NCT00473668|26473723|FG001|Overall Study|Withdrawal by Subject|2|||
13287475|NCT00473668|26473724|FG002|Overall Study|Withdrawal by Subject|0|||
13287476|NCT00473668|26473722|FG000|Overall Study|Migrated/moved from study area|3|||
13287477|NCT00473668|26473723|FG001|Overall Study|Migrated/moved from study area|2|||
13287478|NCT00473668|26473724|FG002|Overall Study|Migrated/moved from study area|0|||
13287479|NCT00473668|26473722|FG000|Overall Study|Lost to Follow-up|0|||
13287480|NCT00473668|26473723|FG001|Overall Study|Lost to Follow-up|4|||
13287481|NCT00473668|26473724|FG002|Overall Study|Lost to Follow-up|6|||
13287482|NCT00473668|26473722|FG000|Overall Study|Other|2|||
13287483|NCT00473668|26473723|FG001|Overall Study|Other|3|||
13287484|NCT00473668|26473724|FG002|Overall Study|Other|4|||
13287485|NCT00473655|26473766|FG000|Overall Study|Lost to Follow-up|9|||
13287486|NCT00473655|26473767|FG001|Overall Study|Lost to Follow-up|5|||
13287487|NCT00473655|26473768|FG002|Overall Study|Lost to Follow-up|8|||
13287488|NCT00473590|26473791|FG000|Overall Study|Adverse Event|3|||
13287489|NCT00473590|26473792|FG001|Overall Study|Adverse Event|3|||
13325129|NCT01154036|26580313|FG005|Phase II|Lost to Follow-up|0|||
13325130|NCT01154036|26580314|FG006|Phase II|Lost to Follow-up|2|||
13325131|NCT01154036|26580315|FG007|Phase II|Lost to Follow-up|1|||
13325132|NCT01154036|26580308|FG000|Phase II|Protocol Violation|0|||
13325133|NCT01154036|26580309|FG001|Phase II|Protocol Violation|0|||
13325134|NCT01154036|26580310|FG002|Phase II|Protocol Violation|0|||
13325135|NCT01154036|26580311|FG003|Phase II|Protocol Violation|0|||
13325136|NCT01154036|26580312|FG004|Phase II|Protocol Violation|1|||
13325137|NCT01154036|26580313|FG005|Phase II|Protocol Violation|2|||
13325138|NCT01154036|26580314|FG006|Phase II|Protocol Violation|0|||
13325139|NCT01154036|26580315|FG007|Phase II|Protocol Violation|0|||
13325140|NCT01154036|26580308|FG000|Phase II|Withdrawal by Subject|0|||
13325141|NCT01154036|26580309|FG001|Phase II|Withdrawal by Subject|0|||
13325142|NCT01154036|26580310|FG002|Phase II|Withdrawal by Subject|0|||
13325143|NCT01154036|26580311|FG003|Phase II|Withdrawal by Subject|0|||
13325144|NCT01154036|26580312|FG004|Phase II|Withdrawal by Subject|4|||
13325145|NCT01154036|26580313|FG005|Phase II|Withdrawal by Subject|2|||
13325146|NCT01154036|26580314|FG006|Phase II|Withdrawal by Subject|5|||
13325147|NCT01154036|26580315|FG007|Phase II|Withdrawal by Subject|4|||
13325148|NCT01154010|26580328|FG000|Overall Study|Lost to Follow-up|0|||
13325149|NCT01154010|26580329|FG001|Overall Study|Lost to Follow-up|1|||
13325150|NCT01153984|26580342|FG000|Overall Study|Withdrawal by Subject|1|||
13325151|NCT01153984|26580342|FG000|Overall Study|Adverse Event|1|||
13325152|NCT01153971|26580365|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2|||
13325153|NCT01153971|26580365|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1|||
13325154|NCT01153971|26580365|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2|||
13325155|NCT01153971|26580365|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1|||
13325156|NCT01153971|26580365|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1|||
13325157|NCT01153971|26580365|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1|||
13325158|NCT01153971|26580365|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2|||
13325159|NCT01153958|26580388|FG000|Overall Study|Study Terminated|36|||
13325160|NCT01153958|26580389|FG001|Overall Study|Study Terminated|32|||
13325161|NCT01153893|26580420|FG000|Overall Study|Adverse Event|1|||
13325162|NCT01153893|26580421|FG001|Overall Study|Adverse Event|0|||
13325163|NCT01153841|26580442|FG000|Overall Study|Adverse Event|1|||
13325164|NCT01153841|26580443|FG001|Overall Study|Adverse Event|0|||
13325165|NCT01153841|26580442|FG000|Overall Study|Withdrawal by Subject|1|||
13287490|NCT00473590|26473791|FG000|Overall Study|Death|4|||
13287491|NCT00473590|26473792|FG001|Overall Study|Death|2|||
13325166|NCT01153841|26580443|FG001|Overall Study|Withdrawal by Subject|0|||
13325167|NCT01153841|26580442|FG000|Overall Study|Protocol Violation|2|||
13325168|NCT01153841|26580443|FG001|Overall Study|Protocol Violation|0|||
13287492|NCT00473590|26473791|FG000|Overall Study|Progression not resulting in death|24|||
13325169|NCT01153841|26580442|FG000|Overall Study|Lost to Follow-up|2|||
13325170|NCT01153841|26580443|FG001|Overall Study|Lost to Follow-up|0|||
13287493|NCT00473590|26473792|FG001|Overall Study|Progression not resulting in death|20|||
13325171|NCT01153815|26580472|FG000|Overall Study|Adverse Event|3|||
13325172|NCT01153815|26580473|FG001|Overall Study|Adverse Event|1|||
13325173|NCT01153815|26580472|FG000|Overall Study|Withdrawal by Subject|6|||
13325174|NCT01153815|26580473|FG001|Overall Study|Withdrawal by Subject|4|||
13325175|NCT01153763|26580491|FG000|Overall Study|Study Closed|16|||
13325176|NCT01153763|26580491|FG000|Overall Study|Lost to Follow-up|1|||
13325177|NCT01153763|26580491|FG000|Overall Study|Physician Decision|2|||
13325178|NCT01153763|26580491|FG000|Overall Study|Withdrawal by Subject|2|||
13325179|NCT01153724|26580513|FG000|Treatment Period 1|Withdrawal by Subject|1|||
13325180|NCT01153724|26580513|FG000|Treatment Period 2|Adverse Event|1|||
13325181|NCT01153724|26580513|FG000|Treatment Period 2|Other reason not defined above|1|||
13325182|NCT01153698|26580529|FG000|Overall Study|Adverse Event|12|||
13325183|NCT01153698|26580529|FG000|Overall Study|Lost to Follow-up|4|||
13325184|NCT01153698|26580529|FG000|Overall Study|Withdrawal by Subject|2|||
13325185|NCT01153698|26580529|FG000|Overall Study|Switch to other anticoagulants|4|||
13325186|NCT01153698|26580529|FG000|Overall Study|Other|2|||
13325187|NCT01153698|26580529|FG000|Overall Study|Not treated with Pradaxa|5|||
13325188|NCT01153633|26580552|FG000|Overall Study|Protocol Violation|1|||
13325189|NCT01153633|26580553|FG001|Overall Study|Protocol Violation|1|||
13325190|NCT01153633|26580552|FG000|Overall Study|Therapeutic failure|3|||
13325191|NCT01153633|26580553|FG001|Overall Study|Therapeutic failure|3|||
13325192|NCT01153516|26580570|FG000|Overall Study|Both subjects refused surgery|2|||
13325193|NCT01153516|26580571|FG001|Overall Study|Both subjects refused surgery|0|||
13325194|NCT01153425|26580586|FG000|Overall Study|Withdrawal by Subject|3|||
13325195|NCT01153425|26580587|FG001|Overall Study|Withdrawal by Subject|3|||
13325196|NCT01153347|26580698|FG000|Overall Study|Withdrawal by Subject|7|||
13325197|NCT01153347|26580699|FG001|Overall Study|Withdrawal by Subject|7|||
13325198|NCT01153347|26580700|FG002|Overall Study|Withdrawal by Subject|7|||
13325199|NCT01153347|26580701|FG003|Overall Study|Withdrawal by Subject|7|||
13325200|NCT01153347|26580698|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
13325201|NCT01153347|26580699|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
13325202|NCT01153347|26580700|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
13325203|NCT01153347|26580701|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
13325204|NCT01153347|26580698|FG000|Overall Study|Adverse Event|3|||
13325205|NCT01153347|26580699|FG001|Overall Study|Adverse Event|9|||
13325206|NCT01153347|26580700|FG002|Overall Study|Adverse Event|21|||
13325207|NCT01153347|26580701|FG003|Overall Study|Adverse Event|7|||
13325208|NCT01153347|26580698|FG000|Overall Study|Severe non-compliance to protocol|6|||
13325209|NCT01153347|26580699|FG001|Overall Study|Severe non-compliance to protocol|7|||
13325210|NCT01153347|26580700|FG002|Overall Study|Severe non-compliance to protocol|4|||
13325211|NCT01153347|26580701|FG003|Overall Study|Severe non-compliance to protocol|3|||
13325212|NCT01153347|26580698|FG000|Overall Study|Condition under investigation worsened|1|||
13325213|NCT01153347|26580699|FG001|Overall Study|Condition under investigation worsened|1|||
13325214|NCT01153347|26580700|FG002|Overall Study|Condition under investigation worsened|0|||
13325215|NCT01153347|26580701|FG003|Overall Study|Condition under investigation worsened|0|||
13325216|NCT01153347|26580698|FG000|Overall Study|Lack of Efficacy|2|||
13325217|NCT01153347|26580699|FG001|Overall Study|Lack of Efficacy|2|||
13325218|NCT01153347|26580700|FG002|Overall Study|Lack of Efficacy|0|||
13325219|NCT01153347|26580701|FG003|Overall Study|Lack of Efficacy|4|||
13325220|NCT01153347|26580698|FG000|Overall Study|Study-specific withdrawal criteria|4|||
13325221|NCT01153347|26580699|FG001|Overall Study|Study-specific withdrawal criteria|3|||
13325222|NCT01153347|26580700|FG002|Overall Study|Study-specific withdrawal criteria|1|||
13325223|NCT01153347|26580701|FG003|Overall Study|Study-specific withdrawal criteria|2|||
13325224|NCT01153347|26580698|FG000|Overall Study|Lost to Follow-up|4|||
13325225|NCT01153347|26580699|FG001|Overall Study|Lost to Follow-up|9|||
13325226|NCT01153347|26580700|FG002|Overall Study|Lost to Follow-up|11|||
13325227|NCT01153347|26580701|FG003|Overall Study|Lost to Follow-up|8|||
13325228|NCT01153347|26580698|FG000|Overall Study|Other|5|||
13325229|NCT01153347|26580699|FG001|Overall Study|Other|5|||
13325230|NCT01153347|26580700|FG002|Overall Study|Other|4|||
13325231|NCT01153347|26580701|FG003|Overall Study|Other|0|||
13325232|NCT01153347|26580698|FG000|Overall Study|Death|1|||
13325233|NCT01153347|26580699|FG001|Overall Study|Death|0|||
13325234|NCT01153347|26580700|FG002|Overall Study|Death|0|||
13325235|NCT01153347|26580701|FG003|Overall Study|Death|0|||
13325236|NCT01153321|26580820|FG000|Overall Study|Development of study withdrawal criteria|0|||
13325237|NCT01153321|26580821|FG001|Overall Study|Development of study withdrawal criteria|1|||
13325238|NCT01153321|26580820|FG000|Overall Study|Withdrawal by Subject|0|||
13325239|NCT01153321|26580821|FG001|Overall Study|Withdrawal by Subject|1|||
13325240|NCT01153321|26580820|FG000|Overall Study|Adverse Event|1|||
13325241|NCT01153321|26580821|FG001|Overall Study|Adverse Event|1|||
13325242|NCT01153269|26580882|FG000|Overall Study|Withdrawal by Subject|1|||
13325243|NCT01153269|26580882|FG000|Overall Study|Antiretroviral therapy break|1|||
13325244|NCT01153009|26580925|FG000|Overall Study|Adverse Event|4|||
13325245|NCT01153009|26580926|FG001|Overall Study|Adverse Event|14|||
13325246|NCT01153009|26580927|FG002|Overall Study|Adverse Event|14|||
13325247|NCT01153009|26580928|FG003|Overall Study|Adverse Event|10|||
13325248|NCT01153009|26580925|FG000|Overall Study|Lack of Efficacy|9|||
13325249|NCT01153009|26580926|FG001|Overall Study|Lack of Efficacy|0|||
13325250|NCT01153009|26580927|FG002|Overall Study|Lack of Efficacy|2|||
13325251|NCT01153009|26580928|FG003|Overall Study|Lack of Efficacy|1|||
13325252|NCT01153009|26580925|FG000|Overall Study|Noncompliance with Study Medication|1|||
13325253|NCT01153009|26580926|FG001|Overall Study|Noncompliance with Study Medication|3|||
13325254|NCT01153009|26580927|FG002|Overall Study|Noncompliance with Study Medication|4|||
13325255|NCT01153009|26580928|FG003|Overall Study|Noncompliance with Study Medication|1|||
13325256|NCT01153009|26580925|FG000|Overall Study|Protocol Deviations|4|||
13325257|NCT01153009|26580926|FG001|Overall Study|Protocol Deviations|3|||
13325258|NCT01153009|26580927|FG002|Overall Study|Protocol Deviations|3|||
13325259|NCT01153009|26580928|FG003|Overall Study|Protocol Deviations|2|||
13325260|NCT01153009|26580925|FG000|Overall Study|Withdrawal of Consent|5|||
13325261|NCT01153009|26580926|FG001|Overall Study|Withdrawal of Consent|5|||
13325262|NCT01153009|26580927|FG002|Overall Study|Withdrawal of Consent|4|||
13325263|NCT01153009|26580928|FG003|Overall Study|Withdrawal of Consent|6|||
13325264|NCT01153009|26580925|FG000|Overall Study|Lost to Follow-up|8|||
13325265|NCT01153009|26580926|FG001|Overall Study|Lost to Follow-up|8|||
13325266|NCT01153009|26580927|FG002|Overall Study|Lost to Follow-up|11|||
13325267|NCT01153009|26580928|FG003|Overall Study|Lost to Follow-up|15|||
13325268|NCT01153009|26580925|FG000|Overall Study|Other|1|||
13325269|NCT01153009|26580926|FG001|Overall Study|Other|1|||
13325270|NCT01153009|26580927|FG002|Overall Study|Other|3|||
13325271|NCT01153009|26580928|FG003|Overall Study|Other|2|||
13325272|NCT01152996|26580943|FG000|Overall Study|Withdrawal by Subject|142|||
13325273|NCT01152996|26580943|FG000|Overall Study|Adverse Event|115|||
13325274|NCT01152996|26580943|FG000|Overall Study|Lost to Follow-up|112|||
13325275|NCT01152996|26580943|FG000|Overall Study|Lack of Efficacy|68|||
13325276|NCT01152996|26580943|FG000|Overall Study|Noncompliance|41|||
13325277|NCT01152996|26580943|FG000|Overall Study|Other|36|||
13325278|NCT01152996|26580943|FG000|Overall Study|Protocol Violation|22|||
13325279|NCT01152996|26580943|FG000|Overall Study|Elevated liver enzymes|1|||
13325280|NCT01152814|26580952|FG000|Overall Study|Lost to Follow-up|2|||
13325281|NCT01152788|26580971|FG000|Overall Study|Withdrawal by Subject|0|||
13325282|NCT01152788|26580972|FG001|Overall Study|Withdrawal by Subject|3|||
13325283|NCT01152788|26580971|FG000|Overall Study|No treatment|0|||
13325284|NCT01152788|26580972|FG001|Overall Study|No treatment|1|||
13373485|NCT00802867|26723892|FG000|Overall Study|Lost to Follow-up|6|||
13373486|NCT00802867|26723892|FG000|Overall Study|Protocol Violation|6|||
13373487|NCT00802867|26723892|FG000|Overall Study|Withdrawal by Subject|1|||
13373488|NCT00802841|26723921|FG000|Overall Study|Administrative problems|1|||
13373489|NCT00802841|26723922|FG001|Overall Study|Administrative problems|0|||
13373490|NCT00802841|26723921|FG000|Overall Study|Lost to Follow-up|2|||
13373491|NCT00802841|26723922|FG001|Overall Study|Lost to Follow-up|1|||
13373492|NCT00802841|26723921|FG000|Overall Study|Death|1|||
13373493|NCT00802841|26723922|FG001|Overall Study|Death|2|||
13373494|NCT00802841|26723921|FG000|Overall Study|Adverse Event|8|||
13373495|NCT00802841|26723922|FG001|Overall Study|Adverse Event|2|||
13373496|NCT00802841|26723921|FG000|Overall Study|Disease progression|7|||
13373497|NCT00802841|26723922|FG001|Overall Study|Disease progression|3|||
13373498|NCT00802841|26723921|FG000|Overall Study|Withdrawal by Subject|9|||
13373499|NCT00802841|26723922|FG001|Overall Study|Withdrawal by Subject|5|||
13373500|NCT00802841|26723921|FG000|Overall Study|Protocol deviation|2|||
13373501|NCT00802841|26723922|FG001|Overall Study|Protocol deviation|6|||
13373502|NCT00802841|26723921|FG000|Overall Study|Treatment duration completed|66|||
13373503|NCT00802841|26723922|FG001|Overall Study|Treatment duration completed|76|||
13373504|NCT00802737|26723978|FG000|Overall Study|Withdrawn due to Disease Progression|9|||
13373505|NCT00802737|26723979|FG001|Overall Study|Withdrawn due to Disease Progression|3|||
13373506|NCT00802737|26723980|FG002|Overall Study|Withdrawn due to Disease Progression|0|||
13373507|NCT00802737|26723978|FG000|Overall Study|Death|6|||
13373508|NCT00802737|26723979|FG001|Overall Study|Death|5|||
13373509|NCT00802737|26723980|FG002|Overall Study|Death|1|||
13373510|NCT00802737|26723978|FG000|Overall Study|Adverse Event|1|||
13373511|NCT00802737|26723979|FG001|Overall Study|Adverse Event|0|||
13373512|NCT00802737|26723980|FG002|Overall Study|Adverse Event|0|||
13373513|NCT00802737|26723978|FG000|Overall Study|Received Prohibited Therapy|1|||
13373514|NCT00802737|26723979|FG001|Overall Study|Received Prohibited Therapy|0|||
13373515|NCT00802737|26723980|FG002|Overall Study|Received Prohibited Therapy|0|||
13373516|NCT00802737|26723978|FG000|Overall Study|Ongoing CLL-Treatment|0|||
13373517|NCT00802737|26723979|FG001|Overall Study|Ongoing CLL-Treatment|1|||
13373518|NCT00802737|26723980|FG002|Overall Study|Ongoing CLL-Treatment|0|||
13373519|NCT00802737|26723978|FG000|Overall Study|Participant too Unwell|0|||
13373520|NCT00802737|26723979|FG001|Overall Study|Participant too Unwell|2|||
13373521|NCT00802737|26723980|FG002|Overall Study|Participant too Unwell|0|||
13373522|NCT00802672|26724004|FG000|Overall Study|Lack of fungal pathogen at baseline|56|||
13373523|NCT00802672|26724005|FG001|Overall Study|Lack of fungal pathogen at baseline|43|||
13373524|NCT00802672|26724006|FG002|Overall Study|Lack of fungal pathogen at baseline|25|||
13373525|NCT00802672|26724004|FG000|Overall Study|Adverse Event|1|||
13373526|NCT00802672|26724005|FG001|Overall Study|Adverse Event|1|||
13325285|NCT01152580|26580999|FG000|Overall Study|Withdrawal by Subject|0|||
13325286|NCT01152580|26581000|FG001|Overall Study|Withdrawal by Subject|1|||
13325287|NCT01152554|26581029|FG000|Overall Study|Withdrawal by Subject|73|||
13325288|NCT01152554|26581030|FG001|Overall Study|Withdrawal by Subject|28|||
13325289|NCT01152554|26581029|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
13325290|NCT01152554|26581030|FG001|Overall Study|Eligiblity criteria not fulfilled|1|||
13325291|NCT01152554|26581029|FG000|Overall Study|Adverse Event|67|||
13325292|NCT01152554|26581030|FG001|Overall Study|Adverse Event|14|||
13325293|NCT01152554|26581029|FG000|Overall Study|Severe non-compliance to protocol|36|||
13325294|NCT01152554|26581030|FG001|Overall Study|Severe non-compliance to protocol|14|||
13325295|NCT01152554|26581029|FG000|Overall Study|Condition under investigation worsened|5|||
13325296|NCT01152554|26581030|FG001|Overall Study|Condition under investigation worsened|2|||
13325297|NCT01152554|26581029|FG000|Overall Study|Lack of Efficacy|20|||
13325298|NCT01152554|26581030|FG001|Overall Study|Lack of Efficacy|3|||
13325299|NCT01152554|26581029|FG000|Overall Study|Study-specific withdrawal criteria|17|||
13325300|NCT01152554|26581030|FG001|Overall Study|Study-specific withdrawal criteria|8|||
13325301|NCT01152554|26581029|FG000|Overall Study|Lost to Follow-up|87|||
13325302|NCT01152554|26581030|FG001|Overall Study|Lost to Follow-up|32|||
13325303|NCT01152554|26581029|FG000|Overall Study|Other|28|||
13325304|NCT01152554|26581030|FG001|Overall Study|Other|8|||
13325305|NCT01152554|26581029|FG000|Overall Study|Death|1|||
13325306|NCT01152554|26581030|FG001|Overall Study|Death|1|||
13325307|NCT01152450|26581105|FG000|Period 1 (4 Weeks)|Adverse Event|0|||
13325308|NCT01152450|26581106|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
13325309|NCT01152450|26581107|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
13325310|NCT01152450|26581108|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
13325311|NCT01152450|26581109|FG004|Period 1 (4 Weeks)|Adverse Event|1|||
13325312|NCT01152450|26581110|FG005|Period 1 (4 Weeks)|Adverse Event|1|||
13325313|NCT01152450|26581105|FG000|Period 1 (4 Weeks)|Protocol Violation|0|||
13325314|NCT01152450|26581106|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
13325315|NCT01152450|26581107|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
13325316|NCT01152450|26581108|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
13325317|NCT01152450|26581109|FG004|Period 1 (4 Weeks)|Protocol Violation|1|||
13325318|NCT01152450|26581110|FG005|Period 1 (4 Weeks)|Protocol Violation|0|||
13325319|NCT01152450|26581105|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0|||
13325320|NCT01152450|26581106|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1|||
13325321|NCT01152450|26581107|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1|||
13325322|NCT01152450|26581108|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
13325323|NCT01152450|26581109|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
13325324|NCT01152450|26581110|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0|||
13325325|NCT01152437|26581136|FG000|Overall Study|Other Adverse Event|8|||
13325326|NCT01152437|26581137|FG001|Overall Study|Other Adverse Event|1|||
13325327|NCT01152437|26581138|FG002|Overall Study|Other Adverse Event|7|||
13325328|NCT01152437|26581136|FG000|Overall Study|Not treated|0|||
13325329|NCT01152437|26581137|FG001|Overall Study|Not treated|1|||
13325330|NCT01152437|26581138|FG002|Overall Study|Not treated|2|||
13325331|NCT01152437|26581136|FG000|Overall Study|Progressive disease|27|||
13325332|NCT01152437|26581137|FG001|Overall Study|Progressive disease|13|||
13325333|NCT01152437|26581138|FG002|Overall Study|Progressive disease|32|||
13325334|NCT01152437|26581136|FG000|Overall Study|Refusal to continue taking trial medicat|1|||
13325335|NCT01152437|26581137|FG001|Overall Study|Refusal to continue taking trial medicat|0|||
13325336|NCT01152437|26581138|FG002|Overall Study|Refusal to continue taking trial medicat|2|||
13325337|NCT01152385|26581189|FG000|Overall Study|Withdrawal by Subject|3|||
13325338|NCT01152385|26581190|FG001|Overall Study|Withdrawal by Subject|1|||
13325339|NCT01152385|26581191|FG002|Overall Study|Withdrawal by Subject|1|||
13325340|NCT01152385|26581192|FG003|Overall Study|Withdrawal by Subject|1|||
13325341|NCT01152385|26581189|FG000|Overall Study|Protocol Violation|0|||
13325342|NCT01152385|26581190|FG001|Overall Study|Protocol Violation|0|||
13325343|NCT01152385|26581191|FG002|Overall Study|Protocol Violation|0|||
13325344|NCT01152385|26581192|FG003|Overall Study|Protocol Violation|1|||
13325345|NCT01152385|26581189|FG000|Overall Study|Adverse Event|1|||
13325346|NCT01152385|26581190|FG001|Overall Study|Adverse Event|1|||
13325347|NCT01152385|26581191|FG002|Overall Study|Adverse Event|0|||
13325348|NCT01152385|26581192|FG003|Overall Study|Adverse Event|0|||
13325349|NCT01152385|26581189|FG000|Overall Study|Study-specific withdrawal criteria|1|||
13325350|NCT01152385|26581190|FG001|Overall Study|Study-specific withdrawal criteria|1|||
13325351|NCT01152385|26581191|FG002|Overall Study|Study-specific withdrawal criteria|2|||
13325352|NCT01152385|26581192|FG003|Overall Study|Study-specific withdrawal criteria|0|||
13325353|NCT01152385|26581189|FG000|Overall Study|Other|4|||
13325354|NCT01152385|26581190|FG001|Overall Study|Other|3|||
13325355|NCT01152385|26581191|FG002|Overall Study|Other|2|||
13325356|NCT01152385|26581192|FG003|Overall Study|Other|3|||
13325357|NCT01152190|26581211|FG000|Overall Study|Adverse Event|2|||
13325358|NCT01152190|26581212|FG001|Overall Study|Adverse Event|4|||
13325359|NCT01152190|26581211|FG000|Overall Study|Death|1|||
13325360|NCT01152190|26581212|FG001|Overall Study|Death|0|||
13325361|NCT01152190|26581211|FG000|Overall Study|Protocol Violation|1|||
13325362|NCT01152190|26581212|FG001|Overall Study|Protocol Violation|1|||
13325363|NCT01152190|26581211|FG000|Overall Study|Withdrawal by Subject|1|||
13325364|NCT01152190|26581212|FG001|Overall Study|Withdrawal by Subject|3|||
13325365|NCT01152021|26581227|FG000|Overall Study|Adverse Event|4|||
13325366|NCT01152021|26581228|FG001|Overall Study|Adverse Event|4|||
13325367|NCT01152021|26581227|FG000|Overall Study|Study drug had expired|1|||
13325368|NCT01152021|26581228|FG001|Overall Study|Study drug had expired|0|||
13325369|NCT01152021|26581227|FG000|Overall Study|Physician Decision|1|||
13325370|NCT01152021|26581228|FG001|Overall Study|Physician Decision|1|||
13325371|NCT01152021|26581227|FG000|Overall Study|No access to study drug in Pharmacy|0|||
13325372|NCT01152021|26581228|FG001|Overall Study|No access to study drug in Pharmacy|1|||
13325373|NCT01151618|26581236|FG000|Overall Study|Adverse Event|2|||
13325374|NCT01151618|26581236|FG000|Overall Study|Withdrawal by Subject|7|||
13325375|NCT01151579|26581253|FG000|Overall Study|Physician Decision|3|||
13325376|NCT01151579|26581254|FG001|Overall Study|Physician Decision|1|||
13325377|NCT01151579|26581253|FG000|Overall Study|Withdrawal by Subject|3|||
13325378|NCT01151579|26581254|FG001|Overall Study|Withdrawal by Subject|2|||
13325379|NCT01151579|26581253|FG000|Overall Study|Not meet inclusion criteria|6|||
13325380|NCT01151579|26581254|FG001|Overall Study|Not meet inclusion criteria|4|||
13325381|NCT01151540|26581265|FG000|Overall Study|Other|2|||
13325382|NCT01151540|26581265|FG000|Overall Study|Adverse event, non-fatal|4|||
13325383|NCT01151540|26581265|FG000|Overall Study|Withdrawal by Subject|7|||
13325384|NCT01151423|26581318|FG000|Overall Study|Study terminated by Sponsor|9|||
13325385|NCT01151423|26581319|FG001|Overall Study|Study terminated by Sponsor|10|||
13325386|NCT01151423|26581318|FG000|Overall Study|Protocol Violation|0|||
13325387|NCT01151423|26581319|FG001|Overall Study|Protocol Violation|1|||
13325388|NCT01151423|26581318|FG000|Overall Study|Physician Decision|1|||
13325389|NCT01151423|26581319|FG001|Overall Study|Physician Decision|1|||
13325390|NCT01151423|26581318|FG000|Overall Study|Pregnancy|0|||
13325391|NCT01151423|26581319|FG001|Overall Study|Pregnancy|1|||
13325392|NCT01151423|26581318|FG000|Overall Study|Death|0|||
13325393|NCT01151423|26581319|FG001|Overall Study|Death|1|||
13325394|NCT01151423|26581318|FG000|Overall Study|Adverse Event|3|||
13325395|NCT01151423|26581319|FG001|Overall Study|Adverse Event|0|||
13325396|NCT01151423|26581318|FG000|Overall Study|Withdrawal by Subject|1|||
13325397|NCT01151423|26581319|FG001|Overall Study|Withdrawal by Subject|3|||
13325398|NCT01151423|26581318|FG000|Overall Study|Lost to Follow-up|1|||
13325399|NCT01151423|26581319|FG001|Overall Study|Lost to Follow-up|0|||
13325400|NCT01151423|26581318|FG000|Overall Study|Diagnosed as non-TTP patient|0|||
13325401|NCT01151423|26581319|FG001|Overall Study|Diagnosed as non-TTP patient|1|||
13325402|NCT01151423|26581318|FG000|Overall Study|Participated in other clinical trial|1|||
13325403|NCT01151423|26581319|FG001|Overall Study|Participated in other clinical trial|0|||
13325404|NCT01151410|26581336|FG000|Overall Study|Withdrawal by Subject|3|||
13325405|NCT01151410|26581337|FG001|Overall Study|Withdrawal by Subject|5|||
13325406|NCT01151410|26581336|FG000|Overall Study|Lost to Follow-up|3|||
13325407|NCT01151410|26581337|FG001|Overall Study|Lost to Follow-up|4|||
13325408|NCT01151410|26581336|FG000|Overall Study|Adverse Event|1|||
13325409|NCT01151410|26581337|FG001|Overall Study|Adverse Event|2|||
13325410|NCT01151410|26581336|FG000|Overall Study|Protocol deviation|2|||
13325411|NCT01151410|26581337|FG001|Overall Study|Protocol deviation|1|||
13325412|NCT01151410|26581336|FG000|Overall Study|Administrative problems|1|||
13325413|NCT01151410|26581337|FG001|Overall Study|Administrative problems|1|||
13325414|NCT01151410|26581336|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
13325415|NCT01151410|26581337|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
13325416|NCT01151410|26581336|FG000|Overall Study|Abnormal laboratory value(s)|0|||
13325417|NCT01151410|26581337|FG001|Overall Study|Abnormal laboratory value(s)|1|||
13325418|NCT01151345|26581354|FG000|First Intervention Period|Protocol Violation|0|||
13325419|NCT01151345|26581355|FG001|First Intervention Period|Protocol Violation|1|||
13325420|NCT01151280|26581367|FG000|Overall Study|Adverse Event|1|||
13325421|NCT01151280|26581367|FG000|Overall Study|Lack of Efficacy|3|||
13325422|NCT01151215|26581388|FG000|Overall Study|Worsening of condition under study|1|||
13325423|NCT01151215|26581389|FG001|Overall Study|Worsening of condition under study|1|||
13325424|NCT01151215|26581390|FG002|Overall Study|Worsening of condition under study|1|||
13325425|NCT01151215|26581388|FG000|Overall Study|Death|16|||
13325426|NCT01151215|26581389|FG001|Overall Study|Death|20|||
13325427|NCT01151215|26581390|FG002|Overall Study|Death|11|||
13325428|NCT01151215|26581388|FG000|Overall Study|Lost to Follow-up|0|||
13325429|NCT01151215|26581389|FG001|Overall Study|Lost to Follow-up|0|||
13325430|NCT01151215|26581390|FG002|Overall Study|Lost to Follow-up|3|||
13325431|NCT01151215|26581388|FG000|Overall Study|Withdrawal by Subject|3|||
13325432|NCT01151215|26581389|FG001|Overall Study|Withdrawal by Subject|1|||
13325433|NCT01151215|26581390|FG002|Overall Study|Withdrawal by Subject|2|||
13325434|NCT01151215|26581388|FG000|Overall Study|Disease progression|0|||
13325435|NCT01151215|26581389|FG001|Overall Study|Disease progression|1|||
13325436|NCT01151215|26581390|FG002|Overall Study|Disease progression|1|||
13325437|NCT01151215|26581388|FG000|Overall Study|Safety as judged by the investigator|0|||
13325438|NCT01151215|26581389|FG001|Overall Study|Safety as judged by the investigator|0|||
13325439|NCT01151215|26581390|FG002|Overall Study|Safety as judged by the investigator|1|||
13325440|NCT01151137|26581415|FG000|Overall Study|Death|15|||
13325441|NCT01151137|26581416|FG001|Overall Study|Death|27|||
13325442|NCT01151137|26581415|FG000|Overall Study|Lost to Follow-up|1|||
13325443|NCT01151137|26581416|FG001|Overall Study|Lost to Follow-up|1|||
13325444|NCT01151098|26581422|FG000|Overall Study|Adverse Event|82|||
13325445|NCT01151098|26581422|FG000|Overall Study|Lost to Follow-up|6|||
13325446|NCT01151098|26581422|FG000|Overall Study|Lack of Efficacy|15|||
13325447|NCT01151098|26581422|FG000|Overall Study|Protocol Violation|1|||
13325448|NCT01151098|26581422|FG000|Overall Study|Miscellaneous|13|||
13325449|NCT01151085|26581440|FG000|Overall Study|Lost to Follow-up|31|||
13325450|NCT01151085|26581440|FG000|Overall Study|Protocol Violation|25|||
13325451|NCT01151020|26581447|FG000|Overall Study|Death|25|||
13325452|NCT01151020|26581447|FG000|Overall Study|Conversion to open repair|1|||
13325453|NCT01151020|26581447|FG000|Overall Study|Lost to Follow-up|4|||
13325454|NCT01151020|26581447|FG000|Overall Study|Withdrawal by Subject|22|||
13325455|NCT01151020|26581447|FG000|Overall Study|Patients did not receive the device|2|||
13325456|NCT01150474|26581476|FG000|Overall Study|Withdrawal by Subject|5|||
13325457|NCT01150474|26581477|FG001|Overall Study|Withdrawal by Subject|2|||
13325458|NCT01150474|26581476|FG000|Overall Study|Cancer found|1|||
13325459|NCT01150474|26581477|FG001|Overall Study|Cancer found|0|||
13325460|NCT01150474|26581476|FG000|Overall Study|Multiple Studies|0|||
13325461|NCT01150474|26581477|FG001|Overall Study|Multiple Studies|1|||
13325462|NCT01150474|26581476|FG000|Overall Study|Rectotomy|1|||
13325463|NCT01150474|26581477|FG001|Overall Study|Rectotomy|0|||
13325464|NCT01150474|26581476|FG000|Overall Study|Drug did not arrive in time|1|||
13325465|NCT01150474|26581477|FG001|Overall Study|Drug did not arrive in time|0|||
13325466|NCT01150474|26581476|FG000|Overall Study|Drug not administered|1|||
13325467|NCT01150474|26581477|FG001|Overall Study|Drug not administered|0|||
13325468|NCT01150474|26581476|FG000|Overall Study|Surgery Changed|1|||
13325469|NCT01150474|26581477|FG001|Overall Study|Surgery Changed|0|||
13325470|NCT01150357|26581549|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0|||
13325471|NCT01150357|26581550|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1|||
13325472|NCT01150357|26581551|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1|||
13325473|NCT01150357|26581549|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1|||
13325474|NCT01150357|26581550|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
13325475|NCT01150357|26581551|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
13325476|NCT01150357|26581549|FG000|Dose Response Phase (Phase 1)|Adverse Event|0|||
13325477|NCT01150357|26581550|FG001|Dose Response Phase (Phase 1)|Adverse Event|0|||
13325478|NCT01150357|26581551|FG002|Dose Response Phase (Phase 1)|Adverse Event|1|||
13325479|NCT01150357|26581549|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0|||
13325480|NCT01150357|26581550|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2|||
13325481|NCT01150357|26581551|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1|||
13325482|NCT01150357|26581549|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
13325483|NCT01150357|26581550|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
13325484|NCT01150357|26581551|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2|||
13325485|NCT01150357|26581549|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2|||
13325486|NCT01150357|26581550|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
13325487|NCT01150357|26581551|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
13325488|NCT01150357|26581549|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1|||
13325489|NCT01150357|26581550|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
13325490|NCT01150357|26581551|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
13325491|NCT01150123|26581779|FG000|Overall Study|Withdrawal by Subject|1|||
13325492|NCT01150123|26581780|FG001|Overall Study|Withdrawal by Subject|1|||
13325493|NCT01150123|26581781|FG002|Overall Study|Withdrawal by Subject|2|||
13325494|NCT01150123|26581782|FG003|Overall Study|Withdrawal by Subject|1|||
13325495|NCT01150123|26581783|FG004|Overall Study|Withdrawal by Subject|1|||
13325496|NCT01150123|26581784|FG005|Overall Study|Withdrawal by Subject|1|||
13325497|NCT01150123|26581785|FG006|Overall Study|Withdrawal by Subject|0|||
13325498|NCT01150123|26581786|FG007|Overall Study|Withdrawal by Subject|3|||
13325499|NCT01150123|26581787|FG008|Overall Study|Withdrawal by Subject|2|||
13325500|NCT01150123|26581788|FG009|Overall Study|Withdrawal by Subject|0|||
13325501|NCT01150123|26581789|FG010|Overall Study|Withdrawal by Subject|1|||
13325502|NCT01150123|26581790|FG011|Overall Study|Withdrawal by Subject|0|||
13325503|NCT01150123|26581791|FG012|Overall Study|Withdrawal by Subject|1|||
13325504|NCT01150123|26581792|FG013|Overall Study|Withdrawal by Subject|0|||
13325505|NCT01150123|26581793|FG014|Overall Study|Withdrawal by Subject|0|||
13325506|NCT01150123|26581794|FG015|Overall Study|Withdrawal by Subject|1|||
13325507|NCT01150123|26581795|FG016|Overall Study|Withdrawal by Subject|0|||
13325508|NCT01150123|26581796|FG017|Overall Study|Withdrawal by Subject|1|||
13325509|NCT01150123|26581779|FG000|Overall Study|Lost to Follow-up|2|||
13325510|NCT01150123|26581780|FG001|Overall Study|Lost to Follow-up|1|||
13325511|NCT01150123|26581781|FG002|Overall Study|Lost to Follow-up|2|||
13122303|NCT02966340|25946665|FG000|Overall Study|data acquisition error|1|||
13325512|NCT01150123|26581782|FG003|Overall Study|Lost to Follow-up|2|||
13325513|NCT01150123|26581783|FG004|Overall Study|Lost to Follow-up|2|||
13325514|NCT01150123|26581784|FG005|Overall Study|Lost to Follow-up|5|||
13325515|NCT01150123|26581785|FG006|Overall Study|Lost to Follow-up|0|||
13325516|NCT01150123|26581786|FG007|Overall Study|Lost to Follow-up|0|||
13325517|NCT01150123|26581787|FG008|Overall Study|Lost to Follow-up|3|||
13325518|NCT01150123|26581788|FG009|Overall Study|Lost to Follow-up|1|||
13325519|NCT01150123|26581789|FG010|Overall Study|Lost to Follow-up|1|||
13325520|NCT01150123|26581790|FG011|Overall Study|Lost to Follow-up|1|||
13325521|NCT01150123|26581791|FG012|Overall Study|Lost to Follow-up|2|||
13325522|NCT01150123|26581792|FG013|Overall Study|Lost to Follow-up|0|||
13325523|NCT01150123|26581793|FG014|Overall Study|Lost to Follow-up|0|||
13325524|NCT01150123|26581794|FG015|Overall Study|Lost to Follow-up|0|||
13325525|NCT01150123|26581795|FG016|Overall Study|Lost to Follow-up|0|||
13325526|NCT01150123|26581796|FG017|Overall Study|Lost to Follow-up|0|||
13325527|NCT01150097|26581829|FG000|Months 24 to 36 Post-transplantation|Death|2|||
13325528|NCT01150097|26581830|FG001|Months 24 to 36 Post-transplantation|Death|0|||
13325529|NCT01150097|26581831|FG002|Months 24 to 36 Post-transplantation|Death|0|||
13325530|NCT01150097|26581829|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5|||
13325531|NCT01150097|26581830|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2|||
13325532|NCT01150097|26581831|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2|||
13325533|NCT01150097|26581829|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
13325534|NCT01150097|26581830|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
13325535|NCT01150097|26581831|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3|||
13325536|NCT01150097|26581829|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
13325537|NCT01150097|26581830|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0|||
13325538|NCT01150097|26581831|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
13325539|NCT01150097|26581829|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5|||
13325540|NCT01150097|26581830|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4|||
13325541|NCT01150097|26581831|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0|||
13325542|NCT01150097|26581829|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4|||
13325543|NCT01150097|26581830|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
13325544|NCT01150097|26581831|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
13325545|NCT01150097|26581829|FG000|Months 24 to 48 Post-transplantation|Death|2|||
13325546|NCT01150097|26581830|FG001|Months 24 to 48 Post-transplantation|Death|0|||
13325547|NCT01150097|26581831|FG002|Months 24 to 48 Post-transplantation|Death|0|||
13325548|NCT01149863|26581838|FG000|Overall Study|Missing data or Not receiveing studydrug|3|||
13325549|NCT01149681|26581846|FG000|Overall Study|Withdrawal by Subject|7|||
13325550|NCT01149681|26581846|FG000|Overall Study|Progressive disease|1|||
13325551|NCT01149681|26581846|FG000|Overall Study|Physician Decision|2|||
13325552|NCT01149681|26581846|FG000|Overall Study|adverse events nonrelated study drug|2|||
13325553|NCT01149655|26581883|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1|||
13325554|NCT01149655|26581884|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0|||
13325555|NCT01149655|26581885|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0|||
13325556|NCT01149655|26581886|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0|||
13325557|NCT01149655|26581883|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4|||
13325558|NCT01149655|26581884|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
13325559|NCT01149655|26581885|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
13325560|NCT01149655|26581886|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
13325561|NCT01149655|26581883|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
13325562|NCT01149655|26581884|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
13325563|NCT01149655|26581885|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
13325564|NCT01149655|26581886|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
13325565|NCT01149655|26581883|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
13325566|NCT01149655|26581884|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
13325567|NCT01149655|26581885|FG002|Period 1 - Conversion Phase|Physician Decision|0|||
13325568|NCT01149655|26581886|FG003|Period 1 - Conversion Phase|Physician Decision|0|||
13325569|NCT01149655|26581883|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
13325570|NCT01149655|26581884|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
13325571|NCT01149655|26581885|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
13325572|NCT01149655|26581886|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
13325573|NCT01149655|26581883|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3|||
13325574|NCT01149655|26581884|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
13325575|NCT01149655|26581885|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
13325576|NCT01149655|26581886|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
13325577|NCT01149655|26581883|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
13325578|NCT01149655|26581884|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16|||
13325579|NCT01149655|26581885|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
13122304|NCT02966340|25946666|FG001|Overall Study|data acquisition error|0|||
13122305|NCT02966340|25946665|FG000|Overall Study|startle non-responder|1|||
13325580|NCT01149655|26581886|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
13325581|NCT01149655|26581883|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
13325582|NCT01149655|26581884|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7|||
13325583|NCT01149655|26581885|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
13325584|NCT01149655|26581886|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
13325585|NCT01149655|26581883|FG000|Period 2-Stabilization Phase|Physician Decision|0|||
13325586|NCT01149655|26581884|FG001|Period 2-Stabilization Phase|Physician Decision|3|||
13325587|NCT01149655|26581885|FG002|Period 2-Stabilization Phase|Physician Decision|0|||
13325588|NCT01149655|26581886|FG003|Period 2-Stabilization Phase|Physician Decision|0|||
13325589|NCT01149655|26581883|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
13325590|NCT01149655|26581884|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5|||
13325591|NCT01149655|26581885|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
13325592|NCT01149655|26581886|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
13325593|NCT01149655|26581883|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
13325594|NCT01149655|26581884|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6|||
13325595|NCT01149655|26581885|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
13325596|NCT01149655|26581886|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
13325597|NCT01149655|26581883|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
13325598|NCT01149655|26581884|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
13325599|NCT01149655|26581885|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58|||
13325600|NCT01149655|26581886|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19|||
13325601|NCT01149655|26581883|FG000|Period 3-DB Maintenance Phase|Physician Decision|0|||
13325602|NCT01149655|26581884|FG001|Period 3-DB Maintenance Phase|Physician Decision|0|||
13325603|NCT01149655|26581885|FG002|Period 3-DB Maintenance Phase|Physician Decision|1|||
13325604|NCT01149655|26581886|FG003|Period 3-DB Maintenance Phase|Physician Decision|0|||
13325605|NCT01149655|26581883|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
13325606|NCT01149655|26581884|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
13325607|NCT01149655|26581885|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
13325608|NCT01149655|26581886|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
13325609|NCT01149655|26581883|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
13325610|NCT01149655|26581884|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
13325611|NCT01149655|26581885|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
13325612|NCT01149655|26581886|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
13325613|NCT01149655|26581883|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0|||
13325614|NCT01149655|26581884|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0|||
13325615|NCT01149655|26581885|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19|||
13325616|NCT01149655|26581886|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18|||
13325617|NCT01149538|26581907|FG000|Overall Study|Lost to Follow-up|0|||
13325618|NCT01149538|26581908|FG001|Overall Study|Lost to Follow-up|1|||
13325619|NCT01149538|26581907|FG000|Overall Study|Withdrawal by Subject|5|||
13325620|NCT01149538|26581908|FG001|Overall Study|Withdrawal by Subject|3|||
13325621|NCT01149486|26581937|FG000|First Intervention|Adverse Event|0|||
13325622|NCT01149486|26581938|FG001|First Intervention|Adverse Event|1|||
13325623|NCT01149473|26581961|FG000|First Intervention|Adverse Event|1|||
13325624|NCT01149473|26581962|FG001|First Intervention|Adverse Event|1|||
13325625|NCT01149473|26581961|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
13325626|NCT01149473|26581962|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
13325627|NCT01149460|26581985|FG000|Overall Study|Withdrawal by Subject|0|||
13325628|NCT01149460|26581986|FG001|Overall Study|Withdrawal by Subject|2|||
13325629|NCT01149421|26582075|FG000|Overall Study|Adverse Event|22|||
13325630|NCT01149421|26582076|FG001|Overall Study|Adverse Event|6|||
13325631|NCT01149421|26582077|FG002|Overall Study|Adverse Event|11|||
13325632|NCT01149421|26582075|FG000|Overall Study|Withdrawal by Subject|20|||
13325633|NCT01149421|26582076|FG001|Overall Study|Withdrawal by Subject|12|||
13325634|NCT01149421|26582077|FG002|Overall Study|Withdrawal by Subject|13|||
13325635|NCT01149421|26582075|FG000|Overall Study|Sponsor Decision|0|||
13325636|NCT01149421|26582076|FG001|Overall Study|Sponsor Decision|1|||
13325637|NCT01149421|26582077|FG002|Overall Study|Sponsor Decision|1|||
13325638|NCT01149421|26582075|FG000|Overall Study|Lost to Follow-up|2|||
13325639|NCT01149421|26582076|FG001|Overall Study|Lost to Follow-up|4|||
13325640|NCT01149421|26582077|FG002|Overall Study|Lost to Follow-up|5|||
13325641|NCT01149421|26582075|FG000|Overall Study|Physician Decision|5|||
13325642|NCT01149421|26582076|FG001|Overall Study|Physician Decision|3|||
13325643|NCT01149421|26582077|FG002|Overall Study|Physician Decision|6|||
13325644|NCT01149421|26582075|FG000|Overall Study|Entry Criteria Not Met|1|||
13325645|NCT01149421|26582076|FG001|Overall Study|Entry Criteria Not Met|1|||
13325646|NCT01149421|26582077|FG002|Overall Study|Entry Criteria Not Met|2|||
13325647|NCT01149421|26582075|FG000|Overall Study|Protocol Violation|2|||
13325648|NCT01149421|26582076|FG001|Overall Study|Protocol Violation|2|||
13325649|NCT01149421|26582077|FG002|Overall Study|Protocol Violation|6|||
13325650|NCT01149369|26582248|FG000|Overall Study|Adverse Event|6|||
13325651|NCT01149369|26582249|FG001|Overall Study|Adverse Event|3|||
13325652|NCT01149343|26582345|FG000|Overall Study|Withdrawal by Subject|1|||
13325653|NCT01149343|26582346|FG001|Overall Study|Withdrawal by Subject|1|||
13325654|NCT01149343|26582347|FG002|Overall Study|Withdrawal by Subject|1|||
13325655|NCT01149343|26582348|FG003|Overall Study|Withdrawal by Subject|5|||
13325656|NCT01149343|26582345|FG000|Overall Study|Death|10|||
13325657|NCT01149343|26582346|FG001|Overall Study|Death|13|||
13325658|NCT01149343|26582347|FG002|Overall Study|Death|18|||
13325659|NCT01149343|26582348|FG003|Overall Study|Death|18|||
13325660|NCT01149343|26582345|FG000|Overall Study|Lost to Follow-up|1|||
13325661|NCT01149343|26582346|FG001|Overall Study|Lost to Follow-up|0|||
13325662|NCT01149343|26582347|FG002|Overall Study|Lost to Follow-up|0|||
13325663|NCT01149343|26582348|FG003|Overall Study|Lost to Follow-up|1|||
13325664|NCT01149343|26582345|FG000|Overall Study|Other|8|||
13325665|NCT01149343|26582346|FG001|Overall Study|Other|10|||
13325666|NCT01149343|26582347|FG002|Overall Study|Other|2|||
13325667|NCT01149343|26582348|FG003|Overall Study|Other|14|||
13325668|NCT01149343|26582345|FG000|Overall Study|Sponsor study termination|0|||
13325669|NCT01149343|26582346|FG001|Overall Study|Sponsor study termination|0|||
13325670|NCT01149343|26582347|FG002|Overall Study|Sponsor study termination|0|||
13325671|NCT01149343|26582348|FG003|Overall Study|Sponsor study termination|2|||
13325672|NCT01149343|26582345|FG000|Overall Study|Recurrence / Progressive disease|0|||
13325673|NCT01149343|26582346|FG001|Overall Study|Recurrence / Progressive disease|0|||
13325674|NCT01149343|26582347|FG002|Overall Study|Recurrence / Progressive disease|1|||
13325675|NCT01149343|26582348|FG003|Overall Study|Recurrence / Progressive disease|0|||
13325676|NCT01149148|26582363|FG000|Overall Study|Lost to Follow-up|1|||
13325677|NCT01149148|26582364|FG001|Overall Study|Lost to Follow-up|2|||
13325678|NCT01149148|26582363|FG000|Overall Study|Death|1|||
13325679|NCT01149148|26582364|FG001|Overall Study|Death|0|||
13325680|NCT01149096|26582395|FG000|Overall Study|Lost to Follow-up|0|||
13325681|NCT01149096|26582396|FG001|Overall Study|Lost to Follow-up|1|||
13325682|NCT01149057|26582423|FG000|Overall Study|Lack of Efficacy|16|||
13325683|NCT01149057|26582423|FG000|Overall Study|Adverse Event|13|||
13325684|NCT01149057|26582423|FG000|Overall Study|Withdrawal by Subject|9|||
13325685|NCT01149057|26582423|FG000|Overall Study|Positive Hepatitis B Core Antibody|5|||
13325686|NCT01149057|26582423|FG000|Overall Study|B Cell Depletion|4|||
13325687|NCT01149057|26582423|FG000|Overall Study|Participant Non-Compliance|2|||
13325688|NCT01149057|26582423|FG000|Overall Study|Lost to Follow-up|1|||
13325689|NCT01149057|26582423|FG000|Overall Study|High Parathyroid Hormone Value|1|||
13325690|NCT01149057|26582423|FG000|Overall Study|Other|6|||
13325691|NCT01148979|26582436|FG000|Overall Study|Lost to Follow-up|0|||
13325692|NCT01148979|26582437|FG001|Overall Study|Lost to Follow-up|1|||
13325693|NCT01148862|26582448|FG000|Second Intervention|Withdrawal by Subject|0|||
13325694|NCT01148862|26582449|FG001|Second Intervention|Withdrawal by Subject|2|||
13325695|NCT01148810|26582481|FG000|Overall Study|Adverse Event|0|||
13325696|NCT01148810|26582482|FG001|Overall Study|Adverse Event|2|||
13325697|NCT01148810|26582481|FG000|Overall Study|Lack of Efficacy|0|||
13325698|NCT01148810|26582482|FG001|Overall Study|Lack of Efficacy|1|||
13325699|NCT01148810|26582481|FG000|Overall Study|Withdrawal by Subject|0|||
13325700|NCT01148810|26582482|FG001|Overall Study|Withdrawal by Subject|2|||
13325701|NCT01148810|26582481|FG000|Overall Study|Protocol Violation|1|||
13325702|NCT01148810|26582482|FG001|Overall Study|Protocol Violation|0|||
13325703|NCT01148771|26582501|FG000|Washout Period|Withdrawal by Subject|0|||
13325704|NCT01148771|26582502|FG001|Washout Period|Withdrawal by Subject|1|||
13325705|NCT01148693|26582515|FG000|Overall Study|Attempts for cannulation were failed|13|||
13325706|NCT01148693|26582516|FG001|Overall Study|Attempts for cannulation were failed|10|||
13325707|NCT01148537|26582547|FG000|Overall Study|Withdrawal by Subject|1|||
13325708|NCT01148537|26582548|FG001|Overall Study|Withdrawal by Subject|0|||
13325709|NCT01148537|26582549|FG002|Overall Study|Withdrawal by Subject|2|||
13325710|NCT01148537|26582547|FG000|Overall Study|Adverse Event|2|||
13325711|NCT01148537|26582548|FG001|Overall Study|Adverse Event|0|||
13325712|NCT01148537|26582549|FG002|Overall Study|Adverse Event|1|||
13287494|NCT00473590|26473791|FG000|Overall Study|Non-protocol-specified therapy|7|||
13287495|NCT00473590|26473792|FG001|Overall Study|Non-protocol-specified therapy|5|||
13287496|NCT00473590|26473791|FG000|Overall Study|Physician Decision|2|||
13287497|NCT00473590|26473792|FG001|Overall Study|Physician Decision|4|||
13287498|NCT00473590|26473791|FG000|Overall Study|Withdrawal by Subject|5|||
13287499|NCT00473590|26473792|FG001|Overall Study|Withdrawal by Subject|3|||
13287500|NCT00473590|26473791|FG000|Overall Study|Other|0|||
13287501|NCT00473590|26473792|FG001|Overall Study|Other|1|||
13287502|NCT00473564|26473799|FG000|Overall Study|robot surgery aborted in OR|23|||
13287503|NCT00473512|26473873|FG000|Period 1 (Phase 1)|Adverse Event|0|||
13287504|NCT00473512|26473874|FG001|Period 1 (Phase 1)|Adverse Event|0|||
13287505|NCT00473512|26473875|FG002|Period 1 (Phase 1)|Adverse Event|0|||
13287506|NCT00473512|26473876|FG003|Period 1 (Phase 1)|Adverse Event|5|||
13287507|NCT00473512|26473877|FG004|Period 1 (Phase 1)|Adverse Event|0|||
13287508|NCT00473512|26473873|FG000|Period 1 (Phase 1)|Death|0|||
13287509|NCT00473512|26473874|FG001|Period 1 (Phase 1)|Death|0|||
13287510|NCT00473512|26473875|FG002|Period 1 (Phase 1)|Death|0|||
13325713|NCT01148511|26582576|FG000|Exposed to Study Drug|Protocol Violation|2|||
13287511|NCT00473512|26473876|FG003|Period 1 (Phase 1)|Death|1|||
13287512|NCT00473512|26473877|FG004|Period 1 (Phase 1)|Death|0|||
13287513|NCT00473512|26473873|FG000|Period 1 (Phase 1)|Disease Progression|1|||
13287514|NCT00473512|26473874|FG001|Period 1 (Phase 1)|Disease Progression|1|||
13287515|NCT00473512|26473875|FG002|Period 1 (Phase 1)|Disease Progression|0|||
13287516|NCT00473512|26473876|FG003|Period 1 (Phase 1)|Disease Progression|10|||
13287517|NCT00473512|26473877|FG004|Period 1 (Phase 1)|Disease Progression|1|||
13287518|NCT00473512|26473873|FG000|Period 1 (Phase 1)|Other|0|||
13287519|NCT00473512|26473874|FG001|Period 1 (Phase 1)|Other|0|||
13287520|NCT00473512|26473875|FG002|Period 1 (Phase 1)|Other|0|||
13287521|NCT00473512|26473876|FG003|Period 1 (Phase 1)|Other|1|||
13287522|NCT00473512|26473877|FG004|Period 1 (Phase 1)|Other|0|||
13287523|NCT00473512|26473873|FG000|Period 2 (Phase 2)|Adverse Event|0|||
13287524|NCT00473512|26473874|FG001|Period 2 (Phase 2)|Adverse Event|0|||
13287525|NCT00473512|26473875|FG002|Period 2 (Phase 2)|Adverse Event|0|||
13287526|NCT00473512|26473876|FG003|Period 2 (Phase 2)|Adverse Event|1|||
13325714|NCT01148511|26582577|FG001|Exposed to Study Drug|Protocol Violation|0|||
13325715|NCT01148511|26582578|FG002|Exposed to Study Drug|Protocol Violation|0|||
13325716|NCT01148511|26582576|FG000|Exposed to Study Drug|Lost to Follow-up|4|||
13325717|NCT01148511|26582577|FG001|Exposed to Study Drug|Lost to Follow-up|0|||
13325718|NCT01148511|26582578|FG002|Exposed to Study Drug|Lost to Follow-up|0|||
13325719|NCT01148511|26582576|FG000|Randomized|Adverse Event|0|||
13325720|NCT01148511|26582577|FG001|Randomized|Adverse Event|1|||
13325721|NCT01148511|26582578|FG002|Randomized|Adverse Event|0|||
13325722|NCT01148511|26582576|FG000|Randomized|Protocol Violation|0|||
13325723|NCT01148511|26582577|FG001|Randomized|Protocol Violation|2|||
13325724|NCT01148511|26582578|FG002|Randomized|Protocol Violation|1|||
13325725|NCT01148511|26582576|FG000|Randomized|Lost to Follow-up|0|||
13325726|NCT01148511|26582577|FG001|Randomized|Lost to Follow-up|1|||
13325727|NCT01148511|26582578|FG002|Randomized|Lost to Follow-up|1|||
13287527|NCT00473512|26473877|FG004|Period 2 (Phase 2)|Adverse Event|0|||
13287528|NCT00473512|26473873|FG000|Period 2 (Phase 2)|Death|0|||
13287529|NCT00473512|26473874|FG001|Period 2 (Phase 2)|Death|0|||
13287530|NCT00473512|26473875|FG002|Period 2 (Phase 2)|Death|0|||
13287531|NCT00473512|26473876|FG003|Period 2 (Phase 2)|Death|1|||
13287532|NCT00473512|26473877|FG004|Period 2 (Phase 2)|Death|1|||
13287533|NCT00473512|26473873|FG000|Period 2 (Phase 2)|Disease Progression|0|||
13287534|NCT00473512|26473874|FG001|Period 2 (Phase 2)|Disease Progression|2|||
13287535|NCT00473512|26473875|FG002|Period 2 (Phase 2)|Disease Progression|2|||
13287536|NCT00473512|26473876|FG003|Period 2 (Phase 2)|Disease Progression|17|||
13287537|NCT00473512|26473877|FG004|Period 2 (Phase 2)|Disease Progression|1|||
13287538|NCT00473512|26473873|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
13287539|NCT00473512|26473874|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
13287540|NCT00473512|26473875|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
13287541|NCT00473512|26473876|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1|||
13287542|NCT00473512|26473877|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
13287543|NCT00473512|26473873|FG000|Period 2 (Phase 2)|Other|1|||
13287544|NCT00473512|26473874|FG001|Period 2 (Phase 2)|Other|0|||
13287545|NCT00473512|26473875|FG002|Period 2 (Phase 2)|Other|0|||
13287546|NCT00473512|26473876|FG003|Period 2 (Phase 2)|Other|3|||
13287547|NCT00473512|26473877|FG004|Period 2 (Phase 2)|Other|0|||
13287548|NCT00473434|26473941|FG000|Overall Study|Physician Decision|3|||
13287549|NCT00473434|26473941|FG000|Overall Study|Withdrawal by Subject|9|||
13287550|NCT00473434|26473941|FG000|Overall Study|Compliance|3|||
13287551|NCT00473434|26473941|FG000|Overall Study|Lack of Efficacy|3|||
13287552|NCT00473434|26473941|FG000|Overall Study|Adverse Event|3|||
13287553|NCT00473434|26473941|FG000|Overall Study|Patient was selling medication to others|1|||
13287554|NCT00473434|26473941|FG000|Overall Study|Safety evaluation|1|||
13287555|NCT00473434|26473941|FG000|Overall Study|Reason not specified|6|||
13287556|NCT00473434|26473941|FG000|Overall Study|Ceased in favor of Paliperidone|1|||
13287557|NCT00473434|26473941|FG000|Overall Study|Switching to trial medication|1|||
13287558|NCT00473434|26473941|FG000|Overall Study|No longer required|1|||
13287559|NCT00473382|26474006|FG000|Core Study|Adverse Event|3|||
13287560|NCT00473382|26474007|FG001|Core Study|Adverse Event|1|||
13287561|NCT00473382|26474008|FG002|Core Study|Adverse Event|1|||
13287562|NCT00473382|26474006|FG000|Core Study|Death|3|||
13287563|NCT00473382|26474007|FG001|Core Study|Death|5|||
13287564|NCT00473382|26474008|FG002|Core Study|Death|10|||
13287565|NCT00473382|26474006|FG000|Core Study|Lost to Follow-up|3|||
13325728|NCT01148511|26582576|FG000|Randomized|Consent withdrawal|0|||
13325729|NCT01148511|26582577|FG001|Randomized|Consent withdrawal|5|||
13203964|NCT01978119|26226503|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
13203965|NCT01978119|26226504|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
13203966|NCT01978093|26226553|FG000|Overall Study|Death|1|||
13203967|NCT01978093|26226554|FG001|Overall Study|Death|0|||
13203968|NCT01978093|26226553|FG000|Overall Study|Adverse Event|0|||
13203969|NCT01978093|26226554|FG001|Overall Study|Adverse Event|5|||
13203970|NCT01978093|26226553|FG000|Overall Study|Protocol Violation|8|||
13203971|NCT01978093|26226554|FG001|Overall Study|Protocol Violation|2|||
13203972|NCT01978093|26226553|FG000|Overall Study|Withdrawal by Subject|29|||
13203973|NCT01978093|26226554|FG001|Overall Study|Withdrawal by Subject|25|||
13203974|NCT01978093|26226553|FG000|Overall Study|Lost to Follow-up|11|||
13203975|NCT01978093|26226554|FG001|Overall Study|Lost to Follow-up|15|||
13203976|NCT01978093|26226553|FG000|Overall Study|Migrated/moved from study area|11|||
13203977|NCT01978093|26226554|FG001|Overall Study|Migrated/moved from study area|13|||
13203978|NCT01978093|26226553|FG000|Overall Study|Loss of kaiser coverage|4|||
13203979|NCT01978093|26226554|FG001|Overall Study|Loss of kaiser coverage|10|||
13203980|NCT01978093|26226553|FG000|Overall Study|Lost kaiser health plan unable to contac|1|||
13203981|NCT01978093|26226554|FG001|Overall Study|Lost kaiser health plan unable to contac|0|||
13203982|NCT01978093|26226553|FG000|Overall Study|Mother lost custody of child|0|||
13203983|NCT01978093|26226554|FG001|Overall Study|Mother lost custody of child|1|||
13203984|NCT01978093|26226553|FG000|Overall Study|Child was in care of grandmother|0|||
13203985|NCT01978093|26226554|FG001|Overall Study|Child was in care of grandmother|1|||
13203986|NCT01978093|26226553|FG000|Overall Study|N/A for vaccine administration|0|||
13203987|NCT01978093|26226554|FG001|Overall Study|N/A for vaccine administration|1|||
13203988|NCT01977937|26226569|FG000|Overall Study|Withdrawal by Subject|2|||
13203989|NCT01977937|26226570|FG001|Overall Study|Withdrawal by Subject|1|||
13203990|NCT01977937|26226569|FG000|Overall Study|Adverse Event|1|||
13203991|NCT01977937|26226570|FG001|Overall Study|Adverse Event|0|||
13203992|NCT01977937|26226569|FG000|Overall Study|Physician Decision|0|||
13203993|NCT01977937|26226570|FG001|Overall Study|Physician Decision|1|||
13203994|NCT01977898|26226603|FG000|Overall Study|Non functioning catheter|1|||
13203995|NCT01977898|26226604|FG001|Overall Study|Non functioning catheter|1|||
13287566|NCT00473382|26474007|FG001|Core Study|Lost to Follow-up|3|||
13287567|NCT00473382|26474008|FG002|Core Study|Lost to Follow-up|3|||
13287568|NCT00473382|26474006|FG000|Core Study|Physician Decision|1|||
13287569|NCT00473382|26474007|FG001|Core Study|Physician Decision|2|||
13287570|NCT00473382|26474008|FG002|Core Study|Physician Decision|2|||
13287571|NCT00473382|26474006|FG000|Core Study|Subject non-compliance|5|||
13287572|NCT00473382|26474007|FG001|Core Study|Subject non-compliance|2|||
13287573|NCT00473382|26474008|FG002|Core Study|Subject non-compliance|1|||
13287574|NCT00473382|26474006|FG000|Core Study|Subject needed other treatment|1|||
13287575|NCT00473382|26474007|FG001|Core Study|Subject needed other treatment|3|||
13287576|NCT00473382|26474008|FG002|Core Study|Subject needed other treatment|2|||
13287577|NCT00473382|26474006|FG000|Core Study|Subject's decision|12|||
13287578|NCT00473382|26474007|FG001|Core Study|Subject's decision|11|||
13287579|NCT00473382|26474008|FG002|Core Study|Subject's decision|10|||
13287580|NCT00473382|26474006|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
13287581|NCT00473382|26474007|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
13287582|NCT00473382|26474008|FG002|Open-label Extension Through Month 48|Adverse Event|1|||
13287583|NCT00473382|26474006|FG000|Open-label Extension Through Month 48|Death|1|||
13287584|NCT00473382|26474007|FG001|Open-label Extension Through Month 48|Death|3|||
13287585|NCT00473382|26474008|FG002|Open-label Extension Through Month 48|Death|3|||
13287586|NCT00473382|26474006|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
13287587|NCT00473382|26474007|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2|||
13287588|NCT00473382|26474008|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1|||
13287589|NCT00473382|26474006|FG000|Open-label Extension Through Month 48|Subject's Decision|5|||
13287590|NCT00473382|26474007|FG001|Open-label Extension Through Month 48|Subject's Decision|1|||
13287591|NCT00473382|26474008|FG002|Open-label Extension Through Month 48|Subject's Decision|6|||
13287592|NCT00473382|26474006|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41|||
13287593|NCT00473382|26474007|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34|||
13287594|NCT00473382|26474008|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36|||
13287595|NCT00473382|26474006|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2|||
13287596|NCT00473382|26474007|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1|||
13287597|NCT00473382|26474008|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0|||
13287598|NCT00473382|26474006|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
13287599|NCT00473382|26474007|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
13287600|NCT00473382|26474008|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
13287601|NCT00473382|26474006|FG000|Open-label Extension Through Month 60|Death|1|||
13287602|NCT00473382|26474007|FG001|Open-label Extension Through Month 60|Death|7|||
13287603|NCT00473382|26474008|FG002|Open-label Extension Through Month 60|Death|4|||
13287604|NCT00473382|26474006|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1|||
13287605|NCT00473382|26474007|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3|||
13287606|NCT00473382|26474008|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1|||
13287607|NCT00473382|26474006|FG000|Open-label Extension Through Month 60|Subject's Decision|7|||
13287608|NCT00473382|26474007|FG001|Open-label Extension Through Month 60|Subject's Decision|1|||
13287609|NCT00473382|26474008|FG002|Open-label Extension Through Month 60|Subject's Decision|6|||
13287610|NCT00473382|26474006|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75|||
13287611|NCT00473382|26474007|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70|||
13292263|NCT00706914|26485082|FG001|Overall Study|Protocol Violation|1|||
13287612|NCT00473382|26474008|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69|||
13287613|NCT00473382|26474006|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2|||
13287614|NCT00473382|26474007|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1|||
13287615|NCT00473382|26474008|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0|||
13287616|NCT00473265|26474019|FG000|Overall Study|Unrelated adverse event|5|||
13287617|NCT00473265|26474019|FG000|Overall Study|Off treatment early|15|||
13287618|NCT00473083|26474055|FG000|Overall Study|Adverse Event|1|||
13287619|NCT00473083|26474056|FG001|Overall Study|Adverse Event|0|||
13287620|NCT00473083|26474057|FG002|Overall Study|Adverse Event|0|||
13287621|NCT00472641|26474064|FG000|Overall Study|Lack of Efficacy|3|||
13287622|NCT00472641|26474064|FG000|Overall Study|Adverse Event|3|||
13287623|NCT00472641|26474064|FG000|Overall Study|Lost to Follow-up|1|||
13287624|NCT00472446|26474107|FG000|Overall Study|Protocol Violation|0|||
13287625|NCT00472446|26474108|FG001|Overall Study|Protocol Violation|0|||
13287626|NCT00472446|26474109|FG002|Overall Study|Protocol Violation|0|||
13287627|NCT00472446|26474110|FG003|Overall Study|Protocol Violation|1|||
13287628|NCT00472446|26474107|FG000|Overall Study|Reintervention|0|||
13287629|NCT00472446|26474108|FG001|Overall Study|Reintervention|0|||
13287630|NCT00472446|26474109|FG002|Overall Study|Reintervention|1|||
13287631|NCT00472446|26474110|FG003|Overall Study|Reintervention|1|||
13287632|NCT00472446|26474107|FG000|Overall Study|Questionnaires not returned|5|||
13287633|NCT00472446|26474108|FG001|Overall Study|Questionnaires not returned|6|||
13287634|NCT00472446|26474109|FG002|Overall Study|Questionnaires not returned|6|||
13287635|NCT00472446|26474110|FG003|Overall Study|Questionnaires not returned|4|||
13287636|NCT00472420|26474118|FG000|Induction Treatment Period|Physician Decision|9|||
13287637|NCT00472420|26474118|FG000|Induction Treatment Period|Adverse Event|3|||
13287638|NCT00472420|26474118|FG000|Induction Treatment Period|Non-compliance|1|||
13287639|NCT00472420|26474118|FG000|Induction Treatment Period|Death|3|||
13287640|NCT00472420|26474118|FG000|Follow-up Period|Death|5|||
13287641|NCT00472420|26474118|FG000|Follow-up Period|Physician Decision|9|||
13287642|NCT00472420|26474118|FG000|Follow-up Period|Lost to Follow-up|2|||
13287643|NCT00472420|26474118|FG000|Follow-up Period|Protocol Violation|1|||
13287644|NCT00472303|26474189|FG000|Titration Phase|Adverse Event|22|||
13287645|NCT00472303|26474190|FG001|Titration Phase|Adverse Event|12|||
13287646|NCT00472303|26474191|FG002|Titration Phase|Adverse Event|0|||
13287647|NCT00472303|26474189|FG000|Titration Phase|Death|4|||
13287648|NCT00472303|26474190|FG001|Titration Phase|Death|2|||
13287649|NCT00472303|26474191|FG002|Titration Phase|Death|0|||
13287650|NCT00472303|26474189|FG000|Titration Phase|Lack of Efficacy|10|||
13287651|NCT00472303|26474190|FG001|Titration Phase|Lack of Efficacy|0|||
13287652|NCT00472303|26474191|FG002|Titration Phase|Lack of Efficacy|0|||
13287653|NCT00472303|26474189|FG000|Titration Phase|Withdrawal by Subject|16|||
13287654|NCT00472303|26474190|FG001|Titration Phase|Withdrawal by Subject|13|||
13287655|NCT00472303|26474191|FG002|Titration Phase|Withdrawal by Subject|0|||
13287656|NCT00472303|26474189|FG000|Titration Phase|Trial Medication non-compliant|4|||
13287657|NCT00472303|26474190|FG001|Titration Phase|Trial Medication non-compliant|1|||
13287658|NCT00472303|26474191|FG002|Titration Phase|Trial Medication non-compliant|0|||
13287659|NCT00472303|26474189|FG000|Titration Phase|Other|3|||
13287660|NCT00472303|26474190|FG001|Titration Phase|Other|1|||
13287661|NCT00472303|26474191|FG002|Titration Phase|Other|0|||
13287662|NCT00472303|26474189|FG000|Discontinuations After Titration Phase|Adverse Event|6|||
13287663|NCT00472303|26474190|FG001|Discontinuations After Titration Phase|Adverse Event|0|||
13287664|NCT00472303|26474191|FG002|Discontinuations After Titration Phase|Adverse Event|0|||
13287665|NCT00472303|26474189|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48|||
13287666|NCT00472303|26474190|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17|||
13287667|NCT00472303|26474191|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0|||
13287668|NCT00472303|26474189|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
13287669|NCT00472303|26474190|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
13325730|NCT01148511|26582578|FG002|Randomized|Consent withdrawal|3|||
13325731|NCT01148511|26582576|FG000|Randomized|Other|0|||
13325732|NCT01148511|26582577|FG001|Randomized|Other|1|||
13325733|NCT01148511|26582578|FG002|Randomized|Other|1|||
13325734|NCT01148459|26582627|FG000|Overall Study|Serious Adverse Event|5|||
13325735|NCT01148459|26582628|FG001|Overall Study|Serious Adverse Event|4|||
13325736|NCT01148459|26582627|FG000|Overall Study|Withdrawal by Subject|1|||
13325737|NCT01148459|26582628|FG001|Overall Study|Withdrawal by Subject|0|||
13325738|NCT01148459|26582627|FG000|Overall Study|Migrated/moved from study area|3|||
13325739|NCT01148459|26582628|FG001|Overall Study|Migrated/moved from study area|6|||
13325740|NCT01148459|26582627|FG000|Overall Study|Lost to Follow-up|2|||
13325741|NCT01148459|26582628|FG001|Overall Study|Lost to Follow-up|0|||
13325742|NCT01148459|26582627|FG000|Overall Study|Refusal|1|||
13325743|NCT01148459|26582628|FG001|Overall Study|Refusal|0|||
13287670|NCT00472303|26474191|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0|||
13325744|NCT01148459|26582627|FG000|Overall Study|Failure to comply with study procedures|0|||
13325745|NCT01148459|26582628|FG001|Overall Study|Failure to comply with study procedures|1|||
13325746|NCT01148225|26582668|FG000|Overall Study|Other|185|||
13287671|NCT00472303|26474189|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
13287672|NCT00472303|26474190|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1|||
13287673|NCT00472303|26474191|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
13287674|NCT00472303|26474189|FG000|Discontinuations After Titration Phase|Other|5|||
13287675|NCT00472303|26474190|FG001|Discontinuations After Titration Phase|Other|0|||
13287676|NCT00472303|26474191|FG002|Discontinuations After Titration Phase|Other|0|||
13287677|NCT00472303|26474189|FG000|Maintenance Phase|Adverse Event|5|||
13287678|NCT00472303|26474190|FG001|Maintenance Phase|Adverse Event|6|||
13287679|NCT00472303|26474191|FG002|Maintenance Phase|Adverse Event|6|||
13287680|NCT00472303|26474189|FG000|Maintenance Phase|Death|3|||
13287681|NCT00472303|26474190|FG001|Maintenance Phase|Death|0|||
13287682|NCT00472303|26474191|FG002|Maintenance Phase|Death|2|||
13287683|NCT00472303|26474189|FG000|Maintenance Phase|Lack of Efficacy|2|||
13287684|NCT00472303|26474190|FG001|Maintenance Phase|Lack of Efficacy|2|||
13287685|NCT00472303|26474191|FG002|Maintenance Phase|Lack of Efficacy|4|||
13287686|NCT00472303|26474189|FG000|Maintenance Phase|Withdrawal by Subject|6|||
13287687|NCT00472303|26474190|FG001|Maintenance Phase|Withdrawal by Subject|7|||
13287688|NCT00472303|26474191|FG002|Maintenance Phase|Withdrawal by Subject|3|||
13287689|NCT00472303|26474189|FG000|Maintenance Phase|Trial medication non-compliant|0|||
13287690|NCT00472303|26474190|FG001|Maintenance Phase|Trial medication non-compliant|0|||
13287691|NCT00472303|26474191|FG002|Maintenance Phase|Trial medication non-compliant|1|||
13287692|NCT00472303|26474189|FG000|Maintenance Phase|Resolution of pain|0|||
13287693|NCT00472303|26474190|FG001|Maintenance Phase|Resolution of pain|0|||
13287694|NCT00472303|26474191|FG002|Maintenance Phase|Resolution of pain|1|||
13287695|NCT00472303|26474189|FG000|Maintenance Phase|Other|1|||
13287696|NCT00472303|26474190|FG001|Maintenance Phase|Other|1|||
13287697|NCT00472303|26474191|FG002|Maintenance Phase|Other|0|||
13287698|NCT00472290|26474203|FG000|Overall Study|Progression of Therapy-Related MDS|1|||
13287699|NCT00472290|26474203|FG000|Overall Study|Protocol Specified Criteria|7|||
13287700|NCT00472290|26474203|FG000|Overall Study|Administrative Decision|37|||
13287701|NCT00472290|26474203|FG000|Overall Study|Death|3|||
13287702|NCT00472290|26474203|FG000|Overall Study|Lost to Follow-up|1|||
13287703|NCT00472290|26474203|FG000|Overall Study|Lack of Efficacy|1|||
13287704|NCT00472290|26474203|FG000|Overall Study|Disease Progression|4|||
13287705|NCT00472290|26474203|FG000|Overall Study|Withdrawal by Subject|5|||
13287706|NCT00472290|26474203|FG000|Overall Study|Adverse Event|6|||
13287707|NCT00472290|26474203|FG000|Overall Study|Requirement for alternative therapy|7|||
13287708|NCT00472212|26474220|FG000|Overall Study|Lost to Follow-up|6|||
13287709|NCT00472212|26474221|FG001|Overall Study|Lost to Follow-up|4|||
13287710|NCT00472199|26474294|FG000|Overall Study|Adverse Event|19|||
13287711|NCT00472199|26474295|FG001|Overall Study|Adverse Event|23|||
13287712|NCT00472199|26474294|FG000|Overall Study|Lack of Efficacy|4|||
13287713|NCT00472199|26474295|FG001|Overall Study|Lack of Efficacy|25|||
13287714|NCT00472199|26474294|FG000|Overall Study|Lost to Follow-up|2|||
13287715|NCT00472199|26474295|FG001|Overall Study|Lost to Follow-up|4|||
13287716|NCT00472199|26474294|FG000|Overall Study|Protocol Violation|3|||
13287717|NCT00472199|26474295|FG001|Overall Study|Protocol Violation|2|||
13287718|NCT00472199|26474294|FG000|Overall Study|Withdrawal by Subject|6|||
13287719|NCT00472199|26474295|FG001|Overall Study|Withdrawal by Subject|5|||
13287720|NCT00472199|26474294|FG000|Overall Study|personal reason|0|||
13287721|NCT00472199|26474295|FG001|Overall Study|personal reason|1|||
13287722|NCT00472199|26474294|FG000|Overall Study|patient was asymptomatic|1|||
13287723|NCT00472199|26474295|FG001|Overall Study|patient was asymptomatic|0|||
13287724|NCT00472082|26474302|FG000|Overall Study|Study prematurely terminated|5|||
13287725|NCT00471887|26474313|FG000|Overall Study|Adverse Event|9|||
13287726|NCT00471718|26474324|FG000|Overall Study|Adverse Event|3|||
13287727|NCT00471718|26474324|FG000|Overall Study|other complicating disease|1|||
13287728|NCT00471718|26474324|FG000|Overall Study|disease progression|22|||
13287729|NCT00471718|26474324|FG000|Overall Study|Withdrawal by Subject|1|||
13287730|NCT00471536|26474335|FG000|Overall Study|Withdrawal by Subject|1|||
13287731|NCT00471445|26474348|FG000|Overall Study|Withdrawal by Subject|1|||
13287732|NCT00471445|26474349|FG001|Overall Study|Withdrawal by Subject|1|||
13287733|NCT00471445|26474348|FG000|Overall Study|Ineligible|1|||
13287734|NCT00471445|26474349|FG001|Overall Study|Ineligible|0|||
13325747|NCT01148017|26582718|FG000|Overall Study|Withdrawal by Subject|31|||
13486400|NCT03645863|27036043|FG000|Overall Study|Withdrawal by Subject|1|||
13287735|NCT00471445|26474348|FG000|Overall Study|Protocol Violation|0|||
13287736|NCT00471445|26474349|FG001|Overall Study|Protocol Violation|1|||
13287737|NCT00471354|26474361|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
13287738|NCT00471354|26474361|FG000|Overall Study|Adverse Event|13|||
13287739|NCT00471354|26474361|FG000|Overall Study|Protocol Violation|12|||
13287740|NCT00471354|26474361|FG000|Overall Study|Withdrawal by Subject|1|||
13287741|NCT00471354|26474361|FG000|Overall Study|Physician Decision|4|||
13287742|NCT00471354|26474361|FG000|Overall Study|Sponsor Decision|1|||
13287743|NCT00471354|26474361|FG000|Overall Study|Lost to Follow-up|3|||
13287744|NCT00471354|26474361|FG000|Overall Study|Lack of Efficacy|5|||
13287745|NCT00471354|26474361|FG000|Overall Study|Patient/Caregiver Decision|12|||
13287746|NCT00471328|26474387|FG000|Core Phase|Adverse Event|18|||
13287747|NCT00471328|26474388|FG001|Core Phase|Adverse Event|6|||
13287748|NCT00471328|26474387|FG000|Core Phase|Death|8|||
13287749|NCT00471328|26474388|FG001|Core Phase|Death|4|||
13287750|NCT00471328|26474387|FG000|Core Phase|Withdrawal by Subject|2|||
13287751|NCT00471328|26474388|FG001|Core Phase|Withdrawal by Subject|2|||
13287752|NCT00471328|26474387|FG000|Core Phase|Abnormal laboratory value|1|||
13287753|NCT00471328|26474388|FG001|Core Phase|Abnormal laboratory value|0|||
13287754|NCT00471328|26474387|FG000|Core Phase|Disease Progression|78|||
13287755|NCT00471328|26474388|FG001|Core Phase|Disease Progression|53|||
13287756|NCT00471328|26474387|FG000|Core Phase|Administrative Problem|0|||
13287757|NCT00471328|26474388|FG001|Core Phase|Administrative Problem|1|||
13325748|NCT01148017|26582719|FG001|Overall Study|Withdrawal by Subject|14|||
13325749|NCT01148017|26582720|FG002|Overall Study|Withdrawal by Subject|0|||
13287758|NCT00471328|26474387|FG000|Core Phase|Protocol Deviation|0|||
13287759|NCT00471328|26474388|FG001|Core Phase|Protocol Deviation|1|||
13287760|NCT00471328|26474387|FG000|Extension Phase|Adverse Event|3|||
13287761|NCT00471328|26474388|FG001|Extension Phase|Adverse Event|12|||
13287762|NCT00471328|26474387|FG000|Extension Phase|Withdrawal by Subject|0|||
13287763|NCT00471328|26474388|FG001|Extension Phase|Withdrawal by Subject|2|||
13287764|NCT00471328|26474387|FG000|Extension Phase|Death|1|||
13287765|NCT00471328|26474388|FG001|Extension Phase|Death|7|||
13287766|NCT00471328|26474387|FG000|Extension Phase|Protocol Deviation|3|||
13287767|NCT00471328|26474388|FG001|Extension Phase|Protocol Deviation|1|||
13287768|NCT00471328|26474387|FG000|Extension Phase|Treatment duration as per protocol|0|||
13287769|NCT00471328|26474388|FG001|Extension Phase|Treatment duration as per protocol|1|||
13287770|NCT00471328|26474387|FG000|Extension Phase|Disease Progression|32|||
13287771|NCT00471328|26474388|FG001|Extension Phase|Disease Progression|44|||
13287772|NCT00471328|26474387|FG000|Extension Phase|New cancer Therapy|1|||
13287773|NCT00471328|26474388|FG001|Extension Phase|New cancer Therapy|0|||
13287774|NCT00471328|26474387|FG000|Extension Phase|Administrative Problem|1|||
13287775|NCT00471328|26474388|FG001|Extension Phase|Administrative Problem|0|||
13287776|NCT00471315|26474395|FG000|Overall Study|Adverse Event|7|||
13287777|NCT00471315|26474395|FG000|Overall Study|Withdrawal by Subject|1|||
13287778|NCT00471237|26474565|FG000|Overall Study|Adverse Event|6|||
13325750|NCT01148017|26582721|FG003|Overall Study|Withdrawal by Subject|0|||
13325751|NCT01148017|26582718|FG000|Overall Study|Lost to Follow-up|23|||
13325752|NCT01148017|26582719|FG001|Overall Study|Lost to Follow-up|10|||
13325753|NCT01148017|26582720|FG002|Overall Study|Lost to Follow-up|0|||
13325754|NCT01148017|26582721|FG003|Overall Study|Lost to Follow-up|0|||
13325755|NCT01148017|26582718|FG000|Overall Study|Inappropriate enrollment|1|||
13325756|NCT01148017|26582719|FG001|Overall Study|Inappropriate enrollment|0|||
13325757|NCT01148017|26582720|FG002|Overall Study|Inappropriate enrollment|0|||
13325758|NCT01148017|26582721|FG003|Overall Study|Inappropriate enrollment|0|||
13325759|NCT01148017|26582718|FG000|Overall Study|Administrative reason|22|||
13325760|NCT01148017|26582719|FG001|Overall Study|Administrative reason|9|||
13325761|NCT01148017|26582720|FG002|Overall Study|Administrative reason|0|||
13325762|NCT01148017|26582721|FG003|Overall Study|Administrative reason|0|||
13325763|NCT01148017|26582718|FG000|Overall Study|Unable to classify|3|||
13325764|NCT01148017|26582719|FG001|Overall Study|Unable to classify|1|||
13325765|NCT01148017|26582720|FG002|Overall Study|Unable to classify|0|||
13325766|NCT01148017|26582721|FG003|Overall Study|Unable to classify|0|||
13325767|NCT01147926|26582760|FG000|Overall Study|Subject Withdrew Consent|9|||
13325768|NCT01147926|26582761|FG001|Overall Study|Subject Withdrew Consent|10|||
13325769|NCT01147926|26582760|FG000|Overall Study|Adverse Event|7|||
13325770|NCT01147926|26582761|FG001|Overall Study|Adverse Event|6|||
13287779|NCT00471237|26474566|FG001|Overall Study|Adverse Event|5|||
13287780|NCT00471237|26474567|FG002|Overall Study|Adverse Event|4|||
13287781|NCT00471237|26474568|FG003|Overall Study|Adverse Event|8|||
13287782|NCT00471237|26474569|FG004|Overall Study|Adverse Event|7|||
13287783|NCT00471237|26474570|FG005|Overall Study|Adverse Event|5|||
13287784|NCT00471237|26474571|FG006|Overall Study|Adverse Event|0|||
13287785|NCT00471237|26474565|FG000|Overall Study|Lost to Follow-up|1|||
13287786|NCT00471237|26474566|FG001|Overall Study|Lost to Follow-up|1|||
13287787|NCT00471237|26474567|FG002|Overall Study|Lost to Follow-up|0|||
13287788|NCT00471237|26474568|FG003|Overall Study|Lost to Follow-up|2|||
13287789|NCT00471237|26474569|FG004|Overall Study|Lost to Follow-up|3|||
13287790|NCT00471237|26474570|FG005|Overall Study|Lost to Follow-up|0|||
13287791|NCT00471237|26474571|FG006|Overall Study|Lost to Follow-up|0|||
13287792|NCT00471237|26474565|FG000|Overall Study|Protocol Violation|3|||
13287793|NCT00471237|26474566|FG001|Overall Study|Protocol Violation|6|||
13287794|NCT00471237|26474567|FG002|Overall Study|Protocol Violation|3|||
13287795|NCT00471237|26474568|FG003|Overall Study|Protocol Violation|2|||
13287796|NCT00471237|26474569|FG004|Overall Study|Protocol Violation|2|||
13325771|NCT01147926|26582760|FG000|Overall Study|Subject Non-Compliant|5|||
13325772|NCT01147926|26582761|FG001|Overall Study|Subject Non-Compliant|4|||
13325773|NCT01147926|26582760|FG000|Overall Study|Principal investigator left hospital|1|||
13325774|NCT01147926|26582761|FG001|Overall Study|Principal investigator left hospital|3|||
13287797|NCT00471237|26474570|FG005|Overall Study|Protocol Violation|4|||
13287798|NCT00471237|26474571|FG006|Overall Study|Protocol Violation|1|||
13287799|NCT00471237|26474565|FG000|Overall Study|Withdrawal by Subject|8|||
13287800|NCT00471237|26474566|FG001|Overall Study|Withdrawal by Subject|6|||
13287801|NCT00471237|26474567|FG002|Overall Study|Withdrawal by Subject|5|||
13287802|NCT00471237|26474568|FG003|Overall Study|Withdrawal by Subject|8|||
13287803|NCT00471237|26474569|FG004|Overall Study|Withdrawal by Subject|7|||
13287804|NCT00471237|26474570|FG005|Overall Study|Withdrawal by Subject|4|||
13287805|NCT00471237|26474571|FG006|Overall Study|Withdrawal by Subject|2|||
13287806|NCT00471237|26474565|FG000|Overall Study|Sponsor terminated study|20|||
13287807|NCT00471237|26474566|FG001|Overall Study|Sponsor terminated study|23|||
13287808|NCT00471237|26474567|FG002|Overall Study|Sponsor terminated study|19|||
13287809|NCT00471237|26474568|FG003|Overall Study|Sponsor terminated study|22|||
13287810|NCT00471237|26474569|FG004|Overall Study|Sponsor terminated study|18|||
13287811|NCT00471237|26474570|FG005|Overall Study|Sponsor terminated study|24|||
13287812|NCT00471237|26474571|FG006|Overall Study|Sponsor terminated study|0|||
13287813|NCT00471237|26474565|FG000|Overall Study|Non-compliance|0|||
13287814|NCT00471237|26474566|FG001|Overall Study|Non-compliance|1|||
13287815|NCT00471237|26474567|FG002|Overall Study|Non-compliance|0|||
13287816|NCT00471237|26474568|FG003|Overall Study|Non-compliance|1|||
13287817|NCT00471237|26474569|FG004|Overall Study|Non-compliance|0|||
13287818|NCT00471237|26474570|FG005|Overall Study|Non-compliance|0|||
13287819|NCT00471237|26474571|FG006|Overall Study|Non-compliance|0|||
13287820|NCT00471237|26474565|FG000|Overall Study|Met serum creatinine withdrawal criteria|1|||
13287821|NCT00471237|26474566|FG001|Overall Study|Met serum creatinine withdrawal criteria|0|||
13287822|NCT00471237|26474567|FG002|Overall Study|Met serum creatinine withdrawal criteria|2|||
13287823|NCT00471237|26474568|FG003|Overall Study|Met serum creatinine withdrawal criteria|2|||
13287824|NCT00471237|26474569|FG004|Overall Study|Met serum creatinine withdrawal criteria|0|||
13287825|NCT00471237|26474570|FG005|Overall Study|Met serum creatinine withdrawal criteria|0|||
13287826|NCT00471237|26474571|FG006|Overall Study|Met serum creatinine withdrawal criteria|0|||
13287827|NCT00471237|26474565|FG000|Overall Study|Early stopping due to non-efficacy|1|||
13287828|NCT00471237|26474566|FG001|Overall Study|Early stopping due to non-efficacy|0|||
13287829|NCT00471237|26474567|FG002|Overall Study|Early stopping due to non-efficacy|0|||
13287830|NCT00471237|26474568|FG003|Overall Study|Early stopping due to non-efficacy|0|||
13287831|NCT00471237|26474569|FG004|Overall Study|Early stopping due to non-efficacy|1|||
13287832|NCT00471237|26474570|FG005|Overall Study|Early stopping due to non-efficacy|0|||
13287833|NCT00471237|26474571|FG006|Overall Study|Early stopping due to non-efficacy|0|||
13325775|NCT01147926|26582760|FG000|Overall Study|Selection criteria not met|3|||
13325776|NCT01147926|26582761|FG001|Overall Study|Selection criteria not met|1|||
13325777|NCT01147926|26582760|FG000|Overall Study|Lost to Follow-up|0|||
13325778|NCT01147926|26582761|FG001|Overall Study|Lost to Follow-up|2|||
13287834|NCT00471237|26474565|FG000|Overall Study|Participant planned to travel to abraod|1|||
13287835|NCT00471237|26474566|FG001|Overall Study|Participant planned to travel to abraod|0|||
13287836|NCT00471237|26474567|FG002|Overall Study|Participant planned to travel to abraod|0|||
13287837|NCT00471237|26474568|FG003|Overall Study|Participant planned to travel to abraod|0|||
13287838|NCT00471237|26474569|FG004|Overall Study|Participant planned to travel to abraod|0|||
13287839|NCT00471237|26474570|FG005|Overall Study|Participant planned to travel to abraod|1|||
13287840|NCT00471237|26474571|FG006|Overall Study|Participant planned to travel to abraod|0|||
13122306|NCT02966340|25946666|FG001|Overall Study|startle non-responder|1|||
13122307|NCT02966223|25946674|FG000|Overall Study|Physician Decision|3|||
13287841|NCT00471237|26474565|FG000|Overall Study|High parathyroid hormone|0|||
13287842|NCT00471237|26474566|FG001|Overall Study|High parathyroid hormone|0|||
13287843|NCT00471237|26474567|FG002|Overall Study|High parathyroid hormone|1|||
13287844|NCT00471237|26474568|FG003|Overall Study|High parathyroid hormone|0|||
13287845|NCT00471237|26474569|FG004|Overall Study|High parathyroid hormone|0|||
13325779|NCT01147926|26582760|FG000|Overall Study|Sponsor's Decision|0|||
13325780|NCT01147926|26582761|FG001|Overall Study|Sponsor's Decision|1|||
13325781|NCT01147926|26582760|FG000|Overall Study|Lack of Efficacy|1|||
13325782|NCT01147926|26582761|FG001|Overall Study|Lack of Efficacy|0|||
13287846|NCT00471237|26474570|FG005|Overall Study|High parathyroid hormone|0|||
13287847|NCT00471237|26474571|FG006|Overall Study|High parathyroid hormone|0|||
13287848|NCT00471237|26474565|FG000|Overall Study|Participant lost medication|0|||
13287849|NCT00471237|26474566|FG001|Overall Study|Participant lost medication|0|||
13287850|NCT00471237|26474567|FG002|Overall Study|Participant lost medication|0|||
13287851|NCT00471237|26474568|FG003|Overall Study|Participant lost medication|0|||
13287852|NCT00471237|26474569|FG004|Overall Study|Participant lost medication|1|||
13287853|NCT00471237|26474570|FG005|Overall Study|Participant lost medication|0|||
13287854|NCT00471237|26474571|FG006|Overall Study|Participant lost medication|0|||
13325783|NCT01147926|26582760|FG000|Overall Study|Too busy, no time for study|1|||
13325784|NCT01147926|26582761|FG001|Overall Study|Too busy, no time for study|0|||
13325785|NCT01147926|26582760|FG000|Overall Study|Went on holiday|0|||
13325786|NCT01147926|26582761|FG001|Overall Study|Went on holiday|1|||
13325787|NCT01147926|26582760|FG000|Overall Study|Colonoscopy result|0|||
13325788|NCT01147926|26582761|FG001|Overall Study|Colonoscopy result|1|||
13325789|NCT01147900|26582830|FG000|At Year 10|Lost to Follow-up|0|||
13325790|NCT01147900|26582831|FG001|At Year 10|Lost to Follow-up|1|||
13325791|NCT01147900|26582832|FG002|At Year 10|Lost to Follow-up|0|||
13325792|NCT01147874|26582840|FG000|Overall Study|Adverse Event|5|||
13325793|NCT01147874|26582840|FG000|Overall Study|Investigator's Request|1|||
13325794|NCT01147874|26582840|FG000|Overall Study|Lost to Follow-up|25|||
13325795|NCT01147874|26582840|FG000|Overall Study|Other|5|||
13325796|NCT01147874|26582840|FG000|Overall Study|Protocol Violation|5|||
13325797|NCT01147874|26582840|FG000|Overall Study|Sponsor's Decision|2|||
13325798|NCT01147874|26582840|FG000|Overall Study|Withdrawal by Subject|24|||
13325799|NCT01147848|26582878|FG000|Run-in Period|Screen Failure|623|||
13325800|NCT01147848|26582879|FG001|Run-in Period|Screen Failure|0|||
13325801|NCT01147848|26582880|FG002|Run-in Period|Screen Failure|0|||
13325802|NCT01147848|26582878|FG000|Run-in Period|Run-in Failure|135|||
13325803|NCT01147848|26582879|FG001|Run-in Period|Run-in Failure|0|||
13287855|NCT00471237|26474565|FG000|Overall Study|Administration of prohibited medicine|0|||
13287856|NCT00471237|26474566|FG001|Overall Study|Administration of prohibited medicine|0|||
13287857|NCT00471237|26474567|FG002|Overall Study|Administration of prohibited medicine|0|||
13287858|NCT00471237|26474568|FG003|Overall Study|Administration of prohibited medicine|0|||
13287859|NCT00471237|26474569|FG004|Overall Study|Administration of prohibited medicine|1|||
13287860|NCT00471237|26474570|FG005|Overall Study|Administration of prohibited medicine|0|||
13287861|NCT00471237|26474571|FG006|Overall Study|Administration of prohibited medicine|0|||
13325804|NCT01147848|26582880|FG002|Run-in Period|Run-in Failure|0|||
13325805|NCT01147848|26582878|FG000|Randomized Phase|Adverse Event|0|||
13325806|NCT01147848|26582879|FG001|Randomized Phase|Adverse Event|6|||
13287862|NCT00471237|26474565|FG000|Overall Study|Participant shifted residence|0|||
13287863|NCT00471237|26474566|FG001|Overall Study|Participant shifted residence|0|||
13287864|NCT00471237|26474567|FG002|Overall Study|Participant shifted residence|0|||
13287865|NCT00471237|26474568|FG003|Overall Study|Participant shifted residence|0|||
13287866|NCT00471237|26474569|FG004|Overall Study|Participant shifted residence|1|||
13287867|NCT00471237|26474570|FG005|Overall Study|Participant shifted residence|0|||
13287868|NCT00471237|26474571|FG006|Overall Study|Participant shifted residence|0|||
13287869|NCT00471237|26474565|FG000|Overall Study|Participant's decision|0|||
13287870|NCT00471237|26474566|FG001|Overall Study|Participant's decision|0|||
13287871|NCT00471237|26474567|FG002|Overall Study|Participant's decision|0|||
13287872|NCT00471237|26474568|FG003|Overall Study|Participant's decision|0|||
13287873|NCT00471237|26474569|FG004|Overall Study|Participant's decision|0|||
13287874|NCT00471237|26474570|FG005|Overall Study|Participant's decision|1|||
13287875|NCT00471237|26474571|FG006|Overall Study|Participant's decision|0|||
13287876|NCT00471081|26474615|FG000|Active Phase|Protocol Violation|1|||
13287877|NCT00471081|26474616|FG001|Active Phase|Protocol Violation|1|||
13287878|NCT00471081|26474615|FG000|Active Phase|Withdrawal by Subject|0|||
13287879|NCT00471081|26474616|FG001|Active Phase|Withdrawal by Subject|3|||
13287880|NCT00471081|26474615|FG000|Active Phase|Lost to Follow-up|0|||
13287881|NCT00471081|26474616|FG001|Active Phase|Lost to Follow-up|1|||
13287882|NCT00471081|26474615|FG000|Active Phase|Lost health plan/insurance|1|||
13287883|NCT00471081|26474616|FG001|Active Phase|Lost health plan/insurance|8|||
13287884|NCT00471081|26474615|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1|||
13287885|NCT00471081|26474616|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4|||
13287886|NCT00471081|26474615|FG000|Extended Safety Follow-Up|Lost to Follow-up|1|||
13287887|NCT00471081|26474616|FG001|Extended Safety Follow-Up|Lost to Follow-up|8|||
13287888|NCT00471081|26474615|FG000|Extended Safety Follow-Up|Missing confirmed|0|||
13287889|NCT00471081|26474616|FG001|Extended Safety Follow-Up|Missing confirmed|1|||
13287890|NCT00470847|26474629|FG000|Overall Study|Pt still receiving treatment|1|||
13287891|NCT00470834|26474650|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16|||
13287892|NCT00470834|26474651|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14|||
13287893|NCT00470834|26474650|FG000|Treatment Period (18 Months)|Adverse Event|7|||
13287894|NCT00470834|26474651|FG001|Treatment Period (18 Months)|Adverse Event|6|||
13287895|NCT00470834|26474650|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4|||
13287896|NCT00470834|26474651|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5|||
13287897|NCT00470834|26474650|FG000|Treatment Period (18 Months)|Physician Decision|4|||
13287898|NCT00470834|26474651|FG001|Treatment Period (18 Months)|Physician Decision|4|||
13287899|NCT00470834|26474650|FG000|Treatment Period (18 Months)|Protocol Violation|3|||
13287900|NCT00470834|26474651|FG001|Treatment Period (18 Months)|Protocol Violation|1|||
13287901|NCT00470834|26474650|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
13287902|NCT00470834|26474651|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
13287903|NCT00470834|26474650|FG000|Treatment Period (18 Months)|Lost to Follow-up|1|||
13287904|NCT00470834|26474651|FG001|Treatment Period (18 Months)|Lost to Follow-up|0|||
13325807|NCT01147848|26582880|FG002|Randomized Phase|Adverse Event|8|||
13325808|NCT01147848|26582878|FG000|Randomized Phase|Lack of Efficacy|0|||
13325809|NCT01147848|26582879|FG001|Randomized Phase|Lack of Efficacy|20|||
13325810|NCT01147848|26582880|FG002|Randomized Phase|Lack of Efficacy|11|||
13325811|NCT01147848|26582878|FG000|Randomized Phase|Protocol Violation|0|||
13325812|NCT01147848|26582879|FG001|Randomized Phase|Protocol Violation|7|||
13287905|NCT00470834|26474650|FG000|Treatment Period (18 Months)|Non-compliance|1|||
13287906|NCT00470834|26474651|FG001|Treatment Period (18 Months)|Non-compliance|0|||
13287907|NCT00470834|26474650|FG000|Treatment Period (18 Months)|Lack of Efficacy|1|||
13287908|NCT00470834|26474651|FG001|Treatment Period (18 Months)|Lack of Efficacy|0|||
13287909|NCT00470834|26474650|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6|||
13287910|NCT00470834|26474651|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7|||
13287911|NCT00470834|26474650|FG000|Extension Period (24 Months)|Adverse Event|3|||
13287912|NCT00470834|26474651|FG001|Extension Period (24 Months)|Adverse Event|4|||
13287913|NCT00470834|26474650|FG000|Extension Period (24 Months)|Withdrawal by Subject|2|||
13287914|NCT00470834|26474651|FG001|Extension Period (24 Months)|Withdrawal by Subject|5|||
13287915|NCT00470834|26474650|FG000|Extension Period (24 Months)|Physician Decision|4|||
13287916|NCT00470834|26474651|FG001|Extension Period (24 Months)|Physician Decision|3|||
13287917|NCT00470834|26474650|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0|||
13287918|NCT00470834|26474651|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1|||
13287919|NCT00470834|26474650|FG000|Extension Period (24 Months)|Lost to Follow-up|0|||
13287920|NCT00470834|26474651|FG001|Extension Period (24 Months)|Lost to Follow-up|1|||
13287921|NCT00470834|26474650|FG000|Extension Period (24 Months)|Non-compliance|0|||
13287922|NCT00470834|26474651|FG001|Extension Period (24 Months)|Non-compliance|1|||
13287923|NCT00470834|26474650|FG000|Extension Period (24 Months)|Disease Progression|0|||
13287924|NCT00470834|26474651|FG001|Extension Period (24 Months)|Disease Progression|1|||
13287925|NCT00470704|26474674|FG000|Overall Study|Withdrawal by Subject|4|||
13287926|NCT00470704|26474675|FG001|Overall Study|Withdrawal by Subject|3|||
13287927|NCT00470704|26474674|FG000|Overall Study|Relapse/Progression|37|||
13287928|NCT00470704|26474675|FG001|Overall Study|Relapse/Progression|42|||
13287929|NCT00470704|26474674|FG000|Overall Study|toxicity|0|||
13287930|NCT00470704|26474675|FG001|Overall Study|toxicity|1|||
13287931|NCT00470535|26474686|FG000|Overall Study|Disease Progression|13|||
13287932|NCT00470535|26474686|FG000|Overall Study|Withdrawal by Subject|1|||
13287933|NCT00470535|26474686|FG000|Overall Study|Adverse Event|1|||
13287934|NCT00470535|26474686|FG000|Overall Study|Death|1|||
13287935|NCT00470535|26474686|FG000|Overall Study|Other|2|||
13287936|NCT00470470|26474693|FG000|Overall Study|Adverse Event|2|||
13287937|NCT00470470|26474693|FG000|Overall Study|Death|2|||
13287938|NCT00470470|26474693|FG000|Overall Study|Not treated|1|||
13287939|NCT00470418|26474708|FG000|Overall Study|Withdrawal by Subject|1|||
13287940|NCT00470418|26474709|FG001|Overall Study|Withdrawal by Subject|0|||
13287941|NCT00470366|26474718|FG000|Overall Study|Adverse Event|3|||
13287942|NCT00470366|26474718|FG000|Overall Study|Poor compliance|1|||
13325813|NCT01147848|26582880|FG002|Randomized Phase|Protocol Violation|10|||
13325814|NCT01147848|26582878|FG000|Randomized Phase|Lost to Follow-up|0|||
13325815|NCT01147848|26582879|FG001|Randomized Phase|Lost to Follow-up|5|||
13325816|NCT01147848|26582880|FG002|Randomized Phase|Lost to Follow-up|7|||
13325817|NCT01147848|26582878|FG000|Randomized Phase|Physician Decision|0|||
13325818|NCT01147848|26582879|FG001|Randomized Phase|Physician Decision|0|||
13287943|NCT00470275|26474724|FG000|Overall Study|Death|1|||
13287944|NCT00470275|26474724|FG000|Overall Study|Lack of Efficacy|7|||
13287945|NCT00470275|26474724|FG000|Overall Study|Withdrawal by Subject|2|||
13287946|NCT00470184|26474733|FG000|Overall Study|Not Treated(became ineligible)|4|||
13287947|NCT00470184|26474733|FG000|Overall Study|Not treated (other)|1|||
13287948|NCT00470184|26474733|FG000|Overall Study|disease Progression|4|||
13287949|NCT00470184|26474733|FG000|Overall Study|Adverse Event|3|||
13287950|NCT00470184|26474733|FG000|Overall Study|Withdrawal by Subject|4|||
13287951|NCT00470184|26474733|FG000|Overall Study|other|5|||
13287952|NCT00470184|26474733|FG000|Overall Study|recurrence|1|||
13287953|NCT00470158|26474761|FG000|Overall Study|Death|0|||
13287954|NCT00470158|26474762|FG001|Overall Study|Death|0|||
13287955|NCT00470158|26474763|FG002|Overall Study|Death|0|||
13287956|NCT00470158|26474764|FG003|Overall Study|Death|0|||
13287957|NCT00470158|26474765|FG004|Overall Study|Death|2|||
13287958|NCT00470158|26474761|FG000|Overall Study|Lost to Follow-up|7|||
13287959|NCT00470158|26474762|FG001|Overall Study|Lost to Follow-up|8|||
13287960|NCT00470158|26474763|FG002|Overall Study|Lost to Follow-up|8|||
13287961|NCT00470158|26474764|FG003|Overall Study|Lost to Follow-up|5|||
13287962|NCT00470158|26474765|FG004|Overall Study|Lost to Follow-up|4|||
13287963|NCT00470158|26474761|FG000|Overall Study|Protocol Violation|1|||
13287964|NCT00470158|26474762|FG001|Overall Study|Protocol Violation|0|||
13287965|NCT00470158|26474763|FG002|Overall Study|Protocol Violation|0|||
13287966|NCT00470158|26474764|FG003|Overall Study|Protocol Violation|0|||
13287967|NCT00470158|26474765|FG004|Overall Study|Protocol Violation|0|||
13287968|NCT00470093|26474774|FG000|Overall Study|Adverse Event|2|||
13287969|NCT00470067|26474780|FG000|Overall Study|Death|1|||
13287970|NCT00470067|26474780|FG000|Overall Study|Disease Progression|6|||
13287971|NCT00470054|26474790|FG000|Overall Study|Ineligible|1|||
13287972|NCT00475540|26474805|FG000|36 Months|Lost to Follow-up|4|||
13287973|NCT00475540|26474806|FG001|36 Months|Lost to Follow-up|4|||
13287974|NCT00475540|26474805|FG000|36 Months|Death|1|||
13325819|NCT01147848|26582880|FG002|Randomized Phase|Physician Decision|1|||
13373527|NCT00802672|26724006|FG002|Overall Study|Adverse Event|1|||
13287975|NCT00475540|26474806|FG001|36 Months|Death|2|||
13287976|NCT00475540|26474805|FG000|36 Months|Censored due to reoperation|3|||
13287977|NCT00475540|26474806|FG001|36 Months|Censored due to reoperation|0|||
13287978|NCT00472186|26474821|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1|||
13287979|NCT00472186|26474822|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0|||
13287980|NCT00479713|26474853|FG000|Overall Study|Adverse Event|8|||
13287981|NCT00479713|26474854|FG001|Overall Study|Adverse Event|6|||
13287982|NCT00479713|26474853|FG000|Overall Study|Death|1|||
13287983|NCT00479713|26474854|FG001|Overall Study|Death|0|||
13287984|NCT00479713|26474853|FG000|Overall Study|Lost to Follow-up|0|||
13287985|NCT00479713|26474854|FG001|Overall Study|Lost to Follow-up|1|||
13287986|NCT00479713|26474853|FG000|Overall Study|Protocol Violation|0|||
13287987|NCT00479713|26474854|FG001|Overall Study|Protocol Violation|1|||
13287988|NCT00479713|26474853|FG000|Overall Study|Withdrawal by Subject|4|||
13287989|NCT00479713|26474854|FG001|Overall Study|Withdrawal by Subject|1|||
13287990|NCT00474188|26474863|FG000|Overall Study|Withdrawal by Subject|1|||
13287991|NCT00474188|26474863|FG000|Overall Study|Study discontinued by sponsor|5|||
13287992|NCT00474526|26475076|FG000|Overall Study|ADMINISTRATIVE REASON|11|||
13287993|NCT00474526|26475077|FG001|Overall Study|ADMINISTRATIVE REASON|9|||
13287994|NCT00474526|26475078|FG002|Overall Study|ADMINISTRATIVE REASON|9|||
13325820|NCT01147848|26582878|FG000|Randomized Phase|Withdrawal by Subject|0|||
13325821|NCT01147848|26582879|FG001|Randomized Phase|Withdrawal by Subject|7|||
13325822|NCT01147848|26582880|FG002|Randomized Phase|Withdrawal by Subject|9|||
13325823|NCT01147809|26583013|FG000|Phase I (168 Days)|Adverse Event|0|||
13325824|NCT01147809|26583014|FG001|Phase I (168 Days)|Adverse Event|0|||
13325825|NCT01147809|26583015|FG002|Phase I (168 Days)|Adverse Event|0|||
13325826|NCT01147809|26583016|FG003|Phase I (168 Days)|Adverse Event|1|||
13325827|NCT01147809|26583017|FG004|Phase I (168 Days)|Adverse Event|0|||
13325828|NCT01147809|26583018|FG005|Phase I (168 Days)|Adverse Event|0|||
13325829|NCT01147809|26583013|FG000|Phase I (168 Days)|Lost to Follow-up|1|||
13325830|NCT01147809|26583014|FG001|Phase I (168 Days)|Lost to Follow-up|0|||
13325831|NCT01147809|26583015|FG002|Phase I (168 Days)|Lost to Follow-up|0|||
13325832|NCT01147809|26583016|FG003|Phase I (168 Days)|Lost to Follow-up|1|||
13325833|NCT01147809|26583017|FG004|Phase I (168 Days)|Lost to Follow-up|0|||
13325834|NCT01147809|26583018|FG005|Phase I (168 Days)|Lost to Follow-up|0|||
13325835|NCT01147809|26583013|FG000|Phase I (168 Days)|Physician Decision|0|||
13325836|NCT01147809|26583014|FG001|Phase I (168 Days)|Physician Decision|1|||
13325837|NCT01147809|26583015|FG002|Phase I (168 Days)|Physician Decision|2|||
13325838|NCT01147809|26583016|FG003|Phase I (168 Days)|Physician Decision|0|||
13325839|NCT01147809|26583017|FG004|Phase I (168 Days)|Physician Decision|0|||
13325840|NCT01147809|26583018|FG005|Phase I (168 Days)|Physician Decision|0|||
13325841|NCT01147809|26583013|FG000|Phase I (168 Days)|Withdrawal by Subject|0|||
13325842|NCT01147809|26583014|FG001|Phase I (168 Days)|Withdrawal by Subject|0|||
13287995|NCT00474526|26475079|FG003|Overall Study|ADMINISTRATIVE REASON|20|||
13287996|NCT00474526|26475080|FG004|Overall Study|ADMINISTRATIVE REASON|9|||
13287997|NCT00474526|26475081|FG005|Overall Study|ADMINISTRATIVE REASON|1|||
13287998|NCT00474526|26475082|FG006|Overall Study|ADMINISTRATIVE REASON|1|||
13287999|NCT00474526|26475083|FG007|Overall Study|ADMINISTRATIVE REASON|0|||
13288000|NCT00474526|26475084|FG008|Overall Study|ADMINISTRATIVE REASON|2|||
13288001|NCT00474526|26475085|FG009|Overall Study|ADMINISTRATIVE REASON|1|||
13288002|NCT00474526|26475086|FG010|Overall Study|ADMINISTRATIVE REASON|1|||
13288003|NCT00474526|26475087|FG011|Overall Study|ADMINISTRATIVE REASON|1|||
13288004|NCT00474526|26475088|FG012|Overall Study|ADMINISTRATIVE REASON|1|||
13288005|NCT00474526|26475089|FG013|Overall Study|ADMINISTRATIVE REASON|1|||
13288006|NCT00474526|26475090|FG014|Overall Study|ADMINISTRATIVE REASON|2|||
13288007|NCT00474526|26475091|FG015|Overall Study|ADMINISTRATIVE REASON|0|||
13288008|NCT00474526|26475092|FG016|Overall Study|ADMINISTRATIVE REASON|0|||
13288009|NCT00474526|26475076|FG000|Overall Study|Adverse Event|2|||
13288010|NCT00474526|26475077|FG001|Overall Study|Adverse Event|0|||
13288011|NCT00474526|26475078|FG002|Overall Study|Adverse Event|2|||
13288012|NCT00474526|26475079|FG003|Overall Study|Adverse Event|4|||
13288013|NCT00474526|26475080|FG004|Overall Study|Adverse Event|2|||
13288014|NCT00474526|26475081|FG005|Overall Study|Adverse Event|1|||
13288015|NCT00474526|26475082|FG006|Overall Study|Adverse Event|1|||
13288016|NCT00474526|26475083|FG007|Overall Study|Adverse Event|0|||
13288017|NCT00474526|26475084|FG008|Overall Study|Adverse Event|0|||
13288018|NCT00474526|26475085|FG009|Overall Study|Adverse Event|0|||
13288019|NCT00474526|26475086|FG010|Overall Study|Adverse Event|0|||
13288020|NCT00474526|26475087|FG011|Overall Study|Adverse Event|0|||
13288021|NCT00474526|26475088|FG012|Overall Study|Adverse Event|0|||
13288022|NCT00474526|26475089|FG013|Overall Study|Adverse Event|0|||
13288023|NCT00474526|26475090|FG014|Overall Study|Adverse Event|1|||
13288024|NCT00474526|26475091|FG015|Overall Study|Adverse Event|1|||
13325843|NCT01147809|26583015|FG002|Phase I (168 Days)|Withdrawal by Subject|0|||
13325844|NCT01147809|26583016|FG003|Phase I (168 Days)|Withdrawal by Subject|3|||
13325845|NCT01147809|26583017|FG004|Phase I (168 Days)|Withdrawal by Subject|0|||
13325846|NCT01147809|26583018|FG005|Phase I (168 Days)|Withdrawal by Subject|0|||
13288025|NCT00474526|26475092|FG016|Overall Study|Adverse Event|0|||
13288026|NCT00474526|26475076|FG000|Overall Study|Death|0|||
13288027|NCT00474526|26475077|FG001|Overall Study|Death|0|||
13288028|NCT00474526|26475078|FG002|Overall Study|Death|0|||
13288029|NCT00474526|26475079|FG003|Overall Study|Death|0|||
13288030|NCT00474526|26475080|FG004|Overall Study|Death|0|||
13288031|NCT00474526|26475081|FG005|Overall Study|Death|0|||
13288032|NCT00474526|26475082|FG006|Overall Study|Death|0|||
13288033|NCT00474526|26475083|FG007|Overall Study|Death|0|||
13288034|NCT00474526|26475084|FG008|Overall Study|Death|0|||
13288035|NCT00474526|26475085|FG009|Overall Study|Death|0|||
13288036|NCT00474526|26475086|FG010|Overall Study|Death|0|||
13325847|NCT01147809|26583013|FG000|Phase II (168 Days)|Adverse Event|0|||
13325848|NCT01147809|26583014|FG001|Phase II (168 Days)|Adverse Event|0|||
13325849|NCT01147809|26583015|FG002|Phase II (168 Days)|Adverse Event|0|||
13325850|NCT01147809|26583016|FG003|Phase II (168 Days)|Adverse Event|0|||
13325851|NCT01147809|26583017|FG004|Phase II (168 Days)|Adverse Event|3|||
13325852|NCT01147809|26583018|FG005|Phase II (168 Days)|Adverse Event|6|||
13325853|NCT01147809|26583013|FG000|Phase II (168 Days)|Protocol Violation|0|||
13325854|NCT01147809|26583014|FG001|Phase II (168 Days)|Protocol Violation|0|||
13325855|NCT01147809|26583015|FG002|Phase II (168 Days)|Protocol Violation|0|||
13325856|NCT01147809|26583016|FG003|Phase II (168 Days)|Protocol Violation|0|||
13325857|NCT01147809|26583017|FG004|Phase II (168 Days)|Protocol Violation|0|||
13325858|NCT01147809|26583018|FG005|Phase II (168 Days)|Protocol Violation|1|||
13325859|NCT01147809|26583013|FG000|Phase II (168 Days)|Physician Decision|0|||
13325860|NCT01147809|26583014|FG001|Phase II (168 Days)|Physician Decision|0|||
13325861|NCT01147809|26583015|FG002|Phase II (168 Days)|Physician Decision|0|||
13325862|NCT01147809|26583016|FG003|Phase II (168 Days)|Physician Decision|0|||
13325863|NCT01147809|26583017|FG004|Phase II (168 Days)|Physician Decision|5|||
13325864|NCT01147809|26583018|FG005|Phase II (168 Days)|Physician Decision|11|||
13325865|NCT01147809|26583013|FG000|Phase II (168 Days)|Withdrawal by Subject|0|||
13325866|NCT01147809|26583014|FG001|Phase II (168 Days)|Withdrawal by Subject|0|||
13325867|NCT01147809|26583015|FG002|Phase II (168 Days)|Withdrawal by Subject|0|||
13325868|NCT01147809|26583016|FG003|Phase II (168 Days)|Withdrawal by Subject|0|||
13325869|NCT01147809|26583017|FG004|Phase II (168 Days)|Withdrawal by Subject|7|||
13325870|NCT01147809|26583018|FG005|Phase II (168 Days)|Withdrawal by Subject|15|||
13325871|NCT01147809|26583013|FG000|Phase II (168 Days)|Ongoing|0|||
13325872|NCT01147809|26583014|FG001|Phase II (168 Days)|Ongoing|0|||
13325873|NCT01147809|26583015|FG002|Phase II (168 Days)|Ongoing|0|||
13325874|NCT01147809|26583016|FG003|Phase II (168 Days)|Ongoing|0|||
13325875|NCT01147809|26583017|FG004|Phase II (168 Days)|Ongoing|1|||
13325876|NCT01147809|26583018|FG005|Phase II (168 Days)|Ongoing|0|||
13325877|NCT01147744|26583133|FG000|Overall Study|Protocol Violation|1|||
13325878|NCT01147744|26583134|FG001|Overall Study|Protocol Violation|0|||
13325879|NCT01147744|26583135|FG002|Overall Study|Protocol Violation|1|||
13325880|NCT01147744|26583136|FG003|Overall Study|Protocol Violation|0|||
13325881|NCT01147744|26583137|FG004|Overall Study|Protocol Violation|1|||
13325882|NCT01147744|26583138|FG005|Overall Study|Protocol Violation|3|||
13325883|NCT01147744|26583139|FG006|Overall Study|Protocol Violation|1|||
13325884|NCT01147744|26583133|FG000|Overall Study|Physician Decision|0|||
13325885|NCT01147744|26583134|FG001|Overall Study|Physician Decision|1|||
13325886|NCT01147744|26583135|FG002|Overall Study|Physician Decision|1|||
13325887|NCT01147744|26583136|FG003|Overall Study|Physician Decision|0|||
13325888|NCT01147744|26583137|FG004|Overall Study|Physician Decision|0|||
13325889|NCT01147744|26583138|FG005|Overall Study|Physician Decision|0|||
13325890|NCT01147744|26583139|FG006|Overall Study|Physician Decision|1|||
13325891|NCT01147744|26583133|FG000|Overall Study|Lack of Efficacy|11|||
13325892|NCT01147744|26583134|FG001|Overall Study|Lack of Efficacy|11|||
13325893|NCT01147744|26583135|FG002|Overall Study|Lack of Efficacy|9|||
13325894|NCT01147744|26583136|FG003|Overall Study|Lack of Efficacy|11|||
13325895|NCT01147744|26583137|FG004|Overall Study|Lack of Efficacy|13|||
13325896|NCT01147744|26583138|FG005|Overall Study|Lack of Efficacy|8|||
13325897|NCT01147744|26583139|FG006|Overall Study|Lack of Efficacy|7|||
13325898|NCT01147744|26583133|FG000|Overall Study|Adverse Event|1|||
13288037|NCT00474526|26475087|FG011|Overall Study|Death|0|||
13288038|NCT00474526|26475088|FG012|Overall Study|Death|0|||
13288039|NCT00474526|26475089|FG013|Overall Study|Death|3|||
13288040|NCT00474526|26475090|FG014|Overall Study|Death|0|||
13288041|NCT00474526|26475091|FG015|Overall Study|Death|0|||
13288042|NCT00474526|26475092|FG016|Overall Study|Death|0|||
13288043|NCT00474526|26475076|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
13288044|NCT00474526|26475077|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
13288045|NCT00474526|26475078|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
13325899|NCT01147744|26583134|FG001|Overall Study|Adverse Event|2|||
13325900|NCT01147744|26583135|FG002|Overall Study|Adverse Event|3|||
13325901|NCT01147744|26583136|FG003|Overall Study|Adverse Event|0|||
13325902|NCT01147744|26583137|FG004|Overall Study|Adverse Event|2|||
13325903|NCT01147744|26583138|FG005|Overall Study|Adverse Event|1|||
13288046|NCT00474526|26475079|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
13288047|NCT00474526|26475080|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
13325904|NCT01147744|26583139|FG006|Overall Study|Adverse Event|2|||
13288048|NCT00474526|26475081|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
13288049|NCT00474526|26475082|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
13288050|NCT00474526|26475083|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
13288051|NCT00474526|26475084|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
13288052|NCT00474526|26475085|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
13288053|NCT00474526|26475086|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
13288054|NCT00474526|26475087|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
13288055|NCT00474526|26475088|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
13288056|NCT00474526|26475089|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
13288057|NCT00474526|26475090|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
13288058|NCT00474526|26475091|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
13288059|NCT00474526|26475092|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
13288060|NCT00474526|26475076|FG000|Overall Study|Lost to Follow-up|8|||
13288061|NCT00474526|26475077|FG001|Overall Study|Lost to Follow-up|6|||
13288062|NCT00474526|26475078|FG002|Overall Study|Lost to Follow-up|13|||
13288063|NCT00474526|26475079|FG003|Overall Study|Lost to Follow-up|29|||
13288064|NCT00474526|26475080|FG004|Overall Study|Lost to Follow-up|11|||
13288065|NCT00474526|26475081|FG005|Overall Study|Lost to Follow-up|5|||
13288066|NCT00474526|26475082|FG006|Overall Study|Lost to Follow-up|8|||
13288067|NCT00474526|26475083|FG007|Overall Study|Lost to Follow-up|1|||
13288068|NCT00474526|26475084|FG008|Overall Study|Lost to Follow-up|0|||
13288069|NCT00474526|26475085|FG009|Overall Study|Lost to Follow-up|6|||
13288070|NCT00474526|26475086|FG010|Overall Study|Lost to Follow-up|2|||
13288071|NCT00474526|26475087|FG011|Overall Study|Lost to Follow-up|4|||
13288072|NCT00474526|26475088|FG012|Overall Study|Lost to Follow-up|6|||
13288073|NCT00474526|26475089|FG013|Overall Study|Lost to Follow-up|74|||
13288074|NCT00474526|26475090|FG014|Overall Study|Lost to Follow-up|29|||
13288075|NCT00474526|26475091|FG015|Overall Study|Lost to Follow-up|4|||
13288076|NCT00474526|26475092|FG016|Overall Study|Lost to Follow-up|5|||
13288077|NCT00474526|26475076|FG000|Overall Study|Protocol Violation|2|||
13288078|NCT00474526|26475077|FG001|Overall Study|Protocol Violation|6|||
13288079|NCT00474526|26475078|FG002|Overall Study|Protocol Violation|4|||
13288080|NCT00474526|26475079|FG003|Overall Study|Protocol Violation|12|||
13288081|NCT00474526|26475080|FG004|Overall Study|Protocol Violation|3|||
13288082|NCT00474526|26475081|FG005|Overall Study|Protocol Violation|1|||
13288083|NCT00474526|26475082|FG006|Overall Study|Protocol Violation|3|||
13288084|NCT00474526|26475083|FG007|Overall Study|Protocol Violation|0|||
13288085|NCT00474526|26475084|FG008|Overall Study|Protocol Violation|0|||
13288086|NCT00474526|26475085|FG009|Overall Study|Protocol Violation|4|||
13288087|NCT00474526|26475086|FG010|Overall Study|Protocol Violation|2|||
13288088|NCT00474526|26475087|FG011|Overall Study|Protocol Violation|2|||
13288089|NCT00474526|26475088|FG012|Overall Study|Protocol Violation|4|||
13288090|NCT00474526|26475089|FG013|Overall Study|Protocol Violation|19|||
13288091|NCT00474526|26475090|FG014|Overall Study|Protocol Violation|9|||
13288092|NCT00474526|26475091|FG015|Overall Study|Protocol Violation|6|||
13288093|NCT00474526|26475092|FG016|Overall Study|Protocol Violation|2|||
13288094|NCT00474526|26475076|FG000|Overall Study|UNABLE TO CLASSIFY|1|||
13288095|NCT00474526|26475077|FG001|Overall Study|UNABLE TO CLASSIFY|0|||
13288096|NCT00474526|26475078|FG002|Overall Study|UNABLE TO CLASSIFY|0|||
13288097|NCT00474526|26475079|FG003|Overall Study|UNABLE TO CLASSIFY|1|||
13288098|NCT00474526|26475080|FG004|Overall Study|UNABLE TO CLASSIFY|3|||
13288099|NCT00474526|26475081|FG005|Overall Study|UNABLE TO CLASSIFY|2|||
13288100|NCT00474526|26475082|FG006|Overall Study|UNABLE TO CLASSIFY|0|||
13288101|NCT00474526|26475083|FG007|Overall Study|UNABLE TO CLASSIFY|1|||
13288102|NCT00474526|26475084|FG008|Overall Study|UNABLE TO CLASSIFY|0|||
13288103|NCT00474526|26475085|FG009|Overall Study|UNABLE TO CLASSIFY|3|||
13288104|NCT00474526|26475086|FG010|Overall Study|UNABLE TO CLASSIFY|0|||
13288105|NCT00474526|26475087|FG011|Overall Study|UNABLE TO CLASSIFY|0|||
13288106|NCT00474526|26475088|FG012|Overall Study|UNABLE TO CLASSIFY|0|||
13288107|NCT00474526|26475089|FG013|Overall Study|UNABLE TO CLASSIFY|20|||
13288108|NCT00474526|26475090|FG014|Overall Study|UNABLE TO CLASSIFY|12|||
13288109|NCT00474526|26475091|FG015|Overall Study|UNABLE TO CLASSIFY|6|||
13288110|NCT00474526|26475092|FG016|Overall Study|UNABLE TO CLASSIFY|1|||
13288111|NCT00474526|26475076|FG000|Overall Study|Withdrawal by Subject|9|||
13288112|NCT00474526|26475077|FG001|Overall Study|Withdrawal by Subject|24|||
13288113|NCT00474526|26475078|FG002|Overall Study|Withdrawal by Subject|21|||
13288114|NCT00474526|26475079|FG003|Overall Study|Withdrawal by Subject|52|||
13288115|NCT00474526|26475080|FG004|Overall Study|Withdrawal by Subject|38|||
13288116|NCT00474526|26475081|FG005|Overall Study|Withdrawal by Subject|6|||
13288117|NCT00474526|26475082|FG006|Overall Study|Withdrawal by Subject|12|||
13288118|NCT00474526|26475083|FG007|Overall Study|Withdrawal by Subject|4|||
13288119|NCT00474526|26475084|FG008|Overall Study|Withdrawal by Subject|4|||
13288120|NCT00474526|26475085|FG009|Overall Study|Withdrawal by Subject|13|||
13288121|NCT00474526|26475086|FG010|Overall Study|Withdrawal by Subject|5|||
13288122|NCT00474526|26475087|FG011|Overall Study|Withdrawal by Subject|4|||
13288123|NCT00474526|26475088|FG012|Overall Study|Withdrawal by Subject|4|||
13288124|NCT00474526|26475089|FG013|Overall Study|Withdrawal by Subject|37|||
13288125|NCT00474526|26475090|FG014|Overall Study|Withdrawal by Subject|22|||
13288126|NCT00474526|26475091|FG015|Overall Study|Withdrawal by Subject|1|||
13288127|NCT00474526|26475092|FG016|Overall Study|Withdrawal by Subject|1|||
13288128|NCT00478426|26475102|FG000|Overall Study|Withdrawal by Subject|1|||
13288129|NCT00475982|26475127|FG000|Overall Study|surgery rescheduled|7|||
13288130|NCT00475982|26475128|FG001|Overall Study|surgery rescheduled|3|||
13288131|NCT00475020|26475135|FG000|Overall Study|Physician Decision|3|||
13288132|NCT00475020|26475135|FG000|Overall Study|Insurance Denial|1|||
13288133|NCT00475020|26475135|FG000|Overall Study|Donor not able to donate the last minute|1|||
13288134|NCT00477412|26475158|FG000|Overall Study|Death|0|||
13288135|NCT00477412|26475159|FG001|Overall Study|Death|0|||
13288136|NCT00477412|26475160|FG002|Overall Study|Death|0|||
13288137|NCT00477412|26475161|FG003|Overall Study|Death|4|||
13288138|NCT00477412|26475158|FG000|Overall Study|Lost to Follow-up|0|||
13288139|NCT00477412|26475159|FG001|Overall Study|Lost to Follow-up|0|||
13288140|NCT00477412|26475160|FG002|Overall Study|Lost to Follow-up|0|||
13288141|NCT00477412|26475161|FG003|Overall Study|Lost to Follow-up|1|||
13288142|NCT00477412|26475158|FG000|Overall Study|Withdrawal by Subject|0|||
13288143|NCT00477412|26475159|FG001|Overall Study|Withdrawal by Subject|0|||
13288144|NCT00477412|26475160|FG002|Overall Study|Withdrawal by Subject|0|||
13288145|NCT00477412|26475161|FG003|Overall Study|Withdrawal by Subject|2|||
13288146|NCT00477412|26475158|FG000|Overall Study|Second Malignancy|0|||
13288147|NCT00477412|26475159|FG001|Overall Study|Second Malignancy|0|||
13288148|NCT00477412|26475160|FG002|Overall Study|Second Malignancy|0|||
13325905|NCT01147744|26583133|FG000|Overall Study|Withdrawal by Subject|8|||
13325906|NCT01147744|26583134|FG001|Overall Study|Withdrawal by Subject|4|||
13325907|NCT01147744|26583135|FG002|Overall Study|Withdrawal by Subject|2|||
13325908|NCT01147744|26583136|FG003|Overall Study|Withdrawal by Subject|2|||
13325909|NCT01147744|26583137|FG004|Overall Study|Withdrawal by Subject|2|||
13325910|NCT01147744|26583138|FG005|Overall Study|Withdrawal by Subject|5|||
13325911|NCT01147744|26583139|FG006|Overall Study|Withdrawal by Subject|2|||
13325912|NCT01147744|26583133|FG000|Overall Study|Lost to Follow-up|0|||
13325913|NCT01147744|26583134|FG001|Overall Study|Lost to Follow-up|1|||
13325914|NCT01147744|26583135|FG002|Overall Study|Lost to Follow-up|0|||
13325915|NCT01147744|26583136|FG003|Overall Study|Lost to Follow-up|0|||
13325916|NCT01147744|26583137|FG004|Overall Study|Lost to Follow-up|0|||
13288149|NCT00477412|26475161|FG003|Overall Study|Second Malignancy|1|||
13288150|NCT00477412|26475158|FG000|Overall Study|Adverse Event|1|||
13288151|NCT00477412|26475159|FG001|Overall Study|Adverse Event|0|||
13288152|NCT00477412|26475160|FG002|Overall Study|Adverse Event|1|||
13288153|NCT00477412|26475161|FG003|Overall Study|Adverse Event|0|||
13288154|NCT01089647|26475174|FG000|Overall Study|Lost to Follow-up|2|||
13288155|NCT01089647|26475175|FG001|Overall Study|Lost to Follow-up|2|||
13288156|NCT01089647|26475174|FG000|Overall Study|Withdrawal by Subject|2|||
13288157|NCT01089647|26475175|FG001|Overall Study|Withdrawal by Subject|1|||
13288158|NCT01089647|26475174|FG000|Overall Study|Adverse Event|0|||
13288159|NCT01089647|26475175|FG001|Overall Study|Adverse Event|1|||
13288160|NCT01089608|26475188|FG000|Overall Study|Adverse Event|0|||
13288161|NCT01089608|26475189|FG001|Overall Study|Adverse Event|4|||
13288162|NCT01089608|26475188|FG000|Overall Study|Lost to Follow-up|0|||
13288163|NCT01089608|26475189|FG001|Overall Study|Lost to Follow-up|2|||
13325917|NCT01147744|26583138|FG005|Overall Study|Lost to Follow-up|0|||
13325918|NCT01147744|26583139|FG006|Overall Study|Lost to Follow-up|0|||
13325919|NCT01147744|26583133|FG000|Overall Study|Sponsor decision to amend protocol|7|||
13325920|NCT01147744|26583134|FG001|Overall Study|Sponsor decision to amend protocol|4|||
13325921|NCT01147744|26583135|FG002|Overall Study|Sponsor decision to amend protocol|2|||
13325922|NCT01147744|26583136|FG003|Overall Study|Sponsor decision to amend protocol|5|||
13325923|NCT01147744|26583137|FG004|Overall Study|Sponsor decision to amend protocol|7|||
13325924|NCT01147744|26583138|FG005|Overall Study|Sponsor decision to amend protocol|2|||
13325925|NCT01147744|26583139|FG006|Overall Study|Sponsor decision to amend protocol|6|||
13325926|NCT01147744|26583133|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
13325927|NCT01147744|26583134|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
13325928|NCT01147744|26583135|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0|||
13325929|NCT01147744|26583136|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0|||
13325930|NCT01147744|26583137|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0|||
13325931|NCT01147744|26583138|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1|||
13325932|NCT01147744|26583139|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0|||
13325933|NCT01147640|26583154|FG000|Overall Study|Adverse Event|2|||
13325934|NCT01147640|26583155|FG001|Overall Study|Adverse Event|0|||
13325935|NCT01147640|26583154|FG000|Overall Study|Physician Decision|1|||
13325936|NCT01147640|26583155|FG001|Overall Study|Physician Decision|0|||
13325937|NCT01147640|26583154|FG000|Overall Study|Withdrawal by Subject|1|||
13325938|NCT01147640|26583155|FG001|Overall Study|Withdrawal by Subject|0|||
13325939|NCT01147640|26583154|FG000|Overall Study|Lost to Follow-up|0|||
13325940|NCT01147640|26583155|FG001|Overall Study|Lost to Follow-up|1|||
13325941|NCT01147640|26583154|FG000|Overall Study|Didn't meet eligibility criteria|1|||
13325942|NCT01147640|26583155|FG001|Overall Study|Didn't meet eligibility criteria|0|||
13325943|NCT01147536|26583161|FG000|Overall Study|Administrative study close|2|||
13292264|NCT00706914|26485083|FG002|Overall Study|Protocol Violation|1|||
13325944|NCT01147536|26583161|FG000|Overall Study|Death|1|||
13325945|NCT01147497|26583186|FG000|Overall Study|failed insertion|2|||
13325946|NCT01147497|26583187|FG001|Overall Study|failed insertion|0|||
13325947|NCT01147471|26583208|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0|||
13325948|NCT01147471|26583209|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1|||
13325949|NCT01147471|26583208|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0|||
13325950|NCT01147471|26583209|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1|||
13325951|NCT01147471|26583208|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0|||
13325952|NCT01147471|26583209|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1|||
13288164|NCT01089556|26475270|FG000|Study Period II (Weeks 1-8)|Adverse Event|35|||
13288165|NCT01089556|26475271|FG001|Study Period II (Weeks 1-8)|Adverse Event|39|||
13288166|NCT01089556|26475272|FG002|Study Period II (Weeks 1-8)|Adverse Event|0|||
13288167|NCT01089556|26475273|FG003|Study Period II (Weeks 1-8)|Adverse Event|0|||
13288168|NCT01089556|26475274|FG004|Study Period II (Weeks 1-8)|Adverse Event|0|||
13288169|NCT01089556|26475275|FG005|Study Period II (Weeks 1-8)|Adverse Event|0|||
13288170|NCT01089556|26475270|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12|||
13288171|NCT01089556|26475271|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8|||
13288172|NCT01089556|26475272|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
13288173|NCT01089556|26475273|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
13288174|NCT01089556|26475274|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
13288175|NCT01089556|26475275|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
13288176|NCT01089556|26475270|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1|||
13288177|NCT01089556|26475271|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2|||
13288178|NCT01089556|26475272|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
13288179|NCT01089556|26475273|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
13288180|NCT01089556|26475274|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
13288181|NCT01089556|26475275|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
13288182|NCT01089556|26475270|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
13288183|NCT01089556|26475271|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3|||
13288184|NCT01089556|26475272|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
13288185|NCT01089556|26475273|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
13288186|NCT01089556|26475274|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
13288187|NCT01089556|26475275|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
13288188|NCT01089556|26475270|FG000|Study Period II (Weeks 1-8)|Physician Decision|4|||
13288189|NCT01089556|26475271|FG001|Study Period II (Weeks 1-8)|Physician Decision|0|||
13288190|NCT01089556|26475272|FG002|Study Period II (Weeks 1-8)|Physician Decision|0|||
13288191|NCT01089556|26475273|FG003|Study Period II (Weeks 1-8)|Physician Decision|0|||
13288192|NCT01089556|26475274|FG004|Study Period II (Weeks 1-8)|Physician Decision|0|||
13288193|NCT01089556|26475275|FG005|Study Period II (Weeks 1-8)|Physician Decision|0|||
13288194|NCT01089556|26475270|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4|||
13288195|NCT01089556|26475271|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4|||
13288196|NCT01089556|26475272|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0|||
13288197|NCT01089556|26475273|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0|||
13288198|NCT01089556|26475274|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0|||
13288199|NCT01089556|26475275|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0|||
13288200|NCT01089556|26475270|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12|||
13325953|NCT01147471|26583208|FG000|3 Month Follow Up|Lost to Follow-up|1|||
13325954|NCT01147471|26583209|FG001|3 Month Follow Up|Lost to Follow-up|1|||
13325955|NCT01147471|26583208|FG000|3 Month Follow Up|Physician Decision|0|||
13325956|NCT01147471|26583209|FG001|3 Month Follow Up|Physician Decision|1|||
13325957|NCT01147471|26583208|FG000|6 Month Follow Up|Lost to Follow-up|4|||
13288201|NCT01089556|26475271|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14|||
13288202|NCT01089556|26475272|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
13325958|NCT01147471|26583209|FG001|6 Month Follow Up|Lost to Follow-up|2|||
13325959|NCT01147458|26583262|FG000|First Intervention|Study terminated by sponsor|8|||
13325960|NCT01147458|26583263|FG001|First Intervention|Study terminated by sponsor|8|||
13325961|NCT01147458|26583264|FG002|First Intervention|Study terminated by sponsor|7|||
13325962|NCT01147458|26583265|FG003|First Intervention|Study terminated by sponsor|8|||
13325963|NCT01147458|26583262|FG000|First Intervention|Protocol Violation|2|||
13325964|NCT01147458|26583263|FG001|First Intervention|Protocol Violation|3|||
13325965|NCT01147458|26583264|FG002|First Intervention|Protocol Violation|2|||
13325966|NCT01147458|26583265|FG003|First Intervention|Protocol Violation|3|||
13325967|NCT01147458|26583262|FG000|First Intervention|Withdrawal by Subject|3|||
13325968|NCT01147458|26583263|FG001|First Intervention|Withdrawal by Subject|0|||
13325969|NCT01147458|26583264|FG002|First Intervention|Withdrawal by Subject|1|||
13325970|NCT01147458|26583265|FG003|First Intervention|Withdrawal by Subject|0|||
13325971|NCT01147458|26583262|FG000|First Intervention|Adverse Event|0|||
13325972|NCT01147458|26583263|FG001|First Intervention|Adverse Event|3|||
13325973|NCT01147458|26583264|FG002|First Intervention|Adverse Event|2|||
13325974|NCT01147458|26583265|FG003|First Intervention|Adverse Event|3|||
13325975|NCT01147458|26583262|FG000|First Intervention|Other|1|||
13325976|NCT01147458|26583263|FG001|First Intervention|Other|2|||
13325977|NCT01147458|26583264|FG002|First Intervention|Other|0|||
13325978|NCT01147458|26583265|FG003|First Intervention|Other|0|||
13325979|NCT01147458|26583262|FG000|Second Intervention|Study terminated by sponsor|7|||
13325980|NCT01147458|26583263|FG001|Second Intervention|Study terminated by sponsor|5|||
13325981|NCT01147458|26583264|FG002|Second Intervention|Study terminated by sponsor|5|||
13325982|NCT01147458|26583265|FG003|Second Intervention|Study terminated by sponsor|3|||
13325983|NCT01147458|26583262|FG000|Second Intervention|Protocol Violation|0|||
13325984|NCT01147458|26583263|FG001|Second Intervention|Protocol Violation|1|||
13325985|NCT01147458|26583264|FG002|Second Intervention|Protocol Violation|1|||
13325986|NCT01147458|26583265|FG003|Second Intervention|Protocol Violation|0|||
13325987|NCT01147458|26583262|FG000|Second Intervention|Withdrawal by Subject|0|||
13325988|NCT01147458|26583263|FG001|Second Intervention|Withdrawal by Subject|1|||
13325989|NCT01147458|26583264|FG002|Second Intervention|Withdrawal by Subject|0|||
13325990|NCT01147458|26583265|FG003|Second Intervention|Withdrawal by Subject|0|||
13325991|NCT01147458|26583262|FG000|Second Intervention|Adverse Event|2|||
13325992|NCT01147458|26583263|FG001|Second Intervention|Adverse Event|0|||
13325993|NCT01147458|26583264|FG002|Second Intervention|Adverse Event|1|||
13325994|NCT01147458|26583265|FG003|Second Intervention|Adverse Event|1|||
13325995|NCT01147458|26583262|FG000|Second Intervention|Other|0|||
13325996|NCT01147458|26583263|FG001|Second Intervention|Other|0|||
13325997|NCT01147458|26583264|FG002|Second Intervention|Other|1|||
13325998|NCT01147458|26583265|FG003|Second Intervention|Other|0|||
13325999|NCT01147393|26583275|FG000|Dose Level 1|Dose limiting Toxicity|2|||
13326000|NCT01147393|26583275|FG000|Dose Level -1|Dose Limited Toxicity|1|||
13326001|NCT01147341|26583310|FG000|Double Blind Period|Lack of Efficacy|1|||
13326002|NCT01147341|26583311|FG001|Double Blind Period|Lack of Efficacy|1|||
13326003|NCT01147341|26583310|FG000|Double Blind Period|Withdrawal by Subject|0|||
13326004|NCT01147341|26583311|FG001|Double Blind Period|Withdrawal by Subject|1|||
13326005|NCT01147341|26583310|FG000|Open Label Period|Lack of Efficacy|3|||
13326006|NCT01147341|26583311|FG001|Open Label Period|Lack of Efficacy|0|||
13326007|NCT01147341|26583310|FG000|Open Label Period|Subject moved|1|||
13326008|NCT01147341|26583311|FG001|Open Label Period|Subject moved|0|||
13326009|NCT01147250|26583330|FG000|Overall Study|Lost to Follow-up|14|||
13326010|NCT01147250|26583331|FG001|Overall Study|Lost to Follow-up|11|||
13326011|NCT01147250|26583330|FG000|Overall Study|Withdrawal by Subject|83|||
13326012|NCT01147250|26583331|FG001|Overall Study|Withdrawal by Subject|88|||
13326013|NCT01147250|26583330|FG000|Overall Study|Site termination by sponsor|13|||
13326014|NCT01147250|26583331|FG001|Overall Study|Site termination by sponsor|5|||
13326015|NCT01147250|26583330|FG000|Overall Study|Other than specified|0|||
13326016|NCT01147250|26583331|FG001|Overall Study|Other than specified|1|||
13326017|NCT01147172|26583344|FG000|Overall Study|Withdrawal by Subject|2|||
13326018|NCT01147172|26583344|FG000|Overall Study|Lost to Follow-up|2|||
13326019|NCT01147107|26583357|FG000|Overall Study|Lack of Efficacy|5|||
13326020|NCT01147107|26583358|FG001|Overall Study|Lack of Efficacy|0|||
13326021|NCT01147107|26583357|FG000|Overall Study|Withdrawal by Subject|1|||
13326022|NCT01147107|26583358|FG001|Overall Study|Withdrawal by Subject|1|||
13326023|NCT01147068|26583410|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
13326024|NCT01147068|26583411|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
13326025|NCT01147068|26583412|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
13326026|NCT01147068|26583413|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
13326027|NCT01147068|26583414|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
13326028|NCT01147068|26583415|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
13326029|NCT01147068|26583416|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
13326030|NCT01147068|26583410|FG000|Subjects That Received 2nd Dose|Ineligible|0|||
13326031|NCT01147068|26583411|FG001|Subjects That Received 2nd Dose|Ineligible|1|||
13326032|NCT01147068|26583412|FG002|Subjects That Received 2nd Dose|Ineligible|0|||
13326033|NCT01147068|26583413|FG003|Subjects That Received 2nd Dose|Ineligible|0|||
13326034|NCT01147068|26583414|FG004|Subjects That Received 2nd Dose|Ineligible|0|||
13326035|NCT01147068|26583415|FG005|Subjects That Received 2nd Dose|Ineligible|0|||
13326036|NCT01147068|26583416|FG006|Subjects That Received 2nd Dose|Ineligible|0|||
13326037|NCT01147068|26583410|FG000|Subjects That Received 2nd Dose|Did not complete the study|0|||
13326038|NCT01147068|26583411|FG001|Subjects That Received 2nd Dose|Did not complete the study|1|||
13326039|NCT01147068|26583412|FG002|Subjects That Received 2nd Dose|Did not complete the study|0|||
13326040|NCT01147068|26583413|FG003|Subjects That Received 2nd Dose|Did not complete the study|0|||
13326041|NCT01147068|26583414|FG004|Subjects That Received 2nd Dose|Did not complete the study|0|||
13326042|NCT01147068|26583415|FG005|Subjects That Received 2nd Dose|Did not complete the study|1|||
13326043|NCT01147068|26583416|FG006|Subjects That Received 2nd Dose|Did not complete the study|0|||
13326044|NCT01147068|26583410|FG000|Subjects That Received 2nd Dose|Other|0|||
13326045|NCT01147068|26583411|FG001|Subjects That Received 2nd Dose|Other|3|||
13326046|NCT01147068|26583412|FG002|Subjects That Received 2nd Dose|Other|3|||
13326047|NCT01147068|26583413|FG003|Subjects That Received 2nd Dose|Other|0|||
13326048|NCT01147068|26583414|FG004|Subjects That Received 2nd Dose|Other|1|||
13326049|NCT01147068|26583415|FG005|Subjects That Received 2nd Dose|Other|0|||
13326050|NCT01147068|26583416|FG006|Subjects That Received 2nd Dose|Other|0|||
13326051|NCT01147068|26583410|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
13326052|NCT01147068|26583411|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
13326053|NCT01147068|26583412|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
13326054|NCT01147068|26583413|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
13326055|NCT01147068|26583414|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
13326056|NCT01147068|26583415|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
13326057|NCT01147068|26583416|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
13326058|NCT01147068|26583410|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
13326059|NCT01147068|26583411|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
13326060|NCT01147068|26583412|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
13326061|NCT01147068|26583413|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2|||
13326062|NCT01147068|26583414|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
13326063|NCT01147068|26583415|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
13326064|NCT01147068|26583416|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
13326065|NCT01147068|26583410|FG000|Subjects That Completed Safety Follow-up|Ineligible|0|||
13326066|NCT01147068|26583411|FG001|Subjects That Completed Safety Follow-up|Ineligible|1|||
13326067|NCT01147068|26583412|FG002|Subjects That Completed Safety Follow-up|Ineligible|0|||
13326068|NCT01147068|26583413|FG003|Subjects That Completed Safety Follow-up|Ineligible|0|||
13326069|NCT01147068|26583414|FG004|Subjects That Completed Safety Follow-up|Ineligible|0|||
13326070|NCT01147068|26583415|FG005|Subjects That Completed Safety Follow-up|Ineligible|0|||
13326071|NCT01147068|26583416|FG006|Subjects That Completed Safety Follow-up|Ineligible|0|||
13326072|NCT01147055|26583451|FG000|First Intervention Period|Lost to Follow-up|1|||
13326073|NCT01147055|26583452|FG001|First Intervention Period|Lost to Follow-up|0|||
13326074|NCT01146951|26583473|FG000|Overall Study|Adverse Event|4|||
13326075|NCT01146951|26583474|FG001|Overall Study|Adverse Event|1|||
13326076|NCT01146912|26583517|FG000|Overall Study|Already received influenza vaccination|817|||
13326077|NCT01146912|26583518|FG001|Overall Study|Already received influenza vaccination|822|||
13326078|NCT01146912|26583519|FG002|Overall Study|Already received influenza vaccination|13|||
13326079|NCT01146912|26583520|FG003|Overall Study|Already received influenza vaccination|15|||
13326080|NCT01146912|26583521|FG004|Overall Study|Already received influenza vaccination|41|||
13326081|NCT01146912|26583522|FG005|Overall Study|Already received influenza vaccination|61|||
13326082|NCT01146912|26583523|FG006|Overall Study|Already received influenza vaccination|56|||
13326083|NCT01146912|26583524|FG007|Overall Study|Already received influenza vaccination|0|||
13326084|NCT01146912|26583517|FG000|Overall Study|< 14 weeks gestational age|0|||
13326085|NCT01146912|26583518|FG001|Overall Study|< 14 weeks gestational age|0|||
13326086|NCT01146912|26583519|FG002|Overall Study|< 14 weeks gestational age|3|||
13326087|NCT01146912|26583520|FG003|Overall Study|< 14 weeks gestational age|2|||
13326088|NCT01146912|26583521|FG004|Overall Study|< 14 weeks gestational age|0|||
13326089|NCT01146912|26583522|FG005|Overall Study|< 14 weeks gestational age|0|||
13326090|NCT01146912|26583523|FG006|Overall Study|< 14 weeks gestational age|0|||
13326091|NCT01146912|26583524|FG007|Overall Study|< 14 weeks gestational age|0|||
13326092|NCT01146912|26583517|FG000|Overall Study|Duplicate patient|0|||
13326093|NCT01146912|26583518|FG001|Overall Study|Duplicate patient|0|||
13326094|NCT01146912|26583519|FG002|Overall Study|Duplicate patient|1|||
13326095|NCT01146912|26583520|FG003|Overall Study|Duplicate patient|0|||
13326096|NCT01146912|26583521|FG004|Overall Study|Duplicate patient|0|||
13326097|NCT01146912|26583522|FG005|Overall Study|Duplicate patient|0|||
13326098|NCT01146912|26583523|FG006|Overall Study|Duplicate patient|0|||
13326099|NCT01146912|26583524|FG007|Overall Study|Duplicate patient|0|||
13326100|NCT01146873|26583545|FG000|Overall Study|Transfer out|0|||
13326101|NCT01146873|26583546|FG001|Overall Study|Transfer out|6|||
13326102|NCT01146860|26583567|FG000|Overall Study|Withdrawal by Subject|0|||
13326103|NCT01146860|26583568|FG001|Overall Study|Withdrawal by Subject|1|||
13326104|NCT01146795|26583577|FG000|Overall Study|Withdrawal by Subject|4|||
13326105|NCT01146795|26583577|FG000|Overall Study|Adverse Event|6|||
13326106|NCT01146795|26583577|FG000|Overall Study|Still in treatment at study closure|10|||
13326107|NCT01146782|26583586|FG000|Screening Cohort|Screen Failure|187|||
13326108|NCT01146782|26583586|FG000|Screening Cohort|Lost to Follow-up|4|||
13326109|NCT01146782|26583586|FG000|Screening Cohort|Physician Decision|1|||
13326110|NCT01146782|26583586|FG000|Screening Cohort|Withdrawal by Subject|29|||
13326111|NCT01146782|26583586|FG000|Safety Cohort|Screen Failure|61|||
13326112|NCT01146782|26583586|FG000|Safety Cohort|Withdrawal by Subject|4|||
13326113|NCT01146782|26583586|FG000|Safety Cohort|Control AHI <5|4|||
13326114|NCT01146782|26583586|FG000|Safety Cohort|TST <4 hrs|14|||
13326115|NCT01146782|26583586|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5|||
13326116|NCT01146782|26583586|FG000|Primary Endpoint Cohort|Physician Decision|1|||
13326117|NCT01146665|26583623|FG000|Overall Study|Withdrawal by Subject|10|||
13326118|NCT01146665|26583624|FG001|Overall Study|Withdrawal by Subject|16|||
13326119|NCT01146652|26583698|FG000|Overall Study|Adverse Event|506|||
13326120|NCT01146652|26583699|FG001|Overall Study|Adverse Event|15|||
13326121|NCT01146652|26583698|FG000|Overall Study|Lack of Efficacy|91|||
13326122|NCT01146652|26583699|FG001|Overall Study|Lack of Efficacy|7|||
13326123|NCT01146652|26583698|FG000|Overall Study|Poor compliance to protocol|38|||
13326124|NCT01146652|26583699|FG001|Overall Study|Poor compliance to protocol|1|||
13326125|NCT01146652|26583698|FG000|Overall Study|Other unspecified reasons|314|||
13326126|NCT01146652|26583699|FG001|Overall Study|Other unspecified reasons|22|||
13326127|NCT01146652|26583698|FG000|Overall Study|Enrolled but not treated|2|||
13326128|NCT01146652|26583699|FG001|Overall Study|Enrolled but not treated|0|||
13326129|NCT01146613|26583712|FG000|Overall Study|Lost to Follow-up|3|||
13326130|NCT01146613|26583713|FG001|Overall Study|Lost to Follow-up|8|||
13326131|NCT01146613|26583712|FG000|Overall Study|Lack of Efficacy|0|||
13326132|NCT01146613|26583713|FG001|Overall Study|Lack of Efficacy|1|||
13326133|NCT01146613|26583712|FG000|Overall Study|Death|1|||
13326134|NCT01146613|26583713|FG001|Overall Study|Death|0|||
13326135|NCT01146613|26583712|FG000|Overall Study|Physician Decision|1|||
13326136|NCT01146613|26583713|FG001|Overall Study|Physician Decision|0|||
13326137|NCT01146613|26583712|FG000|Overall Study|Withdrawal by Subject|0|||
13326138|NCT01146613|26583713|FG001|Overall Study|Withdrawal by Subject|3|||
13326139|NCT01146613|26583712|FG000|Overall Study|schedule conflict|1|||
13326140|NCT01146613|26583713|FG001|Overall Study|schedule conflict|0|||
13326141|NCT01146613|26583712|FG000|Overall Study|Outpatient detox|1|||
13326142|NCT01146613|26583713|FG001|Overall Study|Outpatient detox|0|||
13326143|NCT01146561|26583736|FG000|Overall Study|Withdrawal by Subject|1|||
13326144|NCT01146561|26583736|FG000|Overall Study|Lost to Follow-up|1|||
13326145|NCT01146288|26583752|FG000|First Intervention(1 Day)|Adverse Event|0|||
13326146|NCT01146288|26583753|FG001|First Intervention(1 Day)|Adverse Event|1|||
13326147|NCT01146054|26583763|FG000|Overall Study|Did not meet dose constraints for SBRT|5|||
13326148|NCT01146054|26583763|FG000|Overall Study|Rapid tumor progression|2|||
13326149|NCT01146054|26583763|FG000|Overall Study|Other illness precluded treatment|2|||
13326150|NCT01146054|26583763|FG000|Overall Study|Lost to Follow-up|1|||
13326151|NCT01145898|26583801|FG000|3-year Treatment|medication change by treating physician|3|||
13326152|NCT01145898|26583802|FG001|3-year Treatment|medication change by treating physician|16|||
13326153|NCT01145885|26583836|FG000|Overall Study|Progressive Disease|7|||
13326154|NCT01145755|26583860|FG000|Overall Study|Adverse Event|2|||
13326155|NCT01145755|26583861|FG001|Overall Study|Adverse Event|4|||
13326156|NCT01145755|26583862|FG002|Overall Study|Adverse Event|2|||
13326157|NCT01145755|26583860|FG000|Overall Study|Withdrawal by Subject|2|||
13326158|NCT01145755|26583861|FG001|Overall Study|Withdrawal by Subject|2|||
13326159|NCT01145755|26583862|FG002|Overall Study|Withdrawal by Subject|2|||
13326160|NCT01145755|26583860|FG000|Overall Study|Lost to Follow-up|2|||
13326161|NCT01145755|26583861|FG001|Overall Study|Lost to Follow-up|3|||
13326162|NCT01145755|26583862|FG002|Overall Study|Lost to Follow-up|1|||
13326163|NCT01145755|26583860|FG000|Overall Study|Protocol Violation|0|||
13326164|NCT01145755|26583861|FG001|Overall Study|Protocol Violation|3|||
13326165|NCT01145755|26583862|FG002|Overall Study|Protocol Violation|1|||
13326166|NCT01145755|26583860|FG000|Overall Study|Study Closure|14|||
13326167|NCT01145755|26583861|FG001|Overall Study|Study Closure|14|||
13326168|NCT01145755|26583862|FG002|Overall Study|Study Closure|17|||
13326169|NCT01145755|26583860|FG000|Overall Study|Lack of Efficacy|0|||
13326170|NCT01145755|26583861|FG001|Overall Study|Lack of Efficacy|1|||
13326171|NCT01145755|26583862|FG002|Overall Study|Lack of Efficacy|0|||
13326172|NCT01145755|26583860|FG000|Overall Study|Patient could not swollow medication|0|||
13326173|NCT01145755|26583861|FG001|Overall Study|Patient could not swollow medication|0|||
13326174|NCT01145755|26583862|FG002|Overall Study|Patient could not swollow medication|1|||
13326175|NCT01145755|26583860|FG000|Overall Study|Withdrawal by Subject|0|||
13326176|NCT01145755|26583861|FG001|Overall Study|Withdrawal by Subject|0|||
13326177|NCT01145755|26583862|FG002|Overall Study|Withdrawal by Subject|1|||
13326178|NCT01145755|26583860|FG000|Overall Study|Positive urine ethanol|0|||
13326179|NCT01145755|26583861|FG001|Overall Study|Positive urine ethanol|1|||
13326180|NCT01145755|26583862|FG002|Overall Study|Positive urine ethanol|0|||
13326181|NCT01145625|26583879|FG000|Overall Study|Lost to Follow-up|8|||
13326182|NCT01145625|26583880|FG001|Overall Study|Lost to Follow-up|9|||
13326183|NCT01145625|26583879|FG000|Overall Study|Adverse Event|6|||
13326184|NCT01145625|26583880|FG001|Overall Study|Adverse Event|4|||
13326185|NCT01145625|26583879|FG000|Overall Study|Protocol Violation|3|||
13326186|NCT01145625|26583880|FG001|Overall Study|Protocol Violation|1|||
13326187|NCT01145625|26583879|FG000|Overall Study|Withdrawal by Subject|7|||
13326188|NCT01145625|26583880|FG001|Overall Study|Withdrawal by Subject|16|||
13326189|NCT01145625|26583879|FG000|Overall Study|Pregnancy|0|||
13326190|NCT01145625|26583880|FG001|Overall Study|Pregnancy|1|||
13326191|NCT01145560|26583907|FG000|Overall Study|Withdrawal by Subject|2|||
13326192|NCT01145560|26583908|FG001|Overall Study|Withdrawal by Subject|1|||
13326193|NCT01145560|26583909|FG002|Overall Study|Withdrawal by Subject|0|||
13326194|NCT01145560|26583907|FG000|Overall Study|Lost to Follow-up|1|||
13326195|NCT01145560|26583908|FG001|Overall Study|Lost to Follow-up|1|||
13326196|NCT01145560|26583909|FG002|Overall Study|Lost to Follow-up|1|||
13326197|NCT01145560|26583907|FG000|Overall Study|No study drug by 24h after organ failure|1|||
13326198|NCT01145560|26583908|FG001|Overall Study|No study drug by 24h after organ failure|0|||
13326199|NCT01145560|26583909|FG002|Overall Study|No study drug by 24h after organ failure|0|||
13326200|NCT01145560|26583907|FG000|Overall Study|Accidental unblinding of study treatment|0|||
13326201|NCT01145560|26583908|FG001|Overall Study|Accidental unblinding of study treatment|1|||
13326202|NCT01145560|26583909|FG002|Overall Study|Accidental unblinding of study treatment|0|||
13326203|NCT01145560|26583907|FG000|Overall Study|False insurance information|0|||
13326204|NCT01145560|26583908|FG001|Overall Study|False insurance information|1|||
13326205|NCT01145560|26583909|FG002|Overall Study|False insurance information|0|||
13326206|NCT01145560|26583907|FG000|Overall Study|Withdrawal of therapy|0|||
13326207|NCT01145560|26583908|FG001|Overall Study|Withdrawal of therapy|0|||
13326208|NCT01145560|26583909|FG002|Overall Study|Withdrawal of therapy|1|||
13326209|NCT01145508|26583922|FG000|Overall Study|Adverse Event|1|||
13326210|NCT01145508|26583923|FG001|Overall Study|Adverse Event|0|||
13326211|NCT01145508|26583922|FG000|Overall Study|Death|1|||
13326212|NCT01145508|26583923|FG001|Overall Study|Death|0|||
13326213|NCT01145508|26583922|FG000|Overall Study|Physician Decision|2|||
13326214|NCT01145508|26583923|FG001|Overall Study|Physician Decision|1|||
13326215|NCT01145508|26583922|FG000|Overall Study|Never started treatment|1|||
13326216|NCT01145508|26583923|FG001|Overall Study|Never started treatment|1|||
13326217|NCT01145495|26583929|FG000|Overall Study|Adverse Event|6|||
13326218|NCT01145495|26583929|FG000|Overall Study|Withdrawal by Subject|5|||
13326219|NCT01145495|26583929|FG000|Overall Study|Disease progression after respone|1|||
13326220|NCT01145482|26583944|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
13326221|NCT01145482|26583945|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
13326222|NCT01145417|26583974|FG000|Overall Study|Death|1|||
13326223|NCT01145417|26583975|FG001|Overall Study|Death|0|||
13326224|NCT01145417|26583974|FG000|Overall Study|Lost to Follow-up|2|||
13326225|NCT01145417|26583975|FG001|Overall Study|Lost to Follow-up|1|||
13326226|NCT01145417|26583974|FG000|Overall Study|Withdrawal by Subject|1|||
13326227|NCT01145417|26583975|FG001|Overall Study|Withdrawal by Subject|2|||
13326228|NCT01145417|26583974|FG000|Overall Study|Pregnancy|1|||
13326229|NCT01145417|26583975|FG001|Overall Study|Pregnancy|0|||
13326230|NCT01145417|26583974|FG000|Overall Study|Adverse Event|0|||
13326231|NCT01145417|26583975|FG001|Overall Study|Adverse Event|1|||
13326232|NCT01145417|26583974|FG000|Overall Study|Study terminated by sponsor|35|||
13326233|NCT01145417|26583975|FG001|Overall Study|Study terminated by sponsor|43|||
13326234|NCT01145417|26583974|FG000|Overall Study|Other|1|||
13326235|NCT01145417|26583975|FG001|Overall Study|Other|0|||
13326236|NCT01145352|26583985|FG000|Overall Study|Found to have been registered twice|6|||
13326237|NCT01145352|26583985|FG000|Overall Study|Treated before marketing approval|4|||
13326238|NCT01145352|26583985|FG000|Overall Study|Syringe formulation was used|1|||
13326239|NCT01145222|26584016|FG000|Overall Study|Procedure not done (no anesthesiologist)|0|||
13326240|NCT01145222|26584017|FG001|Overall Study|Procedure not done (no anesthesiologist)|0|||
13326241|NCT01145222|26584018|FG002|Overall Study|Procedure not done (no anesthesiologist)|1|||
13326242|NCT01145222|26584019|FG003|Overall Study|Procedure not done (no anesthesiologist)|0|||
13326243|NCT01145222|26584016|FG000|Overall Study|Poor bowel preparation|0|||
13326244|NCT01145222|26584017|FG001|Overall Study|Poor bowel preparation|0|||
13326245|NCT01145222|26584018|FG002|Overall Study|Poor bowel preparation|0|||
13326246|NCT01145222|26584019|FG003|Overall Study|Poor bowel preparation|1|||
13326247|NCT01145066|26584097|FG000|Overall Study|To resume NSAIDs|2|||
13326248|NCT01145066|26584098|FG001|Overall Study|To resume NSAIDs|2|||
13326249|NCT01145066|26584099|FG002|Overall Study|To resume NSAIDs|1|||
13326250|NCT01145066|26584097|FG000|Overall Study|Non-related surgery|0|||
13326251|NCT01145066|26584098|FG001|Overall Study|Non-related surgery|0|||
13326252|NCT01145066|26584099|FG002|Overall Study|Non-related surgery|1|||
13326253|NCT01145066|26584097|FG000|Overall Study|Withdrawal by Subject|0|||
13326254|NCT01145066|26584098|FG001|Overall Study|Withdrawal by Subject|0|||
13326255|NCT01145066|26584099|FG002|Overall Study|Withdrawal by Subject|2|||
13326256|NCT01145066|26584097|FG000|Overall Study|To start new med|1|||
13326257|NCT01145066|26584098|FG001|Overall Study|To start new med|0|||
13326258|NCT01145066|26584099|FG002|Overall Study|To start new med|0|||
13326259|NCT01145066|26584097|FG000|Overall Study|problems swallowing capsule|1|||
13326260|NCT01145066|26584098|FG001|Overall Study|problems swallowing capsule|0|||
13326261|NCT01145066|26584099|FG002|Overall Study|problems swallowing capsule|0|||
13326262|NCT01145066|26584097|FG000|Overall Study|Abdominal discomfort|0|||
13326263|NCT01145066|26584098|FG001|Overall Study|Abdominal discomfort|1|||
13326264|NCT01145066|26584099|FG002|Overall Study|Abdominal discomfort|0|||
13326265|NCT01145066|26584097|FG000|Overall Study|Low platelet count|0|||
13326266|NCT01145066|26584098|FG001|Overall Study|Low platelet count|1|||
13326267|NCT01145066|26584099|FG002|Overall Study|Low platelet count|0|||
13326268|NCT01145053|26584111|FG000|Overall Study|Adverse Event|22|||
13326269|NCT01145053|26584111|FG000|Overall Study|Lost to Follow-up|28|||
13326270|NCT01145053|26584111|FG000|Overall Study|Withdrawal by Subject|25|||
13326271|NCT01145053|26584111|FG000|Overall Study|Other|18|||
13326272|NCT01144715|26584130|FG000|Overall Study|Lost to Follow-up|2|||
13326273|NCT01144715|26584131|FG001|Overall Study|Lost to Follow-up|1|||
13326274|NCT01144715|26584130|FG000|Overall Study|Withdrawal by Subject|2|||
13373528|NCT00802672|26724004|FG000|Overall Study|Protocol Violation|2|||
13288203|NCT01089556|26475273|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
13288204|NCT01089556|26475274|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
13288205|NCT01089556|26475275|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
13288206|NCT01089556|26475270|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3|||
13288207|NCT01089556|26475271|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4|||
13288208|NCT01089556|26475272|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0|||
13288209|NCT01089556|26475273|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0|||
13288210|NCT01089556|26475274|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0|||
13288211|NCT01089556|26475275|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0|||
13288212|NCT01089556|26475270|FG000|Study Period III (Weeks 9-16)|Adverse Event|0|||
13288213|NCT01089556|26475271|FG001|Study Period III (Weeks 9-16)|Adverse Event|0|||
13288214|NCT01089556|26475272|FG002|Study Period III (Weeks 9-16)|Adverse Event|4|||
13288215|NCT01089556|26475273|FG003|Study Period III (Weeks 9-16)|Adverse Event|2|||
13288216|NCT01089556|26475274|FG004|Study Period III (Weeks 9-16)|Adverse Event|4|||
13288217|NCT01089556|26475275|FG005|Study Period III (Weeks 9-16)|Adverse Event|3|||
13288218|NCT01089556|26475270|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
13288219|NCT01089556|26475271|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
13288220|NCT01089556|26475272|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
13288221|NCT01089556|26475273|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
13288222|NCT01089556|26475274|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
13288223|NCT01089556|26475275|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
13288224|NCT01089556|26475270|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
13288225|NCT01089556|26475271|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
13288226|NCT01089556|26475272|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
13288227|NCT01089556|26475273|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2|||
13288228|NCT01089556|26475274|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1|||
13288229|NCT01089556|26475275|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
13288230|NCT01089556|26475270|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
13288231|NCT01089556|26475271|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
13288232|NCT01089556|26475272|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1|||
13288233|NCT01089556|26475273|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
13288234|NCT01089556|26475274|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
13288235|NCT01089556|26475275|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
13288236|NCT01089556|26475270|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0|||
13288237|NCT01089556|26475271|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0|||
13288238|NCT01089556|26475272|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1|||
13288239|NCT01089556|26475273|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1|||
13288240|NCT01089556|26475274|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1|||
13288241|NCT01089556|26475275|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0|||
13288242|NCT01089556|26475270|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
13288243|NCT01089556|26475271|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
13288244|NCT01089556|26475272|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
13288245|NCT01089556|26475273|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3|||
13288246|NCT01089556|26475274|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
13288247|NCT01089556|26475275|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1|||
13288248|NCT01089556|26475270|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
13288249|NCT01089556|26475271|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
13288250|NCT01089556|26475272|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3|||
13288251|NCT01089556|26475273|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
13288252|NCT01089556|26475274|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1|||
13288253|NCT01089556|26475275|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2|||
13288254|NCT01089543|26475302|FG000|Overall Study|Withdrawal by Subject|2|||
13288255|NCT01089543|26475303|FG001|Overall Study|Withdrawal by Subject|3|||
13288256|NCT01089543|26475304|FG002|Overall Study|Withdrawal by Subject|3|||
13288257|NCT01089543|26475305|FG003|Overall Study|Withdrawal by Subject|1|||
13288258|NCT01089543|26475302|FG000|Overall Study|Physician Decision|1|||
13288259|NCT01089543|26475303|FG001|Overall Study|Physician Decision|0|||
13288260|NCT01089543|26475304|FG002|Overall Study|Physician Decision|0|||
13288261|NCT01089543|26475305|FG003|Overall Study|Physician Decision|1|||
13288262|NCT01089543|26475302|FG000|Overall Study|Adverse Event|0|||
13288263|NCT01089543|26475303|FG001|Overall Study|Adverse Event|1|||
13288264|NCT01089543|26475304|FG002|Overall Study|Adverse Event|0|||
13288265|NCT01089543|26475305|FG003|Overall Study|Adverse Event|0|||
13288266|NCT01089504|26475322|FG000|Overall Study|Lost to Follow-up|1|||
13288267|NCT01089504|26475323|FG001|Overall Study|Lost to Follow-up|1|||
13288268|NCT01089504|26475322|FG000|Overall Study|Withdrawal by Subject|2|||
13288269|NCT01089504|26475323|FG001|Overall Study|Withdrawal by Subject|0|||
13326275|NCT01144715|26584131|FG001|Overall Study|Withdrawal by Subject|1|||
13326276|NCT01144715|26584130|FG000|Overall Study|Adverse Event|0|||
13326277|NCT01144715|26584131|FG001|Overall Study|Adverse Event|1|||
13326278|NCT01144663|26584344|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2|||
13326279|NCT01144663|26584345|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0|||
13326280|NCT01144663|26584346|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1|||
13326281|NCT01144663|26584347|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0|||
13326282|NCT01144663|26584344|FG000|Primary Vaccination Phase|Adverse Event|1|||
13326283|NCT01144663|26584345|FG001|Primary Vaccination Phase|Adverse Event|0|||
13326284|NCT01144663|26584346|FG002|Primary Vaccination Phase|Adverse Event|0|||
13326285|NCT01144663|26584347|FG003|Primary Vaccination Phase|Adverse Event|1|||
13326286|NCT01144663|26584344|FG000|Primary Vaccination Phase|Protocol Violation|2|||
13326287|NCT01144663|26584345|FG001|Primary Vaccination Phase|Protocol Violation|0|||
13326288|NCT01144663|26584346|FG002|Primary Vaccination Phase|Protocol Violation|1|||
13326289|NCT01144663|26584347|FG003|Primary Vaccination Phase|Protocol Violation|0|||
13326290|NCT01144663|26584344|FG000|Primary Vaccination Phase|Withdrawal by Subject|9|||
13326291|NCT01144663|26584345|FG001|Primary Vaccination Phase|Withdrawal by Subject|5|||
13326292|NCT01144663|26584346|FG002|Primary Vaccination Phase|Withdrawal by Subject|3|||
13326293|NCT01144663|26584347|FG003|Primary Vaccination Phase|Withdrawal by Subject|10|||
13326294|NCT01144663|26584344|FG000|Primary Vaccination Phase|Migrated/moved from study area|4|||
13326295|NCT01144663|26584345|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
13326296|NCT01144663|26584346|FG002|Primary Vaccination Phase|Migrated/moved from study area|2|||
13326297|NCT01144663|26584347|FG003|Primary Vaccination Phase|Migrated/moved from study area|3|||
13326298|NCT01144663|26584344|FG000|Primary Vaccination Phase|Lost to Follow-up|2|||
13326299|NCT01144663|26584345|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
13326300|NCT01144663|26584346|FG002|Primary Vaccination Phase|Lost to Follow-up|1|||
13326301|NCT01144663|26584347|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
13326302|NCT01144663|26584344|FG000|Primary Vaccination Phase|Other|0|||
13326303|NCT01144663|26584345|FG001|Primary Vaccination Phase|Other|1|||
13326304|NCT01144663|26584346|FG002|Primary Vaccination Phase|Other|0|||
13326305|NCT01144663|26584347|FG003|Primary Vaccination Phase|Other|2|||
13326306|NCT01144663|26584344|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
13326307|NCT01144663|26584345|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
13326308|NCT01144663|26584346|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
13326309|NCT01144663|26584347|FG003|Booster Vaccination Phase|Withdrawal by Subject|1|||
13326310|NCT01144663|26584344|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
13326311|NCT01144663|26584345|FG001|Booster Vaccination Phase|Migrated/moved from study area|1|||
13326312|NCT01144663|26584346|FG002|Booster Vaccination Phase|Migrated/moved from study area|1|||
13326313|NCT01144663|26584347|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
13326314|NCT01144663|26584344|FG000|Booster Vaccination Phase|Lost to Follow-up|2|||
13326315|NCT01144663|26584345|FG001|Booster Vaccination Phase|Lost to Follow-up|1|||
13326316|NCT01144663|26584346|FG002|Booster Vaccination Phase|Lost to Follow-up|3|||
13326317|NCT01144663|26584347|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
13326318|NCT01144663|26584344|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
13326319|NCT01144663|26584345|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
13326320|NCT01144663|26584346|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
13326321|NCT01144663|26584347|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
13326322|NCT01144663|26584344|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
13326323|NCT01144663|26584345|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3|||
13326324|NCT01144663|26584346|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
13326325|NCT01144663|26584347|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0|||
13326326|NCT01144663|26584344|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4|||
13326327|NCT01144663|26584345|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6|||
13326328|NCT01144663|26584346|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5|||
13326329|NCT01144663|26584347|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0|||
13326330|NCT01144403|26584356|FG000|Overall Study|Lost to Follow-up|3|||
13326331|NCT01144403|26584356|FG000|Overall Study|Death|1|||
13326332|NCT01144403|26584356|FG000|Overall Study|Adverse Event|1|||
13326333|NCT01144377|26584419|FG000|52 Week Treatment Period|Adverse Event|0|||
13326334|NCT01144377|26584420|FG001|52 Week Treatment Period|Adverse Event|0|||
13326335|NCT01144377|26584421|FG002|52 Week Treatment Period|Adverse Event|3|||
13326336|NCT01144377|26584422|FG003|52 Week Treatment Period|Adverse Event|2|||
13326337|NCT01144377|26584423|FG004|52 Week Treatment Period|Adverse Event|1|||
13326338|NCT01144377|26584419|FG000|52 Week Treatment Period|Entry Criteria Not Met|0|||
13326339|NCT01144377|26584420|FG001|52 Week Treatment Period|Entry Criteria Not Met|0|||
13326340|NCT01144377|26584421|FG002|52 Week Treatment Period|Entry Criteria Not Met|1|||
13326341|NCT01144377|26584422|FG003|52 Week Treatment Period|Entry Criteria Not Met|1|||
13326342|NCT01144377|26584423|FG004|52 Week Treatment Period|Entry Criteria Not Met|0|||
13326343|NCT01144377|26584419|FG000|52 Week Treatment Period|Protocol Violation|0|||
13326344|NCT01144377|26584420|FG001|52 Week Treatment Period|Protocol Violation|0|||
13326345|NCT01144377|26584421|FG002|52 Week Treatment Period|Protocol Violation|0|||
13326346|NCT01144377|26584422|FG003|52 Week Treatment Period|Protocol Violation|0|||
13326347|NCT01144377|26584423|FG004|52 Week Treatment Period|Protocol Violation|1|||
13326348|NCT01144377|26584419|FG000|52 Week Treatment Period|Lost to Follow-up|1|||
13326349|NCT01144377|26584420|FG001|52 Week Treatment Period|Lost to Follow-up|0|||
13326350|NCT01144377|26584421|FG002|52 Week Treatment Period|Lost to Follow-up|0|||
13326351|NCT01144377|26584422|FG003|52 Week Treatment Period|Lost to Follow-up|0|||
13326352|NCT01144377|26584423|FG004|52 Week Treatment Period|Lost to Follow-up|0|||
13326353|NCT01144377|26584419|FG000|52 Week Treatment Period|Withdrawal by Subject|4|||
13326354|NCT01144377|26584420|FG001|52 Week Treatment Period|Withdrawal by Subject|1|||
13326355|NCT01144377|26584421|FG002|52 Week Treatment Period|Withdrawal by Subject|1|||
13326356|NCT01144377|26584422|FG003|52 Week Treatment Period|Withdrawal by Subject|1|||
13326357|NCT01144377|26584423|FG004|52 Week Treatment Period|Withdrawal by Subject|0|||
13326358|NCT01144377|26584419|FG000|52 Week Treatment Period|Sponsor Decision|0|||
13326359|NCT01144377|26584420|FG001|52 Week Treatment Period|Sponsor Decision|0|||
13326360|NCT01144377|26584421|FG002|52 Week Treatment Period|Sponsor Decision|0|||
13326361|NCT01144377|26584422|FG003|52 Week Treatment Period|Sponsor Decision|0|||
13326362|NCT01144377|26584423|FG004|52 Week Treatment Period|Sponsor Decision|1|||
13326363|NCT01144377|26584419|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
13326364|NCT01144377|26584420|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
13326365|NCT01144377|26584421|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
13326366|NCT01144377|26584422|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
13326367|NCT01144377|26584423|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
13326368|NCT01144377|26584419|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
13326369|NCT01144377|26584420|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
13326370|NCT01144377|26584421|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
13326371|NCT01144377|26584422|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
13326372|NCT01144377|26584423|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1|||
13326373|NCT01144377|26584419|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1|||
13326374|NCT01144377|26584420|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
13326375|NCT01144377|26584421|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
13326376|NCT01144377|26584422|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
13326377|NCT01144377|26584423|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
13326378|NCT01144364|26584455|FG000|Induction Phase|Disease progression|14|||
13326379|NCT01144364|26584456|FG001|Induction Phase|Disease progression|0|||
13326380|NCT01144364|26584457|FG002|Induction Phase|Disease progression|0|||
13326381|NCT01144364|26584455|FG000|Induction Phase|Adverse Event|9|||
13326382|NCT01144364|26584456|FG001|Induction Phase|Adverse Event|0|||
13326383|NCT01144364|26584457|FG002|Induction Phase|Adverse Event|0|||
13326384|NCT01144364|26584455|FG000|Induction Phase|Death|1|||
13326385|NCT01144364|26584456|FG001|Induction Phase|Death|0|||
13326386|NCT01144364|26584457|FG002|Induction Phase|Death|0|||
13326387|NCT01144364|26584455|FG000|Induction Phase|Withdrawal by Subject|1|||
13326388|NCT01144364|26584456|FG001|Induction Phase|Withdrawal by Subject|0|||
13326389|NCT01144364|26584457|FG002|Induction Phase|Withdrawal by Subject|0|||
13326390|NCT01144364|26584455|FG000|Induction Phase|Lost to Follow-up|2|||
13326391|NCT01144364|26584456|FG001|Induction Phase|Lost to Follow-up|0|||
13326392|NCT01144364|26584457|FG002|Induction Phase|Lost to Follow-up|0|||
13326393|NCT01144364|26584455|FG000|Induction Phase|Physician Decision|1|||
13326394|NCT01144364|26584456|FG001|Induction Phase|Physician Decision|0|||
13326395|NCT01144364|26584457|FG002|Induction Phase|Physician Decision|0|||
13326396|NCT01144364|26584455|FG000|Induction Phase|Stable disease|2|||
13326397|NCT01144364|26584456|FG001|Induction Phase|Stable disease|0|||
13326398|NCT01144364|26584457|FG002|Induction Phase|Stable disease|0|||
13326399|NCT01144364|26584455|FG000|Induction Phase|Secondary neoplasia|1|||
13326400|NCT01144364|26584456|FG001|Induction Phase|Secondary neoplasia|0|||
13326401|NCT01144364|26584457|FG002|Induction Phase|Secondary neoplasia|0|||
13326402|NCT01144364|26584455|FG000|Induction Phase|Protocol Violation|1|||
13326403|NCT01144364|26584456|FG001|Induction Phase|Protocol Violation|0|||
13326404|NCT01144364|26584457|FG002|Induction Phase|Protocol Violation|0|||
13326405|NCT01144364|26584455|FG000|Follow-Up/Maintenance Phase|Disease progression|0|||
13326406|NCT01144364|26584456|FG001|Follow-Up/Maintenance Phase|Disease progression|23|||
13326407|NCT01144364|26584457|FG002|Follow-Up/Maintenance Phase|Disease progression|29|||
13326408|NCT01144364|26584455|FG000|Follow-Up/Maintenance Phase|Adverse Event|0|||
13326409|NCT01144364|26584456|FG001|Follow-Up/Maintenance Phase|Adverse Event|3|||
13326410|NCT01144364|26584457|FG002|Follow-Up/Maintenance Phase|Adverse Event|1|||
13326411|NCT01144364|26584455|FG000|Follow-Up/Maintenance Phase|Death|0|||
13326412|NCT01144364|26584456|FG001|Follow-Up/Maintenance Phase|Death|2|||
13326413|NCT01144364|26584457|FG002|Follow-Up/Maintenance Phase|Death|0|||
13326414|NCT01144364|26584455|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0|||
13326415|NCT01144364|26584456|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
13326416|NCT01144364|26584457|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
13373529|NCT00802672|26724005|FG001|Overall Study|Protocol Violation|1|||
13326417|NCT01144364|26584455|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0|||
13326418|NCT01144364|26584456|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1|||
13326419|NCT01144364|26584457|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4|||
13326420|NCT01144364|26584455|FG000|Follow-Up/Maintenance Phase|Relapse|0|||
13326421|NCT01144364|26584456|FG001|Follow-Up/Maintenance Phase|Relapse|5|||
13326422|NCT01144364|26584457|FG002|Follow-Up/Maintenance Phase|Relapse|5|||
13326423|NCT01144364|26584455|FG000|Follow-Up/Maintenance Phase|Physician Decision|0|||
13326424|NCT01144364|26584456|FG001|Follow-Up/Maintenance Phase|Physician Decision|0|||
13326425|NCT01144364|26584457|FG002|Follow-Up/Maintenance Phase|Physician Decision|1|||
13326426|NCT01144299|26584486|FG000|Overall Study|Lost to Follow-up|1|||
13326427|NCT01144299|26584487|FG001|Overall Study|Lost to Follow-up|0|||
13326428|NCT01144299|26584486|FG000|Overall Study|Withdrawal by Subject|1|||
13326429|NCT01144299|26584487|FG001|Overall Study|Withdrawal by Subject|0|||
13326430|NCT01144182|26584524|FG000|Overall Study|Death|5|||
13326431|NCT01144182|26584525|FG001|Overall Study|Death|6|||
13326432|NCT01144182|26584524|FG000|Overall Study|Withdrawal by Subject|3|||
13326433|NCT01144182|26584525|FG001|Overall Study|Withdrawal by Subject|6|||
13326434|NCT01144182|26584524|FG000|Overall Study|Lost to Follow-up|9|||
13326435|NCT01144182|26584525|FG001|Overall Study|Lost to Follow-up|9|||
13326436|NCT01144052|26584552|FG000|Overall Study|Withdrawal by Subject|1|||
13326437|NCT01144052|26584553|FG001|Overall Study|Withdrawal by Subject|1|||
13326438|NCT01143896|26584576|FG000|Overall Study|Did not complete Baseline Interview|5|||
13326439|NCT01143896|26584577|FG001|Overall Study|Did not complete Baseline Interview|4|||
13326440|NCT01143896|26584576|FG000|Overall Study|Lost to Follow-up|18|||
13326441|NCT01143896|26584577|FG001|Overall Study|Lost to Follow-up|13|||
13326442|NCT01143896|26584576|FG000|Overall Study|Withdrawal by Subject|13|||
13326443|NCT01143896|26584577|FG001|Overall Study|Withdrawal by Subject|5|||
13326444|NCT01143896|26584576|FG000|Overall Study|Death|6|||
13326445|NCT01143896|26584577|FG001|Overall Study|Death|3|||
13326446|NCT01143714|26584592|FG000|Overall Study|Adverse Event|4|||
13326447|NCT01143714|26584593|FG001|Overall Study|Adverse Event|2|||
13326448|NCT01143714|26584592|FG000|Overall Study|Withdrawal by Subject|1|||
13326449|NCT01143714|26584593|FG001|Overall Study|Withdrawal by Subject|0|||
13326450|NCT01143714|26584592|FG000|Overall Study|Subject non-compliance|0|||
13326451|NCT01143714|26584593|FG001|Overall Study|Subject non-compliance|1|||
13326452|NCT01143714|26584592|FG000|Overall Study|wound closed = deemed healed|1|||
13326453|NCT01143714|26584593|FG001|Overall Study|wound closed = deemed healed|0|||
13326454|NCT01143714|26584592|FG000|Overall Study|wound size increased|1|||
13326455|NCT01143714|26584593|FG001|Overall Study|wound size increased|0|||
13373530|NCT00802672|26724006|FG002|Overall Study|Protocol Violation|1|||
13373531|NCT00802672|26724004|FG000|Overall Study|Lost to Follow-up|5|||
13373532|NCT00802672|26724005|FG001|Overall Study|Lost to Follow-up|5|||
13373533|NCT00802672|26724006|FG002|Overall Study|Lost to Follow-up|3|||
13373534|NCT00802672|26724004|FG000|Overall Study|Withdrawal by Subject|1|||
13373535|NCT00802672|26724005|FG001|Overall Study|Withdrawal by Subject|1|||
13373536|NCT00802672|26724006|FG002|Overall Study|Withdrawal by Subject|2|||
13373537|NCT00802672|26724004|FG000|Overall Study|other|3|||
13373538|NCT00802672|26724005|FG001|Overall Study|other|1|||
13373539|NCT00802672|26724006|FG002|Overall Study|other|2|||
13373540|NCT00802659|26724045|FG000|Overall Study|Physician Decision|0|||
13373541|NCT00802659|26724046|FG001|Overall Study|Physician Decision|1|||
13373542|NCT00802659|26724047|FG002|Overall Study|Physician Decision|0|||
13373543|NCT00802659|26724048|FG003|Overall Study|Physician Decision|0|||
13373544|NCT00802529|26724065|FG000|Overall Study|Lost to Follow-up|0|||
13373545|NCT00802529|26724066|FG001|Overall Study|Lost to Follow-up|1|||
13373546|NCT00802464|26724165|FG000|Month 0 - Month 8|Adverse Event|0|||
13373547|NCT00802464|26724166|FG001|Month 0 - Month 8|Adverse Event|1|||
13373548|NCT00802464|26724167|FG002|Month 0 - Month 8|Adverse Event|1|||
13373549|NCT00802464|26724168|FG003|Month 0 - Month 8|Adverse Event|2|||
13373550|NCT00802464|26724165|FG000|Month 0 - Month 8|Protocol Violation|0|||
13373551|NCT00802464|26724166|FG001|Month 0 - Month 8|Protocol Violation|0|||
13373552|NCT00802464|26724167|FG002|Month 0 - Month 8|Protocol Violation|1|||
13486401|NCT03645863|27036044|FG001|Overall Study|Withdrawal by Subject|0|||
13203996|NCT01977846|26226627|FG000|Total Study - Prospective|Death|0|||
13373553|NCT00802464|26724168|FG003|Month 0 - Month 8|Protocol Violation|0|||
13373554|NCT00802464|26724165|FG000|Month 0 - Month 8|Withdrawal by Subject|0|||
13373555|NCT00802464|26724166|FG001|Month 0 - Month 8|Withdrawal by Subject|1|||
13373556|NCT00802464|26724167|FG002|Month 0 - Month 8|Withdrawal by Subject|2|||
13373557|NCT00802464|26724168|FG003|Month 0 - Month 8|Withdrawal by Subject|5|||
13373558|NCT00802464|26724165|FG000|Month 0 - Month 8|Lost to Follow-up|0|||
13373559|NCT00802464|26724166|FG001|Month 0 - Month 8|Lost to Follow-up|1|||
13373560|NCT00802464|26724167|FG002|Month 0 - Month 8|Lost to Follow-up|2|||
13373561|NCT00802464|26724168|FG003|Month 0 - Month 8|Lost to Follow-up|2|||
13373562|NCT00802464|26724165|FG000|Month 0 - Month 8|Other|0|||
13373563|NCT00802464|26724166|FG001|Month 0 - Month 8|Other|0|||
13373564|NCT00802464|26724167|FG002|Month 0 - Month 8|Other|1|||
13373565|NCT00802464|26724168|FG003|Month 0 - Month 8|Other|0|||
13373566|NCT00802464|26724165|FG000|Month 8 - Month 14|Adverse Event|0|||
13326456|NCT01143402|26584612|FG000|Overall Study|Rapid clinical decline|1|||
13326457|NCT01143402|26584613|FG001|Overall Study|Rapid clinical decline|1|||
13326458|NCT01143402|26584614|FG002|Overall Study|Rapid clinical decline|0|||
13326459|NCT01143402|26584612|FG000|Overall Study|Not Treated|0|||
13326460|NCT01143402|26584613|FG001|Overall Study|Not Treated|0|||
13326461|NCT01143402|26584614|FG002|Overall Study|Not Treated|1|||
13326462|NCT01143389|26584633|FG000|Overall Study|Lost to Follow-up|26|||
13326463|NCT01143389|26584634|FG001|Overall Study|Lost to Follow-up|25|||
13326464|NCT01143337|26584656|FG000|Overall Study|Adverse Event|3|||
13326465|NCT01143337|26584657|FG001|Overall Study|Adverse Event|9|||
13326466|NCT01143337|26584658|FG002|Overall Study|Adverse Event|5|||
13326467|NCT01143337|26584656|FG000|Overall Study|Lack of Efficacy|6|||
13326468|NCT01143337|26584657|FG001|Overall Study|Lack of Efficacy|2|||
13326469|NCT01143337|26584658|FG002|Overall Study|Lack of Efficacy|1|||
13326470|NCT01143337|26584656|FG000|Overall Study|Protocol Violation|1|||
13326471|NCT01143337|26584657|FG001|Overall Study|Protocol Violation|0|||
13326472|NCT01143337|26584658|FG002|Overall Study|Protocol Violation|0|||
13326473|NCT01143337|26584656|FG000|Overall Study|Withdrawal by Subject|0|||
13326474|NCT01143337|26584657|FG001|Overall Study|Withdrawal by Subject|0|||
13326475|NCT01143337|26584658|FG002|Overall Study|Withdrawal by Subject|1|||
13326476|NCT01143337|26584656|FG000|Overall Study|Other reason|0|||
13326477|NCT01143337|26584657|FG001|Overall Study|Other reason|0|||
13326478|NCT01143337|26584658|FG002|Overall Study|Other reason|5|||
13326479|NCT01143324|26584676|FG000|Overall Study|Lost to Follow-up|11|||
13326480|NCT01143324|26584676|FG000|Overall Study|Withdrawal by Subject|4|||
13326481|NCT01143324|26584676|FG000|Overall Study|Explant of the device|4|||
13326482|NCT01143259|26584691|FG000|Overall Study|Withdrawal by Subject|3|||
13326483|NCT01143259|26584692|FG001|Overall Study|Withdrawal by Subject|2|||
13326484|NCT01143259|26584691|FG000|Overall Study|Protocol Violation|13|||
13326485|NCT01143259|26584692|FG001|Overall Study|Protocol Violation|9|||
13326486|NCT01143259|26584691|FG000|Overall Study|Screen Failure|7|||
13326487|NCT01143259|26584692|FG001|Overall Study|Screen Failure|9|||
13326488|NCT01143207|26584703|FG000|Overall Study|Lost to Follow-up|2|||
13326489|NCT01143090|26584709|FG000|Overall Study|Lack of Efficacy|2|||
13326490|NCT01143090|26584709|FG000|Overall Study|Adverse Event|17|||
13326491|NCT01143090|26584709|FG000|Overall Study|Lost to Follow-up|9|||
13326492|NCT01143090|26584709|FG000|Overall Study|Protocol Violation|2|||
13326493|NCT01143090|26584709|FG000|Overall Study|Withdrawal by Subject|18|||
13326494|NCT01143090|26584709|FG000|Overall Study|Non-compliance with study drug|1|||
13326495|NCT01143090|26584709|FG000|Overall Study|Failure to meet eligibility criteria|1|||
13326496|NCT01143090|26584709|FG000|Overall Study|Administrative|1|||
13326497|NCT01143077|26584730|FG000|Overall Study|Lack of Efficacy|0|||
13326498|NCT01143077|26584731|FG001|Overall Study|Lack of Efficacy|2|||
13326499|NCT01143077|26584732|FG002|Overall Study|Lack of Efficacy|1|||
13326500|NCT01143077|26584730|FG000|Overall Study|Adverse Event|5|||
13326501|NCT01143077|26584731|FG001|Overall Study|Adverse Event|6|||
13326502|NCT01143077|26584732|FG002|Overall Study|Adverse Event|5|||
13326503|NCT01143077|26584730|FG000|Overall Study|Lost to Follow-up|2|||
13326504|NCT01143077|26584731|FG001|Overall Study|Lost to Follow-up|3|||
13326505|NCT01143077|26584732|FG002|Overall Study|Lost to Follow-up|4|||
13326506|NCT01143077|26584730|FG000|Overall Study|Protocol Violation|2|||
13326507|NCT01143077|26584731|FG001|Overall Study|Protocol Violation|0|||
13326508|NCT01143077|26584732|FG002|Overall Study|Protocol Violation|0|||
13326509|NCT01143077|26584730|FG000|Overall Study|Withdrawal by Subject|4|||
13326510|NCT01143077|26584731|FG001|Overall Study|Withdrawal by Subject|3|||
13326511|NCT01143077|26584732|FG002|Overall Study|Withdrawal by Subject|3|||
13326512|NCT01143077|26584730|FG000|Overall Study|Non-compliance with study drug|0|||
13326513|NCT01143077|26584731|FG001|Overall Study|Non-compliance with study drug|1|||
13326514|NCT01143077|26584732|FG002|Overall Study|Non-compliance with study drug|1|||
13326515|NCT01143077|26584730|FG000|Overall Study|Administrative|1|||
13326516|NCT01143077|26584731|FG001|Overall Study|Administrative|0|||
13326517|NCT01143077|26584732|FG002|Overall Study|Administrative|0|||
13326518|NCT01143077|26584730|FG000|Overall Study|Principal Investigator Decision|2|||
13326519|NCT01143077|26584731|FG001|Overall Study|Principal Investigator Decision|0|||
13326520|NCT01143077|26584732|FG002|Overall Study|Principal Investigator Decision|1|||
13326521|NCT01143051|26584800|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
13326522|NCT01143051|26584801|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
13326523|NCT01143051|26584802|FG002|3-14 Day Washout|Withdrawal by Subject|1|||
13326524|NCT01143051|26584803|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
13326525|NCT01143051|26584804|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
13326526|NCT01143051|26584805|FG005|3-14 Day Washout|Withdrawal by Subject|0|||
13326527|NCT01143051|26584800|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
13326528|NCT01143051|26584801|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
13326529|NCT01143051|26584802|FG002|3-14 Day Washout|Withdrawal by Subject|0|||
13326530|NCT01143051|26584803|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
13326531|NCT01143051|26584804|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
13326532|NCT01143051|26584805|FG005|3-14 Day Washout|Withdrawal by Subject|1|||
13326533|NCT01143038|26584815|FG000|Overall Study|Withdrawal by Subject|4|||
13326534|NCT01143038|26584815|FG000|Overall Study|Requirement for alternative therapy|5|||
13326535|NCT01143038|26584815|FG000|Overall Study|Adverse Event|3|||
13326536|NCT01143038|26584815|FG000|Overall Study|Lost to Follow-up|2|||
13326537|NCT01143038|26584815|FG000|Overall Study|Protocol Deviation|1|||
13326538|NCT01143038|26584815|FG000|Overall Study|Death|1|||
13326539|NCT01142908|26584868|FG000|Overall Study|Lost to Follow-up|19|||
13326540|NCT01142908|26584869|FG001|Overall Study|Lost to Follow-up|13|||
13326541|NCT01142908|26584868|FG000|Overall Study|Death|1|||
13326542|NCT01142908|26584869|FG001|Overall Study|Death|4|||
13326543|NCT01142908|26584868|FG000|Overall Study|Excluded - did not meet criteria|9|||
13326544|NCT01142908|26584869|FG001|Overall Study|Excluded - did not meet criteria|5|||
13326545|NCT01142908|26584868|FG000|Overall Study|Withdrawal by Subject|3|||
13326546|NCT01142908|26584869|FG001|Overall Study|Withdrawal by Subject|0|||
13326547|NCT01142791|26584876|FG000|Overall Study|Alternative Treatment|1|||
13326548|NCT01142791|26584877|FG001|Overall Study|Alternative Treatment|0|||
13326549|NCT01142791|26584876|FG000|Overall Study|Lost to Follow-up|1|||
13326550|NCT01142791|26584877|FG001|Overall Study|Lost to Follow-up|0|||
13326551|NCT01142791|26584876|FG000|Overall Study|Withdrawal by Subject|5|||
13326552|NCT01142791|26584877|FG001|Overall Study|Withdrawal by Subject|0|||
13326553|NCT01142791|26584876|FG000|Overall Study|Received only 1 sonication|0|||
13326554|NCT01142791|26584877|FG001|Overall Study|Received only 1 sonication|6|||
13326555|NCT01142726|26584950|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
13326556|NCT01142726|26584951|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8|||
13326557|NCT01142726|26584952|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
13326558|NCT01142726|26584950|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4|||
13326559|NCT01142726|26584951|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9|||
13326560|NCT01142726|26584952|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3|||
13326561|NCT01142726|26584950|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
13326562|NCT01142726|26584951|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2|||
13326563|NCT01142726|26584952|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
13326564|NCT01142726|26584950|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1|||
13326565|NCT01142726|26584951|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
13326566|NCT01142726|26584952|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
13326567|NCT01142726|26584950|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5|||
13326568|NCT01142726|26584951|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6|||
13326569|NCT01142726|26584952|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11|||
13326570|NCT01142726|26584950|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
13326571|NCT01142726|26584951|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
13326572|NCT01142726|26584952|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1|||
13326573|NCT01142726|26584950|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
13326574|NCT01142726|26584951|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
13326575|NCT01142726|26584952|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2|||
13326576|NCT01142726|26584950|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
13326577|NCT01142726|26584951|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0|||
13326578|NCT01142726|26584952|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
13326579|NCT01142726|26584950|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2|||
13326580|NCT01142726|26584951|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
13326581|NCT01142726|26584952|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
13326582|NCT01142726|26584950|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1|||
13326583|NCT01142726|26584951|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
13326584|NCT01142726|26584952|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
13326585|NCT01142726|26584950|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65|||
13326586|NCT01142726|26584951|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54|||
13326587|NCT01142726|26584952|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53|||
13326588|NCT01142726|26584950|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0|||
13326589|NCT01142726|26584951|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
13326590|NCT01142726|26584952|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
13326591|NCT01142726|26584950|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
13326592|NCT01142726|26584951|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
13326593|NCT01142726|26584952|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1|||
13326594|NCT01142726|26584950|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
13326595|NCT01142726|26584951|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
13326596|NCT01142726|26584952|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
13326597|NCT01142726|26584950|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
13326598|NCT01142726|26584951|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
13326599|NCT01142726|26584952|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1|||
13326600|NCT01142726|26584950|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
13326601|NCT01142726|26584951|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1|||
13326602|NCT01142726|26584952|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
13326603|NCT01142661|26584959|FG000|Overall Study|Adverse Event|2|||
13326604|NCT01142661|26584959|FG000|Overall Study|Withdrawal by Subject|1|||
13326605|NCT01142661|26584959|FG000|Overall Study|Physician Decision|1|||
13326606|NCT01142596|26585016|FG000|Overall Study|Withdrawal by Subject|9|||
13326607|NCT01142596|26585017|FG001|Overall Study|Withdrawal by Subject|35|||
13326608|NCT01142596|26585016|FG000|Overall Study|Adverse Event|8|||
13326609|NCT01142596|26585017|FG001|Overall Study|Adverse Event|35|||
13326610|NCT01142596|26585016|FG000|Overall Study|Lack of Efficacy|5|||
13326611|NCT01142596|26585017|FG001|Overall Study|Lack of Efficacy|9|||
13326612|NCT01142596|26585016|FG000|Overall Study|Lost to Follow-up|2|||
13326613|NCT01142596|26585017|FG001|Overall Study|Lost to Follow-up|3|||
13326614|NCT01142596|26585016|FG000|Overall Study|Other reason (not specified)|5|||
13326615|NCT01142596|26585017|FG001|Overall Study|Other reason (not specified)|4|||
13326616|NCT01142466|26585042|FG000|Overall Study|Adverse Event|2|||
13326617|NCT01142466|26585043|FG001|Overall Study|Adverse Event|1|||
13326618|NCT01142466|26585042|FG000|Overall Study|Withdrawal by Subject|1|||
13326619|NCT01142466|26585043|FG001|Overall Study|Withdrawal by Subject|1|||
13326620|NCT01142388|26585060|FG000|Overall Study|Lack of Efficacy|21|||
13326621|NCT01142388|26585061|FG001|Overall Study|Lack of Efficacy|31|||
13326622|NCT01142388|26585060|FG000|Overall Study|Adverse Event|9|||
13326623|NCT01142388|26585061|FG001|Overall Study|Adverse Event|5|||
13326624|NCT01142388|26585060|FG000|Overall Study|Death|3|||
13326625|NCT01142388|26585061|FG001|Overall Study|Death|2|||
13326626|NCT01142388|26585060|FG000|Overall Study|Withdrawal by Subject|5|||
13326627|NCT01142388|26585061|FG001|Overall Study|Withdrawal by Subject|3|||
13326628|NCT01142388|26585060|FG000|Overall Study|Alternative therapy|1|||
13326629|NCT01142388|26585061|FG001|Overall Study|Alternative therapy|0|||
13326630|NCT01142388|26585060|FG000|Overall Study|Other complications|0|||
13326631|NCT01142388|26585061|FG001|Overall Study|Other complications|2|||
13326632|NCT01142388|26585060|FG000|Overall Study|Other|1|||
13326633|NCT01142388|26585061|FG001|Overall Study|Other|1|||
13326634|NCT01142388|26585060|FG000|Overall Study|Never started therapy|7|||
13326635|NCT01142388|26585061|FG001|Overall Study|Never started therapy|3|||
13326636|NCT01142336|26585078|FG000|Overall Study|Adverse Event|1|||
13326637|NCT01142336|26585079|FG001|Overall Study|Adverse Event|1|||
13326638|NCT01142336|26585078|FG000|Overall Study|Lost to Follow-up|0|||
13326639|NCT01142336|26585079|FG001|Overall Study|Lost to Follow-up|1|||
13326640|NCT01142232|26585108|FG000|Overall Study|Adverse Event|1|||
13326641|NCT01142232|26585109|FG001|Overall Study|Adverse Event|2|||
13326642|NCT01142232|26585110|FG002|Overall Study|Adverse Event|1|||
13326643|NCT01142232|26585111|FG003|Overall Study|Adverse Event|0|||
13326644|NCT01142232|26585112|FG004|Overall Study|Adverse Event|4|||
13326645|NCT01142232|26585108|FG000|Overall Study|Death|0|||
13326646|NCT01142232|26585109|FG001|Overall Study|Death|0|||
13326647|NCT01142232|26585110|FG002|Overall Study|Death|0|||
13326648|NCT01142232|26585111|FG003|Overall Study|Death|0|||
13326649|NCT01142232|26585112|FG004|Overall Study|Death|1|||
13326650|NCT01142232|26585108|FG000|Overall Study|Disease Progression|2|||
13326651|NCT01142232|26585109|FG001|Overall Study|Disease Progression|0|||
13326652|NCT01142232|26585110|FG002|Overall Study|Disease Progression|1|||
13326653|NCT01142232|26585111|FG003|Overall Study|Disease Progression|2|||
13326654|NCT01142232|26585112|FG004|Overall Study|Disease Progression|12|||
13326655|NCT01142232|26585108|FG000|Overall Study|Withdrawal by Subject|0|||
13326656|NCT01142232|26585109|FG001|Overall Study|Withdrawal by Subject|0|||
13326657|NCT01142232|26585110|FG002|Overall Study|Withdrawal by Subject|0|||
13326658|NCT01142232|26585111|FG003|Overall Study|Withdrawal by Subject|1|||
13326659|NCT01142232|26585112|FG004|Overall Study|Withdrawal by Subject|3|||
13326660|NCT01142232|26585108|FG000|Overall Study|Physician Decision|0|||
13326661|NCT01142232|26585109|FG001|Overall Study|Physician Decision|1|||
13326662|NCT01142232|26585110|FG002|Overall Study|Physician Decision|0|||
13326663|NCT01142232|26585111|FG003|Overall Study|Physician Decision|2|||
13326664|NCT01142232|26585112|FG004|Overall Study|Physician Decision|10|||
13326665|NCT01142232|26585108|FG000|Overall Study|Alternative Therapy|0|||
13326666|NCT01142232|26585109|FG001|Overall Study|Alternative Therapy|1|||
13326667|NCT01142232|26585110|FG002|Overall Study|Alternative Therapy|1|||
13326668|NCT01142232|26585111|FG003|Overall Study|Alternative Therapy|0|||
13326669|NCT01142232|26585112|FG004|Overall Study|Alternative Therapy|1|||
13326670|NCT01142232|26585108|FG000|Overall Study|Off Trt for other complicating disease|0|||
13326671|NCT01142232|26585109|FG001|Overall Study|Off Trt for other complicating disease|0|||
13326672|NCT01142232|26585110|FG002|Overall Study|Off Trt for other complicating disease|0|||
13326673|NCT01142232|26585111|FG003|Overall Study|Off Trt for other complicating disease|0|||
13326674|NCT01142232|26585112|FG004|Overall Study|Off Trt for other complicating disease|1|||
13326675|NCT01142232|26585108|FG000|Overall Study|Noncompliance|0|||
13326676|NCT01142232|26585109|FG001|Overall Study|Noncompliance|0|||
13326677|NCT01142232|26585110|FG002|Overall Study|Noncompliance|0|||
13326678|NCT01142232|26585111|FG003|Overall Study|Noncompliance|0|||
13326679|NCT01142232|26585112|FG004|Overall Study|Noncompliance|2|||
13326680|NCT01142193|26585143|FG000|Overall Study|Adverse Event|12|||
13122308|NCT02966223|25946674|FG000|Overall Study|Withdrawal by Subject|11|||
13122309|NCT02966223|25946674|FG000|Overall Study|Lost to Follow-up|1|||
13122310|NCT02966028|25946730|FG000|Overall Study|Adverse Event|7|||
13122311|NCT02966028|25946731|FG001|Overall Study|Adverse Event|13|||
13122312|NCT02966028|25946732|FG002|Overall Study|Adverse Event|10|||
13122313|NCT02966028|25946730|FG000|Overall Study|Physician Decision|1|||
13326681|NCT01142193|26585144|FG001|Overall Study|Adverse Event|4|||
13326682|NCT01142193|26585143|FG000|Overall Study|Lack of Efficacy|2|||
13326683|NCT01142193|26585144|FG001|Overall Study|Lack of Efficacy|1|||
13326684|NCT01142193|26585143|FG000|Overall Study|Physician Decision|1|||
13326685|NCT01142193|26585144|FG001|Overall Study|Physician Decision|1|||
13326686|NCT01142193|26585143|FG000|Overall Study|Withdrawal by Subject|4|||
13326687|NCT01142193|26585144|FG001|Overall Study|Withdrawal by Subject|3|||
13326688|NCT01142193|26585143|FG000|Overall Study|Protocol Discontinuation Criterion Met|1|||
13326689|NCT01142193|26585144|FG001|Overall Study|Protocol Discontinuation Criterion Met|0|||
13326690|NCT01142193|26585143|FG000|Overall Study|Other|1|||
13326691|NCT01142193|26585144|FG001|Overall Study|Other|2|||
13326692|NCT01142128|26585164|FG000|Overall Study|Physician Decision|1|||
13326693|NCT01142128|26585164|FG000|Overall Study|Lost to Follow-up|1|||
13326694|NCT01142128|26585164|FG000|Overall Study|Withdrawal by Subject|2|||
13326695|NCT01142115|26585182|FG000|First Intervention|Lack of Efficacy|1|||
13326696|NCT01142115|26585183|FG001|First Intervention|Lack of Efficacy|1|||
13326697|NCT01142115|26585182|FG000|First Intervention|Adverse Event|1|||
13326698|NCT01142115|26585183|FG001|First Intervention|Adverse Event|0|||
13326699|NCT01142089|26585198|FG000|Overall Study|Physician Decision|1|||
13326700|NCT01142089|26585199|FG001|Overall Study|Physician Decision|0|||
13326701|NCT01142089|26585198|FG000|Overall Study|Withdrawal by Subject|1|||
13326702|NCT01142089|26585199|FG001|Overall Study|Withdrawal by Subject|2|||
13326703|NCT01142089|26585198|FG000|Overall Study|Use of prohibited medications|0|||
13326704|NCT01142089|26585199|FG001|Overall Study|Use of prohibited medications|1|||
13326705|NCT01142089|26585198|FG000|Overall Study|Noncompliance with study procedures|2|||
13326706|NCT01142089|26585199|FG001|Overall Study|Noncompliance with study procedures|1|||
13326707|NCT01142089|26585198|FG000|Overall Study|Patient required rescue medication|8|||
13326708|NCT01142089|26585199|FG001|Overall Study|Patient required rescue medication|17|||
13326709|NCT01141660|26585214|FG000|Overall Study|Physician Decision|0|||
13326710|NCT01141660|26585215|FG001|Overall Study|Physician Decision|12|||
13326711|NCT01141478|26585228|FG000|Overall Study|Withdrawal by Subject|1|||
13326712|NCT01141478|26585229|FG001|Overall Study|Withdrawal by Subject|1|||
13326713|NCT01141283|26585235|FG000|Overall Study|Adverse Event|56|||
13326714|NCT01141283|26585235|FG000|Overall Study|Lost to Follow-up|4|||
13326715|NCT01141283|26585235|FG000|Overall Study|Withdrawal by Subject|14|||
13326716|NCT01141283|26585235|FG000|Overall Study|Administrative|4|||
13326717|NCT01141283|26585235|FG000|Overall Study|Lack of Efficacy|10|||
13326718|NCT01141205|26585254|FG000|Overall Study|Physician Decision|1|||
13326719|NCT01141205|26585255|FG001|Overall Study|Physician Decision|1|||
13326720|NCT01141205|26585254|FG000|Overall Study|Lost to Follow-up|1|||
13326721|NCT01141205|26585255|FG001|Overall Study|Lost to Follow-up|0|||
13326722|NCT01141205|26585254|FG000|Overall Study|Withdrawal by Subject|1|||
13326723|NCT01141205|26585255|FG001|Overall Study|Withdrawal by Subject|1|||
13326724|NCT01140906|26585306|FG000|Overall Study|Adverse Event|7|||
13326725|NCT01140906|26585307|FG001|Overall Study|Adverse Event|10|||
13326726|NCT01140906|26585308|FG002|Overall Study|Adverse Event|17|||
13326727|NCT01140906|26585309|FG003|Overall Study|Adverse Event|7|||
13326728|NCT01140906|26585306|FG000|Overall Study|Lack of Efficacy|6|||
13326729|NCT01140906|26585307|FG001|Overall Study|Lack of Efficacy|8|||
13326730|NCT01140906|26585308|FG002|Overall Study|Lack of Efficacy|2|||
13326731|NCT01140906|26585309|FG003|Overall Study|Lack of Efficacy|1|||
13326732|NCT01140906|26585306|FG000|Overall Study|Non-compliance|0|||
13326733|NCT01140906|26585307|FG001|Overall Study|Non-compliance|1|||
13326734|NCT01140906|26585308|FG002|Overall Study|Non-compliance|0|||
13326735|NCT01140906|26585309|FG003|Overall Study|Non-compliance|1|||
13326736|NCT01140906|26585306|FG000|Overall Study|Protocol Violation|5|||
13326737|NCT01140906|26585307|FG001|Overall Study|Protocol Violation|3|||
13326738|NCT01140906|26585308|FG002|Overall Study|Protocol Violation|2|||
13326739|NCT01140906|26585309|FG003|Overall Study|Protocol Violation|1|||
13326740|NCT01140906|26585306|FG000|Overall Study|Withdrawal of consent|6|||
13326741|NCT01140906|26585307|FG001|Overall Study|Withdrawal of consent|6|||
13326742|NCT01140906|26585308|FG002|Overall Study|Withdrawal of consent|2|||
13326743|NCT01140906|26585309|FG003|Overall Study|Withdrawal of consent|2|||
13326744|NCT01140906|26585306|FG000|Overall Study|Lost to Follow-up|1|||
13326745|NCT01140906|26585307|FG001|Overall Study|Lost to Follow-up|1|||
13326746|NCT01140906|26585308|FG002|Overall Study|Lost to Follow-up|0|||
13326747|NCT01140906|26585309|FG003|Overall Study|Lost to Follow-up|2|||
13326748|NCT01140906|26585306|FG000|Overall Study|Administrative or other reason|0|||
13326749|NCT01140906|26585307|FG001|Overall Study|Administrative or other reason|5|||
13326750|NCT01140906|26585308|FG002|Overall Study|Administrative or other reason|3|||
13326751|NCT01140906|26585309|FG003|Overall Study|Administrative or other reason|2|||
13326752|NCT01140880|26585328|FG000|Overall Study|Death|0|||
13326753|NCT01140880|26585329|FG001|Overall Study|Death|1|||
13326754|NCT01140880|26585328|FG000|Overall Study|Withdrawal by Subject|6|||
13326755|NCT01140880|26585329|FG001|Overall Study|Withdrawal by Subject|3|||
13326756|NCT01140880|26585328|FG000|Overall Study|Lost to Follow-up|8|||
13326757|NCT01140880|26585329|FG001|Overall Study|Lost to Follow-up|10|||
13326758|NCT01140880|26585328|FG000|Overall Study|Protocol Violation|0|||
13326759|NCT01140880|26585329|FG001|Overall Study|Protocol Violation|30|||
13326760|NCT01140646|26585339|FG000|Overall Study|Adverse Event|4|||
13326761|NCT01140646|26585339|FG000|Overall Study|Refused Further Treatment|5|||
13326762|NCT01140568|26585346|FG000|Overall Study|disease progression|31|||
13326763|NCT01140568|26585346|FG000|Overall Study|Withdrawal by Subject|1|||
13326764|NCT01140568|26585346|FG000|Overall Study|Screen Fail|4|||
13326765|NCT01140503|26585354|FG000|Overall Study|Withdrawal by Subject|1|||
13326766|NCT01140477|26585370|FG000|Overall Study|Lost to Follow-up|4|||
13326767|NCT01140477|26585371|FG001|Overall Study|Lost to Follow-up|0|||
13326768|NCT01140477|26585370|FG000|Overall Study|Withdrawal by Subject|1|||
13326769|NCT01140477|26585371|FG001|Overall Study|Withdrawal by Subject|4|||
13326770|NCT01140477|26585370|FG000|Overall Study|Surgical complication preventing implant|2|||
13326771|NCT01140477|26585371|FG001|Overall Study|Surgical complication preventing implant|0|||
13326772|NCT01140477|26585370|FG000|Overall Study|Death|1|||
13326773|NCT01140477|26585371|FG001|Overall Study|Death|1|||
13326774|NCT01140477|26585370|FG000|Overall Study|Subject explanted|0|||
13326775|NCT01140477|26585371|FG001|Overall Study|Subject explanted|1|||
13326776|NCT01140451|26585437|FG000|Overall Study|Withdrawal by Subject|26|||
13326777|NCT01140451|26585438|FG001|Overall Study|Withdrawal by Subject|33|||
13326778|NCT01140451|26585437|FG000|Overall Study|Adverse Event|2|||
13326779|NCT01140451|26585438|FG001|Overall Study|Adverse Event|6|||
13326780|NCT01140451|26585437|FG000|Overall Study|Physician Decision|5|||
13326781|NCT01140451|26585438|FG001|Overall Study|Physician Decision|3|||
13326782|NCT01140451|26585437|FG000|Overall Study|Lost to Follow-up|2|||
13326783|NCT01140451|26585438|FG001|Overall Study|Lost to Follow-up|0|||
13326784|NCT01140451|26585437|FG000|Overall Study|Participants Planning Pregnancy|3|||
13326785|NCT01140451|26585438|FG001|Overall Study|Participants Planning Pregnancy|0|||
13326786|NCT01140347|26585468|FG000|Overall Study|Lost to Follow-up|5|||
13326787|NCT01140347|26585469|FG001|Overall Study|Lost to Follow-up|6|||
13326788|NCT01140347|26585468|FG000|Overall Study|Withdrawal by Subject|13|||
13326789|NCT01140347|26585469|FG001|Overall Study|Withdrawal by Subject|8|||
13326790|NCT01140061|26585527|FG000|Part I|Adverse Event|1|||
13326791|NCT01140061|26585528|FG001|Part I|Adverse Event|0|||
13326792|NCT01140061|26585529|FG002|Part I|Adverse Event|0|||
13326793|NCT01140061|26585530|FG003|Part I|Adverse Event|0|||
13326794|NCT01140061|26585531|FG004|Part I|Adverse Event|0|||
13326795|NCT01140061|26585532|FG005|Part I|Adverse Event|0|||
13326796|NCT01140061|26585533|FG006|Part I|Adverse Event|0|||
13326797|NCT01140061|26585534|FG007|Part I|Adverse Event|0|||
13326798|NCT01140061|26585535|FG008|Part I|Adverse Event|0|||
13326799|NCT01140061|26585536|FG009|Part I|Adverse Event|0|||
13326800|NCT01140061|26585527|FG000|Extension|Laboratory Adverse Event|0|||
13326801|NCT01140061|26585528|FG001|Extension|Laboratory Adverse Event|0|||
13326802|NCT01140061|26585529|FG002|Extension|Laboratory Adverse Event|0|||
13326803|NCT01140061|26585530|FG003|Extension|Laboratory Adverse Event|0|||
13326804|NCT01140061|26585531|FG004|Extension|Laboratory Adverse Event|0|||
13326805|NCT01140061|26585532|FG005|Extension|Laboratory Adverse Event|0|||
13326806|NCT01140061|26585533|FG006|Extension|Laboratory Adverse Event|0|||
13326807|NCT01140061|26585534|FG007|Extension|Laboratory Adverse Event|0|||
13326808|NCT01140061|26585535|FG008|Extension|Laboratory Adverse Event|0|||
13326809|NCT01140061|26585536|FG009|Extension|Laboratory Adverse Event|1|||
13326810|NCT01139775|26585576|FG000|Overall Study|Adverse Event|0|||
13326811|NCT01139775|26585577|FG001|Overall Study|Adverse Event|6|||
13326812|NCT01139775|26585578|FG002|Overall Study|Adverse Event|2|||
13326813|NCT01139775|26585576|FG000|Overall Study|Protocol Violation|0|||
13326814|NCT01139775|26585577|FG001|Overall Study|Protocol Violation|5|||
13326815|NCT01139775|26585578|FG002|Overall Study|Protocol Violation|0|||
13326816|NCT01139775|26585576|FG000|Overall Study|Withdrawal by Subject|1|||
13326817|NCT01139775|26585577|FG001|Overall Study|Withdrawal by Subject|0|||
13326818|NCT01139775|26585578|FG002|Overall Study|Withdrawal by Subject|2|||
13326819|NCT01139775|26585576|FG000|Overall Study|Physician Decision|0|||
13326820|NCT01139775|26585577|FG001|Overall Study|Physician Decision|2|||
13326821|NCT01139775|26585578|FG002|Overall Study|Physician Decision|2|||
13326822|NCT01139762|26585619|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258|||
13326823|NCT01139762|26585620|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
13326824|NCT01139762|26585621|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
13326825|NCT01139762|26585619|FG000|Washout and Placebo Lead-In Period|Adverse Event|1|||
13326826|NCT01139762|26585620|FG001|Washout and Placebo Lead-In Period|Adverse Event|0|||
13326827|NCT01139762|26585621|FG002|Washout and Placebo Lead-In Period|Adverse Event|0|||
13326828|NCT01139762|26585619|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83|||
13326829|NCT01139762|26585620|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
13326830|NCT01139762|26585621|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
13326831|NCT01139762|26585619|FG000|Washout and Placebo Lead-In Period|Physician Decision|12|||
13326832|NCT01139762|26585620|FG001|Washout and Placebo Lead-In Period|Physician Decision|0|||
13326833|NCT01139762|26585621|FG002|Washout and Placebo Lead-In Period|Physician Decision|0|||
13326834|NCT01139762|26585619|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10|||
13326835|NCT01139762|26585620|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
13326836|NCT01139762|26585621|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
13326837|NCT01139762|26585619|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10|||
13326838|NCT01139762|26585620|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
13326839|NCT01139762|26585621|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
13326840|NCT01139762|26585619|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0|||
13326841|NCT01139762|26585620|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4|||
13326842|NCT01139762|26585621|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10|||
13326843|NCT01139762|26585619|FG000|Double-Blind Randomized Active Treatment|Death|0|||
13326844|NCT01139762|26585620|FG001|Double-Blind Randomized Active Treatment|Death|1|||
13326845|NCT01139762|26585621|FG002|Double-Blind Randomized Active Treatment|Death|1|||
13326846|NCT01139762|26585619|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0|||
13326847|NCT01139762|26585620|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14|||
13326848|NCT01139762|26585621|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17|||
13326849|NCT01139762|26585619|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0|||
13326850|NCT01139762|26585620|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2|||
13326851|NCT01139762|26585621|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8|||
13326852|NCT01139762|26585619|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0|||
13326853|NCT01139762|26585620|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6|||
13326854|NCT01139762|26585621|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13|||
13326855|NCT01139762|26585619|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0|||
13326856|NCT01139762|26585620|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2|||
13326857|NCT01139762|26585621|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0|||
13326858|NCT01139762|26585619|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0|||
13326859|NCT01139762|26585620|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5|||
13326860|NCT01139762|26585621|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6|||
13326861|NCT01139762|26585619|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0|||
13326862|NCT01139762|26585620|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3|||
13326863|NCT01139762|26585621|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5|||
13326864|NCT01139762|26585619|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0|||
13326865|NCT01139762|26585620|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3|||
13326866|NCT01139762|26585621|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4|||
13326867|NCT01139658|26585664|FG000|Overall Study|Adverse Event|10|||
13326868|NCT01139658|26585665|FG001|Overall Study|Adverse Event|27|||
13326869|NCT01139658|26585664|FG000|Overall Study|Lack of Efficacy|15|||
13326870|NCT01139658|26585665|FG001|Overall Study|Lack of Efficacy|7|||
13326871|NCT01139658|26585664|FG000|Overall Study|Withdrawal by Subject|2|||
13326872|NCT01139658|26585665|FG001|Overall Study|Withdrawal by Subject|4|||
13326873|NCT01139658|26585664|FG000|Overall Study|No documentation of treatment|1|||
13326874|NCT01139658|26585665|FG001|Overall Study|No documentation of treatment|0|||
13326875|NCT01139658|26585664|FG000|Overall Study|Other|28|||
13326876|NCT01139658|26585665|FG001|Overall Study|Other|75|||
13326877|NCT01139580|26585688|FG000|Overall Study|Adverse Event|5|||
13326878|NCT01139580|26585689|FG001|Overall Study|Adverse Event|4|||
13326879|NCT01139580|26585688|FG000|Overall Study|Lost to Follow-up|9|||
13326880|NCT01139580|26585689|FG001|Overall Study|Lost to Follow-up|1|||
13326881|NCT01139580|26585688|FG000|Overall Study|Lack of Efficacy|0|||
13326882|NCT01139580|26585689|FG001|Overall Study|Lack of Efficacy|2|||
13326883|NCT01139580|26585688|FG000|Overall Study|Withdrawal by Subject|6|||
13326884|NCT01139580|26585689|FG001|Overall Study|Withdrawal by Subject|9|||
13326885|NCT01139580|26585688|FG000|Overall Study|Used Excluded Medicine After Enrollment|1|||
13326886|NCT01139580|26585689|FG001|Overall Study|Used Excluded Medicine After Enrollment|0|||
13326887|NCT01139580|26585688|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
13326888|NCT01139580|26585689|FG001|Overall Study|Did Not Meet Exclusion Criteria|0|||
13326889|NCT01139580|26585688|FG000|Overall Study|Misrandomized|1|||
13326890|NCT01139580|26585689|FG001|Overall Study|Misrandomized|0|||
13326891|NCT01139580|26585688|FG000|Overall Study|Beginning Study Exclusion Treatment|0|||
13326892|NCT01139580|26585689|FG001|Overall Study|Beginning Study Exclusion Treatment|1|||
13326893|NCT01139580|26585688|FG000|Overall Study|Participant Randomization in Error|0|||
13326894|NCT01139580|26585689|FG001|Overall Study|Participant Randomization in Error|1|||
13326895|NCT01139450|26585707|FG000|Overall Study|Withdrawal by Subject|7|||
13326896|NCT01139450|26585708|FG001|Overall Study|Withdrawal by Subject|10|||
13326897|NCT01139450|26585709|FG002|Overall Study|Withdrawal by Subject|13|||
13326898|NCT01139450|26585707|FG000|Overall Study|Lack of Efficacy|3|||
13486402|NCT03645863|27036045|FG002|Overall Study|Withdrawal by Subject|0|||
13326899|NCT01139450|26585708|FG001|Overall Study|Lack of Efficacy|1|||
13326900|NCT01139450|26585709|FG002|Overall Study|Lack of Efficacy|8|||
13326901|NCT01139450|26585707|FG000|Overall Study|Protocol Violation|6|||
13326902|NCT01139450|26585708|FG001|Overall Study|Protocol Violation|5|||
13326903|NCT01139450|26585709|FG002|Overall Study|Protocol Violation|2|||
13326904|NCT01139450|26585707|FG000|Overall Study|Lost to Follow-up|9|||
13326905|NCT01139450|26585708|FG001|Overall Study|Lost to Follow-up|7|||
13326906|NCT01139450|26585709|FG002|Overall Study|Lost to Follow-up|11|||
13326907|NCT01139450|26585707|FG000|Overall Study|Administrative|0|||
13326908|NCT01139450|26585708|FG001|Overall Study|Administrative|0|||
13326909|NCT01139450|26585709|FG002|Overall Study|Administrative|1|||
13326910|NCT01139450|26585707|FG000|Overall Study|Adverse Event|2|||
13326911|NCT01139450|26585708|FG001|Overall Study|Adverse Event|2|||
13326912|NCT01139450|26585709|FG002|Overall Study|Adverse Event|3|||
13326913|NCT01139164|26585733|FG000|Overall Study|Withdrawn prior to study start|0|||
13326914|NCT01139164|26585734|FG001|Overall Study|Withdrawn prior to study start|2|||
13326915|NCT01139164|26585735|FG002|Overall Study|Withdrawn prior to study start|0|||
13326916|NCT01139125|26585741|FG000|Overall Study|Withdrawal by Subject|1|||
13326917|NCT01139047|26585752|FG000|Overall Study|Withdrawal by Subject|1|||
13326918|NCT01139021|26585807|FG000|Overall Study|Adverse Event|0|||
13326919|NCT01139021|26585808|FG001|Overall Study|Adverse Event|0|||
13326920|NCT01139021|26585809|FG002|Overall Study|Adverse Event|0|||
13326921|NCT01139021|26585810|FG003|Overall Study|Adverse Event|0|||
13326922|NCT01139021|26585811|FG004|Overall Study|Adverse Event|1|||
13326923|NCT01139021|26585812|FG005|Overall Study|Adverse Event|0|||
13326924|NCT01139021|26585807|FG000|Overall Study|Lost to Follow-up|0|||
13326925|NCT01139021|26585808|FG001|Overall Study|Lost to Follow-up|0|||
13326926|NCT01139021|26585809|FG002|Overall Study|Lost to Follow-up|0|||
13326927|NCT01139021|26585810|FG003|Overall Study|Lost to Follow-up|0|||
13326928|NCT01139021|26585811|FG004|Overall Study|Lost to Follow-up|2|||
13326929|NCT01139021|26585812|FG005|Overall Study|Lost to Follow-up|0|||
13326930|NCT01139021|26585807|FG000|Overall Study|Protocol Violation|1|||
13326931|NCT01139021|26585808|FG001|Overall Study|Protocol Violation|0|||
13326932|NCT01139021|26585809|FG002|Overall Study|Protocol Violation|0|||
13326933|NCT01139021|26585810|FG003|Overall Study|Protocol Violation|0|||
13326934|NCT01139021|26585811|FG004|Overall Study|Protocol Violation|2|||
13326935|NCT01139021|26585812|FG005|Overall Study|Protocol Violation|0|||
13326936|NCT01139021|26585807|FG000|Overall Study|Withdrawal by Subject|0|||
13326937|NCT01139021|26585808|FG001|Overall Study|Withdrawal by Subject|0|||
13326938|NCT01139021|26585809|FG002|Overall Study|Withdrawal by Subject|0|||
13326939|NCT01139021|26585810|FG003|Overall Study|Withdrawal by Subject|1|||
13326940|NCT01139021|26585811|FG004|Overall Study|Withdrawal by Subject|4|||
13326941|NCT01139021|26585812|FG005|Overall Study|Withdrawal by Subject|0|||
13326942|NCT01139008|26585823|FG000|Overall Study|Withdrawal by Subject|5|||
13326943|NCT01139008|26585823|FG000|Overall Study|Non-compliant, lost product|1|||
13326944|NCT01138826|26585850|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
13326945|NCT01138826|26585851|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
13326946|NCT01138826|26585852|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
13326947|NCT01138826|26585853|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
13326948|NCT01138826|26585854|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
13326949|NCT01138826|26585855|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
13326950|NCT01138657|26585906|FG000|Overall Study|Adverse Event|3|||
13326951|NCT01138657|26585907|FG001|Overall Study|Adverse Event|10|||
13326952|NCT01138657|26585906|FG000|Overall Study|Lack of Efficacy|2|||
13326953|NCT01138657|26585907|FG001|Overall Study|Lack of Efficacy|1|||
13326954|NCT01138657|26585906|FG000|Overall Study|Lost to Follow-up|0|||
13326955|NCT01138657|26585907|FG001|Overall Study|Lost to Follow-up|3|||
13326956|NCT01138657|26585906|FG000|Overall Study|Miscellaneous Reasons|3|||
13326957|NCT01138657|26585907|FG001|Overall Study|Miscellaneous Reasons|4|||
13326958|NCT01138501|26585914|FG000|Overall Study|Protocol Violation|2|||
13326959|NCT01138501|26585914|FG000|Overall Study|Withdrawal by Subject|3|||
13326960|NCT01138150|26585973|FG000|Overall Study|blood unable to be processed|0|||
13326961|NCT01138150|26585974|FG001|Overall Study|blood unable to be processed|1|||
13326962|NCT01138150|26585973|FG000|Overall Study|Physician Decision|1|||
13326963|NCT01138150|26585974|FG001|Overall Study|Physician Decision|0|||
13326964|NCT01138111|26586005|FG000|Overall Study|Withdrawal by Subject|5|||
13326965|NCT01138111|26586005|FG000|Overall Study|Adverse Event|1|||
13326966|NCT01138111|26586005|FG000|Overall Study|Death|1|||
13326967|NCT01138111|26586005|FG000|Overall Study|Lost to Follow-up|2|||
13326968|NCT01138046|26586024|FG000|Overall Study|Withdrawal due to death|6|||
13326969|NCT01138007|26586066|FG000|Overall Study|Adverse Event|4|||
13326970|NCT01138007|26586067|FG001|Overall Study|Adverse Event|12|||
13326971|NCT01138007|26586068|FG002|Overall Study|Adverse Event|9|||
13326972|NCT01138007|26586066|FG000|Overall Study|Lack of Efficacy|2|||
13326973|NCT01138007|26586067|FG001|Overall Study|Lack of Efficacy|0|||
13326974|NCT01138007|26586068|FG002|Overall Study|Lack of Efficacy|6|||
13326975|NCT01138007|26586066|FG000|Overall Study|Protocol Violation|2|||
13326976|NCT01138007|26586067|FG001|Overall Study|Protocol Violation|3|||
13326977|NCT01138007|26586068|FG002|Overall Study|Protocol Violation|2|||
13326978|NCT01138007|26586066|FG000|Overall Study|Protocol-Defined Stopping Criteria|6|||
13326979|NCT01138007|26586067|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
13326980|NCT01138007|26586068|FG002|Overall Study|Protocol-Defined Stopping Criteria|8|||
13326981|NCT01138007|26586066|FG000|Overall Study|Lost to Follow-up|3|||
13326982|NCT01138007|26586067|FG001|Overall Study|Lost to Follow-up|3|||
13326983|NCT01138007|26586068|FG002|Overall Study|Lost to Follow-up|5|||
13326984|NCT01138007|26586066|FG000|Overall Study|Physician Decision|0|||
13326985|NCT01138007|26586067|FG001|Overall Study|Physician Decision|5|||
13326986|NCT01138007|26586068|FG002|Overall Study|Physician Decision|3|||
13326987|NCT01138007|26586066|FG000|Overall Study|Withdrawal by Subject|5|||
13326988|NCT01138007|26586067|FG001|Overall Study|Withdrawal by Subject|6|||
13326989|NCT01138007|26586068|FG002|Overall Study|Withdrawal by Subject|15|||
13326990|NCT01137955|26586087|FG000|Overall Study|Withdrawal by Subject|5|||
13326991|NCT01137955|26586088|FG001|Overall Study|Withdrawal by Subject|4|||
13326992|NCT01137812|26586113|FG000|Overall Study|Adverse Event|21|||
13326993|NCT01137812|26586114|FG001|Overall Study|Adverse Event|14|||
13326994|NCT01137812|26586113|FG000|Overall Study|Lost to Follow-up|6|||
13326995|NCT01137812|26586114|FG001|Overall Study|Lost to Follow-up|8|||
13326996|NCT01137812|26586113|FG000|Overall Study|Physician Decision|25|||
13326997|NCT01137812|26586114|FG001|Overall Study|Physician Decision|17|||
13326998|NCT01137812|26586113|FG000|Overall Study|Protocol Violation|5|||
13326999|NCT01137812|26586114|FG001|Overall Study|Protocol Violation|4|||
13327000|NCT01137812|26586113|FG000|Overall Study|Withdrawal by Subject|5|||
13327001|NCT01137812|26586114|FG001|Overall Study|Withdrawal by Subject|13|||
13327002|NCT01137812|26586113|FG000|Overall Study|Death|2|||
13327003|NCT01137812|26586114|FG001|Overall Study|Death|0|||
13327004|NCT01137812|26586113|FG000|Overall Study|Patient met glycemic withdrawal criteria|40|||
13327005|NCT01137812|26586114|FG001|Overall Study|Patient met glycemic withdrawal criteria|85|||
13327006|NCT01137812|26586113|FG000|Overall Study|Other|19|||
13327007|NCT01137812|26586114|FG001|Overall Study|Other|27|||
13327008|NCT01137786|26586129|FG000|Overall Study|Lost to Follow-up|0|||
13327009|NCT01137786|26586130|FG001|Overall Study|Lost to Follow-up|2|||
13327010|NCT01137786|26586129|FG000|Overall Study|Withdrawal by Subject|1|||
13327011|NCT01137786|26586130|FG001|Overall Study|Withdrawal by Subject|1|||
13327012|NCT01137682|26586186|FG000|Overall Study|Adverse Event-CORE|2|||
13327013|NCT01137682|26586187|FG001|Overall Study|Adverse Event-CORE|4|||
13327014|NCT01137682|26586188|FG002|Overall Study|Adverse Event-CORE|0|||
13327015|NCT01137682|26586186|FG000|Overall Study|Withdrawal by Subject-CORE|2|||
13327016|NCT01137682|26586187|FG001|Overall Study|Withdrawal by Subject-CORE|2|||
13327017|NCT01137682|26586188|FG002|Overall Study|Withdrawal by Subject-CORE|2|||
13327018|NCT01137682|26586186|FG000|Overall Study|Administrative problems-CORE|2|||
13327019|NCT01137682|26586187|FG001|Overall Study|Administrative problems-CORE|1|||
13327020|NCT01137682|26586188|FG002|Overall Study|Administrative problems-CORE|0|||
13327021|NCT01137682|26586186|FG000|Overall Study|Protocol Violation-CORE|0|||
13327022|NCT01137682|26586187|FG001|Overall Study|Protocol Violation-CORE|1|||
13327023|NCT01137682|26586188|FG002|Overall Study|Protocol Violation-CORE|1|||
13327024|NCT01137682|26586186|FG000|Overall Study|Adverse Event-Extension|4|||
13327025|NCT01137682|26586187|FG001|Overall Study|Adverse Event-Extension|8|||
13327026|NCT01137682|26586188|FG002|Overall Study|Adverse Event-Extension|7|||
13327027|NCT01137682|26586186|FG000|Overall Study|Lack of Efficacy-Extension|15|||
13327028|NCT01137682|26586187|FG001|Overall Study|Lack of Efficacy-Extension|9|||
13327029|NCT01137682|26586188|FG002|Overall Study|Lack of Efficacy-Extension|13|||
13327030|NCT01137682|26586186|FG000|Overall Study|Withdrawal by Subject-Extension|6|||
13327031|NCT01137682|26586187|FG001|Overall Study|Withdrawal by Subject-Extension|8|||
13327032|NCT01137682|26586188|FG002|Overall Study|Withdrawal by Subject-Extension|8|||
13327033|NCT01137682|26586186|FG000|Overall Study|Lost to Follow Up-Extension|0|||
13327034|NCT01137682|26586187|FG001|Overall Study|Lost to Follow Up-Extension|1|||
13327035|NCT01137682|26586188|FG002|Overall Study|Lost to Follow Up-Extension|0|||
13327036|NCT01137682|26586186|FG000|Overall Study|Administrative problems-Extension|0|||
13327037|NCT01137682|26586187|FG001|Overall Study|Administrative problems-Extension|2|||
13327038|NCT01137682|26586188|FG002|Overall Study|Administrative problems-Extension|0|||
13327039|NCT01137682|26586186|FG000|Overall Study|Death-Extension|2|||
13327040|NCT01137682|26586187|FG001|Overall Study|Death-Extension|0|||
13327041|NCT01137682|26586188|FG002|Overall Study|Death-Extension|0|||
13327042|NCT01137682|26586186|FG000|Overall Study|Protocol Violation-Extension|2|||
13327043|NCT01137682|26586187|FG001|Overall Study|Protocol Violation-Extension|1|||
13327044|NCT01137682|26586188|FG002|Overall Study|Protocol Violation-Extension|0|||
13327045|NCT01137682|26586186|FG000|Overall Study|Did not enter extension|2|||
13327046|NCT01137682|26586187|FG001|Overall Study|Did not enter extension|3|||
13327047|NCT01137682|26586188|FG002|Overall Study|Did not enter extension|2|||
13327048|NCT01137682|26586186|FG000|Overall Study|Did not receive treatment in extension|0|||
13327049|NCT01137682|26586187|FG001|Overall Study|Did not receive treatment in extension|0|||
13327050|NCT01137682|26586188|FG002|Overall Study|Did not receive treatment in extension|1|||
13327051|NCT01137604|26586235|FG000|Overall Study|Adverse Event|3|||
13327052|NCT01137604|26586236|FG001|Overall Study|Adverse Event|6|||
13327053|NCT01137604|26586237|FG002|Overall Study|Adverse Event|9|||
13327054|NCT01137604|26586238|FG003|Overall Study|Adverse Event|9|||
13327055|NCT01137604|26586235|FG000|Overall Study|Participant Choice|0|||
13327056|NCT01137604|26586236|FG001|Overall Study|Participant Choice|2|||
13327057|NCT01137604|26586237|FG002|Overall Study|Participant Choice|2|||
13327058|NCT01137604|26586238|FG003|Overall Study|Participant Choice|0|||
13327059|NCT01137604|26586235|FG000|Overall Study|Withdrawal of consent|0|||
13327060|NCT01137604|26586236|FG001|Overall Study|Withdrawal of consent|0|||
13327061|NCT01137604|26586237|FG002|Overall Study|Withdrawal of consent|0|||
13327062|NCT01137604|26586238|FG003|Overall Study|Withdrawal of consent|2|||
13327063|NCT01137604|26586235|FG000|Overall Study|Clinical progression/deterioration|1|||
13327064|NCT01137604|26586236|FG001|Overall Study|Clinical progression/deterioration|2|||
13327065|NCT01137604|26586237|FG002|Overall Study|Clinical progression/deterioration|2|||
13327066|NCT01137604|26586238|FG003|Overall Study|Clinical progression/deterioration|0|||
13327067|NCT01137578|26586282|FG000|Overall Study|Participant requested to Discontinue|3|||
13327068|NCT01137578|26586283|FG001|Overall Study|Participant requested to Discontinue|0|||
13327069|NCT01137578|26586284|FG002|Overall Study|Participant requested to Discontinue|0|||
13327070|NCT01137578|26586282|FG000|Overall Study|Withdrawal by Subject|1|||
13327071|NCT01137578|26586283|FG001|Overall Study|Withdrawal by Subject|0|||
13327072|NCT01137578|26586284|FG002|Overall Study|Withdrawal by Subject|0|||
13327073|NCT01137578|26586282|FG000|Overall Study|Other|12|||
13327074|NCT01137578|26586283|FG001|Overall Study|Other|2|||
13327075|NCT01137578|26586284|FG002|Overall Study|Other|6|||
13327076|NCT01137474|26586315|FG000|Overall Study|Adverse Event|3|||
13327077|NCT01137474|26586316|FG001|Overall Study|Adverse Event|5|||
13327078|NCT01137474|26586317|FG002|Overall Study|Adverse Event|1|||
13327079|NCT01137474|26586318|FG003|Overall Study|Adverse Event|3|||
13327080|NCT01137474|26586315|FG000|Overall Study|Withdrawal by Subject|7|||
13327081|NCT01137474|26586316|FG001|Overall Study|Withdrawal by Subject|2|||
13327082|NCT01137474|26586317|FG002|Overall Study|Withdrawal by Subject|6|||
13327083|NCT01137474|26586318|FG003|Overall Study|Withdrawal by Subject|9|||
13327084|NCT01137474|26586315|FG000|Overall Study|No longer met study criteria|6|||
13327085|NCT01137474|26586316|FG001|Overall Study|No longer met study criteria|1|||
13327086|NCT01137474|26586317|FG002|Overall Study|No longer met study criteria|0|||
13327087|NCT01137474|26586318|FG003|Overall Study|No longer met study criteria|5|||
13327088|NCT01137474|26586315|FG000|Overall Study|Lost to Follow-up|5|||
13327089|NCT01137474|26586316|FG001|Overall Study|Lost to Follow-up|1|||
13327090|NCT01137474|26586317|FG002|Overall Study|Lost to Follow-up|0|||
13327091|NCT01137474|26586318|FG003|Overall Study|Lost to Follow-up|2|||
13327092|NCT01137474|26586315|FG000|Overall Study|Lack of Efficacy|0|||
13327093|NCT01137474|26586316|FG001|Overall Study|Lack of Efficacy|0|||
13327094|NCT01137474|26586317|FG002|Overall Study|Lack of Efficacy|0|||
13327095|NCT01137474|26586318|FG003|Overall Study|Lack of Efficacy|2|||
13327096|NCT01137474|26586315|FG000|Overall Study|Other|3|||
13327097|NCT01137474|26586316|FG001|Overall Study|Other|1|||
13327098|NCT01137474|26586317|FG002|Overall Study|Other|0|||
13327099|NCT01137474|26586318|FG003|Overall Study|Other|0|||
13327100|NCT01137474|26586315|FG000|Overall Study|Pregnancy|0|||
13327101|NCT01137474|26586316|FG001|Overall Study|Pregnancy|1|||
13327102|NCT01137474|26586317|FG002|Overall Study|Pregnancy|0|||
13327103|NCT01137474|26586318|FG003|Overall Study|Pregnancy|0|||
13327104|NCT01137474|26586315|FG000|Overall Study|Administrative reason by sponsor|0|||
13327105|NCT01137474|26586316|FG001|Overall Study|Administrative reason by sponsor|1|||
13327106|NCT01137474|26586317|FG002|Overall Study|Administrative reason by sponsor|0|||
13327107|NCT01137474|26586318|FG003|Overall Study|Administrative reason by sponsor|0|||
13327108|NCT01137435|26586327|FG000|Overall Study|Lost to Follow-up|24|||
13327109|NCT01137435|26586327|FG000|Overall Study|Off label usage|4|||
13327110|NCT01137292|26586336|FG000|Overall Study|Death|30|||
13327111|NCT01137292|26586336|FG000|Overall Study|Adverse Event|3|||
13327112|NCT01137292|26586336|FG000|Overall Study|Lack of Efficacy|13|||
13327113|NCT01137292|26586336|FG000|Overall Study|Lost to Follow-up|1|||
13327114|NCT01137292|26586336|FG000|Overall Study|Other|7|||
13327115|NCT01137110|26586349|FG000|Overall Study|Protocol Violation|1|||
13327116|NCT01137110|26586350|FG001|Overall Study|Protocol Violation|0|||
13327117|NCT01137071|26586413|FG000|Overall Study|Disease Progression|11|||
13327118|NCT01137071|26586413|FG000|Overall Study|Withdrawal by Subject|2|||
13327119|NCT01137071|26586413|FG000|Overall Study|Wrongly Included|1|||
13327120|NCT01136967|26586440|FG000|Overall Study|Adverse Event|9|||
13327121|NCT01136967|26586441|FG001|Overall Study|Adverse Event|12|||
13327122|NCT01136967|26586440|FG000|Overall Study|Participant Choice|8|||
13327123|NCT01136967|26586441|FG001|Overall Study|Participant Choice|3|||
13327124|NCT01136967|26586440|FG000|Overall Study|Lost to Follow-up|0|||
13327125|NCT01136967|26586441|FG001|Overall Study|Lost to Follow-up|1|||
13327126|NCT01136967|26586440|FG000|Overall Study|Withdrawal by Subject|1|||
13327127|NCT01136967|26586441|FG001|Overall Study|Withdrawal by Subject|2|||
13327128|NCT01136967|26586440|FG000|Overall Study|Clinical Progression|3|||
13327129|NCT01136967|26586441|FG001|Overall Study|Clinical Progression|5|||
13327130|NCT01136967|26586440|FG000|Overall Study|Radiation|1|||
13327131|NCT01136967|26586441|FG001|Overall Study|Radiation|0|||
13327132|NCT01136967|26586440|FG000|Overall Study|Non-compliance|1|||
13327133|NCT01136967|26586441|FG001|Overall Study|Non-compliance|0|||
13327134|NCT01136967|26586440|FG000|Overall Study|Investigator's Choice|1|||
13327135|NCT01136967|26586441|FG001|Overall Study|Investigator's Choice|1|||
13327136|NCT01136967|26586440|FG000|Overall Study|Increase in Lesion Size|0|||
13327137|NCT01136967|26586441|FG001|Overall Study|Increase in Lesion Size|2|||
13327138|NCT01136967|26586440|FG000|Overall Study|Diagnosis of Second Primary Cancer|0|||
13327139|NCT01136967|26586441|FG001|Overall Study|Diagnosis of Second Primary Cancer|1|||
13327140|NCT01136954|26586460|FG000|Overall Study|Adverse Event|3|||
13327141|NCT01136954|26586461|FG001|Overall Study|Adverse Event|2|||
13327142|NCT01136954|26586460|FG000|Overall Study|Withdrawal by Subject|6|||
13327143|NCT01136954|26586461|FG001|Overall Study|Withdrawal by Subject|2|||
13327144|NCT01136954|26586460|FG000|Overall Study|Lack of Efficacy|14|||
13327145|NCT01136954|26586461|FG001|Overall Study|Lack of Efficacy|13|||
13327146|NCT01136954|26586460|FG000|Overall Study|Physician Decision|0|||
13327147|NCT01136954|26586461|FG001|Overall Study|Physician Decision|1|||
13327148|NCT01136954|26586460|FG000|Overall Study|Other|1|||
13327149|NCT01136954|26586461|FG001|Overall Study|Other|3|||
13327150|NCT01136915|26586476|FG000|Overall Study|Lost to Follow-up|2|||
13327151|NCT01136915|26586477|FG001|Overall Study|Lost to Follow-up|0|||
13327152|NCT01136915|26586476|FG000|Overall Study|Exclusion criterion met|0|||
13327153|NCT01136915|26586477|FG001|Overall Study|Exclusion criterion met|1|||
13327154|NCT01136876|26586492|FG000|Overall Study|Lost to Follow-up|0|||
13327155|NCT01136876|26586493|FG001|Overall Study|Lost to Follow-up|1|||
13327156|NCT01136876|26586492|FG000|Overall Study|Physician Decision|3|||
13327157|NCT01136876|26586493|FG001|Overall Study|Physician Decision|5|||
13327158|NCT01136876|26586492|FG000|Overall Study|Missing NGAL measurement|2|||
13327159|NCT01136876|26586493|FG001|Overall Study|Missing NGAL measurement|5|||
13327160|NCT01136811|26586502|FG000|Overall Study|Physician Decision|11|||
13327161|NCT01136785|26586522|FG000|Overall Study|Protocol Violation|2|||
13327162|NCT01136785|26586523|FG001|Overall Study|Protocol Violation|1|||
13327163|NCT01136772|26586538|FG000|Overall Study|Adverse Event|15|||
13327164|NCT01136772|26586539|FG001|Overall Study|Adverse Event|14|||
13327165|NCT01136772|26586538|FG000|Overall Study|Lack of Efficacy|42|||
13327166|NCT01136772|26586539|FG001|Overall Study|Lack of Efficacy|39|||
13327167|NCT01136772|26586538|FG000|Overall Study|Administrative|14|||
13327168|NCT01136772|26586539|FG001|Overall Study|Administrative|12|||
13327169|NCT01136772|26586538|FG000|Overall Study|Withdrawal by Subject|33|||
13327170|NCT01136772|26586539|FG001|Overall Study|Withdrawal by Subject|36|||
13327171|NCT01136772|26586538|FG000|Overall Study|Did not receive injection|10|||
13327172|NCT01136772|26586539|FG001|Overall Study|Did not receive injection|7|||
13327173|NCT01136772|26586538|FG000|Overall Study|Did not follow up after first injection|2|||
13327174|NCT01136772|26586539|FG001|Overall Study|Did not follow up after first injection|2|||
13327175|NCT01136746|26586606|FG000|Overall Study|Lost to Follow-up|0|||
13327176|NCT01136746|26586607|FG001|Overall Study|Lost to Follow-up|2|||
13327177|NCT01136746|26586606|FG000|Overall Study|Protocol Violation|2|||
13327178|NCT01136746|26586607|FG001|Overall Study|Protocol Violation|1|||
13327179|NCT01136746|26586606|FG000|Overall Study|Death|1|||
13327180|NCT01136746|26586607|FG001|Overall Study|Death|0|||
13327181|NCT01136733|26586712|FG000|Phase 1b|Adverse Event|0|||
13327182|NCT01136733|26586713|FG001|Phase 1b|Adverse Event|3|||
13327183|NCT01136733|26586714|FG002|Phase 1b|Adverse Event|1|||
13327184|NCT01136733|26586715|FG003|Phase 1b|Adverse Event|0|||
13327185|NCT01136733|26586716|FG004|Phase 1b|Adverse Event|0|||
13327186|NCT01136733|26586717|FG005|Phase 1b|Adverse Event|0|||
13327187|NCT01136733|26586718|FG006|Phase 1b|Adverse Event|0|||
13327188|NCT01136733|26586712|FG000|Phase 1b|Participant Choice|0|||
13327189|NCT01136733|26586713|FG001|Phase 1b|Participant Choice|0|||
13327190|NCT01136733|26586714|FG002|Phase 1b|Participant Choice|1|||
13327191|NCT01136733|26586715|FG003|Phase 1b|Participant Choice|0|||
13327192|NCT01136733|26586716|FG004|Phase 1b|Participant Choice|0|||
13327193|NCT01136733|26586717|FG005|Phase 1b|Participant Choice|0|||
13327194|NCT01136733|26586718|FG006|Phase 1b|Participant Choice|0|||
13327195|NCT01136733|26586712|FG000|Phase 1b|Administrative-Withdrew Consent|0|||
13327196|NCT01136733|26586713|FG001|Phase 1b|Administrative-Withdrew Consent|1|||
13327197|NCT01136733|26586714|FG002|Phase 1b|Administrative-Withdrew Consent|0|||
13327198|NCT01136733|26586715|FG003|Phase 1b|Administrative-Withdrew Consent|0|||
13327199|NCT01136733|26586716|FG004|Phase 1b|Administrative-Withdrew Consent|0|||
13327200|NCT01136733|26586717|FG005|Phase 1b|Administrative-Withdrew Consent|0|||
13327201|NCT01136733|26586718|FG006|Phase 1b|Administrative-Withdrew Consent|0|||
13327202|NCT01136733|26586712|FG000|Phase 1b|Clinical Progression|1|||
13327203|NCT01136733|26586713|FG001|Phase 1b|Clinical Progression|1|||
13327204|NCT01136733|26586714|FG002|Phase 1b|Clinical Progression|0|||
13327205|NCT01136733|26586715|FG003|Phase 1b|Clinical Progression|0|||
13327206|NCT01136733|26586716|FG004|Phase 1b|Clinical Progression|0|||
13327207|NCT01136733|26586717|FG005|Phase 1b|Clinical Progression|0|||
13327208|NCT01136733|26586718|FG006|Phase 1b|Clinical Progression|0|||
13327209|NCT01136733|26586712|FG000|Phase 2|Disease Progression|0|||
13327210|NCT01136733|26586713|FG001|Phase 2|Disease Progression|0|||
13327211|NCT01136733|26586714|FG002|Phase 2|Disease Progression|0|||
13327212|NCT01136733|26586715|FG003|Phase 2|Disease Progression|0|||
13327213|NCT01136733|26586716|FG004|Phase 2|Disease Progression|30|||
13327214|NCT01136733|26586717|FG005|Phase 2|Disease Progression|32|||
13327215|NCT01136733|26586718|FG006|Phase 2|Disease Progression|38|||
13327216|NCT01136733|26586712|FG000|Phase 2|Adverse Event|0|||
13327217|NCT01136733|26586713|FG001|Phase 2|Adverse Event|0|||
13327218|NCT01136733|26586714|FG002|Phase 2|Adverse Event|0|||
13327219|NCT01136733|26586715|FG003|Phase 2|Adverse Event|0|||
13327220|NCT01136733|26586716|FG004|Phase 2|Adverse Event|11|||
13327221|NCT01136733|26586717|FG005|Phase 2|Adverse Event|13|||
13327222|NCT01136733|26586718|FG006|Phase 2|Adverse Event|5|||
13327223|NCT01136733|26586712|FG000|Phase 2|Participant Choice|0|||
13327224|NCT01136733|26586713|FG001|Phase 2|Participant Choice|0|||
13327225|NCT01136733|26586714|FG002|Phase 2|Participant Choice|0|||
13327226|NCT01136733|26586715|FG003|Phase 2|Participant Choice|0|||
13327227|NCT01136733|26586716|FG004|Phase 2|Participant Choice|3|||
13327228|NCT01136733|26586717|FG005|Phase 2|Participant Choice|0|||
13327229|NCT01136733|26586718|FG006|Phase 2|Participant Choice|1|||
13327230|NCT01136733|26586712|FG000|Phase 2|Administrative-Withdrew Consent|0|||
13327231|NCT01136733|26586713|FG001|Phase 2|Administrative-Withdrew Consent|0|||
13327232|NCT01136733|26586714|FG002|Phase 2|Administrative-Withdrew Consent|0|||
13327233|NCT01136733|26586715|FG003|Phase 2|Administrative-Withdrew Consent|0|||
13327234|NCT01136733|26586716|FG004|Phase 2|Administrative-Withdrew Consent|1|||
13327235|NCT01136733|26586717|FG005|Phase 2|Administrative-Withdrew Consent|0|||
13327236|NCT01136733|26586718|FG006|Phase 2|Administrative-Withdrew Consent|0|||
13327237|NCT01136733|26586712|FG000|Phase 2|Other|0|||
13327238|NCT01136733|26586713|FG001|Phase 2|Other|0|||
13327239|NCT01136733|26586714|FG002|Phase 2|Other|0|||
13327240|NCT01136733|26586715|FG003|Phase 2|Other|0|||
13327241|NCT01136733|26586716|FG004|Phase 2|Other|6|||
13327242|NCT01136733|26586717|FG005|Phase 2|Other|7|||
13327243|NCT01136733|26586718|FG006|Phase 2|Other|6|||
13327244|NCT01136655|26586746|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1|||
13327245|NCT01136655|26586746|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1|||
13327246|NCT01136655|26586746|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1|||
13327247|NCT01136655|26586746|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1|||
13327248|NCT01136408|26586811|FG000|Overall Study|Adverse Event|4|||
13327249|NCT01136408|26586812|FG001|Overall Study|Adverse Event|8|||
13327250|NCT01136408|26586813|FG002|Overall Study|Adverse Event|4|||
13327251|NCT01136408|26586811|FG000|Overall Study|Protocol Violation|1|||
13327252|NCT01136408|26586812|FG001|Overall Study|Protocol Violation|1|||
13327253|NCT01136408|26586813|FG002|Overall Study|Protocol Violation|1|||
13327254|NCT01136382|26586846|FG000|Overall Study|Other|8|||
13327255|NCT01136382|26586847|FG001|Overall Study|Other|3|||
13327256|NCT01136382|26586846|FG000|Overall Study|Study-Specific Withdrawal Criteria|48|||
13327257|NCT01136382|26586847|FG001|Overall Study|Study-Specific Withdrawal Criteria|25|||
13327258|NCT01136382|26586846|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
13327259|NCT01136382|26586847|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
13327260|NCT01136382|26586846|FG000|Overall Study|Withdrawal by Subject|4|||
13327261|NCT01136382|26586847|FG001|Overall Study|Withdrawal by Subject|1|||
13327262|NCT01136356|26586859|FG000|First 18-day Withdrawal|Withdrawal by Subject|3|||
13327263|NCT01136356|26586860|FG001|First 18-day Withdrawal|Withdrawal by Subject|0|||
13327264|NCT01136356|26586859|FG000|First 18-day Withdrawal|Physician Decision|1|||
13327265|NCT01136356|26586860|FG001|First 18-day Withdrawal|Physician Decision|0|||
13327266|NCT01136356|26586859|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0|||
13327267|NCT01136356|26586860|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1|||
13327268|NCT01136291|26586877|FG000|Overall Study|Lost to Follow-up|1|||
13327269|NCT01136291|26586878|FG001|Overall Study|Lost to Follow-up|1|||
13327270|NCT01136174|26586971|FG000|Overall Study|Adverse Event|0|||
13327271|NCT01136174|26586972|FG001|Overall Study|Adverse Event|0|||
13327272|NCT01136174|26586973|FG002|Overall Study|Adverse Event|0|||
13327273|NCT01136174|26586974|FG003|Overall Study|Adverse Event|4|||
13327274|NCT01135992|26586985|FG000|Overall Study|Adverse Event|1|||
13327275|NCT01135992|26586985|FG000|Overall Study|Lack of Efficacy|1|||
13327276|NCT01135992|26586985|FG000|Overall Study|Protocol Violation|2|||
13327277|NCT01135992|26586985|FG000|Overall Study|Withdrawal criteria|10|||
13327278|NCT01135992|26586985|FG000|Overall Study|Unclassified|7|||
13327279|NCT01135914|26587024|FG000|Overall Study|Withdrawal by Subject|1|||
13327280|NCT01135914|26587025|FG001|Overall Study|Withdrawal by Subject|3|||
13327281|NCT01135914|26587026|FG002|Overall Study|Withdrawal by Subject|6|||
13327282|NCT01135914|26587024|FG000|Overall Study|Lost to Follow-up|1|||
13327283|NCT01135914|26587025|FG001|Overall Study|Lost to Follow-up|0|||
13327284|NCT01135914|26587026|FG002|Overall Study|Lost to Follow-up|1|||
13327285|NCT01135914|26587024|FG000|Overall Study|Protocol Violation|0|||
13327286|NCT01135914|26587025|FG001|Overall Study|Protocol Violation|0|||
13327287|NCT01135914|26587026|FG002|Overall Study|Protocol Violation|3|||
13327288|NCT01135914|26587024|FG000|Overall Study|Lack of Efficacy|2|||
13327289|NCT01135914|26587025|FG001|Overall Study|Lack of Efficacy|1|||
13327290|NCT01135914|26587026|FG002|Overall Study|Lack of Efficacy|10|||
13327291|NCT01135914|26587024|FG000|Overall Study|Adverse Event|0|||
13327292|NCT01135914|26587025|FG001|Overall Study|Adverse Event|1|||
13327293|NCT01135914|26587026|FG002|Overall Study|Adverse Event|2|||
13327294|NCT01135524|26587032|FG000|Overall Study|Withdrawal by Subject|14|||
13327295|NCT01135524|26587032|FG000|Overall Study|Adverse Event|20|||
13327296|NCT01135524|26587032|FG000|Overall Study|Lost to Follow-up|3|||
13327297|NCT01135524|26587032|FG000|Overall Study|Administrative|151|||
13327298|NCT01135524|26587032|FG000|Overall Study|Lack of Efficacy|8|||
13327299|NCT01135511|26587342|FG000|Overall Study|Adverse Event|0|||
13327300|NCT01135511|26587343|FG001|Overall Study|Adverse Event|1|||
13327301|NCT01135511|26587344|FG002|Overall Study|Adverse Event|2|||
13327302|NCT01135511|26587345|FG003|Overall Study|Adverse Event|0|||
13327303|NCT01135511|26587346|FG004|Overall Study|Adverse Event|0|||
13327304|NCT01135511|26587347|FG005|Overall Study|Adverse Event|1|||
13327305|NCT01135511|26587348|FG006|Overall Study|Adverse Event|0|||
13327306|NCT01135511|26587349|FG007|Overall Study|Adverse Event|1|||
13327307|NCT01135511|26587350|FG008|Overall Study|Adverse Event|0|||
13327308|NCT01135511|26587342|FG000|Overall Study|Lack of Efficacy|0|||
13327309|NCT01135511|26587343|FG001|Overall Study|Lack of Efficacy|1|||
13327310|NCT01135511|26587344|FG002|Overall Study|Lack of Efficacy|1|||
13327311|NCT01135511|26587345|FG003|Overall Study|Lack of Efficacy|2|||
13327312|NCT01135511|26587346|FG004|Overall Study|Lack of Efficacy|0|||
13327313|NCT01135511|26587347|FG005|Overall Study|Lack of Efficacy|0|||
13327314|NCT01135511|26587348|FG006|Overall Study|Lack of Efficacy|0|||
13327315|NCT01135511|26587349|FG007|Overall Study|Lack of Efficacy|0|||
13327316|NCT01135511|26587350|FG008|Overall Study|Lack of Efficacy|0|||
13327317|NCT01135511|26587342|FG000|Overall Study|Protocol Violation|0|||
13327318|NCT01135511|26587343|FG001|Overall Study|Protocol Violation|0|||
13327319|NCT01135511|26587344|FG002|Overall Study|Protocol Violation|3|||
13327320|NCT01135511|26587345|FG003|Overall Study|Protocol Violation|0|||
13327321|NCT01135511|26587346|FG004|Overall Study|Protocol Violation|0|||
13327322|NCT01135511|26587347|FG005|Overall Study|Protocol Violation|0|||
13327323|NCT01135511|26587348|FG006|Overall Study|Protocol Violation|0|||
13327324|NCT01135511|26587349|FG007|Overall Study|Protocol Violation|0|||
13327325|NCT01135511|26587350|FG008|Overall Study|Protocol Violation|0|||
13327326|NCT01135511|26587342|FG000|Overall Study|Pregnancy|0|||
13327327|NCT01135511|26587343|FG001|Overall Study|Pregnancy|0|||
13327328|NCT01135511|26587344|FG002|Overall Study|Pregnancy|0|||
13327329|NCT01135511|26587345|FG003|Overall Study|Pregnancy|1|||
13327330|NCT01135511|26587346|FG004|Overall Study|Pregnancy|0|||
13327331|NCT01135511|26587347|FG005|Overall Study|Pregnancy|0|||
13327332|NCT01135511|26587348|FG006|Overall Study|Pregnancy|0|||
13327333|NCT01135511|26587349|FG007|Overall Study|Pregnancy|0|||
13327334|NCT01135511|26587350|FG008|Overall Study|Pregnancy|0|||
13327335|NCT01135511|26587342|FG000|Overall Study|could not visit the clinic|0|||
13327336|NCT01135511|26587343|FG001|Overall Study|could not visit the clinic|1|||
13327337|NCT01135511|26587344|FG002|Overall Study|could not visit the clinic|2|||
13327338|NCT01135511|26587345|FG003|Overall Study|could not visit the clinic|0|||
13327339|NCT01135511|26587346|FG004|Overall Study|could not visit the clinic|0|||
13327340|NCT01135511|26587347|FG005|Overall Study|could not visit the clinic|0|||
13327341|NCT01135511|26587348|FG006|Overall Study|could not visit the clinic|0|||
13327342|NCT01135511|26587349|FG007|Overall Study|could not visit the clinic|0|||
13327343|NCT01135511|26587350|FG008|Overall Study|could not visit the clinic|0|||
13327344|NCT01135511|26587342|FG000|Overall Study|noncompliance with study drug taken|0|||
13327345|NCT01135511|26587343|FG001|Overall Study|noncompliance with study drug taken|0|||
13327346|NCT01135511|26587344|FG002|Overall Study|noncompliance with study drug taken|0|||
13327347|NCT01135511|26587345|FG003|Overall Study|noncompliance with study drug taken|0|||
13327348|NCT01135511|26587346|FG004|Overall Study|noncompliance with study drug taken|1|||
13327349|NCT01135511|26587347|FG005|Overall Study|noncompliance with study drug taken|0|||
13327350|NCT01135511|26587348|FG006|Overall Study|noncompliance with study drug taken|0|||
13327351|NCT01135511|26587349|FG007|Overall Study|noncompliance with study drug taken|0|||
13327352|NCT01135511|26587350|FG008|Overall Study|noncompliance with study drug taken|0|||
13327353|NCT01135511|26587342|FG000|Overall Study|Withdrawal by Subject|0|||
13327354|NCT01135511|26587343|FG001|Overall Study|Withdrawal by Subject|0|||
13327355|NCT01135511|26587344|FG002|Overall Study|Withdrawal by Subject|0|||
13327356|NCT01135511|26587345|FG003|Overall Study|Withdrawal by Subject|0|||
13327357|NCT01135511|26587346|FG004|Overall Study|Withdrawal by Subject|0|||
13327358|NCT01135511|26587347|FG005|Overall Study|Withdrawal by Subject|0|||
13327359|NCT01135511|26587348|FG006|Overall Study|Withdrawal by Subject|1|||
13327360|NCT01135511|26587349|FG007|Overall Study|Withdrawal by Subject|0|||
13327361|NCT01135511|26587350|FG008|Overall Study|Withdrawal by Subject|1|||
13327362|NCT01135498|26587361|FG000|Overall Study|Adverse Event|20|||
13327363|NCT01135498|26587361|FG000|Overall Study|Progressive disease|38|||
13327364|NCT01135498|26587361|FG000|Overall Study|Investigator judgement|25|||
13327365|NCT01135498|26587361|FG000|Overall Study|Withdrawal by Subject|4|||
13327366|NCT01135498|26587361|FG000|Overall Study|Death|1|||
13327367|NCT01135498|26587361|FG000|Overall Study|Ongoing at time of analysis|2|||
13327368|NCT01135394|26587367|FG000|Screening|Lost to Follow-up|2|||
13327369|NCT01135394|26587367|FG000|Screening|Withdrawal by Subject|10|||
13327370|NCT01135394|26587367|FG000|Screening|Screening failure|16|||
13327371|NCT01135394|26587367|FG000|Screening|Physician Decision|5|||
13327372|NCT01135394|26587367|FG000|Baseline Assessment|Withdrawal by Subject|9|||
13327373|NCT01135394|26587367|FG000|Baseline Assessment|Physician Decision|3|||
13327374|NCT01135394|26587367|FG000|Baseline Assessment|Lost to Follow-up|2|||
13327375|NCT01135394|26587367|FG000|Baseline Assessment|Adverse Event|1|||
13327376|NCT01135394|26587367|FG000|Study Treatment|Withdrawal by Subject|1|||
13327377|NCT01135394|26587367|FG000|Study Treatment|Physician Decision|1|||
13327378|NCT01135394|26587367|FG000|Study Treatment|Adverse Event|2|||
13327379|NCT01135134|26587382|FG000|Overall Study|Adverse Event|1|||
13327380|NCT01135134|26587383|FG001|Overall Study|Adverse Event|1|||
13327381|NCT01135134|26587382|FG000|Overall Study|Did not meet protocol eligibility|1|||
13327382|NCT01135134|26587383|FG001|Overall Study|Did not meet protocol eligibility|0|||
13327383|NCT01135017|26587406|FG000|Overall Study|Adverse Event|3|||
13327384|NCT01135017|26587407|FG001|Overall Study|Adverse Event|8|||
13327385|NCT01135017|26587406|FG000|Overall Study|Other than above|3|||
13327386|NCT01135017|26587407|FG001|Overall Study|Other than above|4|||
13327387|NCT01134939|26587542|FG000|Overall Study|Adverse Event|9|||
13327388|NCT01134939|26587543|FG001|Overall Study|Adverse Event|3|||
13327389|NCT01134939|26587544|FG002|Overall Study|Adverse Event|4|||
13327390|NCT01134939|26587545|FG003|Overall Study|Adverse Event|5|||
13327391|NCT01134939|26587546|FG004|Overall Study|Adverse Event|5|||
13327392|NCT01134939|26587547|FG005|Overall Study|Adverse Event|5|||
13327393|NCT01134939|26587548|FG006|Overall Study|Adverse Event|1|||
13327394|NCT01134939|26587549|FG007|Overall Study|Adverse Event|0|||
13327395|NCT01134939|26587542|FG000|Overall Study|Lack of Efficacy|2|||
13327396|NCT01134939|26587543|FG001|Overall Study|Lack of Efficacy|5|||
13327397|NCT01134939|26587544|FG002|Overall Study|Lack of Efficacy|1|||
13327398|NCT01134939|26587545|FG003|Overall Study|Lack of Efficacy|0|||
13327399|NCT01134939|26587546|FG004|Overall Study|Lack of Efficacy|3|||
13327400|NCT01134939|26587547|FG005|Overall Study|Lack of Efficacy|0|||
13327401|NCT01134939|26587548|FG006|Overall Study|Lack of Efficacy|1|||
13327402|NCT01134939|26587549|FG007|Overall Study|Lack of Efficacy|0|||
13327403|NCT01134939|26587542|FG000|Overall Study|Lost to Follow-up|2|||
13327404|NCT01134939|26587543|FG001|Overall Study|Lost to Follow-up|3|||
13327405|NCT01134939|26587544|FG002|Overall Study|Lost to Follow-up|0|||
13327406|NCT01134939|26587545|FG003|Overall Study|Lost to Follow-up|1|||
13327407|NCT01134939|26587546|FG004|Overall Study|Lost to Follow-up|2|||
13327408|NCT01134939|26587547|FG005|Overall Study|Lost to Follow-up|1|||
13327409|NCT01134939|26587548|FG006|Overall Study|Lost to Follow-up|0|||
13327410|NCT01134939|26587549|FG007|Overall Study|Lost to Follow-up|0|||
13327411|NCT01134939|26587542|FG000|Overall Study|Death|0|||
13327412|NCT01134939|26587543|FG001|Overall Study|Death|1|||
13327413|NCT01134939|26587544|FG002|Overall Study|Death|0|||
13327414|NCT01134939|26587545|FG003|Overall Study|Death|0|||
13327415|NCT01134939|26587546|FG004|Overall Study|Death|0|||
13327416|NCT01134939|26587547|FG005|Overall Study|Death|0|||
13327417|NCT01134939|26587548|FG006|Overall Study|Death|0|||
13327418|NCT01134939|26587549|FG007|Overall Study|Death|0|||
13327419|NCT01134939|26587542|FG000|Overall Study|Termination page not available|4|||
13327420|NCT01134939|26587543|FG001|Overall Study|Termination page not available|6|||
13327421|NCT01134939|26587544|FG002|Overall Study|Termination page not available|5|||
13327422|NCT01134939|26587545|FG003|Overall Study|Termination page not available|8|||
13327423|NCT01134939|26587546|FG004|Overall Study|Termination page not available|0|||
13327424|NCT01134939|26587547|FG005|Overall Study|Termination page not available|3|||
13327425|NCT01134939|26587548|FG006|Overall Study|Termination page not available|7|||
13327426|NCT01134939|26587549|FG007|Overall Study|Termination page not available|0|||
13327427|NCT01134783|26587572|FG000|Overall Study|Pregnancy|16|||
13327428|NCT01134783|26587573|FG001|Overall Study|Pregnancy|8|||
13327429|NCT01134783|26587572|FG000|Overall Study|Withdrawal by Subject|15|||
13327430|NCT01134783|26587573|FG001|Overall Study|Withdrawal by Subject|9|||
13327431|NCT01134783|26587572|FG000|Overall Study|Lost to Follow-up|5|||
13327432|NCT01134783|26587573|FG001|Overall Study|Lost to Follow-up|20|||
13327433|NCT01134731|26587594|FG000|Overall Study|Adverse Event|3|||
13327434|NCT01134731|26587595|FG001|Overall Study|Adverse Event|2|||
13327435|NCT01134731|26587596|FG002|Overall Study|Adverse Event|1|||
13327436|NCT01134731|26587594|FG000|Overall Study|Physician Decision|2|||
13327437|NCT01134731|26587595|FG001|Overall Study|Physician Decision|2|||
13327438|NCT01134731|26587596|FG002|Overall Study|Physician Decision|2|||
13327439|NCT01134731|26587594|FG000|Overall Study|Lack of Efficacy|0|||
13327440|NCT01134731|26587595|FG001|Overall Study|Lack of Efficacy|0|||
13327441|NCT01134731|26587596|FG002|Overall Study|Lack of Efficacy|1|||
13327442|NCT01134731|26587594|FG000|Overall Study|Withdrawal by Subject|3|||
13327443|NCT01134731|26587595|FG001|Overall Study|Withdrawal by Subject|3|||
13327444|NCT01134731|26587596|FG002|Overall Study|Withdrawal by Subject|1|||
13327445|NCT01134731|26587594|FG000|Overall Study|Lost to Follow-up|5|||
13327446|NCT01134731|26587595|FG001|Overall Study|Lost to Follow-up|4|||
13327447|NCT01134731|26587596|FG002|Overall Study|Lost to Follow-up|3|||
13327448|NCT01134705|26587613|FG000|Overall Study|Adverse Event|1|||
13327449|NCT01134705|26587614|FG001|Overall Study|Adverse Event|7|||
13327450|NCT01134705|26587613|FG000|Overall Study|Withdrawal by Subject|6|||
13327451|NCT01134705|26587614|FG001|Overall Study|Withdrawal by Subject|6|||
13327452|NCT01134705|26587613|FG000|Overall Study|Pregnancy|1|||
13327453|NCT01134705|26587614|FG001|Overall Study|Pregnancy|0|||
13327454|NCT01134705|26587613|FG000|Overall Study|Lost to Follow-up|5|||
13327455|NCT01134705|26587614|FG001|Overall Study|Lost to Follow-up|2|||
13327456|NCT01134705|26587613|FG000|Overall Study|Protocol Violation|1|||
13327457|NCT01134705|26587614|FG001|Overall Study|Protocol Violation|1|||
13327458|NCT01134705|26587613|FG000|Overall Study|Other|1|||
13327459|NCT01134705|26587614|FG001|Overall Study|Other|6|||
13327460|NCT01134627|26587649|FG000|Overall Study|Adverse Event|47|||
13327461|NCT01134627|26587650|FG001|Overall Study|Adverse Event|31|||
13327462|NCT01134627|26587649|FG000|Overall Study|Lost to Follow-up|1|||
13327463|NCT01134627|26587650|FG001|Overall Study|Lost to Follow-up|2|||
13327464|NCT01134627|26587649|FG000|Overall Study|Protocol Violation|3|||
13327465|NCT01134627|26587650|FG001|Overall Study|Protocol Violation|5|||
13327466|NCT01134627|26587649|FG000|Overall Study|Lack of Efficacy|2|||
13327467|NCT01134627|26587650|FG001|Overall Study|Lack of Efficacy|12|||
13327468|NCT01134627|26587649|FG000|Overall Study|Withdrawal by Subject|4|||
13327469|NCT01134627|26587650|FG001|Overall Study|Withdrawal by Subject|3|||
13327470|NCT01134627|26587649|FG000|Overall Study|Planning to become pregnant/pregnancy|1|||
13327471|NCT01134627|26587650|FG001|Overall Study|Planning to become pregnant/pregnancy|0|||
13327472|NCT01134627|26587649|FG000|Overall Study|Other|11|||
13327473|NCT01134627|26587650|FG001|Overall Study|Other|14|||
13327474|NCT01134614|26587667|FG000|Overall Study|Still on treatment as of March 2013|21|||
13327475|NCT01134614|26587668|FG001|Overall Study|Still on treatment as of March 2013|13|||
13327476|NCT01134614|26587667|FG000|Overall Study|Progressive disease|60|||
13327477|NCT01134614|26587668|FG001|Overall Study|Progressive disease|54|||
13327478|NCT01134614|26587667|FG000|Overall Study|Adverse Event|26|||
13327479|NCT01134614|26587668|FG001|Overall Study|Adverse Event|39|||
13327480|NCT01134614|26587667|FG000|Overall Study|Death|5|||
13327481|NCT01134614|26587668|FG001|Overall Study|Death|8|||
13327482|NCT01134614|26587667|FG000|Overall Study|Withdrawal by Subject|3|||
13327483|NCT01134614|26587668|FG001|Overall Study|Withdrawal by Subject|2|||
13327484|NCT01134614|26587667|FG000|Overall Study|Alternative therapy|2|||
13327485|NCT01134614|26587668|FG001|Overall Study|Alternative therapy|0|||
13327486|NCT01134614|26587667|FG000|Overall Study|Complicating disease|2|||
13327487|NCT01134614|26587668|FG001|Overall Study|Complicating disease|1|||
13327488|NCT01134614|26587667|FG000|Overall Study|Physician's decision|0|||
13327489|NCT01134614|26587668|FG001|Overall Study|Physician's decision|1|||
13327490|NCT01134614|26587667|FG000|Overall Study|Never started treatment|4|||
13327491|NCT01134614|26587668|FG001|Overall Study|Never started treatment|1|||
13327492|NCT01134614|26587667|FG000|Overall Study|Pt received tx not allowed on study|0|||
13327493|NCT01134614|26587668|FG001|Overall Study|Pt received tx not allowed on study|1|||
13327494|NCT01134614|26587667|FG000|Overall Study|Symptomatic deterioration|0|||
13327495|NCT01134614|26587668|FG001|Overall Study|Symptomatic deterioration|1|||
13327496|NCT01134614|26587667|FG000|Overall Study|Patient in hospice care|0|||
13327497|NCT01134614|26587668|FG001|Overall Study|Patient in hospice care|1|||
13327498|NCT01134562|26587748|FG000|Overall Study|Adverse Event|0|||
13327499|NCT01134562|26587749|FG001|Overall Study|Adverse Event|1|||
13327500|NCT01134562|26587750|FG002|Overall Study|Adverse Event|0|||
13327501|NCT01134562|26587751|FG003|Overall Study|Adverse Event|0|||
13327502|NCT01134562|26587752|FG004|Overall Study|Adverse Event|0|||
13327503|NCT01134393|26587768|FG000|Overall Study|Adverse Event|18|||
13327504|NCT01134393|26587768|FG000|Overall Study|Lack of Efficacy|2|||
13327505|NCT01134393|26587768|FG000|Overall Study|Protocol Violation|12|||
13327506|NCT01134393|26587768|FG000|Overall Study|Lost to Follow-up|3|||
13327507|NCT01134393|26587768|FG000|Overall Study|Withdrawal by Subject|11|||
13327508|NCT01134393|26587768|FG000|Overall Study|Other|6|||
13327509|NCT01134315|26587795|FG000|Overall Study|Adverse Event|1|||
13327510|NCT01134315|26587796|FG001|Overall Study|Adverse Event|2|||
13327511|NCT01134315|26587795|FG000|Overall Study|Other Reason|8|||
13327512|NCT01134315|26587796|FG001|Overall Study|Other Reason|17|||
13327513|NCT01134263|26587834|FG000|Overall Study|Serious adverse event|2|||
13327514|NCT01134263|26587835|FG001|Overall Study|Serious adverse event|1|||
13327515|NCT01134263|26587836|FG002|Overall Study|Serious adverse event|1|||
13327516|NCT01134263|26587837|FG003|Overall Study|Serious adverse event|1|||
13327517|NCT01134263|26587838|FG004|Overall Study|Serious adverse event|1|||
13327518|NCT01134263|26587834|FG000|Overall Study|Other adverse event|1|||
13327519|NCT01134263|26587835|FG001|Overall Study|Other adverse event|2|||
13327520|NCT01134263|26587836|FG002|Overall Study|Other adverse event|5|||
13327521|NCT01134263|26587837|FG003|Overall Study|Other adverse event|3|||
13327522|NCT01134263|26587838|FG004|Overall Study|Other adverse event|0|||
13327523|NCT01134263|26587834|FG000|Overall Study|Protocol Violation|8|||
13327524|NCT01134263|26587835|FG001|Overall Study|Protocol Violation|7|||
13327525|NCT01134263|26587836|FG002|Overall Study|Protocol Violation|2|||
13327526|NCT01134263|26587837|FG003|Overall Study|Protocol Violation|4|||
13327527|NCT01134263|26587838|FG004|Overall Study|Protocol Violation|2|||
13327528|NCT01134263|26587834|FG000|Overall Study|Lost to Follow-up|4|||
13327529|NCT01134263|26587835|FG001|Overall Study|Lost to Follow-up|3|||
13327530|NCT01134263|26587836|FG002|Overall Study|Lost to Follow-up|5|||
13327531|NCT01134263|26587837|FG003|Overall Study|Lost to Follow-up|3|||
13327532|NCT01134263|26587838|FG004|Overall Study|Lost to Follow-up|1|||
13327533|NCT01134263|26587834|FG000|Overall Study|Withdrawal by Subject|8|||
13327534|NCT01134263|26587835|FG001|Overall Study|Withdrawal by Subject|6|||
13327535|NCT01134263|26587836|FG002|Overall Study|Withdrawal by Subject|16|||
13327536|NCT01134263|26587837|FG003|Overall Study|Withdrawal by Subject|7|||
13327537|NCT01134263|26587838|FG004|Overall Study|Withdrawal by Subject|5|||
13327538|NCT01134263|26587834|FG000|Overall Study|Enrolled, but not treated|1|||
13327539|NCT01134263|26587835|FG001|Overall Study|Enrolled, but not treated|1|||
13327540|NCT01134263|26587836|FG002|Overall Study|Enrolled, but not treated|0|||
13327541|NCT01134263|26587837|FG003|Overall Study|Enrolled, but not treated|1|||
13327542|NCT01134263|26587838|FG004|Overall Study|Enrolled, but not treated|0|||
13327543|NCT01134107|26587877|FG000|Period 1-First Treatment Intervention|Adverse Event|1|||
13327544|NCT01134107|26587878|FG001|Period 1-First Treatment Intervention|Adverse Event|0|||
13327545|NCT01134107|26587877|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
13327546|NCT01134107|26587878|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
13327547|NCT01134107|26587877|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3|||
13327548|NCT01134107|26587878|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4|||
13327549|NCT01134107|26587877|FG000|Period 1-First Treatment Intervention|Physician Decision|1|||
13327550|NCT01134107|26587878|FG001|Period 1-First Treatment Intervention|Physician Decision|0|||
13327551|NCT01134107|26587877|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2|||
13327552|NCT01134107|26587878|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0|||
13327553|NCT01134107|26587877|FG000|Period 2-Second Treatment Intervention|Physician Decision|1|||
13327554|NCT01134107|26587878|FG001|Period 2-Second Treatment Intervention|Physician Decision|0|||
13327555|NCT01134107|26587877|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1|||
13327556|NCT01134107|26587878|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0|||
13327557|NCT01134055|26588031|FG000|Overall Study|Adverse Event|5|||
13327558|NCT01134055|26588032|FG001|Overall Study|Adverse Event|2|||
13327559|NCT01134055|26588033|FG002|Overall Study|Adverse Event|2|||
13327560|NCT01134055|26588034|FG003|Overall Study|Adverse Event|2|||
13327561|NCT01134055|26588035|FG004|Overall Study|Adverse Event|5|||
13327562|NCT01134055|26588036|FG005|Overall Study|Adverse Event|7|||
13327563|NCT01134055|26588037|FG006|Overall Study|Adverse Event|2|||
13327564|NCT01134055|26588031|FG000|Overall Study|Lost to Follow-up|0|||
13327565|NCT01134055|26588032|FG001|Overall Study|Lost to Follow-up|1|||
13327566|NCT01134055|26588033|FG002|Overall Study|Lost to Follow-up|0|||
13327567|NCT01134055|26588034|FG003|Overall Study|Lost to Follow-up|1|||
13327568|NCT01134055|26588035|FG004|Overall Study|Lost to Follow-up|0|||
13327569|NCT01134055|26588036|FG005|Overall Study|Lost to Follow-up|0|||
13327570|NCT01134055|26588037|FG006|Overall Study|Lost to Follow-up|0|||
13327571|NCT01134055|26588031|FG000|Overall Study|Withdrawal by Subject|3|||
13327572|NCT01134055|26588032|FG001|Overall Study|Withdrawal by Subject|3|||
13327573|NCT01134055|26588033|FG002|Overall Study|Withdrawal by Subject|1|||
13327574|NCT01134055|26588034|FG003|Overall Study|Withdrawal by Subject|2|||
13327575|NCT01134055|26588035|FG004|Overall Study|Withdrawal by Subject|0|||
13327576|NCT01134055|26588036|FG005|Overall Study|Withdrawal by Subject|0|||
13327577|NCT01134055|26588037|FG006|Overall Study|Withdrawal by Subject|8|||
13327578|NCT01134055|26588031|FG000|Overall Study|Protocol Violation|0|||
13327579|NCT01134055|26588032|FG001|Overall Study|Protocol Violation|0|||
13327580|NCT01134055|26588033|FG002|Overall Study|Protocol Violation|0|||
13327581|NCT01134055|26588034|FG003|Overall Study|Protocol Violation|1|||
13327582|NCT01134055|26588035|FG004|Overall Study|Protocol Violation|1|||
13327583|NCT01134055|26588036|FG005|Overall Study|Protocol Violation|0|||
13327584|NCT01134055|26588037|FG006|Overall Study|Protocol Violation|0|||
13327585|NCT01134055|26588031|FG000|Overall Study|Physician Decision|0|||
13327586|NCT01134055|26588032|FG001|Overall Study|Physician Decision|0|||
13327587|NCT01134055|26588033|FG002|Overall Study|Physician Decision|0|||
13327588|NCT01134055|26588034|FG003|Overall Study|Physician Decision|0|||
13327589|NCT01134055|26588035|FG004|Overall Study|Physician Decision|0|||
13327590|NCT01134055|26588036|FG005|Overall Study|Physician Decision|0|||
13327591|NCT01134055|26588037|FG006|Overall Study|Physician Decision|1|||
13327592|NCT01134042|26588085|FG000|Overall Study|Adverse Event|3|||
13327593|NCT01134042|26588086|FG001|Overall Study|Adverse Event|7|||
13327594|NCT01134042|26588087|FG002|Overall Study|Adverse Event|2|||
13327595|NCT01134042|26588085|FG000|Overall Study|Lack of Efficacy|21|||
13327596|NCT01134042|26588086|FG001|Overall Study|Lack of Efficacy|6|||
13327597|NCT01134042|26588087|FG002|Overall Study|Lack of Efficacy|18|||
13327598|NCT01134042|26588085|FG000|Overall Study|Protocol Violation|5|||
13327599|NCT01134042|26588086|FG001|Overall Study|Protocol Violation|3|||
13327600|NCT01134042|26588087|FG002|Overall Study|Protocol Violation|5|||
13327601|NCT01134042|26588085|FG000|Overall Study|Lost to Follow-up|2|||
13327602|NCT01134042|26588086|FG001|Overall Study|Lost to Follow-up|0|||
13327603|NCT01134042|26588087|FG002|Overall Study|Lost to Follow-up|1|||
13327604|NCT01134042|26588085|FG000|Overall Study|Physician Decision|4|||
13327605|NCT01134042|26588086|FG001|Overall Study|Physician Decision|8|||
13327606|NCT01134042|26588087|FG002|Overall Study|Physician Decision|1|||
13327607|NCT01134042|26588085|FG000|Overall Study|Withdrawal by Subject|13|||
13327608|NCT01134042|26588086|FG001|Overall Study|Withdrawal by Subject|4|||
13327609|NCT01134042|26588087|FG002|Overall Study|Withdrawal by Subject|7|||
13373567|NCT00802464|26724166|FG001|Month 8 - Month 14|Adverse Event|1|||
13373568|NCT00802464|26724167|FG002|Month 8 - Month 14|Adverse Event|0|||
13373569|NCT00802464|26724168|FG003|Month 8 - Month 14|Adverse Event|0|||
13373570|NCT00802464|26724165|FG000|Month 8 - Month 14|Withdrawal by Subject|1|||
13373571|NCT00802464|26724166|FG001|Month 8 - Month 14|Withdrawal by Subject|1|||
13373572|NCT00802464|26724167|FG002|Month 8 - Month 14|Withdrawal by Subject|0|||
13373573|NCT00802464|26724168|FG003|Month 8 - Month 14|Withdrawal by Subject|0|||
13373574|NCT00802464|26724165|FG000|Month 8 - Month 14|Lost to Follow-up|0|||
13373575|NCT00802464|26724166|FG001|Month 8 - Month 14|Lost to Follow-up|0|||
13373576|NCT00802464|26724167|FG002|Month 8 - Month 14|Lost to Follow-up|1|||
13373577|NCT00802464|26724168|FG003|Month 8 - Month 14|Lost to Follow-up|0|||
13373578|NCT00802438|26724175|FG000|Overall Study|Screen Failure|20|||
13373579|NCT00802438|26724175|FG000|Overall Study|Withdrawal by Subject|7|||
13373580|NCT00802438|26724175|FG000|Overall Study|Physician Decision|1|||
13373581|NCT00802360|26724228|FG000|Overall Study|Stimulation failure|4|||
13373582|NCT00802360|26724229|FG001|Overall Study|Stimulation failure|0|||
13373583|NCT00802360|26724230|FG002|Overall Study|Stimulation failure|3|||
13373584|NCT00802360|26724231|FG003|Overall Study|Stimulation failure|3|||
13373585|NCT00802360|26724228|FG000|Overall Study|Inadequate number of oocytes retrieved|0|||
13373586|NCT00802360|26724229|FG001|Overall Study|Inadequate number of oocytes retrieved|0|||
13373587|NCT00802360|26724230|FG002|Overall Study|Inadequate number of oocytes retrieved|0|||
13373588|NCT00802360|26724231|FG003|Overall Study|Inadequate number of oocytes retrieved|1|||
13373589|NCT00802360|26724228|FG000|Overall Study|Cycle cancelled|0|||
13373590|NCT00802360|26724229|FG001|Overall Study|Cycle cancelled|1|||
13373591|NCT00802360|26724230|FG002|Overall Study|Cycle cancelled|1|||
13373592|NCT00802360|26724231|FG003|Overall Study|Cycle cancelled|1|||
13373593|NCT00802360|26724228|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
13373594|NCT00802360|26724229|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
13373595|NCT00802360|26724230|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
13373596|NCT00802360|26724231|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1|||
13373597|NCT00802360|26724228|FG000|Overall Study|No positive serum pregnancy|17|||
13373598|NCT00802360|26724229|FG001|Overall Study|No positive serum pregnancy|20|||
13373599|NCT00802360|26724230|FG002|Overall Study|No positive serum pregnancy|14|||
13373600|NCT00802360|26724231|FG003|Overall Study|No positive serum pregnancy|10|||
13373601|NCT00802360|26724228|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1|||
13373602|NCT00802360|26724229|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
13373603|NCT00802360|26724230|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1|||
13373604|NCT00802360|26724231|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0|||
13373605|NCT00802360|26724228|FG000|Overall Study|Pregnancy loss/miscarriage|0|||
13373606|NCT00802360|26724229|FG001|Overall Study|Pregnancy loss/miscarriage|2|||
13373607|NCT00802360|26724230|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
13373608|NCT00802360|26724231|FG003|Overall Study|Pregnancy loss/miscarriage|3|||
13373609|NCT00802360|26724228|FG000|Overall Study|Other|2|||
13373610|NCT00802360|26724229|FG001|Overall Study|Other|3|||
13373611|NCT00802360|26724230|FG002|Overall Study|Other|6|||
13373612|NCT00802360|26724231|FG003|Overall Study|Other|3|||
13373613|NCT00802178|26724240|FG000|Overall Study|Lack of Efficacy|36|||
13373614|NCT00802178|26724240|FG000|Overall Study|Insufficient tolerability (IT)|17|||
13373615|NCT00802178|26724240|FG000|Overall Study|Withdrawal by Subject|18|||
13373616|NCT00802178|26724240|FG000|Overall Study|Other|32|||
13373617|NCT00802178|26724240|FG000|Overall Study|Lack of efficacy and patient wish|1|||
13373618|NCT00802178|26724240|FG000|Overall Study|IT and patient wish|8|||
13373619|NCT00802178|26724240|FG000|Overall Study|Patients wish and other reason|1|||
13373620|NCT00802074|26724291|FG000|Overall Study|Adverse Event|1|||
13373621|NCT00802074|26724292|FG001|Overall Study|Adverse Event|1|||
13373622|NCT00802074|26724293|FG002|Overall Study|Adverse Event|1|||
13373623|NCT00802074|26724294|FG003|Overall Study|Adverse Event|0|||
13373624|NCT00802074|26724295|FG004|Overall Study|Adverse Event|0|||
13373625|NCT00802074|26724296|FG005|Overall Study|Adverse Event|0|||
13373626|NCT00802074|26724291|FG000|Overall Study|Withdrawal by Subject|1|||
13373627|NCT00802074|26724292|FG001|Overall Study|Withdrawal by Subject|0|||
13373628|NCT00802074|26724293|FG002|Overall Study|Withdrawal by Subject|0|||
13373629|NCT00802074|26724294|FG003|Overall Study|Withdrawal by Subject|0|||
13373630|NCT00802074|26724295|FG004|Overall Study|Withdrawal by Subject|0|||
13373631|NCT00802074|26724296|FG005|Overall Study|Withdrawal by Subject|0|||
13373632|NCT00801983|26724309|FG000|Period 1|Lost to Follow-up|2|||
13373633|NCT00801983|26724310|FG001|Period 1|Lost to Follow-up|0|||
13373634|NCT00801983|26724309|FG000|Period 1|Withdrawal by Subject|2|||
13373635|NCT00801983|26724310|FG001|Period 1|Withdrawal by Subject|8|||
13373636|NCT00801983|26724309|FG000|Period 2|Withdrawal by Subject|2|||
13327610|NCT01133977|26588120|FG000|Overall Study|Adverse Event|0|||
13327611|NCT01133977|26588121|FG001|Overall Study|Adverse Event|0|||
13327612|NCT01133977|26588122|FG002|Overall Study|Adverse Event|1|||
13327613|NCT01133977|26588123|FG003|Overall Study|Adverse Event|0|||
13327614|NCT01133977|26588124|FG004|Overall Study|Adverse Event|0|||
13327615|NCT01133977|26588120|FG000|Overall Study|Death|1|||
13327616|NCT01133977|26588121|FG001|Overall Study|Death|1|||
13327617|NCT01133977|26588122|FG002|Overall Study|Death|1|||
13327618|NCT01133977|26588123|FG003|Overall Study|Death|7|||
13327619|NCT01133977|26588124|FG004|Overall Study|Death|3|||
13327620|NCT01133977|26588120|FG000|Overall Study|Started a New Line of Therapy|2|||
13327621|NCT01133977|26588121|FG001|Overall Study|Started a New Line of Therapy|6|||
13327622|NCT01133977|26588122|FG002|Overall Study|Started a New Line of Therapy|4|||
13327623|NCT01133977|26588123|FG003|Overall Study|Started a New Line of Therapy|25|||
13327624|NCT01133977|26588124|FG004|Overall Study|Started a New Line of Therapy|33|||
13327625|NCT01133977|26588120|FG000|Overall Study|Lost to Follow-up|0|||
13327626|NCT01133977|26588121|FG001|Overall Study|Lost to Follow-up|0|||
13327627|NCT01133977|26588122|FG002|Overall Study|Lost to Follow-up|0|||
13327628|NCT01133977|26588123|FG003|Overall Study|Lost to Follow-up|2|||
13327629|NCT01133977|26588124|FG004|Overall Study|Lost to Follow-up|1|||
13327630|NCT01133977|26588120|FG000|Overall Study|Withdrawal by Subject|0|||
13327631|NCT01133977|26588121|FG001|Overall Study|Withdrawal by Subject|0|||
13327632|NCT01133977|26588122|FG002|Overall Study|Withdrawal by Subject|0|||
13327633|NCT01133977|26588123|FG003|Overall Study|Withdrawal by Subject|5|||
13327634|NCT01133977|26588124|FG004|Overall Study|Withdrawal by Subject|1|||
13327635|NCT01133847|26588172|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5|||
13327636|NCT01133847|26588173|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1|||
13327637|NCT01133847|26588174|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3|||
13327638|NCT01133847|26588172|FG000|Follow-Up Phase|Lost to Follow-up|1|||
13327639|NCT01133847|26588173|FG001|Follow-Up Phase|Lost to Follow-up|3|||
13327640|NCT01133847|26588174|FG002|Follow-Up Phase|Lost to Follow-up|7|||
13327641|NCT01133821|26588189|FG000|Overall Study|Lost to Follow-up|8|||
13327642|NCT01133821|26588190|FG001|Overall Study|Lost to Follow-up|11|||
13327643|NCT01133821|26588189|FG000|Overall Study|Withdrawal by Subject|8|||
13327644|NCT01133821|26588190|FG001|Overall Study|Withdrawal by Subject|3|||
13327645|NCT01133821|26588189|FG000|Overall Study|preferred other treatment|1|||
13327646|NCT01133821|26588190|FG001|Overall Study|preferred other treatment|1|||
13327647|NCT01133821|26588189|FG000|Overall Study|Protocol Violation|0|||
13327648|NCT01133821|26588190|FG001|Overall Study|Protocol Violation|1|||
13327649|NCT01133821|26588189|FG000|Overall Study|Refused participation|1|||
13327650|NCT01133821|26588190|FG001|Overall Study|Refused participation|3|||
13327651|NCT01133756|26588214|FG000|Overall Study|Adverse Event|1|||
13327652|NCT01133756|26588215|FG001|Overall Study|Adverse Event|2|||
13327653|NCT01133756|26588216|FG002|Overall Study|Adverse Event|1|||
13327654|NCT01133756|26588214|FG000|Overall Study|Investigator Decision|1|||
13327655|NCT01133756|26588215|FG001|Overall Study|Investigator Decision|0|||
13327656|NCT01133756|26588216|FG002|Overall Study|Investigator Decision|0|||
13327657|NCT01133756|26588214|FG000|Overall Study|Withdrawal by Subject|0|||
13327658|NCT01133756|26588215|FG001|Overall Study|Withdrawal by Subject|1|||
13327659|NCT01133756|26588216|FG002|Overall Study|Withdrawal by Subject|0|||
13327660|NCT01133756|26588214|FG000|Overall Study|Progression of Disease|0|||
13327661|NCT01133756|26588215|FG001|Overall Study|Progression of Disease|0|||
13327662|NCT01133756|26588216|FG002|Overall Study|Progression of Disease|1|||
13327663|NCT01133704|26588231|FG000|Overall Study|Death|44|||
13327664|NCT01133704|26588232|FG001|Overall Study|Death|26|||
13327665|NCT01133704|26588231|FG000|Overall Study|Patient refused to continue|4|||
13327666|NCT01133704|26588232|FG001|Overall Study|Patient refused to continue|0|||
13327667|NCT01133704|26588231|FG000|Overall Study|Study Closure|1|||
13327668|NCT01133704|26588232|FG001|Overall Study|Study Closure|0|||
13327669|NCT01133678|26588245|FG000|Overall Study|Death|1|||
13327670|NCT01133678|26588246|FG001|Overall Study|Death|1|||
13327671|NCT01133665|26588289|FG000|Overall Study|Physician Decision|2|||
13327672|NCT01133626|26588307|FG000|Overall Study|Adverse Event|0|||
13327673|NCT01133626|26588308|FG001|Overall Study|Adverse Event|1|||
13327674|NCT01133626|26588309|FG002|Overall Study|Adverse Event|0|||
13327675|NCT01133626|26588307|FG000|Overall Study|Withdrawal by Subject|1|||
13327676|NCT01133626|26588308|FG001|Overall Study|Withdrawal by Subject|2|||
13327677|NCT01133626|26588309|FG002|Overall Study|Withdrawal by Subject|2|||
13327678|NCT01133626|26588307|FG000|Overall Study|Other|0|||
13327679|NCT01133626|26588308|FG001|Overall Study|Other|2|||
13327680|NCT01133626|26588309|FG002|Overall Study|Other|0|||
13327681|NCT01133522|26588406|FG000|Overall Study|Withdrawal by Subject|0|||
13327682|NCT01133522|26588407|FG001|Overall Study|Withdrawal by Subject|1|||
13327683|NCT01133522|26588408|FG002|Overall Study|Withdrawal by Subject|0|||
13327684|NCT01133522|26588409|FG003|Overall Study|Withdrawal by Subject|1|||
13327685|NCT01133522|26588410|FG004|Overall Study|Withdrawal by Subject|0|||
13327686|NCT01133522|26588411|FG005|Overall Study|Withdrawal by Subject|0|||
13327687|NCT01133522|26588412|FG006|Overall Study|Withdrawal by Subject|0|||
13327688|NCT01133522|26588413|FG007|Overall Study|Withdrawal by Subject|0|||
13327689|NCT01133522|26588414|FG008|Overall Study|Withdrawal by Subject|0|||
13327690|NCT01133522|26588415|FG009|Overall Study|Withdrawal by Subject|0|||
13327691|NCT01133522|26588406|FG000|Overall Study|Physician Decision|0|||
13327692|NCT01133522|26588407|FG001|Overall Study|Physician Decision|0|||
13327693|NCT01133522|26588408|FG002|Overall Study|Physician Decision|0|||
13327694|NCT01133522|26588409|FG003|Overall Study|Physician Decision|0|||
13327695|NCT01133522|26588410|FG004|Overall Study|Physician Decision|1|||
13327696|NCT01133522|26588411|FG005|Overall Study|Physician Decision|0|||
13327697|NCT01133522|26588412|FG006|Overall Study|Physician Decision|0|||
13327698|NCT01133522|26588413|FG007|Overall Study|Physician Decision|0|||
13327699|NCT01133522|26588414|FG008|Overall Study|Physician Decision|0|||
13327700|NCT01133522|26588415|FG009|Overall Study|Physician Decision|0|||
13327701|NCT01133418|26588434|FG000|Overall Study|Lost to Follow-up|5|||
13327702|NCT01133418|26588435|FG001|Overall Study|Lost to Follow-up|6|||
13327703|NCT01133405|26588515|FG000|Period 1|Withdrawal by Subject|0|||
13327704|NCT01133405|26588516|FG001|Period 1|Withdrawal by Subject|1|||
13327705|NCT01133405|26588517|FG002|Period 1|Withdrawal by Subject|0|||
13327706|NCT01133405|26588518|FG003|Period 1|Withdrawal by Subject|1|||
13327707|NCT01133405|26588519|FG004|Period 1|Withdrawal by Subject|0|||
13327708|NCT01133405|26588520|FG005|Period 1|Withdrawal by Subject|1|||
13327709|NCT01133405|26588521|FG006|Period 1|Withdrawal by Subject|0|||
13327710|NCT01133405|26588522|FG007|Period 1|Withdrawal by Subject|0|||
13327711|NCT01133405|26588523|FG008|Period 1|Withdrawal by Subject|0|||
13327712|NCT01133405|26588524|FG009|Period 1|Withdrawal by Subject|0|||
13327713|NCT01133405|26588515|FG000|Period 1|Physician Decision|0|||
13327714|NCT01133405|26588516|FG001|Period 1|Physician Decision|0|||
13327715|NCT01133405|26588517|FG002|Period 1|Physician Decision|0|||
13327716|NCT01133405|26588518|FG003|Period 1|Physician Decision|1|||
13327717|NCT01133405|26588519|FG004|Period 1|Physician Decision|0|||
13327718|NCT01133405|26588520|FG005|Period 1|Physician Decision|0|||
13327719|NCT01133405|26588521|FG006|Period 1|Physician Decision|0|||
13327720|NCT01133405|26588522|FG007|Period 1|Physician Decision|0|||
13327721|NCT01133405|26588523|FG008|Period 1|Physician Decision|0|||
13327722|NCT01133405|26588524|FG009|Period 1|Physician Decision|0|||
13327723|NCT01133405|26588515|FG000|Period 1|Discontinued after randomization|1|||
13327724|NCT01133405|26588516|FG001|Period 1|Discontinued after randomization|0|||
13327725|NCT01133405|26588517|FG002|Period 1|Discontinued after randomization|0|||
13327726|NCT01133405|26588518|FG003|Period 1|Discontinued after randomization|0|||
13327727|NCT01133405|26588519|FG004|Period 1|Discontinued after randomization|0|||
13327728|NCT01133405|26588520|FG005|Period 1|Discontinued after randomization|0|||
13327729|NCT01133405|26588521|FG006|Period 1|Discontinued after randomization|1|||
13327730|NCT01133405|26588522|FG007|Period 1|Discontinued after randomization|0|||
13327731|NCT01133405|26588523|FG008|Period 1|Discontinued after randomization|0|||
13327732|NCT01133405|26588524|FG009|Period 1|Discontinued after randomization|0|||
13327733|NCT01133405|26588515|FG000|Period 1|Received drug only in period 2|0|||
13327734|NCT01133405|26588516|FG001|Period 1|Received drug only in period 2|1|||
13327735|NCT01133405|26588517|FG002|Period 1|Received drug only in period 2|0|||
13327736|NCT01133405|26588518|FG003|Period 1|Received drug only in period 2|2|||
13327737|NCT01133405|26588519|FG004|Period 1|Received drug only in period 2|0|||
13327738|NCT01133405|26588520|FG005|Period 1|Received drug only in period 2|1|||
13327739|NCT01133405|26588521|FG006|Period 1|Received drug only in period 2|0|||
13327740|NCT01133405|26588522|FG007|Period 1|Received drug only in period 2|0|||
13327741|NCT01133405|26588523|FG008|Period 1|Received drug only in period 2|0|||
13327742|NCT01133405|26588524|FG009|Period 1|Received drug only in period 2|0|||
13327743|NCT01133405|26588515|FG000|Period 1|Received drug only in period 3|0|||
13327744|NCT01133405|26588516|FG001|Period 1|Received drug only in period 3|1|||
13327745|NCT01133405|26588517|FG002|Period 1|Received drug only in period 3|1|||
13327746|NCT01133405|26588518|FG003|Period 1|Received drug only in period 3|0|||
13327747|NCT01133405|26588519|FG004|Period 1|Received drug only in period 3|0|||
13327748|NCT01133405|26588520|FG005|Period 1|Received drug only in period 3|0|||
13327749|NCT01133405|26588521|FG006|Period 1|Received drug only in period 3|0|||
13327750|NCT01133405|26588522|FG007|Period 1|Received drug only in period 3|0|||
13327751|NCT01133405|26588523|FG008|Period 1|Received drug only in period 3|0|||
13327752|NCT01133405|26588524|FG009|Period 1|Received drug only in period 3|0|||
13327753|NCT01133405|26588515|FG000|Period 2|Adverse Event|0|||
13327754|NCT01133405|26588516|FG001|Period 2|Adverse Event|0|||
13327755|NCT01133405|26588517|FG002|Period 2|Adverse Event|1|||
13327756|NCT01133405|26588518|FG003|Period 2|Adverse Event|0|||
13327757|NCT01133405|26588519|FG004|Period 2|Adverse Event|0|||
13327758|NCT01133405|26588520|FG005|Period 2|Adverse Event|0|||
13327759|NCT01133405|26588521|FG006|Period 2|Adverse Event|0|||
13327760|NCT01133405|26588522|FG007|Period 2|Adverse Event|0|||
13327761|NCT01133405|26588523|FG008|Period 2|Adverse Event|0|||
13327762|NCT01133405|26588524|FG009|Period 2|Adverse Event|0|||
13327763|NCT01133405|26588515|FG000|Period 2|Withdrawal by Subject|0|||
13327764|NCT01133405|26588516|FG001|Period 2|Withdrawal by Subject|0|||
13327765|NCT01133405|26588517|FG002|Period 2|Withdrawal by Subject|0|||
13327766|NCT01133405|26588518|FG003|Period 2|Withdrawal by Subject|1|||
13327767|NCT01133405|26588519|FG004|Period 2|Withdrawal by Subject|0|||
13327768|NCT01133405|26588520|FG005|Period 2|Withdrawal by Subject|1|||
13327769|NCT01133405|26588521|FG006|Period 2|Withdrawal by Subject|0|||
13327770|NCT01133405|26588522|FG007|Period 2|Withdrawal by Subject|0|||
13327771|NCT01133405|26588523|FG008|Period 2|Withdrawal by Subject|0|||
13327772|NCT01133405|26588524|FG009|Period 2|Withdrawal by Subject|0|||
13327773|NCT01133405|26588515|FG000|Period 2|Entry Criteria Not Met|0|||
13327774|NCT01133405|26588516|FG001|Period 2|Entry Criteria Not Met|1|||
13327775|NCT01133405|26588517|FG002|Period 2|Entry Criteria Not Met|0|||
13327776|NCT01133405|26588518|FG003|Period 2|Entry Criteria Not Met|0|||
13327777|NCT01133405|26588519|FG004|Period 2|Entry Criteria Not Met|0|||
13327778|NCT01133405|26588520|FG005|Period 2|Entry Criteria Not Met|0|||
13327779|NCT01133405|26588521|FG006|Period 2|Entry Criteria Not Met|0|||
13327780|NCT01133405|26588522|FG007|Period 2|Entry Criteria Not Met|0|||
13327781|NCT01133405|26588523|FG008|Period 2|Entry Criteria Not Met|0|||
13327782|NCT01133405|26588524|FG009|Period 2|Entry Criteria Not Met|0|||
13327783|NCT01133405|26588515|FG000|Period 2|Physician Decision|0|||
13327784|NCT01133405|26588516|FG001|Period 2|Physician Decision|0|||
13327785|NCT01133405|26588517|FG002|Period 2|Physician Decision|0|||
13327786|NCT01133405|26588518|FG003|Period 2|Physician Decision|0|||
13327787|NCT01133405|26588519|FG004|Period 2|Physician Decision|0|||
13327788|NCT01133405|26588520|FG005|Period 2|Physician Decision|1|||
13327789|NCT01133405|26588521|FG006|Period 2|Physician Decision|0|||
13327790|NCT01133405|26588522|FG007|Period 2|Physician Decision|0|||
13327791|NCT01133405|26588523|FG008|Period 2|Physician Decision|0|||
13327792|NCT01133405|26588524|FG009|Period 2|Physician Decision|0|||
13327793|NCT01133392|26588545|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0|||
13327794|NCT01133392|26588546|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1|||
13327795|NCT01133392|26588545|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0|||
13327796|NCT01133392|26588546|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1|||
13327797|NCT01133379|26588609|FG000|Overall Study|Withdrawal by Subject|0|||
13327798|NCT01133379|26588610|FG001|Overall Study|Withdrawal by Subject|1|||
13327799|NCT01133379|26588611|FG002|Overall Study|Withdrawal by Subject|1|||
13327800|NCT01133379|26588609|FG000|Overall Study|Lost to Follow-up|1|||
13327801|NCT01133379|26588610|FG001|Overall Study|Lost to Follow-up|1|||
13327802|NCT01133379|26588611|FG002|Overall Study|Lost to Follow-up|1|||
13327803|NCT01133288|26588618|FG000|Eligibility Assessment|met exclusion criteria|5|||
13327804|NCT01133288|26588618|FG000|Intervention Allocation|study terminated|2|||
13327805|NCT01133275|26588625|FG000|Overall Study|Withdrawal by Subject|1|||
13327806|NCT01133275|26588625|FG000|Overall Study|Cerebrovascular accident (CVA)|1|||
13327807|NCT01133171|26588645|FG000|Overall Study|Withdrawal by Subject|1|||
13327808|NCT01133171|26588646|FG001|Overall Study|Withdrawal by Subject|2|||
13327809|NCT01133171|26588647|FG002|Overall Study|Withdrawal by Subject|0|||
13327810|NCT01133067|26588654|FG000|Overall Study|Death|136|||
13327811|NCT01133067|26588654|FG000|Overall Study|Lost to Follow-up|3|||
13327812|NCT01132820|26588665|FG000|Overall Study|Ineligible: wrong cell type|1|||
13327813|NCT01132820|26588665|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1|||
13327814|NCT01132820|26588665|FG000|Overall Study|Ineligible:Inadequate pathology|1|||
13327815|NCT01132820|26588665|FG000|Overall Study|Never treated|1|||
13327816|NCT01132820|26588665|FG000|Overall Study|Inadequate data|1|||
13327817|NCT01132807|26588679|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9|||
13327818|NCT01132807|26588680|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
13327819|NCT01132807|26588681|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
13327820|NCT01132807|26588679|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6|||
13327821|NCT01132807|26588680|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
13327822|NCT01132807|26588681|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
13327823|NCT01132755|26588688|FG000|Overall Study|Procedure not done due to medical reason|23|||
13327824|NCT01132755|26588688|FG000|Overall Study|Protocol Violation|15|||
13327825|NCT01132755|26588688|FG000|Overall Study|Withdrawal by Subject|4|||
13327826|NCT01132664|26588736|FG000|Phase lb|Adverse Event|0|||
13327827|NCT01132664|26588737|FG001|Phase lb|Adverse Event|1|||
13327828|NCT01132664|26588738|FG002|Phase lb|Adverse Event|0|||
13327829|NCT01132664|26588739|FG003|Phase lb|Adverse Event|0|||
13327830|NCT01132664|26588740|FG004|Phase lb|Adverse Event|0|||
13327831|NCT01132664|26588736|FG000|Phase lb|Withdrawal by Subject|1|||
13327832|NCT01132664|26588737|FG001|Phase lb|Withdrawal by Subject|2|||
13327833|NCT01132664|26588738|FG002|Phase lb|Withdrawal by Subject|0|||
13327834|NCT01132664|26588739|FG003|Phase lb|Withdrawal by Subject|0|||
13327835|NCT01132664|26588740|FG004|Phase lb|Withdrawal by Subject|0|||
13327836|NCT01132664|26588736|FG000|Phase lb|Disease Progression|4|||
13327837|NCT01132664|26588737|FG001|Phase lb|Disease Progression|9|||
13327838|NCT01132664|26588738|FG002|Phase lb|Disease Progression|0|||
13327839|NCT01132664|26588739|FG003|Phase lb|Disease Progression|0|||
13327840|NCT01132664|26588740|FG004|Phase lb|Disease Progression|0|||
13327841|NCT01132664|26588736|FG000|Phase ll|Death|0|||
13327842|NCT01132664|26588737|FG001|Phase ll|Death|0|||
13327843|NCT01132664|26588738|FG002|Phase ll|Death|2|||
13327844|NCT01132664|26588739|FG003|Phase ll|Death|0|||
13327845|NCT01132664|26588740|FG004|Phase ll|Death|0|||
13327846|NCT01132664|26588736|FG000|Phase ll|Adverse Event|0|||
13327847|NCT01132664|26588737|FG001|Phase ll|Adverse Event|0|||
13327848|NCT01132664|26588738|FG002|Phase ll|Adverse Event|10|||
13327849|NCT01132664|26588739|FG003|Phase ll|Adverse Event|0|||
13327850|NCT01132664|26588740|FG004|Phase ll|Adverse Event|0|||
13327851|NCT01132664|26588736|FG000|Phase ll|Withdrawal by Subject|0|||
13327852|NCT01132664|26588737|FG001|Phase ll|Withdrawal by Subject|0|||
13327853|NCT01132664|26588738|FG002|Phase ll|Withdrawal by Subject|3|||
13327854|NCT01132664|26588739|FG003|Phase ll|Withdrawal by Subject|0|||
13327855|NCT01132664|26588740|FG004|Phase ll|Withdrawal by Subject|0|||
13327856|NCT01132664|26588736|FG000|Phase ll|Disease progression|0|||
13327857|NCT01132664|26588737|FG001|Phase ll|Disease progression|0|||
13327858|NCT01132664|26588738|FG002|Phase ll|Disease progression|35|||
13327859|NCT01132664|26588739|FG003|Phase ll|Disease progression|0|||
13327860|NCT01132664|26588740|FG004|Phase ll|Disease progression|0|||
13327861|NCT01132664|26588736|FG000|BM Cohort|Disease progression|0|||
13327862|NCT01132664|26588737|FG001|BM Cohort|Disease progression|0|||
13327863|NCT01132664|26588738|FG002|BM Cohort|Disease progression|0|||
13327864|NCT01132664|26588739|FG003|BM Cohort|Disease progression|3|||
13327865|NCT01132664|26588740|FG004|BM Cohort|Disease progression|4|||
13327866|NCT01132664|26588736|FG000|BM Cohort|Adverse Event|0|||
13327867|NCT01132664|26588737|FG001|BM Cohort|Adverse Event|0|||
13327868|NCT01132664|26588738|FG002|BM Cohort|Adverse Event|0|||
13327869|NCT01132664|26588739|FG003|BM Cohort|Adverse Event|0|||
13327870|NCT01132664|26588740|FG004|BM Cohort|Adverse Event|1|||
13327871|NCT01132664|26588736|FG000|BM Cohort|Withdrawal by Subject|0|||
13327872|NCT01132664|26588737|FG001|BM Cohort|Withdrawal by Subject|0|||
13327873|NCT01132664|26588738|FG002|BM Cohort|Withdrawal by Subject|0|||
13327874|NCT01132664|26588739|FG003|BM Cohort|Withdrawal by Subject|0|||
13327875|NCT01132664|26588740|FG004|BM Cohort|Withdrawal by Subject|1|||
13327876|NCT01132651|26588755|FG000|Overall Study|Lost to Follow-up|1|||
13327877|NCT01132651|26588756|FG001|Overall Study|Lost to Follow-up|1|||
13327878|NCT01132612|26588780|FG000|Overall Study|Death|0|||
13327879|NCT01132612|26588781|FG001|Overall Study|Death|0|||
13327880|NCT01132612|26588782|FG002|Overall Study|Death|1|||
13327881|NCT01132612|26588780|FG000|Overall Study|Protocol deviation|0|||
13327882|NCT01132612|26588781|FG001|Overall Study|Protocol deviation|0|||
13327883|NCT01132612|26588782|FG002|Overall Study|Protocol deviation|3|||
13327884|NCT01132612|26588780|FG000|Overall Study|Lost to Follow-up|2|||
13327885|NCT01132612|26588781|FG001|Overall Study|Lost to Follow-up|2|||
13327886|NCT01132612|26588782|FG002|Overall Study|Lost to Follow-up|7|||
13327887|NCT01132612|26588780|FG000|Overall Study|Adverse Event|5|||
13327888|NCT01132612|26588781|FG001|Overall Study|Adverse Event|2|||
13327889|NCT01132612|26588782|FG002|Overall Study|Adverse Event|15|||
13327890|NCT01132612|26588780|FG000|Overall Study|Withdrawal by Subject|5|||
13327891|NCT01132612|26588781|FG001|Overall Study|Withdrawal by Subject|8|||
13327892|NCT01132612|26588782|FG002|Overall Study|Withdrawal by Subject|19|||
13327893|NCT01132612|26588780|FG000|Overall Study|Administrative problems|5|||
13327894|NCT01132612|26588781|FG001|Overall Study|Administrative problems|1|||
13327895|NCT01132612|26588782|FG002|Overall Study|Administrative problems|52|||
13327896|NCT01132612|26588780|FG000|Overall Study|Lack of Efficacy|23|||
13327897|NCT01132612|26588781|FG001|Overall Study|Lack of Efficacy|22|||
13327898|NCT01132612|26588782|FG002|Overall Study|Lack of Efficacy|73|||
13327899|NCT01132547|26588799|FG000|Overall Study|Withdrawal by Subject|3|||
13327900|NCT01132547|26588800|FG001|Overall Study|Withdrawal by Subject|1|||
13327901|NCT01132547|26588799|FG000|Overall Study|Death|1|||
13327902|NCT01132547|26588800|FG001|Overall Study|Death|0|||
13327903|NCT01132495|26588824|FG000|Overall Study|Various reasons|40|||
13327904|NCT01132495|26588825|FG001|Overall Study|Various reasons|38|||
13327905|NCT01132495|26588826|FG002|Overall Study|Various reasons|20|||
13327906|NCT01132495|26588827|FG003|Overall Study|Various reasons|12|||
13327907|NCT01132482|26588852|FG000|Overall Study|Adverse Event|1|||
13327908|NCT01132482|26588853|FG001|Overall Study|Adverse Event|0|||
13327909|NCT01132326|26588859|FG000|Overall Study|Lack of Efficacy|25|||
13327910|NCT01132326|26588859|FG000|Overall Study|Adverse Event|37|||
13327911|NCT01132326|26588859|FG000|Overall Study|Protocol Violation|1|||
13327912|NCT01132326|26588859|FG000|Overall Study|Lost to Follow-up|16|||
13327913|NCT01132326|26588859|FG000|Overall Study|Withdrawal by Subject|40|||
13327914|NCT01132326|26588859|FG000|Overall Study|Physician Decision|10|||
13327915|NCT01132326|26588859|FG000|Overall Study|Study Termination|80|||
13327916|NCT01132326|26588859|FG000|Overall Study|Declining Health|1|||
13327917|NCT01132326|26588859|FG000|Overall Study|Pregnancy|1|||
13327918|NCT01132326|26588859|FG000|Overall Study|Caregiver Withdrew Consent|1|||
13327919|NCT01132326|26588859|FG000|Overall Study|Death|5|||
13327920|NCT01132326|26588859|FG000|Overall Study|Subject Unable to Come To Visits|1|||
13327921|NCT01132313|26588951|FG000|Overall Study|Lack of Efficacy|1|||
13327922|NCT01132313|26588952|FG001|Overall Study|Lack of Efficacy|0|||
13327923|NCT01132313|26588953|FG002|Overall Study|Lack of Efficacy|0|||
13327924|NCT01132313|26588954|FG003|Overall Study|Lack of Efficacy|0|||
13327925|NCT01132313|26588955|FG004|Overall Study|Lack of Efficacy|0|||
13327926|NCT01132313|26588956|FG005|Overall Study|Lack of Efficacy|0|||
13327927|NCT01132313|26588957|FG006|Overall Study|Lack of Efficacy|0|||
13327928|NCT01132313|26588958|FG007|Overall Study|Lack of Efficacy|3|||
13327929|NCT01132313|26588959|FG008|Overall Study|Lack of Efficacy|14|||
13327930|NCT01132313|26588960|FG009|Overall Study|Lack of Efficacy|16|||
13327931|NCT01132313|26588961|FG010|Overall Study|Lack of Efficacy|0|||
13327932|NCT01132313|26588962|FG011|Overall Study|Lack of Efficacy|0|||
13327933|NCT01132313|26588951|FG000|Overall Study|Not treated|2|||
13327934|NCT01132313|26588952|FG001|Overall Study|Not treated|0|||
13327935|NCT01132313|26588953|FG002|Overall Study|Not treated|0|||
13327936|NCT01132313|26588954|FG003|Overall Study|Not treated|0|||
13327937|NCT01132313|26588955|FG004|Overall Study|Not treated|2|||
13327938|NCT01132313|26588956|FG005|Overall Study|Not treated|1|||
13327939|NCT01132313|26588957|FG006|Overall Study|Not treated|3|||
13327940|NCT01132313|26588958|FG007|Overall Study|Not treated|0|||
13327941|NCT01132313|26588959|FG008|Overall Study|Not treated|0|||
13327942|NCT01132313|26588960|FG009|Overall Study|Not treated|0|||
13327943|NCT01132313|26588961|FG010|Overall Study|Not treated|0|||
13327944|NCT01132313|26588962|FG011|Overall Study|Not treated|0|||
13327945|NCT01132313|26588951|FG000|Overall Study|Adverse Event|0|||
13327946|NCT01132313|26588952|FG001|Overall Study|Adverse Event|0|||
13327947|NCT01132313|26588953|FG002|Overall Study|Adverse Event|4|||
13327948|NCT01132313|26588954|FG003|Overall Study|Adverse Event|10|||
13327949|NCT01132313|26588955|FG004|Overall Study|Adverse Event|19|||
13327950|NCT01132313|26588956|FG005|Overall Study|Adverse Event|6|||
13327951|NCT01132313|26588957|FG006|Overall Study|Adverse Event|5|||
13327952|NCT01132313|26588958|FG007|Overall Study|Adverse Event|3|||
13327953|NCT01132313|26588959|FG008|Overall Study|Adverse Event|7|||
13327954|NCT01132313|26588960|FG009|Overall Study|Adverse Event|2|||
13327955|NCT01132313|26588961|FG010|Overall Study|Adverse Event|0|||
13327956|NCT01132313|26588962|FG011|Overall Study|Adverse Event|0|||
13327957|NCT01132313|26588951|FG000|Overall Study|Protocol Violation|0|||
13327958|NCT01132313|26588952|FG001|Overall Study|Protocol Violation|0|||
13327959|NCT01132313|26588953|FG002|Overall Study|Protocol Violation|0|||
13327960|NCT01132313|26588954|FG003|Overall Study|Protocol Violation|1|||
13327961|NCT01132313|26588955|FG004|Overall Study|Protocol Violation|0|||
13327962|NCT01132313|26588956|FG005|Overall Study|Protocol Violation|0|||
13327963|NCT01132313|26588957|FG006|Overall Study|Protocol Violation|0|||
13327964|NCT01132313|26588958|FG007|Overall Study|Protocol Violation|0|||
13327965|NCT01132313|26588959|FG008|Overall Study|Protocol Violation|0|||
13327966|NCT01132313|26588960|FG009|Overall Study|Protocol Violation|0|||
13327967|NCT01132313|26588961|FG010|Overall Study|Protocol Violation|0|||
13327968|NCT01132313|26588962|FG011|Overall Study|Protocol Violation|0|||
13327969|NCT01132313|26588951|FG000|Overall Study|Lost to Follow-up|0|||
13327970|NCT01132313|26588952|FG001|Overall Study|Lost to Follow-up|0|||
13327971|NCT01132313|26588953|FG002|Overall Study|Lost to Follow-up|1|||
13327972|NCT01132313|26588954|FG003|Overall Study|Lost to Follow-up|0|||
13327973|NCT01132313|26588955|FG004|Overall Study|Lost to Follow-up|0|||
13327974|NCT01132313|26588956|FG005|Overall Study|Lost to Follow-up|0|||
13327975|NCT01132313|26588957|FG006|Overall Study|Lost to Follow-up|0|||
13327976|NCT01132313|26588958|FG007|Overall Study|Lost to Follow-up|1|||
13327977|NCT01132313|26588959|FG008|Overall Study|Lost to Follow-up|0|||
13327978|NCT01132313|26588960|FG009|Overall Study|Lost to Follow-up|0|||
13327979|NCT01132313|26588961|FG010|Overall Study|Lost to Follow-up|0|||
13327980|NCT01132313|26588962|FG011|Overall Study|Lost to Follow-up|0|||
13327981|NCT01132313|26588951|FG000|Overall Study|Withdrawal by Subject|0|||
13327982|NCT01132313|26588952|FG001|Overall Study|Withdrawal by Subject|0|||
13327983|NCT01132313|26588953|FG002|Overall Study|Withdrawal by Subject|3|||
13327984|NCT01132313|26588954|FG003|Overall Study|Withdrawal by Subject|3|||
13327985|NCT01132313|26588955|FG004|Overall Study|Withdrawal by Subject|6|||
13327986|NCT01132313|26588956|FG005|Overall Study|Withdrawal by Subject|0|||
13327987|NCT01132313|26588957|FG006|Overall Study|Withdrawal by Subject|1|||
13327988|NCT01132313|26588958|FG007|Overall Study|Withdrawal by Subject|0|||
13327989|NCT01132313|26588959|FG008|Overall Study|Withdrawal by Subject|0|||
13327990|NCT01132313|26588960|FG009|Overall Study|Withdrawal by Subject|2|||
13327991|NCT01132313|26588961|FG010|Overall Study|Withdrawal by Subject|0|||
13327992|NCT01132313|26588962|FG011|Overall Study|Withdrawal by Subject|0|||
13327993|NCT01132313|26588951|FG000|Overall Study|Lack of antiviral response|0|||
13327994|NCT01132313|26588952|FG001|Overall Study|Lack of antiviral response|0|||
13327995|NCT01132313|26588953|FG002|Overall Study|Lack of antiviral response|12|||
13327996|NCT01132313|26588954|FG003|Overall Study|Lack of antiviral response|18|||
13327997|NCT01132313|26588955|FG004|Overall Study|Lack of antiviral response|18|||
13327998|NCT01132313|26588956|FG005|Overall Study|Lack of antiviral response|18|||
13327999|NCT01132313|26588957|FG006|Overall Study|Lack of antiviral response|21|||
13328000|NCT01132313|26588958|FG007|Overall Study|Lack of antiviral response|0|||
13328001|NCT01132313|26588959|FG008|Overall Study|Lack of antiviral response|0|||
13328002|NCT01132313|26588960|FG009|Overall Study|Lack of antiviral response|0|||
13328003|NCT01132313|26588961|FG010|Overall Study|Lack of antiviral response|1|||
13328004|NCT01132313|26588962|FG011|Overall Study|Lack of antiviral response|0|||
13328005|NCT01132313|26588951|FG000|Overall Study|Other reason not defined above|0|||
13328006|NCT01132313|26588952|FG001|Overall Study|Other reason not defined above|0|||
13328007|NCT01132313|26588953|FG002|Overall Study|Other reason not defined above|0|||
13328008|NCT01132313|26588954|FG003|Overall Study|Other reason not defined above|0|||
13328009|NCT01132313|26588955|FG004|Overall Study|Other reason not defined above|0|||
13328010|NCT01132313|26588956|FG005|Overall Study|Other reason not defined above|0|||
13328011|NCT01132313|26588957|FG006|Overall Study|Other reason not defined above|0|||
13328012|NCT01132313|26588958|FG007|Overall Study|Other reason not defined above|1|||
13328013|NCT01132313|26588959|FG008|Overall Study|Other reason not defined above|0|||
13328014|NCT01132313|26588960|FG009|Overall Study|Other reason not defined above|0|||
13328015|NCT01132313|26588961|FG010|Overall Study|Other reason not defined above|0|||
13328016|NCT01132313|26588962|FG011|Overall Study|Other reason not defined above|0|||
13328017|NCT01132118|26588987|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
13328018|NCT01132118|26588988|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
13328019|NCT01132118|26588987|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
13328020|NCT01132118|26588988|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3|||
13328021|NCT01132118|26588987|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
13328022|NCT01132118|26588988|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
13328023|NCT01131676|26589031|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5|||
13328024|NCT01131676|26589032|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3|||
13328025|NCT01131676|26589033|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4|||
13328026|NCT01131676|26589031|FG000|Discontinuation From Treatment|Not treated|4|||
13328027|NCT01131676|26589032|FG001|Discontinuation From Treatment|Not treated|2|||
13328028|NCT01131676|26589033|FG002|Discontinuation From Treatment|Not treated|2|||
13328029|NCT01131676|26589031|FG000|Discontinuation From Treatment|Lack of Efficacy|11|||
13328030|NCT01131676|26589032|FG001|Discontinuation From Treatment|Lack of Efficacy|1|||
13328031|NCT01131676|26589033|FG002|Discontinuation From Treatment|Lack of Efficacy|0|||
13328032|NCT01131676|26589031|FG000|Discontinuation From Treatment|Non compliant with protocol|15|||
13328033|NCT01131676|26589032|FG001|Discontinuation From Treatment|Non compliant with protocol|15|||
13328034|NCT01131676|26589033|FG002|Discontinuation From Treatment|Non compliant with protocol|12|||
13328035|NCT01131676|26589031|FG000|Discontinuation From Treatment|Lost to Follow-up|15|||
13328036|NCT01131676|26589032|FG001|Discontinuation From Treatment|Lost to Follow-up|9|||
13328037|NCT01131676|26589033|FG002|Discontinuation From Treatment|Lost to Follow-up|6|||
13328038|NCT01131676|26589031|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172|||
13328039|NCT01131676|26589032|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118|||
13328040|NCT01131676|26589033|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122|||
13328041|NCT01131676|26589031|FG000|Discontinuation From Treatment|Other than those specified|162|||
13328042|NCT01131676|26589032|FG001|Discontinuation From Treatment|Other than those specified|142|||
13328043|NCT01131676|26589033|FG002|Discontinuation From Treatment|Other than those specified|125|||
13328044|NCT01131676|26589031|FG000|Discontinuation From Treatment|Adverse Event|303|||
13328045|NCT01131676|26589032|FG001|Discontinuation From Treatment|Adverse Event|267|||
13328046|NCT01131676|26589033|FG002|Discontinuation From Treatment|Adverse Event|273|||
13328047|NCT01131676|26589031|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23|||
13328048|NCT01131676|26589032|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35|||
13328049|NCT01131676|26589033|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25|||
13328050|NCT01131676|26589031|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8|||
13328051|NCT01131676|26589032|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6|||
13328052|NCT01131676|26589033|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5|||
13328053|NCT01131676|26589031|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20|||
13328054|NCT01131676|26589032|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21|||
13328055|NCT01131676|26589033|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19|||
13328056|NCT01131676|26589031|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5|||
13328057|NCT01131676|26589032|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9|||
13328058|NCT01131676|26589033|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7|||
13328059|NCT01131676|26589031|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7|||
13328060|NCT01131676|26589032|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6|||
13328061|NCT01131676|26589033|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5|||
13328062|NCT01131676|26589031|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
13328063|NCT01131676|26589032|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
13328064|NCT01131676|26589033|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2|||
13328065|NCT01131585|26589046|FG000|Overall Study|Adverse Event|0|||
13328066|NCT01131585|26589047|FG001|Overall Study|Adverse Event|2|||
13328067|NCT01131585|26589046|FG000|Overall Study|Abnormal laboratory value|1|||
13328068|NCT01131585|26589047|FG001|Overall Study|Abnormal laboratory value|0|||
13328069|NCT01131585|26589046|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
13328070|NCT01131585|26589047|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
13328071|NCT01131585|26589046|FG000|Overall Study|Protocol Violation|2|||
13328072|NCT01131585|26589047|FG001|Overall Study|Protocol Violation|1|||
13328073|NCT01131585|26589046|FG000|Overall Study|Withdrawal by Subject|3|||
13328074|NCT01131585|26589047|FG001|Overall Study|Withdrawal by Subject|3|||
13328075|NCT01131585|26589046|FG000|Overall Study|Lost to Follow-up|0|||
13328076|NCT01131585|26589047|FG001|Overall Study|Lost to Follow-up|1|||
13328077|NCT01131585|26589046|FG000|Overall Study|Administrative problems|1|||
13328078|NCT01131585|26589047|FG001|Overall Study|Administrative problems|1|||
13328079|NCT01131585|26589046|FG000|Overall Study|Study termination|78|||
13328080|NCT01131585|26589047|FG001|Overall Study|Study termination|32|||
13328081|NCT01131520|26589076|FG000|Overall Study|Computer problem|1|||
13328082|NCT01131520|26589077|FG001|Overall Study|Computer problem|0|||
13328083|NCT01131520|26589076|FG000|Overall Study|Counselor not available|0|||
13328084|NCT01131520|26589077|FG001|Overall Study|Counselor not available|3|||
13328085|NCT01131520|26589076|FG000|Overall Study|Subject changed history after enrollment|0|||
13328086|NCT01131520|26589077|FG001|Overall Study|Subject changed history after enrollment|1|||
13328087|NCT01131507|26589084|FG000|Overall Study|Adverse Event|1|||
13328088|NCT01131507|26589084|FG000|Overall Study|Lost to Follow-up|1|||
13328089|NCT01131507|26589084|FG000|Overall Study|Withdrawal by Subject|1|||
13328090|NCT01131494|26589093|FG000|Overall Study|Withdrawal by Subject|2|||
13328091|NCT01131455|26589111|FG000|Overall Study|Death of PI|6|||
13328092|NCT01131455|26589112|FG001|Overall Study|Death of PI|4|||
13328093|NCT01131455|26589113|FG002|Overall Study|Death of PI|0|||
13328094|NCT01131351|26589168|FG000|Overall Study|Adverse Event|0|||
13328095|NCT01131351|26589169|FG001|Overall Study|Adverse Event|2|||
13328096|NCT01131351|26589168|FG000|Overall Study|Protocol Deviation|0|||
13328097|NCT01131351|26589169|FG001|Overall Study|Protocol Deviation|1|||
13328098|NCT01131325|26589181|FG000|Overall Study|Adverse Event|1|||
13328099|NCT01131325|26589181|FG000|Overall Study|The participants discontinued the study as the study got terminated|2|||
13328100|NCT01131312|26589202|FG000|Overall Study|Lost to Follow-up|425|||
13328101|NCT01131312|26589203|FG001|Overall Study|Lost to Follow-up|229|||
13328102|NCT01131312|26589204|FG002|Overall Study|Lost to Follow-up|351|||
13328103|NCT01131299|26589218|FG000|Overall Study|Withdrawal by Subject|4|||
13328104|NCT01131299|26589219|FG001|Overall Study|Withdrawal by Subject|7|||
13328105|NCT01131260|26589272|FG000|Overall Study|Randomization error|5|||
13328106|NCT01131260|26589273|FG001|Overall Study|Randomization error|1|||
13328107|NCT01131260|26589272|FG000|Overall Study|Declined to continue participation|8|||
13328108|NCT01131260|26589273|FG001|Overall Study|Declined to continue participation|13|||
13328109|NCT01131260|26589272|FG000|Overall Study|Physician Decision|22|||
13328110|NCT01131260|26589273|FG001|Overall Study|Physician Decision|24|||
13328111|NCT01131260|26589272|FG000|Overall Study|Technical problems|7|||
13328112|NCT01131260|26589273|FG001|Overall Study|Technical problems|6|||
13328113|NCT01131260|26589272|FG000|Overall Study|Staff error|2|||
13328114|NCT01131260|26589273|FG001|Overall Study|Staff error|1|||
13328115|NCT01131260|26589272|FG000|Overall Study|Ineligible|0|||
13328116|NCT01131260|26589273|FG001|Overall Study|Ineligible|2|||
13328117|NCT01131182|26589288|FG000|Overall Study|Withdrawal by Subject|1|||
13328118|NCT01131182|26589289|FG001|Overall Study|Withdrawal by Subject|1|||
13328119|NCT01131182|26589288|FG000|Overall Study|Lost to Follow-up|14|||
13328120|NCT01131182|26589289|FG001|Overall Study|Lost to Follow-up|15|||
13328121|NCT01131182|26589288|FG000|Overall Study|Other Reason|1|||
13328122|NCT01131182|26589289|FG001|Overall Study|Other Reason|0|||
13328123|NCT01131130|26589304|FG000|Period 1 - Baseline|Pregnancy|1|||
13328124|NCT01131130|26589304|FG000|Period 3- Crossover|+ Slit lamp finding|1|||
13328125|NCT01131104|26589310|FG000|Overall Study|Withdrawal by Subject|3|||
13328126|NCT01131104|26589310|FG000|Overall Study|Physician Decision|4|||
13328127|NCT01131104|26589310|FG000|Overall Study|Information Not Available|5|||
13328128|NCT01131104|26589310|FG000|Overall Study|No Information on Index Date of Onset|1|||
13328129|NCT01131078|26589376|FG000|Overall Study|Adverse Event|22|||
13328130|NCT01131078|26589377|FG001|Overall Study|Adverse Event|12|||
13328131|NCT01131078|26589378|FG002|Overall Study|Adverse Event|17|||
13328132|NCT01131078|26589376|FG000|Overall Study|Progressive Disease|58|||
13328133|NCT01131078|26589377|FG001|Overall Study|Progressive Disease|77|||
13328134|NCT01131078|26589378|FG002|Overall Study|Progressive Disease|71|||
13328135|NCT01131078|26589376|FG000|Overall Study|Protocol Violation|1|||
13328136|NCT01131078|26589377|FG001|Overall Study|Protocol Violation|0|||
13328137|NCT01131078|26589378|FG002|Overall Study|Protocol Violation|0|||
13328138|NCT01131078|26589376|FG000|Overall Study|Lost to Follow-up|1|||
13328139|NCT01131078|26589377|FG001|Overall Study|Lost to Follow-up|1|||
13328140|NCT01131078|26589378|FG002|Overall Study|Lost to Follow-up|1|||
13328141|NCT01131078|26589376|FG000|Overall Study|Withdrawal by Subject|2|||
13328142|NCT01131078|26589377|FG001|Overall Study|Withdrawal by Subject|4|||
13328143|NCT01131078|26589378|FG002|Overall Study|Withdrawal by Subject|3|||
13328144|NCT01131078|26589376|FG000|Overall Study|Non-compliance|3|||
13328145|NCT01131078|26589377|FG001|Overall Study|Non-compliance|0|||
13328146|NCT01131078|26589378|FG002|Overall Study|Non-compliance|0|||
13328147|NCT01131078|26589376|FG000|Overall Study|Physician Decision|10|||
13328148|NCT01131078|26589377|FG001|Overall Study|Physician Decision|6|||
13328149|NCT01131078|26589378|FG002|Overall Study|Physician Decision|8|||
13328150|NCT01131078|26589376|FG000|Overall Study|Death|4|||
13328151|NCT01131078|26589377|FG001|Overall Study|Death|0|||
13328152|NCT01131078|26589378|FG002|Overall Study|Death|2|||
13328153|NCT01131078|26589376|FG000|Overall Study|Other|0|||
13328154|NCT01131078|26589377|FG001|Overall Study|Other|1|||
13328155|NCT01131078|26589378|FG002|Overall Study|Other|0|||
13328156|NCT01130974|26589405|FG000|Overall Study|Protocol Violation|10|||
13328157|NCT01130974|26589406|FG001|Overall Study|Protocol Violation|10|||
13328158|NCT01130974|26589405|FG000|Overall Study|Withdrawal by Subject|0|||
13328159|NCT01130974|26589406|FG001|Overall Study|Withdrawal by Subject|1|||
13328160|NCT01130974|26589405|FG000|Overall Study|Ineligibility criteria|5|||
13328161|NCT01130974|26589406|FG001|Overall Study|Ineligibility criteria|2|||
13328162|NCT01130883|26589422|FG000|Overall Study|Patient Noncompliance|6|||
13328163|NCT01130883|26589422|FG000|Overall Study|Reason Unknown|1|||
13328164|NCT01130883|26589422|FG000|Overall Study|Adverse Event|3|||
13328165|NCT01130831|26589450|FG000|Overall Study|Withdrawal by Subject|7|||
13328166|NCT01130831|26589450|FG000|Overall Study|Death|4|||
13328167|NCT01130831|26589450|FG000|Overall Study|Information was missing|3|||
13328168|NCT01130597|26589474|FG000|Overall Study|Protocol-specified (High K+)|1|||
13328169|NCT01130597|26589474|FG000|Overall Study|Adverse Event|4|||
13328170|NCT01130597|26589474|FG000|Overall Study|Death|1|||
13328171|NCT01130597|26589474|FG000|Overall Study|Protocol Violation|1|||
13328172|NCT01130532|26589530|FG000|Period III (Weeks 0-12)|Adverse Event|3|||
13328173|NCT01130532|26589531|FG001|Period III (Weeks 0-12)|Adverse Event|3|||
13328174|NCT01130532|26589532|FG002|Period III (Weeks 0-12)|Adverse Event|2|||
13328175|NCT01130532|26589533|FG003|Period III (Weeks 0-12)|Adverse Event|0|||
13328176|NCT01130532|26589530|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
13328177|NCT01130532|26589531|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2|||
13328178|NCT01130532|26589532|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
13328179|NCT01130532|26589533|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0|||
13328180|NCT01130532|26589530|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2|||
13328181|NCT01130532|26589531|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0|||
13328182|NCT01130532|26589532|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1|||
13328183|NCT01130532|26589533|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0|||
13328184|NCT01130532|26589530|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2|||
13328185|NCT01130532|26589531|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2|||
13328186|NCT01130532|26589532|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3|||
13328187|NCT01130532|26589533|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0|||
13328188|NCT01130532|26589530|FG000|Period III (Weeks 0-12)|Protocol Violation|0|||
13328189|NCT01130532|26589531|FG001|Period III (Weeks 0-12)|Protocol Violation|0|||
13328190|NCT01130532|26589532|FG002|Period III (Weeks 0-12)|Protocol Violation|1|||
13328191|NCT01130532|26589533|FG003|Period III (Weeks 0-12)|Protocol Violation|0|||
13328192|NCT01130532|26589530|FG000|Period III (Weeks 0-12)|Sponsor Decision|3|||
13328193|NCT01130532|26589531|FG001|Period III (Weeks 0-12)|Sponsor Decision|4|||
13328194|NCT01130532|26589532|FG002|Period III (Weeks 0-12)|Sponsor Decision|2|||
13328195|NCT01130532|26589533|FG003|Period III (Weeks 0-12)|Sponsor Decision|0|||
13328196|NCT01130532|26589530|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
13328197|NCT01130532|26589531|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
13328198|NCT01130532|26589532|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6|||
13328199|NCT01130532|26589533|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0|||
13328200|NCT01130532|26589530|FG000|Period IV (Weeks 13-16)|Adverse Event|0|||
13328201|NCT01130532|26589531|FG001|Period IV (Weeks 13-16)|Adverse Event|0|||
13328202|NCT01130532|26589532|FG002|Period IV (Weeks 13-16)|Adverse Event|0|||
13328203|NCT01130532|26589533|FG003|Period IV (Weeks 13-16)|Adverse Event|1|||
13328204|NCT01130532|26589530|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
13328205|NCT01130532|26589531|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
13328206|NCT01130532|26589532|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
13328207|NCT01130532|26589533|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1|||
13328208|NCT01130532|26589530|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
13328209|NCT01130532|26589531|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
13328210|NCT01130532|26589532|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
13328211|NCT01130532|26589533|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5|||
13328212|NCT01130532|26589530|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
13328213|NCT01130532|26589531|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
13328214|NCT01130532|26589532|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
13328215|NCT01130532|26589533|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3|||
13328216|NCT01130493|26589554|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1|||
13328217|NCT01130493|26589555|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0|||
13328218|NCT01130493|26589556|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0|||
13328219|NCT01130493|26589554|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3|||
13328220|NCT01130493|26589555|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
13328221|NCT01130493|26589556|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
13328222|NCT01130493|26589554|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7|||
13328223|NCT01130493|26589555|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
13328224|NCT01130493|26589556|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
13328225|NCT01130493|26589554|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7|||
13328226|NCT01130493|26589555|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
13328227|NCT01130493|26589556|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
13328228|NCT01130493|26589554|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1|||
13328229|NCT01130493|26589555|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
13328230|NCT01130493|26589556|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
13328231|NCT01130493|26589554|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
13328232|NCT01130493|26589555|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1|||
13328233|NCT01130493|26589556|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
13328234|NCT01130493|26589554|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
13328235|NCT01130493|26589555|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1|||
13328236|NCT01130493|26589556|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
13328237|NCT01130493|26589554|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
13328238|NCT01130493|26589555|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1|||
13328239|NCT01130493|26589556|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
13328240|NCT01130493|26589554|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
13328241|NCT01130493|26589555|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
13328242|NCT01130493|26589556|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1|||
13328243|NCT01130493|26589554|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
13328244|NCT01130493|26589555|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
13328245|NCT01130493|26589556|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1|||
13328246|NCT01130493|26589554|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
13328247|NCT01130493|26589555|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
13328248|NCT01130493|26589556|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1|||
13328249|NCT01130493|26589554|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
13328250|NCT01130493|26589555|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
13328251|NCT01130493|26589556|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1|||
13328252|NCT01130493|26589554|FG000|Part 2: OLE|Adverse Event|0|||
13328253|NCT01130493|26589555|FG001|Part 2: OLE|Adverse Event|2|||
13328254|NCT01130493|26589556|FG002|Part 2: OLE|Adverse Event|1|||
13328255|NCT01130493|26589554|FG000|Part 2: OLE|Withdrawal by Subject|0|||
13328256|NCT01130493|26589555|FG001|Part 2: OLE|Withdrawal by Subject|1|||
13328257|NCT01130493|26589556|FG002|Part 2: OLE|Withdrawal by Subject|4|||
13328258|NCT01130337|26589565|FG000|Overall Study|Withdrawal by Subject|3|||
13328259|NCT01130337|26589565|FG000|Overall Study|Principal investigator decision|1|||
13328260|NCT01130337|26589565|FG000|Overall Study|Death|1|||
13328261|NCT01130337|26589565|FG000|Overall Study|Disease progression|1|||
13328262|NCT01130337|26589565|FG000|Overall Study|Toxicity, AE/intercurrent disease|7|||
13328263|NCT01130337|26589565|FG000|Overall Study|Surgical resection (R2)|1|||
13328264|NCT01130272|26589618|FG000|Overall Study|Adverse Event|2|||
13328265|NCT01130272|26589619|FG001|Overall Study|Adverse Event|5|||
13328266|NCT01130272|26589620|FG002|Overall Study|Adverse Event|6|||
13328267|NCT01130272|26589621|FG003|Overall Study|Adverse Event|22|||
13328268|NCT01130272|26589622|FG004|Overall Study|Adverse Event|7|||
13328269|NCT01130272|26589618|FG000|Overall Study|IVRS-confirmed constipation|0|||
13328270|NCT01130272|26589619|FG001|Overall Study|IVRS-confirmed constipation|1|||
13328271|NCT01130272|26589620|FG002|Overall Study|IVRS-confirmed constipation|1|||
13328272|NCT01130272|26589621|FG003|Overall Study|IVRS-confirmed constipation|2|||
13328273|NCT01130272|26589622|FG004|Overall Study|IVRS-confirmed constipation|0|||
13328274|NCT01130272|26589618|FG000|Overall Study|Rescue medications due to diarrhea|3|||
13328275|NCT01130272|26589619|FG001|Overall Study|Rescue medications due to diarrhea|5|||
13328276|NCT01130272|26589620|FG002|Overall Study|Rescue medications due to diarrhea|8|||
13328277|NCT01130272|26589621|FG003|Overall Study|Rescue medications due to diarrhea|8|||
13328278|NCT01130272|26589622|FG004|Overall Study|Rescue medications due to diarrhea|6|||
13328279|NCT01130272|26589618|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
13328280|NCT01130272|26589619|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
13328281|NCT01130272|26589620|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
13328282|NCT01130272|26589621|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
13328283|NCT01130272|26589622|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2|||
13328284|NCT01130272|26589618|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
13328285|NCT01130272|26589619|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
13328286|NCT01130272|26589620|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
13328287|NCT01130272|26589621|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1|||
13328288|NCT01130272|26589622|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
13328289|NCT01130272|26589618|FG000|Overall Study|Protocol Violation|0|||
13328290|NCT01130272|26589619|FG001|Overall Study|Protocol Violation|0|||
13328291|NCT01130272|26589620|FG002|Overall Study|Protocol Violation|3|||
13328292|NCT01130272|26589621|FG003|Overall Study|Protocol Violation|5|||
13328293|NCT01130272|26589622|FG004|Overall Study|Protocol Violation|5|||
13328294|NCT01130272|26589618|FG000|Overall Study|Lost to Follow-up|4|||
13328295|NCT01130272|26589619|FG001|Overall Study|Lost to Follow-up|3|||
13328296|NCT01130272|26589620|FG002|Overall Study|Lost to Follow-up|4|||
13328297|NCT01130272|26589621|FG003|Overall Study|Lost to Follow-up|7|||
13328298|NCT01130272|26589622|FG004|Overall Study|Lost to Follow-up|6|||
13328299|NCT01130272|26589618|FG000|Overall Study|Withdrawal by Subject|4|||
13328300|NCT01130272|26589619|FG001|Overall Study|Withdrawal by Subject|11|||
13328301|NCT01130272|26589620|FG002|Overall Study|Withdrawal by Subject|10|||
13328302|NCT01130272|26589621|FG003|Overall Study|Withdrawal by Subject|9|||
13328303|NCT01130272|26589622|FG004|Overall Study|Withdrawal by Subject|8|||
13328304|NCT01130272|26589618|FG000|Overall Study|Physician Decision|1|||
13328305|NCT01130272|26589619|FG001|Overall Study|Physician Decision|1|||
13328306|NCT01130272|26589620|FG002|Overall Study|Physician Decision|0|||
13328307|NCT01130272|26589621|FG003|Overall Study|Physician Decision|1|||
13328308|NCT01130272|26589622|FG004|Overall Study|Physician Decision|2|||
13328309|NCT01130272|26589618|FG000|Overall Study|Sponsor decision|6|||
13328310|NCT01130272|26589619|FG001|Overall Study|Sponsor decision|15|||
13328311|NCT01130272|26589620|FG002|Overall Study|Sponsor decision|16|||
13328312|NCT01130272|26589621|FG003|Overall Study|Sponsor decision|13|||
13328313|NCT01130272|26589622|FG004|Overall Study|Sponsor decision|16|||
13328314|NCT01130272|26589618|FG000|Overall Study|Study arm discontinued|38|||
13328315|NCT01130272|26589619|FG001|Overall Study|Study arm discontinued|0|||
13328316|NCT01130272|26589620|FG002|Overall Study|Study arm discontinued|0|||
13328317|NCT01130272|26589621|FG003|Overall Study|Study arm discontinued|0|||
13328318|NCT01130272|26589622|FG004|Overall Study|Study arm discontinued|0|||
13328319|NCT01130168|26589664|FG000|Period 1|Withdrawal by Subject|0|||
13328320|NCT01130168|26589665|FG001|Period 1|Withdrawal by Subject|1|||
13328321|NCT01130168|26589666|FG002|Period 1|Withdrawal by Subject|0|||
13328322|NCT01130168|26589667|FG003|Period 1|Withdrawal by Subject|1|||
13328323|NCT01130168|26589668|FG004|Period 1|Withdrawal by Subject|0|||
13328324|NCT01130168|26589669|FG005|Period 1|Withdrawal by Subject|0|||
13328325|NCT01130168|26589664|FG000|Period 1|Discontinued For Other Reason|0|||
13328326|NCT01130168|26589665|FG001|Period 1|Discontinued For Other Reason|0|||
13328327|NCT01130168|26589666|FG002|Period 1|Discontinued For Other Reason|1|||
13328328|NCT01130168|26589667|FG003|Period 1|Discontinued For Other Reason|1|||
13328329|NCT01130168|26589668|FG004|Period 1|Discontinued For Other Reason|0|||
13328330|NCT01130168|26589669|FG005|Period 1|Discontinued For Other Reason|0|||
13328331|NCT01130168|26589664|FG000|Period 1|Adverse Event|0|||
13328332|NCT01130168|26589665|FG001|Period 1|Adverse Event|0|||
13328333|NCT01130168|26589666|FG002|Period 1|Adverse Event|0|||
13328334|NCT01130168|26589667|FG003|Period 1|Adverse Event|1|||
13328335|NCT01130168|26589668|FG004|Period 1|Adverse Event|0|||
13328336|NCT01130168|26589669|FG005|Period 1|Adverse Event|0|||
13328337|NCT01130103|26589690|FG000|Randomized Treatment|Adverse Event|1|||
13328338|NCT01130103|26589691|FG001|Randomized Treatment|Adverse Event|1|||
13328339|NCT01130103|26589690|FG000|Randomized Treatment|Lost to Follow-up|1|||
13328340|NCT01130103|26589691|FG001|Randomized Treatment|Lost to Follow-up|0|||
13328341|NCT01130103|26589690|FG000|Randomized Treatment|Protocol Violation|3|||
13328342|NCT01130103|26589691|FG001|Randomized Treatment|Protocol Violation|2|||
13328343|NCT01130103|26589690|FG000|Randomized Treatment|Withdrawal by Subject|1|||
13328344|NCT01130103|26589691|FG001|Randomized Treatment|Withdrawal by Subject|2|||
13328345|NCT01130103|26589690|FG000|Maintenance Treatment|Lack of Efficacy|0|||
13328346|NCT01130103|26589691|FG001|Maintenance Treatment|Lack of Efficacy|1|||
13328347|NCT01130103|26589690|FG000|Maintenance Treatment|Lost to Follow-up|1|||
13328348|NCT01130103|26589691|FG001|Maintenance Treatment|Lost to Follow-up|1|||
13328349|NCT01130103|26589690|FG000|Maintenance Treatment|Withdrawal by Subject|1|||
13328350|NCT01130103|26589691|FG001|Maintenance Treatment|Withdrawal by Subject|0|||
13328351|NCT01130051|26589704|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
13328352|NCT01130051|26589705|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
13328353|NCT01130051|26589704|FG000|Washout Period of 14 Days|Protocol Violation|1|||
13328354|NCT01130051|26589705|FG001|Washout Period of 14 Days|Protocol Violation|1|||
13328355|NCT01129960|26589728|FG000|Overall Study|Withdrawal by Subject|3|||
13328356|NCT01129960|26589729|FG001|Overall Study|Withdrawal by Subject|0|||
13328357|NCT01129960|26589730|FG002|Overall Study|Withdrawal by Subject|3|||
13328358|NCT01129960|26589731|FG003|Overall Study|Withdrawal by Subject|2|||
13328359|NCT01129960|26589728|FG000|Overall Study|Lack of Efficacy|1|||
13328360|NCT01129960|26589729|FG001|Overall Study|Lack of Efficacy|1|||
13328361|NCT01129960|26589730|FG002|Overall Study|Lack of Efficacy|1|||
13328362|NCT01129960|26589731|FG003|Overall Study|Lack of Efficacy|1|||
13328363|NCT01129960|26589728|FG000|Overall Study|Adverse Event|23|||
13328364|NCT01129960|26589729|FG001|Overall Study|Adverse Event|16|||
13328365|NCT01129960|26589730|FG002|Overall Study|Adverse Event|16|||
13328366|NCT01129960|26589731|FG003|Overall Study|Adverse Event|7|||
13328367|NCT01129960|26589728|FG000|Overall Study|Protocol Violation|1|||
13328368|NCT01129960|26589729|FG001|Overall Study|Protocol Violation|2|||
13328369|NCT01129960|26589730|FG002|Overall Study|Protocol Violation|3|||
13328370|NCT01129960|26589731|FG003|Overall Study|Protocol Violation|0|||
13328371|NCT01129960|26589728|FG000|Overall Study|Lost to Follow-up|0|||
13328372|NCT01129960|26589729|FG001|Overall Study|Lost to Follow-up|2|||
13328373|NCT01129960|26589730|FG002|Overall Study|Lost to Follow-up|3|||
13328374|NCT01129960|26589731|FG003|Overall Study|Lost to Follow-up|3|||
13328375|NCT01129960|26589728|FG000|Overall Study|Discontinuation of the study by Sponsor|0|||
13328376|NCT01129960|26589729|FG001|Overall Study|Discontinuation of the study by Sponsor|1|||
13328377|NCT01129960|26589730|FG002|Overall Study|Discontinuation of the study by Sponsor|0|||
13328378|NCT01129960|26589731|FG003|Overall Study|Discontinuation of the study by Sponsor|0|||
13328379|NCT01129960|26589728|FG000|Overall Study|Physician Decision|1|||
13328380|NCT01129960|26589729|FG001|Overall Study|Physician Decision|0|||
13328381|NCT01129960|26589730|FG002|Overall Study|Physician Decision|0|||
13328382|NCT01129960|26589731|FG003|Overall Study|Physician Decision|0|||
13328383|NCT01129960|26589728|FG000|Overall Study|Pregnancy|1|||
13328384|NCT01129960|26589729|FG001|Overall Study|Pregnancy|0|||
13328385|NCT01129960|26589730|FG002|Overall Study|Pregnancy|0|||
13328386|NCT01129960|26589731|FG003|Overall Study|Pregnancy|0|||
13328387|NCT01129921|26589748|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2|||
13328388|NCT01129921|26589749|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1|||
13328389|NCT01129921|26589748|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0|||
13328390|NCT01129921|26589749|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1|||
13328391|NCT01129921|26589748|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0|||
13328392|NCT01129921|26589749|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4|||
13328393|NCT01129921|26589748|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0|||
13328394|NCT01129921|26589749|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1|||
13328395|NCT01129882|26589756|FG000|Overall Study|Adverse Event|39|||
13328396|NCT01129882|26589756|FG000|Overall Study|Death|6|||
13328397|NCT01129882|26589756|FG000|Overall Study|Lack of Efficacy|5|||
13328398|NCT01129882|26589756|FG000|Overall Study|Lost to Follow-up|13|||
13328399|NCT01129882|26589756|FG000|Overall Study|Physician Decision|27|||
13328400|NCT01129882|26589756|FG000|Overall Study|Protocol Deviation|3|||
13328401|NCT01129882|26589756|FG000|Overall Study|Withdrawal Criteria Met|19|||
13328402|NCT01129882|26589756|FG000|Overall Study|Trial Termination by Sponsor|6|||
13328403|NCT01129882|26589756|FG000|Overall Study|Withdrawal by Subject|160|||
13328404|NCT01129622|26589763|FG000|Overall Study|Withdrawal by Subject|2|||
13328405|NCT01129583|26589780|FG000|Overall Study|Death|1|||
13328406|NCT01129583|26589781|FG001|Overall Study|Death|0|||
13328407|NCT01129583|26589780|FG000|Overall Study|Lost to Follow-up|1|||
13328408|NCT01129583|26589781|FG001|Overall Study|Lost to Follow-up|1|||
13328409|NCT01129583|26589780|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1|||
13328410|NCT01129583|26589781|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1|||
13328411|NCT01129557|26589859|FG000|Overall Study|Adverse Event|1|||
13328412|NCT01129557|26589860|FG001|Overall Study|Adverse Event|2|||
13328413|NCT01129557|26589861|FG002|Overall Study|Adverse Event|2|||
13328414|NCT01129557|26589859|FG000|Overall Study|Novartis terminated study early|3|||
13328415|NCT01129557|26589860|FG001|Overall Study|Novartis terminated study early|3|||
13328416|NCT01129557|26589861|FG002|Overall Study|Novartis terminated study early|2|||
13328417|NCT01129336|26589880|FG000|Overall Study|Protocol Violation|1|||
13328418|NCT01129336|26589881|FG001|Overall Study|Protocol Violation|0|||
13328419|NCT01129336|26589880|FG000|Overall Study|Disease Progression|1|||
13328420|NCT01129336|26589881|FG001|Overall Study|Disease Progression|4|||
13328421|NCT01129336|26589880|FG000|Overall Study|Lost to Follow-up|1|||
13328422|NCT01129336|26589881|FG001|Overall Study|Lost to Follow-up|0|||
13328423|NCT01129336|26589880|FG000|Overall Study|Withdrawal by Subject|7|||
13328424|NCT01129336|26589881|FG001|Overall Study|Withdrawal by Subject|4|||
13328425|NCT01129336|26589880|FG000|Overall Study|Adverse Event|0|||
13328426|NCT01129336|26589881|FG001|Overall Study|Adverse Event|1|||
13328427|NCT01129336|26589880|FG000|Overall Study|Missing Study Completion Status|2|||
13328428|NCT01129336|26589881|FG001|Overall Study|Missing Study Completion Status|3|||
13328429|NCT01129336|26589880|FG000|Overall Study|Death|0|||
13328430|NCT01129336|26589881|FG001|Overall Study|Death|4|||
13328431|NCT01129284|26589902|FG000|Overall Study|Adverse Event|2|||
13328432|NCT01129284|26589903|FG001|Overall Study|Adverse Event|0|||
13328433|NCT01129284|26589904|FG002|Overall Study|Adverse Event|1|||
13328434|NCT01129128|26589934|FG000|Overall Study|Lost to Follow-up|2|||
13328435|NCT01129128|26589935|FG001|Overall Study|Lost to Follow-up|2|||
13328436|NCT01129128|26589936|FG002|Overall Study|Lost to Follow-up|1|||
13328437|NCT01129128|26589934|FG000|Overall Study|Protocol Violation|0|||
13328438|NCT01129128|26589935|FG001|Overall Study|Protocol Violation|1|||
13328439|NCT01129128|26589936|FG002|Overall Study|Protocol Violation|0|||
13328440|NCT01129128|26589934|FG000|Overall Study|Withdrawal by Subject|0|||
13328441|NCT01129128|26589935|FG001|Overall Study|Withdrawal by Subject|1|||
13328442|NCT01129128|26589936|FG002|Overall Study|Withdrawal by Subject|3|||
13328443|NCT01129128|26589934|FG000|Overall Study|Physician Decision|1|||
13328444|NCT01129128|26589935|FG001|Overall Study|Physician Decision|0|||
13328445|NCT01129128|26589936|FG002|Overall Study|Physician Decision|0|||
13328446|NCT01129115|26589983|FG000|Overall Study|Adverse Event|1|||
13328447|NCT01129115|26589984|FG001|Overall Study|Adverse Event|2|||
13328448|NCT01129115|26589985|FG002|Overall Study|Adverse Event|3|||
13328449|NCT01129115|26589986|FG003|Overall Study|Adverse Event|3|||
13328450|NCT01129115|26589983|FG000|Overall Study|Withdrawal by Subject|1|||
13328451|NCT01129115|26589984|FG001|Overall Study|Withdrawal by Subject|3|||
13328452|NCT01129115|26589985|FG002|Overall Study|Withdrawal by Subject|1|||
13328453|NCT01129115|26589986|FG003|Overall Study|Withdrawal by Subject|4|||
13328454|NCT01129115|26589983|FG000|Overall Study|Protocol Violation|0|||
13328455|NCT01129115|26589984|FG001|Overall Study|Protocol Violation|2|||
13328456|NCT01129115|26589985|FG002|Overall Study|Protocol Violation|2|||
13328457|NCT01129115|26589986|FG003|Overall Study|Protocol Violation|2|||
13328458|NCT01129102|26590005|FG000|Overall Study|No study drug treatment|2|||
13328459|NCT01129102|26590006|FG001|Overall Study|No study drug treatment|3|||
13328460|NCT01129102|26590007|FG002|Overall Study|No study drug treatment|1|||
13328461|NCT01129102|26590005|FG000|Overall Study|Withdrawal by Subject|2|||
13328462|NCT01129102|26590006|FG001|Overall Study|Withdrawal by Subject|0|||
13328463|NCT01129102|26590007|FG002|Overall Study|Withdrawal by Subject|3|||
13328464|NCT01129102|26590005|FG000|Overall Study|Protocol Violation|0|||
13328465|NCT01129102|26590006|FG001|Overall Study|Protocol Violation|1|||
13328466|NCT01129102|26590007|FG002|Overall Study|Protocol Violation|1|||
13328467|NCT01129102|26590005|FG000|Overall Study|Pregnancy|0|||
13328468|NCT01129102|26590006|FG001|Overall Study|Pregnancy|0|||
13328469|NCT01129102|26590007|FG002|Overall Study|Pregnancy|1|||
13328470|NCT01129102|26590005|FG000|Overall Study|Adverse Event|2|||
13328471|NCT01129102|26590006|FG001|Overall Study|Adverse Event|2|||
13328472|NCT01129102|26590007|FG002|Overall Study|Adverse Event|1|||
13328473|NCT01129102|26590005|FG000|Overall Study|Lost to Follow-up|2|||
13328474|NCT01129102|26590006|FG001|Overall Study|Lost to Follow-up|0|||
13328475|NCT01129102|26590007|FG002|Overall Study|Lost to Follow-up|0|||
13328476|NCT01129024|26590018|FG000|Overall Study|Physician Decision|5|||
13328477|NCT01129024|26590018|FG000|Overall Study|Study Terminated by Sponsor|8|||
13328478|NCT01129024|26590018|FG000|Overall Study|Withdrawal by Subject|2|||
13328479|NCT01129024|26590018|FG000|Overall Study|Lack of Efficacy|3|||
13328480|NCT01129024|26590018|FG000|Overall Study|Needed a Platelet Transfusion|1|||
13328481|NCT01129011|26590047|FG000|Overall Study|Adverse Event|20|||
13328482|NCT01129011|26590048|FG001|Overall Study|Adverse Event|30|||
13328483|NCT01129011|26590047|FG000|Overall Study|Withdrawal by Subject|24|||
13328484|NCT01129011|26590048|FG001|Overall Study|Withdrawal by Subject|8|||
13328485|NCT01129011|26590047|FG000|Overall Study|Lost to Follow-up|6|||
13328486|NCT01129011|26590048|FG001|Overall Study|Lost to Follow-up|7|||
13328487|NCT01129011|26590047|FG000|Overall Study|Duodenal Ulcer|2|||
13328488|NCT01129011|26590048|FG001|Overall Study|Duodenal Ulcer|8|||
13328489|NCT01129011|26590047|FG000|Overall Study|misc|7|||
13328490|NCT01129011|26590048|FG001|Overall Study|misc|4|||
13328491|NCT01128959|26590056|FG000|Lead in Period|Adverse Event|3|||
13328492|NCT01128959|26590056|FG000|Treatment Period|Adverse Event|3|||
13328493|NCT01128959|26590056|FG000|Treatment Period|Withdrawal by Subject|1|||
13328494|NCT01128946|26590077|FG000|Period I|Protocol Violation|0|||
13328495|NCT01128946|26590078|FG001|Period I|Protocol Violation|1|||
13328496|NCT01128946|26590079|FG002|Period I|Protocol Violation|0|||
13328497|NCT01128946|26590080|FG003|Period I|Protocol Violation|0|||
13328498|NCT01128946|26590077|FG000|Period I|Withdrawal by Subject|0|||
13328499|NCT01128946|26590078|FG001|Period I|Withdrawal by Subject|0|||
13328500|NCT01128946|26590079|FG002|Period I|Withdrawal by Subject|1|||
13328501|NCT01128946|26590080|FG003|Period I|Withdrawal by Subject|1|||
13328502|NCT01128946|26590077|FG000|Period II|Protocol Violation|0|||
13328503|NCT01128946|26590078|FG001|Period II|Protocol Violation|1|||
13328504|NCT01128946|26590079|FG002|Period II|Protocol Violation|0|||
13328505|NCT01128946|26590080|FG003|Period II|Protocol Violation|0|||
13328506|NCT01128946|26590077|FG000|Period II|Withdrawal by Subject|0|||
13328507|NCT01128946|26590078|FG001|Period II|Withdrawal by Subject|0|||
13328508|NCT01128946|26590079|FG002|Period II|Withdrawal by Subject|0|||
13328509|NCT01128946|26590080|FG003|Period II|Withdrawal by Subject|1|||
13328510|NCT01128946|26590077|FG000|Period III|Protocol Violation|1|||
13328511|NCT01128946|26590078|FG001|Period III|Protocol Violation|0|||
13328512|NCT01128946|26590079|FG002|Period III|Protocol Violation|0|||
13328513|NCT01128946|26590080|FG003|Period III|Protocol Violation|0|||
13328514|NCT01128894|26590105|FG000|Overall Study|Adverse Event|31|||
13328515|NCT01128894|26590106|FG001|Overall Study|Adverse Event|41|||
13328516|NCT01128894|26590105|FG000|Overall Study|Protocol Violation|2|||
13328517|NCT01128894|26590106|FG001|Overall Study|Protocol Violation|1|||
13328518|NCT01128894|26590105|FG000|Overall Study|Noncompliance|4|||
13328519|NCT01128894|26590106|FG001|Overall Study|Noncompliance|5|||
13328520|NCT01128894|26590105|FG000|Overall Study|Lost to Follow-up|8|||
13328521|NCT01128894|26590106|FG001|Overall Study|Lost to Follow-up|8|||
13328522|NCT01128894|26590105|FG000|Overall Study|Withdrawal by Subject|10|||
13328523|NCT01128894|26590106|FG001|Overall Study|Withdrawal by Subject|12|||
13328524|NCT01128894|26590105|FG000|Overall Study|Physician Decision|2|||
13328525|NCT01128894|26590106|FG001|Overall Study|Physician Decision|1|||
13328526|NCT01128894|26590105|FG000|Overall Study|Conflicting HbA1c Results at Screening|1|||
13328527|NCT01128894|26590106|FG001|Overall Study|Conflicting HbA1c Results at Screening|0|||
13328528|NCT01128842|26590118|FG000|Overall Study|Adverse Event|1|||
13328529|NCT01128842|26590118|FG000|Overall Study|Disease Progression|6|||
13328530|NCT01128738|26590248|FG000|First Treatment Phase (TP)|Lost to Follow-up|1|||
13328531|NCT01128738|26590249|FG001|First Treatment Phase (TP)|Lost to Follow-up|0|||
13328532|NCT01128738|26590248|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3|||
13328533|NCT01128738|26590249|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1|||
13328534|NCT01128738|26590248|FG000|Second TP|Lost to Follow-up|0|||
13328535|NCT01128738|26590249|FG001|Second TP|Lost to Follow-up|1|||
13328536|NCT01128738|26590248|FG000|Second TP|Withdrawal by Subject|0|||
13328537|NCT01128738|26590249|FG001|Second TP|Withdrawal by Subject|2|||
13328538|NCT01128621|26590377|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0|||
13328539|NCT01128621|26590378|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2|||
13328540|NCT01128595|26590413|FG000|Treatment Period 3|Withdrawal by Subject|0|||
13328541|NCT01128595|26590414|FG001|Treatment Period 3|Withdrawal by Subject|1|||
13328542|NCT01128595|26590415|FG002|Treatment Period 3|Withdrawal by Subject|0|||
13328543|NCT01128595|26590416|FG003|Treatment Period 3|Withdrawal by Subject|0|||
13328544|NCT01128569|26590440|FG000|Washout Period 1|Adverse Event|0|||
13328545|NCT01128569|26590441|FG001|Washout Period 1|Adverse Event|0|||
13328546|NCT01128569|26590442|FG002|Washout Period 1|Adverse Event|1|||
13328547|NCT01128569|26590443|FG003|Washout Period 1|Adverse Event|0|||
13328548|NCT01128569|26590444|FG004|Washout Period 1|Adverse Event|0|||
13328549|NCT01128569|26590445|FG005|Washout Period 1|Adverse Event|0|||
13328550|NCT01128569|26590440|FG000|Treatment Period 2|Withdrawal by Subject|0|||
13328551|NCT01128569|26590441|FG001|Treatment Period 2|Withdrawal by Subject|1|||
13328552|NCT01128569|26590442|FG002|Treatment Period 2|Withdrawal by Subject|0|||
13328553|NCT01128569|26590443|FG003|Treatment Period 2|Withdrawal by Subject|0|||
13328554|NCT01128569|26590444|FG004|Treatment Period 2|Withdrawal by Subject|0|||
13328555|NCT01128569|26590445|FG005|Treatment Period 2|Withdrawal by Subject|0|||
13328556|NCT01128543|26590453|FG000|Overall Study|Withdrawal by Subject|3|||
13328557|NCT01128543|26590453|FG000|Overall Study|Protocol Violation|1|||
13328558|NCT01128413|26590466|FG000|Overall Study|Withdrawal by Subject|1|||
13328559|NCT01128413|26590467|FG001|Overall Study|Withdrawal by Subject|0|||
13328560|NCT01128413|26590466|FG000|Overall Study|NICOM Monitor Problems|2|||
13328561|NCT01128413|26590467|FG001|Overall Study|NICOM Monitor Problems|1|||
13328562|NCT01128413|26590466|FG000|Overall Study|Pt made DNR|1|||
13328563|NCT01128413|26590467|FG001|Overall Study|Pt made DNR|0|||
13328564|NCT01128400|26590488|FG000|Overall Study|Lost to Follow-up|1|||
13328565|NCT01128400|26590489|FG001|Overall Study|Lost to Follow-up|0|||
13328566|NCT01128400|26590490|FG002|Overall Study|Lost to Follow-up|1|||
13328567|NCT01128400|26590488|FG000|Overall Study|Screening failure|1|||
13328568|NCT01128400|26590489|FG001|Overall Study|Screening failure|0|||
13328569|NCT01128400|26590490|FG002|Overall Study|Screening failure|0|||
13328570|NCT01128400|26590488|FG000|Overall Study|were not invited to participate on taste|0|||
13328571|NCT01128400|26590489|FG001|Overall Study|were not invited to participate on taste|0|||
13328572|NCT01128400|26590490|FG002|Overall Study|were not invited to participate on taste|15|||
13328573|NCT01128400|26590488|FG000|Overall Study|Excluded due to sinus problems|0|||
13328574|NCT01128400|26590489|FG001|Overall Study|Excluded due to sinus problems|1|||
13328575|NCT01128400|26590490|FG002|Overall Study|Excluded due to sinus problems|0|||
13328576|NCT01128387|26590505|FG000|Overall Study|Physician Decision|0|||
13328577|NCT01128387|26590506|FG001|Overall Study|Physician Decision|1|||
13328578|NCT01128361|26590525|FG000|Overall Study|Lost to Follow-up|0|||
13328579|NCT01128361|26590526|FG001|Overall Study|Lost to Follow-up|1|||
13328580|NCT01128361|26590525|FG000|Overall Study|Withdrawal by Subject|5|||
13328581|NCT01128361|26590526|FG001|Overall Study|Withdrawal by Subject|2|||
13328582|NCT01128296|26590551|FG000|Overall Study|Physician Decision|0|||
13328583|NCT01128296|26590552|FG001|Overall Study|Physician Decision|0|||
13328584|NCT01128296|26590553|FG002|Overall Study|Physician Decision|0|||
13328585|NCT01128296|26590554|FG003|Overall Study|Physician Decision|0|||
13328586|NCT01128296|26590555|FG004|Overall Study|Physician Decision|0|||
13328587|NCT01128296|26590556|FG005|Overall Study|Physician Decision|3|||
13328588|NCT01128296|26590551|FG000|Overall Study|Withdrawal by Subject|0|||
13328589|NCT01128296|26590552|FG001|Overall Study|Withdrawal by Subject|0|||
13328590|NCT01128296|26590553|FG002|Overall Study|Withdrawal by Subject|0|||
13328591|NCT01128296|26590554|FG003|Overall Study|Withdrawal by Subject|0|||
13328592|NCT01128296|26590555|FG004|Overall Study|Withdrawal by Subject|0|||
13328593|NCT01128296|26590556|FG005|Overall Study|Withdrawal by Subject|2|||
13328594|NCT01128244|26590566|FG000|Overall Study|Adverse Event|1|||
13328595|NCT01128244|26590566|FG000|Overall Study|Scheduling conflict|2|||
13328596|NCT01128179|26590591|FG000|Overall Study|Death|1|||
13328597|NCT01128179|26590592|FG001|Overall Study|Death|0|||
13328598|NCT01128179|26590591|FG000|Overall Study|Protocol Violation|1|||
13328599|NCT01128179|26590592|FG001|Overall Study|Protocol Violation|0|||
13328600|NCT01128153|26590615|FG000|Overall Study|Adverse Event|1|||
13328601|NCT01128153|26590616|FG001|Overall Study|Adverse Event|3|||
13328602|NCT01128153|26590615|FG000|Overall Study|Condition under investigation worsened|8|||
13328603|NCT01128153|26590616|FG001|Overall Study|Condition under investigation worsened|7|||
13328604|NCT01128153|26590615|FG000|Overall Study|Withdrawal by Subject|2|||
13328605|NCT01128153|26590616|FG001|Overall Study|Withdrawal by Subject|3|||
13328606|NCT01128153|26590615|FG000|Overall Study|Incorrect enrolment to study|2|||
13328607|NCT01128153|26590616|FG001|Overall Study|Incorrect enrolment to study|1|||
13328608|NCT01128153|26590615|FG000|Overall Study|Protocol Violation|2|||
13328609|NCT01128153|26590616|FG001|Overall Study|Protocol Violation|0|||
13328610|NCT01128153|26590615|FG000|Overall Study|Developed discontinuation criteria|1|||
13328611|NCT01128153|26590616|FG001|Overall Study|Developed discontinuation criteria|1|||
13328612|NCT01128114|26590622|FG000|Overall Study|Treatment Withdrawn|6|||
13328613|NCT01128114|26590622|FG000|Overall Study|Screening Failed|2|||
13328614|NCT01127893|26590649|FG000|Overall Study|Study Termination by the Sponsor|1|||
13328615|NCT01127763|26590660|FG000|Overall Study|Adverse Event|2|||
13328616|NCT01127763|26590660|FG000|Overall Study|Withdrawal by Subject|1|||
13328617|NCT01127763|26590660|FG000|Overall Study|Physician Decision|2|||
13328618|NCT01127646|26590699|FG000|Overall Study|Entry Criteria Not Met|1|||
13328619|NCT01127646|26590700|FG001|Overall Study|Entry Criteria Not Met|0|||
13328620|NCT01127646|26590699|FG000|Overall Study|Protocol Violation|0|||
13328621|NCT01127646|26590700|FG001|Overall Study|Protocol Violation|1|||
13328622|NCT01127633|26590737|FG000|Overall Study|Adverse Event|74|||
13328623|NCT01127633|26590738|FG001|Overall Study|Adverse Event|73|||
13328624|NCT01127633|26590737|FG000|Overall Study|Death|40|||
13328625|NCT01127633|26590738|FG001|Overall Study|Death|43|||
13328626|NCT01127633|26590737|FG000|Overall Study|Lost to Follow-up|4|||
13328627|NCT01127633|26590738|FG001|Overall Study|Lost to Follow-up|0|||
13328628|NCT01127633|26590737|FG000|Overall Study|Parent/Caregiver Decision|246|||
13328629|NCT01127633|26590738|FG001|Overall Study|Parent/Caregiver Decision|228|||
13328630|NCT01127633|26590737|FG000|Overall Study|Physician Decision|60|||
13328631|NCT01127633|26590738|FG001|Overall Study|Physician Decision|45|||
13328632|NCT01127633|26590737|FG000|Overall Study|Withdrawal by Subject|57|||
13328633|NCT01127633|26590738|FG001|Overall Study|Withdrawal by Subject|72|||
13328634|NCT01127633|26590737|FG000|Overall Study|Sponsor Decision|163|||
13328635|NCT01127633|26590738|FG001|Overall Study|Sponsor Decision|195|||
13328636|NCT01127633|26590737|FG000|Overall Study|Protocol Violation|8|||
13328637|NCT01127633|26590738|FG001|Overall Study|Protocol Violation|16|||
13328638|NCT01127633|26590737|FG000|Overall Study|Abnormal Lab/ECG Result|0|||
13328639|NCT01127633|26590738|FG001|Overall Study|Abnormal Lab/ECG Result|1|||
13328640|NCT01127633|26590737|FG000|Overall Study|Not treated|1|||
13328641|NCT01127633|26590738|FG001|Overall Study|Not treated|0|||
13328642|NCT01127607|26590816|FG000|Phase II (Between Subjects)|Lost to Follow-up|0|||
13328643|NCT01127607|26590817|FG001|Phase II (Between Subjects)|Lost to Follow-up|2|||
13328644|NCT01127607|26590816|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1|||
13328645|NCT01127607|26590817|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0|||
13328646|NCT01127451|26590844|FG000|Overall Study|Other|2|||
13328647|NCT01127451|26590845|FG001|Overall Study|Other|1|||
13328648|NCT01127451|26590844|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14|||
13328649|NCT01127451|26590845|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12|||
13328650|NCT01127451|26590844|FG000|Overall Study|Death|22|||
13328651|NCT01127451|26590845|FG001|Overall Study|Death|17|||
13328652|NCT01127451|26590844|FG000|Overall Study|Lost to Follow-up|3|||
13328653|NCT01127451|26590845|FG001|Overall Study|Lost to Follow-up|0|||
13328654|NCT01127451|26590844|FG000|Overall Study|Administrative Reason by Sponsor|2|||
13328655|NCT01127451|26590845|FG001|Overall Study|Administrative Reason by Sponsor|2|||
13328656|NCT01127373|26590862|FG000|Overall Study|Not Treated|3|||
13328657|NCT01127373|26590862|FG000|Overall Study|Lost to Follow-up|7|||
13328658|NCT01127373|26590862|FG000|Overall Study|Withdrawal by Subject|1|||
13328659|NCT01127373|26590862|FG000|Overall Study|Disease progression|1|||
13328660|NCT01127165|26590881|FG000|Overall Study|Adverse Event|2|||
13328661|NCT01127165|26590882|FG001|Overall Study|Adverse Event|2|||
13328662|NCT01127165|26590881|FG000|Overall Study|Lack of Efficacy|10|||
13328663|NCT01127165|26590882|FG001|Overall Study|Lack of Efficacy|8|||
13328664|NCT01127165|26590881|FG000|Overall Study|Lost to Follow-up|3|||
13328665|NCT01127165|26590882|FG001|Overall Study|Lost to Follow-up|5|||
13328666|NCT01127165|26590881|FG000|Overall Study|Withdrawal by Subject|1|||
13328667|NCT01127165|26590882|FG001|Overall Study|Withdrawal by Subject|3|||
13328668|NCT01127165|26590881|FG000|Overall Study|Protocol Violation|0|||
13328669|NCT01127165|26590882|FG001|Overall Study|Protocol Violation|1|||
13328670|NCT01127139|26590899|FG000|Overall Study|Adverse Event|40|||
13328671|NCT01127139|26590899|FG000|Overall Study|Incompliance|12|||
13328672|NCT01127139|26590899|FG000|Overall Study|Lack of Efficacy|4|||
13328673|NCT01127139|26590899|FG000|Overall Study|Reason not specified|1|||
13328674|NCT01127061|26590936|FG000|Overall Study|Lost to Follow-up|7|||
13328675|NCT01127061|26590937|FG001|Overall Study|Lost to Follow-up|10|||
13328676|NCT01127061|26590936|FG000|Overall Study|Physician Decision|3|||
13328677|NCT01127061|26590937|FG001|Overall Study|Physician Decision|3|||
13328678|NCT01126879|26590956|FG000|Overall Study|Progressive Disease|3|||
13328679|NCT01126879|26590957|FG001|Overall Study|Progressive Disease|1|||
13328680|NCT01126879|26590956|FG000|Overall Study|Withdrawal by Subject|1|||
13328681|NCT01126879|26590957|FG001|Overall Study|Withdrawal by Subject|0|||
13328682|NCT01126879|26590956|FG000|Overall Study|Adverse Event|0|||
13328683|NCT01126879|26590957|FG001|Overall Study|Adverse Event|1|||
13328684|NCT01126879|26590956|FG000|Overall Study|Physician Decision|1|||
13328685|NCT01126879|26590957|FG001|Overall Study|Physician Decision|0|||
13328686|NCT01126736|26590990|FG000|Overall Study|Death|2|||
13328687|NCT01126736|26590991|FG001|Overall Study|Death|2|||
13328688|NCT01126736|26590992|FG002|Overall Study|Death|1|||
13328689|NCT01126736|26590993|FG003|Overall Study|Death|19|||
13328690|NCT01126736|26590994|FG004|Overall Study|Death|19|||
13328691|NCT01126736|26590990|FG000|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
13328692|NCT01126736|26590991|FG001|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
13328693|NCT01126736|26590992|FG002|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
13328694|NCT01126736|26590993|FG003|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
13328695|NCT01126736|26590994|FG004|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
13328696|NCT01126736|26590990|FG000|Overall Study|Lost to Follow-up|0|||
13328697|NCT01126736|26590991|FG001|Overall Study|Lost to Follow-up|0|||
13328698|NCT01126736|26590992|FG002|Overall Study|Lost to Follow-up|0|||
13328699|NCT01126736|26590993|FG003|Overall Study|Lost to Follow-up|1|||
13328700|NCT01126736|26590994|FG004|Overall Study|Lost to Follow-up|1|||
13328701|NCT01126736|26590990|FG000|Overall Study|Administrative reasons|0|||
13328702|NCT01126736|26590991|FG001|Overall Study|Administrative reasons|0|||
13328703|NCT01126736|26590992|FG002|Overall Study|Administrative reasons|0|||
13328704|NCT01126736|26590993|FG003|Overall Study|Administrative reasons|0|||
13328705|NCT01126736|26590994|FG004|Overall Study|Administrative reasons|1|||
13328706|NCT01126736|26590990|FG000|Overall Study|Progressive disease|0|||
13328707|NCT01126736|26590991|FG001|Overall Study|Progressive disease|0|||
13328708|NCT01126736|26590992|FG002|Overall Study|Progressive disease|0|||
13328709|NCT01126736|26590993|FG003|Overall Study|Progressive disease|2|||
13328710|NCT01126736|26590994|FG004|Overall Study|Progressive disease|1|||
13328711|NCT01126736|26590990|FG000|Overall Study|Withdrawal by Subject|0|||
13328712|NCT01126736|26590991|FG001|Overall Study|Withdrawal by Subject|0|||
13328713|NCT01126736|26590992|FG002|Overall Study|Withdrawal by Subject|0|||
13328714|NCT01126736|26590993|FG003|Overall Study|Withdrawal by Subject|1|||
13328715|NCT01126736|26590994|FG004|Overall Study|Withdrawal by Subject|1|||
13328716|NCT01126736|26590990|FG000|Overall Study|Other|2|||
13328717|NCT01126736|26590991|FG001|Overall Study|Other|4|||
13328718|NCT01126736|26590992|FG002|Overall Study|Other|4|||
13328719|NCT01126736|26590993|FG003|Overall Study|Other|16|||
13328720|NCT01126736|26590994|FG004|Overall Study|Other|15|||
13328721|NCT01126619|26591008|FG000|Overall Study|Not eligible for the study|2|||
13328722|NCT01126619|26591008|FG000|Overall Study|Investigator decision|4|||
13328723|NCT01126619|26591008|FG000|Overall Study|Serious adverse event|1|||
13328724|NCT01126619|26591008|FG000|Overall Study|Withdrawal by Subject|9|||
13328725|NCT01126619|26591008|FG000|Overall Study|Non-compliance|1|||
13373637|NCT00801983|26724310|FG001|Period 2|Withdrawal by Subject|1|||
13373638|NCT00801892|26724333|FG000|Main Study Period|Withdrawal by Subject|0|||
13373639|NCT00801892|26724334|FG001|Main Study Period|Withdrawal by Subject|1|||
13373640|NCT00801892|26724333|FG000|Sham Crossover Period|Lost to Follow-up|0|||
13373641|NCT00801892|26724334|FG001|Sham Crossover Period|Lost to Follow-up|2|||
13373642|NCT00801632|26724347|FG000|Overall Study|Re-transplant|1|||
13373643|NCT00801242|26724360|FG000|Overall Study|Adverse Event|10|||
13373644|NCT00801242|26724360|FG000|Overall Study|Withdrawal by Subject|13|||
13373645|NCT00801242|26724360|FG000|Overall Study|Protocol Violation|5|||
13373646|NCT00801242|26724360|FG000|Overall Study|Physician Decision|3|||
13373647|NCT00801242|26724360|FG000|Overall Study|Lost to Follow-up|1|||
13373648|NCT00801242|26724360|FG000|Overall Study|Miscellaneous reasons|20|||
13373649|NCT00801229|26724373|FG000|Signed Consent|Withdrawal by Subject|2|||
13373650|NCT00801229|26724374|FG001|Signed Consent|Withdrawal by Subject|2|||
13373651|NCT00801229|26724373|FG000|Signed Consent|Found Ineligible|1|||
13373652|NCT00801229|26724374|FG001|Signed Consent|Found Ineligible|1|||
13373653|NCT00801229|26724373|FG000|Received Study Drug/Placebo|Elevated SGOT level|1|||
13373654|NCT00801229|26724374|FG001|Received Study Drug/Placebo|Elevated SGOT level|0|||
13373655|NCT00801229|26724373|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0|||
13373656|NCT00801229|26724374|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1|||
13373657|NCT00801229|26724373|FG000|Received Study Drug/Placebo|Simulator sickness|1|||
13373658|NCT00801229|26724374|FG001|Received Study Drug/Placebo|Simulator sickness|1|||
13373659|NCT00801229|26724373|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1|||
13373660|NCT00801229|26724374|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0|||
13373661|NCT00801229|26724373|FG000|Received Study Drug/Placebo|Lost to Follow-up|0|||
13373662|NCT00801229|26724374|FG001|Received Study Drug/Placebo|Lost to Follow-up|1|||
13373663|NCT00801229|26724373|FG000|Received Study Drug/Placebo|Adverse Event|1|||
13373664|NCT00801229|26724374|FG001|Received Study Drug/Placebo|Adverse Event|1|||
13373665|NCT00801099|26724380|FG000|Overall Study|Lost to Follow-up|101|||
13373666|NCT00800982|26724393|FG000|Overall Study|Lost to Follow-up|1|||
13373667|NCT00800982|26724394|FG001|Overall Study|Lost to Follow-up|2|||
13373668|NCT00800982|26724393|FG000|Overall Study|Withdrawal by Subject|0|||
13373669|NCT00800982|26724394|FG001|Overall Study|Withdrawal by Subject|1|||
13373670|NCT00800982|26724393|FG000|Overall Study|Patient moved out of state|1|||
13373671|NCT00800982|26724394|FG001|Overall Study|Patient moved out of state|0|||
13328726|NCT01126580|26591110|FG000|Overall Study|Adverse Event|14|||
13328727|NCT01126580|26591111|FG001|Overall Study|Adverse Event|8|||
13328728|NCT01126580|26591112|FG002|Overall Study|Adverse Event|12|||
13328729|NCT01126580|26591110|FG000|Overall Study|Withdrawal by Subject|11|||
13328730|NCT01126580|26591111|FG001|Overall Study|Withdrawal by Subject|19|||
13328731|NCT01126580|26591112|FG002|Overall Study|Withdrawal by Subject|14|||
13328732|NCT01126580|26591110|FG000|Overall Study|Sponsor Decision|5|||
13328733|NCT01126580|26591111|FG001|Overall Study|Sponsor Decision|4|||
13328734|NCT01126580|26591112|FG002|Overall Study|Sponsor Decision|7|||
13328735|NCT01126580|26591110|FG000|Overall Study|Physician Decision|1|||
13328736|NCT01126580|26591111|FG001|Overall Study|Physician Decision|1|||
13328737|NCT01126580|26591112|FG002|Overall Study|Physician Decision|2|||
13328738|NCT01126580|26591110|FG000|Overall Study|Entry Criteria Not Met|1|||
13328739|NCT01126580|26591111|FG001|Overall Study|Entry Criteria Not Met|1|||
13328740|NCT01126580|26591112|FG002|Overall Study|Entry Criteria Not Met|2|||
13328741|NCT01126580|26591110|FG000|Overall Study|Lack of Efficacy|2|||
13328742|NCT01126580|26591111|FG001|Overall Study|Lack of Efficacy|3|||
13328743|NCT01126580|26591112|FG002|Overall Study|Lack of Efficacy|4|||
13328744|NCT01126580|26591110|FG000|Overall Study|Protocol Violation|0|||
13328745|NCT01126580|26591111|FG001|Overall Study|Protocol Violation|1|||
13328746|NCT01126580|26591112|FG002|Overall Study|Protocol Violation|2|||
13328747|NCT01126580|26591110|FG000|Overall Study|Lost to Follow-up|15|||
13328748|NCT01126580|26591111|FG001|Overall Study|Lost to Follow-up|13|||
13328749|NCT01126580|26591112|FG002|Overall Study|Lost to Follow-up|9|||
13328750|NCT01126580|26591110|FG000|Overall Study|Treatment Non-compliance|0|||
13328751|NCT01126580|26591111|FG001|Overall Study|Treatment Non-compliance|2|||
13328752|NCT01126580|26591112|FG002|Overall Study|Treatment Non-compliance|3|||
13328753|NCT01126541|26591203|FG000|Overall Study|Adverse Event|0|||
13328754|NCT01126541|26591204|FG001|Overall Study|Adverse Event|2|||
13328755|NCT01126541|26591205|FG002|Overall Study|Adverse Event|4|||
13328756|NCT01126541|26591203|FG000|Overall Study|Death|0|||
13328757|NCT01126541|26591204|FG001|Overall Study|Death|1|||
13328758|NCT01126541|26591205|FG002|Overall Study|Death|0|||
13328759|NCT01126541|26591203|FG000|Overall Study|Lack of Efficacy|6|||
13328760|NCT01126541|26591204|FG001|Overall Study|Lack of Efficacy|1|||
13328761|NCT01126541|26591205|FG002|Overall Study|Lack of Efficacy|11|||
13328762|NCT01126541|26591203|FG000|Overall Study|Lost to Follow-up|1|||
13328763|NCT01126541|26591204|FG001|Overall Study|Lost to Follow-up|2|||
13328764|NCT01126541|26591205|FG002|Overall Study|Lost to Follow-up|2|||
13328765|NCT01126541|26591203|FG000|Overall Study|Withdrawal by Subject|2|||
13328766|NCT01126541|26591204|FG001|Overall Study|Withdrawal by Subject|5|||
13328767|NCT01126541|26591205|FG002|Overall Study|Withdrawal by Subject|6|||
13328768|NCT01126541|26591203|FG000|Overall Study|Protocol Violation|0|||
13328769|NCT01126541|26591204|FG001|Overall Study|Protocol Violation|0|||
13328770|NCT01126541|26591205|FG002|Overall Study|Protocol Violation|1|||
13328771|NCT01126541|26591203|FG000|Overall Study|Administrative reason or other|1|||
13328772|NCT01126541|26591204|FG001|Overall Study|Administrative reason or other|1|||
13328773|NCT01126541|26591205|FG002|Overall Study|Administrative reason or other|2|||
13373672|NCT00800735|26724400|FG000|Overall Study|Administrative/Other|2|||
13373673|NCT00800735|26724400|FG000|Overall Study|Insufficient Therapeutic Response|2|||
13373674|NCT00800735|26724400|FG000|Overall Study|Violation of Selection Criteria at Entry|7|||
13373675|NCT00800735|26724400|FG000|Overall Study|Withdrew Consent|3|||
13373676|NCT00800683|26724453|FG000|Overall Study|Adverse Event|11|||
13373677|NCT00800683|26724454|FG001|Overall Study|Adverse Event|8|||
13373678|NCT00800683|26724453|FG000|Overall Study|Lost to Follow-up|3|||
13373679|NCT00800683|26724454|FG001|Overall Study|Lost to Follow-up|1|||
13373680|NCT00800683|26724453|FG000|Overall Study|Withdrawal by Subject|1|||
13373681|NCT00800683|26724454|FG001|Overall Study|Withdrawal by Subject|7|||
13373682|NCT00800683|26724453|FG000|Overall Study|Lack of Efficacy|1|||
13373683|NCT00800683|26724454|FG001|Overall Study|Lack of Efficacy|1|||
13373684|NCT00800683|26724453|FG000|Overall Study|Other|1|||
13373685|NCT00800683|26724454|FG001|Overall Study|Other|2|||
13373686|NCT00800540|26724485|FG000|Period One: 6 Weeks|Noncompliance|1|||
13373687|NCT00800540|26724486|FG001|Period One: 6 Weeks|Noncompliance|0|||
13373688|NCT00800540|26724485|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0|||
13373689|NCT00800540|26724486|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1|||
13373690|NCT00800540|26724485|FG000|Period 2: 6 Weeks|Adverse Event|0|||
13373691|NCT00800540|26724486|FG001|Period 2: 6 Weeks|Adverse Event|1|||
13373692|NCT00800436|26724552|FG000|Overall Study|Withdrawal by Subject|0|||
13373693|NCT00800436|26724553|FG001|Overall Study|Withdrawal by Subject|0|||
13373694|NCT00800436|26724554|FG002|Overall Study|Withdrawal by Subject|1|||
13373695|NCT00800436|26724555|FG003|Overall Study|Withdrawal by Subject|1|||
13373696|NCT00800436|26724556|FG004|Overall Study|Withdrawal by Subject|0|||
13373697|NCT00800436|26724557|FG005|Overall Study|Withdrawal by Subject|0|||
13373698|NCT00800436|26724558|FG006|Overall Study|Withdrawal by Subject|0|||
13373699|NCT00800384|26724573|FG000|Overall Study|Withdrawal by Subject|24|||
13373700|NCT00800384|26724574|FG001|Overall Study|Withdrawal by Subject|17|||
13373701|NCT00800384|26724573|FG000|Overall Study|Lost to Follow-up|17|||
13328774|NCT01126437|26591247|FG000|Overall Study|Not treated|11|||
13328775|NCT01126437|26591248|FG001|Overall Study|Not treated|18|||
13328776|NCT01126437|26591249|FG002|Overall Study|Not treated|19|||
13328777|NCT01126437|26591247|FG000|Overall Study|Sites with data irregularities/fraud|6|||
13328778|NCT01126437|26591248|FG001|Overall Study|Sites with data irregularities/fraud|6|||
13328779|NCT01126437|26591249|FG002|Overall Study|Sites with data irregularities/fraud|7|||
13328780|NCT01126437|26591247|FG000|Overall Study|Adverse Event|602|||
13328781|NCT01126437|26591248|FG001|Overall Study|Adverse Event|606|||
13328782|NCT01126437|26591249|FG002|Overall Study|Adverse Event|635|||
13328783|NCT01126437|26591247|FG000|Overall Study|Lack of Efficacy|65|||
13328784|NCT01126437|26591248|FG001|Overall Study|Lack of Efficacy|60|||
13328785|NCT01126437|26591249|FG002|Overall Study|Lack of Efficacy|59|||
13328786|NCT01126437|26591247|FG000|Overall Study|Protocol Violation|64|||
13328787|NCT01126437|26591248|FG001|Overall Study|Protocol Violation|66|||
13328788|NCT01126437|26591249|FG002|Overall Study|Protocol Violation|41|||
13328789|NCT01126437|26591247|FG000|Overall Study|Lost to Follow-up|52|||
13328790|NCT01126437|26591248|FG001|Overall Study|Lost to Follow-up|63|||
13328791|NCT01126437|26591249|FG002|Overall Study|Lost to Follow-up|55|||
13328792|NCT01126437|26591247|FG000|Overall Study|Withdrawal by Subject|331|||
13328793|NCT01126437|26591248|FG001|Overall Study|Withdrawal by Subject|335|||
13328794|NCT01126437|26591249|FG002|Overall Study|Withdrawal by Subject|319|||
13328795|NCT01126437|26591247|FG000|Overall Study|Other reason not specified|210|||
13328796|NCT01126437|26591248|FG001|Overall Study|Other reason not specified|176|||
13328797|NCT01126437|26591249|FG002|Overall Study|Other reason not specified|178|||
13328798|NCT01126424|26591291|FG000|Overall Study|Adverse Event|0|||
13328799|NCT01126424|26591292|FG001|Overall Study|Adverse Event|0|||
13328800|NCT01126424|26591293|FG002|Overall Study|Adverse Event|0|||
13328801|NCT01126424|26591294|FG003|Overall Study|Adverse Event|0|||
13328802|NCT01126424|26591295|FG004|Overall Study|Adverse Event|1|||
13328803|NCT01126424|26591296|FG005|Overall Study|Adverse Event|0|||
13328804|NCT01126424|26591291|FG000|Overall Study|Withdrawal by Subject|0|||
13328805|NCT01126424|26591292|FG001|Overall Study|Withdrawal by Subject|0|||
13328806|NCT01126424|26591293|FG002|Overall Study|Withdrawal by Subject|1|||
13328807|NCT01126424|26591294|FG003|Overall Study|Withdrawal by Subject|3|||
13328808|NCT01126424|26591295|FG004|Overall Study|Withdrawal by Subject|1|||
13328809|NCT01126424|26591296|FG005|Overall Study|Withdrawal by Subject|0|||
13328810|NCT01126359|26591311|FG000|First Intervention (20-minutes)|Physician Decision|0|||
13328811|NCT01126359|26591312|FG001|First Intervention (20-minutes)|Physician Decision|1|||
13328812|NCT01126268|26591336|FG000|Overall Study|Adverse Event|1|||
13328813|NCT01126060|26591349|FG000|Overall Study|Protocol Violation|0|||
13328814|NCT01126060|26591350|FG001|Overall Study|Protocol Violation|2|||
13328815|NCT01125930|26591511|FG000|Overall Study|Adverse Event|0|||
13328816|NCT01125930|26591512|FG001|Overall Study|Adverse Event|1|||
13328817|NCT01125930|26591511|FG000|Overall Study|Withdrawal by Subject|1|||
13328818|NCT01125930|26591512|FG001|Overall Study|Withdrawal by Subject|6|||
13328819|NCT01125930|26591511|FG000|Overall Study|Protocol Violation|0|||
13328820|NCT01125930|26591512|FG001|Overall Study|Protocol Violation|1|||
13328821|NCT01125930|26591511|FG000|Overall Study|Lost to Follow-up|0|||
13328822|NCT01125930|26591512|FG001|Overall Study|Lost to Follow-up|2|||
13328823|NCT01125917|26591518|FG000|Overall Study|Adverse Event|43|||
13328824|NCT01125917|26591518|FG000|Overall Study|Lost to Follow-up|23|||
13328825|NCT01125917|26591518|FG000|Overall Study|Withdrawal by Subject|31|||
13328826|NCT01125917|26591518|FG000|Overall Study|Administrative|223|||
13328827|NCT01125917|26591518|FG000|Overall Study|Lack of Efficacy|19|||
13328828|NCT01125813|26591525|FG000|Overall Study|Death|1|||
13328829|NCT01125813|26591525|FG000|Overall Study|Withdrawal by Subject|1|||
13328830|NCT01125813|26591525|FG000|Overall Study|Screen Failures|4|||
13328831|NCT01125800|26591578|FG000|Phase I|Protocol Violation|0|||
13328832|NCT01125800|26591579|FG001|Phase I|Protocol Violation|3|||
13328833|NCT01125800|26591580|FG002|Phase I|Protocol Violation|1|||
13328834|NCT01125800|26591581|FG003|Phase I|Protocol Violation|1|||
13328835|NCT01125800|26591582|FG004|Phase I|Protocol Violation|0|||
13328836|NCT01125800|26591578|FG000|Phase I|Adverse Event|2|||
13328837|NCT01125800|26591579|FG001|Phase I|Adverse Event|2|||
13328838|NCT01125800|26591580|FG002|Phase I|Adverse Event|1|||
13328839|NCT01125800|26591581|FG003|Phase I|Adverse Event|7|||
13328840|NCT01125800|26591582|FG004|Phase I|Adverse Event|0|||
13328841|NCT01125800|26591578|FG000|Phase I|Administrative problems|1|||
13328842|NCT01125800|26591579|FG001|Phase I|Administrative problems|0|||
13328843|NCT01125800|26591580|FG002|Phase I|Administrative problems|0|||
13328844|NCT01125800|26591581|FG003|Phase I|Administrative problems|0|||
13328845|NCT01125800|26591582|FG004|Phase I|Administrative problems|0|||
13328846|NCT01125800|26591578|FG000|Phase I|Withdrawal by Subject|0|||
13328847|NCT01125800|26591579|FG001|Phase I|Withdrawal by Subject|0|||
13328848|NCT01125800|26591580|FG002|Phase I|Withdrawal by Subject|1|||
13328849|NCT01125800|26591581|FG003|Phase I|Withdrawal by Subject|0|||
13328850|NCT01125800|26591582|FG004|Phase I|Withdrawal by Subject|0|||
13328851|NCT01125800|26591578|FG000|Phase I|Disease progression|5|||
13328852|NCT01125800|26591579|FG001|Phase I|Disease progression|4|||
13328853|NCT01125800|26591580|FG002|Phase I|Disease progression|1|||
13328854|NCT01125800|26591581|FG003|Phase I|Disease progression|3|||
13328855|NCT01125800|26591582|FG004|Phase I|Disease progression|0|||
13328856|NCT01125800|26591578|FG000|Phase II|Protocol Violation|0|||
13328857|NCT01125800|26591579|FG001|Phase II|Protocol Violation|0|||
13328858|NCT01125800|26591580|FG002|Phase II|Protocol Violation|0|||
13328859|NCT01125800|26591581|FG003|Phase II|Protocol Violation|0|||
13328860|NCT01125800|26591582|FG004|Phase II|Protocol Violation|1|||
13328861|NCT01125800|26591578|FG000|Phase II|Adverse Event|0|||
13328862|NCT01125800|26591579|FG001|Phase II|Adverse Event|0|||
13328863|NCT01125800|26591580|FG002|Phase II|Adverse Event|0|||
13328864|NCT01125800|26591581|FG003|Phase II|Adverse Event|0|||
13328865|NCT01125800|26591582|FG004|Phase II|Adverse Event|2|||
13328866|NCT01125800|26591578|FG000|Phase II|Disease progression|0|||
13328867|NCT01125800|26591579|FG001|Phase II|Disease progression|0|||
13328868|NCT01125800|26591580|FG002|Phase II|Disease progression|0|||
13328869|NCT01125800|26591581|FG003|Phase II|Disease progression|1|||
13328870|NCT01125800|26591582|FG004|Phase II|Disease progression|8|||
13328871|NCT01125748|26591597|FG000|Overall Study|Adverse Event|0|||
13328872|NCT01125748|26591598|FG001|Overall Study|Adverse Event|2|||
13328873|NCT01125748|26591597|FG000|Overall Study|Lost to Follow-up|0|||
13328874|NCT01125748|26591598|FG001|Overall Study|Lost to Follow-up|1|||
13328875|NCT01125748|26591597|FG000|Overall Study|Physician Decision|8|||
13328876|NCT01125748|26591598|FG001|Overall Study|Physician Decision|7|||
13328877|NCT01125748|26591597|FG000|Overall Study|Patient Decision to Withdraw|2|||
13328878|NCT01125748|26591598|FG001|Overall Study|Patient Decision to Withdraw|4|||
13328879|NCT01125722|26591619|FG000|Overall Study|Withdrawal by Subject|2|||
13328880|NCT01125722|26591620|FG001|Overall Study|Withdrawal by Subject|1|||
13328881|NCT01125722|26591619|FG000|Overall Study|Lost to Follow-up|1|||
13328882|NCT01125722|26591620|FG001|Overall Study|Lost to Follow-up|0|||
13328883|NCT01125566|26591641|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182|||
13328884|NCT01125566|26591642|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119|||
13328885|NCT01125566|26591643|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0|||
13328886|NCT01125566|26591641|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
13328887|NCT01125566|26591642|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
13328888|NCT01125566|26591643|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0|||
13328889|NCT01125566|26591641|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25|||
13328890|NCT01125566|26591642|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5|||
13328891|NCT01125566|26591643|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0|||
13328892|NCT01125566|26591641|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
13328893|NCT01125566|26591642|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2|||
13328894|NCT01125566|26591643|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
13328895|NCT01125566|26591641|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24|||
13328896|NCT01125566|26591642|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23|||
13328897|NCT01125566|26591643|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0|||
13328898|NCT01125566|26591641|FG000|Patients Before the Switch (26Apr2013)|Not treated|2|||
13328899|NCT01125566|26591642|FG001|Patients Before the Switch (26Apr2013)|Not treated|0|||
13328900|NCT01125566|26591643|FG002|Patients Before the Switch (26Apr2013)|Not treated|0|||
13328901|NCT01125566|26591641|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25|||
13328902|NCT01125566|26591642|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13|||
13328903|NCT01125566|26591643|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0|||
13328904|NCT01125566|26591641|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
13328905|NCT01125566|26591642|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
13328906|NCT01125566|26591643|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0|||
13328907|NCT01125566|26591641|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
13328908|NCT01125566|26591642|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
13328909|NCT01125566|26591643|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59|||
13328910|NCT01125566|26591641|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
13328911|NCT01125566|26591642|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
13328912|NCT01125566|26591643|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7|||
13328913|NCT01125566|26591641|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
13328914|NCT01125566|26591642|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
13328915|NCT01125566|26591643|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3|||
13328916|NCT01125566|26591641|FG000|Patients Who Switched From AV to TV|Other than listed above|0|||
13328917|NCT01125566|26591642|FG001|Patients Who Switched From AV to TV|Other than listed above|0|||
13328918|NCT01125566|26591643|FG002|Patients Who Switched From AV to TV|Other than listed above|4|||
13328919|NCT01125514|26591717|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1|||
13373702|NCT00800384|26724574|FG001|Overall Study|Lost to Follow-up|26|||
13328920|NCT01125514|26591717|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1|||
13328921|NCT01125514|26591717|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3|||
13328922|NCT01125514|26591717|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2|||
13328923|NCT01125514|26591717|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1|||
13328924|NCT01125514|26591717|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1|||
13328925|NCT01125358|26591759|FG000|Overall Study|Adverse Event|3|||
13328926|NCT01125358|26591760|FG001|Overall Study|Adverse Event|0|||
13328927|NCT01125358|26591761|FG002|Overall Study|Adverse Event|0|||
13328928|NCT01125358|26591762|FG003|Overall Study|Adverse Event|2|||
13328929|NCT01125358|26591759|FG000|Overall Study|Perceived Lack of Efficacy|6|||
13328930|NCT01125358|26591760|FG001|Overall Study|Perceived Lack of Efficacy|3|||
13328931|NCT01125358|26591761|FG002|Overall Study|Perceived Lack of Efficacy|7|||
13328932|NCT01125358|26591762|FG003|Overall Study|Perceived Lack of Efficacy|4|||
13328933|NCT01125358|26591759|FG000|Overall Study|Protocol Violation|1|||
13328934|NCT01125358|26591760|FG001|Overall Study|Protocol Violation|0|||
13328935|NCT01125358|26591761|FG002|Overall Study|Protocol Violation|0|||
13328936|NCT01125358|26591762|FG003|Overall Study|Protocol Violation|0|||
13328937|NCT01125358|26591759|FG000|Overall Study|Sponsor Decision|0|||
13328938|NCT01125358|26591760|FG001|Overall Study|Sponsor Decision|0|||
13328939|NCT01125358|26591761|FG002|Overall Study|Sponsor Decision|1|||
13328940|NCT01125358|26591762|FG003|Overall Study|Sponsor Decision|1|||
13328941|NCT01125358|26591759|FG000|Overall Study|Withdrawal by Subject|2|||
13328942|NCT01125358|26591760|FG001|Overall Study|Withdrawal by Subject|1|||
13328943|NCT01125358|26591761|FG002|Overall Study|Withdrawal by Subject|1|||
13328944|NCT01125358|26591762|FG003|Overall Study|Withdrawal by Subject|1|||
13328945|NCT01125293|26591807|FG000|Overall Study|Disease Progression|1|||
13328946|NCT01125293|26591808|FG001|Overall Study|Disease Progression|3|||
13328947|NCT01125293|26591809|FG002|Overall Study|Disease Progression|4|||
13328948|NCT01125293|26591810|FG003|Overall Study|Disease Progression|3|||
13328949|NCT01125293|26591811|FG004|Overall Study|Disease Progression|5|||
13328950|NCT01125293|26591812|FG005|Overall Study|Disease Progression|12|||
13328951|NCT01125293|26591807|FG000|Overall Study|Adverse Event|1|||
13328952|NCT01125293|26591808|FG001|Overall Study|Adverse Event|0|||
13328953|NCT01125293|26591809|FG002|Overall Study|Adverse Event|0|||
13328954|NCT01125293|26591810|FG003|Overall Study|Adverse Event|0|||
13328955|NCT01125293|26591811|FG004|Overall Study|Adverse Event|2|||
13328956|NCT01125293|26591812|FG005|Overall Study|Adverse Event|8|||
13328957|NCT01125293|26591807|FG000|Overall Study|Symptomatic Deterioration|1|||
13328958|NCT01125293|26591808|FG001|Overall Study|Symptomatic Deterioration|0|||
13328959|NCT01125293|26591809|FG002|Overall Study|Symptomatic Deterioration|0|||
13328960|NCT01125293|26591810|FG003|Overall Study|Symptomatic Deterioration|0|||
13328961|NCT01125293|26591811|FG004|Overall Study|Symptomatic Deterioration|0|||
13328962|NCT01125293|26591812|FG005|Overall Study|Symptomatic Deterioration|0|||
13328963|NCT01125293|26591807|FG000|Overall Study|Death|0|||
13328964|NCT01125293|26591808|FG001|Overall Study|Death|0|||
13328965|NCT01125293|26591809|FG002|Overall Study|Death|0|||
13328966|NCT01125293|26591810|FG003|Overall Study|Death|0|||
13328967|NCT01125293|26591811|FG004|Overall Study|Death|1|||
13328968|NCT01125293|26591812|FG005|Overall Study|Death|0|||
13328969|NCT01125293|26591807|FG000|Overall Study|Withdrawal by Subject|0|||
13328970|NCT01125293|26591808|FG001|Overall Study|Withdrawal by Subject|0|||
13328971|NCT01125293|26591809|FG002|Overall Study|Withdrawal by Subject|0|||
13328972|NCT01125293|26591810|FG003|Overall Study|Withdrawal by Subject|0|||
13328973|NCT01125293|26591811|FG004|Overall Study|Withdrawal by Subject|2|||
13328974|NCT01125293|26591812|FG005|Overall Study|Withdrawal by Subject|1|||
13328975|NCT01125293|26591807|FG000|Overall Study|Physician Decision|0|||
13328976|NCT01125293|26591808|FG001|Overall Study|Physician Decision|0|||
13328977|NCT01125293|26591809|FG002|Overall Study|Physician Decision|0|||
13328978|NCT01125293|26591810|FG003|Overall Study|Physician Decision|0|||
13328979|NCT01125293|26591811|FG004|Overall Study|Physician Decision|0|||
13328980|NCT01125293|26591812|FG005|Overall Study|Physician Decision|2|||
13328981|NCT01125189|26591848|FG000|Treatment Period|Lack of Efficacy|15|||
13328982|NCT01125189|26591849|FG001|Treatment Period|Lack of Efficacy|18|||
13328983|NCT01125189|26591850|FG002|Treatment Period|Lack of Efficacy|25|||
13328984|NCT01125189|26591848|FG000|Treatment Period|Adverse Event|7|||
13328985|NCT01125189|26591849|FG001|Treatment Period|Adverse Event|8|||
13328986|NCT01125189|26591850|FG002|Treatment Period|Adverse Event|8|||
13328987|NCT01125189|26591848|FG000|Treatment Period|Withdrawal by Subject|3|||
13328988|NCT01125189|26591849|FG001|Treatment Period|Withdrawal by Subject|1|||
13328989|NCT01125189|26591850|FG002|Treatment Period|Withdrawal by Subject|1|||
13328990|NCT01125189|26591848|FG000|Treatment Period|Death|1|||
13486403|NCT03564145|27036051|FG000|Overall Study|Adverse Event|4|||
13328991|NCT01125189|26591849|FG001|Treatment Period|Death|0|||
13328992|NCT01125189|26591850|FG002|Treatment Period|Death|0|||
13328993|NCT01125189|26591848|FG000|Treatment Period|Lost to Follow-up|1|||
13328994|NCT01125189|26591849|FG001|Treatment Period|Lost to Follow-up|2|||
13328995|NCT01125189|26591850|FG002|Treatment Period|Lost to Follow-up|1|||
13328996|NCT01125189|26591848|FG000|Treatment Period|Poor compliance/noncompliance|0|||
13328997|NCT01125189|26591849|FG001|Treatment Period|Poor compliance/noncompliance|1|||
13328998|NCT01125189|26591850|FG002|Treatment Period|Poor compliance/noncompliance|0|||
13328999|NCT01125189|26591848|FG000|Treatment Period|Participants requested to discontinue|1|||
13329000|NCT01125189|26591849|FG001|Treatment Period|Participants requested to discontinue|3|||
13329001|NCT01125189|26591850|FG002|Treatment Period|Participants requested to discontinue|4|||
13329002|NCT01125189|26591848|FG000|Treatment Period|Other reasons|1|||
13329003|NCT01125189|26591849|FG001|Treatment Period|Other reasons|1|||
13329004|NCT01125189|26591850|FG002|Treatment Period|Other reasons|0|||
13329005|NCT01125189|26591848|FG000|Treatment Period|Completed 24 week treatment period only|2|||
13329006|NCT01125189|26591849|FG001|Treatment Period|Completed 24 week treatment period only|1|||
13329007|NCT01125189|26591850|FG002|Treatment Period|Completed 24 week treatment period only|2|||
13329008|NCT01125189|26591848|FG000|Follow up Period|Withdrawal by Subject|3|||
13329009|NCT01125189|26591849|FG001|Follow up Period|Withdrawal by Subject|2|||
13329010|NCT01125189|26591850|FG002|Follow up Period|Withdrawal by Subject|5|||
13329011|NCT01125189|26591848|FG000|Follow up Period|Death|1|||
13329012|NCT01125189|26591849|FG001|Follow up Period|Death|0|||
13329013|NCT01125189|26591850|FG002|Follow up Period|Death|0|||
13329014|NCT01125189|26591848|FG000|Follow up Period|Lost to Follow-up|12|||
13329015|NCT01125189|26591849|FG001|Follow up Period|Lost to Follow-up|9|||
13329016|NCT01125189|26591850|FG002|Follow up Period|Lost to Follow-up|6|||
13329017|NCT01125189|26591848|FG000|Follow up Period|Other reasons|4|||
13329018|NCT01125189|26591849|FG001|Follow up Period|Other reasons|4|||
13329019|NCT01125189|26591850|FG002|Follow up Period|Other reasons|5|||
13329020|NCT01125046|26591860|FG000|First 6 Months of Treatment|Death|1|||
13329021|NCT01125046|26591860|FG000|First 6 Months of Treatment|Withdrawal by Subject|2|||
13329022|NCT01125046|26591860|FG000|First 6 Months of Treatment|Non-compliance|1|||
13329023|NCT01125046|26591860|FG000|First 6 Months of Treatment|Surgery|1|||
13329024|NCT01125046|26591860|FG000|First 6 Months of Treatment|Progressive Disease|7|||
13329025|NCT01125046|26591860|FG000|First 6 Months of Treatment|Adverse Event|2|||
13329026|NCT01125046|26591860|FG000|Continued Treatment After 6 Months|Progressive Disease|2|||
13329027|NCT01125046|26591860|FG000|Continued Treatment After 6 Months|Adverse Event|1|||
13329028|NCT01125046|26591860|FG000|Follow-up/Data Cut Off Point|Death|29|||
13329029|NCT01125046|26591860|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4|||
13329030|NCT01124916|26591875|FG000|Overall Study|Lost to Follow-up|3|||
13329031|NCT01124916|26591876|FG001|Overall Study|Lost to Follow-up|2|||
13329032|NCT01124864|26591927|FG000|Overall Study|Follow up phase competed as per protocol|18|||
13329033|NCT01124864|26591928|FG001|Overall Study|Follow up phase competed as per protocol|22|||
13329034|NCT01124864|26591929|FG002|Overall Study|Follow up phase competed as per protocol|24|||
13329035|NCT01124864|26591930|FG003|Overall Study|Follow up phase competed as per protocol|18|||
13329036|NCT01124864|26591931|FG004|Overall Study|Follow up phase competed as per protocol|26|||
13329037|NCT01124864|26591932|FG005|Overall Study|Follow up phase competed as per protocol|2|||
13329038|NCT01124864|26591927|FG000|Overall Study|Death|6|||
13329039|NCT01124864|26591928|FG001|Overall Study|Death|9|||
13329040|NCT01124864|26591929|FG002|Overall Study|Death|6|||
13329041|NCT01124864|26591930|FG003|Overall Study|Death|2|||
13329042|NCT01124864|26591931|FG004|Overall Study|Death|1|||
13329043|NCT01124864|26591932|FG005|Overall Study|Death|0|||
13329044|NCT01124864|26591927|FG000|Overall Study|Withdrawal by Subject|2|||
13329045|NCT01124864|26591928|FG001|Overall Study|Withdrawal by Subject|3|||
13329046|NCT01124864|26591929|FG002|Overall Study|Withdrawal by Subject|4|||
13329047|NCT01124864|26591930|FG003|Overall Study|Withdrawal by Subject|0|||
13329048|NCT01124864|26591931|FG004|Overall Study|Withdrawal by Subject|2|||
13329049|NCT01124864|26591932|FG005|Overall Study|Withdrawal by Subject|1|||
13329050|NCT01124864|26591927|FG000|Overall Study|Lost to Follow-up|1|||
13329051|NCT01124864|26591928|FG001|Overall Study|Lost to Follow-up|1|||
13329052|NCT01124864|26591929|FG002|Overall Study|Lost to Follow-up|0|||
13329053|NCT01124864|26591930|FG003|Overall Study|Lost to Follow-up|1|||
13329054|NCT01124864|26591931|FG004|Overall Study|Lost to Follow-up|0|||
13329055|NCT01124864|26591932|FG005|Overall Study|Lost to Follow-up|0|||
13329056|NCT01124864|26591927|FG000|Overall Study|Protocol Violation|1|||
13329057|NCT01124864|26591928|FG001|Overall Study|Protocol Violation|0|||
13329058|NCT01124864|26591929|FG002|Overall Study|Protocol Violation|0|||
13329059|NCT01124864|26591930|FG003|Overall Study|Protocol Violation|0|||
13329060|NCT01124864|26591931|FG004|Overall Study|Protocol Violation|1|||
13329061|NCT01124864|26591932|FG005|Overall Study|Protocol Violation|0|||
13329062|NCT01124838|26591983|FG000|Overall Study|Miscellaneous|4|||
13329063|NCT01124838|26591984|FG001|Overall Study|Miscellaneous|2|||
13329064|NCT01124838|26591983|FG000|Overall Study|Adverse Event|7|||
13329065|NCT01124838|26591984|FG001|Overall Study|Adverse Event|11|||
13329066|NCT01124838|26591983|FG000|Overall Study|Lack of Efficacy|2|||
13329067|NCT01124838|26591984|FG001|Overall Study|Lack of Efficacy|0|||
13329068|NCT01124838|26591983|FG000|Overall Study|Withdrawal by Subject|3|||
13329069|NCT01124838|26591984|FG001|Overall Study|Withdrawal by Subject|2|||
13329070|NCT01124838|26591983|FG000|Overall Study|Lost to Follow-up|2|||
13329071|NCT01124838|26591984|FG001|Overall Study|Lost to Follow-up|0|||
13329072|NCT01124734|26591997|FG000|Overall Study|Disease progression|13|||
13329073|NCT01124734|26591997|FG000|Overall Study|Adverse Event|1|||
13329074|NCT01124734|26591997|FG000|Overall Study|Withdrawal by Subject|1|||
13329075|NCT01124734|26591997|FG000|Overall Study|Elected for alternative treatment|2|||
13329076|NCT01124643|26592011|FG000|Overall Study|Death|1|||
13329077|NCT01124617|26592048|FG000|Overall Study|Adverse Event|5|||
13329078|NCT01124617|26592049|FG001|Overall Study|Adverse Event|2|||
13329079|NCT01124617|26592048|FG000|Overall Study|Lack of Efficacy|2|||
13329080|NCT01124617|26592049|FG001|Overall Study|Lack of Efficacy|1|||
13329081|NCT01124617|26592048|FG000|Overall Study|Protocol Violation|1|||
13329082|NCT01124617|26592049|FG001|Overall Study|Protocol Violation|1|||
13329083|NCT01124617|26592048|FG000|Overall Study|Withdrawal by Subject|9|||
13329084|NCT01124617|26592049|FG001|Overall Study|Withdrawal by Subject|1|||
13329085|NCT01124617|26592048|FG000|Overall Study|Other|2|||
13329086|NCT01124617|26592049|FG001|Overall Study|Other|1|||
13329087|NCT01124604|26592093|FG000|Overall Study|Adverse Event|10|||
13329088|NCT01124604|26592094|FG001|Overall Study|Adverse Event|1|||
13329089|NCT01124604|26592093|FG000|Overall Study|Lack of Efficacy|1|||
13329090|NCT01124604|26592094|FG001|Overall Study|Lack of Efficacy|0|||
13329091|NCT01124604|26592093|FG000|Overall Study|Withdrawal by Subject|4|||
13329092|NCT01124604|26592094|FG001|Overall Study|Withdrawal by Subject|0|||
13329093|NCT01124604|26592093|FG000|Overall Study|Disease Progression|0|||
13329094|NCT01124604|26592094|FG001|Overall Study|Disease Progression|1|||
13329095|NCT01124448|26592107|FG000|Overall Study|Lost to Follow-up|0|||
13329096|NCT01124448|26592108|FG001|Overall Study|Lost to Follow-up|3|||
13329097|NCT01124448|26592107|FG000|Overall Study|Protocol Violation|2|||
13329098|NCT01124448|26592108|FG001|Overall Study|Protocol Violation|0|||
13329099|NCT01124422|26592158|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5|||
13329100|NCT01124422|26592159|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
13329101|NCT01124422|26592160|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
13329102|NCT01124422|26592158|FG000|4-Week Open-label Run-in Phase|Adverse Event|7|||
13329103|NCT01124422|26592159|FG001|4-Week Open-label Run-in Phase|Adverse Event|0|||
13329104|NCT01124422|26592160|FG002|4-Week Open-label Run-in Phase|Adverse Event|0|||
13329105|NCT01124422|26592158|FG000|4-Week Open-label Run-in Phase|Physician Decision|4|||
13329106|NCT01124422|26592159|FG001|4-Week Open-label Run-in Phase|Physician Decision|0|||
13329107|NCT01124422|26592160|FG002|4-Week Open-label Run-in Phase|Physician Decision|0|||
13329108|NCT01124422|26592158|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1|||
13329109|NCT01124422|26592159|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
13329110|NCT01124422|26592160|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
13329111|NCT01124422|26592158|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61|||
13329112|NCT01124422|26592159|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
13329113|NCT01124422|26592160|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
13329114|NCT01124422|26592158|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5|||
13329115|NCT01124422|26592159|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0|||
13329116|NCT01124422|26592160|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0|||
13329117|NCT01124422|26592158|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
13329118|NCT01124422|26592159|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
13329119|NCT01124422|26592160|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3|||
13329120|NCT01124422|26592158|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0|||
13329121|NCT01124422|26592159|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6|||
13329122|NCT01124422|26592160|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3|||
13329123|NCT01124422|26592158|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0|||
13329124|NCT01124422|26592159|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5|||
13329125|NCT01124422|26592160|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2|||
13329126|NCT01124422|26592158|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
13329127|NCT01124422|26592159|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
13329128|NCT01124422|26592160|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1|||
13329129|NCT01124292|26592226|FG000|Overall Study|Lost to Follow-up|2|||
13329130|NCT01124292|26592227|FG001|Overall Study|Lost to Follow-up|4|||
13329131|NCT01124292|26592228|FG002|Overall Study|Lost to Follow-up|3|||
13329132|NCT01124292|26592226|FG000|Overall Study|Physician Decision|0|||
13329133|NCT01124292|26592227|FG001|Overall Study|Physician Decision|3|||
13329134|NCT01124292|26592228|FG002|Overall Study|Physician Decision|2|||
13329135|NCT01124292|26592226|FG000|Overall Study|Withdrawal by Subject|0|||
13329136|NCT01124292|26592227|FG001|Overall Study|Withdrawal by Subject|6|||
13329137|NCT01124292|26592228|FG002|Overall Study|Withdrawal by Subject|2|||
13329138|NCT01124292|26592226|FG000|Overall Study|medical issue unrelated to the study|0|||
13329139|NCT01124292|26592227|FG001|Overall Study|medical issue unrelated to the study|0|||
13329140|NCT01124292|26592228|FG002|Overall Study|medical issue unrelated to the study|2|||
13329141|NCT01124292|26592226|FG000|Overall Study|piercing track closed|0|||
13329142|NCT01124292|26592227|FG001|Overall Study|piercing track closed|2|||
13329143|NCT01124292|26592228|FG002|Overall Study|piercing track closed|1|||
13329144|NCT01124175|26592251|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
13329145|NCT01124175|26592252|FG001|Washout of 7 Days|Withdrawal by Subject|2|||
13329146|NCT01124162|26592275|FG000|First Intervention|Adverse Event|2|||
13329147|NCT01124162|26592276|FG001|First Intervention|Adverse Event|0|||
13329148|NCT01124162|26592275|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
13329149|NCT01124162|26592276|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
13329150|NCT01124149|26592294|FG000|Acute Phase|Withdrawal by Subject|22|||
13329151|NCT01124149|26592294|FG000|Acute Phase|Adverse Event|21|||
13329152|NCT01124149|26592294|FG000|Acute Phase|Lack of Efficacy|17|||
13329153|NCT01124149|26592294|FG000|Acute Phase|Protocol Violation|14|||
13329154|NCT01124149|26592294|FG000|Acute Phase|Lost to Follow-up|2|||
13329155|NCT01124149|26592294|FG000|Acute Phase|Prolonged antibiotic therapy|1|||
13329156|NCT01124149|26592294|FG000|Acute Phase|Sponsor request|1|||
13329157|NCT01124149|26592294|FG000|Acute Phase|UC symptoms not ameliorated|1|||
13329158|NCT01124149|26592294|FG000|Acute Phase|Non-compliance|1|||
13329159|NCT01124149|26592294|FG000|Acute Phase|Low hemoglobin|1|||
13329160|NCT01124149|26592294|FG000|Acute Phase|Travelling to another country|1|||
13329161|NCT01124149|26592294|FG000|Acute Phase|Sponsor decision|1|||
13329162|NCT01124149|26592294|FG000|Maintenance Phase|Lack of Efficacy|40|||
13329163|NCT01124149|26592294|FG000|Maintenance Phase|Adverse Event|24|||
13329164|NCT01124149|26592294|FG000|Maintenance Phase|Lost to Follow-up|15|||
13329165|NCT01124149|26592294|FG000|Maintenance Phase|Withdrawal by Subject|10|||
13329166|NCT01124149|26592294|FG000|Maintenance Phase|Protocol Violation|5|||
13329167|NCT01124149|26592294|FG000|Maintenance Phase|Coordinator error|1|||
13329168|NCT01124149|26592294|FG000|Maintenance Phase|Non-compliance|1|||
13329169|NCT01124097|26592317|FG000|Overall Study|Withdrawal by Subject|4|||
13329170|NCT01124097|26592318|FG001|Overall Study|Withdrawal by Subject|3|||
13329171|NCT01124097|26592319|FG002|Overall Study|Withdrawal by Subject|2|||
13329172|NCT01124097|26592320|FG003|Overall Study|Withdrawal by Subject|3|||
13329173|NCT01124097|26592317|FG000|Overall Study|Lack of Efficacy|2|||
13329174|NCT01124097|26592318|FG001|Overall Study|Lack of Efficacy|3|||
13329175|NCT01124097|26592319|FG002|Overall Study|Lack of Efficacy|1|||
13329176|NCT01124097|26592320|FG003|Overall Study|Lack of Efficacy|3|||
13329177|NCT01124097|26592317|FG000|Overall Study|Adverse Event|24|||
13329178|NCT01124097|26592318|FG001|Overall Study|Adverse Event|15|||
13329179|NCT01124097|26592319|FG002|Overall Study|Adverse Event|15|||
13329180|NCT01124097|26592320|FG003|Overall Study|Adverse Event|7|||
13329181|NCT01124097|26592317|FG000|Overall Study|Protocol Violation|2|||
13329182|NCT01124097|26592318|FG001|Overall Study|Protocol Violation|0|||
13329183|NCT01124097|26592319|FG002|Overall Study|Protocol Violation|2|||
13329184|NCT01124097|26592320|FG003|Overall Study|Protocol Violation|1|||
13329185|NCT01124097|26592317|FG000|Overall Study|Physician Decision|2|||
13329186|NCT01124097|26592318|FG001|Overall Study|Physician Decision|1|||
13329187|NCT01124097|26592319|FG002|Overall Study|Physician Decision|0|||
13329188|NCT01124097|26592320|FG003|Overall Study|Physician Decision|0|||
13329189|NCT01124045|26592357|FG000|Overall Study|Lost to Follow-up|0|||
13329190|NCT01124045|26592358|FG001|Overall Study|Lost to Follow-up|1|||
13329191|NCT01124045|26592357|FG000|Overall Study|Physician Decision|0|||
13329192|NCT01124045|26592358|FG001|Overall Study|Physician Decision|2|||
13329193|NCT01124006|26592394|FG000|Overall Study|Withdrawal by Subject|2|||
13329194|NCT01124006|26592395|FG001|Overall Study|Withdrawal by Subject|2|||
13329195|NCT01124006|26592396|FG002|Overall Study|Withdrawal by Subject|0|||
13329196|NCT01124006|26592394|FG000|Overall Study|Lost to Follow-up|1|||
13329197|NCT01124006|26592395|FG001|Overall Study|Lost to Follow-up|0|||
13329198|NCT01124006|26592396|FG002|Overall Study|Lost to Follow-up|1|||
13329199|NCT01124006|26592394|FG000|Overall Study|Other|0|||
13329200|NCT01124006|26592395|FG001|Overall Study|Other|0|||
13329201|NCT01124006|26592396|FG002|Overall Study|Other|1|||
13329202|NCT01123980|26592421|FG000|Overall Study|Adverse Event|1|||
13329203|NCT01123980|26592422|FG001|Overall Study|Adverse Event|1|||
13329204|NCT01123980|26592421|FG000|Overall Study|Lack of Efficacy|1|||
13329205|NCT01123980|26592422|FG001|Overall Study|Lack of Efficacy|0|||
13329206|NCT01123980|26592421|FG000|Overall Study|Physician Decision|0|||
13329207|NCT01123980|26592422|FG001|Overall Study|Physician Decision|1|||
13329208|NCT01123980|26592421|FG000|Overall Study|Lost to Follow-up|0|||
13329209|NCT01123980|26592422|FG001|Overall Study|Lost to Follow-up|6|||
13329210|NCT01123980|26592421|FG000|Overall Study|Protocol Violation|6|||
13329211|NCT01123980|26592422|FG001|Overall Study|Protocol Violation|6|||
13288270|NCT01089413|26475348|FG000|Overall Study|Lost to Follow-up|1|||
13288271|NCT01089413|26475348|FG000|Overall Study|Progressive Disease|93|||
13288272|NCT01089413|26475348|FG000|Overall Study|Participant Withdrew Consent|1|||
13288273|NCT01089413|26475348|FG000|Overall Study|Unacceptable Toxicity|12|||
13288274|NCT01089413|26475348|FG000|Overall Study|Death|10|||
13288275|NCT01089413|26475348|FG000|Overall Study|Metastasectomy|13|||
13288276|NCT01089413|26475348|FG000|Overall Study|Other|71|||
13288277|NCT01089127|26475387|FG000|Overall Study|Adverse Event|5|||
13288278|NCT01089127|26475388|FG001|Overall Study|Adverse Event|1|||
13288279|NCT01089127|26475389|FG002|Overall Study|Adverse Event|1|||
13288280|NCT01089127|26475390|FG003|Overall Study|Adverse Event|0|||
13329212|NCT01123980|26592421|FG000|Overall Study|Withdrawal by Subject|5|||
13329213|NCT01123980|26592422|FG001|Overall Study|Withdrawal by Subject|3|||
13288281|NCT01089127|26475391|FG004|Overall Study|Adverse Event|0|||
13329214|NCT01123980|26592421|FG000|Overall Study|Unclassified|6|||
13329215|NCT01123980|26592422|FG001|Overall Study|Unclassified|7|||
13329216|NCT01123941|26592441|FG000|Overall Study|Lost to Follow-up|2|||
13329217|NCT01123941|26592442|FG001|Overall Study|Lost to Follow-up|1|||
13329218|NCT01123889|26592459|FG000|Overall Study|Lost to Follow-up|3|||
13329219|NCT01123889|26592460|FG001|Overall Study|Lost to Follow-up|1|||
13329220|NCT01123850|26592467|FG000|Overall Study|Slow enrollment|45|||
13329221|NCT01123655|26592547|FG000|Overall Study|Medication for RA had to be changed|1|||
13329222|NCT01123655|26592548|FG001|Overall Study|Medication for RA had to be changed|0|||
13329223|NCT01123655|26592549|FG002|Overall Study|Medication for RA had to be changed|0|||
13329224|NCT01123655|26592547|FG000|Overall Study|new illness|0|||
13329225|NCT01123655|26592548|FG001|Overall Study|new illness|1|||
13329226|NCT01123655|26592549|FG002|Overall Study|new illness|0|||
13329227|NCT01123655|26592547|FG000|Overall Study|began prohibitive drug|0|||
13329228|NCT01123655|26592548|FG001|Overall Study|began prohibitive drug|0|||
13329229|NCT01123655|26592549|FG002|Overall Study|began prohibitive drug|1|||
13329230|NCT01123642|26592558|FG000|Overall Study|Lost to Follow-up|23|||
13329231|NCT01123642|26592558|FG000|Overall Study|Withdrawal by Subject|9|||
13329232|NCT01123642|26592558|FG000|Overall Study|ineligible at baseline assessment|36|||
13329233|NCT01123395|26592571|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
13329234|NCT01123395|26592572|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
13329235|NCT01123382|26592601|FG000|Overall Study|Withdrawal by Subject|1|||
13329236|NCT01123382|26592602|FG001|Overall Study|Withdrawal by Subject|4|||
13329237|NCT01123382|26592601|FG000|Overall Study|Lost to Follow-up|1|||
13329238|NCT01123382|26592602|FG001|Overall Study|Lost to Follow-up|2|||
13329239|NCT01123356|26592612|FG000|Overall Study|Adverse Event|2|||
13329240|NCT01123356|26592612|FG000|Overall Study|Lack of Efficacy|4|||
13329241|NCT01123356|26592612|FG000|Overall Study|Withdrawal by Subject|1|||
13329242|NCT01123200|26592619|FG000|Overall Study|Withdrawal by Subject|1|||
13329243|NCT01123161|26592644|FG000|Overall Study|Lost to Follow-up|1|||
13329244|NCT01123161|26592645|FG001|Overall Study|Lost to Follow-up|0|||
13329245|NCT01123161|26592644|FG000|Overall Study|Withdrawal by Subject|1|||
13329246|NCT01123161|26592645|FG001|Overall Study|Withdrawal by Subject|0|||
13329247|NCT01123148|26592651|FG000|Overall Study|Coughing caused unacceptable EEG quality|1|||
13329248|NCT01123148|26592651|FG000|Overall Study|Didn't meet milestone criteria|1|||
13329249|NCT01123083|26592682|FG000|Overall Study|Investigator recommendation|1|||
13329250|NCT01123083|26592683|FG001|Overall Study|Investigator recommendation|1|||
13329251|NCT01123083|26592682|FG000|Overall Study|Administrative reasons|0|||
13329252|NCT01123083|26592683|FG001|Overall Study|Administrative reasons|4|||
13329253|NCT01123083|26592682|FG000|Overall Study|Lost to Follow-up|2|||
13329254|NCT01123083|26592683|FG001|Overall Study|Lost to Follow-up|6|||
13329255|NCT01123083|26592682|FG000|Overall Study|Adverse Event|1|||
13329256|NCT01123083|26592683|FG001|Overall Study|Adverse Event|0|||
13329257|NCT01123083|26592682|FG000|Overall Study|Withdrew for another reason not covered|0|||
13329258|NCT01123083|26592683|FG001|Overall Study|Withdrew for another reason not covered|1|||
13329259|NCT01123083|26592682|FG000|Overall Study|Participant/legal representative request|7|||
13329260|NCT01123083|26592683|FG001|Overall Study|Participant/legal representative request|3|||
13329261|NCT01123070|26592719|FG000|Part B Double Blind Period|Protocol Violation|0|||
13329262|NCT01123070|26592720|FG001|Part B Double Blind Period|Protocol Violation|0|||
13329263|NCT01123070|26592721|FG002|Part B Double Blind Period|Protocol Violation|0|||
13329264|NCT01123070|26592722|FG003|Part B Double Blind Period|Protocol Violation|1|||
13329265|NCT01123070|26592719|FG000|Part B Double Blind Period|Adverse Event|0|||
13329266|NCT01123070|26592720|FG001|Part B Double Blind Period|Adverse Event|0|||
13329267|NCT01123070|26592721|FG002|Part B Double Blind Period|Adverse Event|2|||
13329268|NCT01123070|26592722|FG003|Part B Double Blind Period|Adverse Event|0|||
13329269|NCT01123070|26592719|FG000|Part B Double Blind Period|Sponsor's Decision|0|||
13329270|NCT01123070|26592720|FG001|Part B Double Blind Period|Sponsor's Decision|0|||
13329271|NCT01123070|26592721|FG002|Part B Double Blind Period|Sponsor's Decision|2|||
13329272|NCT01123070|26592722|FG003|Part B Double Blind Period|Sponsor's Decision|2|||
13329273|NCT01122927|26592756|FG000|Period 1 - Conversion Phase|Adverse Event|3|||
13329274|NCT01122927|26592757|FG001|Period 1 - Conversion Phase|Adverse Event|0|||
13329275|NCT01122927|26592756|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
13329276|NCT01122927|26592757|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
13329277|NCT01122927|26592756|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
13329278|NCT01122927|26592757|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
13329279|NCT01122927|26592756|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
13329280|NCT01122927|26592757|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
13329281|NCT01122927|26592756|FG000|Period 1 - Conversion Phase|Protocol Deviation|1|||
13329282|NCT01122927|26592757|FG001|Period 1 - Conversion Phase|Protocol Deviation|0|||
13329283|NCT01122927|26592756|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0|||
13329284|NCT01122927|26592757|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21|||
13329285|NCT01122927|26592756|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0|||
13329286|NCT01122927|26592757|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33|||
13329287|NCT01122927|26592756|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0|||
13329288|NCT01122927|26592757|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165|||
13329289|NCT01122927|26592756|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0|||
13329290|NCT01122927|26592757|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9|||
13329291|NCT01122927|26592756|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0|||
13329292|NCT01122927|26592757|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12|||
13329293|NCT01122927|26592756|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0|||
13329294|NCT01122927|26592757|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65|||
13329295|NCT01122927|26592756|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0|||
13329296|NCT01122927|26592757|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7|||
13329297|NCT01122862|26592779|FG000|Period 1|Protocol Violation|0|||
13329298|NCT01122862|26592780|FG001|Period 1|Protocol Violation|1|||
13329299|NCT01122862|26592781|FG002|Period 1|Protocol Violation|0|||
13329300|NCT01122862|26592779|FG000|Period 2|Adverse Event|0|||
13329301|NCT01122862|26592780|FG001|Period 2|Adverse Event|0|||
13329302|NCT01122862|26592781|FG002|Period 2|Adverse Event|1|||
13329303|NCT01122680|26592848|FG000|Period 1 (4 Weeks)|Adverse Event|1|||
13329304|NCT01122680|26592849|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
13329305|NCT01122680|26592850|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
13329306|NCT01122680|26592851|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
13329307|NCT01122680|26592848|FG000|Period 1 (4 Weeks)|Protocol Violation|1|||
13329308|NCT01122680|26592849|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
13329309|NCT01122680|26592850|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
13329310|NCT01122680|26592851|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
13329311|NCT01122680|26592848|FG000|Period 1 (4 Weeks)|Other|1|||
13329312|NCT01122680|26592849|FG001|Period 1 (4 Weeks)|Other|1|||
13329313|NCT01122680|26592850|FG002|Period 1 (4 Weeks)|Other|0|||
13329314|NCT01122680|26592851|FG003|Period 1 (4 Weeks)|Other|0|||
13329315|NCT01122680|26592848|FG000|Period 2 (4 Weeks)|Protocol Violation|0|||
13329316|NCT01122680|26592849|FG001|Period 2 (4 Weeks)|Protocol Violation|0|||
13329317|NCT01122680|26592850|FG002|Period 2 (4 Weeks)|Protocol Violation|0|||
13329318|NCT01122680|26592851|FG003|Period 2 (4 Weeks)|Protocol Violation|1|||
13329319|NCT01122680|26592848|FG000|Period 2 (4 Weeks)|Other|1|||
13329320|NCT01122680|26592849|FG001|Period 2 (4 Weeks)|Other|0|||
13329321|NCT01122680|26592850|FG002|Period 2 (4 Weeks)|Other|0|||
13329322|NCT01122680|26592851|FG003|Period 2 (4 Weeks)|Other|0|||
13329323|NCT01122680|26592848|FG000|Period 3 (4 Weeks)|Adverse Event|1|||
13329324|NCT01122680|26592849|FG001|Period 3 (4 Weeks)|Adverse Event|0|||
13329325|NCT01122680|26592850|FG002|Period 3 (4 Weeks)|Adverse Event|0|||
13329326|NCT01122680|26592851|FG003|Period 3 (4 Weeks)|Adverse Event|0|||
13329327|NCT01122680|26592848|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
13329328|NCT01122680|26592849|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
13329329|NCT01122680|26592850|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
13329330|NCT01122680|26592851|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
13329331|NCT01122576|26592998|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0|||
13329332|NCT01122576|26592999|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1|||
13329333|NCT01122576|26593000|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2|||
13329334|NCT01122576|26592998|FG000|Post-Cataract Surgery|Central Macular Edema|0|||
13329335|NCT01122576|26592999|FG001|Post-Cataract Surgery|Central Macular Edema|0|||
13329336|NCT01122576|26593000|FG002|Post-Cataract Surgery|Central Macular Edema|1|||
13329337|NCT01122576|26592998|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0|||
13329338|NCT01122576|26592999|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0|||
13329339|NCT01122576|26593000|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1|||
13329340|NCT01122394|26593021|FG000|Overall Study|Withdrawal by Subject|1|||
13329341|NCT01122394|26593022|FG001|Overall Study|Withdrawal by Subject|1|||
13329342|NCT01122394|26593021|FG000|Overall Study|Lost to Follow-up|2|||
13329343|NCT01122394|26593022|FG001|Overall Study|Lost to Follow-up|2|||
13329344|NCT01122394|26593021|FG000|Overall Study|Adverse Event|0|||
13329345|NCT01122394|26593022|FG001|Overall Study|Adverse Event|1|||
13329346|NCT01122381|26593035|FG000|Overall Study|study terminated early|0|||
13329347|NCT01122381|26593036|FG001|Overall Study|study terminated early|1|||
13329348|NCT01122264|26593103|FG000|Overall Study|Adverse Event|6|||
13329349|NCT01122264|26593104|FG001|Overall Study|Adverse Event|5|||
13329350|NCT01122264|26593105|FG002|Overall Study|Adverse Event|7|||
13329351|NCT01122264|26593103|FG000|Overall Study|Death|1|||
13329352|NCT01122264|26593104|FG001|Overall Study|Death|0|||
13329353|NCT01122264|26593105|FG002|Overall Study|Death|0|||
13329354|NCT01122264|26593103|FG000|Overall Study|Lost to Follow-up|5|||
13486404|NCT03564145|27036051|FG000|Overall Study|Lost to Follow-up|21|||
13329355|NCT01122264|26593104|FG001|Overall Study|Lost to Follow-up|9|||
13329356|NCT01122264|26593105|FG002|Overall Study|Lost to Follow-up|13|||
13329357|NCT01122264|26593103|FG000|Overall Study|Entry Criteria Not Met|1|||
13329358|NCT01122264|26593104|FG001|Overall Study|Entry Criteria Not Met|0|||
13329359|NCT01122264|26593105|FG002|Overall Study|Entry Criteria Not Met|0|||
13329360|NCT01122264|26593103|FG000|Overall Study|Protocol Violation|7|||
13329361|NCT01122264|26593104|FG001|Overall Study|Protocol Violation|7|||
13329362|NCT01122264|26593105|FG002|Overall Study|Protocol Violation|9|||
13329363|NCT01122264|26593103|FG000|Overall Study|Withdrawal by Subject|6|||
13329364|NCT01122264|26593104|FG001|Overall Study|Withdrawal by Subject|6|||
13329365|NCT01122264|26593105|FG002|Overall Study|Withdrawal by Subject|16|||
13329366|NCT01122264|26593103|FG000|Overall Study|Physician Decision|3|||
13329367|NCT01122264|26593104|FG001|Overall Study|Physician Decision|1|||
13329368|NCT01122264|26593105|FG002|Overall Study|Physician Decision|1|||
13329369|NCT01122264|26593103|FG000|Overall Study|Lack of Efficacy|3|||
13329370|NCT01122264|26593104|FG001|Overall Study|Lack of Efficacy|1|||
13329371|NCT01122264|26593105|FG002|Overall Study|Lack of Efficacy|1|||
13329372|NCT01122173|26593114|FG000|Overall Study|Lost to Follow-up|3|||
13329373|NCT01122173|26593114|FG000|Overall Study|Withdrawal by Subject|3|||
13329374|NCT01122173|26593114|FG000|Overall Study|Left study for other reasons|3|||
13329375|NCT01121991|26593127|FG000|Overall Study|Lack of Ovarian Response|2|||
13329376|NCT01121991|26593127|FG000|Overall Study|No Oocytes Retrieved|3|||
13329377|NCT01121991|26593127|FG000|Overall Study|No Fertilization|1|||
13329378|NCT01121926|26593148|FG000|First Intervention Period|Adverse Event|1|||
13329379|NCT01121926|26593149|FG001|First Intervention Period|Adverse Event|0|||
13329380|NCT01121926|26593148|FG000|Washout Period|Adverse Event|0|||
13329381|NCT01121926|26593149|FG001|Washout Period|Adverse Event|1|||
13329382|NCT01121926|26593148|FG000|Washout Period|Positive pregnancy test|0|||
13329383|NCT01121926|26593149|FG001|Washout Period|Positive pregnancy test|1|||
13329384|NCT01121913|26593184|FG000|First Intervention Period|Adverse Event|0|||
13329385|NCT01121913|26593185|FG001|First Intervention Period|Adverse Event|0|||
13329386|NCT01121913|26593186|FG002|First Intervention Period|Adverse Event|1|||
13329387|NCT01121913|26593187|FG003|First Intervention Period|Adverse Event|0|||
13329388|NCT01121913|26593184|FG000|First Washout Period|Withdrawal by Subject|1|||
13329389|NCT01121913|26593185|FG001|First Washout Period|Withdrawal by Subject|0|||
13329390|NCT01121913|26593186|FG002|First Washout Period|Withdrawal by Subject|0|||
13329391|NCT01121913|26593187|FG003|First Washout Period|Withdrawal by Subject|0|||
13329392|NCT01121913|26593184|FG000|Second Intervention Period|Adverse Event|0|||
13329393|NCT01121913|26593185|FG001|Second Intervention Period|Adverse Event|0|||
13329394|NCT01121913|26593186|FG002|Second Intervention Period|Adverse Event|1|||
13329395|NCT01121913|26593187|FG003|Second Intervention Period|Adverse Event|0|||
13329396|NCT01121913|26593184|FG000|Second Washout Period|Withdrawal by Subject|0|||
13329397|NCT01121913|26593185|FG001|Second Washout Period|Withdrawal by Subject|0|||
13329398|NCT01121913|26593186|FG002|Second Washout Period|Withdrawal by Subject|1|||
13329399|NCT01121913|26593187|FG003|Second Washout Period|Withdrawal by Subject|0|||
13329400|NCT01121913|26593184|FG000|Third Washout Period|Adverse Event|1|||
13329401|NCT01121913|26593185|FG001|Third Washout Period|Adverse Event|0|||
13329402|NCT01121913|26593186|FG002|Third Washout Period|Adverse Event|0|||
13329403|NCT01121913|26593187|FG003|Third Washout Period|Adverse Event|0|||
13329404|NCT01121900|26593208|FG000|First Intervention Period|Adverse Event|1|||
13329405|NCT01121900|26593209|FG001|First Intervention Period|Adverse Event|1|||
13329406|NCT01121900|26593208|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
13329407|NCT01121900|26593209|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
13329408|NCT01121757|26593230|FG000|First Drug|Death|1|||
13329409|NCT01121757|26593231|FG001|First Drug|Death|0|||
13329410|NCT01121757|26593230|FG000|First Drug|Disease Progression|0|||
13329411|NCT01121757|26593231|FG001|First Drug|Disease Progression|2|||
13329412|NCT01121757|26593230|FG000|Combination|Physician Decision|0|||
13329413|NCT01121757|26593231|FG001|Combination|Physician Decision|1|||
13329414|NCT01121757|26593230|FG000|Combination|Disease Progression|2|||
13329415|NCT01121757|26593231|FG001|Combination|Disease Progression|0|||
13329416|NCT01121666|26593288|FG000|Overall Study|Protocol Violation|29|||
13329417|NCT01121666|26593289|FG001|Overall Study|Protocol Violation|10|||
13329418|NCT01121575|26593432|FG000|Overall Study|Participant Refused Further Follow-Up|0|||
13329419|NCT01121575|26593433|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
13329420|NCT01121575|26593434|FG002|Overall Study|Participant Refused Further Follow-Up|0|||
13329421|NCT01121575|26593435|FG003|Overall Study|Participant Refused Further Follow-Up|0|||
13329422|NCT01121575|26593436|FG004|Overall Study|Participant Refused Further Follow-Up|5|||
13329423|NCT01121575|26593437|FG005|Overall Study|Participant Refused Further Follow-Up|1|||
13329424|NCT01121575|26593432|FG000|Overall Study|Unspecified Reasons|8|||
13329425|NCT01121575|26593433|FG001|Overall Study|Unspecified Reasons|6|||
13329426|NCT01121575|26593434|FG002|Overall Study|Unspecified Reasons|7|||
13329427|NCT01121575|26593435|FG003|Overall Study|Unspecified Reasons|5|||
13329428|NCT01121575|26593436|FG004|Overall Study|Unspecified Reasons|13|||
13329429|NCT01121575|26593437|FG005|Overall Study|Unspecified Reasons|10|||
13329430|NCT01121575|26593432|FG000|Overall Study|Death|6|||
13329431|NCT01121575|26593433|FG001|Overall Study|Death|0|||
13329432|NCT01121575|26593434|FG002|Overall Study|Death|0|||
13329433|NCT01121575|26593435|FG003|Overall Study|Death|1|||
13329434|NCT01121575|26593436|FG004|Overall Study|Death|7|||
13329435|NCT01121575|26593437|FG005|Overall Study|Death|1|||
13329436|NCT01121562|26593448|FG000|Overall Study|Objective progression or relapse|8|||
13329437|NCT01121562|26593448|FG000|Overall Study|Withdrawal by Subject|1|||
13329438|NCT01121562|26593448|FG000|Overall Study|Adverse Event|1|||
13329439|NCT01121562|26593448|FG000|Overall Study|Sponsor Decision|1|||
13329440|NCT01121562|26593448|FG000|Overall Study|Met study discontinuation criteria|1|||
13329441|NCT01121549|26593461|FG000|Overall Study|Adverse Event|10|||
13329442|NCT01121549|26593461|FG000|Overall Study|Lack of Efficacy|11|||
13329443|NCT01121549|26593461|FG000|Overall Study|Lost to Follow-up|12|||
13329444|NCT01121549|26593461|FG000|Overall Study|Did not meet entrance criteria|9|||
13329445|NCT01121549|26593461|FG000|Overall Study|Study terminated by sponsor|197|||
13329446|NCT01121549|26593461|FG000|Overall Study|Pregnancy|1|||
13329447|NCT01121549|26593461|FG000|Overall Study|Protocol Violation|33|||
13329448|NCT01121549|26593461|FG000|Overall Study|Withdrawal by Subject|16|||
13329449|NCT01121549|26593461|FG000|Overall Study|Other|58|||
13329450|NCT01121536|26593482|FG000|Overall Study|Adverse Event|63|||
13329451|NCT01121536|26593482|FG000|Overall Study|Lack of Efficacy|35|||
13329452|NCT01121536|26593482|FG000|Overall Study|Withdrawal by Subject|65|||
13329453|NCT01121536|26593482|FG000|Overall Study|Protocol Violation|20|||
13329454|NCT01121536|26593482|FG000|Overall Study|Noncompliance with study medication|12|||
13329455|NCT01121536|26593482|FG000|Overall Study|Noncompliance with study procedures|9|||
13329456|NCT01121536|26593482|FG000|Overall Study|Lost to Follow-up|39|||
13329457|NCT01121536|26593482|FG000|Overall Study|Other|118|||
13329458|NCT01121484|26593505|FG000|Overall Study|Adverse Event|12|||
13329459|NCT01121484|26593506|FG001|Overall Study|Adverse Event|5|||
13329460|NCT01121484|26593505|FG000|Overall Study|Lack of Efficacy|3|||
13329461|NCT01121484|26593506|FG001|Overall Study|Lack of Efficacy|11|||
13329462|NCT01121484|26593505|FG000|Overall Study|Lost to Follow-up|5|||
13329463|NCT01121484|26593506|FG001|Overall Study|Lost to Follow-up|9|||
13329464|NCT01121484|26593505|FG000|Overall Study|Physician Decision|0|||
13329465|NCT01121484|26593506|FG001|Overall Study|Physician Decision|3|||
13329466|NCT01121484|26593505|FG000|Overall Study|Protocol Violation|1|||
13329467|NCT01121484|26593506|FG001|Overall Study|Protocol Violation|0|||
13329468|NCT01121484|26593505|FG000|Overall Study|Withdrawal by Subject|8|||
13329469|NCT01121484|26593506|FG001|Overall Study|Withdrawal by Subject|7|||
13329470|NCT01121484|26593505|FG000|Overall Study|Discontinuation of study by sponsor|0|||
13329471|NCT01121484|26593506|FG001|Overall Study|Discontinuation of study by sponsor|1|||
13329472|NCT01121484|26593505|FG000|Overall Study|Other|3|||
13329473|NCT01121484|26593506|FG001|Overall Study|Other|3|||
13329474|NCT01121484|26593505|FG000|Overall Study|Randomized, not treated|1|||
13329475|NCT01121484|26593506|FG001|Overall Study|Randomized, not treated|4|||
13329476|NCT01121406|26593561|FG000|Overall Study|Progressive disease RECIST|44|||
13329477|NCT01121406|26593562|FG001|Overall Study|Progressive disease RECIST|28|||
13329478|NCT01121406|26593561|FG000|Overall Study|Wors. or AE of underlying cancer disease|4|||
13329479|NCT01121406|26593562|FG001|Overall Study|Wors. or AE of underlying cancer disease|6|||
13329480|NCT01121406|26593561|FG000|Overall Study|Other AE|3|||
13329481|NCT01121406|26593562|FG001|Overall Study|Other AE|10|||
13329482|NCT01121406|26593561|FG000|Overall Study|Non-compliant with protocol|0|||
13329483|NCT01121406|26593562|FG001|Overall Study|Non-compliant with protocol|2|||
13329484|NCT01121406|26593561|FG000|Overall Study|Lost to Follow-up|0|||
13329485|NCT01121406|26593562|FG001|Overall Study|Lost to Follow-up|1|||
13329486|NCT01121406|26593561|FG000|Overall Study|Refused continuation of study med.|1|||
13329487|NCT01121406|26593562|FG001|Overall Study|Refused continuation of study med.|2|||
13329488|NCT01121406|26593561|FG000|Overall Study|Reason other than specified above|2|||
13329489|NCT01121406|26593562|FG001|Overall Study|Reason other than specified above|6|||
13329490|NCT01121406|26593561|FG000|Overall Study|Not treated|1|||
13329491|NCT01121406|26593562|FG001|Overall Study|Not treated|0|||
13329492|NCT01121393|26593612|FG000|Overall Study|Progressive disease|201|||
13329493|NCT01121393|26593613|FG001|Overall Study|Progressive disease|20|||
13329494|NCT01121393|26593612|FG000|Overall Study|Other Adverse events|24|||
13329495|NCT01121393|26593613|FG001|Overall Study|Other Adverse events|45|||
13329496|NCT01121393|26593612|FG000|Overall Study|Non-compliant with protocol|0|||
13329497|NCT01121393|26593613|FG001|Overall Study|Non-compliant with protocol|3|||
13329498|NCT01121393|26593612|FG000|Overall Study|Lost to Follow-up|1|||
13329499|NCT01121393|26593613|FG001|Overall Study|Lost to Follow-up|0|||
13329500|NCT01121393|26593612|FG000|Overall Study|Refused cont. medication|7|||
13329501|NCT01121393|26593613|FG001|Overall Study|Refused cont. medication|7|||
13329502|NCT01121393|26593612|FG000|Overall Study|Not treated|3|||
13329503|NCT01121393|26593613|FG001|Overall Study|Not treated|9|||
13329504|NCT01121393|26593612|FG000|Overall Study|Other than listed|6|||
13329505|NCT01121393|26593613|FG001|Overall Study|Other than listed|0|||
13329506|NCT01121263|26593628|FG000|Overall Study|Death|3|||
13329507|NCT01121263|26593629|FG001|Overall Study|Death|2|||
13329508|NCT01121263|26593628|FG000|Overall Study|Lost to Follow-up|22|||
13329509|NCT01121263|26593629|FG001|Overall Study|Lost to Follow-up|12|||
13329510|NCT01121263|26593628|FG000|Overall Study|Withdrawal by Subject|0|||
13329511|NCT01121263|26593629|FG001|Overall Study|Withdrawal by Subject|1|||
13329512|NCT01121185|26593658|FG000|Overall Study|Not infused|0|||
13329513|NCT01121185|26593659|FG001|Overall Study|Not infused|1|||
13329514|NCT01121185|26593658|FG000|Overall Study|Not transplanted|1|||
13329515|NCT01121185|26593659|FG001|Overall Study|Not transplanted|0|||
13329516|NCT01121146|26593680|FG000|Overall Study|Death|17|||
13329517|NCT01121146|26593681|FG001|Overall Study|Death|15|||
13329518|NCT01121146|26593680|FG000|Overall Study|Adverse Event|2|||
13329519|NCT01121146|26593681|FG001|Overall Study|Adverse Event|11|||
13329520|NCT01121146|26593680|FG000|Overall Study|Lost to Follow-up|7|||
13329521|NCT01121146|26593681|FG001|Overall Study|Lost to Follow-up|16|||
13329522|NCT01120964|26593728|FG000|Overall Study|Did not receive full treatment|1|||
13329523|NCT01120964|26593729|FG001|Overall Study|Did not receive full treatment|0|||
13329524|NCT01120899|26593751|FG000|Overall Study|Withdrawal by Subject|3|||
13329525|NCT01120782|26593757|FG000|Overall Study|Test article shipping error|11|||
13329526|NCT01120756|26593772|FG000|Overall Study|Withdrawal by Subject|1|||
13329527|NCT01120756|26593773|FG001|Overall Study|Withdrawal by Subject|1|||
13329528|NCT01120717|26593796|FG000|Overall Study|Withdrawal by Subject|11|||
13329529|NCT01120717|26593797|FG001|Overall Study|Withdrawal by Subject|6|||
13329530|NCT01120717|26593796|FG000|Overall Study|Adverse Event|10|||
13329531|NCT01120717|26593797|FG001|Overall Study|Adverse Event|6|||
13329532|NCT01120717|26593796|FG000|Overall Study|Protocol Deviation|2|||
13329533|NCT01120717|26593797|FG001|Overall Study|Protocol Deviation|5|||
13329534|NCT01120717|26593796|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
13329535|NCT01120717|26593797|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
13329536|NCT01120717|26593796|FG000|Overall Study|Lost to Follow-up|2|||
13329537|NCT01120717|26593797|FG001|Overall Study|Lost to Follow-up|3|||
13329538|NCT01120717|26593796|FG000|Overall Study|Death|3|||
13329539|NCT01120717|26593797|FG001|Overall Study|Death|1|||
13329540|NCT01120717|26593796|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
13329541|NCT01120717|26593797|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
13329542|NCT01120691|26593849|FG000|Overall Study|Adverse Event|59|||
13329543|NCT01120691|26593850|FG001|Overall Study|Adverse Event|67|||
13329544|NCT01120691|26593851|FG002|Overall Study|Adverse Event|47|||
13329545|NCT01120691|26593849|FG000|Overall Study|Subject withdrew consent|33|||
13329546|NCT01120691|26593850|FG001|Overall Study|Subject withdrew consent|50|||
13329547|NCT01120691|26593851|FG002|Overall Study|Subject withdrew consent|44|||
13329548|NCT01120691|26593849|FG000|Overall Study|Death|21|||
13329549|NCT01120691|26593850|FG001|Overall Study|Death|22|||
13329550|NCT01120691|26593851|FG002|Overall Study|Death|24|||
13329551|NCT01120691|26593849|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
13329552|NCT01120691|26593850|FG001|Overall Study|Unsatisfactory therapeutic effect|32|||
13329553|NCT01120691|26593851|FG002|Overall Study|Unsatisfactory therapeutic effect|38|||
13329554|NCT01120691|26593849|FG000|Overall Study|Administrative problems|15|||
13329555|NCT01120691|26593850|FG001|Overall Study|Administrative problems|8|||
13329556|NCT01120691|26593851|FG002|Overall Study|Administrative problems|9|||
13329557|NCT01120691|26593849|FG000|Overall Study|Protocol deviation|13|||
13329558|NCT01120691|26593850|FG001|Overall Study|Protocol deviation|12|||
13329559|NCT01120691|26593851|FG002|Overall Study|Protocol deviation|12|||
13329560|NCT01120691|26593849|FG000|Overall Study|Lost to Follow-up|5|||
13329561|NCT01120691|26593850|FG001|Overall Study|Lost to Follow-up|6|||
13329562|NCT01120691|26593851|FG002|Overall Study|Lost to Follow-up|4|||
13329563|NCT01120691|26593849|FG000|Overall Study|Abnormal test procedure result(s)|3|||
13329564|NCT01120691|26593850|FG001|Overall Study|Abnormal test procedure result(s)|2|||
13329565|NCT01120691|26593851|FG002|Overall Study|Abnormal test procedure result(s)|1|||
13329566|NCT01120691|26593849|FG000|Overall Study|Patient's inability to use the device|3|||
13329567|NCT01120691|26593850|FG001|Overall Study|Patient's inability to use the device|1|||
13329568|NCT01120691|26593851|FG002|Overall Study|Patient's inability to use the device|0|||
13329569|NCT01120691|26593849|FG000|Overall Study|Abnormal laboratory value(s)|1|||
13329570|NCT01120691|26593850|FG001|Overall Study|Abnormal laboratory value(s)|3|||
13329571|NCT01120691|26593851|FG002|Overall Study|Abnormal laboratory value(s)|4|||
13329572|NCT01120626|26593866|FG000|Overall Study|Withdrawal by Subject|1|||
13329573|NCT01120626|26593867|FG001|Overall Study|Withdrawal by Subject|0|||
13329574|NCT01120600|26593898|FG000|Overall Study|Adverse Event|7|||
13329575|NCT01120600|26593899|FG001|Overall Study|Adverse Event|7|||
13329576|NCT01120600|26593898|FG000|Overall Study|Excessive Bone Loss|0|||
13329577|NCT01120600|26593899|FG001|Overall Study|Excessive Bone Loss|4|||
13329578|NCT01120600|26593898|FG000|Overall Study|Lost to Follow-up|1|||
13329579|NCT01120600|26593899|FG001|Overall Study|Lost to Follow-up|3|||
13329580|NCT01120600|26593898|FG000|Overall Study|Physician Decision|1|||
13329581|NCT01120600|26593899|FG001|Overall Study|Physician Decision|3|||
13329582|NCT01120600|26593898|FG000|Overall Study|Protocol Violation|0|||
13329583|NCT01120600|26593899|FG001|Overall Study|Protocol Violation|4|||
13329584|NCT01120600|26593898|FG000|Overall Study|Withdrawal by Subject|10|||
13329585|NCT01120600|26593899|FG001|Overall Study|Withdrawal by Subject|11|||
13329586|NCT01120379|26593937|FG000|One Year Timepoint|Withdrawal by Subject|41|||
13329587|NCT01120379|26593937|FG000|One Year Timepoint|Lost to Follow-up|115|||
13329588|NCT01120379|26593937|FG000|One Year Timepoint|Death|108|||
13329589|NCT01120379|26593937|FG000|One Year Timepoint|Physician Decision|9|||
13329590|NCT01120379|26593937|FG000|One Year Timepoint|Any other reason for early termination|5|||
13329591|NCT01120379|26593937|FG000|Two Year Timepoint|Withdrawal by Subject|11|||
13329592|NCT01120379|26593937|FG000|Two Year Timepoint|Lost to Follow-up|87|||
13329593|NCT01120379|26593937|FG000|Two Year Timepoint|Death|123|||
13329594|NCT01120379|26593937|FG000|Two Year Timepoint|Physician Decision|12|||
13329595|NCT01120379|26593937|FG000|Two Year Timepoint|Any other reason for early termination|4|||
13329596|NCT01120379|26593937|FG000|Three Year Timepoint|Withdrawal by Subject|25|||
13329597|NCT01120379|26593937|FG000|Three Year Timepoint|Lost to Follow-up|43|||
13329598|NCT01120379|26593937|FG000|Three Year Timepoint|Death|120|||
13329599|NCT01120379|26593937|FG000|Three Year Timepoint|Physician Decision|9|||
13329600|NCT01120379|26593937|FG000|Three Year Timepoint|Any other reason for early termination|17|||
13329601|NCT01120379|26593937|FG000|Four Year Timepoint|Withdrawal by Subject|5|||
13329602|NCT01120379|26593937|FG000|Four Year Timepoint|Lost to Follow-up|10|||
13329603|NCT01120379|26593937|FG000|Four Year Timepoint|Death|131|||
13329604|NCT01120379|26593937|FG000|Four Year Timepoint|Physician Decision|5|||
13329605|NCT01120379|26593937|FG000|Four Year Timepoint|Any other reason for early termination|217|||
13329606|NCT01120275|26593946|FG000|Overall Study|Adverse Event|3|||
13329607|NCT01120275|26593946|FG000|Overall Study|Progression|27|||
13329608|NCT01120275|26593946|FG000|Overall Study|Ineligible|3|||
13329609|NCT01120275|26593946|FG000|Overall Study|Withdrawal by Subject|1|||
13329610|NCT01120275|26593946|FG000|Overall Study|Refusal|1|||
13329611|NCT01120275|26593946|FG000|Overall Study|Not specific|1|||
13329612|NCT01120210|26593983|FG000|MAIN INFUSION|Adverse Event|1|||
13329613|NCT01120210|26593984|FG001|MAIN INFUSION|Adverse Event|0|||
13329614|NCT01120210|26593983|FG000|MAIN INFUSION|Withdrawal by Subject|0|||
13329615|NCT01120210|26593984|FG001|MAIN INFUSION|Withdrawal by Subject|1|||
13329616|NCT01120184|26594116|FG000|Overall Study|Adverse Event|0|||
13329617|NCT01120184|26594117|FG001|Overall Study|Adverse Event|1|||
13329618|NCT01120184|26594118|FG002|Overall Study|Adverse Event|0|||
13329619|NCT01120184|26594116|FG000|Overall Study|Lost to Follow-up|13|||
13329620|NCT01120184|26594117|FG001|Overall Study|Lost to Follow-up|13|||
13329621|NCT01120184|26594118|FG002|Overall Study|Lost to Follow-up|11|||
13329622|NCT01120184|26594116|FG000|Overall Study|Physician Decision|9|||
13329623|NCT01120184|26594117|FG001|Overall Study|Physician Decision|1|||
13329624|NCT01120184|26594118|FG002|Overall Study|Physician Decision|3|||
13329625|NCT01120184|26594116|FG000|Overall Study|Reason not Specified|8|||
13329626|NCT01120184|26594117|FG001|Overall Study|Reason not Specified|3|||
13329627|NCT01120184|26594118|FG002|Overall Study|Reason not Specified|12|||
13329628|NCT01120184|26594116|FG000|Overall Study|Sponsor Decision to Terminate Study|133|||
13329629|NCT01120184|26594117|FG001|Overall Study|Sponsor Decision to Terminate Study|144|||
13329630|NCT01120184|26594118|FG002|Overall Study|Sponsor Decision to Terminate Study|143|||
13329631|NCT01120184|26594116|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32|||
13329632|NCT01120184|26594117|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29|||
13329633|NCT01120184|26594118|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25|||
13329634|NCT01120184|26594116|FG000|Overall Study|Death|170|||
13329635|NCT01120184|26594117|FG001|Overall Study|Death|176|||
13329636|NCT01120184|26594118|FG002|Overall Study|Death|169|||
13329637|NCT01120093|26594151|FG000|Treatment Period 1|Adverse Event|0|||
13329638|NCT01120093|26594152|FG001|Treatment Period 1|Adverse Event|0|||
13329639|NCT01120093|26594153|FG002|Treatment Period 1|Adverse Event|1|||
13329640|NCT01120093|26594154|FG003|Treatment Period 1|Adverse Event|0|||
13329641|NCT01120093|26594155|FG004|Treatment Period 1|Adverse Event|1|||
13329642|NCT01120093|26594151|FG000|Treatment Period 1|Withdrawal by Subject|0|||
13329643|NCT01120093|26594152|FG001|Treatment Period 1|Withdrawal by Subject|1|||
13329644|NCT01120093|26594153|FG002|Treatment Period 1|Withdrawal by Subject|0|||
13329645|NCT01120093|26594154|FG003|Treatment Period 1|Withdrawal by Subject|0|||
13329646|NCT01120093|26594155|FG004|Treatment Period 1|Withdrawal by Subject|0|||
13329647|NCT01120093|26594151|FG000|Treatment Period 2|Adverse Event|0|||
13329648|NCT01120093|26594152|FG001|Treatment Period 2|Adverse Event|0|||
13329649|NCT01120093|26594153|FG002|Treatment Period 2|Adverse Event|0|||
13329650|NCT01120093|26594154|FG003|Treatment Period 2|Adverse Event|1|||
13329651|NCT01120093|26594155|FG004|Treatment Period 2|Adverse Event|0|||
13329652|NCT01120093|26594151|FG000|Treatment Period 2|Withdrawal by Subject|0|||
13329653|NCT01120093|26594152|FG001|Treatment Period 2|Withdrawal by Subject|0|||
13329654|NCT01120093|26594153|FG002|Treatment Period 2|Withdrawal by Subject|0|||
13329655|NCT01120093|26594154|FG003|Treatment Period 2|Withdrawal by Subject|0|||
13329656|NCT01120093|26594155|FG004|Treatment Period 2|Withdrawal by Subject|1|||
13329657|NCT01120093|26594151|FG000|Treatment Period 3|Lack of Efficacy|0|||
13329658|NCT01120093|26594152|FG001|Treatment Period 3|Lack of Efficacy|0|||
13329659|NCT01120093|26594153|FG002|Treatment Period 3|Lack of Efficacy|0|||
13329660|NCT01120093|26594154|FG003|Treatment Period 3|Lack of Efficacy|1|||
13329661|NCT01120093|26594155|FG004|Treatment Period 3|Lack of Efficacy|0|||
13329662|NCT01120093|26594151|FG000|Treatment Period 3|Adverse Event|0|||
13329663|NCT01120093|26594152|FG001|Treatment Period 3|Adverse Event|0|||
13329664|NCT01120093|26594153|FG002|Treatment Period 3|Adverse Event|0|||
13329665|NCT01120093|26594154|FG003|Treatment Period 3|Adverse Event|0|||
13329666|NCT01120093|26594155|FG004|Treatment Period 3|Adverse Event|1|||
13329667|NCT01120093|26594151|FG000|Treatment Period 3|Withdrawal by Subject|0|||
13329668|NCT01120093|26594152|FG001|Treatment Period 3|Withdrawal by Subject|0|||
13329669|NCT01120093|26594153|FG002|Treatment Period 3|Withdrawal by Subject|1|||
13329670|NCT01120093|26594154|FG003|Treatment Period 3|Withdrawal by Subject|0|||
13329671|NCT01120093|26594155|FG004|Treatment Period 3|Withdrawal by Subject|0|||
13329672|NCT01120093|26594151|FG000|Treatment Period 4|Adverse Event|1|||
13329673|NCT01120093|26594152|FG001|Treatment Period 4|Adverse Event|0|||
13329674|NCT01120093|26594153|FG002|Treatment Period 4|Adverse Event|0|||
13329675|NCT01120093|26594154|FG003|Treatment Period 4|Adverse Event|0|||
13329676|NCT01120093|26594155|FG004|Treatment Period 4|Adverse Event|0|||
13329677|NCT01120093|26594151|FG000|Treatment Period 5|Adverse Event|0|||
13329678|NCT01120093|26594152|FG001|Treatment Period 5|Adverse Event|1|||
13329679|NCT01120093|26594153|FG002|Treatment Period 5|Adverse Event|0|||
13329680|NCT01120093|26594154|FG003|Treatment Period 5|Adverse Event|1|||
13329681|NCT01120093|26594155|FG004|Treatment Period 5|Adverse Event|0|||
13329682|NCT01120067|26594168|FG000|Overall Study|Lost to Follow-up|3|||
13329683|NCT01120067|26594169|FG001|Overall Study|Lost to Follow-up|1|||
13329684|NCT01120067|26594168|FG000|Overall Study|fail to engage >3 sessions|2|||
13329685|NCT01120067|26594169|FG001|Overall Study|fail to engage >3 sessions|0|||
13329686|NCT01120028|26594204|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
13329687|NCT01120028|26594205|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5|||
13329688|NCT01120028|26594206|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
13329689|NCT01120028|26594207|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
13329690|NCT01120028|26594204|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14|||
13329691|NCT01120028|26594205|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18|||
13329692|NCT01120028|26594206|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
13329693|NCT01120028|26594207|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
13329694|NCT01119963|26594224|FG000|Overall Study|Lost to Follow-up|1|||
13329695|NCT01119963|26594225|FG001|Overall Study|Lost to Follow-up|1|||
13329696|NCT01119950|26594472|FG000|Overall Study|Adverse Event|25|||
13329697|NCT01119950|26594472|FG000|Overall Study|Withdrawal by Subject|9|||
13329698|NCT01119950|26594472|FG000|Overall Study|Protocol Violation|5|||
13329699|NCT01119950|26594472|FG000|Overall Study|Lost to Follow-up|4|||
13329700|NCT01119950|26594472|FG000|Overall Study|Administrative|2|||
13329701|NCT01119950|26594472|FG000|Overall Study|Abnormal lab value|1|||
13329702|NCT01119950|26594472|FG000|Overall Study|Death|1|||
13329703|NCT01119937|26594505|FG000|Overall Study|Adverse Event|11|||
13329704|NCT01119937|26594506|FG001|Overall Study|Adverse Event|5|||
13329705|NCT01119937|26594505|FG000|Overall Study|Protocol deviation|3|||
13329706|NCT01119937|26594506|FG001|Overall Study|Protocol deviation|1|||
13329707|NCT01119937|26594505|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
13329708|NCT01119937|26594506|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
13329709|NCT01119937|26594505|FG000|Overall Study|Withdrawal by Subject|2|||
13329710|NCT01119937|26594506|FG001|Overall Study|Withdrawal by Subject|1|||
13329711|NCT01119898|26594537|FG000|Overall Study|Adverse Event|4|||
13329712|NCT01119898|26594538|FG001|Overall Study|Adverse Event|5|||
13329713|NCT01119898|26594537|FG000|Overall Study|Withdrawal by Subject|1|||
13329714|NCT01119898|26594538|FG001|Overall Study|Withdrawal by Subject|4|||
13329715|NCT01119898|26594537|FG000|Overall Study|Lack of Efficacy|0|||
13329716|NCT01119898|26594538|FG001|Overall Study|Lack of Efficacy|2|||
13329717|NCT01119898|26594537|FG000|Overall Study|Protocol Violation|1|||
13329718|NCT01119898|26594538|FG001|Overall Study|Protocol Violation|1|||
13329719|NCT01119898|26594537|FG000|Overall Study|Medical procedure|1|||
13329720|NCT01119898|26594538|FG001|Overall Study|Medical procedure|0|||
13329721|NCT01119898|26594537|FG000|Overall Study|Randomized in error did not participate|1|||
13329722|NCT01119898|26594538|FG001|Overall Study|Randomized in error did not participate|0|||
13329723|NCT01119859|26594561|FG000|Overall Study|Adverse Event|9|||
13329724|NCT01119859|26594562|FG001|Overall Study|Adverse Event|10|||
13329725|NCT01119859|26594561|FG000|Overall Study|Death|2|||
13329726|NCT01119859|26594562|FG001|Overall Study|Death|0|||
13329727|NCT01119859|26594561|FG000|Overall Study|Insufficient therapeutic response|7|||
13329728|NCT01119859|26594562|FG001|Overall Study|Insufficient therapeutic response|14|||
13329729|NCT01119859|26594561|FG000|Overall Study|Refused treatment|3|||
13329730|NCT01119859|26594562|FG001|Overall Study|Refused treatment|6|||
13329731|NCT01119859|26594561|FG000|Overall Study|Failure to return|3|||
13329732|NCT01119859|26594562|FG001|Overall Study|Failure to return|0|||
13329733|NCT01119846|26594780|FG000|Overall Study|Adverse Event|1|||
13329734|NCT01119846|26594781|FG001|Overall Study|Adverse Event|0|||
13329735|NCT01119846|26594782|FG002|Overall Study|Adverse Event|6|||
13329736|NCT01119846|26594780|FG000|Overall Study|Physician Decision|1|||
13329737|NCT01119846|26594781|FG001|Overall Study|Physician Decision|0|||
13329738|NCT01119846|26594782|FG002|Overall Study|Physician Decision|0|||
13329739|NCT01119846|26594780|FG000|Overall Study|Protocol Violation|0|||
13329740|NCT01119846|26594781|FG001|Overall Study|Protocol Violation|0|||
13329741|NCT01119846|26594782|FG002|Overall Study|Protocol Violation|1|||
13329742|NCT01119846|26594780|FG000|Overall Study|Withdrawal by Subject|0|||
13329743|NCT01119846|26594781|FG001|Overall Study|Withdrawal by Subject|0|||
13329744|NCT01119846|26594782|FG002|Overall Study|Withdrawal by Subject|4|||
13329745|NCT01119768|26594811|FG000|Treatment Period|Lack of Efficacy|18|||
13329746|NCT01119768|26594812|FG001|Treatment Period|Lack of Efficacy|25|||
13329747|NCT01119703|26594831|FG000|Overall Study|Adverse Event|0|||
13329748|NCT01119703|26594832|FG001|Overall Study|Adverse Event|1|||
13329749|NCT01119625|26594879|FG000|Overall Study|Lost to Follow-up|1|||
13329750|NCT01119625|26594880|FG001|Overall Study|Lost to Follow-up|2|||
13329751|NCT01119625|26594879|FG000|Overall Study|Withdrawal by Subject|2|||
13329752|NCT01119625|26594880|FG001|Overall Study|Withdrawal by Subject|1|||
13329753|NCT01119625|26594879|FG000|Overall Study|Other|0|||
13329754|NCT01119625|26594880|FG001|Overall Study|Other|1|||
13329755|NCT01119508|26594886|FG000|Overall Study|Adverse Event|56|||
13329756|NCT01119508|26594886|FG000|Overall Study|Withdrawal by Subject|2|||
13329757|NCT01119508|26594886|FG000|Overall Study|Died before tumor response evaluation|1|||
13329758|NCT01119443|26594930|FG000|Crossover Period 1 (5 Days)|Adverse Event|0|||
13329759|NCT01119443|26594931|FG001|Crossover Period 1 (5 Days)|Adverse Event|1|||
13329760|NCT01119287|26594963|FG000|Overall Study|Patient Decision, not related to AE|0|||
13329761|NCT01119287|26594964|FG001|Overall Study|Patient Decision, not related to AE|0|||
13329762|NCT01119287|26594965|FG002|Overall Study|Patient Decision, not related to AE|2|||
13329763|NCT01119287|26594966|FG003|Overall Study|Patient Decision, not related to AE|2|||
13329764|NCT01119287|26594967|FG004|Overall Study|Patient Decision, not related to AE|1|||
13329765|NCT01119287|26594968|FG005|Overall Study|Patient Decision, not related to AE|0|||
13373703|NCT00800202|26724599|FG000|Overall Study|Adverse Event|7|||
13373704|NCT00800202|26724600|FG001|Overall Study|Adverse Event|6|||
13373705|NCT00800202|26724599|FG000|Overall Study|Death|1|||
13373706|NCT00800202|26724600|FG001|Overall Study|Death|0|||
13373707|NCT00800202|26724599|FG000|Overall Study|Other|5|||
13373708|NCT00800202|26724600|FG001|Overall Study|Other|0|||
13373709|NCT00800202|26724599|FG000|Overall Study|Disease Progression|54|||
13373710|NCT00800202|26724600|FG001|Overall Study|Disease Progression|18|||
13373711|NCT00800176|26724693|FG000|Overall Study|Adverse Event|2|||
13373712|NCT00800176|26724694|FG001|Overall Study|Adverse Event|1|||
13373713|NCT00800176|26724695|FG002|Overall Study|Adverse Event|0|||
13373714|NCT00800176|26724696|FG003|Overall Study|Adverse Event|2|||
13373715|NCT00800176|26724697|FG004|Overall Study|Adverse Event|1|||
13373716|NCT00800176|26724698|FG005|Overall Study|Adverse Event|1|||
13373717|NCT00800176|26724693|FG000|Overall Study|Refused treatment|3|||
13373718|NCT00800176|26724694|FG001|Overall Study|Refused treatment|2|||
13373719|NCT00800176|26724695|FG002|Overall Study|Refused treatment|0|||
13373720|NCT00800176|26724696|FG003|Overall Study|Refused treatment|0|||
13373721|NCT00800176|26724697|FG004|Overall Study|Refused treatment|1|||
13373722|NCT00800176|26724698|FG005|Overall Study|Refused treatment|4|||
13373723|NCT00800176|26724693|FG000|Overall Study|Failure to return|3|||
13373724|NCT00800176|26724694|FG001|Overall Study|Failure to return|3|||
13373725|NCT00800176|26724695|FG002|Overall Study|Failure to return|0|||
13373726|NCT00800176|26724696|FG003|Overall Study|Failure to return|2|||
13373727|NCT00800176|26724697|FG004|Overall Study|Failure to return|0|||
13373728|NCT00800176|26724698|FG005|Overall Study|Failure to return|0|||
13373729|NCT00800176|26724693|FG000|Overall Study|Other|1|||
13373730|NCT00800176|26724694|FG001|Overall Study|Other|0|||
13373731|NCT00800176|26724695|FG002|Overall Study|Other|0|||
13373732|NCT00800176|26724696|FG003|Overall Study|Other|0|||
13373733|NCT00800176|26724697|FG004|Overall Study|Other|2|||
13373734|NCT00800176|26724698|FG005|Overall Study|Other|0|||
13373735|NCT00799903|26724725|FG000|Overall Study|Investigator Site Closed|25|||
13373736|NCT00799903|26724726|FG001|Overall Study|Investigator Site Closed|23|||
13373737|NCT00799903|26724725|FG000|Overall Study|Withdrawal by Subject|179|||
13373738|NCT00799903|26724726|FG001|Overall Study|Withdrawal by Subject|175|||
13373739|NCT00799903|26724725|FG000|Overall Study|Lost to Follow-up|69|||
13373740|NCT00799903|26724726|FG001|Overall Study|Lost to Follow-up|80|||
13373741|NCT00799825|26724734|FG000|Overall Study|Adverse Event|1|||
13373742|NCT00799825|26724734|FG000|Overall Study|Withdrawal by Subject|6|||
13373743|NCT00799825|26724734|FG000|Overall Study|Lost to Follow-up|38|||
13373744|NCT00799825|26724734|FG000|Overall Study|Pregnancy|3|||
13373745|NCT00799708|26724754|FG000|Overall Study|non-compliance|1|||
13373746|NCT00799708|26724755|FG001|Overall Study|non-compliance|0|||
13373747|NCT00799708|26724756|FG002|Overall Study|non-compliance|0|||
13373748|NCT00799617|26724841|FG000|Main Testosterone Trial|Randomized in error|1|||
13373749|NCT00799617|26724842|FG001|Main Testosterone Trial|Randomized in error|1|||
13373750|NCT00799617|26724841|FG000|Main Testosterone Trial|Lost to Follow-up|18|||
13373751|NCT00799617|26724842|FG001|Main Testosterone Trial|Lost to Follow-up|20|||
13373752|NCT00799617|26724841|FG000|Sexual Funtion Trial|Lost to Follow-up|12|||
13373753|NCT00799617|26724842|FG001|Sexual Funtion Trial|Lost to Follow-up|14|||
13373754|NCT00799617|26724841|FG000|Sexual Funtion Trial|No Baseline Data|4|||
13373755|NCT00799617|26724842|FG001|Sexual Funtion Trial|No Baseline Data|7|||
13373756|NCT00799617|26724841|FG000|Physical Function Trial|Lost to Follow-up|6|||
13373757|NCT00799617|26724842|FG001|Physical Function Trial|Lost to Follow-up|11|||
13373758|NCT00799617|26724841|FG000|Vitality Trial|Lost to Follow-up|7|||
13373759|NCT00799617|26724842|FG001|Vitality Trial|Lost to Follow-up|22|||
13373760|NCT00799617|26724841|FG000|Cardiovascular Trial|Month 12 scan not available|15|||
13373761|NCT00799617|26724842|FG001|Cardiovascular Trial|Month 12 scan not available|15|||
13373762|NCT00799617|26724841|FG000|Cardiovascular Trial|Baseline scan not analyzable|0|||
13373763|NCT00799617|26724842|FG001|Cardiovascular Trial|Baseline scan not analyzable|2|||
13373764|NCT00799617|26724841|FG000|Bone Trial|Month 12 scan not available|6|||
13486405|NCT03564145|27036051|FG000|Overall Study|Protocol Violation|2|||
13329766|NCT01119248|26594976|FG000|Overall Study|Physician Decision|5|||
13329767|NCT01119131|26595015|FG000|Overall Study|Adverse Event|1|||
13329768|NCT01119131|26595016|FG001|Overall Study|Adverse Event|1|||
13329769|NCT01119131|26595017|FG002|Overall Study|Adverse Event|1|||
13329770|NCT01119131|26595015|FG000|Overall Study|Non-Compliance|1|||
13329771|NCT01119131|26595016|FG001|Overall Study|Non-Compliance|0|||
13329772|NCT01119131|26595017|FG002|Overall Study|Non-Compliance|4|||
13329773|NCT01119131|26595015|FG000|Overall Study|Physician Decision|0|||
13329774|NCT01119131|26595016|FG001|Overall Study|Physician Decision|0|||
13329775|NCT01119131|26595017|FG002|Overall Study|Physician Decision|1|||
13329776|NCT01119118|26595027|FG000|Overall Study|Adverse Event|1|||
13329777|NCT01119105|26595048|FG000|Overall Study|Withdrawal by Subject|1|||
13329778|NCT01119105|26595049|FG001|Overall Study|Withdrawal by Subject|1|||
13329779|NCT01119105|26595050|FG002|Overall Study|Withdrawal by Subject|1|||
13329780|NCT01119105|26595048|FG000|Overall Study|Lost to Follow-up|0|||
13329781|NCT01119105|26595049|FG001|Overall Study|Lost to Follow-up|2|||
13329782|NCT01119105|26595050|FG002|Overall Study|Lost to Follow-up|5|||
13329783|NCT01119105|26595048|FG000|Overall Study|Adverse Event|1|||
13329784|NCT01119105|26595049|FG001|Overall Study|Adverse Event|0|||
13329785|NCT01119105|26595050|FG002|Overall Study|Adverse Event|1|||
13329786|NCT01119105|26595048|FG000|Overall Study|study drug missed on 2 consecutive days|1|||
13329787|NCT01119105|26595049|FG001|Overall Study|study drug missed on 2 consecutive days|2|||
13329788|NCT01119105|26595050|FG002|Overall Study|study drug missed on 2 consecutive days|1|||
13329789|NCT01119105|26595048|FG000|Overall Study|Other|1|||
13329790|NCT01119105|26595049|FG001|Overall Study|Other|1|||
13329791|NCT01119105|26595050|FG002|Overall Study|Other|0|||
13329792|NCT01119066|26595105|FG000|Overall Study|Withdrawal by Subject|4|||
13329793|NCT01119066|26595106|FG001|Overall Study|Withdrawal by Subject|6|||
13329794|NCT01119066|26595107|FG002|Overall Study|Withdrawal by Subject|0|||
13329795|NCT01119066|26595108|FG003|Overall Study|Withdrawal by Subject|0|||
13329796|NCT01119066|26595105|FG000|Overall Study|Concern regarding adequacy of transplant cell dose|2|||
13329797|NCT01119066|26595106|FG001|Overall Study|Concern regarding adequacy of transplant cell dose|1|||
13329798|NCT01119066|26595107|FG002|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
13329799|NCT01119066|26595108|FG003|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
13329800|NCT01119066|26595105|FG000|Overall Study|Relapse identified before transplant|1|||
13329801|NCT01119066|26595106|FG001|Overall Study|Relapse identified before transplant|0|||
13329802|NCT01119066|26595107|FG002|Overall Study|Relapse identified before transplant|0|||
13329803|NCT01119066|26595108|FG003|Overall Study|Relapse identified before transplant|0|||
13329804|NCT01119066|26595105|FG000|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
13329805|NCT01119066|26595106|FG001|Overall Study|Intercurrent medication condition rendered patient ineligible|3|||
13329806|NCT01119066|26595107|FG002|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
13329807|NCT01119066|26595108|FG003|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
13329808|NCT01119066|26595105|FG000|Overall Study|Relapse identified before transplant|0|||
13329809|NCT01119066|26595106|FG001|Overall Study|Relapse identified before transplant|4|||
13329810|NCT01119066|26595107|FG002|Overall Study|Relapse identified before transplant|0|||
13329811|NCT01119066|26595108|FG003|Overall Study|Relapse identified before transplant|0|||
13329812|NCT01119001|26595116|FG000|Overall Study|Withdrawal by Subject|2|||
13329813|NCT01118975|26595129|FG000|Overall Study|Adverse Event|0|||
13329814|NCT01118975|26595130|FG001|Overall Study|Adverse Event|1|||
13329815|NCT01118962|26595137|FG000|Overall Study|Adverse Event|2|||
13329816|NCT01118962|26595137|FG000|Overall Study|Lack of Efficacy|1|||
13329817|NCT01118962|26595137|FG000|Overall Study|Protocol Violation|1|||
13329818|NCT01118962|26595137|FG000|Overall Study|Withdrawal by Subject|4|||
13329819|NCT01118962|26595137|FG000|Overall Study|Pregnancy|1|||
13329820|NCT01118962|26595137|FG000|Overall Study|Non-compliance with Medicinal Product|1|||
13329821|NCT01118949|26595148|FG000|Overall Study|Adverse Event|5|||
13329822|NCT01118949|26595148|FG000|Overall Study|Withdrawal by Subject|4|||
13329823|NCT01118780|26595202|FG000|Overall Study|Adverse Event|15|||
13329824|NCT01118780|26595203|FG001|Overall Study|Adverse Event|15|||
13329825|NCT01118780|26595202|FG000|Overall Study|Death|1|||
13329826|NCT01118780|26595203|FG001|Overall Study|Death|0|||
13329827|NCT01118780|26595202|FG000|Overall Study|Lack of Efficacy|2|||
13329828|NCT01118780|26595203|FG001|Overall Study|Lack of Efficacy|6|||
13329829|NCT01118780|26595202|FG000|Overall Study|Physician Decision|2|||
13329830|NCT01118780|26595203|FG001|Overall Study|Physician Decision|0|||
13329831|NCT01118780|26595202|FG000|Overall Study|Protocol Violation|3|||
13329832|NCT01118780|26595203|FG001|Overall Study|Protocol Violation|6|||
13329833|NCT01118780|26595202|FG000|Overall Study|Withdrawal by Subject|13|||
13329834|NCT01118780|26595203|FG001|Overall Study|Withdrawal by Subject|8|||
13329835|NCT01118728|26595210|FG000|Overall Study|Adverse Event|17|||
13329836|NCT01118728|26595210|FG000|Overall Study|Lack of Efficacy|27|||
13329837|NCT01118728|26595210|FG000|Overall Study|Sponsor's decision to discontinue study|172|||
13329838|NCT01118728|26595210|FG000|Overall Study|Withdrawal by Subject|3|||
13122314|NCT02966028|25946731|FG001|Overall Study|Physician Decision|0|||
13329839|NCT01118728|26595210|FG000|Overall Study|Lost to Follow-up|4|||
13329840|NCT01118663|26595231|FG000|Overall Study|Adverse Event|2|||
13329841|NCT01118663|26595232|FG001|Overall Study|Adverse Event|1|||
13329842|NCT01118663|26595231|FG000|Overall Study|Withdrawal by Subject|0|||
13329843|NCT01118663|26595232|FG001|Overall Study|Withdrawal by Subject|1|||
13329844|NCT01118520|26595253|FG000|Overall Study|AAA repair|9|||
13329845|NCT01118520|26595254|FG001|Overall Study|AAA repair|7|||
13329846|NCT01118520|26595255|FG002|Overall Study|AAA repair|9|||
13329847|NCT01118520|26595253|FG000|Overall Study|Adverse Event|3|||
13329848|NCT01118520|26595254|FG001|Overall Study|Adverse Event|3|||
13329849|NCT01118520|26595255|FG002|Overall Study|Adverse Event|3|||
13329850|NCT01118520|26595253|FG000|Overall Study|Withdrawal by Subject|8|||
13329851|NCT01118520|26595254|FG001|Overall Study|Withdrawal by Subject|13|||
13329852|NCT01118520|26595255|FG002|Overall Study|Withdrawal by Subject|8|||
13329853|NCT01118455|26595290|FG000|Baseline [Visits 1 & 2]|Adverse Event|1|||
13329854|NCT01118455|26595291|FG001|Baseline [Visits 1 & 2]|Adverse Event|0|||
13329855|NCT01118377|26595299|FG000|Overall Study|Did Not Receive Study Medication|1|||
13329856|NCT01118377|26595299|FG000|Overall Study|Death|38|||
13329857|NCT01118377|26595299|FG000|Overall Study|Failure to Return|3|||
13329858|NCT01118351|26595309|FG000|Overall Study|Adverse Event|3|||
13329859|NCT01118351|26595309|FG000|Overall Study|Withdrawal by Subject|1|||
13329860|NCT01118325|26595363|FG000|Overall Study|Adverse Event|1|||
13329861|NCT01118325|26595364|FG001|Overall Study|Adverse Event|0|||
13329862|NCT01118325|26595365|FG002|Overall Study|Adverse Event|1|||
13329863|NCT01118312|26595380|FG000|Overall Study|Lost to Follow-up|33|||
13329864|NCT01118312|26595381|FG001|Overall Study|Lost to Follow-up|32|||
13329865|NCT01118312|26595380|FG000|Overall Study|Withdrawal by Subject|1|||
13329866|NCT01118312|26595381|FG001|Overall Study|Withdrawal by Subject|3|||
13329867|NCT01118299|26595395|FG000|Overall Study|Death|7|||
13329868|NCT01118299|26595396|FG001|Overall Study|Death|5|||
13329869|NCT01118299|26595395|FG000|Overall Study|Withdrawal by Subject|8|||
13329870|NCT01118299|26595396|FG001|Overall Study|Withdrawal by Subject|8|||
13329871|NCT01118299|26595395|FG000|Overall Study|Lost to Follow-up|2|||
13329872|NCT01118299|26595396|FG001|Overall Study|Lost to Follow-up|1|||
13329873|NCT01118299|26595395|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6|||
13329874|NCT01118299|26595396|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15|||
13329875|NCT01118143|26595411|FG000|Overall Study|Withdrawal by Subject|2|||
13329876|NCT01118143|26595412|FG001|Overall Study|Withdrawal by Subject|5|||
13329877|NCT01118117|26595438|FG000|Overall Study|Death|8|||
13329878|NCT01118117|26595439|FG001|Overall Study|Death|0|||
13329879|NCT01118117|26595438|FG000|Overall Study|Lost to Follow-up|6|||
13329880|NCT01118117|26595439|FG001|Overall Study|Lost to Follow-up|0|||
13329881|NCT01118117|26595438|FG000|Overall Study|Missed 12 Month Visit|7|||
13329882|NCT01118117|26595439|FG001|Overall Study|Missed 12 Month Visit|0|||
13329883|NCT01118052|26595454|FG000|Overall Study|Never treated|2|||
13329884|NCT01117987|26595471|FG000|Overall Study|Protocol deviation|0|||
13329885|NCT01117987|26595472|FG001|Overall Study|Protocol deviation|1|||
13329886|NCT01117987|26595471|FG000|Overall Study|Subject no longer requires study drug|1|||
13329887|NCT01117987|26595472|FG001|Overall Study|Subject no longer requires study drug|0|||
13329888|NCT01117987|26595471|FG000|Overall Study|Lost to Follow-up|1|||
13329889|NCT01117987|26595472|FG001|Overall Study|Lost to Follow-up|1|||
13329890|NCT01117987|26595471|FG000|Overall Study|Abnormal test procedure result|2|||
13329891|NCT01117987|26595472|FG001|Overall Study|Abnormal test procedure result|0|||
13329892|NCT01117987|26595471|FG000|Overall Study|Lack of Efficacy|3|||
13329893|NCT01117987|26595472|FG001|Overall Study|Lack of Efficacy|4|||
13329894|NCT01117987|26595471|FG000|Overall Study|Death|5|||
13329895|NCT01117987|26595472|FG001|Overall Study|Death|10|||
13329896|NCT01117987|26595471|FG000|Overall Study|Withdrawal by Subject|5|||
13329897|NCT01117987|26595472|FG001|Overall Study|Withdrawal by Subject|10|||
13329898|NCT01117987|26595471|FG000|Overall Study|Adverse Event|19|||
13329899|NCT01117987|26595472|FG001|Overall Study|Adverse Event|26|||
13329900|NCT01117987|26595471|FG000|Overall Study|Administrative problems|25|||
13329901|NCT01117987|26595472|FG001|Overall Study|Administrative problems|22|||
13329902|NCT01117870|26595493|FG000|Overall Study|Inability to place needle|1|||
13329903|NCT01117870|26595494|FG001|Overall Study|Inability to place needle|0|||
13329904|NCT01117857|26595504|FG000|Overall Study|Lost to Follow-up|4|||
13329905|NCT01117857|26595504|FG000|Overall Study|Withdrawal by Subject|4|||
13329906|NCT01117857|26595504|FG000|Overall Study|Physician Decision|1|||
13329907|NCT01117792|26595510|FG000|Overall Study|Death|1|||
13329908|NCT01117792|26595510|FG000|Overall Study|Adverse Event|3|||
13329909|NCT01117766|26595537|FG000|First Intervention|Adverse Event|0|||
13329910|NCT01117766|26595538|FG001|First Intervention|Adverse Event|1|||
13329911|NCT01117766|26595537|FG000|First Intervention|Protocol Violation|1|||
13329912|NCT01117766|26595538|FG001|First Intervention|Protocol Violation|0|||
13329913|NCT01117766|26595537|FG000|Washout Period|Protocol Violation|0|||
13329914|NCT01117766|26595538|FG001|Washout Period|Protocol Violation|2|||
13329915|NCT01117766|26595537|FG000|Second Intervention|Lost to Follow-up|1|||
13329916|NCT01117766|26595538|FG001|Second Intervention|Lost to Follow-up|0|||
13329917|NCT01117766|26595537|FG000|Second Intervention|Other|1|||
13329918|NCT01117766|26595538|FG001|Second Intervention|Other|2|||
13329919|NCT01117766|26595537|FG000|Second Intervention|Adverse Event|0|||
13329920|NCT01117766|26595538|FG001|Second Intervention|Adverse Event|2|||
13329921|NCT01117766|26595537|FG000|Second Intervention|Withdrawal by Subject|0|||
13329922|NCT01117766|26595538|FG001|Second Intervention|Withdrawal by Subject|1|||
13329923|NCT01117623|26595715|FG000|Overall Study|Adverse Event|0|||
13329924|NCT01117623|26595716|FG001|Overall Study|Adverse Event|2|||
13329925|NCT01117623|26595717|FG002|Overall Study|Adverse Event|4|||
13329926|NCT01117623|26595718|FG003|Overall Study|Adverse Event|0|||
13329927|NCT01117623|26595719|FG004|Overall Study|Adverse Event|2|||
13329928|NCT01117623|26595720|FG005|Overall Study|Adverse Event|0|||
13329929|NCT01117623|26595721|FG006|Overall Study|Adverse Event|0|||
13329930|NCT01117623|26595722|FG007|Overall Study|Adverse Event|2|||
13329931|NCT01117623|26595715|FG000|Overall Study|Disease progression, recurrence, relapse|3|||
13329932|NCT01117623|26595716|FG001|Overall Study|Disease progression, recurrence, relapse|6|||
13329933|NCT01117623|26595717|FG002|Overall Study|Disease progression, recurrence, relapse|5|||
13329934|NCT01117623|26595718|FG003|Overall Study|Disease progression, recurrence, relapse|6|||
13329935|NCT01117623|26595719|FG004|Overall Study|Disease progression, recurrence, relapse|8|||
13329936|NCT01117623|26595720|FG005|Overall Study|Disease progression, recurrence, relapse|14|||
13329937|NCT01117623|26595721|FG006|Overall Study|Disease progression, recurrence, relapse|5|||
13329938|NCT01117623|26595722|FG007|Overall Study|Disease progression, recurrence, relapse|22|||
13329939|NCT01117623|26595715|FG000|Overall Study|Withdrawal by Subject|0|||
13329940|NCT01117623|26595716|FG001|Overall Study|Withdrawal by Subject|0|||
13329941|NCT01117623|26595717|FG002|Overall Study|Withdrawal by Subject|2|||
13329942|NCT01117623|26595718|FG003|Overall Study|Withdrawal by Subject|0|||
13329943|NCT01117623|26595719|FG004|Overall Study|Withdrawal by Subject|0|||
13329944|NCT01117623|26595720|FG005|Overall Study|Withdrawal by Subject|1|||
13329945|NCT01117623|26595721|FG006|Overall Study|Withdrawal by Subject|1|||
13329946|NCT01117623|26595722|FG007|Overall Study|Withdrawal by Subject|1|||
13329947|NCT01117623|26595715|FG000|Overall Study|Non-compliance with study medication|0|||
13329948|NCT01117623|26595716|FG001|Overall Study|Non-compliance with study medication|0|||
13329949|NCT01117623|26595717|FG002|Overall Study|Non-compliance with study medication|0|||
13329950|NCT01117623|26595718|FG003|Overall Study|Non-compliance with study medication|0|||
13329951|NCT01117623|26595719|FG004|Overall Study|Non-compliance with study medication|0|||
13329952|NCT01117623|26595720|FG005|Overall Study|Non-compliance with study medication|0|||
13329953|NCT01117623|26595721|FG006|Overall Study|Non-compliance with study medication|0|||
13329954|NCT01117623|26595722|FG007|Overall Study|Non-compliance with study medication|1|||
13329955|NCT01117623|26595715|FG000|Overall Study|Invest. text: completed all planned txs|0|||
13329956|NCT01117623|26595716|FG001|Overall Study|Invest. text: completed all planned txs|0|||
13329957|NCT01117623|26595717|FG002|Overall Study|Invest. text: completed all planned txs|0|||
13329958|NCT01117623|26595718|FG003|Overall Study|Invest. text: completed all planned txs|0|||
13329959|NCT01117623|26595719|FG004|Overall Study|Invest. text: completed all planned txs|0|||
13329960|NCT01117623|26595720|FG005|Overall Study|Invest. text: completed all planned txs|1|||
13329961|NCT01117623|26595721|FG006|Overall Study|Invest. text: completed all planned txs|0|||
13329962|NCT01117623|26595722|FG007|Overall Study|Invest. text: completed all planned txs|0|||
13329963|NCT01117480|26595730|FG000|Overall Study|Protocol Violation|8|||
13329964|NCT01117480|26595730|FG000|Overall Study|Did Not Start Adalimumab Therapy|20|||
13329965|NCT01117454|26595743|FG000|Overall Study|Pregnancy|0|||
13329966|NCT01117454|26595744|FG001|Overall Study|Pregnancy|1|||
13329967|NCT01117428|26595795|FG000|Overall Study|Lack of Efficacy|1|||
13329968|NCT01117428|26595796|FG001|Overall Study|Lack of Efficacy|0|||
13329969|NCT01117428|26595797|FG002|Overall Study|Lack of Efficacy|0|||
13329970|NCT01117428|26595798|FG003|Overall Study|Lack of Efficacy|0|||
13329971|NCT01117428|26595799|FG004|Overall Study|Lack of Efficacy|0|||
13329972|NCT01117428|26595800|FG005|Overall Study|Lack of Efficacy|0|||
13329973|NCT01117428|26595795|FG000|Overall Study|Adverse Event|4|||
13329974|NCT01117428|26595796|FG001|Overall Study|Adverse Event|0|||
13329975|NCT01117428|26595797|FG002|Overall Study|Adverse Event|0|||
13329976|NCT01117428|26595798|FG003|Overall Study|Adverse Event|0|||
13329977|NCT01117428|26595799|FG004|Overall Study|Adverse Event|1|||
13329978|NCT01117428|26595800|FG005|Overall Study|Adverse Event|2|||
13329979|NCT01117428|26595795|FG000|Overall Study|Death|0|||
13329980|NCT01117428|26595796|FG001|Overall Study|Death|1|||
13329981|NCT01117428|26595797|FG002|Overall Study|Death|2|||
13329982|NCT01117428|26595798|FG003|Overall Study|Death|0|||
13329983|NCT01117428|26595799|FG004|Overall Study|Death|0|||
13329984|NCT01117428|26595800|FG005|Overall Study|Death|1|||
13329985|NCT01117428|26595795|FG000|Overall Study|Physician Decision|0|||
13329986|NCT01117428|26595796|FG001|Overall Study|Physician Decision|1|||
13329987|NCT01117428|26595797|FG002|Overall Study|Physician Decision|0|||
13329988|NCT01117428|26595798|FG003|Overall Study|Physician Decision|0|||
13329989|NCT01117428|26595799|FG004|Overall Study|Physician Decision|0|||
13329990|NCT01117428|26595800|FG005|Overall Study|Physician Decision|0|||
13329991|NCT01117428|26595795|FG000|Overall Study|Withdrawal by Subject|0|||
13329992|NCT01117428|26595796|FG001|Overall Study|Withdrawal by Subject|0|||
13329993|NCT01117428|26595797|FG002|Overall Study|Withdrawal by Subject|1|||
13329994|NCT01117428|26595798|FG003|Overall Study|Withdrawal by Subject|0|||
13329995|NCT01117428|26595799|FG004|Overall Study|Withdrawal by Subject|0|||
13329996|NCT01117428|26595800|FG005|Overall Study|Withdrawal by Subject|0|||
13329997|NCT01117428|26595795|FG000|Overall Study|Progressive disease|15|||
13329998|NCT01117428|26595796|FG001|Overall Study|Progressive disease|27|||
13329999|NCT01117428|26595797|FG002|Overall Study|Progressive disease|10|||
13330000|NCT01117428|26595798|FG003|Overall Study|Progressive disease|12|||
13330001|NCT01117428|26595799|FG004|Overall Study|Progressive disease|16|||
13330002|NCT01117428|26595800|FG005|Overall Study|Progressive disease|17|||
13330003|NCT01117350|26595837|FG000|Comparative Period|Not Treated|5|||
13330004|NCT01117350|26595838|FG001|Comparative Period|Not Treated|8|||
13330005|NCT01117350|26595837|FG000|Comparative Period|Adverse Event|6|||
13330006|NCT01117350|26595838|FG001|Comparative Period|Adverse Event|33|||
13330007|NCT01117350|26595837|FG000|Comparative Period|Lost to Follow-up|11|||
13330008|NCT01117350|26595838|FG001|Comparative Period|Lost to Follow-up|7|||
13330009|NCT01117350|26595837|FG000|Comparative Period|Withdrawal by Subject|9|||
13330010|NCT01117350|26595838|FG001|Comparative Period|Withdrawal by Subject|13|||
13330011|NCT01117350|26595837|FG000|Comparative Period|Protocol Violation|8|||
13330012|NCT01117350|26595838|FG001|Comparative Period|Protocol Violation|12|||
13330013|NCT01117350|26595837|FG000|Comparative Period|Lack of Efficacy|1|||
13330014|NCT01117350|26595838|FG001|Comparative Period|Lack of Efficacy|0|||
13330015|NCT01117350|26595837|FG000|Comparative Period|Physician Decision|0|||
13330016|NCT01117350|26595838|FG001|Comparative Period|Physician Decision|1|||
13330017|NCT01117350|26595837|FG000|Comparative Period|Move to another city/country|2|||
13330018|NCT01117350|26595838|FG001|Comparative Period|Move to another city/country|1|||
13330019|NCT01117350|26595837|FG000|Extension Period|Not included in extension, not treated|0|||
13330020|NCT01117350|26595838|FG001|Extension Period|Not included in extension, not treated|50|||
13330021|NCT01117350|26595837|FG000|Extension Period|Adverse Event|0|||
13330022|NCT01117350|26595838|FG001|Extension Period|Adverse Event|2|||
13330023|NCT01117350|26595837|FG000|Extension Period|Protocol Violation|0|||
13330024|NCT01117350|26595838|FG001|Extension Period|Protocol Violation|2|||
13330025|NCT01117350|26595837|FG000|Extension Period|Lost to Follow-up|0|||
13330026|NCT01117350|26595838|FG001|Extension Period|Lost to Follow-up|2|||
13330027|NCT01117350|26595837|FG000|Extension Period|Withdrawal by Subject|0|||
13330028|NCT01117350|26595838|FG001|Extension Period|Withdrawal by Subject|3|||
13330029|NCT01117350|26595837|FG000|Extension Period|Lack of Efficacy|0|||
13330030|NCT01117350|26595838|FG001|Extension Period|Lack of Efficacy|2|||
13330031|NCT01117350|26595837|FG000|Extension Period|Inclusion criteria not respected|0|||
13330032|NCT01117350|26595838|FG001|Extension Period|Inclusion criteria not respected|1|||
13330033|NCT01117350|26595837|FG000|Extension Period|Prohibited medication|0|||
13330034|NCT01117350|26595838|FG001|Extension Period|Prohibited medication|1|||
13330035|NCT01117337|26595855|FG000|Overall Study|Lost to Follow-up|4|||
13330036|NCT01117337|26595856|FG001|Overall Study|Lost to Follow-up|0|||
13330037|NCT01117181|26595883|FG000|Overall Study|Lost to Follow-up|1|||
13330038|NCT01117181|26595884|FG001|Overall Study|Lost to Follow-up|0|||
13330039|NCT01117181|26595883|FG000|Overall Study|Withdrawal by Subject|0|||
13330040|NCT01117181|26595884|FG001|Overall Study|Withdrawal by Subject|2|||
13330041|NCT01117051|26595899|FG000|Overall Study|Withdrawal by Subject|5|||
13330042|NCT01117051|26595900|FG001|Overall Study|Withdrawal by Subject|3|||
13330043|NCT01117051|26595899|FG000|Overall Study|Adverse Event|4|||
13330044|NCT01117051|26595900|FG001|Overall Study|Adverse Event|3|||
13330045|NCT01117051|26595899|FG000|Overall Study|Lost to Follow-up|0|||
13330046|NCT01117051|26595900|FG001|Overall Study|Lost to Follow-up|1|||
13330047|NCT01117051|26595899|FG000|Overall Study|Did not meet in-/exclusion criteria|0|||
13330048|NCT01117051|26595900|FG001|Overall Study|Did not meet in-/exclusion criteria|1|||
13330049|NCT01117051|26595899|FG000|Overall Study|Sponsor's decision|3|||
13330050|NCT01117051|26595900|FG001|Overall Study|Sponsor's decision|1|||
13330051|NCT01117051|26595899|FG000|Overall Study|Surgical procedure|0|||
13330052|NCT01117051|26595900|FG001|Overall Study|Surgical procedure|1|||
13330053|NCT01117051|26595899|FG000|Overall Study|Randomized by mistake|0|||
13330054|NCT01117051|26595900|FG001|Overall Study|Randomized by mistake|1|||
13330055|NCT01117051|26595899|FG000|Overall Study|Convenience issue|1|||
13330056|NCT01117051|26595900|FG001|Overall Study|Convenience issue|0|||
13330057|NCT01117012|26595923|FG000|Overall Study|Adverse Event|0|||
13330058|NCT01117012|26595924|FG001|Overall Study|Adverse Event|1|||
13330059|NCT01117012|26595923|FG000|Overall Study|Death|1|||
13330060|NCT01117012|26595924|FG001|Overall Study|Death|1|||
13330061|NCT01117012|26595923|FG000|Overall Study|Withdrawal by Subject|3|||
13330062|NCT01117012|26595924|FG001|Overall Study|Withdrawal by Subject|0|||
13330063|NCT01117012|26595923|FG000|Overall Study|Undefined|4|||
13330064|NCT01117012|26595924|FG001|Overall Study|Undefined|3|||
13330065|NCT01116882|26595969|FG000|30-day|Lost to Follow-up|50|||
13330066|NCT01116882|26595970|FG001|30-day|Lost to Follow-up|21|||
13330067|NCT01116882|26595969|FG000|30-day|Withdrawal by Subject|2|||
13330068|NCT01116882|26595970|FG001|30-day|Withdrawal by Subject|4|||
13330069|NCT01116882|26595969|FG000|30-day|Other Reasons|16|||
13330070|NCT01116882|26595970|FG001|30-day|Other Reasons|6|||
13330071|NCT01116882|26595969|FG000|12-month|Lost to Follow-up|111|||
13330072|NCT01116882|26595970|FG001|12-month|Lost to Follow-up|42|||
13330073|NCT01116882|26595969|FG000|12-month|Other Reasons|151|||
13330074|NCT01116882|26595970|FG001|12-month|Other Reasons|49|||
13330075|NCT01116882|26595969|FG000|12-month|Withdrawal by Subject|5|||
13330076|NCT01116882|26595970|FG001|12-month|Withdrawal by Subject|8|||
13330077|NCT01116739|26595997|FG000|Overall Study|Child had 2 years of HS|110|||
13330078|NCT01116739|26595998|FG001|Overall Study|Child had 2 years of HS|128|||
13330079|NCT01116739|26595997|FG000|Overall Study|Withdrawal by Subject|6|||
13330080|NCT01116739|26595998|FG001|Overall Study|Withdrawal by Subject|0|||
13330081|NCT01116739|26595997|FG000|Overall Study|child too young|2|||
13330082|NCT01116739|26595998|FG001|Overall Study|child too young|6|||
13330083|NCT01116739|26595997|FG000|Overall Study|child not enrolled in head start|10|||
13330084|NCT01116739|26595998|FG001|Overall Study|child not enrolled in head start|2|||
13330085|NCT01116739|26595997|FG000|Overall Study|enrolled caregiver not legal guardian|2|||
13330086|NCT01116739|26595998|FG001|Overall Study|enrolled caregiver not legal guardian|0|||
13330087|NCT01116687|26596007|FG000|Overall Study|Withdrawal by Subject|4|||
13330088|NCT01116648|26596078|FG000|Phase 1 Dose Level 3|Adverse Event|0|||
13330089|NCT01116648|26596079|FG001|Phase 1 Dose Level 3|Adverse Event|0|||
13330090|NCT01116648|26596080|FG002|Phase 1 Dose Level 3|Adverse Event|0|||
13330091|NCT01116648|26596081|FG003|Phase 1 Dose Level 3|Adverse Event|2|||
13330092|NCT01116648|26596082|FG004|Phase 1 Dose Level 3|Adverse Event|0|||
13330093|NCT01116648|26596083|FG005|Phase 1 Dose Level 3|Adverse Event|0|||
13330094|NCT01116648|26596084|FG006|Phase 1 Dose Level 3|Adverse Event|0|||
13330095|NCT01116648|26596085|FG007|Phase 1 Dose Level 3|Adverse Event|0|||
13330096|NCT01116648|26596086|FG008|Phase 1 Dose Level 3|Adverse Event|0|||
13330097|NCT01116648|26596087|FG009|Phase 1 Dose Level 3|Adverse Event|0|||
13330098|NCT01116648|26596088|FG010|Phase 1 Dose Level 3|Adverse Event|0|||
13330099|NCT01116648|26596089|FG011|Phase 1 Dose Level 3|Adverse Event|0|||
13330100|NCT01116648|26596090|FG012|Phase 1 Dose Level 3|Adverse Event|0|||
13330101|NCT01116648|26596091|FG013|Phase 1 Dose Level 3|Adverse Event|0|||
13330102|NCT01116648|26596092|FG014|Phase 1 Dose Level 3|Adverse Event|0|||
13330103|NCT01116544|26596115|FG000|Overall Study|Protocol Violation|1|||
13330104|NCT01116544|26596116|FG001|Overall Study|Protocol Violation|0|||
13330105|NCT01116544|26596115|FG000|Overall Study|Withdrawal by Subject|1|||
13330106|NCT01116544|26596116|FG001|Overall Study|Withdrawal by Subject|1|||
13330107|NCT01116440|26596137|FG000|Treatment|Withdrawal by Subject|2|||
13330108|NCT01116440|26596138|FG001|Treatment|Withdrawal by Subject|2|||
13330109|NCT01116440|26596137|FG000|Treatment|Lost to Follow-up|1|||
13330110|NCT01116440|26596138|FG001|Treatment|Lost to Follow-up|1|||
13330111|NCT01116440|26596137|FG000|Treatment|Protocol Violation|0|||
13330112|NCT01116440|26596138|FG001|Treatment|Protocol Violation|2|||
13330113|NCT01116440|26596137|FG000|Treatment|Lack of Efficacy|0|||
13330114|NCT01116440|26596138|FG001|Treatment|Lack of Efficacy|1|||
13330115|NCT01116440|26596137|FG000|Treatment|Adverse Event|0|||
13330116|NCT01116440|26596138|FG001|Treatment|Adverse Event|1|||
13330117|NCT01116440|26596137|FG000|Withdrawal|Withdrawal by Subject|0|||
13330118|NCT01116440|26596138|FG001|Withdrawal|Withdrawal by Subject|1|||
13330119|NCT01116440|26596137|FG000|Withdrawal|Lost to Follow-up|0|||
13330120|NCT01116440|26596138|FG001|Withdrawal|Lost to Follow-up|1|||
13330121|NCT01116440|26596137|FG000|Follow-up|Lost to Follow-up|0|||
13330122|NCT01116440|26596138|FG001|Follow-up|Lost to Follow-up|1|||
13330123|NCT01116440|26596137|FG000|Follow-up|Withdrawal by Subject|0|||
13330124|NCT01116440|26596138|FG001|Follow-up|Withdrawal by Subject|1|||
13330125|NCT01116427|26596181|FG000|Core Phase|Adverse Event|0|||
13330126|NCT01116427|26596182|FG001|Core Phase|Adverse Event|1|||
13330127|NCT01116427|26596181|FG000|Core Phase|Lost to Follow-up|1|||
13330128|NCT01116427|26596182|FG001|Core Phase|Lost to Follow-up|0|||
13330129|NCT01116427|26596181|FG000|Core Phase|Withdrawal by Subject|3|||
13330130|NCT01116427|26596182|FG001|Core Phase|Withdrawal by Subject|0|||
13330131|NCT01116427|26596181|FG000|Core Phase|Worsening Multiple Sclerosis|1|||
13330132|NCT01116427|26596182|FG001|Core Phase|Worsening Multiple Sclerosis|0|||
13330133|NCT01116427|26596181|FG000|Extension Phase|Adverse Event|1|||
13330134|NCT01116427|26596182|FG001|Extension Phase|Adverse Event|1|||
13330135|NCT01116427|26596181|FG000|Extension Phase|Lost to Follow-up|2|||
13330136|NCT01116427|26596182|FG001|Extension Phase|Lost to Follow-up|0|||
13330137|NCT01116427|26596181|FG000|Extension Phase|Withdrawal by Subject|5|||
13330138|NCT01116427|26596182|FG001|Extension Phase|Withdrawal by Subject|1|||
13330139|NCT01116427|26596181|FG000|Extension Phase|Not using appropriate birth control|1|||
13330140|NCT01116427|26596182|FG001|Extension Phase|Not using appropriate birth control|0|||
13330141|NCT01116232|26596195|FG000|Overall Study|Progressive diease|4|||
13330142|NCT01115998|26596212|FG000|Overall Study|Lost to Follow-up|6|||
13330143|NCT01115998|26596213|FG001|Overall Study|Lost to Follow-up|6|||
13330144|NCT01115933|26596310|FG000|Overall Study|Did not receive XIENCE PRIME SV|1|||
13330145|NCT01115855|26596365|FG000|Overall Study|Adverse Event|16|||
13330146|NCT01115855|26596366|FG001|Overall Study|Adverse Event|18|||
13330147|NCT01115855|26596365|FG000|Overall Study|Death|6|||
13330148|NCT01115855|26596366|FG001|Overall Study|Death|5|||
13330149|NCT01115855|26596365|FG000|Overall Study|Lab Abnormality|1|||
13330150|NCT01115855|26596366|FG001|Overall Study|Lab Abnormality|1|||
13330151|NCT01115855|26596365|FG000|Overall Study|Protocol Violation|0|||
13330152|NCT01115855|26596366|FG001|Overall Study|Protocol Violation|1|||
13330153|NCT01115855|26596365|FG000|Overall Study|Withdrawal by Subject|5|||
13330154|NCT01115855|26596366|FG001|Overall Study|Withdrawal by Subject|5|||
13330155|NCT01115855|26596365|FG000|Overall Study|Other|8|||
13330156|NCT01115855|26596366|FG001|Overall Study|Other|6|||
13330157|NCT01115803|26596448|FG000|Overall Study|Withdrawal by Subject|0|||
13330158|NCT01115803|26596449|FG001|Overall Study|Withdrawal by Subject|0|||
13330159|NCT01115803|26596450|FG002|Overall Study|Withdrawal by Subject|0|||
13330160|NCT01115803|26596451|FG003|Overall Study|Withdrawal by Subject|0|||
13330161|NCT01115803|26596452|FG004|Overall Study|Withdrawal by Subject|0|||
13330162|NCT01115803|26596453|FG005|Overall Study|Withdrawal by Subject|0|||
13330163|NCT01115803|26596454|FG006|Overall Study|Withdrawal by Subject|1|||
13330164|NCT01115803|26596448|FG000|Overall Study|Lost to Follow-up|0|||
13330165|NCT01115803|26596449|FG001|Overall Study|Lost to Follow-up|0|||
13330166|NCT01115803|26596450|FG002|Overall Study|Lost to Follow-up|1|||
13330167|NCT01115803|26596451|FG003|Overall Study|Lost to Follow-up|0|||
13330168|NCT01115803|26596452|FG004|Overall Study|Lost to Follow-up|0|||
13330169|NCT01115803|26596453|FG005|Overall Study|Lost to Follow-up|0|||
13330170|NCT01115803|26596454|FG006|Overall Study|Lost to Follow-up|0|||
13330171|NCT01115803|26596448|FG000|Overall Study|Progressive Disease during Cycle1|0|||
13330172|NCT01115803|26596449|FG001|Overall Study|Progressive Disease during Cycle1|0|||
13330173|NCT01115803|26596450|FG002|Overall Study|Progressive Disease during Cycle1|0|||
13330174|NCT01115803|26596451|FG003|Overall Study|Progressive Disease during Cycle1|0|||
13330175|NCT01115803|26596452|FG004|Overall Study|Progressive Disease during Cycle1|0|||
13330176|NCT01115803|26596453|FG005|Overall Study|Progressive Disease during Cycle1|0|||
13330177|NCT01115803|26596454|FG006|Overall Study|Progressive Disease during Cycle1|1|||
13330178|NCT01115738|26596498|FG000|Overall Study|Death|1|||
13330179|NCT01115738|26596499|FG001|Overall Study|Death|0|||
13330180|NCT01115738|26596500|FG002|Overall Study|Death|0|||
13330181|NCT01115738|26596498|FG000|Overall Study|Lost to Follow-up|0|||
13330182|NCT01115738|26596499|FG001|Overall Study|Lost to Follow-up|0|||
13330183|NCT01115738|26596500|FG002|Overall Study|Lost to Follow-up|1|||
13330184|NCT01115738|26596498|FG000|Overall Study|Physician Decision|18|||
13330185|NCT01115738|26596499|FG001|Overall Study|Physician Decision|15|||
13330186|NCT01115738|26596500|FG002|Overall Study|Physician Decision|17|||
13330187|NCT01115738|26596498|FG000|Overall Study|Withdrawal by Subject|6|||
13330188|NCT01115738|26596499|FG001|Overall Study|Withdrawal by Subject|6|||
13330189|NCT01115738|26596500|FG002|Overall Study|Withdrawal by Subject|9|||
13330190|NCT01115569|26596508|FG000|Conversion/Titration Phase|Adverse Event|59|||
13330191|NCT01115569|26596509|FG001|Conversion/Titration Phase|Adverse Event|0|||
13330192|NCT01115569|26596508|FG000|Conversion/Titration Phase|Lost to Follow-up|3|||
13330193|NCT01115569|26596509|FG001|Conversion/Titration Phase|Lost to Follow-up|0|||
13330194|NCT01115569|26596508|FG000|Conversion/Titration Phase|Physician Decision|5|||
13330195|NCT01115569|26596509|FG001|Conversion/Titration Phase|Physician Decision|0|||
13330196|NCT01115569|26596508|FG000|Conversion/Titration Phase|Protocol Violation|68|||
13330197|NCT01115569|26596509|FG001|Conversion/Titration Phase|Protocol Violation|0|||
13330198|NCT01115569|26596508|FG000|Conversion/Titration Phase|Withdrawal by Subject|26|||
13330199|NCT01115569|26596509|FG001|Conversion/Titration Phase|Withdrawal by Subject|0|||
13330200|NCT01115569|26596508|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53|||
13330201|NCT01115569|26596509|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0|||
13330202|NCT01115569|26596508|FG000|Maintenance Phase|Adverse Event|0|||
13330203|NCT01115569|26596509|FG001|Maintenance Phase|Adverse Event|43|||
13330204|NCT01115569|26596508|FG000|Maintenance Phase|Lost to Follow-up|0|||
13330205|NCT01115569|26596509|FG001|Maintenance Phase|Lost to Follow-up|8|||
13330206|NCT01115569|26596508|FG000|Maintenance Phase|Physician Decision|0|||
13330207|NCT01115569|26596509|FG001|Maintenance Phase|Physician Decision|3|||
13330208|NCT01115569|26596508|FG000|Maintenance Phase|Protocol Violation|0|||
13330209|NCT01115569|26596509|FG001|Maintenance Phase|Protocol Violation|9|||
13330210|NCT01115569|26596508|FG000|Maintenance Phase|Withdrawal by Subject|0|||
13330211|NCT01115569|26596509|FG001|Maintenance Phase|Withdrawal by Subject|27|||
13330212|NCT01115569|26596508|FG000|Maintenance Phase|Non-Compliance with Study Drug|0|||
13330213|NCT01115569|26596509|FG001|Maintenance Phase|Non-Compliance with Study Drug|48|||
13330214|NCT01115569|26596508|FG000|Maintenance Phase|Administrative|0|||
13330215|NCT01115569|26596509|FG001|Maintenance Phase|Administrative|1|||
13330216|NCT01115491|26596520|FG000|Overall Study|Death|22|||
13330217|NCT01115491|26596520|FG000|Overall Study|Adverse Event|3|||
13330218|NCT01115491|26596520|FG000|Overall Study|Lost to Follow-up|3|||
13330219|NCT01115491|26596520|FG000|Overall Study|Withdrawal by Subject|1|||
13330220|NCT01115491|26596520|FG000|Overall Study|Physician Decision|1|||
13330221|NCT01115309|26596530|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2|||
13330222|NCT01115309|26596530|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1|||
13330223|NCT01115309|26596530|FG000|Long-term Follow-up|Lost to Follow-up|6|||
13330224|NCT01114880|26596587|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4|||
13330225|NCT01114880|26596588|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0|||
13330226|NCT01114880|26596587|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1|||
13330227|NCT01114880|26596588|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0|||
13330228|NCT01114880|26596587|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0|||
13330229|NCT01114880|26596588|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1|||
13330230|NCT01114880|26596587|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0|||
13330231|NCT01114880|26596588|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1|||
13330232|NCT01114880|26596587|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3|||
13330233|NCT01114880|26596588|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0|||
13330234|NCT01114880|26596587|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0|||
13330235|NCT01114880|26596588|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2|||
13330236|NCT01114828|26596603|FG000|Overall Study|Adverse Event|1|||
13330237|NCT01114828|26596604|FG001|Overall Study|Adverse Event|1|||
13330238|NCT01114828|26596603|FG000|Overall Study|Lack of Efficacy|0|||
13330239|NCT01114828|26596604|FG001|Overall Study|Lack of Efficacy|2|||
13330240|NCT01114828|26596603|FG000|Overall Study|Protocol Violation|2|||
13330241|NCT01114828|26596604|FG001|Overall Study|Protocol Violation|0|||
13330242|NCT01114828|26596603|FG000|Overall Study|Withdrawal by Subject|0|||
13330243|NCT01114828|26596604|FG001|Overall Study|Withdrawal by Subject|1|||
13330244|NCT01114737|26596659|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
13330245|NCT01114737|26596660|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
13330246|NCT01114737|26596659|FG000|Randomized Treatment Period|Lost to Follow-up|1|||
13330247|NCT01114737|26596660|FG001|Randomized Treatment Period|Lost to Follow-up|1|||
13330248|NCT01114737|26596659|FG000|Randomized Treatment Period|Pregnancy|1|||
13330249|NCT01114737|26596660|FG001|Randomized Treatment Period|Pregnancy|0|||
13330250|NCT01114737|26596659|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
13330251|NCT01114737|26596660|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
13330252|NCT01114737|26596659|FG000|Open-Label Treatment Period|Lost to Follow-up|3|||
13330253|NCT01114737|26596660|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
13330254|NCT01114737|26596659|FG000|Open-Label Treatment Period|Difficult Personal Events|1|||
13330255|NCT01114737|26596660|FG001|Open-Label Treatment Period|Difficult Personal Events|0|||
13330256|NCT01114724|26596680|FG000|Overall Study|Death|8|||
13330257|NCT01114724|26596680|FG000|Overall Study|Lost to Follow-up|1|||
13330258|NCT01114724|26596680|FG000|Overall Study|Withdrawal by Subject|1|||
13330259|NCT01114672|26596693|FG000|Overall Study|Death|0|||
13330260|NCT01114672|26596694|FG001|Overall Study|Death|1|||
13330261|NCT01114672|26596693|FG000|Overall Study|Withdrawal by Subject|2|||
13330262|NCT01114672|26596694|FG001|Overall Study|Withdrawal by Subject|1|||
13330263|NCT01114672|26596693|FG000|Overall Study|Lost to Follow-up|1|||
13330264|NCT01114672|26596694|FG001|Overall Study|Lost to Follow-up|0|||
13330265|NCT01114672|26596693|FG000|Overall Study|transplanted|1|||
13330266|NCT01114672|26596694|FG001|Overall Study|transplanted|0|||
13330267|NCT01114646|26596707|FG000|Overall Study|Withdrawal by Subject|3|||
13330268|NCT01114646|26596708|FG001|Overall Study|Withdrawal by Subject|2|||
13330269|NCT01114529|26596735|FG000|Completed Study Medication at Month 24|Adverse Event|87|||
13330270|NCT01114529|26596736|FG001|Completed Study Medication at Month 24|Adverse Event|18|||
13330271|NCT01114529|26596737|FG002|Completed Study Medication at Month 24|Adverse Event|17|||
13330272|NCT01114529|26596735|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6|||
13330273|NCT01114529|26596736|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0|||
13330274|NCT01114529|26596737|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1|||
13330275|NCT01114529|26596735|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3|||
13330276|NCT01114529|26596736|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0|||
13330277|NCT01114529|26596737|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1|||
13330278|NCT01114529|26596735|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2|||
13330279|NCT01114529|26596736|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1|||
13330280|NCT01114529|26596737|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2|||
13330281|NCT01114529|26596735|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
13330282|NCT01114529|26596736|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
13330283|NCT01114529|26596737|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
13330284|NCT01114529|26596735|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18|||
13330285|NCT01114529|26596736|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8|||
13330286|NCT01114529|26596737|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2|||
13330287|NCT01114529|26596735|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1|||
13330288|NCT01114529|26596736|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4|||
13330289|NCT01114529|26596737|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2|||
13330290|NCT01114529|26596735|FG000|Completed Study Medication at Month 24|Administrative problems|2|||
13330291|NCT01114529|26596736|FG001|Completed Study Medication at Month 24|Administrative problems|1|||
13330292|NCT01114529|26596737|FG002|Completed Study Medication at Month 24|Administrative problems|2|||
13330293|NCT01114529|26596735|FG000|Completed Study Medication at Month 24|Death|2|||
13330294|NCT01114529|26596736|FG001|Completed Study Medication at Month 24|Death|1|||
13330295|NCT01114529|26596737|FG002|Completed Study Medication at Month 24|Death|2|||
13330296|NCT01114529|26596735|FG000|Completed Study Medication at Month 24|Graft loss|0|||
13330297|NCT01114529|26596736|FG001|Completed Study Medication at Month 24|Graft loss|2|||
13203997|NCT01977846|26226628|FG001|Total Study - Prospective|Death|1|||
13203998|NCT01977846|26226627|FG000|Total Study - Prospective|Lost to Follow-up|0|||
13203999|NCT01977846|26226628|FG001|Total Study - Prospective|Lost to Follow-up|8|||
13204000|NCT01977846|26226627|FG000|Total Study - Prospective|Withdrawal by Subject|0|||
13204001|NCT01977846|26226628|FG001|Total Study - Prospective|Withdrawal by Subject|13|||
13330298|NCT01114529|26596737|FG002|Completed Study Medication at Month 24|Graft loss|0|||
13330299|NCT01114529|26596735|FG000|Completed Study Medication at Month 24|Protocol Violation|0|||
13330300|NCT01114529|26596736|FG001|Completed Study Medication at Month 24|Protocol Violation|5|||
13330301|NCT01114529|26596737|FG002|Completed Study Medication at Month 24|Protocol Violation|2|||
13330302|NCT01114529|26596735|FG000|Completed Study Medication at Month 24|Missing|2|||
13330303|NCT01114529|26596736|FG001|Completed Study Medication at Month 24|Missing|0|||
13330304|NCT01114529|26596737|FG002|Completed Study Medication at Month 24|Missing|0|||
13330305|NCT01114529|26596735|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18|||
13330306|NCT01114529|26596736|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6|||
13330307|NCT01114529|26596737|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3|||
13330308|NCT01114529|26596735|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10|||
13330309|NCT01114529|26596736|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5|||
13330310|NCT01114529|26596737|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7|||
13330311|NCT01114529|26596735|FG000|Completed Study Phase at Month 24|Death|8|||
13330312|NCT01114529|26596736|FG001|Completed Study Phase at Month 24|Death|5|||
13330313|NCT01114529|26596737|FG002|Completed Study Phase at Month 24|Death|4|||
13330314|NCT01114529|26596735|FG000|Completed Study Phase at Month 24|Other|2|||
13330315|NCT01114529|26596736|FG001|Completed Study Phase at Month 24|Other|0|||
13330316|NCT01114529|26596737|FG002|Completed Study Phase at Month 24|Other|0|||
13330317|NCT01114529|26596735|FG000|Completed Study Phase at Month 24|Missing|2|||
13330318|NCT01114529|26596736|FG001|Completed Study Phase at Month 24|Missing|0|||
13330319|NCT01114529|26596737|FG002|Completed Study Phase at Month 24|Missing|0|||
13330320|NCT01114516|26596758|FG000|Overall Study|Lost to Follow-up|2|||
13330321|NCT01114516|26596759|FG001|Overall Study|Lost to Follow-up|1|||
13330322|NCT01114438|26596771|FG000|Overall Study|Adverse Event|10|||
13330323|NCT01114438|26596771|FG000|Overall Study|concomitant medication|1|||
13330324|NCT01114438|26596771|FG000|Overall Study|Physician Decision|1|||
13330325|NCT01114438|26596771|FG000|Overall Study|Withdrawal by Subject|2|||
13330326|NCT01114373|26596806|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
13330327|NCT01114373|26596807|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
13330328|NCT01114373|26596806|FG000|Intervention 1 (4 Weeks)|Incarceration|1|||
13330329|NCT01114373|26596807|FG001|Intervention 1 (4 Weeks)|Incarceration|0|||
13330330|NCT01114373|26596806|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1|||
13330331|NCT01114373|26596807|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0|||
13330332|NCT01114373|26596806|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0|||
13330333|NCT01114373|26596807|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1|||
13330334|NCT01114360|26596846|FG000|Intervention 1 (4 Weeks)|Physician Decision|0|||
13330335|NCT01114360|26596847|FG001|Intervention 1 (4 Weeks)|Physician Decision|1|||
13330336|NCT01114217|26596864|FG000|Overall Study|Adverse Event|5|||
13330337|NCT01114217|26596865|FG001|Overall Study|Adverse Event|3|||
13330338|NCT01114217|26596864|FG000|Overall Study|Lost to Follow-up|17|||
13330339|NCT01114217|26596865|FG001|Overall Study|Lost to Follow-up|33|||
13330340|NCT01114217|26596864|FG000|Overall Study|Withdrawal by Subject|21|||
13330341|NCT01114217|26596865|FG001|Overall Study|Withdrawal by Subject|28|||
13330342|NCT01114217|26596864|FG000|Overall Study|Other-Clerical Error|3|||
13330343|NCT01114217|26596865|FG001|Overall Study|Other-Clerical Error|0|||
13330344|NCT01114217|26596864|FG000|Overall Study|Other-Early termination|6|||
13330345|NCT01114217|26596865|FG001|Overall Study|Other-Early termination|10|||
13330346|NCT01114217|26596864|FG000|Overall Study|Other-Procedure|1|||
13330347|NCT01114217|26596865|FG001|Overall Study|Other-Procedure|1|||
13330348|NCT01114217|26596864|FG000|Overall Study|Other-Pregnancy|2|||
13330349|NCT01114217|26596865|FG001|Overall Study|Other-Pregnancy|4|||
13330350|NCT01114217|26596864|FG000|Overall Study|Other-Protocol Violation|1|||
13330351|NCT01114217|26596865|FG001|Overall Study|Other-Protocol Violation|3|||
13330352|NCT01114217|26596864|FG000|Overall Study|Other-Lack of Efficacy|1|||
13330353|NCT01114217|26596865|FG001|Overall Study|Other-Lack of Efficacy|0|||
13330354|NCT01114217|26596864|FG000|Overall Study|Other-Non Compliance|2|||
13330355|NCT01114217|26596865|FG001|Overall Study|Other-Non Compliance|0|||
13330356|NCT01114217|26596864|FG000|Overall Study|Other-Physician Decision|1|||
13330357|NCT01114217|26596865|FG001|Overall Study|Other-Physician Decision|1|||
13330358|NCT01114217|26596864|FG000|Overall Study|Other-Sponsor Decision|10|||
13330359|NCT01114217|26596865|FG001|Overall Study|Other-Sponsor Decision|12|||
13330360|NCT01114217|26596864|FG000|Overall Study|Other-Study Termination|0|||
13330361|NCT01114217|26596865|FG001|Overall Study|Other-Study Termination|1|||
13330362|NCT01114217|26596864|FG000|Overall Study|Other-Study Withdrawn|1|||
13330363|NCT01114217|26596865|FG001|Overall Study|Other-Study Withdrawn|1|||
13330364|NCT01114217|26596864|FG000|Overall Study|Other-Site Stopped Communicating|2|||
13330365|NCT01114217|26596865|FG001|Overall Study|Other-Site Stopped Communicating|0|||
13330366|NCT01114217|26596864|FG000|Overall Study|Other-Lost to Follow-up|1|||
13330367|NCT01114217|26596865|FG001|Overall Study|Other-Lost to Follow-up|0|||
13330368|NCT01114217|26596864|FG000|Overall Study|Other-Withdrawal by Subject|1|||
13330369|NCT01114217|26596865|FG001|Overall Study|Other-Withdrawal by Subject|1|||
13330370|NCT01114204|26596888|FG000|Overall Study|Adverse Event|3|||
13330371|NCT01114204|26596889|FG001|Overall Study|Adverse Event|2|||
13330372|NCT01114204|26596888|FG000|Overall Study|Lost to Follow-up|1|||
13330373|NCT01114204|26596889|FG001|Overall Study|Lost to Follow-up|0|||
13330374|NCT01114204|26596888|FG000|Overall Study|Withdrawal by Subject|10|||
13330375|NCT01114204|26596889|FG001|Overall Study|Withdrawal by Subject|6|||
13330376|NCT01114204|26596888|FG000|Overall Study|Death|1|||
13330377|NCT01114204|26596889|FG001|Overall Study|Death|0|||
13330378|NCT01114204|26596888|FG000|Overall Study|Other-Personal reasons|2|||
13330379|NCT01114204|26596889|FG001|Overall Study|Other-Personal reasons|0|||
13330380|NCT01114204|26596888|FG000|Overall Study|Other-Medical monitor request|1|||
13330381|NCT01114204|26596889|FG001|Overall Study|Other-Medical monitor request|0|||
13330382|NCT01114204|26596888|FG000|Overall Study|Other-Participant request|2|||
13330383|NCT01114204|26596889|FG001|Overall Study|Other-Participant request|0|||
13330384|NCT01114204|26596888|FG000|Overall Study|Other-Protocol Violation|1|||
13330385|NCT01114204|26596889|FG001|Overall Study|Other-Protocol Violation|0|||
13330386|NCT01114139|26596912|FG000|Overall Study|Adverse Event|3|||
13330387|NCT01114139|26596913|FG001|Overall Study|Adverse Event|2|||
13330388|NCT01114139|26596912|FG000|Overall Study|Lost to Follow-up|15|||
13330389|NCT01114139|26596913|FG001|Overall Study|Lost to Follow-up|3|||
13330390|NCT01114139|26596912|FG000|Overall Study|Withdrawal by Subject|17|||
13330391|NCT01114139|26596913|FG001|Overall Study|Withdrawal by Subject|6|||
13330392|NCT01114139|26596912|FG000|Overall Study|Other-Missed 1 visit|1|||
13330393|NCT01114139|26596913|FG001|Overall Study|Other-Missed 1 visit|0|||
13330394|NCT01114139|26596912|FG000|Overall Study|Other-Protocol Violation|1|||
13330395|NCT01114139|26596913|FG001|Overall Study|Other-Protocol Violation|0|||
13330396|NCT01114139|26596912|FG000|Overall Study|Other-Out of window for study drug dose|1|||
13330397|NCT01114139|26596913|FG001|Overall Study|Other-Out of window for study drug dose|0|||
13330398|NCT01114139|26596912|FG000|Overall Study|Other-Participant falsified records|0|||
13330399|NCT01114139|26596913|FG001|Overall Study|Other-Participant falsified records|1|||
13330400|NCT01114139|26596912|FG000|Overall Study|Other-Participant went on hospice|0|||
13330401|NCT01114139|26596913|FG001|Overall Study|Other-Participant went on hospice|1|||
13330402|NCT01114139|26596912|FG000|Overall Study|Other-Physician changed treatment|1|||
13330403|NCT01114139|26596913|FG001|Overall Study|Other-Physician changed treatment|0|||
13330404|NCT01114139|26596912|FG000|Overall Study|Other-Withdrew prior to receiving dose|1|||
13330405|NCT01114139|26596913|FG001|Overall Study|Other-Withdrew prior to receiving dose|3|||
13330406|NCT01113931|26596932|FG000|Overall Study|Adverse Event|2|||
13330407|NCT01113931|26596933|FG001|Overall Study|Adverse Event|2|||
13330408|NCT01113931|26596932|FG000|Overall Study|Physician Decision|0|||
13330409|NCT01113931|26596933|FG001|Overall Study|Physician Decision|2|||
13330410|NCT01113931|26596932|FG000|Overall Study|Lost to Follow-up|12|||
13330411|NCT01113931|26596933|FG001|Overall Study|Lost to Follow-up|9|||
13330412|NCT01113931|26596932|FG000|Overall Study|Various|2|||
13330413|NCT01113931|26596933|FG001|Overall Study|Various|4|||
13330414|NCT01113931|26596932|FG000|Overall Study|Withdrawal by Subject|3|||
13330415|NCT01113931|26596933|FG001|Overall Study|Withdrawal by Subject|0|||
13330416|NCT01113892|26596966|FG000|Overall Study|Lost to Follow-up|2|||
13330417|NCT01113892|26596967|FG001|Overall Study|Lost to Follow-up|2|||
13330418|NCT01113892|26596966|FG000|Overall Study|Withdrawal by Subject|1|||
13330419|NCT01113892|26596967|FG001|Overall Study|Withdrawal by Subject|1|||
13330420|NCT01113892|26596966|FG000|Overall Study|Death|2|||
13330421|NCT01113892|26596967|FG001|Overall Study|Death|4|||
13330422|NCT01113892|26596966|FG000|Overall Study|Graft no longer evaluable|9|||
13330423|NCT01113892|26596967|FG001|Overall Study|Graft no longer evaluable|9|||
13330424|NCT01113879|26596982|FG000|Period 1: Block 1|Withdrawal by Subject|2|||
13330425|NCT01113879|26596983|FG001|Period 1: Block 1|Withdrawal by Subject|0|||
13330426|NCT01113801|26597022|FG000|Overall Study|Adverse Event|4|||
13330427|NCT01113801|26597023|FG001|Overall Study|Adverse Event|0|||
13330428|NCT01113801|26597024|FG002|Overall Study|Adverse Event|2|||
13330429|NCT01113801|26597025|FG003|Overall Study|Adverse Event|6|||
13330430|NCT01113801|26597022|FG000|Overall Study|Death|4|||
13330431|NCT01113801|26597023|FG001|Overall Study|Death|5|||
13330432|NCT01113801|26597024|FG002|Overall Study|Death|3|||
13330433|NCT01113801|26597025|FG003|Overall Study|Death|4|||
13330434|NCT01113801|26597022|FG000|Overall Study|Protocol Violation|0|||
13330435|NCT01113801|26597023|FG001|Overall Study|Protocol Violation|1|||
13330436|NCT01113801|26597024|FG002|Overall Study|Protocol Violation|0|||
13330437|NCT01113801|26597025|FG003|Overall Study|Protocol Violation|0|||
13330438|NCT01113801|26597022|FG000|Overall Study|Withdrawal by Subject|9|||
13330439|NCT01113801|26597023|FG001|Overall Study|Withdrawal by Subject|7|||
13330440|NCT01113801|26597024|FG002|Overall Study|Withdrawal by Subject|7|||
13330441|NCT01113801|26597025|FG003|Overall Study|Withdrawal by Subject|8|||
13330442|NCT01113801|26597022|FG000|Overall Study|Physician Decision|2|||
13330443|NCT01113801|26597023|FG001|Overall Study|Physician Decision|2|||
13330444|NCT01113801|26597024|FG002|Overall Study|Physician Decision|3|||
13330445|NCT01113801|26597025|FG003|Overall Study|Physician Decision|3|||
13330446|NCT01113801|26597022|FG000|Overall Study|Sponsor Decision|15|||
13330447|NCT01113801|26597023|FG001|Overall Study|Sponsor Decision|21|||
13330448|NCT01113801|26597024|FG002|Overall Study|Sponsor Decision|20|||
13330449|NCT01113801|26597025|FG003|Overall Study|Sponsor Decision|15|||
13330450|NCT01113801|26597022|FG000|Overall Study|Clinical Endpoint (ESRD)|7|||
13330451|NCT01113801|26597023|FG001|Overall Study|Clinical Endpoint (ESRD)|4|||
13330452|NCT01113801|26597024|FG002|Overall Study|Clinical Endpoint (ESRD)|2|||
13330453|NCT01113801|26597025|FG003|Overall Study|Clinical Endpoint (ESRD)|5|||
13330454|NCT01113749|26597042|FG000|Overall Study|Lost to Follow-up|1|||
13330455|NCT01113749|26597043|FG001|Overall Study|Lost to Follow-up|2|||
13330456|NCT01113710|26597054|FG000|Overall Study|Adverse Event|64|||
13330457|NCT01113710|26597054|FG000|Overall Study|Lack of Efficacy|41|||
13330458|NCT01113710|26597054|FG000|Overall Study|No Information Available|40|||
13330459|NCT01113710|26597054|FG000|Overall Study|Withdrawal by Subject|28|||
13330460|NCT01113710|26597054|FG000|Overall Study|Lost to Follow-up|20|||
13330461|NCT01113710|26597054|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13|||
13330462|NCT01113710|26597054|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11|||
13330463|NCT01113710|26597054|FG000|Overall Study|Lack of Patient's Compliance|8|||
13330464|NCT01113710|26597054|FG000|Overall Study|Other|7|||
13330465|NCT01113710|26597054|FG000|Overall Study|Adverse Event/Other|5|||
13330466|NCT01113710|26597054|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5|||
13330467|NCT01113710|26597054|FG000|Overall Study|Lack of Efficacy/Other|4|||
13330468|NCT01113710|26597054|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4|||
13330469|NCT01113710|26597054|FG000|Overall Study|Lack of Efficacy/Adverse Event|3|||
13330470|NCT01113710|26597054|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2|||
13330471|NCT01113710|26597054|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2|||
13330472|NCT01113710|26597054|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2|||
13330473|NCT01113710|26597054|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1|||
13330474|NCT01113710|26597054|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1|||
13330475|NCT01113710|26597054|FG000|Overall Study|Compliance/Efficacy/AE/Other|1|||
13330476|NCT01113710|26597054|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1|||
13330477|NCT01113710|26597054|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1|||
13330478|NCT01113710|26597054|FG000|Overall Study|Lack of Patient's Compliance/Other|1|||
13330479|NCT01113710|26597054|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1|||
13330480|NCT01113710|26597054|FG000|Overall Study|Subject Did Not Receive Neupro|3|||
13330481|NCT01113580|26597075|FG000|Overall Study|Protocol Violation|1|||
13330482|NCT01113580|26597076|FG001|Overall Study|Protocol Violation|0|||
13330483|NCT01113541|26597111|FG000|Overall Study|Withdrawal by Subject|1|||
13330484|NCT01113541|26597111|FG000|Overall Study|Protocol Violation|1|||
13330485|NCT01113541|26597111|FG000|Overall Study|Study Terminated by Sponsor|7|||
13330486|NCT01113541|26597111|FG000|Overall Study|Adverse Event|4|||
13330487|NCT01113502|26597153|FG000|Overall Study|Withdrawal by Subject|1|||
13330488|NCT01113502|26597154|FG001|Overall Study|Withdrawal by Subject|0|||
13330489|NCT01113502|26597155|FG002|Overall Study|Withdrawal by Subject|1|||
13330490|NCT01113502|26597156|FG003|Overall Study|Withdrawal by Subject|1|||
13330491|NCT01113502|26597157|FG004|Overall Study|Withdrawal by Subject|0|||
13330492|NCT01113502|26597153|FG000|Overall Study|Adverse Event|0|||
13330493|NCT01113502|26597154|FG001|Overall Study|Adverse Event|0|||
13330494|NCT01113502|26597155|FG002|Overall Study|Adverse Event|3|||
13330495|NCT01113502|26597156|FG003|Overall Study|Adverse Event|2|||
13330496|NCT01113502|26597157|FG004|Overall Study|Adverse Event|0|||
13330497|NCT01113463|26597164|FG000|Overall Study|Physician Decision|5|||
13330498|NCT01112982|26597178|FG000|Overall Study|Withdrawal by Subject|1|||
13330499|NCT01112982|26597178|FG000|Overall Study|exceeded weight limit to complete MRI|1|||
13330500|NCT01112917|26597186|FG000|Overall Study|Death|2|||
13330501|NCT01112917|26597187|FG001|Overall Study|Death|11|||
13330502|NCT01112917|26597186|FG000|Overall Study|Lost to Follow-up|1|||
13330503|NCT01112917|26597187|FG001|Overall Study|Lost to Follow-up|1|||
13330504|NCT01112917|26597186|FG000|Overall Study|Withdrawal by Subject|1|||
13330505|NCT01112917|26597187|FG001|Overall Study|Withdrawal by Subject|3|||
13330506|NCT01112917|26597186|FG000|Overall Study|Unable to Convert Filter|3|||
13330507|NCT01112917|26597187|FG001|Overall Study|Unable to Convert Filter|0|||
13330508|NCT01112579|26597204|FG000|Overall Study|Missed Visit|1|||
13330509|NCT01112579|26597205|FG001|Overall Study|Missed Visit|1|||
13330510|NCT01112579|26597204|FG000|Overall Study|Death|0|||
13330511|NCT01112579|26597205|FG001|Overall Study|Death|2|||
13330512|NCT01112514|26597211|FG000|Overall Study|Lost to Follow-up|1|||
13330513|NCT01112267|26597236|FG000|Overall Study|Adverse Event|24|||
13330514|NCT01112267|26597237|FG001|Overall Study|Adverse Event|6|||
13330515|NCT01112267|26597236|FG000|Overall Study|Withdrawal by Subject|3|||
13330516|NCT01112267|26597237|FG001|Overall Study|Withdrawal by Subject|5|||
13330517|NCT01112267|26597236|FG000|Overall Study|Protocol Violation|5|||
13330518|NCT01112267|26597237|FG001|Overall Study|Protocol Violation|3|||
13330519|NCT01112267|26597236|FG000|Overall Study|Participants not compliant|1|||
13330520|NCT01112267|26597237|FG001|Overall Study|Participants not compliant|2|||
13330521|NCT01112267|26597236|FG000|Overall Study|Participants not receive any study drug|1|||
13330522|NCT01112267|26597237|FG001|Overall Study|Participants not receive any study drug|2|||
13330523|NCT01112059|26597256|FG000|Overall Study|Withdrawal by Subject|1|||
13330524|NCT01112059|26597257|FG001|Overall Study|Withdrawal by Subject|0|||
13330525|NCT01111851|26597276|FG000|Overall Study|All planned PET scans were not obtained.|2|||
13330526|NCT01111851|26597277|FG001|Overall Study|All planned PET scans were not obtained.|0|||
13330527|NCT01111838|26597283|FG000|Overall Study|Patient Ineligible|2|||
13330528|NCT01111838|26597283|FG000|Overall Study|Not Treated|3|||
13330529|NCT01111838|26597283|FG000|Overall Study|Clinical deterioration|1|||
13330530|NCT01111838|26597283|FG000|Overall Study|Other Complicating Disease|1|||
13330531|NCT01111825|26597315|FG000|Overall Study|Withdrawal by Subject|0|||
13330532|NCT01111825|26597316|FG001|Overall Study|Withdrawal by Subject|0|||
13330533|NCT01111825|26597317|FG002|Overall Study|Withdrawal by Subject|1|||
13330534|NCT01111825|26597318|FG003|Overall Study|Withdrawal by Subject|0|||
13330535|NCT01111825|26597315|FG000|Overall Study|Lost to Follow-up|0|||
13330536|NCT01111825|26597316|FG001|Overall Study|Lost to Follow-up|0|||
13330537|NCT01111825|26597317|FG002|Overall Study|Lost to Follow-up|3|||
13330538|NCT01111825|26597318|FG003|Overall Study|Lost to Follow-up|1|||
13330539|NCT01111825|26597315|FG000|Overall Study|Adverse Event|2|||
13330540|NCT01111825|26597316|FG001|Overall Study|Adverse Event|1|||
13330541|NCT01111825|26597317|FG002|Overall Study|Adverse Event|4|||
13330542|NCT01111825|26597318|FG003|Overall Study|Adverse Event|0|||
13330543|NCT01111825|26597315|FG000|Overall Study|Disease Progression|1|||
13330544|NCT01111825|26597316|FG001|Overall Study|Disease Progression|0|||
13330545|NCT01111825|26597317|FG002|Overall Study|Disease Progression|0|||
13330546|NCT01111825|26597318|FG003|Overall Study|Disease Progression|0|||
13330547|NCT01111825|26597315|FG000|Overall Study|Discontinuation by Sponsor|0|||
13330548|NCT01111825|26597316|FG001|Overall Study|Discontinuation by Sponsor|0|||
13330549|NCT01111825|26597317|FG002|Overall Study|Discontinuation by Sponsor|0|||
13330550|NCT01111825|26597318|FG003|Overall Study|Discontinuation by Sponsor|20|||
13330551|NCT01111604|26597366|FG000|Overall Study|Lost to Follow-up|0|||
13330552|NCT01111604|26597367|FG001|Overall Study|Lost to Follow-up|0|||
13330553|NCT01111604|26597368|FG002|Overall Study|Lost to Follow-up|1|||
13330554|NCT01111604|26597366|FG000|Overall Study|Withdrew Consent|3|||
13330555|NCT01111604|26597367|FG001|Overall Study|Withdrew Consent|0|||
13330556|NCT01111604|26597368|FG002|Overall Study|Withdrew Consent|2|||
13330557|NCT01111604|26597366|FG000|Overall Study|Withdrawal by Subject|2|||
13330558|NCT01111604|26597367|FG001|Overall Study|Withdrawal by Subject|0|||
13330559|NCT01111604|26597368|FG002|Overall Study|Withdrawal by Subject|0|||
13330560|NCT01111604|26597366|FG000|Overall Study|Death|1|||
13330561|NCT01111604|26597367|FG001|Overall Study|Death|0|||
13330562|NCT01111604|26597368|FG002|Overall Study|Death|0|||
13330563|NCT01111604|26597366|FG000|Overall Study|Met Exclusion Criteria|2|||
13330564|NCT01111604|26597367|FG001|Overall Study|Met Exclusion Criteria|0|||
13330565|NCT01111604|26597368|FG002|Overall Study|Met Exclusion Criteria|0|||
13330566|NCT01111552|26597390|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9|||
13330567|NCT01111552|26597391|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
13330568|NCT01111552|26597392|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
13330569|NCT01111552|26597393|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
13330570|NCT01111552|26597394|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
13330571|NCT01111552|26597390|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4|||
13330572|NCT01111552|26597391|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
13330573|NCT01111552|26597392|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
13330574|NCT01111552|26597393|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
13330575|NCT01111552|26597394|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
13330576|NCT01111552|26597390|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89|||
13330577|NCT01111552|26597391|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
13330578|NCT01111552|26597392|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
13330579|NCT01111552|26597393|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
13330580|NCT01111552|26597394|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
13330581|NCT01111552|26597390|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3|||
13330582|NCT01111552|26597391|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
13330583|NCT01111552|26597392|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
13330584|NCT01111552|26597393|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
13330585|NCT01111552|26597394|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
13330586|NCT01111552|26597390|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3|||
13330587|NCT01111552|26597391|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
13330588|NCT01111552|26597392|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
13330589|NCT01111552|26597393|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
13330590|NCT01111552|26597394|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
13330591|NCT01111552|26597390|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7|||
13330592|NCT01111552|26597391|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
13330593|NCT01111552|26597392|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
13330594|NCT01111552|26597393|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
13330595|NCT01111552|26597394|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
13330596|NCT01111552|26597390|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1|||
13330597|NCT01111552|26597391|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
13330598|NCT01111552|26597392|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
13330599|NCT01111552|26597393|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
13330600|NCT01111552|26597394|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
13330601|NCT01111552|26597390|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1|||
13330602|NCT01111552|26597391|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
13330603|NCT01111552|26597392|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
13330604|NCT01111552|26597393|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
13330605|NCT01111552|26597394|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
13330606|NCT01111552|26597390|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
13330607|NCT01111552|26597391|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
13330608|NCT01111552|26597392|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
13330609|NCT01111552|26597393|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
13330610|NCT01111552|26597394|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
13330611|NCT01111552|26597390|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
13330612|NCT01111552|26597391|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
13330613|NCT01111552|26597392|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
13330614|NCT01111552|26597393|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
13330615|NCT01111552|26597394|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
13330616|NCT01111552|26597390|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
13330617|NCT01111552|26597391|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2|||
13330618|NCT01111552|26597392|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
13330619|NCT01111552|26597393|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
13330620|NCT01111552|26597394|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
13330621|NCT01111552|26597390|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
13330622|NCT01111552|26597391|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1|||
13330623|NCT01111552|26597392|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
13330624|NCT01111552|26597393|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
13330625|NCT01111552|26597394|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
13330626|NCT01111552|26597390|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
13330627|NCT01111552|26597391|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1|||
13330628|NCT01111552|26597392|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
13330629|NCT01111552|26597393|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
13330630|NCT01111552|26597394|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
13330631|NCT01111552|26597390|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
13330632|NCT01111552|26597391|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
13330633|NCT01111552|26597392|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
13330634|NCT01111552|26597393|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
13330635|NCT01111552|26597394|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
13330636|NCT01111539|26597416|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6|||
13330637|NCT01111539|26597417|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
13330638|NCT01111539|26597418|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
13330639|NCT01111539|26597419|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
13330640|NCT01111539|26597420|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
13330641|NCT01111539|26597416|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5|||
13330642|NCT01111539|26597417|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
13330643|NCT01111539|26597418|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
13330644|NCT01111539|26597419|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
13330645|NCT01111539|26597420|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
13330646|NCT01111539|26597416|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60|||
13330647|NCT01111539|26597417|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
13330648|NCT01111539|26597418|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
13330649|NCT01111539|26597419|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
13330650|NCT01111539|26597420|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
13330651|NCT01111539|26597416|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1|||
13330652|NCT01111539|26597417|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
13330653|NCT01111539|26597418|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
13330654|NCT01111539|26597419|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
13330655|NCT01111539|26597420|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
13330656|NCT01111539|26597416|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7|||
13330657|NCT01111539|26597417|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
13330658|NCT01111539|26597418|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
13330659|NCT01111539|26597419|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
13330660|NCT01111539|26597420|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
13330661|NCT01111539|26597416|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2|||
13330662|NCT01111539|26597417|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
13330663|NCT01111539|26597418|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
13330664|NCT01111539|26597419|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
13330665|NCT01111539|26597420|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
13330666|NCT01111539|26597416|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1|||
13330667|NCT01111539|26597417|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
13330668|NCT01111539|26597418|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
13330669|NCT01111539|26597419|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
13330670|NCT01111539|26597420|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
13330671|NCT01111539|26597416|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
13330672|NCT01111539|26597417|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
13330673|NCT01111539|26597418|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
13330674|NCT01111539|26597419|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
13330675|NCT01111539|26597420|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
13330676|NCT01111539|26597416|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
13330677|NCT01111539|26597417|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
13330678|NCT01111539|26597418|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
13330679|NCT01111539|26597419|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
13330680|NCT01111539|26597420|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2|||
13330681|NCT01111539|26597416|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
13330682|NCT01111539|26597417|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
13330683|NCT01111539|26597418|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
13330684|NCT01111539|26597419|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
13330685|NCT01111539|26597420|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
13330686|NCT01111539|26597416|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
13330687|NCT01111539|26597417|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
13330688|NCT01111539|26597418|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
13330689|NCT01111539|26597419|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
13330690|NCT01111539|26597420|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1|||
13330691|NCT01111539|26597416|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
13330692|NCT01111539|26597417|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
13330693|NCT01111539|26597418|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
13330694|NCT01111539|26597419|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1|||
13330695|NCT01111539|26597420|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
13330696|NCT01111539|26597416|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
13330697|NCT01111539|26597417|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
13330698|NCT01111539|26597418|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
13330699|NCT01111539|26597419|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2|||
13330700|NCT01111539|26597420|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
13330701|NCT01111539|26597416|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
13330702|NCT01111539|26597417|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
13330703|NCT01111539|26597418|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
13330704|NCT01111539|26597419|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
13330705|NCT01111539|26597420|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
13330706|NCT01111526|26597436|FG000|Overall Study|GVHD Disease Progression|0|||
13330707|NCT01111526|26597437|FG001|Overall Study|GVHD Disease Progression|1|||
13330708|NCT01111526|26597438|FG002|Overall Study|GVHD Disease Progression|2|||
13330709|NCT01111474|26597448|FG000|Overall Study|Lost to Follow-up|12|||
13330710|NCT01111461|26597463|FG000|Overall Study|Adverse Event|32|||
13330711|NCT01111461|26597463|FG000|Overall Study|Participant choice|11|||
13330712|NCT01111461|26597463|FG000|Overall Study|Lost to Follow-up|1|||
13330713|NCT01111461|26597463|FG000|Overall Study|Withdrawal by Subject|1|||
13330714|NCT01111461|26597463|FG000|Overall Study|Other|6|||
13330715|NCT01111292|26597476|FG000|Treatment|Physician Decision|1|||
13330716|NCT01111292|26597477|FG001|Treatment|Physician Decision|1|||
13330717|NCT01111240|26597501|FG000|Overall Study|Adverse Event|190|||
13330718|NCT01111240|26597501|FG000|Overall Study|Lack of Efficacy|545|||
13330719|NCT01111240|26597501|FG000|Overall Study|Lack of Efficacy and Adverse Event|19|||
13330720|NCT01111240|26597501|FG000|Overall Study|Other|312|||
13330721|NCT01111149|26597585|FG000|Overall Study|Protocol Violation|1|||
13330722|NCT01111149|26597586|FG001|Overall Study|Protocol Violation|1|||
13330723|NCT01111149|26597587|FG002|Overall Study|Protocol Violation|2|||
13330724|NCT01111149|26597585|FG000|Overall Study|Withdrawal by Subject|1|||
13330725|NCT01111149|26597586|FG001|Overall Study|Withdrawal by Subject|0|||
13330726|NCT01111149|26597587|FG002|Overall Study|Withdrawal by Subject|2|||
13330727|NCT01111123|26597602|FG000|Open- Label Phase|Failed to be clear or almost cleared|14|||
13330728|NCT01111123|26597603|FG001|Open- Label Phase|Failed to be clear or almost cleared|0|||
13330729|NCT01111123|26597602|FG000|Maintenance Phase|Lost to Follow-up|0|||
13330730|NCT01111123|26597603|FG001|Maintenance Phase|Lost to Follow-up|2|||
13330731|NCT01111019|26597624|FG000|Overall Study|Withdrew Prematurely|2|||
13330732|NCT01111019|26597624|FG000|Overall Study|Other|1|||
13330733|NCT01110915|26597646|FG000|Overall Study|Death|2|||
13330734|NCT01110915|26597647|FG001|Overall Study|Death|1|||
13330735|NCT01110915|26597646|FG000|Overall Study|Lost to Follow-up|1|||
13330736|NCT01110915|26597647|FG001|Overall Study|Lost to Follow-up|0|||
13330737|NCT01110915|26597646|FG000|Overall Study|Withdrawal by Subject|7|||
13330738|NCT01110915|26597647|FG001|Overall Study|Withdrawal by Subject|1|||
13330739|NCT01110707|26597676|FG000|Overall Study|Protocol Violation|0|||
13330740|NCT01110707|26597677|FG001|Overall Study|Protocol Violation|3|||
13330741|NCT01110408|26597702|FG000|Overall Study|Protocol Violation|1|||
13330742|NCT01110408|26597703|FG001|Overall Study|Protocol Violation|0|||
13330743|NCT01110382|26597728|FG000|Overall Study|Withdrawal by Subject|0|||
13330744|NCT01110382|26597729|FG001|Overall Study|Withdrawal by Subject|1|||
13330745|NCT01110382|26597728|FG000|Overall Study|Protocol Violation|0|||
13330746|NCT01110382|26597729|FG001|Overall Study|Protocol Violation|1|||
13373765|NCT00799617|26724842|FG001|Bone Trial|Month 12 scan not available|16|||
13373766|NCT00799617|26724841|FG000|Cognitive Function Trial|Lost to Follow-up|0|||
13373767|NCT00799617|26724842|FG001|Cognitive Function Trial|Lost to Follow-up|1|||
13373768|NCT00799617|26724841|FG000|Anemia Trial|Withdrawal by Subject|3|||
13373769|NCT00799617|26724842|FG001|Anemia Trial|Withdrawal by Subject|3|||
13373770|NCT00799591|26724855|FG000|Overall Study|De-escalation of doses|20|||
13373771|NCT00799591|26724855|FG000|Overall Study|Death|14|||
13373772|NCT00799591|26724855|FG000|Overall Study|Technical failure|12|||
13373773|NCT00799591|26724855|FG000|Overall Study|Resistant germ|11|||
13373774|NCT00799591|26724855|FG000|Overall Study|New infection|4|||
13373775|NCT00799591|26724855|FG000|Overall Study|Resistance germ and technical failure|2|||
13373776|NCT00799591|26724855|FG000|Overall Study|Persistance of fever undetermined origin|1|||
13373777|NCT00799591|26724855|FG000|Overall Study|Antibiotic changed, no apparent reason|1|||
13373778|NCT00799591|26724855|FG000|Overall Study|Infectious origin not probable|1|||
13373779|NCT00799487|26724945|FG000|Dose Adjustment Period|Lost to Follow-up|1|||
13373780|NCT00799487|26724946|FG001|Dose Adjustment Period|Lost to Follow-up|0|||
13373781|NCT00799487|26724947|FG002|Dose Adjustment Period|Lost to Follow-up|0|||
13373782|NCT00799487|26724945|FG000|Dose Adjustment Period|Adverse Event|2|||
13373783|NCT00799487|26724946|FG001|Dose Adjustment Period|Adverse Event|0|||
13373784|NCT00799487|26724947|FG002|Dose Adjustment Period|Adverse Event|0|||
13373785|NCT00799487|26724945|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8|||
13373786|NCT00799487|26724946|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
13373787|NCT00799487|26724947|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
13373788|NCT00799487|26724945|FG000|Dose Adjustment Period|Investigator Discretion|2|||
13373789|NCT00799487|26724946|FG001|Dose Adjustment Period|Investigator Discretion|0|||
13373790|NCT00799487|26724947|FG002|Dose Adjustment Period|Investigator Discretion|0|||
13373791|NCT00799487|26724945|FG000|Dose Adjustment Period|Withdrawal by Subject|3|||
13373792|NCT00799487|26724946|FG001|Dose Adjustment Period|Withdrawal by Subject|0|||
13373793|NCT00799487|26724947|FG002|Dose Adjustment Period|Withdrawal by Subject|0|||
13373794|NCT00799487|26724945|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1|||
13373795|NCT00799487|26724946|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
13373796|NCT00799487|26724947|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
13373797|NCT00799487|26724945|FG000|Dose Adjustment Period|Child too young (exclusion)|1|||
13373798|NCT00799487|26724946|FG001|Dose Adjustment Period|Child too young (exclusion)|0|||
13373799|NCT00799487|26724947|FG002|Dose Adjustment Period|Child too young (exclusion)|0|||
13373800|NCT00799487|26724945|FG000|Dose Adjustment Period|Missed laboratory day 1|1|||
13373801|NCT00799487|26724946|FG001|Dose Adjustment Period|Missed laboratory day 1|0|||
13373802|NCT00799487|26724947|FG002|Dose Adjustment Period|Missed laboratory day 1|0|||
13373803|NCT00799487|26724945|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2|||
13373804|NCT00799487|26724946|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
13373805|NCT00799487|26724947|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
13373806|NCT00799487|26724945|FG000|Double-Blind Assessment Period|Lost to Follow-up|0|||
13486406|NCT03564145|27036051|FG000|Overall Study|Withdrawal by Subject|48|||
13122315|NCT02966028|25946732|FG002|Overall Study|Physician Decision|2|||
13330747|NCT01110330|26597750|FG000|Overall Study|Adverse Event|0|||
13330748|NCT01110330|26597751|FG001|Overall Study|Adverse Event|4|||
13330749|NCT01110330|26597752|FG002|Overall Study|Adverse Event|3|||
13330750|NCT01110330|26597750|FG000|Overall Study|Lack of Efficacy|3|||
13330751|NCT01110330|26597751|FG001|Overall Study|Lack of Efficacy|1|||
13330752|NCT01110330|26597752|FG002|Overall Study|Lack of Efficacy|1|||
13330753|NCT01110330|26597750|FG000|Overall Study|Lost to Follow-up|9|||
13330754|NCT01110330|26597751|FG001|Overall Study|Lost to Follow-up|10|||
13330755|NCT01110330|26597752|FG002|Overall Study|Lost to Follow-up|15|||
13330756|NCT01110330|26597750|FG000|Overall Study|Physician Decision|0|||
13330757|NCT01110330|26597751|FG001|Overall Study|Physician Decision|1|||
13330758|NCT01110330|26597752|FG002|Overall Study|Physician Decision|0|||
13330759|NCT01110330|26597750|FG000|Overall Study|Protocol Violation|2|||
13330760|NCT01110330|26597751|FG001|Overall Study|Protocol Violation|0|||
13330761|NCT01110330|26597752|FG002|Overall Study|Protocol Violation|4|||
13330762|NCT01110330|26597750|FG000|Overall Study|Withdrawal by Subject|0|||
13330763|NCT01110330|26597751|FG001|Overall Study|Withdrawal by Subject|6|||
13330764|NCT01110330|26597752|FG002|Overall Study|Withdrawal by Subject|2|||
13330765|NCT01110330|26597750|FG000|Overall Study|Other|1|||
13330766|NCT01110330|26597751|FG001|Overall Study|Other|1|||
13330767|NCT01110330|26597752|FG002|Overall Study|Other|1|||
13330768|NCT01110239|26597779|FG000|Sham Preconditioning|Withdrawal by Subject|0|||
13330769|NCT01110239|26597780|FG001|Sham Preconditioning|Withdrawal by Subject|0|||
13330770|NCT01110239|26597781|FG002|Sham Preconditioning|Withdrawal by Subject|1|||
13330771|NCT01110239|26597782|FG003|Sham Preconditioning|Withdrawal by Subject|0|||
13330772|NCT01110239|26597779|FG000|7.5 Min Ischemia|Withdrawal by Subject|0|||
13330773|NCT01110239|26597780|FG001|7.5 Min Ischemia|Withdrawal by Subject|0|||
13330774|NCT01110239|26597781|FG002|7.5 Min Ischemia|Withdrawal by Subject|1|||
13330775|NCT01110239|26597782|FG003|7.5 Min Ischemia|Withdrawal by Subject|0|||
13330776|NCT01110200|26597803|FG000|Overall Study|Adverse Event|28|||
13330777|NCT01110200|26597804|FG001|Overall Study|Adverse Event|28|||
13330778|NCT01110200|26597803|FG000|Overall Study|Withdrawal by Subject|25|||
13330779|NCT01110200|26597804|FG001|Overall Study|Withdrawal by Subject|32|||
13330780|NCT01110200|26597803|FG000|Overall Study|Lack of Efficacy|16|||
13330781|NCT01110200|26597804|FG001|Overall Study|Lack of Efficacy|25|||
13330782|NCT01110200|26597803|FG000|Overall Study|Protocol Violation|14|||
13330783|NCT01110200|26597804|FG001|Overall Study|Protocol Violation|12|||
13330784|NCT01110200|26597803|FG000|Overall Study|Physician Decision|13|||
13330785|NCT01110200|26597804|FG001|Overall Study|Physician Decision|17|||
13330786|NCT01110200|26597803|FG000|Overall Study|Lost to Follow-up|10|||
13330787|NCT01110200|26597804|FG001|Overall Study|Lost to Follow-up|7|||
13330788|NCT01110005|26597821|FG000|Overall Study|ineligible|1|||
13330789|NCT01110005|26597822|FG001|Overall Study|ineligible|2|||
13330790|NCT01110005|26597821|FG000|Overall Study|missing consent|3|||
13330791|NCT01110005|26597822|FG001|Overall Study|missing consent|2|||
13330792|NCT01110005|26597821|FG000|Overall Study|Withdrawal by Subject|0|||
13330793|NCT01110005|26597822|FG001|Overall Study|Withdrawal by Subject|1|||
13330794|NCT01109992|26597841|FG000|Overall Study|Withdrawal by Subject|0|||
13330795|NCT01109992|26597842|FG001|Overall Study|Withdrawal by Subject|1|||
13330796|NCT01109992|26597841|FG000|Overall Study|Movement during rest scan.|0|||
13330797|NCT01109992|26597842|FG001|Overall Study|Movement during rest scan.|1|||
13330798|NCT01109979|26597855|FG000|Overall Study|Physician Decision|2|||
13330799|NCT01109979|26597856|FG001|Overall Study|Physician Decision|0|||
13330800|NCT01109979|26597855|FG000|Overall Study|Withdrawal by Subject|0|||
13330801|NCT01109979|26597856|FG001|Overall Study|Withdrawal by Subject|1|||
13330802|NCT01109940|26597895|FG000|Overall Study|Administrative problems|2|||
13330803|NCT01109940|26597896|FG001|Overall Study|Administrative problems|0|||
13330804|NCT01109940|26597897|FG002|Overall Study|Administrative problems|0|||
13330805|NCT01109940|26597898|FG003|Overall Study|Administrative problems|0|||
13330806|NCT01109940|26597895|FG000|Overall Study|Serious Adverse Event|2|||
13330807|NCT01109940|26597896|FG001|Overall Study|Serious Adverse Event|1|||
13330808|NCT01109940|26597897|FG002|Overall Study|Serious Adverse Event|0|||
13330809|NCT01109940|26597898|FG003|Overall Study|Serious Adverse Event|0|||
13330810|NCT01109940|26597895|FG000|Overall Study|Lost to Follow-up|1|||
13330811|NCT01109940|26597896|FG001|Overall Study|Lost to Follow-up|0|||
13330812|NCT01109940|26597897|FG002|Overall Study|Lost to Follow-up|0|||
13330813|NCT01109940|26597898|FG003|Overall Study|Lost to Follow-up|0|||
13330814|NCT01109940|26597895|FG000|Overall Study|Patient withdrew consent|1|||
13330815|NCT01109940|26597896|FG001|Overall Study|Patient withdrew consent|1|||
13330816|NCT01109940|26597897|FG002|Overall Study|Patient withdrew consent|0|||
13330817|NCT01109940|26597898|FG003|Overall Study|Patient withdrew consent|0|||
13330818|NCT01109940|26597895|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
13330819|NCT01109940|26597896|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
13330820|NCT01109940|26597897|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
13330821|NCT01109940|26597898|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
13330822|NCT01109849|26597957|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9|||
13330823|NCT01109849|26597958|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35|||
13330824|NCT01109849|26597959|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
13330825|NCT01109849|26597960|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
13330826|NCT01109849|26597961|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
13330827|NCT01109849|26597957|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1|||
13330828|NCT01109849|26597958|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
13330829|NCT01109849|26597959|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
13330830|NCT01109849|26597960|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
13330831|NCT01109849|26597961|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
13330832|NCT01109849|26597957|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6|||
13330833|NCT01109849|26597958|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7|||
13330834|NCT01109849|26597959|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
13330835|NCT01109849|26597960|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
13330836|NCT01109849|26597961|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
13330837|NCT01109849|26597957|FG000|Initial Randomization: ADHD Treatment|move away|2|||
13330838|NCT01109849|26597958|FG001|Initial Randomization: ADHD Treatment|move away|7|||
13330839|NCT01109849|26597959|FG002|Initial Randomization: ADHD Treatment|move away|0|||
13330840|NCT01109849|26597960|FG003|Initial Randomization: ADHD Treatment|move away|0|||
13330841|NCT01109849|26597961|FG004|Initial Randomization: ADHD Treatment|move away|0|||
13330842|NCT01109849|26597957|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
13330843|NCT01109849|26597958|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
13330844|NCT01109849|26597959|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
13330845|NCT01109849|26597960|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
13330846|NCT01109849|26597961|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
13330847|NCT01109849|26597957|FG000|Adaptive Randomization: Weight Recovery|moved away|0|||
13330848|NCT01109849|26597958|FG001|Adaptive Randomization: Weight Recovery|moved away|0|||
13330849|NCT01109849|26597959|FG002|Adaptive Randomization: Weight Recovery|moved away|0|||
13330850|NCT01109849|26597960|FG003|Adaptive Randomization: Weight Recovery|moved away|2|||
13330851|NCT01109849|26597961|FG004|Adaptive Randomization: Weight Recovery|moved away|0|||
13330852|NCT01109524|26597973|FG000|Overall Study|Disease Progression|29|||
13330853|NCT01109524|26597973|FG000|Overall Study|Study Drug toxicity|6|||
13330854|NCT01109524|26597973|FG000|Overall Study|Adverse Event|4|||
13330855|NCT01109524|26597973|FG000|Overall Study|Withdrawal by Subject|2|||
13330856|NCT01109524|26597973|FG000|Overall Study|Maximum clinical benefit|3|||
13330857|NCT01109524|26597973|FG000|Overall Study|Death|2|||
13330858|NCT01109524|26597973|FG000|Overall Study|No longer meets criteria|2|||
13330859|NCT01109524|26597973|FG000|Overall Study|Participant requested to end treatment|4|||
13330860|NCT01109524|26597973|FG000|Overall Study|Other|5|||
13330861|NCT01109316|26598036|FG000|Study Period 1|Adverse Event|0|||
13330862|NCT01109316|26598037|FG001|Study Period 1|Adverse Event|0|||
13330863|NCT01109316|26598038|FG002|Study Period 1|Adverse Event|1|||
13330864|NCT01109316|26598039|FG003|Study Period 1|Adverse Event|0|||
13330865|NCT01109316|26598040|FG004|Study Period 1|Adverse Event|0|||
13330866|NCT01109316|26598041|FG005|Study Period 1|Adverse Event|0|||
13330867|NCT01109316|26598036|FG000|Study Period 1|Lost to Follow-up|0|||
13330868|NCT01109316|26598037|FG001|Study Period 1|Lost to Follow-up|0|||
13330869|NCT01109316|26598038|FG002|Study Period 1|Lost to Follow-up|1|||
13330870|NCT01109316|26598039|FG003|Study Period 1|Lost to Follow-up|1|||
13330871|NCT01109316|26598040|FG004|Study Period 1|Lost to Follow-up|0|||
13330872|NCT01109316|26598041|FG005|Study Period 1|Lost to Follow-up|0|||
13330873|NCT01109316|26598036|FG000|Study Period 1|Withdrawal by Subject|0|||
13330874|NCT01109316|26598037|FG001|Study Period 1|Withdrawal by Subject|0|||
13330875|NCT01109316|26598038|FG002|Study Period 1|Withdrawal by Subject|1|||
13330876|NCT01109316|26598039|FG003|Study Period 1|Withdrawal by Subject|0|||
13330877|NCT01109316|26598040|FG004|Study Period 1|Withdrawal by Subject|2|||
13330878|NCT01109316|26598041|FG005|Study Period 1|Withdrawal by Subject|0|||
13330879|NCT01109316|26598036|FG000|Study Period 1|Sponsor Decision|0|||
13330880|NCT01109316|26598037|FG001|Study Period 1|Sponsor Decision|0|||
13330881|NCT01109316|26598038|FG002|Study Period 1|Sponsor Decision|0|||
13330882|NCT01109316|26598039|FG003|Study Period 1|Sponsor Decision|0|||
13330883|NCT01109316|26598040|FG004|Study Period 1|Sponsor Decision|0|||
13330884|NCT01109316|26598041|FG005|Study Period 1|Sponsor Decision|2|||
13330885|NCT01109316|26598036|FG000|Study Period 2|Entry Criteria Not Met|0|||
13330886|NCT01109316|26598037|FG001|Study Period 2|Entry Criteria Not Met|1|||
13330887|NCT01109316|26598038|FG002|Study Period 2|Entry Criteria Not Met|0|||
13330888|NCT01109316|26598039|FG003|Study Period 2|Entry Criteria Not Met|0|||
13330889|NCT01109316|26598040|FG004|Study Period 2|Entry Criteria Not Met|0|||
13330890|NCT01109316|26598041|FG005|Study Period 2|Entry Criteria Not Met|0|||
13330891|NCT01109316|26598036|FG000|Study Period 2|Physician Decision|0|||
13330892|NCT01109316|26598037|FG001|Study Period 2|Physician Decision|0|||
13330893|NCT01109316|26598038|FG002|Study Period 2|Physician Decision|0|||
13330894|NCT01109316|26598039|FG003|Study Period 2|Physician Decision|1|||
13330895|NCT01109316|26598040|FG004|Study Period 2|Physician Decision|0|||
13330896|NCT01109316|26598041|FG005|Study Period 2|Physician Decision|0|||
13330897|NCT01109316|26598036|FG000|Study Period 2|Protocol Violation|1|||
13330898|NCT01109316|26598037|FG001|Study Period 2|Protocol Violation|0|||
13330899|NCT01109316|26598038|FG002|Study Period 2|Protocol Violation|0|||
13330900|NCT01109316|26598039|FG003|Study Period 2|Protocol Violation|0|||
13330901|NCT01109316|26598040|FG004|Study Period 2|Protocol Violation|0|||
13330902|NCT01109316|26598041|FG005|Study Period 2|Protocol Violation|0|||
13330903|NCT01109316|26598036|FG000|Study Period 2|Withdrawal by Subject|0|||
13330904|NCT01109316|26598037|FG001|Study Period 2|Withdrawal by Subject|0|||
13330905|NCT01109316|26598038|FG002|Study Period 2|Withdrawal by Subject|1|||
13330906|NCT01109316|26598039|FG003|Study Period 2|Withdrawal by Subject|0|||
13330907|NCT01109316|26598040|FG004|Study Period 2|Withdrawal by Subject|0|||
13330908|NCT01109316|26598041|FG005|Study Period 2|Withdrawal by Subject|1|||
13330909|NCT01109316|26598036|FG000|Study Period 3|Lost to Follow-up|0|||
13330910|NCT01109316|26598037|FG001|Study Period 3|Lost to Follow-up|0|||
13330911|NCT01109316|26598038|FG002|Study Period 3|Lost to Follow-up|0|||
13330912|NCT01109316|26598039|FG003|Study Period 3|Lost to Follow-up|0|||
13330913|NCT01109316|26598040|FG004|Study Period 3|Lost to Follow-up|1|||
13330914|NCT01109316|26598041|FG005|Study Period 3|Lost to Follow-up|0|||
13330915|NCT01109316|26598036|FG000|Study Period 3|Withdrawal by Subject|1|||
13330916|NCT01109316|26598037|FG001|Study Period 3|Withdrawal by Subject|0|||
13330917|NCT01109316|26598038|FG002|Study Period 3|Withdrawal by Subject|0|||
13330918|NCT01109316|26598039|FG003|Study Period 3|Withdrawal by Subject|0|||
13330919|NCT01109316|26598040|FG004|Study Period 3|Withdrawal by Subject|1|||
13330920|NCT01109316|26598041|FG005|Study Period 3|Withdrawal by Subject|0|||
13330921|NCT01109173|26598068|FG000|Overall Study|Adverse Event|15|||
13330922|NCT01109173|26598069|FG001|Overall Study|Adverse Event|17|||
13330923|NCT01109173|26598070|FG002|Overall Study|Adverse Event|9|||
13330924|NCT01109173|26598071|FG003|Overall Study|Adverse Event|6|||
13330925|NCT01109173|26598068|FG000|Overall Study|Lost to Follow-up|0|||
13330926|NCT01109173|26598069|FG001|Overall Study|Lost to Follow-up|1|||
13330927|NCT01109173|26598070|FG002|Overall Study|Lost to Follow-up|0|||
13330928|NCT01109173|26598071|FG003|Overall Study|Lost to Follow-up|0|||
13330929|NCT01109173|26598068|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5|||
13330930|NCT01109173|26598069|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
13330931|NCT01109173|26598070|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2|||
13330932|NCT01109173|26598071|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
13330933|NCT01109173|26598068|FG000|Overall Study|Noncompliance|0|||
13330934|NCT01109173|26598069|FG001|Overall Study|Noncompliance|1|||
13330935|NCT01109173|26598070|FG002|Overall Study|Noncompliance|0|||
13330936|NCT01109173|26598071|FG003|Overall Study|Noncompliance|0|||
13330937|NCT01109173|26598068|FG000|Overall Study|Treatment Failure|25|||
13330938|NCT01109173|26598069|FG001|Overall Study|Treatment Failure|32|||
13330939|NCT01109173|26598070|FG002|Overall Study|Treatment Failure|69|||
13330940|NCT01109173|26598071|FG003|Overall Study|Treatment Failure|64|||
13330941|NCT01109173|26598068|FG000|Overall Study|Protocol Violation|4|||
13330942|NCT01109173|26598069|FG001|Overall Study|Protocol Violation|5|||
13330943|NCT01109173|26598070|FG002|Overall Study|Protocol Violation|1|||
13330944|NCT01109173|26598071|FG003|Overall Study|Protocol Violation|2|||
13330945|NCT01109173|26598068|FG000|Overall Study|Patient Did Not Use Study Medication|34|||
13330946|NCT01109173|26598069|FG001|Overall Study|Patient Did Not Use Study Medication|26|||
13330947|NCT01109173|26598070|FG002|Overall Study|Patient Did Not Use Study Medication|11|||
13330948|NCT01109173|26598071|FG003|Overall Study|Patient Did Not Use Study Medication|7|||
13330949|NCT01109173|26598068|FG000|Overall Study|Not Specifiied|5|||
13330950|NCT01109173|26598069|FG001|Overall Study|Not Specifiied|4|||
13330951|NCT01109173|26598070|FG002|Overall Study|Not Specifiied|9|||
13330952|NCT01109173|26598071|FG003|Overall Study|Not Specifiied|14|||
13330953|NCT01108809|26598086|FG000|Overall Study|Adverse Event|3|||
13330954|NCT01108809|26598086|FG000|Overall Study|Lost to Follow-up|1|||
13330955|NCT01108796|26598129|FG000|Overall Study|Adverse Event|0|||
13330956|NCT01108796|26598130|FG001|Overall Study|Adverse Event|1|||
13330957|NCT01108796|26598129|FG000|Overall Study|Lost to Follow-up|7|||
13330958|NCT01108796|26598130|FG001|Overall Study|Lost to Follow-up|6|||
13330959|NCT01108731|26598147|FG000|Overall Study|Withdrawal by Subject|1|||
13330960|NCT01108731|26598148|FG001|Overall Study|Withdrawal by Subject|1|||
13122316|NCT02966028|25946730|FG000|Overall Study|Withdrawal by Subject|7|||
13122317|NCT02966028|25946731|FG001|Overall Study|Withdrawal by Subject|5|||
13330961|NCT01108731|26598147|FG000|Overall Study|Adverse Event|3|||
13330962|NCT01108731|26598148|FG001|Overall Study|Adverse Event|3|||
13330963|NCT01108718|26598160|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1|||
13330964|NCT01108718|26598161|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0|||
13330965|NCT01108523|26598168|FG000|Overall Study|Protocol Violation|4|||
13330966|NCT01108510|26598195|FG000|Overall Study|Randomized but Not Treated|5|||
13330967|NCT01108510|26598196|FG001|Overall Study|Randomized but Not Treated|1|||
13330968|NCT01108510|26598195|FG000|Overall Study|Joined Another Gilead-sponsored Study|186|||
13330969|NCT01108510|26598196|FG001|Overall Study|Joined Another Gilead-sponsored Study|195|||
13330970|NCT01108510|26598195|FG000|Overall Study|Adverse Event|26|||
13330971|NCT01108510|26598196|FG001|Overall Study|Adverse Event|19|||
13330972|NCT01108510|26598195|FG000|Overall Study|Lost to Follow-up|20|||
13330973|NCT01108510|26598196|FG001|Overall Study|Lost to Follow-up|17|||
13330974|NCT01108510|26598195|FG000|Overall Study|Withdrew Consent|21|||
13330975|NCT01108510|26598196|FG001|Overall Study|Withdrew Consent|15|||
13330976|NCT01108510|26598195|FG000|Overall Study|Investigator's Discretion|12|||
13330977|NCT01108510|26598196|FG001|Overall Study|Investigator's Discretion|10|||
13330978|NCT01108510|26598195|FG000|Overall Study|Participant Noncompliance|5|||
13330979|NCT01108510|26598196|FG001|Overall Study|Participant Noncompliance|7|||
13330980|NCT01108510|26598195|FG000|Overall Study|Lack of Efficacy|3|||
13330981|NCT01108510|26598196|FG001|Overall Study|Lack of Efficacy|0|||
13330982|NCT01108510|26598195|FG000|Overall Study|Pregnancy|0|||
13330983|NCT01108510|26598196|FG001|Overall Study|Pregnancy|3|||
13330984|NCT01108510|26598195|FG000|Overall Study|Death|1|||
13330985|NCT01108510|26598196|FG001|Overall Study|Death|1|||
13330986|NCT01108458|26598207|FG000|Overall Study|Withdrawal by Subject|1|||
13330987|NCT01108341|26598214|FG000|Overall Study|Death|2|||
13330988|NCT01108341|26598214|FG000|Overall Study|Withdrawal by Subject|1|||
13330989|NCT01108341|26598214|FG000|Overall Study|Lost to Follow-up|1|||
13330990|NCT01108341|26598214|FG000|Overall Study|Other|1|||
13330991|NCT01108263|26598229|FG000|Overall Study|Adverse Event|0|||
13330992|NCT01108263|26598230|FG001|Overall Study|Adverse Event|1|||
13330993|NCT01108237|26598243|FG000|Overall Study|No alignment data|2|||
13330994|NCT01108237|26598244|FG001|Overall Study|No alignment data|17|||
13330995|NCT01108237|26598243|FG000|Overall Study|Did not meet criteria for analysis|7|||
13330996|NCT01108237|26598244|FG001|Overall Study|Did not meet criteria for analysis|0|||
13330997|NCT01108185|26598259|FG000|Overall Study|Non-compliance|15|||
13330998|NCT01108185|26598259|FG000|Overall Study|Lost to Follow-up|12|||
13330999|NCT01108094|26598293|FG000|Overall Study|Adverse Event|2|||
13331000|NCT01108094|26598294|FG001|Overall Study|Adverse Event|0|||
13331001|NCT01108094|26598295|FG002|Overall Study|Adverse Event|0|||
13331002|NCT01108094|26598296|FG003|Overall Study|Adverse Event|0|||
13331003|NCT01108094|26598293|FG000|Overall Study|Withdrawal by Subject|1|||
13331004|NCT01108094|26598294|FG001|Overall Study|Withdrawal by Subject|0|||
13331005|NCT01108094|26598295|FG002|Overall Study|Withdrawal by Subject|0|||
13331006|NCT01108094|26598296|FG003|Overall Study|Withdrawal by Subject|0|||
13331007|NCT01108068|26598310|FG000|Overall Study|5 not started, 1 stop due to side effect|6|||
13331008|NCT01108068|26598311|FG001|Overall Study|5 not started, 1 stop due to side effect|0|||
13331009|NCT01108055|26598321|FG000|Overall Study|Ineligible|11|||
13331010|NCT01108055|26598321|FG000|Overall Study|Not evaluable- didn't complete treatment|4|||
13331011|NCT01107925|26598370|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
13331012|NCT01107925|26598371|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
13331013|NCT01107925|26598372|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
13331014|NCT01107925|26598373|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
13331015|NCT01107925|26598374|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
13331016|NCT01107925|26598375|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
13331017|NCT01107925|26598370|FG000|Period 2|Withdrawal by Subject|0|||
13331018|NCT01107925|26598371|FG001|Period 2|Withdrawal by Subject|1|||
13331019|NCT01107925|26598372|FG002|Period 2|Withdrawal by Subject|0|||
13331020|NCT01107925|26598373|FG003|Period 2|Withdrawal by Subject|0|||
13331021|NCT01107925|26598374|FG004|Period 2|Withdrawal by Subject|0|||
13331022|NCT01107925|26598375|FG005|Period 2|Withdrawal by Subject|1|||
13331023|NCT01107912|26598424|FG000|Period 1|Adverse Event|0|||
13331024|NCT01107912|26598425|FG001|Period 1|Adverse Event|0|||
13122318|NCT02966028|25946732|FG002|Overall Study|Withdrawal by Subject|5|||
13122319|NCT02966028|25946730|FG000|Overall Study|Kidney transplant Changed dialysis units|9|||
13122320|NCT02966028|25946731|FG001|Overall Study|Kidney transplant Changed dialysis units|16|||
13122321|NCT02966028|25946732|FG002|Overall Study|Kidney transplant Changed dialysis units|14|||
13122322|NCT02966015|25946745|FG000|Inclusion Visit|did not answer questionnaire|8|||
13122323|NCT02966015|25946746|FG001|Inclusion Visit|did not answer questionnaire|3|||
13122324|NCT02966002|25946755|FG000|Overall Study|Withdrawal by Subject|2|||
13122325|NCT02966002|25946755|FG000|Overall Study|Adverse Event|1|||
13331025|NCT01107912|26598426|FG002|Period 1|Adverse Event|0|||
13331026|NCT01107912|26598427|FG003|Period 1|Adverse Event|0|||
13331027|NCT01107912|26598428|FG004|Period 1|Adverse Event|2|||
13331028|NCT01107912|26598429|FG005|Period 1|Adverse Event|0|||
13331029|NCT01107912|26598424|FG000|Period 1|Physician Decision|0|||
13331030|NCT01107912|26598425|FG001|Period 1|Physician Decision|0|||
13331031|NCT01107912|26598426|FG002|Period 1|Physician Decision|0|||
13331032|NCT01107912|26598427|FG003|Period 1|Physician Decision|0|||
13331033|NCT01107912|26598428|FG004|Period 1|Physician Decision|1|||
13331034|NCT01107912|26598429|FG005|Period 1|Physician Decision|0|||
13331035|NCT01107912|26598424|FG000|Period 1|Withdrawal by Subject|1|||
13331036|NCT01107912|26598425|FG001|Period 1|Withdrawal by Subject|0|||
13331037|NCT01107912|26598426|FG002|Period 1|Withdrawal by Subject|0|||
13331038|NCT01107912|26598427|FG003|Period 1|Withdrawal by Subject|0|||
13331039|NCT01107912|26598428|FG004|Period 1|Withdrawal by Subject|0|||
13331040|NCT01107912|26598429|FG005|Period 1|Withdrawal by Subject|0|||
13331041|NCT01107912|26598424|FG000|Period 2|Physician Decision|0|||
13331042|NCT01107912|26598425|FG001|Period 2|Physician Decision|0|||
13331043|NCT01107912|26598426|FG002|Period 2|Physician Decision|1|||
13331044|NCT01107912|26598427|FG003|Period 2|Physician Decision|0|||
13331045|NCT01107912|26598428|FG004|Period 2|Physician Decision|0|||
13331046|NCT01107912|26598429|FG005|Period 2|Physician Decision|0|||
13331047|NCT01107912|26598424|FG000|Period 3|Adverse Event|0|||
13331048|NCT01107912|26598425|FG001|Period 3|Adverse Event|1|||
13331049|NCT01107912|26598426|FG002|Period 3|Adverse Event|1|||
13331050|NCT01107912|26598427|FG003|Period 3|Adverse Event|0|||
13331051|NCT01107912|26598428|FG004|Period 3|Adverse Event|0|||
13331052|NCT01107912|26598429|FG005|Period 3|Adverse Event|0|||
13331053|NCT01107912|26598424|FG000|Period 3|Withdrawal by Subject|0|||
13331054|NCT01107912|26598425|FG001|Period 3|Withdrawal by Subject|0|||
13331055|NCT01107912|26598426|FG002|Period 3|Withdrawal by Subject|0|||
13331056|NCT01107912|26598427|FG003|Period 3|Withdrawal by Subject|1|||
13331057|NCT01107912|26598428|FG004|Period 3|Withdrawal by Subject|0|||
13331058|NCT01107912|26598429|FG005|Period 3|Withdrawal by Subject|0|||
13331059|NCT01107899|26598483|FG000|Overall Study|Physician Decision|5|||
13331060|NCT01107899|26598484|FG001|Overall Study|Physician Decision|0|||
13331061|NCT01107899|26598485|FG002|Overall Study|Physician Decision|3|||
13331062|NCT01107899|26598483|FG000|Overall Study|Withdrawal by Subject|0|||
13331063|NCT01107899|26598484|FG001|Overall Study|Withdrawal by Subject|0|||
13331064|NCT01107899|26598485|FG002|Overall Study|Withdrawal by Subject|1|||
13331065|NCT01107886|26598502|FG000|Overall Study|Lost to Follow-up|15|||
13331066|NCT01107886|26598503|FG001|Overall Study|Lost to Follow-up|13|||
13331067|NCT01107886|26598502|FG000|Overall Study|Withdrawal by Subject|180|||
13331068|NCT01107886|26598503|FG001|Overall Study|Withdrawal by Subject|196|||
13331069|NCT01107886|26598502|FG000|Overall Study|Administrative withdrawal of consent|7|||
13331070|NCT01107886|26598503|FG001|Overall Study|Administrative withdrawal of consent|5|||
13331071|NCT01107743|26598591|FG000|Overall Study|Protocol Violation|46|||
13331072|NCT01107626|26598619|FG000|Step 1: Induction Therapy|Lack of Efficacy|167|||
13331073|NCT01107626|26598620|FG001|Step 1: Induction Therapy|Lack of Efficacy|0|||
13331074|NCT01107626|26598621|FG002|Step 1: Induction Therapy|Lack of Efficacy|0|||
13331075|NCT01107626|26598622|FG003|Step 1: Induction Therapy|Lack of Efficacy|0|||
13331076|NCT01107626|26598619|FG000|Step 1: Induction Therapy|Adverse Event|198|||
13331077|NCT01107626|26598620|FG001|Step 1: Induction Therapy|Adverse Event|0|||
13331078|NCT01107626|26598621|FG002|Step 1: Induction Therapy|Adverse Event|0|||
13331079|NCT01107626|26598622|FG003|Step 1: Induction Therapy|Adverse Event|0|||
13331080|NCT01107626|26598619|FG000|Step 1: Induction Therapy|Death|62|||
13331081|NCT01107626|26598620|FG001|Step 1: Induction Therapy|Death|0|||
13331082|NCT01107626|26598621|FG002|Step 1: Induction Therapy|Death|0|||
13331083|NCT01107626|26598622|FG003|Step 1: Induction Therapy|Death|0|||
13331084|NCT01107626|26598619|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54|||
13331085|NCT01107626|26598620|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0|||
13331086|NCT01107626|26598621|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0|||
13331087|NCT01107626|26598622|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0|||
13331088|NCT01107626|26598619|FG000|Step 1: Induction Therapy|Complicating disease|13|||
13331089|NCT01107626|26598620|FG001|Step 1: Induction Therapy|Complicating disease|0|||
13331090|NCT01107626|26598621|FG002|Step 1: Induction Therapy|Complicating disease|0|||
13331091|NCT01107626|26598622|FG003|Step 1: Induction Therapy|Complicating disease|0|||
13331092|NCT01107626|26598619|FG000|Step 1: Induction Therapy|Alternative therapy|12|||
13331093|NCT01107626|26598620|FG001|Step 1: Induction Therapy|Alternative therapy|0|||
13331094|NCT01107626|26598621|FG002|Step 1: Induction Therapy|Alternative therapy|0|||
13331095|NCT01107626|26598622|FG003|Step 1: Induction Therapy|Alternative therapy|0|||
13331096|NCT01107626|26598619|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10|||
13331097|NCT01107626|26598620|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0|||
13331098|NCT01107626|26598621|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0|||
13331099|NCT01107626|26598622|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0|||
13331100|NCT01107626|26598619|FG000|Step 1: Induction Therapy|Non-compliance|4|||
13331101|NCT01107626|26598620|FG001|Step 1: Induction Therapy|Non-compliance|0|||
13331102|NCT01107626|26598621|FG002|Step 1: Induction Therapy|Non-compliance|0|||
13331103|NCT01107626|26598622|FG003|Step 1: Induction Therapy|Non-compliance|0|||
13331104|NCT01107626|26598619|FG000|Step 1: Induction Therapy|Pain|4|||
13331105|NCT01107626|26598620|FG001|Step 1: Induction Therapy|Pain|0|||
13331106|NCT01107626|26598621|FG002|Step 1: Induction Therapy|Pain|0|||
13331107|NCT01107626|26598622|FG003|Step 1: Induction Therapy|Pain|0|||
13331108|NCT01107626|26598619|FG000|Step 1: Induction Therapy|Protocol Violation|1|||
13331109|NCT01107626|26598620|FG001|Step 1: Induction Therapy|Protocol Violation|0|||
13331110|NCT01107626|26598621|FG002|Step 1: Induction Therapy|Protocol Violation|0|||
13331111|NCT01107626|26598622|FG003|Step 1: Induction Therapy|Protocol Violation|0|||
13331112|NCT01107626|26598619|FG000|Step 1: Induction Therapy|Hospice care|1|||
13331113|NCT01107626|26598620|FG001|Step 1: Induction Therapy|Hospice care|0|||
13331114|NCT01107626|26598621|FG002|Step 1: Induction Therapy|Hospice care|0|||
13331115|NCT01107626|26598622|FG003|Step 1: Induction Therapy|Hospice care|0|||
13331116|NCT01107626|26598619|FG000|Step 1: Induction Therapy|Physician Decision|1|||
13331117|NCT01107626|26598620|FG001|Step 1: Induction Therapy|Physician Decision|0|||
13331118|NCT01107626|26598621|FG002|Step 1: Induction Therapy|Physician Decision|0|||
13331119|NCT01107626|26598622|FG003|Step 1: Induction Therapy|Physician Decision|0|||
13331120|NCT01107626|26598619|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50|||
13331121|NCT01107626|26598620|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0|||
13331122|NCT01107626|26598621|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0|||
13331123|NCT01107626|26598622|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0|||
13331124|NCT01107626|26598619|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0|||
13331125|NCT01107626|26598620|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
13331126|NCT01107626|26598621|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
13331127|NCT01107626|26598622|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170|||
13331128|NCT01107626|26598619|FG000|Step 2: Maintenance Therapy|Adverse Event|0|||
13331129|NCT01107626|26598620|FG001|Step 2: Maintenance Therapy|Adverse Event|32|||
13331130|NCT01107626|26598621|FG002|Step 2: Maintenance Therapy|Adverse Event|29|||
13331131|NCT01107626|26598622|FG003|Step 2: Maintenance Therapy|Adverse Event|46|||
13331132|NCT01107626|26598619|FG000|Step 2: Maintenance Therapy|Death|0|||
13331133|NCT01107626|26598620|FG001|Step 2: Maintenance Therapy|Death|8|||
13331134|NCT01107626|26598621|FG002|Step 2: Maintenance Therapy|Death|2|||
13331135|NCT01107626|26598622|FG003|Step 2: Maintenance Therapy|Death|13|||
13331136|NCT01107626|26598619|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0|||
13331137|NCT01107626|26598620|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11|||
13331138|NCT01107626|26598621|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21|||
13331139|NCT01107626|26598622|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27|||
13331140|NCT01107626|26598619|FG000|Step 2: Maintenance Therapy|Alternative therapy|0|||
13331141|NCT01107626|26598620|FG001|Step 2: Maintenance Therapy|Alternative therapy|2|||
13331142|NCT01107626|26598621|FG002|Step 2: Maintenance Therapy|Alternative therapy|4|||
13331143|NCT01107626|26598622|FG003|Step 2: Maintenance Therapy|Alternative therapy|5|||
13331144|NCT01107626|26598619|FG000|Step 2: Maintenance Therapy|Other complicating disease|0|||
13331145|NCT01107626|26598620|FG001|Step 2: Maintenance Therapy|Other complicating disease|2|||
13331146|NCT01107626|26598621|FG002|Step 2: Maintenance Therapy|Other complicating disease|5|||
13331147|NCT01107626|26598622|FG003|Step 2: Maintenance Therapy|Other complicating disease|9|||
13331148|NCT01107626|26598619|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0|||
13331149|NCT01107626|26598620|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2|||
13331150|NCT01107626|26598621|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4|||
13331151|NCT01107626|26598622|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3|||
13331152|NCT01107626|26598619|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0|||
13331153|NCT01107626|26598620|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
13331154|NCT01107626|26598621|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
13331155|NCT01107626|26598622|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3|||
13331156|NCT01107626|26598619|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
13331157|NCT01107626|26598620|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
13331158|NCT01107626|26598621|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
13331159|NCT01107626|26598622|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
13331160|NCT01107626|26598619|FG000|Step 2: Maintenance Therapy|Financial reason|0|||
13331161|NCT01107626|26598620|FG001|Step 2: Maintenance Therapy|Financial reason|2|||
13331162|NCT01107626|26598621|FG002|Step 2: Maintenance Therapy|Financial reason|0|||
13331163|NCT01107626|26598622|FG003|Step 2: Maintenance Therapy|Financial reason|0|||
13331164|NCT01107626|26598619|FG000|Step 2: Maintenance Therapy|Physician Decision|0|||
13331165|NCT01107626|26598620|FG001|Step 2: Maintenance Therapy|Physician Decision|2|||
13331166|NCT01107626|26598621|FG002|Step 2: Maintenance Therapy|Physician Decision|3|||
13331167|NCT01107626|26598622|FG003|Step 2: Maintenance Therapy|Physician Decision|3|||
13331168|NCT01107626|26598619|FG000|Step 2: Maintenance Therapy|Hospice care|0|||
13331169|NCT01107626|26598620|FG001|Step 2: Maintenance Therapy|Hospice care|1|||
13331170|NCT01107626|26598621|FG002|Step 2: Maintenance Therapy|Hospice care|2|||
13331171|NCT01107626|26598622|FG003|Step 2: Maintenance Therapy|Hospice care|0|||
13331172|NCT01107626|26598619|FG000|Step 2: Maintenance Therapy|Non-compliance|0|||
13331173|NCT01107626|26598620|FG001|Step 2: Maintenance Therapy|Non-compliance|0|||
13331174|NCT01107626|26598621|FG002|Step 2: Maintenance Therapy|Non-compliance|0|||
13331175|NCT01107626|26598622|FG003|Step 2: Maintenance Therapy|Non-compliance|2|||
13331176|NCT01107626|26598619|FG000|Step 2: Maintenance Therapy|Pain|0|||
13331177|NCT01107626|26598620|FG001|Step 2: Maintenance Therapy|Pain|0|||
13331178|NCT01107626|26598621|FG002|Step 2: Maintenance Therapy|Pain|0|||
13331179|NCT01107626|26598622|FG003|Step 2: Maintenance Therapy|Pain|1|||
13331180|NCT01107626|26598619|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0|||
13331181|NCT01107626|26598620|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
13331182|NCT01107626|26598621|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
13331183|NCT01107626|26598622|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10|||
13331184|NCT01107535|26598632|FG000|Overall Study|Death|5|||
13331185|NCT01107457|26598775|FG000|Part A|Adverse Event|1|||
13331186|NCT01107457|26598776|FG001|Part A|Adverse Event|2|||
13331187|NCT01107457|26598777|FG002|Part A|Adverse Event|1|||
13331188|NCT01107457|26598778|FG003|Part A|Adverse Event|0|||
13331189|NCT01107457|26598779|FG004|Part A|Adverse Event|0|||
13331190|NCT01107457|26598780|FG005|Part A|Adverse Event|0|||
13331191|NCT01107457|26598775|FG000|Part A|Withdrawal by Subject|3|||
13331192|NCT01107457|26598776|FG001|Part A|Withdrawal by Subject|3|||
13331193|NCT01107457|26598777|FG002|Part A|Withdrawal by Subject|0|||
13331194|NCT01107457|26598778|FG003|Part A|Withdrawal by Subject|3|||
13331195|NCT01107457|26598779|FG004|Part A|Withdrawal by Subject|1|||
13204002|NCT01977846|26226627|FG000|Total Study - Prospective|Not available at time of visit|0|||
13204003|NCT01977846|26226628|FG001|Total Study - Prospective|Not available at time of visit|5|||
13204004|NCT01977846|26226627|FG000|Total Study - Prospective|No show|0|||
13204005|NCT01977846|26226628|FG001|Total Study - Prospective|No show|1|||
13204006|NCT01977846|26226627|FG000|Total Study - Prospective|Protocol Violation|0|||
13204007|NCT01977846|26226628|FG001|Total Study - Prospective|Protocol Violation|1|||
13204008|NCT01977820|26226641|FG000|Overall Study|Sponsor terminated the study|1|||
13204009|NCT01977820|26226642|FG001|Overall Study|Sponsor terminated the study|1|||
13204010|NCT01977794|26226663|FG000|Overall Study|Adverse Event|2|||
13204011|NCT01977794|26226664|FG001|Overall Study|Adverse Event|2|||
13204012|NCT01977794|26226663|FG000|Overall Study|Lost to Follow-up|2|||
13204013|NCT01977794|26226664|FG001|Overall Study|Lost to Follow-up|1|||
13204014|NCT01977794|26226663|FG000|Overall Study|Protocol Violation|1|||
13204015|NCT01977794|26226664|FG001|Overall Study|Protocol Violation|0|||
13204016|NCT01977794|26226663|FG000|Overall Study|Death|1|||
13204017|NCT01977794|26226664|FG001|Overall Study|Death|1|||
13204018|NCT01977794|26226663|FG000|Overall Study|Withdrew consent|2|||
13204019|NCT01977794|26226664|FG001|Overall Study|Withdrew consent|1|||
13204020|NCT01977794|26226663|FG000|Overall Study|Other|0|||
13204021|NCT01977794|26226664|FG001|Overall Study|Other|1|||
13204022|NCT01977729|26226676|FG000|Overall Study|Study terminated|1|||
13204023|NCT01977690|26226689|FG000|Overall Study|Withdrawal by Subject|0|||
13204024|NCT01977690|26226690|FG001|Overall Study|Withdrawal by Subject|4|||
13204025|NCT01977677|26226711|FG000|Overall Study|Unrelated Adverse Event|0|||
13204026|NCT01977677|26226712|FG001|Overall Study|Unrelated Adverse Event|0|||
13204027|NCT01977677|26226713|FG002|Overall Study|Unrelated Adverse Event|1|||
13206740|NCT01954342|26235463|FG002|Overall Study|Missing data from 13-16week study visit|0|||
13206741|NCT01954342|26235464|FG003|Overall Study|Missing data from 13-16week study visit|1|||
13206742|NCT01954342|26235461|FG000|Overall Study|Miscarriage|0|||
13206743|NCT01954342|26235462|FG001|Overall Study|Miscarriage|0|||
13206744|NCT01954342|26235463|FG002|Overall Study|Miscarriage|0|||
13206745|NCT01954342|26235464|FG003|Overall Study|Miscarriage|3|||
13206746|NCT01954342|26235461|FG000|Overall Study|Lost to Follow-up|0|||
13206747|NCT01954342|26235462|FG001|Overall Study|Lost to Follow-up|0|||
13206748|NCT01954342|26235463|FG002|Overall Study|Lost to Follow-up|0|||
13206749|NCT01954342|26235464|FG003|Overall Study|Lost to Follow-up|5|||
13206750|NCT01954342|26235461|FG000|Overall Study|Preterm delivery|0|||
13206751|NCT01954342|26235462|FG001|Overall Study|Preterm delivery|0|||
13206752|NCT01954342|26235463|FG002|Overall Study|Preterm delivery|0|||
13206753|NCT01954342|26235464|FG003|Overall Study|Preterm delivery|3|||
13206754|NCT01954342|26235461|FG000|Overall Study|Pre-eclampsia|0|||
13206755|NCT01954342|26235462|FG001|Overall Study|Pre-eclampsia|0|||
13206756|NCT01954342|26235463|FG002|Overall Study|Pre-eclampsia|0|||
13206757|NCT01954342|26235464|FG003|Overall Study|Pre-eclampsia|4|||
13206758|NCT01954342|26235461|FG000|Overall Study|Unreliable Data|0|||
13206759|NCT01954342|26235462|FG001|Overall Study|Unreliable Data|0|||
13206760|NCT01954342|26235463|FG002|Overall Study|Unreliable Data|0|||
13206761|NCT01954342|26235464|FG003|Overall Study|Unreliable Data|2|||
13206762|NCT01954251|26235505|FG000|Overall Study|Adverse Event|5|||
13206763|NCT01954251|26235506|FG001|Overall Study|Adverse Event|7|||
13206764|NCT01954251|26235505|FG000|Overall Study|Lost to Follow-up|6|||
13206765|NCT01954251|26235506|FG001|Overall Study|Lost to Follow-up|6|||
13206766|NCT01954251|26235505|FG000|Overall Study|Withdrawal by Subject|2|||
13206767|NCT01954251|26235506|FG001|Overall Study|Withdrawal by Subject|6|||
13206768|NCT01954121|26235527|FG000|Overall Study|Lack of Efficacy|94|||
13206769|NCT01954121|26235528|FG001|Overall Study|Lack of Efficacy|41|||
13206770|NCT01954121|26235527|FG000|Overall Study|Protocol Violation|0|||
13206771|NCT01954121|26235528|FG001|Overall Study|Protocol Violation|2|||
13206772|NCT01954121|26235527|FG000|Overall Study|Lost to Follow-up|5|||
13206773|NCT01954121|26235528|FG001|Overall Study|Lost to Follow-up|6|||
13206774|NCT01954121|26235527|FG000|Overall Study|Withdrawal by Subject|18|||
13206775|NCT01954121|26235528|FG001|Overall Study|Withdrawal by Subject|12|||
13206776|NCT01954121|26235527|FG000|Overall Study|Pregnancy|1|||
13206777|NCT01954121|26235528|FG001|Overall Study|Pregnancy|1|||
13206778|NCT01954121|26235527|FG000|Overall Study|AE, serious fatal|1|||
13206779|NCT01954121|26235528|FG001|Overall Study|AE, serious fatal|0|||
13206780|NCT01954121|26235527|FG000|Overall Study|AE, non-serious non-fatal|5|||
13206781|NCT01954121|26235528|FG001|Overall Study|AE, non-serious non-fatal|22|||
13206782|NCT01954121|26235527|FG000|Overall Study|SAE, non-fatal|1|||
13206783|NCT01954121|26235528|FG001|Overall Study|SAE, non-fatal|4|||
13204028|NCT01977651|26226719|FG000|4 Month Treatment Period|Adverse Event|34|||
13204029|NCT01977651|26226719|FG000|4 Month Treatment Period|Death|3|||
13204030|NCT01977651|26226719|FG000|4 Month Treatment Period|Progressive Disease|43|||
13204031|NCT01977651|26226719|FG000|4 Month Treatment Period|Withdrawal by Subject|17|||
13204032|NCT01977651|26226719|FG000|4 Month Treatment Period|Physician Decision|4|||
13204033|NCT01977651|26226719|FG000|1 Year Extension Period|Adverse Event|14|||
13204034|NCT01977651|26226719|FG000|1 Year Extension Period|Death|10|||
13204035|NCT01977651|26226719|FG000|1 Year Extension Period|Lost to Follow-up|2|||
13204036|NCT01977651|26226719|FG000|1 Year Extension Period|Progressive Disease|86|||
13204037|NCT01977651|26226719|FG000|1 Year Extension Period|Withdrawal by Subject|11|||
13204038|NCT01977651|26226719|FG000|1 Year Extension Period|Physician Decision|6|||
13204039|NCT01977651|26226719|FG000|1 Year Extension Period|Miscellaneous|1|||
13204040|NCT01977651|26226719|FG000|Post 1 Year Extension Period|Adverse Event|5|||
13204041|NCT01977651|26226719|FG000|Post 1 Year Extension Period|Death|13|||
13204042|NCT01977651|26226719|FG000|Post 1 Year Extension Period|Progressive Disease|60|||
13204043|NCT01977651|26226719|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13|||
13204044|NCT01977651|26226719|FG000|Post 1 Year Extension Period|Physician Decision|4|||
13204045|NCT01977651|26226719|FG000|Post 1 Year Extension Period|Miscellaneous|49|||
13204046|NCT01977625|26226730|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
13204047|NCT01977625|26226731|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
13204048|NCT01977625|26226730|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
13204049|NCT01977625|26226731|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
13204050|NCT01977612|26226756|FG000|Overall Study|Lost to Follow-up|1|||
13204051|NCT01977612|26226757|FG001|Overall Study|Lost to Follow-up|1|||
13204052|NCT01977573|26226878|FG000|Overall Study|Adverse Event|7|||
13204053|NCT01977573|26226879|FG001|Overall Study|Adverse Event|0|||
13204054|NCT01977573|26226880|FG002|Overall Study|Adverse Event|2|||
13204055|NCT01977573|26226881|FG003|Overall Study|Adverse Event|1|||
13204056|NCT01977573|26226878|FG000|Overall Study|Lost to Follow-up|1|||
13204057|NCT01977573|26226879|FG001|Overall Study|Lost to Follow-up|0|||
13204058|NCT01977573|26226880|FG002|Overall Study|Lost to Follow-up|0|||
13204059|NCT01977573|26226881|FG003|Overall Study|Lost to Follow-up|1|||
13204060|NCT01977573|26226878|FG000|Overall Study|Physician Decision|1|||
13204061|NCT01977573|26226879|FG001|Overall Study|Physician Decision|0|||
13204062|NCT01977573|26226880|FG002|Overall Study|Physician Decision|0|||
13204063|NCT01977573|26226881|FG003|Overall Study|Physician Decision|0|||
13204064|NCT01977573|26226878|FG000|Overall Study|Protocol Violation|3|||
13204065|NCT01977573|26226879|FG001|Overall Study|Protocol Violation|1|||
13204066|NCT01977573|26226880|FG002|Overall Study|Protocol Violation|0|||
13204067|NCT01977573|26226881|FG003|Overall Study|Protocol Violation|0|||
13204068|NCT01977573|26226878|FG000|Overall Study|Reached Defined Stopping Criteria|2|||
13204069|NCT01977573|26226879|FG001|Overall Study|Reached Defined Stopping Criteria|1|||
13331196|NCT01107457|26598780|FG005|Part A|Withdrawal by Subject|0|||
13331197|NCT01107457|26598775|FG000|Part A|Lost to Follow-up|0|||
13331198|NCT01107457|26598776|FG001|Part A|Lost to Follow-up|1|||
13331199|NCT01107457|26598777|FG002|Part A|Lost to Follow-up|0|||
13331200|NCT01107457|26598778|FG003|Part A|Lost to Follow-up|0|||
13331201|NCT01107457|26598779|FG004|Part A|Lost to Follow-up|0|||
13331202|NCT01107457|26598780|FG005|Part A|Lost to Follow-up|0|||
13331203|NCT01107457|26598775|FG000|Part A|Lack of Efficacy|1|||
13331204|NCT01107457|26598776|FG001|Part A|Lack of Efficacy|0|||
13331205|NCT01107457|26598777|FG002|Part A|Lack of Efficacy|0|||
13331206|NCT01107457|26598778|FG003|Part A|Lack of Efficacy|0|||
13331207|NCT01107457|26598779|FG004|Part A|Lack of Efficacy|0|||
13331208|NCT01107457|26598780|FG005|Part A|Lack of Efficacy|0|||
13331209|NCT01107457|26598775|FG000|Part A|Protocol Violation|0|||
13331210|NCT01107457|26598776|FG001|Part A|Protocol Violation|1|||
13331211|NCT01107457|26598777|FG002|Part A|Protocol Violation|0|||
13331212|NCT01107457|26598778|FG003|Part A|Protocol Violation|0|||
13331213|NCT01107457|26598779|FG004|Part A|Protocol Violation|0|||
13331214|NCT01107457|26598780|FG005|Part A|Protocol Violation|0|||
13331215|NCT01107457|26598775|FG000|Part B and C|Adverse Event|0|||
13331216|NCT01107457|26598776|FG001|Part B and C|Adverse Event|0|||
13331217|NCT01107457|26598777|FG002|Part B and C|Adverse Event|0|||
13331218|NCT01107457|26598778|FG003|Part B and C|Adverse Event|0|||
13331219|NCT01107457|26598779|FG004|Part B and C|Adverse Event|0|||
13331220|NCT01107457|26598780|FG005|Part B and C|Adverse Event|12|||
13331221|NCT01107457|26598775|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
13331222|NCT01107457|26598776|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
13331223|NCT01107457|26598777|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
13331224|NCT01107457|26598778|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
13331225|NCT01107457|26598779|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
13331226|NCT01107457|26598780|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1|||
13331227|NCT01107457|26598775|FG000|Part B and C|Physician Decision|0|||
13331228|NCT01107457|26598776|FG001|Part B and C|Physician Decision|0|||
13204070|NCT01977573|26226880|FG002|Overall Study|Reached Defined Stopping Criteria|1|||
13331229|NCT01107457|26598777|FG002|Part B and C|Physician Decision|0|||
13331230|NCT01107457|26598778|FG003|Part B and C|Physician Decision|0|||
13331231|NCT01107457|26598779|FG004|Part B and C|Physician Decision|0|||
13331232|NCT01107457|26598780|FG005|Part B and C|Physician Decision|3|||
13331233|NCT01107457|26598775|FG000|Part B and C|Lack of Efficacy|0|||
13331234|NCT01107457|26598776|FG001|Part B and C|Lack of Efficacy|0|||
13331235|NCT01107457|26598777|FG002|Part B and C|Lack of Efficacy|0|||
13331236|NCT01107457|26598778|FG003|Part B and C|Lack of Efficacy|0|||
13331237|NCT01107457|26598779|FG004|Part B and C|Lack of Efficacy|0|||
13331238|NCT01107457|26598780|FG005|Part B and C|Lack of Efficacy|7|||
13331239|NCT01107457|26598775|FG000|Part B and C|Lost to Follow-up|0|||
13331240|NCT01107457|26598776|FG001|Part B and C|Lost to Follow-up|0|||
13331241|NCT01107457|26598777|FG002|Part B and C|Lost to Follow-up|0|||
13331242|NCT01107457|26598778|FG003|Part B and C|Lost to Follow-up|0|||
13331243|NCT01107457|26598779|FG004|Part B and C|Lost to Follow-up|0|||
13331244|NCT01107457|26598780|FG005|Part B and C|Lost to Follow-up|10|||
13331245|NCT01107457|26598775|FG000|Part B and C|Protocol Violation|0|||
13331246|NCT01107457|26598776|FG001|Part B and C|Protocol Violation|0|||
13331247|NCT01107457|26598777|FG002|Part B and C|Protocol Violation|0|||
13331248|NCT01107457|26598778|FG003|Part B and C|Protocol Violation|0|||
13331249|NCT01107457|26598779|FG004|Part B and C|Protocol Violation|0|||
13331250|NCT01107457|26598780|FG005|Part B and C|Protocol Violation|1|||
13331251|NCT01107457|26598775|FG000|Part B and C|Sponsor Decision|0|||
13331252|NCT01107457|26598776|FG001|Part B and C|Sponsor Decision|0|||
13331253|NCT01107457|26598777|FG002|Part B and C|Sponsor Decision|0|||
13331254|NCT01107457|26598778|FG003|Part B and C|Sponsor Decision|0|||
13331255|NCT01107457|26598779|FG004|Part B and C|Sponsor Decision|0|||
13331256|NCT01107457|26598780|FG005|Part B and C|Sponsor Decision|66|||
13331257|NCT01107457|26598775|FG000|Part B and C|Withdrawal by Subject|0|||
13331258|NCT01107457|26598776|FG001|Part B and C|Withdrawal by Subject|0|||
13331259|NCT01107457|26598777|FG002|Part B and C|Withdrawal by Subject|0|||
13331260|NCT01107457|26598778|FG003|Part B and C|Withdrawal by Subject|0|||
13331261|NCT01107457|26598779|FG004|Part B and C|Withdrawal by Subject|0|||
13331262|NCT01107457|26598780|FG005|Part B and C|Withdrawal by Subject|16|||
13331263|NCT01107457|26598775|FG000|Part B and C|Clinical Relapse|0|||
13331264|NCT01107457|26598776|FG001|Part B and C|Clinical Relapse|0|||
13331265|NCT01107457|26598777|FG002|Part B and C|Clinical Relapse|0|||
13331266|NCT01107457|26598778|FG003|Part B and C|Clinical Relapse|0|||
13331267|NCT01107457|26598779|FG004|Part B and C|Clinical Relapse|0|||
13331268|NCT01107457|26598780|FG005|Part B and C|Clinical Relapse|4|||
13331269|NCT01107444|26598817|FG000|Overall Study|Withdrawal by Subject|8|||
13331270|NCT01107444|26598818|FG001|Overall Study|Withdrawal by Subject|12|||
13331271|NCT01107444|26598817|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
13331272|NCT01107444|26598818|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
13331273|NCT01107418|26598896|FG000|Overall Study|Disease Progression|45|||
13331274|NCT01107418|26598896|FG000|Overall Study|Adverse Event|3|||
13331275|NCT01107418|26598896|FG000|Overall Study|Withdrawal by Subject|1|||
13331276|NCT01107418|26598896|FG000|Overall Study|Study Closing|1|||
13331277|NCT01107418|26598896|FG000|Overall Study|Started Other Therapy|1|||
13331278|NCT01107418|26598896|FG000|Overall Study|Entered Extension Study|1|||
13331279|NCT01107405|26598949|FG000|Overall Study|Adverse Event|1|||
13331280|NCT01107405|26598950|FG001|Overall Study|Adverse Event|1|||
13331281|NCT01107405|26598951|FG002|Overall Study|Adverse Event|0|||
13331282|NCT01107405|26598952|FG003|Overall Study|Adverse Event|0|||
13331283|NCT01107405|26598953|FG004|Overall Study|Adverse Event|2|||
13331284|NCT01107405|26598949|FG000|Overall Study|Withdrawal by Subject|1|||
13331285|NCT01107405|26598950|FG001|Overall Study|Withdrawal by Subject|0|||
13331286|NCT01107405|26598951|FG002|Overall Study|Withdrawal by Subject|1|||
13331287|NCT01107405|26598952|FG003|Overall Study|Withdrawal by Subject|2|||
13331288|NCT01107405|26598953|FG004|Overall Study|Withdrawal by Subject|1|||
13331289|NCT01107405|26598949|FG000|Overall Study|Protocol Violation|0|||
13331290|NCT01107405|26598950|FG001|Overall Study|Protocol Violation|0|||
13331291|NCT01107405|26598951|FG002|Overall Study|Protocol Violation|1|||
13331292|NCT01107405|26598952|FG003|Overall Study|Protocol Violation|1|||
13331293|NCT01107405|26598953|FG004|Overall Study|Protocol Violation|0|||
13331294|NCT01107392|26598972|FG000|Overall Study|Adverse Event|2|||
13331295|NCT01107392|26598973|FG001|Overall Study|Adverse Event|0|||
13331296|NCT01107392|26598972|FG000|Overall Study|Personal Reasons|2|||
13331297|NCT01107392|26598973|FG001|Overall Study|Personal Reasons|3|||
13331298|NCT01107392|26598972|FG000|Overall Study|Administrative decision|1|||
13331299|NCT01107392|26598973|FG001|Overall Study|Administrative decision|0|||
13331300|NCT01107379|26598984|FG000|Overall Study|Withdrawal by Subject|18|||
13331301|NCT01107379|26598984|FG000|Overall Study|Lost to Follow-up|3|||
13331302|NCT01107353|26598997|FG000|Overall Study|Positive Drug Screen|1|||
13331303|NCT01107353|26598998|FG001|Overall Study|Positive Drug Screen|0|||
13331304|NCT01107197|26599023|FG000|Overall Study|Death|12|||
13331305|NCT01107197|26599024|FG001|Overall Study|Death|10|||
13331306|NCT01107197|26599023|FG000|Overall Study|Lost to Follow-up|5|||
13331307|NCT01107197|26599024|FG001|Overall Study|Lost to Follow-up|8|||
13331308|NCT01107197|26599023|FG000|Overall Study|Withdrawal by Subject|3|||
13331309|NCT01107197|26599024|FG001|Overall Study|Withdrawal by Subject|5|||
13331310|NCT01106976|26599030|FG000|Overall Study|Lost to Follow-up|8|||
13331311|NCT01106911|26599036|FG000|Overall Study|Physician Decision|2|||
13331312|NCT01106911|26599036|FG000|Overall Study|deemed ineligible after screening|3|||
13331313|NCT01106898|26599042|FG000|Overall Study|Adverse Event|6|||
13331314|NCT01106846|26599055|FG000|Overall Study|Change in surgical procedure|0|||
13331315|NCT01106846|26599056|FG001|Overall Study|Change in surgical procedure|1|||
13331316|NCT01106690|26599098|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
13331317|NCT01106690|26599099|FG001|Core Period: Baseline to Week 26|Adverse Event|1|||
13331318|NCT01106690|26599100|FG002|Core Period: Baseline to Week 26|Adverse Event|4|||
13331319|NCT01106690|26599098|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
13331320|NCT01106690|26599099|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
13331321|NCT01106690|26599100|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
13331322|NCT01106690|26599098|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
13331323|NCT01106690|26599099|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
13331324|NCT01106690|26599100|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
13331325|NCT01106690|26599098|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
13331326|NCT01106690|26599099|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
13331327|NCT01106690|26599100|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0|||
13331328|NCT01106690|26599098|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0|||
13331329|NCT01106690|26599099|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
13331330|NCT01106690|26599100|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
13331331|NCT01106690|26599098|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
13331332|NCT01106690|26599099|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
13331333|NCT01106690|26599100|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
13331334|NCT01106690|26599098|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
13331335|NCT01106690|26599099|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
13331336|NCT01106690|26599100|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
13331337|NCT01106690|26599098|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
13122326|NCT02966002|25946755|FG000|Overall Study|Lost to Follow-up|1|||
13331338|NCT01106690|26599099|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
13331339|NCT01106690|26599100|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
13331340|NCT01106690|26599098|FG000|Core Period: Baseline to Week 26|Other|10|||
13331341|NCT01106690|26599099|FG001|Core Period: Baseline to Week 26|Other|2|||
13331342|NCT01106690|26599100|FG002|Core Period: Baseline to Week 26|Other|6|||
13331343|NCT01106690|26599098|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
13331344|NCT01106690|26599099|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
13331345|NCT01106690|26599100|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
13331346|NCT01106690|26599098|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
13331347|NCT01106690|26599099|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
13331348|NCT01106690|26599100|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
13331349|NCT01106690|26599098|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
13331350|NCT01106690|26599099|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2|||
13331351|NCT01106690|26599100|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
13331352|NCT01106690|26599098|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
13331353|NCT01106690|26599099|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
13331354|NCT01106690|26599100|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
13331355|NCT01106690|26599098|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
13331356|NCT01106690|26599099|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
13331357|NCT01106690|26599100|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
13331358|NCT01106690|26599098|FG000|Extension Period: Week 26 to Week 52|Other|8|||
13331359|NCT01106690|26599099|FG001|Extension Period: Week 26 to Week 52|Other|3|||
13331360|NCT01106690|26599100|FG002|Extension Period: Week 26 to Week 52|Other|4|||
13331361|NCT01106690|26599098|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
13331362|NCT01106690|26599099|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
13331363|NCT01106690|26599100|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
13331364|NCT01106677|26599173|FG000|Core Period: Baseline to Week 26|Adverse Event|7|||
13331365|NCT01106677|26599174|FG001|Core Period: Baseline to Week 26|Adverse Event|18|||
13331366|NCT01106677|26599175|FG002|Core Period: Baseline to Week 26|Adverse Event|6|||
13331367|NCT01106677|26599176|FG003|Core Period: Baseline to Week 26|Adverse Event|8|||
13331368|NCT01106677|26599173|FG000|Core Period: Baseline to Week 26|Death|0|||
13331369|NCT01106677|26599174|FG001|Core Period: Baseline to Week 26|Death|0|||
13331370|NCT01106677|26599175|FG002|Core Period: Baseline to Week 26|Death|1|||
13331371|NCT01106677|26599176|FG003|Core Period: Baseline to Week 26|Death|0|||
13331372|NCT01106677|26599173|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1|||
13331373|NCT01106677|26599174|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
13331374|NCT01106677|26599175|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
13331375|NCT01106677|26599176|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
13331376|NCT01106677|26599173|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
13331377|NCT01106677|26599174|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
13331378|NCT01106677|26599175|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6|||
13331379|NCT01106677|26599176|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
13331380|NCT01106677|26599173|FG000|Core Period: Baseline to Week 26|Physician Decision|2|||
13331381|NCT01106677|26599174|FG001|Core Period: Baseline to Week 26|Physician Decision|1|||
13331382|NCT01106677|26599175|FG002|Core Period: Baseline to Week 26|Physician Decision|3|||
13331383|NCT01106677|26599176|FG003|Core Period: Baseline to Week 26|Physician Decision|1|||
13331384|NCT01106677|26599173|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
13331385|NCT01106677|26599174|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
13331386|NCT01106677|26599175|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
13331387|NCT01106677|26599176|FG003|Core Period: Baseline to Week 26|Protocol Violation|3|||
13331388|NCT01106677|26599173|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5|||
13331389|NCT01106677|26599174|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
13331390|NCT01106677|26599175|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
13331391|NCT01106677|26599176|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
13331392|NCT01106677|26599173|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
13331393|NCT01106677|26599174|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
13331394|NCT01106677|26599175|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
13331395|NCT01106677|26599176|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
13331396|NCT01106677|26599173|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
13331397|NCT01106677|26599174|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
13331398|NCT01106677|26599175|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
13331399|NCT01106677|26599176|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
13331400|NCT01106677|26599173|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
13331401|NCT01106677|26599174|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1|||
13331402|NCT01106677|26599175|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2|||
13331403|NCT01106677|26599176|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
13331404|NCT01106677|26599173|FG000|Core Period: Baseline to Week 26|Product quality complaint|0|||
13331405|NCT01106677|26599174|FG001|Core Period: Baseline to Week 26|Product quality complaint|1|||
13331406|NCT01106677|26599175|FG002|Core Period: Baseline to Week 26|Product quality complaint|1|||
13331407|NCT01106677|26599176|FG003|Core Period: Baseline to Week 26|Product quality complaint|0|||
13331408|NCT01106677|26599173|FG000|Core Period: Baseline to Week 26|Other|8|||
13331409|NCT01106677|26599174|FG001|Core Period: Baseline to Week 26|Other|14|||
13331410|NCT01106677|26599175|FG002|Core Period: Baseline to Week 26|Other|8|||
13331411|NCT01106677|26599176|FG003|Core Period: Baseline to Week 26|Other|23|||
13331412|NCT01106677|26599173|FG000|Core Period: Baseline to Week 26|Pregnancy|0|||
13331413|NCT01106677|26599174|FG001|Core Period: Baseline to Week 26|Pregnancy|1|||
13331414|NCT01106677|26599175|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
13331415|NCT01106677|26599176|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
13331416|NCT01106677|26599173|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
13331417|NCT01106677|26599174|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
13331418|NCT01106677|26599175|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5|||
13331419|NCT01106677|26599176|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9|||
13331420|NCT01106677|26599173|FG000|Extension Period: Week 26 to Week 52|Death|0|||
13331421|NCT01106677|26599174|FG001|Extension Period: Week 26 to Week 52|Death|0|||
13331422|NCT01106677|26599175|FG002|Extension Period: Week 26 to Week 52|Death|0|||
13331423|NCT01106677|26599176|FG003|Extension Period: Week 26 to Week 52|Death|1|||
13331424|NCT01106677|26599173|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2|||
13331425|NCT01106677|26599174|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
13331426|NCT01106677|26599175|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
13331427|NCT01106677|26599176|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4|||
13331428|NCT01106677|26599173|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
13331429|NCT01106677|26599174|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
13331430|NCT01106677|26599175|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
13331431|NCT01106677|26599176|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
13331432|NCT01106677|26599173|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
13331433|NCT01106677|26599174|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3|||
13331434|NCT01106677|26599175|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
13331435|NCT01106677|26599176|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3|||
13331436|NCT01106677|26599173|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
13331437|NCT01106677|26599174|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
13331438|NCT01106677|26599175|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
13331439|NCT01106677|26599176|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
13331440|NCT01106677|26599173|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
13331441|NCT01106677|26599174|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3|||
13331442|NCT01106677|26599175|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
13331443|NCT01106677|26599176|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
13331444|NCT01106677|26599173|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
13331445|NCT01106677|26599174|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
13331446|NCT01106677|26599175|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3|||
13331447|NCT01106677|26599176|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
13331448|NCT01106677|26599173|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
13331449|NCT01106677|26599174|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
13331450|NCT01106677|26599175|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
13331451|NCT01106677|26599176|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
13331452|NCT01106677|26599173|FG000|Extension Period: Week 26 to Week 52|Other|6|||
13331453|NCT01106677|26599174|FG001|Extension Period: Week 26 to Week 52|Other|5|||
13331454|NCT01106677|26599175|FG002|Extension Period: Week 26 to Week 52|Other|8|||
13331455|NCT01106677|26599176|FG003|Extension Period: Week 26 to Week 52|Other|5|||
13331456|NCT01106651|26599236|FG000|Overall Study|Adverse Event|17|||
13331457|NCT01106651|26599237|FG001|Overall Study|Adverse Event|9|||
13331458|NCT01106651|26599238|FG002|Overall Study|Adverse Event|23|||
13331459|NCT01106651|26599236|FG000|Overall Study|Lost to Follow-up|8|||
13331460|NCT01106651|26599237|FG001|Overall Study|Lost to Follow-up|2|||
13331461|NCT01106651|26599238|FG002|Overall Study|Lost to Follow-up|6|||
13331462|NCT01106651|26599236|FG000|Overall Study|Physician Decision|4|||
13331463|NCT01106651|26599237|FG001|Overall Study|Physician Decision|3|||
13331464|NCT01106651|26599238|FG002|Overall Study|Physician Decision|1|||
13331465|NCT01106651|26599236|FG000|Overall Study|Protocol Violation|1|||
13331466|NCT01106651|26599237|FG001|Overall Study|Protocol Violation|2|||
13331467|NCT01106651|26599238|FG002|Overall Study|Protocol Violation|1|||
13331468|NCT01106651|26599236|FG000|Overall Study|Withdrawal by Subject|14|||
13331469|NCT01106651|26599237|FG001|Overall Study|Withdrawal by Subject|7|||
13331470|NCT01106651|26599238|FG002|Overall Study|Withdrawal by Subject|4|||
13331471|NCT01106651|26599236|FG000|Overall Study|Noncompliance with study drug|1|||
13331472|NCT01106651|26599237|FG001|Overall Study|Noncompliance with study drug|0|||
13331473|NCT01106651|26599238|FG002|Overall Study|Noncompliance with study drug|2|||
13331474|NCT01106651|26599236|FG000|Overall Study|Other|34|||
13331475|NCT01106651|26599237|FG001|Overall Study|Other|31|||
13331476|NCT01106651|26599238|FG002|Overall Study|Other|21|||
13331477|NCT01106651|26599236|FG000|Overall Study|Death|0|||
13331478|NCT01106651|26599237|FG001|Overall Study|Death|3|||
13331479|NCT01106651|26599238|FG002|Overall Study|Death|0|||
13331480|NCT01106625|26599277|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
13331481|NCT01106625|26599278|FG001|Core Period: Baseline to Week 26|Adverse Event|8|||
13331482|NCT01106625|26599279|FG002|Core Period: Baseline to Week 26|Adverse Event|8|||
13331483|NCT01106625|26599277|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
13331484|NCT01106625|26599278|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
13331485|NCT01106625|26599279|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4|||
13331486|NCT01106625|26599277|FG000|Core Period: Baseline to Week 26|Physician Decision|1|||
13331487|NCT01106625|26599278|FG001|Core Period: Baseline to Week 26|Physician Decision|0|||
13331488|NCT01106625|26599279|FG002|Core Period: Baseline to Week 26|Physician Decision|0|||
13331489|NCT01106625|26599277|FG000|Core Period: Baseline to Week 26|Protocol Violation|2|||
13331490|NCT01106625|26599278|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
13331491|NCT01106625|26599279|FG002|Core Period: Baseline to Week 26|Protocol Violation|3|||
13331492|NCT01106625|26599277|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
13331493|NCT01106625|26599278|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
13331494|NCT01106625|26599279|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7|||
13331495|NCT01106625|26599277|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4|||
13331496|NCT01106625|26599278|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
13331497|NCT01106625|26599279|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
13331498|NCT01106625|26599277|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0|||
13331499|NCT01106625|26599278|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
13331500|NCT01106625|26599279|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
13331501|NCT01106625|26599277|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
13331502|NCT01106625|26599278|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
13331503|NCT01106625|26599279|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
13331504|NCT01106625|26599277|FG000|Core Period: Baseline to Week 26|Other|8|||
13331505|NCT01106625|26599278|FG001|Core Period: Baseline to Week 26|Other|7|||
13331506|NCT01106625|26599279|FG002|Core Period: Baseline to Week 26|Other|4|||
13331507|NCT01106625|26599277|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
13331508|NCT01106625|26599278|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2|||
13331509|NCT01106625|26599279|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3|||
13331510|NCT01106625|26599277|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
13331511|NCT01106625|26599278|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3|||
13331512|NCT01106625|26599279|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
13331513|NCT01106625|26599277|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
13331514|NCT01106625|26599278|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
13331515|NCT01106625|26599279|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1|||
13331516|NCT01106625|26599277|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
13331517|NCT01106625|26599278|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
13331518|NCT01106625|26599279|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
13331519|NCT01106625|26599277|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4|||
13331520|NCT01106625|26599278|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
13331521|NCT01106625|26599279|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
13331522|NCT01106625|26599277|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14|||
13331523|NCT01106625|26599278|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5|||
13331524|NCT01106625|26599279|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4|||
13331525|NCT01106625|26599277|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
13331526|NCT01106625|26599278|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
13331527|NCT01106625|26599279|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
13331528|NCT01106625|26599277|FG000|Extension Period: Week 26 to Week 52|Other|5|||
13331529|NCT01106625|26599278|FG001|Extension Period: Week 26 to Week 52|Other|5|||
13331530|NCT01106625|26599279|FG002|Extension Period: Week 26 to Week 52|Other|4|||
13331531|NCT01106586|26599304|FG000|Overall Study|Adverse Event|9|||
13331532|NCT01106586|26599305|FG001|Overall Study|Adverse Event|15|||
13331533|NCT01106586|26599304|FG000|Overall Study|Death|1|||
13331534|NCT01106586|26599305|FG001|Overall Study|Death|3|||
13331535|NCT01106586|26599304|FG000|Overall Study|Pregnancy|2|||
13331536|NCT01106586|26599305|FG001|Overall Study|Pregnancy|2|||
13331537|NCT01106586|26599304|FG000|Overall Study|Lack of Efficacy|1|||
13331538|NCT01106586|26599305|FG001|Overall Study|Lack of Efficacy|0|||
13331539|NCT01106586|26599304|FG000|Overall Study|Investigator's Discretion|5|||
13331540|NCT01106586|26599305|FG001|Overall Study|Investigator's Discretion|8|||
13331541|NCT01106586|26599304|FG000|Overall Study|Withdrew Consent|18|||
13331542|NCT01106586|26599305|FG001|Overall Study|Withdrew Consent|30|||
13331543|NCT01106586|26599304|FG000|Overall Study|Lost to Follow-up|24|||
13331544|NCT01106586|26599305|FG001|Overall Study|Lost to Follow-up|20|||
13331545|NCT01106586|26599304|FG000|Overall Study|Participant Noncompliance|12|||
13331546|NCT01106586|26599305|FG001|Overall Study|Participant Noncompliance|10|||
13331547|NCT01106586|26599304|FG000|Overall Study|Protocol Violation|1|||
13331548|NCT01106586|26599305|FG001|Overall Study|Protocol Violation|0|||
13331549|NCT01106586|26599304|FG000|Overall Study|Participant Transferred to Another Study|212|||
13331550|NCT01106586|26599305|FG001|Overall Study|Participant Transferred to Another Study|197|||
13331551|NCT01106534|26599328|FG000|Overall Study|Withdrawal by Subject|18|||
13331552|NCT01106534|26599328|FG000|Overall Study|Lost to Follow-up|2|||
13331553|NCT01106534|26599328|FG000|Overall Study|Death|16|||
13331554|NCT01106534|26599328|FG000|Overall Study|Physician Decision|1|||
13331555|NCT01106430|26599355|FG000|Overall Study|Adverse Event|8|||
13331556|NCT01106430|26599356|FG001|Overall Study|Adverse Event|10|||
13331557|NCT01106430|26599355|FG000|Overall Study|Lack of Efficacy|2|||
13331558|NCT01106430|26599356|FG001|Overall Study|Lack of Efficacy|13|||
13331559|NCT01106430|26599355|FG000|Overall Study|Lost to Follow-up|5|||
13331560|NCT01106430|26599356|FG001|Overall Study|Lost to Follow-up|1|||
13331561|NCT01106430|26599355|FG000|Overall Study|Early Termination Requested By Sponsor|1|||
13331562|NCT01106430|26599356|FG001|Overall Study|Early Termination Requested By Sponsor|0|||
13331563|NCT01106430|26599355|FG000|Overall Study|Moved Out Of State|0|||
13331564|NCT01106430|26599356|FG001|Overall Study|Moved Out Of State|1|||
13331565|NCT01106430|26599355|FG000|Overall Study|Refused To Take Medication|0|||
13331566|NCT01106430|26599356|FG001|Overall Study|Refused To Take Medication|1|||
13331567|NCT01106430|26599355|FG000|Overall Study|Noncompliance|0|||
13331568|NCT01106430|26599356|FG001|Overall Study|Noncompliance|1|||
13331569|NCT01106430|26599355|FG000|Overall Study|Hard Time Swallowing The Pills|1|||
13331570|NCT01106430|26599356|FG001|Overall Study|Hard Time Swallowing The Pills|0|||
13331571|NCT01106430|26599355|FG000|Overall Study|Previous Use Of Marijuana|1|||
13331572|NCT01106430|26599356|FG001|Overall Study|Previous Use Of Marijuana|0|||
13331573|NCT01106430|26599355|FG000|Overall Study|Protocol Violation|7|||
13331574|NCT01106430|26599356|FG001|Overall Study|Protocol Violation|2|||
13331575|NCT01106430|26599355|FG000|Overall Study|Withdrawal by Subject|8|||
13331576|NCT01106430|26599356|FG001|Overall Study|Withdrawal by Subject|4|||
13331577|NCT01106404|26599376|FG000|Period I (First 6 Weeks)|Adverse Event|2|||
13331578|NCT01106404|26599377|FG001|Period I (First 6 Weeks)|Adverse Event|0|||
13331579|NCT01106404|26599376|FG000|Period I (First 6 Weeks)|Physician Decision|1|||
13331580|NCT01106404|26599377|FG001|Period I (First 6 Weeks)|Physician Decision|0|||
13331581|NCT01106404|26599376|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0|||
13331582|NCT01106404|26599377|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1|||
13331583|NCT01106404|26599376|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0|||
13331584|NCT01106404|26599377|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1|||
13331585|NCT01106352|26599479|FG000|Overall Study|Subjects untreated|0|||
13331586|NCT01106352|26599480|FG001|Overall Study|Subjects untreated|0|||
13331587|NCT01106352|26599481|FG002|Overall Study|Subjects untreated|0|||
13331588|NCT01106352|26599482|FG003|Overall Study|Subjects untreated|3|||
13331589|NCT01106352|26599483|FG004|Overall Study|Subjects untreated|4|||
13331590|NCT01106352|26599479|FG000|Overall Study|Sponsor Decision|1|||
13331591|NCT01106352|26599480|FG001|Overall Study|Sponsor Decision|0|||
13331592|NCT01106352|26599481|FG002|Overall Study|Sponsor Decision|0|||
13331593|NCT01106352|26599482|FG003|Overall Study|Sponsor Decision|0|||
13331594|NCT01106352|26599483|FG004|Overall Study|Sponsor Decision|0|||
13331595|NCT01106352|26599479|FG000|Overall Study|Too ill to come in for the visit|0|||
13331596|NCT01106352|26599480|FG001|Overall Study|Too ill to come in for the visit|0|||
13331597|NCT01106352|26599481|FG002|Overall Study|Too ill to come in for the visit|1|||
13331598|NCT01106352|26599482|FG003|Overall Study|Too ill to come in for the visit|0|||
13331599|NCT01106352|26599483|FG004|Overall Study|Too ill to come in for the visit|0|||
13331600|NCT01106352|26599479|FG000|Overall Study|Lost to Follow-up|0|||
13331601|NCT01106352|26599480|FG001|Overall Study|Lost to Follow-up|0|||
13331602|NCT01106352|26599481|FG002|Overall Study|Lost to Follow-up|0|||
13331603|NCT01106352|26599482|FG003|Overall Study|Lost to Follow-up|0|||
13331604|NCT01106352|26599483|FG004|Overall Study|Lost to Follow-up|1|||
13331605|NCT01106352|26599479|FG000|Overall Study|Death|0|||
13331606|NCT01106352|26599480|FG001|Overall Study|Death|0|||
13331607|NCT01106352|26599481|FG002|Overall Study|Death|1|||
13331608|NCT01106352|26599482|FG003|Overall Study|Death|3|||
13331609|NCT01106352|26599483|FG004|Overall Study|Death|1|||
13331610|NCT01106352|26599479|FG000|Overall Study|Disease progression|0|||
13331611|NCT01106352|26599480|FG001|Overall Study|Disease progression|0|||
13331612|NCT01106352|26599481|FG002|Overall Study|Disease progression|0|||
13331613|NCT01106352|26599482|FG003|Overall Study|Disease progression|1|||
13331614|NCT01106352|26599483|FG004|Overall Study|Disease progression|0|||
13331615|NCT01106352|26599479|FG000|Overall Study|Withdrawal by Subject|0|||
13331616|NCT01106352|26599480|FG001|Overall Study|Withdrawal by Subject|0|||
13331617|NCT01106352|26599481|FG002|Overall Study|Withdrawal by Subject|0|||
13331618|NCT01106352|26599482|FG003|Overall Study|Withdrawal by Subject|3|||
13331619|NCT01106352|26599483|FG004|Overall Study|Withdrawal by Subject|2|||
13331620|NCT01106352|26599479|FG000|Overall Study|Went on hospice|0|||
13331621|NCT01106352|26599480|FG001|Overall Study|Went on hospice|0|||
13331622|NCT01106352|26599481|FG002|Overall Study|Went on hospice|0|||
13331623|NCT01106352|26599482|FG003|Overall Study|Went on hospice|1|||
13331624|NCT01106352|26599483|FG004|Overall Study|Went on hospice|0|||
13331625|NCT01106352|26599479|FG000|Overall Study|Subject entered hospice|0|||
13331626|NCT01106352|26599480|FG001|Overall Study|Subject entered hospice|0|||
13331627|NCT01106352|26599481|FG002|Overall Study|Subject entered hospice|0|||
13331628|NCT01106352|26599482|FG003|Overall Study|Subject entered hospice|1|||
13331629|NCT01106352|26599483|FG004|Overall Study|Subject entered hospice|0|||
13331630|NCT01106352|26599479|FG000|Overall Study|Home hospice since July 2013|0|||
13331631|NCT01106352|26599480|FG001|Overall Study|Home hospice since July 2013|0|||
13331632|NCT01106352|26599481|FG002|Overall Study|Home hospice since July 2013|0|||
13331633|NCT01106352|26599482|FG003|Overall Study|Home hospice since July 2013|1|||
13331634|NCT01106352|26599483|FG004|Overall Study|Home hospice since July 2013|0|||
13331635|NCT01106287|26599516|FG000|Overall Study|Adverse Event|1|||
13331636|NCT01106287|26599517|FG001|Overall Study|Adverse Event|0|||
13331637|NCT01106287|26599518|FG002|Overall Study|Adverse Event|0|||
13331638|NCT01106287|26599519|FG003|Overall Study|Adverse Event|0|||
13331639|NCT01106248|26599527|FG000|Overall Study|Adverse Event|1|||
13331640|NCT01106248|26599527|FG000|Overall Study|Administrative|2|||
13331641|NCT01106157|26599558|FG000|Overall Study|Withdrawal by Subject|1|||
13331642|NCT01106157|26599559|FG001|Overall Study|Withdrawal by Subject|0|||
13331643|NCT01106092|26599650|FG000|Overall Study|Withdrawal by Subject|0|||
13331644|NCT01106092|26599651|FG001|Overall Study|Withdrawal by Subject|0|||
13331645|NCT01106092|26599652|FG002|Overall Study|Withdrawal by Subject|0|||
13331646|NCT01106092|26599653|FG003|Overall Study|Withdrawal by Subject|1|||
13331647|NCT01106027|26599659|FG000|Overall Study|Lost graft early, discontinued|1|||
13331648|NCT01106014|26599676|FG000|Overall Study|Morbidity or Mortality primary endpoint|155|||
13331649|NCT01106014|26599677|FG001|Overall Study|Morbidity or Mortality primary endpoint|242|||
13331650|NCT01106014|26599676|FG000|Overall Study|Adverse Event|78|||
13331651|NCT01106014|26599677|FG001|Overall Study|Adverse Event|42|||
13331652|NCT01106014|26599676|FG000|Overall Study|Withdrawal by Subject|43|||
13331653|NCT01106014|26599677|FG001|Overall Study|Withdrawal by Subject|37|||
13331654|NCT01106014|26599676|FG000|Overall Study|Administrative reason|7|||
13331655|NCT01106014|26599677|FG001|Overall Study|Administrative reason|6|||
13331656|NCT01106014|26599676|FG000|Overall Study|Lost to Follow-up|2|||
13331657|NCT01106014|26599677|FG001|Overall Study|Lost to Follow-up|3|||
13331658|NCT01105975|26599856|FG000|Overall Study|Adverse Event|2|||
13331659|NCT01105975|26599857|FG001|Overall Study|Adverse Event|1|||
13331660|NCT01105975|26599858|FG002|Overall Study|Adverse Event|5|||
13331661|NCT01105975|26599859|FG003|Overall Study|Adverse Event|1|||
13331662|NCT01105975|26599860|FG004|Overall Study|Adverse Event|0|||
13331663|NCT01105975|26599861|FG005|Overall Study|Adverse Event|1|||
13331664|NCT01105975|26599862|FG006|Overall Study|Adverse Event|2|||
13331665|NCT01105975|26599863|FG007|Overall Study|Adverse Event|4|||
13331666|NCT01105975|26599864|FG008|Overall Study|Adverse Event|1|||
13331667|NCT01105975|26599865|FG009|Overall Study|Adverse Event|4|||
13331668|NCT01105975|26599856|FG000|Overall Study|Withdrawal by Subject|2|||
13331669|NCT01105975|26599857|FG001|Overall Study|Withdrawal by Subject|2|||
13331670|NCT01105975|26599858|FG002|Overall Study|Withdrawal by Subject|2|||
13331671|NCT01105975|26599859|FG003|Overall Study|Withdrawal by Subject|0|||
13331672|NCT01105975|26599860|FG004|Overall Study|Withdrawal by Subject|4|||
13331673|NCT01105975|26599861|FG005|Overall Study|Withdrawal by Subject|1|||
13331674|NCT01105975|26599862|FG006|Overall Study|Withdrawal by Subject|2|||
13331675|NCT01105975|26599863|FG007|Overall Study|Withdrawal by Subject|1|||
13331676|NCT01105975|26599864|FG008|Overall Study|Withdrawal by Subject|0|||
13331677|NCT01105975|26599865|FG009|Overall Study|Withdrawal by Subject|3|||
13331678|NCT01105975|26599856|FG000|Overall Study|Lost to Follow-up|1|||
13331679|NCT01105975|26599857|FG001|Overall Study|Lost to Follow-up|0|||
13331680|NCT01105975|26599858|FG002|Overall Study|Lost to Follow-up|0|||
13331681|NCT01105975|26599859|FG003|Overall Study|Lost to Follow-up|1|||
13331682|NCT01105975|26599860|FG004|Overall Study|Lost to Follow-up|1|||
13331683|NCT01105975|26599861|FG005|Overall Study|Lost to Follow-up|0|||
13331684|NCT01105975|26599862|FG006|Overall Study|Lost to Follow-up|0|||
13331685|NCT01105975|26599863|FG007|Overall Study|Lost to Follow-up|0|||
13331686|NCT01105975|26599864|FG008|Overall Study|Lost to Follow-up|1|||
13331687|NCT01105975|26599865|FG009|Overall Study|Lost to Follow-up|0|||
13331688|NCT01105975|26599856|FG000|Overall Study|Physician Decision|0|||
13331689|NCT01105975|26599857|FG001|Overall Study|Physician Decision|0|||
13331690|NCT01105975|26599858|FG002|Overall Study|Physician Decision|0|||
13331691|NCT01105975|26599859|FG003|Overall Study|Physician Decision|0|||
13331692|NCT01105975|26599860|FG004|Overall Study|Physician Decision|0|||
13331693|NCT01105975|26599861|FG005|Overall Study|Physician Decision|0|||
13331694|NCT01105975|26599862|FG006|Overall Study|Physician Decision|2|||
13331695|NCT01105975|26599863|FG007|Overall Study|Physician Decision|0|||
13331696|NCT01105975|26599864|FG008|Overall Study|Physician Decision|0|||
13331697|NCT01105975|26599865|FG009|Overall Study|Physician Decision|0|||
13331698|NCT01105975|26599856|FG000|Overall Study|Protocol Violation|0|||
13331699|NCT01105975|26599857|FG001|Overall Study|Protocol Violation|2|||
13331700|NCT01105975|26599858|FG002|Overall Study|Protocol Violation|2|||
13331701|NCT01105975|26599859|FG003|Overall Study|Protocol Violation|0|||
13331702|NCT01105975|26599860|FG004|Overall Study|Protocol Violation|1|||
13331703|NCT01105975|26599861|FG005|Overall Study|Protocol Violation|1|||
13331704|NCT01105975|26599862|FG006|Overall Study|Protocol Violation|1|||
13331705|NCT01105975|26599863|FG007|Overall Study|Protocol Violation|1|||
13331706|NCT01105975|26599864|FG008|Overall Study|Protocol Violation|2|||
13331707|NCT01105975|26599865|FG009|Overall Study|Protocol Violation|2|||
13331708|NCT01105975|26599856|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
13331709|NCT01105975|26599857|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
13331710|NCT01105975|26599858|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
13331711|NCT01105975|26599859|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
13331712|NCT01105975|26599860|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
13331713|NCT01105975|26599861|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
13331714|NCT01105975|26599862|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
13331715|NCT01105975|26599863|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
13331716|NCT01105975|26599864|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
13331717|NCT01105975|26599865|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
13331718|NCT01105936|26599896|FG000|Period 1|Adverse Event|0|||
13331719|NCT01105936|26599897|FG001|Period 1|Adverse Event|0|||
13331720|NCT01105936|26599898|FG002|Period 1|Adverse Event|0|||
13331721|NCT01105936|26599899|FG003|Period 1|Adverse Event|1|||
13331722|NCT01105936|26599896|FG000|Period 2|Adverse Event|1|||
13331723|NCT01105936|26599897|FG001|Period 2|Adverse Event|0|||
13331724|NCT01105936|26599898|FG002|Period 2|Adverse Event|0|||
13331725|NCT01105936|26599899|FG003|Period 2|Adverse Event|0|||
13331726|NCT01105936|26599896|FG000|Period 3|Protocol Violation|0|||
13331727|NCT01105936|26599897|FG001|Period 3|Protocol Violation|2|||
13331728|NCT01105936|26599898|FG002|Period 3|Protocol Violation|0|||
13331729|NCT01105936|26599899|FG003|Period 3|Protocol Violation|0|||
13331730|NCT01105767|26599920|FG000|Overall Study|Lost to Follow-up|1160|||
13331731|NCT01105767|26599921|FG001|Overall Study|Lost to Follow-up|1614|||
13331732|NCT01105767|26599922|FG002|Overall Study|Lost to Follow-up|1184|||
13331733|NCT01105533|26600020|FG000|Overall Study|Death|0|||
13331734|NCT01105533|26600021|FG001|Overall Study|Death|0|||
13331735|NCT01105533|26600022|FG002|Overall Study|Death|0|||
13331736|NCT01105533|26600023|FG003|Overall Study|Death|0|||
13331737|NCT01105533|26600024|FG004|Overall Study|Death|1|||
13331738|NCT01105533|26600025|FG005|Overall Study|Death|0|||
13331739|NCT01105533|26600026|FG006|Overall Study|Death|0|||
13331740|NCT01105533|26600027|FG007|Overall Study|Death|0|||
13331741|NCT01105533|26600028|FG008|Overall Study|Death|0|||
13331742|NCT01105533|26600020|FG000|Overall Study|Lack of Efficacy|1|||
13331743|NCT01105533|26600021|FG001|Overall Study|Lack of Efficacy|1|||
13331744|NCT01105533|26600022|FG002|Overall Study|Lack of Efficacy|3|||
13331745|NCT01105533|26600023|FG003|Overall Study|Lack of Efficacy|3|||
13331746|NCT01105533|26600024|FG004|Overall Study|Lack of Efficacy|4|||
13331747|NCT01105533|26600025|FG005|Overall Study|Lack of Efficacy|5|||
13331748|NCT01105533|26600026|FG006|Overall Study|Lack of Efficacy|3|||
13331749|NCT01105533|26600027|FG007|Overall Study|Lack of Efficacy|2|||
13331750|NCT01105533|26600028|FG008|Overall Study|Lack of Efficacy|9|||
13331751|NCT01105533|26600020|FG000|Overall Study|Adverse Event|0|||
13331752|NCT01105533|26600021|FG001|Overall Study|Adverse Event|0|||
13331753|NCT01105533|26600022|FG002|Overall Study|Adverse Event|0|||
13331754|NCT01105533|26600023|FG003|Overall Study|Adverse Event|0|||
13331755|NCT01105533|26600024|FG004|Overall Study|Adverse Event|1|||
13331756|NCT01105533|26600025|FG005|Overall Study|Adverse Event|2|||
13331757|NCT01105533|26600026|FG006|Overall Study|Adverse Event|2|||
13331758|NCT01105533|26600027|FG007|Overall Study|Adverse Event|0|||
13331759|NCT01105533|26600028|FG008|Overall Study|Adverse Event|1|||
13331760|NCT01105533|26600020|FG000|Overall Study|Other|0|||
13331761|NCT01105533|26600021|FG001|Overall Study|Other|0|||
13331762|NCT01105533|26600022|FG002|Overall Study|Other|0|||
13331763|NCT01105533|26600023|FG003|Overall Study|Other|0|||
13331764|NCT01105533|26600024|FG004|Overall Study|Other|1|||
13331765|NCT01105533|26600025|FG005|Overall Study|Other|0|||
13331766|NCT01105533|26600026|FG006|Overall Study|Other|3|||
13331767|NCT01105533|26600027|FG007|Overall Study|Other|1|||
13331768|NCT01105533|26600028|FG008|Overall Study|Other|2|||
13331769|NCT01105533|26600020|FG000|Overall Study|Physician Decision|0|||
13331770|NCT01105533|26600021|FG001|Overall Study|Physician Decision|0|||
13331771|NCT01105533|26600022|FG002|Overall Study|Physician Decision|0|||
13331772|NCT01105533|26600023|FG003|Overall Study|Physician Decision|0|||
13331773|NCT01105533|26600024|FG004|Overall Study|Physician Decision|0|||
13331774|NCT01105533|26600025|FG005|Overall Study|Physician Decision|0|||
13331775|NCT01105533|26600026|FG006|Overall Study|Physician Decision|0|||
13331776|NCT01105533|26600027|FG007|Overall Study|Physician Decision|1|||
13331777|NCT01105533|26600028|FG008|Overall Study|Physician Decision|0|||
13331778|NCT01105377|26600043|FG000|Overall Study|Withdrawal by Subject|0|||
13331779|NCT01105377|26600044|FG001|Overall Study|Withdrawal by Subject|1|||
13331780|NCT01105130|26600071|FG000|Overall Study|Withdrawal by Subject|4|||
13331781|NCT01105130|26600072|FG001|Overall Study|Withdrawal by Subject|6|||
13331782|NCT01105130|26600073|FG002|Overall Study|Withdrawal by Subject|2|||
13331783|NCT01105130|26600071|FG000|Overall Study|Never Started|2|||
13288282|NCT01089127|26475392|FG005|Overall Study|Adverse Event|1|||
13288283|NCT01089127|26475387|FG000|Overall Study|Subject withdrew consent|0|||
13288284|NCT01089127|26475388|FG001|Overall Study|Subject withdrew consent|1|||
13288285|NCT01089127|26475389|FG002|Overall Study|Subject withdrew consent|1|||
13288286|NCT01089127|26475390|FG003|Overall Study|Subject withdrew consent|1|||
13288287|NCT01089127|26475391|FG004|Overall Study|Subject withdrew consent|0|||
13288288|NCT01089127|26475392|FG005|Overall Study|Subject withdrew consent|2|||
13288289|NCT01089127|26475387|FG000|Overall Study|Abnormal test procedure result(s)|2|||
13288290|NCT01089127|26475388|FG001|Overall Study|Abnormal test procedure result(s)|1|||
13288291|NCT01089127|26475389|FG002|Overall Study|Abnormal test procedure result(s)|0|||
13288292|NCT01089127|26475390|FG003|Overall Study|Abnormal test procedure result(s)|0|||
13331784|NCT01105130|26600072|FG001|Overall Study|Never Started|2|||
13331785|NCT01105130|26600073|FG002|Overall Study|Never Started|4|||
13331786|NCT01105130|26600071|FG000|Overall Study|Toxicity|1|||
13288293|NCT01089127|26475391|FG004|Overall Study|Abnormal test procedure result(s)|0|||
13288294|NCT01089127|26475392|FG005|Overall Study|Abnormal test procedure result(s)|0|||
13288295|NCT01089127|26475387|FG000|Overall Study|Lost to Follow-up|1|||
13288296|NCT01089127|26475388|FG001|Overall Study|Lost to Follow-up|1|||
13288297|NCT01089127|26475389|FG002|Overall Study|Lost to Follow-up|0|||
13288298|NCT01089127|26475390|FG003|Overall Study|Lost to Follow-up|0|||
13288299|NCT01089127|26475391|FG004|Overall Study|Lost to Follow-up|1|||
13288300|NCT01089127|26475392|FG005|Overall Study|Lost to Follow-up|0|||
13288301|NCT01089127|26475387|FG000|Overall Study|Protocol deviation|0|||
13288302|NCT01089127|26475388|FG001|Overall Study|Protocol deviation|1|||
13331787|NCT01105130|26600072|FG001|Overall Study|Toxicity|3|||
13331788|NCT01105130|26600073|FG002|Overall Study|Toxicity|2|||
13331789|NCT01105130|26600071|FG000|Overall Study|Multiple Reasons|3|||
13331790|NCT01105130|26600072|FG001|Overall Study|Multiple Reasons|0|||
13331791|NCT01105130|26600073|FG002|Overall Study|Multiple Reasons|2|||
13331792|NCT01105091|26600104|FG000|Overall Study|Death|2|||
13331793|NCT01105091|26600105|FG001|Overall Study|Death|0|||
13331794|NCT01105065|26600113|FG000|Overall Study|Adverse Event|5|||
13331795|NCT01105065|26600113|FG000|Overall Study|Technical Problems|1|||
13288303|NCT01089127|26475389|FG002|Overall Study|Protocol deviation|0|||
13288304|NCT01089127|26475390|FG003|Overall Study|Protocol deviation|0|||
13288305|NCT01089127|26475391|FG004|Overall Study|Protocol deviation|1|||
13288306|NCT01089127|26475392|FG005|Overall Study|Protocol deviation|0|||
13288307|NCT01089023|26475406|FG000|Overall Study|Lost to Follow-up|3|||
13288308|NCT01089023|26475406|FG000|Overall Study|Adverse Event|1|||
13288309|NCT01089023|26475406|FG000|Overall Study|Withdrawal by Subject|1|||
13288310|NCT01089023|26475406|FG000|Overall Study|Protocol Violation|1|||
13288311|NCT01089023|26475406|FG000|Overall Study|Lack of Efficacy|1|||
13288312|NCT01088997|26475422|FG000|Overall Study|Physician Decision|1|||
13288313|NCT01088997|26475423|FG001|Overall Study|Physician Decision|1|||
13331796|NCT01104870|26600152|FG000|Overall Study|Adverse Event|1|||
13331797|NCT01104870|26600153|FG001|Overall Study|Adverse Event|1|||
13331798|NCT01104870|26600154|FG002|Overall Study|Adverse Event|0|||
13331799|NCT01104870|26600152|FG000|Overall Study|Death|0|||
13288314|NCT01088997|26475422|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
13288315|NCT01088997|26475423|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
13288316|NCT01088997|26475422|FG000|Overall Study|Excluded prior to receiving drug|1|||
13288317|NCT01088997|26475423|FG001|Overall Study|Excluded prior to receiving drug|1|||
13288318|NCT01088984|26475448|FG000|Phase 1|Death|2|||
13288319|NCT01088984|26475449|FG001|Phase 1|Death|1|||
13288320|NCT01088984|26475448|FG000|Phase 1|Disease Progression|2|||
13288321|NCT01088984|26475449|FG001|Phase 1|Disease Progression|4|||
13288322|NCT01088984|26475448|FG000|Phase 1|Other|1|||
13288323|NCT01088984|26475449|FG001|Phase 1|Other|1|||
13288324|NCT01088984|26475448|FG000|Phase 2|Death|0|||
13288325|NCT01088984|26475449|FG001|Phase 2|Death|5|||
13288326|NCT01088984|26475448|FG000|Phase 2|Withdrawal by Subject|0|||
13288327|NCT01088984|26475449|FG001|Phase 2|Withdrawal by Subject|1|||
13288328|NCT01088984|26475448|FG000|Phase 2|DIsease Progression|0|||
13288329|NCT01088984|26475449|FG001|Phase 2|DIsease Progression|25|||
13288330|NCT01088984|26475448|FG000|Phase 2|Other|0|||
13288331|NCT01088984|26475449|FG001|Phase 2|Other|1|||
13288332|NCT01088529|26475466|FG000|Overall Study|Did not receive study treatment|0|||
13288333|NCT01088529|26475467|FG001|Overall Study|Did not receive study treatment|1|||
13288334|NCT01088438|26475484|FG000|Overall Study|Withdrawal by Subject|11|||
13288335|NCT01088438|26475485|FG001|Overall Study|Withdrawal by Subject|6|||
13288336|NCT01088438|26475484|FG000|Overall Study|Lost to Follow-up|18|||
13288337|NCT01088438|26475485|FG001|Overall Study|Lost to Follow-up|30|||
13288338|NCT01088243|26475508|FG000|Overall Study|Adverse Event|1|||
13288339|NCT01088243|26475509|FG001|Overall Study|Adverse Event|0|||
13288340|NCT01088048|26475633|FG000|Overall Study|Adverse Event|7|||
13288341|NCT01088048|26475634|FG001|Overall Study|Adverse Event|9|||
13288342|NCT01088048|26475635|FG002|Overall Study|Adverse Event|7|||
13288343|NCT01088048|26475636|FG003|Overall Study|Adverse Event|5|||
13288344|NCT01088048|26475637|FG004|Overall Study|Adverse Event|6|||
13288345|NCT01088048|26475638|FG005|Overall Study|Adverse Event|3|||
13288346|NCT01088048|26475639|FG006|Overall Study|Adverse Event|3|||
13288347|NCT01088048|26475640|FG007|Overall Study|Adverse Event|0|||
13288348|NCT01088048|26475641|FG008|Overall Study|Adverse Event|2|||
13288349|NCT01088048|26475642|FG009|Overall Study|Adverse Event|2|||
13288350|NCT01088048|26475633|FG000|Overall Study|Withdrew Consent|1|||
13331800|NCT01104870|26600153|FG001|Overall Study|Death|0|||
13331801|NCT01104870|26600154|FG002|Overall Study|Death|1|||
13331802|NCT01104870|26600152|FG000|Overall Study|Withdrawal by Subject|0|||
13331803|NCT01104870|26600153|FG001|Overall Study|Withdrawal by Subject|0|||
13331804|NCT01104870|26600154|FG002|Overall Study|Withdrawal by Subject|1|||
13331805|NCT01104792|26600161|FG000|Overall Study|Adverse Event|77|||
13331806|NCT01104792|26600161|FG000|Overall Study|Insufficient Therapeutic Response|22|||
13288351|NCT01088048|26475634|FG001|Overall Study|Withdrew Consent|1|||
13288352|NCT01088048|26475635|FG002|Overall Study|Withdrew Consent|1|||
13288353|NCT01088048|26475636|FG003|Overall Study|Withdrew Consent|1|||
13288354|NCT01088048|26475637|FG004|Overall Study|Withdrew Consent|2|||
13288355|NCT01088048|26475638|FG005|Overall Study|Withdrew Consent|1|||
13288356|NCT01088048|26475639|FG006|Overall Study|Withdrew Consent|0|||
13288357|NCT01088048|26475640|FG007|Overall Study|Withdrew Consent|2|||
13288358|NCT01088048|26475641|FG008|Overall Study|Withdrew Consent|2|||
13288359|NCT01088048|26475642|FG009|Overall Study|Withdrew Consent|1|||
13288360|NCT01088048|26475633|FG000|Overall Study|Concomitant Medication Prohibited|1|||
13288361|NCT01088048|26475634|FG001|Overall Study|Concomitant Medication Prohibited|0|||
13288362|NCT01088048|26475635|FG002|Overall Study|Concomitant Medication Prohibited|0|||
13288363|NCT01088048|26475636|FG003|Overall Study|Concomitant Medication Prohibited|0|||
13288364|NCT01088048|26475637|FG004|Overall Study|Concomitant Medication Prohibited|0|||
13288365|NCT01088048|26475638|FG005|Overall Study|Concomitant Medication Prohibited|0|||
13288366|NCT01088048|26475639|FG006|Overall Study|Concomitant Medication Prohibited|0|||
13288367|NCT01088048|26475640|FG007|Overall Study|Concomitant Medication Prohibited|0|||
13288368|NCT01088048|26475641|FG008|Overall Study|Concomitant Medication Prohibited|0|||
13288369|NCT01088048|26475642|FG009|Overall Study|Concomitant Medication Prohibited|0|||
13292265|NCT00706901|26485116|FG000|Overall Study|Lost to Follow-up|2|||
13288370|NCT01088048|26475633|FG000|Overall Study|Investigator Request|2|||
13288371|NCT01088048|26475634|FG001|Overall Study|Investigator Request|2|||
13288372|NCT01088048|26475635|FG002|Overall Study|Investigator Request|0|||
13288373|NCT01088048|26475636|FG003|Overall Study|Investigator Request|0|||
13288374|NCT01088048|26475637|FG004|Overall Study|Investigator Request|3|||
13288375|NCT01088048|26475638|FG005|Overall Study|Investigator Request|1|||
13331807|NCT01104792|26600161|FG000|Overall Study|Protocol Violation|45|||
13331808|NCT01104792|26600161|FG000|Overall Study|Withdrawal of Consent|179|||
13331809|NCT01104792|26600161|FG000|Overall Study|Lost to Follow-up|43|||
13331810|NCT01104792|26600161|FG000|Overall Study|Reasons Not Specified|27|||
13331811|NCT01104792|26600161|FG000|Overall Study|Did Not Meet Eligibility Criteria|133|||
13331812|NCT01104779|26600182|FG000|Overall Study|Protocol Violation|1|||
13331813|NCT01104779|26600183|FG001|Overall Study|Protocol Violation|2|||
13331814|NCT01104779|26600184|FG002|Overall Study|Protocol Violation|2|||
13331815|NCT01104779|26600182|FG000|Overall Study|Lack of Efficacy|26|||
13331816|NCT01104779|26600183|FG001|Overall Study|Lack of Efficacy|12|||
13331817|NCT01104779|26600184|FG002|Overall Study|Lack of Efficacy|13|||
13331818|NCT01104779|26600182|FG000|Overall Study|Adverse Event|13|||
13331819|NCT01104779|26600183|FG001|Overall Study|Adverse Event|14|||
13331820|NCT01104779|26600184|FG002|Overall Study|Adverse Event|13|||
13331821|NCT01104779|26600182|FG000|Overall Study|Did not meet inc/exc criteria|1|||
13331822|NCT01104779|26600183|FG001|Overall Study|Did not meet inc/exc criteria|1|||
13331823|NCT01104779|26600184|FG002|Overall Study|Did not meet inc/exc criteria|1|||
13331824|NCT01104779|26600182|FG000|Overall Study|Other reasons|0|||
13331825|NCT01104779|26600183|FG001|Overall Study|Other reasons|1|||
13331826|NCT01104779|26600184|FG002|Overall Study|Other reasons|0|||
13331827|NCT01104779|26600182|FG000|Overall Study|Lost to Follow-up|2|||
13331828|NCT01104779|26600183|FG001|Overall Study|Lost to Follow-up|0|||
13331829|NCT01104779|26600184|FG002|Overall Study|Lost to Follow-up|1|||
13331830|NCT01104779|26600182|FG000|Overall Study|Withdrawal by Subject|16|||
13331831|NCT01104779|26600183|FG001|Overall Study|Withdrawal by Subject|25|||
13331832|NCT01104779|26600184|FG002|Overall Study|Withdrawal by Subject|32|||
13331833|NCT01104766|26600211|FG000|Overall Study|Did not meet inc/exc criteria|1|||
13331834|NCT01104766|26600212|FG001|Overall Study|Did not meet inc/exc criteria|0|||
13331835|NCT01104766|26600213|FG002|Overall Study|Did not meet inc/exc criteria|0|||
13331836|NCT01104766|26600214|FG003|Overall Study|Did not meet inc/exc criteria|0|||
13331837|NCT01104766|26600211|FG000|Overall Study|Adverse Event|17|||
13331838|NCT01104766|26600212|FG001|Overall Study|Adverse Event|15|||
13331839|NCT01104766|26600213|FG002|Overall Study|Adverse Event|20|||
13288376|NCT01088048|26475639|FG006|Overall Study|Investigator Request|1|||
13288377|NCT01088048|26475640|FG007|Overall Study|Investigator Request|0|||
13288378|NCT01088048|26475641|FG008|Overall Study|Investigator Request|0|||
13288379|NCT01088048|26475642|FG009|Overall Study|Investigator Request|0|||
13331840|NCT01104766|26600214|FG003|Overall Study|Adverse Event|14|||
13331841|NCT01104766|26600211|FG000|Overall Study|Lack of Efficacy|20|||
13331842|NCT01104766|26600212|FG001|Overall Study|Lack of Efficacy|15|||
13331843|NCT01104766|26600213|FG002|Overall Study|Lack of Efficacy|14|||
13331844|NCT01104766|26600214|FG003|Overall Study|Lack of Efficacy|8|||
13331845|NCT01104766|26600211|FG000|Overall Study|Protocol Violation|2|||
13331846|NCT01104766|26600212|FG001|Overall Study|Protocol Violation|0|||
13331847|NCT01104766|26600213|FG002|Overall Study|Protocol Violation|0|||
13331848|NCT01104766|26600214|FG003|Overall Study|Protocol Violation|0|||
13331849|NCT01104766|26600211|FG000|Overall Study|Withdrawal by Subject|17|||
13331850|NCT01104766|26600212|FG001|Overall Study|Withdrawal by Subject|19|||
13331851|NCT01104766|26600213|FG002|Overall Study|Withdrawal by Subject|25|||
13331852|NCT01104766|26600214|FG003|Overall Study|Withdrawal by Subject|15|||
13331853|NCT01104766|26600211|FG000|Overall Study|Lost to Follow-up|1|||
13331854|NCT01104766|26600212|FG001|Overall Study|Lost to Follow-up|2|||
13331855|NCT01104766|26600213|FG002|Overall Study|Lost to Follow-up|1|||
13331856|NCT01104766|26600214|FG003|Overall Study|Lost to Follow-up|1|||
13331857|NCT01104701|26600281|FG000|Overall Study|Withdrawal by Subject|0|||
13331858|NCT01104701|26600282|FG001|Overall Study|Withdrawal by Subject|1|||
13331859|NCT01104701|26600283|FG002|Overall Study|Withdrawal by Subject|2|||
13331860|NCT01104701|26600284|FG003|Overall Study|Withdrawal by Subject|1|||
13331861|NCT01104701|26600281|FG000|Overall Study|Adverse Event|0|||
13331862|NCT01104701|26600282|FG001|Overall Study|Adverse Event|0|||
13331863|NCT01104701|26600283|FG002|Overall Study|Adverse Event|0|||
13331864|NCT01104701|26600284|FG003|Overall Study|Adverse Event|1|||
13331865|NCT01104701|26600281|FG000|Overall Study|Physician Decision|0|||
13331866|NCT01104701|26600282|FG001|Overall Study|Physician Decision|2|||
13331867|NCT01104701|26600283|FG002|Overall Study|Physician Decision|0|||
13288380|NCT01088048|26475633|FG000|Overall Study|Patient Non-compliance|0|||
13331868|NCT01104701|26600284|FG003|Overall Study|Physician Decision|0|||
13331869|NCT01104662|26600335|FG000|Overall Study|Adverse Event|2|||
13331870|NCT01104662|26600336|FG001|Overall Study|Adverse Event|2|||
13331871|NCT01104662|26600337|FG002|Overall Study|Adverse Event|0|||
13331872|NCT01104662|26600338|FG003|Overall Study|Adverse Event|1|||
13331873|NCT01104662|26600339|FG004|Overall Study|Adverse Event|1|||
13331874|NCT01104662|26600340|FG005|Overall Study|Adverse Event|1|||
13331875|NCT01104662|26600341|FG006|Overall Study|Adverse Event|0|||
13331876|NCT01104662|26600342|FG007|Overall Study|Adverse Event|0|||
13331877|NCT01104662|26600335|FG000|Overall Study|Clinical Failure|1|||
13331878|NCT01104662|26600336|FG001|Overall Study|Clinical Failure|0|||
13331879|NCT01104662|26600337|FG002|Overall Study|Clinical Failure|0|||
13331880|NCT01104662|26600338|FG003|Overall Study|Clinical Failure|0|||
13331881|NCT01104662|26600339|FG004|Overall Study|Clinical Failure|0|||
13331882|NCT01104662|26600340|FG005|Overall Study|Clinical Failure|1|||
13331883|NCT01104662|26600341|FG006|Overall Study|Clinical Failure|0|||
13331884|NCT01104662|26600342|FG007|Overall Study|Clinical Failure|0|||
13331885|NCT01104662|26600335|FG000|Overall Study|Participant left investigator's care|1|||
13331886|NCT01104662|26600336|FG001|Overall Study|Participant left investigator's care|1|||
13331887|NCT01104662|26600337|FG002|Overall Study|Participant left investigator's care|0|||
13331888|NCT01104662|26600338|FG003|Overall Study|Participant left investigator's care|0|||
13331889|NCT01104662|26600339|FG004|Overall Study|Participant left investigator's care|0|||
13331890|NCT01104662|26600340|FG005|Overall Study|Participant left investigator's care|0|||
13288381|NCT01088048|26475634|FG001|Overall Study|Patient Non-compliance|1|||
13288382|NCT01088048|26475635|FG002|Overall Study|Patient Non-compliance|0|||
13288383|NCT01088048|26475636|FG003|Overall Study|Patient Non-compliance|0|||
13288384|NCT01088048|26475637|FG004|Overall Study|Patient Non-compliance|0|||
13288385|NCT01088048|26475638|FG005|Overall Study|Patient Non-compliance|0|||
13288386|NCT01088048|26475639|FG006|Overall Study|Patient Non-compliance|0|||
13288387|NCT01088048|26475640|FG007|Overall Study|Patient Non-compliance|0|||
13288388|NCT01088048|26475641|FG008|Overall Study|Patient Non-compliance|0|||
13288389|NCT01088048|26475642|FG009|Overall Study|Patient Non-compliance|0|||
13288390|NCT01088048|26475633|FG000|Overall Study|Disease Progression|7|||
13288391|NCT01088048|26475634|FG001|Overall Study|Disease Progression|4|||
13288392|NCT01088048|26475635|FG002|Overall Study|Disease Progression|3|||
13288393|NCT01088048|26475636|FG003|Overall Study|Disease Progression|5|||
13288394|NCT01088048|26475637|FG004|Overall Study|Disease Progression|3|||
13288395|NCT01088048|26475638|FG005|Overall Study|Disease Progression|3|||
13288396|NCT01088048|26475639|FG006|Overall Study|Disease Progression|2|||
13288397|NCT01088048|26475640|FG007|Overall Study|Disease Progression|1|||
13288398|NCT01088048|26475641|FG008|Overall Study|Disease Progression|0|||
13288399|NCT01088048|26475642|FG009|Overall Study|Disease Progression|0|||
13288400|NCT01088048|26475633|FG000|Overall Study|Death|1|||
13288401|NCT01088048|26475634|FG001|Overall Study|Death|5|||
13288402|NCT01088048|26475635|FG002|Overall Study|Death|3|||
13288403|NCT01088048|26475636|FG003|Overall Study|Death|3|||
13288404|NCT01088048|26475637|FG004|Overall Study|Death|1|||
13288405|NCT01088048|26475638|FG005|Overall Study|Death|3|||
13288406|NCT01088048|26475639|FG006|Overall Study|Death|0|||
13288407|NCT01088048|26475640|FG007|Overall Study|Death|0|||
13288408|NCT01088048|26475641|FG008|Overall Study|Death|3|||
13288409|NCT01088048|26475642|FG009|Overall Study|Death|1|||
13288410|NCT01088048|26475633|FG000|Overall Study|Other|3|||
13288411|NCT01088048|26475634|FG001|Overall Study|Other|5|||
13288412|NCT01088048|26475635|FG002|Overall Study|Other|0|||
13288413|NCT01088048|26475636|FG003|Overall Study|Other|0|||
13288414|NCT01088048|26475637|FG004|Overall Study|Other|2|||
13288415|NCT01088048|26475638|FG005|Overall Study|Other|0|||
13288416|NCT01088048|26475639|FG006|Overall Study|Other|0|||
13288417|NCT01088048|26475640|FG007|Overall Study|Other|2|||
13288418|NCT01088048|26475641|FG008|Overall Study|Other|0|||
13288419|NCT01088048|26475642|FG009|Overall Study|Other|0|||
13288420|NCT01087970|26475654|FG000|Overall Study|Protocol Violation|2|||
13288421|NCT01087957|26475687|FG000|Overall Study|Death|2|||
13288422|NCT01087957|26475688|FG001|Overall Study|Death|2|||
13288423|NCT01087957|26475687|FG000|Overall Study|Lost to Follow-up|3|||
13288424|NCT01087957|26475688|FG001|Overall Study|Lost to Follow-up|4|||
13288425|NCT01087957|26475687|FG000|Overall Study|Protocol Violation|13|||
13288426|NCT01087957|26475688|FG001|Overall Study|Protocol Violation|25|||
13288427|NCT01087957|26475687|FG000|Overall Study|Withdrawal by Subject|18|||
13288428|NCT01087957|26475688|FG001|Overall Study|Withdrawal by Subject|15|||
13288429|NCT01087957|26475687|FG000|Overall Study|Physician Decision|5|||
13288430|NCT01087957|26475688|FG001|Overall Study|Physician Decision|9|||
13288431|NCT01087944|26475719|FG000|Period 1 (Week 1-3)|Adverse Event|1|||
13288432|NCT01087944|26475720|FG001|Period 1 (Week 1-3)|Adverse Event|0|||
13288433|NCT01087944|26475719|FG000|Period 2 (Week 4-6)|Adverse Event|0|||
13288434|NCT01087944|26475720|FG001|Period 2 (Week 4-6)|Adverse Event|2|||
13288435|NCT01087905|26475765|FG000|Overall Study|Lost to Follow-up|24|||
13288436|NCT01087905|26475766|FG001|Overall Study|Lost to Follow-up|28|||
13288437|NCT01087905|26475767|FG002|Overall Study|Lost to Follow-up|18|||
13331891|NCT01104662|26600341|FG006|Overall Study|Participant left investigator's care|0|||
13331892|NCT01104662|26600342|FG007|Overall Study|Participant left investigator's care|0|||
13288438|NCT01087905|26475768|FG003|Overall Study|Lost to Follow-up|31|||
13288439|NCT01087905|26475769|FG004|Overall Study|Lost to Follow-up|27|||
13288440|NCT01087905|26475770|FG005|Overall Study|Lost to Follow-up|25|||
13288441|NCT01087905|26475771|FG006|Overall Study|Lost to Follow-up|20|||
13288442|NCT01087905|26475772|FG007|Overall Study|Lost to Follow-up|24|||
13288443|NCT01087905|26475765|FG000|Overall Study|Withdrawal by Subject|5|||
13288444|NCT01087905|26475766|FG001|Overall Study|Withdrawal by Subject|4|||
13288445|NCT01087905|26475767|FG002|Overall Study|Withdrawal by Subject|4|||
13288446|NCT01087905|26475768|FG003|Overall Study|Withdrawal by Subject|5|||
13288447|NCT01087905|26475769|FG004|Overall Study|Withdrawal by Subject|4|||
13288448|NCT01087905|26475770|FG005|Overall Study|Withdrawal by Subject|3|||
13288449|NCT01087905|26475771|FG006|Overall Study|Withdrawal by Subject|3|||
13288450|NCT01087905|26475772|FG007|Overall Study|Withdrawal by Subject|5|||
13288451|NCT01087814|26475785|FG000|First Intervention (5 Days)|Withdrawal by Subject|3|||
13288452|NCT01087814|26475786|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
13288453|NCT01087814|26475785|FG000|Second Intervention (5 Days)|Physician Decision|1|||
13288454|NCT01087814|26475786|FG001|Second Intervention (5 Days)|Physician Decision|0|||
13288455|NCT01087788|26475823|FG000|24-weeks Double-blind Period|Lack of Efficacy|2|||
13288456|NCT01087788|26475824|FG001|24-weeks Double-blind Period|Lack of Efficacy|0|||
13288457|NCT01087788|26475825|FG002|24-weeks Double-blind Period|Lack of Efficacy|1|||
13288458|NCT01087788|26475823|FG000|24-weeks Double-blind Period|Protocol Violation|0|||
13288459|NCT01087788|26475824|FG001|24-weeks Double-blind Period|Protocol Violation|1|||
13288460|NCT01087788|26475825|FG002|24-weeks Double-blind Period|Protocol Violation|0|||
13288461|NCT01087788|26475823|FG000|24-weeks Double-blind Period|Lost to Follow-up|4|||
13288462|NCT01087788|26475824|FG001|24-weeks Double-blind Period|Lost to Follow-up|1|||
13288463|NCT01087788|26475825|FG002|24-weeks Double-blind Period|Lost to Follow-up|1|||
13288464|NCT01087788|26475823|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7|||
13288465|NCT01087788|26475824|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2|||
13288466|NCT01087788|26475825|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5|||
13288467|NCT01087788|26475823|FG000|24-weeks Double-blind Period|AE, serious fatal|0|||
13288468|NCT01087788|26475824|FG001|24-weeks Double-blind Period|AE, serious fatal|1|||
13288469|NCT01087788|26475825|FG002|24-weeks Double-blind Period|AE, serious fatal|1|||
13288470|NCT01087788|26475823|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0|||
13331893|NCT01104662|26600335|FG000|Overall Study|Reason not specified|3|||
13331894|NCT01104662|26600336|FG001|Overall Study|Reason not specified|3|||
13331895|NCT01104662|26600337|FG002|Overall Study|Reason not specified|0|||
13331896|NCT01104662|26600338|FG003|Overall Study|Reason not specified|0|||
13331897|NCT01104662|26600339|FG004|Overall Study|Reason not specified|0|||
13331898|NCT01104662|26600340|FG005|Overall Study|Reason not specified|1|||
13331899|NCT01104662|26600341|FG006|Overall Study|Reason not specified|0|||
13331900|NCT01104662|26600342|FG007|Overall Study|Reason not specified|0|||
13331901|NCT01104662|26600335|FG000|Overall Study|Randomized but not treated|3|||
13331902|NCT01104662|26600336|FG001|Overall Study|Randomized but not treated|4|||
13331903|NCT01104662|26600337|FG002|Overall Study|Randomized but not treated|1|||
13331904|NCT01104662|26600338|FG003|Overall Study|Randomized but not treated|0|||
13331905|NCT01104662|26600339|FG004|Overall Study|Randomized but not treated|0|||
13331906|NCT01104662|26600340|FG005|Overall Study|Randomized but not treated|1|||
13331907|NCT01104662|26600341|FG006|Overall Study|Randomized but not treated|0|||
13331908|NCT01104662|26600342|FG007|Overall Study|Randomized but not treated|0|||
13331909|NCT01104636|26600349|FG000|Overall Study|Lack of Efficacy|43|||
13331910|NCT01104636|26600349|FG000|Overall Study|Lost to Follow-up|24|||
13331911|NCT01104636|26600349|FG000|Overall Study|Withdrawal by Subject|4|||
13331912|NCT01104636|26600349|FG000|Overall Study|Other|43|||
13331913|NCT01104636|26600349|FG000|Overall Study|Study terminated by sponsor|1|||
13331914|NCT01104636|26600349|FG000|Overall Study|Pregnancy|2|||
13331915|NCT01104636|26600349|FG000|Overall Study|Adverse Event|40|||
13331916|NCT01104636|26600349|FG000|Overall Study|Ongoing|21|||
13331917|NCT01104584|26600421|FG000|Overall Study|Study drug never administered|21|||
13331918|NCT01104584|26600421|FG000|Overall Study|Study prematurely discontinued|2|||
13331919|NCT01104558|26600464|FG000|Overall Study|Protocol Violation|6|||
13331920|NCT01104558|26600464|FG000|Overall Study|Missing of primary efficacy assessment|10|||
13331921|NCT01104558|26600464|FG000|Overall Study|Missing of genetic analysis results|1|||
13331922|NCT01104545|26600629|FG000|Overall Study|Adverse Event|0|||
13331923|NCT01104545|26600630|FG001|Overall Study|Adverse Event|1|||
13331924|NCT01104545|26600631|FG002|Overall Study|Adverse Event|2|||
13331925|NCT01104493|26600656|FG000|Overall Study|Lost to Follow-up|0|||
13331926|NCT01104493|26600657|FG001|Overall Study|Lost to Follow-up|2|||
13331927|NCT01104415|26600683|FG000|Core Phase|Consent withdrawn by subjects|1|||
13331928|NCT01104415|26600684|FG001|Core Phase|Consent withdrawn by subjects|0|||
13331929|NCT01104415|26600683|FG000|Extension Period|Progressive disease|0|||
13331930|NCT01104415|26600684|FG001|Extension Period|Progressive disease|4|||
13331931|NCT01104415|26600683|FG000|Extension Period|Death|0|||
13288471|NCT01087788|26475824|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2|||
13288472|NCT01087788|26475825|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3|||
13331932|NCT01104415|26600684|FG001|Extension Period|Death|1|||
13331933|NCT01104415|26600683|FG000|Extension Period|Physician Decision|0|||
13331934|NCT01104415|26600684|FG001|Extension Period|Physician Decision|1|||
13288473|NCT01087788|26475823|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
13288474|NCT01087788|26475824|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1|||
13288475|NCT01087788|26475825|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
13288476|NCT01087788|26475823|FG000|24-weeks Double-blind Period|AE, unknown type|0|||
13288477|NCT01087788|26475824|FG001|24-weeks Double-blind Period|AE, unknown type|0|||
13288478|NCT01087788|26475825|FG002|24-weeks Double-blind Period|AE, unknown type|1|||
13288479|NCT01087788|26475823|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1|||
13288480|NCT01087788|26475824|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
13288481|NCT01087788|26475825|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
13288482|NCT01087788|26475823|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
13288483|NCT01087788|26475824|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1|||
13288484|NCT01087788|26475825|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
13288485|NCT01087788|26475823|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
13288486|NCT01087788|26475824|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1|||
13288487|NCT01087788|26475825|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
13288488|NCT01087788|26475823|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
13288489|NCT01087788|26475824|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
13288490|NCT01087788|26475825|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1|||
13288491|NCT01087788|26475823|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0|||
13288492|NCT01087788|26475824|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2|||
13288493|NCT01087788|26475825|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1|||
13288494|NCT01087788|26475823|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1|||
13288495|NCT01087788|26475824|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0|||
13331935|NCT01104415|26600683|FG000|Extension Period|Transition to Study LX1606.302|0|||
13331936|NCT01104415|26600684|FG001|Extension Period|Transition to Study LX1606.302|4|||
13331937|NCT01104415|26600683|FG000|Extension Period|Heart surgery/feeling miserable|0|||
13331938|NCT01104415|26600684|FG001|Extension Period|Heart surgery/feeling miserable|1|||
13288496|NCT01087788|26475825|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1|||
13288497|NCT01087788|26475823|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1|||
13288498|NCT01087788|26475824|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
13288499|NCT01087788|26475825|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
13288500|NCT01087788|26475823|FG000|24-weeks Dose-blind Period|AE, serious fatal|0|||
13288501|NCT01087788|26475824|FG001|24-weeks Dose-blind Period|AE, serious fatal|1|||
13288502|NCT01087788|26475825|FG002|24-weeks Dose-blind Period|AE, serious fatal|0|||
13288503|NCT01087788|26475823|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
13288504|NCT01087788|26475824|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1|||
13288505|NCT01087788|26475825|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
13288506|NCT01087788|26475823|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2|||
13288507|NCT01087788|26475824|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
13288508|NCT01087788|26475825|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
13288509|NCT01087788|26475823|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1|||
13288510|NCT01087788|26475824|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
13288511|NCT01087788|26475825|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
13288512|NCT01087788|26475823|FG000|24-weeks Dose-blind Period|Patient moved|0|||
13288513|NCT01087788|26475824|FG001|24-weeks Dose-blind Period|Patient moved|0|||
13288514|NCT01087788|26475825|FG002|24-weeks Dose-blind Period|Patient moved|1|||
13331939|NCT01104376|26600690|FG000|Overall Study|Withdrawal by Subject|15|||
13331940|NCT01104376|26600690|FG000|Overall Study|Consented but excluded after labs|13|||
13331941|NCT01104311|26600715|FG000|Overall Study|Withdrawal by Subject|6|||
13331942|NCT01104311|26600716|FG001|Overall Study|Withdrawal by Subject|6|||
13331943|NCT01104311|26600715|FG000|Overall Study|Protocol Violation|0|||
13331944|NCT01104311|26600716|FG001|Overall Study|Protocol Violation|1|||
13331945|NCT01104311|26600715|FG000|Overall Study|Physician Decision|2|||
13331946|NCT01104311|26600716|FG001|Overall Study|Physician Decision|2|||
13331947|NCT01104311|26600715|FG000|Overall Study|low compliance|1|||
13331948|NCT01104311|26600716|FG001|Overall Study|low compliance|1|||
13331949|NCT01104311|26600715|FG000|Overall Study|Adverse Event|1|||
13331950|NCT01104311|26600716|FG001|Overall Study|Adverse Event|2|||
13331951|NCT01104246|26600722|FG000|Overall Study|Withdrawal by Subject|1|||
13331952|NCT01104246|26600722|FG000|Overall Study|did not meet inclusion criteria|4|||
13331953|NCT01104155|26600743|FG000|Overall Study|Adverse Event|15|||
13331954|NCT01104155|26600744|FG001|Overall Study|Adverse Event|8|||
13331955|NCT01104155|26600743|FG000|Overall Study|Participant choice|6|||
13331956|NCT01104155|26600744|FG001|Overall Study|Participant choice|5|||
13331957|NCT01104155|26600743|FG000|Overall Study|Withdrawal of consent|1|||
13331958|NCT01104155|26600744|FG001|Overall Study|Withdrawal of consent|1|||
13331959|NCT01104155|26600743|FG000|Overall Study|Other|3|||
13331960|NCT01104155|26600744|FG001|Overall Study|Other|4|||
13331961|NCT01103960|26600775|FG000|Overall Study|Adverse Event|2|||
13331962|NCT01103960|26600776|FG001|Overall Study|Adverse Event|1|||
13331963|NCT01103960|26600775|FG000|Overall Study|Withdrawal by Subject|2|||
13331964|NCT01103960|26600776|FG001|Overall Study|Withdrawal by Subject|1|||
13331965|NCT01103960|26600775|FG000|Overall Study|Other|1|||
13331966|NCT01103960|26600776|FG001|Overall Study|Other|0|||
13331967|NCT01103778|26600785|FG000|Overall Study|Lost to Follow-up|1|||
13331968|NCT01103778|26600785|FG000|Overall Study|Proteinuria improved prior to enrollment|1|||
13331969|NCT01103778|26600785|FG000|Overall Study|Screen failure|1|||
13331970|NCT01103713|26600813|FG000|Overall Study|Lost to Follow-up|2|||
13331971|NCT01103713|26600813|FG000|Overall Study|Withdrawal by Subject|8|||
13331972|NCT01103713|26600813|FG000|Overall Study|Study terminated by sponsor|2|||
13331973|NCT01103713|26600813|FG000|Overall Study|Other|1|||
13331974|NCT01103479|26600836|FG000|Overall Study|Up to date with CRC screening|1|||
13331975|NCT01103479|26600837|FG001|Overall Study|Up to date with CRC screening|9|||
13288515|NCT01087788|26475823|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4|||
13288516|NCT01087788|26475824|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2|||
13288517|NCT01087788|26475825|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3|||
13288518|NCT01087788|26475823|FG000|Open-Label Period (OL-P)|Protocol Violation|2|||
13288519|NCT01087788|26475824|FG001|Open-Label Period (OL-P)|Protocol Violation|1|||
13288520|NCT01087788|26475825|FG002|Open-Label Period (OL-P)|Protocol Violation|0|||
13288521|NCT01087788|26475823|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0|||
13288522|NCT01087788|26475824|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4|||
13288523|NCT01087788|26475825|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2|||
13288524|NCT01087788|26475823|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13|||
13288525|NCT01087788|26475824|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8|||
13288526|NCT01087788|26475825|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10|||
13288527|NCT01087788|26475823|FG000|Open-Label Period (OL-P)|AE, serious fatal|2|||
13288528|NCT01087788|26475824|FG001|Open-Label Period (OL-P)|AE, serious fatal|0|||
13331976|NCT01103479|26600838|FG002|Overall Study|Up to date with CRC screening|12|||
13331977|NCT01103479|26600836|FG000|Overall Study|Family history of CRC|1|||
13331978|NCT01103479|26600837|FG001|Overall Study|Family history of CRC|0|||
13331979|NCT01103479|26600838|FG002|Overall Study|Family history of CRC|2|||
13331980|NCT01103479|26600836|FG000|Overall Study|Active cancer|1|||
13331981|NCT01103479|26600837|FG001|Overall Study|Active cancer|0|||
13331982|NCT01103479|26600838|FG002|Overall Study|Active cancer|0|||
13331983|NCT01103479|26600836|FG000|Overall Study|Saw non-study physician|2|||
13331984|NCT01103479|26600837|FG001|Overall Study|Saw non-study physician|0|||
13331985|NCT01103479|26600838|FG002|Overall Study|Saw non-study physician|0|||
13288529|NCT01087788|26475825|FG002|Open-Label Period (OL-P)|AE, serious fatal|1|||
13288530|NCT01087788|26475823|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1|||
13288531|NCT01087788|26475824|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3|||
13288532|NCT01087788|26475825|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4|||
13288533|NCT01087788|26475823|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6|||
13288534|NCT01087788|26475824|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
13288535|NCT01087788|26475825|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
13288536|NCT01087788|26475823|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
13331986|NCT01103466|26600850|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2|||
13331987|NCT01103466|26600851|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0|||
13331988|NCT01103466|26600852|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0|||
13331989|NCT01103466|26600850|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2|||
13331990|NCT01103466|26600851|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1|||
13331991|NCT01103466|26600852|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0|||
13331992|NCT01103466|26600850|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0|||
13331993|NCT01103466|26600851|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
13331994|NCT01103466|26600852|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
13331995|NCT01103466|26600850|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1|||
13331996|NCT01103466|26600851|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0|||
13331997|NCT01103466|26600852|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0|||
13331998|NCT01103466|26600850|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1|||
13331999|NCT01103466|26600851|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
13332000|NCT01103466|26600852|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
13332001|NCT01103466|26600850|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
13332002|NCT01103466|26600851|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
13288537|NCT01087788|26475824|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1|||
13288538|NCT01087788|26475825|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
13288539|NCT01087788|26475823|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1|||
13288540|NCT01087788|26475824|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
13288541|NCT01087788|26475825|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
13288542|NCT01087788|26475823|FG000|Open-Label Period (OL-P)|Sponsor request|1|||
13288543|NCT01087788|26475824|FG001|Open-Label Period (OL-P)|Sponsor request|0|||
13288544|NCT01087788|26475825|FG002|Open-Label Period (OL-P)|Sponsor request|0|||
13288545|NCT01087788|26475823|FG000|Open-Label Period (OL-P)|Principal investigator decision|0|||
13288546|NCT01087788|26475824|FG001|Open-Label Period (OL-P)|Principal investigator decision|1|||
13288547|NCT01087788|26475825|FG002|Open-Label Period (OL-P)|Principal investigator decision|2|||
13288548|NCT01087788|26475823|FG000|Open-Label Period (OL-P)|No participation in study extension|0|||
13288549|NCT01087788|26475824|FG001|Open-Label Period (OL-P)|No participation in study extension|0|||
13288550|NCT01087788|26475825|FG002|Open-Label Period (OL-P)|No participation in study extension|1|||
13288551|NCT01087788|26475823|FG000|Open-Label Period (OL-P)|Personal reasons|0|||
13288552|NCT01087788|26475824|FG001|Open-Label Period (OL-P)|Personal reasons|0|||
13288553|NCT01087788|26475825|FG002|Open-Label Period (OL-P)|Personal reasons|1|||
13288554|NCT01087775|26475832|FG000|Overall Study|failed inclusion criteria|2|||
13288555|NCT01087723|26475861|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0|||
13288556|NCT01087723|26475862|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1|||
13288557|NCT01087723|26475861|FG000|Overall Study|Withdrawal by Subject|10|||
13288558|NCT01087723|26475862|FG001|Overall Study|Withdrawal by Subject|13|||
13288559|NCT01087723|26475861|FG000|Overall Study|Physician Decision|2|||
13288560|NCT01087723|26475862|FG001|Overall Study|Physician Decision|0|||
13288561|NCT01087723|26475861|FG000|Overall Study|Lost to Follow-up|1|||
13288562|NCT01087723|26475862|FG001|Overall Study|Lost to Follow-up|4|||
13288563|NCT01087723|26475861|FG000|Overall Study|Reason Not Specified|1|||
13288564|NCT01087723|26475862|FG001|Overall Study|Reason Not Specified|2|||
13288565|NCT01087528|26475874|FG000|Overall Study|Withdrawal by Subject|1|||
13288566|NCT01087528|26475874|FG000|Overall Study|Incomplete CE procedure|6|||
13288567|NCT01087502|26475900|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5|||
13288568|NCT01087502|26475901|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4|||
13288569|NCT01087502|26475900|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
13288570|NCT01087502|26475901|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
13288571|NCT01087502|26475900|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
13288572|NCT01087502|26475901|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
13288573|NCT01087502|26475900|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1|||
13288574|NCT01087502|26475901|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0|||
13288575|NCT01087502|26475900|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1|||
13288576|NCT01087502|26475901|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2|||
13288577|NCT01087502|26475900|FG000|Up to Final Analysis (Week 52)|Adverse Event|17|||
13288578|NCT01087502|26475901|FG001|Up to Final Analysis (Week 52)|Adverse Event|10|||
13288579|NCT01087502|26475900|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1|||
13288580|NCT01087502|26475901|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2|||
13288581|NCT01087502|26475900|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4|||
13288582|NCT01087502|26475901|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0|||
13288583|NCT01087502|26475900|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2|||
13288584|NCT01087502|26475901|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0|||
13288585|NCT01087502|26475900|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3|||
13288586|NCT01087502|26475901|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2|||
13288587|NCT01087502|26475900|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1|||
13288588|NCT01087502|26475901|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5|||
13288589|NCT01087502|26475900|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5|||
13288590|NCT01087502|26475901|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4|||
13288591|NCT01086969|26475928|FG000|Overall Study|Withdrawal by Subject|1|||
13288592|NCT01086969|26475929|FG001|Overall Study|Withdrawal by Subject|2|||
13288593|NCT01086969|26475930|FG002|Overall Study|Withdrawal by Subject|0|||
13288594|NCT01086423|26475981|FG000|Overall Study|Protocol Violation|0|||
13332003|NCT01103466|26600852|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1|||
13332004|NCT01103362|26600858|FG000|Overall Study|study terminated|596|||
13332005|NCT01103323|26600880|FG000|Without/Before Drug Switch|Adverse Event|50|||
13332006|NCT01103323|26600881|FG001|Without/Before Drug Switch|Adverse Event|7|||
13332007|NCT01103323|26600880|FG000|Without/Before Drug Switch|Withdrawal by Subject|17|||
13332008|NCT01103323|26600881|FG001|Without/Before Drug Switch|Withdrawal by Subject|5|||
13332009|NCT01103323|26600880|FG000|Without/Before Drug Switch|Protocol Violation|2|||
13332010|NCT01103323|26600881|FG001|Without/Before Drug Switch|Protocol Violation|0|||
13332011|NCT01103323|26600880|FG000|Without/Before Drug Switch|Physician Decision|2|||
13332012|NCT01103323|26600881|FG001|Without/Before Drug Switch|Physician Decision|0|||
13332013|NCT01103323|26600880|FG000|Without/Before Drug Switch|did not receive study treatment|5|||
13332014|NCT01103323|26600881|FG001|Without/Before Drug Switch|did not receive study treatment|2|||
13332015|NCT01103323|26600880|FG000|Without/Before Drug Switch|Switch to Regorafenib|0|||
13332016|NCT01103323|26600881|FG001|Without/Before Drug Switch|Switch to Regorafenib|4|||
13332017|NCT01103323|26600880|FG000|Switched From Placebo to Regorafenib|Adverse Event|0|||
13332018|NCT01103323|26600881|FG001|Switched From Placebo to Regorafenib|Adverse Event|1|||
13332019|NCT01103284|26600902|FG000|Overall Study|Death|2|||
13332020|NCT01103284|26600903|FG001|Overall Study|Death|0|||
13332021|NCT01103284|26600902|FG000|Overall Study|Lost to Follow-up|9|||
13332022|NCT01103284|26600903|FG001|Overall Study|Lost to Follow-up|10|||
13332023|NCT01103284|26600902|FG000|Overall Study|Pregnancy|3|||
13332024|NCT01103284|26600903|FG001|Overall Study|Pregnancy|1|||
13332025|NCT01103284|26600902|FG000|Overall Study|Protocol Violation|12|||
13332026|NCT01103284|26600903|FG001|Overall Study|Protocol Violation|5|||
13332027|NCT01103284|26600902|FG000|Overall Study|Adverse Event|0|||
13332028|NCT01103284|26600903|FG001|Overall Study|Adverse Event|5|||
13332029|NCT01103284|26600902|FG000|Overall Study|Withdrawal by Subject|14|||
13332030|NCT01103284|26600903|FG001|Overall Study|Withdrawal by Subject|18|||
13332031|NCT01103284|26600902|FG000|Overall Study|Dermal Hypersensitivity|0|||
13122327|NCT02965846|25946773|FG000|Overall Study|Lost to Follow-up|1|||
13288595|NCT01086423|26475982|FG001|Overall Study|Protocol Violation|0|||
13288596|NCT01086423|26475983|FG002|Overall Study|Protocol Violation|1|||
13288597|NCT01086423|26475981|FG000|Overall Study|Migrated/moved from study area|2|||
13288598|NCT01086423|26475982|FG001|Overall Study|Migrated/moved from study area|0|||
13288599|NCT01086423|26475983|FG002|Overall Study|Migrated/moved from study area|4|||
13122328|NCT02965846|25946774|FG001|Overall Study|Lost to Follow-up|0|||
13122329|NCT02965846|25946775|FG002|Overall Study|Lost to Follow-up|0|||
13122330|NCT02965846|25946773|FG000|Overall Study|Withdrawal by Subject|0|||
13122331|NCT02965846|25946774|FG001|Overall Study|Withdrawal by Subject|1|||
13122332|NCT02965846|25946775|FG002|Overall Study|Withdrawal by Subject|0|||
13122333|NCT02965846|25946773|FG000|Overall Study|Study Terminated By Sponsor|4|||
13122334|NCT02965846|25946774|FG001|Overall Study|Study Terminated By Sponsor|4|||
13122335|NCT02965846|25946775|FG002|Overall Study|Study Terminated By Sponsor|0|||
13122336|NCT02965846|25946773|FG000|Overall Study|Participants not randomized|0|||
13122337|NCT02965846|25946774|FG001|Overall Study|Participants not randomized|0|||
13122338|NCT02965846|25946775|FG002|Overall Study|Participants not randomized|33|||
13122339|NCT02965833|25946784|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
13122340|NCT02965833|25946785|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
13122341|NCT02965833|25946784|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
13122342|NCT02965833|25946785|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
13122343|NCT02965833|25946784|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1|||
13122344|NCT02965833|25946785|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0|||
13122345|NCT02965833|25946784|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
13122346|NCT02965833|25946785|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
13288600|NCT01086423|26475981|FG000|Overall Study|Adverse event, fatal|1|||
13288601|NCT01086423|26475982|FG001|Overall Study|Adverse event, fatal|1|||
13288602|NCT01086423|26475983|FG002|Overall Study|Adverse event, fatal|0|||
13288603|NCT01086423|26475981|FG000|Overall Study|Adverse event, non-fatal|2|||
13288604|NCT01086423|26475982|FG001|Overall Study|Adverse event, non-fatal|1|||
13288605|NCT01086423|26475983|FG002|Overall Study|Adverse event, non-fatal|0|||
13288606|NCT01086423|26475981|FG000|Overall Study|Withdrawal by Subject|5|||
13288607|NCT01086423|26475982|FG001|Overall Study|Withdrawal by Subject|1|||
13288608|NCT01086423|26475983|FG002|Overall Study|Withdrawal by Subject|3|||
13288609|NCT01086423|26475981|FG000|Overall Study|Lost to Follow-up|0|||
13288610|NCT01086423|26475982|FG001|Overall Study|Lost to Follow-up|0|||
13288611|NCT01086423|26475983|FG002|Overall Study|Lost to Follow-up|1|||
13288612|NCT01086410|26476090|FG000|Overall Study|Adverse Event|1|||
13288613|NCT01086410|26476091|FG001|Overall Study|Adverse Event|0|||
13288614|NCT01086410|26476092|FG002|Overall Study|Adverse Event|0|||
13288615|NCT01086410|26476093|FG003|Overall Study|Adverse Event|2|||
13288616|NCT01086410|26476090|FG000|Overall Study|Lack of Efficacy|1|||
13288617|NCT01086410|26476091|FG001|Overall Study|Lack of Efficacy|1|||
13288618|NCT01086410|26476092|FG002|Overall Study|Lack of Efficacy|0|||
13288619|NCT01086410|26476093|FG003|Overall Study|Lack of Efficacy|0|||
13288620|NCT01086410|26476090|FG000|Overall Study|Protocol Violation|1|||
13288621|NCT01086410|26476091|FG001|Overall Study|Protocol Violation|1|||
13288622|NCT01086410|26476092|FG002|Overall Study|Protocol Violation|0|||
13288623|NCT01086410|26476093|FG003|Overall Study|Protocol Violation|0|||
13288624|NCT01086410|26476090|FG000|Overall Study|Lost to Follow-up|0|||
13288625|NCT01086410|26476091|FG001|Overall Study|Lost to Follow-up|0|||
13288626|NCT01086410|26476092|FG002|Overall Study|Lost to Follow-up|1|||
13288627|NCT01086410|26476093|FG003|Overall Study|Lost to Follow-up|0|||
13288628|NCT01086215|26476124|FG000|Overall Study|Death|14|||
13288629|NCT01086215|26476125|FG001|Overall Study|Death|8|||
13288630|NCT01086215|26476126|FG002|Overall Study|Death|8|||
13288631|NCT01086215|26476127|FG003|Overall Study|Death|1|||
13288632|NCT01086215|26476124|FG000|Overall Study|Lost to Follow-up|22|||
13288633|NCT01086215|26476125|FG001|Overall Study|Lost to Follow-up|39|||
13122347|NCT02965833|25946784|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2|||
13288634|NCT01086215|26476126|FG002|Overall Study|Lost to Follow-up|18|||
13288635|NCT01086215|26476127|FG003|Overall Study|Lost to Follow-up|2|||
13288636|NCT01086150|26476148|FG000|Overall Study|Withdrawal by Subject|0|||
13288637|NCT01086150|26476149|FG001|Overall Study|Withdrawal by Subject|4|||
13332032|NCT01103284|26600903|FG001|Overall Study|Dermal Hypersensitivity|1|||
13288638|NCT01086150|26476150|FG002|Overall Study|Withdrawal by Subject|1|||
13288639|NCT01086150|26476148|FG000|Overall Study|Lost to Follow-up|0|||
13288640|NCT01086150|26476149|FG001|Overall Study|Lost to Follow-up|1|||
13288641|NCT01086150|26476150|FG002|Overall Study|Lost to Follow-up|0|||
13288642|NCT01086150|26476148|FG000|Overall Study|Screen Failure|0|||
13332033|NCT01103284|26600902|FG000|Overall Study|Termination by the Sponsor|0|||
13288643|NCT01086150|26476149|FG001|Overall Study|Screen Failure|1|||
13288644|NCT01086150|26476150|FG002|Overall Study|Screen Failure|0|||
13288645|NCT01086033|26476164|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86|||
13288646|NCT01086033|26476164|FG000|Overall Study|Lost to Follow-up|86|||
13122348|NCT02965833|25946785|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0|||
13288647|NCT01086033|26476164|FG000|Overall Study|Adverse Event|42|||
13288648|NCT01086033|26476164|FG000|Overall Study|Withdrawal by Subject|41|||
13288649|NCT01086033|26476164|FG000|Overall Study|Other|14|||
13288650|NCT01086033|26476164|FG000|Overall Study|Other|13|||
13288651|NCT01086033|26476164|FG000|Overall Study|AE and Withdrew Consent|5|||
13288652|NCT01086033|26476164|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5|||
13288653|NCT01086033|26476164|FG000|Overall Study|Withdrew consent and Other Reason|4|||
13288654|NCT01086033|26476164|FG000|Overall Study|AE and Lack of Efficacy|4|||
13288655|NCT01086033|26476164|FG000|Overall Study|Death|1|||
13288656|NCT01086033|26476164|FG000|Overall Study|AE and Lost to Follow-up|1|||
13288657|NCT01086033|26476164|FG000|Overall Study|AE and Other Reason|1|||
13288658|NCT01086033|26476164|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1|||
13288659|NCT01085812|26476174|FG000|Open-Label Period|Adverse Event|0|||
13288660|NCT01085812|26476175|FG001|Open-Label Period|Adverse Event|80|||
13288661|NCT01085812|26476174|FG000|Open-Label Period|Lack of Efficacy|0|||
13288662|NCT01085812|26476175|FG001|Open-Label Period|Lack of Efficacy|26|||
13288663|NCT01085812|26476174|FG000|Open-Label Period|Protocol Violation|0|||
13288664|NCT01085812|26476175|FG001|Open-Label Period|Protocol Violation|39|||
13288665|NCT01085812|26476174|FG000|Open-Label Period|Withdrawal by Subject|0|||
13288666|NCT01085812|26476175|FG001|Open-Label Period|Withdrawal by Subject|53|||
13288667|NCT01085812|26476174|FG000|Open-Label Period|Lost to Follow-up|0|||
13288668|NCT01085812|26476175|FG001|Open-Label Period|Lost to Follow-up|42|||
13288669|NCT01085812|26476174|FG000|Double-Blind Period|Adverse Event|3|||
13288670|NCT01085812|26476175|FG001|Double-Blind Period|Adverse Event|8|||
13288671|NCT01085812|26476174|FG000|Double-Blind Period|Protocol Violation|2|||
13288672|NCT01085812|26476175|FG001|Double-Blind Period|Protocol Violation|7|||
13288673|NCT01085812|26476174|FG000|Double-Blind Period|Withdrawal by Subject|11|||
13288674|NCT01085812|26476175|FG001|Double-Blind Period|Withdrawal by Subject|24|||
13288675|NCT01085812|26476174|FG000|Double-Blind Period|Lost to Follow-up|5|||
13288676|NCT01085812|26476175|FG001|Double-Blind Period|Lost to Follow-up|17|||
13288677|NCT01085812|26476174|FG000|Double-Blind Period|Other Reasons|0|||
13288678|NCT01085812|26476175|FG001|Double-Blind Period|Other Reasons|2|||
13288679|NCT01085812|26476174|FG000|Double-blind Intent-to-treat Population|Adverse Event|3|||
13288680|NCT01085812|26476175|FG001|Double-blind Intent-to-treat Population|Adverse Event|8|||
13288681|NCT01085812|26476174|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2|||
13288682|NCT01085812|26476175|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7|||
13288683|NCT01085812|26476174|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11|||
13288684|NCT01085812|26476175|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22|||
13288685|NCT01085812|26476174|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4|||
13288686|NCT01085812|26476175|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17|||
13288687|NCT01085812|26476174|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0|||
13288688|NCT01085812|26476175|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2|||
13288689|NCT01085734|26476192|FG000|Overall Study|Adverse Event|0|||
13288690|NCT01085734|26476193|FG001|Overall Study|Adverse Event|2|||
13288691|NCT01085734|26476192|FG000|Overall Study|Death|1|||
13288692|NCT01085734|26476193|FG001|Overall Study|Death|0|||
13288693|NCT01085734|26476192|FG000|Overall Study|Lost to Follow-up|0|||
13288694|NCT01085734|26476193|FG001|Overall Study|Lost to Follow-up|1|||
13288695|NCT01085734|26476192|FG000|Overall Study|Withdrawal by Subject|0|||
13288696|NCT01085734|26476193|FG001|Overall Study|Withdrawal by Subject|1|||
13288697|NCT01085682|26476206|FG000|Overall Study|Withdrawal by Subject|25|||
13288698|NCT01085682|26476207|FG001|Overall Study|Withdrawal by Subject|25|||
13288699|NCT01085591|26476240|FG000|Overall Study|Adverse Event|0|||
13288700|NCT01085591|26476241|FG001|Overall Study|Adverse Event|1|||
13288701|NCT01085591|26476242|FG002|Overall Study|Adverse Event|3|||
13288702|NCT01085591|26476240|FG000|Overall Study|Physician Decision|1|||
13332034|NCT01103284|26600903|FG001|Overall Study|Termination by the Sponsor|1|||
13122349|NCT02965820|25946794|FG000|Period 2, Second 30 Days|Adverse Event|1|||
13288703|NCT01085591|26476241|FG001|Overall Study|Physician Decision|0|||
13288704|NCT01085591|26476242|FG002|Overall Study|Physician Decision|1|||
13288705|NCT01085591|26476240|FG000|Overall Study|Withdrawal by Subject|0|||
13288706|NCT01085591|26476241|FG001|Overall Study|Withdrawal by Subject|2|||
13288707|NCT01085591|26476242|FG002|Overall Study|Withdrawal by Subject|1|||
13288708|NCT01085591|26476240|FG000|Overall Study|Lost to Follow-up|0|||
13288709|NCT01085591|26476241|FG001|Overall Study|Lost to Follow-up|1|||
13288710|NCT01085591|26476242|FG002|Overall Study|Lost to Follow-up|1|||
13288711|NCT01085591|26476240|FG000|Overall Study|Protocol Violation|1|||
13288712|NCT01085591|26476241|FG001|Overall Study|Protocol Violation|1|||
13288713|NCT01085591|26476242|FG002|Overall Study|Protocol Violation|1|||
13288714|NCT01085591|26476240|FG000|Overall Study|Other|0|||
13288715|NCT01085591|26476241|FG001|Overall Study|Other|1|||
13288716|NCT01085591|26476242|FG002|Overall Study|Other|0|||
13288717|NCT01085591|26476240|FG000|Overall Study|Not Properly Consented|1|||
13288718|NCT01085591|26476241|FG001|Overall Study|Not Properly Consented|0|||
13288719|NCT01085591|26476242|FG002|Overall Study|Not Properly Consented|0|||
13288720|NCT01085357|26476259|FG000|Overall Study|Adverse Event|1|||
13288721|NCT01085357|26476260|FG001|Overall Study|Adverse Event|1|||
13288722|NCT01085357|26476259|FG000|Overall Study|Subject Decision|4|||
13288723|NCT01085357|26476260|FG001|Overall Study|Subject Decision|3|||
13288724|NCT01085357|26476259|FG000|Overall Study|Investigator Decision|1|||
13288725|NCT01085357|26476260|FG001|Overall Study|Investigator Decision|1|||
13288726|NCT01085357|26476259|FG000|Overall Study|Death|11|||
13288727|NCT01085357|26476260|FG001|Overall Study|Death|1|||
13288728|NCT01085357|26476259|FG000|Overall Study|Lost to Follow-up|2|||
13288729|NCT01085357|26476260|FG001|Overall Study|Lost to Follow-up|0|||
13288730|NCT01085214|26476269|FG000|Overall Study|Alternate treatment required|1|||
13288731|NCT01085201|26476307|FG000|Overall Study|Scheduling conflict|1|||
13288732|NCT01085201|26476308|FG001|Overall Study|Scheduling conflict|0|||
13288733|NCT01085201|26476309|FG002|Overall Study|Scheduling conflict|1|||
13288734|NCT01085201|26476310|FG003|Overall Study|Scheduling conflict|0|||
13288735|NCT01085201|26476311|FG004|Overall Study|Scheduling conflict|0|||
13288736|NCT01085201|26476307|FG000|Overall Study|Unknown- no study drug|2|||
13288737|NCT01085201|26476308|FG001|Overall Study|Unknown- no study drug|0|||
13288738|NCT01085201|26476309|FG002|Overall Study|Unknown- no study drug|0|||
13288739|NCT01085201|26476310|FG003|Overall Study|Unknown- no study drug|0|||
13122350|NCT02965820|25946795|FG001|Period 2, Second 30 Days|Adverse Event|1|||
13122351|NCT02965599|25946864|FG000|Overall Study|Protocol-defined stop criteria reached|1|||
13122352|NCT02965599|25946865|FG001|Overall Study|Protocol-defined stop criteria reached|0|||
13122353|NCT02965573|25946916|FG000|Overall Study|Lack of Efficacy|1|||
13288740|NCT01085201|26476311|FG004|Overall Study|Unknown- no study drug|0|||
13288741|NCT01085201|26476307|FG000|Overall Study|Fond ineligible after consent|0|||
13288742|NCT01085201|26476308|FG001|Overall Study|Fond ineligible after consent|1|||
13288743|NCT01085201|26476309|FG002|Overall Study|Fond ineligible after consent|1|||
13288744|NCT01085201|26476310|FG003|Overall Study|Fond ineligible after consent|0|||
13288745|NCT01085201|26476311|FG004|Overall Study|Fond ineligible after consent|0|||
13288746|NCT01085136|26476331|FG000|Part A|Other Adverse event|223|||
13288747|NCT01085136|26476332|FG001|Part A|Other Adverse event|0|||
13288748|NCT01085136|26476333|FG002|Part A|Other Adverse event|0|||
13288749|NCT01085136|26476331|FG000|Part A|Protocol Violation|3|||
13288750|NCT01085136|26476332|FG001|Part A|Protocol Violation|0|||
13288751|NCT01085136|26476333|FG002|Part A|Protocol Violation|0|||
13288752|NCT01085136|26476331|FG000|Part A|Lost to Follow-up|3|||
13288753|NCT01085136|26476332|FG001|Part A|Lost to Follow-up|0|||
13288754|NCT01085136|26476333|FG002|Part A|Lost to Follow-up|0|||
13288755|NCT01085136|26476331|FG000|Part A|Refusal to continue trial medication|64|||
13288756|NCT01085136|26476332|FG001|Part A|Refusal to continue trial medication|0|||
13288757|NCT01085136|26476333|FG002|Part A|Refusal to continue trial medication|0|||
13288758|NCT01085136|26476331|FG000|Part A|Other reason not defined above|30|||
13288759|NCT01085136|26476332|FG001|Part A|Other reason not defined above|0|||
13288760|NCT01085136|26476333|FG002|Part A|Other reason not defined above|0|||
13288761|NCT01085136|26476331|FG000|Part B|Other AE|0|||
13288762|NCT01085136|26476332|FG001|Part B|Other AE|29|||
13288763|NCT01085136|26476333|FG002|Part B|Other AE|8|||
13288764|NCT01085136|26476331|FG000|Part B|Refusal to continue trial medication|0|||
13288765|NCT01085136|26476332|FG001|Part B|Refusal to continue trial medication|12|||
13288766|NCT01085136|26476333|FG002|Part B|Refusal to continue trial medication|7|||
13288767|NCT01085136|26476331|FG000|Part B|Not treated|0|||
13288768|NCT01085136|26476332|FG001|Part B|Not treated|4|||
13288769|NCT01085136|26476333|FG002|Part B|Not treated|8|||
13288770|NCT01085136|26476331|FG000|Part B|Other reason not defined above|0|||
13332035|NCT01103284|26600902|FG000|Overall Study|Not described|2|||
13122354|NCT02965573|25946917|FG001|Overall Study|Lack of Efficacy|0|||
13122355|NCT02965456|25946938|FG000|Overall Study|Lost to Follow-up|40|||
13122356|NCT02965456|25946939|FG001|Overall Study|Lost to Follow-up|18|||
13122357|NCT02965456|25946938|FG000|Overall Study|Subject Request|22|||
13122358|NCT02965456|25946939|FG001|Overall Study|Subject Request|13|||
13122359|NCT02965456|25946938|FG000|Overall Study|Withdrawal by Parent or Guardian|3|||
13288771|NCT01085136|26476332|FG001|Part B|Other reason not defined above|6|||
13288772|NCT01085136|26476333|FG002|Part B|Other reason not defined above|3|||
13288773|NCT01085084|26476357|FG000|Overall Study|Withdrawal by Subject|1|||
13288774|NCT01085084|26476358|FG001|Overall Study|Withdrawal by Subject|0|||
13288775|NCT01085084|26476359|FG002|Overall Study|Withdrawal by Subject|0|||
13288776|NCT01085084|26476357|FG000|Overall Study|Lost to Follow-up|2|||
13288777|NCT01085084|26476358|FG001|Overall Study|Lost to Follow-up|1|||
13288778|NCT01085084|26476359|FG002|Overall Study|Lost to Follow-up|1|||
13288779|NCT01085084|26476357|FG000|Overall Study|Adverse Event|4|||
13288780|NCT01085084|26476358|FG001|Overall Study|Adverse Event|3|||
13288781|NCT01085084|26476359|FG002|Overall Study|Adverse Event|6|||
13288782|NCT01085084|26476357|FG000|Overall Study|Treatment Failure|0|||
13122360|NCT02965456|25946939|FG001|Overall Study|Withdrawal by Parent or Guardian|6|||
13122361|NCT02965456|25946938|FG000|Overall Study|Adverse Event|3|||
13288783|NCT01085084|26476358|FG001|Overall Study|Treatment Failure|1|||
13288784|NCT01085084|26476359|FG002|Overall Study|Treatment Failure|2|||
13288785|NCT01085045|26476461|FG000|Part A|Withdrawal by Subject|4|||
13288786|NCT01085045|26476461|FG000|Part A|Adverse Event|6|||
13288787|NCT01085045|26476461|FG000|Part A|Protocol Violation|1|||
13288788|NCT01085045|26476461|FG000|Part A|Protocol Specified Criteria|7|||
13332036|NCT01103284|26600903|FG001|Overall Study|Not described|1|||
13332037|NCT01103284|26600902|FG000|Overall Study|Missing CRF entries for study completion|0|||
13332038|NCT01103284|26600903|FG001|Overall Study|Missing CRF entries for study completion|2|||
13332039|NCT01103245|26600930|FG000|Overall Study|Withdrawal by Subject|1|||
13332040|NCT01103245|26600931|FG001|Overall Study|Withdrawal by Subject|0|||
13332041|NCT01103245|26600932|FG002|Overall Study|Withdrawal by Subject|3|||
13332042|NCT01103245|26600933|FG003|Overall Study|Withdrawal by Subject|0|||
13332043|NCT01103245|26600930|FG000|Overall Study|Inadequate IV access|1|||
13288789|NCT01085045|26476461|FG000|Part B|Withdrawal by Subject|2|||
13288790|NCT01085045|26476461|FG000|Part B|Protocol Specified Criteria|6|||
13288791|NCT01085045|26476461|FG000|Part B|Lost to Follow-up|1|||
13288792|NCT01085045|26476461|FG000|Part B|Adverse Event|6|||
13288793|NCT01084772|26476498|FG000|Baseline|Withdrawal by Subject|7|||
13288794|NCT01084772|26476499|FG001|Baseline|Withdrawal by Subject|6|||
13288795|NCT01084772|26476498|FG000|3 Months|Death|1|||
13288796|NCT01084772|26476499|FG001|3 Months|Death|0|||
13288797|NCT01084772|26476498|FG000|3 Months|Study Termination|2|||
13288798|NCT01084772|26476499|FG001|3 Months|Study Termination|2|||
13288799|NCT01084772|26476498|FG000|1 Year|Withdrawal by Subject|0|||
13288800|NCT01084772|26476499|FG001|1 Year|Withdrawal by Subject|1|||
13288801|NCT01084772|26476498|FG000|1 Year|Lost to Follow-up|3|||
13288802|NCT01084772|26476499|FG001|1 Year|Lost to Follow-up|0|||
13288803|NCT01084772|26476498|FG000|1 Year|Study Termination|0|||
13288804|NCT01084772|26476499|FG001|1 Year|Study Termination|7|||
13288805|NCT01084772|26476498|FG000|2 Years|Withdrawal by Subject|1|||
13288806|NCT01084772|26476499|FG001|2 Years|Withdrawal by Subject|0|||
13332044|NCT01103245|26600931|FG001|Overall Study|Inadequate IV access|0|||
13332045|NCT01103245|26600932|FG002|Overall Study|Inadequate IV access|0|||
13332046|NCT01103245|26600933|FG003|Overall Study|Inadequate IV access|0|||
13332047|NCT01103245|26600930|FG000|Overall Study|Adverse Event|0|||
13332048|NCT01103245|26600931|FG001|Overall Study|Adverse Event|2|||
13332049|NCT01103245|26600932|FG002|Overall Study|Adverse Event|1|||
13332050|NCT01103245|26600933|FG003|Overall Study|Adverse Event|0|||
13332051|NCT01103245|26600930|FG000|Overall Study|Physician Decision|1|||
13332052|NCT01103245|26600931|FG001|Overall Study|Physician Decision|0|||
13332053|NCT01103245|26600932|FG002|Overall Study|Physician Decision|0|||
13332054|NCT01103245|26600933|FG003|Overall Study|Physician Decision|0|||
13332055|NCT01103232|26600946|FG000|Overall Study|Withdrawal by Subject|1|||
13332056|NCT01103232|26600947|FG001|Overall Study|Withdrawal by Subject|1|||
13332057|NCT01103232|26600946|FG000|Overall Study|Protocol Violation|0|||
13332058|NCT01103232|26600947|FG001|Overall Study|Protocol Violation|1|||
13332059|NCT01103180|26600962|FG000|Overall Study|Withdrawal by Subject|8|||
13332060|NCT01103180|26600963|FG001|Overall Study|Withdrawal by Subject|13|||
13332061|NCT01103180|26600962|FG000|Overall Study|Lost to Follow-up|13|||
13332062|NCT01103180|26600963|FG001|Overall Study|Lost to Follow-up|7|||
13332063|NCT01103180|26600962|FG000|Overall Study|Physician Decision|1|||
13332064|NCT01103180|26600963|FG001|Overall Study|Physician Decision|0|||
13332065|NCT01103180|26600962|FG000|Overall Study|Protocol Violation|0|||
13332066|NCT01103180|26600963|FG001|Overall Study|Protocol Violation|1|||
13332067|NCT01103141|26600976|FG000|Overall Study|Death|0|||
13332068|NCT01103141|26600977|FG001|Overall Study|Death|1|||
13332069|NCT01103141|26600976|FG000|Overall Study|Lost to Follow-up|2|||
13332070|NCT01103141|26600977|FG001|Overall Study|Lost to Follow-up|1|||
13332071|NCT01103063|26601050|FG000|Overall Study|Adverse Event|3|||
13332072|NCT01103063|26601051|FG001|Overall Study|Adverse Event|1|||
13332073|NCT01103063|26601050|FG000|Overall Study|Lost to Follow-up|68|||
13332074|NCT01103063|26601051|FG001|Overall Study|Lost to Follow-up|51|||
13332075|NCT01103063|26601050|FG000|Overall Study|Withdrawal by Subject|60|||
13332076|NCT01103063|26601051|FG001|Overall Study|Withdrawal by Subject|15|||
13332077|NCT01103063|26601050|FG000|Overall Study|Other|16|||
13332078|NCT01103063|26601051|FG001|Overall Study|Other|11|||
13332079|NCT01103063|26601050|FG000|Overall Study|Protocol Violation|1|||
13288807|NCT01084772|26476498|FG000|2 Years|Lost to Follow-up|5|||
13288808|NCT01084772|26476499|FG001|2 Years|Lost to Follow-up|2|||
13288809|NCT01084772|26476498|FG000|2 Years|Study Termination|3|||
13288810|NCT01084772|26476499|FG001|2 Years|Study Termination|2|||
13332080|NCT01103063|26601051|FG001|Overall Study|Protocol Violation|0|||
13332081|NCT01103063|26601050|FG000|Overall Study|Study terminated by Sponsor|326|||
13288811|NCT01084707|26476535|FG000|Overall Study|Withdrawal by Subject|6|||
13288812|NCT01084668|26476546|FG000|Overall Study|Lack of Efficacy|5|||
13288813|NCT01084668|26476546|FG000|Overall Study|Withdrawal by Subject|2|||
13332082|NCT01103063|26601051|FG001|Overall Study|Study terminated by Sponsor|342|||
13332083|NCT01103063|26601050|FG000|Overall Study|Death|3|||
13332084|NCT01103063|26601051|FG001|Overall Study|Death|1|||
13332085|NCT01102972|26601110|FG000|Overall Study|Adverse Event|8|||
13332086|NCT01102972|26601111|FG001|Overall Study|Adverse Event|2|||
13332087|NCT01102972|26601110|FG000|Overall Study|Lack of Efficacy|2|||
13332088|NCT01102972|26601111|FG001|Overall Study|Lack of Efficacy|1|||
13332089|NCT01102972|26601110|FG000|Overall Study|Protocol Violation|1|||
13332090|NCT01102972|26601111|FG001|Overall Study|Protocol Violation|0|||
13332091|NCT01102972|26601110|FG000|Overall Study|Lost to Follow-up|10|||
13332092|NCT01102972|26601111|FG001|Overall Study|Lost to Follow-up|5|||
13332093|NCT01102972|26601110|FG000|Overall Study|Investigator Discretion|2|||
13332094|NCT01102972|26601111|FG001|Overall Study|Investigator Discretion|0|||
13332095|NCT01102972|26601110|FG000|Overall Study|Withdrawal by Subject|6|||
13122362|NCT02965456|25946939|FG001|Overall Study|Adverse Event|0|||
13122363|NCT02965456|25946938|FG000|Overall Study|Noncompliance with Study Drug|1|||
13122364|NCT02965456|25946939|FG001|Overall Study|Noncompliance with Study Drug|1|||
13122365|NCT02965456|25946938|FG000|Overall Study|Worsening Condition|0|||
13122366|NCT02965456|25946939|FG001|Overall Study|Worsening Condition|2|||
13122367|NCT02965456|25946938|FG000|Overall Study|Lack of Efficacy|1|||
13122368|NCT02965456|25946939|FG001|Overall Study|Lack of Efficacy|0|||
13122369|NCT02965456|25946938|FG000|Overall Study|Physician Decision|0|||
13122370|NCT02965456|25946939|FG001|Overall Study|Physician Decision|1|||
13122371|NCT02965456|25946938|FG000|Overall Study|Pregnancy|1|||
13122372|NCT02965456|25946939|FG001|Overall Study|Pregnancy|0|||
13122373|NCT02965456|25946938|FG000|Overall Study|Protocol Violation|0|||
13122374|NCT02965456|25946939|FG001|Overall Study|Protocol Violation|1|||
13122375|NCT02965456|25946938|FG000|Overall Study|Participant ran out of study drug|0|||
13122376|NCT02965456|25946939|FG001|Overall Study|Participant ran out of study drug|1|||
13122377|NCT02965378|25946955|FG000|Overall Study|Progression|16|||
13122378|NCT02965378|25946956|FG001|Overall Study|Progression|4|||
13122379|NCT02965378|25946955|FG000|Overall Study|Adverse Event|5|||
13122380|NCT02965378|25946956|FG001|Overall Study|Adverse Event|2|||
13122381|NCT02965378|25946955|FG000|Overall Study|Death|2|||
13122382|NCT02965378|25946956|FG001|Overall Study|Death|0|||
13122383|NCT02965378|25946955|FG000|Overall Study|Refusal|2|||
13122384|NCT02965378|25946956|FG001|Overall Study|Refusal|1|||
13122385|NCT02965378|25946955|FG000|Overall Study|Not protocol specified|0|||
13122386|NCT02965378|25946956|FG001|Overall Study|Not protocol specified|2|||
13122387|NCT02964741|25946984|FG000|Overall Study|Protocol Violation|1|||
13122388|NCT02964741|25946985|FG001|Overall Study|Protocol Violation|0|||
13122389|NCT02964741|25946986|FG002|Overall Study|Protocol Violation|0|||
13122390|NCT02964741|25946984|FG000|Overall Study|Withdrawal by Subject|0|||
13122391|NCT02964741|25946985|FG001|Overall Study|Withdrawal by Subject|1|||
13122392|NCT02964741|25946986|FG002|Overall Study|Withdrawal by Subject|0|||
13122393|NCT02964741|25946984|FG000|Overall Study|claustrophobia|1|||
13122394|NCT02964741|25946985|FG001|Overall Study|claustrophobia|0|||
13122395|NCT02964741|25946986|FG002|Overall Study|claustrophobia|0|||
13122396|NCT02964338|25947040|FG000|Overall Study|Sponsor terminated study for futility|12|||
13122397|NCT02964338|25947041|FG001|Overall Study|Sponsor terminated study for futility|15|||
13122398|NCT02964338|25947042|FG002|Overall Study|Sponsor terminated study for futility|14|||
13122399|NCT02964338|25947040|FG000|Overall Study|Lack of Efficacy|0|||
13122400|NCT02964338|25947041|FG001|Overall Study|Lack of Efficacy|3|||
13122401|NCT02964338|25947042|FG002|Overall Study|Lack of Efficacy|0|||
13122402|NCT02964338|25947040|FG000|Overall Study|Lost to Follow-up|1|||
13122403|NCT02964338|25947041|FG001|Overall Study|Lost to Follow-up|0|||
13122404|NCT02964338|25947042|FG002|Overall Study|Lost to Follow-up|3|||
13122405|NCT02964338|25947040|FG000|Overall Study|Protocol Violation|0|||
13122406|NCT02964338|25947041|FG001|Overall Study|Protocol Violation|1|||
13122407|NCT02964338|25947042|FG002|Overall Study|Protocol Violation|0|||
13122408|NCT02964338|25947040|FG000|Overall Study|Withdrawal by Subject|1|||
13122409|NCT02964338|25947041|FG001|Overall Study|Withdrawal by Subject|3|||
13122410|NCT02964338|25947042|FG002|Overall Study|Withdrawal by Subject|1|||
13122411|NCT02964338|25947040|FG000|Overall Study|Adverse Event|2|||
13122412|NCT02964338|25947041|FG001|Overall Study|Adverse Event|1|||
13122413|NCT02964338|25947042|FG002|Overall Study|Adverse Event|1|||
13122414|NCT02964338|25947040|FG000|Overall Study|Non-compliant with e-diary|0|||
13122415|NCT02964338|25947041|FG001|Overall Study|Non-compliant with e-diary|1|||
13122416|NCT02964338|25947042|FG002|Overall Study|Non-compliant with e-diary|0|||
13288814|NCT01084668|26476546|FG000|Overall Study|Pregnancy|1|||
13288815|NCT01084668|26476546|FG000|Overall Study|Non-compliance|1|||
13288816|NCT01084655|26476591|FG000|Overall Study|Radiographic disease progression|3|||
13288817|NCT01084655|26476592|FG001|Overall Study|Radiographic disease progression|2|||
13288818|NCT01084655|26476593|FG002|Overall Study|Radiographic disease progression|8|||
13288819|NCT01084655|26476591|FG000|Overall Study|Withdrawal by Subject|1|||
13288820|NCT01084655|26476592|FG001|Overall Study|Withdrawal by Subject|0|||
13288821|NCT01084655|26476593|FG002|Overall Study|Withdrawal by Subject|4|||
13288822|NCT01084655|26476591|FG000|Overall Study|Adverse Event|2|||
13332096|NCT01102972|26601111|FG001|Overall Study|Withdrawal by Subject|6|||
13332097|NCT01102803|26601130|FG000|Baseline to Post-Treatment|Lost to Follow-up|3|||
13122417|NCT02964338|25947040|FG000|Overall Study|Did not meet criteria|1|||
13122418|NCT02964338|25947041|FG001|Overall Study|Did not meet criteria|0|||
13332098|NCT01102803|26601131|FG001|Baseline to Post-Treatment|Lost to Follow-up|0|||
13332099|NCT01102803|26601130|FG000|Post to Follow-Up|Lost to Follow-up|1|||
13332100|NCT01102803|26601131|FG001|Post to Follow-Up|Lost to Follow-up|3|||
13332101|NCT01102777|26601162|FG000|Overall Study|Death|2|||
13332102|NCT01102777|26601163|FG001|Overall Study|Death|6|||
13332103|NCT01102777|26601162|FG000|Overall Study|Lost to Follow-up|7|||
13332104|NCT01102777|26601163|FG001|Overall Study|Lost to Follow-up|10|||
13332105|NCT01102491|26601176|FG000|Overall Study|Protocol Violation|11|||
13332106|NCT01102491|26601177|FG001|Overall Study|Protocol Violation|12|||
13373807|NCT00799487|26724946|FG001|Double-Blind Assessment Period|Lost to Follow-up|0|||
13373808|NCT00799487|26724947|FG002|Double-Blind Assessment Period|Lost to Follow-up|1|||
13373809|NCT00799487|26724945|FG000|Double-Blind Assessment Period|Subject was out of the state|0|||
13373810|NCT00799487|26724946|FG001|Double-Blind Assessment Period|Subject was out of the state|0|||
13373811|NCT00799487|26724947|FG002|Double-Blind Assessment Period|Subject was out of the state|1|||
13373812|NCT00799487|26724945|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
13373813|NCT00799487|26724946|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1|||
13373814|NCT00799487|26724947|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
13373815|NCT00799422|26724968|FG000|First Week of Wear|Lost to Follow-up|0|||
13373816|NCT00799422|26724969|FG001|First Week of Wear|Lost to Follow-up|0|||
13373817|NCT00799422|26724970|FG002|First Week of Wear|Lost to Follow-up|1|||
13288823|NCT01084655|26476592|FG001|Overall Study|Adverse Event|1|||
13288824|NCT01084655|26476593|FG002|Overall Study|Adverse Event|2|||
13288825|NCT01084655|26476591|FG000|Overall Study|Other|0|||
13288826|NCT01084655|26476592|FG001|Overall Study|Other|3|||
13288827|NCT01084655|26476593|FG002|Overall Study|Other|2|||
13373818|NCT00799422|26724971|FG003|First Week of Wear|Lost to Follow-up|0|||
13373819|NCT00799422|26724972|FG004|First Week of Wear|Lost to Follow-up|0|||
13373820|NCT00799422|26724973|FG005|First Week of Wear|Lost to Follow-up|0|||
13373821|NCT00799422|26724968|FG000|First Week of Wear|Adverse Event|0|||
13373822|NCT00799422|26724969|FG001|First Week of Wear|Adverse Event|0|||
13373823|NCT00799422|26724970|FG002|First Week of Wear|Adverse Event|0|||
13373824|NCT00799422|26724971|FG003|First Week of Wear|Adverse Event|1|||
13373825|NCT00799422|26724972|FG004|First Week of Wear|Adverse Event|0|||
13373826|NCT00799422|26724973|FG005|First Week of Wear|Adverse Event|0|||
13373827|NCT00799409|26725063|FG000|Overall Study|Withdrawal by Subject|1|||
13373828|NCT00799409|26725064|FG001|Overall Study|Withdrawal by Subject|0|||
13373829|NCT00799409|26725065|FG002|Overall Study|Withdrawal by Subject|0|||
13373830|NCT00799409|26725063|FG000|Overall Study|Lost to Follow-up|1|||
13373831|NCT00799409|26725064|FG001|Overall Study|Lost to Follow-up|0|||
13373832|NCT00799409|26725065|FG002|Overall Study|Lost to Follow-up|0|||
13373833|NCT00799409|26725063|FG000|Overall Study|Optimal Dose Not Achieved|2|||
13373834|NCT00799409|26725064|FG001|Overall Study|Optimal Dose Not Achieved|0|||
13373835|NCT00799409|26725065|FG002|Overall Study|Optimal Dose Not Achieved|0|||
13373836|NCT00799409|26725063|FG000|Overall Study|Failure to follow study protocol)|1|||
13373837|NCT00799409|26725064|FG001|Overall Study|Failure to follow study protocol)|0|||
13373838|NCT00799409|26725065|FG002|Overall Study|Failure to follow study protocol)|0|||
13373839|NCT00799409|26725063|FG000|Overall Study|Did not attend lab school day 1|1|||
13373840|NCT00799409|26725064|FG001|Overall Study|Did not attend lab school day 1|0|||
13373841|NCT00799409|26725065|FG002|Overall Study|Did not attend lab school day 1|0|||
13373842|NCT00799409|26725063|FG000|Overall Study|medication compliance|1|||
13373843|NCT00799409|26725064|FG001|Overall Study|medication compliance|0|||
13373844|NCT00799409|26725065|FG002|Overall Study|medication compliance|0|||
13373845|NCT00799383|26725092|FG000|Overall Study|Protocol Violation|1|||
13373846|NCT00799383|26725093|FG001|Overall Study|Protocol Violation|1|||
13373847|NCT00799383|26725092|FG000|Overall Study|Adverse Event|0|||
13373848|NCT00799383|26725093|FG001|Overall Study|Adverse Event|1|||
13373849|NCT00799383|26725092|FG000|Overall Study|Lost to Follow-up|1|||
13373850|NCT00799383|26725093|FG001|Overall Study|Lost to Follow-up|2|||
13373851|NCT00799383|26725092|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
13373852|NCT00799383|26725093|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
13122419|NCT02964338|25947042|FG002|Overall Study|Did not meet criteria|0|||
13122420|NCT02964325|25947069|FG000|Overall Study|Lost to Follow-up|3|||
13122421|NCT02964325|25947070|FG001|Overall Study|Lost to Follow-up|3|||
13288828|NCT01084655|26476591|FG000|Overall Study|Symptomatic deterioration|0|||
13288829|NCT01084655|26476592|FG001|Overall Study|Symptomatic deterioration|0|||
13288830|NCT01084655|26476593|FG002|Overall Study|Symptomatic deterioration|2|||
13288831|NCT01084655|26476591|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
13288832|NCT01084655|26476592|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
13288833|NCT01084655|26476593|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1|||
13288834|NCT01084603|26476628|FG000|Baseline|Withdrawal by Subject|2|||
13288835|NCT01084603|26476628|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1|||
13373853|NCT00799383|26725092|FG000|Overall Study|Withdrawal by Subject|0|||
13373854|NCT00799383|26725093|FG001|Overall Study|Withdrawal by Subject|1|||
13288836|NCT01084603|26476628|FG000|Nicorette® Gum|Withdrawal by Subject|1|||
13122422|NCT02964325|25947069|FG000|Overall Study|Physician Decision|5|||
13122423|NCT02964325|25947070|FG001|Overall Study|Physician Decision|4|||
13122424|NCT02964325|25947069|FG000|Overall Study|Death|1|||
13122425|NCT02964325|25947070|FG001|Overall Study|Death|3|||
13122426|NCT02964325|25947069|FG000|Overall Study|Withdrawal by Subject|2|||
13288837|NCT01084603|26476628|FG000|Oral Nicotine 1|Withdrawal by Subject|1|||
13288838|NCT01084603|26476628|FG000|Washout Period 4|Adverse Event|1|||
13288839|NCT01084551|26476676|FG000|Overall Study|Adverse Event|2|||
13288840|NCT01084551|26476677|FG001|Overall Study|Adverse Event|9|||
13288841|NCT01084551|26476678|FG002|Overall Study|Adverse Event|4|||
13288842|NCT01084551|26476676|FG000|Overall Study|Lack of Efficacy|2|||
13288843|NCT01084551|26476677|FG001|Overall Study|Lack of Efficacy|0|||
13288844|NCT01084551|26476678|FG002|Overall Study|Lack of Efficacy|1|||
13288845|NCT01084551|26476676|FG000|Overall Study|Withdrawal by Subject|2|||
13288846|NCT01084551|26476677|FG001|Overall Study|Withdrawal by Subject|1|||
13288847|NCT01084551|26476678|FG002|Overall Study|Withdrawal by Subject|0|||
13288848|NCT01084551|26476676|FG000|Overall Study|Protocol Violation|2|||
13288849|NCT01084551|26476677|FG001|Overall Study|Protocol Violation|4|||
13288850|NCT01084551|26476678|FG002|Overall Study|Protocol Violation|0|||
13288851|NCT01084551|26476676|FG000|Overall Study|Lost to Follow-up|0|||
13288852|NCT01084551|26476677|FG001|Overall Study|Lost to Follow-up|0|||
13288853|NCT01084551|26476678|FG002|Overall Study|Lost to Follow-up|3|||
13288854|NCT01084551|26476676|FG000|Overall Study|Physician Decision|1|||
13288855|NCT01084551|26476677|FG001|Overall Study|Physician Decision|0|||
13288856|NCT01084551|26476678|FG002|Overall Study|Physician Decision|0|||
13288857|NCT01084538|26476687|FG000|Overall Study|Drug not available|30|||
13288858|NCT01084538|26476687|FG000|Overall Study|Adverse Event|9|||
13288859|NCT01084538|26476687|FG000|Overall Study|Kidney transplant|6|||
13288860|NCT01084538|26476687|FG000|Overall Study|Serious Adverse Event|3|||
13288861|NCT01084538|26476687|FG000|Overall Study|Lack of effectiveness|2|||
13288862|NCT01084538|26476687|FG000|Overall Study|Patient noncompliance|2|||
13288863|NCT01084538|26476687|FG000|Overall Study|Hyperphosphatemia|2|||
13288864|NCT01084538|26476687|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2|||
13288865|NCT01084538|26476687|FG000|Overall Study|Change of residence|2|||
13288866|NCT01084538|26476687|FG000|Overall Study|Over-suppression of parathyroid gland|2|||
13288867|NCT01084538|26476687|FG000|Overall Study|Reason unknown|8|||
13288868|NCT01084174|26476712|FG000|Overall Study|gastrointestinal symptoms|1|||
13288869|NCT01084174|26476713|FG001|Overall Study|gastrointestinal symptoms|1|||
13288870|NCT01084174|26476712|FG000|Overall Study|Eosinophilic esophagitis|0|||
13288871|NCT01084174|26476713|FG001|Overall Study|Eosinophilic esophagitis|1|||
13288872|NCT01084174|26476712|FG000|Overall Study|Anaphylaxis|0|||
13288873|NCT01084174|26476713|FG001|Overall Study|Anaphylaxis|1|||
13288874|NCT01084174|26476712|FG000|Overall Study|Participant noncompliance|0|||
13288875|NCT01084174|26476713|FG001|Overall Study|Participant noncompliance|1|||
13288876|NCT01084135|26476734|FG000|20 Week|Physician Decision|0|||
13122427|NCT02964325|25947070|FG001|Overall Study|Withdrawal by Subject|1|||
13122428|NCT02964325|25947069|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10|||
13122429|NCT02964325|25947070|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12|||
13122430|NCT02964312|25947081|FG000|Overall Study|Lost to Follow-up|28|||
13122431|NCT02964312|25947081|FG000|Overall Study|Withdrawal by Subject|11|||
13122432|NCT02964312|25947081|FG000|Overall Study|Lack of Efficacy|10|||
13122433|NCT02964312|25947081|FG000|Overall Study|Did not consent to long-term FU|14|||
13122434|NCT02964312|25947081|FG000|Overall Study|Death|1|||
13122435|NCT02964247|25947144|FG000|Overall Study|Lost to Follow-up|2|||
13288877|NCT01084135|26476735|FG001|20 Week|Physician Decision|1|||
13288878|NCT01084083|26476743|FG000|Overall Study|Adverse Event|5|||
13288879|NCT01084083|26476743|FG000|Overall Study|Death|1|||
13122436|NCT02964247|25947145|FG001|Overall Study|Lost to Follow-up|0|||
13122437|NCT02964247|25947144|FG000|Overall Study|Withdrawal by Subject|1|||
13122438|NCT02964247|25947145|FG001|Overall Study|Withdrawal by Subject|2|||
13122439|NCT02964234|25947162|FG000|Overall Study|Lost to Follow-up|22|||
13122440|NCT02964234|25947163|FG001|Overall Study|Lost to Follow-up|13|||
13122441|NCT02964039|25947196|FG000|Overall Study|Medical reason unrelated to study participation|1|||
13122442|NCT02964039|25947197|FG001|Overall Study|Medical reason unrelated to study participation|0|||
13122443|NCT02964039|25947198|FG002|Overall Study|Medical reason unrelated to study participation|3|||
13122444|NCT02964039|25947196|FG000|Overall Study|Research shutdown due to pandemic|2|||
13122445|NCT02964039|25947197|FG001|Overall Study|Research shutdown due to pandemic|0|||
13122446|NCT02964039|25947198|FG002|Overall Study|Research shutdown due to pandemic|1|||
13288880|NCT01084083|26476743|FG000|Overall Study|Withdrawal by Subject|2|||
13288881|NCT01084083|26476743|FG000|Overall Study|Complicating disease|1|||
13288882|NCT01084083|26476743|FG000|Overall Study|Other|2|||
13288883|NCT01084083|26476743|FG000|Overall Study|Never started assigned therapy|1|||
13288884|NCT01084005|26476778|FG000|Overall Study|Adverse Event|1|||
13288885|NCT01084005|26476779|FG001|Overall Study|Adverse Event|8|||
13288886|NCT01084005|26476778|FG000|Overall Study|Protocol Violation|3|||
13288887|NCT01084005|26476779|FG001|Overall Study|Protocol Violation|7|||
13288888|NCT01084005|26476778|FG000|Overall Study|Withdrawal by Subject|1|||
13122447|NCT02964039|25947196|FG000|Overall Study|Withdrawal by Subject|0|||
13122448|NCT02964039|25947197|FG001|Overall Study|Withdrawal by Subject|1|||
13122449|NCT02964039|25947198|FG002|Overall Study|Withdrawal by Subject|0|||
13122450|NCT02964039|25947196|FG000|Overall Study|Lost to Follow-up|1|||
13122451|NCT02964039|25947197|FG001|Overall Study|Lost to Follow-up|0|||
13122452|NCT02964039|25947198|FG002|Overall Study|Lost to Follow-up|1|||
13122453|NCT02963935|25947311|FG000|Overall Study|Adverse Event|12|||
13122454|NCT02963935|25947312|FG001|Overall Study|Adverse Event|6|||
13122455|NCT02963935|25947311|FG000|Overall Study|Protocol Violation|2|||
13122456|NCT02963935|25947312|FG001|Overall Study|Protocol Violation|1|||
13122457|NCT02963935|25947311|FG000|Overall Study|Lack of Efficacy|0|||
13122458|NCT02963935|25947312|FG001|Overall Study|Lack of Efficacy|2|||
13122459|NCT02963935|25947311|FG000|Overall Study|Lost to Follow-up|1|||
13122460|NCT02963935|25947312|FG001|Overall Study|Lost to Follow-up|6|||
13122461|NCT02963935|25947311|FG000|Overall Study|Unclassified|13|||
13122462|NCT02963935|25947312|FG001|Overall Study|Unclassified|22|||
13122463|NCT02963922|25947415|FG000|Overall Study|Adverse Event|15|||
13122464|NCT02963922|25947416|FG001|Overall Study|Adverse Event|6|||
13122465|NCT02963922|25947415|FG000|Overall Study|Protocol deviation|6|||
13122466|NCT02963922|25947416|FG001|Overall Study|Protocol deviation|6|||
13122467|NCT02963922|25947415|FG000|Overall Study|Lack of Efficacy|1|||
13122468|NCT02963922|25947416|FG001|Overall Study|Lack of Efficacy|1|||
13122469|NCT02963922|25947415|FG000|Overall Study|Lost to Follow-up|2|||
13122470|NCT02963922|25947416|FG001|Overall Study|Lost to Follow-up|3|||
13122471|NCT02963922|25947415|FG000|Overall Study|Other|8|||
13122472|NCT02963922|25947416|FG001|Overall Study|Other|14|||
13288889|NCT01084005|26476779|FG001|Overall Study|Withdrawal by Subject|1|||
13288890|NCT01083810|26476810|FG000|Overall Study|Lost to Follow-up|23|||
13288891|NCT01083810|26476811|FG001|Overall Study|Lost to Follow-up|11|||
13288892|NCT01083810|26476812|FG002|Overall Study|Lost to Follow-up|4|||
13288893|NCT01083810|26476810|FG000|Overall Study|Adverse Event|15|||
13288894|NCT01083810|26476811|FG001|Overall Study|Adverse Event|11|||
13288895|NCT01083810|26476812|FG002|Overall Study|Adverse Event|4|||
13288896|NCT01083810|26476810|FG000|Overall Study|Withdrawal by Subject|7|||
13288897|NCT01083810|26476811|FG001|Overall Study|Withdrawal by Subject|2|||
13288898|NCT01083810|26476812|FG002|Overall Study|Withdrawal by Subject|4|||
13288899|NCT01083810|26476810|FG000|Overall Study|Reason not reported|6|||
13288900|NCT01083810|26476811|FG001|Overall Study|Reason not reported|1|||
13288901|NCT01083810|26476812|FG002|Overall Study|Reason not reported|1|||
13288902|NCT01083810|26476810|FG000|Overall Study|Non-compliance|4|||
13288903|NCT01083810|26476811|FG001|Overall Study|Non-compliance|7|||
13288904|NCT01083810|26476812|FG002|Overall Study|Non-compliance|2|||
13288905|NCT01083810|26476810|FG000|Overall Study|Simplification|4|||
13288906|NCT01083810|26476811|FG001|Overall Study|Simplification|1|||
13288907|NCT01083810|26476812|FG002|Overall Study|Simplification|0|||
13288908|NCT01083810|26476810|FG000|Overall Study|Death|2|||
13288909|NCT01083810|26476811|FG001|Overall Study|Death|2|||
13288910|NCT01083810|26476812|FG002|Overall Study|Death|3|||
13288911|NCT01083810|26476810|FG000|Overall Study|Co-morbidities|1|||
13288912|NCT01083810|26476811|FG001|Overall Study|Co-morbidities|0|||
13288913|NCT01083810|26476812|FG002|Overall Study|Co-morbidities|0|||
13288914|NCT01083810|26476810|FG000|Overall Study|Participation in study|1|||
13288915|NCT01083810|26476811|FG001|Overall Study|Participation in study|0|||
13288916|NCT01083810|26476812|FG002|Overall Study|Participation in study|0|||
13288917|NCT01083810|26476810|FG000|Overall Study|Therapy break|1|||
13288918|NCT01083810|26476811|FG001|Overall Study|Therapy break|2|||
13332107|NCT01102426|26601222|FG000|Overall Study|Randomized but not treated|4|||
13332108|NCT01102426|26601223|FG001|Overall Study|Randomized but not treated|1|||
13332109|NCT01102426|26601222|FG000|Overall Study|Adverse Events (treatment-related)|15|||
13373855|NCT00799266|26725131|FG000|Overall Study|Adverse Event|0|||
13122473|NCT02963701|25947453|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1|||
13288919|NCT01083810|26476812|FG002|Overall Study|Therapy break|2|||
13288920|NCT01083810|26476810|FG000|Overall Study|Virologic failure|1|||
13288921|NCT01083810|26476811|FG001|Overall Study|Virologic failure|8|||
13288922|NCT01083810|26476812|FG002|Overall Study|Virologic failure|0|||
13288923|NCT01083771|26476819|FG000|Overall Study|non-compliant|2|||
13122474|NCT02963701|25947454|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0|||
13122475|NCT02963506|25947530|FG000|Double-Blind Period|Adverse Event|0|||
13122476|NCT02963506|25947531|FG001|Double-Blind Period|Adverse Event|0|||
13122477|NCT02963506|25947532|FG002|Double-Blind Period|Adverse Event|1|||
13122478|NCT02963506|25947533|FG003|Double-Blind Period|Adverse Event|0|||
13122479|NCT02963506|25947534|FG004|Double-Blind Period|Adverse Event|0|||
13122480|NCT02963506|25947535|FG005|Double-Blind Period|Adverse Event|0|||
13288924|NCT01083771|26476819|FG000|Overall Study|Withdrawal by Subject|3|||
13122481|NCT02963506|25947536|FG006|Double-Blind Period|Adverse Event|0|||
13122482|NCT02963506|25947537|FG007|Double-Blind Period|Adverse Event|0|||
13288925|NCT01083693|26476864|FG000|Overall Study|Adverse Event|1|||
13288926|NCT01083693|26476865|FG001|Overall Study|Adverse Event|1|||
13288927|NCT01083693|26476866|FG002|Overall Study|Adverse Event|0|||
13288928|NCT01083693|26476864|FG000|Overall Study|Lost to Follow-up|2|||
13288929|NCT01083693|26476865|FG001|Overall Study|Lost to Follow-up|0|||
13288930|NCT01083693|26476866|FG002|Overall Study|Lost to Follow-up|2|||
13288931|NCT01083693|26476864|FG000|Overall Study|Lack of effectiveness|13|||
13288932|NCT01083693|26476865|FG001|Overall Study|Lack of effectiveness|2|||
13288933|NCT01083693|26476866|FG002|Overall Study|Lack of effectiveness|2|||
13288934|NCT01083693|26476864|FG000|Overall Study|Patient Moved|0|||
13332110|NCT01102426|26601223|FG001|Overall Study|Adverse Events (treatment-related)|8|||
13332111|NCT01102426|26601222|FG000|Overall Study|Physician Decision|9|||
13332112|NCT01102426|26601223|FG001|Overall Study|Physician Decision|6|||
13332113|NCT01102426|26601222|FG000|Overall Study|Progressive Disease|85|||
13332114|NCT01102426|26601223|FG001|Overall Study|Progressive Disease|44|||
13332115|NCT01102426|26601222|FG000|Overall Study|Adverse Events (unrelated to|9|||
13332116|NCT01102426|26601223|FG001|Overall Study|Adverse Events (unrelated to|1|||
13332117|NCT01102426|26601222|FG000|Overall Study|Patient Refusal|24|||
13332118|NCT01102426|26601223|FG001|Overall Study|Patient Refusal|12|||
13332119|NCT01102426|26601222|FG000|Overall Study|Death (due to adverse events|0|||
13332120|NCT01102426|26601223|FG001|Overall Study|Death (due to adverse events|1|||
13332121|NCT01102426|26601222|FG000|Overall Study|Death (non-related to the study|19|||
13332122|NCT01102426|26601223|FG001|Overall Study|Death (non-related to the study|8|||
13332123|NCT01102374|26601264|FG000|Overall Study|Death|9|||
13332124|NCT01102374|26601265|FG001|Overall Study|Death|13|||
13332125|NCT01102374|26601264|FG000|Overall Study|Lost to Follow-up|7|||
13332126|NCT01102374|26601265|FG001|Overall Study|Lost to Follow-up|6|||
13332127|NCT01102257|26601278|FG000|Overall Study|Adverse Event|1|||
13332128|NCT01102257|26601279|FG001|Overall Study|Adverse Event|0|||
13332129|NCT01102257|26601278|FG000|Overall Study|Adverse Event|1|||
13332130|NCT01102257|26601279|FG001|Overall Study|Adverse Event|0|||
13332131|NCT01102231|26601287|FG000|Overall Study|Protocol Violation|3|||
13332132|NCT01102231|26601287|FG000|Overall Study|Lack of Efficacy|2|||
13332133|NCT01102231|26601287|FG000|Overall Study|Death|2|||
13332134|NCT01102231|26601287|FG000|Overall Study|Adverse Event|3|||
13332135|NCT01102231|26601287|FG000|Overall Study|Withdrawal by Subject|1|||
13332136|NCT01102231|26601287|FG000|Overall Study|Did not received the treatment|4|||
13332137|NCT01102140|26601306|FG000|Overall Study|Lost to Follow-up|1|||
13332138|NCT01102140|26601307|FG001|Overall Study|Lost to Follow-up|0|||
13332139|NCT01102140|26601306|FG000|Overall Study|Investigator terminated study|2|||
13332140|NCT01102140|26601307|FG001|Overall Study|Investigator terminated study|2|||
13332141|NCT01101997|26601315|FG000|Overall Study|Withdrawal by Subject|2|||
13332142|NCT01101841|26601360|FG000|Overall Study|Adverse Event|15|||
13332143|NCT01101841|26601361|FG001|Overall Study|Adverse Event|15|||
13122483|NCT02963506|25947538|FG008|Double-Blind Period|Adverse Event|0|||
13288935|NCT01083693|26476865|FG001|Overall Study|Patient Moved|1|||
13288936|NCT01083693|26476866|FG002|Overall Study|Patient Moved|0|||
13288937|NCT01083693|26476864|FG000|Overall Study|Complete remission|0|||
13288938|NCT01083693|26476865|FG001|Overall Study|Complete remission|1|||
13288939|NCT01083693|26476866|FG002|Overall Study|Complete remission|0|||
13288940|NCT01083693|26476864|FG000|Overall Study|Other medical condition/surgery|1|||
13288941|NCT01083693|26476865|FG001|Overall Study|Other medical condition/surgery|1|||
13122484|NCT02963506|25947539|FG009|Double-Blind Period|Adverse Event|0|||
13122485|NCT02963506|25947540|FG010|Double-Blind Period|Adverse Event|0|||
13122486|NCT02963506|25947541|FG011|Double-Blind Period|Adverse Event|0|||
13122487|NCT02963506|25947542|FG012|Double-Blind Period|Adverse Event|0|||
13122488|NCT02963506|25947530|FG000|Double-Blind Period|Death|0|||
13122489|NCT02963506|25947531|FG001|Double-Blind Period|Death|0|||
13122490|NCT02963506|25947532|FG002|Double-Blind Period|Death|0|||
13122491|NCT02963506|25947533|FG003|Double-Blind Period|Death|1|||
13122492|NCT02963506|25947534|FG004|Double-Blind Period|Death|0|||
13122493|NCT02963506|25947535|FG005|Double-Blind Period|Death|0|||
13288942|NCT01083693|26476866|FG002|Overall Study|Other medical condition/surgery|0|||
13288943|NCT01083693|26476864|FG000|Overall Study|Withdrawal by Subject|3|||
13288944|NCT01083693|26476865|FG001|Overall Study|Withdrawal by Subject|0|||
13288945|NCT01083693|26476866|FG002|Overall Study|Withdrawal by Subject|2|||
13288946|NCT01083693|26476864|FG000|Overall Study|Reason unknown|0|||
13122494|NCT02963506|25947536|FG006|Double-Blind Period|Death|0|||
13122495|NCT02963506|25947537|FG007|Double-Blind Period|Death|0|||
13288947|NCT01083693|26476865|FG001|Overall Study|Reason unknown|0|||
13288948|NCT01083693|26476866|FG002|Overall Study|Reason unknown|1|||
13288949|NCT01083680|26476877|FG000|Overall Study|Lost to Follow-up|2758|||
13288950|NCT01083680|26476877|FG000|Overall Study|Withdrawal by Subject|1086|||
13288951|NCT01083641|26476886|FG000|Overall Study|Withdrawal by Subject|2|||
13288952|NCT01083602|26476897|FG000|Overall Study|Adverse Event|11|||
13288953|NCT01083602|26476897|FG000|Overall Study|New Cancer Therapy|2|||
13288954|NCT01083602|26476897|FG000|Overall Study|Death|1|||
13288955|NCT01083602|26476897|FG000|Overall Study|Withdrawal by Subject|5|||
13288956|NCT01083602|26476897|FG000|Overall Study|Lack of Efficacy|36|||
13288957|NCT01083576|26476932|FG000|Overall Study|Treatment Failure|6|||
13332144|NCT01101841|26601360|FG000|Overall Study|Lost to Follow-up|9|||
13122496|NCT02963506|25947538|FG008|Double-Blind Period|Death|0|||
13288958|NCT01083576|26476933|FG001|Overall Study|Treatment Failure|1|||
13288959|NCT01083485|26476948|FG000|Overall Study|Adverse Event|0|||
13288960|NCT01083485|26476949|FG001|Overall Study|Adverse Event|1|||
13288961|NCT01083485|26476948|FG000|Overall Study|Protocol Violation|1|||
13288962|NCT01083485|26476949|FG001|Overall Study|Protocol Violation|0|||
13288963|NCT01083485|26476948|FG000|Overall Study|Withdrawal by Subject|5|||
13288964|NCT01083485|26476949|FG001|Overall Study|Withdrawal by Subject|2|||
13288965|NCT01083485|26476948|FG000|Overall Study|Other|1|||
13288966|NCT01083485|26476949|FG001|Overall Study|Other|0|||
13288967|NCT01083316|26476958|FG000|Overall Study|Adverse Event|2|||
13288968|NCT01083316|26476958|FG000|Overall Study|Withdrawal by Subject|1|||
13288969|NCT01083186|26477001|FG000|Overall Study|Lost to Follow-up|48|||
13288970|NCT01083186|26477001|FG000|Overall Study|Consent Withdrawal|7|||
13288971|NCT01083186|26477001|FG000|Overall Study|Death|3|||
13288972|NCT01083186|26477001|FG000|Overall Study|Adverse Event|3|||
13288973|NCT01083186|26477001|FG000|Overall Study|Lack of Efficacy|2|||
13288974|NCT01083186|26477001|FG000|Overall Study|Hemodialysis Initiation|28|||
13288975|NCT01083186|26477001|FG000|Overall Study|Administrative Reasons|2|||
13288976|NCT01083186|26477001|FG000|Overall Study|Non-compliance to Study Treatment|1|||
13288977|NCT01083173|26477022|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
13288978|NCT01083173|26477023|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
13288979|NCT01083173|26477022|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1|||
13288980|NCT01083173|26477023|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0|||
13288981|NCT01083173|26477022|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201|||
13288982|NCT01083173|26477023|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0|||
13288983|NCT01083173|26477022|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168|||
13288984|NCT01083173|26477023|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0|||
13288985|NCT01083173|26477022|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13|||
13288986|NCT01083173|26477023|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0|||
13288987|NCT01083173|26477022|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
13288988|NCT01083173|26477023|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
13288989|NCT01083173|26477022|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0|||
13288990|NCT01083173|26477023|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1|||
13288991|NCT01083173|26477022|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0|||
13288992|NCT01083173|26477023|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101|||
13288993|NCT01083173|26477022|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0|||
13288994|NCT01083173|26477023|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195|||
13288995|NCT01083173|26477022|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0|||
13288996|NCT01083173|26477023|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136|||
13288997|NCT01083173|26477022|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0|||
13288998|NCT01083173|26477023|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46|||
13288999|NCT01083160|26477032|FG000|Overall Study|Adverse Event|1|||
13289000|NCT01083121|26477042|FG000|Overall Study|Use of Humira outside the approved label|81|||
13289001|NCT01082640|26477072|FG000|Overall Study|Adverse Event|9|||
13289002|NCT01082640|26477073|FG001|Overall Study|Adverse Event|5|||
13289003|NCT01082640|26477074|FG002|Overall Study|Adverse Event|3|||
13289004|NCT01082640|26477072|FG000|Overall Study|Withdrawal by Subject|3|||
13289005|NCT01082640|26477073|FG001|Overall Study|Withdrawal by Subject|3|||
13289006|NCT01082640|26477074|FG002|Overall Study|Withdrawal by Subject|2|||
13289007|NCT01082640|26477072|FG000|Overall Study|Major protocol deviation|3|||
13289008|NCT01082640|26477073|FG001|Overall Study|Major protocol deviation|3|||
13289009|NCT01082640|26477074|FG002|Overall Study|Major protocol deviation|0|||
13289010|NCT01082640|26477072|FG000|Overall Study|Lost to Follow-up|0|||
13289011|NCT01082640|26477073|FG001|Overall Study|Lost to Follow-up|3|||
13332145|NCT01101841|26601361|FG001|Overall Study|Lost to Follow-up|3|||
13332146|NCT01101841|26601360|FG000|Overall Study|Withdrawal by Subject|21|||
13332147|NCT01101841|26601361|FG001|Overall Study|Withdrawal by Subject|40|||
13332148|NCT01101841|26601360|FG000|Overall Study|Protocol Violation|1|||
13332149|NCT01101841|26601361|FG001|Overall Study|Protocol Violation|1|||
13332150|NCT01101841|26601360|FG000|Overall Study|Physician Decision|0|||
13332151|NCT01101841|26601361|FG001|Overall Study|Physician Decision|2|||
13332152|NCT01101841|26601360|FG000|Overall Study|Lack of Efficacy|0|||
13332153|NCT01101841|26601361|FG001|Overall Study|Lack of Efficacy|2|||
13332154|NCT01101841|26601360|FG000|Overall Study|Other|0|||
13332155|NCT01101841|26601361|FG001|Overall Study|Other|1|||
13289012|NCT01082640|26477074|FG002|Overall Study|Lost to Follow-up|0|||
13332156|NCT01101841|26601360|FG000|Overall Study|Suicidality Tracking Scale|3|||
13204071|NCT01977573|26226881|FG003|Overall Study|Reached Defined Stopping Criteria|0|||
13204072|NCT01977573|26226878|FG000|Overall Study|Withdrawal by Subject|6|||
13204073|NCT01977573|26226879|FG001|Overall Study|Withdrawal by Subject|1|||
13204074|NCT01977573|26226880|FG002|Overall Study|Withdrawal by Subject|1|||
13332157|NCT01101841|26601361|FG001|Overall Study|Suicidality Tracking Scale|1|||
13332158|NCT01101841|26601360|FG000|Overall Study|Eligibility Criteria|1|||
13332159|NCT01101841|26601361|FG001|Overall Study|Eligibility Criteria|2|||
13332160|NCT01101542|26601376|FG000|Year 3 Surveillance Period|Lost to Follow-up|7|||
13332161|NCT01101542|26601376|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4|||
13332162|NCT01101542|26601376|FG000|Year 4 Surveillance Period|Other|287|||
13332163|NCT01101542|26601376|FG000|Year 5 Surveillance Period|Lost to Follow-up|140|||
13332164|NCT01101542|26601376|FG000|Year 5 Surveillance Period|Pregnancy|1|||
13204075|NCT01977573|26226881|FG003|Overall Study|Withdrawal by Subject|1|||
13204076|NCT01977482|26227015|FG000|Overall Study|Adverse Event|0|||
13204077|NCT01977482|26227016|FG001|Overall Study|Adverse Event|1|||
13204078|NCT01977482|26227017|FG002|Overall Study|Adverse Event|1|||
13204079|NCT01977482|26227018|FG003|Overall Study|Adverse Event|0|||
13204080|NCT01977482|26227019|FG004|Overall Study|Adverse Event|2|||
13204081|NCT01977482|26227020|FG005|Overall Study|Adverse Event|0|||
13204082|NCT01977482|26227015|FG000|Overall Study|Lost to Follow-up|1|||
13204083|NCT01977482|26227016|FG001|Overall Study|Lost to Follow-up|0|||
13204084|NCT01977482|26227017|FG002|Overall Study|Lost to Follow-up|0|||
13204085|NCT01977482|26227018|FG003|Overall Study|Lost to Follow-up|0|||
13204086|NCT01977482|26227019|FG004|Overall Study|Lost to Follow-up|0|||
13204087|NCT01977482|26227020|FG005|Overall Study|Lost to Follow-up|0|||
13204088|NCT01977482|26227015|FG000|Overall Study|Physician Decision|0|||
13204089|NCT01977482|26227016|FG001|Overall Study|Physician Decision|1|||
13204090|NCT01977482|26227017|FG002|Overall Study|Physician Decision|0|||
13204091|NCT01977482|26227018|FG003|Overall Study|Physician Decision|0|||
13204092|NCT01977482|26227019|FG004|Overall Study|Physician Decision|0|||
13204093|NCT01977482|26227020|FG005|Overall Study|Physician Decision|0|||
13204094|NCT01977482|26227015|FG000|Overall Study|Protocol Violation|0|||
13204095|NCT01977482|26227016|FG001|Overall Study|Protocol Violation|0|||
13204096|NCT01977482|26227017|FG002|Overall Study|Protocol Violation|1|||
13204097|NCT01977482|26227018|FG003|Overall Study|Protocol Violation|0|||
13204098|NCT01977482|26227019|FG004|Overall Study|Protocol Violation|0|||
13332165|NCT01101542|26601376|FG000|Year 6 Surveillance Period|Lost to Follow-up|986|||
13122497|NCT02963506|25947539|FG009|Double-Blind Period|Death|0|||
13122498|NCT02963506|25947540|FG010|Double-Blind Period|Death|0|||
13122499|NCT02963506|25947541|FG011|Double-Blind Period|Death|0|||
13122500|NCT02963506|25947542|FG012|Double-Blind Period|Death|0|||
13122501|NCT02963506|25947530|FG000|Double-Blind Period|Lost to Follow-up|0|||
13122502|NCT02963506|25947531|FG001|Double-Blind Period|Lost to Follow-up|1|||
13122503|NCT02963506|25947532|FG002|Double-Blind Period|Lost to Follow-up|0|||
13122504|NCT02963506|25947533|FG003|Double-Blind Period|Lost to Follow-up|0|||
13122505|NCT02963506|25947534|FG004|Double-Blind Period|Lost to Follow-up|0|||
13122506|NCT02963506|25947535|FG005|Double-Blind Period|Lost to Follow-up|0|||
13122507|NCT02963506|25947536|FG006|Double-Blind Period|Lost to Follow-up|0|||
13122508|NCT02963506|25947537|FG007|Double-Blind Period|Lost to Follow-up|0|||
13122509|NCT02963506|25947538|FG008|Double-Blind Period|Lost to Follow-up|0|||
13122510|NCT02963506|25947539|FG009|Double-Blind Period|Lost to Follow-up|0|||
13122511|NCT02963506|25947540|FG010|Double-Blind Period|Lost to Follow-up|0|||
13122512|NCT02963506|25947541|FG011|Double-Blind Period|Lost to Follow-up|0|||
13122513|NCT02963506|25947542|FG012|Double-Blind Period|Lost to Follow-up|0|||
13122514|NCT02963506|25947530|FG000|Double-Blind Period|Withdrawal by Subject|0|||
13122515|NCT02963506|25947531|FG001|Double-Blind Period|Withdrawal by Subject|0|||
13122516|NCT02963506|25947532|FG002|Double-Blind Period|Withdrawal by Subject|1|||
13122517|NCT02963506|25947533|FG003|Double-Blind Period|Withdrawal by Subject|1|||
13122518|NCT02963506|25947534|FG004|Double-Blind Period|Withdrawal by Subject|0|||
13122519|NCT02963506|25947535|FG005|Double-Blind Period|Withdrawal by Subject|0|||
13122520|NCT02963506|25947536|FG006|Double-Blind Period|Withdrawal by Subject|0|||
13122521|NCT02963506|25947537|FG007|Double-Blind Period|Withdrawal by Subject|0|||
13122522|NCT02963506|25947538|FG008|Double-Blind Period|Withdrawal by Subject|0|||
13122523|NCT02963506|25947539|FG009|Double-Blind Period|Withdrawal by Subject|0|||
13122524|NCT02963506|25947540|FG010|Double-Blind Period|Withdrawal by Subject|0|||
13122525|NCT02963506|25947541|FG011|Double-Blind Period|Withdrawal by Subject|0|||
13122526|NCT02963506|25947542|FG012|Double-Blind Period|Withdrawal by Subject|0|||
13122527|NCT02963506|25947530|FG000|Double-Blind Period|No compliance|0|||
13204099|NCT01977482|26227020|FG005|Overall Study|Protocol Violation|0|||
13204100|NCT01977482|26227015|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
13204101|NCT01977482|26227016|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3|||
13204102|NCT01977482|26227017|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2|||
13204103|NCT01977482|26227018|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
13204104|NCT01977482|26227019|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
13204105|NCT01977482|26227020|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
13122528|NCT02963506|25947531|FG001|Double-Blind Period|No compliance|1|||
13122529|NCT02963506|25947532|FG002|Double-Blind Period|No compliance|0|||
13122530|NCT02963506|25947533|FG003|Double-Blind Period|No compliance|0|||
13122531|NCT02963506|25947534|FG004|Double-Blind Period|No compliance|0|||
13122532|NCT02963506|25947535|FG005|Double-Blind Period|No compliance|0|||
13122533|NCT02963506|25947536|FG006|Double-Blind Period|No compliance|0|||
13204106|NCT01977482|26227015|FG000|Overall Study|Withdrawal by Subject|2|||
13204107|NCT01977482|26227016|FG001|Overall Study|Withdrawal by Subject|4|||
13204108|NCT01977482|26227017|FG002|Overall Study|Withdrawal by Subject|1|||
13204109|NCT01977482|26227018|FG003|Overall Study|Withdrawal by Subject|3|||
13204110|NCT01977482|26227019|FG004|Overall Study|Withdrawal by Subject|1|||
13204111|NCT01977482|26227020|FG005|Overall Study|Withdrawal by Subject|5|||
13204112|NCT01977456|26227029|FG000|Overall Study|Death|5|||
13204113|NCT01977352|26227054|FG000|Overall Study|Lost to Follow-up|1|||
13204114|NCT01977352|26227055|FG001|Overall Study|Lost to Follow-up|2|||
13204115|NCT01977222|26227068|FG000|Overall Study|Withdrawal by Subject|1|||
13204116|NCT01977092|26227085|FG000|Overall Study|Death|3|||
13204117|NCT01977092|26227086|FG001|Overall Study|Death|4|||
13204118|NCT01977092|26227085|FG000|Overall Study|Lost to Follow-up|23|||
13332166|NCT01101542|26601376|FG000|Year 6 Surveillance Period|Pregnancy|1|||
13332167|NCT01101542|26601376|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4|||
13332168|NCT01101477|26601394|FG000|Overall Study|Protocol Violation|5|||
13332169|NCT01101477|26601395|FG001|Overall Study|Protocol Violation|3|||
13122534|NCT02963506|25947537|FG007|Double-Blind Period|No compliance|0|||
13122535|NCT02963506|25947538|FG008|Double-Blind Period|No compliance|0|||
13122536|NCT02963506|25947539|FG009|Double-Blind Period|No compliance|0|||
13122537|NCT02963506|25947540|FG010|Double-Blind Period|No compliance|0|||
13122538|NCT02963506|25947541|FG011|Double-Blind Period|No compliance|0|||
13122539|NCT02963506|25947542|FG012|Double-Blind Period|No compliance|0|||
13122540|NCT02963506|25947530|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
13122541|NCT02963506|25947531|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1|||
13122542|NCT02963506|25947532|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
13122543|NCT02963506|25947533|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
13122544|NCT02963506|25947534|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
13122545|NCT02963506|25947535|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
13122546|NCT02963506|25947536|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
13122547|NCT02963506|25947537|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
13122548|NCT02963506|25947538|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
13122549|NCT02963506|25947539|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
13122550|NCT02963506|25947540|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
13122551|NCT02963506|25947541|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
13122552|NCT02963506|25947542|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
13122553|NCT02963506|25947530|FG000|Dose-Blind Period|Adverse Event|0|||
13122554|NCT02963506|25947531|FG001|Dose-Blind Period|Adverse Event|0|||
13122555|NCT02963506|25947532|FG002|Dose-Blind Period|Adverse Event|0|||
13122556|NCT02963506|25947533|FG003|Dose-Blind Period|Adverse Event|0|||
13122557|NCT02963506|25947534|FG004|Dose-Blind Period|Adverse Event|0|||
13122558|NCT02963506|25947535|FG005|Dose-Blind Period|Adverse Event|1|||
13122559|NCT02963506|25947536|FG006|Dose-Blind Period|Adverse Event|3|||
13122560|NCT02963506|25947537|FG007|Dose-Blind Period|Adverse Event|2|||
13122561|NCT02963506|25947538|FG008|Dose-Blind Period|Adverse Event|2|||
13122562|NCT02963506|25947539|FG009|Dose-Blind Period|Adverse Event|2|||
13122563|NCT02963506|25947540|FG010|Dose-Blind Period|Adverse Event|1|||
13122564|NCT02963506|25947541|FG011|Dose-Blind Period|Adverse Event|1|||
13122565|NCT02963506|25947542|FG012|Dose-Blind Period|Adverse Event|6|||
13122566|NCT02963506|25947530|FG000|Dose-Blind Period|Lack of Efficacy|0|||
13122567|NCT02963506|25947531|FG001|Dose-Blind Period|Lack of Efficacy|0|||
13122568|NCT02963506|25947532|FG002|Dose-Blind Period|Lack of Efficacy|0|||
13122569|NCT02963506|25947533|FG003|Dose-Blind Period|Lack of Efficacy|0|||
13122570|NCT02963506|25947534|FG004|Dose-Blind Period|Lack of Efficacy|0|||
13122571|NCT02963506|25947535|FG005|Dose-Blind Period|Lack of Efficacy|0|||
13122572|NCT02963506|25947536|FG006|Dose-Blind Period|Lack of Efficacy|0|||
13122573|NCT02963506|25947537|FG007|Dose-Blind Period|Lack of Efficacy|1|||
13122574|NCT02963506|25947538|FG008|Dose-Blind Period|Lack of Efficacy|0|||
13122575|NCT02963506|25947539|FG009|Dose-Blind Period|Lack of Efficacy|1|||
13122576|NCT02963506|25947540|FG010|Dose-Blind Period|Lack of Efficacy|0|||
13122577|NCT02963506|25947541|FG011|Dose-Blind Period|Lack of Efficacy|0|||
13122578|NCT02963506|25947542|FG012|Dose-Blind Period|Lack of Efficacy|0|||
13122579|NCT02963506|25947530|FG000|Dose-Blind Period|Lost to Follow-up|0|||
13122580|NCT02963506|25947531|FG001|Dose-Blind Period|Lost to Follow-up|0|||
13122581|NCT02963506|25947532|FG002|Dose-Blind Period|Lost to Follow-up|0|||
13122582|NCT02963506|25947533|FG003|Dose-Blind Period|Lost to Follow-up|0|||
13122583|NCT02963506|25947534|FG004|Dose-Blind Period|Lost to Follow-up|0|||
13122584|NCT02963506|25947535|FG005|Dose-Blind Period|Lost to Follow-up|1|||
13122585|NCT02963506|25947536|FG006|Dose-Blind Period|Lost to Follow-up|0|||
13122586|NCT02963506|25947537|FG007|Dose-Blind Period|Lost to Follow-up|0|||
13122587|NCT02963506|25947538|FG008|Dose-Blind Period|Lost to Follow-up|1|||
13122588|NCT02963506|25947539|FG009|Dose-Blind Period|Lost to Follow-up|0|||
13204119|NCT01977092|26227086|FG001|Overall Study|Lost to Follow-up|14|||
13204120|NCT01977092|26227085|FG000|Overall Study|Withdrawal by Subject|2|||
13204121|NCT01977092|26227086|FG001|Overall Study|Withdrawal by Subject|1|||
13332170|NCT01101477|26601396|FG002|Overall Study|Protocol Violation|1|||
13204122|NCT01977092|26227085|FG000|Overall Study|In prison|3|||
13204123|NCT01977092|26227086|FG001|Overall Study|In prison|11|||
13204124|NCT01977040|26227098|FG000|Overall Study|Vasa previa not confirmed|2|||
13204125|NCT01976845|26227122|FG000|Overall Study|Physician Decision|8|||
13204126|NCT01976845|26227123|FG001|Overall Study|Physician Decision|8|||
13204127|NCT01976845|26227124|FG002|Overall Study|Physician Decision|3|||
13204128|NCT01976806|26227159|FG000|Overall Study|Lost to Follow-up|1|||
13204129|NCT01976806|26227160|FG001|Overall Study|Lost to Follow-up|4|||
13204130|NCT01976806|26227159|FG000|Overall Study|Adverse Event|1|||
13204131|NCT01976806|26227160|FG001|Overall Study|Adverse Event|1|||
13204132|NCT01976806|26227159|FG000|Overall Study|Withdrawal by Subject|1|||
13204133|NCT01976806|26227160|FG001|Overall Study|Withdrawal by Subject|1|||
13204134|NCT01976741|26227494|FG000|Overall Study|Withdrawal by Subject|1|||
13204135|NCT01976741|26227495|FG001|Overall Study|Withdrawal by Subject|0|||
13204136|NCT01976741|26227496|FG002|Overall Study|Withdrawal by Subject|1|||
13204137|NCT01976741|26227497|FG003|Overall Study|Withdrawal by Subject|1|||
13204138|NCT01976741|26227498|FG004|Overall Study|Withdrawal by Subject|0|||
13204139|NCT01976741|26227499|FG005|Overall Study|Withdrawal by Subject|0|||
13204140|NCT01976741|26227500|FG006|Overall Study|Withdrawal by Subject|1|||
13204141|NCT01976741|26227501|FG007|Overall Study|Withdrawal by Subject|4|||
13204142|NCT01976741|26227502|FG008|Overall Study|Withdrawal by Subject|0|||
13204143|NCT01976741|26227503|FG009|Overall Study|Withdrawal by Subject|0|||
13204144|NCT01976741|26227494|FG000|Overall Study|Adverse Event|0|||
13204145|NCT01976741|26227495|FG001|Overall Study|Adverse Event|0|||
13204146|NCT01976741|26227496|FG002|Overall Study|Adverse Event|2|||
13204147|NCT01976741|26227497|FG003|Overall Study|Adverse Event|0|||
13204148|NCT01976741|26227498|FG004|Overall Study|Adverse Event|0|||
13204149|NCT01976741|26227499|FG005|Overall Study|Adverse Event|0|||
13289013|NCT01082640|26477072|FG000|Overall Study|Other|2|||
13289014|NCT01082640|26477073|FG001|Overall Study|Other|1|||
13289015|NCT01082640|26477074|FG002|Overall Study|Other|3|||
13289016|NCT01082614|26477091|FG000|Overall Study|Adverse Event|1|||
13289017|NCT01082614|26477092|FG001|Overall Study|Adverse Event|4|||
13289018|NCT01082614|26477091|FG000|Overall Study|Equipment Malfunction|0|||
13332171|NCT01101438|26601417|FG000|Overall Study|Withdrawal by Subject|8|||
13122589|NCT02963506|25947540|FG010|Dose-Blind Period|Lost to Follow-up|0|||
13122590|NCT02963506|25947541|FG011|Dose-Blind Period|Lost to Follow-up|1|||
13332172|NCT01101438|26601418|FG001|Overall Study|Withdrawal by Subject|9|||
13332173|NCT01101334|26601437|FG000|Overall Study|Adverse Event|9|||
13332174|NCT01101334|26601438|FG001|Overall Study|Adverse Event|4|||
13332175|NCT01101334|26601437|FG000|Overall Study|Death|7|||
13332176|NCT01101334|26601438|FG001|Overall Study|Death|1|||
13332177|NCT01101334|26601437|FG000|Overall Study|Withdrawal by Subject|4|||
13332178|NCT01101334|26601438|FG001|Overall Study|Withdrawal by Subject|3|||
13332179|NCT01101334|26601437|FG000|Overall Study|Withdrawal by Sponsor|1|||
13332180|NCT01101334|26601438|FG001|Overall Study|Withdrawal by Sponsor|1|||
13122591|NCT02963506|25947542|FG012|Dose-Blind Period|Lost to Follow-up|0|||
13122592|NCT02963506|25947530|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
13332181|NCT01101334|26601437|FG000|Overall Study|Progressive Disease|22|||
13332182|NCT01101334|26601438|FG001|Overall Study|Progressive Disease|35|||
13332183|NCT01101334|26601437|FG000|Overall Study|Other|2|||
13332184|NCT01101334|26601438|FG001|Overall Study|Other|1|||
13332185|NCT01101321|26601451|FG000|Period 1|Withdrawal by Subject|1|||
13332186|NCT01101321|26601452|FG001|Period 1|Withdrawal by Subject|1|||
13332187|NCT01101321|26601451|FG000|Period 1|Adverse Event|3|||
13332188|NCT01101321|26601452|FG001|Period 1|Adverse Event|3|||
13332189|NCT01101308|26601466|FG000|Period 1|Adverse Event|2|||
13332190|NCT01101308|26601467|FG001|Period 1|Adverse Event|1|||
13122593|NCT02963506|25947531|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
13122594|NCT02963506|25947532|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
13122595|NCT02963506|25947533|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
13122596|NCT02963506|25947534|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
13122597|NCT02963506|25947535|FG005|Dose-Blind Period|Withdrawal by Subject|1|||
13122598|NCT02963506|25947536|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
13289019|NCT01082614|26477092|FG001|Overall Study|Equipment Malfunction|1|||
13289020|NCT01082614|26477091|FG000|Overall Study|Physician Decision|2|||
13289021|NCT01082614|26477092|FG001|Overall Study|Physician Decision|0|||
13289022|NCT01082367|26477113|FG000|Double-blind Period|Administrative problems|0|||
13289023|NCT01082367|26477114|FG001|Double-blind Period|Administrative problems|1|||
13289024|NCT01082367|26477113|FG000|Double-blind Period|Lack of Efficacy|5|||
13289025|NCT01082367|26477114|FG001|Double-blind Period|Lack of Efficacy|11|||
13289026|NCT01082367|26477113|FG000|Double-blind Period|Adverse Event|0|||
13289027|NCT01082367|26477114|FG001|Double-blind Period|Adverse Event|1|||
13289028|NCT01082367|26477113|FG000|Follow-up (F-U) Period|Administrative problems|1|||
13289029|NCT01082367|26477114|FG001|Follow-up (F-U) Period|Administrative problems|0|||
13292266|NCT00706901|26485117|FG001|Overall Study|Lost to Follow-up|3|||
13332191|NCT01101308|26601466|FG000|Period 1|Positive for cotinine|1|||
13122599|NCT02963506|25947537|FG007|Dose-Blind Period|Withdrawal by Subject|2|||
13122600|NCT02963506|25947538|FG008|Dose-Blind Period|Withdrawal by Subject|0|||
13289030|NCT01082367|26477113|FG000|Follow-up (F-U) Period|Abnormal lab values|1|||
13289031|NCT01082367|26477114|FG001|Follow-up (F-U) Period|Abnormal lab values|0|||
13289032|NCT01082367|26477113|FG000|Follow-up (F-U) Period|Adverse Event|0|||
13289033|NCT01082367|26477114|FG001|Follow-up (F-U) Period|Adverse Event|1|||
13289034|NCT01082211|26477134|FG000|Overall Study|Protocol Violation|4|||
13289035|NCT01082211|26477134|FG000|Overall Study|No protocol treatment received|3|||
13289036|NCT01082081|26477194|FG000|Overall Study|Lost to Follow-up|0|||
13289037|NCT01082081|26477195|FG001|Overall Study|Lost to Follow-up|0|||
13289038|NCT01082081|26477196|FG002|Overall Study|Lost to Follow-up|1|||
13289039|NCT01082081|26477194|FG000|Overall Study|Withdrawal by Subject|0|||
13332192|NCT01101308|26601467|FG001|Period 1|Positive for cotinine|0|||
13332193|NCT01101191|26601481|FG000|Period 1|Withdrawal by Subject|1|||
13332194|NCT01101191|26601482|FG001|Period 1|Withdrawal by Subject|0|||
13332195|NCT01101191|26601481|FG000|Period 1|Adverse Event|1|||
13332196|NCT01101191|26601482|FG001|Period 1|Adverse Event|2|||
13122601|NCT02963506|25947539|FG009|Dose-Blind Period|Withdrawal by Subject|1|||
13122602|NCT02963506|25947540|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
13122603|NCT02963506|25947541|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
13122604|NCT02963506|25947542|FG012|Dose-Blind Period|Withdrawal by Subject|0|||
13122605|NCT02963506|25947530|FG000|Dose-Blind Period|Sponsor decision|0|||
13122606|NCT02963506|25947531|FG001|Dose-Blind Period|Sponsor decision|0|||
13122607|NCT02963506|25947532|FG002|Dose-Blind Period|Sponsor decision|0|||
13122608|NCT02963506|25947533|FG003|Dose-Blind Period|Sponsor decision|0|||
13122609|NCT02963506|25947534|FG004|Dose-Blind Period|Sponsor decision|0|||
13289040|NCT01082081|26477195|FG001|Overall Study|Withdrawal by Subject|0|||
13332197|NCT01101178|26601496|FG000|Period 1|Withdrawal by Subject|1|||
13332198|NCT01101178|26601497|FG001|Period 1|Withdrawal by Subject|2|||
13332199|NCT01101178|26601496|FG000|Period 1|Positive drug screen|1|||
13332200|NCT01101178|26601497|FG001|Period 1|Positive drug screen|1|||
13332201|NCT01101178|26601496|FG000|Period 1|Adverse Event|2|||
13332202|NCT01101178|26601497|FG001|Period 1|Adverse Event|1|||
13332203|NCT01101178|26601496|FG000|Period 2|Withdrawal by Subject|0|||
13332204|NCT01101178|26601497|FG001|Period 2|Withdrawal by Subject|1|||
13332205|NCT01101165|26601510|FG000|Period 1|Adverse Event|1|||
13332206|NCT01101165|26601511|FG001|Period 1|Adverse Event|2|||
13332207|NCT01101165|26601510|FG000|Period 1|Withdrawal by Subject|0|||
13332208|NCT01101165|26601511|FG001|Period 1|Withdrawal by Subject|2|||
13332209|NCT01101165|26601510|FG000|Period 1|Positive Drug Screen|0|||
13332210|NCT01101165|26601511|FG001|Period 1|Positive Drug Screen|1|||
13332211|NCT01101165|26601510|FG000|Period 1|Lost to Follow-up|1|||
13332212|NCT01101165|26601511|FG001|Period 1|Lost to Follow-up|0|||
13332213|NCT01101165|26601510|FG000|Period 2|Withdrawal by Subject|3|||
13332214|NCT01101165|26601511|FG001|Period 2|Withdrawal by Subject|1|||
13332215|NCT01101165|26601510|FG000|Period 2|Adverse Event|1|||
13332216|NCT01101165|26601511|FG001|Period 2|Adverse Event|0|||
13332217|NCT01101061|26601608|FG000|Overall Study|Adverse Event|0|||
13332218|NCT01101061|26601609|FG001|Overall Study|Adverse Event|0|||
13332219|NCT01101061|26601610|FG002|Overall Study|Adverse Event|1|||
13332220|NCT01101061|26601611|FG003|Overall Study|Adverse Event|0|||
13332221|NCT01101061|26601612|FG004|Overall Study|Adverse Event|0|||
13332222|NCT01101061|26601613|FG005|Overall Study|Adverse Event|0|||
13332223|NCT01101035|26601638|FG000|Overall Study|Adverse Event|191|||
13332224|NCT01101035|26601639|FG001|Overall Study|Adverse Event|172|||
13332225|NCT01101035|26601638|FG000|Overall Study|Major Protocol Deviation|52|||
13332226|NCT01101035|26601639|FG001|Overall Study|Major Protocol Deviation|46|||
13332227|NCT01101035|26601638|FG000|Overall Study|Lost to Follow-up|226|||
13332228|NCT01101035|26601639|FG001|Overall Study|Lost to Follow-up|223|||
13289041|NCT01082081|26477196|FG002|Overall Study|Withdrawal by Subject|1|||
13289042|NCT01082081|26477194|FG000|Overall Study|Other Reason|0|||
13332229|NCT01101035|26601638|FG000|Overall Study|Voluntary Withdrawal|595|||
13332230|NCT01101035|26601639|FG001|Overall Study|Voluntary Withdrawal|587|||
13289043|NCT01082081|26477195|FG001|Overall Study|Other Reason|1|||
13289044|NCT01082081|26477196|FG002|Overall Study|Other Reason|0|||
13289045|NCT01081886|26477211|FG000|Overall Study|Study termination|11|||
13289046|NCT01081886|26477212|FG001|Overall Study|Study termination|13|||
13289047|NCT01081873|26477281|FG000|Overall Study|Death|86|||
13289048|NCT01081873|26477281|FG000|Overall Study|Withdrawal by Subject|10|||
13289049|NCT01081873|26477281|FG000|Overall Study|Lost to Follow-up|142|||
13289050|NCT01081873|26477281|FG000|Overall Study|Progression of prostate cancer|13|||
13332231|NCT01101035|26601638|FG000|Overall Study|Reason not Specified|333|||
13289051|NCT01081873|26477281|FG000|Overall Study|Other|47|||
13289052|NCT01081795|26477326|FG000|Overall Study|Adverse Event|18|||
13289053|NCT01081795|26477327|FG001|Overall Study|Adverse Event|23|||
13289054|NCT01081795|26477328|FG002|Overall Study|Adverse Event|6|||
13332232|NCT01101035|26601639|FG001|Overall Study|Reason not Specified|363|||
13122610|NCT02963506|25947535|FG005|Dose-Blind Period|Sponsor decision|1|||
13122611|NCT02963506|25947536|FG006|Dose-Blind Period|Sponsor decision|0|||
13332233|NCT01101022|26601680|FG000|Overall Study|Adverse Event|6|||
13332234|NCT01101022|26601681|FG001|Overall Study|Adverse Event|2|||
13332235|NCT01101022|26601680|FG000|Overall Study|Protocol Violation|4|||
13289055|NCT01081795|26477326|FG000|Overall Study|Lack of Efficacy|7|||
13289056|NCT01081795|26477327|FG001|Overall Study|Lack of Efficacy|5|||
13289057|NCT01081795|26477328|FG002|Overall Study|Lack of Efficacy|19|||
13289058|NCT01081795|26477326|FG000|Overall Study|Subject's schedule|1|||
13289059|NCT01081795|26477327|FG001|Overall Study|Subject's schedule|1|||
13289060|NCT01081795|26477328|FG002|Overall Study|Subject's schedule|2|||
13289061|NCT01081795|26477326|FG000|Overall Study|Revocation of informed consent|2|||
13289062|NCT01081795|26477327|FG001|Overall Study|Revocation of informed consent|0|||
13289063|NCT01081795|26477328|FG002|Overall Study|Revocation of informed consent|0|||
13289064|NCT01081795|26477326|FG000|Overall Study|Ineligible for participation|1|||
13289065|NCT01081795|26477327|FG001|Overall Study|Ineligible for participation|0|||
13289066|NCT01081795|26477328|FG002|Overall Study|Ineligible for participation|0|||
13289067|NCT01081795|26477326|FG000|Overall Study|Use of a prohibited concomitant drug|1|||
13289068|NCT01081795|26477327|FG001|Overall Study|Use of a prohibited concomitant drug|1|||
13289069|NCT01081795|26477328|FG002|Overall Study|Use of a prohibited concomitant drug|1|||
13289070|NCT01081795|26477326|FG000|Overall Study|Using drug with restricted days of use|2|||
13289071|NCT01081795|26477327|FG001|Overall Study|Using drug with restricted days of use|3|||
13332236|NCT01101022|26601681|FG001|Overall Study|Protocol Violation|3|||
13332237|NCT01101022|26601680|FG000|Overall Study|Withdrawal by Subject|3|||
13332238|NCT01101022|26601681|FG001|Overall Study|Withdrawal by Subject|8|||
13332239|NCT01101022|26601680|FG000|Overall Study|Lost to Follow-up|1|||
13332240|NCT01101022|26601681|FG001|Overall Study|Lost to Follow-up|4|||
13332241|NCT01101022|26601680|FG000|Overall Study|Lack of Efficacy|0|||
13332242|NCT01101022|26601681|FG001|Overall Study|Lack of Efficacy|7|||
13332243|NCT01101022|26601680|FG000|Overall Study|Sponsor decision|1|||
13332244|NCT01101022|26601681|FG001|Overall Study|Sponsor decision|1|||
13122612|NCT02963506|25947537|FG007|Dose-Blind Period|Sponsor decision|0|||
13289072|NCT01081795|26477328|FG002|Overall Study|Using drug with restricted days of use|2|||
13289073|NCT01081795|26477326|FG000|Overall Study|Other|1|||
13289074|NCT01081795|26477327|FG001|Overall Study|Other|2|||
13289075|NCT01081795|26477328|FG002|Overall Study|Other|0|||
13289076|NCT01081769|26477369|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10|||
13289077|NCT01081769|26477370|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12|||
13289078|NCT01081769|26477369|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
13289079|NCT01081769|26477370|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
13289080|NCT01081769|26477369|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6|||
13289081|NCT01081769|26477370|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7|||
13289082|NCT01081769|26477369|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2|||
13289083|NCT01081769|26477370|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0|||
13122613|NCT02963506|25947538|FG008|Dose-Blind Period|Sponsor decision|0|||
13122614|NCT02963506|25947539|FG009|Dose-Blind Period|Sponsor decision|0|||
13122615|NCT02963506|25947540|FG010|Dose-Blind Period|Sponsor decision|0|||
13122616|NCT02963506|25947541|FG011|Dose-Blind Period|Sponsor decision|0|||
13122617|NCT02963506|25947542|FG012|Dose-Blind Period|Sponsor decision|0|||
13122618|NCT02963506|25947530|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0|||
13122619|NCT02963506|25947531|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0|||
13122620|NCT02963506|25947532|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0|||
13122621|NCT02963506|25947533|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0|||
13122622|NCT02963506|25947534|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0|||
13122623|NCT02963506|25947535|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0|||
13122624|NCT02963506|25947536|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0|||
13122625|NCT02963506|25947537|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0|||
13122626|NCT02963506|25947538|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0|||
13122627|NCT02963506|25947539|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0|||
13122628|NCT02963506|25947540|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0|||
13122629|NCT02963506|25947541|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0|||
13289084|NCT01081769|26477369|FG000|CORE Intent-To-Treat|Adverse Event|14|||
13289085|NCT01081769|26477370|FG001|CORE Intent-To-Treat|Adverse Event|11|||
13289086|NCT01081769|26477369|FG000|CORE Intent-To-Treat|Death|1|||
13122630|NCT02963506|25947542|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1|||
13289087|NCT01081769|26477370|FG001|CORE Intent-To-Treat|Death|1|||
13289088|NCT01081769|26477369|FG000|CORE Intent-To-Treat|Lack of Efficacy|2|||
13289089|NCT01081769|26477370|FG001|CORE Intent-To-Treat|Lack of Efficacy|6|||
13289090|NCT01081769|26477369|FG000|CORE Intent-To-Treat|Lost to Follow-up|4|||
13289091|NCT01081769|26477370|FG001|CORE Intent-To-Treat|Lost to Follow-up|5|||
13289092|NCT01081769|26477369|FG000|CORE Intent-To-Treat|Pregnancy|1|||
13289093|NCT01081769|26477370|FG001|CORE Intent-To-Treat|Pregnancy|0|||
13289094|NCT01081769|26477369|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52|||
13332245|NCT01101022|26601680|FG000|Overall Study|Non-compliance|1|||
13332246|NCT01101022|26601681|FG001|Overall Study|Non-compliance|0|||
13122631|NCT02963441|25947582|FG000|Overall Study|Protocol violation or withdrawn|8|||
13122632|NCT02963441|25947582|FG000|Overall Study|Ungradeable by FPRC or IDx|40|||
13122633|NCT02963441|25947582|FG000|Overall Study|IDx-DR insufficient quality|33|||
13289095|NCT01081769|26477370|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60|||
13122634|NCT02963311|25947608|FG000|Overall Study|Withdrawal by Subject|1|||
13122635|NCT02963311|25947608|FG000|Overall Study|Screen Failure|4|||
13122636|NCT02962908|25947685|FG000|Overall Study|Lost to Follow-up|0|||
13122637|NCT02962908|25947686|FG001|Overall Study|Lost to Follow-up|3|||
13122638|NCT02962908|25947687|FG002|Overall Study|Lost to Follow-up|0|||
13289096|NCT01081769|26477369|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0|||
13289097|NCT01081769|26477370|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5|||
13289098|NCT01081769|26477369|FG000|CORE Intent-To-Treat|Other|0|||
13289099|NCT01081769|26477370|FG001|CORE Intent-To-Treat|Other|1|||
13289100|NCT01081769|26477369|FG000|CORE Intent-To-Treat|Ineligibility|3|||
13289101|NCT01081769|26477370|FG001|CORE Intent-To-Treat|Ineligibility|4|||
13289102|NCT01081769|26477369|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1|||
13289103|NCT01081769|26477370|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2|||
13289104|NCT01081769|26477369|FG000|CORE Intent-To-Treat|Patient Moved|2|||
13332247|NCT01101022|26601680|FG000|Overall Study|Work schedule|1|||
13332248|NCT01101022|26601681|FG001|Overall Study|Work schedule|1|||
13332249|NCT01101022|26601680|FG000|Overall Study|Vacation|0|||
13332250|NCT01101022|26601681|FG001|Overall Study|Vacation|1|||
13332251|NCT01100944|26601730|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2|||
13332252|NCT01100944|26601731|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
13332253|NCT01100944|26601732|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
13332254|NCT01100944|26601730|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1|||
13332255|NCT01100944|26601731|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
13332256|NCT01100944|26601732|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
13332257|NCT01100944|26601730|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1|||
13332258|NCT01100944|26601731|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
13332259|NCT01100944|26601732|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
13332260|NCT01100944|26601730|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
13332261|NCT01100944|26601731|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2|||
13332262|NCT01100944|26601732|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
13332263|NCT01100853|26601755|FG000|Overall Study|Lost to Follow-up|11|||
13332264|NCT01100853|26601756|FG001|Overall Study|Lost to Follow-up|6|||
13332265|NCT01100853|26601755|FG000|Overall Study|Received <4 study injections|10|||
13332266|NCT01100853|26601756|FG001|Overall Study|Received <4 study injections|13|||
13332267|NCT01100853|26601755|FG000|Overall Study|Withdrawal by Subject|6|||
13332268|NCT01100853|26601756|FG001|Overall Study|Withdrawal by Subject|4|||
13332269|NCT01100658|26601763|FG000|Overall Study|Withdrawal by Subject|1|||
13332270|NCT01100567|26601778|FG000|Overall Study|Withdrawal by Subject|5|||
13332271|NCT01100567|26601779|FG001|Overall Study|Withdrawal by Subject|8|||
13332272|NCT01100567|26601778|FG000|Overall Study|Early Hospital Discharge|6|||
13332273|NCT01100567|26601779|FG001|Overall Study|Early Hospital Discharge|4|||
13332274|NCT01100567|26601778|FG000|Overall Study|Lost to Follow-up|1|||
13332275|NCT01100567|26601779|FG001|Overall Study|Lost to Follow-up|2|||
13332276|NCT01100567|26601778|FG000|Overall Study|Physician Decision|0|||
13332277|NCT01100567|26601779|FG001|Overall Study|Physician Decision|1|||
13332278|NCT01100567|26601778|FG000|Overall Study|Deemed ineligible after consent|0|||
13332279|NCT01100567|26601779|FG001|Overall Study|Deemed ineligible after consent|1|||
13332280|NCT01100528|26601787|FG000|Overall Study|Death|1|||
13332281|NCT01100528|26601787|FG000|Overall Study|Withdrawal by Subject|2|||
13332282|NCT01100502|26601806|FG000|Overall Study|Withdrawal by Subject|18|||
13332283|NCT01100502|26601807|FG001|Overall Study|Withdrawal by Subject|25|||
13332284|NCT01100502|26601806|FG000|Overall Study|Lost to Follow-up|13|||
13332285|NCT01100502|26601807|FG001|Overall Study|Lost to Follow-up|28|||
13332286|NCT01100502|26601806|FG000|Overall Study|Site request to end participation in study|0|||
13332287|NCT01100502|26601807|FG001|Overall Study|Site request to end participation in study|1|||
13332288|NCT01100502|26601806|FG000|Overall Study|Death|45|||
13332289|NCT01100502|26601807|FG001|Overall Study|Death|40|||
13332290|NCT01100437|26601848|FG000|Titration/Stabilization|Adverse Event|0|||
13332291|NCT01100437|26601849|FG001|Titration/Stabilization|Adverse Event|0|||
13332292|NCT01100437|26601850|FG002|Titration/Stabilization|Adverse Event|4|||
13332293|NCT01100437|26601848|FG000|Titration/Stabilization|Non-compliance|0|||
13332294|NCT01100437|26601849|FG001|Titration/Stabilization|Non-compliance|0|||
13332295|NCT01100437|26601850|FG002|Titration/Stabilization|Non-compliance|1|||
13332296|NCT01100437|26601848|FG000|Titration/Stabilization|Sponsor canceled study|0|||
13332297|NCT01100437|26601849|FG001|Titration/Stabilization|Sponsor canceled study|0|||
13332298|NCT01100437|26601850|FG002|Titration/Stabilization|Sponsor canceled study|1|||
13332299|NCT01100437|26601848|FG000|Maintenance|Withdrawal by Subject|0|||
13332300|NCT01100437|26601849|FG001|Maintenance|Withdrawal by Subject|0|||
13332301|NCT01100437|26601850|FG002|Maintenance|Withdrawal by Subject|1|||
13332302|NCT01100437|26601848|FG000|Maintenance|Sponsor termination of study|0|||
13332303|NCT01100437|26601849|FG001|Maintenance|Sponsor termination of study|0|||
13122639|NCT02962908|25947688|FG003|Overall Study|Lost to Follow-up|1|||
13122640|NCT02962908|25947685|FG000|Overall Study|Withdrawal by Subject|0|||
13332304|NCT01100437|26601850|FG002|Maintenance|Sponsor termination of study|1|||
13332305|NCT01100320|26601863|FG000|Period 1|Withdrawal by Subject|2|||
13332306|NCT01100320|26601864|FG001|Period 1|Withdrawal by Subject|4|||
13332307|NCT01100320|26601863|FG000|Period 1|Positive Drug Screen|1|||
13332308|NCT01100320|26601864|FG001|Period 1|Positive Drug Screen|1|||
13332309|NCT01100320|26601863|FG000|Period 1|Adverse Event|2|||
13332310|NCT01100320|26601864|FG001|Period 1|Adverse Event|2|||
13332311|NCT01100320|26601863|FG000|Period 2|Withdrawal by Subject|1|||
13332312|NCT01100320|26601864|FG001|Period 2|Withdrawal by Subject|1|||
13332313|NCT01100307|26601913|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
13332314|NCT01100307|26601914|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
13332315|NCT01100307|26601913|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0|||
13332316|NCT01100307|26601914|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1|||
13332317|NCT01100307|26601913|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5|||
13332318|NCT01100307|26601914|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2|||
13332319|NCT01100307|26601913|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1|||
13332320|NCT01100307|26601914|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2|||
13332321|NCT01100307|26601913|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2|||
13332322|NCT01100307|26601914|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3|||
13332323|NCT01100307|26601913|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3|||
13332324|NCT01100307|26601914|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8|||
13332325|NCT01100086|26601927|FG000|Period 1|Withdrawal by Subject|1|||
13332326|NCT01100086|26601928|FG001|Period 1|Withdrawal by Subject|0|||
13332327|NCT01100073|26601945|FG000|Overall Study|Lack of Efficacy|4|||
13332328|NCT01100073|26601945|FG000|Overall Study|Insufficient Tolerability|21|||
13332329|NCT01100073|26601945|FG000|Overall Study|Withdrawal by Subject|13|||
13332330|NCT01100073|26601945|FG000|Overall Study|Lost to Follow-up|39|||
13332331|NCT01100073|26601945|FG000|Overall Study|Lack of effect + patient's wish|2|||
13332332|NCT01100073|26601945|FG000|Overall Study|Insufficient tolerability +patients wish|8|||
13332333|NCT01100073|26601945|FG000|Overall Study|Other|8|||
13332334|NCT01100073|26601945|FG000|Overall Study|Missing|5|||
13332335|NCT01100034|26601956|FG000|Overall Study|Lost to Follow-up|11|||
13332336|NCT01100034|26601956|FG000|Overall Study|Withdrawal of parent/guardian consent|1|||
13332337|NCT01100034|26601956|FG000|Overall Study|Withdrawal by Subject|4|||
13332338|NCT01100034|26601956|FG000|Overall Study|Sponsor decision|21|||
13332339|NCT01100034|26601956|FG000|Overall Study|Participated in another clinical trial|1|||
13332340|NCT01100034|26601956|FG000|Overall Study|Participants moved to another hospital|4|||
13332341|NCT01100034|26601956|FG000|Overall Study|Site closed due to non-responsiveness|1|||
13332342|NCT01099917|26601962|FG000|Overall Study|Adverse Event|3|||
13332343|NCT01099917|26601962|FG000|Overall Study|Not Treated|24|||
13332344|NCT01099709|26601975|FG000|Period 1|Withdrawal by Subject|0|||
13332345|NCT01099709|26601976|FG001|Period 1|Withdrawal by Subject|1|||
13332346|NCT01099709|26601975|FG000|Period 1|Positive cotinine test|0|||
13332347|NCT01099709|26601976|FG001|Period 1|Positive cotinine test|1|||
13332348|NCT01099709|26601975|FG000|Period 1|Adverse Event|1|||
13332349|NCT01099709|26601976|FG001|Period 1|Adverse Event|0|||
13332350|NCT01099579|26602040|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4|||
13332351|NCT01099579|26602041|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1|||
13332352|NCT01099579|26602042|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0|||
13332353|NCT01099579|26602040|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
13332354|NCT01099579|26602041|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
13332355|NCT01099579|26602042|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1|||
13332356|NCT01099579|26602040|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
13332357|NCT01099579|26602041|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2|||
13332358|NCT01099579|26602042|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
13332359|NCT01099579|26602040|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
13332360|NCT01099579|26602041|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2|||
13332361|NCT01099579|26602042|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
13332362|NCT01099579|26602040|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
13332363|NCT01099579|26602041|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
13332364|NCT01099579|26602042|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1|||
13332365|NCT01099579|26602040|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
13332366|NCT01099579|26602041|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
13332367|NCT01099579|26602042|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
13332368|NCT01099579|26602040|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
13332369|NCT01099579|26602041|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
13332370|NCT01099579|26602042|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2|||
13332371|NCT01099579|26602040|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
13332372|NCT01099579|26602041|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
13332373|NCT01099579|26602042|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
13332374|NCT01099579|26602040|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2|||
13332375|NCT01099579|26602041|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0|||
13332376|NCT01099579|26602042|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1|||
13332377|NCT01099579|26602040|FG000|Stage 2 (ATV Capsule)|Adverse Event|0|||
13332378|NCT01099579|26602041|FG001|Stage 2 (ATV Capsule)|Adverse Event|1|||
13332379|NCT01099579|26602042|FG002|Stage 2 (ATV Capsule)|Adverse Event|0|||
13332380|NCT01099397|26602049|FG000|Overall Study|Lost to Follow-up|4|||
13332381|NCT01099397|26602049|FG000|Overall Study|Protocol Violation|4|||
13332382|NCT01099397|26602049|FG000|Overall Study|Withdrawal by Subject|5|||
13332383|NCT01099267|26602059|FG000|MDS-003 Study|Adverse Event|37|||
13332384|NCT01099267|26602059|FG000|MDS-003 Study|Lack of Efficacy|52|||
13332385|NCT01099267|26602059|FG000|MDS-003 Study|Withdrawal by Subject|8|||
13332386|NCT01099267|26602059|FG000|MDS-003 Study|Lost to Follow-up|1|||
13332387|NCT01099267|26602059|FG000|MDS-003 Study|Death|11|||
13332388|NCT01099267|26602059|FG000|MDS-003 Study|Study Closed by Sponsor|2|||
13332389|NCT01099267|26602059|FG000|MDS-003 Study|Disease Progression|7|||
13332390|NCT01099267|26602059|FG000|MDS-003 Study|Investigator Decision|2|||
13332391|NCT01099267|26602059|FG000|MDS-003 Study|Non-Compliance|2|||
13332392|NCT01099267|26602059|FG000|MDS-003 Study|Loss of Response|1|||
13332393|NCT01099267|26602059|FG000|MDS-003 Study|Secondary Malign Disease|1|||
13332394|NCT01099215|26602102|FG000|Overall Study|Withdrawal by Subject|1|||
13332395|NCT01099215|26602103|FG001|Overall Study|Withdrawal by Subject|0|||
13332396|NCT01099215|26602102|FG000|Overall Study|Adverse Event|0|||
13332397|NCT01099215|26602103|FG001|Overall Study|Adverse Event|1|||
13332398|NCT01098851|26602118|FG000|Overall Study|Equipment failure|1|||
13332399|NCT01098851|26602119|FG001|Overall Study|Equipment failure|0|||
13332400|NCT01098812|26602139|FG000|Overall Study|Death|2|||
13332401|NCT01098812|26602140|FG001|Overall Study|Death|0|||
13332402|NCT01098812|26602141|FG002|Overall Study|Death|1|||
13332403|NCT01098812|26602139|FG000|Overall Study|Lost to Follow-up|0|||
13332404|NCT01098812|26602140|FG001|Overall Study|Lost to Follow-up|1|||
13332405|NCT01098812|26602141|FG002|Overall Study|Lost to Follow-up|0|||
13332406|NCT01098539|26602184|FG000|Overall Study|Adverse Event|26|||
13332407|NCT01098539|26602185|FG001|Overall Study|Adverse Event|26|||
13332408|NCT01098539|26602184|FG000|Overall Study|Protocol Violation|1|||
13332409|NCT01098539|26602185|FG001|Overall Study|Protocol Violation|4|||
13332410|NCT01098539|26602184|FG000|Overall Study|Noncompliance|3|||
13332411|NCT01098539|26602185|FG001|Overall Study|Noncompliance|5|||
13332412|NCT01098539|26602184|FG000|Overall Study|Lost to Follow-up|4|||
13332413|NCT01098539|26602185|FG001|Overall Study|Lost to Follow-up|4|||
13332414|NCT01098539|26602184|FG000|Overall Study|Withdrawal by Subject|12|||
13332415|NCT01098539|26602185|FG001|Overall Study|Withdrawal by Subject|26|||
13332416|NCT01098539|26602184|FG000|Overall Study|Physician Decision|5|||
13332417|NCT01098539|26602185|FG001|Overall Study|Physician Decision|3|||
13332418|NCT01098487|26602199|FG000|Overall Study|Adverse Event|22|||
13332419|NCT01098487|26602199|FG000|Overall Study|Lack of Efficacy|11|||
13332420|NCT01098487|26602199|FG000|Overall Study|Withdrawal by Subject|7|||
13332421|NCT01098487|26602199|FG000|Overall Study|Lost to Follow-up|3|||
13332422|NCT01098487|26602199|FG000|Overall Study|Physician Decision|1|||
13332423|NCT01098474|26602448|FG000|Active Phase|Other|0|||
13332424|NCT01098474|26602449|FG001|Active Phase|Other|0|||
13332425|NCT01098474|26602450|FG002|Active Phase|Other|3|||
13332426|NCT01098474|26602451|FG003|Active Phase|Other|0|||
13332427|NCT01098474|26602452|FG004|Active Phase|Other|0|||
13332428|NCT01098474|26602453|FG005|Active Phase|Other|0|||
13332429|NCT01098474|26602448|FG000|Active Phase|Withdrawal by Subject|1|||
13332430|NCT01098474|26602449|FG001|Active Phase|Withdrawal by Subject|1|||
13332431|NCT01098474|26602450|FG002|Active Phase|Withdrawal by Subject|2|||
13332432|NCT01098474|26602451|FG003|Active Phase|Withdrawal by Subject|0|||
13332433|NCT01098474|26602452|FG004|Active Phase|Withdrawal by Subject|0|||
13332434|NCT01098474|26602453|FG005|Active Phase|Withdrawal by Subject|0|||
13332435|NCT01098474|26602448|FG000|Active Phase|Lost to Follow-up|1|||
13332436|NCT01098474|26602449|FG001|Active Phase|Lost to Follow-up|0|||
13332437|NCT01098474|26602450|FG002|Active Phase|Lost to Follow-up|0|||
13332438|NCT01098474|26602451|FG003|Active Phase|Lost to Follow-up|0|||
13332439|NCT01098474|26602452|FG004|Active Phase|Lost to Follow-up|0|||
13332440|NCT01098474|26602453|FG005|Active Phase|Lost to Follow-up|0|||
13122641|NCT02962908|25947686|FG001|Overall Study|Withdrawal by Subject|3|||
13122642|NCT02962908|25947687|FG002|Overall Study|Withdrawal by Subject|0|||
13122643|NCT02962908|25947688|FG003|Overall Study|Withdrawal by Subject|2|||
13122644|NCT02962908|25947685|FG000|Overall Study|Protocol Violation|0|||
13332441|NCT01098474|26602448|FG000|Follow Up Phase|Travelled out of study area|0|||
13332442|NCT01098474|26602449|FG001|Follow Up Phase|Travelled out of study area|0|||
13332443|NCT01098474|26602450|FG002|Follow Up Phase|Travelled out of study area|0|||
13332444|NCT01098474|26602451|FG003|Follow Up Phase|Travelled out of study area|0|||
13332445|NCT01098474|26602452|FG004|Follow Up Phase|Travelled out of study area|1|||
13332446|NCT01098474|26602453|FG005|Follow Up Phase|Travelled out of study area|0|||
13332447|NCT01098474|26602448|FG000|Follow Up Phase|Other|0|||
13332448|NCT01098474|26602449|FG001|Follow Up Phase|Other|0|||
13332449|NCT01098474|26602450|FG002|Follow Up Phase|Other|0|||
13332450|NCT01098474|26602451|FG003|Follow Up Phase|Other|0|||
13332451|NCT01098474|26602452|FG004|Follow Up Phase|Other|0|||
13332452|NCT01098474|26602453|FG005|Follow Up Phase|Other|4|||
13122645|NCT02962908|25947686|FG001|Overall Study|Protocol Violation|1|||
13122646|NCT02962908|25947687|FG002|Overall Study|Protocol Violation|0|||
13122647|NCT02962908|25947688|FG003|Overall Study|Protocol Violation|0|||
13122648|NCT02962908|25947685|FG000|Overall Study|Physician Decision|0|||
13122649|NCT02962908|25947686|FG001|Overall Study|Physician Decision|1|||
13122650|NCT02962908|25947687|FG002|Overall Study|Physician Decision|0|||
13122651|NCT02962908|25947688|FG003|Overall Study|Physician Decision|0|||
13122652|NCT02962882|25947699|FG000|Overall Study|Adverse Event|2|||
13122653|NCT02962882|25947699|FG000|Overall Study|Withdrawal by Subject|2|||
13122654|NCT02962882|25947699|FG000|Overall Study|Transfer from ICU|32|||
13122655|NCT02962765|25947712|FG000|Overall Study|Protocol Violation|9|||
13332453|NCT01098474|26602448|FG000|Follow Up Phase|Withdrawal by Subject|0|||
13332454|NCT01098474|26602449|FG001|Follow Up Phase|Withdrawal by Subject|0|||
13332455|NCT01098474|26602450|FG002|Follow Up Phase|Withdrawal by Subject|0|||
13332456|NCT01098474|26602451|FG003|Follow Up Phase|Withdrawal by Subject|2|||
13332457|NCT01098474|26602452|FG004|Follow Up Phase|Withdrawal by Subject|0|||
13332458|NCT01098474|26602453|FG005|Follow Up Phase|Withdrawal by Subject|1|||
13332459|NCT01098474|26602448|FG000|Follow Up Phase|Lost to Follow-up|0|||
13332460|NCT01098474|26602449|FG001|Follow Up Phase|Lost to Follow-up|0|||
13332461|NCT01098474|26602450|FG002|Follow Up Phase|Lost to Follow-up|0|||
13332462|NCT01098474|26602451|FG003|Follow Up Phase|Lost to Follow-up|0|||
13332463|NCT01098474|26602452|FG004|Follow Up Phase|Lost to Follow-up|1|||
13332464|NCT01098474|26602453|FG005|Follow Up Phase|Lost to Follow-up|0|||
13332465|NCT01098461|26602496|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10|||
13289105|NCT01081769|26477370|FG001|CORE Intent-To-Treat|Patient Moved|2|||
13289106|NCT01081678|26477413|FG000|Overall Study|Ineligibility Determined|0|||
13289107|NCT01081678|26477414|FG001|Overall Study|Ineligibility Determined|0|||
13289108|NCT01081678|26477415|FG002|Overall Study|Ineligibility Determined|1|||
13289109|NCT01081678|26477416|FG003|Overall Study|Ineligibility Determined|1|||
13289110|NCT01081678|26477413|FG000|Overall Study|Noncompliance|3|||
13289111|NCT01081678|26477414|FG001|Overall Study|Noncompliance|4|||
13289112|NCT01081678|26477415|FG002|Overall Study|Noncompliance|5|||
13289113|NCT01081678|26477416|FG003|Overall Study|Noncompliance|2|||
13289114|NCT01081678|26477413|FG000|Overall Study|Adverse Event|2|||
13332466|NCT01098461|26602497|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2|||
13332467|NCT01098461|26602498|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
13332468|NCT01098461|26602499|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
13332469|NCT01098461|26602496|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
13332470|NCT01098461|26602497|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2|||
13332471|NCT01098461|26602498|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
13332472|NCT01098461|26602499|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3|||
13332473|NCT01098461|26602496|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1|||
13332474|NCT01098461|26602497|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2|||
13332475|NCT01098461|26602498|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
13332476|NCT01098461|26602499|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
13332477|NCT01098461|26602496|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
13332478|NCT01098461|26602497|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1|||
13332479|NCT01098461|26602498|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
13332480|NCT01098461|26602499|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
13332481|NCT01098461|26602496|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
13332482|NCT01098461|26602497|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1|||
13332483|NCT01098461|26602498|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
13332484|NCT01098461|26602499|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
13332485|NCT01098461|26602496|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
13332486|NCT01098461|26602497|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1|||
13332487|NCT01098461|26602498|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
13332488|NCT01098461|26602499|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
13332489|NCT01098461|26602496|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
13332490|NCT01098461|26602497|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
13122656|NCT02962765|25947712|FG000|Overall Study|Withdrawal by Subject|3|||
13122657|NCT02962765|25947712|FG000|Overall Study|Lost to Follow-up|1|||
13122658|NCT02962765|25947712|FG000|Overall Study|Death|1|||
13332491|NCT01098461|26602498|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
13122659|NCT02962765|25947712|FG000|Overall Study|Limited access to study medication|3|||
13122660|NCT02962739|25947725|FG000|Overall Study|Withdrawal by Subject|0|||
13122661|NCT02962739|25947726|FG001|Overall Study|Withdrawal by Subject|1|||
13122662|NCT02962739|25947727|FG002|Overall Study|Withdrawal by Subject|0|||
13122663|NCT02962739|25947728|FG003|Overall Study|Withdrawal by Subject|0|||
13122664|NCT02962739|25947729|FG004|Overall Study|Withdrawal by Subject|0|||
13122665|NCT02962739|25947730|FG005|Overall Study|Withdrawal by Subject|0|||
13289115|NCT01081678|26477414|FG001|Overall Study|Adverse Event|1|||
13332492|NCT01098461|26602499|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
13122666|NCT02962739|25947725|FG000|Overall Study|Protocol Violation|0|||
13122667|NCT02962739|25947726|FG001|Overall Study|Protocol Violation|0|||
13122668|NCT02962739|25947727|FG002|Overall Study|Protocol Violation|1|||
13122669|NCT02962739|25947728|FG003|Overall Study|Protocol Violation|0|||
13122670|NCT02962739|25947729|FG004|Overall Study|Protocol Violation|1|||
13122671|NCT02962739|25947730|FG005|Overall Study|Protocol Violation|0|||
13122672|NCT02962674|25947749|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49|||
13122673|NCT02962648|25947763|FG000|Overall Study|Withdrawal by Subject|3|||
13122674|NCT02962648|25947763|FG000|Overall Study|Lost to Follow-up|3|||
13122675|NCT02962648|25947763|FG000|Overall Study|Physician Decision|1|||
13122676|NCT02962648|25947763|FG000|Overall Study|Subject had problems with transportation|2|||
13122677|NCT02962284|25947786|FG000|Overall Study|Death|2|||
13122678|NCT02962284|25947787|FG001|Overall Study|Death|0|||
13122679|NCT02962284|25947786|FG000|Overall Study|Progressive disease|2|||
13122680|NCT02962284|25947787|FG001|Overall Study|Progressive disease|3|||
13122681|NCT02962284|25947786|FG000|Overall Study|Withdrawal by Subject|1|||
13122682|NCT02962284|25947787|FG001|Overall Study|Withdrawal by Subject|0|||
13122683|NCT02961920|25947800|FG000|Overall Study|did not achive stydy protocol schedule|1|||
13122684|NCT02961920|25947801|FG001|Overall Study|did not achive stydy protocol schedule|1|||
13122685|NCT02961790|25947835|FG000|Overall Study|Canceled|4|||
13122686|NCT02961790|25947836|FG001|Overall Study|Canceled|5|||
13122687|NCT02961790|25947837|FG002|Overall Study|Canceled|1|||
13122688|NCT02961790|25947838|FG003|Overall Study|Canceled|4|||
13122689|NCT02961790|25947835|FG000|Overall Study|without baseline data|4|||
13122690|NCT02961790|25947836|FG001|Overall Study|without baseline data|0|||
13122691|NCT02961790|25947837|FG002|Overall Study|without baseline data|1|||
13122692|NCT02961790|25947838|FG003|Overall Study|without baseline data|0|||
13122693|NCT02961790|25947835|FG000|Overall Study|without post baseline data|7|||
13122694|NCT02961790|25947836|FG001|Overall Study|without post baseline data|6|||
13122695|NCT02961790|25947837|FG002|Overall Study|without post baseline data|4|||
13332493|NCT01098305|26602514|FG000|Overall Study|Lost to Follow-up|31|||
13332494|NCT01098305|26602515|FG001|Overall Study|Lost to Follow-up|33|||
13332495|NCT01098266|26602540|FG000|Overall Study|Physician Decision|1|||
13332496|NCT01098266|26602541|FG001|Overall Study|Physician Decision|0|||
13332497|NCT01098266|26602540|FG000|Overall Study|Death|3|||
13332498|NCT01098266|26602541|FG001|Overall Study|Death|2|||
13332499|NCT01098266|26602540|FG000|Overall Study|Withdrawal by Subject|3|||
13332500|NCT01098266|26602541|FG001|Overall Study|Withdrawal by Subject|5|||
13332501|NCT01098240|26602575|FG000|Open-Label Phase|Study Terminated by Sponsor|27|||
13332502|NCT01098240|26602576|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
13332503|NCT01098240|26602577|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
13332504|NCT01098240|26602575|FG000|Open-Label Phase|Protocol Violation|4|||
13332505|NCT01098240|26602576|FG001|Open-Label Phase|Protocol Violation|0|||
13332506|NCT01098240|26602577|FG002|Open-Label Phase|Protocol Violation|0|||
13332507|NCT01098240|26602575|FG000|Open-Label Phase|Lost to Follow-up|13|||
13332508|NCT01098240|26602576|FG001|Open-Label Phase|Lost to Follow-up|0|||
13332509|NCT01098240|26602577|FG002|Open-Label Phase|Lost to Follow-up|0|||
13332510|NCT01098240|26602575|FG000|Open-Label Phase|Other|19|||
13332511|NCT01098240|26602576|FG001|Open-Label Phase|Other|0|||
13332512|NCT01098240|26602577|FG002|Open-Label Phase|Other|0|||
13332513|NCT01098240|26602575|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50|||
13332514|NCT01098240|26602576|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
13332515|NCT01098240|26602577|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
13122696|NCT02961790|25947838|FG003|Overall Study|without post baseline data|1|||
13122697|NCT02961764|25947919|FG000|Overall Study|Protocol Violation|0|||
13122698|NCT02961764|25947920|FG001|Overall Study|Protocol Violation|1|||
13122699|NCT02961764|25947919|FG000|Overall Study|Death|2|||
13122700|NCT02961764|25947920|FG001|Overall Study|Death|0|||
13122701|NCT02961764|25947919|FG000|Overall Study|Lost to Follow-up|35|||
13122702|NCT02961764|25947920|FG001|Overall Study|Lost to Follow-up|24|||
13122703|NCT02961764|25947919|FG000|Overall Study|Withdrawal by Subject|2|||
13122704|NCT02961764|25947920|FG001|Overall Study|Withdrawal by Subject|0|||
13122705|NCT02961751|25947933|FG000|Overall Study|Lost to Follow-up|11|||
13122706|NCT02961751|25947933|FG000|Overall Study|Physician Decision|2|||
13122707|NCT02961751|25947933|FG000|Overall Study|Not Eligible at Enrollment|1|||
13122708|NCT02961751|25947933|FG000|Overall Study|Protocol Violation|1|||
13122709|NCT02961374|25947947|FG000|Overall Study|Adverse Event|4|||
13122710|NCT02961244|25947962|FG000|Overall Study|Protocol Violation|0|||
13122711|NCT02961244|25947963|FG001|Overall Study|Protocol Violation|1|||
13122712|NCT02961244|25947962|FG000|Overall Study|Withdrawal by Subject|1|||
13122713|NCT02961244|25947963|FG001|Overall Study|Withdrawal by Subject|2|||
13122714|NCT02961244|25947962|FG000|Overall Study|Surgery plan change after study approval|0|||
13122715|NCT02961244|25947963|FG001|Overall Study|Surgery plan change after study approval|2|||
13332516|NCT01098240|26602575|FG000|Open-Label Phase|Pregnancy|1|||
13332517|NCT01098240|26602576|FG001|Open-Label Phase|Pregnancy|0|||
13332518|NCT01098240|26602577|FG002|Open-Label Phase|Pregnancy|0|||
13332519|NCT01098240|26602575|FG000|Open-Label Phase|Withdrawal by Subject|9|||
13122716|NCT02961244|25947962|FG000|Overall Study|Lost to Follow-up|0|||
13122717|NCT02961244|25947963|FG001|Overall Study|Lost to Follow-up|2|||
13122718|NCT02961244|25947962|FG000|Overall Study|İnadequate data|0|||
13122719|NCT02961244|25947963|FG001|Overall Study|İnadequate data|2|||
13122720|NCT02961218|25948005|FG000|Overall Study|Lost to Follow-up|0|||
13122721|NCT02961218|25948006|FG001|Overall Study|Lost to Follow-up|2|||
13122722|NCT02961218|25948005|FG000|Overall Study|Physician Decision|0|||
13122723|NCT02961218|25948006|FG001|Overall Study|Physician Decision|2|||
13122724|NCT02961218|25948005|FG000|Overall Study|Subject/Guardian Decision|3|||
13122725|NCT02961218|25948006|FG001|Overall Study|Subject/Guardian Decision|1|||
13122726|NCT02960893|25948029|FG000|Randomization Phase (8-week)|Adverse Event|5|||
13122727|NCT02960893|25948030|FG001|Randomization Phase (8-week)|Adverse Event|0|||
13122728|NCT02960893|25948029|FG000|Randomization Phase (8-week)|Withdrawal by Subject|2|||
13122729|NCT02960893|25948030|FG001|Randomization Phase (8-week)|Withdrawal by Subject|1|||
13122730|NCT02960893|25948029|FG000|Randomization Phase (8-week)|Reason Not Specified|0|||
13122731|NCT02960893|25948030|FG001|Randomization Phase (8-week)|Reason Not Specified|1|||
13122732|NCT02960893|25948029|FG000|Extension Phase (48-week)|Adverse Event|2|||
13122733|NCT02960893|25948030|FG001|Extension Phase (48-week)|Adverse Event|3|||
13122734|NCT02960893|25948029|FG000|Extension Phase (48-week)|Withdrawal by Subject|8|||
13122735|NCT02960893|25948030|FG001|Extension Phase (48-week)|Withdrawal by Subject|8|||
13122736|NCT02960893|25948029|FG000|Extension Phase (48-week)|Other Reason|2|||
13122737|NCT02960893|25948030|FG001|Extension Phase (48-week)|Other Reason|1|||
13122738|NCT02960893|25948029|FG000|Extension Phase (48-week)|Lost to Follow-up|1|||
13122739|NCT02960893|25948030|FG001|Extension Phase (48-week)|Lost to Follow-up|1|||
13122740|NCT02960893|25948029|FG000|Extension Phase (48-week)|Sponsors Decision|1|||
13122741|NCT02960893|25948030|FG001|Extension Phase (48-week)|Sponsors Decision|0|||
13122742|NCT02960854|25948067|FG000|Overall Study|Not Disclosed|2|||
13332520|NCT01098240|26602576|FG001|Open-Label Phase|Withdrawal by Subject|0|||
13332521|NCT01098240|26602577|FG002|Open-Label Phase|Withdrawal by Subject|0|||
13332522|NCT01098240|26602575|FG000|Open-Label Phase|Adverse Event|12|||
13332523|NCT01098240|26602576|FG001|Open-Label Phase|Adverse Event|0|||
13332524|NCT01098240|26602577|FG002|Open-Label Phase|Adverse Event|0|||
13332525|NCT01098240|26602575|FG000|Double-Blind Phase|Study Terminated by Sponsor|0|||
13122743|NCT02960854|25948068|FG001|Overall Study|Not Disclosed|2|||
13122744|NCT02960854|25948067|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
13122745|NCT02960854|25948068|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
13122746|NCT02960854|25948067|FG000|Overall Study|Subject Withdrew Consent|0|||
13122747|NCT02960854|25948068|FG001|Overall Study|Subject Withdrew Consent|1|||
13122748|NCT02960854|25948067|FG000|Overall Study|Death|4|||
13122749|NCT02960854|25948068|FG001|Overall Study|Death|6|||
13122750|NCT02960490|25948257|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3|||
13122751|NCT02960490|25948258|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2|||
13122752|NCT02960490|25948259|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
13122753|NCT02960490|25948260|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
13122754|NCT02960490|25948261|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
13332526|NCT01098240|26602576|FG001|Double-Blind Phase|Study Terminated by Sponsor|5|||
13332527|NCT01098240|26602577|FG002|Double-Blind Phase|Study Terminated by Sponsor|8|||
13332528|NCT01098240|26602575|FG000|Double-Blind Phase|Protocol Violation|0|||
13332529|NCT01098240|26602576|FG001|Double-Blind Phase|Protocol Violation|2|||
13332530|NCT01098240|26602577|FG002|Double-Blind Phase|Protocol Violation|4|||
13122755|NCT02960490|25948262|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
13332531|NCT01098240|26602575|FG000|Double-Blind Phase|Lost to Follow-up|0|||
13332532|NCT01098240|26602576|FG001|Double-Blind Phase|Lost to Follow-up|2|||
13332533|NCT01098240|26602577|FG002|Double-Blind Phase|Lost to Follow-up|0|||
13332534|NCT01098240|26602575|FG000|Double-Blind Phase|Other|0|||
13332535|NCT01098240|26602576|FG001|Double-Blind Phase|Other|2|||
13332536|NCT01098240|26602577|FG002|Double-Blind Phase|Other|2|||
13332537|NCT01098240|26602575|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
13332538|NCT01098240|26602576|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1|||
13332539|NCT01098240|26602577|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
13332540|NCT01098240|26602575|FG000|Double-Blind Phase|Insufficient Clinical Response|0|||
13332541|NCT01098240|26602576|FG001|Double-Blind Phase|Insufficient Clinical Response|1|||
13332542|NCT01098240|26602577|FG002|Double-Blind Phase|Insufficient Clinical Response|2|||
13122756|NCT02960490|25948263|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
13122757|NCT02960490|25948264|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
13122758|NCT02960490|25948265|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
13122759|NCT02960490|25948266|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
13122760|NCT02960490|25948257|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
13122761|NCT02960490|25948258|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1|||
13332543|NCT01098240|26602575|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
13332544|NCT01098240|26602576|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
13332545|NCT01098240|26602577|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
13332546|NCT01098240|26602575|FG000|Double-Blind Phase|Adverse Event|0|||
13122762|NCT02960490|25948259|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
13122763|NCT02960490|25948260|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
13122764|NCT02960490|25948261|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
13122765|NCT02960490|25948262|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
13122766|NCT02960490|25948263|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
13332547|NCT01098240|26602576|FG001|Double-Blind Phase|Adverse Event|3|||
13332548|NCT01098240|26602577|FG002|Double-Blind Phase|Adverse Event|3|||
13332549|NCT01098162|26602588|FG000|Overall Study|Adverse Event|37|||
13332550|NCT01098162|26602588|FG000|Overall Study|Lack of Efficacy|4|||
13332551|NCT01098162|26602588|FG000|Overall Study|Wish of Patient|7|||
13332552|NCT01098162|26602588|FG000|Overall Study|Lost to Follow-up|9|||
13332553|NCT01098162|26602588|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5|||
13332554|NCT01098162|26602588|FG000|Overall Study|Adverse Event & Lack of Efficacy|6|||
13332555|NCT01098162|26602588|FG000|Overall Study|Adverse Event & Wish of Patient|13|||
13332556|NCT01098162|26602588|FG000|Overall Study|Adverse Event & Lost to Follow-up|2|||
13332557|NCT01098162|26602588|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1|||
13332558|NCT01098162|26602588|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1|||
13332559|NCT01098162|26602588|FG000|Overall Study|Other Reason|1|||
13332560|NCT01098162|26602588|FG000|Overall Study|Reason Unknown|26|||
13332561|NCT01098110|26602639|FG000|Overall Study|Withdrawal by Subject|14|||
13332562|NCT01098110|26602640|FG001|Overall Study|Withdrawal by Subject|24|||
13332563|NCT01098110|26602641|FG002|Overall Study|Withdrawal by Subject|19|||
13332564|NCT01098110|26602639|FG000|Overall Study|Adverse Event|30|||
13332565|NCT01098110|26602640|FG001|Overall Study|Adverse Event|32|||
13332566|NCT01098110|26602641|FG002|Overall Study|Adverse Event|43|||
13332567|NCT01098110|26602639|FG000|Overall Study|Lack of Efficacy|13|||
13332568|NCT01098110|26602640|FG001|Overall Study|Lack of Efficacy|9|||
13332569|NCT01098110|26602641|FG002|Overall Study|Lack of Efficacy|27|||
13332570|NCT01098110|26602639|FG000|Overall Study|Other|4|||
13332571|NCT01098110|26602640|FG001|Overall Study|Other|7|||
13332572|NCT01098110|26602641|FG002|Overall Study|Other|5|||
13122767|NCT02960490|25948264|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
13122768|NCT02960490|25948265|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
13122769|NCT02960490|25948266|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
13122770|NCT02960490|25948257|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1|||
13122771|NCT02960490|25948258|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2|||
13122772|NCT02960490|25948259|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
13122773|NCT02960490|25948260|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
13122774|NCT02960490|25948261|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
13122775|NCT02960490|25948262|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
13122776|NCT02960490|25948263|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
13122777|NCT02960490|25948264|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
13122778|NCT02960490|25948265|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
13122779|NCT02960490|25948266|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
13122780|NCT02960490|25948257|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
13122781|NCT02960490|25948258|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
13122782|NCT02960490|25948259|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
13122783|NCT02960490|25948260|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
13122784|NCT02960490|25948261|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
13122785|NCT02960490|25948262|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
13122786|NCT02960490|25948263|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
13122787|NCT02960490|25948264|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
13122788|NCT02960490|25948265|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
13122789|NCT02960490|25948266|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
13122790|NCT02960490|25948257|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
13122791|NCT02960490|25948258|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
13122792|NCT02960490|25948259|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
13122793|NCT02960490|25948260|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
13122794|NCT02960490|25948261|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
13122795|NCT02960490|25948262|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2|||
13122796|NCT02960490|25948263|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
13204150|NCT01976741|26227500|FG006|Overall Study|Adverse Event|3|||
13332573|NCT01098110|26602639|FG000|Overall Study|Untreated|1|||
13332574|NCT01098110|26602640|FG001|Overall Study|Untreated|1|||
13332575|NCT01098110|26602641|FG002|Overall Study|Untreated|0|||
13332576|NCT01098097|26602652|FG000|Overall Study|Adverse Event|17|||
13332577|NCT01098097|26602652|FG000|Overall Study|Lost to Follow-up|18|||
13332578|NCT01098097|26602652|FG000|Overall Study|Status unknown|16|||
13332579|NCT01098097|26602652|FG000|Overall Study|No reason reported|31|||
13332580|NCT01098071|26602665|FG000|Overall Study|Surgery (adenoidectomy)|2|||
13332581|NCT01098071|26602665|FG000|Overall Study|Lost to Follow-up|13|||
13122797|NCT02960490|25948264|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
13122798|NCT02960490|25948265|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
13122799|NCT02960490|25948266|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
13332582|NCT01097863|26602683|FG000|Overall Study|Discomfort|1|||
13332583|NCT01097863|26602684|FG001|Overall Study|Discomfort|0|||
13332584|NCT01097863|26602685|FG002|Overall Study|Discomfort|1|||
13332585|NCT01097863|26602683|FG000|Overall Study|Did not return for final visit|0|||
13332586|NCT01097863|26602684|FG001|Overall Study|Did not return for final visit|0|||
13332587|NCT01097863|26602685|FG002|Overall Study|Did not return for final visit|1|||
13332588|NCT01097707|26602748|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
13332589|NCT01097707|26602749|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
13332590|NCT01097707|26602750|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
13332591|NCT01097707|26602751|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
13332592|NCT01097707|26602752|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
13332593|NCT01097707|26602748|FG000|Overall Study|Adverse Event|4|||
13332594|NCT01097707|26602749|FG001|Overall Study|Adverse Event|2|||
13332595|NCT01097707|26602750|FG002|Overall Study|Adverse Event|3|||
13332596|NCT01097707|26602751|FG003|Overall Study|Adverse Event|1|||
13332597|NCT01097707|26602752|FG004|Overall Study|Adverse Event|3|||
13332598|NCT01097707|26602748|FG000|Overall Study|Entry Criteria Not Met|2|||
13332599|NCT01097707|26602749|FG001|Overall Study|Entry Criteria Not Met|1|||
13332600|NCT01097707|26602750|FG002|Overall Study|Entry Criteria Not Met|1|||
13332601|NCT01097707|26602751|FG003|Overall Study|Entry Criteria Not Met|0|||
13332602|NCT01097707|26602752|FG004|Overall Study|Entry Criteria Not Met|1|||
13332603|NCT01097707|26602748|FG000|Overall Study|Lack of Efficacy|1|||
13332604|NCT01097707|26602749|FG001|Overall Study|Lack of Efficacy|0|||
13332605|NCT01097707|26602750|FG002|Overall Study|Lack of Efficacy|0|||
13332606|NCT01097707|26602751|FG003|Overall Study|Lack of Efficacy|1|||
13332607|NCT01097707|26602752|FG004|Overall Study|Lack of Efficacy|0|||
13332608|NCT01097707|26602748|FG000|Overall Study|Lost to Follow-up|1|||
13332609|NCT01097707|26602749|FG001|Overall Study|Lost to Follow-up|1|||
13332610|NCT01097707|26602750|FG002|Overall Study|Lost to Follow-up|2|||
13332611|NCT01097707|26602751|FG003|Overall Study|Lost to Follow-up|0|||
13332612|NCT01097707|26602752|FG004|Overall Study|Lost to Follow-up|3|||
13332613|NCT01097707|26602748|FG000|Overall Study|Protocol Violation|2|||
13332614|NCT01097707|26602749|FG001|Overall Study|Protocol Violation|2|||
13332615|NCT01097707|26602750|FG002|Overall Study|Protocol Violation|3|||
13332616|NCT01097707|26602751|FG003|Overall Study|Protocol Violation|2|||
13332617|NCT01097707|26602752|FG004|Overall Study|Protocol Violation|2|||
13332618|NCT01097707|26602748|FG000|Overall Study|Sponsor Decision|31|||
13332619|NCT01097707|26602749|FG001|Overall Study|Sponsor Decision|31|||
13332620|NCT01097707|26602750|FG002|Overall Study|Sponsor Decision|34|||
13332621|NCT01097707|26602751|FG003|Overall Study|Sponsor Decision|35|||
13332622|NCT01097707|26602752|FG004|Overall Study|Sponsor Decision|36|||
13332623|NCT01097707|26602748|FG000|Overall Study|Withdrawal by Subject|3|||
13332624|NCT01097707|26602749|FG001|Overall Study|Withdrawal by Subject|6|||
13332625|NCT01097707|26602750|FG002|Overall Study|Withdrawal by Subject|1|||
13332626|NCT01097707|26602751|FG003|Overall Study|Withdrawal by Subject|4|||
13332627|NCT01097707|26602752|FG004|Overall Study|Withdrawal by Subject|3|||
13332628|NCT01097707|26602748|FG000|Overall Study|Reason unknown|0|||
13332629|NCT01097707|26602749|FG001|Overall Study|Reason unknown|0|||
13332630|NCT01097707|26602750|FG002|Overall Study|Reason unknown|0|||
13332631|NCT01097707|26602751|FG003|Overall Study|Reason unknown|0|||
13332632|NCT01097707|26602752|FG004|Overall Study|Reason unknown|1|||
13332633|NCT01097694|26602819|FG000|Overall Study|Adverse Event|5|||
13332634|NCT01097694|26602820|FG001|Overall Study|Adverse Event|0|||
13332635|NCT01097694|26602819|FG000|Overall Study|Lost to Follow-up|0|||
13332636|NCT01097694|26602820|FG001|Overall Study|Lost to Follow-up|3|||
13332637|NCT01097694|26602819|FG000|Overall Study|Withdrawal by Subject|3|||
13332638|NCT01097694|26602820|FG001|Overall Study|Withdrawal by Subject|1|||
13122800|NCT02960490|25948257|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
13122801|NCT02960490|25948258|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
13122802|NCT02960490|25948259|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
13122803|NCT02960490|25948260|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
13332639|NCT01097668|26602837|FG000|Overall Study|Withdrawal by Subject|1|||
13332640|NCT01097668|26602838|FG001|Overall Study|Withdrawal by Subject|2|||
13332641|NCT01097668|26602837|FG000|Overall Study|Lost to Follow-up|1|||
13332642|NCT01097668|26602838|FG001|Overall Study|Lost to Follow-up|0|||
13332643|NCT01097655|26602847|FG000|Overall Study|Withdrawal by Subject|1|||
13332644|NCT01097655|26602847|FG000|Overall Study|Subject Documented Twice|1|||
13332645|NCT01097655|26602847|FG000|Overall Study|Did Not Meet Inclusion Criteria|8|||
13332646|NCT01097629|26602910|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10|||
13332647|NCT01097629|26602911|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19|||
13332648|NCT01097629|26602912|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17|||
13332649|NCT01097629|26602913|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
13373856|NCT00799266|26725132|FG001|Overall Study|Adverse Event|1|||
13122804|NCT02960490|25948261|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
13122805|NCT02960490|25948262|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
13122806|NCT02960490|25948263|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
13122807|NCT02960490|25948264|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
13122808|NCT02960490|25948265|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
13122809|NCT02960490|25948266|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
13122810|NCT02960490|25948257|FG000|Re-randomized Participants: 12 Weeks|Other|0|||
13332650|NCT01097629|26602914|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
13332651|NCT01097629|26602915|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
13332652|NCT01097629|26602916|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
13332653|NCT01097629|26602917|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
13332654|NCT01097629|26602910|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
13332655|NCT01097629|26602911|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9|||
13122811|NCT02960490|25948258|FG001|Re-randomized Participants: 12 Weeks|Other|0|||
13122812|NCT02960490|25948259|FG002|Re-randomized Participants: 12 Weeks|Other|0|||
13122813|NCT02960490|25948260|FG003|Re-randomized Participants: 12 Weeks|Other|1|||
13122814|NCT02960490|25948261|FG004|Re-randomized Participants: 12 Weeks|Other|0|||
13122815|NCT02960490|25948262|FG005|Re-randomized Participants: 12 Weeks|Other|0|||
13122816|NCT02960490|25948263|FG006|Re-randomized Participants: 12 Weeks|Other|0|||
13122817|NCT02960490|25948264|FG007|Re-randomized Participants: 12 Weeks|Other|0|||
13122818|NCT02960490|25948265|FG008|Re-randomized Participants: 12 Weeks|Other|0|||
13122819|NCT02960490|25948266|FG009|Re-randomized Participants: 12 Weeks|Other|0|||
13122820|NCT02960490|25948257|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
13122821|NCT02960490|25948258|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
13332656|NCT01097629|26602912|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19|||
13332657|NCT01097629|26602913|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
13332658|NCT01097629|26602914|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
13332659|NCT01097629|26602915|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
13332660|NCT01097629|26602916|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
13332661|NCT01097629|26602917|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
13332662|NCT01097629|26602910|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
13332663|NCT01097629|26602911|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4|||
13332664|NCT01097629|26602912|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8|||
13332665|NCT01097629|26602913|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
13332666|NCT01097629|26602914|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
13332667|NCT01097629|26602915|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
13332668|NCT01097629|26602916|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
13332669|NCT01097629|26602917|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
13332670|NCT01097629|26602910|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2|||
13332671|NCT01097629|26602911|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4|||
13332672|NCT01097629|26602912|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
13332673|NCT01097629|26602913|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
13332674|NCT01097629|26602914|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
13332675|NCT01097629|26602915|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
13332676|NCT01097629|26602916|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
13332677|NCT01097629|26602917|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
13332678|NCT01097629|26602910|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
13332679|NCT01097629|26602911|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4|||
13332680|NCT01097629|26602912|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8|||
13332681|NCT01097629|26602913|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
13332682|NCT01097629|26602914|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
13332683|NCT01097629|26602915|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
13332684|NCT01097629|26602916|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
13122822|NCT02960490|25948259|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
13122823|NCT02960490|25948260|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
13122824|NCT02960490|25948261|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
13122825|NCT02960490|25948262|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
13122826|NCT02960490|25948263|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3|||
13122827|NCT02960490|25948264|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
13122828|NCT02960490|25948265|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
13122829|NCT02960490|25948266|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
13122830|NCT02960490|25948257|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
13122831|NCT02960490|25948258|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
13122832|NCT02960490|25948259|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
13204151|NCT01976741|26227501|FG007|Overall Study|Adverse Event|8|||
13122833|NCT02960490|25948260|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
13122834|NCT02960490|25948261|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
13122835|NCT02960490|25948262|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
13122836|NCT02960490|25948263|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
13122837|NCT02960490|25948264|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1|||
13122838|NCT02960490|25948265|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
13122839|NCT02960490|25948266|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
13122840|NCT02960490|25948257|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
13122841|NCT02960490|25948258|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
13122842|NCT02960490|25948259|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
13122843|NCT02960490|25948260|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
13122844|NCT02960490|25948261|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
13122845|NCT02960490|25948262|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
13122846|NCT02960490|25948263|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4|||
13122847|NCT02960490|25948264|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
13122848|NCT02960490|25948265|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
13122849|NCT02960490|25948266|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7|||
13122850|NCT02960490|25948257|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
13122851|NCT02960490|25948258|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
13122852|NCT02960490|25948259|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
13122853|NCT02960490|25948260|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
13122854|NCT02960490|25948261|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
13122855|NCT02960490|25948262|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
13122856|NCT02960490|25948263|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2|||
13122857|NCT02960490|25948264|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
13122858|NCT02960490|25948265|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
13122859|NCT02960490|25948266|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
13122860|NCT02960490|25948257|FG000|Extension Phase(Open-label): 80 Weeks|Other|0|||
13122861|NCT02960490|25948258|FG001|Extension Phase(Open-label): 80 Weeks|Other|0|||
13122862|NCT02960490|25948259|FG002|Extension Phase(Open-label): 80 Weeks|Other|0|||
13122863|NCT02960490|25948260|FG003|Extension Phase(Open-label): 80 Weeks|Other|0|||
13122864|NCT02960490|25948261|FG004|Extension Phase(Open-label): 80 Weeks|Other|0|||
13122865|NCT02960490|25948262|FG005|Extension Phase(Open-label): 80 Weeks|Other|0|||
13122866|NCT02960490|25948263|FG006|Extension Phase(Open-label): 80 Weeks|Other|0|||
13122867|NCT02960490|25948264|FG007|Extension Phase(Open-label): 80 Weeks|Other|1|||
13122868|NCT02960490|25948265|FG008|Extension Phase(Open-label): 80 Weeks|Other|0|||
13332685|NCT01097629|26602917|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
13332686|NCT01097629|26602910|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2|||
13332687|NCT01097629|26602911|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1|||
13332688|NCT01097629|26602912|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
13332689|NCT01097629|26602913|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
13332690|NCT01097629|26602914|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
13332691|NCT01097629|26602915|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
13332692|NCT01097629|26602916|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
13332693|NCT01097629|26602917|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
13332694|NCT01097629|26602910|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
13332695|NCT01097629|26602911|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5|||
13332696|NCT01097629|26602912|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4|||
13332697|NCT01097629|26602913|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
13332698|NCT01097629|26602914|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
13332699|NCT01097629|26602915|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
13332700|NCT01097629|26602916|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
13332701|NCT01097629|26602917|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
13332702|NCT01097629|26602910|FG000|DB RO Phase|Withdrawal by Subject|0|||
13332703|NCT01097629|26602911|FG001|DB RO Phase|Withdrawal by Subject|0|||
13332704|NCT01097629|26602912|FG002|DB RO Phase|Withdrawal by Subject|0|||
13332705|NCT01097629|26602913|FG003|DB RO Phase|Withdrawal by Subject|0|||
13332706|NCT01097629|26602914|FG004|DB RO Phase|Withdrawal by Subject|0|||
13332707|NCT01097629|26602915|FG005|DB RO Phase|Withdrawal by Subject|0|||
13332708|NCT01097629|26602916|FG006|DB RO Phase|Withdrawal by Subject|0|||
13332709|NCT01097629|26602917|FG007|DB RO Phase|Withdrawal by Subject|1|||
13332710|NCT01097629|26602910|FG000|DB RO Phase|Protocol Violation|0|||
13332711|NCT01097629|26602911|FG001|DB RO Phase|Protocol Violation|0|||
13122869|NCT02960490|25948266|FG009|Extension Phase(Open-label): 80 Weeks|Other|0|||
13332712|NCT01097629|26602912|FG002|DB RO Phase|Protocol Violation|0|||
13332713|NCT01097629|26602913|FG003|DB RO Phase|Protocol Violation|1|||
13332714|NCT01097629|26602914|FG004|DB RO Phase|Protocol Violation|0|||
13122870|NCT02960438|25948449|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
13122871|NCT02960438|25948450|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1|||
13122872|NCT02960438|25948451|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
13122873|NCT02960438|25948452|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5|||
13122874|NCT02960438|25948449|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2|||
13332715|NCT01097629|26602915|FG005|DB RO Phase|Protocol Violation|1|||
13332716|NCT01097629|26602916|FG006|DB RO Phase|Protocol Violation|1|||
13332717|NCT01097629|26602917|FG007|DB RO Phase|Protocol Violation|0|||
13332718|NCT01097629|26602910|FG000|DB RO Phase|Lost to Follow-up|0|||
13332719|NCT01097629|26602911|FG001|DB RO Phase|Lost to Follow-up|0|||
13332720|NCT01097629|26602912|FG002|DB RO Phase|Lost to Follow-up|0|||
13332721|NCT01097629|26602913|FG003|DB RO Phase|Lost to Follow-up|0|||
13332722|NCT01097629|26602914|FG004|DB RO Phase|Lost to Follow-up|0|||
13332723|NCT01097629|26602915|FG005|DB RO Phase|Lost to Follow-up|0|||
13332724|NCT01097629|26602916|FG006|DB RO Phase|Lost to Follow-up|2|||
13332725|NCT01097629|26602917|FG007|DB RO Phase|Lost to Follow-up|0|||
13332726|NCT01097616|26603003|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6|||
13332727|NCT01097616|26603004|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15|||
13332728|NCT01097616|26603005|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21|||
13332729|NCT01097616|26603006|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
13332730|NCT01097616|26603007|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
13332731|NCT01097616|26603008|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
13332732|NCT01097616|26603009|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
13332733|NCT01097616|26603010|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
13332734|NCT01097616|26603003|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6|||
13332735|NCT01097616|26603004|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
13332736|NCT01097616|26603005|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12|||
13332737|NCT01097616|26603006|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
13332738|NCT01097616|26603007|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
13332739|NCT01097616|26603008|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
13332740|NCT01097616|26603009|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
13332741|NCT01097616|26603010|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
13332742|NCT01097616|26603003|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
13332743|NCT01097616|26603004|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3|||
13332744|NCT01097616|26603005|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1|||
13332745|NCT01097616|26603006|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
13332746|NCT01097616|26603007|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
13332747|NCT01097616|26603008|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
13332748|NCT01097616|26603009|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
13332749|NCT01097616|26603010|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
13332750|NCT01097616|26603003|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
13332751|NCT01097616|26603004|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
13332752|NCT01097616|26603005|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
13332753|NCT01097616|26603006|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
13332754|NCT01097616|26603007|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
13332755|NCT01097616|26603008|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
13332756|NCT01097616|26603009|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
13332757|NCT01097616|26603010|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
13332758|NCT01097616|26603003|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1|||
13332759|NCT01097616|26603004|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
13332760|NCT01097616|26603005|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9|||
13332761|NCT01097616|26603006|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
13332762|NCT01097616|26603007|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
13332763|NCT01097616|26603008|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
13332764|NCT01097616|26603009|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
13332765|NCT01097616|26603010|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
13332766|NCT01097616|26603003|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
13332767|NCT01097616|26603004|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
13332768|NCT01097616|26603005|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
13332769|NCT01097616|26603006|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
13332770|NCT01097616|26603007|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
13332771|NCT01097616|26603008|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
13332772|NCT01097616|26603009|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
13332773|NCT01097616|26603010|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
13332774|NCT01097616|26603003|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4|||
13332775|NCT01097616|26603004|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3|||
13332776|NCT01097616|26603005|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
13332777|NCT01097616|26603006|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
13332778|NCT01097616|26603007|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
13332779|NCT01097616|26603008|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
13332780|NCT01097616|26603009|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
13332781|NCT01097616|26603010|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
13122875|NCT02960438|25948450|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1|||
13122876|NCT02960438|25948451|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0|||
13122877|NCT02960438|25948452|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3|||
13122878|NCT02960438|25948449|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2|||
13122879|NCT02960438|25948450|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
13122880|NCT02960438|25948451|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
13122881|NCT02960438|25948452|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
13122882|NCT02960438|25948449|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
13122883|NCT02960438|25948450|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
13122884|NCT02960438|25948451|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
13122885|NCT02960438|25948452|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
13122886|NCT02960438|25948449|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
13122887|NCT02960438|25948450|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
13122888|NCT02960438|25948451|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1|||
13122889|NCT02960438|25948452|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
13122890|NCT02960438|25948449|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2|||
13332782|NCT01097616|26603003|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
13332783|NCT01097616|26603004|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
13332784|NCT01097616|26603005|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
13332785|NCT01097616|26603006|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
13332786|NCT01097616|26603007|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
13332787|NCT01097616|26603008|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
13332788|NCT01097616|26603009|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
13122891|NCT02960438|25948450|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
13332789|NCT01097616|26603010|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
13332790|NCT01097616|26603003|FG000|Optional DB EXT Phase|Adverse Event|0|||
13332791|NCT01097616|26603004|FG001|Optional DB EXT Phase|Adverse Event|7|||
13332792|NCT01097616|26603005|FG002|Optional DB EXT Phase|Adverse Event|2|||
13332793|NCT01097616|26603006|FG003|Optional DB EXT Phase|Adverse Event|0|||
13332794|NCT01097616|26603007|FG004|Optional DB EXT Phase|Adverse Event|0|||
13332795|NCT01097616|26603008|FG005|Optional DB EXT Phase|Adverse Event|0|||
13332796|NCT01097616|26603009|FG006|Optional DB EXT Phase|Adverse Event|0|||
13332797|NCT01097616|26603010|FG007|Optional DB EXT Phase|Adverse Event|0|||
13332798|NCT01097616|26603003|FG000|Optional DB EXT Phase|Withdrawal by Subject|12|||
13332799|NCT01097616|26603004|FG001|Optional DB EXT Phase|Withdrawal by Subject|6|||
13332800|NCT01097616|26603005|FG002|Optional DB EXT Phase|Withdrawal by Subject|3|||
13332801|NCT01097616|26603006|FG003|Optional DB EXT Phase|Withdrawal by Subject|0|||
13332802|NCT01097616|26603007|FG004|Optional DB EXT Phase|Withdrawal by Subject|0|||
13332803|NCT01097616|26603008|FG005|Optional DB EXT Phase|Withdrawal by Subject|0|||
13332804|NCT01097616|26603009|FG006|Optional DB EXT Phase|Withdrawal by Subject|0|||
13332805|NCT01097616|26603010|FG007|Optional DB EXT Phase|Withdrawal by Subject|0|||
13332806|NCT01097616|26603003|FG000|Optional DB EXT Phase|Protocol Violation|0|||
13332807|NCT01097616|26603004|FG001|Optional DB EXT Phase|Protocol Violation|2|||
13122892|NCT02960438|25948451|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0|||
13122893|NCT02960438|25948452|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
13122894|NCT02960438|25948449|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
13122895|NCT02960438|25948450|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2|||
13122896|NCT02960438|25948451|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4|||
13122897|NCT02960438|25948452|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
13289116|NCT01081678|26477415|FG002|Overall Study|Adverse Event|2|||
13289117|NCT01081678|26477416|FG003|Overall Study|Adverse Event|2|||
13289118|NCT01081678|26477413|FG000|Overall Study|Withdrawal by Subject|15|||
13289119|NCT01081678|26477414|FG001|Overall Study|Withdrawal by Subject|7|||
13289120|NCT01081678|26477415|FG002|Overall Study|Withdrawal by Subject|17|||
13289121|NCT01081678|26477416|FG003|Overall Study|Withdrawal by Subject|14|||
13289122|NCT01081678|26477413|FG000|Overall Study|Administrative Decision|1|||
13289123|NCT01081678|26477414|FG001|Overall Study|Administrative Decision|0|||
13289124|NCT01081678|26477415|FG002|Overall Study|Administrative Decision|0|||
13289125|NCT01081678|26477416|FG003|Overall Study|Administrative Decision|1|||
13332808|NCT01097616|26603005|FG002|Optional DB EXT Phase|Protocol Violation|3|||
13332809|NCT01097616|26603006|FG003|Optional DB EXT Phase|Protocol Violation|0|||
13332810|NCT01097616|26603007|FG004|Optional DB EXT Phase|Protocol Violation|0|||
13332811|NCT01097616|26603008|FG005|Optional DB EXT Phase|Protocol Violation|0|||
13332812|NCT01097616|26603009|FG006|Optional DB EXT Phase|Protocol Violation|0|||
13332813|NCT01097616|26603010|FG007|Optional DB EXT Phase|Protocol Violation|0|||
13332814|NCT01097616|26603003|FG000|Optional DB EXT Phase|Lost to Follow-up|1|||
13332815|NCT01097616|26603004|FG001|Optional DB EXT Phase|Lost to Follow-up|5|||
13332816|NCT01097616|26603005|FG002|Optional DB EXT Phase|Lost to Follow-up|1|||
13332817|NCT01097616|26603006|FG003|Optional DB EXT Phase|Lost to Follow-up|0|||
13332818|NCT01097616|26603007|FG004|Optional DB EXT Phase|Lost to Follow-up|0|||
13332819|NCT01097616|26603008|FG005|Optional DB EXT Phase|Lost to Follow-up|0|||
13332820|NCT01097616|26603009|FG006|Optional DB EXT Phase|Lost to Follow-up|0|||
13332821|NCT01097616|26603010|FG007|Optional DB EXT Phase|Lost to Follow-up|0|||
13332822|NCT01097616|26603003|FG000|Optional DB EXT Phase|Lack of Efficacy|1|||
13332823|NCT01097616|26603004|FG001|Optional DB EXT Phase|Lack of Efficacy|1|||
13332824|NCT01097616|26603005|FG002|Optional DB EXT Phase|Lack of Efficacy|1|||
13332825|NCT01097616|26603006|FG003|Optional DB EXT Phase|Lack of Efficacy|0|||
13122898|NCT02960438|25948449|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
13332826|NCT01097616|26603007|FG004|Optional DB EXT Phase|Lack of Efficacy|0|||
13332827|NCT01097616|26603008|FG005|Optional DB EXT Phase|Lack of Efficacy|0|||
13332828|NCT01097616|26603009|FG006|Optional DB EXT Phase|Lack of Efficacy|0|||
13332829|NCT01097616|26603010|FG007|Optional DB EXT Phase|Lack of Efficacy|0|||
13332830|NCT01097616|26603003|FG000|Optional DB EXT Phase|Physician Decision|1|||
13332831|NCT01097616|26603004|FG001|Optional DB EXT Phase|Physician Decision|0|||
13332832|NCT01097616|26603005|FG002|Optional DB EXT Phase|Physician Decision|0|||
13332833|NCT01097616|26603006|FG003|Optional DB EXT Phase|Physician Decision|0|||
13332834|NCT01097616|26603007|FG004|Optional DB EXT Phase|Physician Decision|0|||
13332835|NCT01097616|26603008|FG005|Optional DB EXT Phase|Physician Decision|0|||
13332836|NCT01097616|26603009|FG006|Optional DB EXT Phase|Physician Decision|0|||
13332837|NCT01097616|26603010|FG007|Optional DB EXT Phase|Physician Decision|0|||
13332838|NCT01097616|26603003|FG000|DB RO Phase|Adverse Event|0|||
13332839|NCT01097616|26603004|FG001|DB RO Phase|Adverse Event|0|||
13332840|NCT01097616|26603005|FG002|DB RO Phase|Adverse Event|0|||
13332841|NCT01097616|26603006|FG003|DB RO Phase|Adverse Event|0|||
13332842|NCT01097616|26603007|FG004|DB RO Phase|Adverse Event|0|||
13332843|NCT01097616|26603008|FG005|DB RO Phase|Adverse Event|0|||
13332844|NCT01097616|26603009|FG006|DB RO Phase|Adverse Event|1|||
13332845|NCT01097616|26603010|FG007|DB RO Phase|Adverse Event|0|||
13332846|NCT01097616|26603003|FG000|DB RO Phase|Withdrawal by Subject|0|||
13332847|NCT01097616|26603004|FG001|DB RO Phase|Withdrawal by Subject|0|||
13332848|NCT01097616|26603005|FG002|DB RO Phase|Withdrawal by Subject|0|||
13332849|NCT01097616|26603006|FG003|DB RO Phase|Withdrawal by Subject|0|||
13332850|NCT01097616|26603007|FG004|DB RO Phase|Withdrawal by Subject|0|||
13332851|NCT01097616|26603008|FG005|DB RO Phase|Withdrawal by Subject|1|||
13332852|NCT01097616|26603009|FG006|DB RO Phase|Withdrawal by Subject|0|||
13332853|NCT01097616|26603010|FG007|DB RO Phase|Withdrawal by Subject|0|||
13332854|NCT01097616|26603003|FG000|DB RO Phase|Lost to Follow-up|0|||
13332855|NCT01097616|26603004|FG001|DB RO Phase|Lost to Follow-up|0|||
13332856|NCT01097616|26603005|FG002|DB RO Phase|Lost to Follow-up|0|||
13332857|NCT01097616|26603006|FG003|DB RO Phase|Lost to Follow-up|1|||
13332858|NCT01097616|26603007|FG004|DB RO Phase|Lost to Follow-up|1|||
13332859|NCT01097616|26603008|FG005|DB RO Phase|Lost to Follow-up|0|||
13332860|NCT01097616|26603009|FG006|DB RO Phase|Lost to Follow-up|0|||
13332861|NCT01097616|26603010|FG007|DB RO Phase|Lost to Follow-up|1|||
13332862|NCT01097616|26603003|FG000|DB RO Phase|Not Treated in RO|0|||
13332863|NCT01097616|26603004|FG001|DB RO Phase|Not Treated in RO|0|||
13122899|NCT02960438|25948450|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
13122900|NCT02960438|25948451|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1|||
13122901|NCT02960438|25948452|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
13122902|NCT02960438|25948449|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
13122903|NCT02960438|25948450|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
13122904|NCT02960438|25948451|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0|||
13122905|NCT02960438|25948452|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
13122906|NCT02960438|25948449|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
13122907|NCT02960438|25948450|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5|||
13122908|NCT02960438|25948451|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
13332864|NCT01097616|26603005|FG002|DB RO Phase|Not Treated in RO|0|||
13332865|NCT01097616|26603006|FG003|DB RO Phase|Not Treated in RO|0|||
13332866|NCT01097616|26603007|FG004|DB RO Phase|Not Treated in RO|0|||
13332867|NCT01097616|26603008|FG005|DB RO Phase|Not Treated in RO|1|||
13332868|NCT01097616|26603009|FG006|DB RO Phase|Not Treated in RO|0|||
13332869|NCT01097616|26603010|FG007|DB RO Phase|Not Treated in RO|0|||
13332870|NCT01097577|26603033|FG000|Overall Study|Adverse Event|0|||
13332871|NCT01097577|26603034|FG001|Overall Study|Adverse Event|1|||
13332872|NCT01097421|26603046|FG000|Overall Study|Adverse Event|8|||
13332873|NCT01097421|26603046|FG000|Overall Study|Protocol Violation|2|||
13332874|NCT01097421|26603046|FG000|Overall Study|Lost to Follow-up|1|||
13332875|NCT01097421|26603046|FG000|Overall Study|Withdrawal by Subject|3|||
13332876|NCT01097330|26603063|FG000|Overall Study|Study terminated early|7|||
13332877|NCT01097330|26603064|FG001|Overall Study|Study terminated early|5|||
13332878|NCT01097057|26603073|FG000|Overall Study|Physician Decision|3|||
13332879|NCT01097044|26603098|FG000|Overall Study|Withdrawal by Subject|4|||
13332880|NCT01097044|26603099|FG001|Overall Study|Withdrawal by Subject|4|||
13332881|NCT01097044|26603098|FG000|Overall Study|Lost to Follow-up|1|||
13332882|NCT01097044|26603099|FG001|Overall Study|Lost to Follow-up|0|||
13332883|NCT01097044|26603098|FG000|Overall Study|Withdrawal by Sponsor|0|||
13332884|NCT01097044|26603099|FG001|Overall Study|Withdrawal by Sponsor|1|||
13122909|NCT02960438|25948452|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6|||
13122910|NCT02960438|25948449|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
13122911|NCT02960438|25948450|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
13122912|NCT02960438|25948451|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
13122913|NCT02960438|25948452|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
13122914|NCT02960438|25948449|FG000|Extension Phase (Open-label): 80 Weeks|Other|0|||
13122915|NCT02960438|25948450|FG001|Extension Phase (Open-label): 80 Weeks|Other|0|||
13122916|NCT02960438|25948451|FG002|Extension Phase (Open-label): 80 Weeks|Other|1|||
13122917|NCT02960438|25948452|FG003|Extension Phase (Open-label): 80 Weeks|Other|1|||
13122918|NCT02960217|25948511|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1|||
13122919|NCT02960217|25948512|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0|||
13122920|NCT02960217|25948511|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0|||
13122921|NCT02960217|25948512|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1|||
13122922|NCT02960217|25948511|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0|||
13122923|NCT02960217|25948512|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1|||
13122924|NCT02960217|25948511|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1|||
13122925|NCT02960217|25948512|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0|||
13332885|NCT01097005|26603107|FG000|Overall Study|Case Report Form not collected|18|||
13332886|NCT01097005|26603107|FG000|Overall Study|Subjects cannot visit the hospital|1|||
13332887|NCT01097005|26603107|FG000|Overall Study|Poor medication compliance|1|||
13332888|NCT01097005|26603107|FG000|Overall Study|No examination data available|244|||
13332889|NCT01097005|26603107|FG000|Overall Study|Deviation from exclusion criteria|37|||
13332890|NCT01097005|26603107|FG000|Overall Study|Adverse Event|14|||
13332891|NCT01097005|26603107|FG000|Overall Study|Discontinuance by complication|50|||
13332892|NCT01096849|26603170|FG000|Overall Study|Consent Withdrawn|1|||
13332893|NCT01096849|26603171|FG001|Overall Study|Consent Withdrawn|4|||
13332894|NCT01096849|26603172|FG002|Overall Study|Consent Withdrawn|2|||
13332895|NCT01096849|26603170|FG000|Overall Study|Lack of Efficacy|0|||
13332896|NCT01096849|26603171|FG001|Overall Study|Lack of Efficacy|2|||
13332897|NCT01096849|26603172|FG002|Overall Study|Lack of Efficacy|0|||
13332898|NCT01096849|26603170|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0|||
13332899|NCT01096849|26603171|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
13332900|NCT01096849|26603172|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
13332901|NCT01096849|26603170|FG000|Overall Study|Investigator or Medical Monitor Decision|0|||
13332902|NCT01096849|26603171|FG001|Overall Study|Investigator or Medical Monitor Decision|1|||
13332903|NCT01096849|26603172|FG002|Overall Study|Investigator or Medical Monitor Decision|0|||
13332904|NCT01096849|26603170|FG000|Overall Study|Administrative Reasons|0|||
13332905|NCT01096849|26603171|FG001|Overall Study|Administrative Reasons|1|||
13332906|NCT01096849|26603172|FG002|Overall Study|Administrative Reasons|2|||
13332907|NCT01096849|26603170|FG000|Overall Study|Lost to Follow-up|1|||
13332908|NCT01096849|26603171|FG001|Overall Study|Lost to Follow-up|3|||
13122926|NCT02960217|25948511|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0|||
13122927|NCT02960217|25948512|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1|||
13122928|NCT02960217|25948511|FG000|Open-Label Extension Phase|Adverse Event|1|||
13122929|NCT02960217|25948512|FG001|Open-Label Extension Phase|Adverse Event|0|||
13122930|NCT02960217|25948511|FG000|Open-Label Extension Phase|Sponsor Decision|18|||
13122931|NCT02960217|25948512|FG001|Open-Label Extension Phase|Sponsor Decision|11|||
13122932|NCT02960217|25948511|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
13122933|NCT02960217|25948512|FG001|Open-Label Extension Phase|Lack of Efficacy|1|||
13122934|NCT02960217|25948511|FG000|Open-Label Extension Phase|Other, Not Specified|0|||
13122935|NCT02960217|25948512|FG001|Open-Label Extension Phase|Other, Not Specified|1|||
13122936|NCT02959983|25948531|FG000|Overall Study|Protocol Violation|0|||
13122937|NCT02959983|25948532|FG001|Overall Study|Protocol Violation|1|||
13122938|NCT02959983|25948531|FG000|Overall Study|Lack of Efficacy|0|||
13122939|NCT02959983|25948532|FG001|Overall Study|Lack of Efficacy|1|||
13122940|NCT02959983|25948531|FG000|Overall Study|Lost to Follow-up|12|||
13122941|NCT02959983|25948532|FG001|Overall Study|Lost to Follow-up|9|||
13332909|NCT01096849|26603172|FG002|Overall Study|Lost to Follow-up|1|||
13332910|NCT01096784|26603211|FG000|Overall Study|Withdrawal by Subject|2|||
13332911|NCT01096784|26603212|FG001|Overall Study|Withdrawal by Subject|1|||
13332912|NCT01096784|26603211|FG000|Overall Study|Adverse Event|11|||
13332913|NCT01096784|26603212|FG001|Overall Study|Adverse Event|9|||
13332914|NCT01096784|26603211|FG000|Overall Study|Protocol Deviation|2|||
13122942|NCT02959983|25948531|FG000|Overall Study|Other|1|||
13122943|NCT02959983|25948532|FG001|Overall Study|Other|1|||
13122944|NCT02959983|25948531|FG000|Overall Study|Physician Decision|1|||
13122945|NCT02959983|25948532|FG001|Overall Study|Physician Decision|0|||
13122946|NCT02959983|25948531|FG000|Overall Study|Adverse Event|5|||
13122947|NCT02959983|25948532|FG001|Overall Study|Adverse Event|1|||
13122948|NCT02959983|25948531|FG000|Overall Study|Withdrawal by Subject|7|||
13122949|NCT02959983|25948532|FG001|Overall Study|Withdrawal by Subject|12|||
13122950|NCT02959970|25948571|FG000|Overall Study|Adverse Event|1|||
13122951|NCT02959970|25948572|FG001|Overall Study|Adverse Event|0|||
13122952|NCT02959970|25948571|FG000|Overall Study|Withdrawal by Subject|0|||
13122953|NCT02959970|25948572|FG001|Overall Study|Withdrawal by Subject|2|||
13122954|NCT02959970|25948571|FG000|Overall Study|Lost to Follow-up|1|||
13122955|NCT02959970|25948572|FG001|Overall Study|Lost to Follow-up|5|||
13122956|NCT02959892|25948587|FG000|Overall Study|PET tracer synthesis failure|1|||
13122957|NCT02959892|25948588|FG001|Overall Study|PET tracer synthesis failure|0|||
13122958|NCT02959892|25948587|FG000|Overall Study|Study termination|0|||
13122959|NCT02959892|25948588|FG001|Overall Study|Study termination|1|||
13122960|NCT02959866|25948595|FG000|Overall Study|Withdrawal by Subject|1|||
13122961|NCT02959814|25948616|FG000|Overall Study|Excluded based on diagnostic angiography|16|||
13122962|NCT02959814|25948616|FG000|Overall Study|Excluded based on anatomical criteria|2|||
13122963|NCT02959814|25948616|FG000|Overall Study|Protocol Violation|7|||
13122964|NCT02959814|25948616|FG000|Overall Study|FFR not measured|2|||
13122965|NCT02959814|25948616|FG000|Overall Study|In-procedure QFR not computed|6|||
13122966|NCT02959814|25948616|FG000|Overall Study|Excluded by FFR core-lab|24|||
13122967|NCT02959671|25948626|FG000|Overall Study|Adverse Event|2|||
13122968|NCT02959671|25948626|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3|||
13122969|NCT02959437|25948662|FG000|Overall Study|Death|33|||
13122970|NCT02959437|25948663|FG001|Overall Study|Death|3|||
13122971|NCT02959437|25948664|FG002|Overall Study|Death|0|||
13122972|NCT02959437|25948665|FG003|Overall Study|Death|0|||
13122973|NCT02959437|25948662|FG000|Overall Study|Lost to Follow-up|3|||
13122974|NCT02959437|25948663|FG001|Overall Study|Lost to Follow-up|1|||
13122975|NCT02959437|25948664|FG002|Overall Study|Lost to Follow-up|0|||
13122976|NCT02959437|25948665|FG003|Overall Study|Lost to Follow-up|0|||
13122977|NCT02959437|25948662|FG000|Overall Study|Withdrawal by Subject|11|||
13122978|NCT02959437|25948663|FG001|Overall Study|Withdrawal by Subject|3|||
13122979|NCT02959437|25948664|FG002|Overall Study|Withdrawal by Subject|0|||
13122980|NCT02959437|25948665|FG003|Overall Study|Withdrawal by Subject|0|||
13122981|NCT02959437|25948662|FG000|Overall Study|Progressive Disease|9|||
13122982|NCT02959437|25948663|FG001|Overall Study|Progressive Disease|1|||
13122983|NCT02959437|25948664|FG002|Overall Study|Progressive Disease|0|||
13122984|NCT02959437|25948665|FG003|Overall Study|Progressive Disease|0|||
13122985|NCT02959437|25948662|FG000|Overall Study|Study Terminated by Sponsor|4|||
13122986|NCT02959437|25948663|FG001|Overall Study|Study Terminated by Sponsor|0|||
13122987|NCT02959437|25948664|FG002|Overall Study|Study Terminated by Sponsor|0|||
13122988|NCT02959437|25948665|FG003|Overall Study|Study Terminated by Sponsor|0|||
13122989|NCT02959437|25948662|FG000|Overall Study|Other Unspecified|2|||
13122990|NCT02959437|25948663|FG001|Overall Study|Other Unspecified|0|||
13122991|NCT02959437|25948664|FG002|Overall Study|Other Unspecified|0|||
13122992|NCT02959437|25948665|FG003|Overall Study|Other Unspecified|0|||
13122993|NCT02959190|25948772|FG000|Open Label|Adverse Event|5|||
13122994|NCT02959190|25948773|FG001|Open Label|Adverse Event|7|||
13122995|NCT02959190|25948774|FG002|Open Label|Adverse Event|3|||
13122996|NCT02959190|25948775|FG003|Open Label|Adverse Event|4|||
13122997|NCT02959190|25948772|FG000|Open Label|Pregnancy|0|||
13122998|NCT02959190|25948773|FG001|Open Label|Pregnancy|1|||
13122999|NCT02959190|25948774|FG002|Open Label|Pregnancy|0|||
13123000|NCT02959190|25948775|FG003|Open Label|Pregnancy|0|||
13123001|NCT02959190|25948772|FG000|Open Label|Withdrawal by Subject|2|||
13123002|NCT02959190|25948773|FG001|Open Label|Withdrawal by Subject|8|||
13123003|NCT02959190|25948774|FG002|Open Label|Withdrawal by Subject|0|||
13123004|NCT02959190|25948775|FG003|Open Label|Withdrawal by Subject|0|||
13123005|NCT02959190|25948772|FG000|Open Label|Physician Decision|0|||
13123006|NCT02959190|25948773|FG001|Open Label|Physician Decision|0|||
13332915|NCT01096784|26603212|FG001|Overall Study|Protocol Deviation|2|||
13332916|NCT01096784|26603211|FG000|Overall Study|Administrative Decision|0|||
13332917|NCT01096784|26603212|FG001|Overall Study|Administrative Decision|1|||
13332918|NCT01096784|26603211|FG000|Overall Study|Other Unspecified|0|||
13332919|NCT01096784|26603212|FG001|Overall Study|Other Unspecified|1|||
13332920|NCT01096667|26603366|FG000|Overall Study|Lost to Follow-up|1|||
13332921|NCT01096667|26603367|FG001|Overall Study|Lost to Follow-up|1|||
13123007|NCT02959190|25948774|FG002|Open Label|Physician Decision|1|||
13123008|NCT02959190|25948775|FG003|Open Label|Physician Decision|0|||
13123009|NCT02959190|25948772|FG000|Open Label|Protocol Violation|0|||
13123010|NCT02959190|25948773|FG001|Open Label|Protocol Violation|0|||
13123011|NCT02959190|25948774|FG002|Open Label|Protocol Violation|0|||
13123012|NCT02959190|25948775|FG003|Open Label|Protocol Violation|2|||
13332922|NCT01096667|26603368|FG002|Overall Study|Lost to Follow-up|1|||
13123013|NCT02959190|25948772|FG000|Post Treatment Follow Up|Adverse Event|1|||
13123014|NCT02959190|25948773|FG001|Post Treatment Follow Up|Adverse Event|1|||
13123015|NCT02959190|25948774|FG002|Post Treatment Follow Up|Adverse Event|0|||
13123016|NCT02959190|25948775|FG003|Post Treatment Follow Up|Adverse Event|0|||
13123017|NCT02959190|25948772|FG000|Post Treatment Follow Up|Withdrawal by Subject|2|||
13123018|NCT02959190|25948773|FG001|Post Treatment Follow Up|Withdrawal by Subject|0|||
13123019|NCT02959190|25948774|FG002|Post Treatment Follow Up|Withdrawal by Subject|1|||
13123020|NCT02959190|25948775|FG003|Post Treatment Follow Up|Withdrawal by Subject|0|||
13123021|NCT02959177|25948837|FG000|Double-Blind Treatment Phase|Adverse Event|5|||
13123022|NCT02959177|25948838|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
13123023|NCT02959177|25948839|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
13123024|NCT02959177|25948837|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
13123025|NCT02959177|25948838|FG001|Double-Blind Treatment Phase|Physician Decision|0|||
13123026|NCT02959177|25948839|FG002|Double-Blind Treatment Phase|Physician Decision|0|||
13123027|NCT02959177|25948837|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
13123028|NCT02959177|25948838|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
13123029|NCT02959177|25948839|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
13123030|NCT02959177|25948837|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
13123031|NCT02959177|25948838|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
13123032|NCT02959177|25948839|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
13332923|NCT01096667|26603369|FG003|Overall Study|Lost to Follow-up|0|||
13123033|NCT02959177|25948837|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1|||
13123034|NCT02959177|25948838|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
13123035|NCT02959177|25948839|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
13123036|NCT02959177|25948837|FG000|Follow-up Post Treatment Phase|Adverse Event|0|||
13123037|NCT02959177|25948838|FG001|Follow-up Post Treatment Phase|Adverse Event|1|||
13123038|NCT02959177|25948839|FG002|Follow-up Post Treatment Phase|Adverse Event|0|||
13123039|NCT02959177|25948837|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
13123040|NCT02959177|25948838|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
13123041|NCT02959177|25948839|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2|||
13123042|NCT02959138|25948872|FG000|Overall Study|Enrolled but Never Treated|0|||
13332924|NCT01096667|26603370|FG004|Overall Study|Lost to Follow-up|0|||
13332925|NCT01096667|26603366|FG000|Overall Study|Withdrawal by Subject|1|||
13332926|NCT01096667|26603367|FG001|Overall Study|Withdrawal by Subject|0|||
13332927|NCT01096667|26603368|FG002|Overall Study|Withdrawal by Subject|0|||
13332928|NCT01096667|26603369|FG003|Overall Study|Withdrawal by Subject|1|||
13332929|NCT01096667|26603370|FG004|Overall Study|Withdrawal by Subject|0|||
13332930|NCT01096667|26603366|FG000|Overall Study|Reason not available|0|||
13332931|NCT01096667|26603367|FG001|Overall Study|Reason not available|1|||
13332932|NCT01096667|26603368|FG002|Overall Study|Reason not available|1|||
13332933|NCT01096667|26603369|FG003|Overall Study|Reason not available|1|||
13123043|NCT02959138|25948873|FG001|Overall Study|Enrolled but Never Treated|1|||
13123044|NCT02959138|25948874|FG002|Overall Study|Enrolled but Never Treated|0|||
13123045|NCT02958865|25949195|FG000|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
13332934|NCT01096667|26603370|FG004|Overall Study|Reason not available|0|||
13332935|NCT01096667|26603366|FG000|Overall Study|Protocol Violation|0|||
13332936|NCT01096667|26603367|FG001|Overall Study|Protocol Violation|0|||
13332937|NCT01096667|26603368|FG002|Overall Study|Protocol Violation|0|||
13332938|NCT01096667|26603369|FG003|Overall Study|Protocol Violation|1|||
13332939|NCT01096667|26603370|FG004|Overall Study|Protocol Violation|0|||
13204152|NCT01976741|26227502|FG008|Overall Study|Adverse Event|1|||
13332940|NCT01096667|26603366|FG000|Overall Study|Not treated|1|||
13332941|NCT01096667|26603367|FG001|Overall Study|Not treated|0|||
13332942|NCT01096667|26603368|FG002|Overall Study|Not treated|0|||
13332943|NCT01096667|26603369|FG003|Overall Study|Not treated|0|||
13332944|NCT01096667|26603370|FG004|Overall Study|Not treated|0|||
13332945|NCT01096589|26603397|FG000|Overall Study|Adverse Event|2|||
13332946|NCT01096589|26603398|FG001|Overall Study|Adverse Event|1|||
13332947|NCT01096589|26603399|FG002|Overall Study|Adverse Event|2|||
13332948|NCT01096589|26603400|FG003|Overall Study|Adverse Event|1|||
13332949|NCT01096589|26603397|FG000|Overall Study|Withdrawal by Subject|2|||
13332950|NCT01096589|26603398|FG001|Overall Study|Withdrawal by Subject|1|||
13332951|NCT01096589|26603399|FG002|Overall Study|Withdrawal by Subject|1|||
13332952|NCT01096589|26603400|FG003|Overall Study|Withdrawal by Subject|1|||
13332953|NCT01096589|26603397|FG000|Overall Study|Compliance with protocol|0|||
13332954|NCT01096589|26603398|FG001|Overall Study|Compliance with protocol|0|||
13332955|NCT01096589|26603399|FG002|Overall Study|Compliance with protocol|1|||
13332956|NCT01096589|26603400|FG003|Overall Study|Compliance with protocol|0|||
13332957|NCT01096589|26603397|FG000|Overall Study|found treatment exhausting|0|||
13332958|NCT01096589|26603398|FG001|Overall Study|found treatment exhausting|0|||
13332959|NCT01096589|26603399|FG002|Overall Study|found treatment exhausting|0|||
13332960|NCT01096589|26603400|FG003|Overall Study|found treatment exhausting|1|||
13332961|NCT01096446|26603412|FG000|Overall Study|Death|1|||
13332962|NCT01096446|26603413|FG001|Overall Study|Death|0|||
13332963|NCT01096446|26603412|FG000|Overall Study|Protocol Violation|2|||
13123046|NCT02958865|25949196|FG001|Induction Period (Day 1 to Week 8)|Adverse Event|4|||
13123047|NCT02958865|25949197|FG002|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
13123048|NCT02958865|25949198|FG003|Induction Period (Day 1 to Week 8)|Adverse Event|5|||
13123049|NCT02958865|25949199|FG004|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
13123050|NCT02958865|25949200|FG005|Induction Period (Day 1 to Week 8)|Adverse Event|2|||
13123051|NCT02958865|25949201|FG006|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
13123052|NCT02958865|25949202|FG007|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
13123053|NCT02958865|25949203|FG008|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
13123054|NCT02958865|25949204|FG009|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
13123055|NCT02958865|25949205|FG010|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
13123056|NCT02958865|25949206|FG011|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
13123057|NCT02958865|25949207|FG012|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
13123058|NCT02958865|25949208|FG013|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
13123059|NCT02958865|25949209|FG014|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
13123060|NCT02958865|25949210|FG015|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
13123061|NCT02958865|25949195|FG000|Induction Period (Day 1 to Week 8)|Death|0|||
13123062|NCT02958865|25949196|FG001|Induction Period (Day 1 to Week 8)|Death|1|||
13123063|NCT02958865|25949197|FG002|Induction Period (Day 1 to Week 8)|Death|0|||
13123064|NCT02958865|25949198|FG003|Induction Period (Day 1 to Week 8)|Death|0|||
13123065|NCT02958865|25949199|FG004|Induction Period (Day 1 to Week 8)|Death|0|||
13123066|NCT02958865|25949200|FG005|Induction Period (Day 1 to Week 8)|Death|0|||
13123067|NCT02958865|25949201|FG006|Induction Period (Day 1 to Week 8)|Death|0|||
13123068|NCT02958865|25949202|FG007|Induction Period (Day 1 to Week 8)|Death|0|||
13123069|NCT02958865|25949203|FG008|Induction Period (Day 1 to Week 8)|Death|0|||
13123070|NCT02958865|25949204|FG009|Induction Period (Day 1 to Week 8)|Death|0|||
13123071|NCT02958865|25949205|FG010|Induction Period (Day 1 to Week 8)|Death|0|||
13123072|NCT02958865|25949206|FG011|Induction Period (Day 1 to Week 8)|Death|0|||
13123073|NCT02958865|25949207|FG012|Induction Period (Day 1 to Week 8)|Death|0|||
13123074|NCT02958865|25949208|FG013|Induction Period (Day 1 to Week 8)|Death|0|||
13123075|NCT02958865|25949209|FG014|Induction Period (Day 1 to Week 8)|Death|0|||
13123076|NCT02958865|25949210|FG015|Induction Period (Day 1 to Week 8)|Death|0|||
13123077|NCT02958865|25949195|FG000|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
13123078|NCT02958865|25949196|FG001|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
13123079|NCT02958865|25949197|FG002|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
13123080|NCT02958865|25949198|FG003|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
13123081|NCT02958865|25949199|FG004|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
13123082|NCT02958865|25949200|FG005|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
13123083|NCT02958865|25949201|FG006|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
13123084|NCT02958865|25949202|FG007|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
13204153|NCT01976741|26227503|FG009|Overall Study|Adverse Event|4|||
13289126|NCT01081678|26477413|FG000|Overall Study|Lost to Follow-up|4|||
13289127|NCT01081678|26477414|FG001|Overall Study|Lost to Follow-up|1|||
13289128|NCT01081678|26477415|FG002|Overall Study|Lost to Follow-up|4|||
13289129|NCT01081678|26477416|FG003|Overall Study|Lost to Follow-up|3|||
13289130|NCT01081678|26477413|FG000|Overall Study|Death|2|||
13289131|NCT01081678|26477414|FG001|Overall Study|Death|2|||
13289132|NCT01081678|26477415|FG002|Overall Study|Death|2|||
13289133|NCT01081678|26477416|FG003|Overall Study|Death|6|||
13289134|NCT01081678|26477413|FG000|Overall Study|Other|0|||
13289135|NCT01081678|26477414|FG001|Overall Study|Other|1|||
13289136|NCT01081678|26477415|FG002|Overall Study|Other|0|||
13289137|NCT01081678|26477416|FG003|Overall Study|Other|0|||
13289138|NCT01081665|26477428|FG000|Overall Study|Death|41|||
13289139|NCT01081665|26477428|FG000|Overall Study|Lost to Follow-up|18|||
13289140|NCT01081665|26477428|FG000|Overall Study|Withdrawal by Subject|17|||
13289141|NCT01081665|26477428|FG000|Overall Study|Change of dialysis unit|10|||
13289142|NCT01081665|26477428|FG000|Overall Study|Regulation of iPTH|5|||
13289143|NCT01081665|26477428|FG000|Overall Study|Change in renal replacement therapy|2|||
13289144|NCT01081665|26477428|FG000|Overall Study|Adverse Event|1|||
13289145|NCT01081665|26477428|FG000|Overall Study|Lack of Efficacy|1|||
13289146|NCT01081626|26477461|FG000|Overall Study|Dosing error|1|||
13289147|NCT01081626|26477462|FG001|Overall Study|Dosing error|1|||
13289148|NCT01081626|26477461|FG000|Overall Study|Missing Estradiol|25|||
13289149|NCT01081626|26477462|FG001|Overall Study|Missing Estradiol|28|||
13289150|NCT01081626|26477461|FG000|Overall Study|Low antral follicle count|1|||
13289151|NCT01081626|26477462|FG001|Overall Study|Low antral follicle count|0|||
13289152|NCT01081626|26477461|FG000|Overall Study|Overstimulation|0|||
13289153|NCT01081626|26477462|FG001|Overall Study|Overstimulation|1|||
13289154|NCT01081626|26477461|FG000|Overall Study|Lost to Follow-up|0|||
13289155|NCT01081626|26477462|FG001|Overall Study|Lost to Follow-up|1|||
13289156|NCT01081626|26477461|FG000|Overall Study|Other|33|||
13289157|NCT01081626|26477462|FG001|Overall Study|Other|30|||
13289158|NCT01081301|26477502|FG000|Overall Study|Bereaved|3|||
13289159|NCT01081301|26477502|FG000|Overall Study|Too busy|5|||
13289160|NCT01081301|26477502|FG000|Overall Study|Patient too ill|2|||
13123085|NCT02958865|25949203|FG008|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
13123086|NCT02958865|25949204|FG009|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
13123087|NCT02958865|25949205|FG010|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
13123088|NCT02958865|25949206|FG011|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
13332964|NCT01096446|26603413|FG001|Overall Study|Protocol Violation|0|||
13332965|NCT01096342|26603421|FG000|Overall Study|Protocol Violation|1|||
13332966|NCT01096316|26603438|FG000|Overall Study|Lost to Follow-up|15|||
13332967|NCT01096316|26603439|FG001|Overall Study|Lost to Follow-up|9|||
13332968|NCT01096186|26603447|FG000|Overall Study|Adverse Event|16|||
13332969|NCT01096186|26603447|FG000|Overall Study|Death|4|||
13332970|NCT01096186|26603447|FG000|Overall Study|Lack of Efficacy|4|||
13332971|NCT01096186|26603447|FG000|Overall Study|Lost to Follow-up|2|||
13332972|NCT01096186|26603447|FG000|Overall Study|Withdrawal by Subject|22|||
13332973|NCT01096186|26603447|FG000|Overall Study|Physician Decision|1|||
13332974|NCT01096186|26603447|FG000|Overall Study|Noncompliance with study drug|1|||
13332975|NCT01096160|26603534|FG000|Overall Study|Adverse Event|0|||
13332976|NCT01096160|26603535|FG001|Overall Study|Adverse Event|0|||
13332977|NCT01096160|26603536|FG002|Overall Study|Adverse Event|1|||
13332978|NCT01096160|26603537|FG003|Overall Study|Adverse Event|0|||
13332979|NCT01096160|26603538|FG004|Overall Study|Adverse Event|0|||
13332980|NCT01096160|26603539|FG005|Overall Study|Adverse Event|0|||
13332981|NCT01096160|26603540|FG006|Overall Study|Adverse Event|0|||
13332982|NCT01096160|26603541|FG007|Overall Study|Adverse Event|0|||
13332983|NCT01096160|26603542|FG008|Overall Study|Adverse Event|0|||
13332984|NCT01096160|26603543|FG009|Overall Study|Adverse Event|1|||
13332985|NCT01096160|26603534|FG000|Overall Study|Met stopping criteria per protocol|0|||
13332986|NCT01096160|26603535|FG001|Overall Study|Met stopping criteria per protocol|0|||
13332987|NCT01096160|26603536|FG002|Overall Study|Met stopping criteria per protocol|0|||
13332988|NCT01096160|26603537|FG003|Overall Study|Met stopping criteria per protocol|0|||
13332989|NCT01096160|26603538|FG004|Overall Study|Met stopping criteria per protocol|1|||
13332990|NCT01096160|26603539|FG005|Overall Study|Met stopping criteria per protocol|0|||
13332991|NCT01096160|26603540|FG006|Overall Study|Met stopping criteria per protocol|2|||
13332992|NCT01096160|26603541|FG007|Overall Study|Met stopping criteria per protocol|0|||
13332993|NCT01096160|26603542|FG008|Overall Study|Met stopping criteria per protocol|2|||
13332994|NCT01096160|26603543|FG009|Overall Study|Met stopping criteria per protocol|0|||
13332995|NCT01096056|26603582|FG000|Overall Study|Lost to Follow-up|0|||
13332996|NCT01096056|26603583|FG001|Overall Study|Lost to Follow-up|1|||
13332997|NCT01096017|26603614|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1|||
13332998|NCT01096017|26603615|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1|||
13332999|NCT01095978|26603644|FG000|Overall Study|Did not take Klacid SR|2|||
13333000|NCT01095978|26603644|FG000|Overall Study|Adverse Event|1|||
13333001|NCT01095835|26603690|FG000|Overall Study|Adverse Event|8|||
13333002|NCT01095835|26603691|FG001|Overall Study|Adverse Event|6|||
13333003|NCT01095835|26603692|FG002|Overall Study|Adverse Event|6|||
13333004|NCT01095835|26603690|FG000|Overall Study|Lack of Efficacy|0|||
13333005|NCT01095835|26603691|FG001|Overall Study|Lack of Efficacy|1|||
13333006|NCT01095835|26603692|FG002|Overall Study|Lack of Efficacy|0|||
13123089|NCT02958865|25949207|FG012|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
13123090|NCT02958865|25949208|FG013|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
13333007|NCT01095835|26603690|FG000|Overall Study|Physician Decision|0|||
13333008|NCT01095835|26603691|FG001|Overall Study|Physician Decision|0|||
13333009|NCT01095835|26603692|FG002|Overall Study|Physician Decision|1|||
13333010|NCT01095835|26603690|FG000|Overall Study|Withdrawal by Subject|1|||
13333011|NCT01095835|26603691|FG001|Overall Study|Withdrawal by Subject|3|||
13333012|NCT01095835|26603692|FG002|Overall Study|Withdrawal by Subject|0|||
13333013|NCT01095835|26603690|FG000|Overall Study|Non study compliance|0|||
13333014|NCT01095835|26603691|FG001|Overall Study|Non study compliance|0|||
13333015|NCT01095835|26603692|FG002|Overall Study|Non study compliance|1|||
13333016|NCT01095835|26603690|FG000|Overall Study|Protocol Violation|1|||
13333017|NCT01095835|26603691|FG001|Overall Study|Protocol Violation|2|||
13333018|NCT01095835|26603692|FG002|Overall Study|Protocol Violation|0|||
13333019|NCT01095796|26603717|FG000|Overall Study|Randomized but Not Treated|5|||
13333020|NCT01095796|26603718|FG001|Overall Study|Randomized but Not Treated|2|||
13333021|NCT01095796|26603717|FG000|Overall Study|Adverse Event|9|||
13333022|NCT01095796|26603718|FG001|Overall Study|Adverse Event|19|||
13333023|NCT01095796|26603717|FG000|Overall Study|Death|3|||
13333024|NCT01095796|26603718|FG001|Overall Study|Death|2|||
13333025|NCT01095796|26603717|FG000|Overall Study|Pregnancy|2|||
13333026|NCT01095796|26603718|FG001|Overall Study|Pregnancy|0|||
13333027|NCT01095796|26603717|FG000|Overall Study|Lack of Efficacy|5|||
13333028|NCT01095796|26603718|FG001|Overall Study|Lack of Efficacy|3|||
13333029|NCT01095796|26603717|FG000|Overall Study|Investigator's Discretion|7|||
13333030|NCT01095796|26603718|FG001|Overall Study|Investigator's Discretion|2|||
13333031|NCT01095796|26603717|FG000|Overall Study|Withdrew Consent|16|||
13333032|NCT01095796|26603718|FG001|Overall Study|Withdrew Consent|22|||
13333033|NCT01095796|26603717|FG000|Overall Study|Lost to Follow-up|27|||
13333034|NCT01095796|26603718|FG001|Overall Study|Lost to Follow-up|29|||
13333035|NCT01095796|26603717|FG000|Overall Study|Participant Noncompliance|5|||
13333036|NCT01095796|26603718|FG001|Overall Study|Participant Noncompliance|10|||
13333037|NCT01095796|26603717|FG000|Overall Study|Protocol Violation|1|||
13333038|NCT01095796|26603718|FG001|Overall Study|Protocol Violation|0|||
13333039|NCT01095796|26603717|FG000|Overall Study|Participant Transferred to Another Study|215|||
13333040|NCT01095796|26603718|FG001|Overall Study|Participant Transferred to Another Study|200|||
13333041|NCT01095666|26603748|FG000|Overall Study|Lack of Efficacy|0|||
13333042|NCT01095666|26603749|FG001|Overall Study|Lack of Efficacy|0|||
13333043|NCT01095666|26603750|FG002|Overall Study|Lack of Efficacy|1|||
13333044|NCT01095666|26603748|FG000|Overall Study|Adverse Event|2|||
13333045|NCT01095666|26603749|FG001|Overall Study|Adverse Event|1|||
13333046|NCT01095666|26603750|FG002|Overall Study|Adverse Event|3|||
13333047|NCT01095666|26603748|FG000|Overall Study|Lost to Follow-up|2|||
13333048|NCT01095666|26603749|FG001|Overall Study|Lost to Follow-up|2|||
13333049|NCT01095666|26603750|FG002|Overall Study|Lost to Follow-up|0|||
13333050|NCT01095666|26603748|FG000|Overall Study|Withdrawal by Subject|6|||
13333051|NCT01095666|26603749|FG001|Overall Study|Withdrawal by Subject|6|||
13333052|NCT01095666|26603750|FG002|Overall Study|Withdrawal by Subject|1|||
13333053|NCT01095666|26603748|FG000|Overall Study|Non-compliance, not met criteria etc.|7|||
13333054|NCT01095666|26603749|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
13333055|NCT01095666|26603750|FG002|Overall Study|Non-compliance, not met criteria etc.|2|||
13333056|NCT01095653|26603780|FG000|Overall Study|Lack of Efficacy|3|||
13333057|NCT01095653|26603781|FG001|Overall Study|Lack of Efficacy|0|||
13333058|NCT01095653|26603782|FG002|Overall Study|Lack of Efficacy|0|||
13333059|NCT01095653|26603780|FG000|Overall Study|Adverse Event|1|||
13333060|NCT01095653|26603781|FG001|Overall Study|Adverse Event|4|||
13333061|NCT01095653|26603782|FG002|Overall Study|Adverse Event|4|||
13333062|NCT01095653|26603780|FG000|Overall Study|Lost to Follow-up|1|||
13333063|NCT01095653|26603781|FG001|Overall Study|Lost to Follow-up|0|||
13333064|NCT01095653|26603782|FG002|Overall Study|Lost to Follow-up|4|||
13123091|NCT02958865|25949209|FG014|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
13123092|NCT02958865|25949210|FG015|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
13123093|NCT02958865|25949195|FG000|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|2|||
13123094|NCT02958865|25949196|FG001|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
13123095|NCT02958865|25949197|FG002|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|3|||
13123096|NCT02958865|25949198|FG003|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
13123097|NCT02958865|25949199|FG004|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
13123098|NCT02958865|25949200|FG005|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
13123099|NCT02958865|25949201|FG006|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
13123100|NCT02958865|25949202|FG007|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
13123101|NCT02958865|25949203|FG008|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
13123102|NCT02958865|25949204|FG009|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
13123103|NCT02958865|25949205|FG010|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
13333065|NCT01095653|26603780|FG000|Overall Study|Withdrawal by Subject|4|||
13333066|NCT01095653|26603781|FG001|Overall Study|Withdrawal by Subject|5|||
13333067|NCT01095653|26603782|FG002|Overall Study|Withdrawal by Subject|3|||
13333068|NCT01095653|26603780|FG000|Overall Study|non-compliance, not met criteria, etc.|10|||
13333069|NCT01095653|26603781|FG001|Overall Study|non-compliance, not met criteria, etc.|6|||
13333070|NCT01095653|26603782|FG002|Overall Study|non-compliance, not met criteria, etc.|5|||
13333071|NCT01095250|26603825|FG000|Overall Study|administrative reasons|8|||
13123104|NCT02958865|25949206|FG011|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
13123105|NCT02958865|25949207|FG012|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
13123106|NCT02958865|25949208|FG013|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
13123107|NCT02958865|25949209|FG014|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
13123108|NCT02958865|25949210|FG015|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
13123109|NCT02958865|25949195|FG000|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
13123110|NCT02958865|25949196|FG001|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
13123111|NCT02958865|25949197|FG002|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
13123112|NCT02958865|25949198|FG003|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
13123113|NCT02958865|25949199|FG004|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
13123114|NCT02958865|25949200|FG005|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
13333072|NCT01095250|26603826|FG001|Overall Study|administrative reasons|10|||
13333073|NCT01095250|26603827|FG002|Overall Study|administrative reasons|7|||
13333074|NCT01095250|26603828|FG003|Overall Study|administrative reasons|5|||
13333075|NCT01095250|26603825|FG000|Overall Study|Withdrawal by Subject|0|||
13333076|NCT01095250|26603826|FG001|Overall Study|Withdrawal by Subject|0|||
13333077|NCT01095250|26603827|FG002|Overall Study|Withdrawal by Subject|1|||
13333078|NCT01095250|26603828|FG003|Overall Study|Withdrawal by Subject|0|||
13333079|NCT01095094|26603835|FG000|Overall Study|Withdrawal by Subject|1|||
13333080|NCT01095094|26603835|FG000|Overall Study|Death|1|||
13333081|NCT01095094|26603835|FG000|Overall Study|Physician Decision|1|||
13333082|NCT01094886|26603844|FG000|Overall Study|Adverse Event|2|||
13333083|NCT01094886|26603844|FG000|Overall Study|Withdrawal by Subject|5|||
13333084|NCT01094808|26603889|FG000|Overall Study|Withdrawal by Subject|1|||
13333085|NCT01094808|26603890|FG001|Overall Study|Withdrawal by Subject|1|||
13333086|NCT01094808|26603891|FG002|Overall Study|Withdrawal by Subject|0|||
13333087|NCT01094782|26603954|FG000|Overall Study|Withdrawal by Subject|5|||
13333088|NCT01094782|26603955|FG001|Overall Study|Withdrawal by Subject|5|||
13333089|NCT01094782|26603956|FG002|Overall Study|Withdrawal by Subject|1|||
13333090|NCT01094782|26603957|FG003|Overall Study|Withdrawal by Subject|5|||
13333091|NCT01094782|26603958|FG004|Overall Study|Withdrawal by Subject|5|||
13333092|NCT01094782|26603959|FG005|Overall Study|Withdrawal by Subject|0|||
13333093|NCT01094782|26603954|FG000|Overall Study|Lost to Follow-up|1|||
13333094|NCT01094782|26603955|FG001|Overall Study|Lost to Follow-up|0|||
13333095|NCT01094782|26603956|FG002|Overall Study|Lost to Follow-up|0|||
13333096|NCT01094782|26603957|FG003|Overall Study|Lost to Follow-up|2|||
13333097|NCT01094782|26603958|FG004|Overall Study|Lost to Follow-up|1|||
13333098|NCT01094782|26603959|FG005|Overall Study|Lost to Follow-up|4|||
13333099|NCT01094782|26603954|FG000|Overall Study|Positive Drug Screen|2|||
13333100|NCT01094782|26603955|FG001|Overall Study|Positive Drug Screen|2|||
13333101|NCT01094782|26603956|FG002|Overall Study|Positive Drug Screen|1|||
13333102|NCT01094782|26603957|FG003|Overall Study|Positive Drug Screen|1|||
13333103|NCT01094782|26603958|FG004|Overall Study|Positive Drug Screen|3|||
13333104|NCT01094782|26603959|FG005|Overall Study|Positive Drug Screen|2|||
13333105|NCT01094782|26603954|FG000|Overall Study|Sensory Deficit at Site of QST|0|||
13333106|NCT01094782|26603955|FG001|Overall Study|Sensory Deficit at Site of QST|1|||
13333107|NCT01094782|26603956|FG002|Overall Study|Sensory Deficit at Site of QST|0|||
13333108|NCT01094782|26603957|FG003|Overall Study|Sensory Deficit at Site of QST|0|||
13333109|NCT01094782|26603958|FG004|Overall Study|Sensory Deficit at Site of QST|0|||
13333110|NCT01094782|26603959|FG005|Overall Study|Sensory Deficit at Site of QST|0|||
13333111|NCT01094782|26603954|FG000|Overall Study|Unable to Complete Questionnaires|0|||
13333112|NCT01094782|26603955|FG001|Overall Study|Unable to Complete Questionnaires|1|||
13333113|NCT01094782|26603956|FG002|Overall Study|Unable to Complete Questionnaires|0|||
13333114|NCT01094782|26603957|FG003|Overall Study|Unable to Complete Questionnaires|0|||
13333115|NCT01094782|26603958|FG004|Overall Study|Unable to Complete Questionnaires|0|||
13333116|NCT01094782|26603959|FG005|Overall Study|Unable to Complete Questionnaires|0|||
13333117|NCT01094782|26603954|FG000|Overall Study|Healthy Subject Had Pain|0|||
13333118|NCT01094782|26603955|FG001|Overall Study|Healthy Subject Had Pain|1|||
13333119|NCT01094782|26603956|FG002|Overall Study|Healthy Subject Had Pain|0|||
13333120|NCT01094782|26603957|FG003|Overall Study|Healthy Subject Had Pain|0|||
13333121|NCT01094782|26603958|FG004|Overall Study|Healthy Subject Had Pain|0|||
13333122|NCT01094782|26603959|FG005|Overall Study|Healthy Subject Had Pain|0|||
13333123|NCT01094782|26603954|FG000|Overall Study|Hypertension|0|||
13333124|NCT01094782|26603955|FG001|Overall Study|Hypertension|0|||
13333125|NCT01094782|26603956|FG002|Overall Study|Hypertension|1|||
13333126|NCT01094782|26603957|FG003|Overall Study|Hypertension|0|||
13333127|NCT01094782|26603958|FG004|Overall Study|Hypertension|0|||
13333128|NCT01094782|26603959|FG005|Overall Study|Hypertension|0|||
13333129|NCT01094782|26603954|FG000|Overall Study|Wrong Pain Condition|0|||
13333130|NCT01094782|26603955|FG001|Overall Study|Wrong Pain Condition|0|||
13333131|NCT01094782|26603956|FG002|Overall Study|Wrong Pain Condition|0|||
13333132|NCT01094782|26603957|FG003|Overall Study|Wrong Pain Condition|2|||
13333133|NCT01094782|26603958|FG004|Overall Study|Wrong Pain Condition|1|||
13333134|NCT01094782|26603959|FG005|Overall Study|Wrong Pain Condition|1|||
13333135|NCT01094782|26603954|FG000|Overall Study|Recent Interventional Injection|0|||
13333136|NCT01094782|26603955|FG001|Overall Study|Recent Interventional Injection|0|||
13333137|NCT01094782|26603956|FG002|Overall Study|Recent Interventional Injection|0|||
13333138|NCT01094782|26603957|FG003|Overall Study|Recent Interventional Injection|0|||
13333139|NCT01094782|26603958|FG004|Overall Study|Recent Interventional Injection|0|||
13333140|NCT01094782|26603959|FG005|Overall Study|Recent Interventional Injection|1|||
13333141|NCT01094782|26603954|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
13333142|NCT01094782|26603955|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
13333143|NCT01094782|26603956|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
13333144|NCT01094782|26603957|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
13333145|NCT01094782|26603958|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1|||
13333146|NCT01094782|26603959|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
13333147|NCT01094782|26603954|FG000|Overall Study|Noncompliance With Study Schedule|0|||
13333148|NCT01094782|26603955|FG001|Overall Study|Noncompliance With Study Schedule|0|||
13333149|NCT01094782|26603956|FG002|Overall Study|Noncompliance With Study Schedule|0|||
13333150|NCT01094782|26603957|FG003|Overall Study|Noncompliance With Study Schedule|1|||
13333151|NCT01094782|26603958|FG004|Overall Study|Noncompliance With Study Schedule|0|||
13333152|NCT01094782|26603959|FG005|Overall Study|Noncompliance With Study Schedule|0|||
13333153|NCT01094743|26603978|FG000|Period 1|Unsatisfactory comfort at lens fitting|2|||
13333154|NCT01094730|26603992|FG000|Period 1 (14 Days)|Lost to Follow-up|0|||
13333155|NCT01094730|26603993|FG001|Period 1 (14 Days)|Lost to Follow-up|1|||
13333156|NCT01094730|26603992|FG000|Period 1 (14 Days)|Withdrawal by Subject|0|||
13333157|NCT01094730|26603993|FG001|Period 1 (14 Days)|Withdrawal by Subject|1|||
13333158|NCT01094730|26603992|FG000|Period 1 (14 Days)|No time for the follow-up visit|1|||
13333159|NCT01094730|26603993|FG001|Period 1 (14 Days)|No time for the follow-up visit|0|||
13333160|NCT01094730|26603992|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1|||
13333161|NCT01094730|26603993|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0|||
13333162|NCT01094730|26603992|FG000|Period 2 (14 Days)|Protocol Violation|2|||
13333163|NCT01094730|26603993|FG001|Period 2 (14 Days)|Protocol Violation|0|||
13333164|NCT01094730|26603992|FG000|Period 2 (14 Days)|No time for the follow-up visit|1|||
13333165|NCT01094730|26603993|FG001|Period 2 (14 Days)|No time for the follow-up visit|0|||
13333166|NCT01094730|26603992|FG000|Period 2 (14 Days)|Adverse Event|0|||
13333167|NCT01094730|26603993|FG001|Period 2 (14 Days)|Adverse Event|1|||
13333168|NCT01094730|26603992|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0|||
13333169|NCT01094730|26603993|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1|||
13333170|NCT01094301|26604017|FG000|Trial Stage|Withdrawal by Subject|1|||
13333171|NCT01094301|26604017|FG000|Implant Stage|Adverse Event|1|||
13333172|NCT01094301|26604017|FG000|Implant Stage|Protocol Violation|1|||
13333173|NCT01094301|26604017|FG000|Implant Stage|Withdrawal by Subject|2|||
13333174|NCT01094301|26604017|FG000|Implant Stage|No return of pain|4|||
13333175|NCT01094288|26604152|FG000|Overall Study|Adverse Event|0|||
13333176|NCT01094288|26604153|FG001|Overall Study|Adverse Event|3|||
13333177|NCT01094288|26604154|FG002|Overall Study|Adverse Event|1|||
13333178|NCT01094288|26604155|FG003|Overall Study|Adverse Event|1|||
13333179|NCT01094288|26604156|FG004|Overall Study|Adverse Event|0|||
13333180|NCT01094288|26604157|FG005|Overall Study|Adverse Event|0|||
13333181|NCT01094288|26604158|FG006|Overall Study|Adverse Event|0|||
13333182|NCT01094288|26604159|FG007|Overall Study|Adverse Event|0|||
13333183|NCT01094288|26604152|FG000|Overall Study|Withdrawal by Subject|0|||
13333184|NCT01094288|26604153|FG001|Overall Study|Withdrawal by Subject|1|||
13333185|NCT01094288|26604154|FG002|Overall Study|Withdrawal by Subject|2|||
13333186|NCT01094288|26604155|FG003|Overall Study|Withdrawal by Subject|0|||
13333187|NCT01094288|26604156|FG004|Overall Study|Withdrawal by Subject|0|||
13333188|NCT01094288|26604157|FG005|Overall Study|Withdrawal by Subject|0|||
13333189|NCT01094288|26604158|FG006|Overall Study|Withdrawal by Subject|0|||
13333190|NCT01094288|26604159|FG007|Overall Study|Withdrawal by Subject|2|||
13333191|NCT01094288|26604152|FG000|Overall Study|Initiation of Alternative Therapy|0|||
13333192|NCT01094288|26604153|FG001|Overall Study|Initiation of Alternative Therapy|0|||
13333193|NCT01094288|26604154|FG002|Overall Study|Initiation of Alternative Therapy|1|||
13123115|NCT02958865|25949201|FG006|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
13333194|NCT01094288|26604155|FG003|Overall Study|Initiation of Alternative Therapy|0|||
13333195|NCT01094288|26604156|FG004|Overall Study|Initiation of Alternative Therapy|0|||
13333196|NCT01094288|26604157|FG005|Overall Study|Initiation of Alternative Therapy|0|||
13333197|NCT01094288|26604158|FG006|Overall Study|Initiation of Alternative Therapy|0|||
13333198|NCT01094288|26604159|FG007|Overall Study|Initiation of Alternative Therapy|0|||
13333199|NCT01094288|26604152|FG000|Overall Study|Reason not Specified|2|||
13333200|NCT01094288|26604153|FG001|Overall Study|Reason not Specified|3|||
13123116|NCT02958865|25949202|FG007|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
13123117|NCT02958865|25949203|FG008|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
13289161|NCT01081301|26477502|FG000|Overall Study|Lost to Follow-up|4|||
13289162|NCT01081249|26477511|FG000|Overall Study|Diagnosed with Bipolar Disorder|0|||
13289163|NCT01081249|26477512|FG001|Overall Study|Diagnosed with Bipolar Disorder|1|||
13289164|NCT01081145|26477541|FG000|Open-Label Phase|Lack of Efficacy|56|||
13289165|NCT01081145|26477542|FG001|Open-Label Phase|Lack of Efficacy|0|||
13289166|NCT01081145|26477541|FG000|Open-Label Phase|Response criteria not met|46|||
13289167|NCT01081145|26477542|FG001|Open-Label Phase|Response criteria not met|0|||
13289168|NCT01081145|26477541|FG000|Open-Label Phase|Adverse Event|42|||
13289169|NCT01081145|26477542|FG001|Open-Label Phase|Adverse Event|0|||
13289170|NCT01081145|26477541|FG000|Open-Label Phase|Withdrawal by Subject|41|||
13289171|NCT01081145|26477542|FG001|Open-Label Phase|Withdrawal by Subject|0|||
13289172|NCT01081145|26477541|FG000|Open-Label Phase|Other|12|||
13289173|NCT01081145|26477542|FG001|Open-Label Phase|Other|0|||
13289174|NCT01081145|26477541|FG000|Open-Label Phase|Lost to Follow-up|11|||
13289175|NCT01081145|26477542|FG001|Open-Label Phase|Lost to Follow-up|0|||
13289176|NCT01081145|26477541|FG000|Open-Label Phase|Protocol Violation|4|||
13289177|NCT01081145|26477542|FG001|Open-Label Phase|Protocol Violation|0|||
13289178|NCT01081145|26477541|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3|||
13289179|NCT01081145|26477542|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2|||
13289180|NCT01081145|26477541|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1|||
13289181|NCT01081145|26477542|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0|||
13289182|NCT01081145|26477541|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10|||
13289183|NCT01081145|26477542|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8|||
13289184|NCT01081145|26477541|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3|||
13333201|NCT01094288|26604154|FG002|Overall Study|Reason not Specified|0|||
13333202|NCT01094288|26604155|FG003|Overall Study|Reason not Specified|1|||
13333203|NCT01094288|26604156|FG004|Overall Study|Reason not Specified|0|||
13333204|NCT01094288|26604157|FG005|Overall Study|Reason not Specified|0|||
13333205|NCT01094288|26604158|FG006|Overall Study|Reason not Specified|0|||
13333206|NCT01094288|26604159|FG007|Overall Study|Reason not Specified|0|||
13333207|NCT01094288|26604152|FG000|Overall Study|Ongoing Participants|0|||
13333208|NCT01094288|26604153|FG001|Overall Study|Ongoing Participants|3|||
13333209|NCT01094288|26604154|FG002|Overall Study|Ongoing Participants|0|||
13333210|NCT01094288|26604155|FG003|Overall Study|Ongoing Participants|0|||
13333211|NCT01094288|26604156|FG004|Overall Study|Ongoing Participants|0|||
13333212|NCT01094288|26604157|FG005|Overall Study|Ongoing Participants|0|||
13333213|NCT01094288|26604158|FG006|Overall Study|Ongoing Participants|0|||
13333214|NCT01094288|26604159|FG007|Overall Study|Ongoing Participants|0|||
13333215|NCT01094184|26604400|FG000|Overall Study|Death|35|||
13333216|NCT01094184|26604401|FG001|Overall Study|Death|11|||
13333217|NCT01094171|26604410|FG000|Overall Study|Lost to Follow-up|2|||
13333218|NCT01094171|26604410|FG000|Overall Study|Informed consent withdrawal|4|||
13333219|NCT01094171|26604410|FG000|Overall Study|Migration from the study area|3|||
13333220|NCT01094171|26604410|FG000|Overall Study|Other|1|||
13333221|NCT01094119|26604425|FG000|Overall Study|Lack of Efficacy|2|||
13333222|NCT01094119|26604426|FG001|Overall Study|Lack of Efficacy|4|||
13333223|NCT01093885|26604433|FG000|Overall Study|Adverse Event|4|||
13333224|NCT01093885|26604433|FG000|Overall Study|Lost to Follow-up|1|||
13333225|NCT01093846|26604449|FG000|Overall Study|Adverse Event|0|||
13333226|NCT01093846|26604450|FG001|Overall Study|Adverse Event|0|||
13333227|NCT01093846|26604451|FG002|Overall Study|Adverse Event|1|||
13333228|NCT01093846|26604449|FG000|Overall Study|Lack of Efficacy|0|||
13333229|NCT01093846|26604450|FG001|Overall Study|Lack of Efficacy|0|||
13333230|NCT01093846|26604451|FG002|Overall Study|Lack of Efficacy|4|||
13333231|NCT01093846|26604449|FG000|Overall Study|Condition no longer required study drug|1|||
13333232|NCT01093846|26604450|FG001|Overall Study|Condition no longer required study drug|1|||
13333233|NCT01093846|26604451|FG002|Overall Study|Condition no longer required study drug|1|||
13333234|NCT01093846|26604449|FG000|Overall Study|Administrative Problems|18|||
13333235|NCT01093846|26604450|FG001|Overall Study|Administrative Problems|17|||
13333236|NCT01093846|26604451|FG002|Overall Study|Administrative Problems|15|||
13333237|NCT01093755|26604466|FG000|Overall Study|Withdrawal by Subject|3|||
13333238|NCT01093755|26604467|FG001|Overall Study|Withdrawal by Subject|4|||
13333239|NCT01093625|26604492|FG000|Baseline and Dispensed|Withdrawal by Subject|2|||
13333240|NCT01093625|26604493|FG001|Baseline and Dispensed|Withdrawal by Subject|0|||
13333241|NCT01093625|26604492|FG000|2-Week Visit|Withdrawal by Subject|1|||
13333242|NCT01093625|26604493|FG001|2-Week Visit|Withdrawal by Subject|0|||
13333243|NCT01093625|26604492|FG000|1-Month Visit|Lost to Follow-up|2|||
13333244|NCT01093625|26604493|FG001|1-Month Visit|Lost to Follow-up|0|||
13333245|NCT01093625|26604492|FG000|3-Month Visit|Lost to Follow-up|2|||
13333246|NCT01093625|26604493|FG001|3-Month Visit|Lost to Follow-up|0|||
13333247|NCT01093625|26604492|FG000|6-Month Visit|Withdrawal by Subject|6|||
13333248|NCT01093625|26604493|FG001|6-Month Visit|Withdrawal by Subject|7|||
13333249|NCT01093625|26604492|FG000|6-Month Visit|Lost to Follow-up|2|||
13333250|NCT01093625|26604493|FG001|6-Month Visit|Lost to Follow-up|2|||
13333251|NCT01093625|26604492|FG000|1-Year Visit|Lost to Follow-up|5|||
13333252|NCT01093625|26604493|FG001|1-Year Visit|Lost to Follow-up|3|||
13333253|NCT01093599|26604506|FG000|Overall Study|Lost to Follow-up|32|||
13333254|NCT01093599|26604507|FG001|Overall Study|Lost to Follow-up|46|||
13333255|NCT01093586|26604527|FG000|Overall Study|Failed to engraft|3|||
13333256|NCT01093534|26604642|FG000|Overall Study|Adverse Event|2|||
13333257|NCT01093534|26604643|FG001|Overall Study|Adverse Event|5|||
13333258|NCT01093534|26604644|FG002|Overall Study|Adverse Event|2|||
13333259|NCT01093534|26604642|FG000|Overall Study|Lack of Efficacy|2|||
13333260|NCT01093534|26604643|FG001|Overall Study|Lack of Efficacy|1|||
13333261|NCT01093534|26604644|FG002|Overall Study|Lack of Efficacy|1|||
13333262|NCT01093534|26604642|FG000|Overall Study|Withdrawal by Subject|5|||
13333263|NCT01093534|26604643|FG001|Overall Study|Withdrawal by Subject|7|||
13333264|NCT01093534|26604644|FG002|Overall Study|Withdrawal by Subject|2|||
13333265|NCT01093534|26604642|FG000|Overall Study|Other|1|||
13333266|NCT01093534|26604643|FG001|Overall Study|Other|3|||
13333267|NCT01093534|26604644|FG002|Overall Study|Other|4|||
13333268|NCT01093222|26604653|FG000|Overall Study|Ineligible|6|||
13333269|NCT01093222|26604653|FG000|Overall Study|Adverse Event|7|||
13333270|NCT01093222|26604653|FG000|Overall Study|Progression/relapse|24|||
13333271|NCT01093222|26604653|FG000|Overall Study|Death|2|||
13333272|NCT01093222|26604653|FG000|Overall Study|Not protocol specified|1|||
13333273|NCT01092832|26604672|FG000|Overall Study|Other|1|||
13333274|NCT01092832|26604673|FG001|Overall Study|Other|0|||
13373857|NCT00799266|26725131|FG000|Overall Study|Subject withdrew consent|3|||
13373858|NCT00799266|26725132|FG001|Overall Study|Subject withdrew consent|0|||
13373859|NCT00799058|26725168|FG000|Overall Study|Withdrawal by Subject|2|||
13373860|NCT00799058|26725169|FG001|Overall Study|Withdrawal by Subject|2|||
13333275|NCT01092780|26604708|FG000|Washout Period 1|Adverse Event|0|||
13333276|NCT01092780|26604709|FG001|Washout Period 1|Adverse Event|1|||
13333277|NCT01092780|26604710|FG002|Washout Period 1|Adverse Event|0|||
13333278|NCT01092780|26604711|FG003|Washout Period 1|Adverse Event|0|||
13333279|NCT01092780|26604708|FG000|Washout Period 1|Noncompliance with nCPAP|1|||
13333280|NCT01092780|26604709|FG001|Washout Period 1|Noncompliance with nCPAP|0|||
13333281|NCT01092780|26604710|FG002|Washout Period 1|Noncompliance with nCPAP|0|||
13333282|NCT01092780|26604711|FG003|Washout Period 1|Noncompliance with nCPAP|0|||
13333283|NCT01092780|26604708|FG000|Washout Period 2|Adverse Event|0|||
13333284|NCT01092780|26604709|FG001|Washout Period 2|Adverse Event|1|||
13333285|NCT01092780|26604710|FG002|Washout Period 2|Adverse Event|1|||
13333286|NCT01092780|26604711|FG003|Washout Period 2|Adverse Event|0|||
13333287|NCT01092728|26604726|FG000|Overall Study|Withdrawal by Subject|2|||
13333288|NCT01092728|26604727|FG001|Overall Study|Withdrawal by Subject|0|||
13333289|NCT01092728|26604726|FG000|Overall Study|Adverse Event|0|||
13333290|NCT01092728|26604727|FG001|Overall Study|Adverse Event|1|||
13333291|NCT01092728|26604726|FG000|Overall Study|Disease Progression|1|||
13333292|NCT01092728|26604727|FG001|Overall Study|Disease Progression|13|||
13123118|NCT02958865|25949204|FG009|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
13123119|NCT02958865|25949205|FG010|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
13123120|NCT02958865|25949206|FG011|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
13123121|NCT02958865|25949207|FG012|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
13123122|NCT02958865|25949208|FG013|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
13123123|NCT02958865|25949209|FG014|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
13123124|NCT02958865|25949210|FG015|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
13123125|NCT02958865|25949195|FG000|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
13123126|NCT02958865|25949196|FG001|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
13123127|NCT02958865|25949197|FG002|Induction Period (Day 1 to Week 8)|Protocol Violation|1|||
13123128|NCT02958865|25949198|FG003|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
13123129|NCT02958865|25949199|FG004|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
13123130|NCT02958865|25949200|FG005|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
13123131|NCT02958865|25949201|FG006|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
13123132|NCT02958865|25949202|FG007|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
13123133|NCT02958865|25949203|FG008|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
13123134|NCT02958865|25949204|FG009|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
13123135|NCT02958865|25949205|FG010|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
13123136|NCT02958865|25949206|FG011|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
13123137|NCT02958865|25949207|FG012|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
13123138|NCT02958865|25949208|FG013|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
13123139|NCT02958865|25949209|FG014|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
13123140|NCT02958865|25949210|FG015|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
13123141|NCT02958865|25949195|FG000|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
13333293|NCT01092728|26604726|FG000|Overall Study|Prohibited Concomitant Medications|1|||
13333294|NCT01092728|26604727|FG001|Overall Study|Prohibited Concomitant Medications|0|||
13333295|NCT01092702|26604733|FG000|Overall Study|Withdrawal by Subject|7|||
13333296|NCT01092702|26604733|FG000|Overall Study|Lost to Follow-up|2|||
13333297|NCT01096550|26604746|FG000|Overall Study|discontinued site|10|||
13123142|NCT02958865|25949196|FG001|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
13123143|NCT02958865|25949197|FG002|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
13123144|NCT02958865|25949198|FG003|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
13123145|NCT02958865|25949199|FG004|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
13123146|NCT02958865|25949200|FG005|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
13123147|NCT02958865|25949201|FG006|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
13123148|NCT02958865|25949202|FG007|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
13123149|NCT02958865|25949203|FG008|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
13123150|NCT02958865|25949204|FG009|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
13123151|NCT02958865|25949205|FG010|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
13123152|NCT02958865|25949206|FG011|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
13123153|NCT02958865|25949207|FG012|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
13123154|NCT02958865|25949208|FG013|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
13123155|NCT02958865|25949209|FG014|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
13123156|NCT02958865|25949210|FG015|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
13123157|NCT02958865|25949195|FG000|Induction Period (Day 1 to Week 8)|Other|0|||
13123158|NCT02958865|25949196|FG001|Induction Period (Day 1 to Week 8)|Other|0|||
13123159|NCT02958865|25949197|FG002|Induction Period (Day 1 to Week 8)|Other|1|||
13123160|NCT02958865|25949198|FG003|Induction Period (Day 1 to Week 8)|Other|2|||
13123161|NCT02958865|25949199|FG004|Induction Period (Day 1 to Week 8)|Other|0|||
13333298|NCT01096550|26604747|FG001|Overall Study|discontinued site|11|||
13333299|NCT01096550|26604746|FG000|Overall Study|non-regular treatment track at clinic|1|||
13123162|NCT02958865|25949200|FG005|Induction Period (Day 1 to Week 8)|Other|1|||
13123163|NCT02958865|25949201|FG006|Induction Period (Day 1 to Week 8)|Other|0|||
13123164|NCT02958865|25949202|FG007|Induction Period (Day 1 to Week 8)|Other|0|||
13123165|NCT02958865|25949203|FG008|Induction Period (Day 1 to Week 8)|Other|0|||
13123166|NCT02958865|25949204|FG009|Induction Period (Day 1 to Week 8)|Other|0|||
13123167|NCT02958865|25949205|FG010|Induction Period (Day 1 to Week 8)|Other|0|||
13123168|NCT02958865|25949206|FG011|Induction Period (Day 1 to Week 8)|Other|0|||
13123169|NCT02958865|25949207|FG012|Induction Period (Day 1 to Week 8)|Other|0|||
13123170|NCT02958865|25949208|FG013|Induction Period (Day 1 to Week 8)|Other|0|||
13123171|NCT02958865|25949209|FG014|Induction Period (Day 1 to Week 8)|Other|0|||
13123172|NCT02958865|25949210|FG015|Induction Period (Day 1 to Week 8)|Other|0|||
13123173|NCT02958865|25949195|FG000|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
13123174|NCT02958865|25949196|FG001|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
13123175|NCT02958865|25949197|FG002|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
13123176|NCT02958865|25949198|FG003|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
13123177|NCT02958865|25949199|FG004|Induction Period (Day 1 to Week 8)|Lost to Follow-up|1|||
13123178|NCT02958865|25949200|FG005|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
13123179|NCT02958865|25949201|FG006|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
13123180|NCT02958865|25949202|FG007|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
13123181|NCT02958865|25949203|FG008|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
13123182|NCT02958865|25949204|FG009|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
13123183|NCT02958865|25949205|FG010|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
13123184|NCT02958865|25949206|FG011|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
13123185|NCT02958865|25949207|FG012|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
13123186|NCT02958865|25949208|FG013|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
13123187|NCT02958865|25949209|FG014|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
13123188|NCT02958865|25949210|FG015|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
13123189|NCT02958865|25949195|FG000|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
13123190|NCT02958865|25949196|FG001|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
13333300|NCT01096550|26604747|FG001|Overall Study|non-regular treatment track at clinic|1|||
13333301|NCT01096550|26604746|FG000|Overall Study|clinic readmission|1|||
13333302|NCT01096550|26604747|FG001|Overall Study|clinic readmission|1|||
13333303|NCT01096550|26604746|FG000|Overall Study|Withdrawal by Subject|0|||
13333304|NCT01096550|26604747|FG001|Overall Study|Withdrawal by Subject|1|||
13333305|NCT01096550|26604746|FG000|Overall Study|non-African American participant|13|||
13333306|NCT01096550|26604747|FG001|Overall Study|non-African American participant|6|||
13333307|NCT01096550|26604746|FG000|Overall Study|Lost to Follow-up|12|||
13333308|NCT01096550|26604747|FG001|Overall Study|Lost to Follow-up|9|||
13333309|NCT01092663|26604800|FG000|Overall Study|Withdrawal by Subject|3|||
13333310|NCT01092663|26604801|FG001|Overall Study|Withdrawal by Subject|2|||
13333311|NCT01092663|26604800|FG000|Overall Study|Glucose >300mg/dL|1|||
13333312|NCT01092663|26604801|FG001|Overall Study|Glucose >300mg/dL|0|||
13333313|NCT01092663|26604800|FG000|Overall Study|High fasting triglyceride|2|||
13333314|NCT01092663|26604801|FG001|Overall Study|High fasting triglyceride|0|||
13333315|NCT01092663|26604800|FG000|Overall Study|Adverse Event|1|||
13333316|NCT01092663|26604801|FG001|Overall Study|Adverse Event|1|||
13333317|NCT01092663|26604800|FG000|Overall Study|Protocol Violation|0|||
13333318|NCT01092663|26604801|FG001|Overall Study|Protocol Violation|1|||
13333319|NCT01092637|26604818|FG000|Overall Study|Death|47|||
13123191|NCT02958865|25949197|FG002|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
13123192|NCT02958865|25949198|FG003|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
13123193|NCT02958865|25949199|FG004|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
13123194|NCT02958865|25949200|FG005|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
13123195|NCT02958865|25949201|FG006|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
13123196|NCT02958865|25949202|FG007|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
13123197|NCT02958865|25949203|FG008|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
13123198|NCT02958865|25949204|FG009|Chronic Period (Week 8 to Week 32)|Adverse Event|2|||
13123199|NCT02958865|25949205|FG010|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
13123200|NCT02958865|25949206|FG011|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
13123201|NCT02958865|25949207|FG012|Chronic Period (Week 8 to Week 32)|Adverse Event|4|||
13123202|NCT02958865|25949208|FG013|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
13123203|NCT02958865|25949209|FG014|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
13123204|NCT02958865|25949210|FG015|Chronic Period (Week 8 to Week 32)|Adverse Event|5|||
13123205|NCT02958865|25949195|FG000|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
13123206|NCT02958865|25949196|FG001|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
13123207|NCT02958865|25949197|FG002|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
13123208|NCT02958865|25949198|FG003|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
13123209|NCT02958865|25949199|FG004|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
13123210|NCT02958865|25949200|FG005|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
13333320|NCT01092637|26604819|FG001|Overall Study|Death|49|||
13486407|NCT03564145|27036051|FG000|Overall Study|Study Terminated by Sponsor|146|||
13486408|NCT03564145|27036051|FG000|Overall Study|Physician Decision|1|||
13123211|NCT02958865|25949201|FG006|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
13123212|NCT02958865|25949202|FG007|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
13123213|NCT02958865|25949203|FG008|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
13123214|NCT02958865|25949204|FG009|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|1|||
13123215|NCT02958865|25949205|FG010|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
13123216|NCT02958865|25949206|FG011|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|5|||
13123217|NCT02958865|25949207|FG012|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
13123218|NCT02958865|25949208|FG013|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
13123219|NCT02958865|25949209|FG014|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
13123220|NCT02958865|25949210|FG015|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|8|||
13123221|NCT02958865|25949195|FG000|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
13123222|NCT02958865|25949196|FG001|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
13123223|NCT02958865|25949197|FG002|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
13123224|NCT02958865|25949198|FG003|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
13123225|NCT02958865|25949199|FG004|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
13123226|NCT02958865|25949200|FG005|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
13123227|NCT02958865|25949201|FG006|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
13123228|NCT02958865|25949202|FG007|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
13123229|NCT02958865|25949203|FG008|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
13123230|NCT02958865|25949204|FG009|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
13123231|NCT02958865|25949205|FG010|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
13123232|NCT02958865|25949206|FG011|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
13123233|NCT02958865|25949207|FG012|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
13123234|NCT02958865|25949208|FG013|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
13123235|NCT02958865|25949209|FG014|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
13123236|NCT02958865|25949210|FG015|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
13123237|NCT02958865|25949195|FG000|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
13123238|NCT02958865|25949196|FG001|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
13123239|NCT02958865|25949197|FG002|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
13123240|NCT02958865|25949198|FG003|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
13123241|NCT02958865|25949199|FG004|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
13123242|NCT02958865|25949200|FG005|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
13123243|NCT02958865|25949201|FG006|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
13123244|NCT02958865|25949202|FG007|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
13123245|NCT02958865|25949203|FG008|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
13123246|NCT02958865|25949204|FG009|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
13123247|NCT02958865|25949205|FG010|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
13123248|NCT02958865|25949206|FG011|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|1|||
13123249|NCT02958865|25949207|FG012|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|6|||
13123250|NCT02958865|25949208|FG013|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
13123251|NCT02958865|25949209|FG014|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
13123252|NCT02958865|25949210|FG015|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|2|||
13123253|NCT02958865|25949195|FG000|Chronic Period (Week 8 to Week 32)|Other|0|||
13123254|NCT02958865|25949196|FG001|Chronic Period (Week 8 to Week 32)|Other|0|||
13123255|NCT02958865|25949197|FG002|Chronic Period (Week 8 to Week 32)|Other|0|||
13123256|NCT02958865|25949198|FG003|Chronic Period (Week 8 to Week 32)|Other|0|||
13123257|NCT02958865|25949199|FG004|Chronic Period (Week 8 to Week 32)|Other|0|||
13123258|NCT02958865|25949200|FG005|Chronic Period (Week 8 to Week 32)|Other|0|||
13333321|NCT01092546|26604826|FG000|Overall Study|Subjects withdrawn prior to dosing|4|||
13333322|NCT01092507|26604851|FG000|Overall Study|Withdrawal by Subject|2|||
13333323|NCT01092507|26604852|FG001|Overall Study|Withdrawal by Subject|0|||
13333324|NCT01092416|26604863|FG000|Enrollment|Atherectomy device not inserted|3|||
13333325|NCT01092416|26604863|FG000|30-Day Follow-up|Death|2|||
13333326|NCT01092416|26604863|FG000|30-Day Follow-up|Missed 30-day follow-up|3|||
13333327|NCT01092416|26604863|FG000|30-Day Follow-up|Data collected after close of 30D window|5|||
13333328|NCT01092416|26604863|FG000|12-Month Follow-up|Death|16|||
13333329|NCT01092416|26604863|FG000|12-Month Follow-up|Lost to Follow-up|4|||
13333330|NCT01092416|26604863|FG000|12-Month Follow-up|Withdrawal by Subject|2|||
13333331|NCT01092416|26604863|FG000|12-Month Follow-up|Missed 1-year follow-up|1|||
13333332|NCT01092416|26604863|FG000|12-Month Follow-up|Data collected after close of 1Y window|2|||
13333333|NCT01092182|26604893|FG000|Overall Study|Death|0|||
13333334|NCT01092182|26604894|FG001|Overall Study|Death|5|||
13333335|NCT01092182|26604895|FG002|Overall Study|Death|3|||
13333336|NCT01092182|26604893|FG000|Overall Study|participant safety|1|||
13333337|NCT01092182|26604894|FG001|Overall Study|participant safety|2|||
13333338|NCT01092182|26604895|FG002|Overall Study|participant safety|0|||
13333339|NCT01092182|26604893|FG000|Overall Study|Physician Decision|0|||
13333340|NCT01092182|26604894|FG001|Overall Study|Physician Decision|6|||
13333341|NCT01092182|26604895|FG002|Overall Study|Physician Decision|0|||
13333342|NCT01092182|26604893|FG000|Overall Study|Did not meet criteria|0|||
13333343|NCT01092182|26604894|FG001|Overall Study|Did not meet criteria|0|||
13333344|NCT01092182|26604895|FG002|Overall Study|Did not meet criteria|25|||
13333345|NCT01092182|26604893|FG000|Overall Study|Non-compliance|0|||
13333346|NCT01092182|26604894|FG001|Overall Study|Non-compliance|3|||
13333347|NCT01092182|26604895|FG002|Overall Study|Non-compliance|0|||
13333348|NCT01092182|26604893|FG000|Overall Study|Participant refused follow-up|0|||
13333349|NCT01092182|26604894|FG001|Overall Study|Participant refused follow-up|2|||
13333350|NCT01092182|26604895|FG002|Overall Study|Participant refused follow-up|0|||
13333351|NCT01091974|26604922|FG000|Overall Study|Did not start intervention|3|||
13333352|NCT01091974|26604923|FG001|Overall Study|Did not start intervention|1|||
13333353|NCT01091974|26604924|FG002|Overall Study|Did not start intervention|3|||
13333354|NCT01091974|26604925|FG003|Overall Study|Did not start intervention|1|||
13333355|NCT01091974|26604922|FG000|Overall Study|resumed sleep medication|0|||
13333356|NCT01091974|26604923|FG001|Overall Study|resumed sleep medication|0|||
13333357|NCT01091974|26604924|FG002|Overall Study|resumed sleep medication|1|||
13333358|NCT01091974|26604925|FG003|Overall Study|resumed sleep medication|2|||
13333359|NCT01091974|26604922|FG000|Overall Study|Withdrawal by Subject|1|||
13333360|NCT01091974|26604923|FG001|Overall Study|Withdrawal by Subject|3|||
13333361|NCT01091974|26604924|FG002|Overall Study|Withdrawal by Subject|2|||
13333362|NCT01091974|26604925|FG003|Overall Study|Withdrawal by Subject|2|||
13333363|NCT01091974|26604922|FG000|Overall Study|side-effects|1|||
13333364|NCT01091974|26604923|FG001|Overall Study|side-effects|1|||
13333365|NCT01091974|26604924|FG002|Overall Study|side-effects|0|||
13333366|NCT01091974|26604925|FG003|Overall Study|side-effects|2|||
13333367|NCT01091675|26604931|FG000|Overall Study|Adverse Event|7|||
13333368|NCT01091675|26604931|FG000|Overall Study|Lack of Efficacy|27|||
13333369|NCT01091662|26604974|FG000|Overall Study|Adverse Event|1|||
13333370|NCT01091662|26604975|FG001|Overall Study|Adverse Event|9|||
13333371|NCT01091662|26604974|FG000|Overall Study|Physician Decision|1|||
13333372|NCT01091662|26604975|FG001|Overall Study|Physician Decision|1|||
13333373|NCT01091662|26604974|FG000|Overall Study|Withdrawal by Subject|7|||
13333374|NCT01091662|26604975|FG001|Overall Study|Withdrawal by Subject|6|||
13333375|NCT01091662|26604974|FG000|Overall Study|met exit criteria|7|||
13333376|NCT01091662|26604975|FG001|Overall Study|met exit criteria|13|||
13333377|NCT01091662|26604974|FG000|Overall Study|met exclusion criteria|1|||
13333378|NCT01091662|26604975|FG001|Overall Study|met exclusion criteria|0|||
13333379|NCT01091662|26604974|FG000|Overall Study|Lost to Follow-up|0|||
13333380|NCT01091662|26604975|FG001|Overall Study|Lost to Follow-up|1|||
13333381|NCT01091662|26604974|FG000|Overall Study|Pregnancy|0|||
13333382|NCT01091662|26604975|FG001|Overall Study|Pregnancy|1|||
13333383|NCT01091662|26604974|FG000|Overall Study|Protocol Violation|0|||
13333384|NCT01091662|26604975|FG001|Overall Study|Protocol Violation|2|||
13333385|NCT01091662|26604974|FG000|Overall Study|unable to swallow capsule|0|||
13333386|NCT01091662|26604975|FG001|Overall Study|unable to swallow capsule|1|||
13333387|NCT01091519|26604994|FG000|Overall Study|Adverse Event|12|||
13333388|NCT01091519|26604995|FG001|Overall Study|Adverse Event|16|||
13333389|NCT01091519|26604994|FG000|Overall Study|Death|1|||
13333390|NCT01091519|26604995|FG001|Overall Study|Death|0|||
13123259|NCT02958865|25949201|FG006|Chronic Period (Week 8 to Week 32)|Other|0|||
13123260|NCT02958865|25949202|FG007|Chronic Period (Week 8 to Week 32)|Other|1|||
13123261|NCT02958865|25949203|FG008|Chronic Period (Week 8 to Week 32)|Other|0|||
13123262|NCT02958865|25949204|FG009|Chronic Period (Week 8 to Week 32)|Other|1|||
13123263|NCT02958865|25949205|FG010|Chronic Period (Week 8 to Week 32)|Other|0|||
13123264|NCT02958865|25949206|FG011|Chronic Period (Week 8 to Week 32)|Other|0|||
13123265|NCT02958865|25949207|FG012|Chronic Period (Week 8 to Week 32)|Other|1|||
13123266|NCT02958865|25949208|FG013|Chronic Period (Week 8 to Week 32)|Other|0|||
13123267|NCT02958865|25949209|FG014|Chronic Period (Week 8 to Week 32)|Other|0|||
13123268|NCT02958865|25949210|FG015|Chronic Period (Week 8 to Week 32)|Other|1|||
13123269|NCT02958865|25949195|FG000|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
13123270|NCT02958865|25949196|FG001|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
13123271|NCT02958865|25949197|FG002|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
13123272|NCT02958865|25949198|FG003|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
13123273|NCT02958865|25949199|FG004|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
13123274|NCT02958865|25949200|FG005|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
13123275|NCT02958865|25949201|FG006|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
13123276|NCT02958865|25949202|FG007|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
13123277|NCT02958865|25949203|FG008|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
13123278|NCT02958865|25949204|FG009|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
13123279|NCT02958865|25949205|FG010|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
13123280|NCT02958865|25949206|FG011|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
13123281|NCT02958865|25949207|FG012|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
13123282|NCT02958865|25949208|FG013|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|1|||
13123283|NCT02958865|25949209|FG014|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
13333391|NCT01091519|26604994|FG000|Overall Study|Lack of Efficacy|16|||
13333392|NCT01091519|26604995|FG001|Overall Study|Lack of Efficacy|19|||
13123284|NCT02958865|25949210|FG015|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
13123285|NCT02958865|25949195|FG000|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
13123286|NCT02958865|25949196|FG001|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
13123287|NCT02958865|25949197|FG002|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
13123288|NCT02958865|25949198|FG003|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
13123289|NCT02958865|25949199|FG004|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
13123290|NCT02958865|25949200|FG005|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
13123291|NCT02958865|25949201|FG006|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
13123292|NCT02958865|25949202|FG007|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
13123293|NCT02958865|25949203|FG008|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
13123294|NCT02958865|25949204|FG009|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
13123295|NCT02958865|25949205|FG010|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
13123296|NCT02958865|25949206|FG011|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
13123297|NCT02958865|25949207|FG012|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
13333393|NCT01091519|26604994|FG000|Overall Study|Lost to Follow-up|14|||
13333394|NCT01091519|26604995|FG001|Overall Study|Lost to Follow-up|24|||
13123298|NCT02958865|25949208|FG013|Chronic Period (Week 8 to Week 32)|Protocol Violation|1|||
13123299|NCT02958865|25949209|FG014|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
13333395|NCT01091519|26604994|FG000|Overall Study|Withdrawal by Subject|2|||
13333396|NCT01091519|26604995|FG001|Overall Study|Withdrawal by Subject|2|||
13333397|NCT01091519|26604994|FG000|Overall Study|Other|6|||
13333398|NCT01091519|26604995|FG001|Overall Study|Other|8|||
13333399|NCT01091519|26604994|FG000|Overall Study|Randomized not treated|4|||
13333400|NCT01091519|26604995|FG001|Overall Study|Randomized not treated|4|||
13333401|NCT01091454|26605006|FG000|Overall Study|Ineligible|1|||
13333402|NCT01091428|26605120|FG000|Phase 1|Progressive Disease|24|||
13333403|NCT01091428|26605121|FG001|Phase 1|Progressive Disease|8|||
13333404|NCT01091428|26605122|FG002|Phase 1|Progressive Disease|0|||
13333405|NCT01091428|26605123|FG003|Phase 1|Progressive Disease|0|||
13333406|NCT01091428|26605120|FG000|Phase 1|Symptomatic Deterioration|3|||
13333407|NCT01091428|26605121|FG001|Phase 1|Symptomatic Deterioration|2|||
13333408|NCT01091428|26605122|FG002|Phase 1|Symptomatic Deterioration|0|||
13333409|NCT01091428|26605123|FG003|Phase 1|Symptomatic Deterioration|0|||
13333410|NCT01091428|26605120|FG000|Phase 1|Adverse Event|2|||
13333411|NCT01091428|26605121|FG001|Phase 1|Adverse Event|0|||
13333412|NCT01091428|26605122|FG002|Phase 1|Adverse Event|0|||
13333413|NCT01091428|26605123|FG003|Phase 1|Adverse Event|0|||
13333414|NCT01091428|26605120|FG000|Phase 1|Withdrawal by Subject|7|||
13123300|NCT02958865|25949210|FG015|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
13123301|NCT02958865|25949195|FG000|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
13123302|NCT02958865|25949196|FG001|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
13123303|NCT02958865|25949197|FG002|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
13123304|NCT02958865|25949198|FG003|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
13123305|NCT02958865|25949199|FG004|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
13123306|NCT02958865|25949200|FG005|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
13123307|NCT02958865|25949201|FG006|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
13123308|NCT02958865|25949202|FG007|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
13333415|NCT01091428|26605121|FG001|Phase 1|Withdrawal by Subject|0|||
13333416|NCT01091428|26605122|FG002|Phase 1|Withdrawal by Subject|0|||
13333417|NCT01091428|26605123|FG003|Phase 1|Withdrawal by Subject|0|||
13123309|NCT02958865|25949203|FG008|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
13123310|NCT02958865|25949204|FG009|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|1|||
13123311|NCT02958865|25949205|FG010|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
13123312|NCT02958865|25949206|FG011|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
13123313|NCT02958865|25949207|FG012|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
13123314|NCT02958865|25949208|FG013|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
13123315|NCT02958865|25949209|FG014|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
13123316|NCT02958865|25949210|FG015|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
13123317|NCT02958553|25949233|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1|||
13123318|NCT02958553|25949233|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2|||
13123319|NCT02958527|25949250|FG000|Overall Study|Not collected CRFs|12|||
13123320|NCT02958267|25949267|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1|||
13123321|NCT02958267|25949268|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0|||
13123322|NCT02958267|25949267|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1|||
13333418|NCT01091428|26605120|FG000|Phase 1|Reason not specified|0|||
13333419|NCT01091428|26605121|FG001|Phase 1|Reason not specified|1|||
13333420|NCT01091428|26605122|FG002|Phase 1|Reason not specified|0|||
13333421|NCT01091428|26605123|FG003|Phase 1|Reason not specified|0|||
13333422|NCT01091428|26605120|FG000|Phase 1|Single-Patient IND|2|||
13333423|NCT01091428|26605121|FG001|Phase 1|Single-Patient IND|0|||
13333424|NCT01091428|26605122|FG002|Phase 1|Single-Patient IND|0|||
13333425|NCT01091428|26605123|FG003|Phase 1|Single-Patient IND|0|||
13333426|NCT01091428|26605120|FG000|Phase 2|Progressive Disease|0|||
13333427|NCT01091428|26605121|FG001|Phase 2|Progressive Disease|0|||
13333428|NCT01091428|26605122|FG002|Phase 2|Progressive Disease|44|||
13123323|NCT02958267|25949268|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0|||
13123324|NCT02958267|25949267|FG000|Follow-up Visits|Additional treatment pursued|2|||
13123325|NCT02958267|25949268|FG001|Follow-up Visits|Additional treatment pursued|1|||
13123326|NCT02957942|25949289|FG000|Overall Study|Withdrawal by Subject|0|||
13123327|NCT02957942|25949290|FG001|Overall Study|Withdrawal by Subject|1|||
13123328|NCT02957942|25949289|FG000|Overall Study|Practicing experiment protocol|0|||
13123329|NCT02957942|25949290|FG001|Overall Study|Practicing experiment protocol|6|||
13123330|NCT02957747|25949331|FG000|Overall Study|Withdrawal by Subject|0|||
13123331|NCT02957747|25949332|FG001|Overall Study|Withdrawal by Subject|3|||
13123332|NCT02957747|25949331|FG000|Overall Study|Lost to Follow-up|10|||
13123333|NCT02957747|25949332|FG001|Overall Study|Lost to Follow-up|5|||
13123334|NCT02957682|25949369|FG000|Overall Study|Adverse Event|64|||
13123335|NCT02957682|25949370|FG001|Overall Study|Adverse Event|67|||
13333429|NCT01091428|26605123|FG003|Phase 2|Progressive Disease|46|||
13333430|NCT01091428|26605120|FG000|Phase 2|Symptomatic Deterioration|0|||
13333431|NCT01091428|26605121|FG001|Phase 2|Symptomatic Deterioration|0|||
13333432|NCT01091428|26605122|FG002|Phase 2|Symptomatic Deterioration|1|||
13333433|NCT01091428|26605123|FG003|Phase 2|Symptomatic Deterioration|6|||
13333434|NCT01091428|26605120|FG000|Phase 2|Adverse Event|0|||
13333435|NCT01091428|26605121|FG001|Phase 2|Adverse Event|0|||
13333436|NCT01091428|26605122|FG002|Phase 2|Adverse Event|12|||
13333437|NCT01091428|26605123|FG003|Phase 2|Adverse Event|5|||
13333438|NCT01091428|26605120|FG000|Phase 2|Withdrawal by Subject|0|||
13333439|NCT01091428|26605121|FG001|Phase 2|Withdrawal by Subject|0|||
13333440|NCT01091428|26605122|FG002|Phase 2|Withdrawal by Subject|9|||
13333441|NCT01091428|26605123|FG003|Phase 2|Withdrawal by Subject|8|||
13333442|NCT01091428|26605120|FG000|Phase 2|Unsatisfactory Therapeutic Response|0|||
13333443|NCT01091428|26605121|FG001|Phase 2|Unsatisfactory Therapeutic Response|0|||
13333444|NCT01091428|26605122|FG002|Phase 2|Unsatisfactory Therapeutic Response|1|||
13333445|NCT01091428|26605123|FG003|Phase 2|Unsatisfactory Therapeutic Response|1|||
13333446|NCT01091428|26605120|FG000|Phase 2|Reason not specified|0|||
13333447|NCT01091428|26605121|FG001|Phase 2|Reason not specified|0|||
13333448|NCT01091428|26605122|FG002|Phase 2|Reason not specified|4|||
13333449|NCT01091428|26605123|FG003|Phase 2|Reason not specified|3|||
13333450|NCT01091428|26605120|FG000|Phase 2|Physician Decision|0|||
13333451|NCT01091428|26605121|FG001|Phase 2|Physician Decision|0|||
13333452|NCT01091428|26605122|FG002|Phase 2|Physician Decision|2|||
13333453|NCT01091428|26605123|FG003|Phase 2|Physician Decision|0|||
13123336|NCT02957682|25949369|FG000|Overall Study|Poor Compliance to Protocol|30|||
13123337|NCT02957682|25949370|FG001|Overall Study|Poor Compliance to Protocol|26|||
13123338|NCT02957682|25949369|FG000|Overall Study|Physician Decision|4|||
13123339|NCT02957682|25949370|FG001|Overall Study|Physician Decision|4|||
13123340|NCT02957682|25949369|FG000|Overall Study|Study Terminated by Sponsor|4|||
13123341|NCT02957682|25949370|FG001|Overall Study|Study Terminated by Sponsor|3|||
13123342|NCT02957682|25949369|FG000|Overall Study|Subject Moved|10|||
13123343|NCT02957682|25949370|FG001|Overall Study|Subject Moved|16|||
13123344|NCT02957682|25949369|FG000|Overall Study|Withdrawal by Subject|64|||
13123345|NCT02957682|25949370|FG001|Overall Study|Withdrawal by Subject|33|||
13123346|NCT02957682|25949369|FG000|Overall Study|Related to IMP Administration|3|||
13123347|NCT02957682|25949370|FG001|Overall Study|Related to IMP Administration|6|||
13123348|NCT02957682|25949369|FG000|Overall Study|Non-disclosed|16|||
13123349|NCT02957682|25949370|FG001|Overall Study|Non-disclosed|12|||
13123350|NCT02957682|25949369|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3|||
13123351|NCT02957682|25949370|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2|||
13123352|NCT02957331|25949385|FG000|Overall Study|Protocol Violation|1|||
13123353|NCT02957331|25949386|FG001|Overall Study|Protocol Violation|0|||
13123354|NCT02957136|25949415|FG000|Overall Study|Withdrawal by Subject|2|||
13123355|NCT02957136|25949416|FG001|Overall Study|Withdrawal by Subject|1|||
13123356|NCT02956967|25949441|FG000|Overall Study|Adverse Event|3|||
13123357|NCT02956967|25949441|FG000|Overall Study|Reason non-related to neutropenia|10|||
13123358|NCT02956967|25949441|FG000|Overall Study|Lost to Follow-up|5|||
13123359|NCT02956967|25949441|FG000|Overall Study|Missing|1|||
13292267|NCT00706901|26485118|FG002|Overall Study|Lost to Follow-up|2|||
13292268|NCT00706901|26485116|FG000|Overall Study|Withdrawal by Subject|4|||
13292269|NCT00706901|26485117|FG001|Overall Study|Withdrawal by Subject|2|||
13292270|NCT00706901|26485118|FG002|Overall Study|Withdrawal by Subject|5|||
13292271|NCT00706901|26485116|FG000|Overall Study|In Jail|1|||
13292272|NCT00706901|26485117|FG001|Overall Study|In Jail|0|||
13292273|NCT00706901|26485118|FG002|Overall Study|In Jail|1|||
13292274|NCT00706901|26485116|FG000|Overall Study|Death|1|||
13292275|NCT00706901|26485117|FG001|Overall Study|Death|0|||
13292276|NCT00706901|26485118|FG002|Overall Study|Death|0|||
13333454|NCT01091363|26605140|FG000|Overall Study|Withdrawal by Subject|11|||
13333455|NCT01091363|26605141|FG001|Overall Study|Withdrawal by Subject|15|||
13333456|NCT01091363|26605140|FG000|Overall Study|Lost to Follow-up|2|||
13333457|NCT01091363|26605141|FG001|Overall Study|Lost to Follow-up|2|||
13333458|NCT01091259|26605151|FG000|Overall Study|Adverse Event|3|||
13333459|NCT01091259|26605151|FG000|Overall Study|Lack of Efficacy|2|||
13333460|NCT01091246|26605235|FG000|Overall Study|Lost to Follow-up|23|||
13333461|NCT01091246|26605236|FG001|Overall Study|Lost to Follow-up|11|||
13333462|NCT01091246|26605237|FG002|Overall Study|Lost to Follow-up|7|||
13333463|NCT01091246|26605235|FG000|Overall Study|Adverse Event|1|||
13333464|NCT01091246|26605236|FG001|Overall Study|Adverse Event|0|||
13333465|NCT01091246|26605237|FG002|Overall Study|Adverse Event|1|||
13333466|NCT01091246|26605235|FG000|Overall Study|Withdrawal by Subject|9|||
13333467|NCT01091246|26605236|FG001|Overall Study|Withdrawal by Subject|5|||
13333468|NCT01091246|26605237|FG002|Overall Study|Withdrawal by Subject|4|||
13333469|NCT01091246|26605235|FG000|Overall Study|Subject not dosed|2|||
13333470|NCT01091246|26605236|FG001|Overall Study|Subject not dosed|0|||
13333471|NCT01091246|26605237|FG002|Overall Study|Subject not dosed|1|||
13333472|NCT01091168|26605254|FG000|Overall Study|Progressive disease|250|||
13333473|NCT01091168|26605255|FG001|Overall Study|Progressive disease|234|||
13333474|NCT01091168|26605254|FG000|Overall Study|Adverse Event|21|||
13333475|NCT01091168|26605255|FG001|Overall Study|Adverse Event|24|||
13123360|NCT02956967|25949441|FG000|Overall Study|Termination of Nivestim administration|29|||
13123361|NCT02956837|25949544|FG000|Overall Study|Serious Adverse Events|0|||
13123362|NCT02956837|25949545|FG001|Overall Study|Serious Adverse Events|1|||
13123363|NCT02956837|25949546|FG002|Overall Study|Serious Adverse Events|0|||
13123364|NCT02956837|25949547|FG003|Overall Study|Serious Adverse Events|0|||
13123365|NCT02956837|25949544|FG000|Overall Study|Withdrawal by Subject|0|||
13123366|NCT02956837|25949545|FG001|Overall Study|Withdrawal by Subject|1|||
13123367|NCT02956837|25949546|FG002|Overall Study|Withdrawal by Subject|0|||
13123368|NCT02956837|25949547|FG003|Overall Study|Withdrawal by Subject|3|||
13123369|NCT02956837|25949544|FG000|Overall Study|Lost to Follow-up|0|||
13123370|NCT02956837|25949545|FG001|Overall Study|Lost to Follow-up|1|||
13123371|NCT02956837|25949546|FG002|Overall Study|Lost to Follow-up|2|||
13123372|NCT02956837|25949547|FG003|Overall Study|Lost to Follow-up|0|||
13123373|NCT02956629|25949628|FG000|Overall Study|Adverse Event|0|||
13123374|NCT02956629|25949629|FG001|Overall Study|Adverse Event|0|||
13123375|NCT02956629|25949630|FG002|Overall Study|Adverse Event|1|||
13123376|NCT02956629|25949631|FG003|Overall Study|Adverse Event|0|||
13123377|NCT02956629|25949632|FG004|Overall Study|Adverse Event|0|||
13123378|NCT02956629|25949633|FG005|Overall Study|Adverse Event|0|||
13123379|NCT02956629|25949628|FG000|Overall Study|Lost to Follow-up|2|||
13123380|NCT02956629|25949629|FG001|Overall Study|Lost to Follow-up|5|||
13123381|NCT02956629|25949630|FG002|Overall Study|Lost to Follow-up|3|||
13333476|NCT01091168|26605254|FG000|Overall Study|Lost to Follow-up|0|||
13333477|NCT01091168|26605255|FG001|Overall Study|Lost to Follow-up|1|||
13333478|NCT01091168|26605254|FG000|Overall Study|Physician, patient's decision, other|27|||
13333479|NCT01091168|26605255|FG001|Overall Study|Physician, patient's decision, other|37|||
13333480|NCT01091103|26605277|FG000|Overall Study|Adverse Event|1|||
13333481|NCT01091103|26605277|FG000|Overall Study|Progressive Disease|3|||
13333482|NCT01090973|26605289|FG000|Overall Study|Disease progression|1|||
13333483|NCT01090765|26605341|FG000|Overall Study|Patient withdrew consent|0|||
13333484|NCT01090765|26605342|FG001|Overall Study|Patient withdrew consent|0|||
13333485|NCT01090765|26605343|FG002|Overall Study|Patient withdrew consent|0|||
13333486|NCT01090765|26605344|FG003|Overall Study|Patient withdrew consent|0|||
13333487|NCT01090765|26605345|FG004|Overall Study|Patient withdrew consent|1|||
13333488|NCT01090765|26605346|FG005|Overall Study|Patient withdrew consent|1|||
13333489|NCT01090765|26605341|FG000|Overall Study|Developed a DVT, needed anticoagulation|0|||
13333490|NCT01090765|26605342|FG001|Overall Study|Developed a DVT, needed anticoagulation|0|||
13333491|NCT01090765|26605343|FG002|Overall Study|Developed a DVT, needed anticoagulation|0|||
13333492|NCT01090765|26605344|FG003|Overall Study|Developed a DVT, needed anticoagulation|1|||
13333493|NCT01090765|26605345|FG004|Overall Study|Developed a DVT, needed anticoagulation|0|||
13333494|NCT01090765|26605346|FG005|Overall Study|Developed a DVT, needed anticoagulation|0|||
13333495|NCT01090765|26605341|FG000|Overall Study|Vasovagal reaction with first infusion|0|||
13333496|NCT01090765|26605342|FG001|Overall Study|Vasovagal reaction with first infusion|0|||
13333497|NCT01090765|26605343|FG002|Overall Study|Vasovagal reaction with first infusion|0|||
13333498|NCT01090765|26605344|FG003|Overall Study|Vasovagal reaction with first infusion|0|||
13333499|NCT01090765|26605345|FG004|Overall Study|Vasovagal reaction with first infusion|1|||
13333500|NCT01090765|26605346|FG005|Overall Study|Vasovagal reaction with first infusion|0|||
13333501|NCT01090739|26605365|FG000|Enrollment|Withdrawal by Subject|24|||
13333502|NCT01090739|26605365|FG000|Enrollment|Protocol Violation|14|||
13333503|NCT01090739|26605365|FG000|Enrollment|Lost to Follow-up|5|||
13333504|NCT01090739|26605365|FG000|Enrollment|Physician Decision|5|||
13333505|NCT01090739|26605365|FG000|Enrollment|Sponsor termination of site|4|||
13123382|NCT02956629|25949631|FG003|Overall Study|Lost to Follow-up|1|||
13123383|NCT02956629|25949632|FG004|Overall Study|Lost to Follow-up|0|||
13333506|NCT01090739|26605365|FG000|Enrollment|Study implant limit reached|2|||
13333507|NCT01090739|26605365|FG000|Enrollment|Adverse Event|1|||
13333508|NCT01090739|26605365|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
13333509|NCT01090739|26605365|FG000|12 Month Follow-up|Lost to Follow-up|1|||
13333510|NCT01090739|26605365|FG000|12 Month Follow-up|Physician Decision|1|||
13333511|NCT01090739|26605365|FG000|12 Month Follow-up|Death|1|||
13333512|NCT01090739|26605365|FG000|24 Month Follow-up|Withdrawal by Subject|7|||
13333513|NCT01090739|26605365|FG000|24 Month Follow-up|Lost to Follow-up|1|||
13333514|NCT01090739|26605365|FG000|24 Month Follow-up|Death|1|||
13333515|NCT01090739|26605365|FG000|36 Month Follow-up|Withdrawal by Subject|6|||
13333516|NCT01090739|26605365|FG000|36 Month Follow-up|Visit still pending|17|||
13333517|NCT01090492|26605447|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1|||
13333518|NCT01090492|26605448|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1|||
13333519|NCT01090492|26605449|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1|||
13333520|NCT01090492|26605450|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2|||
13333521|NCT01090492|26605451|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0|||
13333522|NCT01090492|26605452|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0|||
13333523|NCT01090492|26605453|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1|||
13333524|NCT01090492|26605454|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0|||
13333525|NCT01090492|26605447|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
13333526|NCT01090492|26605448|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2|||
13333527|NCT01090492|26605449|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
13333528|NCT01090492|26605450|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
13333529|NCT01090492|26605451|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
13333530|NCT01090492|26605452|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
13333531|NCT01090492|26605453|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
13333532|NCT01090492|26605454|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1|||
13333533|NCT01090492|26605447|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
13333534|NCT01090492|26605448|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
13333535|NCT01090492|26605449|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1|||
13333536|NCT01090492|26605450|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
13333537|NCT01090492|26605451|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
13333538|NCT01090492|26605452|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
13333539|NCT01090492|26605453|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
13333540|NCT01090492|26605454|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
13333541|NCT01090492|26605447|FG000|First Intervention Period (4 Weeks)|Other|0|||
13333542|NCT01090492|26605448|FG001|First Intervention Period (4 Weeks)|Other|0|||
13333543|NCT01090492|26605449|FG002|First Intervention Period (4 Weeks)|Other|1|||
13333544|NCT01090492|26605450|FG003|First Intervention Period (4 Weeks)|Other|1|||
13333545|NCT01090492|26605451|FG004|First Intervention Period (4 Weeks)|Other|2|||
13333546|NCT01090492|26605452|FG005|First Intervention Period (4 Weeks)|Other|0|||
13333547|NCT01090492|26605453|FG006|First Intervention Period (4 Weeks)|Other|0|||
13333548|NCT01090492|26605454|FG007|First Intervention Period (4 Weeks)|Other|0|||
13333549|NCT01090492|26605447|FG000|First Intervention Period (4 Weeks)|Pregnancy|0|||
13123384|NCT02956629|25949633|FG005|Overall Study|Lost to Follow-up|1|||
13123385|NCT02956629|25949628|FG000|Overall Study|Withdrawal by Subject|3|||
13123386|NCT02956629|25949629|FG001|Overall Study|Withdrawal by Subject|1|||
13123387|NCT02956629|25949630|FG002|Overall Study|Withdrawal by Subject|0|||
13333550|NCT01090492|26605448|FG001|First Intervention Period (4 Weeks)|Pregnancy|0|||
13333551|NCT01090492|26605449|FG002|First Intervention Period (4 Weeks)|Pregnancy|0|||
13333552|NCT01090492|26605450|FG003|First Intervention Period (4 Weeks)|Pregnancy|0|||
13333553|NCT01090492|26605451|FG004|First Intervention Period (4 Weeks)|Pregnancy|1|||
13333554|NCT01090492|26605452|FG005|First Intervention Period (4 Weeks)|Pregnancy|0|||
13333555|NCT01090492|26605453|FG006|First Intervention Period (4 Weeks)|Pregnancy|0|||
13333556|NCT01090492|26605454|FG007|First Intervention Period (4 Weeks)|Pregnancy|0|||
13333557|NCT01090492|26605447|FG000|First Intervention Period (4 Weeks)|Adverse Event|0|||
13333558|NCT01090492|26605448|FG001|First Intervention Period (4 Weeks)|Adverse Event|2|||
13333559|NCT01090492|26605449|FG002|First Intervention Period (4 Weeks)|Adverse Event|0|||
13333560|NCT01090492|26605450|FG003|First Intervention Period (4 Weeks)|Adverse Event|3|||
13333561|NCT01090492|26605451|FG004|First Intervention Period (4 Weeks)|Adverse Event|1|||
13333562|NCT01090492|26605452|FG005|First Intervention Period (4 Weeks)|Adverse Event|2|||
13333563|NCT01090492|26605453|FG006|First Intervention Period (4 Weeks)|Adverse Event|0|||
13333564|NCT01090492|26605454|FG007|First Intervention Period (4 Weeks)|Adverse Event|5|||
13333565|NCT01090492|26605447|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
13333566|NCT01090492|26605448|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
13333567|NCT01090492|26605449|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
13333568|NCT01090492|26605450|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
13333569|NCT01090492|26605451|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
13333570|NCT01090492|26605452|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
13333571|NCT01090492|26605453|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
13333572|NCT01090492|26605454|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
13333573|NCT01090492|26605447|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0|||
13333574|NCT01090492|26605448|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1|||
13333575|NCT01090492|26605449|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0|||
13333576|NCT01090492|26605450|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0|||
13333577|NCT01090492|26605451|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0|||
13333578|NCT01090492|26605452|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0|||
13333579|NCT01090492|26605453|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0|||
13333580|NCT01090492|26605454|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0|||
13333581|NCT01090492|26605447|FG000|Second Intervention Period (4 Weeks)|Other|0|||
13333582|NCT01090492|26605448|FG001|Second Intervention Period (4 Weeks)|Other|1|||
13333583|NCT01090492|26605449|FG002|Second Intervention Period (4 Weeks)|Other|1|||
13333584|NCT01090492|26605450|FG003|Second Intervention Period (4 Weeks)|Other|0|||
13333585|NCT01090492|26605451|FG004|Second Intervention Period (4 Weeks)|Other|0|||
13333586|NCT01090492|26605452|FG005|Second Intervention Period (4 Weeks)|Other|0|||
13333587|NCT01090492|26605453|FG006|Second Intervention Period (4 Weeks)|Other|0|||
13333588|NCT01090492|26605454|FG007|Second Intervention Period (4 Weeks)|Other|0|||
13333589|NCT01090492|26605447|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0|||
13333590|NCT01090492|26605448|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0|||
13333591|NCT01090492|26605449|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1|||
13333592|NCT01090492|26605450|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0|||
13333593|NCT01090492|26605451|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1|||
13333594|NCT01090492|26605452|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1|||
13333595|NCT01090492|26605453|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7|||
13333596|NCT01090492|26605454|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1|||
13333597|NCT01090492|26605447|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
13333598|NCT01090492|26605448|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
13333599|NCT01090492|26605449|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
13333600|NCT01090492|26605450|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
13333601|NCT01090492|26605451|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
13333602|NCT01090492|26605452|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
13333603|NCT01090492|26605453|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1|||
13333604|NCT01090492|26605454|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
13333605|NCT01090453|26605509|FG000|Overall Study|Withdrawal by Subject|1|||
13333606|NCT01090453|26605510|FG001|Overall Study|Withdrawal by Subject|2|||
13333607|NCT01090453|26605509|FG000|Overall Study|Lost to Follow-up|7|||
13333608|NCT01090453|26605510|FG001|Overall Study|Lost to Follow-up|7|||
13333609|NCT01090453|26605509|FG000|Overall Study|Non serious AEs|1|||
13333610|NCT01090453|26605510|FG001|Overall Study|Non serious AEs|0|||
13333611|NCT01090453|26605509|FG000|Overall Study|Protocol Violation|2|||
13333612|NCT01090453|26605510|FG001|Overall Study|Protocol Violation|0|||
13333613|NCT01090453|26605509|FG000|Overall Study|Other|2|||
13333614|NCT01090453|26605510|FG001|Overall Study|Other|4|||
13333615|NCT01090453|26605509|FG000|Overall Study|Eligibility Criteria|0|||
13333616|NCT01090453|26605510|FG001|Overall Study|Eligibility Criteria|1|||
13333617|NCT01090427|26605557|FG000|After Controlled Period|Death|0|||
13123388|NCT02956629|25949631|FG003|Overall Study|Withdrawal by Subject|0|||
13123389|NCT02956629|25949632|FG004|Overall Study|Withdrawal by Subject|0|||
13123390|NCT02956629|25949633|FG005|Overall Study|Withdrawal by Subject|0|||
13123391|NCT02956486|25949692|FG000|Core Phase|Adverse Event|51|||
13123392|NCT02956486|25949693|FG001|Core Phase|Adverse Event|88|||
13123393|NCT02956486|25949694|FG002|Core Phase|Adverse Event|0|||
13123394|NCT02956486|25949692|FG000|Core Phase|Lost to Follow-up|8|||
13123395|NCT02956486|25949693|FG001|Core Phase|Lost to Follow-up|6|||
13123396|NCT02956486|25949694|FG002|Core Phase|Lost to Follow-up|0|||
13123397|NCT02956486|25949692|FG000|Core Phase|Inadequate therapeutic effect|4|||
13123398|NCT02956486|25949693|FG001|Core Phase|Inadequate therapeutic effect|5|||
13123399|NCT02956486|25949694|FG002|Core Phase|Inadequate therapeutic effect|0|||
13123400|NCT02956486|25949692|FG000|Core Phase|Withdrawal by Subject|101|||
13123401|NCT02956486|25949693|FG001|Core Phase|Withdrawal by Subject|104|||
13123402|NCT02956486|25949694|FG002|Core Phase|Withdrawal by Subject|0|||
13123403|NCT02956486|25949692|FG000|Core Phase|Study terminated by sponsor|888|||
13123404|NCT02956486|25949693|FG001|Core Phase|Study terminated by sponsor|848|||
13333618|NCT01090427|26605558|FG001|After Controlled Period|Death|0|||
13333619|NCT01090427|26605559|FG002|After Controlled Period|Death|0|||
13333620|NCT01090427|26605560|FG003|After Controlled Period|Death|0|||
13333621|NCT01090427|26605561|FG004|After Controlled Period|Death|0|||
13123405|NCT02956486|25949694|FG002|Core Phase|Study terminated by sponsor|0|||
13123406|NCT02956486|25949692|FG000|Core Phase|Other|27|||
13123407|NCT02956486|25949693|FG001|Core Phase|Other|18|||
13123408|NCT02956486|25949694|FG002|Core Phase|Other|0|||
13123409|NCT02956486|25949692|FG000|Core Phase|Not treated|0|||
13123410|NCT02956486|25949693|FG001|Core Phase|Not treated|3|||
13123411|NCT02956486|25949694|FG002|Core Phase|Not treated|0|||
13123412|NCT02956486|25949692|FG000|Extension Phase|Adverse Event|0|||
13123413|NCT02956486|25949693|FG001|Extension Phase|Adverse Event|0|||
13123414|NCT02956486|25949694|FG002|Extension Phase|Adverse Event|2|||
13123415|NCT02956486|25949692|FG000|Extension Phase|Study terminated by sponsor|0|||
13123416|NCT02956486|25949693|FG001|Extension Phase|Study terminated by sponsor|0|||
13123417|NCT02956486|25949694|FG002|Extension Phase|Study terminated by sponsor|16|||
13123418|NCT02956486|25949692|FG000|Extension Phase|Not Treated|0|||
13123419|NCT02956486|25949693|FG001|Extension Phase|Not Treated|0|||
13123420|NCT02956486|25949694|FG002|Extension Phase|Not Treated|1|||
13123421|NCT02956460|25949727|FG000|Lens 1|Lost to Follow-up|1|||
13123422|NCT02956460|25949728|FG001|Lens 1|Lost to Follow-up|0|||
13123423|NCT02956278|25949752|FG000|Overall Study|Withdrawal by Subject|6|||
13123424|NCT02956278|25949753|FG001|Overall Study|Withdrawal by Subject|2|||
13123425|NCT02956278|25949754|FG002|Overall Study|Withdrawal by Subject|0|||
13123426|NCT02956057|25949793|FG000|Overall Study|Discontinued intervention|14|||
13333622|NCT01090427|26605562|FG005|After Controlled Period|Death|1|||
13333623|NCT01090427|26605563|FG006|After Controlled Period|Death|0|||
13333624|NCT01090427|26605557|FG000|After Controlled Period|Lack of Efficacy|0|||
13333625|NCT01090427|26605558|FG001|After Controlled Period|Lack of Efficacy|0|||
13333626|NCT01090427|26605559|FG002|After Controlled Period|Lack of Efficacy|0|||
13333627|NCT01090427|26605560|FG003|After Controlled Period|Lack of Efficacy|0|||
13333628|NCT01090427|26605561|FG004|After Controlled Period|Lack of Efficacy|0|||
13333629|NCT01090427|26605562|FG005|After Controlled Period|Lack of Efficacy|3|||
13333630|NCT01090427|26605563|FG006|After Controlled Period|Lack of Efficacy|2|||
13333631|NCT01090427|26605557|FG000|After Controlled Period|Adverse Event|0|||
13333632|NCT01090427|26605558|FG001|After Controlled Period|Adverse Event|0|||
13333633|NCT01090427|26605559|FG002|After Controlled Period|Adverse Event|0|||
13333634|NCT01090427|26605560|FG003|After Controlled Period|Adverse Event|2|||
13333635|NCT01090427|26605561|FG004|After Controlled Period|Adverse Event|0|||
13333636|NCT01090427|26605562|FG005|After Controlled Period|Adverse Event|1|||
13333637|NCT01090427|26605563|FG006|After Controlled Period|Adverse Event|0|||
13333638|NCT01090414|26605641|FG000|Study 101-99|Progressive Disease|28|||
13333639|NCT01090414|26605642|FG001|Study 101-99|Progressive Disease|48|||
13333640|NCT01090414|26605643|FG002|Study 101-99|Progressive Disease|10|||
13333641|NCT01090414|26605644|FG003|Study 101-99|Progressive Disease|4|||
13333642|NCT01090414|26605641|FG000|Study 101-99|Adverse Event|10|||
13333643|NCT01090414|26605642|FG001|Study 101-99|Adverse Event|28|||
13333644|NCT01090414|26605643|FG002|Study 101-99|Adverse Event|18|||
13333645|NCT01090414|26605644|FG003|Study 101-99|Adverse Event|0|||
13333646|NCT01090414|26605641|FG000|Study 101-99|Investigator Request|1|||
13333647|NCT01090414|26605642|FG001|Study 101-99|Investigator Request|11|||
13123427|NCT02956057|25949794|FG001|Overall Study|Discontinued intervention|10|||
13123428|NCT02956057|25949795|FG002|Overall Study|Discontinued intervention|7|||
13123429|NCT02956057|25949796|FG003|Overall Study|Discontinued intervention|14|||
13123430|NCT02956057|25949797|FG004|Overall Study|Discontinued intervention|4|||
13123431|NCT02956057|25949798|FG005|Overall Study|Discontinued intervention|17|||
13123432|NCT02956057|25949793|FG000|Overall Study|Lost to Follow-up|0|||
13123433|NCT02956057|25949794|FG001|Overall Study|Lost to Follow-up|2|||
13123434|NCT02956057|25949795|FG002|Overall Study|Lost to Follow-up|1|||
13123435|NCT02956057|25949796|FG003|Overall Study|Lost to Follow-up|1|||
13123436|NCT02956057|25949797|FG004|Overall Study|Lost to Follow-up|1|||
13123437|NCT02956057|25949798|FG005|Overall Study|Lost to Follow-up|0|||
13123438|NCT02956005|25949805|FG000|Overall Study|Not eligible|1|||
13123439|NCT02956005|25949805|FG000|Overall Study|Withdrawal by Subject|3|||
13123440|NCT02956005|25949805|FG000|Overall Study|Physician Decision|12|||
13123441|NCT02955797|25949834|FG000|Overall Study|Protocol Violation|1|||
13123442|NCT02955797|25949835|FG001|Overall Study|Protocol Violation|0|||
13123443|NCT02955797|25949836|FG002|Overall Study|Protocol Violation|0|||
13123444|NCT02955797|25949837|FG003|Overall Study|Protocol Violation|1|||
13123445|NCT02955797|25949834|FG000|Overall Study|Withdrawal by Subject|2|||
13123446|NCT02955797|25949835|FG001|Overall Study|Withdrawal by Subject|2|||
13123447|NCT02955797|25949836|FG002|Overall Study|Withdrawal by Subject|0|||
13123448|NCT02955797|25949837|FG003|Overall Study|Withdrawal by Subject|1|||
13123449|NCT02955797|25949834|FG000|Overall Study|Lost to Follow-up|0|||
13123450|NCT02955797|25949835|FG001|Overall Study|Lost to Follow-up|1|||
13123451|NCT02955797|25949836|FG002|Overall Study|Lost to Follow-up|0|||
13123452|NCT02955797|25949837|FG003|Overall Study|Lost to Follow-up|0|||
13123453|NCT02955602|25949909|FG000|Overall Study|Adverse Event|0|||
13333648|NCT01090414|26605643|FG002|Study 101-99|Investigator Request|4|||
13333649|NCT01090414|26605644|FG003|Study 101-99|Investigator Request|0|||
13333650|NCT01090414|26605641|FG000|Study 101-99|Death|3|||
13333651|NCT01090414|26605642|FG001|Study 101-99|Death|8|||
13333652|NCT01090414|26605643|FG002|Study 101-99|Death|1|||
13123454|NCT02955602|25949910|FG001|Overall Study|Adverse Event|3|||
13123455|NCT02955602|25949911|FG002|Overall Study|Adverse Event|0|||
13123456|NCT02955602|25949909|FG000|Overall Study|Withdrawal of informed consent|1|||
13333653|NCT01090414|26605644|FG003|Study 101-99|Death|0|||
13123457|NCT02955602|25949910|FG001|Overall Study|Withdrawal of informed consent|3|||
13123458|NCT02955602|25949911|FG002|Overall Study|Withdrawal of informed consent|2|||
13123459|NCT02955602|25949909|FG000|Overall Study|Lost to Follow-up|0|||
13123460|NCT02955602|25949910|FG001|Overall Study|Lost to Follow-up|0|||
13123461|NCT02955602|25949911|FG002|Overall Study|Lost to Follow-up|1|||
13123462|NCT02955602|25949909|FG000|Overall Study|Other|0|||
13123463|NCT02955602|25949910|FG001|Overall Study|Other|1|||
13123464|NCT02955602|25949911|FG002|Overall Study|Other|3|||
13123465|NCT02955212|25949943|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4|||
13123466|NCT02955212|25949944|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7|||
13123467|NCT02955212|25949943|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8|||
13123468|NCT02955212|25949944|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3|||
13123469|NCT02955212|25949943|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1|||
13123470|NCT02955212|25949944|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0|||
13123471|NCT02955212|25949943|FG000|Period 1: Double-blind Treatment Period|Other|3|||
13123472|NCT02955212|25949944|FG001|Period 1: Double-blind Treatment Period|Other|2|||
13123473|NCT02955212|25949943|FG000|Period 2: Open-label Extension|Adverse Event|11|||
13123474|NCT02955212|25949944|FG001|Period 2: Open-label Extension|Adverse Event|7|||
13123475|NCT02955212|25949943|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1|||
13123476|NCT02955212|25949944|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4|||
13123477|NCT02955212|25949943|FG000|Period 2: Open-label Extension|Lack of Efficacy|3|||
13123478|NCT02955212|25949944|FG001|Period 2: Open-label Extension|Lack of Efficacy|2|||
13123479|NCT02955212|25949943|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0|||
13123480|NCT02955212|25949944|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1|||
13123481|NCT02955212|25949943|FG000|Period 2: Open-label Extension|Other|2|||
13123482|NCT02955212|25949944|FG001|Period 2: Open-label Extension|Other|4|||
13123483|NCT02955186|25949963|FG000|Overall Study|Withdrawal by Subject|6|||
13123484|NCT02955186|25949964|FG001|Overall Study|Withdrawal by Subject|2|||
13123485|NCT02955186|25949963|FG000|Overall Study|Protocol Violation|1|||
13123486|NCT02955186|25949964|FG001|Overall Study|Protocol Violation|0|||
13123487|NCT02955069|25950014|FG000|Overall Study|Adverse Event|7|||
13123488|NCT02955069|25950015|FG001|Overall Study|Adverse Event|2|||
13123489|NCT02955069|25950014|FG000|Overall Study|Death|7|||
13123490|NCT02955069|25950015|FG001|Overall Study|Death|3|||
13123491|NCT02955069|25950014|FG000|Overall Study|Physician Decision|10|||
13123492|NCT02955069|25950015|FG001|Overall Study|Physician Decision|2|||
13123493|NCT02955069|25950014|FG000|Overall Study|Progressive disease|64|||
13123494|NCT02955069|25950015|FG001|Overall Study|Progressive disease|13|||
13123495|NCT02955069|25950014|FG000|Overall Study|Study terminated by sponsor|4|||
13123496|NCT02955069|25950015|FG001|Overall Study|Study terminated by sponsor|0|||
13123497|NCT02955069|25950014|FG000|Overall Study|Subject/Guardian decision|3|||
13123498|NCT02955069|25950015|FG001|Overall Study|Subject/Guardian decision|1|||
13123499|NCT02954952|25950033|FG000|Overall Study|Withdrawal by Subject|1|||
13123500|NCT02954952|25950034|FG001|Overall Study|Withdrawal by Subject|0|||
13123501|NCT02954952|25950035|FG002|Overall Study|Withdrawal by Subject|0|||
13123502|NCT02954952|25950033|FG000|Overall Study|No data collected|0|||
13123503|NCT02954952|25950034|FG001|Overall Study|No data collected|1|||
13123504|NCT02954952|25950035|FG002|Overall Study|No data collected|0|||
13123505|NCT02954887|25950064|FG000|Overall Study|Withdrawal by Subject|3|||
13123506|NCT02954887|25950064|FG000|Overall Study|Lack of Efficacy|3|||
13123507|NCT02954887|25950064|FG000|Overall Study|Other|1|||
13123508|NCT02954848|25950129|FG000|Overall Study|Randomized but Not Treated|0|||
13123509|NCT02954848|25950130|FG001|Overall Study|Randomized but Not Treated|1|||
13123510|NCT02954848|25950129|FG000|Overall Study|Adverse Event|2|||
13123511|NCT02954848|25950130|FG001|Overall Study|Adverse Event|3|||
13123512|NCT02954848|25950129|FG000|Overall Study|Withdrawal by Participant|0|||
13123513|NCT02954848|25950130|FG001|Overall Study|Withdrawal by Participant|1|||
13123514|NCT02954653|25950259|FG000|Overall Study|Death|3|||
13123515|NCT02954653|25950260|FG001|Overall Study|Death|1|||
13123516|NCT02954653|25950261|FG002|Overall Study|Death|0|||
13123517|NCT02954653|25950262|FG003|Overall Study|Death|0|||
13123518|NCT02954653|25950263|FG004|Overall Study|Death|0|||
13123519|NCT02954653|25950264|FG005|Overall Study|Death|0|||
13123520|NCT02954653|25950265|FG006|Overall Study|Death|0|||
13123521|NCT02954653|25950266|FG007|Overall Study|Death|0|||
13123522|NCT02954653|25950267|FG008|Overall Study|Death|0|||
13123523|NCT02954653|25950259|FG000|Overall Study|Randomized but did not receive treatment|1|||
13123524|NCT02954653|25950260|FG001|Overall Study|Randomized but did not receive treatment|0|||
13123525|NCT02954653|25950261|FG002|Overall Study|Randomized but did not receive treatment|0|||
13123526|NCT02954653|25950262|FG003|Overall Study|Randomized but did not receive treatment|0|||
13123527|NCT02954653|25950263|FG004|Overall Study|Randomized but did not receive treatment|0|||
13123528|NCT02954653|25950264|FG005|Overall Study|Randomized but did not receive treatment|0|||
13292277|NCT00706849|26485169|FG000|Treatment Period|Adverse Event|0|||
13292278|NCT00706849|26485170|FG001|Treatment Period|Adverse Event|9|||
13292279|NCT00706849|26485169|FG000|Treatment Period|Other|0|||
13123529|NCT02954653|25950265|FG006|Overall Study|Randomized but did not receive treatment|0|||
13123530|NCT02954653|25950266|FG007|Overall Study|Randomized but did not receive treatment|0|||
13123531|NCT02954653|25950267|FG008|Overall Study|Randomized but did not receive treatment|0|||
13123532|NCT02954653|25950259|FG000|Overall Study|Started another anti-cancer therapy|0|||
13123533|NCT02954653|25950260|FG001|Overall Study|Started another anti-cancer therapy|1|||
13123534|NCT02954653|25950261|FG002|Overall Study|Started another anti-cancer therapy|0|||
13123535|NCT02954653|25950262|FG003|Overall Study|Started another anti-cancer therapy|0|||
13123536|NCT02954653|25950263|FG004|Overall Study|Started another anti-cancer therapy|0|||
13123537|NCT02954653|25950264|FG005|Overall Study|Started another anti-cancer therapy|0|||
13123538|NCT02954653|25950265|FG006|Overall Study|Started another anti-cancer therapy|0|||
13123539|NCT02954653|25950266|FG007|Overall Study|Started another anti-cancer therapy|0|||
13123540|NCT02954653|25950267|FG008|Overall Study|Started another anti-cancer therapy|0|||
13123541|NCT02954653|25950259|FG000|Overall Study|Treatment failure and consent withdrawal|0|||
13123542|NCT02954653|25950260|FG001|Overall Study|Treatment failure and consent withdrawal|1|||
13123543|NCT02954653|25950261|FG002|Overall Study|Treatment failure and consent withdrawal|0|||
13123544|NCT02954653|25950262|FG003|Overall Study|Treatment failure and consent withdrawal|0|||
13123545|NCT02954653|25950263|FG004|Overall Study|Treatment failure and consent withdrawal|0|||
13123546|NCT02954653|25950264|FG005|Overall Study|Treatment failure and consent withdrawal|0|||
13123547|NCT02954653|25950265|FG006|Overall Study|Treatment failure and consent withdrawal|0|||
13123548|NCT02954653|25950266|FG007|Overall Study|Treatment failure and consent withdrawal|0|||
13123549|NCT02954653|25950267|FG008|Overall Study|Treatment failure and consent withdrawal|0|||
13123550|NCT02954601|25950302|FG000|First Intervention (Five Days)|Withdrawal by Subject|0|||
13123551|NCT02954601|25950303|FG001|First Intervention (Five Days)|Withdrawal by Subject|0|||
13123552|NCT02954601|25950304|FG002|First Intervention (Five Days)|Withdrawal by Subject|1|||
13123553|NCT02954601|25950305|FG003|First Intervention (Five Days)|Withdrawal by Subject|0|||
13123554|NCT02954575|25950324|FG000|Overall Study|Withdrawal by Subject|2|||
13123555|NCT02954575|25950324|FG000|Overall Study|Adverse Event|1|||
13123556|NCT02954458|25950460|FG000|Overall Study|Adverse Event|0|||
13123557|NCT02954458|25950461|FG001|Overall Study|Adverse Event|0|||
13123558|NCT02954458|25950462|FG002|Overall Study|Adverse Event|0|||
13123559|NCT02954458|25950463|FG003|Overall Study|Adverse Event|1|||
13123560|NCT02954458|25950460|FG000|Overall Study|Withdrawal by Subject|0|||
13123561|NCT02954458|25950461|FG001|Overall Study|Withdrawal by Subject|0|||
13123562|NCT02954458|25950462|FG002|Overall Study|Withdrawal by Subject|0|||
13123563|NCT02954458|25950463|FG003|Overall Study|Withdrawal by Subject|1|||
13123564|NCT02954458|25950460|FG000|Overall Study|Physician Decision|0|||
13123565|NCT02954458|25950461|FG001|Overall Study|Physician Decision|0|||
13123566|NCT02954458|25950462|FG002|Overall Study|Physician Decision|1|||
13333654|NCT01090414|26605641|FG000|Study 101-99|Sponsor Discontinued Study|0|||
13333655|NCT01090414|26605642|FG001|Study 101-99|Sponsor Discontinued Study|7|||
13333656|NCT01090414|26605643|FG002|Study 101-99|Sponsor Discontinued Study|5|||
13333657|NCT01090414|26605644|FG003|Study 101-99|Sponsor Discontinued Study|0|||
13333658|NCT01090414|26605641|FG000|Study 101-99|Other (Unknown Reasons)|3|||
13333659|NCT01090414|26605642|FG001|Study 101-99|Other (Unknown Reasons)|3|||
13333660|NCT01090414|26605643|FG002|Study 101-99|Other (Unknown Reasons)|0|||
13123567|NCT02954458|25950463|FG003|Overall Study|Physician Decision|1|||
13123568|NCT02954458|25950460|FG000|Overall Study|Lost to Follow-up|1|||
13123569|NCT02954458|25950461|FG001|Overall Study|Lost to Follow-up|0|||
13123570|NCT02954458|25950462|FG002|Overall Study|Lost to Follow-up|0|||
13123571|NCT02954458|25950463|FG003|Overall Study|Lost to Follow-up|1|||
13123572|NCT02954458|25950460|FG000|Overall Study|Death|0|||
13123573|NCT02954458|25950461|FG001|Overall Study|Death|0|||
13123574|NCT02954458|25950462|FG002|Overall Study|Death|0|||
13123575|NCT02954458|25950463|FG003|Overall Study|Death|1|||
13123576|NCT02954458|25950460|FG000|Overall Study|Other|0|||
13123577|NCT02954458|25950461|FG001|Overall Study|Other|0|||
13123578|NCT02954458|25950462|FG002|Overall Study|Other|0|||
13123579|NCT02954458|25950463|FG003|Overall Study|Other|7|||
13123580|NCT02954406|25950578|FG000|Overall Study|Adverse Event|0|||
13123581|NCT02954406|25950579|FG001|Overall Study|Adverse Event|1|||
13123582|NCT02954406|25950580|FG002|Overall Study|Adverse Event|0|||
13123583|NCT02954406|25950581|FG003|Overall Study|Adverse Event|0|||
13123584|NCT02954406|25950582|FG004|Overall Study|Adverse Event|1|||
13123585|NCT02954406|25950583|FG005|Overall Study|Adverse Event|0|||
13123586|NCT02954406|25950584|FG006|Overall Study|Adverse Event|0|||
13123587|NCT02954406|25950585|FG007|Overall Study|Adverse Event|0|||
13123588|NCT02954406|25950586|FG008|Overall Study|Adverse Event|1|||
13123589|NCT02954406|25950587|FG009|Overall Study|Adverse Event|1|||
13123590|NCT02954406|25950588|FG010|Overall Study|Adverse Event|0|||
13333661|NCT01090414|26605644|FG003|Study 101-99|Other (Unknown Reasons)|0|||
13333662|NCT01090414|26605641|FG000|Study 101-99|Withdrew Consent|0|||
13333663|NCT01090414|26605642|FG001|Study 101-99|Withdrew Consent|2|||
13333664|NCT01090414|26605643|FG002|Study 101-99|Withdrew Consent|3|||
13123591|NCT02954406|25950578|FG000|Overall Study|Progressive Disease|3|||
13123592|NCT02954406|25950579|FG001|Overall Study|Progressive Disease|4|||
13333665|NCT01090414|26605644|FG003|Study 101-99|Withdrew Consent|1|||
13333666|NCT01090414|26605641|FG000|Study 101-99|Participant Request|3|||
13333667|NCT01090414|26605642|FG001|Study 101-99|Participant Request|1|||
13333668|NCT01090414|26605643|FG002|Study 101-99|Participant Request|0|||
13333669|NCT01090414|26605644|FG003|Study 101-99|Participant Request|0|||
13123593|NCT02954406|25950580|FG002|Overall Study|Progressive Disease|3|||
13123594|NCT02954406|25950581|FG003|Overall Study|Progressive Disease|4|||
13123595|NCT02954406|25950582|FG004|Overall Study|Progressive Disease|3|||
13123596|NCT02954406|25950583|FG005|Overall Study|Progressive Disease|3|||
13123597|NCT02954406|25950584|FG006|Overall Study|Progressive Disease|2|||
13123598|NCT02954406|25950585|FG007|Overall Study|Progressive Disease|2|||
13123599|NCT02954406|25950586|FG008|Overall Study|Progressive Disease|1|||
13123600|NCT02954406|25950587|FG009|Overall Study|Progressive Disease|1|||
13123601|NCT02954406|25950588|FG010|Overall Study|Progressive Disease|0|||
13123602|NCT02954406|25950578|FG000|Overall Study|Symptomatic Deterioration|0|||
13123603|NCT02954406|25950579|FG001|Overall Study|Symptomatic Deterioration|1|||
13123604|NCT02954406|25950580|FG002|Overall Study|Symptomatic Deterioration|0|||
13123605|NCT02954406|25950581|FG003|Overall Study|Symptomatic Deterioration|0|||
13123606|NCT02954406|25950582|FG004|Overall Study|Symptomatic Deterioration|0|||
13123607|NCT02954406|25950583|FG005|Overall Study|Symptomatic Deterioration|0|||
13123608|NCT02954406|25950584|FG006|Overall Study|Symptomatic Deterioration|0|||
13123609|NCT02954406|25950585|FG007|Overall Study|Symptomatic Deterioration|0|||
13123610|NCT02954406|25950586|FG008|Overall Study|Symptomatic Deterioration|0|||
13123611|NCT02954406|25950587|FG009|Overall Study|Symptomatic Deterioration|0|||
13123612|NCT02954406|25950588|FG010|Overall Study|Symptomatic Deterioration|0|||
13123613|NCT02954406|25950578|FG000|Overall Study|Death|0|||
13123614|NCT02954406|25950579|FG001|Overall Study|Death|0|||
13123615|NCT02954406|25950580|FG002|Overall Study|Death|0|||
13123616|NCT02954406|25950581|FG003|Overall Study|Death|0|||
13123617|NCT02954406|25950582|FG004|Overall Study|Death|1|||
13123618|NCT02954406|25950583|FG005|Overall Study|Death|0|||
13123619|NCT02954406|25950584|FG006|Overall Study|Death|0|||
13123620|NCT02954406|25950585|FG007|Overall Study|Death|0|||
13123621|NCT02954406|25950586|FG008|Overall Study|Death|1|||
13123622|NCT02954406|25950587|FG009|Overall Study|Death|1|||
13123623|NCT02954406|25950588|FG010|Overall Study|Death|0|||
13123624|NCT02954406|25950578|FG000|Overall Study|Reason Not Specified|0|||
13123625|NCT02954406|25950579|FG001|Overall Study|Reason Not Specified|0|||
13123626|NCT02954406|25950580|FG002|Overall Study|Reason Not Specified|3|||
13123627|NCT02954406|25950581|FG003|Overall Study|Reason Not Specified|2|||
13123628|NCT02954406|25950582|FG004|Overall Study|Reason Not Specified|2|||
13333670|NCT01090323|26605659|FG000|Overall Study|Adverse Event|12|||
13333671|NCT01090323|26605660|FG001|Overall Study|Adverse Event|2|||
13333672|NCT01090323|26605659|FG000|Overall Study|Abnormal Lab Values|3|||
13123629|NCT02954406|25950583|FG005|Overall Study|Reason Not Specified|0|||
13123630|NCT02954406|25950584|FG006|Overall Study|Reason Not Specified|1|||
13123631|NCT02954406|25950585|FG007|Overall Study|Reason Not Specified|0|||
13123632|NCT02954406|25950586|FG008|Overall Study|Reason Not Specified|1|||
13123633|NCT02954406|25950587|FG009|Overall Study|Reason Not Specified|0|||
13123634|NCT02954406|25950588|FG010|Overall Study|Reason Not Specified|0|||
13123635|NCT02954354|25950682|FG000|Overall Study|Adverse Event|2|||
13123636|NCT02954354|25950683|FG001|Overall Study|Adverse Event|2|||
13123637|NCT02954354|25950684|FG002|Overall Study|Adverse Event|4|||
13123638|NCT02954354|25950682|FG000|Overall Study|Failure to Meet Eligibility Criteria|1|||
13123639|NCT02954354|25950683|FG001|Overall Study|Failure to Meet Eligibility Criteria|0|||
13123640|NCT02954354|25950684|FG002|Overall Study|Failure to Meet Eligibility Criteria|0|||
13123641|NCT02954354|25950682|FG000|Overall Study|Lack of Efficacy|0|||
13123642|NCT02954354|25950683|FG001|Overall Study|Lack of Efficacy|2|||
13123643|NCT02954354|25950684|FG002|Overall Study|Lack of Efficacy|0|||
13123644|NCT02954354|25950682|FG000|Overall Study|Withdrawal by Subject|17|||
13123645|NCT02954354|25950683|FG001|Overall Study|Withdrawal by Subject|9|||
13123646|NCT02954354|25950684|FG002|Overall Study|Withdrawal by Subject|11|||
13123647|NCT02954354|25950682|FG000|Overall Study|Lost to Follow-up|12|||
13123648|NCT02954354|25950683|FG001|Overall Study|Lost to Follow-up|5|||
13123649|NCT02954354|25950684|FG002|Overall Study|Lost to Follow-up|0|||
13123650|NCT02954354|25950682|FG000|Overall Study|Miscellaneous|2|||
13123651|NCT02954354|25950683|FG001|Overall Study|Miscellaneous|2|||
13123652|NCT02954354|25950684|FG002|Overall Study|Miscellaneous|1|||
13123653|NCT02954237|25950692|FG000|Overall Study|Withdrawal by Subject|25|||
13123654|NCT02954237|25950692|FG000|Overall Study|Missed visit|16|||
13123655|NCT02954237|25950692|FG000|Overall Study|Death|2|||
13333673|NCT01090323|26605660|FG001|Overall Study|Abnormal Lab Values|1|||
13333674|NCT01090323|26605659|FG000|Overall Study|Abnormal Test Procedure Results|2|||
13123656|NCT02954172|25950709|FG000|Overall Study|Protocol Violation|3|||
13123657|NCT02954172|25950710|FG001|Overall Study|Protocol Violation|0|||
13123658|NCT02954172|25950709|FG000|Overall Study|allergic reaction|2|||
13123659|NCT02954172|25950710|FG001|Overall Study|allergic reaction|1|||
13123660|NCT02954172|25950709|FG000|Overall Study|non-measurable lesions at baseline|1|||
13123661|NCT02954172|25950710|FG001|Overall Study|non-measurable lesions at baseline|2|||
13123662|NCT02954159|25950729|FG000|Overall Study|Study ended prematurely due to low enrol|1|||
13123663|NCT02954159|25950730|FG001|Overall Study|Study ended prematurely due to low enrol|0|||
13123664|NCT02954159|25950729|FG000|Overall Study|Withdrawal by Subject|0|||
13123665|NCT02954159|25950730|FG001|Overall Study|Withdrawal by Subject|1|||
13123666|NCT02953938|25950752|FG000|Overall Study|Adverse Event|0|||
13123667|NCT02953938|25950753|FG001|Overall Study|Adverse Event|1|||
13123668|NCT02953938|25950752|FG000|Overall Study|Withdrawal by Subject|1|||
13123669|NCT02953938|25950753|FG001|Overall Study|Withdrawal by Subject|1|||
13123670|NCT02953821|25950778|FG000|Overall Study|Adverse Event|0|||
13123671|NCT02953821|25950779|FG001|Overall Study|Adverse Event|4|||
13123672|NCT02953821|25950778|FG000|Overall Study|Death|1|||
13123673|NCT02953821|25950779|FG001|Overall Study|Death|0|||
13123674|NCT02953821|25950778|FG000|Overall Study|Progressive Disease|5|||
13123675|NCT02953821|25950779|FG001|Overall Study|Progressive Disease|1|||
13123676|NCT02953821|25950778|FG000|Overall Study|Lost to Follow-up|2|||
13123677|NCT02953821|25950779|FG001|Overall Study|Lost to Follow-up|0|||
13123678|NCT02953821|25950778|FG000|Overall Study|Physician Decision|1|||
13123679|NCT02953821|25950779|FG001|Overall Study|Physician Decision|1|||
13123680|NCT02953821|25950778|FG000|Overall Study|Withdrawal by Subject|3|||
13123681|NCT02953821|25950779|FG001|Overall Study|Withdrawal by Subject|3|||
13123682|NCT02953821|25950778|FG000|Overall Study|Change of address|0|||
13123683|NCT02953821|25950779|FG001|Overall Study|Change of address|1|||
13123684|NCT02953821|25950778|FG000|Overall Study|Lack of Efficacy|1|||
13123685|NCT02953821|25950779|FG001|Overall Study|Lack of Efficacy|0|||
13123686|NCT02953821|25950778|FG000|Overall Study|Out of state for indeterminate time|0|||
13123687|NCT02953821|25950779|FG001|Overall Study|Out of state for indeterminate time|1|||
13123688|NCT02953821|25950778|FG000|Overall Study|No improvement|0|||
13123689|NCT02953821|25950779|FG001|Overall Study|No improvement|1|||
13123690|NCT02953821|25950778|FG000|Overall Study|Refused follow-up visit|2|||
13123691|NCT02953821|25950779|FG001|Overall Study|Refused follow-up visit|1|||
13123692|NCT02953782|25950876|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5|||
13123693|NCT02953782|25950877|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2|||
13123694|NCT02953782|25950878|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
13123695|NCT02953782|25950879|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
13123696|NCT02953782|25950880|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4|||
13123697|NCT02953782|25950881|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
13123698|NCT02953782|25950882|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
13123699|NCT02953782|25950883|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
13123700|NCT02953782|25950876|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
13123701|NCT02953782|25950877|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
13123702|NCT02953782|25950878|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2|||
13123703|NCT02953782|25950879|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
13123704|NCT02953782|25950880|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
13123705|NCT02953782|25950881|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
13123706|NCT02953782|25950882|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
13123707|NCT02953782|25950883|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
13123708|NCT02953782|25950876|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
13123709|NCT02953782|25950877|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
13123710|NCT02953782|25950878|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
13123711|NCT02953782|25950879|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
13123712|NCT02953782|25950880|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
13123713|NCT02953782|25950881|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
13123714|NCT02953782|25950882|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
13123715|NCT02953782|25950883|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
13123716|NCT02953782|25950876|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
13123717|NCT02953782|25950877|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
13123718|NCT02953782|25950878|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
13123719|NCT02953782|25950879|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
13123720|NCT02953782|25950880|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
13123721|NCT02953782|25950881|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
13123722|NCT02953782|25950882|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
13123723|NCT02953782|25950883|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
13292280|NCT00706849|26485170|FG001|Treatment Period|Other|1|||
13292281|NCT00706849|26485169|FG000|Follow-up Period|Withdrawal by Subject|0|||
13292282|NCT00706849|26485170|FG001|Follow-up Period|Withdrawal by Subject|2|||
13292283|NCT00706849|26485169|FG000|Follow-up Period|Protocol non-compliance|0|||
13292284|NCT00706849|26485170|FG001|Follow-up Period|Protocol non-compliance|1|||
13292285|NCT00706797|26485217|FG000|Overall Study|Lack of Efficacy|3|||
13292286|NCT00706797|26485218|FG001|Overall Study|Lack of Efficacy|0|||
13333675|NCT01090323|26605660|FG001|Overall Study|Abnormal Test Procedure Results|0|||
13333676|NCT01090323|26605659|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
13333677|NCT01090323|26605660|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
13333678|NCT01090323|26605659|FG000|Overall Study|Condition no longer requires drug|5|||
13333679|NCT01090323|26605660|FG001|Overall Study|Condition no longer requires drug|4|||
13333680|NCT01090323|26605659|FG000|Overall Study|Protocol Violation|2|||
13333681|NCT01090323|26605660|FG001|Overall Study|Protocol Violation|1|||
13333682|NCT01090323|26605659|FG000|Overall Study|Withdrew consent|33|||
13333683|NCT01090323|26605660|FG001|Overall Study|Withdrew consent|11|||
13333684|NCT01090323|26605659|FG000|Overall Study|Lost to Follow-up|11|||
13333685|NCT01090323|26605660|FG001|Overall Study|Lost to Follow-up|6|||
13333686|NCT01090323|26605659|FG000|Overall Study|Administrative problems|6|||
13333687|NCT01090323|26605660|FG001|Overall Study|Administrative problems|4|||
13333688|NCT01090323|26605659|FG000|Overall Study|Death|1|||
13333689|NCT01090323|26605660|FG001|Overall Study|Death|2|||
13333690|NCT01090323|26605659|FG000|Overall Study|Stopped end of core|7|||
13333691|NCT01090323|26605660|FG001|Overall Study|Stopped end of core|0|||
13333692|NCT01090323|26605659|FG000|Overall Study|Stopped end of extension 1#|3|||
13333693|NCT01090323|26605660|FG001|Overall Study|Stopped end of extension 1#|1|||
13333694|NCT01090310|26605699|FG000|Core Study|Adverse Event|2|||
13333695|NCT01090310|26605700|FG001|Core Study|Adverse Event|2|||
13333696|NCT01090310|26605701|FG002|Core Study|Adverse Event|1|||
13333697|NCT01090310|26605702|FG003|Core Study|Adverse Event|1|||
13333698|NCT01090310|26605699|FG000|Core Study|Subject withdrew consent|0|||
13333699|NCT01090310|26605700|FG001|Core Study|Subject withdrew consent|3|||
13333700|NCT01090310|26605701|FG002|Core Study|Subject withdrew consent|1|||
13333701|NCT01090310|26605702|FG003|Core Study|Subject withdrew consent|1|||
13333702|NCT01090310|26605699|FG000|Core Study|Abnormal test procedure result|0|||
13333703|NCT01090310|26605700|FG001|Core Study|Abnormal test procedure result|0|||
13333704|NCT01090310|26605701|FG002|Core Study|Abnormal test procedure result|1|||
13333705|NCT01090310|26605702|FG003|Core Study|Abnormal test procedure result|0|||
13333706|NCT01090310|26605699|FG000|Core Study|Administrative reasons|5|||
13333707|NCT01090310|26605700|FG001|Core Study|Administrative reasons|6|||
13333708|NCT01090310|26605701|FG002|Core Study|Administrative reasons|4|||
13333709|NCT01090310|26605702|FG003|Core Study|Administrative reasons|4|||
13333710|NCT01090310|26605699|FG000|Core Study|Protocol deviation|1|||
13333711|NCT01090310|26605700|FG001|Core Study|Protocol deviation|0|||
13333712|NCT01090310|26605701|FG002|Core Study|Protocol deviation|0|||
13333713|NCT01090310|26605702|FG003|Core Study|Protocol deviation|1|||
13333714|NCT01090310|26605699|FG000|Extension Study|Aministrative problems|13|||
13333715|NCT01090310|26605700|FG001|Extension Study|Aministrative problems|15|||
13333716|NCT01090310|26605701|FG002|Extension Study|Aministrative problems|14|||
13123724|NCT02953782|25950876|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
13123725|NCT02953782|25950877|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
13123726|NCT02953782|25950878|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
13123727|NCT02953782|25950879|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
13123728|NCT02953782|25950880|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
13123729|NCT02953782|25950881|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14|||
13123730|NCT02953782|25950882|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11|||
13123731|NCT02953782|25950883|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8|||
13123732|NCT02953782|25950876|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
13123733|NCT02953782|25950877|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
13123734|NCT02953782|25950878|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
13123735|NCT02953782|25950879|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
13123736|NCT02953782|25950880|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
13123737|NCT02953782|25950881|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1|||
13123738|NCT02953782|25950882|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2|||
13123739|NCT02953782|25950883|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3|||
13123740|NCT02953782|25950876|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
13123741|NCT02953782|25950877|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
13123742|NCT02953782|25950878|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
13123743|NCT02953782|25950879|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
13123744|NCT02953782|25950880|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
13123745|NCT02953782|25950881|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
13123746|NCT02953782|25950882|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
13123747|NCT02953782|25950883|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4|||
13123748|NCT02953782|25950876|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
13123749|NCT02953782|25950877|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
13123750|NCT02953782|25950878|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
13333717|NCT01090310|26605702|FG003|Extension Study|Aministrative problems|18|||
13333718|NCT01090310|26605699|FG000|Extension Study|Adverse Event|0|||
13333719|NCT01090310|26605700|FG001|Extension Study|Adverse Event|0|||
13123751|NCT02953782|25950879|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
13123752|NCT02953782|25950880|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
13123753|NCT02953782|25950881|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
13123754|NCT02953782|25950882|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1|||
13123755|NCT02953782|25950883|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
13123756|NCT02953678|25950898|FG000|Overall Study|Adverse Event|20|||
13123757|NCT02953678|25950898|FG000|Overall Study|Death|7|||
13123758|NCT02953678|25950898|FG000|Overall Study|Physician Decision|23|||
13123759|NCT02953678|25950898|FG000|Overall Study|Progressive Disease of GVHD|7|||
13123760|NCT02953678|25950898|FG000|Overall Study|Relapse of Underlying Malignancy|3|||
13123761|NCT02953678|25950898|FG000|Overall Study|Withdrawal by participant|3|||
13123762|NCT02953678|25950898|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5|||
13123763|NCT02953678|25950898|FG000|Overall Study|Participants were transferred to commercial product.|3|||
13123764|NCT02953639|25950944|FG000|Overall Study|Adverse Event|2|||
13123765|NCT02953639|25950945|FG001|Overall Study|Adverse Event|0|||
13123766|NCT02953639|25950946|FG002|Overall Study|Adverse Event|1|||
13123767|NCT02953639|25950944|FG000|Overall Study|Lost to Follow-up|8|||
13123768|NCT02953639|25950945|FG001|Overall Study|Lost to Follow-up|4|||
13123769|NCT02953639|25950946|FG002|Overall Study|Lost to Follow-up|3|||
13123770|NCT02953639|25950944|FG000|Overall Study|Non-Compliance With Study Drug|0|||
13123771|NCT02953639|25950945|FG001|Overall Study|Non-Compliance With Study Drug|2|||
13123772|NCT02953639|25950946|FG002|Overall Study|Non-Compliance With Study Drug|1|||
13123773|NCT02953639|25950944|FG000|Overall Study|Multiple Reasons|1|||
13123774|NCT02953639|25950945|FG001|Overall Study|Multiple Reasons|0|||
13123775|NCT02953639|25950946|FG002|Overall Study|Multiple Reasons|1|||
13123776|NCT02953639|25950944|FG000|Overall Study|Physician Decision|1|||
13123777|NCT02953639|25950945|FG001|Overall Study|Physician Decision|0|||
13123778|NCT02953639|25950946|FG002|Overall Study|Physician Decision|0|||
13123779|NCT02953639|25950944|FG000|Overall Study|Withdrawal by Subject|7|||
13333720|NCT01090310|26605701|FG002|Extension Study|Adverse Event|0|||
13333721|NCT01090310|26605702|FG003|Extension Study|Adverse Event|1|||
13333722|NCT01090310|26605699|FG000|Extension Study|Unsatisfactory therapeutic effect|1|||
13333723|NCT01090310|26605700|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
13333724|NCT01090310|26605701|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
13333725|NCT01090310|26605702|FG003|Extension Study|Unsatisfactory therapeutic effect|1|||
13333726|NCT01090310|26605699|FG000|Extension Study|Subject withdrew consent|0|||
13333727|NCT01090310|26605700|FG001|Extension Study|Subject withdrew consent|1|||
13333728|NCT01090310|26605701|FG002|Extension Study|Subject withdrew consent|0|||
13333729|NCT01090310|26605702|FG003|Extension Study|Subject withdrew consent|0|||
13333730|NCT01090102|26605717|FG000|First 12 Weeks|Withdrawal by Subject|1|||
13333731|NCT01090102|26605718|FG001|First 12 Weeks|Withdrawal by Subject|1|||
13333732|NCT01090102|26605717|FG000|First 12 Weeks|Adverse Event|2|||
13333733|NCT01090102|26605718|FG001|First 12 Weeks|Adverse Event|0|||
13333734|NCT01090102|26605717|FG000|First 12 Weeks|Death|1|||
13333735|NCT01090102|26605718|FG001|First 12 Weeks|Death|1|||
13333736|NCT01090102|26605717|FG000|Second 12 Weeks|Withdrawal by Subject|0|||
13333737|NCT01090102|26605718|FG001|Second 12 Weeks|Withdrawal by Subject|1|||
13123780|NCT02953639|25950945|FG001|Overall Study|Withdrawal by Subject|8|||
13123781|NCT02953639|25950946|FG002|Overall Study|Withdrawal by Subject|10|||
13123782|NCT02953639|25950944|FG000|Overall Study|Completed or Discontinued information is missing|1|||
13123783|NCT02953639|25950945|FG001|Overall Study|Completed or Discontinued information is missing|0|||
13123784|NCT02953639|25950946|FG002|Overall Study|Completed or Discontinued information is missing|0|||
13123785|NCT02953340|25950981|FG000|Overall Study|Death|0|||
13123786|NCT02953340|25950982|FG001|Overall Study|Death|1|||
13123787|NCT02953340|25950981|FG000|Overall Study|Investigator Decision|3|||
13123788|NCT02953340|25950982|FG001|Overall Study|Investigator Decision|3|||
13123789|NCT02953340|25950981|FG000|Overall Study|Initiated Non-Protocol Therapy|5|||
13123790|NCT02953340|25950982|FG001|Overall Study|Initiated Non-Protocol Therapy|14|||
13123791|NCT02953340|25950981|FG000|Overall Study|Myeloid Growth Factors Treatment|0|||
13123792|NCT02953340|25950982|FG001|Overall Study|Myeloid Growth Factors Treatment|1|||
13123793|NCT02953340|25950981|FG000|Overall Study|Withdrawal by Subject|9|||
13123794|NCT02953340|25950982|FG001|Overall Study|Withdrawal by Subject|9|||
13123795|NCT02953340|25950981|FG000|Overall Study|Sponsor decision|0|||
13123796|NCT02953340|25950982|FG001|Overall Study|Sponsor decision|2|||
13123797|NCT02953340|25950981|FG000|Overall Study|Lost to Follow-up|3|||
13123798|NCT02953340|25950982|FG001|Overall Study|Lost to Follow-up|2|||
13123799|NCT02953340|25950981|FG000|Overall Study|Reason not specified|2|||
13123800|NCT02953340|25950982|FG001|Overall Study|Reason not specified|2|||
13123801|NCT02953314|25951012|FG000|Overall Study|Adverse Event|0|||
13123802|NCT02953314|25951013|FG001|Overall Study|Adverse Event|1|||
13123803|NCT02953314|25951012|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
13123804|NCT02953314|25951013|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
13123805|NCT02953262|25951048|FG000|Overall Study|Used portal during 6 months prior to randomization|3|||
13333738|NCT01090076|26605735|FG000|Overall Study|Death|1|||
13123806|NCT02953262|25951049|FG001|Overall Study|Used portal during 6 months prior to randomization|6|||
13123807|NCT02953262|25951050|FG002|Overall Study|Used portal during 6 months prior to randomization|3|||
13123808|NCT02953262|25951051|FG003|Overall Study|Used portal during 6 months prior to randomization|3|||
13333739|NCT01090076|26605736|FG001|Overall Study|Death|1|||
13333740|NCT01090076|26605735|FG000|Overall Study|Withdrawal by Subject|0|||
13333741|NCT01090076|26605736|FG001|Overall Study|Withdrawal by Subject|1|||
13333742|NCT01090063|26605752|FG000|Screen|Screen Failed|4|||
13333743|NCT01090063|26605752|FG000|Treatment|Withdrawal by Subject|4|||
13333744|NCT01090050|26605779|FG000|Overall Study|Lost to Follow-up|0|||
13333745|NCT01090050|26605780|FG001|Overall Study|Lost to Follow-up|1|||
13333746|NCT01090050|26605779|FG000|Overall Study|Lack of Efficacy|1|||
13333747|NCT01090050|26605780|FG001|Overall Study|Lack of Efficacy|5|||
13333748|NCT01090050|26605779|FG000|Overall Study|Physician Decision|0|||
13333749|NCT01090050|26605780|FG001|Overall Study|Physician Decision|1|||
13333750|NCT01090024|26605813|FG000|Period 1|Met exclusion criteria|0|||
13333751|NCT01090024|26605814|FG001|Period 1|Met exclusion criteria|0|||
13333752|NCT01090024|26605815|FG002|Period 1|Met exclusion criteria|0|||
13333753|NCT01090024|26605816|FG003|Period 1|Met exclusion criteria|0|||
13333754|NCT01090024|26605817|FG004|Period 1|Met exclusion criteria|0|||
13333755|NCT01090024|26605818|FG005|Period 1|Met exclusion criteria|0|||
13333756|NCT01090024|26605819|FG006|Period 1|Met exclusion criteria|0|||
13333757|NCT01090024|26605820|FG007|Period 1|Met exclusion criteria|0|||
13333758|NCT01090024|26605821|FG008|Period 1|Met exclusion criteria|0|||
13333759|NCT01090024|26605822|FG009|Period 1|Met exclusion criteria|0|||
13333760|NCT01090024|26605823|FG010|Period 1|Met exclusion criteria|0|||
13333761|NCT01090024|26605824|FG011|Period 1|Met exclusion criteria|0|||
13333762|NCT01090024|26605825|FG012|Period 1|Met exclusion criteria|0|||
13333763|NCT01090024|26605826|FG013|Period 1|Met exclusion criteria|0|||
13333764|NCT01090024|26605827|FG014|Period 1|Met exclusion criteria|1|||
13333765|NCT01090024|26605828|FG015|Period 1|Met exclusion criteria|0|||
13333766|NCT01090024|26605829|FG016|Period 1|Met exclusion criteria|0|||
13333767|NCT01090024|26605830|FG017|Period 1|Met exclusion criteria|0|||
13333768|NCT01090024|26605813|FG000|Period 1|Adverse Event|0|||
13333769|NCT01090024|26605814|FG001|Period 1|Adverse Event|0|||
13333770|NCT01090024|26605815|FG002|Period 1|Adverse Event|0|||
13333771|NCT01090024|26605816|FG003|Period 1|Adverse Event|0|||
13333772|NCT01090024|26605817|FG004|Period 1|Adverse Event|0|||
13333773|NCT01090024|26605818|FG005|Period 1|Adverse Event|0|||
13333774|NCT01090024|26605819|FG006|Period 1|Adverse Event|0|||
13123809|NCT02952898|25951069|FG000|Overall Study|Withdrawal by Subject|10|||
13123810|NCT02952898|25951070|FG001|Overall Study|Withdrawal by Subject|8|||
13123811|NCT02952898|25951071|FG002|Overall Study|Withdrawal by Subject|8|||
13123812|NCT02952898|25951069|FG000|Overall Study|Adverse Event|8|||
13123813|NCT02952898|25951070|FG001|Overall Study|Adverse Event|8|||
13123814|NCT02952898|25951071|FG002|Overall Study|Adverse Event|3|||
13123815|NCT02952898|25951069|FG000|Overall Study|Lost to Follow-up|3|||
13123816|NCT02952898|25951070|FG001|Overall Study|Lost to Follow-up|2|||
13123817|NCT02952898|25951071|FG002|Overall Study|Lost to Follow-up|2|||
13123818|NCT02952898|25951069|FG000|Overall Study|Non-compliance with study drug|1|||
13123819|NCT02952898|25951070|FG001|Overall Study|Non-compliance with study drug|1|||
13292287|NCT00706797|26485217|FG000|Overall Study|Adverse Event|0|||
13333775|NCT01090024|26605820|FG007|Period 1|Adverse Event|0|||
13333776|NCT01090024|26605821|FG008|Period 1|Adverse Event|0|||
13333777|NCT01090024|26605822|FG009|Period 1|Adverse Event|1|||
13333778|NCT01090024|26605823|FG010|Period 1|Adverse Event|0|||
13333779|NCT01090024|26605824|FG011|Period 1|Adverse Event|1|||
13333780|NCT01090024|26605825|FG012|Period 1|Adverse Event|0|||
13333781|NCT01090024|26605826|FG013|Period 1|Adverse Event|0|||
13333782|NCT01090024|26605827|FG014|Period 1|Adverse Event|0|||
13333783|NCT01090024|26605828|FG015|Period 1|Adverse Event|0|||
13333784|NCT01090024|26605829|FG016|Period 1|Adverse Event|0|||
13333785|NCT01090024|26605830|FG017|Period 1|Adverse Event|1|||
13333786|NCT01090024|26605813|FG000|Period 1|Withdrawal by Subject|0|||
13333787|NCT01090024|26605814|FG001|Period 1|Withdrawal by Subject|0|||
13333788|NCT01090024|26605815|FG002|Period 1|Withdrawal by Subject|0|||
13333789|NCT01090024|26605816|FG003|Period 1|Withdrawal by Subject|1|||
13333790|NCT01090024|26605817|FG004|Period 1|Withdrawal by Subject|0|||
13333791|NCT01090024|26605818|FG005|Period 1|Withdrawal by Subject|0|||
13333792|NCT01090024|26605819|FG006|Period 1|Withdrawal by Subject|0|||
13333793|NCT01090024|26605820|FG007|Period 1|Withdrawal by Subject|0|||
13292288|NCT00706797|26485218|FG001|Overall Study|Adverse Event|3|||
13292289|NCT00706797|26485217|FG000|Overall Study|Withdrawal by Subject|8|||
13292290|NCT00706797|26485218|FG001|Overall Study|Withdrawal by Subject|1|||
13292291|NCT00706797|26485217|FG000|Overall Study|Death|1|||
13292292|NCT00706797|26485218|FG001|Overall Study|Death|0|||
13292293|NCT00706797|26485217|FG000|Overall Study|Discontinuation of study by sponsor|52|||
13292294|NCT00706797|26485218|FG001|Overall Study|Discontinuation of study by sponsor|63|||
13292295|NCT00706797|26485217|FG000|Overall Study|Protocol Violation|3|||
13292296|NCT00706797|26485218|FG001|Overall Study|Protocol Violation|2|||
13292297|NCT00706797|26485217|FG000|Overall Study|Lost to Follow-up|1|||
13333794|NCT01090024|26605821|FG008|Period 1|Withdrawal by Subject|0|||
13333795|NCT01090024|26605822|FG009|Period 1|Withdrawal by Subject|0|||
13333796|NCT01090024|26605823|FG010|Period 1|Withdrawal by Subject|0|||
13333797|NCT01090024|26605824|FG011|Period 1|Withdrawal by Subject|0|||
13333798|NCT01090024|26605825|FG012|Period 1|Withdrawal by Subject|0|||
13333799|NCT01090024|26605826|FG013|Period 1|Withdrawal by Subject|0|||
13333800|NCT01090024|26605827|FG014|Period 1|Withdrawal by Subject|0|||
13333801|NCT01090024|26605828|FG015|Period 1|Withdrawal by Subject|0|||
13333802|NCT01090024|26605829|FG016|Period 1|Withdrawal by Subject|0|||
13333803|NCT01090024|26605830|FG017|Period 1|Withdrawal by Subject|0|||
13333804|NCT01090024|26605813|FG000|Period 1|Lost to Follow-up|0|||
13333805|NCT01090024|26605814|FG001|Period 1|Lost to Follow-up|1|||
13333806|NCT01090024|26605815|FG002|Period 1|Lost to Follow-up|0|||
13333807|NCT01090024|26605816|FG003|Period 1|Lost to Follow-up|0|||
13333808|NCT01090024|26605817|FG004|Period 1|Lost to Follow-up|0|||
13333809|NCT01090024|26605818|FG005|Period 1|Lost to Follow-up|0|||
13333810|NCT01090024|26605819|FG006|Period 1|Lost to Follow-up|0|||
13333811|NCT01090024|26605820|FG007|Period 1|Lost to Follow-up|0|||
13333812|NCT01090024|26605821|FG008|Period 1|Lost to Follow-up|0|||
13333813|NCT01090024|26605822|FG009|Period 1|Lost to Follow-up|0|||
13333814|NCT01090024|26605823|FG010|Period 1|Lost to Follow-up|0|||
13333815|NCT01090024|26605824|FG011|Period 1|Lost to Follow-up|0|||
13333816|NCT01090024|26605825|FG012|Period 1|Lost to Follow-up|0|||
13333817|NCT01090024|26605826|FG013|Period 1|Lost to Follow-up|0|||
13333818|NCT01090024|26605827|FG014|Period 1|Lost to Follow-up|0|||
13333819|NCT01090024|26605828|FG015|Period 1|Lost to Follow-up|0|||
13333820|NCT01090024|26605829|FG016|Period 1|Lost to Follow-up|0|||
13333821|NCT01090024|26605830|FG017|Period 1|Lost to Follow-up|0|||
13333822|NCT01090024|26605813|FG000|Period 2|Lost to Follow-up|0|||
13333823|NCT01090024|26605814|FG001|Period 2|Lost to Follow-up|0|||
13333824|NCT01090024|26605815|FG002|Period 2|Lost to Follow-up|0|||
13333825|NCT01090024|26605816|FG003|Period 2|Lost to Follow-up|1|||
13333826|NCT01090024|26605817|FG004|Period 2|Lost to Follow-up|0|||
13333827|NCT01090024|26605818|FG005|Period 2|Lost to Follow-up|0|||
13333828|NCT01090024|26605819|FG006|Period 2|Lost to Follow-up|0|||
13333829|NCT01090024|26605820|FG007|Period 2|Lost to Follow-up|0|||
13333830|NCT01090024|26605821|FG008|Period 2|Lost to Follow-up|0|||
13333831|NCT01090024|26605822|FG009|Period 2|Lost to Follow-up|0|||
13333832|NCT01090024|26605823|FG010|Period 2|Lost to Follow-up|0|||
13333833|NCT01090024|26605824|FG011|Period 2|Lost to Follow-up|0|||
13333834|NCT01090024|26605825|FG012|Period 2|Lost to Follow-up|0|||
13333835|NCT01090024|26605826|FG013|Period 2|Lost to Follow-up|0|||
13123820|NCT02952898|25951071|FG002|Overall Study|Non-compliance with study drug|2|||
13133521|NCT02769065|25988343|FG002|Overall Study|Pre-treatment Event/Adverse Event|0|||
13133522|NCT02769065|25988344|FG003|Overall Study|Pre-treatment Event/Adverse Event|0|||
13204154|NCT01976728|26227591|FG000|Overall Study|Subject missed multiple doses of IMP|1|||
13204155|NCT01976728|26227592|FG001|Overall Study|Subject missed multiple doses of IMP|0|||
13204156|NCT01976728|26227593|FG002|Overall Study|Subject missed multiple doses of IMP|0|||
13204157|NCT01976728|26227594|FG003|Overall Study|Subject missed multiple doses of IMP|0|||
13204158|NCT01976663|26227610|FG000|Overall Study|Completed 18 mos but no repeat treatment|24|||
13204159|NCT01976663|26227610|FG000|Overall Study|Personal Reasons|6|||
13204160|NCT01976663|26227610|FG000|Overall Study|Withdrawal by Subject|4|||
13204161|NCT01976663|26227610|FG000|Overall Study|Screen Failure|3|||
13204162|NCT01976663|26227610|FG000|Overall Study|Adverse Event|2|||
13204163|NCT01976663|26227610|FG000|Overall Study|Lost to Follow-up|3|||
13204164|NCT01976624|26227617|FG000|Overall Study|Participants contraindicated|2|||
13204165|NCT01976624|26227617|FG000|Overall Study|Participants age less than 19 years|12|||
13204166|NCT01976507|26227626|FG000|Overall Study|Adverse Event|6|||
13204167|NCT01976507|26227626|FG000|Overall Study|ablation not done, drug not given|1|||
13204168|NCT01976364|26227748|FG000|Main Study (36 Months)|Adverse Event|63|||
13204169|NCT01976364|26227749|FG001|Main Study (36 Months)|Adverse Event|0|||
13204170|NCT01976364|26227750|FG002|Main Study (36 Months)|Adverse Event|0|||
13204171|NCT01976364|26227748|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5|||
13204172|NCT01976364|26227749|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
13204173|NCT01976364|26227750|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
13204174|NCT01976364|26227748|FG000|Main Study (36 Months)|Other|13|||
13204175|NCT01976364|26227749|FG001|Main Study (36 Months)|Other|0|||
13204176|NCT01976364|26227750|FG002|Main Study (36 Months)|Other|0|||
13204177|NCT01976364|26227748|FG000|Main Study (36 Months)|No longer met eligibility criteria|2|||
13204178|NCT01976364|26227749|FG001|Main Study (36 Months)|No longer met eligibility criteria|0|||
13204179|NCT01976364|26227750|FG002|Main Study (36 Months)|No longer met eligibility criteria|0|||
13204180|NCT01976364|26227748|FG000|Main Study (36 Months)|Medication error|1|||
13333836|NCT01090024|26605827|FG014|Period 2|Lost to Follow-up|0|||
13333837|NCT01090024|26605828|FG015|Period 2|Lost to Follow-up|0|||
13333838|NCT01090024|26605829|FG016|Period 2|Lost to Follow-up|0|||
13333839|NCT01090024|26605830|FG017|Period 2|Lost to Follow-up|0|||
13333840|NCT01090024|26605813|FG000|Period 2|Adverse Event|1|||
13333841|NCT01090024|26605814|FG001|Period 2|Adverse Event|0|||
13123821|NCT02952820|25951141|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8|||
13123822|NCT02952820|25951142|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9|||
13123823|NCT02952820|25951143|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16|||
13123824|NCT02952820|25951141|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
13123825|NCT02952820|25951142|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
13123826|NCT02952820|25951143|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6|||
13123827|NCT02952820|25951141|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15|||
13333842|NCT01090024|26605815|FG002|Period 2|Adverse Event|0|||
13333843|NCT01090024|26605816|FG003|Period 2|Adverse Event|0|||
13333844|NCT01090024|26605817|FG004|Period 2|Adverse Event|0|||
13333845|NCT01090024|26605818|FG005|Period 2|Adverse Event|0|||
13333846|NCT01090024|26605819|FG006|Period 2|Adverse Event|0|||
13333847|NCT01090024|26605820|FG007|Period 2|Adverse Event|0|||
13333848|NCT01090024|26605821|FG008|Period 2|Adverse Event|0|||
13333849|NCT01090024|26605822|FG009|Period 2|Adverse Event|0|||
13333850|NCT01090024|26605823|FG010|Period 2|Adverse Event|0|||
13333851|NCT01090024|26605824|FG011|Period 2|Adverse Event|0|||
13333852|NCT01090024|26605825|FG012|Period 2|Adverse Event|0|||
13333853|NCT01090024|26605826|FG013|Period 2|Adverse Event|0|||
13333854|NCT01090024|26605827|FG014|Period 2|Adverse Event|0|||
13333855|NCT01090024|26605828|FG015|Period 2|Adverse Event|0|||
13333856|NCT01090024|26605829|FG016|Period 2|Adverse Event|0|||
13333857|NCT01090024|26605830|FG017|Period 2|Adverse Event|0|||
13333858|NCT01090024|26605813|FG000|Period 3|Withdrawal by Subject|0|||
13333859|NCT01090024|26605814|FG001|Period 3|Withdrawal by Subject|0|||
13333860|NCT01090024|26605815|FG002|Period 3|Withdrawal by Subject|0|||
13333861|NCT01090024|26605816|FG003|Period 3|Withdrawal by Subject|0|||
13333862|NCT01090024|26605817|FG004|Period 3|Withdrawal by Subject|0|||
13333863|NCT01090024|26605818|FG005|Period 3|Withdrawal by Subject|0|||
13123828|NCT02952820|25951142|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12|||
13123829|NCT02952820|25951143|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17|||
13123830|NCT02952820|25951141|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17|||
13123831|NCT02952820|25951142|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12|||
13123832|NCT02952820|25951143|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11|||
13123833|NCT02952820|25951141|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0|||
13123834|NCT02952820|25951142|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14|||
13123835|NCT02952820|25951143|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13|||
13123836|NCT02952820|25951141|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13|||
13123837|NCT02952820|25951142|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11|||
13123838|NCT02952820|25951143|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21|||
13123839|NCT02952820|25951141|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
13123840|NCT02952820|25951142|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
13123841|NCT02952820|25951143|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
13123842|NCT02952820|25951141|FG000|Active Treatment Period (6 Months)|Adverse Event|0|||
13123843|NCT02952820|25951142|FG001|Active Treatment Period (6 Months)|Adverse Event|6|||
13123844|NCT02952820|25951143|FG002|Active Treatment Period (6 Months)|Adverse Event|5|||
13123845|NCT02952820|25951141|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0|||
13123846|NCT02952820|25951142|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4|||
13123847|NCT02952820|25951143|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6|||
13123848|NCT02952820|25951141|FG000|Active Treatment Period (6 Months)|Subject choice|0|||
13123849|NCT02952820|25951142|FG001|Active Treatment Period (6 Months)|Subject choice|10|||
13123850|NCT02952820|25951143|FG002|Active Treatment Period (6 Months)|Subject choice|7|||
13123851|NCT02952820|25951141|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0|||
13123852|NCT02952820|25951142|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6|||
13123853|NCT02952820|25951143|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2|||
13123854|NCT02952820|25951141|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0|||
13123855|NCT02952820|25951142|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6|||
13123856|NCT02952820|25951143|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8|||
13123857|NCT02952820|25951141|FG000|Active Treatment Period (6 Months)|Other than specified|0|||
13123858|NCT02952820|25951142|FG001|Active Treatment Period (6 Months)|Other than specified|6|||
13333864|NCT01090024|26605819|FG006|Period 3|Withdrawal by Subject|0|||
13333865|NCT01090024|26605820|FG007|Period 3|Withdrawal by Subject|0|||
13333866|NCT01090024|26605821|FG008|Period 3|Withdrawal by Subject|0|||
13333867|NCT01090024|26605822|FG009|Period 3|Withdrawal by Subject|0|||
13333868|NCT01090024|26605823|FG010|Period 3|Withdrawal by Subject|0|||
13333869|NCT01090024|26605824|FG011|Period 3|Withdrawal by Subject|0|||
13333870|NCT01090024|26605825|FG012|Period 3|Withdrawal by Subject|0|||
13333871|NCT01090024|26605826|FG013|Period 3|Withdrawal by Subject|0|||
13333872|NCT01090024|26605827|FG014|Period 3|Withdrawal by Subject|0|||
13333873|NCT01090024|26605828|FG015|Period 3|Withdrawal by Subject|1|||
13333874|NCT01090024|26605829|FG016|Period 3|Withdrawal by Subject|0|||
13333875|NCT01090024|26605830|FG017|Period 3|Withdrawal by Subject|0|||
13333876|NCT01090024|26605813|FG000|Period 3|Protocol Violation|0|||
13123859|NCT02952820|25951143|FG002|Active Treatment Period (6 Months)|Other than specified|2|||
13123860|NCT02952820|25951141|FG000|Active Treatment Period (6 Months)|Not treated|0|||
13123861|NCT02952820|25951142|FG001|Active Treatment Period (6 Months)|Not treated|0|||
13123862|NCT02952820|25951143|FG002|Active Treatment Period (6 Months)|Not treated|1|||
13123863|NCT02952586|25951201|FG000|Lead-In Phase (7 Days)|Death|0|||
13123864|NCT02952586|25951202|FG001|Lead-In Phase (7 Days)|Death|1|||
13123865|NCT02952586|25951201|FG000|Lead-In Phase (7 Days)|Adverse Event|3|||
13123866|NCT02952586|25951202|FG001|Lead-In Phase (7 Days)|Adverse Event|0|||
13123867|NCT02952586|25951201|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0|||
13123868|NCT02952586|25951202|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1|||
13123869|NCT02952586|25951201|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
13123870|NCT02952586|25951202|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
13123871|NCT02952586|25951201|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5|||
13123872|NCT02952586|25951202|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8|||
13123873|NCT02952586|25951201|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
13123874|NCT02952586|25951202|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
13123875|NCT02952586|25951201|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2|||
13123876|NCT02952586|25951202|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1|||
13123877|NCT02952586|25951201|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1|||
13123878|NCT02952586|25951202|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0|||
13123879|NCT02952586|25951201|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10|||
13123880|NCT02952586|25951202|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4|||
13123881|NCT02952586|25951201|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
13123882|NCT02952586|25951202|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
13123883|NCT02952586|25951201|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2|||
13123884|NCT02952586|25951202|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1|||
13123885|NCT02952586|25951201|FG000|CRT for Cisplatin (63 Days)|Death|3|||
13123886|NCT02952586|25951202|FG001|CRT for Cisplatin (63 Days)|Death|8|||
13123887|NCT02952586|25951201|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82|||
13123888|NCT02952586|25951202|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81|||
13123889|NCT02952586|25951201|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12|||
13123890|NCT02952586|25951202|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10|||
13123891|NCT02952586|25951201|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1|||
13123892|NCT02952586|25951202|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0|||
13123893|NCT02952586|25951201|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11|||
13123894|NCT02952586|25951202|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3|||
13123895|NCT02952586|25951201|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
13123896|NCT02952586|25951202|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
13123897|NCT02952586|25951201|FG000|CRT for Cisplatin (63 Days)|Other|1|||
13123898|NCT02952586|25951202|FG001|CRT for Cisplatin (63 Days)|Other|1|||
13123899|NCT02952586|25951201|FG000|CRT for IMRT (63 Days)|Death|5|||
13123900|NCT02952586|25951202|FG001|CRT for IMRT (63 Days)|Death|8|||
13123901|NCT02952586|25951201|FG000|CRT for IMRT (63 Days)|Adverse Event|5|||
13123902|NCT02952586|25951202|FG001|CRT for IMRT (63 Days)|Adverse Event|5|||
13123903|NCT02952586|25951201|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1|||
13123904|NCT02952586|25951202|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0|||
13123905|NCT02952586|25951201|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10|||
13123906|NCT02952586|25951202|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6|||
13123907|NCT02952586|25951201|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
13123908|NCT02952586|25951202|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
13123909|NCT02952586|25951201|FG000|CRT for IMRT (63 Days)|Other|1|||
13123910|NCT02952586|25951202|FG001|CRT for IMRT (63 Days)|Other|0|||
13123911|NCT02952586|25951201|FG000|Maintenance Phase (12 Months)|Death|17|||
13123912|NCT02952586|25951202|FG001|Maintenance Phase (12 Months)|Death|11|||
13123913|NCT02952586|25951201|FG000|Maintenance Phase (12 Months)|Progressive disease|60|||
13123914|NCT02952586|25951202|FG001|Maintenance Phase (12 Months)|Progressive disease|54|||
13123915|NCT02952586|25951201|FG000|Maintenance Phase (12 Months)|Adverse Event|24|||
13123916|NCT02952586|25951202|FG001|Maintenance Phase (12 Months)|Adverse Event|21|||
13123917|NCT02952586|25951201|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
13123918|NCT02952586|25951202|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
13123919|NCT02952586|25951201|FG000|Maintenance Phase (12 Months)|Physician Decision|1|||
13123920|NCT02952586|25951202|FG001|Maintenance Phase (12 Months)|Physician Decision|1|||
13123921|NCT02952586|25951201|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14|||
13123922|NCT02952586|25951202|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5|||
13123923|NCT02952586|25951201|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31|||
13123924|NCT02952586|25951202|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25|||
13123925|NCT02952586|25951201|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1|||
13123926|NCT02952586|25951202|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2|||
13123927|NCT02952586|25951201|FG000|Maintenance Phase (12 Months)|Other|2|||
13123928|NCT02952586|25951202|FG001|Maintenance Phase (12 Months)|Other|1|||
13123929|NCT02952586|25951201|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1|||
13123930|NCT02952586|25951202|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6|||
13123931|NCT02952586|25951201|FG000|Follow-Up Phase (90 Days)|Death|12|||
13123932|NCT02952586|25951202|FG001|Follow-Up Phase (90 Days)|Death|10|||
13123933|NCT02952586|25951201|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6|||
13123934|NCT02952586|25951202|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2|||
13123935|NCT02952586|25951201|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
13123936|NCT02952586|25951202|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
13123937|NCT02952586|25951201|FG000|Follow-Up Phase (90 Days)|Other|7|||
13123938|NCT02952586|25951202|FG001|Follow-Up Phase (90 Days)|Other|5|||
13123939|NCT02952586|25951201|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32|||
13333877|NCT01090024|26605814|FG001|Period 3|Protocol Violation|0|||
13333878|NCT01090024|26605815|FG002|Period 3|Protocol Violation|0|||
13333879|NCT01090024|26605816|FG003|Period 3|Protocol Violation|0|||
13333880|NCT01090024|26605817|FG004|Period 3|Protocol Violation|0|||
13333881|NCT01090024|26605818|FG005|Period 3|Protocol Violation|0|||
13333882|NCT01090024|26605819|FG006|Period 3|Protocol Violation|0|||
13333883|NCT01090024|26605820|FG007|Period 3|Protocol Violation|0|||
13333884|NCT01090024|26605821|FG008|Period 3|Protocol Violation|1|||
13333885|NCT01090024|26605822|FG009|Period 3|Protocol Violation|0|||
13333886|NCT01090024|26605823|FG010|Period 3|Protocol Violation|0|||
13333887|NCT01090024|26605824|FG011|Period 3|Protocol Violation|0|||
13333888|NCT01090024|26605825|FG012|Period 3|Protocol Violation|0|||
13333889|NCT01090024|26605826|FG013|Period 3|Protocol Violation|0|||
13333890|NCT01090024|26605827|FG014|Period 3|Protocol Violation|0|||
13333891|NCT01090024|26605828|FG015|Period 3|Protocol Violation|0|||
13333892|NCT01090024|26605829|FG016|Period 3|Protocol Violation|0|||
13333893|NCT01090024|26605830|FG017|Period 3|Protocol Violation|0|||
13333894|NCT01090024|26605813|FG000|Period 3|Adverse Event|0|||
13333895|NCT01090024|26605814|FG001|Period 3|Adverse Event|0|||
13333896|NCT01090024|26605815|FG002|Period 3|Adverse Event|0|||
13333897|NCT01090024|26605816|FG003|Period 3|Adverse Event|0|||
13333898|NCT01090024|26605817|FG004|Period 3|Adverse Event|0|||
13333899|NCT01090024|26605818|FG005|Period 3|Adverse Event|1|||
13333900|NCT01090024|26605819|FG006|Period 3|Adverse Event|0|||
13333901|NCT01090024|26605820|FG007|Period 3|Adverse Event|0|||
13333902|NCT01090024|26605821|FG008|Period 3|Adverse Event|0|||
13123940|NCT02952586|25951202|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50|||
13123941|NCT02952586|25951201|FG000|LT Follow-up (up to 45 Months)|Death|51|||
13123942|NCT02952586|25951202|FG001|LT Follow-up (up to 45 Months)|Death|31|||
13123943|NCT02952586|25951201|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7|||
13333903|NCT01090024|26605822|FG009|Period 3|Adverse Event|0|||
13333904|NCT01090024|26605823|FG010|Period 3|Adverse Event|0|||
13123944|NCT02952586|25951202|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1|||
13123945|NCT02952586|25951201|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2|||
13123946|NCT02952586|25951202|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4|||
13123947|NCT02952586|25951201|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187|||
13123948|NCT02952586|25951202|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201|||
13123949|NCT02952313|25951213|FG000|Primary Endpoint|Lost to Follow-up|4|||
13123950|NCT02952313|25951213|FG000|Primary Endpoint|Withdrawal by Subject|1|||
13123951|NCT02952313|25951213|FG000|Primary Endpoint|Lack of Efficacy|1|||
13123952|NCT02952313|25951213|FG000|Primary Endpoint|Missed visit|1|||
13123953|NCT02952313|25951213|FG000|Long-term Follow-up|Lost to Follow-up|12|||
13123954|NCT02952313|25951213|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7|||
13123955|NCT02952313|25951213|FG000|Long-term Follow-up|Lack of Efficacy|6|||
13123956|NCT02952313|25951213|FG000|Long-term Follow-up|Withdrawal by Subject|5|||
13123957|NCT02952313|25951213|FG000|Long-term Follow-up|Physician Decision|1|||
13123958|NCT02952313|25951213|FG000|Long-term Follow-up|Death|1|||
13333905|NCT01090024|26605824|FG011|Period 3|Adverse Event|0|||
13333906|NCT01090024|26605825|FG012|Period 3|Adverse Event|0|||
13333907|NCT01090024|26605826|FG013|Period 3|Adverse Event|0|||
13333908|NCT01090024|26605827|FG014|Period 3|Adverse Event|0|||
13333909|NCT01090024|26605828|FG015|Period 3|Adverse Event|0|||
13333910|NCT01090024|26605829|FG016|Period 3|Adverse Event|0|||
13333911|NCT01090024|26605830|FG017|Period 3|Adverse Event|0|||
13333912|NCT01090011|26605900|FG000|Overall Study|Progressive disease|128|||
13333913|NCT01090011|26605900|FG000|Overall Study|Adverse Event|32|||
13333914|NCT01090011|26605900|FG000|Overall Study|Protocol Violation|1|||
13333915|NCT01090011|26605900|FG000|Overall Study|Refusal to start/continue medication|5|||
13333916|NCT01090011|26605900|FG000|Overall Study|Other reason not defined above|5|||
13333917|NCT01089725|26606081|FG000|Overall Study|Adverse Event|1|||
13333918|NCT01089725|26606082|FG001|Overall Study|Adverse Event|1|||
13333919|NCT01089725|26606083|FG002|Overall Study|Adverse Event|0|||
13333920|NCT01089725|26606084|FG003|Overall Study|Adverse Event|0|||
13333921|NCT01089725|26606085|FG004|Overall Study|Adverse Event|2|||
13333922|NCT01089725|26606081|FG000|Overall Study|Lack of Efficacy|4|||
13333923|NCT01089725|26606082|FG001|Overall Study|Lack of Efficacy|3|||
13333924|NCT01089725|26606083|FG002|Overall Study|Lack of Efficacy|1|||
13333925|NCT01089725|26606084|FG003|Overall Study|Lack of Efficacy|0|||
13333926|NCT01089725|26606085|FG004|Overall Study|Lack of Efficacy|4|||
13333927|NCT01089725|26606081|FG000|Overall Study|Lost to Follow-up|2|||
13333928|NCT01089725|26606082|FG001|Overall Study|Lost to Follow-up|2|||
13333929|NCT01089725|26606083|FG002|Overall Study|Lost to Follow-up|0|||
13333930|NCT01089725|26606084|FG003|Overall Study|Lost to Follow-up|3|||
13333931|NCT01089725|26606085|FG004|Overall Study|Lost to Follow-up|0|||
13333932|NCT01089725|26606081|FG000|Overall Study|Protocol Violation|0|||
13333933|NCT01089725|26606082|FG001|Overall Study|Protocol Violation|0|||
13333934|NCT01089725|26606083|FG002|Overall Study|Protocol Violation|1|||
13333935|NCT01089725|26606084|FG003|Overall Study|Protocol Violation|1|||
13333936|NCT01089725|26606085|FG004|Overall Study|Protocol Violation|0|||
13333937|NCT01089725|26606081|FG000|Overall Study|Withdrawal by Subject|5|||
13333938|NCT01089725|26606082|FG001|Overall Study|Withdrawal by Subject|5|||
13333939|NCT01089725|26606083|FG002|Overall Study|Withdrawal by Subject|4|||
13333940|NCT01089725|26606084|FG003|Overall Study|Withdrawal by Subject|5|||
13333941|NCT01089725|26606085|FG004|Overall Study|Withdrawal by Subject|4|||
13123959|NCT02952261|25951232|FG000|Overall Study|Withdrawal by Subject|4|||
13123960|NCT02952261|25951233|FG001|Overall Study|Withdrawal by Subject|5|||
13123961|NCT02952261|25951232|FG000|Overall Study|Protocol Violation|1|||
13123962|NCT02952261|25951233|FG001|Overall Study|Protocol Violation|0|||
13123963|NCT02952001|25951252|FG000|Overall Study|Adverse Event|3|||
13123964|NCT02952001|25951253|FG001|Overall Study|Adverse Event|0|||
13123965|NCT02952001|25951252|FG000|Overall Study|Prohibited therapy|10|||
13123966|NCT02952001|25951253|FG001|Overall Study|Prohibited therapy|3|||
13123967|NCT02952001|25951252|FG000|Overall Study|Due to Posterior Capsular Opacity|1|||
13123968|NCT02952001|25951253|FG001|Overall Study|Due to Posterior Capsular Opacity|0|||
13123969|NCT02951988|25951279|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8|||
13123970|NCT02951988|25951280|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0|||
13123971|NCT02951988|25951281|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0|||
13123972|NCT02951988|25951282|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0|||
13123973|NCT02951988|25951279|FG000|Open-Label Treatment Period|Study terminated by sponsor|9|||
13123974|NCT02951988|25951280|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
13333942|NCT01089725|26606081|FG000|Overall Study|Study Terminated by Sponsor|51|||
13123975|NCT02951988|25951281|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
13123976|NCT02951988|25951282|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
13123977|NCT02951988|25951279|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2|||
13123978|NCT02951988|25951280|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0|||
13123979|NCT02951988|25951281|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0|||
13123980|NCT02951988|25951282|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0|||
13123981|NCT02951988|25951279|FG000|Open-Label Treatment Period|Non-compliance with study drug|5|||
13123982|NCT02951988|25951280|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
13123983|NCT02951988|25951281|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
13123984|NCT02951988|25951282|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
13123985|NCT02951988|25951279|FG000|Open-Label Treatment Period|Protocol Violation|22|||
13123986|NCT02951988|25951280|FG001|Open-Label Treatment Period|Protocol Violation|0|||
13123987|NCT02951988|25951281|FG002|Open-Label Treatment Period|Protocol Violation|0|||
13123988|NCT02951988|25951282|FG003|Open-Label Treatment Period|Protocol Violation|0|||
13123989|NCT02951988|25951279|FG000|Open-Label Treatment Period|Pregnancy|2|||
13123990|NCT02951988|25951280|FG001|Open-Label Treatment Period|Pregnancy|0|||
13123991|NCT02951988|25951281|FG002|Open-Label Treatment Period|Pregnancy|0|||
13123992|NCT02951988|25951282|FG003|Open-Label Treatment Period|Pregnancy|0|||
13123993|NCT02951988|25951279|FG000|Open-Label Treatment Period|Lost to Follow-up|28|||
13123994|NCT02951988|25951280|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
13123995|NCT02951988|25951281|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
13123996|NCT02951988|25951282|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
13123997|NCT02951988|25951279|FG000|Open-Label Treatment Period|Withdrawal by Subject|78|||
13123998|NCT02951988|25951280|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
13123999|NCT02951988|25951281|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
13124000|NCT02951988|25951282|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
13124001|NCT02951988|25951279|FG000|Open-Label Treatment Period|Lack of Efficacy|49|||
13124002|NCT02951988|25951280|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
13124003|NCT02951988|25951281|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
13124004|NCT02951988|25951282|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
13124005|NCT02951988|25951279|FG000|Open-Label Treatment Period|Adverse Event|45|||
13124006|NCT02951988|25951280|FG001|Open-Label Treatment Period|Adverse Event|0|||
13124007|NCT02951988|25951281|FG002|Open-Label Treatment Period|Adverse Event|0|||
13124008|NCT02951988|25951282|FG003|Open-Label Treatment Period|Adverse Event|0|||
13333943|NCT01089725|26606082|FG001|Overall Study|Study Terminated by Sponsor|56|||
13333944|NCT01089725|26606083|FG002|Overall Study|Study Terminated by Sponsor|53|||
13333945|NCT01089725|26606084|FG003|Overall Study|Study Terminated by Sponsor|68|||
13333946|NCT01089725|26606085|FG004|Overall Study|Study Terminated by Sponsor|68|||
13124009|NCT02951988|25951279|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0|||
13124010|NCT02951988|25951280|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0|||
13124011|NCT02951988|25951281|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1|||
13124012|NCT02951988|25951282|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1|||
13124013|NCT02951988|25951279|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0|||
13124014|NCT02951988|25951280|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58|||
13124015|NCT02951988|25951281|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54|||
13124016|NCT02951988|25951282|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69|||
13124017|NCT02951988|25951279|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0|||
13124018|NCT02951988|25951280|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1|||
13124019|NCT02951988|25951281|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3|||
13124020|NCT02951988|25951282|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0|||
13124021|NCT02951988|25951279|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
13124022|NCT02951988|25951280|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
13124023|NCT02951988|25951281|FG002|Double-Blind Treatment Period|Protocol Violation|4|||
13124024|NCT02951988|25951282|FG003|Double-Blind Treatment Period|Protocol Violation|8|||
13124025|NCT02951988|25951279|FG000|Double-Blind Treatment Period|Pregnancy|0|||
13124026|NCT02951988|25951280|FG001|Double-Blind Treatment Period|Pregnancy|1|||
13124027|NCT02951988|25951281|FG002|Double-Blind Treatment Period|Pregnancy|1|||
13124028|NCT02951988|25951282|FG003|Double-Blind Treatment Period|Pregnancy|0|||
13124029|NCT02951988|25951279|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
13124030|NCT02951988|25951280|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
13124031|NCT02951988|25951281|FG002|Double-Blind Treatment Period|Lost to Follow-up|12|||
13124032|NCT02951988|25951282|FG003|Double-Blind Treatment Period|Lost to Follow-up|3|||
13124033|NCT02951988|25951279|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
13124034|NCT02951988|25951280|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
13124035|NCT02951988|25951281|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22|||
13124036|NCT02951988|25951282|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28|||
13124037|NCT02951988|25951279|FG000|Double-Blind Treatment Period|Adverse Event|0|||
13124038|NCT02951988|25951280|FG001|Double-Blind Treatment Period|Adverse Event|8|||
13124039|NCT02951988|25951281|FG002|Double-Blind Treatment Period|Adverse Event|3|||
13124040|NCT02951988|25951282|FG003|Double-Blind Treatment Period|Adverse Event|6|||
13124041|NCT02951988|25951279|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
13124042|NCT02951988|25951280|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2|||
13124043|NCT02951988|25951281|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1|||
13124044|NCT02951988|25951282|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
13124045|NCT02951819|25951311|FG000|Overall Study|Death|9|||
13124046|NCT02951819|25951312|FG001|Overall Study|Death|7|||
13124047|NCT02951819|25951311|FG000|Overall Study|Withdrawal by Subject|3|||
13124048|NCT02951819|25951312|FG001|Overall Study|Withdrawal by Subject|0|||
13124049|NCT02951819|25951311|FG000|Overall Study|Adverse Event|1|||
13124050|NCT02951819|25951312|FG001|Overall Study|Adverse Event|0|||
13124051|NCT02951819|25951311|FG000|Overall Study|Lack of Efficacy|4|||
13124052|NCT02951819|25951312|FG001|Overall Study|Lack of Efficacy|0|||
13124053|NCT02951819|25951311|FG000|Overall Study|Lost to Follow-up|1|||
13124054|NCT02951819|25951312|FG001|Overall Study|Lost to Follow-up|0|||
13124055|NCT02951819|25951311|FG000|Overall Study|Progressive Disease|1|||
13124056|NCT02951819|25951312|FG001|Overall Study|Progressive Disease|0|||
13124057|NCT02951819|25951311|FG000|Overall Study|Other|9|||
13124058|NCT02951819|25951312|FG001|Overall Study|Other|0|||
13124059|NCT02951780|25951405|FG000|Period 1|Adverse Event|0|||
13124060|NCT02951780|25951406|FG001|Period 1|Adverse Event|0|||
13124061|NCT02951780|25951407|FG002|Period 1|Adverse Event|0|||
13124062|NCT02951780|25951408|FG003|Period 1|Adverse Event|1|||
13124063|NCT02951780|25951409|FG004|Period 1|Adverse Event|0|||
13124064|NCT02951780|25951410|FG005|Period 1|Adverse Event|0|||
13124065|NCT02951780|25951411|FG006|Period 1|Adverse Event|0|||
13124066|NCT02951780|25951412|FG007|Period 1|Adverse Event|0|||
13124067|NCT02951780|25951413|FG008|Period 1|Adverse Event|0|||
13124068|NCT02951780|25951405|FG000|Period 1|Scheduling Conflicts|0|||
13124069|NCT02951780|25951406|FG001|Period 1|Scheduling Conflicts|0|||
13124070|NCT02951780|25951407|FG002|Period 1|Scheduling Conflicts|0|||
13124071|NCT02951780|25951408|FG003|Period 1|Scheduling Conflicts|0|||
13124072|NCT02951780|25951409|FG004|Period 1|Scheduling Conflicts|0|||
13124073|NCT02951780|25951410|FG005|Period 1|Scheduling Conflicts|0|||
13124074|NCT02951780|25951411|FG006|Period 1|Scheduling Conflicts|0|||
13124075|NCT02951780|25951412|FG007|Period 1|Scheduling Conflicts|1|||
13124076|NCT02951780|25951413|FG008|Period 1|Scheduling Conflicts|0|||
13124077|NCT02951780|25951405|FG000|Period 2|Scheduling Conflicts|0|||
13124078|NCT02951780|25951406|FG001|Period 2|Scheduling Conflicts|0|||
13124079|NCT02951780|25951407|FG002|Period 2|Scheduling Conflicts|0|||
13124080|NCT02951780|25951408|FG003|Period 2|Scheduling Conflicts|0|||
13124081|NCT02951780|25951409|FG004|Period 2|Scheduling Conflicts|0|||
13124082|NCT02951780|25951410|FG005|Period 2|Scheduling Conflicts|0|||
13124083|NCT02951780|25951411|FG006|Period 2|Scheduling Conflicts|0|||
13124084|NCT02951780|25951412|FG007|Period 2|Scheduling Conflicts|1|||
13124085|NCT02951780|25951413|FG008|Period 2|Scheduling Conflicts|0|||
13124086|NCT02951533|25951518|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0|||
13124087|NCT02951533|25951519|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16|||
13124088|NCT02951533|25951520|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0|||
13124089|NCT02951533|25951518|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
13124090|NCT02951533|25951519|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
13124091|NCT02951533|25951520|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0|||
13124092|NCT02951533|25951518|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2|||
13124093|NCT02951533|25951519|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4|||
13124094|NCT02951533|25951520|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0|||
13124095|NCT02951533|25951518|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
13124096|NCT02951533|25951519|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1|||
13124097|NCT02951533|25951520|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
13124098|NCT02951533|25951518|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
13124099|NCT02951533|25951519|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1|||
13124100|NCT02951533|25951520|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
13124101|NCT02951533|25951518|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1|||
13124102|NCT02951533|25951519|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
13124103|NCT02951533|25951520|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
13124104|NCT02951533|25951518|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
13124105|NCT02951533|25951519|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2|||
13124106|NCT02951533|25951520|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
13124107|NCT02951533|25951518|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1|||
13124108|NCT02951533|25951519|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2|||
13124109|NCT02951533|25951520|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0|||
13124110|NCT02951533|25951518|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1|||
13124111|NCT02951533|25951519|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
13124112|NCT02951533|25951520|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
13124113|NCT02951533|25951518|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1|||
13124114|NCT02951533|25951519|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
13124115|NCT02951533|25951520|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
13124116|NCT02951533|25951518|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
13124117|NCT02951533|25951519|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0|||
13124118|NCT02951533|25951520|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
13124119|NCT02951429|25951585|FG000|Overall Study|Adverse Event|3|||
13124120|NCT02951429|25951586|FG001|Overall Study|Adverse Event|7|||
13124121|NCT02951429|25951585|FG000|Overall Study|Death|28|||
13124122|NCT02951429|25951586|FG001|Overall Study|Death|36|||
13124123|NCT02951429|25951585|FG000|Overall Study|Lack of Efficacy|0|||
13124124|NCT02951429|25951586|FG001|Overall Study|Lack of Efficacy|1|||
13124125|NCT02951429|25951585|FG000|Overall Study|Lost to Follow-up|0|||
13124126|NCT02951429|25951586|FG001|Overall Study|Lost to Follow-up|1|||
13124127|NCT02951429|25951585|FG000|Overall Study|Lung Transplantation|9|||
13124128|NCT02951429|25951586|FG001|Overall Study|Lung Transplantation|6|||
13124129|NCT02951429|25951585|FG000|Overall Study|Other|1|||
13124130|NCT02951429|25951586|FG001|Overall Study|Other|3|||
13124131|NCT02951429|25951585|FG000|Overall Study|Progressive Disease|1|||
13124132|NCT02951429|25951586|FG001|Overall Study|Progressive Disease|1|||
13333947|NCT01089725|26606081|FG000|Overall Study|Randomized, but not treated|0|||
13333948|NCT01089725|26606082|FG001|Overall Study|Randomized, but not treated|1|||
13333949|NCT01089725|26606083|FG002|Overall Study|Randomized, but not treated|2|||
13333950|NCT01089725|26606084|FG003|Overall Study|Randomized, but not treated|1|||
13333951|NCT01089725|26606085|FG004|Overall Study|Randomized, but not treated|2|||
13333952|NCT01089725|26606081|FG000|Overall Study|Other|3|||
13333953|NCT01089725|26606082|FG001|Overall Study|Other|0|||
13333954|NCT01089725|26606083|FG002|Overall Study|Other|0|||
13333955|NCT01089725|26606084|FG003|Overall Study|Other|1|||
13333956|NCT01089725|26606085|FG004|Overall Study|Other|0|||
13333957|NCT01089582|26606097|FG000|Overall Study|Death|2|||
13333958|NCT01089582|26606097|FG000|Overall Study|Adverse Event|15|||
13333959|NCT01089582|26606097|FG000|Overall Study|Lost to Follow-up|8|||
13333960|NCT01089582|26606097|FG000|Overall Study|Other|4|||
13333961|NCT01089582|26606097|FG000|Overall Study|Withdrawal by Subject|1|||
13333962|NCT01089361|26606122|FG000|Overall Study|Death|1|||
13333963|NCT01089361|26606123|FG001|Overall Study|Death|0|||
13333964|NCT01088503|26606154|FG000|Overall Study|Withdrawal by Subject|118|||
13333965|NCT01088503|26606155|FG001|Overall Study|Withdrawal by Subject|327|||
13333966|NCT01088503|26606156|FG002|Overall Study|Withdrawal by Subject|10|||
13333967|NCT01088503|26606154|FG000|Overall Study|Death|64|||
13333968|NCT01088503|26606155|FG001|Overall Study|Death|358|||
13333969|NCT01088503|26606156|FG002|Overall Study|Death|7|||
13333970|NCT01088412|26606182|FG000|Overall Study|Adverse Event|38|||
13333971|NCT01088412|26606183|FG001|Overall Study|Adverse Event|0|||
13124133|NCT02951429|25951585|FG000|Overall Study|Withdrawal by Subject|7|||
13124134|NCT02951429|25951586|FG001|Overall Study|Withdrawal by Subject|11|||
13124135|NCT02951429|25951585|FG000|Overall Study|Participant ongoing in the study|23|||
13124136|NCT02951429|25951586|FG001|Overall Study|Participant ongoing in the study|17|||
13124137|NCT02951156|25951654|FG000|Overall Study|Death|3|||
13124138|NCT02951156|25951655|FG001|Overall Study|Death|8|||
13124139|NCT02951156|25951656|FG002|Overall Study|Death|5|||
13124140|NCT02951156|25951654|FG000|Overall Study|Progressive disease|1|||
13124141|NCT02951156|25951655|FG001|Overall Study|Progressive disease|0|||
13124142|NCT02951156|25951656|FG002|Overall Study|Progressive disease|1|||
13124143|NCT02951156|25951654|FG000|Overall Study|Withdrawal by Subject|0|||
13124144|NCT02951156|25951655|FG001|Overall Study|Withdrawal by Subject|0|||
13124145|NCT02951156|25951656|FG002|Overall Study|Withdrawal by Subject|1|||
13124146|NCT02951156|25951654|FG000|Overall Study|Study terminated by sponsor|0|||
13124147|NCT02951156|25951655|FG001|Overall Study|Study terminated by sponsor|0|||
13124148|NCT02951156|25951656|FG002|Overall Study|Study terminated by sponsor|1|||
13124149|NCT02951156|25951654|FG000|Overall Study|Other|5|||
13124150|NCT02951156|25951655|FG001|Overall Study|Other|1|||
13124151|NCT02951156|25951656|FG002|Overall Study|Other|2|||
13124152|NCT02950831|25951681|FG000|Overall Study|Lost to Follow-up|1|||
13124153|NCT02950831|25951681|FG000|Overall Study|Withdrawal by Subject|3|||
13124154|NCT02950831|25951681|FG000|Overall Study|stimulation trail failure|5|||
13124155|NCT02950558|25951702|FG000|Overall Study|Lost to Follow-up|2|||
13124156|NCT02950558|25951703|FG001|Overall Study|Lost to Follow-up|0|||
13124157|NCT02950545|25951729|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
13124158|NCT02950545|25951730|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
13124159|NCT02950545|25951731|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
13124160|NCT02950545|25951732|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
13124161|NCT02950545|25951733|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
13124162|NCT02950545|25951734|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1|||
13124163|NCT02950545|25951729|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
13124164|NCT02950545|25951730|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
13124165|NCT02950545|25951731|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
13124166|NCT02950545|25951732|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
13124167|NCT02950545|25951733|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
13124168|NCT02950545|25951734|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
13124169|NCT02950545|25951729|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
13124170|NCT02950545|25951730|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
13124171|NCT02950545|25951731|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
13124172|NCT02950545|25951732|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
13124173|NCT02950545|25951733|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1|||
13124174|NCT02950545|25951734|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
13124175|NCT02950545|25951729|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1|||
13124176|NCT02950545|25951730|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
13124177|NCT02950545|25951731|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
13124178|NCT02950545|25951732|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
13124179|NCT02950545|25951733|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
13124180|NCT02950545|25951734|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
13124181|NCT02950545|25951729|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
13124182|NCT02950545|25951730|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
13124183|NCT02950545|25951731|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
13124184|NCT02950545|25951732|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
13124185|NCT02950545|25951733|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
13124186|NCT02950545|25951734|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1|||
13124187|NCT02950480|25951751|FG000|Overall Study|Withdrawal by Subject|1|||
13124188|NCT02950480|25951752|FG001|Overall Study|Withdrawal by Subject|0|||
13124189|NCT02949973|25951763|FG000|Overall Study|Physician Decision|1|||
13124190|NCT02949947|25951776|FG000|Overall Study|Non Compliance|0|||
13124191|NCT02949947|25951777|FG001|Overall Study|Non Compliance|1|||
13124192|NCT02949947|25951776|FG000|Overall Study|Insurance change|1|||
13124193|NCT02949947|25951777|FG001|Overall Study|Insurance change|0|||
13124194|NCT02949934|25951816|FG000|Natural Drinking Period|Adverse Event|1|||
13124195|NCT02949934|25951817|FG001|Natural Drinking Period|Adverse Event|0|||
13124196|NCT02949934|25951818|FG002|Natural Drinking Period|Adverse Event|0|||
13124197|NCT02949934|25951819|FG003|Natural Drinking Period|Adverse Event|1|||
13124198|NCT02949934|25951820|FG004|Natural Drinking Period|Adverse Event|0|||
13124199|NCT02949934|25951821|FG005|Natural Drinking Period|Adverse Event|0|||
13124200|NCT02949934|25951816|FG000|Natural Drinking Period|Lost to Follow-up|0|||
13124201|NCT02949934|25951817|FG001|Natural Drinking Period|Lost to Follow-up|0|||
13124202|NCT02949934|25951818|FG002|Natural Drinking Period|Lost to Follow-up|0|||
13124203|NCT02949934|25951819|FG003|Natural Drinking Period|Lost to Follow-up|0|||
13124204|NCT02949934|25951820|FG004|Natural Drinking Period|Lost to Follow-up|1|||
13124205|NCT02949934|25951821|FG005|Natural Drinking Period|Lost to Follow-up|0|||
13124206|NCT02949934|25951816|FG000|Neuroimaging|Protocol Violation|2|||
13124207|NCT02949934|25951817|FG001|Neuroimaging|Protocol Violation|0|||
13124208|NCT02949934|25951818|FG002|Neuroimaging|Protocol Violation|0|||
13124209|NCT02949934|25951819|FG003|Neuroimaging|Protocol Violation|0|||
13124210|NCT02949934|25951820|FG004|Neuroimaging|Protocol Violation|1|||
13124211|NCT02949934|25951821|FG005|Neuroimaging|Protocol Violation|0|||
13124212|NCT02949934|25951816|FG000|Neuroimaging|Motion artifacts in imaging data|1|||
13124213|NCT02949934|25951817|FG001|Neuroimaging|Motion artifacts in imaging data|0|||
13124214|NCT02949934|25951818|FG002|Neuroimaging|Motion artifacts in imaging data|1|||
13124215|NCT02949934|25951819|FG003|Neuroimaging|Motion artifacts in imaging data|0|||
13124216|NCT02949934|25951820|FG004|Neuroimaging|Motion artifacts in imaging data|1|||
13124217|NCT02949934|25951821|FG005|Neuroimaging|Motion artifacts in imaging data|0|||
13124218|NCT02949934|25951816|FG000|Neuroimaging|Not scanned|0|||
13124219|NCT02949934|25951817|FG001|Neuroimaging|Not scanned|0|||
13124220|NCT02949934|25951818|FG002|Neuroimaging|Not scanned|1|||
13124221|NCT02949934|25951819|FG003|Neuroimaging|Not scanned|0|||
13333972|NCT01088412|26606184|FG002|Overall Study|Adverse Event|0|||
13333973|NCT01088412|26606182|FG000|Overall Study|Death|42|||
13333974|NCT01088412|26606183|FG001|Overall Study|Death|6|||
13333975|NCT01088412|26606184|FG002|Overall Study|Death|0|||
13333976|NCT01088412|26606182|FG000|Overall Study|Other Reason per Case Report Form|2089|||
13333977|NCT01088412|26606183|FG001|Overall Study|Other Reason per Case Report Form|103|||
13333978|NCT01088412|26606184|FG002|Overall Study|Other Reason per Case Report Form|9|||
13333979|NCT01088412|26606182|FG000|Overall Study|Withdrawal by Subject|1761|||
13333980|NCT01088412|26606183|FG001|Overall Study|Withdrawal by Subject|25|||
13333981|NCT01088412|26606184|FG002|Overall Study|Withdrawal by Subject|1|||
13333982|NCT01088412|26606182|FG000|Overall Study|Received Another GH Product|79|||
13333983|NCT01088412|26606183|FG001|Overall Study|Received Another GH Product|0|||
13333984|NCT01088412|26606184|FG002|Overall Study|Received Another GH Product|0|||
13333985|NCT01088412|26606182|FG000|Overall Study|Participant Moved|601|||
13124222|NCT02949934|25951820|FG004|Neuroimaging|Not scanned|0|||
13124223|NCT02949934|25951821|FG005|Neuroimaging|Not scanned|2|||
13124224|NCT02949934|25951816|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0|||
13124225|NCT02949934|25951817|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
13333986|NCT01088412|26606183|FG001|Overall Study|Participant Moved|21|||
13333987|NCT01088412|26606184|FG002|Overall Study|Participant Moved|2|||
13333988|NCT01088412|26606182|FG000|Overall Study|Physician Decision|1041|||
13333989|NCT01088412|26606183|FG001|Overall Study|Physician Decision|8|||
13333990|NCT01088412|26606184|FG002|Overall Study|Physician Decision|4|||
13333991|NCT01088412|26606182|FG000|Overall Study|Sponsor Decision|4467|||
13333992|NCT01088412|26606183|FG001|Overall Study|Sponsor Decision|79|||
13333993|NCT01088412|26606184|FG002|Overall Study|Sponsor Decision|23|||
13333994|NCT01088412|26606182|FG000|Overall Study|Third Party Required to Change Brand|487|||
13333995|NCT01088412|26606183|FG001|Overall Study|Third Party Required to Change Brand|0|||
13333996|NCT01088412|26606184|FG002|Overall Study|Third Party Required to Change Brand|0|||
13333997|NCT01088412|26606182|FG000|Overall Study|Lost to Follow-up|3052|||
13124226|NCT02949934|25951818|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
13124227|NCT02949934|25951819|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3|||
13124228|NCT02949934|25951820|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
13124229|NCT02949934|25951821|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1|||
13124230|NCT02949934|25951816|FG000|Bar Laboratory|Adverse Event|1|||
13124231|NCT02949934|25951817|FG001|Bar Laboratory|Adverse Event|0|||
13124232|NCT02949934|25951818|FG002|Bar Laboratory|Adverse Event|2|||
13124233|NCT02949934|25951819|FG003|Bar Laboratory|Adverse Event|0|||
13124234|NCT02949934|25951820|FG004|Bar Laboratory|Adverse Event|1|||
13124235|NCT02949934|25951821|FG005|Bar Laboratory|Adverse Event|0|||
13124236|NCT02949934|25951816|FG000|Bar Laboratory|Protocol Violation|0|||
13124237|NCT02949934|25951817|FG001|Bar Laboratory|Protocol Violation|0|||
13124238|NCT02949934|25951818|FG002|Bar Laboratory|Protocol Violation|0|||
13124239|NCT02949934|25951819|FG003|Bar Laboratory|Protocol Violation|1|||
13124240|NCT02949934|25951820|FG004|Bar Laboratory|Protocol Violation|0|||
13124241|NCT02949934|25951821|FG005|Bar Laboratory|Protocol Violation|0|||
13124242|NCT02949908|25951843|FG000|Overall Study|Study termination|2|||
13124243|NCT02949700|25951865|FG000|Phase I|Withdrawal by Subject|1|||
13124244|NCT02949700|25951866|FG001|Phase I|Withdrawal by Subject|1|||
13124245|NCT02949700|25951867|FG002|Phase I|Withdrawal by Subject|0|||
13124246|NCT02949700|25951868|FG003|Phase I|Withdrawal by Subject|0|||
13124247|NCT02949700|25951865|FG000|Phase I|Protocol Violation|1|||
13124248|NCT02949700|25951866|FG001|Phase I|Protocol Violation|0|||
13124249|NCT02949700|25951867|FG002|Phase I|Protocol Violation|0|||
13124250|NCT02949700|25951868|FG003|Phase I|Protocol Violation|0|||
13124251|NCT02949700|25951865|FG000|Phase II|Withdrawal by Subject|0|||
13124252|NCT02949700|25951866|FG001|Phase II|Withdrawal by Subject|0|||
13124253|NCT02949700|25951867|FG002|Phase II|Withdrawal by Subject|0|||
13124254|NCT02949700|25951868|FG003|Phase II|Withdrawal by Subject|2|||
13486409|NCT03564145|27036051|FG000|Overall Study|Other Than Specified|1|||
13333998|NCT01088412|26606183|FG001|Overall Study|Lost to Follow-up|130|||
13333999|NCT01088412|26606184|FG002|Overall Study|Lost to Follow-up|11|||
13334000|NCT01088412|26606182|FG000|Overall Study|Study Summary Not Completed|4360|||
13124255|NCT02949700|25951865|FG000|Phase II|Protocol Violation|0|||
13124256|NCT02949700|25951866|FG001|Phase II|Protocol Violation|0|||
13124257|NCT02949700|25951867|FG002|Phase II|Protocol Violation|1|||
13124258|NCT02949700|25951868|FG003|Phase II|Protocol Violation|3|||
13124259|NCT02949362|25951935|FG000|Retrospective Period|Inform consent not signed by participant|4|||
13124260|NCT02949362|25951936|FG001|Retrospective Period|Inform consent not signed by participant|1|||
13124261|NCT02949362|25951937|FG002|Retrospective Period|Inform consent not signed by participant|0|||
13124262|NCT02949362|25951938|FG003|Retrospective Period|Inform consent not signed by participant|0|||
13124263|NCT02949362|25951935|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
13124264|NCT02949362|25951936|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
13124265|NCT02949362|25951937|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1|||
13124266|NCT02949362|25951938|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
13124267|NCT02949362|25951935|FG000|Prospective Period|Other|0|||
13124268|NCT02949362|25951936|FG001|Prospective Period|Other|0|||
13124269|NCT02949362|25951937|FG002|Prospective Period|Other|0|||
13124270|NCT02949362|25951938|FG003|Prospective Period|Other|4|||
13124271|NCT02949271|25951971|FG000|Overall Study|Lack of Efficacy|5|||
13124272|NCT02949271|25951972|FG001|Overall Study|Lack of Efficacy|4|||
13124273|NCT02949271|25951971|FG000|Overall Study|Lost to Follow-up|3|||
13124274|NCT02949271|25951972|FG001|Overall Study|Lost to Follow-up|6|||
13124275|NCT02949271|25951971|FG000|Overall Study|Physician Decision|5|||
13124276|NCT02949271|25951972|FG001|Overall Study|Physician Decision|5|||
13124277|NCT02949271|25951971|FG000|Overall Study|Protocol Violation|6|||
13124278|NCT02949271|25951972|FG001|Overall Study|Protocol Violation|3|||
13124279|NCT02949271|25951971|FG000|Overall Study|Withdrawal by Subject|1|||
13124280|NCT02949271|25951972|FG001|Overall Study|Withdrawal by Subject|0|||
13124281|NCT02949271|25951971|FG000|Overall Study|Delivered prior to intervention|7|||
13124282|NCT02949271|25951972|FG001|Overall Study|Delivered prior to intervention|9|||
13124283|NCT02949271|25951971|FG000|Overall Study|Outside the window for cervical dilation|2|||
13124284|NCT02949271|25951972|FG001|Overall Study|Outside the window for cervical dilation|3|||
13124285|NCT02949219|25951981|FG000|Overall Study|Withdrawal by Subject|1|||
13124286|NCT02949128|25951998|FG000|Initial Evaluation Period|Failed to Meet Eligibility Criteria|2|||
13124287|NCT02949128|25951998|FG000|Initial Evaluation Period|Adverse Event|3|||
13124288|NCT02949128|25951998|FG000|Initial Evaluation Period|Death|2|||
13124289|NCT02949128|25951998|FG000|Initial Evaluation Period|Physician Decision|1|||
13124290|NCT02949128|25951998|FG000|Initial Evaluation Period|Protocol Violation|1|||
13124291|NCT02949128|25951998|FG000|Extension Period|Withdrawal by Subject|5|||
13124292|NCT02949128|25951998|FG000|Extension Period|Protocol Violation|1|||
13124293|NCT02949128|25951998|FG000|Extension Period|Physician Decision|2|||
13124294|NCT02949128|25951998|FG000|Extension Period|Ongoing in Extension Period as of 07/02/2019|41|||
13124295|NCT02949024|25952019|FG000|Overall Study|Withdrawal by Subject|0|||
13124296|NCT02949024|25952020|FG001|Overall Study|Withdrawal by Subject|1|||
13124297|NCT02949011|25952098|FG000|Overall Study|Adverse Event|6|||
13124298|NCT02949011|25952099|FG001|Overall Study|Adverse Event|7|||
13124299|NCT02949011|25952100|FG002|Overall Study|Adverse Event|3|||
13124300|NCT02949011|25952098|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
13124301|NCT02949011|25952099|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
13124302|NCT02949011|25952100|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3|||
13124303|NCT02949011|25952098|FG000|Overall Study|Protocol Deviation|5|||
13124304|NCT02949011|25952099|FG001|Overall Study|Protocol Deviation|3|||
13204181|NCT01976364|26227749|FG001|Main Study (36 Months)|Medication error|0|||
13204182|NCT01976364|26227750|FG002|Main Study (36 Months)|Medication error|0|||
13204183|NCT01976364|26227748|FG000|Main Study (36 Months)|Lost to Follow-up|10|||
13204184|NCT01976364|26227749|FG001|Main Study (36 Months)|Lost to Follow-up|0|||
13204185|NCT01976364|26227750|FG002|Main Study (36 Months)|Lost to Follow-up|0|||
13204186|NCT01976364|26227748|FG000|Main Study (36 Months)|Lack of Efficacy|40|||
13204187|NCT01976364|26227749|FG001|Main Study (36 Months)|Lack of Efficacy|0|||
13204188|NCT01976364|26227750|FG002|Main Study (36 Months)|Lack of Efficacy|0|||
13204189|NCT01976364|26227748|FG000|Main Study (36 Months)|Protocol Violation|13|||
13204190|NCT01976364|26227749|FG001|Main Study (36 Months)|Protocol Violation|0|||
13204191|NCT01976364|26227750|FG002|Main Study (36 Months)|Protocol Violation|0|||
13204192|NCT01976364|26227748|FG000|Main Study (36 Months)|Withdrawal by Subject|69|||
13204193|NCT01976364|26227749|FG001|Main Study (36 Months)|Withdrawal by Subject|0|||
13204194|NCT01976364|26227750|FG002|Main Study (36 Months)|Withdrawal by Subject|0|||
13204195|NCT01976364|26227748|FG000|Main Study (36 Months)|Death|5|||
13204196|NCT01976364|26227749|FG001|Main Study (36 Months)|Death|0|||
13204197|NCT01976364|26227750|FG002|Main Study (36 Months)|Death|0|||
13204198|NCT01976364|26227748|FG000|Sub-study (12 Months)|Lost to Follow-up|0|||
13204199|NCT01976364|26227749|FG001|Sub-study (12 Months)|Lost to Follow-up|1|||
13204200|NCT01976364|26227750|FG002|Sub-study (12 Months)|Lost to Follow-up|0|||
13204201|NCT01976364|26227748|FG000|Sub-study (12 Months)|Withdrawal by Subject|0|||
13486410|NCT03564145|27036051|FG000|Overall Study|Pregnancy|1|||
13204202|NCT01976364|26227749|FG001|Sub-study (12 Months)|Withdrawal by Subject|0|||
13486411|NCT03564119|27036068|FG000|Overall Study|Adverse Event|4|||
13124305|NCT02949011|25952100|FG002|Overall Study|Protocol Deviation|3|||
13124306|NCT02949011|25952098|FG000|Overall Study|Lack of Efficacy|0|||
13124307|NCT02949011|25952099|FG001|Overall Study|Lack of Efficacy|2|||
13124308|NCT02949011|25952100|FG002|Overall Study|Lack of Efficacy|0|||
13124309|NCT02949011|25952098|FG000|Overall Study|Withdrawal by Subject|13|||
13124310|NCT02949011|25952099|FG001|Overall Study|Withdrawal by Subject|13|||
13124311|NCT02949011|25952100|FG002|Overall Study|Withdrawal by Subject|21|||
13124312|NCT02949011|25952098|FG000|Overall Study|Lost to Follow-up|7|||
13124313|NCT02949011|25952099|FG001|Overall Study|Lost to Follow-up|5|||
13124314|NCT02949011|25952100|FG002|Overall Study|Lost to Follow-up|5|||
13124315|NCT02949011|25952098|FG000|Overall Study|Death|0|||
13124316|NCT02949011|25952099|FG001|Overall Study|Death|0|||
13124317|NCT02949011|25952100|FG002|Overall Study|Death|1|||
13124318|NCT02949011|25952098|FG000|Overall Study|Miscellaneous|2|||
13124319|NCT02949011|25952099|FG001|Overall Study|Miscellaneous|4|||
13124320|NCT02949011|25952100|FG002|Overall Study|Miscellaneous|6|||
13124321|NCT02948959|25952212|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0|||
13334001|NCT01088412|26606183|FG001|Overall Study|Study Summary Not Completed|64|||
13334002|NCT01088412|26606184|FG002|Overall Study|Study Summary Not Completed|22|||
13334003|NCT01088399|26606217|FG000|Overall Study|Adverse Event|211|||
13334004|NCT01088399|26606218|FG001|Overall Study|Adverse Event|16|||
13334005|NCT01088399|26606219|FG002|Overall Study|Adverse Event|0|||
13334006|NCT01088399|26606217|FG000|Overall Study|Death|204|||
13334007|NCT01088399|26606218|FG001|Overall Study|Death|45|||
13334008|NCT01088399|26606219|FG002|Overall Study|Death|0|||
13334009|NCT01088399|26606217|FG000|Overall Study|Lack of Efficacy|298|||
13334010|NCT01088399|26606218|FG001|Overall Study|Lack of Efficacy|7|||
13334011|NCT01088399|26606219|FG002|Overall Study|Lack of Efficacy|5|||
13334012|NCT01088399|26606217|FG000|Overall Study|Lost to Follow-up|1070|||
13334013|NCT01088399|26606218|FG001|Overall Study|Lost to Follow-up|278|||
13334014|NCT01088399|26606219|FG002|Overall Study|Lost to Follow-up|58|||
13334015|NCT01088399|26606217|FG000|Overall Study|Physician Decision|531|||
13334016|NCT01088399|26606218|FG001|Overall Study|Physician Decision|88|||
13334017|NCT01088399|26606219|FG002|Overall Study|Physician Decision|16|||
13124322|NCT02948959|25952213|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2|||
13124323|NCT02948959|25952212|FG000|52 Weeks Treatment Period|Adverse Event|2|||
13124324|NCT02948959|25952213|FG001|52 Weeks Treatment Period|Adverse Event|5|||
13124325|NCT02948959|25952212|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2|||
13124326|NCT02948959|25952213|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2|||
13124327|NCT02948959|25952212|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1|||
13124328|NCT02948959|25952213|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6|||
13124329|NCT02948959|25952212|FG000|52 Weeks Treatment Period|Randomized by error|0|||
13124330|NCT02948959|25952213|FG001|52 Weeks Treatment Period|Randomized by error|5|||
13124331|NCT02948959|25952212|FG000|52 Weeks Treatment Period|Randomized and not treated|0|||
13124332|NCT02948959|25952213|FG001|52 Weeks Treatment Period|Randomized and not treated|3|||
13124333|NCT02948959|25952212|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0|||
13124334|NCT02948959|25952213|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1|||
13124335|NCT02948959|25952212|FG000|52 Weeks Treatment Period|Change of residence location|0|||
13124336|NCT02948959|25952213|FG001|52 Weeks Treatment Period|Change of residence location|1|||
13124337|NCT02948959|25952212|FG000|12 Weeks Follow-up Period|Adverse Event|0|||
13124338|NCT02948959|25952213|FG001|12 Weeks Follow-up Period|Adverse Event|2|||
13124339|NCT02948959|25952212|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1|||
13124340|NCT02948959|25952213|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2|||
13124341|NCT02948959|25952212|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
13124342|NCT02948959|25952213|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
13124343|NCT02948959|25952212|FG000|12 Weeks Follow-up Period|Randomized by error|0|||
13124344|NCT02948959|25952213|FG001|12 Weeks Follow-up Period|Randomized by error|3|||
13124345|NCT02948959|25952212|FG000|12 Weeks Follow-up Period|Change of residence location|0|||
13124346|NCT02948959|25952213|FG001|12 Weeks Follow-up Period|Change of residence location|2|||
13124347|NCT02948959|25952212|FG000|12 Weeks Follow-up Period|Study site closure|1|||
13124348|NCT02948959|25952213|FG001|12 Weeks Follow-up Period|Study site closure|0|||
13124349|NCT02948829|25952247|FG000|Overall Study|Lost to Follow-up|2|||
13124350|NCT02948829|25952247|FG000|Overall Study|Withdrawal by Subject and/or Subject's Parent(s)/ Legally Authorized Representative (LAR)|5|||
13124351|NCT02948829|25952247|FG000|Overall Study|Pregnancy|1|||
13124352|NCT02948829|25952247|FG000|Overall Study|Other: Reason not Specified|8|||
13124353|NCT02948777|25952277|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1|||
13124354|NCT02948634|25952294|FG000|Overall Study|Lack of efficacy and study suspended|10|||
13124355|NCT02948634|25952295|FG001|Overall Study|Lack of efficacy and study suspended|2|||
13334018|NCT01088399|26606217|FG000|Overall Study|Withdrawal by Subject|544|||
13334019|NCT01088399|26606218|FG001|Overall Study|Withdrawal by Subject|195|||
13334020|NCT01088399|26606219|FG002|Overall Study|Withdrawal by Subject|33|||
13334021|NCT01088399|26606217|FG000|Overall Study|Change to or start of somatropin therapy|234|||
13334022|NCT01088399|26606218|FG001|Overall Study|Change to or start of somatropin therapy|17|||
13124356|NCT02948582|25952395|FG000|Washout Period 1|Adverse Event|0|||
13124357|NCT02948582|25952396|FG001|Washout Period 1|Adverse Event|2|||
13124358|NCT02948582|25952397|FG002|Washout Period 1|Adverse Event|0|||
13124359|NCT02948582|25952398|FG003|Washout Period 1|Adverse Event|0|||
13124360|NCT02948582|25952399|FG004|Washout Period 1|Adverse Event|0|||
13124361|NCT02948582|25952400|FG005|Washout Period 1|Adverse Event|0|||
13124362|NCT02948582|25952395|FG000|Washout Period 1|Protocol Violation|0|||
13124363|NCT02948582|25952396|FG001|Washout Period 1|Protocol Violation|0|||
13124364|NCT02948582|25952397|FG002|Washout Period 1|Protocol Violation|0|||
13124365|NCT02948582|25952398|FG003|Washout Period 1|Protocol Violation|0|||
13124366|NCT02948582|25952399|FG004|Washout Period 1|Protocol Violation|0|||
13124367|NCT02948582|25952400|FG005|Washout Period 1|Protocol Violation|1|||
13124368|NCT02948582|25952395|FG000|Washout Period 2|Adverse Event|0|||
13124369|NCT02948582|25952396|FG001|Washout Period 2|Adverse Event|1|||
13124370|NCT02948582|25952397|FG002|Washout Period 2|Adverse Event|0|||
13124371|NCT02948582|25952398|FG003|Washout Period 2|Adverse Event|0|||
13124372|NCT02948582|25952399|FG004|Washout Period 2|Adverse Event|0|||
13124373|NCT02948582|25952400|FG005|Washout Period 2|Adverse Event|0|||
13124374|NCT02948582|25952395|FG000|Washout Period 2|personal reasons|0|||
13124375|NCT02948582|25952396|FG001|Washout Period 2|personal reasons|0|||
13124376|NCT02948582|25952397|FG002|Washout Period 2|personal reasons|0|||
13124377|NCT02948582|25952398|FG003|Washout Period 2|personal reasons|1|||
13124378|NCT02948582|25952399|FG004|Washout Period 2|personal reasons|0|||
13124379|NCT02948582|25952400|FG005|Washout Period 2|personal reasons|0|||
13124380|NCT02948582|25952395|FG000|Washout Period 4|Adverse Event|1|||
13124381|NCT02948582|25952396|FG001|Washout Period 4|Adverse Event|0|||
13124382|NCT02948582|25952397|FG002|Washout Period 4|Adverse Event|1|||
13124383|NCT02948582|25952398|FG003|Washout Period 4|Adverse Event|0|||
13124384|NCT02948582|25952399|FG004|Washout Period 4|Adverse Event|0|||
13124385|NCT02948582|25952400|FG005|Washout Period 4|Adverse Event|0|||
13124386|NCT02947100|25952410|FG000|Overall Study|study terminated early|3|||
13124387|NCT02947100|25952410|FG000|Overall Study|did not meet inclusion criteria|1|||
13124388|NCT02947022|25952431|FG000|Overall Study|Study Stopped|1|||
13124389|NCT02946931|25952439|FG000|Overall Study|Did not require collection of CRFs|588|||
13124390|NCT02946931|25952439|FG000|Overall Study|Other than listed|37|||
13334023|NCT01088399|26606219|FG002|Overall Study|Change to or start of somatropin therapy|12|||
13124391|NCT02946931|25952439|FG000|Overall Study|Discharge from hospital|118|||
13124392|NCT02946931|25952439|FG000|Overall Study|Adverse Event|81|||
13124393|NCT02946931|25952439|FG000|Overall Study|CRFs not valid|1|||
13124394|NCT02946931|25952439|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6|||
13124395|NCT02946918|25952458|FG000|Overall Study|Patient unblinded himself|1|||
13124396|NCT02946918|25952459|FG001|Overall Study|Patient unblinded himself|0|||
13124397|NCT02946918|25952458|FG000|Overall Study|Physician Decision|0|||
13124398|NCT02946918|25952459|FG001|Overall Study|Physician Decision|2|||
13124399|NCT02946918|25952458|FG000|Overall Study|Ran out of study medication|0|||
13124400|NCT02946918|25952459|FG001|Overall Study|Ran out of study medication|1|||
13124401|NCT02946580|25952482|FG000|Overall Study|Withdrawal by Subject|1|||
13124402|NCT02946580|25952483|FG001|Overall Study|Withdrawal by Subject|2|||
13124403|NCT02946580|25952482|FG000|Overall Study|Adverse Event|0|||
13124404|NCT02946580|25952483|FG001|Overall Study|Adverse Event|2|||
13124405|NCT02946580|25952482|FG000|Overall Study|Did not undergo posterior spinal fusion|0|||
13124406|NCT02946580|25952483|FG001|Overall Study|Did not undergo posterior spinal fusion|1|||
13124407|NCT02946515|25952496|FG000|Overall Study|Lost to Follow-up|2|||
13124408|NCT02946515|25952497|FG001|Overall Study|Lost to Follow-up|1|||
13124409|NCT02946463|25952520|FG000|Primary Evaluation Period|Physician Decision|0|||
13124410|NCT02946463|25952521|FG001|Primary Evaluation Period|Physician Decision|1|||
13124411|NCT02946463|25952520|FG000|Primary Evaluation Period|Withdrawal by Subject|0|||
13124412|NCT02946463|25952521|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
13124413|NCT02946385|25952624|FG000|Overall Study|Lost to Follow-up|0|||
13124414|NCT02946385|25952625|FG001|Overall Study|Lost to Follow-up|0|||
13124415|NCT02946385|25952626|FG002|Overall Study|Lost to Follow-up|3|||
13124416|NCT02946385|25952627|FG003|Overall Study|Lost to Follow-up|0|||
13124417|NCT02946385|25952628|FG004|Overall Study|Lost to Follow-up|2|||
13124418|NCT02946385|25952629|FG005|Overall Study|Lost to Follow-up|1|||
13124419|NCT02945657|25952648|FG000|Overall Study|Adverse Event|1|||
13124420|NCT02945657|25952648|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
13124421|NCT02945410|25952696|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
13124422|NCT02945410|25952697|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3|||
13124423|NCT02945410|25952698|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
13124424|NCT02945410|25952699|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
13124425|NCT02945410|25952700|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
13124426|NCT02945410|25952701|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
13124427|NCT02945410|25952696|FG000|Intervention 1 (5 Days)|Adverse Event|1|||
13124428|NCT02945410|25952697|FG001|Intervention 1 (5 Days)|Adverse Event|0|||
13124429|NCT02945410|25952698|FG002|Intervention 1 (5 Days)|Adverse Event|0|||
13124430|NCT02945410|25952699|FG003|Intervention 1 (5 Days)|Adverse Event|0|||
13124431|NCT02945410|25952700|FG004|Intervention 1 (5 Days)|Adverse Event|0|||
13124432|NCT02945410|25952701|FG005|Intervention 1 (5 Days)|Adverse Event|1|||
13124433|NCT02945410|25952696|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0|||
13124434|NCT02945410|25952697|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0|||
13124435|NCT02945410|25952698|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2|||
13124436|NCT02945410|25952699|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0|||
13124437|NCT02945410|25952700|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1|||
13124438|NCT02945410|25952701|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0|||
13124439|NCT02945254|25952716|FG000|Overall Study|Lost to Follow-up|1|||
13124440|NCT02945254|25952717|FG001|Overall Study|Lost to Follow-up|0|||
13124441|NCT02945254|25952716|FG000|Overall Study|Withdrawal by Subject|1|||
13124442|NCT02945254|25952717|FG001|Overall Study|Withdrawal by Subject|0|||
13124443|NCT02945046|25952780|FG000|Overall Study|Adverse Event|1|||
13124444|NCT02945046|25952781|FG001|Overall Study|Adverse Event|0|||
13124445|NCT02945046|25952782|FG002|Overall Study|Adverse Event|2|||
13124446|NCT02945046|25952780|FG000|Overall Study|Withdrawal by Subject|3|||
13124447|NCT02945046|25952781|FG001|Overall Study|Withdrawal by Subject|3|||
13124448|NCT02945046|25952782|FG002|Overall Study|Withdrawal by Subject|3|||
13124449|NCT02945046|25952780|FG000|Overall Study|Protocol Violation|2|||
13124450|NCT02945046|25952781|FG001|Overall Study|Protocol Violation|3|||
13124451|NCT02945046|25952782|FG002|Overall Study|Protocol Violation|2|||
13124452|NCT02945046|25952780|FG000|Overall Study|Lost to Follow-up|1|||
13124453|NCT02945046|25952781|FG001|Overall Study|Lost to Follow-up|1|||
13124454|NCT02945046|25952782|FG002|Overall Study|Lost to Follow-up|0|||
13124455|NCT02945046|25952780|FG000|Overall Study|Lack of Efficacy|1|||
13124456|NCT02945046|25952781|FG001|Overall Study|Lack of Efficacy|2|||
13124457|NCT02945046|25952782|FG002|Overall Study|Lack of Efficacy|1|||
13124458|NCT02945046|25952780|FG000|Overall Study|Other than specified|5|||
13124459|NCT02945046|25952781|FG001|Overall Study|Other than specified|4|||
13124460|NCT02945046|25952782|FG002|Overall Study|Other than specified|7|||
13124461|NCT02944968|25952789|FG000|Overall Study|Subject excluded before study procedure|1|||
13124462|NCT02944968|25952789|FG000|Overall Study|Subject didn't meet eligibility criteria|2|||
13124463|NCT02944656|25952824|FG000|Overall Study|No longer eligible|3|||
13124464|NCT02944656|25952825|FG001|Overall Study|No longer eligible|0|||
13124465|NCT02944656|25952824|FG000|Overall Study|Lost to Follow-up|7|||
13124466|NCT02944656|25952825|FG001|Overall Study|Lost to Follow-up|10|||
13124467|NCT02944513|25952848|FG000|Overall Study|Withdrawal by Subject|4|||
13124468|NCT02944513|25952849|FG001|Overall Study|Withdrawal by Subject|1|||
13124469|NCT02944448|25952880|FG000|Overall Study|Adverse Event|37|||
13124470|NCT02944448|25952881|FG001|Overall Study|Adverse Event|6|||
13124471|NCT02944448|25952880|FG000|Overall Study|Lack of Efficacy|8|||
13124472|NCT02944448|25952881|FG001|Overall Study|Lack of Efficacy|5|||
13124473|NCT02944448|25952880|FG000|Overall Study|Lost to Follow-up|3|||
13124474|NCT02944448|25952881|FG001|Overall Study|Lost to Follow-up|1|||
13124475|NCT02944448|25952880|FG000|Overall Study|Protocol Violation|25|||
13124476|NCT02944448|25952881|FG001|Overall Study|Protocol Violation|7|||
13124477|NCT02944448|25952880|FG000|Overall Study|Withdrawal by Subject|14|||
13124478|NCT02944448|25952881|FG001|Overall Study|Withdrawal by Subject|4|||
13124479|NCT02944448|25952880|FG000|Overall Study|Sponsor did not supply drug in time|0|||
13124480|NCT02944448|25952881|FG001|Overall Study|Sponsor did not supply drug in time|1|||
13124481|NCT02944448|25952880|FG000|Overall Study|Noncompliant with dosing|1|||
13124482|NCT02944448|25952881|FG001|Overall Study|Noncompliant with dosing|0|||
13124483|NCT02944448|25952880|FG000|Overall Study|Abnormal laboratory values|1|||
13124484|NCT02944448|25952881|FG001|Overall Study|Abnormal laboratory values|0|||
13124485|NCT02944383|25953046|FG000|Overall Study|Lost to Follow-up|0|||
13124486|NCT02944383|25953047|FG001|Overall Study|Lost to Follow-up|0|||
13124487|NCT02944383|25953048|FG002|Overall Study|Lost to Follow-up|1|||
13124488|NCT02944383|25953046|FG000|Overall Study|Withdrawal by Subject|1|||
13292298|NCT00706797|26485218|FG001|Overall Study|Lost to Follow-up|2|||
13292299|NCT00706797|26485217|FG000|Overall Study|Other|1|||
13292300|NCT00706797|26485218|FG001|Overall Study|Other|0|||
13292301|NCT00706654|26485248|FG000|Conversion Phase|Lost to Follow-up|4|||
13292302|NCT00706654|26485249|FG001|Conversion Phase|Lost to Follow-up|0|||
13292303|NCT00706654|26485250|FG002|Conversion Phase|Lost to Follow-up|0|||
13292304|NCT00706654|26485251|FG003|Conversion Phase|Lost to Follow-up|0|||
13292305|NCT00706654|26485248|FG000|Conversion Phase|Sponsor Discontinued Trial|8|||
13292306|NCT00706654|26485249|FG001|Conversion Phase|Sponsor Discontinued Trial|0|||
13292307|NCT00706654|26485250|FG002|Conversion Phase|Sponsor Discontinued Trial|0|||
13292308|NCT00706654|26485251|FG003|Conversion Phase|Sponsor Discontinued Trial|0|||
13292309|NCT00706654|26485248|FG000|Conversion Phase|Met Withdrawal Criteria|2|||
13292310|NCT00706654|26485249|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
13292311|NCT00706654|26485250|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
13292312|NCT00706654|26485251|FG003|Conversion Phase|Met Withdrawal Criteria|0|||
13292313|NCT00706654|26485248|FG000|Conversion Phase|Withdrawn by Investigator|14|||
13292314|NCT00706654|26485249|FG001|Conversion Phase|Withdrawn by Investigator|0|||
13292315|NCT00706654|26485250|FG002|Conversion Phase|Withdrawn by Investigator|0|||
13124489|NCT02944383|25953047|FG001|Overall Study|Withdrawal by Subject|0|||
13124490|NCT02944383|25953048|FG002|Overall Study|Withdrawal by Subject|0|||
13124491|NCT02943993|25953068|FG000|Overall Study|Withdrawal by Subject|52|||
13124492|NCT02943993|25953068|FG000|Overall Study|Transfer to another institution|6|||
13124493|NCT02943993|25953068|FG000|Overall Study|Lost to Follow-up|135|||
13124494|NCT02943993|25953068|FG000|Overall Study|Death|98|||
13124495|NCT02943993|25953068|FG000|Overall Study|Other reason for premature termination|32|||
13124496|NCT02943993|25953068|FG000|Overall Study|Missing reason for termination|7|||
13124497|NCT02943668|25953079|FG000|Overall Study|Disease Progression|1|||
13124498|NCT02943577|25953098|FG000|Overall Study|Protocol Violation|0|||
13124499|NCT02943577|25953099|FG001|Overall Study|Protocol Violation|1|||
13124500|NCT02943577|25953098|FG000|Overall Study|Adverse Event|3|||
13124501|NCT02943577|25953099|FG001|Overall Study|Adverse Event|2|||
13204203|NCT01976364|26227750|FG002|Sub-study (12 Months)|Withdrawal by Subject|1|||
13204204|NCT01976364|26227748|FG000|Sub-study (12 Months)|Protocol Violation|0|||
13204205|NCT01976364|26227749|FG001|Sub-study (12 Months)|Protocol Violation|1|||
13204206|NCT01976364|26227750|FG002|Sub-study (12 Months)|Protocol Violation|1|||
13204207|NCT01976364|26227748|FG000|Sub-study (12 Months)|Adverse Event|0|||
13204208|NCT01976364|26227749|FG001|Sub-study (12 Months)|Adverse Event|4|||
13204209|NCT01976364|26227750|FG002|Sub-study (12 Months)|Adverse Event|3|||
13204210|NCT01976338|26227782|FG000|Overall Study|Physician Decision|0|||
13204211|NCT01976338|26227783|FG001|Overall Study|Physician Decision|1|||
13204212|NCT01976338|26227782|FG000|Overall Study|Lost to Follow-up|3|||
13204213|NCT01976338|26227783|FG001|Overall Study|Lost to Follow-up|0|||
13204214|NCT01976338|26227782|FG000|Overall Study|Withdrawal by Subject|5|||
13204215|NCT01976338|26227783|FG001|Overall Study|Withdrawal by Subject|2|||
13204216|NCT01976338|26227782|FG000|Overall Study|Adverse Event|5|||
13204217|NCT01976338|26227783|FG001|Overall Study|Adverse Event|1|||
13204218|NCT01976312|26227809|FG000|Overall Study|Pregnancy|0|||
13204219|NCT01976312|26227810|FG001|Overall Study|Pregnancy|1|||
13334024|NCT01088399|26606217|FG000|Overall Study|Sponsor decision|1573|||
13334025|NCT01088399|26606218|FG001|Overall Study|Sponsor decision|298|||
13204220|NCT01976312|26227809|FG000|Overall Study|Lost to Follow-up|2|||
13204221|NCT01976312|26227810|FG001|Overall Study|Lost to Follow-up|0|||
13204222|NCT01976312|26227809|FG000|Overall Study|Withdrawal by Subject|7|||
13204223|NCT01976312|26227810|FG001|Overall Study|Withdrawal by Subject|2|||
13204224|NCT01976312|26227809|FG000|Overall Study|Adverse Event|6|||
13204225|NCT01976312|26227810|FG001|Overall Study|Adverse Event|6|||
13204226|NCT01976312|26227809|FG000|Overall Study|Protocol Violation|2|||
13204227|NCT01976312|26227810|FG001|Overall Study|Protocol Violation|0|||
13204228|NCT01976299|26227831|FG000|Overall Study|Withdrawal by Subject|3|||
13204229|NCT01976299|26227832|FG001|Overall Study|Withdrawal by Subject|1|||
13204230|NCT01976299|26227831|FG000|Overall Study|Death|4|||
13204231|NCT01976299|26227832|FG001|Overall Study|Death|2|||
13204232|NCT01976299|26227831|FG000|Overall Study|Lost to Follow-up|7|||
13204233|NCT01976299|26227832|FG001|Overall Study|Lost to Follow-up|1|||
13204234|NCT01976299|26227831|FG000|Overall Study|See clarification above in comments|9|||
13204235|NCT01976299|26227832|FG001|Overall Study|See clarification above in comments|2|||
13204236|NCT01976104|26227871|FG000|Overall Study|Adverse Event|0|||
13204237|NCT01976104|26227872|FG001|Overall Study|Adverse Event|0|||
13204238|NCT01976104|26227873|FG002|Overall Study|Adverse Event|1|||
13204239|NCT01976104|26227874|FG003|Overall Study|Adverse Event|0|||
13204240|NCT01976104|26227871|FG000|Overall Study|Lost to Follow-up|3|||
13204241|NCT01976104|26227872|FG001|Overall Study|Lost to Follow-up|0|||
13204242|NCT01976104|26227873|FG002|Overall Study|Lost to Follow-up|1|||
13204243|NCT01976104|26227874|FG003|Overall Study|Lost to Follow-up|1|||
13204244|NCT01976104|26227871|FG000|Overall Study|Subject Choice|0|||
13204245|NCT01976104|26227872|FG001|Overall Study|Subject Choice|1|||
13204246|NCT01976104|26227873|FG002|Overall Study|Subject Choice|0|||
13204247|NCT01976104|26227874|FG003|Overall Study|Subject Choice|1|||
13204248|NCT01976104|26227871|FG000|Overall Study|Withdrawal by Subject|3|||
13204249|NCT01976104|26227872|FG001|Overall Study|Withdrawal by Subject|0|||
13204250|NCT01976104|26227873|FG002|Overall Study|Withdrawal by Subject|0|||
13204251|NCT01976104|26227874|FG003|Overall Study|Withdrawal by Subject|1|||
13204252|NCT01976104|26227871|FG000|Overall Study|Other|0|||
13204253|NCT01976104|26227872|FG001|Overall Study|Other|1|||
13204254|NCT01976104|26227873|FG002|Overall Study|Other|0|||
13204255|NCT01976104|26227874|FG003|Overall Study|Other|0|||
13204256|NCT01975948|26227911|FG000|Overall Study|Withdrawal by Subject|17|||
13204257|NCT01975948|26227912|FG001|Overall Study|Withdrawal by Subject|21|||
13204258|NCT01975948|26227913|FG002|Overall Study|Withdrawal by Subject|7|||
13204259|NCT01975948|26227914|FG003|Overall Study|Withdrawal by Subject|6|||
13204260|NCT01975701|26227923|FG000|Overall Study|Lost to Follow-up|1|||
13204261|NCT01975701|26227923|FG000|Overall Study|Death|23|||
13204262|NCT01975701|26227923|FG000|Overall Study|Physician Decision|1|||
13204263|NCT01975675|26227956|FG000|Overall Study|Death|0|||
13204264|NCT01975675|26227957|FG001|Overall Study|Death|1|||
13204265|NCT01975675|26227958|FG002|Overall Study|Death|0|||
13204266|NCT01975675|26227959|FG003|Overall Study|Death|0|||
13124502|NCT02943577|25953098|FG000|Overall Study|Lost to Follow-up|0|||
13124503|NCT02943577|25953099|FG001|Overall Study|Lost to Follow-up|1|||
13124504|NCT02943577|25953098|FG000|Overall Study|Withdrawal by Subject|1|||
13334026|NCT01088399|26606219|FG002|Overall Study|Sponsor decision|7|||
13334027|NCT01088399|26606217|FG000|Overall Study|Protocol Violation|10|||
13334028|NCT01088399|26606218|FG001|Overall Study|Protocol Violation|1|||
13334029|NCT01088399|26606219|FG002|Overall Study|Protocol Violation|0|||
13334030|NCT01088399|26606217|FG000|Overall Study|Enrollment criteria not met|48|||
13334031|NCT01088399|26606218|FG001|Overall Study|Enrollment criteria not met|119|||
13334032|NCT01088399|26606219|FG002|Overall Study|Enrollment criteria not met|70|||
13334033|NCT01088399|26606217|FG000|Overall Study|Study summary visit not completed|2398|||
13334034|NCT01088399|26606218|FG001|Overall Study|Study summary visit not completed|283|||
13334035|NCT01088399|26606219|FG002|Overall Study|Study summary visit not completed|80|||
13334036|NCT01087762|26606277|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2|||
13334037|NCT01087762|26606278|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
13334038|NCT01087762|26606279|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3|||
13334039|NCT01087762|26606280|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
13334040|NCT01087762|26606281|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
13334041|NCT01087762|26606277|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6|||
13334042|NCT01087762|26606278|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
13334043|NCT01087762|26606279|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1|||
13334044|NCT01087762|26606280|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
13334045|NCT01087762|26606281|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
13334046|NCT01087762|26606277|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
13334047|NCT01087762|26606278|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2|||
13334048|NCT01087762|26606279|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
13334049|NCT01087762|26606280|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
13334050|NCT01087762|26606281|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
13334051|NCT01087762|26606277|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
13334052|NCT01087762|26606278|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2|||
13334053|NCT01087762|26606279|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
13124505|NCT02943577|25953099|FG001|Overall Study|Withdrawal by Subject|1|||
13124506|NCT02943577|25953098|FG000|Overall Study|Pregnancy|1|||
13124507|NCT02943577|25953099|FG001|Overall Study|Pregnancy|0|||
13124508|NCT02943564|25953120|FG000|Overall Study|Miscellaneous Reasons|0|||
13124509|NCT02943564|25953121|FG001|Overall Study|Miscellaneous Reasons|0|||
13124510|NCT02943564|25953122|FG002|Overall Study|Miscellaneous Reasons|3|||
13124511|NCT02943564|25953120|FG000|Overall Study|Site terminated by sponsor|0|||
13124512|NCT02943564|25953121|FG001|Overall Study|Site terminated by sponsor|1|||
13124513|NCT02943564|25953122|FG002|Overall Study|Site terminated by sponsor|0|||
13124514|NCT02943564|25953120|FG000|Overall Study|Non-compliance with study drug|0|||
13124515|NCT02943564|25953121|FG001|Overall Study|Non-compliance with study drug|1|||
13124516|NCT02943564|25953122|FG002|Overall Study|Non-compliance with study drug|0|||
13124517|NCT02943564|25953120|FG000|Overall Study|Pregnancy|0|||
13124518|NCT02943564|25953121|FG001|Overall Study|Pregnancy|1|||
13124519|NCT02943564|25953122|FG002|Overall Study|Pregnancy|1|||
13124520|NCT02943564|25953120|FG000|Overall Study|Protocol Violation|2|||
13124521|NCT02943564|25953121|FG001|Overall Study|Protocol Violation|2|||
13334054|NCT01087762|26606280|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
13334055|NCT01087762|26606281|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
13334056|NCT01087762|26606277|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
13334057|NCT01087762|26606278|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
13124522|NCT02943564|25953122|FG002|Overall Study|Protocol Violation|2|||
13124523|NCT02943564|25953120|FG000|Overall Study|Lost to Follow-up|1|||
13124524|NCT02943564|25953121|FG001|Overall Study|Lost to Follow-up|0|||
13124525|NCT02943564|25953122|FG002|Overall Study|Lost to Follow-up|0|||
13124526|NCT02943564|25953120|FG000|Overall Study|Withdrawal by Subject|6|||
13124527|NCT02943564|25953121|FG001|Overall Study|Withdrawal by Subject|5|||
13124528|NCT02943564|25953122|FG002|Overall Study|Withdrawal by Subject|2|||
13124529|NCT02943564|25953120|FG000|Overall Study|Adverse Event|1|||
13124530|NCT02943564|25953121|FG001|Overall Study|Adverse Event|2|||
13124531|NCT02943564|25953122|FG002|Overall Study|Adverse Event|1|||
13124532|NCT02943564|25953120|FG000|Overall Study|Lack of Efficacy|0|||
13124533|NCT02943564|25953121|FG001|Overall Study|Lack of Efficacy|1|||
13124534|NCT02943564|25953122|FG002|Overall Study|Lack of Efficacy|0|||
13124535|NCT02943473|25953128|FG000|Overall Study|enrolled but not dosed|1|||
13124536|NCT02943473|25953128|FG000|Overall Study|screen failure|1|||
13124537|NCT02943473|25953128|FG000|Overall Study|Physician Decision|4|||
13124538|NCT02943460|25953153|FG000|Blinded Study Phase|Adverse Event|3|||
13124539|NCT02943460|25953154|FG001|Blinded Study Phase|Adverse Event|0|||
13334058|NCT01087762|26606279|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3|||
13334059|NCT01087762|26606280|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
13334060|NCT01087762|26606281|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
13334061|NCT01087762|26606277|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
13124540|NCT02943460|25953155|FG002|Blinded Study Phase|Adverse Event|0|||
13124541|NCT02943460|25953153|FG000|Blinded Study Phase|Withdrew Consent|0|||
13124542|NCT02943460|25953154|FG001|Blinded Study Phase|Withdrew Consent|1|||
13124543|NCT02943460|25953155|FG002|Blinded Study Phase|Withdrew Consent|0|||
13334062|NCT01087762|26606278|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
13334063|NCT01087762|26606279|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
13334064|NCT01087762|26606280|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4|||
13334065|NCT01087762|26606281|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14|||
13334066|NCT01087762|26606277|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
13334067|NCT01087762|26606278|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
13334068|NCT01087762|26606279|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
13334069|NCT01087762|26606280|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
13334070|NCT01087762|26606281|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
13334071|NCT01087762|26606277|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
13334072|NCT01087762|26606278|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
13334073|NCT01087762|26606279|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
13334074|NCT01087762|26606280|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5|||
13334075|NCT01087762|26606281|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2|||
13334076|NCT01087762|26606277|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
13334077|NCT01087762|26606278|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
13334078|NCT01087762|26606279|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
13334079|NCT01087762|26606280|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22|||
13334080|NCT01087762|26606281|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15|||
13334081|NCT01087762|26606277|FG000|Open-Label Period (Weeks 48-204)|Other|0|||
13334082|NCT01087762|26606278|FG001|Open-Label Period (Weeks 48-204)|Other|0|||
13334083|NCT01087762|26606279|FG002|Open-Label Period (Weeks 48-204)|Other|0|||
13334084|NCT01087762|26606280|FG003|Open-Label Period (Weeks 48-204)|Other|2|||
13334085|NCT01087762|26606281|FG004|Open-Label Period (Weeks 48-204)|Other|4|||
13334086|NCT01087762|26606277|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
13124544|NCT02943460|25953153|FG000|Open Label Extension (OLE) Phase|Adverse Event|2|||
13124545|NCT02943460|25953154|FG001|Open Label Extension (OLE) Phase|Adverse Event|5|||
13124546|NCT02943460|25953155|FG002|Open Label Extension (OLE) Phase|Adverse Event|2|||
13124547|NCT02943460|25953153|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2|||
13124548|NCT02943460|25953154|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1|||
13124549|NCT02943460|25953155|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0|||
13124550|NCT02943460|25953153|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
13124551|NCT02943460|25953154|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
13124552|NCT02943460|25953155|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0|||
13124553|NCT02943447|25953185|FG000|Blinded Study Phase|Withdrew Consent|1|||
13124554|NCT02943447|25953186|FG001|Blinded Study Phase|Withdrew Consent|2|||
13124555|NCT02943447|25953187|FG002|Blinded Study Phase|Withdrew Consent|1|||
13124556|NCT02943447|25953185|FG000|Blinded Study Phase|Adverse Event|3|||
13124557|NCT02943447|25953186|FG001|Blinded Study Phase|Adverse Event|0|||
13124558|NCT02943447|25953187|FG002|Blinded Study Phase|Adverse Event|0|||
13124559|NCT02943447|25953185|FG000|Blinded Study Phase|Investigator's discretion|1|||
13124560|NCT02943447|25953186|FG001|Blinded Study Phase|Investigator's discretion|0|||
13124561|NCT02943447|25953187|FG002|Blinded Study Phase|Investigator's discretion|0|||
13124562|NCT02943447|25953185|FG000|Open-Label Extension Phase|Study terminated by sponsor|10|||
13124563|NCT02943447|25953186|FG001|Open-Label Extension Phase|Study terminated by sponsor|12|||
13124564|NCT02943447|25953187|FG002|Open-Label Extension Phase|Study terminated by sponsor|6|||
13124565|NCT02943447|25953185|FG000|Open-Label Extension Phase|Adverse Event|4|||
13204267|NCT01975428|26227974|FG000|Overall Study|Lost to Follow-up|17|||
13204268|NCT01975428|26227975|FG001|Overall Study|Lost to Follow-up|4|||
13204269|NCT01975428|26227974|FG000|Overall Study|Withdrawal by Subject|3|||
13204270|NCT01975428|26227975|FG001|Overall Study|Withdrawal by Subject|10|||
13204271|NCT01975389|26228040|FG000|Overall Study|Adverse Event|10|||
13204272|NCT01975389|26228041|FG001|Overall Study|Adverse Event|6|||
13204273|NCT01975389|26228040|FG000|Overall Study|Death|61|||
13204274|NCT01975389|26228041|FG001|Overall Study|Death|54|||
13204275|NCT01975389|26228040|FG000|Overall Study|Lost to Follow-up|81|||
13204276|NCT01975389|26228041|FG001|Overall Study|Lost to Follow-up|86|||
13204277|NCT01975389|26228040|FG000|Overall Study|Withdrawal by Subject|90|||
13204278|NCT01975389|26228041|FG001|Overall Study|Withdrawal by Subject|76|||
13204279|NCT01975389|26228040|FG000|Overall Study|Other|6|||
13204280|NCT01975389|26228041|FG001|Overall Study|Other|9|||
13204281|NCT01975389|26228040|FG000|Overall Study|Randomized, not treated|4|||
13204282|NCT01975389|26228041|FG001|Overall Study|Randomized, not treated|5|||
13204283|NCT01975376|26228106|FG000|Overall Study|Adverse Event|5|||
13204284|NCT01975376|26228107|FG001|Overall Study|Adverse Event|5|||
13204285|NCT01975376|26228106|FG000|Overall Study|Death|65|||
13204286|NCT01975376|26228107|FG001|Overall Study|Death|72|||
13204287|NCT01975376|26228106|FG000|Overall Study|Lost to Follow-up|70|||
13204288|NCT01975376|26228107|FG001|Overall Study|Lost to Follow-up|66|||
13124566|NCT02943447|25953186|FG001|Open-Label Extension Phase|Adverse Event|7|||
13124567|NCT02943447|25953187|FG002|Open-Label Extension Phase|Adverse Event|3|||
13124568|NCT02943447|25953185|FG000|Open-Label Extension Phase|Lack of Efficacy|3|||
13124569|NCT02943447|25953186|FG001|Open-Label Extension Phase|Lack of Efficacy|4|||
13124570|NCT02943447|25953187|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
13124571|NCT02943447|25953185|FG000|Open-Label Extension Phase|Withdrew consent|1|||
13124572|NCT02943447|25953186|FG001|Open-Label Extension Phase|Withdrew consent|1|||
13124573|NCT02943447|25953187|FG002|Open-Label Extension Phase|Withdrew consent|1|||
13124574|NCT02943447|25953185|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
13124575|NCT02943447|25953186|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
13124576|NCT02943447|25953187|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
13124577|NCT02943096|25953208|FG000|Overall Study|Lack of Efficacy|0|||
13124578|NCT02943096|25953209|FG001|Overall Study|Lack of Efficacy|1|||
13124579|NCT02943070|25953243|FG000|Overall Study|Physician Decision|1|||
13124580|NCT02943070|25953243|FG000|Overall Study|Adverse Event|2|||
13124581|NCT02943070|25953243|FG000|Overall Study|Death|2|||
13124582|NCT02943070|25953243|FG000|Overall Study|Withdrawal by Subject|3|||
13124583|NCT02943070|25953243|FG000|Overall Study|Lost to Follow-up|4|||
13124584|NCT02943070|25953243|FG000|Overall Study|Retreatment or TURP|13|||
13124585|NCT02943070|25953243|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18|||
13124586|NCT02942771|25953301|FG000|Overall Study|Adverse Event|1|||
13124587|NCT02942771|25953302|FG001|Overall Study|Adverse Event|0|||
13124588|NCT02942771|25953303|FG002|Overall Study|Adverse Event|0|||
13124589|NCT02942771|25953304|FG003|Overall Study|Adverse Event|0|||
13124590|NCT02942771|25953305|FG004|Overall Study|Adverse Event|2|||
13124591|NCT02942771|25953301|FG000|Overall Study|Lost to Follow-up|1|||
13124592|NCT02942771|25953302|FG001|Overall Study|Lost to Follow-up|0|||
13124593|NCT02942771|25953303|FG002|Overall Study|Lost to Follow-up|0|||
13124594|NCT02942771|25953304|FG003|Overall Study|Lost to Follow-up|0|||
13124595|NCT02942771|25953305|FG004|Overall Study|Lost to Follow-up|0|||
13124596|NCT02942771|25953301|FG000|Overall Study|Withdrawal by Subject|1|||
13124597|NCT02942771|25953302|FG001|Overall Study|Withdrawal by Subject|0|||
13124598|NCT02942771|25953303|FG002|Overall Study|Withdrawal by Subject|0|||
13124599|NCT02942771|25953304|FG003|Overall Study|Withdrawal by Subject|0|||
13124600|NCT02942771|25953305|FG004|Overall Study|Withdrawal by Subject|2|||
13124601|NCT02942576|25953324|FG000|Overall Study|Adverse Event|28|||
13124602|NCT02942576|25953325|FG001|Overall Study|Adverse Event|6|||
13124603|NCT02942576|25953324|FG000|Overall Study|Withdrawal by Subject|7|||
13124604|NCT02942576|25953325|FG001|Overall Study|Withdrawal by Subject|5|||
13124605|NCT02942576|25953324|FG000|Overall Study|Physician Decision|1|||
13124606|NCT02942576|25953325|FG001|Overall Study|Physician Decision|4|||
13124607|NCT02942576|25953324|FG000|Overall Study|Other|10|||
13124608|NCT02942576|25953325|FG001|Overall Study|Other|8|||
13124609|NCT02942485|25953342|FG000|Overall Study|Lost to Follow-up|1|||
13124610|NCT02942485|25953343|FG001|Overall Study|Lost to Follow-up|0|||
13124611|NCT02942407|25953378|FG000|Overall Study|Lost to Follow-up|3|||
13124612|NCT02942407|25953379|FG001|Overall Study|Lost to Follow-up|2|||
13124613|NCT02942407|25953378|FG000|Overall Study|Withdrawal by Subject|7|||
13124614|NCT02942407|25953379|FG001|Overall Study|Withdrawal by Subject|9|||
13124615|NCT02942407|25953378|FG000|Overall Study|Death|16|||
13124616|NCT02942407|25953379|FG001|Overall Study|Death|13|||
13124617|NCT02942264|25953441|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
13124618|NCT02942264|25953442|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
13124619|NCT02942264|25953443|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
13124620|NCT02942264|25953444|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
13124621|NCT02942264|25953445|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
13124622|NCT02942264|25953446|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
13124623|NCT02942264|25953447|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
13124624|NCT02942264|25953448|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
13124625|NCT02942264|25953449|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
13124626|NCT02942264|25953441|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
13124627|NCT02942264|25953442|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
13124628|NCT02942264|25953443|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
13289185|NCT01081145|26477542|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2|||
13289186|NCT01081145|26477541|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13|||
13289187|NCT01081145|26477542|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20|||
13289188|NCT01081145|26477541|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47|||
13289189|NCT01081145|26477542|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71|||
13289190|NCT01081145|26477541|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4|||
13289191|NCT01081145|26477542|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3|||
13289192|NCT01081132|26477587|FG000|Overall Study|Lack of Efficacy|25|||
13289193|NCT01081132|26477588|FG001|Overall Study|Lack of Efficacy|9|||
13289194|NCT01081132|26477587|FG000|Overall Study|Withdrawal by Subject|13|||
13289195|NCT01081132|26477588|FG001|Overall Study|Withdrawal by Subject|16|||
13124629|NCT02942264|25953444|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
13124630|NCT02942264|25953445|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
13124631|NCT02942264|25953446|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
13124632|NCT02942264|25953447|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
13124633|NCT02942264|25953448|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
13124634|NCT02942264|25953449|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1|||
13124635|NCT02941627|25953462|FG000|Overall Study|Death|1|||
13124636|NCT02941627|25953462|FG000|Overall Study|Surgical failure|1|||
13124637|NCT02941627|25953462|FG000|Overall Study|cholesteatoma prevented implantation|1|||
13124638|NCT02941523|25953491|FG000|Monotherapy|Withdrawal by Subject|0|||
13124639|NCT02941523|25953492|FG001|Monotherapy|Withdrawal by Subject|1|||
13124640|NCT02941523|25953491|FG000|Carboplatin Combination Therapy|Adverse Event|0|||
13124641|NCT02941523|25953492|FG001|Carboplatin Combination Therapy|Adverse Event|1|||
13124642|NCT02941523|25953491|FG000|Carboplatin Combination Therapy|Death|1|||
13124643|NCT02941523|25953492|FG001|Carboplatin Combination Therapy|Death|2|||
13124644|NCT02941523|25953491|FG000|Carboplatin Combination Therapy|Disease progression|2|||
13124645|NCT02941523|25953492|FG001|Carboplatin Combination Therapy|Disease progression|0|||
13124646|NCT02941523|25953491|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2|||
13124647|NCT02941523|25953492|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1|||
13124648|NCT02940886|25953543|FG000|Overall Study|Adverse Event|7|||
13124649|NCT02940886|25953544|FG001|Overall Study|Adverse Event|3|||
13124650|NCT02940886|25953543|FG000|Overall Study|Protocol Violation|0|||
13124651|NCT02940886|25953544|FG001|Overall Study|Protocol Violation|2|||
13124652|NCT02940886|25953543|FG000|Overall Study|Withdrawal by Subject|28|||
13124653|NCT02940886|25953544|FG001|Overall Study|Withdrawal by Subject|20|||
13124654|NCT02940886|25953543|FG000|Overall Study|Death|1|||
13124655|NCT02940886|25953544|FG001|Overall Study|Death|0|||
13124656|NCT02940886|25953543|FG000|Overall Study|Lack of Efficacy|1|||
13124657|NCT02940886|25953544|FG001|Overall Study|Lack of Efficacy|0|||
13124658|NCT02940886|25953543|FG000|Overall Study|Lost to Follow-up|49|||
13124659|NCT02940886|25953544|FG001|Overall Study|Lost to Follow-up|21|||
13124660|NCT02940886|25953543|FG000|Overall Study|Physician Decision|9|||
13334087|NCT01087762|26606278|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
13124661|NCT02940886|25953544|FG001|Overall Study|Physician Decision|4|||
13124662|NCT02940886|25953543|FG000|Overall Study|Sponsor decision|0|||
13334088|NCT01087762|26606279|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
13334089|NCT01087762|26606280|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7|||
13334090|NCT01087762|26606281|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4|||
13334091|NCT01087762|26606277|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
13334092|NCT01087762|26606278|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
13334093|NCT01087762|26606279|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
13124663|NCT02940886|25953544|FG001|Overall Study|Sponsor decision|1|||
13334094|NCT01087762|26606280|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16|||
13334095|NCT01087762|26606281|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13|||
13334096|NCT01087762|26606277|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
13334097|NCT01087762|26606278|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
13334098|NCT01087762|26606279|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
13334099|NCT01087762|26606280|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2|||
13334100|NCT01087762|26606281|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4|||
13334101|NCT01087736|26606296|FG000|Overall Study|Lost to Follow-up|1|||
13334102|NCT01087736|26606297|FG001|Overall Study|Lost to Follow-up|0|||
13334103|NCT01087736|26606296|FG000|Overall Study|Death|0|||
13334104|NCT01087736|26606297|FG001|Overall Study|Death|1|||
13334105|NCT01087736|26606296|FG000|Overall Study|Withdrawal by Subject|0|||
13334106|NCT01087736|26606297|FG001|Overall Study|Withdrawal by Subject|1|||
13334107|NCT01087489|26606310|FG000|Overall Study|enrolled in another VA study|0|||
13334108|NCT01087489|26606311|FG001|Overall Study|enrolled in another VA study|1|||
13334109|NCT01087489|26606310|FG000|Overall Study|Death|0|||
13334110|NCT01087489|26606311|FG001|Overall Study|Death|1|||
13334111|NCT01087489|26606310|FG000|Overall Study|unable to survey by telephone|0|||
13334112|NCT01087489|26606311|FG001|Overall Study|unable to survey by telephone|1|||
13334113|NCT01087203|26606374|FG000|Overall Study|Lost to Follow-up|2|||
13334114|NCT01087203|26606375|FG001|Overall Study|Lost to Follow-up|0|||
13334115|NCT01087203|26606374|FG000|Overall Study|Withdrawal by Subject|2|||
13334116|NCT01087203|26606375|FG001|Overall Study|Withdrawal by Subject|6|||
13334117|NCT01087203|26606374|FG000|Overall Study|Lack of Efficacy|1|||
13334118|NCT01087203|26606375|FG001|Overall Study|Lack of Efficacy|2|||
13124664|NCT02940886|25953543|FG000|Overall Study|No treatment|7|||
13124665|NCT02940886|25953544|FG001|Overall Study|No treatment|2|||
13124666|NCT02940886|25953543|FG000|Overall Study|Enrolment error|0|||
13334119|NCT01087203|26606374|FG000|Overall Study|Study terminated by sponsor|27|||
13334120|NCT01087203|26606375|FG001|Overall Study|Study terminated by sponsor|27|||
13334121|NCT01086384|26606393|FG000|2-week Run-in Period|Adverse Event|1|||
13124667|NCT02940886|25953544|FG001|Overall Study|Enrolment error|1|||
13124668|NCT02940860|25953595|FG000|Overall Study|Non-serious AE|1|||
13334122|NCT01086384|26606394|FG001|2-week Run-in Period|Adverse Event|0|||
13334123|NCT01086384|26606395|FG002|2-week Run-in Period|Adverse Event|0|||
13334124|NCT01086384|26606393|FG000|2-week Run-in Period|Protocol Violation|1|||
13334125|NCT01086384|26606394|FG001|2-week Run-in Period|Protocol Violation|0|||
13334126|NCT01086384|26606395|FG002|2-week Run-in Period|Protocol Violation|0|||
13334127|NCT01086384|26606393|FG000|2-week Run-in Period|Lost to Follow-up|1|||
13334128|NCT01086384|26606394|FG001|2-week Run-in Period|Lost to Follow-up|0|||
13124669|NCT02940860|25953596|FG001|Overall Study|Non-serious AE|2|||
13124670|NCT02940860|25953595|FG000|Overall Study|Serious AE|7|||
13334129|NCT01086384|26606395|FG002|2-week Run-in Period|Lost to Follow-up|0|||
13334130|NCT01086384|26606393|FG000|2-week Run-in Period|Physician Decision|6|||
13334131|NCT01086384|26606394|FG001|2-week Run-in Period|Physician Decision|0|||
13334132|NCT01086384|26606395|FG002|2-week Run-in Period|Physician Decision|0|||
13334133|NCT01086384|26606393|FG000|2-week Run-in Period|Withdrawal by Subject|19|||
13334134|NCT01086384|26606394|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
13334135|NCT01086384|26606395|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
13334136|NCT01086384|26606393|FG000|2-week Run-in Period|Study Closed/Terminated|42|||
13334137|NCT01086384|26606394|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
13334138|NCT01086384|26606395|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
13334139|NCT01086384|26606393|FG000|2-week Run-in Period|Continuation Criteria Not Met|92|||
13334140|NCT01086384|26606394|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
13334141|NCT01086384|26606395|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
13334142|NCT01086384|26606393|FG000|2-week Run-in Period|Randomized in Error|1|||
13334143|NCT01086384|26606394|FG001|2-week Run-in Period|Randomized in Error|0|||
13334144|NCT01086384|26606395|FG002|2-week Run-in Period|Randomized in Error|0|||
13334145|NCT01086384|26606393|FG000|Treatment Period|Withdrawal by Subject|0|||
13334146|NCT01086384|26606394|FG001|Treatment Period|Withdrawal by Subject|53|||
13334147|NCT01086384|26606395|FG002|Treatment Period|Withdrawal by Subject|55|||
13334148|NCT01086384|26606393|FG000|Treatment Period|Protocol Violation|0|||
13334149|NCT01086384|26606394|FG001|Treatment Period|Protocol Violation|26|||
13334150|NCT01086384|26606395|FG002|Treatment Period|Protocol Violation|17|||
13334151|NCT01086384|26606393|FG000|Treatment Period|Lack of Efficacy|0|||
13124671|NCT02940860|25953596|FG001|Overall Study|Serious AE|3|||
13124672|NCT02940860|25953595|FG000|Overall Study|Withdrawal by Subject|19|||
13124673|NCT02940860|25953596|FG001|Overall Study|Withdrawal by Subject|9|||
13334152|NCT01086384|26606394|FG001|Treatment Period|Lack of Efficacy|22|||
13334153|NCT01086384|26606395|FG002|Treatment Period|Lack of Efficacy|13|||
13334154|NCT01086384|26606393|FG000|Treatment Period|Adverse Event|0|||
13334155|NCT01086384|26606394|FG001|Treatment Period|Adverse Event|19|||
13334156|NCT01086384|26606395|FG002|Treatment Period|Adverse Event|15|||
13334157|NCT01086384|26606393|FG000|Treatment Period|Lost to Follow-up|0|||
13334158|NCT01086384|26606394|FG001|Treatment Period|Lost to Follow-up|11|||
13334159|NCT01086384|26606395|FG002|Treatment Period|Lost to Follow-up|9|||
13334160|NCT01086384|26606393|FG000|Treatment Period|Physician Decision|0|||
13334161|NCT01086384|26606394|FG001|Treatment Period|Physician Decision|9|||
13334162|NCT01086384|26606395|FG002|Treatment Period|Physician Decision|6|||
13334163|NCT01086384|26606393|FG000|Treatment Period|Study Closed/Terminated|0|||
13334164|NCT01086384|26606394|FG001|Treatment Period|Study Closed/Terminated|7|||
13334165|NCT01086384|26606395|FG002|Treatment Period|Study Closed/Terminated|8|||
13334166|NCT01086384|26606393|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0|||
13334167|NCT01086384|26606394|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0|||
13334168|NCT01086384|26606395|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1|||
13334169|NCT01086384|26606393|FG000|Treatment Period|Received Treatment in Error|0|||
13334170|NCT01086384|26606394|FG001|Treatment Period|Received Treatment in Error|1|||
13334171|NCT01086384|26606395|FG002|Treatment Period|Received Treatment in Error|0|||
13334172|NCT01086358|26606410|FG000|First Intervention|Lost to Follow-up|9|||
13334173|NCT01086358|26606411|FG001|First Intervention|Lost to Follow-up|4|||
13334174|NCT01086358|26606410|FG000|First Intervention|Withdrawal by Subject|0|||
13334175|NCT01086358|26606411|FG001|First Intervention|Withdrawal by Subject|1|||
13334176|NCT01086358|26606410|FG000|Second Intervention|Lost to Follow-up|4|||
13334177|NCT01086358|26606411|FG001|Second Intervention|Lost to Follow-up|4|||
13334178|NCT01084252|26606636|FG000|Phase 1 (120 Weeks)|Adverse Event|0|||
13334179|NCT01084252|26606637|FG001|Phase 1 (120 Weeks)|Adverse Event|0|||
13334180|NCT01084252|26606638|FG002|Phase 1 (120 Weeks)|Adverse Event|1|||
13334181|NCT01084252|26606639|FG003|Phase 1 (120 Weeks)|Adverse Event|1|||
13334182|NCT01084252|26606640|FG004|Phase 1 (120 Weeks)|Adverse Event|1|||
13334183|NCT01084252|26606641|FG005|Phase 1 (120 Weeks)|Adverse Event|0|||
13334184|NCT01084252|26606642|FG006|Phase 1 (120 Weeks)|Adverse Event|1|||
13334185|NCT01084252|26606643|FG007|Phase 1 (120 Weeks)|Adverse Event|0|||
13334186|NCT01084252|26606644|FG008|Phase 1 (120 Weeks)|Adverse Event|0|||
13334187|NCT01084252|26606645|FG009|Phase 1 (120 Weeks)|Adverse Event|0|||
13334188|NCT01084252|26606646|FG010|Phase 1 (120 Weeks)|Adverse Event|0|||
13334189|NCT01084252|26606647|FG011|Phase 1 (120 Weeks)|Adverse Event|0|||
13334190|NCT01084252|26606648|FG012|Phase 1 (120 Weeks)|Adverse Event|0|||
13334191|NCT01084252|26606649|FG013|Phase 1 (120 Weeks)|Adverse Event|0|||
13334192|NCT01084252|26606636|FG000|Phase 1 (120 Weeks)|Progressive disease|15|||
13334193|NCT01084252|26606637|FG001|Phase 1 (120 Weeks)|Progressive disease|5|||
13334194|NCT01084252|26606638|FG002|Phase 1 (120 Weeks)|Progressive disease|2|||
13334195|NCT01084252|26606639|FG003|Phase 1 (120 Weeks)|Progressive disease|22|||
13334196|NCT01084252|26606640|FG004|Phase 1 (120 Weeks)|Progressive disease|16|||
13334197|NCT01084252|26606641|FG005|Phase 1 (120 Weeks)|Progressive disease|6|||
13334198|NCT01084252|26606642|FG006|Phase 1 (120 Weeks)|Progressive disease|5|||
13334199|NCT01084252|26606643|FG007|Phase 1 (120 Weeks)|Progressive disease|6|||
13334200|NCT01084252|26606644|FG008|Phase 1 (120 Weeks)|Progressive disease|0|||
13334201|NCT01084252|26606645|FG009|Phase 1 (120 Weeks)|Progressive disease|0|||
13334202|NCT01084252|26606646|FG010|Phase 1 (120 Weeks)|Progressive disease|0|||
13334203|NCT01084252|26606647|FG011|Phase 1 (120 Weeks)|Progressive disease|0|||
13334204|NCT01084252|26606648|FG012|Phase 1 (120 Weeks)|Progressive disease|0|||
13334205|NCT01084252|26606649|FG013|Phase 1 (120 Weeks)|Progressive disease|0|||
13334206|NCT01084252|26606636|FG000|Phase 1 (120 Weeks)|Other than specified above|1|||
13334207|NCT01084252|26606637|FG001|Phase 1 (120 Weeks)|Other than specified above|1|||
13334208|NCT01084252|26606638|FG002|Phase 1 (120 Weeks)|Other than specified above|0|||
13334209|NCT01084252|26606639|FG003|Phase 1 (120 Weeks)|Other than specified above|3|||
13334210|NCT01084252|26606640|FG004|Phase 1 (120 Weeks)|Other than specified above|1|||
13334211|NCT01084252|26606641|FG005|Phase 1 (120 Weeks)|Other than specified above|0|||
13334212|NCT01084252|26606642|FG006|Phase 1 (120 Weeks)|Other than specified above|1|||
13334213|NCT01084252|26606643|FG007|Phase 1 (120 Weeks)|Other than specified above|1|||
13334214|NCT01084252|26606644|FG008|Phase 1 (120 Weeks)|Other than specified above|0|||
13334215|NCT01084252|26606645|FG009|Phase 1 (120 Weeks)|Other than specified above|0|||
13334216|NCT01084252|26606646|FG010|Phase 1 (120 Weeks)|Other than specified above|0|||
13334217|NCT01084252|26606647|FG011|Phase 1 (120 Weeks)|Other than specified above|0|||
13334218|NCT01084252|26606648|FG012|Phase 1 (120 Weeks)|Other than specified above|0|||
13334219|NCT01084252|26606649|FG013|Phase 1 (120 Weeks)|Other than specified above|0|||
13124674|NCT02940860|25953595|FG000|Overall Study|Lost to Follow-up|13|||
13124675|NCT02940860|25953596|FG001|Overall Study|Lost to Follow-up|7|||
13124676|NCT02940860|25953595|FG000|Overall Study|Physician Decision|5|||
13124677|NCT02940860|25953596|FG001|Overall Study|Physician Decision|3|||
13124678|NCT02940860|25953595|FG000|Overall Study|Sponsor Decision|0|||
13124679|NCT02940860|25953596|FG001|Overall Study|Sponsor Decision|1|||
13334220|NCT01084252|26606636|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
13334221|NCT01084252|26606637|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
13334222|NCT01084252|26606638|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
13334223|NCT01084252|26606639|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
13334224|NCT01084252|26606640|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
13334225|NCT01084252|26606641|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
13334226|NCT01084252|26606642|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
13334227|NCT01084252|26606643|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
13334228|NCT01084252|26606644|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
13124680|NCT02940860|25953595|FG000|Overall Study|Protocol Violation|0|||
13124681|NCT02940860|25953596|FG001|Overall Study|Protocol Violation|2|||
13124682|NCT02940860|25953595|FG000|Overall Study|Death|3|||
13124683|NCT02940860|25953596|FG001|Overall Study|Death|2|||
13204289|NCT01975376|26228106|FG000|Overall Study|Withdrew consent|68|||
13204290|NCT01975376|26228107|FG001|Overall Study|Withdrew consent|62|||
13204291|NCT01975376|26228106|FG000|Overall Study|Other|2|||
13204292|NCT01975376|26228107|FG001|Overall Study|Other|4|||
13204293|NCT01975376|26228106|FG000|Overall Study|Randomized, Not Treated|16|||
13204294|NCT01975376|26228107|FG001|Overall Study|Randomized, Not Treated|8|||
13204295|NCT01975285|26228128|FG000|Overall Study|Failed Block and follow up|2|||
13204296|NCT01975285|26228129|FG001|Overall Study|Failed Block and follow up|2|||
13204297|NCT01975272|26228153|FG000|Overall Study|Excluded after protocol amendment|1|||
13204298|NCT01975272|26228154|FG001|Overall Study|Excluded after protocol amendment|1|||
13204299|NCT01975272|26228155|FG002|Overall Study|Excluded after protocol amendment|2|||
13204300|NCT01975246|26228172|FG000|Overall Study|Adverse Event|2|||
13334229|NCT01084252|26606645|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|2|||
13334230|NCT01084252|26606646|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|2|||
13204301|NCT01975246|26228173|FG001|Overall Study|Adverse Event|1|||
13204302|NCT01975246|26228172|FG000|Overall Study|Lack of Efficacy|1|||
13204303|NCT01975246|26228173|FG001|Overall Study|Lack of Efficacy|0|||
13204304|NCT01975246|26228172|FG000|Overall Study|Protocol Violation|1|||
13204305|NCT01975246|26228173|FG001|Overall Study|Protocol Violation|0|||
13204306|NCT01975246|26228172|FG000|Overall Study|Other than stated|0|||
13204307|NCT01975246|26228173|FG001|Overall Study|Other than stated|1|||
13334231|NCT01084252|26606647|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|1|||
13334232|NCT01084252|26606648|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
13334233|NCT01084252|26606649|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
13486412|NCT03564119|27036069|FG001|Overall Study|Adverse Event|0|||
13204308|NCT01975220|26228230|FG000|Test Period 1|Not treated|0|||
13124684|NCT02940860|25953595|FG000|Overall Study|Moved, poor venous access, transport|6|||
13124685|NCT02940860|25953596|FG001|Overall Study|Moved, poor venous access, transport|4|||
13124686|NCT02940860|25953595|FG000|Overall Study|Not treated|2|||
13124687|NCT02940860|25953596|FG001|Overall Study|Not treated|2|||
13124688|NCT02940730|25953617|FG000|Intervention 2|Physician Decision|7|||
13124689|NCT02940730|25953618|FG001|Intervention 2|Physician Decision|0|||
13124690|NCT02940691|25953627|FG000|Overall Study|Lost to Follow-up|5|||
13124691|NCT02940691|25953627|FG000|Overall Study|Incarceration|1|||
13124692|NCT02940626|25953654|FG000|Overall Study|Death|40|||
13124693|NCT02940626|25953655|FG001|Overall Study|Death|32|||
13124694|NCT02940626|25953654|FG000|Overall Study|Lost to Follow-up|5|||
13124695|NCT02940626|25953655|FG001|Overall Study|Lost to Follow-up|2|||
13124696|NCT02940626|25953654|FG000|Overall Study|Withdrawal by Subject|1|||
13124697|NCT02940626|25953655|FG001|Overall Study|Withdrawal by Subject|0|||
13124698|NCT02940626|25953654|FG000|Overall Study|Transfer to Hospice Care|1|||
13124699|NCT02940626|25953655|FG001|Overall Study|Transfer to Hospice Care|0|||
13124700|NCT02940626|25953654|FG000|Overall Study|Prohibited Concomitant Medication|0|||
13124701|NCT02940626|25953655|FG001|Overall Study|Prohibited Concomitant Medication|1|||
13334234|NCT01084252|26606636|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
13334235|NCT01084252|26606637|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
13334236|NCT01084252|26606638|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
13334237|NCT01084252|26606639|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
13334238|NCT01084252|26606640|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
13334239|NCT01084252|26606641|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
13334240|NCT01084252|26606642|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
13334241|NCT01084252|26606643|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
13334242|NCT01084252|26606644|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|20|||
13124702|NCT02940574|25953698|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1|||
13124703|NCT02940574|25953699|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0|||
13124704|NCT02940574|25953698|FG000|1-year Follow-up|Lost to Follow-up|3|||
13124705|NCT02940574|25953699|FG001|1-year Follow-up|Lost to Follow-up|4|||
13124706|NCT02940522|25953722|FG000|Overall Study|Lost to Follow-up|1|||
13124707|NCT02940522|25953723|FG001|Overall Study|Lost to Follow-up|2|||
13124708|NCT02940522|25953722|FG000|Overall Study|Withdrawal by Subject|1|||
13334243|NCT01084252|26606645|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|18|||
13334244|NCT01084252|26606646|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|17|||
13334245|NCT01084252|26606647|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|19|||
13334246|NCT01084252|26606648|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
13334247|NCT01084252|26606649|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
13334248|NCT01084252|26606636|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
13334249|NCT01084252|26606637|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
13334250|NCT01084252|26606638|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
13334251|NCT01084252|26606639|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
13334252|NCT01084252|26606640|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
13334253|NCT01084252|26606641|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
13334254|NCT01084252|26606642|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
13334255|NCT01084252|26606643|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
13334256|NCT01084252|26606644|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|2|||
13334257|NCT01084252|26606645|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
13334258|NCT01084252|26606646|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|4|||
13334259|NCT01084252|26606647|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|3|||
13334260|NCT01084252|26606648|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
13334261|NCT01084252|26606649|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
13334262|NCT01084252|26606636|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
13334263|NCT01084252|26606637|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
13334264|NCT01084252|26606638|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
13334265|NCT01084252|26606639|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
13334266|NCT01084252|26606640|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
13334267|NCT01084252|26606641|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
13334268|NCT01084252|26606642|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
13334269|NCT01084252|26606643|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
13486413|NCT03564119|27036068|FG000|Overall Study|Lost to Follow-up|1|||
13124709|NCT02940522|25953723|FG001|Overall Study|Withdrawal by Subject|0|||
13124710|NCT02940392|25953735|FG000|Overall Study|Lost to Follow-up|3|||
13124711|NCT02940392|25953735|FG000|Overall Study|Retreatment|3|||
13124712|NCT02940392|25953735|FG000|Overall Study|Death|2|||
13124713|NCT02940223|25953752|FG000|Overall Study|Failed Requirement|2|||
13334270|NCT01084252|26606644|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|1|||
13334271|NCT01084252|26606645|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|4|||
13334272|NCT01084252|26606646|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|2|||
13334273|NCT01084252|26606647|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|2|||
13334274|NCT01084252|26606648|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
13334275|NCT01084252|26606649|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
13334276|NCT01084252|26606636|FG000|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
13334277|NCT01084252|26606637|FG001|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
13334278|NCT01084252|26606638|FG002|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
13334279|NCT01084252|26606639|FG003|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
13334280|NCT01084252|26606640|FG004|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
13334281|NCT01084252|26606641|FG005|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
13334282|NCT01084252|26606642|FG006|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
13334283|NCT01084252|26606643|FG007|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
13334284|NCT01084252|26606644|FG008|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
13124714|NCT02940223|25953753|FG001|Overall Study|Failed Requirement|0|||
13124715|NCT02939950|25953768|FG000|Overall Study|Lost to Follow-up|13|||
13334285|NCT01084252|26606645|FG009|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
13334286|NCT01084252|26606646|FG010|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
13334287|NCT01084252|26606647|FG011|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
13334288|NCT01084252|26606648|FG012|Phase 2 Stage 2 (97 Weeks)|Adverse Event|13|||
13334289|NCT01084252|26606649|FG013|Phase 2 Stage 2 (97 Weeks)|Adverse Event|5|||
13334290|NCT01084252|26606636|FG000|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
13334291|NCT01084252|26606637|FG001|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
13334292|NCT01084252|26606638|FG002|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
13334293|NCT01084252|26606639|FG003|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
13334294|NCT01084252|26606640|FG004|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
13334295|NCT01084252|26606641|FG005|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
13334296|NCT01084252|26606642|FG006|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
13334297|NCT01084252|26606643|FG007|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
13334298|NCT01084252|26606644|FG008|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
13334299|NCT01084252|26606645|FG009|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
13334300|NCT01084252|26606646|FG010|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
13334301|NCT01084252|26606647|FG011|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
13334302|NCT01084252|26606648|FG012|Phase 2 Stage 2 (97 Weeks)|Progressive disease|70|||
13334303|NCT01084252|26606649|FG013|Phase 2 Stage 2 (97 Weeks)|Progressive disease|33|||
13334304|NCT01084252|26606636|FG000|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
13334305|NCT01084252|26606637|FG001|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
13334306|NCT01084252|26606638|FG002|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
13334307|NCT01084252|26606639|FG003|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
13334308|NCT01084252|26606640|FG004|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
13334309|NCT01084252|26606641|FG005|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
13334310|NCT01084252|26606642|FG006|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
13334311|NCT01084252|26606643|FG007|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
13334312|NCT01084252|26606644|FG008|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
13334313|NCT01084252|26606645|FG009|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
13334314|NCT01084252|26606646|FG010|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
13334315|NCT01084252|26606647|FG011|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
13334316|NCT01084252|26606648|FG012|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|1|||
13334317|NCT01084252|26606649|FG013|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
13334318|NCT01084252|26606636|FG000|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
13334319|NCT01084252|26606637|FG001|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
13334320|NCT01084252|26606638|FG002|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
13334321|NCT01084252|26606639|FG003|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
13334322|NCT01084252|26606640|FG004|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
13334323|NCT01084252|26606641|FG005|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
13334324|NCT01084252|26606642|FG006|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
13334325|NCT01084252|26606643|FG007|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
13334326|NCT01084252|26606644|FG008|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
13334327|NCT01084252|26606645|FG009|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
13334328|NCT01084252|26606646|FG010|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
13334329|NCT01084252|26606647|FG011|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
13334330|NCT01084252|26606648|FG012|Phase 2 Stage 2 (97 Weeks)|Other than specified above|12|||
13334331|NCT01084252|26606649|FG013|Phase 2 Stage 2 (97 Weeks)|Other than specified above|2|||
13334332|NCT01084252|26606636|FG000|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
13334333|NCT01084252|26606637|FG001|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
13334334|NCT01084252|26606638|FG002|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
13334335|NCT01084252|26606639|FG003|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
13124716|NCT02939950|25953769|FG001|Overall Study|Lost to Follow-up|16|||
13334336|NCT01084252|26606640|FG004|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
13334337|NCT01084252|26606641|FG005|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
13334338|NCT01084252|26606642|FG006|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
13334339|NCT01084252|26606643|FG007|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
13334340|NCT01084252|26606644|FG008|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
13334341|NCT01084252|26606645|FG009|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
13334342|NCT01084252|26606646|FG010|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
13334343|NCT01084252|26606647|FG011|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
13334344|NCT01084252|26606648|FG012|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|13|||
13334345|NCT01084252|26606649|FG013|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|15|||
13334346|NCT01084252|26606636|FG000|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
13334347|NCT01084252|26606637|FG001|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
13334348|NCT01084252|26606638|FG002|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
13334349|NCT01084252|26606639|FG003|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
13334350|NCT01084252|26606640|FG004|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
13334351|NCT01084252|26606641|FG005|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
13334352|NCT01084252|26606642|FG006|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
13334353|NCT01084252|26606643|FG007|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
13334354|NCT01084252|26606644|FG008|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
13334355|NCT01084252|26606645|FG009|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
13334356|NCT01084252|26606646|FG010|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
13334357|NCT01084252|26606647|FG011|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
13334358|NCT01084252|26606648|FG012|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|1|||
13334359|NCT01084252|26606649|FG013|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
13334360|NCT01084239|26606672|FG000|28-Day Follow-up|Lost to Follow-up|4|||
13334361|NCT01084239|26606673|FG001|28-Day Follow-up|Lost to Follow-up|9|||
13334362|NCT01082965|26606698|FG000|Overall Study|Protocol Violation|0|||
13334363|NCT01082965|26606699|FG001|Overall Study|Protocol Violation|1|||
13334364|NCT01082965|26606698|FG000|Overall Study|Other|1|||
13334365|NCT01082965|26606699|FG001|Overall Study|Other|1|||
13334366|NCT01082874|26606722|FG000|Overall Study|Lost to Follow-up|10|||
13334367|NCT01082874|26606723|FG001|Overall Study|Lost to Follow-up|10|||
13334368|NCT01082874|26606724|FG002|Overall Study|Lost to Follow-up|6|||
13334369|NCT01082874|26606725|FG003|Overall Study|Lost to Follow-up|10|||
13334370|NCT01082874|26606722|FG000|Overall Study|Withdrawal by Subject|1|||
13334371|NCT01082874|26606723|FG001|Overall Study|Withdrawal by Subject|2|||
13334372|NCT01082874|26606724|FG002|Overall Study|Withdrawal by Subject|5|||
13334373|NCT01082874|26606725|FG003|Overall Study|Withdrawal by Subject|3|||
13334374|NCT01082328|26606736|FG000|Overall Study|Adverse Event|1|||
13334375|NCT01081834|26606810|FG000|Core Period: Baseline to Week 26|Pregnancy|1|||
13334376|NCT01081834|26606811|FG001|Core Period: Baseline to Week 26|Pregnancy|0|||
13334377|NCT01081834|26606812|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
13334378|NCT01081834|26606813|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
13334379|NCT01081834|26606814|FG004|Core Period: Baseline to Week 26|Pregnancy|0|||
13334380|NCT01081834|26606810|FG000|Core Period: Baseline to Week 26|Adverse Event|2|||
13334381|NCT01081834|26606811|FG001|Core Period: Baseline to Week 26|Adverse Event|5|||
13334382|NCT01081834|26606812|FG002|Core Period: Baseline to Week 26|Adverse Event|3|||
13334383|NCT01081834|26606813|FG003|Core Period: Baseline to Week 26|Adverse Event|1|||
13334384|NCT01081834|26606814|FG004|Core Period: Baseline to Week 26|Adverse Event|1|||
13334385|NCT01081834|26606810|FG000|Core Period: Baseline to Week 26|Death|1|||
13334386|NCT01081834|26606811|FG001|Core Period: Baseline to Week 26|Death|0|||
13334387|NCT01081834|26606812|FG002|Core Period: Baseline to Week 26|Death|0|||
13334388|NCT01081834|26606813|FG003|Core Period: Baseline to Week 26|Death|0|||
13334389|NCT01081834|26606814|FG004|Core Period: Baseline to Week 26|Death|0|||
13334390|NCT01081834|26606810|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
13334391|NCT01081834|26606811|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
13334392|NCT01081834|26606812|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
13334393|NCT01081834|26606813|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
13334394|NCT01081834|26606814|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
13334395|NCT01081834|26606810|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
13334396|NCT01081834|26606811|FG001|Core Period: Baseline to Week 26|Protocol Violation|4|||
13334397|NCT01081834|26606812|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
13334398|NCT01081834|26606813|FG003|Core Period: Baseline to Week 26|Protocol Violation|0|||
13334399|NCT01081834|26606814|FG004|Core Period: Baseline to Week 26|Protocol Violation|2|||
13334400|NCT01081834|26606810|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
13334401|NCT01081834|26606811|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
13334402|NCT01081834|26606812|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
13334403|NCT01081834|26606813|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
13334404|NCT01081834|26606814|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
13334405|NCT01081834|26606810|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
13334406|NCT01081834|26606811|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4|||
13334407|NCT01081834|26606812|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
13393353|NCT00665925|26783412|FG001|Overall Study|Due to exclusion criteria|0|||
13393354|NCT00665925|26783413|FG002|Overall Study|Due to exclusion criteria|0|||
13393355|NCT00665925|26783414|FG003|Overall Study|Due to exclusion criteria|0|||
13393356|NCT00665847|26783428|FG000|Overall Study|Adverse Event|8|||
13393357|NCT00665847|26783428|FG000|Overall Study|Withdrawal by Subject|2|||
13393358|NCT00665847|26783428|FG000|Overall Study|Subject non-compliant|8|||
13393359|NCT00665847|26783428|FG000|Overall Study|Subject reached a virologic endpoint|4|||
13393360|NCT00665847|26783428|FG000|Overall Study|Resistance to TMC125|1|||
13393361|NCT00665847|26783428|FG000|Overall Study|Subject ineligible to continue the trial|1|||
13393362|NCT00665847|26783428|FG000|Overall Study|Switch to Commercial Medication|1|||
13393363|NCT00665652|26783434|FG000|Overall Study|Adverse Event|4|||
13393364|NCT00665652|26783434|FG000|Overall Study|Death|1|||
13393365|NCT00665652|26783434|FG000|Overall Study|No longer met inclusion criteria.|1|||
13393366|NCT00665626|26783507|FG000|Overall Study|Lack of Efficacy|8|||
13393367|NCT00665626|26783508|FG001|Overall Study|Lack of Efficacy|5|||
13393368|NCT00665626|26783507|FG000|Overall Study|Lost to Follow-up|0|||
13393369|NCT00665626|26783508|FG001|Overall Study|Lost to Follow-up|2|||
13393370|NCT00665626|26783507|FG000|Overall Study|Withdrawal by Subject|0|||
13393371|NCT00665626|26783508|FG001|Overall Study|Withdrawal by Subject|1|||
13393372|NCT00665626|26783507|FG000|Overall Study|Protocol Violation|0|||
13393373|NCT00665626|26783508|FG001|Overall Study|Protocol Violation|2|||
13393374|NCT00665626|26783507|FG000|Overall Study|Adverse Event|1|||
13393375|NCT00665626|26783508|FG001|Overall Study|Adverse Event|9|||
13393376|NCT00665626|26783507|FG000|Overall Study|Due to exclusion criteria|0|||
13393377|NCT00665626|26783508|FG001|Overall Study|Due to exclusion criteria|1|||
13393378|NCT00665626|26783507|FG000|Overall Study|Did not fulfil inclusion criteria|0|||
13393379|NCT00665626|26783508|FG001|Overall Study|Did not fulfil inclusion criteria|1|||
13393380|NCT00665626|26783507|FG000|Overall Study|Unably to comply with dosing regimen|0|||
13393381|NCT00665626|26783508|FG001|Overall Study|Unably to comply with dosing regimen|1|||
13393382|NCT00665626|26783507|FG000|Overall Study|Death|1|||
13393383|NCT00665626|26783508|FG001|Overall Study|Death|0|||
13393384|NCT00665561|26783549|FG000|Overall Study|Death recorded on subject summary pages|75|||
13393385|NCT00665561|26783550|FG001|Overall Study|Death recorded on subject summary pages|75|||
13393386|NCT00665561|26783549|FG000|Overall Study|Does not meet entrance criteria|19|||
13393387|NCT00665561|26783550|FG001|Overall Study|Does not meet entrance criteria|21|||
13393388|NCT00665561|26783549|FG000|Overall Study|Lost to Follow-up|203|||
13393389|NCT00665561|26783550|FG001|Overall Study|Lost to Follow-up|264|||
13393390|NCT00665561|26783549|FG000|Overall Study|Withdrawal by Subject|74|||
13393391|NCT00665561|26783550|FG001|Overall Study|Withdrawal by Subject|65|||
13393392|NCT00665561|26783549|FG000|Overall Study|Other|123|||
13393393|NCT00665561|26783550|FG001|Overall Study|Other|108|||
13393394|NCT00665561|26783549|FG000|Overall Study|Site closed|8|||
13393395|NCT00665561|26783550|FG001|Overall Study|Site closed|0|||
13393396|NCT00665561|26783549|FG000|Overall Study|Withdrawn due to pregnancy|0|||
13393397|NCT00665561|26783550|FG001|Overall Study|Withdrawn due to pregnancy|1|||
13393398|NCT00665444|26783561|FG000|Overall Study|Physician Decision|1|||
13393399|NCT00665444|26783561|FG000|Overall Study|Study Terminated by Study Sponsor|1|||
13393400|NCT00665431|26783612|FG000|Overall Study|Adverse Event|16|||
13393401|NCT00665431|26783613|FG001|Overall Study|Adverse Event|22|||
13393402|NCT00665431|26783614|FG002|Overall Study|Adverse Event|6|||
13393403|NCT00665431|26783612|FG000|Overall Study|Withdrawal by Subject|17|||
13393404|NCT00665431|26783613|FG001|Overall Study|Withdrawal by Subject|25|||
13393405|NCT00665431|26783614|FG002|Overall Study|Withdrawal by Subject|15|||
13334408|NCT01081834|26606813|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
13334409|NCT01081834|26606814|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
13334410|NCT01081834|26606810|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
13334411|NCT01081834|26606811|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
13334412|NCT01081834|26606812|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
13334413|NCT01081834|26606813|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
13334414|NCT01081834|26606814|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
13334415|NCT01081834|26606810|FG000|Core Period: Baseline to Week 26|Other|4|||
13334416|NCT01081834|26606811|FG001|Core Period: Baseline to Week 26|Other|4|||
13334417|NCT01081834|26606812|FG002|Core Period: Baseline to Week 26|Other|3|||
13334418|NCT01081834|26606813|FG003|Core Period: Baseline to Week 26|Other|1|||
13334419|NCT01081834|26606814|FG004|Core Period: Baseline to Week 26|Other|0|||
13334420|NCT01081834|26606810|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3|||
13334421|NCT01081834|26606811|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
13334422|NCT01081834|26606812|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
13334423|NCT01081834|26606813|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
13334424|NCT01081834|26606814|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
13393406|NCT00665431|26783612|FG000|Overall Study|Lost to Follow-up|3|||
13334425|NCT01081834|26606810|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
13334426|NCT01081834|26606811|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0|||
13334427|NCT01081834|26606812|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
13334428|NCT01081834|26606813|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0|||
13334429|NCT01081834|26606814|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0|||
13334430|NCT01081834|26606810|FG000|Extension Period: Week 26 to Week 52|Death|1|||
13393407|NCT00665431|26783613|FG001|Overall Study|Lost to Follow-up|3|||
13393408|NCT00665431|26783614|FG002|Overall Study|Lost to Follow-up|1|||
13393409|NCT00665431|26783612|FG000|Overall Study|Other|4|||
13393410|NCT00665431|26783613|FG001|Overall Study|Other|7|||
13393411|NCT00665431|26783614|FG002|Overall Study|Other|2|||
13393412|NCT00665392|26783626|FG000|Overall Study|not treated|1|||
13393413|NCT00665366|26783661|FG000|Overall Study|Lack of Efficacy|11|||
13393414|NCT00665366|26783662|FG001|Overall Study|Lack of Efficacy|10|||
13393415|NCT00665366|26783661|FG000|Overall Study|Adverse Event|25|||
13393416|NCT00665366|26783662|FG001|Overall Study|Adverse Event|23|||
13393417|NCT00665366|26783661|FG000|Overall Study|Withdrawal by Subject|11|||
13393418|NCT00665366|26783662|FG001|Overall Study|Withdrawal by Subject|14|||
13393419|NCT00665366|26783661|FG000|Overall Study|Lost to Follow-up|3|||
13393420|NCT00665366|26783662|FG001|Overall Study|Lost to Follow-up|5|||
13393421|NCT00665366|26783661|FG000|Overall Study|Poor compliance/noncompliance|3|||
13393422|NCT00665366|26783662|FG001|Overall Study|Poor compliance/noncompliance|5|||
13334431|NCT01081834|26606811|FG001|Extension Period: Week 26 to Week 52|Death|0|||
13334432|NCT01081834|26606812|FG002|Extension Period: Week 26 to Week 52|Death|0|||
13334433|NCT01081834|26606813|FG003|Extension Period: Week 26 to Week 52|Death|0|||
13334434|NCT01081834|26606814|FG004|Extension Period: Week 26 to Week 52|Death|0|||
13334435|NCT01081834|26606810|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
13334436|NCT01081834|26606811|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
13334437|NCT01081834|26606812|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
13334438|NCT01081834|26606813|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
13334439|NCT01081834|26606814|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
13334440|NCT01081834|26606810|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
13334441|NCT01081834|26606811|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
13334442|NCT01081834|26606812|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
13334443|NCT01081834|26606813|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
13334444|NCT01081834|26606814|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
13334445|NCT01081834|26606810|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
13334446|NCT01081834|26606811|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
13334447|NCT01081834|26606812|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
13334448|NCT01081834|26606813|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
13334449|NCT01081834|26606814|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
13334450|NCT01081834|26606810|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
13334451|NCT01081834|26606811|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
13334452|NCT01081834|26606812|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
13334453|NCT01081834|26606813|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
13334454|NCT01081834|26606814|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
13334455|NCT01081834|26606810|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
13334456|NCT01081834|26606811|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
13334457|NCT01081834|26606812|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
13334458|NCT01081834|26606813|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
13334459|NCT01081834|26606814|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
13334460|NCT01081834|26606810|FG000|Extension Period: Week 26 to Week 52|Other|4|||
13334461|NCT01081834|26606811|FG001|Extension Period: Week 26 to Week 52|Other|5|||
13334462|NCT01081834|26606812|FG002|Extension Period: Week 26 to Week 52|Other|4|||
13334463|NCT01081834|26606813|FG003|Extension Period: Week 26 to Week 52|Other|0|||
13334464|NCT01081834|26606814|FG004|Extension Period: Week 26 to Week 52|Other|0|||
13334465|NCT01081834|26606810|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7|||
13334466|NCT01081834|26606811|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1|||
13334467|NCT01081834|26606812|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
13334468|NCT01081834|26606813|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
13334469|NCT01081834|26606814|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
13334470|NCT01081834|26606810|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
13334471|NCT01081834|26606811|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1|||
13334472|NCT01081834|26606812|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
13334473|NCT01081834|26606813|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0|||
13393423|NCT00665366|26783661|FG000|Overall Study|Pregnancy|1|||
13393424|NCT00665366|26783662|FG001|Overall Study|Pregnancy|0|||
13393425|NCT00665366|26783661|FG000|Overall Study|No longer meets study criteria|0|||
13393426|NCT00665366|26783662|FG001|Overall Study|No longer meets study criteria|1|||
13393427|NCT00665366|26783661|FG000|Overall Study|Other reasons|4|||
13393428|NCT00665366|26783662|FG001|Overall Study|Other reasons|1|||
13393429|NCT00665353|26783674|FG000|Study Step 1|Adverse Event|1|||
13393430|NCT00665353|26783674|FG000|Study Step 1|Withdrawal by Subject|2|||
13393431|NCT00665353|26783674|FG000|Study Step 2|Lost to Follow-up|2|||
13393432|NCT00665353|26783674|FG000|Study Step 2|Lack of Efficacy|12|||
13393433|NCT00665002|26783681|FG000|Overall Study|Progression/relapse during treatment|11|||
13393434|NCT00665002|26783681|FG000|Overall Study|Cytogenetic resistance|1|||
13393435|NCT00664859|26783702|FG000|Overall Study|Adverse Event|2|||
13393436|NCT00664859|26783703|FG001|Overall Study|Adverse Event|1|||
13393437|NCT00664859|26783704|FG002|Overall Study|Adverse Event|3|||
13393438|NCT00664859|26783702|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6|||
13393439|NCT00664859|26783703|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
13393440|NCT00664859|26783704|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
13393441|NCT00664859|26783702|FG000|Overall Study|Noncompliance with protocol|1|||
13393442|NCT00664859|26783703|FG001|Overall Study|Noncompliance with protocol|0|||
13393443|NCT00664859|26783704|FG002|Overall Study|Noncompliance with protocol|4|||
13393444|NCT00664859|26783702|FG000|Overall Study|Laboratory abnormality|2|||
13393445|NCT00664859|26783703|FG001|Overall Study|Laboratory abnormality|1|||
13393446|NCT00664859|26783704|FG002|Overall Study|Laboratory abnormality|4|||
13393447|NCT00664859|26783702|FG000|Overall Study|Withdrawal by Subject|4|||
13393448|NCT00664859|26783703|FG001|Overall Study|Withdrawal by Subject|1|||
13393449|NCT00664859|26783704|FG002|Overall Study|Withdrawal by Subject|3|||
13393450|NCT00664859|26783702|FG000|Overall Study|Lost to Follow-up|2|||
13393451|NCT00664859|26783703|FG001|Overall Study|Lost to Follow-up|2|||
13393452|NCT00664859|26783704|FG002|Overall Study|Lost to Follow-up|1|||
13393453|NCT00664859|26783702|FG000|Overall Study|Other|0|||
13393454|NCT00664859|26783703|FG001|Overall Study|Other|1|||
13393455|NCT00664859|26783704|FG002|Overall Study|Other|2|||
13393456|NCT00664742|26783711|FG000|Overall Study|Withdrawn due to adverse events|3|||
13393457|NCT00664742|26783711|FG000|Overall Study|Withdrawal by Subject|31|||
13393458|NCT00664742|26783711|FG000|Overall Study|Lost to Follow-up|92|||
13393459|NCT00664560|26783762|FG000|Overall Study|Adverse Event|19|||
13393460|NCT00664560|26783763|FG001|Overall Study|Adverse Event|16|||
13393461|NCT00664560|26783764|FG002|Overall Study|Adverse Event|7|||
13393462|NCT00664560|26783762|FG000|Overall Study|Withdrawal by Subject|9|||
13393463|NCT00664560|26783763|FG001|Overall Study|Withdrawal by Subject|13|||
13393464|NCT00664560|26783764|FG002|Overall Study|Withdrawal by Subject|7|||
13393465|NCT00664560|26783762|FG000|Overall Study|Lost to Follow-up|0|||
13393466|NCT00664560|26783763|FG001|Overall Study|Lost to Follow-up|2|||
13393467|NCT00664560|26783764|FG002|Overall Study|Lost to Follow-up|0|||
13393468|NCT00664560|26783762|FG000|Overall Study|Other|11|||
13393469|NCT00664560|26783763|FG001|Overall Study|Other|4|||
13393470|NCT00664560|26783764|FG002|Overall Study|Other|5|||
13393471|NCT00664534|26783797|FG000|Overall Study|Adverse Event|2|||
13393472|NCT00664534|26783798|FG001|Overall Study|Adverse Event|3|||
13393473|NCT00664534|26783797|FG000|Overall Study|Lost to Follow-up|6|||
13393474|NCT00664534|26783798|FG001|Overall Study|Lost to Follow-up|10|||
13393475|NCT00664534|26783797|FG000|Overall Study|Protocol Violation|10|||
13393476|NCT00664534|26783798|FG001|Overall Study|Protocol Violation|8|||
13393477|NCT00664534|26783797|FG000|Overall Study|Withdrawal by Subject|7|||
13393478|NCT00664534|26783798|FG001|Overall Study|Withdrawal by Subject|6|||
13393479|NCT00664534|26783797|FG000|Overall Study|Physician Decision|8|||
13393480|NCT00664534|26783798|FG001|Overall Study|Physician Decision|0|||
13393481|NCT00664534|26783797|FG000|Overall Study|Sponsor decision|8|||
13393482|NCT00664534|26783798|FG001|Overall Study|Sponsor decision|6|||
13393483|NCT00664521|26783825|FG000|Overall Study|Adverse Event|4|||
13393484|NCT00664521|26783826|FG001|Overall Study|Adverse Event|1|||
13393485|NCT00664521|26783825|FG000|Overall Study|Lost to Follow-up|1|||
13393486|NCT00664521|26783826|FG001|Overall Study|Lost to Follow-up|0|||
13393487|NCT00664521|26783825|FG000|Overall Study|Other|1|||
13393488|NCT00664521|26783826|FG001|Overall Study|Other|0|||
13393489|NCT00664326|26783847|FG000|Overall Study|Adverse Event|14|||
13393490|NCT00664326|26783847|FG000|Overall Study|Noncompliance with study medication|3|||
13393491|NCT00664326|26783847|FG000|Overall Study|Withdrawal by Subject|1|||
13393492|NCT00664326|26783847|FG000|Overall Study|Physician Decision|1|||
13393493|NCT00664326|26783847|FG000|Overall Study|Other Reasons|3|||
13393494|NCT00664326|26783847|FG000|Overall Study|Death|2|||
13393495|NCT00664326|26783847|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24|||
13393496|NCT00664209|26783857|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7|||
13393497|NCT00664209|26783857|FG000|Study Treatment Period|Physician Decision|4|||
13393498|NCT00664209|26783857|FG000|Study Treatment Period|Withdrawal by Subject|2|||
13393499|NCT00664105|26783866|FG000|Overall Study|Death|3|||
13393500|NCT00664105|26783866|FG000|Overall Study|Withdrawal by Subject|5|||
13393501|NCT00664105|26783866|FG000|Overall Study|Adverse Event|9|||
13393502|NCT00664105|26783866|FG000|Overall Study|Disease progression|7|||
13393503|NCT00664066|26783872|FG000|Overall Study|Study terminated|3|||
13393504|NCT00663962|26783885|FG000|Overall Study|somnolence|1|||
13393505|NCT00663962|26783886|FG001|Overall Study|somnolence|0|||
13393506|NCT00663923|26783902|FG000|Overall Study|Lost to Follow-up|2|||
13393507|NCT00663871|26783953|FG000|Overall Study|Lost to Follow-up|5|||
13393508|NCT00663871|26783954|FG001|Overall Study|Lost to Follow-up|5|||
13393509|NCT00663871|26783953|FG000|Overall Study|Withdrawal by Subject|5|||
13393510|NCT00663871|26783954|FG001|Overall Study|Withdrawal by Subject|2|||
13393511|NCT00663858|26783972|FG000|Overall Study|Adverse Event|9|||
13393512|NCT00663858|26783973|FG001|Overall Study|Adverse Event|1|||
13393513|NCT00663858|26783974|FG002|Overall Study|Adverse Event|6|||
13393514|NCT00663858|26783972|FG000|Overall Study|Lack of Efficacy|5|||
13393515|NCT00663858|26783973|FG001|Overall Study|Lack of Efficacy|1|||
13393516|NCT00663858|26783974|FG002|Overall Study|Lack of Efficacy|3|||
13393517|NCT00663858|26783972|FG000|Overall Study|Withdrawal by Subject|7|||
13393518|NCT00663858|26783973|FG001|Overall Study|Withdrawal by Subject|3|||
13393519|NCT00663858|26783974|FG002|Overall Study|Withdrawal by Subject|3|||
13393520|NCT00663858|26783972|FG000|Overall Study|Protocol Violation|5|||
13393521|NCT00663858|26783973|FG001|Overall Study|Protocol Violation|3|||
13393522|NCT00663858|26783974|FG002|Overall Study|Protocol Violation|4|||
13393523|NCT00663858|26783972|FG000|Overall Study|Other|8|||
13393524|NCT00663858|26783973|FG001|Overall Study|Other|2|||
13393525|NCT00663858|26783974|FG002|Overall Study|Other|4|||
13393526|NCT00663702|26784004|FG000|Overall Study|Adverse Event|8|||
13393527|NCT00663702|26784005|FG001|Overall Study|Adverse Event|4|||
13393528|NCT00663702|26784004|FG000|Overall Study|Withdrawal by Subject|3|||
13393529|NCT00663702|26784005|FG001|Overall Study|Withdrawal by Subject|1|||
13393530|NCT00663702|26784004|FG000|Overall Study|Pregnancy|0|||
13334474|NCT01081834|26606814|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0|||
13334475|NCT01080807|26606875|FG000|Overall Study|Adverse Event|9|||
13334476|NCT01080807|26606876|FG001|Overall Study|Adverse Event|1|||
13334477|NCT01080807|26606875|FG000|Overall Study|Lack of Efficacy|0|||
13334478|NCT01080807|26606876|FG001|Overall Study|Lack of Efficacy|1|||
13334479|NCT01080807|26606875|FG000|Overall Study|Withdrawal by Subject|7|||
13334480|NCT01080807|26606876|FG001|Overall Study|Withdrawal by Subject|2|||
13334481|NCT01080807|26606875|FG000|Overall Study|Protocol Violation|7|||
13334482|NCT01080807|26606876|FG001|Overall Study|Protocol Violation|6|||
13334483|NCT01080807|26606875|FG000|Overall Study|Lost to Follow-up|6|||
13334484|NCT01080807|26606876|FG001|Overall Study|Lost to Follow-up|4|||
13334485|NCT01080807|26606875|FG000|Overall Study|Noncompliance with drug administration|1|||
13334486|NCT01080807|26606876|FG001|Overall Study|Noncompliance with drug administration|1|||
13334487|NCT01080807|26606875|FG000|Overall Study|Noncompliance to study procedures|1|||
13334488|NCT01080807|26606876|FG001|Overall Study|Noncompliance to study procedures|1|||
13334489|NCT01080807|26606875|FG000|Overall Study|Began working day shift|0|||
13334490|NCT01080807|26606876|FG001|Overall Study|Began working day shift|2|||
13334491|NCT01080807|26606875|FG000|Overall Study|Laid off or terminated from job|1|||
13334492|NCT01080807|26606876|FG001|Overall Study|Laid off or terminated from job|2|||
13334493|NCT01080807|26606875|FG000|Overall Study|Stopped working consistent night shifts|0|||
13334494|NCT01080807|26606876|FG001|Overall Study|Stopped working consistent night shifts|1|||
13334495|NCT01080807|26606875|FG000|Overall Study|Work schedule changing|1|||
13334496|NCT01080807|26606876|FG001|Overall Study|Work schedule changing|1|||
13334497|NCT01080807|26606875|FG000|Overall Study|Work schedule and travel|0|||
13334498|NCT01080807|26606876|FG001|Overall Study|Work schedule and travel|1|||
13334499|NCT01080807|26606875|FG000|Overall Study|Switched to first shift|1|||
13334500|NCT01080807|26606876|FG001|Overall Study|Switched to first shift|0|||
13334501|NCT01080807|26606875|FG000|Overall Study|Moved away without notifying center|1|||
13334502|NCT01080807|26606876|FG001|Overall Study|Moved away without notifying center|0|||
13334503|NCT01080391|26606901|FG000|Overall Study|Randomized but not treated|7|||
13334504|NCT01080391|26606902|FG001|Overall Study|Randomized but not treated|4|||
13334505|NCT01079988|26606935|FG000|Overall Study|Lost to Follow-up|0|||
13334506|NCT01079988|26606936|FG001|Overall Study|Lost to Follow-up|0|||
13334507|NCT01079988|26606937|FG002|Overall Study|Lost to Follow-up|0|||
13334508|NCT01079988|26606938|FG003|Overall Study|Lost to Follow-up|1|||
13334509|NCT01079988|26606939|FG004|Overall Study|Lost to Follow-up|0|||
13334510|NCT01079988|26606935|FG000|Overall Study|Lack of Efficacy|1|||
13334511|NCT01079988|26606936|FG001|Overall Study|Lack of Efficacy|0|||
13334512|NCT01079988|26606937|FG002|Overall Study|Lack of Efficacy|0|||
13393531|NCT00663702|26784005|FG001|Overall Study|Pregnancy|1|||
13393532|NCT00663702|26784004|FG000|Overall Study|Lost to Follow-up|3|||
13393533|NCT00663702|26784005|FG001|Overall Study|Lost to Follow-up|0|||
13393534|NCT00663702|26784004|FG000|Overall Study|Death|1|||
13334513|NCT01079988|26606938|FG003|Overall Study|Lack of Efficacy|0|||
13334514|NCT01079988|26606939|FG004|Overall Study|Lack of Efficacy|0|||
13334515|NCT01079988|26606935|FG000|Overall Study|Other|0|||
13334516|NCT01079988|26606936|FG001|Overall Study|Other|0|||
13334517|NCT01079988|26606937|FG002|Overall Study|Other|0|||
13334518|NCT01079988|26606938|FG003|Overall Study|Other|2|||
13334519|NCT01079988|26606939|FG004|Overall Study|Other|1|||
13393535|NCT00663702|26784005|FG001|Overall Study|Death|1|||
13334520|NCT01079962|26606972|FG000|Overall Study|Adverse Event|2|||
13334521|NCT01079962|26606973|FG001|Overall Study|Adverse Event|2|||
13334522|NCT01079962|26606972|FG000|Overall Study|Withdrawal by Subject|5|||
13334523|NCT01079962|26606973|FG001|Overall Study|Withdrawal by Subject|7|||
13334524|NCT01079962|26606972|FG000|Overall Study|Protocol Violation|2|||
13334525|NCT01079962|26606973|FG001|Overall Study|Protocol Violation|2|||
13334526|NCT01079962|26606972|FG000|Overall Study|No blood pressure (BP) control|3|||
13334527|NCT01079962|26606973|FG001|Overall Study|No blood pressure (BP) control|0|||
13334528|NCT01079962|26606972|FG000|Overall Study|Inclusion/exclusion criteria|1|||
13334529|NCT01079962|26606973|FG001|Overall Study|Inclusion/exclusion criteria|3|||
13334530|NCT01079962|26606972|FG000|Overall Study|Participant not returning for next visit|1|||
13334531|NCT01079962|26606973|FG001|Overall Study|Participant not returning for next visit|0|||
13334532|NCT01079962|26606972|FG000|Overall Study|Due to arrhythmia/bradycardia|1|||
13334533|NCT01079962|26606973|FG001|Overall Study|Due to arrhythmia/bradycardia|1|||
13334534|NCT01079949|26607022|FG000|Overall Study|Withdrawal before r-hCG administration|2|||
13334535|NCT01079949|26607023|FG001|Overall Study|Withdrawal before r-hCG administration|3|||
13334536|NCT01079949|26607022|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4|||
13334537|NCT01079949|26607023|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8|||
13334538|NCT01079949|26607022|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8|||
13334539|NCT01079949|26607023|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
13334540|NCT01079949|26607022|FG000|Overall Study|Randomized but not treated|1|||
13334541|NCT01079949|26607023|FG001|Overall Study|Randomized but not treated|0|||
13334542|NCT01079936|26607056|FG000|Phase I: MTD|First Remission Status|2|||
13334543|NCT01079936|26607057|FG001|Phase I: MTD|First Remission Status|0|||
13334544|NCT01079936|26607058|FG002|Phase I: MTD|First Remission Status|0|||
13334545|NCT01079936|26607059|FG003|Phase I: MTD|First Remission Status|0|||
13334546|NCT01079936|26607060|FG004|Phase I: MTD|First Remission Status|0|||
13334547|NCT01079936|26607056|FG000|Phase I: MTD|No Stem Cell Transplantation|2|||
13334548|NCT01079936|26607057|FG001|Phase I: MTD|No Stem Cell Transplantation|0|||
13334549|NCT01079936|26607058|FG002|Phase I: MTD|No Stem Cell Transplantation|0|||
13334550|NCT01079936|26607059|FG003|Phase I: MTD|No Stem Cell Transplantation|0|||
13334551|NCT01079936|26607060|FG004|Phase I: MTD|No Stem Cell Transplantation|0|||
13334552|NCT01079936|26607056|FG000|Phase II|Adverse Event|0|||
13334553|NCT01079936|26607057|FG001|Phase II|Adverse Event|0|||
13334554|NCT01079936|26607058|FG002|Phase II|Adverse Event|1|||
13334555|NCT01079936|26607059|FG003|Phase II|Adverse Event|0|||
13334556|NCT01079936|26607060|FG004|Phase II|Adverse Event|0|||
13334557|NCT01079936|26607056|FG000|Phase II|Insurance Issue|0|||
13334558|NCT01079936|26607057|FG001|Phase II|Insurance Issue|0|||
13334559|NCT01079936|26607058|FG002|Phase II|Insurance Issue|0|||
13334560|NCT01079936|26607059|FG003|Phase II|Insurance Issue|0|||
13334561|NCT01079936|26607060|FG004|Phase II|Insurance Issue|1|||
13334562|NCT01079832|26607070|FG000|Overall Study|Withdrawal by Subject|1|||
13334563|NCT01079806|26607107|FG000|Day 1 to Week 96|Adverse Event|0|||
13334564|NCT01079806|26607108|FG001|Day 1 to Week 96|Adverse Event|3|||
13334565|NCT01079806|26607107|FG000|Day 1 to Week 96|Withdrawal by Subject|3|||
13334566|NCT01079806|26607108|FG001|Day 1 to Week 96|Withdrawal by Subject|2|||
13334567|NCT01079806|26607107|FG000|Day 1 to Week 96|Pregnancy|0|||
13334568|NCT01079806|26607108|FG001|Day 1 to Week 96|Pregnancy|1|||
13334569|NCT01079806|26607107|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2|||
13334570|NCT01079806|26607108|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0|||
13334571|NCT01079806|26607107|FG000|Day 1 to Week 96|Lost to Follow-up|1|||
13334572|NCT01079806|26607108|FG001|Day 1 to Week 96|Lost to Follow-up|0|||
13334573|NCT01079806|26607107|FG000|Day 1 to Week 96|Subject request to stop study treatment|1|||
13334574|NCT01079806|26607108|FG001|Day 1 to Week 96|Subject request to stop study treatment|0|||
13334575|NCT01079806|26607107|FG000|Day 1 to Week 96|Removal by Medical Monitor|0|||
13334576|NCT01079806|26607108|FG001|Day 1 to Week 96|Removal by Medical Monitor|1|||
13334577|NCT01079806|26607107|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13|||
13334578|NCT01079806|26607108|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8|||
13334579|NCT01079806|26607107|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0|||
13334580|NCT01079806|26607108|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1|||
13334581|NCT01079806|26607107|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
13334582|NCT01079806|26607108|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
13334583|NCT01079741|26607138|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
13334584|NCT01079741|26607139|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1|||
13334585|NCT01079741|26607140|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
13393536|NCT00663702|26784004|FG000|Overall Study|Lack of Efficacy|3|||
13334586|NCT01079741|26607141|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
13334587|NCT01079741|26607142|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
13334588|NCT01079741|26607138|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
13334589|NCT01079741|26607139|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
13334590|NCT01079741|26607140|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
13334591|NCT01079741|26607141|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
13334592|NCT01079741|26607142|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3|||
13334593|NCT01079663|26607159|FG000|Overall Study|Adverse Event|0|||
13334594|NCT01079663|26607160|FG001|Overall Study|Adverse Event|2|||
13334595|NCT01079663|26607159|FG000|Overall Study|Protocol Violation|0|||
13334596|NCT01079663|26607160|FG001|Overall Study|Protocol Violation|2|||
13334597|NCT01079234|26607189|FG000|Main: Week 0 to 26|Adverse Event|5|||
13334598|NCT01079234|26607190|FG001|Main: Week 0 to 26|Adverse Event|4|||
13334599|NCT01079234|26607191|FG002|Main: Week 0 to 26|Adverse Event|1|||
13334600|NCT01079234|26607192|FG003|Main: Week 0 to 26|Adverse Event|0|||
13334601|NCT01079234|26607189|FG000|Main: Week 0 to 26|Lack of Efficacy|2|||
13334602|NCT01079234|26607190|FG001|Main: Week 0 to 26|Lack of Efficacy|1|||
13334603|NCT01079234|26607191|FG002|Main: Week 0 to 26|Lack of Efficacy|1|||
13334604|NCT01079234|26607192|FG003|Main: Week 0 to 26|Lack of Efficacy|0|||
13334605|NCT01079234|26607189|FG000|Main: Week 0 to 26|Protocol Violation|6|||
13334606|NCT01079234|26607190|FG001|Main: Week 0 to 26|Protocol Violation|2|||
13334607|NCT01079234|26607191|FG002|Main: Week 0 to 26|Protocol Violation|4|||
13334608|NCT01079234|26607192|FG003|Main: Week 0 to 26|Protocol Violation|0|||
13334609|NCT01079234|26607189|FG000|Main: Week 0 to 26|Withdrawal criteria|6|||
13334610|NCT01079234|26607190|FG001|Main: Week 0 to 26|Withdrawal criteria|6|||
13334611|NCT01079234|26607191|FG002|Main: Week 0 to 26|Withdrawal criteria|2|||
13334612|NCT01079234|26607192|FG003|Main: Week 0 to 26|Withdrawal criteria|0|||
13334613|NCT01079234|26607189|FG000|Main: Week 0 to 26|Unclassified|7|||
13334614|NCT01079234|26607190|FG001|Main: Week 0 to 26|Unclassified|13|||
13334615|NCT01079234|26607191|FG002|Main: Week 0 to 26|Unclassified|4|||
13334616|NCT01079234|26607192|FG003|Main: Week 0 to 26|Unclassified|0|||
13334617|NCT01079234|26607189|FG000|Extension: Week 27 to 52|Adverse Event|0|||
13334618|NCT01079234|26607190|FG001|Extension: Week 27 to 52|Adverse Event|0|||
13334619|NCT01079234|26607191|FG002|Extension: Week 27 to 52|Adverse Event|1|||
13334620|NCT01079234|26607192|FG003|Extension: Week 27 to 52|Adverse Event|0|||
13334621|NCT01079234|26607189|FG000|Extension: Week 27 to 52|Lack of Efficacy|0|||
13334622|NCT01079234|26607190|FG001|Extension: Week 27 to 52|Lack of Efficacy|0|||
13334623|NCT01079234|26607191|FG002|Extension: Week 27 to 52|Lack of Efficacy|0|||
13334624|NCT01079234|26607192|FG003|Extension: Week 27 to 52|Lack of Efficacy|2|||
13334625|NCT01079234|26607189|FG000|Extension: Week 27 to 52|Protocol Violation|0|||
13334626|NCT01079234|26607190|FG001|Extension: Week 27 to 52|Protocol Violation|0|||
13334627|NCT01079234|26607191|FG002|Extension: Week 27 to 52|Protocol Violation|2|||
13334628|NCT01079234|26607192|FG003|Extension: Week 27 to 52|Protocol Violation|5|||
13334629|NCT01079234|26607189|FG000|Extension: Week 27 to 52|Withdrawal criteria|0|||
13334630|NCT01079234|26607190|FG001|Extension: Week 27 to 52|Withdrawal criteria|0|||
13334631|NCT01079234|26607191|FG002|Extension: Week 27 to 52|Withdrawal criteria|4|||
13334632|NCT01079234|26607192|FG003|Extension: Week 27 to 52|Withdrawal criteria|2|||
13334633|NCT01079234|26607189|FG000|Extension: Week 27 to 52|Unclassified|0|||
13334634|NCT01079234|26607190|FG001|Extension: Week 27 to 52|Unclassified|0|||
13334635|NCT01079234|26607191|FG002|Extension: Week 27 to 52|Unclassified|4|||
13334636|NCT01079234|26607192|FG003|Extension: Week 27 to 52|Unclassified|7|||
13334637|NCT01079195|26607200|FG000|Overall Study|No Documentation of Tarka Therapy|739|||
13334638|NCT01079195|26607200|FG000|Overall Study|No Documentation Available|437|||
13334639|NCT01079195|26607200|FG000|Overall Study|Adverse Event|157|||
13334640|NCT01079195|26607200|FG000|Overall Study|Reason Unknown|39|||
13334641|NCT01079195|26607200|FG000|Overall Study|Withdrawal by Subject|18|||
13334642|NCT01079195|26607200|FG000|Overall Study|Financial Reasons|15|||
13334643|NCT01079195|26607200|FG000|Overall Study|Lack of Effectiveness|12|||
13334644|NCT01079195|26607200|FG000|Overall Study|Physician Decision|4|||
13334645|NCT01079195|26607200|FG000|Overall Study|Improved Status of Participant|4|||
13334646|NCT01079195|26607200|FG000|Overall Study|No Follow-up Documentation Available|4|||
13334647|NCT01079195|26607200|FG000|Overall Study|Non-compliance|2|||
13334648|NCT01079182|26607229|FG000|Overall Study|Lost to Follow-up|1634|||
13334649|NCT01079182|26607229|FG000|Overall Study|Adverse Drug Reaction (ADR)|261|||
13334650|NCT01079182|26607229|FG000|Overall Study|Lack of Efficacy|514|||
13334651|NCT01079182|26607229|FG000|Overall Study|ADR and Lack of Effectiveness|39|||
13334652|NCT01079182|26607229|FG000|Overall Study|Reasons not Evaluated|271|||
13334653|NCT01079130|26607268|FG000|Overall Study|Adverse Event|1|||
13334654|NCT01079130|26607269|FG001|Overall Study|Adverse Event|1|||
13334655|NCT01079130|26607270|FG002|Overall Study|Adverse Event|0|||
13334656|NCT01079130|26607271|FG003|Overall Study|Adverse Event|1|||
13334657|NCT01079130|26607272|FG004|Overall Study|Adverse Event|5|||
13334658|NCT01079130|26607273|FG005|Overall Study|Adverse Event|1|||
13334659|NCT01079130|26607268|FG000|Overall Study|Administrative problems|1|||
13334660|NCT01079130|26607269|FG001|Overall Study|Administrative problems|3|||
13334661|NCT01079130|26607270|FG002|Overall Study|Administrative problems|0|||
13334662|NCT01079130|26607271|FG003|Overall Study|Administrative problems|0|||
13334663|NCT01079130|26607272|FG004|Overall Study|Administrative problems|0|||
13334664|NCT01079130|26607273|FG005|Overall Study|Administrative problems|1|||
13334665|NCT01079130|26607268|FG000|Overall Study|Withdrawal by Subject|0|||
13334666|NCT01079130|26607269|FG001|Overall Study|Withdrawal by Subject|1|||
13334667|NCT01079130|26607270|FG002|Overall Study|Withdrawal by Subject|0|||
13334668|NCT01079130|26607271|FG003|Overall Study|Withdrawal by Subject|0|||
13334669|NCT01079130|26607272|FG004|Overall Study|Withdrawal by Subject|1|||
13334670|NCT01079130|26607273|FG005|Overall Study|Withdrawal by Subject|3|||
13334671|NCT01079130|26607268|FG000|Overall Study|Protocol deviation|0|||
13334672|NCT01079130|26607269|FG001|Overall Study|Protocol deviation|2|||
13334673|NCT01079130|26607270|FG002|Overall Study|Protocol deviation|1|||
13334674|NCT01079130|26607271|FG003|Overall Study|Protocol deviation|2|||
13334675|NCT01079130|26607272|FG004|Overall Study|Protocol deviation|0|||
13334676|NCT01079130|26607273|FG005|Overall Study|Protocol deviation|0|||
13334677|NCT01079130|26607268|FG000|Overall Study|Abnormal test procedure result(s)|0|||
13334678|NCT01079130|26607269|FG001|Overall Study|Abnormal test procedure result(s)|0|||
13334679|NCT01079130|26607270|FG002|Overall Study|Abnormal test procedure result(s)|0|||
13334680|NCT01079130|26607271|FG003|Overall Study|Abnormal test procedure result(s)|0|||
13334681|NCT01079130|26607272|FG004|Overall Study|Abnormal test procedure result(s)|1|||
13334682|NCT01079130|26607273|FG005|Overall Study|Abnormal test procedure result(s)|0|||
13334683|NCT01079130|26607268|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
13334684|NCT01079130|26607269|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
13334685|NCT01079130|26607270|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
13334686|NCT01079130|26607271|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
13334687|NCT01079130|26607272|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
13334688|NCT01079130|26607273|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
13334689|NCT01079130|26607268|FG000|Overall Study|Lost to Follow-up|0|||
13334690|NCT01079130|26607269|FG001|Overall Study|Lost to Follow-up|0|||
13334691|NCT01079130|26607270|FG002|Overall Study|Lost to Follow-up|0|||
13334692|NCT01079130|26607271|FG003|Overall Study|Lost to Follow-up|0|||
13334693|NCT01079130|26607272|FG004|Overall Study|Lost to Follow-up|1|||
13334694|NCT01079130|26607273|FG005|Overall Study|Lost to Follow-up|0|||
13334695|NCT01078974|26607280|FG000|Overall Study|Adverse Event|3|||
13334696|NCT01078922|26607287|FG000|Overall Study|Adverse Event|1|||
13334697|NCT01078805|26607301|FG000|Overall Study|Clinically significant abnormal lab|5|||
13334698|NCT01078805|26607301|FG000|Overall Study|Death|134|||
13334699|NCT01078805|26607301|FG000|Overall Study|Lost to Follow-up|676|||
13334700|NCT01078805|26607301|FG000|Overall Study|Physician Decision|169|||
13334701|NCT01078805|26607301|FG000|Overall Study|Serious adverse event|26|||
13334702|NCT01078805|26607301|FG000|Overall Study|Sponsor decision|46|||
13334703|NCT01078805|26607301|FG000|Overall Study|Withdrawal by Subject|739|||
13334704|NCT01078805|26607301|FG000|Overall Study|Other|173|||
13334705|NCT01078805|26607301|FG000|Overall Study|Didn't take study drug|82|||
13334706|NCT01078675|26607325|FG000|Overall Study|Withdrawal by Subject|7|||
13334707|NCT01078675|26607326|FG001|Overall Study|Withdrawal by Subject|3|||
13334708|NCT01078675|26607325|FG000|Overall Study|Protocol Violation|56|||
13334709|NCT01078675|26607326|FG001|Overall Study|Protocol Violation|0|||
13334710|NCT01078675|26607325|FG000|Overall Study|Provided in CRF for specific reasons|2|||
13334711|NCT01078675|26607326|FG001|Overall Study|Provided in CRF for specific reasons|3|||
13334712|NCT01078675|26607325|FG000|Overall Study|Adverse Event|3|||
13334713|NCT01078675|26607326|FG001|Overall Study|Adverse Event|0|||
13334714|NCT01078662|26607381|FG000|Overall Study|Death|41|||
13334715|NCT01078662|26607382|FG001|Overall Study|Death|103|||
13334716|NCT01078662|26607383|FG002|Overall Study|Death|18|||
13334717|NCT01078662|26607384|FG003|Overall Study|Death|5|||
13334718|NCT01078662|26607385|FG004|Overall Study|Death|8|||
13334719|NCT01078662|26607381|FG000|Overall Study|Patients reached data cut-off|12|||
13334720|NCT01078662|26607382|FG001|Overall Study|Patients reached data cut-off|53|||
13334721|NCT01078662|26607383|FG002|Overall Study|Patients reached data cut-off|2|||
13334722|NCT01078662|26607384|FG003|Overall Study|Patients reached data cut-off|2|||
13334723|NCT01078662|26607385|FG004|Overall Study|Patients reached data cut-off|3|||
13334724|NCT01078662|26607381|FG000|Overall Study|Withdrawal by Subject|4|||
13334725|NCT01078662|26607382|FG001|Overall Study|Withdrawal by Subject|11|||
13334726|NCT01078662|26607383|FG002|Overall Study|Withdrawal by Subject|1|||
13334727|NCT01078662|26607384|FG003|Overall Study|Withdrawal by Subject|0|||
13334728|NCT01078662|26607385|FG004|Overall Study|Withdrawal by Subject|0|||
13334729|NCT01078662|26607381|FG000|Overall Study|Protocol Violation|0|||
13334730|NCT01078662|26607382|FG001|Overall Study|Protocol Violation|1|||
13334731|NCT01078662|26607383|FG002|Overall Study|Protocol Violation|0|||
13334732|NCT01078662|26607384|FG003|Overall Study|Protocol Violation|0|||
13334733|NCT01078662|26607385|FG004|Overall Study|Protocol Violation|0|||
13334734|NCT01078662|26607381|FG000|Overall Study|Lost to Follow-up|1|||
13334735|NCT01078662|26607382|FG001|Overall Study|Lost to Follow-up|0|||
13334736|NCT01078662|26607383|FG002|Overall Study|Lost to Follow-up|0|||
13334737|NCT01078662|26607384|FG003|Overall Study|Lost to Follow-up|0|||
13334738|NCT01078662|26607385|FG004|Overall Study|Lost to Follow-up|0|||
13334739|NCT01078623|26607428|FG000|Treatment Period 1|Adverse Event|1|||
13334740|NCT01078623|26607429|FG001|Treatment Period 1|Adverse Event|1|||
13393537|NCT00663702|26784005|FG001|Overall Study|Lack of Efficacy|3|||
13334741|NCT01078623|26607430|FG002|Treatment Period 1|Adverse Event|1|||
13334742|NCT01078623|26607431|FG003|Treatment Period 1|Adverse Event|0|||
13334743|NCT01078623|26607432|FG004|Treatment Period 1|Adverse Event|0|||
13334744|NCT01078623|26607433|FG005|Treatment Period 1|Adverse Event|0|||
13334745|NCT01078623|26607434|FG006|Treatment Period 1|Adverse Event|1|||
13334746|NCT01078623|26607435|FG007|Treatment Period 1|Adverse Event|0|||
13334747|NCT01078623|26607436|FG008|Treatment Period 1|Adverse Event|1|||
13334748|NCT01078623|26607437|FG009|Treatment Period 1|Adverse Event|1|||
13334749|NCT01078623|26607438|FG010|Treatment Period 1|Adverse Event|0|||
13334750|NCT01078623|26607439|FG011|Treatment Period 1|Adverse Event|0|||
13334751|NCT01078623|26607440|FG012|Treatment Period 1|Adverse Event|0|||
13334752|NCT01078623|26607441|FG013|Treatment Period 1|Adverse Event|0|||
13334753|NCT01078623|26607442|FG014|Treatment Period 1|Adverse Event|0|||
13334754|NCT01078623|26607443|FG015|Treatment Period 1|Adverse Event|0|||
13334755|NCT01078623|26607444|FG016|Treatment Period 1|Adverse Event|0|||
13334756|NCT01078623|26607445|FG017|Treatment Period 1|Adverse Event|0|||
13334757|NCT01078623|26607446|FG018|Treatment Period 1|Adverse Event|0|||
13334758|NCT01078623|26607447|FG019|Treatment Period 1|Adverse Event|0|||
13334759|NCT01078623|26607428|FG000|Treatment Period 1|Withdrawal by Subject|0|||
13334760|NCT01078623|26607429|FG001|Treatment Period 1|Withdrawal by Subject|0|||
13334761|NCT01078623|26607430|FG002|Treatment Period 1|Withdrawal by Subject|0|||
13334762|NCT01078623|26607431|FG003|Treatment Period 1|Withdrawal by Subject|0|||
13334763|NCT01078623|26607432|FG004|Treatment Period 1|Withdrawal by Subject|0|||
13334764|NCT01078623|26607433|FG005|Treatment Period 1|Withdrawal by Subject|0|||
13334765|NCT01078623|26607434|FG006|Treatment Period 1|Withdrawal by Subject|0|||
13334766|NCT01078623|26607435|FG007|Treatment Period 1|Withdrawal by Subject|1|||
13334767|NCT01078623|26607436|FG008|Treatment Period 1|Withdrawal by Subject|0|||
13334768|NCT01078623|26607437|FG009|Treatment Period 1|Withdrawal by Subject|0|||
13334769|NCT01078623|26607438|FG010|Treatment Period 1|Withdrawal by Subject|1|||
13334770|NCT01078623|26607439|FG011|Treatment Period 1|Withdrawal by Subject|0|||
13334771|NCT01078623|26607440|FG012|Treatment Period 1|Withdrawal by Subject|0|||
13334772|NCT01078623|26607441|FG013|Treatment Period 1|Withdrawal by Subject|0|||
13334773|NCT01078623|26607442|FG014|Treatment Period 1|Withdrawal by Subject|0|||
13334774|NCT01078623|26607443|FG015|Treatment Period 1|Withdrawal by Subject|0|||
13334775|NCT01078623|26607444|FG016|Treatment Period 1|Withdrawal by Subject|0|||
13334776|NCT01078623|26607445|FG017|Treatment Period 1|Withdrawal by Subject|0|||
13334777|NCT01078623|26607446|FG018|Treatment Period 1|Withdrawal by Subject|0|||
13334778|NCT01078623|26607447|FG019|Treatment Period 1|Withdrawal by Subject|0|||
13334779|NCT01078623|26607428|FG000|Treatment Period 1|Protocol Violation|0|||
13334780|NCT01078623|26607429|FG001|Treatment Period 1|Protocol Violation|0|||
13334781|NCT01078623|26607430|FG002|Treatment Period 1|Protocol Violation|0|||
13334782|NCT01078623|26607431|FG003|Treatment Period 1|Protocol Violation|0|||
13334783|NCT01078623|26607432|FG004|Treatment Period 1|Protocol Violation|0|||
13334784|NCT01078623|26607433|FG005|Treatment Period 1|Protocol Violation|1|||
13334785|NCT01078623|26607434|FG006|Treatment Period 1|Protocol Violation|0|||
13334786|NCT01078623|26607435|FG007|Treatment Period 1|Protocol Violation|0|||
13334787|NCT01078623|26607436|FG008|Treatment Period 1|Protocol Violation|0|||
13334788|NCT01078623|26607437|FG009|Treatment Period 1|Protocol Violation|0|||
13334789|NCT01078623|26607438|FG010|Treatment Period 1|Protocol Violation|0|||
13334790|NCT01078623|26607439|FG011|Treatment Period 1|Protocol Violation|0|||
13334791|NCT01078623|26607440|FG012|Treatment Period 1|Protocol Violation|0|||
13334792|NCT01078623|26607441|FG013|Treatment Period 1|Protocol Violation|0|||
13334793|NCT01078623|26607442|FG014|Treatment Period 1|Protocol Violation|0|||
13334794|NCT01078623|26607443|FG015|Treatment Period 1|Protocol Violation|0|||
13334795|NCT01078623|26607444|FG016|Treatment Period 1|Protocol Violation|0|||
13334796|NCT01078623|26607445|FG017|Treatment Period 1|Protocol Violation|0|||
13334797|NCT01078623|26607446|FG018|Treatment Period 1|Protocol Violation|0|||
13334798|NCT01078623|26607447|FG019|Treatment Period 1|Protocol Violation|0|||
13334799|NCT01078623|26607428|FG000|Treatment Period 2|Adverse Event|0|||
13334800|NCT01078623|26607429|FG001|Treatment Period 2|Adverse Event|0|||
13334801|NCT01078623|26607430|FG002|Treatment Period 2|Adverse Event|0|||
13334802|NCT01078623|26607431|FG003|Treatment Period 2|Adverse Event|0|||
13334803|NCT01078623|26607432|FG004|Treatment Period 2|Adverse Event|0|||
13334804|NCT01078623|26607433|FG005|Treatment Period 2|Adverse Event|0|||
13334805|NCT01078623|26607434|FG006|Treatment Period 2|Adverse Event|1|||
13334806|NCT01078623|26607435|FG007|Treatment Period 2|Adverse Event|0|||
13334807|NCT01078623|26607436|FG008|Treatment Period 2|Adverse Event|0|||
13334808|NCT01078623|26607437|FG009|Treatment Period 2|Adverse Event|0|||
13334809|NCT01078623|26607438|FG010|Treatment Period 2|Adverse Event|0|||
13334810|NCT01078623|26607439|FG011|Treatment Period 2|Adverse Event|0|||
13334811|NCT01078623|26607440|FG012|Treatment Period 2|Adverse Event|0|||
13334812|NCT01078623|26607441|FG013|Treatment Period 2|Adverse Event|0|||
13334813|NCT01078623|26607442|FG014|Treatment Period 2|Adverse Event|0|||
13334814|NCT01078623|26607443|FG015|Treatment Period 2|Adverse Event|0|||
13334815|NCT01078623|26607444|FG016|Treatment Period 2|Adverse Event|0|||
13334816|NCT01078623|26607445|FG017|Treatment Period 2|Adverse Event|0|||
13334817|NCT01078623|26607446|FG018|Treatment Period 2|Adverse Event|1|||
13334818|NCT01078623|26607447|FG019|Treatment Period 2|Adverse Event|0|||
13334819|NCT01078623|26607428|FG000|Treatment Period 2|Withdrawal by Subject|0|||
13334820|NCT01078623|26607429|FG001|Treatment Period 2|Withdrawal by Subject|0|||
13334821|NCT01078623|26607430|FG002|Treatment Period 2|Withdrawal by Subject|0|||
13334822|NCT01078623|26607431|FG003|Treatment Period 2|Withdrawal by Subject|0|||
13334823|NCT01078623|26607432|FG004|Treatment Period 2|Withdrawal by Subject|0|||
13334824|NCT01078623|26607433|FG005|Treatment Period 2|Withdrawal by Subject|1|||
13334825|NCT01078623|26607434|FG006|Treatment Period 2|Withdrawal by Subject|0|||
13334826|NCT01078623|26607435|FG007|Treatment Period 2|Withdrawal by Subject|0|||
13334827|NCT01078623|26607436|FG008|Treatment Period 2|Withdrawal by Subject|0|||
13334828|NCT01078623|26607437|FG009|Treatment Period 2|Withdrawal by Subject|0|||
13334829|NCT01078623|26607438|FG010|Treatment Period 2|Withdrawal by Subject|0|||
13334830|NCT01078623|26607439|FG011|Treatment Period 2|Withdrawal by Subject|0|||
13334831|NCT01078623|26607440|FG012|Treatment Period 2|Withdrawal by Subject|0|||
13334832|NCT01078623|26607441|FG013|Treatment Period 2|Withdrawal by Subject|0|||
13334833|NCT01078623|26607442|FG014|Treatment Period 2|Withdrawal by Subject|0|||
13334834|NCT01078623|26607443|FG015|Treatment Period 2|Withdrawal by Subject|0|||
13334835|NCT01078623|26607444|FG016|Treatment Period 2|Withdrawal by Subject|0|||
13334836|NCT01078623|26607445|FG017|Treatment Period 2|Withdrawal by Subject|0|||
13334837|NCT01078623|26607446|FG018|Treatment Period 2|Withdrawal by Subject|0|||
13334838|NCT01078623|26607447|FG019|Treatment Period 2|Withdrawal by Subject|0|||
13334839|NCT01078623|26607428|FG000|Treatment Period 3|Adverse Event|0|||
13334840|NCT01078623|26607429|FG001|Treatment Period 3|Adverse Event|0|||
13334841|NCT01078623|26607430|FG002|Treatment Period 3|Adverse Event|0|||
13334842|NCT01078623|26607431|FG003|Treatment Period 3|Adverse Event|0|||
13334843|NCT01078623|26607432|FG004|Treatment Period 3|Adverse Event|1|||
13334844|NCT01078623|26607433|FG005|Treatment Period 3|Adverse Event|0|||
13334845|NCT01078623|26607434|FG006|Treatment Period 3|Adverse Event|0|||
13334846|NCT01078623|26607435|FG007|Treatment Period 3|Adverse Event|0|||
13334847|NCT01078623|26607436|FG008|Treatment Period 3|Adverse Event|0|||
13334848|NCT01078623|26607437|FG009|Treatment Period 3|Adverse Event|0|||
13334849|NCT01078623|26607438|FG010|Treatment Period 3|Adverse Event|0|||
13334850|NCT01078623|26607439|FG011|Treatment Period 3|Adverse Event|0|||
13334851|NCT01078623|26607440|FG012|Treatment Period 3|Adverse Event|0|||
13334852|NCT01078623|26607441|FG013|Treatment Period 3|Adverse Event|1|||
13334853|NCT01078623|26607442|FG014|Treatment Period 3|Adverse Event|0|||
13334854|NCT01078623|26607443|FG015|Treatment Period 3|Adverse Event|0|||
13334855|NCT01078623|26607444|FG016|Treatment Period 3|Adverse Event|0|||
13334856|NCT01078623|26607445|FG017|Treatment Period 3|Adverse Event|0|||
13334857|NCT01078623|26607446|FG018|Treatment Period 3|Adverse Event|0|||
13334858|NCT01078623|26607447|FG019|Treatment Period 3|Adverse Event|0|||
13334859|NCT01078623|26607428|FG000|Treatment Period 4|Adverse Event|0|||
13334860|NCT01078623|26607429|FG001|Treatment Period 4|Adverse Event|0|||
13334861|NCT01078623|26607430|FG002|Treatment Period 4|Adverse Event|1|||
13334862|NCT01078623|26607431|FG003|Treatment Period 4|Adverse Event|0|||
13334863|NCT01078623|26607432|FG004|Treatment Period 4|Adverse Event|0|||
13334864|NCT01078623|26607433|FG005|Treatment Period 4|Adverse Event|0|||
13334865|NCT01078623|26607434|FG006|Treatment Period 4|Adverse Event|0|||
13334866|NCT01078623|26607435|FG007|Treatment Period 4|Adverse Event|0|||
13334867|NCT01078623|26607436|FG008|Treatment Period 4|Adverse Event|0|||
13334868|NCT01078623|26607437|FG009|Treatment Period 4|Adverse Event|0|||
13334869|NCT01078623|26607438|FG010|Treatment Period 4|Adverse Event|0|||
13334870|NCT01078623|26607439|FG011|Treatment Period 4|Adverse Event|0|||
13334871|NCT01078623|26607440|FG012|Treatment Period 4|Adverse Event|0|||
13334872|NCT01078623|26607441|FG013|Treatment Period 4|Adverse Event|0|||
13334873|NCT01078623|26607442|FG014|Treatment Period 4|Adverse Event|0|||
13334874|NCT01078623|26607443|FG015|Treatment Period 4|Adverse Event|0|||
13334875|NCT01078623|26607444|FG016|Treatment Period 4|Adverse Event|0|||
13334876|NCT01078623|26607445|FG017|Treatment Period 4|Adverse Event|0|||
13334877|NCT01078623|26607446|FG018|Treatment Period 4|Adverse Event|0|||
13334878|NCT01078623|26607447|FG019|Treatment Period 4|Adverse Event|0|||
13334879|NCT01078623|26607428|FG000|Treatment Period 4|Withdrawal by Subject|0|||
13334880|NCT01078623|26607429|FG001|Treatment Period 4|Withdrawal by Subject|0|||
13334881|NCT01078623|26607430|FG002|Treatment Period 4|Withdrawal by Subject|0|||
13334882|NCT01078623|26607431|FG003|Treatment Period 4|Withdrawal by Subject|0|||
13334883|NCT01078623|26607432|FG004|Treatment Period 4|Withdrawal by Subject|0|||
13334884|NCT01078623|26607433|FG005|Treatment Period 4|Withdrawal by Subject|0|||
13334885|NCT01078623|26607434|FG006|Treatment Period 4|Withdrawal by Subject|0|||
13334886|NCT01078623|26607435|FG007|Treatment Period 4|Withdrawal by Subject|0|||
13334887|NCT01078623|26607436|FG008|Treatment Period 4|Withdrawal by Subject|0|||
13334888|NCT01078623|26607437|FG009|Treatment Period 4|Withdrawal by Subject|0|||
13334889|NCT01078623|26607438|FG010|Treatment Period 4|Withdrawal by Subject|0|||
13334890|NCT01078623|26607439|FG011|Treatment Period 4|Withdrawal by Subject|0|||
13334891|NCT01078623|26607440|FG012|Treatment Period 4|Withdrawal by Subject|0|||
13334892|NCT01078623|26607441|FG013|Treatment Period 4|Withdrawal by Subject|0|||
13334893|NCT01078623|26607442|FG014|Treatment Period 4|Withdrawal by Subject|0|||
13334894|NCT01078623|26607443|FG015|Treatment Period 4|Withdrawal by Subject|1|||
13334895|NCT01078623|26607444|FG016|Treatment Period 4|Withdrawal by Subject|0|||
13334896|NCT01078623|26607445|FG017|Treatment Period 4|Withdrawal by Subject|0|||
13334897|NCT01078623|26607446|FG018|Treatment Period 4|Withdrawal by Subject|0|||
13334898|NCT01078623|26607447|FG019|Treatment Period 4|Withdrawal by Subject|0|||
13334899|NCT01078584|26607530|FG000|Overall Study|Final Status Unknown|1073|||
13334900|NCT01078584|26607530|FG000|Overall Study|Lost to Follow-up|670|||
13334901|NCT01078584|26607530|FG000|Overall Study|Non-serious Adverse Event|577|||
13334902|NCT01078584|26607530|FG000|Overall Study|Withdrawal of Consent|244|||
13334903|NCT01078584|26607530|FG000|Overall Study|Physician Withdrew from Study|90|||
13334904|NCT01078584|26607530|FG000|Overall Study|Non-compliance|67|||
13334905|NCT01078584|26607530|FG000|Overall Study|Blood Pressure Controlled|49|||
13334906|NCT01078584|26607530|FG000|Overall Study|Physician Switched Medication|26|||
13334907|NCT01078584|26607530|FG000|Overall Study|Physician Discontinued Patient|12|||
13334908|NCT01078584|26607530|FG000|Overall Study|Lack of Efficacy|98|||
13334909|NCT01078584|26607530|FG000|Overall Study|Protocol Violation|75|||
13334910|NCT01078584|26607530|FG000|Overall Study|Serious Adverse Event|27|||
13334911|NCT01078584|26607530|FG000|Overall Study|Multiple Reasons|2|||
13334912|NCT01078571|26607548|FG000|Overall Study|Adverse Event|36|||
13334913|NCT01078571|26607548|FG000|Overall Study|Lack of effectiveness|36|||
13334914|NCT01078571|26607548|FG000|Overall Study|Reason not reported|21|||
13334915|NCT01078571|26607548|FG000|Overall Study|Withdrawal by Subject|12|||
13334916|NCT01078571|26607548|FG000|Overall Study|Lost to Follow-up|8|||
13334917|NCT01078571|26607548|FG000|Overall Study|Protocol Violation|2|||
13334918|NCT01078545|26607558|FG000|Overall Study|Lost to Follow-up|13|||
13334919|NCT01078545|26607558|FG000|Overall Study|Physician Decision|6|||
13334920|NCT01078545|26607558|FG000|Overall Study|Withdrawal by Subject|3|||
13334921|NCT01078545|26607558|FG000|Overall Study|Death|3|||
13334922|NCT01078545|26607558|FG000|Overall Study|Participant moved to another physician|1|||
13334923|NCT01078441|26607564|FG000|Overall Study|Withdrawal by Subject|1|||
13334924|NCT01078389|26607585|FG000|Overall Study|Adverse Event|10|||
13334925|NCT01078389|26607586|FG001|Overall Study|Adverse Event|6|||
13334926|NCT01078389|26607585|FG000|Overall Study|Major Protocol Deviation|2|||
13334927|NCT01078389|26607586|FG001|Overall Study|Major Protocol Deviation|0|||
13334928|NCT01078389|26607585|FG000|Overall Study|Lost to Follow-up|23|||
13334929|NCT01078389|26607586|FG001|Overall Study|Lost to Follow-up|23|||
13334930|NCT01078389|26607585|FG000|Overall Study|Voluntary Withdrawal|20|||
13334931|NCT01078389|26607586|FG001|Overall Study|Voluntary Withdrawal|36|||
13334932|NCT01078389|26607585|FG000|Overall Study|Other|9|||
13334933|NCT01078389|26607586|FG001|Overall Study|Other|2|||
13334934|NCT01078298|26607619|FG000|Overall Study|Lost to Follow-up|12|||
13334935|NCT01078298|26607620|FG001|Overall Study|Lost to Follow-up|13|||
13334936|NCT01078298|26607619|FG000|Overall Study|Withdrawal by Subject|31|||
13334937|NCT01078298|26607620|FG001|Overall Study|Withdrawal by Subject|33|||
13334938|NCT01078298|26607619|FG000|Overall Study|Protocol Violation|6|||
13334939|NCT01078298|26607620|FG001|Overall Study|Protocol Violation|6|||
13334940|NCT01078298|26607619|FG000|Overall Study|Adverse Event|6|||
13334941|NCT01078298|26607620|FG001|Overall Study|Adverse Event|5|||
13334942|NCT01078298|26607619|FG000|Overall Study|Death|2|||
13334943|NCT01078298|26607620|FG001|Overall Study|Death|0|||
13334944|NCT01078298|26607619|FG000|Overall Study|Did not meet entrance criteria|0|||
13334945|NCT01078298|26607620|FG001|Overall Study|Did not meet entrance criteria|1|||
13334946|NCT01078298|26607619|FG000|Overall Study|Other|24|||
13334947|NCT01078298|26607620|FG001|Overall Study|Other|32|||
13334948|NCT01078168|26607633|FG000|Overall Study|Physician Decision|0|||
13334949|NCT01078168|26607634|FG001|Overall Study|Physician Decision|1|||
13334950|NCT01078155|26607652|FG000|Overall Study|Adverse Event|7|||
13334951|NCT01078155|26607652|FG000|Overall Study|Lack of Efficacy|16|||
13334952|NCT01078155|26607652|FG000|Overall Study|Participant's Decision|6|||
13334953|NCT01078155|26607652|FG000|Overall Study|Lost to Follow-up|15|||
13334954|NCT01078116|26607662|FG000|Overall Study|Lost to Follow-up|17|||
13334955|NCT01078116|26607662|FG000|Overall Study|Adverse Event|5|||
13334956|NCT01078116|26607662|FG000|Overall Study|Withdrawal by Subject|8|||
13334957|NCT01078116|26607662|FG000|Overall Study|Lack of effectiveness|15|||
13334958|NCT01078116|26607662|FG000|Overall Study|Case report form not completed|3|||
13334959|NCT01078090|26607705|FG000|Overall Study|Lost to Follow-up|2363|||
13334960|NCT01078090|26607705|FG000|Overall Study|Adverse drug reaction (ADR)|453|||
13334961|NCT01078090|26607705|FG000|Overall Study|Lack of Efficacy|1193|||
13334962|NCT01078090|26607705|FG000|Overall Study|ADR and lack of efficacy|61|||
13334963|NCT01078090|26607705|FG000|Overall Study|Other|523|||
13334964|NCT01077960|26607716|FG000|Overall Study|Adverse Event|6|||
13334965|NCT01077960|26607716|FG000|Overall Study|Protocol Violation|3|||
13334966|NCT01077960|26607716|FG000|Overall Study|Lost to Follow-up|5|||
13334967|NCT01077960|26607716|FG000|Overall Study|Subject decision|1|||
13334968|NCT01077960|26607716|FG000|Overall Study|Reason unspecified|1|||
13334969|NCT01077804|26607725|FG000|Overall Study|Unreachable|102|||
13334970|NCT01077804|26607725|FG000|Overall Study|Refused to continue|79|||
13334971|NCT01077804|26607725|FG000|Overall Study|Other|18|||
13334972|NCT01077739|26607744|FG000|Overall Study|Premature withdrawal|1|||
13334973|NCT01077739|26607745|FG001|Overall Study|Premature withdrawal|3|||
13334974|NCT01077739|26607744|FG000|Overall Study|Withdrawal by Subject|1|||
13334975|NCT01077739|26607745|FG001|Overall Study|Withdrawal by Subject|0|||
13334976|NCT01077739|26607744|FG000|Overall Study|Death|0|||
13334977|NCT01077739|26607745|FG001|Overall Study|Death|3|||
13334978|NCT01077739|26607744|FG000|Overall Study|Unacceptable toxicity|1|||
13334979|NCT01077739|26607745|FG001|Overall Study|Unacceptable toxicity|2|||
13334980|NCT01077739|26607744|FG000|Overall Study|Other|2|||
13334981|NCT01077739|26607745|FG001|Overall Study|Other|2|||
13334982|NCT01077713|26607776|FG000|Overall Study|Withdrawal by Subject|1|||
13334983|NCT01077713|26607777|FG001|Overall Study|Withdrawal by Subject|2|||
13334984|NCT01077713|26607776|FG000|Overall Study|Progressive Disease (PD)|0|||
13334985|NCT01077713|26607777|FG001|Overall Study|Progressive Disease (PD)|1|||
13334986|NCT01077713|26607776|FG000|Overall Study|Death|28|||
13334987|NCT01077713|26607777|FG001|Overall Study|Death|29|||
13334988|NCT01077713|26607776|FG000|Overall Study|Lost to Follow-up|1|||
13334989|NCT01077713|26607777|FG001|Overall Study|Lost to Follow-up|1|||
13334990|NCT01077713|26607776|FG000|Overall Study|Adverse Event|2|||
13334991|NCT01077713|26607777|FG001|Overall Study|Adverse Event|1|||
13334992|NCT01077713|26607776|FG000|Overall Study|Other|4|||
13334993|NCT01077713|26607777|FG001|Overall Study|Other|2|||
13334994|NCT01077622|26607825|FG000|Overall Study|Physician Decision|2|||
13334995|NCT01077622|26607825|FG000|Overall Study|Withdrawal by Subject|1|||
13334996|NCT01077544|26607858|FG000|Overall Study|New Cancer Therapy|3|||
13334997|NCT01077544|26607859|FG001|Overall Study|New Cancer Therapy|3|||
13334998|NCT01077544|26607858|FG000|Overall Study|Adverse Event|0|||
13334999|NCT01077544|26607859|FG001|Overall Study|Adverse Event|1|||
13335000|NCT01077544|26607858|FG000|Overall Study|Disease Progression|0|||
13335001|NCT01077544|26607859|FG001|Overall Study|Disease Progression|1|||
13335002|NCT01077518|26607925|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8|||
13335003|NCT01077518|26607926|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4|||
13335004|NCT01077518|26607927|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0|||
13335005|NCT01077518|26607925|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10|||
13335006|NCT01077518|26607926|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11|||
13335007|NCT01077518|26607927|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0|||
13335008|NCT01077518|26607925|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28|||
13335009|NCT01077518|26607926|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22|||
13335010|NCT01077518|26607927|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0|||
13335011|NCT01077518|26607925|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32|||
13335012|NCT01077518|26607926|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28|||
13335013|NCT01077518|26607927|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0|||
13335014|NCT01077518|26607925|FG000|Optional Ofa Phase|Physician Decision|0|||
13335015|NCT01077518|26607926|FG001|Optional Ofa Phase|Physician Decision|0|||
13335016|NCT01077518|26607927|FG002|Optional Ofa Phase|Physician Decision|1|||
13335017|NCT01077518|26607925|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0|||
13335018|NCT01077518|26607926|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0|||
13335019|NCT01077518|26607927|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12|||
13335020|NCT01077518|26607925|FG000|Optional Ofa Phase|Withdrawal by Subject|0|||
13335021|NCT01077518|26607926|FG001|Optional Ofa Phase|Withdrawal by Subject|0|||
13335022|NCT01077518|26607927|FG002|Optional Ofa Phase|Withdrawal by Subject|3|||
13335023|NCT01077375|26607942|FG000|Overall Study|Adverse Event|2|||
13335024|NCT01077375|26607943|FG001|Overall Study|Adverse Event|15|||
13335025|NCT01077375|26607942|FG000|Overall Study|Lack of Efficacy|6|||
13335026|NCT01077375|26607943|FG001|Overall Study|Lack of Efficacy|8|||
13335027|NCT01077375|26607942|FG000|Overall Study|Withdrawal by Subject|0|||
13335028|NCT01077375|26607943|FG001|Overall Study|Withdrawal by Subject|6|||
13335029|NCT01077375|26607942|FG000|Overall Study|Lost to Follow-up|2|||
13335030|NCT01077375|26607943|FG001|Overall Study|Lost to Follow-up|5|||
13335031|NCT01077375|26607942|FG000|Overall Study|Other Reason|0|||
13335032|NCT01077375|26607943|FG001|Overall Study|Other Reason|1|||
13335033|NCT01077362|26607986|FG000|Overall Study|Lack of Efficacy|13|||
13335034|NCT01077362|26607987|FG001|Overall Study|Lack of Efficacy|8|||
13335035|NCT01077362|26607988|FG002|Overall Study|Lack of Efficacy|10|||
13335036|NCT01077362|26607986|FG000|Overall Study|Lost to Follow-up|1|||
13335037|NCT01077362|26607987|FG001|Overall Study|Lost to Follow-up|0|||
13335038|NCT01077362|26607988|FG002|Overall Study|Lost to Follow-up|3|||
13335039|NCT01077362|26607986|FG000|Overall Study|Adverse Event|12|||
13335040|NCT01077362|26607987|FG001|Overall Study|Adverse Event|7|||
13335041|NCT01077362|26607988|FG002|Overall Study|Adverse Event|4|||
13335042|NCT01077362|26607986|FG000|Overall Study|Withdrawal by Subject|5|||
13335043|NCT01077362|26607987|FG001|Overall Study|Withdrawal by Subject|3|||
13335044|NCT01077362|26607988|FG002|Overall Study|Withdrawal by Subject|5|||
13335045|NCT01077362|26607986|FG000|Overall Study|Other|0|||
13335046|NCT01077362|26607987|FG001|Overall Study|Other|1|||
13335047|NCT01077362|26607988|FG002|Overall Study|Other|2|||
13335048|NCT01077323|26608015|FG000|Overall Study|<9 months enroll before drug dispensed|11226|||
13335049|NCT01077323|26608016|FG001|Overall Study|<9 months enroll before drug dispensed|263954|||
13335050|NCT01077323|26608017|FG002|Overall Study|<9 months enroll before drug dispensed|11655523|||
13335051|NCT01077323|26608015|FG000|Overall Study|Dispensing of drug in baseline period|0|||
13335052|NCT01077323|26608016|FG001|Overall Study|Dispensing of drug in baseline period|120229|||
13335053|NCT01077323|26608017|FG002|Overall Study|Dispensing of drug in baseline period|256446|||
13393538|NCT00663260|26784029|FG000|Overall Study|Lack of Efficacy|2|||
13335054|NCT01077323|26608015|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152|||
13335055|NCT01077323|26608016|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080|||
13335056|NCT01077323|26608017|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120|||
13335057|NCT01077284|26608044|FG000|Overall Study|Adverse Event|2|||
13335058|NCT01077284|26608045|FG001|Overall Study|Adverse Event|0|||
13335059|NCT01077284|26608046|FG002|Overall Study|Adverse Event|1|||
13335060|NCT01077284|26608044|FG000|Overall Study|Lost to Follow-up|1|||
13335061|NCT01077284|26608045|FG001|Overall Study|Lost to Follow-up|2|||
13335062|NCT01077284|26608046|FG002|Overall Study|Lost to Follow-up|0|||
13335063|NCT01077284|26608044|FG000|Overall Study|Withdrawal by Subject|2|||
13335064|NCT01077284|26608045|FG001|Overall Study|Withdrawal by Subject|3|||
13335065|NCT01077284|26608046|FG002|Overall Study|Withdrawal by Subject|1|||
13335066|NCT01077284|26608044|FG000|Overall Study|Other|0|||
13335067|NCT01077284|26608045|FG001|Overall Study|Other|0|||
13335068|NCT01077284|26608046|FG002|Overall Study|Other|1|||
13335069|NCT01077271|26608094|FG000|Overall Study|Parental desire|8|||
13335070|NCT01077271|26608094|FG000|Overall Study|Screen failure, did not take palivizumab|4|||
13335071|NCT01077271|26608094|FG000|Overall Study|Noncompliance|2|||
13335072|NCT01077271|26608094|FG000|Overall Study|Quota used up (insurance reimb issue)|2|||
13335073|NCT01077271|26608094|FG000|Overall Study|Changed doctors|2|||
13335074|NCT01077271|26608094|FG000|Overall Study|Parents thought too many injections|2|||
13335075|NCT01077271|26608094|FG000|Overall Study|End of RSV season nearly reached|1|||
13335076|NCT01077271|26608094|FG000|Overall Study|Mother unconvinced of the necessity|1|||
13335077|NCT01077258|26608132|FG000|Overall Study|Lost to Follow-up|1390|||
13335078|NCT01077258|26608132|FG000|Overall Study|Adverse drug reaction|218|||
13335079|NCT01077258|26608132|FG000|Overall Study|Lack of Efficacy|663|||
13335080|NCT01077258|26608132|FG000|Overall Study|Clinical remission|37|||
13335081|NCT01077258|26608132|FG000|Overall Study|Other reasons|260|||
13335082|NCT01077193|26608138|FG000|Overall Study|Lost to Follow-up|1|||
13335083|NCT01077193|26608138|FG000|Overall Study|Withdrawal by Subject|2|||
13335084|NCT01077193|26608138|FG000|Overall Study|Lack of Efficacy|1|||
13335085|NCT01077193|26608138|FG000|Overall Study|Study Terminated by Sponsor|40|||
13335086|NCT01077154|26608159|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524|||
13335087|NCT01077154|26608160|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514|||
13335088|NCT01077154|26608159|FG000|Overall Study|Withdrawal by Subject|369|||
13335089|NCT01077154|26608160|FG001|Overall Study|Withdrawal by Subject|385|||
13335090|NCT01077154|26608159|FG000|Overall Study|Death|215|||
13335091|NCT01077154|26608160|FG001|Overall Study|Death|214|||
13335092|NCT01077154|26608159|FG000|Overall Study|Lost to Follow-up|43|||
13335093|NCT01077154|26608160|FG001|Overall Study|Lost to Follow-up|35|||
13335094|NCT01077154|26608159|FG000|Overall Study|Noncompliance|22|||
13335095|NCT01077154|26608160|FG001|Overall Study|Noncompliance|20|||
13335096|NCT01077154|26608159|FG000|Overall Study|Disease Progression|18|||
13335097|NCT01077154|26608160|FG001|Overall Study|Disease Progression|20|||
13335098|NCT01077154|26608159|FG000|Overall Study|Ineligibility Determined|10|||
13335099|NCT01077154|26608160|FG001|Overall Study|Ineligibility Determined|14|||
13335100|NCT01077154|26608159|FG000|Overall Study|Other|14|||
13335101|NCT01077154|26608160|FG001|Overall Study|Other|11|||
13335102|NCT01077154|26608159|FG000|Overall Study|Adverse Event|9|||
13335103|NCT01077154|26608160|FG001|Overall Study|Adverse Event|9|||
13335104|NCT01077154|26608159|FG000|Overall Study|Administrative Decision|1|||
13335105|NCT01077154|26608160|FG001|Overall Study|Administrative Decision|6|||
13335106|NCT01077154|26608159|FG000|Overall Study|Protocol Deviation|1|||
13335107|NCT01077154|26608160|FG001|Overall Study|Protocol Deviation|0|||
13335108|NCT01077128|26608220|FG000|Overall Study|Adverse Event|8|||
13335109|NCT01077128|26608220|FG000|Overall Study|Lack of Efficacy|1|||
13335110|NCT01077128|26608220|FG000|Overall Study|Disease exacerbation|1|||
13335111|NCT01077128|26608220|FG000|Overall Study|Adverse event and consent withdrawal|1|||
13335112|NCT01077128|26608220|FG000|Overall Study|Adverse event and disease exacerbation|1|||
13335113|NCT01077128|26608220|FG000|Overall Study|Lack of efficacy/disease exacerbation|1|||
13335114|NCT01077128|26608220|FG000|Overall Study|Other|54|||
13373861|NCT00799058|26725170|FG002|Overall Study|Withdrawal by Subject|2|||
13373862|NCT00799058|26725168|FG000|Overall Study|Lost to Follow-up|1|||
13373863|NCT00799058|26725169|FG001|Overall Study|Lost to Follow-up|2|||
13373864|NCT00799058|26725170|FG002|Overall Study|Lost to Follow-up|1|||
13373865|NCT00799058|26725168|FG000|Overall Study|Adverse Event|0|||
13373866|NCT00799058|26725169|FG001|Overall Study|Adverse Event|2|||
13373867|NCT00799058|26725170|FG002|Overall Study|Adverse Event|0|||
13373868|NCT00799058|26725168|FG000|Overall Study|Pregnancy|1|||
13373869|NCT00799058|26725169|FG001|Overall Study|Pregnancy|0|||
13373870|NCT00799058|26725170|FG002|Overall Study|Pregnancy|0|||
13373871|NCT00799058|26725168|FG000|Overall Study|Not adherent|3|||
13373872|NCT00799058|26725169|FG001|Overall Study|Not adherent|2|||
13373873|NCT00799058|26725170|FG002|Overall Study|Not adherent|1|||
13373874|NCT00799058|26725168|FG000|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
13373875|NCT00799058|26725169|FG001|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
13373876|NCT00799058|26725170|FG002|Overall Study|discontinued use of IP due to AE, but completed visits|1|||
13335115|NCT01077076|26608235|FG000|First Intervention|Withdrawal by Subject|1|||
13335116|NCT01077076|26608236|FG001|First Intervention|Withdrawal by Subject|0|||
13335117|NCT01077076|26608237|FG002|First Intervention|Withdrawal by Subject|0|||
13335118|NCT01077076|26608238|FG003|First Intervention|Withdrawal by Subject|0|||
13335119|NCT01077076|26608239|FG004|First Intervention|Withdrawal by Subject|0|||
13335120|NCT01077076|26608240|FG005|First Intervention|Withdrawal by Subject|0|||
13335121|NCT01077076|26608235|FG000|Third Intervention|Death in the participant's family|0|||
13335122|NCT01077076|26608236|FG001|Third Intervention|Death in the participant's family|0|||
13335123|NCT01077076|26608237|FG002|Third Intervention|Death in the participant's family|0|||
13335124|NCT01077076|26608238|FG003|Third Intervention|Death in the participant's family|0|||
13335125|NCT01077076|26608239|FG004|Third Intervention|Death in the participant's family|0|||
13335126|NCT01077076|26608240|FG005|Third Intervention|Death in the participant's family|1|||
13335127|NCT01077063|26608253|FG000|Overall Study|Adverse Event|3|||
13335128|NCT01077063|26608254|FG001|Overall Study|Adverse Event|0|||
13335129|NCT01077063|26608253|FG000|Overall Study|Death|1|||
13335130|NCT01077063|26608254|FG001|Overall Study|Death|1|||
13335131|NCT01077063|26608253|FG000|Overall Study|Withdrawal by Subject|0|||
13335132|NCT01077063|26608254|FG001|Overall Study|Withdrawal by Subject|2|||
13335133|NCT01077050|26608260|FG000|Overall Study|Subjects signed ICF could not be located|1|||
13335134|NCT01077050|26608260|FG000|Overall Study|Screen failure|8|||
13335135|NCT01077024|26608285|FG000|Overall Study|Lost to Follow-up|20|||
13335136|NCT01077024|26608286|FG001|Overall Study|Lost to Follow-up|14|||
13335137|NCT01077024|26608285|FG000|Overall Study|Withdrawal by Subject|0|||
13335138|NCT01077024|26608286|FG001|Overall Study|Withdrawal by Subject|2|||
13335139|NCT01077024|26608285|FG000|Overall Study|Incarcerated|7|||
13335140|NCT01077024|26608286|FG001|Overall Study|Incarcerated|8|||
13335141|NCT01077024|26608285|FG000|Overall Study|Other|4|||
13335142|NCT01077024|26608286|FG001|Overall Study|Other|4|||
13335143|NCT01076959|26608305|FG000|Overall Study|Adverse Event|767|||
13335144|NCT01076959|26608305|FG000|Overall Study|Lack of Efficacy|849|||
13335145|NCT01076959|26608305|FG000|Overall Study|Non-compliance|274|||
13335146|NCT01076959|26608305|FG000|Overall Study|Lost to Follow-up|241|||
13335147|NCT01076959|26608305|FG000|Overall Study|Other|119|||
13335148|NCT01076647|26608320|FG000|Overall Study|Adverse Event|4|||
13335149|NCT01076647|26608321|FG001|Overall Study|Adverse Event|1|||
13335150|NCT01076647|26608320|FG000|Overall Study|Lack of Efficacy|0|||
13335151|NCT01076647|26608321|FG001|Overall Study|Lack of Efficacy|1|||
13335152|NCT01076647|26608320|FG000|Overall Study|Protocol Violation|7|||
13335153|NCT01076647|26608321|FG001|Overall Study|Protocol Violation|9|||
13335154|NCT01076647|26608320|FG000|Overall Study|Withdrawal criteria|2|||
13335155|NCT01076647|26608321|FG001|Overall Study|Withdrawal criteria|2|||
13335156|NCT01076647|26608320|FG000|Overall Study|Unclassified|12|||
13335157|NCT01076647|26608321|FG001|Overall Study|Unclassified|12|||
13335158|NCT01076543|26608378|FG000|Overall Study|Withdrawal by Subject|2|||
13335159|NCT01076543|26608379|FG001|Overall Study|Withdrawal by Subject|0|||
13335160|NCT01076543|26608380|FG002|Overall Study|Withdrawal by Subject|0|||
13335161|NCT01076543|26608381|FG003|Overall Study|Withdrawal by Subject|0|||
13335162|NCT01076543|26608382|FG004|Overall Study|Withdrawal by Subject|0|||
13335163|NCT01076543|26608383|FG005|Overall Study|Withdrawal by Subject|0|||
13335164|NCT01076400|26608393|FG000|Overall Study|Adverse Event|2|||
13335165|NCT01076400|26608394|FG001|Overall Study|Adverse Event|0|||
13335166|NCT01076400|26608395|FG002|Overall Study|Adverse Event|0|||
13335167|NCT01076400|26608393|FG000|Overall Study|Progressive Disease|5|||
13335168|NCT01076400|26608394|FG001|Overall Study|Progressive Disease|0|||
13335169|NCT01076400|26608395|FG002|Overall Study|Progressive Disease|0|||
13335170|NCT01076361|26608401|FG000|Overall Study|22 leads were excluded from analysis|21|||
13335171|NCT01076335|26608407|FG000|Overall Study|Withdrawal by Subject|3|||
13335172|NCT01076335|26608407|FG000|Overall Study|Withdrawal without treatment|1|||
13335173|NCT01076205|26608462|FG000|Overall Study|Adverse Drug Reaction|299|||
13335174|NCT01076205|26608462|FG000|Overall Study|Lack of Effectiveness|1423|||
13335175|NCT01076205|26608462|FG000|Overall Study|Other Reason|1075|||
13335176|NCT01076205|26608462|FG000|Overall Study|Unknown Reason|71|||
13335177|NCT01076205|26608462|FG000|Overall Study|Lost to Follow-up|3151|||
13335178|NCT01076192|26608479|FG000|Overall Study|Other|197|||
13335179|NCT01076179|26608504|FG000|Overall Study|Withdrawal by Subject|1|||
13335180|NCT01076166|26608513|FG000|Overall Study|Adverse Event|3|||
13335181|NCT01076166|26608513|FG000|Overall Study|Symptoms improved/resolved|6|||
13335182|NCT01076153|26608523|FG000|Overall Study|Symptoms improved/resolved|10|||
13335183|NCT01076153|26608523|FG000|Overall Study|Adverse Event|1|||
13335184|NCT01076088|26608568|FG000|Overall Study|Adverse Event|1|||
13124717|NCT02939950|25953768|FG000|Overall Study|Positive slit lamp findings|0|||
13335185|NCT01076088|26608569|FG001|Overall Study|Adverse Event|6|||
13335186|NCT01076088|26608570|FG002|Overall Study|Adverse Event|3|||
13335187|NCT01076088|26608571|FG003|Overall Study|Adverse Event|2|||
13335188|NCT01076088|26608572|FG004|Overall Study|Adverse Event|3|||
13335189|NCT01076088|26608573|FG005|Overall Study|Adverse Event|3|||
13335190|NCT01076088|26608568|FG000|Overall Study|Lost to Follow-up|1|||
13335191|NCT01076088|26608569|FG001|Overall Study|Lost to Follow-up|1|||
13335192|NCT01076088|26608570|FG002|Overall Study|Lost to Follow-up|0|||
13335193|NCT01076088|26608571|FG003|Overall Study|Lost to Follow-up|1|||
13335194|NCT01076088|26608572|FG004|Overall Study|Lost to Follow-up|1|||
13335195|NCT01076088|26608573|FG005|Overall Study|Lost to Follow-up|2|||
13335196|NCT01076088|26608568|FG000|Overall Study|Non-compliance with study drug|0|||
13335197|NCT01076088|26608569|FG001|Overall Study|Non-compliance with study drug|0|||
13335198|NCT01076088|26608570|FG002|Overall Study|Non-compliance with study drug|0|||
13335199|NCT01076088|26608571|FG003|Overall Study|Non-compliance with study drug|1|||
13335200|NCT01076088|26608572|FG004|Overall Study|Non-compliance with study drug|0|||
13335201|NCT01076088|26608573|FG005|Overall Study|Non-compliance with study drug|0|||
13335202|NCT01076088|26608568|FG000|Overall Study|Physician Decision|1|||
13335203|NCT01076088|26608569|FG001|Overall Study|Physician Decision|3|||
13335204|NCT01076088|26608570|FG002|Overall Study|Physician Decision|0|||
13335205|NCT01076088|26608571|FG003|Overall Study|Physician Decision|1|||
13335206|NCT01076088|26608572|FG004|Overall Study|Physician Decision|1|||
13335207|NCT01076088|26608573|FG005|Overall Study|Physician Decision|0|||
13335208|NCT01076088|26608568|FG000|Overall Study|Withdrawal by Subject|8|||
13335209|NCT01076088|26608569|FG001|Overall Study|Withdrawal by Subject|8|||
13335210|NCT01076088|26608570|FG002|Overall Study|Withdrawal by Subject|14|||
13335211|NCT01076088|26608571|FG003|Overall Study|Withdrawal by Subject|10|||
13335212|NCT01076088|26608572|FG004|Overall Study|Withdrawal by Subject|11|||
13335213|NCT01076088|26608573|FG005|Overall Study|Withdrawal by Subject|17|||
13335214|NCT01076088|26608568|FG000|Overall Study|Other protocol specified criteria|0|||
13335215|NCT01076088|26608569|FG001|Overall Study|Other protocol specified criteria|0|||
13335216|NCT01076088|26608570|FG002|Overall Study|Other protocol specified criteria|0|||
13335217|NCT01076088|26608571|FG003|Overall Study|Other protocol specified criteria|0|||
13335218|NCT01076088|26608572|FG004|Overall Study|Other protocol specified criteria|0|||
13335219|NCT01076088|26608573|FG005|Overall Study|Other protocol specified criteria|1|||
13335220|NCT01076075|26608594|FG000|Overall Study|Adverse Event|3|||
13335221|NCT01076075|26608595|FG001|Overall Study|Adverse Event|9|||
13335222|NCT01076075|26608594|FG000|Overall Study|Lack of Efficacy|5|||
13335223|NCT01076075|26608595|FG001|Overall Study|Lack of Efficacy|4|||
13335224|NCT01076075|26608594|FG000|Overall Study|Lost to Follow-up|6|||
13335225|NCT01076075|26608595|FG001|Overall Study|Lost to Follow-up|5|||
13335226|NCT01076075|26608594|FG000|Overall Study|other|19|||
13335227|NCT01076075|26608595|FG001|Overall Study|other|9|||
13335228|NCT01076075|26608594|FG000|Overall Study|Protocol Violation|0|||
13335229|NCT01076075|26608595|FG001|Overall Study|Protocol Violation|1|||
13335230|NCT01076075|26608594|FG000|Overall Study|Withdrawal by Subject|8|||
13335231|NCT01076075|26608595|FG001|Overall Study|Withdrawal by Subject|19|||
13335232|NCT01076036|26608602|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2|||
13335233|NCT01076010|26608647|FG000|Overall Study|Death|15|||
13335234|NCT01076010|26608648|FG001|Overall Study|Death|1|||
13335235|NCT01076010|26608649|FG002|Overall Study|Death|0|||
13335236|NCT01076010|26608647|FG000|Overall Study|Adverse Event|7|||
13335237|NCT01076010|26608648|FG001|Overall Study|Adverse Event|2|||
13335238|NCT01076010|26608649|FG002|Overall Study|Adverse Event|0|||
13335239|NCT01076010|26608647|FG000|Overall Study|Progressive disease|90|||
13335240|NCT01076010|26608648|FG001|Overall Study|Progressive disease|30|||
13335241|NCT01076010|26608649|FG002|Overall Study|Progressive disease|1|||
13335242|NCT01076010|26608647|FG000|Overall Study|Lack of Efficacy|4|||
13335243|NCT01076010|26608648|FG001|Overall Study|Lack of Efficacy|0|||
13335244|NCT01076010|26608649|FG002|Overall Study|Lack of Efficacy|0|||
13335245|NCT01076010|26608647|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0|||
13335246|NCT01076010|26608648|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1|||
13335247|NCT01076010|26608649|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0|||
13335248|NCT01076010|26608647|FG000|Overall Study|Significant Surgical Procedure|0|||
13335249|NCT01076010|26608648|FG001|Overall Study|Significant Surgical Procedure|1|||
13335250|NCT01076010|26608649|FG002|Overall Study|Significant Surgical Procedure|0|||
13335251|NCT01076010|26608647|FG000|Overall Study|Protocol Violation|0|||
13335252|NCT01076010|26608648|FG001|Overall Study|Protocol Violation|1|||
13335253|NCT01076010|26608649|FG002|Overall Study|Protocol Violation|0|||
13335254|NCT01076010|26608647|FG000|Overall Study|Noncompliance|1|||
13335255|NCT01076010|26608648|FG001|Overall Study|Noncompliance|1|||
13335256|NCT01076010|26608649|FG002|Overall Study|Noncompliance|0|||
13335257|NCT01076010|26608647|FG000|Overall Study|Withdrawal by Subject|3|||
13335258|NCT01076010|26608648|FG001|Overall Study|Withdrawal by Subject|0|||
13335259|NCT01076010|26608649|FG002|Overall Study|Withdrawal by Subject|1|||
13335260|NCT01076010|26608647|FG000|Overall Study|Other|5|||
13335261|NCT01076010|26608648|FG001|Overall Study|Other|2|||
13335262|NCT01076010|26608649|FG002|Overall Study|Other|0|||
13335263|NCT01075984|26608719|FG000|Treatment Phase|Adverse Event|0|||
13335264|NCT01075984|26608720|FG001|Treatment Phase|Adverse Event|1|||
13335265|NCT01075984|26608721|FG002|Treatment Phase|Adverse Event|3|||
13335266|NCT01075984|26608722|FG003|Treatment Phase|Adverse Event|7|||
13335267|NCT01075984|26608723|FG004|Treatment Phase|Adverse Event|35|||
13335268|NCT01075984|26608719|FG000|Treatment Phase|Protocol Violation|0|||
13373877|NCT00799058|26725168|FG000|Overall Study|IP dispensing error|1|||
13335269|NCT01075984|26608720|FG001|Treatment Phase|Protocol Violation|0|||
13335270|NCT01075984|26608721|FG002|Treatment Phase|Protocol Violation|1|||
13335271|NCT01075984|26608722|FG003|Treatment Phase|Protocol Violation|0|||
13335272|NCT01075984|26608723|FG004|Treatment Phase|Protocol Violation|3|||
13335273|NCT01075984|26608719|FG000|Treatment Phase|Withdrawal by Subject|0|||
13335274|NCT01075984|26608720|FG001|Treatment Phase|Withdrawal by Subject|0|||
13335275|NCT01075984|26608721|FG002|Treatment Phase|Withdrawal by Subject|2|||
13335276|NCT01075984|26608722|FG003|Treatment Phase|Withdrawal by Subject|0|||
13335277|NCT01075984|26608723|FG004|Treatment Phase|Withdrawal by Subject|15|||
13335278|NCT01075984|26608719|FG000|Treatment Phase|Treatment Failure|0|||
13335279|NCT01075984|26608720|FG001|Treatment Phase|Treatment Failure|0|||
13335280|NCT01075984|26608721|FG002|Treatment Phase|Treatment Failure|1|||
13335281|NCT01075984|26608722|FG003|Treatment Phase|Treatment Failure|0|||
13335282|NCT01075984|26608723|FG004|Treatment Phase|Treatment Failure|5|||
13335283|NCT01075984|26608719|FG000|Treatment Phase|Progression of disease|0|||
13335284|NCT01075984|26608720|FG001|Treatment Phase|Progression of disease|0|||
13335285|NCT01075984|26608721|FG002|Treatment Phase|Progression of disease|0|||
13335286|NCT01075984|26608722|FG003|Treatment Phase|Progression of disease|0|||
13335287|NCT01075984|26608723|FG004|Treatment Phase|Progression of disease|2|||
13335288|NCT01075984|26608719|FG000|Follow-up Phase|Protocol Violation|0|||
13335289|NCT01075984|26608720|FG001|Follow-up Phase|Protocol Violation|0|||
13335290|NCT01075984|26608721|FG002|Follow-up Phase|Protocol Violation|1|||
13335291|NCT01075984|26608722|FG003|Follow-up Phase|Protocol Violation|0|||
13335292|NCT01075984|26608723|FG004|Follow-up Phase|Protocol Violation|3|||
13335293|NCT01075984|26608719|FG000|Follow-up Phase|Adverse Event|0|||
13335294|NCT01075984|26608720|FG001|Follow-up Phase|Adverse Event|0|||
13335295|NCT01075984|26608721|FG002|Follow-up Phase|Adverse Event|0|||
13335296|NCT01075984|26608722|FG003|Follow-up Phase|Adverse Event|2|||
13335297|NCT01075984|26608723|FG004|Follow-up Phase|Adverse Event|27|||
13335298|NCT01075984|26608719|FG000|Follow-up Phase|Administrative|0|||
13335299|NCT01075984|26608720|FG001|Follow-up Phase|Administrative|0|||
13335300|NCT01075984|26608721|FG002|Follow-up Phase|Administrative|0|||
13335301|NCT01075984|26608722|FG003|Follow-up Phase|Administrative|0|||
13335302|NCT01075984|26608723|FG004|Follow-up Phase|Administrative|1|||
13335303|NCT01075984|26608719|FG000|Follow-up Phase|Withdrawal by Subject|0|||
13335304|NCT01075984|26608720|FG001|Follow-up Phase|Withdrawal by Subject|0|||
13335305|NCT01075984|26608721|FG002|Follow-up Phase|Withdrawal by Subject|0|||
13335306|NCT01075984|26608722|FG003|Follow-up Phase|Withdrawal by Subject|0|||
13335307|NCT01075984|26608723|FG004|Follow-up Phase|Withdrawal by Subject|10|||
13335308|NCT01075984|26608719|FG000|Follow-up Phase|Progression of disease|0|||
13335309|NCT01075984|26608720|FG001|Follow-up Phase|Progression of disease|0|||
13335310|NCT01075984|26608721|FG002|Follow-up Phase|Progression of disease|0|||
13335311|NCT01075984|26608722|FG003|Follow-up Phase|Progression of disease|0|||
13335312|NCT01075984|26608723|FG004|Follow-up Phase|Progression of disease|2|||
13335313|NCT01075984|26608719|FG000|Follow-up Phase|Treatment failure|0|||
13335314|NCT01075984|26608720|FG001|Follow-up Phase|Treatment failure|0|||
13335315|NCT01075984|26608721|FG002|Follow-up Phase|Treatment failure|0|||
13335316|NCT01075984|26608722|FG003|Follow-up Phase|Treatment failure|0|||
13335317|NCT01075984|26608723|FG004|Follow-up Phase|Treatment failure|4|||
13335318|NCT01075958|26608739|FG000|Overall Study|Blood sample could not be obtained|44|||
13335319|NCT01075815|26608782|FG000|Overall Study|Withdrawal before r-hCG administration|6|||
13335320|NCT01075815|26608783|FG001|Overall Study|Withdrawal before r-hCG administration|1|||
13335321|NCT01075815|26608782|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
13335322|NCT01075815|26608783|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
13335323|NCT01075815|26608782|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3|||
13335324|NCT01075815|26608783|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
13335325|NCT01075763|26608812|FG000|Overall Study|Lost to Follow-up|2|||
13335326|NCT01075763|26608813|FG001|Overall Study|Lost to Follow-up|1|||
13335327|NCT01075763|26608812|FG000|Overall Study|Lack of Efficacy|0|||
13335328|NCT01075763|26608813|FG001|Overall Study|Lack of Efficacy|1|||
13335329|NCT01075763|26608812|FG000|Overall Study|Withdrawal by Subject|2|||
13335330|NCT01075763|26608813|FG001|Overall Study|Withdrawal by Subject|2|||
13335331|NCT01075685|26608832|FG000|Overall Study|Protocol Violation|9|||
13335332|NCT01075685|26608833|FG001|Overall Study|Protocol Violation|1|||
13335333|NCT01075685|26608832|FG000|Overall Study|Withdrawal by Subject|20|||
13335334|NCT01075685|26608833|FG001|Overall Study|Withdrawal by Subject|5|||
13335335|NCT01075685|26608832|FG000|Overall Study|Lost to Follow-up|563|||
13335336|NCT01075685|26608833|FG001|Overall Study|Lost to Follow-up|220|||
13335337|NCT01075646|26608876|FG000|Overall Study|Lost to Follow-up|4|||
13335338|NCT01075646|26608877|FG001|Overall Study|Lost to Follow-up|3|||
13335339|NCT01075646|26608878|FG002|Overall Study|Lost to Follow-up|1|||
13335340|NCT01075646|26608879|FG003|Overall Study|Lost to Follow-up|2|||
13335341|NCT01075516|26608896|FG000|Overall Study|Death|5|||
13335342|NCT01075516|26608897|FG001|Overall Study|Death|9|||
13335343|NCT01075516|26608896|FG000|Overall Study|Lost to Follow-up|10|||
13335344|NCT01075516|26608897|FG001|Overall Study|Lost to Follow-up|2|||
13335345|NCT01075516|26608896|FG000|Overall Study|Withdrawal by Subject|3|||
13335346|NCT01075516|26608897|FG001|Overall Study|Withdrawal by Subject|5|||
13335347|NCT01075412|26608914|FG000|Overall Study|Withdrawal by Subject|0|||
13335348|NCT01075412|26608915|FG001|Overall Study|Withdrawal by Subject|1|||
13335349|NCT01075321|26608935|FG000|Overall Study|Withdrawal by Subject|0|||
13335350|NCT01075321|26608936|FG001|Overall Study|Withdrawal by Subject|0|||
13335351|NCT01075321|26608937|FG002|Overall Study|Withdrawal by Subject|1|||
13335352|NCT01075321|26608938|FG003|Overall Study|Withdrawal by Subject|1|||
13335353|NCT01075321|26608935|FG000|Overall Study|Protocol Violation|0|||
13335354|NCT01075321|26608936|FG001|Overall Study|Protocol Violation|0|||
13335355|NCT01075321|26608937|FG002|Overall Study|Protocol Violation|1|||
13335356|NCT01075321|26608938|FG003|Overall Study|Protocol Violation|0|||
13335357|NCT01075321|26608935|FG000|Overall Study|Treatment Incomplete due to progression|1|||
13335358|NCT01075321|26608936|FG001|Overall Study|Treatment Incomplete due to progression|0|||
13335359|NCT01075321|26608937|FG002|Overall Study|Treatment Incomplete due to progression|0|||
13335360|NCT01075321|26608938|FG003|Overall Study|Treatment Incomplete due to progression|0|||
13335361|NCT01075321|26608935|FG000|Overall Study|Ineligible (miscalculated lab value)|0|||
13335362|NCT01075321|26608936|FG001|Overall Study|Ineligible (miscalculated lab value)|0|||
13335363|NCT01075321|26608937|FG002|Overall Study|Ineligible (miscalculated lab value)|0|||
13335364|NCT01075321|26608938|FG003|Overall Study|Ineligible (miscalculated lab value)|1|||
13335365|NCT01075282|26609028|FG000|Overall Study|Withdrawal by Subject|11|||
13335366|NCT01075282|26609029|FG001|Overall Study|Withdrawal by Subject|7|||
13335367|NCT01075282|26609030|FG002|Overall Study|Withdrawal by Subject|11|||
13335368|NCT01075282|26609028|FG000|Overall Study|Adverse Event|9|||
13335369|NCT01075282|26609029|FG001|Overall Study|Adverse Event|8|||
13335370|NCT01075282|26609030|FG002|Overall Study|Adverse Event|5|||
13335371|NCT01075282|26609028|FG000|Overall Study|Entry Criteria Not Met|3|||
13335372|NCT01075282|26609029|FG001|Overall Study|Entry Criteria Not Met|2|||
13335373|NCT01075282|26609030|FG002|Overall Study|Entry Criteria Not Met|0|||
13335374|NCT01075282|26609028|FG000|Overall Study|Lost to Follow-up|3|||
13335375|NCT01075282|26609029|FG001|Overall Study|Lost to Follow-up|3|||
13335376|NCT01075282|26609030|FG002|Overall Study|Lost to Follow-up|3|||
13335377|NCT01075282|26609028|FG000|Overall Study|Physician Decision|3|||
13335378|NCT01075282|26609029|FG001|Overall Study|Physician Decision|3|||
13335379|NCT01075282|26609030|FG002|Overall Study|Physician Decision|3|||
13335380|NCT01075282|26609028|FG000|Overall Study|Lack of Efficacy|1|||
13335381|NCT01075282|26609029|FG001|Overall Study|Lack of Efficacy|1|||
13335382|NCT01075282|26609030|FG002|Overall Study|Lack of Efficacy|0|||
13335383|NCT01075282|26609028|FG000|Overall Study|Treatment Non-compliance|1|||
13335384|NCT01075282|26609029|FG001|Overall Study|Treatment Non-compliance|2|||
13335385|NCT01075282|26609030|FG002|Overall Study|Treatment Non-compliance|2|||
13335386|NCT01075282|26609028|FG000|Overall Study|Protocol Violation|0|||
13335387|NCT01075282|26609029|FG001|Overall Study|Protocol Violation|2|||
13335388|NCT01075282|26609030|FG002|Overall Study|Protocol Violation|1|||
13335389|NCT01075282|26609028|FG000|Overall Study|Death|0|||
13335390|NCT01075282|26609029|FG001|Overall Study|Death|1|||
13335391|NCT01075282|26609030|FG002|Overall Study|Death|2|||
13335392|NCT01075256|26609069|FG000|Overall Study|Withdrawal by Subject|1|||
13335393|NCT01075256|26609070|FG001|Overall Study|Withdrawal by Subject|0|||
13335394|NCT01075256|26609071|FG002|Overall Study|Withdrawal by Subject|0|||
13335395|NCT01075243|26609131|FG000|Overall Study|Lost to Follow-up|5|||
13335396|NCT01075243|26609132|FG001|Overall Study|Lost to Follow-up|2|||
13335397|NCT01075243|26609133|FG002|Overall Study|Lost to Follow-up|0|||
13335398|NCT01075243|26609131|FG000|Overall Study|Withdrawal by Subject|1|||
13335399|NCT01075243|26609132|FG001|Overall Study|Withdrawal by Subject|1|||
13335400|NCT01075243|26609133|FG002|Overall Study|Withdrawal by Subject|0|||
13335401|NCT01075217|26609156|FG000|Overall Study|Adverse Event|1|||
13335402|NCT01075217|26609157|FG001|Overall Study|Adverse Event|1|||
13335403|NCT01075217|26609156|FG000|Overall Study|Physician Decision|1|||
13335404|NCT01075217|26609157|FG001|Overall Study|Physician Decision|0|||
13335405|NCT01075191|26609168|FG000|Overall Study|Death|1|||
13335406|NCT01075191|26609168|FG000|Overall Study|Intensification|3|||
13335407|NCT01075191|26609168|FG000|Overall Study|Co-morbidities|1|||
13335408|NCT01075191|26609168|FG000|Overall Study|Adverse Event|4|||
13335409|NCT01075191|26609168|FG000|Overall Study|Noncompliance|3|||
13335410|NCT01075191|26609168|FG000|Overall Study|Therapy Break|3|||
13335411|NCT01075191|26609168|FG000|Overall Study|Patient's Wish|2|||
13335412|NCT01075191|26609168|FG000|Overall Study|Unknown Reasons|1|||
13335413|NCT01075178|26609187|FG000|Subject Matching|eligible but not matched|130|||
13335414|NCT01075178|26609188|FG001|Subject Matching|eligible but not matched|403|||
13335415|NCT01075178|26609187|FG000|Subject Chart Review|died before chart review period|0|||
13335416|NCT01075178|26609188|FG001|Subject Chart Review|died before chart review period|2|||
13335417|NCT01075178|26609187|FG000|Subject Chart Review|no data collected due to site closure|3|||
13335418|NCT01075178|26609188|FG001|Subject Chart Review|no data collected due to site closure|4|||
13335419|NCT01075178|26609187|FG000|Subject Chart Review|matched partner excluded (reasons above)|6|||
13335420|NCT01075178|26609188|FG001|Subject Chart Review|matched partner excluded (reasons above)|3|||
13335421|NCT01075152|26609219|FG000|Overall Study|Withdrawal by Subject|1|||
13335422|NCT01075152|26609220|FG001|Overall Study|Withdrawal by Subject|0|||
13335423|NCT01075100|26609243|FG000|Overall Study|Adverse Event|15|||
13335424|NCT01075100|26609244|FG001|Overall Study|Adverse Event|18|||
13335425|NCT01075100|26609243|FG000|Overall Study|Patient Request|4|||
13335426|NCT01075100|26609244|FG001|Overall Study|Patient Request|4|||
13335427|NCT01075100|26609243|FG000|Overall Study|Investigator Request|2|||
13335428|NCT01075100|26609244|FG001|Overall Study|Investigator Request|1|||
13335429|NCT01075100|26609243|FG000|Overall Study|Disease Progression|25|||
13335430|NCT01075100|26609244|FG001|Overall Study|Disease Progression|29|||
13335431|NCT01075100|26609243|FG000|Overall Study|Other|3|||
13335432|NCT01075100|26609244|FG001|Overall Study|Other|1|||
13335433|NCT01075074|26609271|FG000|Overall Study|Surgeon changed to open incisional case|1|||
13335434|NCT01075074|26609272|FG001|Overall Study|Surgeon changed to open incisional case|2|||
13335435|NCT01075074|26609273|FG002|Overall Study|Surgeon changed to open incisional case|2|||
13335436|NCT01075048|26609306|FG000|Overall Study|Death|4|||
13335437|NCT01075048|26609307|FG001|Overall Study|Death|17|||
13335438|NCT01075048|26609308|FG002|Overall Study|Death|12|||
13335439|NCT01075048|26609306|FG000|Overall Study|Start of other or new therapy|4|||
13335440|NCT01075048|26609307|FG001|Overall Study|Start of other or new therapy|36|||
13335441|NCT01075048|26609308|FG002|Overall Study|Start of other or new therapy|46|||
13335442|NCT01075048|26609306|FG000|Overall Study|Withdrawal by Subject|1|||
13335443|NCT01075048|26609307|FG001|Overall Study|Withdrawal by Subject|6|||
13335444|NCT01075048|26609308|FG002|Overall Study|Withdrawal by Subject|3|||
13335445|NCT01075048|26609306|FG000|Overall Study|Lost to Follow-up|0|||
13335446|NCT01075048|26609307|FG001|Overall Study|Lost to Follow-up|1|||
13335447|NCT01075048|26609308|FG002|Overall Study|Lost to Follow-up|1|||
13335448|NCT01074944|26609368|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2|||
13335449|NCT01074944|26609369|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
13335450|NCT01074944|26609370|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
13335451|NCT01074944|26609371|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
13335452|NCT01074944|26609372|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
13335453|NCT01074944|26609368|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1|||
13335454|NCT01074944|26609369|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
13335455|NCT01074944|26609370|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
13335456|NCT01074944|26609371|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
13335457|NCT01074944|26609372|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
13335458|NCT01074944|26609368|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4|||
13335459|NCT01074944|26609369|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
13335460|NCT01074944|26609370|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
13335461|NCT01074944|26609371|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
13335462|NCT01074944|26609372|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
13335463|NCT01074944|26609368|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6|||
13335464|NCT01074944|26609369|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
13335465|NCT01074944|26609370|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
13335466|NCT01074944|26609371|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
13335467|NCT01074944|26609372|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
13335468|NCT01074944|26609368|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
13335469|NCT01074944|26609369|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2|||
13335470|NCT01074944|26609370|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3|||
13335471|NCT01074944|26609371|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
13335472|NCT01074944|26609372|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
13335473|NCT01074944|26609368|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
13335474|NCT01074944|26609369|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6|||
13335475|NCT01074944|26609370|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1|||
13335476|NCT01074944|26609371|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
13335477|NCT01074944|26609372|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
13335478|NCT01074944|26609368|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
13335479|NCT01074944|26609369|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
13335480|NCT01074944|26609370|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
13335481|NCT01074944|26609371|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
13335482|NCT01074944|26609372|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
13335483|NCT01074944|26609368|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
13335484|NCT01074944|26609369|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1|||
13335485|NCT01074944|26609370|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
13335486|NCT01074944|26609371|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
13335487|NCT01074944|26609372|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
13335488|NCT01074944|26609368|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
13335489|NCT01074944|26609369|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
13335490|NCT01074944|26609370|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
13335491|NCT01074944|26609371|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
13335492|NCT01074944|26609372|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
13335493|NCT01074944|26609368|FG000|Long Term Treatment|Adverse Event|0|||
13335494|NCT01074944|26609369|FG001|Long Term Treatment|Adverse Event|0|||
13335495|NCT01074944|26609370|FG002|Long Term Treatment|Adverse Event|0|||
13335496|NCT01074944|26609371|FG003|Long Term Treatment|Adverse Event|3|||
13335497|NCT01074944|26609372|FG004|Long Term Treatment|Adverse Event|0|||
13335498|NCT01074944|26609368|FG000|Long Term Treatment|Lost to Follow-up|0|||
13335499|NCT01074944|26609369|FG001|Long Term Treatment|Lost to Follow-up|0|||
13335500|NCT01074944|26609370|FG002|Long Term Treatment|Lost to Follow-up|0|||
13335501|NCT01074944|26609371|FG003|Long Term Treatment|Lost to Follow-up|2|||
13335502|NCT01074944|26609372|FG004|Long Term Treatment|Lost to Follow-up|0|||
13335503|NCT01074944|26609368|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
13335504|NCT01074944|26609369|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
13335505|NCT01074944|26609370|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
13335506|NCT01074944|26609371|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18|||
13335507|NCT01074944|26609372|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
13335508|NCT01074944|26609368|FG000|Long Term Treatment|Entered in Period, But Not Treated|0|||
13335509|NCT01074944|26609369|FG001|Long Term Treatment|Entered in Period, But Not Treated|0|||
13335510|NCT01074944|26609370|FG002|Long Term Treatment|Entered in Period, But Not Treated|0|||
13335511|NCT01074944|26609371|FG003|Long Term Treatment|Entered in Period, But Not Treated|1|||
13335512|NCT01074944|26609372|FG004|Long Term Treatment|Entered in Period, But Not Treated|0|||
13335513|NCT01074944|26609368|FG000|Long Term Treatment|Withdrawal by Subject|0|||
13335514|NCT01074944|26609369|FG001|Long Term Treatment|Withdrawal by Subject|0|||
13335515|NCT01074944|26609370|FG002|Long Term Treatment|Withdrawal by Subject|0|||
13335516|NCT01074944|26609371|FG003|Long Term Treatment|Withdrawal by Subject|2|||
13335517|NCT01074944|26609372|FG004|Long Term Treatment|Withdrawal by Subject|0|||
13335518|NCT01074944|26609368|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0|||
13335519|NCT01074944|26609369|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0|||
13335520|NCT01074944|26609370|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0|||
13335521|NCT01074944|26609371|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0|||
13335522|NCT01074944|26609372|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2|||
13335523|NCT01074944|26609368|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
13335524|NCT01074944|26609369|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
13335525|NCT01074944|26609370|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
13335526|NCT01074944|26609371|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
13335527|NCT01074944|26609372|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3|||
13335528|NCT01074931|26609386|FG000|Overall Study|Economic reasons|1|||
13335529|NCT01074931|26609386|FG000|Overall Study|Death|5|||
13335530|NCT01074658|26609394|FG000|Overall Study|No implant attempted|19|||
13335531|NCT01074554|26609411|FG000|Overall Study|Adverse Event|3|||
13335532|NCT01074554|26609412|FG001|Overall Study|Adverse Event|3|||
13335533|NCT01074554|26609411|FG000|Overall Study|Lost to Follow-up|0|||
13335534|NCT01074554|26609412|FG001|Overall Study|Lost to Follow-up|1|||
13335535|NCT01074502|26609423|FG000|Overall Study|Withdrawal by Subject|1|||
13335536|NCT01074450|26609440|FG000|First Intervention|Emesis in Dosing Interval|0|||
13335537|NCT01074450|26609441|FG001|First Intervention|Emesis in Dosing Interval|2|||
13335538|NCT01074450|26609440|FG000|Second Intervention|Protocol Violation|1|||
13335539|NCT01074450|26609441|FG001|Second Intervention|Protocol Violation|0|||
13335540|NCT01074450|26609440|FG000|Second Intervention|Physician Decision|0|||
13335541|NCT01074450|26609441|FG001|Second Intervention|Physician Decision|1|||
13335542|NCT01074307|26609468|FG000|Overall Study|No primary endpoint evaluation|14|||
13335543|NCT01074307|26609469|FG001|Overall Study|No primary endpoint evaluation|6|||
13335544|NCT01074307|26609468|FG000|Overall Study|Exclusion criterion|0|||
13335545|NCT01074307|26609469|FG001|Overall Study|Exclusion criterion|1|||
13335546|NCT01074307|26609468|FG000|Overall Study|Protocol Violation|8|||
13335547|NCT01074307|26609469|FG001|Overall Study|Protocol Violation|5|||
13335548|NCT01074268|26609502|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3|||
13335549|NCT01074268|26609503|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1|||
13335550|NCT01074268|26609502|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0|||
13335551|NCT01074268|26609503|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2|||
13335552|NCT01074268|26609502|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3|||
13335553|NCT01074268|26609503|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4|||
13335554|NCT01074268|26609502|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6|||
13335555|NCT01074268|26609503|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3|||
13335556|NCT01074268|26609502|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8|||
13335557|NCT01074268|26609503|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5|||
13335558|NCT01074268|26609502|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
13335559|NCT01074268|26609503|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
13335560|NCT01074268|26609502|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0|||
13335561|NCT01074268|26609503|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2|||
13335562|NCT01074268|26609502|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
13335563|NCT01074268|26609503|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
13335564|NCT01074268|26609502|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3|||
13335565|NCT01074268|26609503|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2|||
13335566|NCT01074255|26609509|FG000|Overall Study|Did not receive EMEND|2|||
13335567|NCT01074242|26609516|FG000|Overall Study|Case report before date of contract|40|||
13335568|NCT01074242|26609516|FG000|Overall Study|Lost to Follow-up|1|||
13335569|NCT01074242|26609516|FG000|Overall Study|Case report unclear|6|||
13335570|NCT01074242|26609516|FG000|Overall Study|Violation of vaccine dose or dosage|351|||
13335571|NCT01074242|26609516|FG000|Overall Study|Duplicate Case Report Form|5|||
13335572|NCT01074229|26609537|FG000|Overall Study|Lost to Follow-up|1|||
13335573|NCT01074229|26609538|FG001|Overall Study|Lost to Follow-up|0|||
13335574|NCT01074229|26609539|FG002|Overall Study|Lost to Follow-up|0|||
13335575|NCT01074229|26609537|FG000|Overall Study|Change to open surgical procedure|1|||
13335576|NCT01074229|26609538|FG001|Overall Study|Change to open surgical procedure|3|||
13335577|NCT01074229|26609539|FG002|Overall Study|Change to open surgical procedure|4|||
13335578|NCT01074216|26609545|FG000|Overall Study|Physician Decision|1|||
13335579|NCT01074216|26609545|FG000|Overall Study|Not Treated|12|||
13335580|NCT01074190|26609578|FG000|Overall Study|Emergency Cesarean Delivery|1|||
13335581|NCT01074190|26609579|FG001|Overall Study|Emergency Cesarean Delivery|2|||
13335582|NCT01074190|26609580|FG002|Overall Study|Emergency Cesarean Delivery|1|||
13335583|NCT01074190|26609578|FG000|Overall Study|Protocol Violation|2|||
13335584|NCT01074190|26609579|FG001|Overall Study|Protocol Violation|1|||
13335585|NCT01074190|26609580|FG002|Overall Study|Protocol Violation|0|||
13335586|NCT01074190|26609578|FG000|Overall Study|Delivered in under 90 minutes|0|||
13335587|NCT01074190|26609579|FG001|Overall Study|Delivered in under 90 minutes|2|||
13335588|NCT01074190|26609580|FG002|Overall Study|Delivered in under 90 minutes|1|||
13335589|NCT01074190|26609578|FG000|Overall Study|Subject withdrew consent|1|||
13335590|NCT01074190|26609579|FG001|Overall Study|Subject withdrew consent|1|||
13335591|NCT01074190|26609580|FG002|Overall Study|Subject withdrew consent|1|||
13335592|NCT01074047|26609661|FG000|Treatment Phase|Adverse Event|89|||
13335593|NCT01074047|26609662|FG001|Treatment Phase|Adverse Event|66|||
13335594|NCT01074047|26609661|FG000|Treatment Phase|Disease Progression|16|||
13335595|NCT01074047|26609662|FG001|Treatment Phase|Disease Progression|21|||
13335596|NCT01074047|26609661|FG000|Treatment Phase|Withdrawal by Subject|27|||
13335597|NCT01074047|26609662|FG001|Treatment Phase|Withdrawal by Subject|48|||
13335598|NCT01074047|26609661|FG000|Treatment Phase|Death|53|||
13335599|NCT01074047|26609662|FG001|Treatment Phase|Death|58|||
13335600|NCT01074047|26609661|FG000|Treatment Phase|Lost to Follow-up|0|||
13335601|NCT01074047|26609662|FG001|Treatment Phase|Lost to Follow-up|1|||
13335602|NCT01074047|26609661|FG000|Treatment Phase|Protocol Violation|0|||
13335603|NCT01074047|26609662|FG001|Treatment Phase|Protocol Violation|1|||
13335604|NCT01074047|26609661|FG000|Treatment Phase|Miscellaneous|32|||
13335605|NCT01074047|26609662|FG001|Treatment Phase|Miscellaneous|39|||
13335606|NCT01074047|26609661|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5|||
13335607|NCT01074047|26609662|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8|||
13335608|NCT01074047|26609661|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
13335609|NCT01074047|26609662|FG001|Survival Follow-Up Phase|Lost to Follow-up|1|||
13335610|NCT01074047|26609661|FG000|Survival Follow-Up Phase|Death|116|||
13335611|NCT01074047|26609662|FG001|Survival Follow-Up Phase|Death|124|||
13335612|NCT01074047|26609661|FG000|Survival Follow-Up Phase|Alive at study closure|1|||
13335613|NCT01074047|26609662|FG001|Survival Follow-Up Phase|Alive at study closure|3|||
13335614|NCT01074047|26609661|FG000|Extension Phase|Physician Decision|1|||
13335615|NCT01074047|26609662|FG001|Extension Phase|Physician Decision|0|||
13335616|NCT01074047|26609661|FG000|Extension Phase|Adverse Event|5|||
13335617|NCT01074047|26609662|FG001|Extension Phase|Adverse Event|0|||
13335618|NCT01074047|26609661|FG000|Extension Phase|Disease Progression|9|||
13335619|NCT01074047|26609662|FG001|Extension Phase|Disease Progression|0|||
13335620|NCT01074047|26609661|FG000|Extension Phase|Withdrawal by Subject|2|||
13335621|NCT01074047|26609662|FG001|Extension Phase|Withdrawal by Subject|0|||
13335622|NCT01074047|26609661|FG000|Extension Phase|Death|5|||
13335623|NCT01074047|26609662|FG001|Extension Phase|Death|0|||
13335624|NCT01074008|26609798|FG000|Overall Study|Adverse Event|0|||
13335625|NCT01074008|26609799|FG001|Overall Study|Adverse Event|1|||
13335626|NCT01074008|26609800|FG002|Overall Study|Adverse Event|0|||
13335627|NCT01074008|26609801|FG003|Overall Study|Adverse Event|0|||
13335628|NCT01074008|26609802|FG004|Overall Study|Adverse Event|0|||
13335629|NCT01074008|26609803|FG005|Overall Study|Adverse Event|0|||
13335630|NCT01074008|26609804|FG006|Overall Study|Adverse Event|0|||
13335631|NCT01074008|26609805|FG007|Overall Study|Adverse Event|0|||
13335632|NCT01074008|26609806|FG008|Overall Study|Adverse Event|0|||
13335633|NCT01074008|26609798|FG000|Overall Study|Withdrawal by Subject|1|||
13335634|NCT01074008|26609799|FG001|Overall Study|Withdrawal by Subject|1|||
13335635|NCT01074008|26609800|FG002|Overall Study|Withdrawal by Subject|1|||
13335636|NCT01074008|26609801|FG003|Overall Study|Withdrawal by Subject|0|||
13335637|NCT01074008|26609802|FG004|Overall Study|Withdrawal by Subject|1|||
13335638|NCT01074008|26609803|FG005|Overall Study|Withdrawal by Subject|0|||
13335639|NCT01074008|26609804|FG006|Overall Study|Withdrawal by Subject|0|||
13335640|NCT01074008|26609805|FG007|Overall Study|Withdrawal by Subject|0|||
13335641|NCT01074008|26609806|FG008|Overall Study|Withdrawal by Subject|0|||
13335642|NCT01074008|26609798|FG000|Overall Study|Lost to Follow-up|0|||
13335643|NCT01074008|26609799|FG001|Overall Study|Lost to Follow-up|1|||
13335644|NCT01074008|26609800|FG002|Overall Study|Lost to Follow-up|1|||
13335645|NCT01074008|26609801|FG003|Overall Study|Lost to Follow-up|1|||
13335646|NCT01074008|26609802|FG004|Overall Study|Lost to Follow-up|1|||
13335647|NCT01074008|26609803|FG005|Overall Study|Lost to Follow-up|0|||
13335648|NCT01074008|26609804|FG006|Overall Study|Lost to Follow-up|1|||
13335649|NCT01074008|26609805|FG007|Overall Study|Lost to Follow-up|0|||
13335650|NCT01074008|26609806|FG008|Overall Study|Lost to Follow-up|4|||
13335651|NCT01073943|26609837|FG000|Overall Study|Withdrawal by Subject|8|||
13335652|NCT01073943|26609838|FG001|Overall Study|Withdrawal by Subject|2|||
13335653|NCT01073943|26609837|FG000|Overall Study|Protocol Violation|2|||
13335654|NCT01073943|26609838|FG001|Overall Study|Protocol Violation|1|||
13335655|NCT01073943|26609837|FG000|Overall Study|Adverse Event|1|||
13335656|NCT01073943|26609838|FG001|Overall Study|Adverse Event|1|||
13335657|NCT01073943|26609837|FG000|Overall Study|Lost to Follow-up|0|||
13335658|NCT01073943|26609838|FG001|Overall Study|Lost to Follow-up|2|||
13335659|NCT01073943|26609837|FG000|Overall Study|Power outage; colonoscopy not done|1|||
13335660|NCT01073943|26609838|FG001|Overall Study|Power outage; colonoscopy not done|0|||
13335661|NCT01073943|26609837|FG000|Overall Study|Subject forgot|0|||
13335662|NCT01073943|26609838|FG001|Overall Study|Subject forgot|1|||
13335663|NCT01073943|26609837|FG000|Overall Study|Unable to return for follow-up|0|||
13335664|NCT01073943|26609838|FG001|Overall Study|Unable to return for follow-up|1|||
13335665|NCT01073943|26609837|FG000|Overall Study|Could not tolerate prep|1|||
13335666|NCT01073943|26609838|FG001|Overall Study|Could not tolerate prep|0|||
13335667|NCT01073930|26609867|FG000|Overall Study|Withdrawal by Subject|3|||
13335668|NCT01073930|26609868|FG001|Overall Study|Withdrawal by Subject|2|||
13335669|NCT01073930|26609867|FG000|Overall Study|Lost to Follow-up|0|||
13335670|NCT01073930|26609868|FG001|Overall Study|Lost to Follow-up|1|||
13335671|NCT01073930|26609867|FG000|Overall Study|Adverse Event|0|||
13335672|NCT01073930|26609868|FG001|Overall Study|Adverse Event|1|||
13335673|NCT01073930|26609867|FG000|Overall Study|Noncompliance with study drug|0|||
13335674|NCT01073930|26609868|FG001|Overall Study|Noncompliance with study drug|1|||
13335675|NCT01073930|26609867|FG000|Overall Study|Inadequate prep; unable to do procedure|0|||
13335676|NCT01073930|26609868|FG001|Overall Study|Inadequate prep; unable to do procedure|1|||
13335677|NCT01073865|26609885|FG000|Overall Study|Reasons other than below|19|||
13335678|NCT01073865|26609886|FG001|Overall Study|Reasons other than below|31|||
13335679|NCT01073865|26609885|FG000|Overall Study|Lost to Follow-up|1|||
13335680|NCT01073865|26609886|FG001|Overall Study|Lost to Follow-up|1|||
13335681|NCT01073865|26609885|FG000|Overall Study|Death|3|||
13335682|NCT01073865|26609886|FG001|Overall Study|Death|2|||
13335683|NCT01073865|26609885|FG000|Overall Study|Withdrawal by Subject|5|||
13335684|NCT01073865|26609886|FG001|Overall Study|Withdrawal by Subject|5|||
13335685|NCT01073631|26609893|FG000|Overall Study|Death|82|||
13335686|NCT01073631|26609893|FG000|Overall Study|Adverse Event|24|||
13335687|NCT01073631|26609893|FG000|Overall Study|Other|63|||
13335688|NCT01073618|26609900|FG000|Overall Study|Death|208|||
13335689|NCT01073618|26609900|FG000|Overall Study|Adverse Event|19|||
13335690|NCT01073618|26609900|FG000|Overall Study|Other|80|||
13335691|NCT01073605|26609954|FG000|Overall Study|Ongoing at Cutoff Date|1|||
13335692|NCT01073605|26609955|FG001|Overall Study|Ongoing at Cutoff Date|1|||
13335693|NCT01073605|26609956|FG002|Overall Study|Ongoing at Cutoff Date|0|||
13335694|NCT01073605|26609954|FG000|Overall Study|Adverse Event|2|||
13335695|NCT01073605|26609955|FG001|Overall Study|Adverse Event|1|||
13335696|NCT01073605|26609956|FG002|Overall Study|Adverse Event|0|||
13335697|NCT01073605|26609954|FG000|Overall Study|Lost to Follow-up|3|||
13335698|NCT01073605|26609955|FG001|Overall Study|Lost to Follow-up|4|||
13335699|NCT01073605|26609956|FG002|Overall Study|Lost to Follow-up|9|||
13335700|NCT01073605|26609954|FG000|Overall Study|Other|25|||
13335701|NCT01073605|26609955|FG001|Overall Study|Other|21|||
13335702|NCT01073605|26609956|FG002|Overall Study|Other|29|||
13335703|NCT01073605|26609954|FG000|Overall Study|Withdrawal by Subject|31|||
13335704|NCT01073605|26609955|FG001|Overall Study|Withdrawal by Subject|39|||
13335705|NCT01073605|26609956|FG002|Overall Study|Withdrawal by Subject|22|||
13335706|NCT01073605|26609954|FG000|Overall Study|Randomized But Not Treated|0|||
13335707|NCT01073605|26609955|FG001|Overall Study|Randomized But Not Treated|1|||
13335708|NCT01073605|26609956|FG002|Overall Study|Randomized But Not Treated|1|||
13335709|NCT01073566|26609975|FG000|Period 2 (6 Weeks)|Adverse Event|1|||
13335710|NCT01073566|26609976|FG001|Period 2 (6 Weeks)|Adverse Event|0|||
13335711|NCT01073462|26609989|FG000|Overall Study|Death|14|||
13335712|NCT01073462|26609989|FG000|Overall Study|Kidney transplant|10|||
13335713|NCT01073462|26609989|FG000|Overall Study|Low parathyroid hormone levels|8|||
13335714|NCT01073462|26609989|FG000|Overall Study|Serious adverse event|2|||
13335715|NCT01073462|26609989|FG000|Overall Study|Lost to Follow-up|7|||
13335716|NCT01073293|26610018|FG000|Overall Study|Lost to Follow-up|0|||
13335717|NCT01073293|26610019|FG001|Overall Study|Lost to Follow-up|1|||
13335718|NCT01073293|26610018|FG000|Overall Study|Withdrawal by Subject|5|||
13335719|NCT01073293|26610019|FG001|Overall Study|Withdrawal by Subject|10|||
13335720|NCT01073267|26610025|FG000|Overall Study|Disease Progression|3|||
13335721|NCT01073163|26610047|FG000|Overall Study|Adverse Event|1|||
13335722|NCT01073163|26610047|FG000|Overall Study|Disease Progression|1|||
13335723|NCT01073163|26610047|FG000|Overall Study|Early termination|1|||
13335724|NCT01073020|26610082|FG000|Overall Study|Withdrawal by Subject|6|||
13335725|NCT01073020|26610083|FG001|Overall Study|Withdrawal by Subject|4|||
13335726|NCT01073020|26610084|FG002|Overall Study|Withdrawal by Subject|1|||
13335727|NCT01073020|26610085|FG003|Overall Study|Withdrawal by Subject|2|||
13335728|NCT01073020|26610082|FG000|Overall Study|Physician Decision|1|||
13335729|NCT01073020|26610083|FG001|Overall Study|Physician Decision|0|||
13335730|NCT01073020|26610084|FG002|Overall Study|Physician Decision|2|||
13335731|NCT01073020|26610085|FG003|Overall Study|Physician Decision|0|||
13335732|NCT01073020|26610082|FG000|Overall Study|Death|0|||
13335733|NCT01073020|26610083|FG001|Overall Study|Death|1|||
13335734|NCT01073020|26610084|FG002|Overall Study|Death|0|||
13335735|NCT01073020|26610085|FG003|Overall Study|Death|0|||
13335736|NCT01072929|26610169|FG000|Overall Study|Adverse Event|8|||
13335737|NCT01072929|26610170|FG001|Overall Study|Adverse Event|11|||
13335738|NCT01072929|26610171|FG002|Overall Study|Adverse Event|2|||
13335739|NCT01072929|26610169|FG000|Overall Study|Lack of Efficacy|7|||
13335740|NCT01072929|26610170|FG001|Overall Study|Lack of Efficacy|4|||
13335741|NCT01072929|26610171|FG002|Overall Study|Lack of Efficacy|0|||
13335742|NCT01072929|26610169|FG000|Overall Study|Withdrawal by Subject|7|||
13335743|NCT01072929|26610170|FG001|Overall Study|Withdrawal by Subject|15|||
13335744|NCT01072929|26610171|FG002|Overall Study|Withdrawal by Subject|3|||
13335745|NCT01072929|26610169|FG000|Overall Study|Protocol Violation|13|||
13335746|NCT01072929|26610170|FG001|Overall Study|Protocol Violation|11|||
13335747|NCT01072929|26610171|FG002|Overall Study|Protocol Violation|2|||
13335748|NCT01072929|26610169|FG000|Overall Study|Lost to Follow-up|8|||
13335749|NCT01072929|26610170|FG001|Overall Study|Lost to Follow-up|4|||
13335750|NCT01072929|26610171|FG002|Overall Study|Lost to Follow-up|1|||
13335751|NCT01072929|26610169|FG000|Overall Study|Noncompliance with study medication|0|||
13335752|NCT01072929|26610170|FG001|Overall Study|Noncompliance with study medication|3|||
13335753|NCT01072929|26610171|FG002|Overall Study|Noncompliance with study medication|0|||
13335754|NCT01072929|26610169|FG000|Overall Study|Noncompliance with study procedures|1|||
13335755|NCT01072929|26610170|FG001|Overall Study|Noncompliance with study procedures|0|||
13335756|NCT01072929|26610171|FG002|Overall Study|Noncompliance with study procedures|1|||
13335757|NCT01072929|26610169|FG000|Overall Study|Other|0|||
13335758|NCT01072929|26610170|FG001|Overall Study|Other|3|||
13335759|NCT01072929|26610171|FG002|Overall Study|Other|0|||
13335760|NCT01072877|26610209|FG000|Overall Study|Lost to Follow-up|1|||
13335761|NCT01072877|26610210|FG001|Overall Study|Lost to Follow-up|1|||
13335762|NCT01072877|26610211|FG002|Overall Study|Lost to Follow-up|0|||
13335763|NCT01072877|26610212|FG003|Overall Study|Lost to Follow-up|2|||
13335764|NCT01072877|26610213|FG004|Overall Study|Lost to Follow-up|0|||
13335765|NCT01072630|26610297|FG000|Overall Study|Adverse Event|11|||
13335766|NCT01072630|26610298|FG001|Overall Study|Adverse Event|19|||
13335767|NCT01072630|26610299|FG002|Overall Study|Adverse Event|2|||
13335768|NCT01072630|26610297|FG000|Overall Study|Lack of Efficacy|10|||
13335769|NCT01072630|26610298|FG001|Overall Study|Lack of Efficacy|10|||
13335770|NCT01072630|26610299|FG002|Overall Study|Lack of Efficacy|1|||
13335771|NCT01072630|26610297|FG000|Overall Study|Withdrawal by Subject|8|||
13335772|NCT01072630|26610298|FG001|Overall Study|Withdrawal by Subject|7|||
13335773|NCT01072630|26610299|FG002|Overall Study|Withdrawal by Subject|2|||
13335774|NCT01072630|26610297|FG000|Overall Study|Protocol Violation|10|||
13335775|NCT01072630|26610298|FG001|Overall Study|Protocol Violation|8|||
13393539|NCT00663260|26784030|FG001|Overall Study|Lack of Efficacy|0|||
13335776|NCT01072630|26610299|FG002|Overall Study|Protocol Violation|4|||
13335777|NCT01072630|26610297|FG000|Overall Study|Lost to Follow-up|11|||
13335778|NCT01072630|26610298|FG001|Overall Study|Lost to Follow-up|11|||
13335779|NCT01072630|26610299|FG002|Overall Study|Lost to Follow-up|1|||
13335780|NCT01072630|26610297|FG000|Overall Study|Noncompliance with study medication|1|||
13335781|NCT01072630|26610298|FG001|Overall Study|Noncompliance with study medication|1|||
13335782|NCT01072630|26610299|FG002|Overall Study|Noncompliance with study medication|1|||
13335783|NCT01072630|26610297|FG000|Overall Study|Noncompliance with study procedures|1|||
13335784|NCT01072630|26610298|FG001|Overall Study|Noncompliance with study procedures|2|||
13335785|NCT01072630|26610299|FG002|Overall Study|Noncompliance with study procedures|1|||
13335786|NCT01072630|26610297|FG000|Overall Study|Other|3|||
13335787|NCT01072630|26610298|FG001|Overall Study|Other|2|||
13335788|NCT01072630|26610299|FG002|Overall Study|Other|1|||
13335789|NCT01072539|26610309|FG000|Overall Study|Treated prior to the Site Initiation|1|||
13335790|NCT01072539|26610309|FG000|Overall Study|Protocol Violation|2|||
13335791|NCT01072500|26610324|FG000|Overall Study|Death|2|||
13335792|NCT01072500|26610325|FG001|Overall Study|Death|2|||
13335793|NCT01072500|26610324|FG000|Overall Study|Lost to Follow-up|5|||
13335794|NCT01072500|26610325|FG001|Overall Study|Lost to Follow-up|2|||
13335795|NCT01072500|26610324|FG000|Overall Study|Withdrawal by Subject|17|||
13335796|NCT01072500|26610325|FG001|Overall Study|Withdrawal by Subject|10|||
13335797|NCT01072448|26610340|FG000|Overall Study|Adverse Event|9|||
13335798|NCT01072448|26610341|FG001|Overall Study|Adverse Event|10|||
13335799|NCT01072448|26610340|FG000|Overall Study|Subject withdrew consent|4|||
13335800|NCT01072448|26610341|FG001|Overall Study|Subject withdrew consent|9|||
13335801|NCT01072448|26610340|FG000|Overall Study|Protocol deviation|3|||
13335802|NCT01072448|26610341|FG001|Overall Study|Protocol deviation|4|||
13335803|NCT01072448|26610340|FG000|Overall Study|Abnormal test procedure result(s)|1|||
13335804|NCT01072448|26610341|FG001|Overall Study|Abnormal test procedure result(s)|0|||
13335805|NCT01072448|26610340|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
13335806|NCT01072448|26610341|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
13335807|NCT01072448|26610340|FG000|Overall Study|Lost to Follow-up|1|||
13335808|NCT01072448|26610341|FG001|Overall Study|Lost to Follow-up|1|||
13335809|NCT01072448|26610340|FG000|Overall Study|Abnormal laboratory value(s)|0|||
13335810|NCT01072448|26610341|FG001|Overall Study|Abnormal laboratory value(s)|1|||
13335811|NCT01072448|26610340|FG000|Overall Study|Death|0|||
13335812|NCT01072448|26610341|FG001|Overall Study|Death|2|||
13335813|NCT01072396|26610358|FG000|Period One|Adverse Event|1|||
13335814|NCT01072396|26610359|FG001|Period One|Adverse Event|1|||
13335815|NCT01072396|26610358|FG000|Period One|Protocol Violation|2|||
13335816|NCT01072396|26610359|FG001|Period One|Protocol Violation|1|||
13335817|NCT01072396|26610358|FG000|Period One|Withdrawal by Subject|2|||
13335818|NCT01072396|26610359|FG001|Period One|Withdrawal by Subject|0|||
13335819|NCT01072396|26610358|FG000|Washout Period|Missing termination information|0|||
13335820|NCT01072396|26610359|FG001|Washout Period|Missing termination information|1|||
13335821|NCT01072396|26610358|FG000|Period Two|Adverse Event|0|||
13335822|NCT01072396|26610359|FG001|Period Two|Adverse Event|3|||
13335823|NCT01072396|26610358|FG000|Period Two|Lost to Follow-up|1|||
13335824|NCT01072396|26610359|FG001|Period Two|Lost to Follow-up|0|||
13335825|NCT01072357|26610374|FG000|Overall Study|Lost to Follow-up|0|||
13335826|NCT01072357|26610375|FG001|Overall Study|Lost to Follow-up|1|||
13335827|NCT01072344|26610396|FG000|Overall Study|Relasped-reached end point|7|||
13335828|NCT01072344|26610397|FG001|Overall Study|Relasped-reached end point|12|||
13335829|NCT01072344|26610396|FG000|Overall Study|Protocol Violation|1|||
13335830|NCT01072344|26610397|FG001|Overall Study|Protocol Violation|2|||
13335831|NCT01072344|26610396|FG000|Overall Study|Lost to Follow-up|3|||
13335832|NCT01072344|26610397|FG001|Overall Study|Lost to Follow-up|4|||
13335833|NCT01072201|26610414|FG000|Overall Study|Lost to Follow-up|0|||
13335834|NCT01072201|26610415|FG001|Overall Study|Lost to Follow-up|1|||
13335835|NCT01072175|26610662|FG000|Part A (Drug-Drug Interaction)|Death|1|||
13335836|NCT01072175|26610663|FG001|Part A (Drug-Drug Interaction)|Death|0|||
13335837|NCT01072175|26610664|FG002|Part A (Drug-Drug Interaction)|Death|0|||
13335838|NCT01072175|26610665|FG003|Part A (Drug-Drug Interaction)|Death|0|||
13335839|NCT01072175|26610666|FG004|Part A (Drug-Drug Interaction)|Death|0|||
13335840|NCT01072175|26610667|FG005|Part A (Drug-Drug Interaction)|Death|0|||
13335841|NCT01072175|26610668|FG006|Part A (Drug-Drug Interaction)|Death|0|||
13335842|NCT01072175|26610669|FG007|Part A (Drug-Drug Interaction)|Death|0|||
13335843|NCT01072175|26610670|FG008|Part A (Drug-Drug Interaction)|Death|0|||
13335844|NCT01072175|26610671|FG009|Part A (Drug-Drug Interaction)|Death|0|||
13335845|NCT01072175|26610672|FG010|Part A (Drug-Drug Interaction)|Death|0|||
13335846|NCT01072175|26610673|FG011|Part A (Drug-Drug Interaction)|Death|0|||
13335847|NCT01072175|26610674|FG012|Part A (Drug-Drug Interaction)|Death|0|||
13335848|NCT01072175|26610662|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6|||
13335849|NCT01072175|26610663|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0|||
13335850|NCT01072175|26610664|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0|||
13335851|NCT01072175|26610665|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0|||
13335852|NCT01072175|26610666|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0|||
13335853|NCT01072175|26610667|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0|||
13335854|NCT01072175|26610668|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0|||
13335855|NCT01072175|26610669|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0|||
13393540|NCT00663260|26784031|FG002|Overall Study|Lack of Efficacy|0|||
13335856|NCT01072175|26610670|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0|||
13335857|NCT01072175|26610671|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0|||
13335858|NCT01072175|26610672|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0|||
13335859|NCT01072175|26610673|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0|||
13335860|NCT01072175|26610674|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0|||
13335861|NCT01072175|26610662|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1|||
13335862|NCT01072175|26610663|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
13335863|NCT01072175|26610664|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
13335864|NCT01072175|26610665|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
13335865|NCT01072175|26610666|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
13335866|NCT01072175|26610667|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
13335867|NCT01072175|26610668|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
13335868|NCT01072175|26610669|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
13335869|NCT01072175|26610670|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
13335870|NCT01072175|26610671|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
13335871|NCT01072175|26610672|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
13335872|NCT01072175|26610673|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
13335873|NCT01072175|26610674|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
13335874|NCT01072175|26610662|FG000|Part B (Dose Escalation and Expansion)|Death|0|||
13335875|NCT01072175|26610663|FG001|Part B (Dose Escalation and Expansion)|Death|4|||
13335876|NCT01072175|26610664|FG002|Part B (Dose Escalation and Expansion)|Death|18|||
13335877|NCT01072175|26610665|FG003|Part B (Dose Escalation and Expansion)|Death|21|||
13335878|NCT01072175|26610666|FG004|Part B (Dose Escalation and Expansion)|Death|68|||
13335879|NCT01072175|26610667|FG005|Part B (Dose Escalation and Expansion)|Death|0|||
13335880|NCT01072175|26610668|FG006|Part B (Dose Escalation and Expansion)|Death|0|||
13335881|NCT01072175|26610669|FG007|Part B (Dose Escalation and Expansion)|Death|0|||
13335882|NCT01072175|26610670|FG008|Part B (Dose Escalation and Expansion)|Death|0|||
13335883|NCT01072175|26610671|FG009|Part B (Dose Escalation and Expansion)|Death|0|||
13335884|NCT01072175|26610672|FG010|Part B (Dose Escalation and Expansion)|Death|0|||
13335885|NCT01072175|26610673|FG011|Part B (Dose Escalation and Expansion)|Death|0|||
13335886|NCT01072175|26610674|FG012|Part B (Dose Escalation and Expansion)|Death|0|||
13335887|NCT01072175|26610662|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
13335888|NCT01072175|26610663|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
13335889|NCT01072175|26610664|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2|||
13335890|NCT01072175|26610665|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
13335891|NCT01072175|26610666|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4|||
13335892|NCT01072175|26610667|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
13335893|NCT01072175|26610668|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
13335894|NCT01072175|26610669|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
13335895|NCT01072175|26610670|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
13335896|NCT01072175|26610671|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
13335897|NCT01072175|26610672|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
13335898|NCT01072175|26610673|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
13335899|NCT01072175|26610674|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
13335900|NCT01072175|26610662|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
13335901|NCT01072175|26610663|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
13335902|NCT01072175|26610664|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
13335903|NCT01072175|26610665|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
13335904|NCT01072175|26610666|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6|||
13335905|NCT01072175|26610667|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
13335906|NCT01072175|26610668|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
13335907|NCT01072175|26610669|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
13335908|NCT01072175|26610670|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
13335909|NCT01072175|26610671|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
13335910|NCT01072175|26610672|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
13335911|NCT01072175|26610673|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
13335912|NCT01072175|26610674|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
13335913|NCT01072175|26610662|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
13335914|NCT01072175|26610663|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
13335915|NCT01072175|26610664|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3|||
13335916|NCT01072175|26610665|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2|||
13335917|NCT01072175|26610666|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10|||
13335918|NCT01072175|26610667|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
13335919|NCT01072175|26610668|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
13335920|NCT01072175|26610669|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
13335921|NCT01072175|26610670|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
13335922|NCT01072175|26610671|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
13335923|NCT01072175|26610672|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
13335924|NCT01072175|26610673|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
13335925|NCT01072175|26610674|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
13335926|NCT01072175|26610662|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
13335927|NCT01072175|26610663|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1|||
13335928|NCT01072175|26610664|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
13335929|NCT01072175|26610665|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3|||
13335930|NCT01072175|26610666|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6|||
13335931|NCT01072175|26610667|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
13335932|NCT01072175|26610668|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
13335933|NCT01072175|26610669|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
13335934|NCT01072175|26610670|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
13335935|NCT01072175|26610671|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
13335936|NCT01072175|26610672|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
13335937|NCT01072175|26610673|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
13335938|NCT01072175|26610674|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
13335939|NCT01072175|26610662|FG000|Part C (Phase II: Randomized Phase)|Death|0|||
13335940|NCT01072175|26610663|FG001|Part C (Phase II: Randomized Phase)|Death|0|||
13335941|NCT01072175|26610664|FG002|Part C (Phase II: Randomized Phase)|Death|0|||
13335942|NCT01072175|26610665|FG003|Part C (Phase II: Randomized Phase)|Death|0|||
13335943|NCT01072175|26610666|FG004|Part C (Phase II: Randomized Phase)|Death|0|||
13335944|NCT01072175|26610667|FG005|Part C (Phase II: Randomized Phase)|Death|44|||
13335945|NCT01072175|26610668|FG006|Part C (Phase II: Randomized Phase)|Death|34|||
13335946|NCT01072175|26610669|FG007|Part C (Phase II: Randomized Phase)|Death|39|||
13335947|NCT01072175|26610670|FG008|Part C (Phase II: Randomized Phase)|Death|0|||
13335948|NCT01072175|26610671|FG009|Part C (Phase II: Randomized Phase)|Death|0|||
13335949|NCT01072175|26610672|FG010|Part C (Phase II: Randomized Phase)|Death|0|||
13335950|NCT01072175|26610673|FG011|Part C (Phase II: Randomized Phase)|Death|0|||
13335951|NCT01072175|26610674|FG012|Part C (Phase II: Randomized Phase)|Death|0|||
13335952|NCT01072175|26610662|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
13335953|NCT01072175|26610663|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
13335954|NCT01072175|26610664|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
13335955|NCT01072175|26610665|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
13335956|NCT01072175|26610666|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
13335957|NCT01072175|26610667|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
13335958|NCT01072175|26610668|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
13335959|NCT01072175|26610669|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
13335960|NCT01072175|26610670|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
13335961|NCT01072175|26610671|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
13335962|NCT01072175|26610672|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
13335963|NCT01072175|26610673|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
13335964|NCT01072175|26610674|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
13335965|NCT01072175|26610662|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
13335966|NCT01072175|26610663|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
13335967|NCT01072175|26610664|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
13335968|NCT01072175|26610665|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
13335969|NCT01072175|26610666|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
13335970|NCT01072175|26610667|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
13335971|NCT01072175|26610668|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
13335972|NCT01072175|26610669|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
13335973|NCT01072175|26610670|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
13335974|NCT01072175|26610671|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
13335975|NCT01072175|26610672|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
13335976|NCT01072175|26610673|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
13335977|NCT01072175|26610674|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
13335978|NCT01072175|26610662|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
13335979|NCT01072175|26610663|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
13335980|NCT01072175|26610664|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
13335981|NCT01072175|26610665|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
13335982|NCT01072175|26610666|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
13335983|NCT01072175|26610667|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6|||
13335984|NCT01072175|26610668|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9|||
13335985|NCT01072175|26610669|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11|||
13335986|NCT01072175|26610670|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
13335987|NCT01072175|26610671|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
13335988|NCT01072175|26610672|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
13335989|NCT01072175|26610673|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
13335990|NCT01072175|26610674|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
13335991|NCT01072175|26610662|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
13335992|NCT01072175|26610663|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
13335993|NCT01072175|26610664|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
13335994|NCT01072175|26610665|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
13335995|NCT01072175|26610666|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
13335996|NCT01072175|26610667|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3|||
13335997|NCT01072175|26610668|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7|||
13335998|NCT01072175|26610669|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
13335999|NCT01072175|26610670|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
13336000|NCT01072175|26610671|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
13336001|NCT01072175|26610672|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
13336002|NCT01072175|26610673|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
13336003|NCT01072175|26610674|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
13336004|NCT01072175|26610662|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0|||
13336005|NCT01072175|26610663|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0|||
13336006|NCT01072175|26610664|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0|||
13336007|NCT01072175|26610665|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0|||
13336008|NCT01072175|26610666|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0|||
13336009|NCT01072175|26610667|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0|||
13336010|NCT01072175|26610668|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0|||
13336011|NCT01072175|26610669|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0|||
13336012|NCT01072175|26610670|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37|||
13336013|NCT01072175|26610671|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0|||
13336014|NCT01072175|26610672|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0|||
13336015|NCT01072175|26610673|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0|||
13336016|NCT01072175|26610674|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0|||
13336017|NCT01072175|26610662|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
13336018|NCT01072175|26610663|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
13336019|NCT01072175|26610664|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
13336020|NCT01072175|26610665|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
13336021|NCT01072175|26610666|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
13336022|NCT01072175|26610667|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
13336023|NCT01072175|26610668|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
13336024|NCT01072175|26610669|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
13336025|NCT01072175|26610670|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1|||
13336026|NCT01072175|26610671|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
13336027|NCT01072175|26610672|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
13336028|NCT01072175|26610673|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
13336029|NCT01072175|26610674|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
13336030|NCT01072175|26610662|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
13336031|NCT01072175|26610663|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
13336032|NCT01072175|26610664|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
13336033|NCT01072175|26610665|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
13336034|NCT01072175|26610666|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
13336035|NCT01072175|26610667|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
13336036|NCT01072175|26610668|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
13336037|NCT01072175|26610669|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
13336038|NCT01072175|26610670|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4|||
13336039|NCT01072175|26610671|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
13336040|NCT01072175|26610672|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
13336041|NCT01072175|26610673|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
13336042|NCT01072175|26610674|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
13336043|NCT01072175|26610662|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
13336044|NCT01072175|26610663|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
13336045|NCT01072175|26610664|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
13336046|NCT01072175|26610665|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
13336047|NCT01072175|26610666|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
13336048|NCT01072175|26610667|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
13336049|NCT01072175|26610668|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
13336050|NCT01072175|26610669|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
13336051|NCT01072175|26610670|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3|||
13336052|NCT01072175|26610671|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
13336053|NCT01072175|26610672|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
13336054|NCT01072175|26610673|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
13336055|NCT01072175|26610674|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
13336056|NCT01072175|26610662|FG000|Part D (HPMC Capsules)|Death|0|||
13336057|NCT01072175|26610663|FG001|Part D (HPMC Capsules)|Death|0|||
13336058|NCT01072175|26610664|FG002|Part D (HPMC Capsules)|Death|0|||
13336059|NCT01072175|26610665|FG003|Part D (HPMC Capsules)|Death|0|||
13336060|NCT01072175|26610666|FG004|Part D (HPMC Capsules)|Death|0|||
13336061|NCT01072175|26610667|FG005|Part D (HPMC Capsules)|Death|0|||
13336062|NCT01072175|26610668|FG006|Part D (HPMC Capsules)|Death|0|||
13336063|NCT01072175|26610669|FG007|Part D (HPMC Capsules)|Death|0|||
13336064|NCT01072175|26610670|FG008|Part D (HPMC Capsules)|Death|0|||
13336065|NCT01072175|26610671|FG009|Part D (HPMC Capsules)|Death|10|||
13336066|NCT01072175|26610672|FG010|Part D (HPMC Capsules)|Death|12|||
13336067|NCT01072175|26610673|FG011|Part D (HPMC Capsules)|Death|28|||
13336068|NCT01072175|26610674|FG012|Part D (HPMC Capsules)|Death|26|||
13336069|NCT01072175|26610662|FG000|Part D (HPMC Capsules)|Physician Decision|0|||
13336070|NCT01072175|26610663|FG001|Part D (HPMC Capsules)|Physician Decision|0|||
13336071|NCT01072175|26610664|FG002|Part D (HPMC Capsules)|Physician Decision|0|||
13336072|NCT01072175|26610665|FG003|Part D (HPMC Capsules)|Physician Decision|0|||
13336073|NCT01072175|26610666|FG004|Part D (HPMC Capsules)|Physician Decision|0|||
13336074|NCT01072175|26610667|FG005|Part D (HPMC Capsules)|Physician Decision|0|||
13336075|NCT01072175|26610668|FG006|Part D (HPMC Capsules)|Physician Decision|0|||
13336076|NCT01072175|26610669|FG007|Part D (HPMC Capsules)|Physician Decision|0|||
13336077|NCT01072175|26610670|FG008|Part D (HPMC Capsules)|Physician Decision|0|||
13336078|NCT01072175|26610671|FG009|Part D (HPMC Capsules)|Physician Decision|0|||
13336079|NCT01072175|26610672|FG010|Part D (HPMC Capsules)|Physician Decision|1|||
13336080|NCT01072175|26610673|FG011|Part D (HPMC Capsules)|Physician Decision|1|||
13336081|NCT01072175|26610674|FG012|Part D (HPMC Capsules)|Physician Decision|1|||
13336082|NCT01072175|26610662|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0|||
13336083|NCT01072175|26610663|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0|||
13336084|NCT01072175|26610664|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0|||
13336085|NCT01072175|26610665|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0|||
13336086|NCT01072175|26610666|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0|||
13336087|NCT01072175|26610667|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0|||
13336088|NCT01072175|26610668|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0|||
13336089|NCT01072175|26610669|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0|||
13336090|NCT01072175|26610670|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0|||
13336091|NCT01072175|26610671|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0|||
13336092|NCT01072175|26610672|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1|||
13336093|NCT01072175|26610673|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1|||
13336094|NCT01072175|26610674|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3|||
13336095|NCT01072175|26610662|FG000|Part D (HPMC Capsules)|Study closed/terminated|0|||
13336096|NCT01072175|26610663|FG001|Part D (HPMC Capsules)|Study closed/terminated|0|||
13336097|NCT01072175|26610664|FG002|Part D (HPMC Capsules)|Study closed/terminated|0|||
13336098|NCT01072175|26610665|FG003|Part D (HPMC Capsules)|Study closed/terminated|0|||
13336099|NCT01072175|26610666|FG004|Part D (HPMC Capsules)|Study closed/terminated|0|||
13336100|NCT01072175|26610667|FG005|Part D (HPMC Capsules)|Study closed/terminated|0|||
13336101|NCT01072175|26610668|FG006|Part D (HPMC Capsules)|Study closed/terminated|0|||
13336102|NCT01072175|26610669|FG007|Part D (HPMC Capsules)|Study closed/terminated|0|||
13336103|NCT01072175|26610670|FG008|Part D (HPMC Capsules)|Study closed/terminated|0|||
13336104|NCT01072175|26610671|FG009|Part D (HPMC Capsules)|Study closed/terminated|2|||
13336105|NCT01072175|26610672|FG010|Part D (HPMC Capsules)|Study closed/terminated|1|||
13336106|NCT01072175|26610673|FG011|Part D (HPMC Capsules)|Study closed/terminated|10|||
13336107|NCT01072175|26610674|FG012|Part D (HPMC Capsules)|Study closed/terminated|9|||
13336108|NCT01072175|26610662|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
13336109|NCT01072175|26610663|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
13336110|NCT01072175|26610664|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
13336111|NCT01072175|26610665|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
13336112|NCT01072175|26610666|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
13336113|NCT01072175|26610667|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
13336114|NCT01072175|26610668|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
13336115|NCT01072175|26610669|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
13336116|NCT01072175|26610670|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
13336117|NCT01072175|26610671|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
13336118|NCT01072175|26610672|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1|||
13336119|NCT01072175|26610673|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3|||
13336120|NCT01072175|26610674|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
13336121|NCT01072149|26610711|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
13336122|NCT01072149|26610712|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
13336123|NCT01072149|26610713|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
13336124|NCT01072149|26610714|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
13336125|NCT01072149|26610715|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
13336126|NCT01072149|26610716|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
13336127|NCT01072149|26610717|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
13336128|NCT01072149|26610718|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
13336129|NCT01072149|26610719|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
13336130|NCT01072149|26610720|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
13336131|NCT01072149|26610721|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
13336132|NCT01072149|26610722|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
13336133|NCT01072149|26610723|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
13336134|NCT01072149|26610724|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
13336135|NCT01072149|26610725|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
13336136|NCT01072149|26610726|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
13336137|NCT01072149|26610727|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
13336138|NCT01072149|26610728|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
13336139|NCT01072149|26610711|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0|||
13336140|NCT01072149|26610712|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0|||
13336141|NCT01072149|26610713|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0|||
13336142|NCT01072149|26610714|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0|||
13336143|NCT01072149|26610715|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0|||
13336144|NCT01072149|26610716|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0|||
13336145|NCT01072149|26610717|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0|||
13336146|NCT01072149|26610718|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0|||
13336147|NCT01072149|26610719|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0|||
13336148|NCT01072149|26610720|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0|||
13336149|NCT01072149|26610721|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0|||
13336150|NCT01072149|26610722|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0|||
13336151|NCT01072149|26610723|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0|||
13336152|NCT01072149|26610724|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0|||
13336153|NCT01072149|26610725|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0|||
13336154|NCT01072149|26610726|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0|||
13336155|NCT01072149|26610727|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0|||
13336156|NCT01072149|26610728|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1|||
13336157|NCT01072149|26610711|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
13336158|NCT01072149|26610712|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
13336159|NCT01072149|26610713|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
13336160|NCT01072149|26610714|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
13336161|NCT01072149|26610715|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
13336162|NCT01072149|26610716|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
13336163|NCT01072149|26610717|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
13336164|NCT01072149|26610718|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
13336165|NCT01072149|26610719|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
13336166|NCT01072149|26610720|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
13336167|NCT01072149|26610721|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
13336168|NCT01072149|26610722|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
13336169|NCT01072149|26610723|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
13336170|NCT01072149|26610724|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
13336171|NCT01072149|26610725|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
13336172|NCT01072149|26610726|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
13336173|NCT01072149|26610727|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
13336174|NCT01072149|26610728|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
13336175|NCT01072149|26610711|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
13336176|NCT01072149|26610712|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1|||
13336177|NCT01072149|26610713|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
13336178|NCT01072149|26610714|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
13336179|NCT01072149|26610715|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
13336180|NCT01072149|26610716|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
13336181|NCT01072149|26610717|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
13336182|NCT01072149|26610718|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
13336183|NCT01072149|26610719|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
13336184|NCT01072149|26610720|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
13336185|NCT01072149|26610721|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
13336186|NCT01072149|26610722|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
13336187|NCT01072149|26610723|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
13336188|NCT01072149|26610724|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
13336189|NCT01072149|26610725|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
13336190|NCT01072149|26610726|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
13336191|NCT01072149|26610727|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
13336192|NCT01072149|26610728|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
13336193|NCT01072149|26610711|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
13336194|NCT01072149|26610712|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
13336195|NCT01072149|26610713|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
13336196|NCT01072149|26610714|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
13336197|NCT01072149|26610715|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
13336198|NCT01072149|26610716|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
13336199|NCT01072149|26610717|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
13336200|NCT01072149|26610718|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
13336201|NCT01072149|26610719|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
13336202|NCT01072149|26610720|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
13336203|NCT01072149|26610721|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
13336204|NCT01072149|26610722|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
13336205|NCT01072149|26610723|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
13336206|NCT01072149|26610724|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
13336207|NCT01072149|26610725|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
13336208|NCT01072149|26610726|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
13336209|NCT01072149|26610727|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
13336210|NCT01072149|26610728|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
13336211|NCT01072149|26610711|FG000|Treatment Period 2 (28 Days)|Physician Decision|0|||
13336212|NCT01072149|26610712|FG001|Treatment Period 2 (28 Days)|Physician Decision|0|||
13336213|NCT01072149|26610713|FG002|Treatment Period 2 (28 Days)|Physician Decision|0|||
13336214|NCT01072149|26610714|FG003|Treatment Period 2 (28 Days)|Physician Decision|0|||
13336215|NCT01072149|26610715|FG004|Treatment Period 2 (28 Days)|Physician Decision|0|||
13336216|NCT01072149|26610716|FG005|Treatment Period 2 (28 Days)|Physician Decision|0|||
13336217|NCT01072149|26610717|FG006|Treatment Period 2 (28 Days)|Physician Decision|0|||
13336218|NCT01072149|26610718|FG007|Treatment Period 2 (28 Days)|Physician Decision|1|||
13336219|NCT01072149|26610719|FG008|Treatment Period 2 (28 Days)|Physician Decision|0|||
13336220|NCT01072149|26610720|FG009|Treatment Period 2 (28 Days)|Physician Decision|0|||
13336221|NCT01072149|26610721|FG010|Treatment Period 2 (28 Days)|Physician Decision|0|||
13336222|NCT01072149|26610722|FG011|Treatment Period 2 (28 Days)|Physician Decision|0|||
13336223|NCT01072149|26610723|FG012|Treatment Period 2 (28 Days)|Physician Decision|0|||
13336224|NCT01072149|26610724|FG013|Treatment Period 2 (28 Days)|Physician Decision|0|||
13336225|NCT01072149|26610725|FG014|Treatment Period 2 (28 Days)|Physician Decision|0|||
13336226|NCT01072149|26610726|FG015|Treatment Period 2 (28 Days)|Physician Decision|0|||
13336227|NCT01072149|26610727|FG016|Treatment Period 2 (28 Days)|Physician Decision|0|||
13336228|NCT01072149|26610728|FG017|Treatment Period 2 (28 Days)|Physician Decision|0|||
13336229|NCT01072149|26610711|FG000|Washout Period 2 (14 Days)|Physician Decision|1|||
13336230|NCT01072149|26610712|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
13336231|NCT01072149|26610713|FG002|Washout Period 2 (14 Days)|Physician Decision|0|||
13336232|NCT01072149|26610714|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
13336233|NCT01072149|26610715|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
13336234|NCT01072149|26610716|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
13336235|NCT01072149|26610717|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
13336236|NCT01072149|26610718|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
13336237|NCT01072149|26610719|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
13336238|NCT01072149|26610720|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
13336239|NCT01072149|26610721|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
13336240|NCT01072149|26610722|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
13336241|NCT01072149|26610723|FG012|Washout Period 2 (14 Days)|Physician Decision|0|||
13336242|NCT01072149|26610724|FG013|Washout Period 2 (14 Days)|Physician Decision|0|||
13336243|NCT01072149|26610725|FG014|Washout Period 2 (14 Days)|Physician Decision|0|||
13336244|NCT01072149|26610726|FG015|Washout Period 2 (14 Days)|Physician Decision|0|||
13336245|NCT01072149|26610727|FG016|Washout Period 2 (14 Days)|Physician Decision|0|||
13336246|NCT01072149|26610728|FG017|Washout Period 2 (14 Days)|Physician Decision|0|||
13336247|NCT01072149|26610711|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
13336248|NCT01072149|26610712|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
13336249|NCT01072149|26610713|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
13336250|NCT01072149|26610714|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
13336251|NCT01072149|26610715|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
13336252|NCT01072149|26610716|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
13336253|NCT01072149|26610717|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
13336254|NCT01072149|26610718|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
13336255|NCT01072149|26610719|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
13336256|NCT01072149|26610720|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
13336257|NCT01072149|26610721|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
13336258|NCT01072149|26610722|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
13336259|NCT01072149|26610723|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
13336260|NCT01072149|26610724|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
13336261|NCT01072149|26610725|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
13336262|NCT01072149|26610726|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1|||
13336263|NCT01072149|26610727|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
13336264|NCT01072149|26610728|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
13336265|NCT01072149|26610711|FG000|Washout Period 2 (14 Days)|Adverse Event|0|||
13336266|NCT01072149|26610712|FG001|Washout Period 2 (14 Days)|Adverse Event|0|||
13336267|NCT01072149|26610713|FG002|Washout Period 2 (14 Days)|Adverse Event|0|||
13336268|NCT01072149|26610714|FG003|Washout Period 2 (14 Days)|Adverse Event|0|||
13336269|NCT01072149|26610715|FG004|Washout Period 2 (14 Days)|Adverse Event|0|||
13336270|NCT01072149|26610716|FG005|Washout Period 2 (14 Days)|Adverse Event|0|||
13336271|NCT01072149|26610717|FG006|Washout Period 2 (14 Days)|Adverse Event|0|||
13336272|NCT01072149|26610718|FG007|Washout Period 2 (14 Days)|Adverse Event|0|||
13336273|NCT01072149|26610719|FG008|Washout Period 2 (14 Days)|Adverse Event|0|||
13336274|NCT01072149|26610720|FG009|Washout Period 2 (14 Days)|Adverse Event|0|||
13336275|NCT01072149|26610721|FG010|Washout Period 2 (14 Days)|Adverse Event|0|||
13336276|NCT01072149|26610722|FG011|Washout Period 2 (14 Days)|Adverse Event|0|||
13336277|NCT01072149|26610723|FG012|Washout Period 2 (14 Days)|Adverse Event|0|||
13336278|NCT01072149|26610724|FG013|Washout Period 2 (14 Days)|Adverse Event|0|||
13336279|NCT01072149|26610725|FG014|Washout Period 2 (14 Days)|Adverse Event|0|||
13336280|NCT01072149|26610726|FG015|Washout Period 2 (14 Days)|Adverse Event|1|||
13336281|NCT01072149|26610727|FG016|Washout Period 2 (14 Days)|Adverse Event|0|||
13336282|NCT01072149|26610728|FG017|Washout Period 2 (14 Days)|Adverse Event|0|||
13336283|NCT01072149|26610711|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
13336284|NCT01072149|26610712|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
13336285|NCT01072149|26610713|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
13336286|NCT01072149|26610714|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
13336287|NCT01072149|26610715|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
13336288|NCT01072149|26610716|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
13336289|NCT01072149|26610717|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
13336290|NCT01072149|26610718|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
13336291|NCT01072149|26610719|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
13336292|NCT01072149|26610720|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
13336293|NCT01072149|26610721|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
13336294|NCT01072149|26610722|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
13336295|NCT01072149|26610723|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1|||
13336296|NCT01072149|26610724|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
13336297|NCT01072149|26610725|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
13336298|NCT01072149|26610726|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
13336299|NCT01072149|26610727|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
13336300|NCT01072149|26610728|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
13336301|NCT01072149|26610711|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
13336302|NCT01072149|26610712|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
13336303|NCT01072149|26610713|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
13336304|NCT01072149|26610714|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
13336305|NCT01072149|26610715|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
13336306|NCT01072149|26610716|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
13336307|NCT01072149|26610717|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
13336308|NCT01072149|26610718|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
13336309|NCT01072149|26610719|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
13336310|NCT01072149|26610720|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
13336311|NCT01072149|26610721|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
13336312|NCT01072149|26610722|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
13336313|NCT01072149|26610723|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
13336314|NCT01072149|26610724|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
13336315|NCT01072149|26610725|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
13336316|NCT01072149|26610726|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
13336317|NCT01072149|26610727|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
13336318|NCT01072149|26610728|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
13336319|NCT01071954|26610739|FG000|Overall Study|Noncompliance|4|||
13336320|NCT01071954|26610739|FG000|Overall Study|Adverse Event|1|||
13336321|NCT01071954|26610739|FG000|Overall Study|Withdrawal by Subject|11|||
13336322|NCT01071954|26610739|FG000|Overall Study|Requirement for Alternative Therapy|5|||
13336323|NCT01071954|26610739|FG000|Overall Study|Administrative Decision|5|||
13336324|NCT01071954|26610739|FG000|Overall Study|Protocol Specified Criteria|1|||
13336325|NCT01071915|26610751|FG000|Overall Study|Adverse Event|3|||
13336326|NCT01071915|26610751|FG000|Overall Study|Physician Decision|2|||
13336327|NCT01071915|26610751|FG000|Overall Study|Withdrawal by Subject|2|||
13336328|NCT01071915|26610751|FG000|Overall Study|Miscellaneous Reasons|2|||
13336329|NCT01071798|26610773|FG000|Participants Who Received One Cycle|Lack of Efficacy|18|||
13336330|NCT01071798|26610773|FG000|Participants Who Received One Cycle|Lack of tolerability|14|||
13336331|NCT01071798|26610773|FG000|Participants Who Received One Cycle|Patient requirement|20|||
13336332|NCT01071798|26610773|FG000|Participants Who Received One Cycle|Death|5|||
13336333|NCT01071798|26610773|FG000|Participants Who Received One Cycle|Change of therapy|6|||
13336334|NCT01071798|26610773|FG000|Participants Who Received One Cycle|Severe concomitant disease|2|||
13336335|NCT01071798|26610773|FG000|Subpopulation Who Received Two Cycles|Remission|1|||
13336336|NCT01071798|26610773|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3|||
13336337|NCT01071798|26610773|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4|||
13336338|NCT01071798|26610773|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7|||
13336339|NCT01071512|26610783|FG000|Overall Study|Adverse Event|1|||
13336340|NCT01071512|26610783|FG000|Overall Study|Development of antibodies to drug|2|||
13336341|NCT01071512|26610783|FG000|Overall Study|positive anti-JC virus antibody test|2|||
13336342|NCT01071317|26610802|FG000|Overall Study|Lost to Follow-up|2|||
13336343|NCT01071317|26610803|FG001|Overall Study|Lost to Follow-up|2|||
13336344|NCT01071278|26610811|FG000|Overall Study|Premature Discontinuation|254|||
13336345|NCT01071278|26610811|FG000|Overall Study|Completion Status Unknown|459|||
13336346|NCT01071252|26610853|FG000|Overall Study|unsatisfactory therapeutic effect|4|||
13336347|NCT01071252|26610854|FG001|Overall Study|unsatisfactory therapeutic effect|6|||
13336348|NCT01071252|26610855|FG002|Overall Study|unsatisfactory therapeutic effect|2|||
13336349|NCT01071252|26610856|FG003|Overall Study|unsatisfactory therapeutic effect|0|||
13336350|NCT01071252|26610857|FG004|Overall Study|unsatisfactory therapeutic effect|6|||
13336351|NCT01071252|26610853|FG000|Overall Study|Withdrawal by Subject|8|||
13336352|NCT01071252|26610854|FG001|Overall Study|Withdrawal by Subject|2|||
13336353|NCT01071252|26610855|FG002|Overall Study|Withdrawal by Subject|1|||
13336354|NCT01071252|26610856|FG003|Overall Study|Withdrawal by Subject|2|||
13336355|NCT01071252|26610857|FG004|Overall Study|Withdrawal by Subject|3|||
13336356|NCT01071252|26610853|FG000|Overall Study|administrative problems|1|||
13336357|NCT01071252|26610854|FG001|Overall Study|administrative problems|1|||
13336358|NCT01071252|26610855|FG002|Overall Study|administrative problems|0|||
13336359|NCT01071252|26610856|FG003|Overall Study|administrative problems|2|||
13336360|NCT01071252|26610857|FG004|Overall Study|administrative problems|1|||
13336361|NCT01071252|26610853|FG000|Overall Study|Lost to Follow-up|1|||
13336362|NCT01071252|26610854|FG001|Overall Study|Lost to Follow-up|0|||
13336363|NCT01071252|26610855|FG002|Overall Study|Lost to Follow-up|1|||
13336364|NCT01071252|26610856|FG003|Overall Study|Lost to Follow-up|2|||
13336365|NCT01071252|26610857|FG004|Overall Study|Lost to Follow-up|0|||
13336366|NCT01071252|26610853|FG000|Overall Study|Adverse Event|1|||
13336367|NCT01071252|26610854|FG001|Overall Study|Adverse Event|1|||
13336368|NCT01071252|26610855|FG002|Overall Study|Adverse Event|0|||
13336369|NCT01071252|26610856|FG003|Overall Study|Adverse Event|1|||
13336370|NCT01071252|26610857|FG004|Overall Study|Adverse Event|0|||
13336371|NCT01071252|26610853|FG000|Overall Study|Death|0|||
13336372|NCT01071252|26610854|FG001|Overall Study|Death|0|||
13336373|NCT01071252|26610855|FG002|Overall Study|Death|0|||
13336374|NCT01071252|26610856|FG003|Overall Study|Death|0|||
13336375|NCT01071252|26610857|FG004|Overall Study|Death|1|||
13336376|NCT01071200|26610896|FG000|Overall Study|Lack of ovarian response|1|||
13336377|NCT01071200|26610897|FG001|Overall Study|Lack of ovarian response|1|||
13336378|NCT01071200|26610896|FG000|Overall Study|No fertilization|4|||
13336379|NCT01071200|26610897|FG001|Overall Study|No fertilization|0|||
13336380|NCT01071200|26610896|FG000|Overall Study|No oocytes retrieved|1|||
13336381|NCT01071200|26610897|FG001|Overall Study|No oocytes retrieved|1|||
13336382|NCT01071200|26610896|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1|||
13336383|NCT01071200|26610897|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0|||
13336384|NCT01071200|26610896|FG000|Overall Study|No viable embryos|0|||
13336385|NCT01071200|26610897|FG001|Overall Study|No viable embryos|1|||
13336386|NCT01071096|26610919|FG000|First Intervention (90 Days)|Lost to Follow-up|1|||
13336387|NCT01071096|26610920|FG001|First Intervention (90 Days)|Lost to Follow-up|0|||
13336388|NCT01071083|26610953|FG000|Overall Study|Adverse Event|1|||
13336389|NCT01071083|26610954|FG001|Overall Study|Adverse Event|0|||
13336390|NCT01071083|26610955|FG002|Overall Study|Adverse Event|1|||
13336391|NCT01071083|26610956|FG003|Overall Study|Adverse Event|0|||
13336392|NCT01071083|26610957|FG004|Overall Study|Adverse Event|1|||
13336393|NCT01071083|26610953|FG000|Overall Study|Withdrawal by Subject|3|||
13336394|NCT01071083|26610954|FG001|Overall Study|Withdrawal by Subject|0|||
13336395|NCT01071083|26610955|FG002|Overall Study|Withdrawal by Subject|2|||
13336396|NCT01071083|26610956|FG003|Overall Study|Withdrawal by Subject|0|||
13336397|NCT01071083|26610957|FG004|Overall Study|Withdrawal by Subject|3|||
13336398|NCT01071083|26610953|FG000|Overall Study|Physician Decision|1|||
13336399|NCT01071083|26610954|FG001|Overall Study|Physician Decision|0|||
13336400|NCT01071083|26610955|FG002|Overall Study|Physician Decision|0|||
13336401|NCT01071083|26610956|FG003|Overall Study|Physician Decision|1|||
13336402|NCT01071083|26610957|FG004|Overall Study|Physician Decision|1|||
13336403|NCT01071083|26610953|FG000|Overall Study|Early Rescue|1|||
13336404|NCT01071083|26610954|FG001|Overall Study|Early Rescue|0|||
13336405|NCT01071083|26610955|FG002|Overall Study|Early Rescue|0|||
13336406|NCT01071083|26610956|FG003|Overall Study|Early Rescue|0|||
13336407|NCT01071083|26610957|FG004|Overall Study|Early Rescue|1|||
13336408|NCT01071083|26610953|FG000|Overall Study|Subject Moved|0|||
13336409|NCT01071083|26610954|FG001|Overall Study|Subject Moved|1|||
13336410|NCT01071083|26610955|FG002|Overall Study|Subject Moved|0|||
13336411|NCT01071083|26610956|FG003|Overall Study|Subject Moved|0|||
13336412|NCT01071083|26610957|FG004|Overall Study|Subject Moved|0|||
13336413|NCT01071083|26610953|FG000|Overall Study|Images Not Usable (Motion)|0|||
13336414|NCT01071083|26610954|FG001|Overall Study|Images Not Usable (Motion)|1|||
13336415|NCT01071083|26610955|FG002|Overall Study|Images Not Usable (Motion)|0|||
13336416|NCT01071083|26610956|FG003|Overall Study|Images Not Usable (Motion)|0|||
13336417|NCT01071083|26610957|FG004|Overall Study|Images Not Usable (Motion)|0|||
13336418|NCT01071083|26610953|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
13336419|NCT01071083|26610954|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
13336420|NCT01071083|26610955|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
13373878|NCT00799058|26725169|FG001|Overall Study|IP dispensing error|0|||
13336421|NCT01071083|26610956|FG003|Overall Study|Did Not Meet Eligibility Criteria|1|||
13336422|NCT01071083|26610957|FG004|Overall Study|Did Not Meet Eligibility Criteria|1|||
13336423|NCT01071083|26610953|FG000|Overall Study|Did Not Want Per Protocol Treatment|0|||
13336424|NCT01071083|26610954|FG001|Overall Study|Did Not Want Per Protocol Treatment|0|||
13336425|NCT01071083|26610955|FG002|Overall Study|Did Not Want Per Protocol Treatment|1|||
13336426|NCT01071083|26610956|FG003|Overall Study|Did Not Want Per Protocol Treatment|0|||
13336427|NCT01071083|26610957|FG004|Overall Study|Did Not Want Per Protocol Treatment|1|||
13336428|NCT01071083|26610953|FG000|Overall Study|Subject Refused to Continue|1|||
13336429|NCT01071083|26610954|FG001|Overall Study|Subject Refused to Continue|0|||
13336430|NCT01071083|26610955|FG002|Overall Study|Subject Refused to Continue|0|||
13336431|NCT01071083|26610956|FG003|Overall Study|Subject Refused to Continue|0|||
13336432|NCT01071083|26610957|FG004|Overall Study|Subject Refused to Continue|0|||
13336433|NCT01071070|26610986|FG000|Overall Study|Adverse Event|0|||
13336434|NCT01071070|26610987|FG001|Overall Study|Adverse Event|3|||
13336435|NCT01071070|26610986|FG000|Overall Study|Withdrawal by Subject|1|||
13336436|NCT01071070|26610987|FG001|Overall Study|Withdrawal by Subject|0|||
13336437|NCT01071070|26610986|FG000|Overall Study|Missed 3 consecutive doses of study drug|2|||
13336438|NCT01071070|26610987|FG001|Overall Study|Missed 3 consecutive doses of study drug|0|||
13336439|NCT01071070|26610986|FG000|Overall Study|Hypercalcemia|1|||
13336440|NCT01071070|26610987|FG001|Overall Study|Hypercalcemia|0|||
13336441|NCT01070979|26611023|FG000|Overall Study|Adverse Event|2|||
13336442|NCT01070979|26611024|FG001|Overall Study|Adverse Event|3|||
13336443|NCT01070979|26611025|FG002|Overall Study|Adverse Event|3|||
13336444|NCT01070979|26611023|FG000|Overall Study|Lost to Follow-up|2|||
13336445|NCT01070979|26611024|FG001|Overall Study|Lost to Follow-up|1|||
13336446|NCT01070979|26611025|FG002|Overall Study|Lost to Follow-up|1|||
13336447|NCT01070979|26611023|FG000|Overall Study|Protocol Violation|0|||
13336448|NCT01070979|26611024|FG001|Overall Study|Protocol Violation|2|||
13336449|NCT01070979|26611025|FG002|Overall Study|Protocol Violation|6|||
13336450|NCT01070979|26611023|FG000|Overall Study|Surgery, moving, personal, abn. labs|4|||
13336451|NCT01070979|26611024|FG001|Overall Study|Surgery, moving, personal, abn. labs|4|||
13336452|NCT01070979|26611025|FG002|Overall Study|Surgery, moving, personal, abn. labs|2|||
13336453|NCT01070979|26611023|FG000|Overall Study|Withdrawal by Subject|3|||
13336454|NCT01070979|26611024|FG001|Overall Study|Withdrawal by Subject|1|||
13336455|NCT01070979|26611025|FG002|Overall Study|Withdrawal by Subject|1|||
13336456|NCT01070979|26611023|FG000|Overall Study|No study drug taken|0|||
13336457|NCT01070979|26611024|FG001|Overall Study|No study drug taken|1|||
13336458|NCT01070979|26611025|FG002|Overall Study|No study drug taken|0|||
13336459|NCT01070966|26611038|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59|||
13336460|NCT01070966|26611038|FG000|Participants for Safety Evaluation|Off-label use|9|||
13336461|NCT01070966|26611038|FG000|Participants for Safety Evaluation|Duplicate Participants|4|||
13336462|NCT01070966|26611038|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3|||
13336463|NCT01070966|26611038|FG000|Participants for Safety Evaluation|TMT given before date of contract|3|||
13336464|NCT01070966|26611038|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61|||
13336465|NCT01070966|26611038|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19|||
13336466|NCT01070966|26611038|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2|||
13336467|NCT01070953|26611051|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612|||
13336468|NCT01070953|26611051|FG000|Participants for Safety Evaluation|Off-label use|283|||
13336469|NCT01070953|26611051|FG000|Participants for Safety Evaluation|Duplicated participants|22|||
13336470|NCT01070953|26611051|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8|||
13336471|NCT01070953|26611051|FG000|Participants for Safety Evaluation|Uncontracted participants|4|||
13336472|NCT01070953|26611051|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1|||
13336473|NCT01070953|26611051|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1|||
13336474|NCT01070953|26611051|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119|||
13336475|NCT01070953|26611051|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106|||
13336476|NCT01070953|26611051|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2|||
13336477|NCT01070888|26611064|FG000|First Intervention (14 Days)|Adverse Event|0|||
13336478|NCT01070888|26611065|FG001|First Intervention (14 Days)|Adverse Event|1|||
13336479|NCT01070888|26611064|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
13336480|NCT01070888|26611065|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
13336481|NCT01070888|26611064|FG000|Washout (14 Days)|Physician Decision|1|||
13336482|NCT01070888|26611065|FG001|Washout (14 Days)|Physician Decision|0|||
13336483|NCT01070784|26611160|FG000|Overall Study|Withdrawal by Subject|6|||
13336484|NCT01070784|26611161|FG001|Overall Study|Withdrawal by Subject|9|||
13336485|NCT01070784|26611160|FG000|Overall Study|Adverse Event|14|||
13336486|NCT01070784|26611161|FG001|Overall Study|Adverse Event|9|||
13393541|NCT00663260|26784029|FG000|Overall Study|Adverse Event|12|||
13336487|NCT01070771|26611168|FG000|Overall Study|Adverse Event|2|||
13336488|NCT01070771|26611168|FG000|Overall Study|Protocol Violation|1|||
13336489|NCT01070550|26611327|FG000|Overall Study|Adverse Event|43|||
13336490|NCT01070550|26611328|FG001|Overall Study|Adverse Event|1|||
13336491|NCT01070550|26611329|FG002|Overall Study|Adverse Event|3|||
13336492|NCT01070550|26611330|FG003|Overall Study|Adverse Event|0|||
13336493|NCT01070550|26611331|FG004|Overall Study|Adverse Event|0|||
13336494|NCT01070550|26611332|FG005|Overall Study|Adverse Event|0|||
13336495|NCT01070550|26611327|FG000|Overall Study|Death|20|||
13336496|NCT01070550|26611328|FG001|Overall Study|Death|4|||
13336497|NCT01070550|26611329|FG002|Overall Study|Death|3|||
13336498|NCT01070550|26611330|FG003|Overall Study|Death|0|||
13336499|NCT01070550|26611331|FG004|Overall Study|Death|0|||
13336500|NCT01070550|26611332|FG005|Overall Study|Death|0|||
13336501|NCT01070550|26611327|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2|||
13336502|NCT01070550|26611328|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
13336503|NCT01070550|26611329|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1|||
13336504|NCT01070550|26611330|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0|||
13336505|NCT01070550|26611331|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0|||
13336506|NCT01070550|26611332|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0|||
13336507|NCT01070550|26611327|FG000|Overall Study|Early termination|3|||
13336508|NCT01070550|26611328|FG001|Overall Study|Early termination|0|||
13336509|NCT01070550|26611329|FG002|Overall Study|Early termination|0|||
13336510|NCT01070550|26611330|FG003|Overall Study|Early termination|0|||
13336511|NCT01070550|26611331|FG004|Overall Study|Early termination|0|||
13336512|NCT01070550|26611332|FG005|Overall Study|Early termination|0|||
13336513|NCT01070550|26611327|FG000|Overall Study|Failed to return|450|||
13336514|NCT01070550|26611328|FG001|Overall Study|Failed to return|33|||
13336515|NCT01070550|26611329|FG002|Overall Study|Failed to return|144|||
13336516|NCT01070550|26611330|FG003|Overall Study|Failed to return|40|||
13336517|NCT01070550|26611331|FG004|Overall Study|Failed to return|1|||
13336518|NCT01070550|26611332|FG005|Overall Study|Failed to return|2|||
13336519|NCT01070550|26611327|FG000|Overall Study|Incomplete treatment|2|||
13336520|NCT01070550|26611328|FG001|Overall Study|Incomplete treatment|0|||
13336521|NCT01070550|26611329|FG002|Overall Study|Incomplete treatment|0|||
13336522|NCT01070550|26611330|FG003|Overall Study|Incomplete treatment|0|||
13336523|NCT01070550|26611331|FG004|Overall Study|Incomplete treatment|0|||
13336524|NCT01070550|26611332|FG005|Overall Study|Incomplete treatment|0|||
13336525|NCT01070550|26611327|FG000|Overall Study|Lab test not done|22|||
13336526|NCT01070550|26611328|FG001|Overall Study|Lab test not done|3|||
13336527|NCT01070550|26611329|FG002|Overall Study|Lab test not done|4|||
13336528|NCT01070550|26611330|FG003|Overall Study|Lab test not done|1|||
13336529|NCT01070550|26611331|FG004|Overall Study|Lab test not done|0|||
13336530|NCT01070550|26611332|FG005|Overall Study|Lab test not done|1|||
13336531|NCT01070550|26611327|FG000|Overall Study|Lack of Efficacy|65|||
13393542|NCT00663260|26784030|FG001|Overall Study|Adverse Event|7|||
13393543|NCT00663260|26784031|FG002|Overall Study|Adverse Event|6|||
13393544|NCT00663260|26784029|FG000|Overall Study|Withdrawal by Subject|3|||
13393545|NCT00663260|26784030|FG001|Overall Study|Withdrawal by Subject|1|||
13393546|NCT00663260|26784031|FG002|Overall Study|Withdrawal by Subject|6|||
13393547|NCT00663260|26784029|FG000|Overall Study|Death|1|||
13393548|NCT00663260|26784030|FG001|Overall Study|Death|0|||
13393549|NCT00663260|26784031|FG002|Overall Study|Death|1|||
13393550|NCT00663260|26784029|FG000|Overall Study|Lost to Follow-up|0|||
13393551|NCT00663260|26784030|FG001|Overall Study|Lost to Follow-up|1|||
13393552|NCT00663260|26784031|FG002|Overall Study|Lost to Follow-up|0|||
13393553|NCT00663260|26784029|FG000|Overall Study|non-compliance, not met criteria, etc.|3|||
13393554|NCT00663260|26784030|FG001|Overall Study|non-compliance, not met criteria, etc.|2|||
13393555|NCT00663260|26784031|FG002|Overall Study|non-compliance, not met criteria, etc.|3|||
13393556|NCT00663234|26784059|FG000|Overall Study|Not willing to adhere to requirements|1|||
13393557|NCT00663208|26784231|FG000|Treatment Period|Lost to Follow-up|0|||
13393558|NCT00663208|26784232|FG001|Treatment Period|Lost to Follow-up|1|||
13393559|NCT00663208|26784233|FG002|Treatment Period|Lost to Follow-up|0|||
13393560|NCT00663208|26784234|FG003|Treatment Period|Lost to Follow-up|0|||
13393561|NCT00663208|26784235|FG004|Treatment Period|Lost to Follow-up|0|||
13393562|NCT00663208|26784236|FG005|Treatment Period|Lost to Follow-up|0|||
13393563|NCT00663208|26784237|FG006|Treatment Period|Lost to Follow-up|0|||
13393564|NCT00663208|26784231|FG000|Follow-up Period|Lost to Follow-up|2|||
13393565|NCT00663208|26784232|FG001|Follow-up Period|Lost to Follow-up|0|||
13393566|NCT00663208|26784233|FG002|Follow-up Period|Lost to Follow-up|3|||
13204309|NCT01975220|26228231|FG001|Test Period 1|Not treated|1|||
13336532|NCT01070550|26611328|FG001|Overall Study|Lack of Efficacy|1|||
13336533|NCT01070550|26611329|FG002|Overall Study|Lack of Efficacy|5|||
13336534|NCT01070550|26611330|FG003|Overall Study|Lack of Efficacy|5|||
13336535|NCT01070550|26611331|FG004|Overall Study|Lack of Efficacy|0|||
13336536|NCT01070550|26611332|FG005|Overall Study|Lack of Efficacy|1|||
13336537|NCT01070550|26611327|FG000|Overall Study|Miscellaneous|12|||
13336538|NCT01070550|26611328|FG001|Overall Study|Miscellaneous|2|||
13336539|NCT01070550|26611329|FG002|Overall Study|Miscellaneous|3|||
13336540|NCT01070550|26611330|FG003|Overall Study|Miscellaneous|1|||
13336541|NCT01070550|26611331|FG004|Overall Study|Miscellaneous|0|||
13336542|NCT01070550|26611332|FG005|Overall Study|Miscellaneous|0|||
13393567|NCT00663208|26784234|FG003|Follow-up Period|Lost to Follow-up|2|||
13393568|NCT00663208|26784235|FG004|Follow-up Period|Lost to Follow-up|0|||
13393569|NCT00663208|26784236|FG005|Follow-up Period|Lost to Follow-up|0|||
13393570|NCT00663208|26784237|FG006|Follow-up Period|Lost to Follow-up|0|||
13393571|NCT00663208|26784231|FG000|Follow-up Period|Other reason|1|||
13393572|NCT00663208|26784232|FG001|Follow-up Period|Other reason|0|||
13336543|NCT01070550|26611327|FG000|Overall Study|New treatment started|3|||
13336544|NCT01070550|26611328|FG001|Overall Study|New treatment started|1|||
13336545|NCT01070550|26611329|FG002|Overall Study|New treatment started|0|||
13336546|NCT01070550|26611330|FG003|Overall Study|New treatment started|2|||
13336547|NCT01070550|26611331|FG004|Overall Study|New treatment started|0|||
13336548|NCT01070550|26611332|FG005|Overall Study|New treatment started|0|||
13336549|NCT01070550|26611327|FG000|Overall Study|Non-responders|493|||
13336550|NCT01070550|26611328|FG001|Overall Study|Non-responders|4|||
13336551|NCT01070550|26611329|FG002|Overall Study|Non-responders|21|||
13336552|NCT01070550|26611330|FG003|Overall Study|Non-responders|20|||
13336553|NCT01070550|26611331|FG004|Overall Study|Non-responders|0|||
13336554|NCT01070550|26611332|FG005|Overall Study|Non-responders|2|||
13336555|NCT01070550|26611327|FG000|Overall Study|Not categorized|33|||
13336556|NCT01070550|26611328|FG001|Overall Study|Not categorized|2|||
13336557|NCT01070550|26611329|FG002|Overall Study|Not categorized|6|||
13336558|NCT01070550|26611330|FG003|Overall Study|Not categorized|1|||
13336559|NCT01070550|26611331|FG004|Overall Study|Not categorized|0|||
13336560|NCT01070550|26611332|FG005|Overall Study|Not categorized|1|||
13336561|NCT01070550|26611327|FG000|Overall Study|Protocol Violation|15|||
13336562|NCT01070550|26611328|FG001|Overall Study|Protocol Violation|1|||
13336563|NCT01070550|26611329|FG002|Overall Study|Protocol Violation|1|||
13336564|NCT01070550|26611330|FG003|Overall Study|Protocol Violation|1|||
13336565|NCT01070550|26611331|FG004|Overall Study|Protocol Violation|0|||
13336566|NCT01070550|26611332|FG005|Overall Study|Protocol Violation|0|||
13336567|NCT01070550|26611327|FG000|Overall Study|Relapse|44|||
13336568|NCT01070550|26611328|FG001|Overall Study|Relapse|5|||
13336569|NCT01070550|26611329|FG002|Overall Study|Relapse|14|||
13336570|NCT01070550|26611330|FG003|Overall Study|Relapse|4|||
13336571|NCT01070550|26611331|FG004|Overall Study|Relapse|0|||
13336572|NCT01070550|26611332|FG005|Overall Study|Relapse|0|||
13336573|NCT01070550|26611327|FG000|Overall Study|Result not available|3|||
13336574|NCT01070550|26611328|FG001|Overall Study|Result not available|1|||
13336575|NCT01070550|26611329|FG002|Overall Study|Result not available|3|||
13336576|NCT01070550|26611330|FG003|Overall Study|Result not available|0|||
13336577|NCT01070550|26611331|FG004|Overall Study|Result not available|0|||
13336578|NCT01070550|26611332|FG005|Overall Study|Result not available|0|||
13336579|NCT01070550|26611327|FG000|Overall Study|Screen failure|1|||
13336580|NCT01070550|26611328|FG001|Overall Study|Screen failure|0|||
13336581|NCT01070550|26611329|FG002|Overall Study|Screen failure|0|||
13336582|NCT01070550|26611330|FG003|Overall Study|Screen failure|0|||
13336583|NCT01070550|26611331|FG004|Overall Study|Screen failure|0|||
13336584|NCT01070550|26611332|FG005|Overall Study|Screen failure|0|||
13336585|NCT01070550|26611327|FG000|Overall Study|Sponsor decision|1|||
13336586|NCT01070550|26611328|FG001|Overall Study|Sponsor decision|0|||
13336587|NCT01070550|26611329|FG002|Overall Study|Sponsor decision|0|||
13336588|NCT01070550|26611330|FG003|Overall Study|Sponsor decision|0|||
13336589|NCT01070550|26611331|FG004|Overall Study|Sponsor decision|0|||
13336590|NCT01070550|26611332|FG005|Overall Study|Sponsor decision|0|||
13336591|NCT01070550|26611327|FG000|Overall Study|Treatment duration shortened|1|||
13336592|NCT01070550|26611328|FG001|Overall Study|Treatment duration shortened|0|||
13336593|NCT01070550|26611329|FG002|Overall Study|Treatment duration shortened|0|||
13336594|NCT01070550|26611330|FG003|Overall Study|Treatment duration shortened|0|||
13336595|NCT01070550|26611331|FG004|Overall Study|Treatment duration shortened|0|||
13336596|NCT01070550|26611332|FG005|Overall Study|Treatment duration shortened|0|||
13336597|NCT01070550|26611327|FG000|Overall Study|Treatment interrupted|7|||
13336598|NCT01070550|26611328|FG001|Overall Study|Treatment interrupted|0|||
13336599|NCT01070550|26611329|FG002|Overall Study|Treatment interrupted|1|||
13336600|NCT01070550|26611330|FG003|Overall Study|Treatment interrupted|1|||
13336601|NCT01070550|26611331|FG004|Overall Study|Treatment interrupted|0|||
13336602|NCT01070550|26611332|FG005|Overall Study|Treatment interrupted|0|||
13336603|NCT01070550|26611327|FG000|Overall Study|Treatment not started|14|||
13336604|NCT01070550|26611328|FG001|Overall Study|Treatment not started|2|||
13336605|NCT01070550|26611329|FG002|Overall Study|Treatment not started|4|||
13336606|NCT01070550|26611330|FG003|Overall Study|Treatment not started|0|||
13336607|NCT01070550|26611331|FG004|Overall Study|Treatment not started|0|||
13336608|NCT01070550|26611332|FG005|Overall Study|Treatment not started|0|||
13336609|NCT01070550|26611327|FG000|Overall Study|Treatment restarted|0|||
13336610|NCT01070550|26611328|FG001|Overall Study|Treatment restarted|1|||
13336611|NCT01070550|26611329|FG002|Overall Study|Treatment restarted|0|||
13336612|NCT01070550|26611330|FG003|Overall Study|Treatment restarted|0|||
13336613|NCT01070550|26611331|FG004|Overall Study|Treatment restarted|0|||
13336614|NCT01070550|26611332|FG005|Overall Study|Treatment restarted|0|||
13336615|NCT01070550|26611327|FG000|Overall Study|Treatment stopped|3|||
13336616|NCT01070550|26611328|FG001|Overall Study|Treatment stopped|0|||
13336617|NCT01070550|26611329|FG002|Overall Study|Treatment stopped|0|||
13336618|NCT01070550|26611330|FG003|Overall Study|Treatment stopped|0|||
13336619|NCT01070550|26611331|FG004|Overall Study|Treatment stopped|0|||
13336620|NCT01070550|26611332|FG005|Overall Study|Treatment stopped|0|||
13336621|NCT01070550|26611327|FG000|Overall Study|Treatment unavailable|1|||
13336622|NCT01070550|26611328|FG001|Overall Study|Treatment unavailable|0|||
13336623|NCT01070550|26611329|FG002|Overall Study|Treatment unavailable|0|||
13336624|NCT01070550|26611330|FG003|Overall Study|Treatment unavailable|0|||
13336625|NCT01070550|26611331|FG004|Overall Study|Treatment unavailable|0|||
13336626|NCT01070550|26611332|FG005|Overall Study|Treatment unavailable|0|||
13336627|NCT01070550|26611327|FG000|Overall Study|Treatment was stopped early|7|||
13336628|NCT01070550|26611328|FG001|Overall Study|Treatment was stopped early|0|||
13336629|NCT01070550|26611329|FG002|Overall Study|Treatment was stopped early|0|||
13336630|NCT01070550|26611330|FG003|Overall Study|Treatment was stopped early|0|||
13336631|NCT01070550|26611331|FG004|Overall Study|Treatment was stopped early|0|||
13336632|NCT01070550|26611332|FG005|Overall Study|Treatment was stopped early|0|||
13336633|NCT01070550|26611327|FG000|Overall Study|Other|5|||
13336634|NCT01070550|26611328|FG001|Overall Study|Other|0|||
13336635|NCT01070550|26611329|FG002|Overall Study|Other|0|||
13336636|NCT01070550|26611330|FG003|Overall Study|Other|1|||
13336637|NCT01070550|26611331|FG004|Overall Study|Other|0|||
13336638|NCT01070550|26611332|FG005|Overall Study|Other|0|||
13336639|NCT01070550|26611327|FG000|Overall Study|Withdrawal by Subject|35|||
13336640|NCT01070550|26611328|FG001|Overall Study|Withdrawal by Subject|0|||
13336641|NCT01070550|26611329|FG002|Overall Study|Withdrawal by Subject|3|||
13336642|NCT01070550|26611330|FG003|Overall Study|Withdrawal by Subject|0|||
13336643|NCT01070550|26611331|FG004|Overall Study|Withdrawal by Subject|0|||
13336644|NCT01070550|26611332|FG005|Overall Study|Withdrawal by Subject|0|||
13336645|NCT01070394|26611345|FG000|Overall Study|Adverse Event|6|||
13336646|NCT01070394|26611345|FG000|Overall Study|Withdrawal by Subject|1|||
13336647|NCT01070381|26611354|FG000|Period 2, 1 Week of Wear|Handling|0|||
13336648|NCT01070381|26611355|FG001|Period 2, 1 Week of Wear|Handling|1|||
13336649|NCT01070381|26611354|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1|||
13336650|NCT01070381|26611355|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0|||
13336651|NCT01070329|26611394|FG000|Overall Study|Adverse Event|13|||
13336652|NCT01070329|26611395|FG001|Overall Study|Adverse Event|10|||
13336653|NCT01070329|26611394|FG000|Overall Study|Lost to Follow-up|22|||
13336654|NCT01070329|26611395|FG001|Overall Study|Lost to Follow-up|12|||
13336655|NCT01070329|26611394|FG000|Overall Study|Withdrawal by Subject|9|||
13336656|NCT01070329|26611395|FG001|Overall Study|Withdrawal by Subject|11|||
13336657|NCT01070329|26611394|FG000|Overall Study|Protocol Violation|3|||
13336658|NCT01070329|26611395|FG001|Overall Study|Protocol Violation|8|||
13336659|NCT01070329|26611394|FG000|Overall Study|Lack of Efficacy|2|||
13336660|NCT01070329|26611395|FG001|Overall Study|Lack of Efficacy|6|||
13336661|NCT01070329|26611394|FG000|Overall Study|Physician Decision|2|||
13336662|NCT01070329|26611395|FG001|Overall Study|Physician Decision|1|||
13336663|NCT01070329|26611394|FG000|Overall Study|Entry Criteria Not Met|1|||
13336664|NCT01070329|26611395|FG001|Overall Study|Entry Criteria Not Met|0|||
13336665|NCT01070329|26611394|FG000|Overall Study|Sponsor Decision|0|||
13336666|NCT01070329|26611395|FG001|Overall Study|Sponsor Decision|1|||
13336667|NCT01070316|26611402|FG000|Extension Phase|Lack of Efficacy|3|||
13336668|NCT01070316|26611402|FG000|Extension Phase|Withdrawal by Subject|1|||
13336669|NCT01070303|26611464|FG000|Overall Study|Adverse Event|39|||
13336670|NCT01070303|26611464|FG000|Overall Study|Withdrawal by Subject|20|||
13336671|NCT01070303|26611464|FG000|Overall Study|Lost to Follow-up|9|||
13336672|NCT01070303|26611464|FG000|Overall Study|Protocol Violation|0|||
13336673|NCT01070303|26611464|FG000|Overall Study|Lack of Efficacy|2|||
13336674|NCT01070303|26611464|FG000|Overall Study|Administrative Reason|1|||
13336675|NCT01070303|26611464|FG000|Overall Study|Other|18|||
13373879|NCT00799058|26725170|FG002|Overall Study|IP dispensing error|0|||
13373880|NCT00799058|26725168|FG000|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
13373881|NCT00799058|26725169|FG001|Overall Study|not enough IP to complete trial due to IP dispending error|1|||
13373882|NCT00799058|26725170|FG002|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
13373883|NCT00799058|26725168|FG000|Overall Study|IP discontinued too long during BV treatment|1|||
13373884|NCT00799058|26725169|FG001|Overall Study|IP discontinued too long during BV treatment|0|||
13373885|NCT00799058|26725170|FG002|Overall Study|IP discontinued too long during BV treatment|0|||
13373886|NCT00799058|26725168|FG000|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
13373887|NCT00799058|26725169|FG001|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
13373888|NCT00799058|26725170|FG002|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|1|||
13373889|NCT00799058|26725168|FG000|Overall Study|participant did not attend clinic visit 6 (final visit)|1|||
13373890|NCT00799058|26725169|FG001|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
13373891|NCT00799058|26725170|FG002|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
13373892|NCT00798967|26725185|FG000|Overall Study|Adverse Event|2|||
13336676|NCT01070069|26611530|FG000|Overall Study|Death|1|||
13336677|NCT01070069|26611531|FG001|Overall Study|Death|0|||
13336678|NCT01070069|26611532|FG002|Overall Study|Death|2|||
13336679|NCT01070069|26611533|FG003|Overall Study|Death|0|||
13336680|NCT01070069|26611534|FG004|Overall Study|Death|1|||
13336681|NCT01070069|26611530|FG000|Overall Study|Withdrawal by Subject|1|||
13336682|NCT01070069|26611531|FG001|Overall Study|Withdrawal by Subject|1|||
13336683|NCT01070069|26611532|FG002|Overall Study|Withdrawal by Subject|4|||
13336684|NCT01070069|26611533|FG003|Overall Study|Withdrawal by Subject|0|||
13336685|NCT01070069|26611534|FG004|Overall Study|Withdrawal by Subject|0|||
13336686|NCT01070069|26611530|FG000|Overall Study|Lost to Follow-up|4|||
13336687|NCT01070069|26611531|FG001|Overall Study|Lost to Follow-up|1|||
13336688|NCT01070069|26611532|FG002|Overall Study|Lost to Follow-up|0|||
13336689|NCT01070069|26611533|FG003|Overall Study|Lost to Follow-up|0|||
13336690|NCT01070069|26611534|FG004|Overall Study|Lost to Follow-up|3|||
13336691|NCT01070043|26611556|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18|||
13336692|NCT01070043|26611557|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0|||
13336693|NCT01070043|26611558|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0|||
13336694|NCT01070043|26611556|FG000|Double-Blind Treatment|Adverse Event|0|||
13336695|NCT01070043|26611557|FG001|Double-Blind Treatment|Adverse Event|0|||
13336696|NCT01070043|26611558|FG002|Double-Blind Treatment|Adverse Event|2|||
13336697|NCT01069861|26611573|FG000|Overall Study|Death|1|||
13336698|NCT01069861|26611573|FG000|Overall Study|Adverse Event|1|||
13336699|NCT01069861|26611573|FG000|Overall Study|Did not meet entrance criteria|1|||
13336700|NCT01069484|26611588|FG000|Overall Study|Death-in-near-family|1|||
13336701|NCT01069484|26611589|FG001|Overall Study|Death-in-near-family|0|||
13336702|NCT01069484|26611588|FG000|Overall Study|No specific reason|8|||
13336703|NCT01069484|26611589|FG001|Overall Study|No specific reason|2|||
13336704|NCT01069484|26611588|FG000|Overall Study|Illness mother or child|3|||
13336705|NCT01069484|26611589|FG001|Overall Study|Illness mother or child|1|||
13336706|NCT01068665|26611604|FG000|Overall Study|Adverse Event|5|||
13336707|NCT01068665|26611605|FG001|Overall Study|Adverse Event|4|||
13336708|NCT01068665|26611604|FG000|Overall Study|Lack of Efficacy|0|||
13336709|NCT01068665|26611605|FG001|Overall Study|Lack of Efficacy|2|||
13336710|NCT01068665|26611604|FG000|Overall Study|Protocol Violation|5|||
13336711|NCT01068665|26611605|FG001|Overall Study|Protocol Violation|2|||
13336712|NCT01068665|26611604|FG000|Overall Study|Withdrawal Criteria|3|||
13336713|NCT01068665|26611605|FG001|Overall Study|Withdrawal Criteria|9|||
13336714|NCT01068665|26611604|FG000|Overall Study|Other|17|||
13336715|NCT01068665|26611605|FG001|Overall Study|Other|12|||
13336716|NCT01068509|26611628|FG000|Overall Study|Death|0|||
13336717|NCT01068509|26611629|FG001|Overall Study|Death|0|||
13336718|NCT01068509|26611630|FG002|Overall Study|Death|1|||
13336719|NCT01068509|26611628|FG000|Overall Study|Disease Progression|5|||
13336720|NCT01068509|26611629|FG001|Overall Study|Disease Progression|20|||
13336721|NCT01068509|26611630|FG002|Overall Study|Disease Progression|18|||
13336722|NCT01068509|26611628|FG000|Overall Study|Lost to Follow-up|1|||
13336723|NCT01068509|26611629|FG001|Overall Study|Lost to Follow-up|0|||
13336724|NCT01068509|26611630|FG002|Overall Study|Lost to Follow-up|0|||
13336725|NCT01068509|26611628|FG000|Overall Study|Withdrew Consent|0|||
13336726|NCT01068509|26611629|FG001|Overall Study|Withdrew Consent|1|||
13336727|NCT01068509|26611630|FG002|Overall Study|Withdrew Consent|2|||
13336728|NCT01068509|26611628|FG000|Overall Study|Reason Not Specified|0|||
13336729|NCT01068509|26611629|FG001|Overall Study|Reason Not Specified|1|||
13336730|NCT01068509|26611630|FG002|Overall Study|Reason Not Specified|0|||
13336731|NCT01067326|26611649|FG000|Overall Study|Adverse Event|0|||
13336732|NCT01067326|26611650|FG001|Overall Study|Adverse Event|2|||
13336733|NCT01067326|26611649|FG000|Overall Study|Withdrawal by Subject|1|||
13336734|NCT01067326|26611650|FG001|Overall Study|Withdrawal by Subject|0|||
13336735|NCT01067326|26611649|FG000|Overall Study|Early Study Termination|1|||
13336736|NCT01067326|26611650|FG001|Overall Study|Early Study Termination|1|||
13336737|NCT01067144|26611673|FG000|Treatment|Did not receive allocated intervention|4|||
13336738|NCT01067144|26611674|FG001|Treatment|Did not receive allocated intervention|7|||
13336739|NCT01067144|26611673|FG000|Follow-up|Lost to Follow-up|22|||
13336740|NCT01067144|26611674|FG001|Follow-up|Lost to Follow-up|12|||
13336741|NCT01067144|26611673|FG000|Follow-up|Censored owing to second surgery|19|||
13336742|NCT01067144|26611674|FG001|Follow-up|Censored owing to second surgery|28|||
13336743|NCT01067144|26611673|FG000|Follow-up|Withdrawal by Subject|18|||
13336744|NCT01067144|26611674|FG001|Follow-up|Withdrawal by Subject|14|||
13336745|NCT01067144|26611673|FG000|Follow-up|Surgery cancelled|0|||
13336746|NCT01067144|26611674|FG001|Follow-up|Surgery cancelled|1|||
13336747|NCT01067144|26611673|FG000|Follow-up|Death|0|||
13336748|NCT01067144|26611674|FG001|Follow-up|Death|1|||
13336749|NCT01066546|26611687|FG000|Overall Study|Study terminated by sponsor|5|||
13336750|NCT01064856|26611727|FG000|Double-blind (DB) Period|Adverse Event|1|||
13336751|NCT01064856|26611728|FG001|Double-blind (DB) Period|Adverse Event|0|||
13336752|NCT01064856|26611729|FG002|Double-blind (DB) Period|Adverse Event|0|||
13336753|NCT01064856|26611730|FG003|Double-blind (DB) Period|Adverse Event|0|||
13336754|NCT01064856|26611727|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1|||
13336755|NCT01064856|26611728|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0|||
13336756|NCT01064856|26611729|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0|||
13336757|NCT01064856|26611730|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0|||
13336758|NCT01064856|26611727|FG000|Open-label (OL) Period|Adverse Event|0|||
13336759|NCT01064856|26611728|FG001|Open-label (OL) Period|Adverse Event|0|||
13336760|NCT01064856|26611729|FG002|Open-label (OL) Period|Adverse Event|12|||
13336761|NCT01064856|26611730|FG003|Open-label (OL) Period|Adverse Event|6|||
13336762|NCT01064856|26611727|FG000|Open-label (OL) Period|Consent withdrawn by participant|0|||
13336763|NCT01064856|26611728|FG001|Open-label (OL) Period|Consent withdrawn by participant|0|||
13336764|NCT01064856|26611729|FG002|Open-label (OL) Period|Consent withdrawn by participant|5|||
13336765|NCT01064856|26611730|FG003|Open-label (OL) Period|Consent withdrawn by participant|6|||
13336766|NCT01064856|26611727|FG000|Open-label (OL) Period|Lost to Follow-up|0|||
13336767|NCT01064856|26611728|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
13336768|NCT01064856|26611729|FG002|Open-label (OL) Period|Lost to Follow-up|2|||
13336769|NCT01064856|26611730|FG003|Open-label (OL) Period|Lost to Follow-up|1|||
13336770|NCT01064856|26611727|FG000|Open-label (OL) Period|Other|0|||
13336771|NCT01064856|26611728|FG001|Open-label (OL) Period|Other|0|||
13336772|NCT01064856|26611729|FG002|Open-label (OL) Period|Other|7|||
13336773|NCT01064856|26611730|FG003|Open-label (OL) Period|Other|7|||
13336774|NCT01064648|26611764|FG000|Phase I Cohort1: Dose Level 1|Progression|5|||
13336775|NCT01064648|26611765|FG001|Phase I Cohort1: Dose Level 1|Progression|0|||
13336776|NCT01064648|26611766|FG002|Phase I Cohort1: Dose Level 1|Progression|0|||
13336777|NCT01064648|26611767|FG003|Phase I Cohort1: Dose Level 1|Progression|0|||
13336778|NCT01064648|26611764|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2|||
13336779|NCT01064648|26611765|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
13336780|NCT01064648|26611766|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
13336781|NCT01064648|26611767|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
13336782|NCT01064648|26611764|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
13336783|NCT01064648|26611765|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3|||
13336784|NCT01064648|26611766|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
13336785|NCT01064648|26611767|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
13336786|NCT01064648|26611764|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
13336787|NCT01064648|26611765|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1|||
13336788|NCT01064648|26611766|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
13336789|NCT01064648|26611767|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
13336790|NCT01064648|26611764|FG000|Phase I Cohort 2: Dose Level 2|Progression|0|||
13336791|NCT01064648|26611765|FG001|Phase I Cohort 2: Dose Level 2|Progression|5|||
13336792|NCT01064648|26611766|FG002|Phase I Cohort 2: Dose Level 2|Progression|0|||
13336793|NCT01064648|26611767|FG003|Phase I Cohort 2: Dose Level 2|Progression|0|||
13336794|NCT01064648|26611764|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
13336795|NCT01064648|26611765|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4|||
13336796|NCT01064648|26611766|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
13336797|NCT01064648|26611767|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
13336798|NCT01064648|26611764|FG000|Phase II|Adverse Event|0|||
13336799|NCT01064648|26611765|FG001|Phase II|Adverse Event|0|||
13336800|NCT01064648|26611766|FG002|Phase II|Adverse Event|15|||
13336801|NCT01064648|26611767|FG003|Phase II|Adverse Event|8|||
13336802|NCT01064648|26611764|FG000|Phase II|Death|0|||
13336803|NCT01064648|26611765|FG001|Phase II|Death|0|||
13336804|NCT01064648|26611766|FG002|Phase II|Death|4|||
13336805|NCT01064648|26611767|FG003|Phase II|Death|5|||
13336806|NCT01064648|26611764|FG000|Phase II|Withdrawal by Subject|0|||
13336807|NCT01064648|26611765|FG001|Phase II|Withdrawal by Subject|0|||
13336808|NCT01064648|26611766|FG002|Phase II|Withdrawal by Subject|2|||
13336809|NCT01064648|26611767|FG003|Phase II|Withdrawal by Subject|5|||
13336810|NCT01064648|26611764|FG000|Phase II|Progression|0|||
13336811|NCT01064648|26611765|FG001|Phase II|Progression|0|||
13336812|NCT01064648|26611766|FG002|Phase II|Progression|21|||
13336813|NCT01064648|26611767|FG003|Phase II|Progression|27|||
13336814|NCT01064648|26611764|FG000|Phase II|Non-protocol specified|0|||
13336815|NCT01064648|26611765|FG001|Phase II|Non-protocol specified|0|||
13336816|NCT01064648|26611766|FG002|Phase II|Non-protocol specified|5|||
13336817|NCT01064648|26611767|FG003|Phase II|Non-protocol specified|3|||
13336818|NCT01064648|26611764|FG000|Phase II|Under Review|0|||
13336819|NCT01064648|26611765|FG001|Phase II|Under Review|0|||
13336820|NCT01064648|26611766|FG002|Phase II|Under Review|2|||
13336821|NCT01064648|26611767|FG003|Phase II|Under Review|0|||
13336822|NCT01064401|26611788|FG000|Overall Study|Adverse Event|47|||
13336823|NCT01064401|26611789|FG001|Overall Study|Adverse Event|56|||
13336824|NCT01064401|26611788|FG000|Overall Study|Lack of Efficacy|46|||
13336825|NCT01064401|26611789|FG001|Overall Study|Lack of Efficacy|23|||
13336826|NCT01064401|26611788|FG000|Overall Study|Lost to Follow-up|12|||
13336827|NCT01064401|26611789|FG001|Overall Study|Lost to Follow-up|9|||
13336828|NCT01064401|26611788|FG000|Overall Study|Consent Withdrawn|98|||
13336829|NCT01064401|26611789|FG001|Overall Study|Consent Withdrawn|80|||
13336830|NCT01064401|26611788|FG000|Overall Study|Investigator Decision|4|||
13336831|NCT01064401|26611789|FG001|Overall Study|Investigator Decision|6|||
13336832|NCT01064401|26611788|FG000|Overall Study|Death|4|||
13336833|NCT01064401|26611789|FG001|Overall Study|Death|0|||
13336834|NCT01064401|26611788|FG000|Overall Study|Pregnancy|4|||
13336835|NCT01064401|26611789|FG001|Overall Study|Pregnancy|7|||
13336836|NCT01064401|26611788|FG000|Overall Study|Noncompliance|7|||
13336837|NCT01064401|26611789|FG001|Overall Study|Noncompliance|8|||
13336838|NCT01064401|26611788|FG000|Overall Study|Site Closure|4|||
13336839|NCT01064401|26611789|FG001|Overall Study|Site Closure|5|||
13336840|NCT01064401|26611788|FG000|Overall Study|Other|2|||
13336841|NCT01064401|26611789|FG001|Overall Study|Other|1|||
13336842|NCT01064310|26611824|FG000|Period 1|Adverse Event|7|||
13336843|NCT01064310|26611825|FG001|Period 1|Adverse Event|10|||
13336844|NCT01064310|26611826|FG002|Period 1|Adverse Event|0|||
13336845|NCT01064310|26611824|FG000|Period 1|Physician Decision|1|||
13336846|NCT01064310|26611825|FG001|Period 1|Physician Decision|0|||
13336847|NCT01064310|26611826|FG002|Period 1|Physician Decision|0|||
13336848|NCT01064310|26611824|FG000|Period 1|Withdrawal by Subject|2|||
13336849|NCT01064310|26611825|FG001|Period 1|Withdrawal by Subject|2|||
13336850|NCT01064310|26611826|FG002|Period 1|Withdrawal by Subject|0|||
13336851|NCT01064310|26611824|FG000|Period 1|Lack of Efficacy|3|||
13336852|NCT01064310|26611825|FG001|Period 1|Lack of Efficacy|5|||
13336853|NCT01064310|26611826|FG002|Period 1|Lack of Efficacy|0|||
13336854|NCT01064310|26611824|FG000|Period 1|Entered Open-label Period|1|||
13336855|NCT01064310|26611825|FG001|Period 1|Entered Open-label Period|1|||
13336856|NCT01064310|26611826|FG002|Period 1|Entered Open-label Period|0|||
13336857|NCT01064310|26611824|FG000|Period 2|Adverse Event|2|||
13336858|NCT01064310|26611825|FG001|Period 2|Adverse Event|1|||
13336859|NCT01064310|26611826|FG002|Period 2|Adverse Event|0|||
13336860|NCT01064310|26611824|FG000|Period 2|Physician Decision|0|||
13336861|NCT01064310|26611825|FG001|Period 2|Physician Decision|1|||
13336862|NCT01064310|26611826|FG002|Period 2|Physician Decision|0|||
13336863|NCT01064310|26611824|FG000|Period 2|Entered Open-label Period|1|||
13336864|NCT01064310|26611825|FG001|Period 2|Entered Open-label Period|0|||
13336865|NCT01064310|26611826|FG002|Period 2|Entered Open-label Period|0|||
13336866|NCT01064310|26611824|FG000|Period 2|Lack of Efficacy|1|||
13336867|NCT01064310|26611825|FG001|Period 2|Lack of Efficacy|4|||
13336868|NCT01064310|26611826|FG002|Period 2|Lack of Efficacy|0|||
13336869|NCT01064310|26611824|FG000|Open Label Pazopinib|Withdrawal by Subject|0|||
13336870|NCT01064310|26611825|FG001|Open Label Pazopinib|Withdrawal by Subject|0|||
13336871|NCT01064310|26611826|FG002|Open Label Pazopinib|Withdrawal by Subject|1|||
13336872|NCT01064310|26611824|FG000|Open Label Pazopinib|Adverse Event|0|||
13336873|NCT01064310|26611825|FG001|Open Label Pazopinib|Adverse Event|0|||
13336874|NCT01064310|26611826|FG002|Open Label Pazopinib|Adverse Event|12|||
13336875|NCT01064310|26611824|FG000|Open Label Pazopinib|Lack of Efficacy|0|||
13336876|NCT01064310|26611825|FG001|Open Label Pazopinib|Lack of Efficacy|0|||
13336877|NCT01064310|26611826|FG002|Open Label Pazopinib|Lack of Efficacy|51|||
13336878|NCT01064310|26611824|FG000|Open Label Pazopinib|Physician Decision|0|||
13336879|NCT01064310|26611825|FG001|Open Label Pazopinib|Physician Decision|0|||
13336880|NCT01064310|26611826|FG002|Open Label Pazopinib|Physician Decision|20|||
13336881|NCT01064297|26611880|FG000|Overall Study|Lost to Follow-up|791|||
13336882|NCT01064297|26611881|FG001|Overall Study|Lost to Follow-up|48|||
13336883|NCT01064297|26611882|FG002|Overall Study|Lost to Follow-up|133|||
13336884|NCT01062763|26611899|FG000|Overall Study|Adverse Event|3|||
13336885|NCT01062763|26611900|FG001|Overall Study|Adverse Event|4|||
13336886|NCT01062256|26611933|FG000|Overall Study|Adverse Event|1|||
13336887|NCT01062256|26611934|FG001|Overall Study|Adverse Event|0|||
13336888|NCT01062256|26611935|FG002|Overall Study|Adverse Event|0|||
13336889|NCT01062256|26611933|FG000|Overall Study|Withdrawal by Subject|1|||
13336890|NCT01062256|26611934|FG001|Overall Study|Withdrawal by Subject|1|||
13336891|NCT01062256|26611935|FG002|Overall Study|Withdrawal by Subject|1|||
13336892|NCT01062256|26611933|FG000|Overall Study|Ineligible|1|||
13336893|NCT01062256|26611934|FG001|Overall Study|Ineligible|4|||
13336894|NCT01062256|26611935|FG002|Overall Study|Ineligible|3|||
13336895|NCT01062256|26611933|FG000|Overall Study|Administrative|0|||
13336896|NCT01062256|26611934|FG001|Overall Study|Administrative|2|||
13336897|NCT01062256|26611935|FG002|Overall Study|Administrative|0|||
13336898|NCT01062113|26611958|FG000|Overall Study|Adverse Event|1|||
13336899|NCT01062113|26611959|FG001|Overall Study|Adverse Event|0|||
13336900|NCT01062113|26611960|FG002|Overall Study|Adverse Event|0|||
13336901|NCT01062113|26611958|FG000|Overall Study|Lack of Efficacy|38|||
13336902|NCT01062113|26611959|FG001|Overall Study|Lack of Efficacy|22|||
13336903|NCT01062113|26611960|FG002|Overall Study|Lack of Efficacy|31|||
13336904|NCT01062113|26611958|FG000|Overall Study|Withdrawal by Subject|1|||
13336905|NCT01062113|26611959|FG001|Overall Study|Withdrawal by Subject|0|||
13336906|NCT01062113|26611960|FG002|Overall Study|Withdrawal by Subject|0|||
13336907|NCT01061736|26612024|FG000|Overall Study|Dose regimen not selected|0|||
13336908|NCT01061736|26612025|FG001|Overall Study|Dose regimen not selected|0|||
13336909|NCT01061736|26612026|FG002|Overall Study|Dose regimen not selected|0|||
13336910|NCT01061736|26612027|FG003|Overall Study|Dose regimen not selected|0|||
13336911|NCT01061736|26612028|FG004|Overall Study|Dose regimen not selected|0|||
13336912|NCT01061736|26612029|FG005|Overall Study|Dose regimen not selected|0|||
13336913|NCT01061736|26612030|FG006|Overall Study|Dose regimen not selected|79|||
13336914|NCT01061736|26612031|FG007|Overall Study|Dose regimen not selected|0|||
13336915|NCT01061736|26612032|FG008|Overall Study|Dose regimen not selected|0|||
13336916|NCT01061736|26612033|FG009|Overall Study|Dose regimen not selected|0|||
13336917|NCT01061736|26612024|FG000|Overall Study|Adverse Event|13|||
13336918|NCT01061736|26612025|FG001|Overall Study|Adverse Event|1|||
13336919|NCT01061736|26612026|FG002|Overall Study|Adverse Event|3|||
13336920|NCT01061736|26612027|FG003|Overall Study|Adverse Event|2|||
13336921|NCT01061736|26612028|FG004|Overall Study|Adverse Event|4|||
13336922|NCT01061736|26612029|FG005|Overall Study|Adverse Event|1|||
13336923|NCT01061736|26612030|FG006|Overall Study|Adverse Event|4|||
13336924|NCT01061736|26612031|FG007|Overall Study|Adverse Event|63|||
13336925|NCT01061736|26612032|FG008|Overall Study|Adverse Event|67|||
13336926|NCT01061736|26612033|FG009|Overall Study|Adverse Event|34|||
13336927|NCT01061736|26612024|FG000|Overall Study|Lack of Efficacy|0|||
13336928|NCT01061736|26612025|FG001|Overall Study|Lack of Efficacy|2|||
13336929|NCT01061736|26612026|FG002|Overall Study|Lack of Efficacy|1|||
13336930|NCT01061736|26612027|FG003|Overall Study|Lack of Efficacy|1|||
13336931|NCT01061736|26612028|FG004|Overall Study|Lack of Efficacy|1|||
13336932|NCT01061736|26612029|FG005|Overall Study|Lack of Efficacy|2|||
13336933|NCT01061736|26612030|FG006|Overall Study|Lack of Efficacy|1|||
13336934|NCT01061736|26612031|FG007|Overall Study|Lack of Efficacy|9|||
13336935|NCT01061736|26612032|FG008|Overall Study|Lack of Efficacy|9|||
13336936|NCT01061736|26612033|FG009|Overall Study|Lack of Efficacy|10|||
13336937|NCT01061736|26612024|FG000|Overall Study|Poor compliance to protocol|0|||
13336938|NCT01061736|26612025|FG001|Overall Study|Poor compliance to protocol|0|||
13336939|NCT01061736|26612026|FG002|Overall Study|Poor compliance to protocol|0|||
13336940|NCT01061736|26612027|FG003|Overall Study|Poor compliance to protocol|0|||
13336941|NCT01061736|26612028|FG004|Overall Study|Poor compliance to protocol|0|||
13336942|NCT01061736|26612029|FG005|Overall Study|Poor compliance to protocol|0|||
13336943|NCT01061736|26612030|FG006|Overall Study|Poor compliance to protocol|0|||
13336944|NCT01061736|26612031|FG007|Overall Study|Poor compliance to protocol|2|||
13336945|NCT01061736|26612032|FG008|Overall Study|Poor compliance to protocol|5|||
13336946|NCT01061736|26612033|FG009|Overall Study|Poor compliance to protocol|9|||
13336947|NCT01061736|26612024|FG000|Overall Study|Not treated|0|||
13336948|NCT01061736|26612025|FG001|Overall Study|Not treated|0|||
13336949|NCT01061736|26612026|FG002|Overall Study|Not treated|0|||
13336950|NCT01061736|26612027|FG003|Overall Study|Not treated|0|||
13336951|NCT01061736|26612028|FG004|Overall Study|Not treated|1|||
13336952|NCT01061736|26612029|FG005|Overall Study|Not treated|0|||
13336953|NCT01061736|26612030|FG006|Overall Study|Not treated|0|||
13336954|NCT01061736|26612031|FG007|Overall Study|Not treated|2|||
13336955|NCT01061736|26612032|FG008|Overall Study|Not treated|1|||
13336956|NCT01061736|26612033|FG009|Overall Study|Not treated|0|||
13336957|NCT01061736|26612024|FG000|Overall Study|Other than specified above|0|||
13336958|NCT01061736|26612025|FG001|Overall Study|Other than specified above|1|||
13336959|NCT01061736|26612026|FG002|Overall Study|Other than specified above|2|||
13336960|NCT01061736|26612027|FG003|Overall Study|Other than specified above|0|||
13336961|NCT01061736|26612028|FG004|Overall Study|Other than specified above|1|||
13336962|NCT01061736|26612029|FG005|Overall Study|Other than specified above|0|||
13336963|NCT01061736|26612030|FG006|Overall Study|Other than specified above|0|||
13336964|NCT01061736|26612031|FG007|Overall Study|Other than specified above|18|||
13336965|NCT01061736|26612032|FG008|Overall Study|Other than specified above|15|||
13336966|NCT01061736|26612033|FG009|Overall Study|Other than specified above|21|||
13336967|NCT01061710|26612043|FG000|Overall Study|Protocol Violation|14|||
13336968|NCT01061359|26612051|FG000|Overall Study|Death|32|||
13336969|NCT01061359|26612051|FG000|Overall Study|Lost to Follow-up|1072|||
13336970|NCT01061359|26612051|FG000|Overall Study|Relapse|187|||
13336971|NCT01061359|26612051|FG000|Overall Study|Secondary neoplasm|11|||
13336972|NCT01061151|26612129|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2|||
13336973|NCT01061151|26612130|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
13336974|NCT01061151|26612131|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
13336975|NCT01061151|26612132|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1|||
13336976|NCT01061151|26612129|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6|||
13336977|NCT01061151|26612130|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9|||
13336978|NCT01061151|26612131|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1|||
13336979|NCT01061151|26612132|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2|||
13336980|NCT01061151|26612129|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89|||
13336981|NCT01061151|26612130|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82|||
13336982|NCT01061151|26612131|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2|||
13336983|NCT01061151|26612132|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10|||
13336984|NCT01061151|26612129|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73|||
13336985|NCT01061151|26612130|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65|||
13336986|NCT01061151|26612131|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2|||
13336987|NCT01061151|26612132|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10|||
13336988|NCT01061151|26612129|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15|||
13336989|NCT01061151|26612130|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19|||
13336990|NCT01061151|26612131|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1|||
13336991|NCT01061151|26612132|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0|||
13336992|NCT01061151|26612129|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44|||
13336993|NCT01061151|26612130|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61|||
13336994|NCT01061151|26612131|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2|||
13336995|NCT01061151|26612132|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5|||
13336996|NCT01061151|26612129|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3|||
13336997|NCT01061151|26612130|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5|||
13336998|NCT01061151|26612131|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1|||
13336999|NCT01061151|26612132|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0|||
13337000|NCT01061151|26612129|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
13337001|NCT01061151|26612130|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
13337002|NCT01061151|26612131|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2|||
13337003|NCT01061151|26612132|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4|||
13337004|NCT01061151|26612129|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1|||
13337005|NCT01061151|26612130|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
13337006|NCT01061151|26612131|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
13337007|NCT01061151|26612132|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
13337008|NCT01061151|26612129|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3|||
13337009|NCT01061151|26612130|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5|||
13337010|NCT01061151|26612131|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
13337011|NCT01061151|26612132|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
13337012|NCT01061151|26612129|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54|||
13337013|NCT01061151|26612130|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52|||
13337014|NCT01061151|26612131|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31|||
13337015|NCT01061151|26612132|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3|||
13337016|NCT01061151|26612129|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49|||
13337017|NCT01061151|26612130|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36|||
13337018|NCT01061151|26612131|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25|||
13337019|NCT01061151|26612132|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4|||
13337020|NCT01061151|26612129|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12|||
13337021|NCT01061151|26612130|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11|||
13337022|NCT01061151|26612131|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2|||
13337023|NCT01061151|26612132|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0|||
13337024|NCT01061151|26612129|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28|||
13337025|NCT01061151|26612130|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26|||
13337026|NCT01061151|26612131|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15|||
13337027|NCT01061151|26612132|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5|||
13337028|NCT01061151|26612129|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5|||
13337029|NCT01061151|26612130|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8|||
13337030|NCT01061151|26612131|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1|||
13337031|NCT01061151|26612132|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3|||
13337032|NCT01059864|26612183|FG000|Open-Label Run-In Phase|Adverse Event|7|||
13337033|NCT01059864|26612184|FG001|Open-Label Run-In Phase|Adverse Event|0|||
13337034|NCT01059864|26612185|FG002|Open-Label Run-In Phase|Adverse Event|0|||
13337035|NCT01059864|26612183|FG000|Open-Label Run-In Phase|Lack of Efficacy|1|||
13337036|NCT01059864|26612184|FG001|Open-Label Run-In Phase|Lack of Efficacy|0|||
13337037|NCT01059864|26612185|FG002|Open-Label Run-In Phase|Lack of Efficacy|0|||
13337038|NCT01059864|26612183|FG000|Open-Label Run-In Phase|Lost to Follow-up|2|||
13337039|NCT01059864|26612184|FG001|Open-Label Run-In Phase|Lost to Follow-up|0|||
13337040|NCT01059864|26612185|FG002|Open-Label Run-In Phase|Lost to Follow-up|0|||
13337041|NCT01059864|26612183|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1|||
13337042|NCT01059864|26612184|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0|||
13337043|NCT01059864|26612185|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0|||
13337044|NCT01059864|26612183|FG000|Open-Label Run-In Phase|Protocol Violation|2|||
13337045|NCT01059864|26612184|FG001|Open-Label Run-In Phase|Protocol Violation|0|||
13337046|NCT01059864|26612185|FG002|Open-Label Run-In Phase|Protocol Violation|0|||
13337047|NCT01059864|26612183|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
13337048|NCT01059864|26612184|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
13337049|NCT01059864|26612185|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
13337050|NCT01059812|26612206|FG000|Overall Study|Adverse Event|9|||
13337051|NCT01059812|26612207|FG001|Overall Study|Adverse Event|5|||
13337052|NCT01059812|26612206|FG000|Overall Study|Lack of Efficacy|2|||
13337053|NCT01059812|26612207|FG001|Overall Study|Lack of Efficacy|2|||
13337054|NCT01059812|26612206|FG000|Overall Study|Protocol Violation|3|||
13337055|NCT01059812|26612207|FG001|Overall Study|Protocol Violation|1|||
13337056|NCT01059812|26612206|FG000|Overall Study|Withdrawal Criteria|9|||
13337057|NCT01059812|26612207|FG001|Overall Study|Withdrawal Criteria|4|||
13337058|NCT01059812|26612206|FG000|Overall Study|Unclassified|14|||
13337059|NCT01059812|26612207|FG001|Overall Study|Unclassified|4|||
13337060|NCT01059799|26612226|FG000|Overall Study|Adverse Event|2|||
13337061|NCT01059799|26612227|FG001|Overall Study|Adverse Event|3|||
13337062|NCT01059799|26612226|FG000|Overall Study|Lack of Efficacy|1|||
13337063|NCT01059799|26612227|FG001|Overall Study|Lack of Efficacy|0|||
13337064|NCT01059799|26612226|FG000|Overall Study|Protocol Violation|3|||
13337065|NCT01059799|26612227|FG001|Overall Study|Protocol Violation|2|||
13337066|NCT01059799|26612226|FG000|Overall Study|Withdrawal criteria|13|||
13337067|NCT01059799|26612227|FG001|Overall Study|Withdrawal criteria|2|||
13337068|NCT01059799|26612226|FG000|Overall Study|Other|12|||
13337069|NCT01059799|26612227|FG001|Overall Study|Other|3|||
13337070|NCT01059630|26612304|FG000|Overall Study|Death|100|||
13337071|NCT01059630|26612305|FG001|Overall Study|Death|84|||
13337072|NCT01059630|26612304|FG000|Overall Study|Lost to Follow-up|4|||
13337073|NCT01059630|26612305|FG001|Overall Study|Lost to Follow-up|1|||
13337074|NCT01059630|26612304|FG000|Overall Study|Physician Decision|2|||
13337075|NCT01059630|26612305|FG001|Overall Study|Physician Decision|4|||
13337076|NCT01059630|26612304|FG000|Overall Study|Withdrawal by Subject|21|||
13337077|NCT01059630|26612305|FG001|Overall Study|Withdrawal by Subject|14|||
13337078|NCT01059539|26612312|FG000|Overall Study|Adverse Event|66|||
13337079|NCT01059539|26612312|FG000|Overall Study|Insufficient Therapeutic Response|26|||
13337080|NCT01059539|26612312|FG000|Overall Study|Protocol Violation|55|||
13337081|NCT01059539|26612312|FG000|Overall Study|Withdrawal of Consent|80|||
13337082|NCT01059539|26612312|FG000|Overall Study|Lost to Follow-up|42|||
13337083|NCT01059539|26612312|FG000|Overall Study|Reason Not Specified|2|||
13337084|NCT01059175|26612341|FG000|Overall Study|Death|17|||
13337085|NCT01059175|26612342|FG001|Overall Study|Death|17|||
13337086|NCT01059175|26612341|FG000|Overall Study|Adverse Event|4|||
13337087|NCT01059175|26612342|FG001|Overall Study|Adverse Event|2|||
13337088|NCT01059175|26612341|FG000|Overall Study|Lost to Follow-up|0|||
13337089|NCT01059175|26612342|FG001|Overall Study|Lost to Follow-up|1|||
13337090|NCT01058668|26612363|FG000|Double-blind Treatment Phase|Adverse Event|8|||
13337091|NCT01058668|26612364|FG001|Double-blind Treatment Phase|Adverse Event|15|||
13337092|NCT01058668|26612365|FG002|Double-blind Treatment Phase|Adverse Event|25|||
13337093|NCT01058668|26612363|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15|||
13337094|NCT01058668|26612364|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2|||
13337095|NCT01058668|26612365|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5|||
13337096|NCT01058668|26612363|FG000|Double-blind Treatment Phase|Protocol Violation|1|||
13337097|NCT01058668|26612364|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
13337098|NCT01058668|26612365|FG002|Double-blind Treatment Phase|Protocol Violation|2|||
13337099|NCT01058668|26612363|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14|||
13337100|NCT01058668|26612364|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18|||
13337101|NCT01058668|26612365|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17|||
13337102|NCT01058668|26612363|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
13337103|NCT01058668|26612364|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
13337104|NCT01058668|26612365|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
13337105|NCT01058668|26612363|FG000|Double-blind Treatment Phase|Other Unspecified|1|||
13337106|NCT01058668|26612364|FG001|Double-blind Treatment Phase|Other Unspecified|1|||
13337107|NCT01058668|26612365|FG002|Double-blind Treatment Phase|Other Unspecified|0|||
13337108|NCT01058096|26612380|FG000|Double-blind Treatment Phase|Adverse Event|11|||
13337109|NCT01058096|26612381|FG001|Double-blind Treatment Phase|Adverse Event|15|||
13337110|NCT01058096|26612380|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16|||
13337111|NCT01058096|26612381|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7|||
13337112|NCT01058096|26612380|FG000|Double-blind Treatment Phase|Protocol Violation|2|||
13337113|NCT01058096|26612381|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
13337114|NCT01058096|26612380|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17|||
13337115|NCT01058096|26612381|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26|||
13337116|NCT01058096|26612380|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
13337117|NCT01058096|26612381|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
13337118|NCT01058096|26612380|FG000|Double-blind Treatment Phase|Other Unspecified|2|||
13337119|NCT01058096|26612381|FG001|Double-blind Treatment Phase|Other Unspecified|0|||
13337120|NCT01057862|26612396|FG000|Overall Study|Withdrawal by Subject|1|||
13337121|NCT01057862|26612397|FG001|Overall Study|Withdrawal by Subject|2|||
13337122|NCT01057810|26612420|FG000|Overall Study|Disease progression|156|||
13337123|NCT01057810|26612421|FG001|Overall Study|Disease progression|197|||
13337124|NCT01057810|26612420|FG000|Overall Study|Study drug toxicity|5|||
13337125|NCT01057810|26612421|FG001|Overall Study|Study drug toxicity|114|||
13337126|NCT01057810|26612420|FG000|Overall Study|Adverse event unrelated to study drug|13|||
13337127|NCT01057810|26612421|FG001|Overall Study|Adverse event unrelated to study drug|29|||
13373893|NCT00798967|26725186|FG001|Overall Study|Adverse Event|3|||
13337128|NCT01057810|26612420|FG000|Overall Study|Withdrawal by Subject|10|||
13337129|NCT01057810|26612421|FG001|Overall Study|Withdrawal by Subject|25|||
13337130|NCT01057810|26612420|FG000|Overall Study|Death|2|||
13337131|NCT01057810|26612421|FG001|Overall Study|Death|12|||
13337132|NCT01057810|26612420|FG000|Overall Study|Maximum clinical benefit|5|||
13337133|NCT01057810|26612421|FG001|Overall Study|Maximum clinical benefit|5|||
13337134|NCT01057810|26612420|FG000|Overall Study|Poor/non-compliance|0|||
13337135|NCT01057810|26612421|FG001|Overall Study|Poor/non-compliance|1|||
13337136|NCT01057810|26612420|FG000|Overall Study|No longer met study criteria|0|||
13337137|NCT01057810|26612421|FG001|Overall Study|No longer met study criteria|1|||
13337138|NCT01057810|26612420|FG000|Overall Study|Other|7|||
13337139|NCT01057810|26612421|FG001|Overall Study|Other|14|||
13337140|NCT01057693|26612471|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45|||
13337141|NCT01057693|26612472|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
13337142|NCT01057693|26612473|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
13337143|NCT01057693|26612471|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7|||
13337144|NCT01057693|26612472|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
13337145|NCT01057693|26612473|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
13337146|NCT01057693|26612471|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14|||
13337147|NCT01057693|26612472|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
13337148|NCT01057693|26612473|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
13337149|NCT01057693|26612471|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9|||
13337150|NCT01057693|26612472|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
13337151|NCT01057693|26612473|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
13337152|NCT01057693|26612471|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22|||
13337153|NCT01057693|26612472|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
13337154|NCT01057693|26612473|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
13337155|NCT01057693|26612471|FG000|Single-Blind Phase (Up to Week 6)|Other|2|||
13337156|NCT01057693|26612472|FG001|Single-Blind Phase (Up to Week 6)|Other|0|||
13337157|NCT01057693|26612473|FG002|Single-Blind Phase (Up to Week 6)|Other|0|||
13337158|NCT01057693|26612471|FG000|Between Single-Blind and Double-Blind|Adverse Event|5|||
13337159|NCT01057693|26612472|FG001|Between Single-Blind and Double-Blind|Adverse Event|0|||
13337160|NCT01057693|26612473|FG002|Between Single-Blind and Double-Blind|Adverse Event|0|||
13337161|NCT01057693|26612471|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247|||
13337162|NCT01057693|26612472|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
13337163|NCT01057693|26612473|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
13337164|NCT01057693|26612471|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1|||
13337165|NCT01057693|26612472|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
13337166|NCT01057693|26612473|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
13337167|NCT01057693|26612471|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7|||
13337168|NCT01057693|26612472|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0|||
13337169|NCT01057693|26612473|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0|||
13337170|NCT01057693|26612471|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4|||
13337171|NCT01057693|26612472|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
13337172|NCT01057693|26612473|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
13337173|NCT01057693|26612471|FG000|Between Single-Blind and Double-Blind|Other|6|||
13337174|NCT01057693|26612472|FG001|Between Single-Blind and Double-Blind|Other|0|||
13337175|NCT01057693|26612473|FG002|Between Single-Blind and Double-Blind|Other|0|||
13337176|NCT01057693|26612471|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0|||
13337177|NCT01057693|26612472|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8|||
13337178|NCT01057693|26612473|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11|||
13337179|NCT01057693|26612471|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0|||
13337180|NCT01057693|26612472|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3|||
13337181|NCT01057693|26612473|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8|||
13337182|NCT01057693|26612471|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0|||
13337183|NCT01057693|26612472|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2|||
13337184|NCT01057693|26612473|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5|||
13337185|NCT01057693|26612471|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
13337186|NCT01057693|26612472|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
13337187|NCT01057693|26612473|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4|||
13337188|NCT01057693|26612471|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0|||
13337189|NCT01057693|26612472|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8|||
13337190|NCT01057693|26612473|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6|||
13337191|NCT01057693|26612471|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
13337192|NCT01057693|26612472|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1|||
13337193|NCT01057693|26612473|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
13337194|NCT01057693|26612471|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
13337195|NCT01057693|26612472|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
13337196|NCT01057693|26612473|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2|||
13337197|NCT01057589|26612484|FG000|Overall Study|Disease Progression|35|||
13337198|NCT01057589|26612484|FG000|Overall Study|Adverse Event|10|||
13337199|NCT01057589|26612484|FG000|Overall Study|Physician Decision|8|||
13337200|NCT01057589|26612484|FG000|Overall Study|Withdrawal by Subject|3|||
13337201|NCT01057589|26612484|FG000|Overall Study|Sponsor Decision|1|||
13337202|NCT01057589|26612484|FG000|Overall Study|Death|8|||
13337203|NCT01057589|26612484|FG000|Overall Study|Lost to Follow-up|1|||
13337204|NCT01056718|26612516|FG000|Overall Study|Withdrawal by Subject|2|||
13337205|NCT01056718|26612516|FG000|Overall Study|Ischemia on baseline stress test|1|||
13337206|NCT01056341|26612551|FG000|Overall Study|Treatment Intolerance|0|||
13337207|NCT01056341|26612552|FG001|Overall Study|Treatment Intolerance|2|||
13337208|NCT01056341|26612553|FG002|Overall Study|Treatment Intolerance|0|||
13337209|NCT01056341|26612554|FG003|Overall Study|Treatment Intolerance|2|||
13337210|NCT01056341|26612555|FG004|Overall Study|Treatment Intolerance|0|||
13337211|NCT01056341|26612551|FG000|Overall Study|Lack of Efficacy|32|||
13337212|NCT01056341|26612552|FG001|Overall Study|Lack of Efficacy|30|||
13337213|NCT01056341|26612553|FG002|Overall Study|Lack of Efficacy|7|||
13337214|NCT01056341|26612554|FG003|Overall Study|Lack of Efficacy|25|||
13337215|NCT01056341|26612555|FG004|Overall Study|Lack of Efficacy|9|||
13337216|NCT01056341|26612551|FG000|Overall Study|Other reasons|4|||
13337217|NCT01056341|26612552|FG001|Overall Study|Other reasons|4|||
13337218|NCT01056341|26612553|FG002|Overall Study|Other reasons|8|||
13337219|NCT01056341|26612554|FG003|Overall Study|Other reasons|9|||
13337220|NCT01056341|26612555|FG004|Overall Study|Other reasons|5|||
13337221|NCT01056289|26612575|FG000|Open-label Phase|Adverse Event|29|||
13337222|NCT01056289|26612576|FG001|Open-label Phase|Adverse Event|0|||
13337223|NCT01056289|26612577|FG002|Open-label Phase|Adverse Event|0|||
13337224|NCT01056289|26612578|FG003|Open-label Phase|Adverse Event|0|||
13337225|NCT01056289|26612575|FG000|Open-label Phase|Lost to Follow-up|30|||
13337226|NCT01056289|26612576|FG001|Open-label Phase|Lost to Follow-up|0|||
13337227|NCT01056289|26612577|FG002|Open-label Phase|Lost to Follow-up|0|||
13337228|NCT01056289|26612578|FG003|Open-label Phase|Lost to Follow-up|0|||
13337229|NCT01056289|26612575|FG000|Open-label Phase|Other|9|||
13337230|NCT01056289|26612576|FG001|Open-label Phase|Other|0|||
13337231|NCT01056289|26612577|FG002|Open-label Phase|Other|0|||
13337232|NCT01056289|26612578|FG003|Open-label Phase|Other|0|||
13337233|NCT01056289|26612575|FG000|Open-label Phase|Protocol Violation|6|||
13337234|NCT01056289|26612576|FG001|Open-label Phase|Protocol Violation|0|||
13337235|NCT01056289|26612577|FG002|Open-label Phase|Protocol Violation|0|||
13337236|NCT01056289|26612578|FG003|Open-label Phase|Protocol Violation|0|||
13337237|NCT01056289|26612575|FG000|Open-label Phase|Withdrawal by Subject|26|||
13337238|NCT01056289|26612576|FG001|Open-label Phase|Withdrawal by Subject|0|||
13337239|NCT01056289|26612577|FG002|Open-label Phase|Withdrawal by Subject|0|||
13337240|NCT01056289|26612578|FG003|Open-label Phase|Withdrawal by Subject|0|||
13337241|NCT01056289|26612575|FG000|Open-label Phase|Lack of Efficacy|18|||
13337242|NCT01056289|26612576|FG001|Open-label Phase|Lack of Efficacy|0|||
13337243|NCT01056289|26612577|FG002|Open-label Phase|Lack of Efficacy|0|||
13337244|NCT01056289|26612578|FG003|Open-label Phase|Lack of Efficacy|0|||
13337245|NCT01056289|26612575|FG000|Open-label Phase|Not randomized to Double-blind phase|1|||
13337246|NCT01056289|26612576|FG001|Open-label Phase|Not randomized to Double-blind phase|0|||
13337247|NCT01056289|26612577|FG002|Open-label Phase|Not randomized to Double-blind phase|0|||
13337248|NCT01056289|26612578|FG003|Open-label Phase|Not randomized to Double-blind phase|0|||
13337249|NCT01056289|26612575|FG000|Double-blind Phase|Adverse Event|0|||
13337250|NCT01056289|26612576|FG001|Double-blind Phase|Adverse Event|1|||
13337251|NCT01056289|26612577|FG002|Double-blind Phase|Adverse Event|2|||
13337252|NCT01056289|26612578|FG003|Double-blind Phase|Adverse Event|1|||
13337253|NCT01056289|26612575|FG000|Double-blind Phase|Lost to Follow-up|0|||
13337254|NCT01056289|26612576|FG001|Double-blind Phase|Lost to Follow-up|2|||
13337255|NCT01056289|26612577|FG002|Double-blind Phase|Lost to Follow-up|2|||
13337256|NCT01056289|26612578|FG003|Double-blind Phase|Lost to Follow-up|2|||
13337257|NCT01056289|26612575|FG000|Double-blind Phase|Other|0|||
13337258|NCT01056289|26612576|FG001|Double-blind Phase|Other|0|||
13337259|NCT01056289|26612577|FG002|Double-blind Phase|Other|1|||
13337260|NCT01056289|26612578|FG003|Double-blind Phase|Other|2|||
13337261|NCT01056289|26612575|FG000|Double-blind Phase|Protocol Violation|0|||
13337262|NCT01056289|26612576|FG001|Double-blind Phase|Protocol Violation|0|||
13337263|NCT01056289|26612577|FG002|Double-blind Phase|Protocol Violation|1|||
13337264|NCT01056289|26612578|FG003|Double-blind Phase|Protocol Violation|1|||
13337265|NCT01056289|26612575|FG000|Double-blind Phase|Withdrawal by Subject|0|||
13337266|NCT01056289|26612576|FG001|Double-blind Phase|Withdrawal by Subject|0|||
13337267|NCT01056289|26612577|FG002|Double-blind Phase|Withdrawal by Subject|4|||
13337268|NCT01056289|26612578|FG003|Double-blind Phase|Withdrawal by Subject|2|||
13337269|NCT01056289|26612575|FG000|Double-blind Phase|Discontinuation symptom|0|||
13337270|NCT01056289|26612576|FG001|Double-blind Phase|Discontinuation symptom|1|||
13337271|NCT01056289|26612577|FG002|Double-blind Phase|Discontinuation symptom|2|||
13337272|NCT01056289|26612578|FG003|Double-blind Phase|Discontinuation symptom|2|||
13337273|NCT01056289|26612575|FG000|Double-blind Phase|Physician Decision|0|||
13337274|NCT01056289|26612576|FG001|Double-blind Phase|Physician Decision|0|||
13337275|NCT01056289|26612577|FG002|Double-blind Phase|Physician Decision|1|||
13337276|NCT01056289|26612578|FG003|Double-blind Phase|Physician Decision|0|||
13337277|NCT01056263|26612584|FG000|Overall Study|Adverse Event|12|||
13337278|NCT01056263|26612584|FG000|Overall Study|Death|1|||
13337279|NCT01056263|26612584|FG000|Overall Study|Withdrawal by Subject|1|||
13337280|NCT01056263|26612584|FG000|Overall Study|Lack of Efficacy|29|||
13337281|NCT01056263|26612584|FG000|Overall Study|Progressive disease|2|||
13337282|NCT01056263|26612584|FG000|Overall Study|Neoplasm progression|1|||
13337283|NCT01056263|26612584|FG000|Overall Study|Objective progression or relapse|1|||
13337284|NCT01056263|26612584|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5|||
13337285|NCT01056107|26612643|FG000|Overall Study|Withdrawal by Subject|0|||
13337286|NCT01056107|26612644|FG001|Overall Study|Withdrawal by Subject|1|||
13337287|NCT01056107|26612645|FG002|Overall Study|Withdrawal by Subject|3|||
13337288|NCT01056107|26612646|FG003|Overall Study|Withdrawal by Subject|0|||
13337289|NCT01055496|26612700|FG000|Overall Study|Withdrawal by Subject|2|||
13337290|NCT01055496|26612701|FG001|Overall Study|Withdrawal by Subject|4|||
13337291|NCT01055496|26612700|FG000|Overall Study|Death|13|||
13337292|NCT01055496|26612701|FG001|Overall Study|Death|23|||
13337293|NCT01055496|26612700|FG000|Overall Study|Lost to Follow-up|0|||
13337294|NCT01055496|26612701|FG001|Overall Study|Lost to Follow-up|2|||
13337295|NCT01055496|26612700|FG000|Overall Study|Other - Unspecified|0|||
13337296|NCT01055496|26612701|FG001|Overall Study|Other - Unspecified|1|||
13337297|NCT01055262|26612714|FG000|Overall Study|Adverse Event|5|||
13337298|NCT01055262|26612714|FG000|Overall Study|Protocol Violation|3|||
13337299|NCT01055262|26612714|FG000|Overall Study|Uncooperativeness|1|||
13337300|NCT01054820|26612730|FG000|Overall Study|Withdrawal by Subject|2|||
13337301|NCT01054599|26612745|FG000|Overall Study|Dizziness due to phenytoin toxicity|1|||
13337302|NCT01054599|26612746|FG001|Overall Study|Dizziness due to phenytoin toxicity|0|||
13337303|NCT01054599|26612745|FG000|Overall Study|Protocol Violation|1|||
13337304|NCT01054599|26612746|FG001|Overall Study|Protocol Violation|0|||
13337305|NCT01054599|26612745|FG000|Overall Study|Spells/seizure-like episodes|1|||
13337306|NCT01054599|26612746|FG001|Overall Study|Spells/seizure-like episodes|1|||
13337307|NCT01054599|26612745|FG000|Overall Study|Timing/scheduling difficulties|1|||
13337308|NCT01054599|26612746|FG001|Overall Study|Timing/scheduling difficulties|1|||
13337309|NCT01054599|26612745|FG000|Overall Study|Visual impairment, WTAR <80|0|||
13337310|NCT01054599|26612746|FG001|Overall Study|Visual impairment, WTAR <80|1|||
13337311|NCT01054599|26612745|FG000|Overall Study|Lost to Follow-up|0|||
13337312|NCT01054599|26612746|FG001|Overall Study|Lost to Follow-up|2|||
13337313|NCT01054599|26612745|FG000|Overall Study|Adverse Event|0|||
13337314|NCT01054599|26612746|FG001|Overall Study|Adverse Event|1|||
13337315|NCT01054599|26612745|FG000|Overall Study|Withdrawal by Subject|0|||
13337316|NCT01054599|26612746|FG001|Overall Study|Withdrawal by Subject|1|||
13337317|NCT01054222|26612767|FG000|Overall Study|Lack of Efficacy|1|||
13337318|NCT01054222|26612767|FG000|Overall Study|Lost to Follow-up|4|||
13337319|NCT01054222|26612767|FG000|Overall Study|Withdrawal by Subject|6|||
13337320|NCT01053663|26612816|FG000|Overall Study|Death|2|||
13337321|NCT01053663|26612816|FG000|Overall Study|Lost to Follow-up|1|||
13337322|NCT01053663|26612816|FG000|Overall Study|Poor IV Access|1|||
13337323|NCT01053663|26612816|FG000|Overall Study|Transferred to Another Hospital|1|||
13337324|NCT01053663|26612816|FG000|Overall Study|Negative Influenza Diagnosis|1|||
13337325|NCT01053429|26612827|FG000|Overall Study|Adverse Event|64|||
13337326|NCT01053429|26612827|FG000|Overall Study|Other|309|||
13337327|NCT01052844|26612842|FG000|Overall Study|Adverse Event|0|||
13337328|NCT01052844|26612843|FG001|Overall Study|Adverse Event|1|||
13337329|NCT01052714|26612891|FG000|Overall Study|Adverse Event|6|||
13337330|NCT01052714|26612892|FG001|Overall Study|Adverse Event|3|||
13337331|NCT01052714|26612893|FG002|Overall Study|Adverse Event|0|||
13337332|NCT01052714|26612891|FG000|Overall Study|Death|1|||
13337333|NCT01052714|26612892|FG001|Overall Study|Death|2|||
13337334|NCT01052714|26612893|FG002|Overall Study|Death|0|||
13337335|NCT01052714|26612891|FG000|Overall Study|Lost to Follow-up|2|||
13337336|NCT01052714|26612892|FG001|Overall Study|Lost to Follow-up|3|||
13337337|NCT01052714|26612893|FG002|Overall Study|Lost to Follow-up|0|||
13337338|NCT01052714|26612891|FG000|Overall Study|Physician Decision|9|||
13337339|NCT01052714|26612892|FG001|Overall Study|Physician Decision|9|||
13337340|NCT01052714|26612893|FG002|Overall Study|Physician Decision|1|||
13337341|NCT01052714|26612891|FG000|Overall Study|Withdrawal by Subject|7|||
13337342|NCT01052714|26612892|FG001|Overall Study|Withdrawal by Subject|12|||
13337343|NCT01052714|26612893|FG002|Overall Study|Withdrawal by Subject|1|||
13337344|NCT01052480|26612948|FG000|Overall Study|Lost to Follow-up|3|||
13337345|NCT01052480|26612949|FG001|Overall Study|Lost to Follow-up|3|||
13337346|NCT01052480|26612948|FG000|Overall Study|Protocol Violation|1|||
13337347|NCT01052480|26612949|FG001|Overall Study|Protocol Violation|0|||
13337348|NCT01052480|26612948|FG000|Overall Study|Withdrawal by Subject|3|||
13337349|NCT01052480|26612949|FG001|Overall Study|Withdrawal by Subject|7|||
13337350|NCT01052480|26612948|FG000|Overall Study|Physician Decision|0|||
13337351|NCT01052480|26612949|FG001|Overall Study|Physician Decision|2|||
13337352|NCT01052480|26612948|FG000|Overall Study|Death|1|||
13337353|NCT01052480|26612949|FG001|Overall Study|Death|5|||
13337354|NCT01052428|26612974|FG000|Overall Study|Death|1|||
13337355|NCT01052428|26612975|FG001|Overall Study|Death|0|||
13337356|NCT01052428|26612974|FG000|Overall Study|Withdrawal by Subject|0|||
13337357|NCT01052428|26612975|FG001|Overall Study|Withdrawal by Subject|1|||
13337358|NCT01052272|26613022|FG000|Overall Study|Death|0|||
13337359|NCT01052272|26613023|FG001|Overall Study|Death|0|||
13337360|NCT01052272|26613024|FG002|Overall Study|Death|1|||
13337361|NCT01052272|26613025|FG003|Overall Study|Death|1|||
13337362|NCT01052272|26613022|FG000|Overall Study|Physician Decision|0|||
13337363|NCT01052272|26613023|FG001|Overall Study|Physician Decision|1|||
13337364|NCT01052272|26613024|FG002|Overall Study|Physician Decision|0|||
13337365|NCT01052272|26613025|FG003|Overall Study|Physician Decision|0|||
13337366|NCT01052272|26613022|FG000|Overall Study|patient refuses follow-up|5|||
13337367|NCT01052272|26613023|FG001|Overall Study|patient refuses follow-up|4|||
13337368|NCT01052272|26613024|FG002|Overall Study|patient refuses follow-up|2|||
13337369|NCT01052272|26613025|FG003|Overall Study|patient refuses follow-up|4|||
13337370|NCT01052272|26613022|FG000|Overall Study|Withdrawal by Subject|0|||
13337371|NCT01052272|26613023|FG001|Overall Study|Withdrawal by Subject|2|||
13337372|NCT01052272|26613024|FG002|Overall Study|Withdrawal by Subject|3|||
13337373|NCT01052272|26613025|FG003|Overall Study|Withdrawal by Subject|2|||
13337374|NCT01052272|26613022|FG000|Overall Study|placed in long-term care|0|||
13337375|NCT01052272|26613023|FG001|Overall Study|placed in long-term care|0|||
13337376|NCT01052272|26613024|FG002|Overall Study|placed in long-term care|1|||
13337377|NCT01052272|26613025|FG003|Overall Study|placed in long-term care|0|||
13337378|NCT01052272|26613022|FG000|Overall Study|decline in health|0|||
13337379|NCT01052272|26613023|FG001|Overall Study|decline in health|0|||
13337380|NCT01052272|26613024|FG002|Overall Study|decline in health|1|||
13337381|NCT01052272|26613025|FG003|Overall Study|decline in health|0|||
13337382|NCT01050634|26613035|FG000|Overall Study|Enrolled, but Not Treated|56|||
13337383|NCT01050634|26613035|FG000|Overall Study|Death|2|||
13337384|NCT01050634|26613035|FG000|Overall Study|Adverse Event|42|||
13204310|NCT01975220|26228232|FG002|Test Period 1|Not treated|0|||
13204311|NCT01975220|26228233|FG003|Test Period 1|Not treated|0|||
13337385|NCT01050634|26613035|FG000|Overall Study|Lost to Follow-up|2|||
13337386|NCT01050634|26613035|FG000|Overall Study|Other|21|||
13337387|NCT01050634|26613035|FG000|Overall Study|Ongoing at Date of Cut-Off|5|||
13337388|NCT01049503|26613083|FG000|Overall Study|Lost to Follow-up|11|||
13337389|NCT01049503|26613084|FG001|Overall Study|Lost to Follow-up|12|||
13337390|NCT01049503|26613085|FG002|Overall Study|Lost to Follow-up|24|||
13337391|NCT01049503|26613086|FG003|Overall Study|Lost to Follow-up|26|||
13337392|NCT01049503|26613087|FG004|Overall Study|Lost to Follow-up|27|||
13337393|NCT01049503|26613088|FG005|Overall Study|Lost to Follow-up|8|||
13337394|NCT01049412|26613122|FG000|Period I|Withdrawal by Subject|4|||
13337395|NCT01049412|26613123|FG001|Period I|Withdrawal by Subject|6|||
13337396|NCT01049412|26613122|FG000|Period I|Lost to Follow-up|2|||
13337397|NCT01049412|26613123|FG001|Period I|Lost to Follow-up|2|||
13337398|NCT01049412|26613122|FG000|Period I|Physician Decision|0|||
13337399|NCT01049412|26613123|FG001|Period I|Physician Decision|3|||
13337400|NCT01049412|26613122|FG000|Period I|Protocol Violation|1|||
13337401|NCT01049412|26613123|FG001|Period I|Protocol Violation|2|||
13337402|NCT01049412|26613122|FG000|Period I|Adverse Event|1|||
13337403|NCT01049412|26613123|FG001|Period I|Adverse Event|0|||
13337404|NCT01049412|26613122|FG000|Period II|Withdrawal by Subject|2|||
13337405|NCT01049412|26613123|FG001|Period II|Withdrawal by Subject|3|||
13337406|NCT01049412|26613122|FG000|Period II|Adverse Event|1|||
13337407|NCT01049412|26613123|FG001|Period II|Adverse Event|0|||
13337408|NCT01049412|26613122|FG000|Period II|Lost to Follow-up|1|||
13337409|NCT01049412|26613123|FG001|Period II|Lost to Follow-up|0|||
13337410|NCT01049217|26613200|FG000|Overall Study|Adverse Event|2|||
13337411|NCT01049217|26613201|FG001|Overall Study|Adverse Event|1|||
13337412|NCT01049217|26613200|FG000|Overall Study|Lack of Efficacy|1|||
13337413|NCT01049217|26613201|FG001|Overall Study|Lack of Efficacy|1|||
13337414|NCT01049217|26613200|FG000|Overall Study|Lost to Follow-up|3|||
13337415|NCT01049217|26613201|FG001|Overall Study|Lost to Follow-up|8|||
13337416|NCT01049217|26613200|FG000|Overall Study|Withdrawal by Subject|4|||
13337417|NCT01049217|26613201|FG001|Overall Study|Withdrawal by Subject|3|||
13337418|NCT01049217|26613200|FG000|Overall Study|Protocol Violation|1|||
13337419|NCT01049217|26613201|FG001|Overall Study|Protocol Violation|3|||
13337420|NCT01049217|26613200|FG000|Overall Study|Pregnancy|1|||
13204312|NCT01975220|26228234|FG004|Test Period 1|Not treated|0|||
13337421|NCT01049217|26613201|FG001|Overall Study|Pregnancy|0|||
13337422|NCT01049217|26613200|FG000|Overall Study|Study Terminated by Sponsor|43|||
13337423|NCT01049217|26613201|FG001|Overall Study|Study Terminated by Sponsor|43|||
13337424|NCT01049217|26613200|FG000|Overall Study|Other|1|||
13204313|NCT01975220|26228235|FG005|Test Period 1|Not treated|0|||
13337425|NCT01049217|26613201|FG001|Overall Study|Other|2|||
13337426|NCT01049217|26613200|FG000|Overall Study|Randomized but not Treated|0|||
13337427|NCT01049217|26613201|FG001|Overall Study|Randomized but not Treated|2|||
13337428|NCT01048541|26613210|FG000|Overall Study|Withdrawal by Subject|1|||
13337429|NCT01048541|26613211|FG001|Overall Study|Withdrawal by Subject|0|||
13337430|NCT01048099|26613221|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57|||
13337431|NCT01048099|26613221|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202|||
13337432|NCT01047501|26613254|FG000|Overall Study|Adverse Event|7|||
13337433|NCT01047501|26613255|FG001|Overall Study|Adverse Event|8|||
13337434|NCT01047501|26613256|FG002|Overall Study|Adverse Event|5|||
13337435|NCT01047501|26613254|FG000|Overall Study|Withdrew Consent|6|||
13337436|NCT01047501|26613255|FG001|Overall Study|Withdrew Consent|2|||
13337437|NCT01047501|26613256|FG002|Overall Study|Withdrew Consent|4|||
13337438|NCT01047501|26613254|FG000|Overall Study|Lost to Follow-up|0|||
13337439|NCT01047501|26613255|FG001|Overall Study|Lost to Follow-up|1|||
13337440|NCT01047501|26613256|FG002|Overall Study|Lost to Follow-up|1|||
13337441|NCT01047501|26613254|FG000|Overall Study|Triglycerides >800 mg/dL|1|||
13337442|NCT01047501|26613255|FG001|Overall Study|Triglycerides >800 mg/dL|0|||
13337443|NCT01047501|26613256|FG002|Overall Study|Triglycerides >800 mg/dL|0|||
13337444|NCT01047501|26613254|FG000|Overall Study|Death|1|||
13337445|NCT01047501|26613255|FG001|Overall Study|Death|0|||
13337446|NCT01047501|26613256|FG002|Overall Study|Death|0|||
13337447|NCT01047501|26613254|FG000|Overall Study|Other discontinuation|1|||
13337448|NCT01047501|26613255|FG001|Overall Study|Other discontinuation|0|||
13337449|NCT01047501|26613256|FG002|Overall Study|Other discontinuation|1|||
13337450|NCT01047501|26613254|FG000|Overall Study|Investigator judgement|0|||
13337451|NCT01047501|26613255|FG001|Overall Study|Investigator judgement|0|||
13337452|NCT01047501|26613256|FG002|Overall Study|Investigator judgement|1|||
13337453|NCT01046903|26613271|FG000|Overall Study|Lost to Follow-up|16|||
13337454|NCT01046903|26613271|FG000|Overall Study|Adverse Event|4|||
13337455|NCT01046903|26613271|FG000|Overall Study|Withdrawal by Subject|3|||
13337456|NCT01046903|26613271|FG000|Overall Study|Other|5|||
13337457|NCT01046136|26613288|FG000|Overall Study|Withdrawal by Subject|0|||
13337458|NCT01046136|26613289|FG001|Overall Study|Withdrawal by Subject|4|||
13337459|NCT01046136|26613288|FG000|Overall Study|Physician Decision|1|||
13337460|NCT01046136|26613289|FG001|Overall Study|Physician Decision|1|||
13337461|NCT01046136|26613288|FG000|Overall Study|Lost to Follow-up|3|||
13337462|NCT01046136|26613289|FG001|Overall Study|Lost to Follow-up|3|||
13337463|NCT01045993|26613376|FG000|Overall Study|Treated-later found eligibility not met|0|||
13337464|NCT01045993|26613377|FG001|Overall Study|Treated-later found eligibility not met|1|||
13337465|NCT01045993|26613378|FG002|Overall Study|Treated-later found eligibility not met|0|||
13337466|NCT01045993|26613379|FG003|Overall Study|Treated-later found eligibility not met|0|||
13337467|NCT01045707|26613402|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5|||
13337468|NCT01045707|26613403|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3|||
13337469|NCT01045707|26613402|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4|||
13337470|NCT01045707|26613403|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2|||
13337471|NCT01045707|26613402|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6|||
13337472|NCT01045707|26613403|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5|||
13337473|NCT01045707|26613402|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22|||
13337474|NCT01045707|26613403|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11|||
13337475|NCT01045707|26613402|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10|||
13337476|NCT01045707|26613403|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11|||
13337477|NCT01045707|26613402|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
13337478|NCT01045707|26613403|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
13337479|NCT01045707|26613402|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2|||
13337480|NCT01045707|26613403|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3|||
13337481|NCT01045707|26613402|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2|||
13337482|NCT01045707|26613403|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1|||
13337483|NCT01045707|26613402|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6|||
13337484|NCT01045707|26613403|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5|||
13337485|NCT01045447|26613418|FG000|Overall Study|Adverse Event|0|||
13337486|NCT01045447|26613419|FG001|Overall Study|Adverse Event|1|||
13337487|NCT01045447|26613418|FG000|Overall Study|Lack of Efficacy|3|||
13337488|NCT01045447|26613419|FG001|Overall Study|Lack of Efficacy|1|||
13337489|NCT01045447|26613418|FG000|Overall Study|Protocol Violation|6|||
13337490|NCT01045447|26613419|FG001|Overall Study|Protocol Violation|3|||
13337491|NCT01045447|26613418|FG000|Overall Study|Withdrawal Criteria|10|||
13337492|NCT01045447|26613419|FG001|Overall Study|Withdrawal Criteria|10|||
13337493|NCT01045447|26613418|FG000|Overall Study|Unclassified|17|||
13337494|NCT01045447|26613419|FG001|Overall Study|Unclassified|13|||
13337495|NCT01045096|26613455|FG000|Overall Study|Withdrawal by Subject|2|||
13337496|NCT01045096|26613456|FG001|Overall Study|Withdrawal by Subject|0|||
13337497|NCT01045096|26613457|FG002|Overall Study|Withdrawal by Subject|0|||
13337498|NCT01045096|26613455|FG000|Overall Study|Other|1|||
13337499|NCT01045096|26613456|FG001|Overall Study|Other|0|||
13337500|NCT01045096|26613457|FG002|Overall Study|Other|0|||
13337501|NCT01043705|26613477|FG000|Overall Study|Death|28|||
13337502|NCT01043705|26613478|FG001|Overall Study|Death|60|||
13337503|NCT01043705|26613479|FG002|Overall Study|Death|26|||
13337504|NCT01043705|26613477|FG000|Overall Study|Lost to Follow-up|27|||
13337505|NCT01043705|26613478|FG001|Overall Study|Lost to Follow-up|12|||
13337506|NCT01043705|26613479|FG002|Overall Study|Lost to Follow-up|0|||
13337507|NCT01043705|26613477|FG000|Overall Study|Multiple Reasons|4|||
13337508|NCT01043705|26613478|FG001|Overall Study|Multiple Reasons|7|||
13337509|NCT01043705|26613479|FG002|Overall Study|Multiple Reasons|0|||
13337510|NCT01043705|26613477|FG000|Overall Study|Protocol Violation|2|||
13337511|NCT01043705|26613478|FG001|Overall Study|Protocol Violation|1|||
13337512|NCT01043705|26613479|FG002|Overall Study|Protocol Violation|0|||
13337513|NCT01043705|26613477|FG000|Overall Study|Withdrawal by Subject|8|||
13337514|NCT01043705|26613478|FG001|Overall Study|Withdrawal by Subject|6|||
13337515|NCT01043705|26613479|FG002|Overall Study|Withdrawal by Subject|0|||
13337516|NCT01043705|26613477|FG000|Overall Study|Site Closure|8|||
13337517|NCT01043705|26613478|FG001|Overall Study|Site Closure|0|||
13337518|NCT01043705|26613479|FG002|Overall Study|Site Closure|0|||
13337519|NCT01043705|26613477|FG000|Overall Study|Subsequent Procedure|9|||
13337520|NCT01043705|26613478|FG001|Overall Study|Subsequent Procedure|24|||
13337521|NCT01043705|26613479|FG002|Overall Study|Subsequent Procedure|29|||
13337522|NCT01043705|26613477|FG000|Overall Study|Adverse Event|0|||
13337523|NCT01043705|26613478|FG001|Overall Study|Adverse Event|2|||
13337524|NCT01043705|26613479|FG002|Overall Study|Adverse Event|0|||
13337525|NCT01043705|26613477|FG000|Overall Study|Screen Fail|21|||
13337526|NCT01043705|26613478|FG001|Overall Study|Screen Fail|0|||
13337527|NCT01043705|26613479|FG002|Overall Study|Screen Fail|0|||
13337528|NCT01043705|26613477|FG000|Overall Study|Other|0|||
13337529|NCT01043705|26613478|FG001|Overall Study|Other|19|||
13337530|NCT01043705|26613479|FG002|Overall Study|Other|25|||
13337531|NCT01042392|26613514|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6|||
13337532|NCT01042392|26613515|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
13337533|NCT01042392|26613516|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5|||
13337534|NCT01042392|26613517|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
13337535|NCT01042392|26613514|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1|||
13337536|NCT01042392|26613515|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
13337537|NCT01042392|26613516|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
13337538|NCT01042392|26613517|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
13337539|NCT01042392|26613514|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1|||
13337540|NCT01042392|26613515|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
13337541|NCT01042392|26613516|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2|||
13337542|NCT01042392|26613517|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
13337543|NCT01042392|26613514|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
13337544|NCT01042392|26613515|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
13337545|NCT01042392|26613516|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1|||
13337546|NCT01042392|26613517|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
13337547|NCT01042392|26613514|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2|||
13337548|NCT01042392|26613515|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
13337549|NCT01042392|26613516|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
13337550|NCT01042392|26613517|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
13337551|NCT01042392|26613514|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
13337552|NCT01042392|26613515|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
13337553|NCT01042392|26613516|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1|||
13337554|NCT01042392|26613517|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
13337555|NCT01042392|26613514|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2|||
13337556|NCT01042392|26613515|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
13337557|NCT01042392|26613516|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
13337558|NCT01042392|26613517|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
13337559|NCT01042392|26613514|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
13337560|NCT01042392|26613515|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
13337561|NCT01042392|26613516|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2|||
13337562|NCT01042392|26613517|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
13337563|NCT01042392|26613514|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0|||
13337564|NCT01042392|26613515|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
13337565|NCT01042392|26613516|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
13337566|NCT01042392|26613517|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
13337567|NCT01042236|26613561|FG000|Treatment Period 1|Adverse Event|0|||
13337568|NCT01042236|26613562|FG001|Treatment Period 1|Adverse Event|1|||
13337569|NCT01042236|26613563|FG002|Treatment Period 1|Adverse Event|0|||
13337570|NCT01042236|26613564|FG003|Treatment Period 1|Adverse Event|0|||
13337571|NCT01042236|26613565|FG004|Treatment Period 1|Adverse Event|1|||
13337572|NCT01042236|26613566|FG005|Treatment Period 1|Adverse Event|0|||
13337573|NCT01042236|26613561|FG000|Treatment Period 3|Adverse Event|0|||
13337574|NCT01042236|26613562|FG001|Treatment Period 3|Adverse Event|0|||
13337575|NCT01042236|26613563|FG002|Treatment Period 3|Adverse Event|0|||
13337576|NCT01042236|26613564|FG003|Treatment Period 3|Adverse Event|1|||
13337577|NCT01042236|26613565|FG004|Treatment Period 3|Adverse Event|0|||
13337578|NCT01042236|26613566|FG005|Treatment Period 3|Adverse Event|0|||
13337579|NCT01042236|26613561|FG000|Treatment Period 3|Protocol Violation|0|||
13337580|NCT01042236|26613562|FG001|Treatment Period 3|Protocol Violation|0|||
13337581|NCT01042236|26613563|FG002|Treatment Period 3|Protocol Violation|0|||
13337582|NCT01042236|26613564|FG003|Treatment Period 3|Protocol Violation|1|||
13337583|NCT01042236|26613565|FG004|Treatment Period 3|Protocol Violation|0|||
13337584|NCT01042236|26613566|FG005|Treatment Period 3|Protocol Violation|0|||
13337585|NCT01041404|26613612|FG000|Overall Study|Adverse Event|45|||
13337586|NCT01041404|26613613|FG001|Overall Study|Adverse Event|35|||
13337587|NCT01041404|26613612|FG000|Overall Study|Lack of Efficacy|200|||
13337588|NCT01041404|26613613|FG001|Overall Study|Lack of Efficacy|210|||
13337589|NCT01041404|26613612|FG000|Overall Study|Violation of Selection Criteria|0|||
13337590|NCT01041404|26613613|FG001|Overall Study|Violation of Selection Criteria|1|||
13337591|NCT01041404|26613612|FG000|Overall Study|Protocol Violation|4|||
13337592|NCT01041404|26613613|FG001|Overall Study|Protocol Violation|0|||
13337593|NCT01041404|26613612|FG000|Overall Study|Withdrawal by Subject|29|||
13337594|NCT01041404|26613613|FG001|Overall Study|Withdrawal by Subject|23|||
13337595|NCT01041404|26613612|FG000|Overall Study|Failure to Return|1|||
13337596|NCT01041404|26613613|FG001|Overall Study|Failure to Return|2|||
13337597|NCT01041404|26613612|FG000|Overall Study|Other|11|||
13337598|NCT01041404|26613613|FG001|Overall Study|Other|23|||
13337599|NCT01040832|26613634|FG000|Overall Study|Adverse Event|4|||
13337600|NCT01040832|26613635|FG001|Overall Study|Adverse Event|5|||
13337601|NCT01040832|26613634|FG000|Overall Study|Death|4|||
13337602|NCT01040832|26613635|FG001|Overall Study|Death|6|||
13337603|NCT01040832|26613634|FG000|Overall Study|Withdrawal by Subject|2|||
13337604|NCT01040832|26613635|FG001|Overall Study|Withdrawal by Subject|3|||
13337605|NCT01040832|26613634|FG000|Overall Study|Progressive disease|32|||
13337606|NCT01040832|26613635|FG001|Overall Study|Progressive disease|17|||
13337607|NCT01040832|26613634|FG000|Overall Study|Symptomatic deterioration|2|||
13337608|NCT01040832|26613635|FG001|Overall Study|Symptomatic deterioration|5|||
13337609|NCT01040832|26613634|FG000|Overall Study|Other|2|||
13337610|NCT01040832|26613635|FG001|Overall Study|Other|1|||
13337611|NCT01040793|26613719|FG000|Overall Study|Adverse Event|5|||
13337612|NCT01040793|26613720|FG001|Overall Study|Adverse Event|3|||
13337613|NCT01040793|26613721|FG002|Overall Study|Adverse Event|0|||
13337614|NCT01040793|26613722|FG003|Overall Study|Adverse Event|2|||
13337615|NCT01040793|26613723|FG004|Overall Study|Adverse Event|2|||
13337616|NCT01040793|26613724|FG005|Overall Study|Adverse Event|1|||
13337617|NCT01040793|26613719|FG000|Overall Study|Protocol Violation|1|||
13337618|NCT01040793|26613720|FG001|Overall Study|Protocol Violation|1|||
13337619|NCT01040793|26613721|FG002|Overall Study|Protocol Violation|1|||
13337620|NCT01040793|26613722|FG003|Overall Study|Protocol Violation|0|||
13337621|NCT01040793|26613723|FG004|Overall Study|Protocol Violation|1|||
13337622|NCT01040793|26613724|FG005|Overall Study|Protocol Violation|0|||
13337623|NCT01040793|26613719|FG000|Overall Study|Lost to Follow-up|0|||
13337624|NCT01040793|26613720|FG001|Overall Study|Lost to Follow-up|1|||
13337625|NCT01040793|26613721|FG002|Overall Study|Lost to Follow-up|1|||
13337626|NCT01040793|26613722|FG003|Overall Study|Lost to Follow-up|0|||
13337627|NCT01040793|26613723|FG004|Overall Study|Lost to Follow-up|0|||
13337628|NCT01040793|26613724|FG005|Overall Study|Lost to Follow-up|0|||
13337629|NCT01040793|26613719|FG000|Overall Study|Withdrawal by Subject|0|||
13337630|NCT01040793|26613720|FG001|Overall Study|Withdrawal by Subject|0|||
13337631|NCT01040793|26613721|FG002|Overall Study|Withdrawal by Subject|0|||
13337632|NCT01040793|26613722|FG003|Overall Study|Withdrawal by Subject|2|||
13337633|NCT01040793|26613723|FG004|Overall Study|Withdrawal by Subject|0|||
13337634|NCT01040793|26613724|FG005|Overall Study|Withdrawal by Subject|0|||
13337635|NCT01040793|26613719|FG000|Overall Study|Other reasons not listed above|0|||
13337636|NCT01040793|26613720|FG001|Overall Study|Other reasons not listed above|0|||
13337637|NCT01040793|26613721|FG002|Overall Study|Other reasons not listed above|1|||
13337638|NCT01040793|26613722|FG003|Overall Study|Other reasons not listed above|0|||
13337639|NCT01040793|26613723|FG004|Overall Study|Other reasons not listed above|1|||
13337640|NCT01040793|26613724|FG005|Overall Study|Other reasons not listed above|0|||
13337641|NCT01040780|26613745|FG000|Overall Study|Protocol Violation|1|||
13337642|NCT01040780|26613746|FG001|Overall Study|Protocol Violation|3|||
13337643|NCT01040403|26613934|FG000|Overall Study|Adverse Event|10|||
13337644|NCT01040403|26613934|FG000|Overall Study|Protocol Violation|2|||
13337645|NCT01040403|26613934|FG000|Overall Study|Lost to Follow-up|1|||
13337646|NCT01040403|26613934|FG000|Overall Study|Not treated|1|||
13337647|NCT01040403|26613934|FG000|Overall Study|Other reason not defined above|6|||
13337648|NCT01040130|26614018|FG000|Overall Study|Adverse Event|1|||
13337649|NCT01040130|26614019|FG001|Overall Study|Adverse Event|1|||
13337650|NCT01040130|26614020|FG002|Overall Study|Adverse Event|0|||
13337651|NCT01040130|26614021|FG003|Overall Study|Adverse Event|5|||
13337652|NCT01040130|26614022|FG004|Overall Study|Adverse Event|0|||
13337653|NCT01040130|26614023|FG005|Overall Study|Adverse Event|3|||
13337654|NCT01040130|26614018|FG000|Overall Study|Protocol Violation|0|||
13337655|NCT01040130|26614019|FG001|Overall Study|Protocol Violation|0|||
13337656|NCT01040130|26614020|FG002|Overall Study|Protocol Violation|2|||
13337657|NCT01040130|26614021|FG003|Overall Study|Protocol Violation|0|||
13337658|NCT01040130|26614022|FG004|Overall Study|Protocol Violation|0|||
13337659|NCT01040130|26614023|FG005|Overall Study|Protocol Violation|0|||
13337660|NCT01040130|26614018|FG000|Overall Study|Withdrawal by Subject|0|||
13337661|NCT01040130|26614019|FG001|Overall Study|Withdrawal by Subject|2|||
13337662|NCT01040130|26614020|FG002|Overall Study|Withdrawal by Subject|0|||
13337663|NCT01040130|26614021|FG003|Overall Study|Withdrawal by Subject|0|||
13337664|NCT01040130|26614022|FG004|Overall Study|Withdrawal by Subject|0|||
13337665|NCT01040130|26614023|FG005|Overall Study|Withdrawal by Subject|1|||
13337666|NCT01040130|26614018|FG000|Overall Study|Other reasons not listed above|2|||
13337667|NCT01040130|26614019|FG001|Overall Study|Other reasons not listed above|0|||
13337668|NCT01040130|26614020|FG002|Overall Study|Other reasons not listed above|0|||
13337669|NCT01040130|26614021|FG003|Overall Study|Other reasons not listed above|0|||
13337670|NCT01040130|26614022|FG004|Overall Study|Other reasons not listed above|0|||
13337671|NCT01040130|26614023|FG005|Overall Study|Other reasons not listed above|0|||
13337672|NCT01039688|26614302|FG000|Overall Study|Adverse Event|38|||
13337673|NCT01039688|26614303|FG001|Overall Study|Adverse Event|39|||
13337674|NCT01039688|26614304|FG002|Overall Study|Adverse Event|24|||
13337675|NCT01039688|26614302|FG000|Overall Study|Lack of Efficacy|20|||
13337676|NCT01039688|26614303|FG001|Overall Study|Lack of Efficacy|11|||
13337677|NCT01039688|26614304|FG002|Overall Study|Lack of Efficacy|26|||
13337678|NCT01039688|26614302|FG000|Overall Study|Lost to Follow-up|11|||
13337679|NCT01039688|26614303|FG001|Overall Study|Lost to Follow-up|9|||
13337680|NCT01039688|26614304|FG002|Overall Study|Lost to Follow-up|5|||
13337681|NCT01039688|26614302|FG000|Overall Study|Other|13|||
13337682|NCT01039688|26614303|FG001|Overall Study|Other|25|||
13337683|NCT01039688|26614304|FG002|Overall Study|Other|12|||
13337684|NCT01039688|26614302|FG000|Overall Study|Withdrawal by Subject|23|||
13337685|NCT01039688|26614303|FG001|Overall Study|Withdrawal by Subject|27|||
13337686|NCT01039688|26614304|FG002|Overall Study|Withdrawal by Subject|13|||
13337687|NCT01039688|26614302|FG000|Overall Study|Death|2|||
13337688|NCT01039688|26614303|FG001|Overall Study|Death|0|||
13337689|NCT01039688|26614304|FG002|Overall Study|Death|0|||
13337690|NCT01039675|26614321|FG000|Overall Study|Adverse Event|0|||
13337691|NCT01039675|26614322|FG001|Overall Study|Adverse Event|2|||
13337692|NCT01039675|26614321|FG000|Overall Study|Lack of Efficacy|0|||
13337693|NCT01039675|26614322|FG001|Overall Study|Lack of Efficacy|2|||
13337694|NCT01039675|26614321|FG000|Overall Study|Withdrawal by Subject|0|||
13337695|NCT01039675|26614322|FG001|Overall Study|Withdrawal by Subject|1|||
13337696|NCT01039675|26614321|FG000|Overall Study|Lost to Follow-up|0|||
13337697|NCT01039675|26614322|FG001|Overall Study|Lost to Follow-up|1|||
13337698|NCT01039675|26614321|FG000|Overall Study|Physician Decision|0|||
13337699|NCT01039675|26614322|FG001|Overall Study|Physician Decision|1|||
13337700|NCT01039584|26614346|FG000|Overall Study|Withdrawal by Subject|4|||
13337701|NCT01039584|26614347|FG001|Overall Study|Withdrawal by Subject|2|||
13337702|NCT01039584|26614348|FG002|Overall Study|Withdrawal by Subject|1|||
13337703|NCT01039584|26614346|FG000|Overall Study|Protocol Violation|10|||
13337704|NCT01039584|26614347|FG001|Overall Study|Protocol Violation|4|||
13337705|NCT01039584|26614348|FG002|Overall Study|Protocol Violation|6|||
13337706|NCT01039584|26614346|FG000|Overall Study|Lost to Follow-up|5|||
13337707|NCT01039584|26614347|FG001|Overall Study|Lost to Follow-up|3|||
13337708|NCT01039584|26614348|FG002|Overall Study|Lost to Follow-up|4|||
13337709|NCT01039584|26614346|FG000|Overall Study|Negative Baseline culture for Candida|59|||
13337710|NCT01039584|26614347|FG001|Overall Study|Negative Baseline culture for Candida|59|||
13337711|NCT01039584|26614348|FG002|Overall Study|Negative Baseline culture for Candida|24|||
13337712|NCT01039584|26614346|FG000|Overall Study|Lack of Efficacy|7|||
13337713|NCT01039584|26614347|FG001|Overall Study|Lack of Efficacy|6|||
13337714|NCT01039584|26614348|FG002|Overall Study|Lack of Efficacy|10|||
13337715|NCT01039584|26614346|FG000|Overall Study|other|1|||
13337716|NCT01039584|26614347|FG001|Overall Study|other|3|||
13337717|NCT01039584|26614348|FG002|Overall Study|other|1|||
13337718|NCT01039584|26614346|FG000|Overall Study|Pap smear with significant pathology|10|||
13337719|NCT01039584|26614347|FG001|Overall Study|Pap smear with significant pathology|10|||
13337720|NCT01039584|26614348|FG002|Overall Study|Pap smear with significant pathology|3|||
13337721|NCT01039584|26614346|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7|||
13337722|NCT01039584|26614347|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10|||
13337723|NCT01039584|26614348|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8|||
13337724|NCT01039519|26614359|FG000|Treatment|Progressive disease|20|||
13337725|NCT01039519|26614359|FG000|Treatment|Treatment failure|2|||
13337726|NCT01039519|26614359|FG000|Treatment|Adverse Event|3|||
13337727|NCT01039519|26614359|FG000|Treatment|Physician Decision|2|||
13337728|NCT01039519|26614359|FG000|Survival Follow-up|Death|23|||
13337729|NCT01039519|26614359|FG000|Survival Follow-up|Sponsor decision|4|||
13337730|NCT01039428|26614388|FG000|Overall Study|Protocol Violation|1|||
13337731|NCT01039428|26614389|FG001|Overall Study|Protocol Violation|0|||
13337732|NCT01039428|26614388|FG000|Overall Study|Withdrawal by Subject|1|||
13337733|NCT01039428|26614389|FG001|Overall Study|Withdrawal by Subject|0|||
13337734|NCT01039376|26614455|FG000|Overall Study|Lost to Follow-up|5|||
13337735|NCT01039376|26614456|FG001|Overall Study|Lost to Follow-up|12|||
13337736|NCT01039376|26614455|FG000|Overall Study|Physician Decision|15|||
13337737|NCT01039376|26614456|FG001|Overall Study|Physician Decision|10|||
13337738|NCT01039376|26614455|FG000|Overall Study|Withdrawal by Subject|20|||
13337739|NCT01039376|26614456|FG001|Overall Study|Withdrawal by Subject|32|||
13337740|NCT01039376|26614455|FG000|Overall Study|Study terminated by Sponsor|90|||
13337741|NCT01039376|26614456|FG001|Overall Study|Study terminated by Sponsor|72|||
13337742|NCT01038921|26614469|FG000|Overall Study|Withdrawal by Subject|1|||
13337743|NCT01038921|26614470|FG001|Overall Study|Withdrawal by Subject|0|||
13337744|NCT01038921|26614469|FG000|Overall Study|Physician Decision|1|||
13337745|NCT01038921|26614470|FG001|Overall Study|Physician Decision|0|||
13337746|NCT01038869|26614480|FG000|Overall Study|Withdrawal by Subject|1|||
13337747|NCT01038869|26614480|FG000|Overall Study|Lost to Follow-up|6|||
13337748|NCT01038856|26614489|FG000|Overall Study|Adverse Event|2|||
13337749|NCT01038752|26614516|FG000|Overall Study|Tumor Progression|2|||
13337750|NCT01038752|26614517|FG001|Overall Study|Tumor Progression|2|||
13337751|NCT01038752|26614516|FG000|Overall Study|Lost to Follow-up|3|||
13337752|NCT01038752|26614517|FG001|Overall Study|Lost to Follow-up|3|||
13337753|NCT01038713|26614547|FG000|Overall Study|Patient to hospice|1|||
13337754|NCT01038713|26614548|FG001|Overall Study|Patient to hospice|1|||
13337755|NCT01038713|26614549|FG002|Overall Study|Patient to hospice|1|||
13337756|NCT01038713|26614547|FG000|Overall Study|Lost to Follow-up|3|||
13337757|NCT01038713|26614548|FG001|Overall Study|Lost to Follow-up|0|||
13337758|NCT01038713|26614549|FG002|Overall Study|Lost to Follow-up|0|||
13337759|NCT01038713|26614547|FG000|Overall Study|Neuroendocrine Tumor|0|||
13337760|NCT01038713|26614548|FG001|Overall Study|Neuroendocrine Tumor|1|||
13337761|NCT01038713|26614549|FG002|Overall Study|Neuroendocrine Tumor|0|||
13337762|NCT01038713|26614547|FG000|Overall Study|died from PEP|0|||
13337763|NCT01038713|26614548|FG001|Overall Study|died from PEP|1|||
13337764|NCT01038713|26614549|FG002|Overall Study|died from PEP|0|||
13337765|NCT01038713|26614547|FG000|Overall Study|Autoimmune Pancreatitis|1|||
13337766|NCT01038713|26614548|FG001|Overall Study|Autoimmune Pancreatitis|0|||
13337767|NCT01038713|26614549|FG002|Overall Study|Autoimmune Pancreatitis|0|||
13337768|NCT01038687|26614591|FG000|Overall Study|Adverse Event|0|||
13337769|NCT01038687|26614592|FG001|Overall Study|Adverse Event|2|||
13337770|NCT01038687|26614593|FG002|Overall Study|Adverse Event|1|||
13337771|NCT01038635|26614642|FG000|Overall Study|Disease Progression|2|||
13337772|NCT01038635|26614643|FG001|Overall Study|Disease Progression|0|||
13337773|NCT01038635|26614644|FG002|Overall Study|Disease Progression|0|||
13337774|NCT01038635|26614645|FG003|Overall Study|Disease Progression|0|||
13337775|NCT01038635|26614646|FG004|Overall Study|Disease Progression|0|||
13337776|NCT01038635|26614647|FG005|Overall Study|Disease Progression|0|||
13337777|NCT01038635|26614648|FG006|Overall Study|Disease Progression|1|||
13337778|NCT01038635|26614649|FG007|Overall Study|Disease Progression|4|||
13337779|NCT01038635|26614650|FG008|Overall Study|Disease Progression|0|||
13337780|NCT01038635|26614642|FG000|Overall Study|Death|0|||
13337781|NCT01038635|26614643|FG001|Overall Study|Death|0|||
13337782|NCT01038635|26614644|FG002|Overall Study|Death|0|||
13337783|NCT01038635|26614645|FG003|Overall Study|Death|0|||
13337784|NCT01038635|26614646|FG004|Overall Study|Death|1|||
13337785|NCT01038635|26614647|FG005|Overall Study|Death|0|||
13337786|NCT01038635|26614648|FG006|Overall Study|Death|1|||
13337787|NCT01038635|26614649|FG007|Overall Study|Death|1|||
13337788|NCT01038635|26614650|FG008|Overall Study|Death|2|||
13337789|NCT01038609|26614708|FG000|Overall Study|Adverse Event|0|||
13337790|NCT01038609|26614709|FG001|Overall Study|Adverse Event|0|||
13337791|NCT01038609|26614710|FG002|Overall Study|Adverse Event|1|||
13337792|NCT01038609|26614711|FG003|Overall Study|Adverse Event|0|||
13337793|NCT01038609|26614712|FG004|Overall Study|Adverse Event|0|||
13337794|NCT01038609|26614708|FG000|Overall Study|Dosing Error|0|||
13337795|NCT01038609|26614709|FG001|Overall Study|Dosing Error|0|||
13337796|NCT01038609|26614710|FG002|Overall Study|Dosing Error|0|||
13337797|NCT01038609|26614711|FG003|Overall Study|Dosing Error|1|||
13337798|NCT01038609|26614712|FG004|Overall Study|Dosing Error|1|||
13337799|NCT01038609|26614708|FG000|Overall Study|Death in the Family|1|||
13337800|NCT01038609|26614709|FG001|Overall Study|Death in the Family|0|||
13337801|NCT01038609|26614710|FG002|Overall Study|Death in the Family|0|||
13337802|NCT01038609|26614711|FG003|Overall Study|Death in the Family|0|||
13337803|NCT01038609|26614712|FG004|Overall Study|Death in the Family|0|||
13337804|NCT01038609|26614708|FG000|Overall Study|Refusal of Blood Draws|0|||
13337805|NCT01038609|26614709|FG001|Overall Study|Refusal of Blood Draws|1|||
13337806|NCT01038609|26614710|FG002|Overall Study|Refusal of Blood Draws|0|||
13337807|NCT01038609|26614711|FG003|Overall Study|Refusal of Blood Draws|0|||
13337808|NCT01038609|26614712|FG004|Overall Study|Refusal of Blood Draws|0|||
13337809|NCT01038427|26614743|FG000|Overall Study|Lost to follow up|1|||
13337810|NCT01038427|26614744|FG001|Overall Study|Lost to follow up|1|||
13337811|NCT01038427|26614745|FG002|Overall Study|Lost to follow up|0|||
13337812|NCT01038427|26614743|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
13337813|NCT01038427|26614744|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
13337814|NCT01038427|26614745|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
13337815|NCT01038427|26614743|FG000|Overall Study|Withdrew consent|0|||
13337816|NCT01038427|26614744|FG001|Overall Study|Withdrew consent|0|||
13337817|NCT01038427|26614745|FG002|Overall Study|Withdrew consent|1|||
13337818|NCT01038427|26614743|FG000|Overall Study|Adverse Event|2|||
13337819|NCT01038427|26614744|FG001|Overall Study|Adverse Event|2|||
13337820|NCT01038427|26614745|FG002|Overall Study|Adverse Event|1|||
13337821|NCT01038427|26614743|FG000|Overall Study|Enrolled in error|0|||
13337822|NCT01038427|26614744|FG001|Overall Study|Enrolled in error|1|||
13337823|NCT01038427|26614745|FG002|Overall Study|Enrolled in error|1|||
13337824|NCT01038427|26614743|FG000|Overall Study|Other|0|||
13337825|NCT01038427|26614744|FG001|Overall Study|Other|2|||
13337826|NCT01038427|26614745|FG002|Overall Study|Other|0|||
13337827|NCT01038323|26614769|FG000|Overall Study|Withdrawal by Subject|3|||
13337828|NCT01038323|26614770|FG001|Overall Study|Withdrawal by Subject|2|||
13337829|NCT01038323|26614771|FG002|Overall Study|Withdrawal by Subject|4|||
13337830|NCT01038297|26614816|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1|||
13337831|NCT01038297|26614817|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
13337832|NCT01038297|26614818|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
13337833|NCT01038128|26614828|FG000|Overall Study|Lack of Efficacy|1|||
13337834|NCT01038128|26614828|FG000|Overall Study|Lost to Follow-up|1|||
13337835|NCT01038128|26614828|FG000|Overall Study|Withdrawal by Subject|2|||
13337836|NCT01037985|26614856|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3|||
13337837|NCT01037985|26614857|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0|||
13337838|NCT01037985|26614856|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1|||
13337839|NCT01037985|26614857|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0|||
13337840|NCT01037985|26614856|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0|||
13337841|NCT01037985|26614857|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1|||
13337842|NCT01037985|26614856|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0|||
13337843|NCT01037985|26614857|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4|||
13337844|NCT01037413|26614882|FG000|Part A: Skin Testing|Adverse Event|1|||
13337845|NCT01037413|26614883|FG001|Part A: Skin Testing|Adverse Event|0|||
13337846|NCT01037413|26614882|FG000|Part A: Skin Testing|Protocol Violation|1|||
13337847|NCT01037413|26614883|FG001|Part A: Skin Testing|Protocol Violation|0|||
13337848|NCT01037413|26614882|FG000|Part B: Scar Revision|Withdrawal by Subject|0|||
13337849|NCT01037413|26614883|FG001|Part B: Scar Revision|Withdrawal by Subject|1|||
13337850|NCT01037413|26614882|FG000|Part B: Scar Revision|Assigned But Not Treated|0|||
13337851|NCT01037413|26614883|FG001|Part B: Scar Revision|Assigned But Not Treated|1|||
13337852|NCT01037244|26614954|FG000|Overall Study|Adverse Event|3|||
13337853|NCT01037244|26614955|FG001|Overall Study|Adverse Event|2|||
13337854|NCT01037244|26614956|FG002|Overall Study|Adverse Event|6|||
13337855|NCT01037244|26614957|FG003|Overall Study|Adverse Event|3|||
13337856|NCT01037244|26614954|FG000|Overall Study|Lack of Efficacy|1|||
13337857|NCT01037244|26614955|FG001|Overall Study|Lack of Efficacy|1|||
13337858|NCT01037244|26614956|FG002|Overall Study|Lack of Efficacy|0|||
13337859|NCT01037244|26614957|FG003|Overall Study|Lack of Efficacy|1|||
13337860|NCT01037244|26614954|FG000|Overall Study|Lost to Follow-up|3|||
13337861|NCT01037244|26614955|FG001|Overall Study|Lost to Follow-up|3|||
13337862|NCT01037244|26614956|FG002|Overall Study|Lost to Follow-up|4|||
13337863|NCT01037244|26614957|FG003|Overall Study|Lost to Follow-up|4|||
13337864|NCT01037244|26614954|FG000|Overall Study|Withdrawal by Subject|1|||
13337865|NCT01037244|26614955|FG001|Overall Study|Withdrawal by Subject|5|||
13337866|NCT01037244|26614956|FG002|Overall Study|Withdrawal by Subject|3|||
13337867|NCT01037244|26614957|FG003|Overall Study|Withdrawal by Subject|5|||
13337868|NCT01037244|26614954|FG000|Overall Study|Partner Withdrew Consent|2|||
13337869|NCT01037244|26614955|FG001|Overall Study|Partner Withdrew Consent|1|||
13337870|NCT01037244|26614956|FG002|Overall Study|Partner Withdrew Consent|0|||
13337871|NCT01037244|26614957|FG003|Overall Study|Partner Withdrew Consent|0|||
13337872|NCT01037244|26614954|FG000|Overall Study|Various|3|||
13337873|NCT01037244|26614955|FG001|Overall Study|Various|2|||
13337874|NCT01037244|26614956|FG002|Overall Study|Various|1|||
13337875|NCT01037244|26614957|FG003|Overall Study|Various|1|||
13337876|NCT01037218|26615028|FG000|Overall Study|Adverse Event|4|||
13337877|NCT01037218|26615029|FG001|Overall Study|Adverse Event|2|||
13337878|NCT01037218|26615030|FG002|Overall Study|Adverse Event|2|||
13337879|NCT01037218|26615031|FG003|Overall Study|Adverse Event|1|||
13337880|NCT01037218|26615028|FG000|Overall Study|Lack of Efficacy|0|||
13337881|NCT01037218|26615029|FG001|Overall Study|Lack of Efficacy|2|||
13337882|NCT01037218|26615030|FG002|Overall Study|Lack of Efficacy|1|||
13337883|NCT01037218|26615031|FG003|Overall Study|Lack of Efficacy|5|||
13337884|NCT01037218|26615028|FG000|Overall Study|Lost to Follow-up|3|||
13337885|NCT01037218|26615029|FG001|Overall Study|Lost to Follow-up|5|||
13337886|NCT01037218|26615030|FG002|Overall Study|Lost to Follow-up|4|||
13337887|NCT01037218|26615031|FG003|Overall Study|Lost to Follow-up|2|||
13337888|NCT01037218|26615028|FG000|Overall Study|Withdrawal by Subject|6|||
13337889|NCT01037218|26615029|FG001|Overall Study|Withdrawal by Subject|7|||
13337890|NCT01037218|26615030|FG002|Overall Study|Withdrawal by Subject|7|||
13337891|NCT01037218|26615031|FG003|Overall Study|Withdrawal by Subject|4|||
13337892|NCT01037218|26615028|FG000|Overall Study|Partner Withdrew Consent|0|||
13337893|NCT01037218|26615029|FG001|Overall Study|Partner Withdrew Consent|3|||
13337894|NCT01037218|26615030|FG002|Overall Study|Partner Withdrew Consent|2|||
13337895|NCT01037218|26615031|FG003|Overall Study|Partner Withdrew Consent|1|||
13337896|NCT01037218|26615028|FG000|Overall Study|Protocol Violation|0|||
13337897|NCT01037218|26615029|FG001|Overall Study|Protocol Violation|0|||
13337898|NCT01037218|26615030|FG002|Overall Study|Protocol Violation|2|||
13337899|NCT01037218|26615031|FG003|Overall Study|Protocol Violation|2|||
13337900|NCT01037218|26615028|FG000|Overall Study|Various|3|||
13337901|NCT01037218|26615029|FG001|Overall Study|Various|2|||
13337902|NCT01037218|26615030|FG002|Overall Study|Various|3|||
13337903|NCT01037218|26615031|FG003|Overall Study|Various|1|||
13337904|NCT01037127|26615070|FG000|Overall Study|Lost to Follow-up|2|||
13337905|NCT01037127|26615071|FG001|Overall Study|Lost to Follow-up|4|||
13337906|NCT01037127|26615070|FG000|Overall Study|Physician Decision|1|||
13337907|NCT01037127|26615071|FG001|Overall Study|Physician Decision|0|||
13337908|NCT01037127|26615070|FG000|Overall Study|Study Closed Terminated|2|||
13337909|NCT01037127|26615071|FG001|Overall Study|Study Closed Terminated|17|||
13337910|NCT01037114|26615086|FG000|Year 20|Others|1|||
13337911|NCT01037088|26615099|FG000|Overall Study|Withdrawal by Subject|3|||
13337912|NCT01036763|26615111|FG000|Overall Study|Adverse Event|25|||
13337913|NCT01036763|26615111|FG000|Overall Study|Lost to Follow-up|28|||
13337914|NCT01036763|26615111|FG000|Overall Study|Other reason (not specified)|40|||
13337915|NCT01036724|26615126|FG000|Overall Study|Adverse Event|1|||
13337916|NCT01036724|26615127|FG001|Overall Study|Adverse Event|2|||
13337917|NCT01036724|26615126|FG000|Overall Study|Lack of Efficacy|1|||
13337918|NCT01036724|26615127|FG001|Overall Study|Lack of Efficacy|1|||
13337919|NCT01036724|26615126|FG000|Overall Study|Protocol Violation|4|||
13337920|NCT01036724|26615127|FG001|Overall Study|Protocol Violation|5|||
13373894|NCT00798967|26725185|FG000|Overall Study|Withdrawal by Subject|0|||
13373895|NCT00798967|26725186|FG001|Overall Study|Withdrawal by Subject|1|||
13373896|NCT00798967|26725185|FG000|Overall Study|Physician Decision|1|||
13373897|NCT00798967|26725186|FG001|Overall Study|Physician Decision|0|||
13373898|NCT00798967|26725185|FG000|Overall Study|Randomized in error by site|1|||
13373899|NCT00798967|26725186|FG001|Overall Study|Randomized in error by site|0|||
13373900|NCT00798889|26725192|FG000|Overall Study|Adverse Event|53|||
13373901|NCT00798889|26725192|FG000|Overall Study|Protocol Violation|2|||
13373902|NCT00798889|26725192|FG000|Overall Study|Withdrawal by Subject|31|||
13373903|NCT00798889|26725192|FG000|Overall Study|Lost to Follow-up|1|||
13373904|NCT00798889|26725192|FG000|Overall Study|Lack of Efficacy|213|||
13373905|NCT00798889|26725192|FG000|Overall Study|Decision of Sponsor|11|||
13373906|NCT00798889|26725192|FG000|Overall Study|Enrolled, Not treated|3|||
13373907|NCT00798759|26725207|FG000|Overall Study|Adverse Event|3|||
13373908|NCT00798759|26725208|FG001|Overall Study|Adverse Event|3|||
13373909|NCT00798759|26725207|FG000|Overall Study|Lost to Follow-up|1|||
13373910|NCT00798759|26725208|FG001|Overall Study|Lost to Follow-up|1|||
13373911|NCT00798759|26725207|FG000|Overall Study|Protocol Violation|4|||
13373912|NCT00798759|26725208|FG001|Overall Study|Protocol Violation|8|||
13373913|NCT00798759|26725207|FG000|Overall Study|Other|0|||
13373914|NCT00798759|26725208|FG001|Overall Study|Other|1|||
13373915|NCT00798707|26725268|FG000|Overall Study|Adverse Event|6|||
13373916|NCT00798707|26725269|FG001|Overall Study|Adverse Event|8|||
13373917|NCT00798707|26725270|FG002|Overall Study|Adverse Event|8|||
13373918|NCT00798707|26725268|FG000|Overall Study|Failed to return|2|||
13373919|NCT00798707|26725269|FG001|Overall Study|Failed to return|2|||
13373920|NCT00798707|26725270|FG002|Overall Study|Failed to return|0|||
13373921|NCT00798707|26725268|FG000|Overall Study|Investigator|0|||
13373922|NCT00798707|26725269|FG001|Overall Study|Investigator|1|||
13373923|NCT00798707|26725270|FG002|Overall Study|Investigator|2|||
13124718|NCT02939950|25953769|FG001|Overall Study|Positive slit lamp findings|1|||
13124719|NCT02939950|25953768|FG000|Overall Study|Chalazion upper lid|0|||
13124720|NCT02939950|25953769|FG001|Overall Study|Chalazion upper lid|1|||
13373924|NCT00798707|26725268|FG000|Overall Study|Lack of Efficacy|2|||
13373925|NCT00798707|26725269|FG001|Overall Study|Lack of Efficacy|2|||
13373926|NCT00798707|26725270|FG002|Overall Study|Lack of Efficacy|1|||
13373927|NCT00798707|26725268|FG000|Overall Study|Lost to Follow-up|5|||
13373928|NCT00798707|26725269|FG001|Overall Study|Lost to Follow-up|6|||
13373929|NCT00798707|26725270|FG002|Overall Study|Lost to Follow-up|6|||
13373930|NCT00798707|26725268|FG000|Overall Study|Other|0|||
13373931|NCT00798707|26725269|FG001|Overall Study|Other|1|||
13373932|NCT00798707|26725270|FG002|Overall Study|Other|0|||
13373933|NCT00798707|26725268|FG000|Overall Study|Protocol Violation|4|||
13373934|NCT00798707|26725269|FG001|Overall Study|Protocol Violation|0|||
13337921|NCT01036594|26615152|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1|||
13337922|NCT01036594|26615153|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0|||
13337923|NCT01036594|26615152|FG000|First Treatment Regimen|Withdrawal by Subject|1|||
13337924|NCT01036594|26615153|FG001|First Treatment Regimen|Withdrawal by Subject|0|||
13337925|NCT01036594|26615152|FG000|Week 12 Evaluation|Adverse Event|5|||
13337926|NCT01036594|26615153|FG001|Week 12 Evaluation|Adverse Event|0|||
13337927|NCT01036594|26615152|FG000|Week 12 Evaluation|Physician Decision|1|||
13337928|NCT01036594|26615153|FG001|Week 12 Evaluation|Physician Decision|0|||
13337929|NCT01036594|26615152|FG000|Treatment Regiments Post Week 12|Physician Decision|1|||
13337930|NCT01036594|26615153|FG001|Treatment Regiments Post Week 12|Physician Decision|1|||
13337931|NCT01036594|26615152|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1|||
13337932|NCT01036594|26615153|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
13337933|NCT01036594|26615152|FG000|Treatment Regiments Post Week 12|Adverse Event|0|||
13337934|NCT01036594|26615153|FG001|Treatment Regiments Post Week 12|Adverse Event|1|||
13337935|NCT01036594|26615152|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0|||
13337936|NCT01036594|26615153|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1|||
13337937|NCT01036594|26615152|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0|||
13337938|NCT01036594|26615153|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1|||
13337939|NCT01036529|26615166|FG000|Overall Study|Adverse Event|0|||
13337940|NCT01036529|26615167|FG001|Overall Study|Adverse Event|1|||
13337941|NCT01036529|26615166|FG000|Overall Study|Lost to Follow-up|0|||
13337942|NCT01036529|26615167|FG001|Overall Study|Lost to Follow-up|1|||
13337943|NCT01036529|26615166|FG000|Overall Study|Physician Decision|1|||
13337944|NCT01036529|26615167|FG001|Overall Study|Physician Decision|0|||
13337945|NCT01036529|26615166|FG000|Overall Study|Withdrawal by Subject|1|||
13337946|NCT01036529|26615167|FG001|Overall Study|Withdrawal by Subject|1|||
13337947|NCT01036529|26615166|FG000|Overall Study|Sponsor study termination|11|||
13337948|NCT01036529|26615167|FG001|Overall Study|Sponsor study termination|12|||
13337949|NCT01036438|26615180|FG000|Overall Study|Adverse Event|7|||
13337950|NCT01036438|26615181|FG001|Overall Study|Adverse Event|8|||
13337951|NCT01036438|26615180|FG000|Overall Study|Death|0|||
13337952|NCT01036438|26615181|FG001|Overall Study|Death|1|||
13337953|NCT01036438|26615180|FG000|Overall Study|No effect of study treatment|3|||
13337954|NCT01036438|26615181|FG001|Overall Study|No effect of study treatment|1|||
13337955|NCT01036321|26615212|FG000|Overall Study|Ineligible after randomization|0|||
13337956|NCT01036321|26615213|FG001|Overall Study|Ineligible after randomization|1|||
13337957|NCT01036321|26615212|FG000|Overall Study|Withdrawal by Subject|3|||
13337958|NCT01036321|26615213|FG001|Overall Study|Withdrawal by Subject|2|||
13337959|NCT01036321|26615212|FG000|Overall Study|Adverse Event|2|||
13337960|NCT01036321|26615213|FG001|Overall Study|Adverse Event|1|||
13337961|NCT01036165|26615220|FG000|Overall Study|Adverse Event|6|||
13337962|NCT01036165|26615220|FG000|Overall Study|Lost to Follow-up|2|||
13337963|NCT01036165|26615220|FG000|Overall Study|Withdrawal by Subject|3|||
13337964|NCT01036165|26615220|FG000|Overall Study|Device Related Issues|3|||
13337965|NCT01036165|26615220|FG000|Overall Study|Problems finding proper area to inject|1|||
13337966|NCT01036087|26615227|FG000|Overall Study|Adverse Event|2|||
13337967|NCT01036087|26615227|FG000|Overall Study|Lack of Efficacy|1|||
13337968|NCT01036022|26615346|FG000|Overall Study|Adverse Event|1|||
13337969|NCT01036022|26615347|FG001|Overall Study|Adverse Event|3|||
13337970|NCT01036022|26615348|FG002|Overall Study|Adverse Event|2|||
13337971|NCT01036022|26615349|FG003|Overall Study|Adverse Event|1|||
13337972|NCT01036022|26615350|FG004|Overall Study|Adverse Event|0|||
13337973|NCT01036022|26615351|FG005|Overall Study|Adverse Event|2|||
13337974|NCT01036022|26615346|FG000|Overall Study|Lack of Efficacy|1|||
13337975|NCT01036022|26615347|FG001|Overall Study|Lack of Efficacy|1|||
13337976|NCT01036022|26615348|FG002|Overall Study|Lack of Efficacy|1|||
13337977|NCT01036022|26615349|FG003|Overall Study|Lack of Efficacy|0|||
13337978|NCT01036022|26615350|FG004|Overall Study|Lack of Efficacy|1|||
13337979|NCT01036022|26615351|FG005|Overall Study|Lack of Efficacy|1|||
13337980|NCT01036022|26615346|FG000|Overall Study|Physician Decision|0|||
13337981|NCT01036022|26615347|FG001|Overall Study|Physician Decision|0|||
13337982|NCT01036022|26615348|FG002|Overall Study|Physician Decision|1|||
13337983|NCT01036022|26615349|FG003|Overall Study|Physician Decision|0|||
13337984|NCT01036022|26615350|FG004|Overall Study|Physician Decision|0|||
13337985|NCT01036022|26615351|FG005|Overall Study|Physician Decision|0|||
13337986|NCT01036022|26615346|FG000|Overall Study|Withdrawal by Subject|0|||
13337987|NCT01036022|26615347|FG001|Overall Study|Withdrawal by Subject|0|||
13337988|NCT01036022|26615348|FG002|Overall Study|Withdrawal by Subject|0|||
13337989|NCT01036022|26615349|FG003|Overall Study|Withdrawal by Subject|1|||
13337990|NCT01036022|26615350|FG004|Overall Study|Withdrawal by Subject|2|||
13337991|NCT01036022|26615351|FG005|Overall Study|Withdrawal by Subject|0|||
13337992|NCT01035905|26615364|FG000|Overall Study|Lack of Efficacy|1|||
13337993|NCT01035905|26615365|FG001|Overall Study|Lack of Efficacy|1|||
13337994|NCT01035606|26615389|FG000|Overall Study|change in health, job demands,family|3|||
13337995|NCT01035606|26615390|FG001|Overall Study|change in health, job demands,family|3|||
13337996|NCT01035606|26615391|FG002|Overall Study|change in health, job demands,family|4|||
13337997|NCT01035463|26615411|FG000|Overall Study|Adverse Event|0|||
13337998|NCT01035463|26615412|FG001|Overall Study|Adverse Event|0|||
13337999|NCT01035463|26615413|FG002|Overall Study|Adverse Event|4|||
13338000|NCT01035463|26615414|FG003|Overall Study|Adverse Event|1|||
13338001|NCT01035463|26615415|FG004|Overall Study|Adverse Event|5|||
13338002|NCT01035463|26615416|FG005|Overall Study|Adverse Event|7|||
13338003|NCT01035463|26615411|FG000|Overall Study|Withdrawal by Subject|0|||
13338004|NCT01035463|26615412|FG001|Overall Study|Withdrawal by Subject|2|||
13338005|NCT01035463|26615413|FG002|Overall Study|Withdrawal by Subject|1|||
13338006|NCT01035463|26615414|FG003|Overall Study|Withdrawal by Subject|0|||
13338007|NCT01035463|26615415|FG004|Overall Study|Withdrawal by Subject|1|||
13338008|NCT01035463|26615416|FG005|Overall Study|Withdrawal by Subject|4|||
13338009|NCT01035463|26615411|FG000|Overall Study|Disease progression|0|||
13338010|NCT01035463|26615412|FG001|Overall Study|Disease progression|0|||
13338011|NCT01035463|26615413|FG002|Overall Study|Disease progression|0|||
13338012|NCT01035463|26615414|FG003|Overall Study|Disease progression|0|||
13338013|NCT01035463|26615415|FG004|Overall Study|Disease progression|0|||
13338014|NCT01035463|26615416|FG005|Overall Study|Disease progression|3|||
13338015|NCT01035463|26615411|FG000|Overall Study|Other Malignancy|0|||
13338016|NCT01035463|26615412|FG001|Overall Study|Other Malignancy|0|||
13338017|NCT01035463|26615413|FG002|Overall Study|Other Malignancy|0|||
13338018|NCT01035463|26615414|FG003|Overall Study|Other Malignancy|0|||
13338019|NCT01035463|26615415|FG004|Overall Study|Other Malignancy|0|||
13338020|NCT01035463|26615416|FG005|Overall Study|Other Malignancy|2|||
13338021|NCT01035463|26615411|FG000|Overall Study|Other|0|||
13338022|NCT01035463|26615412|FG001|Overall Study|Other|0|||
13338023|NCT01035463|26615413|FG002|Overall Study|Other|0|||
13338024|NCT01035463|26615414|FG003|Overall Study|Other|1|||
13338025|NCT01035463|26615415|FG004|Overall Study|Other|0|||
13338026|NCT01035463|26615416|FG005|Overall Study|Other|2|||
13338027|NCT01035255|26615439|FG000|Overall Study|Death|724|||
13338028|NCT01035255|26615440|FG001|Overall Study|Death|844|||
13338029|NCT01035255|26615439|FG000|Overall Study|Lost to Follow-up|2|||
13338030|NCT01035255|26615440|FG001|Overall Study|Lost to Follow-up|5|||
13338031|NCT01035255|26615439|FG000|Overall Study|patient's request|15|||
13338032|NCT01035255|26615440|FG001|Overall Study|patient's request|13|||
13338033|NCT01035229|26615465|FG000|Overall Study|Adverse Event|61|||
13338034|NCT01035229|26615466|FG001|Overall Study|Adverse Event|14|||
13338035|NCT01035229|26615465|FG000|Overall Study|Withdrawal by Subject|20|||
13338036|NCT01035229|26615466|FG001|Overall Study|Withdrawal by Subject|7|||
13338037|NCT01035229|26615465|FG000|Overall Study|Lost to Follow-up|1|||
13338038|NCT01035229|26615466|FG001|Overall Study|Lost to Follow-up|0|||
13338039|NCT01035229|26615465|FG000|Overall Study|Administrative problems|1|||
13338040|NCT01035229|26615466|FG001|Overall Study|Administrative problems|1|||
13338041|NCT01035229|26615465|FG000|Overall Study|Death|13|||
13338042|NCT01035229|26615466|FG001|Overall Study|Death|5|||
13338043|NCT01035229|26615465|FG000|Overall Study|New cancer therapy|2|||
13338044|NCT01035229|26615466|FG001|Overall Study|New cancer therapy|0|||
13338045|NCT01035229|26615465|FG000|Overall Study|Protocol Violation|0|||
13338046|NCT01035229|26615466|FG001|Overall Study|Protocol Violation|2|||
13338047|NCT01035229|26615465|FG000|Overall Study|Sponsor's decision to end study|3|||
13338048|NCT01035229|26615466|FG001|Overall Study|Sponsor's decision to end study|3|||
13338049|NCT01035229|26615465|FG000|Overall Study|Disease Progression|261|||
13338050|NCT01035229|26615466|FG001|Overall Study|Disease Progression|152|||
13338051|NCT01035138|26615530|FG000|Overall Study|Adverse Event|4|||
13338052|NCT01035138|26615531|FG001|Overall Study|Adverse Event|0|||
13338053|NCT01035138|26615532|FG002|Overall Study|Adverse Event|2|||
13338054|NCT01035138|26615530|FG000|Overall Study|Caregiver Decision|2|||
13338055|NCT01035138|26615531|FG001|Overall Study|Caregiver Decision|0|||
13338056|NCT01035138|26615532|FG002|Overall Study|Caregiver Decision|1|||
13338057|NCT01035138|26615530|FG000|Overall Study|Withdrawal by Subject|1|||
13338058|NCT01035138|26615531|FG001|Overall Study|Withdrawal by Subject|0|||
13338059|NCT01035138|26615532|FG002|Overall Study|Withdrawal by Subject|0|||
13338060|NCT01035138|26615530|FG000|Overall Study|Physician Decision|0|||
13338061|NCT01035138|26615531|FG001|Overall Study|Physician Decision|0|||
13338062|NCT01035138|26615532|FG002|Overall Study|Physician Decision|1|||
13338063|NCT01035138|26615530|FG000|Overall Study|Sponsor Decision|66|||
13338064|NCT01035138|26615531|FG001|Overall Study|Sponsor Decision|60|||
13338065|NCT01035138|26615532|FG002|Overall Study|Sponsor Decision|42|||
13338066|NCT01035138|26615530|FG000|Overall Study|Lost to Follow-up|0|||
13338067|NCT01035138|26615531|FG001|Overall Study|Lost to Follow-up|0|||
13338068|NCT01035138|26615532|FG002|Overall Study|Lost to Follow-up|1|||
13338069|NCT01035060|26615545|FG000|Overall Study|Lost to Follow-up|0|||
13338070|NCT01035060|26615546|FG001|Overall Study|Lost to Follow-up|7|||
13338071|NCT01035060|26615545|FG000|Overall Study|Did not quality after 2nd screening|14|||
13338072|NCT01035060|26615546|FG001|Overall Study|Did not quality after 2nd screening|1|||
13338073|NCT01035060|26615545|FG000|Overall Study|Withdrawal by Subject|8|||
13338074|NCT01035060|26615546|FG001|Overall Study|Withdrawal by Subject|6|||
13338075|NCT01035060|26615545|FG000|Overall Study|Physician Decision|2|||
13338076|NCT01035060|26615546|FG001|Overall Study|Physician Decision|0|||
13338077|NCT01034709|26615559|FG000|Overall Study|Protocol Violation|9|||
13338078|NCT01034709|26615560|FG001|Overall Study|Protocol Violation|16|||
13338079|NCT01034657|26615602|FG000|Core Phase|Withdrawal by Subject|1|||
13338080|NCT01034657|26615603|FG001|Core Phase|Withdrawal by Subject|0|||
13338081|NCT01034657|26615604|FG002|Core Phase|Withdrawal by Subject|0|||
13338082|NCT01034657|26615602|FG000|Core Phase|Lack of Efficacy|2|||
13338083|NCT01034657|26615603|FG001|Core Phase|Lack of Efficacy|0|||
13338084|NCT01034657|26615604|FG002|Core Phase|Lack of Efficacy|0|||
13338085|NCT01034657|26615602|FG000|Core Phase|Abnormal laboratory value|1|||
13338086|NCT01034657|26615603|FG001|Core Phase|Abnormal laboratory value|0|||
13338087|NCT01034657|26615604|FG002|Core Phase|Abnormal laboratory value|0|||
13338088|NCT01034657|26615602|FG000|Core Phase|Adverse Event|8|||
13338089|NCT01034657|26615603|FG001|Core Phase|Adverse Event|0|||
13338090|NCT01034657|26615604|FG002|Core Phase|Adverse Event|0|||
13338091|NCT01034657|26615602|FG000|Core Phase|Protocol Violation|2|||
13338092|NCT01034657|26615603|FG001|Core Phase|Protocol Violation|0|||
13338093|NCT01034657|26615604|FG002|Core Phase|Protocol Violation|0|||
13338094|NCT01034657|26615602|FG000|Randomized Phase|Withdrawal by Subject|0|||
13338095|NCT01034657|26615603|FG001|Randomized Phase|Withdrawal by Subject|2|||
13338096|NCT01034657|26615604|FG002|Randomized Phase|Withdrawal by Subject|0|||
13338097|NCT01034657|26615602|FG000|Randomized Phase|Lack of Efficacy|5|||
13338098|NCT01034657|26615603|FG001|Randomized Phase|Lack of Efficacy|1|||
13338099|NCT01034657|26615604|FG002|Randomized Phase|Lack of Efficacy|0|||
13338100|NCT01034657|26615602|FG000|Randomized Phase|Abnormal laboratory value|0|||
13338101|NCT01034657|26615603|FG001|Randomized Phase|Abnormal laboratory value|1|||
13338102|NCT01034657|26615604|FG002|Randomized Phase|Abnormal laboratory value|0|||
13338103|NCT01034657|26615602|FG000|Randomized Phase|Adverse Event|0|||
13338104|NCT01034657|26615603|FG001|Randomized Phase|Adverse Event|2|||
13338105|NCT01034657|26615604|FG002|Randomized Phase|Adverse Event|1|||
13338106|NCT01034631|26615633|FG000|Phase I|Symptomatic Deterioration before Treatme|3|||
13338107|NCT01034631|26615634|FG001|Phase I|Symptomatic Deterioration before Treatme|0|||
13338108|NCT01034631|26615635|FG002|Phase I|Symptomatic Deterioration before Treatme|0|||
13338109|NCT01034631|26615633|FG000|Phase II|Not Evaluable per protocol|0|||
13338110|NCT01034631|26615634|FG001|Phase II|Not Evaluable per protocol|0|||
13338111|NCT01034631|26615635|FG002|Phase II|Not Evaluable per protocol|2|||
13338112|NCT01034631|26615633|FG000|Phase II|Determined Ineligible per protocol|0|||
13338113|NCT01034631|26615634|FG001|Phase II|Determined Ineligible per protocol|1|||
13338114|NCT01034631|26615635|FG002|Phase II|Determined Ineligible per protocol|0|||
13338115|NCT01034540|26615650|FG000|Overall Study|Adverse Event|0|||
13338116|NCT01034540|26615651|FG001|Overall Study|Adverse Event|1|||
13338117|NCT01034462|26615666|FG000|Overall Study|Adverse Event|7|||
13338118|NCT01034462|26615667|FG001|Overall Study|Adverse Event|17|||
13338119|NCT01034462|26615666|FG000|Overall Study|Lack of Efficacy|4|||
13338120|NCT01034462|26615667|FG001|Overall Study|Lack of Efficacy|4|||
13338121|NCT01034462|26615666|FG000|Overall Study|Protocol Violation|10|||
13338122|NCT01034462|26615667|FG001|Overall Study|Protocol Violation|7|||
13338123|NCT01034462|26615666|FG000|Overall Study|Withdrawal by Subject|9|||
13338124|NCT01034462|26615667|FG001|Overall Study|Withdrawal by Subject|8|||
13338125|NCT01034462|26615666|FG000|Overall Study|Lost to Follow-up|14|||
13338126|NCT01034462|26615667|FG001|Overall Study|Lost to Follow-up|16|||
13338127|NCT01034462|26615666|FG000|Overall Study|Other reasons|1|||
13338128|NCT01034462|26615667|FG001|Overall Study|Other reasons|2|||
13338129|NCT01034397|26615823|FG000|Overall Study|Lack of compliance|0|||
13338130|NCT01034397|26615824|FG001|Overall Study|Lack of compliance|1|||
13338131|NCT01034397|26615823|FG000|Overall Study|Lack of Efficacy|3|||
13338132|NCT01034397|26615824|FG001|Overall Study|Lack of Efficacy|0|||
13338133|NCT01034397|26615823|FG000|Overall Study|Adverse Event|4|||
13338134|NCT01034397|26615824|FG001|Overall Study|Adverse Event|0|||
13338135|NCT01034397|26615823|FG000|Overall Study|Other|0|||
13338136|NCT01034397|26615824|FG001|Overall Study|Other|1|||
13338137|NCT01034358|26615830|FG000|Overall Study|Withdrawal by Subject|1|||
13338138|NCT01034358|26615830|FG000|Overall Study|Protocol Violation|1|||
13338139|NCT01034176|26615845|FG000|Overall Study|Physician Decision|2|||
13338140|NCT01034176|26615846|FG001|Overall Study|Physician Decision|0|||
13338141|NCT01034176|26615845|FG000|Overall Study|Withdrawal by Subject|0|||
13338142|NCT01034176|26615846|FG001|Overall Study|Withdrawal by Subject|1|||
13338143|NCT01034176|26615845|FG000|Overall Study|Lost to Follow-up|0|||
13338144|NCT01034176|26615846|FG001|Overall Study|Lost to Follow-up|1|||
13338145|NCT01034163|26615859|FG000|Overall Study|Treatment completed as per protocol|8|||
13338146|NCT01034163|26615860|FG001|Overall Study|Treatment completed as per protocol|7|||
13338147|NCT01034163|26615859|FG000|Overall Study|Withdrawal by Subject|8|||
13338148|NCT01034163|26615860|FG001|Overall Study|Withdrawal by Subject|2|||
13338149|NCT01034163|26615859|FG000|Overall Study|Protocol deviation|1|||
13338150|NCT01034163|26615860|FG001|Overall Study|Protocol deviation|0|||
13338151|NCT01034163|26615859|FG000|Overall Study|Disease progression|3|||
13338152|NCT01034163|26615860|FG001|Overall Study|Disease progression|4|||
13338153|NCT01034163|26615859|FG000|Overall Study|Adverse Event|6|||
13338154|NCT01034163|26615860|FG001|Overall Study|Adverse Event|0|||
13373935|NCT00798707|26725270|FG002|Overall Study|Protocol Violation|2|||
13338155|NCT01034163|26615859|FG000|Overall Study|Administrative problems|0|||
13338156|NCT01034163|26615860|FG001|Overall Study|Administrative problems|1|||
13338157|NCT01034163|26615859|FG000|Overall Study|Abnormal laboratory value|1|||
13338158|NCT01034163|26615860|FG001|Overall Study|Abnormal laboratory value|0|||
13338159|NCT01034137|26616001|FG000|Overall Study|Adverse Event|9|||
13338160|NCT01034137|26616002|FG001|Overall Study|Adverse Event|10|||
13338161|NCT01034137|26616003|FG002|Overall Study|Adverse Event|8|||
13338162|NCT01034137|26616001|FG000|Overall Study|Withdrawal by Subject|4|||
13338163|NCT01034137|26616002|FG001|Overall Study|Withdrawal by Subject|3|||
13338164|NCT01034137|26616003|FG002|Overall Study|Withdrawal by Subject|3|||
13338165|NCT01034137|26616001|FG000|Overall Study|Lack of Efficacy|9|||
13338166|NCT01034137|26616002|FG001|Overall Study|Lack of Efficacy|4|||
13338167|NCT01034137|26616003|FG002|Overall Study|Lack of Efficacy|13|||
13338168|NCT01034137|26616001|FG000|Overall Study|Protocol Violation|2|||
13338169|NCT01034137|26616002|FG001|Overall Study|Protocol Violation|2|||
13338170|NCT01034137|26616003|FG002|Overall Study|Protocol Violation|1|||
13338171|NCT01034137|26616001|FG000|Overall Study|Refused treatment or did not cooperate|2|||
13338172|NCT01034137|26616002|FG001|Overall Study|Refused treatment or did not cooperate|0|||
13338173|NCT01034137|26616003|FG002|Overall Study|Refused treatment or did not cooperate|1|||
13338174|NCT01034137|26616001|FG000|Overall Study|Administrative or other|2|||
13338175|NCT01034137|26616002|FG001|Overall Study|Administrative or other|3|||
13338176|NCT01034137|26616003|FG002|Overall Study|Administrative or other|4|||
13338177|NCT01033942|26616283|FG000|Overall Study|Withdrawal by Subject|1|||
13338178|NCT01033942|26616284|FG001|Overall Study|Withdrawal by Subject|1|||
13338179|NCT01033942|26616285|FG002|Overall Study|Withdrawal by Subject|1|||
13338180|NCT01033942|26616283|FG000|Overall Study|Lost to Follow-up|1|||
13338181|NCT01033942|26616284|FG001|Overall Study|Lost to Follow-up|0|||
13338182|NCT01033942|26616285|FG002|Overall Study|Lost to Follow-up|0|||
13338183|NCT01033942|26616283|FG000|Overall Study|Enrolled in Extension Study|0|||
13338184|NCT01033942|26616284|FG001|Overall Study|Enrolled in Extension Study|3|||
13338185|NCT01033942|26616285|FG002|Overall Study|Enrolled in Extension Study|0|||
13338186|NCT01033851|26616300|FG000|Overall Study|Withdrawal by Subject|3|||
13338187|NCT01033851|26616301|FG001|Overall Study|Withdrawal by Subject|7|||
13338188|NCT01033825|26616542|FG000|Overall Study|Withdrawal by Subject|2|||
13338189|NCT01033825|26616543|FG001|Overall Study|Withdrawal by Subject|3|||
13338190|NCT01033825|26616544|FG002|Overall Study|Withdrawal by Subject|2|||
13338191|NCT01033825|26616545|FG003|Overall Study|Withdrawal by Subject|1|||
13338192|NCT01033825|26616546|FG004|Overall Study|Withdrawal by Subject|1|||
13338193|NCT01033825|26616547|FG005|Overall Study|Withdrawal by Subject|0|||
13338194|NCT01033825|26616548|FG006|Overall Study|Withdrawal by Subject|0|||
13338195|NCT01033825|26616542|FG000|Overall Study|Adverse Event|0|||
13338196|NCT01033825|26616543|FG001|Overall Study|Adverse Event|0|||
13338197|NCT01033825|26616544|FG002|Overall Study|Adverse Event|0|||
13338198|NCT01033825|26616545|FG003|Overall Study|Adverse Event|1|||
13338199|NCT01033825|26616546|FG004|Overall Study|Adverse Event|0|||
13338200|NCT01033825|26616547|FG005|Overall Study|Adverse Event|0|||
13338201|NCT01033825|26616548|FG006|Overall Study|Adverse Event|0|||
13338202|NCT01033825|26616542|FG000|Overall Study|Protocol Violation|1|||
13338203|NCT01033825|26616543|FG001|Overall Study|Protocol Violation|0|||
13338204|NCT01033825|26616544|FG002|Overall Study|Protocol Violation|0|||
13338205|NCT01033825|26616545|FG003|Overall Study|Protocol Violation|0|||
13338206|NCT01033825|26616546|FG004|Overall Study|Protocol Violation|0|||
13338207|NCT01033825|26616547|FG005|Overall Study|Protocol Violation|0|||
13338208|NCT01033825|26616548|FG006|Overall Study|Protocol Violation|0|||
13338209|NCT01033825|26616542|FG000|Overall Study|Other|0|||
13338210|NCT01033825|26616543|FG001|Overall Study|Other|0|||
13338211|NCT01033825|26616544|FG002|Overall Study|Other|0|||
13338212|NCT01033825|26616545|FG003|Overall Study|Other|0|||
13338213|NCT01033825|26616546|FG004|Overall Study|Other|1|||
13338214|NCT01033825|26616547|FG005|Overall Study|Other|0|||
13338215|NCT01033825|26616548|FG006|Overall Study|Other|0|||
13338216|NCT01033747|26616563|FG000|Overall Study|Adverse Event|9|||
13338217|NCT01033747|26616564|FG001|Overall Study|Adverse Event|4|||
13338218|NCT01033747|26616563|FG000|Overall Study|Abnormal Laboratory Value|1|||
13338219|NCT01033747|26616564|FG001|Overall Study|Abnormal Laboratory Value|0|||
13338220|NCT01033747|26616563|FG000|Overall Study|Abnormal test procedure|0|||
13338221|NCT01033747|26616564|FG001|Overall Study|Abnormal test procedure|1|||
13338222|NCT01033747|26616563|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
13338223|NCT01033747|26616564|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
13338224|NCT01033747|26616563|FG000|Overall Study|Protocol Violation|1|||
13338225|NCT01033747|26616564|FG001|Overall Study|Protocol Violation|0|||
13338226|NCT01033747|26616563|FG000|Overall Study|Withdrawal by Subject|9|||
13338227|NCT01033747|26616564|FG001|Overall Study|Withdrawal by Subject|6|||
13338228|NCT01033747|26616563|FG000|Overall Study|Stopped at end of prolongation visit 1|1|||
13338229|NCT01033747|26616564|FG001|Overall Study|Stopped at end of prolongation visit 1|0|||
13338230|NCT01033747|26616563|FG000|Overall Study|Stopped at end of Extension 1|2|||
13338231|NCT01033747|26616564|FG001|Overall Study|Stopped at end of Extension 1|0|||
13338232|NCT01033734|26616618|FG000|Overall Study|Withdrawal by Subject|1|||
13338233|NCT01033643|26616767|FG000|Overall Study|Withdrew Consent|0|||
13338234|NCT01033643|26616768|FG001|Overall Study|Withdrew Consent|3|||
13338235|NCT01033643|26616769|FG002|Overall Study|Withdrew Consent|0|||
13338236|NCT01033643|26616770|FG003|Overall Study|Withdrew Consent|0|||
13338237|NCT01033643|26616771|FG004|Overall Study|Withdrew Consent|0|||
13338238|NCT01033643|26616772|FG005|Overall Study|Withdrew Consent|1|||
13338239|NCT01033487|26616837|FG000|Fourth Intervention Period|Adverse Event|0|||
13338240|NCT01033487|26616838|FG001|Fourth Intervention Period|Adverse Event|0|||
13338241|NCT01033487|26616839|FG002|Fourth Intervention Period|Adverse Event|0|||
13338242|NCT01033487|26616840|FG003|Fourth Intervention Period|Adverse Event|0|||
13338243|NCT01033487|26616841|FG004|Fourth Intervention Period|Adverse Event|0|||
13338244|NCT01033487|26616842|FG005|Fourth Intervention Period|Adverse Event|0|||
13338245|NCT01033487|26616843|FG006|Fourth Intervention Period|Adverse Event|0|||
13338246|NCT01033487|26616844|FG007|Fourth Intervention Period|Adverse Event|0|||
13338247|NCT01033487|26616845|FG008|Fourth Intervention Period|Adverse Event|1|||
13338248|NCT01033487|26616846|FG009|Fourth Intervention Period|Adverse Event|0|||
13338249|NCT01033448|26616856|FG000|Overall Study|Withdrawal by Subject|4|||
13338250|NCT01033448|26616856|FG000|Overall Study|Positive HCV-RNA at week 48|1|||
13338251|NCT01033448|26616856|FG000|Overall Study|Lost to Follow-up|3|||
13338252|NCT01033448|26616856|FG000|Overall Study|Withdrew due to other reasons|3|||
13338253|NCT01033448|26616856|FG000|Overall Study|Unknown disposition|1|||
13338254|NCT01033240|26616883|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10|||
13338255|NCT01033240|26616884|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8|||
13338256|NCT01033240|26616885|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6|||
13338257|NCT01033240|26616883|FG000|Overall Study|Death|2|||
13338258|NCT01033240|26616884|FG001|Overall Study|Death|0|||
13338259|NCT01033240|26616885|FG002|Overall Study|Death|0|||
13338260|NCT01033240|26616883|FG000|Overall Study|Withdrew Consent|2|||
13338261|NCT01033240|26616884|FG001|Overall Study|Withdrew Consent|9|||
13338262|NCT01033240|26616885|FG002|Overall Study|Withdrew Consent|2|||
13338263|NCT01033240|26616883|FG000|Overall Study|Disease Progression|35|||
13338264|NCT01033240|26616884|FG001|Overall Study|Disease Progression|32|||
13338265|NCT01033240|26616885|FG002|Overall Study|Disease Progression|41|||
13338266|NCT01033240|26616883|FG000|Overall Study|Investigator Discretion|0|||
13338267|NCT01033240|26616884|FG001|Overall Study|Investigator Discretion|0|||
13338268|NCT01033240|26616885|FG002|Overall Study|Investigator Discretion|2|||
13338269|NCT01033240|26616883|FG000|Overall Study|Other|0|||
13338270|NCT01033240|26616884|FG001|Overall Study|Other|1|||
13338271|NCT01033240|26616885|FG002|Overall Study|Other|2|||
13338272|NCT01033136|26616900|FG000|Follow-Up (3 Month)|Lost to Follow-up|2|||
13338273|NCT01033136|26616901|FG001|Follow-Up (3 Month)|Lost to Follow-up|2|||
13338274|NCT01033071|26616970|FG000|Overall Study|Adverse Event|28|||
13338275|NCT01033071|26616971|FG001|Overall Study|Adverse Event|51|||
13338276|NCT01033071|26616972|FG002|Overall Study|Adverse Event|26|||
13338277|NCT01033071|26616970|FG000|Overall Study|Protocol Violation|0|||
13338278|NCT01033071|26616971|FG001|Overall Study|Protocol Violation|2|||
13338279|NCT01033071|26616972|FG002|Overall Study|Protocol Violation|1|||
13338280|NCT01033071|26616970|FG000|Overall Study|Lost to Follow-up|4|||
13338281|NCT01033071|26616971|FG001|Overall Study|Lost to Follow-up|5|||
13338282|NCT01033071|26616972|FG002|Overall Study|Lost to Follow-up|5|||
13338283|NCT01033071|26616970|FG000|Overall Study|Withdrawal by Subject|17|||
13338284|NCT01033071|26616971|FG001|Overall Study|Withdrawal by Subject|14|||
13338285|NCT01033071|26616972|FG002|Overall Study|Withdrawal by Subject|11|||
13338286|NCT01033071|26616970|FG000|Overall Study|Lack of Efficacy|0|||
13338287|NCT01033071|26616971|FG001|Overall Study|Lack of Efficacy|1|||
13338288|NCT01033071|26616972|FG002|Overall Study|Lack of Efficacy|1|||
13338289|NCT01033071|26616970|FG000|Overall Study|Other|6|||
13338290|NCT01033071|26616971|FG001|Overall Study|Other|4|||
13338291|NCT01033071|26616972|FG002|Overall Study|Other|3|||
13338292|NCT01033019|26616986|FG000|Overall Study|Withdrawal by Subject|1|||
13338293|NCT01033019|26616987|FG001|Overall Study|Withdrawal by Subject|0|||
13338294|NCT01032915|26617022|FG000|Overall Study|Adverse Event|2|||
13338295|NCT01032915|26617023|FG001|Overall Study|Adverse Event|2|||
13338296|NCT01032915|26617024|FG002|Overall Study|Adverse Event|1|||
13338297|NCT01032915|26617025|FG003|Overall Study|Adverse Event|1|||
13338298|NCT01032915|26617022|FG000|Overall Study|Abnormal test procedure result|0|||
13338299|NCT01032915|26617023|FG001|Overall Study|Abnormal test procedure result|0|||
13338300|NCT01032915|26617024|FG002|Overall Study|Abnormal test procedure result|1|||
13338301|NCT01032915|26617025|FG003|Overall Study|Abnormal test procedure result|0|||
13338302|NCT01032915|26617022|FG000|Overall Study|Withdrawal by Subject|0|||
13393573|NCT00663208|26784233|FG002|Follow-up Period|Other reason|0|||
13338303|NCT01032915|26617023|FG001|Overall Study|Withdrawal by Subject|3|||
13338304|NCT01032915|26617024|FG002|Overall Study|Withdrawal by Subject|1|||
13338305|NCT01032915|26617025|FG003|Overall Study|Withdrawal by Subject|1|||
13338306|NCT01032915|26617022|FG000|Overall Study|Administrative reasons|5|||
13338307|NCT01032915|26617023|FG001|Overall Study|Administrative reasons|6|||
13338308|NCT01032915|26617024|FG002|Overall Study|Administrative reasons|4|||
13338309|NCT01032915|26617025|FG003|Overall Study|Administrative reasons|4|||
13338310|NCT01032915|26617022|FG000|Overall Study|Protocol Violation|1|||
13338311|NCT01032915|26617023|FG001|Overall Study|Protocol Violation|0|||
13338312|NCT01032915|26617024|FG002|Overall Study|Protocol Violation|0|||
13338313|NCT01032915|26617025|FG003|Overall Study|Protocol Violation|1|||
13338314|NCT01032889|26617055|FG000|Overall Study|Adverse Event|2|||
13338315|NCT01032889|26617056|FG001|Overall Study|Adverse Event|2|||
13338316|NCT01032889|26617057|FG002|Overall Study|Adverse Event|0|||
13338317|NCT01032889|26617055|FG000|Overall Study|Withdrawal of Consent|1|||
13338318|NCT01032889|26617056|FG001|Overall Study|Withdrawal of Consent|2|||
13338319|NCT01032889|26617057|FG002|Overall Study|Withdrawal of Consent|1|||
13338320|NCT01032889|26617055|FG000|Overall Study|Patient Request|0|||
13338321|NCT01032889|26617056|FG001|Overall Study|Patient Request|1|||
13338322|NCT01032889|26617057|FG002|Overall Study|Patient Request|0|||
13338323|NCT01032889|26617055|FG000|Overall Study|Lost to Follow-up|1|||
13338324|NCT01032889|26617056|FG001|Overall Study|Lost to Follow-up|1|||
13338325|NCT01032889|26617057|FG002|Overall Study|Lost to Follow-up|0|||
13338326|NCT01032889|26617055|FG000|Overall Study|Lack of Submental Fat|2|||
13338327|NCT01032889|26617056|FG001|Overall Study|Lack of Submental Fat|8|||
13338328|NCT01032889|26617057|FG002|Overall Study|Lack of Submental Fat|1|||
13338329|NCT01032889|26617055|FG000|Overall Study|Miscellaneous Reasons|2|||
13338330|NCT01032889|26617056|FG001|Overall Study|Miscellaneous Reasons|1|||
13338331|NCT01032889|26617057|FG002|Overall Study|Miscellaneous Reasons|1|||
13338332|NCT01032837|26617116|FG000|Overall Study|Adverse event/internal illness|0|||
13338333|NCT01032837|26617117|FG001|Overall Study|Adverse event/internal illness|1|||
13338334|NCT01032837|26617118|FG002|Overall Study|Adverse event/internal illness|0|||
13338335|NCT01032837|26617119|FG003|Overall Study|Adverse event/internal illness|1|||
13338336|NCT01032837|26617116|FG000|Overall Study|Withdrew consent|0|||
13338337|NCT01032837|26617117|FG001|Overall Study|Withdrew consent|2|||
13338338|NCT01032837|26617118|FG002|Overall Study|Withdrew consent|0|||
13338339|NCT01032837|26617119|FG003|Overall Study|Withdrew consent|1|||
13338340|NCT01032837|26617116|FG000|Overall Study|Failed to return|0|||
13338341|NCT01032837|26617117|FG001|Overall Study|Failed to return|0|||
13338342|NCT01032837|26617118|FG002|Overall Study|Failed to return|1|||
13338343|NCT01032837|26617119|FG003|Overall Study|Failed to return|0|||
13338344|NCT01032837|26617116|FG000|Overall Study|Refused treatment|0|||
13338345|NCT01032837|26617117|FG001|Overall Study|Refused treatment|0|||
13338346|NCT01032837|26617118|FG002|Overall Study|Refused treatment|0|||
13338347|NCT01032837|26617119|FG003|Overall Study|Refused treatment|1|||
13338348|NCT01032629|26617174|FG000|Overall Study|Closed Site|21|||
13338349|NCT01032629|26617175|FG001|Overall Study|Closed Site|18|||
13338350|NCT01032629|26617176|FG002|Overall Study|Closed Site|16|||
13338351|NCT01032629|26617174|FG000|Overall Study|Withdrawal by Subject|50|||
13338352|NCT01032629|26617175|FG001|Overall Study|Withdrawal by Subject|36|||
13338353|NCT01032629|26617176|FG002|Overall Study|Withdrawal by Subject|35|||
13338354|NCT01032629|26617174|FG000|Overall Study|Lost to Follow-up|74|||
13338355|NCT01032629|26617175|FG001|Overall Study|Lost to Follow-up|47|||
13338356|NCT01032629|26617176|FG002|Overall Study|Lost to Follow-up|37|||
13338357|NCT01032382|26617209|FG000|Overall Study|Disease dissemination|1|||
13338358|NCT01032382|26617210|FG001|Overall Study|Disease dissemination|1|||
13338359|NCT01032382|26617209|FG000|Overall Study|Treatment failure|3|||
13338360|NCT01032382|26617210|FG001|Overall Study|Treatment failure|1|||
13338361|NCT01032382|26617209|FG000|Overall Study|Index lesion relapse|1|||
13338362|NCT01032382|26617210|FG001|Overall Study|Index lesion relapse|3|||
13338363|NCT01032291|26617244|FG000|Safety Lead-in|Adverse Event|1|||
13338364|NCT01032291|26617245|FG001|Safety Lead-in|Adverse Event|0|||
13338365|NCT01032291|26617246|FG002|Safety Lead-in|Adverse Event|0|||
13338366|NCT01032291|26617244|FG000|Safety Lead-in|Death|1|||
13338367|NCT01032291|26617245|FG001|Safety Lead-in|Death|0|||
13338368|NCT01032291|26617246|FG002|Safety Lead-in|Death|0|||
13338369|NCT01032291|26617244|FG000|Proof of Concept|Adverse Event|0|||
13338370|NCT01032291|26617245|FG001|Proof of Concept|Adverse Event|5|||
13338371|NCT01032291|26617246|FG002|Proof of Concept|Adverse Event|1|||
13338372|NCT01032291|26617244|FG000|Proof of Concept|Death|0|||
13338373|NCT01032291|26617245|FG001|Proof of Concept|Death|1|||
13338374|NCT01032291|26617246|FG002|Proof of Concept|Death|2|||
13338375|NCT01032291|26617244|FG000|Proof of Concept|Lack of Efficacy|0|||
13338376|NCT01032291|26617245|FG001|Proof of Concept|Lack of Efficacy|1|||
13338377|NCT01032291|26617246|FG002|Proof of Concept|Lack of Efficacy|0|||
13338378|NCT01032291|26617244|FG000|Proof of Concept|Never Received Study Drug|0|||
13338379|NCT01032291|26617245|FG001|Proof of Concept|Never Received Study Drug|1|||
13338380|NCT01032291|26617246|FG002|Proof of Concept|Never Received Study Drug|0|||
13338381|NCT01032239|26617281|FG000|Overall Study|Lost to Follow-up|3|||
13393574|NCT00663208|26784234|FG003|Follow-up Period|Other reason|0|||
13338382|NCT01032239|26617282|FG001|Overall Study|Lost to Follow-up|2|||
13338383|NCT01032239|26617281|FG000|Overall Study|Withdrawal by Subject|2|||
13338384|NCT01032239|26617282|FG001|Overall Study|Withdrawal by Subject|3|||
13338385|NCT01032239|26617281|FG000|Overall Study|Death|1|||
13338386|NCT01032239|26617282|FG001|Overall Study|Death|0|||
13338387|NCT01032239|26617281|FG000|Overall Study|Protocol Violation|1|||
13338388|NCT01032239|26617282|FG001|Overall Study|Protocol Violation|0|||
13338389|NCT01032200|26617303|FG000|Overall Study|Death|1|||
13338390|NCT01032200|26617304|FG001|Overall Study|Death|1|||
13338391|NCT01032200|26617303|FG000|Overall Study|Withdrawal by Subject|1|||
13338392|NCT01032200|26617304|FG001|Overall Study|Withdrawal by Subject|3|||
13338393|NCT01032200|26617303|FG000|Overall Study|Toxicity|0|||
13338394|NCT01032200|26617304|FG001|Overall Study|Toxicity|2|||
13338395|NCT01032200|26617303|FG000|Overall Study|Progression|1|||
13338396|NCT01032200|26617304|FG001|Overall Study|Progression|0|||
13338397|NCT01032200|26617303|FG000|Overall Study|Multiple|1|||
13338398|NCT01032200|26617304|FG001|Overall Study|Multiple|1|||
13338399|NCT01032174|26617321|FG000|Overall Study|Adverse Event|0|||
13338400|NCT01032174|26617322|FG001|Overall Study|Adverse Event|1|||
13338401|NCT01032070|26617356|FG000|Overall Study|Disease progression|13|||
13338402|NCT01032070|26617357|FG001|Overall Study|Disease progression|8|||
13338403|NCT01032070|26617356|FG000|Overall Study|Medical or ethical reasons|0|||
13338404|NCT01032070|26617357|FG001|Overall Study|Medical or ethical reasons|2|||
13338405|NCT01032070|26617356|FG000|Overall Study|Withdrawal by Subject|0|||
13338406|NCT01032070|26617357|FG001|Overall Study|Withdrawal by Subject|2|||
13338407|NCT01032044|26617370|FG000|Overall Study|Protocol Violation|14|||
13338408|NCT01032044|26617371|FG001|Overall Study|Protocol Violation|8|||
13338409|NCT01032044|26617370|FG000|Overall Study|Adverse Event|0|||
13338410|NCT01032044|26617371|FG001|Overall Study|Adverse Event|1|||
13338411|NCT01032044|26617370|FG000|Overall Study|Lost to Follow-up|11|||
13338412|NCT01032044|26617371|FG001|Overall Study|Lost to Follow-up|11|||
13338413|NCT01032018|26617386|FG000|Overall Study|Lost to Follow-up|6|||
13338414|NCT01032018|26617387|FG001|Overall Study|Lost to Follow-up|5|||
13338415|NCT01032018|26617386|FG000|Overall Study|Death|0|||
13338416|NCT01032018|26617387|FG001|Overall Study|Death|1|||
13338417|NCT01031979|26617406|FG000|Overall Study|Lost to Follow-up|5|||
13338418|NCT01031979|26617407|FG001|Overall Study|Lost to Follow-up|4|||
13338419|NCT01031836|26617476|FG000|Stage I|Adverse Event|1|||
13338420|NCT01031836|26617477|FG001|Stage I|Adverse Event|1|||
13338421|NCT01031836|26617478|FG002|Stage I|Adverse Event|0|||
13338422|NCT01031836|26617479|FG003|Stage I|Adverse Event|0|||
13338423|NCT01031836|26617480|FG004|Stage I|Adverse Event|0|||
13338424|NCT01031836|26617481|FG005|Stage I|Adverse Event|0|||
13338425|NCT01031836|26617476|FG000|Stage I|Other|0|||
13338426|NCT01031836|26617477|FG001|Stage I|Other|1|||
13338427|NCT01031836|26617478|FG002|Stage I|Other|0|||
13338428|NCT01031836|26617479|FG003|Stage I|Other|0|||
13338429|NCT01031836|26617480|FG004|Stage I|Other|0|||
13338430|NCT01031836|26617481|FG005|Stage I|Other|1|||
13338431|NCT01031836|26617476|FG000|Stage II|Adverse Event|0|||
13338432|NCT01031836|26617477|FG001|Stage II|Adverse Event|0|||
13338433|NCT01031836|26617478|FG002|Stage II|Adverse Event|2|||
13338434|NCT01031836|26617479|FG003|Stage II|Adverse Event|2|||
13338435|NCT01031836|26617480|FG004|Stage II|Adverse Event|1|||
13338436|NCT01031836|26617481|FG005|Stage II|Adverse Event|1|||
13338437|NCT01031836|26617476|FG000|Stage II|Other|2|||
13338438|NCT01031836|26617477|FG001|Stage II|Other|0|||
13338439|NCT01031836|26617478|FG002|Stage II|Other|0|||
13338440|NCT01031836|26617479|FG003|Stage II|Other|1|||
13338441|NCT01031836|26617480|FG004|Stage II|Other|1|||
13338442|NCT01031836|26617481|FG005|Stage II|Other|0|||
13338443|NCT01031706|26617496|FG000|Overall Study|Adverse Event|1|||
13338444|NCT01031706|26617497|FG001|Overall Study|Adverse Event|0|||
13338445|NCT01031706|26617496|FG000|Overall Study|Withdrawal by Subject|1|||
13338446|NCT01031706|26617497|FG001|Overall Study|Withdrawal by Subject|1|||
13338447|NCT01031680|26617520|FG000|Overall Study|Adverse Event|8|||
13338448|NCT01031680|26617521|FG001|Overall Study|Adverse Event|3|||
13338449|NCT01031680|26617520|FG000|Overall Study|Lost to Follow-up|2|||
13338450|NCT01031680|26617521|FG001|Overall Study|Lost to Follow-up|10|||
13338451|NCT01031680|26617520|FG000|Overall Study|Withdrawal by Subject|12|||
13338452|NCT01031680|26617521|FG001|Overall Study|Withdrawal by Subject|16|||
13338453|NCT01031680|26617520|FG000|Overall Study|Death|2|||
13338454|NCT01031680|26617521|FG001|Overall Study|Death|1|||
13338455|NCT01031680|26617520|FG000|Overall Study|Subject No Longer Meets Study Criteria|26|||
13338456|NCT01031680|26617521|FG001|Overall Study|Subject No Longer Meets Study Criteria|17|||
13338457|NCT01031680|26617520|FG000|Overall Study|Poor/Non-compliance|5|||
13338458|NCT01031680|26617521|FG001|Overall Study|Poor/Non-compliance|6|||
13338459|NCT01031680|26617520|FG000|Overall Study|Safety|1|||
13338460|NCT01031680|26617521|FG001|Overall Study|Safety|0|||
13338461|NCT01031680|26617520|FG000|Overall Study|Incorrect Enrolment|1|||
13338462|NCT01031680|26617521|FG001|Overall Study|Incorrect Enrolment|2|||
13338463|NCT01031680|26617520|FG000|Overall Study|Administrative Reason by Sponsor|0|||
13338464|NCT01031680|26617521|FG001|Overall Study|Administrative Reason by Sponsor|1|||
13338465|NCT01031680|26617520|FG000|Overall Study|Various|0|||
13338466|NCT01031680|26617521|FG001|Overall Study|Various|2|||
13338467|NCT01031628|26617544|FG000|Overall Study|Study terminated early|0|||
13338468|NCT01031628|26617545|FG001|Overall Study|Study terminated early|1|||
13338469|NCT01031628|26617546|FG002|Overall Study|Study terminated early|3|||
13338470|NCT01031628|26617547|FG003|Overall Study|Study terminated early|0|||
13338471|NCT01031537|26617554|FG000|Overall Study|medical reasons not related to study|3|||
13338472|NCT01031537|26617554|FG000|Overall Study|Lack of Efficacy|1|||
13338473|NCT01031537|26617554|FG000|Overall Study|retired from NIH, met exclusion criteria|1|||
13338474|NCT01031537|26617554|FG000|Overall Study|moved, met exclusion criteria|10|||
13338475|NCT01031537|26617554|FG000|Overall Study|Withdrawal by Subject|5|||
13338476|NCT01031537|26617554|FG000|Overall Study|PI removal, no longer met eligibility|12|||
13338477|NCT01031446|26617565|FG000|Overall Study|Disease Progression|38|||
13338478|NCT01031446|26617565|FG000|Overall Study|Adverse Event|9|||
13338479|NCT01031446|26617565|FG000|Overall Study|Physician Decision|4|||
13338480|NCT01031446|26617565|FG000|Overall Study|Withdrawal by Subject|3|||
13338481|NCT01031446|26617565|FG000|Overall Study|Still on treatment|1|||
13338482|NCT01031381|26617572|FG000|Overall Study|Physician Decision|3|||
13338483|NCT01031381|26617572|FG000|Overall Study|Withdrawal by Subject|6|||
13338484|NCT01031069|26617681|FG000|Overall Study|Serious Adverse Event|0|||
13338485|NCT01031069|26617682|FG001|Overall Study|Serious Adverse Event|1|||
13338486|NCT01031069|26617683|FG002|Overall Study|Serious Adverse Event|0|||
13338487|NCT01031069|26617684|FG003|Overall Study|Serious Adverse Event|0|||
13338488|NCT01031069|26617681|FG000|Overall Study|Withdrawal by Subject|2|||
13338489|NCT01031069|26617682|FG001|Overall Study|Withdrawal by Subject|3|||
13338490|NCT01031069|26617683|FG002|Overall Study|Withdrawal by Subject|18|||
13338491|NCT01031069|26617684|FG003|Overall Study|Withdrawal by Subject|18|||
13338492|NCT01031069|26617681|FG000|Overall Study|Migrated/moved from study area|1|||
13338493|NCT01031069|26617682|FG001|Overall Study|Migrated/moved from study area|2|||
13338494|NCT01031069|26617683|FG002|Overall Study|Migrated/moved from study area|1|||
13338495|NCT01031069|26617684|FG003|Overall Study|Migrated/moved from study area|1|||
13338496|NCT01031069|26617681|FG000|Overall Study|Lost to Follow-up|9|||
13338497|NCT01031069|26617682|FG001|Overall Study|Lost to Follow-up|5|||
13338498|NCT01031069|26617683|FG002|Overall Study|Lost to Follow-up|21|||
13338499|NCT01031069|26617684|FG003|Overall Study|Lost to Follow-up|15|||
13338500|NCT01031069|26617681|FG000|Overall Study|Other|0|||
13338501|NCT01031069|26617682|FG001|Overall Study|Other|0|||
13338502|NCT01031069|26617683|FG002|Overall Study|Other|1|||
13338503|NCT01031069|26617684|FG003|Overall Study|Other|0|||
13338504|NCT01031004|26617731|FG000|Overall Study|Protocol Violation|0|||
13338505|NCT01031004|26617732|FG001|Overall Study|Protocol Violation|1|||
13338506|NCT01031004|26617731|FG000|Overall Study|Lost to Follow-up|1|||
13338507|NCT01031004|26617732|FG001|Overall Study|Lost to Follow-up|0|||
13338508|NCT01030965|26617763|FG000|Overall Study|Lack of Efficacy|3|||
13338509|NCT01030965|26617764|FG001|Overall Study|Lack of Efficacy|2|||
13338510|NCT01030965|26617765|FG002|Overall Study|Lack of Efficacy|0|||
13338511|NCT01030965|26617766|FG003|Overall Study|Lack of Efficacy|3|||
13338512|NCT01030965|26617763|FG000|Overall Study|Protocol Violation|1|||
13338513|NCT01030965|26617764|FG001|Overall Study|Protocol Violation|1|||
13338514|NCT01030965|26617765|FG002|Overall Study|Protocol Violation|1|||
13338515|NCT01030965|26617766|FG003|Overall Study|Protocol Violation|1|||
13338516|NCT01030965|26617763|FG000|Overall Study|Adverse Event|0|||
13338517|NCT01030965|26617764|FG001|Overall Study|Adverse Event|1|||
13338518|NCT01030965|26617765|FG002|Overall Study|Adverse Event|2|||
13338519|NCT01030965|26617766|FG003|Overall Study|Adverse Event|1|||
13338520|NCT01030965|26617763|FG000|Overall Study|Protocol-defined Stopping Criteria|0|||
13338521|NCT01030965|26617764|FG001|Overall Study|Protocol-defined Stopping Criteria|1|||
13338522|NCT01030965|26617765|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
13338523|NCT01030965|26617766|FG003|Overall Study|Protocol-defined Stopping Criteria|0|||
13338524|NCT01030965|26617763|FG000|Overall Study|Withdrawal by Subject|0|||
13338525|NCT01030965|26617764|FG001|Overall Study|Withdrawal by Subject|1|||
13338526|NCT01030965|26617765|FG002|Overall Study|Withdrawal by Subject|0|||
13338527|NCT01030965|26617766|FG003|Overall Study|Withdrawal by Subject|2|||
13338528|NCT01030952|26617807|FG000|Overall Study|Protocol Violation|0|||
13338529|NCT01030952|26617808|FG001|Overall Study|Protocol Violation|1|||
13338530|NCT01030952|26617807|FG000|Overall Study|Informed consent withdrawal|1|||
13338531|NCT01030952|26617808|FG001|Overall Study|Informed consent withdrawal|0|||
13338532|NCT01030952|26617807|FG000|Overall Study|Lost to Follow-up|0|||
13338533|NCT01030952|26617808|FG001|Overall Study|Lost to Follow-up|1|||
13338534|NCT01030952|26617807|FG000|Overall Study|Unexplained|1|||
13338535|NCT01030952|26617808|FG001|Overall Study|Unexplained|1|||
13338536|NCT01030900|26617817|FG000|Overall Study|Not treated due to congestive heart failure|1|||
13338537|NCT01030900|26617817|FG000|Overall Study|Not treated due to rapid disease|1|||
13338538|NCT01030874|26617832|FG000|Overall Study|Withdrawal by Subject|1|||
13338539|NCT01030874|26617833|FG001|Overall Study|Withdrawal by Subject|0|||
13338540|NCT01030874|26617832|FG000|Overall Study|Discharged in first 2 weeks|17|||
13338541|NCT01030874|26617833|FG001|Overall Study|Discharged in first 2 weeks|16|||
13338542|NCT01030822|26617890|FG000|Overall Study|Moved/migrated from study area|6|||
13338543|NCT01030822|26617891|FG001|Overall Study|Moved/migrated from study area|7|||
13338544|NCT01030822|26617892|FG002|Overall Study|Moved/migrated from study area|3|||
13338545|NCT01030822|26617890|FG000|Overall Study|Withdrawal by Subject|16|||
13338546|NCT01030822|26617891|FG001|Overall Study|Withdrawal by Subject|13|||
13338547|NCT01030822|26617892|FG002|Overall Study|Withdrawal by Subject|16|||
13338548|NCT01030822|26617890|FG000|Overall Study|Lost to Follow-up|9|||
13338549|NCT01030822|26617891|FG001|Overall Study|Lost to Follow-up|4|||
13338550|NCT01030822|26617892|FG002|Overall Study|Lost to Follow-up|7|||
13338551|NCT01030718|26617961|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
13338552|NCT01030718|26617962|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
13338553|NCT01030718|26617963|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11|||
13338554|NCT01030718|26617961|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3|||
13338555|NCT01030718|26617962|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5|||
13338556|NCT01030718|26617963|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1|||
13338557|NCT01030718|26617961|FG000|Studies CA180-031 and -036 Combined|Death|0|||
13338558|NCT01030718|26617962|FG001|Studies CA180-031 and -036 Combined|Death|1|||
13338559|NCT01030718|26617963|FG002|Studies CA180-031 and -036 Combined|Death|0|||
13338560|NCT01030718|26617961|FG000|Studies CA180-031 and -036 Combined|other reasons|0|||
13338561|NCT01030718|26617962|FG001|Studies CA180-031 and -036 Combined|other reasons|2|||
13338562|NCT01030718|26617963|FG002|Studies CA180-031 and -036 Combined|other reasons|0|||
13338563|NCT01030718|26617961|FG000|Study CA180-036 Only|insufficient effect|1|||
13338564|NCT01030718|26617962|FG001|Study CA180-036 Only|insufficient effect|1|||
13338565|NCT01030718|26617963|FG002|Study CA180-036 Only|insufficient effect|5|||
13338566|NCT01030718|26617961|FG000|Study CA180-036 Only|Adverse Event|2|||
13338567|NCT01030718|26617962|FG001|Study CA180-036 Only|Adverse Event|3|||
13338568|NCT01030718|26617963|FG002|Study CA180-036 Only|Adverse Event|0|||
13338569|NCT01030718|26617961|FG000|Study CA180-036 Only|Death|0|||
13338570|NCT01030718|26617962|FG001|Study CA180-036 Only|Death|1|||
13338571|NCT01030718|26617963|FG002|Study CA180-036 Only|Death|0|||
13338572|NCT01030718|26617961|FG000|Study CA180-036 Only|Other Reasons|0|||
13338573|NCT01030718|26617962|FG001|Study CA180-036 Only|Other Reasons|2|||
13338574|NCT01030718|26617963|FG002|Study CA180-036 Only|Other Reasons|0|||
13338575|NCT01030666|26617978|FG000|Overall Study|Lost to Follow-up|3|||
13338576|NCT01030666|26617979|FG001|Overall Study|Lost to Follow-up|2|||
13338577|NCT01030536|26618098|FG000|Overall Study|Withdrawal by Subject|0|||
13338578|NCT01030536|26618099|FG001|Overall Study|Withdrawal by Subject|0|||
13338579|NCT01030536|26618100|FG002|Overall Study|Withdrawal by Subject|1|||
13338580|NCT01030536|26618101|FG003|Overall Study|Withdrawal by Subject|0|||
13338581|NCT01030536|26618102|FG004|Overall Study|Withdrawal by Subject|0|||
13338582|NCT01030536|26618098|FG000|Overall Study|undefined|1|||
13338583|NCT01030536|26618099|FG001|Overall Study|undefined|0|||
13338584|NCT01030536|26618100|FG002|Overall Study|undefined|1|||
13338585|NCT01030536|26618101|FG003|Overall Study|undefined|1|||
13338586|NCT01030536|26618102|FG004|Overall Study|undefined|0|||
13338587|NCT01030536|26618098|FG000|Overall Study|Adverse Event|0|||
13338588|NCT01030536|26618099|FG001|Overall Study|Adverse Event|3|||
13338589|NCT01030536|26618100|FG002|Overall Study|Adverse Event|1|||
13338590|NCT01030536|26618101|FG003|Overall Study|Adverse Event|0|||
13338591|NCT01030536|26618102|FG004|Overall Study|Adverse Event|1|||
13338592|NCT01030536|26618098|FG000|Overall Study|Progressive disease|6|||
13338593|NCT01030536|26618099|FG001|Overall Study|Progressive disease|2|||
13338594|NCT01030536|26618100|FG002|Overall Study|Progressive disease|3|||
13338595|NCT01030536|26618101|FG003|Overall Study|Progressive disease|2|||
13338596|NCT01030536|26618102|FG004|Overall Study|Progressive disease|0|||
13338597|NCT01030536|26618098|FG000|Overall Study|Death|0|||
13338598|NCT01030536|26618099|FG001|Overall Study|Death|1|||
13338599|NCT01030536|26618100|FG002|Overall Study|Death|0|||
13338600|NCT01030536|26618101|FG003|Overall Study|Death|0|||
13338601|NCT01030536|26618102|FG004|Overall Study|Death|0|||
13338602|NCT01030458|26618121|FG000|Overall Study|Lost to Follow-up|9|||
13338603|NCT01030458|26618122|FG001|Overall Study|Lost to Follow-up|10|||
13338604|NCT01030458|26618121|FG000|Overall Study|Withdrawal by Subject|2|||
13338605|NCT01030458|26618122|FG001|Overall Study|Withdrawal by Subject|3|||
13338606|NCT01030458|26618121|FG000|Overall Study|Logistical reasons|9|||
13338607|NCT01030458|26618122|FG001|Overall Study|Logistical reasons|5|||
13338608|NCT01030458|26618121|FG000|Overall Study|Moved or changed job|6|||
13338609|NCT01030458|26618122|FG001|Overall Study|Moved or changed job|13|||
13338610|NCT01030458|26618121|FG000|Overall Study|Side effect of medication|1|||
13338611|NCT01030458|26618122|FG001|Overall Study|Side effect of medication|1|||
13338612|NCT01030341|26618129|FG000|Overall Study|Withdrawal by Subject|1|||
13338613|NCT01030341|26618129|FG000|Overall Study|Lost to Follow-up|2|||
13338614|NCT01030198|26618142|FG000|Overall Study|Could not measure efficacy accurately|0|||
13338615|NCT01030198|26618143|FG001|Overall Study|Could not measure efficacy accurately|7|||
13338616|NCT01030133|26618162|FG000|Overall Study|failed to experience pain at level 7/10|2|||
13338617|NCT01030133|26618163|FG001|Overall Study|failed to experience pain at level 7/10|2|||
13338618|NCT01029925|26618169|FG000|Completion of Cycle 1 (28 Days)|Death|2|||
13338619|NCT01029925|26618169|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2|||
13338620|NCT01029925|26618169|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1|||
13338621|NCT01029886|26618202|FG000|Overall Study|Adverse Event|12|||
13338622|NCT01029886|26618203|FG001|Overall Study|Adverse Event|25|||
13338623|NCT01029886|26618202|FG000|Overall Study|Lost to Follow-up|1|||
13338624|NCT01029886|26618203|FG001|Overall Study|Lost to Follow-up|0|||
13338625|NCT01029886|26618202|FG000|Overall Study|Physician Decision|2|||
13338626|NCT01029886|26618203|FG001|Overall Study|Physician Decision|6|||
13338627|NCT01029886|26618202|FG000|Overall Study|Protocol Violation|17|||
13338628|NCT01029886|26618203|FG001|Overall Study|Protocol Violation|5|||
13338629|NCT01029886|26618202|FG000|Overall Study|Withdrawal by Subject|8|||
13338630|NCT01029886|26618203|FG001|Overall Study|Withdrawal by Subject|18|||
13338631|NCT01029886|26618202|FG000|Overall Study|Entry Criteria Not Met|13|||
13338632|NCT01029886|26618203|FG001|Overall Study|Entry Criteria Not Met|5|||
13338633|NCT01029886|26618202|FG000|Overall Study|Sponsor Decision|1|||
13338634|NCT01029886|26618203|FG001|Overall Study|Sponsor Decision|0|||
13338635|NCT01029886|26618202|FG000|Overall Study|Loss Glucose Control|7|||
13338636|NCT01029886|26618203|FG001|Overall Study|Loss Glucose Control|1|||
13338637|NCT01029795|26618262|FG000|Overall Study|Entry Criteria Not Met|2|||
13338638|NCT01029795|26618263|FG001|Overall Study|Entry Criteria Not Met|1|||
13338639|NCT01029795|26618262|FG000|Overall Study|Physician Decision|2|||
13338640|NCT01029795|26618263|FG001|Overall Study|Physician Decision|1|||
13338641|NCT01029795|26618262|FG000|Overall Study|Sponsor Decision|11|||
13338642|NCT01029795|26618263|FG001|Overall Study|Sponsor Decision|17|||
13338643|NCT01029795|26618262|FG000|Overall Study|Withdrawal by Subject|1|||
13338644|NCT01029795|26618263|FG001|Overall Study|Withdrawal by Subject|3|||
13338645|NCT01029782|26618276|FG000|Overall Study|Lost to Follow-up|2|||
13338646|NCT01029782|26618277|FG001|Overall Study|Lost to Follow-up|2|||
13338647|NCT01029782|26618276|FG000|Overall Study|Diagnosis changed|1|||
13338648|NCT01029782|26618277|FG001|Overall Study|Diagnosis changed|1|||
13338649|NCT01029782|26618276|FG000|Overall Study|Adverse Event|0|||
13338650|NCT01029782|26618277|FG001|Overall Study|Adverse Event|1|||
13338651|NCT01029782|26618276|FG000|Overall Study|Physician Decision|0|||
13338652|NCT01029782|26618277|FG001|Overall Study|Physician Decision|1|||
13338653|NCT01029782|26618276|FG000|Overall Study|Protocol Violation|0|||
13338654|NCT01029782|26618277|FG001|Overall Study|Protocol Violation|2|||
13338655|NCT01029782|26618276|FG000|Overall Study|Withdrawal by Subject|0|||
13338656|NCT01029782|26618277|FG001|Overall Study|Withdrawal by Subject|1|||
13338657|NCT01029704|26618349|FG000|Overall Study|Adverse Event|0|||
13338658|NCT01029704|26618350|FG001|Overall Study|Adverse Event|0|||
13338659|NCT01029704|26618351|FG002|Overall Study|Adverse Event|0|||
13338660|NCT01029704|26618352|FG003|Overall Study|Adverse Event|0|||
13338661|NCT01029704|26618353|FG004|Overall Study|Adverse Event|0|||
13338662|NCT01029704|26618354|FG005|Overall Study|Adverse Event|0|||
13338663|NCT01029704|26618355|FG006|Overall Study|Adverse Event|1|||
13338664|NCT01029704|26618356|FG007|Overall Study|Adverse Event|1|||
13338665|NCT01029704|26618357|FG008|Overall Study|Adverse Event|0|||
13338666|NCT01029704|26618349|FG000|Overall Study|Withdrawal by Subject|0|||
13338667|NCT01029704|26618350|FG001|Overall Study|Withdrawal by Subject|0|||
13338668|NCT01029704|26618351|FG002|Overall Study|Withdrawal by Subject|0|||
13338669|NCT01029704|26618352|FG003|Overall Study|Withdrawal by Subject|0|||
13338670|NCT01029704|26618353|FG004|Overall Study|Withdrawal by Subject|2|||
13338671|NCT01029704|26618354|FG005|Overall Study|Withdrawal by Subject|1|||
13338672|NCT01029704|26618355|FG006|Overall Study|Withdrawal by Subject|1|||
13338673|NCT01029704|26618356|FG007|Overall Study|Withdrawal by Subject|1|||
13338674|NCT01029704|26618357|FG008|Overall Study|Withdrawal by Subject|0|||
13338675|NCT01029704|26618349|FG000|Overall Study|Lost to Follow-up|0|||
13338676|NCT01029704|26618350|FG001|Overall Study|Lost to Follow-up|0|||
13338677|NCT01029704|26618351|FG002|Overall Study|Lost to Follow-up|0|||
13338678|NCT01029704|26618352|FG003|Overall Study|Lost to Follow-up|0|||
13338679|NCT01029704|26618353|FG004|Overall Study|Lost to Follow-up|0|||
13338680|NCT01029704|26618354|FG005|Overall Study|Lost to Follow-up|0|||
13338681|NCT01029704|26618355|FG006|Overall Study|Lost to Follow-up|1|||
13338682|NCT01029704|26618356|FG007|Overall Study|Lost to Follow-up|1|||
13338683|NCT01029704|26618357|FG008|Overall Study|Lost to Follow-up|1|||
13338684|NCT01029704|26618349|FG000|Overall Study|Lack of Efficacy|0|||
13338685|NCT01029704|26618350|FG001|Overall Study|Lack of Efficacy|0|||
13338686|NCT01029704|26618351|FG002|Overall Study|Lack of Efficacy|0|||
13338687|NCT01029704|26618352|FG003|Overall Study|Lack of Efficacy|0|||
13338688|NCT01029704|26618353|FG004|Overall Study|Lack of Efficacy|2|||
13338689|NCT01029704|26618354|FG005|Overall Study|Lack of Efficacy|3|||
13338690|NCT01029704|26618355|FG006|Overall Study|Lack of Efficacy|1|||
13338691|NCT01029704|26618356|FG007|Overall Study|Lack of Efficacy|2|||
13338692|NCT01029704|26618357|FG008|Overall Study|Lack of Efficacy|0|||
13338693|NCT01029704|26618349|FG000|Overall Study|Withdrawn due to major protocol violation|0|||
13338694|NCT01029704|26618350|FG001|Overall Study|Withdrawn due to major protocol violation|0|||
13338695|NCT01029704|26618351|FG002|Overall Study|Withdrawn due to major protocol violation|0|||
13338696|NCT01029704|26618352|FG003|Overall Study|Withdrawn due to major protocol violation|0|||
13338697|NCT01029704|26618353|FG004|Overall Study|Withdrawn due to major protocol violation|1|||
13338698|NCT01029704|26618354|FG005|Overall Study|Withdrawn due to major protocol violation|0|||
13338699|NCT01029704|26618355|FG006|Overall Study|Withdrawn due to major protocol violation|0|||
13338700|NCT01029704|26618356|FG007|Overall Study|Withdrawn due to major protocol violation|1|||
13393575|NCT00663208|26784235|FG004|Follow-up Period|Other reason|0|||
13338701|NCT01029704|26618357|FG008|Overall Study|Withdrawn due to major protocol violation|0|||
13338702|NCT01029691|26618390|FG000|Continued APAP to Delivery|Death|0|||
13338703|NCT01029691|26618391|FG001|Continued APAP to Delivery|Death|0|||
13338704|NCT01029691|26618392|FG002|Continued APAP to Delivery|Death|1|||
13338705|NCT01029652|26618477|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0|||
13338706|NCT01029652|26618478|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4|||
13338707|NCT01029652|26618477|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1|||
13338708|NCT01029652|26618478|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3|||
13338709|NCT01029652|26618477|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3|||
13338710|NCT01029652|26618478|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1|||
13338711|NCT01029652|26618477|FG000|Core Study (0-12 Weeks)|Administrative problems|2|||
13338712|NCT01029652|26618478|FG001|Core Study (0-12 Weeks)|Administrative problems|1|||
13338713|NCT01029652|26618477|FG000|Core Study (0-12 Weeks)|Death|0|||
13338714|NCT01029652|26618478|FG001|Core Study (0-12 Weeks)|Death|1|||
13338715|NCT01029652|26618477|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0|||
13338716|NCT01029652|26618478|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1|||
13338717|NCT01029652|26618477|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2|||
13338718|NCT01029652|26618478|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3|||
13338719|NCT01029652|26618477|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1|||
13338720|NCT01029652|26618478|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0|||
13338721|NCT01029652|26618477|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0|||
13338722|NCT01029652|26618478|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1|||
13338723|NCT01029652|26618477|FG000|Extension Study 2 (25-72 Weeks)|Death|1|||
13338724|NCT01029652|26618478|FG001|Extension Study 2 (25-72 Weeks)|Death|1|||
13338725|NCT01029652|26618477|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0|||
13338726|NCT01029652|26618478|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1|||
13338727|NCT01029652|26618477|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0|||
13338728|NCT01029652|26618478|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1|||
13338729|NCT01029535|26618505|FG000|Overall Study|Lost to Follow-up|24|||
13338730|NCT01029535|26618505|FG000|Overall Study|Protocol Violation|2|||
13338731|NCT01029535|26618505|FG000|Overall Study|Participant Withdrew Consent|2|||
13338732|NCT01029535|26618505|FG000|Overall Study|Adverse Event|1|||
13338733|NCT01029535|26618505|FG000|Overall Study|Use of Another Treatment|1|||
13338734|NCT01029535|26618505|FG000|Overall Study|Death|1|||
13338735|NCT01029405|26618528|FG000|Overall Study|Withdrawal by Subject|0|||
13338736|NCT01029405|26618529|FG001|Overall Study|Withdrawal by Subject|1|||
13338737|NCT01029405|26618530|FG002|Overall Study|Withdrawal by Subject|2|||
13338738|NCT01029405|26618531|FG003|Overall Study|Withdrawal by Subject|0|||
13338739|NCT01029405|26618528|FG000|Overall Study|Protocol Violation|0|||
13338740|NCT01029405|26618529|FG001|Overall Study|Protocol Violation|0|||
13338741|NCT01029405|26618530|FG002|Overall Study|Protocol Violation|0|||
13338742|NCT01029405|26618531|FG003|Overall Study|Protocol Violation|1|||
13338743|NCT01029405|26618528|FG000|Overall Study|Adverse Event|0|||
13338744|NCT01029405|26618529|FG001|Overall Study|Adverse Event|0|||
13338745|NCT01029405|26618530|FG002|Overall Study|Adverse Event|1|||
13338746|NCT01029405|26618531|FG003|Overall Study|Adverse Event|1|||
13338747|NCT01029405|26618528|FG000|Overall Study|Lost to Follow-up|2|||
13338748|NCT01029405|26618529|FG001|Overall Study|Lost to Follow-up|1|||
13338749|NCT01029405|26618530|FG002|Overall Study|Lost to Follow-up|1|||
13338750|NCT01029405|26618531|FG003|Overall Study|Lost to Follow-up|2|||
13338751|NCT01029405|26618528|FG000|Overall Study|Other|0|||
13338752|NCT01029405|26618529|FG001|Overall Study|Other|1|||
13338753|NCT01029405|26618530|FG002|Overall Study|Other|0|||
13338754|NCT01029405|26618531|FG003|Overall Study|Other|1|||
13338755|NCT01029392|26618546|FG000|Overall Study|Withdrawal by Subject|18|||
13338756|NCT01029392|26618547|FG001|Overall Study|Withdrawal by Subject|11|||
13338757|NCT01029392|26618546|FG000|Overall Study|Physician Decision|2|||
13338758|NCT01029392|26618547|FG001|Overall Study|Physician Decision|0|||
13338759|NCT01029366|26618561|FG000|Overall Study|Withdrawal by Subject|1|||
13338760|NCT01029366|26618562|FG001|Overall Study|Withdrawal by Subject|0|||
13338761|NCT01029366|26618561|FG000|Overall Study|Death|1|||
13338762|NCT01029366|26618562|FG001|Overall Study|Death|1|||
13338763|NCT01029366|26618561|FG000|Overall Study|disease progression|2|||
13338764|NCT01029366|26618562|FG001|Overall Study|disease progression|0|||
13338765|NCT01029366|26618561|FG000|Overall Study|manufacturing failure|0|||
13338766|NCT01029366|26618562|FG001|Overall Study|manufacturing failure|1|||
13338767|NCT01029353|26618663|FG000|Overall Study|Lost to Follow-up|4|||
13338768|NCT01029353|26618664|FG001|Overall Study|Lost to Follow-up|5|||
13338769|NCT01029353|26618665|FG002|Overall Study|Lost to Follow-up|5|||
13338770|NCT01029353|26618666|FG003|Overall Study|Lost to Follow-up|4|||
13338771|NCT01029353|26618663|FG000|Overall Study|Consent Withdrawn|2|||
13393576|NCT00663208|26784236|FG005|Follow-up Period|Other reason|0|||
13338772|NCT01029353|26618664|FG001|Overall Study|Consent Withdrawn|0|||
13338773|NCT01029353|26618665|FG002|Overall Study|Consent Withdrawn|0|||
13338774|NCT01029353|26618666|FG003|Overall Study|Consent Withdrawn|0|||
13338775|NCT01029353|26618663|FG000|Overall Study|Primary Outcome Indeterminate|1|||
13338776|NCT01029353|26618664|FG001|Overall Study|Primary Outcome Indeterminate|3|||
13338777|NCT01029353|26618665|FG002|Overall Study|Primary Outcome Indeterminate|2|||
13338778|NCT01029353|26618666|FG003|Overall Study|Primary Outcome Indeterminate|0|||
13338779|NCT01029340|26618712|FG000|Part B Treatment Period|Withdrawal by Subject|0|||
13338780|NCT01029340|26618713|FG001|Part B Treatment Period|Withdrawal by Subject|0|||
13338781|NCT01029340|26618714|FG002|Part B Treatment Period|Withdrawal by Subject|1|||
13338782|NCT01029340|26618715|FG003|Part B Treatment Period|Withdrawal by Subject|0|||
13338783|NCT01029340|26618716|FG004|Part B Treatment Period|Withdrawal by Subject|0|||
13338784|NCT01029340|26618717|FG005|Part B Treatment Period|Withdrawal by Subject|0|||
13338785|NCT01029340|26618712|FG000|Part B Treatment Period|Protocol Violation|0|||
13338786|NCT01029340|26618713|FG001|Part B Treatment Period|Protocol Violation|0|||
13338787|NCT01029340|26618714|FG002|Part B Treatment Period|Protocol Violation|1|||
13338788|NCT01029340|26618715|FG003|Part B Treatment Period|Protocol Violation|0|||
13338789|NCT01029340|26618716|FG004|Part B Treatment Period|Protocol Violation|0|||
13338790|NCT01029340|26618717|FG005|Part B Treatment Period|Protocol Violation|0|||
13338791|NCT01029340|26618712|FG000|Extension Period|Adverse Event|0|||
13338792|NCT01029340|26618713|FG001|Extension Period|Adverse Event|0|||
13338793|NCT01029340|26618714|FG002|Extension Period|Adverse Event|0|||
13338794|NCT01029340|26618715|FG003|Extension Period|Adverse Event|0|||
13338795|NCT01029340|26618716|FG004|Extension Period|Adverse Event|0|||
13338796|NCT01029340|26618717|FG005|Extension Period|Adverse Event|1|||
13338797|NCT01029340|26618712|FG000|Extension Period|starting another study|0|||
13338798|NCT01029340|26618713|FG001|Extension Period|starting another study|0|||
13338799|NCT01029340|26618714|FG002|Extension Period|starting another study|0|||
13338800|NCT01029340|26618715|FG003|Extension Period|starting another study|0|||
13338801|NCT01029340|26618716|FG004|Extension Period|starting another study|0|||
13338802|NCT01029340|26618717|FG005|Extension Period|starting another study|8|||
13338803|NCT01029340|26618712|FG000|Extension Period|non-compliance|0|||
13338804|NCT01029340|26618713|FG001|Extension Period|non-compliance|0|||
13338805|NCT01029340|26618714|FG002|Extension Period|non-compliance|0|||
13338806|NCT01029340|26618715|FG003|Extension Period|non-compliance|0|||
13338807|NCT01029340|26618716|FG004|Extension Period|non-compliance|0|||
13338808|NCT01029340|26618717|FG005|Extension Period|non-compliance|1|||
13338809|NCT01029340|26618712|FG000|Extension Period|Withdrawal by Subject|0|||
13338810|NCT01029340|26618713|FG001|Extension Period|Withdrawal by Subject|0|||
13338811|NCT01029340|26618714|FG002|Extension Period|Withdrawal by Subject|0|||
13338812|NCT01029340|26618715|FG003|Extension Period|Withdrawal by Subject|0|||
13338813|NCT01029340|26618716|FG004|Extension Period|Withdrawal by Subject|0|||
13338814|NCT01029340|26618717|FG005|Extension Period|Withdrawal by Subject|1|||
13338815|NCT01029340|26618712|FG000|Extension Period|Physician Decision|0|||
13338816|NCT01029340|26618713|FG001|Extension Period|Physician Decision|0|||
13338817|NCT01029340|26618714|FG002|Extension Period|Physician Decision|0|||
13338818|NCT01029340|26618715|FG003|Extension Period|Physician Decision|0|||
13338819|NCT01029340|26618716|FG004|Extension Period|Physician Decision|0|||
13338820|NCT01029340|26618717|FG005|Extension Period|Physician Decision|1|||
13338821|NCT01029262|26618786|FG000|Overall Study|Adverse Event|9|||
13338822|NCT01029262|26618787|FG001|Overall Study|Adverse Event|52|||
13338823|NCT01029262|26618786|FG000|Overall Study|Lack of therapeutic effect|57|||
13338824|NCT01029262|26618787|FG001|Overall Study|Lack of therapeutic effect|76|||
13338825|NCT01029262|26618786|FG000|Overall Study|Withdrawal by Subject|10|||
13338826|NCT01029262|26618787|FG001|Overall Study|Withdrawal by Subject|17|||
13338827|NCT01029262|26618786|FG000|Overall Study|Protocol Violation|2|||
13338828|NCT01029262|26618787|FG001|Overall Study|Protocol Violation|3|||
13338829|NCT01029262|26618786|FG000|Overall Study|Miscellaneous|1|||
13338830|NCT01029262|26618787|FG001|Overall Study|Miscellaneous|9|||
13338831|NCT01029262|26618786|FG000|Overall Study|Death|0|||
13338832|NCT01029262|26618787|FG001|Overall Study|Death|3|||
13338833|NCT01028651|26618810|FG000|Overall Study|Death|2|||
13338834|NCT01028651|26618810|FG000|Overall Study|Adverse Event|1|||
13338835|NCT01028560|26618829|FG000|Overall Study|Lack of Efficacy|3|||
13338836|NCT01028560|26618830|FG001|Overall Study|Lack of Efficacy|6|||
13338837|NCT01028560|26618829|FG000|Overall Study|Withdrawal by Subject|7|||
13338838|NCT01028560|26618830|FG001|Overall Study|Withdrawal by Subject|12|||
13338839|NCT01028391|26618845|FG000|Overall Study|Adverse Event|4|||
13338840|NCT01028391|26618846|FG001|Overall Study|Adverse Event|0|||
13338841|NCT01028391|26618845|FG000|Overall Study|Lack of Efficacy|0|||
13338842|NCT01028391|26618846|FG001|Overall Study|Lack of Efficacy|2|||
13338843|NCT01028391|26618845|FG000|Overall Study|Lost to Follow-up|3|||
13338844|NCT01028391|26618846|FG001|Overall Study|Lost to Follow-up|4|||
13338845|NCT01028391|26618845|FG000|Overall Study|Physician Decision|0|||
13338846|NCT01028391|26618846|FG001|Overall Study|Physician Decision|1|||
13338847|NCT01028391|26618845|FG000|Overall Study|Withdrawal by Subject|6|||
13338848|NCT01028391|26618846|FG001|Overall Study|Withdrawal by Subject|3|||
13338849|NCT01028391|26618845|FG000|Overall Study|Needed excluded medication|1|||
13338850|NCT01028391|26618846|FG001|Overall Study|Needed excluded medication|1|||
13338851|NCT01028378|26618860|FG000|Overall Study|Lost to Follow-up|12|||
13338852|NCT01028378|26618860|FG000|Overall Study|Withdrawal by Subject|1|||
13338853|NCT01028378|26618860|FG000|Overall Study|Adminstrative Reasons|4|||
13338854|NCT01028352|26618867|FG000|Overall Study|Ineligible due to baseline average pain|5|||
13338855|NCT01028352|26618867|FG000|Overall Study|Withdrawal by Subject|1|||
13338856|NCT01028300|26618876|FG000|Overall Study|Study Terminated|4|||
13338857|NCT01028222|26618904|FG000|Overall Study|Protocol deviation|1|||
13338858|NCT01028222|26618905|FG001|Overall Study|Protocol deviation|0|||
13338859|NCT01028222|26618904|FG000|Overall Study|Disease progression|33|||
13338860|NCT01028222|26618905|FG001|Overall Study|Disease progression|9|||
13338861|NCT01028222|26618904|FG000|Overall Study|Administrative problems|1|||
13338862|NCT01028222|26618905|FG001|Overall Study|Administrative problems|1|||
13338863|NCT01028222|26618904|FG000|Overall Study|Lost to Follow-up|0|||
13338864|NCT01028222|26618905|FG001|Overall Study|Lost to Follow-up|1|||
13338865|NCT01028222|26618904|FG000|Overall Study|Withdrawal by Subject|1|||
13338866|NCT01028222|26618905|FG001|Overall Study|Withdrawal by Subject|0|||
13338867|NCT01028222|26618904|FG000|Overall Study|Crossover to nilotinib w/out progression|0|||
13338868|NCT01028222|26618905|FG001|Overall Study|Crossover to nilotinib w/out progression|2|||
13338869|NCT01028222|26618904|FG000|Overall Study|Adverse Event|2|||
13338870|NCT01028222|26618905|FG001|Overall Study|Adverse Event|0|||
13338871|NCT01028053|26618913|FG000|Overall Study|Screen Failure|113|||
13338872|NCT01028053|26618913|FG000|Overall Study|Patient Request|11|||
13338873|NCT01028053|26618913|FG000|Overall Study|Protocol Violation|1|||
13338874|NCT01028053|26618913|FG000|Overall Study|Physician Decision|2|||
13338875|NCT01028053|26618913|FG000|Overall Study|Technical Problem|1|||
13338876|NCT01028053|26618913|FG000|Overall Study|Terminated by Sponsor|1|||
13338877|NCT01028053|26618913|FG000|Overall Study|Various reasons|4|||
13338878|NCT01028027|26618936|FG000|Overall Study|Lost to Follow-up|4|||
13338879|NCT01028027|26618937|FG001|Overall Study|Lost to Follow-up|1|||
13338880|NCT01028027|26618936|FG000|Overall Study|Withdrawal by Subject|5|||
13338881|NCT01028027|26618937|FG001|Overall Study|Withdrawal by Subject|3|||
13338882|NCT01028027|26618936|FG000|Overall Study|Adverse Event|4|||
13338883|NCT01028027|26618937|FG001|Overall Study|Adverse Event|7|||
13338884|NCT01028027|26618936|FG000|Overall Study|Protocol Violation|3|||
13338885|NCT01028027|26618937|FG001|Overall Study|Protocol Violation|1|||
13338886|NCT01028027|26618936|FG000|Overall Study|Lack of Efficacy|0|||
13338887|NCT01028027|26618937|FG001|Overall Study|Lack of Efficacy|1|||
13338888|NCT01028014|26618982|FG000|Overall Study|Lost to Follow-up|1|||
13338889|NCT01028014|26618983|FG001|Overall Study|Lost to Follow-up|2|||
13338890|NCT01028014|26618984|FG002|Overall Study|Lost to Follow-up|0|||
13338891|NCT01028014|26618985|FG003|Overall Study|Lost to Follow-up|1|||
13338892|NCT01028014|26618986|FG004|Overall Study|Lost to Follow-up|1|||
13338893|NCT01028014|26618987|FG005|Overall Study|Lost to Follow-up|2|||
13338894|NCT01027949|26618993|FG000|Overall Study|Death|174|||
13338895|NCT01027949|26618993|FG000|Overall Study|Progressive Disease|163|||
13338896|NCT01027949|26618993|FG000|Overall Study|Adverse Event|172|||
13338897|NCT01027949|26618993|FG000|Overall Study|Withdrawal by Subject|113|||
13338898|NCT01027949|26618993|FG000|Overall Study|Lost to Follow-up|17|||
13338899|NCT01027949|26618993|FG000|Overall Study|Protocol Violation|13|||
13338900|NCT01027949|26618993|FG000|Overall Study|PI Decision|8|||
13338901|NCT01027949|26618993|FG000|Overall Study|Limited Study Drug Effectiveness|7|||
13338902|NCT01027949|26618993|FG000|Overall Study|Non-compliance with Study Procedures|7|||
13338903|NCT01027949|26618993|FG000|Overall Study|Lung Transplant|5|||
13338904|NCT01027949|26618993|FG000|Overall Study|Unable to Tolerate Study Drug|2|||
13338905|NCT01027949|26618993|FG000|Overall Study|Use of Excluded Medication|2|||
13338906|NCT01027949|26618993|FG000|Overall Study|Patient Self-discontinuation|1|||
13338907|NCT01027949|26618993|FG000|Overall Study|Pregnancy|1|||
13338908|NCT01027949|26618993|FG000|Overall Study|Surgery|1|||
13338909|NCT01027897|26619001|FG000|Overall Study|Protocol Violation|1|||
13338910|NCT01027897|26619001|FG000|Overall Study|Withdrawal by Subject|1|||
13338911|NCT01027884|26619022|FG000|Overall Study|Adverse Event|2|||
13338912|NCT01027884|26619023|FG001|Overall Study|Adverse Event|1|||
13338913|NCT01027884|26619022|FG000|Overall Study|Protocol Violation|1|||
13338914|NCT01027884|26619023|FG001|Overall Study|Protocol Violation|0|||
13338915|NCT01027884|26619022|FG000|Overall Study|Non-compliance|1|||
13338916|NCT01027884|26619023|FG001|Overall Study|Non-compliance|1|||
13338917|NCT01027884|26619022|FG000|Overall Study|Withdrawal by Subject|0|||
13338918|NCT01027884|26619023|FG001|Overall Study|Withdrawal by Subject|1|||
13338919|NCT01027884|26619022|FG000|Overall Study|Lost to Follow-up|0|||
13338920|NCT01027884|26619023|FG001|Overall Study|Lost to Follow-up|1|||
13338921|NCT01027884|26619022|FG000|Overall Study|Spinal fixation surgery|0|||
13338922|NCT01027884|26619023|FG001|Overall Study|Spinal fixation surgery|3|||
13338923|NCT01027871|26619090|FG000|Overall Study|Physician Decision|1|||
13338924|NCT01027871|26619091|FG001|Overall Study|Physician Decision|5|||
13338925|NCT01027871|26619092|FG002|Overall Study|Physician Decision|0|||
13338926|NCT01027871|26619090|FG000|Overall Study|Protocol Violation|0|||
13338927|NCT01027871|26619091|FG001|Overall Study|Protocol Violation|2|||
13338928|NCT01027871|26619092|FG002|Overall Study|Protocol Violation|2|||
13338929|NCT01027871|26619090|FG000|Overall Study|Withdrawal by Subject|1|||
13338930|NCT01027871|26619091|FG001|Overall Study|Withdrawal by Subject|2|||
13338931|NCT01027871|26619092|FG002|Overall Study|Withdrawal by Subject|2|||
13338932|NCT01027871|26619090|FG000|Overall Study|Adverse Event|0|||
13338933|NCT01027871|26619091|FG001|Overall Study|Adverse Event|2|||
13338934|NCT01027871|26619092|FG002|Overall Study|Adverse Event|2|||
13338935|NCT01027871|26619090|FG000|Overall Study|Sponsor Decision|0|||
13338936|NCT01027871|26619091|FG001|Overall Study|Sponsor Decision|2|||
13338937|NCT01027871|26619092|FG002|Overall Study|Sponsor Decision|0|||
13338938|NCT01027871|26619090|FG000|Overall Study|Discontinued Prior to Treatment|0|||
13338939|NCT01027871|26619091|FG001|Overall Study|Discontinued Prior to Treatment|0|||
13338940|NCT01027871|26619092|FG002|Overall Study|Discontinued Prior to Treatment|1|||
13338941|NCT01027845|26619151|FG000|Primary Vaccination Phase|Serious Adverse Event|2|||
13338942|NCT01027845|26619152|FG001|Primary Vaccination Phase|Serious Adverse Event|0|||
13338943|NCT01027845|26619153|FG002|Primary Vaccination Phase|Serious Adverse Event|0|||
13338944|NCT01027845|26619154|FG003|Primary Vaccination Phase|Serious Adverse Event|0|||
13338945|NCT01027845|26619151|FG000|Primary Vaccination Phase|Adverse Event|1|||
13338946|NCT01027845|26619152|FG001|Primary Vaccination Phase|Adverse Event|0|||
13338947|NCT01027845|26619153|FG002|Primary Vaccination Phase|Adverse Event|0|||
13338948|NCT01027845|26619154|FG003|Primary Vaccination Phase|Adverse Event|0|||
13338949|NCT01027845|26619151|FG000|Primary Vaccination Phase|Protocol Violation|1|||
13338950|NCT01027845|26619152|FG001|Primary Vaccination Phase|Protocol Violation|0|||
13338951|NCT01027845|26619153|FG002|Primary Vaccination Phase|Protocol Violation|0|||
13338952|NCT01027845|26619154|FG003|Primary Vaccination Phase|Protocol Violation|0|||
13338953|NCT01027845|26619151|FG000|Primary Vaccination Phase|Migrated/moved from study area|0|||
13338954|NCT01027845|26619152|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
13338955|NCT01027845|26619153|FG002|Primary Vaccination Phase|Migrated/moved from study area|0|||
13338956|NCT01027845|26619154|FG003|Primary Vaccination Phase|Migrated/moved from study area|0|||
13338957|NCT01027845|26619151|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
13338958|NCT01027845|26619152|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
13338959|NCT01027845|26619153|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
13338960|NCT01027845|26619154|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
13338961|NCT01027845|26619151|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
13338962|NCT01027845|26619152|FG001|Booster Vaccination Phase|Migrated/moved from study area|0|||
13338963|NCT01027845|26619153|FG002|Booster Vaccination Phase|Migrated/moved from study area|0|||
13338964|NCT01027845|26619154|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
13338965|NCT01027754|26619195|FG000|Overall Study|withdrew/lost to follow-up after interve|2|||
13338966|NCT01027754|26619196|FG001|Overall Study|withdrew/lost to follow-up after interve|3|||
13338967|NCT01027754|26619195|FG000|Overall Study|Withdrawal by Subject|0|||
13338968|NCT01027754|26619196|FG001|Overall Study|Withdrawal by Subject|5|||
13373936|NCT00798707|26725268|FG000|Overall Study|Withdrawal by Subject|3|||
13373937|NCT00798707|26725269|FG001|Overall Study|Withdrawal by Subject|8|||
13373938|NCT00798707|26725270|FG002|Overall Study|Withdrawal by Subject|2|||
13373939|NCT00798707|26725268|FG000|Overall Study|Randomized not treated|4|||
13373940|NCT00798707|26725269|FG001|Overall Study|Randomized not treated|5|||
13373941|NCT00798707|26725270|FG002|Overall Study|Randomized not treated|1|||
13373942|NCT00798694|26725301|FG000|Overall Study|Lost to Follow-up|1|||
13373943|NCT00798694|26725302|FG001|Overall Study|Lost to Follow-up|1|||
13373944|NCT00798694|26725301|FG000|Overall Study|Physician Decision|1|||
13373945|NCT00798694|26725302|FG001|Overall Study|Physician Decision|0|||
13373946|NCT00798655|26725309|FG000|Overall Study|Did not receive at least one dose of pan|2|||
13373947|NCT00798603|26725331|FG000|Overall Study|Still on treatment as of 11/6/2012|1|||
13373948|NCT00798603|26725331|FG000|Overall Study|Withdrawal by Subject|10|||
13373949|NCT00798603|26725331|FG000|Overall Study|Adverse Event|22|||
13373950|NCT00798603|26725331|FG000|Overall Study|Physician Decision|1|||
13373951|NCT00798603|26725331|FG000|Overall Study|Lack of insurance coverage|1|||
13373952|NCT00798590|26725346|FG000|Overall Study|P.I, Left institution. Study terminated|11|||
13373953|NCT00798590|26725347|FG001|Overall Study|P.I, Left institution. Study terminated|8|||
13373954|NCT00798434|26725434|FG000|Double-Blind|Adverse Event|22|||
13373955|NCT00798434|26725435|FG001|Double-Blind|Adverse Event|46|||
13373956|NCT00798434|26725434|FG000|Double-Blind|Death|0|||
13373957|NCT00798434|26725435|FG001|Double-Blind|Death|1|||
13373958|NCT00798434|26725434|FG000|Double-Blind|Lost to Follow-up|1|||
13373959|NCT00798434|26725435|FG001|Double-Blind|Lost to Follow-up|0|||
13373960|NCT00798434|26725434|FG000|Double-Blind|Lack of Efficacy|8|||
13373961|NCT00798434|26725435|FG001|Double-Blind|Lack of Efficacy|12|||
13373962|NCT00798434|26725434|FG000|Double-Blind|Withdrawal by Subject|17|||
13373963|NCT00798434|26725435|FG001|Double-Blind|Withdrawal by Subject|14|||
13373964|NCT00798434|26725434|FG000|Double-Blind|Protocol Violation|1|||
13373965|NCT00798434|26725435|FG001|Double-Blind|Protocol Violation|4|||
13373966|NCT00798434|26725434|FG000|Double-Blind|Did Not Meet Entrance Criteria|2|||
13373967|NCT00798434|26725435|FG001|Double-Blind|Did Not Meet Entrance Criteria|1|||
13373968|NCT00798434|26725434|FG000|Double-Blind|Other|1|||
13373969|NCT00798434|26725435|FG001|Double-Blind|Other|0|||
13373970|NCT00798434|26725434|FG000|Double-Blind|Not Treated|3|||
13373971|NCT00798434|26725435|FG001|Double-Blind|Not Treated|6|||
13373972|NCT00798434|26725434|FG000|Open-Label|Adverse Event|33|||
13373973|NCT00798434|26725435|FG001|Open-Label|Adverse Event|11|||
13338969|NCT01027702|26619222|FG000|Overall Study|Received subsequent therapy|1|||
13338970|NCT01027702|26619223|FG001|Overall Study|Received subsequent therapy|2|||
13338971|NCT01027702|26619224|FG002|Overall Study|Received subsequent therapy|0|||
13338972|NCT01027702|26619225|FG003|Overall Study|Received subsequent therapy|4|||
13338973|NCT01027702|26619226|FG004|Overall Study|Received subsequent therapy|1|||
13338974|NCT01027702|26619227|FG005|Overall Study|Received subsequent therapy|0|||
13338975|NCT01027702|26619228|FG006|Overall Study|Received subsequent therapy|1|||
13338976|NCT01027702|26619222|FG000|Overall Study|Death|0|||
13338977|NCT01027702|26619223|FG001|Overall Study|Death|0|||
13338978|NCT01027702|26619224|FG002|Overall Study|Death|1|||
13338979|NCT01027702|26619225|FG003|Overall Study|Death|0|||
13338980|NCT01027702|26619226|FG004|Overall Study|Death|0|||
13338981|NCT01027702|26619227|FG005|Overall Study|Death|0|||
13338982|NCT01027702|26619228|FG006|Overall Study|Death|0|||
13338983|NCT01027650|26619295|FG000|Overall Study|Personal Reasons|0|||
13338984|NCT01027650|26619296|FG001|Overall Study|Personal Reasons|0|||
13338985|NCT01027650|26619297|FG002|Overall Study|Personal Reasons|0|||
13338986|NCT01027650|26619298|FG003|Overall Study|Personal Reasons|0|||
13338987|NCT01027650|26619299|FG004|Overall Study|Personal Reasons|2|||
13338988|NCT01027650|26619300|FG005|Overall Study|Personal Reasons|1|||
13338989|NCT01027650|26619301|FG006|Overall Study|Personal Reasons|0|||
13338990|NCT01027650|26619302|FG007|Overall Study|Personal Reasons|0|||
13338991|NCT01027650|26619295|FG000|Overall Study|Lost to Follow-up|0|||
13338992|NCT01027650|26619296|FG001|Overall Study|Lost to Follow-up|0|||
13338993|NCT01027650|26619297|FG002|Overall Study|Lost to Follow-up|0|||
13338994|NCT01027650|26619298|FG003|Overall Study|Lost to Follow-up|0|||
13338995|NCT01027650|26619299|FG004|Overall Study|Lost to Follow-up|0|||
13338996|NCT01027650|26619300|FG005|Overall Study|Lost to Follow-up|0|||
13338997|NCT01027650|26619301|FG006|Overall Study|Lost to Follow-up|1|||
13338998|NCT01027650|26619302|FG007|Overall Study|Lost to Follow-up|0|||
13338999|NCT01027650|26619295|FG000|Overall Study|Lack of Efficacy|0|||
13339000|NCT01027650|26619296|FG001|Overall Study|Lack of Efficacy|0|||
13339001|NCT01027650|26619297|FG002|Overall Study|Lack of Efficacy|0|||
13339002|NCT01027650|26619298|FG003|Overall Study|Lack of Efficacy|0|||
13339003|NCT01027650|26619299|FG004|Overall Study|Lack of Efficacy|0|||
13339004|NCT01027650|26619300|FG005|Overall Study|Lack of Efficacy|1|||
13339005|NCT01027650|26619301|FG006|Overall Study|Lack of Efficacy|0|||
13339006|NCT01027650|26619302|FG007|Overall Study|Lack of Efficacy|0|||
13339007|NCT01027416|26619317|FG000|Overall Study|Withdrawal by Subject|0|||
13339008|NCT01027416|26619318|FG001|Overall Study|Withdrawal by Subject|1|||
13339009|NCT01027416|26619317|FG000|Overall Study|Physician Decision|1|||
13339010|NCT01027416|26619318|FG001|Overall Study|Physician Decision|4|||
13339011|NCT01027364|26619420|FG000|Overall Study|Adverse Event|1|||
13339012|NCT01027364|26619421|FG001|Overall Study|Adverse Event|0|||
13339013|NCT01027364|26619422|FG002|Overall Study|Adverse Event|1|||
13339014|NCT01027364|26619423|FG003|Overall Study|Adverse Event|0|||
13339015|NCT01027364|26619420|FG000|Overall Study|Lost to Follow-up|1|||
13339016|NCT01027364|26619421|FG001|Overall Study|Lost to Follow-up|0|||
13339017|NCT01027364|26619422|FG002|Overall Study|Lost to Follow-up|0|||
13339018|NCT01027364|26619423|FG003|Overall Study|Lost to Follow-up|0|||
13339019|NCT01027364|26619420|FG000|Overall Study|Protocol Violation|1|||
13339020|NCT01027364|26619421|FG001|Overall Study|Protocol Violation|0|||
13339021|NCT01027364|26619422|FG002|Overall Study|Protocol Violation|0|||
13339022|NCT01027364|26619423|FG003|Overall Study|Protocol Violation|1|||
13339023|NCT01027364|26619420|FG000|Overall Study|Withdrawal by Subject|1|||
13339024|NCT01027364|26619421|FG001|Overall Study|Withdrawal by Subject|2|||
13339025|NCT01027364|26619422|FG002|Overall Study|Withdrawal by Subject|0|||
13339026|NCT01027364|26619423|FG003|Overall Study|Withdrawal by Subject|0|||
13339027|NCT01027351|26619524|FG000|Overall Study|Withdrawal by Subject|1|||
13339028|NCT01027351|26619525|FG001|Overall Study|Withdrawal by Subject|0|||
13339029|NCT01027351|26619526|FG002|Overall Study|Withdrawal by Subject|1|||
13339030|NCT01027351|26619527|FG003|Overall Study|Withdrawal by Subject|0|||
13339031|NCT01027351|26619528|FG004|Overall Study|Withdrawal by Subject|3|||
13339032|NCT01027351|26619529|FG005|Overall Study|Withdrawal by Subject|5|||
13339033|NCT01027351|26619524|FG000|Overall Study|Lost to Follow-up|1|||
13339034|NCT01027351|26619525|FG001|Overall Study|Lost to Follow-up|1|||
13339035|NCT01027351|26619526|FG002|Overall Study|Lost to Follow-up|0|||
13339036|NCT01027351|26619527|FG003|Overall Study|Lost to Follow-up|1|||
13339037|NCT01027351|26619528|FG004|Overall Study|Lost to Follow-up|6|||
13339038|NCT01027351|26619529|FG005|Overall Study|Lost to Follow-up|0|||
13339039|NCT01027351|26619524|FG000|Overall Study|Inappropriate enrollment|0|||
13339040|NCT01027351|26619525|FG001|Overall Study|Inappropriate enrollment|0|||
13339041|NCT01027351|26619526|FG002|Overall Study|Inappropriate enrollment|0|||
13339042|NCT01027351|26619527|FG003|Overall Study|Inappropriate enrollment|0|||
13339043|NCT01027351|26619528|FG004|Overall Study|Inappropriate enrollment|1|||
13339044|NCT01027351|26619529|FG005|Overall Study|Inappropriate enrollment|0|||
13339045|NCT01027351|26619524|FG000|Overall Study|Protocol Violation|1|||
13339046|NCT01027351|26619525|FG001|Overall Study|Protocol Violation|0|||
13339047|NCT01027351|26619526|FG002|Overall Study|Protocol Violation|0|||
13339048|NCT01027351|26619527|FG003|Overall Study|Protocol Violation|1|||
13339049|NCT01027351|26619528|FG004|Overall Study|Protocol Violation|1|||
13339050|NCT01027351|26619529|FG005|Overall Study|Protocol Violation|0|||
13339051|NCT01027286|26619554|FG000|Overall Study|Unable to Obtain Required Blood Volume|1|||
13339052|NCT01027286|26619555|FG001|Overall Study|Unable to Obtain Required Blood Volume|0|||
13339053|NCT01027286|26619554|FG000|Overall Study|Lost to Follow-up|0|||
13339054|NCT01027286|26619555|FG001|Overall Study|Lost to Follow-up|1|||
13339055|NCT01027273|26619578|FG000|Overall Study|Lost to Follow-up|57|||
13339056|NCT01027273|26619579|FG001|Overall Study|Lost to Follow-up|31|||
13339057|NCT01027273|26619578|FG000|Overall Study|Death|2|||
13339058|NCT01027273|26619579|FG001|Overall Study|Death|2|||
13339059|NCT01026974|26619649|FG000|Overall Study|Withdrawal by Subject|0|||
13339060|NCT01026974|26619650|FG001|Overall Study|Withdrawal by Subject|1|||
13339061|NCT01026974|26619651|FG002|Overall Study|Withdrawal by Subject|7|||
13339062|NCT01026974|26619652|FG003|Overall Study|Withdrawal by Subject|2|||
13339063|NCT01026974|26619649|FG000|Overall Study|Lost to Follow-up|1|||
13339064|NCT01026974|26619650|FG001|Overall Study|Lost to Follow-up|1|||
13339065|NCT01026974|26619651|FG002|Overall Study|Lost to Follow-up|4|||
13339066|NCT01026974|26619652|FG003|Overall Study|Lost to Follow-up|0|||
13339067|NCT01026974|26619649|FG000|Overall Study|Adverse Event|0|||
13339068|NCT01026974|26619650|FG001|Overall Study|Adverse Event|0|||
13339069|NCT01026974|26619651|FG002|Overall Study|Adverse Event|0|||
13339070|NCT01026974|26619652|FG003|Overall Study|Adverse Event|1|||
13339071|NCT01026974|26619649|FG000|Overall Study|Inappropriate enrollment|0|||
13339072|NCT01026974|26619650|FG001|Overall Study|Inappropriate enrollment|0|||
13339073|NCT01026974|26619651|FG002|Overall Study|Inappropriate enrollment|1|||
13339074|NCT01026974|26619652|FG003|Overall Study|Inappropriate enrollment|0|||
13339075|NCT01026948|26619659|FG000|Overall Study|Physician Decision|8|||
13339076|NCT01026831|26619674|FG000|Overall Study|Adverse Event|4|||
13339077|NCT01026831|26619675|FG001|Overall Study|Adverse Event|3|||
13339078|NCT01026831|26619674|FG000|Overall Study|Lost to Follow-up|2|||
13339079|NCT01026831|26619675|FG001|Overall Study|Lost to Follow-up|0|||
13339080|NCT01026831|26619674|FG000|Overall Study|Physician Decision|1|||
13339081|NCT01026831|26619675|FG001|Overall Study|Physician Decision|1|||
13339082|NCT01026831|26619674|FG000|Overall Study|Protocol Violation|0|||
13339083|NCT01026831|26619675|FG001|Overall Study|Protocol Violation|2|||
13339084|NCT01026831|26619674|FG000|Overall Study|Withdrawal by Subject|7|||
13339085|NCT01026831|26619675|FG001|Overall Study|Withdrawal by Subject|5|||
13339086|NCT01026818|26619764|FG000|Screening Period|Entry Criteria Not Met|105|||
13339087|NCT01026818|26619765|FG001|Screening Period|Entry Criteria Not Met|0|||
13339088|NCT01026818|26619766|FG002|Screening Period|Entry Criteria Not Met|0|||
13339089|NCT01026818|26619767|FG003|Screening Period|Entry Criteria Not Met|0|||
13339090|NCT01026818|26619764|FG000|Screening Period|Withdrawal by Subject|49|||
13339091|NCT01026818|26619765|FG001|Screening Period|Withdrawal by Subject|0|||
13339092|NCT01026818|26619766|FG002|Screening Period|Withdrawal by Subject|0|||
13339093|NCT01026818|26619767|FG003|Screening Period|Withdrawal by Subject|0|||
13339094|NCT01026818|26619764|FG000|Screening Period|Protocol Deviation|3|||
13339095|NCT01026818|26619765|FG001|Screening Period|Protocol Deviation|0|||
13339096|NCT01026818|26619766|FG002|Screening Period|Protocol Deviation|0|||
13339097|NCT01026818|26619767|FG003|Screening Period|Protocol Deviation|0|||
13339098|NCT01026818|26619764|FG000|Screening Period|Adverse Event|2|||
13339099|NCT01026818|26619765|FG001|Screening Period|Adverse Event|0|||
13339100|NCT01026818|26619766|FG002|Screening Period|Adverse Event|0|||
13339101|NCT01026818|26619767|FG003|Screening Period|Adverse Event|0|||
13339102|NCT01026818|26619764|FG000|Screening Period|Physician Decision|1|||
13339103|NCT01026818|26619765|FG001|Screening Period|Physician Decision|0|||
13339104|NCT01026818|26619766|FG002|Screening Period|Physician Decision|0|||
13339105|NCT01026818|26619767|FG003|Screening Period|Physician Decision|0|||
13339106|NCT01026818|26619764|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0|||
13339107|NCT01026818|26619765|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10|||
13339108|NCT01026818|26619766|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6|||
13339109|NCT01026818|26619767|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4|||
13339110|NCT01026818|26619764|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0|||
13339111|NCT01026818|26619765|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7|||
13339112|NCT01026818|26619766|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
13339113|NCT01026818|26619767|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
13339114|NCT01026818|26619764|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0|||
13339115|NCT01026818|26619765|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3|||
13339116|NCT01026818|26619766|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2|||
13339117|NCT01026818|26619767|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6|||
13339118|NCT01026818|26619764|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
13339119|NCT01026818|26619765|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3|||
13339120|NCT01026818|26619766|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
13339121|NCT01026818|26619767|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4|||
13339122|NCT01026818|26619764|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0|||
13339123|NCT01026818|26619765|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2|||
13339124|NCT01026818|26619766|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9|||
13339125|NCT01026818|26619767|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7|||
13339126|NCT01026818|26619764|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
13339127|NCT01026818|26619765|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
13339128|NCT01026818|26619766|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1|||
13339129|NCT01026818|26619767|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2|||
13339130|NCT01026818|26619764|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0|||
13339131|NCT01026818|26619765|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
13339132|NCT01026818|26619766|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1|||
13339133|NCT01026818|26619767|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
13339134|NCT01026818|26619764|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0|||
13339135|NCT01026818|26619765|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
13339136|NCT01026818|26619766|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1|||
13339137|NCT01026818|26619767|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
13339138|NCT01026818|26619764|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
13339139|NCT01026818|26619765|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1|||
13339140|NCT01026818|26619766|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
13339141|NCT01026818|26619767|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
13339142|NCT01026818|26619764|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
13339143|NCT01026818|26619765|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1|||
13339144|NCT01026818|26619766|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
13339145|NCT01026818|26619767|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2|||
13339146|NCT01026818|26619764|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
13339147|NCT01026818|26619765|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
13339148|NCT01026818|26619766|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
13339149|NCT01026818|26619767|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
13339150|NCT01026818|26619764|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
13339151|NCT01026818|26619765|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1|||
13339152|NCT01026818|26619766|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
13339153|NCT01026818|26619767|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
13339154|NCT01026818|26619764|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
13339155|NCT01026818|26619765|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1|||
13339156|NCT01026818|26619766|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2|||
13339157|NCT01026818|26619767|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
13339158|NCT01026818|26619764|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
13339159|NCT01026818|26619765|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
13339160|NCT01026818|26619766|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
13339161|NCT01026818|26619767|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1|||
13339162|NCT01026818|26619764|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
13339163|NCT01026818|26619765|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2|||
13339164|NCT01026818|26619766|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
13339165|NCT01026818|26619767|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
13339166|NCT01026818|26619764|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
13339167|NCT01026818|26619765|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1|||
13339168|NCT01026818|26619766|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
13339169|NCT01026818|26619767|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
13339170|NCT01026818|26619764|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0|||
13339171|NCT01026818|26619765|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
13339172|NCT01026818|26619766|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2|||
13339173|NCT01026818|26619767|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
13339174|NCT01026818|26619764|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0|||
13339175|NCT01026818|26619765|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
13339176|NCT01026818|26619766|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3|||
13339177|NCT01026818|26619767|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
13339178|NCT01026818|26619764|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
13339179|NCT01026818|26619765|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2|||
13339180|NCT01026818|26619766|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
13339181|NCT01026818|26619767|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1|||
13339182|NCT01026792|26619773|FG000|Overall Study|Protocol Violation|1|||
13339183|NCT01026493|26619824|FG000|Overall Study|Protocol Violation|0|||
13339184|NCT01026493|26619825|FG001|Overall Study|Protocol Violation|1|||
13339185|NCT01026493|26619826|FG002|Overall Study|Protocol Violation|0|||
13339186|NCT01026493|26619827|FG003|Overall Study|Protocol Violation|0|||
13339187|NCT01026493|26619828|FG004|Overall Study|Protocol Violation|2|||
13339188|NCT01026493|26619829|FG005|Overall Study|Protocol Violation|3|||
13339189|NCT01026493|26619830|FG006|Overall Study|Protocol Violation|4|||
13339190|NCT01026493|26619831|FG007|Overall Study|Protocol Violation|1|||
13339191|NCT01026454|26619844|FG000|Second Intervention|Pregnancy|1|||
13339192|NCT01026454|26619845|FG001|Second Intervention|Pregnancy|1|||
13339193|NCT01026389|26619864|FG000|Overall Study|Withdrawal by Subject|1|||
13339194|NCT01026389|26619865|FG001|Overall Study|Withdrawal by Subject|3|||
13339195|NCT01026389|26619864|FG000|Overall Study|change of treatment, patient moved|4|||
13339196|NCT01026389|26619865|FG001|Overall Study|change of treatment, patient moved|2|||
13339197|NCT01026324|26619885|FG000|Follow up/Survival|Withdrawal by Subject|1|||
13339198|NCT01026324|26619886|FG001|Follow up/Survival|Withdrawal by Subject|0|||
13339199|NCT01026324|26619887|FG002|Follow up/Survival|Withdrawal by Subject|0|||
13339200|NCT01026220|26619913|FG000|Induction|Death|1|||
13339201|NCT01026220|26619914|FG001|Induction|Death|0|||
13339202|NCT01026220|26619915|FG002|Induction|Death|0|||
13339203|NCT01026220|26619913|FG000|Induction|Lack of Efficacy|2|||
13339204|NCT01026220|26619914|FG001|Induction|Lack of Efficacy|0|||
13339205|NCT01026220|26619915|FG002|Induction|Lack of Efficacy|0|||
13339206|NCT01026220|26619913|FG000|Induction|Physician Decision|12|||
13339207|NCT01026220|26619914|FG001|Induction|Physician Decision|0|||
13339208|NCT01026220|26619915|FG002|Induction|Physician Decision|0|||
13339209|NCT01026220|26619913|FG000|Induction|Withdrawal by Subject|9|||
13339210|NCT01026220|26619914|FG001|Induction|Withdrawal by Subject|0|||
13339211|NCT01026220|26619915|FG002|Induction|Withdrawal by Subject|0|||
13339212|NCT01026220|26619913|FG000|Induction|Ineligible|1|||
13339213|NCT01026220|26619914|FG001|Induction|Ineligible|0|||
13339214|NCT01026220|26619915|FG002|Induction|Ineligible|0|||
13339215|NCT01026220|26619913|FG000|Consolidation Maintenance|Death|0|||
13339216|NCT01026220|26619914|FG001|Consolidation Maintenance|Death|1|||
13339217|NCT01026220|26619915|FG002|Consolidation Maintenance|Death|0|||
13339218|NCT01026220|26619913|FG000|Consolidation Maintenance|Lack of Efficacy|0|||
13339219|NCT01026220|26619914|FG001|Consolidation Maintenance|Lack of Efficacy|1|||
13339220|NCT01026220|26619915|FG002|Consolidation Maintenance|Lack of Efficacy|1|||
13339221|NCT01026220|26619913|FG000|Consolidation Maintenance|Physician Decision|0|||
13339222|NCT01026220|26619914|FG001|Consolidation Maintenance|Physician Decision|2|||
13339223|NCT01026220|26619915|FG002|Consolidation Maintenance|Physician Decision|7|||
13339224|NCT01026220|26619913|FG000|Consolidation Maintenance|Withdrawal by Subject|0|||
13339225|NCT01026220|26619914|FG001|Consolidation Maintenance|Withdrawal by Subject|2|||
13339226|NCT01026220|26619915|FG002|Consolidation Maintenance|Withdrawal by Subject|6|||
13339227|NCT01026194|26619936|FG000|Period 1：Double Blind Period|Adverse Event|2|||
13339228|NCT01026194|26619937|FG001|Period 1：Double Blind Period|Adverse Event|1|||
13339229|NCT01026194|26619936|FG000|Period 1：Double Blind Period|Lack of Efficacy|1|||
13339230|NCT01026194|26619937|FG001|Period 1：Double Blind Period|Lack of Efficacy|0|||
13339231|NCT01026194|26619936|FG000|Period 1：Double Blind Period|Physician Decision|0|||
13339232|NCT01026194|26619937|FG001|Period 1：Double Blind Period|Physician Decision|4|||
13339233|NCT01026194|26619936|FG000|Period 2：Open-label Period|Adverse Event|4|||
13339234|NCT01026194|26619937|FG001|Period 2：Open-label Period|Adverse Event|5|||
13339235|NCT01026194|26619936|FG000|Period 2：Open-label Period|Physician Decision|3|||
13339236|NCT01026194|26619937|FG001|Period 2：Open-label Period|Physician Decision|1|||
13339237|NCT01026194|26619936|FG000|Period 2：Open-label Period|Withdrawal by Subject|0|||
13339238|NCT01026194|26619937|FG001|Period 2：Open-label Period|Withdrawal by Subject|4|||
13339239|NCT01026142|26619966|FG000|Overall Study|Death|136|||
13339240|NCT01026142|26619967|FG001|Overall Study|Death|134|||
13339241|NCT01026142|26619966|FG000|Overall Study|Withdrew consent or lost to follow-up|36|||
13339242|NCT01026142|26619967|FG001|Overall Study|Withdrew consent or lost to follow-up|29|||
13339243|NCT01026103|26619976|FG000|Overall Study|Physician Decision|1|||
13339244|NCT01026103|26619976|FG000|Overall Study|did not receive study device bc of error|1|||
13339245|NCT01026038|26620021|FG000|Overall Study|Lost to Follow-up|1|||
13339246|NCT01026038|26620022|FG001|Overall Study|Lost to Follow-up|1|||
13339247|NCT01026038|26620023|FG002|Overall Study|Lost to Follow-up|0|||
13339248|NCT01025843|26620128|FG000|Washout 4|Withdrawal by Subject|0|||
13339249|NCT01025843|26620129|FG001|Washout 4|Withdrawal by Subject|0|||
13339250|NCT01025843|26620130|FG002|Washout 4|Withdrawal by Subject|1|||
13339251|NCT01025843|26620131|FG003|Washout 4|Withdrawal by Subject|1|||
13339252|NCT01025843|26620132|FG004|Washout 4|Withdrawal by Subject|0|||
13339253|NCT01025843|26620133|FG005|Washout 4|Withdrawal by Subject|0|||
13339254|NCT01025843|26620134|FG006|Washout 4|Withdrawal by Subject|0|||
13339255|NCT01025843|26620135|FG007|Washout 4|Withdrawal by Subject|0|||
13339256|NCT01025843|26620136|FG008|Washout 4|Withdrawal by Subject|0|||
13339257|NCT01025843|26620137|FG009|Washout 4|Withdrawal by Subject|0|||
13339258|NCT01025817|26620162|FG000|Completed Study Medication|Adverse Event|66|||
13339259|NCT01025817|26620163|FG001|Completed Study Medication|Adverse Event|39|||
13339260|NCT01025817|26620162|FG000|Completed Study Medication|Protocol Deviation|9|||
13339261|NCT01025817|26620163|FG001|Completed Study Medication|Protocol Deviation|8|||
13339262|NCT01025817|26620162|FG000|Completed Study Medication|Withdrawal by Subject|8|||
13339263|NCT01025817|26620163|FG001|Completed Study Medication|Withdrawal by Subject|9|||
13339264|NCT01025817|26620162|FG000|Completed Study Medication|Administrative problems|7|||
13339265|NCT01025817|26620163|FG001|Completed Study Medication|Administrative problems|5|||
13339266|NCT01025817|26620162|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7|||
13373974|NCT00798434|26725434|FG000|Open-Label|Lack of Efficacy|5|||
13339267|NCT01025817|26620163|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0|||
13339268|NCT01025817|26620162|FG000|Completed Study Medication|Abnormal test procedure|4|||
13339269|NCT01025817|26620163|FG001|Completed Study Medication|Abnormal test procedure|0|||
13339270|NCT01025817|26620162|FG000|Completed Study Medication|Graft loss|2|||
13339271|NCT01025817|26620163|FG001|Completed Study Medication|Graft loss|5|||
13339272|NCT01025817|26620162|FG000|Completed Study Medication|Death|2|||
13339273|NCT01025817|26620163|FG001|Completed Study Medication|Death|2|||
13339274|NCT01025817|26620162|FG000|Completed Study Medication|Abnormal lab values|0|||
13339275|NCT01025817|26620163|FG001|Completed Study Medication|Abnormal lab values|2|||
13339276|NCT01025817|26620162|FG000|Completed Study Medication|Subject no longer required study drug|0|||
13339277|NCT01025817|26620163|FG001|Completed Study Medication|Subject no longer required study drug|1|||
13339278|NCT01025817|26620162|FG000|Completed Study Medication|Lost to Follow-up|0|||
13339279|NCT01025817|26620163|FG001|Completed Study Medication|Lost to Follow-up|1|||
13339280|NCT01025817|26620162|FG000|Completed Study|Withdrawal by Subject|8|||
13339281|NCT01025817|26620163|FG001|Completed Study|Withdrawal by Subject|16|||
13339282|NCT01025817|26620162|FG000|Completed Study|Death|6|||
13339283|NCT01025817|26620163|FG001|Completed Study|Death|5|||
13339284|NCT01025817|26620162|FG000|Completed Study|Missing|2|||
13339285|NCT01025817|26620163|FG001|Completed Study|Missing|0|||
13339286|NCT01025817|26620162|FG000|Completed Study|Lost to Follow-up|0|||
13339287|NCT01025817|26620163|FG001|Completed Study|Lost to Follow-up|1|||
13339288|NCT01025752|26620188|FG000|Overall Study|Lost to Follow-up|7|||
13339289|NCT01025752|26620189|FG001|Overall Study|Lost to Follow-up|10|||
13339290|NCT01025752|26620188|FG000|Overall Study|Physician Decision|1|||
13339291|NCT01025752|26620189|FG001|Overall Study|Physician Decision|3|||
13339292|NCT01025635|26620208|FG000|Overall Study|Withdrawal by Subject|6|||
13339293|NCT01025635|26620209|FG001|Overall Study|Withdrawal by Subject|7|||
13339294|NCT01025635|26620208|FG000|Overall Study|Protocol Violation|4|||
13339295|NCT01025635|26620209|FG001|Overall Study|Protocol Violation|2|||
13339296|NCT01025635|26620208|FG000|Overall Study|Lack of Efficacy|0|||
13339297|NCT01025635|26620209|FG001|Overall Study|Lack of Efficacy|1|||
13339298|NCT01025635|26620208|FG000|Overall Study|Lost to Follow-up|9|||
13339299|NCT01025635|26620209|FG001|Overall Study|Lost to Follow-up|13|||
13339300|NCT01025635|26620208|FG000|Overall Study|Reason not known|4|||
13339301|NCT01025635|26620209|FG001|Overall Study|Reason not known|2|||
13339302|NCT01025336|26620277|FG000|Overall Study|Protocol Violation|0|||
13339303|NCT01025336|26620278|FG001|Overall Study|Protocol Violation|0|||
13339304|NCT01025336|26620279|FG002|Overall Study|Protocol Violation|0|||
13339305|NCT01025336|26620280|FG003|Overall Study|Protocol Violation|2|||
13339306|NCT01025336|26620281|FG004|Overall Study|Protocol Violation|0|||
13339307|NCT01025284|26620309|FG000|Overall Study|Investigator Decision|0|||
13339308|NCT01025284|26620310|FG001|Overall Study|Investigator Decision|1|||
13339309|NCT01025284|26620311|FG002|Overall Study|Investigator Decision|0|||
13339310|NCT01025284|26620309|FG000|Overall Study|Withdrawal by Subject|0|||
13339311|NCT01025284|26620310|FG001|Overall Study|Withdrawal by Subject|1|||
13339312|NCT01025284|26620311|FG002|Overall Study|Withdrawal by Subject|0|||
13339313|NCT01025232|26620336|FG000|Overall Study|Study drug no longer available|3|||
13339314|NCT01025232|26620337|FG001|Overall Study|Study drug no longer available|6|||
13339315|NCT01025193|26620349|FG000|Overall Study|Protocol Violation|1|||
13339316|NCT01025193|26620349|FG000|Overall Study|Adverse Event|3|||
13339317|NCT01025154|26620356|FG000|Overall Study|Lost to Follow-up|1|||
13339318|NCT01025154|26620356|FG000|Overall Study|Withdrawal by Subject|1|||
13339319|NCT01025037|26620367|FG000|Overall Study|Adverse Event|3|||
13339320|NCT01025037|26620367|FG000|Overall Study|Lost to Follow-up|7|||
13339321|NCT01025037|26620367|FG000|Overall Study|Withdrawal by Subject|1|||
13339322|NCT01024959|26620378|FG000|Overall Study|ineligible|12|||
13339323|NCT01024959|26620378|FG000|Overall Study|results not evaluable|12|||
13339324|NCT01024959|26620378|FG000|Overall Study|missing results required for analysis|17|||
13339325|NCT01024946|26620384|FG000|Overall Study|Screen Failure|3|||
13339326|NCT01024946|26620384|FG000|Overall Study|Withdrawal by Subject|1|||
13339327|NCT01024946|26620384|FG000|Overall Study|Adverse Event|1|||
13339328|NCT01024920|26620451|FG000|Overall Study|Progressive disease|47|||
13339329|NCT01024920|26620452|FG001|Overall Study|Progressive disease|25|||
13339330|NCT01024920|26620451|FG000|Overall Study|Adverse Event|8|||
13339331|NCT01024920|26620452|FG001|Overall Study|Adverse Event|4|||
13339332|NCT01024920|26620451|FG000|Overall Study|Lost to Follow-up|0|||
13339333|NCT01024920|26620452|FG001|Overall Study|Lost to Follow-up|1|||
13339334|NCT01024920|26620451|FG000|Overall Study|Patient refusal to continue|4|||
13339335|NCT01024920|26620452|FG001|Overall Study|Patient refusal to continue|0|||
13339336|NCT01024920|26620451|FG000|Overall Study|Other than listed|5|||
13339337|NCT01024920|26620452|FG001|Overall Study|Other than listed|1|||
13339338|NCT01024920|26620451|FG000|Overall Study|Not treated|3|||
13339339|NCT01024920|26620452|FG001|Overall Study|Not treated|0|||
13339340|NCT01024920|26620451|FG000|Overall Study|Protocol Violation|0|||
13339341|NCT01024920|26620452|FG001|Overall Study|Protocol Violation|1|||
13339342|NCT01024855|26620459|FG000|Overall Study|Inclusion/exclusion criteria|1|||
13339343|NCT01024751|26620474|FG000|Enrolled Participants|Ineligible at baseline|3|||
13339344|NCT01024751|26620475|FG001|Enrolled Participants|Ineligible at baseline|4|||
13339345|NCT01024751|26620474|FG000|Eligible Participants|Withdrawal by Subject|0|||
13339346|NCT01024751|26620475|FG001|Eligible Participants|Withdrawal by Subject|1|||
13339347|NCT01024751|26620474|FG000|Eligible Participants|Lost to Follow-up|0|||
13339348|NCT01024751|26620475|FG001|Eligible Participants|Lost to Follow-up|1|||
13339349|NCT01024751|26620474|FG000|Eligible Participants|Ineligible|0|||
13339350|NCT01024751|26620475|FG001|Eligible Participants|Ineligible|1|||
13339351|NCT01024465|26620481|FG000|Overall Study|Adverse Event|2|||
13339352|NCT01024465|26620481|FG000|Overall Study|Physician Decision|1|||
13339353|NCT01024387|26620491|FG000|Overall Study|Radiographic Progression|29|||
13339354|NCT01024387|26620491|FG000|Overall Study|Symptomatic Progression|10|||
13339355|NCT01024387|26620491|FG000|Overall Study|Physician Decision|5|||
13339356|NCT01024387|26620491|FG000|Overall Study|Withdrawal by Subject|5|||
13339357|NCT01024387|26620491|FG000|Overall Study|Death|2|||
13339358|NCT01024387|26620491|FG000|Overall Study|Prolonged Treatment Delay|1|||
13339359|NCT01024387|26620491|FG000|Overall Study|Adverse Event|3|||
13339360|NCT01024387|26620491|FG000|Overall Study|Other|5|||
13339361|NCT01024309|26620520|FG000|Overall Study|Physician Decision|4|||
13339362|NCT01024309|26620521|FG001|Overall Study|Physician Decision|0|||
13339363|NCT01024309|26620520|FG000|Overall Study|Withdrawal by Subject|4|||
13339364|NCT01024309|26620521|FG001|Overall Study|Withdrawal by Subject|4|||
13339365|NCT01024244|26620649|FG000|Overall Study|Adverse Event|1|||
13339366|NCT01024244|26620650|FG001|Overall Study|Adverse Event|2|||
13339367|NCT01024244|26620651|FG002|Overall Study|Adverse Event|0|||
13339368|NCT01024244|26620652|FG003|Overall Study|Adverse Event|1|||
13339369|NCT01024244|26620653|FG004|Overall Study|Adverse Event|2|||
13339370|NCT01024244|26620649|FG000|Overall Study|Entry Criteria Not Met|0|||
13339371|NCT01024244|26620650|FG001|Overall Study|Entry Criteria Not Met|1|||
13339372|NCT01024244|26620651|FG002|Overall Study|Entry Criteria Not Met|0|||
13339373|NCT01024244|26620652|FG003|Overall Study|Entry Criteria Not Met|0|||
13339374|NCT01024244|26620653|FG004|Overall Study|Entry Criteria Not Met|0|||
13339375|NCT01024244|26620649|FG000|Overall Study|Lack of Efficacy|1|||
13339376|NCT01024244|26620650|FG001|Overall Study|Lack of Efficacy|0|||
13339377|NCT01024244|26620651|FG002|Overall Study|Lack of Efficacy|0|||
13339378|NCT01024244|26620652|FG003|Overall Study|Lack of Efficacy|0|||
13339379|NCT01024244|26620653|FG004|Overall Study|Lack of Efficacy|0|||
13339380|NCT01024244|26620649|FG000|Overall Study|Protocol Violation|1|||
13339381|NCT01024244|26620650|FG001|Overall Study|Protocol Violation|0|||
13339382|NCT01024244|26620651|FG002|Overall Study|Protocol Violation|0|||
13339383|NCT01024244|26620652|FG003|Overall Study|Protocol Violation|0|||
13339384|NCT01024244|26620653|FG004|Overall Study|Protocol Violation|2|||
13339385|NCT01024244|26620649|FG000|Overall Study|Sponsor Decision|14|||
13339386|NCT01024244|26620650|FG001|Overall Study|Sponsor Decision|7|||
13339387|NCT01024244|26620651|FG002|Overall Study|Sponsor Decision|14|||
13339388|NCT01024244|26620652|FG003|Overall Study|Sponsor Decision|12|||
13339389|NCT01024244|26620653|FG004|Overall Study|Sponsor Decision|10|||
13339390|NCT01024244|26620649|FG000|Overall Study|Withdrawal by Subject|0|||
13339391|NCT01024244|26620650|FG001|Overall Study|Withdrawal by Subject|1|||
13339392|NCT01024244|26620651|FG002|Overall Study|Withdrawal by Subject|0|||
13339393|NCT01024244|26620652|FG003|Overall Study|Withdrawal by Subject|0|||
13339394|NCT01024244|26620653|FG004|Overall Study|Withdrawal by Subject|0|||
13339395|NCT01024231|26620826|FG000|Overall Study|Other Reasons|1|||
13339396|NCT01024231|26620827|FG001|Overall Study|Other Reasons|2|||
13339397|NCT01024231|26620828|FG002|Overall Study|Other Reasons|0|||
13339398|NCT01024231|26620829|FG003|Overall Study|Other Reasons|0|||
13339399|NCT01024231|26620830|FG004|Overall Study|Other Reasons|2|||
13339400|NCT01024231|26620831|FG005|Overall Study|Other Reasons|0|||
13339401|NCT01024231|26620832|FG006|Overall Study|Other Reasons|1|||
13339402|NCT01024231|26620826|FG000|Overall Study|Maximum Clinical Benefit|1|||
13339403|NCT01024231|26620827|FG001|Overall Study|Maximum Clinical Benefit|2|||
13339404|NCT01024231|26620828|FG002|Overall Study|Maximum Clinical Benefit|0|||
13339405|NCT01024231|26620829|FG003|Overall Study|Maximum Clinical Benefit|1|||
13339406|NCT01024231|26620830|FG004|Overall Study|Maximum Clinical Benefit|1|||
13339407|NCT01024231|26620831|FG005|Overall Study|Maximum Clinical Benefit|0|||
13339408|NCT01024231|26620832|FG006|Overall Study|Maximum Clinical Benefit|0|||
13339409|NCT01024231|26620826|FG000|Overall Study|Disease Progression|3|||
13339410|NCT01024231|26620827|FG001|Overall Study|Disease Progression|1|||
13339411|NCT01024231|26620828|FG002|Overall Study|Disease Progression|3|||
13339412|NCT01024231|26620829|FG003|Overall Study|Disease Progression|0|||
13339413|NCT01024231|26620830|FG004|Overall Study|Disease Progression|4|||
13339414|NCT01024231|26620831|FG005|Overall Study|Disease Progression|11|||
13339415|NCT01024231|26620832|FG006|Overall Study|Disease Progression|6|||
13339416|NCT01024231|26620826|FG000|Overall Study|AE unrelated to Study Drug|0|||
13339417|NCT01024231|26620827|FG001|Overall Study|AE unrelated to Study Drug|1|||
13339418|NCT01024231|26620828|FG002|Overall Study|AE unrelated to Study Drug|0|||
13339419|NCT01024231|26620829|FG003|Overall Study|AE unrelated to Study Drug|0|||
13339420|NCT01024231|26620830|FG004|Overall Study|AE unrelated to Study Drug|0|||
13339421|NCT01024231|26620831|FG005|Overall Study|AE unrelated to Study Drug|0|||
13339422|NCT01024231|26620832|FG006|Overall Study|AE unrelated to Study Drug|0|||
13339423|NCT01024231|26620826|FG000|Overall Study|No longer meets criteria|0|||
13339424|NCT01024231|26620827|FG001|Overall Study|No longer meets criteria|0|||
13339425|NCT01024231|26620828|FG002|Overall Study|No longer meets criteria|0|||
13339426|NCT01024231|26620829|FG003|Overall Study|No longer meets criteria|0|||
13339427|NCT01024231|26620830|FG004|Overall Study|No longer meets criteria|1|||
13339428|NCT01024231|26620831|FG005|Overall Study|No longer meets criteria|0|||
13339429|NCT01024231|26620832|FG006|Overall Study|No longer meets criteria|1|||
13339430|NCT01024231|26620826|FG000|Overall Study|Study Drug Toxicity|1|||
13339431|NCT01024231|26620827|FG001|Overall Study|Study Drug Toxicity|6|||
13339432|NCT01024231|26620828|FG002|Overall Study|Study Drug Toxicity|6|||
13339433|NCT01024231|26620829|FG003|Overall Study|Study Drug Toxicity|4|||
13339434|NCT01024231|26620830|FG004|Overall Study|Study Drug Toxicity|2|||
13339435|NCT01024231|26620831|FG005|Overall Study|Study Drug Toxicity|0|||
13339436|NCT01024231|26620832|FG006|Overall Study|Study Drug Toxicity|7|||
13339437|NCT01024231|26620826|FG000|Overall Study|Death|6|||
13339438|NCT01024231|26620827|FG001|Overall Study|Death|2|||
13339439|NCT01024231|26620828|FG002|Overall Study|Death|1|||
13339440|NCT01024231|26620829|FG003|Overall Study|Death|0|||
13339441|NCT01024231|26620830|FG004|Overall Study|Death|4|||
13339442|NCT01024231|26620831|FG005|Overall Study|Death|3|||
13339443|NCT01024231|26620832|FG006|Overall Study|Death|5|||
13339444|NCT01024231|26620826|FG000|Overall Study|Lost to Follow-up|0|||
13339445|NCT01024231|26620827|FG001|Overall Study|Lost to Follow-up|0|||
13339446|NCT01024231|26620828|FG002|Overall Study|Lost to Follow-up|0|||
13339447|NCT01024231|26620829|FG003|Overall Study|Lost to Follow-up|0|||
13339448|NCT01024231|26620830|FG004|Overall Study|Lost to Follow-up|0|||
13339449|NCT01024231|26620831|FG005|Overall Study|Lost to Follow-up|0|||
13339450|NCT01024231|26620832|FG006|Overall Study|Lost to Follow-up|1|||
13339451|NCT01024231|26620826|FG000|Overall Study|Withdrew Consent|0|||
13339452|NCT01024231|26620827|FG001|Overall Study|Withdrew Consent|1|||
13339453|NCT01024231|26620828|FG002|Overall Study|Withdrew Consent|0|||
13339454|NCT01024231|26620829|FG003|Overall Study|Withdrew Consent|0|||
13339455|NCT01024231|26620830|FG004|Overall Study|Withdrew Consent|0|||
13339456|NCT01024231|26620831|FG005|Overall Study|Withdrew Consent|0|||
13339457|NCT01024231|26620832|FG006|Overall Study|Withdrew Consent|0|||
13339458|NCT01024231|26620826|FG000|Overall Study|Continuing on Treatment|0|||
13339459|NCT01024231|26620827|FG001|Overall Study|Continuing on Treatment|0|||
13339460|NCT01024231|26620828|FG002|Overall Study|Continuing on Treatment|0|||
13339461|NCT01024231|26620829|FG003|Overall Study|Continuing on Treatment|0|||
13339462|NCT01024231|26620830|FG004|Overall Study|Continuing on Treatment|3|||
13339463|NCT01024231|26620831|FG005|Overall Study|Continuing on Treatment|2|||
13339464|NCT01024231|26620832|FG006|Overall Study|Continuing on Treatment|0|||
13339465|NCT01024036|26620870|FG000|Blinded Treatment|Adverse Event|1|||
13339466|NCT01024036|26620871|FG001|Blinded Treatment|Adverse Event|1|||
13339467|NCT01024036|26620870|FG000|Blinded Treatment|Lack of Efficacy|16|||
13339468|NCT01024036|26620871|FG001|Blinded Treatment|Lack of Efficacy|14|||
13339469|NCT01024036|26620870|FG000|Blinded Treatment|Physician Decision|1|||
13339470|NCT01024036|26620871|FG001|Blinded Treatment|Physician Decision|0|||
13339471|NCT01024036|26620870|FG000|Blinded Treatment|Death|0|||
13339472|NCT01024036|26620871|FG001|Blinded Treatment|Death|2|||
13339473|NCT01024036|26620870|FG000|Blinded Treatment|Withdrawal by Subject|4|||
13339474|NCT01024036|26620871|FG001|Blinded Treatment|Withdrawal by Subject|3|||
13339475|NCT01024036|26620870|FG000|Unblinded Treatment|Adverse Event|0|||
13339476|NCT01024036|26620871|FG001|Unblinded Treatment|Adverse Event|1|||
13339477|NCT01024036|26620870|FG000|Unblinded Treatment|Lack of Efficacy|0|||
13339478|NCT01024036|26620871|FG001|Unblinded Treatment|Lack of Efficacy|2|||
13339479|NCT01024036|26620870|FG000|Follow-Up Period|Lost to Follow-up|1|||
13339480|NCT01024036|26620871|FG001|Follow-Up Period|Lost to Follow-up|1|||
13339481|NCT01024036|26620870|FG000|Follow-Up Period|Withdrawal by Subject|0|||
13339482|NCT01024036|26620871|FG001|Follow-Up Period|Withdrawal by Subject|1|||
13339483|NCT01024036|26620870|FG000|Follow-Up Period|Adverse Event|4|||
13339484|NCT01024036|26620871|FG001|Follow-Up Period|Adverse Event|1|||
13339485|NCT01023958|26620900|FG000|Overall Study|Progressive disease|48|||
13339486|NCT01023958|26620900|FG000|Overall Study|Other adverse event|1|||
13124721|NCT02939950|25953768|FG000|Overall Study|Lack of motivation|0|||
13339487|NCT01023958|26620900|FG000|Overall Study|Refused to continue medication|1|||
13339488|NCT01023815|26620932|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144|||
13339489|NCT01023815|26620933|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
13339490|NCT01023815|26620934|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
13339491|NCT01023815|26620935|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
13339492|NCT01023815|26620932|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
13339493|NCT01023815|26620933|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
13339494|NCT01023815|26620934|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
13339495|NCT01023815|26620935|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
13339496|NCT01023815|26620932|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
13339497|NCT01023815|26620933|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
13339498|NCT01023815|26620934|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
13339499|NCT01023815|26620935|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
13339500|NCT01023815|26620932|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0|||
13339501|NCT01023815|26620933|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1|||
13339502|NCT01023815|26620934|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6|||
13339503|NCT01023815|26620935|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2|||
13339504|NCT01023815|26620932|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
13339505|NCT01023815|26620933|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1|||
13339506|NCT01023815|26620934|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
13339507|NCT01023815|26620935|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
13339508|NCT01023789|26621004|FG000|3 - Year Visit|Death|29|||
13339509|NCT01023789|26621004|FG000|3 - Year Visit|Withdrawal of consent|1|||
13339510|NCT01023789|26621004|FG000|3 - Year Visit|Lost to Follow-up|13|||
13339511|NCT01023672|26621010|FG000|Overall Study|Worsening disease|2|||
13339512|NCT01023672|26621010|FG000|Overall Study|Death|1|||
13339513|NCT01023659|26621029|FG000|Overall Study|Lost to Follow-up|73|||
13339514|NCT01023659|26621030|FG001|Overall Study|Lost to Follow-up|228|||
13339515|NCT01023659|26621031|FG002|Overall Study|Lost to Follow-up|99|||
13339516|NCT01023581|26621083|FG000|Overall Study|Adverse Event|4|||
13339517|NCT01023581|26621084|FG001|Overall Study|Adverse Event|4|||
13339518|NCT01023581|26621085|FG002|Overall Study|Adverse Event|7|||
13339519|NCT01023581|26621086|FG003|Overall Study|Adverse Event|3|||
13339520|NCT01023581|26621087|FG004|Overall Study|Adverse Event|2|||
13339521|NCT01023581|26621088|FG005|Overall Study|Adverse Event|5|||
13339522|NCT01023581|26621089|FG006|Overall Study|Adverse Event|11|||
13339523|NCT01023581|26621083|FG000|Overall Study|Major protocol deviation|2|||
13339524|NCT01023581|26621084|FG001|Overall Study|Major protocol deviation|0|||
13339525|NCT01023581|26621085|FG002|Overall Study|Major protocol deviation|3|||
13339526|NCT01023581|26621086|FG003|Overall Study|Major protocol deviation|0|||
13339527|NCT01023581|26621087|FG004|Overall Study|Major protocol deviation|0|||
13339528|NCT01023581|26621088|FG005|Overall Study|Major protocol deviation|0|||
13339529|NCT01023581|26621089|FG006|Overall Study|Major protocol deviation|0|||
13339530|NCT01023581|26621083|FG000|Overall Study|Lost to Follow-up|4|||
13339531|NCT01023581|26621084|FG001|Overall Study|Lost to Follow-up|8|||
13339532|NCT01023581|26621085|FG002|Overall Study|Lost to Follow-up|7|||
13339533|NCT01023581|26621086|FG003|Overall Study|Lost to Follow-up|2|||
13339534|NCT01023581|26621087|FG004|Overall Study|Lost to Follow-up|5|||
13339535|NCT01023581|26621088|FG005|Overall Study|Lost to Follow-up|2|||
13339536|NCT01023581|26621089|FG006|Overall Study|Lost to Follow-up|2|||
13339537|NCT01023581|26621083|FG000|Overall Study|Withdrawal by Subject|13|||
13339538|NCT01023581|26621084|FG001|Overall Study|Withdrawal by Subject|8|||
13339539|NCT01023581|26621085|FG002|Overall Study|Withdrawal by Subject|16|||
13339540|NCT01023581|26621086|FG003|Overall Study|Withdrawal by Subject|10|||
13339541|NCT01023581|26621087|FG004|Overall Study|Withdrawal by Subject|6|||
13339542|NCT01023581|26621088|FG005|Overall Study|Withdrawal by Subject|8|||
13339543|NCT01023581|26621089|FG006|Overall Study|Withdrawal by Subject|5|||
13339544|NCT01023581|26621083|FG000|Overall Study|Pregnancy|0|||
13339545|NCT01023581|26621084|FG001|Overall Study|Pregnancy|0|||
13339546|NCT01023581|26621085|FG002|Overall Study|Pregnancy|0|||
13339547|NCT01023581|26621086|FG003|Overall Study|Pregnancy|2|||
13339548|NCT01023581|26621087|FG004|Overall Study|Pregnancy|0|||
13339549|NCT01023581|26621088|FG005|Overall Study|Pregnancy|1|||
13339550|NCT01023581|26621089|FG006|Overall Study|Pregnancy|0|||
13339551|NCT01023581|26621083|FG000|Overall Study|Lack of Efficacy|9|||
13339552|NCT01023581|26621084|FG001|Overall Study|Lack of Efficacy|3|||
13339553|NCT01023581|26621085|FG002|Overall Study|Lack of Efficacy|6|||
13339554|NCT01023581|26621086|FG003|Overall Study|Lack of Efficacy|2|||
13339555|NCT01023581|26621087|FG004|Overall Study|Lack of Efficacy|1|||
13339556|NCT01023581|26621088|FG005|Overall Study|Lack of Efficacy|2|||
13339557|NCT01023581|26621089|FG006|Overall Study|Lack of Efficacy|1|||
13339558|NCT01023581|26621083|FG000|Overall Study|Physician Decision|2|||
13339559|NCT01023581|26621084|FG001|Overall Study|Physician Decision|0|||
13339560|NCT01023581|26621085|FG002|Overall Study|Physician Decision|2|||
13339561|NCT01023581|26621086|FG003|Overall Study|Physician Decision|1|||
13339562|NCT01023581|26621087|FG004|Overall Study|Physician Decision|1|||
13339563|NCT01023581|26621088|FG005|Overall Study|Physician Decision|1|||
13339564|NCT01023581|26621089|FG006|Overall Study|Physician Decision|1|||
13339565|NCT01023581|26621083|FG000|Overall Study|Other|1|||
13339566|NCT01023581|26621084|FG001|Overall Study|Other|0|||
13339567|NCT01023581|26621085|FG002|Overall Study|Other|1|||
13339568|NCT01023581|26621086|FG003|Overall Study|Other|0|||
13339569|NCT01023581|26621087|FG004|Overall Study|Other|1|||
13339570|NCT01023581|26621088|FG005|Overall Study|Other|0|||
13339571|NCT01023581|26621089|FG006|Overall Study|Other|0|||
13339572|NCT01023516|26621176|FG000|Overall Study|Voluntary discontinuation|7|||
13339573|NCT01023516|26621177|FG001|Overall Study|Voluntary discontinuation|5|||
13339574|NCT01023516|26621176|FG000|Overall Study|Adverse Event|9|||
13339575|NCT01023516|26621177|FG001|Overall Study|Adverse Event|6|||
13339576|NCT01023516|26621176|FG000|Overall Study|Safety reason|0|||
13339577|NCT01023516|26621177|FG001|Overall Study|Safety reason|3|||
13339578|NCT01023516|26621176|FG000|Overall Study|Study-specific criteria|4|||
13339579|NCT01023516|26621177|FG001|Overall Study|Study-specific criteria|2|||
13339580|NCT01023516|26621176|FG000|Overall Study|Incorrect enrolment|4|||
13339581|NCT01023516|26621177|FG001|Overall Study|Incorrect enrolment|2|||
13339582|NCT01023308|26621210|FG000|Overall Study|Abnormal test proceedure results|3|||
13339583|NCT01023308|26621211|FG001|Overall Study|Abnormal test proceedure results|8|||
13339584|NCT01023308|26621210|FG000|Overall Study|Administrative problems|2|||
13339585|NCT01023308|26621211|FG001|Overall Study|Administrative problems|1|||
13339586|NCT01023308|26621210|FG000|Overall Study|Adverse Event|130|||
13339587|NCT01023308|26621211|FG001|Overall Study|Adverse Event|66|||
13339588|NCT01023308|26621210|FG000|Overall Study|Death|21|||
13339589|NCT01023308|26621211|FG001|Overall Study|Death|17|||
13339590|NCT01023308|26621210|FG000|Overall Study|Disease progression|82|||
13339591|NCT01023308|26621211|FG001|Overall Study|Disease progression|153|||
13339592|NCT01023308|26621210|FG000|Overall Study|New Cancer therapy|4|||
13339593|NCT01023308|26621211|FG001|Overall Study|New Cancer therapy|7|||
13339594|NCT01023308|26621210|FG000|Overall Study|Protocol Violation|3|||
13339595|NCT01023308|26621211|FG001|Overall Study|Protocol Violation|4|||
13339596|NCT01023308|26621210|FG000|Overall Study|Untreated|5|||
13339597|NCT01023308|26621211|FG001|Overall Study|Untreated|5|||
13339598|NCT01023308|26621210|FG000|Overall Study|Lost to Follow-up|1|||
13339599|NCT01023308|26621211|FG001|Overall Study|Lost to Follow-up|0|||
13339600|NCT01023308|26621210|FG000|Overall Study|Withdrawal by Subject|34|||
13339601|NCT01023308|26621211|FG001|Overall Study|Withdrawal by Subject|18|||
13339602|NCT01023269|26621218|FG000|Overall Study|early termination of the study|2|||
13339603|NCT01023269|26621219|FG001|Overall Study|early termination of the study|0|||
13339604|NCT01023256|26621272|FG000|Overall Study|Protocol Violation|2|||
13339605|NCT01023256|26621273|FG001|Overall Study|Protocol Violation|3|||
13339606|NCT01023256|26621274|FG002|Overall Study|Protocol Violation|0|||
13339607|NCT01023256|26621275|FG003|Overall Study|Protocol Violation|0|||
13339608|NCT01023256|26621272|FG000|Overall Study|Randomized but not treated|1|||
13339609|NCT01023256|26621273|FG001|Overall Study|Randomized but not treated|0|||
13339610|NCT01023256|26621274|FG002|Overall Study|Randomized but not treated|1|||
13339611|NCT01023256|26621275|FG003|Overall Study|Randomized but not treated|0|||
13339612|NCT01023256|26621272|FG000|Overall Study|Other|1|||
13339613|NCT01023256|26621273|FG001|Overall Study|Other|0|||
13339614|NCT01023256|26621274|FG002|Overall Study|Other|0|||
13339615|NCT01023256|26621275|FG003|Overall Study|Other|2|||
13339616|NCT01023256|26621272|FG000|Overall Study|Adverse Event|0|||
13339617|NCT01023256|26621273|FG001|Overall Study|Adverse Event|0|||
13339618|NCT01023256|26621274|FG002|Overall Study|Adverse Event|0|||
13339619|NCT01023256|26621275|FG003|Overall Study|Adverse Event|1|||
13339620|NCT01023256|26621272|FG000|Overall Study|Withdrawal by Subject|0|||
13339621|NCT01023256|26621273|FG001|Overall Study|Withdrawal by Subject|0|||
13339622|NCT01023256|26621274|FG002|Overall Study|Withdrawal by Subject|0|||
13339623|NCT01023256|26621275|FG003|Overall Study|Withdrawal by Subject|2|||
13339624|NCT01023217|26621288|FG000|Overall Study|Withdrawal by Subject|1|||
13339625|NCT01023217|26621289|FG001|Overall Study|Withdrawal by Subject|0|||
13339626|NCT01023061|26621297|FG000|Overall Study|Withdrawal prior to treatment|2|||
13339627|NCT01023035|26621317|FG000|Treatment Period|Adverse Event|27|||
13339628|NCT01023035|26621318|FG001|Treatment Period|Adverse Event|32|||
13339629|NCT01023035|26621319|FG002|Treatment Period|Adverse Event|50|||
13339630|NCT01023035|26621317|FG000|Treatment Period|Non-Medical Reasons|19|||
13339631|NCT01023035|26621318|FG001|Treatment Period|Non-Medical Reasons|22|||
13339632|NCT01023035|26621319|FG002|Treatment Period|Non-Medical Reasons|44|||
13339633|NCT01023035|26621317|FG000|Treatment Period|Treatment Failure|26|||
13339634|NCT01023035|26621318|FG001|Treatment Period|Treatment Failure|31|||
13339635|NCT01023035|26621319|FG002|Treatment Period|Treatment Failure|24|||
13339636|NCT01023035|26621317|FG000|Follow-up Period (up to Week 72)|Adverse Event|2|||
13339637|NCT01023035|26621318|FG001|Follow-up Period (up to Week 72)|Adverse Event|0|||
13339638|NCT01023035|26621319|FG002|Follow-up Period (up to Week 72)|Adverse Event|1|||
13339639|NCT01023035|26621317|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26|||
13339640|NCT01023035|26621318|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28|||
13339641|NCT01023035|26621319|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38|||
13339642|NCT01023022|26621327|FG000|Overall Study|Death|5|||
13339643|NCT01023022|26621327|FG000|Overall Study|Lost to Follow-up|7|||
13339644|NCT01023022|26621327|FG000|Overall Study|due to technical issues|2|||
13339645|NCT01022996|26621338|FG000|Overall Study|Adverse Event|14|||
13339646|NCT01022996|26621338|FG000|Overall Study|Withdrawal by Subject|3|||
13339647|NCT01022996|26621338|FG000|Overall Study|Lost to Follow-up|1|||
13339648|NCT01022996|26621338|FG000|Overall Study|Administrative problems|6|||
13339649|NCT01022996|26621338|FG000|Overall Study|Disease Progression|32|||
13339650|NCT01022996|26621338|FG000|Overall Study|Protocol Violation|1|||
13339651|NCT01022853|26621431|FG000|Overall Study|Progressive disease|2|||
13339652|NCT01022853|26621432|FG001|Overall Study|Progressive disease|3|||
13339653|NCT01022853|26621433|FG002|Overall Study|Progressive disease|11|||
13339654|NCT01022853|26621434|FG003|Overall Study|Progressive disease|7|||
13339655|NCT01022853|26621435|FG004|Overall Study|Progressive disease|1|||
13339656|NCT01022853|26621431|FG000|Overall Study|Dose-limiting toxicity|0|||
13339657|NCT01022853|26621432|FG001|Overall Study|Dose-limiting toxicity|0|||
13339658|NCT01022853|26621433|FG002|Overall Study|Dose-limiting toxicity|0|||
13339659|NCT01022853|26621434|FG003|Overall Study|Dose-limiting toxicity|0|||
13339660|NCT01022853|26621435|FG004|Overall Study|Dose-limiting toxicity|1|||
13339661|NCT01022853|26621431|FG000|Overall Study|Withdrawal by Subject|0|||
13339662|NCT01022853|26621432|FG001|Overall Study|Withdrawal by Subject|1|||
13339663|NCT01022853|26621433|FG002|Overall Study|Withdrawal by Subject|1|||
13339664|NCT01022853|26621434|FG003|Overall Study|Withdrawal by Subject|1|||
13339665|NCT01022853|26621435|FG004|Overall Study|Withdrawal by Subject|0|||
13339666|NCT01022853|26621431|FG000|Overall Study|Other not stated above|1|||
13339667|NCT01022853|26621432|FG001|Overall Study|Other not stated above|0|||
13339668|NCT01022853|26621433|FG002|Overall Study|Other not stated above|1|||
13339669|NCT01022853|26621434|FG003|Overall Study|Other not stated above|0|||
13339670|NCT01022853|26621435|FG004|Overall Study|Other not stated above|0|||
13339671|NCT01022762|26621468|FG000|Overall Study|Adverse Event|3|||
13339672|NCT01022762|26621469|FG001|Overall Study|Adverse Event|1|||
13339673|NCT01022762|26621468|FG000|Overall Study|Lack of Efficacy|0|||
13339674|NCT01022762|26621469|FG001|Overall Study|Lack of Efficacy|1|||
13339675|NCT01022762|26621468|FG000|Overall Study|Protocol Violation|7|||
13339676|NCT01022762|26621469|FG001|Overall Study|Protocol Violation|6|||
13339677|NCT01022762|26621468|FG000|Overall Study|Unclassified|12|||
13339678|NCT01022762|26621469|FG001|Overall Study|Unclassified|20|||
13339679|NCT01022580|26621490|FG000|Overall Study|Death|18|||
13339680|NCT01022580|26621491|FG001|Overall Study|Death|22|||
13339681|NCT01022502|26621507|FG000|Overall Study|Adverse Event|1|||
13339682|NCT01022502|26621507|FG000|Overall Study|employment related reasons|1|||
13339683|NCT01022502|26621507|FG000|Overall Study|Withdrawal by Subject|1|||
13339684|NCT01022424|26621522|FG000|Overall Study|Adverse Event|1|||
13339685|NCT01022424|26621522|FG000|Overall Study|Physician Decision|1|||
13339686|NCT01022424|26621522|FG000|Overall Study|eGFR under the withdrawal criteria|2|||
13339687|NCT01022398|26621534|FG000|Overall Study|Study terminated|2|||
13339688|NCT01022398|26621535|FG001|Overall Study|Study terminated|2|||
13339689|NCT01022268|26621548|FG000|Overall Study|Withdrawal by Subject|1|||
13339690|NCT01022268|26621549|FG001|Overall Study|Withdrawal by Subject|0|||
13339691|NCT01022268|26621548|FG000|Overall Study|Withdrawal by Subject|1|||
13339692|NCT01022268|26621549|FG001|Overall Study|Withdrawal by Subject|0|||
13339693|NCT01022203|26621566|FG000|Post Treatment Assessment|Withdrawal by Subject|12|||
13339694|NCT01022203|26621567|FG001|Post Treatment Assessment|Withdrawal by Subject|12|||
13339695|NCT01022203|26621566|FG000|Post Treatment Assessment|Physician Decision|2|||
13339696|NCT01022203|26621567|FG001|Post Treatment Assessment|Physician Decision|0|||
13339697|NCT01022203|26621566|FG000|Post Treatment Assessment|Adverse Event|0|||
13339698|NCT01022203|26621567|FG001|Post Treatment Assessment|Adverse Event|2|||
13339699|NCT01022203|26621566|FG000|Follow-Up Assessment|Lost to Follow-up|2|||
13339700|NCT01022203|26621567|FG001|Follow-Up Assessment|Lost to Follow-up|2|||
13339701|NCT01022112|26621595|FG000|Overall Study|Adverse Event|1|||
13339702|NCT01022112|26621596|FG001|Overall Study|Adverse Event|2|||
13339703|NCT01022112|26621597|FG002|Overall Study|Adverse Event|0|||
13339704|NCT01022112|26621598|FG003|Overall Study|Adverse Event|1|||
13339705|NCT01022112|26621599|FG004|Overall Study|Adverse Event|0|||
13339706|NCT01022112|26621595|FG000|Overall Study|Lack of Efficacy|1|||
13339707|NCT01022112|26621596|FG001|Overall Study|Lack of Efficacy|0|||
13339708|NCT01022112|26621597|FG002|Overall Study|Lack of Efficacy|0|||
13339709|NCT01022112|26621598|FG003|Overall Study|Lack of Efficacy|0|||
13339710|NCT01022112|26621599|FG004|Overall Study|Lack of Efficacy|1|||
13339711|NCT01022112|26621595|FG000|Overall Study|Physician Decision|0|||
13339712|NCT01022112|26621596|FG001|Overall Study|Physician Decision|0|||
13339713|NCT01022112|26621597|FG002|Overall Study|Physician Decision|1|||
13339714|NCT01022112|26621598|FG003|Overall Study|Physician Decision|0|||
13339715|NCT01022112|26621599|FG004|Overall Study|Physician Decision|1|||
13339716|NCT01022112|26621595|FG000|Overall Study|Withdrawal by Subject|0|||
13339717|NCT01022112|26621596|FG001|Overall Study|Withdrawal by Subject|1|||
13339718|NCT01022112|26621597|FG002|Overall Study|Withdrawal by Subject|2|||
13339719|NCT01022112|26621598|FG003|Overall Study|Withdrawal by Subject|2|||
13339720|NCT01022112|26621599|FG004|Overall Study|Withdrawal by Subject|1|||
13339721|NCT01022112|26621595|FG000|Overall Study|Fasting plasma glucose level increased|1|||
13339722|NCT01022112|26621596|FG001|Overall Study|Fasting plasma glucose level increased|0|||
13339723|NCT01022112|26621597|FG002|Overall Study|Fasting plasma glucose level increased|0|||
13339724|NCT01022112|26621598|FG003|Overall Study|Fasting plasma glucose level increased|0|||
13339725|NCT01022112|26621599|FG004|Overall Study|Fasting plasma glucose level increased|7|||
13339726|NCT01021878|26621620|FG000|Overall Study|Lost to Follow-up|4|||
13339727|NCT01021878|26621621|FG001|Overall Study|Lost to Follow-up|3|||
13339728|NCT01021878|26621620|FG000|Overall Study|Death|0|||
13339729|NCT01021878|26621621|FG001|Overall Study|Death|1|||
13339730|NCT01021878|26621620|FG000|Overall Study|Adverse Event|6|||
13339731|NCT01021878|26621621|FG001|Overall Study|Adverse Event|5|||
13339732|NCT01021878|26621620|FG000|Overall Study|Transplantation|6|||
13339733|NCT01021878|26621621|FG001|Overall Study|Transplantation|1|||
13339734|NCT01021852|26621680|FG000|Treatment Period 1|Adverse Event|3|||
13339735|NCT01021852|26621681|FG001|Treatment Period 1|Adverse Event|1|||
13339736|NCT01021852|26621682|FG002|Treatment Period 1|Adverse Event|1|||
13339737|NCT01021852|26621683|FG003|Treatment Period 1|Adverse Event|0|||
13339738|NCT01021852|26621684|FG004|Treatment Period 1|Adverse Event|2|||
13339739|NCT01021852|26621685|FG005|Treatment Period 1|Adverse Event|2|||
13339740|NCT01021852|26621686|FG006|Treatment Period 1|Adverse Event|0|||
13339741|NCT01021852|26621687|FG007|Treatment Period 1|Adverse Event|0|||
13339742|NCT01021852|26621680|FG000|Treatment Period 1|Pregnancy|0|||
13339743|NCT01021852|26621681|FG001|Treatment Period 1|Pregnancy|0|||
13339744|NCT01021852|26621682|FG002|Treatment Period 1|Pregnancy|1|||
13339745|NCT01021852|26621683|FG003|Treatment Period 1|Pregnancy|0|||
13339746|NCT01021852|26621684|FG004|Treatment Period 1|Pregnancy|0|||
13339747|NCT01021852|26621685|FG005|Treatment Period 1|Pregnancy|0|||
13339748|NCT01021852|26621686|FG006|Treatment Period 1|Pregnancy|0|||
13339749|NCT01021852|26621687|FG007|Treatment Period 1|Pregnancy|0|||
13339750|NCT01021852|26621680|FG000|Treatment Period 1|Withdrawal by Subject|0|||
13339751|NCT01021852|26621681|FG001|Treatment Period 1|Withdrawal by Subject|0|||
13339752|NCT01021852|26621682|FG002|Treatment Period 1|Withdrawal by Subject|0|||
13339753|NCT01021852|26621683|FG003|Treatment Period 1|Withdrawal by Subject|0|||
13339754|NCT01021852|26621684|FG004|Treatment Period 1|Withdrawal by Subject|1|||
13339755|NCT01021852|26621685|FG005|Treatment Period 1|Withdrawal by Subject|0|||
13339756|NCT01021852|26621686|FG006|Treatment Period 1|Withdrawal by Subject|0|||
13339757|NCT01021852|26621687|FG007|Treatment Period 1|Withdrawal by Subject|1|||
13339758|NCT01021852|26621680|FG000|Treatment Period 1|Not Treated|0|||
13339759|NCT01021852|26621681|FG001|Treatment Period 1|Not Treated|0|||
13339760|NCT01021852|26621682|FG002|Treatment Period 1|Not Treated|0|||
13339761|NCT01021852|26621683|FG003|Treatment Period 1|Not Treated|2|||
13339762|NCT01021852|26621684|FG004|Treatment Period 1|Not Treated|0|||
13339763|NCT01021852|26621685|FG005|Treatment Period 1|Not Treated|0|||
13339764|NCT01021852|26621686|FG006|Treatment Period 1|Not Treated|0|||
13339765|NCT01021852|26621687|FG007|Treatment Period 1|Not Treated|0|||
13339766|NCT01021852|26621680|FG000|Washout Period-Placebo|Adverse Event|0|||
13339767|NCT01021852|26621681|FG001|Washout Period-Placebo|Adverse Event|0|||
13339768|NCT01021852|26621682|FG002|Washout Period-Placebo|Adverse Event|0|||
13339769|NCT01021852|26621683|FG003|Washout Period-Placebo|Adverse Event|1|||
13339770|NCT01021852|26621684|FG004|Washout Period-Placebo|Adverse Event|0|||
13339771|NCT01021852|26621685|FG005|Washout Period-Placebo|Adverse Event|1|||
13339772|NCT01021852|26621686|FG006|Washout Period-Placebo|Adverse Event|0|||
13339773|NCT01021852|26621687|FG007|Washout Period-Placebo|Adverse Event|0|||
13339774|NCT01021852|26621680|FG000|Washout Period-Placebo|Lost to Follow-up|0|||
13339775|NCT01021852|26621681|FG001|Washout Period-Placebo|Lost to Follow-up|0|||
13339776|NCT01021852|26621682|FG002|Washout Period-Placebo|Lost to Follow-up|0|||
13339777|NCT01021852|26621683|FG003|Washout Period-Placebo|Lost to Follow-up|0|||
13339778|NCT01021852|26621684|FG004|Washout Period-Placebo|Lost to Follow-up|1|||
13339779|NCT01021852|26621685|FG005|Washout Period-Placebo|Lost to Follow-up|0|||
13339780|NCT01021852|26621686|FG006|Washout Period-Placebo|Lost to Follow-up|0|||
13339781|NCT01021852|26621687|FG007|Washout Period-Placebo|Lost to Follow-up|0|||
13339782|NCT01021852|26621680|FG000|Washout Period-Placebo|Protocol Violation|0|||
13339783|NCT01021852|26621681|FG001|Washout Period-Placebo|Protocol Violation|0|||
13339784|NCT01021852|26621682|FG002|Washout Period-Placebo|Protocol Violation|0|||
13339785|NCT01021852|26621683|FG003|Washout Period-Placebo|Protocol Violation|0|||
13339786|NCT01021852|26621684|FG004|Washout Period-Placebo|Protocol Violation|0|||
13339787|NCT01021852|26621685|FG005|Washout Period-Placebo|Protocol Violation|0|||
13339788|NCT01021852|26621686|FG006|Washout Period-Placebo|Protocol Violation|1|||
13339789|NCT01021852|26621687|FG007|Washout Period-Placebo|Protocol Violation|0|||
13339790|NCT01021852|26621680|FG000|Washout Period-No Drug|Adverse Event|1|||
13339791|NCT01021852|26621681|FG001|Washout Period-No Drug|Adverse Event|0|||
13339792|NCT01021852|26621682|FG002|Washout Period-No Drug|Adverse Event|0|||
13339793|NCT01021852|26621683|FG003|Washout Period-No Drug|Adverse Event|0|||
13339794|NCT01021852|26621684|FG004|Washout Period-No Drug|Adverse Event|0|||
13339795|NCT01021852|26621685|FG005|Washout Period-No Drug|Adverse Event|1|||
13339796|NCT01021852|26621686|FG006|Washout Period-No Drug|Adverse Event|0|||
13339797|NCT01021852|26621687|FG007|Washout Period-No Drug|Adverse Event|0|||
13339798|NCT01021852|26621680|FG000|Treatment Period 2|Adverse Event|0|||
13339799|NCT01021852|26621681|FG001|Treatment Period 2|Adverse Event|1|||
13486414|NCT03564119|27036069|FG001|Overall Study|Lost to Follow-up|4|||
13339800|NCT01021852|26621682|FG002|Treatment Period 2|Adverse Event|0|||
13339801|NCT01021852|26621683|FG003|Treatment Period 2|Adverse Event|0|||
13339802|NCT01021852|26621684|FG004|Treatment Period 2|Adverse Event|1|||
13339803|NCT01021852|26621685|FG005|Treatment Period 2|Adverse Event|0|||
13339804|NCT01021852|26621686|FG006|Treatment Period 2|Adverse Event|1|||
13339805|NCT01021852|26621687|FG007|Treatment Period 2|Adverse Event|0|||
13339806|NCT01021852|26621680|FG000|Treatment Period 2|Lack of Efficacy|0|||
13339807|NCT01021852|26621681|FG001|Treatment Period 2|Lack of Efficacy|0|||
13339808|NCT01021852|26621682|FG002|Treatment Period 2|Lack of Efficacy|0|||
13339809|NCT01021852|26621683|FG003|Treatment Period 2|Lack of Efficacy|0|||
13339810|NCT01021852|26621684|FG004|Treatment Period 2|Lack of Efficacy|0|||
13339811|NCT01021852|26621685|FG005|Treatment Period 2|Lack of Efficacy|1|||
13339812|NCT01021852|26621686|FG006|Treatment Period 2|Lack of Efficacy|0|||
13339813|NCT01021852|26621687|FG007|Treatment Period 2|Lack of Efficacy|0|||
13393577|NCT00663208|26784237|FG006|Follow-up Period|Other reason|1|||
13393578|NCT00663117|26784256|FG000|Overall Study|Lack of Efficacy|1|||
13393579|NCT00663117|26784257|FG001|Overall Study|Lack of Efficacy|0|||
13393580|NCT00663052|26784344|FG000|Overall Study|Adverse Event|6|||
13393581|NCT00663052|26784345|FG001|Overall Study|Adverse Event|3|||
13393582|NCT00663052|26784344|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
13393583|NCT00663052|26784345|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
13393584|NCT00663052|26784344|FG000|Overall Study|Protocol Violation|1|||
13393585|NCT00663052|26784345|FG001|Overall Study|Protocol Violation|0|||
13393586|NCT00663052|26784344|FG000|Overall Study|Withdrawal by Subject|2|||
13393587|NCT00663052|26784345|FG001|Overall Study|Withdrawal by Subject|5|||
13393588|NCT00663052|26784344|FG000|Overall Study|Unsatisfactory Response - Efficacy|1|||
13393589|NCT00663052|26784345|FG001|Overall Study|Unsatisfactory Response - Efficacy|1|||
13393590|NCT00663052|26784344|FG000|Overall Study|Other|0|||
13393591|NCT00663052|26784345|FG001|Overall Study|Other|1|||
13393592|NCT00663026|26784375|FG000|Overall Study|Lost to Follow-up|1|||
13393593|NCT00663026|26784376|FG001|Overall Study|Lost to Follow-up|0|||
13393594|NCT00663026|26784377|FG002|Overall Study|Lost to Follow-up|0|||
13393595|NCT00663026|26784375|FG000|Overall Study|Other|1|||
13393596|NCT00663026|26784376|FG001|Overall Study|Other|2|||
13393597|NCT00663026|26784377|FG002|Overall Study|Other|0|||
13393598|NCT00663026|26784375|FG000|Overall Study|Adverse Event|0|||
13393599|NCT00663026|26784376|FG001|Overall Study|Adverse Event|2|||
13393600|NCT00663026|26784377|FG002|Overall Study|Adverse Event|3|||
13393601|NCT00663026|26784375|FG000|Overall Study|Caregiver Request|0|||
13393602|NCT00663026|26784376|FG001|Overall Study|Caregiver Request|2|||
13393603|NCT00663026|26784377|FG002|Overall Study|Caregiver Request|0|||
13393604|NCT00663026|26784375|FG000|Overall Study|Withdrawal by Subject|0|||
13393605|NCT00663026|26784376|FG001|Overall Study|Withdrawal by Subject|0|||
13393606|NCT00663026|26784377|FG002|Overall Study|Withdrawal by Subject|1|||
13393607|NCT00662909|26784485|FG000|Overall Study|Adverse Event|17|||
13393608|NCT00662909|26784486|FG001|Overall Study|Adverse Event|18|||
13393609|NCT00662909|26784487|FG002|Overall Study|Adverse Event|19|||
13393610|NCT00662909|26784485|FG000|Overall Study|Lack of Efficacy|9|||
13393611|NCT00662909|26784486|FG001|Overall Study|Lack of Efficacy|1|||
13393612|NCT00662909|26784487|FG002|Overall Study|Lack of Efficacy|5|||
13393613|NCT00662909|26784485|FG000|Overall Study|Withdrawal by Subject|29|||
13393614|NCT00662909|26784486|FG001|Overall Study|Withdrawal by Subject|22|||
13393615|NCT00662909|26784487|FG002|Overall Study|Withdrawal by Subject|16|||
13393616|NCT00662909|26784485|FG000|Overall Study|Lost to Follow-up|2|||
13393617|NCT00662909|26784486|FG001|Overall Study|Lost to Follow-up|9|||
13393618|NCT00662909|26784487|FG002|Overall Study|Lost to Follow-up|3|||
13339814|NCT01021852|26621680|FG000|Treatment Period 2|Physician Decision|0|||
13339815|NCT01021852|26621681|FG001|Treatment Period 2|Physician Decision|0|||
13339816|NCT01021852|26621682|FG002|Treatment Period 2|Physician Decision|1|||
13339817|NCT01021852|26621683|FG003|Treatment Period 2|Physician Decision|0|||
13339818|NCT01021852|26621684|FG004|Treatment Period 2|Physician Decision|0|||
13339819|NCT01021852|26621685|FG005|Treatment Period 2|Physician Decision|0|||
13339820|NCT01021852|26621686|FG006|Treatment Period 2|Physician Decision|0|||
13339821|NCT01021852|26621687|FG007|Treatment Period 2|Physician Decision|0|||
13339822|NCT01021852|26621680|FG000|Treatment Period 2|Protocol Violation|0|||
13339823|NCT01021852|26621681|FG001|Treatment Period 2|Protocol Violation|0|||
13339824|NCT01021852|26621682|FG002|Treatment Period 2|Protocol Violation|0|||
13339825|NCT01021852|26621683|FG003|Treatment Period 2|Protocol Violation|0|||
13339826|NCT01021852|26621684|FG004|Treatment Period 2|Protocol Violation|1|||
13339827|NCT01021852|26621685|FG005|Treatment Period 2|Protocol Violation|0|||
13393619|NCT00662909|26784485|FG000|Overall Study|Protocol Violation|7|||
13393620|NCT00662909|26784486|FG001|Overall Study|Protocol Violation|4|||
13393621|NCT00662909|26784487|FG002|Overall Study|Protocol Violation|5|||
13124722|NCT02939950|25953769|FG001|Overall Study|Lack of motivation|2|||
13339828|NCT01021852|26621686|FG006|Treatment Period 2|Protocol Violation|1|||
13339829|NCT01021852|26621687|FG007|Treatment Period 2|Protocol Violation|0|||
13339830|NCT01021852|26621680|FG000|Treatment Period 2|Withdrawal by Subject|0|||
13339831|NCT01021852|26621681|FG001|Treatment Period 2|Withdrawal by Subject|0|||
13339832|NCT01021852|26621682|FG002|Treatment Period 2|Withdrawal by Subject|0|||
13339833|NCT01021852|26621683|FG003|Treatment Period 2|Withdrawal by Subject|0|||
13339834|NCT01021852|26621684|FG004|Treatment Period 2|Withdrawal by Subject|0|||
13339835|NCT01021852|26621685|FG005|Treatment Period 2|Withdrawal by Subject|0|||
13393622|NCT00662909|26784485|FG000|Overall Study|Randomized- never received study drug|1|||
13393623|NCT00662909|26784486|FG001|Overall Study|Randomized- never received study drug|0|||
13486415|NCT03564119|27036068|FG000|Overall Study|Protocol Violation|1|||
13339836|NCT01021852|26621686|FG006|Treatment Period 2|Withdrawal by Subject|1|||
13339837|NCT01021852|26621687|FG007|Treatment Period 2|Withdrawal by Subject|2|||
13339838|NCT01021813|26621736|FG000|DB Treatment Phase|Adverse Event|60|||
13339839|NCT01021813|26621737|FG001|DB Treatment Phase|Adverse Event|22|||
13339840|NCT01021813|26621738|FG002|DB Treatment Phase|Adverse Event|0|||
13339841|NCT01021813|26621739|FG003|DB Treatment Phase|Adverse Event|0|||
13339842|NCT01021813|26621740|FG004|DB Treatment Phase|Adverse Event|0|||
13339843|NCT01021813|26621736|FG000|DB Treatment Phase|Lack of Efficacy|44|||
13339844|NCT01021813|26621737|FG001|DB Treatment Phase|Lack of Efficacy|28|||
13339845|NCT01021813|26621738|FG002|DB Treatment Phase|Lack of Efficacy|0|||
13339846|NCT01021813|26621739|FG003|DB Treatment Phase|Lack of Efficacy|0|||
13339847|NCT01021813|26621740|FG004|DB Treatment Phase|Lack of Efficacy|0|||
13339848|NCT01021813|26621736|FG000|DB Treatment Phase|Lost to Follow-up|14|||
13339849|NCT01021813|26621737|FG001|DB Treatment Phase|Lost to Follow-up|12|||
13339850|NCT01021813|26621738|FG002|DB Treatment Phase|Lost to Follow-up|0|||
13339851|NCT01021813|26621739|FG003|DB Treatment Phase|Lost to Follow-up|0|||
13339852|NCT01021813|26621740|FG004|DB Treatment Phase|Lost to Follow-up|0|||
13339853|NCT01021813|26621736|FG000|DB Treatment Phase|Physician Decision|17|||
13339854|NCT01021813|26621737|FG001|DB Treatment Phase|Physician Decision|8|||
13339855|NCT01021813|26621738|FG002|DB Treatment Phase|Physician Decision|0|||
13339856|NCT01021813|26621739|FG003|DB Treatment Phase|Physician Decision|0|||
13339857|NCT01021813|26621740|FG004|DB Treatment Phase|Physician Decision|0|||
13339858|NCT01021813|26621736|FG000|DB Treatment Phase|Pregnancy|1|||
13339859|NCT01021813|26621737|FG001|DB Treatment Phase|Pregnancy|0|||
13339860|NCT01021813|26621738|FG002|DB Treatment Phase|Pregnancy|0|||
13339861|NCT01021813|26621739|FG003|DB Treatment Phase|Pregnancy|0|||
13339862|NCT01021813|26621740|FG004|DB Treatment Phase|Pregnancy|0|||
13339863|NCT01021813|26621736|FG000|DB Treatment Phase|Protocol Violation|4|||
13339864|NCT01021813|26621737|FG001|DB Treatment Phase|Protocol Violation|3|||
13339865|NCT01021813|26621738|FG002|DB Treatment Phase|Protocol Violation|0|||
13339866|NCT01021813|26621739|FG003|DB Treatment Phase|Protocol Violation|0|||
13339867|NCT01021813|26621740|FG004|DB Treatment Phase|Protocol Violation|0|||
13339868|NCT01021813|26621736|FG000|DB Treatment Phase|Withdrawal by Subject|60|||
13339869|NCT01021813|26621737|FG001|DB Treatment Phase|Withdrawal by Subject|24|||
13339870|NCT01021813|26621738|FG002|DB Treatment Phase|Withdrawal by Subject|0|||
13339871|NCT01021813|26621739|FG003|DB Treatment Phase|Withdrawal by Subject|0|||
13339872|NCT01021813|26621740|FG004|DB Treatment Phase|Withdrawal by Subject|0|||
13339873|NCT01021813|26621736|FG000|DB Randomized Discontinuation Phase|Adverse Event|0|||
13339874|NCT01021813|26621737|FG001|DB Randomized Discontinuation Phase|Adverse Event|0|||
13339875|NCT01021813|26621738|FG002|DB Randomized Discontinuation Phase|Adverse Event|0|||
13339876|NCT01021813|26621739|FG003|DB Randomized Discontinuation Phase|Adverse Event|3|||
13339877|NCT01021813|26621740|FG004|DB Randomized Discontinuation Phase|Adverse Event|1|||
13339878|NCT01021813|26621736|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
13339879|NCT01021813|26621737|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
13339880|NCT01021813|26621738|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
13339881|NCT01021813|26621739|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1|||
13339882|NCT01021813|26621740|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
13339883|NCT01021813|26621736|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
13339884|NCT01021813|26621737|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
13339885|NCT01021813|26621738|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
13339886|NCT01021813|26621739|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
13339887|NCT01021813|26621740|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1|||
13339888|NCT01021813|26621736|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0|||
13339889|NCT01021813|26621737|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0|||
13339890|NCT01021813|26621738|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1|||
13339891|NCT01021813|26621739|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0|||
13339892|NCT01021813|26621740|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0|||
13339893|NCT01021813|26621736|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
13339894|NCT01021813|26621737|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
13339895|NCT01021813|26621738|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
13339896|NCT01021813|26621739|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1|||
13339897|NCT01021813|26621740|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
13339898|NCT01021748|26621815|FG000|Overall Study|Adverse Event|2|||
13339899|NCT01021748|26621816|FG001|Overall Study|Adverse Event|1|||
13339900|NCT01021748|26621817|FG002|Overall Study|Adverse Event|2|||
13339901|NCT01021748|26621818|FG003|Overall Study|Adverse Event|0|||
13339902|NCT01021748|26621819|FG004|Overall Study|Adverse Event|2|||
13339903|NCT01021748|26621820|FG005|Overall Study|Adverse Event|0|||
13339904|NCT01021748|26621821|FG006|Overall Study|Adverse Event|1|||
13339905|NCT01021748|26621822|FG007|Overall Study|Adverse Event|0|||
13339906|NCT01021748|26621823|FG008|Overall Study|Adverse Event|7|||
13339907|NCT01021748|26621815|FG000|Overall Study|Physician Decision|1|||
13339908|NCT01021748|26621816|FG001|Overall Study|Physician Decision|0|||
13339909|NCT01021748|26621817|FG002|Overall Study|Physician Decision|1|||
13339910|NCT01021748|26621818|FG003|Overall Study|Physician Decision|1|||
13204314|NCT01974895|26228272|FG000|Overall Study|Protocol Violation|1|||
13204315|NCT01974895|26228273|FG001|Overall Study|Protocol Violation|0|||
13204316|NCT01974895|26228272|FG000|Overall Study|Lost to Follow-up|4|||
13204317|NCT01974895|26228273|FG001|Overall Study|Lost to Follow-up|6|||
13204318|NCT01974895|26228272|FG000|Overall Study|Withdrawal by Subject|0|||
13339911|NCT01021748|26621819|FG004|Overall Study|Physician Decision|0|||
13339912|NCT01021748|26621820|FG005|Overall Study|Physician Decision|0|||
13339913|NCT01021748|26621821|FG006|Overall Study|Physician Decision|1|||
13339914|NCT01021748|26621822|FG007|Overall Study|Physician Decision|1|||
13339915|NCT01021748|26621823|FG008|Overall Study|Physician Decision|2|||
13339916|NCT01021748|26621815|FG000|Overall Study|Progressive Disease|3|||
13339917|NCT01021748|26621816|FG001|Overall Study|Progressive Disease|3|||
13339918|NCT01021748|26621817|FG002|Overall Study|Progressive Disease|4|||
13339919|NCT01021748|26621818|FG003|Overall Study|Progressive Disease|6|||
13339920|NCT01021748|26621819|FG004|Overall Study|Progressive Disease|7|||
13339921|NCT01021748|26621820|FG005|Overall Study|Progressive Disease|3|||
13339922|NCT01021748|26621821|FG006|Overall Study|Progressive Disease|0|||
13339923|NCT01021748|26621822|FG007|Overall Study|Progressive Disease|5|||
13339924|NCT01021748|26621823|FG008|Overall Study|Progressive Disease|6|||
13339925|NCT01021748|26621815|FG000|Overall Study|Withdrawal by Subject|0|||
13339926|NCT01021748|26621816|FG001|Overall Study|Withdrawal by Subject|0|||
13339927|NCT01021748|26621817|FG002|Overall Study|Withdrawal by Subject|0|||
13339928|NCT01021748|26621818|FG003|Overall Study|Withdrawal by Subject|0|||
13339929|NCT01021748|26621819|FG004|Overall Study|Withdrawal by Subject|0|||
13339930|NCT01021748|26621820|FG005|Overall Study|Withdrawal by Subject|0|||
13339931|NCT01021748|26621821|FG006|Overall Study|Withdrawal by Subject|1|||
13339932|NCT01021748|26621822|FG007|Overall Study|Withdrawal by Subject|0|||
13339933|NCT01021748|26621823|FG008|Overall Study|Withdrawal by Subject|1|||
13339934|NCT01021748|26621815|FG000|Overall Study|Not Treated|0|||
13339935|NCT01021748|26621816|FG001|Overall Study|Not Treated|1|||
13339936|NCT01021748|26621817|FG002|Overall Study|Not Treated|0|||
13339937|NCT01021748|26621818|FG003|Overall Study|Not Treated|0|||
13339938|NCT01021748|26621819|FG004|Overall Study|Not Treated|0|||
13339939|NCT01021748|26621820|FG005|Overall Study|Not Treated|0|||
13339940|NCT01021748|26621821|FG006|Overall Study|Not Treated|0|||
13339941|NCT01021748|26621822|FG007|Overall Study|Not Treated|0|||
13339942|NCT01021748|26621823|FG008|Overall Study|Not Treated|0|||
13339943|NCT01021683|26621837|FG000|Overall Study|Lack of Efficacy|12|||
13339944|NCT01021683|26621837|FG000|Overall Study|Recovery of neutrophil count|51|||
13339945|NCT01021683|26621837|FG000|Overall Study|Other|8|||
13339946|NCT01021553|26621899|FG000|Overall Study|Adverse Event|1|||
13339947|NCT01021553|26621900|FG001|Overall Study|Adverse Event|0|||
13339948|NCT01021553|26621901|FG002|Overall Study|Adverse Event|0|||
13339949|NCT01021553|26621899|FG000|Overall Study|Lack of Efficacy|2|||
13339950|NCT01021553|26621900|FG001|Overall Study|Lack of Efficacy|2|||
13339951|NCT01021553|26621901|FG002|Overall Study|Lack of Efficacy|0|||
13339952|NCT01021553|26621899|FG000|Overall Study|Protocol Violation|0|||
13339953|NCT01021553|26621900|FG001|Overall Study|Protocol Violation|2|||
13339954|NCT01021553|26621901|FG002|Overall Study|Protocol Violation|2|||
13339955|NCT01021553|26621899|FG000|Overall Study|Lost to Follow-up|0|||
13339956|NCT01021553|26621900|FG001|Overall Study|Lost to Follow-up|0|||
13339957|NCT01021553|26621901|FG002|Overall Study|Lost to Follow-up|1|||
13339958|NCT01021553|26621899|FG000|Overall Study|Withdrawal by Subject|1|||
13339959|NCT01021553|26621900|FG001|Overall Study|Withdrawal by Subject|1|||
13339960|NCT01021553|26621901|FG002|Overall Study|Withdrawal by Subject|0|||
13339961|NCT01021423|26621924|FG000|Overall Study|Study terminated|4|||
13339962|NCT01021423|26621925|FG001|Overall Study|Study terminated|5|||
13339963|NCT01021332|26621961|FG000|Overall Study|Not fulfilling incl./excl.criteria|5|||
13486416|NCT03564119|27036069|FG001|Overall Study|Protocol Violation|0|||
13339964|NCT01021332|26621961|FG000|Overall Study|Adverse Event|43|||
13339965|NCT01021332|26621961|FG000|Overall Study|Lack of Efficacy|19|||
13339966|NCT01021332|26621961|FG000|Overall Study|Withdrawal of Consent|23|||
13339967|NCT01021332|26621961|FG000|Overall Study|Lost to Follow-up|4|||
13339968|NCT01021332|26621961|FG000|Overall Study|Protocol Violation|9|||
13339969|NCT01021332|26621961|FG000|Overall Study|Miscellaneous|3|||
13339970|NCT01021293|26621985|FG000|Overall Study|Serious Adverse Event|2|||
13339971|NCT01021293|26621986|FG001|Overall Study|Serious Adverse Event|1|||
13339972|NCT01021293|26621985|FG000|Overall Study|Adverse Event|2|||
13339973|NCT01021293|26621986|FG001|Overall Study|Adverse Event|1|||
13339974|NCT01021293|26621985|FG000|Overall Study|Withdrawal by Subject|1|||
13339975|NCT01021293|26621986|FG001|Overall Study|Withdrawal by Subject|3|||
13339976|NCT01021293|26621985|FG000|Overall Study|Migrated/moved from study area|6|||
13339977|NCT01021293|26621986|FG001|Overall Study|Migrated/moved from study area|18|||
13339978|NCT01021293|26621985|FG000|Overall Study|Lost to Follow-up|1|||
13204319|NCT01974895|26228273|FG001|Overall Study|Withdrawal by Subject|1|||
13339979|NCT01021293|26621986|FG001|Overall Study|Lost to Follow-up|1|||
13339980|NCT01021215|26622003|FG000|Overall Study|Lost to Follow-up|3|||
13339981|NCT01021215|26622004|FG001|Overall Study|Lost to Follow-up|0|||
13339982|NCT01021137|26622055|FG000|Overall Study|Lost to Follow-up|9|||
13339983|NCT01021137|26622056|FG001|Overall Study|Lost to Follow-up|4|||
13204320|NCT01974895|26228272|FG000|Overall Study|Other (Missed Visit)|1|||
13204321|NCT01974895|26228273|FG001|Overall Study|Other (Missed Visit)|0|||
13204322|NCT01974895|26228272|FG000|Overall Study|Other (Reason unknown)|9|||
13204323|NCT01974895|26228273|FG001|Overall Study|Other (Reason unknown)|8|||
13339984|NCT01021137|26622057|FG002|Overall Study|Lost to Follow-up|2|||
13339985|NCT01021137|26622058|FG003|Overall Study|Lost to Follow-up|6|||
13339986|NCT01021137|26622055|FG000|Overall Study|Withdrawal by Subject|1|||
13339987|NCT01021137|26622056|FG001|Overall Study|Withdrawal by Subject|0|||
13339988|NCT01021137|26622057|FG002|Overall Study|Withdrawal by Subject|0|||
13339989|NCT01021137|26622058|FG003|Overall Study|Withdrawal by Subject|3|||
13339990|NCT01021020|26622074|FG000|Period I|Protocol Violation|1|||
13339991|NCT01021020|26622074|FG000|Period I|Withdrawal by Subject|1|||
13339992|NCT01021020|26622074|FG000|14 Day Washout Period A|Physician Decision|1|||
13339993|NCT01021007|26622091|FG000|Overall Study|Lost to Follow-up|1|||
13339994|NCT01021007|26622092|FG001|Overall Study|Lost to Follow-up|1|||
13339995|NCT01021007|26622091|FG000|Overall Study|Adverse Event|1|||
13339996|NCT01021007|26622092|FG001|Overall Study|Adverse Event|3|||
13339997|NCT01020981|26622109|FG000|Overall Study|Did not return mailed survey|74|||
13339998|NCT01020981|26622110|FG001|Overall Study|Did not return mailed survey|58|||
13339999|NCT01020981|26622109|FG000|Overall Study|Survey returned undeliverable|8|||
13340000|NCT01020981|26622110|FG001|Overall Study|Survey returned undeliverable|32|||
13340001|NCT01020981|26622109|FG000|Overall Study|Participant declined to complete survey|2|||
13340002|NCT01020981|26622110|FG001|Overall Study|Participant declined to complete survey|0|||
13340003|NCT01020877|26622127|FG000|Second Intervention|Withdrawal by Subject|1|||
13340004|NCT01020877|26622128|FG001|Second Intervention|Withdrawal by Subject|0|||
13340005|NCT01020838|26622145|FG000|Overall Study|Death|90|||
13340006|NCT01020838|26622145|FG000|Overall Study|Adverse Event|1|||
13340007|NCT01020838|26622145|FG000|Overall Study|Withdrawal by Subject|9|||
13340008|NCT01020838|26622145|FG000|Overall Study|Lost to Follow-up|6|||
13340009|NCT01020838|26622145|FG000|Overall Study|Most common: Study ended by sponsor|77|||
13340010|NCT01020812|26622154|FG000|Overall Study|Physician Decision|1|||
13340011|NCT01020812|26622154|FG000|Overall Study|Withdrawal by Subject|1|||
13340012|NCT01020812|26622154|FG000|Overall Study|Protocol Violation|1|||
13340013|NCT01020799|26622187|FG000|Overall Study|Adverse Event|4|||
13340014|NCT01020799|26622188|FG001|Overall Study|Adverse Event|3|||
13340015|NCT01020799|26622189|FG002|Overall Study|Adverse Event|2|||
13340016|NCT01020799|26622187|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4|||
13340017|NCT01020799|26622188|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3|||
13340018|NCT01020799|26622189|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0|||
13340019|NCT01020799|26622187|FG000|Overall Study|Protocol Violation|3|||
13340020|NCT01020799|26622188|FG001|Overall Study|Protocol Violation|2|||
13340021|NCT01020799|26622189|FG002|Overall Study|Protocol Violation|0|||
13340022|NCT01020799|26622187|FG000|Overall Study|Withdrawal by Subject|2|||
13340023|NCT01020799|26622188|FG001|Overall Study|Withdrawal by Subject|2|||
13340024|NCT01020799|26622189|FG002|Overall Study|Withdrawal by Subject|3|||
13340025|NCT01020799|26622187|FG000|Overall Study|Lost to Follow-up|6|||
13340026|NCT01020799|26622188|FG001|Overall Study|Lost to Follow-up|4|||
13340027|NCT01020799|26622189|FG002|Overall Study|Lost to Follow-up|2|||
13340028|NCT01020786|26622203|FG000|Induction Period|Entry Criteria Not Met|2|||
13340029|NCT01020786|26622203|FG000|Induction Period|Adverse Event|10|||
13340030|NCT01020786|26622203|FG000|Induction Period|Progressive Disease|31|||
13340031|NCT01020786|26622203|FG000|Induction Period|Investigator Decision|3|||
13340032|NCT01020786|26622203|FG000|Induction Period|Withdrawal by Subject|3|||
13340033|NCT01020786|26622203|FG000|Maintenance Period|Adverse Event|8|||
13340034|NCT01020786|26622203|FG000|Maintenance Period|Progressive Disease|43|||
13340035|NCT01020786|26622203|FG000|Maintenance Period|Withdrawal by Subject|8|||
13340036|NCT01020786|26622203|FG000|Maintenance Period|Sponsor Decision|1|||
13340037|NCT01020773|26622216|FG000|Overall Study|Withdrawal by Subject|4|||
13340038|NCT01020773|26622217|FG001|Overall Study|Withdrawal by Subject|3|||
13340039|NCT01020747|26622224|FG000|Overall Study|Withdrawal by Subject|1|||
13340040|NCT01020526|26622230|FG000|Overall Study|Withdrawal by Subject|5|||
13340041|NCT01020526|26622230|FG000|Overall Study|Other reasons|3|||
13340042|NCT01020526|26622230|FG000|Overall Study|Insufficient clinical response|3|||
13340043|NCT01020526|26622230|FG000|Overall Study|Lost to Follow-up|1|||
13340044|NCT01020526|26622230|FG000|Overall Study|Adverse Event|2|||
13393624|NCT00662909|26784487|FG002|Overall Study|Randomized- never received study drug|0|||
13340045|NCT01020487|26622261|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0|||
13340046|NCT01020487|26622262|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2|||
13340047|NCT01020487|26622263|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1|||
13340048|NCT01020487|26622261|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
13340049|NCT01020487|26622262|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
13340050|NCT01020487|26622263|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1|||
13340051|NCT01020487|26622261|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
13340052|NCT01020487|26622262|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
13340053|NCT01020487|26622263|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3|||
13340054|NCT01020487|26622261|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
13340055|NCT01020487|26622262|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
13340056|NCT01020487|26622263|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1|||
13340057|NCT01020487|26622261|FG000|Part 2 Open-label Period|Adverse Event|0|||
13340058|NCT01020487|26622262|FG001|Part 2 Open-label Period|Adverse Event|4|||
13340059|NCT01020487|26622263|FG002|Part 2 Open-label Period|Adverse Event|1|||
13340060|NCT01020474|26622290|FG000|Overall Study|Adverse Event|4|||
13340061|NCT01020474|26622291|FG001|Overall Study|Adverse Event|4|||
13340062|NCT01020474|26622290|FG000|Overall Study|Protocol Violation|0|||
13340063|NCT01020474|26622291|FG001|Overall Study|Protocol Violation|2|||
13340064|NCT01020474|26622290|FG000|Overall Study|Withdrawal by Subject|5|||
13340065|NCT01020474|26622291|FG001|Overall Study|Withdrawal by Subject|7|||
13340066|NCT01020474|26622290|FG000|Overall Study|Other Reasons|1|||
13340067|NCT01020474|26622291|FG001|Overall Study|Other Reasons|1|||
13340068|NCT01020474|26622290|FG000|Overall Study|Insufficient Clinical Response|0|||
13340069|NCT01020474|26622291|FG001|Overall Study|Insufficient Clinical Response|3|||
13340070|NCT01020448|26622302|FG000|Pre-assignment|Adverse Event|6|||
13340071|NCT01020448|26622302|FG000|Pre-assignment|Withdrawal by Subject|5|||
13340072|NCT01020448|26622302|FG000|Pre-assignment|Does Not Meet Entry Criteria|2|||
13340073|NCT01020448|26622302|FG000|Treatment|Adverse Event|11|||
13340074|NCT01020448|26622302|FG000|Treatment|Consent Withdrawn|3|||
13340075|NCT01020448|26622302|FG000|Treatment|Disease Progression|2|||
13340076|NCT01020448|26622302|FG000|Treatment|Lack of Efficacy|8|||
13340077|NCT01020448|26622302|FG000|Treatment|Lost to Follow-up|2|||
13340078|NCT01020435|26622317|FG000|Overall Study|Lost to Follow-up|0|||
13340079|NCT01020435|26622318|FG001|Overall Study|Lost to Follow-up|1|||
13340080|NCT01020305|26622324|FG000|Overall Study|Adverse Event|2|||
13340081|NCT01020123|26622539|FG000|Main Period|Withdrawal by Subject|6|||
13340082|NCT01020123|26622540|FG001|Main Period|Withdrawal by Subject|5|||
13340083|NCT01020123|26622541|FG002|Main Period|Withdrawal by Subject|3|||
13340084|NCT01020123|26622542|FG003|Main Period|Withdrawal by Subject|1|||
13340085|NCT01020123|26622543|FG004|Main Period|Withdrawal by Subject|6|||
13340086|NCT01020123|26622544|FG005|Main Period|Withdrawal by Subject|3|||
13340087|NCT01020123|26622545|FG006|Main Period|Withdrawal by Subject|2|||
13340088|NCT01020123|26622539|FG000|Main Period|Eligibility Criteria not fullfilled|0|||
13340089|NCT01020123|26622540|FG001|Main Period|Eligibility Criteria not fullfilled|1|||
13340090|NCT01020123|26622541|FG002|Main Period|Eligibility Criteria not fullfilled|0|||
13340091|NCT01020123|26622542|FG003|Main Period|Eligibility Criteria not fullfilled|0|||
13340092|NCT01020123|26622543|FG004|Main Period|Eligibility Criteria not fullfilled|1|||
13340093|NCT01020123|26622544|FG005|Main Period|Eligibility Criteria not fullfilled|0|||
13340094|NCT01020123|26622545|FG006|Main Period|Eligibility Criteria not fullfilled|0|||
13340095|NCT01020123|26622539|FG000|Main Period|Adverse Event|5|||
13340096|NCT01020123|26622540|FG001|Main Period|Adverse Event|2|||
13340097|NCT01020123|26622541|FG002|Main Period|Adverse Event|2|||
13340098|NCT01020123|26622542|FG003|Main Period|Adverse Event|1|||
13340099|NCT01020123|26622543|FG004|Main Period|Adverse Event|1|||
13340100|NCT01020123|26622544|FG005|Main Period|Adverse Event|2|||
13340101|NCT01020123|26622545|FG006|Main Period|Adverse Event|1|||
13340102|NCT01020123|26622539|FG000|Main Period|Protocol Violation|4|||
13340103|NCT01020123|26622540|FG001|Main Period|Protocol Violation|4|||
13340104|NCT01020123|26622541|FG002|Main Period|Protocol Violation|2|||
13340105|NCT01020123|26622542|FG003|Main Period|Protocol Violation|5|||
13340106|NCT01020123|26622543|FG004|Main Period|Protocol Violation|2|||
13340107|NCT01020123|26622544|FG005|Main Period|Protocol Violation|3|||
13340108|NCT01020123|26622545|FG006|Main Period|Protocol Violation|2|||
13340109|NCT01020123|26622539|FG000|Main Period|Lost to Follow-up|0|||
13340110|NCT01020123|26622540|FG001|Main Period|Lost to Follow-up|2|||
13340111|NCT01020123|26622541|FG002|Main Period|Lost to Follow-up|0|||
13340112|NCT01020123|26622542|FG003|Main Period|Lost to Follow-up|0|||
13340113|NCT01020123|26622543|FG004|Main Period|Lost to Follow-up|0|||
13340114|NCT01020123|26622544|FG005|Main Period|Lost to Follow-up|0|||
13340115|NCT01020123|26622545|FG006|Main Period|Lost to Follow-up|0|||
13340116|NCT01020123|26622539|FG000|Main Period|Unclasified|2|||
13340117|NCT01020123|26622540|FG001|Main Period|Unclasified|0|||
13340118|NCT01020123|26622541|FG002|Main Period|Unclasified|1|||
13340119|NCT01020123|26622542|FG003|Main Period|Unclasified|0|||
13340120|NCT01020123|26622543|FG004|Main Period|Unclasified|1|||
13340121|NCT01020123|26622544|FG005|Main Period|Unclasified|3|||
13340122|NCT01020123|26622545|FG006|Main Period|Unclasified|6|||
13340123|NCT01020123|26622539|FG000|Extention Period|Withdrawal by Subject|2|||
13340124|NCT01020123|26622540|FG001|Extention Period|Withdrawal by Subject|1|||
13340125|NCT01020123|26622541|FG002|Extention Period|Withdrawal by Subject|1|||
13340126|NCT01020123|26622542|FG003|Extention Period|Withdrawal by Subject|0|||
13340127|NCT01020123|26622543|FG004|Extention Period|Withdrawal by Subject|0|||
13340128|NCT01020123|26622544|FG005|Extention Period|Withdrawal by Subject|0|||
13340129|NCT01020123|26622545|FG006|Extention Period|Withdrawal by Subject|0|||
13340130|NCT01020123|26622539|FG000|Extention Period|Adverse Event|0|||
13340131|NCT01020123|26622540|FG001|Extention Period|Adverse Event|0|||
13340132|NCT01020123|26622541|FG002|Extention Period|Adverse Event|0|||
13340133|NCT01020123|26622542|FG003|Extention Period|Adverse Event|1|||
13340134|NCT01020123|26622543|FG004|Extention Period|Adverse Event|0|||
13340135|NCT01020123|26622544|FG005|Extention Period|Adverse Event|0|||
13340136|NCT01020123|26622545|FG006|Extention Period|Adverse Event|0|||
13340137|NCT01020123|26622539|FG000|Extention Period|Protocol Violation|1|||
13340138|NCT01020123|26622540|FG001|Extention Period|Protocol Violation|1|||
13340139|NCT01020123|26622541|FG002|Extention Period|Protocol Violation|1|||
13340140|NCT01020123|26622542|FG003|Extention Period|Protocol Violation|0|||
13340141|NCT01020123|26622543|FG004|Extention Period|Protocol Violation|0|||
13340142|NCT01020123|26622544|FG005|Extention Period|Protocol Violation|0|||
13340143|NCT01020123|26622545|FG006|Extention Period|Protocol Violation|1|||
13340144|NCT01020123|26622539|FG000|Extention Period|Lost to Follow-up|0|||
13340145|NCT01020123|26622540|FG001|Extention Period|Lost to Follow-up|0|||
13340146|NCT01020123|26622541|FG002|Extention Period|Lost to Follow-up|0|||
13340147|NCT01020123|26622542|FG003|Extention Period|Lost to Follow-up|0|||
13340148|NCT01020123|26622543|FG004|Extention Period|Lost to Follow-up|0|||
13340149|NCT01020123|26622544|FG005|Extention Period|Lost to Follow-up|2|||
13340150|NCT01020123|26622545|FG006|Extention Period|Lost to Follow-up|0|||
13340151|NCT01020019|26622558|FG000|Overall Study|Lost to Follow-up|21|||
13340152|NCT01020019|26622559|FG001|Overall Study|Lost to Follow-up|18|||
13340153|NCT01020019|26622558|FG000|Overall Study|Adverse Event|1|||
13340154|NCT01020019|26622559|FG001|Overall Study|Adverse Event|5|||
13340155|NCT01020019|26622558|FG000|Overall Study|not interested in treatment|4|||
13340156|NCT01020019|26622559|FG001|Overall Study|not interested in treatment|4|||
13340157|NCT01020019|26622558|FG000|Overall Study|moving|0|||
13340158|NCT01020019|26622559|FG001|Overall Study|moving|2|||
13340159|NCT01019980|26622572|FG000|Overall Study|Drug not available.|2|||
13340160|NCT01019980|26622573|FG001|Overall Study|Drug not available.|0|||
13340161|NCT01019694|26622705|FG000|Overall Study|Adverse Event|12|||
13340162|NCT01019694|26622706|FG001|Overall Study|Adverse Event|16|||
13340163|NCT01019694|26622707|FG002|Overall Study|Adverse Event|19|||
13340164|NCT01019694|26622705|FG000|Overall Study|Protocol Violation|2|||
13340165|NCT01019694|26622706|FG001|Overall Study|Protocol Violation|6|||
13340166|NCT01019694|26622707|FG002|Overall Study|Protocol Violation|4|||
13340167|NCT01019694|26622705|FG000|Overall Study|Lost to Follow-up|5|||
13340168|NCT01019694|26622706|FG001|Overall Study|Lost to Follow-up|3|||
13340169|NCT01019694|26622707|FG002|Overall Study|Lost to Follow-up|3|||
13340170|NCT01019694|26622705|FG000|Overall Study|Withdrawal by Subject|4|||
13340171|NCT01019694|26622706|FG001|Overall Study|Withdrawal by Subject|6|||
13340172|NCT01019694|26622707|FG002|Overall Study|Withdrawal by Subject|12|||
13340173|NCT01019694|26622705|FG000|Overall Study|Not treated|0|||
13340174|NCT01019694|26622706|FG001|Overall Study|Not treated|2|||
13340175|NCT01019694|26622707|FG002|Overall Study|Not treated|3|||
13340176|NCT01019694|26622705|FG000|Overall Study|Other reason (not specified)|1|||
13340177|NCT01019694|26622706|FG001|Overall Study|Other reason (not specified)|5|||
13340178|NCT01019694|26622707|FG002|Overall Study|Other reason (not specified)|6|||
13340179|NCT01019486|26622729|FG000|Overall Study|Withdrawal by Subject|1|||
13340180|NCT01019486|26622730|FG001|Overall Study|Withdrawal by Subject|1|||
13340181|NCT01019486|26622731|FG002|Overall Study|Withdrawal by Subject|1|||
13340182|NCT01019369|26622754|FG000|Overall Study|Lost to Follow-up|10|||
13340183|NCT01019369|26622755|FG001|Overall Study|Lost to Follow-up|6|||
13340184|NCT01019369|26622754|FG000|Overall Study|Withdrawal by Subject|0|||
13340185|NCT01019369|26622755|FG001|Overall Study|Withdrawal by Subject|1|||
13340186|NCT01019317|26622761|FG000|Overall Study|Not Eligible|4|||
13373975|NCT00798434|26725435|FG001|Open-Label|Lack of Efficacy|11|||
13373976|NCT00798434|26725434|FG000|Open-Label|Withdrawal by Subject|2|||
13373977|NCT00798434|26725435|FG001|Open-Label|Withdrawal by Subject|7|||
13373978|NCT00798434|26725434|FG000|Open-Label|Protocol Violation|1|||
13373979|NCT00798434|26725435|FG001|Open-Label|Protocol Violation|0|||
13373980|NCT00798434|26725434|FG000|Open-Label|Other|1|||
13373981|NCT00798434|26725435|FG001|Open-Label|Other|2|||
13373982|NCT00798434|26725434|FG000|Open-Label|Not Treated|0|||
13373983|NCT00798434|26725435|FG001|Open-Label|Not Treated|1|||
13373984|NCT00798369|26725499|FG000|Overall Study|Subject withdrew consent|0|||
13373985|NCT00798369|26725500|FG001|Overall Study|Subject withdrew consent|0|||
13373986|NCT00798369|26725501|FG002|Overall Study|Subject withdrew consent|1|||
13373987|NCT00798369|26725502|FG003|Overall Study|Subject withdrew consent|1|||
13373988|NCT00798369|26725503|FG004|Overall Study|Subject withdrew consent|0|||
13373989|NCT00798369|26725504|FG005|Overall Study|Subject withdrew consent|2|||
13373990|NCT00798369|26725499|FG000|Overall Study|Lost to Follow-up|1|||
13373991|NCT00798369|26725500|FG001|Overall Study|Lost to Follow-up|1|||
13373992|NCT00798369|26725501|FG002|Overall Study|Lost to Follow-up|1|||
13373993|NCT00798369|26725502|FG003|Overall Study|Lost to Follow-up|0|||
13373994|NCT00798369|26725503|FG004|Overall Study|Lost to Follow-up|1|||
13373995|NCT00798369|26725504|FG005|Overall Study|Lost to Follow-up|0|||
13373996|NCT00798369|26725499|FG000|Overall Study|Adminstrative problems|0|||
13340187|NCT01019252|26622778|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2|||
13340188|NCT01019252|26622779|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0|||
13340189|NCT01019252|26622778|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1|||
13340190|NCT01019252|26622779|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0|||
13340191|NCT01019252|26622778|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0|||
13340192|NCT01019252|26622779|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2|||
13340193|NCT01019252|26622778|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0|||
13340194|NCT01019252|26622779|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5|||
13340195|NCT01019135|26622815|FG000|Overall Study|Did not receive allocated intervention|12|||
13340196|NCT01019135|26622816|FG001|Overall Study|Did not receive allocated intervention|6|||
13340197|NCT01019135|26622817|FG002|Overall Study|Did not receive allocated intervention|25|||
13340198|NCT01019135|26622815|FG000|Overall Study|Did not attend CR|8|||
13340199|NCT01019135|26622816|FG001|Overall Study|Did not attend CR|13|||
13340200|NCT01019135|26622817|FG002|Overall Study|Did not attend CR|6|||
13340201|NCT01018992|26622836|FG000|Overall Study|Adverse Event|8|||
13340202|NCT01018992|26622837|FG001|Overall Study|Adverse Event|3|||
13340203|NCT01018992|26622836|FG000|Overall Study|Withdrawal by Subject|3|||
13340204|NCT01018992|26622837|FG001|Overall Study|Withdrawal by Subject|8|||
13340205|NCT01018992|26622836|FG000|Overall Study|Protocol Violation|0|||
13340206|NCT01018992|26622837|FG001|Overall Study|Protocol Violation|4|||
13340207|NCT01018992|26622836|FG000|Overall Study|Lost to Follow-up|5|||
13340208|NCT01018992|26622837|FG001|Overall Study|Lost to Follow-up|1|||
13340209|NCT01018979|26622874|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3|||
13340210|NCT01018979|26622875|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9|||
13340211|NCT01018979|26622874|FG000|Overall Study|Not received at least one dose|0|||
13340212|NCT01018979|26622875|FG001|Overall Study|Not received at least one dose|1|||
13340213|NCT01018953|26622887|FG000|Overall Study|Adverse Event|2|||
13340214|NCT01018953|26622887|FG000|Overall Study|Withdrawal by Subject|1|||
13340215|NCT01018953|26622887|FG000|Overall Study|Study termination by sponsor|5|||
13340216|NCT01018862|26622914|FG000|Overall Study|Adverse Event|2|||
13340217|NCT01018862|26622915|FG001|Overall Study|Adverse Event|0|||
13340218|NCT01018862|26622916|FG002|Overall Study|Adverse Event|6|||
13340219|NCT01018862|26622914|FG000|Overall Study|Lack of Efficacy|1|||
13340220|NCT01018862|26622915|FG001|Overall Study|Lack of Efficacy|0|||
13340221|NCT01018862|26622916|FG002|Overall Study|Lack of Efficacy|2|||
13340222|NCT01018862|26622914|FG000|Overall Study|Lost to Follow-up|3|||
13340223|NCT01018862|26622915|FG001|Overall Study|Lost to Follow-up|1|||
13340224|NCT01018862|26622916|FG002|Overall Study|Lost to Follow-up|0|||
13340225|NCT01018862|26622914|FG000|Overall Study|Protocol Violation|1|||
13340226|NCT01018862|26622915|FG001|Overall Study|Protocol Violation|3|||
13340227|NCT01018862|26622916|FG002|Overall Study|Protocol Violation|3|||
13340228|NCT01018862|26622914|FG000|Overall Study|Withdrawal by Subject|1|||
13340229|NCT01018862|26622915|FG001|Overall Study|Withdrawal by Subject|2|||
13340230|NCT01018862|26622916|FG002|Overall Study|Withdrawal by Subject|1|||
13340231|NCT01018862|26622914|FG000|Overall Study|administrative problems|5|||
13340232|NCT01018862|26622915|FG001|Overall Study|administrative problems|4|||
13340233|NCT01018862|26622916|FG002|Overall Study|administrative problems|4|||
13340234|NCT01018810|26622989|FG000|Overall Study|Withdrawal by Subject|0|||
13340235|NCT01018810|26622990|FG001|Overall Study|Withdrawal by Subject|1|||
13340236|NCT01018810|26622991|FG002|Overall Study|Withdrawal by Subject|0|||
13340237|NCT01018810|26622992|FG003|Overall Study|Withdrawal by Subject|0|||
13340238|NCT01018810|26622993|FG004|Overall Study|Withdrawal by Subject|0|||
13340239|NCT01018810|26622989|FG000|Overall Study|Sponsor Decision|2|||
13340240|NCT01018810|26622990|FG001|Overall Study|Sponsor Decision|0|||
13340241|NCT01018810|26622991|FG002|Overall Study|Sponsor Decision|1|||
13340242|NCT01018810|26622992|FG003|Overall Study|Sponsor Decision|1|||
13340243|NCT01018810|26622993|FG004|Overall Study|Sponsor Decision|1|||
13340244|NCT01018732|26623035|FG000|Overall Study|Lost to Follow-up|0|||
13340245|NCT01018732|26623036|FG001|Overall Study|Lost to Follow-up|0|||
13340246|NCT01018732|26623037|FG002|Overall Study|Lost to Follow-up|3|||
13340247|NCT01018732|26623035|FG000|Overall Study|Protocol Violation|1|||
13340248|NCT01018732|26623036|FG001|Overall Study|Protocol Violation|1|||
13340249|NCT01018732|26623037|FG002|Overall Study|Protocol Violation|0|||
13340250|NCT01018732|26623035|FG000|Overall Study|Inappropriate Enrollment|0|||
13340251|NCT01018732|26623036|FG001|Overall Study|Inappropriate Enrollment|1|||
13340252|NCT01018732|26623037|FG002|Overall Study|Inappropriate Enrollment|0|||
13340253|NCT01018732|26623035|FG000|Overall Study|Unable to Classify|0|||
13340254|NCT01018732|26623036|FG001|Overall Study|Unable to Classify|0|||
13340255|NCT01018732|26623037|FG002|Overall Study|Unable to Classify|1|||
13340256|NCT01018680|26623084|FG000|Overall Study|Adverse Event|23|||
13340257|NCT01018680|26623085|FG001|Overall Study|Adverse Event|40|||
13340258|NCT01018680|26623084|FG000|Overall Study|Withdrawal by Subject|10|||
13340259|NCT01018680|26623085|FG001|Overall Study|Withdrawal by Subject|10|||
13340260|NCT01018680|26623084|FG000|Overall Study|Protocol Violation|5|||
13340261|NCT01018680|26623085|FG001|Overall Study|Protocol Violation|8|||
13340262|NCT01018680|26623084|FG000|Overall Study|Sponsor Decision|6|||
13340263|NCT01018680|26623085|FG001|Overall Study|Sponsor Decision|7|||
13340264|NCT01018680|26623084|FG000|Overall Study|Lack of Efficacy|8|||
13340265|NCT01018680|26623085|FG001|Overall Study|Lack of Efficacy|2|||
13340266|NCT01018680|26623084|FG000|Overall Study|Lost to Follow-up|5|||
13340267|NCT01018680|26623085|FG001|Overall Study|Lost to Follow-up|3|||
13340268|NCT01018680|26623084|FG000|Overall Study|Entry Criteria Not Met|1|||
13340269|NCT01018680|26623085|FG001|Overall Study|Entry Criteria Not Met|4|||
13340270|NCT01018680|26623084|FG000|Overall Study|Physician Decision|3|||
13340271|NCT01018680|26623085|FG001|Overall Study|Physician Decision|1|||
13340272|NCT01018511|26623265|FG000|Overall Study|Not fulfilling eligibility criteria|6|||
13340273|NCT01018511|26623266|FG001|Overall Study|Not fulfilling eligibility criteria|7|||
13340274|NCT01018511|26623267|FG002|Overall Study|Not fulfilling eligibility criteria|7|||
13340275|NCT01018511|26623268|FG003|Overall Study|Not fulfilling eligibility criteria|3|||
13340276|NCT01018511|26623265|FG000|Overall Study|Adverse Event|5|||
13340277|NCT01018511|26623266|FG001|Overall Study|Adverse Event|9|||
13340278|NCT01018511|26623267|FG002|Overall Study|Adverse Event|13|||
13340279|NCT01018511|26623268|FG003|Overall Study|Adverse Event|10|||
13340280|NCT01018511|26623265|FG000|Overall Study|Lack of Efficacy|4|||
13340281|NCT01018511|26623266|FG001|Overall Study|Lack of Efficacy|1|||
13340282|NCT01018511|26623267|FG002|Overall Study|Lack of Efficacy|1|||
13340283|NCT01018511|26623268|FG003|Overall Study|Lack of Efficacy|2|||
13340284|NCT01018511|26623265|FG000|Overall Study|Withdrawal by Subject|6|||
13340285|NCT01018511|26623266|FG001|Overall Study|Withdrawal by Subject|5|||
13340286|NCT01018511|26623267|FG002|Overall Study|Withdrawal by Subject|11|||
13340287|NCT01018511|26623268|FG003|Overall Study|Withdrawal by Subject|9|||
13340288|NCT01018511|26623265|FG000|Overall Study|Lost to Follow-up|0|||
13340289|NCT01018511|26623266|FG001|Overall Study|Lost to Follow-up|0|||
13340290|NCT01018511|26623267|FG002|Overall Study|Lost to Follow-up|1|||
13340291|NCT01018511|26623268|FG003|Overall Study|Lost to Follow-up|0|||
13340292|NCT01018511|26623265|FG000|Overall Study|Protocol Violation|5|||
13340293|NCT01018511|26623266|FG001|Overall Study|Protocol Violation|8|||
13340294|NCT01018511|26623267|FG002|Overall Study|Protocol Violation|7|||
13340295|NCT01018511|26623268|FG003|Overall Study|Protocol Violation|9|||
13340296|NCT01018511|26623265|FG000|Overall Study|Miscellaneous|0|||
13340297|NCT01018511|26623266|FG001|Overall Study|Miscellaneous|2|||
13340298|NCT01018511|26623267|FG002|Overall Study|Miscellaneous|0|||
13340299|NCT01018511|26623268|FG003|Overall Study|Miscellaneous|0|||
13340300|NCT01018394|26623283|FG000|Overall Study|Withdrawal by Subject|5|||
13340301|NCT01018394|26623284|FG001|Overall Study|Withdrawal by Subject|5|||
13340302|NCT01018394|26623283|FG000|Overall Study|Lost to Follow-up|4|||
13340303|NCT01018394|26623284|FG001|Overall Study|Lost to Follow-up|3|||
13340304|NCT01018264|26623305|FG000|Overall Study|Withdrawal by Subject|1|||
13340305|NCT01018264|26623306|FG001|Overall Study|Withdrawal by Subject|0|||
13340306|NCT01018264|26623305|FG000|Overall Study|Lost to Follow-up|0|||
13340307|NCT01018264|26623306|FG001|Overall Study|Lost to Follow-up|1|||
13340308|NCT01018186|26623403|FG000|2-week Run-in Period|Protocol Violation|1|||
13340309|NCT01018186|26623404|FG001|2-week Run-in Period|Protocol Violation|0|||
13340310|NCT01018186|26623405|FG002|2-week Run-in Period|Protocol Violation|0|||
13340311|NCT01018186|26623406|FG003|2-week Run-in Period|Protocol Violation|0|||
13340312|NCT01018186|26623403|FG000|2-week Run-in Period|Lost to Follow-up|2|||
13340313|NCT01018186|26623404|FG001|2-week Run-in Period|Lost to Follow-up|0|||
13340314|NCT01018186|26623405|FG002|2-week Run-in Period|Lost to Follow-up|0|||
13340315|NCT01018186|26623406|FG003|2-week Run-in Period|Lost to Follow-up|0|||
13340316|NCT01018186|26623403|FG000|2-week Run-in Period|Physician Decision|3|||
13340317|NCT01018186|26623404|FG001|2-week Run-in Period|Physician Decision|0|||
13340318|NCT01018186|26623405|FG002|2-week Run-in Period|Physician Decision|0|||
13340319|NCT01018186|26623406|FG003|2-week Run-in Period|Physician Decision|0|||
13340320|NCT01018186|26623403|FG000|2-week Run-in Period|Withdrawal by Subject|11|||
13340321|NCT01018186|26623404|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
13340322|NCT01018186|26623405|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
13340323|NCT01018186|26623406|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
13340324|NCT01018186|26623403|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97|||
13340325|NCT01018186|26623404|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
13340326|NCT01018186|26623405|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
13340327|NCT01018186|26623406|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
13340328|NCT01018186|26623403|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
13340329|NCT01018186|26623404|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
13340330|NCT01018186|26623405|FG002|52-week Double-blind Treatment Period|Adverse Event|3|||
13340331|NCT01018186|26623406|FG003|52-week Double-blind Treatment Period|Adverse Event|6|||
13340332|NCT01018186|26623403|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
13340333|NCT01018186|26623404|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
13340334|NCT01018186|26623405|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4|||
13340335|NCT01018186|26623406|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
13340336|NCT01018186|26623403|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
13393625|NCT00662909|26784485|FG000|Overall Study|Non-compliance with study procedures|3|||
13340337|NCT01018186|26623404|FG001|52-week Double-blind Treatment Period|Protocol Violation|8|||
13340338|NCT01018186|26623405|FG002|52-week Double-blind Treatment Period|Protocol Violation|8|||
13340339|NCT01018186|26623406|FG003|52-week Double-blind Treatment Period|Protocol Violation|2|||
13340340|NCT01018186|26623403|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
13340341|NCT01018186|26623404|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14|||
13340342|NCT01018186|26623405|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16|||
13340343|NCT01018186|26623406|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
13340344|NCT01018186|26623403|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
13340345|NCT01018186|26623404|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1|||
13340346|NCT01018186|26623405|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3|||
13340347|NCT01018186|26623406|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4|||
13340348|NCT01018186|26623403|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
13340349|NCT01018186|26623404|FG001|52-week Double-blind Treatment Period|Physician Decision|1|||
13340350|NCT01018186|26623405|FG002|52-week Double-blind Treatment Period|Physician Decision|0|||
13340351|NCT01018186|26623406|FG003|52-week Double-blind Treatment Period|Physician Decision|3|||
13340352|NCT01018186|26623403|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
13340353|NCT01018186|26623404|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10|||
13340354|NCT01018186|26623405|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7|||
13340355|NCT01018186|26623406|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9|||
13340356|NCT01018030|26623463|FG000|Overall Study|Adverse Event|10|||
13340357|NCT01018030|26623464|FG001|Overall Study|Adverse Event|5|||
13340358|NCT01018030|26623465|FG002|Overall Study|Adverse Event|5|||
13340359|NCT01018030|26623463|FG000|Overall Study|Withdrawal by Subject|2|||
13340360|NCT01018030|26623464|FG001|Overall Study|Withdrawal by Subject|2|||
13340361|NCT01018030|26623465|FG002|Overall Study|Withdrawal by Subject|4|||
13340362|NCT01018030|26623463|FG000|Overall Study|Lost to Follow-up|2|||
13340363|NCT01018030|26623464|FG001|Overall Study|Lost to Follow-up|0|||
13340364|NCT01018030|26623465|FG002|Overall Study|Lost to Follow-up|3|||
13340365|NCT01018030|26623463|FG000|Overall Study|Protocol Violation|2|||
13340366|NCT01018030|26623464|FG001|Overall Study|Protocol Violation|1|||
13340367|NCT01018030|26623465|FG002|Overall Study|Protocol Violation|0|||
13340368|NCT01018030|26623463|FG000|Overall Study|Physician Decision|1|||
13340369|NCT01018030|26623464|FG001|Overall Study|Physician Decision|0|||
13340370|NCT01018030|26623465|FG002|Overall Study|Physician Decision|1|||
13340371|NCT01018030|26623463|FG000|Overall Study|Lack of Efficacy|1|||
13340372|NCT01018030|26623464|FG001|Overall Study|Lack of Efficacy|0|||
13340373|NCT01018030|26623465|FG002|Overall Study|Lack of Efficacy|0|||
13340374|NCT01018030|26623463|FG000|Overall Study|Did Not Receive Study Drug|1|||
13340375|NCT01018030|26623464|FG001|Overall Study|Did Not Receive Study Drug|3|||
13340376|NCT01018030|26623465|FG002|Overall Study|Did Not Receive Study Drug|0|||
13340377|NCT01017952|26623501|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356|||
13340378|NCT01017952|26623502|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
13340379|NCT01017952|26623503|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
13340380|NCT01017952|26623504|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
13340381|NCT01017952|26623505|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
13340382|NCT01017952|26623501|FG000|4-week, Open-label Run-In Period|Adverse Event|23|||
13340383|NCT01017952|26623502|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
13340384|NCT01017952|26623503|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
13340385|NCT01017952|26623504|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
13340386|NCT01017952|26623505|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
13340387|NCT01017952|26623501|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1|||
13340388|NCT01017952|26623502|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
13340389|NCT01017952|26623503|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
13340390|NCT01017952|26623504|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
13340391|NCT01017952|26623505|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
13340392|NCT01017952|26623501|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
13340393|NCT01017952|26623502|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
13340394|NCT01017952|26623503|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
13340395|NCT01017952|26623504|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
13340396|NCT01017952|26623505|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
13340397|NCT01017952|26623501|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
13340398|NCT01017952|26623502|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
13340399|NCT01017952|26623503|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
13340400|NCT01017952|26623504|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
13340401|NCT01017952|26623505|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
13340402|NCT01017952|26623501|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63|||
13340403|NCT01017952|26623502|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
13340404|NCT01017952|26623503|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
13340405|NCT01017952|26623504|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
13340406|NCT01017952|26623505|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
13340407|NCT01017952|26623501|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
13340408|NCT01017952|26623502|FG001|52-week, Double-blind Treatment Period|Adverse Event|25|||
13340409|NCT01017952|26623503|FG002|52-week, Double-blind Treatment Period|Adverse Event|32|||
13340410|NCT01017952|26623504|FG003|52-week, Double-blind Treatment Period|Adverse Event|35|||
13340411|NCT01017952|26623505|FG004|52-week, Double-blind Treatment Period|Adverse Event|30|||
13340412|NCT01017952|26623501|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
13340413|NCT01017952|26623502|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30|||
13340414|NCT01017952|26623503|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
13340415|NCT01017952|26623504|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
13340416|NCT01017952|26623505|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
13340417|NCT01017952|26623501|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
13340418|NCT01017952|26623502|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35|||
13340419|NCT01017952|26623503|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
13340420|NCT01017952|26623504|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
13340421|NCT01017952|26623505|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
13340422|NCT01017952|26623501|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
13340423|NCT01017952|26623502|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7|||
13340424|NCT01017952|26623503|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11|||
13340425|NCT01017952|26623504|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9|||
13340426|NCT01017952|26623505|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8|||
13340427|NCT01017952|26623501|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
13340428|NCT01017952|26623502|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
13340429|NCT01017952|26623503|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
13340430|NCT01017952|26623504|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12|||
13340431|NCT01017952|26623505|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
13340432|NCT01017952|26623501|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
13340433|NCT01017952|26623502|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
13340434|NCT01017952|26623503|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
13340435|NCT01017952|26623504|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
13340436|NCT01017952|26623505|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
13340437|NCT01017952|26623501|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
13340438|NCT01017952|26623502|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
13340439|NCT01017952|26623503|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8|||
13340440|NCT01017952|26623504|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
13340441|NCT01017952|26623505|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10|||
13340442|NCT01017952|26623501|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
13340443|NCT01017952|26623502|FG001|52-week, Double-blind Treatment Period|Physician Decision|10|||
13340444|NCT01017952|26623503|FG002|52-week, Double-blind Treatment Period|Physician Decision|8|||
13340445|NCT01017952|26623504|FG003|52-week, Double-blind Treatment Period|Physician Decision|9|||
13340446|NCT01017952|26623505|FG004|52-week, Double-blind Treatment Period|Physician Decision|7|||
13340447|NCT01017874|26623530|FG000|Overall Study|Withdrawal by Subject|23|||
13340448|NCT01017874|26623531|FG001|Overall Study|Withdrawal by Subject|20|||
13340449|NCT01017874|26623530|FG000|Overall Study|Sponsor decision|3|||
13340450|NCT01017874|26623531|FG001|Overall Study|Sponsor decision|1|||
13340451|NCT01017874|26623530|FG000|Overall Study|Lost to Follow-up|3|||
13340452|NCT01017874|26623531|FG001|Overall Study|Lost to Follow-up|2|||
13340453|NCT01017874|26623530|FG000|Overall Study|Physician Decision|1|||
13340454|NCT01017874|26623531|FG001|Overall Study|Physician Decision|3|||
13340455|NCT01017731|26623550|FG000|Overall Study|Lost to Follow-up|2|||
13340456|NCT01017731|26623550|FG000|Overall Study|Withdrawal by Subject|3|||
13340457|NCT01017731|26623550|FG000|Overall Study|Physician Decision|2|||
13340458|NCT01017731|26623550|FG000|Overall Study|Adverse Event|1|||
13340459|NCT01017601|26623579|FG000|Overall Study|Disease Progression|12|||
13340460|NCT01017601|26623580|FG001|Overall Study|Disease Progression|12|||
13340461|NCT01017601|26623579|FG000|Overall Study|Withdrawal by Subject|0|||
13340462|NCT01017601|26623580|FG001|Overall Study|Withdrawal by Subject|1|||
13340463|NCT01017575|26623633|FG000|Overall Study|Lack of Efficacy|0|||
13340464|NCT01017575|26623634|FG001|Overall Study|Lack of Efficacy|1|||
13340465|NCT01017575|26623635|FG002|Overall Study|Lack of Efficacy|0|||
13340466|NCT01017575|26623636|FG003|Overall Study|Lack of Efficacy|1|||
13340467|NCT01017575|26623637|FG004|Overall Study|Lack of Efficacy|1|||
13340468|NCT01017575|26623633|FG000|Overall Study|Adverse Event|0|||
13340469|NCT01017575|26623634|FG001|Overall Study|Adverse Event|1|||
13340470|NCT01017575|26623635|FG002|Overall Study|Adverse Event|0|||
13340471|NCT01017575|26623636|FG003|Overall Study|Adverse Event|0|||
13340472|NCT01017575|26623637|FG004|Overall Study|Adverse Event|2|||
13340473|NCT01017575|26623633|FG000|Overall Study|Withdrawal by Subject|1|||
13340474|NCT01017575|26623634|FG001|Overall Study|Withdrawal by Subject|0|||
13340475|NCT01017575|26623635|FG002|Overall Study|Withdrawal by Subject|0|||
13340476|NCT01017575|26623636|FG003|Overall Study|Withdrawal by Subject|0|||
13340477|NCT01017575|26623637|FG004|Overall Study|Withdrawal by Subject|0|||
13340478|NCT01017549|26623644|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1|||
13340479|NCT01017549|26623644|FG000|One-year Follow-up|Lost to Follow-up|2|||
13340480|NCT01017549|26623644|FG000|One-year Follow-up|Withdrawal by Subject|5|||
13340481|NCT01017549|26623644|FG000|5 Year Follow-up|Lost to Follow-up|9|||
13340482|NCT01017549|26623644|FG000|5 Year Follow-up|Mastectomy|3|||
13340483|NCT01017263|26623650|FG000|Overall Study|not eligible|12|||
13340484|NCT01017146|26623693|FG000|Overall Study|Adverse Event|11|||
13340485|NCT01017146|26623694|FG001|Overall Study|Adverse Event|1|||
13340486|NCT01017146|26623693|FG000|Overall Study|Lost to Follow-up|14|||
13340487|NCT01017146|26623694|FG001|Overall Study|Lost to Follow-up|14|||
13340488|NCT01017146|26623693|FG000|Overall Study|Noncompliance with Study Product|1|||
13340489|NCT01017146|26623694|FG001|Overall Study|Noncompliance with Study Product|1|||
13340490|NCT01017146|26623693|FG000|Overall Study|Withdrawal by Subject|32|||
13340491|NCT01017146|26623694|FG001|Overall Study|Withdrawal by Subject|16|||
13340492|NCT01017146|26623693|FG000|Overall Study|Relocation|0|||
13340493|NCT01017146|26623694|FG001|Overall Study|Relocation|4|||
13340494|NCT01017146|26623693|FG000|Overall Study|Pregnancy|2|||
13340495|NCT01017146|26623694|FG001|Overall Study|Pregnancy|1|||
13340496|NCT01017146|26623693|FG000|Overall Study|Protocol Violation|2|||
13340497|NCT01017146|26623694|FG001|Overall Study|Protocol Violation|0|||
13340498|NCT01017146|26623693|FG000|Overall Study|Took Excluded Medication|2|||
13340499|NCT01017146|26623694|FG001|Overall Study|Took Excluded Medication|0|||
13340500|NCT01017146|26623693|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
13340501|NCT01017146|26623694|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
13340502|NCT01017146|26623693|FG000|Overall Study|Change in Work Situation|1|||
13340503|NCT01017146|26623694|FG001|Overall Study|Change in Work Situation|0|||
13340504|NCT01017120|26623749|FG000|Overall Study|Adverse Event|9|||
13340505|NCT01017120|26623750|FG001|Overall Study|Adverse Event|0|||
13340506|NCT01017120|26623749|FG000|Overall Study|Lost to Follow-up|13|||
13340507|NCT01017120|26623750|FG001|Overall Study|Lost to Follow-up|11|||
13340508|NCT01017120|26623749|FG000|Overall Study|Lack of Efficacy|1|||
13340509|NCT01017120|26623750|FG001|Overall Study|Lack of Efficacy|0|||
13340510|NCT01017120|26623749|FG000|Overall Study|Withdrawal by Subject|39|||
13340511|NCT01017120|26623750|FG001|Overall Study|Withdrawal by Subject|21|||
13340512|NCT01017120|26623749|FG000|Overall Study|Pregnancy|1|||
13340513|NCT01017120|26623750|FG001|Overall Study|Pregnancy|1|||
13340514|NCT01017120|26623749|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
13340515|NCT01017120|26623750|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
13340516|NCT01017120|26623749|FG000|Overall Study|Relocated Out of Town|0|||
13340517|NCT01017120|26623750|FG001|Overall Study|Relocated Out of Town|2|||
13340518|NCT01017120|26623749|FG000|Overall Study|Protocol Violation|1|||
13340519|NCT01017120|26623750|FG001|Overall Study|Protocol Violation|0|||
13340520|NCT01017120|26623749|FG000|Overall Study|Parent Unable to Provide Transportation|1|||
13340521|NCT01017120|26623750|FG001|Overall Study|Parent Unable to Provide Transportation|0|||
13340522|NCT01017029|26623773|FG000|Overall Study|Lost to Follow-up|1|||
13340523|NCT01017029|26623774|FG001|Overall Study|Lost to Follow-up|0|||
13340524|NCT01017029|26623773|FG000|Overall Study|Administrative problem|0|||
13340525|NCT01017029|26623774|FG001|Overall Study|Administrative problem|1|||
13340526|NCT01017029|26623773|FG000|Overall Study|Death|3|||
13340527|NCT01017029|26623774|FG001|Overall Study|Death|1|||
13340528|NCT01016977|26623815|FG000|Overall Study|Lost to Follow-up|1|||
13340529|NCT01016977|26623816|FG001|Overall Study|Lost to Follow-up|0|||
13340530|NCT01016977|26623815|FG000|Overall Study|Withdrawal by Subject|2|||
13340531|NCT01016977|26623816|FG001|Overall Study|Withdrawal by Subject|2|||
13340532|NCT01016964|26623829|FG000|Overall Study|Lost to Follow-up|3|||
13340533|NCT01016964|26623830|FG001|Overall Study|Lost to Follow-up|3|||
13340534|NCT01016912|26623888|FG000|End of Treatment Period|Lack of Efficacy|0|||
13340535|NCT01016912|26623889|FG001|End of Treatment Period|Lack of Efficacy|1|||
13340536|NCT01016912|26623890|FG002|End of Treatment Period|Lack of Efficacy|0|||
13340537|NCT01016912|26623891|FG003|End of Treatment Period|Lack of Efficacy|4|||
13340538|NCT01016912|26623892|FG004|End of Treatment Period|Lack of Efficacy|4|||
13340539|NCT01016912|26623888|FG000|End of Treatment Period|Adverse Event|0|||
13340540|NCT01016912|26623889|FG001|End of Treatment Period|Adverse Event|1|||
13340541|NCT01016912|26623890|FG002|End of Treatment Period|Adverse Event|1|||
13340542|NCT01016912|26623891|FG003|End of Treatment Period|Adverse Event|0|||
13340543|NCT01016912|26623892|FG004|End of Treatment Period|Adverse Event|0|||
13340544|NCT01016912|26623888|FG000|End of Treatment Period|Completed double-blind period only|0|||
13340545|NCT01016912|26623889|FG001|End of Treatment Period|Completed double-blind period only|1|||
13340546|NCT01016912|26623890|FG002|End of Treatment Period|Completed double-blind period only|0|||
13340547|NCT01016912|26623891|FG003|End of Treatment Period|Completed double-blind period only|0|||
13340548|NCT01016912|26623892|FG004|End of Treatment Period|Completed double-blind period only|0|||
13340549|NCT01016912|26623888|FG000|Follow-up Period|Other reason|0|||
13340550|NCT01016912|26623889|FG001|Follow-up Period|Other reason|0|||
13340551|NCT01016912|26623890|FG002|Follow-up Period|Other reason|1|||
13340552|NCT01016912|26623891|FG003|Follow-up Period|Other reason|1|||
13340553|NCT01016912|26623892|FG004|Follow-up Period|Other reason|0|||
13340554|NCT01016600|26623968|FG000|Overall Study|Did not start treatment|1|||
13340555|NCT01016600|26623969|FG001|Overall Study|Did not start treatment|0|||
13340556|NCT01016600|26623970|FG002|Overall Study|Did not start treatment|0|||
13340557|NCT01016600|26623971|FG003|Overall Study|Did not start treatment|0|||
13340558|NCT01016262|26624007|FG000|Double-blind Phase|Adverse Event|0|||
13340559|NCT01016262|26624008|FG001|Double-blind Phase|Adverse Event|0|||
13340560|NCT01016262|26624009|FG002|Double-blind Phase|Adverse Event|1|||
13340561|NCT01016262|26624010|FG003|Double-blind Phase|Adverse Event|0|||
13340562|NCT01016262|26624011|FG004|Double-blind Phase|Adverse Event|0|||
13340563|NCT01016262|26624012|FG005|Double-blind Phase|Adverse Event|0|||
13340564|NCT01016262|26624007|FG000|Double-blind Phase|Lack of Efficacy|1|||
13340565|NCT01016262|26624008|FG001|Double-blind Phase|Lack of Efficacy|0|||
13340566|NCT01016262|26624009|FG002|Double-blind Phase|Lack of Efficacy|5|||
13340567|NCT01016262|26624010|FG003|Double-blind Phase|Lack of Efficacy|0|||
13340568|NCT01016262|26624011|FG004|Double-blind Phase|Lack of Efficacy|0|||
13340569|NCT01016262|26624012|FG005|Double-blind Phase|Lack of Efficacy|0|||
13340570|NCT01016262|26624007|FG000|Double-blind Phase|Disease Progression|0|||
13340571|NCT01016262|26624008|FG001|Double-blind Phase|Disease Progression|1|||
13340572|NCT01016262|26624009|FG002|Double-blind Phase|Disease Progression|2|||
13340573|NCT01016262|26624010|FG003|Double-blind Phase|Disease Progression|0|||
13340574|NCT01016262|26624011|FG004|Double-blind Phase|Disease Progression|0|||
13340575|NCT01016262|26624012|FG005|Double-blind Phase|Disease Progression|0|||
13340576|NCT01016262|26624007|FG000|Double-blind Phase|Withdrawal of Informed Consent|0|||
13340577|NCT01016262|26624008|FG001|Double-blind Phase|Withdrawal of Informed Consent|0|||
13340578|NCT01016262|26624009|FG002|Double-blind Phase|Withdrawal of Informed Consent|1|||
13340579|NCT01016262|26624010|FG003|Double-blind Phase|Withdrawal of Informed Consent|0|||
13340580|NCT01016262|26624011|FG004|Double-blind Phase|Withdrawal of Informed Consent|0|||
13340581|NCT01016262|26624012|FG005|Double-blind Phase|Withdrawal of Informed Consent|0|||
13340582|NCT01016262|26624007|FG000|Open-Label Phase|Adverse Event|0|||
13340583|NCT01016262|26624008|FG001|Open-Label Phase|Adverse Event|0|||
13340584|NCT01016262|26624009|FG002|Open-Label Phase|Adverse Event|0|||
13340585|NCT01016262|26624010|FG003|Open-Label Phase|Adverse Event|1|||
13340586|NCT01016262|26624011|FG004|Open-Label Phase|Adverse Event|0|||
13340587|NCT01016262|26624012|FG005|Open-Label Phase|Adverse Event|0|||
13340588|NCT01016262|26624007|FG000|Open-Label Phase|Lost to Follow-up|0|||
13340589|NCT01016262|26624008|FG001|Open-Label Phase|Lost to Follow-up|0|||
13340590|NCT01016262|26624009|FG002|Open-Label Phase|Lost to Follow-up|0|||
13340591|NCT01016262|26624010|FG003|Open-Label Phase|Lost to Follow-up|0|||
13340592|NCT01016262|26624011|FG004|Open-Label Phase|Lost to Follow-up|1|||
13340593|NCT01016262|26624012|FG005|Open-Label Phase|Lost to Follow-up|0|||
13340594|NCT01016262|26624007|FG000|Open-Label Phase|Lack of Efficacy|0|||
13340595|NCT01016262|26624008|FG001|Open-Label Phase|Lack of Efficacy|0|||
13340596|NCT01016262|26624009|FG002|Open-Label Phase|Lack of Efficacy|0|||
13340597|NCT01016262|26624010|FG003|Open-Label Phase|Lack of Efficacy|1|||
13340598|NCT01016262|26624011|FG004|Open-Label Phase|Lack of Efficacy|0|||
13340599|NCT01016262|26624012|FG005|Open-Label Phase|Lack of Efficacy|0|||
13340600|NCT01016262|26624007|FG000|Open-Label Phase|Withdrawal of Informed Consent|0|||
13340601|NCT01016262|26624008|FG001|Open-Label Phase|Withdrawal of Informed Consent|0|||
13340602|NCT01016262|26624009|FG002|Open-Label Phase|Withdrawal of Informed Consent|0|||
13340603|NCT01016262|26624010|FG003|Open-Label Phase|Withdrawal of Informed Consent|0|||
13340604|NCT01016262|26624011|FG004|Open-Label Phase|Withdrawal of Informed Consent|1|||
13340605|NCT01016262|26624012|FG005|Open-Label Phase|Withdrawal of Informed Consent|0|||
13340606|NCT01016132|26624018|FG000|Overall Study|Discomfort|1|||
13340607|NCT01016067|26624043|FG000|Overall Study|Lost to Follow-up|1|||
13340608|NCT01016067|26624044|FG001|Overall Study|Lost to Follow-up|2|||
13340609|NCT01016067|26624043|FG000|Overall Study|Physician Decision|1|||
13340610|NCT01016067|26624044|FG001|Overall Study|Physician Decision|1|||
13340611|NCT01016067|26624043|FG000|Overall Study|Withdrew due to Relocation|0|||
13340612|NCT01016067|26624044|FG001|Overall Study|Withdrew due to Relocation|1|||
13340613|NCT01016015|26624050|FG000|Overall Study|Not Treated|3|||
13340614|NCT01016015|26624050|FG000|Overall Study|Withdrawal by Subject|1|||
13340615|NCT01016015|26624050|FG000|Overall Study|Adverse Event|15|||
13340616|NCT01015833|26624071|FG000|Overall Study|Death|1|||
13340617|NCT01015833|26624072|FG001|Overall Study|Death|0|||
13340618|NCT01015833|26624071|FG000|Overall Study|Withdrawal by Subject|3|||
13340619|NCT01015833|26624072|FG001|Overall Study|Withdrawal by Subject|2|||
13340620|NCT01015833|26624071|FG000|Overall Study|Adverse Event|0|||
13340621|NCT01015833|26624072|FG001|Overall Study|Adverse Event|1|||
13340622|NCT01015833|26624071|FG000|Overall Study|Physician Decision|2|||
13340623|NCT01015833|26624072|FG001|Overall Study|Physician Decision|0|||
13340624|NCT01015833|26624071|FG000|Overall Study|Symptomatic deterioration|0|||
13340625|NCT01015833|26624072|FG001|Overall Study|Symptomatic deterioration|1|||
13340626|NCT01015833|26624071|FG000|Overall Study|Other|5|||
13340627|NCT01015833|26624072|FG001|Overall Study|Other|1|||
13340628|NCT01015833|26624071|FG000|Overall Study|Motor Vehicle Accidents|1|||
13340629|NCT01015833|26624072|FG001|Overall Study|Motor Vehicle Accidents|0|||
13340630|NCT01015833|26624071|FG000|Overall Study|Did not start treatment|1|||
13340631|NCT01015833|26624072|FG001|Overall Study|Did not start treatment|0|||
13340632|NCT01015820|26624087|FG000|Overall Study|Suboptimal measurements|1|||
13340633|NCT01015820|26624088|FG001|Overall Study|Suboptimal measurements|0|||
13340634|NCT01015768|26624101|FG000|Overall Study|Some subject data unuseable|4|||
13340635|NCT01015768|26624102|FG001|Overall Study|Some subject data unuseable|4|||
13340636|NCT01015703|26624130|FG000|Overall Study|Withdrawal by Subject|0|||
13340637|NCT01015703|26624131|FG001|Overall Study|Withdrawal by Subject|1|||
13340638|NCT01015703|26624132|FG002|Overall Study|Withdrawal by Subject|0|||
13340639|NCT01015703|26624133|FG003|Overall Study|Withdrawal by Subject|0|||
13340640|NCT01015703|26624134|FG004|Overall Study|Withdrawal by Subject|0|||
13340641|NCT01015703|26624130|FG000|Overall Study|Adverse Event|1|||
13340642|NCT01015703|26624131|FG001|Overall Study|Adverse Event|0|||
13340643|NCT01015703|26624132|FG002|Overall Study|Adverse Event|0|||
13340644|NCT01015703|26624133|FG003|Overall Study|Adverse Event|0|||
13340645|NCT01015703|26624134|FG004|Overall Study|Adverse Event|0|||
13340646|NCT01015703|26624130|FG000|Overall Study|Protocol Violation|1|||
13340647|NCT01015703|26624131|FG001|Overall Study|Protocol Violation|0|||
13340648|NCT01015703|26624132|FG002|Overall Study|Protocol Violation|0|||
13340649|NCT01015703|26624133|FG003|Overall Study|Protocol Violation|0|||
13340650|NCT01015703|26624134|FG004|Overall Study|Protocol Violation|0|||
13340651|NCT01015677|26624164|FG000|Overall Study|Adverse Event|0|||
13340652|NCT01015677|26624165|FG001|Overall Study|Adverse Event|1|||
13340653|NCT01015677|26624166|FG002|Overall Study|Adverse Event|0|||
13340654|NCT01015677|26624164|FG000|Overall Study|Lack of Efficacy|0|||
13340655|NCT01015677|26624165|FG001|Overall Study|Lack of Efficacy|1|||
13340656|NCT01015677|26624166|FG002|Overall Study|Lack of Efficacy|0|||
13340657|NCT01015677|26624164|FG000|Overall Study|Protocol Violation|0|||
13340658|NCT01015677|26624165|FG001|Overall Study|Protocol Violation|1|||
13340659|NCT01015677|26624166|FG002|Overall Study|Protocol Violation|0|||
13340660|NCT01015677|26624164|FG000|Overall Study|Withdrawal by Subject|1|||
13340661|NCT01015677|26624165|FG001|Overall Study|Withdrawal by Subject|1|||
13340662|NCT01015677|26624166|FG002|Overall Study|Withdrawal by Subject|0|||
13340663|NCT01015638|26624201|FG000|Overall Study|Withdrawal by Subject|1|||
13340664|NCT01015638|26624202|FG001|Overall Study|Withdrawal by Subject|0|||
13340665|NCT01015612|26624214|FG000|Overall Study|Death|113|||
13340666|NCT01015612|26624214|FG000|Overall Study|Withdrawal by Subject|40|||
13340667|NCT01015560|26624220|FG000|Overall Study|Adverse Event|1|||
13340668|NCT01015560|26624220|FG000|Overall Study|Not protocol specified|1|||
13340669|NCT01015560|26624220|FG000|Overall Study|Withdrawal by Subject|1|||
13340670|NCT01015287|26624253|FG000|Overall Study|Death|21|||
13340671|NCT01015287|26624254|FG001|Overall Study|Death|16|||
13340672|NCT01015287|26624253|FG000|Overall Study|Adverse Event|1|||
13340673|NCT01015287|26624254|FG001|Overall Study|Adverse Event|0|||
13340674|NCT01015287|26624253|FG000|Overall Study|Sponsor Decision|3|||
13340675|NCT01015287|26624254|FG001|Overall Study|Sponsor Decision|7|||
13340676|NCT01015287|26624253|FG000|Overall Study|Physician Decision|19|||
13340677|NCT01015287|26624254|FG001|Overall Study|Physician Decision|21|||
13340678|NCT01015287|26624253|FG000|Overall Study|Withdrawal by Subject|14|||
13340679|NCT01015287|26624254|FG001|Overall Study|Withdrawal by Subject|19|||
13340680|NCT01015287|26624253|FG000|Overall Study|Entry Criteria not Met|11|||
13340681|NCT01015287|26624254|FG001|Overall Study|Entry Criteria not Met|14|||
13340682|NCT01015287|26624253|FG000|Overall Study|Lost to Follow-up|2|||
13340683|NCT01015287|26624254|FG001|Overall Study|Lost to Follow-up|1|||
13340684|NCT01015287|26624253|FG000|Overall Study|Protocol Violation|1|||
13340685|NCT01015287|26624254|FG001|Overall Study|Protocol Violation|1|||
13340686|NCT01015131|26624270|FG000|Overall Study|Physician Decision|1|||
13340687|NCT01015131|26624270|FG000|Overall Study|Protocol Violation|1|||
13340688|NCT01015131|26624270|FG000|Overall Study|Withdrawal by Subject|2|||
13340689|NCT01015131|26624270|FG000|Overall Study|Other Protocol Specified Criteria|4|||
13340690|NCT01015118|26624299|FG000|Overall Study|Protocol Violation|5|||
13340691|NCT01015118|26624300|FG001|Overall Study|Protocol Violation|6|||
13340692|NCT01015118|26624299|FG000|Overall Study|Withdrawal by Subject|103|||
13340693|NCT01015118|26624300|FG001|Overall Study|Withdrawal by Subject|27|||
13340694|NCT01015118|26624299|FG000|Overall Study|Other Adverse Event (AE)|141|||
13340695|NCT01015118|26624300|FG001|Overall Study|Other Adverse Event (AE)|33|||
13340696|NCT01015118|26624299|FG000|Overall Study|Worsening or AE of underlying disease|5|||
13340697|NCT01015118|26624300|FG001|Overall Study|Worsening or AE of underlying disease|4|||
13340698|NCT01015118|26624299|FG000|Overall Study|Progressive disease|364|||
13340699|NCT01015118|26624300|FG001|Overall Study|Progressive disease|229|||
13340700|NCT01015118|26624299|FG000|Overall Study|Not treated|9|||
13340701|NCT01015118|26624300|FG001|Overall Study|Not treated|5|||
13340702|NCT01015118|26624299|FG000|Overall Study|Other than stated above|42|||
13340703|NCT01015118|26624300|FG001|Overall Study|Other than stated above|23|||
13340704|NCT01014988|26624491|FG000|Overall Study|Adverse Event|20|||
13340705|NCT01014988|26624492|FG001|Overall Study|Adverse Event|0|||
13340706|NCT01014988|26624493|FG002|Overall Study|Adverse Event|1|||
13340707|NCT01014988|26624494|FG003|Overall Study|Adverse Event|0|||
13340708|NCT01014988|26624495|FG004|Overall Study|Adverse Event|1|||
13340709|NCT01014988|26624496|FG005|Overall Study|Adverse Event|3|||
13340710|NCT01014988|26624491|FG000|Overall Study|Lost to Follow-up|1|||
13340711|NCT01014988|26624492|FG001|Overall Study|Lost to Follow-up|0|||
13340712|NCT01014988|26624493|FG002|Overall Study|Lost to Follow-up|1|||
13340713|NCT01014988|26624494|FG003|Overall Study|Lost to Follow-up|0|||
13340714|NCT01014988|26624495|FG004|Overall Study|Lost to Follow-up|0|||
13340715|NCT01014988|26624496|FG005|Overall Study|Lost to Follow-up|0|||
13340716|NCT01014988|26624491|FG000|Overall Study|Physician Decision|1|||
13340717|NCT01014988|26624492|FG001|Overall Study|Physician Decision|0|||
13340718|NCT01014988|26624493|FG002|Overall Study|Physician Decision|0|||
13340719|NCT01014988|26624494|FG003|Overall Study|Physician Decision|0|||
13340720|NCT01014988|26624495|FG004|Overall Study|Physician Decision|0|||
13340721|NCT01014988|26624496|FG005|Overall Study|Physician Decision|0|||
13340722|NCT01014988|26624491|FG000|Overall Study|Withdrawal by Subject|1|||
13340723|NCT01014988|26624492|FG001|Overall Study|Withdrawal by Subject|0|||
13340724|NCT01014988|26624493|FG002|Overall Study|Withdrawal by Subject|0|||
13340725|NCT01014988|26624494|FG003|Overall Study|Withdrawal by Subject|0|||
13340726|NCT01014988|26624495|FG004|Overall Study|Withdrawal by Subject|0|||
13340727|NCT01014988|26624496|FG005|Overall Study|Withdrawal by Subject|0|||
13340728|NCT01014975|26624508|FG000|Overall Study|Withdrawal by Subject|1|||
13340729|NCT01014975|26624509|FG001|Overall Study|Withdrawal by Subject|0|||
13340730|NCT01014975|26624510|FG002|Overall Study|Withdrawal by Subject|1|||
13340731|NCT01014975|26624508|FG000|Overall Study|Death|3|||
13340732|NCT01014975|26624509|FG001|Overall Study|Death|3|||
13340733|NCT01014975|26624510|FG002|Overall Study|Death|4|||
13340734|NCT01014975|26624508|FG000|Overall Study|Lost to Follow-up|0|||
13340735|NCT01014975|26624509|FG001|Overall Study|Lost to Follow-up|0|||
13340736|NCT01014975|26624510|FG002|Overall Study|Lost to Follow-up|1|||
13340737|NCT01014910|26624525|FG000|Overall Study|Withdrawal by Subject|0|||
13340738|NCT01014910|26624526|FG001|Overall Study|Withdrawal by Subject|2|||
13340739|NCT01014767|26624553|FG000|Overall Study|PI left institution, data unavailable|12|||
13340740|NCT01014767|26624554|FG001|Overall Study|PI left institution, data unavailable|1|||
13340741|NCT01014767|26624555|FG002|Overall Study|PI left institution, data unavailable|4|||
13340742|NCT01014767|26624556|FG003|Overall Study|PI left institution, data unavailable|1|||
13340743|NCT01014689|26624571|FG000|Overall Study|Lack of Efficacy|0|||
13340744|NCT01014689|26624572|FG001|Overall Study|Lack of Efficacy|1|||
13340745|NCT01014689|26624571|FG000|Overall Study|Adverse Event|3|||
13340746|NCT01014689|26624572|FG001|Overall Study|Adverse Event|0|||
13340747|NCT01014689|26624571|FG000|Overall Study|Withdrawal by Subject|5|||
13340748|NCT01014689|26624572|FG001|Overall Study|Withdrawal by Subject|4|||
13340749|NCT01014689|26624571|FG000|Overall Study|Protocol Violation|1|||
13340750|NCT01014689|26624572|FG001|Overall Study|Protocol Violation|1|||
13340751|NCT01014689|26624571|FG000|Overall Study|Lost to Follow-up|3|||
13340752|NCT01014689|26624572|FG001|Overall Study|Lost to Follow-up|7|||
13340753|NCT01014689|26624571|FG000|Overall Study|Pregnancy|1|||
13340754|NCT01014689|26624572|FG001|Overall Study|Pregnancy|0|||
13340755|NCT01014624|26624599|FG000|Overall Study|Adverse Event|0|||
13340756|NCT01014624|26624600|FG001|Overall Study|Adverse Event|1|||
13340757|NCT01014624|26624599|FG000|Overall Study|Protocol Violation|1|||
13340758|NCT01014624|26624600|FG001|Overall Study|Protocol Violation|0|||
13340759|NCT01014624|26624599|FG000|Overall Study|Withdrawal by Subject|1|||
13340760|NCT01014624|26624600|FG001|Overall Study|Withdrawal by Subject|0|||
13340761|NCT01014585|26624631|FG000|Overall Study|Adverse Event|0|||
13340762|NCT01014585|26624632|FG001|Overall Study|Adverse Event|2|||
13340763|NCT01014585|26624633|FG002|Overall Study|Adverse Event|0|||
13340764|NCT01014585|26624634|FG003|Overall Study|Adverse Event|3|||
13340765|NCT01014585|26624631|FG000|Overall Study|Withdrawal by Subject|2|||
13340766|NCT01014585|26624632|FG001|Overall Study|Withdrawal by Subject|0|||
13340767|NCT01014585|26624633|FG002|Overall Study|Withdrawal by Subject|1|||
13340768|NCT01014585|26624634|FG003|Overall Study|Withdrawal by Subject|3|||
13340769|NCT01014585|26624631|FG000|Overall Study|Lost to Follow-up|0|||
13340770|NCT01014585|26624632|FG001|Overall Study|Lost to Follow-up|0|||
13340771|NCT01014585|26624633|FG002|Overall Study|Lost to Follow-up|0|||
13340772|NCT01014585|26624634|FG003|Overall Study|Lost to Follow-up|2|||
13340773|NCT01014585|26624631|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18|||
13340774|NCT01014585|26624632|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23|||
13340775|NCT01014585|26624633|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
13340776|NCT01014585|26624634|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
13340777|NCT01014533|26624651|FG000|Overall Study|Protocol Violation|3|||
13340778|NCT01014533|26624652|FG001|Overall Study|Protocol Violation|2|||
13340779|NCT01014533|26624651|FG000|Overall Study|Withdrawal by Subject|2|||
13340780|NCT01014533|26624652|FG001|Overall Study|Withdrawal by Subject|0|||
13340781|NCT01014533|26624651|FG000|Overall Study|unable to come to appointment|0|||
13340782|NCT01014533|26624652|FG001|Overall Study|unable to come to appointment|3|||
13340783|NCT01014442|26624771|FG000|Overall Study|Adverse Event|0|||
13340784|NCT01014442|26624772|FG001|Overall Study|Adverse Event|8|||
13340785|NCT01014442|26624771|FG000|Overall Study|Withdrawal by Subject|4|||
13340786|NCT01014442|26624772|FG001|Overall Study|Withdrawal by Subject|4|||
13340787|NCT01014442|26624771|FG000|Overall Study|Protocol Violation|2|||
13340788|NCT01014442|26624772|FG001|Overall Study|Protocol Violation|5|||
13340789|NCT01014442|26624771|FG000|Overall Study|Lack of Compliance|0|||
13340790|NCT01014442|26624772|FG001|Overall Study|Lack of Compliance|1|||
13340791|NCT01014442|26624771|FG000|Overall Study|Unspecified Reason|1|||
13340792|NCT01014442|26624772|FG001|Overall Study|Unspecified Reason|1|||
13340793|NCT01014208|26624805|FG000|Overall Study|Lost to Follow-up|2|||
13340794|NCT01014208|26624806|FG001|Overall Study|Lost to Follow-up|5|||
13340795|NCT01014208|26624805|FG000|Overall Study|Participant Withdrew Consent|12|||
13340796|NCT01014208|26624806|FG001|Overall Study|Participant Withdrew Consent|12|||
13340797|NCT01014208|26624805|FG000|Overall Study|Did Not Receive Study Drug|2|||
13340798|NCT01014208|26624806|FG001|Overall Study|Did Not Receive Study Drug|0|||
13340799|NCT01014208|26624805|FG000|Overall Study|Study Closed/terminated|78|||
13340800|NCT01014208|26624806|FG001|Overall Study|Study Closed/terminated|83|||
13340801|NCT01014143|26624824|FG000|Second Intervention|Lost to Follow-up|2|||
13340802|NCT01014143|26624825|FG001|Second Intervention|Lost to Follow-up|0|||
13340803|NCT01014143|26624826|FG002|Second Intervention|Lost to Follow-up|0|||
13340804|NCT01014013|26624843|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
13340805|NCT01014013|26624844|FG001|Overall Study|Inclusion/Exclusion criteria not met|3|||
13340806|NCT01014013|26624843|FG000|Overall Study|Clinical adverse experience|4|||
13340807|NCT01014013|26624844|FG001|Overall Study|Clinical adverse experience|2|||
13340808|NCT01014013|26624843|FG000|Overall Study|Laboratory adverse experience|1|||
13340809|NCT01014013|26624844|FG001|Overall Study|Laboratory adverse experience|1|||
13340810|NCT01014013|26624843|FG000|Overall Study|Protocol Violation|1|||
13340811|NCT01014013|26624844|FG001|Overall Study|Protocol Violation|3|||
13340812|NCT01014013|26624843|FG000|Overall Study|Withdrawal by Subject|7|||
13340813|NCT01014013|26624844|FG001|Overall Study|Withdrawal by Subject|4|||
13340814|NCT01014013|26624843|FG000|Overall Study|Clinical/microbiologic failure|1|||
13340815|NCT01014013|26624844|FG001|Overall Study|Clinical/microbiologic failure|2|||
13340816|NCT01014013|26624843|FG000|Overall Study|Pathogen culture = no growth|26|||
13340817|NCT01014013|26624844|FG001|Overall Study|Pathogen culture = no growth|34|||
13340818|NCT01014013|26624843|FG000|Overall Study|Negative urine culture|2|||
13340819|NCT01014013|26624844|FG001|Overall Study|Negative urine culture|0|||
13340820|NCT01014013|26624843|FG000|Overall Study|Pathogen resistant|7|||
13340821|NCT01014013|26624844|FG001|Overall Study|Pathogen resistant|4|||
13340822|NCT01014013|26624843|FG000|Overall Study|Physician Decision|0|||
13340823|NCT01014013|26624844|FG001|Overall Study|Physician Decision|1|||
13340824|NCT01014013|26624843|FG000|Overall Study|Another antibiotic therapy required|0|||
13340825|NCT01014013|26624844|FG001|Overall Study|Another antibiotic therapy required|1|||
13340826|NCT01014013|26624843|FG000|Overall Study|Appendectomy|1|||
13340827|NCT01014013|26624844|FG001|Overall Study|Appendectomy|0|||
13340828|NCT01014013|26624843|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0|||
13340829|NCT01014013|26624844|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1|||
13340830|NCT01013961|26624867|FG000|Overall Study|Adverse Event|2|||
13340831|NCT01013961|26624868|FG001|Overall Study|Adverse Event|2|||
13340832|NCT01013961|26624867|FG000|Overall Study|Withdrawal by Subject|1|||
13340833|NCT01013961|26624868|FG001|Overall Study|Withdrawal by Subject|0|||
13340834|NCT01013961|26624867|FG000|Overall Study|Physician Decision|0|||
13340835|NCT01013961|26624868|FG001|Overall Study|Physician Decision|1|||
13340836|NCT01013883|26624885|FG000|Overall Study|Lost to Follow-up|2|||
13340837|NCT01013883|26624886|FG001|Overall Study|Lost to Follow-up|2|||
13340838|NCT01013870|26624915|FG000|Overall Study|Lost to Follow-up|1|||
13340839|NCT01013870|26624916|FG001|Overall Study|Lost to Follow-up|3|||
13340840|NCT01013792|26624929|FG000|Overall Study|Study suspended|2|||
13340841|NCT01013792|26624930|FG001|Overall Study|Study suspended|1|||
13340842|NCT01013792|26624929|FG000|Overall Study|Adverse Event|0|||
13340843|NCT01013792|26624930|FG001|Overall Study|Adverse Event|3|||
13340844|NCT01013792|26624929|FG000|Overall Study|Lost to Follow-up|0|||
13340845|NCT01013792|26624930|FG001|Overall Study|Lost to Follow-up|1|||
13340846|NCT01013753|26625126|FG000|Overall Study|Adverse Event|8|||
13340847|NCT01013753|26625126|FG000|Overall Study|Protocol Violation|3|||
13340848|NCT01013753|26625126|FG000|Overall Study|Lost to Follow-up|1|||
13340849|NCT01013753|26625126|FG000|Overall Study|Withdrawal by Subject|2|||
13340850|NCT01013753|26625126|FG000|Overall Study|Other|2|||
13340851|NCT01013740|26625157|FG000|Overall Study|Lost to Follow-up|3|||
13340852|NCT01013740|26625158|FG001|Overall Study|Lost to Follow-up|5|||
13340853|NCT01013740|26625157|FG000|Overall Study|Physician Decision|2|||
13340854|NCT01013740|26625158|FG001|Overall Study|Physician Decision|0|||
13340855|NCT01013740|26625157|FG000|Overall Study|Withdrawal by Subject|2|||
13340856|NCT01013740|26625158|FG001|Overall Study|Withdrawal by Subject|10|||
13340857|NCT01013740|26625157|FG000|Overall Study|study close / terminated : done in error|2|||
13340858|NCT01013740|26625158|FG001|Overall Study|study close / terminated : done in error|1|||
13340859|NCT01013740|26625157|FG000|Overall Study|Missing|2|||
13340860|NCT01013740|26625158|FG001|Overall Study|Missing|1|||
13340861|NCT01013740|26625157|FG000|Overall Study|Ongoing: Study records not completed|0|||
13340862|NCT01013740|26625158|FG001|Overall Study|Ongoing: Study records not completed|2|||
13340863|NCT01013701|26625167|FG000|Overall Study|study prematurely terminated|7|||
13340864|NCT01013597|26625179|FG000|Overall Study|Withdrawal by Subject|1|||
13340865|NCT01013350|26625197|FG000|Overall Study|Lost to Follow-up|15|||
13340866|NCT01013350|26625198|FG001|Overall Study|Lost to Follow-up|95|||
13340867|NCT01013350|26625197|FG000|Overall Study|Adverse Event|0|||
13340868|NCT01013350|26625198|FG001|Overall Study|Adverse Event|1|||
13340869|NCT01013350|26625197|FG000|Overall Study|Physician Decision|4|||
13340870|NCT01013350|26625198|FG001|Overall Study|Physician Decision|20|||
13340871|NCT01013350|26625197|FG000|Overall Study|Withdrawal by Subject|15|||
13340872|NCT01013350|26625198|FG001|Overall Study|Withdrawal by Subject|38|||
13340873|NCT01013350|26625197|FG000|Overall Study|Death|3|||
13340874|NCT01013350|26625198|FG001|Overall Study|Death|5|||
13340875|NCT01013350|26625197|FG000|Overall Study|Participant entered interventional study|0|||
13340876|NCT01013350|26625198|FG001|Overall Study|Participant entered interventional study|8|||
13340877|NCT01013350|26625197|FG000|Overall Study|Other|1|||
13340878|NCT01013350|26625198|FG001|Overall Study|Other|25|||
13340879|NCT01013285|26625218|FG000|Overall Study|Death|48|||
13340880|NCT01013285|26625219|FG001|Overall Study|Death|89|||
13340881|NCT01013207|26625226|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6|||
13340882|NCT01012999|26625232|FG000|Overall Study|Protocol Violation|1|||
13340883|NCT01012973|26625259|FG000|Overall Study|Adverse Event|5|||
13340884|NCT01012973|26625260|FG001|Overall Study|Adverse Event|5|||
13340885|NCT01012973|26625259|FG000|Overall Study|Lack of Efficacy|0|||
13340886|NCT01012973|26625260|FG001|Overall Study|Lack of Efficacy|5|||
13340887|NCT01012973|26625259|FG000|Overall Study|Lost to Follow-up|1|||
13340888|NCT01012973|26625260|FG001|Overall Study|Lost to Follow-up|0|||
13340889|NCT01012973|26625259|FG000|Overall Study|(Overseas travel - indefinite period)|1|||
13340890|NCT01012973|26625260|FG001|Overall Study|(Overseas travel - indefinite period)|0|||
13340891|NCT01012973|26625259|FG000|Overall Study|Increase in vis. acuity, never injected|0|||
13340892|NCT01012973|26625260|FG001|Overall Study|Increase in vis. acuity, never injected|1|||
13340893|NCT01012973|26625259|FG000|Overall Study|Protocol Violation|5|||
13340894|NCT01012973|26625260|FG001|Overall Study|Protocol Violation|2|||
13340895|NCT01012973|26625259|FG000|Overall Study|Withdrawal by Subject|4|||
13340896|NCT01012973|26625260|FG001|Overall Study|Withdrawal by Subject|6|||
13340897|NCT01012947|26625288|FG000|Overall Study|Lost to Follow-up|131|||
13340898|NCT01012947|26625289|FG001|Overall Study|Lost to Follow-up|135|||
13340899|NCT01012947|26625290|FG002|Overall Study|Lost to Follow-up|130|||
13340900|NCT01012947|26625291|FG003|Overall Study|Lost to Follow-up|118|||
13340901|NCT01012947|26625292|FG004|Overall Study|Lost to Follow-up|142|||
13340902|NCT01012765|26625328|FG000|Treatment Period 1|Adverse Event|1|||
13340903|NCT01012765|26625329|FG001|Treatment Period 1|Adverse Event|0|||
13340904|NCT01012765|26625330|FG002|Treatment Period 1|Adverse Event|1|||
13340905|NCT01012765|26625331|FG003|Treatment Period 1|Adverse Event|0|||
13340906|NCT01012765|26625332|FG004|Treatment Period 1|Adverse Event|0|||
13340907|NCT01012765|26625333|FG005|Treatment Period 1|Adverse Event|0|||
13340908|NCT01012765|26625328|FG000|Treatment Period 1|Withdrawal by Subject|2|||
13340909|NCT01012765|26625329|FG001|Treatment Period 1|Withdrawal by Subject|0|||
13340910|NCT01012765|26625330|FG002|Treatment Period 1|Withdrawal by Subject|0|||
13340911|NCT01012765|26625331|FG003|Treatment Period 1|Withdrawal by Subject|0|||
13340912|NCT01012765|26625332|FG004|Treatment Period 1|Withdrawal by Subject|0|||
13340913|NCT01012765|26625333|FG005|Treatment Period 1|Withdrawal by Subject|0|||
13340914|NCT01012765|26625328|FG000|Treatment Period 1|Administrative problems|0|||
13340915|NCT01012765|26625329|FG001|Treatment Period 1|Administrative problems|0|||
13340916|NCT01012765|26625330|FG002|Treatment Period 1|Administrative problems|1|||
13340917|NCT01012765|26625331|FG003|Treatment Period 1|Administrative problems|1|||
13340918|NCT01012765|26625332|FG004|Treatment Period 1|Administrative problems|1|||
13340919|NCT01012765|26625333|FG005|Treatment Period 1|Administrative problems|0|||
13340920|NCT01012765|26625328|FG000|Treatment Period 1|Protocol Violation|0|||
13340921|NCT01012765|26625329|FG001|Treatment Period 1|Protocol Violation|0|||
13340922|NCT01012765|26625330|FG002|Treatment Period 1|Protocol Violation|0|||
13340923|NCT01012765|26625331|FG003|Treatment Period 1|Protocol Violation|2|||
13340924|NCT01012765|26625332|FG004|Treatment Period 1|Protocol Violation|1|||
13340925|NCT01012765|26625333|FG005|Treatment Period 1|Protocol Violation|0|||
13340926|NCT01012765|26625328|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
13340927|NCT01012765|26625329|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
13340928|NCT01012765|26625330|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
13340929|NCT01012765|26625331|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
13340930|NCT01012765|26625332|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1|||
13340931|NCT01012765|26625333|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
13340932|NCT01012765|26625328|FG000|Treatment Period 2|Withdrawal by Subject|1|||
13340933|NCT01012765|26625329|FG001|Treatment Period 2|Withdrawal by Subject|0|||
13340934|NCT01012765|26625330|FG002|Treatment Period 2|Withdrawal by Subject|1|||
13340935|NCT01012765|26625331|FG003|Treatment Period 2|Withdrawal by Subject|0|||
13340936|NCT01012765|26625332|FG004|Treatment Period 2|Withdrawal by Subject|1|||
13340937|NCT01012765|26625333|FG005|Treatment Period 2|Withdrawal by Subject|0|||
13340938|NCT01012765|26625328|FG000|Treatment Period 2|Abnormal laboratory value(s)|0|||
13340939|NCT01012765|26625329|FG001|Treatment Period 2|Abnormal laboratory value(s)|0|||
13340940|NCT01012765|26625330|FG002|Treatment Period 2|Abnormal laboratory value(s)|0|||
13340941|NCT01012765|26625331|FG003|Treatment Period 2|Abnormal laboratory value(s)|0|||
13340942|NCT01012765|26625332|FG004|Treatment Period 2|Abnormal laboratory value(s)|0|||
13340943|NCT01012765|26625333|FG005|Treatment Period 2|Abnormal laboratory value(s)|1|||
13340944|NCT01012765|26625328|FG000|Treatment Period 2|Adverse Event|0|||
13340945|NCT01012765|26625329|FG001|Treatment Period 2|Adverse Event|1|||
13340946|NCT01012765|26625330|FG002|Treatment Period 2|Adverse Event|1|||
13340947|NCT01012765|26625331|FG003|Treatment Period 2|Adverse Event|0|||
13340948|NCT01012765|26625332|FG004|Treatment Period 2|Adverse Event|0|||
13340949|NCT01012765|26625333|FG005|Treatment Period 2|Adverse Event|0|||
13340950|NCT01012765|26625328|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
13340951|NCT01012765|26625329|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
13340952|NCT01012765|26625330|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
13340953|NCT01012765|26625331|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
13340954|NCT01012765|26625332|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
13340955|NCT01012765|26625333|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
13340956|NCT01012739|26625366|FG000|Treatment Period 1|Adverse Event|0|||
13340957|NCT01012739|26625367|FG001|Treatment Period 1|Adverse Event|0|||
13340958|NCT01012739|26625368|FG002|Treatment Period 1|Adverse Event|0|||
13340959|NCT01012739|26625369|FG003|Treatment Period 1|Adverse Event|1|||
13340960|NCT01012739|26625366|FG000|Treatment Period 2|Abnormal test procedure results|0|||
13340961|NCT01012739|26625367|FG001|Treatment Period 2|Abnormal test procedure results|0|||
13340962|NCT01012739|26625368|FG002|Treatment Period 2|Abnormal test procedure results|0|||
13340963|NCT01012739|26625369|FG003|Treatment Period 2|Abnormal test procedure results|1|||
13340964|NCT01012713|26625377|FG000|Overall Study|Lack of Efficacy|3|||
13340965|NCT01012622|26625398|FG000|Overall Study|Withdrawal by Subject|6|||
13340966|NCT01012622|26625398|FG000|Overall Study|Lost to Follow-up|5|||
13340967|NCT01012622|26625398|FG000|Overall Study|Adverse Event|7|||
13340968|NCT01012622|26625398|FG000|Overall Study|non-compliance with the drug|9|||
13340969|NCT01012622|26625398|FG000|Overall Study|Other|1|||
13340970|NCT01012622|26625398|FG000|Overall Study|screening failure|1|||
13340971|NCT01012622|26625398|FG000|Overall Study|withdrawal of consent by a parent|2|||
13340972|NCT01012609|26625426|FG000|Overall Study|Withdrawal by Subject|1|||
13340973|NCT01012609|26625427|FG001|Overall Study|Withdrawal by Subject|1|||
13340974|NCT01012440|26625433|FG000|Overall Study|Withdrawal by Subject|2|||
13340975|NCT01012414|26625442|FG000|Overall Study|Withdrawal by Subject|2|||
13340976|NCT01012414|26625442|FG000|Overall Study|Lost to Follow-up|1|||
13340977|NCT01012414|26625442|FG000|Overall Study|Trial was stopped before completed|7|||
13340978|NCT01012323|26625466|FG000|Overall Study|Investigator Judgment|1|||
13340979|NCT01012258|26625474|FG000|Overall Study|Death|14|||
13340980|NCT01012258|26625474|FG000|Overall Study|Lost to Follow-up|1|||
13340981|NCT01012258|26625474|FG000|Overall Study|Adverse Event|1|||
13340982|NCT01012258|26625474|FG000|Overall Study|Progressive Disease (PD)|18|||
13340983|NCT01012258|26625474|FG000|Overall Study|Symptomatic Deterioration|1|||
13340984|NCT01012258|26625474|FG000|Overall Study|Another Anti-cancer Drug Received|1|||
13340985|NCT01012258|26625474|FG000|Overall Study|Another Tumor Discovered|1|||
13340986|NCT01012258|26625474|FG000|Overall Study|Ongoing|29|||
13340987|NCT01012219|26625483|FG000|Period 1|Withdrawal by Subject|1|||
13340988|NCT01012219|26625483|FG000|Period 2|Withdrawal by Subject|1|||
13340989|NCT01012037|26625528|FG000|Overall Study|Adverse Event|0|||
13340990|NCT01012037|26625529|FG001|Overall Study|Adverse Event|8|||
13340991|NCT01012037|26625530|FG002|Overall Study|Adverse Event|3|||
13340992|NCT01012037|26625528|FG000|Overall Study|Protocol Violation|0|||
13340993|NCT01012037|26625529|FG001|Overall Study|Protocol Violation|3|||
13340994|NCT01012037|26625530|FG002|Overall Study|Protocol Violation|5|||
13340995|NCT01012037|26625528|FG000|Overall Study|Withdrawal by Subject|0|||
13340996|NCT01012037|26625529|FG001|Overall Study|Withdrawal by Subject|4|||
13340997|NCT01012037|26625530|FG002|Overall Study|Withdrawal by Subject|1|||
13340998|NCT01012037|26625528|FG000|Overall Study|Other reason (not specified)|1|||
13340999|NCT01012037|26625529|FG001|Overall Study|Other reason (not specified)|1|||
13341000|NCT01012037|26625530|FG002|Overall Study|Other reason (not specified)|1|||
13341001|NCT01011946|26625536|FG000|Overall Study|Transferred to another hospital|2|||
13341002|NCT01011946|26625536|FG000|Overall Study|No pathological lab value|1|||
13341003|NCT01011933|26625553|FG000|Overall Study|Wrong cell type|1|||
13341004|NCT01011933|26625553|FG000|Overall Study|Improper pre-protocol Rx|1|||
13341005|NCT01011933|26625553|FG000|Overall Study|Inadequate pathology|1|||
13341006|NCT01011933|26625553|FG000|Overall Study|Never treated|1|||
13341007|NCT01011907|26625570|FG000|Overall Study|Withdrawal by Subject|13|||
13341008|NCT01011907|26625571|FG001|Overall Study|Withdrawal by Subject|11|||
13341009|NCT01011907|26625570|FG000|Overall Study|Adverse Event|1|||
13341010|NCT01011907|26625571|FG001|Overall Study|Adverse Event|4|||
13341011|NCT01011868|26625616|FG000|After Week 18 Follow-up|Adverse Event|8|||
13341012|NCT01011868|26625617|FG001|After Week 18 Follow-up|Adverse Event|6|||
13341013|NCT01011868|26625618|FG002|After Week 18 Follow-up|Adverse Event|13|||
13341014|NCT01011868|26625616|FG000|After Week 18 Follow-up|Lack of Efficacy|1|||
13341015|NCT01011868|26625617|FG001|After Week 18 Follow-up|Lack of Efficacy|0|||
13341016|NCT01011868|26625618|FG002|After Week 18 Follow-up|Lack of Efficacy|0|||
13341017|NCT01011868|26625616|FG000|After Week 18 Follow-up|Protocol Violation|1|||
13341018|NCT01011868|26625617|FG001|After Week 18 Follow-up|Protocol Violation|1|||
13341019|NCT01011868|26625618|FG002|After Week 18 Follow-up|Protocol Violation|1|||
13341020|NCT01011868|26625616|FG000|After Week 18 Follow-up|Lost to Follow-up|5|||
13341021|NCT01011868|26625617|FG001|After Week 18 Follow-up|Lost to Follow-up|3|||
13341022|NCT01011868|26625618|FG002|After Week 18 Follow-up|Lost to Follow-up|0|||
13341023|NCT01011868|26625616|FG000|After Week 18 Follow-up|Withdrawal by Subject|6|||
13341024|NCT01011868|26625617|FG001|After Week 18 Follow-up|Withdrawal by Subject|3|||
13341025|NCT01011868|26625618|FG002|After Week 18 Follow-up|Withdrawal by Subject|0|||
13341026|NCT01011868|26625616|FG000|After Week 18 Follow-up|Other reason not defined above|2|||
13341027|NCT01011868|26625617|FG001|After Week 18 Follow-up|Other reason not defined above|3|||
13341028|NCT01011868|26625618|FG002|After Week 18 Follow-up|Other reason not defined above|12|||
13341029|NCT01011868|26625616|FG000|After Week 78 Follow-up|Adverse Event|14|||
13341030|NCT01011868|26625617|FG001|After Week 78 Follow-up|Adverse Event|18|||
13341031|NCT01011868|26625618|FG002|After Week 78 Follow-up|Adverse Event|21|||
13341032|NCT01011868|26625616|FG000|After Week 78 Follow-up|Lack of Efficacy|4|||
13341033|NCT01011868|26625617|FG001|After Week 78 Follow-up|Lack of Efficacy|0|||
13341034|NCT01011868|26625618|FG002|After Week 78 Follow-up|Lack of Efficacy|0|||
13341035|NCT01011868|26625616|FG000|After Week 78 Follow-up|Protocol Violation|9|||
13341036|NCT01011868|26625617|FG001|After Week 78 Follow-up|Protocol Violation|1|||
13341037|NCT01011868|26625618|FG002|After Week 78 Follow-up|Protocol Violation|2|||
13341038|NCT01011868|26625616|FG000|After Week 78 Follow-up|Lost to Follow-up|11|||
13341039|NCT01011868|26625617|FG001|After Week 78 Follow-up|Lost to Follow-up|6|||
13341040|NCT01011868|26625618|FG002|After Week 78 Follow-up|Lost to Follow-up|4|||
13341041|NCT01011868|26625616|FG000|After Week 78 Follow-up|Withdrawal by Subject|9|||
13341042|NCT01011868|26625617|FG001|After Week 78 Follow-up|Withdrawal by Subject|8|||
13341043|NCT01011868|26625618|FG002|After Week 78 Follow-up|Withdrawal by Subject|1|||
13341044|NCT01011868|26625616|FG000|After Week 78 Follow-up|Other reason not defined above|5|||
13341045|NCT01011868|26625617|FG001|After Week 78 Follow-up|Other reason not defined above|5|||
13341046|NCT01011868|26625618|FG002|After Week 78 Follow-up|Other reason not defined above|16|||
13341047|NCT01011738|26625666|FG000|Overall Study|Death|12|||
13341048|NCT01011738|26625667|FG001|Overall Study|Death|3|||
13341049|NCT01011738|26625668|FG002|Overall Study|Death|0|||
13341050|NCT01011738|26625666|FG000|Overall Study|Unknown reasons|312|||
13341051|NCT01011738|26625667|FG001|Overall Study|Unknown reasons|291|||
13341052|NCT01011738|26625668|FG002|Overall Study|Unknown reasons|17|||
13341053|NCT01011673|26625683|FG000|Randomized|Secondary headache|2|||
13341054|NCT01011673|26625684|FG001|Randomized|Secondary headache|1|||
13341055|NCT01011673|26625683|FG000|24 Hour Follow-up|Lost to Follow-up|3|||
13341056|NCT01011673|26625684|FG001|24 Hour Follow-up|Lost to Follow-up|3|||
13341057|NCT01011556|26625767|FG000|Overall Study|Adverse Event|1|||
13341058|NCT01011556|26625768|FG001|Overall Study|Adverse Event|3|||
13341059|NCT01011556|26625769|FG002|Overall Study|Adverse Event|2|||
13341060|NCT01011556|26625770|FG003|Overall Study|Adverse Event|1|||
13341061|NCT01011556|26625767|FG000|Overall Study|Lost to Follow-up|1|||
13341062|NCT01011556|26625768|FG001|Overall Study|Lost to Follow-up|0|||
13341063|NCT01011556|26625769|FG002|Overall Study|Lost to Follow-up|0|||
13341064|NCT01011556|26625770|FG003|Overall Study|Lost to Follow-up|0|||
13341065|NCT01011556|26625767|FG000|Overall Study|Physician Decision|1|||
13341066|NCT01011556|26625768|FG001|Overall Study|Physician Decision|0|||
13341067|NCT01011556|26625769|FG002|Overall Study|Physician Decision|0|||
13341068|NCT01011556|26625770|FG003|Overall Study|Physician Decision|1|||
13341069|NCT01011556|26625767|FG000|Overall Study|Protocol Violation|0|||
13341070|NCT01011556|26625768|FG001|Overall Study|Protocol Violation|1|||
13341071|NCT01011556|26625769|FG002|Overall Study|Protocol Violation|0|||
13341072|NCT01011556|26625770|FG003|Overall Study|Protocol Violation|0|||
13341073|NCT01011556|26625767|FG000|Overall Study|Withdrawal by Subject|1|||
13341074|NCT01011556|26625768|FG001|Overall Study|Withdrawal by Subject|2|||
13341075|NCT01011556|26625769|FG002|Overall Study|Withdrawal by Subject|4|||
13341076|NCT01011556|26625770|FG003|Overall Study|Withdrawal by Subject|4|||
13341077|NCT01011556|26625767|FG000|Overall Study|Sponsor decision|0|||
13341078|NCT01011556|26625768|FG001|Overall Study|Sponsor decision|1|||
13341079|NCT01011556|26625769|FG002|Overall Study|Sponsor decision|1|||
13341080|NCT01011556|26625770|FG003|Overall Study|Sponsor decision|2|||
13341081|NCT01011556|26625767|FG000|Overall Study|Inclusion/exclusion criteria not met|2|||
13341082|NCT01011556|26625768|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
13341083|NCT01011556|26625769|FG002|Overall Study|Inclusion/exclusion criteria not met|3|||
13341084|NCT01011556|26625770|FG003|Overall Study|Inclusion/exclusion criteria not met|5|||
13341085|NCT01011465|26625823|FG000|Overall Study|Withdrawal by Subject|2|||
13341086|NCT01011465|26625824|FG001|Overall Study|Withdrawal by Subject|1|||
13341087|NCT01011465|26625825|FG002|Overall Study|Withdrawal by Subject|0|||
13341088|NCT01011465|26625826|FG003|Overall Study|Withdrawal by Subject|0|||
13341089|NCT01011465|26625827|FG004|Overall Study|Withdrawal by Subject|1|||
13341090|NCT01011465|26625828|FG005|Overall Study|Withdrawal by Subject|0|||
13341091|NCT01011465|26625829|FG006|Overall Study|Withdrawal by Subject|1|||
13341092|NCT01011465|26625830|FG007|Overall Study|Withdrawal by Subject|0|||
13341093|NCT01011439|26625842|FG000|Overall Study|Death|37|||
13341094|NCT01011439|26625842|FG000|Overall Study|Lost to Follow-up|4|||
13341095|NCT01011439|26625842|FG000|Overall Study|Withdrawal by Subject|1|||
13341096|NCT01011439|26625842|FG000|Overall Study|Sponsor's decision|15|||
13341097|NCT01011387|26625848|FG000|Overall Study|Withdrawal by Subject|3|||
13341098|NCT01011387|26625848|FG000|Overall Study|Adverse Event|2|||
13341099|NCT01011387|26625848|FG000|Overall Study|Protocol Violation|1|||
13341100|NCT01011335|26625907|FG000|Overall Study|Lost to Follow-up|0|||
13341101|NCT01011335|26625908|FG001|Overall Study|Lost to Follow-up|0|||
13341102|NCT01011335|26625909|FG002|Overall Study|Lost to Follow-up|1|||
13341103|NCT01011335|26625910|FG003|Overall Study|Lost to Follow-up|1|||
13341104|NCT01011335|26625911|FG004|Overall Study|Lost to Follow-up|1|||
13341105|NCT01011335|26625912|FG005|Overall Study|Lost to Follow-up|1|||
13341106|NCT01011335|26625913|FG006|Overall Study|Lost to Follow-up|2|||
13341107|NCT01011335|26625914|FG007|Overall Study|Lost to Follow-up|2|||
13341108|NCT01011335|26625915|FG008|Overall Study|Lost to Follow-up|1|||
13341109|NCT01011335|26625916|FG009|Overall Study|Lost to Follow-up|0|||
13341110|NCT01011335|26625917|FG010|Overall Study|Lost to Follow-up|0|||
13341111|NCT01011335|26625918|FG011|Overall Study|Lost to Follow-up|1|||
13341112|NCT01011335|26625919|FG012|Overall Study|Lost to Follow-up|2|||
13341113|NCT01011335|26625907|FG000|Overall Study|Protocol Violation|0|||
13341114|NCT01011335|26625908|FG001|Overall Study|Protocol Violation|1|||
13341115|NCT01011335|26625909|FG002|Overall Study|Protocol Violation|0|||
13341116|NCT01011335|26625910|FG003|Overall Study|Protocol Violation|0|||
13341117|NCT01011335|26625911|FG004|Overall Study|Protocol Violation|0|||
13341118|NCT01011335|26625912|FG005|Overall Study|Protocol Violation|0|||
13341119|NCT01011335|26625913|FG006|Overall Study|Protocol Violation|0|||
13341120|NCT01011335|26625914|FG007|Overall Study|Protocol Violation|0|||
13341121|NCT01011335|26625915|FG008|Overall Study|Protocol Violation|0|||
13341122|NCT01011335|26625916|FG009|Overall Study|Protocol Violation|0|||
13341123|NCT01011335|26625917|FG010|Overall Study|Protocol Violation|0|||
13341124|NCT01011335|26625918|FG011|Overall Study|Protocol Violation|0|||
13341125|NCT01011335|26625919|FG012|Overall Study|Protocol Violation|0|||
13341126|NCT01011335|26625907|FG000|Overall Study|Moved/deployed or no booster|1|||
13341127|NCT01011335|26625908|FG001|Overall Study|Moved/deployed or no booster|0|||
13341128|NCT01011335|26625909|FG002|Overall Study|Moved/deployed or no booster|0|||
13341129|NCT01011335|26625910|FG003|Overall Study|Moved/deployed or no booster|1|||
13341130|NCT01011335|26625911|FG004|Overall Study|Moved/deployed or no booster|0|||
13341131|NCT01011335|26625912|FG005|Overall Study|Moved/deployed or no booster|0|||
13341132|NCT01011335|26625913|FG006|Overall Study|Moved/deployed or no booster|1|||
13341133|NCT01011335|26625914|FG007|Overall Study|Moved/deployed or no booster|0|||
13341134|NCT01011335|26625915|FG008|Overall Study|Moved/deployed or no booster|1|||
13341135|NCT01011335|26625916|FG009|Overall Study|Moved/deployed or no booster|0|||
13341136|NCT01011335|26625917|FG010|Overall Study|Moved/deployed or no booster|2|||
13341137|NCT01011335|26625918|FG011|Overall Study|Moved/deployed or no booster|0|||
13341138|NCT01011335|26625919|FG012|Overall Study|Moved/deployed or no booster|0|||
13341139|NCT01011335|26625907|FG000|Overall Study|Adverse Event|0|||
13341140|NCT01011335|26625908|FG001|Overall Study|Adverse Event|0|||
13341141|NCT01011335|26625909|FG002|Overall Study|Adverse Event|0|||
13341142|NCT01011335|26625910|FG003|Overall Study|Adverse Event|0|||
13341143|NCT01011335|26625911|FG004|Overall Study|Adverse Event|0|||
13341144|NCT01011335|26625912|FG005|Overall Study|Adverse Event|0|||
13341145|NCT01011335|26625913|FG006|Overall Study|Adverse Event|0|||
13341146|NCT01011335|26625914|FG007|Overall Study|Adverse Event|0|||
13341147|NCT01011335|26625915|FG008|Overall Study|Adverse Event|0|||
13341148|NCT01011335|26625916|FG009|Overall Study|Adverse Event|0|||
13341149|NCT01011335|26625917|FG010|Overall Study|Adverse Event|4|||
13341150|NCT01011335|26625918|FG011|Overall Study|Adverse Event|0|||
13341151|NCT01011335|26625919|FG012|Overall Study|Adverse Event|1|||
13341152|NCT01011309|26625943|FG000|Overall Study|Adverse Event|2|||
13341153|NCT01011309|26625944|FG001|Overall Study|Adverse Event|1|||
13341154|NCT01011309|26625945|FG002|Overall Study|Adverse Event|2|||
13341155|NCT01011309|26625943|FG000|Overall Study|Lack of Efficacy|0|||
13341156|NCT01011309|26625944|FG001|Overall Study|Lack of Efficacy|1|||
13341157|NCT01011309|26625945|FG002|Overall Study|Lack of Efficacy|0|||
13341158|NCT01011309|26625943|FG000|Overall Study|Protocol Violation|0|||
13341159|NCT01011309|26625944|FG001|Overall Study|Protocol Violation|1|||
13341160|NCT01011309|26625945|FG002|Overall Study|Protocol Violation|3|||
13341161|NCT01011283|26625960|FG000|Overall Study|Adverse Event|4|||
13341162|NCT01011283|26625961|FG001|Overall Study|Adverse Event|2|||
13341163|NCT01011283|26625960|FG000|Overall Study|Progressive Disease|0|||
13341164|NCT01011283|26625961|FG001|Overall Study|Progressive Disease|2|||
13341165|NCT01011283|26625960|FG000|Overall Study|Terminated by Sponsor|5|||
13341166|NCT01011283|26625961|FG001|Overall Study|Terminated by Sponsor|5|||
13341167|NCT01011283|26625960|FG000|Overall Study|Other|2|||
13341168|NCT01011283|26625961|FG001|Overall Study|Other|2|||
13341169|NCT01011153|26625989|FG000|Overall Study|Less than 78 cases completed|8|||
13341170|NCT01011153|26625990|FG001|Overall Study|Less than 78 cases completed|11|||
13341171|NCT01011153|26625991|FG002|Overall Study|Less than 78 cases completed|9|||
13341172|NCT01011049|26626026|FG000|Overall Study|Protocol Violation|0|||
13341173|NCT01011049|26626027|FG001|Overall Study|Protocol Violation|0|||
13341174|NCT01011049|26626028|FG002|Overall Study|Protocol Violation|2|||
13341175|NCT01011049|26626029|FG003|Overall Study|Protocol Violation|0|||
13341176|NCT01011049|26626026|FG000|Overall Study|Lost to Follow-up|1|||
13341177|NCT01011049|26626027|FG001|Overall Study|Lost to Follow-up|2|||
13341178|NCT01011049|26626028|FG002|Overall Study|Lost to Follow-up|1|||
13341179|NCT01011049|26626029|FG003|Overall Study|Lost to Follow-up|0|||
13341180|NCT01011049|26626026|FG000|Overall Study|Withdrawal by Subject|0|||
13341181|NCT01011049|26626027|FG001|Overall Study|Withdrawal by Subject|0|||
13341182|NCT01011049|26626028|FG002|Overall Study|Withdrawal by Subject|1|||
13341183|NCT01011049|26626029|FG003|Overall Study|Withdrawal by Subject|0|||
13341184|NCT01010971|26626124|FG000|Overall Study|Adverse Event|2|||
13341185|NCT01010971|26626125|FG001|Overall Study|Adverse Event|4|||
13341186|NCT01010971|26626126|FG002|Overall Study|Adverse Event|3|||
13341187|NCT01010971|26626124|FG000|Overall Study|Withdrawal by Subject|0|||
13341188|NCT01010971|26626125|FG001|Overall Study|Withdrawal by Subject|2|||
13341189|NCT01010971|26626126|FG002|Overall Study|Withdrawal by Subject|5|||
13341190|NCT01010971|26626124|FG000|Overall Study|Lost to Follow-up|0|||
13341191|NCT01010971|26626125|FG001|Overall Study|Lost to Follow-up|2|||
13341192|NCT01010971|26626126|FG002|Overall Study|Lost to Follow-up|3|||
13341193|NCT01010971|26626124|FG000|Overall Study|Other|1|||
13341194|NCT01010971|26626125|FG001|Overall Study|Other|0|||
13341195|NCT01010971|26626126|FG002|Overall Study|Other|2|||
13341196|NCT01010867|26626135|FG000|Overall Study|< 50% adherence to probiotic|1|||
13341197|NCT01010776|26626159|FG000|Main Phase|Withdrawal by Subject|14|||
13341198|NCT01010776|26626159|FG000|Main Phase|Lack of Efficacy|8|||
13341199|NCT01010776|26626159|FG000|Main Phase|Adverse Event|7|||
13341200|NCT01010776|26626159|FG000|Main Phase|Lost to Follow-up|6|||
13341201|NCT01010776|26626159|FG000|Main Phase|Non-compliance to study medication|5|||
13341202|NCT01010776|26626159|FG000|Main Phase|Selection failure|2|||
13341203|NCT01010776|26626159|FG000|Main Phase|Inform consent withdrawal|1|||
13341204|NCT01010776|26626159|FG000|Main Phase|Other|1|||
13341205|NCT01010776|26626159|FG000|Main Phase|Did not received study medication|5|||
13341206|NCT01010776|26626159|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15|||
13341207|NCT01010776|26626159|FG000|Extension Phase|Other|3|||
13341208|NCT01010750|26626201|FG000|Second Intervention|Adverse Event|0|||
13341209|NCT01010750|26626202|FG001|Second Intervention|Adverse Event|1|||
13341210|NCT01010750|26626203|FG002|Second Intervention|Adverse Event|0|||
13341211|NCT01010750|26626204|FG003|Second Intervention|Adverse Event|0|||
13341212|NCT01010750|26626205|FG004|Second Intervention|Adverse Event|0|||
13341213|NCT01010750|26626206|FG005|Second Intervention|Adverse Event|0|||
13341214|NCT01010633|26626223|FG000|Overall Study|Adverse Event|1|||
13341215|NCT01010633|26626224|FG001|Overall Study|Adverse Event|1|||
13341216|NCT01010633|26626223|FG000|Overall Study|Protocol Violation|1|||
13341217|NCT01010633|26626224|FG001|Overall Study|Protocol Violation|2|||
13341218|NCT01010633|26626223|FG000|Overall Study|Withdrawal by Subject|2|||
13341219|NCT01010633|26626224|FG001|Overall Study|Withdrawal by Subject|1|||
13341220|NCT01010633|26626223|FG000|Overall Study|Investigator decision|0|||
13341221|NCT01010633|26626224|FG001|Overall Study|Investigator decision|1|||
13373997|NCT00798369|26725500|FG001|Overall Study|Adminstrative problems|0|||
13373998|NCT00798369|26725501|FG002|Overall Study|Adminstrative problems|0|||
13373999|NCT00798369|26725502|FG003|Overall Study|Adminstrative problems|0|||
13374000|NCT00798369|26725503|FG004|Overall Study|Adminstrative problems|0|||
13374001|NCT00798369|26725504|FG005|Overall Study|Adminstrative problems|1|||
13374002|NCT00798317|26725519|FG000|Overall Study|Physician Decision|0|||
13374003|NCT00798317|26725520|FG001|Overall Study|Physician Decision|1|||
13374004|NCT00798317|26725519|FG000|Overall Study|Withdrawal by Subject|5|||
13374005|NCT00798317|26725520|FG001|Overall Study|Withdrawal by Subject|4|||
13374006|NCT00798317|26725519|FG000|Overall Study|Lost to Follow-up|2|||
13374007|NCT00798317|26725520|FG001|Overall Study|Lost to Follow-up|2|||
13374008|NCT00798317|26725519|FG000|Overall Study|Adverse Event|2|||
13374009|NCT00798317|26725520|FG001|Overall Study|Adverse Event|0|||
13374010|NCT00798317|26725519|FG000|Overall Study|Death|1|||
13374011|NCT00798317|26725520|FG001|Overall Study|Death|0|||
13374012|NCT00798304|26725556|FG000|Overall Study|Adverse Event|0|||
13374013|NCT00798304|26725557|FG001|Overall Study|Adverse Event|1|||
13374014|NCT00798304|26725558|FG002|Overall Study|Adverse Event|1|||
13374015|NCT00798304|26725556|FG000|Overall Study|Discontinuation by Sponsor|14|||
13374016|NCT00798304|26725557|FG001|Overall Study|Discontinuation by Sponsor|21|||
13374017|NCT00798304|26725558|FG002|Overall Study|Discontinuation by Sponsor|9|||
13341222|NCT01010503|26626244|FG000|Overall Study|Adverse Event|1|||
13341223|NCT01010503|26626244|FG000|Overall Study|Death|1|||
13341224|NCT01010230|26626281|FG000|Overall Study|Withdrawal by Subject|6|||
13341225|NCT01010230|26626282|FG001|Overall Study|Withdrawal by Subject|5|||
13341226|NCT01010230|26626281|FG000|Overall Study|Lost to Follow-up|4|||
13341227|NCT01010230|26626282|FG001|Overall Study|Lost to Follow-up|2|||
13341228|NCT01010217|26626335|FG000|Overall Study|Lost to Follow-up|4|||
13341229|NCT01010217|26626336|FG001|Overall Study|Lost to Follow-up|5|||
13341230|NCT01010217|26626337|FG002|Overall Study|Lost to Follow-up|1|||
13341231|NCT01010217|26626338|FG003|Overall Study|Lost to Follow-up|0|||
13341232|NCT01010217|26626339|FG004|Overall Study|Lost to Follow-up|0|||
13341233|NCT01010217|26626335|FG000|Overall Study|Withdrawal by Subject|1|||
13341234|NCT01010217|26626336|FG001|Overall Study|Withdrawal by Subject|0|||
13341235|NCT01010217|26626337|FG002|Overall Study|Withdrawal by Subject|0|||
13341236|NCT01010217|26626338|FG003|Overall Study|Withdrawal by Subject|0|||
13341237|NCT01010217|26626339|FG004|Overall Study|Withdrawal by Subject|0|||
13341238|NCT01010217|26626335|FG000|Overall Study|Physician Decision|0|||
13341239|NCT01010217|26626336|FG001|Overall Study|Physician Decision|0|||
13341240|NCT01010217|26626337|FG002|Overall Study|Physician Decision|0|||
13341241|NCT01010217|26626338|FG003|Overall Study|Physician Decision|6|||
13341242|NCT01010217|26626339|FG004|Overall Study|Physician Decision|3|||
13341243|NCT01010204|26626356|FG000|Overall Study|Lost to Follow-up|2|||
13341244|NCT01010204|26626357|FG001|Overall Study|Lost to Follow-up|2|||
13341245|NCT01010204|26626356|FG000|Overall Study|Adverse Event|1|||
13341246|NCT01010204|26626357|FG001|Overall Study|Adverse Event|3|||
13341247|NCT01010204|26626356|FG000|Overall Study|Withdrawal by Subject|2|||
13341248|NCT01010204|26626357|FG001|Overall Study|Withdrawal by Subject|3|||
13341249|NCT01010204|26626356|FG000|Overall Study|psychiatric hospitalization|2|||
13341250|NCT01010204|26626357|FG001|Overall Study|psychiatric hospitalization|1|||
13341251|NCT01010126|26626426|FG000|Overall Study|Withdrawal by Subject|1|||
13341252|NCT01010126|26626427|FG001|Overall Study|Withdrawal by Subject|0|||
13341253|NCT01010126|26626428|FG002|Overall Study|Withdrawal by Subject|1|||
13341254|NCT01010126|26626429|FG003|Overall Study|Withdrawal by Subject|0|||
13341255|NCT01010126|26626430|FG004|Overall Study|Withdrawal by Subject|3|||
13341256|NCT01010126|26626431|FG005|Overall Study|Withdrawal by Subject|0|||
13341257|NCT01010061|26626470|FG000|Overall Study|Adverse Events or Intercurrent Illness|33|||
13341258|NCT01010061|26626471|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
13341259|NCT01010061|26626470|FG000|Overall Study|Disease Progression|2|||
13341260|NCT01010061|26626471|FG001|Overall Study|Disease Progression|8|||
13341261|NCT01010061|26626470|FG000|Overall Study|Withdrew Consent|5|||
13341262|NCT01010061|26626471|FG001|Overall Study|Withdrew Consent|1|||
13341263|NCT01010061|26626470|FG000|Overall Study|Death|3|||
13341264|NCT01010061|26626471|FG001|Overall Study|Death|6|||
13341265|NCT01010061|26626470|FG000|Overall Study|Administrative/Other|0|||
13341266|NCT01010061|26626471|FG001|Overall Study|Administrative/Other|1|||
13341267|NCT01010061|26626470|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2|||
13341268|NCT01010061|26626471|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
13341269|NCT01010061|26626470|FG000|Overall Study|Insufficient Therapeutic Response|1|||
13341270|NCT01010061|26626471|FG001|Overall Study|Insufficient Therapeutic Response|5|||
13341271|NCT01010061|26626470|FG000|Overall Study|Violation of Selection Criteria|0|||
13341272|NCT01010061|26626471|FG001|Overall Study|Violation of Selection Criteria|1|||
13341273|NCT01010061|26626470|FG000|Overall Study|Did Not Receive Treatment|2|||
13341274|NCT01010061|26626471|FG001|Overall Study|Did Not Receive Treatment|2|||
13341275|NCT01009983|26626480|FG000|Overall Study|necessary scans not completed|1|||
13341276|NCT01009840|26626495|FG000|Overall Study|Lost to Follow-up|1|||
13341277|NCT01009840|26626495|FG000|Overall Study|Adverse Event|4|||
13341278|NCT01009840|26626495|FG000|Overall Study|Subject Met Withdrawal Criteria|7|||
13341279|NCT01009840|26626495|FG000|Overall Study|Subject was Withdrawn by Investigator|1|||
13341280|NCT01009840|26626495|FG000|Overall Study|Subject Withdrew Consent to Participate|1|||
13341281|NCT01009814|26626618|FG000|Overall Study|No longer met study criteria|1|||
13341282|NCT01009814|26626619|FG001|Overall Study|No longer met study criteria|1|||
13341283|NCT01009814|26626620|FG002|Overall Study|No longer met study criteria|0|||
13341284|NCT01009814|26626621|FG003|Overall Study|No longer met study criteria|0|||
13341285|NCT01009814|26626622|FG004|Overall Study|No longer met study criteria|0|||
13341286|NCT01009645|26626649|FG000|Overall Study|Lost to Follow-up|2|||
13341287|NCT01009645|26626650|FG001|Overall Study|Lost to Follow-up|8|||
13341288|NCT01009645|26626651|FG002|Overall Study|Lost to Follow-up|4|||
13341289|NCT01009645|26626652|FG003|Overall Study|Lost to Follow-up|5|||
13341290|NCT01009580|26626671|FG000|Overall Study|Adverse Event|4|||
13341291|NCT01009580|26626672|FG001|Overall Study|Adverse Event|4|||
13341292|NCT01009580|26626671|FG000|Overall Study|Lack of Efficacy|0|||
13341293|NCT01009580|26626672|FG001|Overall Study|Lack of Efficacy|1|||
13341294|NCT01009580|26626671|FG000|Overall Study|Protocol Violation|2|||
13341295|NCT01009580|26626672|FG001|Overall Study|Protocol Violation|3|||
13341296|NCT01009580|26626671|FG000|Overall Study|Withdrawal Criteria|4|||
13341297|NCT01009580|26626672|FG001|Overall Study|Withdrawal Criteria|6|||
13341298|NCT01009580|26626671|FG000|Overall Study|Unclassified|17|||
13341299|NCT01009580|26626672|FG001|Overall Study|Unclassified|21|||
13341300|NCT01009554|26626811|FG000|Overall Study|Adverse Event|1|||
13341301|NCT01009554|26626812|FG001|Overall Study|Adverse Event|1|||
13341302|NCT01009554|26626811|FG000|Overall Study|Withdrawal by Subject|1|||
13341303|NCT01009554|26626812|FG001|Overall Study|Withdrawal by Subject|3|||
13341304|NCT01009554|26626811|FG000|Overall Study|Noncompliant with Study Product|0|||
13341305|NCT01009554|26626812|FG001|Overall Study|Noncompliant with Study Product|3|||
13341306|NCT01009515|26626821|FG000|Overall Study|Withdrawal by Subject|3|||
13341307|NCT01009463|26626857|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373|||
13341308|NCT01009463|26626858|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
13341309|NCT01009463|26626859|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
13341310|NCT01009463|26626860|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
13341311|NCT01009463|26626861|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
13341312|NCT01009463|26626857|FG000|4-week, Open-label Run-In Period|Adverse Event|10|||
13341313|NCT01009463|26626858|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
13341314|NCT01009463|26626859|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
13341315|NCT01009463|26626860|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
13341316|NCT01009463|26626861|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
13341317|NCT01009463|26626857|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
13341318|NCT01009463|26626858|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
13341319|NCT01009463|26626859|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
13341320|NCT01009463|26626860|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
13341321|NCT01009463|26626861|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
13341322|NCT01009463|26626857|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
13341323|NCT01009463|26626858|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
13341324|NCT01009463|26626859|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
13341325|NCT01009463|26626860|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
13341326|NCT01009463|26626861|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
13341327|NCT01009463|26626857|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50|||
13341328|NCT01009463|26626858|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
13341329|NCT01009463|26626859|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
13341330|NCT01009463|26626860|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
13341331|NCT01009463|26626861|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
13341332|NCT01009463|26626857|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
13341333|NCT01009463|26626858|FG001|52-week, Double-blind Treatment Period|Adverse Event|22|||
13341334|NCT01009463|26626859|FG002|52-week, Double-blind Treatment Period|Adverse Event|25|||
13341335|NCT01009463|26626860|FG003|52-week, Double-blind Treatment Period|Adverse Event|29|||
13341336|NCT01009463|26626861|FG004|52-week, Double-blind Treatment Period|Adverse Event|31|||
13341337|NCT01009463|26626857|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
13341338|NCT01009463|26626858|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34|||
13341339|NCT01009463|26626859|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18|||
13341340|NCT01009463|26626860|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17|||
13341341|NCT01009463|26626861|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
13341342|NCT01009463|26626857|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
13341343|NCT01009463|26626858|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24|||
13341344|NCT01009463|26626859|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
13341345|NCT01009463|26626860|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11|||
13341346|NCT01009463|26626861|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18|||
13341347|NCT01009463|26626857|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
13341348|NCT01009463|26626858|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8|||
13341349|NCT01009463|26626859|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7|||
13341350|NCT01009463|26626860|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8|||
13341351|NCT01009463|26626861|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7|||
13341352|NCT01009463|26626857|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
13341353|NCT01009463|26626858|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
13341354|NCT01009463|26626859|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14|||
13341355|NCT01009463|26626860|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
13341356|NCT01009463|26626861|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
13341357|NCT01009463|26626857|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
13341358|NCT01009463|26626858|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2|||
13341359|NCT01009463|26626859|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
13341360|NCT01009463|26626860|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
13341361|NCT01009463|26626861|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
13341362|NCT01009463|26626857|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
13341363|NCT01009463|26626858|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11|||
13341364|NCT01009463|26626859|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7|||
13341365|NCT01009463|26626860|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
13341366|NCT01009463|26626861|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5|||
13341367|NCT01009463|26626857|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
13341368|NCT01009463|26626858|FG001|52-week, Double-blind Treatment Period|Physician Decision|4|||
13341369|NCT01009463|26626859|FG002|52-week, Double-blind Treatment Period|Physician Decision|6|||
13341370|NCT01009463|26626860|FG003|52-week, Double-blind Treatment Period|Physician Decision|6|||
13341371|NCT01009463|26626861|FG004|52-week, Double-blind Treatment Period|Physician Decision|8|||
13341372|NCT01009346|26626868|FG000|Overall Study|Adverse Event|4|||
13341373|NCT01009294|26626891|FG000|Overall Study|Study discontinued by Sponsor|6|||
13341374|NCT01009281|26626903|FG000|Overall Study|Administrative problems|7|||
13341375|NCT01009203|26626912|FG000|Overall Study|Withdrawal by Subject|1|||
13341376|NCT01009203|26626912|FG000|Overall Study|Adverse Event|5|||
13341377|NCT01009203|26626912|FG000|Overall Study|Treatment-unrelated death|1|||
13341378|NCT01009099|26626925|FG000|Overall Study|Lost to Follow-up|1|||
13341379|NCT01009099|26626926|FG001|Overall Study|Lost to Follow-up|0|||
13341380|NCT01009099|26626925|FG000|Overall Study|Physician Decision|3|||
13341381|NCT01009099|26626926|FG001|Overall Study|Physician Decision|2|||
13341382|NCT01009099|26626925|FG000|Overall Study|Withdrawal by Subject|1|||
13341383|NCT01009099|26626926|FG001|Overall Study|Withdrawal by Subject|1|||
13341384|NCT01009099|26626925|FG000|Overall Study|Death|0|||
13341385|NCT01009099|26626926|FG001|Overall Study|Death|1|||
13341386|NCT01009086|26626969|FG000|Overall Study|Lack of Efficacy|16|||
13341387|NCT01009086|26626970|FG001|Overall Study|Lack of Efficacy|15|||
13341388|NCT01009086|26626971|FG002|Overall Study|Lack of Efficacy|9|||
13341389|NCT01009086|26626969|FG000|Overall Study|Lost to Follow-up|4|||
13341390|NCT01009086|26626970|FG001|Overall Study|Lost to Follow-up|5|||
13341391|NCT01009086|26626971|FG002|Overall Study|Lost to Follow-up|3|||
13341392|NCT01009086|26626969|FG000|Overall Study|Adverse Event|12|||
13341393|NCT01009086|26626970|FG001|Overall Study|Adverse Event|11|||
13341394|NCT01009086|26626971|FG002|Overall Study|Adverse Event|8|||
13341395|NCT01009086|26626969|FG000|Overall Study|Withdrawal by Subject|9|||
13341396|NCT01009086|26626970|FG001|Overall Study|Withdrawal by Subject|11|||
13341397|NCT01009086|26626971|FG002|Overall Study|Withdrawal by Subject|13|||
13341398|NCT01009086|26626969|FG000|Overall Study|Other|3|||
13341399|NCT01009086|26626970|FG001|Overall Study|Other|5|||
13341400|NCT01009086|26626971|FG002|Overall Study|Other|1|||
13341401|NCT01009060|26627014|FG000|Overall Study|Adverse Event|1|||
13341402|NCT01009060|26627015|FG001|Overall Study|Adverse Event|2|||
13341403|NCT01009060|26627014|FG000|Overall Study|Protocol Violation|0|||
13341404|NCT01009060|26627015|FG001|Overall Study|Protocol Violation|1|||
13341405|NCT01009060|26627014|FG000|Overall Study|Lost to Follow-up|1|||
13341406|NCT01009060|26627015|FG001|Overall Study|Lost to Follow-up|0|||
13341407|NCT01009060|26627014|FG000|Overall Study|Physician Decision|1|||
13341408|NCT01009060|26627015|FG001|Overall Study|Physician Decision|1|||
13341409|NCT01009060|26627014|FG000|Overall Study|Withdrawal by Subject|1|||
13341410|NCT01009060|26627015|FG001|Overall Study|Withdrawal by Subject|1|||
13341411|NCT01009047|26627044|FG000|Overall Study|Adverse Event|5|||
13341412|NCT01009047|26627045|FG001|Overall Study|Adverse Event|0|||
13341413|NCT01009047|26627044|FG000|Overall Study|Lost to Follow-up|0|||
13341414|NCT01009047|26627045|FG001|Overall Study|Lost to Follow-up|2|||
13341415|NCT01009047|26627044|FG000|Overall Study|Lack of Efficacy|4|||
13341416|NCT01009047|26627045|FG001|Overall Study|Lack of Efficacy|11|||
13341417|NCT01009047|26627044|FG000|Overall Study|Withdrawal by consent|16|||
13341418|NCT01009047|26627045|FG001|Overall Study|Withdrawal by consent|11|||
13341419|NCT01009047|26627044|FG000|Overall Study|Other|3|||
13341420|NCT01009047|26627045|FG001|Overall Study|Other|2|||
13341421|NCT01009034|26627053|FG000|Overall Study|Lost to Follow-up|2|||
13341422|NCT01009034|26627053|FG000|Overall Study|Withdrawal by Subject|2|||
13341423|NCT01008995|26627074|FG000|Controlled Period|Adverse Event|1|||
13341424|NCT01008995|26627075|FG001|Controlled Period|Adverse Event|2|||
13341425|NCT01008995|26627076|FG002|Controlled Period|Adverse Event|0|||
13341426|NCT01008995|26627077|FG003|Controlled Period|Adverse Event|0|||
13341427|NCT01008995|26627074|FG000|Controlled Period|Other|2|||
13341428|NCT01008995|26627075|FG001|Controlled Period|Other|1|||
13341429|NCT01008995|26627076|FG002|Controlled Period|Other|0|||
13341430|NCT01008995|26627077|FG003|Controlled Period|Other|0|||
13341431|NCT01008995|26627074|FG000|After Controlled Period|Adverse Event|0|||
13341432|NCT01008995|26627075|FG001|After Controlled Period|Adverse Event|0|||
13341433|NCT01008995|26627076|FG002|After Controlled Period|Adverse Event|1|||
13341434|NCT01008995|26627077|FG003|After Controlled Period|Adverse Event|1|||
13341435|NCT01008995|26627074|FG000|After Controlled Period|Other|0|||
13341436|NCT01008995|26627075|FG001|After Controlled Period|Other|0|||
13341437|NCT01008995|26627076|FG002|After Controlled Period|Other|1|||
13341438|NCT01008995|26627077|FG003|After Controlled Period|Other|0|||
13341439|NCT01008943|26627086|FG000|Overall Study|Withdrawal by Subject|1|||
13341440|NCT01008904|26627093|FG000|Overall Study|Lost to Follow-up|1|||
13341441|NCT01008904|26627093|FG000|Overall Study|Adverse Event|2|||
13341442|NCT01008904|26627093|FG000|Overall Study|unexpected unrelated surgery|1|||
13341443|NCT01008748|26627107|FG000|Overall Study|Lost to Follow-up|80|||
13341444|NCT01008748|26627107|FG000|Overall Study|Other|1|||
13341445|NCT01008696|26627124|FG000|Overall Study|Participant's evasion of hospital visit|5|||
13341446|NCT01008696|26627125|FG001|Overall Study|Participant's evasion of hospital visit|4|||
13341447|NCT01008696|26627124|FG000|Overall Study|Withdrawal by Subject|2|||
13341448|NCT01008696|26627125|FG001|Overall Study|Withdrawal by Subject|4|||
13341449|NCT01008696|26627124|FG000|Overall Study|Physician Decision|5|||
13341450|NCT01008696|26627125|FG001|Overall Study|Physician Decision|1|||
13341451|NCT01008696|26627124|FG000|Overall Study|Adverse Event|1|||
13341452|NCT01008696|26627125|FG001|Overall Study|Adverse Event|0|||
13341453|NCT01008696|26627124|FG000|Overall Study|Participants' non-cooperation|2|||
13341454|NCT01008696|26627125|FG001|Overall Study|Participants' non-cooperation|3|||
13341455|NCT01008696|26627124|FG000|Overall Study|Other|2|||
13341456|NCT01008696|26627125|FG001|Overall Study|Other|3|||
13341457|NCT01008696|26627124|FG000|Overall Study|Other|0|||
13341458|NCT01008696|26627125|FG001|Overall Study|Other|2|||
13341459|NCT01008618|26627154|FG000|Period 1 (Titration Period)|Physician Decision|2|||
13341460|NCT01008618|26627155|FG001|Period 1 (Titration Period)|Physician Decision|0|||
13341461|NCT01008618|26627156|FG002|Period 1 (Titration Period)|Physician Decision|0|||
13341462|NCT01008618|26627154|FG000|Period 1 (Titration Period)|Adverse Event|33|||
13341463|NCT01008618|26627155|FG001|Period 1 (Titration Period)|Adverse Event|0|||
13341464|NCT01008618|26627156|FG002|Period 1 (Titration Period)|Adverse Event|0|||
13341465|NCT01008618|26627154|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11|||
13341466|NCT01008618|26627155|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
13341467|NCT01008618|26627156|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
13341468|NCT01008618|26627154|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20|||
13341469|NCT01008618|26627155|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
13341470|NCT01008618|26627156|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
13341471|NCT01008618|26627154|FG000|Period 1 (Titration Period)|Aggravated symptom|2|||
13341472|NCT01008618|26627155|FG001|Period 1 (Titration Period)|Aggravated symptom|0|||
13341473|NCT01008618|26627156|FG002|Period 1 (Titration Period)|Aggravated symptom|0|||
13341474|NCT01008618|26627154|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
13341475|NCT01008618|26627155|FG001|Period 2 (Double-Blind Period)|Adverse Event|11|||
13341476|NCT01008618|26627156|FG002|Period 2 (Double-Blind Period)|Adverse Event|2|||
13341477|NCT01008618|26627154|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
13341478|NCT01008618|26627155|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3|||
13341479|NCT01008618|26627156|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
13341480|NCT01008618|26627154|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
13341481|NCT01008618|26627155|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
13341482|NCT01008618|26627156|FG002|Period 2 (Double-Blind Period)|Physician Decision|0|||
13341483|NCT01008618|26627154|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
13341484|NCT01008618|26627155|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
13341485|NCT01008618|26627156|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3|||
13341486|NCT01008618|26627154|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
13341487|NCT01008618|26627155|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
13341488|NCT01008618|26627156|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
13341489|NCT01008618|26627154|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
13341490|NCT01008618|26627155|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21|||
13341491|NCT01008618|26627156|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29|||
13341492|NCT01008618|26627154|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
13341493|NCT01008618|26627155|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
13341494|NCT01008618|26627156|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1|||
13341495|NCT01008553|26627185|FG000|Period 1 (Titration Period)|Physician Decision|2|||
13341496|NCT01008553|26627186|FG001|Period 1 (Titration Period)|Physician Decision|0|||
13341497|NCT01008553|26627187|FG002|Period 1 (Titration Period)|Physician Decision|0|||
13341498|NCT01008553|26627185|FG000|Period 1 (Titration Period)|Adverse Event|33|||
13341499|NCT01008553|26627186|FG001|Period 1 (Titration Period)|Adverse Event|0|||
13341500|NCT01008553|26627187|FG002|Period 1 (Titration Period)|Adverse Event|0|||
13341501|NCT01008553|26627185|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6|||
13341502|NCT01008553|26627186|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
13341503|NCT01008553|26627187|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
13341504|NCT01008553|26627185|FG000|Period 1 (Titration Period)|Determined to increase dosage|3|||
13341505|NCT01008553|26627186|FG001|Period 1 (Titration Period)|Determined to increase dosage|0|||
13341506|NCT01008553|26627187|FG002|Period 1 (Titration Period)|Determined to increase dosage|0|||
13341507|NCT01008553|26627185|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50|||
13341508|NCT01008553|26627186|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
13341509|NCT01008553|26627187|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
13341510|NCT01008553|26627185|FG000|Period 1 (Titration Period)|Not appropriate for this study|1|||
13341511|NCT01008553|26627186|FG001|Period 1 (Titration Period)|Not appropriate for this study|0|||
13341512|NCT01008553|26627187|FG002|Period 1 (Titration Period)|Not appropriate for this study|0|||
13341513|NCT01008553|26627185|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
13341514|NCT01008553|26627186|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
13341515|NCT01008553|26627187|FG002|Period 2 (Double-Blind Period)|Physician Decision|2|||
13341516|NCT01008553|26627185|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
13341517|NCT01008553|26627186|FG001|Period 2 (Double-Blind Period)|Adverse Event|14|||
13341518|NCT01008553|26627187|FG002|Period 2 (Double-Blind Period)|Adverse Event|4|||
13341519|NCT01008553|26627185|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
13341520|NCT01008553|26627186|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
13341521|NCT01008553|26627187|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
13341522|NCT01008553|26627185|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
13341523|NCT01008553|26627186|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1|||
13341524|NCT01008553|26627187|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
13341525|NCT01008553|26627185|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
13341526|NCT01008553|26627186|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1|||
13341527|NCT01008553|26627187|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4|||
13341528|NCT01008553|26627185|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
13341529|NCT01008553|26627186|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
13341530|NCT01008553|26627187|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3|||
13341531|NCT01008553|26627185|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
13341532|NCT01008553|26627186|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
13341533|NCT01008553|26627187|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
13341534|NCT01008553|26627185|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
13341535|NCT01008553|26627186|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18|||
13341536|NCT01008553|26627187|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35|||
13341537|NCT01008475|26627237|FG000|Overall Study|Ongoing treatment at data cut-off date|0|||
13341538|NCT01008475|26627238|FG001|Overall Study|Ongoing treatment at data cut-off date|0|||
13341539|NCT01008475|26627239|FG002|Overall Study|Ongoing treatment at data cut-off date|0|||
13341540|NCT01008475|26627240|FG003|Overall Study|Ongoing treatment at data cut-off date|0|||
13341541|NCT01008475|26627241|FG004|Overall Study|Ongoing treatment at data cut-off date|5|||
13341542|NCT01008475|26627242|FG005|Overall Study|Ongoing treatment at data cut-off date|6|||
13341543|NCT01008475|26627243|FG006|Overall Study|Ongoing treatment at data cut-off date|4|||
13341544|NCT01008449|26627270|FG000|Overall Study|Lost to Follow-up|29|||
13341545|NCT01008449|26627271|FG001|Overall Study|Lost to Follow-up|19|||
13341546|NCT01008423|26627302|FG000|Overall Study|Adverse Event|13|||
13341547|NCT01008423|26627303|FG001|Overall Study|Adverse Event|6|||
13341548|NCT01008423|26627302|FG000|Overall Study|Withdrawal by Subject|4|||
13341549|NCT01008423|26627303|FG001|Overall Study|Withdrawal by Subject|7|||
13341550|NCT01008423|26627302|FG000|Overall Study|Lost to Follow-up|0|||
13341551|NCT01008423|26627303|FG001|Overall Study|Lost to Follow-up|2|||
13341552|NCT01008423|26627302|FG000|Overall Study|Low Cortisol|0|||
13341553|NCT01008423|26627303|FG001|Overall Study|Low Cortisol|1|||
13341554|NCT01008423|26627302|FG000|Overall Study|Lack of Efficacy|0|||
13341555|NCT01008423|26627303|FG001|Overall Study|Lack of Efficacy|5|||
13341556|NCT01008423|26627302|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1|||
13341557|NCT01008423|26627303|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0|||
13341558|NCT01008423|26627302|FG000|Overall Study|Personal Conflict|1|||
13341559|NCT01008423|26627303|FG001|Overall Study|Personal Conflict|0|||
13341560|NCT01008423|26627302|FG000|Overall Study|Other|0|||
13341561|NCT01008423|26627303|FG001|Overall Study|Other|1|||
13341562|NCT01008410|26627334|FG000|Overall Study|Adverse Event|13|||
13341563|NCT01008410|26627335|FG001|Overall Study|Adverse Event|7|||
13341564|NCT01008410|26627334|FG000|Overall Study|Withdrawal by Subject|6|||
13341565|NCT01008410|26627335|FG001|Overall Study|Withdrawal by Subject|2|||
13341566|NCT01008410|26627334|FG000|Overall Study|Lost to Follow-up|1|||
13341567|NCT01008410|26627335|FG001|Overall Study|Lost to Follow-up|0|||
13341568|NCT01008410|26627334|FG000|Overall Study|Noncompliance|1|||
13341569|NCT01008410|26627335|FG001|Overall Study|Noncompliance|0|||
13341570|NCT01008410|26627334|FG000|Overall Study|Low Cortisol|2|||
13341571|NCT01008410|26627335|FG001|Overall Study|Low Cortisol|0|||
13341572|NCT01008410|26627334|FG000|Overall Study|Lack of Efficacy|2|||
13341573|NCT01008410|26627335|FG001|Overall Study|Lack of Efficacy|6|||
13341574|NCT01008410|26627334|FG000|Overall Study|Met Exclusion Criterion|0|||
13341575|NCT01008410|26627335|FG001|Overall Study|Met Exclusion Criterion|1|||
13341576|NCT01008150|26627378|FG000|Overall Study|did not receive study drug|1|||
13341577|NCT01008150|26627379|FG001|Overall Study|did not receive study drug|1|||
13341578|NCT01008150|26627380|FG002|Overall Study|did not receive study drug|1|||
13341579|NCT01008150|26627381|FG003|Overall Study|did not receive study drug|0|||
13341580|NCT01007942|26627410|FG000|Overall Study|Adverse Event|29|||
13341581|NCT01007942|26627411|FG001|Overall Study|Adverse Event|14|||
13341582|NCT01007942|26627410|FG000|Overall Study|Abnormal test procedure|0|||
13341583|NCT01007942|26627411|FG001|Overall Study|Abnormal test procedure|1|||
13341584|NCT01007942|26627410|FG000|Overall Study|Disease progression|217|||
13341585|NCT01007942|26627411|FG001|Overall Study|Disease progression|242|||
13341586|NCT01007942|26627410|FG000|Overall Study|New cancer therapy|5|||
13341587|NCT01007942|26627411|FG001|Overall Study|New cancer therapy|1|||
13341588|NCT01007942|26627410|FG000|Overall Study|Protocol Violation|1|||
13341589|NCT01007942|26627411|FG001|Overall Study|Protocol Violation|1|||
13341590|NCT01007942|26627410|FG000|Overall Study|Withdrawal by Subject|19|||
13341591|NCT01007942|26627411|FG001|Overall Study|Withdrawal by Subject|14|||
13341592|NCT01007942|26627410|FG000|Overall Study|Lost to Follow-up|1|||
13341593|NCT01007942|26627411|FG001|Overall Study|Lost to Follow-up|0|||
13341594|NCT01007942|26627410|FG000|Overall Study|Administrative problems|2|||
13341595|NCT01007942|26627411|FG001|Overall Study|Administrative problems|0|||
13341596|NCT01007942|26627410|FG000|Overall Study|Death|3|||
13341597|NCT01007942|26627411|FG001|Overall Study|Death|2|||
13341598|NCT01007942|26627410|FG000|Overall Study|Patients untreated|4|||
13341599|NCT01007942|26627411|FG001|Overall Study|Patients untreated|3|||
13341600|NCT01007916|26627420|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1|||
13341601|NCT01007916|26627421|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0|||
13341602|NCT01007916|26627420|FG000|Period 2, 4 Weeks of Wear|Relocation|1|||
13341603|NCT01007916|26627421|FG001|Period 2, 4 Weeks of Wear|Relocation|0|||
13341604|NCT01007838|26627444|FG000|Overall Study|Withdrawal by Subject|1|||
13341605|NCT01007838|26627445|FG001|Overall Study|Withdrawal by Subject|0|||
13341606|NCT01007838|26627446|FG002|Overall Study|Withdrawal by Subject|0|||
13341607|NCT01007838|26627447|FG003|Overall Study|Withdrawal by Subject|0|||
13341608|NCT01007838|26627444|FG000|Overall Study|Physician Decision|1|||
13341609|NCT01007838|26627445|FG001|Overall Study|Physician Decision|0|||
13341610|NCT01007838|26627446|FG002|Overall Study|Physician Decision|0|||
13341611|NCT01007838|26627447|FG003|Overall Study|Physician Decision|0|||
13341612|NCT01007838|26627444|FG000|Overall Study|Started home haemodialysis|1|||
13341613|NCT01007838|26627445|FG001|Overall Study|Started home haemodialysis|0|||
13341614|NCT01007838|26627446|FG002|Overall Study|Started home haemodialysis|0|||
13341615|NCT01007838|26627447|FG003|Overall Study|Started home haemodialysis|0|||
13341616|NCT01007812|26627456|FG000|Period 1, One Week|Lost to Follow-up|0|||
13341617|NCT01007812|26627457|FG001|Period 1, One Week|Lost to Follow-up|1|||
13341618|NCT01007812|26627456|FG000|Period 1, One Week|Discomfort|1|||
13341619|NCT01007812|26627457|FG001|Period 1, One Week|Discomfort|0|||
13341620|NCT01007552|26627469|FG000|Overall Study|Withdrawal by Subject|1|||
13341621|NCT01007448|26627504|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1|||
13341622|NCT01007448|26627505|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0|||
13341623|NCT01007448|26627504|FG000|Overall Study|Staph Skin Infection Flare|1|||
13341624|NCT01007448|26627505|FG001|Overall Study|Staph Skin Infection Flare|0|||
13341625|NCT01007448|26627504|FG000|Overall Study|Participant Leaving the Country|1|||
13341626|NCT01007448|26627505|FG001|Overall Study|Participant Leaving the Country|0|||
13341627|NCT01007448|26627504|FG000|Overall Study|Participant Given Prohibited Medication|1|||
13341628|NCT01007448|26627505|FG001|Overall Study|Participant Given Prohibited Medication|0|||
13341629|NCT01007448|26627504|FG000|Overall Study|Progressive Disease|1|||
13341630|NCT01007448|26627505|FG001|Overall Study|Progressive Disease|2|||
13341631|NCT01007448|26627504|FG000|Overall Study|Lack of Efficacy|2|||
13341632|NCT01007448|26627505|FG001|Overall Study|Lack of Efficacy|0|||
13341633|NCT01007448|26627504|FG000|Overall Study|Withdrawal by Subject|2|||
13341634|NCT01007448|26627505|FG001|Overall Study|Withdrawal by Subject|3|||
13341635|NCT01007448|26627504|FG000|Overall Study|Adverse Event|1|||
13341636|NCT01007448|26627505|FG001|Overall Study|Adverse Event|4|||
13341637|NCT01007435|26627560|FG000|Overall Study|Adverse Event|16|||
13341638|NCT01007435|26627561|FG001|Overall Study|Adverse Event|25|||
13341639|NCT01007435|26627562|FG002|Overall Study|Adverse Event|47|||
13341640|NCT01007435|26627563|FG003|Overall Study|Adverse Event|31|||
13341641|NCT01007435|26627560|FG000|Overall Study|Death|2|||
13341642|NCT01007435|26627561|FG001|Overall Study|Death|4|||
13341643|NCT01007435|26627562|FG002|Overall Study|Death|2|||
13341644|NCT01007435|26627563|FG003|Overall Study|Death|1|||
13341645|NCT01007435|26627560|FG000|Overall Study|Insufficient Therapeutic Response|21|||
13341646|NCT01007435|26627561|FG001|Overall Study|Insufficient Therapeutic Response|7|||
13341647|NCT01007435|26627562|FG002|Overall Study|Insufficient Therapeutic Response|2|||
13341648|NCT01007435|26627563|FG003|Overall Study|Insufficient Therapeutic Response|9|||
13341649|NCT01007435|26627560|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
13341650|NCT01007435|26627561|FG001|Overall Study|Violation of Selection Criteria at Entry|5|||
13341651|NCT01007435|26627562|FG002|Overall Study|Violation of Selection Criteria at Entry|2|||
13341652|NCT01007435|26627563|FG003|Overall Study|Violation of Selection Criteria at Entry|0|||
13341653|NCT01007435|26627560|FG000|Overall Study|Other Protocol Violation|2|||
13341654|NCT01007435|26627561|FG001|Overall Study|Other Protocol Violation|0|||
13204324|NCT01974817|26228279|FG000|Overall Study|Death|4|||
13341655|NCT01007435|26627562|FG002|Overall Study|Other Protocol Violation|1|||
13341656|NCT01007435|26627563|FG003|Overall Study|Other Protocol Violation|0|||
13341657|NCT01007435|26627560|FG000|Overall Study|Refused Treatment|13|||
13341658|NCT01007435|26627561|FG001|Overall Study|Refused Treatment|13|||
13341659|NCT01007435|26627562|FG002|Overall Study|Refused Treatment|5|||
13341660|NCT01007435|26627563|FG003|Overall Study|Refused Treatment|8|||
13341661|NCT01007435|26627560|FG000|Overall Study|Failure to Return|5|||
13341662|NCT01007435|26627561|FG001|Overall Study|Failure to Return|4|||
13341663|NCT01007435|26627562|FG002|Overall Study|Failure to Return|3|||
13341664|NCT01007435|26627563|FG003|Overall Study|Failure to Return|6|||
13341665|NCT01007435|26627560|FG000|Overall Study|Reason not Specified|1|||
13341666|NCT01007435|26627561|FG001|Overall Study|Reason not Specified|1|||
13341667|NCT01007435|26627562|FG002|Overall Study|Reason not Specified|2|||
13341668|NCT01007435|26627563|FG003|Overall Study|Reason not Specified|1|||
13341669|NCT01007396|26627570|FG000|Overall Study|Lost to Follow-up|47|||
13341670|NCT01007253|26627605|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1|||
13341671|NCT01007253|26627606|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0|||
13341672|NCT01007253|26627607|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0|||
13341673|NCT01007253|26627608|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0|||
13341674|NCT01007149|26627637|FG000|Overall Study|Administrative problems|0|||
13341675|NCT01007149|26627638|FG001|Overall Study|Administrative problems|1|||
13341676|NCT01007123|26627680|FG000|Overall Study|Adverse Event|3|||
13341677|NCT01007123|26627681|FG001|Overall Study|Adverse Event|4|||
13341678|NCT01007123|26627682|FG002|Overall Study|Adverse Event|7|||
13341679|NCT01007123|26627683|FG003|Overall Study|Adverse Event|1|||
13341680|NCT01007123|26627680|FG000|Overall Study|Lack of Efficacy|1|||
13341681|NCT01007123|26627681|FG001|Overall Study|Lack of Efficacy|0|||
13341682|NCT01007123|26627682|FG002|Overall Study|Lack of Efficacy|1|||
13341683|NCT01007123|26627683|FG003|Overall Study|Lack of Efficacy|4|||
13341684|NCT01007123|26627680|FG000|Overall Study|Protocol Violation|1|||
13341685|NCT01007123|26627681|FG001|Overall Study|Protocol Violation|1|||
13341686|NCT01007123|26627682|FG002|Overall Study|Protocol Violation|2|||
13341687|NCT01007123|26627683|FG003|Overall Study|Protocol Violation|1|||
13341688|NCT01007123|26627680|FG000|Overall Study|Withdrawal by Subject|1|||
13341689|NCT01007123|26627681|FG001|Overall Study|Withdrawal by Subject|0|||
13341690|NCT01007123|26627682|FG002|Overall Study|Withdrawal by Subject|1|||
13341691|NCT01007123|26627683|FG003|Overall Study|Withdrawal by Subject|0|||
13341692|NCT01007123|26627680|FG000|Overall Study|Lost to Follow-up|0|||
13341693|NCT01007123|26627681|FG001|Overall Study|Lost to Follow-up|1|||
13341694|NCT01007123|26627682|FG002|Overall Study|Lost to Follow-up|0|||
13341695|NCT01007123|26627683|FG003|Overall Study|Lost to Follow-up|0|||
13341696|NCT01007032|26627738|FG000|Overall Study|On Study Treatment at Cut-off Date|0|||
13341697|NCT01007032|26627739|FG001|Overall Study|On Study Treatment at Cut-off Date|1|||
13341698|NCT01007032|26627740|FG002|Overall Study|On Study Treatment at Cut-off Date|1|||
13341699|NCT01007032|26627741|FG003|Overall Study|On Study Treatment at Cut-off Date|0|||
13341700|NCT01007032|26627738|FG000|Overall Study|Withdrawal by Subject|0|||
13341701|NCT01007032|26627739|FG001|Overall Study|Withdrawal by Subject|0|||
13341702|NCT01007032|26627740|FG002|Overall Study|Withdrawal by Subject|0|||
13341703|NCT01007032|26627741|FG003|Overall Study|Withdrawal by Subject|1|||
13341704|NCT01006980|26627768|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1|||
13341705|NCT01006980|26627769|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45|||
13341706|NCT01006980|26627768|FG000|Vemurafenib and Dacarbazine|Adverse Event|25|||
13341707|NCT01006980|26627769|FG001|Vemurafenib and Dacarbazine|Adverse Event|5|||
13341708|NCT01006980|26627768|FG000|Vemurafenib and Dacarbazine|Death|13|||
13341709|NCT01006980|26627769|FG001|Vemurafenib and Dacarbazine|Death|12|||
13341710|NCT01006980|26627768|FG000|Vemurafenib and Dacarbazine|Progression|257|||
13341711|NCT01006980|26627769|FG001|Vemurafenib and Dacarbazine|Progression|218|||
13341712|NCT01006980|26627768|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4|||
13341713|NCT01006980|26627769|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6|||
13341714|NCT01006980|26627768|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9|||
13341715|NCT01006980|26627769|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6|||
13341716|NCT01006980|26627768|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2|||
13341717|NCT01006980|26627769|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3|||
13341718|NCT01006980|26627768|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26|||
13341719|NCT01006980|26627769|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43|||
13341720|NCT01006980|26627768|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0|||
13341721|NCT01006980|26627769|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4|||
13341722|NCT01006980|26627768|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0|||
13341723|NCT01006980|26627769|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4|||
13341724|NCT01006980|26627768|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0|||
13341725|NCT01006980|26627769|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65|||
13341726|NCT01006980|26627768|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0|||
13341727|NCT01006980|26627769|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1|||
13341728|NCT01006980|26627768|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0|||
13341729|NCT01006980|26627769|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10|||
13341730|NCT01006889|26627782|FG000|Overall Study|Withdrawal by Subject|3|||
13341731|NCT01006707|26627797|FG000|Study Session 1|Lost to Follow-up|2|||
13341732|NCT01006707|26627798|FG001|Study Session 1|Lost to Follow-up|0|||
13341733|NCT01006707|26627799|FG002|Study Session 1|Lost to Follow-up|0|||
13341734|NCT01006707|26627797|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3|||
13341735|NCT01006707|26627798|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0|||
13341736|NCT01006707|26627799|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0|||
13341737|NCT01006629|26627812|FG000|Overall Study|Adverse Event|1|||
13341738|NCT01006629|26627812|FG000|Overall Study|Parent refused to continue participation|1|||
13341739|NCT01006629|26627812|FG000|Overall Study|Parent unable to perform site visit|4|||
13341740|NCT01006616|26627959|FG000|Period 1 (6 Months)|Adverse Event|10|||
13124723|NCT02939950|25953768|FG000|Overall Study|Unacceptable distance lens visual acuity|1|||
13124724|NCT02939950|25953769|FG001|Overall Study|Unacceptable distance lens visual acuity|1|||
13124725|NCT02939950|25953768|FG000|Overall Study|Military orders|1|||
13341741|NCT01006616|26627960|FG001|Period 1 (6 Months)|Adverse Event|31|||
13341742|NCT01006616|26627961|FG002|Period 1 (6 Months)|Adverse Event|37|||
13341743|NCT01006616|26627962|FG003|Period 1 (6 Months)|Adverse Event|9|||
13341744|NCT01006616|26627959|FG000|Period 1 (6 Months)|Lack of Efficacy|3|||
13341745|NCT01006616|26627960|FG001|Period 1 (6 Months)|Lack of Efficacy|4|||
13341746|NCT01006616|26627961|FG002|Period 1 (6 Months)|Lack of Efficacy|0|||
13341747|NCT01006616|26627962|FG003|Period 1 (6 Months)|Lack of Efficacy|4|||
13341748|NCT01006616|26627959|FG000|Period 1 (6 Months)|Lost to Follow-up|0|||
13341749|NCT01006616|26627960|FG001|Period 1 (6 Months)|Lost to Follow-up|0|||
13341750|NCT01006616|26627961|FG002|Period 1 (6 Months)|Lost to Follow-up|1|||
13341751|NCT01006616|26627962|FG003|Period 1 (6 Months)|Lost to Follow-up|0|||
13341752|NCT01006616|26627959|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6|||
13341753|NCT01006616|26627960|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5|||
13341754|NCT01006616|26627961|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2|||
13341755|NCT01006616|26627962|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3|||
13341756|NCT01006616|26627959|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0|||
13341757|NCT01006616|26627960|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3|||
13124726|NCT02939950|25953769|FG001|Overall Study|Military orders|0|||
13124727|NCT02939950|25953768|FG000|Overall Study|Participant Relocated|5|||
13124728|NCT02939950|25953769|FG001|Overall Study|Participant Relocated|3|||
13124729|NCT02939950|25953768|FG000|Overall Study|Study related symptoms|8|||
13124730|NCT02939950|25953769|FG001|Overall Study|Study related symptoms|8|||
13124731|NCT02939950|25953768|FG000|Overall Study|Unacceptable lens movement|2|||
13124732|NCT02939950|25953769|FG001|Overall Study|Unacceptable lens movement|0|||
13124733|NCT02939950|25953768|FG000|Overall Study|Protocol Violation|6|||
13124734|NCT02939950|25953769|FG001|Overall Study|Protocol Violation|3|||
13124735|NCT02939950|25953768|FG000|Overall Study|Physician Decision|2|||
13124736|NCT02939950|25953769|FG001|Overall Study|Physician Decision|0|||
13124737|NCT02939950|25953768|FG000|Overall Study|Pregnancy|6|||
13124738|NCT02939950|25953769|FG001|Overall Study|Pregnancy|7|||
13124739|NCT02939950|25953768|FG000|Overall Study|Withdrawal by Subject|12|||
13124740|NCT02939950|25953769|FG001|Overall Study|Withdrawal by Subject|28|||
13124741|NCT02939950|25953768|FG000|Overall Study|Adverse Event|7|||
13124742|NCT02939950|25953769|FG001|Overall Study|Adverse Event|3|||
13124743|NCT02939950|25953768|FG000|Overall Study|Randomized, not dispensed|1|||
13124744|NCT02939950|25953769|FG001|Overall Study|Randomized, not dispensed|0|||
13124745|NCT02939950|25953768|FG000|Overall Study|Ineligible at Baseline|2|||
13124746|NCT02939950|25953769|FG001|Overall Study|Ineligible at Baseline|8|||
13124747|NCT02939937|25953790|FG000|Overall Study|Adverse Event|5|||
13124748|NCT02939937|25953791|FG001|Overall Study|Adverse Event|0|||
13124749|NCT02939937|25953790|FG000|Overall Study|Lost to Follow-up|1|||
13124750|NCT02939937|25953791|FG001|Overall Study|Lost to Follow-up|3|||
13124751|NCT02939781|25953798|FG000|Overall Study|Protocol Violation|8|||
13124752|NCT02939781|25953798|FG000|Overall Study|Withdrawal by Subject|1|||
13124753|NCT02939716|25953828|FG000|Overall Study|scanner failure|0|||
13341758|NCT01006616|26627961|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1|||
13341759|NCT01006616|26627962|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2|||
13341760|NCT01006616|26627959|FG000|Period 1 (6 Months)|Withdrawal by Subject|2|||
13341761|NCT01006616|26627960|FG001|Period 1 (6 Months)|Withdrawal by Subject|2|||
13341762|NCT01006616|26627961|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
13341763|NCT01006616|26627962|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
13341764|NCT01006616|26627959|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
13341765|NCT01006616|26627960|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7|||
13341766|NCT01006616|26627961|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
13341767|NCT01006616|26627962|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
13341768|NCT01006616|26627959|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0|||
13341769|NCT01006616|26627960|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2|||
13124754|NCT02939716|25953829|FG001|Overall Study|scanner failure|0|||
13341770|NCT01006616|26627961|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2|||
13341771|NCT01006616|26627962|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3|||
13341772|NCT01006616|26627959|FG000|Period 1 (6 Months)|Not Treated|0|||
13341773|NCT01006616|26627960|FG001|Period 1 (6 Months)|Not Treated|0|||
13341774|NCT01006616|26627961|FG002|Period 1 (6 Months)|Not Treated|1|||
13341775|NCT01006616|26627962|FG003|Period 1 (6 Months)|Not Treated|1|||
13341776|NCT01006616|26627959|FG000|Period 2 (18 Months)|Adverse Event|6|||
13341777|NCT01006616|26627960|FG001|Period 2 (18 Months)|Adverse Event|6|||
13341778|NCT01006616|26627961|FG002|Period 2 (18 Months)|Adverse Event|6|||
13341779|NCT01006616|26627962|FG003|Period 2 (18 Months)|Adverse Event|4|||
13341780|NCT01006616|26627959|FG000|Period 2 (18 Months)|Lack of Efficacy|0|||
13341781|NCT01006616|26627960|FG001|Period 2 (18 Months)|Lack of Efficacy|0|||
13341782|NCT01006616|26627961|FG002|Period 2 (18 Months)|Lack of Efficacy|1|||
13341783|NCT01006616|26627962|FG003|Period 2 (18 Months)|Lack of Efficacy|2|||
13341784|NCT01006616|26627959|FG000|Period 2 (18 Months)|Lost to Follow-up|2|||
13341785|NCT01006616|26627960|FG001|Period 2 (18 Months)|Lost to Follow-up|0|||
13341786|NCT01006616|26627961|FG002|Period 2 (18 Months)|Lost to Follow-up|0|||
13341787|NCT01006616|26627962|FG003|Period 2 (18 Months)|Lost to Follow-up|0|||
13341788|NCT01006616|26627959|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
13341789|NCT01006616|26627960|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0|||
13341790|NCT01006616|26627961|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
13341791|NCT01006616|26627962|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2|||
13341792|NCT01006616|26627959|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0|||
13341793|NCT01006616|26627960|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6|||
13341794|NCT01006616|26627961|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1|||
13341795|NCT01006616|26627962|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2|||
13341796|NCT01006616|26627959|FG000|Period 2 (18 Months)|Withdrawal by Subject|1|||
13341797|NCT01006616|26627960|FG001|Period 2 (18 Months)|Withdrawal by Subject|4|||
13341798|NCT01006616|26627961|FG002|Period 2 (18 Months)|Withdrawal by Subject|0|||
13341799|NCT01006616|26627962|FG003|Period 2 (18 Months)|Withdrawal by Subject|1|||
13341800|NCT01006616|26627959|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0|||
13341801|NCT01006616|26627960|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1|||
13341802|NCT01006616|26627961|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0|||
13341803|NCT01006616|26627962|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1|||
13341804|NCT01006616|26627959|FG000|Period 2 (18 Months)|Study Terminated|63|||
13341805|NCT01006616|26627960|FG001|Period 2 (18 Months)|Study Terminated|46|||
13341806|NCT01006616|26627961|FG002|Period 2 (18 Months)|Study Terminated|44|||
13341807|NCT01006616|26627962|FG003|Period 2 (18 Months)|Study Terminated|70|||
13341808|NCT01006603|26627987|FG000|Overall Study|Withdrawal by Subject|17|||
13341809|NCT01006603|26627988|FG001|Overall Study|Withdrawal by Subject|19|||
13341810|NCT01006603|26627987|FG000|Overall Study|Lost to Follow-up|0|||
13341811|NCT01006603|26627988|FG001|Overall Study|Lost to Follow-up|1|||
13341812|NCT01006603|26627987|FG000|Overall Study|Safety reason|1|||
13341813|NCT01006603|26627988|FG001|Overall Study|Safety reason|1|||
13341814|NCT01006603|26627987|FG000|Overall Study|Protocol Violation|1|||
13341815|NCT01006603|26627988|FG001|Overall Study|Protocol Violation|3|||
13341816|NCT01006603|26627987|FG000|Overall Study|Incorrect enrolment|0|||
13341817|NCT01006603|26627988|FG001|Overall Study|Incorrect enrolment|2|||
13341818|NCT01006603|26627987|FG000|Overall Study|Adverse Event|15|||
13341819|NCT01006603|26627988|FG001|Overall Study|Adverse Event|7|||
13341820|NCT01006603|26627987|FG000|Overall Study|Death|1|||
13341821|NCT01006603|26627988|FG001|Overall Study|Death|1|||
13341822|NCT01006603|26627987|FG000|Overall Study|Study specific discontinuation criteria|33|||
13341823|NCT01006603|26627988|FG001|Overall Study|Study specific discontinuation criteria|34|||
13341824|NCT01006603|26627987|FG000|Overall Study|Other|3|||
13341825|NCT01006603|26627988|FG001|Overall Study|Other|7|||
13341826|NCT01006590|26628011|FG000|Overall Study|Adverse Event|2|||
13341827|NCT01006590|26628012|FG001|Overall Study|Adverse Event|3|||
13341828|NCT01006590|26628011|FG000|Overall Study|Death|1|||
13341829|NCT01006590|26628012|FG001|Overall Study|Death|1|||
13341830|NCT01006590|26628011|FG000|Overall Study|Lost to Follow-up|1|||
13341831|NCT01006590|26628012|FG001|Overall Study|Lost to Follow-up|1|||
13341832|NCT01006590|26628011|FG000|Overall Study|Protocol Violation|1|||
13341833|NCT01006590|26628012|FG001|Overall Study|Protocol Violation|0|||
13341834|NCT01006590|26628011|FG000|Overall Study|Withdrawal by Subject|4|||
13341835|NCT01006590|26628012|FG001|Overall Study|Withdrawal by Subject|2|||
13341836|NCT01006590|26628011|FG000|Overall Study|Study specific discontinuation criteria|16|||
13341837|NCT01006590|26628012|FG001|Overall Study|Study specific discontinuation criteria|23|||
13341838|NCT01006590|26628011|FG000|Overall Study|Other|3|||
13341839|NCT01006590|26628012|FG001|Overall Study|Other|2|||
13341840|NCT01006356|26628026|FG000|Overall Study|Adverse Event|6|||
13341841|NCT01006356|26628026|FG000|Overall Study|Physician Decision|1|||
13341842|NCT01006356|26628026|FG000|Overall Study|Paticipants did not cooperate|6|||
13341843|NCT01006356|26628026|FG000|Overall Study|Withdrawal by Subject|1|||
13341844|NCT01006356|26628026|FG000|Overall Study|Choice by participants|2|||
13341845|NCT01006356|26628026|FG000|Overall Study|Protocol Violation|3|||
13341846|NCT01006356|26628026|FG000|Overall Study|Other|23|||
13341847|NCT01006291|26628053|FG000|Overall Study|Adverse Event|2|||
13341848|NCT01006291|26628054|FG001|Overall Study|Adverse Event|1|||
13341849|NCT01006291|26628055|FG002|Overall Study|Adverse Event|2|||
13341850|NCT01006291|26628053|FG000|Overall Study|Lack of Efficacy|2|||
13341851|NCT01006291|26628054|FG001|Overall Study|Lack of Efficacy|2|||
13341852|NCT01006291|26628055|FG002|Overall Study|Lack of Efficacy|1|||
13341853|NCT01006291|26628053|FG000|Overall Study|Protocol Violation|3|||
13341854|NCT01006291|26628054|FG001|Overall Study|Protocol Violation|3|||
13341855|NCT01006291|26628055|FG002|Overall Study|Protocol Violation|3|||
13341856|NCT01006291|26628053|FG000|Overall Study|Withdrawal criteria|5|||
13341857|NCT01006291|26628054|FG001|Overall Study|Withdrawal criteria|4|||
13341858|NCT01006291|26628055|FG002|Overall Study|Withdrawal criteria|4|||
13341859|NCT01006291|26628053|FG000|Overall Study|Other|14|||
13341860|NCT01006291|26628054|FG001|Overall Study|Other|14|||
13341861|NCT01006291|26628055|FG002|Overall Study|Other|17|||
13341862|NCT01006265|26628086|FG000|Overall Study|Lost to Follow-up|1|||
13341863|NCT01006265|26628087|FG001|Overall Study|Lost to Follow-up|0|||
13341864|NCT01006265|26628088|FG002|Overall Study|Lost to Follow-up|1|||
13341865|NCT01006265|26628089|FG003|Overall Study|Lost to Follow-up|0|||
13341866|NCT01006265|26628086|FG000|Overall Study|Withdrawal by Subject|4|||
13341867|NCT01006265|26628087|FG001|Overall Study|Withdrawal by Subject|7|||
13341868|NCT01006265|26628088|FG002|Overall Study|Withdrawal by Subject|5|||
13341869|NCT01006265|26628089|FG003|Overall Study|Withdrawal by Subject|5|||
13341870|NCT01006265|26628086|FG000|Overall Study|Administrative reason|1|||
13341871|NCT01006265|26628087|FG001|Overall Study|Administrative reason|2|||
13341872|NCT01006265|26628088|FG002|Overall Study|Administrative reason|3|||
13341873|NCT01006265|26628089|FG003|Overall Study|Administrative reason|0|||
13341874|NCT01006135|26628098|FG000|Overall Study|Adverse Event|22|||
13341875|NCT01006135|26628098|FG000|Overall Study|Protocol Violation|14|||
13341876|NCT01006135|26628098|FG000|Overall Study|Lost to Follow-up|32|||
13341877|NCT01006135|26628098|FG000|Overall Study|Other|72|||
13341878|NCT01006122|26628139|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
13341879|NCT01006122|26628140|FG001|First Double-blind Intervention Period|Lost to Follow-up|2|||
13341880|NCT01006122|26628139|FG000|First Double-blind Intervention Period|Protocol Violation|1|||
13341881|NCT01006122|26628140|FG001|First Double-blind Intervention Period|Protocol Violation|1|||
13341882|NCT01006122|26628139|FG000|First Double-blind Intervention Period|Pregnancy|0|||
13341883|NCT01006122|26628140|FG001|First Double-blind Intervention Period|Pregnancy|1|||
13341884|NCT01006122|26628139|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9|||
13341885|NCT01006122|26628140|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8|||
13341886|NCT01006122|26628139|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1|||
13341887|NCT01006122|26628140|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0|||
13341888|NCT01006122|26628139|FG000|First Double-blind Intervention Period|Lack of Efficacy|2|||
13341889|NCT01006122|26628140|FG001|First Double-blind Intervention Period|Lack of Efficacy|1|||
13341890|NCT01006122|26628139|FG000|First Double-blind Intervention Period|Other|3|||
13341891|NCT01006122|26628140|FG001|First Double-blind Intervention Period|Other|0|||
13341892|NCT01006122|26628139|FG000|First Double-blind Intervention Period|Adverse Event|0|||
13341893|NCT01006122|26628140|FG001|First Double-blind Intervention Period|Adverse Event|4|||
13341894|NCT01006122|26628139|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
13341895|NCT01006122|26628140|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
13341896|NCT01006122|26628139|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
13341897|NCT01006122|26628140|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
13341898|NCT01006122|26628139|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
13341899|NCT01006122|26628140|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3|||
13341900|NCT01006122|26628139|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
13341901|NCT01006122|26628140|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2|||
13341902|NCT01006122|26628139|FG000|Second Double-blind Intervention Period|Death|0|||
13341903|NCT01006122|26628140|FG001|Second Double-blind Intervention Period|Death|1|||
13341904|NCT01005966|26628166|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
13341905|NCT01005966|26628167|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
13341906|NCT01005966|26628168|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
13341907|NCT01005966|26628169|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
13341908|NCT01005966|26628170|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
13341909|NCT01005966|26628166|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
13341910|NCT01005966|26628167|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0|||
13341911|NCT01005966|26628168|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1|||
13341912|NCT01005966|26628169|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0|||
13341913|NCT01005966|26628170|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0|||
13341914|NCT01005966|26628166|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
13341915|NCT01005966|26628167|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
13341916|NCT01005966|26628168|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
13341917|NCT01005966|26628169|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1|||
13341918|NCT01005966|26628170|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
13341919|NCT01005966|26628166|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
13341920|NCT01005966|26628167|FG001|Treatment Period 2 (14 Days)|Adverse Event|1|||
13341921|NCT01005966|26628168|FG002|Treatment Period 2 (14 Days)|Adverse Event|1|||
13341922|NCT01005966|26628169|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
13341923|NCT01005966|26628170|FG004|Treatment Period 2 (14 Days)|Adverse Event|0|||
13341924|NCT01005966|26628166|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
13341925|NCT01005966|26628167|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
13341926|NCT01005966|26628168|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
13341927|NCT01005966|26628169|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
13341928|NCT01005966|26628170|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
13341929|NCT01005966|26628166|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
13341930|NCT01005966|26628167|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
13341931|NCT01005966|26628168|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
13341932|NCT01005966|26628169|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
13341933|NCT01005966|26628170|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
13341934|NCT01005966|26628166|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0|||
13341935|NCT01005966|26628167|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1|||
13341936|NCT01005966|26628168|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0|||
13341937|NCT01005966|26628169|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0|||
13341938|NCT01005966|26628170|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1|||
13341939|NCT01005966|26628166|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0|||
13341940|NCT01005966|26628167|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1|||
13341941|NCT01005966|26628168|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0|||
13341942|NCT01005966|26628169|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0|||
13341943|NCT01005966|26628170|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0|||
13341944|NCT01005966|26628166|FG000|Treatment Period 4 (14 Days)|Other Reason|0|||
13341945|NCT01005966|26628167|FG001|Treatment Period 4 (14 Days)|Other Reason|0|||
13341946|NCT01005966|26628168|FG002|Treatment Period 4 (14 Days)|Other Reason|0|||
13341947|NCT01005966|26628169|FG003|Treatment Period 4 (14 Days)|Other Reason|0|||
13341948|NCT01005966|26628170|FG004|Treatment Period 4 (14 Days)|Other Reason|1|||
13341949|NCT01005901|26628215|FG000|Overall Study|Withdrawal by Subject|38|||
13341950|NCT01005901|26628216|FG001|Overall Study|Withdrawal by Subject|14|||
13341951|NCT01005901|26628215|FG000|Overall Study|Adverse Event|30|||
13341952|NCT01005901|26628216|FG001|Overall Study|Adverse Event|16|||
13341953|NCT01005901|26628215|FG000|Overall Study|Administrative problems|21|||
13341954|NCT01005901|26628216|FG001|Overall Study|Administrative problems|13|||
13341955|NCT01005901|26628215|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
13341956|NCT01005901|26628216|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
13341957|NCT01005901|26628215|FG000|Overall Study|Protocol Violation|4|||
13341958|NCT01005901|26628216|FG001|Overall Study|Protocol Violation|3|||
13341959|NCT01005901|26628215|FG000|Overall Study|Death|2|||
13341960|NCT01005901|26628216|FG001|Overall Study|Death|3|||
13341961|NCT01005901|26628215|FG000|Overall Study|Lost to Follow-up|1|||
13341962|NCT01005901|26628216|FG001|Overall Study|Lost to Follow-up|2|||
13341963|NCT01005901|26628215|FG000|Overall Study|Patient's inability to use the device|1|||
13341964|NCT01005901|26628216|FG001|Overall Study|Patient's inability to use the device|1|||
13341965|NCT01005901|26628215|FG000|Overall Study|No longer requires study drug|0|||
13341966|NCT01005901|26628216|FG001|Overall Study|No longer requires study drug|1|||
13341967|NCT01005875|26628226|FG000|Overall Study|Death|3|||
13341968|NCT01005732|26628244|FG000|Overall Study|Lost to Follow-up|10|||
13341969|NCT01005732|26628244|FG000|Overall Study|Death|1|||
13341970|NCT01005719|26628307|FG000|Period 1|Adverse Event|0|||
13341971|NCT01005719|26628308|FG001|Period 1|Adverse Event|0|||
13341972|NCT01005719|26628309|FG002|Period 1|Adverse Event|0|||
13341973|NCT01005719|26628310|FG003|Period 1|Adverse Event|1|||
13341974|NCT01005719|26628311|FG004|Period 1|Adverse Event|0|||
13341975|NCT01005719|26628312|FG005|Period 1|Adverse Event|0|||
13341976|NCT01005719|26628307|FG000|Period 1|Delay in completing study procedures|0|||
13341977|NCT01005719|26628308|FG001|Period 1|Delay in completing study procedures|0|||
13341978|NCT01005719|26628309|FG002|Period 1|Delay in completing study procedures|0|||
13341979|NCT01005719|26628310|FG003|Period 1|Delay in completing study procedures|0|||
13341980|NCT01005719|26628311|FG004|Period 1|Delay in completing study procedures|0|||
13341981|NCT01005719|26628312|FG005|Period 1|Delay in completing study procedures|1|||
13341982|NCT01005719|26628307|FG000|Period 2|Adverse Event|0|||
13341983|NCT01005719|26628308|FG001|Period 2|Adverse Event|0|||
13341984|NCT01005719|26628309|FG002|Period 2|Adverse Event|0|||
13341985|NCT01005719|26628310|FG003|Period 2|Adverse Event|0|||
13341986|NCT01005719|26628311|FG004|Period 2|Adverse Event|1|||
13341987|NCT01005719|26628312|FG005|Period 2|Adverse Event|1|||
13341988|NCT01005680|26628341|FG000|Overall Study|Lost to Follow-up|4|||
13341989|NCT01005680|26628342|FG001|Overall Study|Lost to Follow-up|6|||
13341990|NCT01005680|26628341|FG000|Overall Study|Withdrawal by Subject|1|||
13341991|NCT01005680|26628342|FG001|Overall Study|Withdrawal by Subject|4|||
13341992|NCT01005680|26628341|FG000|Overall Study|Physician Decision|1|||
13341993|NCT01005680|26628342|FG001|Overall Study|Physician Decision|1|||
13341994|NCT01005602|26628369|FG000|Overall Study|Excluded due to unreliable clinical data|1|||
13341995|NCT01005602|26628370|FG001|Overall Study|Excluded due to unreliable clinical data|0|||
13341996|NCT01005329|26628382|FG000|Overall Study|Ineligible or received no protocol trt.|4|||
13341997|NCT01005316|26628445|FG000|Overall Study|Adverse Event|0|||
13341998|NCT01005316|26628446|FG001|Overall Study|Adverse Event|0|||
13341999|NCT01005316|26628447|FG002|Overall Study|Adverse Event|0|||
13342000|NCT01005316|26628448|FG003|Overall Study|Adverse Event|1|||
13342001|NCT01005316|26628445|FG000|Overall Study|Death|20|||
13342002|NCT01005316|26628446|FG001|Overall Study|Death|5|||
13342003|NCT01005316|26628447|FG002|Overall Study|Death|1|||
13342004|NCT01005316|26628448|FG003|Overall Study|Death|15|||
13342005|NCT01005316|26628445|FG000|Overall Study|Study Termination|5|||
13342006|NCT01005316|26628446|FG001|Overall Study|Study Termination|63|||
13342007|NCT01005316|26628447|FG002|Overall Study|Study Termination|9|||
13342008|NCT01005316|26628448|FG003|Overall Study|Study Termination|85|||
13342009|NCT01005316|26628445|FG000|Overall Study|Lost to Follow-up|1|||
13342010|NCT01005316|26628446|FG001|Overall Study|Lost to Follow-up|3|||
13342011|NCT01005316|26628447|FG002|Overall Study|Lost to Follow-up|0|||
13342012|NCT01005316|26628448|FG003|Overall Study|Lost to Follow-up|2|||
13342013|NCT01005316|26628445|FG000|Overall Study|Physician Decision|6|||
13342014|NCT01005316|26628446|FG001|Overall Study|Physician Decision|0|||
13342015|NCT01005316|26628447|FG002|Overall Study|Physician Decision|0|||
13342016|NCT01005316|26628448|FG003|Overall Study|Physician Decision|0|||
13342017|NCT01005316|26628445|FG000|Overall Study|Sponsor Decision|6|||
13342018|NCT01005316|26628446|FG001|Overall Study|Sponsor Decision|3|||
13342019|NCT01005316|26628447|FG002|Overall Study|Sponsor Decision|0|||
13342020|NCT01005316|26628448|FG003|Overall Study|Sponsor Decision|0|||
13342021|NCT01005316|26628445|FG000|Overall Study|Withdrawal by Subject|1|||
13342022|NCT01005316|26628446|FG001|Overall Study|Withdrawal by Subject|1|||
13342023|NCT01005316|26628447|FG002|Overall Study|Withdrawal by Subject|0|||
13342024|NCT01005316|26628448|FG003|Overall Study|Withdrawal by Subject|2|||
13342025|NCT01005316|26628445|FG000|Overall Study|Consented to Another Study|2|||
13342026|NCT01005316|26628446|FG001|Overall Study|Consented to Another Study|0|||
13342027|NCT01005316|26628447|FG002|Overall Study|Consented to Another Study|0|||
13342028|NCT01005316|26628448|FG003|Overall Study|Consented to Another Study|0|||
13342029|NCT01005316|26628445|FG000|Overall Study|Delisted|8|||
13342030|NCT01005316|26628446|FG001|Overall Study|Delisted|0|||
13342031|NCT01005316|26628447|FG002|Overall Study|Delisted|0|||
13342032|NCT01005316|26628448|FG003|Overall Study|Delisted|0|||
13342033|NCT01005316|26628445|FG000|Overall Study|Transferred Care|1|||
13342034|NCT01005316|26628446|FG001|Overall Study|Transferred Care|0|||
13342035|NCT01005316|26628447|FG002|Overall Study|Transferred Care|1|||
13342036|NCT01005316|26628448|FG003|Overall Study|Transferred Care|3|||
13342037|NCT01005316|26628445|FG000|Overall Study|Retransplanted|0|||
13342038|NCT01005316|26628446|FG001|Overall Study|Retransplanted|1|||
13342039|NCT01005316|26628447|FG002|Overall Study|Retransplanted|0|||
13342040|NCT01005316|26628448|FG003|Overall Study|Retransplanted|0|||
13342041|NCT01005251|26628481|FG000|Overall Study|Withdrawal by Subject|2|||
13342042|NCT01005251|26628482|FG001|Overall Study|Withdrawal by Subject|5|||
13342043|NCT01005251|26628483|FG002|Overall Study|Withdrawal by Subject|3|||
13342044|NCT01005251|26628484|FG003|Overall Study|Withdrawal by Subject|4|||
13342045|NCT01005251|26628485|FG004|Overall Study|Withdrawal by Subject|9|||
13342046|NCT01005251|26628481|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
13342047|NCT01005251|26628482|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
13342048|NCT01005251|26628483|FG002|Overall Study|Eligibility criteria not fulfilled|4|||
13342049|NCT01005251|26628484|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
13342050|NCT01005251|26628485|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
13342051|NCT01005251|26628481|FG000|Overall Study|Adverse Event|2|||
13342052|NCT01005251|26628482|FG001|Overall Study|Adverse Event|6|||
13342053|NCT01005251|26628483|FG002|Overall Study|Adverse Event|8|||
13342054|NCT01005251|26628484|FG003|Overall Study|Adverse Event|5|||
13342055|NCT01005251|26628485|FG004|Overall Study|Adverse Event|4|||
13342056|NCT01005251|26628481|FG000|Overall Study|Protocol Violation|1|||
13342057|NCT01005251|26628482|FG001|Overall Study|Protocol Violation|0|||
13342058|NCT01005251|26628483|FG002|Overall Study|Protocol Violation|0|||
13342059|NCT01005251|26628484|FG003|Overall Study|Protocol Violation|0|||
13342060|NCT01005251|26628485|FG004|Overall Study|Protocol Violation|2|||
13342061|NCT01005251|26628481|FG000|Overall Study|Developed study-specific withdrawal crit|2|||
13342062|NCT01005251|26628482|FG001|Overall Study|Developed study-specific withdrawal crit|0|||
13342063|NCT01005251|26628483|FG002|Overall Study|Developed study-specific withdrawal crit|3|||
13342064|NCT01005251|26628484|FG003|Overall Study|Developed study-specific withdrawal crit|0|||
13342065|NCT01005251|26628485|FG004|Overall Study|Developed study-specific withdrawal crit|1|||
13342066|NCT01005251|26628481|FG000|Overall Study|Lost to Follow-up|1|||
13342067|NCT01005251|26628482|FG001|Overall Study|Lost to Follow-up|4|||
13342068|NCT01005251|26628483|FG002|Overall Study|Lost to Follow-up|2|||
13342069|NCT01005251|26628484|FG003|Overall Study|Lost to Follow-up|0|||
13342070|NCT01005251|26628485|FG004|Overall Study|Lost to Follow-up|0|||
13342071|NCT01005251|26628481|FG000|Overall Study|Physician Decision|0|||
13342072|NCT01005251|26628482|FG001|Overall Study|Physician Decision|0|||
13342073|NCT01005251|26628483|FG002|Overall Study|Physician Decision|0|||
13342074|NCT01005251|26628484|FG003|Overall Study|Physician Decision|0|||
13342075|NCT01005251|26628485|FG004|Overall Study|Physician Decision|2|||
13342076|NCT01005251|26628481|FG000|Overall Study|Patient moved|1|||
13342077|NCT01005251|26628482|FG001|Overall Study|Patient moved|0|||
13342078|NCT01005251|26628483|FG002|Overall Study|Patient moved|0|||
13342079|NCT01005251|26628484|FG003|Overall Study|Patient moved|0|||
13342080|NCT01005251|26628485|FG004|Overall Study|Patient moved|0|||
13342081|NCT01005251|26628481|FG000|Overall Study|Wrong drug dispensed|0|||
13342082|NCT01005251|26628482|FG001|Overall Study|Wrong drug dispensed|1|||
13342083|NCT01005251|26628483|FG002|Overall Study|Wrong drug dispensed|0|||
13342084|NCT01005251|26628484|FG003|Overall Study|Wrong drug dispensed|0|||
13342085|NCT01005251|26628485|FG004|Overall Study|Wrong drug dispensed|0|||
13342086|NCT01005251|26628481|FG000|Overall Study|Randomized in error|0|||
13342087|NCT01005251|26628482|FG001|Overall Study|Randomized in error|0|||
13342088|NCT01005251|26628483|FG002|Overall Study|Randomized in error|1|||
13342089|NCT01005251|26628484|FG003|Overall Study|Randomized in error|1|||
13342090|NCT01005251|26628485|FG004|Overall Study|Randomized in error|0|||
13342091|NCT01005251|26628481|FG000|Overall Study|Lack of Efficacy|0|||
13342092|NCT01005251|26628482|FG001|Overall Study|Lack of Efficacy|0|||
13342093|NCT01005251|26628483|FG002|Overall Study|Lack of Efficacy|1|||
13342094|NCT01005251|26628484|FG003|Overall Study|Lack of Efficacy|1|||
13342095|NCT01005251|26628485|FG004|Overall Study|Lack of Efficacy|0|||
13342096|NCT01004848|26628522|FG000|Overall Study|Lost to Follow-up|55|||
13342097|NCT01004848|26628523|FG001|Overall Study|Lost to Follow-up|45|||
13342098|NCT01004822|26628657|FG000|Overall Study|Objective progression or relapse|3|||
13342099|NCT01004822|26628658|FG001|Overall Study|Objective progression or relapse|3|||
13342100|NCT01004822|26628659|FG002|Overall Study|Objective progression or relapse|0|||
13342101|NCT01004822|26628660|FG003|Overall Study|Objective progression or relapse|1|||
13342102|NCT01004822|26628661|FG004|Overall Study|Objective progression or relapse|2|||
13342103|NCT01004822|26628662|FG005|Overall Study|Objective progression or relapse|2|||
13342104|NCT01004822|26628663|FG006|Overall Study|Objective progression or relapse|1|||
13342105|NCT01004822|26628664|FG007|Overall Study|Objective progression or relapse|4|||
13342106|NCT01004822|26628657|FG000|Overall Study|Global deterioration of health status|0|||
13342107|NCT01004822|26628658|FG001|Overall Study|Global deterioration of health status|0|||
13342108|NCT01004822|26628659|FG002|Overall Study|Global deterioration of health status|0|||
13342109|NCT01004822|26628660|FG003|Overall Study|Global deterioration of health status|1|||
13342110|NCT01004822|26628661|FG004|Overall Study|Global deterioration of health status|0|||
13342111|NCT01004822|26628662|FG005|Overall Study|Global deterioration of health status|0|||
13342112|NCT01004822|26628663|FG006|Overall Study|Global deterioration of health status|1|||
13342113|NCT01004822|26628664|FG007|Overall Study|Global deterioration of health status|0|||
13342114|NCT01004822|26628657|FG000|Overall Study|No longer willing to continue|0|||
13342115|NCT01004822|26628658|FG001|Overall Study|No longer willing to continue|0|||
13342116|NCT01004822|26628659|FG002|Overall Study|No longer willing to continue|0|||
13342117|NCT01004822|26628660|FG003|Overall Study|No longer willing to continue|1|||
13342118|NCT01004822|26628661|FG004|Overall Study|No longer willing to continue|2|||
13342119|NCT01004822|26628662|FG005|Overall Study|No longer willing to continue|1|||
13342120|NCT01004822|26628663|FG006|Overall Study|No longer willing to continue|1|||
13342121|NCT01004822|26628664|FG007|Overall Study|No longer willing to continue|0|||
13342122|NCT01004822|26628657|FG000|Overall Study|Adverse Event|0|||
13342123|NCT01004822|26628658|FG001|Overall Study|Adverse Event|0|||
13342124|NCT01004822|26628659|FG002|Overall Study|Adverse Event|0|||
13342125|NCT01004822|26628660|FG003|Overall Study|Adverse Event|0|||
13342126|NCT01004822|26628661|FG004|Overall Study|Adverse Event|0|||
13342127|NCT01004822|26628662|FG005|Overall Study|Adverse Event|0|||
13342128|NCT01004822|26628663|FG006|Overall Study|Adverse Event|1|||
13342129|NCT01004822|26628664|FG007|Overall Study|Adverse Event|1|||
13342130|NCT01004822|26628657|FG000|Overall Study|Other|0|||
13342131|NCT01004822|26628658|FG001|Overall Study|Other|0|||
13342132|NCT01004822|26628659|FG002|Overall Study|Other|4|||
13342133|NCT01004822|26628660|FG003|Overall Study|Other|1|||
13342134|NCT01004822|26628661|FG004|Overall Study|Other|0|||
13342135|NCT01004822|26628662|FG005|Overall Study|Other|1|||
13342136|NCT01004822|26628663|FG006|Overall Study|Other|0|||
13342137|NCT01004822|26628664|FG007|Overall Study|Other|0|||
13342138|NCT01004614|26628711|FG000|Washout|Withdrawal by Subject|0|||
13342139|NCT01004614|26628712|FG001|Washout|Withdrawal by Subject|1|||
13342140|NCT01004614|26628713|FG002|Washout|Withdrawal by Subject|0|||
13342141|NCT01004614|26628714|FG003|Washout|Withdrawal by Subject|0|||
13342142|NCT01004510|26628720|FG000|Overall Study|Adverse Event|1|||
13342143|NCT01004432|26628746|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20|||
13342144|NCT01004432|26628747|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
13342145|NCT01004432|26628748|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
13342146|NCT01004432|26628749|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
13342147|NCT01004432|26628750|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
13342148|NCT01004432|26628746|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29|||
13342149|NCT01004432|26628747|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
13342150|NCT01004432|26628748|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
13342151|NCT01004432|26628749|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
13342152|NCT01004432|26628750|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
13342153|NCT01004432|26628746|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17|||
13342154|NCT01004432|26628747|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
13342155|NCT01004432|26628748|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
13342156|NCT01004432|26628749|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
13342157|NCT01004432|26628750|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
13342158|NCT01004432|26628746|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15|||
13342159|NCT01004432|26628747|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
13342160|NCT01004432|26628748|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
13342161|NCT01004432|26628749|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
13342162|NCT01004432|26628750|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
13342163|NCT01004432|26628746|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2|||
13342164|NCT01004432|26628747|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
13342165|NCT01004432|26628748|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
13342166|NCT01004432|26628749|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
13342167|NCT01004432|26628750|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
13342168|NCT01004432|26628746|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
13342169|NCT01004432|26628747|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1|||
13342170|NCT01004432|26628748|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5|||
13342171|NCT01004432|26628749|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6|||
13342172|NCT01004432|26628750|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
13342173|NCT01004432|26628746|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
13342174|NCT01004432|26628747|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
13342175|NCT01004432|26628748|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
13342176|NCT01004432|26628749|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4|||
13342177|NCT01004432|26628750|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
13342178|NCT01004432|26628746|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
13342179|NCT01004432|26628747|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1|||
13342180|NCT01004432|26628748|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4|||
13342181|NCT01004432|26628749|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7|||
13342182|NCT01004432|26628750|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
13342183|NCT01004432|26628746|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
13342184|NCT01004432|26628747|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
13342185|NCT01004432|26628748|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
13342186|NCT01004432|26628749|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1|||
13342187|NCT01004432|26628750|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
13342188|NCT01004432|26628746|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
13342189|NCT01004432|26628747|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2|||
13342190|NCT01004432|26628748|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24|||
13342191|NCT01004432|26628749|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37|||
13342192|NCT01004432|26628750|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
13342193|NCT01004432|26628746|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
13342194|NCT01004432|26628747|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
13342195|NCT01004432|26628748|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1|||
13342196|NCT01004432|26628749|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
13342197|NCT01004432|26628750|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
13342198|NCT01004432|26628746|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
13342199|NCT01004432|26628747|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
13342200|NCT01004432|26628748|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
13342201|NCT01004432|26628749|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
13342202|NCT01004432|26628750|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2|||
13342203|NCT01004432|26628746|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
13342204|NCT01004432|26628747|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
13342205|NCT01004432|26628748|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
13342206|NCT01004432|26628749|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
13342207|NCT01004432|26628750|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4|||
13342208|NCT01004432|26628746|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
13342209|NCT01004432|26628747|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
13342210|NCT01004432|26628748|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
13342211|NCT01004432|26628749|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
13342212|NCT01004432|26628750|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2|||
13342213|NCT01004432|26628746|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
13342214|NCT01004432|26628747|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
13342215|NCT01004432|26628748|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
13342216|NCT01004432|26628749|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
13342217|NCT01004432|26628750|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10|||
13342218|NCT01004406|26628769|FG000|Overall Study|Withdrawal by Subject|2|||
13342219|NCT01004406|26628770|FG001|Overall Study|Withdrawal by Subject|0|||
13342220|NCT01004406|26628769|FG000|Overall Study|Lost to Follow-up|1|||
13342221|NCT01004406|26628770|FG001|Overall Study|Lost to Follow-up|0|||
13342222|NCT01004263|26628780|FG000|Overall Study|Adverse Event|15|||
13342223|NCT01004263|26628780|FG000|Overall Study|Withdrawal by Subject|58|||
13342224|NCT01004263|26628780|FG000|Overall Study|Protocol Violation|10|||
13342225|NCT01004263|26628780|FG000|Overall Study|Lost to Follow-up|64|||
13342226|NCT01004263|26628780|FG000|Overall Study|Lack of Efficacy|13|||
13342227|NCT01004263|26628780|FG000|Overall Study|Pregnancy|2|||
13342228|NCT01004263|26628780|FG000|Overall Study|Physician Decision|15|||
13342229|NCT01004263|26628780|FG000|Overall Study|Lack of Qualifying Event|2|||
13342230|NCT01004250|26628792|FG000|Induction Therapy Period|Adverse Event|10|||
13342231|NCT01004250|26628792|FG000|Induction Therapy Period|Entry Criteria Not Met|1|||
13342232|NCT01004250|26628792|FG000|Induction Therapy Period|Withdrawal by Subject|2|||
13342233|NCT01004250|26628792|FG000|Induction Therapy Period|Physician Decision|2|||
13342234|NCT01004250|26628792|FG000|Maintenance Therapy Period|Adverse Event|15|||
13342235|NCT01004250|26628792|FG000|Maintenance Therapy Period|Lost to Follow-up|1|||
13342236|NCT01004250|26628792|FG000|Maintenance Therapy Period|Protocol Violation|1|||
13342237|NCT01004250|26628792|FG000|Maintenance Therapy Period|Withdrawal by Subject|5|||
13342238|NCT01004250|26628792|FG000|Maintenance Therapy Period|Physician Decision|4|||
13342239|NCT01004250|26628792|FG000|Follow-Up (FU) Period|Lost to Follow-up|1|||
13342240|NCT01004185|26628807|FG000|Overall Study|Adverse Event|1|||
13342241|NCT01004185|26628808|FG001|Overall Study|Adverse Event|1|||
13342242|NCT01004185|26628807|FG000|Overall Study|Lost to Follow-up|0|||
13342243|NCT01004185|26628808|FG001|Overall Study|Lost to Follow-up|1|||
13342244|NCT01004185|26628807|FG000|Overall Study|Lack of Efficacy|2|||
13342245|NCT01004185|26628808|FG001|Overall Study|Lack of Efficacy|1|||
13342246|NCT01004185|26628807|FG000|Overall Study|Sponsor Terminated Study|4|||
13342247|NCT01004185|26628808|FG001|Overall Study|Sponsor Terminated Study|5|||
13342248|NCT01004185|26628807|FG000|Overall Study|Withdrawal by Subject|2|||
13342249|NCT01004185|26628808|FG001|Overall Study|Withdrawal by Subject|1|||
13342250|NCT01004172|26628818|FG000|Overall Study|Progressive Disease in CNS Only|16|||
13342251|NCT01004172|26628818|FG000|Overall Study|Progressive Disease in Non-CNS Only|16|||
13342252|NCT01004172|26628818|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2|||
13342253|NCT01004172|26628818|FG000|Overall Study|Adverse Event|1|||
13342254|NCT01004172|26628818|FG000|Overall Study|Physician Decision|1|||
13342255|NCT01004172|26628818|FG000|Overall Study|Symptomatic Deterioration|2|||
13342256|NCT01004159|26628825|FG000|Overall Study|Adverse Event|2|||
13342257|NCT01004159|26628825|FG000|Overall Study|Disease Progression|18|||
13342258|NCT01004146|26628838|FG000|Overall Study|Withdrawal by Subject|4|||
13342259|NCT01004146|26628839|FG001|Overall Study|Withdrawal by Subject|5|||
13342260|NCT01004003|26628895|FG000|Overall Study|Progressive disease|2|||
13342261|NCT01004003|26628896|FG001|Overall Study|Progressive disease|1|||
13342262|NCT01004003|26628897|FG002|Overall Study|Progressive disease|1|||
13342263|NCT01004003|26628898|FG003|Overall Study|Progressive disease|0|||
13342264|NCT01004003|26628899|FG004|Overall Study|Progressive disease|2|||
13342265|NCT01004003|26628900|FG005|Overall Study|Progressive disease|1|||
13342266|NCT01004003|26628901|FG006|Overall Study|Progressive disease|1|||
13342267|NCT01004003|26628902|FG007|Overall Study|Progressive disease|39|||
13342268|NCT01004003|26628903|FG008|Overall Study|Progressive disease|22|||
13342269|NCT01004003|26628895|FG000|Overall Study|Adverse Event|4|||
13342270|NCT01004003|26628896|FG001|Overall Study|Adverse Event|2|||
13342271|NCT01004003|26628897|FG002|Overall Study|Adverse Event|3|||
13342272|NCT01004003|26628898|FG003|Overall Study|Adverse Event|3|||
13342273|NCT01004003|26628899|FG004|Overall Study|Adverse Event|2|||
13342274|NCT01004003|26628900|FG005|Overall Study|Adverse Event|2|||
13342275|NCT01004003|26628901|FG006|Overall Study|Adverse Event|7|||
13342276|NCT01004003|26628902|FG007|Overall Study|Adverse Event|21|||
13342277|NCT01004003|26628903|FG008|Overall Study|Adverse Event|6|||
13342278|NCT01004003|26628895|FG000|Overall Study|Refused to continue taking trial med.|0|||
13342279|NCT01004003|26628896|FG001|Overall Study|Refused to continue taking trial med.|0|||
13342280|NCT01004003|26628897|FG002|Overall Study|Refused to continue taking trial med.|0|||
13342281|NCT01004003|26628898|FG003|Overall Study|Refused to continue taking trial med.|0|||
13342282|NCT01004003|26628899|FG004|Overall Study|Refused to continue taking trial med.|0|||
13342283|NCT01004003|26628900|FG005|Overall Study|Refused to continue taking trial med.|0|||
13342284|NCT01004003|26628901|FG006|Overall Study|Refused to continue taking trial med.|0|||
13342285|NCT01004003|26628902|FG007|Overall Study|Refused to continue taking trial med.|0|||
13342286|NCT01004003|26628903|FG008|Overall Study|Refused to continue taking trial med.|2|||
13342287|NCT01004003|26628895|FG000|Overall Study|Other|0|||
13342288|NCT01004003|26628896|FG001|Overall Study|Other|0|||
13342289|NCT01004003|26628897|FG002|Overall Study|Other|0|||
13342290|NCT01004003|26628898|FG003|Overall Study|Other|0|||
13342291|NCT01004003|26628899|FG004|Overall Study|Other|0|||
13342292|NCT01004003|26628900|FG005|Overall Study|Other|1|||
13342293|NCT01004003|26628901|FG006|Overall Study|Other|0|||
13342294|NCT01004003|26628902|FG007|Overall Study|Other|0|||
13342295|NCT01004003|26628903|FG008|Overall Study|Other|0|||
13342296|NCT01003990|26628921|FG000|Overall Study|Adverse Event|8|||
13342297|NCT01003990|26628922|FG001|Overall Study|Adverse Event|5|||
13342298|NCT01003990|26628923|FG002|Overall Study|Adverse Event|11|||
13342299|NCT01003990|26628921|FG000|Overall Study|Death|0|||
13342300|NCT01003990|26628922|FG001|Overall Study|Death|8|||
13342301|NCT01003990|26628923|FG002|Overall Study|Death|1|||
13342302|NCT01003990|26628921|FG000|Overall Study|Lack of Efficacy|10|||
13342303|NCT01003990|26628922|FG001|Overall Study|Lack of Efficacy|2|||
13342304|NCT01003990|26628923|FG002|Overall Study|Lack of Efficacy|3|||
13342305|NCT01003990|26628921|FG000|Overall Study|Lost to Follow-up|30|||
13342306|NCT01003990|26628922|FG001|Overall Study|Lost to Follow-up|12|||
13342307|NCT01003990|26628923|FG002|Overall Study|Lost to Follow-up|7|||
13342308|NCT01003990|26628921|FG000|Overall Study|Reasons Not Identified|14|||
13342309|NCT01003990|26628922|FG001|Overall Study|Reasons Not Identified|13|||
13342310|NCT01003990|26628923|FG002|Overall Study|Reasons Not Identified|8|||
13342311|NCT01003990|26628921|FG000|Overall Study|Poor/Non-compliance|4|||
13342312|NCT01003990|26628922|FG001|Overall Study|Poor/Non-compliance|3|||
13342313|NCT01003990|26628923|FG002|Overall Study|Poor/Non-compliance|2|||
13342314|NCT01003990|26628921|FG000|Overall Study|Pregnancy|10|||
13342315|NCT01003990|26628922|FG001|Overall Study|Pregnancy|2|||
13342316|NCT01003990|26628923|FG002|Overall Study|Pregnancy|4|||
13342317|NCT01003990|26628921|FG000|Overall Study|No Longer Met Study Criteria|4|||
13342318|NCT01003990|26628922|FG001|Overall Study|No Longer Met Study Criteria|1|||
13342319|NCT01003990|26628923|FG002|Overall Study|No Longer Met Study Criteria|0|||
13342320|NCT01003990|26628921|FG000|Overall Study|Subject Withdrew Consent|12|||
13342321|NCT01003990|26628922|FG001|Overall Study|Subject Withdrew Consent|5|||
13342322|NCT01003990|26628923|FG002|Overall Study|Subject Withdrew Consent|7|||
13342323|NCT01003899|26628934|FG000|Overall Study|Other Adverse Event|8|||
13342324|NCT01003899|26628934|FG000|Overall Study|Not entered|4|||
13342325|NCT01003899|26628934|FG000|Overall Study|Not treated|1|||
13342326|NCT01003899|26628934|FG000|Overall Study|Progressive disease|34|||
13342327|NCT01003886|26628945|FG000|Overall Study|Lack of Efficacy|5|||
13342328|NCT01003886|26628945|FG000|Overall Study|Lost to Follow-up|169|||
13342329|NCT01003886|26628945|FG000|Overall Study|Withdrawal by Subject|39|||
13342330|NCT01003886|26628945|FG000|Overall Study|Other|14|||
13342331|NCT01003886|26628945|FG000|Overall Study|Adverse Event|3|||
13342332|NCT01003691|26629131|FG000|Overall Study|Adverse Event|0|||
13342333|NCT01003691|26629132|FG001|Overall Study|Adverse Event|0|||
13342334|NCT01003691|26629133|FG002|Overall Study|Adverse Event|0|||
13342335|NCT01003691|26629134|FG003|Overall Study|Adverse Event|1|||
13342336|NCT01003639|26629153|FG000|Overall Study|Lost to Follow-up|6|||
13342337|NCT01003639|26629154|FG001|Overall Study|Lost to Follow-up|9|||
13342338|NCT01003639|26629153|FG000|Overall Study|Withdrawal by Subject|9|||
13342339|NCT01003639|26629154|FG001|Overall Study|Withdrawal by Subject|5|||
13342340|NCT01003639|26629153|FG000|Overall Study|Lack of Efficacy|1|||
13342341|NCT01003639|26629154|FG001|Overall Study|Lack of Efficacy|6|||
13342342|NCT01003639|26629153|FG000|Overall Study|Adverse Event|0|||
13342343|NCT01003639|26629154|FG001|Overall Study|Adverse Event|1|||
13342344|NCT01003639|26629153|FG000|Overall Study|Protocol Violation|0|||
13342345|NCT01003639|26629154|FG001|Overall Study|Protocol Violation|1|||
13342346|NCT01003639|26629153|FG000|Overall Study|Physician Decision|1|||
13342347|NCT01003639|26629154|FG001|Overall Study|Physician Decision|0|||
13342348|NCT01003249|26629173|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
13342349|NCT01003249|26629174|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
13342350|NCT01003249|26629173|FG000|First Intervention (4 Weeks)|Non-Serious Event|1|||
13342351|NCT01003249|26629174|FG001|First Intervention (4 Weeks)|Non-Serious Event|1|||
13342352|NCT01003249|26629173|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
13342353|NCT01003249|26629174|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
13342354|NCT01003249|26629173|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
13342355|NCT01003249|26629174|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
13342356|NCT01003210|26629191|FG000|Overall Study|Lost to Follow-up|1|||
13342357|NCT01003210|26629192|FG001|Overall Study|Lost to Follow-up|3|||
13342358|NCT01003184|26629231|FG000|Overall Study|Adverse Event|12|||
13342359|NCT01003184|26629232|FG001|Overall Study|Adverse Event|5|||
13342360|NCT01003184|26629231|FG000|Overall Study|Lost to Follow-up|1|||
13342361|NCT01003184|26629232|FG001|Overall Study|Lost to Follow-up|0|||
13342362|NCT01003184|26629231|FG000|Overall Study|Loss of glucose control|1|||
13342363|NCT01003184|26629232|FG001|Overall Study|Loss of glucose control|1|||
13342364|NCT01003184|26629231|FG000|Overall Study|Protocol Violation|3|||
13342365|NCT01003184|26629232|FG001|Overall Study|Protocol Violation|0|||
13342366|NCT01003184|26629231|FG000|Overall Study|Withdrawal by Subject|1|||
13342367|NCT01003184|26629232|FG001|Overall Study|Withdrawal by Subject|6|||
13342368|NCT01003184|26629231|FG000|Overall Study|Physician Decision|1|||
13342369|NCT01003184|26629232|FG001|Overall Study|Physician Decision|0|||
13342370|NCT01002989|26629241|FG000|Overall Study|exclusion criteria, no consent|5|||
13342371|NCT01002820|26629247|FG000|Overall Study|Adverse Event|1|||
13342372|NCT01002820|26629247|FG000|Overall Study|Withdrawal by Subject|2|||
13342373|NCT01002820|26629247|FG000|Overall Study|Lack of Efficacy|1|||
13342374|NCT01002573|26629272|FG000|Overall Study|Subject did not receive at least 1 dose|11|||
13342375|NCT01002573|26629273|FG001|Overall Study|Subject did not receive at least 1 dose|7|||
13342376|NCT01002547|26629339|FG000|Overall Study|Withdrawal by Subject|4|||
13342377|NCT01002547|26629340|FG001|Overall Study|Withdrawal by Subject|0|||
13342378|NCT01002547|26629341|FG002|Overall Study|Withdrawal by Subject|5|||
13342379|NCT01002547|26629339|FG000|Overall Study|Lost to Follow-up|2|||
13342380|NCT01002547|26629340|FG001|Overall Study|Lost to Follow-up|1|||
13342381|NCT01002547|26629341|FG002|Overall Study|Lost to Follow-up|1|||
13342382|NCT01002547|26629339|FG000|Overall Study|Physician Decision|1|||
13342383|NCT01002547|26629340|FG001|Overall Study|Physician Decision|0|||
13342384|NCT01002547|26629341|FG002|Overall Study|Physician Decision|0|||
13342385|NCT01002547|26629339|FG000|Overall Study|Death|0|||
13342386|NCT01002547|26629340|FG001|Overall Study|Death|2|||
13342387|NCT01002547|26629341|FG002|Overall Study|Death|2|||
13342388|NCT01002547|26629339|FG000|Overall Study|Adverse Event|1|||
13342389|NCT01002547|26629340|FG001|Overall Study|Adverse Event|0|||
13342390|NCT01002547|26629341|FG002|Overall Study|Adverse Event|0|||
13342391|NCT01002482|26629368|FG000|Overall Study|Withdrawal by Subject|14|||
13342392|NCT01002482|26629369|FG001|Overall Study|Withdrawal by Subject|21|||
13342393|NCT01002482|26629368|FG000|Overall Study|Included twice|1|||
13342394|NCT01002482|26629369|FG001|Overall Study|Included twice|0|||
13342395|NCT01002339|26629432|FG000|Overall Study|Withdrawal by Subject|0|||
13342396|NCT01002339|26629433|FG001|Overall Study|Withdrawal by Subject|1|||
13342397|NCT01002339|26629434|FG002|Overall Study|Withdrawal by Subject|0|||
13342398|NCT01002339|26629432|FG000|Overall Study|Incorrect treatment assignment|0|||
13342399|NCT01002339|26629433|FG001|Overall Study|Incorrect treatment assignment|0|||
13342400|NCT01002339|26629434|FG002|Overall Study|Incorrect treatment assignment|1|||
13342401|NCT01002339|26629432|FG000|Overall Study|Protocol Violation|0|||
13342402|NCT01002339|26629433|FG001|Overall Study|Protocol Violation|0|||
13342403|NCT01002339|26629434|FG002|Overall Study|Protocol Violation|2|||
13342404|NCT01002339|26629432|FG000|Overall Study|Lung cancer detected before transplant|0|||
13342405|NCT01002339|26629433|FG001|Overall Study|Lung cancer detected before transplant|0|||
13342406|NCT01002339|26629434|FG002|Overall Study|Lung cancer detected before transplant|1|||
13342407|NCT01002339|26629432|FG000|Overall Study|Randomized. Not transplanted|0|||
13342408|NCT01002339|26629433|FG001|Overall Study|Randomized. Not transplanted|0|||
13342409|NCT01002339|26629434|FG002|Overall Study|Randomized. Not transplanted|1|||
13342410|NCT01002105|26629457|FG000|Overall Study|Lost to Follow-up|10|||
13342411|NCT01002105|26629458|FG001|Overall Study|Lost to Follow-up|16|||
13342412|NCT01002105|26629457|FG000|Overall Study|non compliance|5|||
13342413|NCT01002105|26629458|FG001|Overall Study|non compliance|3|||
13342414|NCT01002105|26629457|FG000|Overall Study|condition worsened|4|||
13342415|NCT01002105|26629458|FG001|Overall Study|condition worsened|2|||
13342416|NCT01001988|26629465|FG000|Overall Study|Protocol Violation|84|||
13342417|NCT01001988|26629465|FG000|Overall Study|Withdrawal by Subject|18|||
13342418|NCT01001988|26629465|FG000|Overall Study|Lost to Follow-up|15|||
13342419|NCT01001910|26629474|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6|||
13342420|NCT01001832|26629524|FG000|Short-term Period|Adverse Event|2|||
13342421|NCT01001832|26629525|FG001|Short-term Period|Adverse Event|3|||
13342422|NCT01001832|26629524|FG000|Long-term Period|Adverse Event|2|||
13342423|NCT01001832|26629525|FG001|Long-term Period|Adverse Event|1|||
13342424|NCT01001832|26629524|FG000|Long-term Period|Withdrawal by Subject|1|||
13342425|NCT01001832|26629525|FG001|Long-term Period|Withdrawal by Subject|0|||
13342426|NCT01001832|26629524|FG000|Long-term Period|Lack of Efficacy|0|||
13342427|NCT01001832|26629525|FG001|Long-term Period|Lack of Efficacy|2|||
13342428|NCT01001832|26629524|FG000|Long-term Period|Other|1|||
13342429|NCT01001832|26629525|FG001|Long-term Period|Other|2|||
13342430|NCT01001832|26629524|FG000|Follow-up Period|Withdrawal by Subject|1|||
13342431|NCT01001832|26629525|FG001|Follow-up Period|Withdrawal by Subject|0|||
13342432|NCT01001832|26629524|FG000|Follow-up Period|Follow-up no longer required /protocol|15|||
13342433|NCT01001832|26629525|FG001|Follow-up Period|Follow-up no longer required /protocol|20|||
13342434|NCT01001832|26629524|FG000|Follow-up Period|Other|2|||
13342435|NCT01001832|26629525|FG001|Follow-up Period|Other|1|||
13374018|NCT00798174|26725565|FG000|Overall Study|inability to implant azygos coil|3|||
13374019|NCT00798174|26725566|FG001|Overall Study|inability to implant azygos coil|3|||
13374020|NCT00798174|26725565|FG000|Overall Study|Inability to sedate for DFT testing|1|||
13374021|NCT00798174|26725566|FG001|Overall Study|Inability to sedate for DFT testing|0|||
13374022|NCT00798161|26725695|FG000|Overall Study|Adverse Event|3|||
13342436|NCT01001767|26629538|FG000|Overall Study|no baseline study performed|1|||
13342437|NCT01001767|26629539|FG001|Overall Study|no baseline study performed|0|||
13342438|NCT01001767|26629538|FG000|Overall Study|Protocol Violation|1|||
13342439|NCT01001767|26629539|FG001|Overall Study|Protocol Violation|0|||
13342440|NCT01001767|26629538|FG000|Overall Study|Lost to Follow-up|1|||
13342441|NCT01001767|26629539|FG001|Overall Study|Lost to Follow-up|0|||
13342442|NCT01001767|26629538|FG000|Overall Study|Physician Decision|1|||
13342443|NCT01001767|26629539|FG001|Overall Study|Physician Decision|0|||
13342444|NCT01001702|26629552|FG000|Overall Study|Lost to Follow-up|7|||
13342445|NCT01001702|26629552|FG000|Overall Study|Adverse Event|7|||
13342446|NCT01001702|26629552|FG000|Overall Study|Sponsor Discontinued Study|4|||
13342447|NCT01001702|26629552|FG000|Overall Study|Subject met Withdrawal Criteria|22|||
13342448|NCT01001702|26629552|FG000|Overall Study|Investigator withdrew Subject|10|||
13342449|NCT01001702|26629552|FG000|Overall Study|Withdrawal by Subject|19|||
13342450|NCT01001702|26629552|FG000|Overall Study|Lack of Efficacy per Investigator|3|||
13342451|NCT01001598|26629560|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1|||
13342452|NCT01001598|26629560|FG000|Overall Study|Adverse Event|1|||
13342453|NCT01001572|26629582|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32|||
13342454|NCT01001572|26629583|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
13342455|NCT01001572|26629584|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
13342456|NCT01001572|26629582|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11|||
13342457|NCT01001572|26629583|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0|||
13342458|NCT01001572|26629584|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0|||
13342459|NCT01001572|26629582|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96|||
13342460|NCT01001572|26629583|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
13342461|NCT01001572|26629584|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
13342462|NCT01001572|26629582|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7|||
13342463|NCT01001572|26629583|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
13342464|NCT01001572|26629584|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
13342465|NCT01001572|26629582|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1|||
13342466|NCT01001572|26629583|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
13342467|NCT01001572|26629584|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
13342468|NCT01001572|26629582|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4|||
13342469|NCT01001572|26629583|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
13342470|NCT01001572|26629584|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
13342471|NCT01001572|26629582|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82|||
13342472|NCT01001572|26629583|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0|||
13342473|NCT01001572|26629584|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0|||
13342474|NCT01001572|26629582|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45|||
13342475|NCT01001572|26629583|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
13342476|NCT01001572|26629584|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
13342477|NCT01001572|26629582|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
13342478|NCT01001572|26629583|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
13342479|NCT01001572|26629584|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
13342480|NCT01001572|26629582|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
13342481|NCT01001572|26629583|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8|||
13342482|NCT01001572|26629584|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
13342483|NCT01001572|26629582|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
13342484|NCT01001572|26629583|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
13342485|NCT01001572|26629584|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1|||
13342486|NCT01001572|26629582|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
13342487|NCT01001572|26629583|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
13342488|NCT01001572|26629584|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1|||
13342489|NCT01001572|26629582|FG000|Double-Blind Treatment Phase|Protocol deviation|0|||
13342490|NCT01001572|26629583|FG001|Double-Blind Treatment Phase|Protocol deviation|0|||
13342491|NCT01001572|26629584|FG002|Double-Blind Treatment Phase|Protocol deviation|1|||
13342492|NCT01001572|26629582|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
13342493|NCT01001572|26629583|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
13342494|NCT01001572|26629584|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
13342495|NCT01001520|26629611|FG000|Medication Period 1|Withdrawal by Subject|2|||
13342496|NCT01001520|26629612|FG001|Medication Period 1|Withdrawal by Subject|2|||
13342497|NCT01001520|26629611|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0|||
13342498|NCT01001520|26629612|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3|||
13342499|NCT01001520|26629611|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0|||
13342500|NCT01001520|26629612|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2|||
13342501|NCT01001520|26629611|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2|||
13342502|NCT01001520|26629612|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0|||
13342503|NCT01001520|26629611|FG000|Washout Period|Withdrawal by Subject|2|||
13342504|NCT01001520|26629612|FG001|Washout Period|Withdrawal by Subject|1|||
13342505|NCT01001520|26629611|FG000|Medication Period 2|Withdrawal by Subject|0|||
13342506|NCT01001520|26629612|FG001|Medication Period 2|Withdrawal by Subject|3|||
13342507|NCT01001494|26629642|FG000|Overall Study|Adverse Event|8|||
13342508|NCT01001494|26629643|FG001|Overall Study|Adverse Event|4|||
13342509|NCT01001494|26629644|FG002|Overall Study|Adverse Event|6|||
13342510|NCT01001494|26629642|FG000|Overall Study|Protocol Violation|0|||
13342511|NCT01001494|26629643|FG001|Overall Study|Protocol Violation|1|||
13342512|NCT01001494|26629644|FG002|Overall Study|Protocol Violation|1|||
13342513|NCT01001494|26629642|FG000|Overall Study|Lost to Follow-up|2|||
13342514|NCT01001494|26629643|FG001|Overall Study|Lost to Follow-up|0|||
13342515|NCT01001494|26629644|FG002|Overall Study|Lost to Follow-up|1|||
13342516|NCT01001494|26629642|FG000|Overall Study|Withdrawal by Subject|9|||
13342517|NCT01001494|26629643|FG001|Overall Study|Withdrawal by Subject|7|||
13342518|NCT01001494|26629644|FG002|Overall Study|Withdrawal by Subject|17|||
13342519|NCT01001494|26629642|FG000|Overall Study|COPD exacerbation|3|||
13342520|NCT01001494|26629643|FG001|Overall Study|COPD exacerbation|4|||
13342521|NCT01001494|26629644|FG002|Overall Study|COPD exacerbation|5|||
13342522|NCT01001494|26629642|FG000|Overall Study|Lack of Efficacy|2|||
13342523|NCT01001494|26629643|FG001|Overall Study|Lack of Efficacy|0|||
13342524|NCT01001494|26629644|FG002|Overall Study|Lack of Efficacy|8|||
13342525|NCT01001494|26629642|FG000|Overall Study|Other|0|||
13342526|NCT01001494|26629643|FG001|Overall Study|Other|1|||
13342527|NCT01001494|26629644|FG002|Overall Study|Other|3|||
13342528|NCT01001429|26629681|FG000|Overall Study|surgery cancelled|0|||
13342529|NCT01001429|26629682|FG001|Overall Study|surgery cancelled|1|||
13342530|NCT01001390|26629691|FG000|Overall Study|Failure to wear AFO device|2|||
13342531|NCT01001390|26629692|FG001|Overall Study|Failure to wear AFO device|0|||
13342532|NCT01001377|26629727|FG000|Overall Study|Ineligibility determined|2|||
13342533|NCT01001377|26629728|FG001|Overall Study|Ineligibility determined|0|||
13342534|NCT01001377|26629727|FG000|Overall Study|Withdrawal by Subject|19|||
13342535|NCT01001377|26629728|FG001|Overall Study|Withdrawal by Subject|20|||
13342536|NCT01001377|26629727|FG000|Overall Study|Lost to Follow-up|14|||
13342537|NCT01001377|26629728|FG001|Overall Study|Lost to Follow-up|17|||
13342538|NCT01001377|26629727|FG000|Overall Study|Death|391|||
13342539|NCT01001377|26629728|FG001|Overall Study|Death|384|||
13342540|NCT01001325|26629741|FG000|Overall Study|Lost to Follow-up|16|||
13342541|NCT01001325|26629742|FG001|Overall Study|Lost to Follow-up|10|||
13342542|NCT01001325|26629741|FG000|Overall Study|Protocol Violation|2|||
13342543|NCT01001325|26629742|FG001|Overall Study|Protocol Violation|0|||
13342544|NCT01001299|26629768|FG000|Overall Study|Insufficient Therapeutic Response|20|||
13342545|NCT01001299|26629768|FG000|Overall Study|Adverse event or Intercurrent Illness|1|||
13342546|NCT01001299|26629768|FG000|Overall Study|Death|1|||
13342547|NCT01001299|26629768|FG000|Overall Study|Began Taking Commercially Available Drug|2|||
13342548|NCT01001299|26629768|FG000|Overall Study|Withdrew Consent|1|||
13342549|NCT01001234|26629796|FG000|Overall Study|Withdrawal by Subject|2|||
13342550|NCT01001234|26629797|FG001|Overall Study|Withdrawal by Subject|0|||
13342551|NCT01001234|26629798|FG002|Overall Study|Withdrawal by Subject|3|||
13342552|NCT01001234|26629799|FG003|Overall Study|Withdrawal by Subject|0|||
13342553|NCT01001234|26629800|FG004|Overall Study|Withdrawal by Subject|0|||
13342554|NCT01001234|26629796|FG000|Overall Study|Protocol Violation|34|||
13342555|NCT01001234|26629797|FG001|Overall Study|Protocol Violation|3|||
13342556|NCT01001234|26629798|FG002|Overall Study|Protocol Violation|19|||
13342557|NCT01001234|26629799|FG003|Overall Study|Protocol Violation|18|||
13342558|NCT01001234|26629800|FG004|Overall Study|Protocol Violation|0|||
13342559|NCT01001234|26629796|FG000|Overall Study|Lost to Follow-up|0|||
13342560|NCT01001234|26629797|FG001|Overall Study|Lost to Follow-up|0|||
13342561|NCT01001234|26629798|FG002|Overall Study|Lost to Follow-up|1|||
13342562|NCT01001234|26629799|FG003|Overall Study|Lost to Follow-up|2|||
13342563|NCT01001234|26629800|FG004|Overall Study|Lost to Follow-up|0|||
13342564|NCT01001234|26629796|FG000|Overall Study|Physician Decision|1|||
13342565|NCT01001234|26629797|FG001|Overall Study|Physician Decision|0|||
13342566|NCT01001234|26629798|FG002|Overall Study|Physician Decision|0|||
13342567|NCT01001234|26629799|FG003|Overall Study|Physician Decision|0|||
13342568|NCT01001234|26629800|FG004|Overall Study|Physician Decision|0|||
13342569|NCT01001234|26629796|FG000|Overall Study|Not Treated: Adverse Event|1|||
13342570|NCT01001234|26629797|FG001|Overall Study|Not Treated: Adverse Event|0|||
13342571|NCT01001234|26629798|FG002|Overall Study|Not Treated: Adverse Event|0|||
13342572|NCT01001234|26629799|FG003|Overall Study|Not Treated: Adverse Event|0|||
13342573|NCT01001234|26629800|FG004|Overall Study|Not Treated: Adverse Event|0|||
13342574|NCT01001234|26629796|FG000|Overall Study|Not Treated: Withdrawal by Subject|23|||
13342575|NCT01001234|26629797|FG001|Overall Study|Not Treated: Withdrawal by Subject|2|||
13342576|NCT01001234|26629798|FG002|Overall Study|Not Treated: Withdrawal by Subject|2|||
13342577|NCT01001234|26629799|FG003|Overall Study|Not Treated: Withdrawal by Subject|0|||
13342578|NCT01001234|26629800|FG004|Overall Study|Not Treated: Withdrawal by Subject|0|||
13342579|NCT01001234|26629796|FG000|Overall Study|Not Treated: Protocol Violation|3|||
13342580|NCT01001234|26629797|FG001|Overall Study|Not Treated: Protocol Violation|0|||
13342581|NCT01001234|26629798|FG002|Overall Study|Not Treated: Protocol Violation|0|||
13342582|NCT01001234|26629799|FG003|Overall Study|Not Treated: Protocol Violation|0|||
13342583|NCT01001234|26629800|FG004|Overall Study|Not Treated: Protocol Violation|0|||
13342584|NCT01001234|26629796|FG000|Overall Study|Not Treated: Lost to Follow-up|53|||
13342585|NCT01001234|26629797|FG001|Overall Study|Not Treated: Lost to Follow-up|4|||
13342586|NCT01001234|26629798|FG002|Overall Study|Not Treated: Lost to Follow-up|7|||
13342587|NCT01001234|26629799|FG003|Overall Study|Not Treated: Lost to Follow-up|5|||
13342588|NCT01001234|26629800|FG004|Overall Study|Not Treated: Lost to Follow-up|0|||
13342589|NCT01001234|26629796|FG000|Overall Study|Not Treated: Pregnancy|3|||
13342590|NCT01001234|26629797|FG001|Overall Study|Not Treated: Pregnancy|0|||
13342591|NCT01001234|26629798|FG002|Overall Study|Not Treated: Pregnancy|0|||
13342592|NCT01001234|26629799|FG003|Overall Study|Not Treated: Pregnancy|0|||
13342593|NCT01001234|26629800|FG004|Overall Study|Not Treated: Pregnancy|0|||
13342594|NCT01001234|26629796|FG000|Overall Study|Not Treated: Physician Decision|37|||
13342595|NCT01001234|26629797|FG001|Overall Study|Not Treated: Physician Decision|4|||
13342596|NCT01001234|26629798|FG002|Overall Study|Not Treated: Physician Decision|0|||
13342597|NCT01001234|26629799|FG003|Overall Study|Not Treated: Physician Decision|0|||
13342598|NCT01001234|26629800|FG004|Overall Study|Not Treated: Physician Decision|0|||
13342599|NCT01001234|26629796|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248|||
13342600|NCT01001234|26629797|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13|||
13342601|NCT01001234|26629798|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0|||
13342602|NCT01001234|26629799|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0|||
13342603|NCT01001234|26629800|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0|||
13342604|NCT01001221|26629987|FG000|Overall Study|Adverse Event|1|||
13342605|NCT01001221|26629988|FG001|Overall Study|Adverse Event|2|||
13342606|NCT01001221|26629989|FG002|Overall Study|Adverse Event|0|||
13342607|NCT01001221|26629990|FG003|Overall Study|Adverse Event|2|||
13342608|NCT01001221|26629991|FG004|Overall Study|Adverse Event|0|||
13342609|NCT01001221|26629987|FG000|Overall Study|Disease progression|3|||
13342610|NCT01001221|26629988|FG001|Overall Study|Disease progression|2|||
13342611|NCT01001221|26629989|FG002|Overall Study|Disease progression|2|||
13342612|NCT01001221|26629990|FG003|Overall Study|Disease progression|4|||
13342613|NCT01001221|26629991|FG004|Overall Study|Disease progression|0|||
13342614|NCT01001221|26629987|FG000|Overall Study|Other|1|||
13342615|NCT01001221|26629988|FG001|Overall Study|Other|1|||
13342616|NCT01001221|26629989|FG002|Overall Study|Other|0|||
13342617|NCT01001221|26629990|FG003|Overall Study|Other|0|||
13342618|NCT01001221|26629991|FG004|Overall Study|Other|0|||
13342619|NCT01001221|26629987|FG000|Overall Study|Not treated; protocol exclusion|0|||
13342620|NCT01001221|26629988|FG001|Overall Study|Not treated; protocol exclusion|0|||
13342621|NCT01001221|26629989|FG002|Overall Study|Not treated; protocol exclusion|1|||
13342622|NCT01001221|26629990|FG003|Overall Study|Not treated; protocol exclusion|0|||
13342623|NCT01001221|26629991|FG004|Overall Study|Not treated; protocol exclusion|0|||
13342624|NCT01001208|26630022|FG000|Overall Study|Adverse Event|10|||
13342625|NCT01001208|26630023|FG001|Overall Study|Adverse Event|5|||
13342626|NCT01001208|26630022|FG000|Overall Study|Lost to Follow-up|5|||
13342627|NCT01001208|26630023|FG001|Overall Study|Lost to Follow-up|9|||
13342628|NCT01001208|26630022|FG000|Overall Study|Physician Decision|1|||
13342629|NCT01001208|26630023|FG001|Overall Study|Physician Decision|0|||
13342630|NCT01001208|26630022|FG000|Overall Study|Withdrawal by Subject|4|||
13342631|NCT01001208|26630023|FG001|Overall Study|Withdrawal by Subject|5|||
13342632|NCT01001208|26630022|FG000|Overall Study|Ineligibility Determined|4|||
13342633|NCT01001208|26630023|FG001|Overall Study|Ineligibility Determined|2|||
13342634|NCT01001208|26630022|FG000|Overall Study|Noncompliance|4|||
13342635|NCT01001208|26630023|FG001|Overall Study|Noncompliance|7|||
13342636|NCT01001208|26630022|FG000|Overall Study|Disease Progression|0|||
13342637|NCT01001208|26630023|FG001|Overall Study|Disease Progression|3|||
13342638|NCT01001208|26630022|FG000|Overall Study|Other|0|||
13342639|NCT01001208|26630023|FG001|Overall Study|Other|2|||
13342640|NCT01001169|26630134|FG000|Overall Study|Withdrawal by Subject|2|||
13342641|NCT01001169|26630135|FG001|Overall Study|Withdrawal by Subject|1|||
13342642|NCT01001104|26630193|FG000|Overall Study|Adverse Event|2|||
13342643|NCT01001104|26630194|FG001|Overall Study|Adverse Event|1|||
13342644|NCT01001104|26630195|FG002|Overall Study|Adverse Event|0|||
13342645|NCT01001104|26630196|FG003|Overall Study|Adverse Event|0|||
13342646|NCT01001104|26630193|FG000|Overall Study|Lost to Follow-up|0|||
13342647|NCT01001104|26630194|FG001|Overall Study|Lost to Follow-up|0|||
13342648|NCT01001104|26630195|FG002|Overall Study|Lost to Follow-up|1|||
13342649|NCT01001104|26630196|FG003|Overall Study|Lost to Follow-up|0|||
13342650|NCT01001104|26630193|FG000|Overall Study|Entry Criteria Not Met|0|||
13342651|NCT01001104|26630194|FG001|Overall Study|Entry Criteria Not Met|0|||
13342652|NCT01001104|26630195|FG002|Overall Study|Entry Criteria Not Met|0|||
13342653|NCT01001104|26630196|FG003|Overall Study|Entry Criteria Not Met|1|||
13342654|NCT01001104|26630193|FG000|Overall Study|Withdrawal by Subject|0|||
13342655|NCT01001104|26630194|FG001|Overall Study|Withdrawal by Subject|0|||
13342656|NCT01001104|26630195|FG002|Overall Study|Withdrawal by Subject|0|||
13342657|NCT01001104|26630196|FG003|Overall Study|Withdrawal by Subject|2|||
13342658|NCT01000974|26630313|FG000|Primary Vaccination Phase|Withdrawal by Subject|109|||
13342659|NCT01000974|26630314|FG001|Primary Vaccination Phase|Withdrawal by Subject|17|||
13342660|NCT01000974|26630315|FG002|Primary Vaccination Phase|Withdrawal by Subject|21|||
13342661|NCT01000974|26630313|FG000|Primary Vaccination Phase|Lost to Follow-up|171|||
13342662|NCT01000974|26630314|FG001|Primary Vaccination Phase|Lost to Follow-up|19|||
13342663|NCT01000974|26630315|FG002|Primary Vaccination Phase|Lost to Follow-up|26|||
13342664|NCT01000974|26630313|FG000|Primary Vaccination Phase|Protocol Violation|40|||
13342665|NCT01000974|26630314|FG001|Primary Vaccination Phase|Protocol Violation|3|||
13342666|NCT01000974|26630315|FG002|Primary Vaccination Phase|Protocol Violation|2|||
13342667|NCT01000974|26630313|FG000|Primary Vaccination Phase|Adverse Event|14|||
13342668|NCT01000974|26630314|FG001|Primary Vaccination Phase|Adverse Event|2|||
13342669|NCT01000974|26630315|FG002|Primary Vaccination Phase|Adverse Event|2|||
13342670|NCT01000974|26630313|FG000|Primary Vaccination Phase|Other|4|||
13342671|NCT01000974|26630314|FG001|Primary Vaccination Phase|Other|9|||
13342672|NCT01000974|26630315|FG002|Primary Vaccination Phase|Other|12|||
13342673|NCT01000974|26630313|FG000|Booster Vaccination Phase|Protocol Violation|0|||
13342674|NCT01000974|26630314|FG001|Booster Vaccination Phase|Protocol Violation|0|||
13342675|NCT01000974|26630315|FG002|Booster Vaccination Phase|Protocol Violation|2|||
13342676|NCT01000974|26630313|FG000|Booster Vaccination Phase|Withdrawal by Subject|3|||
13342677|NCT01000974|26630314|FG001|Booster Vaccination Phase|Withdrawal by Subject|1|||
13342678|NCT01000974|26630315|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
13342679|NCT01000974|26630313|FG000|Booster Vaccination Phase|Lost to Follow-up|40|||
13342680|NCT01000974|26630314|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
13342681|NCT01000974|26630315|FG002|Booster Vaccination Phase|Lost to Follow-up|7|||
13342682|NCT01000974|26630313|FG000|Booster Vaccination Phase|Other|24|||
13342683|NCT01000974|26630314|FG001|Booster Vaccination Phase|Other|6|||
13342684|NCT01000974|26630315|FG002|Booster Vaccination Phase|Other|4|||
13342685|NCT01000961|26630330|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
13342686|NCT01000961|26630331|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
13342687|NCT01000961|26630330|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0|||
13342688|NCT01000961|26630331|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1|||
13342689|NCT01000805|26630370|FG000|Overall Study|Adverse Event|21|||
13342690|NCT01000805|26630371|FG001|Overall Study|Adverse Event|9|||
13342691|NCT01000805|26630370|FG000|Overall Study|Lack of Efficacy|5|||
13342692|NCT01000805|26630371|FG001|Overall Study|Lack of Efficacy|16|||
13342693|NCT01000805|26630370|FG000|Overall Study|Lost to Follow-up|16|||
13342694|NCT01000805|26630371|FG001|Overall Study|Lost to Follow-up|21|||
13342695|NCT01000805|26630370|FG000|Overall Study|Physician Decision|0|||
13342696|NCT01000805|26630371|FG001|Overall Study|Physician Decision|1|||
13342697|NCT01000805|26630370|FG000|Overall Study|Protocol Violation|12|||
13342698|NCT01000805|26630371|FG001|Overall Study|Protocol Violation|8|||
13342699|NCT01000805|26630370|FG000|Overall Study|Withdrawal by Subject|16|||
13342700|NCT01000805|26630371|FG001|Overall Study|Withdrawal by Subject|6|||
13342701|NCT01000805|26630370|FG000|Overall Study|Sponsor Decision|0|||
13342702|NCT01000805|26630371|FG001|Overall Study|Sponsor Decision|1|||
13342703|NCT01000727|26630406|FG000|Overall Study|Lost to Follow-up|41|||
13342704|NCT01000727|26630407|FG001|Overall Study|Lost to Follow-up|43|||
13342705|NCT01000727|26630406|FG000|Overall Study|Withdrawal by Subject|111|||
13342706|NCT01000727|26630407|FG001|Overall Study|Withdrawal by Subject|109|||
13342707|NCT01000727|26630406|FG000|Overall Study|Study closed/terminated|23|||
13342708|NCT01000727|26630407|FG001|Overall Study|Study closed/terminated|24|||
13342709|NCT01000649|26630501|FG000|Overall Study|Adverse Event|5|||
13342710|NCT01000649|26630502|FG001|Overall Study|Adverse Event|1|||
13342711|NCT01000649|26630503|FG002|Overall Study|Adverse Event|2|||
13342712|NCT01000649|26630504|FG003|Overall Study|Adverse Event|4|||
13342713|NCT01000649|26630501|FG000|Overall Study|Lost to Follow-up|0|||
13342714|NCT01000649|26630502|FG001|Overall Study|Lost to Follow-up|2|||
13342715|NCT01000649|26630503|FG002|Overall Study|Lost to Follow-up|0|||
13342716|NCT01000649|26630504|FG003|Overall Study|Lost to Follow-up|2|||
13342717|NCT01000636|26630511|FG000|Overall Study|Withdrawal by Subject|1|||
13342718|NCT01000636|26630511|FG000|Overall Study|Adverse Event|1|||
13342719|NCT01000610|26630520|FG000|Overall Study|Adverse Event|1|||
13342720|NCT01000610|26630520|FG000|Overall Study|Lost to Follow-up|4|||
13342721|NCT01000610|26630520|FG000|Overall Study|Treatment failure|1|||
13342722|NCT01000506|26630575|FG000|Overall Study|Adverse Event|6|||
13342723|NCT01000506|26630576|FG001|Overall Study|Adverse Event|5|||
13342724|NCT01000506|26630577|FG002|Overall Study|Adverse Event|8|||
13342725|NCT01000506|26630578|FG003|Overall Study|Adverse Event|9|||
13342726|NCT01000506|26630575|FG000|Overall Study|Lack of Efficacy|8|||
13342727|NCT01000506|26630576|FG001|Overall Study|Lack of Efficacy|6|||
13342728|NCT01000506|26630577|FG002|Overall Study|Lack of Efficacy|4|||
13342729|NCT01000506|26630578|FG003|Overall Study|Lack of Efficacy|4|||
13342730|NCT01000506|26630575|FG000|Overall Study|Protocol Violation|1|||
13342731|NCT01000506|26630576|FG001|Overall Study|Protocol Violation|1|||
13342732|NCT01000506|26630577|FG002|Overall Study|Protocol Violation|0|||
13342733|NCT01000506|26630578|FG003|Overall Study|Protocol Violation|0|||
13342734|NCT01000506|26630575|FG000|Overall Study|Lost to Follow-up|1|||
13342735|NCT01000506|26630576|FG001|Overall Study|Lost to Follow-up|1|||
13342736|NCT01000506|26630577|FG002|Overall Study|Lost to Follow-up|4|||
13342737|NCT01000506|26630578|FG003|Overall Study|Lost to Follow-up|0|||
13342738|NCT01000506|26630575|FG000|Overall Study|Physician Decision|1|||
13342739|NCT01000506|26630576|FG001|Overall Study|Physician Decision|3|||
13342740|NCT01000506|26630577|FG002|Overall Study|Physician Decision|3|||
13124755|NCT02939716|25953830|FG002|Overall Study|scanner failure|0|||
13124756|NCT02939716|25953831|FG003|Overall Study|scanner failure|1|||
13124757|NCT02939716|25953832|FG004|Overall Study|scanner failure|1|||
13124758|NCT02939716|25953833|FG005|Overall Study|scanner failure|1|||
13124759|NCT02939599|25953854|FG000|Overall Study|Adverse Event|1|||
13124760|NCT02939599|25953855|FG001|Overall Study|Adverse Event|0|||
13124761|NCT02939599|25953854|FG000|Overall Study|Study Terminated By Sponsor|2|||
13124762|NCT02939599|25953855|FG001|Overall Study|Study Terminated By Sponsor|2|||
13124763|NCT02939560|25953866|FG000|Overall Study|Withdrawal by Subject|2|||
13124764|NCT02939560|25953866|FG000|Overall Study|Protocol Violation|1|||
13204325|NCT01974817|26228279|FG000|Overall Study|Lost to Follow-up|2|||
13204326|NCT01974817|26228279|FG000|Overall Study|Protocol Violation|2|||
13204327|NCT01974752|26228298|FG000|Overall Study|Death|33|||
13204328|NCT01974752|26228299|FG001|Overall Study|Death|11|||
13204329|NCT01974752|26228298|FG000|Overall Study|Lost to Follow-up|2|||
13204330|NCT01974752|26228299|FG001|Overall Study|Lost to Follow-up|0|||
13204331|NCT01974752|26228298|FG000|Overall Study|Withdrawal by Subject|2|||
13204332|NCT01974752|26228299|FG001|Overall Study|Withdrawal by Subject|3|||
13204333|NCT01974752|26228298|FG000|Overall Study|Other Eligibility Criteria|0|||
13204334|NCT01974752|26228299|FG001|Overall Study|Other Eligibility Criteria|1|||
13204335|NCT01974323|26228328|FG000|Overall Study|Other Reasons|25|||
13204336|NCT01974323|26228329|FG001|Overall Study|Other Reasons|28|||
13204337|NCT01974323|26228328|FG000|Overall Study|Protocol Violation|2|||
13204338|NCT01974323|26228329|FG001|Overall Study|Protocol Violation|2|||
13204339|NCT01974323|26228328|FG000|Overall Study|Personal Reasons|15|||
13204340|NCT01974323|26228329|FG001|Overall Study|Personal Reasons|19|||
13204341|NCT01974323|26228328|FG000|Overall Study|Lost to Follow-up|45|||
13204342|NCT01974323|26228329|FG001|Overall Study|Lost to Follow-up|40|||
13204343|NCT01974323|26228328|FG000|Overall Study|Pregnancy|2|||
13204344|NCT01974323|26228329|FG001|Overall Study|Pregnancy|1|||
13204345|NCT01974323|26228328|FG000|Overall Study|Lack of Efficacy|1|||
13204346|NCT01974323|26228329|FG001|Overall Study|Lack of Efficacy|1|||
13204347|NCT01974323|26228328|FG000|Overall Study|Adverse Event|2|||
13204348|NCT01974323|26228329|FG001|Overall Study|Adverse Event|2|||
13204349|NCT01974206|26228352|FG000|Overall Study|Did Not Take Study Drug|0|||
13204350|NCT01974206|26228353|FG001|Overall Study|Did Not Take Study Drug|1|||
13204351|NCT01974206|26228352|FG000|Overall Study|Physician Decision|1|||
13204352|NCT01974206|26228353|FG001|Overall Study|Physician Decision|0|||
13204353|NCT01974206|26228352|FG000|Overall Study|Withdrawal by Subject|3|||
13204354|NCT01974206|26228353|FG001|Overall Study|Withdrawal by Subject|0|||
13204355|NCT01974206|26228352|FG000|Overall Study|Lost to Follow-up|1|||
13204356|NCT01974206|26228353|FG001|Overall Study|Lost to Follow-up|0|||
13204357|NCT01974206|26228352|FG000|Overall Study|Death|1|||
13342741|NCT01000506|26630578|FG003|Overall Study|Physician Decision|3|||
13342742|NCT01000506|26630575|FG000|Overall Study|Withdrawal by Subject|11|||
13342743|NCT01000506|26630576|FG001|Overall Study|Withdrawal by Subject|8|||
13342744|NCT01000506|26630577|FG002|Overall Study|Withdrawal by Subject|2|||
13342745|NCT01000506|26630578|FG003|Overall Study|Withdrawal by Subject|7|||
13342746|NCT01000493|26630635|FG000|Overall Study|Adverse Event|3|||
13342747|NCT01000493|26630636|FG001|Overall Study|Adverse Event|6|||
13342748|NCT01000493|26630635|FG000|Overall Study|Lack of Efficacy|1|||
13342749|NCT01000493|26630636|FG001|Overall Study|Lack of Efficacy|1|||
13342750|NCT01000493|26630635|FG000|Overall Study|Protocol Violation|1|||
13342751|NCT01000493|26630636|FG001|Overall Study|Protocol Violation|8|||
13342752|NCT01000493|26630635|FG000|Overall Study|Study closed/terminated|25|||
13342753|NCT01000493|26630636|FG001|Overall Study|Study closed/terminated|23|||
13342754|NCT01000493|26630635|FG000|Overall Study|Lost to Follow-up|5|||
13342755|NCT01000493|26630636|FG001|Overall Study|Lost to Follow-up|9|||
13342756|NCT01000493|26630635|FG000|Overall Study|Physician Decision|1|||
13342757|NCT01000493|26630636|FG001|Overall Study|Physician Decision|1|||
13342758|NCT01000493|26630635|FG000|Overall Study|Withdrawal by Subject|3|||
13342759|NCT01000493|26630636|FG001|Overall Study|Withdrawal by Subject|7|||
13342760|NCT01000480|26630644|FG000|Induction Phase|Adverse Event|2|||
13342761|NCT01000480|26630644|FG000|Induction Phase|Lost to Follow-up|1|||
13342762|NCT01000480|26630644|FG000|Induction Phase|Physician Decision|1|||
13342763|NCT01000480|26630644|FG000|Induction Phase|Entry Criteria Not Met|3|||
13124765|NCT02939131|25953967|FG000|Overall Study|Unable to get to clinic|6|||
13204358|NCT01974206|26228353|FG001|Overall Study|Death|0|||
13204359|NCT01974141|26228382|FG000|Overall Study|Other Reasons|28|||
13204360|NCT01974141|26228383|FG001|Overall Study|Other Reasons|18|||
13204361|NCT01974141|26228382|FG000|Overall Study|Protocol Violation|2|||
13342764|NCT01000480|26630644|FG000|Concurrent Therapy Phase|Adverse Event|4|||
13342765|NCT01000480|26630644|FG000|Concurrent Therapy Phase|Protocol Violation|2|||
13342766|NCT01000480|26630644|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3|||
13342767|NCT01000480|26630644|FG000|Concurrent Therapy Phase|Physician Decision|1|||
13342768|NCT01000376|26630659|FG000|Cycle 1 Day 1|Adverse Event|1|||
13342769|NCT01000376|26630660|FG001|Cycle 1 Day 1|Adverse Event|0|||
13342770|NCT01000376|26630659|FG000|Cycle 1 Day 1|Progressive Disease|1|||
13342771|NCT01000376|26630660|FG001|Cycle 1 Day 1|Progressive Disease|0|||
13342772|NCT01000337|26630673|FG000|Overall Study|Lost to Follow-up|4|||
13342773|NCT01000337|26630674|FG001|Overall Study|Lost to Follow-up|3|||
13342774|NCT01000311|26630709|FG000|Overall Study|Adverse Event|2|||
13342775|NCT01000311|26630710|FG001|Overall Study|Adverse Event|5|||
13124766|NCT02939131|25953968|FG001|Overall Study|Unable to get to clinic|4|||
13124767|NCT02939131|25953967|FG000|Overall Study|Lost to Follow-up|2|||
13124768|NCT02939131|25953968|FG001|Overall Study|Lost to Follow-up|4|||
13124769|NCT02939131|25953967|FG000|Overall Study|severe debilitation|1|||
13124770|NCT02939131|25953968|FG001|Overall Study|severe debilitation|0|||
13124771|NCT02939131|25953967|FG000|Overall Study|Other|0|||
13124772|NCT02939131|25953968|FG001|Overall Study|Other|1|||
13124773|NCT02939131|25953967|FG000|Overall Study|not willing to adhere to protocol|2|||
13124774|NCT02939131|25953968|FG001|Overall Study|not willing to adhere to protocol|0|||
13124775|NCT02939079|25954003|FG000|Overall Study|Adverse Event|2|||
13124776|NCT02939079|25954004|FG001|Overall Study|Adverse Event|1|||
13342776|NCT01000311|26630709|FG000|Overall Study|Withdrawal by Subject|16|||
13342777|NCT01000311|26630710|FG001|Overall Study|Withdrawal by Subject|24|||
13342778|NCT01000311|26630709|FG000|Overall Study|Lost to Follow-up|15|||
13342779|NCT01000311|26630710|FG001|Overall Study|Lost to Follow-up|24|||
13342780|NCT01000311|26630709|FG000|Overall Study|Protocol Violation|1|||
13342781|NCT01000311|26630710|FG001|Overall Study|Protocol Violation|2|||
13342782|NCT01000311|26630709|FG000|Overall Study|Inappropriate enrollment|2|||
13342783|NCT01000311|26630710|FG001|Overall Study|Inappropriate enrollment|0|||
13342784|NCT01000311|26630709|FG000|Overall Study|Administrative reason|9|||
13342785|NCT01000311|26630710|FG001|Overall Study|Administrative reason|15|||
13342786|NCT01000155|26630718|FG000|Overall Study|Withdrawal by Subject|1|||
13342787|NCT01000155|26630718|FG000|Overall Study|Adverse Event|1|||
13342788|NCT01000064|26630742|FG000|Overall Study|Withdrawal by Subject|1|||
13342789|NCT01000064|26630743|FG001|Overall Study|Withdrawal by Subject|1|||
13342790|NCT01000051|26630756|FG000|Overall Study|Withdrawal by Subject|1|||
13342791|NCT01000051|26630757|FG001|Overall Study|Withdrawal by Subject|1|||
13342792|NCT01000051|26630756|FG000|Overall Study|Disease Progression|1|||
13342793|NCT01000051|26630757|FG001|Overall Study|Disease Progression|0|||
13342794|NCT01000051|26630756|FG000|Overall Study|Serious noncompliance|1|||
13342795|NCT01000051|26630757|FG001|Overall Study|Serious noncompliance|0|||
13342796|NCT01000025|26630780|FG000|Overall Study|Adverse Event|43|||
13342797|NCT01000025|26630781|FG001|Overall Study|Adverse Event|2|||
13342798|NCT01000025|26630780|FG000|Overall Study|Withdrawal by Subject|13|||
13342799|NCT01000025|26630781|FG001|Overall Study|Withdrawal by Subject|8|||
13342800|NCT01000025|26630780|FG000|Overall Study|Death|23|||
13342801|NCT01000025|26630781|FG001|Overall Study|Death|13|||
13342802|NCT01000025|26630780|FG000|Overall Study|Lack of Efficacy|363|||
13342803|NCT01000025|26630781|FG001|Overall Study|Lack of Efficacy|208|||
13342804|NCT01000025|26630780|FG000|Overall Study|Intercurrent Illness|26|||
13342805|NCT01000025|26630781|FG001|Overall Study|Intercurrent Illness|7|||
13342806|NCT00999921|26630798|FG000|Overall Study|Lost to Follow-up|10|||
13342807|NCT00999921|26630799|FG001|Overall Study|Lost to Follow-up|19|||
13342808|NCT00999908|26630817|FG000|Treatment Period 1|Subject withdrew consent|2|||
13342809|NCT00999908|26630818|FG001|Treatment Period 1|Subject withdrew consent|0|||
13342810|NCT00999908|26630819|FG002|Treatment Period 1|Subject withdrew consent|0|||
13342811|NCT00999908|26630817|FG000|Treatment Period 2|Protocol Violation|1|||
13342812|NCT00999908|26630818|FG001|Treatment Period 2|Protocol Violation|0|||
13342813|NCT00999908|26630819|FG002|Treatment Period 2|Protocol Violation|0|||
13342814|NCT00999713|26630840|FG000|Overall Study|Physician Decision|2|||
13342815|NCT00999713|26630841|FG001|Overall Study|Physician Decision|0|||
13342816|NCT00999687|26630850|FG000|First Intervention|Withdrawal by Subject|1|||
13342817|NCT00999687|26630850|FG000|Second Intervention|Withdrawal by Subject|2|||
13486417|NCT03564119|27036068|FG000|Overall Study|Withdrawal by Subject|9|||
13124777|NCT02939079|25954003|FG000|Overall Study|Lost to Follow-up|0|||
13289196|NCT01081132|26477587|FG000|Overall Study|Lost to Follow-up|4|||
13124778|NCT02939079|25954004|FG001|Overall Study|Lost to Follow-up|2|||
13289197|NCT01081132|26477588|FG001|Overall Study|Lost to Follow-up|11|||
13289198|NCT01081132|26477587|FG000|Overall Study|Adverse Event|3|||
13289199|NCT01081132|26477588|FG001|Overall Study|Adverse Event|9|||
13289200|NCT01081132|26477587|FG000|Overall Study|Non Compliance|4|||
13289201|NCT01081132|26477588|FG001|Overall Study|Non Compliance|2|||
13289202|NCT01081132|26477587|FG000|Overall Study|Lack Of Compliance|0|||
13289203|NCT01081132|26477588|FG001|Overall Study|Lack Of Compliance|1|||
13289204|NCT01081132|26477587|FG000|Overall Study|Missed Visits|1|||
13289205|NCT01081132|26477588|FG001|Overall Study|Missed Visits|1|||
13289206|NCT01081132|26477587|FG000|Overall Study|Stopped Taking Meds|2|||
13289207|NCT01081132|26477588|FG001|Overall Study|Stopped Taking Meds|0|||
13342818|NCT00999687|26630850|FG000|Second Intervention|Lack of Efficacy|1|||
13342819|NCT00999661|26630858|FG000|Overall Study|Lost to Follow-up|59|||
13342820|NCT00999661|26630858|FG000|Overall Study|Adverse Event|1|||
13342821|NCT00999661|26630858|FG000|Overall Study|Withdrawal by Subject|1|||
13342822|NCT00999661|26630858|FG000|Overall Study|Not meeting eligibility criteria|9|||
13342823|NCT00999596|26630865|FG000|Overall Study|Statistical population not required|101|||
13342824|NCT00999544|26630900|FG000|Overall Study|Withdrawal by Subject|1|||
13342825|NCT00999518|26631102|FG000|Overall Study|Adverse Event|1|||
13342826|NCT00999518|26631103|FG001|Overall Study|Adverse Event|6|||
13342827|NCT00999518|26631104|FG002|Overall Study|Adverse Event|3|||
13342828|NCT00999518|26631105|FG003|Overall Study|Adverse Event|1|||
13342829|NCT00999518|26631106|FG004|Overall Study|Adverse Event|2|||
13342830|NCT00999518|26631102|FG000|Overall Study|Lack of Efficacy|2|||
13342831|NCT00999518|26631103|FG001|Overall Study|Lack of Efficacy|0|||
13342832|NCT00999518|26631104|FG002|Overall Study|Lack of Efficacy|0|||
13342833|NCT00999518|26631105|FG003|Overall Study|Lack of Efficacy|2|||
13342834|NCT00999518|26631106|FG004|Overall Study|Lack of Efficacy|2|||
13342835|NCT00999518|26631102|FG000|Overall Study|Lost to Follow-up|0|||
13342836|NCT00999518|26631103|FG001|Overall Study|Lost to Follow-up|0|||
13342837|NCT00999518|26631104|FG002|Overall Study|Lost to Follow-up|0|||
13342838|NCT00999518|26631105|FG003|Overall Study|Lost to Follow-up|4|||
13342839|NCT00999518|26631106|FG004|Overall Study|Lost to Follow-up|1|||
13342840|NCT00999518|26631102|FG000|Overall Study|Did not meet entrance criteria|0|||
13342841|NCT00999518|26631103|FG001|Overall Study|Did not meet entrance criteria|0|||
13342842|NCT00999518|26631104|FG002|Overall Study|Did not meet entrance criteria|0|||
13342843|NCT00999518|26631105|FG003|Overall Study|Did not meet entrance criteria|0|||
13342844|NCT00999518|26631106|FG004|Overall Study|Did not meet entrance criteria|1|||
13342845|NCT00999518|26631102|FG000|Overall Study|Study terminated by sponsor|10|||
13342846|NCT00999518|26631103|FG001|Overall Study|Study terminated by sponsor|6|||
13342847|NCT00999518|26631104|FG002|Overall Study|Study terminated by sponsor|5|||
13342848|NCT00999518|26631105|FG003|Overall Study|Study terminated by sponsor|5|||
13342849|NCT00999518|26631106|FG004|Overall Study|Study terminated by sponsor|9|||
13342850|NCT00999518|26631102|FG000|Overall Study|Pregnancy|0|||
13342851|NCT00999518|26631103|FG001|Overall Study|Pregnancy|0|||
13342852|NCT00999518|26631104|FG002|Overall Study|Pregnancy|1|||
13342853|NCT00999518|26631105|FG003|Overall Study|Pregnancy|0|||
13342854|NCT00999518|26631106|FG004|Overall Study|Pregnancy|0|||
13342855|NCT00999518|26631102|FG000|Overall Study|Protocol Violation|0|||
13342856|NCT00999518|26631103|FG001|Overall Study|Protocol Violation|1|||
13342857|NCT00999518|26631104|FG002|Overall Study|Protocol Violation|0|||
13342858|NCT00999518|26631105|FG003|Overall Study|Protocol Violation|0|||
13342859|NCT00999518|26631106|FG004|Overall Study|Protocol Violation|2|||
13342860|NCT00999518|26631102|FG000|Overall Study|Withdrawal by Subject|5|||
13342861|NCT00999518|26631103|FG001|Overall Study|Withdrawal by Subject|4|||
13342862|NCT00999518|26631104|FG002|Overall Study|Withdrawal by Subject|10|||
13342863|NCT00999518|26631105|FG003|Overall Study|Withdrawal by Subject|6|||
13342864|NCT00999518|26631106|FG004|Overall Study|Withdrawal by Subject|1|||
13342865|NCT00999518|26631102|FG000|Overall Study|Other|5|||
13342866|NCT00999518|26631103|FG001|Overall Study|Other|7|||
13342867|NCT00999518|26631104|FG002|Overall Study|Other|1|||
13342868|NCT00999518|26631105|FG003|Overall Study|Other|4|||
13342869|NCT00999518|26631106|FG004|Overall Study|Other|5|||
13342870|NCT00999518|26631102|FG000|Overall Study|Randomized but not Treated|1|||
13342871|NCT00999518|26631103|FG001|Overall Study|Randomized but not Treated|1|||
13342872|NCT00999518|26631104|FG002|Overall Study|Randomized but not Treated|2|||
13342873|NCT00999518|26631105|FG003|Overall Study|Randomized but not Treated|0|||
13342874|NCT00999518|26631106|FG004|Overall Study|Randomized but not Treated|1|||
13342875|NCT00999466|26631391|FG000|Main Part|Withdrawal by Subject|0|||
13342876|NCT00999466|26631392|FG001|Main Part|Withdrawal by Subject|0|||
13342877|NCT00999466|26631393|FG002|Main Part|Withdrawal by Subject|2|||
13342878|NCT00999466|26631391|FG000|Main Part|Adverse Event|0|||
13342879|NCT00999466|26631392|FG001|Main Part|Adverse Event|4|||
13342880|NCT00999466|26631393|FG002|Main Part|Adverse Event|2|||
13342881|NCT00999167|26631415|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4|||
13342882|NCT00999167|26631416|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
13342883|NCT00999167|26631417|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
13342884|NCT00999167|26631415|FG000|Part A: Open Label Safety run-in|Adverse Event|3|||
13342885|NCT00999167|26631416|FG001|Part A: Open Label Safety run-in|Adverse Event|0|||
13342886|NCT00999167|26631417|FG002|Part A: Open Label Safety run-in|Adverse Event|0|||
13342887|NCT00999167|26631415|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0|||
13342888|NCT00999167|26631416|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19|||
13342889|NCT00999167|26631417|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16|||
13342890|NCT00999167|26631415|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0|||
13342891|NCT00999167|26631416|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7|||
13342892|NCT00999167|26631417|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4|||
13342893|NCT00999167|26631415|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0|||
13342894|NCT00999167|26631416|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6|||
13342895|NCT00999167|26631417|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1|||
13342896|NCT00999167|26631415|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
13342897|NCT00999167|26631416|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1|||
13342898|NCT00999167|26631417|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
13342899|NCT00999167|26631415|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
13342900|NCT00999167|26631416|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1|||
13342901|NCT00999167|26631417|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
13342902|NCT00999167|26631415|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
13342903|NCT00999167|26631416|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1|||
13342904|NCT00999167|26631417|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
13342905|NCT00998985|26631526|FG000|Overall Study|Withdrawal by Subject|0|||
13342906|NCT00998985|26631527|FG001|Overall Study|Withdrawal by Subject|0|||
13342907|NCT00998985|26631528|FG002|Overall Study|Withdrawal by Subject|0|||
13342908|NCT00998985|26631529|FG003|Overall Study|Withdrawal by Subject|0|||
13342909|NCT00998985|26631530|FG004|Overall Study|Withdrawal by Subject|0|||
13342910|NCT00998985|26631531|FG005|Overall Study|Withdrawal by Subject|0|||
13342911|NCT00998985|26631532|FG006|Overall Study|Withdrawal by Subject|0|||
13342912|NCT00998985|26631533|FG007|Overall Study|Withdrawal by Subject|0|||
13342913|NCT00998985|26631534|FG008|Overall Study|Withdrawal by Subject|1|||
13342914|NCT00998985|26631535|FG009|Overall Study|Withdrawal by Subject|0|||
13342915|NCT00998985|26631536|FG010|Overall Study|Withdrawal by Subject|0|||
13342916|NCT00998985|26631537|FG011|Overall Study|Withdrawal by Subject|0|||
13342917|NCT00998985|26631538|FG012|Overall Study|Withdrawal by Subject|0|||
13342918|NCT00998985|26631539|FG013|Overall Study|Withdrawal by Subject|0|||
13342919|NCT00998985|26631526|FG000|Overall Study|Protocol Violation|0|||
13342920|NCT00998985|26631527|FG001|Overall Study|Protocol Violation|0|||
13342921|NCT00998985|26631528|FG002|Overall Study|Protocol Violation|0|||
13342922|NCT00998985|26631529|FG003|Overall Study|Protocol Violation|0|||
13342923|NCT00998985|26631530|FG004|Overall Study|Protocol Violation|0|||
13342924|NCT00998985|26631531|FG005|Overall Study|Protocol Violation|1|||
13342925|NCT00998985|26631532|FG006|Overall Study|Protocol Violation|0|||
13342926|NCT00998985|26631533|FG007|Overall Study|Protocol Violation|0|||
13342927|NCT00998985|26631534|FG008|Overall Study|Protocol Violation|0|||
13342928|NCT00998985|26631535|FG009|Overall Study|Protocol Violation|0|||
13342929|NCT00998985|26631536|FG010|Overall Study|Protocol Violation|0|||
13342930|NCT00998985|26631537|FG011|Overall Study|Protocol Violation|0|||
13342931|NCT00998985|26631538|FG012|Overall Study|Protocol Violation|0|||
13342932|NCT00998985|26631539|FG013|Overall Study|Protocol Violation|0|||
13342933|NCT00998946|26631548|FG000|Overall Study|Lost to Follow-up|1|||
13342934|NCT00998946|26631548|FG000|Overall Study|Withdrawal by Subject|1|||
13342935|NCT00998946|26631548|FG000|Overall Study|Death|2|||
13342936|NCT00998946|26631548|FG000|Overall Study|Reason Unspecified|3|||
13342937|NCT00998946|26631548|FG000|Overall Study|Enrolled but not Dosed|2|||
13342938|NCT00998881|26631567|FG000|Overall Study|Adverse Event|2|||
13342939|NCT00998881|26631568|FG001|Overall Study|Adverse Event|2|||
13342940|NCT00998881|26631567|FG000|Overall Study|Lack of Efficacy|1|||
13342941|NCT00998881|26631568|FG001|Overall Study|Lack of Efficacy|0|||
13342942|NCT00998881|26631567|FG000|Overall Study|Physician Decision|3|||
13342943|NCT00998881|26631568|FG001|Overall Study|Physician Decision|0|||
13342944|NCT00998881|26631567|FG000|Overall Study|Withdrawal by Subject|1|||
13342945|NCT00998881|26631568|FG001|Overall Study|Withdrawal by Subject|0|||
13342946|NCT00998881|26631567|FG000|Overall Study|Personal matter|1|||
13342947|NCT00998881|26631568|FG001|Overall Study|Personal matter|0|||
13342948|NCT00998790|26631578|FG000|Overall Study|Withdrawal by Subject|21|||
13342949|NCT00998764|26631607|FG000|Overall Study|Lack of Efficacy|3|||
13342950|NCT00998764|26631608|FG001|Overall Study|Lack of Efficacy|6|||
13342951|NCT00998764|26631607|FG000|Overall Study|Adverse Event|17|||
13342952|NCT00998764|26631608|FG001|Overall Study|Adverse Event|12|||
13342953|NCT00998764|26631607|FG000|Overall Study|Withdrawal by Subject|19|||
13342954|NCT00998764|26631608|FG001|Overall Study|Withdrawal by Subject|25|||
13342955|NCT00998764|26631607|FG000|Overall Study|Physician Decision|3|||
13342956|NCT00998764|26631608|FG001|Overall Study|Physician Decision|3|||
13342957|NCT00998764|26631607|FG000|Overall Study|Death|3|||
13342958|NCT00998764|26631608|FG001|Overall Study|Death|1|||
13342959|NCT00998764|26631607|FG000|Overall Study|Discontinuation of Study by Sponsor|164|||
13342960|NCT00998764|26631608|FG001|Overall Study|Discontinuation of Study by Sponsor|217|||
13342961|NCT00998764|26631607|FG000|Overall Study|Protocol Violation|0|||
13342962|NCT00998764|26631608|FG001|Overall Study|Protocol Violation|1|||
13342963|NCT00998764|26631607|FG000|Overall Study|Failed to Return|1|||
13342964|NCT00998764|26631608|FG001|Overall Study|Failed to Return|1|||
13342965|NCT00998764|26631607|FG000|Overall Study|Lost to Follow-up|1|||
13342966|NCT00998764|26631608|FG001|Overall Study|Lost to Follow-up|1|||
13342967|NCT00998764|26631607|FG000|Overall Study|Loss of Caregiver|0|||
13342968|NCT00998764|26631608|FG001|Overall Study|Loss of Caregiver|3|||
13342969|NCT00998764|26631607|FG000|Overall Study|Other|4|||
13342970|NCT00998764|26631608|FG001|Overall Study|Other|4|||
13342971|NCT00998764|26631607|FG000|Overall Study|Recurrent Episode of vasogenic edema|1|||
13342972|NCT00998764|26631608|FG001|Overall Study|Recurrent Episode of vasogenic edema|0|||
13342973|NCT00998738|26631622|FG000|Overall Study|Uknown|1|||
13342974|NCT00998400|26631657|FG000|Overall Study|Lack of interest/motivation|1|||
13342975|NCT00998400|26631658|FG001|Overall Study|Lack of interest/motivation|2|||
13342976|NCT00998400|26631657|FG000|Overall Study|Logistical problems|1|||
13342977|NCT00998400|26631658|FG001|Overall Study|Logistical problems|0|||
13342978|NCT00998335|26631693|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0|||
13342979|NCT00998335|26631694|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2|||
13342980|NCT00998309|26631752|FG000|Overall Study|Protocol Violation|4|||
13342981|NCT00998296|26631853|FG000|Overall Study|Progressive disease|0|||
13342982|NCT00998296|26631854|FG001|Overall Study|Progressive disease|1|||
13342983|NCT00998296|26631855|FG002|Overall Study|Progressive disease|0|||
13342984|NCT00998296|26631856|FG003|Overall Study|Progressive disease|0|||
13342985|NCT00998296|26631857|FG004|Overall Study|Progressive disease|0|||
13342986|NCT00998296|26631858|FG005|Overall Study|Progressive disease|0|||
13342987|NCT00998296|26631859|FG006|Overall Study|Progressive disease|1|||
13342988|NCT00998296|26631860|FG007|Overall Study|Progressive disease|0|||
13342989|NCT00998296|26631861|FG008|Overall Study|Progressive disease|0|||
13342990|NCT00998296|26631862|FG009|Overall Study|Progressive disease|14|||
13342991|NCT00998296|26631863|FG010|Overall Study|Progressive disease|5|||
13342992|NCT00998296|26631853|FG000|Overall Study|Dose limiting or dose reducing toxicity|0|||
13342993|NCT00998296|26631854|FG001|Overall Study|Dose limiting or dose reducing toxicity|0|||
13342994|NCT00998296|26631855|FG002|Overall Study|Dose limiting or dose reducing toxicity|0|||
13342995|NCT00998296|26631856|FG003|Overall Study|Dose limiting or dose reducing toxicity|0|||
13342996|NCT00998296|26631857|FG004|Overall Study|Dose limiting or dose reducing toxicity|1|||
13342997|NCT00998296|26631858|FG005|Overall Study|Dose limiting or dose reducing toxicity|0|||
13342998|NCT00998296|26631859|FG006|Overall Study|Dose limiting or dose reducing toxicity|0|||
13342999|NCT00998296|26631860|FG007|Overall Study|Dose limiting or dose reducing toxicity|2|||
13343000|NCT00998296|26631861|FG008|Overall Study|Dose limiting or dose reducing toxicity|2|||
13343001|NCT00998296|26631862|FG009|Overall Study|Dose limiting or dose reducing toxicity|0|||
13343002|NCT00998296|26631863|FG010|Overall Study|Dose limiting or dose reducing toxicity|0|||
13343003|NCT00998296|26631853|FG000|Overall Study|Other adverse event|0|||
13343004|NCT00998296|26631854|FG001|Overall Study|Other adverse event|0|||
13343005|NCT00998296|26631855|FG002|Overall Study|Other adverse event|0|||
13343006|NCT00998296|26631856|FG003|Overall Study|Other adverse event|0|||
13343007|NCT00998296|26631857|FG004|Overall Study|Other adverse event|1|||
13343008|NCT00998296|26631858|FG005|Overall Study|Other adverse event|0|||
13343009|NCT00998296|26631859|FG006|Overall Study|Other adverse event|0|||
13343010|NCT00998296|26631860|FG007|Overall Study|Other adverse event|0|||
13343011|NCT00998296|26631861|FG008|Overall Study|Other adverse event|0|||
13343012|NCT00998296|26631862|FG009|Overall Study|Other adverse event|1|||
13343013|NCT00998296|26631863|FG010|Overall Study|Other adverse event|2|||
13343014|NCT00998296|26631853|FG000|Overall Study|Refused to continue taking trial med.|0|||
13343015|NCT00998296|26631854|FG001|Overall Study|Refused to continue taking trial med.|0|||
13343016|NCT00998296|26631855|FG002|Overall Study|Refused to continue taking trial med.|0|||
13343017|NCT00998296|26631856|FG003|Overall Study|Refused to continue taking trial med.|0|||
13343018|NCT00998296|26631857|FG004|Overall Study|Refused to continue taking trial med.|0|||
13343019|NCT00998296|26631858|FG005|Overall Study|Refused to continue taking trial med.|0|||
13343020|NCT00998296|26631859|FG006|Overall Study|Refused to continue taking trial med.|0|||
13343021|NCT00998296|26631860|FG007|Overall Study|Refused to continue taking trial med.|0|||
13343022|NCT00998296|26631861|FG008|Overall Study|Refused to continue taking trial med.|0|||
13343023|NCT00998296|26631862|FG009|Overall Study|Refused to continue taking trial med.|2|||
13343024|NCT00998296|26631863|FG010|Overall Study|Refused to continue taking trial med.|0|||
13343025|NCT00998296|26631853|FG000|Overall Study|Reason other than those specified above|0|||
13343026|NCT00998296|26631854|FG001|Overall Study|Reason other than those specified above|0|||
13343027|NCT00998296|26631855|FG002|Overall Study|Reason other than those specified above|0|||
13343028|NCT00998296|26631856|FG003|Overall Study|Reason other than those specified above|0|||
13343029|NCT00998296|26631857|FG004|Overall Study|Reason other than those specified above|0|||
13343030|NCT00998296|26631858|FG005|Overall Study|Reason other than those specified above|0|||
13343031|NCT00998296|26631859|FG006|Overall Study|Reason other than those specified above|0|||
13343032|NCT00998296|26631860|FG007|Overall Study|Reason other than those specified above|0|||
13343033|NCT00998296|26631861|FG008|Overall Study|Reason other than those specified above|0|||
13343034|NCT00998296|26631862|FG009|Overall Study|Reason other than those specified above|1|||
13343035|NCT00998296|26631863|FG010|Overall Study|Reason other than those specified above|0|||
13343036|NCT00997984|26631939|FG000|Overall Study|Adverse Event|1|||
13343037|NCT00997984|26631940|FG001|Overall Study|Adverse Event|8|||
13343038|NCT00997984|26631941|FG002|Overall Study|Adverse Event|8|||
13343039|NCT00997984|26631939|FG000|Overall Study|Protocol Violation|1|||
13343040|NCT00997984|26631940|FG001|Overall Study|Protocol Violation|3|||
13343041|NCT00997984|26631941|FG002|Overall Study|Protocol Violation|0|||
13343042|NCT00997984|26631939|FG000|Overall Study|Withdrawal by Subject|6|||
13343043|NCT00997984|26631940|FG001|Overall Study|Withdrawal by Subject|9|||
13343044|NCT00997984|26631941|FG002|Overall Study|Withdrawal by Subject|5|||
13343045|NCT00997984|26631939|FG000|Overall Study|Lost to Follow-up|8|||
13343046|NCT00997984|26631940|FG001|Overall Study|Lost to Follow-up|5|||
13343047|NCT00997984|26631941|FG002|Overall Study|Lost to Follow-up|4|||
13343048|NCT00997984|26631939|FG000|Overall Study|Lack of Efficacy|20|||
13343049|NCT00997984|26631940|FG001|Overall Study|Lack of Efficacy|6|||
13343050|NCT00997984|26631941|FG002|Overall Study|Lack of Efficacy|3|||
13343051|NCT00997984|26631939|FG000|Overall Study|Met exclusion criteria|1|||
13343052|NCT00997984|26631940|FG001|Overall Study|Met exclusion criteria|0|||
13343053|NCT00997984|26631941|FG002|Overall Study|Met exclusion criteria|0|||
13343054|NCT00997984|26631939|FG000|Overall Study|non-compliance|0|||
13343055|NCT00997984|26631940|FG001|Overall Study|non-compliance|2|||
13343056|NCT00997984|26631941|FG002|Overall Study|non-compliance|3|||
13343057|NCT00997984|26631939|FG000|Overall Study|Wrong medication dispensed|0|||
13343058|NCT00997984|26631940|FG001|Overall Study|Wrong medication dispensed|1|||
13343059|NCT00997984|26631941|FG002|Overall Study|Wrong medication dispensed|0|||
13343060|NCT00997984|26631939|FG000|Overall Study|Suicidal ideation|0|||
13343061|NCT00997984|26631940|FG001|Overall Study|Suicidal ideation|0|||
13343062|NCT00997984|26631941|FG002|Overall Study|Suicidal ideation|1|||
13343063|NCT00997984|26631939|FG000|Overall Study|Work schedule|0|||
13343064|NCT00997984|26631940|FG001|Overall Study|Work schedule|0|||
13343065|NCT00997984|26631941|FG002|Overall Study|Work schedule|2|||
13343066|NCT00997893|26631971|FG000|Overall Study|Adverse Event|1|||
13343067|NCT00997893|26631972|FG001|Overall Study|Adverse Event|0|||
13343068|NCT00997893|26631973|FG002|Overall Study|Adverse Event|0|||
13343069|NCT00997893|26631971|FG000|Overall Study|Unable to meet study timelines|1|||
13343070|NCT00997893|26631972|FG001|Overall Study|Unable to meet study timelines|0|||
13343071|NCT00997893|26631973|FG002|Overall Study|Unable to meet study timelines|0|||
13343072|NCT00997893|26631971|FG000|Overall Study|Pain/pain meds during Visit 4|0|||
13343073|NCT00997893|26631972|FG001|Overall Study|Pain/pain meds during Visit 4|1|||
13343074|NCT00997893|26631973|FG002|Overall Study|Pain/pain meds during Visit 4|0|||
13343075|NCT00997503|26632015|FG000|Overall Study|Death|53|||
13343076|NCT00997503|26632015|FG000|Overall Study|Withdrawal by Subject|76|||
13343077|NCT00997503|26632015|FG000|Overall Study|Lost to Follow-up|33|||
13343078|NCT00997503|26632015|FG000|Overall Study|Adverse Event|3|||
13343079|NCT00997503|26632015|FG000|Overall Study|Physician Decision|10|||
13343080|NCT00997503|26632015|FG000|Overall Study|Missed 12-month follow-up|85|||
13343081|NCT00997503|26632015|FG000|Overall Study|Other reason|13|||
13343082|NCT00997438|26632060|FG000|Overall Study|Blood draw difficulty|2|||
13343083|NCT00997438|26632061|FG001|Overall Study|Blood draw difficulty|0|||
13343084|NCT00997438|26632062|FG002|Overall Study|Blood draw difficulty|1|||
13343085|NCT00997438|26632060|FG000|Overall Study|Withdrawal by Subject|1|||
13343086|NCT00997438|26632061|FG001|Overall Study|Withdrawal by Subject|1|||
13343087|NCT00997438|26632062|FG002|Overall Study|Withdrawal by Subject|0|||
13343088|NCT00997438|26632060|FG000|Overall Study|Exclusion criteria at visit 1|2|||
13343089|NCT00997438|26632061|FG001|Overall Study|Exclusion criteria at visit 1|2|||
13343090|NCT00997438|26632062|FG002|Overall Study|Exclusion criteria at visit 1|3|||
13343091|NCT00997386|26632071|FG000|Overall Study|Death|7|||
13343092|NCT00997373|26632084|FG000|Overall Study|Withdrawal by Subject|5|||
13343093|NCT00997373|26632085|FG001|Overall Study|Withdrawal by Subject|0|||
13343094|NCT00997373|26632084|FG000|Overall Study|wrong tumor type|4|||
13343095|NCT00997373|26632085|FG001|Overall Study|wrong tumor type|0|||
13343096|NCT00997373|26632084|FG000|Overall Study|could not have hysterectomy|6|||
13343097|NCT00997373|26632085|FG001|Overall Study|could not have hysterectomy|0|||
13343098|NCT00997334|26632094|FG000|Overall Study|still on therapy|12|||
13343099|NCT00997334|26632094|FG000|Overall Study|Adverse Event|3|||
13343100|NCT00997334|26632094|FG000|Overall Study|Patient non-compliance|1|||
13343101|NCT00997334|26632094|FG000|Overall Study|Withdrawal by Subject|3|||
13343102|NCT00997334|26632094|FG000|Overall Study|Death|2|||
13343103|NCT00997334|26632094|FG000|Overall Study|Urgent Palliative Care|2|||
13343104|NCT00997334|26632094|FG000|Overall Study|No lesion amenable|1|||
13343105|NCT00997334|26632094|FG000|Overall Study|Ineligible|1|||
13343106|NCT00997321|26632113|FG000|Overall Study|did not undergo sedation after enrollmen|0|||
13343107|NCT00997321|26632114|FG001|Overall Study|did not undergo sedation after enrollmen|3|||
13343108|NCT00997243|26632126|FG000|Overall Study|Early termination of study by sponsor|7|||
13343109|NCT00997126|26632147|FG000|Overall Study|Physician Decision|7|||
13343110|NCT00997126|26632148|FG001|Overall Study|Physician Decision|11|||
13343111|NCT00997035|26632179|FG000|3-week Followup Visit|Lost to Follow-up|9|||
13343112|NCT00997035|26632180|FG001|3-week Followup Visit|Lost to Follow-up|6|||
13343113|NCT00997035|26632179|FG000|3-month Follow-up Visit|Lost to Follow-up|12|||
13343114|NCT00997035|26632180|FG001|3-month Follow-up Visit|Lost to Follow-up|6|||
13343115|NCT00996996|26632214|FG000|Overall Study|Progressive Disease|10|||
13343116|NCT00996996|26632214|FG000|Overall Study|Non-compliance|8|||
13343117|NCT00996996|26632214|FG000|Overall Study|Lost to Follow-up|9|||
13343118|NCT00996996|26632214|FG000|Overall Study|Death|5|||
13486418|NCT03564119|27036069|FG001|Overall Study|Withdrawal by Subject|4|||
13343119|NCT00996996|26632214|FG000|Overall Study|Did Not Receive Study Medications|1|||
13343120|NCT00996944|26632263|FG000|Double-blind Treatment Period|Adverse Event|2|||
13343121|NCT00996944|26632264|FG001|Double-blind Treatment Period|Adverse Event|1|||
13343122|NCT00996944|26632263|FG000|Double-blind Treatment Period|Protocol Violation|1|||
13343123|NCT00996944|26632264|FG001|Double-blind Treatment Period|Protocol Violation|0|||
13343124|NCT00996944|26632263|FG000|Double-blind Treatment Period|Study Closed/Terminated|6|||
13343125|NCT00996944|26632264|FG001|Double-blind Treatment Period|Study Closed/Terminated|5|||
13343126|NCT00996944|26632263|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
13343127|NCT00996944|26632264|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
13343128|NCT00996944|26632263|FG000|Long-term Treatment Period|Study Closed/Terminated|12|||
13343129|NCT00996944|26632264|FG001|Long-term Treatment Period|Study Closed/Terminated|5|||
13343130|NCT00996918|26632324|FG000|Overall Study|Lack of Efficacy|1|||
13343131|NCT00996918|26632325|FG001|Overall Study|Lack of Efficacy|1|||
13343132|NCT00996918|26632326|FG002|Overall Study|Lack of Efficacy|2|||
13343133|NCT00996918|26632327|FG003|Overall Study|Lack of Efficacy|2|||
13343134|NCT00996918|26632328|FG004|Overall Study|Lack of Efficacy|0|||
13343135|NCT00996918|26632324|FG000|Overall Study|Adverse Event|2|||
13343136|NCT00996918|26632325|FG001|Overall Study|Adverse Event|5|||
13343137|NCT00996918|26632326|FG002|Overall Study|Adverse Event|2|||
13343138|NCT00996918|26632327|FG003|Overall Study|Adverse Event|6|||
13343139|NCT00996918|26632328|FG004|Overall Study|Adverse Event|0|||
13343140|NCT00996918|26632324|FG000|Overall Study|Withdrawal by Subject|1|||
13343141|NCT00996918|26632325|FG001|Overall Study|Withdrawal by Subject|4|||
13343142|NCT00996918|26632326|FG002|Overall Study|Withdrawal by Subject|3|||
13343143|NCT00996918|26632327|FG003|Overall Study|Withdrawal by Subject|3|||
13343144|NCT00996918|26632328|FG004|Overall Study|Withdrawal by Subject|2|||
13343145|NCT00996918|26632324|FG000|Overall Study|Physician Decision|1|||
13343146|NCT00996918|26632325|FG001|Overall Study|Physician Decision|0|||
13343147|NCT00996918|26632326|FG002|Overall Study|Physician Decision|0|||
13343148|NCT00996918|26632327|FG003|Overall Study|Physician Decision|0|||
13343149|NCT00996918|26632328|FG004|Overall Study|Physician Decision|0|||
13343150|NCT00996918|26632324|FG000|Overall Study|Discontinuation of Study by Sponsor|31|||
13343151|NCT00996918|26632325|FG001|Overall Study|Discontinuation of Study by Sponsor|54|||
13343152|NCT00996918|26632326|FG002|Overall Study|Discontinuation of Study by Sponsor|30|||
13343153|NCT00996918|26632327|FG003|Overall Study|Discontinuation of Study by Sponsor|45|||
13343154|NCT00996918|26632328|FG004|Overall Study|Discontinuation of Study by Sponsor|2|||
13343155|NCT00996918|26632324|FG000|Overall Study|Loss of Caregiver|0|||
13343156|NCT00996918|26632325|FG001|Overall Study|Loss of Caregiver|1|||
13343157|NCT00996918|26632326|FG002|Overall Study|Loss of Caregiver|0|||
13343158|NCT00996918|26632327|FG003|Overall Study|Loss of Caregiver|0|||
13343159|NCT00996918|26632328|FG004|Overall Study|Loss of Caregiver|0|||
13343160|NCT00996918|26632324|FG000|Overall Study|Other|3|||
13343161|NCT00996918|26632325|FG001|Overall Study|Other|1|||
13343162|NCT00996918|26632326|FG002|Overall Study|Other|0|||
13343163|NCT00996918|26632327|FG003|Overall Study|Other|0|||
13343164|NCT00996918|26632328|FG004|Overall Study|Other|0|||
13343165|NCT00996892|26632938|FG000|Dose-Escalation Stage 1|Adverse Event|0|||
13343166|NCT00996892|26632939|FG001|Dose-Escalation Stage 1|Adverse Event|0|||
13343167|NCT00996892|26632940|FG002|Dose-Escalation Stage 1|Adverse Event|0|||
13343168|NCT00996892|26632941|FG003|Dose-Escalation Stage 1|Adverse Event|2|||
13343169|NCT00996892|26632942|FG004|Dose-Escalation Stage 1|Adverse Event|0|||
13343170|NCT00996892|26632943|FG005|Dose-Escalation Stage 1|Adverse Event|0|||
13343171|NCT00996892|26632944|FG006|Dose-Escalation Stage 1|Adverse Event|1|||
13343172|NCT00996892|26632945|FG007|Dose-Escalation Stage 1|Adverse Event|0|||
13343173|NCT00996892|26632946|FG008|Dose-Escalation Stage 1|Adverse Event|0|||
13343174|NCT00996892|26632947|FG009|Dose-Escalation Stage 1|Adverse Event|0|||
13343175|NCT00996892|26632948|FG010|Dose-Escalation Stage 1|Adverse Event|0|||
13343176|NCT00996892|26632949|FG011|Dose-Escalation Stage 1|Adverse Event|0|||
13343177|NCT00996892|26632950|FG012|Dose-Escalation Stage 1|Adverse Event|0|||
13343178|NCT00996892|26632951|FG013|Dose-Escalation Stage 1|Adverse Event|0|||
13343179|NCT00996892|26632952|FG014|Dose-Escalation Stage 1|Adverse Event|0|||
13343180|NCT00996892|26632953|FG015|Dose-Escalation Stage 1|Adverse Event|0|||
13343181|NCT00996892|26632954|FG016|Dose-Escalation Stage 1|Adverse Event|0|||
13343182|NCT00996892|26632955|FG017|Dose-Escalation Stage 1|Adverse Event|0|||
13343183|NCT00996892|26632956|FG018|Dose-Escalation Stage 1|Adverse Event|0|||
13343184|NCT00996892|26632957|FG019|Dose-Escalation Stage 1|Adverse Event|0|||
13343185|NCT00996892|26632938|FG000|Dose-Escalation Stage 1|Death|1|||
13343186|NCT00996892|26632939|FG001|Dose-Escalation Stage 1|Death|0|||
13343187|NCT00996892|26632940|FG002|Dose-Escalation Stage 1|Death|0|||
13343188|NCT00996892|26632941|FG003|Dose-Escalation Stage 1|Death|0|||
13343189|NCT00996892|26632942|FG004|Dose-Escalation Stage 1|Death|0|||
13343190|NCT00996892|26632943|FG005|Dose-Escalation Stage 1|Death|1|||
13343191|NCT00996892|26632944|FG006|Dose-Escalation Stage 1|Death|0|||
13343192|NCT00996892|26632945|FG007|Dose-Escalation Stage 1|Death|0|||
13343193|NCT00996892|26632946|FG008|Dose-Escalation Stage 1|Death|0|||
13343194|NCT00996892|26632947|FG009|Dose-Escalation Stage 1|Death|0|||
13343195|NCT00996892|26632948|FG010|Dose-Escalation Stage 1|Death|0|||
13343196|NCT00996892|26632949|FG011|Dose-Escalation Stage 1|Death|0|||
13343197|NCT00996892|26632950|FG012|Dose-Escalation Stage 1|Death|0|||
13343198|NCT00996892|26632951|FG013|Dose-Escalation Stage 1|Death|0|||
13343199|NCT00996892|26632952|FG014|Dose-Escalation Stage 1|Death|0|||
13343200|NCT00996892|26632953|FG015|Dose-Escalation Stage 1|Death|0|||
13343201|NCT00996892|26632954|FG016|Dose-Escalation Stage 1|Death|0|||
13343202|NCT00996892|26632955|FG017|Dose-Escalation Stage 1|Death|0|||
13343203|NCT00996892|26632956|FG018|Dose-Escalation Stage 1|Death|0|||
13343204|NCT00996892|26632957|FG019|Dose-Escalation Stage 1|Death|0|||
13343205|NCT00996892|26632938|FG000|Dose-Escalation Stage 1|Physician Decision|1|||
13343206|NCT00996892|26632939|FG001|Dose-Escalation Stage 1|Physician Decision|0|||
13343207|NCT00996892|26632940|FG002|Dose-Escalation Stage 1|Physician Decision|0|||
13343208|NCT00996892|26632941|FG003|Dose-Escalation Stage 1|Physician Decision|1|||
13343209|NCT00996892|26632942|FG004|Dose-Escalation Stage 1|Physician Decision|0|||
13343210|NCT00996892|26632943|FG005|Dose-Escalation Stage 1|Physician Decision|1|||
13343211|NCT00996892|26632944|FG006|Dose-Escalation Stage 1|Physician Decision|2|||
13343212|NCT00996892|26632945|FG007|Dose-Escalation Stage 1|Physician Decision|0|||
13343213|NCT00996892|26632946|FG008|Dose-Escalation Stage 1|Physician Decision|0|||
13343214|NCT00996892|26632947|FG009|Dose-Escalation Stage 1|Physician Decision|0|||
13343215|NCT00996892|26632948|FG010|Dose-Escalation Stage 1|Physician Decision|0|||
13343216|NCT00996892|26632949|FG011|Dose-Escalation Stage 1|Physician Decision|0|||
13343217|NCT00996892|26632950|FG012|Dose-Escalation Stage 1|Physician Decision|0|||
13343218|NCT00996892|26632951|FG013|Dose-Escalation Stage 1|Physician Decision|0|||
13343219|NCT00996892|26632952|FG014|Dose-Escalation Stage 1|Physician Decision|0|||
13343220|NCT00996892|26632953|FG015|Dose-Escalation Stage 1|Physician Decision|0|||
13343221|NCT00996892|26632954|FG016|Dose-Escalation Stage 1|Physician Decision|0|||
13343222|NCT00996892|26632955|FG017|Dose-Escalation Stage 1|Physician Decision|0|||
13343223|NCT00996892|26632956|FG018|Dose-Escalation Stage 1|Physician Decision|0|||
13343224|NCT00996892|26632957|FG019|Dose-Escalation Stage 1|Physician Decision|0|||
13343225|NCT00996892|26632938|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
13343226|NCT00996892|26632939|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
13343227|NCT00996892|26632940|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
13343228|NCT00996892|26632941|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2|||
13343229|NCT00996892|26632942|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
13343230|NCT00996892|26632943|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
13343231|NCT00996892|26632944|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
13343232|NCT00996892|26632945|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
13343233|NCT00996892|26632946|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
13343234|NCT00996892|26632947|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
13343235|NCT00996892|26632948|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
13343236|NCT00996892|26632949|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
13343237|NCT00996892|26632950|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
13343238|NCT00996892|26632951|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
13343239|NCT00996892|26632952|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
13343240|NCT00996892|26632953|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
13343241|NCT00996892|26632954|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
13343242|NCT00996892|26632955|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
13343243|NCT00996892|26632956|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
13343244|NCT00996892|26632957|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
13343245|NCT00996892|26632938|FG000|Dose-Escalation Stage 1|Disease Progression|2|||
13343246|NCT00996892|26632939|FG001|Dose-Escalation Stage 1|Disease Progression|2|||
13343247|NCT00996892|26632940|FG002|Dose-Escalation Stage 1|Disease Progression|3|||
13343248|NCT00996892|26632941|FG003|Dose-Escalation Stage 1|Disease Progression|4|||
13343249|NCT00996892|26632942|FG004|Dose-Escalation Stage 1|Disease Progression|10|||
13343250|NCT00996892|26632943|FG005|Dose-Escalation Stage 1|Disease Progression|7|||
13343251|NCT00996892|26632944|FG006|Dose-Escalation Stage 1|Disease Progression|0|||
13343252|NCT00996892|26632945|FG007|Dose-Escalation Stage 1|Disease Progression|0|||
13343253|NCT00996892|26632946|FG008|Dose-Escalation Stage 1|Disease Progression|0|||
13343254|NCT00996892|26632947|FG009|Dose-Escalation Stage 1|Disease Progression|0|||
13343255|NCT00996892|26632948|FG010|Dose-Escalation Stage 1|Disease Progression|0|||
13343256|NCT00996892|26632949|FG011|Dose-Escalation Stage 1|Disease Progression|0|||
13343257|NCT00996892|26632950|FG012|Dose-Escalation Stage 1|Disease Progression|0|||
13343258|NCT00996892|26632951|FG013|Dose-Escalation Stage 1|Disease Progression|0|||
13343259|NCT00996892|26632952|FG014|Dose-Escalation Stage 1|Disease Progression|0|||
13343260|NCT00996892|26632953|FG015|Dose-Escalation Stage 1|Disease Progression|0|||
13343261|NCT00996892|26632954|FG016|Dose-Escalation Stage 1|Disease Progression|0|||
13343262|NCT00996892|26632955|FG017|Dose-Escalation Stage 1|Disease Progression|0|||
13343263|NCT00996892|26632956|FG018|Dose-Escalation Stage 1|Disease Progression|0|||
13343264|NCT00996892|26632957|FG019|Dose-Escalation Stage 1|Disease Progression|0|||
13343265|NCT00996892|26632938|FG000|Dose-Escalation Stage 1A|Adverse Event|0|||
13343266|NCT00996892|26632939|FG001|Dose-Escalation Stage 1A|Adverse Event|0|||
13343267|NCT00996892|26632940|FG002|Dose-Escalation Stage 1A|Adverse Event|0|||
13343268|NCT00996892|26632941|FG003|Dose-Escalation Stage 1A|Adverse Event|0|||
13343269|NCT00996892|26632942|FG004|Dose-Escalation Stage 1A|Adverse Event|0|||
13343270|NCT00996892|26632943|FG005|Dose-Escalation Stage 1A|Adverse Event|0|||
13343271|NCT00996892|26632944|FG006|Dose-Escalation Stage 1A|Adverse Event|0|||
13343272|NCT00996892|26632945|FG007|Dose-Escalation Stage 1A|Adverse Event|0|||
13343273|NCT00996892|26632946|FG008|Dose-Escalation Stage 1A|Adverse Event|0|||
13343274|NCT00996892|26632947|FG009|Dose-Escalation Stage 1A|Adverse Event|0|||
13343275|NCT00996892|26632948|FG010|Dose-Escalation Stage 1A|Adverse Event|1|||
13343276|NCT00996892|26632949|FG011|Dose-Escalation Stage 1A|Adverse Event|0|||
13343277|NCT00996892|26632950|FG012|Dose-Escalation Stage 1A|Adverse Event|0|||
13343278|NCT00996892|26632951|FG013|Dose-Escalation Stage 1A|Adverse Event|1|||
13343279|NCT00996892|26632952|FG014|Dose-Escalation Stage 1A|Adverse Event|0|||
13343280|NCT00996892|26632953|FG015|Dose-Escalation Stage 1A|Adverse Event|0|||
13343281|NCT00996892|26632954|FG016|Dose-Escalation Stage 1A|Adverse Event|0|||
13343282|NCT00996892|26632955|FG017|Dose-Escalation Stage 1A|Adverse Event|0|||
13343283|NCT00996892|26632956|FG018|Dose-Escalation Stage 1A|Adverse Event|0|||
13343284|NCT00996892|26632957|FG019|Dose-Escalation Stage 1A|Adverse Event|0|||
13343285|NCT00996892|26632938|FG000|Dose-Escalation Stage 1A|Death|0|||
13343286|NCT00996892|26632939|FG001|Dose-Escalation Stage 1A|Death|0|||
13343287|NCT00996892|26632940|FG002|Dose-Escalation Stage 1A|Death|0|||
13343288|NCT00996892|26632941|FG003|Dose-Escalation Stage 1A|Death|0|||
13343289|NCT00996892|26632942|FG004|Dose-Escalation Stage 1A|Death|0|||
13343290|NCT00996892|26632943|FG005|Dose-Escalation Stage 1A|Death|0|||
13343291|NCT00996892|26632944|FG006|Dose-Escalation Stage 1A|Death|0|||
13343292|NCT00996892|26632945|FG007|Dose-Escalation Stage 1A|Death|0|||
13343293|NCT00996892|26632946|FG008|Dose-Escalation Stage 1A|Death|0|||
13343294|NCT00996892|26632947|FG009|Dose-Escalation Stage 1A|Death|2|||
13343295|NCT00996892|26632948|FG010|Dose-Escalation Stage 1A|Death|0|||
13343296|NCT00996892|26632949|FG011|Dose-Escalation Stage 1A|Death|1|||
13343297|NCT00996892|26632950|FG012|Dose-Escalation Stage 1A|Death|1|||
13343298|NCT00996892|26632951|FG013|Dose-Escalation Stage 1A|Death|0|||
13343299|NCT00996892|26632952|FG014|Dose-Escalation Stage 1A|Death|0|||
13343300|NCT00996892|26632953|FG015|Dose-Escalation Stage 1A|Death|0|||
13289208|NCT01081132|26477587|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0|||
13289209|NCT01081132|26477588|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1|||
13289210|NCT01081132|26477587|FG000|Overall Study|Declined Taper Phase|0|||
13289211|NCT01081132|26477588|FG001|Overall Study|Declined Taper Phase|1|||
13289212|NCT01081132|26477587|FG000|Overall Study|Protocol Violation|3|||
13289213|NCT01081132|26477588|FG001|Overall Study|Protocol Violation|1|||
13289214|NCT01080768|26477601|FG000|Overall Study|Protocol Deviation|2|||
13289215|NCT01080768|26477602|FG001|Overall Study|Protocol Deviation|1|||
13289216|NCT01080716|26477629|FG000|Part 1|Physician Decision|1|||
13289217|NCT01080716|26477630|FG001|Part 1|Physician Decision|0|||
13289218|NCT01080716|26477631|FG002|Part 1|Physician Decision|0|||
13289219|NCT01080716|26477632|FG003|Part 1|Physician Decision|0|||
13343301|NCT00996892|26632954|FG016|Dose-Escalation Stage 1A|Death|0|||
13343302|NCT00996892|26632955|FG017|Dose-Escalation Stage 1A|Death|0|||
13343303|NCT00996892|26632956|FG018|Dose-Escalation Stage 1A|Death|0|||
13343304|NCT00996892|26632957|FG019|Dose-Escalation Stage 1A|Death|0|||
13343305|NCT00996892|26632938|FG000|Dose-Escalation Stage 1A|Physician Decision|0|||
13343306|NCT00996892|26632939|FG001|Dose-Escalation Stage 1A|Physician Decision|0|||
13343307|NCT00996892|26632940|FG002|Dose-Escalation Stage 1A|Physician Decision|0|||
13343308|NCT00996892|26632941|FG003|Dose-Escalation Stage 1A|Physician Decision|0|||
13343309|NCT00996892|26632942|FG004|Dose-Escalation Stage 1A|Physician Decision|0|||
13343310|NCT00996892|26632943|FG005|Dose-Escalation Stage 1A|Physician Decision|0|||
13343311|NCT00996892|26632944|FG006|Dose-Escalation Stage 1A|Physician Decision|0|||
13343312|NCT00996892|26632945|FG007|Dose-Escalation Stage 1A|Physician Decision|1|||
13343313|NCT00996892|26632946|FG008|Dose-Escalation Stage 1A|Physician Decision|0|||
13343314|NCT00996892|26632947|FG009|Dose-Escalation Stage 1A|Physician Decision|0|||
13343315|NCT00996892|26632948|FG010|Dose-Escalation Stage 1A|Physician Decision|0|||
13343316|NCT00996892|26632949|FG011|Dose-Escalation Stage 1A|Physician Decision|0|||
13343317|NCT00996892|26632950|FG012|Dose-Escalation Stage 1A|Physician Decision|0|||
13343318|NCT00996892|26632951|FG013|Dose-Escalation Stage 1A|Physician Decision|0|||
13343319|NCT00996892|26632952|FG014|Dose-Escalation Stage 1A|Physician Decision|0|||
13343320|NCT00996892|26632953|FG015|Dose-Escalation Stage 1A|Physician Decision|0|||
13343321|NCT00996892|26632954|FG016|Dose-Escalation Stage 1A|Physician Decision|0|||
13343322|NCT00996892|26632955|FG017|Dose-Escalation Stage 1A|Physician Decision|0|||
13343323|NCT00996892|26632956|FG018|Dose-Escalation Stage 1A|Physician Decision|0|||
13343324|NCT00996892|26632957|FG019|Dose-Escalation Stage 1A|Physician Decision|0|||
13343325|NCT00996892|26632938|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
13343326|NCT00996892|26632939|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
13343327|NCT00996892|26632940|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
13374023|NCT00798161|26725696|FG001|Overall Study|Adverse Event|4|||
13289220|NCT01080625|26477650|FG000|Overall Study|Physician Decision|0|||
13289221|NCT01080625|26477651|FG001|Overall Study|Physician Decision|2|||
13343328|NCT00996892|26632941|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
13343329|NCT00996892|26632942|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
13343330|NCT00996892|26632943|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
13343331|NCT00996892|26632944|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
13343332|NCT00996892|26632945|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
13343333|NCT00996892|26632946|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
13343334|NCT00996892|26632947|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
13343335|NCT00996892|26632948|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
13343336|NCT00996892|26632949|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
13343337|NCT00996892|26632950|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
13343338|NCT00996892|26632951|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
13343339|NCT00996892|26632952|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
13343340|NCT00996892|26632953|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
13343341|NCT00996892|26632954|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
13343342|NCT00996892|26632955|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
13343343|NCT00996892|26632956|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
13343344|NCT00996892|26632957|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
13343345|NCT00996892|26632938|FG000|Dose-Escalation Stage 1A|Disease Progression|0|||
13343346|NCT00996892|26632939|FG001|Dose-Escalation Stage 1A|Disease Progression|0|||
13343347|NCT00996892|26632940|FG002|Dose-Escalation Stage 1A|Disease Progression|0|||
13343348|NCT00996892|26632941|FG003|Dose-Escalation Stage 1A|Disease Progression|0|||
13343349|NCT00996892|26632942|FG004|Dose-Escalation Stage 1A|Disease Progression|0|||
13343350|NCT00996892|26632943|FG005|Dose-Escalation Stage 1A|Disease Progression|0|||
13343351|NCT00996892|26632944|FG006|Dose-Escalation Stage 1A|Disease Progression|0|||
13343352|NCT00996892|26632945|FG007|Dose-Escalation Stage 1A|Disease Progression|2|||
13343353|NCT00996892|26632946|FG008|Dose-Escalation Stage 1A|Disease Progression|3|||
13343354|NCT00996892|26632947|FG009|Dose-Escalation Stage 1A|Disease Progression|1|||
13343355|NCT00996892|26632948|FG010|Dose-Escalation Stage 1A|Disease Progression|5|||
13343356|NCT00996892|26632949|FG011|Dose-Escalation Stage 1A|Disease Progression|7|||
13343357|NCT00996892|26632950|FG012|Dose-Escalation Stage 1A|Disease Progression|6|||
13343358|NCT00996892|26632951|FG013|Dose-Escalation Stage 1A|Disease Progression|4|||
13343359|NCT00996892|26632952|FG014|Dose-Escalation Stage 1A|Disease Progression|0|||
13343360|NCT00996892|26632953|FG015|Dose-Escalation Stage 1A|Disease Progression|0|||
13343361|NCT00996892|26632954|FG016|Dose-Escalation Stage 1A|Disease Progression|0|||
13343362|NCT00996892|26632955|FG017|Dose-Escalation Stage 1A|Disease Progression|0|||
13343363|NCT00996892|26632956|FG018|Dose-Escalation Stage 1A|Disease Progression|0|||
13343364|NCT00996892|26632957|FG019|Dose-Escalation Stage 1A|Disease Progression|0|||
13343365|NCT00996892|26632938|FG000|Dose-Escalation Stage 1B|Physician Decision|0|||
13343366|NCT00996892|26632939|FG001|Dose-Escalation Stage 1B|Physician Decision|0|||
13343367|NCT00996892|26632940|FG002|Dose-Escalation Stage 1B|Physician Decision|0|||
13343368|NCT00996892|26632941|FG003|Dose-Escalation Stage 1B|Physician Decision|0|||
13343369|NCT00996892|26632942|FG004|Dose-Escalation Stage 1B|Physician Decision|0|||
13343370|NCT00996892|26632943|FG005|Dose-Escalation Stage 1B|Physician Decision|0|||
13343371|NCT00996892|26632944|FG006|Dose-Escalation Stage 1B|Physician Decision|0|||
13343372|NCT00996892|26632945|FG007|Dose-Escalation Stage 1B|Physician Decision|0|||
13343373|NCT00996892|26632946|FG008|Dose-Escalation Stage 1B|Physician Decision|0|||
13343374|NCT00996892|26632947|FG009|Dose-Escalation Stage 1B|Physician Decision|0|||
13343375|NCT00996892|26632948|FG010|Dose-Escalation Stage 1B|Physician Decision|0|||
13343376|NCT00996892|26632949|FG011|Dose-Escalation Stage 1B|Physician Decision|0|||
13343377|NCT00996892|26632950|FG012|Dose-Escalation Stage 1B|Physician Decision|0|||
13343378|NCT00996892|26632951|FG013|Dose-Escalation Stage 1B|Physician Decision|0|||
13343379|NCT00996892|26632952|FG014|Dose-Escalation Stage 1B|Physician Decision|0|||
13343380|NCT00996892|26632953|FG015|Dose-Escalation Stage 1B|Physician Decision|0|||
13343381|NCT00996892|26632954|FG016|Dose-Escalation Stage 1B|Physician Decision|0|||
13343382|NCT00996892|26632955|FG017|Dose-Escalation Stage 1B|Physician Decision|2|||
13343383|NCT00996892|26632956|FG018|Dose-Escalation Stage 1B|Physician Decision|0|||
13343384|NCT00996892|26632957|FG019|Dose-Escalation Stage 1B|Physician Decision|0|||
13343385|NCT00996892|26632938|FG000|Dose-Escalation Stage 1B|Disease Progression|0|||
13343386|NCT00996892|26632939|FG001|Dose-Escalation Stage 1B|Disease Progression|0|||
13343387|NCT00996892|26632940|FG002|Dose-Escalation Stage 1B|Disease Progression|0|||
13343388|NCT00996892|26632941|FG003|Dose-Escalation Stage 1B|Disease Progression|0|||
13343389|NCT00996892|26632942|FG004|Dose-Escalation Stage 1B|Disease Progression|0|||
13343390|NCT00996892|26632943|FG005|Dose-Escalation Stage 1B|Disease Progression|0|||
13343391|NCT00996892|26632944|FG006|Dose-Escalation Stage 1B|Disease Progression|0|||
13343392|NCT00996892|26632945|FG007|Dose-Escalation Stage 1B|Disease Progression|0|||
13343393|NCT00996892|26632946|FG008|Dose-Escalation Stage 1B|Disease Progression|0|||
13343394|NCT00996892|26632947|FG009|Dose-Escalation Stage 1B|Disease Progression|0|||
13343395|NCT00996892|26632948|FG010|Dose-Escalation Stage 1B|Disease Progression|0|||
13343396|NCT00996892|26632949|FG011|Dose-Escalation Stage 1B|Disease Progression|0|||
13343397|NCT00996892|26632950|FG012|Dose-Escalation Stage 1B|Disease Progression|0|||
13343398|NCT00996892|26632951|FG013|Dose-Escalation Stage 1B|Disease Progression|0|||
13343399|NCT00996892|26632952|FG014|Dose-Escalation Stage 1B|Disease Progression|4|||
13343400|NCT00996892|26632953|FG015|Dose-Escalation Stage 1B|Disease Progression|3|||
13343401|NCT00996892|26632954|FG016|Dose-Escalation Stage 1B|Disease Progression|3|||
13343402|NCT00996892|26632955|FG017|Dose-Escalation Stage 1B|Disease Progression|3|||
13343403|NCT00996892|26632956|FG018|Dose-Escalation Stage 1B|Disease Progression|0|||
13343404|NCT00996892|26632957|FG019|Dose-Escalation Stage 1B|Disease Progression|0|||
13343405|NCT00996892|26632938|FG000|Expansion Stage 2|Adverse Event|0|||
13343406|NCT00996892|26632939|FG001|Expansion Stage 2|Adverse Event|0|||
13343407|NCT00996892|26632940|FG002|Expansion Stage 2|Adverse Event|0|||
13343408|NCT00996892|26632941|FG003|Expansion Stage 2|Adverse Event|0|||
13343409|NCT00996892|26632942|FG004|Expansion Stage 2|Adverse Event|0|||
13343410|NCT00996892|26632943|FG005|Expansion Stage 2|Adverse Event|0|||
13343411|NCT00996892|26632944|FG006|Expansion Stage 2|Adverse Event|0|||
13343412|NCT00996892|26632945|FG007|Expansion Stage 2|Adverse Event|0|||
13343413|NCT00996892|26632946|FG008|Expansion Stage 2|Adverse Event|0|||
13343414|NCT00996892|26632947|FG009|Expansion Stage 2|Adverse Event|0|||
13343415|NCT00996892|26632948|FG010|Expansion Stage 2|Adverse Event|0|||
13343416|NCT00996892|26632949|FG011|Expansion Stage 2|Adverse Event|0|||
13343417|NCT00996892|26632950|FG012|Expansion Stage 2|Adverse Event|0|||
13343418|NCT00996892|26632951|FG013|Expansion Stage 2|Adverse Event|0|||
13343419|NCT00996892|26632952|FG014|Expansion Stage 2|Adverse Event|0|||
13343420|NCT00996892|26632953|FG015|Expansion Stage 2|Adverse Event|0|||
13343421|NCT00996892|26632954|FG016|Expansion Stage 2|Adverse Event|0|||
13343422|NCT00996892|26632955|FG017|Expansion Stage 2|Adverse Event|0|||
13343423|NCT00996892|26632956|FG018|Expansion Stage 2|Adverse Event|3|||
13343424|NCT00996892|26632957|FG019|Expansion Stage 2|Adverse Event|0|||
13343425|NCT00996892|26632938|FG000|Expansion Stage 2|Death|0|||
13343426|NCT00996892|26632939|FG001|Expansion Stage 2|Death|0|||
13343427|NCT00996892|26632940|FG002|Expansion Stage 2|Death|0|||
13343428|NCT00996892|26632941|FG003|Expansion Stage 2|Death|0|||
13343429|NCT00996892|26632942|FG004|Expansion Stage 2|Death|0|||
13343430|NCT00996892|26632943|FG005|Expansion Stage 2|Death|0|||
13343431|NCT00996892|26632944|FG006|Expansion Stage 2|Death|0|||
13343432|NCT00996892|26632945|FG007|Expansion Stage 2|Death|0|||
13343433|NCT00996892|26632946|FG008|Expansion Stage 2|Death|0|||
13343434|NCT00996892|26632947|FG009|Expansion Stage 2|Death|0|||
13343435|NCT00996892|26632948|FG010|Expansion Stage 2|Death|0|||
13343436|NCT00996892|26632949|FG011|Expansion Stage 2|Death|0|||
13343437|NCT00996892|26632950|FG012|Expansion Stage 2|Death|0|||
13343438|NCT00996892|26632951|FG013|Expansion Stage 2|Death|0|||
13343439|NCT00996892|26632952|FG014|Expansion Stage 2|Death|0|||
13343440|NCT00996892|26632953|FG015|Expansion Stage 2|Death|0|||
13343441|NCT00996892|26632954|FG016|Expansion Stage 2|Death|0|||
13343442|NCT00996892|26632955|FG017|Expansion Stage 2|Death|0|||
13343443|NCT00996892|26632956|FG018|Expansion Stage 2|Death|2|||
13343444|NCT00996892|26632957|FG019|Expansion Stage 2|Death|0|||
13343445|NCT00996892|26632938|FG000|Expansion Stage 2|Physician Decision|0|||
13343446|NCT00996892|26632939|FG001|Expansion Stage 2|Physician Decision|0|||
13343447|NCT00996892|26632940|FG002|Expansion Stage 2|Physician Decision|0|||
13343448|NCT00996892|26632941|FG003|Expansion Stage 2|Physician Decision|0|||
13343449|NCT00996892|26632942|FG004|Expansion Stage 2|Physician Decision|0|||
13343450|NCT00996892|26632943|FG005|Expansion Stage 2|Physician Decision|0|||
13343451|NCT00996892|26632944|FG006|Expansion Stage 2|Physician Decision|0|||
13343452|NCT00996892|26632945|FG007|Expansion Stage 2|Physician Decision|0|||
13343453|NCT00996892|26632946|FG008|Expansion Stage 2|Physician Decision|0|||
13343454|NCT00996892|26632947|FG009|Expansion Stage 2|Physician Decision|0|||
13343455|NCT00996892|26632948|FG010|Expansion Stage 2|Physician Decision|0|||
13343456|NCT00996892|26632949|FG011|Expansion Stage 2|Physician Decision|0|||
13343457|NCT00996892|26632950|FG012|Expansion Stage 2|Physician Decision|0|||
13343458|NCT00996892|26632951|FG013|Expansion Stage 2|Physician Decision|0|||
13343459|NCT00996892|26632952|FG014|Expansion Stage 2|Physician Decision|0|||
13343460|NCT00996892|26632953|FG015|Expansion Stage 2|Physician Decision|0|||
13343461|NCT00996892|26632954|FG016|Expansion Stage 2|Physician Decision|0|||
13343462|NCT00996892|26632955|FG017|Expansion Stage 2|Physician Decision|0|||
13343463|NCT00996892|26632956|FG018|Expansion Stage 2|Physician Decision|1|||
13343464|NCT00996892|26632957|FG019|Expansion Stage 2|Physician Decision|0|||
13343465|NCT00996892|26632938|FG000|Expansion Stage 2|Withdrawal by Subject|0|||
13343466|NCT00996892|26632939|FG001|Expansion Stage 2|Withdrawal by Subject|0|||
13343467|NCT00996892|26632940|FG002|Expansion Stage 2|Withdrawal by Subject|0|||
13343468|NCT00996892|26632941|FG003|Expansion Stage 2|Withdrawal by Subject|0|||
13343469|NCT00996892|26632942|FG004|Expansion Stage 2|Withdrawal by Subject|0|||
13343470|NCT00996892|26632943|FG005|Expansion Stage 2|Withdrawal by Subject|0|||
13343471|NCT00996892|26632944|FG006|Expansion Stage 2|Withdrawal by Subject|0|||
13343472|NCT00996892|26632945|FG007|Expansion Stage 2|Withdrawal by Subject|0|||
13343473|NCT00996892|26632946|FG008|Expansion Stage 2|Withdrawal by Subject|0|||
13343474|NCT00996892|26632947|FG009|Expansion Stage 2|Withdrawal by Subject|0|||
13343475|NCT00996892|26632948|FG010|Expansion Stage 2|Withdrawal by Subject|0|||
13343476|NCT00996892|26632949|FG011|Expansion Stage 2|Withdrawal by Subject|0|||
13343477|NCT00996892|26632950|FG012|Expansion Stage 2|Withdrawal by Subject|0|||
13343478|NCT00996892|26632951|FG013|Expansion Stage 2|Withdrawal by Subject|0|||
13343479|NCT00996892|26632952|FG014|Expansion Stage 2|Withdrawal by Subject|0|||
13343480|NCT00996892|26632953|FG015|Expansion Stage 2|Withdrawal by Subject|0|||
13343481|NCT00996892|26632954|FG016|Expansion Stage 2|Withdrawal by Subject|0|||
13343482|NCT00996892|26632955|FG017|Expansion Stage 2|Withdrawal by Subject|0|||
13343483|NCT00996892|26632956|FG018|Expansion Stage 2|Withdrawal by Subject|1|||
13343484|NCT00996892|26632957|FG019|Expansion Stage 2|Withdrawal by Subject|0|||
13343485|NCT00996892|26632938|FG000|Expansion Stage 2|Disease Progression|0|||
13343486|NCT00996892|26632939|FG001|Expansion Stage 2|Disease Progression|0|||
13343487|NCT00996892|26632940|FG002|Expansion Stage 2|Disease Progression|0|||
13343488|NCT00996892|26632941|FG003|Expansion Stage 2|Disease Progression|0|||
13343489|NCT00996892|26632942|FG004|Expansion Stage 2|Disease Progression|0|||
13343490|NCT00996892|26632943|FG005|Expansion Stage 2|Disease Progression|0|||
13343491|NCT00996892|26632944|FG006|Expansion Stage 2|Disease Progression|0|||
13343492|NCT00996892|26632945|FG007|Expansion Stage 2|Disease Progression|0|||
13343493|NCT00996892|26632946|FG008|Expansion Stage 2|Disease Progression|0|||
13343494|NCT00996892|26632947|FG009|Expansion Stage 2|Disease Progression|0|||
13343495|NCT00996892|26632948|FG010|Expansion Stage 2|Disease Progression|0|||
13343496|NCT00996892|26632949|FG011|Expansion Stage 2|Disease Progression|0|||
13343497|NCT00996892|26632950|FG012|Expansion Stage 2|Disease Progression|0|||
13343498|NCT00996892|26632951|FG013|Expansion Stage 2|Disease Progression|0|||
13343499|NCT00996892|26632952|FG014|Expansion Stage 2|Disease Progression|0|||
13343500|NCT00996892|26632953|FG015|Expansion Stage 2|Disease Progression|0|||
13343501|NCT00996892|26632954|FG016|Expansion Stage 2|Disease Progression|0|||
13343502|NCT00996892|26632955|FG017|Expansion Stage 2|Disease Progression|0|||
13343503|NCT00996892|26632956|FG018|Expansion Stage 2|Disease Progression|28|||
13343504|NCT00996892|26632957|FG019|Expansion Stage 2|Disease Progression|0|||
13343505|NCT00996892|26632938|FG000|Expansion Stage 2A|Adverse Event|0|||
13343506|NCT00996892|26632939|FG001|Expansion Stage 2A|Adverse Event|0|||
13343507|NCT00996892|26632940|FG002|Expansion Stage 2A|Adverse Event|0|||
13343508|NCT00996892|26632941|FG003|Expansion Stage 2A|Adverse Event|0|||
13343509|NCT00996892|26632942|FG004|Expansion Stage 2A|Adverse Event|0|||
13343510|NCT00996892|26632943|FG005|Expansion Stage 2A|Adverse Event|0|||
13343511|NCT00996892|26632944|FG006|Expansion Stage 2A|Adverse Event|0|||
13343512|NCT00996892|26632945|FG007|Expansion Stage 2A|Adverse Event|0|||
13343513|NCT00996892|26632946|FG008|Expansion Stage 2A|Adverse Event|0|||
13343514|NCT00996892|26632947|FG009|Expansion Stage 2A|Adverse Event|0|||
13343515|NCT00996892|26632948|FG010|Expansion Stage 2A|Adverse Event|0|||
13343516|NCT00996892|26632949|FG011|Expansion Stage 2A|Adverse Event|0|||
13343517|NCT00996892|26632950|FG012|Expansion Stage 2A|Adverse Event|0|||
13343518|NCT00996892|26632951|FG013|Expansion Stage 2A|Adverse Event|0|||
13343519|NCT00996892|26632952|FG014|Expansion Stage 2A|Adverse Event|0|||
13343520|NCT00996892|26632953|FG015|Expansion Stage 2A|Adverse Event|0|||
13204362|NCT01974141|26228383|FG001|Overall Study|Protocol Violation|6|||
13204363|NCT01974141|26228382|FG000|Overall Study|Personal Reasons|21|||
13204364|NCT01974141|26228383|FG001|Overall Study|Personal Reasons|20|||
13204365|NCT01974141|26228382|FG000|Overall Study|Lost to Follow-up|38|||
13204366|NCT01974141|26228383|FG001|Overall Study|Lost to Follow-up|29|||
13204367|NCT01974141|26228382|FG000|Overall Study|Pregnancy|3|||
13204368|NCT01974141|26228383|FG001|Overall Study|Pregnancy|3|||
13204369|NCT01974141|26228382|FG000|Overall Study|Lack of Efficacy|0|||
13204370|NCT01974141|26228383|FG001|Overall Study|Lack of Efficacy|1|||
13204371|NCT01974141|26228382|FG000|Overall Study|Adverse Event|4|||
13343521|NCT00996892|26632954|FG016|Expansion Stage 2A|Adverse Event|0|||
13343522|NCT00996892|26632955|FG017|Expansion Stage 2A|Adverse Event|0|||
13343523|NCT00996892|26632956|FG018|Expansion Stage 2A|Adverse Event|0|||
13343524|NCT00996892|26632957|FG019|Expansion Stage 2A|Adverse Event|8|||
13343525|NCT00996892|26632938|FG000|Expansion Stage 2A|Physician Decision|0|||
13343526|NCT00996892|26632939|FG001|Expansion Stage 2A|Physician Decision|0|||
13343527|NCT00996892|26632940|FG002|Expansion Stage 2A|Physician Decision|0|||
13343528|NCT00996892|26632941|FG003|Expansion Stage 2A|Physician Decision|0|||
13343529|NCT00996892|26632942|FG004|Expansion Stage 2A|Physician Decision|0|||
13343530|NCT00996892|26632943|FG005|Expansion Stage 2A|Physician Decision|0|||
13343531|NCT00996892|26632944|FG006|Expansion Stage 2A|Physician Decision|0|||
13343532|NCT00996892|26632945|FG007|Expansion Stage 2A|Physician Decision|0|||
13343533|NCT00996892|26632946|FG008|Expansion Stage 2A|Physician Decision|0|||
13343534|NCT00996892|26632947|FG009|Expansion Stage 2A|Physician Decision|0|||
13343535|NCT00996892|26632948|FG010|Expansion Stage 2A|Physician Decision|0|||
13343536|NCT00996892|26632949|FG011|Expansion Stage 2A|Physician Decision|0|||
13343537|NCT00996892|26632950|FG012|Expansion Stage 2A|Physician Decision|0|||
13343538|NCT00996892|26632951|FG013|Expansion Stage 2A|Physician Decision|0|||
13343539|NCT00996892|26632952|FG014|Expansion Stage 2A|Physician Decision|0|||
13343540|NCT00996892|26632953|FG015|Expansion Stage 2A|Physician Decision|0|||
13343541|NCT00996892|26632954|FG016|Expansion Stage 2A|Physician Decision|0|||
13343542|NCT00996892|26632955|FG017|Expansion Stage 2A|Physician Decision|0|||
13204372|NCT01974141|26228383|FG001|Overall Study|Adverse Event|5|||
13204373|NCT01973998|26228400|FG000|Overall Study|Death|2|||
13343543|NCT00996892|26632956|FG018|Expansion Stage 2A|Physician Decision|0|||
13343544|NCT00996892|26632957|FG019|Expansion Stage 2A|Physician Decision|2|||
13343545|NCT00996892|26632938|FG000|Expansion Stage 2A|Withdrawal by Subject|0|||
13343546|NCT00996892|26632939|FG001|Expansion Stage 2A|Withdrawal by Subject|0|||
13343547|NCT00996892|26632940|FG002|Expansion Stage 2A|Withdrawal by Subject|0|||
13343548|NCT00996892|26632941|FG003|Expansion Stage 2A|Withdrawal by Subject|0|||
13343549|NCT00996892|26632942|FG004|Expansion Stage 2A|Withdrawal by Subject|0|||
13343550|NCT00996892|26632943|FG005|Expansion Stage 2A|Withdrawal by Subject|0|||
13343551|NCT00996892|26632944|FG006|Expansion Stage 2A|Withdrawal by Subject|0|||
13343552|NCT00996892|26632945|FG007|Expansion Stage 2A|Withdrawal by Subject|0|||
13343553|NCT00996892|26632946|FG008|Expansion Stage 2A|Withdrawal by Subject|0|||
13343554|NCT00996892|26632947|FG009|Expansion Stage 2A|Withdrawal by Subject|0|||
13343555|NCT00996892|26632948|FG010|Expansion Stage 2A|Withdrawal by Subject|0|||
13343556|NCT00996892|26632949|FG011|Expansion Stage 2A|Withdrawal by Subject|0|||
13343557|NCT00996892|26632950|FG012|Expansion Stage 2A|Withdrawal by Subject|0|||
13343558|NCT00996892|26632951|FG013|Expansion Stage 2A|Withdrawal by Subject|0|||
13343559|NCT00996892|26632952|FG014|Expansion Stage 2A|Withdrawal by Subject|0|||
13343560|NCT00996892|26632953|FG015|Expansion Stage 2A|Withdrawal by Subject|0|||
13343561|NCT00996892|26632954|FG016|Expansion Stage 2A|Withdrawal by Subject|0|||
13343562|NCT00996892|26632955|FG017|Expansion Stage 2A|Withdrawal by Subject|0|||
13343563|NCT00996892|26632956|FG018|Expansion Stage 2A|Withdrawal by Subject|0|||
13343564|NCT00996892|26632957|FG019|Expansion Stage 2A|Withdrawal by Subject|4|||
13343565|NCT00996892|26632938|FG000|Expansion Stage 2A|Disease Progression|0|||
13343566|NCT00996892|26632939|FG001|Expansion Stage 2A|Disease Progression|0|||
13343567|NCT00996892|26632940|FG002|Expansion Stage 2A|Disease Progression|0|||
13343568|NCT00996892|26632941|FG003|Expansion Stage 2A|Disease Progression|0|||
13343569|NCT00996892|26632942|FG004|Expansion Stage 2A|Disease Progression|0|||
13343570|NCT00996892|26632943|FG005|Expansion Stage 2A|Disease Progression|0|||
13343571|NCT00996892|26632944|FG006|Expansion Stage 2A|Disease Progression|0|||
13343572|NCT00996892|26632945|FG007|Expansion Stage 2A|Disease Progression|0|||
13343573|NCT00996892|26632946|FG008|Expansion Stage 2A|Disease Progression|0|||
13343574|NCT00996892|26632947|FG009|Expansion Stage 2A|Disease Progression|0|||
13343575|NCT00996892|26632948|FG010|Expansion Stage 2A|Disease Progression|0|||
13343576|NCT00996892|26632949|FG011|Expansion Stage 2A|Disease Progression|0|||
13343577|NCT00996892|26632950|FG012|Expansion Stage 2A|Disease Progression|0|||
13343578|NCT00996892|26632951|FG013|Expansion Stage 2A|Disease Progression|0|||
13343579|NCT00996892|26632952|FG014|Expansion Stage 2A|Disease Progression|0|||
13343580|NCT00996892|26632953|FG015|Expansion Stage 2A|Disease Progression|0|||
13343581|NCT00996892|26632954|FG016|Expansion Stage 2A|Disease Progression|0|||
13343582|NCT00996892|26632955|FG017|Expansion Stage 2A|Disease Progression|0|||
13343583|NCT00996892|26632956|FG018|Expansion Stage 2A|Disease Progression|0|||
13343584|NCT00996892|26632957|FG019|Expansion Stage 2A|Disease Progression|31|||
13343585|NCT00996840|26633117|FG000|Overall Study|Adverse Event|0|||
13343586|NCT00996840|26633118|FG001|Overall Study|Adverse Event|1|||
13343587|NCT00996840|26633119|FG002|Overall Study|Adverse Event|0|||
13343588|NCT00996840|26633120|FG003|Overall Study|Adverse Event|0|||
13343589|NCT00996840|26633121|FG004|Overall Study|Adverse Event|0|||
13343590|NCT00996840|26633117|FG000|Overall Study|Physician Decision|0|||
13343591|NCT00996840|26633118|FG001|Overall Study|Physician Decision|0|||
13343592|NCT00996840|26633119|FG002|Overall Study|Physician Decision|1|||
13343593|NCT00996840|26633120|FG003|Overall Study|Physician Decision|1|||
13343594|NCT00996840|26633121|FG004|Overall Study|Physician Decision|2|||
13343595|NCT00996840|26633117|FG000|Overall Study|Withdrawal by Subject|1|||
13343596|NCT00996840|26633118|FG001|Overall Study|Withdrawal by Subject|1|||
13343597|NCT00996840|26633119|FG002|Overall Study|Withdrawal by Subject|0|||
13343598|NCT00996840|26633120|FG003|Overall Study|Withdrawal by Subject|0|||
13343599|NCT00996840|26633121|FG004|Overall Study|Withdrawal by Subject|0|||
13343600|NCT00996801|26633241|FG000|Overall Study|Adverse Event|6|||
13343601|NCT00996801|26633242|FG001|Overall Study|Adverse Event|4|||
13343602|NCT00996801|26633243|FG002|Overall Study|Adverse Event|12|||
13343603|NCT00996801|26633244|FG003|Overall Study|Adverse Event|17|||
13343604|NCT00996801|26633245|FG004|Overall Study|Adverse Event|31|||
13343605|NCT00996801|26633246|FG005|Overall Study|Adverse Event|3|||
13343606|NCT00996801|26633241|FG000|Overall Study|Lack of Efficacy|3|||
13343607|NCT00996801|26633242|FG001|Overall Study|Lack of Efficacy|0|||
13343608|NCT00996801|26633243|FG002|Overall Study|Lack of Efficacy|1|||
13343609|NCT00996801|26633244|FG003|Overall Study|Lack of Efficacy|3|||
13343610|NCT00996801|26633245|FG004|Overall Study|Lack of Efficacy|0|||
13343611|NCT00996801|26633246|FG005|Overall Study|Lack of Efficacy|1|||
13343612|NCT00996801|26633241|FG000|Overall Study|Lost to Follow-up|0|||
13343613|NCT00996801|26633242|FG001|Overall Study|Lost to Follow-up|0|||
13343614|NCT00996801|26633243|FG002|Overall Study|Lost to Follow-up|0|||
13343615|NCT00996801|26633244|FG003|Overall Study|Lost to Follow-up|3|||
13343616|NCT00996801|26633245|FG004|Overall Study|Lost to Follow-up|3|||
13343617|NCT00996801|26633246|FG005|Overall Study|Lost to Follow-up|2|||
13343618|NCT00996801|26633241|FG000|Overall Study|Physician Decision|0|||
13343619|NCT00996801|26633242|FG001|Overall Study|Physician Decision|0|||
13343620|NCT00996801|26633243|FG002|Overall Study|Physician Decision|0|||
13343621|NCT00996801|26633244|FG003|Overall Study|Physician Decision|1|||
13343622|NCT00996801|26633245|FG004|Overall Study|Physician Decision|0|||
13343623|NCT00996801|26633246|FG005|Overall Study|Physician Decision|0|||
13343624|NCT00996801|26633241|FG000|Overall Study|Progressive Disease|0|||
13343625|NCT00996801|26633242|FG001|Overall Study|Progressive Disease|1|||
13343626|NCT00996801|26633243|FG002|Overall Study|Progressive Disease|0|||
13343627|NCT00996801|26633244|FG003|Overall Study|Progressive Disease|0|||
13343628|NCT00996801|26633245|FG004|Overall Study|Progressive Disease|0|||
13343629|NCT00996801|26633246|FG005|Overall Study|Progressive Disease|0|||
13343630|NCT00996801|26633241|FG000|Overall Study|Protocol Violation|3|||
13343631|NCT00996801|26633242|FG001|Overall Study|Protocol Violation|4|||
13343632|NCT00996801|26633243|FG002|Overall Study|Protocol Violation|1|||
13343633|NCT00996801|26633244|FG003|Overall Study|Protocol Violation|2|||
13343634|NCT00996801|26633245|FG004|Overall Study|Protocol Violation|3|||
13343635|NCT00996801|26633246|FG005|Overall Study|Protocol Violation|4|||
13343636|NCT00996801|26633241|FG000|Overall Study|Study Terminated by Sponsor|0|||
13343637|NCT00996801|26633242|FG001|Overall Study|Study Terminated by Sponsor|1|||
13343638|NCT00996801|26633243|FG002|Overall Study|Study Terminated by Sponsor|0|||
13343639|NCT00996801|26633244|FG003|Overall Study|Study Terminated by Sponsor|0|||
13343640|NCT00996801|26633245|FG004|Overall Study|Study Terminated by Sponsor|46|||
13343641|NCT00996801|26633246|FG005|Overall Study|Study Terminated by Sponsor|0|||
13343642|NCT00996801|26633241|FG000|Overall Study|Withdrawal by Subject|8|||
13343643|NCT00996801|26633242|FG001|Overall Study|Withdrawal by Subject|6|||
13343644|NCT00996801|26633243|FG002|Overall Study|Withdrawal by Subject|9|||
13343645|NCT00996801|26633244|FG003|Overall Study|Withdrawal by Subject|5|||
13343646|NCT00996801|26633245|FG004|Overall Study|Withdrawal by Subject|5|||
13343647|NCT00996801|26633246|FG005|Overall Study|Withdrawal by Subject|9|||
13343648|NCT00996736|26633271|FG000|Overall Study|Death|1|||
13343649|NCT00996736|26633272|FG001|Overall Study|Death|1|||
13343650|NCT00996736|26633271|FG000|Overall Study|Lost to Follow-up|15|||
13343651|NCT00996736|26633272|FG001|Overall Study|Lost to Follow-up|14|||
13343652|NCT00996736|26633271|FG000|Overall Study|Visit not within 3-month window|5|||
13343653|NCT00996736|26633272|FG001|Overall Study|Visit not within 3-month window|3|||
13343654|NCT00996658|26633305|FG000|Overall Study|Adverse Event|2|||
13343655|NCT00996658|26633306|FG001|Overall Study|Adverse Event|5|||
13343656|NCT00996658|26633305|FG000|Overall Study|Protocol Violation|0|||
13343657|NCT00996658|26633306|FG001|Overall Study|Protocol Violation|1|||
13343658|NCT00996658|26633305|FG000|Overall Study|Lost to Follow-up|2|||
13343659|NCT00996658|26633306|FG001|Overall Study|Lost to Follow-up|5|||
13343660|NCT00996658|26633305|FG000|Overall Study|Non-compliance issues|3|||
13343661|NCT00996658|26633306|FG001|Overall Study|Non-compliance issues|3|||
13343662|NCT00996658|26633305|FG000|Overall Study|Other|9|||
13343663|NCT00996658|26633306|FG001|Overall Study|Other|7|||
13343664|NCT00996632|26633321|FG000|Overall Study|Physician Decision|0|||
13343665|NCT00996632|26633322|FG001|Overall Study|Physician Decision|0|||
13343666|NCT00996606|26633418|FG000|Overall Study|Adverse Event or Intercurrent Illness|2|||
13343667|NCT00996606|26633418|FG000|Overall Study|Insufficient Therapeutic Response|2|||
13343668|NCT00996606|26633418|FG000|Overall Study|Protocol Violation|1|||
13343669|NCT00996606|26633418|FG000|Overall Study|Withdrawal by Subject|3|||
13343670|NCT00996593|26633448|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7|||
13343671|NCT00996593|26633448|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3|||
13343672|NCT00996593|26633448|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22|||
13343673|NCT00996593|26633448|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
13343674|NCT00996593|26633448|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6|||
13343675|NCT00996593|26633448|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3|||
13343676|NCT00996593|26633448|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1|||
13343677|NCT00996593|26633448|FG000|Long-Term Follow-Up|Withdrawal by Subject|2|||
13343678|NCT00996593|26633448|FG000|Long-Term Follow-Up|Site Closed|1|||
13343679|NCT00996580|26633478|FG000|Overall Study|Adverse Event|466|||
13124779|NCT02939079|25954003|FG000|Overall Study|Protocol Violation|1|||
13124780|NCT02939079|25954004|FG001|Overall Study|Protocol Violation|0|||
13124781|NCT02939079|25954003|FG000|Overall Study|Withdrawal by Subject|0|||
13124782|NCT02939079|25954004|FG001|Overall Study|Withdrawal by Subject|1|||
13124783|NCT02939079|25954003|FG000|Overall Study|relapse during the study|1|||
13124784|NCT02939079|25954004|FG001|Overall Study|relapse during the study|1|||
13124785|NCT02939014|25954044|FG000|Overall Study|Lost to Follow-up|1|||
13124786|NCT02939014|25954045|FG001|Overall Study|Lost to Follow-up|0|||
13124787|NCT02939014|25954044|FG000|Overall Study|Death|4|||
13343680|NCT00996580|26633478|FG000|Overall Study|Lost to Follow-up|480|||
13343681|NCT00996580|26633478|FG000|Overall Study|Noncompliance with the protocol|137|||
13343682|NCT00996580|26633478|FG000|Overall Study|Physician Decision|5|||
13343683|NCT00996580|26633478|FG000|Overall Study|Pregnancy|68|||
13343684|NCT00996580|26633478|FG000|Overall Study|Protocol Violation|16|||
13343685|NCT00996580|26633478|FG000|Overall Study|Sponsor requested participant withdrawal|35|||
13343686|NCT00996580|26633478|FG000|Overall Study|Withdrawal by Subject|217|||
13343687|NCT00996580|26633478|FG000|Overall Study|Other|29|||
13343688|NCT00996489|26633495|FG000|Overall Study|Device failure|45|||
13343689|NCT00996489|26633495|FG000|Overall Study|Discontinued|116|||
13343690|NCT00996476|26633577|FG000|Overall Study|Withdrawal by Subject|1|||
13343691|NCT00996476|26633578|FG001|Overall Study|Withdrawal by Subject|2|||
13343692|NCT00996476|26633579|FG002|Overall Study|Withdrawal by Subject|1|||
13343693|NCT00996476|26633580|FG003|Overall Study|Withdrawal by Subject|0|||
13343694|NCT00996476|26633581|FG004|Overall Study|Withdrawal by Subject|1|||
13343695|NCT00996476|26633577|FG000|Overall Study|Adverse Event|0|||
13343696|NCT00996476|26633578|FG001|Overall Study|Adverse Event|1|||
13343697|NCT00996476|26633579|FG002|Overall Study|Adverse Event|0|||
13343698|NCT00996476|26633580|FG003|Overall Study|Adverse Event|0|||
13343699|NCT00996476|26633581|FG004|Overall Study|Adverse Event|1|||
13343700|NCT00996437|26633608|FG000|Overall Study|Death|1|||
13343701|NCT00996437|26633609|FG001|Overall Study|Death|0|||
13343702|NCT00996437|26633608|FG000|Overall Study|Dropped|2|||
13343703|NCT00996437|26633609|FG001|Overall Study|Dropped|2|||
13343704|NCT00996437|26633608|FG000|Overall Study|Missed|2|||
13343705|NCT00996437|26633609|FG001|Overall Study|Missed|5|||
13343706|NCT00996333|26633617|FG000|Overall Study|Screen failure|1|||
13343707|NCT00996333|26633617|FG000|Overall Study|Withdrawal by Subject|1|||
13343708|NCT00996333|26633617|FG000|Overall Study|Death|4|||
13343709|NCT00996333|26633617|FG000|Overall Study|Adverse Event|1|||
13343710|NCT00996333|26633617|FG000|Overall Study|Physician Decision|1|||
13343711|NCT00996333|26633617|FG000|Overall Study|Other|5|||
13343712|NCT00996307|26633688|FG000|Overall Study|Adverse Event|0|||
13343713|NCT00996307|26633689|FG001|Overall Study|Adverse Event|1|||
13343714|NCT00996307|26633690|FG002|Overall Study|Adverse Event|0|||
13343715|NCT00996307|26633691|FG003|Overall Study|Adverse Event|0|||
13343716|NCT00996307|26633688|FG000|Overall Study|Withdrawal by Subject|3|||
13343717|NCT00996307|26633689|FG001|Overall Study|Withdrawal by Subject|2|||
13343718|NCT00996307|26633690|FG002|Overall Study|Withdrawal by Subject|5|||
13343719|NCT00996307|26633691|FG003|Overall Study|Withdrawal by Subject|5|||
13343720|NCT00996307|26633688|FG000|Overall Study|Lost to Follow-up|13|||
13343721|NCT00996307|26633689|FG001|Overall Study|Lost to Follow-up|13|||
13343722|NCT00996307|26633690|FG002|Overall Study|Lost to Follow-up|7|||
13343723|NCT00996307|26633691|FG003|Overall Study|Lost to Follow-up|15|||
13343724|NCT00996307|26633688|FG000|Overall Study|Administrative reason|0|||
13343725|NCT00996307|26633689|FG001|Overall Study|Administrative reason|1|||
13343726|NCT00996307|26633690|FG002|Overall Study|Administrative reason|0|||
13343727|NCT00996307|26633691|FG003|Overall Study|Administrative reason|0|||
13343728|NCT00996307|26633688|FG000|Overall Study|Unable to classify|4|||
13343729|NCT00996307|26633689|FG001|Overall Study|Unable to classify|0|||
13343730|NCT00996307|26633690|FG002|Overall Study|Unable to classify|2|||
13343731|NCT00996307|26633691|FG003|Overall Study|Unable to classify|1|||
13343732|NCT00996281|26633706|FG000|Overall Study|Adverse Event|75|||
13343733|NCT00996281|26633707|FG001|Overall Study|Adverse Event|37|||
13343734|NCT00996281|26633706|FG000|Overall Study|Major Protocol Deviation|6|||
13343735|NCT00996281|26633707|FG001|Overall Study|Major Protocol Deviation|7|||
13343736|NCT00996281|26633706|FG000|Overall Study|Lost to Follow-up|14|||
13343737|NCT00996281|26633707|FG001|Overall Study|Lost to Follow-up|16|||
13343738|NCT00996281|26633706|FG000|Overall Study|Withdrawal by Subject|31|||
13343739|NCT00996281|26633707|FG001|Overall Study|Withdrawal by Subject|20|||
13343740|NCT00996281|26633706|FG000|Overall Study|Lack of Efficacy|0|||
13343741|NCT00996281|26633707|FG001|Overall Study|Lack of Efficacy|2|||
13343742|NCT00996281|26633706|FG000|Overall Study|Other|5|||
13343743|NCT00996281|26633707|FG001|Overall Study|Other|7|||
13343744|NCT00996216|26633725|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1|||
13343745|NCT00996216|26633725|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3|||
13343746|NCT00996216|26633725|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1|||
13343747|NCT00996203|26633746|FG000|Overall Study|Adverse Event|3|||
13343748|NCT00996203|26633746|FG000|Overall Study|Lost to Follow-up|1|||
13343749|NCT00996203|26633746|FG000|Overall Study|Lack of Efficacy|1|||
13343750|NCT00996203|26633746|FG000|Overall Study|Protocol Violation|2|||
13343751|NCT00996125|26633773|FG000|Overall Study|Adverse Event|0|||
13343752|NCT00996125|26633774|FG001|Overall Study|Adverse Event|2|||
13343753|NCT00996125|26633773|FG000|Overall Study|Lost to Follow-up|1|||
13343754|NCT00996125|26633774|FG001|Overall Study|Lost to Follow-up|6|||
13343755|NCT00996125|26633773|FG000|Overall Study|Withdrawal by Subject|4|||
13343756|NCT00996125|26633774|FG001|Overall Study|Withdrawal by Subject|3|||
13343757|NCT00996034|26633780|FG000|Overall Study|Lost to Follow-up|2|||
13343758|NCT00996034|26633780|FG000|Overall Study|withdrawn by PI|1|||
13343759|NCT00995930|26633816|FG000|Overall Study|Protocol deviation|2|||
13343760|NCT00995930|26633817|FG001|Overall Study|Protocol deviation|5|||
13343761|NCT00995930|26633816|FG000|Overall Study|Death|0|||
13343762|NCT00995930|26633817|FG001|Overall Study|Death|1|||
13343763|NCT00995930|26633816|FG000|Overall Study|Administrative problems|4|||
13343764|NCT00995930|26633817|FG001|Overall Study|Administrative problems|2|||
13343765|NCT00995930|26633816|FG000|Overall Study|Lost to Follow-up|1|||
13343766|NCT00995930|26633817|FG001|Overall Study|Lost to Follow-up|2|||
13343767|NCT00995930|26633816|FG000|Overall Study|Withdrawal by Subject|3|||
13343768|NCT00995930|26633817|FG001|Overall Study|Withdrawal by Subject|4|||
13343769|NCT00995930|26633816|FG000|Overall Study|Adverse Event|11|||
13343770|NCT00995930|26633817|FG001|Overall Study|Adverse Event|14|||
13343771|NCT00995865|26633847|FG000|Overall Study|Protocol Violation|2|||
13343772|NCT00995865|26633848|FG001|Overall Study|Protocol Violation|0|||
13343773|NCT00995865|26633849|FG002|Overall Study|Protocol Violation|0|||
13343774|NCT00995865|26633847|FG000|Overall Study|Lost to Follow-up|0|||
13343775|NCT00995865|26633848|FG001|Overall Study|Lost to Follow-up|0|||
13343776|NCT00995865|26633849|FG002|Overall Study|Lost to Follow-up|1|||
13343777|NCT00995774|26633866|FG000|Training Period 2|Withdrawal by Subject|2|||
13343778|NCT00995774|26633867|FG001|Training Period 2|Withdrawal by Subject|0|||
13343779|NCT00995709|26633900|FG000|Overall Study|Adverse Event|4|||
13343780|NCT00995709|26633901|FG001|Overall Study|Adverse Event|2|||
13343781|NCT00995709|26633902|FG002|Overall Study|Adverse Event|0|||
13343782|NCT00995709|26633900|FG000|Overall Study|Lack of Efficacy|0|||
13343783|NCT00995709|26633901|FG001|Overall Study|Lack of Efficacy|1|||
13343784|NCT00995709|26633902|FG002|Overall Study|Lack of Efficacy|4|||
13343785|NCT00995709|26633900|FG000|Overall Study|Withdrawal by Subject|0|||
13343786|NCT00995709|26633901|FG001|Overall Study|Withdrawal by Subject|4|||
13343787|NCT00995709|26633902|FG002|Overall Study|Withdrawal by Subject|1|||
13343788|NCT00995709|26633900|FG000|Overall Study|Lost to Follow-up|1|||
13343789|NCT00995709|26633901|FG001|Overall Study|Lost to Follow-up|0|||
13343790|NCT00995709|26633902|FG002|Overall Study|Lost to Follow-up|0|||
13343791|NCT00995709|26633900|FG000|Overall Study|Death|0|||
13343792|NCT00995709|26633901|FG001|Overall Study|Death|1|||
13343793|NCT00995709|26633902|FG002|Overall Study|Death|0|||
13343794|NCT00995709|26633900|FG000|Overall Study|Protocol Violation|2|||
13343795|NCT00995709|26633901|FG001|Overall Study|Protocol Violation|1|||
13343796|NCT00995709|26633902|FG002|Overall Study|Protocol Violation|0|||
13343797|NCT00995670|26633920|FG000|Overall Study|Failed arterial cannulation|1|||
13343798|NCT00995670|26633921|FG001|Overall Study|Failed arterial cannulation|0|||
13343799|NCT00995670|26633922|FG002|Overall Study|Failed arterial cannulation|3|||
13343800|NCT00995566|26633936|FG000|Overall Study|Adverse Event|2|||
13343801|NCT00995566|26633936|FG000|Overall Study|Early study termination|52|||
13343802|NCT00995553|26633951|FG000|Overall Study|Withdrawal by Subject|2|||
13343803|NCT00995553|26633952|FG001|Overall Study|Withdrawal by Subject|6|||
13343804|NCT00995488|26633959|FG000|Overall Study|Withdrawal by Subject|1|||
13343805|NCT00995436|26633977|FG000|Overall Study|Withdrawal by Subject|2|||
13343806|NCT00995436|26633978|FG001|Overall Study|Withdrawal by Subject|5|||
13343807|NCT00995436|26633979|FG002|Overall Study|Withdrawal by Subject|0|||
13343808|NCT00995410|26633986|FG000|Overall Study|Adverse Event|51|||
13343809|NCT00995410|26633986|FG000|Overall Study|Withdrawal by Subject|7|||
13343810|NCT00995410|26633986|FG000|Overall Study|Lost to Follow-up|2|||
13343811|NCT00995410|26633986|FG000|Overall Study|Misc|28|||
13343812|NCT00995371|26634006|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
13343813|NCT00995371|26634007|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
13343814|NCT00995345|26634050|FG000|Overall Study|Withdrawal by Subject|4|||
13343815|NCT00995345|26634051|FG001|Overall Study|Withdrawal by Subject|2|||
13343816|NCT00995345|26634052|FG002|Overall Study|Withdrawal by Subject|1|||
13343817|NCT00995345|26634053|FG003|Overall Study|Withdrawal by Subject|3|||
13343818|NCT00995345|26634054|FG004|Overall Study|Withdrawal by Subject|1|||
13343819|NCT00995345|26634050|FG000|Overall Study|Adverse Event|3|||
13343820|NCT00995345|26634051|FG001|Overall Study|Adverse Event|1|||
13343821|NCT00995345|26634052|FG002|Overall Study|Adverse Event|2|||
13343822|NCT00995345|26634053|FG003|Overall Study|Adverse Event|0|||
13343823|NCT00995345|26634054|FG004|Overall Study|Adverse Event|1|||
13343824|NCT00995345|26634050|FG000|Overall Study|Lost to Follow-up|2|||
13343825|NCT00995345|26634051|FG001|Overall Study|Lost to Follow-up|2|||
13343826|NCT00995345|26634052|FG002|Overall Study|Lost to Follow-up|2|||
13343827|NCT00995345|26634053|FG003|Overall Study|Lost to Follow-up|1|||
13343828|NCT00995345|26634054|FG004|Overall Study|Lost to Follow-up|0|||
13343829|NCT00995345|26634050|FG000|Overall Study|all other reasons combined|2|||
13343830|NCT00995345|26634051|FG001|Overall Study|all other reasons combined|2|||
13343831|NCT00995345|26634052|FG002|Overall Study|all other reasons combined|2|||
13343832|NCT00995345|26634053|FG003|Overall Study|all other reasons combined|1|||
13343833|NCT00995345|26634054|FG004|Overall Study|all other reasons combined|3|||
13343834|NCT00995085|26634060|FG000|Overall Study|Withdrawal by Subject|5|||
13343835|NCT00995020|26634075|FG000|Overall Study|margin analysis not performed|2|||
13343836|NCT00995020|26634076|FG001|Overall Study|margin analysis not performed|5|||
13343837|NCT00995020|26634075|FG000|Overall Study|specimen fragmentation, thermal damage|1|||
13343838|NCT00995020|26634076|FG001|Overall Study|specimen fragmentation, thermal damage|2|||
13374024|NCT00798161|26725697|FG002|Overall Study|Adverse Event|6|||
13374025|NCT00798161|26725698|FG003|Overall Study|Adverse Event|6|||
13374026|NCT00798161|26725699|FG004|Overall Study|Adverse Event|5|||
13374027|NCT00798161|26725700|FG005|Overall Study|Adverse Event|2|||
13374028|NCT00798161|26725701|FG006|Overall Study|Adverse Event|4|||
13374029|NCT00798161|26725695|FG000|Overall Study|Protocol Violation|2|||
13374030|NCT00798161|26725696|FG001|Overall Study|Protocol Violation|1|||
13343839|NCT00995007|26634099|FG000|Overall Study|Withdrew consent|1|||
13343840|NCT00995007|26634100|FG001|Overall Study|Withdrew consent|0|||
13343841|NCT00995007|26634099|FG000|Overall Study|Refused further treatment|8|||
13343842|NCT00995007|26634100|FG001|Overall Study|Refused further treatment|2|||
13343843|NCT00995007|26634099|FG000|Overall Study|Toxicity|8|||
13343844|NCT00995007|26634100|FG001|Overall Study|Toxicity|0|||
13343845|NCT00994890|26634238|FG000|Overall Study|Adverse Event|13|||
13343846|NCT00994890|26634239|FG001|Overall Study|Adverse Event|9|||
13343847|NCT00994890|26634240|FG002|Overall Study|Adverse Event|11|||
13343848|NCT00994890|26634238|FG000|Overall Study|Lack of Efficacy|0|||
13343849|NCT00994890|26634239|FG001|Overall Study|Lack of Efficacy|0|||
13343850|NCT00994890|26634240|FG002|Overall Study|Lack of Efficacy|1|||
13343851|NCT00994890|26634238|FG000|Overall Study|Lost to Follow-up|6|||
13343852|NCT00994890|26634239|FG001|Overall Study|Lost to Follow-up|1|||
13343853|NCT00994890|26634240|FG002|Overall Study|Lost to Follow-up|3|||
13343854|NCT00994890|26634238|FG000|Overall Study|No longer willing to participate|8|||
13343855|NCT00994890|26634239|FG001|Overall Study|No longer willing to participate|5|||
13343856|NCT00994890|26634240|FG002|Overall Study|No longer willing to participate|13|||
13343857|NCT00994890|26634238|FG000|Overall Study|Protocol Violation|2|||
13343858|NCT00994890|26634239|FG001|Overall Study|Protocol Violation|4|||
13343859|NCT00994890|26634240|FG002|Overall Study|Protocol Violation|0|||
13343860|NCT00994890|26634238|FG000|Overall Study|Study terminated by sponsor|199|||
13343861|NCT00994890|26634239|FG001|Overall Study|Study terminated by sponsor|201|||
13343862|NCT00994890|26634240|FG002|Overall Study|Study terminated by sponsor|197|||
13343863|NCT00994890|26634238|FG000|Overall Study|Randomized, but not treated|1|||
13343864|NCT00994890|26634239|FG001|Overall Study|Randomized, but not treated|0|||
13343865|NCT00994890|26634240|FG002|Overall Study|Randomized, but not treated|0|||
13343866|NCT00994890|26634238|FG000|Overall Study|Other|2|||
13343867|NCT00994890|26634239|FG001|Overall Study|Other|2|||
13343868|NCT00994890|26634240|FG002|Overall Study|Other|1|||
13343869|NCT00994682|26634291|FG000|Double Bilnd|Withdrawal by Subject|5|||
13343870|NCT00994682|26634292|FG001|Double Bilnd|Withdrawal by Subject|6|||
13343871|NCT00994682|26634291|FG000|Double Bilnd|Lost to Follow-up|3|||
13343872|NCT00994682|26634292|FG001|Double Bilnd|Lost to Follow-up|3|||
13343873|NCT00994682|26634291|FG000|Double Bilnd|Adverse Event|1|||
13343874|NCT00994682|26634292|FG001|Double Bilnd|Adverse Event|0|||
13343875|NCT00994682|26634291|FG000|Pioglitazone Open Label|Withdrawal by Subject|4|||
13343876|NCT00994682|26634292|FG001|Pioglitazone Open Label|Withdrawal by Subject|4|||
13343877|NCT00994682|26634291|FG000|Pioglitazone Open Label|Lost to Follow-up|3|||
13343878|NCT00994682|26634292|FG001|Pioglitazone Open Label|Lost to Follow-up|2|||
13343879|NCT00994682|26634291|FG000|Pioglitazone Open Label|Physician Decision|6|||
13343880|NCT00994682|26634292|FG001|Pioglitazone Open Label|Physician Decision|1|||
13343881|NCT00994643|26634298|FG000|Overall Study|Withdrawal by Subject|1|||
13343882|NCT00994461|26634334|FG000|Overall Study|Adverse Event|2|||
13343883|NCT00994461|26634335|FG001|Overall Study|Adverse Event|1|||
13343884|NCT00994461|26634336|FG002|Overall Study|Adverse Event|0|||
13343885|NCT00994448|26634349|FG000|Overall Study|Adverse Event|1|||
13343886|NCT00994448|26634350|FG001|Overall Study|Adverse Event|0|||
13343887|NCT00994448|26634349|FG000|Overall Study|Lost to Follow-up|5|||
13343888|NCT00994448|26634350|FG001|Overall Study|Lost to Follow-up|1|||
13343889|NCT00994448|26634349|FG000|Overall Study|Withdrawal by Subject|1|||
13343890|NCT00994448|26634350|FG001|Overall Study|Withdrawal by Subject|1|||
13343891|NCT00994448|26634349|FG000|Overall Study|Physician Decision|1|||
13343892|NCT00994448|26634350|FG001|Overall Study|Physician Decision|0|||
13343893|NCT00994422|26634367|FG000|Overall Study|Lost to Follow-up|7|||
13343894|NCT00994422|26634368|FG001|Overall Study|Lost to Follow-up|1|||
13343895|NCT00994279|26634383|FG000|Overall Study|Withdrawal by Subject|2|||
13343896|NCT00994279|26634384|FG001|Overall Study|Withdrawal by Subject|2|||
13343897|NCT00994279|26634383|FG000|Overall Study|Toxicity|1|||
13343898|NCT00994279|26634384|FG001|Overall Study|Toxicity|0|||
13343899|NCT00994279|26634383|FG000|Overall Study|Multiple reasons|1|||
13343900|NCT00994279|26634384|FG001|Overall Study|Multiple reasons|3|||
13343901|NCT00994240|26634397|FG000|Overall Study|Lost to Follow-up|3|||
13343902|NCT00994240|26634398|FG001|Overall Study|Lost to Follow-up|2|||
13343903|NCT00994240|26634397|FG000|Overall Study|Withdrawal by Subject|1|||
13343904|NCT00994240|26634398|FG001|Overall Study|Withdrawal by Subject|0|||
13343905|NCT00994240|26634397|FG000|Overall Study|study termination|2|||
13343906|NCT00994240|26634398|FG001|Overall Study|study termination|3|||
13343907|NCT00994214|26634455|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
13343908|NCT00994214|26634456|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1|||
13343909|NCT00994214|26634457|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
13343910|NCT00994214|26634458|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
13343911|NCT00994214|26634455|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
13343912|NCT00994214|26634456|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
13343913|NCT00994214|26634457|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
13343914|NCT00994214|26634458|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1|||
13343915|NCT00994214|26634455|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1|||
13343916|NCT00994214|26634456|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
13343917|NCT00994214|26634457|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
13343918|NCT00994214|26634458|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
13343919|NCT00994214|26634455|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
13343920|NCT00994214|26634456|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12|||
13343921|NCT00994214|26634457|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
13343922|NCT00994214|26634458|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14|||
13343923|NCT00994214|26634455|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
13343924|NCT00994214|26634456|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
13343925|NCT00994214|26634457|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
13343926|NCT00994214|26634458|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1|||
13343927|NCT00994214|26634455|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4|||
13343928|NCT00994214|26634456|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3|||
13343929|NCT00994214|26634457|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
13343930|NCT00994214|26634458|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
13343931|NCT00994162|26634489|FG000|Overall Study|Withdrawal by Subject|1|||
13343932|NCT00994162|26634489|FG000|Overall Study|Lost to Follow-up|2|||
13343933|NCT00994162|26634489|FG000|Overall Study|Product Complaint|1|||
13343934|NCT00994162|26634489|FG000|Overall Study|Poor Compliance|5|||
13343935|NCT00994162|26634489|FG000|Overall Study|Lack of Response|3|||
13343936|NCT00994162|26634489|FG000|Overall Study|Discharged from Hospital|4|||
13343937|NCT00994162|26634489|FG000|Overall Study|Death|2|||
13343938|NCT00994162|26634489|FG000|Overall Study|Care Transferred to Another Physician|2|||
13343939|NCT00994162|26634489|FG000|Overall Study|Discontinued and Changed to Iodoflex|1|||
13343940|NCT00994162|26634489|FG000|Overall Study|Physician Decision|2|||
13343941|NCT00994162|26634489|FG000|Overall Study|Surrounding Wound Erythematous|1|||
13343942|NCT00994162|26634489|FG000|Overall Study|Machine Losing Vaccum|1|||
13343943|NCT00994162|26634489|FG000|Overall Study|Patient Lived Too Far Away|1|||
13343944|NCT00994162|26634489|FG000|Overall Study|Above Knee Amputation|1|||
13343945|NCT00994162|26634489|FG000|Overall Study|Reason Not Reported By Site|1|||
13343946|NCT00994110|26634502|FG000|Overall Study|Withdrawal by Subject|9|||
13343947|NCT00994110|26634503|FG001|Overall Study|Withdrawal by Subject|9|||
13343948|NCT00994110|26634502|FG000|Overall Study|Not Treated|4|||
13343949|NCT00994110|26634503|FG001|Overall Study|Not Treated|8|||
13343950|NCT00994110|26634502|FG000|Overall Study|Adverse Event|1|||
13343951|NCT00994110|26634503|FG001|Overall Study|Adverse Event|0|||
13343952|NCT00994110|26634502|FG000|Overall Study|Patient not resected|41|||
13343953|NCT00994110|26634503|FG001|Overall Study|Patient not resected|52|||
13343954|NCT00994110|26634502|FG000|Overall Study|Pt not eligible|10|||
13343955|NCT00994110|26634503|FG001|Overall Study|Pt not eligible|5|||
13343956|NCT00993967|26634510|FG000|Overall Study|Adverse Event|8|||
13343957|NCT00993967|26634510|FG000|Overall Study|Death|1|||
13343958|NCT00993967|26634510|FG000|Overall Study|Lost to Follow-up|14|||
13343959|NCT00993967|26634510|FG000|Overall Study|Withdrawal by Subject|36|||
13343960|NCT00993967|26634510|FG000|Overall Study|Protocol Violation|2|||
13343961|NCT00993954|26634528|FG000|Overall Study|Protocol Violation|21|||
13343962|NCT00993954|26634529|FG001|Overall Study|Protocol Violation|2|||
13343963|NCT00993928|26634550|FG000|Overall Study|Withdrawal by Subject|4|||
13343964|NCT00993928|26634551|FG001|Overall Study|Withdrawal by Subject|7|||
13343965|NCT00993928|26634550|FG000|Overall Study|ineligible|1|||
13343966|NCT00993928|26634551|FG001|Overall Study|ineligible|0|||
13343967|NCT00993915|26634562|FG000|Overall Study|Insufficient clinical response|3|||
13343968|NCT00993915|26634562|FG000|Overall Study|Withdrawal by Subject|2|||
13343969|NCT00993915|26634562|FG000|Overall Study|Other|1|||
13343970|NCT00993915|26634562|FG000|Overall Study|Ongoing|3|||
13343971|NCT00993668|26634594|FG000|Single-Blind Period|Adverse Event|1|||
13343972|NCT00993668|26634595|FG001|Single-Blind Period|Adverse Event|1|||
13343973|NCT00993668|26634594|FG000|Single-Blind Period|Lack of Efficacy|0|||
13343974|NCT00993668|26634595|FG001|Single-Blind Period|Lack of Efficacy|1|||
13343975|NCT00993668|26634594|FG000|Single-Blind Period|Lost to Follow-up|3|||
13343976|NCT00993668|26634595|FG001|Single-Blind Period|Lost to Follow-up|1|||
13343977|NCT00993668|26634594|FG000|Open-Label Period|Adverse Event|9|||
13343978|NCT00993668|26634595|FG001|Open-Label Period|Adverse Event|8|||
13343979|NCT00993668|26634594|FG000|Open-Label Period|Lack of Efficacy|4|||
13343980|NCT00993668|26634595|FG001|Open-Label Period|Lack of Efficacy|3|||
13343981|NCT00993668|26634594|FG000|Open-Label Period|Withdrawal by Subject|4|||
13343982|NCT00993668|26634595|FG001|Open-Label Period|Withdrawal by Subject|3|||
13343983|NCT00993668|26634594|FG000|Open-Label Period|Lost to Follow-up|6|||
13343984|NCT00993668|26634595|FG001|Open-Label Period|Lost to Follow-up|1|||
13343985|NCT00993616|26634609|FG000|Overall Study|No tumor at entry|1|||
13343986|NCT00993616|26634609|FG000|Overall Study|Never treated|1|||
13343987|NCT00993499|26634708|FG000|Run-in Period (8 Days)|Adverse Event|0|||
13343988|NCT00993499|26634709|FG001|Run-in Period (8 Days)|Adverse Event|1|||
13343989|NCT00993499|26634710|FG002|Run-in Period (8 Days)|Adverse Event|0|||
13343990|NCT00993499|26634711|FG003|Run-in Period (8 Days)|Adverse Event|0|||
13343991|NCT00993499|26634712|FG004|Run-in Period (8 Days)|Adverse Event|0|||
13343992|NCT00993499|26634713|FG005|Run-in Period (8 Days)|Adverse Event|0|||
13343993|NCT00993499|26634708|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1|||
13343994|NCT00993499|26634709|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
13343995|NCT00993499|26634710|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
13343996|NCT00993499|26634711|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
13343997|NCT00993499|26634712|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
13343998|NCT00993499|26634713|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
13343999|NCT00993499|26634708|FG000|Run-in Period (8 Days)|Consent withdrawn|0|||
13344000|NCT00993499|26634709|FG001|Run-in Period (8 Days)|Consent withdrawn|1|||
13344001|NCT00993499|26634710|FG002|Run-in Period (8 Days)|Consent withdrawn|0|||
13344002|NCT00993499|26634711|FG003|Run-in Period (8 Days)|Consent withdrawn|0|||
13344003|NCT00993499|26634712|FG004|Run-in Period (8 Days)|Consent withdrawn|0|||
13344004|NCT00993499|26634713|FG005|Run-in Period (8 Days)|Consent withdrawn|0|||
13344005|NCT00993499|26634708|FG000|Run-in Period (8 Days)|Progressive disease|0|||
13344006|NCT00993499|26634709|FG001|Run-in Period (8 Days)|Progressive disease|1|||
13344007|NCT00993499|26634710|FG002|Run-in Period (8 Days)|Progressive disease|1|||
13344008|NCT00993499|26634711|FG003|Run-in Period (8 Days)|Progressive disease|0|||
13344009|NCT00993499|26634712|FG004|Run-in Period (8 Days)|Progressive disease|0|||
13344010|NCT00993499|26634713|FG005|Run-in Period (8 Days)|Progressive disease|0|||
13344011|NCT00993499|26634708|FG000|Discontinued Before Starting Course 3|Progressive Disease|2|||
13344012|NCT00993499|26634709|FG001|Discontinued Before Starting Course 3|Progressive Disease|2|||
13344013|NCT00993499|26634710|FG002|Discontinued Before Starting Course 3|Progressive Disease|0|||
13344014|NCT00993499|26634711|FG003|Discontinued Before Starting Course 3|Progressive Disease|0|||
13344015|NCT00993499|26634712|FG004|Discontinued Before Starting Course 3|Progressive Disease|0|||
13344016|NCT00993499|26634713|FG005|Discontinued Before Starting Course 3|Progressive Disease|0|||
13344017|NCT00993499|26634708|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
13344018|NCT00993499|26634709|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
13344019|NCT00993499|26634710|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
13344020|NCT00993499|26634711|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
13344021|NCT00993499|26634712|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
13344022|NCT00993499|26634713|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
13344023|NCT00993499|26634708|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
13344024|NCT00993499|26634709|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
13344025|NCT00993499|26634710|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
13344026|NCT00993499|26634711|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
13344027|NCT00993499|26634712|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
13344028|NCT00993499|26634713|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
13344029|NCT00993499|26634708|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
13344030|NCT00993499|26634709|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
13344031|NCT00993499|26634710|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2|||
13344032|NCT00993499|26634711|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
13344033|NCT00993499|26634712|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
13344034|NCT00993499|26634713|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
13344035|NCT00993499|26634708|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
13344036|NCT00993499|26634709|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1|||
13344037|NCT00993499|26634710|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
13344038|NCT00993499|26634711|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
13344039|NCT00993499|26634712|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
13344040|NCT00993499|26634713|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
13344041|NCT00993499|26634708|FG000|Discontinued After Starting Course 3|Progressive Disease|6|||
13344042|NCT00993499|26634709|FG001|Discontinued After Starting Course 3|Progressive Disease|4|||
13344043|NCT00993499|26634710|FG002|Discontinued After Starting Course 3|Progressive Disease|3|||
13344044|NCT00993499|26634711|FG003|Discontinued After Starting Course 3|Progressive Disease|1|||
13344045|NCT00993499|26634712|FG004|Discontinued After Starting Course 3|Progressive Disease|3|||
13344046|NCT00993499|26634713|FG005|Discontinued After Starting Course 3|Progressive Disease|3|||
13344047|NCT00993499|26634708|FG000|Discontinued After Starting Course 3|DLT|1|||
13344048|NCT00993499|26634709|FG001|Discontinued After Starting Course 3|DLT|0|||
13344049|NCT00993499|26634710|FG002|Discontinued After Starting Course 3|DLT|2|||
13344050|NCT00993499|26634711|FG003|Discontinued After Starting Course 3|DLT|1|||
13344051|NCT00993499|26634712|FG004|Discontinued After Starting Course 3|DLT|0|||
13344052|NCT00993499|26634713|FG005|Discontinued After Starting Course 3|DLT|0|||
13344053|NCT00993499|26634708|FG000|Discontinued After Starting Course 3|Other adverse event|1|||
13344054|NCT00993499|26634709|FG001|Discontinued After Starting Course 3|Other adverse event|0|||
13344055|NCT00993499|26634710|FG002|Discontinued After Starting Course 3|Other adverse event|1|||
13344056|NCT00993499|26634711|FG003|Discontinued After Starting Course 3|Other adverse event|0|||
13344057|NCT00993499|26634712|FG004|Discontinued After Starting Course 3|Other adverse event|0|||
13344058|NCT00993499|26634713|FG005|Discontinued After Starting Course 3|Other adverse event|0|||
13344059|NCT00993473|26634756|FG000|Overall Study|Adverse Event|0|||
13344060|NCT00993473|26634757|FG001|Overall Study|Adverse Event|2|||
13344061|NCT00993473|26634756|FG000|Overall Study|Protocol Violation|1|||
13344062|NCT00993473|26634757|FG001|Overall Study|Protocol Violation|2|||
13344063|NCT00993473|26634756|FG000|Overall Study|Lost to Follow-up|1|||
13344064|NCT00993473|26634757|FG001|Overall Study|Lost to Follow-up|0|||
13344065|NCT00993473|26634756|FG000|Overall Study|Withdrawal by Subject|1|||
13344066|NCT00993473|26634757|FG001|Overall Study|Withdrawal by Subject|5|||
13344067|NCT00993473|26634756|FG000|Overall Study|Technical problem with CGM device|0|||
13344068|NCT00993473|26634757|FG001|Overall Study|Technical problem with CGM device|1|||
13344069|NCT00993473|26634756|FG000|Overall Study|Family event|1|||
13344070|NCT00993473|26634757|FG001|Overall Study|Family event|0|||
13344071|NCT00993421|26634928|FG000|Overall Study|Adverse Event|2|||
13344072|NCT00993421|26634929|FG001|Overall Study|Adverse Event|7|||
13344073|NCT00993421|26634930|FG002|Overall Study|Adverse Event|6|||
13344074|NCT00993421|26634931|FG003|Overall Study|Adverse Event|9|||
13344075|NCT00993421|26634932|FG004|Overall Study|Adverse Event|5|||
13344076|NCT00993421|26634933|FG005|Overall Study|Adverse Event|7|||
13344077|NCT00993421|26634934|FG006|Overall Study|Adverse Event|1|||
13344078|NCT00993421|26634928|FG000|Overall Study|Sponsor Decision|36|||
13344079|NCT00993421|26634929|FG001|Overall Study|Sponsor Decision|31|||
13344080|NCT00993421|26634930|FG002|Overall Study|Sponsor Decision|28|||
13344081|NCT00993421|26634931|FG003|Overall Study|Sponsor Decision|30|||
13344082|NCT00993421|26634932|FG004|Overall Study|Sponsor Decision|38|||
13344083|NCT00993421|26634933|FG005|Overall Study|Sponsor Decision|30|||
13344084|NCT00993421|26634934|FG006|Overall Study|Sponsor Decision|29|||
13344085|NCT00993421|26634928|FG000|Overall Study|Lost to Follow-up|3|||
13344086|NCT00993421|26634929|FG001|Overall Study|Lost to Follow-up|5|||
13344087|NCT00993421|26634930|FG002|Overall Study|Lost to Follow-up|5|||
13344088|NCT00993421|26634931|FG003|Overall Study|Lost to Follow-up|0|||
13344089|NCT00993421|26634932|FG004|Overall Study|Lost to Follow-up|0|||
13344090|NCT00993421|26634933|FG005|Overall Study|Lost to Follow-up|0|||
13344091|NCT00993421|26634934|FG006|Overall Study|Lost to Follow-up|6|||
13344092|NCT00993421|26634928|FG000|Overall Study|Withdrawal by Subject|3|||
13344093|NCT00993421|26634929|FG001|Overall Study|Withdrawal by Subject|2|||
13344094|NCT00993421|26634930|FG002|Overall Study|Withdrawal by Subject|3|||
13344095|NCT00993421|26634931|FG003|Overall Study|Withdrawal by Subject|3|||
13344096|NCT00993421|26634932|FG004|Overall Study|Withdrawal by Subject|3|||
13344097|NCT00993421|26634933|FG005|Overall Study|Withdrawal by Subject|5|||
13344098|NCT00993421|26634934|FG006|Overall Study|Withdrawal by Subject|3|||
13344099|NCT00993421|26634928|FG000|Overall Study|Death|0|||
13344100|NCT00993421|26634929|FG001|Overall Study|Death|0|||
13344101|NCT00993421|26634930|FG002|Overall Study|Death|0|||
13344102|NCT00993421|26634931|FG003|Overall Study|Death|0|||
13344103|NCT00993421|26634932|FG004|Overall Study|Death|0|||
13344104|NCT00993421|26634933|FG005|Overall Study|Death|0|||
13344105|NCT00993421|26634934|FG006|Overall Study|Death|1|||
13344106|NCT00993421|26634928|FG000|Overall Study|Entry Criteria Exclusion|0|||
13344107|NCT00993421|26634929|FG001|Overall Study|Entry Criteria Exclusion|0|||
13344108|NCT00993421|26634930|FG002|Overall Study|Entry Criteria Exclusion|1|||
13344109|NCT00993421|26634931|FG003|Overall Study|Entry Criteria Exclusion|3|||
13344110|NCT00993421|26634932|FG004|Overall Study|Entry Criteria Exclusion|0|||
13344111|NCT00993421|26634933|FG005|Overall Study|Entry Criteria Exclusion|1|||
13344112|NCT00993421|26634934|FG006|Overall Study|Entry Criteria Exclusion|0|||
13344113|NCT00993421|26634928|FG000|Overall Study|Physician Decision|0|||
13344114|NCT00993421|26634929|FG001|Overall Study|Physician Decision|0|||
13344115|NCT00993421|26634930|FG002|Overall Study|Physician Decision|0|||
13344116|NCT00993421|26634931|FG003|Overall Study|Physician Decision|0|||
13344117|NCT00993421|26634932|FG004|Overall Study|Physician Decision|0|||
13344118|NCT00993421|26634933|FG005|Overall Study|Physician Decision|1|||
13344119|NCT00993421|26634934|FG006|Overall Study|Physician Decision|1|||
13344120|NCT00993421|26634928|FG000|Overall Study|Protocol Violation|0|||
13344121|NCT00993421|26634929|FG001|Overall Study|Protocol Violation|0|||
13344122|NCT00993421|26634930|FG002|Overall Study|Protocol Violation|0|||
13344123|NCT00993421|26634931|FG003|Overall Study|Protocol Violation|0|||
13344124|NCT00993421|26634932|FG004|Overall Study|Protocol Violation|0|||
13344125|NCT00993421|26634933|FG005|Overall Study|Protocol Violation|2|||
13344126|NCT00993421|26634934|FG006|Overall Study|Protocol Violation|1|||
13344127|NCT00993317|26634959|FG000|Overall Study|Adverse Event|2|||
13344128|NCT00993317|26634960|FG001|Overall Study|Adverse Event|4|||
13344129|NCT00993317|26634959|FG000|Overall Study|Lack of Efficacy|18|||
13344130|NCT00993317|26634960|FG001|Overall Study|Lack of Efficacy|18|||
13344131|NCT00993317|26634959|FG000|Overall Study|Withdrawal by Subject|0|||
13344132|NCT00993317|26634960|FG001|Overall Study|Withdrawal by Subject|2|||
13344133|NCT00993317|26634959|FG000|Overall Study|Investigator's opinion|0|||
13344134|NCT00993317|26634960|FG001|Overall Study|Investigator's opinion|1|||
13344135|NCT00993317|26634959|FG000|Overall Study|Early study termination at the site|1|||
13344136|NCT00993317|26634960|FG001|Overall Study|Early study termination at the site|0|||
13344137|NCT00993291|26634966|FG000|Overall Study|Withdrawal by Subject|1|||
13344138|NCT00993265|26634991|FG000|Overall Study|Adverse Event|1|||
13344139|NCT00993265|26634992|FG001|Overall Study|Adverse Event|0|||
13344140|NCT00993265|26634991|FG000|Overall Study|Changed dose of concomitant drug|2|||
13344141|NCT00993265|26634992|FG001|Overall Study|Changed dose of concomitant drug|0|||
13344142|NCT00993265|26634991|FG000|Overall Study|Non-compliant with study medication|1|||
13344143|NCT00993265|26634992|FG001|Overall Study|Non-compliant with study medication|0|||
13344144|NCT00993148|26635006|FG000|Overall Study|Lost to Follow-up|2|||
13344145|NCT00993148|26635006|FG000|Overall Study|never initiated treatment|1|||
13344146|NCT00993044|26635013|FG000|Irinotecan 50 mg|Physician Decision|1|||
13344147|NCT00993031|26635052|FG000|Overall Study|Death|0|||
13344148|NCT00993031|26635053|FG001|Overall Study|Death|1|||
13344149|NCT00993031|26635052|FG000|Overall Study|Physician Decision|0|||
13344150|NCT00993031|26635053|FG001|Overall Study|Physician Decision|2|||
13344151|NCT00993031|26635052|FG000|Overall Study|Withdrawal by Subject|3|||
13344152|NCT00993031|26635053|FG001|Overall Study|Withdrawal by Subject|3|||
13344153|NCT00993031|26635052|FG000|Overall Study|Lost to Follow-up|19|||
13344154|NCT00993031|26635053|FG001|Overall Study|Lost to Follow-up|13|||
13344155|NCT00992992|26635075|FG000|Overall Study|Lost to Follow-up|3|||
13344156|NCT00992992|26635075|FG000|Overall Study|Death|16|||
13344157|NCT00992992|26635075|FG000|Overall Study|GlaxoSmithKline Closed the Study|2|||
13344158|NCT00992992|26635075|FG000|Overall Study|Sponsor Closed the Study|4|||
13344159|NCT00992836|26635089|FG000|Overall Study|Lost to Follow-up|1|||
13344160|NCT00992836|26635089|FG000|Overall Study|Withdrawal by Subject|2|||
13344161|NCT00992836|26635089|FG000|Overall Study|Protocol Violation|2|||
13344162|NCT00992784|26635167|FG000|Overall Study|Adverse Event|2|||
13344163|NCT00992784|26635168|FG001|Overall Study|Adverse Event|1|||
13344164|NCT00992784|26635169|FG002|Overall Study|Adverse Event|0|||
13344165|NCT00992784|26635167|FG000|Overall Study|Withdrawal by Subject|1|||
13344166|NCT00992784|26635168|FG001|Overall Study|Withdrawal by Subject|1|||
13344167|NCT00992784|26635169|FG002|Overall Study|Withdrawal by Subject|1|||
13344168|NCT00992589|26635216|FG000|Open-Label Phase|Adverse Event|4|||
13344169|NCT00992589|26635217|FG001|Open-Label Phase|Adverse Event|0|||
13344170|NCT00992589|26635218|FG002|Open-Label Phase|Adverse Event|0|||
13344171|NCT00992589|26635219|FG003|Open-Label Phase|Adverse Event|0|||
13344172|NCT00992589|26635216|FG000|Open-Label Phase|Withdrawal by Subject|20|||
13344173|NCT00992589|26635217|FG001|Open-Label Phase|Withdrawal by Subject|0|||
13344174|NCT00992589|26635218|FG002|Open-Label Phase|Withdrawal by Subject|0|||
13344175|NCT00992589|26635219|FG003|Open-Label Phase|Withdrawal by Subject|0|||
13344176|NCT00992589|26635216|FG000|Open-Label Phase|Lost to Follow-up|1|||
13344177|NCT00992589|26635217|FG001|Open-Label Phase|Lost to Follow-up|0|||
13344178|NCT00992589|26635218|FG002|Open-Label Phase|Lost to Follow-up|0|||
13344179|NCT00992589|26635219|FG003|Open-Label Phase|Lost to Follow-up|0|||
13344180|NCT00992589|26635216|FG000|Open-Label Phase|Protocol Violation|3|||
13374031|NCT00798161|26725697|FG002|Overall Study|Protocol Violation|3|||
13289222|NCT01080625|26477652|FG002|Overall Study|Physician Decision|1|||
13289223|NCT01080326|26477658|FG000|Overall Study|Patient deterioration prior to procedure|3|||
13289224|NCT01080326|26477658|FG000|Overall Study|Surgeon decision|1|||
13289225|NCT01080300|26477693|FG000|Overall Study|Adverse Event|49|||
13289226|NCT01080300|26477694|FG001|Overall Study|Adverse Event|35|||
13289227|NCT01080300|26477693|FG000|Overall Study|Lack of Efficacy|12|||
13289228|NCT01080300|26477694|FG001|Overall Study|Lack of Efficacy|15|||
13289229|NCT01080300|26477693|FG000|Overall Study|Protocol Violation|7|||
13289230|NCT01080300|26477694|FG001|Overall Study|Protocol Violation|13|||
13289231|NCT01080300|26477693|FG000|Overall Study|Lost to Follow-up|10|||
13289232|NCT01080300|26477694|FG001|Overall Study|Lost to Follow-up|6|||
13289233|NCT01080300|26477693|FG000|Overall Study|Death|0|||
13289234|NCT01080300|26477694|FG001|Overall Study|Death|1|||
13289235|NCT01080300|26477693|FG000|Overall Study|Withdrawal by Subject|12|||
13289236|NCT01080300|26477694|FG001|Overall Study|Withdrawal by Subject|28|||
13289237|NCT01080300|26477693|FG000|Overall Study|Reasons not specified|4|||
13289238|NCT01080300|26477694|FG001|Overall Study|Reasons not specified|6|||
13289239|NCT01080131|26477778|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
13289240|NCT01080131|26477779|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
13289241|NCT01080131|26477778|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6|||
13289242|NCT01080131|26477779|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4|||
13289243|NCT01080131|26477778|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5|||
13289244|NCT01080131|26477779|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3|||
13289245|NCT01080131|26477778|FG000|Core Study (0- 12 Weeks)|Administrative problems|0|||
13289246|NCT01080131|26477779|FG001|Core Study (0- 12 Weeks)|Administrative problems|1|||
13289247|NCT01080131|26477778|FG000|Core Study (0- 12 Weeks)|Death|1|||
13289248|NCT01080131|26477779|FG001|Core Study (0- 12 Weeks)|Death|0|||
13289249|NCT01080131|26477778|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0|||
13344181|NCT00992589|26635217|FG001|Open-Label Phase|Protocol Violation|0|||
13344182|NCT00992589|26635218|FG002|Open-Label Phase|Protocol Violation|0|||
13344183|NCT00992589|26635219|FG003|Open-Label Phase|Protocol Violation|0|||
13344184|NCT00992589|26635216|FG000|Open-Label Phase|Physician Decision|4|||
13344185|NCT00992589|26635217|FG001|Open-Label Phase|Physician Decision|0|||
13344186|NCT00992589|26635218|FG002|Open-Label Phase|Physician Decision|0|||
13344187|NCT00992589|26635219|FG003|Open-Label Phase|Physician Decision|0|||
13344188|NCT00992589|26635216|FG000|Open-Label Phase|Other|45|||
13344189|NCT00992589|26635217|FG001|Open-Label Phase|Other|0|||
13344190|NCT00992589|26635218|FG002|Open-Label Phase|Other|0|||
13344191|NCT00992589|26635219|FG003|Open-Label Phase|Other|0|||
13344192|NCT00992589|26635216|FG000|Double-Blind Phase|Adverse Event|0|||
13344193|NCT00992589|26635217|FG001|Double-Blind Phase|Adverse Event|6|||
13344194|NCT00992589|26635218|FG002|Double-Blind Phase|Adverse Event|2|||
13344195|NCT00992589|26635219|FG003|Double-Blind Phase|Adverse Event|3|||
13344196|NCT00992589|26635216|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
13344197|NCT00992589|26635217|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
13344198|NCT00992589|26635218|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
13344199|NCT00992589|26635219|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
13344200|NCT00992589|26635216|FG000|Double-Blind Phase|Lost to Follow-up|0|||
13344201|NCT00992589|26635217|FG001|Double-Blind Phase|Lost to Follow-up|0|||
13344202|NCT00992589|26635218|FG002|Double-Blind Phase|Lost to Follow-up|0|||
13344203|NCT00992589|26635219|FG003|Double-Blind Phase|Lost to Follow-up|2|||
13344204|NCT00992589|26635216|FG000|Double-Blind Phase|Other|0|||
13344205|NCT00992589|26635217|FG001|Double-Blind Phase|Other|1|||
13344206|NCT00992589|26635218|FG002|Double-Blind Phase|Other|6|||
13344207|NCT00992589|26635219|FG003|Double-Blind Phase|Other|3|||
13344208|NCT00992511|26635314|FG000|Overall Study|Migrated/moved from study area|1|||
13344209|NCT00992511|26635315|FG001|Overall Study|Migrated/moved from study area|0|||
13344210|NCT00992511|26635316|FG002|Overall Study|Migrated/moved from study area|1|||
13344211|NCT00992511|26635317|FG003|Overall Study|Migrated/moved from study area|2|||
13344212|NCT00992511|26635314|FG000|Overall Study|Lost to Follow-up|1|||
13344213|NCT00992511|26635315|FG001|Overall Study|Lost to Follow-up|0|||
13344214|NCT00992511|26635316|FG002|Overall Study|Lost to Follow-up|0|||
13344215|NCT00992511|26635317|FG003|Overall Study|Lost to Follow-up|2|||
13344216|NCT00992511|26635314|FG000|Overall Study|Withdrawal by Subject|0|||
13344217|NCT00992511|26635315|FG001|Overall Study|Withdrawal by Subject|0|||
13344218|NCT00992511|26635316|FG002|Overall Study|Withdrawal by Subject|1|||
13344219|NCT00992511|26635317|FG003|Overall Study|Withdrawal by Subject|1|||
13344220|NCT00992459|26635348|FG000|Overall Study|Withdrawal by Subject|0|||
13344221|NCT00992459|26635349|FG001|Overall Study|Withdrawal by Subject|1|||
13344222|NCT00992459|26635348|FG000|Overall Study|Adverse Event|1|||
13344223|NCT00992459|26635349|FG001|Overall Study|Adverse Event|0|||
13344224|NCT00992446|26635359|FG000|Overall Study|Disease Progression|1|||
13344225|NCT00992446|26635359|FG000|Overall Study|Withdrawal by Subject|2|||
13344226|NCT00992446|26635359|FG000|Overall Study|Maintenance Therapy Screen Fail|5|||
13344227|NCT00992407|26635414|FG000|Overall Study|Protocol Violation|2|||
13344228|NCT00992407|26635415|FG001|Overall Study|Protocol Violation|1|||
13344229|NCT00992407|26635414|FG000|Overall Study|Lost to Follow-up|3|||
13344230|NCT00992407|26635415|FG001|Overall Study|Lost to Follow-up|3|||
13344231|NCT00992407|26635414|FG000|Overall Study|Adverse Event|3|||
13344232|NCT00992407|26635415|FG001|Overall Study|Adverse Event|2|||
13344233|NCT00992407|26635414|FG000|Overall Study|protocol Violation & Adverse events|2|||
13344234|NCT00992407|26635415|FG001|Overall Study|protocol Violation & Adverse events|4|||
13344235|NCT00992407|26635414|FG000|Overall Study|Other|2|||
13344236|NCT00992407|26635415|FG001|Overall Study|Other|0|||
13344237|NCT00992407|26635414|FG000|Overall Study|Loss of follow-up & Adverse events|2|||
13344238|NCT00992407|26635415|FG001|Overall Study|Loss of follow-up & Adverse events|1|||
13344239|NCT00992407|26635414|FG000|Overall Study|Study medication not administered|17|||
13344240|NCT00992407|26635415|FG001|Overall Study|Study medication not administered|13|||
13344241|NCT00992394|26635464|FG000|Overall Study|Lack of Efficacy|6|||
13344242|NCT00992394|26635465|FG001|Overall Study|Lack of Efficacy|3|||
13344243|NCT00992394|26635464|FG000|Overall Study|Adverse Event|4|||
13344244|NCT00992394|26635465|FG001|Overall Study|Adverse Event|5|||
13344245|NCT00992394|26635464|FG000|Overall Study|Withdrawal by Subject|8|||
13344246|NCT00992394|26635465|FG001|Overall Study|Withdrawal by Subject|2|||
13344247|NCT00992394|26635464|FG000|Overall Study|Physician Decision|1|||
13344248|NCT00992394|26635465|FG001|Overall Study|Physician Decision|0|||
13344249|NCT00992394|26635464|FG000|Overall Study|Protocol Violation|2|||
13344250|NCT00992394|26635465|FG001|Overall Study|Protocol Violation|4|||
13344251|NCT00992394|26635464|FG000|Overall Study|Lost to Follow-up|2|||
13344252|NCT00992394|26635465|FG001|Overall Study|Lost to Follow-up|0|||
13344253|NCT00992394|26635464|FG000|Overall Study|Other event|1|||
13344254|NCT00992394|26635465|FG001|Overall Study|Other event|0|||
13344255|NCT00992225|26635477|FG000|Overall Study|Entry Criteria Not Met|8|||
13344256|NCT00992225|26635477|FG000|Overall Study|Adverse Event|2|||
13344257|NCT00992186|26635496|FG000|Overall Study|Withdrawal by Subject|2|||
13344258|NCT00992186|26635496|FG000|Overall Study|Protocol Violation|1|||
13344259|NCT00992186|26635496|FG000|Overall Study|Physician Decision|1|||
13344260|NCT00992186|26635496|FG000|Overall Study|Adverse Event|9|||
13344261|NCT00992186|26635496|FG000|Overall Study|Progressive Disease|30|||
13344262|NCT00992186|26635496|FG000|Overall Study|Refusal To Receive Study Agent|3|||
13344263|NCT00992108|26635515|FG000|Overall Study|Lost to Follow-up|0|||
13344264|NCT00992108|26635516|FG001|Overall Study|Lost to Follow-up|1|||
13344265|NCT00992056|26635529|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1|||
13344266|NCT00992056|26635530|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2|||
13344267|NCT00992056|26635529|FG000|Washout Period (2 Weeks)|Physician Decision|1|||
13344268|NCT00992056|26635530|FG001|Washout Period (2 Weeks)|Physician Decision|0|||
13344269|NCT00992017|26635545|FG000|Overall Study|Lost to Follow-up|2|||
13344270|NCT00992017|26635545|FG000|Overall Study|Withdrawal by Subject|2|||
13344271|NCT00992017|26635545|FG000|Overall Study|Unable to get to clinic|5|||
13344272|NCT00992017|26635545|FG000|Overall Study|Not adhere to study requirements|1|||
13344273|NCT00991952|26635558|FG000|Overall Study|Adverse Event|0|||
13344274|NCT00991952|26635559|FG001|Overall Study|Adverse Event|1|||
13344275|NCT00991939|26635598|FG000|Overall Study|Lost to Follow-up|0|||
13344276|NCT00991939|26635599|FG001|Overall Study|Lost to Follow-up|1|||
13344277|NCT00991939|26635598|FG000|Overall Study|Withdrawal by Subject|1|||
13344278|NCT00991939|26635599|FG001|Overall Study|Withdrawal by Subject|0|||
13344279|NCT00991939|26635598|FG000|Overall Study|Entire study terminated|4|||
13344280|NCT00991939|26635599|FG001|Overall Study|Entire study terminated|1|||
13344281|NCT00991887|26635612|FG000|Overall Study|Lost to Follow-up|2|||
13344282|NCT00991887|26635613|FG001|Overall Study|Lost to Follow-up|1|||
13344283|NCT00991510|26635642|FG000|Period I (Days 1-14)|Adverse Event|1|||
13344284|NCT00991510|26635643|FG001|Period I (Days 1-14)|Adverse Event|0|||
13344285|NCT00991510|26635642|FG000|Period III (Days 29-112)|Adverse Event|1|||
13344286|NCT00991510|26635643|FG001|Period III (Days 29-112)|Adverse Event|1|||
13344287|NCT00991406|26635652|FG000|Overall Study|One participant did not respond to FES.|1|||
13344288|NCT00991341|26635695|FG000|Overall Study|no surgery w/in 30 days of randomization|11|||
13344289|NCT00991341|26635696|FG001|Overall Study|no surgery w/in 30 days of randomization|18|||
13344290|NCT00991341|26635695|FG000|Overall Study|Death|3|||
13344291|NCT00991341|26635696|FG001|Overall Study|Death|0|||
13344292|NCT00991341|26635695|FG000|Overall Study|no RBCs received 96hrs after randomized|186|||
13344293|NCT00991341|26635696|FG001|Overall Study|no RBCs received 96hrs after randomized|155|||
13344294|NCT00991341|26635695|FG000|Overall Study|Physician Decision|1|||
13344295|NCT00991341|26635696|FG001|Overall Study|Physician Decision|2|||
13344296|NCT00991341|26635695|FG000|Overall Study|Withdrawal by Subject|3|||
13344297|NCT00991341|26635696|FG001|Overall Study|Withdrawal by Subject|4|||
13344298|NCT00991302|26635719|FG000|Overall Study|Death|0|||
13344299|NCT00991302|26635720|FG001|Overall Study|Death|1|||
13344300|NCT00991302|26635719|FG000|Overall Study|Lost to Follow-up|14|||
13344301|NCT00991302|26635720|FG001|Overall Study|Lost to Follow-up|12|||
13344302|NCT00991289|26635736|FG000|Overall Study|Adverse Event|1|||
13344303|NCT00991289|26635736|FG000|Overall Study|Physician Decision|2|||
13344304|NCT00991289|26635736|FG000|Overall Study|Withdrawal by Subject|3|||
13344305|NCT00991289|26635736|FG000|Overall Study|Lost to Follow-up|4|||
13344306|NCT00991289|26635736|FG000|Overall Study|Protocol Violation|2|||
13344307|NCT00991276|26635853|FG000|First Intervention Period|Adverse Event|0|||
13344308|NCT00991276|26635854|FG001|First Intervention Period|Adverse Event|1|||
13344309|NCT00991276|26635855|FG002|First Intervention Period|Adverse Event|0|||
13344310|NCT00991276|26635856|FG003|First Intervention Period|Adverse Event|1|||
13344311|NCT00991276|26635857|FG004|First Intervention Period|Adverse Event|0|||
13344312|NCT00991276|26635858|FG005|First Intervention Period|Adverse Event|0|||
13344313|NCT00991276|26635853|FG000|First Intervention Period|Protocol Violation|0|||
13344314|NCT00991276|26635854|FG001|First Intervention Period|Protocol Violation|0|||
13344315|NCT00991276|26635855|FG002|First Intervention Period|Protocol Violation|0|||
13344316|NCT00991276|26635856|FG003|First Intervention Period|Protocol Violation|0|||
13344317|NCT00991276|26635857|FG004|First Intervention Period|Protocol Violation|2|||
13344318|NCT00991276|26635858|FG005|First Intervention Period|Protocol Violation|0|||
13344319|NCT00991276|26635853|FG000|First Intervention Period|Insufficient clinical response|0|||
13344320|NCT00991276|26635854|FG001|First Intervention Period|Insufficient clinical response|0|||
13344321|NCT00991276|26635855|FG002|First Intervention Period|Insufficient clinical response|0|||
13344322|NCT00991276|26635856|FG003|First Intervention Period|Insufficient clinical response|0|||
13344323|NCT00991276|26635857|FG004|First Intervention Period|Insufficient clinical response|1|||
13344324|NCT00991276|26635858|FG005|First Intervention Period|Insufficient clinical response|0|||
13344325|NCT00991276|26635853|FG000|First Intervention Period|Other|0|||
13344326|NCT00991276|26635854|FG001|First Intervention Period|Other|0|||
13344327|NCT00991276|26635855|FG002|First Intervention Period|Other|0|||
13344328|NCT00991276|26635856|FG003|First Intervention Period|Other|1|||
13344329|NCT00991276|26635857|FG004|First Intervention Period|Other|1|||
13344330|NCT00991276|26635858|FG005|First Intervention Period|Other|0|||
13344331|NCT00991276|26635853|FG000|First Intervention Period|Withdrawal by Subject|0|||
13344332|NCT00991276|26635854|FG001|First Intervention Period|Withdrawal by Subject|1|||
13344333|NCT00991276|26635855|FG002|First Intervention Period|Withdrawal by Subject|0|||
13344334|NCT00991276|26635856|FG003|First Intervention Period|Withdrawal by Subject|1|||
13344335|NCT00991276|26635857|FG004|First Intervention Period|Withdrawal by Subject|0|||
13344336|NCT00991276|26635858|FG005|First Intervention Period|Withdrawal by Subject|1|||
13344337|NCT00991276|26635853|FG000|First Intervention Period|Lost to Follow-up|0|||
13344338|NCT00991276|26635854|FG001|First Intervention Period|Lost to Follow-up|1|||
13344339|NCT00991276|26635855|FG002|First Intervention Period|Lost to Follow-up|0|||
13344340|NCT00991276|26635856|FG003|First Intervention Period|Lost to Follow-up|1|||
13344341|NCT00991276|26635857|FG004|First Intervention Period|Lost to Follow-up|0|||
13344342|NCT00991276|26635858|FG005|First Intervention Period|Lost to Follow-up|0|||
13344343|NCT00991276|26635853|FG000|Second Intervention Period|Adverse Event|0|||
13344344|NCT00991276|26635854|FG001|Second Intervention Period|Adverse Event|2|||
13344345|NCT00991276|26635855|FG002|Second Intervention Period|Adverse Event|0|||
13344346|NCT00991276|26635856|FG003|Second Intervention Period|Adverse Event|1|||
13344347|NCT00991276|26635857|FG004|Second Intervention Period|Adverse Event|1|||
13344348|NCT00991276|26635858|FG005|Second Intervention Period|Adverse Event|0|||
13344349|NCT00991276|26635853|FG000|Second Intervention Period|Protocol Violation|1|||
13344350|NCT00991276|26635854|FG001|Second Intervention Period|Protocol Violation|0|||
13344351|NCT00991276|26635855|FG002|Second Intervention Period|Protocol Violation|0|||
13344352|NCT00991276|26635856|FG003|Second Intervention Period|Protocol Violation|0|||
13344353|NCT00991276|26635857|FG004|Second Intervention Period|Protocol Violation|0|||
13344354|NCT00991276|26635858|FG005|Second Intervention Period|Protocol Violation|0|||
13344355|NCT00991276|26635853|FG000|Second Intervention Period|Other|0|||
13344356|NCT00991276|26635854|FG001|Second Intervention Period|Other|0|||
13344357|NCT00991276|26635855|FG002|Second Intervention Period|Other|0|||
13344358|NCT00991276|26635856|FG003|Second Intervention Period|Other|1|||
13344359|NCT00991276|26635857|FG004|Second Intervention Period|Other|0|||
13344360|NCT00991276|26635858|FG005|Second Intervention Period|Other|1|||
13344361|NCT00991276|26635853|FG000|Third Intervention Period|Protocol Violation|1|||
13344362|NCT00991276|26635854|FG001|Third Intervention Period|Protocol Violation|0|||
13344363|NCT00991276|26635855|FG002|Third Intervention Period|Protocol Violation|0|||
13344364|NCT00991276|26635856|FG003|Third Intervention Period|Protocol Violation|0|||
13344365|NCT00991276|26635857|FG004|Third Intervention Period|Protocol Violation|0|||
13344366|NCT00991276|26635858|FG005|Third Intervention Period|Protocol Violation|0|||
13344367|NCT00991276|26635853|FG000|Third Intervention Period|Other|0|||
13344368|NCT00991276|26635854|FG001|Third Intervention Period|Other|0|||
13344369|NCT00991276|26635855|FG002|Third Intervention Period|Other|0|||
13344370|NCT00991276|26635856|FG003|Third Intervention Period|Other|0|||
13344371|NCT00991276|26635857|FG004|Third Intervention Period|Other|0|||
13344372|NCT00991276|26635858|FG005|Third Intervention Period|Other|1|||
13344373|NCT00991276|26635853|FG000|Third Intervention Period|Adverse Event|0|||
13344374|NCT00991276|26635854|FG001|Third Intervention Period|Adverse Event|0|||
13344375|NCT00991276|26635855|FG002|Third Intervention Period|Adverse Event|1|||
13344376|NCT00991276|26635856|FG003|Third Intervention Period|Adverse Event|0|||
13344377|NCT00991276|26635857|FG004|Third Intervention Period|Adverse Event|0|||
13344378|NCT00991276|26635858|FG005|Third Intervention Period|Adverse Event|0|||
13344379|NCT00991276|26635853|FG000|Third Intervention Period|Withdrawal by Subject|0|||
13344380|NCT00991276|26635854|FG001|Third Intervention Period|Withdrawal by Subject|0|||
13344381|NCT00991276|26635855|FG002|Third Intervention Period|Withdrawal by Subject|0|||
13344382|NCT00991276|26635856|FG003|Third Intervention Period|Withdrawal by Subject|1|||
13344383|NCT00991276|26635857|FG004|Third Intervention Period|Withdrawal by Subject|0|||
13344384|NCT00991276|26635858|FG005|Third Intervention Period|Withdrawal by Subject|0|||
13344385|NCT00990821|26635918|FG000|Overall Study|Withdrawal by Subject|0|||
13344386|NCT00990821|26635919|FG001|Overall Study|Withdrawal by Subject|2|||
13344387|NCT00990821|26635920|FG002|Overall Study|Withdrawal by Subject|0|||
13344388|NCT00990821|26635921|FG003|Overall Study|Withdrawal by Subject|0|||
13344389|NCT00990821|26635922|FG004|Overall Study|Withdrawal by Subject|3|||
13344390|NCT00990821|26635923|FG005|Overall Study|Withdrawal by Subject|3|||
13344391|NCT00990821|26635924|FG006|Overall Study|Withdrawal by Subject|1|||
13344392|NCT00990821|26635925|FG007|Overall Study|Withdrawal by Subject|0|||
13344393|NCT00990821|26635926|FG008|Overall Study|Withdrawal by Subject|0|||
13344394|NCT00990821|26635927|FG009|Overall Study|Withdrawal by Subject|1|||
13344395|NCT00990821|26635928|FG010|Overall Study|Withdrawal by Subject|3|||
13344396|NCT00990821|26635929|FG011|Overall Study|Withdrawal by Subject|5|||
13344397|NCT00990821|26635930|FG012|Overall Study|Withdrawal by Subject|2|||
13344398|NCT00990821|26635931|FG013|Overall Study|Withdrawal by Subject|1|||
13344399|NCT00990704|26635958|FG000|Overall Study|Adverse Event|1|||
13344400|NCT00990704|26635959|FG001|Overall Study|Adverse Event|1|||
13344401|NCT00990704|26635958|FG000|Overall Study|Physician Decision|0|||
13344402|NCT00990704|26635959|FG001|Overall Study|Physician Decision|1|||
13344403|NCT00990665|26635968|FG000|Overall Study|Unsuccessful Implant|8|||
13344404|NCT00990665|26635968|FG000|Overall Study|Death|29|||
13344405|NCT00990665|26635968|FG000|Overall Study|Heart Transplant|1|||
13344406|NCT00990665|26635968|FG000|Overall Study|Withdrawal by Subject|6|||
13344407|NCT00990665|26635968|FG000|Overall Study|Lost to Follow-up|1|||
13344408|NCT00990665|26635968|FG000|Overall Study|System Explant|3|||
13344409|NCT00990652|26635978|FG000|Pre-surgical Bortezomib|Adverse Event|1|||
13344410|NCT00990652|26635978|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1|||
13344411|NCT00990340|26635999|FG000|First 14-day Treatment|Not Compliant|2|||
13344412|NCT00990340|26636000|FG001|First 14-day Treatment|Not Compliant|1|||
13344413|NCT00990340|26635999|FG000|First 14-day Treatment|Lost to Follow-up|2|||
13344414|NCT00990340|26636000|FG001|First 14-day Treatment|Lost to Follow-up|1|||
13344415|NCT00990340|26635999|FG000|First 14-day Treatment|Protocol Violation|2|||
13344416|NCT00990340|26636000|FG001|First 14-day Treatment|Protocol Violation|2|||
13344417|NCT00990314|26636011|FG000|Overall Study|Death|2|||
13344418|NCT00990314|26636011|FG000|Overall Study|Adverse Event|2|||
13344419|NCT00990314|26636011|FG000|Overall Study|Withdrawal by Subject|3|||
13344420|NCT00990314|26636011|FG000|Overall Study|Non-Compliance|1|||
13344421|NCT00990314|26636011|FG000|Overall Study|Physician Decision|3|||
13344422|NCT00990314|26636011|FG000|Overall Study|Lack of Efficacy|1|||
13344423|NCT00990249|26636017|FG000|Overall Study|Disease Progression|8|||
13344424|NCT00990249|26636017|FG000|Overall Study|Non-Compliance|1|||
13344425|NCT00990249|26636017|FG000|Overall Study|Death|2|||
13344426|NCT00990249|26636017|FG000|Overall Study|Not treated|2|||
13344427|NCT00990184|26636025|FG000|Overall Study|Physician Decision|1|||
13344428|NCT00990106|26636042|FG000|Overall Study|"too busy to continue"|1|||
13344429|NCT00990106|26636043|FG001|Overall Study|"too busy to continue"|2|||
13344430|NCT00990106|26636042|FG000|Overall Study|Lost to Follow-up|1|||
13344431|NCT00990106|26636043|FG001|Overall Study|Lost to Follow-up|3|||
13344432|NCT00990106|26636042|FG000|Overall Study|Withdrawal by Subject|2|||
13344433|NCT00990106|26636043|FG001|Overall Study|Withdrawal by Subject|1|||
13344434|NCT00990106|26636042|FG000|Overall Study|opted for open label prazosin|1|||
13344435|NCT00990106|26636043|FG001|Overall Study|opted for open label prazosin|1|||
13344436|NCT00990106|26636042|FG000|Overall Study|relocation/deployment|4|||
13344437|NCT00990106|26636043|FG001|Overall Study|relocation/deployment|1|||
13344438|NCT00990106|26636042|FG000|Overall Study|started exclusionary medication|0|||
13344439|NCT00990106|26636043|FG001|Overall Study|started exclusionary medication|1|||
13344440|NCT00990106|26636042|FG000|Overall Study|planned major surgery|0|||
13344441|NCT00990106|26636043|FG001|Overall Study|planned major surgery|1|||
13344442|NCT00990106|26636042|FG000|Overall Study|scheduling conflicts|0|||
13344443|NCT00990106|26636043|FG001|Overall Study|scheduling conflicts|2|||
13344444|NCT00990093|26636052|FG000|Test Period 1 (1-14 Days)|Adverse Event|1|||
13344445|NCT00990093|26636053|FG001|Test Period 1 (1-14 Days)|Adverse Event|0|||
13344446|NCT00990093|26636052|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2|||
13344447|NCT00990093|26636053|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0|||
13344448|NCT00990093|26636052|FG000|Test Period 1 (1-14 Days)|Other|1|||
13344449|NCT00990093|26636053|FG001|Test Period 1 (1-14 Days)|Other|0|||
13344450|NCT00990093|26636052|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0|||
13344451|NCT00990093|26636053|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2|||
13344452|NCT00990093|26636052|FG000|Test Period 2 (15-28 Days)|Adverse Event|1|||
13344453|NCT00990093|26636053|FG001|Test Period 2 (15-28 Days)|Adverse Event|0|||
13344454|NCT00990093|26636052|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1|||
13344455|NCT00990093|26636053|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0|||
13344456|NCT00990093|26636052|FG000|Test Period 2 (15-28 Days)|Other|0|||
13344457|NCT00990093|26636053|FG001|Test Period 2 (15-28 Days)|Other|1|||
13344458|NCT00989833|26636092|FG000|Overall Study|Lost to Follow-up|0|||
13344459|NCT00989833|26636093|FG001|Overall Study|Lost to Follow-up|1|||
13344460|NCT00989833|26636094|FG002|Overall Study|Lost to Follow-up|0|||
13344461|NCT00989833|26636092|FG000|Overall Study|Protocol Violation|1|||
13344462|NCT00989833|26636093|FG001|Overall Study|Protocol Violation|2|||
13344463|NCT00989833|26636094|FG002|Overall Study|Protocol Violation|1|||
13344464|NCT00989833|26636092|FG000|Overall Study|Withdrawal by Subject|0|||
13344465|NCT00989833|26636093|FG001|Overall Study|Withdrawal by Subject|0|||
13344466|NCT00989833|26636094|FG002|Overall Study|Withdrawal by Subject|1|||
13344467|NCT00989833|26636092|FG000|Overall Study|Incorrectly randomized|1|||
13344468|NCT00989833|26636093|FG001|Overall Study|Incorrectly randomized|0|||
13344469|NCT00989833|26636094|FG002|Overall Study|Incorrectly randomized|0|||
13344470|NCT00989287|26636201|FG000|Overall Study|Adverse Event|1|||
13344471|NCT00989287|26636202|FG001|Overall Study|Adverse Event|0|||
13344472|NCT00989287|26636201|FG000|Overall Study|Lost to Follow-up|0|||
13344473|NCT00989287|26636202|FG001|Overall Study|Lost to Follow-up|1|||
13344474|NCT00988637|26636239|FG000|Overall Study|Lost to Follow-up|2|||
13344475|NCT00988637|26636240|FG001|Overall Study|Lost to Follow-up|1|||
13344476|NCT00988637|26636239|FG000|Overall Study|Withdrawal by Subject|1|||
13344477|NCT00988637|26636240|FG001|Overall Study|Withdrawal by Subject|1|||
13344478|NCT00988637|26636239|FG000|Overall Study|non-compliance with study drug|0|||
13344479|NCT00988637|26636240|FG001|Overall Study|non-compliance with study drug|1|||
13344480|NCT00988598|26636271|FG000|Overall Study|Withdrawal by Subject|2|||
13344481|NCT00988598|26636272|FG001|Overall Study|Withdrawal by Subject|0|||
13344482|NCT00988442|26636339|FG000|Overall Study|Death|1|||
13344483|NCT00988442|26636340|FG001|Overall Study|Death|2|||
13344484|NCT00988442|26636339|FG000|Overall Study|Lost to Follow-up|0|||
13344485|NCT00988442|26636340|FG001|Overall Study|Lost to Follow-up|1|||
13344486|NCT00988442|26636339|FG000|Overall Study|Early Study Closure|29|||
13344487|NCT00988442|26636340|FG001|Overall Study|Early Study Closure|25|||
13344488|NCT00988429|26636361|FG000|Overall Study|Adverse Event|9|||
13344489|NCT00988429|26636362|FG001|Overall Study|Adverse Event|21|||
13344490|NCT00988429|26636363|FG002|Overall Study|Adverse Event|45|||
13344491|NCT00988429|26636361|FG000|Overall Study|Lack of Efficacy|0|||
13344492|NCT00988429|26636362|FG001|Overall Study|Lack of Efficacy|0|||
13344493|NCT00988429|26636363|FG002|Overall Study|Lack of Efficacy|1|||
13344494|NCT00988429|26636361|FG000|Overall Study|Non-Compliance with Study Drug|5|||
13344495|NCT00988429|26636362|FG001|Overall Study|Non-Compliance with Study Drug|1|||
13344496|NCT00988429|26636363|FG002|Overall Study|Non-Compliance with Study Drug|3|||
13344497|NCT00988429|26636361|FG000|Overall Study|Physician Decision|1|||
13344498|NCT00988429|26636362|FG001|Overall Study|Physician Decision|0|||
13344499|NCT00988429|26636363|FG002|Overall Study|Physician Decision|3|||
13344500|NCT00988429|26636361|FG000|Overall Study|Pregnancy|2|||
13344501|NCT00988429|26636362|FG001|Overall Study|Pregnancy|1|||
13344502|NCT00988429|26636363|FG002|Overall Study|Pregnancy|0|||
13344503|NCT00988429|26636361|FG000|Overall Study|Protocol Violation|4|||
13344504|NCT00988429|26636362|FG001|Overall Study|Protocol Violation|3|||
13344505|NCT00988429|26636363|FG002|Overall Study|Protocol Violation|3|||
13344506|NCT00988429|26636361|FG000|Overall Study|Withdrawal by Subject|7|||
13344507|NCT00988429|26636362|FG001|Overall Study|Withdrawal by Subject|7|||
13344508|NCT00988429|26636363|FG002|Overall Study|Withdrawal by Subject|12|||
13344509|NCT00988429|26636361|FG000|Overall Study|Administrative Reasons|1|||
13344510|NCT00988429|26636362|FG001|Overall Study|Administrative Reasons|2|||
13344511|NCT00988429|26636363|FG002|Overall Study|Administrative Reasons|1|||
13344512|NCT00988429|26636361|FG000|Overall Study|other reasons|8|||
13344513|NCT00988429|26636362|FG001|Overall Study|other reasons|8|||
13344514|NCT00988429|26636363|FG002|Overall Study|other reasons|1|||
13344515|NCT00988221|26636545|FG000|Part I|Adverse Event|0|||
13344516|NCT00988221|26636546|FG001|Part I|Adverse Event|1|||
13344517|NCT00988221|26636547|FG002|Part I|Adverse Event|2|||
13344518|NCT00988221|26636548|FG003|Part I|Adverse Event|0|||
13344519|NCT00988221|26636545|FG000|Part I|Insufficient Therapeutic Response|4|||
13344520|NCT00988221|26636546|FG001|Part I|Insufficient Therapeutic Response|6|||
13344521|NCT00988221|26636547|FG002|Part I|Insufficient Therapeutic Response|5|||
13344522|NCT00988221|26636548|FG003|Part I|Insufficient Therapeutic Response|0|||
13344523|NCT00988221|26636545|FG000|Part I|Refused Treatment|0|||
13344524|NCT00988221|26636546|FG001|Part I|Refused Treatment|2|||
13344525|NCT00988221|26636547|FG002|Part I|Refused Treatment|1|||
13344526|NCT00988221|26636548|FG003|Part I|Refused Treatment|0|||
13344527|NCT00988221|26636545|FG000|Part I|Lost to Follow-up|0|||
13344528|NCT00988221|26636546|FG001|Part I|Lost to Follow-up|1|||
13344529|NCT00988221|26636547|FG002|Part I|Lost to Follow-up|0|||
13344530|NCT00988221|26636548|FG003|Part I|Lost to Follow-up|0|||
13344531|NCT00988221|26636545|FG000|Part II|Adverse Event|1|||
13344532|NCT00988221|26636546|FG001|Part II|Adverse Event|0|||
13344533|NCT00988221|26636547|FG002|Part II|Adverse Event|0|||
13344534|NCT00988221|26636548|FG003|Part II|Adverse Event|1|||
13344535|NCT00988221|26636545|FG000|Part II|Withdrawal by Subject|0|||
13344536|NCT00988221|26636546|FG001|Part II|Withdrawal by Subject|0|||
13344537|NCT00988221|26636547|FG002|Part II|Withdrawal by Subject|2|||
13344538|NCT00988221|26636548|FG003|Part II|Withdrawal by Subject|2|||
13344539|NCT00988221|26636545|FG000|Part II|Reason not Specified|0|||
13344540|NCT00988221|26636546|FG001|Part II|Reason not Specified|0|||
13344541|NCT00988221|26636547|FG002|Part II|Reason not Specified|1|||
13344542|NCT00988221|26636548|FG003|Part II|Reason not Specified|0|||
13344543|NCT00988221|26636545|FG000|Part III|Adverse Event|1|||
13344544|NCT00988221|26636546|FG001|Part III|Adverse Event|0|||
13344545|NCT00988221|26636547|FG002|Part III|Adverse Event|1|||
13344546|NCT00988221|26636548|FG003|Part III|Adverse Event|0|||
13344547|NCT00988221|26636545|FG000|Part III|Insufficient Therapeutic Response|0|||
13344548|NCT00988221|26636546|FG001|Part III|Insufficient Therapeutic Response|1|||
13344549|NCT00988221|26636547|FG002|Part III|Insufficient Therapeutic Response|1|||
13344550|NCT00988221|26636548|FG003|Part III|Insufficient Therapeutic Response|0|||
13124788|NCT02939014|25954045|FG001|Overall Study|Death|3|||
13344551|NCT00988221|26636545|FG000|Part III|Refused Treatment|0|||
13344552|NCT00988221|26636546|FG001|Part III|Refused Treatment|0|||
13344553|NCT00988221|26636547|FG002|Part III|Refused Treatment|1|||
13344554|NCT00988221|26636548|FG003|Part III|Refused Treatment|0|||
13344555|NCT00988208|26636573|FG000|Overall Study|Adverse Event|71|||
13344556|NCT00988208|26636574|FG001|Overall Study|Adverse Event|122|||
13344557|NCT00988208|26636573|FG000|Overall Study|Disease Progression|103|||
13344558|NCT00988208|26636574|FG001|Overall Study|Disease Progression|89|||
13344559|NCT00988208|26636573|FG000|Overall Study|Withdrawal by Subject|50|||
13344560|NCT00988208|26636574|FG001|Overall Study|Withdrawal by Subject|57|||
13344561|NCT00988208|26636573|FG000|Overall Study|Death|9|||
13344562|NCT00988208|26636574|FG001|Overall Study|Death|15|||
13344563|NCT00988208|26636573|FG000|Overall Study|Lost to Follow-up|2|||
13344564|NCT00988208|26636574|FG001|Overall Study|Lost to Follow-up|3|||
13344565|NCT00988208|26636573|FG000|Overall Study|Protocol Violation|9|||
13344566|NCT00988208|26636574|FG001|Overall Study|Protocol Violation|2|||
13344567|NCT00988208|26636573|FG000|Overall Study|Sponsor Decision|102|||
13344568|NCT00988208|26636574|FG001|Overall Study|Sponsor Decision|78|||
13344569|NCT00988208|26636573|FG000|Overall Study|Clinical Progression|17|||
13344570|NCT00988208|26636574|FG001|Overall Study|Clinical Progression|16|||
13344571|NCT00988208|26636573|FG000|Overall Study|Biochemical Progression|21|||
13344572|NCT00988208|26636574|FG001|Overall Study|Biochemical Progression|7|||
13344573|NCT00988208|26636573|FG000|Overall Study|Clinical Deterioration|7|||
13344574|NCT00988208|26636574|FG001|Overall Study|Clinical Deterioration|14|||
13344575|NCT00988208|26636573|FG000|Overall Study|Subject Decision/Investigator Discretion|32|||
13344576|NCT00988208|26636574|FG001|Overall Study|Subject Decision/Investigator Discretion|32|||
13344577|NCT00988208|26636573|FG000|Overall Study|Other|8|||
13344578|NCT00988208|26636574|FG001|Overall Study|Other|3|||
13344579|NCT00987389|26636599|FG000|Overall Study|Ineligible|0|||
13344580|NCT00987389|26636600|FG001|Overall Study|Ineligible|3|||
13344581|NCT00987389|26636601|FG002|Overall Study|Ineligible|0|||
13344582|NCT00987389|26636602|FG003|Overall Study|Ineligible|0|||
13344583|NCT00987389|26636599|FG000|Overall Study|Lost to Follow-up|4|||
13344584|NCT00987389|26636600|FG001|Overall Study|Lost to Follow-up|1|||
13344585|NCT00987389|26636601|FG002|Overall Study|Lost to Follow-up|3|||
13344586|NCT00987389|26636602|FG003|Overall Study|Lost to Follow-up|1|||
13344587|NCT00987389|26636599|FG000|Overall Study|Withdrawal by Subject|4|||
13344588|NCT00987389|26636600|FG001|Overall Study|Withdrawal by Subject|3|||
13344589|NCT00987389|26636601|FG002|Overall Study|Withdrawal by Subject|2|||
13344590|NCT00987389|26636602|FG003|Overall Study|Withdrawal by Subject|1|||
13344591|NCT00987389|26636599|FG000|Overall Study|Withdrawn from Treatment|0|||
13344592|NCT00987389|26636600|FG001|Overall Study|Withdrawn from Treatment|1|||
13344593|NCT00987389|26636601|FG002|Overall Study|Withdrawn from Treatment|0|||
13344594|NCT00987389|26636602|FG003|Overall Study|Withdrawn from Treatment|0|||
13344595|NCT00987389|26636599|FG000|Overall Study|Multiple different reasons|1|||
13344596|NCT00987389|26636600|FG001|Overall Study|Multiple different reasons|0|||
13344597|NCT00987389|26636601|FG002|Overall Study|Multiple different reasons|3|||
13344598|NCT00987389|26636602|FG003|Overall Study|Multiple different reasons|1|||
13344599|NCT00987337|26636656|FG000|Overall Study|Adverse Event|10|||
13344600|NCT00987337|26636657|FG001|Overall Study|Adverse Event|9|||
13344601|NCT00987337|26636658|FG002|Overall Study|Adverse Event|8|||
13344602|NCT00987337|26636656|FG000|Overall Study|Insufficient Virologic Response|10|||
13344603|NCT00987337|26636657|FG001|Overall Study|Insufficient Virologic Response|7|||
13344604|NCT00987337|26636658|FG002|Overall Study|Insufficient Virologic Response|12|||
13344605|NCT00987337|26636656|FG000|Overall Study|Virologic Breakthrough|2|||
13344606|NCT00987337|26636657|FG001|Overall Study|Virologic Breakthrough|2|||
13344607|NCT00987337|26636658|FG002|Overall Study|Virologic Breakthrough|8|||
13344608|NCT00987337|26636656|FG000|Overall Study|Lost to Follow-up|10|||
13344609|NCT00987337|26636657|FG001|Overall Study|Lost to Follow-up|6|||
13344610|NCT00987337|26636658|FG002|Overall Study|Lost to Follow-up|2|||
13344611|NCT00987337|26636656|FG000|Overall Study|Withdrawal by Subject|6|||
13344612|NCT00987337|26636657|FG001|Overall Study|Withdrawal by Subject|9|||
13344613|NCT00987337|26636658|FG002|Overall Study|Withdrawal by Subject|9|||
13344614|NCT00987337|26636656|FG000|Overall Study|Other|0|||
13344615|NCT00987337|26636657|FG001|Overall Study|Other|2|||
13344616|NCT00987337|26636658|FG002|Overall Study|Other|5|||
13344617|NCT00987337|26636656|FG000|Overall Study|Protocol Violation|1|||
13344618|NCT00987337|26636657|FG001|Overall Study|Protocol Violation|0|||
13344619|NCT00987337|26636658|FG002|Overall Study|Protocol Violation|2|||
13344620|NCT00987337|26636656|FG000|Overall Study|Participant Relapsed|18|||
13344621|NCT00987337|26636657|FG001|Overall Study|Participant Relapsed|20|||
13344622|NCT00987337|26636658|FG002|Overall Study|Participant Relapsed|5|||
13344623|NCT00986830|26636672|FG000|Overall Study|Death|1|||
13344624|NCT00986830|26636672|FG000|Overall Study|Lost to Follow-up|1|||
13344625|NCT00986830|26636672|FG000|Overall Study|Lack of Efficacy|1|||
13344626|NCT00986830|26636672|FG000|Overall Study|Unable to access sinus with device|5|||
13344627|NCT00986479|26636709|FG000|Period 1|Improved mood|1|||
13344628|NCT00986479|26636710|FG001|Period 1|Improved mood|0|||
13344629|NCT00986479|26636709|FG000|Period 1|Administrative reasons|1|||
13344630|NCT00986479|26636710|FG001|Period 1|Administrative reasons|0|||
13344631|NCT00986245|26636746|FG000|First Intervention|Poor compliance|8|||
13344632|NCT00986245|26636747|FG001|First Intervention|Poor compliance|4|||
13344633|NCT00986245|26636746|FG000|First Intervention|Lack of Efficacy|1|||
13344634|NCT00986245|26636747|FG001|First Intervention|Lack of Efficacy|2|||
13344635|NCT00986245|26636746|FG000|First Intervention|Withdrawal by Subject|0|||
13344636|NCT00986245|26636747|FG001|First Intervention|Withdrawal by Subject|1|||
13344637|NCT00986245|26636746|FG000|First Intervention|Protocol Violation|0|||
13344638|NCT00986245|26636747|FG001|First Intervention|Protocol Violation|1|||
13344639|NCT00986245|26636746|FG000|First Intervention|Out of indication|1|||
13344640|NCT00986245|26636747|FG001|First Intervention|Out of indication|0|||
13344641|NCT00986245|26636746|FG000|Second Intervention|Poor compliance|1|||
13344642|NCT00986245|26636747|FG001|Second Intervention|Poor compliance|0|||
13344643|NCT00986245|26636746|FG000|Second Intervention|Lost to Follow-up|1|||
13344644|NCT00986245|26636747|FG001|Second Intervention|Lost to Follow-up|0|||
13344645|NCT00986245|26636746|FG000|Second Intervention|Protocol Violation|0|||
13344646|NCT00986245|26636747|FG001|Second Intervention|Protocol Violation|1|||
13344647|NCT00986232|26636832|FG000|Overall Study|Adverse Event|1|||
13344648|NCT00986232|26636833|FG001|Overall Study|Adverse Event|2|||
13344649|NCT00986232|26636834|FG002|Overall Study|Adverse Event|3|||
13344650|NCT00986232|26636835|FG003|Overall Study|Adverse Event|0|||
13344651|NCT00986232|26636832|FG000|Overall Study|Lost to Follow-up|19|||
13344652|NCT00986232|26636833|FG001|Overall Study|Lost to Follow-up|12|||
13344653|NCT00986232|26636834|FG002|Overall Study|Lost to Follow-up|12|||
13344654|NCT00986232|26636835|FG003|Overall Study|Lost to Follow-up|7|||
13344655|NCT00986232|26636832|FG000|Overall Study|Protocol Violation|2|||
13344656|NCT00986232|26636833|FG001|Overall Study|Protocol Violation|3|||
13344657|NCT00986232|26636834|FG002|Overall Study|Protocol Violation|0|||
13344658|NCT00986232|26636835|FG003|Overall Study|Protocol Violation|1|||
13344659|NCT00986232|26636832|FG000|Overall Study|Withdrawal by Subject|13|||
13344660|NCT00986232|26636833|FG001|Overall Study|Withdrawal by Subject|16|||
13344661|NCT00986232|26636834|FG002|Overall Study|Withdrawal by Subject|12|||
13344662|NCT00986232|26636835|FG003|Overall Study|Withdrawal by Subject|3|||
13344663|NCT00986232|26636832|FG000|Overall Study|Missed one or more bleeds|13|||
13344664|NCT00986232|26636833|FG001|Overall Study|Missed one or more bleeds|10|||
13344665|NCT00986232|26636834|FG002|Overall Study|Missed one or more bleeds|6|||
13344666|NCT00986232|26636835|FG003|Overall Study|Missed one or more bleeds|7|||
13344667|NCT00986232|26636832|FG000|Overall Study|Incomplete safety follow-up|3|||
13344668|NCT00986232|26636833|FG001|Overall Study|Incomplete safety follow-up|7|||
13344669|NCT00986232|26636834|FG002|Overall Study|Incomplete safety follow-up|2|||
13344670|NCT00986232|26636835|FG003|Overall Study|Incomplete safety follow-up|2|||
13344671|NCT00986154|26636852|FG000|Overall Study|Death|136|||
13344672|NCT00986154|26636853|FG001|Overall Study|Death|127|||
13344673|NCT00986154|26636852|FG000|Overall Study|Lost to Follow-up|7|||
13344674|NCT00986154|26636853|FG001|Overall Study|Lost to Follow-up|4|||
13344675|NCT00986154|26636852|FG000|Overall Study|Withdrawal by Subject|32|||
13344676|NCT00986154|26636853|FG001|Overall Study|Withdrawal by Subject|33|||
13344677|NCT00986154|26636852|FG000|Overall Study|investigator/subject decide not continue|6|||
13344678|NCT00986154|26636853|FG001|Overall Study|investigator/subject decide not continue|3|||
13344679|NCT00986154|26636852|FG000|Overall Study|never received study drug|25|||
13344680|NCT00986154|26636853|FG001|Overall Study|never received study drug|27|||
13344681|NCT00985985|26636904|FG000|Overall Study|Adverse Event|4|||
13344682|NCT00985985|26636905|FG001|Overall Study|Adverse Event|2|||
13344683|NCT00985985|26636906|FG002|Overall Study|Adverse Event|2|||
13344684|NCT00985985|26636907|FG003|Overall Study|Adverse Event|2|||
13344685|NCT00985985|26636904|FG000|Overall Study|Lost to Follow-up|4|||
13344686|NCT00985985|26636905|FG001|Overall Study|Lost to Follow-up|11|||
13344687|NCT00985985|26636906|FG002|Overall Study|Lost to Follow-up|2|||
13344688|NCT00985985|26636907|FG003|Overall Study|Lost to Follow-up|3|||
13344689|NCT00985985|26636904|FG000|Overall Study|Protocol Violation|1|||
13344690|NCT00985985|26636905|FG001|Overall Study|Protocol Violation|2|||
13344691|NCT00985985|26636906|FG002|Overall Study|Protocol Violation|0|||
13344692|NCT00985985|26636907|FG003|Overall Study|Protocol Violation|1|||
13344693|NCT00985985|26636904|FG000|Overall Study|Lack of Efficacy|5|||
13344694|NCT00985985|26636905|FG001|Overall Study|Lack of Efficacy|6|||
13344695|NCT00985985|26636906|FG002|Overall Study|Lack of Efficacy|1|||
13344696|NCT00985985|26636907|FG003|Overall Study|Lack of Efficacy|3|||
13344697|NCT00985985|26636904|FG000|Overall Study|Withdrawal by Subject|4|||
13344698|NCT00985985|26636905|FG001|Overall Study|Withdrawal by Subject|2|||
13344699|NCT00985985|26636906|FG002|Overall Study|Withdrawal by Subject|2|||
13344700|NCT00985985|26636907|FG003|Overall Study|Withdrawal by Subject|2|||
13344701|NCT00985985|26636904|FG000|Overall Study|Other Reason|6|||
13344702|NCT00985985|26636905|FG001|Overall Study|Other Reason|1|||
13344703|NCT00985985|26636906|FG002|Overall Study|Other Reason|4|||
13344704|NCT00985985|26636907|FG003|Overall Study|Other Reason|2|||
13344705|NCT00985621|26637110|FG000|Overall Study|Adverse Event|2|||
13344706|NCT00985621|26637111|FG001|Overall Study|Adverse Event|3|||
13344707|NCT00985621|26637112|FG002|Overall Study|Adverse Event|4|||
13204374|NCT01973998|26228401|FG001|Overall Study|Death|2|||
13344708|NCT00985621|26637113|FG003|Overall Study|Adverse Event|16|||
13344709|NCT00985621|26637110|FG000|Overall Study|Lack of Efficacy|10|||
13344710|NCT00985621|26637111|FG001|Overall Study|Lack of Efficacy|6|||
13344711|NCT00985621|26637112|FG002|Overall Study|Lack of Efficacy|5|||
13344712|NCT00985621|26637113|FG003|Overall Study|Lack of Efficacy|12|||
13344713|NCT00985621|26637110|FG000|Overall Study|Lost to Follow-up|2|||
13344714|NCT00985621|26637111|FG001|Overall Study|Lost to Follow-up|3|||
13344715|NCT00985621|26637112|FG002|Overall Study|Lost to Follow-up|4|||
13344716|NCT00985621|26637113|FG003|Overall Study|Lost to Follow-up|4|||
13344717|NCT00985621|26637110|FG000|Overall Study|Study Terminated by Sponsor|89|||
13344718|NCT00985621|26637111|FG001|Overall Study|Study Terminated by Sponsor|108|||
13344719|NCT00985621|26637112|FG002|Overall Study|Study Terminated by Sponsor|99|||
13344720|NCT00985621|26637113|FG003|Overall Study|Study Terminated by Sponsor|92|||
13344721|NCT00985621|26637110|FG000|Overall Study|Protocol Violation|1|||
13344722|NCT00985621|26637111|FG001|Overall Study|Protocol Violation|1|||
13344723|NCT00985621|26637112|FG002|Overall Study|Protocol Violation|1|||
13344724|NCT00985621|26637113|FG003|Overall Study|Protocol Violation|0|||
13344725|NCT00985621|26637110|FG000|Overall Study|Withdrawal by Subject|8|||
13344726|NCT00985621|26637111|FG001|Overall Study|Withdrawal by Subject|10|||
13344727|NCT00985621|26637112|FG002|Overall Study|Withdrawal by Subject|8|||
13344728|NCT00985621|26637113|FG003|Overall Study|Withdrawal by Subject|12|||
13344729|NCT00985621|26637110|FG000|Overall Study|Other|1|||
13344730|NCT00985621|26637111|FG001|Overall Study|Other|0|||
13344731|NCT00985621|26637112|FG002|Overall Study|Other|0|||
13344732|NCT00985621|26637113|FG003|Overall Study|Other|0|||
13344733|NCT00985621|26637110|FG000|Overall Study|Randomized but not Treated|1|||
13344734|NCT00985621|26637111|FG001|Overall Study|Randomized but not Treated|0|||
13344735|NCT00985621|26637112|FG002|Overall Study|Randomized but not Treated|2|||
13344736|NCT00985621|26637113|FG003|Overall Study|Randomized but not Treated|1|||
13344737|NCT00984620|26637156|FG000|Overall Study|Adverse Event|5|||
13344738|NCT00984620|26637157|FG001|Overall Study|Adverse Event|5|||
13344739|NCT00984620|26637156|FG000|Overall Study|Lost to Follow-up|1|||
13344740|NCT00984620|26637157|FG001|Overall Study|Lost to Follow-up|1|||
13344741|NCT00984620|26637156|FG000|Overall Study|Withdrawal by Subject|0|||
13344742|NCT00984620|26637157|FG001|Overall Study|Withdrawal by Subject|2|||
13344743|NCT00984620|26637156|FG000|Overall Study|reason other than listed above|0|||
13344744|NCT00984620|26637157|FG001|Overall Study|reason other than listed above|4|||
13344745|NCT00984295|26637232|FG000|Overall Study|Lost to Follow-up|31|||
13344746|NCT00984295|26637233|FG001|Overall Study|Lost to Follow-up|12|||
13344747|NCT00984295|26637234|FG002|Overall Study|Lost to Follow-up|13|||
13344748|NCT00984295|26637232|FG000|Overall Study|Protocol Violation|2|||
13344749|NCT00984295|26637233|FG001|Overall Study|Protocol Violation|1|||
13344750|NCT00984295|26637234|FG002|Overall Study|Protocol Violation|4|||
13344751|NCT00984295|26637232|FG000|Overall Study|Withdrawal by Subject|18|||
13344752|NCT00984295|26637233|FG001|Overall Study|Withdrawal by Subject|9|||
13344753|NCT00984295|26637234|FG002|Overall Study|Withdrawal by Subject|12|||
13344754|NCT00984295|26637232|FG000|Overall Study|CAE - discontinued test vaccine|0|||
13344755|NCT00984295|26637233|FG001|Overall Study|CAE - discontinued test vaccine|1|||
13344756|NCT00984295|26637234|FG002|Overall Study|CAE - discontinued test vaccine|3|||
13344757|NCT00984295|26637232|FG000|Overall Study|Missed one or more blood samplings|3|||
13344758|NCT00984295|26637233|FG001|Overall Study|Missed one or more blood samplings|7|||
13344759|NCT00984295|26637234|FG002|Overall Study|Missed one or more blood samplings|2|||
13344760|NCT00984295|26637232|FG000|Overall Study|Incomplete safety follow-up|11|||
13344761|NCT00984295|26637233|FG001|Overall Study|Incomplete safety follow-up|2|||
13344762|NCT00984295|26637234|FG002|Overall Study|Incomplete safety follow-up|3|||
13344763|NCT00984282|26637262|FG000|Double Blind Treatment|Adverse Event|40|||
13344764|NCT00984282|26637263|FG001|Double Blind Treatment|Adverse Event|6|||
13344765|NCT00984282|26637262|FG000|Double Blind Treatment|Progression, recurrence or relapse|25|||
13344766|NCT00984282|26637263|FG001|Double Blind Treatment|Progression, recurrence or relapse|3|||
13344767|NCT00984282|26637262|FG000|Double Blind Treatment|Physician Decision|1|||
13344768|NCT00984282|26637263|FG001|Double Blind Treatment|Physician Decision|2|||
13344769|NCT00984282|26637262|FG000|Double Blind Treatment|Noncompliance with study medication|3|||
13344770|NCT00984282|26637263|FG001|Double Blind Treatment|Noncompliance with study medication|0|||
13344771|NCT00984282|26637262|FG000|Double Blind Treatment|Progression by clinical judgment|2|||
13344772|NCT00984282|26637263|FG001|Double Blind Treatment|Progression by clinical judgment|0|||
13344773|NCT00984282|26637262|FG000|Double Blind Treatment|Withdrawal by Subject|13|||
13344774|NCT00984282|26637263|FG001|Double Blind Treatment|Withdrawal by Subject|18|||
13344775|NCT00984282|26637262|FG000|Double Blind Treatment|Lost to Follow-up|3|||
13344776|NCT00984282|26637263|FG001|Double Blind Treatment|Lost to Follow-up|0|||
13344777|NCT00984282|26637262|FG000|Double Blind Treatment|Death|8|||
13344778|NCT00984282|26637263|FG001|Double Blind Treatment|Death|4|||
13344779|NCT00984282|26637262|FG000|Double Blind Treatment|Not treated|0|||
13344780|NCT00984282|26637263|FG001|Double Blind Treatment|Not treated|1|||
13344781|NCT00984282|26637262|FG000|Double Blind Treatment|Switched to commercial drug|6|||
13344782|NCT00984282|26637263|FG001|Double Blind Treatment|Switched to commercial drug|1|||
13344783|NCT00984282|26637262|FG000|Double Blind Treatment|protocol driven decision point|1|||
13344784|NCT00984282|26637263|FG001|Double Blind Treatment|protocol driven decision point|1|||
13344785|NCT00984282|26637262|FG000|Double Blind Treatment|Radiological and clinical progression|0|||
13344786|NCT00984282|26637263|FG001|Double Blind Treatment|Radiological and clinical progression|1|||
13344787|NCT00984282|26637262|FG000|Double Blind Treatment|Transferred to treat. continuation study|2|||
13344788|NCT00984282|26637263|FG001|Double Blind Treatment|Transferred to treat. continuation study|1|||
13344789|NCT00984282|26637262|FG000|Open-label Treatment|Adverse Event|20|||
13344790|NCT00984282|26637263|FG001|Open-label Treatment|Adverse Event|30|||
13344791|NCT00984282|26637262|FG000|Open-label Treatment|Withdrawal by Subject|6|||
13344792|NCT00984282|26637263|FG001|Open-label Treatment|Withdrawal by Subject|21|||
13344793|NCT00984282|26637262|FG000|Open-label Treatment|Death|7|||
13344794|NCT00984282|26637263|FG001|Open-label Treatment|Death|15|||
13374032|NCT00798161|26725698|FG003|Overall Study|Protocol Violation|3|||
13344795|NCT00984282|26637262|FG000|Open-label Treatment|Progression, recurrence or relapse|40|||
13344796|NCT00984282|26637263|FG001|Open-label Treatment|Progression, recurrence or relapse|82|||
13344797|NCT00984282|26637262|FG000|Open-label Treatment|Lost to Follow-up|1|||
13344798|NCT00984282|26637263|FG001|Open-label Treatment|Lost to Follow-up|1|||
13344799|NCT00984282|26637262|FG000|Open-label Treatment|Patient convenience|1|||
13344800|NCT00984282|26637263|FG001|Open-label Treatment|Patient convenience|0|||
13344801|NCT00984282|26637262|FG000|Open-label Treatment|Non-compliant with study medication|1|||
13344802|NCT00984282|26637263|FG001|Open-label Treatment|Non-compliant with study medication|0|||
13344803|NCT00984282|26637262|FG000|Open-label Treatment|Target lesion removed|0|||
13344804|NCT00984282|26637263|FG001|Open-label Treatment|Target lesion removed|1|||
13344805|NCT00984282|26637262|FG000|Open-label Treatment|Protocol driven decision point|1|||
13344806|NCT00984282|26637263|FG001|Open-label Treatment|Protocol driven decision point|1|||
13344807|NCT00984282|26637262|FG000|Open-label Treatment|Transferred to treat. continuation study|2|||
13344808|NCT00984282|26637263|FG001|Open-label Treatment|Transferred to treat. continuation study|3|||
13344809|NCT00984282|26637262|FG000|Open-label Treatment|Switched to commercial drug|6|||
13344810|NCT00984282|26637263|FG001|Open-label Treatment|Switched to commercial drug|7|||
13344811|NCT00984282|26637262|FG000|Open-label Treatment|Physician Decision|1|||
13344812|NCT00984282|26637263|FG001|Open-label Treatment|Physician Decision|0|||
13344813|NCT00984282|26637262|FG000|Long Term Follow-up|Withdrawal by Subject|8|||
13344814|NCT00984282|26637263|FG001|Long Term Follow-up|Withdrawal by Subject|14|||
13344815|NCT00984282|26637262|FG000|Long Term Follow-up|Death|27|||
13344816|NCT00984282|26637263|FG001|Long Term Follow-up|Death|68|||
13344817|NCT00984282|26637262|FG000|Long Term Follow-up|Lost to Follow-up|3|||
13344818|NCT00984282|26637263|FG001|Long Term Follow-up|Lost to Follow-up|6|||
13344819|NCT00984282|26637262|FG000|Long Term Follow-up|Protocol driven decision point|25|||
13344820|NCT00984282|26637263|FG001|Long Term Follow-up|Protocol driven decision point|26|||
13344821|NCT00984282|26637262|FG000|Long Term Follow-up|Transferred to treat. continuation study|2|||
13344822|NCT00984282|26637263|FG001|Long Term Follow-up|Transferred to treat. continuation study|3|||
13344823|NCT00984282|26637262|FG000|Long Term Follow-up|Switched to commercial drug|4|||
13344824|NCT00984282|26637263|FG001|Long Term Follow-up|Switched to commercial drug|2|||
13344825|NCT00984282|26637262|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0|||
13344826|NCT00984282|26637263|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1|||
13344827|NCT00984165|26637289|FG000|Overall Study|Death on study|2|||
13344828|NCT00984165|26637290|FG001|Overall Study|Death on study|0|||
13344829|NCT00984165|26637291|FG002|Overall Study|Death on study|0|||
13344830|NCT00984165|26637292|FG003|Overall Study|Death on study|0|||
13344831|NCT00984165|26637289|FG000|Overall Study|Disease progression on study|5|||
13344832|NCT00984165|26637290|FG001|Overall Study|Disease progression on study|1|||
13344833|NCT00984165|26637291|FG002|Overall Study|Disease progression on study|0|||
13344834|NCT00984165|26637292|FG003|Overall Study|Disease progression on study|0|||
13344835|NCT00984165|26637289|FG000|Overall Study|Death of recipient|0|||
13344836|NCT00984165|26637290|FG001|Overall Study|Death of recipient|0|||
13344837|NCT00984165|26637291|FG002|Overall Study|Death of recipient|0|||
13344838|NCT00984165|26637292|FG003|Overall Study|Death of recipient|1|||
13344839|NCT00984165|26637289|FG000|Overall Study|New protocol|0|||
13344840|NCT00984165|26637290|FG001|Overall Study|New protocol|0|||
13344841|NCT00984165|26637291|FG002|Overall Study|New protocol|0|||
13344842|NCT00984165|26637292|FG003|Overall Study|New protocol|1|||
13344843|NCT00984165|26637289|FG000|Overall Study|P+/donor pair removed from protocol|0|||
13344844|NCT00984165|26637290|FG001|Overall Study|P+/donor pair removed from protocol|0|||
13344845|NCT00984165|26637291|FG002|Overall Study|P+/donor pair removed from protocol|0|||
13344846|NCT00984165|26637292|FG003|Overall Study|P+/donor pair removed from protocol|1|||
13344847|NCT00984165|26637289|FG000|Overall Study|removed with a pair recipient|0|||
13344848|NCT00984165|26637290|FG001|Overall Study|removed with a pair recipient|0|||
13344849|NCT00984165|26637291|FG002|Overall Study|removed with a pair recipient|0|||
13344850|NCT00984165|26637292|FG003|Overall Study|removed with a pair recipient|1|||
13344851|NCT00984126|26637330|FG000|Overall Study|Protocol Violation|0|||
13344852|NCT00984126|26637331|FG001|Overall Study|Protocol Violation|0|||
13344853|NCT00984126|26637332|FG002|Overall Study|Protocol Violation|1|||
13344854|NCT00984126|26637333|FG003|Overall Study|Protocol Violation|2|||
13344855|NCT00984126|26637330|FG000|Overall Study|Adverse Event|0|||
13344856|NCT00984126|26637331|FG001|Overall Study|Adverse Event|0|||
13344857|NCT00984126|26637332|FG002|Overall Study|Adverse Event|0|||
13344858|NCT00984126|26637333|FG003|Overall Study|Adverse Event|2|||
13344859|NCT00984126|26637330|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7|||
13344860|NCT00984126|26637331|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7|||
13344861|NCT00984126|26637332|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3|||
13344862|NCT00984126|26637333|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46|||
13344863|NCT00984126|26637330|FG000|Overall Study|Withdrawal criteria|0|||
13344864|NCT00984126|26637331|FG001|Overall Study|Withdrawal criteria|1|||
13344865|NCT00984126|26637332|FG002|Overall Study|Withdrawal criteria|3|||
13344866|NCT00984126|26637333|FG003|Overall Study|Withdrawal criteria|9|||
13344867|NCT00983476|26637375|FG000|Overall Study|Did not receive intervention|17|||
13344868|NCT00983476|26637376|FG001|Overall Study|Did not receive intervention|22|||
13344869|NCT00983476|26637377|FG002|Overall Study|Did not receive intervention|0|||
13344870|NCT00983385|26637424|FG000|Observation Period|Not eligible to be dosed|20|||
13344871|NCT00983385|26637424|FG000|Observation Period|Not Evaluable due to Non Compliance|12|||
13344872|NCT00982657|26637476|FG000|Overall Study|Death|1|||
13344873|NCT00982657|26637477|FG001|Overall Study|Death|0|||
13344874|NCT00982657|26637478|FG002|Overall Study|Death|1|||
13344875|NCT00982657|26637479|FG003|Overall Study|Death|1|||
13344876|NCT00982657|26637476|FG000|Overall Study|Withdrawal by Subject|0|||
13344877|NCT00982657|26637477|FG001|Overall Study|Withdrawal by Subject|0|||
13344878|NCT00982657|26637478|FG002|Overall Study|Withdrawal by Subject|1|||
13344879|NCT00982657|26637479|FG003|Overall Study|Withdrawal by Subject|3|||
13344880|NCT00982657|26637476|FG000|Overall Study|Other|0|||
13344881|NCT00982657|26637477|FG001|Overall Study|Other|0|||
13344882|NCT00982657|26637478|FG002|Overall Study|Other|0|||
13344883|NCT00982657|26637479|FG003|Overall Study|Other|4|||
13344884|NCT00982657|26637476|FG000|Overall Study|On going at date of cut-off|0|||
13344885|NCT00982657|26637477|FG001|Overall Study|On going at date of cut-off|0|||
13344886|NCT00982657|26637478|FG002|Overall Study|On going at date of cut-off|0|||
13344887|NCT00982657|26637479|FG003|Overall Study|On going at date of cut-off|1|||
13344888|NCT00982644|26637508|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20|||
13344889|NCT00982644|26637509|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5|||
13344890|NCT00982644|26637508|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7|||
13344891|NCT00982644|26637509|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2|||
13344892|NCT00982644|26637508|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46|||
13344893|NCT00982644|26637509|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18|||
13344894|NCT00982644|26637508|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9|||
13344895|NCT00982644|26637509|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5|||
13344896|NCT00982644|26637508|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84|||
13344897|NCT00982644|26637509|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30|||
13344898|NCT00982644|26637508|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12|||
13344899|NCT00982644|26637509|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5|||
13344900|NCT00982644|26637508|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3|||
13344901|NCT00982644|26637509|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1|||
13344902|NCT00982644|26637508|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2|||
13344903|NCT00982644|26637509|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4|||
13344904|NCT00982644|26637508|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6|||
13344905|NCT00982644|26637509|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3|||
13344906|NCT00982644|26637508|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23|||
13344907|NCT00982644|26637509|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7|||
13344908|NCT00982228|26637540|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12|||
13344909|NCT00982228|26637541|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2|||
13344910|NCT00982228|26637540|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2|||
13344911|NCT00982228|26637541|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0|||
13344912|NCT00982228|26637540|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11|||
13344913|NCT00982228|26637541|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2|||
13344914|NCT00982228|26637540|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15|||
13344915|NCT00982228|26637541|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3|||
13344916|NCT00982228|26637540|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28|||
13344917|NCT00982228|26637541|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13|||
13344918|NCT00982228|26637540|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3|||
13344919|NCT00982228|26637541|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2|||
13344920|NCT00982228|26637540|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1|||
13344921|NCT00982228|26637541|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0|||
13344922|NCT00982228|26637540|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1|||
13344923|NCT00982228|26637541|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2|||
13344924|NCT00982228|26637540|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5|||
13344925|NCT00982228|26637541|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0|||
13344926|NCT00982228|26637540|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11|||
13344927|NCT00982228|26637541|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1|||
13344928|NCT00981409|26637562|FG000|Overall Study|Adverse Event|4|||
13344929|NCT00981409|26637563|FG001|Overall Study|Adverse Event|0|||
13344930|NCT00981409|26637562|FG000|Overall Study|Protocol Violation|0|||
13344931|NCT00981409|26637563|FG001|Overall Study|Protocol Violation|1|||
13344932|NCT00981409|26637562|FG000|Overall Study|Prostate Cancer Treatment before Trial|2|||
13344933|NCT00981409|26637563|FG001|Overall Study|Prostate Cancer Treatment before Trial|0|||
13344934|NCT00981058|26637590|FG000|Overall Study|Adverse Event|1|||
13344935|NCT00981058|26637591|FG001|Overall Study|Adverse Event|1|||
13344936|NCT00981058|26637590|FG000|Overall Study|Progressive Disease|61|||
13344937|NCT00981058|26637591|FG001|Overall Study|Progressive Disease|49|||
13344938|NCT00981058|26637590|FG000|Overall Study|Lost to Follow-up|16|||
13344939|NCT00981058|26637591|FG001|Overall Study|Lost to Follow-up|15|||
13344940|NCT00981058|26637590|FG000|Overall Study|New Anticancer Therapy|6|||
13344941|NCT00981058|26637591|FG001|Overall Study|New Anticancer Therapy|6|||
13344942|NCT00981058|26637590|FG000|Overall Study|Noncompliance|1|||
13344943|NCT00981058|26637591|FG001|Overall Study|Noncompliance|0|||
13344944|NCT00981058|26637590|FG000|Overall Study|Radiologist Error|0|||
13344945|NCT00981058|26637591|FG001|Overall Study|Radiologist Error|1|||
13344946|NCT00981058|26637590|FG000|Overall Study|Randomization Error|1|||
13344947|NCT00981058|26637591|FG001|Overall Study|Randomization Error|2|||
13344948|NCT00981058|26637590|FG000|Overall Study|Withdrawal by Subject|25|||
13344949|NCT00981058|26637591|FG001|Overall Study|Withdrawal by Subject|23|||
13344950|NCT00981058|26637590|FG000|Overall Study|On study treatment at conclusion|9|||
13344951|NCT00981058|26637591|FG001|Overall Study|On study treatment at conclusion|0|||
13344952|NCT00980980|26637630|FG000|Overall Study|Withdrawal by Hospital|0|||
13344953|NCT00980980|26637631|FG001|Overall Study|Withdrawal by Hospital|1|||
13344954|NCT00980980|26637632|FG002|Overall Study|Withdrawal by Hospital|0|||
13344955|NCT00980200|26637655|FG000|7-day Treatment Period 1|Withdrawal by Subject|0|||
13344956|NCT00980200|26637656|FG001|7-day Treatment Period 1|Withdrawal by Subject|1|||
13344957|NCT00980200|26637657|FG002|7-day Treatment Period 1|Withdrawal by Subject|0|||
13344958|NCT00980200|26637658|FG003|7-day Treatment Period 1|Withdrawal by Subject|0|||
13344959|NCT00980200|26637659|FG004|7-day Treatment Period 1|Withdrawal by Subject|0|||
13344960|NCT00980200|26637655|FG000|7-day Treatment Period 3|Lack of Efficacy|0|||
13344961|NCT00980200|26637656|FG001|7-day Treatment Period 3|Lack of Efficacy|1|||
13344962|NCT00980200|26637657|FG002|7-day Treatment Period 3|Lack of Efficacy|0|||
13344963|NCT00980200|26637658|FG003|7-day Treatment Period 3|Lack of Efficacy|0|||
13344964|NCT00980200|26637659|FG004|7-day Treatment Period 3|Lack of Efficacy|1|||
13344965|NCT00979992|26637669|FG000|Overall Study|Ineligible - inadequate pathology|1|||
13344966|NCT00979992|26637669|FG000|Overall Study|Ineligible - wrong cell type|2|||
13344967|NCT00979992|26637669|FG000|Overall Study|Refused - Never Treated|2|||
13344968|NCT00979953|26637692|FG000|Overall Study|Adverse Event|5|||
13344969|NCT00979953|26637693|FG001|Overall Study|Adverse Event|2|||
13344970|NCT00979953|26637694|FG002|Overall Study|Adverse Event|17|||
13344971|NCT00979953|26637695|FG003|Overall Study|Adverse Event|4|||
13344972|NCT00979953|26637692|FG000|Overall Study|Lack of Efficacy|1|||
13344973|NCT00979953|26637693|FG001|Overall Study|Lack of Efficacy|2|||
13344974|NCT00979953|26637694|FG002|Overall Study|Lack of Efficacy|0|||
13344975|NCT00979953|26637695|FG003|Overall Study|Lack of Efficacy|0|||
13344976|NCT00979953|26637692|FG000|Overall Study|Lost to Follow-up|1|||
13344977|NCT00979953|26637693|FG001|Overall Study|Lost to Follow-up|1|||
13344978|NCT00979953|26637694|FG002|Overall Study|Lost to Follow-up|1|||
13344979|NCT00979953|26637695|FG003|Overall Study|Lost to Follow-up|0|||
13344980|NCT00979953|26637692|FG000|Overall Study|Withdrawal by Subject|0|||
13344981|NCT00979953|26637693|FG001|Overall Study|Withdrawal by Subject|0|||
13344982|NCT00979953|26637694|FG002|Overall Study|Withdrawal by Subject|2|||
13344983|NCT00979953|26637695|FG003|Overall Study|Withdrawal by Subject|1|||
13344984|NCT00979953|26637692|FG000|Overall Study|Protocol Violation|1|||
13344985|NCT00979953|26637693|FG001|Overall Study|Protocol Violation|0|||
13344986|NCT00979953|26637694|FG002|Overall Study|Protocol Violation|2|||
13344987|NCT00979953|26637695|FG003|Overall Study|Protocol Violation|2|||
13344988|NCT00979901|26637732|FG000|Overall Study|Adverse Event|1|||
13344989|NCT00979901|26637733|FG001|Overall Study|Adverse Event|3|||
13344990|NCT00979901|26637734|FG002|Overall Study|Adverse Event|9|||
13344991|NCT00979901|26637735|FG003|Overall Study|Adverse Event|2|||
13344992|NCT00979901|26637732|FG000|Overall Study|Lack of Efficacy|8|||
13344993|NCT00979901|26637733|FG001|Overall Study|Lack of Efficacy|4|||
13344994|NCT00979901|26637734|FG002|Overall Study|Lack of Efficacy|9|||
13344995|NCT00979901|26637735|FG003|Overall Study|Lack of Efficacy|0|||
13344996|NCT00979901|26637732|FG000|Overall Study|Lost to Follow-up|1|||
13344997|NCT00979901|26637733|FG001|Overall Study|Lost to Follow-up|1|||
13344998|NCT00979901|26637734|FG002|Overall Study|Lost to Follow-up|2|||
13344999|NCT00979901|26637735|FG003|Overall Study|Lost to Follow-up|0|||
13345000|NCT00979901|26637732|FG000|Overall Study|Protocol Violation|2|||
13345001|NCT00979901|26637733|FG001|Overall Study|Protocol Violation|2|||
13345002|NCT00979901|26637734|FG002|Overall Study|Protocol Violation|7|||
13345003|NCT00979901|26637735|FG003|Overall Study|Protocol Violation|1|||
13345004|NCT00979901|26637732|FG000|Overall Study|Withdrawal by Subject|2|||
13345005|NCT00979901|26637733|FG001|Overall Study|Withdrawal by Subject|1|||
13345006|NCT00979901|26637734|FG002|Overall Study|Withdrawal by Subject|1|||
13345007|NCT00979901|26637735|FG003|Overall Study|Withdrawal by Subject|1|||
13345008|NCT00979901|26637732|FG000|Overall Study|Noncompliance|1|||
13345009|NCT00979901|26637733|FG001|Overall Study|Noncompliance|0|||
13345010|NCT00979901|26637734|FG002|Overall Study|Noncompliance|0|||
13345011|NCT00979901|26637735|FG003|Overall Study|Noncompliance|0|||
13345012|NCT00979901|26637732|FG000|Overall Study|out-of-state|1|||
13345013|NCT00979901|26637733|FG001|Overall Study|out-of-state|0|||
13345014|NCT00979901|26637734|FG002|Overall Study|out-of-state|0|||
13345015|NCT00979901|26637735|FG003|Overall Study|out-of-state|0|||
13345016|NCT00979901|26637732|FG000|Overall Study|vacation|1|||
13345017|NCT00979901|26637733|FG001|Overall Study|vacation|0|||
13345018|NCT00979901|26637734|FG002|Overall Study|vacation|0|||
13345019|NCT00979901|26637735|FG003|Overall Study|vacation|0|||
13345020|NCT00979901|26637732|FG000|Overall Study|elevated lab values pre-randomization|1|||
13345021|NCT00979901|26637733|FG001|Overall Study|elevated lab values pre-randomization|0|||
13345022|NCT00979901|26637734|FG002|Overall Study|elevated lab values pre-randomization|0|||
13345023|NCT00979901|26637735|FG003|Overall Study|elevated lab values pre-randomization|0|||
13345024|NCT00979901|26637732|FG000|Overall Study|Discontinued in Error|0|||
13345025|NCT00979901|26637733|FG001|Overall Study|Discontinued in Error|1|||
13345026|NCT00979901|26637734|FG002|Overall Study|Discontinued in Error|0|||
13345027|NCT00979901|26637735|FG003|Overall Study|Discontinued in Error|0|||
13345028|NCT00979901|26637732|FG000|Overall Study|Left Country|0|||
13345029|NCT00979901|26637733|FG001|Overall Study|Left Country|0|||
13345030|NCT00979901|26637734|FG002|Overall Study|Left Country|1|||
13345031|NCT00979901|26637735|FG003|Overall Study|Left Country|0|||
13345032|NCT00979901|26637732|FG000|Overall Study|Treatment Group Terminated by Sponsor|0|||
13345033|NCT00979901|26637733|FG001|Overall Study|Treatment Group Terminated by Sponsor|0|||
13345034|NCT00979901|26637734|FG002|Overall Study|Treatment Group Terminated by Sponsor|0|||
13345035|NCT00979901|26637735|FG003|Overall Study|Treatment Group Terminated by Sponsor|112|||
13345036|NCT00979654|26637749|FG000|Overall Study|Lost to Follow-up|1|||
13345037|NCT00979654|26637749|FG000|Overall Study|Withdrawal by Subject|22|||
13345038|NCT00979654|26637749|FG000|Overall Study|Death|1|||
13345039|NCT00979654|26637749|FG000|Overall Study|Lack of Efficacy|6|||
13345040|NCT00979654|26637749|FG000|Overall Study|Adverse Event|1|||
13345041|NCT00979654|26637749|FG000|Overall Study|Adverse Event of Diverticulitis|1|||
13345042|NCT00979654|26637749|FG000|Overall Study|Per Principal Investigator's Discretion|1|||
13345043|NCT00979654|26637749|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1|||
13345044|NCT00979654|26637749|FG000|Overall Study|Serious Adverse Event|1|||
13345045|NCT00979654|26637749|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1|||
13345046|NCT00979628|26637770|FG000|Overall Study|received regimen < 24 hours|7|||
13345047|NCT00979628|26637771|FG001|Overall Study|received regimen < 24 hours|6|||
13345048|NCT00979628|26637772|FG002|Overall Study|received regimen < 24 hours|5|||
13345049|NCT00979628|26637770|FG000|Overall Study|received steroids|1|||
13345050|NCT00979628|26637771|FG001|Overall Study|received steroids|1|||
13345051|NCT00979628|26637772|FG002|Overall Study|received steroids|0|||
13345052|NCT00979628|26637770|FG000|Overall Study|transferred to ICU|1|||
13345053|NCT00979628|26637771|FG001|Overall Study|transferred to ICU|2|||
13345054|NCT00979628|26637772|FG002|Overall Study|transferred to ICU|1|||
13345055|NCT00979602|26637947|FG000|Overall Study|Serious Adverse Event|5|||
13345056|NCT00979602|26637948|FG001|Overall Study|Serious Adverse Event|3|||
13345057|NCT00979602|26637947|FG000|Overall Study|Protocol Violation|3|||
13345058|NCT00979602|26637948|FG001|Overall Study|Protocol Violation|0|||
13345059|NCT00979602|26637947|FG000|Overall Study|Withdrawal by Subject|31|||
13345060|NCT00979602|26637948|FG001|Overall Study|Withdrawal by Subject|25|||
13345061|NCT00979602|26637947|FG000|Overall Study|Lost to Follow-up|100|||
13345062|NCT00979602|26637948|FG001|Overall Study|Lost to Follow-up|96|||
13345063|NCT00979602|26637947|FG000|Overall Study|Migrated/moved from study area|3|||
13345064|NCT00979602|26637948|FG001|Overall Study|Migrated/moved from study area|6|||
13345065|NCT00979602|26637947|FG000|Overall Study|Others|3|||
13345066|NCT00979602|26637948|FG001|Overall Study|Others|3|||
13345067|NCT00979576|26637989|FG000|Combination Treatment Phase|Progressive disease|3|||
13345068|NCT00979576|26637990|FG001|Combination Treatment Phase|Progressive disease|1|||
13345069|NCT00979576|26637991|FG002|Combination Treatment Phase|Progressive disease|5|||
13345070|NCT00979576|26637989|FG000|Combination Treatment Phase|Dose limiting toxicity|0|||
13345071|NCT00979576|26637990|FG001|Combination Treatment Phase|Dose limiting toxicity|3|||
13345072|NCT00979576|26637991|FG002|Combination Treatment Phase|Dose limiting toxicity|2|||
13345073|NCT00979576|26637989|FG000|Combination Treatment Phase|Adverse Event|0|||
13345074|NCT00979576|26637990|FG001|Combination Treatment Phase|Adverse Event|2|||
13345075|NCT00979576|26637991|FG002|Combination Treatment Phase|Adverse Event|2|||
13345076|NCT00979576|26637989|FG000|Combination Followed by Monotherapy|Progressive Disease|0|||
13345077|NCT00979576|26637990|FG001|Combination Followed by Monotherapy|Progressive Disease|2|||
13345078|NCT00979576|26637991|FG002|Combination Followed by Monotherapy|Progressive Disease|1|||
13345079|NCT00979420|26638072|FG000|Overall Study|Adverse Event|1|||
13345080|NCT00979420|26638073|FG001|Overall Study|Adverse Event|0|||
13345081|NCT00979420|26638074|FG002|Overall Study|Adverse Event|0|||
13345082|NCT00979420|26638075|FG003|Overall Study|Adverse Event|0|||
13345083|NCT00979420|26638072|FG000|Overall Study|Lack of Efficacy|3|||
13345084|NCT00979420|26638073|FG001|Overall Study|Lack of Efficacy|0|||
13345085|NCT00979420|26638074|FG002|Overall Study|Lack of Efficacy|1|||
13345086|NCT00979420|26638075|FG003|Overall Study|Lack of Efficacy|1|||
13345087|NCT00979420|26638072|FG000|Overall Study|Other reasons not related to Viramune|3|||
13345088|NCT00979420|26638073|FG001|Overall Study|Other reasons not related to Viramune|0|||
13345089|NCT00979420|26638074|FG002|Overall Study|Other reasons not related to Viramune|0|||
13374033|NCT00798161|26725699|FG004|Overall Study|Protocol Violation|3|||
13204375|NCT01973595|26228428|FG000|Washout|Withdrawal by Subject|1|||
13345090|NCT00979420|26638075|FG003|Overall Study|Other reasons not related to Viramune|1|||
13345091|NCT00979407|26638122|FG000|Overall Study|Withdrawal by Subject|3|||
13345092|NCT00979407|26638123|FG001|Overall Study|Withdrawal by Subject|4|||
13345093|NCT00979407|26638122|FG000|Overall Study|Lost to Follow-up|3|||
13345094|NCT00979407|26638123|FG001|Overall Study|Lost to Follow-up|3|||
13374034|NCT00798161|26725700|FG005|Overall Study|Protocol Violation|2|||
13374035|NCT00798161|26725701|FG006|Overall Study|Protocol Violation|0|||
13374036|NCT00798161|26725695|FG000|Overall Study|Lost to Follow-up|1|||
13374037|NCT00798161|26725696|FG001|Overall Study|Lost to Follow-up|3|||
13374038|NCT00798161|26725697|FG002|Overall Study|Lost to Follow-up|4|||
13374039|NCT00798161|26725698|FG003|Overall Study|Lost to Follow-up|3|||
13374040|NCT00798161|26725699|FG004|Overall Study|Lost to Follow-up|4|||
13374041|NCT00798161|26725700|FG005|Overall Study|Lost to Follow-up|0|||
13374042|NCT00798161|26725701|FG006|Overall Study|Lost to Follow-up|0|||
13374043|NCT00798161|26725695|FG000|Overall Study|Withdrawal by Subject|5|||
13374044|NCT00798161|26725696|FG001|Overall Study|Withdrawal by Subject|4|||
13374045|NCT00798161|26725697|FG002|Overall Study|Withdrawal by Subject|5|||
13374046|NCT00798161|26725698|FG003|Overall Study|Withdrawal by Subject|4|||
13374047|NCT00798161|26725699|FG004|Overall Study|Withdrawal by Subject|2|||
13374048|NCT00798161|26725700|FG005|Overall Study|Withdrawal by Subject|3|||
13374049|NCT00798161|26725701|FG006|Overall Study|Withdrawal by Subject|1|||
13374050|NCT00798161|26725695|FG000|Overall Study|Other reason (incl. lack of efficacy)|7|||
13374051|NCT00798161|26725696|FG001|Overall Study|Other reason (incl. lack of efficacy)|5|||
13374052|NCT00798161|26725697|FG002|Overall Study|Other reason (incl. lack of efficacy)|3|||
13374053|NCT00798161|26725698|FG003|Overall Study|Other reason (incl. lack of efficacy)|5|||
13374054|NCT00798161|26725699|FG004|Overall Study|Other reason (incl. lack of efficacy)|2|||
13374055|NCT00798161|26725700|FG005|Overall Study|Other reason (incl. lack of efficacy)|4|||
13374056|NCT00798161|26725701|FG006|Overall Study|Other reason (incl. lack of efficacy)|5|||
13374057|NCT00798135|26725709|FG000|Overall Study|Disease progression, relapse|11|||
13374058|NCT00798135|26725709|FG000|Overall Study|Disease progression, refractory|1|||
13374059|NCT00798135|26725709|FG000|Overall Study|Physician Decision|1|||
13374060|NCT00798096|26725718|FG000|Overall Study|Ongoing|2|||
13374061|NCT00797966|26725795|FG000|Phase A|Lost to Follow-up|0|||
13374062|NCT00797966|26725796|FG001|Phase A|Lost to Follow-up|0|||
13374063|NCT00797966|26725797|FG002|Phase A|Lost to Follow-up|0|||
13374064|NCT00797966|26725798|FG003|Phase A|Lost to Follow-up|0|||
13374065|NCT00797966|26725799|FG004|Phase A|Lost to Follow-up|33|||
13374066|NCT00797966|26725800|FG005|Phase A|Lost to Follow-up|0|||
13374067|NCT00797966|26725795|FG000|Phase A|Adverse Event|0|||
13374068|NCT00797966|26725796|FG001|Phase A|Adverse Event|0|||
13374069|NCT00797966|26725797|FG002|Phase A|Adverse Event|0|||
13374070|NCT00797966|26725798|FG003|Phase A|Adverse Event|0|||
13374071|NCT00797966|26725799|FG004|Phase A|Adverse Event|46|||
13374072|NCT00797966|26725800|FG005|Phase A|Adverse Event|0|||
13374073|NCT00797966|26725795|FG000|Phase A|Met withdrawal criteria|0|||
13374074|NCT00797966|26725796|FG001|Phase A|Met withdrawal criteria|0|||
13374075|NCT00797966|26725797|FG002|Phase A|Met withdrawal criteria|0|||
13374076|NCT00797966|26725798|FG003|Phase A|Met withdrawal criteria|0|||
13374077|NCT00797966|26725799|FG004|Phase A|Met withdrawal criteria|4|||
13374078|NCT00797966|26725800|FG005|Phase A|Met withdrawal criteria|0|||
13374079|NCT00797966|26725795|FG000|Phase A|Physician Decision|0|||
13374080|NCT00797966|26725796|FG001|Phase A|Physician Decision|0|||
13374081|NCT00797966|26725797|FG002|Phase A|Physician Decision|0|||
13374082|NCT00797966|26725798|FG003|Phase A|Physician Decision|0|||
13374083|NCT00797966|26725799|FG004|Phase A|Physician Decision|13|||
13374084|NCT00797966|26725800|FG005|Phase A|Physician Decision|0|||
13374085|NCT00797966|26725795|FG000|Phase A|Withdrawal by Subject|0|||
13374086|NCT00797966|26725796|FG001|Phase A|Withdrawal by Subject|0|||
13374087|NCT00797966|26725797|FG002|Phase A|Withdrawal by Subject|0|||
13374088|NCT00797966|26725798|FG003|Phase A|Withdrawal by Subject|0|||
13374089|NCT00797966|26725799|FG004|Phase A|Withdrawal by Subject|33|||
13374090|NCT00797966|26725800|FG005|Phase A|Withdrawal by Subject|0|||
13374091|NCT00797966|26725795|FG000|Phase A|Protocol deviation|0|||
13374092|NCT00797966|26725796|FG001|Phase A|Protocol deviation|0|||
13374093|NCT00797966|26725797|FG002|Phase A|Protocol deviation|0|||
13374094|NCT00797966|26725798|FG003|Phase A|Protocol deviation|0|||
13374095|NCT00797966|26725799|FG004|Phase A|Protocol deviation|56|||
13374096|NCT00797966|26725800|FG005|Phase A|Protocol deviation|0|||
13374097|NCT00797966|26725795|FG000|Phase B|Lost to Follow-up|0|||
13374098|NCT00797966|26725796|FG001|Phase B|Lost to Follow-up|1|||
13374099|NCT00797966|26725797|FG002|Phase B|Lost to Follow-up|3|||
13374100|NCT00797966|26725798|FG003|Phase B|Lost to Follow-up|0|||
13374101|NCT00797966|26725799|FG004|Phase B|Lost to Follow-up|0|||
13374102|NCT00797966|26725800|FG005|Phase B|Lost to Follow-up|0|||
13374103|NCT00797966|26725795|FG000|Phase B|Adverse Event|2|||
13204376|NCT01973595|26228429|FG001|Washout|Withdrawal by Subject|0|||
13374104|NCT00797966|26725796|FG001|Phase B|Adverse Event|1|||
13374105|NCT00797966|26725797|FG002|Phase B|Adverse Event|3|||
13374106|NCT00797966|26725798|FG003|Phase B|Adverse Event|1|||
13374107|NCT00797966|26725799|FG004|Phase B|Adverse Event|0|||
13345095|NCT00979134|26638185|FG000|Overall Study|Disease progression|18|||
13345096|NCT00979134|26638186|FG001|Overall Study|Disease progression|2|||
13345097|NCT00979134|26638187|FG002|Overall Study|Disease progression|5|||
13345098|NCT00979134|26638185|FG000|Overall Study|Adverse Event|0|||
13345099|NCT00979134|26638186|FG001|Overall Study|Adverse Event|0|||
13124789|NCT02938585|25954220|FG000|Overall Study|Withdrawal by parent or guardian|0|||
13345100|NCT00979134|26638187|FG002|Overall Study|Adverse Event|2|||
13345101|NCT00979134|26638185|FG000|Overall Study|Withdrawal by Subject|1|||
13345102|NCT00979134|26638186|FG001|Overall Study|Withdrawal by Subject|1|||
13345103|NCT00979134|26638187|FG002|Overall Study|Withdrawal by Subject|2|||
13345104|NCT00979134|26638185|FG000|Overall Study|Lost to Follow-up|2|||
13345105|NCT00979134|26638186|FG001|Overall Study|Lost to Follow-up|2|||
13345106|NCT00979134|26638187|FG002|Overall Study|Lost to Follow-up|0|||
13345107|NCT00979134|26638185|FG000|Overall Study|Death|4|||
13345108|NCT00979134|26638186|FG001|Overall Study|Death|0|||
13345109|NCT00979134|26638187|FG002|Overall Study|Death|26|||
13345110|NCT00979134|26638185|FG000|Overall Study|Other|8|||
13345111|NCT00979134|26638186|FG001|Overall Study|Other|1|||
13345112|NCT00979134|26638187|FG002|Overall Study|Other|5|||
13124790|NCT02938585|25954221|FG001|Overall Study|Withdrawal by parent or guardian|1|||
13124791|NCT02938585|25954222|FG002|Overall Study|Withdrawal by parent or guardian|0|||
13124792|NCT02938585|25954223|FG003|Overall Study|Withdrawal by parent or guardian|0|||
13124793|NCT02938585|25954220|FG000|Overall Study|Withdrawal by Subject|0|||
13124794|NCT02938585|25954221|FG001|Overall Study|Withdrawal by Subject|0|||
13124795|NCT02938585|25954222|FG002|Overall Study|Withdrawal by Subject|0|||
13124796|NCT02938585|25954223|FG003|Overall Study|Withdrawal by Subject|5|||
13124797|NCT02937870|25954241|FG000|Overall Study|Adverse Event|1|||
13124798|NCT02937870|25954241|FG000|Overall Study|Protocol Deviation|2|||
13124799|NCT02937740|25954262|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3|||
13124800|NCT02937740|25954263|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14|||
13124801|NCT02937740|25954262|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0|||
13124802|NCT02937740|25954263|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10|||
13345113|NCT00978757|26638200|FG000|Overall Study|Physician Decision|1|||
13345114|NCT00978757|26638201|FG001|Overall Study|Physician Decision|3|||
13345115|NCT00978731|26638252|FG000|Overall Study|Death|4|||
13345116|NCT00978731|26638253|FG001|Overall Study|Death|1|||
13345117|NCT00978731|26638254|FG002|Overall Study|Death|1|||
13345118|NCT00978731|26638255|FG003|Overall Study|Death|0|||
13345119|NCT00978731|26638252|FG000|Overall Study|Lost to Follow-up|0|||
13345120|NCT00978731|26638253|FG001|Overall Study|Lost to Follow-up|0|||
13345121|NCT00978731|26638254|FG002|Overall Study|Lost to Follow-up|0|||
13345122|NCT00978731|26638255|FG003|Overall Study|Lost to Follow-up|1|||
13345123|NCT00978731|26638252|FG000|Overall Study|Adverse Event|5|||
13345124|NCT00978731|26638253|FG001|Overall Study|Adverse Event|2|||
13345125|NCT00978731|26638254|FG002|Overall Study|Adverse Event|0|||
13345126|NCT00978731|26638255|FG003|Overall Study|Adverse Event|0|||
13345127|NCT00978731|26638252|FG000|Overall Study|Participant's request|1|||
13345128|NCT00978731|26638253|FG001|Overall Study|Participant's request|0|||
13345129|NCT00978731|26638254|FG002|Overall Study|Participant's request|0|||
13345130|NCT00978731|26638255|FG003|Overall Study|Participant's request|0|||
13345131|NCT00978731|26638252|FG000|Overall Study|Administrative reason|3|||
13345132|NCT00978731|26638253|FG001|Overall Study|Administrative reason|3|||
13345133|NCT00978731|26638254|FG002|Overall Study|Administrative reason|1|||
13345134|NCT00978731|26638255|FG003|Overall Study|Administrative reason|0|||
13345135|NCT00978731|26638252|FG000|Overall Study|Deterioration without progression|0|||
13345136|NCT00978731|26638253|FG001|Overall Study|Deterioration without progression|1|||
13345137|NCT00978731|26638254|FG002|Overall Study|Deterioration without progression|0|||
13345138|NCT00978731|26638255|FG003|Overall Study|Deterioration without progression|0|||
13345139|NCT00978731|26638252|FG000|Overall Study|Disease progression/relapse|5|||
13345140|NCT00978731|26638253|FG001|Overall Study|Disease progression/relapse|4|||
13345141|NCT00978731|26638254|FG002|Overall Study|Disease progression/relapse|2|||
13345142|NCT00978731|26638255|FG003|Overall Study|Disease progression/relapse|2|||
13345143|NCT00978731|26638252|FG000|Overall Study|Study closure|3|||
13345144|NCT00978731|26638253|FG001|Overall Study|Study closure|4|||
13345145|NCT00978731|26638254|FG002|Overall Study|Study closure|1|||
13345146|NCT00978731|26638255|FG003|Overall Study|Study closure|1|||
13345147|NCT00978731|26638252|FG000|Overall Study|No response|1|||
13345148|NCT00978731|26638253|FG001|Overall Study|No response|0|||
13345149|NCT00978731|26638254|FG002|Overall Study|No response|0|||
13345150|NCT00978731|26638255|FG003|Overall Study|No response|0|||
13345151|NCT00978627|26638284|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4|||
13345152|NCT00978627|26638285|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3|||
13345153|NCT00978627|26638284|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2|||
13345154|NCT00978627|26638285|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0|||
13124803|NCT02937740|25954262|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2|||
13124804|NCT02937740|25954263|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7|||
13345155|NCT00978627|26638284|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8|||
13345156|NCT00978627|26638285|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6|||
13345157|NCT00978627|26638284|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7|||
13345158|NCT00978627|26638285|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5|||
13345159|NCT00978627|26638284|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25|||
13345160|NCT00978627|26638285|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12|||
13345161|NCT00978627|26638284|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3|||
13345162|NCT00978627|26638285|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0|||
13345163|NCT00978627|26638284|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4|||
13345164|NCT00978627|26638285|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1|||
13345165|NCT00978627|26638284|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2|||
13345166|NCT00978627|26638285|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1|||
13345167|NCT00978627|26638284|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12|||
13345168|NCT00978627|26638285|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7|||
13345169|NCT00978562|26638297|FG000|Overall Study|Withdrawal by participant before receiving study drug/imaging|2|||
13345170|NCT00978432|26638327|FG000|Overall Study|Withdrawal by Subject|0|||
13345171|NCT00978432|26638328|FG001|Overall Study|Withdrawal by Subject|0|||
13345172|NCT00978432|26638329|FG002|Overall Study|Withdrawal by Subject|1|||
13345173|NCT00978432|26638327|FG000|Overall Study|Lack of Efficacy|1|||
13124805|NCT02937740|25954262|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1|||
13124806|NCT02937740|25954263|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0|||
13124807|NCT02937740|25954262|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0|||
13124808|NCT02937740|25954263|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1|||
13124809|NCT02937740|25954262|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0|||
13124810|NCT02937740|25954263|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1|||
13124811|NCT02937701|25954302|FG000|Day 1 to Week 22|Adverse Event|11|||
13124812|NCT02937701|25954303|FG001|Day 1 to Week 22|Adverse Event|14|||
13124813|NCT02937701|25954304|FG002|Day 1 to Week 22|Adverse Event|0|||
13124814|NCT02937701|25954305|FG003|Day 1 to Week 22|Adverse Event|0|||
13124815|NCT02937701|25954306|FG004|Day 1 to Week 22|Adverse Event|0|||
13124816|NCT02937701|25954302|FG000|Day 1 to Week 22|Protocol Specified Criteria|7|||
13124817|NCT02937701|25954303|FG001|Day 1 to Week 22|Protocol Specified Criteria|7|||
13124818|NCT02937701|25954304|FG002|Day 1 to Week 22|Protocol Specified Criteria|0|||
13204377|NCT01973595|26228430|FG002|Washout|Withdrawal by Subject|1|||
13204378|NCT01973595|26228431|FG003|Washout|Withdrawal by Subject|0|||
13204379|NCT01973569|26228467|FG000|Overall Study|Adverse Event|9|||
13345174|NCT00978432|26638328|FG001|Overall Study|Lack of Efficacy|1|||
13204380|NCT01973569|26228468|FG001|Overall Study|Adverse Event|2|||
13204381|NCT01973569|26228469|FG002|Overall Study|Adverse Event|4|||
13204382|NCT01973569|26228467|FG000|Overall Study|Protocol Violation|2|||
13204383|NCT01973569|26228468|FG001|Overall Study|Protocol Violation|1|||
13204384|NCT01973569|26228469|FG002|Overall Study|Protocol Violation|3|||
13204385|NCT01973569|26228467|FG000|Overall Study|Withdrawal by Subject|7|||
13204386|NCT01973569|26228468|FG001|Overall Study|Withdrawal by Subject|5|||
13204387|NCT01973569|26228469|FG002|Overall Study|Withdrawal by Subject|2|||
13204388|NCT01973569|26228467|FG000|Overall Study|Invasive dental treatment|3|||
13204389|NCT01973569|26228468|FG001|Overall Study|Invasive dental treatment|5|||
13204390|NCT01973569|26228469|FG002|Overall Study|Invasive dental treatment|6|||
13204391|NCT01973569|26228467|FG000|Overall Study|Prohibited concomitant d|1|||
13345175|NCT00978432|26638329|FG002|Overall Study|Lack of Efficacy|3|||
13345176|NCT00978432|26638327|FG000|Overall Study|Adverse Event|2|||
13345177|NCT00978432|26638328|FG001|Overall Study|Adverse Event|0|||
13345178|NCT00978432|26638329|FG002|Overall Study|Adverse Event|1|||
13345179|NCT00978380|26638337|FG000|Overall Study|Protocol Violation|2|||
13345180|NCT00978380|26638337|FG000|Overall Study|Withdrawal criteria|9|||
13345181|NCT00978380|26638337|FG000|Overall Study|Unclassified|8|||
13345182|NCT00978341|26638358|FG000|Washout Period of 2 Weeks|Adverse Event|1|||
13345183|NCT00978341|26638359|FG001|Washout Period of 2 Weeks|Adverse Event|0|||
13345184|NCT00978250|26638384|FG000|Overall Study|Late determination of ineligibility|0|||
13345185|NCT00978250|26638385|FG001|Overall Study|Late determination of ineligibility|1|||
13345186|NCT00978250|26638386|FG002|Overall Study|Late determination of ineligibility|0|||
13345187|NCT00978250|26638387|FG003|Overall Study|Late determination of ineligibility|1|||
13345188|NCT00978120|26638450|FG000|Overall Study|Death|0|||
13345189|NCT00978120|26638451|FG001|Overall Study|Death|0|||
13345190|NCT00978120|26638452|FG002|Overall Study|Death|0|||
13345191|NCT00978120|26638453|FG003|Overall Study|Death|1|||
13345192|NCT00978120|26638450|FG000|Overall Study|Lost to Follow-up|0|||
13345193|NCT00978120|26638451|FG001|Overall Study|Lost to Follow-up|0|||
13345194|NCT00978120|26638452|FG002|Overall Study|Lost to Follow-up|3|||
13345195|NCT00978120|26638453|FG003|Overall Study|Lost to Follow-up|0|||
13345196|NCT00978120|26638450|FG000|Overall Study|Withdrawal by Subject|2|||
13345197|NCT00978120|26638451|FG001|Overall Study|Withdrawal by Subject|0|||
13345198|NCT00978120|26638452|FG002|Overall Study|Withdrawal by Subject|0|||
13345199|NCT00978120|26638453|FG003|Overall Study|Withdrawal by Subject|0|||
13345200|NCT00978120|26638450|FG000|Overall Study|Moved out of state|0|||
13204392|NCT01973569|26228468|FG001|Overall Study|Prohibited concomitant d|5|||
13345201|NCT00978120|26638451|FG001|Overall Study|Moved out of state|0|||
13345202|NCT00978120|26638452|FG002|Overall Study|Moved out of state|0|||
13345203|NCT00978120|26638453|FG003|Overall Study|Moved out of state|1|||
13345204|NCT00978068|26638476|FG000|Overall Study|Were Awaiting Initiation of ART|2|||
13345205|NCT00978068|26638477|FG001|Overall Study|Were Awaiting Initiation of ART|2|||
13345206|NCT00978068|26638476|FG000|Overall Study|Death|1|||
13345207|NCT00978068|26638477|FG001|Overall Study|Death|2|||
13345208|NCT00978068|26638476|FG000|Overall Study|Lost to Follow-up|1|||
13345209|NCT00978068|26638477|FG001|Overall Study|Lost to Follow-up|2|||
13345210|NCT00978068|26638476|FG000|Overall Study|Physician Decision|0|||
13345211|NCT00978068|26638477|FG001|Overall Study|Physician Decision|1|||
13345212|NCT00978068|26638476|FG000|Overall Study|Unable to Comply with Study|0|||
13345213|NCT00978068|26638477|FG001|Overall Study|Unable to Comply with Study|2|||
13345214|NCT00978042|26638494|FG000|Initial Treatment Period|Treated in Error|0|||
13345215|NCT00978042|26638495|FG001|Initial Treatment Period|Treated in Error|3|||
13345216|NCT00978042|26638494|FG000|Initial Treatment Period|Ineligibility|1|||
13345217|NCT00978042|26638495|FG001|Initial Treatment Period|Ineligibility|0|||
13345218|NCT00978042|26638494|FG000|Initial Treatment Period|Lost to Follow-up|21|||
13345219|NCT00978042|26638495|FG001|Initial Treatment Period|Lost to Follow-up|3|||
13345220|NCT00978042|26638494|FG000|Initial Treatment Period|Adverse Event|2|||
13345221|NCT00978042|26638495|FG001|Initial Treatment Period|Adverse Event|0|||
13345222|NCT00978042|26638494|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2|||
13345223|NCT00978042|26638495|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0|||
13345224|NCT00978042|26638494|FG000|Initial Treatment Period|Consent withdrawn|22|||
13345225|NCT00978042|26638495|FG001|Initial Treatment Period|Consent withdrawn|9|||
13345226|NCT00978042|26638494|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13|||
13345227|NCT00978042|26638495|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0|||
13345228|NCT00978029|26638528|FG000|Overall Study|Adverse Event|1|||
13345229|NCT00978029|26638529|FG001|Overall Study|Adverse Event|2|||
13345230|NCT00978029|26638530|FG002|Overall Study|Adverse Event|5|||
13345231|NCT00978029|26638528|FG000|Overall Study|Withdrawal by Subject|0|||
13345232|NCT00978029|26638529|FG001|Overall Study|Withdrawal by Subject|0|||
13345233|NCT00978029|26638530|FG002|Overall Study|Withdrawal by Subject|1|||
13345234|NCT00978029|26638528|FG000|Overall Study|Protocol Violation|0|||
13345235|NCT00978029|26638529|FG001|Overall Study|Protocol Violation|1|||
13124819|NCT02937701|25954305|FG003|Day 1 to Week 22|Protocol Specified Criteria|0|||
13345236|NCT00978029|26638530|FG002|Overall Study|Protocol Violation|0|||
13345237|NCT00977938|26638577|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132|||
13345238|NCT00977938|26638578|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116|||
13345239|NCT00977938|26638579|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13|||
13345240|NCT00977938|26638580|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20|||
13345241|NCT00977938|26638577|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88|||
13345242|NCT00977938|26638578|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91|||
13345243|NCT00977938|26638579|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30|||
13345244|NCT00977938|26638580|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37|||
13345245|NCT00977938|26638577|FG000|Treatment (12-30 mo. Post Procedure)|Other|17|||
13345246|NCT00977938|26638578|FG001|Treatment (12-30 mo. Post Procedure)|Other|18|||
13345247|NCT00977938|26638579|FG002|Treatment (12-30 mo. Post Procedure)|Other|3|||
13345248|NCT00977938|26638580|FG003|Treatment (12-30 mo. Post Procedure)|Other|4|||
13345249|NCT00977938|26638577|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9|||
13345250|NCT00977938|26638578|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12|||
13345251|NCT00977938|26638579|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2|||
13345252|NCT00977938|26638580|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0|||
13345253|NCT00977938|26638577|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34|||
13345254|NCT00977938|26638578|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42|||
13345255|NCT00977938|26638579|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10|||
13345256|NCT00977938|26638580|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3|||
13345257|NCT00977938|26638577|FG000|Observation (30-33 mo. Post Procedure)|Other|8|||
13345258|NCT00977938|26638578|FG001|Observation (30-33 mo. Post Procedure)|Other|4|||
13345259|NCT00977938|26638579|FG002|Observation (30-33 mo. Post Procedure)|Other|0|||
13345260|NCT00977938|26638580|FG003|Observation (30-33 mo. Post Procedure)|Other|0|||
13345261|NCT00977665|26638619|FG000|Overall Study|Withdrawal by Subject|1|||
13345262|NCT00977665|26638620|FG001|Overall Study|Withdrawal by Subject|3|||
13345263|NCT00977665|26638619|FG000|Overall Study|Physician Decision|2|||
13345264|NCT00977665|26638620|FG001|Overall Study|Physician Decision|1|||
13345265|NCT00977665|26638619|FG000|Overall Study|Sponsor requested withdrawal|0|||
13345266|NCT00977665|26638620|FG001|Overall Study|Sponsor requested withdrawal|1|||
13345267|NCT00977665|26638619|FG000|Overall Study|Lost to Follow-up|1|||
13345268|NCT00977665|26638620|FG001|Overall Study|Lost to Follow-up|0|||
13345269|NCT00977665|26638619|FG000|Overall Study|Death|3|||
13345270|NCT00977665|26638620|FG001|Overall Study|Death|2|||
13345271|NCT00977665|26638619|FG000|Overall Study|Adverse Event|14|||
13345272|NCT00977665|26638620|FG001|Overall Study|Adverse Event|7|||
13345273|NCT00977665|26638619|FG000|Overall Study|Treatment failure|0|||
13345274|NCT00977665|26638620|FG001|Overall Study|Treatment failure|1|||
13345275|NCT00977613|26638626|FG000|Overall Study|Lost to Follow-up|16|||
13345276|NCT00977574|26638653|FG000|Overall Study|Never Treated|4|||
13345277|NCT00977574|26638654|FG001|Overall Study|Never Treated|2|||
13345278|NCT00977574|26638655|FG002|Overall Study|Never Treated|4|||
13345279|NCT00977561|26638689|FG000|Overall Study|Death|3|||
13345280|NCT00977561|26638690|FG001|Overall Study|Death|2|||
13345281|NCT00977561|26638689|FG000|Overall Study|Study terminated|0|||
13345282|NCT00977561|26638690|FG001|Overall Study|Study terminated|2|||
13345283|NCT00977561|26638689|FG000|Overall Study|Other|2|||
13345284|NCT00977561|26638690|FG001|Overall Study|Other|0|||
13345285|NCT00977548|26638699|FG000|Overall Study|Ineligible|4|||
13345286|NCT00977548|26638699|FG000|Overall Study|Adverse Event|8|||
13345287|NCT00977548|26638699|FG000|Overall Study|Withdrawal by Subject|1|||
13345288|NCT00977470|26638724|FG000|Overall Study|Lack of Efficacy|32|||
13345289|NCT00977470|26638725|FG001|Overall Study|Lack of Efficacy|30|||
13345290|NCT00977470|26638724|FG000|Overall Study|Physician Decision|2|||
13345291|NCT00977470|26638725|FG001|Overall Study|Physician Decision|0|||
13345292|NCT00977470|26638724|FG000|Overall Study|Adverse Event|1|||
13345293|NCT00977470|26638725|FG001|Overall Study|Adverse Event|2|||
13345294|NCT00977470|26638724|FG000|Overall Study|Protocol Violation|1|||
13345295|NCT00977470|26638725|FG001|Overall Study|Protocol Violation|0|||
13345296|NCT00977470|26638724|FG000|Overall Study|Withdrawal by Subject|0|||
13345297|NCT00977470|26638725|FG001|Overall Study|Withdrawal by Subject|2|||
13345298|NCT00977470|26638724|FG000|Overall Study|Death|0|||
13345299|NCT00977470|26638725|FG001|Overall Study|Death|2|||
13345300|NCT00977470|26638724|FG000|Overall Study|clinical decline|0|||
13345301|NCT00977470|26638725|FG001|Overall Study|clinical decline|1|||
13345302|NCT00977470|26638724|FG000|Overall Study|prolonged recovery post-surgery|0|||
13345303|NCT00977470|26638725|FG001|Overall Study|prolonged recovery post-surgery|1|||
13345304|NCT00977470|26638724|FG000|Overall Study|Still on-study|2|||
13345305|NCT00977470|26638725|FG001|Overall Study|Still on-study|0|||
13345306|NCT00977431|26638772|FG000|Overall Study|Other than listed|1|||
13345307|NCT00977431|26638773|FG001|Overall Study|Other than listed|0|||
13345308|NCT00977431|26638774|FG002|Overall Study|Other than listed|0|||
13345309|NCT00977431|26638775|FG003|Overall Study|Other than listed|0|||
13345310|NCT00977431|26638776|FG004|Overall Study|Other than listed|2|||
13345311|NCT00977431|26638772|FG000|Overall Study|Protocol Violation|0|||
13345312|NCT00977431|26638773|FG001|Overall Study|Protocol Violation|0|||
13345313|NCT00977431|26638774|FG002|Overall Study|Protocol Violation|1|||
13345314|NCT00977431|26638775|FG003|Overall Study|Protocol Violation|0|||
13345315|NCT00977431|26638776|FG004|Overall Study|Protocol Violation|0|||
13345316|NCT00977431|26638772|FG000|Overall Study|Adverse Event|3|||
13345317|NCT00977431|26638773|FG001|Overall Study|Adverse Event|0|||
13345318|NCT00977431|26638774|FG002|Overall Study|Adverse Event|4|||
13345319|NCT00977431|26638775|FG003|Overall Study|Adverse Event|0|||
13345320|NCT00977431|26638776|FG004|Overall Study|Adverse Event|6|||
13345321|NCT00977431|26638772|FG000|Overall Study|Dose-limiting toxicity (DLT)|1|||
13345322|NCT00977431|26638773|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
13345323|NCT00977431|26638774|FG002|Overall Study|Dose-limiting toxicity (DLT)|1|||
13345324|NCT00977431|26638775|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
13345325|NCT00977431|26638776|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
13345326|NCT00977431|26638772|FG000|Overall Study|Progressive disease|2|||
13345327|NCT00977431|26638773|FG001|Overall Study|Progressive disease|6|||
13345328|NCT00977431|26638774|FG002|Overall Study|Progressive disease|1|||
13345329|NCT00977431|26638775|FG003|Overall Study|Progressive disease|3|||
13345330|NCT00977431|26638776|FG004|Overall Study|Progressive disease|5|||
13345331|NCT00977379|26638817|FG000|Overall Study|Withdrawal by Subject|1|||
13345332|NCT00977379|26638818|FG001|Overall Study|Withdrawal by Subject|1|||
13345333|NCT00977379|26638817|FG000|Overall Study|Death|7|||
13345334|NCT00977379|26638818|FG001|Overall Study|Death|9|||
13345335|NCT00977379|26638817|FG000|Overall Study|Premature Study Termination|4|||
13345336|NCT00977379|26638818|FG001|Overall Study|Premature Study Termination|0|||
13345337|NCT00977379|26638817|FG000|Overall Study|Participant Moving House|0|||
13345338|NCT00977379|26638818|FG001|Overall Study|Participant Moving House|1|||
13345339|NCT00977379|26638817|FG000|Overall Study|Randomization Error|0|||
13345340|NCT00977379|26638818|FG001|Overall Study|Randomization Error|1|||
13345341|NCT00977314|26638831|FG000|Overall Study|Withdrawal by Subject|1|||
13345342|NCT00977314|26638832|FG001|Overall Study|Withdrawal by Subject|0|||
13345343|NCT00977314|26638831|FG000|Overall Study|Physician Decision|1|||
13345344|NCT00977314|26638832|FG001|Overall Study|Physician Decision|0|||
13345345|NCT00977197|26638867|FG000|Overall Study|Withdrawal by Subject|3|||
13345346|NCT00977197|26638868|FG001|Overall Study|Withdrawal by Subject|4|||
13345347|NCT00977197|26638867|FG000|Overall Study|Adverse Event|3|||
13345348|NCT00977197|26638868|FG001|Overall Study|Adverse Event|1|||
13345349|NCT00977197|26638867|FG000|Overall Study|Lack of Efficacy|1|||
13345350|NCT00977197|26638868|FG001|Overall Study|Lack of Efficacy|0|||
13345351|NCT00977197|26638867|FG000|Overall Study|Lost to Follow-up|1|||
13345352|NCT00977197|26638868|FG001|Overall Study|Lost to Follow-up|3|||
13345353|NCT00977197|26638867|FG000|Overall Study|Nonadherence|1|||
13345354|NCT00977197|26638868|FG001|Overall Study|Nonadherence|1|||
13345355|NCT00977106|26638963|FG000|Overall Study|Adverse Event|5|||
13345356|NCT00977106|26638964|FG001|Overall Study|Adverse Event|6|||
13345357|NCT00977106|26638963|FG000|Overall Study|Withdrawal by Subject|2|||
13345358|NCT00977106|26638964|FG001|Overall Study|Withdrawal by Subject|2|||
13345359|NCT00977106|26638963|FG000|Overall Study|Lack of Efficacy|2|||
13345360|NCT00977106|26638964|FG001|Overall Study|Lack of Efficacy|2|||
13345361|NCT00977106|26638963|FG000|Overall Study|Protocol Violation|0|||
13345362|NCT00977106|26638964|FG001|Overall Study|Protocol Violation|1|||
13345363|NCT00977106|26638963|FG000|Overall Study|Other|1|||
13345364|NCT00977106|26638964|FG001|Overall Study|Other|0|||
13345365|NCT00977080|26639007|FG000|Overall Study|Adverse Event|2|||
13345366|NCT00977080|26639008|FG001|Overall Study|Adverse Event|7|||
13345367|NCT00977080|26639009|FG002|Overall Study|Adverse Event|7|||
13345368|NCT00977080|26639010|FG003|Overall Study|Adverse Event|7|||
13345369|NCT00977080|26639007|FG000|Overall Study|Withdrawal by Subject|1|||
13345370|NCT00977080|26639008|FG001|Overall Study|Withdrawal by Subject|5|||
13345371|NCT00977080|26639009|FG002|Overall Study|Withdrawal by Subject|1|||
13345372|NCT00977080|26639010|FG003|Overall Study|Withdrawal by Subject|5|||
13345373|NCT00977080|26639007|FG000|Overall Study|Protocol Violation|7|||
13345374|NCT00977080|26639008|FG001|Overall Study|Protocol Violation|3|||
13345375|NCT00977080|26639009|FG002|Overall Study|Protocol Violation|4|||
13345376|NCT00977080|26639010|FG003|Overall Study|Protocol Violation|3|||
13345377|NCT00977080|26639007|FG000|Overall Study|Noncompliance|0|||
13345378|NCT00977080|26639008|FG001|Overall Study|Noncompliance|2|||
13345379|NCT00977080|26639009|FG002|Overall Study|Noncompliance|1|||
13345380|NCT00977080|26639010|FG003|Overall Study|Noncompliance|0|||
13345381|NCT00977080|26639007|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
13345382|NCT00977080|26639008|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
13345383|NCT00977080|26639009|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
13345384|NCT00977080|26639010|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1|||
13345385|NCT00977080|26639007|FG000|Overall Study|Required kidney transplantation|1|||
13345386|NCT00977080|26639008|FG001|Overall Study|Required kidney transplantation|3|||
13345387|NCT00977080|26639009|FG002|Overall Study|Required kidney transplantation|3|||
13345388|NCT00977080|26639010|FG003|Overall Study|Required kidney transplantation|1|||
13345389|NCT00977080|26639007|FG000|Overall Study|Travel for family reasons|1|||
13345390|NCT00977080|26639008|FG001|Overall Study|Travel for family reasons|0|||
13345391|NCT00977080|26639009|FG002|Overall Study|Travel for family reasons|0|||
13345392|NCT00977080|26639010|FG003|Overall Study|Travel for family reasons|0|||
13345393|NCT00976989|26639061|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
13345394|NCT00976989|26639062|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
13345395|NCT00976989|26639063|FG002|Overall Study|Violation of Selection Criteria at Entry|1|||
13345396|NCT00976989|26639061|FG000|Overall Study|Death|5|||
13345397|NCT00976989|26639062|FG001|Overall Study|Death|7|||
13345398|NCT00976989|26639063|FG002|Overall Study|Death|10|||
13345399|NCT00976989|26639061|FG000|Overall Study|Refused Treatment|4|||
13345400|NCT00976989|26639062|FG001|Overall Study|Refused Treatment|3|||
13345401|NCT00976989|26639063|FG002|Overall Study|Refused Treatment|5|||
13345402|NCT00976989|26639061|FG000|Overall Study|Failure to Return|2|||
13345403|NCT00976989|26639062|FG001|Overall Study|Failure to Return|1|||
13345404|NCT00976989|26639063|FG002|Overall Study|Failure to Return|0|||
13345405|NCT00976989|26639061|FG000|Overall Study|Recurrence of Disease|0|||
13345406|NCT00976989|26639062|FG001|Overall Study|Recurrence of Disease|1|||
13345407|NCT00976989|26639063|FG002|Overall Study|Recurrence of Disease|0|||
13345408|NCT00976989|26639061|FG000|Overall Study|Other|1|||
13345409|NCT00976989|26639062|FG001|Overall Study|Other|0|||
13345410|NCT00976989|26639063|FG002|Overall Study|Other|1|||
13345411|NCT00976950|26639071|FG000|Overall Study|Adverse Event|3|||
13345412|NCT00976950|26639071|FG000|Overall Study|Events with no relationship to Aptivus|3|||
13345413|NCT00976937|26639118|FG000|Overall Study|Adverse Event|4|||
13345414|NCT00976937|26639119|FG001|Overall Study|Adverse Event|5|||
13345415|NCT00976937|26639118|FG000|Overall Study|Lost to Follow-up|2|||
13345416|NCT00976937|26639119|FG001|Overall Study|Lost to Follow-up|1|||
13345417|NCT00976937|26639118|FG000|Overall Study|Withdrawal by Subject|5|||
13345418|NCT00976937|26639119|FG001|Overall Study|Withdrawal by Subject|3|||
13345419|NCT00976937|26639118|FG000|Overall Study|Poor compliance to protocol|3|||
13345420|NCT00976937|26639119|FG001|Overall Study|Poor compliance to protocol|0|||
13345421|NCT00976937|26639118|FG000|Overall Study|Personal and Familial Reason|2|||
13345422|NCT00976937|26639119|FG001|Overall Study|Personal and Familial Reason|2|||
13345423|NCT00976911|26639144|FG000|Overall Study|Withdrawal by Subject|4|||
13345424|NCT00976911|26639145|FG001|Overall Study|Withdrawal by Subject|6|||
13345425|NCT00976911|26639144|FG000|Overall Study|Death|138|||
13345426|NCT00976911|26639145|FG001|Overall Study|Death|126|||
13345427|NCT00976911|26639144|FG000|Overall Study|Adverse Event|0|||
13345428|NCT00976911|26639145|FG001|Overall Study|Adverse Event|1|||
13345429|NCT00976911|26639144|FG000|Overall Study|Protocol Violation|2|||
13345430|NCT00976911|26639145|FG001|Overall Study|Protocol Violation|0|||
13345431|NCT00976911|26639144|FG000|Overall Study|Other|8|||
13345432|NCT00976911|26639145|FG001|Overall Study|Other|9|||
13345433|NCT00976911|26639144|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30|||
13345434|NCT00976911|26639145|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37|||
13345435|NCT00976898|26639154|FG000|Overall Study|Protocol Violation|1|||
13345436|NCT00976898|26639154|FG000|Overall Study|Adverse Event|1|||
13345437|NCT00976898|26639154|FG000|Overall Study|Physician Decision|1|||
13345438|NCT00976898|26639154|FG000|Overall Study|Liver Transplant|1|||
13345439|NCT00976898|26639154|FG000|Overall Study|Progressive Disease|1|||
13345440|NCT00976820|26639503|FG000|Overall Study|Lost to Follow-up|5|||
13345441|NCT00976820|26639504|FG001|Overall Study|Lost to Follow-up|16|||
13345442|NCT00976820|26639505|FG002|Overall Study|Lost to Follow-up|2|||
13345443|NCT00976820|26639506|FG003|Overall Study|Lost to Follow-up|3|||
13345444|NCT00976820|26639503|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
13345445|NCT00976820|26639504|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
13345446|NCT00976820|26639505|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
13345447|NCT00976820|26639506|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
13345448|NCT00976820|26639503|FG000|Overall Study|Withdrawal by Subject|2|||
13345449|NCT00976820|26639504|FG001|Overall Study|Withdrawal by Subject|4|||
13345450|NCT00976820|26639505|FG002|Overall Study|Withdrawal by Subject|1|||
13345451|NCT00976820|26639506|FG003|Overall Study|Withdrawal by Subject|4|||
13345452|NCT00976716|26639524|FG000|Overall Study|Adverse Event|1|||
13345453|NCT00976703|26639543|FG000|Overall Study|Physician Decision|1|||
13345454|NCT00976703|26639544|FG001|Overall Study|Physician Decision|1|||
13345455|NCT00976703|26639543|FG000|Overall Study|ineligible for study|2|||
13345456|NCT00976703|26639544|FG001|Overall Study|ineligible for study|2|||
13345457|NCT00976677|26639557|FG000|Overall Study|Adverse Event|1|||
13345458|NCT00976677|26639558|FG001|Overall Study|Adverse Event|0|||
13345459|NCT00976677|26639557|FG000|Overall Study|Withdrawal by Subject|0|||
13345460|NCT00976677|26639558|FG001|Overall Study|Withdrawal by Subject|2|||
13345461|NCT00976677|26639557|FG000|Overall Study|Disease progression|1|||
13345462|NCT00976677|26639558|FG001|Overall Study|Disease progression|1|||
13345463|NCT00976677|26639557|FG000|Overall Study|Trial unblinded|2|||
13345464|NCT00976677|26639558|FG001|Overall Study|Trial unblinded|2|||
13345465|NCT00976677|26639557|FG000|Overall Study|Unknown/Missing|1|||
13345466|NCT00976677|26639558|FG001|Overall Study|Unknown/Missing|0|||
13345467|NCT00976573|26639577|FG000|Overall Study|Ineligible|0|||
13345468|NCT00976573|26639578|FG001|Overall Study|Ineligible|1|||
13345469|NCT00976573|26639577|FG000|Overall Study|Cancel prior to receiving treatment|4|||
13345470|NCT00976573|26639578|FG001|Overall Study|Cancel prior to receiving treatment|2|||
13345471|NCT00976560|26639633|FG000|Overall Study|Adverse Event|5|||
13345472|NCT00976560|26639634|FG001|Overall Study|Adverse Event|5|||
13345473|NCT00976560|26639633|FG000|Overall Study|Lack of Efficacy|3|||
13345474|NCT00976560|26639634|FG001|Overall Study|Lack of Efficacy|5|||
13345475|NCT00976560|26639633|FG000|Overall Study|Protocol Violation|1|||
13345476|NCT00976560|26639634|FG001|Overall Study|Protocol Violation|0|||
13345477|NCT00976560|26639633|FG000|Overall Study|Lost to Follow-up|1|||
13345478|NCT00976560|26639634|FG001|Overall Study|Lost to Follow-up|0|||
13345479|NCT00976560|26639633|FG000|Overall Study|Physician Decision|2|||
13345480|NCT00976560|26639634|FG001|Overall Study|Physician Decision|0|||
13345481|NCT00976560|26639633|FG000|Overall Study|Withdrawal by Subject|2|||
13345482|NCT00976560|26639634|FG001|Overall Study|Withdrawal by Subject|3|||
13345483|NCT00976508|26639671|FG000|Overall Study|Death|7|||
13345484|NCT00976508|26639672|FG001|Overall Study|Death|1|||
13345485|NCT00976508|26639671|FG000|Overall Study|Lost to Follow-up|1|||
13345486|NCT00976508|26639672|FG001|Overall Study|Lost to Follow-up|0|||
13345487|NCT00976508|26639671|FG000|Overall Study|Withdrawal by Subject|1|||
13345488|NCT00976508|26639672|FG001|Overall Study|Withdrawal by Subject|0|||
13345489|NCT00976508|26639671|FG000|Overall Study|Disease Progression|4|||
13345490|NCT00976508|26639672|FG001|Overall Study|Disease Progression|4|||
13345491|NCT00976508|26639671|FG000|Overall Study|Subject Enrolled in Hospice|1|||
13345492|NCT00976508|26639672|FG001|Overall Study|Subject Enrolled in Hospice|0|||
13345493|NCT00976508|26639671|FG000|Overall Study|Terminated by the Sponsor|0|||
13345494|NCT00976508|26639672|FG001|Overall Study|Terminated by the Sponsor|1|||
13345495|NCT00976495|26639699|FG000|Overall Study|Withdrawal by Subject|0|||
13345496|NCT00976495|26639700|FG001|Overall Study|Withdrawal by Subject|1|||
13345497|NCT00976495|26639701|FG002|Overall Study|Withdrawal by Subject|0|||
13345498|NCT00976482|26639707|FG000|Overall Study|Death|208|||
13345499|NCT00976482|26639707|FG000|Overall Study|Withdrawal by Subject|45|||
13345500|NCT00976482|26639707|FG000|Overall Study|Center terminated|1|||
13345501|NCT00976482|26639707|FG000|Overall Study|Protocol Violation|5|||
13345502|NCT00976456|26639722|FG000|Overall Study|Adverse Event|17|||
13345503|NCT00976456|26639723|FG001|Overall Study|Adverse Event|22|||
13345504|NCT00976456|26639722|FG000|Overall Study|Death|7|||
13345505|NCT00976456|26639723|FG001|Overall Study|Death|9|||
13345506|NCT00976456|26639722|FG000|Overall Study|Lack of Efficacy|5|||
13345507|NCT00976456|26639723|FG001|Overall Study|Lack of Efficacy|2|||
13345508|NCT00976456|26639722|FG000|Overall Study|Withdrawal by Subject|3|||
13345509|NCT00976456|26639723|FG001|Overall Study|Withdrawal by Subject|1|||
13345510|NCT00976456|26639722|FG000|Overall Study|screening failure, unknown|11|||
13345511|NCT00976456|26639723|FG001|Overall Study|screening failure, unknown|4|||
13345512|NCT00976391|26639750|FG000|Treatment Period (52 Weeks)|Adverse Event|16|||
13345513|NCT00976391|26639751|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
13345514|NCT00976391|26639750|FG000|Treatment Period (52 Weeks)|Protocol Violation|1|||
13345515|NCT00976391|26639751|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
13345516|NCT00976391|26639750|FG000|Treatment Period (52 Weeks)|Noncompliance|4|||
13345517|NCT00976391|26639751|FG001|Treatment Period (52 Weeks)|Noncompliance|4|||
13345518|NCT00976391|26639750|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10|||
13345519|NCT00976391|26639751|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8|||
13345520|NCT00976391|26639750|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9|||
13345521|NCT00976391|26639751|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19|||
13345522|NCT00976391|26639750|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
13345523|NCT00976391|26639751|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
13345524|NCT00976391|26639750|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0|||
13345525|NCT00976391|26639751|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4|||
13345526|NCT00976391|26639750|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
13345527|NCT00976391|26639751|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
13345528|NCT00976391|26639750|FG000|Follow-up Period (8 Weeks)|Adverse Event|3|||
13345529|NCT00976391|26639751|FG001|Follow-up Period (8 Weeks)|Adverse Event|1|||
13345530|NCT00976391|26639750|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
13345531|NCT00976391|26639751|FG001|Follow-up Period (8 Weeks)|Noncompliance|2|||
13345532|NCT00976391|26639750|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14|||
13345533|NCT00976391|26639751|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
13345534|NCT00976391|26639750|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6|||
13345535|NCT00976391|26639751|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8|||
13345536|NCT00976391|26639750|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
13345537|NCT00976391|26639751|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7|||
13345538|NCT00976391|26639750|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
13345539|NCT00976391|26639751|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
13345540|NCT00976274|26639766|FG000|Overall Study|Lost to Follow-up|5|||
13345541|NCT00976274|26639767|FG001|Overall Study|Lost to Follow-up|5|||
13345542|NCT00976274|26639766|FG000|Overall Study|Withdrawal by Subject|1|||
13345543|NCT00976274|26639767|FG001|Overall Study|Withdrawal by Subject|1|||
13345544|NCT00976274|26639766|FG000|Overall Study|Physician Decision|1|||
13345545|NCT00976274|26639767|FG001|Overall Study|Physician Decision|2|||
13345546|NCT00976209|26639780|FG000|Treatment Period 1|Protocol Violation|1|||
13345547|NCT00976209|26639781|FG001|Treatment Period 1|Protocol Violation|0|||
13345548|NCT00976209|26639780|FG000|Treatment Period 1|Lost to Follow-up|2|||
13345549|NCT00976209|26639781|FG001|Treatment Period 1|Lost to Follow-up|0|||
13345550|NCT00976209|26639780|FG000|Treatment Period 1|Other|0|||
13345551|NCT00976209|26639781|FG001|Treatment Period 1|Other|1|||
13345552|NCT00976209|26639780|FG000|Wash-out Period|Adverse Event|1|||
13345553|NCT00976209|26639781|FG001|Wash-out Period|Adverse Event|2|||
13345554|NCT00976209|26639780|FG000|Wash-out Period|Lost to Follow-up|1|||
13345555|NCT00976209|26639781|FG001|Wash-out Period|Lost to Follow-up|0|||
13345556|NCT00976209|26639780|FG000|Wash-out Period|Protocol Violation|1|||
13345557|NCT00976209|26639781|FG001|Wash-out Period|Protocol Violation|0|||
13345558|NCT00976209|26639780|FG000|Wash-out Period|Other|1|||
13345559|NCT00976209|26639781|FG001|Wash-out Period|Other|0|||
13345560|NCT00976209|26639780|FG000|Treatment Period 2|Withdrawal by Subject|0|||
13345561|NCT00976209|26639781|FG001|Treatment Period 2|Withdrawal by Subject|1|||
13345562|NCT00976209|26639780|FG000|Treatment Period 2|Lost to Follow-up|0|||
13345563|NCT00976209|26639781|FG001|Treatment Period 2|Lost to Follow-up|1|||
13345564|NCT00976027|26639800|FG000|Overall Study|Serious Adverse Event|36|||
13345565|NCT00976027|26639801|FG001|Overall Study|Serious Adverse Event|17|||
13345566|NCT00976027|26639800|FG000|Overall Study|Adverse Event|0|||
13345567|NCT00976027|26639801|FG001|Overall Study|Adverse Event|2|||
13345568|NCT00976027|26639800|FG000|Overall Study|Protocol Violation|60|||
13345569|NCT00976027|26639801|FG001|Overall Study|Protocol Violation|27|||
13345570|NCT00976027|26639800|FG000|Overall Study|Lost to Follow-up|208|||
13345571|NCT00976027|26639801|FG001|Overall Study|Lost to Follow-up|103|||
13345572|NCT00976027|26639800|FG000|Overall Study|Withdrawal by Subject|107|||
13345573|NCT00976027|26639801|FG001|Overall Study|Withdrawal by Subject|66|||
13345574|NCT00975975|26639809|FG000|Overall Study|Death|6|||
13345575|NCT00975923|26639824|FG000|Overall Study|Withdrawal by Subject|0|||
13345576|NCT00975923|26639825|FG001|Overall Study|Withdrawal by Subject|1|||
13345577|NCT00975884|26639986|FG000|Overall Study|Adverse Event|1|||
13345578|NCT00975884|26639987|FG001|Overall Study|Adverse Event|0|||
13345579|NCT00975884|26639986|FG000|Overall Study|Lost to Follow-up|5|||
13345580|NCT00975884|26639987|FG001|Overall Study|Lost to Follow-up|3|||
13345581|NCT00975884|26639986|FG000|Overall Study|Withdrawal by Subject|9|||
13345582|NCT00975884|26639987|FG001|Overall Study|Withdrawal by Subject|9|||
13345583|NCT00975884|26639986|FG000|Overall Study|Other|1|||
13345584|NCT00975884|26639987|FG001|Overall Study|Other|3|||
13345585|NCT00975806|26640019|FG000|Overall Study|Adverse Event|2|||
13345586|NCT00975806|26640020|FG001|Overall Study|Adverse Event|1|||
13345587|NCT00975806|26640021|FG002|Overall Study|Adverse Event|2|||
13345588|NCT00975806|26640019|FG000|Overall Study|Disease Progression|1|||
13345589|NCT00975806|26640020|FG001|Overall Study|Disease Progression|5|||
13345590|NCT00975806|26640021|FG002|Overall Study|Disease Progression|1|||
13345591|NCT00975806|26640019|FG000|Overall Study|Withdrawal by Subject|1|||
13345592|NCT00975806|26640020|FG001|Overall Study|Withdrawal by Subject|0|||
13345593|NCT00975806|26640021|FG002|Overall Study|Withdrawal by Subject|0|||
13345594|NCT00975806|26640019|FG000|Overall Study|Death|0|||
13345595|NCT00975806|26640020|FG001|Overall Study|Death|1|||
13345596|NCT00975806|26640021|FG002|Overall Study|Death|0|||
13345597|NCT00975806|26640019|FG000|Overall Study|Physician decision and disease related|1|||
13345598|NCT00975806|26640020|FG001|Overall Study|Physician decision and disease related|0|||
13345599|NCT00975806|26640021|FG002|Overall Study|Physician decision and disease related|1|||
13345600|NCT00975780|26640036|FG000|Follow Up|Death|88|||
13345601|NCT00975780|26640037|FG001|Follow Up|Death|122|||
13345602|NCT00975780|26640036|FG000|Follow Up|Facility Withdrawal|7|||
13345603|NCT00975780|26640037|FG001|Follow Up|Facility Withdrawal|23|||
13345604|NCT00975780|26640036|FG000|Follow Up|Discharged from Facility|7|||
13345605|NCT00975780|26640037|FG001|Follow Up|Discharged from Facility|12|||
13345606|NCT00975715|26640058|FG000|Titration Period|Adverse Event|6|||
13345607|NCT00975715|26640059|FG001|Titration Period|Adverse Event|0|||
13345608|NCT00975715|26640058|FG000|Titration Period|Protocol Violation|1|||
13345609|NCT00975715|26640059|FG001|Titration Period|Protocol Violation|0|||
13345610|NCT00975715|26640058|FG000|Maintenance Period|Adverse Event|2|||
13345611|NCT00975715|26640059|FG001|Maintenance Period|Adverse Event|1|||
13345612|NCT00975689|26640072|FG000|Overall Study|Adverse Event|0|||
13345613|NCT00975689|26640073|FG001|Overall Study|Adverse Event|3|||
13345614|NCT00975689|26640072|FG000|Overall Study|Withdrawal by Subject|1|||
13345615|NCT00975689|26640073|FG001|Overall Study|Withdrawal by Subject|0|||
13345616|NCT00975689|26640072|FG000|Overall Study|Physician Decision|1|||
13345617|NCT00975689|26640073|FG001|Overall Study|Physician Decision|0|||
13345618|NCT00975676|26640097|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6|||
13345619|NCT00975676|26640098|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8|||
13345620|NCT00975611|26640104|FG000|Overall Study|Screen Fail|16|||
13345621|NCT00975611|26640104|FG000|Overall Study|Physician Decision|1|||
13345622|NCT00975585|26640129|FG000|Overall Study|Adverse Event|0|||
13345623|NCT00975585|26640130|FG001|Overall Study|Adverse Event|4|||
13345624|NCT00975585|26640129|FG000|Overall Study|Lost to Follow-up|3|||
13345625|NCT00975585|26640130|FG001|Overall Study|Lost to Follow-up|5|||
13345626|NCT00975585|26640129|FG000|Overall Study|Withdrawal by Subject|2|||
13345627|NCT00975585|26640130|FG001|Overall Study|Withdrawal by Subject|1|||
13345628|NCT00975585|26640129|FG000|Overall Study|Lens issue|2|||
13345629|NCT00975585|26640130|FG001|Overall Study|Lens issue|2|||
13345630|NCT00975507|26640157|FG000|Overall Study|Adverse Event|1|||
13345631|NCT00975507|26640158|FG001|Overall Study|Adverse Event|0|||
13345632|NCT00975507|26640157|FG000|Overall Study|Lost to Follow-up|7|||
13345633|NCT00975507|26640158|FG001|Overall Study|Lost to Follow-up|1|||
13345634|NCT00975507|26640157|FG000|Overall Study|Protocol Violation|2|||
13345635|NCT00975507|26640158|FG001|Overall Study|Protocol Violation|0|||
13345636|NCT00975507|26640157|FG000|Overall Study|Withdrawal by Subject|10|||
13345637|NCT00975507|26640158|FG001|Overall Study|Withdrawal by Subject|3|||
13345638|NCT00975481|26640263|FG000|Second Intervention Period|Adverse Event|2|||
13345639|NCT00975481|26640264|FG001|Second Intervention Period|Adverse Event|1|||
13345640|NCT00975481|26640265|FG002|Second Intervention Period|Adverse Event|0|||
13345641|NCT00975481|26640266|FG003|Second Intervention Period|Adverse Event|0|||
13345642|NCT00975481|26640267|FG004|Second Intervention Period|Adverse Event|0|||
13345643|NCT00975481|26640268|FG005|Second Intervention Period|Adverse Event|0|||
13345644|NCT00975481|26640263|FG000|Second Intervention Period|Withdrawal by Subject|0|||
13345645|NCT00975481|26640264|FG001|Second Intervention Period|Withdrawal by Subject|0|||
13345646|NCT00975481|26640265|FG002|Second Intervention Period|Withdrawal by Subject|1|||
13345647|NCT00975481|26640266|FG003|Second Intervention Period|Withdrawal by Subject|0|||
13345648|NCT00975481|26640267|FG004|Second Intervention Period|Withdrawal by Subject|0|||
13345649|NCT00975481|26640268|FG005|Second Intervention Period|Withdrawal by Subject|0|||
13345650|NCT00975481|26640263|FG000|Fourth Intervention Period|Withdrawal by Subject|0|||
13345651|NCT00975481|26640264|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
13345652|NCT00975481|26640265|FG002|Fourth Intervention Period|Withdrawal by Subject|1|||
13345653|NCT00975481|26640266|FG003|Fourth Intervention Period|Withdrawal by Subject|1|||
13345654|NCT00975481|26640267|FG004|Fourth Intervention Period|Withdrawal by Subject|0|||
13345655|NCT00975481|26640268|FG005|Fourth Intervention Period|Withdrawal by Subject|0|||
13345656|NCT00975481|26640263|FG000|Fifth Intervention Period|Withdrawal by Subject|0|||
13345657|NCT00975481|26640264|FG001|Fifth Intervention Period|Withdrawal by Subject|0|||
13345658|NCT00975481|26640265|FG002|Fifth Intervention Period|Withdrawal by Subject|0|||
13345659|NCT00975481|26640266|FG003|Fifth Intervention Period|Withdrawal by Subject|0|||
13345660|NCT00975481|26640267|FG004|Fifth Intervention Period|Withdrawal by Subject|1|||
13345661|NCT00975481|26640268|FG005|Fifth Intervention Period|Withdrawal by Subject|0|||
13345662|NCT00975416|26640282|FG000|Overall Study|early discharge from tx|3|||
13345663|NCT00975416|26640283|FG001|Overall Study|early discharge from tx|5|||
13345664|NCT00975286|26640320|FG000|Overall Study|Adverse Event|9|||
13345665|NCT00975286|26640321|FG001|Overall Study|Adverse Event|19|||
13345666|NCT00975286|26640320|FG000|Overall Study|Protocol Violation|1|||
13345667|NCT00975286|26640321|FG001|Overall Study|Protocol Violation|2|||
13345668|NCT00975286|26640320|FG000|Overall Study|Withdrawal by Subject|0|||
13345669|NCT00975286|26640321|FG001|Overall Study|Withdrawal by Subject|2|||
13345670|NCT00975286|26640320|FG000|Overall Study|Familial and Personal Reasons|2|||
13345671|NCT00975286|26640321|FG001|Overall Study|Familial and Personal Reasons|2|||
13345672|NCT00975286|26640320|FG000|Overall Study|Poor Compliance to Protocol|0|||
13345673|NCT00975286|26640321|FG001|Overall Study|Poor Compliance to Protocol|2|||
13345674|NCT00975286|26640320|FG000|Overall Study|Sponsor Decision|0|||
13345675|NCT00975286|26640321|FG001|Overall Study|Sponsor Decision|2|||
13345676|NCT00975221|26640342|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2|||
13345677|NCT00975221|26640343|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3|||
13345678|NCT00975221|26640342|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1|||
13345679|NCT00975221|26640343|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0|||
13345680|NCT00975221|26640342|FG000|Titration Phase (Weeks 1-12)|Other|0|||
13345681|NCT00975221|26640343|FG001|Titration Phase (Weeks 1-12)|Other|1|||
13345682|NCT00975221|26640342|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0|||
13345683|NCT00975221|26640343|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1|||
13345684|NCT00975221|26640342|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
13345685|NCT00975221|26640343|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
13345686|NCT00975221|26640342|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1|||
13345687|NCT00975221|26640343|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0|||
13345688|NCT00975195|26640408|FG000|Overall Study|Adverse Event|108|||
13345689|NCT00975195|26640409|FG001|Overall Study|Adverse Event|101|||
13345690|NCT00975195|26640408|FG000|Overall Study|Lack of Efficacy|6|||
13345691|NCT00975195|26640409|FG001|Overall Study|Lack of Efficacy|6|||
13345692|NCT00975195|26640408|FG000|Overall Study|Protocol Violation|27|||
13345693|NCT00975195|26640409|FG001|Overall Study|Protocol Violation|23|||
13345694|NCT00975195|26640408|FG000|Overall Study|Lost to Follow-up|9|||
13345695|NCT00975195|26640409|FG001|Overall Study|Lost to Follow-up|7|||
13345696|NCT00975195|26640408|FG000|Overall Study|Withdrawal by Subject|48|||
13345697|NCT00975195|26640409|FG001|Overall Study|Withdrawal by Subject|61|||
13345698|NCT00975195|26640408|FG000|Overall Study|Other reason not defined above|29|||
13345699|NCT00975195|26640409|FG001|Overall Study|Other reason not defined above|33|||
13345700|NCT00975195|26640408|FG000|Overall Study|Not treated|1|||
13345701|NCT00975195|26640409|FG001|Overall Study|Not treated|2|||
13345702|NCT00975156|26640426|FG000|Overall Study|Protocol Violation|0|||
13345703|NCT00975156|26640427|FG001|Overall Study|Protocol Violation|1|||
13345704|NCT00975143|26640444|FG000|Overall Study|Adverse Event|19|||
13345705|NCT00975143|26640445|FG001|Overall Study|Adverse Event|15|||
13345706|NCT00975143|26640444|FG000|Overall Study|Withdrawal by Subject|15|||
13345707|NCT00975143|26640445|FG001|Overall Study|Withdrawal by Subject|15|||
13345708|NCT00975143|26640444|FG000|Overall Study|Lost to Follow-up|20|||
13345709|NCT00975143|26640445|FG001|Overall Study|Lost to Follow-up|16|||
13345710|NCT00975143|26640444|FG000|Overall Study|Non-compliance|5|||
13345711|NCT00975143|26640445|FG001|Overall Study|Non-compliance|8|||
13345712|NCT00975143|26640444|FG000|Overall Study|Physician Decision|1|||
13345713|NCT00975143|26640445|FG001|Overall Study|Physician Decision|2|||
13345714|NCT00975143|26640444|FG000|Overall Study|Details not available|10|||
13345715|NCT00975143|26640445|FG001|Overall Study|Details not available|4|||
13345716|NCT00975130|26640631|FG000|Study Part 1|Adverse Event|150|||
13345717|NCT00975130|26640632|FG001|Study Part 1|Adverse Event|0|||
13345718|NCT00975130|26640633|FG002|Study Part 1|Adverse Event|0|||
13345719|NCT00975130|26640631|FG000|Study Part 1|Lost to Follow-up|19|||
13345720|NCT00975130|26640632|FG001|Study Part 1|Lost to Follow-up|0|||
13345721|NCT00975130|26640633|FG002|Study Part 1|Lost to Follow-up|0|||
13345722|NCT00975130|26640631|FG000|Study Part 1|Withdrawal by Subject|61|||
13345723|NCT00975130|26640632|FG001|Study Part 1|Withdrawal by Subject|0|||
13345724|NCT00975130|26640633|FG002|Study Part 1|Withdrawal by Subject|0|||
13345725|NCT00975130|26640631|FG000|Study Part 1|Protocol Violation|13|||
13345726|NCT00975130|26640632|FG001|Study Part 1|Protocol Violation|0|||
13345727|NCT00975130|26640633|FG002|Study Part 1|Protocol Violation|0|||
13345728|NCT00975130|26640631|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9|||
13345729|NCT00975130|26640632|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0|||
13345730|NCT00975130|26640633|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0|||
13345731|NCT00975130|26640631|FG000|Study Part 1|Administrative|4|||
13345732|NCT00975130|26640632|FG001|Study Part 1|Administrative|0|||
13345733|NCT00975130|26640633|FG002|Study Part 1|Administrative|0|||
13345734|NCT00975130|26640631|FG000|Study Part 1|Withdrew Consent|24|||
13345735|NCT00975130|26640632|FG001|Study Part 1|Withdrew Consent|0|||
13345736|NCT00975130|26640633|FG002|Study Part 1|Withdrew Consent|0|||
13345737|NCT00975130|26640631|FG000|Study Part 2|Adverse Event|0|||
13345738|NCT00975130|26640632|FG001|Study Part 2|Adverse Event|14|||
13345739|NCT00975130|26640633|FG002|Study Part 2|Adverse Event|7|||
13345740|NCT00975130|26640631|FG000|Study Part 2|Lost to Follow-up|0|||
13345741|NCT00975130|26640632|FG001|Study Part 2|Lost to Follow-up|0|||
13345742|NCT00975130|26640633|FG002|Study Part 2|Lost to Follow-up|1|||
13345743|NCT00975130|26640631|FG000|Study Part 2|Withdrawal by Subject|0|||
13345744|NCT00975130|26640632|FG001|Study Part 2|Withdrawal by Subject|13|||
13345745|NCT00975130|26640633|FG002|Study Part 2|Withdrawal by Subject|5|||
13345746|NCT00975130|26640631|FG000|Study Part 2|Withdrew Consent|0|||
13345747|NCT00975130|26640632|FG001|Study Part 2|Withdrew Consent|6|||
13345748|NCT00975130|26640633|FG002|Study Part 2|Withdrew Consent|2|||
13345749|NCT00975130|26640631|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0|||
13345750|NCT00975130|26640632|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4|||
13345751|NCT00975130|26640633|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1|||
13345752|NCT00975130|26640631|FG000|Study Part 2|Administrative|0|||
13345753|NCT00975130|26640632|FG001|Study Part 2|Administrative|1|||
13345754|NCT00975130|26640633|FG002|Study Part 2|Administrative|0|||
13345755|NCT00975130|26640631|FG000|Study Part 2|Protocol Violation|0|||
13345756|NCT00975130|26640632|FG001|Study Part 2|Protocol Violation|0|||
13345757|NCT00975130|26640633|FG002|Study Part 2|Protocol Violation|1|||
13345758|NCT00975000|26640662|FG000|Overall Study|Other|1|||
13345759|NCT00975000|26640663|FG001|Overall Study|Other|0|||
13345760|NCT00975000|26640662|FG000|Overall Study|Adverse Event|1|||
13345761|NCT00975000|26640663|FG001|Overall Study|Adverse Event|1|||
13345762|NCT00975000|26640662|FG000|Overall Study|Withdrawal by Subject|2|||
13345763|NCT00975000|26640663|FG001|Overall Study|Withdrawal by Subject|2|||
13345764|NCT00975000|26640662|FG000|Overall Study|Lost to Follow-up|0|||
13345765|NCT00975000|26640663|FG001|Overall Study|Lost to Follow-up|1|||
13345766|NCT00975000|26640662|FG000|Overall Study|Protocol-specified Criteria|1|||
13345767|NCT00975000|26640663|FG001|Overall Study|Protocol-specified Criteria|0|||
13345768|NCT00975000|26640662|FG000|Overall Study|Non-compliance|0|||
13345769|NCT00975000|26640663|FG001|Overall Study|Non-compliance|1|||
13345770|NCT00974974|26640680|FG000|IR CD-LD Dose Adjustment|Adverse Event|0|||
13345771|NCT00974974|26640681|FG001|IR CD-LD Dose Adjustment|Adverse Event|3|||
13345772|NCT00974974|26640680|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0|||
13345773|NCT00974974|26640681|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1|||
13345774|NCT00974974|26640680|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0|||
13345775|NCT00974974|26640681|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1|||
13345776|NCT00974974|26640680|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0|||
13345777|NCT00974974|26640681|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7|||
13345778|NCT00974974|26640680|FG000|IR CD-LD Dose Adjustment|Various|0|||
13345779|NCT00974974|26640681|FG001|IR CD-LD Dose Adjustment|Various|9|||
13345780|NCT00974974|26640680|FG000|IPX066 Dose Conversion|Adverse Event|23|||
13345781|NCT00974974|26640681|FG001|IPX066 Dose Conversion|Adverse Event|0|||
13345782|NCT00974974|26640680|FG000|IPX066 Dose Conversion|Death|2|||
13345783|NCT00974974|26640681|FG001|IPX066 Dose Conversion|Death|0|||
13345784|NCT00974974|26640680|FG000|IPX066 Dose Conversion|Lack of Efficacy|13|||
13345785|NCT00974974|26640681|FG001|IPX066 Dose Conversion|Lack of Efficacy|0|||
13345786|NCT00974974|26640680|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12|||
13345787|NCT00974974|26640681|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0|||
13345788|NCT00974974|26640680|FG000|IPX066 Dose Conversion|Various|3|||
13345789|NCT00974974|26640681|FG001|IPX066 Dose Conversion|Various|0|||
13345790|NCT00974974|26640680|FG000|IPX066 Dose Conversion|Protocol Violation|4|||
13345791|NCT00974974|26640681|FG001|IPX066 Dose Conversion|Protocol Violation|0|||
13345792|NCT00974974|26640680|FG000|Maintenance - Double Blind Treatment|Adverse Event|3|||
13345793|NCT00974974|26640681|FG001|Maintenance - Double Blind Treatment|Adverse Event|3|||
13345794|NCT00974974|26640680|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1|||
13345795|NCT00974974|26640681|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1|||
13345796|NCT00974974|26640680|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0|||
13345797|NCT00974974|26640681|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1|||
13345798|NCT00974974|26640680|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
13345799|NCT00974974|26640681|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
13345800|NCT00974974|26640680|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0|||
13345801|NCT00974974|26640681|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1|||
13345802|NCT00974974|26640680|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5|||
13345803|NCT00974974|26640681|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2|||
13345804|NCT00974974|26640680|FG000|Maintenance - Double Blind Treatment|Various|4|||
13345805|NCT00974974|26640681|FG001|Maintenance - Double Blind Treatment|Various|0|||
13345806|NCT00974922|26640688|FG000|Overall Study|study terminated|24|||
13345807|NCT00974675|26640747|FG000|Overall Study|Adverse Event|2|||
13345808|NCT00974675|26640748|FG001|Overall Study|Adverse Event|1|||
13345809|NCT00974675|26640749|FG002|Overall Study|Adverse Event|1|||
13345810|NCT00974675|26640750|FG003|Overall Study|Adverse Event|1|||
13345811|NCT00974675|26640747|FG000|Overall Study|Physician Decision|0|||
13345812|NCT00974675|26640748|FG001|Overall Study|Physician Decision|0|||
13345813|NCT00974675|26640749|FG002|Overall Study|Physician Decision|1|||
13345814|NCT00974675|26640750|FG003|Overall Study|Physician Decision|0|||
13345815|NCT00974675|26640747|FG000|Overall Study|Participant on holiday; unable to attend|0|||
13345816|NCT00974675|26640748|FG001|Overall Study|Participant on holiday; unable to attend|0|||
13345817|NCT00974675|26640749|FG002|Overall Study|Participant on holiday; unable to attend|0|||
13345818|NCT00974675|26640750|FG003|Overall Study|Participant on holiday; unable to attend|1|||
13345819|NCT00974311|26640793|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5|||
13345820|NCT00974311|26640794|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2|||
13345821|NCT00974311|26640793|FG000|DB Phase (up to 24 Months)|Death|561|||
13345822|NCT00974311|26640794|FG001|DB Phase (up to 24 Months)|Death|298|||
13345823|NCT00974311|26640793|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16|||
13345824|NCT00974311|26640794|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7|||
13345825|NCT00974311|26640793|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108|||
13345826|NCT00974311|26640794|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42|||
13345827|NCT00974311|26640793|FG000|DB Phase (up to 24 Months)|Other|1|||
13345828|NCT00974311|26640794|FG001|DB Phase (up to 24 Months)|Other|0|||
13345829|NCT00974311|26640793|FG000|OLE Phase (up to 77 Months)|Death|14|||
13345830|NCT00974311|26640794|FG001|OLE Phase (up to 77 Months)|Death|21|||
13345831|NCT00974311|26640793|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78|||
13345832|NCT00974311|26640794|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26|||
13345833|NCT00974311|26640793|FG000|OLE Phase (up to 77 Months)|Other|15|||
13345834|NCT00974311|26640794|FG001|OLE Phase (up to 77 Months)|Other|2|||
13345835|NCT00974311|26640793|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2|||
13345836|NCT00974311|26640794|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1|||
13345837|NCT00974259|26640813|FG000|Overall Study|Technically inadequate PbtO2 recordings|2|||
13345838|NCT00974259|26640814|FG001|Overall Study|Technically inadequate PbtO2 recordings|1|||
13345839|NCT00974233|26640829|FG000|Induction Chemoimmunotherapy|Death|2|||
13345840|NCT00974233|26640829|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5|||
13345841|NCT00974233|26640829|FG000|Induction Chemoimmunotherapy|Adverse Event|7|||
13345842|NCT00974233|26640829|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1|||
13345843|NCT00974233|26640829|FG000|Maintenance Lenalidomide|Lack of Efficacy|5|||
13345844|NCT00974233|26640829|FG000|Maintenance Lenalidomide|Adverse Event|8|||
13345845|NCT00974220|26640844|FG000|Treatment Period 1|Adverse Event|2|||
13345846|NCT00974220|26640845|FG001|Treatment Period 1|Adverse Event|1|||
13345847|NCT00974220|26640844|FG000|Treatment Period 1|noncompliant subjects|0|||
13345848|NCT00974220|26640845|FG001|Treatment Period 1|noncompliant subjects|1|||
13345849|NCT00974090|26640866|FG000|Period 1: Double Blind Period|Adverse Event|2|||
13345850|NCT00974090|26640867|FG001|Period 1: Double Blind Period|Adverse Event|1|||
13345851|NCT00974090|26640866|FG000|Period 1: Double Blind Period|Physician Decision|1|||
13345852|NCT00974090|26640867|FG001|Period 1: Double Blind Period|Physician Decision|0|||
13345853|NCT00974090|26640866|FG000|Period 2: Open-label Period|Adverse Event|4|||
13345854|NCT00974090|26640867|FG001|Period 2: Open-label Period|Adverse Event|6|||
13345855|NCT00974090|26640866|FG000|Period 2: Open-label Period|Lack of Efficacy|3|||
13345856|NCT00974090|26640867|FG001|Period 2: Open-label Period|Lack of Efficacy|1|||
13345857|NCT00974090|26640866|FG000|Period 2: Open-label Period|Physician Decision|0|||
13345858|NCT00974090|26640867|FG001|Period 2: Open-label Period|Physician Decision|3|||
13345859|NCT00974090|26640866|FG000|Period 2: Open-label Period|Withdrawal by Subject|1|||
13345860|NCT00974090|26640867|FG001|Period 2: Open-label Period|Withdrawal by Subject|0|||
13345861|NCT00973973|26640934|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1|||
13345862|NCT00973973|26640935|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3|||
13345863|NCT00973973|26640934|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1|||
13345864|NCT00973973|26640935|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0|||
13345865|NCT00973973|26640934|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1|||
13345866|NCT00973973|26640935|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3|||
13345867|NCT00973973|26640934|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1|||
13345868|NCT00973973|26640935|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0|||
13345869|NCT00973973|26640934|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
13345870|NCT00973973|26640935|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
13345871|NCT00973973|26640934|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
13345872|NCT00973973|26640935|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
13345873|NCT00973973|26640934|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1|||
13345874|NCT00973973|26640935|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2|||
13345875|NCT00973973|26640934|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1|||
13345876|NCT00973973|26640935|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0|||
13345877|NCT00973973|26640934|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1|||
13345878|NCT00973973|26640935|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0|||
13345879|NCT00973973|26640934|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1|||
13374108|NCT00797966|26725800|FG005|Phase B|Adverse Event|0|||
13345880|NCT00973973|26640935|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3|||
13345881|NCT00973973|26640934|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1|||
13345882|NCT00973973|26640935|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0|||
13345883|NCT00973973|26640934|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1|||
13345884|NCT00973973|26640935|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0|||
13345885|NCT00973921|26640944|FG000|Overall Study|IVUS results were not available|9|||
13345886|NCT00973765|26640957|FG000|Overall Study|Lost to Follow-up|8|||
13345887|NCT00973765|26640958|FG001|Overall Study|Lost to Follow-up|14|||
13345888|NCT00973700|26641021|FG000|Overall Study|Withdrawal by Subject|2|||
13345889|NCT00973700|26641022|FG001|Overall Study|Withdrawal by Subject|2|||
13345890|NCT00973700|26641023|FG002|Overall Study|Withdrawal by Subject|8|||
13345891|NCT00973700|26641024|FG003|Overall Study|Withdrawal by Subject|4|||
13345892|NCT00973700|26641025|FG004|Overall Study|Withdrawal by Subject|4|||
13345893|NCT00973700|26641021|FG000|Overall Study|Lost to Follow-up|5|||
13345894|NCT00973700|26641022|FG001|Overall Study|Lost to Follow-up|0|||
13345895|NCT00973700|26641023|FG002|Overall Study|Lost to Follow-up|1|||
13345896|NCT00973700|26641024|FG003|Overall Study|Lost to Follow-up|8|||
13345897|NCT00973700|26641025|FG004|Overall Study|Lost to Follow-up|5|||
13345898|NCT00973700|26641021|FG000|Overall Study|Inappropriate enrolment|0|||
13345899|NCT00973700|26641022|FG001|Overall Study|Inappropriate enrolment|0|||
13345900|NCT00973700|26641023|FG002|Overall Study|Inappropriate enrolment|0|||
13345901|NCT00973700|26641024|FG003|Overall Study|Inappropriate enrolment|4|||
13345902|NCT00973700|26641025|FG004|Overall Study|Inappropriate enrolment|0|||
13345903|NCT00973700|26641021|FG000|Overall Study|Unable to Classify|0|||
13345904|NCT00973700|26641022|FG001|Overall Study|Unable to Classify|0|||
13345905|NCT00973700|26641023|FG002|Overall Study|Unable to Classify|1|||
13345906|NCT00973700|26641024|FG003|Overall Study|Unable to Classify|2|||
13345907|NCT00973700|26641025|FG004|Overall Study|Unable to Classify|1|||
13345908|NCT00973674|26641044|FG000|Overall Study|Protocol Violation|2|||
13345909|NCT00973674|26641045|FG001|Overall Study|Protocol Violation|0|||
13345910|NCT00973622|26641058|FG000|Overall Study|did not attend MRI|14|||
13345911|NCT00973622|26641059|FG001|Overall Study|did not attend MRI|3|||
13345912|NCT00973622|26641058|FG000|Overall Study|did not pass MRI screen|6|||
13345913|NCT00973622|26641059|FG001|Overall Study|did not pass MRI screen|0|||
13345914|NCT00973622|26641058|FG000|Overall Study|did not complete rTMS sessions|11|||
13345915|NCT00973622|26641059|FG001|Overall Study|did not complete rTMS sessions|2|||
13345916|NCT00973479|26641082|FG000|Overall Study|Lost to Follow-up|0|||
13345917|NCT00973479|26641083|FG001|Overall Study|Lost to Follow-up|3|||
13345918|NCT00973479|26641082|FG000|Overall Study|Death|2|||
13345919|NCT00973479|26641083|FG001|Overall Study|Death|2|||
13345920|NCT00973479|26641082|FG000|Overall Study|Withdrawal by Subject|15|||
13345921|NCT00973479|26641083|FG001|Overall Study|Withdrawal by Subject|16|||
13345922|NCT00973479|26641082|FG000|Overall Study|Lack of Efficacy|5|||
13345923|NCT00973479|26641083|FG001|Overall Study|Lack of Efficacy|7|||
13345924|NCT00973479|26641082|FG000|Overall Study|Adverse Event|12|||
13345925|NCT00973479|26641083|FG001|Overall Study|Adverse Event|32|||
13345926|NCT00973479|26641082|FG000|Overall Study|Protocol Violation|2|||
13345927|NCT00973479|26641083|FG001|Overall Study|Protocol Violation|2|||
13345928|NCT00973479|26641082|FG000|Overall Study|Other|1|||
13345929|NCT00973479|26641083|FG001|Overall Study|Other|7|||
13345930|NCT00973362|26641099|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25|||
13345931|NCT00973362|26641100|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0|||
13345932|NCT00973362|26641099|FG000|Baseline Evaluation|No colposcopy visit|62|||
13345933|NCT00973362|26641100|FG001|Baseline Evaluation|No colposcopy visit|0|||
13345934|NCT00973362|26641099|FG000|Baseline Evaluation|Inevaluable|686|||
13345935|NCT00973362|26641100|FG001|Baseline Evaluation|Inevaluable|223|||
13345936|NCT00973362|26641099|FG000|3-Year Follow-up|Lost to Follow-up|17|||
13345937|NCT00973362|26641100|FG001|3-Year Follow-up|Lost to Follow-up|0|||
13345938|NCT00973349|26641247|FG000|Overall Study|Adverse Event|0|||
13345939|NCT00973349|26641248|FG001|Overall Study|Adverse Event|0|||
13345940|NCT00973349|26641249|FG002|Overall Study|Adverse Event|0|||
13345941|NCT00973349|26641250|FG003|Overall Study|Adverse Event|0|||
13345942|NCT00973349|26641251|FG004|Overall Study|Adverse Event|1|||
13345943|NCT00973349|26641252|FG005|Overall Study|Adverse Event|0|||
13345944|NCT00973349|26641253|FG006|Overall Study|Adverse Event|0|||
13345945|NCT00973349|26641254|FG007|Overall Study|Adverse Event|0|||
13345946|NCT00973349|26641255|FG008|Overall Study|Adverse Event|1|||
13345947|NCT00973349|26641256|FG009|Overall Study|Adverse Event|0|||
13345948|NCT00973349|26641257|FG010|Overall Study|Adverse Event|0|||
13345949|NCT00973349|26641258|FG011|Overall Study|Adverse Event|0|||
13345950|NCT00973349|26641259|FG012|Overall Study|Adverse Event|0|||
13345951|NCT00973349|26641260|FG013|Overall Study|Adverse Event|0|||
13345952|NCT00973349|26641261|FG014|Overall Study|Adverse Event|1|||
13345953|NCT00973349|26641262|FG015|Overall Study|Adverse Event|0|||
13345954|NCT00973349|26641247|FG000|Overall Study|Withdrawal by Subject|1|||
13345955|NCT00973349|26641248|FG001|Overall Study|Withdrawal by Subject|2|||
13345956|NCT00973349|26641249|FG002|Overall Study|Withdrawal by Subject|2|||
13345957|NCT00973349|26641250|FG003|Overall Study|Withdrawal by Subject|3|||
13345958|NCT00973349|26641251|FG004|Overall Study|Withdrawal by Subject|2|||
13345959|NCT00973349|26641252|FG005|Overall Study|Withdrawal by Subject|0|||
13345960|NCT00973349|26641253|FG006|Overall Study|Withdrawal by Subject|2|||
13345961|NCT00973349|26641254|FG007|Overall Study|Withdrawal by Subject|2|||
13345962|NCT00973349|26641255|FG008|Overall Study|Withdrawal by Subject|0|||
13345963|NCT00973349|26641256|FG009|Overall Study|Withdrawal by Subject|2|||
13345964|NCT00973349|26641257|FG010|Overall Study|Withdrawal by Subject|0|||
13345965|NCT00973349|26641258|FG011|Overall Study|Withdrawal by Subject|1|||
13345966|NCT00973349|26641259|FG012|Overall Study|Withdrawal by Subject|0|||
13345967|NCT00973349|26641260|FG013|Overall Study|Withdrawal by Subject|0|||
13345968|NCT00973349|26641261|FG014|Overall Study|Withdrawal by Subject|0|||
13345969|NCT00973349|26641262|FG015|Overall Study|Withdrawal by Subject|0|||
13345970|NCT00973349|26641247|FG000|Overall Study|Lost to Follow-up|3|||
13345971|NCT00973349|26641248|FG001|Overall Study|Lost to Follow-up|1|||
13345972|NCT00973349|26641249|FG002|Overall Study|Lost to Follow-up|2|||
13345973|NCT00973349|26641250|FG003|Overall Study|Lost to Follow-up|2|||
13345974|NCT00973349|26641251|FG004|Overall Study|Lost to Follow-up|1|||
13345975|NCT00973349|26641252|FG005|Overall Study|Lost to Follow-up|3|||
13345976|NCT00973349|26641253|FG006|Overall Study|Lost to Follow-up|0|||
13345977|NCT00973349|26641254|FG007|Overall Study|Lost to Follow-up|1|||
13345978|NCT00973349|26641255|FG008|Overall Study|Lost to Follow-up|2|||
13345979|NCT00973349|26641256|FG009|Overall Study|Lost to Follow-up|1|||
13345980|NCT00973349|26641257|FG010|Overall Study|Lost to Follow-up|0|||
13345981|NCT00973349|26641258|FG011|Overall Study|Lost to Follow-up|1|||
13345982|NCT00973349|26641259|FG012|Overall Study|Lost to Follow-up|0|||
13345983|NCT00973349|26641260|FG013|Overall Study|Lost to Follow-up|0|||
13345984|NCT00973349|26641261|FG014|Overall Study|Lost to Follow-up|0|||
13345985|NCT00973349|26641262|FG015|Overall Study|Lost to Follow-up|1|||
13345986|NCT00973349|26641247|FG000|Overall Study|Inappropriate enrolment|0|||
13345987|NCT00973349|26641248|FG001|Overall Study|Inappropriate enrolment|0|||
13345988|NCT00973349|26641249|FG002|Overall Study|Inappropriate enrolment|1|||
13345989|NCT00973349|26641250|FG003|Overall Study|Inappropriate enrolment|0|||
13345990|NCT00973349|26641251|FG004|Overall Study|Inappropriate enrolment|0|||
13345991|NCT00973349|26641252|FG005|Overall Study|Inappropriate enrolment|0|||
13345992|NCT00973349|26641253|FG006|Overall Study|Inappropriate enrolment|0|||
13345993|NCT00973349|26641254|FG007|Overall Study|Inappropriate enrolment|0|||
13345994|NCT00973349|26641255|FG008|Overall Study|Inappropriate enrolment|0|||
13345995|NCT00973349|26641256|FG009|Overall Study|Inappropriate enrolment|2|||
13345996|NCT00973349|26641257|FG010|Overall Study|Inappropriate enrolment|0|||
13345997|NCT00973349|26641258|FG011|Overall Study|Inappropriate enrolment|0|||
13345998|NCT00973349|26641259|FG012|Overall Study|Inappropriate enrolment|1|||
13345999|NCT00973349|26641260|FG013|Overall Study|Inappropriate enrolment|0|||
13346000|NCT00973349|26641261|FG014|Overall Study|Inappropriate enrolment|1|||
13346001|NCT00973349|26641262|FG015|Overall Study|Inappropriate enrolment|1|||
13346002|NCT00973349|26641247|FG000|Overall Study|Protocol Violation|0|||
13346003|NCT00973349|26641248|FG001|Overall Study|Protocol Violation|0|||
13346004|NCT00973349|26641249|FG002|Overall Study|Protocol Violation|0|||
13346005|NCT00973349|26641250|FG003|Overall Study|Protocol Violation|0|||
13346006|NCT00973349|26641251|FG004|Overall Study|Protocol Violation|0|||
13346007|NCT00973349|26641252|FG005|Overall Study|Protocol Violation|0|||
13346008|NCT00973349|26641253|FG006|Overall Study|Protocol Violation|0|||
13346009|NCT00973349|26641254|FG007|Overall Study|Protocol Violation|0|||
13346010|NCT00973349|26641255|FG008|Overall Study|Protocol Violation|1|||
13346011|NCT00973349|26641256|FG009|Overall Study|Protocol Violation|0|||
13346012|NCT00973349|26641257|FG010|Overall Study|Protocol Violation|0|||
13346013|NCT00973349|26641258|FG011|Overall Study|Protocol Violation|0|||
13346014|NCT00973349|26641259|FG012|Overall Study|Protocol Violation|0|||
13346015|NCT00973349|26641260|FG013|Overall Study|Protocol Violation|0|||
13346016|NCT00973349|26641261|FG014|Overall Study|Protocol Violation|0|||
13346017|NCT00973349|26641262|FG015|Overall Study|Protocol Violation|0|||
13346018|NCT00973349|26641247|FG000|Overall Study|Unable to classify|0|||
13346019|NCT00973349|26641248|FG001|Overall Study|Unable to classify|0|||
13346020|NCT00973349|26641249|FG002|Overall Study|Unable to classify|0|||
13346021|NCT00973349|26641250|FG003|Overall Study|Unable to classify|0|||
13346022|NCT00973349|26641251|FG004|Overall Study|Unable to classify|1|||
13346023|NCT00973349|26641252|FG005|Overall Study|Unable to classify|1|||
13346024|NCT00973349|26641253|FG006|Overall Study|Unable to classify|0|||
13346025|NCT00973349|26641254|FG007|Overall Study|Unable to classify|0|||
13346026|NCT00973349|26641255|FG008|Overall Study|Unable to classify|0|||
13346027|NCT00973349|26641256|FG009|Overall Study|Unable to classify|1|||
13346028|NCT00973349|26641257|FG010|Overall Study|Unable to classify|0|||
13346029|NCT00973349|26641258|FG011|Overall Study|Unable to classify|0|||
13346030|NCT00973349|26641259|FG012|Overall Study|Unable to classify|0|||
13346031|NCT00973349|26641260|FG013|Overall Study|Unable to classify|0|||
13346032|NCT00973349|26641261|FG014|Overall Study|Unable to classify|0|||
13346033|NCT00973349|26641262|FG015|Overall Study|Unable to classify|0|||
13346034|NCT00973102|26641277|FG000|Overall Study|Protocol Violation|1|||
13346035|NCT00973102|26641278|FG001|Overall Study|Protocol Violation|0|||
13346036|NCT00973102|26641277|FG000|Overall Study|Prisoner|0|||
13346037|NCT00973102|26641278|FG001|Overall Study|Prisoner|1|||
13346038|NCT00972816|26641385|FG000|Overall Study|Adverse Event|0|||
13346039|NCT00972816|26641386|FG001|Overall Study|Adverse Event|0|||
13346040|NCT00972816|26641387|FG002|Overall Study|Adverse Event|1|||
13346041|NCT00972816|26641388|FG003|Overall Study|Adverse Event|0|||
13346042|NCT00972816|26641389|FG004|Overall Study|Adverse Event|0|||
13346043|NCT00972816|26641390|FG005|Overall Study|Adverse Event|0|||
13346044|NCT00972816|26641391|FG006|Overall Study|Adverse Event|0|||
13346045|NCT00972816|26641392|FG007|Overall Study|Adverse Event|0|||
13346046|NCT00972816|26641385|FG000|Overall Study|Withdrawal by Subject|4|||
13346047|NCT00972816|26641386|FG001|Overall Study|Withdrawal by Subject|2|||
13346048|NCT00972816|26641387|FG002|Overall Study|Withdrawal by Subject|1|||
13346049|NCT00972816|26641388|FG003|Overall Study|Withdrawal by Subject|3|||
13346050|NCT00972816|26641389|FG004|Overall Study|Withdrawal by Subject|0|||
13346051|NCT00972816|26641390|FG005|Overall Study|Withdrawal by Subject|1|||
13346052|NCT00972816|26641391|FG006|Overall Study|Withdrawal by Subject|1|||
13346053|NCT00972816|26641392|FG007|Overall Study|Withdrawal by Subject|2|||
13346054|NCT00972816|26641385|FG000|Overall Study|Lost to Follow-up|11|||
13346055|NCT00972816|26641386|FG001|Overall Study|Lost to Follow-up|9|||
13346056|NCT00972816|26641387|FG002|Overall Study|Lost to Follow-up|7|||
13346057|NCT00972816|26641388|FG003|Overall Study|Lost to Follow-up|5|||
13346058|NCT00972816|26641389|FG004|Overall Study|Lost to Follow-up|11|||
13346059|NCT00972816|26641390|FG005|Overall Study|Lost to Follow-up|10|||
13346060|NCT00972816|26641391|FG006|Overall Study|Lost to Follow-up|7|||
13346061|NCT00972816|26641392|FG007|Overall Study|Lost to Follow-up|7|||
13346062|NCT00972816|26641385|FG000|Overall Study|Inappropriate enrolment|0|||
13346063|NCT00972816|26641386|FG001|Overall Study|Inappropriate enrolment|0|||
13346064|NCT00972816|26641387|FG002|Overall Study|Inappropriate enrolment|0|||
13346065|NCT00972816|26641388|FG003|Overall Study|Inappropriate enrolment|0|||
13346066|NCT00972816|26641389|FG004|Overall Study|Inappropriate enrolment|0|||
13346067|NCT00972816|26641390|FG005|Overall Study|Inappropriate enrolment|0|||
13346068|NCT00972816|26641391|FG006|Overall Study|Inappropriate enrolment|2|||
13346069|NCT00972816|26641392|FG007|Overall Study|Inappropriate enrolment|0|||
13346070|NCT00972816|26641385|FG000|Overall Study|Unable to classify|2|||
13346071|NCT00972816|26641386|FG001|Overall Study|Unable to classify|0|||
13346072|NCT00972816|26641387|FG002|Overall Study|Unable to classify|0|||
13346073|NCT00972816|26641388|FG003|Overall Study|Unable to classify|0|||
13346074|NCT00972816|26641389|FG004|Overall Study|Unable to classify|1|||
13346075|NCT00972816|26641390|FG005|Overall Study|Unable to classify|0|||
13346076|NCT00972816|26641391|FG006|Overall Study|Unable to classify|0|||
13346077|NCT00972816|26641392|FG007|Overall Study|Unable to classify|0|||
13346078|NCT00972777|26641411|FG000|Overall Study|Adverse Event|3|||
13346079|NCT00972777|26641412|FG001|Overall Study|Adverse Event|2|||
13346080|NCT00972777|26641411|FG000|Overall Study|Lost to Follow-up|0|||
13346081|NCT00972777|26641412|FG001|Overall Study|Lost to Follow-up|4|||
13346082|NCT00972777|26641411|FG000|Overall Study|Withdrawal by Subject|4|||
13346083|NCT00972777|26641412|FG001|Overall Study|Withdrawal by Subject|5|||
13346084|NCT00972777|26641411|FG000|Overall Study|Physician Decision|4|||
13346085|NCT00972777|26641412|FG001|Overall Study|Physician Decision|0|||
13346086|NCT00972777|26641411|FG000|Overall Study|Protocol Violation|0|||
13346087|NCT00972777|26641412|FG001|Overall Study|Protocol Violation|2|||
13346088|NCT00972777|26641411|FG000|Overall Study|Screening Failure|2|||
13346089|NCT00972777|26641412|FG001|Overall Study|Screening Failure|1|||
13346090|NCT00972777|26641411|FG000|Overall Study|Missed visit|1|||
13346091|NCT00972777|26641412|FG001|Overall Study|Missed visit|0|||
13346092|NCT00972595|26641423|FG000|Period 1|Adverse Event|1|||
13346093|NCT00972595|26641424|FG001|Period 1|Adverse Event|0|||
13346094|NCT00972543|26641505|FG000|Overall Study|Adverse Event|1|||
13346095|NCT00972543|26641506|FG001|Overall Study|Adverse Event|0|||
13346096|NCT00972543|26641505|FG000|Overall Study|Early study termination by sponsor|4|||
13346097|NCT00972543|26641506|FG001|Overall Study|Early study termination by sponsor|1|||
13346098|NCT00972517|26641608|FG000|Overall Study|Adverse Event|0|||
13346099|NCT00972517|26641609|FG001|Overall Study|Adverse Event|0|||
13346100|NCT00972517|26641610|FG002|Overall Study|Adverse Event|0|||
13346101|NCT00972517|26641611|FG003|Overall Study|Adverse Event|1|||
13346102|NCT00972517|26641612|FG004|Overall Study|Adverse Event|0|||
13346103|NCT00972517|26641613|FG005|Overall Study|Adverse Event|0|||
13346104|NCT00972517|26641608|FG000|Overall Study|Withdrawal by Subject|0|||
13346105|NCT00972517|26641609|FG001|Overall Study|Withdrawal by Subject|1|||
13346106|NCT00972517|26641610|FG002|Overall Study|Withdrawal by Subject|0|||
13346107|NCT00972517|26641611|FG003|Overall Study|Withdrawal by Subject|2|||
13346108|NCT00972517|26641612|FG004|Overall Study|Withdrawal by Subject|1|||
13346109|NCT00972517|26641613|FG005|Overall Study|Withdrawal by Subject|0|||
13346110|NCT00972504|26641645|FG000|Overall Study|Adverse Event|2|||
13346111|NCT00972504|26641645|FG000|Overall Study|Investigator discretion|1|||
13346126|NCT00972322|26641680|FG000|Overall Study|Adverse Event|2|||
13346127|NCT00972322|26641681|FG001|Overall Study|Adverse Event|1|||
13346128|NCT00972322|26641680|FG000|Overall Study|Positive drug screen|0|||
13346129|NCT00972322|26641681|FG001|Overall Study|Positive drug screen|1|||
13346130|NCT00972322|26641680|FG000|Overall Study|Lost to Follow-up|0|||
13346131|NCT00972322|26641681|FG001|Overall Study|Lost to Follow-up|1|||
13346132|NCT00972322|26641680|FG000|Overall Study|Consistently high glucose values|1|||
13346133|NCT00972322|26641681|FG001|Overall Study|Consistently high glucose values|0|||
13346134|NCT00972283|26641710|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31|||
13346135|NCT00972283|26641711|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9|||
13346136|NCT00972283|26641710|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3|||
13346137|NCT00972283|26641711|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0|||
13346138|NCT00972283|26641710|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23|||
13346139|NCT00972283|26641711|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12|||
13346140|NCT00972283|26641710|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8|||
13346141|NCT00972283|26641711|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2|||
13346142|NCT00972283|26641710|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72|||
13346143|NCT00972283|26641711|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17|||
13346144|NCT00972283|26641710|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4|||
13346145|NCT00972283|26641711|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0|||
13346146|NCT00972283|26641710|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
13346147|NCT00972283|26641711|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
13346148|NCT00972283|26641710|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5|||
13346149|NCT00972283|26641711|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0|||
13346150|NCT00972283|26641710|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6|||
13346151|NCT00972283|26641711|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2|||
13346152|NCT00972283|26641710|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11|||
13346153|NCT00972283|26641711|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5|||
13346154|NCT00972244|26641749|FG000|Overall Study|Incorrect Enrolment|1|||
13346155|NCT00972244|26641750|FG001|Overall Study|Incorrect Enrolment|0|||
13346156|NCT00972244|26641751|FG002|Overall Study|Incorrect Enrolment|0|||
13346157|NCT00972244|26641752|FG003|Overall Study|Incorrect Enrolment|0|||
13346158|NCT00972244|26641753|FG004|Overall Study|Incorrect Enrolment|0|||
13346159|NCT00972244|26641749|FG000|Overall Study|Adverse Event|0|||
13346160|NCT00972244|26641750|FG001|Overall Study|Adverse Event|1|||
13346161|NCT00972244|26641751|FG002|Overall Study|Adverse Event|1|||
13346162|NCT00972244|26641752|FG003|Overall Study|Adverse Event|0|||
13346163|NCT00972244|26641753|FG004|Overall Study|Adverse Event|0|||
13346164|NCT00972244|26641749|FG000|Overall Study|Subject No Longer Meets Study Criteria|2|||
13346165|NCT00972244|26641750|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
13346166|NCT00972244|26641751|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
13346167|NCT00972244|26641752|FG003|Overall Study|Subject No Longer Meets Study Criteria|0|||
13346168|NCT00972244|26641753|FG004|Overall Study|Subject No Longer Meets Study Criteria|5|||
13346169|NCT00972244|26641749|FG000|Overall Study|Withdrawal by Subject|1|||
13346170|NCT00972244|26641750|FG001|Overall Study|Withdrawal by Subject|2|||
13346171|NCT00972244|26641751|FG002|Overall Study|Withdrawal by Subject|1|||
13346172|NCT00972244|26641752|FG003|Overall Study|Withdrawal by Subject|0|||
13346173|NCT00972244|26641753|FG004|Overall Study|Withdrawal by Subject|1|||
13346174|NCT00972244|26641749|FG000|Overall Study|Safety|0|||
13346175|NCT00972244|26641750|FG001|Overall Study|Safety|0|||
13346176|NCT00972244|26641751|FG002|Overall Study|Safety|0|||
13346177|NCT00972244|26641752|FG003|Overall Study|Safety|0|||
13346178|NCT00972244|26641753|FG004|Overall Study|Safety|1|||
13346179|NCT00972244|26641749|FG000|Overall Study|Death|1|||
13346180|NCT00972244|26641750|FG001|Overall Study|Death|0|||
13346181|NCT00972244|26641751|FG002|Overall Study|Death|0|||
13346182|NCT00972244|26641752|FG003|Overall Study|Death|0|||
13346183|NCT00972244|26641753|FG004|Overall Study|Death|0|||
13346184|NCT00972244|26641749|FG000|Overall Study|Various|0|||
13346185|NCT00972244|26641750|FG001|Overall Study|Various|0|||
13346186|NCT00972244|26641751|FG002|Overall Study|Various|0|||
13346187|NCT00972244|26641752|FG003|Overall Study|Various|0|||
13346188|NCT00972244|26641753|FG004|Overall Study|Various|2|||
13346189|NCT00972179|26641829|FG000|Overall Study|Noncompliance|1|||
13346190|NCT00972179|26641830|FG001|Overall Study|Noncompliance|0|||
13346191|NCT00972179|26641831|FG002|Overall Study|Noncompliance|0|||
13346192|NCT00972179|26641832|FG003|Overall Study|Noncompliance|0|||
13346193|NCT00972179|26641833|FG004|Overall Study|Noncompliance|1|||
13346194|NCT00972179|26641834|FG005|Overall Study|Noncompliance|0|||
13346195|NCT00972179|26641835|FG006|Overall Study|Noncompliance|1|||
13346196|NCT00972179|26641829|FG000|Overall Study|Withdrawal by Subject|0|||
13346197|NCT00972179|26641830|FG001|Overall Study|Withdrawal by Subject|3|||
13346198|NCT00972179|26641831|FG002|Overall Study|Withdrawal by Subject|0|||
13346199|NCT00972179|26641832|FG003|Overall Study|Withdrawal by Subject|1|||
13346200|NCT00972179|26641833|FG004|Overall Study|Withdrawal by Subject|0|||
13346201|NCT00972179|26641834|FG005|Overall Study|Withdrawal by Subject|0|||
13346202|NCT00972179|26641835|FG006|Overall Study|Withdrawal by Subject|2|||
13346203|NCT00972179|26641829|FG000|Overall Study|Administrative Decision|0|||
13346204|NCT00972179|26641830|FG001|Overall Study|Administrative Decision|0|||
13346205|NCT00972179|26641831|FG002|Overall Study|Administrative Decision|0|||
13346206|NCT00972179|26641832|FG003|Overall Study|Administrative Decision|0|||
13346207|NCT00972179|26641833|FG004|Overall Study|Administrative Decision|1|||
13346208|NCT00972179|26641834|FG005|Overall Study|Administrative Decision|0|||
13346209|NCT00972179|26641835|FG006|Overall Study|Administrative Decision|0|||
13346210|NCT00972179|26641829|FG000|Overall Study|Lost to Follow-up|0|||
13346211|NCT00972179|26641830|FG001|Overall Study|Lost to Follow-up|0|||
13346212|NCT00972179|26641831|FG002|Overall Study|Lost to Follow-up|1|||
13346213|NCT00972179|26641832|FG003|Overall Study|Lost to Follow-up|0|||
13346214|NCT00972179|26641833|FG004|Overall Study|Lost to Follow-up|0|||
13346215|NCT00972179|26641834|FG005|Overall Study|Lost to Follow-up|3|||
13124820|NCT02937701|25954306|FG004|Day 1 to Week 22|Protocol Specified Criteria|0|||
13124821|NCT02937701|25954302|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5|||
13124822|NCT02937701|25954303|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9|||
13124823|NCT02937701|25954304|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
13124824|NCT02937701|25954305|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
13124825|NCT02937701|25954306|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
13204393|NCT01973569|26228469|FG002|Overall Study|Prohibited concomitant d|0|||
13204394|NCT01973569|26228467|FG000|Overall Study|Disease progression|0|||
13204395|NCT01973569|26228468|FG001|Overall Study|Disease progression|3|||
13346216|NCT00972179|26641835|FG006|Overall Study|Lost to Follow-up|1|||
13346217|NCT00972153|26641856|FG000|Overall Study|Equipment malfunction during case|0|||
13346218|NCT00972153|26641857|FG001|Overall Study|Equipment malfunction during case|1|||
13346219|NCT00972153|26641858|FG002|Overall Study|Equipment malfunction during case|0|||
13346220|NCT00972023|26641867|FG000|Overall Study|Withdrawal by Subject|1|||
13346221|NCT00971997|26641887|FG000|Overall Study|Adverse Event|2|||
13346222|NCT00971997|26641887|FG000|Overall Study|Death|1|||
13346223|NCT00971997|26641887|FG000|Overall Study|Protocol Violation|4|||
13346224|NCT00971997|26641887|FG000|Overall Study|Withdrawal by Subject|5|||
13346225|NCT00971997|26641887|FG000|Overall Study|Physician Decision|7|||
13346226|NCT00971945|26641896|FG000|Overall Study|Progressive Disease|3|||
13346227|NCT00971945|26641896|FG000|Overall Study|Change in treatment policy|1|||
13346228|NCT00971945|26641896|FG000|Overall Study|Other reasons|2|||
13346229|NCT00971932|26641908|FG000|Overall Study|Withdrawal by Subject|1|||
13346230|NCT00971932|26641908|FG000|Overall Study|Investigator's decision|2|||
13346231|NCT00971932|26641908|FG000|Overall Study|Ongoing|4|||
13374109|NCT00797966|26725795|FG000|Phase B|Met Withdrawal Criteria|3|||
13374110|NCT00797966|26725796|FG001|Phase B|Met Withdrawal Criteria|3|||
13374111|NCT00797966|26725797|FG002|Phase B|Met Withdrawal Criteria|6|||
13374112|NCT00797966|26725798|FG003|Phase B|Met Withdrawal Criteria|1|||
13374113|NCT00797966|26725799|FG004|Phase B|Met Withdrawal Criteria|0|||
13374114|NCT00797966|26725800|FG005|Phase B|Met Withdrawal Criteria|0|||
13374115|NCT00797966|26725795|FG000|Phase B|Physician Decision|1|||
13374116|NCT00797966|26725796|FG001|Phase B|Physician Decision|0|||
13374117|NCT00797966|26725797|FG002|Phase B|Physician Decision|3|||
13374118|NCT00797966|26725798|FG003|Phase B|Physician Decision|1|||
13374119|NCT00797966|26725799|FG004|Phase B|Physician Decision|0|||
13374120|NCT00797966|26725800|FG005|Phase B|Physician Decision|0|||
13374121|NCT00797966|26725795|FG000|Phase B|Withdrawal by Subject|1|||
13374122|NCT00797966|26725796|FG001|Phase B|Withdrawal by Subject|4|||
13374123|NCT00797966|26725797|FG002|Phase B|Withdrawal by Subject|3|||
13374124|NCT00797966|26725798|FG003|Phase B|Withdrawal by Subject|3|||
13374125|NCT00797966|26725799|FG004|Phase B|Withdrawal by Subject|0|||
13374126|NCT00797966|26725800|FG005|Phase B|Withdrawal by Subject|0|||
13374127|NCT00797966|26725795|FG000|Phase B|Protocol Deviation|4|||
13374128|NCT00797966|26725796|FG001|Phase B|Protocol Deviation|8|||
13374129|NCT00797966|26725797|FG002|Phase B|Protocol Deviation|2|||
13374130|NCT00797966|26725798|FG003|Phase B|Protocol Deviation|6|||
13374131|NCT00797966|26725799|FG004|Phase B|Protocol Deviation|0|||
13374132|NCT00797966|26725800|FG005|Phase B|Protocol Deviation|0|||
13374133|NCT00797966|26725795|FG000|Phase B|Lack of Efficacy|0|||
13374134|NCT00797966|26725796|FG001|Phase B|Lack of Efficacy|1|||
13374135|NCT00797966|26725797|FG002|Phase B|Lack of Efficacy|1|||
13374136|NCT00797966|26725798|FG003|Phase B|Lack of Efficacy|4|||
13346232|NCT00971867|26641922|FG000|Overall Study|Adverse Event|4|||
13346233|NCT00971867|26641922|FG000|Overall Study|Participant Withdrew Consent|1|||
13346234|NCT00971867|26641922|FG000|Overall Study|Disease Progression|6|||
13346235|NCT00971425|26641963|FG000|Overall Study|Adverse Event|1|||
13346236|NCT00971425|26641964|FG001|Overall Study|Adverse Event|1|||
13346237|NCT00971425|26641963|FG000|Overall Study|Withdrawal by Subject|0|||
13346238|NCT00971425|26641964|FG001|Overall Study|Withdrawal by Subject|1|||
13346239|NCT00971321|26642021|FG000|Up to Month 7|Withdrawal by Subject|1|||
13346240|NCT00971321|26642022|FG001|Up to Month 7|Withdrawal by Subject|0|||
13346241|NCT00971321|26642021|FG000|Up to Month 7|Migrated/moved from study area|3|||
13346242|NCT00971321|26642022|FG001|Up to Month 7|Migrated/moved from study area|2|||
13346243|NCT00971321|26642021|FG000|Up to Month 11-12|Withdrawal by Subject|2|||
13346244|NCT00971321|26642022|FG001|Up to Month 11-12|Withdrawal by Subject|1|||
13346245|NCT00971321|26642021|FG000|Up to Month 11-12|Migrated/moved from study area|2|||
13346246|NCT00971321|26642022|FG001|Up to Month 11-12|Migrated/moved from study area|2|||
13346247|NCT00971321|26642021|FG000|Up to Month 11-12|Lost to Follow-up|1|||
13346248|NCT00971321|26642022|FG001|Up to Month 11-12|Lost to Follow-up|0|||
13346249|NCT00971243|26642055|FG000|Double Blind Period|Adverse Event|2|||
13346250|NCT00971243|26642056|FG001|Double Blind Period|Adverse Event|3|||
13346251|NCT00971243|26642057|FG002|Double Blind Period|Adverse Event|2|||
13346252|NCT00971243|26642058|FG003|Double Blind Period|Adverse Event|2|||
13346253|NCT00971243|26642059|FG004|Double Blind Period|Adverse Event|3|||
13346254|NCT00971243|26642055|FG000|Double Blind Period|Lost to Follow-up|0|||
13346255|NCT00971243|26642056|FG001|Double Blind Period|Lost to Follow-up|1|||
13346256|NCT00971243|26642057|FG002|Double Blind Period|Lost to Follow-up|1|||
13346257|NCT00971243|26642058|FG003|Double Blind Period|Lost to Follow-up|0|||
13346258|NCT00971243|26642059|FG004|Double Blind Period|Lost to Follow-up|1|||
13346259|NCT00971243|26642055|FG000|Double Blind Period|Physician Decision|10|||
13346260|NCT00971243|26642056|FG001|Double Blind Period|Physician Decision|6|||
13346261|NCT00971243|26642057|FG002|Double Blind Period|Physician Decision|7|||
13346262|NCT00971243|26642058|FG003|Double Blind Period|Physician Decision|6|||
13346263|NCT00971243|26642059|FG004|Double Blind Period|Physician Decision|7|||
13346264|NCT00971243|26642055|FG000|Double Blind Period|Protocol Violation|2|||
13346265|NCT00971243|26642056|FG001|Double Blind Period|Protocol Violation|0|||
13346266|NCT00971243|26642057|FG002|Double Blind Period|Protocol Violation|3|||
13346267|NCT00971243|26642058|FG003|Double Blind Period|Protocol Violation|2|||
13346268|NCT00971243|26642059|FG004|Double Blind Period|Protocol Violation|2|||
13346269|NCT00971243|26642055|FG000|Double Blind Period|Withdrawal by Subject|4|||
13346270|NCT00971243|26642056|FG001|Double Blind Period|Withdrawal by Subject|1|||
13346271|NCT00971243|26642057|FG002|Double Blind Period|Withdrawal by Subject|4|||
13346272|NCT00971243|26642058|FG003|Double Blind Period|Withdrawal by Subject|4|||
13346273|NCT00971243|26642059|FG004|Double Blind Period|Withdrawal by Subject|4|||
13346274|NCT00971243|26642055|FG000|Double Blind Period|Other reasons|1|||
13346275|NCT00971243|26642056|FG001|Double Blind Period|Other reasons|0|||
13346276|NCT00971243|26642057|FG002|Double Blind Period|Other reasons|2|||
13346277|NCT00971243|26642058|FG003|Double Blind Period|Other reasons|0|||
13346278|NCT00971243|26642059|FG004|Double Blind Period|Other reasons|1|||
13346279|NCT00971243|26642055|FG000|Open-label Period|Adverse Event|1|||
13346280|NCT00971243|26642056|FG001|Open-label Period|Adverse Event|0|||
13346281|NCT00971243|26642057|FG002|Open-label Period|Adverse Event|1|||
13346282|NCT00971243|26642058|FG003|Open-label Period|Adverse Event|1|||
13346283|NCT00971243|26642059|FG004|Open-label Period|Adverse Event|0|||
13346284|NCT00971243|26642055|FG000|Open-label Period|Physician Decision|5|||
13346285|NCT00971243|26642056|FG001|Open-label Period|Physician Decision|9|||
13346286|NCT00971243|26642057|FG002|Open-label Period|Physician Decision|3|||
13346287|NCT00971243|26642058|FG003|Open-label Period|Physician Decision|7|||
13346288|NCT00971243|26642059|FG004|Open-label Period|Physician Decision|2|||
13346289|NCT00971243|26642055|FG000|Open-label Period|Protocol Violation|1|||
13346290|NCT00971243|26642056|FG001|Open-label Period|Protocol Violation|1|||
13346291|NCT00971243|26642057|FG002|Open-label Period|Protocol Violation|1|||
13346292|NCT00971243|26642058|FG003|Open-label Period|Protocol Violation|0|||
13346293|NCT00971243|26642059|FG004|Open-label Period|Protocol Violation|1|||
13346294|NCT00971243|26642055|FG000|Open-label Period|Withdrawal by Subject|1|||
13346295|NCT00971243|26642056|FG001|Open-label Period|Withdrawal by Subject|0|||
13346296|NCT00971243|26642057|FG002|Open-label Period|Withdrawal by Subject|0|||
13346297|NCT00971243|26642058|FG003|Open-label Period|Withdrawal by Subject|2|||
13346298|NCT00971243|26642059|FG004|Open-label Period|Withdrawal by Subject|1|||
13346299|NCT00971243|26642055|FG000|Open-label Period|Other reason|0|||
13346300|NCT00971243|26642056|FG001|Open-label Period|Other reason|0|||
13346301|NCT00971243|26642057|FG002|Open-label Period|Other reason|0|||
13346302|NCT00971243|26642058|FG003|Open-label Period|Other reason|0|||
13346303|NCT00971243|26642059|FG004|Open-label Period|Other reason|2|||
13346304|NCT00971204|26642065|FG000|Overall Study|Did not meet all criteria-not treated|14|||
13346305|NCT00971204|26642065|FG000|Overall Study|Lost to Follow-up|10|||
13346306|NCT00971178|26642083|FG000|Overall Study|Lost to Follow-up|2|||
13346307|NCT00971178|26642084|FG001|Overall Study|Lost to Follow-up|2|||
13346308|NCT00971178|26642085|FG002|Overall Study|Lost to Follow-up|2|||
13346309|NCT00971048|26642120|FG000|Overall Study|Protocol Violation|1|||
13346310|NCT00971048|26642121|FG001|Overall Study|Protocol Violation|2|||
13346311|NCT00971048|26642122|FG002|Overall Study|Protocol Violation|0|||
13346312|NCT00971048|26642123|FG003|Overall Study|Protocol Violation|1|||
13346313|NCT00971048|26642120|FG000|Overall Study|Adverse Event|0|||
13346314|NCT00971048|26642121|FG001|Overall Study|Adverse Event|0|||
13346315|NCT00971048|26642122|FG002|Overall Study|Adverse Event|1|||
13346316|NCT00971048|26642123|FG003|Overall Study|Adverse Event|0|||
13346317|NCT00971048|26642120|FG000|Overall Study|Physician Decision|0|||
13346318|NCT00971048|26642121|FG001|Overall Study|Physician Decision|0|||
13346319|NCT00971048|26642122|FG002|Overall Study|Physician Decision|0|||
13346320|NCT00971048|26642123|FG003|Overall Study|Physician Decision|1|||
13346321|NCT00970944|26642138|FG000|Overall Study|Death|1|||
13346322|NCT00970944|26642139|FG001|Overall Study|Death|0|||
13346323|NCT00970944|26642138|FG000|Overall Study|Physician Decision|0|||
13346324|NCT00970944|26642139|FG001|Overall Study|Physician Decision|2|||
13346325|NCT00970684|26642147|FG000|Overall Study|Lack of Efficacy|5|||
13346326|NCT00970684|26642147|FG000|Overall Study|Adverse Event|4|||
13346327|NCT00970684|26642147|FG000|Overall Study|Withdrawal by Subject|1|||
13346328|NCT00970632|26642213|FG000|Overall Study|Adverse Event|2|||
13346329|NCT00970632|26642214|FG001|Overall Study|Adverse Event|2|||
13346330|NCT00970632|26642215|FG002|Overall Study|Adverse Event|1|||
13346331|NCT00970632|26642213|FG000|Overall Study|Lack of Efficacy|3|||
13346332|NCT00970632|26642214|FG001|Overall Study|Lack of Efficacy|0|||
13346333|NCT00970632|26642215|FG002|Overall Study|Lack of Efficacy|0|||
13346334|NCT00970632|26642213|FG000|Overall Study|Lost to Follow-up|3|||
13346335|NCT00970632|26642214|FG001|Overall Study|Lost to Follow-up|0|||
13346336|NCT00970632|26642215|FG002|Overall Study|Lost to Follow-up|2|||
13346337|NCT00970632|26642213|FG000|Overall Study|Protocol Violation|8|||
13346338|NCT00970632|26642214|FG001|Overall Study|Protocol Violation|5|||
13346339|NCT00970632|26642215|FG002|Overall Study|Protocol Violation|8|||
13346340|NCT00970632|26642213|FG000|Overall Study|Withdrawal by Subject|7|||
13346341|NCT00970632|26642214|FG001|Overall Study|Withdrawal by Subject|6|||
13346342|NCT00970632|26642215|FG002|Overall Study|Withdrawal by Subject|4|||
13346343|NCT00970632|26642213|FG000|Overall Study|Entry criteria not met|0|||
13346344|NCT00970632|26642214|FG001|Overall Study|Entry criteria not met|2|||
13346345|NCT00970632|26642215|FG002|Overall Study|Entry criteria not met|2|||
13346346|NCT00970632|26642213|FG000|Overall Study|Sponsor decision|1|||
13346347|NCT00970632|26642214|FG001|Overall Study|Sponsor decision|0|||
13346348|NCT00970632|26642215|FG002|Overall Study|Sponsor decision|1|||
13346349|NCT00970593|26642319|FG000|Overall Study|Adverse Event|1|||
13346350|NCT00970593|26642320|FG001|Overall Study|Adverse Event|1|||
13346351|NCT00970593|26642321|FG002|Overall Study|Adverse Event|0|||
13346352|NCT00970593|26642322|FG003|Overall Study|Adverse Event|0|||
13346353|NCT00970593|26642323|FG004|Overall Study|Adverse Event|0|||
13346354|NCT00970593|26642324|FG005|Overall Study|Adverse Event|0|||
13346355|NCT00970593|26642325|FG006|Overall Study|Adverse Event|0|||
13346356|NCT00970593|26642319|FG000|Overall Study|Discontinuation of study by sponsor|0|||
13346357|NCT00970593|26642320|FG001|Overall Study|Discontinuation of study by sponsor|0|||
13346358|NCT00970593|26642321|FG002|Overall Study|Discontinuation of study by sponsor|5|||
13346359|NCT00970593|26642322|FG003|Overall Study|Discontinuation of study by sponsor|0|||
13346360|NCT00970593|26642323|FG004|Overall Study|Discontinuation of study by sponsor|0|||
13346361|NCT00970593|26642324|FG005|Overall Study|Discontinuation of study by sponsor|0|||
13346362|NCT00970593|26642325|FG006|Overall Study|Discontinuation of study by sponsor|2|||
13346363|NCT00970593|26642319|FG000|Overall Study|Withdrawal by Subject|0|||
13346364|NCT00970593|26642320|FG001|Overall Study|Withdrawal by Subject|0|||
13346365|NCT00970593|26642321|FG002|Overall Study|Withdrawal by Subject|1|||
13346366|NCT00970593|26642322|FG003|Overall Study|Withdrawal by Subject|0|||
13346367|NCT00970593|26642323|FG004|Overall Study|Withdrawal by Subject|0|||
13346368|NCT00970593|26642324|FG005|Overall Study|Withdrawal by Subject|0|||
13346369|NCT00970593|26642325|FG006|Overall Study|Withdrawal by Subject|0|||
13346370|NCT00970502|26642336|FG000|Overall Study|Withdrawal by Subject|1|||
13346371|NCT00970489|26642355|FG000|Overall Study|Death/Withdrew/Criteria Violation|54|||
13346372|NCT00970489|26642356|FG001|Overall Study|Death/Withdrew/Criteria Violation|41|||
13346373|NCT00970359|26642364|FG000|Overall Study|Not Treated|4|||
13346374|NCT00970307|26642448|FG000|Overall Study|Serious Adverse Event|1|||
13346375|NCT00970307|26642449|FG001|Overall Study|Serious Adverse Event|0|||
13346376|NCT00970307|26642450|FG002|Overall Study|Serious Adverse Event|0|||
13346377|NCT00970307|26642448|FG000|Overall Study|Withdrawal by Subject|2|||
13346378|NCT00970307|26642449|FG001|Overall Study|Withdrawal by Subject|3|||
13346379|NCT00970307|26642450|FG002|Overall Study|Withdrawal by Subject|2|||
13346380|NCT00970294|26642458|FG000|Overall Study|Physician Decision|4|||
13346381|NCT00970294|26642458|FG000|Overall Study|Withdrawal by Subject|1|||
13346382|NCT00970281|26642481|FG000|Overall Study|Lack of Efficacy|1|||
13346383|NCT00970281|26642482|FG001|Overall Study|Lack of Efficacy|14|||
13346384|NCT00970281|26642481|FG000|Overall Study|Withdrawal by Subject|0|||
13346385|NCT00970281|26642482|FG001|Overall Study|Withdrawal by Subject|1|||
13346386|NCT00970281|26642481|FG000|Overall Study|Physician Decision|1|||
13346387|NCT00970281|26642482|FG001|Overall Study|Physician Decision|1|||
13346388|NCT00970268|26642503|FG000|Overall Study|Withdrawal by Subject|12|||
13346389|NCT00970268|26642504|FG001|Overall Study|Withdrawal by Subject|19|||
13346390|NCT00970268|26642503|FG000|Overall Study|Adverse Event|15|||
13346391|NCT00970268|26642504|FG001|Overall Study|Adverse Event|12|||
13346392|NCT00970268|26642503|FG000|Overall Study|Lack of Efficacy|3|||
13346393|NCT00970268|26642504|FG001|Overall Study|Lack of Efficacy|6|||
13346394|NCT00970268|26642503|FG000|Overall Study|Protocol Violation|4|||
13346395|NCT00970268|26642504|FG001|Overall Study|Protocol Violation|7|||
13346396|NCT00970268|26642503|FG000|Overall Study|Other Reason|3|||
13346397|NCT00970268|26642504|FG001|Overall Study|Other Reason|1|||
13346398|NCT00970268|26642503|FG000|Overall Study|COPD Exacerbation|4|||
13346399|NCT00970268|26642504|FG001|Overall Study|COPD Exacerbation|2|||
13346400|NCT00970268|26642503|FG000|Overall Study|Lost to Follow-up|1|||
13346401|NCT00970268|26642504|FG001|Overall Study|Lost to Follow-up|2|||
13346402|NCT00970268|26642503|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
13346403|NCT00970268|26642504|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
13346404|NCT00969761|26642843|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
13346405|NCT00969761|26642844|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
13346406|NCT00969761|26642845|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
13346407|NCT00969761|26642846|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
13346408|NCT00969761|26642847|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
13346409|NCT00969761|26642848|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
13346410|NCT00969761|26642849|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
13346411|NCT00969761|26642850|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
13346412|NCT00969761|26642851|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
13346413|NCT00969761|26642852|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
13346414|NCT00969761|26642853|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
13346415|NCT00969761|26642854|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
13346416|NCT00969761|26642843|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
13346417|NCT00969761|26642844|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
13346418|NCT00969761|26642845|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1|||
13346419|NCT00969761|26642846|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
13346420|NCT00969761|26642847|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
13346421|NCT00969761|26642848|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
13346422|NCT00969761|26642849|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
13346423|NCT00969761|26642850|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
13346424|NCT00969761|26642851|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
13346425|NCT00969761|26642852|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
13346426|NCT00969761|26642853|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
13346427|NCT00969761|26642854|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
13346428|NCT00969761|26642843|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
13346429|NCT00969761|26642844|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
13346430|NCT00969761|26642845|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1|||
13346431|NCT00969761|26642846|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
13346432|NCT00969761|26642847|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
13346433|NCT00969761|26642848|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
13346434|NCT00969761|26642849|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
13346435|NCT00969761|26642850|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
13346436|NCT00969761|26642851|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
13346437|NCT00969761|26642852|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
13346438|NCT00969761|26642853|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
13346439|NCT00969761|26642854|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
13346440|NCT00969761|26642843|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
13346441|NCT00969761|26642844|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
13346442|NCT00969761|26642845|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
13346443|NCT00969761|26642846|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
13346444|NCT00969761|26642847|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
13346445|NCT00969761|26642848|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
13346446|NCT00969761|26642849|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
13346447|NCT00969761|26642850|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
13346448|NCT00969761|26642851|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1|||
13346449|NCT00969761|26642852|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
13346450|NCT00969761|26642853|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
13374137|NCT00797966|26725799|FG004|Phase B|Lack of Efficacy|0|||
13346451|NCT00969761|26642854|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
13346452|NCT00969761|26642843|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
13346453|NCT00969761|26642844|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
13346454|NCT00969761|26642845|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10|||
13346455|NCT00969761|26642846|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
13346456|NCT00969761|26642847|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
13346457|NCT00969761|26642848|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
13346458|NCT00969761|26642849|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
13346459|NCT00969761|26642850|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6|||
13346460|NCT00969761|26642851|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9|||
13346461|NCT00969761|26642852|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
13346462|NCT00969761|26642853|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
13346463|NCT00969761|26642854|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
13346464|NCT00969761|26642843|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
13346465|NCT00969761|26642844|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
13346466|NCT00969761|26642845|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
13346467|NCT00969761|26642846|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
13346468|NCT00969761|26642847|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1|||
13346469|NCT00969761|26642848|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
13346470|NCT00969761|26642849|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
13346471|NCT00969761|26642850|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
13346472|NCT00969761|26642851|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
13346473|NCT00969761|26642852|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
13346474|NCT00969761|26642853|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
13346475|NCT00969761|26642854|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
13346476|NCT00969709|26642881|FG000|Overall Study|Adverse Event|3|||
13346477|NCT00969709|26642882|FG001|Overall Study|Adverse Event|13|||
13346478|NCT00969709|26642883|FG002|Overall Study|Adverse Event|26|||
13346479|NCT00969709|26642884|FG003|Overall Study|Adverse Event|12|||
13346480|NCT00969709|26642881|FG000|Overall Study|Lack of Efficacy|7|||
13346481|NCT00969709|26642882|FG001|Overall Study|Lack of Efficacy|4|||
13346482|NCT00969709|26642883|FG002|Overall Study|Lack of Efficacy|1|||
13346483|NCT00969709|26642884|FG003|Overall Study|Lack of Efficacy|3|||
13346484|NCT00969709|26642881|FG000|Overall Study|Protocol Violation|9|||
13346485|NCT00969709|26642882|FG001|Overall Study|Protocol Violation|5|||
13346486|NCT00969709|26642883|FG002|Overall Study|Protocol Violation|9|||
13346487|NCT00969709|26642884|FG003|Overall Study|Protocol Violation|10|||
13346488|NCT00969709|26642881|FG000|Overall Study|Withdrawal by Subject|9|||
13346489|NCT00969709|26642882|FG001|Overall Study|Withdrawal by Subject|12|||
13346490|NCT00969709|26642883|FG002|Overall Study|Withdrawal by Subject|11|||
13346491|NCT00969709|26642884|FG003|Overall Study|Withdrawal by Subject|23|||
13346492|NCT00969709|26642881|FG000|Overall Study|Lost to Follow-up|10|||
13346493|NCT00969709|26642882|FG001|Overall Study|Lost to Follow-up|14|||
13346494|NCT00969709|26642883|FG002|Overall Study|Lost to Follow-up|8|||
13346495|NCT00969709|26642884|FG003|Overall Study|Lost to Follow-up|15|||
13346496|NCT00969709|26642881|FG000|Overall Study|Other reasons|0|||
13346497|NCT00969709|26642882|FG001|Overall Study|Other reasons|0|||
13346498|NCT00969709|26642883|FG002|Overall Study|Other reasons|3|||
13346499|NCT00969709|26642884|FG003|Overall Study|Other reasons|0|||
13346500|NCT00969618|26642897|FG000|Overall Study|Adverse Event|29|||
13346501|NCT00969618|26642897|FG000|Overall Study|Entry Criteria Not Met|3|||
13346502|NCT00969618|26642897|FG000|Overall Study|Lack of Efficacy|2|||
13346503|NCT00969618|26642897|FG000|Overall Study|Lost to Follow-up|7|||
13346504|NCT00969618|26642897|FG000|Overall Study|Physician Decision|1|||
13346505|NCT00969618|26642897|FG000|Overall Study|Protocol Violation|9|||
13346506|NCT00969618|26642897|FG000|Overall Study|Withdrawal by Subject|27|||
13346507|NCT00969553|26643066|FG000|Overall Study|Progressive disease (PD)|2|||
13346508|NCT00969553|26643067|FG001|Overall Study|Progressive disease (PD)|2|||
13346509|NCT00969553|26643068|FG002|Overall Study|Progressive disease (PD)|6|||
13346510|NCT00969553|26643069|FG003|Overall Study|Progressive disease (PD)|9|||
13346511|NCT00969553|26643070|FG004|Overall Study|Progressive disease (PD)|2|||
13346512|NCT00969553|26643071|FG005|Overall Study|Progressive disease (PD)|4|||
13346513|NCT00969553|26643072|FG006|Overall Study|Progressive disease (PD)|2|||
13346514|NCT00969553|26643073|FG007|Overall Study|Progressive disease (PD)|12|||
13346515|NCT00969553|26643074|FG008|Overall Study|Progressive disease (PD)|3|||
13346516|NCT00969553|26643066|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
13346517|NCT00969553|26643067|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
13346518|NCT00969553|26643068|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
13346519|NCT00969553|26643069|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
13346520|NCT00969553|26643070|FG004|Overall Study|Dose limiting Toxicity (DLT)|1|||
13346521|NCT00969553|26643071|FG005|Overall Study|Dose limiting Toxicity (DLT)|0|||
13346522|NCT00969553|26643072|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
13346523|NCT00969553|26643073|FG007|Overall Study|Dose limiting Toxicity (DLT)|0|||
13346524|NCT00969553|26643074|FG008|Overall Study|Dose limiting Toxicity (DLT)|0|||
13346525|NCT00969553|26643066|FG000|Overall Study|Other Adverse Event|0|||
13346526|NCT00969553|26643067|FG001|Overall Study|Other Adverse Event|0|||
13346527|NCT00969553|26643068|FG002|Overall Study|Other Adverse Event|0|||
13346528|NCT00969553|26643069|FG003|Overall Study|Other Adverse Event|1|||
13346529|NCT00969553|26643070|FG004|Overall Study|Other Adverse Event|0|||
13346530|NCT00969553|26643071|FG005|Overall Study|Other Adverse Event|0|||
13346531|NCT00969553|26643072|FG006|Overall Study|Other Adverse Event|1|||
13346532|NCT00969553|26643073|FG007|Overall Study|Other Adverse Event|0|||
13346533|NCT00969553|26643074|FG008|Overall Study|Other Adverse Event|0|||
13346534|NCT00969553|26643066|FG000|Overall Study|Refused cont. medication|1|||
13346535|NCT00969553|26643067|FG001|Overall Study|Refused cont. medication|1|||
13346536|NCT00969553|26643068|FG002|Overall Study|Refused cont. medication|0|||
13346537|NCT00969553|26643069|FG003|Overall Study|Refused cont. medication|2|||
13346538|NCT00969553|26643070|FG004|Overall Study|Refused cont. medication|0|||
13346539|NCT00969553|26643071|FG005|Overall Study|Refused cont. medication|0|||
13346540|NCT00969553|26643072|FG006|Overall Study|Refused cont. medication|0|||
13346541|NCT00969553|26643073|FG007|Overall Study|Refused cont. medication|1|||
13346542|NCT00969553|26643074|FG008|Overall Study|Refused cont. medication|0|||
13346543|NCT00969553|26643066|FG000|Overall Study|Not specified above|0|||
13346544|NCT00969553|26643067|FG001|Overall Study|Not specified above|0|||
13346545|NCT00969553|26643068|FG002|Overall Study|Not specified above|0|||
13346546|NCT00969553|26643069|FG003|Overall Study|Not specified above|4|||
13346547|NCT00969553|26643070|FG004|Overall Study|Not specified above|0|||
13346548|NCT00969553|26643071|FG005|Overall Study|Not specified above|0|||
13346549|NCT00969553|26643072|FG006|Overall Study|Not specified above|1|||
13346550|NCT00969553|26643073|FG007|Overall Study|Not specified above|1|||
13346551|NCT00969553|26643074|FG008|Overall Study|Not specified above|0|||
13346552|NCT00969540|26643099|FG000|Overall Study|Lost to Follow-up|1|||
13346553|NCT00969540|26643100|FG001|Overall Study|Lost to Follow-up|1|||
13346554|NCT00969436|26643142|FG000|Overall Study|Protocol Violation|1|||
13346555|NCT00969436|26643143|FG001|Overall Study|Protocol Violation|3|||
13346556|NCT00969436|26643144|FG002|Overall Study|Protocol Violation|0|||
13346557|NCT00969436|26643142|FG000|Overall Study|Migrated/moved from study area|12|||
13346558|NCT00969436|26643143|FG001|Overall Study|Migrated/moved from study area|10|||
13346559|NCT00969436|26643144|FG002|Overall Study|Migrated/moved from study area|2|||
13346560|NCT00969436|26643142|FG000|Overall Study|Father - serious health problem|0|||
13346561|NCT00969436|26643143|FG001|Overall Study|Father - serious health problem|0|||
13346562|NCT00969436|26643144|FG002|Overall Study|Father - serious health problem|1|||
13346563|NCT00969436|26643142|FG000|Overall Study|Parents personal problem|0|||
13346564|NCT00969436|26643143|FG001|Overall Study|Parents personal problem|0|||
13346565|NCT00969436|26643144|FG002|Overall Study|Parents personal problem|1|||
13346566|NCT00969436|26643142|FG000|Overall Study|Subject eliminated (other vaccine)|1|||
13346567|NCT00969436|26643143|FG001|Overall Study|Subject eliminated (other vaccine)|0|||
13346568|NCT00969436|26643144|FG002|Overall Study|Subject eliminated (other vaccine)|0|||
13346569|NCT00969436|26643142|FG000|Overall Study|Withdrawal by Subject|3|||
13346570|NCT00969436|26643143|FG001|Overall Study|Withdrawal by Subject|0|||
13346571|NCT00969436|26643144|FG002|Overall Study|Withdrawal by Subject|2|||
13346572|NCT00969436|26643142|FG000|Overall Study|Lost to Follow-up|8|||
13346573|NCT00969436|26643143|FG001|Overall Study|Lost to Follow-up|8|||
13346574|NCT00969436|26643144|FG002|Overall Study|Lost to Follow-up|5|||
13346575|NCT00969332|26643160|FG000|Overall Study|Physician Decision|8|||
13346576|NCT00969332|26643160|FG000|Overall Study|Withdrawal by Subject|3|||
13346577|NCT00969280|26643173|FG000|Overall Study|Protocol Violation|2|||
13346578|NCT00969280|26643174|FG001|Overall Study|Protocol Violation|1|||
13346579|NCT00969280|26643173|FG000|Overall Study|Withdrawal by Subject|0|||
13346580|NCT00969280|26643174|FG001|Overall Study|Withdrawal by Subject|1|||
13346581|NCT00969280|26643173|FG000|Overall Study|infection of influenza A(H1N1)|0|||
13346582|NCT00969280|26643174|FG001|Overall Study|infection of influenza A(H1N1)|1|||
13346583|NCT00969228|26643197|FG000|Overall Study|Adverse Event|1|||
13346584|NCT00969228|26643198|FG001|Overall Study|Adverse Event|0|||
13346585|NCT00969228|26643197|FG000|Overall Study|Withdrawal by Subject|4|||
13346586|NCT00969228|26643198|FG001|Overall Study|Withdrawal by Subject|0|||
13346587|NCT00969228|26643197|FG000|Overall Study|Porcine circovirus detection in vaccine|38|||
13346588|NCT00969228|26643198|FG001|Overall Study|Porcine circovirus detection in vaccine|14|||
13346589|NCT00969150|26643213|FG000|Overall Study|Adverse Event|4|||
13346590|NCT00969150|26643214|FG001|Overall Study|Adverse Event|14|||
13346591|NCT00969150|26643213|FG000|Overall Study|Lack of Efficacy|1|||
13346592|NCT00969150|26643214|FG001|Overall Study|Lack of Efficacy|1|||
13346593|NCT00969150|26643213|FG000|Overall Study|Protocol Violation|9|||
13346594|NCT00969150|26643214|FG001|Overall Study|Protocol Violation|12|||
13346595|NCT00969150|26643213|FG000|Overall Study|Withdrawal by Subject|13|||
13346596|NCT00969150|26643214|FG001|Overall Study|Withdrawal by Subject|9|||
13346597|NCT00969150|26643213|FG000|Overall Study|Lost to Follow-up|5|||
13346598|NCT00969150|26643214|FG001|Overall Study|Lost to Follow-up|4|||
13346599|NCT00969150|26643213|FG000|Overall Study|Other reasons|1|||
13346600|NCT00969150|26643214|FG001|Overall Study|Other reasons|0|||
13346601|NCT00969124|26643222|FG000|Overall Study|Protocol Violation|2|||
13346602|NCT00969124|26643222|FG000|Overall Study|Inadequate bowel preparation|15|||
13346603|NCT00969124|26643222|FG000|Overall Study|Inability to reach cecum|9|||
13346604|NCT00969124|26643222|FG000|Overall Study|Previously unrecognized disease|3|||
13346605|NCT00969124|26643222|FG000|Overall Study|Technical error|1|||
13346606|NCT00968981|26643268|FG000|Overall Study|Adverse Event|2|||
13346607|NCT00968981|26643269|FG001|Overall Study|Adverse Event|0|||
13346608|NCT00968981|26643270|FG002|Overall Study|Adverse Event|0|||
13346609|NCT00968981|26643268|FG000|Overall Study|Disease Progression|14|||
13346610|NCT00968981|26643269|FG001|Overall Study|Disease Progression|16|||
13346611|NCT00968981|26643270|FG002|Overall Study|Disease Progression|13|||
13346612|NCT00968981|26643268|FG000|Overall Study|Lost to Follow-up|0|||
13346613|NCT00968981|26643269|FG001|Overall Study|Lost to Follow-up|0|||
13346614|NCT00968981|26643270|FG002|Overall Study|Lost to Follow-up|1|||
13346615|NCT00968981|26643268|FG000|Overall Study|Physician Decision|5|||
13346616|NCT00968981|26643269|FG001|Overall Study|Physician Decision|3|||
13346617|NCT00968981|26643270|FG002|Overall Study|Physician Decision|5|||
13346618|NCT00968981|26643268|FG000|Overall Study|Withdrawal by Subject|1|||
13346619|NCT00968981|26643269|FG001|Overall Study|Withdrawal by Subject|3|||
13346620|NCT00968981|26643270|FG002|Overall Study|Withdrawal by Subject|3|||
13346621|NCT00968968|26643292|FG000|Overall Study|Study closed/terminated|10|||
13346622|NCT00968968|26643293|FG001|Overall Study|Study closed/terminated|10|||
13346623|NCT00968968|26643292|FG000|Overall Study|Protocol defined stopping criteria|3|||
13346624|NCT00968968|26643293|FG001|Overall Study|Protocol defined stopping criteria|1|||
13346625|NCT00968968|26643292|FG000|Overall Study|Withdrawal by Subject|2|||
13346626|NCT00968968|26643293|FG001|Overall Study|Withdrawal by Subject|0|||
13346627|NCT00968968|26643292|FG000|Overall Study|Physician Decision|1|||
13346628|NCT00968968|26643293|FG001|Overall Study|Physician Decision|2|||
13346629|NCT00968968|26643292|FG000|Overall Study|Lost to Follow-up|0|||
13346630|NCT00968968|26643293|FG001|Overall Study|Lost to Follow-up|1|||
13346631|NCT00968864|26643311|FG000|Overall Study|Protocol exception/ not evaluable|1|||
13346632|NCT00968812|26643341|FG000|Overall Study|Adverse Event|30|||
13346633|NCT00968812|26643342|FG001|Overall Study|Adverse Event|46|||
13346634|NCT00968812|26643343|FG002|Overall Study|Adverse Event|33|||
13346635|NCT00968812|26643341|FG000|Overall Study|Death|2|||
13346636|NCT00968812|26643342|FG001|Overall Study|Death|2|||
13346637|NCT00968812|26643343|FG002|Overall Study|Death|1|||
13346638|NCT00968812|26643341|FG000|Overall Study|Lack of Efficacy|9|||
13346639|NCT00968812|26643342|FG001|Overall Study|Lack of Efficacy|7|||
13346640|NCT00968812|26643343|FG002|Overall Study|Lack of Efficacy|16|||
13346641|NCT00968812|26643341|FG000|Overall Study|Lost to Follow-up|17|||
13346642|NCT00968812|26643342|FG001|Overall Study|Lost to Follow-up|12|||
13346643|NCT00968812|26643343|FG002|Overall Study|Lost to Follow-up|11|||
13346644|NCT00968812|26643341|FG000|Overall Study|Physician Decision|8|||
13346645|NCT00968812|26643342|FG001|Overall Study|Physician Decision|5|||
13346646|NCT00968812|26643343|FG002|Overall Study|Physician Decision|9|||
13346647|NCT00968812|26643341|FG000|Overall Study|Protocol Violation|7|||
13346648|NCT00968812|26643342|FG001|Overall Study|Protocol Violation|4|||
13346649|NCT00968812|26643343|FG002|Overall Study|Protocol Violation|3|||
13346650|NCT00968812|26643341|FG000|Overall Study|Withdrawal by Subject|17|||
13346651|NCT00968812|26643342|FG001|Overall Study|Withdrawal by Subject|23|||
13346652|NCT00968812|26643343|FG002|Overall Study|Withdrawal by Subject|25|||
13346653|NCT00968812|26643341|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9|||
13346654|NCT00968812|26643342|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13|||
13346655|NCT00968812|26643343|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7|||
13346656|NCT00968812|26643341|FG000|Overall Study|Noncompliance with study drug|4|||
13346657|NCT00968812|26643342|FG001|Overall Study|Noncompliance with study drug|1|||
13346658|NCT00968812|26643343|FG002|Overall Study|Noncompliance with study drug|6|||
13346659|NCT00968812|26643341|FG000|Overall Study|Unable to take rescue therapy|12|||
13346660|NCT00968812|26643342|FG001|Overall Study|Unable to take rescue therapy|12|||
13346661|NCT00968812|26643343|FG002|Overall Study|Unable to take rescue therapy|17|||
13346662|NCT00968812|26643341|FG000|Overall Study|Other|25|||
13346663|NCT00968812|26643342|FG001|Overall Study|Other|37|||
13346664|NCT00968812|26643343|FG002|Overall Study|Other|40|||
13346665|NCT00968799|26643353|FG000|Overall Study|Advanced disease, HIPEC not applicable|2|||
13346666|NCT00968708|26643368|FG000|Overall Study|Adverse Event|169|||
13346667|NCT00968708|26643369|FG001|Overall Study|Adverse Event|150|||
13346668|NCT00968708|26643368|FG000|Overall Study|Major Protocol Deviation|0|||
13346669|NCT00968708|26643369|FG001|Overall Study|Major Protocol Deviation|1|||
13346670|NCT00968708|26643368|FG000|Overall Study|Lost to Follow-up|19|||
13346671|NCT00968708|26643369|FG001|Overall Study|Lost to Follow-up|11|||
13346672|NCT00968708|26643368|FG000|Overall Study|Voluntary Withdrawal|104|||
13346673|NCT00968708|26643369|FG001|Overall Study|Voluntary Withdrawal|101|||
13346674|NCT00968708|26643368|FG000|Overall Study|Investigator Discretion|0|||
13346675|NCT00968708|26643369|FG001|Overall Study|Investigator Discretion|1|||
13346676|NCT00968708|26643368|FG000|Overall Study|Other|26|||
13346677|NCT00968708|26643369|FG001|Overall Study|Other|34|||
13346678|NCT00968669|26643472|FG000|Overall Study|Lost to Follow-up|5|||
13346679|NCT00968669|26643473|FG001|Overall Study|Lost to Follow-up|2|||
13346680|NCT00968669|26643474|FG002|Overall Study|Lost to Follow-up|1|||
13346681|NCT00968669|26643475|FG003|Overall Study|Lost to Follow-up|4|||
13346682|NCT00968669|26643472|FG000|Overall Study|Withdrawal by Subject|9|||
13346683|NCT00968669|26643473|FG001|Overall Study|Withdrawal by Subject|7|||
13346684|NCT00968669|26643474|FG002|Overall Study|Withdrawal by Subject|5|||
13346685|NCT00968669|26643475|FG003|Overall Study|Withdrawal by Subject|3|||
13346686|NCT00968669|26643472|FG000|Overall Study|Pregnancy|0|||
13346687|NCT00968669|26643473|FG001|Overall Study|Pregnancy|0|||
13346688|NCT00968669|26643474|FG002|Overall Study|Pregnancy|2|||
13346689|NCT00968669|26643475|FG003|Overall Study|Pregnancy|0|||
13346690|NCT00968669|26643472|FG000|Overall Study|AE|1|||
13346691|NCT00968669|26643473|FG001|Overall Study|AE|0|||
13346692|NCT00968669|26643474|FG002|Overall Study|AE|0|||
13346693|NCT00968669|26643475|FG003|Overall Study|AE|0|||
13346694|NCT00968669|26643472|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
13346695|NCT00968669|26643473|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
13346696|NCT00968669|26643474|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
13346697|NCT00968669|26643475|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1|||
13346698|NCT00968669|26643472|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1|||
13346699|NCT00968669|26643473|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
13346700|NCT00968669|26643474|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
13346701|NCT00968669|26643475|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
13346702|NCT00968669|26643472|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1|||
13346703|NCT00968669|26643473|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
13346704|NCT00968669|26643474|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
13346705|NCT00968669|26643475|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
13346706|NCT00968669|26643472|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
13346707|NCT00968669|26643473|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
13346708|NCT00968669|26643474|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1|||
13346709|NCT00968669|26643475|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
13346710|NCT00968669|26643472|FG000|Overall Study|EARLY WITHDRAWAL|0|||
13346711|NCT00968669|26643473|FG001|Overall Study|EARLY WITHDRAWAL|1|||
13346712|NCT00968669|26643474|FG002|Overall Study|EARLY WITHDRAWAL|0|||
13346713|NCT00968669|26643475|FG003|Overall Study|EARLY WITHDRAWAL|0|||
13346714|NCT00968669|26643472|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
13346715|NCT00968669|26643473|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
13346716|NCT00968669|26643474|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1|||
13346717|NCT00968669|26643475|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
13346718|NCT00968669|26643472|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1|||
13346719|NCT00968669|26643473|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
13346720|NCT00968669|26643474|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
13346721|NCT00968669|26643475|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
13346722|NCT00968669|26643472|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
13346723|NCT00968669|26643473|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1|||
13346724|NCT00968669|26643474|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
13346725|NCT00968669|26643475|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
13346726|NCT00968669|26643472|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
13346727|NCT00968669|26643473|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1|||
13346728|NCT00968669|26643474|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
13346729|NCT00968669|26643475|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
13346730|NCT00968669|26643472|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
13346731|NCT00968669|26643473|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1|||
13346732|NCT00968669|26643474|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
13346733|NCT00968669|26643475|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
13124826|NCT02937701|25954302|FG000|Day 1 to Week 22|Withdrawal by Subject|6|||
13346734|NCT00968669|26643472|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
13346735|NCT00968669|26643473|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1|||
13346736|NCT00968669|26643474|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
13346737|NCT00968669|26643475|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
13346738|NCT00968669|26643472|FG000|Overall Study|SPONSOR DECISION|0|||
13346739|NCT00968669|26643473|FG001|Overall Study|SPONSOR DECISION|1|||
13346740|NCT00968669|26643474|FG002|Overall Study|SPONSOR DECISION|0|||
13346741|NCT00968669|26643475|FG003|Overall Study|SPONSOR DECISION|0|||
13346742|NCT00968669|26643472|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
13346743|NCT00968669|26643473|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
13346744|NCT00968669|26643474|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1|||
13346745|NCT00968669|26643475|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
13346746|NCT00968669|26643472|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
13346747|NCT00968669|26643473|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1|||
13346748|NCT00968669|26643474|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
13346749|NCT00968669|26643475|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
13393626|NCT00662909|26784486|FG001|Overall Study|Non-compliance with study procedures|3|||
13346750|NCT00968669|26643472|FG000|Overall Study|SUBJECT INCARCERATED|0|||
13346751|NCT00968669|26643473|FG001|Overall Study|SUBJECT INCARCERATED|1|||
13346752|NCT00968669|26643474|FG002|Overall Study|SUBJECT INCARCERATED|0|||
13346753|NCT00968669|26643475|FG003|Overall Study|SUBJECT INCARCERATED|0|||
13346754|NCT00968669|26643472|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
13346755|NCT00968669|26643473|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1|||
13346756|NCT00968669|26643474|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
13346757|NCT00968669|26643475|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
13124827|NCT02937701|25954303|FG001|Day 1 to Week 22|Withdrawal by Subject|6|||
13124828|NCT02937701|25954304|FG002|Day 1 to Week 22|Withdrawal by Subject|0|||
13124829|NCT02937701|25954305|FG003|Day 1 to Week 22|Withdrawal by Subject|0|||
13124830|NCT02937701|25954306|FG004|Day 1 to Week 22|Withdrawal by Subject|0|||
13124831|NCT02937701|25954302|FG000|Day 1 to Week 22|Death|1|||
13124832|NCT02937701|25954303|FG001|Day 1 to Week 22|Death|1|||
13124833|NCT02937701|25954304|FG002|Day 1 to Week 22|Death|0|||
13124834|NCT02937701|25954305|FG003|Day 1 to Week 22|Death|0|||
13124835|NCT02937701|25954306|FG004|Day 1 to Week 22|Death|0|||
13124836|NCT02937701|25954302|FG000|Day 1 to Week 22|Protocol Violation|1|||
13124837|NCT02937701|25954303|FG001|Day 1 to Week 22|Protocol Violation|1|||
13204396|NCT01973569|26228469|FG002|Overall Study|Disease progression|0|||
13204397|NCT01973569|26228467|FG000|Overall Study|Other|1|||
13204398|NCT01973569|26228468|FG001|Overall Study|Other|1|||
13204399|NCT01973569|26228469|FG002|Overall Study|Other|0|||
13204400|NCT01973569|26228467|FG000|Overall Study|Did not receive study drug|6|||
13204401|NCT01973569|26228468|FG001|Overall Study|Did not receive study drug|3|||
13204402|NCT01973569|26228469|FG002|Overall Study|Did not receive study drug|3|||
13346758|NCT00968669|26643472|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
13346759|NCT00968669|26643473|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
13346760|NCT00968669|26643474|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
13346761|NCT00968669|26643475|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1|||
13204403|NCT01973491|26228487|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17|||
13346762|NCT00968617|26643489|FG000|Overall Study|Study terminated by sponsor|6|||
13346763|NCT00968539|26643554|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
13346764|NCT00968539|26643555|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
13346765|NCT00968526|26643652|FG000|Overall Study|Adverse Event|2|||
13346766|NCT00968526|26643653|FG001|Overall Study|Adverse Event|0|||
13346767|NCT00968526|26643652|FG000|Overall Study|Migrated/moved from study area|1|||
13346768|NCT00968526|26643653|FG001|Overall Study|Migrated/moved from study area|0|||
13346769|NCT00968253|26643677|FG000|Overall Study|Death|0|||
13346770|NCT00968253|26643678|FG001|Overall Study|Death|0|||
13346771|NCT00968253|26643679|FG002|Overall Study|Death|2|||
13346772|NCT00968253|26643677|FG000|Overall Study|Withdrawal by Subject|0|||
13346773|NCT00968253|26643678|FG001|Overall Study|Withdrawal by Subject|0|||
13346774|NCT00968253|26643679|FG002|Overall Study|Withdrawal by Subject|1|||
13346775|NCT00968253|26643677|FG000|Overall Study|Disease Progression|0|||
13346776|NCT00968253|26643678|FG001|Overall Study|Disease Progression|3|||
13346777|NCT00968253|26643679|FG002|Overall Study|Disease Progression|3|||
13346778|NCT00968253|26643677|FG000|Overall Study|Adverse Event|0|||
13346779|NCT00968253|26643678|FG001|Overall Study|Adverse Event|0|||
13346780|NCT00968253|26643679|FG002|Overall Study|Adverse Event|1|||
13346781|NCT00967798|26643700|FG000|Overall Study|Withdrawal by Subject|5|||
13346782|NCT00967798|26643701|FG001|Overall Study|Withdrawal by Subject|2|||
13346783|NCT00967798|26643700|FG000|Overall Study|Lost to Follow-up|4|||
13346784|NCT00967798|26643701|FG001|Overall Study|Lost to Follow-up|1|||
13346785|NCT00967694|26643707|FG000|Overall Study|Withdrawal by Subject|6|||
13346786|NCT00967668|26643728|FG000|Overall Study|Withdrawal by Subject|13|||
13346787|NCT00967668|26643729|FG001|Overall Study|Withdrawal by Subject|8|||
13346788|NCT00967668|26643730|FG002|Overall Study|Withdrawal by Subject|8|||
13346789|NCT00967668|26643728|FG000|Overall Study|Death|0|||
13346790|NCT00967668|26643729|FG001|Overall Study|Death|2|||
13346791|NCT00967668|26643730|FG002|Overall Study|Death|4|||
13346792|NCT00967668|26643728|FG000|Overall Study|Removed due to behavior|1|||
13346793|NCT00967668|26643729|FG001|Overall Study|Removed due to behavior|1|||
13346794|NCT00967668|26643730|FG002|Overall Study|Removed due to behavior|2|||
13346795|NCT00967668|26643728|FG000|Overall Study|Refused Year 2|11|||
13346796|NCT00967668|26643729|FG001|Overall Study|Refused Year 2|6|||
13346797|NCT00967668|26643730|FG002|Overall Study|Refused Year 2|4|||
13346798|NCT00967668|26643728|FG000|Overall Study|Lost to follow-up at 12-mo|27|||
13346799|NCT00967668|26643729|FG001|Overall Study|Lost to follow-up at 12-mo|29|||
13346800|NCT00967668|26643730|FG002|Overall Study|Lost to follow-up at 12-mo|26|||
13346801|NCT00967668|26643728|FG000|Overall Study|Lost to Follow-up|15|||
13346802|NCT00967668|26643729|FG001|Overall Study|Lost to Follow-up|9|||
13346803|NCT00967668|26643730|FG002|Overall Study|Lost to Follow-up|16|||
13346804|NCT00967668|26643728|FG000|Overall Study|Refused 12-mo assessment|3|||
13393627|NCT00662909|26784487|FG002|Overall Study|Non-compliance with study procedures|2|||
13204404|NCT01973491|26228487|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1|||
13346805|NCT00967668|26643729|FG001|Overall Study|Refused 12-mo assessment|1|||
13346806|NCT00967668|26643730|FG002|Overall Study|Refused 12-mo assessment|9|||
13346807|NCT00967668|26643728|FG000|Overall Study|Pregnancy|1|||
13346808|NCT00967668|26643729|FG001|Overall Study|Pregnancy|0|||
13346809|NCT00967668|26643730|FG002|Overall Study|Pregnancy|0|||
13346810|NCT00967616|26643751|FG000|Overall Study|Adverse Event or Serious Adverse Event|2|||
13346811|NCT00967616|26643752|FG001|Overall Study|Adverse Event or Serious Adverse Event|17|||
13346812|NCT00967616|26643751|FG000|Overall Study|Death|0|||
13346813|NCT00967616|26643752|FG001|Overall Study|Death|3|||
13346814|NCT00967616|26643751|FG000|Overall Study|Withdrawal by Subject|8|||
13346815|NCT00967616|26643752|FG001|Overall Study|Withdrawal by Subject|4|||
13346816|NCT00967616|26643751|FG000|Overall Study|Progressive Disease|31|||
13346817|NCT00967616|26643752|FG001|Overall Study|Progressive Disease|18|||
13346818|NCT00967616|26643751|FG000|Overall Study|Other|8|||
13346819|NCT00967616|26643752|FG001|Overall Study|Other|8|||
13346820|NCT00967616|26643751|FG000|Overall Study|Protocol Violation|1|||
13346821|NCT00967616|26643752|FG001|Overall Study|Protocol Violation|0|||
13346822|NCT00967499|26643775|FG000|Overall Study|Adverse Event|0|||
13346823|NCT00967499|26643776|FG001|Overall Study|Adverse Event|1|||
13346824|NCT00967499|26643775|FG000|Overall Study|Protocol Violation|1|||
13346825|NCT00967499|26643776|FG001|Overall Study|Protocol Violation|0|||
13346826|NCT00967499|26643775|FG000|Overall Study|Sponsor Decision|1|||
13346827|NCT00967499|26643776|FG001|Overall Study|Sponsor Decision|0|||
13346828|NCT00967499|26643775|FG000|Overall Study|Randomized but not treated|63|||
13346829|NCT00967499|26643776|FG001|Overall Study|Randomized but not treated|59|||
13346830|NCT00967343|26643788|FG000|Overall Study|Study termination by sponsor|12|||
13346831|NCT00967343|26643788|FG000|Overall Study|Death|24|||
13346832|NCT00967343|26643788|FG000|Overall Study|Relapse|1|||
13346833|NCT00967343|26643788|FG000|Overall Study|Lost to Follow-up|1|||
13346834|NCT00967330|26643823|FG000|Overall Study|Protocol Violation|3|||
13346835|NCT00967330|26643824|FG001|Overall Study|Protocol Violation|4|||
13346836|NCT00967330|26643823|FG000|Overall Study|Regular|10|||
13346837|NCT00967330|26643824|FG001|Overall Study|Regular|3|||
13346838|NCT00967330|26643823|FG000|Overall Study|Withdrawal by Subject|6|||
13346839|NCT00967330|26643824|FG001|Overall Study|Withdrawal by Subject|0|||
13346840|NCT00967330|26643823|FG000|Overall Study|Lost to Follow-up|1|||
13346841|NCT00967330|26643824|FG001|Overall Study|Lost to Follow-up|1|||
13346842|NCT00967330|26643823|FG000|Overall Study|Death|102|||
13346843|NCT00967330|26643824|FG001|Overall Study|Death|51|||
13346844|NCT00967330|26643823|FG000|Overall Study|Severe protocol deviation|0|||
13346845|NCT00967330|26643824|FG001|Overall Study|Severe protocol deviation|1|||
13346846|NCT00967226|26643861|FG000|Overall Study|Adverse Event|0|||
13346847|NCT00967226|26643862|FG001|Overall Study|Adverse Event|5|||
13346848|NCT00967226|26643861|FG000|Overall Study|Protocol Violation|2|||
13346849|NCT00967226|26643862|FG001|Overall Study|Protocol Violation|0|||
13346850|NCT00967226|26643861|FG000|Overall Study|Physician Decision|0|||
13346851|NCT00967226|26643862|FG001|Overall Study|Physician Decision|1|||
13346852|NCT00967018|26643871|FG000|Overall Study|Adverse Event|2|||
13346853|NCT00967018|26643871|FG000|Overall Study|Physician Decision|7|||
13346854|NCT00967018|26643871|FG000|Overall Study|Lost to Follow-up|2|||
13346855|NCT00967018|26643871|FG000|Overall Study|Withdrawal by Subject|1|||
13346856|NCT00967018|26643871|FG000|Overall Study|Miscellaneous Reasons|9|||
13346857|NCT00967005|26643930|FG000|Overall Study|Lost to Follow-up|7|||
13346858|NCT00967005|26643931|FG001|Overall Study|Lost to Follow-up|10|||
13346859|NCT00966940|26643956|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2|||
13346860|NCT00966940|26643957|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0|||
13346861|NCT00966940|26643956|FG000|Period 1, First 6 Weeks|Protocol Violation|1|||
13346862|NCT00966940|26643957|FG001|Period 1, First 6 Weeks|Protocol Violation|0|||
13346863|NCT00966875|26644304|FG000|Part A|Adverse Event|2|||
13346864|NCT00966875|26644305|FG001|Part A|Adverse Event|1|||
13346865|NCT00966875|26644306|FG002|Part A|Adverse Event|0|||
13346866|NCT00966875|26644307|FG003|Part A|Adverse Event|1|||
13346867|NCT00966875|26644308|FG004|Part A|Adverse Event|0|||
13346868|NCT00966875|26644309|FG005|Part A|Adverse Event|1|||
13346869|NCT00966875|26644310|FG006|Part A|Adverse Event|0|||
13346870|NCT00966875|26644311|FG007|Part A|Adverse Event|3|||
13346871|NCT00966875|26644312|FG008|Part A|Adverse Event|3|||
13346872|NCT00966875|26644304|FG000|Part A|Entry Criteria|0|||
13346873|NCT00966875|26644305|FG001|Part A|Entry Criteria|0|||
13346874|NCT00966875|26644306|FG002|Part A|Entry Criteria|0|||
13346875|NCT00966875|26644307|FG003|Part A|Entry Criteria|0|||
13346876|NCT00966875|26644308|FG004|Part A|Entry Criteria|0|||
13346877|NCT00966875|26644309|FG005|Part A|Entry Criteria|2|||
13346878|NCT00966875|26644310|FG006|Part A|Entry Criteria|0|||
13346879|NCT00966875|26644311|FG007|Part A|Entry Criteria|0|||
13346880|NCT00966875|26644312|FG008|Part A|Entry Criteria|0|||
13346881|NCT00966875|26644304|FG000|Part A|Lack of Efficacy|0|||
13346882|NCT00966875|26644305|FG001|Part A|Lack of Efficacy|1|||
13346883|NCT00966875|26644306|FG002|Part A|Lack of Efficacy|0|||
13346884|NCT00966875|26644307|FG003|Part A|Lack of Efficacy|0|||
13346885|NCT00966875|26644308|FG004|Part A|Lack of Efficacy|0|||
13346886|NCT00966875|26644309|FG005|Part A|Lack of Efficacy|0|||
13346887|NCT00966875|26644310|FG006|Part A|Lack of Efficacy|4|||
13346888|NCT00966875|26644311|FG007|Part A|Lack of Efficacy|0|||
13346889|NCT00966875|26644312|FG008|Part A|Lack of Efficacy|0|||
13346890|NCT00966875|26644304|FG000|Part A|Lost to Follow-up|2|||
13346891|NCT00966875|26644305|FG001|Part A|Lost to Follow-up|0|||
13346892|NCT00966875|26644306|FG002|Part A|Lost to Follow-up|0|||
13346893|NCT00966875|26644307|FG003|Part A|Lost to Follow-up|0|||
13346894|NCT00966875|26644308|FG004|Part A|Lost to Follow-up|0|||
13346895|NCT00966875|26644309|FG005|Part A|Lost to Follow-up|1|||
13346896|NCT00966875|26644310|FG006|Part A|Lost to Follow-up|0|||
13346897|NCT00966875|26644311|FG007|Part A|Lost to Follow-up|0|||
13346898|NCT00966875|26644312|FG008|Part A|Lost to Follow-up|0|||
13346899|NCT00966875|26644304|FG000|Part A|Parent/Caregiver Decision|0|||
13346900|NCT00966875|26644305|FG001|Part A|Parent/Caregiver Decision|0|||
13346901|NCT00966875|26644306|FG002|Part A|Parent/Caregiver Decision|0|||
13346902|NCT00966875|26644307|FG003|Part A|Parent/Caregiver Decision|1|||
13346903|NCT00966875|26644308|FG004|Part A|Parent/Caregiver Decision|0|||
13346904|NCT00966875|26644309|FG005|Part A|Parent/Caregiver Decision|0|||
13346905|NCT00966875|26644310|FG006|Part A|Parent/Caregiver Decision|0|||
13346906|NCT00966875|26644311|FG007|Part A|Parent/Caregiver Decision|0|||
13346907|NCT00966875|26644312|FG008|Part A|Parent/Caregiver Decision|0|||
13346908|NCT00966875|26644304|FG000|Part A|Physician Decision|0|||
13346909|NCT00966875|26644305|FG001|Part A|Physician Decision|0|||
13346910|NCT00966875|26644306|FG002|Part A|Physician Decision|0|||
13346911|NCT00966875|26644307|FG003|Part A|Physician Decision|0|||
13346912|NCT00966875|26644308|FG004|Part A|Physician Decision|1|||
13346913|NCT00966875|26644309|FG005|Part A|Physician Decision|0|||
13346914|NCT00966875|26644310|FG006|Part A|Physician Decision|1|||
13346915|NCT00966875|26644311|FG007|Part A|Physician Decision|0|||
13346916|NCT00966875|26644312|FG008|Part A|Physician Decision|2|||
13346917|NCT00966875|26644304|FG000|Part A|Sponsor Decision|0|||
13346918|NCT00966875|26644305|FG001|Part A|Sponsor Decision|0|||
13346919|NCT00966875|26644306|FG002|Part A|Sponsor Decision|1|||
13346920|NCT00966875|26644307|FG003|Part A|Sponsor Decision|0|||
13346921|NCT00966875|26644308|FG004|Part A|Sponsor Decision|1|||
13346922|NCT00966875|26644309|FG005|Part A|Sponsor Decision|0|||
13346923|NCT00966875|26644310|FG006|Part A|Sponsor Decision|0|||
13346924|NCT00966875|26644311|FG007|Part A|Sponsor Decision|2|||
13346925|NCT00966875|26644312|FG008|Part A|Sponsor Decision|1|||
13346926|NCT00966875|26644304|FG000|Part A|Withdrawal by Subject|2|||
13346927|NCT00966875|26644305|FG001|Part A|Withdrawal by Subject|2|||
13346928|NCT00966875|26644306|FG002|Part A|Withdrawal by Subject|1|||
13346929|NCT00966875|26644307|FG003|Part A|Withdrawal by Subject|1|||
13346930|NCT00966875|26644308|FG004|Part A|Withdrawal by Subject|3|||
13346931|NCT00966875|26644309|FG005|Part A|Withdrawal by Subject|0|||
13346932|NCT00966875|26644310|FG006|Part A|Withdrawal by Subject|5|||
13346933|NCT00966875|26644311|FG007|Part A|Withdrawal by Subject|1|||
13346934|NCT00966875|26644312|FG008|Part A|Withdrawal by Subject|1|||
13346935|NCT00966875|26644304|FG000|Part A|Protocol Violation|0|||
13346936|NCT00966875|26644305|FG001|Part A|Protocol Violation|0|||
13346937|NCT00966875|26644306|FG002|Part A|Protocol Violation|0|||
13346938|NCT00966875|26644307|FG003|Part A|Protocol Violation|0|||
13346939|NCT00966875|26644308|FG004|Part A|Protocol Violation|0|||
13346940|NCT00966875|26644309|FG005|Part A|Protocol Violation|0|||
13346941|NCT00966875|26644310|FG006|Part A|Protocol Violation|2|||
13346942|NCT00966875|26644311|FG007|Part A|Protocol Violation|1|||
13346943|NCT00966875|26644312|FG008|Part A|Protocol Violation|1|||
13346944|NCT00966875|26644304|FG000|Part B|Adverse Event|0|||
13346945|NCT00966875|26644305|FG001|Part B|Adverse Event|1|||
13346946|NCT00966875|26644306|FG002|Part B|Adverse Event|1|||
13346947|NCT00966875|26644307|FG003|Part B|Adverse Event|0|||
13346948|NCT00966875|26644308|FG004|Part B|Adverse Event|1|||
13346949|NCT00966875|26644309|FG005|Part B|Adverse Event|0|||
13346950|NCT00966875|26644310|FG006|Part B|Adverse Event|5|||
13346951|NCT00966875|26644311|FG007|Part B|Adverse Event|2|||
13346952|NCT00966875|26644312|FG008|Part B|Adverse Event|2|||
13346953|NCT00966875|26644304|FG000|Part B|Death|0|||
13346954|NCT00966875|26644305|FG001|Part B|Death|0|||
13346955|NCT00966875|26644306|FG002|Part B|Death|1|||
13346956|NCT00966875|26644307|FG003|Part B|Death|0|||
13346957|NCT00966875|26644308|FG004|Part B|Death|0|||
13346958|NCT00966875|26644309|FG005|Part B|Death|0|||
13346959|NCT00966875|26644310|FG006|Part B|Death|0|||
13346960|NCT00966875|26644311|FG007|Part B|Death|1|||
13346961|NCT00966875|26644312|FG008|Part B|Death|0|||
13346962|NCT00966875|26644304|FG000|Part B|Lack of Efficacy|2|||
13346963|NCT00966875|26644305|FG001|Part B|Lack of Efficacy|1|||
13346964|NCT00966875|26644306|FG002|Part B|Lack of Efficacy|1|||
13346965|NCT00966875|26644307|FG003|Part B|Lack of Efficacy|1|||
13346966|NCT00966875|26644308|FG004|Part B|Lack of Efficacy|2|||
13346967|NCT00966875|26644309|FG005|Part B|Lack of Efficacy|3|||
13346968|NCT00966875|26644310|FG006|Part B|Lack of Efficacy|12|||
13346969|NCT00966875|26644311|FG007|Part B|Lack of Efficacy|9|||
13346970|NCT00966875|26644312|FG008|Part B|Lack of Efficacy|6|||
13346971|NCT00966875|26644304|FG000|Part B|Lost to Follow-up|0|||
13346972|NCT00966875|26644305|FG001|Part B|Lost to Follow-up|0|||
13346973|NCT00966875|26644306|FG002|Part B|Lost to Follow-up|0|||
13346974|NCT00966875|26644307|FG003|Part B|Lost to Follow-up|1|||
13346975|NCT00966875|26644308|FG004|Part B|Lost to Follow-up|0|||
13346976|NCT00966875|26644309|FG005|Part B|Lost to Follow-up|0|||
13346977|NCT00966875|26644310|FG006|Part B|Lost to Follow-up|0|||
13346978|NCT00966875|26644311|FG007|Part B|Lost to Follow-up|0|||
13346979|NCT00966875|26644312|FG008|Part B|Lost to Follow-up|1|||
13346980|NCT00966875|26644304|FG000|Part B|Physician Decision|0|||
13346981|NCT00966875|26644305|FG001|Part B|Physician Decision|0|||
13346982|NCT00966875|26644306|FG002|Part B|Physician Decision|1|||
13346983|NCT00966875|26644307|FG003|Part B|Physician Decision|0|||
13346984|NCT00966875|26644308|FG004|Part B|Physician Decision|2|||
13346985|NCT00966875|26644309|FG005|Part B|Physician Decision|1|||
13346986|NCT00966875|26644310|FG006|Part B|Physician Decision|0|||
13346987|NCT00966875|26644311|FG007|Part B|Physician Decision|0|||
13346988|NCT00966875|26644312|FG008|Part B|Physician Decision|2|||
13346989|NCT00966875|26644304|FG000|Part B|Sponsor Decision|1|||
13346990|NCT00966875|26644305|FG001|Part B|Sponsor Decision|0|||
13346991|NCT00966875|26644306|FG002|Part B|Sponsor Decision|0|||
13346992|NCT00966875|26644307|FG003|Part B|Sponsor Decision|0|||
13346993|NCT00966875|26644308|FG004|Part B|Sponsor Decision|0|||
13346994|NCT00966875|26644309|FG005|Part B|Sponsor Decision|1|||
13346995|NCT00966875|26644310|FG006|Part B|Sponsor Decision|0|||
13346996|NCT00966875|26644311|FG007|Part B|Sponsor Decision|2|||
13346997|NCT00966875|26644312|FG008|Part B|Sponsor Decision|1|||
13346998|NCT00966875|26644304|FG000|Part B|Withdrawal by Subject|2|||
13346999|NCT00966875|26644305|FG001|Part B|Withdrawal by Subject|1|||
13347000|NCT00966875|26644306|FG002|Part B|Withdrawal by Subject|2|||
13347001|NCT00966875|26644307|FG003|Part B|Withdrawal by Subject|1|||
13347002|NCT00966875|26644308|FG004|Part B|Withdrawal by Subject|2|||
13347003|NCT00966875|26644309|FG005|Part B|Withdrawal by Subject|1|||
13347004|NCT00966875|26644310|FG006|Part B|Withdrawal by Subject|4|||
13347005|NCT00966875|26644311|FG007|Part B|Withdrawal by Subject|5|||
13347006|NCT00966875|26644312|FG008|Part B|Withdrawal by Subject|5|||
13347007|NCT00966875|26644304|FG000|Part B|Entry Criteria|0|||
13347008|NCT00966875|26644305|FG001|Part B|Entry Criteria|0|||
13347009|NCT00966875|26644306|FG002|Part B|Entry Criteria|0|||
13347010|NCT00966875|26644307|FG003|Part B|Entry Criteria|0|||
13347011|NCT00966875|26644308|FG004|Part B|Entry Criteria|0|||
13347012|NCT00966875|26644309|FG005|Part B|Entry Criteria|0|||
13347013|NCT00966875|26644310|FG006|Part B|Entry Criteria|1|||
13347014|NCT00966875|26644311|FG007|Part B|Entry Criteria|0|||
13347015|NCT00966875|26644312|FG008|Part B|Entry Criteria|1|||
13347016|NCT00966719|26644339|FG000|Overall Study|Lost to Follow-up|6|||
13347017|NCT00966719|26644340|FG001|Overall Study|Lost to Follow-up|11|||
13347018|NCT00966693|26644387|FG000|Overall Study|Adverse Event|0|||
13347019|NCT00966693|26644388|FG001|Overall Study|Adverse Event|0|||
13347020|NCT00966693|26644389|FG002|Overall Study|Adverse Event|1|||
13347021|NCT00966693|26644390|FG003|Overall Study|Adverse Event|2|||
13347022|NCT00966693|26644387|FG000|Overall Study|Death|0|||
13347023|NCT00966693|26644388|FG001|Overall Study|Death|0|||
13347024|NCT00966693|26644389|FG002|Overall Study|Death|1|||
13347025|NCT00966693|26644390|FG003|Overall Study|Death|0|||
13347026|NCT00966693|26644387|FG000|Overall Study|Withdrawal by Subject|1|||
13347027|NCT00966693|26644388|FG001|Overall Study|Withdrawal by Subject|0|||
13347028|NCT00966693|26644389|FG002|Overall Study|Withdrawal by Subject|0|||
13347029|NCT00966693|26644390|FG003|Overall Study|Withdrawal by Subject|5|||
13347030|NCT00966693|26644387|FG000|Overall Study|Disease Progression|0|||
13347031|NCT00966693|26644388|FG001|Overall Study|Disease Progression|0|||
13347032|NCT00966693|26644389|FG002|Overall Study|Disease Progression|1|||
13347033|NCT00966693|26644390|FG003|Overall Study|Disease Progression|16|||
13347034|NCT00966654|26644400|FG000|Overall Study|Study was terminated,PI left institution|12|||
13347035|NCT00966355|26644421|FG000|Overall Study|non-variceal bleeding on endoscopy|68|||
13347036|NCT00966355|26644422|FG001|Overall Study|non-variceal bleeding on endoscopy|70|||
13347037|NCT00966355|26644423|FG002|Overall Study|non-variceal bleeding on endoscopy|71|||
13347038|NCT00966355|26644421|FG000|Overall Study|newly diagnosed advanced HCC|11|||
13347039|NCT00966355|26644422|FG001|Overall Study|newly diagnosed advanced HCC|12|||
13347040|NCT00966355|26644423|FG002|Overall Study|newly diagnosed advanced HCC|10|||
13347041|NCT00966355|26644421|FG000|Overall Study|Lost to Follow-up|5|||
13347042|NCT00966355|26644422|FG001|Overall Study|Lost to Follow-up|4|||
13347043|NCT00966355|26644423|FG002|Overall Study|Lost to Follow-up|3|||
13347044|NCT00966277|26644436|FG000|Overall Study|Withdrawal by Subject|3|||
13347045|NCT00966277|26644437|FG001|Overall Study|Withdrawal by Subject|0|||
13347046|NCT00966277|26644436|FG000|Overall Study|Ineligible|1|||
13347047|NCT00966277|26644437|FG001|Overall Study|Ineligible|3|||
13347048|NCT00966277|26644436|FG000|Overall Study|Treatment Plan Changed|0|||
13347049|NCT00966277|26644437|FG001|Overall Study|Treatment Plan Changed|1|||
13347050|NCT00966264|26644450|FG000|Overall Study|Lost to Follow-up|4|||
13347051|NCT00966264|26644451|FG001|Overall Study|Lost to Follow-up|3|||
13347052|NCT00965848|26644472|FG000|Overall Study|Protocol Violation|3|||
13347053|NCT00965848|26644473|FG001|Overall Study|Protocol Violation|0|||
13347054|NCT00965848|26644474|FG002|Overall Study|Protocol Violation|1|||
13347055|NCT00965848|26644472|FG000|Overall Study|Death|11|||
13347056|NCT00965848|26644473|FG001|Overall Study|Death|1|||
13347057|NCT00965848|26644474|FG002|Overall Study|Death|5|||
13347058|NCT00965848|26644472|FG000|Overall Study|Lost to Follow-up|0|||
13347059|NCT00965848|26644473|FG001|Overall Study|Lost to Follow-up|0|||
13347060|NCT00965848|26644474|FG002|Overall Study|Lost to Follow-up|1|||
13347061|NCT00965848|26644472|FG000|Overall Study|Withdrawal by Subject|1|||
13347062|NCT00965848|26644473|FG001|Overall Study|Withdrawal by Subject|0|||
13347063|NCT00965848|26644474|FG002|Overall Study|Withdrawal by Subject|0|||
13347064|NCT00965848|26644472|FG000|Overall Study|Indeterminate Clinical Outcome|2|||
13347065|NCT00965848|26644473|FG001|Overall Study|Indeterminate Clinical Outcome|0|||
13347066|NCT00965848|26644474|FG002|Overall Study|Indeterminate Clinical Outcome|1|||
13347067|NCT00965848|26644472|FG000|Overall Study|Not Clinically Evaluable|7|||
13347068|NCT00965848|26644473|FG001|Overall Study|Not Clinically Evaluable|1|||
13347069|NCT00965848|26644474|FG002|Overall Study|Not Clinically Evaluable|1|||
13347070|NCT00965848|26644472|FG000|Overall Study|Other|5|||
13347071|NCT00965848|26644473|FG001|Overall Study|Other|0|||
13347072|NCT00965848|26644474|FG002|Overall Study|Other|1|||
13347073|NCT00965731|26644545|FG000|Overall Study|Death|0|||
13347074|NCT00965731|26644546|FG001|Overall Study|Death|4|||
13347075|NCT00965731|26644545|FG000|Overall Study|Withdrawal by Subject|0|||
13347076|NCT00965731|26644546|FG001|Overall Study|Withdrawal by Subject|1|||
13347077|NCT00965731|26644545|FG000|Overall Study|Other|7|||
13347078|NCT00965731|26644546|FG001|Overall Study|Other|15|||
13347079|NCT00965718|26644558|FG000|Overall Study|Withdrawal by Subject|4|||
13347080|NCT00965575|26644573|FG000|Overall Study|subject unwillingness to swallow study c|1|||
13347081|NCT00965575|26644574|FG001|Overall Study|subject unwillingness to swallow study c|0|||
13347082|NCT00965562|26644622|FG000|Overall Study|Lost to Follow-up|1|||
13347083|NCT00965562|26644623|FG001|Overall Study|Lost to Follow-up|2|||
13347084|NCT00965562|26644624|FG002|Overall Study|Lost to Follow-up|3|||
13347085|NCT00965562|26644622|FG000|Overall Study|Withdrawal by Subject|2|||
13347086|NCT00965562|26644623|FG001|Overall Study|Withdrawal by Subject|2|||
13347087|NCT00965562|26644624|FG002|Overall Study|Withdrawal by Subject|0|||
13347088|NCT00965523|26644631|FG000|Study 221|Progressive Disease|4|||
13347089|NCT00965523|26644631|FG000|Study 221|Physician Decision|3|||
13347090|NCT00965523|26644631|FG000|Study 224|Progressive Disease|5|||
13347091|NCT00965523|26644631|FG000|Study 224|Physician Decision|1|||
13347092|NCT00965497|26644638|FG000|Overall Study|Physician Decision|1|||
13347093|NCT00965484|26644647|FG000|Overall Study|Protocol Violation|1|||
13347094|NCT00965484|26644647|FG000|Overall Study|Withdrawal by Subject|1|||
13347095|NCT00965458|26644670|FG000|Overall Study|Adverse Event|1|||
13347096|NCT00965458|26644671|FG001|Overall Study|Adverse Event|0|||
13347097|NCT00965458|26644670|FG000|Overall Study|Lost to Follow-up|1|||
13347098|NCT00965458|26644671|FG001|Overall Study|Lost to Follow-up|3|||
13347099|NCT00965458|26644670|FG000|Overall Study|Withdrawal by Subject|0|||
13347100|NCT00965458|26644671|FG001|Overall Study|Withdrawal by Subject|1|||
13347101|NCT00965419|26644717|FG000|Open Label Treatment for Responders|Adverse Event|33|||
13347102|NCT00965419|26644717|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1|||
13347103|NCT00965419|26644717|FG000|Open Label Treatment for Responders|Protocol Violation|21|||
13347104|NCT00965419|26644717|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27|||
13347105|NCT00965419|26644717|FG000|Open Label Treatment for Responders|Physician Decision|6|||
13347106|NCT00965419|26644717|FG000|Open Label Treatment for Responders|Sponsor Decision|5|||
13347107|NCT00965419|26644717|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41|||
13347108|NCT00965419|26644717|FG000|Open Label Treatment for Responders|Lack of Efficacy|67|||
13347109|NCT00965419|26644717|FG000|Open Label Treatment for Responders|Lost to Follow-up|46|||
13347110|NCT00965419|26644717|FG000|Follow-up Phase|Adverse Event|9|||
13347111|NCT00965419|26644717|FG000|Follow-up Phase|Protocol Violation|4|||
13347112|NCT00965419|26644717|FG000|Follow-up Phase|Withdrawal by Subject|8|||
13347113|NCT00965419|26644717|FG000|Follow-up Phase|Physician Decision|4|||
13347114|NCT00965419|26644717|FG000|Follow-up Phase|Parent/Caregiver Decision|9|||
13347115|NCT00965419|26644717|FG000|Follow-up Phase|Lack of Efficacy|28|||
13347116|NCT00965341|26644732|FG000|Overall Study|Withdrew consent|1|||
13347117|NCT00965341|26644733|FG001|Overall Study|Withdrew consent|5|||
13347118|NCT00965341|26644732|FG000|Overall Study|Lost to Follow-up|1|||
13347119|NCT00965341|26644733|FG001|Overall Study|Lost to Follow-up|0|||
13347120|NCT00965341|26644732|FG000|Overall Study|Transportation issues|4|||
13347121|NCT00965341|26644733|FG001|Overall Study|Transportation issues|3|||
13347122|NCT00965263|26644770|FG000|Overall Study|Physician Decision|2|||
13347123|NCT00965263|26644771|FG001|Overall Study|Physician Decision|0|||
13347124|NCT00965263|26644770|FG000|Overall Study|Family emergency|0|||
13347125|NCT00965263|26644771|FG001|Overall Study|Family emergency|1|||
13347126|NCT00965263|26644770|FG000|Overall Study|Protocol Violation|0|||
13347127|NCT00965263|26644771|FG001|Overall Study|Protocol Violation|2|||
13347128|NCT00965185|26644798|FG000|Overall Study|Lost to Follow-up|2|||
13347129|NCT00965185|26644799|FG001|Overall Study|Lost to Follow-up|0|||
13347130|NCT00965185|26644798|FG000|Overall Study|Withdrawal by Subject|0|||
13347131|NCT00965185|26644799|FG001|Overall Study|Withdrawal by Subject|1|||
13347132|NCT00965146|26644806|FG000|Overall Study|Death|7|||
13347133|NCT00965146|26644806|FG000|Overall Study|Lost to Follow-up|22|||
13347134|NCT00965146|26644806|FG000|Overall Study|Withdrawal by Subject|17|||
13347135|NCT00965146|26644806|FG000|Overall Study|Unable to return|1|||
13347136|NCT00965146|26644806|FG000|Overall Study|Unwilling to return|11|||
13347137|NCT00965146|26644806|FG000|Overall Study|Intercurrent illness|1|||
13347138|NCT00965146|26644806|FG000|Overall Study|Revision / Removal of Study Implant|6|||
13347139|NCT00965146|26644806|FG000|Overall Study|Overall Study Termination|145|||
13347140|NCT00965094|26644827|FG000|Overall Study|Adverse Event|5|||
13347141|NCT00965094|26644828|FG001|Overall Study|Adverse Event|0|||
13347142|NCT00965094|26644827|FG000|Overall Study|Lost to Follow-up|0|||
13347143|NCT00965094|26644828|FG001|Overall Study|Lost to Follow-up|1|||
13347144|NCT00965081|26644858|FG000|Overall Study|Adverse Event|14|||
13347145|NCT00965081|26644859|FG001|Overall Study|Adverse Event|9|||
13347146|NCT00965081|26644858|FG000|Overall Study|Lack of Efficacy|2|||
13347147|NCT00965081|26644859|FG001|Overall Study|Lack of Efficacy|5|||
13347148|NCT00965081|26644858|FG000|Overall Study|Lost to Follow-up|4|||
13347149|NCT00965081|26644859|FG001|Overall Study|Lost to Follow-up|5|||
13347150|NCT00965081|26644858|FG000|Overall Study|Physician Decision|2|||
13347151|NCT00965081|26644859|FG001|Overall Study|Physician Decision|0|||
13347152|NCT00965081|26644858|FG000|Overall Study|Protocol Violation|2|||
13347153|NCT00965081|26644859|FG001|Overall Study|Protocol Violation|5|||
13347154|NCT00965081|26644858|FG000|Overall Study|Sponsor Decision|1|||
13347155|NCT00965081|26644859|FG001|Overall Study|Sponsor Decision|0|||
13347156|NCT00965081|26644858|FG000|Overall Study|Withdrawal by Subject|4|||
13347157|NCT00965081|26644859|FG001|Overall Study|Withdrawal by Subject|7|||
13347158|NCT00965081|26644858|FG000|Overall Study|Switched to Rescue Arm|5|||
13347159|NCT00965081|26644859|FG001|Overall Study|Switched to Rescue Arm|12|||
13347160|NCT00964886|26644886|FG000|Overall Study|Lost to Follow-up|2|||
13347161|NCT00964886|26644887|FG001|Overall Study|Lost to Follow-up|2|||
13347162|NCT00964886|26644888|FG002|Overall Study|Lost to Follow-up|6|||
13347163|NCT00964886|26644889|FG003|Overall Study|Lost to Follow-up|4|||
13347164|NCT00964886|26644886|FG000|Overall Study|Withdrawal by Subject|6|||
13347165|NCT00964886|26644887|FG001|Overall Study|Withdrawal by Subject|2|||
13347166|NCT00964886|26644888|FG002|Overall Study|Withdrawal by Subject|5|||
13347167|NCT00964886|26644889|FG003|Overall Study|Withdrawal by Subject|3|||
13347168|NCT00964886|26644886|FG000|Overall Study|Adverse Event|3|||
13347169|NCT00964886|26644887|FG001|Overall Study|Adverse Event|1|||
13347170|NCT00964886|26644888|FG002|Overall Study|Adverse Event|5|||
13347171|NCT00964886|26644889|FG003|Overall Study|Adverse Event|2|||
13347172|NCT00964886|26644886|FG000|Overall Study|Protocol Violation|0|||
13347173|NCT00964886|26644887|FG001|Overall Study|Protocol Violation|2|||
13347174|NCT00964886|26644888|FG002|Overall Study|Protocol Violation|0|||
13347175|NCT00964886|26644889|FG003|Overall Study|Protocol Violation|0|||
13347176|NCT00964860|26644904|FG000|Overall Study|Withdrawal by Subject|0|||
13347177|NCT00964860|26644905|FG001|Overall Study|Withdrawal by Subject|1|||
13347178|NCT00964795|26644914|FG000|Overall Study|Withdrawal by Subject|79|||
13347179|NCT00964795|26644914|FG000|Overall Study|Adverse Event|12|||
13347180|NCT00964795|26644914|FG000|Overall Study|Death|14|||
13347181|NCT00964795|26644914|FG000|Overall Study|Lost to Follow-up|7|||
13347182|NCT00964795|26644914|FG000|Overall Study|Termination of Study by Sponsor|169|||
13347183|NCT00964795|26644914|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3|||
13347184|NCT00964795|26644914|FG000|Overall Study|Other|23|||
13347185|NCT00964782|26644935|FG000|Overall Study|Lost to Follow-up|1|||
13347186|NCT00964782|26644936|FG001|Overall Study|Lost to Follow-up|0|||
13347187|NCT00964743|26644946|FG000|Overall Study|Neither patient completed 8 weeks of tre|2|||
13347188|NCT00964678|26644955|FG000|Overall Study|Physician Decision|4|||
13347189|NCT00964392|26644970|FG000|Overall Study|Withdrawal by Subject|4|||
13347190|NCT00964392|26644971|FG001|Overall Study|Withdrawal by Subject|6|||
13347191|NCT00964392|26644970|FG000|Overall Study|Lost to Follow-up|4|||
13347192|NCT00964392|26644971|FG001|Overall Study|Lost to Follow-up|10|||
13347193|NCT00964392|26644970|FG000|Overall Study|Early Termination, non-study arrhythmia|1|||
13347194|NCT00964392|26644971|FG001|Overall Study|Early Termination, non-study arrhythmia|6|||
13347195|NCT00964392|26644970|FG000|Overall Study|Not completed|44|||
13347196|NCT00964392|26644971|FG001|Overall Study|Not completed|168|||
13347197|NCT00964366|26644992|FG000|Overall Study|Did not qualify at Day 1|1|||
13347198|NCT00964366|26644993|FG001|Overall Study|Did not qualify at Day 1|0|||
13347199|NCT00964366|26644992|FG000|Overall Study|Withdrawal by Subject|0|||
13347200|NCT00964366|26644993|FG001|Overall Study|Withdrawal by Subject|1|||
13347201|NCT00964223|26645060|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
13347202|NCT00964158|26645139|FG000|Overall Study|Lost to Follow-up|0|||
13347203|NCT00964158|26645140|FG001|Overall Study|Lost to Follow-up|1|||
13347204|NCT00964158|26645141|FG002|Overall Study|Lost to Follow-up|2|||
13347205|NCT00964158|26645139|FG000|Overall Study|Withdrawal by Subject|0|||
13204405|NCT01973491|26228487|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
13204406|NCT01973439|26228496|FG000|Overall Study|Lost samples from one PK Day|2|||
13347206|NCT00964158|26645140|FG001|Overall Study|Withdrawal by Subject|0|||
13347207|NCT00964158|26645141|FG002|Overall Study|Withdrawal by Subject|6|||
13347208|NCT00964028|26645160|FG000|Overall Study|Withdrawal by Subject|0|||
13347209|NCT00964028|26645161|FG001|Overall Study|Withdrawal by Subject|1|||
13347210|NCT00963937|26645207|FG000|Overall Study|Protocol Violation|1|||
13347211|NCT00963937|26645208|FG001|Overall Study|Protocol Violation|1|||
13347212|NCT00963937|26645209|FG002|Overall Study|Protocol Violation|0|||
13347213|NCT00963937|26645207|FG000|Overall Study|Physician Decision|18|||
13347214|NCT00963937|26645208|FG001|Overall Study|Physician Decision|10|||
13347215|NCT00963937|26645209|FG002|Overall Study|Physician Decision|4|||
13347216|NCT00963924|26645238|FG000|Overall Study|Adverse Event|1|||
13347217|NCT00963924|26645239|FG001|Overall Study|Adverse Event|0|||
13347218|NCT00963924|26645238|FG000|Overall Study|Withdrawal by Subject|0|||
13347219|NCT00963924|26645239|FG001|Overall Study|Withdrawal by Subject|1|||
13347220|NCT00963924|26645238|FG000|Overall Study|Changed antipsychotic|0|||
13347221|NCT00963924|26645239|FG001|Overall Study|Changed antipsychotic|1|||
13347222|NCT00963924|26645238|FG000|Overall Study|Lost to Follow-up|0|||
13347223|NCT00963924|26645239|FG001|Overall Study|Lost to Follow-up|1|||
13347224|NCT00963820|26645388|FG000|Dose Escalation Phase|Progressive Disease|3|||
13347225|NCT00963820|26645389|FG001|Dose Escalation Phase|Progressive Disease|3|||
13347226|NCT00963820|26645390|FG002|Dose Escalation Phase|Progressive Disease|3|||
13347227|NCT00963820|26645391|FG003|Dose Escalation Phase|Progressive Disease|3|||
13347228|NCT00963820|26645392|FG004|Dose Escalation Phase|Progressive Disease|4|||
13347229|NCT00963820|26645393|FG005|Dose Escalation Phase|Progressive Disease|3|||
13347230|NCT00963820|26645394|FG006|Dose Escalation Phase|Progressive Disease|3|||
13347231|NCT00963820|26645395|FG007|Dose Escalation Phase|Progressive Disease|2|||
13347232|NCT00963820|26645396|FG008|Dose Escalation Phase|Progressive Disease|0|||
13347233|NCT00963820|26645397|FG009|Dose Escalation Phase|Progressive Disease|0|||
13347234|NCT00963820|26645398|FG010|Dose Escalation Phase|Progressive Disease|0|||
13347235|NCT00963820|26645399|FG011|Dose Escalation Phase|Progressive Disease|0|||
13347236|NCT00963820|26645388|FG000|Dose Escalation Phase|Adverse Event|0|||
13347237|NCT00963820|26645389|FG001|Dose Escalation Phase|Adverse Event|0|||
13347238|NCT00963820|26645390|FG002|Dose Escalation Phase|Adverse Event|0|||
13347239|NCT00963820|26645391|FG003|Dose Escalation Phase|Adverse Event|0|||
13347240|NCT00963820|26645392|FG004|Dose Escalation Phase|Adverse Event|0|||
13347241|NCT00963820|26645393|FG005|Dose Escalation Phase|Adverse Event|0|||
13347242|NCT00963820|26645394|FG006|Dose Escalation Phase|Adverse Event|3|||
13347243|NCT00963820|26645395|FG007|Dose Escalation Phase|Adverse Event|1|||
13347244|NCT00963820|26645396|FG008|Dose Escalation Phase|Adverse Event|0|||
13347245|NCT00963820|26645397|FG009|Dose Escalation Phase|Adverse Event|0|||
13347246|NCT00963820|26645398|FG010|Dose Escalation Phase|Adverse Event|0|||
13347247|NCT00963820|26645399|FG011|Dose Escalation Phase|Adverse Event|0|||
13347248|NCT00963820|26645388|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
13347249|NCT00963820|26645389|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
13347250|NCT00963820|26645390|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
13347251|NCT00963820|26645391|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
13347252|NCT00963820|26645392|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
13347253|NCT00963820|26645393|FG005|Dose Escalation Phase|Withdrawal by Subject|0|||
13347254|NCT00963820|26645394|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
13347255|NCT00963820|26645395|FG007|Dose Escalation Phase|Withdrawal by Subject|2|||
13347256|NCT00963820|26645396|FG008|Dose Escalation Phase|Withdrawal by Subject|0|||
13347257|NCT00963820|26645397|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
13347258|NCT00963820|26645398|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
13347259|NCT00963820|26645399|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
13347260|NCT00963820|26645388|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
13347261|NCT00963820|26645389|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
13347262|NCT00963820|26645390|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
13347263|NCT00963820|26645391|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
13347264|NCT00963820|26645392|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
13347265|NCT00963820|26645393|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
13347266|NCT00963820|26645394|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
13347267|NCT00963820|26645395|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
13347268|NCT00963820|26645396|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
13347269|NCT00963820|26645397|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
13347270|NCT00963820|26645398|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
13347271|NCT00963820|26645399|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
13347272|NCT00963820|26645388|FG000|Expansion Phase|Progressive Disease|0|||
13347273|NCT00963820|26645389|FG001|Expansion Phase|Progressive Disease|0|||
13347274|NCT00963820|26645390|FG002|Expansion Phase|Progressive Disease|0|||
13347275|NCT00963820|26645391|FG003|Expansion Phase|Progressive Disease|0|||
13347276|NCT00963820|26645392|FG004|Expansion Phase|Progressive Disease|0|||
13347277|NCT00963820|26645393|FG005|Expansion Phase|Progressive Disease|0|||
13347278|NCT00963820|26645394|FG006|Expansion Phase|Progressive Disease|0|||
13347279|NCT00963820|26645395|FG007|Expansion Phase|Progressive Disease|0|||
13347280|NCT00963820|26645396|FG008|Expansion Phase|Progressive Disease|8|||
13347281|NCT00963820|26645397|FG009|Expansion Phase|Progressive Disease|6|||
13347282|NCT00963820|26645398|FG010|Expansion Phase|Progressive Disease|4|||
13347283|NCT00963820|26645399|FG011|Expansion Phase|Progressive Disease|2|||
13347284|NCT00963820|26645388|FG000|Expansion Phase|Adverse Event|0|||
13347285|NCT00963820|26645389|FG001|Expansion Phase|Adverse Event|0|||
13347286|NCT00963820|26645390|FG002|Expansion Phase|Adverse Event|0|||
13347287|NCT00963820|26645391|FG003|Expansion Phase|Adverse Event|0|||
13347288|NCT00963820|26645392|FG004|Expansion Phase|Adverse Event|0|||
13347289|NCT00963820|26645393|FG005|Expansion Phase|Adverse Event|0|||
13347290|NCT00963820|26645394|FG006|Expansion Phase|Adverse Event|0|||
13347291|NCT00963820|26645395|FG007|Expansion Phase|Adverse Event|0|||
13347292|NCT00963820|26645396|FG008|Expansion Phase|Adverse Event|1|||
13347293|NCT00963820|26645397|FG009|Expansion Phase|Adverse Event|3|||
13347294|NCT00963820|26645398|FG010|Expansion Phase|Adverse Event|0|||
13347295|NCT00963820|26645399|FG011|Expansion Phase|Adverse Event|0|||
13347296|NCT00963820|26645388|FG000|Expansion Phase|Withdrawal by Subject|0|||
13347297|NCT00963820|26645389|FG001|Expansion Phase|Withdrawal by Subject|0|||
13347298|NCT00963820|26645390|FG002|Expansion Phase|Withdrawal by Subject|0|||
13347299|NCT00963820|26645391|FG003|Expansion Phase|Withdrawal by Subject|0|||
13347300|NCT00963820|26645392|FG004|Expansion Phase|Withdrawal by Subject|0|||
13347301|NCT00963820|26645393|FG005|Expansion Phase|Withdrawal by Subject|0|||
13347302|NCT00963820|26645394|FG006|Expansion Phase|Withdrawal by Subject|0|||
13347303|NCT00963820|26645395|FG007|Expansion Phase|Withdrawal by Subject|0|||
13347304|NCT00963820|26645396|FG008|Expansion Phase|Withdrawal by Subject|1|||
13347305|NCT00963820|26645397|FG009|Expansion Phase|Withdrawal by Subject|0|||
13347306|NCT00963820|26645398|FG010|Expansion Phase|Withdrawal by Subject|1|||
13347307|NCT00963820|26645399|FG011|Expansion Phase|Withdrawal by Subject|1|||
13347308|NCT00963820|26645388|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
13347309|NCT00963820|26645389|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
13347310|NCT00963820|26645390|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
13347311|NCT00963820|26645391|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
13347312|NCT00963820|26645392|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
13347313|NCT00963820|26645393|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
13347314|NCT00963820|26645394|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
13347315|NCT00963820|26645395|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
13347316|NCT00963820|26645396|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
13347317|NCT00963820|26645397|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
13347318|NCT00963820|26645398|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
13347319|NCT00963820|26645399|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1|||
13347320|NCT00963807|26645410|FG000|Overall Study|Physician Decision|2|||
13347321|NCT00963807|26645410|FG000|Overall Study|Reaction to study chemotherapy regimen|1|||
13347322|NCT00963807|26645410|FG000|Overall Study|Disease progression|15|||
13347323|NCT00963599|26645477|FG000|Overall Study|Adverse Event|2|||
13347324|NCT00963599|26645478|FG001|Overall Study|Adverse Event|0|||
13347325|NCT00963599|26645479|FG002|Overall Study|Adverse Event|1|||
13347326|NCT00963599|26645480|FG003|Overall Study|Adverse Event|2|||
13347327|NCT00963599|26645477|FG000|Overall Study|Lack of Efficacy|0|||
13347328|NCT00963599|26645478|FG001|Overall Study|Lack of Efficacy|2|||
13347329|NCT00963599|26645479|FG002|Overall Study|Lack of Efficacy|1|||
13347330|NCT00963599|26645480|FG003|Overall Study|Lack of Efficacy|4|||
13347331|NCT00963599|26645477|FG000|Overall Study|Lost to Follow-up|0|||
13347332|NCT00963599|26645478|FG001|Overall Study|Lost to Follow-up|1|||
13347333|NCT00963599|26645479|FG002|Overall Study|Lost to Follow-up|1|||
13347334|NCT00963599|26645480|FG003|Overall Study|Lost to Follow-up|1|||
13347335|NCT00963599|26645477|FG000|Overall Study|Protocol Violation|2|||
13347336|NCT00963599|26645478|FG001|Overall Study|Protocol Violation|2|||
13347337|NCT00963599|26645479|FG002|Overall Study|Protocol Violation|3|||
13347338|NCT00963599|26645480|FG003|Overall Study|Protocol Violation|4|||
13347339|NCT00963599|26645477|FG000|Overall Study|Withdrawal by Subject|2|||
13347340|NCT00963599|26645478|FG001|Overall Study|Withdrawal by Subject|1|||
13347341|NCT00963599|26645479|FG002|Overall Study|Withdrawal by Subject|3|||
13347342|NCT00963599|26645480|FG003|Overall Study|Withdrawal by Subject|3|||
13347343|NCT00963547|26645520|FG000|Overall Study|Adverse Event|0|||
13347344|NCT00963547|26645521|FG001|Overall Study|Adverse Event|1|||
13347345|NCT00963547|26645522|FG002|Overall Study|Adverse Event|0|||
13347346|NCT00963547|26645523|FG003|Overall Study|Adverse Event|1|||
13347347|NCT00963547|26645524|FG004|Overall Study|Adverse Event|0|||
13347348|NCT00963547|26645525|FG005|Overall Study|Adverse Event|0|||
13347349|NCT00963547|26645526|FG006|Overall Study|Adverse Event|0|||
13347350|NCT00963547|26645520|FG000|Overall Study|Physician Decision|1|||
13347351|NCT00963547|26645521|FG001|Overall Study|Physician Decision|1|||
13347352|NCT00963547|26645522|FG002|Overall Study|Physician Decision|0|||
13347353|NCT00963547|26645523|FG003|Overall Study|Physician Decision|0|||
13347354|NCT00963547|26645524|FG004|Overall Study|Physician Decision|0|||
13347355|NCT00963547|26645525|FG005|Overall Study|Physician Decision|0|||
13347356|NCT00963547|26645526|FG006|Overall Study|Physician Decision|0|||
13347357|NCT00963547|26645520|FG000|Overall Study|Progressive Disease|3|||
13347358|NCT00963547|26645521|FG001|Overall Study|Progressive Disease|8|||
13347359|NCT00963547|26645522|FG002|Overall Study|Progressive Disease|9|||
13347360|NCT00963547|26645523|FG003|Overall Study|Progressive Disease|5|||
13347361|NCT00963547|26645524|FG004|Overall Study|Progressive Disease|0|||
13347362|NCT00963547|26645525|FG005|Overall Study|Progressive Disease|0|||
13347363|NCT00963547|26645526|FG006|Overall Study|Progressive Disease|0|||
13347364|NCT00963547|26645520|FG000|Overall Study|Withdrawal by Subject|0|||
13347365|NCT00963547|26645521|FG001|Overall Study|Withdrawal by Subject|0|||
13347366|NCT00963547|26645522|FG002|Overall Study|Withdrawal by Subject|3|||
13347367|NCT00963547|26645523|FG003|Overall Study|Withdrawal by Subject|0|||
13347368|NCT00963547|26645524|FG004|Overall Study|Withdrawal by Subject|0|||
13347369|NCT00963547|26645525|FG005|Overall Study|Withdrawal by Subject|0|||
13347370|NCT00963547|26645526|FG006|Overall Study|Withdrawal by Subject|0|||
13347371|NCT00963547|26645520|FG000|Overall Study|Reason Unknown|0|||
13347372|NCT00963547|26645521|FG001|Overall Study|Reason Unknown|1|||
13347373|NCT00963547|26645522|FG002|Overall Study|Reason Unknown|0|||
13347374|NCT00963547|26645523|FG003|Overall Study|Reason Unknown|0|||
13347375|NCT00963547|26645524|FG004|Overall Study|Reason Unknown|0|||
13347376|NCT00963547|26645525|FG005|Overall Study|Reason Unknown|0|||
13347377|NCT00963547|26645526|FG006|Overall Study|Reason Unknown|0|||
13347378|NCT00963235|26645547|FG000|Overall Study|Withdrawal by Subject|22|||
13347379|NCT00963235|26645547|FG000|Overall Study|Lost to Follow-up|14|||
13347380|NCT00963235|26645547|FG000|Overall Study|Failed to return|9|||
13347381|NCT00963235|26645547|FG000|Overall Study|Protocol Violation|7|||
13347382|NCT00963235|26645547|FG000|Overall Study|Adverse Event|5|||
13347383|NCT00963235|26645547|FG000|Overall Study|Physician Decision|2|||
13347384|NCT00963235|26645547|FG000|Overall Study|Other|1|||
13347385|NCT00962780|26645616|FG000|Overall Study|Death|0|||
13347386|NCT00962780|26645617|FG001|Overall Study|Death|1|||
13347387|NCT00962780|26645616|FG000|Overall Study|Protocol Violation|9|||
13347388|NCT00962780|26645617|FG001|Overall Study|Protocol Violation|4|||
13347389|NCT00962780|26645616|FG000|Overall Study|Withdrawal by Subject|1|||
13347390|NCT00962780|26645617|FG001|Overall Study|Withdrawal by Subject|8|||
13347391|NCT00962780|26645616|FG000|Overall Study|Other|0|||
13347392|NCT00962780|26645617|FG001|Overall Study|Other|1|||
13347393|NCT00962741|26645710|FG000|Overall Study|Failed to return|3|||
13347394|NCT00962741|26645710|FG000|Overall Study|Lost to Follow-up|2|||
13347395|NCT00962741|26645710|FG000|Overall Study|Withdrawal by Subject|1|||
13347396|NCT00962741|26645710|FG000|Overall Study|Lack of Efficacy|1|||
13347397|NCT00962741|26645710|FG000|Overall Study|drug ineffective+prohibited drug taken|1|||
13347398|NCT00962650|26645716|FG000|Overall Study|Transgastric DP was not completed|2|||
13347399|NCT00962585|26645787|FG000|Overall Study|Adverse Event|0|||
13347400|NCT00962585|26645788|FG001|Overall Study|Adverse Event|2|||
13347401|NCT00962585|26645789|FG002|Overall Study|Adverse Event|1|||
13347402|NCT00962585|26645790|FG003|Overall Study|Adverse Event|0|||
13347403|NCT00962585|26645787|FG000|Overall Study|Lost to Follow-up|3|||
13347404|NCT00962585|26645788|FG001|Overall Study|Lost to Follow-up|0|||
13347405|NCT00962585|26645789|FG002|Overall Study|Lost to Follow-up|1|||
13347406|NCT00962585|26645790|FG003|Overall Study|Lost to Follow-up|0|||
13347407|NCT00962585|26645787|FG000|Overall Study|Protocol Violation|0|||
13347408|NCT00962585|26645788|FG001|Overall Study|Protocol Violation|0|||
13347409|NCT00962585|26645789|FG002|Overall Study|Protocol Violation|1|||
13347410|NCT00962585|26645790|FG003|Overall Study|Protocol Violation|0|||
13347411|NCT00962585|26645787|FG000|Overall Study|Withdrawal by Subject|1|||
13347412|NCT00962585|26645788|FG001|Overall Study|Withdrawal by Subject|0|||
13347413|NCT00962585|26645789|FG002|Overall Study|Withdrawal by Subject|0|||
13347414|NCT00962585|26645790|FG003|Overall Study|Withdrawal by Subject|0|||
13347415|NCT00962585|26645787|FG000|Overall Study|Withdrew Consent|2|||
13347416|NCT00962585|26645788|FG001|Overall Study|Withdrew Consent|0|||
13347417|NCT00962585|26645789|FG002|Overall Study|Withdrew Consent|0|||
13347418|NCT00962585|26645790|FG003|Overall Study|Withdrew Consent|0|||
13347419|NCT00962390|26645865|FG000|Overall Study|Adverse Event|0|||
13347420|NCT00962390|26645866|FG001|Overall Study|Adverse Event|0|||
13347421|NCT00962390|26645867|FG002|Overall Study|Adverse Event|3|||
13347422|NCT00962390|26645868|FG003|Overall Study|Adverse Event|1|||
13347423|NCT00962390|26645865|FG000|Overall Study|Lost to Follow-up|2|||
13347424|NCT00962390|26645866|FG001|Overall Study|Lost to Follow-up|2|||
13347425|NCT00962390|26645867|FG002|Overall Study|Lost to Follow-up|0|||
13347426|NCT00962390|26645868|FG003|Overall Study|Lost to Follow-up|0|||
13347427|NCT00962390|26645865|FG000|Overall Study|Protocol Violation|1|||
13347428|NCT00962390|26645866|FG001|Overall Study|Protocol Violation|0|||
13347429|NCT00962390|26645867|FG002|Overall Study|Protocol Violation|0|||
13347430|NCT00962390|26645868|FG003|Overall Study|Protocol Violation|0|||
13347431|NCT00962390|26645865|FG000|Overall Study|Withdrawal by Subject|1|||
13347432|NCT00962390|26645866|FG001|Overall Study|Withdrawal by Subject|1|||
13347433|NCT00962390|26645867|FG002|Overall Study|Withdrawal by Subject|1|||
13347434|NCT00962390|26645868|FG003|Overall Study|Withdrawal by Subject|0|||
13347435|NCT00962247|26645879|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4|||
13347436|NCT00962247|26645879|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1|||
13347437|NCT00962208|26645892|FG000|Overall Study|Could not achieve good vision|9|||
13347438|NCT00962208|26645893|FG001|Overall Study|Could not achieve good vision|0|||
13347439|NCT00962208|26645892|FG000|Overall Study|Contraindicated to continue study|5|||
13347440|NCT00962208|26645893|FG001|Overall Study|Contraindicated to continue study|1|||
13347441|NCT00962208|26645892|FG000|Overall Study|Lost to Follow-up|0|||
13347442|NCT00962208|26645893|FG001|Overall Study|Lost to Follow-up|9|||
13347443|NCT00962104|26645926|FG000|Overall Study|Adverse Event|10|||
13347444|NCT00962104|26645927|FG001|Overall Study|Adverse Event|3|||
13347445|NCT00962104|26645926|FG000|Overall Study|Entry Criteria Not Met|1|||
13347446|NCT00962104|26645927|FG001|Overall Study|Entry Criteria Not Met|2|||
13347447|NCT00962104|26645926|FG000|Overall Study|Lack of Efficacy|0|||
13347448|NCT00962104|26645927|FG001|Overall Study|Lack of Efficacy|1|||
13347449|NCT00962104|26645926|FG000|Overall Study|Lost to Follow-up|10|||
13347450|NCT00962104|26645927|FG001|Overall Study|Lost to Follow-up|4|||
13347451|NCT00962104|26645926|FG000|Overall Study|Physician Decision|1|||
13347452|NCT00962104|26645927|FG001|Overall Study|Physician Decision|0|||
13347453|NCT00962104|26645926|FG000|Overall Study|Protocol Violation|6|||
13347454|NCT00962104|26645927|FG001|Overall Study|Protocol Violation|8|||
13347455|NCT00962104|26645926|FG000|Overall Study|Sponsor Decision|0|||
13347456|NCT00962104|26645927|FG001|Overall Study|Sponsor Decision|1|||
13347457|NCT00962104|26645926|FG000|Overall Study|Withdrawal by Subject|10|||
13347458|NCT00962104|26645927|FG001|Overall Study|Withdrawal by Subject|6|||
13347459|NCT00962104|26645926|FG000|Overall Study|Other|2|||
13347460|NCT00962104|26645927|FG001|Overall Study|Other|0|||
13374138|NCT00797966|26725800|FG005|Phase B|Lack of Efficacy|0|||
13374139|NCT00797966|26725795|FG000|Phase A+|Lost to Follow-up|0|||
13374140|NCT00797966|26725796|FG001|Phase A+|Lost to Follow-up|0|||
13374141|NCT00797966|26725797|FG002|Phase A+|Lost to Follow-up|0|||
13374142|NCT00797966|26725798|FG003|Phase A+|Lost to Follow-up|0|||
13374143|NCT00797966|26725799|FG004|Phase A+|Lost to Follow-up|0|||
13374144|NCT00797966|26725800|FG005|Phase A+|Lost to Follow-up|9|||
13374145|NCT00797966|26725795|FG000|Phase A+|Met withdrawal criteria|0|||
13374146|NCT00797966|26725796|FG001|Phase A+|Met withdrawal criteria|0|||
13374147|NCT00797966|26725797|FG002|Phase A+|Met withdrawal criteria|0|||
13374148|NCT00797966|26725798|FG003|Phase A+|Met withdrawal criteria|0|||
13374149|NCT00797966|26725799|FG004|Phase A+|Met withdrawal criteria|0|||
13374150|NCT00797966|26725800|FG005|Phase A+|Met withdrawal criteria|5|||
13374151|NCT00797966|26725795|FG000|Phase A+|Withdrawal by Subject|0|||
13374152|NCT00797966|26725796|FG001|Phase A+|Withdrawal by Subject|0|||
13374153|NCT00797966|26725797|FG002|Phase A+|Withdrawal by Subject|0|||
13374154|NCT00797966|26725798|FG003|Phase A+|Withdrawal by Subject|0|||
13374155|NCT00797966|26725799|FG004|Phase A+|Withdrawal by Subject|0|||
13374156|NCT00797966|26725800|FG005|Phase A+|Withdrawal by Subject|6|||
13374157|NCT00797966|26725795|FG000|Phase A+|Adverse Event|0|||
13374158|NCT00797966|26725796|FG001|Phase A+|Adverse Event|0|||
13374159|NCT00797966|26725797|FG002|Phase A+|Adverse Event|0|||
13374160|NCT00797966|26725798|FG003|Phase A+|Adverse Event|0|||
13374161|NCT00797966|26725799|FG004|Phase A+|Adverse Event|0|||
13374162|NCT00797966|26725800|FG005|Phase A+|Adverse Event|4|||
13374163|NCT00797966|26725795|FG000|Phase A+|Protocol deviation|0|||
13374164|NCT00797966|26725796|FG001|Phase A+|Protocol deviation|0|||
13374165|NCT00797966|26725797|FG002|Phase A+|Protocol deviation|0|||
13374166|NCT00797966|26725798|FG003|Phase A+|Protocol deviation|0|||
13374167|NCT00797966|26725799|FG004|Phase A+|Protocol deviation|0|||
13374168|NCT00797966|26725800|FG005|Phase A+|Protocol deviation|4|||
13374169|NCT00797862|26725836|FG000|Overall Study|Adverse Event|86|||
13374170|NCT00797862|26725837|FG001|Overall Study|Adverse Event|44|||
13374171|NCT00797862|26725838|FG002|Overall Study|Adverse Event|58|||
13374172|NCT00797862|26725836|FG000|Overall Study|Abnormal Test Procedure Result|0|||
13374173|NCT00797862|26725837|FG001|Overall Study|Abnormal Test Procedure Result|1|||
13374174|NCT00797862|26725838|FG002|Overall Study|Abnormal Test Procedure Result|1|||
13374175|NCT00797862|26725836|FG000|Overall Study|Lack of Efficacy|1|||
13374176|NCT00797862|26725837|FG001|Overall Study|Lack of Efficacy|7|||
13374177|NCT00797862|26725838|FG002|Overall Study|Lack of Efficacy|6|||
13374178|NCT00797862|26725836|FG000|Overall Study|No longer required study medication|1|||
13374179|NCT00797862|26725837|FG001|Overall Study|No longer required study medication|0|||
13374180|NCT00797862|26725838|FG002|Overall Study|No longer required study medication|0|||
13374181|NCT00797862|26725836|FG000|Overall Study|Withdrawal by Subject|14|||
13374182|NCT00797862|26725837|FG001|Overall Study|Withdrawal by Subject|7|||
13374183|NCT00797862|26725838|FG002|Overall Study|Withdrawal by Subject|7|||
13374184|NCT00797862|26725836|FG000|Overall Study|Lost to Follow-up|11|||
13374185|NCT00797862|26725837|FG001|Overall Study|Lost to Follow-up|0|||
13374186|NCT00797862|26725838|FG002|Overall Study|Lost to Follow-up|5|||
13374187|NCT00797862|26725836|FG000|Overall Study|Administrative Problem|4|||
13374188|NCT00797862|26725837|FG001|Overall Study|Administrative Problem|0|||
13374189|NCT00797862|26725838|FG002|Overall Study|Administrative Problem|0|||
13374190|NCT00797862|26725836|FG000|Overall Study|Protocol Violation|4|||
13374191|NCT00797862|26725837|FG001|Overall Study|Protocol Violation|6|||
13374192|NCT00797862|26725838|FG002|Overall Study|Protocol Violation|8|||
13374193|NCT00797862|26725836|FG000|Overall Study|Mis-randomized|3|||
13374194|NCT00797862|26725837|FG001|Overall Study|Mis-randomized|3|||
13374195|NCT00797862|26725838|FG002|Overall Study|Mis-randomized|1|||
13374196|NCT00797823|26725857|FG000|First Period (Initial Randomization)|Physician Decision|1|||
13374197|NCT00797823|26725858|FG001|First Period (Initial Randomization)|Physician Decision|0|||
13347461|NCT00962091|26645994|FG000|Overall Study|Withdrawal by Subject|1|||
13347462|NCT00962091|26645995|FG001|Overall Study|Withdrawal by Subject|2|||
13347463|NCT00962091|26645996|FG002|Overall Study|Withdrawal by Subject|1|||
13347464|NCT00962091|26645997|FG003|Overall Study|Withdrawal by Subject|1|||
13347465|NCT00962091|26645998|FG004|Overall Study|Withdrawal by Subject|0|||
13347466|NCT00962091|26645999|FG005|Overall Study|Withdrawal by Subject|1|||
13347467|NCT00962091|26646000|FG006|Overall Study|Withdrawal by Subject|0|||
13347468|NCT00962091|26645994|FG000|Overall Study|Adverse Event|0|||
13347469|NCT00962091|26645995|FG001|Overall Study|Adverse Event|0|||
13347470|NCT00962091|26645996|FG002|Overall Study|Adverse Event|0|||
13347471|NCT00962091|26645997|FG003|Overall Study|Adverse Event|0|||
13347472|NCT00962091|26645998|FG004|Overall Study|Adverse Event|0|||
13347473|NCT00962091|26645999|FG005|Overall Study|Adverse Event|0|||
13347474|NCT00962091|26646000|FG006|Overall Study|Adverse Event|1|||
13347475|NCT00962013|26646011|FG000|Overall Study|Did not have surgery|1|||
13347476|NCT00962013|26646011|FG000|Overall Study|Death|8|||
13347477|NCT00962013|26646011|FG000|Overall Study|Lost to Follow-up|12|||
13347478|NCT00962013|26646011|FG000|Overall Study|Unable/Unwilling to return|6|||
13347479|NCT00962013|26646011|FG000|Overall Study|Withdrawal by Subject|8|||
13347480|NCT00962013|26646011|FG000|Overall Study|Removal of study device|3|||
13347481|NCT00962013|26646011|FG000|Overall Study|Site Termination|24|||
13347482|NCT00962013|26646011|FG000|Overall Study|No 5 year evaluation|6|||
13347483|NCT00961961|26646046|FG000|Phase I|Withdrawal by Subject|7|||
13347484|NCT00961961|26646047|FG001|Phase I|Withdrawal by Subject|0|||
13347485|NCT00961961|26646048|FG002|Phase I|Withdrawal by Subject|0|||
13347486|NCT00961961|26646049|FG003|Phase I|Withdrawal by Subject|0|||
13347487|NCT00961961|26646046|FG000|Phase I|Lost to Follow-up|10|||
13347488|NCT00961961|26646047|FG001|Phase I|Lost to Follow-up|0|||
13347489|NCT00961961|26646048|FG002|Phase I|Lost to Follow-up|0|||
13347490|NCT00961961|26646049|FG003|Phase I|Lost to Follow-up|0|||
13347491|NCT00961961|26646046|FG000|Phase I|Lack of Efficacy|94|||
13347492|NCT00961961|26646047|FG001|Phase I|Lack of Efficacy|0|||
13347493|NCT00961961|26646048|FG002|Phase I|Lack of Efficacy|0|||
13347494|NCT00961961|26646049|FG003|Phase I|Lack of Efficacy|0|||
13347495|NCT00961961|26646046|FG000|Phase I|Adverse Event|7|||
13347496|NCT00961961|26646047|FG001|Phase I|Adverse Event|0|||
13347497|NCT00961961|26646048|FG002|Phase I|Adverse Event|0|||
13347498|NCT00961961|26646049|FG003|Phase I|Adverse Event|0|||
13347499|NCT00961961|26646046|FG000|Phase I|Physician Decision|8|||
13347500|NCT00961961|26646047|FG001|Phase I|Physician Decision|0|||
13347501|NCT00961961|26646048|FG002|Phase I|Physician Decision|0|||
13347502|NCT00961961|26646049|FG003|Phase I|Physician Decision|0|||
13347503|NCT00961961|26646046|FG000|Phase II|Lost to Follow-up|0|||
13347504|NCT00961961|26646047|FG001|Phase II|Lost to Follow-up|0|||
13347505|NCT00961961|26646048|FG002|Phase II|Lost to Follow-up|10|||
13347506|NCT00961961|26646049|FG003|Phase II|Lost to Follow-up|7|||
13347507|NCT00961961|26646046|FG000|Phase II|Adverse Event|0|||
13347508|NCT00961961|26646047|FG001|Phase II|Adverse Event|0|||
13347509|NCT00961961|26646048|FG002|Phase II|Adverse Event|0|||
13347510|NCT00961961|26646049|FG003|Phase II|Adverse Event|1|||
13347511|NCT00961961|26646046|FG000|Phase II|Physician Decision|0|||
13347512|NCT00961961|26646047|FG001|Phase II|Physician Decision|0|||
13347513|NCT00961961|26646048|FG002|Phase II|Physician Decision|1|||
13347514|NCT00961961|26646049|FG003|Phase II|Physician Decision|0|||
13347515|NCT00961961|26646046|FG000|Phase II|Withdrawal by Subject|0|||
13347516|NCT00961961|26646047|FG001|Phase II|Withdrawal by Subject|0|||
13347517|NCT00961961|26646048|FG002|Phase II|Withdrawal by Subject|1|||
13347518|NCT00961961|26646049|FG003|Phase II|Withdrawal by Subject|0|||
13347519|NCT00961896|26646078|FG000|Overall Study|Abnormal laboratory value|0|||
13347520|NCT00961896|26646079|FG001|Overall Study|Abnormal laboratory value|0|||
13347521|NCT00961896|26646080|FG002|Overall Study|Abnormal laboratory value|1|||
13347522|NCT00961649|26646104|FG000|Overall Study|Adverse Event|4|||
13347523|NCT00961649|26646105|FG001|Overall Study|Adverse Event|0|||
13347524|NCT00961649|26646106|FG002|Overall Study|Adverse Event|0|||
13347525|NCT00961649|26646107|FG003|Overall Study|Adverse Event|2|||
13347526|NCT00961649|26646104|FG000|Overall Study|Inadequate control of IOP|0|||
13347527|NCT00961649|26646105|FG001|Overall Study|Inadequate control of IOP|0|||
13347528|NCT00961649|26646106|FG002|Overall Study|Inadequate control of IOP|0|||
13347529|NCT00961649|26646107|FG003|Overall Study|Inadequate control of IOP|1|||
13347530|NCT00961649|26646104|FG000|Overall Study|Patient has travel plans during holidays|0|||
13347531|NCT00961649|26646105|FG001|Overall Study|Patient has travel plans during holidays|0|||
13347532|NCT00961649|26646106|FG002|Overall Study|Patient has travel plans during holidays|1|||
13347533|NCT00961649|26646107|FG003|Overall Study|Patient has travel plans during holidays|0|||
13347534|NCT00961649|26646104|FG000|Overall Study|Patient left to Mexico-family emergency|1|||
13347535|NCT00961649|26646105|FG001|Overall Study|Patient left to Mexico-family emergency|0|||
13347536|NCT00961649|26646106|FG002|Overall Study|Patient left to Mexico-family emergency|0|||
13347537|NCT00961649|26646107|FG003|Overall Study|Patient left to Mexico-family emergency|0|||
13347538|NCT00961649|26646104|FG000|Overall Study|Study terminated by sponsor|4|||
13347539|NCT00961649|26646105|FG001|Overall Study|Study terminated by sponsor|4|||
13347540|NCT00961649|26646106|FG002|Overall Study|Study terminated by sponsor|4|||
13347541|NCT00961649|26646107|FG003|Overall Study|Study terminated by sponsor|1|||
13347542|NCT00961636|26646128|FG000|Overall Study|Adverse Event|35|||
13347543|NCT00961636|26646129|FG001|Overall Study|Adverse Event|54|||
13347544|NCT00961636|26646130|FG002|Overall Study|Adverse Event|13|||
13347545|NCT00961636|26646128|FG000|Overall Study|Flushing Symptoms|29|||
13347546|NCT00961636|26646129|FG001|Overall Study|Flushing Symptoms|46|||
13347547|NCT00961636|26646130|FG002|Overall Study|Flushing Symptoms|3|||
13347548|NCT00961636|26646128|FG000|Overall Study|Lost to Follow-up|2|||
13347549|NCT00961636|26646129|FG001|Overall Study|Lost to Follow-up|3|||
13347550|NCT00961636|26646130|FG002|Overall Study|Lost to Follow-up|1|||
13347551|NCT00961636|26646128|FG000|Overall Study|Physician Decision|3|||
13347552|NCT00961636|26646129|FG001|Overall Study|Physician Decision|1|||
13347553|NCT00961636|26646130|FG002|Overall Study|Physician Decision|1|||
13347554|NCT00961636|26646128|FG000|Overall Study|Protocol Violation|9|||
13347555|NCT00961636|26646129|FG001|Overall Study|Protocol Violation|5|||
13347556|NCT00961636|26646130|FG002|Overall Study|Protocol Violation|1|||
13347557|NCT00961636|26646128|FG000|Overall Study|Withdrawal by Subject|29|||
13347558|NCT00961636|26646129|FG001|Overall Study|Withdrawal by Subject|22|||
13347559|NCT00961636|26646130|FG002|Overall Study|Withdrawal by Subject|13|||
13347560|NCT00961571|26646136|FG000|Overall Study|Physician Decision|39|||
13347561|NCT00961415|26646167|FG000|Induction Treatment Phase|Withdrawal by Subject|11|||
13347562|NCT00961415|26646168|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
13347563|NCT00961415|26646169|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
13347564|NCT00961415|26646167|FG000|Induction Treatment Phase|Death|77|||
13347565|NCT00961415|26646168|FG001|Induction Treatment Phase|Death|0|||
13347566|NCT00961415|26646169|FG002|Induction Treatment Phase|Death|0|||
13347567|NCT00961415|26646167|FG000|Induction Treatment Phase|Protocol Violation|1|||
13347568|NCT00961415|26646168|FG001|Induction Treatment Phase|Protocol Violation|0|||
13347569|NCT00961415|26646169|FG002|Induction Treatment Phase|Protocol Violation|0|||
13347570|NCT00961415|26646167|FG000|Induction Treatment Phase|Physician Decision|2|||
13347571|NCT00961415|26646168|FG001|Induction Treatment Phase|Physician Decision|0|||
13347572|NCT00961415|26646169|FG002|Induction Treatment Phase|Physician Decision|0|||
13347573|NCT00961415|26646167|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27|||
13347574|NCT00961415|26646168|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
13347575|NCT00961415|26646169|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
13347576|NCT00961415|26646167|FG000|Induction Treatment Phase|Other Reason|5|||
13347577|NCT00961415|26646168|FG001|Induction Treatment Phase|Other Reason|0|||
13347578|NCT00961415|26646169|FG002|Induction Treatment Phase|Other Reason|0|||
13347579|NCT00961415|26646167|FG000|Maintenance Treatment Phase|Death|0|||
13347580|NCT00961415|26646168|FG001|Maintenance Treatment Phase|Death|42|||
13347581|NCT00961415|26646169|FG002|Maintenance Treatment Phase|Death|34|||
13347582|NCT00961415|26646167|FG000|Maintenance Treatment Phase|Investigators decision|0|||
13347583|NCT00961415|26646168|FG001|Maintenance Treatment Phase|Investigators decision|2|||
13347584|NCT00961415|26646169|FG002|Maintenance Treatment Phase|Investigators decision|0|||
13347585|NCT00961415|26646167|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
13347586|NCT00961415|26646168|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3|||
13347587|NCT00961415|26646169|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8|||
13347588|NCT00961415|26646167|FG000|Maintenance Treatment Phase|Other reason|0|||
13347589|NCT00961415|26646168|FG001|Maintenance Treatment Phase|Other reason|1|||
13347590|NCT00961415|26646169|FG002|Maintenance Treatment Phase|Other reason|3|||
13347591|NCT00961350|26646190|FG000|Overall Study|Adverse Event|18|||
13347592|NCT00961350|26646191|FG001|Overall Study|Adverse Event|33|||
13347593|NCT00961350|26646190|FG000|Overall Study|Withdrawal by Subject|10|||
13347594|NCT00961350|26646191|FG001|Overall Study|Withdrawal by Subject|10|||
13347595|NCT00961350|26646190|FG000|Overall Study|Lost to Follow-up|3|||
13347596|NCT00961350|26646191|FG001|Overall Study|Lost to Follow-up|3|||
13347597|NCT00961350|26646190|FG000|Overall Study|Misc|16|||
13347598|NCT00961350|26646191|FG001|Overall Study|Misc|21|||
13347599|NCT00961298|26646200|FG000|Two Week Placebo Run in|Withdrawal by Subject|1|||
13347600|NCT00961298|26646200|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2|||
13347601|NCT00961298|26646200|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1|||
13347602|NCT00961259|26646221|FG000|Washout Period of 7 Days|due to concomitant medication used|0|||
13347603|NCT00961259|26646222|FG001|Washout Period of 7 Days|due to concomitant medication used|1|||
13347604|NCT00961259|26646223|FG002|Washout Period of 7 Days|due to concomitant medication used|0|||
13347605|NCT00961220|26646241|FG000|Overall Study|Adverse Event|3|||
13347606|NCT00961220|26646241|FG000|Overall Study|Lack of Efficacy|1|||
13347607|NCT00961220|26646241|FG000|Overall Study|No IV access for O6BG|1|||
13347608|NCT00961220|26646241|FG000|Overall Study|O6BG no longer supplied|1|||
13347609|NCT00961220|26646241|FG000|Overall Study|Complete Response prior to 12 courses|1|||
13347610|NCT00961181|26646256|FG000|Overall Study|Death|2|||
13347611|NCT00961181|26646256|FG000|Overall Study|Withdrawal by Subject|2|||
13347612|NCT00961181|26646256|FG000|Overall Study|Lost to Follow-up|1|||
13347613|NCT00961116|26646269|FG000|Washout Period of 7 Days|Adverse Event|1|||
13347614|NCT00961116|26646270|FG001|Washout Period of 7 Days|Adverse Event|1|||
13347615|NCT00961116|26646269|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
13347616|NCT00961116|26646270|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
13347617|NCT00961116|26646269|FG000|Washout Period of 7 Days|Protocol Violation|0|||
13347618|NCT00961116|26646270|FG001|Washout Period of 7 Days|Protocol Violation|1|||
13347619|NCT00961064|26646280|FG000|Initial Treatment (Weeks 1 - 20)|No Response|11|||
13347620|NCT00961064|26646280|FG000|Initial Treatment (Weeks 1 - 20)|Disease Progression|3|||
13347621|NCT00961064|26646280|FG000|Initial Treatment (Weeks 1 - 20)|Death|1|||
13347622|NCT00961064|26646280|FG000|Initial Treatment (Weeks 1 - 20)|Withdrawal by Subject|1|||
13347623|NCT00961064|26646280|FG000|Extended Access: Week 20 to Up to Year 5|Disease Progression|3|||
13347624|NCT00961064|26646280|FG000|Extended Access: Week 20 to Up to Year 5|Lost Response|1|||
13347625|NCT00961064|26646280|FG000|Extended Access: Week 20 to Up to Year 5|Non-compliant|1|||
13347626|NCT00961064|26646280|FG000|Extended Access: Week 20 to Up to Year 5|Withdrawal by Subject|2|||
13347627|NCT00960999|26646315|FG000|Overall Study|Withdrawal by Subject|1|||
13347628|NCT00960999|26646316|FG001|Overall Study|Withdrawal by Subject|0|||
13347629|NCT00960999|26646315|FG000|Overall Study|Protocol Violation|5|||
13347630|NCT00960999|26646316|FG001|Overall Study|Protocol Violation|2|||
13347631|NCT00960999|26646315|FG000|Overall Study|RT dose constraints not met|2|||
13347632|NCT00960999|26646316|FG001|Overall Study|RT dose constraints not met|0|||
13347633|NCT00960986|26646399|FG000|Period 1 (Screening and Washout)|Adverse Event|1|||
13347634|NCT00960986|26646400|FG001|Period 1 (Screening and Washout)|Adverse Event|2|||
13347635|NCT00960986|26646401|FG002|Period 1 (Screening and Washout)|Adverse Event|1|||
13347636|NCT00960986|26646402|FG003|Period 1 (Screening and Washout)|Adverse Event|1|||
13347637|NCT00960986|26646399|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
13347638|NCT00960986|26646400|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
13347639|NCT00960986|26646401|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2|||
13347640|NCT00960986|26646402|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1|||
13347641|NCT00960986|26646399|FG000|Period 1 (Screening and Washout)|Protocol Violation|1|||
13347642|NCT00960986|26646400|FG001|Period 1 (Screening and Washout)|Protocol Violation|0|||
13347643|NCT00960986|26646401|FG002|Period 1 (Screening and Washout)|Protocol Violation|0|||
13347644|NCT00960986|26646402|FG003|Period 1 (Screening and Washout)|Protocol Violation|0|||
13347645|NCT00960986|26646399|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
13347646|NCT00960986|26646400|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2|||
13347647|NCT00960986|26646401|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
13347648|NCT00960986|26646402|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
13347649|NCT00960986|26646399|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17|||
13347650|NCT00960986|26646400|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15|||
13347651|NCT00960986|26646401|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10|||
13347652|NCT00960986|26646402|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12|||
13347653|NCT00960986|26646399|FG000|Period 3 (7-week Therapy Period)|Death|0|||
13347654|NCT00960986|26646400|FG001|Period 3 (7-week Therapy Period)|Death|0|||
13347655|NCT00960986|26646401|FG002|Period 3 (7-week Therapy Period)|Death|1|||
13347656|NCT00960986|26646402|FG003|Period 3 (7-week Therapy Period)|Death|0|||
13347657|NCT00960986|26646399|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
13347658|NCT00960986|26646400|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
13347659|NCT00960986|26646401|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1|||
13347660|NCT00960986|26646402|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
13347661|NCT00960986|26646399|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10|||
13347662|NCT00960986|26646400|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4|||
13347663|NCT00960986|26646401|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3|||
13347664|NCT00960986|26646402|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11|||
13347665|NCT00960986|26646399|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
13347666|NCT00960986|26646400|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
13347667|NCT00960986|26646401|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4|||
13347668|NCT00960986|26646402|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
13347669|NCT00960986|26646399|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
13347670|NCT00960986|26646400|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2|||
13347671|NCT00960986|26646401|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
13347672|NCT00960986|26646402|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0|||
13347673|NCT00960934|26646531|FG000|Overall Study|Adverse Event|2|||
13347674|NCT00960934|26646532|FG001|Overall Study|Adverse Event|3|||
13347675|NCT00960934|26646533|FG002|Overall Study|Adverse Event|3|||
13347676|NCT00960934|26646534|FG003|Overall Study|Adverse Event|2|||
13347677|NCT00960934|26646535|FG004|Overall Study|Adverse Event|4|||
13347678|NCT00960934|26646536|FG005|Overall Study|Adverse Event|3|||
13347679|NCT00960934|26646531|FG000|Overall Study|Lack of Efficacy|1|||
13347680|NCT00960934|26646532|FG001|Overall Study|Lack of Efficacy|0|||
13347681|NCT00960934|26646533|FG002|Overall Study|Lack of Efficacy|0|||
13347682|NCT00960934|26646534|FG003|Overall Study|Lack of Efficacy|0|||
13347683|NCT00960934|26646535|FG004|Overall Study|Lack of Efficacy|0|||
13347684|NCT00960934|26646536|FG005|Overall Study|Lack of Efficacy|0|||
13347685|NCT00960934|26646531|FG000|Overall Study|Lost to Follow-up|0|||
13347686|NCT00960934|26646532|FG001|Overall Study|Lost to Follow-up|1|||
13347687|NCT00960934|26646533|FG002|Overall Study|Lost to Follow-up|0|||
13347688|NCT00960934|26646534|FG003|Overall Study|Lost to Follow-up|0|||
13347689|NCT00960934|26646535|FG004|Overall Study|Lost to Follow-up|0|||
13347690|NCT00960934|26646536|FG005|Overall Study|Lost to Follow-up|0|||
13347691|NCT00960934|26646531|FG000|Overall Study|Other|2|||
13347692|NCT00960934|26646532|FG001|Overall Study|Other|1|||
13347693|NCT00960934|26646533|FG002|Overall Study|Other|5|||
13347694|NCT00960934|26646534|FG003|Overall Study|Other|4|||
13347695|NCT00960934|26646535|FG004|Overall Study|Other|2|||
13347696|NCT00960934|26646536|FG005|Overall Study|Other|2|||
13347697|NCT00960934|26646531|FG000|Overall Study|Physician Decision|0|||
13347698|NCT00960934|26646532|FG001|Overall Study|Physician Decision|1|||
13347699|NCT00960934|26646533|FG002|Overall Study|Physician Decision|0|||
13347700|NCT00960934|26646534|FG003|Overall Study|Physician Decision|0|||
13347701|NCT00960934|26646535|FG004|Overall Study|Physician Decision|0|||
13347702|NCT00960934|26646536|FG005|Overall Study|Physician Decision|0|||
13347703|NCT00960934|26646531|FG000|Overall Study|Progressive Disease|1|||
13347704|NCT00960934|26646532|FG001|Overall Study|Progressive Disease|1|||
13347705|NCT00960934|26646533|FG002|Overall Study|Progressive Disease|0|||
13347706|NCT00960934|26646534|FG003|Overall Study|Progressive Disease|0|||
13347707|NCT00960934|26646535|FG004|Overall Study|Progressive Disease|1|||
13347708|NCT00960934|26646536|FG005|Overall Study|Progressive Disease|1|||
13347709|NCT00960934|26646531|FG000|Overall Study|Protocol Violation|3|||
13347710|NCT00960934|26646532|FG001|Overall Study|Protocol Violation|4|||
13347711|NCT00960934|26646533|FG002|Overall Study|Protocol Violation|0|||
13347712|NCT00960934|26646534|FG003|Overall Study|Protocol Violation|3|||
13347713|NCT00960934|26646535|FG004|Overall Study|Protocol Violation|3|||
13347714|NCT00960934|26646536|FG005|Overall Study|Protocol Violation|2|||
13347715|NCT00960934|26646531|FG000|Overall Study|Withdrawal by Subject|5|||
13347716|NCT00960934|26646532|FG001|Overall Study|Withdrawal by Subject|6|||
13347717|NCT00960934|26646533|FG002|Overall Study|Withdrawal by Subject|4|||
13347718|NCT00960934|26646534|FG003|Overall Study|Withdrawal by Subject|5|||
13347719|NCT00960934|26646535|FG004|Overall Study|Withdrawal by Subject|5|||
13347720|NCT00960934|26646536|FG005|Overall Study|Withdrawal by Subject|7|||
13347721|NCT00960934|26646531|FG000|Overall Study|Study Terminated by Sponsor|50|||
13347722|NCT00960934|26646532|FG001|Overall Study|Study Terminated by Sponsor|46|||
13347723|NCT00960934|26646533|FG002|Overall Study|Study Terminated by Sponsor|52|||
13347724|NCT00960934|26646534|FG003|Overall Study|Study Terminated by Sponsor|50|||
13347725|NCT00960934|26646535|FG004|Overall Study|Study Terminated by Sponsor|49|||
13347726|NCT00960934|26646536|FG005|Overall Study|Study Terminated by Sponsor|49|||
13347727|NCT00960869|26646557|FG000|Overall Study|Adverse Event|17|||
13347728|NCT00960869|26646558|FG001|Overall Study|Adverse Event|26|||
13347729|NCT00960869|26646557|FG000|Overall Study|Withdrawal by Subject|16|||
13347730|NCT00960869|26646558|FG001|Overall Study|Withdrawal by Subject|14|||
13347731|NCT00960869|26646557|FG000|Overall Study|Lost to Follow-up|1|||
13347732|NCT00960869|26646558|FG001|Overall Study|Lost to Follow-up|4|||
13347733|NCT00960869|26646557|FG000|Overall Study|Misc|19|||
13347734|NCT00960869|26646558|FG001|Overall Study|Misc|18|||
13347735|NCT00960856|26646581|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
13347736|NCT00960856|26646582|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
13347737|NCT00960856|26646583|FG002|Washout Period of 7 Days|Withdrawal by Subject|0|||
13347738|NCT00960856|26646584|FG003|Washout Period of 7 Days|Withdrawal by Subject|0|||
13347739|NCT00960856|26646581|FG000|Washout Period of 7 Days|Adverse Event|0|||
13124838|NCT02937701|25954304|FG002|Day 1 to Week 22|Protocol Violation|0|||
13124839|NCT02937701|25954305|FG003|Day 1 to Week 22|Protocol Violation|0|||
13124840|NCT02937701|25954306|FG004|Day 1 to Week 22|Protocol Violation|0|||
13124841|NCT02937701|25954302|FG000|Day 1 to Week 22|Lost to Follow-up|1|||
13124842|NCT02937701|25954303|FG001|Day 1 to Week 22|Lost to Follow-up|1|||
13124843|NCT02937701|25954304|FG002|Day 1 to Week 22|Lost to Follow-up|0|||
13124844|NCT02937701|25954305|FG003|Day 1 to Week 22|Lost to Follow-up|0|||
13124845|NCT02937701|25954306|FG004|Day 1 to Week 22|Lost to Follow-up|0|||
13124846|NCT02937701|25954302|FG000|Day 1 to Week 22|Physician Decision|2|||
13124847|NCT02937701|25954303|FG001|Day 1 to Week 22|Physician Decision|0|||
13124848|NCT02937701|25954304|FG002|Day 1 to Week 22|Physician Decision|0|||
13124849|NCT02937701|25954305|FG003|Day 1 to Week 22|Physician Decision|0|||
13124850|NCT02937701|25954306|FG004|Day 1 to Week 22|Physician Decision|0|||
13124851|NCT02937701|25954302|FG000|Day 1 to Week 22|Other|1|||
13347740|NCT00960856|26646582|FG001|Washout Period of 7 Days|Adverse Event|0|||
13347741|NCT00960856|26646583|FG002|Washout Period of 7 Days|Adverse Event|1|||
13124852|NCT02937701|25954303|FG001|Day 1 to Week 22|Other|0|||
13347742|NCT00960856|26646584|FG003|Washout Period of 7 Days|Adverse Event|0|||
13347743|NCT00960843|26646601|FG000|Overall Study|Lost to Follow-up|2|||
13347744|NCT00960843|26646602|FG001|Overall Study|Lost to Follow-up|0|||
13347745|NCT00960843|26646601|FG000|Overall Study|Protocol Violation|0|||
13347746|NCT00960843|26646602|FG001|Overall Study|Protocol Violation|4|||
13347747|NCT00960843|26646601|FG000|Overall Study|Repeated needle dislodgment|0|||
13347748|NCT00960843|26646602|FG001|Overall Study|Repeated needle dislodgment|1|||
13347749|NCT00960804|26646662|FG000|Overall Study|Adverse Event|1|||
13347750|NCT00960804|26646663|FG001|Overall Study|Adverse Event|0|||
13347751|NCT00960804|26646664|FG002|Overall Study|Adverse Event|0|||
13347752|NCT00960804|26646662|FG000|Overall Study|Withdrawal by Subject|1|||
13347753|NCT00960804|26646663|FG001|Overall Study|Withdrawal by Subject|0|||
13347754|NCT00960804|26646664|FG002|Overall Study|Withdrawal by Subject|0|||
13347755|NCT00960804|26646662|FG000|Overall Study|Study terminated by the sponsor|5|||
13347756|NCT00960804|26646663|FG001|Overall Study|Study terminated by the sponsor|4|||
13347757|NCT00960804|26646664|FG002|Overall Study|Study terminated by the sponsor|10|||
13347758|NCT00960752|26646685|FG000|Overall Study|Adverse Event|0|||
13347759|NCT00960752|26646686|FG001|Overall Study|Adverse Event|0|||
13347760|NCT00960752|26646687|FG002|Overall Study|Adverse Event|1|||
13347761|NCT00960752|26646685|FG000|Overall Study|Progression|0|||
13347762|NCT00960752|26646686|FG001|Overall Study|Progression|0|||
13347763|NCT00960752|26646687|FG002|Overall Study|Progression|1|||
13347764|NCT00960687|26646700|FG000|Washout Period of 7 Days|Adverse Event|3|||
13347765|NCT00960687|26646701|FG001|Washout Period of 7 Days|Adverse Event|2|||
13347766|NCT00960687|26646700|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
13347767|NCT00960687|26646701|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
13347768|NCT00960661|26646739|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6|||
13347769|NCT00960661|26646740|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
13347770|NCT00960661|26646741|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
13347771|NCT00960661|26646739|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4|||
13347772|NCT00960661|26646740|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
13347773|NCT00960661|26646741|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
13347774|NCT00960661|26646739|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331|||
13347775|NCT00960661|26646740|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
13347776|NCT00960661|26646741|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
13347777|NCT00960661|26646739|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47|||
13347778|NCT00960661|26646740|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
13347779|NCT00960661|26646741|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
13347780|NCT00960661|26646739|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8|||
13347781|NCT00960661|26646740|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
13347782|NCT00960661|26646741|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
13347783|NCT00960661|26646739|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3|||
13347784|NCT00960661|26646740|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
13347785|NCT00960661|26646741|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
13347786|NCT00960661|26646739|FG000|Interventional Phase|Adverse Event|0|||
13347787|NCT00960661|26646740|FG001|Interventional Phase|Adverse Event|17|||
13347788|NCT00960661|26646741|FG002|Interventional Phase|Adverse Event|8|||
13347789|NCT00960661|26646739|FG000|Interventional Phase|Death|0|||
13347790|NCT00960661|26646740|FG001|Interventional Phase|Death|1|||
13347791|NCT00960661|26646741|FG002|Interventional Phase|Death|0|||
13347792|NCT00960661|26646739|FG000|Interventional Phase|Lost to Follow-up|0|||
13347793|NCT00960661|26646740|FG001|Interventional Phase|Lost to Follow-up|0|||
13347794|NCT00960661|26646741|FG002|Interventional Phase|Lost to Follow-up|2|||
13347795|NCT00960661|26646739|FG000|Interventional Phase|entry criteria not met|0|||
13347796|NCT00960661|26646740|FG001|Interventional Phase|entry criteria not met|3|||
13347797|NCT00960661|26646741|FG002|Interventional Phase|entry criteria not met|0|||
13347798|NCT00960661|26646739|FG000|Interventional Phase|Protocol Violation|0|||
13347799|NCT00960661|26646740|FG001|Interventional Phase|Protocol Violation|7|||
13347800|NCT00960661|26646741|FG002|Interventional Phase|Protocol Violation|2|||
13347801|NCT00960661|26646739|FG000|Interventional Phase|Withdrawal by Subject|0|||
13347802|NCT00960661|26646740|FG001|Interventional Phase|Withdrawal by Subject|18|||
13347803|NCT00960661|26646741|FG002|Interventional Phase|Withdrawal by Subject|29|||
13347804|NCT00960661|26646739|FG000|Interventional Phase|Physician Decision|0|||
13347805|NCT00960661|26646740|FG001|Interventional Phase|Physician Decision|3|||
13347806|NCT00960661|26646741|FG002|Interventional Phase|Physician Decision|5|||
13347807|NCT00960661|26646739|FG000|Interventional Phase|sponsor decision|0|||
13347808|NCT00960661|26646740|FG001|Interventional Phase|sponsor decision|1|||
13347809|NCT00960661|26646741|FG002|Interventional Phase|sponsor decision|0|||
13347810|NCT00960661|26646739|FG000|Interventional Phase|Lack of Efficacy|0|||
13347811|NCT00960661|26646740|FG001|Interventional Phase|Lack of Efficacy|2|||
13347812|NCT00960661|26646741|FG002|Interventional Phase|Lack of Efficacy|0|||
13347813|NCT00960570|26646754|FG000|21 Day Washout Period|Adverse Event|1|||
13347814|NCT00960570|26646754|FG000|21 Day Washout Period|Withdrawal by Subject|1|||
13347815|NCT00960570|26646754|FG000|1 Day Period Between Dosing|Adverse Event|2|||
13124853|NCT02937701|25954304|FG002|Day 1 to Week 22|Other|0|||
13124854|NCT02937701|25954305|FG003|Day 1 to Week 22|Other|0|||
13347816|NCT00960570|26646754|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1|||
13347817|NCT00960531|26646829|FG000|Overall Study|Lack of Efficacy|1|||
13124855|NCT02937701|25954306|FG004|Day 1 to Week 22|Other|0|||
13347818|NCT00960531|26646830|FG001|Overall Study|Lack of Efficacy|0|||
13347819|NCT00960531|26646831|FG002|Overall Study|Lack of Efficacy|0|||
13347820|NCT00960531|26646832|FG003|Overall Study|Lack of Efficacy|0|||
13347821|NCT00960531|26646833|FG004|Overall Study|Lack of Efficacy|0|||
13347822|NCT00960531|26646834|FG005|Overall Study|Lack of Efficacy|0|||
13347823|NCT00960531|26646835|FG006|Overall Study|Lack of Efficacy|0|||
13347824|NCT00960531|26646836|FG007|Overall Study|Lack of Efficacy|0|||
13347825|NCT00960531|26646837|FG008|Overall Study|Lack of Efficacy|0|||
13347826|NCT00960531|26646838|FG009|Overall Study|Lack of Efficacy|0|||
13347827|NCT00960531|26646829|FG000|Overall Study|Withdrawal by Subject|1|||
13347828|NCT00960531|26646830|FG001|Overall Study|Withdrawal by Subject|0|||
13347829|NCT00960531|26646831|FG002|Overall Study|Withdrawal by Subject|5|||
13347830|NCT00960531|26646832|FG003|Overall Study|Withdrawal by Subject|2|||
13347831|NCT00960531|26646833|FG004|Overall Study|Withdrawal by Subject|0|||
13347832|NCT00960531|26646834|FG005|Overall Study|Withdrawal by Subject|0|||
13347833|NCT00960531|26646835|FG006|Overall Study|Withdrawal by Subject|2|||
13347834|NCT00960531|26646836|FG007|Overall Study|Withdrawal by Subject|0|||
13124856|NCT02937701|25954302|FG000|Week 22 to Week 50|Adverse Event|0|||
13124857|NCT02937701|25954303|FG001|Week 22 to Week 50|Adverse Event|0|||
13124858|NCT02937701|25954304|FG002|Week 22 to Week 50|Adverse Event|10|||
13124859|NCT02937701|25954305|FG003|Week 22 to Week 50|Adverse Event|3|||
13124860|NCT02937701|25954306|FG004|Week 22 to Week 50|Adverse Event|3|||
13347835|NCT00960531|26646837|FG008|Overall Study|Withdrawal by Subject|1|||
13347836|NCT00960531|26646838|FG009|Overall Study|Withdrawal by Subject|0|||
13347837|NCT00960531|26646829|FG000|Overall Study|Caregiver Request|2|||
13347838|NCT00960531|26646830|FG001|Overall Study|Caregiver Request|0|||
13347839|NCT00960531|26646831|FG002|Overall Study|Caregiver Request|6|||
13347840|NCT00960531|26646832|FG003|Overall Study|Caregiver Request|5|||
13347841|NCT00960531|26646833|FG004|Overall Study|Caregiver Request|0|||
13347842|NCT00960531|26646834|FG005|Overall Study|Caregiver Request|2|||
13347843|NCT00960531|26646835|FG006|Overall Study|Caregiver Request|3|||
13347844|NCT00960531|26646836|FG007|Overall Study|Caregiver Request|1|||
13347845|NCT00960531|26646837|FG008|Overall Study|Caregiver Request|3|||
13347846|NCT00960531|26646838|FG009|Overall Study|Caregiver Request|0|||
13347847|NCT00960531|26646829|FG000|Overall Study|Investigator Request|0|||
13347848|NCT00960531|26646830|FG001|Overall Study|Investigator Request|0|||
13347849|NCT00960531|26646831|FG002|Overall Study|Investigator Request|1|||
13347850|NCT00960531|26646832|FG003|Overall Study|Investigator Request|0|||
13347851|NCT00960531|26646833|FG004|Overall Study|Investigator Request|0|||
13347852|NCT00960531|26646834|FG005|Overall Study|Investigator Request|0|||
13347853|NCT00960531|26646835|FG006|Overall Study|Investigator Request|0|||
13347854|NCT00960531|26646836|FG007|Overall Study|Investigator Request|0|||
13347855|NCT00960531|26646837|FG008|Overall Study|Investigator Request|0|||
13347856|NCT00960531|26646838|FG009|Overall Study|Investigator Request|0|||
13347857|NCT00960531|26646829|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
13347858|NCT00960531|26646830|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
13347859|NCT00960531|26646831|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
13347860|NCT00960531|26646832|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
13347861|NCT00960531|26646833|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
13347862|NCT00960531|26646834|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
13347863|NCT00960531|26646835|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
13347864|NCT00960531|26646836|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
13347865|NCT00960531|26646837|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
13347866|NCT00960531|26646838|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
13347867|NCT00960531|26646829|FG000|Overall Study|Lost to Follow-up|0|||
13347868|NCT00960531|26646830|FG001|Overall Study|Lost to Follow-up|0|||
13347869|NCT00960531|26646831|FG002|Overall Study|Lost to Follow-up|1|||
13347870|NCT00960531|26646832|FG003|Overall Study|Lost to Follow-up|0|||
13347871|NCT00960531|26646833|FG004|Overall Study|Lost to Follow-up|0|||
13347872|NCT00960531|26646834|FG005|Overall Study|Lost to Follow-up|0|||
13347873|NCT00960531|26646835|FG006|Overall Study|Lost to Follow-up|1|||
13347874|NCT00960531|26646836|FG007|Overall Study|Lost to Follow-up|0|||
13347875|NCT00960531|26646837|FG008|Overall Study|Lost to Follow-up|0|||
13347876|NCT00960531|26646838|FG009|Overall Study|Lost to Follow-up|0|||
13347877|NCT00960531|26646829|FG000|Overall Study|Failed to Return|2|||
13347878|NCT00960531|26646830|FG001|Overall Study|Failed to Return|0|||
13347879|NCT00960531|26646831|FG002|Overall Study|Failed to Return|0|||
13347880|NCT00960531|26646832|FG003|Overall Study|Failed to Return|0|||
13347881|NCT00960531|26646833|FG004|Overall Study|Failed to Return|0|||
13347882|NCT00960531|26646834|FG005|Overall Study|Failed to Return|0|||
13347883|NCT00960531|26646835|FG006|Overall Study|Failed to Return|0|||
13347884|NCT00960531|26646836|FG007|Overall Study|Failed to Return|2|||
13347885|NCT00960531|26646837|FG008|Overall Study|Failed to Return|0|||
13347886|NCT00960531|26646838|FG009|Overall Study|Failed to Return|0|||
13347887|NCT00960531|26646829|FG000|Overall Study|Adverse Event (AE)|2|||
13347888|NCT00960531|26646830|FG001|Overall Study|Adverse Event (AE)|0|||
13124861|NCT02937701|25954302|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
13347889|NCT00960531|26646831|FG002|Overall Study|Adverse Event (AE)|0|||
13347890|NCT00960531|26646832|FG003|Overall Study|Adverse Event (AE)|0|||
13347891|NCT00960531|26646833|FG004|Overall Study|Adverse Event (AE)|0|||
13347892|NCT00960531|26646834|FG005|Overall Study|Adverse Event (AE)|1|||
13347893|NCT00960531|26646835|FG006|Overall Study|Adverse Event (AE)|2|||
13347894|NCT00960531|26646836|FG007|Overall Study|Adverse Event (AE)|0|||
13347895|NCT00960531|26646837|FG008|Overall Study|Adverse Event (AE)|2|||
13347896|NCT00960531|26646838|FG009|Overall Study|Adverse Event (AE)|0|||
13347897|NCT00960531|26646829|FG000|Overall Study|Reason not Specified|2|||
13347898|NCT00960531|26646830|FG001|Overall Study|Reason not Specified|1|||
13347899|NCT00960531|26646831|FG002|Overall Study|Reason not Specified|13|||
13347900|NCT00960531|26646832|FG003|Overall Study|Reason not Specified|1|||
13347901|NCT00960531|26646833|FG004|Overall Study|Reason not Specified|2|||
13347902|NCT00960531|26646834|FG005|Overall Study|Reason not Specified|0|||
13347903|NCT00960531|26646835|FG006|Overall Study|Reason not Specified|16|||
13347904|NCT00960531|26646836|FG007|Overall Study|Reason not Specified|0|||
13347905|NCT00960531|26646837|FG008|Overall Study|Reason not Specified|8|||
13347906|NCT00960531|26646838|FG009|Overall Study|Reason not Specified|1|||
13347907|NCT00960440|26647021|FG000|Overall Study|Death|0|||
13347908|NCT00960440|26647022|FG001|Overall Study|Death|0|||
13347909|NCT00960440|26647023|FG002|Overall Study|Death|0|||
13347910|NCT00960440|26647024|FG003|Overall Study|Death|1|||
13347911|NCT00960440|26647021|FG000|Overall Study|Adverse Event|12|||
13347912|NCT00960440|26647022|FG001|Overall Study|Adverse Event|12|||
13347913|NCT00960440|26647023|FG002|Overall Study|Adverse Event|4|||
13347914|NCT00960440|26647024|FG003|Overall Study|Adverse Event|4|||
13347915|NCT00960440|26647021|FG000|Overall Study|Lack of Efficacy|2|||
13347916|NCT00960440|26647022|FG001|Overall Study|Lack of Efficacy|5|||
13347917|NCT00960440|26647023|FG002|Overall Study|Lack of Efficacy|3|||
13347918|NCT00960440|26647024|FG003|Overall Study|Lack of Efficacy|8|||
13347919|NCT00960440|26647021|FG000|Overall Study|Protocol Violation|2|||
13347920|NCT00960440|26647022|FG001|Overall Study|Protocol Violation|8|||
13347921|NCT00960440|26647023|FG002|Overall Study|Protocol Violation|3|||
13347922|NCT00960440|26647024|FG003|Overall Study|Protocol Violation|4|||
13347923|NCT00960440|26647021|FG000|Overall Study|Withdrawal by Subject|9|||
13347924|NCT00960440|26647022|FG001|Overall Study|Withdrawal by Subject|5|||
13347925|NCT00960440|26647023|FG002|Overall Study|Withdrawal by Subject|2|||
13347926|NCT00960440|26647024|FG003|Overall Study|Withdrawal by Subject|1|||
13347927|NCT00960440|26647021|FG000|Overall Study|Other|1|||
13347928|NCT00960440|26647022|FG001|Overall Study|Other|1|||
13347929|NCT00960440|26647023|FG002|Overall Study|Other|1|||
13347930|NCT00960440|26647024|FG003|Overall Study|Other|0|||
13347931|NCT00960375|26647039|FG000|Overall Study|Lost to Follow-up|20|||
13347932|NCT00960375|26647040|FG001|Overall Study|Lost to Follow-up|22|||
13347933|NCT00960323|26647053|FG000|Atorvastatin Alone|Withdrawal by Subject|1|||
13347934|NCT00960206|26647081|FG000|Overall Study|Death|7|||
13347935|NCT00960206|26647082|FG001|Overall Study|Death|4|||
13347936|NCT00960206|26647083|FG002|Overall Study|Death|1|||
13347937|NCT00960206|26647081|FG000|Overall Study|Unwilling/Unable to return|1|||
13347938|NCT00960206|26647082|FG001|Overall Study|Unwilling/Unable to return|2|||
13347939|NCT00960206|26647083|FG002|Overall Study|Unwilling/Unable to return|0|||
13347940|NCT00960206|26647081|FG000|Overall Study|Lost to Follow-up|8|||
13347941|NCT00960206|26647082|FG001|Overall Study|Lost to Follow-up|14|||
13347942|NCT00960206|26647083|FG002|Overall Study|Lost to Follow-up|8|||
13347943|NCT00960206|26647081|FG000|Overall Study|Withdrawal by Subject|2|||
13347944|NCT00960206|26647082|FG001|Overall Study|Withdrawal by Subject|4|||
13347945|NCT00960206|26647083|FG002|Overall Study|Withdrawal by Subject|0|||
13347946|NCT00960206|26647081|FG000|Overall Study|Revision of study component|2|||
13347947|NCT00960206|26647082|FG001|Overall Study|Revision of study component|2|||
13347948|NCT00960206|26647083|FG002|Overall Study|Revision of study component|2|||
13347949|NCT00960206|26647081|FG000|Overall Study|Missing 10 year data|20|||
13347950|NCT00960206|26647082|FG001|Overall Study|Missing 10 year data|1|||
13347951|NCT00960206|26647083|FG002|Overall Study|Missing 10 year data|1|||
13347952|NCT00960193|26647096|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
13347953|NCT00960154|26647111|FG000|Overall Study|Study termination|25|||
13347954|NCT00960154|26647112|FG001|Overall Study|Study termination|25|||
13347955|NCT00960115|26647131|FG000|Overall Study|Ongoing treatment at data cut-off date|19|||
13347956|NCT00960115|26647132|FG001|Overall Study|Ongoing treatment at data cut-off date|15|||
13347957|NCT00960076|26647151|FG000|Overall Study|Adverse Event|1|||
13347958|NCT00960076|26647152|FG001|Overall Study|Adverse Event|7|||
13347959|NCT00960076|26647151|FG000|Overall Study|No longer met study criteria|1|||
13347960|NCT00960076|26647152|FG001|Overall Study|No longer met study criteria|5|||
13347961|NCT00960076|26647151|FG000|Overall Study|Withdrawal by Subject|1|||
13347962|NCT00960076|26647152|FG001|Overall Study|Withdrawal by Subject|2|||
13347963|NCT00960076|26647151|FG000|Overall Study|Lost to Follow-up|3|||
13347964|NCT00960076|26647152|FG001|Overall Study|Lost to Follow-up|3|||
13347965|NCT00960076|26647151|FG000|Overall Study|Severe non-compliance to protocol|1|||
13347966|NCT00960076|26647152|FG001|Overall Study|Severe non-compliance to protocol|2|||
13347967|NCT00960076|26647151|FG000|Overall Study|Hyperglycemia|1|||
13347968|NCT00960076|26647152|FG001|Overall Study|Hyperglycemia|5|||
13347969|NCT00960076|26647151|FG000|Overall Study|Did not attend the termination visit|0|||
13347970|NCT00960076|26647152|FG001|Overall Study|Did not attend the termination visit|1|||
13347971|NCT00960063|26647200|FG000|Overall Study|Adverse Event|1|||
13347972|NCT00960063|26647201|FG001|Overall Study|Adverse Event|0|||
13347973|NCT00960063|26647202|FG002|Overall Study|Adverse Event|0|||
13347974|NCT00960063|26647200|FG000|Overall Study|Progression of Disease|0|||
13347975|NCT00960063|26647201|FG001|Overall Study|Progression of Disease|0|||
13347976|NCT00960063|26647202|FG002|Overall Study|Progression of Disease|3|||
13347977|NCT00960011|26647249|FG000|Overall Study|Death|5|||
13347978|NCT00960011|26647250|FG001|Overall Study|Death|0|||
13347979|NCT00960011|26647249|FG000|Overall Study|Lost to Follow-up|6|||
13347980|NCT00960011|26647250|FG001|Overall Study|Lost to Follow-up|2|||
13347981|NCT00959946|26647326|FG000|Overall Study|Adverse Event|0|||
13347982|NCT00959946|26647327|FG001|Overall Study|Adverse Event|0|||
13347983|NCT00959946|26647328|FG002|Overall Study|Adverse Event|2|||
13347984|NCT00959946|26647329|FG003|Overall Study|Adverse Event|1|||
13347985|NCT00959946|26647330|FG004|Overall Study|Adverse Event|0|||
13347986|NCT00959946|26647331|FG005|Overall Study|Adverse Event|1|||
13347987|NCT00959946|26647332|FG006|Overall Study|Adverse Event|0|||
13347988|NCT00959946|26647333|FG007|Overall Study|Adverse Event|0|||
13347989|NCT00959946|26647326|FG000|Overall Study|Death|0|||
13347990|NCT00959946|26647327|FG001|Overall Study|Death|0|||
13347991|NCT00959946|26647328|FG002|Overall Study|Death|0|||
13347992|NCT00959946|26647329|FG003|Overall Study|Death|0|||
13347993|NCT00959946|26647330|FG004|Overall Study|Death|0|||
13347994|NCT00959946|26647331|FG005|Overall Study|Death|1|||
13347995|NCT00959946|26647332|FG006|Overall Study|Death|0|||
13347996|NCT00959946|26647333|FG007|Overall Study|Death|0|||
13347997|NCT00959946|26647326|FG000|Overall Study|Disease Progression|2|||
13347998|NCT00959946|26647327|FG001|Overall Study|Disease Progression|4|||
13347999|NCT00959946|26647328|FG002|Overall Study|Disease Progression|2|||
13348000|NCT00959946|26647329|FG003|Overall Study|Disease Progression|4|||
13348001|NCT00959946|26647330|FG004|Overall Study|Disease Progression|4|||
13348002|NCT00959946|26647331|FG005|Overall Study|Disease Progression|6|||
13348003|NCT00959946|26647332|FG006|Overall Study|Disease Progression|2|||
13348004|NCT00959946|26647333|FG007|Overall Study|Disease Progression|2|||
13348005|NCT00959946|26647326|FG000|Overall Study|Withdrawal by Subject|0|||
13348006|NCT00959946|26647327|FG001|Overall Study|Withdrawal by Subject|0|||
13348007|NCT00959946|26647328|FG002|Overall Study|Withdrawal by Subject|0|||
13348008|NCT00959946|26647329|FG003|Overall Study|Withdrawal by Subject|0|||
13348009|NCT00959946|26647330|FG004|Overall Study|Withdrawal by Subject|0|||
13348010|NCT00959946|26647331|FG005|Overall Study|Withdrawal by Subject|1|||
13348011|NCT00959946|26647332|FG006|Overall Study|Withdrawal by Subject|0|||
13348012|NCT00959946|26647333|FG007|Overall Study|Withdrawal by Subject|0|||
13348013|NCT00959907|26647350|FG000|Overall Study|Protocol Violation|0|||
13348014|NCT00959907|26647351|FG001|Overall Study|Protocol Violation|1|||
13348015|NCT00959907|26647350|FG000|Overall Study|Adverse Event|1|||
13348016|NCT00959907|26647351|FG001|Overall Study|Adverse Event|0|||
13348017|NCT00959907|26647350|FG000|Overall Study|Withdrawal by Subject|2|||
13348018|NCT00959907|26647351|FG001|Overall Study|Withdrawal by Subject|0|||
13348019|NCT00959894|26647381|FG000|Overall Study|Lost to Follow-up|10|||
13348020|NCT00959894|26647381|FG000|Overall Study|Adverse Event|3|||
13348021|NCT00959894|26647381|FG000|Overall Study|Withdrawal by Subject|1|||
13348022|NCT00959894|26647381|FG000|Overall Study|Need for contraindicated medication|1|||
13348023|NCT00959894|26647381|FG000|Overall Study|Subject moved out of town|1|||
13348024|NCT00959751|26647408|FG000|Overall Study|Lost to Follow-up|2|||
13348025|NCT00959751|26647409|FG001|Overall Study|Lost to Follow-up|3|||
13348026|NCT00959751|26647408|FG000|Overall Study|Consent Withdrawn|0|||
13348027|NCT00959751|26647409|FG001|Overall Study|Consent Withdrawn|1|||
13348028|NCT00959751|26647408|FG000|Overall Study|Non-compliance to Study Procedures|0|||
13348029|NCT00959751|26647409|FG001|Overall Study|Non-compliance to Study Procedures|1|||
13348030|NCT00959751|26647408|FG000|Overall Study|No migraine headache without aura|7|||
13348031|NCT00959751|26647409|FG001|Overall Study|No migraine headache without aura|7|||
13348032|NCT00959699|26647433|FG000|Treatment Period|Adverse Event|3|||
13348033|NCT00959699|26647434|FG001|Treatment Period|Adverse Event|13|||
13348034|NCT00959699|26647433|FG000|Treatment Period|Lack of Efficacy|15|||
13348035|NCT00959699|26647434|FG001|Treatment Period|Lack of Efficacy|6|||
13348036|NCT00959699|26647433|FG000|Treatment Period|Lost to Follow-up|0|||
13348037|NCT00959699|26647434|FG001|Treatment Period|Lost to Follow-up|1|||
13348038|NCT00959699|26647433|FG000|Treatment Period|Withdrawal by Subject|1|||
13348039|NCT00959699|26647434|FG001|Treatment Period|Withdrawal by Subject|3|||
13348040|NCT00959699|26647433|FG000|Treatment Period|Non-Compliance with Protocol|0|||
13348041|NCT00959699|26647434|FG001|Treatment Period|Non-Compliance with Protocol|1|||
13348042|NCT00959699|26647433|FG000|Treatment Period|Did not receive treatment|0|||
13348043|NCT00959699|26647434|FG001|Treatment Period|Did not receive treatment|1|||
13348044|NCT00959699|26647433|FG000|Treatment Period|Futility/crossover to boceprevir|4|||
13348045|NCT00959699|26647434|FG001|Treatment Period|Futility/crossover to boceprevir|0|||
13348046|NCT00959699|26647433|FG000|Follow-up Period|Lost to Follow-up|3|||
13348047|NCT00959699|26647434|FG001|Follow-up Period|Lost to Follow-up|2|||
13348048|NCT00959699|26647433|FG000|Follow-up Period|Withdrawal by Subject|3|||
13348049|NCT00959699|26647434|FG001|Follow-up Period|Withdrawal by Subject|4|||
13348050|NCT00959647|26647441|FG000|Overall Study|Adverse Event|2|||
13348051|NCT00959647|26647441|FG000|Overall Study|Progressive disease|6|||
13348052|NCT00959647|26647441|FG000|Overall Study|Study terminated by sponsor|4|||
13348053|NCT00959647|26647441|FG000|Overall Study|Withdrawal by Subject|7|||
13348054|NCT00959374|26647453|FG000|Overall Study|Withdrawal by Subject|2|||
13348055|NCT00959374|26647453|FG000|Overall Study|Lost to Follow-up|14|||
13348056|NCT00959374|26647453|FG000|Overall Study|Death|1|||
13348057|NCT00959374|26647453|FG000|Overall Study|Protocol Violation|1|||
13348058|NCT00959374|26647453|FG000|Overall Study|Implant Removed/Not Replaced|4|||
13348059|NCT00959374|26647453|FG000|Overall Study|Physician Decision|1|||
13348060|NCT00959192|26647508|FG000|Overall Study|Adverse Event|1|||
13348061|NCT00959192|26647509|FG001|Overall Study|Adverse Event|1|||
13348062|NCT00959192|26647510|FG002|Overall Study|Adverse Event|1|||
13348063|NCT00959192|26647511|FG003|Overall Study|Adverse Event|0|||
13348064|NCT00959192|26647508|FG000|Overall Study|Investigator Request|1|||
13348065|NCT00959192|26647509|FG001|Overall Study|Investigator Request|0|||
13348066|NCT00959192|26647510|FG002|Overall Study|Investigator Request|0|||
13348067|NCT00959192|26647511|FG003|Overall Study|Investigator Request|0|||
13348068|NCT00959192|26647508|FG000|Overall Study|Caregiver Request|0|||
13348069|NCT00959192|26647509|FG001|Overall Study|Caregiver Request|0|||
13348070|NCT00959192|26647510|FG002|Overall Study|Caregiver Request|2|||
13348071|NCT00959192|26647511|FG003|Overall Study|Caregiver Request|1|||
13348072|NCT00959049|26647580|FG000|Overall Study|Adverse Event|1|||
13348073|NCT00959049|26647581|FG001|Overall Study|Adverse Event|0|||
13348074|NCT00959049|26647582|FG002|Overall Study|Adverse Event|0|||
13348075|NCT00959049|26647583|FG003|Overall Study|Adverse Event|0|||
13348076|NCT00959049|26647584|FG004|Overall Study|Adverse Event|0|||
13348077|NCT00959049|26647585|FG005|Overall Study|Adverse Event|0|||
13348078|NCT00959049|26647580|FG000|Overall Study|Lost to Follow-up|17|||
13348079|NCT00959049|26647581|FG001|Overall Study|Lost to Follow-up|5|||
13348080|NCT00959049|26647582|FG002|Overall Study|Lost to Follow-up|1|||
13348081|NCT00959049|26647583|FG003|Overall Study|Lost to Follow-up|10|||
13348082|NCT00959049|26647584|FG004|Overall Study|Lost to Follow-up|9|||
13348083|NCT00959049|26647585|FG005|Overall Study|Lost to Follow-up|1|||
13348084|NCT00959049|26647580|FG000|Overall Study|Contraindicated medication|0|||
13348085|NCT00959049|26647581|FG001|Overall Study|Contraindicated medication|0|||
13348086|NCT00959049|26647582|FG002|Overall Study|Contraindicated medication|0|||
13348087|NCT00959049|26647583|FG003|Overall Study|Contraindicated medication|1|||
13348088|NCT00959049|26647584|FG004|Overall Study|Contraindicated medication|0|||
13348089|NCT00959049|26647585|FG005|Overall Study|Contraindicated medication|0|||
13348090|NCT00959049|26647580|FG000|Overall Study|Withdrawal by Subject|0|||
13348091|NCT00959049|26647581|FG001|Overall Study|Withdrawal by Subject|2|||
13348092|NCT00959049|26647582|FG002|Overall Study|Withdrawal by Subject|0|||
13348093|NCT00959049|26647583|FG003|Overall Study|Withdrawal by Subject|0|||
13348094|NCT00959049|26647584|FG004|Overall Study|Withdrawal by Subject|0|||
13348095|NCT00959049|26647585|FG005|Overall Study|Withdrawal by Subject|0|||
13348096|NCT00958893|26647591|FG000|Overall Study|Study prematurely terminated|4|||
13348097|NCT00958880|26647606|FG000|Overall Study|Lost to Follow-up|2|||
13348098|NCT00958880|26647607|FG001|Overall Study|Lost to Follow-up|2|||
13348099|NCT00958841|26647627|FG000|Overall Study|Abnormal laboratory value(s)|1|||
13348100|NCT00958841|26647627|FG000|Overall Study|Abnormal test procedure result(s)|3|||
13348101|NCT00958841|26647627|FG000|Overall Study|Administrative problems|1|||
13348102|NCT00958841|26647627|FG000|Overall Study|Adverse Event|8|||
13348103|NCT00958841|26647627|FG000|Overall Study|New cancer therapy|5|||
13348104|NCT00958841|26647627|FG000|Overall Study|Withdrawal by Subject|1|||
13348105|NCT00958841|26647627|FG000|Overall Study|Unsatisfactory therapeutic effect|22|||
13348106|NCT00958841|26647627|FG000|Overall Study|Completed M6/did not enter extension|27|||
13348107|NCT00958841|26647627|FG000|Overall Study|Discontinued prior to M*|28|||
13348108|NCT00958828|26647636|FG000|Period 1, 1 Week of Wear|Randomization break|0|||
13348109|NCT00958828|26647637|FG001|Period 1, 1 Week of Wear|Randomization break|1|||
13348110|NCT00958828|26647636|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0|||
13348111|NCT00958828|26647637|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1|||
13348112|NCT00958789|26647657|FG000|Overall Study|Death|5|||
13348113|NCT00958789|26647657|FG000|Overall Study|Lost to Follow-up|14|||
13348114|NCT00958789|26647657|FG000|Overall Study|Withdrawal by Subject|17|||
13348115|NCT00958789|26647657|FG000|Overall Study|No 2 yr. Knee Society Score data|4|||
13348116|NCT00958789|26647657|FG000|Overall Study|2 yr. Knee Society Score not calculable|1|||
13348117|NCT00958789|26647657|FG000|Overall Study|Subject terminated|2|||
13348118|NCT00958789|26647657|FG000|Overall Study|Revision|7|||
13348119|NCT00958776|26647694|FG000|Overall Study|Adverse Event|0|||
13348120|NCT00958776|26647695|FG001|Overall Study|Adverse Event|1|||
13348121|NCT00958776|26647694|FG000|Overall Study|Physician Decision|1|||
13348122|NCT00958776|26647695|FG001|Overall Study|Physician Decision|0|||
13348123|NCT00958776|26647694|FG000|Overall Study|Lost to Follow-up|2|||
13348124|NCT00958776|26647695|FG001|Overall Study|Lost to Follow-up|6|||
13348125|NCT00958776|26647694|FG000|Overall Study|Withdrawal by Subject|7|||
13348126|NCT00958776|26647695|FG001|Overall Study|Withdrawal by Subject|16|||
13348127|NCT00958776|26647694|FG000|Overall Study|Protocol Violation|1|||
13348128|NCT00958776|26647695|FG001|Overall Study|Protocol Violation|1|||
13348129|NCT00958776|26647694|FG000|Overall Study|Death|2|||
13348130|NCT00958776|26647695|FG001|Overall Study|Death|1|||
13348131|NCT00958776|26647694|FG000|Overall Study|Noncompliance; Protocol Deviations|2|||
13348132|NCT00958776|26647695|FG001|Overall Study|Noncompliance; Protocol Deviations|3|||
13348133|NCT00958776|26647694|FG000|Overall Study|Missing|1|||
13348134|NCT00958776|26647695|FG001|Overall Study|Missing|1|||
13348135|NCT00958724|26647707|FG000|Overall Study|Disease Progression|6|||
13348136|NCT00958711|26647740|FG000|Overall Study|Withdrawal by Subject|0|||
13348137|NCT00958711|26647741|FG001|Overall Study|Withdrawal by Subject|4|||
13348138|NCT00958711|26647740|FG000|Overall Study|Physician Decision|5|||
13348139|NCT00958711|26647741|FG001|Overall Study|Physician Decision|7|||
13348140|NCT00958711|26647740|FG000|Overall Study|Lost to Follow-up|4|||
13348141|NCT00958711|26647741|FG001|Overall Study|Lost to Follow-up|1|||
13348142|NCT00958711|26647740|FG000|Overall Study|Other|2|||
13348143|NCT00958711|26647741|FG001|Overall Study|Other|5|||
13348144|NCT00958711|26647740|FG000|Overall Study|Death|1|||
13348145|NCT00958711|26647741|FG001|Overall Study|Death|2|||
13348146|NCT00958711|26647740|FG000|Overall Study|Adverse Event|1|||
13348147|NCT00958711|26647741|FG001|Overall Study|Adverse Event|2|||
13348148|NCT00958568|26647827|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80|||
13348149|NCT00958568|26647828|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
13348150|NCT00958568|26647829|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
13348151|NCT00958568|26647830|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
13348152|NCT00958568|26647827|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44|||
13348153|NCT00958568|26647828|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
13348154|NCT00958568|26647829|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
13348155|NCT00958568|26647830|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
13348156|NCT00958568|26647827|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34|||
13348157|NCT00958568|26647828|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
13348158|NCT00958568|26647829|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
13348159|NCT00958568|26647830|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
13348160|NCT00958568|26647827|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39|||
13348161|NCT00958568|26647828|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
13348162|NCT00958568|26647829|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
13348163|NCT00958568|26647830|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
13348164|NCT00958568|26647827|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14|||
13348165|NCT00958568|26647828|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
13348166|NCT00958568|26647829|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
13348167|NCT00958568|26647830|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
13348168|NCT00958568|26647827|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13|||
13348169|NCT00958568|26647828|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
13348170|NCT00958568|26647829|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
13348171|NCT00958568|26647830|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
13348172|NCT00958568|26647827|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4|||
13348173|NCT00958568|26647828|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
13348174|NCT00958568|26647829|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
13348175|NCT00958568|26647830|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
13348176|NCT00958568|26647827|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8|||
13348177|NCT00958568|26647828|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
13348178|NCT00958568|26647829|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
13348179|NCT00958568|26647830|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
13348180|NCT00958568|26647827|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1|||
13348181|NCT00958568|26647828|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
13348182|NCT00958568|26647829|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
13348183|NCT00958568|26647830|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
13348184|NCT00958568|26647827|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
13348185|NCT00958568|26647828|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62|||
13348186|NCT00958568|26647829|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
13348187|NCT00958568|26647830|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
13348188|NCT00958568|26647827|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
13348189|NCT00958568|26647828|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30|||
13348190|NCT00958568|26647829|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
13348191|NCT00958568|26647830|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
13348192|NCT00958568|26647827|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
13348193|NCT00958568|26647828|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28|||
13348194|NCT00958568|26647829|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
13348195|NCT00958568|26647830|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
13348196|NCT00958568|26647827|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
13348197|NCT00958568|26647828|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41|||
13348198|NCT00958568|26647829|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
13348199|NCT00958568|26647830|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
13348200|NCT00958568|26647827|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
13348201|NCT00958568|26647828|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24|||
13348202|NCT00958568|26647829|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
13348203|NCT00958568|26647830|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
13348204|NCT00958568|26647827|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
13348205|NCT00958568|26647828|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9|||
13348206|NCT00958568|26647829|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
13348207|NCT00958568|26647830|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
13348208|NCT00958568|26647827|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
13348209|NCT00958568|26647828|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6|||
13348210|NCT00958568|26647829|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
13348211|NCT00958568|26647830|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
13348212|NCT00958568|26647827|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
13348213|NCT00958568|26647828|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5|||
13348214|NCT00958568|26647829|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
13348215|NCT00958568|26647830|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
13348216|NCT00958568|26647827|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
13348217|NCT00958568|26647828|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4|||
13348218|NCT00958568|26647829|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
13348219|NCT00958568|26647830|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
13348220|NCT00958568|26647827|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
13348221|NCT00958568|26647828|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1|||
13348222|NCT00958568|26647829|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
13348223|NCT00958568|26647830|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
13348224|NCT00958568|26647827|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
13348225|NCT00958568|26647828|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1|||
13348226|NCT00958568|26647829|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
13348227|NCT00958568|26647830|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
13348228|NCT00958568|26647827|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
13348229|NCT00958568|26647828|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
13348230|NCT00958568|26647829|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24|||
13348231|NCT00958568|26647830|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63|||
13348232|NCT00958568|26647827|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
13348233|NCT00958568|26647828|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
13348234|NCT00958568|26647829|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19|||
13348235|NCT00958568|26647830|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10|||
13348236|NCT00958568|26647827|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
13348237|NCT00958568|26647828|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
13348238|NCT00958568|26647829|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16|||
13348239|NCT00958568|26647830|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15|||
13348240|NCT00958568|26647827|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
13348241|NCT00958568|26647828|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
13348242|NCT00958568|26647829|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11|||
13348243|NCT00958568|26647830|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5|||
13348244|NCT00958568|26647827|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
13348245|NCT00958568|26647828|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
13348246|NCT00958568|26647829|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3|||
13348247|NCT00958568|26647830|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8|||
13348248|NCT00958568|26647827|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
13348249|NCT00958568|26647828|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
13348250|NCT00958568|26647829|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5|||
13348251|NCT00958568|26647830|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4|||
13348252|NCT00958568|26647827|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
13348253|NCT00958568|26647828|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
13348254|NCT00958568|26647829|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2|||
13348255|NCT00958568|26647830|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1|||
13348256|NCT00958568|26647827|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
13348257|NCT00958568|26647828|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
13348258|NCT00958568|26647829|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1|||
13348259|NCT00958568|26647830|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
13348260|NCT00958568|26647827|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
13348261|NCT00958568|26647828|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
13348262|NCT00958568|26647829|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1|||
13348263|NCT00958568|26647830|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
13348264|NCT00958438|26647863|FG000|Overall Study|Protocol Violation|3|||
13348265|NCT00958438|26647864|FG001|Overall Study|Protocol Violation|2|||
13348266|NCT00958438|26647865|FG002|Overall Study|Protocol Violation|2|||
13348267|NCT00958438|26647863|FG000|Overall Study|Withdrawal by Subject|4|||
13348268|NCT00958438|26647864|FG001|Overall Study|Withdrawal by Subject|2|||
13348269|NCT00958438|26647865|FG002|Overall Study|Withdrawal by Subject|1|||
13348270|NCT00958438|26647863|FG000|Overall Study|Adverse Event|0|||
13348271|NCT00958438|26647864|FG001|Overall Study|Adverse Event|3|||
13348272|NCT00958438|26647865|FG002|Overall Study|Adverse Event|0|||
13348273|NCT00958438|26647863|FG000|Overall Study|Physician Decision|1|||
13348274|NCT00958438|26647864|FG001|Overall Study|Physician Decision|0|||
13348275|NCT00958438|26647865|FG002|Overall Study|Physician Decision|1|||
13348276|NCT00958438|26647863|FG000|Overall Study|Other than specified above|2|||
13348277|NCT00958438|26647864|FG001|Overall Study|Other than specified above|3|||
13348278|NCT00958438|26647865|FG002|Overall Study|Other than specified above|2|||
13348279|NCT00958412|26647871|FG000|Overall Study|Study prematurely terminated|18|||
13348280|NCT00958360|26647892|FG000|Overall Study|Withdrawal by Subject|3|||
13348281|NCT00958360|26647893|FG001|Overall Study|Withdrawal by Subject|1|||
13348282|NCT00958360|26647892|FG000|Overall Study|Death|6|||
13348283|NCT00958360|26647893|FG001|Overall Study|Death|7|||
13348284|NCT00958360|26647892|FG000|Overall Study|Physician Decision|2|||
13348285|NCT00958360|26647893|FG001|Overall Study|Physician Decision|1|||
13348286|NCT00958360|26647892|FG000|Overall Study|Lost to Follow-up|0|||
13348287|NCT00958360|26647893|FG001|Overall Study|Lost to Follow-up|1|||
13348288|NCT00958347|26647899|FG000|Overall Study|Death|43|||
13348289|NCT00958347|26647899|FG000|Overall Study|Withdrawal by Subject|23|||
13348290|NCT00958347|26647899|FG000|Overall Study|Lost to Follow-up|15|||
13348291|NCT00958347|26647899|FG000|Overall Study|revision/removal|10|||
13348292|NCT00958347|26647899|FG000|Overall Study|study termination|135|||
13348293|NCT00958256|26647905|FG000|Overall Study|Adverse Event|3|||
13348294|NCT00958243|26647980|FG000|Overall Study|Withdrawal by Subject|0|||
13348295|NCT00958243|26647981|FG001|Overall Study|Withdrawal by Subject|1|||
13348296|NCT00958243|26647982|FG002|Overall Study|Withdrawal by Subject|3|||
13348297|NCT00958243|26647983|FG003|Overall Study|Withdrawal by Subject|1|||
13348298|NCT00958243|26647984|FG004|Overall Study|Withdrawal by Subject|1|||
13348299|NCT00958243|26647985|FG005|Overall Study|Withdrawal by Subject|5|||
13348300|NCT00958243|26647980|FG000|Overall Study|Lost to Follow-up|2|||
13348301|NCT00958243|26647981|FG001|Overall Study|Lost to Follow-up|5|||
13348302|NCT00958243|26647982|FG002|Overall Study|Lost to Follow-up|11|||
13348303|NCT00958243|26647983|FG003|Overall Study|Lost to Follow-up|2|||
13348304|NCT00958243|26647984|FG004|Overall Study|Lost to Follow-up|8|||
13348305|NCT00958243|26647985|FG005|Overall Study|Lost to Follow-up|5|||
13348306|NCT00958217|26648003|FG000|Overall Study|Death|2|||
13348307|NCT00958217|26648004|FG001|Overall Study|Death|1|||
13348308|NCT00958217|26648003|FG000|Overall Study|Withdrawal by Subject|4|||
13348309|NCT00958217|26648004|FG001|Overall Study|Withdrawal by Subject|3|||
13348310|NCT00958217|26648003|FG000|Overall Study|Lost to Follow-up|17|||
13348311|NCT00958217|26648004|FG001|Overall Study|Lost to Follow-up|19|||
13348312|NCT00958217|26648003|FG000|Overall Study|Moved out of area|1|||
13348313|NCT00958217|26648004|FG001|Overall Study|Moved out of area|1|||
13348314|NCT00958217|26648003|FG000|Overall Study|Inpatient hospitalization|0|||
13348315|NCT00958217|26648004|FG001|Overall Study|Inpatient hospitalization|1|||
13348316|NCT00958191|26648021|FG000|Overall Study|Death|4|||
13348317|NCT00958191|26648021|FG000|Overall Study|Lost to Follow-up|5|||
13348318|NCT00958191|26648021|FG000|Overall Study|Inadequate 5 yr x-ray quality|10|||
13348319|NCT00958191|26648021|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21|||
13348320|NCT00958191|26648021|FG000|Overall Study|Revision of study device|4|||
13348321|NCT00958191|26648021|FG000|Overall Study|Site termination|11|||
13348322|NCT00958191|26648021|FG000|Overall Study|No 5 yr x-rays|56|||
13348323|NCT00958165|26648027|FG000|Overall Study|Lost to Follow-up|5|||
13348324|NCT00958165|26648027|FG000|Overall Study|Not eligible|9|||
13348325|NCT00958126|26648122|FG000|Overall Study|Serious Adverse Event|0|||
13348326|NCT00958126|26648123|FG001|Overall Study|Serious Adverse Event|2|||
13348327|NCT00958126|26648124|FG002|Overall Study|Serious Adverse Event|0|||
13348328|NCT00958126|26648125|FG003|Overall Study|Serious Adverse Event|0|||
13348329|NCT00958126|26648126|FG004|Overall Study|Serious Adverse Event|0|||
13348330|NCT00958126|26648127|FG005|Overall Study|Serious Adverse Event|0|||
13348331|NCT00958126|26648128|FG006|Overall Study|Serious Adverse Event|1|||
13348332|NCT00958126|26648129|FG007|Overall Study|Serious Adverse Event|0|||
13348333|NCT00958126|26648122|FG000|Overall Study|Withdrawal by Subject|0|||
13348334|NCT00958126|26648123|FG001|Overall Study|Withdrawal by Subject|2|||
13348335|NCT00958126|26648124|FG002|Overall Study|Withdrawal by Subject|0|||
13348336|NCT00958126|26648125|FG003|Overall Study|Withdrawal by Subject|0|||
13348337|NCT00958126|26648126|FG004|Overall Study|Withdrawal by Subject|0|||
13348338|NCT00958126|26648127|FG005|Overall Study|Withdrawal by Subject|0|||
13348339|NCT00958126|26648128|FG006|Overall Study|Withdrawal by Subject|0|||
13348340|NCT00958126|26648129|FG007|Overall Study|Withdrawal by Subject|0|||
13348341|NCT00958126|26648122|FG000|Overall Study|Moved away from study area|0|||
13348342|NCT00958126|26648123|FG001|Overall Study|Moved away from study area|0|||
13348343|NCT00958126|26648124|FG002|Overall Study|Moved away from study area|1|||
13348344|NCT00958126|26648125|FG003|Overall Study|Moved away from study area|1|||
13348345|NCT00958126|26648126|FG004|Overall Study|Moved away from study area|0|||
13348346|NCT00958126|26648127|FG005|Overall Study|Moved away from study area|0|||
13348347|NCT00958126|26648128|FG006|Overall Study|Moved away from study area|0|||
13348348|NCT00958126|26648129|FG007|Overall Study|Moved away from study area|0|||
13348349|NCT00958126|26648122|FG000|Overall Study|Lost to Follow-up|1|||
13348350|NCT00958126|26648123|FG001|Overall Study|Lost to Follow-up|5|||
13348351|NCT00958126|26648124|FG002|Overall Study|Lost to Follow-up|9|||
13348352|NCT00958126|26648125|FG003|Overall Study|Lost to Follow-up|8|||
13348353|NCT00958126|26648126|FG004|Overall Study|Lost to Follow-up|0|||
13348354|NCT00958126|26648127|FG005|Overall Study|Lost to Follow-up|0|||
13348355|NCT00958126|26648128|FG006|Overall Study|Lost to Follow-up|0|||
13348356|NCT00958126|26648129|FG007|Overall Study|Lost to Follow-up|0|||
13348357|NCT00958126|26648122|FG000|Overall Study|Sponsor/Investigator decision|0|||
13348358|NCT00958126|26648123|FG001|Overall Study|Sponsor/Investigator decision|0|||
13348359|NCT00958126|26648124|FG002|Overall Study|Sponsor/Investigator decision|0|||
13348360|NCT00958126|26648125|FG003|Overall Study|Sponsor/Investigator decision|1|||
13348361|NCT00958126|26648126|FG004|Overall Study|Sponsor/Investigator decision|0|||
13348362|NCT00958126|26648127|FG005|Overall Study|Sponsor/Investigator decision|0|||
13348363|NCT00958126|26648128|FG006|Overall Study|Sponsor/Investigator decision|0|||
13348364|NCT00958126|26648129|FG007|Overall Study|Sponsor/Investigator decision|0|||
13348365|NCT00958126|26648122|FG000|Overall Study|Other Reason|0|||
13348366|NCT00958126|26648123|FG001|Overall Study|Other Reason|0|||
13348367|NCT00958126|26648124|FG002|Overall Study|Other Reason|0|||
13348368|NCT00958126|26648125|FG003|Overall Study|Other Reason|1|||
13348369|NCT00958126|26648126|FG004|Overall Study|Other Reason|0|||
13348370|NCT00958126|26648127|FG005|Overall Study|Other Reason|1|||
13348371|NCT00958126|26648128|FG006|Overall Study|Other Reason|0|||
13348372|NCT00958126|26648129|FG007|Overall Study|Other Reason|0|||
13348373|NCT00958074|26648150|FG000|Overall Study|Withdrawal by Subject|0|||
13348374|NCT00958074|26648151|FG001|Overall Study|Withdrawal by Subject|1|||
13348375|NCT00958009|26648158|FG000|Overall Study|Adverse Event|1|||
13348376|NCT00958009|26648158|FG000|Overall Study|Subject found device difficult to use|1|||
13348377|NCT00957996|26648195|FG000|Overall Study|Death|4|||
13348378|NCT00957996|26648196|FG001|Overall Study|Death|10|||
13348379|NCT00957996|26648195|FG000|Overall Study|Lost to Follow-up|4|||
13348380|NCT00957996|26648196|FG001|Overall Study|Lost to Follow-up|7|||
13348381|NCT00957996|26648195|FG000|Overall Study|Withdrawal by Subject|9|||
13348382|NCT00957996|26648196|FG001|Overall Study|Withdrawal by Subject|2|||
13348383|NCT00957996|26648195|FG000|Overall Study|Adverse Event|2|||
13348384|NCT00957996|26648196|FG001|Overall Study|Adverse Event|1|||
13348385|NCT00957996|26648195|FG000|Overall Study|Physician Decision|1|||
13348386|NCT00957996|26648196|FG001|Overall Study|Physician Decision|1|||
13348387|NCT00957996|26648195|FG000|Overall Study|Influenza-related complication|0|||
13348388|NCT00957996|26648196|FG001|Overall Study|Influenza-related complication|1|||
13348389|NCT00957996|26648195|FG000|Overall Study|Missing|1|||
13348390|NCT00957996|26648196|FG001|Overall Study|Missing|0|||
13348391|NCT00957996|26648195|FG000|Overall Study|Noncompliance; Protocol Deviations|5|||
13348392|NCT00957996|26648196|FG001|Overall Study|Noncompliance; Protocol Deviations|6|||
13348393|NCT00957944|26648237|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0|||
13348394|NCT00957944|26648238|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1|||
13348395|NCT00957931|26648248|FG000|Overall Study|Death|4|||
13348396|NCT00957905|26648261|FG000|Part B|Not Treated|0|||
13348397|NCT00957905|26648262|FG001|Part B|Not Treated|1|||
13348398|NCT00957905|26648261|FG000|Part B|Physician Decision|0|||
13348399|NCT00957905|26648262|FG001|Part B|Physician Decision|1|||
13348400|NCT00957905|26648261|FG000|Part B|Death|0|||
13348401|NCT00957905|26648262|FG001|Part B|Death|1|||
13348402|NCT00957905|26648261|FG000|Part B|Protocol Violation|0|||
13348403|NCT00957905|26648262|FG001|Part B|Protocol Violation|1|||
13348404|NCT00957853|26648283|FG000|Overall Study|Withdrawal by Subject|1|||
13348405|NCT00957853|26648284|FG001|Overall Study|Withdrawal by Subject|0|||
13348406|NCT00957853|26648285|FG002|Overall Study|Withdrawal by Subject|0|||
13348407|NCT00957801|26648464|FG000|Overall Study|Withdrawal by Subject|0|||
13348408|NCT00957801|26648465|FG001|Overall Study|Withdrawal by Subject|0|||
13348409|NCT00957801|26648466|FG002|Overall Study|Withdrawal by Subject|0|||
13348410|NCT00957801|26648467|FG003|Overall Study|Withdrawal by Subject|1|||
13348411|NCT00957723|26648483|FG000|Overall Study|Death|3|||
13348412|NCT00957723|26648483|FG000|Overall Study|Revision/ Removal of Study Implant|3|||
13348413|NCT00957723|26648483|FG000|Overall Study|Lost to Follow-up|8|||
13348414|NCT00957723|26648483|FG000|Overall Study|Withdrawal by Subject|24|||
13348415|NCT00957723|26648483|FG000|Overall Study|Investigative Site Terminated|61|||
13348416|NCT00957723|26648483|FG000|Overall Study|Intercurrent Illness|2|||
13348417|NCT00957723|26648483|FG000|Overall Study|2yr ROM Data Not Evaluable|12|||
13348418|NCT00957658|26648498|FG000|Overall Study|Death|1|||
13348419|NCT00957658|26648498|FG000|Overall Study|Lost to Follow-up|4|||
13348420|NCT00957658|26648498|FG000|Overall Study|Withdrawal by Subject|12|||
13348421|NCT00957658|26648498|FG000|Overall Study|Revision|1|||
13348422|NCT00957658|26648498|FG000|Overall Study|Incomplete 2 yr data|28|||
13348423|NCT00957658|26648498|FG000|Overall Study|Site termination|10|||
13348424|NCT00957658|26648498|FG000|Overall Study|unwilling/unable to return|2|||
13348425|NCT00957658|26648498|FG000|Overall Study|surgery cancelled|2|||
13348426|NCT00957658|26648498|FG000|Overall Study|Protocol Violation|5|||
13348427|NCT00957580|26648652|FG000|Overall Study|Ongoing at data cut-off|0|||
13348428|NCT00957580|26648653|FG001|Overall Study|Ongoing at data cut-off|1|||
13348429|NCT00957580|26648654|FG002|Overall Study|Ongoing at data cut-off|0|||
13348430|NCT00957580|26648652|FG000|Overall Study|Enrolled but not treated|0|||
13348431|NCT00957580|26648653|FG001|Overall Study|Enrolled but not treated|1|||
13348432|NCT00957580|26648654|FG002|Overall Study|Enrolled but not treated|0|||
13348433|NCT00957528|26648687|FG000|Overall Study|Protocol Violation|0|||
13348434|NCT00957528|26648688|FG001|Overall Study|Protocol Violation|1|||
13348435|NCT00957528|26648689|FG002|Overall Study|Protocol Violation|0|||
13348436|NCT00957528|26648687|FG000|Overall Study|Withdrawal by Subject|0|||
13348437|NCT00957528|26648688|FG001|Overall Study|Withdrawal by Subject|0|||
13348438|NCT00957528|26648689|FG002|Overall Study|Withdrawal by Subject|1|||
13348439|NCT00957424|26648698|FG000|Overall Study|Lost to Follow-up|19|||
13348440|NCT00957424|26648698|FG000|Overall Study|Protocol Violation|3|||
13348441|NCT00957424|26648698|FG000|Overall Study|Withdrawal by Subject|1|||
13348442|NCT00957372|26648725|FG000|PART I|Lost to Follow-up|0|||
13348443|NCT00957372|26648726|FG001|PART I|Lost to Follow-up|0|||
13348444|NCT00957372|26648727|FG002|PART I|Lost to Follow-up|1|||
13348445|NCT00957372|26648728|FG003|PART I|Lost to Follow-up|0|||
13348446|NCT00957372|26648725|FG000|PART II|Withdrawal by Subject|0|||
13348447|NCT00957372|26648726|FG001|PART II|Withdrawal by Subject|0|||
13348448|NCT00957372|26648727|FG002|PART II|Withdrawal by Subject|0|||
13348449|NCT00957372|26648728|FG003|PART II|Withdrawal by Subject|8|||
13348450|NCT00957372|26648725|FG000|PART II|Physician Decision|0|||
13348451|NCT00957372|26648726|FG001|PART II|Physician Decision|0|||
13348452|NCT00957372|26648727|FG002|PART II|Physician Decision|0|||
13348453|NCT00957372|26648728|FG003|PART II|Physician Decision|1|||
13348454|NCT00957372|26648725|FG000|PART II|Pregnancy|0|||
13348455|NCT00957372|26648726|FG001|PART II|Pregnancy|0|||
13289250|NCT01080131|26477779|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2|||
13289251|NCT01080131|26477778|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1|||
13289252|NCT01080131|26477779|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0|||
13289253|NCT01080131|26477778|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0|||
13289254|NCT01080131|26477779|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1|||
13289255|NCT01080131|26477778|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4|||
13289256|NCT01080131|26477779|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3|||
13289257|NCT01080131|26477778|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1|||
13289258|NCT01080131|26477779|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0|||
13289259|NCT01080131|26477778|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1|||
13289260|NCT01080131|26477779|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2|||
13289261|NCT01080131|26477778|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3|||
13289262|NCT01080131|26477779|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4|||
13289263|NCT01080131|26477778|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4|||
13289264|NCT01080131|26477779|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5|||
13289265|NCT01085097|26477800|FG000|Overall Study|Adverse Event|0|||
13289266|NCT01085097|26477801|FG001|Overall Study|Adverse Event|0|||
13289267|NCT01085097|26477802|FG002|Overall Study|Adverse Event|2|||
13289268|NCT01085097|26477800|FG000|Overall Study|Treatment failure|2|||
13289269|NCT01085097|26477801|FG001|Overall Study|Treatment failure|0|||
13289270|NCT01085097|26477802|FG002|Overall Study|Treatment failure|0|||
13289271|NCT01085630|26477819|FG000|Overall Study|Insufficient data|1|||
13289272|NCT01085630|26477820|FG001|Overall Study|Insufficient data|0|||
13289273|NCT01085630|26477819|FG000|Overall Study|Ineligible|3|||
13289274|NCT01085630|26477820|FG001|Overall Study|Ineligible|0|||
13289275|NCT01084694|26477843|FG000|Overall Study|Withdrawal by Subject|2|||
13289276|NCT01084694|26477844|FG001|Overall Study|Withdrawal by Subject|1|||
13289277|NCT01084694|26477843|FG000|Overall Study|Death|2|||
13289278|NCT01084694|26477844|FG001|Overall Study|Death|12|||
13289279|NCT01084694|26477843|FG000|Overall Study|eligibility not maintained|2|||
13289280|NCT01084694|26477844|FG001|Overall Study|eligibility not maintained|7|||
13348456|NCT00957372|26648727|FG002|PART II|Pregnancy|0|||
13348457|NCT00957372|26648728|FG003|PART II|Pregnancy|1|||
13348458|NCT00957372|26648725|FG000|PART II|Not Know|0|||
13348459|NCT00957372|26648726|FG001|PART II|Not Know|0|||
13348460|NCT00957372|26648727|FG002|PART II|Not Know|0|||
13348461|NCT00957372|26648728|FG003|PART II|Not Know|20|||
13348462|NCT00957372|26648725|FG000|PART II|Adverse Event|0|||
13348463|NCT00957372|26648726|FG001|PART II|Adverse Event|0|||
13348464|NCT00957372|26648727|FG002|PART II|Adverse Event|0|||
13348465|NCT00957372|26648728|FG003|PART II|Adverse Event|10|||
13348466|NCT00957372|26648725|FG000|PART II|Patient non-compliance|0|||
13348467|NCT00957372|26648726|FG001|PART II|Patient non-compliance|0|||
13348468|NCT00957372|26648727|FG002|PART II|Patient non-compliance|0|||
13348469|NCT00957372|26648728|FG003|PART II|Patient non-compliance|4|||
13348470|NCT00957268|26648806|FG000|Overall Study|Voluntary Withdrawal|0|||
13348471|NCT00957268|26648807|FG001|Overall Study|Voluntary Withdrawal|0|||
13348472|NCT00957268|26648808|FG002|Overall Study|Voluntary Withdrawal|1|||
13348473|NCT00957268|26648809|FG003|Overall Study|Voluntary Withdrawal|0|||
13348474|NCT00957268|26648810|FG004|Overall Study|Voluntary Withdrawal|0|||
13348475|NCT00957229|26648827|FG000|Study Start|Adverse Event|0|||
13348476|NCT00957229|26648828|FG001|Study Start|Adverse Event|3|||
13348477|NCT00957229|26648827|FG000|Study Start|Disease Progression|1|||
13348478|NCT00957229|26648828|FG001|Study Start|Disease Progression|0|||
13348479|NCT00957229|26648827|FG000|Reallocated to or Continued Vismodegib|Death|1|||
13348480|NCT00957229|26648828|FG001|Reallocated to or Continued Vismodegib|Death|1|||
13348481|NCT00957229|26648827|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2|||
13348482|NCT00957229|26648828|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1|||
13348483|NCT00957034|26648861|FG000|Overall Study|Adverse Event|0|||
13348484|NCT00957034|26648862|FG001|Overall Study|Adverse Event|1|||
13348485|NCT00957034|26648863|FG002|Overall Study|Adverse Event|1|||
13348486|NCT00957034|26648861|FG000|Overall Study|Sponsor Terminated Study|6|||
13348487|NCT00957034|26648862|FG001|Overall Study|Sponsor Terminated Study|1|||
13348488|NCT00957034|26648863|FG002|Overall Study|Sponsor Terminated Study|5|||
13348489|NCT00957034|26648861|FG000|Overall Study|Withdrawal by Subject|0|||
13348490|NCT00957034|26648862|FG001|Overall Study|Withdrawal by Subject|2|||
13348491|NCT00957034|26648863|FG002|Overall Study|Withdrawal by Subject|0|||
13348492|NCT00957021|26648874|FG000|Overall Study|Death|5|||
13348493|NCT00957021|26648874|FG000|Overall Study|Lost to Follow-up|8|||
13348494|NCT00957021|26648874|FG000|Overall Study|Withdrawal by Subject|34|||
13348495|NCT00957021|26648874|FG000|Overall Study|No 2 yr ROM data|35|||
13348496|NCT00957021|26648874|FG000|Overall Study|Revised study component by 2 yr visit|8|||
13348497|NCT00957021|26648874|FG000|Overall Study|Site Termination by the 2 yr visit|16|||
13348498|NCT00957021|26648874|FG000|Overall Study|Surgery Cancelled|9|||
13348499|NCT00957021|26648874|FG000|Overall Study|Termination due to language issue|2|||
13348500|NCT00957008|26648913|FG000|Overall Study|Withdrawal by Subject|13|||
13348501|NCT00957008|26648914|FG001|Overall Study|Withdrawal by Subject|10|||
13348502|NCT00957008|26648915|FG002|Overall Study|Withdrawal by Subject|12|||
13348503|NCT00957008|26648916|FG003|Overall Study|Withdrawal by Subject|16|||
13348504|NCT00957008|26648913|FG000|Overall Study|Lost to Follow-up|3|||
13348505|NCT00957008|26648914|FG001|Overall Study|Lost to Follow-up|1|||
13348506|NCT00957008|26648915|FG002|Overall Study|Lost to Follow-up|3|||
13348507|NCT00957008|26648916|FG003|Overall Study|Lost to Follow-up|4|||
13348508|NCT00957008|26648913|FG000|Overall Study|Physician Decision|1|||
13348509|NCT00957008|26648914|FG001|Overall Study|Physician Decision|0|||
13348510|NCT00957008|26648915|FG002|Overall Study|Physician Decision|1|||
13348511|NCT00957008|26648916|FG003|Overall Study|Physician Decision|1|||
13348512|NCT00957008|26648913|FG000|Overall Study|Relocated; Family conflict|4|||
13348513|NCT00957008|26648914|FG001|Overall Study|Relocated; Family conflict|1|||
13348514|NCT00957008|26648915|FG002|Overall Study|Relocated; Family conflict|1|||
13348515|NCT00957008|26648916|FG003|Overall Study|Relocated; Family conflict|3|||
13348516|NCT00956943|26648931|FG000|Overall Study|Lost to Follow-up|9|||
13348517|NCT00956943|26648932|FG001|Overall Study|Lost to Follow-up|10|||
13348518|NCT00956839|26648953|FG000|Overall Study|Lost to Follow-up|3|||
13348519|NCT00956839|26648954|FG001|Overall Study|Lost to Follow-up|0|||
13348520|NCT00956839|26648955|FG002|Overall Study|Lost to Follow-up|3|||
13348521|NCT00956813|26648977|FG000|Flaxseed and Placebo|Withdrawal by Subject|5|||
13348522|NCT00956813|26648978|FG001|Flaxseed and Placebo|Withdrawal by Subject|4|||
13348523|NCT00956813|26648977|FG000|Flaxseed and Placebo|Ineligible|3|||
13348524|NCT00956813|26648978|FG001|Flaxseed and Placebo|Ineligible|1|||
13348525|NCT00956592|26649001|FG000|Overall Study|Protocol Violation|1|||
13348526|NCT00956592|26649002|FG001|Overall Study|Protocol Violation|3|||
13348527|NCT00956293|26649034|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0|||
13348528|NCT00956293|26649035|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0|||
13348529|NCT00956293|26649036|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1|||
13348530|NCT00956293|26649034|FG000|Main Period (Pre-randomization)|Death|0|||
13348531|NCT00956293|26649035|FG001|Main Period (Pre-randomization)|Death|0|||
13348532|NCT00956293|26649036|FG002|Main Period (Pre-randomization)|Death|1|||
13348533|NCT00956293|26649034|FG000|Main Period (Pre-randomization)|Protocol Violation|0|||
13348534|NCT00956293|26649035|FG001|Main Period (Pre-randomization)|Protocol Violation|0|||
13348535|NCT00956293|26649036|FG002|Main Period (Pre-randomization)|Protocol Violation|1|||
13348536|NCT00956293|26649034|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
13348537|NCT00956293|26649035|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
13348538|NCT00956293|26649036|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2|||
13348539|NCT00956293|26649034|FG000|Main Period (Pre-randomization)|Administrative problems|0|||
13348540|NCT00956293|26649035|FG001|Main Period (Pre-randomization)|Administrative problems|0|||
13348541|NCT00956293|26649036|FG002|Main Period (Pre-randomization)|Administrative problems|6|||
13348542|NCT00956293|26649034|FG000|Main Period (Pre-randomization)|Graft loss|0|||
13348543|NCT00956293|26649035|FG001|Main Period (Pre-randomization)|Graft loss|0|||
13348544|NCT00956293|26649036|FG002|Main Period (Pre-randomization)|Graft loss|7|||
13348545|NCT00956293|26649034|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
13348546|NCT00956293|26649035|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
13348547|NCT00956293|26649036|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12|||
13348548|NCT00956293|26649034|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0|||
13348549|NCT00956293|26649035|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0|||
13348550|NCT00956293|26649036|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20|||
13348551|NCT00956293|26649034|FG000|Main Period (Pre-randomization)|Adverse Event|0|||
13348552|NCT00956293|26649035|FG001|Main Period (Pre-randomization)|Adverse Event|0|||
13348553|NCT00956293|26649036|FG002|Main Period (Pre-randomization)|Adverse Event|36|||
13348554|NCT00956293|26649034|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
13348555|NCT00956293|26649035|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
13348556|NCT00956293|26649036|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44|||
13348557|NCT00956293|26649034|FG000|Main Period (Randomization)|Abnormal laboratory value|0|||
13348558|NCT00956293|26649035|FG001|Main Period (Randomization)|Abnormal laboratory value|2|||
13348559|NCT00956293|26649036|FG002|Main Period (Randomization)|Abnormal laboratory value|0|||
13348560|NCT00956293|26649034|FG000|Main Period (Randomization)|Lack of Efficacy|1|||
13348561|NCT00956293|26649035|FG001|Main Period (Randomization)|Lack of Efficacy|10|||
13348562|NCT00956293|26649036|FG002|Main Period (Randomization)|Lack of Efficacy|0|||
13348563|NCT00956293|26649034|FG000|Main Period (Randomization)|Adverse Event|0|||
13348564|NCT00956293|26649035|FG001|Main Period (Randomization)|Adverse Event|15|||
13348565|NCT00956293|26649036|FG002|Main Period (Randomization)|Adverse Event|0|||
13348566|NCT00956293|26649034|FG000|Follow-up Period|Follow-up period was terminated.|20|||
13348567|NCT00956293|26649035|FG001|Follow-up Period|Follow-up period was terminated.|32|||
13348568|NCT00956293|26649036|FG002|Follow-up Period|Follow-up period was terminated.|0|||
13348569|NCT00955968|26649082|FG000|Overall Study|Death|2|||
13348570|NCT00955968|26649083|FG001|Overall Study|Death|4|||
13348571|NCT00955968|26649082|FG000|Overall Study|Withdrawal by Subject|35|||
13348572|NCT00955968|26649083|FG001|Overall Study|Withdrawal by Subject|31|||
13348573|NCT00955968|26649082|FG000|Overall Study|Lost to Follow-up|45|||
13348574|NCT00955968|26649083|FG001|Overall Study|Lost to Follow-up|39|||
13204407|NCT01973439|26228496|FG000|Overall Study|Vomiting after commencing once daily|1|||
13204408|NCT01973439|26228496|FG000|Overall Study|PK curve incomplete|2|||
13204409|NCT01973387|26228517|FG000|Overall Study|Adverse Event|14|||
13204410|NCT01973387|26228518|FG001|Overall Study|Adverse Event|4|||
13204411|NCT01973387|26228517|FG000|Overall Study|Withdrawal by Subject|7|||
13204412|NCT01973387|26228518|FG001|Overall Study|Withdrawal by Subject|4|||
13204413|NCT01973387|26228517|FG000|Overall Study|Study terminated by sponsor|63|||
13204414|NCT01973387|26228518|FG001|Overall Study|Study terminated by sponsor|0|||
13204415|NCT01973387|26228517|FG000|Overall Study|Progressive disease or relapse|16|||
13348575|NCT00955968|26649082|FG000|Overall Study|Site closed|55|||
13348576|NCT00955968|26649083|FG001|Overall Study|Site closed|52|||
13348577|NCT00955955|26649107|FG000|Overall Study|Lost to Follow-up|2|||
13348578|NCT00955955|26649108|FG001|Overall Study|Lost to Follow-up|0|||
13348579|NCT00955955|26649109|FG002|Overall Study|Lost to Follow-up|0|||
13348580|NCT00955825|26649122|FG000|Overall Study|Adverse Event|15|||
13348581|NCT00955825|26649123|FG001|Overall Study|Adverse Event|2|||
13348582|NCT00955825|26649122|FG000|Overall Study|Withdrawal by Subject|4|||
13348583|NCT00955825|26649123|FG001|Overall Study|Withdrawal by Subject|6|||
13348584|NCT00955825|26649122|FG000|Overall Study|Any other reason not above-mentioned|7|||
13348585|NCT00955825|26649123|FG001|Overall Study|Any other reason not above-mentioned|9|||
13348586|NCT00955721|26649140|FG000|Overall Study|Physician Decision|1|||
13348587|NCT00955721|26649141|FG001|Overall Study|Physician Decision|0|||
13348588|NCT00955721|26649140|FG000|Overall Study|Death|1|||
13348589|NCT00955721|26649141|FG001|Overall Study|Death|0|||
13348590|NCT00955721|26649140|FG000|Overall Study|Withdrawal by Subject|1|||
13348591|NCT00955721|26649141|FG001|Overall Study|Withdrawal by Subject|0|||
13348592|NCT00955708|26649147|FG000|Overall Study|Death|269|||
13289281|NCT01086540|26477904|FG000|Overall Study|Death|3|||
13289282|NCT01086540|26477905|FG001|Overall Study|Death|1|||
13289283|NCT01086540|26477904|FG000|Overall Study|Physician Decision|2|||
13289284|NCT01086540|26477905|FG001|Overall Study|Physician Decision|1|||
13289285|NCT01086540|26477904|FG000|Overall Study|Addition of new therapy for PAH|1|||
13289286|NCT01086540|26477905|FG001|Overall Study|Addition of new therapy for PAH|0|||
13348593|NCT00955708|26649147|FG000|Overall Study|Lost to Follow-up|72|||
13348594|NCT00955708|26649147|FG000|Overall Study|Physician Decision|36|||
13348595|NCT00955708|26649147|FG000|Overall Study|Protocol Violation|134|||
13348596|NCT00955708|26649147|FG000|Overall Study|Registry Conclusion|186|||
13348597|NCT00955708|26649147|FG000|Overall Study|Product removed from service|94|||
13348598|NCT00955708|26649147|FG000|Overall Study|Patient Refused to participate further|116|||
13348599|NCT00955708|26649147|FG000|Overall Study|Closure of study location|60|||
13348600|NCT00955708|26649147|FG000|Overall Study|Patient changed care provider/moved|91|||
13348601|NCT00955682|26649260|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
13348602|NCT00955682|26649261|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
13348603|NCT00955617|26649274|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2|||
13348604|NCT00955617|26649275|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1|||
13348605|NCT00955617|26649274|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0|||
13348606|NCT00955617|26649275|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1|||
13348607|NCT00955617|26649274|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0|||
13348608|NCT00955617|26649275|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1|||
13348609|NCT00955617|26649274|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1|||
13348610|NCT00955617|26649275|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0|||
13348611|NCT00955474|26649316|FG000|Overall Study|Physician Decision|7|||
13348612|NCT00955474|26649317|FG001|Overall Study|Physician Decision|5|||
13348613|NCT00955409|26649392|FG000|Overall Study|Lack of Efficacy|1|||
13348614|NCT00955409|26649393|FG001|Overall Study|Lack of Efficacy|0|||
13348615|NCT00955409|26649394|FG002|Overall Study|Lack of Efficacy|0|||
13348616|NCT00955409|26649395|FG003|Overall Study|Lack of Efficacy|0|||
13348617|NCT00955409|26649396|FG004|Overall Study|Lack of Efficacy|0|||
13348618|NCT00955409|26649397|FG005|Overall Study|Lack of Efficacy|0|||
13348619|NCT00955409|26649398|FG006|Overall Study|Lack of Efficacy|0|||
13348620|NCT00955409|26649399|FG007|Overall Study|Lack of Efficacy|0|||
13348621|NCT00955409|26649400|FG008|Overall Study|Lack of Efficacy|0|||
13348622|NCT00955409|26649401|FG009|Overall Study|Lack of Efficacy|0|||
13348623|NCT00955409|26649392|FG000|Overall Study|Withdrawal by Subject|1|||
13348624|NCT00955409|26649393|FG001|Overall Study|Withdrawal by Subject|0|||
13348625|NCT00955409|26649394|FG002|Overall Study|Withdrawal by Subject|5|||
13348626|NCT00955409|26649395|FG003|Overall Study|Withdrawal by Subject|2|||
13348627|NCT00955409|26649396|FG004|Overall Study|Withdrawal by Subject|0|||
13348628|NCT00955409|26649397|FG005|Overall Study|Withdrawal by Subject|0|||
13348629|NCT00955409|26649398|FG006|Overall Study|Withdrawal by Subject|2|||
13348630|NCT00955409|26649399|FG007|Overall Study|Withdrawal by Subject|0|||
13348631|NCT00955409|26649400|FG008|Overall Study|Withdrawal by Subject|1|||
13348632|NCT00955409|26649401|FG009|Overall Study|Withdrawal by Subject|0|||
13348633|NCT00955409|26649392|FG000|Overall Study|Caregiver Request|2|||
13348634|NCT00955409|26649393|FG001|Overall Study|Caregiver Request|0|||
13348635|NCT00955409|26649394|FG002|Overall Study|Caregiver Request|6|||
13348636|NCT00955409|26649395|FG003|Overall Study|Caregiver Request|5|||
13348637|NCT00955409|26649396|FG004|Overall Study|Caregiver Request|0|||
13348638|NCT00955409|26649397|FG005|Overall Study|Caregiver Request|2|||
13348639|NCT00955409|26649398|FG006|Overall Study|Caregiver Request|3|||
13348640|NCT00955409|26649399|FG007|Overall Study|Caregiver Request|1|||
13348641|NCT00955409|26649400|FG008|Overall Study|Caregiver Request|3|||
13348642|NCT00955409|26649401|FG009|Overall Study|Caregiver Request|0|||
13348643|NCT00955409|26649392|FG000|Overall Study|Investigator Request|0|||
13348644|NCT00955409|26649393|FG001|Overall Study|Investigator Request|0|||
13348645|NCT00955409|26649394|FG002|Overall Study|Investigator Request|1|||
13348646|NCT00955409|26649395|FG003|Overall Study|Investigator Request|0|||
13348647|NCT00955409|26649396|FG004|Overall Study|Investigator Request|0|||
13348648|NCT00955409|26649397|FG005|Overall Study|Investigator Request|0|||
13348649|NCT00955409|26649398|FG006|Overall Study|Investigator Request|0|||
13348650|NCT00955409|26649399|FG007|Overall Study|Investigator Request|0|||
13348651|NCT00955409|26649400|FG008|Overall Study|Investigator Request|0|||
13348652|NCT00955409|26649401|FG009|Overall Study|Investigator Request|0|||
13348653|NCT00955409|26649392|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
13348654|NCT00955409|26649393|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
13348655|NCT00955409|26649394|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
13348656|NCT00955409|26649395|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
13348657|NCT00955409|26649396|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
13348658|NCT00955409|26649397|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
13348659|NCT00955409|26649398|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
13348660|NCT00955409|26649399|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
13348661|NCT00955409|26649400|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
13348662|NCT00955409|26649401|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
13348663|NCT00955409|26649392|FG000|Overall Study|Lost to Follow-up|0|||
13348664|NCT00955409|26649393|FG001|Overall Study|Lost to Follow-up|0|||
13348665|NCT00955409|26649394|FG002|Overall Study|Lost to Follow-up|1|||
13393628|NCT00662909|26784485|FG000|Overall Study|Physician Decision|1|||
13348666|NCT00955409|26649395|FG003|Overall Study|Lost to Follow-up|0|||
13348667|NCT00955409|26649396|FG004|Overall Study|Lost to Follow-up|0|||
13348668|NCT00955409|26649397|FG005|Overall Study|Lost to Follow-up|0|||
13348669|NCT00955409|26649398|FG006|Overall Study|Lost to Follow-up|1|||
13348670|NCT00955409|26649399|FG007|Overall Study|Lost to Follow-up|0|||
13348671|NCT00955409|26649400|FG008|Overall Study|Lost to Follow-up|0|||
13348672|NCT00955409|26649401|FG009|Overall Study|Lost to Follow-up|0|||
13348673|NCT00955409|26649392|FG000|Overall Study|Failed to Return|2|||
13348674|NCT00955409|26649393|FG001|Overall Study|Failed to Return|0|||
13348675|NCT00955409|26649394|FG002|Overall Study|Failed to Return|0|||
13348676|NCT00955409|26649395|FG003|Overall Study|Failed to Return|0|||
13348677|NCT00955409|26649396|FG004|Overall Study|Failed to Return|0|||
13348678|NCT00955409|26649397|FG005|Overall Study|Failed to Return|0|||
13348679|NCT00955409|26649398|FG006|Overall Study|Failed to Return|0|||
13348680|NCT00955409|26649399|FG007|Overall Study|Failed to Return|2|||
13348681|NCT00955409|26649400|FG008|Overall Study|Failed to Return|0|||
13348682|NCT00955409|26649401|FG009|Overall Study|Failed to Return|0|||
13348683|NCT00955409|26649392|FG000|Overall Study|Adverse Event (AE)|2|||
13348684|NCT00955409|26649393|FG001|Overall Study|Adverse Event (AE)|0|||
13348685|NCT00955409|26649394|FG002|Overall Study|Adverse Event (AE)|0|||
13348686|NCT00955409|26649395|FG003|Overall Study|Adverse Event (AE)|0|||
13348687|NCT00955409|26649396|FG004|Overall Study|Adverse Event (AE)|0|||
13348688|NCT00955409|26649397|FG005|Overall Study|Adverse Event (AE)|1|||
13348689|NCT00955409|26649398|FG006|Overall Study|Adverse Event (AE)|2|||
13348690|NCT00955409|26649399|FG007|Overall Study|Adverse Event (AE)|0|||
13348691|NCT00955409|26649400|FG008|Overall Study|Adverse Event (AE)|2|||
13348692|NCT00955409|26649401|FG009|Overall Study|Adverse Event (AE)|0|||
13348693|NCT00955409|26649392|FG000|Overall Study|Reason not Specified|2|||
13348694|NCT00955409|26649393|FG001|Overall Study|Reason not Specified|1|||
13348695|NCT00955409|26649394|FG002|Overall Study|Reason not Specified|13|||
13348696|NCT00955409|26649395|FG003|Overall Study|Reason not Specified|1|||
13348697|NCT00955409|26649396|FG004|Overall Study|Reason not Specified|2|||
13348698|NCT00955409|26649397|FG005|Overall Study|Reason not Specified|0|||
13348699|NCT00955409|26649398|FG006|Overall Study|Reason not Specified|16|||
13348700|NCT00955409|26649399|FG007|Overall Study|Reason not Specified|0|||
13348701|NCT00955409|26649400|FG008|Overall Study|Reason not Specified|8|||
13348702|NCT00955409|26649401|FG009|Overall Study|Reason not Specified|1|||
13348703|NCT00955357|26649414|FG000|Titration Phase|Adverse Event|9|||
13348704|NCT00955357|26649415|FG001|Titration Phase|Adverse Event|46|||
13348705|NCT00955357|26649414|FG000|Titration Phase|Lack of Efficacy|0|||
13348706|NCT00955357|26649415|FG001|Titration Phase|Lack of Efficacy|2|||
13348707|NCT00955357|26649414|FG000|Titration Phase|Protocol Violation|3|||
13348708|NCT00955357|26649415|FG001|Titration Phase|Protocol Violation|7|||
13348709|NCT00955357|26649414|FG000|Titration Phase|Lost to Follow-up|1|||
13348710|NCT00955357|26649415|FG001|Titration Phase|Lost to Follow-up|3|||
13348711|NCT00955357|26649414|FG000|Titration Phase|Withdrawal by Subject|3|||
13348712|NCT00955357|26649415|FG001|Titration Phase|Withdrawal by Subject|5|||
13348713|NCT00955357|26649414|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0|||
13348714|NCT00955357|26649415|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1|||
13348715|NCT00955357|26649414|FG000|Titration Phase|Study medication not tolerated|0|||
13348716|NCT00955357|26649415|FG001|Titration Phase|Study medication not tolerated|1|||
13348717|NCT00955357|26649414|FG000|Titration Phase|Non compliance to study procedures|0|||
13348718|NCT00955357|26649415|FG001|Titration Phase|Non compliance to study procedures|1|||
13348719|NCT00955357|26649414|FG000|Maintenance Phase|Adverse Event|3|||
13348720|NCT00955357|26649415|FG001|Maintenance Phase|Adverse Event|23|||
13348721|NCT00955357|26649414|FG000|Maintenance Phase|Lack of Efficacy|0|||
13348722|NCT00955357|26649415|FG001|Maintenance Phase|Lack of Efficacy|4|||
13348723|NCT00955357|26649414|FG000|Maintenance Phase|Protocol Violation|2|||
13348724|NCT00955357|26649415|FG001|Maintenance Phase|Protocol Violation|6|||
13348725|NCT00955357|26649414|FG000|Maintenance Phase|Lost to Follow-up|2|||
13348726|NCT00955357|26649415|FG001|Maintenance Phase|Lost to Follow-up|7|||
13348727|NCT00955357|26649414|FG000|Maintenance Phase|Withdrawal by Subject|4|||
13348728|NCT00955357|26649415|FG001|Maintenance Phase|Withdrawal by Subject|4|||
13348729|NCT00955357|26649414|FG000|Maintenance Phase|Patient moving out of area|0|||
13348730|NCT00955357|26649415|FG001|Maintenance Phase|Patient moving out of area|1|||
13348731|NCT00955357|26649414|FG000|Maintenance Phase|Non compliance to study procedures|1|||
13348732|NCT00955357|26649415|FG001|Maintenance Phase|Non compliance to study procedures|0|||
13348733|NCT00955305|26649432|FG000|Overall Study|Disease progression|39|||
13348734|NCT00955305|26649433|FG001|Overall Study|Disease progression|41|||
13348735|NCT00955305|26649432|FG000|Overall Study|Adverse Event|22|||
13348736|NCT00955305|26649433|FG001|Overall Study|Adverse Event|22|||
13348737|NCT00955305|26649432|FG000|Overall Study|Death|2|||
13348738|NCT00955305|26649433|FG001|Overall Study|Death|1|||
13348739|NCT00955305|26649432|FG000|Overall Study|Withdrawal by Subject|5|||
13348740|NCT00955305|26649433|FG001|Overall Study|Withdrawal by Subject|4|||
13348741|NCT00955305|26649432|FG000|Overall Study|Alternative therapy|4|||
13348742|NCT00955305|26649433|FG001|Overall Study|Alternative therapy|0|||
13348743|NCT00955305|26649432|FG000|Overall Study|Other complicating disease|2|||
13348744|NCT00955305|26649433|FG001|Overall Study|Other complicating disease|4|||
13348745|NCT00955305|26649432|FG000|Overall Study|Physician Decision|1|||
13348746|NCT00955305|26649433|FG001|Overall Study|Physician Decision|0|||
13348747|NCT00955305|26649432|FG000|Overall Study|Continued presence of residual disease|0|||
13348748|NCT00955305|26649433|FG001|Overall Study|Continued presence of residual disease|1|||
13348749|NCT00955305|26649432|FG000|Overall Study|Functional decline|2|||
13348750|NCT00955305|26649433|FG001|Overall Study|Functional decline|0|||
13348751|NCT00955305|26649432|FG000|Overall Study|Maximum response achieved|0|||
13348752|NCT00955305|26649433|FG001|Overall Study|Maximum response achieved|1|||
13348753|NCT00955305|26649432|FG000|Overall Study|Lost to Follow-up|0|||
13348754|NCT00955305|26649433|FG001|Overall Study|Lost to Follow-up|1|||
13348755|NCT00955305|26649432|FG000|Overall Study|No off-treatment reason submitted|1|||
13348756|NCT00955305|26649433|FG001|Overall Study|No off-treatment reason submitted|0|||
13348757|NCT00955305|26649432|FG000|Overall Study|Never started protocol treatment|5|||
13348758|NCT00955305|26649433|FG001|Overall Study|Never started protocol treatment|5|||
13348759|NCT00955305|26649432|FG000|Overall Study|Ineligible|5|||
13348760|NCT00955305|26649433|FG001|Overall Study|Ineligible|7|||
13374198|NCT00797823|26725859|FG002|First Period (Initial Randomization)|Physician Decision|0|||
13374199|NCT00797732|26725879|FG000|Overall Study|Withdrawal by Subject|3|||
13374200|NCT00797732|26725880|FG001|Overall Study|Withdrawal by Subject|3|||
13374201|NCT00797732|26725881|FG002|Overall Study|Withdrawal by Subject|0|||
13374202|NCT00797732|26725879|FG000|Overall Study|Lost to Follow-up|1|||
13374203|NCT00797732|26725880|FG001|Overall Study|Lost to Follow-up|0|||
13374204|NCT00797732|26725881|FG002|Overall Study|Lost to Follow-up|0|||
13374205|NCT00797732|26725879|FG000|Overall Study|Death|1|||
13374206|NCT00797732|26725880|FG001|Overall Study|Death|0|||
13374207|NCT00797732|26725881|FG002|Overall Study|Death|0|||
13374208|NCT00797732|26725879|FG000|Overall Study|Not meet inclusion criteria|0|||
13374209|NCT00797732|26725880|FG001|Overall Study|Not meet inclusion criteria|0|||
13374210|NCT00797732|26725881|FG002|Overall Study|Not meet inclusion criteria|7|||
13374211|NCT00797732|26725879|FG000|Overall Study|Excluded due to time constraints|0|||
13374212|NCT00797732|26725880|FG001|Overall Study|Excluded due to time constraints|0|||
13374213|NCT00797732|26725881|FG002|Overall Study|Excluded due to time constraints|24|||
13374214|NCT00797732|26725879|FG000|Overall Study|Refused to Participate|0|||
13374215|NCT00797732|26725880|FG001|Overall Study|Refused to Participate|0|||
13374216|NCT00797732|26725881|FG002|Overall Study|Refused to Participate|123|||
13374217|NCT00797667|26725917|FG000|Overall Study|Lack of Efficacy|0|||
13374218|NCT00797667|26725918|FG001|Overall Study|Lack of Efficacy|1|||
13374219|NCT00797667|26725919|FG002|Overall Study|Lack of Efficacy|0|||
13374220|NCT00797667|26725917|FG000|Overall Study|Lost to Follow-up|8|||
13374221|NCT00797667|26725918|FG001|Overall Study|Lost to Follow-up|12|||
13374222|NCT00797667|26725919|FG002|Overall Study|Lost to Follow-up|2|||
13374223|NCT00797667|26725917|FG000|Overall Study|Physician Decision|3|||
13374224|NCT00797667|26725918|FG001|Overall Study|Physician Decision|1|||
13374225|NCT00797667|26725919|FG002|Overall Study|Physician Decision|0|||
13374226|NCT00797667|26725917|FG000|Overall Study|Pregnancy|2|||
13374227|NCT00797667|26725918|FG001|Overall Study|Pregnancy|0|||
13374228|NCT00797667|26725919|FG002|Overall Study|Pregnancy|0|||
13374229|NCT00797667|26725917|FG000|Overall Study|Protocol Violation|2|||
13374230|NCT00797667|26725918|FG001|Overall Study|Protocol Violation|7|||
13374231|NCT00797667|26725919|FG002|Overall Study|Protocol Violation|0|||
13374232|NCT00797667|26725917|FG000|Overall Study|Study Terminated by Sponsor|217|||
13374233|NCT00797667|26725918|FG001|Overall Study|Study Terminated by Sponsor|216|||
13374234|NCT00797667|26725919|FG002|Overall Study|Study Terminated by Sponsor|115|||
13374235|NCT00797667|26725917|FG000|Overall Study|Withdrawal by Subject|9|||
13374236|NCT00797667|26725918|FG001|Overall Study|Withdrawal by Subject|14|||
13374237|NCT00797667|26725919|FG002|Overall Study|Withdrawal by Subject|2|||
13374238|NCT00797667|26725917|FG000|Overall Study|Adverse Event|19|||
13374239|NCT00797667|26725918|FG001|Overall Study|Adverse Event|8|||
13374240|NCT00797667|26725919|FG002|Overall Study|Adverse Event|8|||
13374241|NCT00797563|26725927|FG000|Overall Study|Adverse Event|1|||
13374242|NCT00797511|26725937|FG000|Overall Study|Withdrawal by Subject|1|||
13374243|NCT00797316|26725958|FG000|Overall Study|Administrative problems|1|||
13374244|NCT00797316|26725959|FG001|Overall Study|Administrative problems|0|||
13374245|NCT00797316|26725958|FG000|Overall Study|Adverse Event|5|||
13374246|NCT00797316|26725959|FG001|Overall Study|Adverse Event|3|||
13374247|NCT00797316|26725958|FG000|Overall Study|Lost to Follow-up|4|||
13374248|NCT00797316|26725959|FG001|Overall Study|Lost to Follow-up|8|||
13374249|NCT00797316|26725958|FG000|Overall Study|Protocol Deviation|1|||
13374250|NCT00797316|26725959|FG001|Overall Study|Protocol Deviation|2|||
13374251|NCT00797316|26725958|FG000|Overall Study|Patient withdrew consent|12|||
13374252|NCT00797316|26725959|FG001|Overall Study|Patient withdrew consent|6|||
13374253|NCT00797316|26725958|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
13374254|NCT00797316|26725959|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
13374255|NCT00797225|26726084|FG000|Weeks 1 to 12|Adverse Event|0|||
13374256|NCT00797225|26726085|FG001|Weeks 1 to 12|Adverse Event|0|||
13374257|NCT00797225|26726086|FG002|Weeks 1 to 12|Adverse Event|1|||
13374258|NCT00797225|26726087|FG003|Weeks 1 to 12|Adverse Event|0|||
13348761|NCT00955279|26649463|FG000|Overall Study|Other|0|||
13348762|NCT00955279|26649464|FG001|Overall Study|Other|0|||
13348763|NCT00955279|26649465|FG002|Overall Study|Other|3|||
13348764|NCT00955279|26649463|FG000|Overall Study|Death|1|||
13348765|NCT00955279|26649464|FG001|Overall Study|Death|1|||
13348766|NCT00955279|26649465|FG002|Overall Study|Death|1|||
13348767|NCT00955279|26649463|FG000|Overall Study|Lost to Follow-up|0|||
13348768|NCT00955279|26649464|FG001|Overall Study|Lost to Follow-up|3|||
13348769|NCT00955279|26649465|FG002|Overall Study|Lost to Follow-up|1|||
13348770|NCT00955279|26649463|FG000|Overall Study|Withdrawal by Subject|2|||
13348771|NCT00955279|26649464|FG001|Overall Study|Withdrawal by Subject|0|||
13348772|NCT00955279|26649465|FG002|Overall Study|Withdrawal by Subject|3|||
13348773|NCT00955110|26649479|FG000|Qualification Phase|Did not meet eligibility criteria|24|||
13348774|NCT00955110|26649479|FG000|Treatment Phase|Adverse Event|2|||
13348775|NCT00955110|26649479|FG000|Treatment Phase|Administrative reasons|2|||
13348776|NCT00955110|26649479|FG000|Treatment Phase|Non-compliance with study restrictions|1|||
13348777|NCT00955110|26649479|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1|||
13348778|NCT00954941|26649494|FG000|Overall Study|Received treatment at home|1|||
13348779|NCT00954941|26649495|FG001|Overall Study|Received treatment at home|0|||
13348780|NCT00954941|26649494|FG000|Overall Study|Withdrawal by Subject|1|||
13348781|NCT00954941|26649495|FG001|Overall Study|Withdrawal by Subject|0|||
13348782|NCT00954941|26649494|FG000|Overall Study|Insurance Denial|2|||
13348783|NCT00954941|26649495|FG001|Overall Study|Insurance Denial|2|||
13348784|NCT00954941|26649494|FG000|Overall Study|Physician Decision|2|||
13348785|NCT00954941|26649495|FG001|Overall Study|Physician Decision|2|||
13348786|NCT00954941|26649494|FG000|Overall Study|Ineligible|2|||
13348787|NCT00954941|26649495|FG001|Overall Study|Ineligible|2|||
13348788|NCT00954941|26649494|FG000|Overall Study|Adverse Event|0|||
13348789|NCT00954941|26649495|FG001|Overall Study|Adverse Event|1|||
13348790|NCT00954733|26649501|FG000|Overall Study|blood gas machine did not work|1|||
13348791|NCT00954707|26649519|FG000|Overall Study|Death|34|||
13348792|NCT00954707|26649519|FG000|Overall Study|Withdrawal by Subject|100|||
13348793|NCT00954707|26649519|FG000|Overall Study|Lost to Follow-up|33|||
13348794|NCT00954538|26649541|FG000|Part III|Withdrawal by Subject|0|||
13348795|NCT00954538|26649542|FG001|Part III|Withdrawal by Subject|0|||
13348796|NCT00954538|26649543|FG002|Part III|Withdrawal by Subject|0|||
13348797|NCT00954538|26649544|FG003|Part III|Withdrawal by Subject|0|||
13348798|NCT00954538|26649545|FG004|Part III|Withdrawal by Subject|1|||
13348799|NCT00954538|26649546|FG005|Part III|Withdrawal by Subject|0|||
13348800|NCT00954512|26649584|FG000|Overall Study|Withdrawal by Subject|0|||
13348801|NCT00954512|26649585|FG001|Overall Study|Withdrawal by Subject|0|||
13348802|NCT00954512|26649586|FG002|Overall Study|Withdrawal by Subject|0|||
13348803|NCT00954512|26649587|FG003|Overall Study|Withdrawal by Subject|0|||
13348804|NCT00954512|26649588|FG004|Overall Study|Withdrawal by Subject|0|||
13348805|NCT00954512|26649589|FG005|Overall Study|Withdrawal by Subject|1|||
13348806|NCT00954512|26649584|FG000|Overall Study|Adverse Event|0|||
13348807|NCT00954512|26649585|FG001|Overall Study|Adverse Event|0|||
13348808|NCT00954512|26649586|FG002|Overall Study|Adverse Event|0|||
13348809|NCT00954512|26649587|FG003|Overall Study|Adverse Event|0|||
13348810|NCT00954512|26649588|FG004|Overall Study|Adverse Event|1|||
13348811|NCT00954512|26649589|FG005|Overall Study|Adverse Event|2|||
13348812|NCT00954512|26649584|FG000|Overall Study|Physician Decision|0|||
13348813|NCT00954512|26649585|FG001|Overall Study|Physician Decision|1|||
13348814|NCT00954512|26649586|FG002|Overall Study|Physician Decision|0|||
13348815|NCT00954512|26649587|FG003|Overall Study|Physician Decision|1|||
13348816|NCT00954512|26649588|FG004|Overall Study|Physician Decision|0|||
13348817|NCT00954512|26649589|FG005|Overall Study|Physician Decision|0|||
13348818|NCT00954512|26649584|FG000|Overall Study|Symptomatic Deterioration|0|||
13348819|NCT00954512|26649585|FG001|Overall Study|Symptomatic Deterioration|1|||
13348820|NCT00954512|26649586|FG002|Overall Study|Symptomatic Deterioration|0|||
13348821|NCT00954512|26649587|FG003|Overall Study|Symptomatic Deterioration|0|||
13348822|NCT00954512|26649588|FG004|Overall Study|Symptomatic Deterioration|2|||
13348823|NCT00954512|26649589|FG005|Overall Study|Symptomatic Deterioration|0|||
13348824|NCT00954512|26649584|FG000|Overall Study|Progression of Disease|2|||
13348825|NCT00954512|26649585|FG001|Overall Study|Progression of Disease|1|||
13348826|NCT00954512|26649586|FG002|Overall Study|Progression of Disease|0|||
13348827|NCT00954512|26649587|FG003|Overall Study|Progression of Disease|1|||
13348828|NCT00954512|26649588|FG004|Overall Study|Progression of Disease|1|||
13348829|NCT00954512|26649589|FG005|Overall Study|Progression of Disease|1|||
13348830|NCT00954447|26649632|FG000|Overall Study|Adverse Event|33|||
13289287|NCT02218697|26477950|FG000|Overall Study|Adverse Event|0|||
13289288|NCT02218697|26477951|FG001|Overall Study|Adverse Event|2|||
13289289|NCT02218697|26477950|FG000|Overall Study|Unwilling to be vaccinated in left arm|0|||
13289290|NCT02218697|26477951|FG001|Overall Study|Unwilling to be vaccinated in left arm|1|||
13289291|NCT02218697|26477950|FG000|Overall Study|Withdrawal by Subject|2|||
13289292|NCT02218697|26477951|FG001|Overall Study|Withdrawal by Subject|3|||
13289293|NCT02211417|26477997|FG000|Overall Study|Withdrawal by Subject|11|||
13289294|NCT02211417|26477998|FG001|Overall Study|Withdrawal by Subject|8|||
13348831|NCT00954447|26649633|FG001|Overall Study|Adverse Event|25|||
13348832|NCT00954447|26649632|FG000|Overall Study|Lack of Efficacy|17|||
13348833|NCT00954447|26649633|FG001|Overall Study|Lack of Efficacy|3|||
13348834|NCT00954447|26649632|FG000|Overall Study|Protocol Violation|5|||
13348835|NCT00954447|26649633|FG001|Overall Study|Protocol Violation|7|||
13348836|NCT00954447|26649632|FG000|Overall Study|Lost to Follow-up|8|||
13348837|NCT00954447|26649633|FG001|Overall Study|Lost to Follow-up|14|||
13348838|NCT00954447|26649632|FG000|Overall Study|Withdrawal by Subject|26|||
13348839|NCT00954447|26649633|FG001|Overall Study|Withdrawal by Subject|21|||
13348840|NCT00954447|26649632|FG000|Overall Study|Other|21|||
13348841|NCT00954447|26649633|FG001|Overall Study|Other|18|||
13348842|NCT00954421|26649641|FG000|Screening|screen failures|3|||
13348843|NCT00954421|26649641|FG000|6 Months of DBS|Withdrawal by Subject|1|||
13348844|NCT00954421|26649641|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1|||
13348845|NCT00954174|26649674|FG000|Overall Study|Adverse Event|28|||
13348846|NCT00954174|26649675|FG001|Overall Study|Adverse Event|23|||
13348847|NCT00954174|26649676|FG002|Overall Study|Adverse Event|4|||
13348848|NCT00954174|26649677|FG003|Overall Study|Adverse Event|9|||
13348849|NCT00954174|26649674|FG000|Overall Study|Death|4|||
13348850|NCT00954174|26649675|FG001|Overall Study|Death|2|||
13348851|NCT00954174|26649676|FG002|Overall Study|Death|0|||
13348852|NCT00954174|26649677|FG003|Overall Study|Death|0|||
13348853|NCT00954174|26649674|FG000|Overall Study|Lack of Efficacy|32|||
13348854|NCT00954174|26649675|FG001|Overall Study|Lack of Efficacy|22|||
13348855|NCT00954174|26649676|FG002|Overall Study|Lack of Efficacy|8|||
13348856|NCT00954174|26649677|FG003|Overall Study|Lack of Efficacy|6|||
13348857|NCT00954174|26649674|FG000|Overall Study|Withdrawal by Subject|14|||
13348858|NCT00954174|26649675|FG001|Overall Study|Withdrawal by Subject|10|||
13348859|NCT00954174|26649676|FG002|Overall Study|Withdrawal by Subject|4|||
13348860|NCT00954174|26649677|FG003|Overall Study|Withdrawal by Subject|3|||
13348861|NCT00954174|26649674|FG000|Overall Study|Medical Reason|4|||
13348862|NCT00954174|26649675|FG001|Overall Study|Medical Reason|2|||
13348863|NCT00954174|26649676|FG002|Overall Study|Medical Reason|1|||
13348864|NCT00954174|26649677|FG003|Overall Study|Medical Reason|0|||
13348865|NCT00954174|26649674|FG000|Overall Study|Ineligible|40|||
13348866|NCT00954174|26649675|FG001|Overall Study|Ineligible|47|||
13348867|NCT00954174|26649676|FG002|Overall Study|Ineligible|7|||
13348868|NCT00954174|26649677|FG003|Overall Study|Ineligible|4|||
13348869|NCT00954174|26649674|FG000|Overall Study|Never Treated|4|||
13348870|NCT00954174|26649675|FG001|Overall Study|Never Treated|17|||
13348871|NCT00954174|26649676|FG002|Overall Study|Never Treated|0|||
13348872|NCT00954174|26649677|FG003|Overall Study|Never Treated|3|||
13348873|NCT00954122|26649689|FG000|Overall Study|Withdrawal by Subject|5|||
13348874|NCT00954122|26649689|FG000|Overall Study|Adverse Event|1|||
13348875|NCT00954122|26649689|FG000|Overall Study|Safety Reason|1|||
13348876|NCT00953927|26649714|FG000|Overall Study|Lost to Follow-up|61|||
13348877|NCT00953927|26649715|FG001|Overall Study|Lost to Follow-up|65|||
13348878|NCT00953927|26649714|FG000|Overall Study|Withdrawal by Subject|36|||
13348879|NCT00953927|26649715|FG001|Overall Study|Withdrawal by Subject|25|||
13348880|NCT00953927|26649714|FG000|Overall Study|Death|7|||
13348881|NCT00953927|26649715|FG001|Overall Study|Death|4|||
13348882|NCT00953927|26649714|FG000|Overall Study|Other study discontinuation|1|||
13348883|NCT00953927|26649715|FG001|Overall Study|Other study discontinuation|1|||
13348884|NCT00953745|26649730|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1|||
13348885|NCT00953745|26649731|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0|||
13348886|NCT00953745|26649730|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2|||
13348887|NCT00953745|26649731|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0|||
13348888|NCT00953745|26649730|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3|||
13348889|NCT00953745|26649731|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0|||
13348890|NCT00953745|26649730|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1|||
13348891|NCT00953745|26649731|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0|||
13348892|NCT00953745|26649730|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6|||
13348893|NCT00953745|26649731|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0|||
13348894|NCT00953745|26649730|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1|||
13348895|NCT00953745|26649731|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0|||
13348896|NCT00953706|26649772|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2|||
13348897|NCT00953706|26649773|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3|||
13348898|NCT00953706|26649774|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
13348899|NCT00953706|26649775|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
13348900|NCT00953706|26649772|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
13348901|NCT00953706|26649773|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1|||
13348902|NCT00953706|26649774|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
13348903|NCT00953706|26649775|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
13348904|NCT00953706|26649772|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
13348905|NCT00953706|26649773|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2|||
13374259|NCT00797225|26726088|FG004|Weeks 1 to 12|Adverse Event|0|||
13348906|NCT00953706|26649774|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
13348907|NCT00953706|26649775|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
13348908|NCT00953706|26649772|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
13348909|NCT00953706|26649773|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1|||
13348910|NCT00953706|26649774|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
13348911|NCT00953706|26649775|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
13348912|NCT00953706|26649772|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
13348913|NCT00953706|26649773|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1|||
13348914|NCT00953706|26649774|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
13348915|NCT00953706|26649775|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
13348916|NCT00953706|26649772|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
13348917|NCT00953706|26649773|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
13348918|NCT00953706|26649774|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
13348919|NCT00953706|26649775|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2|||
13348920|NCT00953706|26649772|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
13348921|NCT00953706|26649773|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
13348922|NCT00953706|26649774|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
13348923|NCT00953706|26649775|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1|||
13348924|NCT00953706|26649772|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
13348925|NCT00953706|26649773|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
13348926|NCT00953706|26649774|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
13348927|NCT00953706|26649775|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1|||
13348928|NCT00953706|26649772|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
13348929|NCT00953706|26649773|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
13348930|NCT00953706|26649774|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4|||
13348931|NCT00953706|26649775|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25|||
13348932|NCT00953706|26649772|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
13348933|NCT00953706|26649773|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
13348934|NCT00953706|26649774|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1|||
13348935|NCT00953706|26649775|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2|||
13348936|NCT00953706|26649772|FG000|Part B (96-Week Open-Label Extension)|Other|0|||
13348937|NCT00953706|26649773|FG001|Part B (96-Week Open-Label Extension)|Other|0|||
13348938|NCT00953706|26649774|FG002|Part B (96-Week Open-Label Extension)|Other|0|||
13348939|NCT00953706|26649775|FG003|Part B (96-Week Open-Label Extension)|Other|2|||
13348940|NCT00953680|26649790|FG000|Period 1|Withdrawal by Subject|0|||
13348941|NCT00953680|26649791|FG001|Period 1|Withdrawal by Subject|1|||
13348942|NCT00953667|26649798|FG000|Overall Study|Lost to Follow-up|11|||
13348943|NCT00953667|26649798|FG000|Overall Study|Physician Decision|35|||
13348944|NCT00953667|26649798|FG000|Overall Study|Withdrawal by Subject|63|||
13348945|NCT00953667|26649798|FG000|Overall Study|Adverse Event|10|||
13348946|NCT00953667|26649798|FG000|Overall Study|poor venous access,unable to draw blood|4|||
13348947|NCT00953615|26649807|FG000|Overall Study|Adverse Event|1|||
13348948|NCT00953576|26649825|FG000|Overall Study|Adverse Event|0|||
13348949|NCT00953576|26649826|FG001|Overall Study|Adverse Event|1|||
13348950|NCT00953576|26649825|FG000|Overall Study|Ineligible after Consent|2|||
13348951|NCT00953576|26649826|FG001|Overall Study|Ineligible after Consent|0|||
13348952|NCT00953524|26649877|FG000|Overall Study|Adverse Event|2|||
13348953|NCT00953524|26649878|FG001|Overall Study|Adverse Event|0|||
13348954|NCT00953524|26649879|FG002|Overall Study|Adverse Event|1|||
13348955|NCT00953524|26649880|FG003|Overall Study|Adverse Event|2|||
13348956|NCT00953524|26649877|FG000|Overall Study|Protocol Violation|18|||
13348957|NCT00953524|26649878|FG001|Overall Study|Protocol Violation|10|||
13348958|NCT00953524|26649879|FG002|Overall Study|Protocol Violation|11|||
13348959|NCT00953524|26649880|FG003|Overall Study|Protocol Violation|6|||
13348960|NCT00953524|26649877|FG000|Overall Study|Lost to Follow-up|0|||
13348961|NCT00953524|26649878|FG001|Overall Study|Lost to Follow-up|1|||
13348962|NCT00953524|26649879|FG002|Overall Study|Lost to Follow-up|1|||
13348963|NCT00953524|26649880|FG003|Overall Study|Lost to Follow-up|0|||
13348964|NCT00953524|26649877|FG000|Overall Study|Withdrawal by Subject|2|||
13348965|NCT00953524|26649878|FG001|Overall Study|Withdrawal by Subject|4|||
13348966|NCT00953524|26649879|FG002|Overall Study|Withdrawal by Subject|1|||
13348967|NCT00953524|26649880|FG003|Overall Study|Withdrawal by Subject|0|||
13348968|NCT00953407|26649908|FG000|Overall Study|Failed inclusion criteria|1|||
13348969|NCT00953407|26649909|FG001|Overall Study|Failed inclusion criteria|1|||
13348970|NCT00953407|26649910|FG002|Overall Study|Failed inclusion criteria|1|||
13348971|NCT00953407|26649911|FG003|Overall Study|Failed inclusion criteria|1|||
13348972|NCT00953407|26649912|FG004|Overall Study|Failed inclusion criteria|1|||
13348973|NCT00953407|26649908|FG000|Overall Study|Lost to Follow-up|0|||
13348974|NCT00953407|26649909|FG001|Overall Study|Lost to Follow-up|0|||
13348975|NCT00953407|26649910|FG002|Overall Study|Lost to Follow-up|0|||
13348976|NCT00953407|26649911|FG003|Overall Study|Lost to Follow-up|1|||
13348977|NCT00953407|26649912|FG004|Overall Study|Lost to Follow-up|0|||
13348978|NCT00953329|26649918|FG000|Overall Study|Lack of Efficacy|1|||
13348979|NCT00953225|26649933|FG000|Overall Study|Withdrawal by Subject|2|||
13348980|NCT00953225|26649934|FG001|Overall Study|Withdrawal by Subject|0|||
13348981|NCT00953160|26649942|FG000|Overall Study|Lost to Follow-up|23|||
13348982|NCT00953160|26649942|FG000|Overall Study|Withdrawal by Subject|4|||
13348983|NCT00953147|26649999|FG000|Overall Study|Adverse Event|8|||
13348984|NCT00953147|26650000|FG001|Overall Study|Adverse Event|16|||
13348985|NCT00953147|26650001|FG002|Overall Study|Adverse Event|6|||
13348986|NCT00953147|26649999|FG000|Overall Study|Protocol Violation|2|||
13348987|NCT00953147|26650000|FG001|Overall Study|Protocol Violation|8|||
13348988|NCT00953147|26650001|FG002|Overall Study|Protocol Violation|4|||
13348989|NCT00953147|26649999|FG000|Overall Study|Withdrawal by Subject|13|||
13348990|NCT00953147|26650000|FG001|Overall Study|Withdrawal by Subject|15|||
13348991|NCT00953147|26650001|FG002|Overall Study|Withdrawal by Subject|12|||
13348992|NCT00953147|26649999|FG000|Overall Study|Lost to Follow-up|8|||
13348993|NCT00953147|26650000|FG001|Overall Study|Lost to Follow-up|9|||
13348994|NCT00953147|26650001|FG002|Overall Study|Lost to Follow-up|4|||
13348995|NCT00953147|26649999|FG000|Overall Study|Physician Decision|2|||
13348996|NCT00953147|26650000|FG001|Overall Study|Physician Decision|7|||
13348997|NCT00953147|26650001|FG002|Overall Study|Physician Decision|3|||
13348998|NCT00953147|26649999|FG000|Overall Study|Other|4|||
13348999|NCT00953147|26650000|FG001|Overall Study|Other|11|||
13349000|NCT00953147|26650001|FG002|Overall Study|Other|13|||
13349001|NCT00953056|26650042|FG000|Overall Study|Withdrew Consent|0|||
13349002|NCT00953056|26650043|FG001|Overall Study|Withdrew Consent|0|||
13349003|NCT00953056|26650044|FG002|Overall Study|Withdrew Consent|0|||
13349004|NCT00953056|26650045|FG003|Overall Study|Withdrew Consent|0|||
13349005|NCT00953056|26650046|FG004|Overall Study|Withdrew Consent|2|||
13349006|NCT00953056|26650047|FG005|Overall Study|Withdrew Consent|3|||
13349007|NCT00953056|26650042|FG000|Overall Study|Serious Adverse Event|0|||
13349008|NCT00953056|26650043|FG001|Overall Study|Serious Adverse Event|0|||
13349009|NCT00953056|26650044|FG002|Overall Study|Serious Adverse Event|0|||
13349010|NCT00953056|26650045|FG003|Overall Study|Serious Adverse Event|0|||
13349011|NCT00953056|26650046|FG004|Overall Study|Serious Adverse Event|0|||
13349012|NCT00953056|26650047|FG005|Overall Study|Serious Adverse Event|1|||
13349013|NCT00953043|26650074|FG000|Overall Study|Withdrawal by Subject|4|||
13349014|NCT00953043|26650075|FG001|Overall Study|Withdrawal by Subject|0|||
13349015|NCT00953043|26650074|FG000|Overall Study|Physician Decision|0|||
13349016|NCT00953043|26650075|FG001|Overall Study|Physician Decision|2|||
13349017|NCT00953017|26650110|FG000|Overall Study|DId not show up for colonoscopy|4|||
13349018|NCT00953017|26650111|FG001|Overall Study|DId not show up for colonoscopy|4|||
13349019|NCT00953017|26650112|FG002|Overall Study|DId not show up for colonoscopy|5|||
13349020|NCT00953017|26650113|FG003|Overall Study|DId not show up for colonoscopy|4|||
13349021|NCT00953017|26650110|FG000|Overall Study|Incomplete data|1|||
13349022|NCT00953017|26650111|FG001|Overall Study|Incomplete data|1|||
13349023|NCT00953017|26650112|FG002|Overall Study|Incomplete data|0|||
13349024|NCT00953017|26650113|FG003|Overall Study|Incomplete data|0|||
13349025|NCT00953017|26650110|FG000|Overall Study|Procedure incomplete due to pain/looping|0|||
13349026|NCT00953017|26650111|FG001|Overall Study|Procedure incomplete due to pain/looping|1|||
13349027|NCT00953017|26650112|FG002|Overall Study|Procedure incomplete due to pain/looping|0|||
13349028|NCT00953017|26650113|FG003|Overall Study|Procedure incomplete due to pain/looping|1|||
13349029|NCT00953017|26650110|FG000|Overall Study|Brown stool prior to procedure|0|||
13349030|NCT00953017|26650111|FG001|Overall Study|Brown stool prior to procedure|0|||
13349031|NCT00953017|26650112|FG002|Overall Study|Brown stool prior to procedure|1|||
13349032|NCT00953017|26650113|FG003|Overall Study|Brown stool prior to procedure|0|||
13349033|NCT00952848|26650122|FG000|Overall Study|Withdrawal by Subject|4|||
13349034|NCT00952822|26650157|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
13349035|NCT00952822|26650158|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1|||
13349036|NCT00952822|26650159|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
13349037|NCT00952822|26650160|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
13349038|NCT00952822|26650157|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
13349039|NCT00952822|26650158|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
13349040|NCT00952822|26650159|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1|||
13349041|NCT00952822|26650160|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
13349042|NCT00952731|26650183|FG000|Overall Study|Drug supply expired|1|||
13349043|NCT00952731|26650184|FG001|Overall Study|Drug supply expired|0|||
13349044|NCT00952705|26650256|FG000|Overall Study|Lost to Follow-up|24|||
13349045|NCT00952705|26650257|FG001|Overall Study|Lost to Follow-up|8|||
13349046|NCT00952705|26650258|FG002|Overall Study|Lost to Follow-up|9|||
13349047|NCT00952705|26650256|FG000|Overall Study|Withdrawal by Subject|2|||
13349048|NCT00952705|26650257|FG001|Overall Study|Withdrawal by Subject|1|||
13349049|NCT00952705|26650258|FG002|Overall Study|Withdrawal by Subject|1|||
13349050|NCT00952705|26650256|FG000|Overall Study|Death|2|||
13349051|NCT00952705|26650257|FG001|Overall Study|Death|0|||
13349052|NCT00952705|26650258|FG002|Overall Study|Death|0|||
13349053|NCT00952705|26650256|FG000|Overall Study|Incarcerated post dose|5|||
13349054|NCT00952705|26650257|FG001|Overall Study|Incarcerated post dose|0|||
13349055|NCT00952705|26650258|FG002|Overall Study|Incarcerated post dose|0|||
13349056|NCT00952705|26650256|FG000|Overall Study|Exclusion criteria not met pre dose|0|||
13349057|NCT00952705|26650257|FG001|Overall Study|Exclusion criteria not met pre dose|1|||
13349058|NCT00952705|26650258|FG002|Overall Study|Exclusion criteria not met pre dose|0|||
13349059|NCT00952614|26650265|FG000|Overall Study|Death|3|||
13349060|NCT00952614|26650265|FG000|Overall Study|Lost to Follow-up|3|||
13349061|NCT00952614|26650265|FG000|Overall Study|other reason|1|||
13349062|NCT00952588|26650290|FG000|Overall Study|Death|28|||
13349063|NCT00952588|26650291|FG001|Overall Study|Death|13|||
13349064|NCT00952588|26650290|FG000|Overall Study|Withdrawal by Subject|2|||
13349065|NCT00952588|26650291|FG001|Overall Study|Withdrawal by Subject|5|||
13349066|NCT00952588|26650290|FG000|Overall Study|Adverse Event|2|||
13349067|NCT00952588|26650291|FG001|Overall Study|Adverse Event|3|||
13349068|NCT00952588|26650290|FG000|Overall Study|Lost to Follow-up|2|||
13349069|NCT00952588|26650291|FG001|Overall Study|Lost to Follow-up|0|||
13349070|NCT00952588|26650290|FG000|Overall Study|Physician Decision|0|||
13349071|NCT00952588|26650291|FG001|Overall Study|Physician Decision|1|||
13349072|NCT00952588|26650290|FG000|Overall Study|Lack of Efficacy|2|||
13349073|NCT00952588|26650291|FG001|Overall Study|Lack of Efficacy|2|||
13349074|NCT00952523|26650299|FG000|Overall Study|Withdrawal by Subject|7|||
13349075|NCT00952484|26650333|FG000|Overall Study|Withdrawal by Subject|0|||
13349076|NCT00952484|26650334|FG001|Overall Study|Withdrawal by Subject|1|||
13349077|NCT00952484|26650335|FG002|Overall Study|Withdrawal by Subject|0|||
13349078|NCT00952419|26650377|FG000|Overall Study|Adverse Event|2|||
13349079|NCT00952419|26650378|FG001|Overall Study|Adverse Event|0|||
13349080|NCT00952419|26650379|FG002|Overall Study|Adverse Event|0|||
13349081|NCT00952419|26650377|FG000|Overall Study|Protocol Violation|3|||
13349082|NCT00952419|26650378|FG001|Overall Study|Protocol Violation|7|||
13349083|NCT00952419|26650379|FG002|Overall Study|Protocol Violation|0|||
13349084|NCT00952419|26650377|FG000|Overall Study|Withdrawal by Subject|1|||
13349085|NCT00952419|26650378|FG001|Overall Study|Withdrawal by Subject|3|||
13349086|NCT00952419|26650379|FG002|Overall Study|Withdrawal by Subject|0|||
13349087|NCT00952380|26650496|FG000|Overall Study|Other|0|||
13349088|NCT00952380|26650497|FG001|Overall Study|Other|0|||
13349089|NCT00952380|26650498|FG002|Overall Study|Other|0|||
13349090|NCT00952380|26650499|FG003|Overall Study|Other|0|||
13349091|NCT00952380|26650500|FG004|Overall Study|Other|1|||
13349092|NCT00952380|26650496|FG000|Overall Study|Withdrawal by Subject|0|||
13349093|NCT00952380|26650497|FG001|Overall Study|Withdrawal by Subject|0|||
13349094|NCT00952380|26650498|FG002|Overall Study|Withdrawal by Subject|1|||
13349095|NCT00952380|26650499|FG003|Overall Study|Withdrawal by Subject|0|||
13349096|NCT00952380|26650500|FG004|Overall Study|Withdrawal by Subject|2|||
13349097|NCT00952380|26650496|FG000|Overall Study|Adverse Event|0|||
13349098|NCT00952380|26650497|FG001|Overall Study|Adverse Event|1|||
13349099|NCT00952380|26650498|FG002|Overall Study|Adverse Event|0|||
13349100|NCT00952380|26650499|FG003|Overall Study|Adverse Event|0|||
13349101|NCT00952380|26650500|FG004|Overall Study|Adverse Event|3|||
13349102|NCT00952380|26650496|FG000|Overall Study|Physician Decision|0|||
13349103|NCT00952380|26650497|FG001|Overall Study|Physician Decision|0|||
13349104|NCT00952380|26650498|FG002|Overall Study|Physician Decision|1|||
13349105|NCT00952380|26650499|FG003|Overall Study|Physician Decision|2|||
13349106|NCT00952380|26650500|FG004|Overall Study|Physician Decision|0|||
13349107|NCT00952380|26650496|FG000|Overall Study|Non-compliant to protocol|0|||
13349108|NCT00952380|26650497|FG001|Overall Study|Non-compliant to protocol|0|||
13349109|NCT00952380|26650498|FG002|Overall Study|Non-compliant to protocol|0|||
13349110|NCT00952380|26650499|FG003|Overall Study|Non-compliant to protocol|1|||
13349111|NCT00952380|26650500|FG004|Overall Study|Non-compliant to protocol|0|||
13349112|NCT00952367|26650515|FG000|Overall Study|Withdrawal by Subject|2|||
13349113|NCT00952367|26650515|FG000|Overall Study|Noncoordination|1|||
13349114|NCT00952367|26650515|FG000|Overall Study|Protocol Violation|3|||
13349115|NCT00952341|26650542|FG000|Cycle 1|Adverse Event|4|||
13349116|NCT00952341|26650543|FG001|Cycle 1|Adverse Event|1|||
13349117|NCT00952341|26650542|FG000|Cycle 1|Withdrawal by Subject|3|||
13349118|NCT00952341|26650543|FG001|Cycle 1|Withdrawal by Subject|8|||
13349119|NCT00952341|26650542|FG000|Cycle 1|Protocol Violation|2|||
13349120|NCT00952341|26650543|FG001|Cycle 1|Protocol Violation|1|||
13349121|NCT00952341|26650542|FG000|Cycle 1|Lost to Follow-up|11|||
13349122|NCT00952341|26650543|FG001|Cycle 1|Lost to Follow-up|2|||
13349123|NCT00952341|26650542|FG000|Cycle 1|Physician Decision|0|||
13349124|NCT00952341|26650543|FG001|Cycle 1|Physician Decision|1|||
13349125|NCT00952341|26650542|FG000|Cycle 2|Withdrawal by Subject|1|||
13349126|NCT00952341|26650543|FG001|Cycle 2|Withdrawal by Subject|1|||
13349127|NCT00952341|26650542|FG000|Cycle 2|Protocol Violation|1|||
13349128|NCT00952341|26650543|FG001|Cycle 2|Protocol Violation|0|||
13349129|NCT00952341|26650542|FG000|Cycle 2|Lost to Follow-up|6|||
13349130|NCT00952341|26650543|FG001|Cycle 2|Lost to Follow-up|9|||
13349131|NCT00952341|26650542|FG000|Cycle 2|Physician Decision|1|||
13349132|NCT00952341|26650543|FG001|Cycle 2|Physician Decision|1|||
13349133|NCT00952341|26650542|FG000|Cycle 2|Progressive Disease|0|||
13349134|NCT00952341|26650543|FG001|Cycle 2|Progressive Disease|1|||
13349135|NCT00952289|26650574|FG000|All Participants|Death|9|||
13349136|NCT00952289|26650575|FG001|All Participants|Death|9|||
13349137|NCT00952289|26650574|FG000|All Participants|Adverse Event|8|||
13349138|NCT00952289|26650575|FG001|All Participants|Adverse Event|8|||
13349139|NCT00952289|26650574|FG000|All Participants|Disease progression|3|||
13349140|NCT00952289|26650575|FG001|All Participants|Disease progression|12|||
13349141|NCT00952289|26650574|FG000|All Participants|Withdrawal by Subject|1|||
13349142|NCT00952289|26650575|FG001|All Participants|Withdrawal by Subject|10|||
13349143|NCT00952289|26650574|FG000|All Participants|Data lost during site relocation|0|||
13349144|NCT00952289|26650575|FG001|All Participants|Data lost during site relocation|1|||
13349145|NCT00952289|26650574|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0|||
13349146|NCT00952289|26650575|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19|||
13349147|NCT00952289|26650574|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0|||
13349148|NCT00952289|26650575|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15|||
13349149|NCT00952289|26650574|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0|||
13349150|NCT00952289|26650575|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11|||
13349151|NCT00952289|26650574|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0|||
13349152|NCT00952289|26650575|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2|||
13349153|NCT00952289|26650574|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0|||
13349154|NCT00952289|26650575|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7|||
13349155|NCT00952276|26650638|FG000|Overall Study|Withdrawal by Subject|1|||
13349156|NCT00952276|26650639|FG001|Overall Study|Withdrawal by Subject|0|||
13349157|NCT00952276|26650640|FG002|Overall Study|Withdrawal by Subject|0|||
13349158|NCT00952276|26650641|FG003|Overall Study|Withdrawal by Subject|1|||
13349159|NCT00952276|26650642|FG004|Overall Study|Withdrawal by Subject|0|||
13349160|NCT00952068|26650652|FG000|Overall Study|Adverse Event|3|||
13349161|NCT00952068|26650652|FG000|Overall Study|Withdrawal by Subject|4|||
13349162|NCT00951912|26650712|FG000|Overall Study|Lack of Efficacy|1|||
13349163|NCT00951912|26650713|FG001|Overall Study|Lack of Efficacy|0|||
13349164|NCT00951912|26650714|FG002|Overall Study|Lack of Efficacy|0|||
13349165|NCT00951912|26650712|FG000|Overall Study|Adverse Event|0|||
13349166|NCT00951912|26650713|FG001|Overall Study|Adverse Event|1|||
13349167|NCT00951912|26650714|FG002|Overall Study|Adverse Event|1|||
13349168|NCT00951912|26650712|FG000|Overall Study|Lost to Follow-up|2|||
13349169|NCT00951912|26650713|FG001|Overall Study|Lost to Follow-up|2|||
13349170|NCT00951912|26650714|FG002|Overall Study|Lost to Follow-up|0|||
13349171|NCT00951912|26650712|FG000|Overall Study|Physician Decision|1|||
13349172|NCT00951912|26650713|FG001|Overall Study|Physician Decision|0|||
13349173|NCT00951912|26650714|FG002|Overall Study|Physician Decision|1|||
13349174|NCT00951912|26650712|FG000|Overall Study|Withdrawal by Subject|1|||
13349175|NCT00951912|26650713|FG001|Overall Study|Withdrawal by Subject|1|||
13349176|NCT00951912|26650714|FG002|Overall Study|Withdrawal by Subject|0|||
13349177|NCT00951912|26650712|FG000|Overall Study|Other:Depression|1|||
13289295|NCT02211417|26477997|FG000|Overall Study|Protocol Violation|1|||
13289296|NCT02211417|26477998|FG001|Overall Study|Protocol Violation|0|||
13289297|NCT02211417|26477997|FG000|Overall Study|Pregnancy|0|||
13289298|NCT02211417|26477998|FG001|Overall Study|Pregnancy|1|||
13289299|NCT02211417|26477997|FG000|Overall Study|Lost to Follow-up|2|||
13289300|NCT02211417|26477998|FG001|Overall Study|Lost to Follow-up|3|||
13289301|NCT02211417|26477997|FG000|Overall Study|Adverse Event|1|||
13289302|NCT02211417|26477998|FG001|Overall Study|Adverse Event|4|||
13289303|NCT02215096|26478089|FG000|Run-In Period (Up to Week 2)|Adverse Event|1|||
13289304|NCT02215096|26478090|FG001|Run-In Period (Up to Week 2)|Adverse Event|0|||
13289305|NCT02215096|26478091|FG002|Run-In Period (Up to Week 2)|Adverse Event|0|||
13289306|NCT02215096|26478092|FG003|Run-In Period (Up to Week 2)|Adverse Event|0|||
13289307|NCT02215096|26478093|FG004|Run-In Period (Up to Week 2)|Adverse Event|0|||
13289308|NCT02215096|26478089|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
13289309|NCT02215096|26478090|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
13289310|NCT02215096|26478091|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
13289311|NCT02215096|26478092|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
13289312|NCT02215096|26478093|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1|||
13289313|NCT02215096|26478089|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
13289314|NCT02215096|26478090|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
13289315|NCT02215096|26478091|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
13289316|NCT02215096|26478092|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1|||
13289317|NCT02215096|26478093|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
13289318|NCT02215096|26478089|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
13349178|NCT00951912|26650713|FG001|Overall Study|Other:Depression|0|||
13349179|NCT00951912|26650714|FG002|Overall Study|Other:Depression|0|||
13349180|NCT00951912|26650712|FG000|Overall Study|Other: Colon cancer|1|||
13349181|NCT00951912|26650713|FG001|Overall Study|Other: Colon cancer|0|||
13349182|NCT00951912|26650714|FG002|Overall Study|Other: Colon cancer|0|||
13349183|NCT00951912|26650712|FG000|Overall Study|Other: Stroke|0|||
13349184|NCT00951912|26650713|FG001|Overall Study|Other: Stroke|1|||
13349185|NCT00951912|26650714|FG002|Overall Study|Other: Stroke|0|||
13349186|NCT00951665|26650834|FG000|Phase 1b|Adverse Event|2|||
13349187|NCT00951665|26650835|FG001|Phase 1b|Adverse Event|1|||
13349188|NCT00951665|26650836|FG002|Phase 1b|Adverse Event|0|||
13349189|NCT00951665|26650837|FG003|Phase 1b|Adverse Event|1|||
13349190|NCT00951665|26650838|FG004|Phase 1b|Adverse Event|0|||
13349191|NCT00951665|26650839|FG005|Phase 1b|Adverse Event|0|||
13349192|NCT00951665|26650834|FG000|Phase 1b|Death|1|||
13349193|NCT00951665|26650835|FG001|Phase 1b|Death|0|||
13349194|NCT00951665|26650836|FG002|Phase 1b|Death|2|||
13349195|NCT00951665|26650837|FG003|Phase 1b|Death|0|||
13349196|NCT00951665|26650838|FG004|Phase 1b|Death|0|||
13349197|NCT00951665|26650839|FG005|Phase 1b|Death|0|||
13349198|NCT00951665|26650834|FG000|Phase 1b|Physician Decision|4|||
13349199|NCT00951665|26650835|FG001|Phase 1b|Physician Decision|0|||
13349200|NCT00951665|26650836|FG002|Phase 1b|Physician Decision|1|||
13349201|NCT00951665|26650837|FG003|Phase 1b|Physician Decision|0|||
13349202|NCT00951665|26650838|FG004|Phase 1b|Physician Decision|0|||
13349203|NCT00951665|26650839|FG005|Phase 1b|Physician Decision|0|||
13349204|NCT00951665|26650834|FG000|Phase 1b|Withdrawal by Subject|0|||
13349205|NCT00951665|26650835|FG001|Phase 1b|Withdrawal by Subject|1|||
13349206|NCT00951665|26650836|FG002|Phase 1b|Withdrawal by Subject|0|||
13349207|NCT00951665|26650837|FG003|Phase 1b|Withdrawal by Subject|0|||
13349208|NCT00951665|26650838|FG004|Phase 1b|Withdrawal by Subject|0|||
13349209|NCT00951665|26650839|FG005|Phase 1b|Withdrawal by Subject|0|||
13349210|NCT00951665|26650834|FG000|Phase 1b|Disease Progression|13|||
13349211|NCT00951665|26650835|FG001|Phase 1b|Disease Progression|2|||
13349212|NCT00951665|26650836|FG002|Phase 1b|Disease Progression|14|||
13349213|NCT00951665|26650837|FG003|Phase 1b|Disease Progression|0|||
13349214|NCT00951665|26650838|FG004|Phase 1b|Disease Progression|0|||
13349215|NCT00951665|26650839|FG005|Phase 1b|Disease Progression|0|||
13349216|NCT00951665|26650834|FG000|Phase 1b|Protocol Violation|2|||
13349217|NCT00951665|26650835|FG001|Phase 1b|Protocol Violation|0|||
13349218|NCT00951665|26650836|FG002|Phase 1b|Protocol Violation|0|||
13349219|NCT00951665|26650837|FG003|Phase 1b|Protocol Violation|0|||
13349220|NCT00951665|26650838|FG004|Phase 1b|Protocol Violation|0|||
13349221|NCT00951665|26650839|FG005|Phase 1b|Protocol Violation|0|||
13349222|NCT00951665|26650834|FG000|Phase 2a|Adverse Event|0|||
13349223|NCT00951665|26650835|FG001|Phase 2a|Adverse Event|0|||
13349224|NCT00951665|26650836|FG002|Phase 2a|Adverse Event|0|||
13349225|NCT00951665|26650837|FG003|Phase 2a|Adverse Event|0|||
13349226|NCT00951665|26650838|FG004|Phase 2a|Adverse Event|2|||
13349227|NCT00951665|26650839|FG005|Phase 2a|Adverse Event|0|||
13349228|NCT00951665|26650834|FG000|Phase 2a|Death|0|||
13349229|NCT00951665|26650835|FG001|Phase 2a|Death|0|||
13349230|NCT00951665|26650836|FG002|Phase 2a|Death|0|||
13349231|NCT00951665|26650837|FG003|Phase 2a|Death|0|||
13349232|NCT00951665|26650838|FG004|Phase 2a|Death|1|||
13349233|NCT00951665|26650839|FG005|Phase 2a|Death|1|||
13349234|NCT00951665|26650834|FG000|Phase 2a|Lost to Follow-up|0|||
13349235|NCT00951665|26650835|FG001|Phase 2a|Lost to Follow-up|0|||
13349236|NCT00951665|26650836|FG002|Phase 2a|Lost to Follow-up|0|||
13349237|NCT00951665|26650837|FG003|Phase 2a|Lost to Follow-up|0|||
13349238|NCT00951665|26650838|FG004|Phase 2a|Lost to Follow-up|1|||
13349239|NCT00951665|26650839|FG005|Phase 2a|Lost to Follow-up|0|||
13349240|NCT00951665|26650834|FG000|Phase 2a|Physician Decision|0|||
13349241|NCT00951665|26650835|FG001|Phase 2a|Physician Decision|0|||
13349242|NCT00951665|26650836|FG002|Phase 2a|Physician Decision|0|||
13349243|NCT00951665|26650837|FG003|Phase 2a|Physician Decision|0|||
13349244|NCT00951665|26650838|FG004|Phase 2a|Physician Decision|0|||
13349245|NCT00951665|26650839|FG005|Phase 2a|Physician Decision|1|||
13349246|NCT00951665|26650834|FG000|Phase 2a|Withdrawal by Subject|0|||
13349247|NCT00951665|26650835|FG001|Phase 2a|Withdrawal by Subject|0|||
13349248|NCT00951665|26650836|FG002|Phase 2a|Withdrawal by Subject|0|||
13349249|NCT00951665|26650837|FG003|Phase 2a|Withdrawal by Subject|0|||
13349250|NCT00951665|26650838|FG004|Phase 2a|Withdrawal by Subject|2|||
13349251|NCT00951665|26650839|FG005|Phase 2a|Withdrawal by Subject|0|||
13349252|NCT00951665|26650834|FG000|Phase 2a|Disease Progression|0|||
13349253|NCT00951665|26650835|FG001|Phase 2a|Disease Progression|0|||
13349254|NCT00951665|26650836|FG002|Phase 2a|Disease Progression|0|||
13349255|NCT00951665|26650837|FG003|Phase 2a|Disease Progression|0|||
13349256|NCT00951665|26650838|FG004|Phase 2a|Disease Progression|6|||
13349257|NCT00951665|26650839|FG005|Phase 2a|Disease Progression|5|||
13349258|NCT00951509|26650849|FG000|Overall Study|Withdrawal by Subject|2|||
13349259|NCT00951496|26650885|FG000|Overall Study|Did not initiate study treatment|10|||
13349260|NCT00951496|26650886|FG001|Overall Study|Did not initiate study treatment|8|||
13349261|NCT00951496|26650887|FG002|Overall Study|Did not initiate study treatment|13|||
13349262|NCT00951483|26650912|FG000|Overall Study|Physician Decision|4|||
13349263|NCT00951483|26650913|FG001|Overall Study|Physician Decision|0|||
13349264|NCT00951483|26650912|FG000|Overall Study|Withdrawal by Subject|15|||
13349265|NCT00951483|26650913|FG001|Overall Study|Withdrawal by Subject|0|||
13349266|NCT00951379|26650962|FG000|Overall Study|Adverse Event|4|||
13349267|NCT00951379|26650963|FG001|Overall Study|Adverse Event|1|||
13349268|NCT00951379|26650962|FG000|Overall Study|Withdrawal by Subject|1|||
13349269|NCT00951379|26650963|FG001|Overall Study|Withdrawal by Subject|0|||
13349270|NCT00951379|26650962|FG000|Overall Study|Noncompliance|1|||
13349271|NCT00951379|26650963|FG001|Overall Study|Noncompliance|0|||
13349272|NCT00951379|26650962|FG000|Overall Study|Disease Progression|0|||
13349273|NCT00951379|26650963|FG001|Overall Study|Disease Progression|1|||
13349274|NCT00951275|26650995|FG000|Overall Study|Administrative Reason|1|||
13349275|NCT00951275|26650995|FG000|Overall Study|Adverse Event|7|||
13349276|NCT00951275|26650995|FG000|Overall Study|Withdrawal by Subject|4|||
13349277|NCT00951275|26650995|FG000|Overall Study|Protocol Violation|1|||
13349278|NCT00951171|26651008|FG000|Overall Study|Adverse Event|2|||
13349279|NCT00951171|26651009|FG001|Overall Study|Adverse Event|0|||
13349280|NCT00951080|26651022|FG000|Overall Study|Adverse Event|3|||
13349281|NCT00951080|26651023|FG001|Overall Study|Adverse Event|3|||
13349282|NCT00951080|26651022|FG000|Overall Study|Lost to Follow-up|0|||
13349283|NCT00951080|26651023|FG001|Overall Study|Lost to Follow-up|1|||
13349284|NCT00951080|26651022|FG000|Overall Study|Physician Decision|4|||
13349285|NCT00951080|26651023|FG001|Overall Study|Physician Decision|1|||
13349286|NCT00951080|26651022|FG000|Overall Study|Other|19|||
13349287|NCT00951080|26651023|FG001|Overall Study|Other|22|||
13349288|NCT00951041|26651081|FG000|Overall Study|Withdrawal by Subject|1|||
13349289|NCT00951041|26651082|FG001|Overall Study|Withdrawal by Subject|1|||
13349290|NCT00951041|26651081|FG000|Overall Study|Lost to Follow-up|1|||
13349291|NCT00951041|26651082|FG001|Overall Study|Lost to Follow-up|0|||
13349292|NCT00951041|26651081|FG000|Overall Study|Other|3|||
13349293|NCT00951041|26651082|FG001|Overall Study|Other|0|||
13349294|NCT00951015|26651191|FG000|Randomization Phase 96 Week|Adverse Event|1|||
13349295|NCT00951015|26651192|FG001|Randomization Phase 96 Week|Adverse Event|1|||
13349296|NCT00951015|26651193|FG002|Randomization Phase 96 Week|Adverse Event|2|||
13349297|NCT00951015|26651194|FG003|Randomization Phase 96 Week|Adverse Event|5|||
13349298|NCT00951015|26651195|FG004|Randomization Phase 96 Week|Adverse Event|0|||
13349299|NCT00951015|26651191|FG000|Randomization Phase 96 Week|Lack of Efficacy|1|||
13349300|NCT00951015|26651192|FG001|Randomization Phase 96 Week|Lack of Efficacy|1|||
13349301|NCT00951015|26651193|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
13349302|NCT00951015|26651194|FG003|Randomization Phase 96 Week|Lack of Efficacy|0|||
13349303|NCT00951015|26651195|FG004|Randomization Phase 96 Week|Lack of Efficacy|0|||
13349304|NCT00951015|26651191|FG000|Randomization Phase 96 Week|Protocol Violation|1|||
13349305|NCT00951015|26651192|FG001|Randomization Phase 96 Week|Protocol Violation|1|||
13349306|NCT00951015|26651193|FG002|Randomization Phase 96 Week|Protocol Violation|1|||
13349307|NCT00951015|26651194|FG003|Randomization Phase 96 Week|Protocol Violation|0|||
13349308|NCT00951015|26651195|FG004|Randomization Phase 96 Week|Protocol Violation|0|||
13349309|NCT00951015|26651191|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
13349310|NCT00951015|26651192|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
13349311|NCT00951015|26651193|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
13349312|NCT00951015|26651194|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1|||
13349313|NCT00951015|26651195|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
13349314|NCT00951015|26651191|FG000|Randomization Phase 96 Week|Lost to Follow-up|0|||
13349315|NCT00951015|26651192|FG001|Randomization Phase 96 Week|Lost to Follow-up|3|||
13349316|NCT00951015|26651193|FG002|Randomization Phase 96 Week|Lost to Follow-up|1|||
13349317|NCT00951015|26651194|FG003|Randomization Phase 96 Week|Lost to Follow-up|2|||
13349318|NCT00951015|26651195|FG004|Randomization Phase 96 Week|Lost to Follow-up|0|||
13349319|NCT00951015|26651191|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
13349320|NCT00951015|26651192|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1|||
13349321|NCT00951015|26651193|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1|||
13349322|NCT00951015|26651194|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2|||
13349323|NCT00951015|26651195|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0|||
13349324|NCT00951015|26651191|FG000|Open-label Phase|Adverse Event|0|||
13349325|NCT00951015|26651192|FG001|Open-label Phase|Adverse Event|0|||
13349326|NCT00951015|26651193|FG002|Open-label Phase|Adverse Event|0|||
13349327|NCT00951015|26651194|FG003|Open-label Phase|Adverse Event|0|||
13349328|NCT00951015|26651195|FG004|Open-label Phase|Adverse Event|3|||
13349329|NCT00951015|26651191|FG000|Open-label Phase|Lack of Efficacy|0|||
13349330|NCT00951015|26651192|FG001|Open-label Phase|Lack of Efficacy|0|||
13349331|NCT00951015|26651193|FG002|Open-label Phase|Lack of Efficacy|0|||
13349332|NCT00951015|26651194|FG003|Open-label Phase|Lack of Efficacy|0|||
13349333|NCT00951015|26651195|FG004|Open-label Phase|Lack of Efficacy|1|||
13349334|NCT00951015|26651191|FG000|Open-label Phase|Protocol Violation|0|||
13349335|NCT00951015|26651192|FG001|Open-label Phase|Protocol Violation|0|||
13349336|NCT00951015|26651193|FG002|Open-label Phase|Protocol Violation|0|||
13349337|NCT00951015|26651194|FG003|Open-label Phase|Protocol Violation|0|||
13349338|NCT00951015|26651195|FG004|Open-label Phase|Protocol Violation|12|||
13349339|NCT00951015|26651191|FG000|Open-label Phase|Lost to Follow-up|0|||
13349340|NCT00951015|26651192|FG001|Open-label Phase|Lost to Follow-up|0|||
13349341|NCT00951015|26651193|FG002|Open-label Phase|Lost to Follow-up|0|||
13349342|NCT00951015|26651194|FG003|Open-label Phase|Lost to Follow-up|0|||
13349343|NCT00951015|26651195|FG004|Open-label Phase|Lost to Follow-up|12|||
13349344|NCT00951015|26651191|FG000|Open-label Phase|Withdrawal by Subject|0|||
13349345|NCT00951015|26651192|FG001|Open-label Phase|Withdrawal by Subject|0|||
13349346|NCT00951015|26651193|FG002|Open-label Phase|Withdrawal by Subject|0|||
13349347|NCT00951015|26651194|FG003|Open-label Phase|Withdrawal by Subject|0|||
13349348|NCT00951015|26651195|FG004|Open-label Phase|Withdrawal by Subject|14|||
13349349|NCT00951015|26651191|FG000|Open-label Phase|Physician Decision|0|||
13349350|NCT00951015|26651192|FG001|Open-label Phase|Physician Decision|0|||
13349351|NCT00951015|26651193|FG002|Open-label Phase|Physician Decision|0|||
13349352|NCT00951015|26651194|FG003|Open-label Phase|Physician Decision|0|||
13349353|NCT00951015|26651195|FG004|Open-label Phase|Physician Decision|8|||
13349354|NCT00950963|26651216|FG000|Overall Study|Lost to Follow-up|29|||
13349355|NCT00950963|26651217|FG001|Overall Study|Lost to Follow-up|24|||
13349356|NCT00950950|26651285|FG000|Overall Study|Adverse Event|1|||
13349357|NCT00950950|26651286|FG001|Overall Study|Adverse Event|0|||
13349358|NCT00950950|26651285|FG000|Overall Study|Withdrawal by Subject|0|||
13349359|NCT00950950|26651286|FG001|Overall Study|Withdrawal by Subject|1|||
13349360|NCT00950911|26651299|FG000|Overall Study|Adverse Event|0|||
13349361|NCT00950911|26651300|FG001|Overall Study|Adverse Event|2|||
13349362|NCT00950911|26651299|FG000|Overall Study|Death|4|||
13349363|NCT00950911|26651300|FG001|Overall Study|Death|6|||
13349364|NCT00950911|26651299|FG000|Overall Study|Disease progression|2|||
13349365|NCT00950911|26651300|FG001|Overall Study|Disease progression|2|||
13349366|NCT00950911|26651299|FG000|Overall Study|Consent withdrawn|1|||
13349367|NCT00950911|26651300|FG001|Overall Study|Consent withdrawn|3|||
13349368|NCT00950911|26651299|FG000|Overall Study|Administrative decision|3|||
13349369|NCT00950911|26651300|FG001|Overall Study|Administrative decision|1|||
13349370|NCT00950911|26651299|FG000|Overall Study|Ineligibility determined|1|||
13349371|NCT00950911|26651300|FG001|Overall Study|Ineligibility determined|0|||
13349372|NCT00950911|26651299|FG000|Overall Study|Noncompliance|1|||
13349373|NCT00950911|26651300|FG001|Overall Study|Noncompliance|0|||
13349374|NCT00950911|26651299|FG000|Overall Study|Poor performance status|0|||
13349375|NCT00950911|26651300|FG001|Overall Study|Poor performance status|1|||
13349376|NCT00950872|26651309|FG000|Overall Study|Withdrawal by Subject|1|||
13349377|NCT00950872|26651309|FG000|Overall Study|Did not have surgery|2|||
13349378|NCT00950859|26651356|FG000|Overall Study|Adverse Event|3|||
13349379|NCT00950859|26651357|FG001|Overall Study|Adverse Event|3|||
13349380|NCT00950859|26651356|FG000|Overall Study|Insufficient Viral Load Response|12|||
13349381|NCT00950859|26651357|FG001|Overall Study|Insufficient Viral Load Response|3|||
13349382|NCT00950859|26651356|FG000|Overall Study|Protocol Violation|1|||
13349383|NCT00950859|26651357|FG001|Overall Study|Protocol Violation|1|||
13349384|NCT00950859|26651356|FG000|Overall Study|Lost to Follow-up|0|||
13349385|NCT00950859|26651357|FG001|Overall Study|Lost to Follow-up|3|||
13349386|NCT00950807|26651410|FG000|Treatment Period 1|Lack of Efficacy|1|||
13349387|NCT00950807|26651411|FG001|Treatment Period 1|Lack of Efficacy|0|||
13349388|NCT00950807|26651412|FG002|Treatment Period 1|Lack of Efficacy|0|||
13349389|NCT00950807|26651413|FG003|Treatment Period 1|Lack of Efficacy|0|||
13349390|NCT00950807|26651414|FG004|Treatment Period 1|Lack of Efficacy|0|||
13349391|NCT00950807|26651415|FG005|Treatment Period 1|Lack of Efficacy|1|||
13349392|NCT00950807|26651416|FG006|Treatment Period 1|Lack of Efficacy|0|||
13349393|NCT00950807|26651417|FG007|Treatment Period 1|Lack of Efficacy|0|||
13349394|NCT00950807|26651418|FG008|Treatment Period 1|Lack of Efficacy|0|||
13349395|NCT00950807|26651419|FG009|Treatment Period 1|Lack of Efficacy|0|||
13349396|NCT00950807|26651410|FG000|Treatment Period 1|Protocol Violation|1|||
13349397|NCT00950807|26651411|FG001|Treatment Period 1|Protocol Violation|0|||
13349398|NCT00950807|26651412|FG002|Treatment Period 1|Protocol Violation|0|||
13349399|NCT00950807|26651413|FG003|Treatment Period 1|Protocol Violation|0|||
13349400|NCT00950807|26651414|FG004|Treatment Period 1|Protocol Violation|0|||
13349401|NCT00950807|26651415|FG005|Treatment Period 1|Protocol Violation|0|||
13349402|NCT00950807|26651416|FG006|Treatment Period 1|Protocol Violation|0|||
13349403|NCT00950807|26651417|FG007|Treatment Period 1|Protocol Violation|0|||
13349404|NCT00950807|26651418|FG008|Treatment Period 1|Protocol Violation|0|||
13349405|NCT00950807|26651419|FG009|Treatment Period 1|Protocol Violation|0|||
13349406|NCT00950807|26651410|FG000|Treatment Period 1|Lost to Follow-up|0|||
13349407|NCT00950807|26651411|FG001|Treatment Period 1|Lost to Follow-up|0|||
13349408|NCT00950807|26651412|FG002|Treatment Period 1|Lost to Follow-up|1|||
13349409|NCT00950807|26651413|FG003|Treatment Period 1|Lost to Follow-up|0|||
13349410|NCT00950807|26651414|FG004|Treatment Period 1|Lost to Follow-up|0|||
13349411|NCT00950807|26651415|FG005|Treatment Period 1|Lost to Follow-up|0|||
13349412|NCT00950807|26651416|FG006|Treatment Period 1|Lost to Follow-up|0|||
13349413|NCT00950807|26651417|FG007|Treatment Period 1|Lost to Follow-up|0|||
13349414|NCT00950807|26651418|FG008|Treatment Period 1|Lost to Follow-up|0|||
13349415|NCT00950807|26651419|FG009|Treatment Period 1|Lost to Follow-up|0|||
13349416|NCT00950807|26651410|FG000|Treatment Period 1|Withdrawal by Subject|1|||
13349417|NCT00950807|26651411|FG001|Treatment Period 1|Withdrawal by Subject|0|||
13349418|NCT00950807|26651412|FG002|Treatment Period 1|Withdrawal by Subject|0|||
13349419|NCT00950807|26651413|FG003|Treatment Period 1|Withdrawal by Subject|0|||
13349420|NCT00950807|26651414|FG004|Treatment Period 1|Withdrawal by Subject|1|||
13349421|NCT00950807|26651415|FG005|Treatment Period 1|Withdrawal by Subject|0|||
13349422|NCT00950807|26651416|FG006|Treatment Period 1|Withdrawal by Subject|0|||
13349423|NCT00950807|26651417|FG007|Treatment Period 1|Withdrawal by Subject|0|||
13349424|NCT00950807|26651418|FG008|Treatment Period 1|Withdrawal by Subject|1|||
13349425|NCT00950807|26651419|FG009|Treatment Period 1|Withdrawal by Subject|0|||
13349426|NCT00950807|26651410|FG000|Treatment Period 1|Adverse Event|0|||
13349427|NCT00950807|26651411|FG001|Treatment Period 1|Adverse Event|0|||
13349428|NCT00950807|26651412|FG002|Treatment Period 1|Adverse Event|0|||
13349429|NCT00950807|26651413|FG003|Treatment Period 1|Adverse Event|0|||
13349430|NCT00950807|26651414|FG004|Treatment Period 1|Adverse Event|0|||
13349431|NCT00950807|26651415|FG005|Treatment Period 1|Adverse Event|1|||
13349432|NCT00950807|26651416|FG006|Treatment Period 1|Adverse Event|0|||
13349433|NCT00950807|26651417|FG007|Treatment Period 1|Adverse Event|0|||
13349434|NCT00950807|26651418|FG008|Treatment Period 1|Adverse Event|0|||
13349435|NCT00950807|26651419|FG009|Treatment Period 1|Adverse Event|0|||
13349436|NCT00950807|26651410|FG000|Washout Period 1|Lack of Efficacy|0|||
13349437|NCT00950807|26651411|FG001|Washout Period 1|Lack of Efficacy|0|||
13349438|NCT00950807|26651412|FG002|Washout Period 1|Lack of Efficacy|0|||
13349439|NCT00950807|26651413|FG003|Washout Period 1|Lack of Efficacy|0|||
13349440|NCT00950807|26651414|FG004|Washout Period 1|Lack of Efficacy|0|||
13349441|NCT00950807|26651415|FG005|Washout Period 1|Lack of Efficacy|0|||
13349442|NCT00950807|26651416|FG006|Washout Period 1|Lack of Efficacy|1|||
13349443|NCT00950807|26651417|FG007|Washout Period 1|Lack of Efficacy|0|||
13349444|NCT00950807|26651418|FG008|Washout Period 1|Lack of Efficacy|0|||
13349445|NCT00950807|26651419|FG009|Washout Period 1|Lack of Efficacy|0|||
13349446|NCT00950807|26651410|FG000|Washout Period 1|Withdrawal by Subject|0|||
13349447|NCT00950807|26651411|FG001|Washout Period 1|Withdrawal by Subject|0|||
13349448|NCT00950807|26651412|FG002|Washout Period 1|Withdrawal by Subject|0|||
13349449|NCT00950807|26651413|FG003|Washout Period 1|Withdrawal by Subject|0|||
13349450|NCT00950807|26651414|FG004|Washout Period 1|Withdrawal by Subject|0|||
13349451|NCT00950807|26651415|FG005|Washout Period 1|Withdrawal by Subject|0|||
13349452|NCT00950807|26651416|FG006|Washout Period 1|Withdrawal by Subject|0|||
13349453|NCT00950807|26651417|FG007|Washout Period 1|Withdrawal by Subject|0|||
13349454|NCT00950807|26651418|FG008|Washout Period 1|Withdrawal by Subject|1|||
13349455|NCT00950807|26651419|FG009|Washout Period 1|Withdrawal by Subject|0|||
13349456|NCT00950807|26651410|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3|||
13349457|NCT00950807|26651411|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0|||
13349458|NCT00950807|26651412|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0|||
13349459|NCT00950807|26651413|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0|||
13349460|NCT00950807|26651414|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0|||
13349461|NCT00950807|26651415|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0|||
13349462|NCT00950807|26651416|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1|||
13349463|NCT00950807|26651417|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1|||
13349464|NCT00950807|26651418|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0|||
13349465|NCT00950807|26651419|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0|||
13349466|NCT00950807|26651410|FG000|Washout Period 1|Adverse Event|2|||
13349467|NCT00950807|26651411|FG001|Washout Period 1|Adverse Event|0|||
13349468|NCT00950807|26651412|FG002|Washout Period 1|Adverse Event|0|||
13349469|NCT00950807|26651413|FG003|Washout Period 1|Adverse Event|1|||
13349470|NCT00950807|26651414|FG004|Washout Period 1|Adverse Event|1|||
13349471|NCT00950807|26651415|FG005|Washout Period 1|Adverse Event|0|||
13349472|NCT00950807|26651416|FG006|Washout Period 1|Adverse Event|0|||
13349473|NCT00950807|26651417|FG007|Washout Period 1|Adverse Event|0|||
13349474|NCT00950807|26651418|FG008|Washout Period 1|Adverse Event|0|||
13349475|NCT00950807|26651419|FG009|Washout Period 1|Adverse Event|0|||
13349476|NCT00950807|26651410|FG000|Treatment Period 2|Lack of Efficacy|1|||
13349477|NCT00950807|26651411|FG001|Treatment Period 2|Lack of Efficacy|0|||
13349478|NCT00950807|26651412|FG002|Treatment Period 2|Lack of Efficacy|0|||
13349479|NCT00950807|26651413|FG003|Treatment Period 2|Lack of Efficacy|0|||
13349480|NCT00950807|26651414|FG004|Treatment Period 2|Lack of Efficacy|0|||
13349481|NCT00950807|26651415|FG005|Treatment Period 2|Lack of Efficacy|0|||
13349482|NCT00950807|26651416|FG006|Treatment Period 2|Lack of Efficacy|0|||
13349483|NCT00950807|26651417|FG007|Treatment Period 2|Lack of Efficacy|0|||
13349484|NCT00950807|26651418|FG008|Treatment Period 2|Lack of Efficacy|0|||
13349485|NCT00950807|26651419|FG009|Treatment Period 2|Lack of Efficacy|0|||
13349486|NCT00950807|26651410|FG000|Treatment Period 2|Withdrawal by Subject|0|||
13349487|NCT00950807|26651411|FG001|Treatment Period 2|Withdrawal by Subject|0|||
13349488|NCT00950807|26651412|FG002|Treatment Period 2|Withdrawal by Subject|0|||
13349489|NCT00950807|26651413|FG003|Treatment Period 2|Withdrawal by Subject|0|||
13349490|NCT00950807|26651414|FG004|Treatment Period 2|Withdrawal by Subject|0|||
13349491|NCT00950807|26651415|FG005|Treatment Period 2|Withdrawal by Subject|0|||
13349492|NCT00950807|26651416|FG006|Treatment Period 2|Withdrawal by Subject|1|||
13349493|NCT00950807|26651417|FG007|Treatment Period 2|Withdrawal by Subject|2|||
13349494|NCT00950807|26651418|FG008|Treatment Period 2|Withdrawal by Subject|0|||
13349495|NCT00950807|26651419|FG009|Treatment Period 2|Withdrawal by Subject|0|||
13349496|NCT00950807|26651410|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
13349497|NCT00950807|26651411|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
13349498|NCT00950807|26651412|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
13349499|NCT00950807|26651413|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
13349500|NCT00950807|26651414|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
13349501|NCT00950807|26651415|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
13349502|NCT00950807|26651416|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
13349503|NCT00950807|26651417|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
13349504|NCT00950807|26651418|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
13349505|NCT00950807|26651419|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
13349506|NCT00950807|26651410|FG000|Treatment Period 2|Adverse Event|0|||
13349507|NCT00950807|26651411|FG001|Treatment Period 2|Adverse Event|1|||
13349508|NCT00950807|26651412|FG002|Treatment Period 2|Adverse Event|0|||
13349509|NCT00950807|26651413|FG003|Treatment Period 2|Adverse Event|1|||
13349510|NCT00950807|26651414|FG004|Treatment Period 2|Adverse Event|0|||
13349511|NCT00950807|26651415|FG005|Treatment Period 2|Adverse Event|1|||
13349512|NCT00950807|26651416|FG006|Treatment Period 2|Adverse Event|0|||
13349513|NCT00950807|26651417|FG007|Treatment Period 2|Adverse Event|1|||
13349514|NCT00950807|26651418|FG008|Treatment Period 2|Adverse Event|0|||
13349515|NCT00950807|26651419|FG009|Treatment Period 2|Adverse Event|0|||
13349516|NCT00950807|26651410|FG000|Washout Period 2|Lack of Efficacy|1|||
13349517|NCT00950807|26651411|FG001|Washout Period 2|Lack of Efficacy|0|||
13349518|NCT00950807|26651412|FG002|Washout Period 2|Lack of Efficacy|0|||
13349519|NCT00950807|26651413|FG003|Washout Period 2|Lack of Efficacy|0|||
13349520|NCT00950807|26651414|FG004|Washout Period 2|Lack of Efficacy|0|||
13349521|NCT00950807|26651415|FG005|Washout Period 2|Lack of Efficacy|0|||
13349522|NCT00950807|26651416|FG006|Washout Period 2|Lack of Efficacy|0|||
13349523|NCT00950807|26651417|FG007|Washout Period 2|Lack of Efficacy|0|||
13349524|NCT00950807|26651418|FG008|Washout Period 2|Lack of Efficacy|0|||
13349525|NCT00950807|26651419|FG009|Washout Period 2|Lack of Efficacy|0|||
13349526|NCT00950807|26651410|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0|||
13349527|NCT00950807|26651411|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1|||
13349528|NCT00950807|26651412|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0|||
13349529|NCT00950807|26651413|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0|||
13349530|NCT00950807|26651414|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1|||
13349531|NCT00950807|26651415|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0|||
13349532|NCT00950807|26651416|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1|||
13349533|NCT00950807|26651417|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1|||
13349534|NCT00950807|26651418|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0|||
13349535|NCT00950807|26651419|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0|||
13349536|NCT00950807|26651410|FG000|Washout Period 2|Adverse Event|3|||
13349537|NCT00950807|26651411|FG001|Washout Period 2|Adverse Event|0|||
13349538|NCT00950807|26651412|FG002|Washout Period 2|Adverse Event|0|||
13349539|NCT00950807|26651413|FG003|Washout Period 2|Adverse Event|1|||
13349540|NCT00950807|26651414|FG004|Washout Period 2|Adverse Event|0|||
13349541|NCT00950807|26651415|FG005|Washout Period 2|Adverse Event|0|||
13349542|NCT00950807|26651416|FG006|Washout Period 2|Adverse Event|0|||
13349543|NCT00950807|26651417|FG007|Washout Period 2|Adverse Event|0|||
13349544|NCT00950807|26651418|FG008|Washout Period 2|Adverse Event|0|||
13349545|NCT00950807|26651419|FG009|Washout Period 2|Adverse Event|0|||
13349546|NCT00950807|26651410|FG000|Treatment Period 3|Withdrawal by Subject|0|||
13349547|NCT00950807|26651411|FG001|Treatment Period 3|Withdrawal by Subject|0|||
13349548|NCT00950807|26651412|FG002|Treatment Period 3|Withdrawal by Subject|0|||
13349549|NCT00950807|26651413|FG003|Treatment Period 3|Withdrawal by Subject|0|||
13349550|NCT00950807|26651414|FG004|Treatment Period 3|Withdrawal by Subject|0|||
13349551|NCT00950807|26651415|FG005|Treatment Period 3|Withdrawal by Subject|0|||
13349552|NCT00950807|26651416|FG006|Treatment Period 3|Withdrawal by Subject|0|||
13349553|NCT00950807|26651417|FG007|Treatment Period 3|Withdrawal by Subject|0|||
13349554|NCT00950807|26651418|FG008|Treatment Period 3|Withdrawal by Subject|0|||
13349555|NCT00950807|26651419|FG009|Treatment Period 3|Withdrawal by Subject|1|||
13349556|NCT00950807|26651410|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
13349557|NCT00950807|26651411|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
13349558|NCT00950807|26651412|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
13349559|NCT00950807|26651413|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
13349560|NCT00950807|26651414|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
13349561|NCT00950807|26651415|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
13349562|NCT00950807|26651416|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
13349563|NCT00950807|26651417|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
13289319|NCT02215096|26478090|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2|||
13289320|NCT02215096|26478091|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
13289321|NCT02215096|26478092|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
13289322|NCT02215096|26478093|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
13289323|NCT02211131|26478141|FG000|Overall Study|Death|20|||
13289324|NCT02211131|26478142|FG001|Overall Study|Death|11|||
13289325|NCT02211131|26478141|FG000|Overall Study|Lost to Follow-up|1|||
13289326|NCT02211131|26478142|FG001|Overall Study|Lost to Follow-up|0|||
13289327|NCT02211131|26478141|FG000|Overall Study|Decision by Sponsor|1|||
13289328|NCT02211131|26478142|FG001|Overall Study|Decision by Sponsor|1|||
13289329|NCT02211131|26478141|FG000|Overall Study|Withdrawal by Subject|3|||
13289330|NCT02211131|26478142|FG001|Overall Study|Withdrawal by Subject|4|||
13289331|NCT02211131|26478141|FG000|Overall Study|Continuing on Study|49|||
13289332|NCT02211131|26478142|FG001|Overall Study|Continuing on Study|60|||
13289333|NCT02214160|26478206|FG000|Overall Study|Withdrawal by Subject|1|||
13289334|NCT02214160|26478207|FG001|Overall Study|Withdrawal by Subject|0|||
13289335|NCT02214160|26478208|FG002|Overall Study|Withdrawal by Subject|6|||
13289336|NCT02214160|26478206|FG000|Overall Study|Death|2|||
13289337|NCT02214160|26478207|FG001|Overall Study|Death|2|||
13289338|NCT02214160|26478208|FG002|Overall Study|Death|1|||
13349564|NCT00950807|26651418|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
13349565|NCT00950807|26651419|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
13349566|NCT00950807|26651410|FG000|Treatment Period 3|Adverse Event|0|||
13349567|NCT00950807|26651411|FG001|Treatment Period 3|Adverse Event|0|||
13349568|NCT00950807|26651412|FG002|Treatment Period 3|Adverse Event|0|||
13349569|NCT00950807|26651413|FG003|Treatment Period 3|Adverse Event|0|||
13349570|NCT00950807|26651414|FG004|Treatment Period 3|Adverse Event|0|||
13349571|NCT00950807|26651415|FG005|Treatment Period 3|Adverse Event|0|||
13349572|NCT00950807|26651416|FG006|Treatment Period 3|Adverse Event|1|||
13349573|NCT00950807|26651417|FG007|Treatment Period 3|Adverse Event|0|||
13349574|NCT00950807|26651418|FG008|Treatment Period 3|Adverse Event|0|||
13349575|NCT00950807|26651419|FG009|Treatment Period 3|Adverse Event|0|||
13349576|NCT00950755|26651445|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
13349577|NCT00950755|26651445|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1|||
13349578|NCT00950755|26651445|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27|||
13349579|NCT00950755|26651445|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
13349580|NCT00950755|26651445|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1|||
13349581|NCT00950755|26651445|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1|||
13349582|NCT00950755|26651445|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6|||
13349583|NCT00950755|26651445|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1|||
13349584|NCT00950755|26651445|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
13349585|NCT00950755|26651445|FG000|Long-Term Follow-Up|Death|8|||
13349586|NCT00950742|26651468|FG000|Overall Study|Other Adverse Event|1|||
13349587|NCT00950742|26651469|FG001|Overall Study|Other Adverse Event|0|||
13349588|NCT00950742|26651468|FG000|Overall Study|Withdrawal by Subject|3|||
13349589|NCT00950742|26651469|FG001|Overall Study|Withdrawal by Subject|0|||
13349590|NCT00950742|26651468|FG000|Overall Study|Progressive Disease|6|||
13349591|NCT00950742|26651469|FG001|Overall Study|Progressive Disease|2|||
13349592|NCT00950742|26651468|FG000|Overall Study|Dose limiting toxicity|6|||
13349593|NCT00950742|26651469|FG001|Overall Study|Dose limiting toxicity|0|||
13349594|NCT00950690|26651476|FG000|Overall Study|Death|4|||
13349595|NCT00950690|26651476|FG000|Overall Study|Adverse Event|15|||
13349596|NCT00950690|26651476|FG000|Overall Study|Lack of Efficacy|22|||
13349597|NCT00950690|26651476|FG000|Overall Study|Lost to Follow-up|40|||
13349598|NCT00950690|26651476|FG000|Overall Study|Other|163|||
13349599|NCT00950664|26651501|FG000|First Intervention|Lost to Follow-up|1|||
13349600|NCT00950664|26651502|FG001|First Intervention|Lost to Follow-up|3|||
13349601|NCT00950664|26651501|FG000|First Intervention|Withdrawal by Subject|2|||
13349602|NCT00950664|26651502|FG001|First Intervention|Withdrawal by Subject|2|||
13349603|NCT00950651|26651555|FG000|Overall Study|Adverse Event|17|||
13349604|NCT00950651|26651556|FG001|Overall Study|Adverse Event|20|||
13349605|NCT00950651|26651555|FG000|Overall Study|Death|1|||
13349606|NCT00950651|26651556|FG001|Overall Study|Death|0|||
13349607|NCT00950651|26651555|FG000|Overall Study|Lack of Efficacy|2|||
13349608|NCT00950651|26651556|FG001|Overall Study|Lack of Efficacy|2|||
13349609|NCT00950651|26651555|FG000|Overall Study|Protocol Violation|3|||
13349610|NCT00950651|26651556|FG001|Overall Study|Protocol Violation|4|||
13349611|NCT00950651|26651555|FG000|Overall Study|Withdrawal by Subject|8|||
13349612|NCT00950651|26651556|FG001|Overall Study|Withdrawal by Subject|9|||
13349613|NCT00950599|26652145|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
13349614|NCT00950599|26652146|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
13289339|NCT02214160|26478206|FG000|Overall Study|Subject Non-Compliance|0|||
13349615|NCT00950599|26652147|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
13349616|NCT00950599|26652148|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1|||
13349617|NCT00950599|26652149|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
13349618|NCT00950599|26652150|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
13349619|NCT00950599|26652151|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
13349620|NCT00950599|26652152|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
13349621|NCT00950599|26652153|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
13349622|NCT00950599|26652154|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
13349623|NCT00950599|26652145|FG000|Double-Blind Treatment Period|Adverse Event|0|||
13349624|NCT00950599|26652146|FG001|Double-Blind Treatment Period|Adverse Event|1|||
13349625|NCT00950599|26652147|FG002|Double-Blind Treatment Period|Adverse Event|1|||
13349626|NCT00950599|26652148|FG003|Double-Blind Treatment Period|Adverse Event|1|||
13349627|NCT00950599|26652149|FG004|Double-Blind Treatment Period|Adverse Event|1|||
13349628|NCT00950599|26652150|FG005|Double-Blind Treatment Period|Adverse Event|1|||
13349629|NCT00950599|26652151|FG006|Double-Blind Treatment Period|Adverse Event|0|||
13349630|NCT00950599|26652152|FG007|Double-Blind Treatment Period|Adverse Event|0|||
13349631|NCT00950599|26652153|FG008|Double-Blind Treatment Period|Adverse Event|0|||
13349632|NCT00950599|26652154|FG009|Double-Blind Treatment Period|Adverse Event|0|||
13349633|NCT00950599|26652145|FG000|Double-Blind Treatment Period|Lack of Efficacy|2|||
13349634|NCT00950599|26652146|FG001|Double-Blind Treatment Period|Lack of Efficacy|5|||
13349635|NCT00950599|26652147|FG002|Double-Blind Treatment Period|Lack of Efficacy|5|||
13349636|NCT00950599|26652148|FG003|Double-Blind Treatment Period|Lack of Efficacy|7|||
13349637|NCT00950599|26652149|FG004|Double-Blind Treatment Period|Lack of Efficacy|3|||
13349638|NCT00950599|26652150|FG005|Double-Blind Treatment Period|Lack of Efficacy|6|||
13349639|NCT00950599|26652151|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
13349640|NCT00950599|26652152|FG007|Double-Blind Treatment Period|Lack of Efficacy|1|||
13349641|NCT00950599|26652153|FG008|Double-Blind Treatment Period|Lack of Efficacy|0|||
13349642|NCT00950599|26652154|FG009|Double-Blind Treatment Period|Lack of Efficacy|0|||
13349643|NCT00950599|26652145|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
13349644|NCT00950599|26652146|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
13349645|NCT00950599|26652147|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
13349646|NCT00950599|26652148|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
13349647|NCT00950599|26652149|FG004|Double-Blind Treatment Period|Lost to Follow-up|1|||
13349648|NCT00950599|26652150|FG005|Double-Blind Treatment Period|Lost to Follow-up|2|||
13349649|NCT00950599|26652151|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
13349650|NCT00950599|26652152|FG007|Double-Blind Treatment Period|Lost to Follow-up|1|||
13349651|NCT00950599|26652153|FG008|Double-Blind Treatment Period|Lost to Follow-up|0|||
13349652|NCT00950599|26652154|FG009|Double-Blind Treatment Period|Lost to Follow-up|0|||
13349653|NCT00950599|26652145|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1|||
13349654|NCT00950599|26652146|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1|||
13349655|NCT00950599|26652147|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0|||
13349656|NCT00950599|26652148|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0|||
13349657|NCT00950599|26652149|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0|||
13349658|NCT00950599|26652150|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0|||
13349659|NCT00950599|26652151|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0|||
13349660|NCT00950599|26652152|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1|||
13349661|NCT00950599|26652153|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0|||
13349662|NCT00950599|26652154|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0|||
13349663|NCT00950599|26652145|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
13349664|NCT00950599|26652146|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
13349665|NCT00950599|26652147|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
13349666|NCT00950599|26652148|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
13349667|NCT00950599|26652149|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
13349668|NCT00950599|26652150|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
13349669|NCT00950599|26652151|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
13349670|NCT00950599|26652152|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
13349671|NCT00950599|26652153|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
13349672|NCT00950599|26652154|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
13349673|NCT00950599|26652145|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4|||
13349674|NCT00950599|26652146|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3|||
13349675|NCT00950599|26652147|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3|||
13349676|NCT00950599|26652148|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1|||
13349677|NCT00950599|26652149|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1|||
13349678|NCT00950599|26652150|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2|||
13349679|NCT00950599|26652151|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0|||
13349680|NCT00950599|26652152|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3|||
13349681|NCT00950599|26652153|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0|||
13349682|NCT00950599|26652154|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0|||
13349683|NCT00950599|26652145|FG000|Follow-Up Period|Adverse Event|0|||
13349684|NCT00950599|26652146|FG001|Follow-Up Period|Adverse Event|0|||
13349685|NCT00950599|26652147|FG002|Follow-Up Period|Adverse Event|0|||
13349686|NCT00950599|26652148|FG003|Follow-Up Period|Adverse Event|0|||
13349687|NCT00950599|26652149|FG004|Follow-Up Period|Adverse Event|0|||
13349688|NCT00950599|26652150|FG005|Follow-Up Period|Adverse Event|0|||
13349689|NCT00950599|26652151|FG006|Follow-Up Period|Adverse Event|0|||
13349690|NCT00950599|26652152|FG007|Follow-Up Period|Adverse Event|0|||
13349691|NCT00950599|26652153|FG008|Follow-Up Period|Adverse Event|1|||
13349692|NCT00950599|26652154|FG009|Follow-Up Period|Adverse Event|0|||
13349693|NCT00950599|26652145|FG000|Follow-Up Period|Lack of Efficacy|0|||
13349694|NCT00950599|26652146|FG001|Follow-Up Period|Lack of Efficacy|0|||
13349695|NCT00950599|26652147|FG002|Follow-Up Period|Lack of Efficacy|0|||
13349696|NCT00950599|26652148|FG003|Follow-Up Period|Lack of Efficacy|0|||
13349697|NCT00950599|26652149|FG004|Follow-Up Period|Lack of Efficacy|0|||
13349698|NCT00950599|26652150|FG005|Follow-Up Period|Lack of Efficacy|0|||
13349699|NCT00950599|26652151|FG006|Follow-Up Period|Lack of Efficacy|0|||
13349700|NCT00950599|26652152|FG007|Follow-Up Period|Lack of Efficacy|0|||
13349701|NCT00950599|26652153|FG008|Follow-Up Period|Lack of Efficacy|3|||
13349702|NCT00950599|26652154|FG009|Follow-Up Period|Lack of Efficacy|0|||
13349703|NCT00950599|26652145|FG000|Follow-Up Period|Lost to Follow-up|0|||
13349704|NCT00950599|26652146|FG001|Follow-Up Period|Lost to Follow-up|0|||
13349705|NCT00950599|26652147|FG002|Follow-Up Period|Lost to Follow-up|0|||
13349706|NCT00950599|26652148|FG003|Follow-Up Period|Lost to Follow-up|0|||
13349707|NCT00950599|26652149|FG004|Follow-Up Period|Lost to Follow-up|0|||
13349708|NCT00950599|26652150|FG005|Follow-Up Period|Lost to Follow-up|0|||
13349709|NCT00950599|26652151|FG006|Follow-Up Period|Lost to Follow-up|0|||
13349710|NCT00950599|26652152|FG007|Follow-Up Period|Lost to Follow-up|0|||
13349711|NCT00950599|26652153|FG008|Follow-Up Period|Lost to Follow-up|5|||
13349712|NCT00950599|26652154|FG009|Follow-Up Period|Lost to Follow-up|1|||
13349713|NCT00950599|26652145|FG000|Follow-Up Period|Physician Decision|0|||
13349714|NCT00950599|26652146|FG001|Follow-Up Period|Physician Decision|0|||
13349715|NCT00950599|26652147|FG002|Follow-Up Period|Physician Decision|0|||
13349716|NCT00950599|26652148|FG003|Follow-Up Period|Physician Decision|0|||
13349717|NCT00950599|26652149|FG004|Follow-Up Period|Physician Decision|0|||
13349718|NCT00950599|26652150|FG005|Follow-Up Period|Physician Decision|0|||
13349719|NCT00950599|26652151|FG006|Follow-Up Period|Physician Decision|0|||
13349720|NCT00950599|26652152|FG007|Follow-Up Period|Physician Decision|0|||
13349721|NCT00950599|26652153|FG008|Follow-Up Period|Physician Decision|1|||
13349722|NCT00950599|26652154|FG009|Follow-Up Period|Physician Decision|0|||
13349723|NCT00950599|26652145|FG000|Follow-Up Period|Poor/Noncompliance|0|||
13349724|NCT00950599|26652146|FG001|Follow-Up Period|Poor/Noncompliance|0|||
13349725|NCT00950599|26652147|FG002|Follow-Up Period|Poor/Noncompliance|0|||
13349726|NCT00950599|26652148|FG003|Follow-Up Period|Poor/Noncompliance|0|||
13349727|NCT00950599|26652149|FG004|Follow-Up Period|Poor/Noncompliance|0|||
13349728|NCT00950599|26652150|FG005|Follow-Up Period|Poor/Noncompliance|0|||
13349729|NCT00950599|26652151|FG006|Follow-Up Period|Poor/Noncompliance|0|||
13349730|NCT00950599|26652152|FG007|Follow-Up Period|Poor/Noncompliance|0|||
13349731|NCT00950599|26652153|FG008|Follow-Up Period|Poor/Noncompliance|1|||
13349732|NCT00950599|26652154|FG009|Follow-Up Period|Poor/Noncompliance|0|||
13349733|NCT00950599|26652145|FG000|Follow-Up Period|Subject withdrew Consent|0|||
13349734|NCT00950599|26652146|FG001|Follow-Up Period|Subject withdrew Consent|0|||
13349735|NCT00950599|26652147|FG002|Follow-Up Period|Subject withdrew Consent|0|||
13349736|NCT00950599|26652148|FG003|Follow-Up Period|Subject withdrew Consent|0|||
13349737|NCT00950599|26652149|FG004|Follow-Up Period|Subject withdrew Consent|0|||
13349738|NCT00950599|26652150|FG005|Follow-Up Period|Subject withdrew Consent|0|||
13349739|NCT00950599|26652151|FG006|Follow-Up Period|Subject withdrew Consent|0|||
13349740|NCT00950599|26652152|FG007|Follow-Up Period|Subject withdrew Consent|0|||
13349741|NCT00950599|26652153|FG008|Follow-Up Period|Subject withdrew Consent|2|||
13349742|NCT00950599|26652154|FG009|Follow-Up Period|Subject withdrew Consent|1|||
13349743|NCT00950300|26652208|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6|||
13349744|NCT00950300|26652209|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15|||
13349745|NCT00950300|26652208|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1|||
13349746|NCT00950300|26652209|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3|||
13349747|NCT00950300|26652208|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3|||
13349748|NCT00950300|26652209|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0|||
13349749|NCT00950300|26652208|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2|||
13349750|NCT00950300|26652209|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1|||
13349751|NCT00950300|26652208|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1|||
13349752|NCT00950300|26652209|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0|||
13349753|NCT00950300|26652208|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4|||
13349754|NCT00950300|26652209|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5|||
13349755|NCT00950300|26652208|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2|||
13374260|NCT00797225|26726089|FG005|Weeks 1 to 12|Adverse Event|0|||
13349756|NCT00950300|26652209|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1|||
13349757|NCT00950300|26652208|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12|||
13349758|NCT00950300|26652209|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11|||
13349759|NCT00950300|26652208|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10|||
13349760|NCT00950300|26652209|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5|||
13349761|NCT00950300|26652208|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
13349762|NCT00950300|26652209|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
13349763|NCT00950300|26652208|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3|||
13349764|NCT00950300|26652209|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4|||
13349765|NCT00950300|26652208|FG000|TFFU Period|Death|4|||
13349766|NCT00950300|26652209|FG001|TFFU Period|Death|1|||
13349767|NCT00950300|26652208|FG000|TFFU Period|Refused Treatment|10|||
13349768|NCT00950300|26652209|FG001|TFFU Period|Refused Treatment|11|||
13349769|NCT00950300|26652208|FG000|TFFU Period|Failure to Return|16|||
13349770|NCT00950300|26652209|FG001|TFFU Period|Failure to Return|16|||
13349771|NCT00950300|26652208|FG000|TFFU Period|Recurrence of Disease|63|||
13349772|NCT00950300|26652209|FG001|TFFU Period|Recurrence of Disease|72|||
13349773|NCT00950300|26652208|FG000|TFFU Period|Other|4|||
13349774|NCT00950300|26652209|FG001|TFFU Period|Other|3|||
13349775|NCT00950300|26652208|FG000|SFU Period|Death|44|||
13349776|NCT00950300|26652209|FG001|SFU Period|Death|42|||
13349777|NCT00950300|26652208|FG000|SFU Period|Lost to Follow-up|30|||
13349778|NCT00950300|26652209|FG001|SFU Period|Lost to Follow-up|28|||
13349779|NCT00950300|26652208|FG000|SFU Period|Withdrawal by Subject|4|||
13349780|NCT00950300|26652209|FG001|SFU Period|Withdrawal by Subject|8|||
13349781|NCT00950248|26652236|FG000|Year 1: Baseline|Withdrawal by Subject|6|||
13349782|NCT00950248|26652237|FG001|Year 1: Baseline|Withdrawal by Subject|0|||
13349783|NCT00950248|26652238|FG002|Year 1: Baseline|Withdrawal by Subject|0|||
13349784|NCT00950248|26652236|FG000|Year 1: Baseline|worsening of symptoms|2|||
13349785|NCT00950248|26652237|FG001|Year 1: Baseline|worsening of symptoms|0|||
13349786|NCT00950248|26652238|FG002|Year 1: Baseline|worsening of symptoms|0|||
13349787|NCT00950248|26652236|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0|||
13349788|NCT00950248|26652237|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2|||
13349789|NCT00950248|26652238|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4|||
13349790|NCT00950248|26652236|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
13349791|NCT00950248|26652237|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3|||
13349792|NCT00950248|26652238|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
13349793|NCT00950248|26652236|FG000|Year 2&3 Treatment Randomization|Death|0|||
13349794|NCT00950248|26652237|FG001|Year 2&3 Treatment Randomization|Death|0|||
13349795|NCT00950248|26652238|FG002|Year 2&3 Treatment Randomization|Death|1|||
13349796|NCT00950248|26652236|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0|||
13349797|NCT00950248|26652237|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1|||
13349798|NCT00950248|26652238|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0|||
13349799|NCT00950170|26652291|FG000|Overall Study|Parent/Legal Guardian Request|1|||
13349800|NCT00950170|26652291|FG000|Overall Study|Adverse Event|2|||
13349801|NCT00950170|26652291|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
13349802|NCT00949988|26652304|FG000|Overall Study|Withdrawal by Subject|3|||
13349803|NCT00949975|26652435|FG000|Overall Study|Voluntary discontinuation|6|||
13349804|NCT00949975|26652436|FG001|Overall Study|Voluntary discontinuation|5|||
13349805|NCT00949975|26652437|FG002|Overall Study|Voluntary discontinuation|3|||
13349806|NCT00949975|26652438|FG003|Overall Study|Voluntary discontinuation|6|||
13349807|NCT00949975|26652435|FG000|Overall Study|Adverse Event|11|||
13349808|NCT00949975|26652436|FG001|Overall Study|Adverse Event|11|||
13349809|NCT00949975|26652437|FG002|Overall Study|Adverse Event|10|||
13349810|NCT00949975|26652438|FG003|Overall Study|Adverse Event|10|||
13349811|NCT00949975|26652435|FG000|Overall Study|Safety reason|0|||
13349812|NCT00949975|26652436|FG001|Overall Study|Safety reason|1|||
13349813|NCT00949975|26652437|FG002|Overall Study|Safety reason|0|||
13349814|NCT00949975|26652438|FG003|Overall Study|Safety reason|0|||
13349815|NCT00949975|26652435|FG000|Overall Study|Study-specific criteria|0|||
13349816|NCT00949975|26652436|FG001|Overall Study|Study-specific criteria|1|||
13349817|NCT00949975|26652437|FG002|Overall Study|Study-specific criteria|1|||
13349818|NCT00949975|26652438|FG003|Overall Study|Study-specific criteria|0|||
13349819|NCT00949975|26652435|FG000|Overall Study|Incorrect enrolment|5|||
13349820|NCT00949975|26652436|FG001|Overall Study|Incorrect enrolment|10|||
13349821|NCT00949975|26652437|FG002|Overall Study|Incorrect enrolment|4|||
13349822|NCT00949975|26652438|FG003|Overall Study|Incorrect enrolment|7|||
13349823|NCT00949975|26652435|FG000|Overall Study|Severe non-compliance|3|||
13349824|NCT00949975|26652436|FG001|Overall Study|Severe non-compliance|1|||
13349825|NCT00949975|26652437|FG002|Overall Study|Severe non-compliance|0|||
13349826|NCT00949975|26652438|FG003|Overall Study|Severe non-compliance|2|||
13349827|NCT00949975|26652435|FG000|Overall Study|Lost to Follow-up|1|||
13349828|NCT00949975|26652436|FG001|Overall Study|Lost to Follow-up|0|||
13349829|NCT00949975|26652437|FG002|Overall Study|Lost to Follow-up|1|||
13349830|NCT00949975|26652438|FG003|Overall Study|Lost to Follow-up|3|||
13349831|NCT00949975|26652435|FG000|Overall Study|Other|1|||
13349832|NCT00949975|26652436|FG001|Overall Study|Other|0|||
13349833|NCT00949975|26652437|FG002|Overall Study|Other|0|||
13349834|NCT00949975|26652438|FG003|Overall Study|Other|0|||
13349835|NCT00949910|26652450|FG000|Overall Study|Progressive Disease|3750|||
13349836|NCT00949910|26652450|FG000|Overall Study|Symptomatic Deterioration|1088|||
13349837|NCT00949910|26652450|FG000|Overall Study|Lost to Follow-up|100|||
13349838|NCT00949910|26652450|FG000|Overall Study|Study Drug-Related Adverse Event|315|||
13349839|NCT00949910|26652450|FG000|Overall Study|Participant Refusal|390|||
13349840|NCT00949910|26652450|FG000|Overall Study|Death Due to Malignant Disease|456|||
13349841|NCT00949910|26652450|FG000|Overall Study|Death Due to Progression/Deterioration|4|||
13349842|NCT00949910|26652450|FG000|Overall Study|Death Due to Adverse Event|115|||
13349843|NCT00949910|26652450|FG000|Overall Study|Death Due to Toxicity|3|||
13349844|NCT00949910|26652450|FG000|Overall Study|Death from Unknown Cause|5|||
13349845|NCT00949910|26652450|FG000|Overall Study|Unspecified Progression/Deterioration|13|||
13349846|NCT00949910|26652450|FG000|Overall Study|Switched to Compassionate/Other Use|174|||
13349847|NCT00949910|26652450|FG000|Overall Study|Switched to Commercial Treatment|4|||
13349848|NCT00949910|26652450|FG000|Overall Study|Violation of Eligibility|23|||
13349849|NCT00949910|26652450|FG000|Overall Study|Logistical Reasons|13|||
13349850|NCT00949910|26652450|FG000|Overall Study|Non-Compliance|10|||
13349851|NCT00949910|26652450|FG000|Overall Study|Prolonged Dosing Interruption|4|||
13349852|NCT00949910|26652450|FG000|Overall Study|Adverse Event|83|||
13349853|NCT00949910|26652450|FG000|Overall Study|Serious Adverse Event|6|||
13349854|NCT00949910|26652450|FG000|Overall Study|Physician/Participant Decision|7|||
13349855|NCT00949910|26652450|FG000|Overall Study|Other|4|||
13349856|NCT00949910|26652450|FG000|Overall Study|No Data|9|||
13349857|NCT00949884|26652513|FG000|Overall Study|Adverse Event|14|||
13349858|NCT00949884|26652514|FG001|Overall Study|Adverse Event|3|||
13349859|NCT00949884|26652515|FG002|Overall Study|Adverse Event|12|||
13349860|NCT00949884|26652513|FG000|Overall Study|Did not meet inclusion/exclusion|2|||
13349861|NCT00949884|26652514|FG001|Overall Study|Did not meet inclusion/exclusion|1|||
13349862|NCT00949884|26652515|FG002|Overall Study|Did not meet inclusion/exclusion|3|||
13349863|NCT00949884|26652513|FG000|Overall Study|Lost to Follow-up|7|||
13349864|NCT00949884|26652514|FG001|Overall Study|Lost to Follow-up|5|||
13349865|NCT00949884|26652515|FG002|Overall Study|Lost to Follow-up|5|||
13349866|NCT00949884|26652513|FG000|Overall Study|Physician Decision|5|||
13349867|NCT00949884|26652514|FG001|Overall Study|Physician Decision|0|||
13349868|NCT00949884|26652515|FG002|Overall Study|Physician Decision|6|||
13349869|NCT00949884|26652513|FG000|Overall Study|Treatment non-compliance|5|||
13349870|NCT00949884|26652514|FG001|Overall Study|Treatment non-compliance|0|||
13349871|NCT00949884|26652515|FG002|Overall Study|Treatment non-compliance|8|||
13349872|NCT00949884|26652513|FG000|Overall Study|Withdrawal by Subject|13|||
13349873|NCT00949884|26652514|FG001|Overall Study|Withdrawal by Subject|4|||
13349874|NCT00949884|26652515|FG002|Overall Study|Withdrawal by Subject|16|||
13349875|NCT00949884|26652513|FG000|Overall Study|Lack of Efficacy|4|||
13349876|NCT00949884|26652514|FG001|Overall Study|Lack of Efficacy|2|||
13349877|NCT00949884|26652515|FG002|Overall Study|Lack of Efficacy|7|||
13349878|NCT00949884|26652513|FG000|Overall Study|Study terminated by sponsor|0|||
13349879|NCT00949884|26652514|FG001|Overall Study|Study terminated by sponsor|0|||
13349880|NCT00949884|26652515|FG002|Overall Study|Study terminated by sponsor|1|||
13349881|NCT00949715|26652533|FG000|Overall Study|Physician Decision|1|||
13349882|NCT00949715|26652534|FG001|Overall Study|Physician Decision|0|||
13349883|NCT00949715|26652533|FG000|Overall Study|Lost to Follow-up|1|||
13349884|NCT00949715|26652534|FG001|Overall Study|Lost to Follow-up|0|||
13349885|NCT00949715|26652533|FG000|Overall Study|Missing 24 month LVEF measurement|2|||
13349886|NCT00949715|26652534|FG001|Overall Study|Missing 24 month LVEF measurement|0|||
13349887|NCT00949702|26652551|FG000|Overall Study|Death|40|||
13349888|NCT00949702|26652551|FG000|Overall Study|Disease progression|7|||
13349889|NCT00949702|26652551|FG000|Overall Study|Withdrawal of consent|1|||
13349890|NCT00949650|26652594|FG000|Overall Study|Progressive disease|188|||
13349891|NCT00949650|26652595|FG001|Overall Study|Progressive disease|19|||
13349892|NCT00949650|26652594|FG000|Overall Study|Completed 6 courses of chemotherapy|0|||
13349893|NCT00949650|26652595|FG001|Overall Study|Completed 6 courses of chemotherapy|60|||
13349894|NCT00949650|26652594|FG000|Overall Study|Other Adverse Event (AE)|28|||
13349895|NCT00949650|26652595|FG001|Overall Study|Other Adverse Event (AE)|17|||
13349896|NCT00949650|26652594|FG000|Overall Study|Protocol Violation|1|||
13349897|NCT00949650|26652595|FG001|Overall Study|Protocol Violation|4|||
13349898|NCT00949650|26652594|FG000|Overall Study|Refusal to continue medication|7|||
13349899|NCT00949650|26652595|FG001|Overall Study|Refusal to continue medication|11|||
13349900|NCT00949650|26652594|FG000|Overall Study|Not treated|1|||
13349901|NCT00949650|26652595|FG001|Overall Study|Not treated|4|||
13349902|NCT00949650|26652594|FG000|Overall Study|Other not specified above|5|||
13349903|NCT00949650|26652595|FG001|Overall Study|Other not specified above|0|||
13349904|NCT00949533|26652614|FG000|Overall Study|Lost to Follow-up|0|||
13349905|NCT00949533|26652615|FG001|Overall Study|Lost to Follow-up|1|||
13349906|NCT00949325|26652637|FG000|Overall Study|Adverse Event|0|||
13349907|NCT00949325|26652638|FG001|Overall Study|Adverse Event|2|||
13349908|NCT00949325|26652639|FG002|Overall Study|Adverse Event|0|||
13349909|NCT00949117|26652660|FG000|Overall Study|Lack of Efficacy|2|||
13349910|NCT00949117|26652661|FG001|Overall Study|Lack of Efficacy|3|||
13349911|NCT00949117|26652660|FG000|Overall Study|Protocol Violation|1|||
13349912|NCT00949117|26652661|FG001|Overall Study|Protocol Violation|1|||
13349913|NCT00949117|26652660|FG000|Overall Study|Adverse Event|0|||
13349914|NCT00949117|26652661|FG001|Overall Study|Adverse Event|1|||
13349915|NCT00948974|26652678|FG000|Overall Study|Lost to Follow-up|23|||
13349916|NCT00948974|26652679|FG001|Overall Study|Lost to Follow-up|20|||
13349917|NCT00948922|26652704|FG000|Overall Study|Did not start study treatment|2|||
13349918|NCT00948922|26652705|FG001|Overall Study|Did not start study treatment|5|||
13349919|NCT00948922|26652706|FG002|Overall Study|Did not start study treatment|0|||
13349920|NCT00948922|26652704|FG000|Overall Study|Withdrawal by Subject|0|||
13349921|NCT00948922|26652705|FG001|Overall Study|Withdrawal by Subject|2|||
13349922|NCT00948922|26652706|FG002|Overall Study|Withdrawal by Subject|1|||
13349923|NCT00948922|26652704|FG000|Overall Study|Death|3|||
13349924|NCT00948922|26652705|FG001|Overall Study|Death|0|||
13349925|NCT00948922|26652706|FG002|Overall Study|Death|0|||
13349926|NCT00948922|26652704|FG000|Overall Study|Disease progression|0|||
13349927|NCT00948922|26652705|FG001|Overall Study|Disease progression|1|||
13349928|NCT00948922|26652706|FG002|Overall Study|Disease progression|0|||
13349929|NCT00948922|26652704|FG000|Overall Study|Insurance issues|1|||
13349930|NCT00948922|26652705|FG001|Overall Study|Insurance issues|0|||
13349931|NCT00948922|26652706|FG002|Overall Study|Insurance issues|0|||
13349932|NCT00948922|26652704|FG000|Overall Study|Transplant eligibility issues|2|||
13349933|NCT00948922|26652705|FG001|Overall Study|Transplant eligibility issues|3|||
13349934|NCT00948922|26652706|FG002|Overall Study|Transplant eligibility issues|0|||
13349935|NCT00948922|26652704|FG000|Overall Study|Not evaluable at time of analysis|0|||
13349936|NCT00948922|26652705|FG001|Overall Study|Not evaluable at time of analysis|3|||
13349937|NCT00948922|26652706|FG002|Overall Study|Not evaluable at time of analysis|0|||
13349938|NCT00948896|26652765|FG000|Randomization to 24 Months of Age|Death|1|||
13349939|NCT00948896|26652766|FG001|Randomization to 24 Months of Age|Death|0|||
13349940|NCT00948896|26652767|FG002|Randomization to 24 Months of Age|Death|0|||
13349941|NCT00948896|26652768|FG003|Randomization to 24 Months of Age|Death|0|||
13349942|NCT00948896|26652769|FG004|Randomization to 24 Months of Age|Death|2|||
13349943|NCT00948896|26652770|FG005|Randomization to 24 Months of Age|Death|1|||
13349944|NCT00948896|26652771|FG006|Randomization to 24 Months of Age|Death|2|||
13349945|NCT00948896|26652772|FG007|Randomization to 24 Months of Age|Death|1|||
13349946|NCT00948896|26652765|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3|||
13349947|NCT00948896|26652766|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5|||
13349948|NCT00948896|26652767|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
13349949|NCT00948896|26652768|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
13349950|NCT00948896|26652769|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
13349951|NCT00948896|26652770|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1|||
13349952|NCT00948896|26652771|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
13349953|NCT00948896|26652772|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
13349954|NCT00948896|26652765|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4|||
13349955|NCT00948896|26652766|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4|||
13349956|NCT00948896|26652767|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2|||
13349957|NCT00948896|26652768|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5|||
13349958|NCT00948896|26652769|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0|||
13349959|NCT00948896|26652770|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0|||
13349960|NCT00948896|26652771|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1|||
13349961|NCT00948896|26652772|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0|||
13349962|NCT00948896|26652765|FG000|Randomization to 24 Months of Age|Protocol Violation|0|||
13349963|NCT00948896|26652766|FG001|Randomization to 24 Months of Age|Protocol Violation|1|||
13349964|NCT00948896|26652767|FG002|Randomization to 24 Months of Age|Protocol Violation|0|||
13349965|NCT00948896|26652768|FG003|Randomization to 24 Months of Age|Protocol Violation|1|||
13349966|NCT00948896|26652769|FG004|Randomization to 24 Months of Age|Protocol Violation|0|||
13349967|NCT00948896|26652770|FG005|Randomization to 24 Months of Age|Protocol Violation|0|||
13349968|NCT00948896|26652771|FG006|Randomization to 24 Months of Age|Protocol Violation|1|||
13349969|NCT00948896|26652772|FG007|Randomization to 24 Months of Age|Protocol Violation|1|||
13349970|NCT00948896|26652765|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0|||
13349971|NCT00948896|26652766|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3|||
13349972|NCT00948896|26652767|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3|||
13349973|NCT00948896|26652768|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1|||
13349974|NCT00948896|26652769|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0|||
13349975|NCT00948896|26652770|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2|||
13349976|NCT00948896|26652771|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0|||
13349977|NCT00948896|26652772|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0|||
13349978|NCT00948896|26652765|FG000|24 Months of Age to 36 Months of Age|Death|0|||
13349979|NCT00948896|26652766|FG001|24 Months of Age to 36 Months of Age|Death|2|||
13349980|NCT00948896|26652767|FG002|24 Months of Age to 36 Months of Age|Death|2|||
13349981|NCT00948896|26652768|FG003|24 Months of Age to 36 Months of Age|Death|0|||
13349982|NCT00948896|26652769|FG004|24 Months of Age to 36 Months of Age|Death|0|||
13349983|NCT00948896|26652770|FG005|24 Months of Age to 36 Months of Age|Death|1|||
13349984|NCT00948896|26652771|FG006|24 Months of Age to 36 Months of Age|Death|0|||
13349985|NCT00948896|26652772|FG007|24 Months of Age to 36 Months of Age|Death|0|||
13349986|NCT00948896|26652765|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
13349987|NCT00948896|26652766|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
13349988|NCT00948896|26652767|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
13349989|NCT00948896|26652768|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
13349990|NCT00948896|26652769|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
13349991|NCT00948896|26652770|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
13349992|NCT00948896|26652771|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
13349993|NCT00948896|26652772|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
13349994|NCT00948896|26652765|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2|||
13349995|NCT00948896|26652766|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
13349996|NCT00948896|26652767|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
13349997|NCT00948896|26652768|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
13349998|NCT00948896|26652769|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
13349999|NCT00948896|26652770|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
13350000|NCT00948896|26652771|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
13350001|NCT00948896|26652772|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
13350002|NCT00948896|26652765|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
13350003|NCT00948896|26652766|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
13350004|NCT00948896|26652767|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
13350005|NCT00948896|26652768|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
13350006|NCT00948896|26652769|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
13350007|NCT00948896|26652770|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
13350008|NCT00948896|26652771|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
13350009|NCT00948896|26652772|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
13350010|NCT00948896|26652765|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
13350011|NCT00948896|26652766|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
13350012|NCT00948896|26652767|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
13350013|NCT00948896|26652768|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1|||
13350014|NCT00948896|26652769|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
13350015|NCT00948896|26652770|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
13350016|NCT00948896|26652771|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
13350017|NCT00948896|26652772|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
13350018|NCT00948857|26652785|FG000|Overall Study|Lost to Follow-up|1|||
13350019|NCT00948857|26652786|FG001|Overall Study|Lost to Follow-up|0|||
13350020|NCT00948818|26652828|FG000|Overall Study|Adverse Event|10|||
13350021|NCT00948818|26652829|FG001|Overall Study|Adverse Event|32|||
13350022|NCT00948818|26652828|FG000|Overall Study|Protocol Violation|9|||
13350023|NCT00948818|26652829|FG001|Overall Study|Protocol Violation|10|||
13350024|NCT00948818|26652828|FG000|Overall Study|Withdrawal by Subject|25|||
13350025|NCT00948818|26652829|FG001|Overall Study|Withdrawal by Subject|25|||
13350026|NCT00948818|26652828|FG000|Overall Study|Lost to Follow-up|10|||
13350027|NCT00948818|26652829|FG001|Overall Study|Lost to Follow-up|17|||
13350028|NCT00948818|26652828|FG000|Overall Study|Lack of Efficacy|4|||
13350029|NCT00948818|26652829|FG001|Overall Study|Lack of Efficacy|5|||
13350030|NCT00948818|26652828|FG000|Overall Study|Other Reason|4|||
13350031|NCT00948818|26652829|FG001|Overall Study|Other Reason|5|||
13350032|NCT00948766|26652852|FG000|Core Study|Adverse Event|73|||
13350033|NCT00948766|26652853|FG001|Core Study|Adverse Event|51|||
13350034|NCT00948766|26652852|FG000|Core Study|Unsatisfactory Therapeutic Effect|13|||
13350035|NCT00948766|26652853|FG001|Core Study|Unsatisfactory Therapeutic Effect|14|||
13350036|NCT00948766|26652852|FG000|Core Study|Patient Withdrew Consent|27|||
13350037|NCT00948766|26652853|FG001|Core Study|Patient Withdrew Consent|46|||
13350038|NCT00948766|26652852|FG000|Core Study|Lost to Follow-up|3|||
13350039|NCT00948766|26652853|FG001|Core Study|Lost to Follow-up|2|||
13350040|NCT00948766|26652852|FG000|Core Study|Administrative Problems|2|||
13350041|NCT00948766|26652853|FG001|Core Study|Administrative Problems|2|||
13350042|NCT00948766|26652852|FG000|Core Study|Death|1|||
13350043|NCT00948766|26652853|FG001|Core Study|Death|1|||
13350044|NCT00948766|26652852|FG000|Core Study|Protocol Deviation|8|||
13350045|NCT00948766|26652853|FG001|Core Study|Protocol Deviation|10|||
13350046|NCT00948766|26652852|FG000|Extension Study|Adverse Event|43|||
13350047|NCT00948766|26652853|FG001|Extension Study|Adverse Event|0|||
13350048|NCT00948766|26652852|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2|||
13350049|NCT00948766|26652853|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0|||
13374261|NCT00797225|26726090|FG006|Weeks 1 to 12|Adverse Event|0|||
13350050|NCT00948766|26652852|FG000|Extension Study|Study Drug No Longer Required|1|||
13350051|NCT00948766|26652853|FG001|Extension Study|Study Drug No Longer Required|0|||
13350052|NCT00948766|26652852|FG000|Extension Study|Patient Withdrew Consent|32|||
13350053|NCT00948766|26652853|FG001|Extension Study|Patient Withdrew Consent|0|||
13350054|NCT00948766|26652852|FG000|Extension Study|Lost to Follow-up|8|||
13350055|NCT00948766|26652853|FG001|Extension Study|Lost to Follow-up|0|||
13350056|NCT00948766|26652852|FG000|Extension Study|Administrative Problems|1|||
13350057|NCT00948766|26652853|FG001|Extension Study|Administrative Problems|0|||
13350058|NCT00948766|26652852|FG000|Extension Study|Death|4|||
13350059|NCT00948766|26652853|FG001|Extension Study|Death|0|||
13350060|NCT00948688|26652868|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1|||
13350061|NCT00948688|26652869|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0|||
13350062|NCT00948688|26652868|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1|||
13350063|NCT00948688|26652869|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0|||
13350064|NCT00948688|26652868|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0|||
13350065|NCT00948688|26652869|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1|||
13350066|NCT00948675|26652890|FG000|Overall Study|Lost to Follow-up|1|||
13350067|NCT00948675|26652891|FG001|Overall Study|Lost to Follow-up|0|||
13350068|NCT00948506|26652907|FG000|Overall Study|Withdrawal by Subject|3|||
13350069|NCT00948506|26652908|FG001|Overall Study|Withdrawal by Subject|1|||
13350070|NCT00948441|26652923|FG000|Overall Study|no longer meet inclusion criteria|1|||
13350071|NCT00948441|26652924|FG001|Overall Study|no longer meet inclusion criteria|4|||
13350072|NCT00948428|26652948|FG000|Overall Study|Withdrawal by Subject|6|||
13350073|NCT00948428|26652949|FG001|Overall Study|Withdrawal by Subject|12|||
13350074|NCT00948428|26652950|FG002|Overall Study|Withdrawal by Subject|7|||
13350075|NCT00948428|26652948|FG000|Overall Study|Adverse Event|6|||
13350076|NCT00948428|26652949|FG001|Overall Study|Adverse Event|3|||
13350077|NCT00948428|26652950|FG002|Overall Study|Adverse Event|0|||
13350078|NCT00948428|26652948|FG000|Overall Study|Lost to Follow-up|2|||
13350079|NCT00948428|26652949|FG001|Overall Study|Lost to Follow-up|1|||
13350080|NCT00948428|26652950|FG002|Overall Study|Lost to Follow-up|1|||
13350081|NCT00948428|26652948|FG000|Overall Study|Death|2|||
13350082|NCT00948428|26652949|FG001|Overall Study|Death|0|||
13350083|NCT00948428|26652950|FG002|Overall Study|Death|0|||
13350084|NCT00948428|26652948|FG000|Overall Study|Intercurrent Illness|1|||
13350085|NCT00948428|26652949|FG001|Overall Study|Intercurrent Illness|0|||
13350086|NCT00948428|26652950|FG002|Overall Study|Intercurrent Illness|0|||
13350087|NCT00948428|26652948|FG000|Overall Study|Non-compliance|1|||
13350088|NCT00948428|26652949|FG001|Overall Study|Non-compliance|2|||
13350089|NCT00948428|26652950|FG002|Overall Study|Non-compliance|0|||
13350090|NCT00948389|26653003|FG000|Overall Study|Disease Progression/Relapse/Death|3|||
13350091|NCT00948389|26653004|FG001|Overall Study|Disease Progression/Relapse/Death|3|||
13350092|NCT00948389|26653005|FG002|Overall Study|Disease Progression/Relapse/Death|7|||
13350093|NCT00948389|26653006|FG003|Overall Study|Disease Progression/Relapse/Death|8|||
13350094|NCT00948389|26653007|FG004|Overall Study|Disease Progression/Relapse/Death|1|||
13350095|NCT00948389|26653003|FG000|Overall Study|Thrombocytopenia, Grade 4|2|||
13350096|NCT00948389|26653004|FG001|Overall Study|Thrombocytopenia, Grade 4|0|||
13350097|NCT00948389|26653005|FG002|Overall Study|Thrombocytopenia, Grade 4|0|||
13350098|NCT00948389|26653006|FG003|Overall Study|Thrombocytopenia, Grade 4|1|||
13350099|NCT00948389|26653007|FG004|Overall Study|Thrombocytopenia, Grade 4|0|||
13350100|NCT00948389|26653003|FG000|Overall Study|Both Progression and Toxicity|1|||
13350101|NCT00948389|26653004|FG001|Overall Study|Both Progression and Toxicity|0|||
13350102|NCT00948389|26653005|FG002|Overall Study|Both Progression and Toxicity|0|||
13350103|NCT00948389|26653006|FG003|Overall Study|Both Progression and Toxicity|0|||
13350104|NCT00948389|26653007|FG004|Overall Study|Both Progression and Toxicity|0|||
13350105|NCT00948246|26653016|FG000|Overall Study|Lost to Follow-up|11|||
13350106|NCT00948246|26653016|FG000|Overall Study|Adverse Event|11|||
13350107|NCT00948246|26653016|FG000|Overall Study|Death|1|||
13350108|NCT00948246|26653016|FG000|Overall Study|Withdrawal by Subject|1|||
13350109|NCT00948194|26653033|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1|||
13350110|NCT00948194|26653034|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0|||
13350111|NCT00948155|26653061|FG000|First Intervention 21 Days|Lost to Follow-up|2|||
13350112|NCT00948155|26653062|FG001|First Intervention 21 Days|Lost to Follow-up|2|||
13350113|NCT00948155|26653061|FG000|Washout 14 Days|Lost to Follow-up|1|||
13350114|NCT00948155|26653062|FG001|Washout 14 Days|Lost to Follow-up|2|||
13350115|NCT00948064|26653083|FG000|Phase I|No treatment received|1|||
13350116|NCT00948064|26653084|FG001|Phase I|No treatment received|0|||
13350117|NCT00948064|26653085|FG002|Phase I|No treatment received|0|||
13350118|NCT00948064|26653083|FG000|Phase II|Physician Decision|0|||
13350119|NCT00948064|26653084|FG001|Phase II|Physician Decision|0|||
13350120|NCT00948064|26653085|FG002|Phase II|Physician Decision|1|||
13350121|NCT00948064|26653083|FG000|Phase II|Withdrawal by Subject|0|||
13350122|NCT00948064|26653084|FG001|Phase II|Withdrawal by Subject|1|||
13350123|NCT00948064|26653085|FG002|Phase II|Withdrawal by Subject|0|||
13350124|NCT00948025|26653116|FG000|Phase 1 (Pilot Phase)|Adverse Event|1|||
13350125|NCT00948025|26653117|FG001|Phase 1 (Pilot Phase)|Adverse Event|1|||
13350126|NCT00948025|26653116|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7|||
13350127|NCT00948025|26653117|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1|||
13350128|NCT00948025|26653116|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
13350129|NCT00948025|26653117|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
13350130|NCT00947882|26653156|FG000|Overall Study|Adverse Event|0|||
13350131|NCT00947882|26653157|FG001|Overall Study|Adverse Event|1|||
13350132|NCT00947882|26653158|FG002|Overall Study|Adverse Event|4|||
13350133|NCT00947882|26653159|FG003|Overall Study|Adverse Event|4|||
13350134|NCT00947882|26653156|FG000|Overall Study|Withdrawal by Subject|2|||
13350135|NCT00947882|26653157|FG001|Overall Study|Withdrawal by Subject|0|||
13350136|NCT00947882|26653158|FG002|Overall Study|Withdrawal by Subject|8|||
13350137|NCT00947882|26653159|FG003|Overall Study|Withdrawal by Subject|2|||
13350138|NCT00947882|26653156|FG000|Overall Study|Protocol Violation|0|||
13350139|NCT00947882|26653157|FG001|Overall Study|Protocol Violation|0|||
13350140|NCT00947882|26653158|FG002|Overall Study|Protocol Violation|1|||
13350141|NCT00947882|26653159|FG003|Overall Study|Protocol Violation|0|||
13350142|NCT00947882|26653156|FG000|Overall Study|Lost to Follow-up|0|||
13350143|NCT00947882|26653157|FG001|Overall Study|Lost to Follow-up|2|||
13350144|NCT00947882|26653158|FG002|Overall Study|Lost to Follow-up|1|||
13350145|NCT00947882|26653159|FG003|Overall Study|Lost to Follow-up|0|||
13350146|NCT00947882|26653156|FG000|Overall Study|Other/Unknown|10|||
13350147|NCT00947882|26653157|FG001|Overall Study|Other/Unknown|13|||
13350148|NCT00947882|26653158|FG002|Overall Study|Other/Unknown|3|||
13350149|NCT00947882|26653159|FG003|Overall Study|Other/Unknown|6|||
13350150|NCT00947882|26653156|FG000|Overall Study|Trial Terminated by Sponsor|62|||
13350151|NCT00947882|26653157|FG001|Overall Study|Trial Terminated by Sponsor|61|||
13350152|NCT00947882|26653158|FG002|Overall Study|Trial Terminated by Sponsor|62|||
13350153|NCT00947882|26653159|FG003|Overall Study|Trial Terminated by Sponsor|70|||
13350154|NCT00947856|26653193|FG000|Treatment Period|Progressive Disease|33|||
13350155|NCT00947856|26653194|FG001|Treatment Period|Progressive Disease|12|||
13350156|NCT00947856|26653193|FG000|Treatment Period|Adverse Event|15|||
13350157|NCT00947856|26653194|FG001|Treatment Period|Adverse Event|9|||
13350158|NCT00947856|26653193|FG000|Treatment Period|Physician Decision|14|||
13350159|NCT00947856|26653194|FG001|Treatment Period|Physician Decision|6|||
13350160|NCT00947856|26653193|FG000|Treatment Period|Study Stopped by Sponsor|4|||
13350161|NCT00947856|26653194|FG001|Treatment Period|Study Stopped by Sponsor|4|||
13350162|NCT00947856|26653193|FG000|Treatment Period|Withdrawal by Subject|12|||
13350163|NCT00947856|26653194|FG001|Treatment Period|Withdrawal by Subject|1|||
13350164|NCT00947856|26653193|FG000|Follow-up Period|Study Stopped by Sponsor|40|||
13350165|NCT00947856|26653194|FG001|Follow-up Period|Study Stopped by Sponsor|20|||
13350166|NCT00947856|26653193|FG000|Follow-up Period|Re-enrolled for Retreatment|2|||
13350167|NCT00947856|26653194|FG001|Follow-up Period|Re-enrolled for Retreatment|3|||
13350168|NCT00947856|26653193|FG000|Follow-up Period|Lost to Follow-up|7|||
13350169|NCT00947856|26653194|FG001|Follow-up Period|Lost to Follow-up|0|||
13350170|NCT00947856|26653193|FG000|Follow-up Period|Patient unavailable for site visits|1|||
13350171|NCT00947856|26653194|FG001|Follow-up Period|Patient unavailable for site visits|0|||
13350172|NCT00947856|26653193|FG000|Follow-up Period|Withdrawal by Subject|1|||
13350173|NCT00947856|26653194|FG001|Follow-up Period|Withdrawal by Subject|0|||
13350174|NCT00947544|26653221|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1|||
13350175|NCT00947544|26653222|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0|||
13350176|NCT00947531|26653237|FG000|Overall Study|Withdrawal by Subject|10|||
13350177|NCT00947531|26653238|FG001|Overall Study|Withdrawal by Subject|7|||
13350178|NCT00947531|26653237|FG000|Overall Study|Administrative Reason|0|||
13350179|NCT00947531|26653238|FG001|Overall Study|Administrative Reason|1|||
13350180|NCT00947531|26653237|FG000|Overall Study|Adverse Event|2|||
13350181|NCT00947531|26653238|FG001|Overall Study|Adverse Event|2|||
13350182|NCT00947531|26653237|FG000|Overall Study|Lack of Efficacy|1|||
13350183|NCT00947531|26653238|FG001|Overall Study|Lack of Efficacy|0|||
13350184|NCT00947531|26653237|FG000|Overall Study|Other|1|||
13350185|NCT00947531|26653238|FG001|Overall Study|Other|1|||
13350186|NCT00947427|26653251|FG000|Overall Study|Withdrawal by Subject|1|||
13350187|NCT00947427|26653252|FG001|Overall Study|Withdrawal by Subject|3|||
13350188|NCT00947427|26653251|FG000|Overall Study|Protocol Violation|0|||
13350189|NCT00947427|26653252|FG001|Overall Study|Protocol Violation|1|||
13374262|NCT00797225|26726091|FG007|Weeks 1 to 12|Adverse Event|0|||
13374263|NCT00797225|26726084|FG000|Weeks 1 to 12|Non-compliance|0|||
13374264|NCT00797225|26726085|FG001|Weeks 1 to 12|Non-compliance|1|||
13374265|NCT00797225|26726086|FG002|Weeks 1 to 12|Non-compliance|0|||
13374266|NCT00797225|26726087|FG003|Weeks 1 to 12|Non-compliance|0|||
13374267|NCT00797225|26726088|FG004|Weeks 1 to 12|Non-compliance|0|||
13486419|NCT03564119|27036068|FG000|Overall Study|Other Than Specified|0|||
13374268|NCT00797225|26726089|FG005|Weeks 1 to 12|Non-compliance|0|||
13374269|NCT00797225|26726090|FG006|Weeks 1 to 12|Non-compliance|0|||
13374270|NCT00797225|26726091|FG007|Weeks 1 to 12|Non-compliance|0|||
13374271|NCT00797225|26726084|FG000|Weeks 1 to 12|Lack of Efficacy|1|||
13374272|NCT00797225|26726085|FG001|Weeks 1 to 12|Lack of Efficacy|0|||
13374273|NCT00797225|26726086|FG002|Weeks 1 to 12|Lack of Efficacy|0|||
13350190|NCT00947349|26653397|FG000|Triple Treatment Combination Period|Adverse Event|0|||
13350191|NCT00947349|26653398|FG001|Triple Treatment Combination Period|Adverse Event|1|||
13350192|NCT00947349|26653399|FG002|Triple Treatment Combination Period|Adverse Event|0|||
13350193|NCT00947349|26653400|FG003|Triple Treatment Combination Period|Adverse Event|0|||
13350194|NCT00947349|26653397|FG000|Overall Study Standard of Care|Lack of Efficacy|0|||
13350195|NCT00947349|26653398|FG001|Overall Study Standard of Care|Lack of Efficacy|0|||
13350196|NCT00947349|26653399|FG002|Overall Study Standard of Care|Lack of Efficacy|1|||
13350197|NCT00947349|26653400|FG003|Overall Study Standard of Care|Lack of Efficacy|1|||
13350198|NCT00947349|26653397|FG000|Overall Study Standard of Care|Withdrawal by Subject|0|||
13350199|NCT00947349|26653398|FG001|Overall Study Standard of Care|Withdrawal by Subject|0|||
13350200|NCT00947349|26653399|FG002|Overall Study Standard of Care|Withdrawal by Subject|1|||
13350201|NCT00947349|26653400|FG003|Overall Study Standard of Care|Withdrawal by Subject|0|||
13350202|NCT00947349|26653397|FG000|Overall Study Standard of Care|Other|0|||
13350203|NCT00947349|26653398|FG001|Overall Study Standard of Care|Other|0|||
13350204|NCT00947349|26653399|FG002|Overall Study Standard of Care|Other|0|||
13350205|NCT00947349|26653400|FG003|Overall Study Standard of Care|Other|1|||
13350206|NCT00947193|26653413|FG000|Overall Study|Lost to Follow-up|1|||
13350207|NCT00947193|26653414|FG001|Overall Study|Lost to Follow-up|0|||
13350208|NCT00947193|26653413|FG000|Overall Study|Withdrawal by Subject|1|||
13350209|NCT00947193|26653414|FG001|Overall Study|Withdrawal by Subject|0|||
13350210|NCT00947193|26653413|FG000|Overall Study|Factor VIII >1%|1|||
13350211|NCT00947193|26653414|FG001|Overall Study|Factor VIII >1%|0|||
13350212|NCT00947154|26653423|FG000|Overall Study|Lost to Follow-up|1|||
13350213|NCT00947115|26653495|FG000|Overall Study|Missed reporting interval|3|||
13350214|NCT00947115|26653496|FG001|Overall Study|Missed reporting interval|4|||
13350215|NCT00947115|26653497|FG002|Overall Study|Missed reporting interval|2|||
13350216|NCT00947115|26653495|FG000|Overall Study|Physician Decision|0|||
13350217|NCT00947115|26653496|FG001|Overall Study|Physician Decision|2|||
13350218|NCT00947115|26653497|FG002|Overall Study|Physician Decision|0|||
13350219|NCT00947115|26653495|FG000|Overall Study|Death|0|||
13350220|NCT00947115|26653496|FG001|Overall Study|Death|1|||
13350221|NCT00947115|26653497|FG002|Overall Study|Death|1|||
13350222|NCT00947115|26653495|FG000|Overall Study|Migrated from study area|2|||
13350223|NCT00947115|26653496|FG001|Overall Study|Migrated from study area|0|||
13350224|NCT00947115|26653497|FG002|Overall Study|Migrated from study area|0|||
13124862|NCT02937701|25954303|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
13124863|NCT02937701|25954304|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10|||
13124864|NCT02937701|25954305|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3|||
13124865|NCT02937701|25954306|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2|||
13124866|NCT02937701|25954302|FG000|Week 22 to Week 50|Withdrawal by Subject|0|||
13124867|NCT02937701|25954303|FG001|Week 22 to Week 50|Withdrawal by Subject|0|||
13124868|NCT02937701|25954304|FG002|Week 22 to Week 50|Withdrawal by Subject|8|||
13124869|NCT02937701|25954305|FG003|Week 22 to Week 50|Withdrawal by Subject|2|||
13124870|NCT02937701|25954306|FG004|Week 22 to Week 50|Withdrawal by Subject|1|||
13350225|NCT00947115|26653495|FG000|Overall Study|Withdrawal by Subject|1|||
13350226|NCT00947115|26653496|FG001|Overall Study|Withdrawal by Subject|3|||
13350227|NCT00947115|26653497|FG002|Overall Study|Withdrawal by Subject|4|||
13350228|NCT00947115|26653495|FG000|Overall Study|Lost to Follow-up|11|||
13350229|NCT00947115|26653496|FG001|Overall Study|Lost to Follow-up|12|||
13350230|NCT00947115|26653497|FG002|Overall Study|Lost to Follow-up|8|||
13350231|NCT00947011|26653507|FG000|Overall Study|Study was terminated,PI left institution|12|||
13350232|NCT00946998|26653528|FG000|Overall Study|Exited prior to first outcome assessment|5|||
13350233|NCT00946998|26653529|FG001|Overall Study|Exited prior to first outcome assessment|3|||
13350234|NCT00946985|26653535|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4|||
13350235|NCT00946985|26653535|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3|||
13350236|NCT00946985|26653535|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5|||
13350237|NCT00946985|26653535|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4|||
13350238|NCT00946985|26653535|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139|||
13350239|NCT00946985|26653535|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2|||
13350240|NCT00946985|26653535|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1|||
13350241|NCT00946985|26653535|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2|||
13350242|NCT00946985|26653535|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2|||
13350243|NCT00946920|26653557|FG000|Overall Study|Withdrawal by Subject|28|||
13350244|NCT00946920|26653558|FG001|Overall Study|Withdrawal by Subject|15|||
13350245|NCT00946920|26653557|FG000|Overall Study|Lost to Follow-up|2|||
13124871|NCT02937701|25954302|FG000|Week 22 to Week 50|Lost to Follow-up|0|||
13124872|NCT02937701|25954303|FG001|Week 22 to Week 50|Lost to Follow-up|0|||
13350246|NCT00946920|26653558|FG001|Overall Study|Lost to Follow-up|2|||
13350247|NCT00946920|26653557|FG000|Overall Study|Physician Decision|5|||
13350248|NCT00946920|26653558|FG001|Overall Study|Physician Decision|2|||
13350249|NCT00946920|26653557|FG000|Overall Study|Adverse Event|41|||
13350250|NCT00946920|26653558|FG001|Overall Study|Adverse Event|14|||
13350251|NCT00946920|26653557|FG000|Overall Study|Protocol Violation|16|||
13350252|NCT00946920|26653558|FG001|Overall Study|Protocol Violation|8|||
13350253|NCT00946920|26653557|FG000|Overall Study|Miscellaneous reasons|18|||
13350254|NCT00946920|26653558|FG001|Overall Study|Miscellaneous reasons|3|||
13350255|NCT00946881|26653589|FG000|First Treatment|Withdrawal by Subject|1|||
13350256|NCT00946881|26653589|FG000|First Treatment|Patient relocated to another state|1|||
13350257|NCT00946881|26653589|FG000|Retreatment|Withdrawal by Subject|1|||
13350258|NCT00946647|26653635|FG000|Phase 1 Part|Adverse Event|2|||
13350259|NCT00946647|26653636|FG001|Phase 1 Part|Adverse Event|5|||
13350260|NCT00946647|26653637|FG002|Phase 1 Part|Adverse Event|3|||
13350261|NCT00946647|26653638|FG003|Phase 1 Part|Adverse Event|0|||
13350262|NCT00946647|26653639|FG004|Phase 1 Part|Adverse Event|0|||
13350263|NCT00946647|26653635|FG000|Phase 1 Part|Disease progression|3|||
13350264|NCT00946647|26653636|FG001|Phase 1 Part|Disease progression|6|||
13350265|NCT00946647|26653637|FG002|Phase 1 Part|Disease progression|1|||
13350266|NCT00946647|26653638|FG003|Phase 1 Part|Disease progression|0|||
13350267|NCT00946647|26653639|FG004|Phase 1 Part|Disease progression|0|||
13350268|NCT00946647|26653635|FG000|Phase 1 Part|Withdrawal by Subject|1|||
13350269|NCT00946647|26653636|FG001|Phase 1 Part|Withdrawal by Subject|4|||
13350270|NCT00946647|26653637|FG002|Phase 1 Part|Withdrawal by Subject|3|||
13350271|NCT00946647|26653638|FG003|Phase 1 Part|Withdrawal by Subject|0|||
13350272|NCT00946647|26653639|FG004|Phase 1 Part|Withdrawal by Subject|0|||
13350273|NCT00946647|26653635|FG000|Phase 1 Part|Abnormal values|0|||
13350274|NCT00946647|26653636|FG001|Phase 1 Part|Abnormal values|2|||
13350275|NCT00946647|26653637|FG002|Phase 1 Part|Abnormal values|0|||
13350276|NCT00946647|26653638|FG003|Phase 1 Part|Abnormal values|0|||
13350277|NCT00946647|26653639|FG004|Phase 1 Part|Abnormal values|0|||
13350278|NCT00946647|26653635|FG000|Phase 1 Part|Reason missing|0|||
13350279|NCT00946647|26653636|FG001|Phase 1 Part|Reason missing|1|||
13350280|NCT00946647|26653637|FG002|Phase 1 Part|Reason missing|0|||
13350281|NCT00946647|26653638|FG003|Phase 1 Part|Reason missing|0|||
13350282|NCT00946647|26653639|FG004|Phase 1 Part|Reason missing|0|||
13350283|NCT00946647|26653635|FG000|Phase ll Part|Untreated|0|||
13350284|NCT00946647|26653636|FG001|Phase ll Part|Untreated|0|||
13350285|NCT00946647|26653637|FG002|Phase ll Part|Untreated|0|||
13350286|NCT00946647|26653638|FG003|Phase ll Part|Untreated|0|||
13350287|NCT00946647|26653639|FG004|Phase ll Part|Untreated|2|||
13350288|NCT00946647|26653635|FG000|Phase ll Part|Adverse Event|0|||
13350289|NCT00946647|26653636|FG001|Phase ll Part|Adverse Event|0|||
13350290|NCT00946647|26653637|FG002|Phase ll Part|Adverse Event|0|||
13350291|NCT00946647|26653638|FG003|Phase ll Part|Adverse Event|10|||
13350292|NCT00946647|26653639|FG004|Phase ll Part|Adverse Event|6|||
13350293|NCT00946647|26653635|FG000|Phase ll Part|Withdrawal by Subject|0|||
13350294|NCT00946647|26653636|FG001|Phase ll Part|Withdrawal by Subject|0|||
13350295|NCT00946647|26653637|FG002|Phase ll Part|Withdrawal by Subject|0|||
13350296|NCT00946647|26653638|FG003|Phase ll Part|Withdrawal by Subject|8|||
13350297|NCT00946647|26653639|FG004|Phase ll Part|Withdrawal by Subject|6|||
13350298|NCT00946647|26653635|FG000|Phase ll Part|Administrative problems|0|||
13350299|NCT00946647|26653636|FG001|Phase ll Part|Administrative problems|0|||
13350300|NCT00946647|26653637|FG002|Phase ll Part|Administrative problems|0|||
13350301|NCT00946647|26653638|FG003|Phase ll Part|Administrative problems|3|||
13350302|NCT00946647|26653639|FG004|Phase ll Part|Administrative problems|8|||
13350303|NCT00946647|26653635|FG000|Phase ll Part|Death|0|||
13350304|NCT00946647|26653636|FG001|Phase ll Part|Death|0|||
13350305|NCT00946647|26653637|FG002|Phase ll Part|Death|0|||
13350306|NCT00946647|26653638|FG003|Phase ll Part|Death|7|||
13350307|NCT00946647|26653639|FG004|Phase ll Part|Death|4|||
13350308|NCT00946647|26653635|FG000|Phase ll Part|Disease progression|0|||
13350309|NCT00946647|26653636|FG001|Phase ll Part|Disease progression|0|||
13350310|NCT00946647|26653637|FG002|Phase ll Part|Disease progression|0|||
13350311|NCT00946647|26653638|FG003|Phase ll Part|Disease progression|6|||
13350312|NCT00946647|26653639|FG004|Phase ll Part|Disease progression|14|||
13350313|NCT00946647|26653635|FG000|Phase ll Part|Protocol Violation|0|||
13350314|NCT00946647|26653636|FG001|Phase ll Part|Protocol Violation|0|||
13350315|NCT00946647|26653637|FG002|Phase ll Part|Protocol Violation|0|||
13350316|NCT00946647|26653638|FG003|Phase ll Part|Protocol Violation|4|||
13350317|NCT00946647|26653639|FG004|Phase ll Part|Protocol Violation|2|||
13350318|NCT00946647|26653635|FG000|Phase ll Part|Subj cond no longer required study drug|0|||
13350319|NCT00946647|26653636|FG001|Phase ll Part|Subj cond no longer required study drug|0|||
13350320|NCT00946647|26653637|FG002|Phase ll Part|Subj cond no longer required study drug|0|||
13350321|NCT00946647|26653638|FG003|Phase ll Part|Subj cond no longer required study drug|2|||
13350322|NCT00946647|26653639|FG004|Phase ll Part|Subj cond no longer required study drug|0|||
13350323|NCT00946530|26653666|FG000|Overall Study|Withdrawal by Subject|0|||
13350324|NCT00946530|26653667|FG001|Overall Study|Withdrawal by Subject|3|||
13350325|NCT00946530|26653668|FG002|Overall Study|Withdrawal by Subject|0|||
13350326|NCT00946530|26653669|FG003|Overall Study|Withdrawal by Subject|3|||
13350327|NCT00946530|26653666|FG000|Overall Study|Physician Decision|1|||
13350328|NCT00946530|26653667|FG001|Overall Study|Physician Decision|1|||
13350329|NCT00946530|26653668|FG002|Overall Study|Physician Decision|1|||
13350330|NCT00946530|26653669|FG003|Overall Study|Physician Decision|1|||
13350331|NCT00946322|26653682|FG000|Pre-treatment|participant failure to follow up|1|||
13350332|NCT00946322|26653682|FG000|Post-treatment|participant failure to follow up|2|||
13350333|NCT00946309|26653705|FG000|Overall Study|Protocol Violation|1|||
13350334|NCT00946309|26653706|FG001|Overall Study|Protocol Violation|0|||
13350335|NCT00946309|26653705|FG000|Overall Study|Lost to Follow-up|0|||
13350336|NCT00946309|26653706|FG001|Overall Study|Lost to Follow-up|1|||
13350337|NCT00946309|26653705|FG000|Overall Study|Procedure cancelled/discontinued|0|||
13350338|NCT00946309|26653706|FG001|Overall Study|Procedure cancelled/discontinued|3|||
13350339|NCT00946296|26653719|FG000|Overall Study|Physician Decision|3|||
13350340|NCT00946296|26653720|FG001|Overall Study|Physician Decision|0|||
13350341|NCT00946192|26653741|FG000|Overall Study|Lost to Follow-up|6|||
13350342|NCT00946192|26653742|FG001|Overall Study|Lost to Follow-up|11|||
13350343|NCT00946192|26653743|FG002|Overall Study|Lost to Follow-up|9|||
13350344|NCT00946192|26653741|FG000|Overall Study|Withdrawal by Subject|10|||
13350345|NCT00946192|26653742|FG001|Overall Study|Withdrawal by Subject|7|||
13350346|NCT00946192|26653743|FG002|Overall Study|Withdrawal by Subject|3|||
13350347|NCT00946192|26653741|FG000|Overall Study|Did not start medication|2|||
13350348|NCT00946192|26653742|FG001|Overall Study|Did not start medication|0|||
13350349|NCT00946192|26653743|FG002|Overall Study|Did not start medication|0|||
13350350|NCT00946153|26653785|FG000|Phase 2|Adverse Event|0|||
13350351|NCT00946153|26653786|FG001|Phase 2|Adverse Event|0|||
13350352|NCT00946153|26653787|FG002|Phase 2|Adverse Event|0|||
13350353|NCT00946153|26653788|FG003|Phase 2|Adverse Event|0|||
13350354|NCT00946153|26653789|FG004|Phase 2|Adverse Event|6|||
13350355|NCT00946153|26653785|FG000|Phase 2|Need more reduction of dose|0|||
13350356|NCT00946153|26653786|FG001|Phase 2|Need more reduction of dose|0|||
13350357|NCT00946153|26653787|FG002|Phase 2|Need more reduction of dose|0|||
13350358|NCT00946153|26653788|FG003|Phase 2|Need more reduction of dose|0|||
13350359|NCT00946153|26653789|FG004|Phase 2|Need more reduction of dose|2|||
13350360|NCT00946153|26653785|FG000|Phase 2|Physician Decision|0|||
13350361|NCT00946153|26653786|FG001|Phase 2|Physician Decision|0|||
13350362|NCT00946153|26653787|FG002|Phase 2|Physician Decision|0|||
13350363|NCT00946153|26653788|FG003|Phase 2|Physician Decision|0|||
13350364|NCT00946153|26653789|FG004|Phase 2|Physician Decision|1|||
13350365|NCT00946153|26653785|FG000|Phase 2|14 days washout for recovery due to AE|0|||
13350366|NCT00946153|26653786|FG001|Phase 2|14 days washout for recovery due to AE|0|||
13350367|NCT00946153|26653787|FG002|Phase 2|14 days washout for recovery due to AE|0|||
13350368|NCT00946153|26653788|FG003|Phase 2|14 days washout for recovery due to AE|0|||
13350369|NCT00946153|26653789|FG004|Phase 2|14 days washout for recovery due to AE|4|||
13374274|NCT00797225|26726087|FG003|Weeks 1 to 12|Lack of Efficacy|0|||
13374275|NCT00797225|26726088|FG004|Weeks 1 to 12|Lack of Efficacy|0|||
13374276|NCT00797225|26726089|FG005|Weeks 1 to 12|Lack of Efficacy|0|||
13374277|NCT00797225|26726090|FG006|Weeks 1 to 12|Lack of Efficacy|0|||
13374278|NCT00797225|26726091|FG007|Weeks 1 to 12|Lack of Efficacy|0|||
13374279|NCT00797225|26726084|FG000|Weeks 1 to 12|Sponsor Decision|1|||
13374280|NCT00797225|26726085|FG001|Weeks 1 to 12|Sponsor Decision|0|||
13374281|NCT00797225|26726086|FG002|Weeks 1 to 12|Sponsor Decision|0|||
13374282|NCT00797225|26726087|FG003|Weeks 1 to 12|Sponsor Decision|0|||
13374283|NCT00797225|26726088|FG004|Weeks 1 to 12|Sponsor Decision|0|||
13374284|NCT00797225|26726089|FG005|Weeks 1 to 12|Sponsor Decision|0|||
13374285|NCT00797225|26726090|FG006|Weeks 1 to 12|Sponsor Decision|0|||
13374286|NCT00797225|26726091|FG007|Weeks 1 to 12|Sponsor Decision|0|||
13374287|NCT00797225|26726084|FG000|Weeks 13 to 24|Non-compliance|0|||
13374288|NCT00797225|26726085|FG001|Weeks 13 to 24|Non-compliance|2|||
13374289|NCT00797225|26726086|FG002|Weeks 13 to 24|Non-compliance|0|||
13374290|NCT00797225|26726087|FG003|Weeks 13 to 24|Non-compliance|0|||
13374291|NCT00797225|26726088|FG004|Weeks 13 to 24|Non-compliance|0|||
13374292|NCT00797225|26726089|FG005|Weeks 13 to 24|Non-compliance|0|||
13374293|NCT00797225|26726090|FG006|Weeks 13 to 24|Non-compliance|0|||
13374294|NCT00797225|26726091|FG007|Weeks 13 to 24|Non-compliance|0|||
13374295|NCT00797225|26726084|FG000|Weeks 13 to 24|Withdrawal by Subject|0|||
13374296|NCT00797225|26726085|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
13374297|NCT00797225|26726086|FG002|Weeks 13 to 24|Withdrawal by Subject|1|||
13374298|NCT00797225|26726087|FG003|Weeks 13 to 24|Withdrawal by Subject|0|||
13374299|NCT00797225|26726088|FG004|Weeks 13 to 24|Withdrawal by Subject|0|||
13374300|NCT00797225|26726089|FG005|Weeks 13 to 24|Withdrawal by Subject|0|||
13374301|NCT00797225|26726090|FG006|Weeks 13 to 24|Withdrawal by Subject|0|||
13374302|NCT00797225|26726091|FG007|Weeks 13 to 24|Withdrawal by Subject|0|||
13374303|NCT00797225|26726084|FG000|Weeks 13 to 24|Lost to Follow-up|0|||
13374304|NCT00797225|26726085|FG001|Weeks 13 to 24|Lost to Follow-up|0|||
13374305|NCT00797225|26726086|FG002|Weeks 13 to 24|Lost to Follow-up|1|||
13374306|NCT00797225|26726087|FG003|Weeks 13 to 24|Lost to Follow-up|0|||
13374307|NCT00797225|26726088|FG004|Weeks 13 to 24|Lost to Follow-up|1|||
13374308|NCT00797225|26726089|FG005|Weeks 13 to 24|Lost to Follow-up|0|||
13374309|NCT00797225|26726090|FG006|Weeks 13 to 24|Lost to Follow-up|0|||
13374310|NCT00797225|26726091|FG007|Weeks 13 to 24|Lost to Follow-up|0|||
13374311|NCT00797225|26726084|FG000|Weeks 13 to 24|Adverse Event|0|||
13374312|NCT00797225|26726085|FG001|Weeks 13 to 24|Adverse Event|1|||
13374313|NCT00797225|26726086|FG002|Weeks 13 to 24|Adverse Event|0|||
13374314|NCT00797225|26726087|FG003|Weeks 13 to 24|Adverse Event|0|||
13350370|NCT00946114|26653802|FG000|Overall Study|Death|5|||
13350371|NCT00946114|26653803|FG001|Overall Study|Death|2|||
13350372|NCT00946114|26653802|FG000|Overall Study|Other|1|||
13350373|NCT00946114|26653803|FG001|Overall Study|Other|0|||
13350374|NCT00946114|26653802|FG000|Overall Study|Withdrawal by Subject|2|||
13350375|NCT00946114|26653803|FG001|Overall Study|Withdrawal by Subject|0|||
13350376|NCT00946101|26653874|FG000|Overall Study|Lost to Follow-up|2|||
13350377|NCT00946101|26653875|FG001|Overall Study|Lost to Follow-up|1|||
13350378|NCT00946101|26653874|FG000|Overall Study|Withdrawal of consent|2|||
13350379|NCT00946101|26653875|FG001|Overall Study|Withdrawal of consent|0|||
13350380|NCT00946101|26653874|FG000|Overall Study|Physician Decision|0|||
13350381|NCT00946101|26653875|FG001|Overall Study|Physician Decision|1|||
13350382|NCT00946088|26653904|FG000|Overall Study|Withdrawal by Subject|0|||
13350383|NCT00946088|26653905|FG001|Overall Study|Withdrawal by Subject|1|||
13350384|NCT00945945|26653938|FG000|Overall Study|Adverse Event|15|||
13350385|NCT00945945|26653939|FG001|Overall Study|Adverse Event|35|||
13350386|NCT00945945|26653938|FG000|Overall Study|Withdrawal by Subject|7|||
13350387|NCT00945945|26653939|FG001|Overall Study|Withdrawal by Subject|10|||
13350388|NCT00945945|26653938|FG000|Overall Study|Lost to Follow-up|4|||
13350389|NCT00945945|26653939|FG001|Overall Study|Lost to Follow-up|5|||
13350390|NCT00945945|26653938|FG000|Overall Study|Lack of Efficacy|6|||
13350391|NCT00945945|26653939|FG001|Overall Study|Lack of Efficacy|2|||
13350392|NCT00945945|26653938|FG000|Overall Study|Protocol Violation|4|||
13350393|NCT00945945|26653939|FG001|Overall Study|Protocol Violation|2|||
13350394|NCT00945945|26653938|FG000|Overall Study|Entry Criteria Not Met|0|||
13350395|NCT00945945|26653939|FG001|Overall Study|Entry Criteria Not Met|1|||
13350396|NCT00945906|26653950|FG000|Overall Study|Withdrawal by Subject|1|||
13350397|NCT00945906|26653950|FG000|Overall Study|Did not want to return for last visit|2|||
13350398|NCT00945906|26653950|FG000|Overall Study|Unable to return for last visit|2|||
13350399|NCT00945906|26653950|FG000|Overall Study|Moved to another country|2|||
13350400|NCT00945893|26654021|FG000|Overall Study|Lost to Follow-up|2|||
13350401|NCT00945893|26654022|FG001|Overall Study|Lost to Follow-up|8|||
13350402|NCT00945893|26654021|FG000|Overall Study|Withdrawal of consent|1|||
13350403|NCT00945893|26654022|FG001|Overall Study|Withdrawal of consent|2|||
13350404|NCT00945815|26654029|FG000|Overall Study|Death|3|||
13350405|NCT00945815|26654029|FG000|Overall Study|Not protocol specified|1|||
13350406|NCT00945815|26654029|FG000|Overall Study|Ineligible|3|||
13350407|NCT00945815|26654029|FG000|Overall Study|Did not begin protocol therapy|1|||
13350408|NCT00945659|26654083|FG000|Overall Study|Lost to Follow-up|7|||
13350409|NCT00945659|26654084|FG001|Overall Study|Lost to Follow-up|20|||
13350410|NCT00945659|26654085|FG002|Overall Study|Lost to Follow-up|17|||
13350411|NCT00945555|26654098|FG000|Overall Study|Referred to another hospital|5|||
13350412|NCT00945555|26654098|FG000|Overall Study|Worsening condition, intensive care unit|1|||
13350413|NCT00945555|26654098|FG000|Overall Study|Withdrawal by Subject|2|||
13350414|NCT00945555|26654098|FG000|Overall Study|Participant continued treatment at home|1|||
13350415|NCT00945555|26654098|FG000|Overall Study|Death|18|||
13350416|NCT00945555|26654098|FG000|Overall Study|Other|1|||
13350417|NCT00945477|26654105|FG000|Overall Study|Adverse Event|3|||
13350418|NCT00945477|26654105|FG000|Overall Study|Lack of Efficacy|2|||
13350419|NCT00945477|26654105|FG000|Overall Study|Withdrawal by Subject|1|||
13350420|NCT00945321|26654132|FG000|Period 1|Adverse Event|0|||
13350421|NCT00945321|26654133|FG001|Period 1|Adverse Event|0|||
13350422|NCT00945321|26654134|FG002|Period 1|Adverse Event|0|||
13350423|NCT00945321|26654135|FG003|Period 1|Adverse Event|0|||
13350424|NCT00945321|26654136|FG004|Period 1|Adverse Event|1|||
13350425|NCT00945321|26654137|FG005|Period 1|Adverse Event|0|||
13350426|NCT00945321|26654132|FG000|Period 4|Lost to Follow-up|0|||
13350427|NCT00945321|26654133|FG001|Period 4|Lost to Follow-up|0|||
13350428|NCT00945321|26654134|FG002|Period 4|Lost to Follow-up|0|||
13350429|NCT00945321|26654135|FG003|Period 4|Lost to Follow-up|0|||
13350430|NCT00945321|26654136|FG004|Period 4|Lost to Follow-up|0|||
13350431|NCT00945321|26654137|FG005|Period 4|Lost to Follow-up|1|||
13350432|NCT00945243|26654145|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3|||
13350433|NCT00945191|26654153|FG000|Overall Study|Did not achieve a complete response|18|||
13350434|NCT00945191|26654153|FG000|Overall Study|Participant relocated to another state|1|||
13350435|NCT00945191|26654153|FG000|Overall Study|Disease progression|3|||
13350436|NCT00945191|26654153|FG000|Overall Study|Serious adverse event or adverse event|1|||
13350437|NCT00945191|26654153|FG000|Overall Study|Investigator's discretion|1|||
13350438|NCT00944697|26654166|FG000|Overall Study|Withdrawal by Subject|1|||
13350439|NCT00944697|26654167|FG001|Overall Study|Withdrawal by Subject|1|||
13350440|NCT00944697|26654166|FG000|Overall Study|Adverse Event|0|||
13350441|NCT00944697|26654167|FG001|Overall Study|Adverse Event|3|||
13350442|NCT00944697|26654166|FG000|Overall Study|Administrative|1|||
13350443|NCT00944697|26654167|FG001|Overall Study|Administrative|1|||
13350444|NCT00944658|26654186|FG000|Treatment 12 Weeks|Adverse Event|0|||
13350445|NCT00944658|26654187|FG001|Treatment 12 Weeks|Adverse Event|2|||
13350446|NCT00944645|26654202|FG000|Period 2|Adverse Event|1|||
13350447|NCT00944645|26654203|FG001|Period 2|Adverse Event|0|||
13350448|NCT00944645|26654202|FG000|Period 2|Lost to Follow-up|0|||
13350449|NCT00944645|26654203|FG001|Period 2|Lost to Follow-up|3|||
13350450|NCT00944645|26654202|FG000|Period 2|Withdrawal by Subject|7|||
13350451|NCT00944645|26654203|FG001|Period 2|Withdrawal by Subject|6|||
13350452|NCT00944229|26654211|FG000|Overall Study|Withdrawal by Subject|11|||
13350453|NCT00944229|26654211|FG000|Overall Study|Physician Decision|14|||
13350454|NCT00944125|26654220|FG000|3 to 6 Months|Withdrawal by Subject|0|||
13350455|NCT00944125|26654221|FG001|3 to 6 Months|Withdrawal by Subject|2|||
13350456|NCT00944125|26654220|FG000|6 Months to Study Completion|Withdrawal by Subject|0|||
13350457|NCT00944125|26654221|FG001|6 Months to Study Completion|Withdrawal by Subject|2|||
13350458|NCT00944034|26654323|FG000|Overall Study|Inappropriate enrollment|0|||
13350459|NCT00944034|26654324|FG001|Overall Study|Inappropriate enrollment|1|||
13350460|NCT00944034|26654325|FG002|Overall Study|Inappropriate enrollment|0|||
13350461|NCT00944034|26654326|FG003|Overall Study|Inappropriate enrollment|1|||
13350462|NCT00944034|26654327|FG004|Overall Study|Inappropriate enrollment|2|||
13350463|NCT00944034|26654328|FG005|Overall Study|Inappropriate enrollment|1|||
13350464|NCT00944034|26654329|FG006|Overall Study|Inappropriate enrollment|0|||
13350465|NCT00944034|26654330|FG007|Overall Study|Inappropriate enrollment|0|||
13350466|NCT00944034|26654331|FG008|Overall Study|Inappropriate enrollment|1|||
13350467|NCT00944034|26654332|FG009|Overall Study|Inappropriate enrollment|1|||
13350468|NCT00944034|26654333|FG010|Overall Study|Inappropriate enrollment|0|||
13350469|NCT00944034|26654334|FG011|Overall Study|Inappropriate enrollment|0|||
13350470|NCT00944034|26654323|FG000|Overall Study|Withdrawal by Subject|3|||
13350471|NCT00944034|26654324|FG001|Overall Study|Withdrawal by Subject|2|||
13350472|NCT00944034|26654325|FG002|Overall Study|Withdrawal by Subject|6|||
13124873|NCT02937701|25954304|FG002|Week 22 to Week 50|Lost to Follow-up|2|||
13124874|NCT02937701|25954305|FG003|Week 22 to Week 50|Lost to Follow-up|0|||
13124875|NCT02937701|25954306|FG004|Week 22 to Week 50|Lost to Follow-up|1|||
13124876|NCT02937701|25954302|FG000|Week 22 to Week 50|Physician Decision|0|||
13124877|NCT02937701|25954303|FG001|Week 22 to Week 50|Physician Decision|0|||
13124878|NCT02937701|25954304|FG002|Week 22 to Week 50|Physician Decision|2|||
13124879|NCT02937701|25954305|FG003|Week 22 to Week 50|Physician Decision|0|||
13350473|NCT00944034|26654326|FG003|Overall Study|Withdrawal by Subject|2|||
13350474|NCT00944034|26654327|FG004|Overall Study|Withdrawal by Subject|5|||
13350475|NCT00944034|26654328|FG005|Overall Study|Withdrawal by Subject|8|||
13350476|NCT00944034|26654329|FG006|Overall Study|Withdrawal by Subject|2|||
13350477|NCT00944034|26654330|FG007|Overall Study|Withdrawal by Subject|2|||
13350478|NCT00944034|26654331|FG008|Overall Study|Withdrawal by Subject|3|||
13350479|NCT00944034|26654332|FG009|Overall Study|Withdrawal by Subject|4|||
13350480|NCT00944034|26654333|FG010|Overall Study|Withdrawal by Subject|0|||
13350481|NCT00944034|26654334|FG011|Overall Study|Withdrawal by Subject|4|||
13350482|NCT00944034|26654323|FG000|Overall Study|Lost to Follow-up|0|||
13350483|NCT00944034|26654324|FG001|Overall Study|Lost to Follow-up|4|||
13350484|NCT00944034|26654325|FG002|Overall Study|Lost to Follow-up|2|||
13350485|NCT00944034|26654326|FG003|Overall Study|Lost to Follow-up|0|||
13350486|NCT00944034|26654327|FG004|Overall Study|Lost to Follow-up|5|||
13350487|NCT00944034|26654328|FG005|Overall Study|Lost to Follow-up|7|||
13350488|NCT00944034|26654329|FG006|Overall Study|Lost to Follow-up|0|||
13350489|NCT00944034|26654330|FG007|Overall Study|Lost to Follow-up|1|||
13350490|NCT00944034|26654331|FG008|Overall Study|Lost to Follow-up|5|||
13350491|NCT00944034|26654332|FG009|Overall Study|Lost to Follow-up|1|||
13350492|NCT00944034|26654333|FG010|Overall Study|Lost to Follow-up|1|||
13350493|NCT00944034|26654334|FG011|Overall Study|Lost to Follow-up|0|||
13350494|NCT00944034|26654323|FG000|Overall Study|Death|0|||
13350495|NCT00944034|26654324|FG001|Overall Study|Death|0|||
13350496|NCT00944034|26654325|FG002|Overall Study|Death|1|||
13350497|NCT00944034|26654326|FG003|Overall Study|Death|0|||
13350498|NCT00944034|26654327|FG004|Overall Study|Death|0|||
13350499|NCT00944034|26654328|FG005|Overall Study|Death|0|||
13350500|NCT00944034|26654329|FG006|Overall Study|Death|0|||
13350501|NCT00944034|26654330|FG007|Overall Study|Death|0|||
13350502|NCT00944034|26654331|FG008|Overall Study|Death|0|||
13350503|NCT00944034|26654332|FG009|Overall Study|Death|0|||
13350504|NCT00944034|26654333|FG010|Overall Study|Death|0|||
13350505|NCT00944034|26654334|FG011|Overall Study|Death|0|||
13350506|NCT00944034|26654323|FG000|Overall Study|Protocol Violation|2|||
13350507|NCT00944034|26654324|FG001|Overall Study|Protocol Violation|0|||
13350508|NCT00944034|26654325|FG002|Overall Study|Protocol Violation|0|||
13350509|NCT00944034|26654326|FG003|Overall Study|Protocol Violation|1|||
13350510|NCT00944034|26654327|FG004|Overall Study|Protocol Violation|2|||
13350511|NCT00944034|26654328|FG005|Overall Study|Protocol Violation|3|||
13350512|NCT00944034|26654329|FG006|Overall Study|Protocol Violation|0|||
13350513|NCT00944034|26654330|FG007|Overall Study|Protocol Violation|1|||
13350514|NCT00944034|26654331|FG008|Overall Study|Protocol Violation|1|||
13350515|NCT00944034|26654332|FG009|Overall Study|Protocol Violation|4|||
13124880|NCT02937701|25954306|FG004|Week 22 to Week 50|Physician Decision|1|||
13350516|NCT00944034|26654333|FG010|Overall Study|Protocol Violation|0|||
13350517|NCT00944034|26654334|FG011|Overall Study|Protocol Violation|0|||
13350518|NCT00944034|26654323|FG000|Overall Study|Unable to classify|0|||
13350519|NCT00944034|26654324|FG001|Overall Study|Unable to classify|0|||
13350520|NCT00944034|26654325|FG002|Overall Study|Unable to classify|0|||
13350521|NCT00944034|26654326|FG003|Overall Study|Unable to classify|0|||
13350522|NCT00944034|26654327|FG004|Overall Study|Unable to classify|0|||
13350523|NCT00944034|26654328|FG005|Overall Study|Unable to classify|1|||
13350524|NCT00944034|26654329|FG006|Overall Study|Unable to classify|1|||
13350525|NCT00944034|26654330|FG007|Overall Study|Unable to classify|1|||
13350526|NCT00944034|26654331|FG008|Overall Study|Unable to classify|0|||
13350527|NCT00944034|26654332|FG009|Overall Study|Unable to classify|0|||
13350528|NCT00944034|26654333|FG010|Overall Study|Unable to classify|0|||
13350529|NCT00944034|26654334|FG011|Overall Study|Unable to classify|0|||
13350530|NCT00944034|26654323|FG000|Overall Study|Administrative reason|0|||
13350531|NCT00944034|26654324|FG001|Overall Study|Administrative reason|0|||
13350532|NCT00944034|26654325|FG002|Overall Study|Administrative reason|0|||
13350533|NCT00944034|26654326|FG003|Overall Study|Administrative reason|0|||
13350534|NCT00944034|26654327|FG004|Overall Study|Administrative reason|0|||
13350535|NCT00944034|26654328|FG005|Overall Study|Administrative reason|0|||
13350536|NCT00944034|26654329|FG006|Overall Study|Administrative reason|1|||
13350537|NCT00944034|26654330|FG007|Overall Study|Administrative reason|0|||
13350538|NCT00944034|26654331|FG008|Overall Study|Administrative reason|0|||
13350539|NCT00944034|26654332|FG009|Overall Study|Administrative reason|0|||
13350540|NCT00944034|26654333|FG010|Overall Study|Administrative reason|0|||
13350541|NCT00944034|26654334|FG011|Overall Study|Administrative reason|0|||
13350542|NCT00943917|26654427|FG000|Stage I|Adverse Event|1|||
13350543|NCT00943917|26654428|FG001|Stage I|Adverse Event|2|||
13350544|NCT00943917|26654429|FG002|Stage I|Adverse Event|2|||
13350545|NCT00943917|26654430|FG003|Stage I|Adverse Event|0|||
13350546|NCT00943917|26654431|FG004|Stage I|Adverse Event|0|||
13350547|NCT00943917|26654432|FG005|Stage I|Adverse Event|0|||
13350548|NCT00943917|26654433|FG006|Stage I|Adverse Event|0|||
13350549|NCT00943917|26654434|FG007|Stage I|Adverse Event|0|||
13350550|NCT00943917|26654435|FG008|Stage I|Adverse Event|0|||
13350551|NCT00943917|26654436|FG009|Stage I|Adverse Event|0|||
13350552|NCT00943917|26654437|FG010|Stage I|Adverse Event|0|||
13350553|NCT00943917|26654438|FG011|Stage I|Adverse Event|0|||
13350554|NCT00943917|26654439|FG012|Stage I|Adverse Event|0|||
13350555|NCT00943917|26654440|FG013|Stage I|Adverse Event|0|||
13350556|NCT00943917|26654441|FG014|Stage I|Adverse Event|0|||
13350557|NCT00943917|26654427|FG000|Stage I|Lost to Follow-up|0|||
13350558|NCT00943917|26654428|FG001|Stage I|Lost to Follow-up|0|||
13350559|NCT00943917|26654429|FG002|Stage I|Lost to Follow-up|1|||
13350560|NCT00943917|26654430|FG003|Stage I|Lost to Follow-up|0|||
13350561|NCT00943917|26654431|FG004|Stage I|Lost to Follow-up|0|||
13350562|NCT00943917|26654432|FG005|Stage I|Lost to Follow-up|0|||
13350563|NCT00943917|26654433|FG006|Stage I|Lost to Follow-up|0|||
13350564|NCT00943917|26654434|FG007|Stage I|Lost to Follow-up|0|||
13350565|NCT00943917|26654435|FG008|Stage I|Lost to Follow-up|0|||
13350566|NCT00943917|26654436|FG009|Stage I|Lost to Follow-up|0|||
13350567|NCT00943917|26654437|FG010|Stage I|Lost to Follow-up|0|||
13350568|NCT00943917|26654438|FG011|Stage I|Lost to Follow-up|0|||
13350569|NCT00943917|26654439|FG012|Stage I|Lost to Follow-up|0|||
13350570|NCT00943917|26654440|FG013|Stage I|Lost to Follow-up|0|||
13350571|NCT00943917|26654441|FG014|Stage I|Lost to Follow-up|0|||
13350572|NCT00943917|26654427|FG000|Stage I|hyperglycemia|0|||
13350573|NCT00943917|26654428|FG001|Stage I|hyperglycemia|0|||
13350574|NCT00943917|26654429|FG002|Stage I|hyperglycemia|1|||
13350575|NCT00943917|26654430|FG003|Stage I|hyperglycemia|0|||
13350576|NCT00943917|26654431|FG004|Stage I|hyperglycemia|0|||
13350577|NCT00943917|26654432|FG005|Stage I|hyperglycemia|0|||
13350578|NCT00943917|26654433|FG006|Stage I|hyperglycemia|0|||
13350579|NCT00943917|26654434|FG007|Stage I|hyperglycemia|0|||
13350580|NCT00943917|26654435|FG008|Stage I|hyperglycemia|0|||
13350581|NCT00943917|26654436|FG009|Stage I|hyperglycemia|0|||
13350582|NCT00943917|26654437|FG010|Stage I|hyperglycemia|0|||
13350583|NCT00943917|26654438|FG011|Stage I|hyperglycemia|0|||
13350584|NCT00943917|26654439|FG012|Stage I|hyperglycemia|0|||
13350585|NCT00943917|26654440|FG013|Stage I|hyperglycemia|0|||
13350586|NCT00943917|26654441|FG014|Stage I|hyperglycemia|0|||
13350587|NCT00943917|26654427|FG000|Stage I|A1C elevation|1|||
13350588|NCT00943917|26654428|FG001|Stage I|A1C elevation|0|||
13350589|NCT00943917|26654429|FG002|Stage I|A1C elevation|0|||
13350590|NCT00943917|26654430|FG003|Stage I|A1C elevation|0|||
13350591|NCT00943917|26654431|FG004|Stage I|A1C elevation|0|||
13350592|NCT00943917|26654432|FG005|Stage I|A1C elevation|0|||
13350593|NCT00943917|26654433|FG006|Stage I|A1C elevation|0|||
13350594|NCT00943917|26654434|FG007|Stage I|A1C elevation|0|||
13350595|NCT00943917|26654435|FG008|Stage I|A1C elevation|0|||
13350596|NCT00943917|26654436|FG009|Stage I|A1C elevation|0|||
13350597|NCT00943917|26654437|FG010|Stage I|A1C elevation|0|||
13350598|NCT00943917|26654438|FG011|Stage I|A1C elevation|0|||
13350599|NCT00943917|26654439|FG012|Stage I|A1C elevation|0|||
13350600|NCT00943917|26654440|FG013|Stage I|A1C elevation|0|||
13350601|NCT00943917|26654441|FG014|Stage I|A1C elevation|0|||
13350602|NCT00943917|26654427|FG000|Stage I|Withdrawal by Subject|2|||
13350603|NCT00943917|26654428|FG001|Stage I|Withdrawal by Subject|1|||
13350604|NCT00943917|26654429|FG002|Stage I|Withdrawal by Subject|2|||
13350605|NCT00943917|26654430|FG003|Stage I|Withdrawal by Subject|0|||
13350606|NCT00943917|26654431|FG004|Stage I|Withdrawal by Subject|0|||
13350607|NCT00943917|26654432|FG005|Stage I|Withdrawal by Subject|0|||
13350608|NCT00943917|26654433|FG006|Stage I|Withdrawal by Subject|0|||
13350609|NCT00943917|26654434|FG007|Stage I|Withdrawal by Subject|0|||
13350610|NCT00943917|26654435|FG008|Stage I|Withdrawal by Subject|0|||
13350611|NCT00943917|26654436|FG009|Stage I|Withdrawal by Subject|0|||
13350612|NCT00943917|26654437|FG010|Stage I|Withdrawal by Subject|0|||
13350613|NCT00943917|26654438|FG011|Stage I|Withdrawal by Subject|0|||
13350614|NCT00943917|26654439|FG012|Stage I|Withdrawal by Subject|0|||
13350615|NCT00943917|26654440|FG013|Stage I|Withdrawal by Subject|0|||
13350616|NCT00943917|26654441|FG014|Stage I|Withdrawal by Subject|0|||
13350617|NCT00943917|26654427|FG000|Stage II|Adverse Event|0|||
13350618|NCT00943917|26654428|FG001|Stage II|Adverse Event|0|||
13350619|NCT00943917|26654429|FG002|Stage II|Adverse Event|0|||
13350620|NCT00943917|26654430|FG003|Stage II|Adverse Event|0|||
13350621|NCT00943917|26654431|FG004|Stage II|Adverse Event|0|||
13350622|NCT00943917|26654432|FG005|Stage II|Adverse Event|1|||
13350623|NCT00943917|26654433|FG006|Stage II|Adverse Event|3|||
13350624|NCT00943917|26654434|FG007|Stage II|Adverse Event|0|||
13350625|NCT00943917|26654435|FG008|Stage II|Adverse Event|1|||
13350626|NCT00943917|26654436|FG009|Stage II|Adverse Event|0|||
13350627|NCT00943917|26654437|FG010|Stage II|Adverse Event|0|||
13350628|NCT00943917|26654438|FG011|Stage II|Adverse Event|0|||
13350629|NCT00943917|26654439|FG012|Stage II|Adverse Event|0|||
13350630|NCT00943917|26654440|FG013|Stage II|Adverse Event|0|||
13350631|NCT00943917|26654441|FG014|Stage II|Adverse Event|0|||
13350632|NCT00943917|26654427|FG000|Stage II|Withdrawal by Subject|0|||
13350633|NCT00943917|26654428|FG001|Stage II|Withdrawal by Subject|0|||
13350634|NCT00943917|26654429|FG002|Stage II|Withdrawal by Subject|0|||
13350635|NCT00943917|26654430|FG003|Stage II|Withdrawal by Subject|0|||
13350636|NCT00943917|26654431|FG004|Stage II|Withdrawal by Subject|0|||
13350637|NCT00943917|26654432|FG005|Stage II|Withdrawal by Subject|1|||
13350638|NCT00943917|26654433|FG006|Stage II|Withdrawal by Subject|0|||
13350639|NCT00943917|26654434|FG007|Stage II|Withdrawal by Subject|0|||
13350640|NCT00943917|26654435|FG008|Stage II|Withdrawal by Subject|0|||
13350641|NCT00943917|26654436|FG009|Stage II|Withdrawal by Subject|0|||
13350642|NCT00943917|26654437|FG010|Stage II|Withdrawal by Subject|0|||
13350643|NCT00943917|26654438|FG011|Stage II|Withdrawal by Subject|0|||
13350644|NCT00943917|26654439|FG012|Stage II|Withdrawal by Subject|0|||
13350645|NCT00943917|26654440|FG013|Stage II|Withdrawal by Subject|0|||
13350646|NCT00943917|26654441|FG014|Stage II|Withdrawal by Subject|0|||
13350647|NCT00943917|26654427|FG000|Stage II|Pregnancy|0|||
13350648|NCT00943917|26654428|FG001|Stage II|Pregnancy|0|||
13350649|NCT00943917|26654429|FG002|Stage II|Pregnancy|0|||
13350650|NCT00943917|26654430|FG003|Stage II|Pregnancy|0|||
13350651|NCT00943917|26654431|FG004|Stage II|Pregnancy|0|||
13350652|NCT00943917|26654432|FG005|Stage II|Pregnancy|1|||
13350653|NCT00943917|26654433|FG006|Stage II|Pregnancy|0|||
13350654|NCT00943917|26654434|FG007|Stage II|Pregnancy|0|||
13350655|NCT00943917|26654435|FG008|Stage II|Pregnancy|0|||
13350656|NCT00943917|26654436|FG009|Stage II|Pregnancy|0|||
13350657|NCT00943917|26654437|FG010|Stage II|Pregnancy|0|||
13350658|NCT00943917|26654438|FG011|Stage II|Pregnancy|0|||
13350659|NCT00943917|26654439|FG012|Stage II|Pregnancy|0|||
13350660|NCT00943917|26654440|FG013|Stage II|Pregnancy|0|||
13350661|NCT00943917|26654441|FG014|Stage II|Pregnancy|0|||
13350662|NCT00943917|26654427|FG000|Stage II Continuation|Adverse Event|0|||
13350663|NCT00943917|26654428|FG001|Stage II Continuation|Adverse Event|0|||
13350664|NCT00943917|26654429|FG002|Stage II Continuation|Adverse Event|0|||
13350665|NCT00943917|26654430|FG003|Stage II Continuation|Adverse Event|0|||
13350666|NCT00943917|26654431|FG004|Stage II Continuation|Adverse Event|0|||
13350667|NCT00943917|26654432|FG005|Stage II Continuation|Adverse Event|0|||
13350668|NCT00943917|26654433|FG006|Stage II Continuation|Adverse Event|0|||
13350669|NCT00943917|26654434|FG007|Stage II Continuation|Adverse Event|0|||
13350670|NCT00943917|26654435|FG008|Stage II Continuation|Adverse Event|0|||
13350671|NCT00943917|26654436|FG009|Stage II Continuation|Adverse Event|0|||
13350672|NCT00943917|26654437|FG010|Stage II Continuation|Adverse Event|0|||
13350673|NCT00943917|26654438|FG011|Stage II Continuation|Adverse Event|1|||
13350674|NCT00943917|26654439|FG012|Stage II Continuation|Adverse Event|2|||
13350675|NCT00943917|26654440|FG013|Stage II Continuation|Adverse Event|1|||
13350676|NCT00943917|26654441|FG014|Stage II Continuation|Adverse Event|1|||
13350677|NCT00943917|26654427|FG000|Stage II Continuation|Withdrawal by Subject|0|||
13350678|NCT00943917|26654428|FG001|Stage II Continuation|Withdrawal by Subject|0|||
13350679|NCT00943917|26654429|FG002|Stage II Continuation|Withdrawal by Subject|0|||
13350680|NCT00943917|26654430|FG003|Stage II Continuation|Withdrawal by Subject|0|||
13350681|NCT00943917|26654431|FG004|Stage II Continuation|Withdrawal by Subject|0|||
13350682|NCT00943917|26654432|FG005|Stage II Continuation|Withdrawal by Subject|0|||
13350683|NCT00943917|26654433|FG006|Stage II Continuation|Withdrawal by Subject|0|||
13350684|NCT00943917|26654434|FG007|Stage II Continuation|Withdrawal by Subject|0|||
13350685|NCT00943917|26654435|FG008|Stage II Continuation|Withdrawal by Subject|0|||
13350686|NCT00943917|26654436|FG009|Stage II Continuation|Withdrawal by Subject|0|||
13350687|NCT00943917|26654437|FG010|Stage II Continuation|Withdrawal by Subject|0|||
13350688|NCT00943917|26654438|FG011|Stage II Continuation|Withdrawal by Subject|0|||
13350689|NCT00943917|26654439|FG012|Stage II Continuation|Withdrawal by Subject|0|||
13350690|NCT00943917|26654440|FG013|Stage II Continuation|Withdrawal by Subject|1|||
13350691|NCT00943917|26654441|FG014|Stage II Continuation|Withdrawal by Subject|3|||
13350692|NCT00943917|26654427|FG000|Stage II Continuation|Protocol Violation|0|||
13350693|NCT00943917|26654428|FG001|Stage II Continuation|Protocol Violation|0|||
13350694|NCT00943917|26654429|FG002|Stage II Continuation|Protocol Violation|0|||
13350695|NCT00943917|26654430|FG003|Stage II Continuation|Protocol Violation|0|||
13350696|NCT00943917|26654431|FG004|Stage II Continuation|Protocol Violation|0|||
13350697|NCT00943917|26654432|FG005|Stage II Continuation|Protocol Violation|0|||
13350698|NCT00943917|26654433|FG006|Stage II Continuation|Protocol Violation|0|||
13350699|NCT00943917|26654434|FG007|Stage II Continuation|Protocol Violation|0|||
13350700|NCT00943917|26654435|FG008|Stage II Continuation|Protocol Violation|0|||
13350701|NCT00943917|26654436|FG009|Stage II Continuation|Protocol Violation|1|||
13350702|NCT00943917|26654437|FG010|Stage II Continuation|Protocol Violation|0|||
13350703|NCT00943917|26654438|FG011|Stage II Continuation|Protocol Violation|1|||
13350704|NCT00943917|26654439|FG012|Stage II Continuation|Protocol Violation|0|||
13350705|NCT00943917|26654440|FG013|Stage II Continuation|Protocol Violation|0|||
13350706|NCT00943917|26654441|FG014|Stage II Continuation|Protocol Violation|0|||
13350707|NCT00943917|26654427|FG000|Stage II Continuation|hypoglycemia|0|||
13350708|NCT00943917|26654428|FG001|Stage II Continuation|hypoglycemia|0|||
13350709|NCT00943917|26654429|FG002|Stage II Continuation|hypoglycemia|0|||
13350710|NCT00943917|26654430|FG003|Stage II Continuation|hypoglycemia|0|||
13350711|NCT00943917|26654431|FG004|Stage II Continuation|hypoglycemia|0|||
13350712|NCT00943917|26654432|FG005|Stage II Continuation|hypoglycemia|0|||
13350713|NCT00943917|26654433|FG006|Stage II Continuation|hypoglycemia|0|||
13350714|NCT00943917|26654434|FG007|Stage II Continuation|hypoglycemia|0|||
13350715|NCT00943917|26654435|FG008|Stage II Continuation|hypoglycemia|0|||
13350716|NCT00943917|26654436|FG009|Stage II Continuation|hypoglycemia|0|||
13350717|NCT00943917|26654437|FG010|Stage II Continuation|hypoglycemia|0|||
13350718|NCT00943917|26654438|FG011|Stage II Continuation|hypoglycemia|0|||
13350719|NCT00943917|26654439|FG012|Stage II Continuation|hypoglycemia|1|||
13350720|NCT00943917|26654440|FG013|Stage II Continuation|hypoglycemia|0|||
13350721|NCT00943917|26654441|FG014|Stage II Continuation|hypoglycemia|0|||
13350722|NCT00943917|26654427|FG000|Stage II Continuation|A1C elevation|0|||
13350723|NCT00943917|26654428|FG001|Stage II Continuation|A1C elevation|0|||
13350724|NCT00943917|26654429|FG002|Stage II Continuation|A1C elevation|0|||
13350725|NCT00943917|26654430|FG003|Stage II Continuation|A1C elevation|0|||
13350726|NCT00943917|26654431|FG004|Stage II Continuation|A1C elevation|0|||
13350727|NCT00943917|26654432|FG005|Stage II Continuation|A1C elevation|0|||
13350728|NCT00943917|26654433|FG006|Stage II Continuation|A1C elevation|0|||
13350729|NCT00943917|26654434|FG007|Stage II Continuation|A1C elevation|0|||
13350730|NCT00943917|26654435|FG008|Stage II Continuation|A1C elevation|0|||
13350731|NCT00943917|26654436|FG009|Stage II Continuation|A1C elevation|0|||
13350732|NCT00943917|26654437|FG010|Stage II Continuation|A1C elevation|0|||
13350733|NCT00943917|26654438|FG011|Stage II Continuation|A1C elevation|0|||
13350734|NCT00943917|26654439|FG012|Stage II Continuation|A1C elevation|0|||
13350735|NCT00943917|26654440|FG013|Stage II Continuation|A1C elevation|1|||
13350736|NCT00943917|26654441|FG014|Stage II Continuation|A1C elevation|0|||
13350737|NCT00943852|26654463|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
13350738|NCT00943852|26654464|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
13350739|NCT00943852|26654465|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
13350740|NCT00943852|26654466|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1|||
13350741|NCT00943852|26654467|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
13350742|NCT00943852|26654468|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
13350743|NCT00943852|26654469|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
13350744|NCT00943852|26654470|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
13350745|NCT00943852|26654471|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
13350746|NCT00943852|26654472|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
13350747|NCT00943852|26654463|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0|||
13350748|NCT00943852|26654464|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0|||
13350749|NCT00943852|26654465|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0|||
13350750|NCT00943852|26654466|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0|||
13350751|NCT00943852|26654467|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0|||
13350752|NCT00943852|26654468|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1|||
13350753|NCT00943852|26654469|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0|||
13350754|NCT00943852|26654470|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0|||
13350755|NCT00943852|26654471|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0|||
13350756|NCT00943852|26654472|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0|||
13350757|NCT00943852|26654463|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
13350758|NCT00943852|26654464|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
13350759|NCT00943852|26654465|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
13350760|NCT00943852|26654466|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
13350761|NCT00943852|26654467|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
13350762|NCT00943852|26654468|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
13350763|NCT00943852|26654469|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1|||
13350764|NCT00943852|26654470|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
13350765|NCT00943852|26654471|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
13350766|NCT00943852|26654472|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
13350767|NCT00943852|26654463|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
13350768|NCT00943852|26654464|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
13350769|NCT00943852|26654465|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
13350770|NCT00943852|26654466|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
13350771|NCT00943852|26654467|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
13350772|NCT00943852|26654468|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
13350773|NCT00943852|26654469|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
13350774|NCT00943852|26654470|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1|||
13350775|NCT00943852|26654471|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
13350776|NCT00943852|26654472|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
13350777|NCT00943852|26654463|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1|||
13350778|NCT00943852|26654464|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0|||
13350779|NCT00943852|26654465|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1|||
13350780|NCT00943852|26654466|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1|||
13350781|NCT00943852|26654467|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0|||
13350782|NCT00943852|26654468|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0|||
13350783|NCT00943852|26654469|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1|||
13350784|NCT00943852|26654470|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0|||
13350785|NCT00943852|26654471|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0|||
13350786|NCT00943852|26654472|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0|||
13350787|NCT00943826|26654497|FG000|Concurrent Phase|Adverse Event|50|||
13350788|NCT00943826|26654498|FG001|Concurrent Phase|Adverse Event|27|||
13350789|NCT00943826|26654497|FG000|Concurrent Phase|Withdrew consent|3|||
13350790|NCT00943826|26654498|FG001|Concurrent Phase|Withdrew consent|7|||
13350791|NCT00943826|26654497|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5|||
13350792|NCT00943826|26654498|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7|||
13350793|NCT00943826|26654497|FG000|Concurrent Phase|Administrative reasons|2|||
13350794|NCT00943826|26654498|FG001|Concurrent Phase|Administrative reasons|1|||
13350795|NCT00943826|26654497|FG000|Concurrent Phase|Protocol Violation|1|||
13350796|NCT00943826|26654498|FG001|Concurrent Phase|Protocol Violation|0|||
13350797|NCT00943826|26654497|FG000|Maintenance Phase|Adverse Event|31|||
13350798|NCT00943826|26654498|FG001|Maintenance Phase|Adverse Event|30|||
13350799|NCT00943826|26654497|FG000|Maintenance Phase|Withdrew consent|2|||
13350800|NCT00943826|26654498|FG001|Maintenance Phase|Withdrew consent|4|||
13350801|NCT00943826|26654497|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6|||
13350802|NCT00943826|26654498|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3|||
13350803|NCT00943826|26654497|FG000|Maintenance Phase|Administrative reasons|4|||
13350804|NCT00943826|26654498|FG001|Maintenance Phase|Administrative reasons|1|||
13350805|NCT00943826|26654497|FG000|Maintenance Phase|Failure to return|0|||
13350806|NCT00943826|26654498|FG001|Maintenance Phase|Failure to return|1|||
13350807|NCT00943826|26654497|FG000|Monotherapy Phase|Adverse Event|42|||
13350808|NCT00943826|26654498|FG001|Monotherapy Phase|Adverse Event|5|||
13350809|NCT00943826|26654497|FG000|Monotherapy Phase|Administrative reasons|11|||
13350810|NCT00943826|26654498|FG001|Monotherapy Phase|Administrative reasons|5|||
13350811|NCT00943826|26654497|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8|||
13350812|NCT00943826|26654498|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2|||
13350813|NCT00943826|26654497|FG000|Monotherapy Phase|Withdrew Consent|2|||
13350814|NCT00943826|26654498|FG001|Monotherapy Phase|Withdrew Consent|3|||
13350815|NCT00943826|26654497|FG000|Monotherapy Phase|Failure to return|2|||
13350816|NCT00943826|26654498|FG001|Monotherapy Phase|Failure to return|1|||
13350817|NCT00943826|26654497|FG000|After Primary Overall Survival Analysis|Adverse Event|11|||
13350818|NCT00943826|26654498|FG001|After Primary Overall Survival Analysis|Adverse Event|0|||
13374315|NCT00797225|26726088|FG004|Weeks 13 to 24|Adverse Event|0|||
13350819|NCT00943826|26654497|FG000|After Primary Overall Survival Analysis|Administrative reasons|10|||
13350820|NCT00943826|26654498|FG001|After Primary Overall Survival Analysis|Administrative reasons|16|||
13350821|NCT00943826|26654497|FG000|After Primary Overall Survival Analysis|Progression of Disease|2|||
13350822|NCT00943826|26654498|FG001|After Primary Overall Survival Analysis|Progression of Disease|4|||
13350823|NCT00943826|26654497|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4|||
13350824|NCT00943826|26654498|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0|||
13350825|NCT00943787|26654505|FG000|Overall Study|Physician Decision|4|||
13350826|NCT00943787|26654505|FG000|Overall Study|Withdrawal by Subject|3|||
13350827|NCT00943761|26654524|FG000|Overall Study|Lost to Follow-up|2|||
13350828|NCT00943761|26654525|FG001|Overall Study|Lost to Follow-up|0|||
13350829|NCT00943761|26654524|FG000|Overall Study|Withdrawal by Subject|2|||
13350830|NCT00943761|26654525|FG001|Overall Study|Withdrawal by Subject|1|||
13350831|NCT00943735|26654560|FG000|Overall Study|Adverse Event|12|||
13350832|NCT00943735|26654560|FG000|Overall Study|Withdrawal by Subject|8|||
13350833|NCT00943735|26654560|FG000|Overall Study|Death|1|||
13350834|NCT00943735|26654560|FG000|Overall Study|Other|8|||
13350835|NCT00943735|26654560|FG000|Overall Study|Other|3|||
13350836|NCT00943722|26654622|FG000|Base Study|Adverse Event|0|||
13350837|NCT00943722|26654623|FG001|Base Study|Adverse Event|0|||
13350838|NCT00943722|26654624|FG002|Base Study|Adverse Event|0|||
13350839|NCT00943722|26654625|FG003|Base Study|Adverse Event|1|||
13350840|NCT00943722|26654626|FG004|Base Study|Adverse Event|0|||
13350841|NCT00943722|26654627|FG005|Base Study|Adverse Event|0|||
13350842|NCT00943722|26654628|FG006|Base Study|Adverse Event|0|||
13350843|NCT00943722|26654622|FG000|Base Study|Lost to Follow-up|12|||
13350844|NCT00943722|26654623|FG001|Base Study|Lost to Follow-up|8|||
13350845|NCT00943722|26654624|FG002|Base Study|Lost to Follow-up|10|||
13350846|NCT00943722|26654625|FG003|Base Study|Lost to Follow-up|8|||
13350847|NCT00943722|26654626|FG004|Base Study|Lost to Follow-up|11|||
13350848|NCT00943722|26654627|FG005|Base Study|Lost to Follow-up|0|||
13350849|NCT00943722|26654628|FG006|Base Study|Lost to Follow-up|0|||
13350850|NCT00943722|26654622|FG000|Base Study|Physician Decision|1|||
13350851|NCT00943722|26654623|FG001|Base Study|Physician Decision|0|||
13350852|NCT00943722|26654624|FG002|Base Study|Physician Decision|0|||
13350853|NCT00943722|26654625|FG003|Base Study|Physician Decision|0|||
13350854|NCT00943722|26654626|FG004|Base Study|Physician Decision|1|||
13350855|NCT00943722|26654627|FG005|Base Study|Physician Decision|0|||
13350856|NCT00943722|26654628|FG006|Base Study|Physician Decision|0|||
13350857|NCT00943722|26654622|FG000|Base Study|Pregnancy|0|||
13350858|NCT00943722|26654623|FG001|Base Study|Pregnancy|0|||
13350859|NCT00943722|26654624|FG002|Base Study|Pregnancy|1|||
13350860|NCT00943722|26654625|FG003|Base Study|Pregnancy|0|||
13350861|NCT00943722|26654626|FG004|Base Study|Pregnancy|2|||
13350862|NCT00943722|26654627|FG005|Base Study|Pregnancy|0|||
13350863|NCT00943722|26654628|FG006|Base Study|Pregnancy|0|||
13350864|NCT00943722|26654622|FG000|Base Study|Protocol Violation|0|||
13350865|NCT00943722|26654623|FG001|Base Study|Protocol Violation|1|||
13350866|NCT00943722|26654624|FG002|Base Study|Protocol Violation|0|||
13350867|NCT00943722|26654625|FG003|Base Study|Protocol Violation|0|||
13350868|NCT00943722|26654626|FG004|Base Study|Protocol Violation|2|||
13350869|NCT00943722|26654627|FG005|Base Study|Protocol Violation|0|||
13350870|NCT00943722|26654628|FG006|Base Study|Protocol Violation|0|||
13350871|NCT00943722|26654622|FG000|Base Study|Withdrawal by Subject|12|||
13350872|NCT00943722|26654623|FG001|Base Study|Withdrawal by Subject|13|||
13350873|NCT00943722|26654624|FG002|Base Study|Withdrawal by Subject|2|||
13350874|NCT00943722|26654625|FG003|Base Study|Withdrawal by Subject|13|||
13350875|NCT00943722|26654626|FG004|Base Study|Withdrawal by Subject|8|||
13350876|NCT00943722|26654627|FG005|Base Study|Withdrawal by Subject|0|||
13350877|NCT00943722|26654628|FG006|Base Study|Withdrawal by Subject|0|||
13350878|NCT00943722|26654622|FG000|Base Study|Month 12 visit not completed|0|||
13350879|NCT00943722|26654623|FG001|Base Study|Month 12 visit not completed|0|||
13350880|NCT00943722|26654624|FG002|Base Study|Month 12 visit not completed|0|||
13350881|NCT00943722|26654625|FG003|Base Study|Month 12 visit not completed|0|||
13350882|NCT00943722|26654626|FG004|Base Study|Month 12 visit not completed|2|||
13350883|NCT00943722|26654627|FG005|Base Study|Month 12 visit not completed|0|||
13350884|NCT00943722|26654628|FG006|Base Study|Month 12 visit not completed|0|||
13350885|NCT00943722|26654622|FG000|First Extension Study: EXT 1|Adverse Event|0|||
13350886|NCT00943722|26654623|FG001|First Extension Study: EXT 1|Adverse Event|0|||
13350887|NCT00943722|26654624|FG002|First Extension Study: EXT 1|Adverse Event|0|||
13350888|NCT00943722|26654625|FG003|First Extension Study: EXT 1|Adverse Event|0|||
13350889|NCT00943722|26654626|FG004|First Extension Study: EXT 1|Adverse Event|0|||
13350890|NCT00943722|26654627|FG005|First Extension Study: EXT 1|Adverse Event|1|||
13350891|NCT00943722|26654628|FG006|First Extension Study: EXT 1|Adverse Event|0|||
13350892|NCT00943722|26654622|FG000|First Extension Study: EXT 1|Lost to Follow-up|0|||
13350893|NCT00943722|26654623|FG001|First Extension Study: EXT 1|Lost to Follow-up|0|||
13350894|NCT00943722|26654624|FG002|First Extension Study: EXT 1|Lost to Follow-up|0|||
13350895|NCT00943722|26654625|FG003|First Extension Study: EXT 1|Lost to Follow-up|0|||
13350896|NCT00943722|26654626|FG004|First Extension Study: EXT 1|Lost to Follow-up|0|||
13350897|NCT00943722|26654627|FG005|First Extension Study: EXT 1|Lost to Follow-up|38|||
13350898|NCT00943722|26654628|FG006|First Extension Study: EXT 1|Lost to Follow-up|10|||
13350899|NCT00943722|26654622|FG000|First Extension Study: EXT 1|Withdrawal by Subject|0|||
13350900|NCT00943722|26654623|FG001|First Extension Study: EXT 1|Withdrawal by Subject|0|||
13350901|NCT00943722|26654624|FG002|First Extension Study: EXT 1|Withdrawal by Subject|0|||
13350902|NCT00943722|26654625|FG003|First Extension Study: EXT 1|Withdrawal by Subject|0|||
13350903|NCT00943722|26654626|FG004|First Extension Study: EXT 1|Withdrawal by Subject|0|||
13350904|NCT00943722|26654627|FG005|First Extension Study: EXT 1|Withdrawal by Subject|32|||
13350905|NCT00943722|26654628|FG006|First Extension Study: EXT 1|Withdrawal by Subject|10|||
13350906|NCT00943722|26654622|FG000|First Extension Study: EXT 1|Disposition Unknown|0|||
13350907|NCT00943722|26654623|FG001|First Extension Study: EXT 1|Disposition Unknown|0|||
13350908|NCT00943722|26654624|FG002|First Extension Study: EXT 1|Disposition Unknown|0|||
13350909|NCT00943722|26654625|FG003|First Extension Study: EXT 1|Disposition Unknown|0|||
13350910|NCT00943722|26654626|FG004|First Extension Study: EXT 1|Disposition Unknown|0|||
13350911|NCT00943722|26654627|FG005|First Extension Study: EXT 1|Disposition Unknown|44|||
13350912|NCT00943722|26654628|FG006|First Extension Study: EXT 1|Disposition Unknown|21|||
13350913|NCT00943722|26654622|FG000|Second Extension Study: EXT 2|Adverse Event|0|||
13350914|NCT00943722|26654623|FG001|Second Extension Study: EXT 2|Adverse Event|0|||
13350915|NCT00943722|26654624|FG002|Second Extension Study: EXT 2|Adverse Event|0|||
13350916|NCT00943722|26654625|FG003|Second Extension Study: EXT 2|Adverse Event|0|||
13350917|NCT00943722|26654626|FG004|Second Extension Study: EXT 2|Adverse Event|0|||
13350918|NCT00943722|26654627|FG005|Second Extension Study: EXT 2|Adverse Event|1|||
13350919|NCT00943722|26654628|FG006|Second Extension Study: EXT 2|Adverse Event|0|||
13350920|NCT00943722|26654622|FG000|Second Extension Study: EXT 2|Lost to Follow-up|0|||
13350921|NCT00943722|26654623|FG001|Second Extension Study: EXT 2|Lost to Follow-up|0|||
13350922|NCT00943722|26654624|FG002|Second Extension Study: EXT 2|Lost to Follow-up|0|||
13350923|NCT00943722|26654625|FG003|Second Extension Study: EXT 2|Lost to Follow-up|0|||
13350924|NCT00943722|26654626|FG004|Second Extension Study: EXT 2|Lost to Follow-up|0|||
13350925|NCT00943722|26654627|FG005|Second Extension Study: EXT 2|Lost to Follow-up|111|||
13350926|NCT00943722|26654628|FG006|Second Extension Study: EXT 2|Lost to Follow-up|46|||
13350927|NCT00943722|26654622|FG000|Second Extension Study: EXT 2|Physician Decision|0|||
13350928|NCT00943722|26654623|FG001|Second Extension Study: EXT 2|Physician Decision|0|||
13350929|NCT00943722|26654624|FG002|Second Extension Study: EXT 2|Physician Decision|0|||
13350930|NCT00943722|26654625|FG003|Second Extension Study: EXT 2|Physician Decision|0|||
13350931|NCT00943722|26654626|FG004|Second Extension Study: EXT 2|Physician Decision|0|||
13350932|NCT00943722|26654627|FG005|Second Extension Study: EXT 2|Physician Decision|1|||
13350933|NCT00943722|26654628|FG006|Second Extension Study: EXT 2|Physician Decision|3|||
13350934|NCT00943722|26654622|FG000|Second Extension Study: EXT 2|Pregnancy|0|||
13350935|NCT00943722|26654623|FG001|Second Extension Study: EXT 2|Pregnancy|0|||
13350936|NCT00943722|26654624|FG002|Second Extension Study: EXT 2|Pregnancy|0|||
13350937|NCT00943722|26654625|FG003|Second Extension Study: EXT 2|Pregnancy|0|||
13350938|NCT00943722|26654626|FG004|Second Extension Study: EXT 2|Pregnancy|0|||
13350939|NCT00943722|26654627|FG005|Second Extension Study: EXT 2|Pregnancy|1|||
13350940|NCT00943722|26654628|FG006|Second Extension Study: EXT 2|Pregnancy|0|||
13350941|NCT00943722|26654622|FG000|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
13350942|NCT00943722|26654623|FG001|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
13350943|NCT00943722|26654624|FG002|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
13350944|NCT00943722|26654625|FG003|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
13350945|NCT00943722|26654626|FG004|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
13350946|NCT00943722|26654627|FG005|Second Extension Study: EXT 2|Withdrawal by Subject|137|||
13350947|NCT00943722|26654628|FG006|Second Extension Study: EXT 2|Withdrawal by Subject|50|||
13350948|NCT00943670|26654664|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2|||
13350949|NCT00943670|26654664|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3|||
13350950|NCT00943670|26654664|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15|||
13350951|NCT00943670|26654664|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2|||
13350952|NCT00943670|26654664|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20|||
13350953|NCT00943670|26654664|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1|||
13350954|NCT00943670|26654664|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4|||
13350955|NCT00943670|26654664|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6|||
13350956|NCT00943670|26654664|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2|||
13350957|NCT00943670|26654664|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5|||
13350958|NCT00943605|26654681|FG000|Overall Study|Study termination|30|||
13350959|NCT00943605|26654682|FG001|Overall Study|Study termination|30|||
13350960|NCT00943592|26654695|FG000|Overall Study|Death|3|||
13350961|NCT00943579|26654721|FG000|Overall Study|Adverse Event|4|||
13350962|NCT00943579|26654722|FG001|Overall Study|Adverse Event|3|||
13350963|NCT00943579|26654721|FG000|Overall Study|Lack of Efficacy|2|||
13350964|NCT00943579|26654722|FG001|Overall Study|Lack of Efficacy|2|||
13350965|NCT00943384|26654738|FG000|Overall Study|Dispositioned prior to treatment|23|||
13350966|NCT00943384|26654738|FG000|Overall Study|Treated off protocol-protocol violation|5|||
13350967|NCT00943384|26654738|FG000|Overall Study|Lost to Follow-up|16|||
13350968|NCT00943384|26654738|FG000|Overall Study|Withdrawal by Subject|5|||
13350969|NCT00943319|26654746|FG000|Overall Study|Death|1|||
13350970|NCT00943306|26654805|FG000|Overall Study|Physician Decision|1|||
13350971|NCT00943306|26654805|FG000|Overall Study|Death|1|||
13350972|NCT00943306|26654805|FG000|Overall Study|Sponsor decision due to non-compliance|1|||
13350973|NCT00943124|26654828|FG000|Period 1|Withdrawal by Subject|1|||
13350974|NCT00943124|26654829|FG001|Period 1|Withdrawal by Subject|1|||
13350975|NCT00943124|26654828|FG000|Period 1|Did Not Follow Study Procedures|1|||
13350976|NCT00943124|26654829|FG001|Period 1|Did Not Follow Study Procedures|0|||
13350977|NCT00943124|26654828|FG000|Period 1|Personal Reasons|0|||
13350978|NCT00943124|26654829|FG001|Period 1|Personal Reasons|1|||
13350979|NCT00943111|26654868|FG000|52-Weeks Primary Analysis Period|Adverse Event|2|||
13350980|NCT00943111|26654869|FG001|52-Weeks Primary Analysis Period|Adverse Event|1|||
13350981|NCT00943111|26654870|FG002|52-Weeks Primary Analysis Period|Adverse Event|0|||
13350982|NCT00943111|26654868|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
13350983|NCT00943111|26654869|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1|||
13350984|NCT00943111|26654870|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
13350985|NCT00943111|26654868|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
13350986|NCT00943111|26654869|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
13350987|NCT00943111|26654870|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51|||
13350988|NCT00943111|26654868|FG000|5 Years Long-term Treatment Period|Adverse Event|0|||
13350989|NCT00943111|26654869|FG001|5 Years Long-term Treatment Period|Adverse Event|0|||
13350990|NCT00943111|26654870|FG002|5 Years Long-term Treatment Period|Adverse Event|9|||
13350991|NCT00943111|26654868|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
13350992|NCT00943111|26654869|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
13350993|NCT00943111|26654870|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8|||
13350994|NCT00943111|26654868|FG000|5 Years Long-term Treatment Period|Pregnancy|0|||
13350995|NCT00943111|26654869|FG001|5 Years Long-term Treatment Period|Pregnancy|0|||
13350996|NCT00943111|26654870|FG002|5 Years Long-term Treatment Period|Pregnancy|4|||
13350997|NCT00943111|26654868|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
13350998|NCT00943111|26654869|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
13350999|NCT00943111|26654870|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1|||
13351000|NCT00943111|26654868|FG000|5 Years Long-term Treatment Period|Other than specified above|0|||
13351001|NCT00943111|26654869|FG001|5 Years Long-term Treatment Period|Other than specified above|0|||
13351002|NCT00943111|26654870|FG002|5 Years Long-term Treatment Period|Other than specified above|2|||
13351003|NCT00943072|26654893|FG000|Overall Study|Adverse Event|0|||
13351004|NCT00943072|26654894|FG001|Overall Study|Adverse Event|3|||
13351005|NCT00943072|26654893|FG000|Overall Study|Death|0|||
13351006|NCT00943072|26654894|FG001|Overall Study|Death|2|||
13351007|NCT00943072|26654893|FG000|Overall Study|Withdrawal by Subject|3|||
13351008|NCT00943072|26654894|FG001|Overall Study|Withdrawal by Subject|1|||
13351009|NCT00943072|26654893|FG000|Overall Study|Protocol Violation|0|||
13351010|NCT00943072|26654894|FG001|Overall Study|Protocol Violation|1|||
13351011|NCT00943072|26654893|FG000|Overall Study|Lost to Follow-up|1|||
13351012|NCT00943072|26654894|FG001|Overall Study|Lost to Follow-up|2|||
13351013|NCT00943072|26654893|FG000|Overall Study|Lack of Efficacy|0|||
13351014|NCT00943072|26654894|FG001|Overall Study|Lack of Efficacy|4|||
13351015|NCT00943072|26654893|FG000|Overall Study|Other|1|||
13351016|NCT00943072|26654894|FG001|Overall Study|Other|1|||
13351017|NCT00942994|26654917|FG000|Overall Study|Adverse Event|7|||
13351018|NCT00942994|26654918|FG001|Overall Study|Adverse Event|4|||
13351019|NCT00942994|26654917|FG000|Overall Study|Abnormal laboratory value(s)|1|||
13351020|NCT00942994|26654918|FG001|Overall Study|Abnormal laboratory value(s)|0|||
13351021|NCT00942994|26654917|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
13351022|NCT00942994|26654918|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
13351023|NCT00942994|26654917|FG000|Overall Study|Patient withdrew consent|5|||
13351024|NCT00942994|26654918|FG001|Overall Study|Patient withdrew consent|8|||
13351025|NCT00942994|26654917|FG000|Overall Study|Lost to Follow-up|1|||
13351026|NCT00942994|26654918|FG001|Overall Study|Lost to Follow-up|4|||
13351027|NCT00942994|26654917|FG000|Overall Study|Protocol deviation|1|||
13351028|NCT00942994|26654918|FG001|Overall Study|Protocol deviation|2|||
13351029|NCT00942968|26654941|FG000|Overall Study|Adverse Event|60|||
13351030|NCT00942968|26654941|FG000|Overall Study|Death|76|||
13351031|NCT00942968|26654941|FG000|Overall Study|Protocol Violation|9|||
13351032|NCT00942968|26654941|FG000|Overall Study|Lost to Follow-up|4|||
13351033|NCT00942968|26654941|FG000|Overall Study|Withdrawal by Subject|44|||
13351034|NCT00942968|26654941|FG000|Overall Study|Sponsor request|5|||
13351035|NCT00942968|26654941|FG000|Overall Study|Physician Decision|11|||
13351036|NCT00942968|26654941|FG000|Overall Study|Progression of disease|12|||
13351037|NCT00942968|26654941|FG000|Overall Study|Inferior vena cava filter placement|4|||
13351038|NCT00942968|26654941|FG000|Overall Study|Pulmonary embolism (PE)|1|||
13351039|NCT00942968|26654941|FG000|Overall Study|Participant required pancreatic biopsy|1|||
13351040|NCT00942968|26654941|FG000|Overall Study|Deep vein thrombosis (DVT)|2|||
13351041|NCT00942734|26654947|FG000|Overall Study|Adverse Event|2|||
13351042|NCT00942734|26654947|FG000|Overall Study|Protocol Violation|3|||
13351043|NCT00942734|26654947|FG000|Overall Study|Disease Progression|2|||
13351044|NCT00942734|26654947|FG000|Overall Study|Physician Decision|1|||
13351045|NCT00942708|26654955|FG000|Overall Study|Withdrawal by Subject|1|||
13351046|NCT00942604|26654970|FG000|Overall Study|Protocol Violation|1|||
13351047|NCT00942604|26654971|FG001|Overall Study|Protocol Violation|1|||
13351048|NCT00942604|26654970|FG000|Overall Study|Adverse Event|0|||
13351049|NCT00942604|26654971|FG001|Overall Study|Adverse Event|1|||
13351050|NCT00942604|26654970|FG000|Overall Study|Withdrawal by Subject|0|||
13351051|NCT00942604|26654971|FG001|Overall Study|Withdrawal by Subject|1|||
13351052|NCT00942604|26654970|FG000|Overall Study|Patient relocation|1|||
13351053|NCT00942604|26654971|FG001|Overall Study|Patient relocation|1|||
13351054|NCT00942422|26654977|FG000|Overall Study|Withdrawal by Subject|1|||
13351055|NCT00942422|26654977|FG000|Overall Study|Death|1|||
13351056|NCT00942422|26654977|FG000|Overall Study|Progressive diease|1|||
13351057|NCT00942409|26654983|FG000|Overall Study|Lack of Efficacy|1|||
13351058|NCT00942409|26654983|FG000|Overall Study|study drug unavailable|2|||
13351059|NCT00942357|26655004|FG000|Overall Study|Ineligible|37|||
13351060|NCT00942357|26655005|FG001|Overall Study|Ineligible|40|||
13351061|NCT00942266|26655030|FG000|Overall Study|Withdrawal by Subject|1|||
13351062|NCT00942266|26655031|FG001|Overall Study|Withdrawal by Subject|0|||
13351063|NCT00942266|26655030|FG000|Overall Study|Adverse Event|2|||
13351064|NCT00942266|26655031|FG001|Overall Study|Adverse Event|1|||
13351065|NCT00942266|26655030|FG000|Overall Study|Disease Progression|38|||
13351066|NCT00942266|26655031|FG001|Overall Study|Disease Progression|11|||
13351067|NCT00942266|26655030|FG000|Overall Study|Failure to thrive and pt withdrawal|0|||
13351068|NCT00942266|26655031|FG001|Overall Study|Failure to thrive and pt withdrawal|1|||
13351069|NCT00942266|26655030|FG000|Overall Study|Intercurrent illness|0|||
13351070|NCT00942266|26655031|FG001|Overall Study|Intercurrent illness|1|||
13351071|NCT00942266|26655030|FG000|Overall Study|Physician Decision|2|||
13351072|NCT00942266|26655031|FG001|Overall Study|Physician Decision|0|||
13351073|NCT00942266|26655030|FG000|Overall Study|medical deterioration (pneumonia)|0|||
13351074|NCT00942266|26655031|FG001|Overall Study|medical deterioration (pneumonia)|1|||
13351075|NCT00942188|26655079|FG000|Overall Study|Adverse Event|0|||
13351076|NCT00942188|26655080|FG001|Overall Study|Adverse Event|3|||
13351077|NCT00942188|26655081|FG002|Overall Study|Adverse Event|2|||
13351078|NCT00942188|26655082|FG003|Overall Study|Adverse Event|0|||
13351079|NCT00942188|26655079|FG000|Overall Study|Lack of Efficacy|0|||
13351080|NCT00942188|26655080|FG001|Overall Study|Lack of Efficacy|0|||
13351081|NCT00942188|26655081|FG002|Overall Study|Lack of Efficacy|0|||
13351082|NCT00942188|26655082|FG003|Overall Study|Lack of Efficacy|1|||
13351083|NCT00942188|26655079|FG000|Overall Study|Protocol Violation|1|||
13351084|NCT00942188|26655080|FG001|Overall Study|Protocol Violation|1|||
13351085|NCT00942188|26655081|FG002|Overall Study|Protocol Violation|0|||
13351086|NCT00942188|26655082|FG003|Overall Study|Protocol Violation|0|||
13351087|NCT00942188|26655079|FG000|Overall Study|Lost to Follow-up|2|||
13351088|NCT00942188|26655080|FG001|Overall Study|Lost to Follow-up|1|||
13351089|NCT00942188|26655081|FG002|Overall Study|Lost to Follow-up|2|||
13351090|NCT00942188|26655082|FG003|Overall Study|Lost to Follow-up|0|||
13351091|NCT00942188|26655079|FG000|Overall Study|Withdrawal by Subject|1|||
13351092|NCT00942188|26655080|FG001|Overall Study|Withdrawal by Subject|3|||
13351093|NCT00942188|26655081|FG002|Overall Study|Withdrawal by Subject|4|||
13351094|NCT00942188|26655082|FG003|Overall Study|Withdrawal by Subject|2|||
13351095|NCT00942188|26655079|FG000|Overall Study|Physician Decision|0|||
13351096|NCT00942188|26655080|FG001|Overall Study|Physician Decision|0|||
13351097|NCT00942188|26655081|FG002|Overall Study|Physician Decision|1|||
13351098|NCT00942188|26655082|FG003|Overall Study|Physician Decision|0|||
13351099|NCT00942188|26655079|FG000|Overall Study|Sponsor Decision|0|||
13351100|NCT00942188|26655080|FG001|Overall Study|Sponsor Decision|2|||
13351101|NCT00942188|26655081|FG002|Overall Study|Sponsor Decision|0|||
13351102|NCT00942188|26655082|FG003|Overall Study|Sponsor Decision|1|||
13351103|NCT00942175|26655145|FG000|Overall Study|Adverse Event|2|||
13351104|NCT00942175|26655146|FG001|Overall Study|Adverse Event|1|||
13351105|NCT00942175|26655147|FG002|Overall Study|Adverse Event|0|||
13351106|NCT00942175|26655148|FG003|Overall Study|Adverse Event|0|||
13351107|NCT00942175|26655145|FG000|Overall Study|Protocol Violation|0|||
13351108|NCT00942175|26655146|FG001|Overall Study|Protocol Violation|1|||
13351109|NCT00942175|26655147|FG002|Overall Study|Protocol Violation|2|||
13351110|NCT00942175|26655148|FG003|Overall Study|Protocol Violation|0|||
13351111|NCT00942175|26655145|FG000|Overall Study|Pregnancy|0|||
13351112|NCT00942175|26655146|FG001|Overall Study|Pregnancy|0|||
13351113|NCT00942175|26655147|FG002|Overall Study|Pregnancy|0|||
13351114|NCT00942175|26655148|FG003|Overall Study|Pregnancy|1|||
13351115|NCT00942175|26655145|FG000|Overall Study|Elevated Alanine Amino Transferase|0|||
13351116|NCT00942175|26655146|FG001|Overall Study|Elevated Alanine Amino Transferase|0|||
13351117|NCT00942175|26655147|FG002|Overall Study|Elevated Alanine Amino Transferase|0|||
13351118|NCT00942175|26655148|FG003|Overall Study|Elevated Alanine Amino Transferase|1|||
13351119|NCT00942175|26655145|FG000|Overall Study|Low Platelet Count|0|||
13351120|NCT00942175|26655146|FG001|Overall Study|Low Platelet Count|2|||
13351121|NCT00942175|26655147|FG002|Overall Study|Low Platelet Count|0|||
13351122|NCT00942175|26655148|FG003|Overall Study|Low Platelet Count|0|||
13351123|NCT00942162|26655225|FG000|Overall Study|Death|45|||
13351124|NCT00942162|26655226|FG001|Overall Study|Death|35|||
13351125|NCT00942162|26655227|FG002|Overall Study|Death|0|||
13351126|NCT00942162|26655225|FG000|Overall Study|Withdrawal by Subject|7|||
13351127|NCT00942162|26655226|FG001|Overall Study|Withdrawal by Subject|2|||
13351128|NCT00942162|26655227|FG002|Overall Study|Withdrawal by Subject|0|||
13351129|NCT00942162|26655225|FG000|Overall Study|Lost to Follow-up|4|||
13351130|NCT00942162|26655226|FG001|Overall Study|Lost to Follow-up|0|||
13351131|NCT00942162|26655227|FG002|Overall Study|Lost to Follow-up|0|||
13351132|NCT00942162|26655225|FG000|Overall Study|Other|14|||
13351133|NCT00942162|26655226|FG001|Overall Study|Other|13|||
13351134|NCT00942162|26655227|FG002|Overall Study|Other|2|||
13351135|NCT00942084|26655238|FG000|Overall Study|Death|2|||
13351136|NCT00941928|26655244|FG000|Overall Study|Withdrawal by Subject|1|||
13351137|NCT00941928|26655244|FG000|Overall Study|Disease Progression|1|||
13351138|NCT00941863|26655285|FG000|Until Primary Completion Date (PCD)|Adverse Event|1|||
13351139|NCT00941863|26655286|FG001|Until Primary Completion Date (PCD)|Adverse Event|2|||
13351140|NCT00941863|26655287|FG002|Until Primary Completion Date (PCD)|Adverse Event|2|||
13351141|NCT00941863|26655288|FG003|Until Primary Completion Date (PCD)|Adverse Event|1|||
13351142|NCT00941863|26655289|FG004|Until Primary Completion Date (PCD)|Adverse Event|5|||
13351143|NCT00941863|26655285|FG000|Until Primary Completion Date (PCD)|Physician Decision|0|||
13351144|NCT00941863|26655286|FG001|Until Primary Completion Date (PCD)|Physician Decision|0|||
13351145|NCT00941863|26655287|FG002|Until Primary Completion Date (PCD)|Physician Decision|0|||
13351146|NCT00941863|26655288|FG003|Until Primary Completion Date (PCD)|Physician Decision|0|||
13351147|NCT00941863|26655289|FG004|Until Primary Completion Date (PCD)|Physician Decision|1|||
13351148|NCT00941863|26655285|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
13351149|NCT00941863|26655286|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
13351150|NCT00941863|26655287|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1|||
13351151|NCT00941863|26655288|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
13351152|NCT00941863|26655289|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8|||
13351153|NCT00941863|26655285|FG000|Until Primary Completion Date (PCD)|Death|0|||
13351154|NCT00941863|26655286|FG001|Until Primary Completion Date (PCD)|Death|0|||
13351155|NCT00941863|26655287|FG002|Until Primary Completion Date (PCD)|Death|1|||
13351156|NCT00941863|26655288|FG003|Until Primary Completion Date (PCD)|Death|2|||
13351157|NCT00941863|26655289|FG004|Until Primary Completion Date (PCD)|Death|7|||
13351158|NCT00941863|26655285|FG000|Until Primary Completion Date (PCD)|Disease progression|6|||
13351159|NCT00941863|26655286|FG001|Until Primary Completion Date (PCD)|Disease progression|1|||
13351160|NCT00941863|26655287|FG002|Until Primary Completion Date (PCD)|Disease progression|8|||
13351161|NCT00941863|26655288|FG003|Until Primary Completion Date (PCD)|Disease progression|14|||
13351162|NCT00941863|26655289|FG004|Until Primary Completion Date (PCD)|Disease progression|73|||
13351163|NCT00941863|26655285|FG000|Continued After PCD|Withdrawal by Subject|0|||
13351164|NCT00941863|26655286|FG001|Continued After PCD|Withdrawal by Subject|0|||
13351165|NCT00941863|26655287|FG002|Continued After PCD|Withdrawal by Subject|0|||
13351166|NCT00941863|26655288|FG003|Continued After PCD|Withdrawal by Subject|0|||
13351167|NCT00941863|26655289|FG004|Continued After PCD|Withdrawal by Subject|1|||
13351168|NCT00941863|26655285|FG000|Continued After PCD|Disease progression, recurrence, relapse|0|||
13351169|NCT00941863|26655286|FG001|Continued After PCD|Disease progression, recurrence, relapse|0|||
13351170|NCT00941863|26655287|FG002|Continued After PCD|Disease progression, recurrence, relapse|0|||
13351171|NCT00941863|26655288|FG003|Continued After PCD|Disease progression, recurrence, relapse|0|||
13351172|NCT00941863|26655289|FG004|Continued After PCD|Disease progression, recurrence, relapse|18|||
13351173|NCT00941798|26655324|FG000|Overall Study|Withdrawal by Subject|72|||
13351174|NCT00941798|26655325|FG001|Overall Study|Withdrawal by Subject|74|||
13351175|NCT00941798|26655324|FG000|Overall Study|Adverse Event|43|||
13351176|NCT00941798|26655325|FG001|Overall Study|Adverse Event|23|||
13351177|NCT00941798|26655324|FG000|Overall Study|Lost to Follow-up|29|||
13351178|NCT00941798|26655325|FG001|Overall Study|Lost to Follow-up|23|||
13351179|NCT00941798|26655324|FG000|Overall Study|Protocol Violation|17|||
13351180|NCT00941798|26655325|FG001|Overall Study|Protocol Violation|20|||
13351181|NCT00941798|26655324|FG000|Overall Study|Administrative problems|13|||
13351182|NCT00941798|26655325|FG001|Overall Study|Administrative problems|23|||
13351183|NCT00941798|26655324|FG000|Overall Study|Lack of Efficacy|10|||
13351184|NCT00941798|26655325|FG001|Overall Study|Lack of Efficacy|17|||
13351185|NCT00941798|26655324|FG000|Overall Study|Patient's inability to use device|6|||
13351186|NCT00941798|26655325|FG001|Overall Study|Patient's inability to use device|1|||
13351187|NCT00941798|26655324|FG000|Overall Study|Abnormal test procedure results|3|||
13351188|NCT00941798|26655325|FG001|Overall Study|Abnormal test procedure results|1|||
13351189|NCT00941798|26655324|FG000|Overall Study|Abnormal laboratory values|1|||
13351190|NCT00941798|26655325|FG001|Overall Study|Abnormal laboratory values|2|||
13351191|NCT00941798|26655324|FG000|Overall Study|Death|0|||
13351192|NCT00941798|26655325|FG001|Overall Study|Death|1|||
13351193|NCT00941733|26655372|FG000|Overall Study|Death|24|||
13351194|NCT00941733|26655373|FG001|Overall Study|Death|10|||
13351195|NCT00941733|26655372|FG000|Overall Study|Withdrawal by Subject|14|||
13351196|NCT00941733|26655373|FG001|Overall Study|Withdrawal by Subject|6|||
13351197|NCT00941733|26655372|FG000|Overall Study|Adverse Event|20|||
13351198|NCT00941733|26655373|FG001|Overall Study|Adverse Event|4|||
13351199|NCT00941733|26655372|FG000|Overall Study|Lost to Follow-up|1|||
13351200|NCT00941733|26655373|FG001|Overall Study|Lost to Follow-up|2|||
13351201|NCT00941733|26655372|FG000|Overall Study|Protocol Violation|15|||
13351202|NCT00941733|26655373|FG001|Overall Study|Protocol Violation|6|||
13351203|NCT00941720|26655381|FG000|Overall Study|Withdrawal by Subject|1|||
13351204|NCT00941720|26655381|FG000|Overall Study|Insurance denied participation|11|||
13351205|NCT00941720|26655381|FG000|Overall Study|ineligible|2|||
13351206|NCT00941655|26655407|FG000|Overall Study|received some chemo, 4 and 9 cycles|1|||
13351207|NCT00941655|26655408|FG001|Overall Study|received some chemo, 4 and 9 cycles|0|||
13351208|NCT00941655|26655407|FG000|Overall Study|not meet criteria for chemo foll surgery|4|||
13351209|NCT00941655|26655408|FG001|Overall Study|not meet criteria for chemo foll surgery|0|||
13351210|NCT00941655|26655407|FG000|Overall Study|progressed while on chemo|0|||
13351211|NCT00941655|26655408|FG001|Overall Study|progressed while on chemo|2|||
13351212|NCT00941655|26655407|FG000|Overall Study|refused further treatment|0|||
13351213|NCT00941655|26655408|FG001|Overall Study|refused further treatment|1|||
13351214|NCT00941655|26655407|FG000|Overall Study|withdrew consent|0|||
13351215|NCT00941655|26655408|FG001|Overall Study|withdrew consent|1|||
13351216|NCT00941655|26655407|FG000|Overall Study|non-compliant|0|||
13351217|NCT00941655|26655408|FG001|Overall Study|non-compliant|1|||
13351218|NCT00941603|26655447|FG000|Overall Study|Adverse Event|10|||
13351219|NCT00941603|26655448|FG001|Overall Study|Adverse Event|15|||
13351220|NCT00941603|26655449|FG002|Overall Study|Adverse Event|5|||
13351221|NCT00941603|26655450|FG003|Overall Study|Adverse Event|1|||
13351222|NCT00941603|26655451|FG004|Overall Study|Adverse Event|4|||
13351223|NCT00941603|26655452|FG005|Overall Study|Adverse Event|0|||
13351224|NCT00941603|26655447|FG000|Overall Study|Lost to Follow-up|0|||
13351225|NCT00941603|26655448|FG001|Overall Study|Lost to Follow-up|0|||
13351226|NCT00941603|26655449|FG002|Overall Study|Lost to Follow-up|0|||
13351227|NCT00941603|26655450|FG003|Overall Study|Lost to Follow-up|1|||
13351228|NCT00941603|26655451|FG004|Overall Study|Lost to Follow-up|0|||
13351229|NCT00941603|26655452|FG005|Overall Study|Lost to Follow-up|2|||
13351230|NCT00941603|26655447|FG000|Overall Study|Withdrawal by Subject|0|||
13351231|NCT00941603|26655448|FG001|Overall Study|Withdrawal by Subject|0|||
13351232|NCT00941603|26655449|FG002|Overall Study|Withdrawal by Subject|0|||
13351233|NCT00941603|26655450|FG003|Overall Study|Withdrawal by Subject|2|||
13351234|NCT00941603|26655451|FG004|Overall Study|Withdrawal by Subject|0|||
13351235|NCT00941603|26655452|FG005|Overall Study|Withdrawal by Subject|1|||
13351236|NCT00941603|26655447|FG000|Overall Study|Protocol Violation|0|||
13351237|NCT00941603|26655448|FG001|Overall Study|Protocol Violation|1|||
13351238|NCT00941603|26655449|FG002|Overall Study|Protocol Violation|0|||
13351239|NCT00941603|26655450|FG003|Overall Study|Protocol Violation|0|||
13351240|NCT00941603|26655451|FG004|Overall Study|Protocol Violation|0|||
13351241|NCT00941603|26655452|FG005|Overall Study|Protocol Violation|0|||
13351242|NCT00941603|26655447|FG000|Overall Study|Did not meet protocol eligibility|1|||
13351243|NCT00941603|26655448|FG001|Overall Study|Did not meet protocol eligibility|0|||
13351244|NCT00941603|26655449|FG002|Overall Study|Did not meet protocol eligibility|0|||
13351245|NCT00941603|26655450|FG003|Overall Study|Did not meet protocol eligibility|0|||
13351246|NCT00941603|26655451|FG004|Overall Study|Did not meet protocol eligibility|0|||
13351247|NCT00941603|26655452|FG005|Overall Study|Did not meet protocol eligibility|0|||
13351248|NCT00941330|26655467|FG000|Overall Study|Other|1|||
13351249|NCT00941330|26655468|FG001|Overall Study|Other|0|||
13351250|NCT00941330|26655467|FG000|Overall Study|Physician Decision|0|||
13351251|NCT00941330|26655468|FG001|Overall Study|Physician Decision|2|||
13351252|NCT00941304|26655546|FG000|Overall Study|Lost to Follow-up|1|||
13351253|NCT00941304|26655547|FG001|Overall Study|Lost to Follow-up|0|||
13351254|NCT00941304|26655548|FG002|Overall Study|Lost to Follow-up|0|||
13351255|NCT00941304|26655549|FG003|Overall Study|Lost to Follow-up|0|||
13351256|NCT00941304|26655550|FG004|Overall Study|Lost to Follow-up|0|||
13351257|NCT00941070|26655568|FG000|Overall Study|Patient non-compliant|1|||
13351258|NCT00941031|26655607|FG000|Induction Period|Lack of Efficacy|2|||
13351259|NCT00941031|26655608|FG001|Induction Period|Lack of Efficacy|1|||
13351260|NCT00941031|26655609|FG002|Induction Period|Lack of Efficacy|0|||
13351261|NCT00941031|26655610|FG003|Induction Period|Lack of Efficacy|5|||
13351262|NCT00941031|26655611|FG004|Induction Period|Lack of Efficacy|0|||
13351263|NCT00941031|26655612|FG005|Induction Period|Lack of Efficacy|0|||
13351264|NCT00941031|26655613|FG006|Induction Period|Lack of Efficacy|0|||
13351265|NCT00941031|26655607|FG000|Induction Period|Withdrawal by Subject|1|||
13351266|NCT00941031|26655608|FG001|Induction Period|Withdrawal by Subject|2|||
13351267|NCT00941031|26655609|FG002|Induction Period|Withdrawal by Subject|2|||
13351268|NCT00941031|26655610|FG003|Induction Period|Withdrawal by Subject|2|||
13351269|NCT00941031|26655611|FG004|Induction Period|Withdrawal by Subject|0|||
13351270|NCT00941031|26655612|FG005|Induction Period|Withdrawal by Subject|0|||
13351271|NCT00941031|26655613|FG006|Induction Period|Withdrawal by Subject|0|||
13351272|NCT00941031|26655607|FG000|Induction Period|Adminstative Problems|1|||
13351273|NCT00941031|26655608|FG001|Induction Period|Adminstative Problems|1|||
13351274|NCT00941031|26655609|FG002|Induction Period|Adminstative Problems|1|||
13351275|NCT00941031|26655610|FG003|Induction Period|Adminstative Problems|0|||
13351276|NCT00941031|26655611|FG004|Induction Period|Adminstative Problems|0|||
13351277|NCT00941031|26655612|FG005|Induction Period|Adminstative Problems|0|||
13351278|NCT00941031|26655613|FG006|Induction Period|Adminstative Problems|0|||
13351279|NCT00941031|26655607|FG000|Induction Period|Adverse Event|1|||
13351280|NCT00941031|26655608|FG001|Induction Period|Adverse Event|0|||
13351281|NCT00941031|26655609|FG002|Induction Period|Adverse Event|3|||
13351282|NCT00941031|26655610|FG003|Induction Period|Adverse Event|2|||
13351283|NCT00941031|26655611|FG004|Induction Period|Adverse Event|0|||
13351284|NCT00941031|26655612|FG005|Induction Period|Adverse Event|0|||
13351285|NCT00941031|26655613|FG006|Induction Period|Adverse Event|0|||
13351286|NCT00941031|26655607|FG000|Maintenance Period|Withdrawal by Subject|0|||
13351287|NCT00941031|26655608|FG001|Maintenance Period|Withdrawal by Subject|0|||
13351288|NCT00941031|26655609|FG002|Maintenance Period|Withdrawal by Subject|0|||
13351289|NCT00941031|26655610|FG003|Maintenance Period|Withdrawal by Subject|0|||
13351290|NCT00941031|26655611|FG004|Maintenance Period|Withdrawal by Subject|6|||
13351291|NCT00941031|26655612|FG005|Maintenance Period|Withdrawal by Subject|2|||
13351292|NCT00941031|26655613|FG006|Maintenance Period|Withdrawal by Subject|13|||
13351293|NCT00941031|26655607|FG000|Maintenance Period|Administrative Problems|0|||
13351294|NCT00941031|26655608|FG001|Maintenance Period|Administrative Problems|0|||
13351295|NCT00941031|26655609|FG002|Maintenance Period|Administrative Problems|0|||
13351296|NCT00941031|26655610|FG003|Maintenance Period|Administrative Problems|0|||
13351297|NCT00941031|26655611|FG004|Maintenance Period|Administrative Problems|1|||
13351298|NCT00941031|26655612|FG005|Maintenance Period|Administrative Problems|0|||
13351299|NCT00941031|26655613|FG006|Maintenance Period|Administrative Problems|1|||
13351300|NCT00941031|26655607|FG000|Maintenance Period|Protocol Violation|0|||
13351301|NCT00941031|26655608|FG001|Maintenance Period|Protocol Violation|0|||
13351302|NCT00941031|26655609|FG002|Maintenance Period|Protocol Violation|0|||
13351303|NCT00941031|26655610|FG003|Maintenance Period|Protocol Violation|0|||
13351304|NCT00941031|26655611|FG004|Maintenance Period|Protocol Violation|0|||
13351305|NCT00941031|26655612|FG005|Maintenance Period|Protocol Violation|0|||
13351306|NCT00941031|26655613|FG006|Maintenance Period|Protocol Violation|1|||
13351307|NCT00941031|26655607|FG000|Maintenance Period|Adverse Event|0|||
13351308|NCT00941031|26655608|FG001|Maintenance Period|Adverse Event|0|||
13351309|NCT00941031|26655609|FG002|Maintenance Period|Adverse Event|0|||
13351310|NCT00941031|26655610|FG003|Maintenance Period|Adverse Event|0|||
13351311|NCT00941031|26655611|FG004|Maintenance Period|Adverse Event|0|||
13351312|NCT00941031|26655612|FG005|Maintenance Period|Adverse Event|2|||
13351313|NCT00941031|26655613|FG006|Maintenance Period|Adverse Event|8|||
13351314|NCT00941031|26655607|FG000|Maintenance Period|Lost to Follow-up|0|||
13351315|NCT00941031|26655608|FG001|Maintenance Period|Lost to Follow-up|0|||
13351316|NCT00941031|26655609|FG002|Maintenance Period|Lost to Follow-up|0|||
13351317|NCT00941031|26655610|FG003|Maintenance Period|Lost to Follow-up|0|||
13351318|NCT00941031|26655611|FG004|Maintenance Period|Lost to Follow-up|2|||
13351319|NCT00941031|26655612|FG005|Maintenance Period|Lost to Follow-up|2|||
13351320|NCT00941031|26655613|FG006|Maintenance Period|Lost to Follow-up|7|||
13351321|NCT00941031|26655607|FG000|Maintenance Period|Lack of Efficacy|0|||
13351322|NCT00941031|26655608|FG001|Maintenance Period|Lack of Efficacy|0|||
13351323|NCT00941031|26655609|FG002|Maintenance Period|Lack of Efficacy|0|||
13351324|NCT00941031|26655610|FG003|Maintenance Period|Lack of Efficacy|0|||
13351325|NCT00941031|26655611|FG004|Maintenance Period|Lack of Efficacy|0|||
13351326|NCT00941031|26655612|FG005|Maintenance Period|Lack of Efficacy|0|||
13351327|NCT00941031|26655613|FG006|Maintenance Period|Lack of Efficacy|13|||
13351328|NCT00940992|26655634|FG000|Overall Study|Adverse Event|2|||
13351329|NCT00940992|26655635|FG001|Overall Study|Adverse Event|0|||
13351330|NCT00940992|26655636|FG002|Overall Study|Adverse Event|1|||
13351331|NCT00940992|26655634|FG000|Overall Study|subject request|2|||
13351332|NCT00940992|26655635|FG001|Overall Study|subject request|1|||
13351333|NCT00940992|26655636|FG002|Overall Study|subject request|0|||
13351334|NCT00940992|26655634|FG000|Overall Study|Lost to Follow-up|0|||
13351335|NCT00940992|26655635|FG001|Overall Study|Lost to Follow-up|1|||
13351336|NCT00940992|26655636|FG002|Overall Study|Lost to Follow-up|1|||
13351337|NCT00940888|26655643|FG000|Overall Study|Unsuccessful Implant|4|||
13351338|NCT00940888|26655643|FG000|Overall Study|Death|461|||
13351339|NCT00940888|26655643|FG000|Overall Study|Withdrawn - Non-Death|364|||
13351340|NCT00940888|26655643|FG000|Overall Study|Lost to Follow-up|6|||
13351341|NCT00940875|26655668|FG000|Treatment Phase|Adverse Event|9|||
13351342|NCT00940875|26655669|FG001|Treatment Phase|Adverse Event|3|||
13351343|NCT00940875|26655668|FG000|Treatment Phase|Death|3|||
13351344|NCT00940875|26655669|FG001|Treatment Phase|Death|5|||
13351345|NCT00940875|26655668|FG000|Treatment Phase|Lack of Efficacy|1|||
13351346|NCT00940875|26655669|FG001|Treatment Phase|Lack of Efficacy|0|||
13351347|NCT00940875|26655668|FG000|Treatment Phase|Withdrawal by Subject|3|||
13351348|NCT00940875|26655669|FG001|Treatment Phase|Withdrawal by Subject|0|||
13351349|NCT00940875|26655668|FG000|Treatment Phase|Disease progression|9|||
13351350|NCT00940875|26655669|FG001|Treatment Phase|Disease progression|11|||
13351351|NCT00940875|26655668|FG000|Treatment Phase|Physician Decision|1|||
13351352|NCT00940875|26655669|FG001|Treatment Phase|Physician Decision|0|||
13351353|NCT00940875|26655668|FG000|Post-Study Treatment|Death|0|||
13351354|NCT00940875|26655669|FG001|Post-Study Treatment|Death|1|||
13351355|NCT00940875|26655668|FG000|Post-Study Treatment|Disease Progression|0|||
13351356|NCT00940875|26655669|FG001|Post-Study Treatment|Disease Progression|2|||
13351357|NCT00940823|26655692|FG000|Overall Study|Death|8|||
13351358|NCT00940823|26655693|FG001|Overall Study|Death|12|||
13351359|NCT00940823|26655692|FG000|Overall Study|Lost to Follow-up|27|||
13351360|NCT00940823|26655693|FG001|Overall Study|Lost to Follow-up|20|||
13351361|NCT00940602|26655737|FG000|Overall Study|Administrative problems|1|||
13351362|NCT00940602|26655738|FG001|Overall Study|Administrative problems|1|||
13351363|NCT00940602|26655737|FG000|Overall Study|Patient/guardian decision|13|||
13351364|NCT00940602|26655738|FG001|Overall Study|Patient/guardian decision|28|||
13351365|NCT00940602|26655737|FG000|Overall Study|Physician Decision|8|||
13351366|NCT00940602|26655738|FG001|Overall Study|Physician Decision|5|||
13351367|NCT00940602|26655737|FG000|Overall Study|Pregnancy|1|||
13351368|NCT00940602|26655738|FG001|Overall Study|Pregnancy|0|||
13351369|NCT00940602|26655737|FG000|Overall Study|Protocol Deviation (untreated)|1|||
13351370|NCT00940602|26655738|FG001|Overall Study|Protocol Deviation (untreated)|0|||
13351371|NCT00940602|26655737|FG000|Overall Study|Disease progression|8|||
13351372|NCT00940602|26655738|FG001|Overall Study|Disease progression|2|||
13351373|NCT00940602|26655737|FG000|Overall Study|Death|38|||
13351374|NCT00940602|26655738|FG001|Overall Study|Death|19|||
13351375|NCT00940602|26655737|FG000|Overall Study|Lost to Follow-up|3|||
13351376|NCT00940602|26655738|FG001|Overall Study|Lost to Follow-up|1|||
13351377|NCT00940602|26655737|FG000|Overall Study|Patient withdrew consent|26|||
13351378|NCT00940602|26655738|FG001|Overall Study|Patient withdrew consent|13|||
13351379|NCT00940602|26655737|FG000|Overall Study|Adverse Event|7|||
13351380|NCT00940602|26655738|FG001|Overall Study|Adverse Event|2|||
13351381|NCT00940602|26655737|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43|||
13351382|NCT00940602|26655738|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5|||
13351383|NCT00940498|26655879|FG000|Overall Study|Death|2|||
13351384|NCT00940498|26655880|FG001|Overall Study|Death|0|||
13351385|NCT00940498|26655881|FG002|Overall Study|Death|0|||
13351386|NCT00940498|26655882|FG003|Overall Study|Death|1|||
13351387|NCT00940498|26655883|FG004|Overall Study|Death|5|||
13351388|NCT00940498|26655884|FG005|Overall Study|Death|0|||
13351389|NCT00940498|26655885|FG006|Overall Study|Death|1|||
13351390|NCT00940498|26655886|FG007|Overall Study|Death|0|||
13351391|NCT00940498|26655879|FG000|Overall Study|Lost to Follow-up|1|||
13351392|NCT00940498|26655880|FG001|Overall Study|Lost to Follow-up|1|||
13351393|NCT00940498|26655881|FG002|Overall Study|Lost to Follow-up|2|||
13351394|NCT00940498|26655882|FG003|Overall Study|Lost to Follow-up|0|||
13351395|NCT00940498|26655883|FG004|Overall Study|Lost to Follow-up|1|||
13351396|NCT00940498|26655884|FG005|Overall Study|Lost to Follow-up|0|||
13351397|NCT00940498|26655885|FG006|Overall Study|Lost to Follow-up|0|||
13351398|NCT00940498|26655886|FG007|Overall Study|Lost to Follow-up|1|||
13351399|NCT00940498|26655879|FG000|Overall Study|Disease Progression|0|||
13351400|NCT00940498|26655880|FG001|Overall Study|Disease Progression|0|||
13351401|NCT00940498|26655881|FG002|Overall Study|Disease Progression|1|||
13351402|NCT00940498|26655882|FG003|Overall Study|Disease Progression|1|||
13351403|NCT00940498|26655883|FG004|Overall Study|Disease Progression|0|||
13351404|NCT00940498|26655884|FG005|Overall Study|Disease Progression|1|||
13351405|NCT00940498|26655885|FG006|Overall Study|Disease Progression|0|||
13351406|NCT00940498|26655886|FG007|Overall Study|Disease Progression|0|||
13351407|NCT00940498|26655879|FG000|Overall Study|Physician Decision|0|||
13351408|NCT00940498|26655880|FG001|Overall Study|Physician Decision|0|||
13351409|NCT00940498|26655881|FG002|Overall Study|Physician Decision|0|||
13351410|NCT00940498|26655882|FG003|Overall Study|Physician Decision|0|||
13351411|NCT00940498|26655883|FG004|Overall Study|Physician Decision|2|||
13351412|NCT00940498|26655884|FG005|Overall Study|Physician Decision|0|||
13351413|NCT00940498|26655885|FG006|Overall Study|Physician Decision|0|||
13351414|NCT00940498|26655886|FG007|Overall Study|Physician Decision|0|||
13351415|NCT00940498|26655879|FG000|Overall Study|Not treated due to disease related pain|0|||
13351416|NCT00940498|26655880|FG001|Overall Study|Not treated due to disease related pain|0|||
13351417|NCT00940498|26655881|FG002|Overall Study|Not treated due to disease related pain|0|||
13351418|NCT00940498|26655882|FG003|Overall Study|Not treated due to disease related pain|0|||
13351419|NCT00940498|26655883|FG004|Overall Study|Not treated due to disease related pain|1|||
13351420|NCT00940498|26655884|FG005|Overall Study|Not treated due to disease related pain|0|||
13351421|NCT00940498|26655885|FG006|Overall Study|Not treated due to disease related pain|0|||
13351422|NCT00940498|26655886|FG007|Overall Study|Not treated due to disease related pain|0|||
13351423|NCT00940485|26655917|FG000|Overall Study|HBeAb positive at Baseline|3|||
13351424|NCT00940485|26655918|FG001|Overall Study|HBeAb positive at Baseline|2|||
13351425|NCT00940485|26655917|FG000|Overall Study|Lost to Follow-up|2|||
13351426|NCT00940485|26655918|FG001|Overall Study|Lost to Follow-up|3|||
13351427|NCT00940485|26655917|FG000|Overall Study|Adverse Event|8|||
13351428|NCT00940485|26655918|FG001|Overall Study|Adverse Event|0|||
13351429|NCT00940485|26655917|FG000|Overall Study|Withdrawal by Subject|1|||
13351430|NCT00940485|26655918|FG001|Overall Study|Withdrawal by Subject|1|||
13351431|NCT00940485|26655917|FG000|Overall Study|Others|1|||
13351432|NCT00940485|26655918|FG001|Overall Study|Others|1|||
13351433|NCT00940342|26655936|FG000|Overall Study|Adverse Event|0|||
13351434|NCT00940342|26655937|FG001|Overall Study|Adverse Event|2|||
13351435|NCT00940342|26655938|FG002|Overall Study|Adverse Event|1|||
13351436|NCT00940316|26655970|FG000|Reached First Response at 8 Weeks|Adverse Event|2|||
13351437|NCT00940316|26655971|FG001|Reached First Response at 8 Weeks|Adverse Event|1|||
13351438|NCT00940316|26655972|FG002|Reached First Response at 8 Weeks|Adverse Event|0|||
13351439|NCT00940316|26655970|FG000|Reached First Response at 8 Weeks|Progressive disease|1|||
13351440|NCT00940316|26655971|FG001|Reached First Response at 8 Weeks|Progressive disease|3|||
13351441|NCT00940316|26655972|FG002|Reached First Response at 8 Weeks|Progressive disease|0|||
13351442|NCT00940316|26655970|FG000|Moved on to be Treated Cycle 5|Adverse Event|2|||
13351443|NCT00940316|26655971|FG001|Moved on to be Treated Cycle 5|Adverse Event|0|||
13351444|NCT00940316|26655972|FG002|Moved on to be Treated Cycle 5|Adverse Event|0|||
13351445|NCT00940316|26655970|FG000|Treated After Cycle 5|Adverse Event|0|||
13351446|NCT00940316|26655971|FG001|Treated After Cycle 5|Adverse Event|0|||
13351447|NCT00940316|26655972|FG002|Treated After Cycle 5|Adverse Event|1|||
13351448|NCT00940316|26655970|FG000|Treated After Cycle 5|Progressive disease|0|||
13351449|NCT00940316|26655971|FG001|Treated After Cycle 5|Progressive disease|1|||
13351450|NCT00940316|26655972|FG002|Treated After Cycle 5|Progressive disease|0|||
13351451|NCT00940108|26656035|FG000|Overall Study|Adverse Event|2|||
13351452|NCT00940108|26656036|FG001|Overall Study|Adverse Event|4|||
13351453|NCT00940108|26656037|FG002|Overall Study|Adverse Event|0|||
13351454|NCT00940108|26656038|FG003|Overall Study|Adverse Event|2|||
13351455|NCT00940108|26656035|FG000|Overall Study|Withdrew Consent|2|||
13351456|NCT00940108|26656036|FG001|Overall Study|Withdrew Consent|1|||
13351457|NCT00940108|26656037|FG002|Overall Study|Withdrew Consent|0|||
13351458|NCT00940108|26656038|FG003|Overall Study|Withdrew Consent|1|||
13351459|NCT00940108|26656035|FG000|Overall Study|Dose 2 contraindicated|1|||
13351460|NCT00940108|26656036|FG001|Overall Study|Dose 2 contraindicated|1|||
13351461|NCT00940108|26656037|FG002|Overall Study|Dose 2 contraindicated|0|||
13351462|NCT00940108|26656038|FG003|Overall Study|Dose 2 contraindicated|1|||
13351463|NCT00940108|26656035|FG000|Overall Study|Declined further vaccination|0|||
13351464|NCT00940108|26656036|FG001|Overall Study|Declined further vaccination|1|||
13351465|NCT00940108|26656037|FG002|Overall Study|Declined further vaccination|3|||
13351466|NCT00940108|26656038|FG003|Overall Study|Declined further vaccination|0|||
13351467|NCT00940108|26656035|FG000|Overall Study|Refused - pyrexia after Dose 1|0|||
13351468|NCT00940108|26656036|FG001|Overall Study|Refused - pyrexia after Dose 1|1|||
13351469|NCT00940108|26656037|FG002|Overall Study|Refused - pyrexia after Dose 1|0|||
13351470|NCT00940108|26656038|FG003|Overall Study|Refused - pyrexia after Dose 1|0|||
13351471|NCT00940108|26656035|FG000|Overall Study|Viral illness after Dose 1|0|||
13351472|NCT00940108|26656036|FG001|Overall Study|Viral illness after Dose 1|1|||
13351473|NCT00940108|26656037|FG002|Overall Study|Viral illness after Dose 1|0|||
13351474|NCT00940108|26656038|FG003|Overall Study|Viral illness after Dose 1|0|||
13351475|NCT00940108|26656035|FG000|Overall Study|Diagnosed with H1N1|0|||
13351476|NCT00940108|26656036|FG001|Overall Study|Diagnosed with H1N1|0|||
13351477|NCT00940108|26656037|FG002|Overall Study|Diagnosed with H1N1|0|||
13351478|NCT00940108|26656038|FG003|Overall Study|Diagnosed with H1N1|1|||
13351479|NCT00940017|26656059|FG000|Overall Study|did not meet entrance criteria|3|||
13351480|NCT00940017|26656059|FG000|Overall Study|Adverse Event|1|||
13351481|NCT00939822|26656078|FG000|Overall Study|Lost to Follow-up|1|||
13351482|NCT00939822|26656079|FG001|Overall Study|Lost to Follow-up|0|||
13351483|NCT00939822|26656078|FG000|Overall Study|withdrew from study due to busy schedule|1|||
13351484|NCT00939822|26656079|FG001|Overall Study|withdrew from study due to busy schedule|1|||
13351485|NCT00939822|26656078|FG000|Overall Study|Mental health issues|0|||
13351486|NCT00939822|26656079|FG001|Overall Study|Mental health issues|2|||
13351487|NCT00939809|26656090|FG000|Overall Study|Adverse Event|2|||
13351488|NCT00939809|26656090|FG000|Overall Study|Death|1|||
13351489|NCT00939783|26656099|FG000|Overall Study|Death|6|||
13351490|NCT00939783|26656099|FG000|Overall Study|Adverse Event|39|||
13351491|NCT00939783|26656099|FG000|Overall Study|Study Terminated by Sponsor|498|||
13351492|NCT00939783|26656099|FG000|Overall Study|Withdrawal by Subject|78|||
13351493|NCT00939783|26656099|FG000|Overall Study|Other|16|||
13351494|NCT00939783|26656099|FG000|Overall Study|Lost to Follow-up|8|||
13351495|NCT00939783|26656099|FG000|Overall Study|Protocol Violation|3|||
13351496|NCT00939783|26656099|FG000|Overall Study|Enrolled but not treated|1|||
13351497|NCT00939770|26656175|FG000|Overall Study|Adverse Event|1|||
13351498|NCT00939770|26656176|FG001|Overall Study|Adverse Event|1|||
13351499|NCT00939770|26656177|FG002|Overall Study|Adverse Event|0|||
13351500|NCT00939770|26656178|FG003|Overall Study|Adverse Event|0|||
13351501|NCT00939770|26656179|FG004|Overall Study|Adverse Event|6|||
13351502|NCT00939770|26656180|FG005|Overall Study|Adverse Event|2|||
13351503|NCT00939770|26656181|FG006|Overall Study|Adverse Event|1|||
13351504|NCT00939770|26656182|FG007|Overall Study|Adverse Event|1|||
13351505|NCT00939770|26656175|FG000|Overall Study|Lack of Efficacy|4|||
13351506|NCT00939770|26656176|FG001|Overall Study|Lack of Efficacy|6|||
13351507|NCT00939770|26656177|FG002|Overall Study|Lack of Efficacy|13|||
13351508|NCT00939770|26656178|FG003|Overall Study|Lack of Efficacy|9|||
13351509|NCT00939770|26656179|FG004|Overall Study|Lack of Efficacy|16|||
13351510|NCT00939770|26656180|FG005|Overall Study|Lack of Efficacy|8|||
13351511|NCT00939770|26656181|FG006|Overall Study|Lack of Efficacy|11|||
13351512|NCT00939770|26656182|FG007|Overall Study|Lack of Efficacy|1|||
13351513|NCT00939770|26656175|FG000|Overall Study|Lost to Follow-up|0|||
13351514|NCT00939770|26656176|FG001|Overall Study|Lost to Follow-up|0|||
13351515|NCT00939770|26656177|FG002|Overall Study|Lost to Follow-up|0|||
13351516|NCT00939770|26656178|FG003|Overall Study|Lost to Follow-up|0|||
13351517|NCT00939770|26656179|FG004|Overall Study|Lost to Follow-up|1|||
13351518|NCT00939770|26656180|FG005|Overall Study|Lost to Follow-up|0|||
13351519|NCT00939770|26656181|FG006|Overall Study|Lost to Follow-up|0|||
13351520|NCT00939770|26656182|FG007|Overall Study|Lost to Follow-up|0|||
13351521|NCT00939770|26656175|FG000|Overall Study|Physician Decision|0|||
13351522|NCT00939770|26656176|FG001|Overall Study|Physician Decision|0|||
13351523|NCT00939770|26656177|FG002|Overall Study|Physician Decision|2|||
13351524|NCT00939770|26656178|FG003|Overall Study|Physician Decision|0|||
13351525|NCT00939770|26656179|FG004|Overall Study|Physician Decision|7|||
13351526|NCT00939770|26656180|FG005|Overall Study|Physician Decision|1|||
13351527|NCT00939770|26656181|FG006|Overall Study|Physician Decision|0|||
13351528|NCT00939770|26656182|FG007|Overall Study|Physician Decision|6|||
13351529|NCT00939770|26656175|FG000|Overall Study|Protocol Violation|0|||
13351530|NCT00939770|26656176|FG001|Overall Study|Protocol Violation|0|||
13351531|NCT00939770|26656177|FG002|Overall Study|Protocol Violation|0|||
13351532|NCT00939770|26656178|FG003|Overall Study|Protocol Violation|0|||
13351533|NCT00939770|26656179|FG004|Overall Study|Protocol Violation|1|||
13351534|NCT00939770|26656180|FG005|Overall Study|Protocol Violation|0|||
13351535|NCT00939770|26656181|FG006|Overall Study|Protocol Violation|0|||
13351536|NCT00939770|26656182|FG007|Overall Study|Protocol Violation|0|||
13351537|NCT00939770|26656175|FG000|Overall Study|Withdrawal by Subject|0|||
13351538|NCT00939770|26656176|FG001|Overall Study|Withdrawal by Subject|1|||
13351539|NCT00939770|26656177|FG002|Overall Study|Withdrawal by Subject|5|||
13351540|NCT00939770|26656178|FG003|Overall Study|Withdrawal by Subject|2|||
13351541|NCT00939770|26656179|FG004|Overall Study|Withdrawal by Subject|6|||
13351542|NCT00939770|26656180|FG005|Overall Study|Withdrawal by Subject|0|||
13351543|NCT00939770|26656181|FG006|Overall Study|Withdrawal by Subject|2|||
13351544|NCT00939770|26656182|FG007|Overall Study|Withdrawal by Subject|2|||
13351545|NCT00939692|26656199|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1|||
13351546|NCT00939692|26656200|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0|||
13351547|NCT00939692|26656199|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0|||
13351548|NCT00939692|26656200|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1|||
13351549|NCT00939640|26656221|FG000|Overall Study|Physician Decision|1|||
13351550|NCT00939627|26656247|FG000|Overall Study|Disease Progression|16|||
13351551|NCT00939627|26656248|FG001|Overall Study|Disease Progression|12|||
13351552|NCT00939627|26656249|FG002|Overall Study|Disease Progression|0|||
13351553|NCT00939627|26656247|FG000|Overall Study|Adverse Event|6|||
13351554|NCT00939627|26656248|FG001|Overall Study|Adverse Event|7|||
13351555|NCT00939627|26656249|FG002|Overall Study|Adverse Event|0|||
13351556|NCT00939627|26656247|FG000|Overall Study|Death|0|||
13351557|NCT00939627|26656248|FG001|Overall Study|Death|2|||
13351558|NCT00939627|26656249|FG002|Overall Study|Death|0|||
13351559|NCT00939627|26656247|FG000|Overall Study|Withdrawal by Subject|2|||
13351560|NCT00939627|26656248|FG001|Overall Study|Withdrawal by Subject|4|||
13351561|NCT00939627|26656249|FG002|Overall Study|Withdrawal by Subject|0|||
13351562|NCT00939627|26656247|FG000|Overall Study|Other complicating disease|1|||
13351563|NCT00939627|26656248|FG001|Overall Study|Other complicating disease|1|||
13351564|NCT00939627|26656249|FG002|Overall Study|Other complicating disease|0|||
13351565|NCT00939627|26656247|FG000|Overall Study|Not compliant|2|||
13351566|NCT00939627|26656248|FG001|Overall Study|Not compliant|0|||
13351567|NCT00939627|26656249|FG002|Overall Study|Not compliant|0|||
13351568|NCT00939627|26656247|FG000|Overall Study|No off-tx reason given|0|||
13351569|NCT00939627|26656248|FG001|Overall Study|No off-tx reason given|2|||
13351570|NCT00939627|26656249|FG002|Overall Study|No off-tx reason given|0|||
13351571|NCT00939523|26656258|FG000|Overall Study|Lack of Efficacy|1|||
13351572|NCT00939523|26656258|FG000|Overall Study|Physician Decision|2|||
13351573|NCT00939510|26656266|FG000|Overall Study|Withdrawal by Subject|1|||
13351574|NCT00939484|26656289|FG000|Overall Study|Progression/Relapse|8|||
13351575|NCT00939484|26656290|FG001|Overall Study|Progression/Relapse|20|||
13351576|NCT00939484|26656291|FG002|Overall Study|Progression/Relapse|3|||
13351577|NCT00939393|26656318|FG000|Overall Study|Withdrawal by Subject|1|||
13351578|NCT00939393|26656319|FG001|Overall Study|Withdrawal by Subject|0|||
13351579|NCT00939393|26656318|FG000|Overall Study|Lost to Follow-up|3|||
13351580|NCT00939393|26656319|FG001|Overall Study|Lost to Follow-up|0|||
13351581|NCT00939341|26656341|FG000|Overall Study|Adverse Event|15|||
13351582|NCT00939341|26656341|FG000|Overall Study|Pregnancy|1|||
13351583|NCT00939341|26656341|FG000|Overall Study|Lost to Follow-up|23|||
13351584|NCT00939341|26656341|FG000|Overall Study|Withdrawal by Subject|13|||
13351585|NCT00939341|26656341|FG000|Overall Study|Protocol Violation|6|||
13351586|NCT00939341|26656341|FG000|Overall Study|Incorrect enrolment|8|||
13351587|NCT00939185|26656350|FG000|Overall Study|Adverse Event|3|||
13351588|NCT00939185|26656350|FG000|Overall Study|Lack of Efficacy|1|||
13351589|NCT00939185|26656350|FG000|Overall Study|Lost to Follow-up|6|||
13351590|NCT00939185|26656350|FG000|Overall Study|Other|3|||
13351591|NCT00939185|26656350|FG000|Overall Study|Withdrawal by Subject|2|||
13351592|NCT00939185|26656350|FG000|Overall Study|Randomized But Did Not Receive Treatment|10|||
13374316|NCT00797225|26726089|FG005|Weeks 13 to 24|Adverse Event|0|||
13374317|NCT00797225|26726090|FG006|Weeks 13 to 24|Adverse Event|1|||
13374318|NCT00797225|26726091|FG007|Weeks 13 to 24|Adverse Event|0|||
13374319|NCT00797225|26726084|FG000|Weeks 13 to 24|Sponsor Decision|0|||
13374320|NCT00797225|26726085|FG001|Weeks 13 to 24|Sponsor Decision|0|||
13374321|NCT00797225|26726086|FG002|Weeks 13 to 24|Sponsor Decision|0|||
13374322|NCT00797225|26726087|FG003|Weeks 13 to 24|Sponsor Decision|0|||
13374323|NCT00797225|26726088|FG004|Weeks 13 to 24|Sponsor Decision|0|||
13374324|NCT00797225|26726089|FG005|Weeks 13 to 24|Sponsor Decision|0|||
13374325|NCT00797225|26726090|FG006|Weeks 13 to 24|Sponsor Decision|1|||
13374326|NCT00797225|26726091|FG007|Weeks 13 to 24|Sponsor Decision|0|||
13374327|NCT00797108|26726133|FG000|Overall Study|Adverse Event|1|||
13374328|NCT00797108|26726134|FG001|Overall Study|Adverse Event|0|||
13374329|NCT00797108|26726135|FG002|Overall Study|Adverse Event|3|||
13374330|NCT00797108|26726133|FG000|Overall Study|Did Not Meet Entrance Criteria|0|||
13374331|NCT00797108|26726134|FG001|Overall Study|Did Not Meet Entrance Criteria|1|||
13374332|NCT00797108|26726135|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
13374333|NCT00797108|26726133|FG000|Overall Study|Global Deterioration of Health Status|0|||
13374334|NCT00797108|26726134|FG001|Overall Study|Global Deterioration of Health Status|1|||
13374335|NCT00797108|26726135|FG002|Overall Study|Global Deterioration of Health Status|0|||
13374336|NCT00797108|26726133|FG000|Overall Study|Lack of Efficacy|1|||
13374337|NCT00797108|26726134|FG001|Overall Study|Lack of Efficacy|0|||
13374338|NCT00797108|26726135|FG002|Overall Study|Lack of Efficacy|1|||
13374339|NCT00797108|26726133|FG000|Overall Study|Other|0|||
13374340|NCT00797108|26726134|FG001|Overall Study|Other|0|||
13374341|NCT00797108|26726135|FG002|Overall Study|Other|2|||
13374342|NCT00797108|26726133|FG000|Overall Study|Randomized but not Treated|2|||
13374343|NCT00797108|26726134|FG001|Overall Study|Randomized but not Treated|0|||
13374344|NCT00797108|26726135|FG002|Overall Study|Randomized but not Treated|0|||
13374345|NCT00796991|26726243|FG000|Overall Study|Adverse Event|0|||
13374346|NCT00796991|26726244|FG001|Overall Study|Adverse Event|0|||
13374347|NCT00796991|26726245|FG002|Overall Study|Adverse Event|1|||
13374348|NCT00796991|26726243|FG000|Overall Study|Death|2|||
13374349|NCT00796991|26726244|FG001|Overall Study|Death|0|||
13374350|NCT00796991|26726245|FG002|Overall Study|Death|0|||
13374351|NCT00796991|26726243|FG000|Overall Study|Disease Progression|10|||
13374352|NCT00796991|26726244|FG001|Overall Study|Disease Progression|9|||
13374353|NCT00796991|26726245|FG002|Overall Study|Disease Progression|7|||
13374354|NCT00796991|26726243|FG000|Overall Study|Study Drug Toxicity|3|||
13374355|NCT00796991|26726244|FG001|Overall Study|Study Drug Toxicity|3|||
13374356|NCT00796991|26726245|FG002|Overall Study|Study Drug Toxicity|5|||
13374357|NCT00796991|26726243|FG000|Overall Study|Withdrawal by Subject|0|||
13374358|NCT00796991|26726244|FG001|Overall Study|Withdrawal by Subject|0|||
13374359|NCT00796991|26726245|FG002|Overall Study|Withdrawal by Subject|1|||
13374360|NCT00796978|26726264|FG000|Overall Study|Cardiac adverse event|5|||
13374361|NCT00796978|26726264|FG000|Overall Study|Adverse Event|4|||
13374362|NCT00796978|26726264|FG000|Overall Study|Withdrawal by Subject|3|||
13374363|NCT00796861|26726270|FG000|Overall Study|Withdrawal by Subject|2|||
13374364|NCT00796861|26726270|FG000|Overall Study|Death|2|||
13374365|NCT00796822|26726285|FG000|Overall Study|Lost to Follow-up|2|||
13374366|NCT00796822|26726286|FG001|Overall Study|Lost to Follow-up|0|||
13374367|NCT00796822|26726285|FG000|Overall Study|Adverse Event|1|||
13374368|NCT00796822|26726286|FG001|Overall Study|Adverse Event|0|||
13374369|NCT00796757|26726300|FG000|Overall Study|Withdrawal by Subject|14|||
13374370|NCT00796757|26726300|FG000|Overall Study|Death|61|||
13374371|NCT00796757|26726300|FG000|Overall Study|Protocol Violation|1|||
13374372|NCT00796757|26726300|FG000|Overall Study|Participant noncompliance|1|||
13374373|NCT00796757|26726300|FG000|Overall Study|Investigator's decision|2|||
13374374|NCT00796757|26726300|FG000|Overall Study|Other|7|||
13374375|NCT00796718|26726309|FG000|Overall Study|Adverse Event|2|||
13374376|NCT00796718|26726309|FG000|Overall Study|Exclusion Criteria|1|||
13374377|NCT00796718|26726309|FG000|Overall Study|Lost to Follow-up|5|||
13374378|NCT00796718|26726309|FG000|Overall Study|Withdrawal by Informed Consent|1|||
13374379|NCT00796666|26726346|FG000|Overall Study|Death|2|||
13374380|NCT00796666|26726347|FG001|Overall Study|Death|4|||
13374381|NCT00796666|26726346|FG000|Overall Study|Withdrawal by Subject|2|||
13374382|NCT00796666|26726347|FG001|Overall Study|Withdrawal by Subject|0|||
13351593|NCT00939107|26656369|FG000|Overall Study|Lost to Follow-up|14|||
13351594|NCT00939107|26656370|FG001|Overall Study|Lost to Follow-up|12|||
13351595|NCT00939094|26656397|FG000|Overall Study|Adverse Event|9|||
13351596|NCT00939094|26656398|FG001|Overall Study|Adverse Event|0|||
13351597|NCT00939094|26656397|FG000|Overall Study|Withdrawal by Subject|1|||
13351598|NCT00939094|26656398|FG001|Overall Study|Withdrawal by Subject|6|||
13351599|NCT00939094|26656397|FG000|Overall Study|Lost to Follow-up|1|||
13351600|NCT00939094|26656398|FG001|Overall Study|Lost to Follow-up|1|||
13351601|NCT00939094|26656397|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
13351602|NCT00939094|26656398|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
13351603|NCT00939094|26656397|FG000|Overall Study|Severe non-compliance to protocol|0|||
13351604|NCT00939094|26656398|FG001|Overall Study|Severe non-compliance to protocol|1|||
13351605|NCT00939094|26656397|FG000|Overall Study|Study stopped by sponsor|0|||
13351606|NCT00939094|26656398|FG001|Overall Study|Study stopped by sponsor|2|||
13351607|NCT00939094|26656397|FG000|Overall Study|Abnormal ECG findings|1|||
13351608|NCT00939094|26656398|FG001|Overall Study|Abnormal ECG findings|0|||
13351609|NCT00939055|26656413|FG000|Overall Study|Discontinuation prior to procedure|4|||
13351610|NCT00939055|26656414|FG001|Overall Study|Discontinuation prior to procedure|0|||
13351611|NCT00939029|26656431|FG000|Overall Study|Withdrawal by Subject|3|||
13351612|NCT00939029|26656432|FG001|Overall Study|Withdrawal by Subject|7|||
13351613|NCT00939029|26656431|FG000|Overall Study|Lost to Follow-up|3|||
13351614|NCT00939029|26656432|FG001|Overall Study|Lost to Follow-up|4|||
13351615|NCT00939029|26656431|FG000|Overall Study|Adverse Event|0|||
13351616|NCT00939029|26656432|FG001|Overall Study|Adverse Event|1|||
13351617|NCT00939003|26656474|FG000|Double-blind Treatment Period|Adverse Event|1|||
13351618|NCT00939003|26656475|FG001|Double-blind Treatment Period|Adverse Event|1|||
13351619|NCT00939003|26656474|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
13351620|NCT00939003|26656475|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
13351621|NCT00939003|26656474|FG000|Double-blind Treatment Period|Pregnancy|0|||
13351622|NCT00939003|26656475|FG001|Double-blind Treatment Period|Pregnancy|1|||
13351623|NCT00939003|26656474|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1|||
13351624|NCT00939003|26656475|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1|||
13351625|NCT00939003|26656474|FG000|Open-label Treatment Period|Adverse Event|4|||
13351626|NCT00939003|26656475|FG001|Open-label Treatment Period|Adverse Event|8|||
13351627|NCT00939003|26656474|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
13351628|NCT00939003|26656475|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
13351629|NCT00939003|26656474|FG000|Open-label Treatment Period|Lack of Efficacy|6|||
13351630|NCT00939003|26656475|FG001|Open-label Treatment Period|Lack of Efficacy|9|||
13351631|NCT00939003|26656474|FG000|Open-label Treatment Period|Pregnancy|1|||
13351632|NCT00939003|26656475|FG001|Open-label Treatment Period|Pregnancy|1|||
13351633|NCT00939003|26656474|FG000|Open-label Treatment Period|Exclusion Criteria|1|||
13351634|NCT00939003|26656475|FG001|Open-label Treatment Period|Exclusion Criteria|0|||
13351635|NCT00939003|26656474|FG000|Open-label Treatment Period|Site Closure|3|||
13351636|NCT00939003|26656475|FG001|Open-label Treatment Period|Site Closure|4|||
13351637|NCT00938964|26656544|FG000|Overall Study|Death|3|||
13351638|NCT00938964|26656545|FG001|Overall Study|Death|3|||
13351639|NCT00938964|26656544|FG000|Overall Study|Lost to Follow-up|2|||
13351640|NCT00938964|26656545|FG001|Overall Study|Lost to Follow-up|3|||
13204416|NCT01973387|26228518|FG001|Overall Study|Progressive disease or relapse|5|||
13204417|NCT01973387|26228517|FG000|Overall Study|Death|4|||
13204418|NCT01973387|26228518|FG001|Overall Study|Death|3|||
13204419|NCT01973387|26228517|FG000|Overall Study|Randomized, not treated|2|||
13204420|NCT01973387|26228518|FG001|Overall Study|Randomized, not treated|2|||
13204421|NCT01973283|26228546|FG000|Overall Study|Lost to Follow-up|4|||
13351641|NCT00938964|26656544|FG000|Overall Study|Withdrawal by Subject|22|||
13351642|NCT00938964|26656545|FG001|Overall Study|Withdrawal by Subject|18|||
13351643|NCT00938964|26656544|FG000|Overall Study|Found to Meet Exclusion Criteria|3|||
13351644|NCT00938964|26656545|FG001|Overall Study|Found to Meet Exclusion Criteria|4|||
13351645|NCT00938886|26656560|FG000|Overall Study|Death|0|||
13351646|NCT00938886|26656561|FG001|Overall Study|Death|1|||
13351647|NCT00938886|26656560|FG000|Overall Study|Withdrawal by Subject|4|||
13351648|NCT00938886|26656561|FG001|Overall Study|Withdrawal by Subject|7|||
13351649|NCT00938886|26656560|FG000|Overall Study|Lost to Follow-up|3|||
13351650|NCT00938886|26656561|FG001|Overall Study|Lost to Follow-up|2|||
13351651|NCT00938860|26656590|FG000|Overall Study|Adverse Event|2|||
13351652|NCT00938860|26656591|FG001|Overall Study|Adverse Event|1|||
13351653|NCT00938860|26656590|FG000|Overall Study|Abnormal laboratory values|2|||
13351654|NCT00938860|26656591|FG001|Overall Study|Abnormal laboratory values|2|||
13351655|NCT00938860|26656590|FG000|Overall Study|Withdrawal by Subject|11|||
13351656|NCT00938860|26656591|FG001|Overall Study|Withdrawal by Subject|8|||
13351657|NCT00938860|26656590|FG000|Overall Study|Lost to Follow-up|4|||
13351658|NCT00938860|26656591|FG001|Overall Study|Lost to Follow-up|4|||
13351659|NCT00938860|26656590|FG000|Overall Study|Administration problems|2|||
13351660|NCT00938860|26656591|FG001|Overall Study|Administration problems|0|||
13486420|NCT03564119|27036069|FG001|Overall Study|Other Than Specified|1|||
13204422|NCT01973231|26228571|FG000|Overall Study|Protocol Violation|1|||
13351661|NCT00938860|26656590|FG000|Overall Study|Death|1|||
13351662|NCT00938860|26656591|FG001|Overall Study|Death|1|||
13351663|NCT00938860|26656590|FG000|Overall Study|Protocol Violation|3|||
13351664|NCT00938860|26656591|FG001|Overall Study|Protocol Violation|1|||
13351665|NCT00938717|26656630|FG000|Overall Study|Adverse Event|10|||
13351666|NCT00938717|26656631|FG001|Overall Study|Adverse Event|41|||
13351667|NCT00938717|26656630|FG000|Overall Study|Protocol Violation|11|||
13351668|NCT00938717|26656631|FG001|Overall Study|Protocol Violation|8|||
13351669|NCT00938717|26656630|FG000|Overall Study|Withdrawal by Subject|26|||
13351670|NCT00938717|26656631|FG001|Overall Study|Withdrawal by Subject|24|||
13351671|NCT00938717|26656630|FG000|Overall Study|Lost to Follow-up|13|||
13351672|NCT00938717|26656631|FG001|Overall Study|Lost to Follow-up|18|||
13351673|NCT00938717|26656630|FG000|Overall Study|Lack of Efficacy|33|||
13351674|NCT00938717|26656631|FG001|Overall Study|Lack of Efficacy|15|||
13351675|NCT00938717|26656630|FG000|Overall Study|Other reason|5|||
13351676|NCT00938717|26656631|FG001|Overall Study|Other reason|2|||
13351677|NCT00938639|26656706|FG000|Overall Study|Moved away from study area|0|||
13351678|NCT00938639|26656707|FG001|Overall Study|Moved away from study area|1|||
13351679|NCT00938639|26656706|FG000|Overall Study|Lost to Follow-up|1|||
13351680|NCT00938639|26656707|FG001|Overall Study|Lost to Follow-up|2|||
13351681|NCT00938639|26656706|FG000|Overall Study|Family issues|1|||
13351682|NCT00938639|26656707|FG001|Overall Study|Family issues|1|||
13351683|NCT00938639|26656706|FG000|Overall Study|Participant noncompliance|1|||
13351684|NCT00938639|26656707|FG001|Overall Study|Participant noncompliance|0|||
13351685|NCT00938470|26656728|FG000|Overall Study|Disease Progression|3|||
13351686|NCT00938470|26656729|FG001|Overall Study|Disease Progression|0|||
13351687|NCT00938470|26656728|FG000|Overall Study|Alternate Treatment|1|||
13351688|NCT00938470|26656729|FG001|Overall Study|Alternate Treatment|0|||
13351689|NCT00938470|26656728|FG000|Overall Study|Death|3|||
13351690|NCT00938470|26656729|FG001|Overall Study|Death|2|||
13351691|NCT00938470|26656728|FG000|Overall Study|Other Reason|0|||
13351692|NCT00938470|26656729|FG001|Overall Study|Other Reason|1|||
13351693|NCT00938431|26656764|FG000|Overall Study|Adverse Event|5|||
13351694|NCT00938431|26656765|FG001|Overall Study|Adverse Event|8|||
13351695|NCT00938431|26656766|FG002|Overall Study|Adverse Event|6|||
13351696|NCT00938431|26656764|FG000|Overall Study|Lack of Efficacy|0|||
13351697|NCT00938431|26656765|FG001|Overall Study|Lack of Efficacy|1|||
13351698|NCT00938431|26656766|FG002|Overall Study|Lack of Efficacy|0|||
13351699|NCT00938431|26656764|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1|||
13351700|NCT00938431|26656765|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0|||
13351701|NCT00938431|26656766|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0|||
13351702|NCT00938431|26656764|FG000|Overall Study|Dosing compliance issue|0|||
13351703|NCT00938431|26656765|FG001|Overall Study|Dosing compliance issue|0|||
13351704|NCT00938431|26656766|FG002|Overall Study|Dosing compliance issue|1|||
13351705|NCT00938431|26656764|FG000|Overall Study|Reached maximum dose early|0|||
13351706|NCT00938431|26656765|FG001|Overall Study|Reached maximum dose early|0|||
13351707|NCT00938431|26656766|FG002|Overall Study|Reached maximum dose early|1|||
13351708|NCT00938392|26656797|FG000|Overall Study|Adverse Event|0|||
13351709|NCT00938392|26656798|FG001|Overall Study|Adverse Event|1|||
13351710|NCT00938392|26656797|FG000|Overall Study|Withdrawal by Subject|0|||
13351711|NCT00938392|26656798|FG001|Overall Study|Withdrawal by Subject|1|||
13351712|NCT00938392|26656797|FG000|Overall Study|Lost to Follow-up|2|||
13351713|NCT00938392|26656798|FG001|Overall Study|Lost to Follow-up|2|||
13351714|NCT00938366|26656825|FG000|Overall Study|Withdrawal by Subject|1|||
13351715|NCT00938366|26656826|FG001|Overall Study|Withdrawal by Subject|0|||
13351716|NCT00938340|26656958|FG000|Overall Study|Withdrawal by Subject|3|||
13351717|NCT00938340|26656958|FG000|Overall Study|Protocol Violation|1|||
13351718|NCT00938340|26656958|FG000|Overall Study|Adverse Event|1|||
13351719|NCT00938327|26656967|FG000|Overall Study|Adverse Event|2|||
13351720|NCT00938327|26656967|FG000|Overall Study|Protocol Violation|1|||
13351721|NCT00938327|26656967|FG000|Overall Study|Withdrawal by Subject|4|||
13351722|NCT00938327|26656967|FG000|Overall Study|Lost to Follow-up|37|||
13351723|NCT00938327|26656967|FG000|Overall Study|2nd dose received outside of the study|7|||
13351724|NCT00938327|26656967|FG000|Overall Study|Vaccine not received as out of stock|9|||
13351725|NCT00938041|26656978|FG000|Overall Study|Lost to Follow-up|6|||
13351726|NCT00938041|26656978|FG000|Overall Study|Received Alternative Therapy|1|||
13351727|NCT00938041|26656978|FG000|Overall Study|Progressive Disease|5|||
13351728|NCT00938041|26656978|FG000|Overall Study|Death|12|||
13351729|NCT00938041|26656978|FG000|Overall Study|Adrenal Insufficiency|3|||
13351730|NCT00938015|26656996|FG000|Overall Study|Death|2|||
13351731|NCT00938015|26656996|FG000|Overall Study|Lost to Follow-up|32|||
13351732|NCT00938015|26656996|FG000|Overall Study|Adverse Event|32|||
13351733|NCT00938015|26656996|FG000|Overall Study|Non-responder|52|||
13351734|NCT00938015|26656996|FG000|Overall Study|Reason not related to Etanercept|29|||
13351735|NCT00937950|26657014|FG000|Overall Study|Withdrawal by Subject|23|||
13351736|NCT00937950|26657014|FG000|Overall Study|Migrated/moved from study area|27|||
13351737|NCT00937950|26657014|FG000|Overall Study|Lost to Follow-up|144|||
13351738|NCT00937950|26657014|FG000|Overall Study|Missing confirmed|4|||
13351739|NCT00937950|26657014|FG000|Overall Study|Other|18|||
13351745|NCT00937833|26657036|FG000|Overall Study|Protocol Violation|1|||
13351746|NCT00937833|26657037|FG001|Overall Study|Protocol Violation|2|||
13351747|NCT00937833|26657036|FG000|Overall Study|Procedure delayed; enrollment closed|0|||
13351748|NCT00937833|26657037|FG001|Overall Study|Procedure delayed; enrollment closed|1|||
13351749|NCT00937833|26657036|FG000|Overall Study|Lost to Follow-up|10|||
13351750|NCT00937833|26657037|FG001|Overall Study|Lost to Follow-up|8|||
13351751|NCT00937833|26657036|FG000|Overall Study|Withdrawal by Subject|4|||
13351752|NCT00937833|26657037|FG001|Overall Study|Withdrawal by Subject|6|||
13351753|NCT00937768|26657064|FG000|Overall Study|Refused Further Treatment|3|||
13351754|NCT00937768|26657065|FG001|Overall Study|Refused Further Treatment|2|||
13351755|NCT00937768|26657064|FG000|Overall Study|Disease Progression|1|||
13351756|NCT00937768|26657065|FG001|Overall Study|Disease Progression|1|||
13351757|NCT00937768|26657064|FG000|Overall Study|Alternate Treatment|0|||
13351758|NCT00937768|26657065|FG001|Overall Study|Alternate Treatment|1|||
13351759|NCT00937768|26657064|FG000|Overall Study|No Further Funding|4|||
13351760|NCT00937768|26657065|FG001|Overall Study|No Further Funding|4|||
13351761|NCT00937560|26657075|FG000|Initial Treatment|Death|6|||
13351762|NCT00937560|26657075|FG000|Initial Treatment|Withdraw consent|3|||
13351763|NCT00937560|26657075|FG000|Initial Treatment|Adverse Event|1|||
13351764|NCT00937560|26657075|FG000|Initial Treatment|Lost to Follow-up|1|||
13351765|NCT00937560|26657075|FG000|Initial Treatment|No end of study page|10|||
13351766|NCT00937560|26657075|FG000|Maintenance Treatment|Death|12|||
13351767|NCT00937560|26657075|FG000|Maintenance Treatment|Withdraw consent|5|||
13351768|NCT00937560|26657075|FG000|Maintenance Treatment|According to protocol|1|||
13351769|NCT00937547|26657114|FG000|Overall Study|misdiagnosis|1|||
13351770|NCT00937547|26657115|FG001|Overall Study|misdiagnosis|6|||
13351771|NCT00937547|26657116|FG002|Overall Study|misdiagnosis|7|||
13351772|NCT00937521|26657247|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0|||
13351773|NCT00937521|26657248|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0|||
13351774|NCT00937521|26657249|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2|||
13351775|NCT00937521|26657250|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0|||
13351776|NCT00937521|26657251|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0|||
13351777|NCT00937521|26657252|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0|||
13351778|NCT00937521|26657253|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1|||
13351779|NCT00937521|26657254|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0|||
13351780|NCT00937521|26657247|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
13351781|NCT00937521|26657248|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
13351782|NCT00937521|26657249|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3|||
13351783|NCT00937521|26657250|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
13351784|NCT00937521|26657251|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
13351785|NCT00937521|26657252|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
13351786|NCT00937521|26657253|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
13351787|NCT00937521|26657254|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
13351788|NCT00937521|26657247|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
13351789|NCT00937521|26657248|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
13351790|NCT00937521|26657249|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
13351791|NCT00937521|26657250|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
13351792|NCT00937521|26657251|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
13351793|NCT00937521|26657252|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
13351794|NCT00937521|26657253|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
13351795|NCT00937521|26657254|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
13351796|NCT00937521|26657247|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
13351797|NCT00937521|26657248|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4|||
13351798|NCT00937521|26657249|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
13351799|NCT00937521|26657250|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
13351800|NCT00937521|26657251|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2|||
13351801|NCT00937521|26657252|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
13351802|NCT00937521|26657253|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
13351803|NCT00937521|26657254|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
13351804|NCT00937521|26657247|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
13351805|NCT00937521|26657248|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
13351806|NCT00937521|26657249|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
13351807|NCT00937521|26657250|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
13351808|NCT00937521|26657251|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
13351809|NCT00937521|26657252|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
13351810|NCT00937521|26657253|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
13351811|NCT00937521|26657254|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
13351812|NCT00937521|26657247|FG000|Booster Phase|Adverse Event|0|||
13351813|NCT00937521|26657248|FG001|Booster Phase|Adverse Event|0|||
13351814|NCT00937521|26657249|FG002|Booster Phase|Adverse Event|0|||
13351815|NCT00937521|26657250|FG003|Booster Phase|Adverse Event|0|||
13351816|NCT00937521|26657251|FG004|Booster Phase|Adverse Event|0|||
13351817|NCT00937521|26657252|FG005|Booster Phase|Adverse Event|0|||
13351818|NCT00937521|26657253|FG006|Booster Phase|Adverse Event|1|||
13351819|NCT00937521|26657254|FG007|Booster Phase|Adverse Event|0|||
13351820|NCT00937521|26657247|FG000|Booster Phase|Withdrawal by Subject|1|||
13351821|NCT00937521|26657248|FG001|Booster Phase|Withdrawal by Subject|0|||
13351822|NCT00937521|26657249|FG002|Booster Phase|Withdrawal by Subject|0|||
13351823|NCT00937521|26657250|FG003|Booster Phase|Withdrawal by Subject|1|||
13351824|NCT00937521|26657251|FG004|Booster Phase|Withdrawal by Subject|0|||
13351825|NCT00937521|26657252|FG005|Booster Phase|Withdrawal by Subject|0|||
13351826|NCT00937521|26657253|FG006|Booster Phase|Withdrawal by Subject|0|||
13351827|NCT00937521|26657254|FG007|Booster Phase|Withdrawal by Subject|2|||
13351828|NCT00937521|26657247|FG000|Booster Phase|Lost to Follow-up|2|||
13351829|NCT00937521|26657248|FG001|Booster Phase|Lost to Follow-up|2|||
13351830|NCT00937521|26657249|FG002|Booster Phase|Lost to Follow-up|4|||
13351831|NCT00937521|26657250|FG003|Booster Phase|Lost to Follow-up|2|||
13351832|NCT00937521|26657251|FG004|Booster Phase|Lost to Follow-up|4|||
13351833|NCT00937521|26657252|FG005|Booster Phase|Lost to Follow-up|4|||
13351834|NCT00937521|26657253|FG006|Booster Phase|Lost to Follow-up|3|||
13351835|NCT00937521|26657254|FG007|Booster Phase|Lost to Follow-up|0|||
13351836|NCT00937521|26657247|FG000|Booster Phase|Administrative Reason|0|||
13351837|NCT00937521|26657248|FG001|Booster Phase|Administrative Reason|0|||
13351838|NCT00937521|26657249|FG002|Booster Phase|Administrative Reason|1|||
13351839|NCT00937521|26657250|FG003|Booster Phase|Administrative Reason|0|||
13351840|NCT00937521|26657251|FG004|Booster Phase|Administrative Reason|1|||
13351841|NCT00937521|26657252|FG005|Booster Phase|Administrative Reason|1|||
13351842|NCT00937521|26657253|FG006|Booster Phase|Administrative Reason|0|||
13351843|NCT00937521|26657254|FG007|Booster Phase|Administrative Reason|0|||
13351844|NCT00937521|26657247|FG000|Booster Phase|Protocol Deviation|0|||
13351845|NCT00937521|26657248|FG001|Booster Phase|Protocol Deviation|0|||
13351846|NCT00937521|26657249|FG002|Booster Phase|Protocol Deviation|0|||
13351847|NCT00937521|26657250|FG003|Booster Phase|Protocol Deviation|0|||
13351848|NCT00937521|26657251|FG004|Booster Phase|Protocol Deviation|0|||
13351849|NCT00937521|26657252|FG005|Booster Phase|Protocol Deviation|0|||
13351850|NCT00937521|26657253|FG006|Booster Phase|Protocol Deviation|1|||
13351851|NCT00937521|26657254|FG007|Booster Phase|Protocol Deviation|0|||
13351852|NCT00937495|26657262|FG000|Overall Study|Protocol Violation|2|||
13351853|NCT00937404|26657271|FG000|Overall Study|Protocol Violation|1|||
13351854|NCT00937404|26657271|FG000|Overall Study|Withdrawal by Subject|1|||
13351855|NCT00937391|26657328|FG000|Stage 2|Withdrawal by Subject|1|||
13351856|NCT00937326|26657570|FG000|Overall Study|Adverse Event|0|||
13351857|NCT00937326|26657571|FG001|Overall Study|Adverse Event|3|||
13351858|NCT00937326|26657572|FG002|Overall Study|Adverse Event|1|||
13351859|NCT00937326|26657573|FG003|Overall Study|Adverse Event|1|||
13351860|NCT00937326|26657574|FG004|Overall Study|Adverse Event|2|||
13351861|NCT00937326|26657570|FG000|Overall Study|Death|0|||
13351862|NCT00937326|26657571|FG001|Overall Study|Death|0|||
13351863|NCT00937326|26657572|FG002|Overall Study|Death|1|||
13351864|NCT00937326|26657573|FG003|Overall Study|Death|0|||
13351865|NCT00937326|26657574|FG004|Overall Study|Death|0|||
13351866|NCT00937326|26657570|FG000|Overall Study|Withdrawal by Subject|3|||
13351867|NCT00937326|26657571|FG001|Overall Study|Withdrawal by Subject|4|||
13351868|NCT00937326|26657572|FG002|Overall Study|Withdrawal by Subject|1|||
13351869|NCT00937326|26657573|FG003|Overall Study|Withdrawal by Subject|4|||
13351870|NCT00937326|26657574|FG004|Overall Study|Withdrawal by Subject|3|||
13351871|NCT00937326|26657570|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0|||
13351872|NCT00937326|26657571|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0|||
13351873|NCT00937326|26657572|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1|||
13351874|NCT00937326|26657573|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0|||
13351875|NCT00937326|26657574|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0|||
13351876|NCT00937157|26657580|FG000|Overall Study|Pregnancy|1|||
13351877|NCT00937157|26657580|FG000|Overall Study|Lost to Follow-up|3|||
13351878|NCT00937040|26657629|FG000|Overall Study|Adverse Event|5|||
13351879|NCT00937040|26657630|FG001|Overall Study|Adverse Event|8|||
13351880|NCT00937040|26657629|FG000|Overall Study|Lost to Follow-up|12|||
13351881|NCT00937040|26657630|FG001|Overall Study|Lost to Follow-up|12|||
13351882|NCT00937040|26657629|FG000|Overall Study|Protocol Violation|3|||
13351883|NCT00937040|26657630|FG001|Overall Study|Protocol Violation|0|||
13351884|NCT00937040|26657629|FG000|Overall Study|Withdrawal by Subject|13|||
13351885|NCT00937040|26657630|FG001|Overall Study|Withdrawal by Subject|7|||
13351886|NCT00937040|26657629|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3|||
13351887|NCT00937040|26657630|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2|||
13351888|NCT00937040|26657629|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5|||
13351889|NCT00937040|26657630|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8|||
13351890|NCT00936975|26657641|FG000|Overall Study|Withdrawal by Subject|1|||
13351891|NCT00936975|26657641|FG000|Overall Study|Disease progression|3|||
13351892|NCT00936975|26657641|FG000|Overall Study|Post-Tx scan uninterpretable|2|||
13351893|NCT00936910|26657650|FG000|Overall Study|Lack of Efficacy|3|||
13351894|NCT00936897|26657669|FG000|Overall Study|Withdrawal by Subject|9|||
13351895|NCT00936897|26657670|FG001|Overall Study|Withdrawal by Subject|19|||
13351896|NCT00936897|26657669|FG000|Overall Study|Adverse Event|4|||
13351897|NCT00936897|26657670|FG001|Overall Study|Adverse Event|13|||
13351898|NCT00936897|26657669|FG000|Overall Study|Other|3|||
13351899|NCT00936897|26657670|FG001|Overall Study|Other|9|||
13351900|NCT00936897|26657669|FG000|Overall Study|Lost to Follow-up|1|||
13351901|NCT00936897|26657670|FG001|Overall Study|Lost to Follow-up|10|||
13351902|NCT00936897|26657669|FG000|Overall Study|Administrative Decision|1|||
13351903|NCT00936897|26657670|FG001|Overall Study|Administrative Decision|2|||
13351904|NCT00936897|26657669|FG000|Overall Study|Protocol Violation|1|||
13351905|NCT00936897|26657670|FG001|Overall Study|Protocol Violation|1|||
13351906|NCT00936897|26657669|FG000|Overall Study|Ineligibility Determined|0|||
13351907|NCT00936897|26657670|FG001|Overall Study|Ineligibility Determined|3|||
13351908|NCT00936897|26657669|FG000|Overall Study|Noncompliance|0|||
13351909|NCT00936897|26657670|FG001|Overall Study|Noncompliance|2|||
13351910|NCT00936897|26657669|FG000|Overall Study|Death|0|||
13351911|NCT00936897|26657670|FG001|Overall Study|Death|1|||
13351912|NCT00936884|26657689|FG000|Double-blind|Withdrawal by Subject|6|||
13351913|NCT00936884|26657690|FG001|Double-blind|Withdrawal by Subject|4|||
13351914|NCT00936884|26657691|FG002|Double-blind|Withdrawal by Subject|0|||
13351915|NCT00936884|26657689|FG000|Double-blind|Death|2|||
13351916|NCT00936884|26657690|FG001|Double-blind|Death|1|||
13351917|NCT00936884|26657691|FG002|Double-blind|Death|0|||
13351918|NCT00936884|26657689|FG000|Double-blind|Lack of Efficacy|1|||
13351919|NCT00936884|26657690|FG001|Double-blind|Lack of Efficacy|1|||
13351920|NCT00936884|26657691|FG002|Double-blind|Lack of Efficacy|0|||
13351921|NCT00936884|26657689|FG000|Double-blind|Adverse Event|1|||
13351922|NCT00936884|26657690|FG001|Double-blind|Adverse Event|0|||
13351923|NCT00936884|26657691|FG002|Double-blind|Adverse Event|0|||
13351924|NCT00936884|26657689|FG000|Double-blind|Physician Decision|1|||
13351925|NCT00936884|26657690|FG001|Double-blind|Physician Decision|0|||
13351926|NCT00936884|26657691|FG002|Double-blind|Physician Decision|0|||
13351927|NCT00936884|26657689|FG000|Double-blind|No post baseline diary entry|1|||
13351928|NCT00936884|26657690|FG001|Double-blind|No post baseline diary entry|0|||
13351929|NCT00936884|26657691|FG002|Double-blind|No post baseline diary entry|0|||
13351930|NCT00936884|26657689|FG000|Double-blind|Did not receive study drug|0|||
13351931|NCT00936884|26657690|FG001|Double-blind|Did not receive study drug|1|||
13351932|NCT00936884|26657691|FG002|Double-blind|Did not receive study drug|0|||
13351933|NCT00936858|26657700|FG000|Overall Study|Death|3|||
13351934|NCT00936858|26657700|FG000|Overall Study|Progression|29|||
13351935|NCT00936858|26657700|FG000|Overall Study|Withdrawal by Subject|5|||
13351936|NCT00936858|26657700|FG000|Overall Study|Adverse Event|1|||
13351937|NCT00936858|26657700|FG000|Overall Study|Physician Decision|7|||
13351938|NCT00936858|26657700|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4|||
13351939|NCT00936858|26657700|FG000|Overall Study|Lost to Follow-up|1|||
13351940|NCT00936715|26657706|FG000|Overall Study|Investigators Discretion|1|||
13351941|NCT00936715|26657706|FG000|Overall Study|Protocol Violation|1|||
13351942|NCT00936715|26657706|FG000|Overall Study|Safety or Tolerability Reasons|4|||
13351943|NCT00936702|26657716|FG000|Overall Study|Disease progression|34|||
13351944|NCT00936702|26657716|FG000|Overall Study|Adverse Event|8|||
13351945|NCT00936702|26657716|FG000|Overall Study|Withdrawal by Subject|2|||
13351946|NCT00936702|26657716|FG000|Overall Study|Alternative Treatment|1|||
13351947|NCT00936702|26657716|FG000|Overall Study|Other|1|||
13351948|NCT00936611|26657727|FG000|Overall Study|Progressive Disease|3|||
13351949|NCT00936611|26657727|FG000|Overall Study|New Systemic Therapy|22|||
13351950|NCT00936611|26657727|FG000|Overall Study|Lost to Follow-up|1|||
13351951|NCT00936611|26657727|FG000|Overall Study|Withdrawal by Subject|2|||
13351952|NCT00936611|26657727|FG000|Overall Study|Still on Follow-up|1|||
13351953|NCT00936611|26657727|FG000|Overall Study|Still on Active Therapy|7|||
13351954|NCT00936611|26657727|FG000|Overall Study|Ineligible for Study Drug|3|||
13351955|NCT00936598|26657744|FG000|Overall Study|Withdrawal by Subject|1|||
13351956|NCT00936598|26657745|FG001|Overall Study|Withdrawal by Subject|0|||
13351957|NCT00936598|26657744|FG000|Overall Study|Ineligible after consent|1|||
13351958|NCT00936598|26657745|FG001|Overall Study|Ineligible after consent|0|||
13351959|NCT00936221|26657764|FG000|Overall Study|Withdrawal by Subject|1|||
13351960|NCT00936221|26657765|FG001|Overall Study|Withdrawal by Subject|1|||
13351961|NCT00936208|26657790|FG000|Overall Study|Protocol Violation|37|||
13351962|NCT00936208|26657791|FG001|Overall Study|Protocol Violation|22|||
13351963|NCT00936117|26657798|FG000|Overall Study|Adverse Event|7|||
13351964|NCT00936117|26657798|FG000|Overall Study|Unable to continue oral medication|3|||
13351965|NCT00936065|26657912|FG000|Overall Study|Adverse Event|1|||
13351966|NCT00936065|26657913|FG001|Overall Study|Adverse Event|0|||
13351967|NCT00936065|26657914|FG002|Overall Study|Adverse Event|1|||
13351968|NCT00936065|26657912|FG000|Overall Study|Lack of Efficacy|1|||
13351969|NCT00936065|26657913|FG001|Overall Study|Lack of Efficacy|0|||
13351970|NCT00936065|26657914|FG002|Overall Study|Lack of Efficacy|1|||
13351971|NCT00936065|26657912|FG000|Overall Study|Lost to Follow-up|1|||
13351972|NCT00936065|26657913|FG001|Overall Study|Lost to Follow-up|0|||
13351973|NCT00936065|26657914|FG002|Overall Study|Lost to Follow-up|0|||
13351974|NCT00936065|26657912|FG000|Overall Study|Protocol Violation|1|||
13351975|NCT00936065|26657913|FG001|Overall Study|Protocol Violation|2|||
13351976|NCT00936065|26657914|FG002|Overall Study|Protocol Violation|1|||
13351977|NCT00936065|26657912|FG000|Overall Study|Withdrawal by Subject|0|||
13351978|NCT00936065|26657913|FG001|Overall Study|Withdrawal by Subject|2|||
13351979|NCT00936065|26657914|FG002|Overall Study|Withdrawal by Subject|4|||
13351980|NCT00935883|26657933|FG000|Treatment Period|Physician Decision|1|||
13351981|NCT00935883|26657934|FG001|Treatment Period|Physician Decision|0|||
13351982|NCT00935883|26657933|FG000|Treatment Period|Withdrawal by Subject|0|||
13351983|NCT00935883|26657934|FG001|Treatment Period|Withdrawal by Subject|2|||
13351984|NCT00935818|26657959|FG000|Overall Study|Withdrawal by Subject|45|||
13351985|NCT00935818|26657960|FG001|Overall Study|Withdrawal by Subject|50|||
13351986|NCT00935818|26657959|FG000|Overall Study|Lost to Follow-up|40|||
13351987|NCT00935818|26657960|FG001|Overall Study|Lost to Follow-up|42|||
13351988|NCT00935818|26657959|FG000|Overall Study|Adverse Event|6|||
13351989|NCT00935818|26657960|FG001|Overall Study|Adverse Event|7|||
13351990|NCT00935818|26657959|FG000|Overall Study|Physician Decision|0|||
13351991|NCT00935818|26657960|FG001|Overall Study|Physician Decision|1|||
13351992|NCT00935701|26657969|FG000|Overall Study|Failure to Transition to Acupuncture|1|||
13351993|NCT00935584|26657986|FG000|Overall Study|Withdrawal by Subject|9|||
13351994|NCT00935584|26657987|FG001|Overall Study|Withdrawal by Subject|0|||
13351995|NCT00935584|26657986|FG000|Overall Study|Death|3|||
13351996|NCT00935584|26657987|FG001|Overall Study|Death|0|||
13351997|NCT00935584|26657986|FG000|Overall Study|Lost to Follow-up|8|||
13351998|NCT00935584|26657987|FG001|Overall Study|Lost to Follow-up|0|||
13351999|NCT00935584|26657986|FG000|Overall Study|No show|9|||
13352000|NCT00935584|26657987|FG001|Overall Study|No show|0|||
13352001|NCT00935584|26657986|FG000|Overall Study|Relocated|3|||
13352002|NCT00935584|26657987|FG001|Overall Study|Relocated|0|||
13352003|NCT00935584|26657986|FG000|Overall Study|Patient changed provider|3|||
13352004|NCT00935584|26657987|FG001|Overall Study|Patient changed provider|0|||
13352005|NCT00935584|26657986|FG000|Overall Study|Provider dropped out of study|14|||
13352006|NCT00935584|26657987|FG001|Overall Study|Provider dropped out of study|4|||
13352007|NCT00935532|26658020|FG000|Overall Study|Adverse Event|11|||
13352008|NCT00935532|26658021|FG001|Overall Study|Adverse Event|6|||
13352009|NCT00935532|26658020|FG000|Overall Study|Death|1|||
13352010|NCT00935532|26658021|FG001|Overall Study|Death|0|||
13352011|NCT00935532|26658020|FG000|Overall Study|Lost to Follow-up|1|||
13352012|NCT00935532|26658021|FG001|Overall Study|Lost to Follow-up|0|||
13352013|NCT00935532|26658020|FG000|Overall Study|Physician Decision|1|||
13352014|NCT00935532|26658021|FG001|Overall Study|Physician Decision|2|||
13352015|NCT00935532|26658020|FG000|Overall Study|Protocol Violation|2|||
13352016|NCT00935532|26658021|FG001|Overall Study|Protocol Violation|1|||
13352017|NCT00935532|26658020|FG000|Overall Study|Subject Decision|2|||
13352018|NCT00935532|26658021|FG001|Overall Study|Subject Decision|1|||
13352019|NCT00935532|26658020|FG000|Overall Study|Sponsor Decision|0|||
13352020|NCT00935532|26658021|FG001|Overall Study|Sponsor Decision|1|||
13352021|NCT00935532|26658020|FG000|Overall Study|Loss Glucose Control|4|||
13352022|NCT00935532|26658021|FG001|Overall Study|Loss Glucose Control|0|||
13352023|NCT00935493|26658045|FG000|Overall Study|Lost to Follow-up|1|||
13352024|NCT00935493|26658046|FG001|Overall Study|Lost to Follow-up|1|||
13352025|NCT00935493|26658047|FG002|Overall Study|Lost to Follow-up|1|||
13352026|NCT00935493|26658045|FG000|Overall Study|Treatment Discontinued|0|||
13352027|NCT00935493|26658046|FG001|Overall Study|Treatment Discontinued|1|||
13352028|NCT00935493|26658047|FG002|Overall Study|Treatment Discontinued|0|||
13352029|NCT00935272|26658063|FG000|Overall Study|Lost to Follow-up|10|||
13352030|NCT00935272|26658064|FG001|Overall Study|Lost to Follow-up|3|||
13352031|NCT00935272|26658063|FG000|Overall Study|Withdrawal by Subject|8|||
13352032|NCT00935272|26658064|FG001|Overall Study|Withdrawal by Subject|2|||
13352033|NCT00935272|26658063|FG000|Overall Study|Physician Decision|1|||
13352034|NCT00935272|26658064|FG001|Overall Study|Physician Decision|0|||
13352035|NCT00935272|26658063|FG000|Overall Study|Protocol Violation|0|||
13352036|NCT00935272|26658064|FG001|Overall Study|Protocol Violation|1|||
13352037|NCT00935259|26658081|FG000|Period 1|Administrative (scheduling conflict)|1|||
13352038|NCT00935259|26658082|FG001|Period 1|Administrative (scheduling conflict)|1|||
13352039|NCT00935220|26658096|FG000|Overall Study|Adverse Event|1|||
13352040|NCT00935220|26658096|FG000|Overall Study|Other reason (not specified)|1|||
13352041|NCT00935012|26658138|FG000|Overall Study|Death|19|||
13352042|NCT00935012|26658138|FG000|Overall Study|Withdrawal by Subject|3|||
13352043|NCT00935012|26658138|FG000|Overall Study|Other|5|||
13352044|NCT00935012|26658138|FG000|Overall Study|Adverse Event|2|||
13352045|NCT00934947|26658157|FG000|Overall Study|Adverse Event|0|||
13352046|NCT00934947|26658158|FG001|Overall Study|Adverse Event|2|||
13352047|NCT00934856|26658273|FG000|Feasibility Part|Progressive disease|4|||
13352048|NCT00934856|26658274|FG001|Feasibility Part|Progressive disease|4|||
13352049|NCT00934856|26658275|FG002|Feasibility Part|Progressive disease|2|||
13352050|NCT00934856|26658276|FG003|Feasibility Part|Progressive disease|3|||
13352051|NCT00934856|26658277|FG004|Feasibility Part|Progressive disease|0|||
13352052|NCT00934856|26658278|FG005|Feasibility Part|Progressive disease|0|||
13352053|NCT00934856|26658273|FG000|Feasibility Part|Physician Decision|0|||
13352054|NCT00934856|26658274|FG001|Feasibility Part|Physician Decision|0|||
13352055|NCT00934856|26658275|FG002|Feasibility Part|Physician Decision|1|||
13352056|NCT00934856|26658276|FG003|Feasibility Part|Physician Decision|0|||
13352057|NCT00934856|26658277|FG004|Feasibility Part|Physician Decision|0|||
13352058|NCT00934856|26658278|FG005|Feasibility Part|Physician Decision|0|||
13352059|NCT00934856|26658273|FG000|Feasibility Part|Adverse Event|1|||
13352060|NCT00934856|26658274|FG001|Feasibility Part|Adverse Event|1|||
13352061|NCT00934856|26658275|FG002|Feasibility Part|Adverse Event|0|||
13352062|NCT00934856|26658276|FG003|Feasibility Part|Adverse Event|1|||
13352063|NCT00934856|26658277|FG004|Feasibility Part|Adverse Event|0|||
13352064|NCT00934856|26658278|FG005|Feasibility Part|Adverse Event|2|||
13352065|NCT00934856|26658273|FG000|Feasibility Part|Withdrawal by Subject|0|||
13352066|NCT00934856|26658274|FG001|Feasibility Part|Withdrawal by Subject|0|||
13352067|NCT00934856|26658275|FG002|Feasibility Part|Withdrawal by Subject|0|||
13352068|NCT00934856|26658276|FG003|Feasibility Part|Withdrawal by Subject|1|||
13352069|NCT00934856|26658277|FG004|Feasibility Part|Withdrawal by Subject|0|||
13352070|NCT00934856|26658278|FG005|Feasibility Part|Withdrawal by Subject|1|||
13352071|NCT00934856|26658273|FG000|Extension Part|Adverse Event|0|||
13352072|NCT00934856|26658274|FG001|Extension Part|Adverse Event|0|||
13352073|NCT00934856|26658275|FG002|Extension Part|Adverse Event|0|||
13352074|NCT00934856|26658276|FG003|Extension Part|Adverse Event|1|||
13352075|NCT00934856|26658277|FG004|Extension Part|Adverse Event|4|||
13352076|NCT00934856|26658278|FG005|Extension Part|Adverse Event|4|||
13352077|NCT00934856|26658273|FG000|Extension Part|Progressive disease|0|||
13352078|NCT00934856|26658274|FG001|Extension Part|Progressive disease|0|||
13352079|NCT00934856|26658275|FG002|Extension Part|Progressive disease|0|||
13352080|NCT00934856|26658276|FG003|Extension Part|Progressive disease|1|||
13352081|NCT00934856|26658277|FG004|Extension Part|Progressive disease|0|||
13352082|NCT00934856|26658278|FG005|Extension Part|Progressive disease|0|||
13352083|NCT00934856|26658273|FG000|Extension Part|Non-compliance with drug|0|||
13352084|NCT00934856|26658274|FG001|Extension Part|Non-compliance with drug|0|||
13352085|NCT00934856|26658275|FG002|Extension Part|Non-compliance with drug|0|||
13352086|NCT00934856|26658276|FG003|Extension Part|Non-compliance with drug|0|||
13352087|NCT00934856|26658277|FG004|Extension Part|Non-compliance with drug|0|||
13352088|NCT00934856|26658278|FG005|Extension Part|Non-compliance with drug|1|||
13352089|NCT00934843|26658299|FG000|Overall Study|Protocol Violation|0|||
13352090|NCT00934843|26658300|FG001|Overall Study|Protocol Violation|1|||
13352091|NCT00934791|26658313|FG000|Overall Study|Withdrawal by Subject|1|||
13352092|NCT00934791|26658314|FG001|Overall Study|Withdrawal by Subject|0|||
13352093|NCT00934700|26658331|FG000|Overall Study|missing scan|5|||
13352094|NCT00934700|26658332|FG001|Overall Study|missing scan|9|||
13352095|NCT00934700|26658331|FG000|Overall Study|Death|8|||
13352096|NCT00934700|26658332|FG001|Overall Study|Death|3|||
13352097|NCT00934661|26658359|FG000|Overall Study|Failure of Combined/Spinal Epidural|1|||
13352098|NCT00934661|26658360|FG001|Overall Study|Failure of Combined/Spinal Epidural|0|||
13352099|NCT00934648|26658369|FG000|Overall Study|Failure to return|8|||
13352100|NCT00934648|26658369|FG000|Overall Study|Withdrawal by Subject|1|||
13352101|NCT00934622|26658376|FG000|Overall Study|Lost to Follow-up|7|||
13352102|NCT00934622|26658376|FG000|Overall Study|2nd Intraoperative exclusion criteria|1|||
13352103|NCT00934544|26658420|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12|||
13352104|NCT00934544|26658421|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4|||
13352105|NCT00934544|26658422|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0|||
13352106|NCT00934544|26658420|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2|||
13352107|NCT00934544|26658421|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9|||
13352108|NCT00934544|26658422|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0|||
13352109|NCT00934544|26658420|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2|||
13352110|NCT00934544|26658421|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
13352111|NCT00934544|26658422|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
13352112|NCT00934544|26658420|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1|||
13352113|NCT00934544|26658421|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3|||
13352114|NCT00934544|26658422|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0|||
13352115|NCT00934544|26658420|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2|||
13352116|NCT00934544|26658421|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
13352117|NCT00934544|26658422|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
13352118|NCT00934544|26658420|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
13352119|NCT00934544|26658421|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1|||
13352120|NCT00934544|26658422|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
13352121|NCT00934544|26658420|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7|||
13352122|NCT00934544|26658421|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7|||
13352123|NCT00934544|26658422|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0|||
13352124|NCT00934544|26658420|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29|||
13352125|NCT00934544|26658421|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18|||
13352126|NCT00934544|26658422|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0|||
13352127|NCT00934544|26658420|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16|||
13352128|NCT00934544|26658421|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9|||
13352129|NCT00934544|26658422|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6|||
13352130|NCT00934544|26658420|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35|||
13352131|NCT00934544|26658421|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5|||
13352132|NCT00934544|26658422|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10|||
13352133|NCT00934544|26658420|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10|||
13352134|NCT00934544|26658421|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9|||
13352135|NCT00934544|26658422|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0|||
13352136|NCT00934544|26658420|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2|||
13352137|NCT00934544|26658421|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0|||
13352138|NCT00934544|26658422|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5|||
13352139|NCT00934544|26658420|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32|||
13352140|NCT00934544|26658421|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4|||
13352141|NCT00934544|26658422|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7|||
13352142|NCT00934544|26658420|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4|||
13352143|NCT00934544|26658421|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0|||
13352144|NCT00934544|26658422|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1|||
13352145|NCT00934544|26658420|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
13352146|NCT00934544|26658421|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1|||
13352147|NCT00934544|26658422|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
13352148|NCT00934544|26658420|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8|||
13352149|NCT00934544|26658421|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0|||
13352150|NCT00934544|26658422|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5|||
13352151|NCT00934440|26658429|FG000|Overall Study|Lost to Follow-up|1|||
13352152|NCT00934362|26658444|FG000|Overall Study|Adverse Event|1|||
13352153|NCT00934362|26658445|FG001|Overall Study|Adverse Event|0|||
13352154|NCT00934128|26658460|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0|||
13352155|NCT00934128|26658461|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1|||
13352156|NCT00934128|26658460|FG000|First Intervention (2 Hours)|Adverse Event|4|||
13352157|NCT00934128|26658461|FG001|First Intervention (2 Hours)|Adverse Event|1|||
13352158|NCT00934128|26658460|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1|||
13352159|NCT00934128|26658461|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0|||
13352160|NCT00934128|26658460|FG000|Washout Period (1 Hour)|Patient preference|1|||
13352161|NCT00934128|26658461|FG001|Washout Period (1 Hour)|Patient preference|3|||
13352162|NCT00934128|26658460|FG000|Washout Period (1 Hour)|Pain|1|||
13352163|NCT00934128|26658461|FG001|Washout Period (1 Hour)|Pain|0|||
13352164|NCT00934128|26658460|FG000|Washout Period (1 Hour)|Too tired|1|||
13352165|NCT00934128|26658461|FG001|Washout Period (1 Hour)|Too tired|0|||
13352166|NCT00934128|26658460|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4|||
13352167|NCT00934128|26658461|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2|||
13352168|NCT00934128|26658460|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0|||
13352169|NCT00934128|26658461|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3|||
13352170|NCT00934102|26658473|FG000|Period 1, One Night of Wear|Personal Reasons|1|||
13352171|NCT00934102|26658474|FG001|Period 1, One Night of Wear|Personal Reasons|0|||
13352172|NCT00934102|26658475|FG002|Period 1, One Night of Wear|Personal Reasons|0|||
13352173|NCT00934089|26658546|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1|||
13352174|NCT00934089|26658547|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0|||
13352175|NCT00934089|26658546|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1|||
13352176|NCT00934089|26658547|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0|||
13352177|NCT00934050|26658576|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
13352178|NCT00934050|26658577|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
13352179|NCT00934050|26658578|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
13352180|NCT00934050|26658579|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
13352181|NCT00934050|26658580|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
13352182|NCT00934050|26658581|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
13352183|NCT00934050|26658576|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
13352184|NCT00934050|26658577|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12|||
13352185|NCT00934050|26658578|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
13352186|NCT00934050|26658579|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13|||
13352187|NCT00934050|26658580|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
13352188|NCT00934050|26658581|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
13352189|NCT00934050|26658576|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
13352190|NCT00934050|26658577|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
13352191|NCT00934050|26658578|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1|||
13352192|NCT00934050|26658579|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
13352193|NCT00934050|26658580|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
13352194|NCT00934050|26658581|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
13352195|NCT00934050|26658576|FG000|Enrolled After 15 Dec 2009|Adverse Event|0|||
13352196|NCT00934050|26658577|FG001|Enrolled After 15 Dec 2009|Adverse Event|0|||
13352197|NCT00934050|26658578|FG002|Enrolled After 15 Dec 2009|Adverse Event|0|||
13352198|NCT00934050|26658579|FG003|Enrolled After 15 Dec 2009|Adverse Event|0|||
13352199|NCT00934050|26658580|FG004|Enrolled After 15 Dec 2009|Adverse Event|3|||
13352200|NCT00934050|26658581|FG005|Enrolled After 15 Dec 2009|Adverse Event|0|||
13352201|NCT00934050|26658576|FG000|Enrolled After 15 Dec 2009|Death|0|||
13352202|NCT00934050|26658577|FG001|Enrolled After 15 Dec 2009|Death|0|||
13352203|NCT00934050|26658578|FG002|Enrolled After 15 Dec 2009|Death|0|||
13352204|NCT00934050|26658579|FG003|Enrolled After 15 Dec 2009|Death|0|||
13352205|NCT00934050|26658580|FG004|Enrolled After 15 Dec 2009|Death|0|||
13352206|NCT00934050|26658581|FG005|Enrolled After 15 Dec 2009|Death|1|||
13352207|NCT00934050|26658576|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
13352208|NCT00934050|26658577|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
13352209|NCT00934050|26658578|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
13352210|NCT00934050|26658579|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
13352211|NCT00934050|26658580|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
13352212|NCT00934050|26658581|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1|||
13352213|NCT00934050|26658576|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
13352214|NCT00934050|26658577|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
13352215|NCT00934050|26658578|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
13352216|NCT00934050|26658579|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
13352217|NCT00934050|26658580|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4|||
13352218|NCT00934050|26658581|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2|||
13352219|NCT00933933|26658611|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
13352220|NCT00933933|26658612|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20|||
13352221|NCT00933933|26658613|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
13352222|NCT00933933|26658611|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
13352223|NCT00933933|26658612|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2|||
13352224|NCT00933933|26658613|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
13352225|NCT00933686|26658638|FG000|Overall Study|Protocol Violation|0|||
13352226|NCT00933686|26658639|FG001|Overall Study|Protocol Violation|1|||
13352227|NCT00933686|26658638|FG000|Overall Study|Lost to Follow-up|2|||
13352228|NCT00933686|26658639|FG001|Overall Study|Lost to Follow-up|2|||
13352229|NCT00933686|26658638|FG000|Overall Study|Withdrawal by Subject|6|||
13352230|NCT00933686|26658639|FG001|Overall Study|Withdrawal by Subject|5|||
13352231|NCT00933686|26658638|FG000|Overall Study|Adverse Event|1|||
13352232|NCT00933686|26658639|FG001|Overall Study|Adverse Event|1|||
13352233|NCT00933686|26658638|FG000|Overall Study|Physician Decision|1|||
13352234|NCT00933686|26658639|FG001|Overall Study|Physician Decision|0|||
13352235|NCT00933686|26658638|FG000|Overall Study|Failure to show up at endpoint visits|0|||
13352236|NCT00933686|26658639|FG001|Overall Study|Failure to show up at endpoint visits|2|||
13352237|NCT00933608|26658652|FG000|Overall Study|Adverse Event|4|||
13352238|NCT00933608|26658653|FG001|Overall Study|Adverse Event|2|||
13352239|NCT00933608|26658652|FG000|Overall Study|Physician Decision|1|||
13352240|NCT00933608|26658653|FG001|Overall Study|Physician Decision|0|||
13352241|NCT00933543|26658716|FG000|Overall Study|Adverse Event|2|||
13352242|NCT00933543|26658717|FG001|Overall Study|Adverse Event|1|||
13352243|NCT00933543|26658716|FG000|Overall Study|Lost to Follow-up|0|||
13352244|NCT00933543|26658717|FG001|Overall Study|Lost to Follow-up|1|||
13352245|NCT00933543|26658716|FG000|Overall Study|Withdrawal by Subject|0|||
13352246|NCT00933543|26658717|FG001|Overall Study|Withdrawal by Subject|1|||
13352247|NCT00933543|26658716|FG000|Overall Study|Lack of Efficacy|0|||
13352248|NCT00933543|26658717|FG001|Overall Study|Lack of Efficacy|3|||
13352249|NCT00933543|26658716|FG000|Overall Study|Other|1|||
13352250|NCT00933543|26658717|FG001|Overall Study|Other|1|||
13352251|NCT00933335|26658794|FG000|Overall Study|Lost to Follow-up|1|||
13352252|NCT00933335|26658795|FG001|Overall Study|Lost to Follow-up|3|||
13352253|NCT00933335|26658794|FG000|Overall Study|Withdrawal by Subject|0|||
13352254|NCT00933335|26658795|FG001|Overall Study|Withdrawal by Subject|1|||
13352255|NCT00933335|26658794|FG000|Overall Study|Progressive Disease|0|||
13352256|NCT00933335|26658795|FG001|Overall Study|Progressive Disease|11|||
13352257|NCT00933335|26658794|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0|||
13352258|NCT00933335|26658795|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1|||
13352259|NCT00933335|26658794|FG000|Overall Study|Co-morbid Illness|1|||
13352260|NCT00933335|26658795|FG001|Overall Study|Co-morbid Illness|0|||
13352261|NCT00933270|26658888|FG000|Overall Study|Withdrawal by Subject|26|||
13352262|NCT00933270|26658888|FG000|Overall Study|Insufficient Follow-up|10|||
13352263|NCT00933270|26658888|FG000|Overall Study|Lost to Follow-up|14|||
13352264|NCT00933270|26658888|FG000|Overall Study|Adverse Event|1|||
13352265|NCT00933270|26658888|FG000|Overall Study|Missed Visit|2|||
13352266|NCT00933270|26658888|FG000|Overall Study|Death|24|||
13352267|NCT00933270|26658888|FG000|Overall Study|Moved or would not return|10|||
13352268|NCT00933244|26658915|FG000|Overall Study|Withdrawal by Subject|5|||
13352269|NCT00933244|26658916|FG001|Overall Study|Withdrawal by Subject|1|||
13352270|NCT00933244|26658917|FG002|Overall Study|Withdrawal by Subject|3|||
13352271|NCT00933166|26658923|FG000|Overall Study|Lost to Follow-up|4|||
13352272|NCT00933166|26658923|FG000|Overall Study|Lack of Efficacy|9|||
13352273|NCT00933166|26658923|FG000|Overall Study|Unavailable|4|||
13352274|NCT00933166|26658923|FG000|Overall Study|Withdrawal by Subject|1|||
13352275|NCT00932893|26658961|FG000|Overall Study|Death|115|||
13352276|NCT00932893|26658962|FG001|Overall Study|Death|24|||
13352277|NCT00932893|26658961|FG000|Overall Study|Lost to Follow-up|8|||
13352278|NCT00932893|26658962|FG001|Overall Study|Lost to Follow-up|0|||
13352279|NCT00932893|26658961|FG000|Overall Study|Withdrawal by Subject|5|||
13352280|NCT00932893|26658962|FG001|Overall Study|Withdrawal by Subject|2|||
13352281|NCT00932893|26658961|FG000|Overall Study|Other|5|||
13352282|NCT00932893|26658962|FG001|Overall Study|Other|144|||
13352283|NCT00932737|26659015|FG000|Overall Study|Not treated in second episode|1|||
13352284|NCT00932737|26659016|FG001|Overall Study|Not treated in second episode|0|||
13352285|NCT00932737|26659015|FG000|Overall Study|Adverse Event|0|||
13352286|NCT00932737|26659016|FG001|Overall Study|Adverse Event|1|||
13352287|NCT00932698|26659219|FG000|Part 1 (Dose Escalation)|Progressive Disease|3|||
13352288|NCT00932698|26659220|FG001|Part 1 (Dose Escalation)|Progressive Disease|2|||
13352289|NCT00932698|26659221|FG002|Part 1 (Dose Escalation)|Progressive Disease|2|||
13352290|NCT00932698|26659222|FG003|Part 1 (Dose Escalation)|Progressive Disease|2|||
13352291|NCT00932698|26659223|FG004|Part 1 (Dose Escalation)|Progressive Disease|3|||
13352292|NCT00932698|26659224|FG005|Part 1 (Dose Escalation)|Progressive Disease|5|||
13352293|NCT00932698|26659225|FG006|Part 1 (Dose Escalation)|Progressive Disease|2|||
13352294|NCT00932698|26659226|FG007|Part 1 (Dose Escalation)|Progressive Disease|0|||
13352295|NCT00932698|26659227|FG008|Part 1 (Dose Escalation)|Progressive Disease|0|||
13352296|NCT00932698|26659228|FG009|Part 1 (Dose Escalation)|Progressive Disease|0|||
13352297|NCT00932698|26659229|FG010|Part 1 (Dose Escalation)|Progressive Disease|0|||
13352298|NCT00932698|26659219|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
13352299|NCT00932698|26659220|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
13352300|NCT00932698|26659221|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
13352301|NCT00932698|26659222|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
13352302|NCT00932698|26659223|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
13352303|NCT00932698|26659224|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
13352304|NCT00932698|26659225|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
13352305|NCT00932698|26659226|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
13352306|NCT00932698|26659227|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
13352307|NCT00932698|26659228|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
13352308|NCT00932698|26659229|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
13352309|NCT00932698|26659219|FG000|Part 1 (Dose Escalation)|Adverse Event|0|||
13352310|NCT00932698|26659220|FG001|Part 1 (Dose Escalation)|Adverse Event|0|||
13352311|NCT00932698|26659221|FG002|Part 1 (Dose Escalation)|Adverse Event|0|||
13352312|NCT00932698|26659222|FG003|Part 1 (Dose Escalation)|Adverse Event|0|||
13352313|NCT00932698|26659223|FG004|Part 1 (Dose Escalation)|Adverse Event|0|||
13352314|NCT00932698|26659224|FG005|Part 1 (Dose Escalation)|Adverse Event|1|||
13352315|NCT00932698|26659225|FG006|Part 1 (Dose Escalation)|Adverse Event|0|||
13352316|NCT00932698|26659226|FG007|Part 1 (Dose Escalation)|Adverse Event|0|||
13352317|NCT00932698|26659227|FG008|Part 1 (Dose Escalation)|Adverse Event|0|||
13352318|NCT00932698|26659228|FG009|Part 1 (Dose Escalation)|Adverse Event|0|||
13352319|NCT00932698|26659229|FG010|Part 1 (Dose Escalation)|Adverse Event|0|||
13352320|NCT00932698|26659219|FG000|Part 1 (Dose Escalation)|Other|0|||
13352321|NCT00932698|26659220|FG001|Part 1 (Dose Escalation)|Other|0|||
13352322|NCT00932698|26659221|FG002|Part 1 (Dose Escalation)|Other|1|||
13352323|NCT00932698|26659222|FG003|Part 1 (Dose Escalation)|Other|0|||
13352324|NCT00932698|26659223|FG004|Part 1 (Dose Escalation)|Other|0|||
13352325|NCT00932698|26659224|FG005|Part 1 (Dose Escalation)|Other|0|||
13352326|NCT00932698|26659225|FG006|Part 1 (Dose Escalation)|Other|1|||
13352327|NCT00932698|26659226|FG007|Part 1 (Dose Escalation)|Other|0|||
13352328|NCT00932698|26659227|FG008|Part 1 (Dose Escalation)|Other|0|||
13352329|NCT00932698|26659228|FG009|Part 1 (Dose Escalation)|Other|0|||
13352330|NCT00932698|26659229|FG010|Part 1 (Dose Escalation)|Other|0|||
13352331|NCT00932698|26659219|FG000|Part 2 (Dose Expansion)|Progressive Disease|0|||
13352332|NCT00932698|26659220|FG001|Part 2 (Dose Expansion)|Progressive Disease|0|||
13352333|NCT00932698|26659221|FG002|Part 2 (Dose Expansion)|Progressive Disease|0|||
13352334|NCT00932698|26659222|FG003|Part 2 (Dose Expansion)|Progressive Disease|0|||
13352335|NCT00932698|26659223|FG004|Part 2 (Dose Expansion)|Progressive Disease|0|||
13352336|NCT00932698|26659224|FG005|Part 2 (Dose Expansion)|Progressive Disease|0|||
13352337|NCT00932698|26659225|FG006|Part 2 (Dose Expansion)|Progressive Disease|0|||
13352338|NCT00932698|26659226|FG007|Part 2 (Dose Expansion)|Progressive Disease|14|||
13352339|NCT00932698|26659227|FG008|Part 2 (Dose Expansion)|Progressive Disease|8|||
13352340|NCT00932698|26659228|FG009|Part 2 (Dose Expansion)|Progressive Disease|3|||
13352341|NCT00932698|26659229|FG010|Part 2 (Dose Expansion)|Progressive Disease|2|||
13352342|NCT00932698|26659219|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
13352343|NCT00932698|26659220|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
13352344|NCT00932698|26659221|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
13352345|NCT00932698|26659222|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
13352346|NCT00932698|26659223|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
13352347|NCT00932698|26659224|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
13352348|NCT00932698|26659225|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
13352349|NCT00932698|26659226|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1|||
13352350|NCT00932698|26659227|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3|||
13352351|NCT00932698|26659228|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2|||
13352352|NCT00932698|26659229|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
13352353|NCT00932698|26659219|FG000|Part 2 (Dose Expansion)|Adverse Event|0|||
13352354|NCT00932698|26659220|FG001|Part 2 (Dose Expansion)|Adverse Event|0|||
13352355|NCT00932698|26659221|FG002|Part 2 (Dose Expansion)|Adverse Event|0|||
13352356|NCT00932698|26659222|FG003|Part 2 (Dose Expansion)|Adverse Event|0|||
13352357|NCT00932698|26659223|FG004|Part 2 (Dose Expansion)|Adverse Event|0|||
13352358|NCT00932698|26659224|FG005|Part 2 (Dose Expansion)|Adverse Event|0|||
13352359|NCT00932698|26659225|FG006|Part 2 (Dose Expansion)|Adverse Event|0|||
13352360|NCT00932698|26659226|FG007|Part 2 (Dose Expansion)|Adverse Event|5|||
13352361|NCT00932698|26659227|FG008|Part 2 (Dose Expansion)|Adverse Event|1|||
13352362|NCT00932698|26659228|FG009|Part 2 (Dose Expansion)|Adverse Event|1|||
13352363|NCT00932698|26659229|FG010|Part 2 (Dose Expansion)|Adverse Event|0|||
13352364|NCT00932646|26659288|FG000|Overall Study|Adverse Event|2|||
13352365|NCT00932646|26659289|FG001|Overall Study|Adverse Event|1|||
13352366|NCT00932646|26659290|FG002|Overall Study|Adverse Event|1|||
13352367|NCT00932646|26659291|FG003|Overall Study|Adverse Event|1|||
13352368|NCT00932646|26659288|FG000|Overall Study|Lost to Follow-up|2|||
13352369|NCT00932646|26659289|FG001|Overall Study|Lost to Follow-up|1|||
13352370|NCT00932646|26659290|FG002|Overall Study|Lost to Follow-up|0|||
13352371|NCT00932646|26659291|FG003|Overall Study|Lost to Follow-up|0|||
13352372|NCT00932646|26659288|FG000|Overall Study|Withdrawal by Subject|1|||
13352373|NCT00932646|26659289|FG001|Overall Study|Withdrawal by Subject|1|||
13352374|NCT00932646|26659290|FG002|Overall Study|Withdrawal by Subject|3|||
13352375|NCT00932646|26659291|FG003|Overall Study|Withdrawal by Subject|0|||
13352376|NCT00932451|26659315|FG000|Overall Study|Withdrawal by Subject|69|||
13352377|NCT00932451|26659315|FG000|Overall Study|Lost to Follow-up|22|||
13352378|NCT00932451|26659315|FG000|Overall Study|Death|726|||
13352379|NCT00932451|26659315|FG000|Overall Study|Other reasons|5|||
13352380|NCT00932425|26659335|FG000|Overall Study|Lost to Follow-up|0|||
13352381|NCT00932425|26659336|FG001|Overall Study|Lost to Follow-up|1|||
13352382|NCT00932425|26659335|FG000|Overall Study|Withdrawal by Subject|0|||
13352383|NCT00932425|26659336|FG001|Overall Study|Withdrawal by Subject|1|||
13352384|NCT00932373|26659470|FG000|Overall Study|Progressive disease|3|||
13352385|NCT00932373|26659471|FG001|Overall Study|Progressive disease|1|||
13352386|NCT00932373|26659472|FG002|Overall Study|Progressive disease|0|||
13352387|NCT00932373|26659473|FG003|Overall Study|Progressive disease|0|||
13352388|NCT00932373|26659474|FG004|Overall Study|Progressive disease|10|||
13352389|NCT00932373|26659475|FG005|Overall Study|Progressive disease|1|||
13352390|NCT00932373|26659476|FG006|Overall Study|Progressive disease|0|||
13352391|NCT00932373|26659477|FG007|Overall Study|Progressive disease|2|||
13352392|NCT00932373|26659478|FG008|Overall Study|Progressive disease|1|||
13352393|NCT00932373|26659479|FG009|Overall Study|Progressive disease|9|||
13352394|NCT00932373|26659480|FG010|Overall Study|Progressive disease|2|||
13352395|NCT00932373|26659470|FG000|Overall Study|Adverse Event|0|||
13352396|NCT00932373|26659471|FG001|Overall Study|Adverse Event|0|||
13352397|NCT00932373|26659472|FG002|Overall Study|Adverse Event|0|||
13352398|NCT00932373|26659473|FG003|Overall Study|Adverse Event|0|||
13352399|NCT00932373|26659474|FG004|Overall Study|Adverse Event|2|||
13352400|NCT00932373|26659475|FG005|Overall Study|Adverse Event|1|||
13352401|NCT00932373|26659476|FG006|Overall Study|Adverse Event|0|||
13352402|NCT00932373|26659477|FG007|Overall Study|Adverse Event|1|||
13352403|NCT00932373|26659478|FG008|Overall Study|Adverse Event|0|||
13352404|NCT00932373|26659479|FG009|Overall Study|Adverse Event|2|||
13352405|NCT00932373|26659480|FG010|Overall Study|Adverse Event|1|||
13352406|NCT00932373|26659470|FG000|Overall Study|Physician Decision|0|||
13352407|NCT00932373|26659471|FG001|Overall Study|Physician Decision|0|||
13352408|NCT00932373|26659472|FG002|Overall Study|Physician Decision|1|||
13352409|NCT00932373|26659473|FG003|Overall Study|Physician Decision|0|||
13352410|NCT00932373|26659474|FG004|Overall Study|Physician Decision|2|||
13352411|NCT00932373|26659475|FG005|Overall Study|Physician Decision|0|||
13352412|NCT00932373|26659476|FG006|Overall Study|Physician Decision|0|||
13352413|NCT00932373|26659477|FG007|Overall Study|Physician Decision|0|||
13352414|NCT00932373|26659478|FG008|Overall Study|Physician Decision|0|||
13352415|NCT00932373|26659479|FG009|Overall Study|Physician Decision|1|||
13352416|NCT00932373|26659480|FG010|Overall Study|Physician Decision|0|||
13352417|NCT00932373|26659470|FG000|Overall Study|Dose limiting toxicity|0|||
13352418|NCT00932373|26659471|FG001|Overall Study|Dose limiting toxicity|0|||
13352419|NCT00932373|26659472|FG002|Overall Study|Dose limiting toxicity|0|||
13352420|NCT00932373|26659473|FG003|Overall Study|Dose limiting toxicity|0|||
13352421|NCT00932373|26659474|FG004|Overall Study|Dose limiting toxicity|0|||
13352422|NCT00932373|26659475|FG005|Overall Study|Dose limiting toxicity|1|||
13352423|NCT00932373|26659476|FG006|Overall Study|Dose limiting toxicity|0|||
13352424|NCT00932373|26659477|FG007|Overall Study|Dose limiting toxicity|0|||
13352425|NCT00932373|26659478|FG008|Overall Study|Dose limiting toxicity|0|||
13352426|NCT00932373|26659479|FG009|Overall Study|Dose limiting toxicity|0|||
13352427|NCT00932373|26659480|FG010|Overall Study|Dose limiting toxicity|0|||
13352428|NCT00932373|26659470|FG000|Overall Study|Withdrawal by Subject|0|||
13352429|NCT00932373|26659471|FG001|Overall Study|Withdrawal by Subject|0|||
13352430|NCT00932373|26659472|FG002|Overall Study|Withdrawal by Subject|0|||
13352431|NCT00932373|26659473|FG003|Overall Study|Withdrawal by Subject|0|||
13352432|NCT00932373|26659474|FG004|Overall Study|Withdrawal by Subject|0|||
13352433|NCT00932373|26659475|FG005|Overall Study|Withdrawal by Subject|0|||
13352434|NCT00932373|26659476|FG006|Overall Study|Withdrawal by Subject|0|||
13352435|NCT00932373|26659477|FG007|Overall Study|Withdrawal by Subject|0|||
13352436|NCT00932373|26659478|FG008|Overall Study|Withdrawal by Subject|1|||
13352437|NCT00932373|26659479|FG009|Overall Study|Withdrawal by Subject|0|||
13352438|NCT00932373|26659480|FG010|Overall Study|Withdrawal by Subject|0|||
13352439|NCT00932373|26659470|FG000|Overall Study|Clinical progression|0|||
13352440|NCT00932373|26659471|FG001|Overall Study|Clinical progression|0|||
13352441|NCT00932373|26659472|FG002|Overall Study|Clinical progression|0|||
13352442|NCT00932373|26659473|FG003|Overall Study|Clinical progression|0|||
13352443|NCT00932373|26659474|FG004|Overall Study|Clinical progression|0|||
13352444|NCT00932373|26659475|FG005|Overall Study|Clinical progression|0|||
13352445|NCT00932373|26659476|FG006|Overall Study|Clinical progression|1|||
13124881|NCT02937701|25954302|FG000|Week 22 to Week 50|Other|0|||
13124882|NCT02937701|25954303|FG001|Week 22 to Week 50|Other|0|||
13124883|NCT02937701|25954304|FG002|Week 22 to Week 50|Other|0|||
13124884|NCT02937701|25954305|FG003|Week 22 to Week 50|Other|0|||
13352446|NCT00932373|26659477|FG007|Overall Study|Clinical progression|0|||
13352447|NCT00932373|26659478|FG008|Overall Study|Clinical progression|0|||
13352448|NCT00932373|26659479|FG009|Overall Study|Clinical progression|0|||
13352449|NCT00932373|26659480|FG010|Overall Study|Clinical progression|0|||
13352450|NCT00932373|26659470|FG000|Overall Study|Lack of Efficacy|0|||
13352451|NCT00932373|26659471|FG001|Overall Study|Lack of Efficacy|0|||
13352452|NCT00932373|26659472|FG002|Overall Study|Lack of Efficacy|0|||
13352453|NCT00932373|26659473|FG003|Overall Study|Lack of Efficacy|0|||
13352454|NCT00932373|26659474|FG004|Overall Study|Lack of Efficacy|0|||
13352455|NCT00932373|26659475|FG005|Overall Study|Lack of Efficacy|0|||
13352456|NCT00932373|26659476|FG006|Overall Study|Lack of Efficacy|0|||
13352457|NCT00932373|26659477|FG007|Overall Study|Lack of Efficacy|0|||
13352458|NCT00932373|26659478|FG008|Overall Study|Lack of Efficacy|0|||
13352459|NCT00932373|26659479|FG009|Overall Study|Lack of Efficacy|1|||
13352460|NCT00932373|26659480|FG010|Overall Study|Lack of Efficacy|0|||
13352461|NCT00932360|26659516|FG000|Washout (One Week)|Withdrawal by Subject|0|||
13352462|NCT00932360|26659517|FG001|Washout (One Week)|Withdrawal by Subject|0|||
13352463|NCT00932360|26659518|FG002|Washout (One Week)|Withdrawal by Subject|0|||
13352464|NCT00932360|26659519|FG003|Washout (One Week)|Withdrawal by Subject|0|||
13352465|NCT00932360|26659520|FG004|Washout (One Week)|Withdrawal by Subject|2|||
13352466|NCT00932360|26659521|FG005|Washout (One Week)|Withdrawal by Subject|0|||
13352467|NCT00932165|26659534|FG000|Overall Study|Lost to Follow-up|1|||
13352468|NCT00932126|26659579|FG000|Overall Study|Adverse Event|0|||
13352469|NCT00932126|26659580|FG001|Overall Study|Adverse Event|0|||
13352470|NCT00932126|26659581|FG002|Overall Study|Adverse Event|0|||
13124885|NCT02937701|25954306|FG004|Week 22 to Week 50|Other|1|||
13352471|NCT00932126|26659582|FG003|Overall Study|Adverse Event|0|||
13352472|NCT00932126|26659583|FG004|Overall Study|Adverse Event|0|||
13352473|NCT00932126|26659584|FG005|Overall Study|Adverse Event|0|||
13352474|NCT00932126|26659585|FG006|Overall Study|Adverse Event|1|||
13352475|NCT00932126|26659586|FG007|Overall Study|Adverse Event|2|||
13352476|NCT00932126|26659579|FG000|Overall Study|Protocol Violation|0|||
13352477|NCT00932126|26659580|FG001|Overall Study|Protocol Violation|0|||
13352478|NCT00932126|26659581|FG002|Overall Study|Protocol Violation|0|||
13352479|NCT00932126|26659582|FG003|Overall Study|Protocol Violation|0|||
13124886|NCT02937636|25954325|FG000|Overall Study|Other (Not specified)|3|||
13352480|NCT00932126|26659583|FG004|Overall Study|Protocol Violation|1|||
13352481|NCT00932126|26659584|FG005|Overall Study|Protocol Violation|0|||
13352482|NCT00932126|26659585|FG006|Overall Study|Protocol Violation|0|||
13352483|NCT00932126|26659586|FG007|Overall Study|Protocol Violation|0|||
13352484|NCT00932126|26659579|FG000|Overall Study|Withdrawal by Subject|0|||
13352485|NCT00932126|26659580|FG001|Overall Study|Withdrawal by Subject|0|||
13352486|NCT00932126|26659581|FG002|Overall Study|Withdrawal by Subject|1|||
13352487|NCT00932126|26659582|FG003|Overall Study|Withdrawal by Subject|0|||
13352488|NCT00932126|26659583|FG004|Overall Study|Withdrawal by Subject|0|||
13352489|NCT00932126|26659584|FG005|Overall Study|Withdrawal by Subject|0|||
13352490|NCT00932126|26659585|FG006|Overall Study|Withdrawal by Subject|0|||
13352491|NCT00932126|26659586|FG007|Overall Study|Withdrawal by Subject|1|||
13352492|NCT00932126|26659579|FG000|Overall Study|Objective progression or relapse|3|||
13352493|NCT00932126|26659580|FG001|Overall Study|Objective progression or relapse|3|||
13352494|NCT00932126|26659581|FG002|Overall Study|Objective progression or relapse|2|||
13352495|NCT00932126|26659582|FG003|Overall Study|Objective progression or relapse|3|||
13352496|NCT00932126|26659583|FG004|Overall Study|Objective progression or relapse|3|||
13352497|NCT00932126|26659584|FG005|Overall Study|Objective progression or relapse|3|||
13352498|NCT00932126|26659585|FG006|Overall Study|Objective progression or relapse|3|||
13352499|NCT00932126|26659586|FG007|Overall Study|Objective progression or relapse|5|||
13352500|NCT00932126|26659579|FG000|Overall Study|Other|0|||
13352501|NCT00932126|26659580|FG001|Overall Study|Other|0|||
13352502|NCT00932126|26659581|FG002|Overall Study|Other|0|||
13352503|NCT00932126|26659582|FG003|Overall Study|Other|0|||
13352504|NCT00932126|26659583|FG004|Overall Study|Other|1|||
13352505|NCT00932126|26659584|FG005|Overall Study|Other|0|||
13352506|NCT00932126|26659585|FG006|Overall Study|Other|1|||
13352507|NCT00932126|26659586|FG007|Overall Study|Other|2|||
13352508|NCT00932113|26659609|FG000|Overall Study|Lost to Follow-up|1|||
13352509|NCT00932113|26659610|FG001|Overall Study|Lost to Follow-up|0|||
13352510|NCT00931944|26659629|FG000|Overall Study|Adverse Event|4|||
13352511|NCT00931944|26659629|FG000|Overall Study|W/D Consent (due to ALS progression))|19|||
13352512|NCT00931944|26659629|FG000|Overall Study|Withdrawal Consent (due to other)|2|||
13352513|NCT00931944|26659629|FG000|Overall Study|Death|28|||
13352514|NCT00931944|26659629|FG000|Overall Study|Other|2|||
13352515|NCT00931918|26659660|FG000|Overall Study|Adverse Event|4|||
13352516|NCT00931918|26659661|FG001|Overall Study|Adverse Event|6|||
13352517|NCT00931918|26659660|FG000|Overall Study|Progressive Disease|2|||
13352518|NCT00931918|26659661|FG001|Overall Study|Progressive Disease|1|||
13352519|NCT00931918|26659660|FG000|Overall Study|Symptomatic Deterioration|1|||
13352520|NCT00931918|26659661|FG001|Overall Study|Symptomatic Deterioration|0|||
13352521|NCT00931918|26659660|FG000|Overall Study|Withdrawal by Patient|3|||
13352522|NCT00931918|26659661|FG001|Overall Study|Withdrawal by Patient|4|||
13352523|NCT00931918|26659660|FG000|Overall Study|Other Reason not Specified|4|||
13352524|NCT00931918|26659661|FG001|Overall Study|Other Reason not Specified|4|||
13352525|NCT00931918|26659660|FG000|Overall Study|Did not receive study drug|3|||
13352526|NCT00931918|26659661|FG001|Overall Study|Did not receive study drug|2|||
13352527|NCT00931892|26659744|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0|||
13352528|NCT00931892|26659745|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1|||
13352529|NCT00931801|26659776|FG000|Overall Study|Adverse Event|0|||
13352530|NCT00931801|26659777|FG001|Overall Study|Adverse Event|0|||
13352531|NCT00931801|26659778|FG002|Overall Study|Adverse Event|1|||
13352532|NCT00931801|26659776|FG000|Overall Study|Lost to Follow-up|0|||
13352533|NCT00931801|26659777|FG001|Overall Study|Lost to Follow-up|1|||
13352534|NCT00931801|26659778|FG002|Overall Study|Lost to Follow-up|0|||
13352535|NCT00931801|26659776|FG000|Overall Study|Withdrawal by Subject|1|||
13352536|NCT00931801|26659777|FG001|Overall Study|Withdrawal by Subject|0|||
13352537|NCT00931801|26659778|FG002|Overall Study|Withdrawal by Subject|0|||
13352538|NCT00931801|26659776|FG000|Overall Study|Confirmed Virologic Failure|0|||
13352539|NCT00931801|26659777|FG001|Overall Study|Confirmed Virologic Failure|0|||
13352540|NCT00931801|26659778|FG002|Overall Study|Confirmed Virologic Failure|3|||
13352541|NCT00931762|26659787|FG000|Overall Study|Abnormal Laboratory Value (s)|2|||
13352542|NCT00931762|26659787|FG000|Overall Study|Administrative Problems|5|||
13352543|NCT00931762|26659787|FG000|Overall Study|Death|1|||
13352544|NCT00931762|26659787|FG000|Overall Study|Disease Progression|3|||
13352545|NCT00931762|26659787|FG000|Overall Study|Adverse Event (s)|11|||
13352546|NCT00931762|26659787|FG000|Overall Study|Subject withdrew consent|13|||
13352547|NCT00931723|26659840|FG000|Overall Study|Withdrawal by Subject|11|||
13352548|NCT00931723|26659841|FG001|Overall Study|Withdrawal by Subject|13|||
13352549|NCT00931723|26659840|FG000|Overall Study|Adverse Event|6|||
13352550|NCT00931723|26659841|FG001|Overall Study|Adverse Event|13|||
13352551|NCT00931723|26659840|FG000|Overall Study|Lithium found in blood|0|||
13352552|NCT00931723|26659841|FG001|Overall Study|Lithium found in blood|1|||
13352553|NCT00931723|26659840|FG000|Overall Study|Condition under investigation worsened|1|||
13352554|NCT00931723|26659841|FG001|Overall Study|Condition under investigation worsened|2|||
13352555|NCT00931723|26659840|FG000|Overall Study|Lost to Follow-up|1|||
13352556|NCT00931723|26659841|FG001|Overall Study|Lost to Follow-up|2|||
13352557|NCT00931723|26659840|FG000|Overall Study|Study-specific discontinuation criteria|1|||
13352558|NCT00931723|26659841|FG001|Overall Study|Study-specific discontinuation criteria|1|||
13352559|NCT00931723|26659840|FG000|Overall Study|Severe non-compliance to protocol|2|||
13352560|NCT00931723|26659841|FG001|Overall Study|Severe non-compliance to protocol|0|||
13352561|NCT00931723|26659840|FG000|Overall Study|Safety reasons|0|||
13352562|NCT00931723|26659841|FG001|Overall Study|Safety reasons|1|||
13352563|NCT00931723|26659840|FG000|Overall Study|Took prohibited concomitant medication|0|||
13352564|NCT00931723|26659841|FG001|Overall Study|Took prohibited concomitant medication|1|||
13352565|NCT00931723|26659840|FG000|Overall Study|Lack or insufficient theraputic response|2|||
13352566|NCT00931723|26659841|FG001|Overall Study|Lack or insufficient theraputic response|5|||
13352567|NCT00931723|26659840|FG000|Overall Study|Sponsor decision|1|||
13352568|NCT00931723|26659841|FG001|Overall Study|Sponsor decision|0|||
13352569|NCT00931723|26659840|FG000|Overall Study|Late hospital discharge|1|||
13352570|NCT00931723|26659841|FG001|Overall Study|Late hospital discharge|0|||
13352571|NCT00931710|26659864|FG000|Overall Study|Adverse Event|16|||
13352572|NCT00931710|26659865|FG001|Overall Study|Adverse Event|10|||
13352573|NCT00931710|26659864|FG000|Overall Study|Abnormal test procedure results|2|||
13352574|NCT00931710|26659865|FG001|Overall Study|Abnormal test procedure results|0|||
13352575|NCT00931710|26659864|FG000|Overall Study|Unsatisfactory therapeutic effects|5|||
13352576|NCT00931710|26659865|FG001|Overall Study|Unsatisfactory therapeutic effects|12|||
13352577|NCT00931710|26659864|FG000|Overall Study|Patient withdrew consent|4|||
13352578|NCT00931710|26659865|FG001|Overall Study|Patient withdrew consent|9|||
13352579|NCT00931710|26659864|FG000|Overall Study|Lost to Follow-up|6|||
13352580|NCT00931710|26659865|FG001|Overall Study|Lost to Follow-up|5|||
13352581|NCT00931710|26659864|FG000|Overall Study|Protocol deviation|1|||
13352582|NCT00931710|26659865|FG001|Overall Study|Protocol deviation|2|||
13352583|NCT00931632|26659892|FG000|Overall Study|Withdrawal by Subject|2|||
13352584|NCT00931632|26659893|FG001|Overall Study|Withdrawal by Subject|3|||
13352585|NCT00931632|26659892|FG000|Overall Study|Adverse Event|19|||
13352586|NCT00931632|26659893|FG001|Overall Study|Adverse Event|15|||
13352587|NCT00931528|26659918|FG000|Overall Study|Protocol Violation|9|||
13352588|NCT00931528|26659919|FG001|Overall Study|Protocol Violation|12|||
13352589|NCT00931528|26659918|FG000|Overall Study|Withdrawal by Subject|4|||
13352590|NCT00931528|26659919|FG001|Overall Study|Withdrawal by Subject|12|||
13352591|NCT00931528|26659918|FG000|Overall Study|Lost to Follow-up|6|||
13352592|NCT00931528|26659919|FG001|Overall Study|Lost to Follow-up|13|||
13352593|NCT00931528|26659918|FG000|Overall Study|Assessment outside of Time Frame|22|||
13352594|NCT00931528|26659919|FG001|Overall Study|Assessment outside of Time Frame|23|||
13352595|NCT00931515|26659932|FG000|Overall Study|Lost to Follow-up|2|||
13352596|NCT00931515|26659933|FG001|Overall Study|Lost to Follow-up|5|||
13352597|NCT00931463|26659954|FG000|Overall Study|Death|8|||
13352598|NCT00931463|26659955|FG001|Overall Study|Death|4|||
13352599|NCT00931463|26659954|FG000|Overall Study|Withdrawal by Subject|5|||
13352600|NCT00931463|26659955|FG001|Overall Study|Withdrawal by Subject|0|||
13352601|NCT00931463|26659954|FG000|Overall Study|Lost to Follow-up|4|||
13352602|NCT00931463|26659955|FG001|Overall Study|Lost to Follow-up|1|||
13374383|NCT00796666|26726346|FG000|Overall Study|Adverse Event|7|||
13374384|NCT00796666|26726347|FG001|Overall Study|Adverse Event|5|||
13374385|NCT00796666|26726346|FG000|Overall Study|Protocol Violation|1|||
13374386|NCT00796666|26726347|FG001|Overall Study|Protocol Violation|0|||
13374387|NCT00796666|26726346|FG000|Overall Study|Other|1|||
13374388|NCT00796666|26726347|FG001|Overall Study|Other|0|||
13374389|NCT00796666|26726346|FG000|Overall Study|Terminated by sponsor|53|||
13374390|NCT00796666|26726347|FG001|Overall Study|Terminated by sponsor|55|||
13374391|NCT00796666|26726346|FG000|Overall Study|Randomized and not treated|1|||
13374392|NCT00796666|26726347|FG001|Overall Study|Randomized and not treated|0|||
13374393|NCT00796653|26726626|FG000|Overall Study|Adverse Event|19|||
13374394|NCT00796653|26726627|FG001|Overall Study|Adverse Event|16|||
13374395|NCT00796653|26726628|FG002|Overall Study|Adverse Event|16|||
13374396|NCT00796653|26726629|FG003|Overall Study|Adverse Event|16|||
13374397|NCT00796653|26726626|FG000|Overall Study|Lost to Follow-up|2|||
13374398|NCT00796653|26726627|FG001|Overall Study|Lost to Follow-up|1|||
13374399|NCT00796653|26726628|FG002|Overall Study|Lost to Follow-up|2|||
13374400|NCT00796653|26726629|FG003|Overall Study|Lost to Follow-up|3|||
13374401|NCT00796653|26726626|FG000|Overall Study|Withdrawal by Subject|16|||
13374402|NCT00796653|26726627|FG001|Overall Study|Withdrawal by Subject|8|||
13374403|NCT00796653|26726628|FG002|Overall Study|Withdrawal by Subject|8|||
13374404|NCT00796653|26726629|FG003|Overall Study|Withdrawal by Subject|13|||
13374405|NCT00796653|26726626|FG000|Overall Study|Lack of Efficacy|8|||
13374406|NCT00796653|26726627|FG001|Overall Study|Lack of Efficacy|1|||
13374407|NCT00796653|26726628|FG002|Overall Study|Lack of Efficacy|3|||
13374408|NCT00796653|26726629|FG003|Overall Study|Lack of Efficacy|2|||
13374409|NCT00796653|26726626|FG000|Overall Study|Non compliance with protocol|2|||
13374410|NCT00796653|26726627|FG001|Overall Study|Non compliance with protocol|2|||
13374411|NCT00796653|26726628|FG002|Overall Study|Non compliance with protocol|0|||
13374412|NCT00796653|26726629|FG003|Overall Study|Non compliance with protocol|2|||
13374413|NCT00796653|26726626|FG000|Overall Study|Other reason not described above|4|||
13352603|NCT00931411|26659983|FG000|First Intervention - 42 Days|Adverse Event|2|||
13352604|NCT00931411|26659984|FG001|First Intervention - 42 Days|Adverse Event|3|||
13352605|NCT00931411|26659983|FG000|First Intervention - 42 Days|Lost to Follow-up|2|||
13352606|NCT00931411|26659984|FG001|First Intervention - 42 Days|Lost to Follow-up|0|||
13352607|NCT00931411|26659983|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0|||
13352608|NCT00931411|26659984|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1|||
13352609|NCT00931385|26660043|FG000|Overall Study|Adverse Event|2|||
13352610|NCT00931385|26660044|FG001|Overall Study|Adverse Event|1|||
13352611|NCT00931385|26660045|FG002|Overall Study|Adverse Event|0|||
13352612|NCT00931385|26660046|FG003|Overall Study|Adverse Event|3|||
13352613|NCT00931385|26660043|FG000|Overall Study|Protocol Violation|0|||
13352614|NCT00931385|26660044|FG001|Overall Study|Protocol Violation|0|||
13352615|NCT00931385|26660045|FG002|Overall Study|Protocol Violation|1|||
13352616|NCT00931385|26660046|FG003|Overall Study|Protocol Violation|0|||
13352617|NCT00931385|26660043|FG000|Overall Study|Withdrawal by Subject|0|||
13352618|NCT00931385|26660044|FG001|Overall Study|Withdrawal by Subject|1|||
13352619|NCT00931385|26660045|FG002|Overall Study|Withdrawal by Subject|0|||
13352620|NCT00931385|26660046|FG003|Overall Study|Withdrawal by Subject|1|||
13352621|NCT00931385|26660043|FG000|Overall Study|Lost to Follow-up|0|||
13352622|NCT00931385|26660044|FG001|Overall Study|Lost to Follow-up|0|||
13352623|NCT00931385|26660045|FG002|Overall Study|Lost to Follow-up|0|||
13352624|NCT00931385|26660046|FG003|Overall Study|Lost to Follow-up|1|||
13352625|NCT00931307|26660052|FG000|Overall Study|Lack of Efficacy|12|||
13352626|NCT00931307|26660052|FG000|Overall Study|Biomicroscopy|1|||
13352627|NCT00931268|26660064|FG000|Overall Study|Lost to Follow-up|6|||
13352628|NCT00931255|26660093|FG000|Overall Study|Follow up biopsy not done|2|||
13352629|NCT00931255|26660094|FG001|Overall Study|Follow up biopsy not done|3|||
13352630|NCT00930982|26660135|FG000|Overall Study|Adverse Event|19|||
13352631|NCT00930982|26660136|FG001|Overall Study|Adverse Event|23|||
13352632|NCT00930982|26660135|FG000|Overall Study|Protocol Violation|1|||
13352633|NCT00930982|26660136|FG001|Overall Study|Protocol Violation|5|||
13352634|NCT00930982|26660135|FG000|Overall Study|Withdrawal by Subject|1|||
13352635|NCT00930982|26660136|FG001|Overall Study|Withdrawal by Subject|1|||
13352636|NCT00930969|26660146|FG000|Overall Study|Death|5|||
13352637|NCT00930969|26660146|FG000|Overall Study|Lost to Follow-up|1|||
13352638|NCT00930969|26660146|FG000|Overall Study|Physician Decision|13|||
13352639|NCT00930969|26660146|FG000|Overall Study|Withdrawal by Subject|19|||
13352640|NCT00930930|26660165|FG000|Overall Study|Death|1|||
13352641|NCT00930930|26660166|FG001|Overall Study|Death|0|||
13352642|NCT00930930|26660165|FG000|Overall Study|Physician Decision|1|||
13352643|NCT00930930|26660166|FG001|Overall Study|Physician Decision|0|||
13352644|NCT00930930|26660165|FG000|Overall Study|Adverse Event|13|||
13352645|NCT00930930|26660166|FG001|Overall Study|Adverse Event|3|||
13352646|NCT00930930|26660165|FG000|Overall Study|Withdrawal by Subject|3|||
13352647|NCT00930930|26660166|FG001|Overall Study|Withdrawal by Subject|1|||
13352648|NCT00930930|26660165|FG000|Overall Study|Disease progression|2|||
13352649|NCT00930930|26660166|FG001|Overall Study|Disease progression|3|||
13352650|NCT00930930|26660165|FG000|Overall Study|excessive lapse btw txs, not eligible|0|||
13352651|NCT00930930|26660166|FG001|Overall Study|excessive lapse btw txs, not eligible|1|||
13352652|NCT00930930|26660165|FG000|Overall Study|patients not compliant|1|||
13352653|NCT00930930|26660166|FG001|Overall Study|patients not compliant|1|||
13352654|NCT00930813|26660181|FG000|Overall Study|Death|4|||
13352655|NCT00930813|26660182|FG001|Overall Study|Death|5|||
13352656|NCT00930813|26660181|FG000|Overall Study|Withdrawal by Subject|2|||
13352657|NCT00930813|26660182|FG001|Overall Study|Withdrawal by Subject|5|||
13352658|NCT00930813|26660181|FG000|Overall Study|Lost to Follow-up|2|||
13352659|NCT00930813|26660182|FG001|Overall Study|Lost to Follow-up|4|||
13352660|NCT00930774|26660233|FG000|Overall Study|Withdrawal by Subject|1|||
13352661|NCT00930774|26660234|FG001|Overall Study|Withdrawal by Subject|9|||
13352662|NCT00930774|26660235|FG002|Overall Study|Withdrawal by Subject|2|||
13352663|NCT00930774|26660236|FG003|Overall Study|Withdrawal by Subject|0|||
13352664|NCT00930761|26660255|FG000|Overall Study|3 newborns died; 1 mother quit the study|4|||
13352665|NCT00930761|26660256|FG001|Overall Study|3 newborns died; 1 mother quit the study|0|||
13352666|NCT00930761|26660255|FG000|Overall Study|less than 3 music therapy sessions|0|||
13352667|NCT00930761|26660256|FG001|Overall Study|less than 3 music therapy sessions|3|||
13352668|NCT00930722|26660273|FG000|Overall Study|Lost to Follow-up|16|||
13352669|NCT00930722|26660273|FG000|Overall Study|No longer willing to participate|9|||
13352670|NCT00930722|26660273|FG000|Overall Study|Study terminated by sponsor|2|||
13352671|NCT00930644|26660288|FG000|Overall Study|Withdrawal by Subject|4|||
13352672|NCT00930644|26660288|FG000|Overall Study|Physician Decision|2|||
13352673|NCT00930644|26660288|FG000|Overall Study|Death|1|||
13352674|NCT00930644|26660288|FG000|Overall Study|Adverse Event|16|||
13352675|NCT00930579|26660294|FG000|Overall Study|Withdrawal by Subject|1|||
13352676|NCT00930579|26660294|FG000|Overall Study|Discontinued due to rescheduled surgery|1|||
13352677|NCT00930553|26660362|FG000|Overall Study|Adverse Event|1|||
13352678|NCT00930553|26660362|FG000|Overall Study|Lack of Efficacy|7|||
13352679|NCT00930553|26660362|FG000|Overall Study|Physician Decision|39|||
13352680|NCT00930553|26660362|FG000|Overall Study|Protocol Violation|1|||
13352681|NCT00930553|26660362|FG000|Overall Study|Pregnancy|1|||
13352682|NCT00930553|26660362|FG000|Overall Study|Withdrawal by Subject|88|||
13352683|NCT00930553|26660362|FG000|Overall Study|Lost to Follow-up|25|||
13352684|NCT00930553|26660362|FG000|Overall Study|Death|9|||
13352685|NCT00930553|26660362|FG000|Overall Study|Study terminated by sponsor|24|||
13352686|NCT00930553|26660362|FG000|Overall Study|Other than specified above|28|||
13352687|NCT00930176|26660369|FG000|Overall Study|Death|1|||
13352688|NCT00930059|26660404|FG000|Overall Study|Death|1|||
13352689|NCT00930059|26660405|FG001|Overall Study|Death|0|||
13352690|NCT00930059|26660404|FG000|Overall Study|Did not meet entrance criteria|1|||
13352691|NCT00930059|26660405|FG001|Overall Study|Did not meet entrance criteria|1|||
13352692|NCT00930059|26660404|FG000|Overall Study|Withdrawal by Subject|3|||
13352693|NCT00930059|26660405|FG001|Overall Study|Withdrawal by Subject|4|||
13352694|NCT00930059|26660404|FG000|Overall Study|Other|1|||
13352695|NCT00930059|26660405|FG001|Overall Study|Other|0|||
13352696|NCT00930059|26660404|FG000|Overall Study|1 site terminated by sponsor|1|||
13352697|NCT00930059|26660405|FG001|Overall Study|1 site terminated by sponsor|1|||
13352698|NCT00930059|26660404|FG000|Overall Study|Adverse Event|1|||
13352699|NCT00930059|26660405|FG001|Overall Study|Adverse Event|6|||
13352700|NCT00930046|26660420|FG000|Overall Study|Wound catheter malfunctioned|1|||
13352701|NCT00930046|26660421|FG001|Overall Study|Wound catheter malfunctioned|2|||
13352702|NCT00929994|26660430|FG000|Overall Study|Withdrawal by Subject|1|||
13352703|NCT00929994|26660430|FG000|Overall Study|medical issue unrelated to intervention|4|||
13352704|NCT00929994|26660430|FG000|Overall Study|employment|1|||
13352705|NCT00929864|26660455|FG000|Overall Study|Death|1|||
13352706|NCT00929864|26660456|FG001|Overall Study|Death|1|||
13352707|NCT00929864|26660455|FG000|Overall Study|Adverse Event|11|||
13352708|NCT00929864|26660456|FG001|Overall Study|Adverse Event|30|||
13352709|NCT00929864|26660455|FG000|Overall Study|Lack of Efficacy|19|||
13352710|NCT00929864|26660456|FG001|Overall Study|Lack of Efficacy|16|||
13352711|NCT00929864|26660455|FG000|Overall Study|Lost to Follow-up|7|||
13352712|NCT00929864|26660456|FG001|Overall Study|Lost to Follow-up|12|||
13352713|NCT00929864|26660455|FG000|Overall Study|Withdrawal by Subject|20|||
13352714|NCT00929864|26660456|FG001|Overall Study|Withdrawal by Subject|9|||
13352715|NCT00929864|26660455|FG000|Overall Study|No longer met criteria|2|||
13352716|NCT00929864|26660456|FG001|Overall Study|No longer met criteria|1|||
13352717|NCT00929864|26660455|FG000|Overall Study|Poor or non-compliance|3|||
13352718|NCT00929864|26660456|FG001|Overall Study|Poor or non-compliance|3|||
13352719|NCT00929864|26660455|FG000|Overall Study|Pregnancy|0|||
13352720|NCT00929864|26660456|FG001|Overall Study|Pregnancy|3|||
13352721|NCT00929864|26660455|FG000|Overall Study|Administrative reason by Sponsor|1|||
13352722|NCT00929864|26660456|FG001|Overall Study|Administrative reason by Sponsor|1|||
13352723|NCT00929864|26660455|FG000|Overall Study|Non-specified|2|||
13352724|NCT00929864|26660456|FG001|Overall Study|Non-specified|7|||
13352725|NCT00929734|26660475|FG000|Overall Study|Lost to Follow-up|2|||
13352726|NCT00929734|26660476|FG001|Overall Study|Lost to Follow-up|1|||
13352727|NCT00929734|26660475|FG000|Overall Study|Withdrawal by Subject|0|||
13352728|NCT00929734|26660476|FG001|Overall Study|Withdrawal by Subject|2|||
13352729|NCT00929708|26660544|FG000|Overall Study|Protocol Violation|2|||
13352730|NCT00929708|26660545|FG001|Overall Study|Protocol Violation|1|||
13352731|NCT00929708|26660546|FG002|Overall Study|Protocol Violation|1|||
13352732|NCT00929708|26660547|FG003|Overall Study|Protocol Violation|1|||
13352733|NCT00929708|26660548|FG004|Overall Study|Protocol Violation|1|||
13352734|NCT00929708|26660544|FG000|Overall Study|Withdrawal by Subject|2|||
13352735|NCT00929708|26660545|FG001|Overall Study|Withdrawal by Subject|0|||
13352736|NCT00929708|26660546|FG002|Overall Study|Withdrawal by Subject|0|||
13352737|NCT00929708|26660547|FG003|Overall Study|Withdrawal by Subject|2|||
13352738|NCT00929708|26660548|FG004|Overall Study|Withdrawal by Subject|1|||
13352739|NCT00929708|26660544|FG000|Overall Study|Adverse Event|0|||
13352740|NCT00929708|26660545|FG001|Overall Study|Adverse Event|0|||
13352741|NCT00929708|26660546|FG002|Overall Study|Adverse Event|0|||
13352742|NCT00929708|26660547|FG003|Overall Study|Adverse Event|0|||
13352743|NCT00929708|26660548|FG004|Overall Study|Adverse Event|3|||
13352744|NCT00929708|26660544|FG000|Overall Study|Physician Decision|0|||
13352745|NCT00929708|26660545|FG001|Overall Study|Physician Decision|2|||
13352746|NCT00929708|26660546|FG002|Overall Study|Physician Decision|2|||
13352747|NCT00929708|26660547|FG003|Overall Study|Physician Decision|2|||
13204423|NCT01973231|26228572|FG001|Overall Study|Protocol Violation|1|||
13352748|NCT00929708|26660548|FG004|Overall Study|Physician Decision|1|||
13352749|NCT00929708|26660544|FG000|Overall Study|Lost to Follow-up|0|||
13352750|NCT00929708|26660545|FG001|Overall Study|Lost to Follow-up|0|||
13352751|NCT00929708|26660546|FG002|Overall Study|Lost to Follow-up|0|||
13352752|NCT00929708|26660547|FG003|Overall Study|Lost to Follow-up|1|||
13352753|NCT00929708|26660548|FG004|Overall Study|Lost to Follow-up|0|||
13352754|NCT00929695|26660585|FG000|Overall Study|Death|2|||
13352755|NCT00929695|26660586|FG001|Overall Study|Death|1|||
13352756|NCT00929695|26660585|FG000|Overall Study|Withdrawal by Subject|0|||
13352757|NCT00929695|26660586|FG001|Overall Study|Withdrawal by Subject|2|||
13352758|NCT00929695|26660585|FG000|Overall Study|discharge home|4|||
13352759|NCT00929695|26660586|FG001|Overall Study|discharge home|3|||
13352760|NCT00929695|26660585|FG000|Overall Study|incorrect stratification|2|||
13352761|NCT00929695|26660586|FG001|Overall Study|incorrect stratification|0|||
13352762|NCT00929669|26660593|FG000|Overall Study|elevated glucose levels|1|||
13352763|NCT00929656|26660614|FG000|Overall Study|Lost to Follow-up|0|||
13352764|NCT00929656|26660615|FG001|Overall Study|Lost to Follow-up|1|||
13352765|NCT00929643|26660626|FG000|Overall Study|Protocol Violation|2|||
13352766|NCT00929526|26660667|FG000|Overall Study|Withdrawal by Subject|1|||
13352767|NCT00929526|26660668|FG001|Overall Study|Withdrawal by Subject|11|||
13352768|NCT00929526|26660667|FG000|Overall Study|Lost to Follow-up|8|||
13352769|NCT00929526|26660668|FG001|Overall Study|Lost to Follow-up|12|||
13352770|NCT00929526|26660667|FG000|Overall Study|Other|8|||
13352771|NCT00929526|26660668|FG001|Overall Study|Other|6|||
13352772|NCT00929240|26660699|FG000|Initial Treatment Phase|Adverse Event|31|||
13352773|NCT00929240|26660700|FG001|Initial Treatment Phase|Adverse Event|0|||
13352774|NCT00929240|26660701|FG002|Initial Treatment Phase|Adverse Event|0|||
13352775|NCT00929240|26660699|FG000|Initial Treatment Phase|Disease progression|41|||
13352776|NCT00929240|26660700|FG001|Initial Treatment Phase|Disease progression|0|||
13352777|NCT00929240|26660701|FG002|Initial Treatment Phase|Disease progression|0|||
13352778|NCT00929240|26660699|FG000|Initial Treatment Phase|Withdrawal by Subject|13|||
13352779|NCT00929240|26660700|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
13352780|NCT00929240|26660701|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
13352781|NCT00929240|26660699|FG000|Initial Treatment Phase|Protocol Violation|5|||
13352782|NCT00929240|26660700|FG001|Initial Treatment Phase|Protocol Violation|0|||
13352783|NCT00929240|26660701|FG002|Initial Treatment Phase|Protocol Violation|0|||
13352784|NCT00929240|26660699|FG000|Initial Treatment Phase|Death|2|||
13352785|NCT00929240|26660700|FG001|Initial Treatment Phase|Death|0|||
13352786|NCT00929240|26660701|FG002|Initial Treatment Phase|Death|0|||
13352787|NCT00929240|26660699|FG000|Initial Treatment Phase|Health authority/Study termination|3|||
13352788|NCT00929240|26660700|FG001|Initial Treatment Phase|Health authority/Study termination|0|||
13352789|NCT00929240|26660701|FG002|Initial Treatment Phase|Health authority/Study termination|0|||
13352790|NCT00929240|26660699|FG000|Initial Treatment Phase|Physician Decision|4|||
13352791|NCT00929240|26660700|FG001|Initial Treatment Phase|Physician Decision|0|||
13352792|NCT00929240|26660701|FG002|Initial Treatment Phase|Physician Decision|0|||
13352793|NCT00929240|26660699|FG000|Maintenance Phase|Disease progression|0|||
13352794|NCT00929240|26660700|FG001|Maintenance Phase|Disease progression|73|||
13352795|NCT00929240|26660701|FG002|Maintenance Phase|Disease progression|60|||
13352796|NCT00929240|26660699|FG000|Maintenance Phase|Adverse Event|0|||
13352797|NCT00929240|26660700|FG001|Maintenance Phase|Adverse Event|9|||
13352798|NCT00929240|26660701|FG002|Maintenance Phase|Adverse Event|12|||
13352799|NCT00929240|26660699|FG000|Maintenance Phase|Withdrawal by Subject|0|||
13352800|NCT00929240|26660700|FG001|Maintenance Phase|Withdrawal by Subject|2|||
13352801|NCT00929240|26660701|FG002|Maintenance Phase|Withdrawal by Subject|6|||
13352802|NCT00929240|26660699|FG000|Maintenance Phase|Protocol Violation|0|||
13352803|NCT00929240|26660700|FG001|Maintenance Phase|Protocol Violation|1|||
13352804|NCT00929240|26660701|FG002|Maintenance Phase|Protocol Violation|0|||
13352805|NCT00929240|26660699|FG000|Maintenance Phase|Health authority/Study termination|0|||
13352806|NCT00929240|26660700|FG001|Maintenance Phase|Health authority/Study termination|1|||
13352807|NCT00929240|26660701|FG002|Maintenance Phase|Health authority/Study termination|2|||
13352808|NCT00929240|26660699|FG000|Maintenance Phase|Physician Decision|0|||
13352809|NCT00929240|26660700|FG001|Maintenance Phase|Physician Decision|2|||
13352810|NCT00929240|26660701|FG002|Maintenance Phase|Physician Decision|1|||
13352811|NCT00929240|26660699|FG000|Maintenance Phase|Change of treatment|0|||
13352812|NCT00929240|26660700|FG001|Maintenance Phase|Change of treatment|4|||
13352813|NCT00929240|26660701|FG002|Maintenance Phase|Change of treatment|0|||
13352814|NCT00929240|26660699|FG000|Maintenance Phase|Treatment ongoing at study closure|0|||
13352815|NCT00929240|26660700|FG001|Maintenance Phase|Treatment ongoing at study closure|0|||
13352816|NCT00929240|26660701|FG002|Maintenance Phase|Treatment ongoing at study closure|10|||
13352817|NCT00929240|26660699|FG000|Maintenance Phase|Participant not treated|0|||
13352818|NCT00929240|26660700|FG001|Maintenance Phase|Participant not treated|2|||
13352819|NCT00929240|26660701|FG002|Maintenance Phase|Participant not treated|0|||
13352820|NCT00929201|26660712|FG000|Period 1|Withdrawal by Subject|0|||
13352821|NCT00929201|26660713|FG001|Period 1|Withdrawal by Subject|1|||
13352822|NCT00929162|26660730|FG000|Overall Study|Adverse Event|8|||
13352823|NCT00929162|26660731|FG001|Overall Study|Adverse Event|5|||
13352824|NCT00929162|26660730|FG000|Overall Study|Withdrawal by Subject|3|||
13352825|NCT00929162|26660731|FG001|Overall Study|Withdrawal by Subject|1|||
13352826|NCT00929162|26660730|FG000|Overall Study|Protocol Violation|32|||
13352827|NCT00929162|26660731|FG001|Overall Study|Protocol Violation|30|||
13352828|NCT00929162|26660730|FG000|Overall Study|Other termination reason|5|||
13352829|NCT00929162|26660731|FG001|Overall Study|Other termination reason|6|||
13352830|NCT00929110|26660806|FG000|Overall Study|Adverse Event|40|||
13352831|NCT00929110|26660807|FG001|Overall Study|Adverse Event|29|||
13204424|NCT01973231|26228571|FG000|Overall Study|Lost to Follow-up|1|||
13352832|NCT00929110|26660808|FG002|Overall Study|Adverse Event|18|||
13352833|NCT00929110|26660806|FG000|Overall Study|Subject withdrew consent|40|||
13352834|NCT00929110|26660807|FG001|Overall Study|Subject withdrew consent|23|||
13352835|NCT00929110|26660808|FG002|Overall Study|Subject withdrew consent|26|||
13352836|NCT00929110|26660806|FG000|Overall Study|Unsatisfactory therapeutic effect|20|||
13352837|NCT00929110|26660807|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
13352838|NCT00929110|26660808|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
13352839|NCT00929110|26660806|FG000|Overall Study|Lost to Follow-up|7|||
13352840|NCT00929110|26660807|FG001|Overall Study|Lost to Follow-up|7|||
13352841|NCT00929110|26660808|FG002|Overall Study|Lost to Follow-up|3|||
13352842|NCT00929110|26660806|FG000|Overall Study|Protocol deviation|5|||
13204425|NCT01973231|26228572|FG001|Overall Study|Lost to Follow-up|1|||
13204426|NCT01973231|26228571|FG000|Overall Study|unclassified|2|||
13204427|NCT01973231|26228572|FG001|Overall Study|unclassified|1|||
13204428|NCT01973231|26228571|FG000|Overall Study|Withdrawal by Subject|7|||
13204429|NCT01973231|26228572|FG001|Overall Study|Withdrawal by Subject|9|||
13204430|NCT01973218|26228600|FG000|Overall Study|Adverse Event|1|||
13204431|NCT01973218|26228601|FG001|Overall Study|Adverse Event|0|||
13204432|NCT01973218|26228600|FG000|Overall Study|Withdrawal by Subject|1|||
13204433|NCT01973218|26228601|FG001|Overall Study|Withdrawal by Subject|0|||
13204434|NCT01972841|26229048|FG000|Overall Study|Randomized but Never Received Treatment|2|||
13204435|NCT01972841|26229049|FG001|Overall Study|Randomized but Never Received Treatment|5|||
13204436|NCT01972841|26229050|FG002|Overall Study|Randomized but Never Received Treatment|4|||
13204437|NCT01972841|26229051|FG003|Overall Study|Randomized but Never Received Treatment|2|||
13204438|NCT01972841|26229052|FG004|Overall Study|Randomized but Never Received Treatment|6|||
13204439|NCT01972841|26229053|FG005|Overall Study|Randomized but Never Received Treatment|13|||
13352843|NCT00929110|26660807|FG001|Overall Study|Protocol deviation|2|||
13352844|NCT00929110|26660808|FG002|Overall Study|Protocol deviation|4|||
13352845|NCT00929110|26660806|FG000|Overall Study|Administrative problems|4|||
13352846|NCT00929110|26660807|FG001|Overall Study|Administrative problems|1|||
13352847|NCT00929110|26660808|FG002|Overall Study|Administrative problems|2|||
13352848|NCT00929110|26660806|FG000|Overall Study|Death|2|||
13352849|NCT00929110|26660807|FG001|Overall Study|Death|2|||
13352850|NCT00929110|26660808|FG002|Overall Study|Death|2|||
13352851|NCT00929110|26660806|FG000|Overall Study|Abnormal laboratory value(s)|0|||
13352852|NCT00929110|26660807|FG001|Overall Study|Abnormal laboratory value(s)|1|||
13352853|NCT00929110|26660808|FG002|Overall Study|Abnormal laboratory value(s)|0|||
13352854|NCT00929110|26660806|FG000|Overall Study|Abnormal test procedure result(s)|0|||
13352855|NCT00929110|26660807|FG001|Overall Study|Abnormal test procedure result(s)|1|||
13352856|NCT00929110|26660808|FG002|Overall Study|Abnormal test procedure result(s)|1|||
13352857|NCT00929110|26660806|FG000|Overall Study|Patient inability to use the device|0|||
13352858|NCT00929110|26660807|FG001|Overall Study|Patient inability to use the device|1|||
13352859|NCT00929110|26660808|FG002|Overall Study|Patient inability to use the device|0|||
13352860|NCT00928889|26660839|FG000|Overall Study|Lost to Follow-up|3|||
13352861|NCT00928889|26660840|FG001|Overall Study|Lost to Follow-up|1|||
13352862|NCT00928889|26660839|FG000|Overall Study|Protocol Violation|0|||
13352863|NCT00928889|26660840|FG001|Overall Study|Protocol Violation|1|||
13352864|NCT00928889|26660839|FG000|Overall Study|Adverse Event|1|||
13352865|NCT00928889|26660840|FG001|Overall Study|Adverse Event|0|||
13352866|NCT00928889|26660839|FG000|Overall Study|Other|1|||
13352867|NCT00928889|26660840|FG001|Overall Study|Other|0|||
13352868|NCT00928746|26660862|FG000|Overall Study|Adverse Event|2|||
13352869|NCT00928746|26660862|FG000|Overall Study|Protocol Violation|1|||
13352870|NCT00928746|26660862|FG000|Overall Study|Withdrawal by Subject|1|||
13352871|NCT00928746|26660862|FG000|Overall Study|Other|2|||
13352872|NCT00928707|26660881|FG000|Overall Study|Protocol Violation|1|||
13352873|NCT00928707|26660882|FG001|Overall Study|Protocol Violation|0|||
13352874|NCT00928668|26660930|FG000|Overall Study|Adverse Event|1|||
13352875|NCT00928668|26660931|FG001|Overall Study|Adverse Event|0|||
13352876|NCT00928668|26660932|FG002|Overall Study|Adverse Event|0|||
13352877|NCT00928668|26660933|FG003|Overall Study|Adverse Event|0|||
13352878|NCT00928668|26660934|FG004|Overall Study|Adverse Event|0|||
13352879|NCT00928668|26660930|FG000|Overall Study|Protocol Violation|0|||
13352880|NCT00928668|26660931|FG001|Overall Study|Protocol Violation|0|||
13352881|NCT00928668|26660932|FG002|Overall Study|Protocol Violation|0|||
13352882|NCT00928668|26660933|FG003|Overall Study|Protocol Violation|0|||
13352883|NCT00928668|26660934|FG004|Overall Study|Protocol Violation|1|||
13352884|NCT00928668|26660930|FG000|Overall Study|Withdrawal by Subject|0|||
13352885|NCT00928668|26660931|FG001|Overall Study|Withdrawal by Subject|1|||
13352886|NCT00928668|26660932|FG002|Overall Study|Withdrawal by Subject|1|||
13352887|NCT00928668|26660933|FG003|Overall Study|Withdrawal by Subject|0|||
13352888|NCT00928668|26660934|FG004|Overall Study|Withdrawal by Subject|0|||
13352889|NCT00928668|26660930|FG000|Overall Study|Other reasons not listed above|0|||
13352890|NCT00928668|26660931|FG001|Overall Study|Other reasons not listed above|0|||
13352891|NCT00928668|26660932|FG002|Overall Study|Other reasons not listed above|0|||
13352892|NCT00928668|26660933|FG003|Overall Study|Other reasons not listed above|1|||
13352893|NCT00928668|26660934|FG004|Overall Study|Other reasons not listed above|0|||
13352894|NCT00928564|26660949|FG000|Overall Study|Lost to Follow-up|6|||
13352895|NCT00928564|26660950|FG001|Overall Study|Lost to Follow-up|0|||
13352896|NCT00928512|26661067|FG000|Overall Study|Adverse Event|4|||
13352897|NCT00928512|26661068|FG001|Overall Study|Adverse Event|3|||
13352898|NCT00928512|26661069|FG002|Overall Study|Adverse Event|2|||
13352899|NCT00928512|26661070|FG003|Overall Study|Adverse Event|8|||
13352900|NCT00928512|26661071|FG004|Overall Study|Adverse Event|6|||
13352901|NCT00928512|26661067|FG000|Overall Study|Lack of Efficacy|2|||
13352902|NCT00928512|26661068|FG001|Overall Study|Lack of Efficacy|0|||
13352903|NCT00928512|26661069|FG002|Overall Study|Lack of Efficacy|4|||
13352904|NCT00928512|26661070|FG003|Overall Study|Lack of Efficacy|7|||
13352905|NCT00928512|26661071|FG004|Overall Study|Lack of Efficacy|3|||
13352906|NCT00928512|26661067|FG000|Overall Study|Protocol Violation|0|||
13352907|NCT00928512|26661068|FG001|Overall Study|Protocol Violation|1|||
13352908|NCT00928512|26661069|FG002|Overall Study|Protocol Violation|0|||
13352909|NCT00928512|26661070|FG003|Overall Study|Protocol Violation|1|||
13352910|NCT00928512|26661071|FG004|Overall Study|Protocol Violation|3|||
13352911|NCT00928512|26661067|FG000|Overall Study|Withdrawal by Subject|3|||
13352912|NCT00928512|26661068|FG001|Overall Study|Withdrawal by Subject|0|||
13352913|NCT00928512|26661069|FG002|Overall Study|Withdrawal by Subject|3|||
13352914|NCT00928512|26661070|FG003|Overall Study|Withdrawal by Subject|4|||
13352915|NCT00928512|26661071|FG004|Overall Study|Withdrawal by Subject|0|||
13352916|NCT00928512|26661067|FG000|Overall Study|Lost to Follow-up|1|||
13352917|NCT00928512|26661068|FG001|Overall Study|Lost to Follow-up|1|||
13352918|NCT00928512|26661069|FG002|Overall Study|Lost to Follow-up|2|||
13352919|NCT00928512|26661070|FG003|Overall Study|Lost to Follow-up|1|||
13352920|NCT00928512|26661071|FG004|Overall Study|Lost to Follow-up|3|||
13352921|NCT00928512|26661067|FG000|Overall Study|Administrative Problems|0|||
13352922|NCT00928512|26661068|FG001|Overall Study|Administrative Problems|1|||
13352923|NCT00928512|26661069|FG002|Overall Study|Administrative Problems|0|||
13352924|NCT00928512|26661070|FG003|Overall Study|Administrative Problems|0|||
13352925|NCT00928512|26661071|FG004|Overall Study|Administrative Problems|0|||
13352926|NCT00928486|26661079|FG000|Overall Study|Adverse Event|2|||
13352927|NCT00928486|26661079|FG000|Overall Study|Disease Progression|7|||
13352928|NCT00928486|26661079|FG000|Overall Study|Withdrawal by Subject|1|||
13352929|NCT00928434|26661161|FG000|Overall Study|Adverse Event|14|||
13352930|NCT00928434|26661162|FG001|Overall Study|Adverse Event|5|||
13352931|NCT00928434|26661163|FG002|Overall Study|Adverse Event|18|||
13352932|NCT00928434|26661161|FG000|Overall Study|Protocol Violation|5|||
13352933|NCT00928434|26661162|FG001|Overall Study|Protocol Violation|0|||
13352934|NCT00928434|26661163|FG002|Overall Study|Protocol Violation|8|||
13352935|NCT00928434|26661161|FG000|Overall Study|Physician Decision|2|||
13352936|NCT00928434|26661162|FG001|Overall Study|Physician Decision|0|||
13352937|NCT00928434|26661163|FG002|Overall Study|Physician Decision|3|||
13352938|NCT00928434|26661161|FG000|Overall Study|Lost to Follow-up|1|||
13352939|NCT00928434|26661162|FG001|Overall Study|Lost to Follow-up|0|||
13352940|NCT00928434|26661163|FG002|Overall Study|Lost to Follow-up|3|||
13352941|NCT00928434|26661161|FG000|Overall Study|Withdrawal by Subject|5|||
13352942|NCT00928434|26661162|FG001|Overall Study|Withdrawal by Subject|3|||
13352943|NCT00928434|26661163|FG002|Overall Study|Withdrawal by Subject|2|||
13352944|NCT00928434|26661161|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10|||
13352945|NCT00928434|26661162|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4|||
13352946|NCT00928434|26661163|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7|||
13352947|NCT00928434|26661161|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2|||
13352948|NCT00928434|26661162|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
13352949|NCT00928434|26661163|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
13352950|NCT00928434|26661161|FG000|Overall Study|Other (not meeting above criteria)|5|||
13352951|NCT00928434|26661162|FG001|Overall Study|Other (not meeting above criteria)|1|||
13352952|NCT00928434|26661163|FG002|Overall Study|Other (not meeting above criteria)|2|||
13352953|NCT00928408|26661194|FG000|Overall Study|Other|2|||
13352954|NCT00928408|26661194|FG000|Overall Study|Withdrawal by Subject|4|||
13352955|NCT00928408|26661194|FG000|Overall Study|Death|5|||
13352956|NCT00928408|26661194|FG000|Overall Study|Lost to Follow-up|12|||
13352957|NCT00928252|26661202|FG000|Overall Study|Physician Decision|3|||
13352958|NCT00928187|26661256|FG000|Overall Study|Death|1|||
13352959|NCT00928187|26661257|FG001|Overall Study|Death|2|||
13352960|NCT00928187|26661258|FG002|Overall Study|Death|3|||
13352961|NCT00928187|26661256|FG000|Overall Study|Lost to Follow-up|1|||
13352962|NCT00928187|26661257|FG001|Overall Study|Lost to Follow-up|2|||
13352963|NCT00928187|26661258|FG002|Overall Study|Lost to Follow-up|1|||
13352964|NCT00928187|26661256|FG000|Overall Study|Withdrawal by Subject|0|||
13352965|NCT00928187|26661257|FG001|Overall Study|Withdrawal by Subject|1|||
13352966|NCT00928187|26661258|FG002|Overall Study|Withdrawal by Subject|1|||
13352967|NCT00928187|26661256|FG000|Overall Study|Protocol Violation|0|||
13352968|NCT00928187|26661257|FG001|Overall Study|Protocol Violation|1|||
13352969|NCT00928187|26661258|FG002|Overall Study|Protocol Violation|0|||
13352970|NCT00928135|26661275|FG000|Overall Study|Withdrawal by Subject|1|||
13352971|NCT00928135|26661276|FG001|Overall Study|Withdrawal by Subject|0|||
13352972|NCT00928070|26661339|FG000|Overall Study|Lost to Follow-up|1|||
13352973|NCT00928070|26661340|FG001|Overall Study|Lost to Follow-up|2|||
13352974|NCT00928070|26661339|FG000|Overall Study|Withdrawal by Subject|10|||
13352975|NCT00928070|26661340|FG001|Overall Study|Withdrawal by Subject|3|||
13352976|NCT00928070|26661339|FG000|Overall Study|Adverse Event|14|||
13352977|NCT00928070|26661340|FG001|Overall Study|Adverse Event|26|||
13352978|NCT00928070|26661339|FG000|Overall Study|Lack of Efficacy|9|||
13352979|NCT00928070|26661340|FG001|Overall Study|Lack of Efficacy|5|||
13352980|NCT00928070|26661339|FG000|Overall Study|Did not meet entrance criteria|16|||
13352981|NCT00928070|26661340|FG001|Overall Study|Did not meet entrance criteria|9|||
13352982|NCT00928070|26661339|FG000|Overall Study|Protocol Violation|6|||
13352983|NCT00928070|26661340|FG001|Overall Study|Protocol Violation|5|||
13352984|NCT00928070|26661339|FG000|Overall Study|Randomized but not treated|2|||
13352985|NCT00928070|26661340|FG001|Overall Study|Randomized but not treated|2|||
13352986|NCT00928070|26661339|FG000|Overall Study|Other|5|||
13352987|NCT00928070|26661340|FG001|Overall Study|Other|5|||
13352988|NCT00928057|26661370|FG000|Overall Study|Adverse Event|1|||
13352989|NCT00928057|26661371|FG001|Overall Study|Adverse Event|2|||
13352990|NCT00928057|26661370|FG000|Overall Study|Withdrawal by Subject|1|||
13352991|NCT00928057|26661371|FG001|Overall Study|Withdrawal by Subject|0|||
13352992|NCT00928057|26661370|FG000|Overall Study|Lost to Follow-up|0|||
13352993|NCT00928057|26661371|FG001|Overall Study|Lost to Follow-up|1|||
13352994|NCT00928057|26661370|FG000|Overall Study|Protocol Violation|0|||
13352995|NCT00928057|26661371|FG001|Overall Study|Protocol Violation|1|||
13352996|NCT00928018|26661396|FG000|Overall Study|Withdrawal by Subject|1|||
13352997|NCT00928018|26661397|FG001|Overall Study|Withdrawal by Subject|0|||
13352998|NCT00927953|26661418|FG000|Overall Study|Death|2|||
13352999|NCT00927953|26661419|FG001|Overall Study|Death|1|||
13353000|NCT00927940|26661426|FG000|Overall Study|Death|1|||
13353001|NCT00927927|26661519|FG000|Overall Study|Withdrawal by Subject|0|||
13353002|NCT00927927|26661520|FG001|Overall Study|Withdrawal by Subject|0|||
13353003|NCT00927927|26661521|FG002|Overall Study|Withdrawal by Subject|0|||
13353004|NCT00927927|26661522|FG003|Overall Study|Withdrawal by Subject|0|||
13353005|NCT00927927|26661523|FG004|Overall Study|Withdrawal by Subject|0|||
13353006|NCT00927927|26661524|FG005|Overall Study|Withdrawal by Subject|0|||
13353007|NCT00927927|26661525|FG006|Overall Study|Withdrawal by Subject|0|||
13353008|NCT00927927|26661526|FG007|Overall Study|Withdrawal by Subject|2|||
13353009|NCT00927927|26661527|FG008|Overall Study|Withdrawal by Subject|0|||
13353010|NCT00927927|26661528|FG009|Overall Study|Withdrawal by Subject|0|||
13353011|NCT00927927|26661529|FG010|Overall Study|Withdrawal by Subject|0|||
13353012|NCT00927927|26661530|FG011|Overall Study|Withdrawal by Subject|2|||
13353013|NCT00927927|26661531|FG012|Overall Study|Withdrawal by Subject|0|||
13353014|NCT00927927|26661532|FG013|Overall Study|Withdrawal by Subject|0|||
13353015|NCT00927927|26661533|FG014|Overall Study|Withdrawal by Subject|0|||
13353016|NCT00927901|26661566|FG000|Treatment Period 1|Subject withdrew consent|0|||
13353017|NCT00927901|26661567|FG001|Treatment Period 1|Subject withdrew consent|0|||
13353018|NCT00927901|26661568|FG002|Treatment Period 1|Subject withdrew consent|1|||
13353019|NCT00927901|26661569|FG003|Treatment Period 1|Subject withdrew consent|0|||
13353020|NCT00927901|26661566|FG000|Treatment Period 4|Adverse Event|0|||
13353021|NCT00927901|26661567|FG001|Treatment Period 4|Adverse Event|0|||
13353022|NCT00927901|26661568|FG002|Treatment Period 4|Adverse Event|0|||
13353023|NCT00927901|26661569|FG003|Treatment Period 4|Adverse Event|1|||
13353024|NCT00927901|26661566|FG000|Treatment Period 4|Subject withdrew consent|0|||
13353025|NCT00927901|26661567|FG001|Treatment Period 4|Subject withdrew consent|0|||
13353026|NCT00927901|26661568|FG002|Treatment Period 4|Subject withdrew consent|1|||
13353027|NCT00927901|26661569|FG003|Treatment Period 4|Subject withdrew consent|0|||
13353028|NCT00927862|26661598|FG000|Overall Study|Missing data needed for endpt analyses|27|||
13353029|NCT00927862|26661599|FG001|Overall Study|Missing data needed for endpt analyses|45|||
13353030|NCT00927823|26661668|FG000|Continuous Dosing Period|Death|0|||
13353031|NCT00927823|26661669|FG001|Continuous Dosing Period|Death|0|||
13353032|NCT00927823|26661670|FG002|Continuous Dosing Period|Death|6|||
13353033|NCT00927823|26661671|FG003|Continuous Dosing Period|Death|0|||
13353034|NCT00927823|26661668|FG000|Continuous Dosing Period|Lost to Follow-up|1|||
13353035|NCT00927823|26661669|FG001|Continuous Dosing Period|Lost to Follow-up|1|||
13353036|NCT00927823|26661670|FG002|Continuous Dosing Period|Lost to Follow-up|9|||
13353037|NCT00927823|26661671|FG003|Continuous Dosing Period|Lost to Follow-up|0|||
13353038|NCT00927823|26661668|FG000|Continuous Dosing Period|Withdrawal by Subject|1|||
13353039|NCT00927823|26661669|FG001|Continuous Dosing Period|Withdrawal by Subject|0|||
13353040|NCT00927823|26661670|FG002|Continuous Dosing Period|Withdrawal by Subject|2|||
13353041|NCT00927823|26661671|FG003|Continuous Dosing Period|Withdrawal by Subject|2|||
13353042|NCT00927823|26661668|FG000|Continuous Dosing Period|Other|1|||
13353043|NCT00927823|26661669|FG001|Continuous Dosing Period|Other|2|||
13353044|NCT00927823|26661670|FG002|Continuous Dosing Period|Other|9|||
13353045|NCT00927823|26661671|FG003|Continuous Dosing Period|Other|3|||
13353046|NCT00927810|26661711|FG000|Overall Study|Withdrawal by Subject|0|||
13353047|NCT00927810|26661712|FG001|Overall Study|Withdrawal by Subject|3|||
13353048|NCT00927810|26661713|FG002|Overall Study|Withdrawal by Subject|0|||
13353049|NCT00927810|26661714|FG003|Overall Study|Withdrawal by Subject|1|||
13353050|NCT00927810|26661711|FG000|Overall Study|Lost to Follow-up|0|||
13353051|NCT00927810|26661712|FG001|Overall Study|Lost to Follow-up|2|||
13353052|NCT00927810|26661713|FG002|Overall Study|Lost to Follow-up|1|||
13353053|NCT00927810|26661714|FG003|Overall Study|Lost to Follow-up|1|||
13353054|NCT00927810|26661711|FG000|Overall Study|Death|0|||
13353055|NCT00927810|26661712|FG001|Overall Study|Death|2|||
13353056|NCT00927810|26661713|FG002|Overall Study|Death|0|||
13353057|NCT00927810|26661714|FG003|Overall Study|Death|0|||
13353058|NCT00927810|26661711|FG000|Overall Study|Abnormal laboratory value(s)|0|||
13353059|NCT00927810|26661712|FG001|Overall Study|Abnormal laboratory value(s)|1|||
13353060|NCT00927810|26661713|FG002|Overall Study|Abnormal laboratory value(s)|0|||
13353061|NCT00927810|26661714|FG003|Overall Study|Abnormal laboratory value(s)|0|||
13353062|NCT00927784|26661751|FG000|Overall Study|Death|1|||
13353063|NCT00927784|26661752|FG001|Overall Study|Death|0|||
13353064|NCT00927784|26661751|FG000|Overall Study|Withdrawal by Subject|1|||
13353065|NCT00927784|26661752|FG001|Overall Study|Withdrawal by Subject|0|||
13353066|NCT00927758|26661767|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
13353067|NCT00927758|26661768|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
13353068|NCT00927758|26661769|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
13353069|NCT00927758|26661770|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
13353070|NCT00927758|26661771|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
13353071|NCT00927758|26661772|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
13353072|NCT00927758|26661767|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
13353073|NCT00927758|26661768|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
13353074|NCT00927758|26661769|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
13353075|NCT00927758|26661770|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
13353076|NCT00927758|26661771|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
13353077|NCT00927758|26661772|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
13353078|NCT00927589|26661796|FG000|Overall Study|Death|1|||
13353079|NCT00927589|26661796|FG000|Overall Study|Physician Decision|1|||
13353080|NCT00927589|26661796|FG000|Overall Study|Withdrawal by Subject|3|||
13353081|NCT00927589|26661796|FG000|Overall Study|Adverse Event|2|||
13353082|NCT00927589|26661796|FG000|Overall Study|Disease Progression|8|||
13353083|NCT00927589|26661796|FG000|Overall Study|Non-compliance|1|||
13353084|NCT00927563|26661804|FG000|Overall Study|Lost to Follow-up|1|||
13353085|NCT00927563|26661804|FG000|Overall Study|Withdrawal by Subject|1|||
13353086|NCT00927485|26661819|FG000|Overall Study|Adverse Event|4|||
13353087|NCT00927485|26661820|FG001|Overall Study|Adverse Event|2|||
13353088|NCT00927485|26661819|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2|||
13353089|NCT00927485|26661820|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2|||
13353090|NCT00927472|26661851|FG000|Overall Study|Withdrawal by Subject|10|||
13353091|NCT00927472|26661852|FG001|Overall Study|Withdrawal by Subject|11|||
13353092|NCT00927472|26661851|FG000|Overall Study|Lost to Follow-up|1|||
13353093|NCT00927472|26661852|FG001|Overall Study|Lost to Follow-up|6|||
13353094|NCT00927472|26661851|FG000|Overall Study|Protocol Violation|0|||
13353095|NCT00927472|26661852|FG001|Overall Study|Protocol Violation|1|||
13353096|NCT00927472|26661851|FG000|Overall Study|Post treatment Assessment out of window|0|||
13353097|NCT00927472|26661852|FG001|Overall Study|Post treatment Assessment out of window|4|||
13353098|NCT00927394|26661887|FG000|Overall Study|Adverse Event|14|||
13353099|NCT00927394|26661888|FG001|Overall Study|Adverse Event|9|||
13353100|NCT00927394|26661887|FG000|Overall Study|Unsatisfactory therapeutic effect|17|||
13353101|NCT00927394|26661888|FG001|Overall Study|Unsatisfactory therapeutic effect|23|||
13353102|NCT00927394|26661887|FG000|Overall Study|Withdrawal by Subject|20|||
13353103|NCT00927394|26661888|FG001|Overall Study|Withdrawal by Subject|24|||
13353104|NCT00927394|26661887|FG000|Overall Study|Lost to Follow-up|8|||
13353105|NCT00927394|26661888|FG001|Overall Study|Lost to Follow-up|14|||
13353106|NCT00927394|26661887|FG000|Overall Study|Administrative Problem|1|||
13353107|NCT00927394|26661888|FG001|Overall Study|Administrative Problem|0|||
13353108|NCT00927394|26661887|FG000|Overall Study|Death|1|||
13353109|NCT00927394|26661888|FG001|Overall Study|Death|1|||
13353110|NCT00927394|26661887|FG000|Overall Study|Protocol deviation|16|||
13353111|NCT00927394|26661888|FG001|Overall Study|Protocol deviation|13|||
13353112|NCT00927394|26661887|FG000|Overall Study|Randomized in error|0|||
13353113|NCT00927394|26661888|FG001|Overall Study|Randomized in error|1|||
13353114|NCT00927368|26661915|FG000|Overall Study|enrollment in another study|1|||
13353115|NCT00927368|26661916|FG001|Overall Study|enrollment in another study|1|||
13353116|NCT00927368|26661917|FG002|Overall Study|enrollment in another study|2|||
13353117|NCT00927368|26661915|FG000|Overall Study|Lost to Follow-up|4|||
13353118|NCT00927368|26661916|FG001|Overall Study|Lost to Follow-up|0|||
13353119|NCT00927368|26661917|FG002|Overall Study|Lost to Follow-up|0|||
13353120|NCT00927368|26661915|FG000|Overall Study|equipment failure|1|||
13353121|NCT00927368|26661916|FG001|Overall Study|equipment failure|0|||
13353122|NCT00927368|26661917|FG002|Overall Study|equipment failure|0|||
13353123|NCT00927368|26661915|FG000|Overall Study|ineligible post randomization|0|||
13353124|NCT00927368|26661916|FG001|Overall Study|ineligible post randomization|3|||
13353125|NCT00927368|26661917|FG002|Overall Study|ineligible post randomization|1|||
13353126|NCT00927368|26661915|FG000|Overall Study|cancellation of surgery|0|||
13353127|NCT00927368|26661916|FG001|Overall Study|cancellation of surgery|1|||
13353128|NCT00927368|26661917|FG002|Overall Study|cancellation of surgery|2|||
13353129|NCT00927355|26661942|FG000|Overall Study|Adverse Event|1|||
13353130|NCT00927355|26661943|FG001|Overall Study|Adverse Event|1|||
13353131|NCT00927251|26661949|FG000|Overall Study|Patients not implanted with 4296 lead|8|||
13353132|NCT00927186|26662072|FG000|12 Months Primary Study|Adverse Event|5|||
13353133|NCT00927186|26662073|FG001|12 Months Primary Study|Adverse Event|2|||
13353134|NCT00927186|26662072|FG000|12 Months Primary Study|Lost to Follow-up|1|||
13353135|NCT00927186|26662073|FG001|12 Months Primary Study|Lost to Follow-up|0|||
13353136|NCT00927186|26662072|FG000|12 Months Primary Study|Protocol Violation|0|||
13353137|NCT00927186|26662073|FG001|12 Months Primary Study|Protocol Violation|1|||
13353138|NCT00927186|26662072|FG000|12 Months Primary Study|Withdrawal by Subject|1|||
13353139|NCT00927186|26662073|FG001|12 Months Primary Study|Withdrawal by Subject|1|||
13353140|NCT00927095|26662091|FG000|Overall Study|Adverse Event|3|||
13353141|NCT00927095|26662092|FG001|Overall Study|Adverse Event|1|||
13353142|NCT00927095|26662093|FG002|Overall Study|Adverse Event|0|||
13353143|NCT00927095|26662091|FG000|Overall Study|Withdrawal by Subject|2|||
13353144|NCT00927095|26662092|FG001|Overall Study|Withdrawal by Subject|1|||
13353145|NCT00927095|26662093|FG002|Overall Study|Withdrawal by Subject|1|||
13353146|NCT00927095|26662091|FG000|Overall Study|Physician Decision|1|||
13353147|NCT00927095|26662092|FG001|Overall Study|Physician Decision|2|||
13353148|NCT00927095|26662093|FG002|Overall Study|Physician Decision|1|||
13353149|NCT00927082|26662168|FG000|Overall Study|Lost to Follow-up|9|||
13353150|NCT00927082|26662169|FG001|Overall Study|Lost to Follow-up|8|||
13353151|NCT00927082|26662170|FG002|Overall Study|Lost to Follow-up|12|||
13353152|NCT00927082|26662171|FG003|Overall Study|Lost to Follow-up|16|||
13353153|NCT00927082|26662168|FG000|Overall Study|Withdrawal by Subject|3|||
13353154|NCT00927082|26662169|FG001|Overall Study|Withdrawal by Subject|2|||
13353155|NCT00927082|26662170|FG002|Overall Study|Withdrawal by Subject|7|||
13353156|NCT00927082|26662171|FG003|Overall Study|Withdrawal by Subject|2|||
13353157|NCT00927082|26662168|FG000|Overall Study|Death|0|||
13353158|NCT00927082|26662169|FG001|Overall Study|Death|0|||
13353159|NCT00927082|26662170|FG002|Overall Study|Death|1|||
13353160|NCT00927082|26662171|FG003|Overall Study|Death|0|||
13353161|NCT00927082|26662168|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0|||
13353162|NCT00927082|26662169|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0|||
13353163|NCT00927082|26662170|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2|||
13353164|NCT00927082|26662171|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1|||
13353165|NCT00927069|26662190|FG000|Week 0 to Week 12|Worsening of psoriasis|1|||
13353166|NCT00927069|26662191|FG001|Week 0 to Week 12|Worsening of psoriasis|1|||
13353167|NCT00927069|26662192|FG002|Week 0 to Week 12|Worsening of psoriasis|0|||
13353168|NCT00927069|26662193|FG003|Week 0 to Week 12|Worsening of psoriasis|0|||
13353169|NCT00927069|26662190|FG000|Week 12 to Week 24|Lack of Efficacy|0|||
13353170|NCT00927069|26662191|FG001|Week 12 to Week 24|Lack of Efficacy|0|||
13353171|NCT00927069|26662192|FG002|Week 12 to Week 24|Lack of Efficacy|2|||
13353172|NCT00927069|26662193|FG003|Week 12 to Week 24|Lack of Efficacy|3|||
13353173|NCT00927069|26662190|FG000|Week 12 to Week 24|Lost to Follow-up|0|||
13353174|NCT00927069|26662191|FG001|Week 12 to Week 24|Lost to Follow-up|0|||
13353175|NCT00927069|26662192|FG002|Week 12 to Week 24|Lost to Follow-up|1|||
13353176|NCT00927069|26662193|FG003|Week 12 to Week 24|Lost to Follow-up|0|||
13353177|NCT00927069|26662190|FG000|Week 12 to Week 24|Withdrawal by Subject|1|||
13353178|NCT00927069|26662191|FG001|Week 12 to Week 24|Withdrawal by Subject|0|||
13353179|NCT00927069|26662192|FG002|Week 12 to Week 24|Withdrawal by Subject|0|||
13353180|NCT00927069|26662193|FG003|Week 12 to Week 24|Withdrawal by Subject|0|||
13353181|NCT00927069|26662190|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1|||
13353182|NCT00927069|26662191|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0|||
13353183|NCT00927069|26662192|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0|||
13353184|NCT00927069|26662193|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0|||
13353185|NCT00926796|26662219|FG000|Overall Study|Did not receive randomized treatment|4|||
13353186|NCT00926796|26662220|FG001|Overall Study|Did not receive randomized treatment|7|||
13353187|NCT00926796|26662219|FG000|Overall Study|Ineligible, negative for gonorrhea|57|||
13353188|NCT00926796|26662220|FG001|Overall Study|Ineligible, negative for gonorrhea|60|||
13353189|NCT00926796|26662219|FG000|Overall Study|Ineligible, but positive for gonorrhea|1|||
13353190|NCT00926796|26662220|FG001|Overall Study|Ineligible, but positive for gonorrhea|1|||
13353191|NCT00926796|26662219|FG000|Overall Study|Adverse Event|7|||
13353192|NCT00926796|26662220|FG001|Overall Study|Adverse Event|14|||
13353193|NCT00926796|26662219|FG000|Overall Study|Lost to Follow-up|22|||
13353194|NCT00926796|26662220|FG001|Overall Study|Lost to Follow-up|13|||
13353195|NCT00926796|26662219|FG000|Overall Study|Protocol Violation|15|||
13353196|NCT00926796|26662220|FG001|Overall Study|Protocol Violation|11|||
13353197|NCT00926796|26662219|FG000|Overall Study|Withdrawal by Subject|1|||
13353198|NCT00926796|26662220|FG001|Overall Study|Withdrawal by Subject|0|||
13353199|NCT00926783|26662243|FG000|Overall Study|Incomplete CFAE Procedures|3|||
13353200|NCT00926783|26662244|FG001|Overall Study|Incomplete CFAE Procedures|3|||
13353201|NCT00926575|26662261|FG000|Overall Study|Adverse Event|1|||
13353202|NCT00926575|26662262|FG001|Overall Study|Adverse Event|1|||
13353203|NCT00926575|26662261|FG000|Overall Study|Death|4|||
13353204|NCT00926575|26662262|FG001|Overall Study|Death|4|||
13353205|NCT00926575|26662261|FG000|Overall Study|Lost to Follow-up|1|||
13353206|NCT00926575|26662262|FG001|Overall Study|Lost to Follow-up|1|||
13353207|NCT00926575|26662261|FG000|Overall Study|Physician Decision|1|||
13353208|NCT00926575|26662262|FG001|Overall Study|Physician Decision|2|||
13353209|NCT00926575|26662261|FG000|Overall Study|Protocol Violation|1|||
13353210|NCT00926575|26662262|FG001|Overall Study|Protocol Violation|0|||
13353211|NCT00926575|26662261|FG000|Overall Study|Withdrawal by Subject|8|||
13353212|NCT00926575|26662262|FG001|Overall Study|Withdrawal by Subject|9|||
13353213|NCT00926536|26662277|FG000|Overall Study|Physician Decision|1|||
13353214|NCT00926536|26662278|FG001|Overall Study|Physician Decision|2|||
13353215|NCT00926393|26662315|FG000|Overall Study|Withdrawal by Subject|1|||
13353216|NCT00926393|26662316|FG001|Overall Study|Withdrawal by Subject|2|||
13353217|NCT00926393|26662315|FG000|Overall Study|Adverse Event|1|||
13353218|NCT00926393|26662316|FG001|Overall Study|Adverse Event|1|||
13353219|NCT00926367|26662363|FG000|Overall Study|Withdrawal by Subject|0|||
13353220|NCT00926367|26662364|FG001|Overall Study|Withdrawal by Subject|1|||
13353221|NCT00926367|26662363|FG000|Overall Study|Lost to Follow-up|1|||
13353222|NCT00926367|26662364|FG001|Overall Study|Lost to Follow-up|0|||
13353223|NCT00926367|26662363|FG000|Overall Study|Skin Irritation|1|||
13353224|NCT00926367|26662364|FG001|Overall Study|Skin Irritation|2|||
13353225|NCT00926328|26662379|FG000|Overall Study|Lost to Follow-up|12|||
13353226|NCT00926328|26662380|FG001|Overall Study|Lost to Follow-up|14|||
13353227|NCT00926289|26662421|FG000|Overall Study|Adverse Event|9|||
13353228|NCT00926289|26662422|FG001|Overall Study|Adverse Event|11|||
13353229|NCT00926289|26662421|FG000|Overall Study|Protocol Violation|8|||
13353230|NCT00926289|26662422|FG001|Overall Study|Protocol Violation|12|||
13353231|NCT00926289|26662421|FG000|Overall Study|Lost to Follow-up|3|||
13353232|NCT00926289|26662422|FG001|Overall Study|Lost to Follow-up|6|||
13353233|NCT00926289|26662421|FG000|Overall Study|Withdrawal by Subject|4|||
13353234|NCT00926289|26662422|FG001|Overall Study|Withdrawal by Subject|4|||
13353235|NCT00926289|26662421|FG000|Overall Study|Other|1|||
13353236|NCT00926289|26662422|FG001|Overall Study|Other|3|||
13353237|NCT00926237|26662435|FG000|Overall Study|Withdrawal by Subject|2|||
13353238|NCT00926237|26662436|FG001|Overall Study|Withdrawal by Subject|1|||
13353239|NCT00926211|26662445|FG000|Overall Study|Lost to Follow-up|1|||
13353240|NCT00926029|26662466|FG000|Overall Study|Lost to Follow-up|2|||
13353241|NCT00926029|26662467|FG001|Overall Study|Lost to Follow-up|1|||
13353242|NCT00926029|26662468|FG002|Overall Study|Lost to Follow-up|1|||
13353243|NCT00926003|26662489|FG000|Post-Training Evaluation|Withdrawal by Subject|1|||
13353244|NCT00926003|26662490|FG001|Post-Training Evaluation|Withdrawal by Subject|0|||
13353245|NCT00926003|26662491|FG002|Post-Training Evaluation|Withdrawal by Subject|0|||
13353246|NCT00926003|26662489|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1|||
13353247|NCT00926003|26662490|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
13353248|NCT00926003|26662491|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
13353249|NCT00925990|26662506|FG000|Overall Study|Adverse Event|1|||
13353250|NCT00925990|26662507|FG001|Overall Study|Adverse Event|3|||
13353251|NCT00925990|26662506|FG000|Overall Study|Withdrawal by Subject|2|||
13353252|NCT00925990|26662507|FG001|Overall Study|Withdrawal by Subject|2|||
13353253|NCT00925990|26662506|FG000|Overall Study|Lost to Follow-up|1|||
13353254|NCT00925990|26662507|FG001|Overall Study|Lost to Follow-up|3|||
13353255|NCT00925990|26662506|FG000|Overall Study|Physician Decision|1|||
13353256|NCT00925990|26662507|FG001|Overall Study|Physician Decision|1|||
13353257|NCT00925990|26662506|FG000|Overall Study|moved out of state, missed medication|0|||
13353258|NCT00925990|26662507|FG001|Overall Study|moved out of state, missed medication|2|||
13353259|NCT00925899|26662532|FG000|Part 1|Death|1|||
13353260|NCT00925899|26662533|FG001|Part 1|Death|2|||
13353261|NCT00925899|26662532|FG000|Part 1|Withdrawal by Subject|10|||
13353262|NCT00925899|26662533|FG001|Part 1|Withdrawal by Subject|9|||
13353263|NCT00925769|26662602|FG000|Overall Study|Major toxicity|1|||
13353264|NCT00925769|26662603|FG001|Overall Study|Major toxicity|0|||
13353265|NCT00925769|26662604|FG002|Overall Study|Major toxicity|1|||
13353266|NCT00925769|26662605|FG003|Overall Study|Major toxicity|1|||
13353267|NCT00925769|26662606|FG004|Overall Study|Major toxicity|0|||
13353268|NCT00925769|26662607|FG005|Overall Study|Major toxicity|0|||
13353269|NCT00925769|26662602|FG000|Overall Study|Disease progression|4|||
13353270|NCT00925769|26662603|FG001|Overall Study|Disease progression|5|||
13204440|NCT01972841|26229048|FG000|Overall Study|Adverse Event|13|||
13353271|NCT00925769|26662604|FG002|Overall Study|Disease progression|3|||
13353272|NCT00925769|26662605|FG003|Overall Study|Disease progression|4|||
13353273|NCT00925769|26662606|FG004|Overall Study|Disease progression|2|||
13353274|NCT00925769|26662607|FG005|Overall Study|Disease progression|3|||
13353275|NCT00925769|26662602|FG000|Overall Study|Death|0|||
13353276|NCT00925769|26662603|FG001|Overall Study|Death|0|||
13353277|NCT00925769|26662604|FG002|Overall Study|Death|1|||
13353278|NCT00925769|26662605|FG003|Overall Study|Death|0|||
13353279|NCT00925769|26662606|FG004|Overall Study|Death|0|||
13353280|NCT00925769|26662607|FG005|Overall Study|Death|0|||
13353281|NCT00925769|26662602|FG000|Overall Study|Physician Decision|1|||
13353282|NCT00925769|26662603|FG001|Overall Study|Physician Decision|0|||
13353283|NCT00925769|26662604|FG002|Overall Study|Physician Decision|0|||
13353284|NCT00925769|26662605|FG003|Overall Study|Physician Decision|0|||
13353285|NCT00925769|26662606|FG004|Overall Study|Physician Decision|0|||
13353286|NCT00925769|26662607|FG005|Overall Study|Physician Decision|0|||
13353287|NCT00925769|26662602|FG000|Overall Study|Missing documentation|0|||
13353288|NCT00925769|26662603|FG001|Overall Study|Missing documentation|1|||
13353289|NCT00925769|26662604|FG002|Overall Study|Missing documentation|0|||
13353290|NCT00925769|26662605|FG003|Overall Study|Missing documentation|0|||
13353291|NCT00925769|26662606|FG004|Overall Study|Missing documentation|0|||
13353292|NCT00925769|26662607|FG005|Overall Study|Missing documentation|0|||
13353293|NCT00925769|26662602|FG000|Overall Study|End of study visit not done|0|||
13353294|NCT00925769|26662603|FG001|Overall Study|End of study visit not done|0|||
13353295|NCT00925769|26662604|FG002|Overall Study|End of study visit not done|1|||
13353296|NCT00925769|26662605|FG003|Overall Study|End of study visit not done|0|||
13353297|NCT00925769|26662606|FG004|Overall Study|End of study visit not done|0|||
13353298|NCT00925769|26662607|FG005|Overall Study|End of study visit not done|0|||
13353299|NCT00925769|26662602|FG000|Overall Study|Participant is unable to swallow drug|0|||
13353300|NCT00925769|26662603|FG001|Overall Study|Participant is unable to swallow drug|0|||
13353301|NCT00925769|26662604|FG002|Overall Study|Participant is unable to swallow drug|0|||
13353302|NCT00925769|26662605|FG003|Overall Study|Participant is unable to swallow drug|1|||
13353303|NCT00925769|26662606|FG004|Overall Study|Participant is unable to swallow drug|0|||
13353304|NCT00925769|26662607|FG005|Overall Study|Participant is unable to swallow drug|0|||
13353305|NCT00925769|26662602|FG000|Overall Study|Adverse Event|0|||
13353306|NCT00925769|26662603|FG001|Overall Study|Adverse Event|0|||
13353307|NCT00925769|26662604|FG002|Overall Study|Adverse Event|0|||
13353308|NCT00925769|26662605|FG003|Overall Study|Adverse Event|0|||
13353309|NCT00925769|26662606|FG004|Overall Study|Adverse Event|1|||
13353310|NCT00925769|26662607|FG005|Overall Study|Adverse Event|0|||
13353311|NCT00925704|26662637|FG000|First Intervention|Withdrew consent|0|||
13353312|NCT00925704|26662638|FG001|First Intervention|Withdrew consent|0|||
13353313|NCT00925704|26662639|FG002|First Intervention|Withdrew consent|0|||
13353314|NCT00925704|26662640|FG003|First Intervention|Withdrew consent|1|||
13353315|NCT00925704|26662641|FG004|First Intervention|Withdrew consent|1|||
13353316|NCT00925704|26662642|FG005|First Intervention|Withdrew consent|0|||
13353317|NCT00925704|26662637|FG000|Second Intervention|Withdrawal by Subject|1|||
13353318|NCT00925704|26662638|FG001|Second Intervention|Withdrawal by Subject|0|||
13353319|NCT00925704|26662639|FG002|Second Intervention|Withdrawal by Subject|0|||
13353320|NCT00925704|26662640|FG003|Second Intervention|Withdrawal by Subject|0|||
13353321|NCT00925704|26662641|FG004|Second Intervention|Withdrawal by Subject|1|||
13353322|NCT00925704|26662642|FG005|Second Intervention|Withdrawal by Subject|0|||
13353323|NCT00925704|26662637|FG000|Third Intervention|Withdrew consent|0|||
13353324|NCT00925704|26662638|FG001|Third Intervention|Withdrew consent|0|||
13353325|NCT00925704|26662639|FG002|Third Intervention|Withdrew consent|0|||
13353326|NCT00925704|26662640|FG003|Third Intervention|Withdrew consent|0|||
13353327|NCT00925704|26662641|FG004|Third Intervention|Withdrew consent|0|||
13353328|NCT00925704|26662642|FG005|Third Intervention|Withdrew consent|1|||
13353329|NCT00925600|26662669|FG000|Overall Study|Withdrawal by Subject|16|||
13353330|NCT00925600|26662670|FG001|Overall Study|Withdrawal by Subject|14|||
13353331|NCT00925600|26662669|FG000|Overall Study|Death|4|||
13353332|NCT00925600|26662670|FG001|Overall Study|Death|3|||
13353333|NCT00925600|26662669|FG000|Overall Study|Lost to Follow-up|2|||
13353334|NCT00925600|26662670|FG001|Overall Study|Lost to Follow-up|2|||
13353335|NCT00925600|26662669|FG000|Overall Study|Disease Progression|1|||
13353336|NCT00925600|26662670|FG001|Overall Study|Disease Progression|3|||
13353337|NCT00925600|26662669|FG000|Overall Study|Administrative Decision|1|||
13353338|NCT00925600|26662670|FG001|Overall Study|Administrative Decision|1|||
13353339|NCT00925600|26662669|FG000|Overall Study|Noncompliance|2|||
13353340|NCT00925600|26662670|FG001|Overall Study|Noncompliance|0|||
13353341|NCT00925600|26662669|FG000|Overall Study|Ineligibility Determined|2|||
13353342|NCT00925600|26662670|FG001|Overall Study|Ineligibility Determined|0|||
13353343|NCT00925600|26662669|FG000|Overall Study|Protocol Deviation|0|||
13353344|NCT00925600|26662670|FG001|Overall Study|Protocol Deviation|1|||
13353345|NCT00925600|26662669|FG000|Overall Study|Requirement for Alternative Therapy|0|||
13353346|NCT00925600|26662670|FG001|Overall Study|Requirement for Alternative Therapy|1|||
13353347|NCT00925600|26662669|FG000|Overall Study|Other|3|||
13353348|NCT00925600|26662670|FG001|Overall Study|Other|1|||
13353349|NCT00925600|26662669|FG000|Overall Study|Adverse Event|1|||
13353350|NCT00925600|26662670|FG001|Overall Study|Adverse Event|2|||
13353351|NCT00925587|26662789|FG000|Overall Study|Protocol Specified Criteria|6|||
13353352|NCT00925587|26662790|FG001|Overall Study|Protocol Specified Criteria|6|||
13353353|NCT00925587|26662789|FG000|Overall Study|Physician Decision|4|||
13353354|NCT00925587|26662790|FG001|Overall Study|Physician Decision|1|||
13353355|NCT00925587|26662789|FG000|Overall Study|Protocol Violation|6|||
13353356|NCT00925587|26662790|FG001|Overall Study|Protocol Violation|4|||
13353357|NCT00925587|26662789|FG000|Overall Study|Withdrawal by Subject|9|||
13353358|NCT00925587|26662790|FG001|Overall Study|Withdrawal by Subject|6|||
13353359|NCT00925587|26662789|FG000|Overall Study|Death|5|||
13353360|NCT00925587|26662790|FG001|Overall Study|Death|5|||
13353361|NCT00925587|26662789|FG000|Overall Study|Adverse Event|6|||
13353362|NCT00925587|26662790|FG001|Overall Study|Adverse Event|2|||
13353363|NCT00925587|26662789|FG000|Overall Study|Lost to Follow-up|0|||
13353364|NCT00925587|26662790|FG001|Overall Study|Lost to Follow-up|1|||
13353365|NCT00925548|26662823|FG000|Overall Study|Discontinuation of trial by sponsor|10|||
13353366|NCT00925548|26662824|FG001|Overall Study|Discontinuation of trial by sponsor|5|||
13353367|NCT00925522|26662830|FG000|Overall Study|study closed -- business decision|20|||
13353368|NCT00925353|26662836|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3|||
13353369|NCT00925301|26662859|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
13353370|NCT00925301|26662860|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2|||
13353371|NCT00925301|26662861|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
13353372|NCT00925301|26662862|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
13353373|NCT00925301|26662859|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0|||
13353374|NCT00925301|26662860|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1|||
13353375|NCT00925301|26662861|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0|||
13353376|NCT00925301|26662862|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0|||
13353377|NCT00925301|26662859|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
13353378|NCT00925301|26662860|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
13353379|NCT00925301|26662861|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1|||
13353380|NCT00925301|26662862|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
13353381|NCT00925301|26662859|FG000|6-Month Open-label (Stage 2)|Adverse Event|0|||
13353382|NCT00925301|26662860|FG001|6-Month Open-label (Stage 2)|Adverse Event|0|||
13353383|NCT00925301|26662861|FG002|6-Month Open-label (Stage 2)|Adverse Event|2|||
13353384|NCT00925301|26662862|FG003|6-Month Open-label (Stage 2)|Adverse Event|0|||
13353385|NCT00925301|26662859|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
13353386|NCT00925301|26662860|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
13353387|NCT00925301|26662861|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
13353388|NCT00925301|26662862|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1|||
13353389|NCT00925301|26662859|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0|||
13353390|NCT00925301|26662860|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0|||
13353391|NCT00925301|26662861|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0|||
13353392|NCT00925301|26662862|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1|||
13353393|NCT00925301|26662859|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
13353394|NCT00925301|26662860|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
13353395|NCT00925301|26662861|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
13353396|NCT00925301|26662862|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1|||
13353397|NCT00925288|26662881|FG000|Overall Study|Lost to Follow-up|9|||
13353398|NCT00925288|26662882|FG001|Overall Study|Lost to Follow-up|7|||
13353399|NCT00925132|26662894|FG000|Overall Study|Withdrawal by Subject|2|||
13353400|NCT00925132|26662895|FG001|Overall Study|Withdrawal by Subject|0|||
13353401|NCT00925132|26662896|FG002|Overall Study|Withdrawal by Subject|0|||
13353402|NCT00925132|26662897|FG003|Overall Study|Withdrawal by Subject|0|||
13353403|NCT00925132|26662898|FG004|Overall Study|Withdrawal by Subject|1|||
13353404|NCT00925132|26662894|FG000|Overall Study|Removed due to disease progression|0|||
13353405|NCT00925132|26662895|FG001|Overall Study|Removed due to disease progression|0|||
13353406|NCT00925132|26662896|FG002|Overall Study|Removed due to disease progression|0|||
13353407|NCT00925132|26662897|FG003|Overall Study|Removed due to disease progression|0|||
13353408|NCT00925132|26662898|FG004|Overall Study|Removed due to disease progression|4|||
13353409|NCT00925015|26662964|FG000|Overall Study|Adverse Event|1|||
13353410|NCT00925015|26662965|FG001|Overall Study|Adverse Event|2|||
13353411|NCT00925015|26662966|FG002|Overall Study|Adverse Event|1|||
13353412|NCT00925015|26662964|FG000|Overall Study|Physician Decision|0|||
13353413|NCT00925015|26662965|FG001|Overall Study|Physician Decision|1|||
13353414|NCT00925015|26662966|FG002|Overall Study|Physician Decision|0|||
13353415|NCT00925015|26662964|FG000|Overall Study|Progressive Disease|7|||
13353416|NCT00925015|26662965|FG001|Overall Study|Progressive Disease|3|||
13353417|NCT00925015|26662966|FG002|Overall Study|Progressive Disease|4|||
13353418|NCT00925015|26662964|FG000|Overall Study|Withdrawal by Subject|0|||
13353419|NCT00925015|26662965|FG001|Overall Study|Withdrawal by Subject|0|||
13353420|NCT00925015|26662966|FG002|Overall Study|Withdrawal by Subject|1|||
13353421|NCT00925002|26663057|FG000|Overall Study|Other|1|||
13353422|NCT00925002|26663058|FG001|Overall Study|Other|4|||
13353423|NCT00925002|26663059|FG002|Overall Study|Other|0|||
13353424|NCT00925002|26663057|FG000|Overall Study|Death|1|||
13353425|NCT00925002|26663058|FG001|Overall Study|Death|1|||
13353426|NCT00925002|26663059|FG002|Overall Study|Death|5|||
13353427|NCT00925002|26663057|FG000|Overall Study|Adverse Event|3|||
13353428|NCT00925002|26663058|FG001|Overall Study|Adverse Event|1|||
13353429|NCT00925002|26663059|FG002|Overall Study|Adverse Event|2|||
13353430|NCT00925002|26663057|FG000|Overall Study|Participant withdrew consent|1|||
13353431|NCT00925002|26663058|FG001|Overall Study|Participant withdrew consent|3|||
13353432|NCT00925002|26663059|FG002|Overall Study|Participant withdrew consent|3|||
13353433|NCT00924950|26663068|FG000|Overall Study|Lost to Follow-up|2|||
13353434|NCT00924898|26663079|FG000|Overall Study|Withdrawal by Subject|2|||
13353435|NCT00924820|26663087|FG000|Overall Study|Death|2|||
13353436|NCT00924820|26663087|FG000|Overall Study|Ineligible, Screen Failure|5|||
13353437|NCT00924781|26663130|FG000|Overall Study|Study terminated by sponsor|12|||
13353438|NCT00924781|26663131|FG001|Overall Study|Study terminated by sponsor|10|||
13353439|NCT00924729|26663146|FG000|Overall Study|insufficient volume for analysis|1|||
13353440|NCT00924729|26663147|FG001|Overall Study|insufficient volume for analysis|0|||
13353441|NCT00924729|26663146|FG000|Overall Study|Protocol Violation|1|||
13353442|NCT00924729|26663147|FG001|Overall Study|Protocol Violation|0|||
13353443|NCT00924703|26663157|FG000|Overall Study|Withdrawal by Subject|11|||
13353444|NCT00924703|26663157|FG000|Overall Study|Physician Decision|5|||
13353445|NCT00924703|26663157|FG000|Overall Study|Lost to Follow-up|3|||
13353446|NCT00924703|26663157|FG000|Overall Study|Adverse Event|2|||
13353447|NCT00924703|26663157|FG000|Overall Study|Withdrawal by Sponsor|1|||
13353448|NCT00924664|26663266|FG000|Overall Study|Adverse Event|23|||
13353449|NCT00924664|26663267|FG001|Overall Study|Adverse Event|39|||
13353450|NCT00924664|26663266|FG000|Overall Study|Lack of Efficacy|10|||
13353451|NCT00924664|26663267|FG001|Overall Study|Lack of Efficacy|15|||
13353452|NCT00924664|26663266|FG000|Overall Study|Lost to Follow-up|10|||
13353453|NCT00924664|26663267|FG001|Overall Study|Lost to Follow-up|12|||
13353454|NCT00924664|26663266|FG000|Overall Study|Withdrawal by Subject|47|||
13353455|NCT00924664|26663267|FG001|Overall Study|Withdrawal by Subject|71|||
13353456|NCT00924664|26663266|FG000|Overall Study|Protocol Violation|2|||
13353457|NCT00924664|26663267|FG001|Overall Study|Protocol Violation|5|||
13353458|NCT00924664|26663266|FG000|Overall Study|Pregnancy|1|||
13353459|NCT00924664|26663267|FG001|Overall Study|Pregnancy|1|||
13353460|NCT00924664|26663266|FG000|Overall Study|Death|0|||
13353461|NCT00924664|26663267|FG001|Overall Study|Death|2|||
13353462|NCT00924664|26663266|FG000|Overall Study|Study terminated by sponsor|199|||
13353463|NCT00924664|26663267|FG001|Overall Study|Study terminated by sponsor|330|||
13353464|NCT00924664|26663266|FG000|Overall Study|Other|29|||
13353465|NCT00924664|26663267|FG001|Overall Study|Other|52|||
13353466|NCT00924664|26663266|FG000|Overall Study|Randomized but not Treated|1|||
13353467|NCT00924664|26663267|FG001|Overall Study|Randomized but not Treated|0|||
13374414|NCT00796653|26726627|FG001|Overall Study|Other reason not described above|9|||
13374415|NCT00796653|26726628|FG002|Overall Study|Other reason not described above|7|||
13374416|NCT00796653|26726629|FG003|Overall Study|Other reason not described above|4|||
13374417|NCT00796614|26726684|FG000|Overall Study|Adverse Event|1|||
13374418|NCT00796614|26726685|FG001|Overall Study|Adverse Event|2|||
13374419|NCT00796614|26726686|FG002|Overall Study|Adverse Event|0|||
13374420|NCT00796614|26726687|FG003|Overall Study|Adverse Event|0|||
13374421|NCT00796614|26726684|FG000|Overall Study|Protocol Violation|0|||
13374422|NCT00796614|26726685|FG001|Overall Study|Protocol Violation|0|||
13374423|NCT00796614|26726686|FG002|Overall Study|Protocol Violation|2|||
13374424|NCT00796614|26726687|FG003|Overall Study|Protocol Violation|0|||
13374425|NCT00796614|26726684|FG000|Overall Study|Lost to Follow-up|2|||
13374426|NCT00796614|26726685|FG001|Overall Study|Lost to Follow-up|2|||
13374427|NCT00796614|26726686|FG002|Overall Study|Lost to Follow-up|1|||
13374428|NCT00796614|26726687|FG003|Overall Study|Lost to Follow-up|0|||
13374429|NCT00796614|26726684|FG000|Overall Study|Withdrawal by Subject|1|||
13374430|NCT00796614|26726685|FG001|Overall Study|Withdrawal by Subject|0|||
13374431|NCT00796614|26726686|FG002|Overall Study|Withdrawal by Subject|0|||
13374432|NCT00796614|26726687|FG003|Overall Study|Withdrawal by Subject|1|||
13374433|NCT00796614|26726684|FG000|Overall Study|Other than stated|1|||
13374434|NCT00796614|26726685|FG001|Overall Study|Other than stated|0|||
13374435|NCT00796614|26726686|FG002|Overall Study|Other than stated|0|||
13374436|NCT00796614|26726687|FG003|Overall Study|Other than stated|0|||
13393629|NCT00662909|26784486|FG001|Overall Study|Physician Decision|1|||
13374437|NCT00796562|26726698|FG000|Overall Study|Death|49|||
13374438|NCT00796549|26726715|FG000|Overall Study|Adverse Event|11|||
13374439|NCT00796549|26726715|FG000|Overall Study|not entered|149|||
13374440|NCT00796549|26726715|FG000|Overall Study|Other|2|||
13374441|NCT00796549|26726715|FG000|Overall Study|Progressive disease|56|||
13374442|NCT00796510|26726732|FG000|Overall Study|Death|1|||
13374443|NCT00796510|26726733|FG001|Overall Study|Death|0|||
13374444|NCT00796510|26726732|FG000|Overall Study|Study Terminated|2|||
13374445|NCT00796510|26726733|FG001|Overall Study|Study Terminated|0|||
13374446|NCT00796445|26726790|FG000|Overall Study|Protocol Violation|5|||
13374447|NCT00796445|26726791|FG001|Overall Study|Protocol Violation|3|||
13374448|NCT00796445|26726790|FG000|Overall Study|Adverse event, serious fatal|10|||
13393630|NCT00662909|26784487|FG002|Overall Study|Physician Decision|2|||
13353468|NCT00924651|26663280|FG000|Overall Study|Chemo started too soon|2|||
13353469|NCT00924651|26663281|FG001|Overall Study|Chemo started too soon|3|||
13353470|NCT00924651|26663280|FG000|Overall Study|No Reason|3|||
13353471|NCT00924651|26663281|FG001|Overall Study|No Reason|7|||
13353472|NCT00924651|26663280|FG000|Overall Study|Overwhelmed|6|||
13353473|NCT00924651|26663281|FG001|Overall Study|Overwhelmed|6|||
13353474|NCT00924651|26663280|FG000|Overall Study|Noncompliant|1|||
13353475|NCT00924651|26663281|FG001|Overall Study|Noncompliant|4|||
13353476|NCT00924651|26663280|FG000|Overall Study|Medical|1|||
13353477|NCT00924651|26663281|FG001|Overall Study|Medical|3|||
13353478|NCT00924651|26663280|FG000|Overall Study|Changed Mind|10|||
13353479|NCT00924651|26663281|FG001|Overall Study|Changed Mind|1|||
13353480|NCT00924651|26663280|FG000|Overall Study|Incomplete Form|2|||
13353481|NCT00924651|26663281|FG001|Overall Study|Incomplete Form|1|||
13353482|NCT00924638|26663307|FG000|Overall Study|Death|3|||
13353483|NCT00924638|26663308|FG001|Overall Study|Death|2|||
13353484|NCT00924638|26663307|FG000|Overall Study|Lost to Follow-up|1|||
13353485|NCT00924638|26663308|FG001|Overall Study|Lost to Follow-up|1|||
13353486|NCT00924638|26663307|FG000|Overall Study|Withdrawal by Subject|5|||
13353487|NCT00924638|26663308|FG001|Overall Study|Withdrawal by Subject|7|||
13353488|NCT00924638|26663307|FG000|Overall Study|Physician Decision|3|||
13353489|NCT00924638|26663308|FG001|Overall Study|Physician Decision|3|||
13353490|NCT00924560|26663362|FG000|Overall Study|Did Not Meet Protocol Requirements|4|||
13353491|NCT00924560|26663363|FG001|Overall Study|Did Not Meet Protocol Requirements|2|||
13353492|NCT00924560|26663364|FG002|Overall Study|Did Not Meet Protocol Requirements|1|||
13353493|NCT00924560|26663362|FG000|Overall Study|Non Compliance with the Protocol|20|||
13353494|NCT00924560|26663363|FG001|Overall Study|Non Compliance with the Protocol|15|||
13353495|NCT00924560|26663364|FG002|Overall Study|Non Compliance with the Protocol|4|||
13353496|NCT00924560|26663362|FG000|Overall Study|Physician Decision|2|||
13353497|NCT00924560|26663363|FG001|Overall Study|Physician Decision|3|||
13353498|NCT00924560|26663364|FG002|Overall Study|Physician Decision|4|||
13353499|NCT00924560|26663362|FG000|Overall Study|Withdrawal by Subject|50|||
13353500|NCT00924560|26663363|FG001|Overall Study|Withdrawal by Subject|44|||
13353501|NCT00924560|26663364|FG002|Overall Study|Withdrawal by Subject|18|||
13353502|NCT00924560|26663362|FG000|Overall Study|Adverse Event|39|||
13353503|NCT00924560|26663363|FG001|Overall Study|Adverse Event|33|||
13353504|NCT00924560|26663364|FG002|Overall Study|Adverse Event|0|||
13353505|NCT00924560|26663362|FG000|Overall Study|Pregnancy|5|||
13353506|NCT00924560|26663363|FG001|Overall Study|Pregnancy|7|||
13353507|NCT00924560|26663364|FG002|Overall Study|Pregnancy|1|||
13353508|NCT00924560|26663362|FG000|Overall Study|Lost to Follow-up|78|||
13353509|NCT00924560|26663363|FG001|Overall Study|Lost to Follow-up|94|||
13353510|NCT00924560|26663364|FG002|Overall Study|Lost to Follow-up|45|||
13353511|NCT00924560|26663362|FG000|Overall Study|Miscellaneous Reasons|13|||
13353512|NCT00924560|26663363|FG001|Overall Study|Miscellaneous Reasons|10|||
13353513|NCT00924560|26663364|FG002|Overall Study|Miscellaneous Reasons|10|||
13353514|NCT00924508|26663373|FG000|Overall Study|Withdrawal by Subject|3|||
13353515|NCT00924469|26663402|FG000|Overall Study|Adverse Event|2|||
13353516|NCT00924469|26663403|FG001|Overall Study|Adverse Event|0|||
13353517|NCT00924469|26663402|FG000|Overall Study|Withdrawal by Subject|0|||
13353518|NCT00924469|26663403|FG001|Overall Study|Withdrawal by Subject|1|||
13353519|NCT00924469|26663402|FG000|Overall Study|Lost to Follow-up|0|||
13353520|NCT00924469|26663403|FG001|Overall Study|Lost to Follow-up|1|||
13353521|NCT00924443|26663413|FG000|Overall Study|Physician Decision|2|||
13353522|NCT00924443|26663413|FG000|Overall Study|Protocol Violation|1|||
13353523|NCT00924404|26663428|FG000|Overall Study|Lost to Follow-up|6|||
13353524|NCT00924404|26663429|FG001|Overall Study|Lost to Follow-up|4|||
13353525|NCT00924313|26663443|FG000|Overall Study|not imaged due to failed tracer imaging|1|||
13353526|NCT00924287|26663451|FG000|Overall Study|Death|1|||
13353527|NCT00924170|26663496|FG000|Overall Study|Refused further treatment|0|||
13353528|NCT00924170|26663497|FG001|Overall Study|Refused further treatment|1|||
13353529|NCT00924170|26663496|FG000|Overall Study|Physician Decision|0|||
13353530|NCT00924170|26663497|FG001|Overall Study|Physician Decision|1|||
13353531|NCT00924170|26663496|FG000|Overall Study|Progressive disease|3|||
13353532|NCT00924170|26663497|FG001|Overall Study|Progressive disease|6|||
13353533|NCT00924170|26663496|FG000|Overall Study|Stopped due to neutralizing antibodies|3|||
13353534|NCT00924170|26663497|FG001|Overall Study|Stopped due to neutralizing antibodies|0|||
13353535|NCT00924170|26663496|FG000|Overall Study|Death|1|||
13353536|NCT00924170|26663497|FG001|Overall Study|Death|0|||
13353537|NCT00923975|26663506|FG000|Overall Study|Did not meet inclusion criteria|1|||
13353538|NCT00923936|26663527|FG000|Overall Study|progressive disease on study|2|||
13353539|NCT00923936|26663528|FG001|Overall Study|progressive disease on study|1|||
13353540|NCT00923936|26663527|FG000|Overall Study|Adverse Event|2|||
13353541|NCT00923936|26663528|FG001|Overall Study|Adverse Event|1|||
13353542|NCT00923936|26663527|FG000|Overall Study|Lost to follow up|2|||
13353543|NCT00923936|26663528|FG001|Overall Study|Lost to follow up|0|||
13353544|NCT00923936|26663527|FG000|Overall Study|Continuing in follow up period|2|||
13353545|NCT00923936|26663528|FG001|Overall Study|Continuing in follow up period|1|||
13353546|NCT00923845|26663556|FG000|Induction Therapy|Poor performance status|0|||
13353547|NCT00923845|26663557|FG001|Induction Therapy|Poor performance status|2|||
13353548|NCT00923702|26663590|FG000|Overall Study|Ongoing enrollment|0|||
13353549|NCT00923702|26663591|FG001|Overall Study|Ongoing enrollment|0|||
13353550|NCT00923702|26663592|FG002|Overall Study|Ongoing enrollment|0|||
13353551|NCT00923702|26663593|FG003|Overall Study|Ongoing enrollment|0|||
13353552|NCT00923702|26663594|FG004|Overall Study|Ongoing enrollment|354|||
13353553|NCT00923559|26663617|FG000|Overall Study|Lost to Follow-up|2|||
13353554|NCT00923559|26663618|FG001|Overall Study|Lost to Follow-up|3|||
13353555|NCT00923364|26663631|FG000|Overall Study|Death|3|||
13353556|NCT00923364|26663632|FG001|Overall Study|Death|0|||
13353557|NCT00923364|26663631|FG000|Overall Study|Did not go to transplant|1|||
13353558|NCT00923364|26663632|FG001|Overall Study|Did not go to transplant|0|||
13353559|NCT00923351|26663650|FG000|Overall Study|no apheresis/adequate tumor sample|0|||
13353560|NCT00923351|26663651|FG001|Overall Study|no apheresis/adequate tumor sample|0|||
13353561|NCT00923351|26663652|FG002|Overall Study|no apheresis/adequate tumor sample|12|||
13353562|NCT00923273|26663691|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
13353563|NCT00923273|26663692|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
13353564|NCT00923273|26663693|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
13353565|NCT00923273|26663694|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1|||
13353566|NCT00923273|26663695|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
13353567|NCT00923273|26663691|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
13353568|NCT00923273|26663692|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
13353569|NCT00923273|26663693|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
13353570|NCT00923273|26663694|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6|||
13353571|NCT00923273|26663695|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
13353572|NCT00923260|26663834|FG000|Overall Study|Lost to Follow-up|1|||
13353573|NCT00923260|26663835|FG001|Overall Study|Lost to Follow-up|1|||
13353574|NCT00923195|26663850|FG000|Overall Study|Death|0|||
13353575|NCT00923195|26663851|FG001|Overall Study|Death|1|||
13353576|NCT00923156|26663887|FG000|Overall Study|Adverse Event|0|||
13353577|NCT00923156|26663888|FG001|Overall Study|Adverse Event|2|||
13353578|NCT00923156|26663889|FG002|Overall Study|Adverse Event|1|||
13353579|NCT00923156|26663887|FG000|Overall Study|Abnormal laboratory values|0|||
13353580|NCT00923156|26663888|FG001|Overall Study|Abnormal laboratory values|0|||
13353581|NCT00923156|26663889|FG002|Overall Study|Abnormal laboratory values|1|||
13353582|NCT00923156|26663887|FG000|Overall Study|Withdrawal by Subject|0|||
13353583|NCT00923156|26663888|FG001|Overall Study|Withdrawal by Subject|1|||
13353584|NCT00923156|26663889|FG002|Overall Study|Withdrawal by Subject|0|||
13353585|NCT00923156|26663887|FG000|Overall Study|Death|0|||
13353586|NCT00923156|26663888|FG001|Overall Study|Death|1|||
13353587|NCT00923156|26663889|FG002|Overall Study|Death|0|||
13353588|NCT00923156|26663887|FG000|Overall Study|Lack of Efficacy|0|||
13353589|NCT00923156|26663888|FG001|Overall Study|Lack of Efficacy|0|||
13353590|NCT00923156|26663889|FG002|Overall Study|Lack of Efficacy|1|||
13353591|NCT00923130|26663907|FG000|Overall Study|Stopped treatment due to progression|17|||
13353592|NCT00923130|26663907|FG000|Overall Study|Death|1|||
13353593|NCT00923130|26663907|FG000|Overall Study|Discontinued treatment due to toxicities|3|||
13353594|NCT00923130|26663907|FG000|Overall Study|Switched to alternative treatment|2|||
13353595|NCT00923130|26663907|FG000|Overall Study|Refused further treatment|2|||
13353596|NCT00923091|26663984|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11|||
13353597|NCT00923091|26663985|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3|||
13353598|NCT00923091|26663986|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7|||
13353599|NCT00923091|26663987|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13|||
13353600|NCT00923091|26663988|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10|||
13353601|NCT00923091|26663989|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5|||
13353602|NCT00923091|26663990|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9|||
13353603|NCT00923091|26663991|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17|||
13353604|NCT00923091|26663992|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
13353605|NCT00923091|26663993|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
13353606|NCT00923091|26663994|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
13353607|NCT00923091|26663995|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
13353608|NCT00923091|26663996|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
13353609|NCT00923091|26663984|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4|||
13353610|NCT00923091|26663985|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
13353611|NCT00923091|26663986|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
13353612|NCT00923091|26663987|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8|||
13353613|NCT00923091|26663988|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7|||
13353614|NCT00923091|26663989|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
13353615|NCT00923091|26663990|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
13353616|NCT00923091|26663991|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
13353617|NCT00923091|26663992|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
13353618|NCT00923091|26663993|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
13353619|NCT00923091|26663994|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
13353620|NCT00923091|26663995|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
13353621|NCT00923091|26663996|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
13353622|NCT00923091|26663984|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
13353623|NCT00923091|26663985|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
13353624|NCT00923091|26663986|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
13353625|NCT00923091|26663987|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5|||
13353626|NCT00923091|26663988|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
13353627|NCT00923091|26663989|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2|||
13353628|NCT00923091|26663990|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
13353629|NCT00923091|26663991|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3|||
13353630|NCT00923091|26663992|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
13353631|NCT00923091|26663993|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
13353632|NCT00923091|26663994|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
13353633|NCT00923091|26663995|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
13353634|NCT00923091|26663996|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
13353635|NCT00923091|26663984|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
13353636|NCT00923091|26663985|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
13353637|NCT00923091|26663986|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
13353638|NCT00923091|26663987|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
13353639|NCT00923091|26663988|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
13353640|NCT00923091|26663989|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1|||
13353641|NCT00923091|26663990|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
13353642|NCT00923091|26663991|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
13353643|NCT00923091|26663992|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
13353644|NCT00923091|26663993|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
13353645|NCT00923091|26663994|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
13353646|NCT00923091|26663995|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
13353647|NCT00923091|26663996|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
13353648|NCT00923091|26663984|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
13353649|NCT00923091|26663985|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
13353650|NCT00923091|26663986|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
13353651|NCT00923091|26663987|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
13353652|NCT00923091|26663988|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
13353653|NCT00923091|26663989|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
13353654|NCT00923091|26663990|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
13353655|NCT00923091|26663991|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
13353656|NCT00923091|26663992|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
13353657|NCT00923091|26663993|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
13353658|NCT00923091|26663994|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
13353659|NCT00923091|26663995|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
13353660|NCT00923091|26663996|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
13353661|NCT00923091|26663984|FG000|Period III (Single-Blind)|Adverse Event|5|||
13353662|NCT00923091|26663985|FG001|Period III (Single-Blind)|Adverse Event|0|||
13353663|NCT00923091|26663986|FG002|Period III (Single-Blind)|Adverse Event|0|||
13353664|NCT00923091|26663987|FG003|Period III (Single-Blind)|Adverse Event|0|||
13353665|NCT00923091|26663988|FG004|Period III (Single-Blind)|Adverse Event|0|||
13353666|NCT00923091|26663989|FG005|Period III (Single-Blind)|Adverse Event|0|||
13353667|NCT00923091|26663990|FG006|Period III (Single-Blind)|Adverse Event|0|||
13353668|NCT00923091|26663991|FG007|Period III (Single-Blind)|Adverse Event|0|||
13353669|NCT00923091|26663992|FG008|Period III (Single-Blind)|Adverse Event|0|||
13353670|NCT00923091|26663993|FG009|Period III (Single-Blind)|Adverse Event|0|||
13353671|NCT00923091|26663994|FG010|Period III (Single-Blind)|Adverse Event|0|||
13353672|NCT00923091|26663995|FG011|Period III (Single-Blind)|Adverse Event|0|||
13353673|NCT00923091|26663996|FG012|Period III (Single-Blind)|Adverse Event|0|||
13353674|NCT00923091|26663984|FG000|Period III (Single-Blind)|Withdrawal by Subject|10|||
13353675|NCT00923091|26663985|FG001|Period III (Single-Blind)|Withdrawal by Subject|0|||
13353676|NCT00923091|26663986|FG002|Period III (Single-Blind)|Withdrawal by Subject|0|||
13353677|NCT00923091|26663987|FG003|Period III (Single-Blind)|Withdrawal by Subject|0|||
13353678|NCT00923091|26663988|FG004|Period III (Single-Blind)|Withdrawal by Subject|0|||
13353679|NCT00923091|26663989|FG005|Period III (Single-Blind)|Withdrawal by Subject|0|||
13353680|NCT00923091|26663990|FG006|Period III (Single-Blind)|Withdrawal by Subject|0|||
13353681|NCT00923091|26663991|FG007|Period III (Single-Blind)|Withdrawal by Subject|0|||
13353682|NCT00923091|26663992|FG008|Period III (Single-Blind)|Withdrawal by Subject|0|||
13353683|NCT00923091|26663993|FG009|Period III (Single-Blind)|Withdrawal by Subject|0|||
13353684|NCT00923091|26663994|FG010|Period III (Single-Blind)|Withdrawal by Subject|0|||
13353685|NCT00923091|26663995|FG011|Period III (Single-Blind)|Withdrawal by Subject|0|||
13353686|NCT00923091|26663996|FG012|Period III (Single-Blind)|Withdrawal by Subject|0|||
13353687|NCT00923091|26663984|FG000|Period III (Single-Blind)|Protocol Violation|3|||
13353688|NCT00923091|26663985|FG001|Period III (Single-Blind)|Protocol Violation|0|||
13353689|NCT00923091|26663986|FG002|Period III (Single-Blind)|Protocol Violation|0|||
13353690|NCT00923091|26663987|FG003|Period III (Single-Blind)|Protocol Violation|0|||
13353691|NCT00923091|26663988|FG004|Period III (Single-Blind)|Protocol Violation|0|||
13353692|NCT00923091|26663989|FG005|Period III (Single-Blind)|Protocol Violation|0|||
13353693|NCT00923091|26663990|FG006|Period III (Single-Blind)|Protocol Violation|0|||
13353694|NCT00923091|26663991|FG007|Period III (Single-Blind)|Protocol Violation|0|||
13353695|NCT00923091|26663992|FG008|Period III (Single-Blind)|Protocol Violation|0|||
13353696|NCT00923091|26663993|FG009|Period III (Single-Blind)|Protocol Violation|0|||
13353697|NCT00923091|26663994|FG010|Period III (Single-Blind)|Protocol Violation|0|||
13353698|NCT00923091|26663995|FG011|Period III (Single-Blind)|Protocol Violation|0|||
13353699|NCT00923091|26663996|FG012|Period III (Single-Blind)|Protocol Violation|0|||
13353700|NCT00923091|26663984|FG000|Period III (Single-Blind)|Lost to Follow-up|2|||
13353701|NCT00923091|26663985|FG001|Period III (Single-Blind)|Lost to Follow-up|0|||
13353702|NCT00923091|26663986|FG002|Period III (Single-Blind)|Lost to Follow-up|0|||
13353703|NCT00923091|26663987|FG003|Period III (Single-Blind)|Lost to Follow-up|0|||
13353704|NCT00923091|26663988|FG004|Period III (Single-Blind)|Lost to Follow-up|0|||
13353705|NCT00923091|26663989|FG005|Period III (Single-Blind)|Lost to Follow-up|0|||
13353706|NCT00923091|26663990|FG006|Period III (Single-Blind)|Lost to Follow-up|0|||
13353707|NCT00923091|26663991|FG007|Period III (Single-Blind)|Lost to Follow-up|0|||
13353708|NCT00923091|26663992|FG008|Period III (Single-Blind)|Lost to Follow-up|0|||
13353709|NCT00923091|26663993|FG009|Period III (Single-Blind)|Lost to Follow-up|0|||
13353710|NCT00923091|26663994|FG010|Period III (Single-Blind)|Lost to Follow-up|0|||
13353711|NCT00923091|26663995|FG011|Period III (Single-Blind)|Lost to Follow-up|0|||
13353712|NCT00923091|26663996|FG012|Period III (Single-Blind)|Lost to Follow-up|0|||
13353713|NCT00923091|26663984|FG000|Period IV (Double-Blind)|Adverse Event|2|||
13353714|NCT00923091|26663985|FG001|Period IV (Double-Blind)|Adverse Event|0|||
13353715|NCT00923091|26663986|FG002|Period IV (Double-Blind)|Adverse Event|0|||
13353716|NCT00923091|26663987|FG003|Period IV (Double-Blind)|Adverse Event|0|||
13353717|NCT00923091|26663988|FG004|Period IV (Double-Blind)|Adverse Event|0|||
13353718|NCT00923091|26663989|FG005|Period IV (Double-Blind)|Adverse Event|0|||
13353719|NCT00923091|26663990|FG006|Period IV (Double-Blind)|Adverse Event|0|||
13353720|NCT00923091|26663991|FG007|Period IV (Double-Blind)|Adverse Event|0|||
13353721|NCT00923091|26663992|FG008|Period IV (Double-Blind)|Adverse Event|0|||
13353722|NCT00923091|26663993|FG009|Period IV (Double-Blind)|Adverse Event|0|||
13353723|NCT00923091|26663994|FG010|Period IV (Double-Blind)|Adverse Event|0|||
13353724|NCT00923091|26663995|FG011|Period IV (Double-Blind)|Adverse Event|0|||
13353725|NCT00923091|26663996|FG012|Period IV (Double-Blind)|Adverse Event|0|||
13353726|NCT00923091|26663984|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0|||
13353727|NCT00923091|26663985|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1|||
13353728|NCT00923091|26663986|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0|||
13353729|NCT00923091|26663987|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0|||
13353730|NCT00923091|26663988|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0|||
13353731|NCT00923091|26663989|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0|||
13353732|NCT00923091|26663990|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0|||
13353733|NCT00923091|26663991|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0|||
13353734|NCT00923091|26663992|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0|||
13353735|NCT00923091|26663993|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0|||
13353736|NCT00923091|26663994|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0|||
13353737|NCT00923091|26663995|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0|||
13353738|NCT00923091|26663996|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0|||
13353739|NCT00923091|26663984|FG000|Period IV (Double-Blind)|Protocol Violation|0|||
13353740|NCT00923091|26663985|FG001|Period IV (Double-Blind)|Protocol Violation|1|||
13353741|NCT00923091|26663986|FG002|Period IV (Double-Blind)|Protocol Violation|0|||
13353742|NCT00923091|26663987|FG003|Period IV (Double-Blind)|Protocol Violation|0|||
13353743|NCT00923091|26663988|FG004|Period IV (Double-Blind)|Protocol Violation|0|||
13353744|NCT00923091|26663989|FG005|Period IV (Double-Blind)|Protocol Violation|0|||
13353745|NCT00923091|26663990|FG006|Period IV (Double-Blind)|Protocol Violation|0|||
13353746|NCT00923091|26663991|FG007|Period IV (Double-Blind)|Protocol Violation|0|||
13353747|NCT00923091|26663992|FG008|Period IV (Double-Blind)|Protocol Violation|0|||
13353748|NCT00923091|26663993|FG009|Period IV (Double-Blind)|Protocol Violation|0|||
13353749|NCT00923091|26663994|FG010|Period IV (Double-Blind)|Protocol Violation|0|||
13353750|NCT00923091|26663995|FG011|Period IV (Double-Blind)|Protocol Violation|0|||
13353751|NCT00923091|26663996|FG012|Period IV (Double-Blind)|Protocol Violation|0|||
13353752|NCT00923091|26663984|FG000|Period V (Double -Blind)|Withdrawal by Subject|0|||
13353753|NCT00923091|26663985|FG001|Period V (Double -Blind)|Withdrawal by Subject|0|||
13353754|NCT00923091|26663986|FG002|Period V (Double -Blind)|Withdrawal by Subject|0|||
13353755|NCT00923091|26663987|FG003|Period V (Double -Blind)|Withdrawal by Subject|0|||
13353756|NCT00923091|26663988|FG004|Period V (Double -Blind)|Withdrawal by Subject|0|||
13353757|NCT00923091|26663989|FG005|Period V (Double -Blind)|Withdrawal by Subject|0|||
13353758|NCT00923091|26663990|FG006|Period V (Double -Blind)|Withdrawal by Subject|0|||
13353759|NCT00923091|26663991|FG007|Period V (Double -Blind)|Withdrawal by Subject|0|||
13353760|NCT00923091|26663992|FG008|Period V (Double -Blind)|Withdrawal by Subject|1|||
13353761|NCT00923091|26663993|FG009|Period V (Double -Blind)|Withdrawal by Subject|0|||
13353762|NCT00923091|26663994|FG010|Period V (Double -Blind)|Withdrawal by Subject|0|||
13353763|NCT00923091|26663995|FG011|Period V (Double -Blind)|Withdrawal by Subject|0|||
13353764|NCT00923091|26663996|FG012|Period V (Double -Blind)|Withdrawal by Subject|1|||
13353765|NCT00923091|26663984|FG000|Period V (Double -Blind)|Protocol Violation|0|||
13353766|NCT00923091|26663985|FG001|Period V (Double -Blind)|Protocol Violation|0|||
13353767|NCT00923091|26663986|FG002|Period V (Double -Blind)|Protocol Violation|0|||
13353768|NCT00923091|26663987|FG003|Period V (Double -Blind)|Protocol Violation|0|||
13353769|NCT00923091|26663988|FG004|Period V (Double -Blind)|Protocol Violation|0|||
13353770|NCT00923091|26663989|FG005|Period V (Double -Blind)|Protocol Violation|0|||
13353771|NCT00923091|26663990|FG006|Period V (Double -Blind)|Protocol Violation|0|||
13353772|NCT00923091|26663991|FG007|Period V (Double -Blind)|Protocol Violation|0|||
13353773|NCT00923091|26663992|FG008|Period V (Double -Blind)|Protocol Violation|0|||
13353774|NCT00923091|26663993|FG009|Period V (Double -Blind)|Protocol Violation|0|||
13353775|NCT00923091|26663994|FG010|Period V (Double -Blind)|Protocol Violation|0|||
13353776|NCT00923091|26663995|FG011|Period V (Double -Blind)|Protocol Violation|0|||
13353777|NCT00923091|26663996|FG012|Period V (Double -Blind)|Protocol Violation|1|||
13353778|NCT00923091|26663984|FG000|Period V (Double -Blind)|Lost to Follow-up|0|||
13353779|NCT00923091|26663985|FG001|Period V (Double -Blind)|Lost to Follow-up|0|||
13353780|NCT00923091|26663986|FG002|Period V (Double -Blind)|Lost to Follow-up|0|||
13353781|NCT00923091|26663987|FG003|Period V (Double -Blind)|Lost to Follow-up|0|||
13353782|NCT00923091|26663988|FG004|Period V (Double -Blind)|Lost to Follow-up|0|||
13353783|NCT00923091|26663989|FG005|Period V (Double -Blind)|Lost to Follow-up|0|||
13353784|NCT00923091|26663990|FG006|Period V (Double -Blind)|Lost to Follow-up|0|||
13353785|NCT00923091|26663991|FG007|Period V (Double -Blind)|Lost to Follow-up|0|||
13353786|NCT00923091|26663992|FG008|Period V (Double -Blind)|Lost to Follow-up|0|||
13353787|NCT00923091|26663993|FG009|Period V (Double -Blind)|Lost to Follow-up|0|||
13353788|NCT00923091|26663994|FG010|Period V (Double -Blind)|Lost to Follow-up|1|||
13353789|NCT00923091|26663995|FG011|Period V (Double -Blind)|Lost to Follow-up|0|||
13353790|NCT00923091|26663996|FG012|Period V (Double -Blind)|Lost to Follow-up|0|||
13353791|NCT00923091|26663984|FG000|Period VI (Open-Label)|Adverse Event|17|||
13353792|NCT00923091|26663985|FG001|Period VI (Open-Label)|Adverse Event|0|||
13353793|NCT00923091|26663986|FG002|Period VI (Open-Label)|Adverse Event|4|||
13353794|NCT00923091|26663987|FG003|Period VI (Open-Label)|Adverse Event|1|||
13353795|NCT00923091|26663988|FG004|Period VI (Open-Label)|Adverse Event|1|||
13353796|NCT00923091|26663989|FG005|Period VI (Open-Label)|Adverse Event|0|||
13353797|NCT00923091|26663990|FG006|Period VI (Open-Label)|Adverse Event|0|||
13353798|NCT00923091|26663991|FG007|Period VI (Open-Label)|Adverse Event|0|||
13353799|NCT00923091|26663992|FG008|Period VI (Open-Label)|Adverse Event|0|||
13353800|NCT00923091|26663993|FG009|Period VI (Open-Label)|Adverse Event|0|||
13353801|NCT00923091|26663994|FG010|Period VI (Open-Label)|Adverse Event|0|||
13353802|NCT00923091|26663995|FG011|Period VI (Open-Label)|Adverse Event|0|||
13353803|NCT00923091|26663996|FG012|Period VI (Open-Label)|Adverse Event|0|||
13353804|NCT00923091|26663984|FG000|Period VI (Open-Label)|Withdrawal by Subject|15|||
13353805|NCT00923091|26663985|FG001|Period VI (Open-Label)|Withdrawal by Subject|7|||
13353806|NCT00923091|26663986|FG002|Period VI (Open-Label)|Withdrawal by Subject|5|||
13353807|NCT00923091|26663987|FG003|Period VI (Open-Label)|Withdrawal by Subject|0|||
13353808|NCT00923091|26663988|FG004|Period VI (Open-Label)|Withdrawal by Subject|1|||
13353809|NCT00923091|26663989|FG005|Period VI (Open-Label)|Withdrawal by Subject|0|||
13353810|NCT00923091|26663990|FG006|Period VI (Open-Label)|Withdrawal by Subject|0|||
13353811|NCT00923091|26663991|FG007|Period VI (Open-Label)|Withdrawal by Subject|0|||
13353812|NCT00923091|26663992|FG008|Period VI (Open-Label)|Withdrawal by Subject|0|||
13353813|NCT00923091|26663993|FG009|Period VI (Open-Label)|Withdrawal by Subject|0|||
13353814|NCT00923091|26663994|FG010|Period VI (Open-Label)|Withdrawal by Subject|0|||
13353815|NCT00923091|26663995|FG011|Period VI (Open-Label)|Withdrawal by Subject|0|||
13353816|NCT00923091|26663996|FG012|Period VI (Open-Label)|Withdrawal by Subject|0|||
13353817|NCT00923091|26663984|FG000|Period VI (Open-Label)|Protocol Violation|6|||
13353818|NCT00923091|26663985|FG001|Period VI (Open-Label)|Protocol Violation|1|||
13353819|NCT00923091|26663986|FG002|Period VI (Open-Label)|Protocol Violation|3|||
13353820|NCT00923091|26663987|FG003|Period VI (Open-Label)|Protocol Violation|1|||
13353821|NCT00923091|26663988|FG004|Period VI (Open-Label)|Protocol Violation|4|||
13353822|NCT00923091|26663989|FG005|Period VI (Open-Label)|Protocol Violation|0|||
13353823|NCT00923091|26663990|FG006|Period VI (Open-Label)|Protocol Violation|0|||
13353824|NCT00923091|26663991|FG007|Period VI (Open-Label)|Protocol Violation|0|||
13353825|NCT00923091|26663992|FG008|Period VI (Open-Label)|Protocol Violation|0|||
13353826|NCT00923091|26663993|FG009|Period VI (Open-Label)|Protocol Violation|0|||
13353827|NCT00923091|26663994|FG010|Period VI (Open-Label)|Protocol Violation|0|||
13353828|NCT00923091|26663995|FG011|Period VI (Open-Label)|Protocol Violation|0|||
13353829|NCT00923091|26663996|FG012|Period VI (Open-Label)|Protocol Violation|0|||
13353830|NCT00923091|26663984|FG000|Period VI (Open-Label)|Lost to Follow-up|1|||
13353831|NCT00923091|26663985|FG001|Period VI (Open-Label)|Lost to Follow-up|0|||
13353832|NCT00923091|26663986|FG002|Period VI (Open-Label)|Lost to Follow-up|1|||
13353833|NCT00923091|26663987|FG003|Period VI (Open-Label)|Lost to Follow-up|0|||
13353834|NCT00923091|26663988|FG004|Period VI (Open-Label)|Lost to Follow-up|0|||
13353835|NCT00923091|26663989|FG005|Period VI (Open-Label)|Lost to Follow-up|0|||
13353836|NCT00923091|26663990|FG006|Period VI (Open-Label)|Lost to Follow-up|0|||
13353837|NCT00923091|26663991|FG007|Period VI (Open-Label)|Lost to Follow-up|0|||
13353838|NCT00923091|26663992|FG008|Period VI (Open-Label)|Lost to Follow-up|0|||
13353839|NCT00923091|26663993|FG009|Period VI (Open-Label)|Lost to Follow-up|0|||
13353840|NCT00923091|26663994|FG010|Period VI (Open-Label)|Lost to Follow-up|0|||
13353841|NCT00923091|26663995|FG011|Period VI (Open-Label)|Lost to Follow-up|0|||
13353842|NCT00923091|26663996|FG012|Period VI (Open-Label)|Lost to Follow-up|0|||
13353843|NCT00923091|26663984|FG000|Period VI (Open-Label)|Other Reason|0|||
13353844|NCT00923091|26663985|FG001|Period VI (Open-Label)|Other Reason|0|||
13353845|NCT00923091|26663986|FG002|Period VI (Open-Label)|Other Reason|0|||
13353846|NCT00923091|26663987|FG003|Period VI (Open-Label)|Other Reason|1|||
13353847|NCT00923091|26663988|FG004|Period VI (Open-Label)|Other Reason|1|||
13353848|NCT00923091|26663989|FG005|Period VI (Open-Label)|Other Reason|0|||
13353849|NCT00923091|26663990|FG006|Period VI (Open-Label)|Other Reason|0|||
13353850|NCT00923091|26663991|FG007|Period VI (Open-Label)|Other Reason|0|||
13353851|NCT00923091|26663992|FG008|Period VI (Open-Label)|Other Reason|0|||
13353852|NCT00923091|26663993|FG009|Period VI (Open-Label)|Other Reason|0|||
13353853|NCT00923091|26663994|FG010|Period VI (Open-Label)|Other Reason|0|||
13353854|NCT00923091|26663995|FG011|Period VI (Open-Label)|Other Reason|0|||
13353855|NCT00923091|26663996|FG012|Period VI (Open-Label)|Other Reason|0|||
13353856|NCT00923078|26664025|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
13353857|NCT00923078|26664026|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
13353858|NCT00923078|26664027|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0|||
13353859|NCT00923078|26664025|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
13353860|NCT00923078|26664026|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
13353861|NCT00923078|26664027|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20|||
13353862|NCT00922987|26664041|FG000|Overall Study|Insufficient clinical response|1|||
13353863|NCT00922987|26664041|FG000|Overall Study|Protocol Violation|2|||
13353864|NCT00922987|26664041|FG000|Overall Study|Adverse Event|1|||
13353865|NCT00922974|26664076|FG000|Phase II Component|Protocol Violation|2|||
13353866|NCT00922974|26664077|FG001|Phase II Component|Protocol Violation|0|||
13353867|NCT00922974|26664076|FG000|Phase II Component|Not evaluable for treatment review|5|||
13353868|NCT00922974|26664077|FG001|Phase II Component|Not evaluable for treatment review|0|||
13353869|NCT00922974|26664076|FG000|Phase III Component|Protocol Violation|8|||
13353870|NCT00922974|26664077|FG001|Phase III Component|Protocol Violation|6|||
13353871|NCT00922935|26664095|FG000|Overall Study|Protocol Violation|0|||
13353872|NCT00922935|26664096|FG001|Overall Study|Protocol Violation|3|||
13353873|NCT00922935|26664097|FG002|Overall Study|Protocol Violation|0|||
13353874|NCT00922935|26664095|FG000|Overall Study|Physician Decision|1|||
13353875|NCT00922935|26664096|FG001|Overall Study|Physician Decision|1|||
13353876|NCT00922935|26664097|FG002|Overall Study|Physician Decision|0|||
13353877|NCT00922935|26664095|FG000|Overall Study|Lost to Follow-up|0|||
13353878|NCT00922935|26664096|FG001|Overall Study|Lost to Follow-up|1|||
13353879|NCT00922935|26664097|FG002|Overall Study|Lost to Follow-up|0|||
13353880|NCT00922779|26664106|FG000|Overall Study|Adverse Event|67|||
13353881|NCT00922779|26664106|FG000|Overall Study|Pregnancy|7|||
13353882|NCT00922779|26664106|FG000|Overall Study|Withdrawal by Subject|308|||
13353883|NCT00922779|26664106|FG000|Overall Study|Lost to Follow-up|44|||
13353884|NCT00922779|26664106|FG000|Overall Study|Other|27|||
13353885|NCT00922779|26664106|FG000|Overall Study|Missing|1874|||
13353886|NCT00922766|26664117|FG000|Overall Study|Death|3|||
13353887|NCT00922766|26664117|FG000|Overall Study|Withdrawal by Subject|2|||
13353888|NCT00922766|26664117|FG000|Overall Study|Other|1|||
13353889|NCT00922766|26664117|FG000|Overall Study|Adverse Event|1|||
13353890|NCT00922636|26664280|FG000|Overall Study|Adverse Event|3|||
13353891|NCT00922636|26664281|FG001|Overall Study|Adverse Event|3|||
13353892|NCT00922636|26664282|FG002|Overall Study|Adverse Event|2|||
13353893|NCT00922636|26664283|FG003|Overall Study|Adverse Event|3|||
13353894|NCT00922636|26664284|FG004|Overall Study|Adverse Event|2|||
13353895|NCT00922636|26664280|FG000|Overall Study|Lack of Efficacy|1|||
13353896|NCT00922636|26664281|FG001|Overall Study|Lack of Efficacy|7|||
13353897|NCT00922636|26664282|FG002|Overall Study|Lack of Efficacy|3|||
13353898|NCT00922636|26664283|FG003|Overall Study|Lack of Efficacy|2|||
13353899|NCT00922636|26664284|FG004|Overall Study|Lack of Efficacy|4|||
13353900|NCT00922636|26664280|FG000|Overall Study|Sponsor Decision|0|||
13353901|NCT00922636|26664281|FG001|Overall Study|Sponsor Decision|0|||
13393631|NCT00662909|26784485|FG000|Overall Study|Eligibility criterion not met|0|||
13353902|NCT00922636|26664282|FG002|Overall Study|Sponsor Decision|2|||
13353903|NCT00922636|26664283|FG003|Overall Study|Sponsor Decision|0|||
13353904|NCT00922636|26664284|FG004|Overall Study|Sponsor Decision|0|||
13353905|NCT00922636|26664280|FG000|Overall Study|Withdrawal by Subject|0|||
13353906|NCT00922636|26664281|FG001|Overall Study|Withdrawal by Subject|0|||
13353907|NCT00922636|26664282|FG002|Overall Study|Withdrawal by Subject|5|||
13353908|NCT00922636|26664283|FG003|Overall Study|Withdrawal by Subject|2|||
13353909|NCT00922636|26664284|FG004|Overall Study|Withdrawal by Subject|4|||
13353910|NCT00922636|26664280|FG000|Overall Study|Protocol Violation|0|||
13353911|NCT00922636|26664281|FG001|Overall Study|Protocol Violation|0|||
13353912|NCT00922636|26664282|FG002|Overall Study|Protocol Violation|2|||
13353913|NCT00922636|26664283|FG003|Overall Study|Protocol Violation|2|||
13353914|NCT00922636|26664284|FG004|Overall Study|Protocol Violation|0|||
13353915|NCT00922636|26664280|FG000|Overall Study|Entry Criteria Not Met|0|||
13353916|NCT00922636|26664281|FG001|Overall Study|Entry Criteria Not Met|0|||
13353917|NCT00922636|26664282|FG002|Overall Study|Entry Criteria Not Met|1|||
13353918|NCT00922636|26664283|FG003|Overall Study|Entry Criteria Not Met|1|||
13353919|NCT00922636|26664284|FG004|Overall Study|Entry Criteria Not Met|0|||
13353920|NCT00922636|26664280|FG000|Overall Study|Parent/Caregiver Decision|2|||
13353921|NCT00922636|26664281|FG001|Overall Study|Parent/Caregiver Decision|4|||
13353922|NCT00922636|26664282|FG002|Overall Study|Parent/Caregiver Decision|3|||
13353923|NCT00922636|26664283|FG003|Overall Study|Parent/Caregiver Decision|5|||
13353924|NCT00922636|26664284|FG004|Overall Study|Parent/Caregiver Decision|2|||
13353925|NCT00922636|26664280|FG000|Overall Study|Lost to Follow-up|1|||
13353926|NCT00922636|26664281|FG001|Overall Study|Lost to Follow-up|2|||
13353927|NCT00922636|26664282|FG002|Overall Study|Lost to Follow-up|2|||
13353928|NCT00922636|26664283|FG003|Overall Study|Lost to Follow-up|2|||
13353929|NCT00922636|26664284|FG004|Overall Study|Lost to Follow-up|4|||
13353930|NCT00922623|26664292|FG000|Overall Study|Other|4|||
13353931|NCT00922623|26664292|FG000|Overall Study|Lost to Follow-up|1|||
13353932|NCT00922480|26664307|FG000|Main Study|Protocol Violation|3|||
13353933|NCT00922480|26664308|FG001|Main Study|Protocol Violation|6|||
13353934|NCT00922480|26664307|FG000|Main Study|Adverse Event|6|||
13353935|NCT00922480|26664308|FG001|Main Study|Adverse Event|7|||
13353936|NCT00922480|26664307|FG000|Main Study|Lack of Efficacy|3|||
13353937|NCT00922480|26664308|FG001|Main Study|Lack of Efficacy|0|||
13353938|NCT00922480|26664307|FG000|Main Study|Withdrawal by Subject|20|||
13353939|NCT00922480|26664308|FG001|Main Study|Withdrawal by Subject|15|||
13353940|NCT00922480|26664307|FG000|Main Study|Lost to Follow-up|5|||
13353941|NCT00922480|26664308|FG001|Main Study|Lost to Follow-up|0|||
13353942|NCT00922480|26664307|FG000|Main Study|Physician Decision|0|||
13353943|NCT00922480|26664308|FG001|Main Study|Physician Decision|1|||
13353944|NCT00922480|26664307|FG000|Extension Study|Protocol Violation|3|||
13353945|NCT00922480|26664308|FG001|Extension Study|Protocol Violation|0|||
13353946|NCT00922480|26664307|FG000|Extension Study|Adverse Event|1|||
13353947|NCT00922480|26664308|FG001|Extension Study|Adverse Event|1|||
13353948|NCT00922480|26664307|FG000|Extension Study|Withdrawal by Subject|1|||
13353949|NCT00922480|26664308|FG001|Extension Study|Withdrawal by Subject|1|||
13353950|NCT00922480|26664307|FG000|Extension Study|Others|0|||
13353951|NCT00922480|26664308|FG001|Extension Study|Others|1|||
13353952|NCT00922441|26664326|FG000|Overall Study|Protocol Violation|0|||
13353953|NCT00922441|26664327|FG001|Overall Study|Protocol Violation|0|||
13353954|NCT00922441|26664328|FG002|Overall Study|Protocol Violation|2|||
13353955|NCT00922441|26664326|FG000|Overall Study|Withdrawal by Subject|0|||
13353956|NCT00922441|26664327|FG001|Overall Study|Withdrawal by Subject|0|||
13353957|NCT00922441|26664328|FG002|Overall Study|Withdrawal by Subject|1|||
13353958|NCT00922428|26664359|FG000|Overall Study|retrospective/extremely implausible data|2|||
13353959|NCT00922428|26664359|FG000|Overall Study|no medication use or questionable use|13|||
13353960|NCT00922272|26664418|FG000|Open-label Phase|Adverse Event|5|||
13353961|NCT00922272|26664419|FG001|Open-label Phase|Adverse Event|0|||
13353962|NCT00922272|26664418|FG000|Open-label Phase|Protocol Violation|1|||
13353963|NCT00922272|26664419|FG001|Open-label Phase|Protocol Violation|0|||
13353964|NCT00922272|26664418|FG000|Open-label Phase|Withdrawal by Subject|11|||
13353965|NCT00922272|26664419|FG001|Open-label Phase|Withdrawal by Subject|0|||
13353966|NCT00922272|26664418|FG000|Open-label Phase|Failure to meet randomization criteria|1|||
13353967|NCT00922272|26664419|FG001|Open-label Phase|Failure to meet randomization criteria|0|||
13353968|NCT00922272|26664418|FG000|Open-label Phase|Withdrawal criteria met|5|||
13353969|NCT00922272|26664419|FG001|Open-label Phase|Withdrawal criteria met|0|||
13353970|NCT00922272|26664418|FG000|Double-blind Phase|Adverse Event|1|||
13353971|NCT00922272|26664419|FG001|Double-blind Phase|Adverse Event|1|||
13353972|NCT00922272|26664418|FG000|Double-blind Phase|Withdrawal by Subject|1|||
13353973|NCT00922272|26664419|FG001|Double-blind Phase|Withdrawal by Subject|1|||
13353974|NCT00922272|26664418|FG000|Double-blind Phase|Lost to Follow-up|2|||
13353975|NCT00922272|26664419|FG001|Double-blind Phase|Lost to Follow-up|1|||
13353976|NCT00922272|26664418|FG000|Double-blind Phase|Withdrawal criteria met|1|||
13353977|NCT00922272|26664419|FG001|Double-blind Phase|Withdrawal criteria met|1|||
13353978|NCT00922272|26664418|FG000|Double-blind Phase|Noncompliance|1|||
13353979|NCT00922272|26664419|FG001|Double-blind Phase|Noncompliance|1|||
13353980|NCT00922272|26664418|FG000|Double-blind Phase|Positive urine drug screen|1|||
13353981|NCT00922272|26664419|FG001|Double-blind Phase|Positive urine drug screen|1|||
13353982|NCT00922207|26664455|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
13353983|NCT00922207|26664456|FG001|Overall Study|Adverse Event/Intercurrent Illness|0|||
13353984|NCT00922207|26664457|FG002|Overall Study|Adverse Event/Intercurrent Illness|0|||
13353985|NCT00922207|26664455|FG000|Overall Study|Insufficient Therapeutic Response|0|||
13353986|NCT00922207|26664456|FG001|Overall Study|Insufficient Therapeutic Response|0|||
13353987|NCT00922207|26664457|FG002|Overall Study|Insufficient Therapeutic Response|1|||
13353988|NCT00922207|26664455|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
13353989|NCT00922207|26664456|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
13353990|NCT00922207|26664457|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
13353991|NCT00922207|26664455|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
13353992|NCT00922207|26664456|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
13353993|NCT00922207|26664457|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0|||
13353994|NCT00922207|26664455|FG000|Overall Study|Withdrew Consent|2|||
13353995|NCT00922207|26664456|FG001|Overall Study|Withdrew Consent|5|||
13353996|NCT00922207|26664457|FG002|Overall Study|Withdrew Consent|2|||
13353997|NCT00922207|26664455|FG000|Overall Study|Abnormality of Laboratory Test|0|||
13353998|NCT00922207|26664456|FG001|Overall Study|Abnormality of Laboratory Test|1|||
13353999|NCT00922207|26664457|FG002|Overall Study|Abnormality of Laboratory Test|1|||
13354000|NCT00922116|26664468|FG000|Overall Study|Adverse Event|4|||
13354001|NCT00922116|26664468|FG000|Overall Study|Death|1|||
13354002|NCT00922116|26664468|FG000|Overall Study|Lost to Follow-up|1|||
13354003|NCT00922116|26664468|FG000|Overall Study|Withdrawal by Subject|4|||
13354004|NCT00922116|26664468|FG000|Overall Study|Other|5|||
13354005|NCT00921557|26664536|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2|||
13354006|NCT00921557|26664537|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
13354007|NCT00921557|26664538|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
13354008|NCT00921557|26664536|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
13354009|NCT00921557|26664537|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1|||
13354010|NCT00921557|26664538|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
13354011|NCT00921557|26664536|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
13354012|NCT00921557|26664537|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
13354013|NCT00921557|26664538|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1|||
13354014|NCT00921557|26664536|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1|||
13354015|NCT00921557|26664537|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
13354016|NCT00921557|26664538|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
13354017|NCT00921557|26664536|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2|||
13354018|NCT00921557|26664537|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
13354019|NCT00921557|26664538|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
13354020|NCT00921024|26664553|FG000|Overall Study|Lost to Follow-up|2|||
13354021|NCT00921024|26664554|FG001|Overall Study|Lost to Follow-up|0|||
13354022|NCT00921024|26664553|FG000|Overall Study|Received concomittant therapy|2|||
13354023|NCT00921024|26664554|FG001|Overall Study|Received concomittant therapy|0|||
13354024|NCT00921024|26664553|FG000|Overall Study|Withdrawal by Subject|0|||
13354025|NCT00921024|26664554|FG001|Overall Study|Withdrawal by Subject|3|||
13354026|NCT00920907|26664599|FG000|Induction Period|Adverse Event|0|||
13354027|NCT00920907|26664600|FG001|Induction Period|Adverse Event|2|||
13354028|NCT00920907|26664599|FG000|Induction Period|Death|1|||
13354029|NCT00920907|26664600|FG001|Induction Period|Death|1|||
13354030|NCT00920907|26664599|FG000|Induction Period|Disease Progression|12|||
13354031|NCT00920907|26664600|FG001|Induction Period|Disease Progression|11|||
13354032|NCT00920907|26664599|FG000|Induction Period|Study Drug Toxicity|8|||
13354033|NCT00920907|26664600|FG001|Induction Period|Study Drug Toxicity|6|||
13354034|NCT00920907|26664599|FG000|Induction Period|No longer meets study criteria|0|||
13354035|NCT00920907|26664600|FG001|Induction Period|No longer meets study criteria|1|||
13354036|NCT00920907|26664599|FG000|Induction Period|Withdrawal by Subject|1|||
13354037|NCT00920907|26664600|FG001|Induction Period|Withdrawal by Subject|1|||
13354038|NCT00920907|26664599|FG000|Maintenance Period|Disease Progression|3|||
13354039|NCT00920907|26664600|FG001|Maintenance Period|Disease Progression|7|||
13354040|NCT00920907|26664599|FG000|Maintenance Period|Administrative (study closure)|7|||
13354041|NCT00920907|26664600|FG001|Maintenance Period|Administrative (study closure)|2|||
13354042|NCT00920907|26664599|FG000|Maintenance Period|Study Drug Toxicity|0|||
13354043|NCT00920907|26664600|FG001|Maintenance Period|Study Drug Toxicity|2|||
13354044|NCT00920907|26664599|FG000|Maintenance Period|Death|1|||
13354045|NCT00920907|26664600|FG001|Maintenance Period|Death|1|||
13354046|NCT00920907|26664599|FG000|Maintenance Period|Withdrawal by Subject|1|||
13354047|NCT00920907|26664600|FG001|Maintenance Period|Withdrawal by Subject|0|||
13354048|NCT00920907|26664599|FG000|Maintenance Period|Adverse Event|0|||
13354049|NCT00920907|26664600|FG001|Maintenance Period|Adverse Event|1|||
13354050|NCT00920855|26664632|FG000|Overall Study|Adverse Event|1|||
13354051|NCT00920855|26664633|FG001|Overall Study|Adverse Event|1|||
13354052|NCT00920855|26664634|FG002|Overall Study|Adverse Event|4|||
13354053|NCT00920855|26664632|FG000|Overall Study|Withdrawal by Subject|2|||
13354054|NCT00920855|26664633|FG001|Overall Study|Withdrawal by Subject|1|||
13354055|NCT00920855|26664634|FG002|Overall Study|Withdrawal by Subject|6|||
13354056|NCT00920855|26664632|FG000|Overall Study|Disease progression|2|||
13354057|NCT00920855|26664633|FG001|Overall Study|Disease progression|1|||
13354058|NCT00920855|26664634|FG002|Overall Study|Disease progression|10|||
13354059|NCT00920855|26664632|FG000|Overall Study|Noncompliance to study medication|0|||
13354060|NCT00920855|26664633|FG001|Overall Study|Noncompliance to study medication|0|||
13354061|NCT00920855|26664634|FG002|Overall Study|Noncompliance to study medication|1|||
13354062|NCT00920855|26664632|FG000|Overall Study|Response plateau; started maintenance|0|||
13354063|NCT00920855|26664633|FG001|Overall Study|Response plateau; started maintenance|0|||
13354064|NCT00920855|26664634|FG002|Overall Study|Response plateau; started maintenance|1|||
13354065|NCT00920829|26664657|FG000|Allocation|No post randomization data|3|||
13354066|NCT00920829|26664658|FG001|Allocation|No post randomization data|1|||
13354067|NCT00920829|26664659|FG002|Allocation|No post randomization data|0|||
13354068|NCT00920829|26664660|FG003|Allocation|No post randomization data|2|||
13354069|NCT00920829|26664657|FG000|Available for Analysis|Withdrawal by Subject|6|||
13354070|NCT00920829|26664658|FG001|Available for Analysis|Withdrawal by Subject|6|||
13354071|NCT00920829|26664659|FG002|Available for Analysis|Withdrawal by Subject|6|||
13354072|NCT00920829|26664660|FG003|Available for Analysis|Withdrawal by Subject|10|||
13354073|NCT00920829|26664657|FG000|Available for Analysis|Required Medical Treatment|0|||
13354074|NCT00920829|26664658|FG001|Available for Analysis|Required Medical Treatment|1|||
13354075|NCT00920829|26664659|FG002|Available for Analysis|Required Medical Treatment|2|||
13354076|NCT00920829|26664660|FG003|Available for Analysis|Required Medical Treatment|0|||
13354077|NCT00920829|26664657|FG000|Available for Analysis|Adverse Event|1|||
13354078|NCT00920829|26664658|FG001|Available for Analysis|Adverse Event|2|||
13354079|NCT00920829|26664659|FG002|Available for Analysis|Adverse Event|1|||
13354080|NCT00920829|26664660|FG003|Available for Analysis|Adverse Event|0|||
13354081|NCT00920829|26664657|FG000|Available for Analysis|Death|1|||
13354082|NCT00920829|26664658|FG001|Available for Analysis|Death|0|||
13354083|NCT00920829|26664659|FG002|Available for Analysis|Death|0|||
13354084|NCT00920829|26664660|FG003|Available for Analysis|Death|0|||
13124887|NCT02937636|25954326|FG001|Overall Study|Other (Not specified)|2|||
13124888|NCT02937584|25954345|FG000|Period 1|Adverse Event|1|||
13124889|NCT02937584|25954346|FG001|Period 1|Adverse Event|2|||
13124890|NCT02937584|25954345|FG000|Washout|Adverse Event|0|||
13354085|NCT00920829|26664657|FG000|Available for Analysis|Protocol Violation|0|||
13354086|NCT00920829|26664658|FG001|Available for Analysis|Protocol Violation|0|||
13354087|NCT00920829|26664659|FG002|Available for Analysis|Protocol Violation|1|||
13124891|NCT02937584|25954346|FG001|Washout|Adverse Event|1|||
13124892|NCT02937545|25954381|FG000|Overall Study|Withdrawal by Subject|1|||
13124893|NCT02937545|25954382|FG001|Overall Study|Withdrawal by Subject|2|||
13124894|NCT02937545|25954383|FG002|Overall Study|Withdrawal by Subject|6|||
13124895|NCT02937545|25954384|FG003|Overall Study|Withdrawal by Subject|7|||
13124896|NCT02937545|25954381|FG000|Overall Study|Lost to Follow-up|1|||
13124897|NCT02937545|25954382|FG001|Overall Study|Lost to Follow-up|0|||
13124898|NCT02937545|25954383|FG002|Overall Study|Lost to Follow-up|0|||
13354088|NCT00920829|26664660|FG003|Available for Analysis|Protocol Violation|0|||
13354089|NCT00920829|26664657|FG000|Available for Analysis|Required more treatment|0|||
13354090|NCT00920829|26664658|FG001|Available for Analysis|Required more treatment|2|||
13354091|NCT00920829|26664659|FG002|Available for Analysis|Required more treatment|0|||
13354092|NCT00920829|26664660|FG003|Available for Analysis|Required more treatment|1|||
13354093|NCT00920816|26664711|FG000|Overall Study|Death|116|||
13354094|NCT00920816|26664712|FG001|Overall Study|Death|63|||
13354095|NCT00920816|26664713|FG002|Overall Study|Death|8|||
13354096|NCT00920816|26664714|FG003|Overall Study|Death|3|||
13354097|NCT00920816|26664711|FG000|Overall Study|Participant refused continued treatment for reason other than adverse events|11|||
13354098|NCT00920816|26664712|FG001|Overall Study|Participant refused continued treatment for reason other than adverse events|5|||
13354099|NCT00920816|26664713|FG002|Overall Study|Participant refused continued treatment for reason other than adverse events|1|||
13354100|NCT00920816|26664714|FG003|Overall Study|Participant refused continued treatment for reason other than adverse events|0|||
13354101|NCT00920816|26664711|FG000|Overall Study|Global deterioration of health status|2|||
13354102|NCT00920816|26664712|FG001|Overall Study|Global deterioration of health status|0|||
13354103|NCT00920816|26664713|FG002|Overall Study|Global deterioration of health status|0|||
13354104|NCT00920816|26664714|FG003|Overall Study|Global deterioration of health status|0|||
13354105|NCT00920816|26664711|FG000|Overall Study|Objective progression or relapse|6|||
13354106|NCT00920816|26664712|FG001|Overall Study|Objective progression or relapse|2|||
13354107|NCT00920816|26664713|FG002|Overall Study|Objective progression or relapse|0|||
13354108|NCT00920816|26664714|FG003|Overall Study|Objective progression or relapse|0|||
13354109|NCT00920816|26664711|FG000|Overall Study|Other|26|||
13354110|NCT00920816|26664712|FG001|Overall Study|Other|15|||
13354111|NCT00920816|26664713|FG002|Overall Study|Other|1|||
13124899|NCT02937545|25954384|FG003|Overall Study|Lost to Follow-up|0|||
13124900|NCT02937454|25954419|FG000|Overall Study|Adverse Event|0|||
13354112|NCT00920816|26664714|FG003|Overall Study|Other|2|||
13354113|NCT00920816|26664711|FG000|Overall Study|Lost to Follow-up|11|||
13354114|NCT00920816|26664712|FG001|Overall Study|Lost to Follow-up|2|||
13354115|NCT00920816|26664713|FG002|Overall Study|Lost to Follow-up|0|||
13354116|NCT00920816|26664714|FG003|Overall Study|Lost to Follow-up|0|||
13354117|NCT00920816|26664711|FG000|Overall Study|Adverse Event|1|||
13354118|NCT00920816|26664712|FG001|Overall Study|Adverse Event|1|||
13354119|NCT00920816|26664713|FG002|Overall Study|Adverse Event|1|||
13354120|NCT00920816|26664714|FG003|Overall Study|Adverse Event|0|||
13354121|NCT00920816|26664711|FG000|Overall Study|Data not disclosed due to lack of HGRAC filings|16|||
13354122|NCT00920816|26664712|FG001|Overall Study|Data not disclosed due to lack of HGRAC filings|8|||
13354123|NCT00920816|26664713|FG002|Overall Study|Data not disclosed due to lack of HGRAC filings|124|||
13354124|NCT00920816|26664714|FG003|Overall Study|Data not disclosed due to lack of HGRAC filings|64|||
13354125|NCT00920816|26664711|FG000|Overall Study|Randomized but not treated|3|||
13354126|NCT00920816|26664712|FG001|Overall Study|Randomized but not treated|0|||
13354127|NCT00920816|26664713|FG002|Overall Study|Randomized but not treated|0|||
13354128|NCT00920816|26664714|FG003|Overall Study|Randomized but not treated|0|||
13354129|NCT00920790|26664725|FG000|Overall Study|aggravation of general condition|14|||
13354130|NCT00920699|26664749|FG000|Overall Study|Withdrawal by Subject|2|||
13354131|NCT00920699|26664750|FG001|Overall Study|Withdrawal by Subject|0|||
13354132|NCT00920699|26664751|FG002|Overall Study|Withdrawal by Subject|2|||
13354133|NCT00920699|26664749|FG000|Overall Study|no longer met eligibility|0|||
13354134|NCT00920699|26664750|FG001|Overall Study|no longer met eligibility|1|||
13354135|NCT00920699|26664751|FG002|Overall Study|no longer met eligibility|0|||
13354136|NCT00920699|26664749|FG000|Overall Study|Lost to Follow-up|0|||
13354137|NCT00920699|26664750|FG001|Overall Study|Lost to Follow-up|0|||
13354138|NCT00920699|26664751|FG002|Overall Study|Lost to Follow-up|2|||
13354139|NCT00920686|26664781|FG000|Overall Study|Lost to Follow-up|2|||
13354140|NCT00920686|26664782|FG001|Overall Study|Lost to Follow-up|3|||
13354141|NCT00920686|26664783|FG002|Overall Study|Lost to Follow-up|1|||
13354142|NCT00920686|26664781|FG000|Overall Study|Study drug dosing criteria not met|17|||
13354143|NCT00920686|26664782|FG001|Overall Study|Study drug dosing criteria not met|19|||
13354144|NCT00920686|26664783|FG002|Overall Study|Study drug dosing criteria not met|12|||
13354145|NCT00920556|26664824|FG000|Overall Study|Adverse Event|16|||
13354146|NCT00920556|26664824|FG000|Overall Study|Physician Decision|7|||
13354147|NCT00920556|26664824|FG000|Overall Study|Withdrawal by Subject|1|||
13354148|NCT00920426|26664902|FG000|ITZ111451|Adverse Event|1|||
13354149|NCT00920426|26664903|FG001|ITZ111451|Adverse Event|0|||
13354150|NCT00920426|26664904|FG002|ITZ111451|Adverse Event|0|||
13354151|NCT00920426|26664905|FG003|ITZ111451|Adverse Event|0|||
13354152|NCT00920387|26664922|FG000|Stage 1|Adverse Event|1|||
13354153|NCT00920387|26664923|FG001|Stage 1|Adverse Event|0|||
13354154|NCT00920387|26664924|FG002|Stage 1|Adverse Event|0|||
13354155|NCT00920218|26665035|FG000|Overall Study|Serious Adverse Event|2|||
13354156|NCT00920218|26665036|FG001|Overall Study|Serious Adverse Event|0|||
13354157|NCT00920218|26665037|FG002|Overall Study|Serious Adverse Event|2|||
13354158|NCT00920218|26665038|FG003|Overall Study|Serious Adverse Event|1|||
13354159|NCT00920218|26665035|FG000|Overall Study|Withdrawal by Subject|0|||
13354160|NCT00920218|26665036|FG001|Overall Study|Withdrawal by Subject|3|||
13354161|NCT00920218|26665037|FG002|Overall Study|Withdrawal by Subject|2|||
13354162|NCT00920218|26665038|FG003|Overall Study|Withdrawal by Subject|0|||
13354163|NCT00920218|26665035|FG000|Overall Study|Migrated/moved from study area|0|||
13354164|NCT00920218|26665036|FG001|Overall Study|Migrated/moved from study area|0|||
13354165|NCT00920218|26665037|FG002|Overall Study|Migrated/moved from study area|1|||
13354166|NCT00920218|26665038|FG003|Overall Study|Migrated/moved from study area|0|||
13354167|NCT00920218|26665035|FG000|Overall Study|Lost to Follow-up|0|||
13354168|NCT00920218|26665036|FG001|Overall Study|Lost to Follow-up|1|||
13354169|NCT00920218|26665037|FG002|Overall Study|Lost to Follow-up|0|||
13354170|NCT00920218|26665038|FG003|Overall Study|Lost to Follow-up|3|||
13354171|NCT00920218|26665035|FG000|Overall Study|Transplant failed/malignancy recurrence|0|||
13354172|NCT00920218|26665036|FG001|Overall Study|Transplant failed/malignancy recurrence|1|||
13354173|NCT00920218|26665037|FG002|Overall Study|Transplant failed/malignancy recurrence|2|||
13354174|NCT00920218|26665038|FG003|Overall Study|Transplant failed/malignancy recurrence|3|||
13354175|NCT00920218|26665035|FG000|Overall Study|Other|0|||
13354176|NCT00920218|26665036|FG001|Overall Study|Other|0|||
13354177|NCT00920218|26665037|FG002|Overall Study|Other|1|||
13354178|NCT00920218|26665038|FG003|Overall Study|Other|0|||
13354179|NCT00920140|26665092|FG000|Phase 1 (Dose Escalation)|Adverse Event|3|||
13354180|NCT00920140|26665093|FG001|Phase 1 (Dose Escalation)|Adverse Event|3|||
13354181|NCT00920140|26665094|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
13354182|NCT00920140|26665095|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
13354183|NCT00920140|26665096|FG004|Phase 1 (Dose Escalation)|Adverse Event|0|||
13354184|NCT00920140|26665092|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2|||
13354185|NCT00920140|26665093|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4|||
13354186|NCT00920140|26665094|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
13354187|NCT00920140|26665095|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
13354188|NCT00920140|26665096|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
13354189|NCT00920140|26665092|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
13354190|NCT00920140|26665093|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2|||
13354191|NCT00920140|26665094|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
13354192|NCT00920140|26665095|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
13354193|NCT00920140|26665096|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
13354194|NCT00920140|26665092|FG000|Phase 2|Adverse Event|0|||
13354195|NCT00920140|26665093|FG001|Phase 2|Adverse Event|0|||
13354196|NCT00920140|26665094|FG002|Phase 2|Adverse Event|14|||
13354197|NCT00920140|26665095|FG003|Phase 2|Adverse Event|2|||
13354198|NCT00920140|26665096|FG004|Phase 2|Adverse Event|3|||
13354199|NCT00920140|26665092|FG000|Phase 2|Lack of Efficacy|0|||
13354200|NCT00920140|26665093|FG001|Phase 2|Lack of Efficacy|0|||
13354201|NCT00920140|26665094|FG002|Phase 2|Lack of Efficacy|29|||
13354202|NCT00920140|26665095|FG003|Phase 2|Lack of Efficacy|14|||
13354203|NCT00920140|26665096|FG004|Phase 2|Lack of Efficacy|5|||
13354204|NCT00920140|26665092|FG000|Phase 2|Lost to Follow-up|0|||
13354205|NCT00920140|26665093|FG001|Phase 2|Lost to Follow-up|0|||
13354206|NCT00920140|26665094|FG002|Phase 2|Lost to Follow-up|0|||
13354207|NCT00920140|26665095|FG003|Phase 2|Lost to Follow-up|1|||
13354208|NCT00920140|26665096|FG004|Phase 2|Lost to Follow-up|0|||
13354209|NCT00920140|26665092|FG000|Phase 2|Physician Decision|0|||
13354210|NCT00920140|26665093|FG001|Phase 2|Physician Decision|0|||
13354211|NCT00920140|26665094|FG002|Phase 2|Physician Decision|3|||
13354212|NCT00920140|26665095|FG003|Phase 2|Physician Decision|3|||
13354213|NCT00920140|26665096|FG004|Phase 2|Physician Decision|2|||
13354214|NCT00920140|26665092|FG000|Phase 2|Withdrawal by Subject|0|||
13354215|NCT00920140|26665093|FG001|Phase 2|Withdrawal by Subject|0|||
13354216|NCT00920140|26665094|FG002|Phase 2|Withdrawal by Subject|4|||
13354217|NCT00920140|26665095|FG003|Phase 2|Withdrawal by Subject|2|||
13354218|NCT00920140|26665096|FG004|Phase 2|Withdrawal by Subject|1|||
13354219|NCT00919867|26665136|FG000|First Intervention|Withdrawal by Subject|0|||
13354220|NCT00919867|26665137|FG001|First Intervention|Withdrawal by Subject|0|||
13354221|NCT00919867|26665138|FG002|First Intervention|Withdrawal by Subject|1|||
13354222|NCT00919867|26665139|FG003|First Intervention|Withdrawal by Subject|0|||
13354223|NCT00919867|26665140|FG004|First Intervention|Withdrawal by Subject|0|||
13354224|NCT00919867|26665141|FG005|First Intervention|Withdrawal by Subject|0|||
13354225|NCT00919867|26665136|FG000|First Intervention|Physician Decision|0|||
13354226|NCT00919867|26665137|FG001|First Intervention|Physician Decision|0|||
13354227|NCT00919867|26665138|FG002|First Intervention|Physician Decision|0|||
13354228|NCT00919867|26665139|FG003|First Intervention|Physician Decision|0|||
13354229|NCT00919867|26665140|FG004|First Intervention|Physician Decision|0|||
13354230|NCT00919867|26665141|FG005|First Intervention|Physician Decision|1|||
13354231|NCT00919854|26665152|FG000|Overall Study|Adverse Event|1|||
13354232|NCT00919711|26665171|FG000|Overall Study|Withdrawal by Subject|15|||
13354233|NCT00919711|26665172|FG001|Overall Study|Withdrawal by Subject|7|||
13354234|NCT00919711|26665171|FG000|Overall Study|Adverse Event|13|||
13354235|NCT00919711|26665172|FG001|Overall Study|Adverse Event|3|||
13354236|NCT00919711|26665171|FG000|Overall Study|Other|1|||
13354237|NCT00919711|26665172|FG001|Overall Study|Other|2|||
13354238|NCT00919711|26665171|FG000|Overall Study|Administrative Decision|0|||
13354239|NCT00919711|26665172|FG001|Overall Study|Administrative Decision|1|||
13354240|NCT00919711|26665171|FG000|Overall Study|Lost to Follow-up|2|||
13354241|NCT00919711|26665172|FG001|Overall Study|Lost to Follow-up|0|||
13354242|NCT00919711|26665171|FG000|Overall Study|Death|1|||
13354243|NCT00919711|26665172|FG001|Overall Study|Death|0|||
13354244|NCT00919711|26665171|FG000|Overall Study|Noncompliance|1|||
13354245|NCT00919711|26665172|FG001|Overall Study|Noncompliance|0|||
13354246|NCT00919633|26665203|FG000|Overall Study|Adverse Event|1|||
13354247|NCT00919633|26665204|FG001|Overall Study|Adverse Event|9|||
13354248|NCT00919633|26665205|FG002|Overall Study|Adverse Event|12|||
13354249|NCT00919633|26665206|FG003|Overall Study|Adverse Event|10|||
13354250|NCT00919633|26665203|FG000|Overall Study|Death|0|||
13354251|NCT00919633|26665204|FG001|Overall Study|Death|0|||
13354252|NCT00919633|26665205|FG002|Overall Study|Death|2|||
13354253|NCT00919633|26665206|FG003|Overall Study|Death|0|||
13354254|NCT00919633|26665203|FG000|Overall Study|Lack of Efficacy|17|||
13354255|NCT00919633|26665204|FG001|Overall Study|Lack of Efficacy|3|||
13354256|NCT00919633|26665205|FG002|Overall Study|Lack of Efficacy|2|||
13354257|NCT00919633|26665206|FG003|Overall Study|Lack of Efficacy|3|||
13354258|NCT00919633|26665203|FG000|Overall Study|Withdrawal by Subject|1|||
13354259|NCT00919633|26665204|FG001|Overall Study|Withdrawal by Subject|2|||
13354260|NCT00919633|26665205|FG002|Overall Study|Withdrawal by Subject|4|||
13354261|NCT00919633|26665206|FG003|Overall Study|Withdrawal by Subject|3|||
13354262|NCT00919633|26665203|FG000|Overall Study|Lost to Follow-up|3|||
13354263|NCT00919633|26665204|FG001|Overall Study|Lost to Follow-up|1|||
13354264|NCT00919633|26665205|FG002|Overall Study|Lost to Follow-up|0|||
13354265|NCT00919633|26665206|FG003|Overall Study|Lost to Follow-up|2|||
13354266|NCT00919633|26665203|FG000|Overall Study|Withdraw consent post transition to SOC|0|||
13354267|NCT00919633|26665204|FG001|Overall Study|Withdraw consent post transition to SOC|0|||
13354268|NCT00919633|26665205|FG002|Overall Study|Withdraw consent post transition to SOC|1|||
13354269|NCT00919633|26665206|FG003|Overall Study|Withdraw consent post transition to SOC|1|||
13354270|NCT00919633|26665203|FG000|Overall Study|Protocol Violation|0|||
13354271|NCT00919633|26665204|FG001|Overall Study|Protocol Violation|0|||
13354272|NCT00919633|26665205|FG002|Overall Study|Protocol Violation|0|||
13354273|NCT00919633|26665206|FG003|Overall Study|Protocol Violation|1|||
13354274|NCT00919633|26665203|FG000|Overall Study|Physician Decision|0|||
13354275|NCT00919633|26665204|FG001|Overall Study|Physician Decision|0|||
13354276|NCT00919633|26665205|FG002|Overall Study|Physician Decision|0|||
13354277|NCT00919633|26665206|FG003|Overall Study|Physician Decision|1|||
13354278|NCT00919633|26665203|FG000|Overall Study|Request of withdrawal w/o future contact|0|||
13354279|NCT00919633|26665204|FG001|Overall Study|Request of withdrawal w/o future contact|0|||
13354280|NCT00919633|26665205|FG002|Overall Study|Request of withdrawal w/o future contact|1|||
13354281|NCT00919633|26665206|FG003|Overall Study|Request of withdrawal w/o future contact|0|||
13354282|NCT00919633|26665203|FG000|Overall Study|Viral rebound outside protocol timepoint|0|||
13354283|NCT00919633|26665204|FG001|Overall Study|Viral rebound outside protocol timepoint|0|||
13354284|NCT00919633|26665205|FG002|Overall Study|Viral rebound outside protocol timepoint|1|||
13354285|NCT00919633|26665206|FG003|Overall Study|Viral rebound outside protocol timepoint|0|||
13354286|NCT00919061|26665213|FG000|Overall Study|Adverse Event|1|||
13354287|NCT00919061|26665213|FG000|Overall Study|Withdrawal by Subject|1|||
13354288|NCT00918957|26665247|FG000|Overall Study|Adverse Event|2|||
13354289|NCT00918957|26665248|FG001|Overall Study|Adverse Event|0|||
13354290|NCT00918957|26665247|FG000|Overall Study|Withdrawal by Subject|1|||
13354291|NCT00918957|26665248|FG001|Overall Study|Withdrawal by Subject|0|||
13354292|NCT00918879|26665267|FG000|Overall Study|Withdrawal by Subject|4|||
13354293|NCT00918879|26665268|FG001|Overall Study|Withdrawal by Subject|4|||
13354294|NCT00918879|26665267|FG000|Overall Study|Lost to Follow-up|1|||
13354295|NCT00918879|26665268|FG001|Overall Study|Lost to Follow-up|1|||
13354296|NCT00918879|26665267|FG000|Overall Study|Severe non-compliance to protocol|1|||
13354297|NCT00918879|26665268|FG001|Overall Study|Severe non-compliance to protocol|1|||
13354298|NCT00918749|26665310|FG000|Overall Study|Adverse Event|1|||
13354299|NCT00918749|26665311|FG001|Overall Study|Adverse Event|0|||
13354300|NCT00918749|26665312|FG002|Overall Study|Adverse Event|1|||
13354301|NCT00918749|26665310|FG000|Overall Study|Lost to Follow-up|0|||
13354302|NCT00918749|26665311|FG001|Overall Study|Lost to Follow-up|0|||
13354303|NCT00918749|26665312|FG002|Overall Study|Lost to Follow-up|1|||
13354304|NCT00918749|26665310|FG000|Overall Study|Withdrawal by Subject|5|||
13354305|NCT00918749|26665311|FG001|Overall Study|Withdrawal by Subject|3|||
13354306|NCT00918749|26665312|FG002|Overall Study|Withdrawal by Subject|5|||
13354307|NCT00918749|26665310|FG000|Overall Study|No Study Medication Taken|1|||
13354308|NCT00918749|26665311|FG001|Overall Study|No Study Medication Taken|0|||
13354309|NCT00918749|26665312|FG002|Overall Study|No Study Medication Taken|0|||
13354310|NCT00918736|26665318|FG000|Overall Study|Withdrawal by Subject|4|||
13354311|NCT00918684|26665326|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16|||
13354312|NCT00918684|26665326|FG000|Treatment Phase|Lack of Efficacy|6|||
13354313|NCT00918684|26665326|FG000|Treatment Phase|Lost to Follow-up|2|||
13354314|NCT00918684|26665326|FG000|Treatment Phase|Physician Decision|8|||
13354315|NCT00918684|26665326|FG000|Treatment Phase|Protocol Violation|1|||
13354316|NCT00918684|26665326|FG000|Treatment Phase|Withdrawal by Subject|8|||
13354317|NCT00918645|26665334|FG000|Overall Study|Withdrawal by Subject|1|||
13354318|NCT00918580|26665354|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1|||
13354319|NCT00918580|26665354|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5|||
13354320|NCT00918580|26665354|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2|||
13354321|NCT00918580|26665354|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2|||
13354322|NCT00918580|26665354|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1|||
13354323|NCT00918580|26665354|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58|||
13354324|NCT00918580|26665354|FG000|After 6-month FU to 1-year FU|Failed to Return|2|||
13354325|NCT00918567|26665387|FG000|Overall Study|Lack of Efficacy|3|||
13354326|NCT00918567|26665388|FG001|Overall Study|Lack of Efficacy|1|||
13354327|NCT00918567|26665387|FG000|Overall Study|Withdrawal by Subject|1|||
13354328|NCT00918567|26665388|FG001|Overall Study|Withdrawal by Subject|1|||
13354329|NCT00918567|26665387|FG000|Overall Study|Adverse Event|1|||
13354330|NCT00918567|26665388|FG001|Overall Study|Adverse Event|0|||
13354331|NCT00918463|26665396|FG000|Overall Study|Death|1|||
13354332|NCT00918463|26665396|FG000|Overall Study|Lack of Efficacy|1|||
13354333|NCT00918385|26665412|FG000|Monotherapy|Adverse Event|1|||
13354334|NCT00918385|26665413|FG001|Monotherapy|Adverse Event|6|||
13354335|NCT00918385|26665412|FG000|Monotherapy|Complicating illness|1|||
13354336|NCT00918385|26665413|FG001|Monotherapy|Complicating illness|0|||
13354337|NCT00918385|26665412|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1|||
13354338|NCT00918385|26665413|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1|||
13354339|NCT00918385|26665412|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
13354340|NCT00918385|26665413|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0|||
13354341|NCT00918385|26665412|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1|||
13354342|NCT00918385|26665413|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0|||
13354343|NCT00918385|26665412|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
13354344|NCT00918385|26665413|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7|||
13354345|NCT00918346|26665430|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0|||
13354346|NCT00918346|26665431|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1|||
13354347|NCT00918333|26665458|FG000|Overall Study|Drug not taken per protocol|1|||
13354348|NCT00918333|26665459|FG001|Overall Study|Drug not taken per protocol|0|||
13354349|NCT00918333|26665458|FG000|Overall Study|Inadequate amount of drugs provided|1|||
13354350|NCT00918333|26665459|FG001|Overall Study|Inadequate amount of drugs provided|4|||
13354351|NCT00918333|26665458|FG000|Overall Study|Ineligible|1|||
13354352|NCT00918333|26665459|FG001|Overall Study|Ineligible|0|||
13354353|NCT00918333|26665458|FG000|Overall Study|Withdrawal by Subject|0|||
13354354|NCT00918333|26665459|FG001|Overall Study|Withdrawal by Subject|1|||
13354355|NCT00918281|26665468|FG000|Overall Study|Physician Decision|29|||
13354356|NCT00918255|26665504|FG000|Overall Study|Adverse Event|1|||
13354357|NCT00918255|26665505|FG001|Overall Study|Adverse Event|0|||
13354358|NCT00918255|26665506|FG002|Overall Study|Adverse Event|0|||
13354359|NCT00918255|26665504|FG000|Overall Study|Withdrawal by Subject|1|||
13354360|NCT00918255|26665505|FG001|Overall Study|Withdrawal by Subject|0|||
13354361|NCT00918255|26665506|FG002|Overall Study|Withdrawal by Subject|2|||
13354362|NCT00918255|26665504|FG000|Overall Study|Lack of Efficacy|1|||
13354363|NCT00918255|26665505|FG001|Overall Study|Lack of Efficacy|0|||
13354364|NCT00918255|26665506|FG002|Overall Study|Lack of Efficacy|0|||
13354365|NCT00918255|26665504|FG000|Overall Study|Lost to Follow-up|1|||
13354366|NCT00918255|26665505|FG001|Overall Study|Lost to Follow-up|0|||
13354367|NCT00918255|26665506|FG002|Overall Study|Lost to Follow-up|2|||
13354368|NCT00918255|26665504|FG000|Overall Study|Exceeded allowed number of interventions|0|||
13354369|NCT00918255|26665505|FG001|Overall Study|Exceeded allowed number of interventions|0|||
13354370|NCT00918255|26665506|FG002|Overall Study|Exceeded allowed number of interventions|1|||
13354371|NCT00918255|26665504|FG000|Overall Study|Non-compliance|1|||
13354372|NCT00918255|26665505|FG001|Overall Study|Non-compliance|0|||
13354373|NCT00918255|26665506|FG002|Overall Study|Non-compliance|0|||
13354374|NCT00918255|26665504|FG000|Overall Study|Investigator discretion|1|||
13354375|NCT00918255|26665505|FG001|Overall Study|Investigator discretion|0|||
13354376|NCT00918255|26665506|FG002|Overall Study|Investigator discretion|0|||
13354377|NCT00918203|26665543|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
13354378|NCT00918203|26665544|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
13354379|NCT00918203|26665545|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0|||
13354380|NCT00918203|26665543|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2|||
13354381|NCT00918203|26665544|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8|||
13354382|NCT00918203|26665545|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0|||
13354383|NCT00918203|26665543|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2|||
13354384|NCT00918203|26665544|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1|||
13354385|NCT00918203|26665545|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0|||
13354386|NCT00918203|26665543|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1|||
13354387|NCT00918203|26665544|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0|||
13354388|NCT00918203|26665545|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0|||
13354389|NCT00918138|26665566|FG000|Overall Study|Subject withdrew consent|1|||
13354390|NCT00918138|26665567|FG001|Overall Study|Subject withdrew consent|1|||
13354391|NCT00918138|26665566|FG000|Overall Study|Death|1|||
13354392|NCT00918138|26665567|FG001|Overall Study|Death|0|||
13354393|NCT00917852|26665574|FG000|Overall Study|Death|6|||
13354394|NCT00917644|26665591|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1|||
13354395|NCT00917644|26665592|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0|||
13354396|NCT00917644|26665591|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1|||
13354397|NCT00917644|26665592|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0|||
13354398|NCT00917644|26665591|FG000|Period 2: Second Intervention|family emergency|1|||
13354399|NCT00917644|26665592|FG001|Period 2: Second Intervention|family emergency|0|||
13354400|NCT00917579|26665609|FG000|Washout >= 2 Weeks|Adverse Event|1|||
13354401|NCT00917579|26665610|FG001|Washout >= 2 Weeks|Adverse Event|0|||
13354402|NCT00917579|26665609|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1|||
13354403|NCT00917579|26665610|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0|||
13354404|NCT00917553|26665631|FG000|Overall Study|Lost to Follow-up|2|||
13354405|NCT00917553|26665632|FG001|Overall Study|Lost to Follow-up|1|||
13354406|NCT00917501|26665645|FG000|Overall Study|Lost to Follow-up|4|||
13354407|NCT00917501|26665646|FG001|Overall Study|Lost to Follow-up|1|||
13354408|NCT00917501|26665645|FG000|Overall Study|Withdrawal by Subject|3|||
13354409|NCT00917501|26665646|FG001|Overall Study|Withdrawal by Subject|1|||
13354410|NCT00917501|26665645|FG000|Overall Study|Lack of Efficacy|1|||
13354411|NCT00917501|26665646|FG001|Overall Study|Lack of Efficacy|2|||
13354412|NCT00917501|26665645|FG000|Overall Study|trouble swollowing capsules|0|||
13354413|NCT00917501|26665646|FG001|Overall Study|trouble swollowing capsules|1|||
13354414|NCT00917462|26665656|FG000|Overall Study|Clinical Deterioration|1|||
13354415|NCT00917384|26665685|FG000|Overall Study|Lost to Follow-up|4|||
13354416|NCT00917384|26665686|FG001|Overall Study|Lost to Follow-up|2|||
13354417|NCT00917384|26665685|FG000|Overall Study|Withdrawal by Subject|10|||
13354418|NCT00917384|26665686|FG001|Overall Study|Withdrawal by Subject|2|||
13354419|NCT00917267|26665719|FG000|Overall Study|Adverse Event|15|||
13354420|NCT00917267|26665720|FG001|Overall Study|Adverse Event|36|||
13354421|NCT00917267|26665719|FG000|Overall Study|Physician Decision|2|||
13354422|NCT00917267|26665720|FG001|Overall Study|Physician Decision|4|||
13354423|NCT00917267|26665719|FG000|Overall Study|Protocol Violation|9|||
13354424|NCT00917267|26665720|FG001|Overall Study|Protocol Violation|18|||
13354425|NCT00917267|26665719|FG000|Overall Study|Withdrawal by Subject|5|||
13354426|NCT00917267|26665720|FG001|Overall Study|Withdrawal by Subject|12|||
13354427|NCT00917267|26665719|FG000|Overall Study|Lost to follow up|0|||
13354428|NCT00917267|26665720|FG001|Overall Study|Lost to follow up|2|||
13354429|NCT00917267|26665719|FG000|Overall Study|Entry Criteria Not Met|1|||
13354430|NCT00917267|26665720|FG001|Overall Study|Entry Criteria Not Met|0|||
13354431|NCT00917267|26665719|FG000|Overall Study|Sponsor Decision|5|||
13354432|NCT00917267|26665720|FG001|Overall Study|Sponsor Decision|5|||
13354433|NCT00917267|26665719|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
13354434|NCT00917267|26665720|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
13354435|NCT00917150|26665751|FG000|Overall Study|Adverse Event|12|||
13354436|NCT00917150|26665752|FG001|Overall Study|Adverse Event|7|||
13354437|NCT00917150|26665753|FG002|Overall Study|Adverse Event|12|||
13354438|NCT00917150|26665754|FG003|Overall Study|Adverse Event|11|||
13354439|NCT00917150|26665751|FG000|Overall Study|Death|1|||
13354440|NCT00917150|26665752|FG001|Overall Study|Death|4|||
13354441|NCT00917150|26665753|FG002|Overall Study|Death|3|||
13354442|NCT00917150|26665754|FG003|Overall Study|Death|2|||
13354443|NCT00917150|26665751|FG000|Overall Study|Lost to Follow-up|1|||
13354444|NCT00917150|26665752|FG001|Overall Study|Lost to Follow-up|0|||
13354445|NCT00917150|26665753|FG002|Overall Study|Lost to Follow-up|4|||
13354446|NCT00917150|26665754|FG003|Overall Study|Lost to Follow-up|2|||
13354447|NCT00917150|26665751|FG000|Overall Study|Physician Decision|0|||
13354448|NCT00917150|26665752|FG001|Overall Study|Physician Decision|2|||
13354449|NCT00917150|26665753|FG002|Overall Study|Physician Decision|0|||
13354450|NCT00917150|26665754|FG003|Overall Study|Physician Decision|1|||
13354451|NCT00917150|26665751|FG000|Overall Study|Protocol Violation|5|||
13354452|NCT00917150|26665752|FG001|Overall Study|Protocol Violation|5|||
13354453|NCT00917150|26665753|FG002|Overall Study|Protocol Violation|3|||
13354454|NCT00917150|26665754|FG003|Overall Study|Protocol Violation|5|||
13354455|NCT00917150|26665751|FG000|Overall Study|Withdrawal by Subject|15|||
13354456|NCT00917150|26665752|FG001|Overall Study|Withdrawal by Subject|16|||
13354457|NCT00917150|26665753|FG002|Overall Study|Withdrawal by Subject|18|||
13354458|NCT00917150|26665754|FG003|Overall Study|Withdrawal by Subject|11|||
13354459|NCT00917150|26665751|FG000|Overall Study|Other than specified|3|||
13354460|NCT00917150|26665752|FG001|Overall Study|Other than specified|3|||
13354461|NCT00917150|26665753|FG002|Overall Study|Other than specified|2|||
13354462|NCT00917150|26665754|FG003|Overall Study|Other than specified|2|||
13354463|NCT00917124|26665769|FG000|Overall Study|Protocol Violation|4|||
13354464|NCT00917124|26665770|FG001|Overall Study|Protocol Violation|6|||
13354465|NCT00916929|26665785|FG000|Overall Study|Lost to Follow-up|1|||
13354466|NCT00916929|26665786|FG001|Overall Study|Lost to Follow-up|3|||
13354467|NCT00916929|26665785|FG000|Overall Study|Death|5|||
13354468|NCT00916929|26665786|FG001|Overall Study|Death|10|||
13354469|NCT00916929|26665785|FG000|Overall Study|Withdrawal by Subject|1|||
13354470|NCT00916929|26665786|FG001|Overall Study|Withdrawal by Subject|5|||
13354471|NCT00916929|26665785|FG000|Overall Study|Left ventricular epicardial lead|1|||
13354472|NCT00916929|26665786|FG001|Overall Study|Left ventricular epicardial lead|2|||
13354473|NCT00916929|26665785|FG000|Overall Study|Transferred to hospice care|1|||
13354474|NCT00916929|26665786|FG001|Overall Study|Transferred to hospice care|1|||
13354475|NCT00916929|26665785|FG000|Overall Study|System explant|1|||
13354476|NCT00916929|26665786|FG001|Overall Study|System explant|0|||
13354477|NCT00916929|26665785|FG000|Overall Study|Moved to another state|0|||
13354478|NCT00916929|26665786|FG001|Overall Study|Moved to another state|1|||
13354479|NCT00916929|26665785|FG000|Overall Study|Device unable to process impedance data|0|||
13354480|NCT00916929|26665786|FG001|Overall Study|Device unable to process impedance data|7|||
13354481|NCT00916721|26665805|FG000|Overall Study|Lost to Follow-up|0|||
13354482|NCT00916721|26665806|FG001|Overall Study|Lost to Follow-up|1|||
13354483|NCT00916721|26665805|FG000|Overall Study|Adverse Event|6|||
13354484|NCT00916721|26665806|FG001|Overall Study|Adverse Event|3|||
13354485|NCT00916721|26665805|FG000|Overall Study|Withdrawal by Subject|2|||
13354486|NCT00916721|26665806|FG001|Overall Study|Withdrawal by Subject|2|||
13354487|NCT00916721|26665805|FG000|Overall Study|Protocol Violation|2|||
13354488|NCT00916721|26665806|FG001|Overall Study|Protocol Violation|4|||
13354489|NCT00916617|26665833|FG000|Overall Study|Adverse Event|3|||
13354490|NCT00916617|26665834|FG001|Overall Study|Adverse Event|2|||
13354491|NCT00916617|26665835|FG002|Overall Study|Adverse Event|6|||
13354492|NCT00916617|26665836|FG003|Overall Study|Adverse Event|3|||
13354493|NCT00916617|26665833|FG000|Overall Study|Withdrawal by Subject|3|||
13354494|NCT00916617|26665834|FG001|Overall Study|Withdrawal by Subject|2|||
13354495|NCT00916617|26665835|FG002|Overall Study|Withdrawal by Subject|0|||
13354496|NCT00916617|26665836|FG003|Overall Study|Withdrawal by Subject|1|||
13354497|NCT00916617|26665833|FG000|Overall Study|Caregiver Request|3|||
13354498|NCT00916617|26665834|FG001|Overall Study|Caregiver Request|2|||
13354499|NCT00916617|26665835|FG002|Overall Study|Caregiver Request|1|||
13354500|NCT00916617|26665836|FG003|Overall Study|Caregiver Request|0|||
13354501|NCT00916617|26665833|FG000|Overall Study|Physician Decision|1|||
13354502|NCT00916617|26665834|FG001|Overall Study|Physician Decision|1|||
13354503|NCT00916617|26665835|FG002|Overall Study|Physician Decision|0|||
13354504|NCT00916617|26665836|FG003|Overall Study|Physician Decision|0|||
13354505|NCT00916617|26665833|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
13354506|NCT00916617|26665834|FG001|Overall Study|Discontinuation of Study by Sponsor|13|||
13354507|NCT00916617|26665835|FG002|Overall Study|Discontinuation of Study by Sponsor|3|||
13354508|NCT00916617|26665836|FG003|Overall Study|Discontinuation of Study by Sponsor|1|||
13354509|NCT00916617|26665833|FG000|Overall Study|Lost to Follow-up|2|||
13354510|NCT00916617|26665834|FG001|Overall Study|Lost to Follow-up|1|||
13354511|NCT00916617|26665835|FG002|Overall Study|Lost to Follow-up|0|||
13354512|NCT00916617|26665836|FG003|Overall Study|Lost to Follow-up|0|||
13354513|NCT00916617|26665833|FG000|Overall Study|Lack of Efficacy|1|||
13354514|NCT00916617|26665834|FG001|Overall Study|Lack of Efficacy|0|||
13354515|NCT00916617|26665835|FG002|Overall Study|Lack of Efficacy|0|||
13354516|NCT00916617|26665836|FG003|Overall Study|Lack of Efficacy|0|||
13354517|NCT00916617|26665833|FG000|Overall Study|Other|2|||
13354518|NCT00916617|26665834|FG001|Overall Study|Other|0|||
13354519|NCT00916617|26665835|FG002|Overall Study|Other|0|||
13354520|NCT00916617|26665836|FG003|Overall Study|Other|2|||
13354521|NCT00916578|26665842|FG000|Overall Study|Physician Decision|2|||
13354522|NCT00916578|26665842|FG000|Overall Study|Withdrawal by Subject|3|||
13354523|NCT00916578|26665842|FG000|Overall Study|Insurance Denial|2|||
13354524|NCT00916383|26665873|FG000|Overall Study|Adverse Event|1|||
13354525|NCT00916383|26665873|FG000|Overall Study|Death|1|||
13354526|NCT00916383|26665873|FG000|Overall Study|Protocol Violation|1|||
13354527|NCT00916370|26666054|FG000|Overall Study|Death|3|||
13354528|NCT00916370|26666055|FG001|Overall Study|Death|1|||
13354529|NCT00916370|26666054|FG000|Overall Study|Withdrawal by Subject|2|||
13354530|NCT00916370|26666055|FG001|Overall Study|Withdrawal by Subject|0|||
13354531|NCT00916370|26666054|FG000|Overall Study|Physician Decision|0|||
13354532|NCT00916370|26666055|FG001|Overall Study|Physician Decision|1|||
13354533|NCT00916357|26666100|FG000|Period 1|Withdrawal by Subject|1|||
13354534|NCT00916357|26666101|FG001|Period 1|Withdrawal by Subject|0|||
13354535|NCT00916357|26666102|FG002|Period 1|Withdrawal by Subject|0|||
13354536|NCT00916357|26666103|FG003|Period 1|Withdrawal by Subject|0|||
13354537|NCT00916357|26666104|FG004|Period 1|Withdrawal by Subject|0|||
13354538|NCT00916357|26666105|FG005|Period 1|Withdrawal by Subject|0|||
13354539|NCT00916357|26666100|FG000|Period 2|Weight loss > 3 kilograms (kg)|0|||
13354540|NCT00916357|26666101|FG001|Period 2|Weight loss > 3 kilograms (kg)|0|||
13354541|NCT00916357|26666102|FG002|Period 2|Weight loss > 3 kilograms (kg)|0|||
13354542|NCT00916357|26666103|FG003|Period 2|Weight loss > 3 kilograms (kg)|1|||
13354543|NCT00916357|26666104|FG004|Period 2|Weight loss > 3 kilograms (kg)|0|||
13354544|NCT00916357|26666105|FG005|Period 2|Weight loss > 3 kilograms (kg)|0|||
13354545|NCT00916344|26666112|FG000|Overall Study|Death|2|||
13354546|NCT00916344|26666112|FG000|Overall Study|ICD upgrade|1|||
13354547|NCT00916344|26666112|FG000|Overall Study|Drop-out|5|||
13354548|NCT00916305|26666127|FG000|Overall Study|Lost to Follow-up|21|||
13354549|NCT00916305|26666128|FG001|Overall Study|Lost to Follow-up|27|||
13354550|NCT00916305|26666127|FG000|Overall Study|Withdrawal by Subject|0|||
13354551|NCT00916305|26666128|FG001|Overall Study|Withdrawal by Subject|1|||
13354552|NCT00916279|26666138|FG000|Overall Study|Death|2|||
13354553|NCT00916279|26666138|FG000|Overall Study|Lost to Follow-up|2|||
13354554|NCT00916149|26666217|FG000|Overall Study|Lost to Follow-up|3|||
13354555|NCT00916149|26666218|FG001|Overall Study|Lost to Follow-up|2|||
13354556|NCT00916149|26666219|FG002|Overall Study|Lost to Follow-up|0|||
13354557|NCT00916149|26666217|FG000|Overall Study|Unable to place scalp EEG leads|1|||
13354558|NCT00916149|26666218|FG001|Overall Study|Unable to place scalp EEG leads|0|||
13354559|NCT00916149|26666219|FG002|Overall Study|Unable to place scalp EEG leads|0|||
13354560|NCT00916058|26666261|FG000|Phase 1|Screen Failure|0|||
13354561|NCT00916058|26666262|FG001|Phase 1|Screen Failure|0|||
13354562|NCT00916058|26666263|FG002|Phase 1|Screen Failure|0|||
13124901|NCT02937454|25954420|FG001|Overall Study|Adverse Event|1|||
13354563|NCT00916058|26666264|FG003|Phase 1|Screen Failure|0|||
13354564|NCT00916058|26666265|FG004|Phase 1|Screen Failure|0|||
13354565|NCT00916058|26666266|FG005|Phase 1|Screen Failure|1|||
13354566|NCT00916058|26666267|FG006|Phase 1|Screen Failure|0|||
13354567|NCT00916058|26666261|FG000|Phase 2|Screen Failure|0|||
13354568|NCT00916058|26666262|FG001|Phase 2|Screen Failure|0|||
13354569|NCT00916058|26666263|FG002|Phase 2|Screen Failure|0|||
13354570|NCT00916058|26666264|FG003|Phase 2|Screen Failure|0|||
13354571|NCT00916058|26666265|FG004|Phase 2|Screen Failure|0|||
13354572|NCT00916058|26666266|FG005|Phase 2|Screen Failure|0|||
13354573|NCT00916058|26666267|FG006|Phase 2|Screen Failure|3|||
13354574|NCT00916006|26666282|FG000|Overall Study|Adverse Event|1|||
13354575|NCT00916006|26666283|FG001|Overall Study|Adverse Event|1|||
13354576|NCT00916006|26666282|FG000|Overall Study|Withdrawal by Subject|2|||
13354577|NCT00916006|26666283|FG001|Overall Study|Withdrawal by Subject|5|||
13354578|NCT00916006|26666282|FG000|Overall Study|Protocol Violation|0|||
13354579|NCT00916006|26666283|FG001|Overall Study|Protocol Violation|1|||
13354580|NCT00915876|26666296|FG000|Overall Study|Adverse Event|0|||
13354581|NCT00915876|26666297|FG001|Overall Study|Adverse Event|1|||
13354582|NCT00915772|26666352|FG000|Overall Study|Adverse Event|12|||
13354583|NCT00915772|26666353|FG001|Overall Study|Adverse Event|13|||
13354584|NCT00915772|26666354|FG002|Overall Study|Adverse Event|11|||
13354585|NCT00915772|26666352|FG000|Overall Study|Protocol Violation|4|||
13354586|NCT00915772|26666353|FG001|Overall Study|Protocol Violation|1|||
13354587|NCT00915772|26666354|FG002|Overall Study|Protocol Violation|2|||
13354588|NCT00915772|26666352|FG000|Overall Study|Lost to Follow-up|1|||
13354589|NCT00915772|26666353|FG001|Overall Study|Lost to Follow-up|2|||
13354590|NCT00915772|26666354|FG002|Overall Study|Lost to Follow-up|2|||
13354591|NCT00915772|26666352|FG000|Overall Study|Lack of Efficacy|9|||
13354592|NCT00915772|26666353|FG001|Overall Study|Lack of Efficacy|15|||
13354593|NCT00915772|26666354|FG002|Overall Study|Lack of Efficacy|3|||
13354594|NCT00915772|26666352|FG000|Overall Study|Refused to continue trial medication|6|||
13354595|NCT00915772|26666353|FG001|Overall Study|Refused to continue trial medication|8|||
13354596|NCT00915772|26666354|FG002|Overall Study|Refused to continue trial medication|4|||
13354597|NCT00915772|26666352|FG000|Overall Study|Any other reason|4|||
13354598|NCT00915772|26666353|FG001|Overall Study|Any other reason|7|||
13354599|NCT00915772|26666354|FG002|Overall Study|Any other reason|7|||
13354600|NCT00915681|26666360|FG000|Overall Study|Screening failures|46|||
13354601|NCT00915551|26666375|FG000|Overall Study|Withdrawal by Subject|0|||
13354602|NCT00915551|26666376|FG001|Overall Study|Withdrawal by Subject|1|||
13354603|NCT00915525|26666484|FG000|Overall Study|Protocol Violation|9|||
13354604|NCT00915525|26666485|FG001|Overall Study|Protocol Violation|4|||
13354605|NCT00915525|26666484|FG000|Overall Study|Withdrawal by Subject|59|||
13354606|NCT00915525|26666485|FG001|Overall Study|Withdrawal by Subject|21|||
13354607|NCT00915525|26666484|FG000|Overall Study|Lost to Follow-up|27|||
13354608|NCT00915525|26666485|FG001|Overall Study|Lost to Follow-up|16|||
13354609|NCT00915525|26666484|FG000|Overall Study|Pregnancy|2|||
13354610|NCT00915525|26666485|FG001|Overall Study|Pregnancy|0|||
13354611|NCT00915525|26666484|FG000|Overall Study|Lack of Efficacy|15|||
13354612|NCT00915525|26666485|FG001|Overall Study|Lack of Efficacy|32|||
13354613|NCT00915525|26666484|FG000|Overall Study|Adverse Event|29|||
13354614|NCT00915525|26666485|FG001|Overall Study|Adverse Event|13|||
13354615|NCT00915525|26666484|FG000|Overall Study|Missing|12|||
13354616|NCT00915525|26666485|FG001|Overall Study|Missing|1|||
13354617|NCT00915525|26666484|FG000|Overall Study|Other Reason|35|||
13354618|NCT00915525|26666485|FG001|Overall Study|Other Reason|12|||
13354619|NCT00915525|26666484|FG000|Overall Study|Site Closed|27|||
13354620|NCT00915525|26666485|FG001|Overall Study|Site Closed|9|||
13354621|NCT00915525|26666484|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4|||
13354622|NCT00915525|26666485|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5|||
13354623|NCT00915525|26666484|FG000|Overall Study|Study Burden|28|||
13354624|NCT00915525|26666485|FG001|Overall Study|Study Burden|12|||
13354625|NCT00915525|26666484|FG000|Overall Study|Non-Compliance|3|||
13354626|NCT00915525|26666485|FG001|Overall Study|Non-Compliance|1|||
13354627|NCT00915525|26666484|FG000|Overall Study|Patient Moved|15|||
13354628|NCT00915525|26666485|FG001|Overall Study|Patient Moved|9|||
13374449|NCT00796445|26726791|FG001|Overall Study|Adverse event, serious fatal|5|||
13374450|NCT00796445|26726790|FG000|Overall Study|Adverse event, non-fatal|4|||
13374451|NCT00796445|26726791|FG001|Overall Study|Adverse event, non-fatal|0|||
13374452|NCT00796445|26726790|FG000|Overall Study|Disease progression/recurrence|537|||
13374453|NCT00796445|26726791|FG001|Overall Study|Disease progression/recurrence|268|||
13374454|NCT00796445|26726790|FG000|Overall Study|Other|10|||
13374455|NCT00796445|26726791|FG001|Overall Study|Other|7|||
13374456|NCT00796445|26726790|FG000|Overall Study|Withdrawal by Subject|18|||
13374457|NCT00796445|26726791|FG001|Overall Study|Withdrawal by Subject|9|||
13374458|NCT00796445|26726790|FG000|Overall Study|Invalid Informed Consent Form|1|||
13289340|NCT02214160|26478207|FG001|Overall Study|Subject Non-Compliance|3|||
13289341|NCT02214160|26478208|FG002|Overall Study|Subject Non-Compliance|1|||
13289342|NCT02214160|26478206|FG000|Overall Study|Adverse Event|0|||
13289343|NCT02214160|26478207|FG001|Overall Study|Adverse Event|1|||
13289344|NCT02214160|26478208|FG002|Overall Study|Adverse Event|1|||
13289345|NCT02214160|26478206|FG000|Overall Study|Sponsor Decision|0|||
13289346|NCT02214160|26478207|FG001|Overall Study|Sponsor Decision|2|||
13289347|NCT02214160|26478208|FG002|Overall Study|Sponsor Decision|0|||
13289348|NCT02214160|26478206|FG000|Overall Study|Protocol Violation|1|||
13289349|NCT02214160|26478207|FG001|Overall Study|Protocol Violation|0|||
13289350|NCT02214160|26478208|FG002|Overall Study|Protocol Violation|0|||
13289351|NCT02214160|26478206|FG000|Overall Study|Physician Decision|0|||
13289352|NCT02214160|26478207|FG001|Overall Study|Physician Decision|0|||
13289353|NCT02214160|26478208|FG002|Overall Study|Physician Decision|1|||
13354629|NCT00915473|26666504|FG000|Screening|Withdrawal by Subject|1|||
13354630|NCT00915473|26666505|FG001|Screening|Withdrawal by Subject|0|||
13354631|NCT00915473|26666504|FG000|4-week Follow Up|Lost to Follow-up|1|||
13354632|NCT00915473|26666505|FG001|4-week Follow Up|Lost to Follow-up|5|||
13354633|NCT00915356|26666583|FG000|Overall Study|Withdrawal by Subject|1|||
13354634|NCT00915356|26666584|FG001|Overall Study|Withdrawal by Subject|0|||
13354635|NCT00915356|26666585|FG002|Overall Study|Withdrawal by Subject|0|||
13354636|NCT00915356|26666586|FG003|Overall Study|Withdrawal by Subject|0|||
13354637|NCT00915356|26666587|FG004|Overall Study|Withdrawal by Subject|0|||
13354638|NCT00915343|26666670|FG000|Part B - Open Label Period|Treatment switch|0|||
13354639|NCT00915343|26666671|FG001|Part B - Open Label Period|Treatment switch|0|||
13354640|NCT00915343|26666672|FG002|Part B - Open Label Period|Treatment switch|1|||
13354641|NCT00915343|26666670|FG000|Part B - Open Label Period|Did not attend the last visit|0|||
13354642|NCT00915343|26666671|FG001|Part B - Open Label Period|Did not attend the last visit|0|||
13354643|NCT00915343|26666672|FG002|Part B - Open Label Period|Did not attend the last visit|1|||
13354644|NCT00915278|26666837|FG000|Overall Study|Death|1|||
13354645|NCT00915278|26666838|FG001|Overall Study|Death|0|||
13354646|NCT00915278|26666839|FG002|Overall Study|Death|0|||
13354647|NCT00915278|26666840|FG003|Overall Study|Death|0|||
13354648|NCT00915278|26666841|FG004|Overall Study|Death|0|||
13354649|NCT00915278|26666842|FG005|Overall Study|Death|0|||
13354650|NCT00915278|26666837|FG000|Overall Study|Lost to Follow-up|0|||
13354651|NCT00915278|26666838|FG001|Overall Study|Lost to Follow-up|1|||
13354652|NCT00915278|26666839|FG002|Overall Study|Lost to Follow-up|0|||
13354653|NCT00915278|26666840|FG003|Overall Study|Lost to Follow-up|0|||
13354654|NCT00915278|26666841|FG004|Overall Study|Lost to Follow-up|0|||
13354655|NCT00915278|26666842|FG005|Overall Study|Lost to Follow-up|0|||
13354656|NCT00915278|26666837|FG000|Overall Study|Withdrawal by Subject|0|||
13354657|NCT00915278|26666838|FG001|Overall Study|Withdrawal by Subject|1|||
13354658|NCT00915278|26666839|FG002|Overall Study|Withdrawal by Subject|0|||
13354659|NCT00915278|26666840|FG003|Overall Study|Withdrawal by Subject|0|||
13354660|NCT00915278|26666841|FG004|Overall Study|Withdrawal by Subject|1|||
13354661|NCT00915278|26666842|FG005|Overall Study|Withdrawal by Subject|4|||
13354662|NCT00915278|26666837|FG000|Overall Study|Adverse Event|4|||
13354663|NCT00915278|26666838|FG001|Overall Study|Adverse Event|1|||
13354664|NCT00915278|26666839|FG002|Overall Study|Adverse Event|0|||
13354665|NCT00915278|26666840|FG003|Overall Study|Adverse Event|0|||
13354666|NCT00915278|26666841|FG004|Overall Study|Adverse Event|0|||
13354667|NCT00915278|26666842|FG005|Overall Study|Adverse Event|0|||
13354668|NCT00915278|26666837|FG000|Overall Study|Progressive disease/clinical progression|0|||
13354669|NCT00915278|26666838|FG001|Overall Study|Progressive disease/clinical progression|0|||
13354670|NCT00915278|26666839|FG002|Overall Study|Progressive disease/clinical progression|0|||
13354671|NCT00915278|26666840|FG003|Overall Study|Progressive disease/clinical progression|3|||
13354672|NCT00915278|26666841|FG004|Overall Study|Progressive disease/clinical progression|1|||
13354673|NCT00915278|26666842|FG005|Overall Study|Progressive disease/clinical progression|2|||
13354674|NCT00915278|26666837|FG000|Overall Study|Infusion related AEs|0|||
13354675|NCT00915278|26666838|FG001|Overall Study|Infusion related AEs|0|||
13354676|NCT00915278|26666839|FG002|Overall Study|Infusion related AEs|0|||
13354677|NCT00915278|26666840|FG003|Overall Study|Infusion related AEs|0|||
13354678|NCT00915278|26666841|FG004|Overall Study|Infusion related AEs|0|||
13354679|NCT00915278|26666842|FG005|Overall Study|Infusion related AEs|2|||
13354680|NCT00915278|26666837|FG000|Overall Study|Admission to hospice|0|||
13354681|NCT00915278|26666838|FG001|Overall Study|Admission to hospice|0|||
13354682|NCT00915278|26666839|FG002|Overall Study|Admission to hospice|1|||
13354683|NCT00915278|26666840|FG003|Overall Study|Admission to hospice|0|||
13354684|NCT00915278|26666841|FG004|Overall Study|Admission to hospice|0|||
13354685|NCT00915278|26666842|FG005|Overall Study|Admission to hospice|0|||
13354686|NCT00915018|26666863|FG000|Overall Study|Death|75|||
13354687|NCT00915018|26666864|FG001|Overall Study|Death|70|||
13354688|NCT00915018|26666863|FG000|Overall Study|Lost to Follow-up|10|||
13354689|NCT00915018|26666864|FG001|Overall Study|Lost to Follow-up|5|||
13354690|NCT00915018|26666863|FG000|Overall Study|Withdrawal by Subject|38|||
13354691|NCT00915018|26666864|FG001|Overall Study|Withdrawal by Subject|27|||
13354692|NCT00915018|26666863|FG000|Overall Study|By Sponsor due to Protocol Amendment|92|||
13354693|NCT00915018|26666864|FG001|Overall Study|By Sponsor due to Protocol Amendment|105|||
13354694|NCT00915005|26666879|FG000|Overall Study|Withdrawal by Subject|4|||
13354695|NCT00915005|26666880|FG001|Overall Study|Withdrawal by Subject|4|||
13354696|NCT00915005|26666879|FG000|Overall Study|Patient preferred protons therapy|6|||
13354697|NCT00915005|26666880|FG001|Overall Study|Patient preferred protons therapy|0|||
13354698|NCT00915005|26666879|FG000|Overall Study|Insurance denial|3|||
13354699|NCT00915005|26666880|FG001|Overall Study|Insurance denial|15|||
13354700|NCT00914966|26666894|FG000|Step 1: 1500 Units|Withdrawal by Subject|1|||
13354701|NCT00914966|26666894|FG000|Step 1: 1500 Units|Physician Decision|1|||
13354702|NCT00914966|26666894|FG000|Step 2: 2000 Units|Withdrawal by Subject|1|||
13354703|NCT00914940|26666904|FG000|D0 to D100 Post-transplant|Death|2|||
13354704|NCT00914940|26666904|FG000|D101 to 2 Years Post-transplant|Death|8|||
13354705|NCT00914940|26666904|FG000|2 Years to 5 Years Post-transplant|Death|3|||
13354706|NCT00914927|26666970|FG000|Overall Study|Adverse Event|0|||
13354707|NCT00914927|26666971|FG001|Overall Study|Adverse Event|0|||
13354708|NCT00914927|26666972|FG002|Overall Study|Adverse Event|0|||
13354709|NCT00914927|26666973|FG003|Overall Study|Adverse Event|0|||
13354710|NCT00914927|26666974|FG004|Overall Study|Adverse Event|1|||
13354711|NCT00914927|26666975|FG005|Overall Study|Adverse Event|0|||
13354712|NCT00914927|26666976|FG006|Overall Study|Adverse Event|0|||
13354713|NCT00914927|26666970|FG000|Overall Study|Withdrawal by Subject|0|||
13354714|NCT00914927|26666971|FG001|Overall Study|Withdrawal by Subject|1|||
13354715|NCT00914927|26666972|FG002|Overall Study|Withdrawal by Subject|0|||
13354716|NCT00914927|26666973|FG003|Overall Study|Withdrawal by Subject|1|||
13354717|NCT00914927|26666974|FG004|Overall Study|Withdrawal by Subject|0|||
13354718|NCT00914927|26666975|FG005|Overall Study|Withdrawal by Subject|0|||
13354719|NCT00914927|26666976|FG006|Overall Study|Withdrawal by Subject|0|||
13354720|NCT00914927|26666970|FG000|Overall Study|Lost to Follow-up|0|||
13354721|NCT00914927|26666971|FG001|Overall Study|Lost to Follow-up|0|||
13354722|NCT00914927|26666972|FG002|Overall Study|Lost to Follow-up|0|||
13354723|NCT00914927|26666973|FG003|Overall Study|Lost to Follow-up|1|||
13354724|NCT00914927|26666974|FG004|Overall Study|Lost to Follow-up|0|||
13354725|NCT00914927|26666975|FG005|Overall Study|Lost to Follow-up|0|||
13354726|NCT00914927|26666976|FG006|Overall Study|Lost to Follow-up|0|||
13354727|NCT00914927|26666970|FG000|Overall Study|Administrative/Other|2|||
13354728|NCT00914927|26666971|FG001|Overall Study|Administrative/Other|1|||
13354729|NCT00914927|26666972|FG002|Overall Study|Administrative/Other|0|||
13354730|NCT00914927|26666973|FG003|Overall Study|Administrative/Other|0|||
13354731|NCT00914927|26666974|FG004|Overall Study|Administrative/Other|1|||
13354732|NCT00914927|26666975|FG005|Overall Study|Administrative/Other|0|||
13354733|NCT00914927|26666976|FG006|Overall Study|Administrative/Other|0|||
13354734|NCT00914849|26667015|FG000|Overall Study|Withdrawal by Subject|1|||
13354735|NCT00914849|26667016|FG001|Overall Study|Withdrawal by Subject|0|||
13354736|NCT00914849|26667015|FG000|Overall Study|Not eligible|0|||
13354737|NCT00914849|26667016|FG001|Overall Study|Not eligible|1|||
13354738|NCT00914810|26667031|FG000|Overall Study|Withdrawal by Subject|1|||
13354739|NCT00914810|26667032|FG001|Overall Study|Withdrawal by Subject|0|||
13354740|NCT00914810|26667031|FG000|Overall Study|Relocated out of state|1|||
13354741|NCT00914810|26667032|FG001|Overall Study|Relocated out of state|0|||
13354742|NCT00914810|26667031|FG000|Overall Study|Hospitalized and unable to follow up.|0|||
13354743|NCT00914810|26667032|FG001|Overall Study|Hospitalized and unable to follow up.|1|||
13354744|NCT00914732|26667069|FG000|Overall Study|Lost to Follow-up|6|||
13354745|NCT00914732|26667070|FG001|Overall Study|Lost to Follow-up|7|||
13354746|NCT00914732|26667071|FG002|Overall Study|Lost to Follow-up|9|||
13354747|NCT00914732|26667069|FG000|Overall Study|Withdrawal by Subject|3|||
13354748|NCT00914732|26667070|FG001|Overall Study|Withdrawal by Subject|0|||
13354749|NCT00914732|26667071|FG002|Overall Study|Withdrawal by Subject|2|||
13354750|NCT00914732|26667069|FG000|Overall Study|Adverse Event|1|||
13354751|NCT00914732|26667070|FG001|Overall Study|Adverse Event|0|||
13354752|NCT00914732|26667071|FG002|Overall Study|Adverse Event|0|||
13354753|NCT00914628|26667106|FG000|Overall Study|Death|35|||
13354754|NCT00914628|26667107|FG001|Overall Study|Death|17|||
13354755|NCT00914628|26667106|FG000|Overall Study|Medical decision|4|||
13354756|NCT00914628|26667107|FG001|Overall Study|Medical decision|0|||
13354757|NCT00914628|26667106|FG000|Overall Study|Protocol Violation|1|||
13354758|NCT00914628|26667107|FG001|Overall Study|Protocol Violation|0|||
13354759|NCT00914628|26667106|FG000|Overall Study|Lack of Efficacy|1|||
13354760|NCT00914628|26667107|FG001|Overall Study|Lack of Efficacy|0|||
13354761|NCT00914628|26667106|FG000|Overall Study|non-randomized|1|||
13354762|NCT00914628|26667107|FG001|Overall Study|non-randomized|0|||
13354763|NCT00914628|26667106|FG000|Overall Study|Relapse|1|||
13354764|NCT00914628|26667107|FG001|Overall Study|Relapse|2|||
13354765|NCT00914628|26667106|FG000|Overall Study|Study terminated by Sponsor|14|||
13354766|NCT00914628|26667107|FG001|Overall Study|Study terminated by Sponsor|8|||
13354767|NCT00914628|26667106|FG000|Overall Study|Patients who did not receive a single dose|7|||
13354768|NCT00914628|26667107|FG001|Overall Study|Patients who did not receive a single dose|1|||
13354769|NCT00914589|26667137|FG000|Overall Study|Adverse Event|1|||
13354770|NCT00914589|26667138|FG001|Overall Study|Adverse Event|0|||
13354771|NCT00914589|26667139|FG002|Overall Study|Adverse Event|1|||
13354772|NCT00914589|26667137|FG000|Overall Study|Protocol Violation|8|||
13354773|NCT00914589|26667138|FG001|Overall Study|Protocol Violation|6|||
13354774|NCT00914589|26667139|FG002|Overall Study|Protocol Violation|3|||
13354775|NCT00914589|26667137|FG000|Overall Study|unclassified|16|||
13354776|NCT00914589|26667138|FG001|Overall Study|unclassified|9|||
13354777|NCT00914589|26667139|FG002|Overall Study|unclassified|7|||
13354778|NCT00914589|26667137|FG000|Overall Study|Death|0|||
13354779|NCT00914589|26667138|FG001|Overall Study|Death|1|||
13354780|NCT00914589|26667139|FG002|Overall Study|Death|1|||
13354781|NCT00914459|26667172|FG000|Overall Study|Protocol Violation|0|||
13354782|NCT00914459|26667173|FG001|Overall Study|Protocol Violation|1|||
13354783|NCT00914459|26667172|FG000|Overall Study|Parent/Legal guardian request|1|||
13354784|NCT00914459|26667173|FG001|Overall Study|Parent/Legal guardian request|0|||
13354785|NCT00914316|26667200|FG000|Phase 1|Physician Decision|4|||
13354786|NCT00914316|26667201|FG001|Phase 1|Physician Decision|0|||
13354787|NCT00914316|26667202|FG002|Phase 1|Physician Decision|1|||
13354788|NCT00914316|26667203|FG003|Phase 1|Physician Decision|2|||
13354789|NCT00914316|26667200|FG000|Phase 1|Withdrawal by Subject|0|||
13354790|NCT00914316|26667201|FG001|Phase 1|Withdrawal by Subject|2|||
13354791|NCT00914316|26667202|FG002|Phase 1|Withdrawal by Subject|4|||
13354792|NCT00914316|26667203|FG003|Phase 1|Withdrawal by Subject|0|||
13354793|NCT00914316|26667200|FG000|Phase 1|Adverse Event|1|||
13354794|NCT00914316|26667201|FG001|Phase 1|Adverse Event|0|||
13354795|NCT00914316|26667202|FG002|Phase 1|Adverse Event|0|||
13354796|NCT00914316|26667203|FG003|Phase 1|Adverse Event|0|||
13354797|NCT00914316|26667200|FG000|Phase 2|Withdrawal by Subject|1|||
13354798|NCT00914316|26667201|FG001|Phase 2|Withdrawal by Subject|0|||
13354799|NCT00914316|26667202|FG002|Phase 2|Withdrawal by Subject|1|||
13354800|NCT00914316|26667203|FG003|Phase 2|Withdrawal by Subject|0|||
13354801|NCT00913978|26667218|FG000|Overall Study|Surgeon choice|1|||
13354802|NCT00913978|26667219|FG001|Overall Study|Surgeon choice|3|||
13354803|NCT00913835|26667262|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2|||
13354804|NCT00913835|26667263|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3|||
13354805|NCT00913835|26667262|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1|||
13354806|NCT00913835|26667263|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0|||
13354807|NCT00913835|26667262|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4|||
13354808|NCT00913835|26667263|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3|||
13354809|NCT00913835|26667262|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
13354810|NCT00913835|26667263|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
13354811|NCT00913835|26667262|FG000|Lip Dox: Olaratumab Monotherapy|Other|0|||
13354812|NCT00913835|26667263|FG001|Lip Dox: Olaratumab Monotherapy|Other|3|||
13354813|NCT00913770|26667284|FG000|Overall Study|Unable to contact|24|||
13354814|NCT00913770|26667285|FG001|Overall Study|Unable to contact|19|||
13354815|NCT00913770|26667286|FG002|Overall Study|Unable to contact|13|||
13354816|NCT00913770|26667284|FG000|Overall Study|Refused|11|||
13354817|NCT00913770|26667285|FG001|Overall Study|Refused|10|||
13354818|NCT00913770|26667286|FG002|Overall Study|Refused|8|||
13354819|NCT00913744|26667299|FG000|Overall Study|Adverse Event|2|||
13354820|NCT00913744|26667300|FG001|Overall Study|Adverse Event|0|||
13354821|NCT00913744|26667299|FG000|Overall Study|Withdrawal by Subject|2|||
13354822|NCT00913744|26667300|FG001|Overall Study|Withdrawal by Subject|1|||
13354823|NCT00913744|26667299|FG000|Overall Study|Death|1|||
13354824|NCT00913744|26667300|FG001|Overall Study|Death|0|||
13354825|NCT00913692|26667312|FG000|Screening (4 Months)|Physician Decision|3|||
13354826|NCT00913692|26667312|FG000|Screening (4 Months)|Not eligible after screening phase.|6|||
13354827|NCT00913692|26667312|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1|||
13354828|NCT00913523|26667345|FG000|Overall Study|Withdrawal by Subject|3|||
13354829|NCT00913523|26667346|FG001|Overall Study|Withdrawal by Subject|2|||
13354830|NCT00913523|26667347|FG002|Overall Study|Withdrawal by Subject|2|||
13354831|NCT00913523|26667345|FG000|Overall Study|Lost to Follow-up|1|||
13354832|NCT00913523|26667346|FG001|Overall Study|Lost to Follow-up|1|||
13354833|NCT00913523|26667347|FG002|Overall Study|Lost to Follow-up|1|||
13354834|NCT00913523|26667345|FG000|Overall Study|Adverse Event|1|||
13354835|NCT00913523|26667346|FG001|Overall Study|Adverse Event|0|||
13354836|NCT00913523|26667347|FG002|Overall Study|Adverse Event|0|||
13354837|NCT00913523|26667345|FG000|Overall Study|Protocol Violation|5|||
13354838|NCT00913523|26667346|FG001|Overall Study|Protocol Violation|8|||
13354839|NCT00913523|26667347|FG002|Overall Study|Protocol Violation|8|||
13354840|NCT00913523|26667345|FG000|Overall Study|Pregnancy|1|||
13354841|NCT00913523|26667346|FG001|Overall Study|Pregnancy|3|||
13354842|NCT00913523|26667347|FG002|Overall Study|Pregnancy|0|||
13354843|NCT00913523|26667345|FG000|Overall Study|Inadequate Number of Tampons Used|7|||
13354844|NCT00913523|26667346|FG001|Overall Study|Inadequate Number of Tampons Used|2|||
13354845|NCT00913523|26667347|FG002|Overall Study|Inadequate Number of Tampons Used|3|||
13354846|NCT00913458|26667446|FG000|Phase 1|Non-Responder|54|||
13354847|NCT00913458|26667447|FG001|Phase 1|Non-Responder|0|||
13354848|NCT00913458|26667448|FG002|Phase 1|Non-Responder|0|||
13354849|NCT00913458|26667449|FG003|Phase 1|Non-Responder|0|||
13354850|NCT00913458|26667450|FG004|Phase 1|Non-Responder|0|||
13354851|NCT00913458|26667451|FG005|Phase 1|Non-Responder|0|||
13354852|NCT00913458|26667452|FG006|Phase 1|Non-Responder|0|||
13354853|NCT00913458|26667446|FG000|Phase 1|Subject Request|17|||
13354854|NCT00913458|26667447|FG001|Phase 1|Subject Request|0|||
13354855|NCT00913458|26667448|FG002|Phase 1|Subject Request|0|||
13354856|NCT00913458|26667449|FG003|Phase 1|Subject Request|0|||
13354857|NCT00913458|26667450|FG004|Phase 1|Subject Request|0|||
13354858|NCT00913458|26667451|FG005|Phase 1|Subject Request|0|||
13354859|NCT00913458|26667452|FG006|Phase 1|Subject Request|0|||
13354860|NCT00913458|26667446|FG000|Phase 1|Adverse Event|20|||
13354861|NCT00913458|26667447|FG001|Phase 1|Adverse Event|0|||
13354862|NCT00913458|26667448|FG002|Phase 1|Adverse Event|0|||
13354863|NCT00913458|26667449|FG003|Phase 1|Adverse Event|0|||
13354864|NCT00913458|26667450|FG004|Phase 1|Adverse Event|0|||
13354865|NCT00913458|26667451|FG005|Phase 1|Adverse Event|0|||
13354866|NCT00913458|26667452|FG006|Phase 1|Adverse Event|0|||
13354867|NCT00913458|26667446|FG000|Phase 1|Lost to Follow-up|2|||
13354868|NCT00913458|26667447|FG001|Phase 1|Lost to Follow-up|0|||
13354869|NCT00913458|26667448|FG002|Phase 1|Lost to Follow-up|0|||
13354870|NCT00913458|26667449|FG003|Phase 1|Lost to Follow-up|0|||
13354871|NCT00913458|26667450|FG004|Phase 1|Lost to Follow-up|0|||
13354872|NCT00913458|26667451|FG005|Phase 1|Lost to Follow-up|0|||
13354873|NCT00913458|26667452|FG006|Phase 1|Lost to Follow-up|0|||
13354874|NCT00913458|26667446|FG000|Phase 1|Protocol Violation|10|||
13354875|NCT00913458|26667447|FG001|Phase 1|Protocol Violation|0|||
13354876|NCT00913458|26667448|FG002|Phase 1|Protocol Violation|0|||
13354877|NCT00913458|26667449|FG003|Phase 1|Protocol Violation|0|||
13354878|NCT00913458|26667450|FG004|Phase 1|Protocol Violation|0|||
13354879|NCT00913458|26667451|FG005|Phase 1|Protocol Violation|0|||
13354880|NCT00913458|26667452|FG006|Phase 1|Protocol Violation|0|||
13354881|NCT00913458|26667446|FG000|Phase 1|Sponsor|2|||
13354882|NCT00913458|26667447|FG001|Phase 1|Sponsor|0|||
13354883|NCT00913458|26667448|FG002|Phase 1|Sponsor|0|||
13354884|NCT00913458|26667449|FG003|Phase 1|Sponsor|0|||
13354885|NCT00913458|26667450|FG004|Phase 1|Sponsor|0|||
13354886|NCT00913458|26667451|FG005|Phase 1|Sponsor|0|||
13354887|NCT00913458|26667452|FG006|Phase 1|Sponsor|0|||
13354888|NCT00913458|26667446|FG000|Phase 1|Unsatisfactory Response per Investigator|7|||
13354889|NCT00913458|26667447|FG001|Phase 1|Unsatisfactory Response per Investigator|0|||
13354890|NCT00913458|26667448|FG002|Phase 1|Unsatisfactory Response per Investigator|0|||
13354891|NCT00913458|26667449|FG003|Phase 1|Unsatisfactory Response per Investigator|0|||
13354892|NCT00913458|26667450|FG004|Phase 1|Unsatisfactory Response per Investigator|0|||
13354893|NCT00913458|26667451|FG005|Phase 1|Unsatisfactory Response per Investigator|0|||
13354894|NCT00913458|26667452|FG006|Phase 1|Unsatisfactory Response per Investigator|0|||
13354895|NCT00913458|26667446|FG000|Phase 2|Non-Responder|0|||
13354896|NCT00913458|26667447|FG001|Phase 2|Non-Responder|5|||
13354897|NCT00913458|26667448|FG002|Phase 2|Non-Responder|7|||
13354898|NCT00913458|26667449|FG003|Phase 2|Non-Responder|12|||
13354899|NCT00913458|26667450|FG004|Phase 2|Non-Responder|0|||
13354900|NCT00913458|26667451|FG005|Phase 2|Non-Responder|0|||
13354901|NCT00913458|26667452|FG006|Phase 2|Non-Responder|0|||
13354902|NCT00913458|26667446|FG000|Phase 2|Subject Request|0|||
13354903|NCT00913458|26667447|FG001|Phase 2|Subject Request|0|||
13354904|NCT00913458|26667448|FG002|Phase 2|Subject Request|1|||
13354905|NCT00913458|26667449|FG003|Phase 2|Subject Request|2|||
13354906|NCT00913458|26667450|FG004|Phase 2|Subject Request|0|||
13354907|NCT00913458|26667451|FG005|Phase 2|Subject Request|0|||
13354908|NCT00913458|26667452|FG006|Phase 2|Subject Request|0|||
13354909|NCT00913458|26667446|FG000|Phase 2|Adverse Event|0|||
13354910|NCT00913458|26667447|FG001|Phase 2|Adverse Event|3|||
13354911|NCT00913458|26667448|FG002|Phase 2|Adverse Event|0|||
13354912|NCT00913458|26667449|FG003|Phase 2|Adverse Event|1|||
13354913|NCT00913458|26667450|FG004|Phase 2|Adverse Event|0|||
13354914|NCT00913458|26667451|FG005|Phase 2|Adverse Event|0|||
13354915|NCT00913458|26667452|FG006|Phase 2|Adverse Event|0|||
13354916|NCT00913458|26667446|FG000|Phase 2|Lost to Follow-up|0|||
13354917|NCT00913458|26667447|FG001|Phase 2|Lost to Follow-up|0|||
13354918|NCT00913458|26667448|FG002|Phase 2|Lost to Follow-up|0|||
13354919|NCT00913458|26667449|FG003|Phase 2|Lost to Follow-up|1|||
13354920|NCT00913458|26667450|FG004|Phase 2|Lost to Follow-up|0|||
13354921|NCT00913458|26667451|FG005|Phase 2|Lost to Follow-up|0|||
13354922|NCT00913458|26667452|FG006|Phase 2|Lost to Follow-up|0|||
13354923|NCT00913458|26667446|FG000|Phase 2|Protocol Violation|0|||
13354924|NCT00913458|26667447|FG001|Phase 2|Protocol Violation|2|||
13354925|NCT00913458|26667448|FG002|Phase 2|Protocol Violation|0|||
13354926|NCT00913458|26667449|FG003|Phase 2|Protocol Violation|0|||
13354927|NCT00913458|26667450|FG004|Phase 2|Protocol Violation|0|||
13354928|NCT00913458|26667451|FG005|Phase 2|Protocol Violation|0|||
13354929|NCT00913458|26667452|FG006|Phase 2|Protocol Violation|0|||
13354930|NCT00913458|26667446|FG000|Phase 2|Unsatisfactory Response per Investigator|0|||
13354931|NCT00913458|26667447|FG001|Phase 2|Unsatisfactory Response per Investigator|0|||
13354932|NCT00913458|26667448|FG002|Phase 2|Unsatisfactory Response per Investigator|11|||
13354933|NCT00913458|26667449|FG003|Phase 2|Unsatisfactory Response per Investigator|17|||
13354934|NCT00913458|26667450|FG004|Phase 2|Unsatisfactory Response per Investigator|0|||
13354935|NCT00913458|26667451|FG005|Phase 2|Unsatisfactory Response per Investigator|0|||
13354936|NCT00913458|26667452|FG006|Phase 2|Unsatisfactory Response per Investigator|0|||
13354937|NCT00913458|26667446|FG000|Phase 3|Adverse Event|0|||
13354938|NCT00913458|26667447|FG001|Phase 3|Adverse Event|0|||
13354939|NCT00913458|26667448|FG002|Phase 3|Adverse Event|0|||
13354940|NCT00913458|26667449|FG003|Phase 3|Adverse Event|0|||
13354941|NCT00913458|26667450|FG004|Phase 3|Adverse Event|5|||
13354942|NCT00913458|26667451|FG005|Phase 3|Adverse Event|4|||
13354943|NCT00913458|26667452|FG006|Phase 3|Adverse Event|1|||
13354944|NCT00913458|26667446|FG000|Phase 3|Lost to Follow-up|0|||
13354945|NCT00913458|26667447|FG001|Phase 3|Lost to Follow-up|0|||
13354946|NCT00913458|26667448|FG002|Phase 3|Lost to Follow-up|0|||
13354947|NCT00913458|26667449|FG003|Phase 3|Lost to Follow-up|0|||
13354948|NCT00913458|26667450|FG004|Phase 3|Lost to Follow-up|2|||
13354949|NCT00913458|26667451|FG005|Phase 3|Lost to Follow-up|0|||
13354950|NCT00913458|26667452|FG006|Phase 3|Lost to Follow-up|0|||
13354951|NCT00913458|26667446|FG000|Phase 3|Non-Responder|0|||
13354952|NCT00913458|26667447|FG001|Phase 3|Non-Responder|0|||
13354953|NCT00913458|26667448|FG002|Phase 3|Non-Responder|0|||
13354954|NCT00913458|26667449|FG003|Phase 3|Non-Responder|0|||
13354955|NCT00913458|26667450|FG004|Phase 3|Non-Responder|0|||
13354956|NCT00913458|26667451|FG005|Phase 3|Non-Responder|1|||
13354957|NCT00913458|26667452|FG006|Phase 3|Non-Responder|3|||
13354958|NCT00913458|26667446|FG000|Phase 3|Withdrawal by Subject|0|||
13354959|NCT00913458|26667447|FG001|Phase 3|Withdrawal by Subject|0|||
13354960|NCT00913458|26667448|FG002|Phase 3|Withdrawal by Subject|0|||
13354961|NCT00913458|26667449|FG003|Phase 3|Withdrawal by Subject|0|||
13354962|NCT00913458|26667450|FG004|Phase 3|Withdrawal by Subject|1|||
13354963|NCT00913458|26667451|FG005|Phase 3|Withdrawal by Subject|2|||
13354964|NCT00913458|26667452|FG006|Phase 3|Withdrawal by Subject|0|||
13354965|NCT00913458|26667446|FG000|Phase 3|Unsatisfactory Response per Investigator|0|||
13354966|NCT00913458|26667447|FG001|Phase 3|Unsatisfactory Response per Investigator|0|||
13354967|NCT00913458|26667448|FG002|Phase 3|Unsatisfactory Response per Investigator|0|||
13354968|NCT00913458|26667449|FG003|Phase 3|Unsatisfactory Response per Investigator|0|||
13354969|NCT00913458|26667450|FG004|Phase 3|Unsatisfactory Response per Investigator|14|||
13354970|NCT00913458|26667451|FG005|Phase 3|Unsatisfactory Response per Investigator|11|||
13354971|NCT00913458|26667452|FG006|Phase 3|Unsatisfactory Response per Investigator|4|||
13354972|NCT00913380|26667485|FG000|Clinical Outcomes|Lost to Follow-up|6|||
13354973|NCT00913380|26667486|FG001|Clinical Outcomes|Lost to Follow-up|6|||
13354974|NCT00912964|26667618|FG000|Overall Study|Eligibility criterion not met|1|||
13354975|NCT00912964|26667619|FG001|Overall Study|Eligibility criterion not met|1|||
13354976|NCT00912964|26667620|FG002|Overall Study|Eligibility criterion not met|0|||
13354977|NCT00912964|26667618|FG000|Overall Study|Adverse Event|15|||
13354978|NCT00912964|26667619|FG001|Overall Study|Adverse Event|18|||
13354979|NCT00912964|26667620|FG002|Overall Study|Adverse Event|12|||
13354980|NCT00912964|26667618|FG000|Overall Study|Lack of Efficacy|11|||
13354981|NCT00912964|26667619|FG001|Overall Study|Lack of Efficacy|4|||
13354982|NCT00912964|26667620|FG002|Overall Study|Lack of Efficacy|3|||
13354983|NCT00912964|26667618|FG000|Overall Study|Withdrawal by Subject|20|||
13354984|NCT00912964|26667619|FG001|Overall Study|Withdrawal by Subject|12|||
13354985|NCT00912964|26667620|FG002|Overall Study|Withdrawal by Subject|18|||
13354986|NCT00912964|26667618|FG000|Overall Study|Lost to Follow-up|4|||
13354987|NCT00912964|26667619|FG001|Overall Study|Lost to Follow-up|3|||
13354988|NCT00912964|26667620|FG002|Overall Study|Lost to Follow-up|3|||
13354989|NCT00912964|26667618|FG000|Overall Study|Protocol Violation|5|||
13354990|NCT00912964|26667619|FG001|Overall Study|Protocol Violation|3|||
13354991|NCT00912964|26667620|FG002|Overall Study|Protocol Violation|8|||
13354992|NCT00912964|26667618|FG000|Overall Study|Taking exclusionary medications|7|||
13354993|NCT00912964|26667619|FG001|Overall Study|Taking exclusionary medications|4|||
13354994|NCT00912964|26667620|FG002|Overall Study|Taking exclusionary medications|8|||
13354995|NCT00912964|26667618|FG000|Overall Study|Medical History|1|||
13354996|NCT00912964|26667619|FG001|Overall Study|Medical History|0|||
13354997|NCT00912964|26667620|FG002|Overall Study|Medical History|0|||
13354998|NCT00912964|26667618|FG000|Overall Study|Non-compliance with study procedures|2|||
13354999|NCT00912964|26667619|FG001|Overall Study|Non-compliance with study procedures|0|||
13355000|NCT00912964|26667620|FG002|Overall Study|Non-compliance with study procedures|0|||
13355001|NCT00912964|26667618|FG000|Overall Study|Violation of exclusion criterion|0|||
13355002|NCT00912964|26667619|FG001|Overall Study|Violation of exclusion criterion|0|||
13355003|NCT00912964|26667620|FG002|Overall Study|Violation of exclusion criterion|2|||
13355004|NCT00912964|26667618|FG000|Overall Study|Randomized but never received study drug|0|||
13355005|NCT00912964|26667619|FG001|Overall Study|Randomized but never received study drug|1|||
13355006|NCT00912964|26667620|FG002|Overall Study|Randomized but never received study drug|0|||
13355007|NCT00912912|26667626|FG000|Overall Study|Withdrawal by Subject|1|||
13355008|NCT00912912|26667626|FG000|Overall Study|Disease Progression|3|||
13355009|NCT00912808|26667641|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
13355010|NCT00912808|26667642|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
13355011|NCT00912808|26667641|FG000|Washout|Withdrawal by Subject|0|||
13355012|NCT00912808|26667642|FG001|Washout|Withdrawal by Subject|1|||
13355013|NCT00912808|26667641|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
13355014|NCT00912808|26667642|FG001|Second Intervention (6 Weeks)|Adverse Event|1|||
13355015|NCT00912808|26667641|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
13355016|NCT00912808|26667642|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
13355017|NCT00912782|26667657|FG000|Overall Study|Death|2|||
13355018|NCT00912782|26667658|FG001|Overall Study|Death|1|||
13355019|NCT00912782|26667657|FG000|Overall Study|Lost to Follow-up|0|||
13355020|NCT00912782|26667658|FG001|Overall Study|Lost to Follow-up|1|||
13355021|NCT00912782|26667657|FG000|Overall Study|Did not receive vascular access type|1|||
13355022|NCT00912782|26667658|FG001|Overall Study|Did not receive vascular access type|2|||
13355023|NCT00912782|26667657|FG000|Overall Study|Relocated before study completion|0|||
13355024|NCT00912782|26667658|FG001|Overall Study|Relocated before study completion|1|||
13355025|NCT00912743|26667675|FG000|Overall Study|Adverse Event|3|||
13355026|NCT00912743|26667676|FG001|Overall Study|Adverse Event|1|||
13355027|NCT00912743|26667675|FG000|Overall Study|Lack of Efficacy|9|||
13355028|NCT00912743|26667676|FG001|Overall Study|Lack of Efficacy|18|||
13355029|NCT00912743|26667675|FG000|Overall Study|Toxicity|0|||
13355030|NCT00912743|26667676|FG001|Overall Study|Toxicity|1|||
13355031|NCT00912743|26667675|FG000|Overall Study|End of treatment form was not collected|1|||
13355032|NCT00912743|26667676|FG001|Overall Study|End of treatment form was not collected|0|||
13355033|NCT00912509|26667691|FG000|Overall Study|Lost to Follow-up|1|||
13355034|NCT00912509|26667692|FG001|Overall Study|Lost to Follow-up|0|||
13355035|NCT00912509|26667691|FG000|Overall Study|Lack of Efficacy|4|||
13355036|NCT00912509|26667692|FG001|Overall Study|Lack of Efficacy|3|||
13355037|NCT00912405|26667701|FG000|Overall Study|Lost to Follow-up|5|||
13355038|NCT00912340|26667722|FG000|Overall Study|Adverse Event|2|||
13355039|NCT00912340|26667723|FG001|Overall Study|Adverse Event|4|||
13355040|NCT00912340|26667724|FG002|Overall Study|Adverse Event|0|||
13355041|NCT00912340|26667722|FG000|Overall Study|Protocol revised to remove arm|0|||
13355042|NCT00912340|26667723|FG001|Overall Study|Protocol revised to remove arm|0|||
13355043|NCT00912340|26667724|FG002|Overall Study|Protocol revised to remove arm|4|||
13355044|NCT00912288|26667753|FG000|Overall Study|Death|0|||
13355045|NCT00912288|26667754|FG001|Overall Study|Death|1|||
13355046|NCT00912288|26667753|FG000|Overall Study|Adverse Event|1|||
13355047|NCT00912288|26667754|FG001|Overall Study|Adverse Event|1|||
13355048|NCT00912288|26667753|FG000|Overall Study|Lost to Follow-up|1|||
13355049|NCT00912288|26667754|FG001|Overall Study|Lost to Follow-up|0|||
13355050|NCT00912288|26667753|FG000|Overall Study|Protocol Violation|1|||
13355051|NCT00912288|26667754|FG001|Overall Study|Protocol Violation|0|||
13355052|NCT00912288|26667753|FG000|Overall Study|Withdrawal by Subject|3|||
13355053|NCT00912288|26667754|FG001|Overall Study|Withdrawal by Subject|3|||
13355054|NCT00912288|26667753|FG000|Overall Study|Study terminated by sponsor|34|||
13355055|NCT00912288|26667754|FG001|Overall Study|Study terminated by sponsor|35|||
13355056|NCT00912288|26667753|FG000|Overall Study|Other|1|||
13355057|NCT00912288|26667754|FG001|Overall Study|Other|0|||
13355058|NCT00912197|26667789|FG000|Overall Study|Withdrawal by Subject|3|||
13355059|NCT00912197|26667790|FG001|Overall Study|Withdrawal by Subject|3|||
13355060|NCT00912093|26667822|FG000|The Controlled Phase|Death|0|||
13355061|NCT00912093|26667823|FG001|The Controlled Phase|Death|1|||
13355062|NCT00912093|26667824|FG002|The Controlled Phase|Death|0|||
13355063|NCT00912093|26667825|FG003|The Controlled Phase|Death|0|||
13355064|NCT00912093|26667826|FG004|The Controlled Phase|Death|0|||
13355065|NCT00912093|26667822|FG000|The Controlled Phase|Medical Condition|0|||
13355066|NCT00912093|26667823|FG001|The Controlled Phase|Medical Condition|1|||
13355067|NCT00912093|26667824|FG002|The Controlled Phase|Medical Condition|0|||
13355068|NCT00912093|26667825|FG003|The Controlled Phase|Medical Condition|0|||
13355069|NCT00912093|26667826|FG004|The Controlled Phase|Medical Condition|0|||
13355070|NCT00912093|26667822|FG000|The Controlled Phase|Lost to Follow-up|0|||
13355071|NCT00912093|26667823|FG001|The Controlled Phase|Lost to Follow-up|0|||
13355072|NCT00912093|26667824|FG002|The Controlled Phase|Lost to Follow-up|0|||
13355073|NCT00912093|26667825|FG003|The Controlled Phase|Lost to Follow-up|0|||
13355074|NCT00912093|26667826|FG004|The Controlled Phase|Lost to Follow-up|1|||
13355075|NCT00912028|26667863|FG000|Overall Study|Lost to Follow-up|2|||
13355076|NCT00912028|26667864|FG001|Overall Study|Lost to Follow-up|3|||
13355077|NCT00912028|26667865|FG002|Overall Study|Lost to Follow-up|0|||
13355078|NCT00912028|26667866|FG003|Overall Study|Lost to Follow-up|1|||
13355079|NCT00912028|26667867|FG004|Overall Study|Lost to Follow-up|3|||
13355080|NCT00912028|26667863|FG000|Overall Study|Withdrawal by Subject|3|||
13355081|NCT00912028|26667864|FG001|Overall Study|Withdrawal by Subject|0|||
13355082|NCT00912028|26667865|FG002|Overall Study|Withdrawal by Subject|0|||
13355083|NCT00912028|26667866|FG003|Overall Study|Withdrawal by Subject|0|||
13355084|NCT00912028|26667867|FG004|Overall Study|Withdrawal by Subject|0|||
13355085|NCT00912015|26667890|FG000|Overall Study|Lack of Efficacy|1|||
13355086|NCT00912015|26667891|FG001|Overall Study|Lack of Efficacy|0|||
13355087|NCT00912015|26667892|FG002|Overall Study|Lack of Efficacy|0|||
13355088|NCT00912015|26667893|FG003|Overall Study|Lack of Efficacy|0|||
13355089|NCT00912015|26667890|FG000|Overall Study|Withdrawal by Subject|8|||
13355090|NCT00912015|26667891|FG001|Overall Study|Withdrawal by Subject|8|||
13355091|NCT00912015|26667892|FG002|Overall Study|Withdrawal by Subject|3|||
13355092|NCT00912015|26667893|FG003|Overall Study|Withdrawal by Subject|0|||
13355093|NCT00912015|26667890|FG000|Overall Study|Protocol Violation|1|||
13355094|NCT00912015|26667891|FG001|Overall Study|Protocol Violation|0|||
13355095|NCT00912015|26667892|FG002|Overall Study|Protocol Violation|0|||
13355096|NCT00912015|26667893|FG003|Overall Study|Protocol Violation|1|||
13355097|NCT00912015|26667890|FG000|Overall Study|Adverse Event|6|||
13355098|NCT00912015|26667891|FG001|Overall Study|Adverse Event|0|||
13355099|NCT00912015|26667892|FG002|Overall Study|Adverse Event|0|||
13355100|NCT00912015|26667893|FG003|Overall Study|Adverse Event|1|||
13355101|NCT00911989|26667899|FG000|Overall Study|Adverse Event|1|||
13355102|NCT00911937|26667966|FG000|Overall Study|Death|1|||
13355103|NCT00911937|26667967|FG001|Overall Study|Death|0|||
13355104|NCT00911937|26667966|FG000|Overall Study|Lost to Follow-up|8|||
13355105|NCT00911937|26667967|FG001|Overall Study|Lost to Follow-up|5|||
13355106|NCT00911937|26667966|FG000|Overall Study|Withdrawal by Subject|10|||
13355107|NCT00911937|26667967|FG001|Overall Study|Withdrawal by Subject|7|||
13355108|NCT00911937|26667966|FG000|Overall Study|Withdrawn due to pregnancy|1|||
13355109|NCT00911937|26667967|FG001|Overall Study|Withdrawn due to pregnancy|0|||
13355110|NCT00911937|26667966|FG000|Overall Study|Adverse Event|11|||
13355111|NCT00911937|26667967|FG001|Overall Study|Adverse Event|25|||
13355112|NCT00911937|26667966|FG000|Overall Study|Lack of Efficacy|11|||
13355113|NCT00911937|26667967|FG001|Overall Study|Lack of Efficacy|6|||
13355114|NCT00911937|26667966|FG000|Overall Study|Did not meet inclusion criteria|9|||
13355115|NCT00911937|26667967|FG001|Overall Study|Did not meet inclusion criteria|11|||
13355116|NCT00911937|26667966|FG000|Overall Study|Protocol Violation|14|||
13355117|NCT00911937|26667967|FG001|Overall Study|Protocol Violation|23|||
13355118|NCT00911937|26667966|FG000|Overall Study|Randomized but not treated|13|||
13355119|NCT00911937|26667967|FG001|Overall Study|Randomized but not treated|13|||
13355120|NCT00911937|26667966|FG000|Overall Study|Other|9|||
13355121|NCT00911937|26667967|FG001|Overall Study|Other|5|||
13355122|NCT00911859|26668001|FG000|Treatment Period|Adverse Event|3|||
13355123|NCT00911859|26668002|FG001|Treatment Period|Adverse Event|3|||
13355124|NCT00911859|26668003|FG002|Treatment Period|Adverse Event|7|||
13355125|NCT00911859|26668001|FG000|Treatment Period|Death|1|||
13355126|NCT00911859|26668002|FG001|Treatment Period|Death|3|||
13355127|NCT00911859|26668003|FG002|Treatment Period|Death|5|||
13355128|NCT00911859|26668001|FG000|Treatment Period|Lack of Efficacy|1|||
13355129|NCT00911859|26668002|FG001|Treatment Period|Lack of Efficacy|7|||
13355130|NCT00911859|26668003|FG002|Treatment Period|Lack of Efficacy|5|||
13355131|NCT00911859|26668001|FG000|Treatment Period|Physician Decision|3|||
13355132|NCT00911859|26668002|FG001|Treatment Period|Physician Decision|3|||
13355133|NCT00911859|26668003|FG002|Treatment Period|Physician Decision|3|||
13355134|NCT00911859|26668001|FG000|Treatment Period|Withdrawal by Subject|0|||
13355135|NCT00911859|26668002|FG001|Treatment Period|Withdrawal by Subject|4|||
13355136|NCT00911859|26668003|FG002|Treatment Period|Withdrawal by Subject|5|||
13355137|NCT00911859|26668001|FG000|Treatment Period|Did not receive study treatment|0|||
13355138|NCT00911859|26668002|FG001|Treatment Period|Did not receive study treatment|1|||
13355139|NCT00911859|26668003|FG002|Treatment Period|Did not receive study treatment|0|||
13355140|NCT00911859|26668001|FG000|Maintainance Period|Lack of Efficacy|0|||
13355141|NCT00911859|26668002|FG001|Maintainance Period|Lack of Efficacy|0|||
13355142|NCT00911859|26668003|FG002|Maintainance Period|Lack of Efficacy|9|||
13355143|NCT00911859|26668001|FG000|Maintainance Period|Physician Decision|0|||
13355144|NCT00911859|26668002|FG001|Maintainance Period|Physician Decision|0|||
13355145|NCT00911859|26668003|FG002|Maintainance Period|Physician Decision|9|||
13355146|NCT00911859|26668001|FG000|Maintainance Period|Withdrawal by Subject|0|||
13355147|NCT00911859|26668002|FG001|Maintainance Period|Withdrawal by Subject|0|||
13355148|NCT00911859|26668003|FG002|Maintainance Period|Withdrawal by Subject|3|||
13355149|NCT00911859|26668001|FG000|Follow-up Period|Death|5|||
13355150|NCT00911859|26668002|FG001|Follow-up Period|Death|8|||
13355151|NCT00911859|26668003|FG002|Follow-up Period|Death|10|||
13355152|NCT00911859|26668001|FG000|Follow-up Period|Lost to Follow-up|1|||
13355153|NCT00911859|26668002|FG001|Follow-up Period|Lost to Follow-up|1|||
13355154|NCT00911859|26668003|FG002|Follow-up Period|Lost to Follow-up|0|||
13355155|NCT00911859|26668001|FG000|Follow-up Period|Withdrawal by Subject|0|||
13355156|NCT00911859|26668002|FG001|Follow-up Period|Withdrawal by Subject|4|||
13355157|NCT00911859|26668003|FG002|Follow-up Period|Withdrawal by Subject|4|||
13355158|NCT00911859|26668001|FG000|Follow-up Period|Study terminated by sponsor|5|||
13355159|NCT00911859|26668002|FG001|Follow-up Period|Study terminated by sponsor|33|||
13355160|NCT00911859|26668003|FG002|Follow-up Period|Study terminated by sponsor|27|||
13355161|NCT00911807|26668021|FG000|Overall Study|Adverse Event|2|||
13355162|NCT00911807|26668022|FG001|Overall Study|Adverse Event|1|||
13355163|NCT00911807|26668023|FG002|Overall Study|Adverse Event|5|||
13355164|NCT00911807|26668021|FG000|Overall Study|Death|0|||
13355165|NCT00911807|26668022|FG001|Overall Study|Death|0|||
13355166|NCT00911807|26668023|FG002|Overall Study|Death|1|||
13355167|NCT00911807|26668021|FG000|Overall Study|Protocol Violation|6|||
13355168|NCT00911807|26668022|FG001|Overall Study|Protocol Violation|4|||
13355169|NCT00911807|26668023|FG002|Overall Study|Protocol Violation|9|||
13355170|NCT00911807|26668021|FG000|Overall Study|Withdrawal by Subject|8|||
13355171|NCT00911807|26668022|FG001|Overall Study|Withdrawal by Subject|10|||
13355172|NCT00911807|26668023|FG002|Overall Study|Withdrawal by Subject|7|||
13355173|NCT00911807|26668021|FG000|Overall Study|Organizational reasons|1|||
13355174|NCT00911807|26668022|FG001|Overall Study|Organizational reasons|3|||
13355175|NCT00911807|26668023|FG002|Overall Study|Organizational reasons|1|||
13355176|NCT00911768|26668040|FG000|Overall Study|Protocol Violation|5|||
13355177|NCT00911768|26668041|FG001|Overall Study|Protocol Violation|4|||
13355178|NCT00911768|26668040|FG000|Overall Study|Withdrawal by Subject|1|||
13355179|NCT00911768|26668041|FG001|Overall Study|Withdrawal by Subject|0|||
13355180|NCT00911625|26668056|FG000|Overall Study|Lost to Follow-up|7|||
13355181|NCT00911625|26668057|FG001|Overall Study|Lost to Follow-up|0|||
13355182|NCT00911534|26668076|FG000|Overall Study|Adverse Event|4|||
13355183|NCT00911534|26668077|FG001|Overall Study|Adverse Event|4|||
13355184|NCT00911534|26668076|FG000|Overall Study|Lost to Follow-up|2|||
13355185|NCT00911534|26668077|FG001|Overall Study|Lost to Follow-up|4|||
13355186|NCT00911534|26668076|FG000|Overall Study|Withdrawal by Subject|2|||
13355187|NCT00911534|26668077|FG001|Overall Study|Withdrawal by Subject|1|||
13355188|NCT00911534|26668076|FG000|Overall Study|Lack of Efficacy|4|||
13355189|NCT00911534|26668077|FG001|Overall Study|Lack of Efficacy|1|||
13355190|NCT00911534|26668076|FG000|Overall Study|Withdrawal of consent|1|||
13355191|NCT00911534|26668077|FG001|Overall Study|Withdrawal of consent|4|||
13355192|NCT00911534|26668076|FG000|Overall Study|Other|2|||
13355193|NCT00911534|26668077|FG001|Overall Study|Other|2|||
13355194|NCT00911508|26668116|FG000|Overall Study|Lost to Follow-up|27|||
13355195|NCT00911508|26668117|FG001|Overall Study|Lost to Follow-up|18|||
13355196|NCT00911508|26668116|FG000|Overall Study|Withdrawal by Subject|79|||
13355197|NCT00911508|26668117|FG001|Overall Study|Withdrawal by Subject|112|||
13355198|NCT00911300|26668148|FG000|Overall Study|Primary Endpoint Component Occurred|1|||
13355199|NCT00911300|26668149|FG001|Overall Study|Primary Endpoint Component Occurred|2|||
13355200|NCT00911300|26668148|FG000|Overall Study|Death|1|||
13355201|NCT00911300|26668149|FG001|Overall Study|Death|0|||
13355202|NCT00911300|26668148|FG000|Overall Study|Thrombus Persistant in Second TEE|3|||
13355203|NCT00911300|26668149|FG001|Overall Study|Thrombus Persistant in Second TEE|7|||
13355204|NCT00911300|26668148|FG000|Overall Study|Adverse Event|14|||
13355205|NCT00911300|26668149|FG001|Overall Study|Adverse Event|6|||
13355206|NCT00911300|26668148|FG000|Overall Study|Protocol Violation|3|||
13355207|NCT00911300|26668149|FG001|Overall Study|Protocol Violation|2|||
13355208|NCT00911300|26668148|FG000|Overall Study|Consent Withdrawn|4|||
13355209|NCT00911300|26668149|FG001|Overall Study|Consent Withdrawn|12|||
13355210|NCT00911300|26668148|FG000|Overall Study|Coronary Angiography Performed|1|||
13355211|NCT00911300|26668149|FG001|Overall Study|Coronary Angiography Performed|0|||
13355212|NCT00911300|26668148|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
13355213|NCT00911300|26668149|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
13355214|NCT00911300|26668148|FG000|Overall Study|Received Commercial Treatment|1|||
13355215|NCT00911300|26668149|FG001|Overall Study|Received Commercial Treatment|0|||
13355216|NCT00911300|26668148|FG000|Overall Study|Recurrent Tachyarrhythmia|1|||
13355217|NCT00911300|26668149|FG001|Overall Study|Recurrent Tachyarrhythmia|1|||
13355218|NCT00911300|26668148|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
13355219|NCT00911300|26668149|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
13355220|NCT00911300|26668148|FG000|Overall Study|Nurse Unavailable in Participant's City|1|||
13355221|NCT00911300|26668149|FG001|Overall Study|Nurse Unavailable in Participant's City|0|||
13355222|NCT00911300|26668148|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1|||
13355223|NCT00911300|26668149|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0|||
13355224|NCT00911300|26668148|FG000|Overall Study|Participant Could Not Stay in Hospital|0|||
13355225|NCT00911300|26668149|FG001|Overall Study|Participant Could Not Stay in Hospital|1|||
13355226|NCT00911300|26668148|FG000|Overall Study|Investigator's Decision; New AF Episode|0|||
13355227|NCT00911300|26668149|FG001|Overall Study|Investigator's Decision; New AF Episode|1|||
13355228|NCT00911300|26668148|FG000|Overall Study|International Normalized Ratio Too High|0|||
13355229|NCT00911300|26668149|FG001|Overall Study|International Normalized Ratio Too High|1|||
13355230|NCT00911300|26668148|FG000|Overall Study|Participant Refused Hospital Consulation|0|||
13355231|NCT00911300|26668149|FG001|Overall Study|Participant Refused Hospital Consulation|1|||
13355232|NCT00911300|26668148|FG000|Overall Study|Underlying Disease (Myocarditis)|0|||
13355233|NCT00911300|26668149|FG001|Overall Study|Underlying Disease (Myocarditis)|1|||
13355234|NCT00911300|26668148|FG000|Overall Study|Physician Decision|0|||
13355235|NCT00911300|26668149|FG001|Overall Study|Physician Decision|1|||
13355236|NCT00911300|26668148|FG000|Overall Study|Treatment Stopped by Mistake|0|||
13355237|NCT00911300|26668149|FG001|Overall Study|Treatment Stopped by Mistake|1|||
13355238|NCT00911300|26668148|FG000|Overall Study|Randomized; No Study Medication Received|0|||
13355239|NCT00911300|26668149|FG001|Overall Study|Randomized; No Study Medication Received|2|||
13355240|NCT00911170|26668178|FG000|Treatment Period|Randomized in error|1|||
13355241|NCT00911170|26668179|FG001|Treatment Period|Randomized in error|1|||
13355242|NCT00911170|26668178|FG000|Treatment Period|Ineligibility determined|1|||
13355243|NCT00911170|26668179|FG001|Treatment Period|Ineligibility determined|3|||
13355244|NCT00911170|26668178|FG000|Treatment Period|Protocol deviation|1|||
13355245|NCT00911170|26668179|FG001|Treatment Period|Protocol deviation|2|||
13355246|NCT00911170|26668178|FG000|Treatment Period|Adverse Event|9|||
13355247|NCT00911170|26668179|FG001|Treatment Period|Adverse Event|10|||
13355248|NCT00911170|26668178|FG000|Treatment Period|Withdrawal by Subject|4|||
13355249|NCT00911170|26668179|FG001|Treatment Period|Withdrawal by Subject|4|||
13355250|NCT00911170|26668178|FG000|Treatment Period|Disease progression|0|||
13355251|NCT00911170|26668179|FG001|Treatment Period|Disease progression|2|||
13355252|NCT00911170|26668178|FG000|Treatment Period|Physician Decision|5|||
13355253|NCT00911170|26668179|FG001|Treatment Period|Physician Decision|5|||
13355254|NCT00911170|26668178|FG000|Treatment Period|Lost to Follow-up|0|||
13355255|NCT00911170|26668179|FG001|Treatment Period|Lost to Follow-up|1|||
13355256|NCT00911170|26668178|FG000|Treatment Period|Death|6|||
13355257|NCT00911170|26668179|FG001|Treatment Period|Death|9|||
13355258|NCT00911170|26668178|FG000|Long Term Follow-Up|Continuing in study|274|||
13355259|NCT00911170|26668179|FG001|Long Term Follow-Up|Continuing in study|269|||
13355260|NCT00911170|26668178|FG000|Long Term Follow-Up|Withdrawal by Subject|20|||
13355261|NCT00911170|26668179|FG001|Long Term Follow-Up|Withdrawal by Subject|21|||
13355262|NCT00911170|26668178|FG000|Long Term Follow-Up|Physician Decision|5|||
13355263|NCT00911170|26668179|FG001|Long Term Follow-Up|Physician Decision|4|||
13355264|NCT00911170|26668178|FG000|Long Term Follow-Up|Lost to Follow-up|8|||
13355265|NCT00911170|26668179|FG001|Long Term Follow-Up|Lost to Follow-up|7|||
13355266|NCT00911170|26668178|FG000|Long Term Follow-Up|Death|116|||
13355267|NCT00911170|26668179|FG001|Long Term Follow-Up|Death|121|||
13355268|NCT00911157|26668200|FG000|Overall Study|Adverse Event|4|||
13355269|NCT00911157|26668201|FG001|Overall Study|Adverse Event|1|||
13355270|NCT00911157|26668200|FG000|Overall Study|Withdrawal by Subject|1|||
13355271|NCT00911157|26668201|FG001|Overall Study|Withdrawal by Subject|1|||
13355272|NCT00911157|26668200|FG000|Overall Study|Need for prohibited drug (heparin)|1|||
13355273|NCT00911157|26668201|FG001|Overall Study|Need for prohibited drug (heparin)|0|||
13355274|NCT00911157|26668200|FG000|Overall Study|Need to treat for lung cancer|1|||
13355275|NCT00911157|26668201|FG001|Overall Study|Need to treat for lung cancer|0|||
13355276|NCT00911144|26668232|FG000|Overall Study|Withdrawal by Subject|16|||
13355277|NCT00911144|26668233|FG001|Overall Study|Withdrawal by Subject|5|||
13355278|NCT00910988|26668288|FG000|Overall Study|Lost to Follow-up|2|||
13355279|NCT00910988|26668289|FG001|Overall Study|Lost to Follow-up|4|||
13355280|NCT00910988|26668290|FG002|Overall Study|Lost to Follow-up|3|||
13355281|NCT00910988|26668291|FG003|Overall Study|Lost to Follow-up|0|||
13355282|NCT00910962|26668391|FG000|Overall Study|Adverse Event|5|||
13355283|NCT00910962|26668392|FG001|Overall Study|Adverse Event|20|||
13355284|NCT00910962|26668393|FG002|Overall Study|Adverse Event|17|||
13355285|NCT00910962|26668391|FG000|Overall Study|Protocol Violation|1|||
13355286|NCT00910962|26668392|FG001|Overall Study|Protocol Violation|3|||
13355287|NCT00910962|26668393|FG002|Overall Study|Protocol Violation|3|||
13355288|NCT00910962|26668391|FG000|Overall Study|Lost to Follow-up|0|||
13355289|NCT00910962|26668392|FG001|Overall Study|Lost to Follow-up|3|||
13355290|NCT00910962|26668393|FG002|Overall Study|Lost to Follow-up|1|||
13355291|NCT00910962|26668391|FG000|Overall Study|Physician Decision|0|||
13355292|NCT00910962|26668392|FG001|Overall Study|Physician Decision|6|||
13355293|NCT00910962|26668393|FG002|Overall Study|Physician Decision|6|||
13355294|NCT00910962|26668391|FG000|Overall Study|Withdrawal by Subject|25|||
13355295|NCT00910962|26668392|FG001|Overall Study|Withdrawal by Subject|32|||
13355296|NCT00910962|26668393|FG002|Overall Study|Withdrawal by Subject|32|||
13355297|NCT00910962|26668391|FG000|Overall Study|Reached defined stopping criteria|12|||
13355298|NCT00910962|26668392|FG001|Overall Study|Reached defined stopping criteria|14|||
13355299|NCT00910962|26668393|FG002|Overall Study|Reached defined stopping criteria|17|||
13355300|NCT00910910|26668436|FG000|Overall Study|Adverse Event|63|||
13355301|NCT00910910|26668437|FG001|Overall Study|Adverse Event|35|||
13355302|NCT00910910|26668436|FG000|Overall Study|PD without histologic change|27|||
13355303|NCT00910910|26668437|FG001|Overall Study|PD without histologic change|23|||
13355304|NCT00910910|26668436|FG000|Overall Study|PD with histologic change|0|||
13355305|NCT00910910|26668437|FG001|Overall Study|PD with histologic change|2|||
13355306|NCT00910910|26668436|FG000|Overall Study|Withdrawal by Subject|7|||
13355307|NCT00910910|26668437|FG001|Overall Study|Withdrawal by Subject|5|||
13355308|NCT00910910|26668436|FG000|Overall Study|Lost to Follow-up|2|||
13355309|NCT00910910|26668437|FG001|Overall Study|Lost to Follow-up|2|||
13355310|NCT00910910|26668436|FG000|Overall Study|Death|9|||
13355311|NCT00910910|26668437|FG001|Overall Study|Death|3|||
13355312|NCT00910910|26668436|FG000|Overall Study|Protocol Violation|2|||
13355313|NCT00910910|26668437|FG001|Overall Study|Protocol Violation|2|||
13355314|NCT00910910|26668436|FG000|Overall Study|Completed 13 cycles of treatment|0|||
13355315|NCT00910910|26668437|FG001|Overall Study|Completed 13 cycles of treatment|118|||
13355316|NCT00910910|26668436|FG000|Overall Study|Other|114|||
13355317|NCT00910910|26668437|FG001|Overall Study|Other|32|||
13355318|NCT00910910|26668436|FG000|Overall Study|Untreated before cycle 1|1|||
13355319|NCT00910910|26668437|FG001|Overall Study|Untreated before cycle 1|2|||
13355320|NCT00910871|26668444|FG000|Overall Study|Adverse Event|5|||
13355321|NCT00910871|26668444|FG000|Overall Study|Death|12|||
13355322|NCT00910871|26668444|FG000|Overall Study|Lost to Follow-up|8|||
13355323|NCT00910871|26668444|FG000|Overall Study|Protocol Violation|11|||
13355324|NCT00910871|26668444|FG000|Overall Study|Withdrawal by Subject|12|||
13355325|NCT00910871|26668444|FG000|Overall Study|Subject didn't meet eligibility criteria|5|||
13355326|NCT00910871|26668444|FG000|Overall Study|Undefined|1|||
13355327|NCT00910858|26668477|FG000|Pharmacokinetic Phase|Adverse Event|1|||
13355328|NCT00910858|26668478|FG001|Pharmacokinetic Phase|Adverse Event|0|||
13355329|NCT00910858|26668479|FG002|Pharmacokinetic Phase|Adverse Event|0|||
13355330|NCT00910858|26668477|FG000|Monotherapy Phase|Adverse Event|3|||
13355331|NCT00910858|26668478|FG001|Monotherapy Phase|Adverse Event|2|||
13355332|NCT00910858|26668479|FG002|Monotherapy Phase|Adverse Event|0|||
13355333|NCT00910858|26668477|FG000|Monotherapy Phase|Lack of therapeutic effect|9|||
13355334|NCT00910858|26668478|FG001|Monotherapy Phase|Lack of therapeutic effect|6|||
13355335|NCT00910858|26668479|FG002|Monotherapy Phase|Lack of therapeutic effect|4|||
13355336|NCT00910858|26668477|FG000|Monotherapy Phase|Withdrawal by Subject|1|||
13355337|NCT00910858|26668478|FG001|Monotherapy Phase|Withdrawal by Subject|3|||
13355338|NCT00910858|26668479|FG002|Monotherapy Phase|Withdrawal by Subject|1|||
13355339|NCT00910858|26668477|FG000|Monotherapy Phase|Protocol Violation|1|||
13355340|NCT00910858|26668478|FG001|Monotherapy Phase|Protocol Violation|0|||
13355341|NCT00910858|26668479|FG002|Monotherapy Phase|Protocol Violation|0|||
13355342|NCT00910858|26668477|FG000|Monotherapy Phase|Other|3|||
13355343|NCT00910858|26668478|FG001|Monotherapy Phase|Other|4|||
13355344|NCT00910858|26668479|FG002|Monotherapy Phase|Other|2|||
13355345|NCT00910858|26668477|FG000|Combined Treatment Phase|Lack of therapeutic effect|8|||
13355346|NCT00910858|26668478|FG001|Combined Treatment Phase|Lack of therapeutic effect|6|||
13355347|NCT00910858|26668479|FG002|Combined Treatment Phase|Lack of therapeutic effect|3|||
13355348|NCT00910858|26668477|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
13355349|NCT00910858|26668478|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
13355350|NCT00910858|26668479|FG002|Combined Treatment Phase|Withdrawal by Subject|0|||
13355351|NCT00910858|26668477|FG000|Combined Treatment Phase|Protocol Violation|1|||
13355352|NCT00910858|26668478|FG001|Combined Treatment Phase|Protocol Violation|0|||
13355353|NCT00910858|26668479|FG002|Combined Treatment Phase|Protocol Violation|0|||
13355354|NCT00910858|26668477|FG000|Combined Treatment Phase|Other|0|||
13355355|NCT00910858|26668478|FG001|Combined Treatment Phase|Other|2|||
13355356|NCT00910858|26668479|FG002|Combined Treatment Phase|Other|1|||
13355357|NCT00910728|26668626|FG000|Overall Study|Lack of Efficacy|2|||
13355358|NCT00910728|26668627|FG001|Overall Study|Lack of Efficacy|3|||
13355359|NCT00910728|26668628|FG002|Overall Study|Lack of Efficacy|1|||
13355360|NCT00910728|26668629|FG003|Overall Study|Lack of Efficacy|2|||
13355361|NCT00910728|26668630|FG004|Overall Study|Lack of Efficacy|1|||
13355362|NCT00910728|26668631|FG005|Overall Study|Lack of Efficacy|0|||
13355363|NCT00910728|26668632|FG006|Overall Study|Lack of Efficacy|2|||
13355364|NCT00910728|26668633|FG007|Overall Study|Lack of Efficacy|2|||
13355365|NCT00910728|26668634|FG008|Overall Study|Lack of Efficacy|2|||
13355366|NCT00910728|26668626|FG000|Overall Study|Withdrawal by Subject|0|||
13355367|NCT00910728|26668627|FG001|Overall Study|Withdrawal by Subject|0|||
13355368|NCT00910728|26668628|FG002|Overall Study|Withdrawal by Subject|0|||
13355369|NCT00910728|26668629|FG003|Overall Study|Withdrawal by Subject|0|||
13355370|NCT00910728|26668630|FG004|Overall Study|Withdrawal by Subject|3|||
13355371|NCT00910728|26668631|FG005|Overall Study|Withdrawal by Subject|1|||
13355372|NCT00910728|26668632|FG006|Overall Study|Withdrawal by Subject|2|||
13355373|NCT00910728|26668633|FG007|Overall Study|Withdrawal by Subject|0|||
13355374|NCT00910728|26668634|FG008|Overall Study|Withdrawal by Subject|0|||
13355375|NCT00910728|26668626|FG000|Overall Study|(not specified)|2|||
13355376|NCT00910728|26668627|FG001|Overall Study|(not specified)|0|||
13355377|NCT00910728|26668628|FG002|Overall Study|(not specified)|1|||
13355378|NCT00910728|26668629|FG003|Overall Study|(not specified)|0|||
13355379|NCT00910728|26668630|FG004|Overall Study|(not specified)|1|||
13355380|NCT00910728|26668631|FG005|Overall Study|(not specified)|0|||
13355381|NCT00910728|26668632|FG006|Overall Study|(not specified)|0|||
13355382|NCT00910728|26668633|FG007|Overall Study|(not specified)|0|||
13355383|NCT00910728|26668634|FG008|Overall Study|(not specified)|0|||
13355384|NCT00910728|26668626|FG000|Overall Study|Adverse Event|2|||
13355385|NCT00910728|26668627|FG001|Overall Study|Adverse Event|0|||
13355386|NCT00910728|26668628|FG002|Overall Study|Adverse Event|1|||
13355387|NCT00910728|26668629|FG003|Overall Study|Adverse Event|1|||
13355388|NCT00910728|26668630|FG004|Overall Study|Adverse Event|0|||
13355389|NCT00910728|26668631|FG005|Overall Study|Adverse Event|0|||
13355390|NCT00910728|26668632|FG006|Overall Study|Adverse Event|2|||
13355391|NCT00910728|26668633|FG007|Overall Study|Adverse Event|1|||
13355392|NCT00910728|26668634|FG008|Overall Study|Adverse Event|1|||
13355393|NCT00910715|26668654|FG000|Overall Study|Lost to Follow-up|22|||
13355394|NCT00910715|26668655|FG001|Overall Study|Lost to Follow-up|26|||
13355395|NCT00910715|26668656|FG002|Overall Study|Lost to Follow-up|0|||
13355396|NCT00910689|26668699|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2|||
13355397|NCT00910689|26668700|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1|||
13355398|NCT00910689|26668701|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5|||
13355399|NCT00910689|26668702|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10|||
13355400|NCT00910689|26668699|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
13355401|NCT00910689|26668700|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4|||
13355402|NCT00910689|26668701|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1|||
13355403|NCT00910689|26668702|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
13355404|NCT00910689|26668699|FG000|Month 2- 4: Treatment Period|Adverse Event|2|||
13355405|NCT00910689|26668700|FG001|Month 2- 4: Treatment Period|Adverse Event|3|||
13355406|NCT00910689|26668701|FG002|Month 2- 4: Treatment Period|Adverse Event|2|||
13355407|NCT00910689|26668702|FG003|Month 2- 4: Treatment Period|Adverse Event|0|||
13355408|NCT00910689|26668699|FG000|Month 2- 4: Treatment Period|Time Demands|1|||
13355409|NCT00910689|26668700|FG001|Month 2- 4: Treatment Period|Time Demands|0|||
13355410|NCT00910689|26668701|FG002|Month 2- 4: Treatment Period|Time Demands|4|||
13355411|NCT00910689|26668702|FG003|Month 2- 4: Treatment Period|Time Demands|8|||
13355412|NCT00910689|26668699|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2|||
13355413|NCT00910689|26668700|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1|||
13355414|NCT00910689|26668701|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
13355415|NCT00910689|26668702|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
13355416|NCT00910689|26668699|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0|||
13355417|NCT00910689|26668700|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0|||
13355418|NCT00910689|26668701|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1|||
13355419|NCT00910689|26668702|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0|||
13355420|NCT00910689|26668699|FG000|Month 2- 4: Treatment Period|Pregnancy|0|||
13355421|NCT00910689|26668700|FG001|Month 2- 4: Treatment Period|Pregnancy|2|||
13355422|NCT00910689|26668701|FG002|Month 2- 4: Treatment Period|Pregnancy|0|||
13355423|NCT00910689|26668702|FG003|Month 2- 4: Treatment Period|Pregnancy|0|||
13355424|NCT00910689|26668699|FG000|Month 2- 4: Treatment Period|Protocol Violation|1|||
13355425|NCT00910689|26668700|FG001|Month 2- 4: Treatment Period|Protocol Violation|0|||
13355426|NCT00910689|26668701|FG002|Month 2- 4: Treatment Period|Protocol Violation|0|||
13355427|NCT00910689|26668702|FG003|Month 2- 4: Treatment Period|Protocol Violation|0|||
13355428|NCT00910689|26668699|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2|||
13355429|NCT00910689|26668700|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5|||
13355430|NCT00910689|26668701|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
13355431|NCT00910689|26668702|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
13355432|NCT00910689|26668699|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1|||
13355433|NCT00910689|26668700|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0|||
13355434|NCT00910689|26668701|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2|||
13355435|NCT00910689|26668702|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4|||
13355436|NCT00910689|26668699|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0|||
13355437|NCT00910689|26668700|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
13355438|NCT00910689|26668701|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
13355439|NCT00910689|26668702|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
13355440|NCT00910689|26668699|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
13355441|NCT00910689|26668700|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
13355442|NCT00910689|26668701|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
13355443|NCT00910689|26668702|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
13355444|NCT00910689|26668699|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
13355445|NCT00910689|26668700|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
13355446|NCT00910689|26668701|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2|||
13355447|NCT00910689|26668702|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
13355448|NCT00910689|26668699|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0|||
13355449|NCT00910689|26668700|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0|||
13355450|NCT00910689|26668701|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1|||
13355451|NCT00910689|26668702|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1|||
13355452|NCT00910689|26668699|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3|||
13355453|NCT00910689|26668700|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0|||
13355454|NCT00910689|26668701|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1|||
13355455|NCT00910689|26668702|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2|||
13355456|NCT00910689|26668699|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2|||
13355457|NCT00910689|26668700|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4|||
13355458|NCT00910689|26668701|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2|||
13355459|NCT00910689|26668702|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2|||
13355460|NCT00910689|26668699|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1|||
13355461|NCT00910689|26668700|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0|||
13355462|NCT00910689|26668701|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0|||
13355463|NCT00910689|26668702|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0|||
13355464|NCT00910689|26668699|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2|||
13355465|NCT00910689|26668700|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
13355466|NCT00910689|26668701|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
13355467|NCT00910689|26668702|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1|||
13355468|NCT00910689|26668699|FG000|Months 11- 16: Evaluation Period II|Time Demands|2|||
13355469|NCT00910689|26668700|FG001|Months 11- 16: Evaluation Period II|Time Demands|1|||
13355470|NCT00910689|26668701|FG002|Months 11- 16: Evaluation Period II|Time Demands|0|||
13355471|NCT00910689|26668702|FG003|Months 11- 16: Evaluation Period II|Time Demands|0|||
13355472|NCT00910689|26668699|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
13355473|NCT00910689|26668700|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
13355474|NCT00910689|26668701|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
13355475|NCT00910689|26668702|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1|||
13355476|NCT00910689|26668699|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0|||
13355477|NCT00910689|26668700|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2|||
13355478|NCT00910689|26668701|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1|||
13355479|NCT00910689|26668702|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0|||
13355480|NCT00910663|26668719|FG000|Period 1|Withdrawal by Subject|0|||
13355481|NCT00910663|26668720|FG001|Period 1|Withdrawal by Subject|1|||
13355482|NCT00910624|26668745|FG000|Treatment Phase|Adverse Event|2|||
13355483|NCT00910624|26668746|FG001|Treatment Phase|Adverse Event|6|||
13355484|NCT00910624|26668747|FG002|Treatment Phase|Adverse Event|6|||
13355485|NCT00910624|26668748|FG003|Treatment Phase|Adverse Event|0|||
13355486|NCT00910624|26668745|FG000|Treatment Phase|Treatment Failure|23|||
13355487|NCT00910624|26668746|FG001|Treatment Phase|Treatment Failure|10|||
13355488|NCT00910624|26668747|FG002|Treatment Phase|Treatment Failure|0|||
13355489|NCT00910624|26668748|FG003|Treatment Phase|Treatment Failure|0|||
13355490|NCT00910624|26668745|FG000|Treatment Phase|Lost to Follow-up|0|||
13355491|NCT00910624|26668746|FG001|Treatment Phase|Lost to Follow-up|0|||
13355492|NCT00910624|26668747|FG002|Treatment Phase|Lost to Follow-up|1|||
13355493|NCT00910624|26668748|FG003|Treatment Phase|Lost to Follow-up|0|||
13355494|NCT00910624|26668745|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
13355495|NCT00910624|26668746|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
13355496|NCT00910624|26668747|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1|||
13355497|NCT00910624|26668748|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0|||
13355498|NCT00910624|26668745|FG000|Treatment Phase|Withdrawal by Subject|2|||
13355499|NCT00910624|26668746|FG001|Treatment Phase|Withdrawal by Subject|1|||
13355500|NCT00910624|26668747|FG002|Treatment Phase|Withdrawal by Subject|0|||
13355501|NCT00910624|26668748|FG003|Treatment Phase|Withdrawal by Subject|0|||
13355502|NCT00910624|26668745|FG000|Treatment Phase|Non-Compliance With Protocol|0|||
13355503|NCT00910624|26668746|FG001|Treatment Phase|Non-Compliance With Protocol|1|||
13355504|NCT00910624|26668747|FG002|Treatment Phase|Non-Compliance With Protocol|1|||
13355505|NCT00910624|26668748|FG003|Treatment Phase|Non-Compliance With Protocol|0|||
13355506|NCT00910624|26668745|FG000|Follow-Up Phase|Adverse Event|0|||
13355507|NCT00910624|26668746|FG001|Follow-Up Phase|Adverse Event|0|||
13355508|NCT00910624|26668747|FG002|Follow-Up Phase|Adverse Event|1|||
13355509|NCT00910624|26668748|FG003|Follow-Up Phase|Adverse Event|0|||
13355510|NCT00910624|26668745|FG000|Follow-Up Phase|Lost to Follow-up|3|||
13355511|NCT00910624|26668746|FG001|Follow-Up Phase|Lost to Follow-up|1|||
13355512|NCT00910624|26668747|FG002|Follow-Up Phase|Lost to Follow-up|2|||
13355513|NCT00910624|26668748|FG003|Follow-Up Phase|Lost to Follow-up|0|||
13355514|NCT00910624|26668745|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1|||
13355515|NCT00910624|26668746|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2|||
13355516|NCT00910624|26668747|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
13355517|NCT00910624|26668748|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
13355518|NCT00910624|26668745|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
13355519|NCT00910624|26668746|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
13355520|NCT00910624|26668747|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
13355521|NCT00910624|26668748|FG003|Follow-Up Phase|Withdrawal by Subject|0|||
13355522|NCT00910624|26668745|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1|||
13355523|NCT00910624|26668746|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
13355524|NCT00910624|26668747|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
13355525|NCT00910624|26668748|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
13355526|NCT00910624|26668745|FG000|Follow-Up Phase|Administrative|0|||
13355527|NCT00910624|26668746|FG001|Follow-Up Phase|Administrative|1|||
13355528|NCT00910624|26668747|FG002|Follow-Up Phase|Administrative|1|||
13355529|NCT00910624|26668748|FG003|Follow-Up Phase|Administrative|0|||
13355530|NCT00910429|26668815|FG000|Overall Study|Death|18|||
13355531|NCT00910429|26668816|FG001|Overall Study|Death|12|||
13355532|NCT00910429|26668815|FG000|Overall Study|Withdrawal by Subject|3|||
13355533|NCT00910429|26668816|FG001|Overall Study|Withdrawal by Subject|2|||
13355534|NCT00910429|26668815|FG000|Overall Study|Protocol Violation|1|||
13355535|NCT00910429|26668816|FG001|Overall Study|Protocol Violation|0|||
13355536|NCT00910429|26668815|FG000|Overall Study|Lost to Follow-up|2|||
13355537|NCT00910429|26668816|FG001|Overall Study|Lost to Follow-up|1|||
13355538|NCT00910429|26668815|FG000|Overall Study|Adverse Event|10|||
13355539|NCT00910429|26668816|FG001|Overall Study|Adverse Event|5|||
13355540|NCT00910429|26668815|FG000|Overall Study|Drug non-compliance|1|||
13355541|NCT00910429|26668816|FG001|Overall Study|Drug non-compliance|0|||
13355542|NCT00910429|26668815|FG000|Overall Study|Lack of Efficacy|4|||
13355543|NCT00910429|26668816|FG001|Overall Study|Lack of Efficacy|1|||
13355544|NCT00910299|26668833|FG000|Overall Study|Withdrawal by Subject|16|||
13355545|NCT00910299|26668834|FG001|Overall Study|Withdrawal by Subject|13|||
13355546|NCT00910299|26668833|FG000|Overall Study|Sponsor Decision|58|||
13124902|NCT02937454|25954419|FG000|Overall Study|Death|98|||
13355547|NCT00910299|26668834|FG001|Overall Study|Sponsor Decision|60|||
13355548|NCT00910299|26668833|FG000|Overall Study|Didn't receive any study drug|2|||
13355549|NCT00910299|26668834|FG001|Overall Study|Didn't receive any study drug|1|||
13355550|NCT00910273|26668891|FG000|Overall Study|Lack of Efficacy|6|||
13355551|NCT00910273|26668892|FG001|Overall Study|Lack of Efficacy|9|||
13355552|NCT00910273|26668891|FG000|Overall Study|Adverse Event|1|||
13355553|NCT00910273|26668892|FG001|Overall Study|Adverse Event|1|||
13355554|NCT00910273|26668891|FG000|Overall Study|Withdrawal by Subject|1|||
13355555|NCT00910273|26668892|FG001|Overall Study|Withdrawal by Subject|0|||
13355556|NCT00910273|26668891|FG000|Overall Study|Discontinuation of study by sponsor|8|||
13355557|NCT00910273|26668892|FG001|Overall Study|Discontinuation of study by sponsor|2|||
13355558|NCT00910273|26668891|FG000|Overall Study|Protocol Violation|1|||
13355559|NCT00910273|26668892|FG001|Overall Study|Protocol Violation|0|||
13355560|NCT00910273|26668891|FG000|Overall Study|Lost to Follow-up|1|||
13355561|NCT00910273|26668892|FG001|Overall Study|Lost to Follow-up|1|||
13355562|NCT00910247|26668914|FG000|Overall Study|Adverse Event|15|||
13355563|NCT00910247|26668914|FG000|Overall Study|Death|2|||
13355564|NCT00910247|26668914|FG000|Overall Study|Lost to Follow-up|10|||
13355565|NCT00910247|26668914|FG000|Overall Study|Physician Decision|3|||
13355566|NCT00910247|26668914|FG000|Overall Study|Protocol Violation|10|||
13355567|NCT00910247|26668914|FG000|Overall Study|Withdrawal by Subject|25|||
13355568|NCT00910247|26668914|FG000|Overall Study|Not collected|4|||
13355569|NCT00910091|26668949|FG000|Pre-assignment|Withdrawal by Subject|0|||
13355570|NCT00910091|26668950|FG001|Pre-assignment|Withdrawal by Subject|2|||
13355571|NCT00910091|26668949|FG000|Treatment and Survival|Withdrawal by Subject|3|||
13355572|NCT00910091|26668950|FG001|Treatment and Survival|Withdrawal by Subject|4|||
13355573|NCT00910091|26668949|FG000|Treatment and Survival|Adverse Event|1|||
13355574|NCT00910091|26668950|FG001|Treatment and Survival|Adverse Event|0|||
13355575|NCT00910039|26668963|FG000|Overall Study|Physician Decision|1|||
13355576|NCT00910000|26668998|FG000|Overall Study|Adverse Event|0|||
13355577|NCT00910000|26668999|FG001|Overall Study|Adverse Event|3|||
13355578|NCT00910000|26669000|FG002|Overall Study|Adverse Event|2|||
13355579|NCT00910000|26669001|FG003|Overall Study|Adverse Event|2|||
13355580|NCT00910000|26669002|FG004|Overall Study|Adverse Event|0|||
13355581|NCT00910000|26669003|FG005|Overall Study|Adverse Event|1|||
13355582|NCT00910000|26668998|FG000|Overall Study|Withdrawal by Subject|0|||
13355583|NCT00910000|26668999|FG001|Overall Study|Withdrawal by Subject|0|||
13355584|NCT00910000|26669000|FG002|Overall Study|Withdrawal by Subject|1|||
13355585|NCT00910000|26669001|FG003|Overall Study|Withdrawal by Subject|0|||
13355586|NCT00910000|26669002|FG004|Overall Study|Withdrawal by Subject|1|||
13355587|NCT00910000|26669003|FG005|Overall Study|Withdrawal by Subject|0|||
13355588|NCT00909870|26669020|FG000|Overall Study|Adverse Event|13|||
13355589|NCT00909870|26669021|FG001|Overall Study|Adverse Event|7|||
13355590|NCT00909870|26669020|FG000|Overall Study|Protocol Violation|1|||
13355591|NCT00909870|26669021|FG001|Overall Study|Protocol Violation|2|||
13355592|NCT00909870|26669020|FG000|Overall Study|Withdrawal by Subject|5|||
13355593|NCT00909870|26669021|FG001|Overall Study|Withdrawal by Subject|8|||
13355594|NCT00909870|26669020|FG000|Overall Study|Lost to Follow-up|3|||
13355595|NCT00909870|26669021|FG001|Overall Study|Lost to Follow-up|3|||
13355596|NCT00909870|26669020|FG000|Overall Study|Physician Decision|0|||
13355597|NCT00909870|26669021|FG001|Overall Study|Physician Decision|2|||
13355598|NCT00909870|26669020|FG000|Overall Study|Other|1|||
13355599|NCT00909870|26669021|FG001|Overall Study|Other|5|||
13355600|NCT00909857|26669168|FG000|Overall Study|Withdrawal by Subject|6|||
13355601|NCT00909857|26669169|FG001|Overall Study|Withdrawal by Subject|10|||
13355602|NCT00909857|26669168|FG000|Overall Study|Adverse Event|5|||
13355603|NCT00909857|26669169|FG001|Overall Study|Adverse Event|5|||
13355604|NCT00909857|26669168|FG000|Overall Study|Lost to Follow-up|2|||
13355605|NCT00909857|26669169|FG001|Overall Study|Lost to Follow-up|5|||
13355606|NCT00909857|26669168|FG000|Overall Study|Protocol Violation|2|||
13355607|NCT00909857|26669169|FG001|Overall Study|Protocol Violation|1|||
13355608|NCT00909857|26669168|FG000|Overall Study|Pregnancy|1|||
13355609|NCT00909857|26669169|FG001|Overall Study|Pregnancy|0|||
13355610|NCT00909857|26669168|FG000|Overall Study|Other|1|||
13355611|NCT00909857|26669169|FG001|Overall Study|Other|0|||
13355612|NCT00909857|26669168|FG000|Overall Study|Did not receive study medication|19|||
13355613|NCT00909857|26669169|FG001|Overall Study|Did not receive study medication|24|||
13355614|NCT00909844|26669189|FG000|Overall Study|Adverse Event|1|||
13355615|NCT00909844|26669189|FG000|Overall Study|Withdrawal by Subject|1|||
13355616|NCT00909844|26669189|FG000|Overall Study|Lost to Follow-up|2|||
13355617|NCT00909792|26669198|FG000|Period 1|Did not meet inclusion criteria|0|||
13355618|NCT00909792|26669199|FG001|Period 1|Did not meet inclusion criteria|1|||
13355619|NCT00909792|26669198|FG000|Period 2|Biomicroscopy|1|||
13355620|NCT00909792|26669199|FG001|Period 2|Biomicroscopy|0|||
13355621|NCT00909792|26669198|FG000|Period 2|Lost to Follow-up|0|||
13355622|NCT00909792|26669199|FG001|Period 2|Lost to Follow-up|1|||
13355623|NCT00909779|26669228|FG000|Overall Study|Adverse Event|53|||
13355624|NCT00909779|26669229|FG001|Overall Study|Adverse Event|55|||
13355625|NCT00909779|26669228|FG000|Overall Study|Lack of Efficacy|7|||
13355626|NCT00909779|26669229|FG001|Overall Study|Lack of Efficacy|4|||
13355627|NCT00909779|26669228|FG000|Overall Study|Lost to Follow-up|19|||
13355628|NCT00909779|26669229|FG001|Overall Study|Lost to Follow-up|15|||
13355629|NCT00909779|26669228|FG000|Overall Study|Physician Decision|8|||
13355630|NCT00909779|26669229|FG001|Overall Study|Physician Decision|2|||
13355631|NCT00909779|26669228|FG000|Overall Study|Protocol Violation|2|||
13355632|NCT00909779|26669229|FG001|Overall Study|Protocol Violation|5|||
13355633|NCT00909779|26669228|FG000|Overall Study|Withdrawal by Subject|116|||
13355634|NCT00909779|26669229|FG001|Overall Study|Withdrawal by Subject|80|||
13355635|NCT00909779|26669228|FG000|Overall Study|Site Ceasing Operation|2|||
13355636|NCT00909779|26669229|FG001|Overall Study|Site Ceasing Operation|2|||
13355637|NCT00909779|26669228|FG000|Overall Study|Medical Monitor Decision|1|||
13355638|NCT00909779|26669229|FG001|Overall Study|Medical Monitor Decision|0|||
13355639|NCT00909779|26669228|FG000|Overall Study|Noncompliance|1|||
13355640|NCT00909779|26669229|FG001|Overall Study|Noncompliance|1|||
13355641|NCT00909779|26669228|FG000|Overall Study|Randomized in error|1|||
13355642|NCT00909779|26669229|FG001|Overall Study|Randomized in error|1|||
13355643|NCT00909727|26669250|FG000|Overall Study|Adverse Event|1|||
13355644|NCT00909727|26669251|FG001|Overall Study|Adverse Event|0|||
13355645|NCT00909727|26669250|FG000|Overall Study|Wrong Genotype|1|||
13355646|NCT00909727|26669251|FG001|Overall Study|Wrong Genotype|0|||
13355647|NCT00909727|26669250|FG000|Overall Study|Withdrawal of Consent|1|||
13355648|NCT00909727|26669251|FG001|Overall Study|Withdrawal of Consent|0|||
13355649|NCT00909727|26669250|FG000|Overall Study|Prohibited Medication|1|||
13355650|NCT00909727|26669251|FG001|Overall Study|Prohibited Medication|0|||
13355651|NCT00909532|26669274|FG000|Overall Study|Adverse Event|4|||
13355652|NCT00909532|26669275|FG001|Overall Study|Adverse Event|1|||
13355653|NCT00909532|26669274|FG000|Overall Study|Pregnancy|0|||
13355654|NCT00909532|26669275|FG001|Overall Study|Pregnancy|1|||
13355655|NCT00909532|26669274|FG000|Overall Study|Prohibited Medication|2|||
13355656|NCT00909532|26669275|FG001|Overall Study|Prohibited Medication|1|||
13355657|NCT00909532|26669274|FG000|Overall Study|Withdrawal of Consent|1|||
13355658|NCT00909532|26669275|FG001|Overall Study|Withdrawal of Consent|1|||
13355659|NCT00909532|26669274|FG000|Overall Study|Noncompliance with Study Requirements|0|||
13355660|NCT00909532|26669275|FG001|Overall Study|Noncompliance with Study Requirements|2|||
13355661|NCT00909532|26669274|FG000|Overall Study|Physician Decision|1|||
13355662|NCT00909532|26669275|FG001|Overall Study|Physician Decision|0|||
13355663|NCT00909532|26669274|FG000|Overall Study|Wrong Genotype|1|||
13355664|NCT00909532|26669275|FG001|Overall Study|Wrong Genotype|0|||
13355665|NCT00909532|26669274|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1|||
13355666|NCT00909532|26669275|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0|||
13355667|NCT00909480|26669314|FG000|Overall Study|Adverse Event|5|||
13355668|NCT00909480|26669315|FG001|Overall Study|Adverse Event|3|||
13355669|NCT00909480|26669314|FG000|Overall Study|Protocol Violation|6|||
13355670|NCT00909480|26669315|FG001|Overall Study|Protocol Violation|8|||
13355671|NCT00909480|26669314|FG000|Overall Study|Withdrawal criteria|9|||
13355672|NCT00909480|26669315|FG001|Overall Study|Withdrawal criteria|11|||
13355673|NCT00909480|26669314|FG000|Overall Study|Unclassified|18|||
13355674|NCT00909480|26669315|FG001|Overall Study|Unclassified|19|||
13355675|NCT00909428|26669332|FG000|Overall Study|Lost to Follow-up|13|||
13355676|NCT00909428|26669333|FG001|Overall Study|Lost to Follow-up|10|||
13355677|NCT00909428|26669334|FG002|Overall Study|Lost to Follow-up|9|||
13355678|NCT00909389|26669340|FG000|Overall Study|Adverse Event|6|||
13355679|NCT00909389|26669340|FG000|Overall Study|Death|4|||
13355680|NCT00909389|26669340|FG000|Overall Study|Poor Compliance|16|||
13355681|NCT00909389|26669340|FG000|Overall Study|Lost to Follow-up|4|||
13355682|NCT00909389|26669340|FG000|Overall Study|No Information|103|||
13355683|NCT00909363|26669367|FG000|Overall Study|Withdrawal by Subject|1|||
13355684|NCT00909363|26669368|FG001|Overall Study|Withdrawal by Subject|0|||
13355685|NCT00909363|26669369|FG002|Overall Study|Withdrawal by Subject|0|||
13355686|NCT00909363|26669367|FG000|Overall Study|Lack of Efficacy|1|||
13355687|NCT00909363|26669368|FG001|Overall Study|Lack of Efficacy|0|||
13355688|NCT00909363|26669369|FG002|Overall Study|Lack of Efficacy|0|||
13355689|NCT00909181|26669387|FG000|Overall Study|Lost to Follow-up|39|||
13355690|NCT00909181|26669388|FG001|Overall Study|Lost to Follow-up|18|||
13355691|NCT00909181|26669389|FG002|Overall Study|Lost to Follow-up|33|||
13355692|NCT00909090|26669408|FG000|Overall Study|Lost to Follow-up|17|||
13355693|NCT00909090|26669409|FG001|Overall Study|Lost to Follow-up|17|||
13355694|NCT00909038|26669420|FG000|Overall Study|Protocol Violation|187|||
13355695|NCT00909038|26669420|FG000|Overall Study|Non-evaluable Subjects|230|||
13355696|NCT00908960|26669444|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1|||
13355697|NCT00908960|26669445|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1|||
13355698|NCT00908960|26669446|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2|||
13355699|NCT00908895|26669461|FG000|Overall Study|Lost to Follow-up|1|||
13355700|NCT00908895|26669462|FG001|Overall Study|Lost to Follow-up|3|||
13355701|NCT00908895|26669461|FG000|Overall Study|algodystrophy|2|||
13355702|NCT00908895|26669462|FG001|Overall Study|algodystrophy|2|||
13355703|NCT00908895|26669461|FG000|Overall Study|Adverse Event|1|||
13355704|NCT00908895|26669462|FG001|Overall Study|Adverse Event|1|||
13355705|NCT00908596|26669505|FG000|Overall Study|Other reasons|46|||
13355706|NCT00908596|26669506|FG001|Overall Study|Other reasons|6|||
13355707|NCT00908596|26669507|FG002|Overall Study|Other reasons|2|||
13355708|NCT00908596|26669508|FG003|Overall Study|Other reasons|0|||
13355709|NCT00908596|26669505|FG000|Overall Study|Lost to Follow-up|0|||
13355710|NCT00908596|26669506|FG001|Overall Study|Lost to Follow-up|1|||
13355711|NCT00908596|26669507|FG002|Overall Study|Lost to Follow-up|12|||
13355712|NCT00908596|26669508|FG003|Overall Study|Lost to Follow-up|4|||
13355713|NCT00908596|26669505|FG000|Overall Study|Death|0|||
13355714|NCT00908596|26669506|FG001|Overall Study|Death|5|||
13355715|NCT00908596|26669507|FG002|Overall Study|Death|57|||
13355716|NCT00908596|26669508|FG003|Overall Study|Death|32|||
13355717|NCT00908596|26669505|FG000|Overall Study|Protocol Violation|1|||
13355718|NCT00908596|26669506|FG001|Overall Study|Protocol Violation|0|||
13355719|NCT00908596|26669507|FG002|Overall Study|Protocol Violation|0|||
13355720|NCT00908596|26669508|FG003|Overall Study|Protocol Violation|0|||
13355721|NCT00908596|26669505|FG000|Overall Study|Withdrawal by Subject|0|||
13355722|NCT00908596|26669506|FG001|Overall Study|Withdrawal by Subject|1|||
13355723|NCT00908596|26669507|FG002|Overall Study|Withdrawal by Subject|3|||
13355724|NCT00908596|26669508|FG003|Overall Study|Withdrawal by Subject|1|||
13355725|NCT00908583|26669528|FG000|Phase 1|Withdrawal by Subject|1|||
13355726|NCT00908583|26669528|FG000|Phase 1|Adverse Event|4|||
13355727|NCT00908583|26669528|FG000|Phase 2|Physician Decision|1|||
13355728|NCT00908583|26669528|FG000|Phase 2|Adverse Event|1|||
13355729|NCT00908583|26669528|FG000|Phase 3|Adverse Event|2|||
13355730|NCT00908583|26669528|FG000|Phase 4|Adverse Event|1|||
13355731|NCT00908583|26669528|FG000|Phase 4|Physician Decision|1|||
13355732|NCT00908583|26669528|FG000|Phase 5|Adverse Event|3|||
13355733|NCT00908544|26669575|FG000|Overall Study|Withdrawal by Subject|2|||
13355734|NCT00908544|26669576|FG001|Overall Study|Withdrawal by Subject|4|||
13355735|NCT00908544|26669575|FG000|Overall Study|Lack of Efficacy|0|||
13355736|NCT00908544|26669576|FG001|Overall Study|Lack of Efficacy|1|||
13355737|NCT00908544|26669575|FG000|Overall Study|Pregnancy|1|||
13355738|NCT00908544|26669576|FG001|Overall Study|Pregnancy|0|||
13355739|NCT00908544|26669575|FG000|Overall Study|Relocation abroad|1|||
13355740|NCT00908544|26669576|FG001|Overall Study|Relocation abroad|1|||
13355741|NCT00908544|26669575|FG000|Overall Study|Unable to visit sutdy center|1|||
13355742|NCT00908544|26669576|FG001|Overall Study|Unable to visit sutdy center|0|||
13355743|NCT00908375|26669593|FG000|Overall Study|Withdrawal by Subject|2|||
13355744|NCT00908375|26669594|FG001|Overall Study|Withdrawal by Subject|4|||
13355745|NCT00908375|26669593|FG000|Overall Study|Lost to Follow-up|8|||
13355746|NCT00908375|26669594|FG001|Overall Study|Lost to Follow-up|6|||
13355747|NCT00908349|26669600|FG000|Overall Study|Adverse Event|10|||
13355748|NCT00908349|26669600|FG000|Overall Study|Withdrawal by Subject|9|||
13355749|NCT00908349|26669600|FG000|Overall Study|Physician Decision|5|||
13355750|NCT00908349|26669600|FG000|Overall Study|Lost to Follow-up|5|||
13355751|NCT00908349|26669600|FG000|Overall Study|Various|6|||
13355752|NCT00908310|26669606|FG000|Overall Study|Death|37|||
13355753|NCT00908310|26669606|FG000|Overall Study|Withdrawal by Subject|7|||
13355754|NCT00908310|26669606|FG000|Overall Study|Lost to Follow-up|7|||
13355755|NCT00908310|26669606|FG000|Overall Study|Screening failure|5|||
13355756|NCT00908310|26669606|FG000|Overall Study|Other reasons|4|||
13355757|NCT00908232|26669627|FG000|Cycle 1 to 4|Death|5|||
13355758|NCT00908232|26669628|FG001|Cycle 1 to 4|Death|0|||
13355759|NCT00908232|26669629|FG002|Cycle 1 to 4|Death|0|||
13355760|NCT00908232|26669630|FG003|Cycle 1 to 4|Death|0|||
13355761|NCT00908232|26669627|FG000|Cycle 1 to 4|Withdrawal by Subject|4|||
13355762|NCT00908232|26669628|FG001|Cycle 1 to 4|Withdrawal by Subject|0|||
13355763|NCT00908232|26669629|FG002|Cycle 1 to 4|Withdrawal by Subject|0|||
13355764|NCT00908232|26669630|FG003|Cycle 1 to 4|Withdrawal by Subject|0|||
13355765|NCT00908232|26669627|FG000|Cycle 1 to 4|Progressive Disease|6|||
13355766|NCT00908232|26669628|FG001|Cycle 1 to 4|Progressive Disease|0|||
13355767|NCT00908232|26669629|FG002|Cycle 1 to 4|Progressive Disease|0|||
13355768|NCT00908232|26669630|FG003|Cycle 1 to 4|Progressive Disease|0|||
13355769|NCT00908232|26669627|FG000|Cycle 1 to 4|Adverse Event|12|||
13355770|NCT00908232|26669628|FG001|Cycle 1 to 4|Adverse Event|0|||
13355771|NCT00908232|26669629|FG002|Cycle 1 to 4|Adverse Event|0|||
13355772|NCT00908232|26669630|FG003|Cycle 1 to 4|Adverse Event|0|||
13355773|NCT00908232|26669627|FG000|Cycle 1 to 4|Other|1|||
13355774|NCT00908232|26669628|FG001|Cycle 1 to 4|Other|0|||
13355775|NCT00908232|26669629|FG002|Cycle 1 to 4|Other|0|||
13355776|NCT00908232|26669630|FG003|Cycle 1 to 4|Other|0|||
13355777|NCT00908232|26669627|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1|||
13355778|NCT00908232|26669628|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
13355779|NCT00908232|26669629|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
13355780|NCT00908232|26669630|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
13355781|NCT00908232|26669627|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5|||
13355782|NCT00908232|26669628|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
13355783|NCT00908232|26669629|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
13355784|NCT00908232|26669630|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
13355785|NCT00908232|26669627|FG000|Randomization (Cycle 5) to Cycle 8|Death|2|||
13355786|NCT00908232|26669628|FG001|Randomization (Cycle 5) to Cycle 8|Death|0|||
13355787|NCT00908232|26669629|FG002|Randomization (Cycle 5) to Cycle 8|Death|0|||
13355788|NCT00908232|26669630|FG003|Randomization (Cycle 5) to Cycle 8|Death|0|||
13355789|NCT00908232|26669627|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4|||
13355790|NCT00908232|26669628|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
13355791|NCT00908232|26669629|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1|||
13355792|NCT00908232|26669630|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
13355793|NCT00908232|26669627|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17|||
13355794|NCT00908232|26669628|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2|||
13355795|NCT00908232|26669629|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
13355796|NCT00908232|26669630|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
13355797|NCT00908232|26669627|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2|||
13355798|NCT00908232|26669628|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
13355799|NCT00908232|26669629|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
13355800|NCT00908232|26669630|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
13355801|NCT00908232|26669627|FG000|Randomization (Cycle 5) to Cycle 8|Other|3|||
13355802|NCT00908232|26669628|FG001|Randomization (Cycle 5) to Cycle 8|Other|1|||
13355803|NCT00908232|26669629|FG002|Randomization (Cycle 5) to Cycle 8|Other|0|||
13355804|NCT00908232|26669630|FG003|Randomization (Cycle 5) to Cycle 8|Other|0|||
13355805|NCT00908232|26669627|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1|||
13355806|NCT00908232|26669628|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
13355807|NCT00908232|26669629|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
13355808|NCT00908232|26669630|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
13355809|NCT00908141|26669643|FG000|Overall Study|Withdrawal by Subject|0|||
13355810|NCT00908141|26669644|FG001|Overall Study|Withdrawal by Subject|1|||
13355811|NCT00908115|26669652|FG000|Overall Study|Other|14|||
13355812|NCT00908037|26669826|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
13355813|NCT00908037|26669827|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
13355814|NCT00908037|26669828|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
13355815|NCT00908037|26669829|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
13355816|NCT00908037|26669830|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
13355817|NCT00908037|26669831|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
13355818|NCT00908037|26669832|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3|||
13355819|NCT00908037|26669833|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
13355820|NCT00908037|26669834|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
13355821|NCT00908037|26669835|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
13355822|NCT00908037|26669836|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
13355823|NCT00908037|26669837|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
13355824|NCT00908037|26669826|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
13355825|NCT00908037|26669827|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
13355826|NCT00908037|26669828|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
13355827|NCT00908037|26669829|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
13355828|NCT00908037|26669830|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2|||
13355829|NCT00908037|26669831|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
13355830|NCT00908037|26669832|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
13355831|NCT00908037|26669833|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
13355832|NCT00908037|26669834|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4|||
13355833|NCT00908037|26669835|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
13355834|NCT00908037|26669836|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
13355835|NCT00908037|26669837|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
13355836|NCT00908037|26669826|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
13355837|NCT00908037|26669827|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
13355838|NCT00908037|26669828|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
13355839|NCT00908037|26669829|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
13355840|NCT00908037|26669830|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
13355841|NCT00908037|26669831|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
13355842|NCT00908037|26669832|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
13355843|NCT00908037|26669833|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
13355844|NCT00908037|26669834|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
13355845|NCT00908037|26669835|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
13355846|NCT00908037|26669836|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
13355847|NCT00908037|26669837|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
13355848|NCT00908037|26669826|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
13355849|NCT00908037|26669827|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
13355850|NCT00908037|26669828|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
13355851|NCT00908037|26669829|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
13355852|NCT00908037|26669830|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
13355853|NCT00908037|26669831|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
13355854|NCT00908037|26669832|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
13355855|NCT00908037|26669833|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
13355856|NCT00908037|26669834|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
13355857|NCT00908037|26669835|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
13355858|NCT00908037|26669836|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
13355859|NCT00908037|26669837|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1|||
13355860|NCT00908037|26669826|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
13355861|NCT00908037|26669827|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
13355862|NCT00908037|26669828|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
13355863|NCT00908037|26669829|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
13355864|NCT00908037|26669830|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
13355865|NCT00908037|26669831|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
13355866|NCT00908037|26669832|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
13355867|NCT00908037|26669833|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
13355868|NCT00908037|26669834|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
13355869|NCT00908037|26669835|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1|||
13355870|NCT00908037|26669836|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
13355871|NCT00908037|26669837|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2|||
13355872|NCT00908037|26669826|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
13355873|NCT00908037|26669827|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
13355874|NCT00908037|26669828|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
13355875|NCT00908037|26669829|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
13355876|NCT00908037|26669830|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
13355877|NCT00908037|26669831|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
13355878|NCT00908037|26669832|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
13355879|NCT00908037|26669833|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
13355880|NCT00908037|26669834|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
13355881|NCT00908037|26669835|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1|||
13355882|NCT00908037|26669836|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
13355883|NCT00908037|26669837|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
13355884|NCT00908037|26669826|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
13355885|NCT00908037|26669827|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
13355886|NCT00908037|26669828|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
13355887|NCT00908037|26669829|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
13355888|NCT00908037|26669830|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
13355889|NCT00908037|26669831|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
13355890|NCT00908037|26669832|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
13355891|NCT00908037|26669833|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
13355892|NCT00908037|26669834|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
13355893|NCT00908037|26669835|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
13355894|NCT00908037|26669836|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2|||
13355895|NCT00908037|26669837|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
13355896|NCT00908037|26669826|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
13355897|NCT00908037|26669827|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
13355898|NCT00908037|26669828|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
13355899|NCT00908037|26669829|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
13355900|NCT00908037|26669830|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
13355901|NCT00908037|26669831|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
13355902|NCT00908037|26669832|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
13355903|NCT00908037|26669833|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
13355904|NCT00908037|26669834|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
13355905|NCT00908037|26669835|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1|||
13355906|NCT00908037|26669836|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
13355907|NCT00908037|26669837|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
13355908|NCT00908037|26669826|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
13355909|NCT00908037|26669827|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
13355910|NCT00908037|26669828|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
13355911|NCT00908037|26669829|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
13355912|NCT00908037|26669830|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
13355913|NCT00908037|26669831|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
13355914|NCT00908037|26669832|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
13355915|NCT00908037|26669833|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
13355916|NCT00908037|26669834|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
13355917|NCT00908037|26669835|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
13355918|NCT00908037|26669836|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2|||
13355919|NCT00908037|26669837|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
13355920|NCT00908011|26669850|FG000|Overall Study|Withdrawal by Subject|2|||
13355921|NCT00908011|26669851|FG001|Overall Study|Withdrawal by Subject|2|||
13355922|NCT00907881|26669860|FG000|Overall Study|Lost to Follow-up|59|||
13355923|NCT00907881|26669860|FG000|Overall Study|Noncompliance|5|||
13355924|NCT00907881|26669860|FG000|Overall Study|Withdrawal by Subject|5|||
13355925|NCT00907881|26669860|FG000|Overall Study|Protocol Violation|1|||
13355926|NCT00907881|26669860|FG000|Overall Study|Missing discontinuation information|15|||
13355927|NCT00907803|26669899|FG000|Overall Study|Withdrawal of consent - long commute|1|||
13355928|NCT00907803|26669900|FG001|Overall Study|Withdrawal of consent - long commute|0|||
13355929|NCT00907803|26669901|FG002|Overall Study|Withdrawal of consent - long commute|0|||
13355930|NCT00907803|26669899|FG000|Overall Study|Adverse Event|2|||
13355931|NCT00907803|26669900|FG001|Overall Study|Adverse Event|0|||
13355932|NCT00907803|26669901|FG002|Overall Study|Adverse Event|0|||
13355933|NCT00907803|26669899|FG000|Overall Study|Withdrawal by Subject|0|||
13355934|NCT00907803|26669900|FG001|Overall Study|Withdrawal by Subject|1|||
13355935|NCT00907803|26669901|FG002|Overall Study|Withdrawal by Subject|0|||
13355936|NCT00907803|26669899|FG000|Overall Study|Lost to Follow-up|0|||
13355937|NCT00907803|26669900|FG001|Overall Study|Lost to Follow-up|1|||
13355938|NCT00907803|26669901|FG002|Overall Study|Lost to Follow-up|0|||
13355939|NCT00907803|26669899|FG000|Overall Study|Protocol Violation|0|||
13355940|NCT00907803|26669900|FG001|Overall Study|Protocol Violation|1|||
13355941|NCT00907803|26669901|FG002|Overall Study|Protocol Violation|0|||
13355942|NCT00907777|26669930|FG000|Overall Study|Withdrawal by Subject|0|||
13355943|NCT00907777|26669931|FG001|Overall Study|Withdrawal by Subject|1|||
13355944|NCT00907738|26669963|FG000|Overall Study|Adverse Event|2|||
13355945|NCT00907738|26669964|FG001|Overall Study|Adverse Event|0|||
13355946|NCT00907738|26669965|FG002|Overall Study|Adverse Event|1|||
13355947|NCT00907738|26669966|FG003|Overall Study|Adverse Event|0|||
13355948|NCT00907738|26669967|FG004|Overall Study|Adverse Event|0|||
13355949|NCT00907738|26669963|FG000|Overall Study|not specified or withdrew consent|3|||
13355950|NCT00907738|26669964|FG001|Overall Study|not specified or withdrew consent|0|||
13355951|NCT00907738|26669965|FG002|Overall Study|not specified or withdrew consent|0|||
13355952|NCT00907738|26669966|FG003|Overall Study|not specified or withdrew consent|0|||
13355953|NCT00907738|26669967|FG004|Overall Study|not specified or withdrew consent|0|||
13355954|NCT00907738|26669963|FG000|Overall Study|Disease progression|8|||
13355955|NCT00907738|26669964|FG001|Overall Study|Disease progression|1|||
13355956|NCT00907738|26669965|FG002|Overall Study|Disease progression|6|||
13355957|NCT00907738|26669966|FG003|Overall Study|Disease progression|4|||
13355958|NCT00907738|26669967|FG004|Overall Study|Disease progression|2|||
13355959|NCT00907621|26669982|FG000|Overall Study|Lost to Follow-up|6|||
13355960|NCT00907621|26669983|FG001|Overall Study|Lost to Follow-up|3|||
13355961|NCT00907621|26669982|FG000|Overall Study|intercurrent febrile illness|1|||
13355962|NCT00907621|26669983|FG001|Overall Study|intercurrent febrile illness|1|||
13355963|NCT00907517|26670021|FG000|Overall Study|Progressive Disease|3|||
13355964|NCT00907517|26670022|FG001|Overall Study|Progressive Disease|3|||
13355965|NCT00907517|26670023|FG002|Overall Study|Progressive Disease|4|||
13355966|NCT00907517|26670024|FG003|Overall Study|Progressive Disease|4|||
13355967|NCT00907517|26670025|FG004|Overall Study|Progressive Disease|4|||
13355968|NCT00907517|26670021|FG000|Overall Study|Symptomatic Deterioration|0|||
13355969|NCT00907517|26670022|FG001|Overall Study|Symptomatic Deterioration|0|||
13355970|NCT00907517|26670023|FG002|Overall Study|Symptomatic Deterioration|0|||
13355971|NCT00907517|26670024|FG003|Overall Study|Symptomatic Deterioration|0|||
13355972|NCT00907517|26670025|FG004|Overall Study|Symptomatic Deterioration|1|||
13355973|NCT00907478|26670063|FG000|Overall Study|Ineligibility determined|0|||
13355974|NCT00907478|26670064|FG001|Overall Study|Ineligibility determined|0|||
13355975|NCT00907478|26670065|FG002|Overall Study|Ineligibility determined|1|||
13355976|NCT00907478|26670063|FG000|Overall Study|Noncompliance|0|||
13355977|NCT00907478|26670064|FG001|Overall Study|Noncompliance|0|||
13355978|NCT00907478|26670065|FG002|Overall Study|Noncompliance|1|||
13355979|NCT00907478|26670063|FG000|Overall Study|Adverse Event|3|||
13355980|NCT00907478|26670064|FG001|Overall Study|Adverse Event|1|||
13355981|NCT00907478|26670065|FG002|Overall Study|Adverse Event|2|||
13355982|NCT00907478|26670063|FG000|Overall Study|Withdrawal by Subject|8|||
13355983|NCT00907478|26670064|FG001|Overall Study|Withdrawal by Subject|9|||
13355984|NCT00907478|26670065|FG002|Overall Study|Withdrawal by Subject|6|||
13355985|NCT00907478|26670063|FG000|Overall Study|Requirement for alternative therapy|1|||
13355986|NCT00907478|26670064|FG001|Overall Study|Requirement for alternative therapy|2|||
13355987|NCT00907478|26670065|FG002|Overall Study|Requirement for alternative therapy|3|||
13355988|NCT00907478|26670063|FG000|Overall Study|Physician Decision|2|||
13355989|NCT00907478|26670064|FG001|Overall Study|Physician Decision|0|||
13355990|NCT00907478|26670065|FG002|Overall Study|Physician Decision|3|||
13355991|NCT00907478|26670063|FG000|Overall Study|Death|4|||
13355992|NCT00907478|26670064|FG001|Overall Study|Death|2|||
13355993|NCT00907478|26670065|FG002|Overall Study|Death|1|||
13355994|NCT00907478|26670063|FG000|Overall Study|Protocol-specified criteria|5|||
13355995|NCT00907478|26670064|FG001|Overall Study|Protocol-specified criteria|2|||
13355996|NCT00907478|26670065|FG002|Overall Study|Protocol-specified criteria|3|||
13355997|NCT00907478|26670063|FG000|Overall Study|Pregnancy|0|||
13355998|NCT00907478|26670064|FG001|Overall Study|Pregnancy|1|||
13355999|NCT00907478|26670065|FG002|Overall Study|Pregnancy|1|||
13356000|NCT00907478|26670063|FG000|Overall Study|Lost to Follow-up|1|||
13356001|NCT00907478|26670064|FG001|Overall Study|Lost to Follow-up|0|||
13356002|NCT00907478|26670065|FG002|Overall Study|Lost to Follow-up|0|||
13356003|NCT00907478|26670063|FG000|Overall Study|Other|3|||
13356004|NCT00907478|26670064|FG001|Overall Study|Other|0|||
13356005|NCT00907478|26670065|FG002|Overall Study|Other|1|||
13374459|NCT00796445|26726791|FG001|Overall Study|Invalid Informed Consent Form|0|||
13374460|NCT00796419|26726808|FG000|Overall Study|Death|0|||
13374461|NCT00796419|26726809|FG001|Overall Study|Death|1|||
13374462|NCT00796367|26726830|FG000|Overall Study|Adverse Event|6|||
13374463|NCT00796367|26726831|FG001|Overall Study|Adverse Event|4|||
13374464|NCT00796367|26726832|FG002|Overall Study|Adverse Event|7|||
13374465|NCT00796367|26726830|FG000|Overall Study|Lost to Follow-up|5|||
13374466|NCT00796367|26726831|FG001|Overall Study|Lost to Follow-up|4|||
13374467|NCT00796367|26726832|FG002|Overall Study|Lost to Follow-up|21|||
13374468|NCT00796367|26726830|FG000|Overall Study|Withdrawal by Subject|9|||
13374469|NCT00796367|26726831|FG001|Overall Study|Withdrawal by Subject|11|||
13374470|NCT00796367|26726832|FG002|Overall Study|Withdrawal by Subject|12|||
13374471|NCT00796367|26726830|FG000|Overall Study|Lack of Efficacy|2|||
13374472|NCT00796367|26726831|FG001|Overall Study|Lack of Efficacy|1|||
13374473|NCT00796367|26726832|FG002|Overall Study|Lack of Efficacy|0|||
13374474|NCT00796367|26726830|FG000|Overall Study|non compliance|3|||
13374475|NCT00796367|26726831|FG001|Overall Study|non compliance|1|||
13374476|NCT00796367|26726832|FG002|Overall Study|non compliance|1|||
13374477|NCT00796367|26726830|FG000|Overall Study|Pregnancy|1|||
13374478|NCT00796367|26726831|FG001|Overall Study|Pregnancy|0|||
13374479|NCT00796367|26726832|FG002|Overall Study|Pregnancy|1|||
13374480|NCT00796367|26726830|FG000|Overall Study|Requirement for restricted medication|2|||
13374481|NCT00796367|26726831|FG001|Overall Study|Requirement for restricted medication|0|||
13374482|NCT00796367|26726832|FG002|Overall Study|Requirement for restricted medication|2|||
13374483|NCT00796367|26726830|FG000|Overall Study|other|2|||
13374484|NCT00796367|26726831|FG001|Overall Study|other|4|||
13374485|NCT00796367|26726832|FG002|Overall Study|other|3|||
13374486|NCT00796328|26726838|FG000|Overall Study|experienced hypotension requiring tx|6|||
13374487|NCT00796315|26726853|FG000|Overall Study|Protocol Violation|0|||
13374488|NCT00796315|26726854|FG001|Overall Study|Protocol Violation|1|||
13374489|NCT00796315|26726855|FG002|Overall Study|Protocol Violation|0|||
13374490|NCT00796224|26726880|FG000|Overall Study|Adverse Event|1|||
13374491|NCT00796224|26726881|FG001|Overall Study|Adverse Event|0|||
13374492|NCT00796224|26726880|FG000|Overall Study|Protocol Violation|0|||
13374493|NCT00796224|26726881|FG001|Overall Study|Protocol Violation|1|||
13374494|NCT00796120|26726902|FG000|Overall Study|Death|3|||
13374495|NCT00796120|26726903|FG001|Overall Study|Death|0|||
13374496|NCT00796120|26726902|FG000|Overall Study|Adverse Event|11|||
13374497|NCT00796120|26726903|FG001|Overall Study|Adverse Event|6|||
13374498|NCT00796120|26726902|FG000|Overall Study|Progressive disease|22|||
13374499|NCT00796120|26726903|FG001|Overall Study|Progressive disease|13|||
13374500|NCT00796120|26726902|FG000|Overall Study|Participant refusal|3|||
13374501|NCT00796120|26726903|FG001|Overall Study|Participant refusal|4|||
13374502|NCT00796120|26726902|FG000|Overall Study|Other|6|||
13374503|NCT00796120|26726903|FG001|Overall Study|Other|17|||
13374504|NCT00796120|26726902|FG000|Overall Study|Physician Decision|16|||
13374505|NCT00796120|26726903|FG001|Overall Study|Physician Decision|17|||
13374506|NCT00796120|26726902|FG000|Overall Study|Randomized but not treated|0|||
13374507|NCT00796120|26726903|FG001|Overall Study|Randomized but not treated|3|||
13374508|NCT00796107|26726912|FG000|Overall Study|Lack of Efficacy|1|||
13374509|NCT00796107|26726912|FG000|Overall Study|Progressive Disease|5|||
13374510|NCT00796003|26726940|FG000|Overall Study|Disease Progression|2|||
13374511|NCT00796003|26726941|FG001|Overall Study|Disease Progression|13|||
13374512|NCT00796003|26726940|FG000|Overall Study|Adverse Event|1|||
13374513|NCT00796003|26726941|FG001|Overall Study|Adverse Event|7|||
13374514|NCT00796003|26726940|FG000|Overall Study|Specified organ function not met|0|||
13374515|NCT00796003|26726941|FG001|Overall Study|Specified organ function not met|1|||
13374516|NCT00796003|26726940|FG000|Overall Study|Physician Decision|0|||
13374517|NCT00796003|26726941|FG001|Overall Study|Physician Decision|4|||
13374518|NCT00796003|26726940|FG000|Overall Study|Withdrawal by Subject|0|||
13374519|NCT00796003|26726941|FG001|Overall Study|Withdrawal by Subject|1|||
13374520|NCT00796003|26726940|FG000|Overall Study|Other|0|||
13374521|NCT00796003|26726941|FG001|Overall Study|Other|1|||
13374522|NCT00796003|26726940|FG000|Overall Study|Participants Not treated|0|||
13374523|NCT00796003|26726941|FG001|Overall Study|Participants Not treated|2|||
13374524|NCT00795951|26727036|FG000|Overall Study|Lost to Follow-up|1|||
13356006|NCT00907374|26670084|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
13356007|NCT00907374|26670085|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
13356008|NCT00907335|26670108|FG000|Overall Study|Withdrawal by Subject|2|||
13356009|NCT00907335|26670109|FG001|Overall Study|Withdrawal by Subject|0|||
13356010|NCT00907335|26670108|FG000|Overall Study|Adverse Event|4|||
13356011|NCT00907335|26670109|FG001|Overall Study|Adverse Event|1|||
13356012|NCT00907335|26670108|FG000|Overall Study|Lost to Follow-up|2|||
13356013|NCT00907335|26670109|FG001|Overall Study|Lost to Follow-up|0|||
13356014|NCT00907296|26670192|FG000|Overall Study|Ineligibility Determined|1|||
13356015|NCT00907296|26670193|FG001|Overall Study|Ineligibility Determined|0|||
13356016|NCT00907296|26670194|FG002|Overall Study|Ineligibility Determined|0|||
13356017|NCT00907296|26670195|FG003|Overall Study|Ineligibility Determined|1|||
13356018|NCT00907296|26670196|FG004|Overall Study|Ineligibility Determined|0|||
13356019|NCT00907296|26670197|FG005|Overall Study|Ineligibility Determined|0|||
13356020|NCT00907296|26670198|FG006|Overall Study|Ineligibility Determined|0|||
13356021|NCT00907296|26670199|FG007|Overall Study|Ineligibility Determined|1|||
13356022|NCT00907296|26670200|FG008|Overall Study|Ineligibility Determined|0|||
13356023|NCT00907296|26670201|FG009|Overall Study|Ineligibility Determined|0|||
13356024|NCT00907296|26670192|FG000|Overall Study|Protocol Deviation|0|||
13356025|NCT00907296|26670193|FG001|Overall Study|Protocol Deviation|1|||
13356026|NCT00907296|26670194|FG002|Overall Study|Protocol Deviation|0|||
13356027|NCT00907296|26670195|FG003|Overall Study|Protocol Deviation|0|||
13356028|NCT00907296|26670196|FG004|Overall Study|Protocol Deviation|0|||
13356029|NCT00907296|26670197|FG005|Overall Study|Protocol Deviation|0|||
13356030|NCT00907296|26670198|FG006|Overall Study|Protocol Deviation|0|||
13356031|NCT00907296|26670199|FG007|Overall Study|Protocol Deviation|0|||
13356032|NCT00907296|26670200|FG008|Overall Study|Protocol Deviation|0|||
13356033|NCT00907296|26670201|FG009|Overall Study|Protocol Deviation|0|||
13356034|NCT00907296|26670192|FG000|Overall Study|Noncompliance|1|||
13356035|NCT00907296|26670193|FG001|Overall Study|Noncompliance|1|||
13356036|NCT00907296|26670194|FG002|Overall Study|Noncompliance|1|||
13356037|NCT00907296|26670195|FG003|Overall Study|Noncompliance|0|||
13356038|NCT00907296|26670196|FG004|Overall Study|Noncompliance|0|||
13356039|NCT00907296|26670197|FG005|Overall Study|Noncompliance|1|||
13356040|NCT00907296|26670198|FG006|Overall Study|Noncompliance|0|||
13356041|NCT00907296|26670199|FG007|Overall Study|Noncompliance|2|||
13356042|NCT00907296|26670200|FG008|Overall Study|Noncompliance|0|||
13356043|NCT00907296|26670201|FG009|Overall Study|Noncompliance|0|||
13356044|NCT00907296|26670192|FG000|Overall Study|Adverse Event|2|||
13356045|NCT00907296|26670193|FG001|Overall Study|Adverse Event|0|||
13356046|NCT00907296|26670194|FG002|Overall Study|Adverse Event|0|||
13356047|NCT00907296|26670195|FG003|Overall Study|Adverse Event|0|||
13356048|NCT00907296|26670196|FG004|Overall Study|Adverse Event|0|||
13356049|NCT00907296|26670197|FG005|Overall Study|Adverse Event|0|||
13356050|NCT00907296|26670198|FG006|Overall Study|Adverse Event|1|||
13356051|NCT00907296|26670199|FG007|Overall Study|Adverse Event|0|||
13356052|NCT00907296|26670200|FG008|Overall Study|Adverse Event|0|||
13356053|NCT00907296|26670201|FG009|Overall Study|Adverse Event|1|||
13356054|NCT00907296|26670192|FG000|Overall Study|Withdrawal by Subject|7|||
13356055|NCT00907296|26670193|FG001|Overall Study|Withdrawal by Subject|2|||
13356056|NCT00907296|26670194|FG002|Overall Study|Withdrawal by Subject|1|||
13356057|NCT00907296|26670195|FG003|Overall Study|Withdrawal by Subject|1|||
13356058|NCT00907296|26670196|FG004|Overall Study|Withdrawal by Subject|1|||
13356059|NCT00907296|26670197|FG005|Overall Study|Withdrawal by Subject|5|||
13356060|NCT00907296|26670198|FG006|Overall Study|Withdrawal by Subject|3|||
13356061|NCT00907296|26670199|FG007|Overall Study|Withdrawal by Subject|2|||
13356062|NCT00907296|26670200|FG008|Overall Study|Withdrawal by Subject|4|||
13356063|NCT00907296|26670201|FG009|Overall Study|Withdrawal by Subject|2|||
13356064|NCT00907296|26670192|FG000|Overall Study|Lost to Follow-up|9|||
13356065|NCT00907296|26670193|FG001|Overall Study|Lost to Follow-up|1|||
13356066|NCT00907296|26670194|FG002|Overall Study|Lost to Follow-up|0|||
13356067|NCT00907296|26670195|FG003|Overall Study|Lost to Follow-up|2|||
13356068|NCT00907296|26670196|FG004|Overall Study|Lost to Follow-up|0|||
13356069|NCT00907296|26670197|FG005|Overall Study|Lost to Follow-up|3|||
13356070|NCT00907296|26670198|FG006|Overall Study|Lost to Follow-up|2|||
13356071|NCT00907296|26670199|FG007|Overall Study|Lost to Follow-up|2|||
13356072|NCT00907296|26670200|FG008|Overall Study|Lost to Follow-up|0|||
13356073|NCT00907296|26670201|FG009|Overall Study|Lost to Follow-up|4|||
13356074|NCT00907257|26670218|FG000|Overall Study|Adverse Event|0|||
13356075|NCT00907257|26670219|FG001|Overall Study|Adverse Event|4|||
13356076|NCT00907257|26670218|FG000|Overall Study|Protocol Violation|1|||
13356077|NCT00907257|26670219|FG001|Overall Study|Protocol Violation|2|||
13356078|NCT00907257|26670218|FG000|Overall Study|Lost to Follow-up|3|||
13356079|NCT00907257|26670219|FG001|Overall Study|Lost to Follow-up|3|||
13356080|NCT00907257|26670218|FG000|Overall Study|Withdrawal by Subject|1|||
13356081|NCT00907257|26670219|FG001|Overall Study|Withdrawal by Subject|2|||
13356082|NCT00907257|26670218|FG000|Overall Study|Per IRB-Subject became vulnerable|1|||
13356083|NCT00907257|26670219|FG001|Overall Study|Per IRB-Subject became vulnerable|0|||
13356084|NCT00907257|26670218|FG000|Overall Study|Moved|1|||
13356085|NCT00907257|26670219|FG001|Overall Study|Moved|0|||
13356086|NCT00907257|26670218|FG000|Overall Study|Personal Reasons|6|||
13356087|NCT00907257|26670219|FG001|Overall Study|Personal Reasons|1|||
13356088|NCT00907153|26670268|FG000|Overall Study|Lost to Follow-up|1|||
13356089|NCT00907153|26670269|FG001|Overall Study|Lost to Follow-up|1|||
13356090|NCT00907153|26670268|FG000|Overall Study|Withdrawal by Subject|1|||
13356091|NCT00907153|26670269|FG001|Overall Study|Withdrawal by Subject|3|||
13356092|NCT00906971|26670284|FG000|Overall Study|Withdrawal by Subject|8|||
13356093|NCT00906971|26670285|FG001|Overall Study|Withdrawal by Subject|2|||
13356094|NCT00906971|26670284|FG000|Overall Study|Lost to Follow-up|0|||
13356095|NCT00906971|26670285|FG001|Overall Study|Lost to Follow-up|1|||
13356096|NCT00906945|26670329|FG000|Overall Study|Found to be not eligible|0|||
13356097|NCT00906945|26670330|FG001|Overall Study|Found to be not eligible|0|||
13356098|NCT00906945|26670331|FG002|Overall Study|Found to be not eligible|0|||
13356099|NCT00906945|26670332|FG003|Overall Study|Found to be not eligible|1|||
13356100|NCT00906945|26670333|FG004|Overall Study|Found to be not eligible|1|||
13356101|NCT00906945|26670334|FG005|Overall Study|Found to be not eligible|1|||
13356102|NCT00906945|26670329|FG000|Overall Study|Physician Decision|0|||
13356103|NCT00906945|26670330|FG001|Overall Study|Physician Decision|0|||
13356104|NCT00906945|26670331|FG002|Overall Study|Physician Decision|0|||
13356105|NCT00906945|26670332|FG003|Overall Study|Physician Decision|0|||
13356106|NCT00906945|26670333|FG004|Overall Study|Physician Decision|0|||
13356107|NCT00906945|26670334|FG005|Overall Study|Physician Decision|1|||
13356108|NCT00906698|26670435|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
13356109|NCT00906698|26670436|FG001|Overall Study|Dose-limiting toxicity (DLT)|6|||
13356110|NCT00906698|26670437|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
13356111|NCT00906698|26670438|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
13356112|NCT00906698|26670439|FG004|Overall Study|Dose-limiting toxicity (DLT)|1|||
13356113|NCT00906698|26670440|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
13356114|NCT00906698|26670435|FG000|Overall Study|Adverse Event|0|||
13356115|NCT00906698|26670436|FG001|Overall Study|Adverse Event|0|||
13356116|NCT00906698|26670437|FG002|Overall Study|Adverse Event|2|||
13356117|NCT00906698|26670438|FG003|Overall Study|Adverse Event|0|||
13356118|NCT00906698|26670439|FG004|Overall Study|Adverse Event|4|||
13356119|NCT00906698|26670440|FG005|Overall Study|Adverse Event|1|||
13356120|NCT00906698|26670435|FG000|Overall Study|Disease progression|3|||
13356121|NCT00906698|26670436|FG001|Overall Study|Disease progression|12|||
13356122|NCT00906698|26670437|FG002|Overall Study|Disease progression|4|||
13356123|NCT00906698|26670438|FG003|Overall Study|Disease progression|4|||
13356124|NCT00906698|26670439|FG004|Overall Study|Disease progression|12|||
13356125|NCT00906698|26670440|FG005|Overall Study|Disease progression|4|||
13356126|NCT00906698|26670435|FG000|Overall Study|Withdrawal by Subject|0|||
13356127|NCT00906698|26670436|FG001|Overall Study|Withdrawal by Subject|0|||
13356128|NCT00906698|26670437|FG002|Overall Study|Withdrawal by Subject|0|||
13356129|NCT00906698|26670438|FG003|Overall Study|Withdrawal by Subject|0|||
13356130|NCT00906698|26670439|FG004|Overall Study|Withdrawal by Subject|1|||
13356131|NCT00906698|26670440|FG005|Overall Study|Withdrawal by Subject|0|||
13356132|NCT00906698|26670435|FG000|Overall Study|incl. non compliance, lost to follow-up|0|||
13356133|NCT00906698|26670436|FG001|Overall Study|incl. non compliance, lost to follow-up|1|||
13356134|NCT00906698|26670437|FG002|Overall Study|incl. non compliance, lost to follow-up|0|||
13356135|NCT00906698|26670438|FG003|Overall Study|incl. non compliance, lost to follow-up|0|||
13356136|NCT00906698|26670439|FG004|Overall Study|incl. non compliance, lost to follow-up|0|||
13356137|NCT00906698|26670440|FG005|Overall Study|incl. non compliance, lost to follow-up|0|||
13356138|NCT00906399|26670475|FG000|Year 1|Randomized But Not Treated|0|||
13356139|NCT00906399|26670476|FG001|Year 1|Randomized But Not Treated|1|||
13356140|NCT00906399|26670477|FG002|Year 1|Randomized But Not Treated|3|||
13356141|NCT00906399|26670478|FG003|Year 1|Randomized But Not Treated|0|||
13356142|NCT00906399|26670479|FG004|Year 1|Randomized But Not Treated|0|||
13356143|NCT00906399|26670480|FG005|Year 1|Randomized But Not Treated|0|||
13356144|NCT00906399|26670481|FG006|Year 1|Randomized But Not Treated|0|||
13356145|NCT00906399|26670475|FG000|Year 1|Adverse Event|4|||
13356146|NCT00906399|26670476|FG001|Year 1|Adverse Event|22|||
13356147|NCT00906399|26670477|FG002|Year 1|Adverse Event|24|||
13356148|NCT00906399|26670478|FG003|Year 1|Adverse Event|0|||
13356149|NCT00906399|26670479|FG004|Year 1|Adverse Event|0|||
13356150|NCT00906399|26670480|FG005|Year 1|Adverse Event|0|||
13356151|NCT00906399|26670481|FG006|Year 1|Adverse Event|0|||
13356152|NCT00906399|26670475|FG000|Year 1|Lost to Follow-up|4|||
13356153|NCT00906399|26670476|FG001|Year 1|Lost to Follow-up|4|||
13124903|NCT02937454|25954420|FG001|Overall Study|Death|95|||
13356154|NCT00906399|26670477|FG002|Year 1|Lost to Follow-up|2|||
13356155|NCT00906399|26670478|FG003|Year 1|Lost to Follow-up|0|||
13356156|NCT00906399|26670479|FG004|Year 1|Lost to Follow-up|0|||
13356157|NCT00906399|26670480|FG005|Year 1|Lost to Follow-up|0|||
13356158|NCT00906399|26670481|FG006|Year 1|Lost to Follow-up|0|||
13356159|NCT00906399|26670475|FG000|Year 1|Withdrawal by Subject|30|||
13356160|NCT00906399|26670476|FG001|Year 1|Withdrawal by Subject|32|||
13356161|NCT00906399|26670477|FG002|Year 1|Withdrawal by Subject|36|||
13356162|NCT00906399|26670478|FG003|Year 1|Withdrawal by Subject|0|||
13356163|NCT00906399|26670479|FG004|Year 1|Withdrawal by Subject|0|||
13356164|NCT00906399|26670480|FG005|Year 1|Withdrawal by Subject|0|||
13356165|NCT00906399|26670481|FG006|Year 1|Withdrawal by Subject|0|||
13356166|NCT00906399|26670475|FG000|Year 1|Physician Decision|0|||
13356167|NCT00906399|26670476|FG001|Year 1|Physician Decision|1|||
13356168|NCT00906399|26670477|FG002|Year 1|Physician Decision|3|||
13356169|NCT00906399|26670478|FG003|Year 1|Physician Decision|0|||
13356170|NCT00906399|26670479|FG004|Year 1|Physician Decision|0|||
13356171|NCT00906399|26670480|FG005|Year 1|Physician Decision|0|||
13356172|NCT00906399|26670481|FG006|Year 1|Physician Decision|0|||
13356173|NCT00906399|26670475|FG000|Year 1|Death|2|||
13356174|NCT00906399|26670476|FG001|Year 1|Death|1|||
13356175|NCT00906399|26670477|FG002|Year 1|Death|1|||
13356176|NCT00906399|26670478|FG003|Year 1|Death|0|||
13356177|NCT00906399|26670479|FG004|Year 1|Death|0|||
13356178|NCT00906399|26670480|FG005|Year 1|Death|0|||
13356179|NCT00906399|26670481|FG006|Year 1|Death|0|||
13356180|NCT00906399|26670475|FG000|Year 1|Other|4|||
13356181|NCT00906399|26670476|FG001|Year 1|Other|2|||
13356182|NCT00906399|26670477|FG002|Year 1|Other|7|||
13356183|NCT00906399|26670478|FG003|Year 1|Other|0|||
13356184|NCT00906399|26670479|FG004|Year 1|Other|0|||
13356185|NCT00906399|26670480|FG005|Year 1|Other|0|||
13356186|NCT00906399|26670481|FG006|Year 1|Other|0|||
13356187|NCT00906399|26670475|FG000|Year 2|Adverse Event|0|||
13356188|NCT00906399|26670476|FG001|Year 2|Adverse Event|0|||
13356189|NCT00906399|26670477|FG002|Year 2|Adverse Event|0|||
13356190|NCT00906399|26670478|FG003|Year 2|Adverse Event|9|||
13356191|NCT00906399|26670479|FG004|Year 2|Adverse Event|8|||
13356192|NCT00906399|26670480|FG005|Year 2|Adverse Event|11|||
13356193|NCT00906399|26670481|FG006|Year 2|Adverse Event|6|||
13356194|NCT00906399|26670475|FG000|Year 2|Lost to Follow-up|0|||
13356195|NCT00906399|26670476|FG001|Year 2|Lost to Follow-up|0|||
13356196|NCT00906399|26670477|FG002|Year 2|Lost to Follow-up|0|||
13356197|NCT00906399|26670478|FG003|Year 2|Lost to Follow-up|1|||
13356198|NCT00906399|26670479|FG004|Year 2|Lost to Follow-up|4|||
13356199|NCT00906399|26670480|FG005|Year 2|Lost to Follow-up|2|||
13356200|NCT00906399|26670481|FG006|Year 2|Lost to Follow-up|4|||
13356201|NCT00906399|26670475|FG000|Year 2|Withdrawal by Subject|0|||
13356202|NCT00906399|26670476|FG001|Year 2|Withdrawal by Subject|0|||
13356203|NCT00906399|26670477|FG002|Year 2|Withdrawal by Subject|0|||
13356204|NCT00906399|26670478|FG003|Year 2|Withdrawal by Subject|17|||
13356205|NCT00906399|26670479|FG004|Year 2|Withdrawal by Subject|18|||
13356206|NCT00906399|26670480|FG005|Year 2|Withdrawal by Subject|27|||
13356207|NCT00906399|26670481|FG006|Year 2|Withdrawal by Subject|13|||
13356208|NCT00906399|26670475|FG000|Year 2|Physician Decision|0|||
13356209|NCT00906399|26670476|FG001|Year 2|Physician Decision|0|||
13356210|NCT00906399|26670477|FG002|Year 2|Physician Decision|0|||
13356211|NCT00906399|26670478|FG003|Year 2|Physician Decision|0|||
13356212|NCT00906399|26670479|FG004|Year 2|Physician Decision|2|||
13356213|NCT00906399|26670480|FG005|Year 2|Physician Decision|6|||
13356214|NCT00906399|26670481|FG006|Year 2|Physician Decision|3|||
13356215|NCT00906399|26670475|FG000|Year 2|Death|0|||
13356216|NCT00906399|26670476|FG001|Year 2|Death|0|||
13356217|NCT00906399|26670477|FG002|Year 2|Death|0|||
13356218|NCT00906399|26670478|FG003|Year 2|Death|1|||
13356219|NCT00906399|26670479|FG004|Year 2|Death|0|||
13356220|NCT00906399|26670480|FG005|Year 2|Death|0|||
13356221|NCT00906399|26670481|FG006|Year 2|Death|3|||
13356222|NCT00906399|26670475|FG000|Year 2|Other|0|||
13356223|NCT00906399|26670476|FG001|Year 2|Other|0|||
13356224|NCT00906399|26670477|FG002|Year 2|Other|0|||
13356225|NCT00906399|26670478|FG003|Year 2|Other|2|||
13356226|NCT00906399|26670479|FG004|Year 2|Other|3|||
13356227|NCT00906399|26670480|FG005|Year 2|Other|1|||
13356228|NCT00906399|26670481|FG006|Year 2|Other|0|||
13356229|NCT00906373|26670525|FG000|Overall Study|Withdrawal by Subject|0|||
13356230|NCT00906373|26670526|FG001|Overall Study|Withdrawal by Subject|5|||
13356231|NCT00906373|26670525|FG000|Overall Study|Other|0|||
13356232|NCT00906373|26670526|FG001|Overall Study|Other|1|||
13356233|NCT00906373|26670525|FG000|Overall Study|Still on treatment at cutoff date|0|||
13356234|NCT00906373|26670526|FG001|Overall Study|Still on treatment at cutoff date|2|||
13356235|NCT00906347|26670553|FG000|Received Study Drug|8 cm prior to initiation of study drug|18|||
13356236|NCT00906347|26670554|FG001|Received Study Drug|8 cm prior to initiation of study drug|30|||
13356237|NCT00906347|26670553|FG000|Received Study Drug|Nonreassuring fetal heart rate|13|||
13356238|NCT00906347|26670554|FG001|Received Study Drug|Nonreassuring fetal heart rate|1|||
13356239|NCT00906347|26670553|FG000|Received Study Drug|Refused study drug|1|||
13356240|NCT00906347|26670554|FG001|Received Study Drug|Refused study drug|0|||
13356241|NCT00906347|26670553|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8|||
13356242|NCT00906347|26670554|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0|||
13356243|NCT00906282|26670564|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
13356244|NCT00906282|26670564|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10|||
13356245|NCT00906282|26670564|FG000|Preoperative Chemotherapy|Progressive disease|6|||
13356246|NCT00906282|26670564|FG000|Preoperative Chemotherapy|Toxicity|1|||
13356247|NCT00906204|26670587|FG000|Primary Endpoint (Early Safety)|Physician Decision|1|||
13356248|NCT00906204|26670588|FG001|Primary Endpoint (Early Safety)|Physician Decision|0|||
13356249|NCT00906204|26670587|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0|||
13356250|NCT00906204|26670588|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1|||
13356251|NCT00906204|26670587|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1|||
13356252|NCT00906204|26670588|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0|||
13356253|NCT00906204|26670587|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
13356254|NCT00906204|26670588|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
13356255|NCT00906204|26670587|FG000|Secondary Endpoints (Long-term Safety)|Death|0|||
13356256|NCT00906204|26670588|FG001|Secondary Endpoints (Long-term Safety)|Death|1|||
13356257|NCT00906087|26670597|FG000|Initial Washout|Withdrawal by Subject|1|||
13356258|NCT00906087|26670597|FG000|Initial Washout|Physician Decision|1|||
13356259|NCT00906035|26670621|FG000|Overall Study|Withdrawal by Subject|2|||
13356260|NCT00906035|26670622|FG001|Overall Study|Withdrawal by Subject|3|||
13356261|NCT00906035|26670623|FG002|Overall Study|Withdrawal by Subject|0|||
13356262|NCT00905840|26670634|FG000|Overall Study|Lost to Follow-up|11|||
13356263|NCT00905840|26670634|FG000|Overall Study|Death|3|||
13356264|NCT00905840|26670634|FG000|Overall Study|Withdrawal by Subject|1|||
13356265|NCT00905840|26670634|FG000|Overall Study|Adverse Event|1|||
13356266|NCT00905632|26670792|FG000|Overall Study|Adverse Event|0|||
13356267|NCT00905632|26670793|FG001|Overall Study|Adverse Event|0|||
13356268|NCT00905632|26670794|FG002|Overall Study|Adverse Event|0|||
13356269|NCT00905632|26670795|FG003|Overall Study|Adverse Event|0|||
13356270|NCT00905632|26670796|FG004|Overall Study|Adverse Event|0|||
13356271|NCT00905632|26670797|FG005|Overall Study|Adverse Event|1|||
13356272|NCT00905632|26670798|FG006|Overall Study|Adverse Event|4|||
13356273|NCT00905489|26670847|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2|||
13356274|NCT00905489|26670847|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3|||
13356275|NCT00905489|26670847|FG000|Optional Extension Phase (OEP)|Adverse Event|1|||
13356276|NCT00905437|26670872|FG000|Overall Study|Adverse Event|3|||
13356277|NCT00905437|26670873|FG001|Overall Study|Adverse Event|2|||
13356278|NCT00905437|26670872|FG000|Overall Study|Lost to Follow-up|0|||
13356279|NCT00905437|26670873|FG001|Overall Study|Lost to Follow-up|1|||
13356280|NCT00905437|26670872|FG000|Overall Study|Withdrawal by Subject|0|||
13356281|NCT00905437|26670873|FG001|Overall Study|Withdrawal by Subject|1|||
13356282|NCT00905437|26670872|FG000|Overall Study|Other|5|||
13356283|NCT00905437|26670873|FG001|Overall Study|Other|6|||
13356284|NCT00905424|26670920|FG000|Overall Study|Lost to Follow-up|3|||
13356285|NCT00905424|26670921|FG001|Overall Study|Lost to Follow-up|3|||
13356286|NCT00905424|26670920|FG000|Overall Study|Withdrawal by Subject|1|||
13356287|NCT00905424|26670921|FG001|Overall Study|Withdrawal by Subject|2|||
13356288|NCT00905424|26670920|FG000|Overall Study|Adverse Event|4|||
13356289|NCT00905424|26670921|FG001|Overall Study|Adverse Event|2|||
13356290|NCT00905424|26670920|FG000|Overall Study|Non-compliance with study medication|2|||
13356291|NCT00905424|26670921|FG001|Overall Study|Non-compliance with study medication|0|||
13356292|NCT00905424|26670920|FG000|Overall Study|Sponsor decision|1|||
13356293|NCT00905424|26670921|FG001|Overall Study|Sponsor decision|0|||
13356294|NCT00905424|26670920|FG000|Overall Study|Positive urine drug screen|0|||
13356295|NCT00905424|26670921|FG001|Overall Study|Positive urine drug screen|1|||
13356296|NCT00905424|26670920|FG000|Overall Study|Non-adherence to visit schedule|0|||
13356297|NCT00905424|26670921|FG001|Overall Study|Non-adherence to visit schedule|1|||
13356298|NCT00905359|26670962|FG000|Overall Study|Lost to Follow-up|17|||
13356299|NCT00905359|26670963|FG001|Overall Study|Lost to Follow-up|10|||
13356300|NCT00905359|26670962|FG000|Overall Study|Death|2|||
13356301|NCT00905359|26670963|FG001|Overall Study|Death|0|||
13356302|NCT00905359|26670962|FG000|Overall Study|Withdrawal consent|5|||
13356303|NCT00905359|26670963|FG001|Overall Study|Withdrawal consent|6|||
13356304|NCT00905307|26671038|FG000|Overall Study|Switched to Open Label Rescue|7|||
13356305|NCT00905307|26671039|FG001|Overall Study|Switched to Open Label Rescue|17|||
13356306|NCT00905307|26671040|FG002|Overall Study|Switched to Open Label Rescue|11|||
13356307|NCT00905307|26671041|FG003|Overall Study|Switched to Open Label Rescue|11|||
13356308|NCT00905307|26671042|FG004|Overall Study|Switched to Open Label Rescue|4|||
13356309|NCT00905307|26671043|FG005|Overall Study|Switched to Open Label Rescue|15|||
13356310|NCT00905307|26671038|FG000|Overall Study|Lost to Follow-up|0|||
13356311|NCT00905307|26671039|FG001|Overall Study|Lost to Follow-up|0|||
13356312|NCT00905307|26671040|FG002|Overall Study|Lost to Follow-up|0|||
13356313|NCT00905307|26671041|FG003|Overall Study|Lost to Follow-up|0|||
13356314|NCT00905307|26671042|FG004|Overall Study|Lost to Follow-up|1|||
13356315|NCT00905307|26671043|FG005|Overall Study|Lost to Follow-up|1|||
13356316|NCT00905307|26671038|FG000|Overall Study|Adverse Event|3|||
13356317|NCT00905307|26671039|FG001|Overall Study|Adverse Event|4|||
13356318|NCT00905307|26671040|FG002|Overall Study|Adverse Event|5|||
13356319|NCT00905307|26671041|FG003|Overall Study|Adverse Event|11|||
13356320|NCT00905307|26671042|FG004|Overall Study|Adverse Event|3|||
13356321|NCT00905307|26671043|FG005|Overall Study|Adverse Event|5|||
13356322|NCT00905307|26671038|FG000|Overall Study|Withdrawal by Subject|5|||
13356323|NCT00905307|26671039|FG001|Overall Study|Withdrawal by Subject|13|||
13356324|NCT00905307|26671040|FG002|Overall Study|Withdrawal by Subject|15|||
13356325|NCT00905307|26671041|FG003|Overall Study|Withdrawal by Subject|11|||
13356326|NCT00905307|26671042|FG004|Overall Study|Withdrawal by Subject|4|||
13356327|NCT00905307|26671043|FG005|Overall Study|Withdrawal by Subject|13|||
13356328|NCT00905307|26671038|FG000|Overall Study|Protocol Violation|1|||
13356329|NCT00905307|26671039|FG001|Overall Study|Protocol Violation|0|||
13356330|NCT00905307|26671040|FG002|Overall Study|Protocol Violation|1|||
13356331|NCT00905307|26671041|FG003|Overall Study|Protocol Violation|0|||
13356332|NCT00905307|26671042|FG004|Overall Study|Protocol Violation|0|||
13356333|NCT00905307|26671043|FG005|Overall Study|Protocol Violation|0|||
13356334|NCT00905307|26671038|FG000|Overall Study|Lack of Efficacy|6|||
13356335|NCT00905307|26671039|FG001|Overall Study|Lack of Efficacy|3|||
13356336|NCT00905307|26671040|FG002|Overall Study|Lack of Efficacy|5|||
13356337|NCT00905307|26671041|FG003|Overall Study|Lack of Efficacy|4|||
13356338|NCT00905307|26671042|FG004|Overall Study|Lack of Efficacy|4|||
13356339|NCT00905307|26671043|FG005|Overall Study|Lack of Efficacy|8|||
13356340|NCT00905255|26671066|FG000|Overall Study|Adverse Event|7|||
13356341|NCT00905255|26671067|FG001|Overall Study|Adverse Event|5|||
13356342|NCT00905255|26671066|FG000|Overall Study|Withdrawal by Subject|5|||
13356343|NCT00905255|26671067|FG001|Overall Study|Withdrawal by Subject|4|||
13356344|NCT00905255|26671066|FG000|Overall Study|Familial and Personal Reasons|1|||
13356345|NCT00905255|26671067|FG001|Overall Study|Familial and Personal Reasons|0|||
13356346|NCT00905034|26671073|FG000|Overall Study|Withdrawal by Subject|1|||
13356347|NCT00905021|26671082|FG000|Overall Study|Adverse Event|2|||
13356348|NCT00904982|26671105|FG000|Overall Study|Withdrawal by Subject|2|||
13356349|NCT00904982|26671106|FG001|Overall Study|Withdrawal by Subject|0|||
13356350|NCT00904982|26671107|FG002|Overall Study|Withdrawal by Subject|0|||
13356351|NCT00904982|26671108|FG003|Overall Study|Withdrawal by Subject|0|||
13356352|NCT00904969|26671160|FG000|Overall Study|Lost to Follow-up|4|||
13356353|NCT00904969|26671160|FG000|Overall Study|Withdrawal by Subject|3|||
13356354|NCT00904969|26671160|FG000|Overall Study|Additional Treatments|11|||
13356355|NCT00904969|26671160|FG000|Overall Study|Case Aborted; Subject Exited|1|||
13356356|NCT00904917|26671189|FG000|Overall Study|Lost to Follow-up|2|||
13356357|NCT00904917|26671190|FG001|Overall Study|Lost to Follow-up|2|||
13356358|NCT00904917|26671191|FG002|Overall Study|Lost to Follow-up|2|||
13356359|NCT00904917|26671192|FG003|Overall Study|Lost to Follow-up|2|||
13356360|NCT00904839|26671234|FG000|Overall Study|Adverse Event|0|||
13356361|NCT00904839|26671235|FG001|Overall Study|Adverse Event|5|||
13356362|NCT00904839|26671236|FG002|Overall Study|Adverse Event|4|||
13356363|NCT00904839|26671234|FG000|Overall Study|Protocol Violation|0|||
13356364|NCT00904839|26671235|FG001|Overall Study|Protocol Violation|1|||
13356365|NCT00904839|26671236|FG002|Overall Study|Protocol Violation|1|||
13356366|NCT00904839|26671234|FG000|Overall Study|Lost to Follow-up|0|||
13356367|NCT00904839|26671235|FG001|Overall Study|Lost to Follow-up|1|||
13356368|NCT00904839|26671236|FG002|Overall Study|Lost to Follow-up|2|||
13356369|NCT00904839|26671234|FG000|Overall Study|Withdrawal by Subject|0|||
13356370|NCT00904839|26671235|FG001|Overall Study|Withdrawal by Subject|2|||
13356371|NCT00904839|26671236|FG002|Overall Study|Withdrawal by Subject|0|||
13356372|NCT00904839|26671234|FG000|Overall Study|Not treated|1|||
13356373|NCT00904839|26671235|FG001|Overall Study|Not treated|0|||
13356374|NCT00904839|26671236|FG002|Overall Study|Not treated|1|||
13356375|NCT00904839|26671234|FG000|Overall Study|Other than above|0|||
13356376|NCT00904839|26671235|FG001|Overall Study|Other than above|9|||
13356377|NCT00904839|26671236|FG002|Overall Study|Other than above|7|||
13356378|NCT00904748|26671267|FG000|Overall Study|Withdrawal by Subject|1|||
13356379|NCT00904748|26671268|FG001|Overall Study|Withdrawal by Subject|1|||
13356380|NCT00904748|26671269|FG002|Overall Study|Withdrawal by Subject|1|||
13356381|NCT00904748|26671270|FG003|Overall Study|Withdrawal by Subject|2|||
13356382|NCT00904748|26671271|FG004|Overall Study|Withdrawal by Subject|0|||
13356383|NCT00904748|26671272|FG005|Overall Study|Withdrawal by Subject|0|||
13356384|NCT00904748|26671267|FG000|Overall Study|Adverse Event|0|||
13356385|NCT00904748|26671268|FG001|Overall Study|Adverse Event|0|||
13356386|NCT00904748|26671269|FG002|Overall Study|Adverse Event|0|||
13356387|NCT00904748|26671270|FG003|Overall Study|Adverse Event|0|||
13356388|NCT00904748|26671271|FG004|Overall Study|Adverse Event|1|||
13356389|NCT00904748|26671272|FG005|Overall Study|Adverse Event|0|||
13356390|NCT00904722|26671279|FG000|Overall Study|Physician Decision|1|||
13356391|NCT00904670|26671303|FG000|Open Label Phase|Withdrawal by Subject|2|||
13356392|NCT00904670|26671304|FG001|Open Label Phase|Withdrawal by Subject|0|||
13356393|NCT00904670|26671303|FG000|Open Label Phase|Adverse Event|2|||
13356394|NCT00904670|26671304|FG001|Open Label Phase|Adverse Event|0|||
13356395|NCT00904670|26671303|FG000|Open Label Phase|Lack of Efficacy|1|||
13356396|NCT00904670|26671304|FG001|Open Label Phase|Lack of Efficacy|0|||
13356397|NCT00904670|26671303|FG000|Open Label Phase|Lost to Follow-up|1|||
13356398|NCT00904670|26671304|FG001|Open Label Phase|Lost to Follow-up|0|||
13356399|NCT00904371|26671320|FG000|Overall Study|Adverse Event|2|||
13356400|NCT00904371|26671320|FG000|Overall Study|Lost to Follow-up|4|||
13356401|NCT00904371|26671320|FG000|Overall Study|Discontinued at target blood pressure|2|||
13356402|NCT00904371|26671320|FG000|Overall Study|Continued with Tritace|1|||
13356403|NCT00904215|26671329|FG000|Overall Study|Adverse Event|25|||
13356404|NCT00904215|26671329|FG000|Overall Study|Protocol Violation|10|||
13356405|NCT00904215|26671329|FG000|Overall Study|Lost to Follow-up|63|||
13356406|NCT00904215|26671329|FG000|Overall Study|Withdrawal by Subject|9|||
13356407|NCT00904215|26671329|FG000|Overall Study|Other|28|||
13356408|NCT00904150|26671354|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3|||
13356409|NCT00904150|26671355|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0|||
13356410|NCT00904150|26671354|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0|||
13356411|NCT00904150|26671355|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145|||
13356412|NCT00904033|26671390|FG000|Overall Study|Withdrawal by Subject|1|||
13356413|NCT00904033|26671391|FG001|Overall Study|Withdrawal by Subject|1|||
13356414|NCT00904033|26671392|FG002|Overall Study|Withdrawal by Subject|0|||
13356415|NCT00904033|26671393|FG003|Overall Study|Withdrawal by Subject|0|||
13356416|NCT00904033|26671390|FG000|Overall Study|Physician Decision|0|||
13356417|NCT00904033|26671391|FG001|Overall Study|Physician Decision|0|||
13356418|NCT00904033|26671392|FG002|Overall Study|Physician Decision|1|||
13356419|NCT00904033|26671393|FG003|Overall Study|Physician Decision|0|||
13356420|NCT00904033|26671390|FG000|Overall Study|Unable to obtain final blood draw|0|||
13356421|NCT00904033|26671391|FG001|Overall Study|Unable to obtain final blood draw|0|||
13356422|NCT00904033|26671392|FG002|Overall Study|Unable to obtain final blood draw|0|||
13356423|NCT00904033|26671393|FG003|Overall Study|Unable to obtain final blood draw|2|||
13356424|NCT00903968|26671436|FG000|Overall Study|Adverse Event|0|||
13356425|NCT00903968|26671437|FG001|Overall Study|Adverse Event|0|||
13356426|NCT00903968|26671438|FG002|Overall Study|Adverse Event|0|||
13356427|NCT00903968|26671439|FG003|Overall Study|Adverse Event|0|||
13356428|NCT00903968|26671440|FG004|Overall Study|Adverse Event|0|||
13356429|NCT00903968|26671441|FG005|Overall Study|Adverse Event|0|||
13356430|NCT00903968|26671442|FG006|Overall Study|Adverse Event|1|||
13356431|NCT00903968|26671443|FG007|Overall Study|Adverse Event|8|||
13356432|NCT00903968|26671436|FG000|Overall Study|DLT|0|||
13356433|NCT00903968|26671437|FG001|Overall Study|DLT|0|||
13356434|NCT00903968|26671438|FG002|Overall Study|DLT|0|||
13356435|NCT00903968|26671439|FG003|Overall Study|DLT|0|||
13356436|NCT00903968|26671440|FG004|Overall Study|DLT|0|||
13356437|NCT00903968|26671441|FG005|Overall Study|DLT|0|||
13356438|NCT00903968|26671442|FG006|Overall Study|DLT|2|||
13356439|NCT00903968|26671443|FG007|Overall Study|DLT|0|||
13356440|NCT00903968|26671436|FG000|Overall Study|Withdrawal by Subject|1|||
13356441|NCT00903968|26671437|FG001|Overall Study|Withdrawal by Subject|0|||
13356442|NCT00903968|26671438|FG002|Overall Study|Withdrawal by Subject|1|||
13356443|NCT00903968|26671439|FG003|Overall Study|Withdrawal by Subject|0|||
13356444|NCT00903968|26671440|FG004|Overall Study|Withdrawal by Subject|1|||
13356445|NCT00903968|26671441|FG005|Overall Study|Withdrawal by Subject|1|||
13356446|NCT00903968|26671442|FG006|Overall Study|Withdrawal by Subject|0|||
13356447|NCT00903968|26671443|FG007|Overall Study|Withdrawal by Subject|4|||
13356448|NCT00903968|26671436|FG000|Overall Study|Non-Compliance|0|||
13356449|NCT00903968|26671437|FG001|Overall Study|Non-Compliance|0|||
13356450|NCT00903968|26671438|FG002|Overall Study|Non-Compliance|0|||
13356451|NCT00903968|26671439|FG003|Overall Study|Non-Compliance|0|||
13356452|NCT00903968|26671440|FG004|Overall Study|Non-Compliance|0|||
13356453|NCT00903968|26671441|FG005|Overall Study|Non-Compliance|1|||
13356454|NCT00903968|26671442|FG006|Overall Study|Non-Compliance|0|||
13356455|NCT00903968|26671443|FG007|Overall Study|Non-Compliance|0|||
13356456|NCT00903968|26671436|FG000|Overall Study|Physician Decision|0|||
13356457|NCT00903968|26671437|FG001|Overall Study|Physician Decision|0|||
13356458|NCT00903968|26671438|FG002|Overall Study|Physician Decision|0|||
13356459|NCT00903968|26671439|FG003|Overall Study|Physician Decision|0|||
13356460|NCT00903968|26671440|FG004|Overall Study|Physician Decision|0|||
13356461|NCT00903968|26671441|FG005|Overall Study|Physician Decision|1|||
13356462|NCT00903968|26671442|FG006|Overall Study|Physician Decision|0|||
13356463|NCT00903968|26671443|FG007|Overall Study|Physician Decision|0|||
13356464|NCT00903968|26671436|FG000|Overall Study|Progressive Disease|2|||
13356465|NCT00903968|26671437|FG001|Overall Study|Progressive Disease|3|||
13356466|NCT00903968|26671438|FG002|Overall Study|Progressive Disease|2|||
13356467|NCT00903968|26671439|FG003|Overall Study|Progressive Disease|3|||
13356468|NCT00903968|26671440|FG004|Overall Study|Progressive Disease|3|||
13356469|NCT00903968|26671441|FG005|Overall Study|Progressive Disease|3|||
13356470|NCT00903968|26671442|FG006|Overall Study|Progressive Disease|0|||
13356471|NCT00903968|26671443|FG007|Overall Study|Progressive Disease|18|||
13356472|NCT00903968|26671436|FG000|Overall Study|Lack of Efficacy|0|||
13356473|NCT00903968|26671437|FG001|Overall Study|Lack of Efficacy|0|||
13356474|NCT00903968|26671438|FG002|Overall Study|Lack of Efficacy|0|||
13356475|NCT00903968|26671439|FG003|Overall Study|Lack of Efficacy|0|||
13356476|NCT00903968|26671440|FG004|Overall Study|Lack of Efficacy|0|||
13356477|NCT00903968|26671441|FG005|Overall Study|Lack of Efficacy|0|||
13356478|NCT00903968|26671442|FG006|Overall Study|Lack of Efficacy|0|||
13356479|NCT00903968|26671443|FG007|Overall Study|Lack of Efficacy|3|||
13356480|NCT00903929|26671454|FG000|Overall Study|Withdrawal by Subject|0|||
13356481|NCT00903929|26671455|FG001|Overall Study|Withdrawal by Subject|0|||
13356482|NCT00903929|26671456|FG002|Overall Study|Withdrawal by Subject|1|||
13356483|NCT00903929|26671457|FG003|Overall Study|Withdrawal by Subject|2|||
13356484|NCT00903929|26671454|FG000|Overall Study|Adverse Event|0|||
13356485|NCT00903929|26671455|FG001|Overall Study|Adverse Event|0|||
13356486|NCT00903929|26671456|FG002|Overall Study|Adverse Event|0|||
13356487|NCT00903929|26671457|FG003|Overall Study|Adverse Event|1|||
13356488|NCT00903877|26671463|FG000|Overall Study|Did not meet study criteria|33|||
13356489|NCT00903877|26671463|FG000|Overall Study|Withdrawal by Subject|3|||
13356490|NCT00903877|26671463|FG000|Overall Study|Adverse Event|2|||
13356491|NCT00903877|26671463|FG000|Overall Study|Lost to Follow-up|1|||
13356492|NCT00903877|26671463|FG000|Overall Study|Participation put on hold|4|||
13356493|NCT00903786|26671473|FG000|Overall Study|Physician Decision|6|||
13356494|NCT00903786|26671473|FG000|Overall Study|Lack of Efficacy|5|||
13356495|NCT00903786|26671473|FG000|Overall Study|Reason other than lack of efficacy|4|||
13356496|NCT00903760|26671488|FG000|Overall Study|Disease Progression/Death|8|||
13356497|NCT00903760|26671489|FG001|Overall Study|Disease Progression/Death|6|||
13356498|NCT00903760|26671488|FG000|Overall Study|Stem Cell Transplant|8|||
13356499|NCT00903760|26671489|FG001|Overall Study|Stem Cell Transplant|4|||
13356500|NCT00903760|26671488|FG000|Overall Study|Physician Decision|1|||
13356501|NCT00903760|26671489|FG001|Overall Study|Physician Decision|2|||
13356502|NCT00903760|26671488|FG000|Overall Study|Death|0|||
13356503|NCT00903760|26671489|FG001|Overall Study|Death|1|||
13356504|NCT00903760|26671488|FG000|Overall Study|Lost to Follow-up|1|||
13356505|NCT00903760|26671489|FG001|Overall Study|Lost to Follow-up|0|||
13356506|NCT00903760|26671488|FG000|Overall Study|Withdrawal by Subject|1|||
13356507|NCT00903760|26671489|FG001|Overall Study|Withdrawal by Subject|2|||
13356508|NCT00903760|26671488|FG000|Overall Study|Off treatment for long period|0|||
13356509|NCT00903760|26671489|FG001|Overall Study|Off treatment for long period|1|||
13356510|NCT00903695|26671516|FG000|Overall Study|medical exclusion after 1st testing|1|||
13356511|NCT00903695|26671517|FG001|Overall Study|medical exclusion after 1st testing|0|||
13356512|NCT00903695|26671516|FG000|Overall Study|lung cancer|1|||
13356513|NCT00903695|26671517|FG001|Overall Study|lung cancer|0|||
13356514|NCT00903682|26671542|FG000|Overall Study|Adverse Event|6|||
13356515|NCT00903682|26671543|FG001|Overall Study|Adverse Event|13|||
13356516|NCT00903682|26671542|FG000|Overall Study|Lost to Follow-up|1|||
13356517|NCT00903682|26671543|FG001|Overall Study|Lost to Follow-up|0|||
13356518|NCT00903682|26671542|FG000|Overall Study|Withdrawal by Subject|5|||
13356519|NCT00903682|26671543|FG001|Overall Study|Withdrawal by Subject|0|||
13356520|NCT00903682|26671542|FG000|Overall Study|Pregnancy|0|||
13356521|NCT00903682|26671543|FG001|Overall Study|Pregnancy|1|||
13356522|NCT00903682|26671542|FG000|Overall Study|Subject Reached A Virologic Endpoint|1|||
13356523|NCT00903682|26671543|FG001|Overall Study|Subject Reached A Virologic Endpoint|1|||
13356524|NCT00903682|26671542|FG000|Overall Study|Subject Non-Compliant|1|||
13356525|NCT00903682|26671543|FG001|Overall Study|Subject Non-Compliant|0|||
13356526|NCT00903682|26671542|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1|||
13356527|NCT00903682|26671543|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0|||
13356528|NCT00903682|26671542|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1|||
13356529|NCT00903682|26671543|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0|||
13356530|NCT00903630|26671567|FG000|Phase 2|Adverse Event|0|||
13356531|NCT00903630|26671568|FG001|Phase 2|Adverse Event|0|||
13356532|NCT00903630|26671569|FG002|Phase 2|Adverse Event|1|||
13356533|NCT00903617|26671676|FG000|Overall Study|Adverse Event|0|||
13356534|NCT00903617|26671677|FG001|Overall Study|Adverse Event|1|||
13356535|NCT00903617|26671678|FG002|Overall Study|Adverse Event|1|||
13356536|NCT00903617|26671679|FG003|Overall Study|Adverse Event|0|||
13356537|NCT00903617|26671676|FG000|Overall Study|Protocol-defined stopping criteria|0|||
13356538|NCT00903617|26671677|FG001|Overall Study|Protocol-defined stopping criteria|2|||
13356539|NCT00903617|26671678|FG002|Overall Study|Protocol-defined stopping criteria|0|||
13356540|NCT00903617|26671679|FG003|Overall Study|Protocol-defined stopping criteria|0|||
13356541|NCT00903617|26671676|FG000|Overall Study|Lost to Follow-up|2|||
13356542|NCT00903617|26671677|FG001|Overall Study|Lost to Follow-up|0|||
13356543|NCT00903617|26671678|FG002|Overall Study|Lost to Follow-up|1|||
13356544|NCT00903617|26671679|FG003|Overall Study|Lost to Follow-up|1|||
13356545|NCT00903617|26671676|FG000|Overall Study|Withdrawal by Subject|1|||
13356546|NCT00903617|26671677|FG001|Overall Study|Withdrawal by Subject|2|||
13356547|NCT00903617|26671678|FG002|Overall Study|Withdrawal by Subject|3|||
13356548|NCT00903617|26671679|FG003|Overall Study|Withdrawal by Subject|0|||
13356549|NCT00903409|26671700|FG000|Overall Study|Adverse Event|11|||
13356550|NCT00903409|26671701|FG001|Overall Study|Adverse Event|9|||
13356551|NCT00903409|26671700|FG000|Overall Study|Non-compliance with Protocol|1|||
13356552|NCT00903409|26671701|FG001|Overall Study|Non-compliance with Protocol|1|||
13356553|NCT00903409|26671700|FG000|Overall Study|Laboratory Abnormality|2|||
13356554|NCT00903409|26671701|FG001|Overall Study|Laboratory Abnormality|0|||
13356555|NCT00903409|26671700|FG000|Overall Study|Withdrawal by Subject|8|||
13356556|NCT00903409|26671701|FG001|Overall Study|Withdrawal by Subject|8|||
13356557|NCT00903409|26671700|FG000|Overall Study|Other|2|||
13356558|NCT00903409|26671701|FG001|Overall Study|Other|3|||
13356559|NCT00903409|26671700|FG000|Overall Study|Lost to Follow-up|2|||
13356560|NCT00903409|26671701|FG001|Overall Study|Lost to Follow-up|6|||
13356561|NCT00903383|26671744|FG000|Overall Study|Adverse Event|1|||
13356562|NCT00903383|26671745|FG001|Overall Study|Adverse Event|2|||
13356563|NCT00903383|26671746|FG002|Overall Study|Adverse Event|3|||
13356564|NCT00903383|26671747|FG003|Overall Study|Adverse Event|1|||
13356565|NCT00903383|26671744|FG000|Overall Study|Physician Decision|1|||
13356566|NCT00903383|26671745|FG001|Overall Study|Physician Decision|2|||
13356567|NCT00903383|26671746|FG002|Overall Study|Physician Decision|0|||
13356568|NCT00903383|26671747|FG003|Overall Study|Physician Decision|0|||
13356569|NCT00903383|26671744|FG000|Overall Study|Lost to Follow-up|0|||
13356570|NCT00903383|26671745|FG001|Overall Study|Lost to Follow-up|0|||
13356571|NCT00903383|26671746|FG002|Overall Study|Lost to Follow-up|0|||
13356572|NCT00903383|26671747|FG003|Overall Study|Lost to Follow-up|1|||
13356573|NCT00903383|26671744|FG000|Overall Study|Decision of Sponsor|1|||
13356574|NCT00903383|26671745|FG001|Overall Study|Decision of Sponsor|0|||
13356575|NCT00903383|26671746|FG002|Overall Study|Decision of Sponsor|0|||
13356576|NCT00903383|26671747|FG003|Overall Study|Decision of Sponsor|0|||
13356577|NCT00903383|26671744|FG000|Overall Study|Withdrawal by Subject|4|||
13356578|NCT00903383|26671745|FG001|Overall Study|Withdrawal by Subject|1|||
13356579|NCT00903383|26671746|FG002|Overall Study|Withdrawal by Subject|0|||
13356580|NCT00903383|26671747|FG003|Overall Study|Withdrawal by Subject|2|||
13356581|NCT00903383|26671744|FG000|Overall Study|Patient Decision - Lack of Efficacy|0|||
13356582|NCT00903383|26671745|FG001|Overall Study|Patient Decision - Lack of Efficacy|1|||
13356583|NCT00903383|26671746|FG002|Overall Study|Patient Decision - Lack of Efficacy|0|||
13356584|NCT00903383|26671747|FG003|Overall Study|Patient Decision - Lack of Efficacy|0|||
13356585|NCT00903383|26671744|FG000|Overall Study|Patient Decision|0|||
13356586|NCT00903383|26671745|FG001|Overall Study|Patient Decision|0|||
13356587|NCT00903383|26671746|FG002|Overall Study|Patient Decision|0|||
13356588|NCT00903383|26671747|FG003|Overall Study|Patient Decision|1|||
13356589|NCT00903370|26671762|FG000|Overall Study|Death|13|||
13356590|NCT00903370|26671763|FG001|Overall Study|Death|10|||
13356591|NCT00903370|26671762|FG000|Overall Study|Withdrawal by Subject|9|||
13356592|NCT00903370|26671763|FG001|Overall Study|Withdrawal by Subject|6|||
13356593|NCT00903370|26671762|FG000|Overall Study|Lost to Follow-up|6|||
13356594|NCT00903370|26671763|FG001|Overall Study|Lost to Follow-up|8|||
13356595|NCT00903357|26671776|FG000|First Intervention|Withdrawal by Subject|5|||
13356596|NCT00903357|26671777|FG001|First Intervention|Withdrawal by Subject|3|||
13356597|NCT00903357|26671776|FG000|First Intervention|Flu|0|||
13356598|NCT00903357|26671777|FG001|First Intervention|Flu|1|||
13356599|NCT00903357|26671776|FG000|Wash Out Period of 2 Weeks|Flu|0|||
13356600|NCT00903357|26671777|FG001|Wash Out Period of 2 Weeks|Flu|1|||
13356601|NCT00903357|26671776|FG000|Second Intervention|Lost to Follow-up|1|||
13356602|NCT00903357|26671777|FG001|Second Intervention|Lost to Follow-up|0|||
13356603|NCT00903344|26671800|FG000|Overall Study|Pregnancy|2|||
13356604|NCT00903344|26671801|FG001|Overall Study|Pregnancy|3|||
13356605|NCT00903344|26671800|FG000|Overall Study|Lost to Follow-up|3|||
13356606|NCT00903344|26671801|FG001|Overall Study|Lost to Follow-up|0|||
13356607|NCT00903331|26671816|FG000|Overall Study|Death|4|||
13356608|NCT00903331|26671817|FG001|Overall Study|Death|8|||
13356609|NCT00903331|26671816|FG000|Overall Study|Withdrawal of consent|1|||
13356610|NCT00903331|26671817|FG001|Overall Study|Withdrawal of consent|8|||
13356611|NCT00903331|26671816|FG000|Overall Study|Lung transplant|0|||
13356612|NCT00903331|26671817|FG001|Overall Study|Lung transplant|2|||
13356613|NCT00903201|26671883|FG000|Overall Study|Adverse Event|1|||
13356614|NCT00903201|26671884|FG001|Overall Study|Adverse Event|4|||
13356615|NCT00903201|26671885|FG002|Overall Study|Adverse Event|0|||
13356616|NCT00903201|26671883|FG000|Overall Study|Protocol Violation|2|||
13356617|NCT00903201|26671884|FG001|Overall Study|Protocol Violation|1|||
13356618|NCT00903201|26671885|FG002|Overall Study|Protocol Violation|0|||
13356619|NCT00903201|26671883|FG000|Overall Study|Lost to Follow-up|0|||
13356620|NCT00903201|26671884|FG001|Overall Study|Lost to Follow-up|1|||
13356621|NCT00903201|26671885|FG002|Overall Study|Lost to Follow-up|0|||
13356622|NCT00903201|26671883|FG000|Overall Study|Physician Decision|1|||
13356623|NCT00903201|26671884|FG001|Overall Study|Physician Decision|0|||
13356624|NCT00903201|26671885|FG002|Overall Study|Physician Decision|1|||
13356625|NCT00903201|26671883|FG000|Overall Study|Withdrawal by Subject|1|||
13356626|NCT00903201|26671884|FG001|Overall Study|Withdrawal by Subject|0|||
13356627|NCT00903201|26671885|FG002|Overall Study|Withdrawal by Subject|1|||
13356628|NCT00903175|26671922|FG000|Period 1 - First Line|Adverse Event|36|||
13356629|NCT00903175|26671923|FG001|Period 1 - First Line|Adverse Event|50|||
13356630|NCT00903175|26671922|FG000|Period 1 - First Line|Abnormal lab value(s)|0|||
13356631|NCT00903175|26671923|FG001|Period 1 - First Line|Abnormal lab value(s)|1|||
13356632|NCT00903175|26671922|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1|||
13356633|NCT00903175|26671923|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0|||
13356634|NCT00903175|26671922|FG000|Period 1 - First Line|Protocol Violation|3|||
13356635|NCT00903175|26671923|FG001|Period 1 - First Line|Protocol Violation|3|||
13356636|NCT00903175|26671922|FG000|Period 1 - First Line|Withdrawal by Subject|8|||
13356637|NCT00903175|26671923|FG001|Period 1 - First Line|Withdrawal by Subject|12|||
13356638|NCT00903175|26671922|FG000|Period 1 - First Line|Administrative problems|12|||
13356639|NCT00903175|26671923|FG001|Period 1 - First Line|Administrative problems|13|||
13356640|NCT00903175|26671922|FG000|Period 1 - First Line|Death|17|||
13356641|NCT00903175|26671923|FG001|Period 1 - First Line|Death|10|||
13356642|NCT00903175|26671922|FG000|Period 2 - Second Line|Missing|1|||
13356643|NCT00903175|26671923|FG001|Period 2 - Second Line|Missing|0|||
13356644|NCT00903175|26671922|FG000|Period 2 - Second Line|Adverse Event|16|||
13356645|NCT00903175|26671923|FG001|Period 2 - Second Line|Adverse Event|20|||
13356646|NCT00903175|26671922|FG000|Period 2 - Second Line|Withdrawal by Subject|7|||
13356647|NCT00903175|26671923|FG001|Period 2 - Second Line|Withdrawal by Subject|5|||
13356648|NCT00903175|26671922|FG000|Period 2 - Second Line|Lost to Follow-up|1|||
13356649|NCT00903175|26671923|FG001|Period 2 - Second Line|Lost to Follow-up|0|||
13356650|NCT00903175|26671922|FG000|Period 2 - Second Line|Administrative problems|19|||
13356651|NCT00903175|26671923|FG001|Period 2 - Second Line|Administrative problems|9|||
13356652|NCT00903175|26671922|FG000|Period 2 - Second Line|Death|5|||
13356653|NCT00903175|26671923|FG001|Period 2 - Second Line|Death|2|||
13356654|NCT00903032|26671936|FG000|Overall Study|Withdrawal by Subject|5|||
13356655|NCT00903032|26671937|FG001|Overall Study|Withdrawal by Subject|3|||
13356656|NCT00903032|26671936|FG000|Overall Study|Lost to Follow-up|2|||
13356657|NCT00903032|26671937|FG001|Overall Study|Lost to Follow-up|2|||
13356658|NCT00903006|26671960|FG000|Overall Study|Withdrawal by Subject|2|||
13356659|NCT00903006|26671961|FG001|Overall Study|Withdrawal by Subject|0|||
13356660|NCT00903006|26671962|FG002|Overall Study|Withdrawal by Subject|0|||
13356661|NCT00903006|26671963|FG003|Overall Study|Withdrawal by Subject|0|||
13356662|NCT00903006|26671960|FG000|Overall Study|Progressive Disease|0|||
13356663|NCT00903006|26671961|FG001|Overall Study|Progressive Disease|3|||
13356664|NCT00903006|26671962|FG002|Overall Study|Progressive Disease|1|||
13356665|NCT00903006|26671963|FG003|Overall Study|Progressive Disease|0|||
13356666|NCT00902850|26671976|FG000|Overall Study|Physician Decision|2|||
13356667|NCT00902850|26671977|FG001|Overall Study|Physician Decision|2|||
13356668|NCT00902746|26671984|FG000|Overall Study|Protocol Violation|7|||
13356669|NCT00902746|26671984|FG000|Overall Study|Withdrawal by Subject|16|||
13356670|NCT00902746|26671984|FG000|Overall Study|Adverse Event|8|||
13356671|NCT00902746|26671984|FG000|Overall Study|Lost to Follow-up|3|||
13356672|NCT00902746|26671984|FG000|Overall Study|Physician Decision|2|||
13356673|NCT00902668|26671990|FG000|Overall Study|Protocol stopped due to slow accrual.|3|||
13356674|NCT00902577|26672021|FG000|Overall Study|Withdrawal by Subject|6|||
13356675|NCT00902577|26672021|FG000|Overall Study|FMISO production failure|2|||
13356676|NCT00902564|26672035|FG000|Overall Study|Withdrawal by Subject|2|||
13356677|NCT00902538|26672078|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49|||
13356678|NCT00902538|26672079|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
13356679|NCT00902538|26672080|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
13356680|NCT00902538|26672081|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
13356681|NCT00902538|26672082|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
13356682|NCT00902538|26672083|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
13356683|NCT00902538|26672078|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30|||
13356684|NCT00902538|26672079|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
13356685|NCT00902538|26672080|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
13356686|NCT00902538|26672081|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
13356687|NCT00902538|26672082|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
13356688|NCT00902538|26672083|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
13356689|NCT00902538|26672078|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22|||
13356690|NCT00902538|26672079|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
13356691|NCT00902538|26672080|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
13356692|NCT00902538|26672081|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
13356693|NCT00902538|26672082|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
13356694|NCT00902538|26672083|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
13356695|NCT00902538|26672078|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13|||
13356696|NCT00902538|26672079|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
13356697|NCT00902538|26672080|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
13356698|NCT00902538|26672081|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
13356699|NCT00902538|26672082|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
13356700|NCT00902538|26672083|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
13356701|NCT00902538|26672078|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4|||
13356702|NCT00902538|26672079|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
13356703|NCT00902538|26672080|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
13356704|NCT00902538|26672081|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
13356705|NCT00902538|26672082|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
13356706|NCT00902538|26672083|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
13356707|NCT00902538|26672078|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4|||
13356708|NCT00902538|26672079|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2|||
13356709|NCT00902538|26672080|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3|||
13356710|NCT00902538|26672081|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
13356711|NCT00902538|26672082|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
13356712|NCT00902538|26672083|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
13356713|NCT00902538|26672078|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
13356714|NCT00902538|26672079|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2|||
13356715|NCT00902538|26672080|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
13356716|NCT00902538|26672081|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
13356717|NCT00902538|26672082|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
13356718|NCT00902538|26672083|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
13356719|NCT00902538|26672078|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1|||
13356720|NCT00902538|26672079|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
13356721|NCT00902538|26672080|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2|||
13356722|NCT00902538|26672081|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
13356723|NCT00902538|26672082|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
13356724|NCT00902538|26672083|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
13356725|NCT00902538|26672078|FG000|2-Randomized Double-blind 3 Treatments|Other|2|||
13356726|NCT00902538|26672079|FG001|2-Randomized Double-blind 3 Treatments|Other|1|||
13356727|NCT00902538|26672080|FG002|2-Randomized Double-blind 3 Treatments|Other|0|||
13356728|NCT00902538|26672081|FG003|2-Randomized Double-blind 3 Treatments|Other|0|||
13356729|NCT00902538|26672082|FG004|2-Randomized Double-blind 3 Treatments|Other|0|||
13356730|NCT00902538|26672083|FG005|2-Randomized Double-blind 3 Treatments|Other|0|||
13356731|NCT00902538|26672078|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
13356732|NCT00902538|26672079|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
13356733|NCT00902538|26672080|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2|||
13356734|NCT00902538|26672081|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
13356735|NCT00902538|26672082|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
13356736|NCT00902538|26672083|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
13356737|NCT00902538|26672078|FG000|3-Single-blind, Single Treatment|Adverse Event|0|||
13356738|NCT00902538|26672079|FG001|3-Single-blind, Single Treatment|Adverse Event|5|||
13356739|NCT00902538|26672080|FG002|3-Single-blind, Single Treatment|Adverse Event|0|||
13356740|NCT00902538|26672081|FG003|3-Single-blind, Single Treatment|Adverse Event|0|||
13356741|NCT00902538|26672082|FG004|3-Single-blind, Single Treatment|Adverse Event|0|||
13356742|NCT00902538|26672083|FG005|3-Single-blind, Single Treatment|Adverse Event|0|||
13356743|NCT00902538|26672078|FG000|3-Single-blind, Single Treatment|Protocol Violation|0|||
13356744|NCT00902538|26672079|FG001|3-Single-blind, Single Treatment|Protocol Violation|5|||
13356745|NCT00902538|26672080|FG002|3-Single-blind, Single Treatment|Protocol Violation|0|||
13356746|NCT00902538|26672081|FG003|3-Single-blind, Single Treatment|Protocol Violation|0|||
13356747|NCT00902538|26672082|FG004|3-Single-blind, Single Treatment|Protocol Violation|0|||
13356748|NCT00902538|26672083|FG005|3-Single-blind, Single Treatment|Protocol Violation|0|||
13356749|NCT00902538|26672078|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
13356750|NCT00902538|26672079|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4|||
13356751|NCT00902538|26672080|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
13356752|NCT00902538|26672081|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
13356753|NCT00902538|26672082|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
13356754|NCT00902538|26672083|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
13356755|NCT00902538|26672078|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
13356756|NCT00902538|26672079|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1|||
13356757|NCT00902538|26672080|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
13356758|NCT00902538|26672081|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
13356759|NCT00902538|26672082|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
13356760|NCT00902538|26672083|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
13356761|NCT00902538|26672078|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
13356762|NCT00902538|26672079|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
13356763|NCT00902538|26672080|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
13356764|NCT00902538|26672081|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3|||
13356765|NCT00902538|26672082|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
13356766|NCT00902538|26672083|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
13356767|NCT00902538|26672078|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
13356768|NCT00902538|26672079|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
13356769|NCT00902538|26672080|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
13356770|NCT00902538|26672081|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3|||
13356771|NCT00902538|26672082|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1|||
13356772|NCT00902538|26672083|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
13356773|NCT00902538|26672078|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
13356774|NCT00902538|26672079|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
13356775|NCT00902538|26672080|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
13356776|NCT00902538|26672081|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3|||
13356777|NCT00902538|26672082|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
13356778|NCT00902538|26672083|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
13356779|NCT00902486|26672234|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
13356780|NCT00902486|26672235|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
13356781|NCT00902486|26672236|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
13356782|NCT00902486|26672237|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
13356783|NCT00902486|26672238|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
13356784|NCT00902486|26672239|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2|||
13356785|NCT00902486|26672234|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1|||
13356786|NCT00902486|26672235|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
13356787|NCT00902486|26672236|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
13356788|NCT00902486|26672237|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
13356789|NCT00902486|26672238|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
13356790|NCT00902486|26672239|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2|||
13356791|NCT00902486|26672234|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
13356792|NCT00902486|26672235|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
13356793|NCT00902486|26672236|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
13356794|NCT00902486|26672237|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
13356795|NCT00902486|26672238|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
13356796|NCT00902486|26672239|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
13356797|NCT00902486|26672234|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
13356798|NCT00902486|26672235|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
13356799|NCT00902486|26672236|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
13356800|NCT00902486|26672237|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1|||
13356801|NCT00902486|26672238|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
13356802|NCT00902486|26672239|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
13356803|NCT00902486|26672234|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
13356804|NCT00902486|26672235|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
13356805|NCT00902486|26672236|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
13356806|NCT00902486|26672237|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1|||
13356807|NCT00902486|26672238|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
13356808|NCT00902486|26672239|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
13356809|NCT00902486|26672234|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
13356810|NCT00902486|26672235|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
13356811|NCT00902486|26672236|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
13356812|NCT00902486|26672237|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
13356813|NCT00902486|26672238|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1|||
13356814|NCT00902486|26672239|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2|||
13356815|NCT00902486|26672234|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
13356816|NCT00902486|26672235|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
13356817|NCT00902486|26672236|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
13356818|NCT00902486|26672237|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
13356819|NCT00902486|26672238|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
13356820|NCT00902486|26672239|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
13356821|NCT00902486|26672234|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
13356822|NCT00902486|26672235|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
13356823|NCT00902486|26672236|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
13356824|NCT00902486|26672237|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
13356825|NCT00902486|26672238|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
13356826|NCT00902486|26672239|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1|||
13356827|NCT00902486|26672234|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
13356828|NCT00902486|26672235|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
13356829|NCT00902486|26672236|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
13356830|NCT00902486|26672237|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1|||
13356831|NCT00902486|26672238|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
13356832|NCT00902486|26672239|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
13356833|NCT00902486|26672234|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
13356834|NCT00902486|26672235|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
13356835|NCT00902486|26672236|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1|||
13356836|NCT00902486|26672237|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
13356837|NCT00902486|26672238|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
13356838|NCT00902486|26672239|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
13356839|NCT00902486|26672234|FG000|Follow-up (After Week 24)|Lost to Follow-up|0|||
13356840|NCT00902486|26672235|FG001|Follow-up (After Week 24)|Lost to Follow-up|0|||
13356841|NCT00902486|26672236|FG002|Follow-up (After Week 24)|Lost to Follow-up|0|||
13356842|NCT00902486|26672237|FG003|Follow-up (After Week 24)|Lost to Follow-up|1|||
13356843|NCT00902486|26672238|FG004|Follow-up (After Week 24)|Lost to Follow-up|0|||
13356844|NCT00902486|26672239|FG005|Follow-up (After Week 24)|Lost to Follow-up|0|||
13356845|NCT00902330|26672280|FG000|Overall Study|Too overwhelmed by treatment|2|||
13356846|NCT00902330|26672281|FG001|Overall Study|Too overwhelmed by treatment|5|||
13356847|NCT00902330|26672280|FG000|Overall Study|Adverse Event|1|||
13356848|NCT00902330|26672281|FG001|Overall Study|Adverse Event|0|||
13356849|NCT00902330|26672280|FG000|Overall Study|No post baseline data|1|||
13356850|NCT00902330|26672281|FG001|Overall Study|No post baseline data|0|||
13356851|NCT00902304|26672336|FG000|Overall Study|Adverse Event|4|||
13356852|NCT00902304|26672337|FG001|Overall Study|Adverse Event|10|||
13356853|NCT00902304|26672338|FG002|Overall Study|Adverse Event|25|||
13356854|NCT00902304|26672336|FG000|Overall Study|Investigator discretion|3|||
13356855|NCT00902304|26672337|FG001|Overall Study|Investigator discretion|5|||
13356856|NCT00902304|26672338|FG002|Overall Study|Investigator discretion|13|||
13356857|NCT00902304|26672336|FG000|Overall Study|Lost to Follow-up|7|||
13356858|NCT00902304|26672337|FG001|Overall Study|Lost to Follow-up|7|||
13356859|NCT00902304|26672338|FG002|Overall Study|Lost to Follow-up|7|||
13356860|NCT00902304|26672336|FG000|Overall Study|Protocol Violation|9|||
13356861|NCT00902304|26672337|FG001|Overall Study|Protocol Violation|18|||
13356862|NCT00902304|26672338|FG002|Overall Study|Protocol Violation|20|||
13356863|NCT00902304|26672336|FG000|Overall Study|Withdrawal by Subject|32|||
13356864|NCT00902304|26672337|FG001|Overall Study|Withdrawal by Subject|22|||
13356865|NCT00902304|26672338|FG002|Overall Study|Withdrawal by Subject|43|||
13356866|NCT00902304|26672336|FG000|Overall Study|includes pregnancy|3|||
13356867|NCT00902304|26672337|FG001|Overall Study|includes pregnancy|9|||
13356868|NCT00902304|26672338|FG002|Overall Study|includes pregnancy|2|||
13356869|NCT00902278|26672371|FG000|Overall Study|Physician Decision|1|||
13356870|NCT00902278|26672372|FG001|Overall Study|Physician Decision|0|||
13356871|NCT00902278|26672373|FG002|Overall Study|Physician Decision|2|||
13356872|NCT00902278|26672374|FG003|Overall Study|Physician Decision|0|||
13356873|NCT00902278|26672375|FG004|Overall Study|Physician Decision|1|||
13356874|NCT00902278|26672371|FG000|Overall Study|Lost to Follow-up|3|||
13356875|NCT00902278|26672372|FG001|Overall Study|Lost to Follow-up|2|||
13356876|NCT00902278|26672373|FG002|Overall Study|Lost to Follow-up|3|||
13356877|NCT00902278|26672374|FG003|Overall Study|Lost to Follow-up|0|||
13356878|NCT00902278|26672375|FG004|Overall Study|Lost to Follow-up|1|||
13356879|NCT00902265|26672389|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1|||
13356880|NCT00902265|26672389|FG000|Overall Study|Adverse Event|2|||
13356881|NCT00902265|26672389|FG000|Overall Study|Lack of Efficacy|2|||
13356882|NCT00902265|26672389|FG000|Overall Study|Protocol Violation|1|||
13356883|NCT00902174|26672432|FG000|Overall Study|Adverse Event|27|||
13356884|NCT00902174|26672433|FG001|Overall Study|Adverse Event|7|||
13356885|NCT00902174|26672432|FG000|Overall Study|Lack of Efficacy|1|||
13356886|NCT00902174|26672433|FG001|Overall Study|Lack of Efficacy|5|||
13356887|NCT00902174|26672432|FG000|Overall Study|Death|2|||
13356888|NCT00902174|26672433|FG001|Overall Study|Death|2|||
13356889|NCT00902174|26672432|FG000|Overall Study|Withdrawal by Subject|2|||
13356890|NCT00902174|26672433|FG001|Overall Study|Withdrawal by Subject|1|||
13356891|NCT00902174|26672432|FG000|Overall Study|Abnormal labs|1|||
13356892|NCT00902174|26672433|FG001|Overall Study|Abnormal labs|1|||
13356893|NCT00902174|26672432|FG000|Overall Study|Protocol Violation|1|||
13356894|NCT00902174|26672433|FG001|Overall Study|Protocol Violation|1|||
13356895|NCT00902174|26672432|FG000|Overall Study|Administration problem|0|||
13356896|NCT00902174|26672433|FG001|Overall Study|Administration problem|1|||
13356897|NCT00901927|26672441|FG000|Overall Study|Lack of Efficacy|1|||
13356898|NCT00901927|26672441|FG000|Overall Study|Protocol Violation|3|||
13356899|NCT00901927|26672441|FG000|Overall Study|Withdrawal by Subject|2|||
13356900|NCT00901901|26672468|FG000|Treatment Period|Adverse Event|120|||
13356901|NCT00901901|26672469|FG001|Treatment Period|Adverse Event|128|||
13356902|NCT00901901|26672468|FG000|Treatment Period|Withdrawal by Subject|26|||
13356903|NCT00901901|26672469|FG001|Treatment Period|Withdrawal by Subject|24|||
13356904|NCT00901901|26672468|FG000|Treatment Period|Physician Decision|2|||
13356905|NCT00901901|26672469|FG001|Treatment Period|Physician Decision|2|||
13356906|NCT00901901|26672468|FG000|Treatment Period|Lost to Follow-up|3|||
13356907|NCT00901901|26672469|FG001|Treatment Period|Lost to Follow-up|5|||
13356908|NCT00901901|26672468|FG000|Treatment Period|Noncompliance with study medication|4|||
13356909|NCT00901901|26672469|FG001|Treatment Period|Noncompliance with study medication|1|||
13356910|NCT00901901|26672468|FG000|Treatment Period|Missing|1|||
13356911|NCT00901901|26672469|FG001|Treatment Period|Missing|0|||
13356912|NCT00901901|26672468|FG000|Treatment Period|Never treated|0|||
13356913|NCT00901901|26672469|FG001|Treatment Period|Never treated|3|||
13356914|NCT00901901|26672468|FG000|Treatment Period|Protocol driven decision point|0|||
13356915|NCT00901901|26672469|FG001|Treatment Period|Protocol driven decision point|2|||
13356916|NCT00901901|26672468|FG000|Treatment Period|Study terminated by sponsor|2|||
13356917|NCT00901901|26672469|FG001|Treatment Period|Study terminated by sponsor|0|||
13356918|NCT00901901|26672468|FG000|Treatment Period|Protocol Violation|5|||
13356919|NCT00901901|26672469|FG001|Treatment Period|Protocol Violation|9|||
13356920|NCT00901901|26672468|FG000|Treatment Period|Switch to commercial drug|1|||
13356921|NCT00901901|26672469|FG001|Treatment Period|Switch to commercial drug|1|||
13356922|NCT00901901|26672468|FG000|Treatment Period|Transfer to treatment continuation study|5|||
13356923|NCT00901901|26672469|FG001|Treatment Period|Transfer to treatment continuation study|2|||
13356924|NCT00901901|26672468|FG000|Follow-up Period|Death|181|||
13356925|NCT00901901|26672469|FG001|Follow-up Period|Death|208|||
13356926|NCT00901901|26672468|FG000|Follow-up Period|Protocol driven decision point|47|||
13356927|NCT00901901|26672469|FG001|Follow-up Period|Protocol driven decision point|36|||
13356928|NCT00901901|26672468|FG000|Follow-up Period|Withdrawal by Subject|6|||
13356929|NCT00901901|26672469|FG001|Follow-up Period|Withdrawal by Subject|9|||
13356930|NCT00901901|26672468|FG000|Follow-up Period|Lost to Follow-up|12|||
13356931|NCT00901901|26672469|FG001|Follow-up Period|Lost to Follow-up|8|||
13356932|NCT00901901|26672468|FG000|Follow-up Period|Missing|94|||
13356933|NCT00901901|26672469|FG001|Follow-up Period|Missing|80|||
13356934|NCT00901628|26672492|FG000|Overall Study|disconnection of catheter|4|||
13356935|NCT00901628|26672493|FG001|Overall Study|disconnection of catheter|8|||
13356936|NCT00901628|26672492|FG000|Overall Study|disconnection of drain|0|||
13356937|NCT00901628|26672493|FG001|Overall Study|disconnection of drain|1|||
13356938|NCT00901628|26672492|FG000|Overall Study|peroneal nerve palsy|0|||
13356939|NCT00901628|26672493|FG001|Overall Study|peroneal nerve palsy|1|||
13356940|NCT00901576|26672533|FG000|Second Intervention|Withdrawal by Subject|0|||
13356941|NCT00901576|26672534|FG001|Second Intervention|Withdrawal by Subject|0|||
13356942|NCT00901576|26672535|FG002|Second Intervention|Withdrawal by Subject|0|||
13356943|NCT00901576|26672536|FG003|Second Intervention|Withdrawal by Subject|1|||
13356944|NCT00901576|26672537|FG004|Second Intervention|Withdrawal by Subject|0|||
13356945|NCT00901576|26672538|FG005|Second Intervention|Withdrawal by Subject|1|||
13356946|NCT00901576|26672533|FG000|Second Intervention|Physician Decision|1|||
13356947|NCT00901576|26672534|FG001|Second Intervention|Physician Decision|0|||
13356948|NCT00901576|26672535|FG002|Second Intervention|Physician Decision|0|||
13356949|NCT00901576|26672536|FG003|Second Intervention|Physician Decision|0|||
13356950|NCT00901576|26672537|FG004|Second Intervention|Physician Decision|0|||
13356951|NCT00901576|26672538|FG005|Second Intervention|Physician Decision|0|||
13356952|NCT00901485|26672573|FG000|Overall Study|Lack of Efficacy|0|||
13356953|NCT00901485|26672574|FG001|Overall Study|Lack of Efficacy|2|||
13356954|NCT00901485|26672573|FG000|Overall Study|Withdrawal by Subject|1|||
13356955|NCT00901485|26672574|FG001|Overall Study|Withdrawal by Subject|2|||
13356956|NCT00901459|26672587|FG000|Overall Study|Withdrawal by Subject|6|||
13356957|NCT00901394|26672605|FG000|Overall Study|Physician Decision|1|||
13356958|NCT00901394|26672606|FG001|Overall Study|Physician Decision|1|||
13356959|NCT00901394|26672607|FG002|Overall Study|Physician Decision|2|||
13356960|NCT00901342|26672613|FG000|Overall Study|Adverse Event|1|||
13356961|NCT00901342|26672613|FG000|Overall Study|Death|4|||
13356962|NCT00901342|26672613|FG000|Overall Study|Disease progression|1|||
13356963|NCT00901342|26672613|FG000|Overall Study|Withdrawal by Subject|9|||
13356964|NCT00901186|26672636|FG000|Overall Study|Lack of Efficacy|0|||
13356965|NCT00901186|26672637|FG001|Overall Study|Lack of Efficacy|1|||
13356966|NCT00901186|26672636|FG000|Overall Study|Abnormal laboratory values|0|||
13356967|NCT00901186|26672637|FG001|Overall Study|Abnormal laboratory values|1|||
13356968|NCT00901186|26672636|FG000|Overall Study|Lost to Follow-up|2|||
13356969|NCT00901186|26672637|FG001|Overall Study|Lost to Follow-up|0|||
13356970|NCT00901186|26672636|FG000|Overall Study|Adverse Event|2|||
13356971|NCT00901186|26672637|FG001|Overall Study|Adverse Event|4|||
13356972|NCT00901186|26672636|FG000|Overall Study|Administration problems|0|||
13356973|NCT00901186|26672637|FG001|Overall Study|Administration problems|1|||
13356974|NCT00901186|26672636|FG000|Overall Study|Protocol deviations|5|||
13356975|NCT00901186|26672637|FG001|Overall Study|Protocol deviations|4|||
13356976|NCT00900796|26672649|FG000|Phase 1|Lacked sufficient information|4|||
13356977|NCT00900796|26672649|FG000|Phase 1|Missing information at Week 16|7|||
13356978|NCT00900796|26672649|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110|||
13356979|NCT00900796|26672649|FG000|Phase 2|Lost to Follow-up|5|||
13356980|NCT00900757|26672659|FG000|Overall Study|screen failure|19|||
13356981|NCT00900731|26672686|FG000|Overall Study|Adverse Event|31|||
13356982|NCT00900731|26672687|FG001|Overall Study|Adverse Event|27|||
13356983|NCT00900731|26672686|FG000|Overall Study|Withdrawal by Subject|8|||
13356984|NCT00900731|26672687|FG001|Overall Study|Withdrawal by Subject|7|||
13356985|NCT00900731|26672686|FG000|Overall Study|Protocol Deviation|8|||
13356986|NCT00900731|26672687|FG001|Overall Study|Protocol Deviation|11|||
13356987|NCT00900731|26672686|FG000|Overall Study|Administrative Problems|5|||
13356988|NCT00900731|26672687|FG001|Overall Study|Administrative Problems|4|||
13356989|NCT00900731|26672686|FG000|Overall Study|Abnormal Test Procedure Result(s)|3|||
13356990|NCT00900731|26672687|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
13356991|NCT00900731|26672686|FG000|Overall Study|Abnormal Laboratory Value(s)|2|||
13356992|NCT00900731|26672687|FG001|Overall Study|Abnormal Laboratory Value(s)|4|||
13356993|NCT00900731|26672686|FG000|Overall Study|Lost to Follow-up|2|||
13356994|NCT00900731|26672687|FG001|Overall Study|Lost to Follow-up|3|||
13356995|NCT00900731|26672686|FG000|Overall Study|Lack of Efficacy|1|||
13356996|NCT00900731|26672687|FG001|Overall Study|Lack of Efficacy|3|||
13356997|NCT00900731|26672686|FG000|Overall Study|Death|0|||
13356998|NCT00900731|26672687|FG001|Overall Study|Death|2|||
13356999|NCT00900627|26672724|FG000|Overall Study|Condition under investigation worsened|4|||
13357000|NCT00900627|26672725|FG001|Overall Study|Condition under investigation worsened|0|||
13357001|NCT00900627|26672726|FG002|Overall Study|Condition under investigation worsened|5|||
13357002|NCT00900627|26672727|FG003|Overall Study|Condition under investigation worsened|3|||
13357003|NCT00900627|26672728|FG004|Overall Study|Condition under investigation worsened|0|||
13357004|NCT00900627|26672729|FG005|Overall Study|Condition under investigation worsened|0|||
13357005|NCT00900627|26672724|FG000|Overall Study|Withdrawal by Subject|1|||
13357006|NCT00900627|26672725|FG001|Overall Study|Withdrawal by Subject|0|||
13357007|NCT00900627|26672726|FG002|Overall Study|Withdrawal by Subject|1|||
13357008|NCT00900627|26672727|FG003|Overall Study|Withdrawal by Subject|0|||
13357009|NCT00900627|26672728|FG004|Overall Study|Withdrawal by Subject|1|||
13357010|NCT00900627|26672729|FG005|Overall Study|Withdrawal by Subject|2|||
13357011|NCT00900627|26672724|FG000|Overall Study|Adverse Event|1|||
13357012|NCT00900627|26672725|FG001|Overall Study|Adverse Event|2|||
13357013|NCT00900627|26672726|FG002|Overall Study|Adverse Event|0|||
13357014|NCT00900627|26672727|FG003|Overall Study|Adverse Event|3|||
13357015|NCT00900627|26672728|FG004|Overall Study|Adverse Event|0|||
13357016|NCT00900627|26672729|FG005|Overall Study|Adverse Event|0|||
13357017|NCT00900627|26672724|FG000|Overall Study|Death|0|||
13357018|NCT00900627|26672725|FG001|Overall Study|Death|0|||
13357019|NCT00900627|26672726|FG002|Overall Study|Death|0|||
13357020|NCT00900627|26672727|FG003|Overall Study|Death|0|||
13357021|NCT00900627|26672728|FG004|Overall Study|Death|28|||
13357022|NCT00900627|26672729|FG005|Overall Study|Death|24|||
13357023|NCT00900601|26672737|FG000|Overall Study|Physician Decision|1|||
13357024|NCT00900562|26672762|FG000|Overall Study|Progressive disease|9|||
13357025|NCT00900562|26672763|FG001|Overall Study|Progressive disease|5|||
13357026|NCT00900562|26672762|FG000|Overall Study|Toxicity|1|||
13357027|NCT00900562|26672763|FG001|Overall Study|Toxicity|0|||
13357028|NCT00900562|26672762|FG000|Overall Study|Death|1|||
13357029|NCT00900562|26672763|FG001|Overall Study|Death|1|||
13357030|NCT00900562|26672762|FG000|Overall Study|Withdrawal by Subject|0|||
13357031|NCT00900562|26672763|FG001|Overall Study|Withdrawal by Subject|1|||
13357032|NCT00900562|26672762|FG000|Overall Study|Unrelated adverse event|1|||
13357033|NCT00900562|26672763|FG001|Overall Study|Unrelated adverse event|0|||
13357034|NCT00900159|26672784|FG000|Second Intervention|disempanelled for inappropriate behavior|1|||
13357035|NCT00900159|26672785|FG001|Second Intervention|disempanelled for inappropriate behavior|0|||
13357036|NCT00900146|26672913|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
13357037|NCT00900146|26672914|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
13357038|NCT00900146|26672915|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5|||
13357039|NCT00900146|26672916|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1|||
13357040|NCT00900146|26672917|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9|||
13357041|NCT00900146|26672913|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2|||
13357042|NCT00900146|26672914|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
13357043|NCT00900146|26672915|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
13357044|NCT00900146|26672916|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1|||
13357045|NCT00900146|26672917|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3|||
13357046|NCT00900146|26672913|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1|||
13357047|NCT00900146|26672914|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0|||
13357048|NCT00900146|26672915|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0|||
13357049|NCT00900146|26672916|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0|||
13357050|NCT00900146|26672917|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0|||
13357051|NCT00900146|26672913|FG000|Intermediate: Period III|Withdrawal by Subject|0|||
13357052|NCT00900146|26672914|FG001|Intermediate: Period III|Withdrawal by Subject|1|||
13357053|NCT00900146|26672915|FG002|Intermediate: Period III|Withdrawal by Subject|0|||
13357054|NCT00900146|26672916|FG003|Intermediate: Period III|Withdrawal by Subject|0|||
13357055|NCT00900146|26672917|FG004|Intermediate: Period III|Withdrawal by Subject|3|||
13357056|NCT00900146|26672913|FG000|Intermediate: Period III|Lost to Follow-up|2|||
13357057|NCT00900146|26672914|FG001|Intermediate: Period III|Lost to Follow-up|0|||
13357058|NCT00900146|26672915|FG002|Intermediate: Period III|Lost to Follow-up|0|||
13357059|NCT00900146|26672916|FG003|Intermediate: Period III|Lost to Follow-up|0|||
13357060|NCT00900146|26672917|FG004|Intermediate: Period III|Lost to Follow-up|1|||
13357061|NCT00900146|26672913|FG000|Intermediate: Period III|Administrative problems|85|||
13357062|NCT00900146|26672914|FG001|Intermediate: Period III|Administrative problems|92|||
13357063|NCT00900146|26672915|FG002|Intermediate: Period III|Administrative problems|84|||
13357064|NCT00900146|26672916|FG003|Intermediate: Period III|Administrative problems|90|||
13357065|NCT00900146|26672917|FG004|Intermediate: Period III|Administrative problems|163|||
13357066|NCT00900029|26672950|FG000|Overall Study|Lost to Follow-up|0|||
13357067|NCT00900029|26672951|FG001|Overall Study|Lost to Follow-up|2|||
13357068|NCT00900029|26672952|FG002|Overall Study|Lost to Follow-up|1|||
13357069|NCT00900029|26672953|FG003|Overall Study|Lost to Follow-up|4|||
13357070|NCT00900029|26672954|FG004|Overall Study|Lost to Follow-up|4|||
13357071|NCT00900029|26672950|FG000|Overall Study|Withdrawal by Subject|2|||
13357072|NCT00900029|26672951|FG001|Overall Study|Withdrawal by Subject|2|||
13357073|NCT00900029|26672952|FG002|Overall Study|Withdrawal by Subject|1|||
13357074|NCT00900029|26672953|FG003|Overall Study|Withdrawal by Subject|1|||
13357075|NCT00900029|26672954|FG004|Overall Study|Withdrawal by Subject|1|||
13357076|NCT00900029|26672950|FG000|Overall Study|Adverse Event|0|||
13357077|NCT00900029|26672951|FG001|Overall Study|Adverse Event|0|||
13357078|NCT00900029|26672952|FG002|Overall Study|Adverse Event|1|||
13357079|NCT00900029|26672953|FG003|Overall Study|Adverse Event|1|||
13357080|NCT00900029|26672954|FG004|Overall Study|Adverse Event|1|||
13357081|NCT00900029|26672950|FG000|Overall Study|Death|1|||
13357082|NCT00900029|26672951|FG001|Overall Study|Death|0|||
13357083|NCT00900029|26672952|FG002|Overall Study|Death|0|||
13357084|NCT00900029|26672953|FG003|Overall Study|Death|1|||
13357085|NCT00900029|26672954|FG004|Overall Study|Death|0|||
13357086|NCT00899847|26672967|FG000|Overall Study|Lack of suitable allogeneic donor|2|||
13357087|NCT00899678|26673005|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6|||
13357088|NCT00899678|26673006|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
13357089|NCT00899678|26673007|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
13357090|NCT00899678|26673005|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17|||
13357091|NCT00899678|26673006|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
13357092|NCT00899678|26673007|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
13357093|NCT00899678|26673005|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1|||
13357094|NCT00899678|26673006|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
13357095|NCT00899678|26673007|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
13357096|NCT00899678|26673005|FG000|Induction Period (Weeks 0 to 6)|Other reason|1|||
13357097|NCT00899678|26673006|FG001|Induction Period (Weeks 0 to 6)|Other reason|0|||
13357098|NCT00899678|26673007|FG002|Induction Period (Weeks 0 to 6)|Other reason|0|||
13357099|NCT00899678|26673005|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0|||
13357100|NCT00899678|26673006|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10|||
13357101|NCT00899678|26673007|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5|||
13357102|NCT00899678|26673005|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0|||
13357103|NCT00899678|26673006|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11|||
13357104|NCT00899678|26673007|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18|||
13357105|NCT00899678|26673005|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0|||
13357106|NCT00899678|26673006|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
13357107|NCT00899678|26673007|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
13357108|NCT00899678|26673005|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0|||
13357109|NCT00899678|26673006|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1|||
13357110|NCT00899678|26673007|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2|||
13357111|NCT00899678|26673005|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0|||
13357112|NCT00899678|26673006|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
13357113|NCT00899678|26673007|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
13357114|NCT00899548|26673021|FG000|Overall Study|Physician Decision|3|||
13357115|NCT00899431|26673042|FG000|Overall Study|Physician Decision|1|||
13357116|NCT00899431|26673043|FG001|Overall Study|Physician Decision|0|||
13357117|NCT00899431|26673044|FG002|Overall Study|Physician Decision|0|||
13357118|NCT00899392|26673063|FG000|Overall Study|Subject didn't finish/partial pilot data|21|||
13357119|NCT00899392|26673064|FG001|Overall Study|Subject didn't finish/partial pilot data|24|||
13357120|NCT00899353|26673087|FG000|Overall Study|Adverse Event|2|||
13357121|NCT00899353|26673087|FG000|Overall Study|Lost to Follow-up|1|||
13357122|NCT00899353|26673087|FG000|Overall Study|Withdrawal by Subject|2|||
13357123|NCT00898807|26673106|FG000|Overall Study|Withdrawal by Subject|5|||
13357124|NCT00898807|26673107|FG001|Overall Study|Withdrawal by Subject|3|||
13357125|NCT00898807|26673106|FG000|Overall Study|Family pressure to discontinue|2|||
13357126|NCT00898807|26673107|FG001|Overall Study|Family pressure to discontinue|2|||
13357127|NCT00898807|26673106|FG000|Overall Study|Lost to Follow-up|1|||
13357128|NCT00898807|26673107|FG001|Overall Study|Lost to Follow-up|3|||
13357129|NCT00898807|26673106|FG000|Overall Study|Death|0|||
13357130|NCT00898807|26673107|FG001|Overall Study|Death|1|||
13357131|NCT00898443|26673122|FG000|Overall Study|Withdrawal by Subject|1|||
13357132|NCT00898443|26673123|FG001|Overall Study|Withdrawal by Subject|0|||
13357133|NCT00897715|26673138|FG000|Overall Study|Lost to Follow-up|0|||
13357134|NCT00897715|26673139|FG001|Overall Study|Lost to Follow-up|1|||
13357135|NCT00897715|26673138|FG000|Overall Study|Physician Decision|1|||
13357136|NCT00897715|26673139|FG001|Overall Study|Physician Decision|0|||
13357137|NCT00897715|26673138|FG000|Overall Study|increased risk of infection|1|||
13357138|NCT00897715|26673139|FG001|Overall Study|increased risk of infection|0|||
13357139|NCT00897390|26673228|FG000|Overall Study|Adverse Event|2|||
13357140|NCT00897390|26673228|FG000|Overall Study|No Longer Met Study Criteria|1|||
13357141|NCT00897390|26673228|FG000|Overall Study|Personal Reasons|1|||
13357142|NCT00897390|26673228|FG000|Overall Study|Did not Return for the Clinic Visit|2|||
13357143|NCT00896649|26673235|FG000|Overall Study|Physician Decision|1|||
13357144|NCT00896649|26673235|FG000|Overall Study|Pregnancy|1|||
13357145|NCT00896649|26673235|FG000|Overall Study|missing documentation|1|||
13357146|NCT00896649|26673235|FG000|Overall Study|technical difficulties|2|||
13357147|NCT00896532|26673402|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
13357148|NCT00896532|26673403|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
13357149|NCT00896532|26673404|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
13357150|NCT00896532|26673405|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
13357151|NCT00896532|26673406|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
13357152|NCT00896532|26673407|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
13357153|NCT00896532|26673408|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
13357154|NCT00896532|26673409|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
13357155|NCT00896532|26673410|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
13357156|NCT00896532|26673411|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
13357157|NCT00896532|26673412|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
13357158|NCT00896532|26673413|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
13357159|NCT00896532|26673414|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
13357160|NCT00896532|26673415|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
13357161|NCT00896532|26673416|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
13357162|NCT00896532|26673417|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
13357163|NCT00896532|26673418|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
13357164|NCT00896532|26673419|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
13357165|NCT00896532|26673420|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
13357166|NCT00896532|26673421|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
13357167|NCT00896532|26673422|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
13357168|NCT00896532|26673423|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
13357169|NCT00896532|26673424|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
13357170|NCT00896532|26673402|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
13357171|NCT00896532|26673403|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
13357172|NCT00896532|26673404|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
13357173|NCT00896532|26673405|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
13357174|NCT00896532|26673406|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
13357175|NCT00896532|26673407|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
13357176|NCT00896532|26673408|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
13357177|NCT00896532|26673409|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
13357178|NCT00896532|26673410|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
13357179|NCT00896532|26673411|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
13357180|NCT00896532|26673412|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
13357181|NCT00896532|26673413|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
13357182|NCT00896532|26673414|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
13357183|NCT00896532|26673415|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
13357184|NCT00896532|26673416|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
13357185|NCT00896532|26673417|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
13357186|NCT00896532|26673418|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
13357187|NCT00896532|26673419|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
13357188|NCT00896532|26673420|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
13357189|NCT00896532|26673421|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
13357190|NCT00896532|26673422|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
13357191|NCT00896532|26673423|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
13357192|NCT00896532|26673424|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
13357193|NCT00896532|26673402|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
13357194|NCT00896532|26673403|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3|||
13357195|NCT00896532|26673404|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
13357196|NCT00896532|26673405|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
13357197|NCT00896532|26673406|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5|||
13357198|NCT00896532|26673407|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
13357199|NCT00896532|26673408|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
13357200|NCT00896532|26673409|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
13357201|NCT00896532|26673410|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
13357202|NCT00896532|26673411|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
13357203|NCT00896532|26673412|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
13357204|NCT00896532|26673413|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
13357205|NCT00896532|26673414|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
13357206|NCT00896532|26673415|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
13357207|NCT00896532|26673416|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
13357208|NCT00896532|26673417|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
13357209|NCT00896532|26673418|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
13357210|NCT00896532|26673419|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
13357211|NCT00896532|26673420|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
13357212|NCT00896532|26673421|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
13357213|NCT00896532|26673422|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
13357214|NCT00896532|26673423|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
13357215|NCT00896532|26673424|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
13357216|NCT00896532|26673402|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
13357217|NCT00896532|26673403|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
13357218|NCT00896532|26673404|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2|||
13357219|NCT00896532|26673405|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
13357220|NCT00896532|26673406|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1|||
13357221|NCT00896532|26673407|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
13357222|NCT00896532|26673408|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
13357223|NCT00896532|26673409|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
13357224|NCT00896532|26673410|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
13357225|NCT00896532|26673411|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
13357226|NCT00896532|26673412|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
13357227|NCT00896532|26673413|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
13357228|NCT00896532|26673414|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
13357229|NCT00896532|26673415|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
13357230|NCT00896532|26673416|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
13357231|NCT00896532|26673417|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
13357232|NCT00896532|26673418|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
13357233|NCT00896532|26673419|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
13357234|NCT00896532|26673420|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
13357235|NCT00896532|26673421|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
13357236|NCT00896532|26673422|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
13357237|NCT00896532|26673423|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
13357238|NCT00896532|26673424|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
13357239|NCT00896532|26673402|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1|||
13357240|NCT00896532|26673403|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0|||
13357241|NCT00896532|26673404|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0|||
13357242|NCT00896532|26673405|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1|||
13357243|NCT00896532|26673406|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0|||
13357244|NCT00896532|26673407|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0|||
13357245|NCT00896532|26673408|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0|||
13357246|NCT00896532|26673409|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0|||
13357247|NCT00896532|26673410|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0|||
13357248|NCT00896532|26673411|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0|||
13357249|NCT00896532|26673412|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0|||
13357250|NCT00896532|26673413|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0|||
13357251|NCT00896532|26673414|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0|||
13357252|NCT00896532|26673415|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0|||
13357253|NCT00896532|26673416|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0|||
13357254|NCT00896532|26673417|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0|||
13357255|NCT00896532|26673418|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0|||
13357256|NCT00896532|26673419|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0|||
13357257|NCT00896532|26673420|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0|||
13357258|NCT00896532|26673421|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0|||
13357259|NCT00896532|26673422|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0|||
13357260|NCT00896532|26673423|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0|||
13357261|NCT00896532|26673424|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0|||
13357262|NCT00896532|26673402|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
13357263|NCT00896532|26673403|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
13357264|NCT00896532|26673404|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1|||
13357265|NCT00896532|26673405|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
13357266|NCT00896532|26673406|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
13357267|NCT00896532|26673407|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
13357268|NCT00896532|26673408|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
13357269|NCT00896532|26673409|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
13357270|NCT00896532|26673410|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
13357271|NCT00896532|26673411|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
13357272|NCT00896532|26673412|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
13357273|NCT00896532|26673413|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
13357274|NCT00896532|26673414|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
13357275|NCT00896532|26673415|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
13357276|NCT00896532|26673416|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
13357277|NCT00896532|26673417|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
13357278|NCT00896532|26673418|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
13357279|NCT00896532|26673419|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
13357280|NCT00896532|26673420|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
13357281|NCT00896532|26673421|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
13357282|NCT00896532|26673422|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
13357283|NCT00896532|26673423|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
13357284|NCT00896532|26673424|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
13357285|NCT00896532|26673402|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
13357286|NCT00896532|26673403|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
13357287|NCT00896532|26673404|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1|||
13357288|NCT00896532|26673405|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
13357289|NCT00896532|26673406|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
13357290|NCT00896532|26673407|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
13357291|NCT00896532|26673408|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
13357292|NCT00896532|26673409|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
13357293|NCT00896532|26673410|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
13357294|NCT00896532|26673411|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
13357295|NCT00896532|26673412|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
13357296|NCT00896532|26673413|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
13357297|NCT00896532|26673414|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
13357298|NCT00896532|26673415|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
13357299|NCT00896532|26673416|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
13357300|NCT00896532|26673417|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
13357301|NCT00896532|26673418|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
13357302|NCT00896532|26673419|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
13357303|NCT00896532|26673420|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
13357304|NCT00896532|26673421|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
13357305|NCT00896532|26673422|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
13357306|NCT00896532|26673423|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
13357307|NCT00896532|26673424|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
13357308|NCT00896532|26673402|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
13357309|NCT00896532|26673403|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
13357310|NCT00896532|26673404|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
13357311|NCT00896532|26673405|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1|||
13357312|NCT00896532|26673406|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
13357313|NCT00896532|26673407|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
13357314|NCT00896532|26673408|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
13357315|NCT00896532|26673409|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
13357316|NCT00896532|26673410|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
13357317|NCT00896532|26673411|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
13357318|NCT00896532|26673412|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
13357319|NCT00896532|26673413|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
13357320|NCT00896532|26673414|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
13357321|NCT00896532|26673415|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
13357322|NCT00896532|26673416|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
13357323|NCT00896532|26673417|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
13357324|NCT00896532|26673418|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
13357325|NCT00896532|26673419|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
13357326|NCT00896532|26673420|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
13357327|NCT00896532|26673421|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
13357328|NCT00896532|26673422|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
13357329|NCT00896532|26673423|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
13357330|NCT00896532|26673424|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
13357331|NCT00896532|26673402|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0|||
13357332|NCT00896532|26673403|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1|||
13357333|NCT00896532|26673404|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0|||
13357334|NCT00896532|26673405|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1|||
13357335|NCT00896532|26673406|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1|||
13357336|NCT00896532|26673407|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0|||
13357337|NCT00896532|26673408|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0|||
13357338|NCT00896532|26673409|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0|||
13357339|NCT00896532|26673410|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0|||
13357340|NCT00896532|26673411|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0|||
13357341|NCT00896532|26673412|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0|||
13357342|NCT00896532|26673413|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0|||
13357343|NCT00896532|26673414|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0|||
13357344|NCT00896532|26673415|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0|||
13357345|NCT00896532|26673416|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0|||
13357346|NCT00896532|26673417|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0|||
13357347|NCT00896532|26673418|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0|||
13357348|NCT00896532|26673419|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0|||
13357349|NCT00896532|26673420|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0|||
13357350|NCT00896532|26673421|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0|||
13357351|NCT00896532|26673422|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0|||
13357352|NCT00896532|26673423|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0|||
13357353|NCT00896532|26673424|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0|||
13357354|NCT00896532|26673402|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
13357355|NCT00896532|26673403|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
13357356|NCT00896532|26673404|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
13357357|NCT00896532|26673405|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
13357358|NCT00896532|26673406|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
13357359|NCT00896532|26673407|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
13357360|NCT00896532|26673408|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
13357361|NCT00896532|26673409|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
13357362|NCT00896532|26673410|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1|||
13357363|NCT00896532|26673411|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
13357364|NCT00896532|26673412|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
13357365|NCT00896532|26673413|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
13357366|NCT00896532|26673414|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
13357367|NCT00896532|26673415|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
13357368|NCT00896532|26673416|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
13357369|NCT00896532|26673417|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
13357370|NCT00896532|26673418|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
13357371|NCT00896532|26673419|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
13357372|NCT00896532|26673420|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
13357373|NCT00896532|26673421|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
13357374|NCT00896532|26673422|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
13357375|NCT00896532|26673423|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
13357376|NCT00896532|26673424|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
13357377|NCT00896532|26673402|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
13357378|NCT00896532|26673403|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
13357379|NCT00896532|26673404|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
13357380|NCT00896532|26673405|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
13357381|NCT00896532|26673406|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
13357382|NCT00896532|26673407|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
13357383|NCT00896532|26673408|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
13357384|NCT00896532|26673409|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
13357385|NCT00896532|26673410|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
13357386|NCT00896532|26673411|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
13357387|NCT00896532|26673412|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
13357388|NCT00896532|26673413|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
13357389|NCT00896532|26673414|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1|||
13357390|NCT00896532|26673415|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
13357391|NCT00896532|26673416|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
13357392|NCT00896532|26673417|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
13357393|NCT00896532|26673418|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
13357394|NCT00896532|26673419|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
13357395|NCT00896532|26673420|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
13357396|NCT00896532|26673421|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
13357397|NCT00896532|26673422|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
13357398|NCT00896532|26673423|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
13357399|NCT00896532|26673424|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
13357400|NCT00896532|26673402|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
13357401|NCT00896532|26673403|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
13357402|NCT00896532|26673404|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
13357403|NCT00896532|26673405|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
13357404|NCT00896532|26673406|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
13357405|NCT00896532|26673407|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
13357406|NCT00896532|26673408|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
13357407|NCT00896532|26673409|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
13357408|NCT00896532|26673410|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
13357409|NCT00896532|26673411|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
13357410|NCT00896532|26673412|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
13357411|NCT00896532|26673413|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
13357412|NCT00896532|26673414|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
13357413|NCT00896532|26673415|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
13357414|NCT00896532|26673416|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
13357415|NCT00896532|26673417|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
13357416|NCT00896532|26673418|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
13357417|NCT00896532|26673419|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
13357418|NCT00896532|26673420|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
13357419|NCT00896532|26673421|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
13357420|NCT00896532|26673422|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
13357421|NCT00896532|26673423|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
13357422|NCT00896532|26673424|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
13357423|NCT00896532|26673402|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
13357424|NCT00896532|26673403|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
13357425|NCT00896532|26673404|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
13357426|NCT00896532|26673405|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
13357427|NCT00896532|26673406|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
13357428|NCT00896532|26673407|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
13357429|NCT00896532|26673408|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
13357430|NCT00896532|26673409|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
13357431|NCT00896532|26673410|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
13357432|NCT00896532|26673411|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
13357433|NCT00896532|26673412|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
13357434|NCT00896532|26673413|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
13357435|NCT00896532|26673414|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
13357436|NCT00896532|26673415|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
13357437|NCT00896532|26673416|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
13357438|NCT00896532|26673417|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
13357439|NCT00896532|26673418|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
13357440|NCT00896532|26673419|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
13357441|NCT00896532|26673420|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
13357442|NCT00896532|26673421|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
13357443|NCT00896532|26673422|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
13357444|NCT00896532|26673423|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
13357445|NCT00896532|26673424|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
13357446|NCT00896532|26673402|FG000|Months 24-36: Denosumab Extension Phase|Other|0|||
13357447|NCT00896532|26673403|FG001|Months 24-36: Denosumab Extension Phase|Other|0|||
13357448|NCT00896532|26673404|FG002|Months 24-36: Denosumab Extension Phase|Other|0|||
13357449|NCT00896532|26673405|FG003|Months 24-36: Denosumab Extension Phase|Other|0|||
13357450|NCT00896532|26673406|FG004|Months 24-36: Denosumab Extension Phase|Other|0|||
13357451|NCT00896532|26673407|FG005|Months 24-36: Denosumab Extension Phase|Other|0|||
13357452|NCT00896532|26673408|FG006|Months 24-36: Denosumab Extension Phase|Other|0|||
13357453|NCT00896532|26673409|FG007|Months 24-36: Denosumab Extension Phase|Other|0|||
13357454|NCT00896532|26673410|FG008|Months 24-36: Denosumab Extension Phase|Other|0|||
13357455|NCT00896532|26673411|FG009|Months 24-36: Denosumab Extension Phase|Other|0|||
13357456|NCT00896532|26673412|FG010|Months 24-36: Denosumab Extension Phase|Other|1|||
13357457|NCT00896532|26673413|FG011|Months 24-36: Denosumab Extension Phase|Other|2|||
13357458|NCT00896532|26673414|FG012|Months 24-36: Denosumab Extension Phase|Other|2|||
13357459|NCT00896532|26673415|FG013|Months 24-36: Denosumab Extension Phase|Other|1|||
13357460|NCT00896532|26673416|FG014|Months 24-36: Denosumab Extension Phase|Other|0|||
13357461|NCT00896532|26673417|FG015|Months 24-36: Denosumab Extension Phase|Other|0|||
13357462|NCT00896532|26673418|FG016|Months 24-36: Denosumab Extension Phase|Other|0|||
13357463|NCT00896532|26673419|FG017|Months 24-36: Denosumab Extension Phase|Other|0|||
13357464|NCT00896532|26673420|FG018|Months 24-36: Denosumab Extension Phase|Other|0|||
13357465|NCT00896532|26673421|FG019|Months 24-36: Denosumab Extension Phase|Other|0|||
13357466|NCT00896532|26673422|FG020|Months 24-36: Denosumab Extension Phase|Other|0|||
13357467|NCT00896532|26673423|FG021|Months 24-36: Denosumab Extension Phase|Other|0|||
13357468|NCT00896532|26673424|FG022|Months 24-36: Denosumab Extension Phase|Other|0|||
13357469|NCT00896532|26673402|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
13357470|NCT00896532|26673403|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
13357471|NCT00896532|26673404|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
13357472|NCT00896532|26673405|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
13357473|NCT00896532|26673406|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
13357474|NCT00896532|26673407|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
13357475|NCT00896532|26673408|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
13357476|NCT00896532|26673409|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
13357477|NCT00896532|26673410|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
13357478|NCT00896532|26673411|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
13357479|NCT00896532|26673412|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
13357480|NCT00896532|26673413|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
13357481|NCT00896532|26673414|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
13357482|NCT00896532|26673415|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
13357483|NCT00896532|26673416|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
13357484|NCT00896532|26673417|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1|||
13357485|NCT00896532|26673418|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3|||
13357486|NCT00896532|26673419|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
13357487|NCT00896532|26673420|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
13357488|NCT00896532|26673421|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
13357489|NCT00896532|26673422|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
13357490|NCT00896532|26673423|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
13357491|NCT00896532|26673424|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
13357492|NCT00896532|26673402|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
13357493|NCT00896532|26673403|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
13357494|NCT00896532|26673404|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
13357495|NCT00896532|26673405|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
13357496|NCT00896532|26673406|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
13357497|NCT00896532|26673407|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
13357498|NCT00896532|26673408|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
13357499|NCT00896532|26673409|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
13357500|NCT00896532|26673410|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
13357501|NCT00896532|26673411|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
13357502|NCT00896532|26673412|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
13357503|NCT00896532|26673413|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
13357504|NCT00896532|26673414|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
13357505|NCT00896532|26673415|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
13357506|NCT00896532|26673416|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
13357507|NCT00896532|26673417|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1|||
13357508|NCT00896532|26673418|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
13357509|NCT00896532|26673419|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
13357510|NCT00896532|26673420|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
13357511|NCT00896532|26673421|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
13357512|NCT00896532|26673422|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
13357513|NCT00896532|26673423|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
13357514|NCT00896532|26673424|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
13357515|NCT00896532|26673402|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
13357516|NCT00896532|26673403|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
13357517|NCT00896532|26673404|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
13357518|NCT00896532|26673405|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
13357519|NCT00896532|26673406|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
13357520|NCT00896532|26673407|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
13357521|NCT00896532|26673408|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
13357522|NCT00896532|26673409|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
13357523|NCT00896532|26673410|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
13357524|NCT00896532|26673411|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
13357525|NCT00896532|26673412|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
13357526|NCT00896532|26673413|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
13357527|NCT00896532|26673414|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
13357528|NCT00896532|26673415|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
13357529|NCT00896532|26673416|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
13357530|NCT00896532|26673417|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
13357531|NCT00896532|26673418|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1|||
13357532|NCT00896532|26673419|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
13357533|NCT00896532|26673420|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
13357534|NCT00896532|26673421|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
13357535|NCT00896532|26673422|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
13357536|NCT00896532|26673423|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
13357537|NCT00896532|26673424|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
13357538|NCT00896532|26673402|FG000|Months 36-48: Romosozumab Retreatment|Other|0|||
13357539|NCT00896532|26673403|FG001|Months 36-48: Romosozumab Retreatment|Other|0|||
13357540|NCT00896532|26673404|FG002|Months 36-48: Romosozumab Retreatment|Other|0|||
13357541|NCT00896532|26673405|FG003|Months 36-48: Romosozumab Retreatment|Other|0|||
13357542|NCT00896532|26673406|FG004|Months 36-48: Romosozumab Retreatment|Other|0|||
13357543|NCT00896532|26673407|FG005|Months 36-48: Romosozumab Retreatment|Other|0|||
13357544|NCT00896532|26673408|FG006|Months 36-48: Romosozumab Retreatment|Other|0|||
13357545|NCT00896532|26673409|FG007|Months 36-48: Romosozumab Retreatment|Other|0|||
13357546|NCT00896532|26673410|FG008|Months 36-48: Romosozumab Retreatment|Other|0|||
13357547|NCT00896532|26673411|FG009|Months 36-48: Romosozumab Retreatment|Other|0|||
13357548|NCT00896532|26673412|FG010|Months 36-48: Romosozumab Retreatment|Other|0|||
13357549|NCT00896532|26673413|FG011|Months 36-48: Romosozumab Retreatment|Other|0|||
13357550|NCT00896532|26673414|FG012|Months 36-48: Romosozumab Retreatment|Other|0|||
13357551|NCT00896532|26673415|FG013|Months 36-48: Romosozumab Retreatment|Other|0|||
13357552|NCT00896532|26673416|FG014|Months 36-48: Romosozumab Retreatment|Other|0|||
13357553|NCT00896532|26673417|FG015|Months 36-48: Romosozumab Retreatment|Other|0|||
13357554|NCT00896532|26673418|FG016|Months 36-48: Romosozumab Retreatment|Other|0|||
13357555|NCT00896532|26673419|FG017|Months 36-48: Romosozumab Retreatment|Other|1|||
13357556|NCT00896532|26673420|FG018|Months 36-48: Romosozumab Retreatment|Other|0|||
13357557|NCT00896532|26673421|FG019|Months 36-48: Romosozumab Retreatment|Other|0|||
13357558|NCT00896532|26673422|FG020|Months 36-48: Romosozumab Retreatment|Other|0|||
13357559|NCT00896532|26673423|FG021|Months 36-48: Romosozumab Retreatment|Other|0|||
13357560|NCT00896532|26673424|FG022|Months 36-48: Romosozumab Retreatment|Other|0|||
13357561|NCT00896532|26673402|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
13357562|NCT00896532|26673403|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
13357563|NCT00896532|26673404|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
13357564|NCT00896532|26673405|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
13357565|NCT00896532|26673406|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
13357566|NCT00896532|26673407|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
13357567|NCT00896532|26673408|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
13357568|NCT00896532|26673409|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
13357569|NCT00896532|26673410|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
13357570|NCT00896532|26673411|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
13357571|NCT00896532|26673412|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
13357572|NCT00896532|26673413|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
13357573|NCT00896532|26673414|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
13357574|NCT00896532|26673415|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
13357575|NCT00896532|26673416|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
13357576|NCT00896532|26673417|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
13357577|NCT00896532|26673418|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1|||
13357578|NCT00896532|26673419|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
13357579|NCT00896532|26673420|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
13357580|NCT00896532|26673421|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
13357581|NCT00896532|26673422|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
13357582|NCT00896532|26673423|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
13357583|NCT00896532|26673424|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
13357584|NCT00896532|26673402|FG000|Months 48-72: Follow-on Phase|Death|0|||
13357585|NCT00896532|26673403|FG001|Months 48-72: Follow-on Phase|Death|0|||
13357586|NCT00896532|26673404|FG002|Months 48-72: Follow-on Phase|Death|0|||
13357587|NCT00896532|26673405|FG003|Months 48-72: Follow-on Phase|Death|0|||
13357588|NCT00896532|26673406|FG004|Months 48-72: Follow-on Phase|Death|0|||
13357589|NCT00896532|26673407|FG005|Months 48-72: Follow-on Phase|Death|0|||
13357590|NCT00896532|26673408|FG006|Months 48-72: Follow-on Phase|Death|0|||
13357591|NCT00896532|26673409|FG007|Months 48-72: Follow-on Phase|Death|0|||
13357592|NCT00896532|26673410|FG008|Months 48-72: Follow-on Phase|Death|0|||
13357593|NCT00896532|26673411|FG009|Months 48-72: Follow-on Phase|Death|0|||
13357594|NCT00896532|26673412|FG010|Months 48-72: Follow-on Phase|Death|0|||
13357595|NCT00896532|26673413|FG011|Months 48-72: Follow-on Phase|Death|0|||
13357596|NCT00896532|26673414|FG012|Months 48-72: Follow-on Phase|Death|0|||
13357597|NCT00896532|26673415|FG013|Months 48-72: Follow-on Phase|Death|0|||
13357598|NCT00896532|26673416|FG014|Months 48-72: Follow-on Phase|Death|0|||
13357599|NCT00896532|26673417|FG015|Months 48-72: Follow-on Phase|Death|0|||
13357600|NCT00896532|26673418|FG016|Months 48-72: Follow-on Phase|Death|0|||
13357601|NCT00896532|26673419|FG017|Months 48-72: Follow-on Phase|Death|0|||
13357602|NCT00896532|26673420|FG018|Months 48-72: Follow-on Phase|Death|1|||
13357603|NCT00896532|26673421|FG019|Months 48-72: Follow-on Phase|Death|0|||
13357604|NCT00896532|26673422|FG020|Months 48-72: Follow-on Phase|Death|0|||
13357605|NCT00896532|26673423|FG021|Months 48-72: Follow-on Phase|Death|0|||
13357606|NCT00896532|26673424|FG022|Months 48-72: Follow-on Phase|Death|0|||
13357607|NCT00896532|26673402|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
13357608|NCT00896532|26673403|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
13357609|NCT00896532|26673404|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
13357610|NCT00896532|26673405|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
13357611|NCT00896532|26673406|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
13357612|NCT00896532|26673407|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
13357613|NCT00896532|26673408|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
13357614|NCT00896532|26673409|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
13357615|NCT00896532|26673410|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
13357616|NCT00896532|26673411|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
13357617|NCT00896532|26673412|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
13357618|NCT00896532|26673413|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
13357619|NCT00896532|26673414|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
13357620|NCT00896532|26673415|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
13357621|NCT00896532|26673416|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
13357622|NCT00896532|26673417|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
13357623|NCT00896532|26673418|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
13357624|NCT00896532|26673419|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
13357625|NCT00896532|26673420|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
13357626|NCT00896532|26673421|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
13357627|NCT00896532|26673422|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
13357628|NCT00896532|26673423|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1|||
13357629|NCT00896532|26673424|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
13357630|NCT00896532|26673402|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
13357631|NCT00896532|26673403|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
13357632|NCT00896532|26673404|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
13357633|NCT00896532|26673405|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
13357634|NCT00896532|26673406|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
13357635|NCT00896532|26673407|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
13357636|NCT00896532|26673408|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
13357637|NCT00896532|26673409|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
13357638|NCT00896532|26673410|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
13357639|NCT00896532|26673411|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
13357640|NCT00896532|26673412|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
13357641|NCT00896532|26673413|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
13357642|NCT00896532|26673414|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
13357643|NCT00896532|26673415|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
13357644|NCT00896532|26673416|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
13357645|NCT00896532|26673417|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
13357646|NCT00896532|26673418|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
13357647|NCT00896532|26673419|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
13357648|NCT00896532|26673420|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
13357649|NCT00896532|26673421|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
13357650|NCT00896532|26673422|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
13357651|NCT00896532|26673423|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1|||
13357652|NCT00896532|26673424|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
13357653|NCT00896480|26673474|FG000|Overall Study|Disease progression/recurrence|21|||
13357654|NCT00896454|26673488|FG000|Overall Study|Death|10|||
13357655|NCT00896454|26673488|FG000|Overall Study|Adverse Event|8|||
13357656|NCT00896454|26673488|FG000|Overall Study|Disease Progression|5|||
13357657|NCT00896454|26673488|FG000|Overall Study|Other|4|||
13357658|NCT00896454|26673488|FG000|Overall Study|Requirement for alternative therapy|3|||
13357659|NCT00896454|26673488|FG000|Overall Study|Ongoing in study|2|||
13357660|NCT00896454|26673488|FG000|Overall Study|Withdrawal by Subject|1|||
13374525|NCT00795951|26727036|FG000|Overall Study|Withdrawal by Subject|1|||
13374526|NCT00795886|26727044|FG000|Overall Study|Death|10|||
13374527|NCT00795821|26727120|FG000|Acute Treatment Phase|Adverse Event|23|||
13374528|NCT00795821|26727121|FG001|Acute Treatment Phase|Adverse Event|4|||
13374529|NCT00795821|26727120|FG000|Acute Treatment Phase|Death|1|||
13374530|NCT00795821|26727121|FG001|Acute Treatment Phase|Death|0|||
13374531|NCT00795821|26727120|FG000|Acute Treatment Phase|Lack of Efficacy|5|||
13374532|NCT00795821|26727121|FG001|Acute Treatment Phase|Lack of Efficacy|2|||
13374533|NCT00795821|26727120|FG000|Acute Treatment Phase|Lost to Follow-up|9|||
13374534|NCT00795821|26727121|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
13374535|NCT00795821|26727120|FG000|Acute Treatment Phase|Physician Decision|1|||
13374536|NCT00795821|26727121|FG001|Acute Treatment Phase|Physician Decision|1|||
13374537|NCT00795821|26727120|FG000|Acute Treatment Phase|Protocol Violation|1|||
13374538|NCT00795821|26727121|FG001|Acute Treatment Phase|Protocol Violation|2|||
13374539|NCT00795821|26727120|FG000|Acute Treatment Phase|Withdrawal by Subject|16|||
13374540|NCT00795821|26727121|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
13374541|NCT00795821|26727120|FG000|Long-term Extension Phase|Adverse Event|25|||
13374542|NCT00795821|26727121|FG001|Long-term Extension Phase|Adverse Event|32|||
13374543|NCT00795821|26727120|FG000|Long-term Extension Phase|Lack of Efficacy|16|||
13374544|NCT00795821|26727121|FG001|Long-term Extension Phase|Lack of Efficacy|12|||
13374545|NCT00795821|26727120|FG000|Long-term Extension Phase|Lost to Follow-up|20|||
13374546|NCT00795821|26727121|FG001|Long-term Extension Phase|Lost to Follow-up|16|||
13374547|NCT00795821|26727120|FG000|Long-term Extension Phase|Physician Decision|1|||
13374548|NCT00795821|26727121|FG001|Long-term Extension Phase|Physician Decision|2|||
13374549|NCT00795821|26727120|FG000|Long-term Extension Phase|Protocol Violation|3|||
13374550|NCT00795821|26727121|FG001|Long-term Extension Phase|Protocol Violation|5|||
13374551|NCT00795821|26727120|FG000|Long-term Extension Phase|Withdrawal by Subject|25|||
13374552|NCT00795821|26727121|FG001|Long-term Extension Phase|Withdrawal by Subject|25|||
13374553|NCT00795821|26727120|FG000|Taper Phase|Adverse Event|2|||
13374554|NCT00795821|26727121|FG001|Taper Phase|Adverse Event|0|||
13374555|NCT00795821|26727120|FG000|Taper Phase|Lost to Follow-up|1|||
13374556|NCT00795821|26727121|FG001|Taper Phase|Lost to Follow-up|0|||
13374557|NCT00795821|26727120|FG000|Taper Phase|Physician Decision|2|||
13374558|NCT00795821|26727121|FG001|Taper Phase|Physician Decision|0|||
13374559|NCT00795821|26727120|FG000|Taper Phase|Withdrawal by Subject|4|||
13374560|NCT00795821|26727121|FG001|Taper Phase|Withdrawal by Subject|0|||
13374561|NCT00795717|26727138|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1|||
13374562|NCT00795717|26727139|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0|||
13374563|NCT00795717|26727138|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
13374564|NCT00795717|26727139|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
13374565|NCT00795717|26727138|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0|||
13374566|NCT00795717|26727139|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1|||
13374567|NCT00795717|26727138|FG000|Phase II|too busy|0|||
13374568|NCT00795717|26727139|FG001|Phase II|too busy|1|||
13374569|NCT00795704|26727156|FG000|Overall Study|Withdrawal by Subject|3|||
13374570|NCT00795704|26727157|FG001|Overall Study|Withdrawal by Subject|2|||
13374571|NCT00795704|26727156|FG000|Overall Study|Adverse Event|1|||
13374572|NCT00795704|26727157|FG001|Overall Study|Adverse Event|1|||
13374573|NCT00795639|26727174|FG000|Overall Study|Death|1|||
13374574|NCT00795639|26727175|FG001|Overall Study|Death|6|||
13374575|NCT00795639|26727174|FG000|Overall Study|Withdrawal by Subject|1|||
13374576|NCT00795639|26727175|FG001|Overall Study|Withdrawal by Subject|3|||
13374577|NCT00795639|26727174|FG000|Overall Study|Pregnancy|1|||
13374578|NCT00795639|26727175|FG001|Overall Study|Pregnancy|0|||
13374579|NCT00795639|26727174|FG000|Overall Study|Adverse Event|5|||
13374580|NCT00795639|26727175|FG001|Overall Study|Adverse Event|2|||
13374581|NCT00795639|26727174|FG000|Overall Study|Other|0|||
13374582|NCT00795639|26727175|FG001|Overall Study|Other|2|||
13374583|NCT00795639|26727174|FG000|Overall Study|Terminated by sponsor|13|||
13374584|NCT00795639|26727175|FG001|Overall Study|Terminated by sponsor|12|||
13374585|NCT00795639|26727174|FG000|Overall Study|Randomized and not treated|0|||
13374586|NCT00795639|26727175|FG001|Overall Study|Randomized and not treated|1|||
13374587|NCT00795600|26727302|FG000|Overall Study|Adverse Event|1|||
13374588|NCT00795600|26727303|FG001|Overall Study|Adverse Event|1|||
13374589|NCT00795600|26727302|FG000|Overall Study|Protocol Violation|1|||
13374590|NCT00795600|26727303|FG001|Overall Study|Protocol Violation|2|||
13374591|NCT00795600|26727302|FG000|Overall Study|Withdrawal by Subject|1|||
13374592|NCT00795600|26727303|FG001|Overall Study|Withdrawal by Subject|0|||
13374593|NCT00795600|26727302|FG000|Overall Study|Unclassified|1|||
13374594|NCT00795600|26727303|FG001|Overall Study|Unclassified|1|||
13374595|NCT00795535|26727312|FG000|Overall Study|incomplete data and technical problems|20|||
13357661|NCT00896363|26673550|FG000|Overall Study|Adverse Event|3|||
13357662|NCT00896363|26673551|FG001|Overall Study|Adverse Event|4|||
13357663|NCT00896363|26673552|FG002|Overall Study|Adverse Event|2|||
13357664|NCT00896363|26673550|FG000|Overall Study|Lack of Efficacy|0|||
13357665|NCT00896363|26673551|FG001|Overall Study|Lack of Efficacy|2|||
13357666|NCT00896363|26673552|FG002|Overall Study|Lack of Efficacy|1|||
13357667|NCT00896363|26673550|FG000|Overall Study|Withdrawal by Subject|3|||
13357668|NCT00896363|26673551|FG001|Overall Study|Withdrawal by Subject|5|||
13357669|NCT00896363|26673552|FG002|Overall Study|Withdrawal by Subject|5|||
13357670|NCT00896337|26673621|FG000|Overall Study|Death|7|||
13357671|NCT00896337|26673621|FG000|Overall Study|Withdrawal by Subject|7|||
13357672|NCT00896337|26673621|FG000|Overall Study|Lost to Follow-up|11|||
13357673|NCT00896233|26673634|FG000|Overall Study|Claustrophobia during MRI|1|||
13357674|NCT00896168|26673669|FG000|Overall Study|Adverse Event|4|||
13357675|NCT00896168|26673670|FG001|Overall Study|Adverse Event|7|||
13357676|NCT00896168|26673669|FG000|Overall Study|Treatment failure|8|||
13357677|NCT00896168|26673670|FG001|Overall Study|Treatment failure|10|||
13357678|NCT00896168|26673669|FG000|Overall Study|Lost to Follow-up|1|||
13357679|NCT00896168|26673670|FG001|Overall Study|Lost to Follow-up|1|||
13357680|NCT00896168|26673669|FG000|Overall Study|Other|1|||
13357681|NCT00896168|26673670|FG001|Overall Study|Other|1|||
13357682|NCT00896051|26673717|FG000|Overall Study|Adverse Event|2|||
13357683|NCT00896051|26673718|FG001|Overall Study|Adverse Event|1|||
13357684|NCT00896051|26673717|FG000|Overall Study|Lost to Follow-up|3|||
13357685|NCT00896051|26673718|FG001|Overall Study|Lost to Follow-up|2|||
13357686|NCT00896051|26673717|FG000|Overall Study|Withdrawal by Subject|3|||
13357687|NCT00896051|26673718|FG001|Overall Study|Withdrawal by Subject|2|||
13357688|NCT00896051|26673717|FG000|Overall Study|Subject noncompliant|1|||
13357689|NCT00896051|26673718|FG001|Overall Study|Subject noncompliant|3|||
13357690|NCT00896051|26673717|FG000|Overall Study|Other|1|||
13357691|NCT00896051|26673718|FG001|Overall Study|Other|1|||
13357692|NCT00895947|26673741|FG000|Overall Study|Adverse Event|3|||
13357693|NCT00895947|26673742|FG001|Overall Study|Adverse Event|4|||
13357694|NCT00895947|26673741|FG000|Overall Study|Lost to Follow-up|3|||
13357695|NCT00895947|26673742|FG001|Overall Study|Lost to Follow-up|4|||
13357696|NCT00895947|26673741|FG000|Overall Study|Protocol Violation|4|||
13357697|NCT00895947|26673742|FG001|Overall Study|Protocol Violation|2|||
13357698|NCT00895947|26673741|FG000|Overall Study|Withdrawal by Subject|2|||
13357699|NCT00895947|26673742|FG001|Overall Study|Withdrawal by Subject|0|||
13357700|NCT00895895|26673870|FG000|Period 1|Adverse Event|7|||
13357701|NCT00895895|26673871|FG001|Period 1|Adverse Event|6|||
13357702|NCT00895895|26673872|FG002|Period 1|Adverse Event|4|||
13357703|NCT00895895|26673873|FG003|Period 1|Adverse Event|6|||
13357704|NCT00895895|26673874|FG004|Period 1|Adverse Event|7|||
13357705|NCT00895895|26673870|FG000|Period 1|Death|0|||
13357706|NCT00895895|26673871|FG001|Period 1|Death|0|||
13357707|NCT00895895|26673872|FG002|Period 1|Death|0|||
13357708|NCT00895895|26673873|FG003|Period 1|Death|0|||
13357709|NCT00895895|26673874|FG004|Period 1|Death|1|||
13357710|NCT00895895|26673870|FG000|Period 1|discontinued by sponsor|2|||
13357711|NCT00895895|26673871|FG001|Period 1|discontinued by sponsor|1|||
13357712|NCT00895895|26673872|FG002|Period 1|discontinued by sponsor|2|||
13357713|NCT00895895|26673873|FG003|Period 1|discontinued by sponsor|1|||
13357714|NCT00895895|26673874|FG004|Period 1|discontinued by sponsor|1|||
13357715|NCT00895895|26673870|FG000|Period 1|failed to return|0|||
13357716|NCT00895895|26673871|FG001|Period 1|failed to return|0|||
13357717|NCT00895895|26673872|FG002|Period 1|failed to return|1|||
13357718|NCT00895895|26673873|FG003|Period 1|failed to return|0|||
13357719|NCT00895895|26673874|FG004|Period 1|failed to return|1|||
13357720|NCT00895895|26673870|FG000|Period 1|investigator request|0|||
13357721|NCT00895895|26673871|FG001|Period 1|investigator request|1|||
13357722|NCT00895895|26673872|FG002|Period 1|investigator request|0|||
13124904|NCT02937454|25954419|FG000|Overall Study|Lost to Follow-up|1|||
13124905|NCT02937454|25954420|FG001|Overall Study|Lost to Follow-up|1|||
13124906|NCT02937454|25954419|FG000|Overall Study|Physician Decision|0|||
13124907|NCT02937454|25954420|FG001|Overall Study|Physician Decision|1|||
13124908|NCT02937454|25954419|FG000|Overall Study|Protocol Violation|6|||
13124909|NCT02937454|25954420|FG001|Overall Study|Protocol Violation|10|||
13124910|NCT02937454|25954419|FG000|Overall Study|Withdrawal by Subject|27|||
13124911|NCT02937454|25954420|FG001|Overall Study|Withdrawal by Subject|15|||
13124912|NCT02937454|25954419|FG000|Overall Study|Other|8|||
13124913|NCT02937454|25954420|FG001|Overall Study|Other|5|||
13124914|NCT02937350|25954460|FG000|Overall Study|Withdrawal by Subject|0|||
13124915|NCT02937350|25954461|FG001|Overall Study|Withdrawal by Subject|1|||
13124916|NCT02937350|25954462|FG002|Overall Study|Withdrawal by Subject|0|||
13124917|NCT02936869|25954477|FG000|Overall Study|Lost to Follow-up|1|||
13124918|NCT02936869|25954478|FG001|Overall Study|Lost to Follow-up|3|||
13124919|NCT02936869|25954477|FG000|Overall Study|Death|0|||
13357723|NCT00895895|26673873|FG003|Period 1|investigator request|0|||
13357724|NCT00895895|26673874|FG004|Period 1|investigator request|0|||
13357725|NCT00895895|26673870|FG000|Period 1|Lost to Follow-up|2|||
13357726|NCT00895895|26673871|FG001|Period 1|Lost to Follow-up|1|||
13124920|NCT02936869|25954478|FG001|Overall Study|Death|1|||
13124921|NCT02936869|25954477|FG000|Overall Study|Legal Case|0|||
13124922|NCT02936869|25954478|FG001|Overall Study|Legal Case|1|||
13124923|NCT02936869|25954477|FG000|Overall Study|Protocol Violation|1|||
13124924|NCT02936869|25954478|FG001|Overall Study|Protocol Violation|0|||
13124925|NCT02936635|25954499|FG000|Overall Study|Adverse Event|43|||
13124926|NCT02936635|25954500|FG001|Overall Study|Adverse Event|25|||
13124927|NCT02936635|25954499|FG000|Overall Study|Progressive Disease|10|||
13124928|NCT02936635|25954500|FG001|Overall Study|Progressive Disease|18|||
13124929|NCT02936635|25954499|FG000|Overall Study|Sponsor Discretion|10|||
13124930|NCT02936635|25954500|FG001|Overall Study|Sponsor Discretion|16|||
13124931|NCT02936635|25954499|FG000|Overall Study|Death|9|||
13124932|NCT02936635|25954500|FG001|Overall Study|Death|15|||
13124933|NCT02936635|25954499|FG000|Overall Study|Withdrawal by Subject|8|||
13124934|NCT02936635|25954500|FG001|Overall Study|Withdrawal by Subject|15|||
13124935|NCT02936635|25954499|FG000|Overall Study|Physician Decision|2|||
13204441|NCT01972841|26229049|FG001|Overall Study|Adverse Event|8|||
13204442|NCT01972841|26229050|FG002|Overall Study|Adverse Event|12|||
13204443|NCT01972841|26229051|FG003|Overall Study|Adverse Event|9|||
13357727|NCT00895895|26673872|FG002|Period 1|Lost to Follow-up|3|||
13357728|NCT00895895|26673873|FG003|Period 1|Lost to Follow-up|2|||
13357729|NCT00895895|26673874|FG004|Period 1|Lost to Follow-up|3|||
13204444|NCT01972841|26229052|FG004|Overall Study|Adverse Event|21|||
13357730|NCT00895895|26673870|FG000|Period 1|Other|1|||
13357731|NCT00895895|26673871|FG001|Period 1|Other|2|||
13357732|NCT00895895|26673872|FG002|Period 1|Other|1|||
13357733|NCT00895895|26673873|FG003|Period 1|Other|1|||
13357734|NCT00895895|26673874|FG004|Period 1|Other|1|||
13357735|NCT00895895|26673870|FG000|Period 1|Protocol Violation|0|||
13357736|NCT00895895|26673871|FG001|Period 1|Protocol Violation|1|||
13357737|NCT00895895|26673872|FG002|Period 1|Protocol Violation|0|||
13357738|NCT00895895|26673873|FG003|Period 1|Protocol Violation|0|||
13357739|NCT00895895|26673874|FG004|Period 1|Protocol Violation|0|||
13357740|NCT00895895|26673870|FG000|Period 1|Withdrawal by Subject|6|||
13357741|NCT00895895|26673871|FG001|Period 1|Withdrawal by Subject|6|||
13357742|NCT00895895|26673872|FG002|Period 1|Withdrawal by Subject|8|||
13357743|NCT00895895|26673873|FG003|Period 1|Withdrawal by Subject|2|||
13357744|NCT00895895|26673874|FG004|Period 1|Withdrawal by Subject|4|||
13357745|NCT00895895|26673870|FG000|Period 1|unsatisfactory response-efficacy|2|||
13357746|NCT00895895|26673871|FG001|Period 1|unsatisfactory response-efficacy|0|||
13357747|NCT00895895|26673872|FG002|Period 1|unsatisfactory response-efficacy|0|||
13357748|NCT00895895|26673873|FG003|Period 1|unsatisfactory response-efficacy|0|||
13357749|NCT00895895|26673874|FG004|Period 1|unsatisfactory response-efficacy|0|||
13357750|NCT00895895|26673870|FG000|Period 1|randomized and not treated|1|||
13357751|NCT00895895|26673871|FG001|Period 1|randomized and not treated|3|||
13357752|NCT00895895|26673872|FG002|Period 1|randomized and not treated|1|||
13357753|NCT00895895|26673873|FG003|Period 1|randomized and not treated|1|||
13357754|NCT00895895|26673874|FG004|Period 1|randomized and not treated|2|||
13357755|NCT00895895|26673870|FG000|After Period 1, Prior to Period 2|Adverse Event|0|||
13357756|NCT00895895|26673871|FG001|After Period 1, Prior to Period 2|Adverse Event|0|||
13357757|NCT00895895|26673872|FG002|After Period 1, Prior to Period 2|Adverse Event|1|||
13357758|NCT00895895|26673873|FG003|After Period 1, Prior to Period 2|Adverse Event|0|||
13357759|NCT00895895|26673874|FG004|After Period 1, Prior to Period 2|Adverse Event|0|||
13357760|NCT00895895|26673870|FG000|After Period 1, Prior to Period 2|Other|0|||
13357761|NCT00895895|26673871|FG001|After Period 1, Prior to Period 2|Other|0|||
13357762|NCT00895895|26673872|FG002|After Period 1, Prior to Period 2|Other|1|||
13357763|NCT00895895|26673873|FG003|After Period 1, Prior to Period 2|Other|0|||
13357764|NCT00895895|26673874|FG004|After Period 1, Prior to Period 2|Other|0|||
13357765|NCT00895895|26673870|FG000|After Period 1, Prior to Period 2|Protocol Violation|0|||
13357766|NCT00895895|26673871|FG001|After Period 1, Prior to Period 2|Protocol Violation|0|||
13357767|NCT00895895|26673872|FG002|After Period 1, Prior to Period 2|Protocol Violation|0|||
13357768|NCT00895895|26673873|FG003|After Period 1, Prior to Period 2|Protocol Violation|0|||
13357769|NCT00895895|26673874|FG004|After Period 1, Prior to Period 2|Protocol Violation|1|||
13357770|NCT00895895|26673870|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
13357771|NCT00895895|26673871|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
13357772|NCT00895895|26673872|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
13357773|NCT00895895|26673873|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
13357774|NCT00895895|26673874|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1|||
13357775|NCT00895895|26673870|FG000|Period 2|Adverse Event|3|||
13357776|NCT00895895|26673871|FG001|Period 2|Adverse Event|3|||
13357777|NCT00895895|26673872|FG002|Period 2|Adverse Event|5|||
13357778|NCT00895895|26673873|FG003|Period 2|Adverse Event|2|||
13357779|NCT00895895|26673874|FG004|Period 2|Adverse Event|5|||
13357780|NCT00895895|26673870|FG000|Period 2|Death|0|||
13204445|NCT01972841|26229053|FG005|Overall Study|Adverse Event|26|||
13124936|NCT02936635|25954500|FG001|Overall Study|Physician Decision|9|||
13124937|NCT02936635|25954499|FG000|Overall Study|Lost to Follow-up|1|||
13124938|NCT02936635|25954500|FG001|Overall Study|Lost to Follow-up|2|||
13357781|NCT00895895|26673871|FG001|Period 2|Death|0|||
13357782|NCT00895895|26673872|FG002|Period 2|Death|1|||
13357783|NCT00895895|26673873|FG003|Period 2|Death|0|||
13357784|NCT00895895|26673874|FG004|Period 2|Death|0|||
13357785|NCT00895895|26673870|FG000|Period 2|discontinued by sponsor|44|||
13357786|NCT00895895|26673871|FG001|Period 2|discontinued by sponsor|44|||
13357787|NCT00895895|26673872|FG002|Period 2|discontinued by sponsor|38|||
13357788|NCT00895895|26673873|FG003|Period 2|discontinued by sponsor|46|||
13357789|NCT00895895|26673874|FG004|Period 2|discontinued by sponsor|37|||
13357790|NCT00895895|26673870|FG000|Period 2|failed to return|2|||
13357791|NCT00895895|26673871|FG001|Period 2|failed to return|0|||
13357792|NCT00895895|26673872|FG002|Period 2|failed to return|0|||
13357793|NCT00895895|26673873|FG003|Period 2|failed to return|0|||
13357794|NCT00895895|26673874|FG004|Period 2|failed to return|0|||
13357795|NCT00895895|26673870|FG000|Period 2|investigator request|2|||
13357796|NCT00895895|26673871|FG001|Period 2|investigator request|0|||
13357797|NCT00895895|26673872|FG002|Period 2|investigator request|0|||
13357798|NCT00895895|26673873|FG003|Period 2|investigator request|0|||
13357799|NCT00895895|26673874|FG004|Period 2|investigator request|0|||
13357800|NCT00895895|26673870|FG000|Period 2|Lost to Follow-up|1|||
13357801|NCT00895895|26673871|FG001|Period 2|Lost to Follow-up|2|||
13357802|NCT00895895|26673872|FG002|Period 2|Lost to Follow-up|1|||
13357803|NCT00895895|26673873|FG003|Period 2|Lost to Follow-up|1|||
13357804|NCT00895895|26673874|FG004|Period 2|Lost to Follow-up|0|||
13357805|NCT00895895|26673870|FG000|Period 2|Other|1|||
13357806|NCT00895895|26673871|FG001|Period 2|Other|1|||
13357807|NCT00895895|26673872|FG002|Period 2|Other|3|||
13357808|NCT00895895|26673873|FG003|Period 2|Other|1|||
13357809|NCT00895895|26673874|FG004|Period 2|Other|1|||
13357810|NCT00895895|26673870|FG000|Period 2|Protocol Violation|1|||
13357811|NCT00895895|26673871|FG001|Period 2|Protocol Violation|0|||
13357812|NCT00895895|26673872|FG002|Period 2|Protocol Violation|1|||
13357813|NCT00895895|26673873|FG003|Period 2|Protocol Violation|1|||
13357814|NCT00895895|26673874|FG004|Period 2|Protocol Violation|1|||
13357815|NCT00895895|26673870|FG000|Period 2|Withdrawal by Subject|0|||
13357816|NCT00895895|26673871|FG001|Period 2|Withdrawal by Subject|2|||
13357817|NCT00895895|26673872|FG002|Period 2|Withdrawal by Subject|0|||
13357818|NCT00895895|26673873|FG003|Period 2|Withdrawal by Subject|3|||
13357819|NCT00895895|26673874|FG004|Period 2|Withdrawal by Subject|5|||
13357820|NCT00895895|26673870|FG000|Period 2|unsatisfactory response-efficacy|2|||
13357821|NCT00895895|26673871|FG001|Period 2|unsatisfactory response-efficacy|1|||
13357822|NCT00895895|26673872|FG002|Period 2|unsatisfactory response-efficacy|0|||
13357823|NCT00895895|26673873|FG003|Period 2|unsatisfactory response-efficacy|0|||
13357824|NCT00895895|26673874|FG004|Period 2|unsatisfactory response-efficacy|0|||
13357825|NCT00895843|26673887|FG000|Overall Study|Protocol Violation|12|||
13357826|NCT00895843|26673888|FG001|Overall Study|Protocol Violation|12|||
13357827|NCT00895661|26673897|FG000|Overall Study|Death|1|||
13357828|NCT00895661|26673897|FG000|Overall Study|reason unknown|2|||
13357829|NCT00895622|26673940|FG000|Overall Study|Protocol Violation|5|||
13357830|NCT00895622|26673941|FG001|Overall Study|Protocol Violation|4|||
13357831|NCT00895622|26673942|FG002|Overall Study|Protocol Violation|4|||
13357832|NCT00895583|26674027|FG000|Overall Study|Adverse Event|28|||
13357833|NCT00895583|26674028|FG001|Overall Study|Adverse Event|4|||
13357834|NCT00895583|26674027|FG000|Overall Study|Death|2|||
13357835|NCT00895583|26674028|FG001|Overall Study|Death|1|||
13357836|NCT00895583|26674027|FG000|Overall Study|Physician Decision|3|||
13357837|NCT00895583|26674028|FG001|Overall Study|Physician Decision|1|||
13357838|NCT00895583|26674027|FG000|Overall Study|Lost to Follow-up|1|||
13357839|NCT00895583|26674028|FG001|Overall Study|Lost to Follow-up|3|||
13357840|NCT00895583|26674027|FG000|Overall Study|Protocol Violation|1|||
13357841|NCT00895583|26674028|FG001|Overall Study|Protocol Violation|0|||
13357842|NCT00895583|26674027|FG000|Overall Study|Withdrawal by Subject|4|||
13357843|NCT00895583|26674028|FG001|Overall Study|Withdrawal by Subject|2|||
13357844|NCT00895583|26674027|FG000|Overall Study|Lack of Efficacy|5|||
13357845|NCT00895583|26674028|FG001|Overall Study|Lack of Efficacy|0|||
13357846|NCT00895583|26674027|FG000|Overall Study|Other|0|||
13357847|NCT00895583|26674028|FG001|Overall Study|Other|1|||
13357848|NCT00895453|26674046|FG000|Overall Study|Lost to Follow-up|25|||
13357849|NCT00895453|26674047|FG001|Overall Study|Lost to Follow-up|25|||
13357850|NCT00895453|26674048|FG002|Overall Study|Lost to Follow-up|23|||
13357851|NCT00895414|26674061|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
13357852|NCT00895414|26674062|FG001|First Intervention (14 Days)|Withdrawal by Subject|0|||
13357853|NCT00895414|26674061|FG000|First Intervention (14 Days)|Physician Decision|0|||
13357854|NCT00895414|26674062|FG001|First Intervention (14 Days)|Physician Decision|1|||
13357855|NCT00895310|26674071|FG000|Overall Study|Withdrawal by Subject|1|||
13357856|NCT00895245|26674080|FG000|Overall Study|Lack of Efficacy|6|||
13357857|NCT00895154|26674119|FG000|Overall Study|Lost to Follow-up|1|||
13357858|NCT00895154|26674120|FG001|Overall Study|Lost to Follow-up|1|||
13357859|NCT00895154|26674119|FG000|Overall Study|Withdrawal by Subject|0|||
13357860|NCT00895154|26674120|FG001|Overall Study|Withdrawal by Subject|1|||
13357861|NCT00895037|26674158|FG000|Overall Study|Death|0|||
13357862|NCT00895037|26674159|FG001|Overall Study|Death|2|||
13357863|NCT00895037|26674160|FG002|Overall Study|Death|1|||
13357864|NCT00895011|26674184|FG000|Overall Study|Withdrawal by Subject|14|||
13357865|NCT00895011|26674185|FG001|Overall Study|Withdrawal by Subject|7|||
13357866|NCT00895011|26674186|FG002|Overall Study|Withdrawal by Subject|2|||
13357867|NCT00895011|26674184|FG000|Overall Study|Lost to Follow-up|5|||
13357868|NCT00895011|26674185|FG001|Overall Study|Lost to Follow-up|4|||
13357869|NCT00895011|26674186|FG002|Overall Study|Lost to Follow-up|1|||
13357870|NCT00895011|26674184|FG000|Overall Study|Protocol Violation|3|||
13357871|NCT00895011|26674185|FG001|Overall Study|Protocol Violation|1|||
13357872|NCT00895011|26674186|FG002|Overall Study|Protocol Violation|3|||
13357873|NCT00895011|26674184|FG000|Overall Study|Adverse Event|1|||
13357874|NCT00895011|26674185|FG001|Overall Study|Adverse Event|2|||
13357875|NCT00895011|26674186|FG002|Overall Study|Adverse Event|2|||
13357876|NCT00895011|26674184|FG000|Overall Study|schedule conflict|1|||
13357877|NCT00895011|26674185|FG001|Overall Study|schedule conflict|0|||
13357878|NCT00895011|26674186|FG002|Overall Study|schedule conflict|0|||
13357879|NCT00894933|26674204|FG000|Overall Study|Lost to Follow-up|2|||
13357880|NCT00894933|26674204|FG000|Overall Study|Cancelled Procedure|1|||
13357881|NCT00894933|26674204|FG000|Overall Study|Did not meeting incl/excl criteria|1|||
13357882|NCT00894803|26674245|FG000|Overall Study|Death|20|||
13357883|NCT00894803|26674246|FG001|Overall Study|Death|4|||
13357884|NCT00894803|26674245|FG000|Overall Study|Lost to Follow-up|0|||
13357885|NCT00894803|26674246|FG001|Overall Study|Lost to Follow-up|1|||
13357886|NCT00894790|26674275|FG000|Overall Study|Protocol Violation|0|||
13357887|NCT00894790|26674276|FG001|Overall Study|Protocol Violation|1|||
13357888|NCT00894790|26674275|FG000|Overall Study|Lost to Follow-up|0|||
13357889|NCT00894790|26674276|FG001|Overall Study|Lost to Follow-up|1|||
13357890|NCT00894790|26674275|FG000|Overall Study|Did not meet entrance criteria|1|||
13357891|NCT00894790|26674276|FG001|Overall Study|Did not meet entrance criteria|0|||
13357892|NCT00894686|26674300|FG000|Overall Study|Withdrawal by Subject|50|||
13357893|NCT00894686|26674300|FG000|Overall Study|Physician Decision|1|||
13357894|NCT00894686|26674300|FG000|Overall Study|Other|5|||
13357895|NCT00894647|26674317|FG000|Overall Study|Adverse Event|5|||
13357896|NCT00894647|26674318|FG001|Overall Study|Adverse Event|4|||
13357897|NCT00894647|26674317|FG000|Overall Study|Withdrawal by Subject|4|||
13357898|NCT00894647|26674318|FG001|Overall Study|Withdrawal by Subject|4|||
13357899|NCT00894647|26674317|FG000|Overall Study|Lost to Follow-up|0|||
13357900|NCT00894647|26674318|FG001|Overall Study|Lost to Follow-up|2|||
13357901|NCT00894647|26674317|FG000|Overall Study|Non-compliance with study procedures|0|||
13357902|NCT00894647|26674318|FG001|Overall Study|Non-compliance with study procedures|2|||
13357903|NCT00894647|26674317|FG000|Overall Study|Other, not due to AE|1|||
13357904|NCT00894647|26674318|FG001|Overall Study|Other, not due to AE|2|||
13357905|NCT00894556|26674338|FG000|Baseline Phase|Did not meet Randomization Criteria|0|||
13357906|NCT00894556|26674339|FG001|Baseline Phase|Did not meet Randomization Criteria|0|||
13357907|NCT00894556|26674340|FG002|Baseline Phase|Did not meet Randomization Criteria|0|||
13357908|NCT00894556|26674341|FG003|Baseline Phase|Did not meet Randomization Criteria|85|||
13357909|NCT00894556|26674338|FG000|Treatment Phase|Lost to Follow-up|2|||
13357910|NCT00894556|26674339|FG001|Treatment Phase|Lost to Follow-up|3|||
13357911|NCT00894556|26674340|FG002|Treatment Phase|Lost to Follow-up|1|||
13357912|NCT00894556|26674341|FG003|Treatment Phase|Lost to Follow-up|0|||
13357913|NCT00894556|26674338|FG000|Treatment Phase|Lack of Qualifying Event|2|||
13357914|NCT00894556|26674339|FG001|Treatment Phase|Lack of Qualifying Event|1|||
13357915|NCT00894556|26674340|FG002|Treatment Phase|Lack of Qualifying Event|0|||
13357916|NCT00894556|26674341|FG003|Treatment Phase|Lack of Qualifying Event|0|||
13357917|NCT00894543|26674370|FG000|Baseline to Week 4|No diary or lost or withdrew|3|||
13357918|NCT00894543|26674371|FG001|Baseline to Week 4|No diary or lost or withdrew|2|||
13357919|NCT00894543|26674370|FG000|Week 4 to Week 8|No diary or lost or withdrew|4|||
13357920|NCT00894543|26674371|FG001|Week 4 to Week 8|No diary or lost or withdrew|2|||
13357921|NCT00894413|26674384|FG000|Overall Study|Physician Decision|0|||
13357922|NCT00894413|26674385|FG001|Overall Study|Physician Decision|2|||
13357923|NCT00894413|26674384|FG000|Overall Study|Adverse Event|0|||
13357924|NCT00894413|26674385|FG001|Overall Study|Adverse Event|2|||
13357925|NCT00894413|26674384|FG000|Overall Study|Withdrawal by Subject|0|||
13357926|NCT00894413|26674385|FG001|Overall Study|Withdrawal by Subject|4|||
13357927|NCT00894387|26674410|FG000|Overall Study|Adverse Event|44|||
13357928|NCT00894387|26674411|FG001|Overall Study|Adverse Event|45|||
13357929|NCT00894387|26674410|FG000|Overall Study|Abnormal Laboratory values|2|||
13357930|NCT00894387|26674411|FG001|Overall Study|Abnormal Laboratory values|2|||
13357931|NCT00894387|26674410|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
13357932|NCT00894387|26674411|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
13357933|NCT00894387|26674410|FG000|Overall Study|Lost to Follow-up|3|||
13357934|NCT00894387|26674411|FG001|Overall Study|Lost to Follow-up|5|||
13357935|NCT00894387|26674410|FG000|Overall Study|Administrative problems|2|||
13357936|NCT00894387|26674411|FG001|Overall Study|Administrative problems|2|||
13357937|NCT00894387|26674410|FG000|Overall Study|Death|77|||
13357938|NCT00894387|26674411|FG001|Overall Study|Death|76|||
13357939|NCT00894387|26674410|FG000|Overall Study|Protocol Deviation|4|||
13357940|NCT00894387|26674411|FG001|Overall Study|Protocol Deviation|0|||
13357941|NCT00894387|26674410|FG000|Overall Study|Patient's request|25|||
13357942|NCT00894387|26674411|FG001|Overall Study|Patient's request|30|||
13357943|NCT00894387|26674410|FG000|Overall Study|Other (Missing)|5|||
13357944|NCT00894387|26674411|FG001|Overall Study|Other (Missing)|3|||
13357945|NCT00894387|26674410|FG000|Overall Study|Mis-randomized|13|||
13357946|NCT00894387|26674411|FG001|Overall Study|Mis-randomized|9|||
13357947|NCT00894387|26674410|FG000|Overall Study|GCP non-compliance|0|||
13357948|NCT00894387|26674411|FG001|Overall Study|GCP non-compliance|2|||
13357949|NCT00894361|26674426|FG000|Overall Study|deaths and less than 2 years followup|24|||
13357950|NCT00894361|26674427|FG001|Overall Study|deaths and less than 2 years followup|64|||
13357951|NCT00894322|26674476|FG000|Overall Study|Withdrawal by Subject|1|||
13357952|NCT00894322|26674477|FG001|Overall Study|Withdrawal by Subject|0|||
13357953|NCT00894322|26674478|FG002|Overall Study|Withdrawal by Subject|0|||
13357954|NCT00894166|26674533|FG000|Overall Study|Withdrew or Lost to Follow-Up|61|||
13357955|NCT00894166|26674534|FG001|Overall Study|Withdrew or Lost to Follow-Up|63|||
13357956|NCT00894166|26674535|FG002|Overall Study|Withdrew or Lost to Follow-Up|62|||
13357957|NCT00894166|26674536|FG003|Overall Study|Withdrew or Lost to Follow-Up|68|||
13357958|NCT00894166|26674537|FG004|Overall Study|Withdrew or Lost to Follow-Up|24|||
13357959|NCT00894166|26674538|FG005|Overall Study|Withdrew or Lost to Follow-Up|16|||
13357960|NCT00894166|26674539|FG006|Overall Study|Withdrew or Lost to Follow-Up|16|||
13357961|NCT00894166|26674540|FG007|Overall Study|Withdrew or Lost to Follow-Up|34|||
13357962|NCT00894166|26674533|FG000|Overall Study|Death|0|||
13357963|NCT00894166|26674534|FG001|Overall Study|Death|0|||
13357964|NCT00894166|26674535|FG002|Overall Study|Death|0|||
13357965|NCT00894166|26674536|FG003|Overall Study|Death|1|||
13357966|NCT00894166|26674537|FG004|Overall Study|Death|0|||
13357967|NCT00894166|26674538|FG005|Overall Study|Death|0|||
13357968|NCT00894166|26674539|FG006|Overall Study|Death|0|||
13357969|NCT00894166|26674540|FG007|Overall Study|Death|0|||
13357970|NCT00893971|26674656|FG000|Overall Study|Physician Decision|3|||
13357971|NCT00893763|26674671|FG000|Overall Study|extubated|110|||
13357972|NCT00893763|26674672|FG001|Overall Study|extubated|110|||
13357973|NCT00893737|26674680|FG000|Overall Study|Adverse Event|4|||
13357974|NCT00893737|26674680|FG000|Overall Study|Withdrawal by Subject|2|||
13357975|NCT00893737|26674680|FG000|Overall Study|Lost to Follow-up|6|||
13357976|NCT00893464|26674821|FG000|Overall Study|Did not complete therapy/experience PD|0|||
13357977|NCT00893464|26674822|FG001|Overall Study|Did not complete therapy/experience PD|0|||
13357978|NCT00893464|26674823|FG002|Overall Study|Did not complete therapy/experience PD|0|||
13357979|NCT00893464|26674824|FG003|Overall Study|Did not complete therapy/experience PD|0|||
13357980|NCT00893464|26674825|FG004|Overall Study|Did not complete therapy/experience PD|0|||
13357981|NCT00893464|26674826|FG005|Overall Study|Did not complete therapy/experience PD|0|||
13357982|NCT00893464|26674827|FG006|Overall Study|Did not complete therapy/experience PD|2|||
13357983|NCT00893464|26674828|FG007|Overall Study|Did not complete therapy/experience PD|2|||
13357984|NCT00893113|26674845|FG000|Overall Study|Lost to Follow-up|4|||
13357985|NCT00893113|26674846|FG001|Overall Study|Lost to Follow-up|8|||
13357986|NCT00893113|26674845|FG000|Overall Study|Early Termination|1|||
13357987|NCT00893113|26674846|FG001|Overall Study|Early Termination|1|||
13357988|NCT00893113|26674845|FG000|Overall Study|Withdrew Consent|8|||
13357989|NCT00893113|26674846|FG001|Overall Study|Withdrew Consent|7|||
13357990|NCT00892957|26674939|FG000|Between Postoperative Day 1 and Day 14|Death|0|||
13357991|NCT00892957|26674940|FG001|Between Postoperative Day 1 and Day 14|Death|2|||
13357992|NCT00892957|26674939|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0|||
13357993|NCT00892957|26674940|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2|||
13357994|NCT00892775|26674971|FG000|Overall Study|Protocol Violation|1|||
13357995|NCT00892775|26674972|FG001|Overall Study|Protocol Violation|0|||
13357996|NCT00892775|26674971|FG000|Overall Study|Subject difficulties with blood drawing|1|||
13357997|NCT00892775|26674972|FG001|Overall Study|Subject difficulties with blood drawing|0|||
13357998|NCT00892775|26674971|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1|||
13357999|NCT00892775|26674972|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0|||
13358000|NCT00892775|26674971|FG000|Overall Study|Migrated/ moved from study area|1|||
13358001|NCT00892775|26674972|FG001|Overall Study|Migrated/ moved from study area|0|||
13358002|NCT00892775|26674971|FG000|Overall Study|Withdrawal by Subject|0|||
13358003|NCT00892775|26674972|FG001|Overall Study|Withdrawal by Subject|1|||
13358004|NCT00892775|26674971|FG000|Overall Study|Lost to Follow-up|1|||
13358005|NCT00892775|26674972|FG001|Overall Study|Lost to Follow-up|0|||
13358006|NCT00892723|26675023|FG000|Overall Study|Lost to Follow-up|1|||
13358007|NCT00892723|26675024|FG001|Overall Study|Lost to Follow-up|3|||
13358008|NCT00892723|26675025|FG002|Overall Study|Lost to Follow-up|1|||
13358009|NCT00892723|26675023|FG000|Overall Study|Withdrawal by Subject|1|||
13358010|NCT00892723|26675024|FG001|Overall Study|Withdrawal by Subject|1|||
13358011|NCT00892723|26675025|FG002|Overall Study|Withdrawal by Subject|1|||
13358012|NCT00892437|26675049|FG000|Randomized Phase|Randomized but not treated|6|||
13358013|NCT00892437|26675050|FG001|Randomized Phase|Randomized but not treated|0|||
13358014|NCT00892437|26675049|FG000|Randomized Phase|Adverse Event|2|||
13358015|NCT00892437|26675050|FG001|Randomized Phase|Adverse Event|2|||
13358016|NCT00892437|26675049|FG000|Randomized Phase|Lost to Follow-up|1|||
13358017|NCT00892437|26675050|FG001|Randomized Phase|Lost to Follow-up|3|||
13358018|NCT00892437|26675049|FG000|Randomized Phase|Investigator's Discretion|1|||
13358019|NCT00892437|26675050|FG001|Randomized Phase|Investigator's Discretion|0|||
13358020|NCT00892437|26675049|FG000|Randomized Phase|Withdrew Consent|1|||
13358021|NCT00892437|26675050|FG001|Randomized Phase|Withdrew Consent|0|||
13358022|NCT00892437|26675049|FG000|Open-Label Extension Phase|Adverse Event|4|||
13358023|NCT00892437|26675050|FG001|Open-Label Extension Phase|Adverse Event|2|||
13358024|NCT00892437|26675049|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
13358025|NCT00892437|26675050|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
13358026|NCT00892437|26675049|FG000|Open-Label Extension Phase|Lost to Follow-up|3|||
13358027|NCT00892437|26675050|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
13358028|NCT00892437|26675049|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
13358029|NCT00892437|26675050|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
13358030|NCT00892437|26675049|FG000|Open-Label Extension Phase|Withdrew Consent|3|||
13358031|NCT00892437|26675050|FG001|Open-Label Extension Phase|Withdrew Consent|1|||
13358032|NCT00892281|26675067|FG000|Overall Study|Adverse Event|65|||
13358033|NCT00892281|26675068|FG001|Overall Study|Adverse Event|8|||
13358034|NCT00892281|26675067|FG000|Overall Study|Lost to Follow-up|81|||
13358035|NCT00892281|26675068|FG001|Overall Study|Lost to Follow-up|8|||
13358036|NCT00892281|26675067|FG000|Overall Study|Pregnancy|1|||
13358037|NCT00892281|26675068|FG001|Overall Study|Pregnancy|0|||
13358038|NCT00892281|26675067|FG000|Overall Study|Protocol Violation|7|||
13358039|NCT00892281|26675068|FG001|Overall Study|Protocol Violation|2|||
13358040|NCT00892281|26675067|FG000|Overall Study|Withdrawal by Subject|86|||
13358041|NCT00892281|26675068|FG001|Overall Study|Withdrawal by Subject|14|||
13358042|NCT00892281|26675067|FG000|Overall Study|Subject failed to return for final visit|2|||
13358043|NCT00892281|26675068|FG001|Overall Study|Subject failed to return for final visit|0|||
13358044|NCT00892281|26675067|FG000|Overall Study|Subject unable to keep follow-up visits|1|||
13358045|NCT00892281|26675068|FG001|Overall Study|Subject unable to keep follow-up visits|0|||
13358046|NCT00892281|26675067|FG000|Overall Study|Final visit completed 4 weeks late|0|||
13358047|NCT00892281|26675068|FG001|Overall Study|Final visit completed 4 weeks late|1|||
13358048|NCT00892281|26675067|FG000|Overall Study|Subject completed day after study closed|1|||
13358049|NCT00892281|26675068|FG001|Overall Study|Subject completed day after study closed|0|||
13358050|NCT00892281|26675067|FG000|Overall Study|Family emergency|1|||
13358051|NCT00892281|26675068|FG001|Overall Study|Family emergency|0|||
13358052|NCT00892281|26675067|FG000|Overall Study|Last visit not done - death in family|1|||
13358053|NCT00892281|26675068|FG001|Overall Study|Last visit not done - death in family|0|||
13358054|NCT00892281|26675067|FG000|Overall Study|Did not meet incl/excl criteria|1|||
13358055|NCT00892281|26675068|FG001|Overall Study|Did not meet incl/excl criteria|0|||
13358056|NCT00892281|26675067|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1|||
13358057|NCT00892281|26675068|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0|||
13358058|NCT00892281|26675067|FG000|Overall Study|Unable to redeem the drug voucher|1|||
13358059|NCT00892281|26675068|FG001|Overall Study|Unable to redeem the drug voucher|0|||
13358060|NCT00892281|26675067|FG000|Overall Study|Subject not good candidate for study|1|||
13358061|NCT00892281|26675068|FG001|Overall Study|Subject not good candidate for study|0|||
13358062|NCT00892281|26675067|FG000|Overall Study|Subject did not return for any visits|1|||
13358063|NCT00892281|26675068|FG001|Overall Study|Subject did not return for any visits|0|||
13358064|NCT00892281|26675067|FG000|Overall Study|Subject missed several visits/lost meds|1|||
13358065|NCT00892281|26675068|FG001|Overall Study|Subject missed several visits/lost meds|0|||
13358066|NCT00892281|26675067|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
13358067|NCT00892281|26675068|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
13358068|NCT00892281|26675067|FG000|Overall Study|Scheduled for knee replacement|0|||
13358069|NCT00892281|26675068|FG001|Overall Study|Scheduled for knee replacement|1|||
13358070|NCT00892281|26675067|FG000|Overall Study|PI complained of inadequate compensation|3|||
13358071|NCT00892281|26675068|FG001|Overall Study|PI complained of inadequate compensation|0|||
13358072|NCT00892281|26675067|FG000|Overall Study|Subject lost interest in program|0|||
13358073|NCT00892281|26675068|FG001|Overall Study|Subject lost interest in program|1|||
13358074|NCT00892281|26675067|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0|||
13358075|NCT00892281|26675068|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1|||
13358076|NCT00892281|26675067|FG000|Overall Study|Death in family|1|||
13358077|NCT00892281|26675068|FG001|Overall Study|Death in family|0|||
13358078|NCT00892281|26675067|FG000|Overall Study|Lack of efficacy of study product|2|||
13358079|NCT00892281|26675068|FG001|Overall Study|Lack of efficacy of study product|0|||
13358080|NCT00892281|26675067|FG000|Overall Study|Subject not seen by PI at final visit|1|||
13358081|NCT00892281|26675068|FG001|Overall Study|Subject not seen by PI at final visit|0|||
13358082|NCT00892281|26675067|FG000|Overall Study|No show Visit 2; prescription not filled|1|||
13358083|NCT00892281|26675068|FG001|Overall Study|No show Visit 2; prescription not filled|0|||
13358084|NCT00892281|26675067|FG000|Overall Study|Missed multiple visits|1|||
13358085|NCT00892281|26675068|FG001|Overall Study|Missed multiple visits|0|||
13358086|NCT00892281|26675067|FG000|Overall Study|Missed visits rescheduled out of window|1|||
13358087|NCT00892281|26675068|FG001|Overall Study|Missed visits rescheduled out of window|0|||
13358088|NCT00892281|26675067|FG000|Overall Study|Non-compliant with visits as scheduled|1|||
13358089|NCT00892281|26675068|FG001|Overall Study|Non-compliant with visits as scheduled|0|||
13358090|NCT00892281|26675067|FG000|Overall Study|Subject had history of drug abuse|1|||
13358091|NCT00892281|26675068|FG001|Overall Study|Subject had history of drug abuse|0|||
13358092|NCT00892281|26675067|FG000|Overall Study|Rash on hand|1|||
13358093|NCT00892281|26675068|FG001|Overall Study|Rash on hand|0|||
13358094|NCT00892281|26675067|FG000|Overall Study|Visit 4 date out of window|1|||
13358095|NCT00892281|26675068|FG001|Overall Study|Visit 4 date out of window|0|||
13358096|NCT00892177|26675106|FG000|Phase II|Ineligible|0|||
13358097|NCT00892177|26675107|FG001|Phase II|Ineligible|0|||
13358098|NCT00892177|26675108|FG002|Phase II|Ineligible|0|||
13358099|NCT00892177|26675109|FG003|Phase II|Ineligible|0|||
13358100|NCT00892177|26675110|FG004|Phase II|Ineligible|1|||
13358101|NCT00892177|26675111|FG005|Phase II|Ineligible|1|||
13358102|NCT00892177|26675106|FG000|Phase II|Withdrawal by Subject|0|||
13358103|NCT00892177|26675107|FG001|Phase II|Withdrawal by Subject|0|||
13358104|NCT00892177|26675108|FG002|Phase II|Withdrawal by Subject|0|||
13358105|NCT00892177|26675109|FG003|Phase II|Withdrawal by Subject|0|||
13358106|NCT00892177|26675110|FG004|Phase II|Withdrawal by Subject|4|||
13358107|NCT00892177|26675111|FG005|Phase II|Withdrawal by Subject|1|||
13358108|NCT00892151|26675119|FG000|Overall Study|Protocol Violation|1|||
13358109|NCT00892099|26675152|FG000|Overall Study|Death|1|||
13358110|NCT00892099|26675153|FG001|Overall Study|Death|0|||
13358111|NCT00892099|26675154|FG002|Overall Study|Death|1|||
13358112|NCT00892099|26675152|FG000|Overall Study|Adverse Event|1|||
13358113|NCT00892099|26675153|FG001|Overall Study|Adverse Event|0|||
13358114|NCT00892099|26675154|FG002|Overall Study|Adverse Event|0|||
13358115|NCT00892099|26675152|FG000|Overall Study|replocated|1|||
13358116|NCT00892099|26675153|FG001|Overall Study|replocated|0|||
13358117|NCT00892099|26675154|FG002|Overall Study|replocated|2|||
13358118|NCT00892099|26675152|FG000|Overall Study|Prolonged hospitalization|1|||
13358119|NCT00892099|26675153|FG001|Overall Study|Prolonged hospitalization|0|||
13358120|NCT00892099|26675154|FG002|Overall Study|Prolonged hospitalization|1|||
13358121|NCT00892099|26675152|FG000|Overall Study|no further details|1|||
13358122|NCT00892099|26675153|FG001|Overall Study|no further details|0|||
13358123|NCT00892099|26675154|FG002|Overall Study|no further details|1|||
13358124|NCT00892099|26675152|FG000|Overall Study|kidney function recovered|0|||
13358125|NCT00892099|26675153|FG001|Overall Study|kidney function recovered|1|||
13358126|NCT00892099|26675154|FG002|Overall Study|kidney function recovered|0|||
13358127|NCT00892099|26675152|FG000|Overall Study|investigator decision|0|||
13358128|NCT00892099|26675153|FG001|Overall Study|investigator decision|0|||
13358129|NCT00892099|26675154|FG002|Overall Study|investigator decision|1|||
13358130|NCT00892099|26675152|FG000|Overall Study|Lost to Follow-up|0|||
13358131|NCT00892099|26675153|FG001|Overall Study|Lost to Follow-up|0|||
13358132|NCT00892099|26675154|FG002|Overall Study|Lost to Follow-up|1|||
13358133|NCT00892047|26675177|FG000|Overall Study|Adverse Event|2|||
13358134|NCT00892047|26675178|FG001|Overall Study|Adverse Event|2|||
13358135|NCT00892047|26675177|FG000|Overall Study|subject burden|2|||
13358136|NCT00892047|26675178|FG001|Overall Study|subject burden|3|||
13358137|NCT00892047|26675177|FG000|Overall Study|Lack of Efficacy|0|||
13358138|NCT00892047|26675178|FG001|Overall Study|Lack of Efficacy|2|||
13358139|NCT00892008|26675194|FG000|Overall Study|Death|5|||
13358140|NCT00892008|26675194|FG000|Overall Study|Lack of Efficacy|3|||
13358141|NCT00892008|26675194|FG000|Overall Study|Lost to Follow-up|142|||
13358142|NCT00892008|26675194|FG000|Overall Study|Other|378|||
13358143|NCT00892008|26675194|FG000|Overall Study|Adverse Event|37|||
13358144|NCT00891930|26675217|FG000|Part 1: Panitumumab +Irinotecan|Death|38|||
13358145|NCT00891930|26675217|FG000|Part 1: Panitumumab +Irinotecan|Withdrawal by Subject|1|||
13358146|NCT00891930|26675217|FG000|Part 1: Panitumumab +Irinotecan|Lost to Follow-up|1|||
13358147|NCT00891930|26675217|FG000|Part 2: Panitumumab + Ganitumab|Death|30|||
13358148|NCT00891930|26675217|FG000|Part 2: Panitumumab + Ganitumab|Withdrawal by Subject|1|||
13358149|NCT00891904|26675226|FG000|Overall Study|Death|1|||
13358150|NCT00891904|26675226|FG000|Overall Study|Adverse Event|1|||
13358151|NCT00891839|26675237|FG000|Overall Study|Adverse Event|2|||
13358152|NCT00891839|26675237|FG000|Overall Study|Withdrawal by Subject|2|||
13358153|NCT00891839|26675237|FG000|Overall Study|Disease progression|3|||
13358154|NCT00891813|26675245|FG000|Overall Study|Adverse Event|3|||
13358155|NCT00891813|26675245|FG000|Overall Study|Withdrawal by Subject|1|||
13358156|NCT00891813|26675245|FG000|Overall Study|Patient Noncompliance|6|||
13358157|NCT00891813|26675245|FG000|Overall Study|Protocol Violation|2|||
13358158|NCT00891774|26675254|FG000|Overall Study|Lost to Follow-up|5|||
13358159|NCT00891774|26675254|FG000|Overall Study|Illness (Self/Mother)|3|||
13358160|NCT00891774|26675254|FG000|Overall Study|Withdrawal by Subject|2|||
13358161|NCT00891774|26675254|FG000|Overall Study|Protocol Violation|4|||
13358162|NCT00891735|26675305|FG000|Overall Study|Adverse Event|2|||
13358163|NCT00891735|26675306|FG001|Overall Study|Adverse Event|0|||
13358164|NCT00891735|26675307|FG002|Overall Study|Adverse Event|2|||
13358165|NCT00891735|26675308|FG003|Overall Study|Adverse Event|0|||
13358166|NCT00891735|26675305|FG000|Overall Study|Death|8|||
13358167|NCT00891735|26675306|FG001|Overall Study|Death|5|||
13358168|NCT00891735|26675307|FG002|Overall Study|Death|4|||
13358169|NCT00891735|26675308|FG003|Overall Study|Death|5|||
13358170|NCT00891735|26675305|FG000|Overall Study|Lost to Follow-up|2|||
13358171|NCT00891735|26675306|FG001|Overall Study|Lost to Follow-up|2|||
13358172|NCT00891735|26675307|FG002|Overall Study|Lost to Follow-up|2|||
13358173|NCT00891735|26675308|FG003|Overall Study|Lost to Follow-up|2|||
13358174|NCT00891735|26675305|FG000|Overall Study|Physician's decision to withdraw patient|1|||
13358175|NCT00891735|26675306|FG001|Overall Study|Physician's decision to withdraw patient|0|||
13358176|NCT00891735|26675307|FG002|Overall Study|Physician's decision to withdraw patient|0|||
13358177|NCT00891735|26675308|FG003|Overall Study|Physician's decision to withdraw patient|0|||
13358178|NCT00891735|26675305|FG000|Overall Study|Patient's decision to withdraw|4|||
13358179|NCT00891735|26675306|FG001|Overall Study|Patient's decision to withdraw|9|||
13358180|NCT00891735|26675307|FG002|Overall Study|Patient's decision to withdraw|4|||
13358181|NCT00891735|26675308|FG003|Overall Study|Patient's decision to withdraw|8|||
13358182|NCT00891657|26675327|FG000|Overall Study|Withdrawal by Subject|1|||
13358183|NCT00891657|26675328|FG001|Overall Study|Withdrawal by Subject|1|||
13358184|NCT00891618|26675334|FG000|Overall Study|Withdrawal by Subject|1|||
13358185|NCT00891527|26675342|FG000|Overall Study|Withdrawal by Subject|2|||
13358186|NCT00891462|26675363|FG000|Overall Study|Withdrawal by Subject|9|||
13358187|NCT00891462|26675364|FG001|Overall Study|Withdrawal by Subject|6|||
13358188|NCT00891462|26675365|FG002|Overall Study|Withdrawal by Subject|7|||
13358189|NCT00891462|26675363|FG000|Overall Study|Adverse Event|7|||
13358190|NCT00891462|26675364|FG001|Overall Study|Adverse Event|8|||
13358191|NCT00891462|26675365|FG002|Overall Study|Adverse Event|7|||
13358192|NCT00891462|26675363|FG000|Overall Study|Lack of Efficacy|10|||
13358193|NCT00891462|26675364|FG001|Overall Study|Lack of Efficacy|5|||
13358194|NCT00891462|26675365|FG002|Overall Study|Lack of Efficacy|1|||
13358195|NCT00891462|26675363|FG000|Overall Study|COPD exacerbation|7|||
13358196|NCT00891462|26675364|FG001|Overall Study|COPD exacerbation|4|||
13358197|NCT00891462|26675365|FG002|Overall Study|COPD exacerbation|1|||
13358198|NCT00891462|26675363|FG000|Overall Study|Other Reason|2|||
13358199|NCT00891462|26675364|FG001|Overall Study|Other Reason|5|||
13358200|NCT00891462|26675365|FG002|Overall Study|Other Reason|3|||
13358201|NCT00891462|26675363|FG000|Overall Study|Protocol Violation|2|||
13358202|NCT00891462|26675364|FG001|Overall Study|Protocol Violation|1|||
13358203|NCT00891462|26675365|FG002|Overall Study|Protocol Violation|3|||
13358204|NCT00891462|26675363|FG000|Overall Study|Inclusion/exclusion criteria|0|||
13358205|NCT00891462|26675364|FG001|Overall Study|Inclusion/exclusion criteria|2|||
13358206|NCT00891462|26675365|FG002|Overall Study|Inclusion/exclusion criteria|2|||
13358207|NCT00891462|26675363|FG000|Overall Study|Lost to Follow-up|0|||
13358208|NCT00891462|26675364|FG001|Overall Study|Lost to Follow-up|2|||
13358209|NCT00891462|26675365|FG002|Overall Study|Lost to Follow-up|0|||
13358210|NCT00891371|26675376|FG000|Pre-assignment|Inclusion/exclusion|5|||
13358211|NCT00891371|26675376|FG000|Pre-assignment|Consent withdrawal|1|||
13358212|NCT00891371|26675376|FG000|Treatment|Lack of Efficacy|5|||
13358213|NCT00891371|26675376|FG000|Treatment|Adverse Event|2|||
13358214|NCT00891371|26675376|FG000|Treatment|Death|1|||
13358215|NCT00891371|26675376|FG000|Treatment|Lost to Follow-up|1|||
13358216|NCT00891293|26675390|FG000|Overall Study|Adverse Event|2|||
13358217|NCT00891293|26675390|FG000|Overall Study|Protocol Violation|2|||
13358218|NCT00891293|26675390|FG000|Overall Study|Laboratory abnormality|4|||
13358219|NCT00891293|26675390|FG000|Overall Study|Lost to Follow-up|7|||
13358220|NCT00891293|26675390|FG000|Overall Study|Subject withdrew consent|7|||
13358221|NCT00891293|26675390|FG000|Overall Study|Sponsor termination|62|||
13358222|NCT00891228|26675420|FG000|Overall Study|Adverse Event|0|||
13358223|NCT00891228|26675421|FG001|Overall Study|Adverse Event|2|||
13358224|NCT00891228|26675422|FG002|Overall Study|Adverse Event|3|||
13358225|NCT00891228|26675420|FG000|Overall Study|Withdrawal by Subject|2|||
13358226|NCT00891228|26675421|FG001|Overall Study|Withdrawal by Subject|4|||
13358227|NCT00891228|26675422|FG002|Overall Study|Withdrawal by Subject|5|||
13358228|NCT00891228|26675420|FG000|Overall Study|Protocol Violation|3|||
13358229|NCT00891228|26675421|FG001|Overall Study|Protocol Violation|1|||
13358230|NCT00891228|26675422|FG002|Overall Study|Protocol Violation|2|||
13358231|NCT00891228|26675420|FG000|Overall Study|Physician Decision|2|||
13358232|NCT00891228|26675421|FG001|Overall Study|Physician Decision|1|||
13358233|NCT00891228|26675422|FG002|Overall Study|Physician Decision|0|||
13358234|NCT00891228|26675420|FG000|Overall Study|Lost to Follow-up|4|||
13358235|NCT00891228|26675421|FG001|Overall Study|Lost to Follow-up|4|||
13358236|NCT00891228|26675422|FG002|Overall Study|Lost to Follow-up|5|||
13358237|NCT00891228|26675420|FG000|Overall Study|Pregnancy|0|||
13358238|NCT00891228|26675421|FG001|Overall Study|Pregnancy|1|||
13358239|NCT00891228|26675422|FG002|Overall Study|Pregnancy|0|||
13358240|NCT00891202|26675453|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1|||
13358241|NCT00891202|26675454|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0|||
13358242|NCT00891202|26675455|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0|||
13358243|NCT00891202|26675456|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0|||
13358244|NCT00891202|26675453|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
13358245|NCT00891202|26675454|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
13358246|NCT00891202|26675455|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4|||
13358247|NCT00891202|26675456|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
13358248|NCT00891202|26675453|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
13358249|NCT00891202|26675454|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
13358250|NCT00891202|26675455|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1|||
13358251|NCT00891202|26675456|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
13358252|NCT00891202|26675453|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
13358253|NCT00891202|26675454|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
13358254|NCT00891202|26675455|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2|||
13358255|NCT00891202|26675456|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5|||
13358256|NCT00891046|26675545|FG000|Overall Study|Protocol Violation|1|||
13358257|NCT00891046|26675546|FG001|Overall Study|Protocol Violation|1|||
13358258|NCT00891046|26675547|FG002|Overall Study|Protocol Violation|0|||
13358259|NCT00891046|26675548|FG003|Overall Study|Protocol Violation|0|||
13358260|NCT00891046|26675549|FG004|Overall Study|Protocol Violation|1|||
13358261|NCT00891046|26675545|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
13358262|NCT00891046|26675546|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
13358263|NCT00891046|26675547|FG002|Overall Study|Unsatisfactory therapeutic effect|19|||
13358264|NCT00891046|26675548|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
13358265|NCT00891046|26675549|FG004|Overall Study|Unsatisfactory therapeutic effect|20|||
13358266|NCT00891046|26675545|FG000|Overall Study|Administrative problems|0|||
13358267|NCT00891046|26675546|FG001|Overall Study|Administrative problems|0|||
13358268|NCT00891046|26675547|FG002|Overall Study|Administrative problems|0|||
13358269|NCT00891046|26675548|FG003|Overall Study|Administrative problems|0|||
13358270|NCT00891046|26675549|FG004|Overall Study|Administrative problems|1|||
13358271|NCT00891046|26675545|FG000|Overall Study|Participant no longer required drug|0|||
13358272|NCT00891046|26675546|FG001|Overall Study|Participant no longer required drug|2|||
13358273|NCT00891046|26675547|FG002|Overall Study|Participant no longer required drug|0|||
13358274|NCT00891046|26675548|FG003|Overall Study|Participant no longer required drug|0|||
13358275|NCT00891046|26675549|FG004|Overall Study|Participant no longer required drug|1|||
13358276|NCT00891046|26675545|FG000|Overall Study|Adverse Event|4|||
13358277|NCT00891046|26675546|FG001|Overall Study|Adverse Event|3|||
13358278|NCT00891046|26675547|FG002|Overall Study|Adverse Event|2|||
13358279|NCT00891046|26675548|FG003|Overall Study|Adverse Event|0|||
13358280|NCT00891046|26675549|FG004|Overall Study|Adverse Event|14|||
13358281|NCT00891046|26675545|FG000|Overall Study|Withdrawal by Subject|2|||
13358282|NCT00891046|26675546|FG001|Overall Study|Withdrawal by Subject|1|||
13358283|NCT00891046|26675547|FG002|Overall Study|Withdrawal by Subject|2|||
13358284|NCT00891046|26675548|FG003|Overall Study|Withdrawal by Subject|1|||
13358285|NCT00891046|26675549|FG004|Overall Study|Withdrawal by Subject|1|||
13358286|NCT00891046|26675545|FG000|Overall Study|Lost to Follow-up|0|||
13358287|NCT00891046|26675546|FG001|Overall Study|Lost to Follow-up|0|||
13358288|NCT00891046|26675547|FG002|Overall Study|Lost to Follow-up|0|||
13358289|NCT00891046|26675548|FG003|Overall Study|Lost to Follow-up|0|||
13358290|NCT00891046|26675549|FG004|Overall Study|Lost to Follow-up|1|||
13358291|NCT00891020|26675590|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11|||
13358292|NCT00891020|26675591|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32|||
13358293|NCT00891020|26675592|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17|||
13358294|NCT00891020|26675590|FG000|24 Week Treatment Period|Death|0|||
13358295|NCT00891020|26675591|FG001|24 Week Treatment Period|Death|2|||
13358296|NCT00891020|26675592|FG002|24 Week Treatment Period|Death|0|||
13358297|NCT00891020|26675590|FG000|24 Week Treatment Period|Insufficient therapeutic response|6|||
13358298|NCT00891020|26675591|FG001|24 Week Treatment Period|Insufficient therapeutic response|9|||
13358299|NCT00891020|26675592|FG002|24 Week Treatment Period|Insufficient therapeutic response|15|||
13358300|NCT00891020|26675590|FG000|24 Week Treatment Period|Failure to return|4|||
13358301|NCT00891020|26675591|FG001|24 Week Treatment Period|Failure to return|5|||
13358302|NCT00891020|26675592|FG002|24 Week Treatment Period|Failure to return|5|||
13358303|NCT00891020|26675590|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1|||
13358304|NCT00891020|26675591|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0|||
13358305|NCT00891020|26675592|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2|||
13358306|NCT00891020|26675590|FG000|24 Week Treatment Period|Other protocol violation|1|||
13358307|NCT00891020|26675591|FG001|24 Week Treatment Period|Other protocol violation|1|||
13358308|NCT00891020|26675592|FG002|24 Week Treatment Period|Other protocol violation|2|||
13358309|NCT00891020|26675590|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3|||
13358310|NCT00891020|26675591|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2|||
13358311|NCT00891020|26675592|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1|||
13358312|NCT00891020|26675590|FG000|24 Week Treatment Period|Withdrew consent|6|||
13358313|NCT00891020|26675591|FG001|24 Week Treatment Period|Withdrew consent|3|||
13358314|NCT00891020|26675592|FG002|24 Week Treatment Period|Withdrew consent|15|||
13358315|NCT00891020|26675590|FG000|24 Week Treatment Period|Administrative/Other|5|||
13358316|NCT00891020|26675591|FG001|24 Week Treatment Period|Administrative/Other|6|||
13358317|NCT00891020|26675592|FG002|24 Week Treatment Period|Administrative/Other|1|||
13358318|NCT00891020|26675590|FG000|Long-term Extension Period|Adverse Event|1|||
13358319|NCT00891020|26675591|FG001|Long-term Extension Period|Adverse Event|11|||
13358320|NCT00891020|26675592|FG002|Long-term Extension Period|Adverse Event|10|||
13358321|NCT00891020|26675590|FG000|Long-term Extension Period|Death|0|||
13358322|NCT00891020|26675591|FG001|Long-term Extension Period|Death|0|||
13358323|NCT00891020|26675592|FG002|Long-term Extension Period|Death|1|||
13358324|NCT00891020|26675590|FG000|Long-term Extension Period|Insufficient therapeutic response|3|||
13358325|NCT00891020|26675591|FG001|Long-term Extension Period|Insufficient therapeutic response|2|||
13358326|NCT00891020|26675592|FG002|Long-term Extension Period|Insufficient therapeutic response|2|||
13358327|NCT00891020|26675590|FG000|Long-term Extension Period|Protocol Violation|0|||
13358328|NCT00891020|26675591|FG001|Long-term Extension Period|Protocol Violation|1|||
13358329|NCT00891020|26675592|FG002|Long-term Extension Period|Protocol Violation|1|||
13358330|NCT00891020|26675590|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1|||
13358331|NCT00891020|26675591|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6|||
13358332|NCT00891020|26675592|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4|||
13358333|NCT00891020|26675590|FG000|Long-term Extension Period|Failure to return|0|||
13358334|NCT00891020|26675591|FG001|Long-term Extension Period|Failure to return|2|||
13358335|NCT00891020|26675592|FG002|Long-term Extension Period|Failure to return|3|||
13358336|NCT00891020|26675590|FG000|Long-term Extension Period|Administrative|1|||
13358337|NCT00891020|26675591|FG001|Long-term Extension Period|Administrative|2|||
13358338|NCT00891020|26675592|FG002|Long-term Extension Period|Administrative|2|||
13358339|NCT00890929|26675606|FG000|Overall Study|Death before treatment|2|||
13358340|NCT00890929|26675606|FG000|Overall Study|Withdrawal by Subject|3|||
13358341|NCT00890929|26675606|FG000|Overall Study|Physician Decision|1|||
13358342|NCT00890825|26675631|FG000|Overall Study|Withdrawal by Subject|1|||
13358343|NCT00890825|26675632|FG001|Overall Study|Withdrawal by Subject|0|||
13358344|NCT00890825|26675631|FG000|Overall Study|Alive at data cut off (DCO)|13|||
13358345|NCT00890825|26675632|FG001|Overall Study|Alive at data cut off (DCO)|14|||
13358346|NCT00890695|26675655|FG000|Overall Study|Protocol Violation|1|||
13358347|NCT00890695|26675656|FG001|Overall Study|Protocol Violation|0|||
13358348|NCT00890552|26675665|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1|||
13358349|NCT00890552|26675665|FG000|On-treatment|Early prog disease/ death|10|||
13358350|NCT00890201|26675678|FG000|Overall Study|Protocol Violation|5|||
13358351|NCT00890201|26675679|FG001|Overall Study|Protocol Violation|56|||
13358352|NCT00890097|26675697|FG000|Overall Study|Adverse Event|21|||
13358353|NCT00890097|26675698|FG001|Overall Study|Adverse Event|32|||
13358354|NCT00890097|26675699|FG002|Overall Study|Adverse Event|28|||
13358355|NCT00890097|26675697|FG000|Overall Study|Decision Unrelated to an Adverse Event|15|||
13358356|NCT00890097|26675698|FG001|Overall Study|Decision Unrelated to an Adverse Event|12|||
13358357|NCT00890097|26675699|FG002|Overall Study|Decision Unrelated to an Adverse Event|17|||
13358358|NCT00890097|26675697|FG000|Overall Study|Withdrew Consent|9|||
13358359|NCT00890097|26675698|FG001|Overall Study|Withdrew Consent|6|||
13358360|NCT00890097|26675699|FG002|Overall Study|Withdrew Consent|9|||
13358361|NCT00890097|26675697|FG000|Overall Study|Lost to Follow-up|5|||
13358362|NCT00890097|26675698|FG001|Overall Study|Lost to Follow-up|5|||
13358363|NCT00890097|26675699|FG002|Overall Study|Lost to Follow-up|5|||
13358364|NCT00890097|26675697|FG000|Overall Study|Noncompliance|0|||
13358365|NCT00890097|26675698|FG001|Overall Study|Noncompliance|4|||
13358366|NCT00890097|26675699|FG002|Overall Study|Noncompliance|4|||
13358367|NCT00890097|26675697|FG000|Overall Study|Sponsor Decision|7|||
13358368|NCT00890097|26675698|FG001|Overall Study|Sponsor Decision|11|||
13358369|NCT00890097|26675699|FG002|Overall Study|Sponsor Decision|7|||
13358370|NCT00890097|26675697|FG000|Overall Study|Did not attend final visit|2|||
13358371|NCT00890097|26675698|FG001|Overall Study|Did not attend final visit|3|||
13358372|NCT00890097|26675699|FG002|Overall Study|Did not attend final visit|0|||
13358373|NCT00890097|26675697|FG000|Overall Study|Subject Decision|3|||
13358374|NCT00890097|26675698|FG001|Overall Study|Subject Decision|2|||
13358375|NCT00890097|26675699|FG002|Overall Study|Subject Decision|6|||
13358376|NCT00890097|26675697|FG000|Overall Study|Randomization Error|2|||
13358377|NCT00890097|26675698|FG001|Overall Study|Randomization Error|0|||
13358378|NCT00890097|26675699|FG002|Overall Study|Randomization Error|0|||
13358379|NCT00890097|26675697|FG000|Overall Study|Failed inclusion criteria|3|||
13358380|NCT00890097|26675698|FG001|Overall Study|Failed inclusion criteria|4|||
13358381|NCT00890097|26675699|FG002|Overall Study|Failed inclusion criteria|0|||
13358382|NCT00890097|26675697|FG000|Overall Study|Transportation|0|||
13358383|NCT00890097|26675698|FG001|Overall Study|Transportation|2|||
13358384|NCT00890097|26675699|FG002|Overall Study|Transportation|0|||
13358385|NCT00890097|26675697|FG000|Overall Study|Subject Moved|0|||
13358386|NCT00890097|26675698|FG001|Overall Study|Subject Moved|4|||
13358387|NCT00890097|26675699|FG002|Overall Study|Subject Moved|0|||
13358388|NCT00890097|26675697|FG000|Overall Study|Protocol Deviation|1|||
13358389|NCT00890097|26675698|FG001|Overall Study|Protocol Deviation|1|||
13358390|NCT00890097|26675699|FG002|Overall Study|Protocol Deviation|1|||
13358391|NCT00890084|26675712|FG000|Overall Study|Adverse Event|16|||
13358392|NCT00890084|26675712|FG000|Overall Study|Lost to Follow-up|126|||
13358393|NCT00890045|26675733|FG000|Overall Study|Death|0|||
13358394|NCT00890045|26675734|FG001|Overall Study|Death|1|||
13358395|NCT00890045|26675733|FG000|Overall Study|Did not receive HeRO Graft|0|||
13358396|NCT00890045|26675734|FG001|Overall Study|Did not receive HeRO Graft|2|||
13358397|NCT00890045|26675733|FG000|Overall Study|Lost to Follow-up|5|||
13358398|NCT00890045|26675734|FG001|Overall Study|Lost to Follow-up|7|||
13358399|NCT00889863|26675759|FG000|Part I: Open Label|Death|1|||
13358400|NCT00889863|26675760|FG001|Part I: Open Label|Death|0|||
13358401|NCT00889863|26675759|FG000|Part I: Open Label|Adverse Event|4|||
13358402|NCT00889863|26675760|FG001|Part I: Open Label|Adverse Event|0|||
13358403|NCT00889863|26675759|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72|||
13358404|NCT00889863|26675760|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0|||
13358405|NCT00889863|26675759|FG000|Part II: Randomized Double Blind|Adverse Event|0|||
13358406|NCT00889863|26675760|FG001|Part II: Randomized Double Blind|Adverse Event|4|||
13358407|NCT00889863|26675759|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11|||
13358408|NCT00889863|26675760|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20|||
13358409|NCT00889863|26675759|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0|||
13358410|NCT00889863|26675760|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1|||
13358411|NCT00889863|26675759|FG000|Part II: Randomized Double Blind|Protocol deviation|0|||
13358412|NCT00889863|26675760|FG001|Part II: Randomized Double Blind|Protocol deviation|1|||
13358413|NCT00889720|26675787|FG000|Overall Study|Withdrawal by Subject|4|||
13358414|NCT00889720|26675787|FG000|Overall Study|Other|4|||
13358415|NCT00889707|26675802|FG000|Overall Study|Adverse Event|1|||
13358416|NCT00889707|26675803|FG001|Overall Study|Adverse Event|0|||
13358417|NCT00889707|26675802|FG000|Overall Study|Withdrawal by Subject|4|||
13358418|NCT00889707|26675803|FG001|Overall Study|Withdrawal by Subject|3|||
13358419|NCT00889707|26675802|FG000|Overall Study|Lost to Follow-up|0|||
13358420|NCT00889707|26675803|FG001|Overall Study|Lost to Follow-up|2|||
13358421|NCT00889707|26675802|FG000|Overall Study|Lack of Efficacy|2|||
13358422|NCT00889707|26675803|FG001|Overall Study|Lack of Efficacy|5|||
13358423|NCT00889681|26675812|FG000|Overall Study|Not meeting qualification Criteria|2|||
13358424|NCT00889681|26675812|FG000|Overall Study|Insurance disapproval|1|||
13358425|NCT00889603|26675827|FG000|Overall Study|Adverse Event|7|||
13358426|NCT00889603|26675827|FG000|Overall Study|Death|3|||
13358427|NCT00889603|26675827|FG000|Overall Study|Lost to Follow-up|19|||
13358428|NCT00889603|26675827|FG000|Overall Study|No longer willing to participant in stud|4|||
13358429|NCT00889603|26675827|FG000|Overall Study|Other|4|||
13358430|NCT00889421|26675837|FG000|Overall Study|Lack of Efficacy|3|||
13358431|NCT00889265|26675844|FG000|Overall Study|Adverse Event|1|||
13358432|NCT00889265|26675844|FG000|Overall Study|Lost to Follow-up|5|||
13358433|NCT00889265|26675844|FG000|Overall Study|Protocol Violation|1|||
13358434|NCT00889252|26675893|FG000|Overall Study|Adverse Event|2|||
13358435|NCT00889252|26675894|FG001|Overall Study|Adverse Event|4|||
13358436|NCT00889252|26675893|FG000|Overall Study|Withdrawal by Subject|3|||
13358437|NCT00889252|26675894|FG001|Overall Study|Withdrawal by Subject|0|||
13358438|NCT00889252|26675893|FG000|Overall Study|Protocol Violation|2|||
13358439|NCT00889252|26675894|FG001|Overall Study|Protocol Violation|0|||
13358440|NCT00889005|26675907|FG000|Overall Study|Lost to Follow-up|4|||
13358441|NCT00889005|26675908|FG001|Overall Study|Lost to Follow-up|2|||
13358442|NCT00889005|26675907|FG000|Overall Study|Withdrawal by Subject|4|||
13358443|NCT00889005|26675908|FG001|Overall Study|Withdrawal by Subject|0|||
13358444|NCT00888940|26675923|FG000|Overall Study|Adverse Event|12|||
13358445|NCT00888940|26675924|FG001|Overall Study|Adverse Event|3|||
13358446|NCT00888940|26675923|FG000|Overall Study|Lost to Follow-up|5|||
13358447|NCT00888940|26675924|FG001|Overall Study|Lost to Follow-up|5|||
13358448|NCT00888940|26675923|FG000|Overall Study|Randomized Not Treated|11|||
13358449|NCT00888940|26675924|FG001|Overall Study|Randomized Not Treated|13|||
13358450|NCT00888927|26675951|FG000|Overall Study|Adverse Event|0|||
13358451|NCT00888927|26675952|FG001|Overall Study|Adverse Event|0|||
13358452|NCT00888927|26675953|FG002|Overall Study|Adverse Event|0|||
13358453|NCT00888927|26675954|FG003|Overall Study|Adverse Event|1|||
13358454|NCT00888927|26675951|FG000|Overall Study|Withdrawal of consent|0|||
13358455|NCT00888927|26675952|FG001|Overall Study|Withdrawal of consent|0|||
13358456|NCT00888927|26675953|FG002|Overall Study|Withdrawal of consent|0|||
13358457|NCT00888927|26675954|FG003|Overall Study|Withdrawal of consent|1|||
13358458|NCT00888849|26675971|FG000|Overall Study|Death|4|||
13358459|NCT00888849|26675972|FG001|Overall Study|Death|7|||
13358460|NCT00888849|26675971|FG000|Overall Study|Lost to Follow-up|1|||
13358461|NCT00888849|26675972|FG001|Overall Study|Lost to Follow-up|2|||
13358462|NCT00888654|26675980|FG000|Overall Study|Problems swallowing oral meds.|1|||
13358463|NCT00888654|26675980|FG000|Overall Study|Not enough oral meds before surgery|3|||
13358464|NCT00888654|26675980|FG000|Overall Study|Surgery aborted|2|||
13358465|NCT00888654|26675980|FG000|Overall Study|Withdrawal by Subject|1|||
13358466|NCT00888654|26675980|FG000|Overall Study|Inelig. due to contraindication of med|1|||
13358467|NCT00888654|26675980|FG000|Overall Study|Change in surg date|1|||
13358468|NCT00888654|26675980|FG000|Overall Study|Stopped meds due to headaches|1|||
13358469|NCT00888615|26675991|FG000|Overall Study|No treatment|2|||
13358470|NCT00888433|26676004|FG000|Overall Study|Withdrawal by Subject|1|||
13358471|NCT00888433|26676005|FG001|Overall Study|Withdrawal by Subject|2|||
13358472|NCT00888433|26676004|FG000|Overall Study|Missed Visit|2|||
13358473|NCT00888433|26676005|FG001|Overall Study|Missed Visit|1|||
13358474|NCT00888381|26676028|FG000|Overall Study|Lost to Follow-up|0|||
13358475|NCT00888381|26676029|FG001|Overall Study|Lost to Follow-up|1|||
13358476|NCT00888329|26676042|FG000|Overall Study|Physician Decision|6|||
13358477|NCT00888329|26676043|FG001|Overall Study|Physician Decision|9|||
13358478|NCT00888238|26676055|FG000|Washout Period After Period 2|Adverse Event|0|||
13358479|NCT00888238|26676056|FG001|Washout Period After Period 2|Adverse Event|0|||
13358480|NCT00888238|26676057|FG002|Washout Period After Period 2|Adverse Event|1|||
13358481|NCT00888173|26676067|FG000|Overall Study|Wrong Primary|1|||
13358482|NCT00888173|26676067|FG000|Overall Study|Ineligible: required test not done|1|||
13358483|NCT00888134|26676077|FG000|Treatment With Study Drug|Withdrawal by Subject|1|||
13358484|NCT00888134|26676077|FG000|Follow-up|being followed for long-term survival|1|||
13358485|NCT00887978|26676120|FG000|Overall Study|Adverse Event|18|||
13358486|NCT00887978|26676121|FG001|Overall Study|Adverse Event|5|||
13358487|NCT00887978|26676120|FG000|Overall Study|Clinical Worsening|4|||
13358488|NCT00887978|26676121|FG001|Overall Study|Clinical Worsening|4|||
13358489|NCT00887978|26676120|FG000|Overall Study|Death|2|||
13358490|NCT00887978|26676121|FG001|Overall Study|Death|3|||
13358491|NCT00887978|26676120|FG000|Overall Study|Withdrawal by Subject|1|||
13358492|NCT00887978|26676121|FG001|Overall Study|Withdrawal by Subject|2|||
13358493|NCT00887978|26676120|FG000|Overall Study|Lost to Follow-up|0|||
13358494|NCT00887978|26676121|FG001|Overall Study|Lost to Follow-up|1|||
13358495|NCT00887913|26676129|FG000|Overall Study|Withdrawal by Subject|6|||
13358496|NCT00887822|26676166|FG000|Overall Study|Insufficient therapeutic response|53|||
13358497|NCT00887822|26676167|FG001|Overall Study|Insufficient therapeutic response|55|||
13358498|NCT00887822|26676166|FG000|Overall Study|Adverse Event|14|||
13358499|NCT00887822|26676167|FG001|Overall Study|Adverse Event|17|||
13358500|NCT00887822|26676166|FG000|Overall Study|Failure to return|11|||
13358501|NCT00887822|26676167|FG001|Overall Study|Failure to return|11|||
13358502|NCT00887822|26676166|FG000|Overall Study|Refused treatment/Did not cooperate|12|||
13358503|NCT00887822|26676167|FG001|Overall Study|Refused treatment/Did not cooperate|10|||
13358504|NCT00887822|26676166|FG000|Overall Study|Administrative/Other than specified|5|||
13358505|NCT00887822|26676167|FG001|Overall Study|Administrative/Other than specified|4|||
13358506|NCT00887822|26676166|FG000|Overall Study|Death|2|||
13358507|NCT00887822|26676167|FG001|Overall Study|Death|3|||
13358508|NCT00887822|26676166|FG000|Overall Study|Protocol Violation|0|||
13358509|NCT00887822|26676167|FG001|Overall Study|Protocol Violation|1|||
13358510|NCT00887822|26676166|FG000|Overall Study|Randomized but not treated|0|||
13358511|NCT00887822|26676167|FG001|Overall Study|Randomized but not treated|1|||
13358512|NCT00887809|26676180|FG000|Overall Study|Patient Not Treated|3|||
13358513|NCT00887809|26676181|FG001|Overall Study|Patient Not Treated|0|||
13358514|NCT00887809|26676180|FG000|Overall Study|Death|1|||
13358515|NCT00887809|26676181|FG001|Overall Study|Death|0|||
13358516|NCT00887744|26676192|FG000|Overall Study|Adverse Event|3|||
13358517|NCT00887744|26676192|FG000|Overall Study|Death|1|||
13358518|NCT00887744|26676192|FG000|Overall Study|Lost to Follow-up|3|||
13358519|NCT00887744|26676192|FG000|Overall Study|Withdrawal by Subject|18|||
13358520|NCT00887744|26676192|FG000|Overall Study|Various reasons|9|||
13358521|NCT00887679|26676203|FG000|Overall Study|Withdrawal by Subject|1|||
13358522|NCT00887679|26676203|FG000|Overall Study|Lost to Follow-up|4|||
13358523|NCT00887679|26676203|FG000|Overall Study|Physician Decision|5|||
13358524|NCT00887588|26676262|FG000|Core Period|Death|1|||
13358525|NCT00887588|26676263|FG001|Core Period|Death|1|||
13358526|NCT00887588|26676262|FG000|Core Period|Lost to Follow-up|3|||
13358527|NCT00887588|26676263|FG001|Core Period|Lost to Follow-up|1|||
13358528|NCT00887588|26676262|FG000|Core Period|Withdrawal by Subject|6|||
13358529|NCT00887588|26676263|FG001|Core Period|Withdrawal by Subject|8|||
13358530|NCT00887588|26676262|FG000|Core Period|Adverse Event|9|||
13358531|NCT00887588|26676263|FG001|Core Period|Adverse Event|11|||
13358532|NCT00887588|26676262|FG000|Extension Period|Adverse Event|4|||
13358533|NCT00887588|26676263|FG001|Extension Period|Adverse Event|4|||
13358534|NCT00887588|26676262|FG000|Extension Period|Death|0|||
13358535|NCT00887588|26676263|FG001|Extension Period|Death|1|||
13358536|NCT00887588|26676262|FG000|Extension Period|Protocol deviation|1|||
13358537|NCT00887588|26676263|FG001|Extension Period|Protocol deviation|0|||
13358538|NCT00887588|26676262|FG000|Extension Period|Lost to Follow-up|1|||
13358539|NCT00887588|26676263|FG001|Extension Period|Lost to Follow-up|0|||
13358540|NCT00887549|26676272|FG000|Induction Therapy|Adverse Event|8|||
13358541|NCT00887549|26676272|FG000|Induction Therapy|Physician Decision|1|||
13358542|NCT00887549|26676272|FG000|Induction Therapy|Progressive Disease|13|||
13358543|NCT00887549|26676272|FG000|Induction Therapy|Death due to Study Disease|4|||
13358544|NCT00887549|26676272|FG000|Induction Therapy|Death due to Study Drug Toxicity|1|||
13358545|NCT00887549|26676272|FG000|Maintenance Therapy|Adverse Event|16|||
13358546|NCT00887549|26676272|FG000|Maintenance Therapy|Physician Decision|1|||
13358547|NCT00887549|26676272|FG000|Maintenance Therapy|Progressive Disease|25|||
13358548|NCT00887549|26676272|FG000|Maintenance Therapy|Death due to adverse event|1|||
13358549|NCT00887484|26676338|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1|||
13358550|NCT00887484|26676338|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
13358551|NCT00887484|26676338|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1|||
13358552|NCT00887432|26676355|FG000|Overall Study|Start Excluded Therapy|3|||
13358553|NCT00887432|26676356|FG001|Overall Study|Start Excluded Therapy|0|||
13358554|NCT00887432|26676355|FG000|Overall Study|Did not complete treatment|6|||
13358555|NCT00887432|26676356|FG001|Overall Study|Did not complete treatment|8|||
13358556|NCT00887432|26676355|FG000|Overall Study|Protocol Violation|2|||
13358557|NCT00887432|26676356|FG001|Overall Study|Protocol Violation|3|||
13358558|NCT00887432|26676355|FG000|Overall Study|Withdrawal by Subject|3|||
13358559|NCT00887432|26676356|FG001|Overall Study|Withdrawal by Subject|2|||
13358560|NCT00887432|26676355|FG000|Overall Study|Lost to Follow-up|1|||
13358561|NCT00887432|26676356|FG001|Overall Study|Lost to Follow-up|0|||
13358562|NCT00887432|26676355|FG000|Overall Study|No reason provided|0|||
13358563|NCT00887432|26676356|FG001|Overall Study|No reason provided|1|||
13358564|NCT00887354|26676381|FG000|Treatment Phase (Week 0 to Week 26)|Death|0|||
13358565|NCT00887354|26676382|FG001|Treatment Phase (Week 0 to Week 26)|Death|1|||
13358566|NCT00887354|26676381|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
13358567|NCT00887354|26676382|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
13358568|NCT00887354|26676381|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2|||
13358569|NCT00887354|26676382|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1|||
13358570|NCT00887354|26676381|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14|||
13358571|NCT00887354|26676382|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8|||
13358572|NCT00887354|26676381|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
13358573|NCT00887354|26676382|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
13358574|NCT00887354|26676381|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2|||
13358575|NCT00887354|26676382|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1|||
13358576|NCT00887354|26676381|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
13358577|NCT00887354|26676382|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
13358578|NCT00887354|26676381|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1|||
13358579|NCT00887354|26676382|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2|||
13358580|NCT00887354|26676381|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20|||
13358581|NCT00887354|26676382|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25|||
13358582|NCT00887354|26676381|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5|||
13358583|NCT00887354|26676382|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3|||
13358584|NCT00887354|26676381|FG000|Open Label Phase (Week 26 to Week 78)|Death|0|||
13358585|NCT00887354|26676382|FG001|Open Label Phase (Week 26 to Week 78)|Death|2|||
13358586|NCT00887354|26676381|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0|||
13358587|NCT00887354|26676382|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1|||
13358588|NCT00887354|26676381|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1|||
13358589|NCT00887354|26676382|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2|||
13358590|NCT00887354|26676381|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1|||
13358591|NCT00887354|26676382|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0|||
13358592|NCT00887354|26676381|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
13358593|NCT00887354|26676382|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
13374596|NCT00795509|26727319|FG000|Overall Study|Protocol Violation|31|||
13374597|NCT00795184|26727331|FG000|Overall Study|Tissue sampling incomplete/conclusive|8|||
13374598|NCT00795184|26727332|FG001|Overall Study|Tissue sampling incomplete/conclusive|13|||
13374599|NCT00795132|26727346|FG000|Overall Study|Death|1|||
13374600|NCT00795132|26727346|FG000|Overall Study|Relapse|2|||
13374601|NCT00794963|26727359|FG000|Overall Study|Withdrawal by Subject|1|||
13374602|NCT00794963|26727360|FG001|Overall Study|Withdrawal by Subject|4|||
13374603|NCT00794950|26727369|FG000|BCG Induction|Withdrawal by Subject|2|||
13374604|NCT00794950|26727369|FG000|BCG Induction|ineligible|3|||
13374605|NCT00794950|26727369|FG000|BCG Induction|noncompliant w. BCG|1|||
13374606|NCT00794950|26727369|FG000|BCG Induction|Adverse Event|1|||
13374607|NCT00794950|26727369|FG000|Beginning Sunitinib Treatment|cystectomy|5|||
13374608|NCT00794950|26727369|FG000|Beginning Sunitinib Treatment|Physician Decision|5|||
13374609|NCT00794950|26727369|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1|||
13374610|NCT00794950|26727369|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1|||
13374611|NCT00794820|26727377|FG000|Overall Study|Adverse Event|11|||
13374612|NCT00794820|26727377|FG000|Overall Study|Secondary Malignancies|2|||
13374613|NCT00794820|26727377|FG000|Overall Study|Resistant Disease|2|||
13374614|NCT00794820|26727377|FG000|Overall Study|Ineligible/Screen Failure|1|||
13374615|NCT00794664|26727428|FG000|Treatment Period|Withdrawal by Subject|0|||
13374616|NCT00794664|26727429|FG001|Treatment Period|Withdrawal by Subject|2|||
13374617|NCT00794664|26727428|FG000|Treatment Period|Protocol non-compliance|0|||
13374618|NCT00794664|26727429|FG001|Treatment Period|Protocol non-compliance|1|||
13374619|NCT00794664|26727428|FG000|Treatment Period|Other|0|||
13358594|NCT00887341|26676423|FG000|Overall Study|Refused treatment|1|||
13358595|NCT00887341|26676424|FG001|Overall Study|Refused treatment|0|||
13358596|NCT00887341|26676423|FG000|Overall Study|Withdrawal by Subject|1|||
13358597|NCT00887341|26676424|FG001|Overall Study|Withdrawal by Subject|1|||
13358598|NCT00887341|26676423|FG000|Overall Study|Adverse Event|0|||
13358599|NCT00887341|26676424|FG001|Overall Study|Adverse Event|1|||
13358600|NCT00887341|26676423|FG000|Overall Study|Lost to Follow-up|0|||
13358601|NCT00887341|26676424|FG001|Overall Study|Lost to Follow-up|1|||
13358602|NCT00887315|26676439|FG000|Overall Study|Study termination|7|||
13358603|NCT00887315|26676440|FG001|Overall Study|Study termination|4|||
13358604|NCT00887289|26676451|FG000|Overall Study|Lack of Efficacy|14|||
13358605|NCT00887289|26676451|FG000|Overall Study|Adverse Event|27|||
13358606|NCT00887289|26676451|FG000|Overall Study|Withdrawal by Subject|26|||
13358607|NCT00887289|26676451|FG000|Overall Study|Lost to Follow-up|8|||
13358608|NCT00887289|26676451|FG000|Overall Study|Other|20|||
13358609|NCT00887224|26676486|FG000|Open-label Response (OLR) Phase|Adverse Event|46|||
13358610|NCT00887224|26676487|FG001|Open-label Response (OLR) Phase|Adverse Event|0|||
13358611|NCT00887224|26676488|FG002|Open-label Response (OLR) Phase|Adverse Event|0|||
13358612|NCT00887224|26676486|FG000|Open-label Response (OLR) Phase|Failed to return|6|||
13358613|NCT00887224|26676487|FG001|Open-label Response (OLR) Phase|Failed to return|0|||
13358614|NCT00887224|26676488|FG002|Open-label Response (OLR) Phase|Failed to return|0|||
13358615|NCT00887224|26676486|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26|||
13358616|NCT00887224|26676487|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
13358617|NCT00887224|26676488|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
13358618|NCT00887224|26676486|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16|||
13358619|NCT00887224|26676487|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
13358620|NCT00887224|26676488|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
13358621|NCT00887224|26676486|FG000|Open-label Response (OLR) Phase|Other|1|||
13358622|NCT00887224|26676487|FG001|Open-label Response (OLR) Phase|Other|0|||
13358623|NCT00887224|26676488|FG002|Open-label Response (OLR) Phase|Other|0|||
13358624|NCT00887224|26676486|FG000|Open-label Response (OLR) Phase|Protocol Violation|12|||
13358625|NCT00887224|26676487|FG001|Open-label Response (OLR) Phase|Protocol Violation|0|||
13358626|NCT00887224|26676488|FG002|Open-label Response (OLR) Phase|Protocol Violation|0|||
13358627|NCT00887224|26676486|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15|||
13358628|NCT00887224|26676487|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
13358629|NCT00887224|26676488|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
13358630|NCT00887224|26676486|FG000|Open-label Stability (OLS) Phase|Adverse Event|22|||
13358631|NCT00887224|26676487|FG001|Open-label Stability (OLS) Phase|Adverse Event|0|||
13358632|NCT00887224|26676488|FG002|Open-label Stability (OLS) Phase|Adverse Event|0|||
13358633|NCT00887224|26676486|FG000|Open-label Stability (OLS) Phase|Failed to return|3|||
13358634|NCT00887224|26676487|FG001|Open-label Stability (OLS) Phase|Failed to return|0|||
13358635|NCT00887224|26676488|FG002|Open-label Stability (OLS) Phase|Failed to return|0|||
13358636|NCT00887224|26676486|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16|||
13358637|NCT00887224|26676487|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
13358638|NCT00887224|26676488|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
13358639|NCT00887224|26676486|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9|||
13358640|NCT00887224|26676487|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
13358641|NCT00887224|26676488|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
13358642|NCT00887224|26676486|FG000|Open-label Stability (OLS) Phase|Other|1|||
13358643|NCT00887224|26676487|FG001|Open-label Stability (OLS) Phase|Other|0|||
13358644|NCT00887224|26676488|FG002|Open-label Stability (OLS) Phase|Other|0|||
13358645|NCT00887224|26676486|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13|||
13358646|NCT00887224|26676487|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0|||
13358647|NCT00887224|26676488|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0|||
13358648|NCT00887224|26676486|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19|||
13358649|NCT00887224|26676487|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
13358650|NCT00887224|26676488|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
13358651|NCT00887224|26676486|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28|||
13358652|NCT00887224|26676487|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0|||
13358653|NCT00887224|26676488|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0|||
13358654|NCT00887224|26676486|FG000|OL Taper Phase / OL Follow Up|Failed to return|17|||
13358655|NCT00887224|26676487|FG001|OL Taper Phase / OL Follow Up|Failed to return|0|||
13358656|NCT00887224|26676488|FG002|OL Taper Phase / OL Follow Up|Failed to return|0|||
13358657|NCT00887224|26676486|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10|||
13358658|NCT00887224|26676487|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0|||
13358659|NCT00887224|26676488|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0|||
13358660|NCT00887224|26676486|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8|||
13358661|NCT00887224|26676487|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
13358662|NCT00887224|26676488|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
13358663|NCT00887224|26676486|FG000|OL Taper Phase / OL Follow Up|Other|30|||
13358664|NCT00887224|26676487|FG001|OL Taper Phase / OL Follow Up|Other|0|||
13374620|NCT00794664|26727429|FG001|Treatment Period|Other|1|||
13358665|NCT00887224|26676488|FG002|OL Taper Phase / OL Follow Up|Other|0|||
13358666|NCT00887224|26676486|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3|||
13358667|NCT00887224|26676487|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
13358668|NCT00887224|26676488|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
13358669|NCT00887224|26676486|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48|||
13358670|NCT00887224|26676487|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
13358671|NCT00887224|26676488|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
13358672|NCT00887224|26676486|FG000|Double-blind (DB) Phase|Adverse Event|0|||
13358673|NCT00887224|26676487|FG001|Double-blind (DB) Phase|Adverse Event|7|||
13358674|NCT00887224|26676488|FG002|Double-blind (DB) Phase|Adverse Event|2|||
13358675|NCT00887224|26676486|FG000|Double-blind (DB) Phase|Failed to return|0|||
13358676|NCT00887224|26676487|FG001|Double-blind (DB) Phase|Failed to return|2|||
13358677|NCT00887224|26676488|FG002|Double-blind (DB) Phase|Failed to return|2|||
13358678|NCT00887224|26676486|FG000|Double-blind (DB) Phase|Lack of Efficacy|0|||
13358679|NCT00887224|26676487|FG001|Double-blind (DB) Phase|Lack of Efficacy|67|||
13358680|NCT00887224|26676488|FG002|Double-blind (DB) Phase|Lack of Efficacy|33|||
13358681|NCT00887224|26676486|FG000|Double-blind (DB) Phase|Lost to Follow-up|0|||
13358682|NCT00887224|26676487|FG001|Double-blind (DB) Phase|Lost to Follow-up|8|||
13358683|NCT00887224|26676488|FG002|Double-blind (DB) Phase|Lost to Follow-up|8|||
13358684|NCT00887224|26676486|FG000|Double-blind (DB) Phase|Other|0|||
13358685|NCT00887224|26676487|FG001|Double-blind (DB) Phase|Other|2|||
13358686|NCT00887224|26676488|FG002|Double-blind (DB) Phase|Other|0|||
13358687|NCT00887224|26676486|FG000|Double-blind (DB) Phase|Protocol Violation|0|||
13358688|NCT00887224|26676487|FG001|Double-blind (DB) Phase|Protocol Violation|8|||
13358689|NCT00887224|26676488|FG002|Double-blind (DB) Phase|Protocol Violation|5|||
13358690|NCT00887224|26676486|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0|||
13358691|NCT00887224|26676487|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6|||
13358692|NCT00887224|26676488|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12|||
13358693|NCT00887224|26676486|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
13358694|NCT00887224|26676487|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5|||
13358695|NCT00887224|26676488|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
13358696|NCT00887224|26676486|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0|||
13358697|NCT00887224|26676487|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5|||
13358698|NCT00887224|26676488|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4|||
13358699|NCT00887224|26676486|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
13358700|NCT00887224|26676487|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6|||
13358701|NCT00887224|26676488|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
13358702|NCT00887224|26676486|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0|||
13358703|NCT00887224|26676487|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
13358704|NCT00887224|26676488|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
13358705|NCT00887224|26676486|FG000|DB Taper Phase / Post Study Follow Up|Other|0|||
13358706|NCT00887224|26676487|FG001|DB Taper Phase / Post Study Follow Up|Other|11|||
13358707|NCT00887224|26676488|FG002|DB Taper Phase / Post Study Follow Up|Other|12|||
13358708|NCT00887224|26676486|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0|||
13358709|NCT00887224|26676487|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4|||
13358710|NCT00887224|26676488|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1|||
13358711|NCT00887224|26676486|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0|||
13358712|NCT00887224|26676487|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8|||
13358713|NCT00887224|26676488|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11|||
13358714|NCT00887198|26676524|FG000|Randomized Period|Ongoing|42|||
13358715|NCT00887198|26676525|FG001|Randomized Period|Ongoing|0|||
13358716|NCT00887198|26676526|FG002|Randomized Period|Ongoing|0|||
13358717|NCT00887198|26676524|FG000|Randomized Period|Adverse Event|50|||
13358718|NCT00887198|26676525|FG001|Randomized Period|Adverse Event|33|||
13358719|NCT00887198|26676526|FG002|Randomized Period|Adverse Event|0|||
13358720|NCT00887198|26676524|FG000|Randomized Period|Lost to Follow-up|1|||
13358721|NCT00887198|26676525|FG001|Randomized Period|Lost to Follow-up|0|||
13358722|NCT00887198|26676526|FG002|Randomized Period|Lost to Follow-up|0|||
13358723|NCT00887198|26676524|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0|||
13358724|NCT00887198|26676525|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51|||
13358725|NCT00887198|26676526|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0|||
13358726|NCT00887198|26676524|FG000|Randomized Period|Withdrawal by Subject|41|||
13358727|NCT00887198|26676525|FG001|Randomized Period|Withdrawal by Subject|56|||
13358728|NCT00887198|26676526|FG002|Randomized Period|Withdrawal by Subject|0|||
13358729|NCT00887198|26676524|FG000|Randomized Period|Progressive disease|366|||
13358730|NCT00887198|26676525|FG001|Randomized Period|Progressive disease|370|||
13358731|NCT00887198|26676526|FG002|Randomized Period|Progressive disease|0|||
13358732|NCT00887198|26676524|FG000|Randomized Period|Other|42|||
13358733|NCT00887198|26676525|FG001|Randomized Period|Other|30|||
13358734|NCT00887198|26676526|FG002|Randomized Period|Other|0|||
13358735|NCT00887198|26676524|FG000|Randomized Period|Randomized, Not treated|4|||
13358736|NCT00887198|26676525|FG001|Randomized Period|Randomized, Not treated|2|||
13358737|NCT00887198|26676526|FG002|Randomized Period|Randomized, Not treated|0|||
13358738|NCT00887198|26676524|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
13358739|NCT00887198|26676525|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
13358740|NCT00887198|26676526|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8|||
13358741|NCT00887198|26676524|FG000|Cross Over (Placebo to AA)|Ongoing|0|||
13358742|NCT00887198|26676525|FG001|Cross Over (Placebo to AA)|Ongoing|0|||
13358743|NCT00887198|26676526|FG002|Cross Over (Placebo to AA)|Ongoing|35|||
13358744|NCT00887198|26676524|FG000|Cross Over (Placebo to AA)|Adverse Event|0|||
13358745|NCT00887198|26676525|FG001|Cross Over (Placebo to AA)|Adverse Event|0|||
13358746|NCT00887198|26676526|FG002|Cross Over (Placebo to AA)|Adverse Event|9|||
13358747|NCT00887198|26676524|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
13358748|NCT00887198|26676525|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
13358749|NCT00887198|26676526|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2|||
13358750|NCT00887198|26676524|FG000|Cross Over (Placebo to AA)|Progressive disease|0|||
13358751|NCT00887198|26676525|FG001|Cross Over (Placebo to AA)|Progressive disease|0|||
13358752|NCT00887198|26676526|FG002|Cross Over (Placebo to AA)|Progressive disease|20|||
13358753|NCT00887198|26676524|FG000|Cross Over (Placebo to AA)|Other|0|||
13358754|NCT00887198|26676525|FG001|Cross Over (Placebo to AA)|Other|0|||
13358755|NCT00887198|26676526|FG002|Cross Over (Placebo to AA)|Other|19|||
13358756|NCT00887159|26676552|FG000|Overall Study|Disease progression|6|||
13358757|NCT00887159|26676553|FG001|Overall Study|Disease progression|39|||
13358758|NCT00887159|26676554|FG002|Overall Study|Disease progression|33|||
13358759|NCT00887159|26676552|FG000|Overall Study|Adverse Event|3|||
13358760|NCT00887159|26676553|FG001|Overall Study|Adverse Event|4|||
13358761|NCT00887159|26676554|FG002|Overall Study|Adverse Event|17|||
13358762|NCT00887159|26676552|FG000|Overall Study|Death|2|||
13358763|NCT00887159|26676553|FG001|Overall Study|Death|2|||
13358764|NCT00887159|26676554|FG002|Overall Study|Death|0|||
13358765|NCT00887159|26676552|FG000|Overall Study|Withdrawal by Subject|4|||
13358766|NCT00887159|26676553|FG001|Overall Study|Withdrawal by Subject|4|||
13358767|NCT00887159|26676554|FG002|Overall Study|Withdrawal by Subject|2|||
13358768|NCT00887159|26676552|FG000|Overall Study|Alternative therapy|2|||
13358769|NCT00887159|26676553|FG001|Overall Study|Alternative therapy|0|||
13358770|NCT00887159|26676554|FG002|Overall Study|Alternative therapy|0|||
13358771|NCT00887159|26676552|FG000|Overall Study|Physician Decision|1|||
13358772|NCT00887159|26676553|FG001|Overall Study|Physician Decision|1|||
13358773|NCT00887159|26676554|FG002|Overall Study|Physician Decision|0|||
13358774|NCT00887159|26676552|FG000|Overall Study|Sympomatic deterioration|1|||
13358775|NCT00887159|26676553|FG001|Overall Study|Sympomatic deterioration|0|||
13358776|NCT00887159|26676554|FG002|Overall Study|Sympomatic deterioration|0|||
13358777|NCT00887159|26676552|FG000|Overall Study|Treatment delayed|1|||
13358778|NCT00887159|26676553|FG001|Overall Study|Treatment delayed|1|||
13358779|NCT00887159|26676554|FG002|Overall Study|Treatment delayed|0|||
13358780|NCT00887159|26676552|FG000|Overall Study|Pt had PD but was SD when re-measured|0|||
13358781|NCT00887159|26676553|FG001|Overall Study|Pt had PD but was SD when re-measured|1|||
13358782|NCT00887159|26676554|FG002|Overall Study|Pt had PD but was SD when re-measured|0|||
13358783|NCT00887159|26676552|FG000|Overall Study|Received more tx instead of observation|1|||
13358784|NCT00887159|26676553|FG001|Overall Study|Received more tx instead of observation|0|||
13358785|NCT00887159|26676554|FG002|Overall Study|Received more tx instead of observation|0|||
13358786|NCT00887159|26676552|FG000|Overall Study|Ineligible|5|||
13358787|NCT00887159|26676553|FG001|Overall Study|Ineligible|1|||
13358788|NCT00887159|26676554|FG002|Overall Study|Ineligible|0|||
13358789|NCT00887159|26676552|FG000|Overall Study|Never started assigned therapy|3|||
13358790|NCT00887159|26676553|FG001|Overall Study|Never started assigned therapy|3|||
13358791|NCT00887159|26676554|FG002|Overall Study|Never started assigned therapy|4|||
13358792|NCT00887068|26676569|FG000|Overall Study|Withdrawal by Subject|2|||
13358793|NCT00887068|26676570|FG001|Overall Study|Withdrawal by Subject|0|||
13358794|NCT00887068|26676569|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4|||
13358795|NCT00887068|26676570|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0|||
13358796|NCT00886938|26676576|FG000|Overall Study|Adverse Event|1|||
13358797|NCT00886938|26676576|FG000|Overall Study|Withdrawal by Subject|1|||
13358798|NCT00886834|26676591|FG000|Overall Study|Protocol Violation|0|||
13358799|NCT00886834|26676592|FG001|Overall Study|Protocol Violation|3|||
13358800|NCT00886821|26676860|FG000|Stage 2|Adverse Event|0|||
13358801|NCT00886821|26676861|FG001|Stage 2|Adverse Event|0|||
13358802|NCT00886821|26676862|FG002|Stage 2|Adverse Event|0|||
13358803|NCT00886821|26676863|FG003|Stage 2|Adverse Event|0|||
13358804|NCT00886821|26676864|FG004|Stage 2|Adverse Event|0|||
13358805|NCT00886821|26676865|FG005|Stage 2|Adverse Event|0|||
13358806|NCT00886821|26676866|FG006|Stage 2|Adverse Event|0|||
13358807|NCT00886821|26676867|FG007|Stage 2|Adverse Event|0|||
13358808|NCT00886821|26676868|FG008|Stage 2|Adverse Event|0|||
13358809|NCT00886821|26676869|FG009|Stage 2|Adverse Event|0|||
13358810|NCT00886821|26676870|FG010|Stage 2|Adverse Event|0|||
13358811|NCT00886821|26676871|FG011|Stage 2|Adverse Event|1|||
13358812|NCT00886821|26676872|FG012|Stage 2|Adverse Event|3|||
13358813|NCT00886821|26676873|FG013|Stage 2|Adverse Event|0|||
13358814|NCT00886821|26676860|FG000|Stage 2|Lost to Follow-up|0|||
13358815|NCT00886821|26676861|FG001|Stage 2|Lost to Follow-up|0|||
13358816|NCT00886821|26676862|FG002|Stage 2|Lost to Follow-up|0|||
13358817|NCT00886821|26676863|FG003|Stage 2|Lost to Follow-up|0|||
13358818|NCT00886821|26676864|FG004|Stage 2|Lost to Follow-up|0|||
13358819|NCT00886821|26676865|FG005|Stage 2|Lost to Follow-up|0|||
13358820|NCT00886821|26676866|FG006|Stage 2|Lost to Follow-up|0|||
13358821|NCT00886821|26676867|FG007|Stage 2|Lost to Follow-up|0|||
13358822|NCT00886821|26676868|FG008|Stage 2|Lost to Follow-up|0|||
13358823|NCT00886821|26676869|FG009|Stage 2|Lost to Follow-up|0|||
13358824|NCT00886821|26676870|FG010|Stage 2|Lost to Follow-up|0|||
13358825|NCT00886821|26676871|FG011|Stage 2|Lost to Follow-up|0|||
13358826|NCT00886821|26676872|FG012|Stage 2|Lost to Follow-up|2|||
13358827|NCT00886821|26676873|FG013|Stage 2|Lost to Follow-up|1|||
13358828|NCT00886795|26676880|FG000|Overall Study|Lack of Efficacy|1|||
13358829|NCT00886769|26676911|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
13358830|NCT00886769|26676912|FG001|Overall Study|Unsatisfactory therapeutic effect|37|||
13358831|NCT00886743|26676922|FG000|Overall Study|Adverse Event|3|||
13358832|NCT00886743|26676922|FG000|Overall Study|Other|1|||
13358833|NCT00886639|26676928|FG000|Overall Study|acute exacerbation|14|||
13358834|NCT00886639|26676928|FG000|Overall Study|non-compliance|2|||
13358835|NCT00886613|26676956|FG000|Overall Study|Protocol deviation (Part B)|1|||
13358836|NCT00886613|26676957|FG001|Overall Study|Protocol deviation (Part B)|0|||
13358837|NCT00886613|26676958|FG002|Overall Study|Protocol deviation (Part B)|0|||
13358838|NCT00886613|26676956|FG000|Overall Study|Lost to follow-up (Part B)|1|||
13358839|NCT00886613|26676957|FG001|Overall Study|Lost to follow-up (Part B)|0|||
13358840|NCT00886613|26676958|FG002|Overall Study|Lost to follow-up (Part B)|1|||
13358841|NCT00886613|26676956|FG000|Overall Study|Subject withdrew consent (Part A)|0|||
13358842|NCT00886613|26676957|FG001|Overall Study|Subject withdrew consent (Part A)|0|||
13358843|NCT00886613|26676958|FG002|Overall Study|Subject withdrew consent (Part A)|2|||
13358844|NCT00886587|26676977|FG000|Overall Study|Adverse Event|2|||
13358845|NCT00886587|26676978|FG001|Overall Study|Adverse Event|1|||
13358846|NCT00886587|26676977|FG000|Overall Study|Protocol Violation|2|||
13358847|NCT00886587|26676978|FG001|Overall Study|Protocol Violation|0|||
13358848|NCT00886587|26676977|FG000|Overall Study|Withdrawal by Subject|0|||
13358849|NCT00886587|26676978|FG001|Overall Study|Withdrawal by Subject|1|||
13358850|NCT00886483|26677001|FG000|Overall Study|Lost to Follow-up|0|||
13358851|NCT00886483|26677002|FG001|Overall Study|Lost to Follow-up|1|||
13358852|NCT00886483|26677001|FG000|Overall Study|Pursue medications|1|||
13358853|NCT00886483|26677002|FG001|Overall Study|Pursue medications|2|||
13358854|NCT00886483|26677001|FG000|Overall Study|Distance to center, poor grades|1|||
13358855|NCT00886483|26677002|FG001|Overall Study|Distance to center, poor grades|0|||
13358856|NCT00886379|26677030|FG000|Overall Study|Transferred Schools|0|||
13358857|NCT00886379|26677031|FG001|Overall Study|Transferred Schools|0|||
13358858|NCT00886379|26677032|FG002|Overall Study|Transferred Schools|2|||
13358859|NCT00886379|26677033|FG003|Overall Study|Transferred Schools|1|||
13358860|NCT00886379|26677034|FG004|Overall Study|Transferred Schools|1|||
13358861|NCT00886379|26677030|FG000|Overall Study|Final blood draw not obtained|3|||
13358862|NCT00886379|26677031|FG001|Overall Study|Final blood draw not obtained|3|||
13358863|NCT00886379|26677032|FG002|Overall Study|Final blood draw not obtained|4|||
13358864|NCT00886379|26677033|FG003|Overall Study|Final blood draw not obtained|2|||
13358865|NCT00886379|26677034|FG004|Overall Study|Final blood draw not obtained|2|||
13358866|NCT00886340|26677047|FG000|Overall Study|Withdrawal by Subject|0|||
13358867|NCT00886340|26677048|FG001|Overall Study|Withdrawal by Subject|7|||
13358868|NCT00886288|26677071|FG000|Overall Study|no respect of the 12 weeks period|657|||
13358869|NCT00886288|26677072|FG001|Overall Study|no respect of the 12 weeks period|227|||
13358870|NCT00886288|26677071|FG000|Overall Study|Lost to Follow-up|86|||
13358871|NCT00886288|26677072|FG001|Overall Study|Lost to Follow-up|0|||
13358872|NCT00886119|26677081|FG000|Period 1|Did not meet inclusion criteria|1|||
13358873|NCT00886119|26677082|FG001|Period 1|Did not meet inclusion criteria|0|||
13358874|NCT00886015|26677105|FG000|Overall Study|Death|0|||
13358875|NCT00886015|26677106|FG001|Overall Study|Death|2|||
13358876|NCT00885846|26677124|FG000|Overall Study|Withdrawal by Subject|2|||
13358877|NCT00885846|26677125|FG001|Overall Study|Withdrawal by Subject|5|||
13358878|NCT00885846|26677126|FG002|Overall Study|Withdrawal by Subject|2|||
13374621|NCT00794664|26727428|FG000|Treatment Period|Adverse Event|1|||
13374622|NCT00794664|26727429|FG001|Treatment Period|Adverse Event|8|||
13374623|NCT00794664|26727428|FG000|Follow-up Period|Other|1|||
13374624|NCT00794664|26727429|FG001|Follow-up Period|Other|2|||
13374625|NCT00794664|26727428|FG000|Follow-up Period|Withdrawal by Subject|0|||
13374626|NCT00794664|26727429|FG001|Follow-up Period|Withdrawal by Subject|2|||
13374627|NCT00794664|26727428|FG000|Follow-up Period|Protocol non-compliance|0|||
13374628|NCT00794664|26727429|FG001|Follow-up Period|Protocol non-compliance|1|||
13374629|NCT00794573|26727464|FG000|Overall Study|Death|3|||
13374630|NCT00794573|26727465|FG001|Overall Study|Death|0|||
13374631|NCT00794573|26727464|FG000|Overall Study|Withdrawal by Subject|9|||
13374632|NCT00794573|26727465|FG001|Overall Study|Withdrawal by Subject|12|||
13374633|NCT00794573|26727464|FG000|Overall Study|Lost to Follow-up|26|||
13374634|NCT00794573|26727465|FG001|Overall Study|Lost to Follow-up|33|||
13358879|NCT04625725|26677176|FG000|Overall Study|Death|4|||
13358880|NCT04625725|26677177|FG001|Overall Study|Death|4|||
13358881|NCT04625725|26677176|FG000|Overall Study|Lost to Follow-up|11|||
13358882|NCT04625725|26677177|FG001|Overall Study|Lost to Follow-up|8|||
13358883|NCT04625725|26677176|FG000|Overall Study|Physician Decision|1|||
13358884|NCT04625725|26677177|FG001|Overall Study|Physician Decision|0|||
13358885|NCT04625725|26677176|FG000|Overall Study|Withdrawal by Subject|56|||
13358886|NCT04625725|26677177|FG001|Overall Study|Withdrawal by Subject|32|||
13358887|NCT04625725|26677176|FG000|Overall Study|"Includes participants who discontinued early with reason other selected."|18|||
13358888|NCT04625725|26677177|FG001|Overall Study|"Includes participants who discontinued early with reason other selected."|10|||
13358889|NCT04625725|26677176|FG000|Overall Study|Ongoing in study|3409|||
13358890|NCT04625725|26677177|FG001|Overall Study|Ongoing in study|1700|||
13358891|NCT04625725|26677176|FG000|Overall Study|Protocol Deviation|1|||
13358892|NCT04625725|26677177|FG001|Overall Study|Protocol Deviation|0|||
13358893|NCT04583956|26677384|FG000|Overall Study|Death|9|||
13358894|NCT04583956|26677385|FG001|Overall Study|Death|11|||
13358895|NCT04583956|26677384|FG000|Overall Study|Lost to Follow-up|7|||
13358896|NCT04583956|26677385|FG001|Overall Study|Lost to Follow-up|9|||
13358897|NCT04583956|26677384|FG000|Overall Study|Protocol Violation|2|||
13358898|NCT04583956|26677385|FG001|Overall Study|Protocol Violation|0|||
13358899|NCT04583956|26677384|FG000|Overall Study|Withdrawal by Subject|0|||
13358900|NCT04583956|26677385|FG001|Overall Study|Withdrawal by Subject|2|||
13358901|NCT04583956|26677384|FG000|Overall Study|Randomized but not dosed|2|||
13358902|NCT04583956|26677385|FG001|Overall Study|Randomized but not dosed|3|||
13358903|NCT04583956|26677384|FG000|Overall Study|Withdrawal of consent before product administration|1|||
13358904|NCT04583956|26677385|FG001|Overall Study|Withdrawal of consent before product administration|0|||
13358905|NCT04533438|26677403|FG000|Crossover Period|Did not meet Eligibility to Crossover|0|||
13358906|NCT04533438|26677404|FG001|Crossover Period|Did not meet Eligibility to Crossover|11|||
13358907|NCT04517253|26677446|FG000|Overall Study|Adverse Event|1|||
13358908|NCT04517253|26677447|FG001|Overall Study|Adverse Event|0|||
13358909|NCT04517253|26677448|FG002|Overall Study|Adverse Event|0|||
13358910|NCT04517253|26677446|FG000|Overall Study|Death|0|||
13358911|NCT04517253|26677447|FG001|Overall Study|Death|1|||
13358912|NCT04517253|26677448|FG002|Overall Study|Death|0|||
13358913|NCT04505722|26677513|FG000|Overall Study|Adverse Event|1|||
13358914|NCT04505722|26677514|FG001|Overall Study|Adverse Event|2|||
13358915|NCT04505722|26677513|FG000|Overall Study|Death|34|||
13124939|NCT02936635|25954499|FG000|Overall Study|Protocol Violation|1|||
13124940|NCT02936635|25954500|FG001|Overall Study|Protocol Violation|0|||
13124941|NCT02936635|25954499|FG000|Overall Study|Lack of effect/Entry into other study|31|||
13124942|NCT02936635|25954500|FG001|Overall Study|Lack of effect/Entry into other study|65|||
13204446|NCT01972841|26229048|FG000|Overall Study|Lack of Efficacy|1|||
13204447|NCT01972841|26229049|FG001|Overall Study|Lack of Efficacy|0|||
13204448|NCT01972841|26229050|FG002|Overall Study|Lack of Efficacy|0|||
13204449|NCT01972841|26229051|FG003|Overall Study|Lack of Efficacy|2|||
13204450|NCT01972841|26229052|FG004|Overall Study|Lack of Efficacy|4|||
13204451|NCT01972841|26229053|FG005|Overall Study|Lack of Efficacy|1|||
13204452|NCT01972841|26229048|FG000|Overall Study|Lost to Follow-up|4|||
13204453|NCT01972841|26229049|FG001|Overall Study|Lost to Follow-up|2|||
13204454|NCT01972841|26229050|FG002|Overall Study|Lost to Follow-up|4|||
13204455|NCT01972841|26229051|FG003|Overall Study|Lost to Follow-up|2|||
13204456|NCT01972841|26229052|FG004|Overall Study|Lost to Follow-up|9|||
13204457|NCT01972841|26229053|FG005|Overall Study|Lost to Follow-up|3|||
13204458|NCT01972841|26229048|FG000|Overall Study|Protocol Violation|2|||
13204459|NCT01972841|26229049|FG001|Overall Study|Protocol Violation|2|||
13204460|NCT01972841|26229050|FG002|Overall Study|Protocol Violation|3|||
13204461|NCT01972841|26229051|FG003|Overall Study|Protocol Violation|5|||
13204462|NCT01972841|26229052|FG004|Overall Study|Protocol Violation|9|||
13204463|NCT01972841|26229053|FG005|Overall Study|Protocol Violation|4|||
13204464|NCT01972841|26229048|FG000|Overall Study|Withdrawal by participants|21|||
13204465|NCT01972841|26229049|FG001|Overall Study|Withdrawal by participants|27|||
13204466|NCT01972841|26229050|FG002|Overall Study|Withdrawal by participants|23|||
13204467|NCT01972841|26229051|FG003|Overall Study|Withdrawal by participants|16|||
13204468|NCT01972841|26229052|FG004|Overall Study|Withdrawal by participants|33|||
13358916|NCT04505722|26677514|FG001|Overall Study|Death|63|||
13358917|NCT04505722|26677513|FG000|Overall Study|Lost to Follow-up|271|||
13358918|NCT04505722|26677514|FG001|Overall Study|Lost to Follow-up|333|||
13358919|NCT04505722|26677513|FG000|Overall Study|Physician Decision|17|||
13358920|NCT04505722|26677514|FG001|Overall Study|Physician Decision|17|||
13358921|NCT04505722|26677513|FG000|Overall Study|Protocol Violation|0|||
13358922|NCT04505722|26677514|FG001|Overall Study|Protocol Violation|1|||
13358923|NCT04505722|26677513|FG000|Overall Study|Withdrawal by Subject|376|||
13358924|NCT04505722|26677514|FG001|Overall Study|Withdrawal by Subject|714|||
13124943|NCT02936037|25954513|FG000|Double-Blind Treatment Period|Protocol Violation|1|||
13124944|NCT02936037|25954514|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
13124945|NCT02936037|25954513|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2|||
13124946|NCT02936037|25954514|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8|||
13358925|NCT04505722|26677513|FG000|Overall Study|Other|61|||
13358926|NCT04505722|26677514|FG001|Overall Study|Other|98|||
13358927|NCT04505722|26677513|FG000|Overall Study|Still ongoing|21138|||
13358928|NCT04505722|26677514|FG001|Overall Study|Still ongoing|20662|||
13358929|NCT04505722|26677513|FG000|Overall Study|Randomized not vaccinated|276|||
13358930|NCT04505722|26677514|FG001|Overall Study|Randomized not vaccinated|260|||
13358931|NCT04441788|26677753|FG000|Overall Study|Voluntary Withdrawl|0|||
13358932|NCT04441788|26677754|FG001|Overall Study|Voluntary Withdrawl|1|||
13358933|NCT04441788|26677755|FG002|Overall Study|Voluntary Withdrawl|0|||
13358934|NCT04441788|26677753|FG000|Overall Study|Ineligibility|1|||
13358935|NCT04441788|26677754|FG001|Overall Study|Ineligibility|0|||
13358936|NCT04441788|26677755|FG002|Overall Study|Ineligibility|0|||
13358937|NCT04441788|26677753|FG000|Overall Study|Adverse Event|0|||
13358938|NCT04441788|26677754|FG001|Overall Study|Adverse Event|0|||
13358939|NCT04441788|26677755|FG002|Overall Study|Adverse Event|4|||
13358940|NCT04441788|26677753|FG000|Overall Study|Study Terminated by Sponsor|16|||
13358941|NCT04441788|26677754|FG001|Overall Study|Study Terminated by Sponsor|16|||
13358942|NCT04441788|26677755|FG002|Overall Study|Study Terminated by Sponsor|12|||
13358943|NCT04399889|26677797|FG000|Overall Study|Death|5|||
13358944|NCT04399889|26677798|FG001|Overall Study|Death|1|||
13358945|NCT04399889|26677799|FG002|Overall Study|Death|1|||
13374635|NCT00794417|26727531|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
13374636|NCT00794417|26727532|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
13374637|NCT00794417|26727533|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2|||
13374638|NCT00794417|26727534|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
13374639|NCT00794417|26727531|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
13374640|NCT00794417|26727532|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
13374641|NCT00794417|26727533|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1|||
13374642|NCT00794417|26727534|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0|||
13374643|NCT00794417|26727531|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
13374644|NCT00794417|26727532|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
13374645|NCT00794417|26727533|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
13374646|NCT00794417|26727534|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7|||
13374647|NCT00794417|26727531|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
13374648|NCT00794417|26727532|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
13374649|NCT00794417|26727533|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
13374650|NCT00794417|26727534|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11|||
13374651|NCT00794417|26727531|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
13374652|NCT00794417|26727532|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
13374653|NCT00794417|26727533|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
13374654|NCT00794417|26727534|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4|||
13374655|NCT00794417|26727531|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
13374656|NCT00794417|26727532|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
13374657|NCT00794417|26727533|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
13374658|NCT00794417|26727534|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13|||
13375474|NCT00790751|26729965|FG000|Overall Study|Protocol non-compliance|16|||
13375475|NCT00790751|26729966|FG001|Overall Study|Protocol non-compliance|16|||
13375476|NCT00790751|26729967|FG002|Overall Study|Protocol non-compliance|10|||
13375477|NCT00790751|26729968|FG003|Overall Study|Protocol non-compliance|11|||
13375478|NCT00790751|26729965|FG000|Overall Study|Lost to Follow-up|4|||
13375479|NCT00790751|26729966|FG001|Overall Study|Lost to Follow-up|9|||
13375480|NCT00790751|26729967|FG002|Overall Study|Lost to Follow-up|4|||
13375481|NCT00790751|26729968|FG003|Overall Study|Lost to Follow-up|5|||
13375482|NCT00790751|26729965|FG000|Overall Study|Adverse Event|5|||
13375483|NCT00790751|26729966|FG001|Overall Study|Adverse Event|3|||
13375484|NCT00790751|26729967|FG002|Overall Study|Adverse Event|5|||
13375485|NCT00790751|26729968|FG003|Overall Study|Adverse Event|4|||
13375486|NCT00790751|26729965|FG000|Overall Study|Requirement for restricted medication|0|||
13375487|NCT00790751|26729966|FG001|Overall Study|Requirement for restricted medication|2|||
13375488|NCT00790751|26729967|FG002|Overall Study|Requirement for restricted medication|0|||
13375489|NCT00790751|26729968|FG003|Overall Study|Requirement for restricted medication|0|||
13375490|NCT00790751|26729965|FG000|Overall Study|Death|0|||
13375491|NCT00790751|26729966|FG001|Overall Study|Death|0|||
13375492|NCT00790751|26729967|FG002|Overall Study|Death|1|||
13375493|NCT00790751|26729968|FG003|Overall Study|Death|0|||
13375494|NCT00790751|26729965|FG000|Overall Study|Physician Decision|0|||
13375495|NCT00790751|26729966|FG001|Overall Study|Physician Decision|0|||
13375496|NCT00790751|26729967|FG002|Overall Study|Physician Decision|0|||
13375497|NCT00790751|26729968|FG003|Overall Study|Physician Decision|1|||
13375498|NCT00790647|26729977|FG000|Overall Study|Adverse Event|1|||
13375499|NCT00790582|26729992|FG000|Overall Study|Death|14|||
13375500|NCT00790582|26729993|FG001|Overall Study|Death|32|||
13375501|NCT00790582|26729992|FG000|Overall Study|Physician Decision|7|||
13375502|NCT00790582|26729993|FG001|Overall Study|Physician Decision|1|||
13375503|NCT00790582|26729992|FG000|Overall Study|Lost to Follow-up|3|||
13358946|NCT04287920|26677826|FG000|Overall Study|Lost to Follow-up|1|||
13358947|NCT04287920|26677827|FG001|Overall Study|Lost to Follow-up|1|||
13358948|NCT04287920|26677826|FG000|Overall Study|Withdrawal by Subject|0|||
13358949|NCT04287920|26677827|FG001|Overall Study|Withdrawal by Subject|3|||
13358950|NCT04202679|26677949|FG000|Overall Study|Adverse Event|2|||
13358951|NCT04202679|26677950|FG001|Overall Study|Adverse Event|0|||
13358952|NCT04202679|26677949|FG000|Overall Study|Poor compliance to protocol|1|||
13358953|NCT04202679|26677950|FG001|Overall Study|Poor compliance to protocol|0|||
13358954|NCT04202679|26677949|FG000|Overall Study|Withdrawal by Subject|23|||
13358955|NCT04202679|26677950|FG001|Overall Study|Withdrawal by Subject|6|||
13358956|NCT04143594|26678047|FG000|Overall Study|Still on study|48|||
13358957|NCT04143594|26678048|FG001|Overall Study|Still on study|42|||
13358958|NCT04143594|26678049|FG002|Overall Study|Still on study|48|||
13358959|NCT04143594|26678050|FG003|Overall Study|Still on study|18|||
13358960|NCT04143594|26678047|FG000|Overall Study|Withdrew consent|0|||
13358961|NCT04143594|26678048|FG001|Overall Study|Withdrew consent|6|||
13358962|NCT04143594|26678049|FG002|Overall Study|Withdrew consent|1|||
13358963|NCT04143594|26678050|FG003|Overall Study|Withdrew consent|1|||
13358964|NCT04143594|26678047|FG000|Overall Study|Lost to Follow-up|2|||
13358965|NCT04143594|26678048|FG001|Overall Study|Lost to Follow-up|2|||
13358966|NCT04143594|26678049|FG002|Overall Study|Lost to Follow-up|3|||
13358967|NCT04143594|26678050|FG003|Overall Study|Lost to Follow-up|0|||
13358968|NCT04143594|26678047|FG000|Overall Study|Investigator's discretion|1|||
13358969|NCT04143594|26678048|FG001|Overall Study|Investigator's discretion|2|||
13358970|NCT04143594|26678049|FG002|Overall Study|Investigator's discretion|0|||
13358971|NCT04143594|26678050|FG003|Overall Study|Investigator's discretion|0|||
13358972|NCT04143594|26678047|FG000|Overall Study|Lack of Efficacy|0|||
13358973|NCT04143594|26678048|FG001|Overall Study|Lack of Efficacy|1|||
13358974|NCT04143594|26678049|FG002|Overall Study|Lack of Efficacy|0|||
13358975|NCT04143594|26678050|FG003|Overall Study|Lack of Efficacy|0|||
13358976|NCT04143594|26678047|FG000|Overall Study|Protocol Violation|0|||
13358977|NCT04143594|26678048|FG001|Overall Study|Protocol Violation|0|||
13358978|NCT04143594|26678049|FG002|Overall Study|Protocol Violation|0|||
13358979|NCT04143594|26678050|FG003|Overall Study|Protocol Violation|1|||
13358980|NCT04138056|26678357|FG000|Primary Study|Lost to Follow-up|3|||
13358981|NCT04138056|26678358|FG001|Primary Study|Lost to Follow-up|4|||
13358982|NCT04138056|26678359|FG002|Primary Study|Lost to Follow-up|1|||
13358983|NCT04138056|26678360|FG003|Primary Study|Lost to Follow-up|1|||
13358984|NCT04138056|26678361|FG004|Primary Study|Lost to Follow-up|4|||
13358985|NCT04138056|26678357|FG000|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|3|||
13358986|NCT04138056|26678358|FG001|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|4|||
13358987|NCT04138056|26678359|FG002|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|2|||
13358988|NCT04138056|26678360|FG003|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|1|||
13358989|NCT04138056|26678361|FG004|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|0|||
13358990|NCT04138056|26678357|FG000|Extension Study|Lost to Follow-up|1|||
13358991|NCT04138056|26678358|FG001|Extension Study|Lost to Follow-up|2|||
13358992|NCT04138056|26678359|FG002|Extension Study|Lost to Follow-up|1|||
13358993|NCT04138056|26678360|FG003|Extension Study|Lost to Follow-up|0|||
13358994|NCT04138056|26678361|FG004|Extension Study|Lost to Follow-up|1|||
13358995|NCT04035668|26678506|FG000|Overall Study|Adverse Event|3|||
13358996|NCT04035668|26678507|FG001|Overall Study|Adverse Event|4|||
13358997|NCT04035668|26678508|FG002|Overall Study|Adverse Event|2|||
13358998|NCT04035668|26678506|FG000|Overall Study|Lost to Follow-up|0|||
13358999|NCT04035668|26678507|FG001|Overall Study|Lost to Follow-up|1|||
13359000|NCT04035668|26678508|FG002|Overall Study|Lost to Follow-up|0|||
13359001|NCT04035668|26678506|FG000|Overall Study|Physician Decision|2|||
13359002|NCT04035668|26678507|FG001|Overall Study|Physician Decision|1|||
13359003|NCT04035668|26678508|FG002|Overall Study|Physician Decision|1|||
13359004|NCT04035668|26678506|FG000|Overall Study|Subject Decision|2|||
13359005|NCT04035668|26678507|FG001|Overall Study|Subject Decision|2|||
13359006|NCT04035668|26678508|FG002|Overall Study|Subject Decision|0|||
13359007|NCT04026165|26678537|FG000|Run-in Placebo Period|Enrollment Error|13|||
13359008|NCT04026165|26678538|FG001|Run-in Placebo Period|Enrollment Error|0|||
13359009|NCT04026165|26678539|FG002|Run-in Placebo Period|Enrollment Error|0|||
13359010|NCT04026165|26678540|FG003|Run-in Placebo Period|Enrollment Error|0|||
13359011|NCT04026165|26678537|FG000|Run-in Placebo Period|Run-in Failure|4|||
13359012|NCT04026165|26678538|FG001|Run-in Placebo Period|Run-in Failure|0|||
13359013|NCT04026165|26678539|FG002|Run-in Placebo Period|Run-in Failure|0|||
13359014|NCT04026165|26678540|FG003|Run-in Placebo Period|Run-in Failure|0|||
13359015|NCT04026165|26678537|FG000|Run-in Placebo Period|Protocol Violation|2|||
13359016|NCT04026165|26678538|FG001|Run-in Placebo Period|Protocol Violation|0|||
13359017|NCT04026165|26678539|FG002|Run-in Placebo Period|Protocol Violation|0|||
13359018|NCT04026165|26678540|FG003|Run-in Placebo Period|Protocol Violation|0|||
13359019|NCT04026165|26678537|FG000|Run-in Placebo Period|Withdrew Consent|2|||
13359020|NCT04026165|26678538|FG001|Run-in Placebo Period|Withdrew Consent|0|||
13359021|NCT04026165|26678539|FG002|Run-in Placebo Period|Withdrew Consent|0|||
13359022|NCT04026165|26678540|FG003|Run-in Placebo Period|Withdrew Consent|0|||
13359023|NCT04026165|26678537|FG000|Run-in Placebo Period|Significant Non-Compliance with Study Drug|1|||
13359024|NCT04026165|26678538|FG001|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
13359025|NCT04026165|26678539|FG002|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
13359026|NCT04026165|26678540|FG003|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
13359027|NCT04026165|26678537|FG000|Run-in SEL Period|Run-in Failure|0|||
13359028|NCT04026165|26678538|FG001|Run-in SEL Period|Run-in Failure|26|||
13359029|NCT04026165|26678539|FG002|Run-in SEL Period|Run-in Failure|0|||
13359030|NCT04026165|26678540|FG003|Run-in SEL Period|Run-in Failure|0|||
13359031|NCT04026165|26678537|FG000|Run-in SEL Period|Withdrew Consent|0|||
13359032|NCT04026165|26678538|FG001|Run-in SEL Period|Withdrew Consent|10|||
13359033|NCT04026165|26678539|FG002|Run-in SEL Period|Withdrew Consent|0|||
13359034|NCT04026165|26678540|FG003|Run-in SEL Period|Withdrew Consent|0|||
13359035|NCT04026165|26678537|FG000|Run-in SEL Period|Enrollment Error|0|||
13359036|NCT04026165|26678538|FG001|Run-in SEL Period|Enrollment Error|4|||
13359037|NCT04026165|26678539|FG002|Run-in SEL Period|Enrollment Error|0|||
13359038|NCT04026165|26678540|FG003|Run-in SEL Period|Enrollment Error|0|||
13359039|NCT04026165|26678537|FG000|Run-in SEL Period|Protocol Violation|0|||
13359040|NCT04026165|26678538|FG001|Run-in SEL Period|Protocol Violation|3|||
13359041|NCT04026165|26678539|FG002|Run-in SEL Period|Protocol Violation|0|||
13359042|NCT04026165|26678540|FG003|Run-in SEL Period|Protocol Violation|0|||
13359043|NCT04026165|26678537|FG000|Run-in SEL Period|Investigator's Discretion|0|||
13359044|NCT04026165|26678538|FG001|Run-in SEL Period|Investigator's Discretion|2|||
13359045|NCT04026165|26678539|FG002|Run-in SEL Period|Investigator's Discretion|0|||
13359046|NCT04026165|26678540|FG003|Run-in SEL Period|Investigator's Discretion|0|||
13359047|NCT04026165|26678537|FG000|Run-in SEL Period|Death|0|||
13359048|NCT04026165|26678538|FG001|Run-in SEL Period|Death|1|||
13359049|NCT04026165|26678539|FG002|Run-in SEL Period|Death|0|||
13359050|NCT04026165|26678540|FG003|Run-in SEL Period|Death|0|||
13359051|NCT04026165|26678537|FG000|Randomized Period|Withdrew Consent|0|||
13359052|NCT04026165|26678538|FG001|Randomized Period|Withdrew Consent|0|||
13359053|NCT04026165|26678539|FG002|Randomized Period|Withdrew Consent|5|||
13359054|NCT04026165|26678540|FG003|Randomized Period|Withdrew Consent|8|||
13359055|NCT04026165|26678537|FG000|Randomized Period|Death|0|||
13359056|NCT04026165|26678538|FG001|Randomized Period|Death|0|||
13359057|NCT04026165|26678539|FG002|Randomized Period|Death|5|||
13359058|NCT04026165|26678540|FG003|Randomized Period|Death|7|||
13359059|NCT04026165|26678537|FG000|Randomized Period|Investigator's Discretion|0|||
13359060|NCT04026165|26678538|FG001|Randomized Period|Investigator's Discretion|0|||
13359061|NCT04026165|26678539|FG002|Randomized Period|Investigator's Discretion|2|||
13359062|NCT04026165|26678540|FG003|Randomized Period|Investigator's Discretion|2|||
13359063|NCT04026165|26678537|FG000|Randomized Period|Lost to Follow-up|0|||
13359064|NCT04026165|26678538|FG001|Randomized Period|Lost to Follow-up|0|||
13359065|NCT04026165|26678539|FG002|Randomized Period|Lost to Follow-up|2|||
13359066|NCT04026165|26678540|FG003|Randomized Period|Lost to Follow-up|2|||
13359067|NCT03996369|26678580|FG000|Overall Study|Protocol deviation|1|||
13359068|NCT03996369|26678581|FG001|Overall Study|Protocol deviation|1|||
13359069|NCT03996369|26678580|FG000|Overall Study|Physician Decision|4|||
13359070|NCT03996369|26678581|FG001|Overall Study|Physician Decision|2|||
13359071|NCT03996369|26678580|FG000|Overall Study|Participant decision|0|||
13359072|NCT03996369|26678581|FG001|Overall Study|Participant decision|1|||
13359073|NCT03996369|26678580|FG000|Overall Study|Lack of Efficacy|4|||
13359074|NCT03996369|26678581|FG001|Overall Study|Lack of Efficacy|0|||
13359075|NCT03996369|26678580|FG000|Overall Study|Adverse Event|9|||
13359076|NCT03996369|26678581|FG001|Overall Study|Adverse Event|0|||
13359077|NCT03996369|26678580|FG000|Overall Study|Withdrawal by Subject|6|||
13359078|NCT03996369|26678581|FG001|Overall Study|Withdrawal by Subject|8|||
13359079|NCT03996369|26678580|FG000|Overall Study|Didn't meet Inclusion/Exclusion criteria|1|||
13359080|NCT03996369|26678581|FG001|Overall Study|Didn't meet Inclusion/Exclusion criteria|0|||
13359081|NCT03996369|26678580|FG000|Overall Study|Lost to Follow-up|0|||
13359082|NCT03996369|26678581|FG001|Overall Study|Lost to Follow-up|1|||
13359083|NCT03945188|26678638|FG000|Overall Study|Protocol Violation|1|||
13359084|NCT03945188|26678639|FG001|Overall Study|Protocol Violation|0|||
13359085|NCT03945188|26678638|FG000|Overall Study|Disease worsening|79|||
13359086|NCT03945188|26678639|FG001|Overall Study|Disease worsening|73|||
13359087|NCT03945188|26678638|FG000|Overall Study|Physician Decision|2|||
13359088|NCT03945188|26678639|FG001|Overall Study|Physician Decision|2|||
13359089|NCT03945188|26678638|FG000|Overall Study|Lack of Efficacy|7|||
13359090|NCT03945188|26678639|FG001|Overall Study|Lack of Efficacy|4|||
13359091|NCT03945188|26678638|FG000|Overall Study|Pregnancy|2|||
13359092|NCT03945188|26678639|FG001|Overall Study|Pregnancy|0|||
13359093|NCT03945188|26678638|FG000|Overall Study|Withdrawal by participant or parent/guardian|24|||
13359094|NCT03945188|26678639|FG001|Overall Study|Withdrawal by participant or parent/guardian|10|||
13359095|NCT03945188|26678638|FG000|Overall Study|Adverse Event|10|||
13359096|NCT03945188|26678639|FG001|Overall Study|Adverse Event|5|||
13359097|NCT03945188|26678638|FG000|Overall Study|Other|2|||
13359098|NCT03945188|26678639|FG001|Overall Study|Other|2|||
13359099|NCT03945188|26678638|FG000|Overall Study|Lost to Follow-up|1|||
13359100|NCT03945188|26678639|FG001|Overall Study|Lost to Follow-up|2|||
13359101|NCT03873493|26678653|FG000|Overall Study|Withdrawal by Subject|1|||
13359102|NCT03873493|26678653|FG000|Overall Study|Death|9|||
13359103|NCT03873493|26678653|FG000|Overall Study|Lost to Follow-up|1|||
13359104|NCT03873493|26678653|FG000|Overall Study|Study Terminated by Sponsor|1|||
13359105|NCT03873493|26678653|FG000|Overall Study|Other|2|||
13359106|NCT03872453|26678740|FG000|Overall Study|Adverse Event|1|||
13359107|NCT03872453|26678741|FG001|Overall Study|Adverse Event|1|||
13359108|NCT03872453|26678742|FG002|Overall Study|Adverse Event|0|||
13359109|NCT03872453|26678743|FG003|Overall Study|Adverse Event|0|||
13359110|NCT03872453|26678740|FG000|Overall Study|Lost to Follow-up|8|||
13359111|NCT03872453|26678741|FG001|Overall Study|Lost to Follow-up|7|||
13359112|NCT03872453|26678742|FG002|Overall Study|Lost to Follow-up|4|||
13359113|NCT03872453|26678743|FG003|Overall Study|Lost to Follow-up|4|||
13359114|NCT03872453|26678740|FG000|Overall Study|Never Treated Migraine|19|||
13359115|NCT03872453|26678741|FG001|Overall Study|Never Treated Migraine|17|||
13359116|NCT03872453|26678742|FG002|Overall Study|Never Treated Migraine|13|||
13359117|NCT03872453|26678743|FG003|Overall Study|Never Treated Migraine|12|||
13359118|NCT03872453|26678740|FG000|Overall Study|Pregnancy|1|||
13359119|NCT03872453|26678741|FG001|Overall Study|Pregnancy|0|||
13359120|NCT03872453|26678742|FG002|Overall Study|Pregnancy|0|||
13359121|NCT03872453|26678743|FG003|Overall Study|Pregnancy|0|||
13359122|NCT03872453|26678740|FG000|Overall Study|Protocol Deviation|2|||
13359123|NCT03872453|26678741|FG001|Overall Study|Protocol Deviation|0|||
13359124|NCT03872453|26678742|FG002|Overall Study|Protocol Deviation|0|||
13359125|NCT03872453|26678743|FG003|Overall Study|Protocol Deviation|2|||
13359126|NCT03872453|26678740|FG000|Overall Study|Withdrawal by Subject|0|||
13359127|NCT03872453|26678741|FG001|Overall Study|Withdrawal by Subject|1|||
13359128|NCT03872453|26678742|FG002|Overall Study|Withdrawal by Subject|2|||
13359129|NCT03872453|26678743|FG003|Overall Study|Withdrawal by Subject|0|||
13359130|NCT03872453|26678740|FG000|Overall Study|Other Than Specified|1|||
13359131|NCT03872453|26678741|FG001|Overall Study|Other Than Specified|0|||
13359132|NCT03872453|26678742|FG002|Overall Study|Other Than Specified|0|||
13359133|NCT03872453|26678743|FG003|Overall Study|Other Than Specified|0|||
13374659|NCT00794365|26727542|FG000|Overall Study|Lost to Follow-up|38|||
13374660|NCT00794365|26727542|FG000|Overall Study|Other|17|||
13374661|NCT00794365|26727542|FG000|Overall Study|Poor Compliance|11|||
13374662|NCT00794365|26727542|FG000|Overall Study|Adverse Event|10|||
13374663|NCT00794365|26727542|FG000|Overall Study|Lack of Efficacy|3|||
13374664|NCT00794339|26727596|FG000|Overall Study|Withdrawal by Subject|3|||
13374665|NCT00794339|26727596|FG000|Overall Study|Ineligible|4|||
13374666|NCT00794339|26727596|FG000|Overall Study|Tx prior to ATSM|3|||
13374667|NCT00794339|26727596|FG000|Overall Study|ATSM imaging not complete or inadequate|3|||
13374668|NCT00794339|26727596|FG000|Overall Study|Tx not per protocol|1|||
13374669|NCT00794196|26727611|FG000|Overall Study|Lost to Follow-up|5|||
13374670|NCT00794196|26727612|FG001|Overall Study|Lost to Follow-up|23|||
13374671|NCT00794157|26727642|FG000|Overall Study|Adverse Event|4|||
13374672|NCT00794157|26727643|FG001|Overall Study|Adverse Event|1|||
13374673|NCT00794157|26727644|FG002|Overall Study|Adverse Event|8|||
13374674|NCT00794157|26727642|FG000|Overall Study|Subject withdrew consent|2|||
13374675|NCT00794157|26727643|FG001|Overall Study|Subject withdrew consent|0|||
13374676|NCT00794157|26727644|FG002|Overall Study|Subject withdrew consent|3|||
13374677|NCT00794157|26727642|FG000|Overall Study|Lost to Follow-up|2|||
13374678|NCT00794157|26727643|FG001|Overall Study|Lost to Follow-up|0|||
13374679|NCT00794157|26727644|FG002|Overall Study|Lost to Follow-up|1|||
13374680|NCT00794157|26727642|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
13374681|NCT00794157|26727643|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
13374682|NCT00794157|26727644|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
13374683|NCT00794157|26727642|FG000|Overall Study|Administrative problems|1|||
13374684|NCT00794157|26727643|FG001|Overall Study|Administrative problems|7|||
13374685|NCT00794157|26727644|FG002|Overall Study|Administrative problems|4|||
13374686|NCT00794157|26727642|FG000|Overall Study|Abnormal test procedure result(s)|0|||
13374687|NCT00794157|26727643|FG001|Overall Study|Abnormal test procedure result(s)|1|||
13374688|NCT00794157|26727644|FG002|Overall Study|Abnormal test procedure result(s)|0|||
13374689|NCT00794157|26727642|FG000|Overall Study|Protocol deviation|0|||
13374690|NCT00794157|26727643|FG001|Overall Study|Protocol deviation|1|||
13374691|NCT00794157|26727644|FG002|Overall Study|Protocol deviation|1|||
13374692|NCT00794118|26727704|FG000|Overall Study|Lost to Follow-up|16|||
13374693|NCT00794118|26727704|FG000|Overall Study|Withdrawal by Subject|9|||
13374694|NCT00794118|26727704|FG000|Overall Study|Changed hospital center|2|||
13374695|NCT00794040|26727725|FG000|Overall Study|Withdrawal by Subject|3|||
13374696|NCT00794040|26727726|FG001|Overall Study|Withdrawal by Subject|4|||
13374697|NCT00794040|26727725|FG000|Overall Study|Physician Decision|0|||
13374698|NCT00794040|26727726|FG001|Overall Study|Physician Decision|1|||
13374699|NCT00793910|26727747|FG000|Overall Study|discarded study pills|0|||
13374700|NCT00793910|26727748|FG001|Overall Study|discarded study pills|1|||
13375504|NCT00790582|26729993|FG001|Overall Study|Lost to Follow-up|3|||
13359134|NCT03856996|26678806|FG000|Overall Study|Withdrawal by Subject|1|||
13359135|NCT03856996|26678807|FG001|Overall Study|Withdrawal by Subject|0|||
13359136|NCT03856996|26678806|FG000|Overall Study|Lost to Follow-up|0|||
13359137|NCT03856996|26678807|FG001|Overall Study|Lost to Follow-up|1|||
13359138|NCT03856996|26678806|FG000|Overall Study|Adverse Event|1|||
13359139|NCT03856996|26678807|FG001|Overall Study|Adverse Event|1|||
13359140|NCT03856996|26678806|FG000|Overall Study|Other|1|||
13359141|NCT03856996|26678807|FG001|Overall Study|Other|0|||
13359142|NCT03783026|26678879|FG000|Treatment Phase|Adverse Event|15|||
13359143|NCT03783026|26678879|FG000|Treatment Phase|Lack of Efficacy|11|||
13359144|NCT03783026|26678879|FG000|Treatment Phase|Withdrawal by Subject|6|||
13359145|NCT03783026|26678879|FG000|Treatment Phase|Lack of Efficacy|2|||
13359146|NCT03783026|26678879|FG000|Treatment Phase|Protocol Deviation|8|||
13359147|NCT03783026|26678879|FG000|Treatment Phase|Did Not Receive Treatment|1|||
13359148|NCT03783026|26678879|FG000|Observational Follow-up Phase|Lost to Follow-up|3|||
13359149|NCT03739840|26678954|FG000|Treatment Period: Wk0-16|Adverse Event|2|||
13359150|NCT03739840|26678955|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
13359151|NCT03739840|26678956|FG002|Treatment Period: Wk0-16|Adverse Event|6|||
13359152|NCT03739840|26678957|FG003|Treatment Period: Wk0-16|Adverse Event|12|||
13359153|NCT03739840|26678954|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0|||
13359154|NCT03739840|26678955|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
13359155|NCT03739840|26678956|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
13359156|NCT03739840|26678957|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3|||
13359157|NCT03739840|26678954|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
13359158|NCT03739840|26678955|FG001|Treatment Period: Wk0-16|Protocol Violation|0|||
13359159|NCT03739840|26678956|FG002|Treatment Period: Wk0-16|Protocol Violation|1|||
13359160|NCT03739840|26678957|FG003|Treatment Period: Wk0-16|Protocol Violation|0|||
13359161|NCT03739840|26678954|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1|||
13359162|NCT03739840|26678955|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3|||
13359163|NCT03739840|26678956|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1|||
13359164|NCT03739840|26678957|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1|||
13359165|NCT03739840|26678954|FG000|Treatment Period: Wk0-16|Program Termination|3|||
13359166|NCT03739840|26678955|FG001|Treatment Period: Wk0-16|Program Termination|0|||
13359167|NCT03739840|26678956|FG002|Treatment Period: Wk0-16|Program Termination|1|||
13359168|NCT03739840|26678957|FG003|Treatment Period: Wk0-16|Program Termination|1|||
13359169|NCT03739840|26678954|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1|||
13359170|NCT03739840|26678955|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
13359171|NCT03739840|26678956|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
13359172|NCT03739840|26678957|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
13359173|NCT03739840|26678954|FG000|Treatment Period: Wk0-16|Sponsors Decision|3|||
13359174|NCT03739840|26678955|FG001|Treatment Period: Wk0-16|Sponsors Decision|2|||
13359175|NCT03739840|26678956|FG002|Treatment Period: Wk0-16|Sponsors Decision|1|||
13359176|NCT03739840|26678957|FG003|Treatment Period: Wk0-16|Sponsors Decision|3|||
13359177|NCT03739840|26678954|FG000|Treatment Period: Wk0-16|Promotor Decision|0|||
13359178|NCT03739840|26678955|FG001|Treatment Period: Wk0-16|Promotor Decision|1|||
13359179|NCT03739840|26678956|FG002|Treatment Period: Wk0-16|Promotor Decision|0|||
13359180|NCT03739840|26678957|FG003|Treatment Period: Wk0-16|Promotor Decision|0|||
13359181|NCT03739840|26678954|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
13359182|NCT03739840|26678955|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1|||
13359183|NCT03739840|26678956|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
13359184|NCT03739840|26678957|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
13359185|NCT03739840|26678954|FG000|Treatment Period: Wk0-16|Premature Program Termination|0|||
13359186|NCT03739840|26678955|FG001|Treatment Period: Wk0-16|Premature Program Termination|1|||
13359187|NCT03739840|26678956|FG002|Treatment Period: Wk0-16|Premature Program Termination|0|||
13359188|NCT03739840|26678957|FG003|Treatment Period: Wk0-16|Premature Program Termination|0|||
13359189|NCT03739840|26678954|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
13359190|NCT03739840|26678955|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1|||
13359191|NCT03739840|26678956|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
13359192|NCT03739840|26678957|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
13359193|NCT03739840|26678954|FG000|Treatment Period: Wk0-16|Study Early Closure|0|||
13359194|NCT03739840|26678955|FG001|Treatment Period: Wk0-16|Study Early Closure|0|||
13359195|NCT03739840|26678956|FG002|Treatment Period: Wk0-16|Study Early Closure|1|||
13359196|NCT03739840|26678957|FG003|Treatment Period: Wk0-16|Study Early Closure|0|||
13359197|NCT03739840|26678954|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
13359198|NCT03739840|26678955|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
13359199|NCT03739840|26678956|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1|||
13359200|NCT03739840|26678957|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
13359201|NCT03739840|26678954|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
13359202|NCT03739840|26678955|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
13359203|NCT03739840|26678956|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1|||
13359204|NCT03739840|26678957|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
13359205|NCT03739840|26678954|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
13359206|NCT03739840|26678955|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
13359207|NCT03739840|26678956|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
13359208|NCT03739840|26678957|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1|||
13359209|NCT03739840|26678954|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
13359210|NCT03739840|26678955|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
13359211|NCT03739840|26678956|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
13359212|NCT03739840|26678957|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1|||
13359213|NCT03739840|26678954|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
13359214|NCT03739840|26678955|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
13359215|NCT03739840|26678956|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
13359216|NCT03739840|26678957|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1|||
13359217|NCT03739840|26678954|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3|||
13359218|NCT03739840|26678955|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0|||
13359219|NCT03739840|26678956|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0|||
13359220|NCT03739840|26678957|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0|||
13359221|NCT03739840|26678954|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
13359222|NCT03739840|26678955|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
13359223|NCT03739840|26678956|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
13359224|NCT03739840|26678957|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1|||
13359225|NCT03739840|26678954|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1|||
13359226|NCT03739840|26678955|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
13359227|NCT03739840|26678956|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
13359228|NCT03739840|26678957|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
13359229|NCT03739840|26678954|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
13359230|NCT03739840|26678955|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1|||
13359231|NCT03739840|26678956|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
13359232|NCT03739840|26678957|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
13359233|NCT03739840|26678954|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
13359234|NCT03739840|26678955|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1|||
13359235|NCT03739840|26678956|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
13359236|NCT03739840|26678957|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
13359237|NCT03739840|26678954|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
13359238|NCT03739840|26678955|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
13359239|NCT03739840|26678956|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1|||
13359240|NCT03739840|26678957|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
13359241|NCT03739840|26678954|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
13359242|NCT03739840|26678955|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
13359243|NCT03739840|26678956|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1|||
13359244|NCT03739840|26678957|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
13359245|NCT03739840|26678954|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
13359246|NCT03739840|26678955|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
13359247|NCT03739840|26678956|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1|||
13359248|NCT03739840|26678957|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
13359249|NCT03732638|26679002|FG000|DBT Phase (Weeks 1 to 12)|Adverse Event|5|||
13359250|NCT03732638|26679003|FG001|DBT Phase (Weeks 1 to 12)|Adverse Event|2|||
13359251|NCT03732638|26679002|FG000|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|8|||
13359252|NCT03732638|26679003|FG001|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|13|||
13359253|NCT03732638|26679002|FG000|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
13359254|NCT03732638|26679003|FG001|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
13359255|NCT03732638|26679002|FG000|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|19|||
13359256|NCT03732638|26679003|FG001|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|12|||
13359257|NCT03732638|26679002|FG000|DBT Phase (Weeks 1 to 12)|Non-compliance|6|||
13359258|NCT03732638|26679003|FG001|DBT Phase (Weeks 1 to 12)|Non-compliance|5|||
13359259|NCT03732638|26679002|FG000|DBT Phase (Weeks 1 to 12)|Physician Decision|0|||
13359260|NCT03732638|26679003|FG001|DBT Phase (Weeks 1 to 12)|Physician Decision|1|||
13359261|NCT03732638|26679002|FG000|DBT Phase (Weeks 1 to 12)|Protocol deviation|4|||
13359262|NCT03732638|26679003|FG001|DBT Phase (Weeks 1 to 12)|Protocol deviation|5|||
13359263|NCT03732638|26679002|FG000|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|11|||
13359264|NCT03732638|26679003|FG001|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|22|||
13359265|NCT03732638|26679002|FG000|OLE Phase (Weeks 13 to 64)|Adverse Event|10|||
13359266|NCT03732638|26679003|FG001|OLE Phase (Weeks 13 to 64)|Adverse Event|9|||
13359267|NCT03732638|26679002|FG000|OLE Phase (Weeks 13 to 64)|Death|1|||
13359268|NCT03732638|26679003|FG001|OLE Phase (Weeks 13 to 64)|Death|1|||
13359269|NCT03732638|26679002|FG000|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|2|||
13359270|NCT03732638|26679003|FG001|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|0|||
13359271|NCT03732638|26679002|FG000|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
13359272|NCT03732638|26679003|FG001|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
13359273|NCT03732638|26679002|FG000|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|19|||
13359274|NCT03732638|26679003|FG001|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|13|||
13359275|NCT03732638|26679002|FG000|OLE Phase (Weeks 13 to 64)|Non-compliance|15|||
13359276|NCT03732638|26679003|FG001|OLE Phase (Weeks 13 to 64)|Non-compliance|14|||
13359277|NCT03732638|26679002|FG000|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
13359278|NCT03732638|26679003|FG001|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
13359279|NCT03732638|26679002|FG000|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
13359280|NCT03732638|26679003|FG001|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
13359281|NCT03732638|26679002|FG000|OLE Phase (Weeks 13 to 64)|Protocol deviation|2|||
13359282|NCT03732638|26679003|FG001|OLE Phase (Weeks 13 to 64)|Protocol deviation|3|||
13359283|NCT03732638|26679002|FG000|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|1|||
13359284|NCT03732638|26679003|FG001|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|0|||
13359285|NCT03732638|26679002|FG000|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|29|||
13359286|NCT03732638|26679003|FG001|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|28|||
13359287|NCT03732638|26679002|FG000|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
13359288|NCT03732638|26679003|FG001|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
13359289|NCT03732638|26679002|FG000|Follow-up Phase (up to 72 Weeks)|Not reported|49|||
13359290|NCT03732638|26679003|FG001|Follow-up Phase (up to 72 Weeks)|Not reported|48|||
13359291|NCT03732638|26679002|FG000|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|10|||
13359292|NCT03732638|26679003|FG001|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|6|||
13359293|NCT03732638|26679002|FG000|Follow-up Phase (up to 72 Weeks)|Non-compliance|2|||
13359294|NCT03732638|26679003|FG001|Follow-up Phase (up to 72 Weeks)|Non-compliance|1|||
13359295|NCT03732638|26679002|FG000|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|4|||
13359296|NCT03732638|26679003|FG001|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|7|||
13359297|NCT03728309|26679125|FG000|Overall Study|Randomized but not Treated|0|||
13359298|NCT03728309|26679126|FG001|Overall Study|Randomized but not Treated|1|||
13359299|NCT03728309|26679125|FG000|Overall Study|Adverse Event|0|||
13359300|NCT03728309|26679126|FG001|Overall Study|Adverse Event|1|||
13359301|NCT03728309|26679125|FG000|Overall Study|Withdrawal by Subject|2|||
13359302|NCT03728309|26679126|FG001|Overall Study|Withdrawal by Subject|8|||
13359303|NCT03728309|26679125|FG000|Overall Study|Lost to Follow-up|9|||
13359304|NCT03728309|26679126|FG001|Overall Study|Lost to Follow-up|10|||
13359305|NCT03728309|26679125|FG000|Overall Study|Protocol Deviation|0|||
13359306|NCT03728309|26679126|FG001|Overall Study|Protocol Deviation|1|||
13359307|NCT03728309|26679125|FG000|Overall Study|Due to COVID|1|||
13359308|NCT03728309|26679126|FG001|Overall Study|Due to COVID|3|||
13359309|NCT03693300|26679171|FG000|Overall Study|Patients ongoing study|43|||
13359310|NCT03693300|26679172|FG001|Overall Study|Patients ongoing study|1|||
13359311|NCT03672175|26679295|FG000|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
13359312|NCT03672175|26679296|FG001|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
13359313|NCT03672175|26679297|FG002|Treatment Period (Days 1 to 14)|Withdrawal by Subject|4|||
13359314|NCT03672175|26679295|FG000|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
13359315|NCT03672175|26679296|FG001|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
13359316|NCT03672175|26679297|FG002|Treatment Period (Days 1 to 14)|Lost to Follow-up|3|||
13359317|NCT03672175|26679295|FG000|Treatment Period (Days 1 to 14)|Randomized but not Treated|3|||
13359318|NCT03672175|26679296|FG001|Treatment Period (Days 1 to 14)|Randomized but not Treated|6|||
13359319|NCT03672175|26679297|FG002|Treatment Period (Days 1 to 14)|Randomized but not Treated|2|||
13359320|NCT03672175|26679295|FG000|FU Period (Days 15 to 42)|Adverse Event|0|||
13359321|NCT03672175|26679296|FG001|FU Period (Days 15 to 42)|Adverse Event|0|||
13359322|NCT03672175|26679297|FG002|FU Period (Days 15 to 42)|Adverse Event|1|||
13359323|NCT03672175|26679295|FG000|FU Period (Days 15 to 42)|Lost to Follow-up|3|||
13359324|NCT03672175|26679296|FG001|FU Period (Days 15 to 42)|Lost to Follow-up|6|||
13359325|NCT03672175|26679297|FG002|FU Period (Days 15 to 42)|Lost to Follow-up|2|||
13359326|NCT03672175|26679295|FG000|FU Period (Days 15 to 42)|Withdrawal by Subject|1|||
13359327|NCT03672175|26679296|FG001|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
13359328|NCT03672175|26679297|FG002|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
13359329|NCT03672175|26679295|FG000|Extended FU Period (Days 43 to 182)|Adverse Event|5|||
13359330|NCT03672175|26679296|FG001|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
13359331|NCT03672175|26679297|FG002|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
13359332|NCT03672175|26679295|FG000|Extended FU Period (Days 43 to 182)|Lost to Follow-up|6|||
13359333|NCT03672175|26679296|FG001|Extended FU Period (Days 43 to 182)|Lost to Follow-up|8|||
13359334|NCT03672175|26679297|FG002|Extended FU Period (Days 43 to 182)|Lost to Follow-up|7|||
13359335|NCT03672175|26679295|FG000|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
13359336|NCT03672175|26679296|FG001|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|0|||
13359337|NCT03672175|26679297|FG002|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
13359338|NCT03672175|26679295|FG000|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
13359339|NCT03672175|26679296|FG001|Extended FU Period (Days 43 to 182)|Reason not Specified|4|||
13359340|NCT03672175|26679297|FG002|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
13359341|NCT03672175|26679295|FG000|Extended FU Period (Days 43 to 182)|Physician Decision|4|||
13359342|NCT03672175|26679296|FG001|Extended FU Period (Days 43 to 182)|Physician Decision|0|||
13359343|NCT03672175|26679297|FG002|Extended FU Period (Days 43 to 182)|Physician Decision|2|||
13359344|NCT03672175|26679295|FG000|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|18|||
13359345|NCT03672175|26679296|FG001|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|24|||
13359346|NCT03672175|26679297|FG002|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|21|||
13359347|NCT03638128|26679335|FG000|Overall Study|Withdrawal by Subject|1|||
13359348|NCT03638128|26679336|FG001|Overall Study|Withdrawal by Subject|7|||
13359349|NCT03638128|26679337|FG002|Overall Study|Withdrawal by Subject|6|||
13359350|NCT03638128|26679335|FG000|Overall Study|Sponsor Decision|15|||
13359351|NCT03638128|26679336|FG001|Overall Study|Sponsor Decision|12|||
13359352|NCT03638128|26679337|FG002|Overall Study|Sponsor Decision|19|||
13359353|NCT03638128|26679335|FG000|Overall Study|Lost to Follow-up|0|||
13359354|NCT03638128|26679336|FG001|Overall Study|Lost to Follow-up|0|||
13359355|NCT03638128|26679337|FG002|Overall Study|Lost to Follow-up|1|||
13359356|NCT03611751|26679397|FG000|Pre-treatment|Randomized but not treated|1|||
13359357|NCT03611751|26679398|FG001|Pre-treatment|Randomized but not treated|1|||
13359358|NCT03611751|26679399|FG002|Pre-treatment|Randomized but not treated|0|||
13359359|NCT03611751|26679397|FG000|Treatment Week 0 - Week 16|Adverse Event|11|||
13359360|NCT03611751|26679398|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
13359361|NCT03611751|26679399|FG002|Treatment Week 0 - Week 16|Adverse Event|12|||
13359362|NCT03611751|26679397|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|6|||
13359363|NCT03611751|26679398|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|9|||
13359364|NCT03611751|26679399|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|4|||
13359365|NCT03611751|26679397|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|5|||
13359366|NCT03611751|26679398|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|6|||
13359367|NCT03611751|26679399|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
13359368|NCT03611751|26679397|FG000|Treatment Week 0 - Week 16|Non-compliance with protocol|5|||
13359369|NCT03611751|26679398|FG001|Treatment Week 0 - Week 16|Non-compliance with protocol|2|||
13359370|NCT03611751|26679399|FG002|Treatment Week 0 - Week 16|Non-compliance with protocol|1|||
13359371|NCT03611751|26679397|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|14|||
13359372|NCT03611751|26679398|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
13359373|NCT03611751|26679399|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
13359374|NCT03611751|26679397|FG000|Treatment Week 0 - Week 16|Other reasons|13|||
13359375|NCT03611751|26679398|FG001|Treatment Week 0 - Week 16|Other reasons|9|||
13359376|NCT03611751|26679399|FG002|Treatment Week 0 - Week 16|Other reasons|7|||
13359377|NCT03611751|26679397|FG000|Treatment Week 0 - Week 16|Pregnancy|0|||
13359378|NCT03611751|26679398|FG001|Treatment Week 0 - Week 16|Pregnancy|0|||
13359379|NCT03611751|26679399|FG002|Treatment Week 0 - Week 16|Pregnancy|1|||
13359380|NCT03611751|26679397|FG000|Treatment Week 0 - Week 16|Death|0|||
13359381|NCT03611751|26679398|FG001|Treatment Week 0 - Week 16|Death|0|||
13359382|NCT03611751|26679399|FG002|Treatment Week 0 - Week 16|Death|1|||
13359383|NCT03611751|26679397|FG000|Treatment Week 16 - Week 24|Adverse Event|7|||
13359384|NCT03611751|26679398|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
13359385|NCT03611751|26679399|FG002|Treatment Week 16 - Week 24|Adverse Event|2|||
13359386|NCT03611751|26679397|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|8|||
13359387|NCT03611751|26679398|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
13359388|NCT03611751|26679399|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|1|||
13359389|NCT03611751|26679397|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
13359390|NCT03611751|26679398|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
13359391|NCT03611751|26679399|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
13359392|NCT03611751|26679397|FG000|Treatment Week 16 - Week 24|Non-compliance with protocol|3|||
13359393|NCT03611751|26679398|FG001|Treatment Week 16 - Week 24|Non-compliance with protocol|0|||
13359394|NCT03611751|26679399|FG002|Treatment Week 16 - Week 24|Non-compliance with protocol|1|||
13359395|NCT03611751|26679397|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
13359396|NCT03611751|26679398|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
13359397|NCT03611751|26679399|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
13359398|NCT03611751|26679397|FG000|Treatment Week 16 - Week 24|Other reasons|2|||
13359399|NCT03611751|26679398|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
13359400|NCT03611751|26679399|FG002|Treatment Week 16 - Week 24|Other reasons|3|||
13359401|NCT03611751|26679397|FG000|Treatment Week 16 - Week 24|Pregnancy|1|||
13359402|NCT03611751|26679398|FG001|Treatment Week 16 - Week 24|Pregnancy|0|||
13359403|NCT03611751|26679399|FG002|Treatment Week 16 - Week 24|Pregnancy|1|||
13359404|NCT03611751|26679397|FG000|Treatment Week 24 - Week 52|Adverse Event|14|||
13359405|NCT03611751|26679398|FG001|Treatment Week 24 - Week 52|Adverse Event|7|||
13359406|NCT03611751|26679399|FG002|Treatment Week 24 - Week 52|Adverse Event|0|||
13359407|NCT03611751|26679397|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
13359408|NCT03611751|26679398|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
13359409|NCT03611751|26679399|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
13359410|NCT03611751|26679397|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|9|||
13359411|NCT03611751|26679398|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|4|||
13359412|NCT03611751|26679399|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
13359413|NCT03611751|26679397|FG000|Treatment Week 24 - Week 52|Non-compliance with protocol|2|||
13359414|NCT03611751|26679398|FG001|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
13359415|NCT03611751|26679399|FG002|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
13359416|NCT03611751|26679397|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|8|||
13359417|NCT03611751|26679398|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|6|||
13359418|NCT03611751|26679399|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
13359419|NCT03611751|26679397|FG000|Treatment Week 24 - Week 52|Other reasons|28|||
13359420|NCT03611751|26679398|FG001|Treatment Week 24 - Week 52|Other reasons|7|||
13359421|NCT03611751|26679399|FG002|Treatment Week 24 - Week 52|Other reasons|0|||
13359422|NCT03611751|26679397|FG000|Treatment Week 24 - Week 52|Pregnancy|0|||
13359423|NCT03611751|26679398|FG001|Treatment Week 24 - Week 52|Pregnancy|1|||
13359424|NCT03611751|26679399|FG002|Treatment Week 24 - Week 52|Pregnancy|0|||
13374701|NCT00793910|26727747|FG000|Overall Study|did not pick up medications|1|||
13374702|NCT00793910|26727748|FG001|Overall Study|did not pick up medications|1|||
13374703|NCT00793910|26727747|FG000|Overall Study|ineligible based on entry criteria|2|||
13374704|NCT00793910|26727748|FG001|Overall Study|ineligible based on entry criteria|3|||
13374705|NCT00793910|26727747|FG000|Overall Study|decided to undergo LASIK instead of PRK|2|||
13374706|NCT00793910|26727748|FG001|Overall Study|decided to undergo LASIK instead of PRK|1|||
13374707|NCT00793910|26727747|FG000|Overall Study|Withdrawal by Subject|0|||
13374708|NCT00793910|26727748|FG001|Overall Study|Withdrawal by Subject|1|||
13374709|NCT00793871|26727762|FG000|Overall Study|Death|50|||
13374710|NCT00793871|26727762|FG000|Overall Study|Lost to Follow-up|3|||
13374711|NCT00793871|26727762|FG000|Overall Study|Study terminated by the Sponsor|7|||
13374712|NCT00793819|26727775|FG000|Overall Study|Adverse Event|8|||
13374713|NCT00793819|26727776|FG001|Overall Study|Adverse Event|4|||
13374714|NCT00793819|26727775|FG000|Overall Study|Lack of Efficacy|1|||
13374715|NCT00793819|26727776|FG001|Overall Study|Lack of Efficacy|1|||
13374716|NCT00793819|26727775|FG000|Overall Study|Withdrawal by Subject|4|||
13374717|NCT00793819|26727776|FG001|Overall Study|Withdrawal by Subject|3|||
13374718|NCT00793819|26727775|FG000|Overall Study|Lost to Follow-up|1|||
13374719|NCT00793819|26727776|FG001|Overall Study|Lost to Follow-up|1|||
13374720|NCT00793793|26728186|FG000|Overall Study|Adverse Event|0|||
13374721|NCT00793793|26728187|FG001|Overall Study|Adverse Event|0|||
13374722|NCT00793793|26728188|FG002|Overall Study|Adverse Event|1|||
13374723|NCT00793793|26728189|FG003|Overall Study|Adverse Event|1|||
13374724|NCT00793793|26728190|FG004|Overall Study|Adverse Event|0|||
13374725|NCT00793793|26728191|FG005|Overall Study|Adverse Event|1|||
13374726|NCT00793793|26728192|FG006|Overall Study|Adverse Event|2|||
13374727|NCT00793793|26728193|FG007|Overall Study|Adverse Event|0|||
13374728|NCT00793793|26728194|FG008|Overall Study|Adverse Event|0|||
13374729|NCT00793793|26728195|FG009|Overall Study|Adverse Event|0|||
13374730|NCT00793793|26728196|FG010|Overall Study|Adverse Event|0|||
13374731|NCT00793793|26728197|FG011|Overall Study|Adverse Event|2|||
13374732|NCT00793793|26728186|FG000|Overall Study|Protocol Violation|0|||
13374733|NCT00793793|26728187|FG001|Overall Study|Protocol Violation|0|||
13374734|NCT00793793|26728188|FG002|Overall Study|Protocol Violation|0|||
13374735|NCT00793793|26728189|FG003|Overall Study|Protocol Violation|1|||
13374736|NCT00793793|26728190|FG004|Overall Study|Protocol Violation|0|||
13374737|NCT00793793|26728191|FG005|Overall Study|Protocol Violation|0|||
13374738|NCT00793793|26728192|FG006|Overall Study|Protocol Violation|0|||
13374739|NCT00793793|26728193|FG007|Overall Study|Protocol Violation|0|||
13374740|NCT00793793|26728194|FG008|Overall Study|Protocol Violation|0|||
13374741|NCT00793793|26728195|FG009|Overall Study|Protocol Violation|0|||
13374742|NCT00793793|26728196|FG010|Overall Study|Protocol Violation|0|||
13374743|NCT00793793|26728197|FG011|Overall Study|Protocol Violation|0|||
13374744|NCT00793793|26728186|FG000|Overall Study|Lost to Follow-up|0|||
13374745|NCT00793793|26728187|FG001|Overall Study|Lost to Follow-up|0|||
13374746|NCT00793793|26728188|FG002|Overall Study|Lost to Follow-up|1|||
13374747|NCT00793793|26728189|FG003|Overall Study|Lost to Follow-up|0|||
13374748|NCT00793793|26728190|FG004|Overall Study|Lost to Follow-up|0|||
13374749|NCT00793793|26728191|FG005|Overall Study|Lost to Follow-up|0|||
13374750|NCT00793793|26728192|FG006|Overall Study|Lost to Follow-up|0|||
13374751|NCT00793793|26728193|FG007|Overall Study|Lost to Follow-up|0|||
13374752|NCT00793793|26728194|FG008|Overall Study|Lost to Follow-up|1|||
13374753|NCT00793793|26728195|FG009|Overall Study|Lost to Follow-up|3|||
13374754|NCT00793793|26728196|FG010|Overall Study|Lost to Follow-up|1|||
13374755|NCT00793793|26728197|FG011|Overall Study|Lost to Follow-up|0|||
13374756|NCT00793793|26728186|FG000|Overall Study|Withdrawal by Subject|0|||
13374757|NCT00793793|26728187|FG001|Overall Study|Withdrawal by Subject|0|||
13374758|NCT00793793|26728188|FG002|Overall Study|Withdrawal by Subject|0|||
13374759|NCT00793793|26728189|FG003|Overall Study|Withdrawal by Subject|0|||
13374760|NCT00793793|26728190|FG004|Overall Study|Withdrawal by Subject|1|||
13374761|NCT00793793|26728191|FG005|Overall Study|Withdrawal by Subject|0|||
13374762|NCT00793793|26728192|FG006|Overall Study|Withdrawal by Subject|0|||
13359425|NCT03481556|26679524|FG000|Overall Study|Adverse Event|1|||
13359426|NCT03481556|26679525|FG001|Overall Study|Adverse Event|0|||
13359427|NCT03481556|26679526|FG002|Overall Study|Adverse Event|0|||
13359428|NCT03481556|26679527|FG003|Overall Study|Adverse Event|0|||
13359429|NCT03481556|26679524|FG000|Overall Study|Death|4|||
13359430|NCT03481556|26679525|FG001|Overall Study|Death|2|||
13359431|NCT03481556|26679526|FG002|Overall Study|Death|3|||
13359432|NCT03481556|26679527|FG003|Overall Study|Death|16|||
13359433|NCT03481556|26679524|FG000|Overall Study|Study Terminated by Sponsor|10|||
13359434|NCT03481556|26679525|FG001|Overall Study|Study Terminated by Sponsor|5|||
13359435|NCT03481556|26679526|FG002|Overall Study|Study Terminated by Sponsor|2|||
13359436|NCT03481556|26679527|FG003|Overall Study|Study Terminated by Sponsor|9|||
13359437|NCT03471767|26679552|FG000|Overall Study|Withdrawal by Subject|3|||
13359438|NCT03471767|26679553|FG001|Overall Study|Withdrawal by Subject|1|||
13359439|NCT03471767|26679552|FG000|Overall Study|Adverse Event|1|||
13359440|NCT03471767|26679553|FG001|Overall Study|Adverse Event|0|||
13359441|NCT03471767|26679552|FG000|Overall Study|Lost to Follow-up|1|||
13359442|NCT03471767|26679553|FG001|Overall Study|Lost to Follow-up|0|||
13359443|NCT03471767|26679552|FG000|Overall Study|PI Withdrawal|1|||
13359444|NCT03471767|26679553|FG001|Overall Study|PI Withdrawal|3|||
13359445|NCT03462576|26679574|FG000|Overall Study|Protocol Violation|5|||
13359446|NCT03462576|26679575|FG001|Overall Study|Protocol Violation|11|||
13359447|NCT03462576|26679576|FG002|Overall Study|Protocol Violation|7|||
13359448|NCT03462576|26679574|FG000|Overall Study|Device Malfunction|0|||
13359449|NCT03462576|26679575|FG001|Overall Study|Device Malfunction|0|||
13359450|NCT03462576|26679576|FG002|Overall Study|Device Malfunction|1|||
13359451|NCT03461757|26679633|FG000|Overall Study|Adverse Event|1|||
13359452|NCT03461757|26679634|FG001|Overall Study|Adverse Event|0|||
13359453|NCT03461757|26679633|FG000|Overall Study|Lost to Follow-up|13|||
13359454|NCT03461757|26679634|FG001|Overall Study|Lost to Follow-up|7|||
13359455|NCT03461757|26679633|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28|||
13359456|NCT03461757|26679634|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25|||
13359457|NCT03461757|26679633|FG000|Overall Study|Non-compliance with study treatment|0|||
13359458|NCT03461757|26679634|FG001|Overall Study|Non-compliance with study treatment|1|||
13359459|NCT03461757|26679633|FG000|Overall Study|Pregnancy|2|||
13359460|NCT03461757|26679634|FG001|Overall Study|Pregnancy|0|||
13359461|NCT03461757|26679633|FG000|Overall Study|Protocol Violation|1|||
13359462|NCT03461757|26679634|FG001|Overall Study|Protocol Violation|1|||
13359463|NCT03461757|26679633|FG000|Overall Study|Withdrawal by Subject|7|||
13359464|NCT03461757|26679634|FG001|Overall Study|Withdrawal by Subject|7|||
13359465|NCT03461757|26679633|FG000|Overall Study|Other Reasons|1|||
13359466|NCT03461757|26679634|FG001|Overall Study|Other Reasons|4|||
13359467|NCT03439189|26679641|FG000|Overall Study|Protocol Violation|19|||
13359468|NCT03439189|26679641|FG000|Overall Study|Lack of Efficacy|63|||
13359469|NCT03406507|26679676|FG000|Extension Period|Lack of Efficacy|0|||
13359470|NCT03406507|26679677|FG001|Extension Period|Lack of Efficacy|1|||
13359471|NCT03406507|26679676|FG000|Extension Period|Ongoing in Extension Period|5|||
13359472|NCT03406507|26679677|FG001|Extension Period|Ongoing in Extension Period|5|||
13359473|NCT03387514|26679695|FG000|Overall Study|Withdrawal by Subject|2|||
13359474|NCT03387514|26679695|FG000|Overall Study|Physician Decision|1|||
13359475|NCT03387514|26679695|FG000|Overall Study|Lost to Follow-up|2|||
13359476|NCT03373383|26679763|FG000|Treatment Period: Wk0-16|Adverse Event|7|||
13359477|NCT03373383|26679764|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
13359478|NCT03373383|26679765|FG002|Treatment Period: Wk0-16|Adverse Event|11|||
13359479|NCT03373383|26679766|FG003|Treatment Period: Wk0-16|Adverse Event|15|||
13359480|NCT03373383|26679767|FG004|Treatment Period: Wk0-16|Adverse Event|21|||
13359481|NCT03373383|26679763|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2|||
13359482|NCT03373383|26679764|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
13359483|NCT03373383|26679765|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
13359484|NCT03373383|26679766|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0|||
13359485|NCT03373383|26679767|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0|||
13359486|NCT03373383|26679763|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
13359487|NCT03373383|26679764|FG001|Treatment Period: Wk0-16|Protocol Violation|4|||
13359488|NCT03373383|26679765|FG002|Treatment Period: Wk0-16|Protocol Violation|2|||
13359489|NCT03373383|26679766|FG003|Treatment Period: Wk0-16|Protocol Violation|1|||
13359490|NCT03373383|26679767|FG004|Treatment Period: Wk0-16|Protocol Violation|0|||
13359491|NCT03373383|26679763|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2|||
13359492|NCT03373383|26679764|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0|||
13359493|NCT03373383|26679765|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0|||
13359494|NCT03373383|26679766|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0|||
13359495|NCT03373383|26679767|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0|||
13359496|NCT03373383|26679763|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
13359497|NCT03373383|26679764|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
13359498|NCT03373383|26679765|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
13359499|NCT03373383|26679766|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
13359500|NCT03373383|26679767|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
13359501|NCT03373383|26679763|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0|||
13359502|NCT03373383|26679764|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1|||
13359503|NCT03373383|26679765|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0|||
13359504|NCT03373383|26679766|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0|||
13359505|NCT03373383|26679767|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0|||
13359506|NCT03373383|26679763|FG000|Treatment Period: Wk0-16|By opinion of investigator|0|||
13359507|NCT03373383|26679764|FG001|Treatment Period: Wk0-16|By opinion of investigator|0|||
13359508|NCT03373383|26679765|FG002|Treatment Period: Wk0-16|By opinion of investigator|0|||
13359509|NCT03373383|26679766|FG003|Treatment Period: Wk0-16|By opinion of investigator|1|||
13359510|NCT03373383|26679767|FG004|Treatment Period: Wk0-16|By opinion of investigator|0|||
13359511|NCT03373383|26679763|FG000|Treatment Period: Wk0-16|Sponsor decision|0|||
13359512|NCT03373383|26679764|FG001|Treatment Period: Wk0-16|Sponsor decision|0|||
13359513|NCT03373383|26679765|FG002|Treatment Period: Wk0-16|Sponsor decision|0|||
13359514|NCT03373383|26679766|FG003|Treatment Period: Wk0-16|Sponsor decision|1|||
13359515|NCT03373383|26679767|FG004|Treatment Period: Wk0-16|Sponsor decision|0|||
13359516|NCT03373383|26679763|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1|||
13359517|NCT03373383|26679764|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
13359518|NCT03373383|26679765|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
13359519|NCT03373383|26679766|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
13359520|NCT03373383|26679767|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
13359521|NCT03367156|26679794|FG000|Overall Study|Lack of interest|3|||
13359522|NCT03367156|26679795|FG001|Overall Study|Lack of interest|1|||
13359523|NCT03367156|26679794|FG000|Overall Study|Death|2|||
13359524|NCT03367156|26679795|FG001|Overall Study|Death|0|||
13359525|NCT03367156|26679794|FG000|Overall Study|Lost to Follow-up|2|||
13359526|NCT03367156|26679795|FG001|Overall Study|Lost to Follow-up|1|||
13359527|NCT03367156|26679794|FG000|Overall Study|Became ineligible|1|||
13359528|NCT03367156|26679795|FG001|Overall Study|Became ineligible|2|||
13359529|NCT03367156|26679794|FG000|Overall Study|Hospitalization|1|||
13359530|NCT03367156|26679795|FG001|Overall Study|Hospitalization|0|||
13359531|NCT03367156|26679794|FG000|Overall Study|Concerned about Treatment|11|||
13359532|NCT03367156|26679795|FG001|Overall Study|Concerned about Treatment|3|||
13359533|NCT03367156|26679794|FG000|Overall Study|Started new treatment|4|||
13359534|NCT03367156|26679795|FG001|Overall Study|Started new treatment|1|||
13359535|NCT03342404|26679860|FG000|Overall Study|Withdrawal by Subject|9|||
13359536|NCT03342404|26679861|FG001|Overall Study|Withdrawal by Subject|10|||
13359537|NCT03342404|26679860|FG000|Overall Study|Lack of Efficacy|1|||
13359538|NCT03342404|26679861|FG001|Overall Study|Lack of Efficacy|17|||
13359539|NCT03342404|26679860|FG000|Overall Study|Adverse Event|3|||
13359540|NCT03342404|26679861|FG001|Overall Study|Adverse Event|4|||
13359541|NCT03342404|26679860|FG000|Overall Study|Noncompliance with study drug|1|||
13359542|NCT03342404|26679861|FG001|Overall Study|Noncompliance with study drug|0|||
13359543|NCT03342404|26679860|FG000|Overall Study|Other reasons|1|||
13359544|NCT03342404|26679861|FG001|Overall Study|Other reasons|0|||
13359545|NCT03266588|26679960|FG000|Observational Period|Screen Failure: Eligibility Criteria|439|||
13359546|NCT03266588|26679961|FG001|Observational Period|Screen Failure: Eligibility Criteria|228|||
13359547|NCT03266588|26679962|FG002|Observational Period|Screen Failure: Eligibility Criteria|140|||
13359548|NCT03266588|26679960|FG000|Observational Period|Withdrawal by Subject|44|||
13359549|NCT03266588|26679961|FG001|Observational Period|Withdrawal by Subject|22|||
13359550|NCT03266588|26679962|FG002|Observational Period|Withdrawal by Subject|13|||
13359551|NCT03266588|26679960|FG000|Observational Period|Non-compliance|18|||
13359552|NCT03266588|26679961|FG001|Observational Period|Non-compliance|12|||
13359553|NCT03266588|26679962|FG002|Observational Period|Non-compliance|10|||
13359554|NCT03266588|26679960|FG000|Observational Period|Lost to Follow-up|8|||
13359555|NCT03266588|26679961|FG001|Observational Period|Lost to Follow-up|12|||
13359556|NCT03266588|26679962|FG002|Observational Period|Lost to Follow-up|4|||
13359557|NCT03266588|26679960|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3|||
13359558|NCT03266588|26679961|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1|||
13359559|NCT03266588|26679962|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0|||
13359560|NCT03266588|26679960|FG000|Observational Period|Protocol Deviation|1|||
13359561|NCT03266588|26679961|FG001|Observational Period|Protocol Deviation|0|||
13359562|NCT03266588|26679962|FG002|Observational Period|Protocol Deviation|0|||
13359563|NCT03266588|26679960|FG000|Observational Period|Other Reasons|3|||
13359564|NCT03266588|26679961|FG001|Observational Period|Other Reasons|0|||
13359565|NCT03266588|26679962|FG002|Observational Period|Other Reasons|1|||
13359566|NCT03266588|26679960|FG000|Long-term Treatment Period|Adverse Event|33|||
13359567|NCT03266588|26679961|FG001|Long-term Treatment Period|Adverse Event|17|||
13359568|NCT03266588|26679962|FG002|Long-term Treatment Period|Adverse Event|8|||
13359569|NCT03266588|26679960|FG000|Long-term Treatment Period|Lack of Efficacy|41|||
13359570|NCT03266588|26679961|FG001|Long-term Treatment Period|Lack of Efficacy|31|||
13359571|NCT03266588|26679962|FG002|Long-term Treatment Period|Lack of Efficacy|5|||
13359572|NCT03266588|26679960|FG000|Long-term Treatment Period|Lost to Follow-up|39|||
13359573|NCT03266588|26679961|FG001|Long-term Treatment Period|Lost to Follow-up|37|||
13359574|NCT03266588|26679962|FG002|Long-term Treatment Period|Lost to Follow-up|8|||
13359575|NCT03266588|26679960|FG000|Long-term Treatment Period|Non-Compliance|126|||
13359576|NCT03266588|26679961|FG001|Long-term Treatment Period|Non-Compliance|57|||
13359577|NCT03266588|26679962|FG002|Long-term Treatment Period|Non-Compliance|7|||
13359578|NCT03266588|26679960|FG000|Long-term Treatment Period|Pregnancy|11|||
13359579|NCT03266588|26679961|FG001|Long-term Treatment Period|Pregnancy|5|||
13359580|NCT03266588|26679962|FG002|Long-term Treatment Period|Pregnancy|0|||
13359581|NCT03266588|26679960|FG000|Long-term Treatment Period|Protocol Deviation|17|||
13359582|NCT03266588|26679961|FG001|Long-term Treatment Period|Protocol Deviation|10|||
13359583|NCT03266588|26679962|FG002|Long-term Treatment Period|Protocol Deviation|4|||
13359584|NCT03266588|26679960|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33|||
13359585|NCT03266588|26679961|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
13359586|NCT03266588|26679962|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
13359587|NCT03266588|26679960|FG000|Long-term Treatment Period|Withdrawal by Subject|100|||
13359588|NCT03266588|26679961|FG001|Long-term Treatment Period|Withdrawal by Subject|63|||
13359589|NCT03266588|26679962|FG002|Long-term Treatment Period|Withdrawal by Subject|16|||
13359590|NCT03266588|26679960|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1|||
13359591|NCT03266588|26679961|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2|||
13359592|NCT03266588|26679962|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0|||
13359593|NCT03266588|26679960|FG000|Long-term Treatment Period|Other Reasons|5|||
13359594|NCT03266588|26679961|FG001|Long-term Treatment Period|Other Reasons|0|||
13359595|NCT03266588|26679962|FG002|Long-term Treatment Period|Other Reasons|0|||
13359596|NCT03266588|26679960|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
13359597|NCT03266588|26679961|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1|||
13359598|NCT03266588|26679962|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
13359599|NCT03252587|26680090|FG000|Overall Study|Adverse Event|3|||
13359600|NCT03252587|26680091|FG001|Overall Study|Adverse Event|8|||
13359601|NCT03252587|26680092|FG002|Overall Study|Adverse Event|6|||
13359602|NCT03252587|26680093|FG003|Overall Study|Adverse Event|12|||
13359603|NCT03252587|26680090|FG000|Overall Study|Lack of Efficacy|7|||
13359604|NCT03252587|26680091|FG001|Overall Study|Lack of Efficacy|2|||
13359605|NCT03252587|26680092|FG002|Overall Study|Lack of Efficacy|2|||
13359606|NCT03252587|26680093|FG003|Overall Study|Lack of Efficacy|4|||
13359607|NCT03252587|26680090|FG000|Overall Study|Lost to Follow-up|2|||
13359608|NCT03252587|26680091|FG001|Overall Study|Lost to Follow-up|0|||
13359609|NCT03252587|26680092|FG002|Overall Study|Lost to Follow-up|0|||
13359610|NCT03252587|26680093|FG003|Overall Study|Lost to Follow-up|2|||
13359611|NCT03252587|26680090|FG000|Overall Study|Pregnancy|2|||
13359612|NCT03252587|26680091|FG001|Overall Study|Pregnancy|1|||
13359613|NCT03252587|26680092|FG002|Overall Study|Pregnancy|0|||
13359614|NCT03252587|26680093|FG003|Overall Study|Pregnancy|1|||
13359615|NCT03252587|26680090|FG000|Overall Study|Withdrawal by Subject|8|||
13359616|NCT03252587|26680091|FG001|Overall Study|Withdrawal by Subject|4|||
13359617|NCT03252587|26680092|FG002|Overall Study|Withdrawal by Subject|4|||
13359618|NCT03252587|26680093|FG003|Overall Study|Withdrawal by Subject|4|||
13359619|NCT03252587|26680090|FG000|Overall Study|Other Reasons|2|||
13359620|NCT03252587|26680091|FG001|Overall Study|Other Reasons|5|||
13359621|NCT03252587|26680092|FG002|Overall Study|Other Reasons|5|||
13359622|NCT03252587|26680093|FG003|Overall Study|Other Reasons|4|||
13359623|NCT03237845|26680168|FG000|Overall Study|Adverse Event|0|||
13359624|NCT03237845|26680169|FG001|Overall Study|Adverse Event|1|||
13359625|NCT03237845|26680168|FG000|Overall Study|Lost to Follow-up|13|||
13359626|NCT03237845|26680169|FG001|Overall Study|Lost to Follow-up|10|||
13359627|NCT03237845|26680168|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26|||
13359628|NCT03237845|26680169|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31|||
13359629|NCT03237845|26680168|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
13359630|NCT03237845|26680169|FG001|Overall Study|Non-Compliance With Study Treatment|1|||
13359631|NCT03237845|26680168|FG000|Overall Study|Physician Decision|1|||
13359632|NCT03237845|26680169|FG001|Overall Study|Physician Decision|2|||
13359633|NCT03237845|26680168|FG000|Overall Study|Pregnancy|1|||
13359634|NCT03237845|26680169|FG001|Overall Study|Pregnancy|0|||
13359635|NCT03237845|26680168|FG000|Overall Study|Protocol Deviation|0|||
13359636|NCT03237845|26680169|FG001|Overall Study|Protocol Deviation|1|||
13359637|NCT03237845|26680168|FG000|Overall Study|Technical Problems|8|||
13359638|NCT03237845|26680169|FG001|Overall Study|Technical Problems|1|||
13359639|NCT03237845|26680168|FG000|Overall Study|Withdrawal by Subject|3|||
13359640|NCT03237845|26680169|FG001|Overall Study|Withdrawal by Subject|3|||
13359641|NCT03237845|26680168|FG000|Overall Study|Other Reasons|4|||
13359642|NCT03237845|26680169|FG001|Overall Study|Other Reasons|0|||
13359643|NCT03235479|26680206|FG000|Overall Study|Lost to Follow-up|8|||
13359644|NCT03235479|26680207|FG001|Overall Study|Lost to Follow-up|11|||
13359645|NCT03235479|26680206|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23|||
13359646|NCT03235479|26680207|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17|||
13359647|NCT03235479|26680206|FG000|Overall Study|Pregnancy|1|||
13359648|NCT03235479|26680207|FG001|Overall Study|Pregnancy|0|||
13359649|NCT03235479|26680206|FG000|Overall Study|Protocol Deviation|1|||
13359650|NCT03235479|26680207|FG001|Overall Study|Protocol Deviation|3|||
13359651|NCT03235479|26680206|FG000|Overall Study|Technical Problems|3|||
13359652|NCT03235479|26680207|FG001|Overall Study|Technical Problems|2|||
13359653|NCT03235479|26680206|FG000|Overall Study|Withdrawal by Subject|2|||
13359654|NCT03235479|26680207|FG001|Overall Study|Withdrawal by Subject|2|||
13359655|NCT03235479|26680206|FG000|Overall Study|Other Reasons|3|||
13359656|NCT03235479|26680207|FG001|Overall Study|Other Reasons|5|||
13359657|NCT03208036|26680238|FG000|Baseline Assessment|Withdrawal by Subject|1|||
13359658|NCT03208036|26680239|FG001|Baseline Assessment|Withdrawal by Subject|1|||
13359659|NCT03208036|26680238|FG000|2nd Baseline Assessment|Withdrawal by Subject|1|||
13359660|NCT03208036|26680239|FG001|2nd Baseline Assessment|Withdrawal by Subject|2|||
13359661|NCT03208036|26680238|FG000|Intervention|Withdrawal by Subject|3|||
13359662|NCT03208036|26680239|FG001|Intervention|Withdrawal by Subject|2|||
13359663|NCT03208036|26680238|FG000|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|1|||
13359664|NCT03208036|26680239|FG001|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|2|||
13359665|NCT03170882|26680276|FG000|Overall Study|Death|17|||
13359666|NCT03170882|26680277|FG001|Overall Study|Death|29|||
13359667|NCT03170882|26680276|FG000|Overall Study|Lost to Follow-up|0|||
13359668|NCT03170882|26680277|FG001|Overall Study|Lost to Follow-up|1|||
13359669|NCT03170882|26680276|FG000|Overall Study|Withdrawal by Subject|4|||
13359670|NCT03170882|26680277|FG001|Overall Study|Withdrawal by Subject|7|||
13359671|NCT03170882|26680276|FG000|Overall Study|Reason not Specified|28|||
13359672|NCT03170882|26680277|FG001|Overall Study|Reason not Specified|36|||
13359673|NCT03150095|26680290|FG000|Overall Study|Death|0|||
13359674|NCT03150095|26680291|FG001|Overall Study|Death|1|||
13359675|NCT03150095|26680290|FG000|Overall Study|Lost to Follow-up|1|||
13359676|NCT03150095|26680291|FG001|Overall Study|Lost to Follow-up|1|||
13359677|NCT03150095|26680290|FG000|Overall Study|Withdrawal by Subject|4|||
13359678|NCT03150095|26680291|FG001|Overall Study|Withdrawal by Subject|0|||
13359679|NCT03150095|26680290|FG000|Overall Study|unable or unwilling to continue health coaching|4|||
13359680|NCT03150095|26680291|FG001|Overall Study|unable or unwilling to continue health coaching|0|||
13359681|NCT03141177|26680331|FG000|Overall Study|Death|62|||
13359682|NCT03141177|26680332|FG001|Overall Study|Death|13|||
13359683|NCT03141177|26680333|FG002|Overall Study|Death|84|||
13359684|NCT03141177|26680331|FG000|Overall Study|Participant withdrew consent|9|||
13359685|NCT03141177|26680332|FG001|Overall Study|Participant withdrew consent|2|||
13359686|NCT03141177|26680333|FG002|Overall Study|Participant withdrew consent|13|||
13359687|NCT03141177|26680331|FG000|Overall Study|Not reported|1|||
13359688|NCT03141177|26680332|FG001|Overall Study|Not reported|0|||
13359689|NCT03141177|26680333|FG002|Overall Study|Not reported|1|||
13359690|NCT03141177|26680331|FG000|Overall Study|Lost to Follow-up|2|||
13359691|NCT03141177|26680332|FG001|Overall Study|Lost to Follow-up|1|||
13359692|NCT03141177|26680333|FG002|Overall Study|Lost to Follow-up|1|||
13359693|NCT03141177|26680331|FG000|Overall Study|Other reasons|4|||
13359694|NCT03141177|26680332|FG001|Overall Study|Other reasons|0|||
13359695|NCT03141177|26680333|FG002|Overall Study|Other reasons|11|||
13359696|NCT03141177|26680331|FG000|Overall Study|Participants did not start treatment period|3|||
13359697|NCT03141177|26680332|FG001|Overall Study|Participants did not start treatment period|0|||
13359698|NCT03141177|26680333|FG002|Overall Study|Participants did not start treatment period|8|||
13374763|NCT00793793|26728193|FG007|Overall Study|Withdrawal by Subject|0|||
13374764|NCT00793793|26728194|FG008|Overall Study|Withdrawal by Subject|1|||
13374765|NCT00793793|26728195|FG009|Overall Study|Withdrawal by Subject|0|||
13374766|NCT00793793|26728196|FG010|Overall Study|Withdrawal by Subject|0|||
13374767|NCT00793793|26728197|FG011|Overall Study|Withdrawal by Subject|0|||
13374768|NCT00793793|26728186|FG000|Overall Study|reason not specified|0|||
13374769|NCT00793793|26728187|FG001|Overall Study|reason not specified|1|||
13374770|NCT00793793|26728188|FG002|Overall Study|reason not specified|0|||
13374771|NCT00793793|26728189|FG003|Overall Study|reason not specified|1|||
13374772|NCT00793793|26728190|FG004|Overall Study|reason not specified|1|||
13374773|NCT00793793|26728191|FG005|Overall Study|reason not specified|1|||
13374774|NCT00793793|26728192|FG006|Overall Study|reason not specified|2|||
13374775|NCT00793793|26728193|FG007|Overall Study|reason not specified|0|||
13374776|NCT00793793|26728194|FG008|Overall Study|reason not specified|7|||
13374777|NCT00793793|26728195|FG009|Overall Study|reason not specified|6|||
13374778|NCT00793793|26728196|FG010|Overall Study|reason not specified|2|||
13374779|NCT00793793|26728197|FG011|Overall Study|reason not specified|4|||
13374780|NCT00793780|26728220|FG000|Overall Study|Withdrawal by Subject|2|||
13374781|NCT00793780|26728221|FG001|Overall Study|Withdrawal by Subject|1|||
13374782|NCT00793624|26728500|FG000|Overall Study|Adverse Event|18|||
13374783|NCT00793624|26728501|FG001|Overall Study|Adverse Event|16|||
13374784|NCT00793624|26728502|FG002|Overall Study|Adverse Event|15|||
13374785|NCT00793624|26728503|FG003|Overall Study|Adverse Event|20|||
13374786|NCT00793624|26728500|FG000|Overall Study|Lost to Follow-up|2|||
13374787|NCT00793624|26728501|FG001|Overall Study|Lost to Follow-up|2|||
13359699|NCT02996110|26680497|FG000|Pre-Treatment|Other Reasons|0|||
13359700|NCT02996110|26680498|FG001|Pre-Treatment|Other Reasons|1|||
13359701|NCT02996110|26680499|FG002|Pre-Treatment|Other Reasons|0|||
13359702|NCT02996110|26680500|FG003|Pre-Treatment|Other Reasons|0|||
13359703|NCT02996110|26680501|FG004|Pre-Treatment|Other Reasons|1|||
13359704|NCT02996110|26680497|FG000|Pre-Treatment|Participant Withdrew Consent|0|||
13359705|NCT02996110|26680498|FG001|Pre-Treatment|Participant Withdrew Consent|0|||
13359706|NCT02996110|26680499|FG002|Pre-Treatment|Participant Withdrew Consent|1|||
13359707|NCT02996110|26680500|FG003|Pre-Treatment|Participant Withdrew Consent|0|||
13359708|NCT02996110|26680501|FG004|Pre-Treatment|Participant Withdrew Consent|1|||
13359709|NCT02996110|26680497|FG000|Track 1|Disease Progression|15|||
13359710|NCT02996110|26680498|FG001|Track 1|Disease Progression|17|||
13359711|NCT02996110|26680499|FG002|Track 1|Disease Progression|0|||
13359712|NCT02996110|26680500|FG003|Track 1|Disease Progression|0|||
13359713|NCT02996110|26680501|FG004|Track 1|Disease Progression|0|||
13359714|NCT02996110|26680497|FG000|Track 1|Adverse Event Unrelated to Study Drug|1|||
13359715|NCT02996110|26680498|FG001|Track 1|Adverse Event Unrelated to Study Drug|1|||
13359716|NCT02996110|26680499|FG002|Track 1|Adverse Event Unrelated to Study Drug|0|||
13359717|NCT02996110|26680500|FG003|Track 1|Adverse Event Unrelated to Study Drug|0|||
13359718|NCT02996110|26680501|FG004|Track 1|Adverse Event Unrelated to Study Drug|0|||
13359719|NCT02996110|26680497|FG000|Track 1|Study Drug Toxicity|5|||
13359720|NCT02996110|26680498|FG001|Track 1|Study Drug Toxicity|3|||
13359721|NCT02996110|26680499|FG002|Track 1|Study Drug Toxicity|0|||
13359722|NCT02996110|26680500|FG003|Track 1|Study Drug Toxicity|0|||
13359723|NCT02996110|26680501|FG004|Track 1|Study Drug Toxicity|0|||
13359724|NCT02996110|26680497|FG000|Track 1|Participant Requested to Discontinue Study Treatment|1|||
13359725|NCT02996110|26680498|FG001|Track 1|Participant Requested to Discontinue Study Treatment|0|||
13359726|NCT02996110|26680499|FG002|Track 1|Participant Requested to Discontinue Study Treatment|0|||
13359727|NCT02996110|26680500|FG003|Track 1|Participant Requested to Discontinue Study Treatment|0|||
13359728|NCT02996110|26680501|FG004|Track 1|Participant Requested to Discontinue Study Treatment|0|||
13359729|NCT02996110|26680497|FG000|Track 1|Administrative Reason by Sponsor|0|||
13359730|NCT02996110|26680498|FG001|Track 1|Administrative Reason by Sponsor|1|||
13359731|NCT02996110|26680499|FG002|Track 1|Administrative Reason by Sponsor|0|||
13359732|NCT02996110|26680500|FG003|Track 1|Administrative Reason by Sponsor|0|||
13359733|NCT02996110|26680501|FG004|Track 1|Administrative Reason by Sponsor|0|||
13359734|NCT02996110|26680497|FG000|Track 1|Participant no Longer Met Study Criteria|1|||
13359735|NCT02996110|26680498|FG001|Track 1|Participant no Longer Met Study Criteria|0|||
13204469|NCT01972841|26229053|FG005|Overall Study|Withdrawal by participants|34|||
13359736|NCT02996110|26680499|FG002|Track 1|Participant no Longer Met Study Criteria|0|||
13359737|NCT02996110|26680500|FG003|Track 1|Participant no Longer Met Study Criteria|0|||
13359738|NCT02996110|26680501|FG004|Track 1|Participant no Longer Met Study Criteria|0|||
13359739|NCT02996110|26680497|FG000|Track 2|Disease Progression|33|||
13359740|NCT02996110|26680498|FG001|Track 2|Disease Progression|26|||
13359741|NCT02996110|26680499|FG002|Track 2|Disease Progression|19|||
13359742|NCT02996110|26680500|FG003|Track 2|Disease Progression|16|||
13359743|NCT02996110|26680501|FG004|Track 2|Disease Progression|15|||
13359744|NCT02996110|26680497|FG000|Track 2|Adverse Event Unrelated to Study Drug|4|||
13359745|NCT02996110|26680498|FG001|Track 2|Adverse Event Unrelated to Study Drug|0|||
13359746|NCT02996110|26680499|FG002|Track 2|Adverse Event Unrelated to Study Drug|0|||
13359747|NCT02996110|26680500|FG003|Track 2|Adverse Event Unrelated to Study Drug|1|||
13359748|NCT02996110|26680501|FG004|Track 2|Adverse Event Unrelated to Study Drug|1|||
13359749|NCT02996110|26680497|FG000|Track 2|Death|0|||
13359750|NCT02996110|26680498|FG001|Track 2|Death|0|||
13359751|NCT02996110|26680499|FG002|Track 2|Death|1|||
13359752|NCT02996110|26680500|FG003|Track 2|Death|0|||
13359753|NCT02996110|26680501|FG004|Track 2|Death|1|||
13359754|NCT02996110|26680497|FG000|Track 2|Study Drug Toxicity|4|||
13359755|NCT02996110|26680498|FG001|Track 2|Study Drug Toxicity|1|||
13359756|NCT02996110|26680499|FG002|Track 2|Study Drug Toxicity|4|||
13359757|NCT02996110|26680500|FG003|Track 2|Study Drug Toxicity|1|||
13359758|NCT02996110|26680501|FG004|Track 2|Study Drug Toxicity|0|||
13359759|NCT02996110|26680497|FG000|Track 2|Participant Requested to Discontinue Study Treatment|0|||
13359760|NCT02996110|26680498|FG001|Track 2|Participant Requested to Discontinue Study Treatment|0|||
13359761|NCT02996110|26680499|FG002|Track 2|Participant Requested to Discontinue Study Treatment|2|||
13359762|NCT02996110|26680500|FG003|Track 2|Participant Requested to Discontinue Study Treatment|1|||
13359763|NCT02996110|26680501|FG004|Track 2|Participant Requested to Discontinue Study Treatment|2|||
13359764|NCT02996110|26680497|FG000|Track 2|Participant Withdrew Consent|1|||
13359765|NCT02996110|26680498|FG001|Track 2|Participant Withdrew Consent|2|||
13359766|NCT02996110|26680499|FG002|Track 2|Participant Withdrew Consent|3|||
13359767|NCT02996110|26680500|FG003|Track 2|Participant Withdrew Consent|1|||
13359768|NCT02996110|26680501|FG004|Track 2|Participant Withdrew Consent|1|||
13359769|NCT02996110|26680497|FG000|Track 2|Other Reasons|0|||
13359770|NCT02996110|26680498|FG001|Track 2|Other Reasons|0|||
13359771|NCT02996110|26680499|FG002|Track 2|Other Reasons|1|||
13359772|NCT02996110|26680500|FG003|Track 2|Other Reasons|0|||
13359773|NCT02996110|26680501|FG004|Track 2|Other Reasons|1|||
13359774|NCT02927262|26680524|FG000|Overall Study|Adverse Event|7|||
13359775|NCT02927262|26680525|FG001|Overall Study|Adverse Event|1|||
13359776|NCT02927262|26680524|FG000|Overall Study|Death|1|||
13359777|NCT02927262|26680525|FG001|Overall Study|Death|0|||
13359778|NCT02927262|26680524|FG000|Overall Study|Withdrawal by Subject|3|||
13359779|NCT02927262|26680525|FG001|Overall Study|Withdrawal by Subject|0|||
13359780|NCT02927262|26680524|FG000|Overall Study|Disease Relapse|23|||
13359781|NCT02927262|26680525|FG001|Overall Study|Disease Relapse|18|||
13359782|NCT02927262|26680524|FG000|Overall Study|Miscellaneous|5|||
13359783|NCT02927262|26680525|FG001|Overall Study|Miscellaneous|4|||
13359784|NCT02927262|26680524|FG000|Overall Study|Ongoing|4|||
13359785|NCT02927262|26680525|FG001|Overall Study|Ongoing|0|||
13359786|NCT02905825|26680533|FG000|Overall Study|Protocol Violation|11|||
13359787|NCT02905825|26680533|FG000|Overall Study|Device Malfunction|1|||
13359788|NCT02860039|26680568|FG000|Overall Study|Death|4|||
13359789|NCT02860039|26680569|FG001|Overall Study|Death|0|||
13359790|NCT02860039|26680568|FG000|Overall Study|Lost to Follow-up|2|||
13359791|NCT02860039|26680569|FG001|Overall Study|Lost to Follow-up|2|||
13359792|NCT02860039|26680568|FG000|Overall Study|Protocol Violation|3|||
13359793|NCT02860039|26680569|FG001|Overall Study|Protocol Violation|1|||
13359794|NCT02860039|26680568|FG000|Overall Study|Withdrawal by Subject|1|||
13359795|NCT02860039|26680569|FG001|Overall Study|Withdrawal by Subject|0|||
13359796|NCT02860039|26680568|FG000|Overall Study|Not otherwise eligible|1|||
13359797|NCT02860039|26680569|FG001|Overall Study|Not otherwise eligible|1|||
13359798|NCT02854436|26680585|FG000|Overall Study|Adverse Event|1|||
13359799|NCT02854436|26680585|FG000|Overall Study|Death|208|||
13359800|NCT02854436|26680585|FG000|Overall Study|Lost to Follow-up|5|||
13359801|NCT02854436|26680585|FG000|Overall Study|Withdrawal by Subject|12|||
13359802|NCT02854436|26680585|FG000|Overall Study|Other|45|||
13359803|NCT02854436|26680585|FG000|Overall Study|Ongoing|18|||
13359804|NCT02702414|26680634|FG000|Overall Study|Death|77|||
13359805|NCT02702414|26680635|FG001|Overall Study|Death|34|||
13359806|NCT02702414|26680634|FG000|Overall Study|Lost to Follow-up|0|||
13359807|NCT02702414|26680635|FG001|Overall Study|Lost to Follow-up|1|||
13359808|NCT02702414|26680634|FG000|Overall Study|Withdrawal by Subject|0|||
13359809|NCT02702414|26680635|FG001|Overall Study|Withdrawal by Subject|1|||
13359810|NCT02702414|26680634|FG000|Overall Study|Participants Ongoing in Study|27|||
13359811|NCT02702414|26680635|FG001|Overall Study|Participants Ongoing in Study|15|||
13359812|NCT02702414|26680634|FG000|Overall Study|Not Treated|1|||
13359813|NCT02702414|26680635|FG001|Overall Study|Not Treated|0|||
13359814|NCT02677922|26680708|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
13359815|NCT02677922|26680709|FG001|Pre-Treatment Period|Withdrawal by Subject|0|||
13359816|NCT02677922|26680710|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
13359817|NCT02677922|26680711|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
13359818|NCT02677922|26680712|FG004|Pre-Treatment Period|Withdrawal by Subject|0|||
13359819|NCT02677922|26680713|FG005|Pre-Treatment Period|Withdrawal by Subject|1|||
13359820|NCT02677922|26680708|FG000|Treatment Period|Adverse Event|0|||
13359821|NCT02677922|26680709|FG001|Treatment Period|Adverse Event|0|||
13359822|NCT02677922|26680710|FG002|Treatment Period|Adverse Event|1|||
13359823|NCT02677922|26680711|FG003|Treatment Period|Adverse Event|3|||
13359824|NCT02677922|26680712|FG004|Treatment Period|Adverse Event|5|||
13359825|NCT02677922|26680713|FG005|Treatment Period|Adverse Event|2|||
13359826|NCT02677922|26680708|FG000|Treatment Period|Progressive Disease|1|||
13359827|NCT02677922|26680709|FG001|Treatment Period|Progressive Disease|1|||
13359828|NCT02677922|26680710|FG002|Treatment Period|Progressive Disease|0|||
13359829|NCT02677922|26680711|FG003|Treatment Period|Progressive Disease|0|||
13359830|NCT02677922|26680712|FG004|Treatment Period|Progressive Disease|8|||
13359831|NCT02677922|26680713|FG005|Treatment Period|Progressive Disease|7|||
13359832|NCT02677922|26680708|FG000|Treatment Period|Lack of Efficacy|0|||
13359833|NCT02677922|26680709|FG001|Treatment Period|Lack of Efficacy|0|||
13359834|NCT02677922|26680710|FG002|Treatment Period|Lack of Efficacy|0|||
13359835|NCT02677922|26680711|FG003|Treatment Period|Lack of Efficacy|1|||
13359836|NCT02677922|26680712|FG004|Treatment Period|Lack of Efficacy|1|||
13359837|NCT02677922|26680713|FG005|Treatment Period|Lack of Efficacy|6|||
13359838|NCT02677922|26680708|FG000|Treatment Period|Withdrawal by Subject|0|||
13359839|NCT02677922|26680709|FG001|Treatment Period|Withdrawal by Subject|0|||
13359840|NCT02677922|26680710|FG002|Treatment Period|Withdrawal by Subject|1|||
13359841|NCT02677922|26680711|FG003|Treatment Period|Withdrawal by Subject|3|||
13359842|NCT02677922|26680712|FG004|Treatment Period|Withdrawal by Subject|5|||
13359843|NCT02677922|26680713|FG005|Treatment Period|Withdrawal by Subject|5|||
13359844|NCT02677922|26680708|FG000|Treatment Period|Transition to Commercially Available Treatment|0|||
13359845|NCT02677922|26680709|FG001|Treatment Period|Transition to Commercially Available Treatment|1|||
13359846|NCT02677922|26680710|FG002|Treatment Period|Transition to Commercially Available Treatment|1|||
13359847|NCT02677922|26680711|FG003|Treatment Period|Transition to Commercially Available Treatment|1|||
13359848|NCT02677922|26680712|FG004|Treatment Period|Transition to Commercially Available Treatment|1|||
13359849|NCT02677922|26680713|FG005|Treatment Period|Transition to Commercially Available Treatment|2|||
13359850|NCT02677922|26680708|FG000|Treatment Period|Disease Relapse|0|||
13359851|NCT02677922|26680709|FG001|Treatment Period|Disease Relapse|0|||
13359852|NCT02677922|26680710|FG002|Treatment Period|Disease Relapse|0|||
13359853|NCT02677922|26680711|FG003|Treatment Period|Disease Relapse|3|||
13359854|NCT02677922|26680712|FG004|Treatment Period|Disease Relapse|6|||
13359855|NCT02677922|26680713|FG005|Treatment Period|Disease Relapse|1|||
13359856|NCT02677922|26680708|FG000|Treatment Period|Allogeneic HSCT|1|||
13359857|NCT02677922|26680709|FG001|Treatment Period|Allogeneic HSCT|0|||
13359858|NCT02677922|26680710|FG002|Treatment Period|Allogeneic HSCT|0|||
13359859|NCT02677922|26680711|FG003|Treatment Period|Allogeneic HSCT|1|||
13359860|NCT02677922|26680712|FG004|Treatment Period|Allogeneic HSCT|4|||
13359861|NCT02677922|26680713|FG005|Treatment Period|Allogeneic HSCT|1|||
13359862|NCT02677922|26680708|FG000|Treatment Period|Other Reasons|0|||
13359863|NCT02677922|26680709|FG001|Treatment Period|Other Reasons|0|||
13359864|NCT02677922|26680710|FG002|Treatment Period|Other Reasons|0|||
13359865|NCT02677922|26680711|FG003|Treatment Period|Other Reasons|1|||
13359866|NCT02677922|26680712|FG004|Treatment Period|Other Reasons|3|||
13359867|NCT02677922|26680713|FG005|Treatment Period|Other Reasons|5|||
13359868|NCT02677922|26680708|FG000|Treatment Period|Death|0|||
13359869|NCT02677922|26680709|FG001|Treatment Period|Death|0|||
13359870|NCT02677922|26680710|FG002|Treatment Period|Death|0|||
13359871|NCT02677922|26680711|FG003|Treatment Period|Death|0|||
13359872|NCT02677922|26680712|FG004|Treatment Period|Death|12|||
13359873|NCT02677922|26680713|FG005|Treatment Period|Death|1|||
13359874|NCT02677922|26680708|FG000|Treatment Period|Non-compliance with Study Drug|0|||
13359875|NCT02677922|26680709|FG001|Treatment Period|Non-compliance with Study Drug|0|||
13359876|NCT02677922|26680710|FG002|Treatment Period|Non-compliance with Study Drug|0|||
13359877|NCT02677922|26680711|FG003|Treatment Period|Non-compliance with Study Drug|0|||
13359878|NCT02677922|26680712|FG004|Treatment Period|Non-compliance with Study Drug|1|||
13359879|NCT02677922|26680713|FG005|Treatment Period|Non-compliance with Study Drug|0|||
13359880|NCT02677922|26680708|FG000|Treatment Period|Physician Decision|0|||
13359881|NCT02677922|26680709|FG001|Treatment Period|Physician Decision|0|||
13359882|NCT02677922|26680710|FG002|Treatment Period|Physician Decision|0|||
13359883|NCT02677922|26680711|FG003|Treatment Period|Physician Decision|0|||
13359884|NCT02677922|26680712|FG004|Treatment Period|Physician Decision|0|||
13359885|NCT02677922|26680713|FG005|Treatment Period|Physician Decision|1|||
13359886|NCT02677922|26680708|FG000|Treatment Period|Symptomatic Deterioration|0|||
13359887|NCT02677922|26680709|FG001|Treatment Period|Symptomatic Deterioration|0|||
13359888|NCT02677922|26680710|FG002|Treatment Period|Symptomatic Deterioration|0|||
13359889|NCT02677922|26680711|FG003|Treatment Period|Symptomatic Deterioration|0|||
13359890|NCT02677922|26680712|FG004|Treatment Period|Symptomatic Deterioration|1|||
13359891|NCT02677922|26680713|FG005|Treatment Period|Symptomatic Deterioration|0|||
13359892|NCT02577406|26680767|FG000|Randomized Period|Death|1|||
13359893|NCT02577406|26680768|FG001|Randomized Period|Death|0|||
13359894|NCT02577406|26680767|FG000|Randomized Period|Other reasons|0|||
13359895|NCT02577406|26680768|FG001|Randomized Period|Other reasons|20|||
13359896|NCT02577406|26680767|FG000|Treatment Period|Transition to commercially available treatment|1|||
13359897|NCT02577406|26680768|FG001|Treatment Period|Transition to commercially available treatment|0|||
13359898|NCT02577406|26680767|FG000|Treatment Period|Progressive disease|47|||
13359899|NCT02577406|26680768|FG001|Treatment Period|Progressive disease|36|||
13359900|NCT02577406|26680767|FG000|Treatment Period|Death|36|||
13359901|NCT02577406|26680768|FG001|Treatment Period|Death|23|||
13359902|NCT02577406|26680767|FG000|Treatment Period|Other reasons|3|||
13359903|NCT02577406|26680768|FG001|Treatment Period|Other reasons|37|||
13359904|NCT02577406|26680767|FG000|Treatment Period|Withdrawal by Subject|10|||
13359905|NCT02577406|26680768|FG001|Treatment Period|Withdrawal by Subject|24|||
13359906|NCT02577406|26680767|FG000|Treatment Period|Adverse Event|17|||
13359907|NCT02577406|26680768|FG001|Treatment Period|Adverse Event|12|||
13359908|NCT02577406|26680767|FG000|Treatment Period|Disease relapse|27|||
13359909|NCT02577406|26680768|FG001|Treatment Period|Disease relapse|1|||
13359910|NCT02577406|26680767|FG000|Treatment Period|HSCT|6|||
13359911|NCT02577406|26680768|FG001|Treatment Period|HSCT|2|||
13359912|NCT02577406|26680767|FG000|Treatment Period|Lost to Follow-up|0|||
13359913|NCT02577406|26680768|FG001|Treatment Period|Lost to Follow-up|1|||
13359914|NCT02577406|26680767|FG000|Treatment Period|Protocol Violation|0|||
13359915|NCT02577406|26680768|FG001|Treatment Period|Protocol Violation|1|||
13359916|NCT02489318|26680834|FG000|Randomized|Withdrawal by Subject|0|||
13359917|NCT02489318|26680835|FG001|Randomized|Withdrawal by Subject|1|||
13359918|NCT02489318|26680834|FG000|Treated|Adverse Event|19|||
13359919|NCT02489318|26680835|FG001|Treated|Adverse Event|62|||
13359920|NCT02489318|26680834|FG000|Treated|Death|13|||
13359921|NCT02489318|26680835|FG001|Treated|Death|11|||
13359922|NCT02489318|26680834|FG000|Treated|Physician Decision|4|||
13359923|NCT02489318|26680835|FG001|Treated|Physician Decision|6|||
13359924|NCT02489318|26680834|FG000|Treated|Protocol Violation|1|||
13359925|NCT02489318|26680835|FG001|Treated|Protocol Violation|2|||
13359926|NCT02489318|26680834|FG000|Treated|Withdrawal by Subject|37|||
13359927|NCT02489318|26680835|FG001|Treated|Withdrawal by Subject|36|||
13359928|NCT02489318|26680834|FG000|Treated|Other: Progressive Disease|245|||
13359929|NCT02489318|26680835|FG001|Treated|Other: Progressive Disease|138|||
13359930|NCT02489318|26680834|FG000|Treated|Other|0|||
13359931|NCT02489318|26680835|FG001|Treated|Other|2|||
13359932|NCT02489318|26680834|FG000|Treated|Ongoing|0|||
13359933|NCT02489318|26680835|FG001|Treated|Ongoing|267|||
13359934|NCT02477696|26680850|FG000|Overall Study|Adverse Event|40|||
13359935|NCT02477696|26680851|FG001|Overall Study|Adverse Event|59|||
13359936|NCT02477696|26680850|FG000|Overall Study|CLL Disease Progression|82|||
13359937|NCT02477696|26680851|FG001|Overall Study|CLL Disease Progression|68|||
13359938|NCT02477696|26680850|FG000|Overall Study|Includes Non-compliance, Relocation, Subject's Decision and Medical Monitor's Decision.|2|||
13359939|NCT02477696|26680851|FG001|Overall Study|Includes Non-compliance, Relocation, Subject's Decision and Medical Monitor's Decision.|10|||
13359940|NCT02477696|26680850|FG000|Overall Study|Death|5|||
13359941|NCT02477696|26680851|FG001|Overall Study|Death|6|||
13359942|NCT02477696|26680850|FG000|Overall Study|Withdrawal by Subject|7|||
13359943|NCT02477696|26680851|FG001|Overall Study|Withdrawal by Subject|7|||
13359944|NCT02477696|26680850|FG000|Overall Study|Physician Decision|5|||
13359945|NCT02477696|26680851|FG001|Overall Study|Physician Decision|5|||
13359946|NCT02432274|26680989|FG000|Overall Study|Radiological Disease Progression|3|||
13359947|NCT02432274|26680990|FG001|Overall Study|Radiological Disease Progression|4|||
13359948|NCT02432274|26680991|FG002|Overall Study|Radiological Disease Progression|7|||
13359949|NCT02432274|26680992|FG003|Overall Study|Radiological Disease Progression|0|||
13359950|NCT02432274|26680993|FG004|Overall Study|Radiological Disease Progression|24|||
13359951|NCT02432274|26680994|FG005|Overall Study|Radiological Disease Progression|6|||
13359952|NCT02432274|26680995|FG006|Overall Study|Radiological Disease Progression|11|||
13359953|NCT02432274|26680996|FG007|Overall Study|Radiological Disease Progression|9|||
13359954|NCT02432274|26680989|FG000|Overall Study|Clinical Disease Progression|0|||
13359955|NCT02432274|26680990|FG001|Overall Study|Clinical Disease Progression|4|||
13359956|NCT02432274|26680991|FG002|Overall Study|Clinical Disease Progression|1|||
13359957|NCT02432274|26680992|FG003|Overall Study|Clinical Disease Progression|0|||
13359958|NCT02432274|26680993|FG004|Overall Study|Clinical Disease Progression|1|||
13359959|NCT02432274|26680994|FG005|Overall Study|Clinical Disease Progression|0|||
13359960|NCT02432274|26680995|FG006|Overall Study|Clinical Disease Progression|0|||
13359961|NCT02432274|26680996|FG007|Overall Study|Clinical Disease Progression|1|||
13359962|NCT02432274|26680989|FG000|Overall Study|Adverse Event|0|||
13359963|NCT02432274|26680990|FG001|Overall Study|Adverse Event|0|||
13359964|NCT02432274|26680991|FG002|Overall Study|Adverse Event|1|||
13359965|NCT02432274|26680992|FG003|Overall Study|Adverse Event|0|||
13359966|NCT02432274|26680993|FG004|Overall Study|Adverse Event|1|||
13359967|NCT02432274|26680994|FG005|Overall Study|Adverse Event|0|||
13359968|NCT02432274|26680995|FG006|Overall Study|Adverse Event|2|||
13359969|NCT02432274|26680996|FG007|Overall Study|Adverse Event|0|||
13359970|NCT02432274|26680989|FG000|Overall Study|Withdrawal by Subject|0|||
13359971|NCT02432274|26680990|FG001|Overall Study|Withdrawal by Subject|0|||
13359972|NCT02432274|26680991|FG002|Overall Study|Withdrawal by Subject|0|||
13359973|NCT02432274|26680992|FG003|Overall Study|Withdrawal by Subject|0|||
13359974|NCT02432274|26680993|FG004|Overall Study|Withdrawal by Subject|2|||
13359975|NCT02432274|26680994|FG005|Overall Study|Withdrawal by Subject|0|||
13359976|NCT02432274|26680995|FG006|Overall Study|Withdrawal by Subject|1|||
13359977|NCT02432274|26680996|FG007|Overall Study|Withdrawal by Subject|2|||
13359978|NCT02432274|26680989|FG000|Overall Study|Participant Choice|0|||
13359979|NCT02432274|26680990|FG001|Overall Study|Participant Choice|0|||
13359980|NCT02432274|26680991|FG002|Overall Study|Participant Choice|1|||
13359981|NCT02432274|26680992|FG003|Overall Study|Participant Choice|0|||
13359982|NCT02432274|26680993|FG004|Overall Study|Participant Choice|0|||
13359983|NCT02432274|26680994|FG005|Overall Study|Participant Choice|0|||
13359984|NCT02432274|26680995|FG006|Overall Study|Participant Choice|1|||
13359985|NCT02432274|26680996|FG007|Overall Study|Participant Choice|0|||
13359986|NCT02432274|26680989|FG000|Overall Study|Other than specified|0|||
13359987|NCT02432274|26680990|FG001|Overall Study|Other than specified|1|||
13359988|NCT02432274|26680991|FG002|Overall Study|Other than specified|0|||
13359989|NCT02432274|26680992|FG003|Overall Study|Other than specified|0|||
13359990|NCT02432274|26680993|FG004|Overall Study|Other than specified|0|||
13359991|NCT02432274|26680994|FG005|Overall Study|Other than specified|1|||
13359992|NCT02432274|26680995|FG006|Overall Study|Other than specified|0|||
13359993|NCT02432274|26680996|FG007|Overall Study|Other than specified|1|||
13359994|NCT02432274|26680989|FG000|Overall Study|Ongoing|0|||
13359995|NCT02432274|26680990|FG001|Overall Study|Ongoing|0|||
13359996|NCT02432274|26680991|FG002|Overall Study|Ongoing|1|||
13359997|NCT02432274|26680992|FG003|Overall Study|Ongoing|1|||
13359998|NCT02432274|26680993|FG004|Overall Study|Ongoing|3|||
13359999|NCT02432274|26680994|FG005|Overall Study|Ongoing|0|||
13360000|NCT02432274|26680995|FG006|Overall Study|Ongoing|0|||
13360001|NCT02432274|26680996|FG007|Overall Study|Ongoing|7|||
13374788|NCT00793624|26728502|FG002|Overall Study|Lost to Follow-up|4|||
13374789|NCT00793624|26728503|FG003|Overall Study|Lost to Follow-up|0|||
13374790|NCT00793624|26728500|FG000|Overall Study|Withdrawal by Subject|20|||
13374791|NCT00793624|26728501|FG001|Overall Study|Withdrawal by Subject|9|||
13360002|NCT02314026|26681004|FG000|Overall Study|Protocol Violation|28|||
13360003|NCT02281955|26681015|FG000|Overall Study|Death|1|||
13360004|NCT02257736|26681036|FG000|Overall Study|Progressive disease|365|||
13360005|NCT02257736|26681037|FG001|Overall Study|Progressive disease|327|||
13360006|NCT02257736|26681036|FG000|Overall Study|Adverse Event|45|||
13360007|NCT02257736|26681037|FG001|Overall Study|Adverse Event|56|||
13360008|NCT02257736|26681036|FG000|Overall Study|Withdrawal by Subject|21|||
13360009|NCT02257736|26681037|FG001|Overall Study|Withdrawal by Subject|38|||
13360010|NCT02257736|26681036|FG000|Overall Study|Death|11|||
13360011|NCT02257736|26681037|FG001|Overall Study|Death|6|||
13360012|NCT02257736|26681036|FG000|Overall Study|Physician Decision|5|||
13360013|NCT02257736|26681037|FG001|Overall Study|Physician Decision|9|||
13360014|NCT02257736|26681036|FG000|Overall Study|Non-Compliance with study drug|1|||
13360015|NCT02257736|26681037|FG001|Overall Study|Non-Compliance with study drug|2|||
13360016|NCT02257736|26681036|FG000|Overall Study|Protocol Violation|1|||
13360017|NCT02257736|26681037|FG001|Overall Study|Protocol Violation|0|||
13360018|NCT02257736|26681036|FG000|Overall Study|Other|1|||
13360019|NCT02257736|26681037|FG001|Overall Study|Other|7|||
13360020|NCT02257736|26681036|FG000|Overall Study|Randomized, not treated|1|||
13360021|NCT02257736|26681037|FG001|Overall Study|Randomized, not treated|2|||
13360022|NCT02143778|26681044|FG000|Overall Study|Withdrawal by Subject|2|||
13360023|NCT02143778|26681044|FG000|Overall Study|Device malfunction|1|||
13360024|NCT02141282|26681082|FG000|Overall Study|Adverse event, not related to progression|8|||
13360025|NCT02141282|26681083|FG001|Overall Study|Adverse event, not related to progression|1|||
13360026|NCT02141282|26681084|FG002|Overall Study|Adverse event, not related to progression|3|||
13360027|NCT02141282|26681085|FG003|Overall Study|Adverse event, not related to progression|1|||
13360028|NCT02141282|26681082|FG000|Overall Study|Adverse event, related to progression|1|||
13360029|NCT02141282|26681083|FG001|Overall Study|Adverse event, related to progression|0|||
13360030|NCT02141282|26681084|FG002|Overall Study|Adverse event, related to progression|2|||
13360031|NCT02141282|26681085|FG003|Overall Study|Adverse event, related to progression|0|||
13360032|NCT02141282|26681082|FG000|Overall Study|COVID-19 infection|1|||
13360033|NCT02141282|26681083|FG001|Overall Study|COVID-19 infection|0|||
13360034|NCT02141282|26681084|FG002|Overall Study|COVID-19 infection|0|||
13360035|NCT02141282|26681085|FG003|Overall Study|COVID-19 infection|0|||
13360036|NCT02141282|26681082|FG000|Overall Study|Lost to Follow-up|0|||
13360037|NCT02141282|26681083|FG001|Overall Study|Lost to Follow-up|0|||
13360038|NCT02141282|26681084|FG002|Overall Study|Lost to Follow-up|4|||
13360039|NCT02141282|26681085|FG003|Overall Study|Lost to Follow-up|2|||
13360040|NCT02141282|26681082|FG000|Overall Study|Other, not specified|14|||
13360041|NCT02141282|26681083|FG001|Overall Study|Other, not specified|11|||
13360042|NCT02141282|26681084|FG002|Overall Study|Other, not specified|23|||
13360043|NCT02141282|26681085|FG003|Overall Study|Other, not specified|9|||
13360044|NCT02141282|26681082|FG000|Overall Study|Progressive disease, Richter's|4|||
13360045|NCT02141282|26681083|FG001|Overall Study|Progressive disease, Richter's|1|||
13360046|NCT02141282|26681084|FG002|Overall Study|Progressive disease, Richter's|1|||
13360047|NCT02141282|26681085|FG003|Overall Study|Progressive disease, Richter's|1|||
13360048|NCT02141282|26681082|FG000|Overall Study|Progressive disease per protocol|12|||
13360049|NCT02141282|26681083|FG001|Overall Study|Progressive disease per protocol|7|||
13360050|NCT02141282|26681084|FG002|Overall Study|Progressive disease per protocol|9|||
13360051|NCT02141282|26681085|FG003|Overall Study|Progressive disease per protocol|2|||
13360052|NCT02141282|26681082|FG000|Overall Study|Stem cell transplant|1|||
13360053|NCT02141282|26681083|FG001|Overall Study|Stem cell transplant|0|||
13360054|NCT02141282|26681084|FG002|Overall Study|Stem cell transplant|1|||
13360055|NCT02141282|26681085|FG003|Overall Study|Stem cell transplant|0|||
13360056|NCT02141282|26681082|FG000|Overall Study|Study terminated by Sponsor|0|||
13360057|NCT02141282|26681083|FG001|Overall Study|Study terminated by Sponsor|1|||
13360058|NCT02141282|26681084|FG002|Overall Study|Study terminated by Sponsor|0|||
13360059|NCT02141282|26681085|FG003|Overall Study|Study terminated by Sponsor|0|||
13360060|NCT02141282|26681082|FG000|Overall Study|Subject non-compliance|0|||
13360061|NCT02141282|26681083|FG001|Overall Study|Subject non-compliance|0|||
13360062|NCT02141282|26681084|FG002|Overall Study|Subject non-compliance|1|||
13360063|NCT02141282|26681085|FG003|Overall Study|Subject non-compliance|0|||
13360064|NCT02141282|26681082|FG000|Overall Study|Withdrew consent|2|||
13360065|NCT02141282|26681083|FG001|Overall Study|Withdrew consent|0|||
13360066|NCT02141282|26681084|FG002|Overall Study|Withdrew consent|4|||
13360067|NCT02141282|26681085|FG003|Overall Study|Withdrew consent|0|||
13360068|NCT01972217|26681150|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
13360069|NCT01972217|26681151|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1|||
13360070|NCT01972217|26681152|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
13360071|NCT01972217|26681153|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
13360072|NCT01972217|26681150|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1|||
13360073|NCT01972217|26681151|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9|||
13360074|NCT01972217|26681152|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
13360075|NCT01972217|26681153|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
13360076|NCT01972217|26681150|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
13360077|NCT01972217|26681151|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1|||
13360078|NCT01972217|26681152|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
13360079|NCT01972217|26681153|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
13360080|NCT01972217|26681150|FG000|Part A: Open-label Safety Run-in Period|Death|0|||
13360081|NCT01972217|26681151|FG001|Part A: Open-label Safety Run-in Period|Death|1|||
13360082|NCT01972217|26681152|FG002|Part A: Open-label Safety Run-in Period|Death|0|||
13360083|NCT01972217|26681153|FG003|Part A: Open-label Safety Run-in Period|Death|0|||
13360084|NCT01972217|26681150|FG000|Part B Double-blind, Randomised Period|Death|0|||
13360085|NCT01972217|26681151|FG001|Part B Double-blind, Randomised Period|Death|0|||
13360086|NCT01972217|26681152|FG002|Part B Double-blind, Randomised Period|Death|43|||
13360087|NCT01972217|26681153|FG003|Part B Double-blind, Randomised Period|Death|44|||
13360088|NCT01972217|26681150|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0|||
13360089|NCT01972217|26681151|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0|||
13360090|NCT01972217|26681152|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1|||
13360091|NCT01972217|26681153|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0|||
13360092|NCT01972217|26681150|FG000|Part B Double-blind, Randomised Period|Screen failure|0|||
13360093|NCT01972217|26681151|FG001|Part B Double-blind, Randomised Period|Screen failure|0|||
13360094|NCT01972217|26681152|FG002|Part B Double-blind, Randomised Period|Screen failure|0|||
13360095|NCT01972217|26681153|FG003|Part B Double-blind, Randomised Period|Screen failure|1|||
13360096|NCT01972217|26681150|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
13360097|NCT01972217|26681151|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
13360098|NCT01972217|26681152|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2|||
13360099|NCT01972217|26681153|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1|||
13360100|NCT01972217|26681150|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
13360101|NCT01972217|26681151|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
13360102|NCT01972217|26681152|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
13360103|NCT01972217|26681153|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1|||
13360104|NCT01958021|26681168|FG000|Overall Study|Progressive disease|87|||
13360105|NCT01958021|26681169|FG001|Overall Study|Progressive disease|146|||
13360106|NCT01958021|26681168|FG000|Overall Study|Adverse Event|25|||
13360107|NCT01958021|26681169|FG001|Overall Study|Adverse Event|7|||
13360108|NCT01958021|26681168|FG000|Overall Study|Subject/guardian decision|12|||
13360109|NCT01958021|26681169|FG001|Overall Study|Subject/guardian decision|13|||
13360110|NCT01958021|26681168|FG000|Overall Study|Physician Decision|10|||
13360111|NCT01958021|26681169|FG001|Overall Study|Physician Decision|13|||
13360112|NCT01958021|26681168|FG000|Overall Study|Protocol Violation|3|||
13360113|NCT01958021|26681169|FG001|Overall Study|Protocol Violation|1|||
13360114|NCT01958021|26681168|FG000|Overall Study|Death|2|||
13360115|NCT01958021|26681169|FG001|Overall Study|Death|0|||
13360116|NCT01909453|26681332|FG000|Overall Study|Ongoing|118|||
13360117|NCT01909453|26681333|FG001|Overall Study|Ongoing|103|||
13360118|NCT01909453|26681334|FG002|Overall Study|Ongoing|83|||
13360119|NCT01909453|26681335|FG003|Overall Study|Ongoing|164|||
13360120|NCT01909453|26681336|FG004|Overall Study|Ongoing|50|||
13360121|NCT01909453|26681332|FG000|Overall Study|Death|69|||
13360122|NCT01909453|26681333|FG001|Overall Study|Death|74|||
13360123|NCT01909453|26681334|FG002|Overall Study|Death|88|||
13360124|NCT01909453|26681335|FG003|Overall Study|Death|86|||
13360125|NCT01909453|26681336|FG004|Overall Study|Death|29|||
13360126|NCT01909453|26681332|FG000|Overall Study|Lost to Follow-up|3|||
13360127|NCT01909453|26681333|FG001|Overall Study|Lost to Follow-up|4|||
13360128|NCT01909453|26681334|FG002|Overall Study|Lost to Follow-up|4|||
13360129|NCT01909453|26681335|FG003|Overall Study|Lost to Follow-up|3|||
13360130|NCT01909453|26681336|FG004|Overall Study|Lost to Follow-up|3|||
13360131|NCT01909453|26681332|FG000|Overall Study|Withdrawal by Subject|2|||
13360132|NCT01909453|26681333|FG001|Overall Study|Withdrawal by Subject|13|||
13360133|NCT01909453|26681334|FG002|Overall Study|Withdrawal by Subject|16|||
13360134|NCT01909453|26681335|FG003|Overall Study|Withdrawal by Subject|5|||
13360135|NCT01909453|26681336|FG004|Overall Study|Withdrawal by Subject|4|||
13360136|NCT01877655|26681359|FG000|Overall Study|Death|57|||
13360137|NCT01877655|26681360|FG001|Overall Study|Death|52|||
13360138|NCT01877655|26681359|FG000|Overall Study|Withdrawal by Subject|18|||
13360139|NCT01877655|26681360|FG001|Overall Study|Withdrawal by Subject|26|||
13360140|NCT01877655|26681359|FG000|Overall Study|Physician Decision|11|||
13360141|NCT01877655|26681360|FG001|Overall Study|Physician Decision|10|||
13360142|NCT01877655|26681359|FG000|Overall Study|Miscellaneous|4|||
13360143|NCT01877655|26681360|FG001|Overall Study|Miscellaneous|4|||
13360144|NCT01877655|26681359|FG000|Overall Study|Randomized but Never Received Drug|8|||
13360145|NCT01877655|26681360|FG001|Overall Study|Randomized but Never Received Drug|5|||
13360146|NCT01832402|26681379|FG000|Overall Study|Lost to Follow-up|2|||
13360147|NCT01832402|26681380|FG001|Overall Study|Lost to Follow-up|0|||
13360148|NCT01832402|26681379|FG000|Overall Study|Withdrawal by Subject|3|||
13360149|NCT01832402|26681380|FG001|Overall Study|Withdrawal by Subject|3|||
13360150|NCT01832402|26681379|FG000|Overall Study|Declining Performance status|2|||
13360151|NCT01832402|26681380|FG001|Overall Study|Declining Performance status|1|||
13360152|NCT01828112|26681393|FG000|Overall Study|Adverse Event|6|||
13360153|NCT01828112|26681394|FG001|Overall Study|Adverse Event|8|||
13360154|NCT01828112|26681393|FG000|Overall Study|Death|9|||
13360155|NCT01828112|26681394|FG001|Overall Study|Death|5|||
13360156|NCT01828112|26681393|FG000|Overall Study|Physician Decision|5|||
13360157|NCT01828112|26681394|FG001|Overall Study|Physician Decision|5|||
13360158|NCT01828112|26681393|FG000|Overall Study|Progressive disease|56|||
13360159|NCT01828112|26681394|FG001|Overall Study|Progressive disease|82|||
13360160|NCT01828112|26681393|FG000|Overall Study|Subject/guardian decision|6|||
13360161|NCT01828112|26681394|FG001|Overall Study|Subject/guardian decision|8|||
13360162|NCT01716117|26681418|FG000|Overall Study|Death|5|||
13360163|NCT01716117|26681419|FG001|Overall Study|Death|2|||
13360164|NCT01716117|26681418|FG000|Overall Study|Withdrawal by Subject|2|||
13360165|NCT01716117|26681419|FG001|Overall Study|Withdrawal by Subject|0|||
13360166|NCT01650831|26681429|FG000|Overall Study|Screen failure|1|||
13360167|NCT01617096|26681449|FG000|Overall Study|Withdrawal by Subject|96|||
13360168|NCT01617096|26681450|FG001|Overall Study|Withdrawal by Subject|81|||
13360169|NCT01617096|26681449|FG000|Overall Study|Lost to Follow-up|37|||
13360170|NCT01617096|26681450|FG001|Overall Study|Lost to Follow-up|32|||
13360171|NCT01617096|26681449|FG000|Overall Study|Physician Decision|10|||
13360172|NCT01617096|26681450|FG001|Overall Study|Physician Decision|18|||
13360173|NCT01617096|26681449|FG000|Overall Study|Death|4|||
13360174|NCT01617096|26681450|FG001|Overall Study|Death|3|||
13360175|NCT01617096|26681449|FG000|Overall Study|Other|1|||
13360176|NCT01617096|26681450|FG001|Overall Study|Other|3|||
13360177|NCT01566695|26681559|FG000|Overall Study|Lack of Efficacy|18|||
13360178|NCT01566695|26681560|FG001|Overall Study|Lack of Efficacy|45|||
13360179|NCT01566695|26681559|FG000|Overall Study|Adverse Event|28|||
13360180|NCT01566695|26681560|FG001|Overall Study|Adverse Event|27|||
13360181|NCT01566695|26681559|FG000|Overall Study|Death|20|||
13360182|NCT01566695|26681560|FG001|Overall Study|Death|8|||
13360183|NCT01566695|26681559|FG000|Overall Study|Withdrawal by Subject|14|||
13360184|NCT01566695|26681560|FG001|Overall Study|Withdrawal by Subject|7|||
13360185|NCT01566695|26681559|FG000|Overall Study|Progressive Disease|11|||
13360186|NCT01566695|26681560|FG001|Overall Study|Progressive Disease|6|||
13360187|NCT01566695|26681559|FG000|Overall Study|Miscellaneous|4|||
13360188|NCT01566695|26681560|FG001|Overall Study|Miscellaneous|6|||
13360189|NCT01430442|26681641|FG000|Overall Study|Subject Withdrew Consent|3|||
13360190|NCT01430442|26681642|FG001|Overall Study|Subject Withdrew Consent|0|||
13360191|NCT01430442|26681643|FG002|Overall Study|Subject Withdrew Consent|1|||
13360192|NCT01430442|26681644|FG003|Overall Study|Subject Withdrew Consent|0|||
13360193|NCT01430442|26681645|FG004|Overall Study|Subject Withdrew Consent|2|||
13360194|NCT01430442|26681646|FG005|Overall Study|Subject Withdrew Consent|1|||
13360195|NCT01430442|26681647|FG006|Overall Study|Subject Withdrew Consent|5|||
13360196|NCT01430442|26681648|FG007|Overall Study|Subject Withdrew Consent|2|||
13360197|NCT01430442|26681641|FG000|Overall Study|Lost to Follow-up|2|||
13360198|NCT01430442|26681642|FG001|Overall Study|Lost to Follow-up|0|||
13360199|NCT01430442|26681643|FG002|Overall Study|Lost to Follow-up|1|||
13360200|NCT01430442|26681644|FG003|Overall Study|Lost to Follow-up|2|||
13360201|NCT01430442|26681645|FG004|Overall Study|Lost to Follow-up|2|||
13360202|NCT01430442|26681646|FG005|Overall Study|Lost to Follow-up|1|||
13360203|NCT01430442|26681647|FG006|Overall Study|Lost to Follow-up|5|||
13360204|NCT01430442|26681648|FG007|Overall Study|Lost to Follow-up|1|||
13360205|NCT01430442|26681641|FG000|Overall Study|Pregnancy|1|||
13360206|NCT01430442|26681642|FG001|Overall Study|Pregnancy|0|||
13360207|NCT01430442|26681643|FG002|Overall Study|Pregnancy|0|||
13360208|NCT01430442|26681644|FG003|Overall Study|Pregnancy|0|||
13360209|NCT01430442|26681645|FG004|Overall Study|Pregnancy|0|||
13360210|NCT01430442|26681646|FG005|Overall Study|Pregnancy|1|||
13360211|NCT01430442|26681647|FG006|Overall Study|Pregnancy|0|||
13360212|NCT01430442|26681648|FG007|Overall Study|Pregnancy|0|||
13360213|NCT01430442|26681641|FG000|Overall Study|Patient No Longer Meets Study Criteria|7|||
13360214|NCT01430442|26681642|FG001|Overall Study|Patient No Longer Meets Study Criteria|6|||
13360215|NCT01430442|26681643|FG002|Overall Study|Patient No Longer Meets Study Criteria|3|||
13360216|NCT01430442|26681644|FG003|Overall Study|Patient No Longer Meets Study Criteria|2|||
13360217|NCT01430442|26681645|FG004|Overall Study|Patient No Longer Meets Study Criteria|5|||
13360218|NCT01430442|26681646|FG005|Overall Study|Patient No Longer Meets Study Criteria|5|||
13360219|NCT01430442|26681647|FG006|Overall Study|Patient No Longer Meets Study Criteria|9|||
13360220|NCT01430442|26681648|FG007|Overall Study|Patient No Longer Meets Study Criteria|6|||
13360221|NCT01314118|26681657|FG000|Overall Study|Adverse Event|9|||
13360222|NCT01314118|26681657|FG000|Overall Study|Progressive disease|27|||
13360223|NCT01314118|26681657|FG000|Overall Study|Physician Decision|11|||
13360224|NCT01314118|26681657|FG000|Overall Study|Death|4|||
13360225|NCT01314118|26681657|FG000|Overall Study|Protocol Violation|5|||
13360226|NCT01314118|26681657|FG000|Overall Study|Withdrawal by Subject|11|||
13360227|NCT01314118|26681657|FG000|Overall Study|Other|2|||
13360228|NCT01314118|26681657|FG000|Overall Study|Ongoing|62|||
13360229|NCT01208974|26681669|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1|||
13360230|NCT01208974|26681670|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
13360231|NCT01208974|26681671|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
13360232|NCT01208974|26681672|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
13360233|NCT01208974|26681669|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1|||
13360234|NCT01208974|26681670|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
13360235|NCT01208974|26681671|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
13360236|NCT01208974|26681672|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
13360237|NCT01208974|26681669|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1|||
13360238|NCT01208974|26681670|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
13360239|NCT01208974|26681671|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
13360240|NCT01208974|26681672|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
13360241|NCT01193842|26681721|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
13360242|NCT01193842|26681722|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1|||
13360243|NCT01193842|26681723|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
13360244|NCT01193842|26681724|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
13360245|NCT01193842|26681725|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
13360246|NCT01193842|26681721|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1|||
13360247|NCT01193842|26681722|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
13360248|NCT01193842|26681723|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
13360249|NCT01193842|26681724|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
13360250|NCT01193842|26681725|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
13360251|NCT01193842|26681721|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
13360252|NCT01193842|26681722|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
13360253|NCT01193842|26681723|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1|||
13360254|NCT01193842|26681724|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
13360255|NCT01193842|26681725|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
13360256|NCT01193842|26681721|FG000|Phase II: Randomized Groups|Death|0|||
13360257|NCT01193842|26681722|FG001|Phase II: Randomized Groups|Death|0|||
13360258|NCT01193842|26681723|FG002|Phase II: Randomized Groups|Death|0|||
13360259|NCT01193842|26681724|FG003|Phase II: Randomized Groups|Death|1|||
13360260|NCT01193842|26681725|FG004|Phase II: Randomized Groups|Death|1|||
13360261|NCT01193842|26681721|FG000|Phase II: Randomized Groups|Adverse Event|0|||
13360262|NCT01193842|26681722|FG001|Phase II: Randomized Groups|Adverse Event|0|||
13360263|NCT01193842|26681723|FG002|Phase II: Randomized Groups|Adverse Event|0|||
13360264|NCT01193842|26681724|FG003|Phase II: Randomized Groups|Adverse Event|5|||
13360265|NCT01193842|26681725|FG004|Phase II: Randomized Groups|Adverse Event|3|||
13360266|NCT01193842|26681721|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0|||
13360267|NCT01193842|26681722|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0|||
13360268|NCT01193842|26681723|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0|||
13360269|NCT01193842|26681724|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1|||
13360270|NCT01193842|26681725|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2|||
13360271|NCT01193842|26681721|FG000|Phase II: Randomized Groups|Ineligible|0|||
13360272|NCT01193842|26681722|FG001|Phase II: Randomized Groups|Ineligible|0|||
13360273|NCT01193842|26681723|FG002|Phase II: Randomized Groups|Ineligible|0|||
13360274|NCT01193842|26681724|FG003|Phase II: Randomized Groups|Ineligible|0|||
13360275|NCT01193842|26681725|FG004|Phase II: Randomized Groups|Ineligible|1|||
13360276|NCT01193842|26681721|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
13360277|NCT01193842|26681722|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
13360278|NCT01193842|26681723|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
13360279|NCT01193842|26681724|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5|||
13360280|NCT01193842|26681725|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3|||
13360281|NCT01171898|26681760|FG000|Overall Study|Death|0|||
13360282|NCT01171898|26681761|FG001|Overall Study|Death|0|||
13360283|NCT01171898|26681762|FG002|Overall Study|Death|2|||
13360284|NCT01171898|26681763|FG003|Overall Study|Death|0|||
13360285|NCT01171898|26681760|FG000|Overall Study|Lost to Follow-up|0|||
13360286|NCT01171898|26681761|FG001|Overall Study|Lost to Follow-up|1|||
13360287|NCT01171898|26681762|FG002|Overall Study|Lost to Follow-up|1|||
13360288|NCT01171898|26681763|FG003|Overall Study|Lost to Follow-up|1|||
13360289|NCT01171898|26681760|FG000|Overall Study|Withdrawal by Subject|1|||
13360290|NCT01171898|26681761|FG001|Overall Study|Withdrawal by Subject|4|||
13360291|NCT01171898|26681762|FG002|Overall Study|Withdrawal by Subject|6|||
13360292|NCT01171898|26681763|FG003|Overall Study|Withdrawal by Subject|3|||
13360293|NCT01171898|26681760|FG000|Overall Study|Terminated by Sponsor|1|||
13360294|NCT01171898|26681761|FG001|Overall Study|Terminated by Sponsor|0|||
13360295|NCT01171898|26681762|FG002|Overall Study|Terminated by Sponsor|0|||
13360296|NCT01171898|26681763|FG003|Overall Study|Terminated by Sponsor|0|||
13360297|NCT01171898|26681760|FG000|Overall Study|Ongoing|1|||
13360298|NCT01171898|26681761|FG001|Overall Study|Ongoing|9|||
13360299|NCT01171898|26681762|FG002|Overall Study|Ongoing|3|||
13360300|NCT01171898|26681763|FG003|Overall Study|Ongoing|0|||
13360301|NCT01171898|26681760|FG000|Overall Study|Other|1|||
13360302|NCT01171898|26681761|FG001|Overall Study|Other|5|||
13360303|NCT01171898|26681762|FG002|Overall Study|Other|0|||
13360304|NCT01171898|26681763|FG003|Overall Study|Other|2|||
13374792|NCT00793624|26728502|FG002|Overall Study|Withdrawal by Subject|11|||
13374793|NCT00793624|26728503|FG003|Overall Study|Withdrawal by Subject|14|||
13374794|NCT00793624|26728500|FG000|Overall Study|Lack of Efficacy|9|||
13374795|NCT00793624|26728501|FG001|Overall Study|Lack of Efficacy|2|||
13374796|NCT00793624|26728502|FG002|Overall Study|Lack of Efficacy|1|||
13374797|NCT00793624|26728503|FG003|Overall Study|Lack of Efficacy|3|||
13374798|NCT00793624|26728500|FG000|Overall Study|Non compliance with protocol|2|||
13374799|NCT00793624|26728501|FG001|Overall Study|Non compliance with protocol|3|||
13374800|NCT00793624|26728502|FG002|Overall Study|Non compliance with protocol|2|||
13374801|NCT00793624|26728503|FG003|Overall Study|Non compliance with protocol|3|||
13374802|NCT00793624|26728500|FG000|Overall Study|Other reason not described above|6|||
13374803|NCT00793624|26728501|FG001|Overall Study|Other reason not described above|4|||
13374804|NCT00793624|26728502|FG002|Overall Study|Other reason not described above|6|||
13374805|NCT00793624|26728503|FG003|Overall Study|Other reason not described above|3|||
13374806|NCT00793598|26728544|FG000|Overall Study|Patient Request|0|||
13374807|NCT00793598|26728545|FG001|Overall Study|Patient Request|1|||
13374808|NCT00793598|26728546|FG002|Overall Study|Patient Request|0|||
13374809|NCT00793598|26728547|FG003|Overall Study|Patient Request|0|||
13374810|NCT00793598|26728548|FG004|Overall Study|Patient Request|0|||
13374811|NCT00793598|26728549|FG005|Overall Study|Patient Request|0|||
13374812|NCT00793598|26728550|FG006|Overall Study|Patient Request|0|||
13374813|NCT00793598|26728551|FG007|Overall Study|Patient Request|0|||
13374814|NCT00793598|26728544|FG000|Overall Study|Protocol Violation|0|||
13374815|NCT00793598|26728545|FG001|Overall Study|Protocol Violation|0|||
13374816|NCT00793598|26728546|FG002|Overall Study|Protocol Violation|0|||
13374817|NCT00793598|26728547|FG003|Overall Study|Protocol Violation|0|||
13374818|NCT00793598|26728548|FG004|Overall Study|Protocol Violation|0|||
13374819|NCT00793598|26728549|FG005|Overall Study|Protocol Violation|0|||
13374820|NCT00793598|26728550|FG006|Overall Study|Protocol Violation|0|||
13374821|NCT00793598|26728551|FG007|Overall Study|Protocol Violation|1|||
13374822|NCT00793598|26728544|FG000|Overall Study|Subject not dosed|0|||
13374823|NCT00793598|26728545|FG001|Overall Study|Subject not dosed|0|||
13374824|NCT00793598|26728546|FG002|Overall Study|Subject not dosed|0|||
13374825|NCT00793598|26728547|FG003|Overall Study|Subject not dosed|0|||
13374826|NCT00793598|26728548|FG004|Overall Study|Subject not dosed|0|||
13374827|NCT00793598|26728549|FG005|Overall Study|Subject not dosed|1|||
13374828|NCT00793598|26728550|FG006|Overall Study|Subject not dosed|0|||
13374829|NCT00793598|26728551|FG007|Overall Study|Subject not dosed|0|||
13374830|NCT00793585|26728566|FG000|Overall Study|Adverse Event|1|||
13374831|NCT00793585|26728567|FG001|Overall Study|Adverse Event|1|||
13374832|NCT00793585|26728566|FG000|Overall Study|Protocol Violation|1|||
13374833|NCT00793585|26728567|FG001|Overall Study|Protocol Violation|2|||
13374834|NCT00793546|26728602|FG000|Overall Study|Death|3|||
13374835|NCT00793546|26728603|FG001|Overall Study|Death|0|||
13374836|NCT00793546|26728602|FG000|Overall Study|Lost to Follow-up|1|||
13374837|NCT00793546|26728603|FG001|Overall Study|Lost to Follow-up|0|||
13374838|NCT00793546|26728602|FG000|Overall Study|Withdrawal by Subject|1|||
13374839|NCT00793546|26728603|FG001|Overall Study|Withdrawal by Subject|1|||
13374840|NCT00793546|26728602|FG000|Overall Study|Study Terminated by Sponsor|8|||
13374841|NCT00793546|26728603|FG001|Overall Study|Study Terminated by Sponsor|27|||
13374842|NCT00793546|26728602|FG000|Overall Study|Other|1|||
13374843|NCT00793546|26728603|FG001|Overall Study|Other|0|||
13374844|NCT00793403|26728652|FG000|Overall Study|Other|73|||
13374845|NCT00793325|26728678|FG000|Overall Study|Protocol Violation|18|||
13374846|NCT00793325|26728678|FG000|Overall Study|Lost to Follow-up|1|||
13374847|NCT00793182|26728691|FG000|Overall Study|Adverse Event|0|||
13374848|NCT00793182|26728692|FG001|Overall Study|Adverse Event|1|||
13374849|NCT00793104|26728702|FG000|Overall Study|Lost to Follow-up|1|||
13374850|NCT00792948|26728713|FG000|Overall Study|Adverse Event|6|||
13374851|NCT00792948|26728713|FG000|Overall Study|Death|4|||
13374852|NCT00792948|26728713|FG000|Overall Study|Withdrawal by Subject|3|||
13374853|NCT00792948|26728713|FG000|Overall Study|Ineligible|2|||
13374854|NCT00792948|26728713|FG000|Overall Study|Insurance denial - not treated|1|||
13374855|NCT00792948|26728713|FG000|Overall Study|Physician Decision|11|||
13374856|NCT00792948|26728713|FG000|Overall Study|Protocol Violation|1|||
13374857|NCT00792935|26728728|FG000|Overall Study|Adverse Event|2|||
13374858|NCT00792935|26728729|FG001|Overall Study|Adverse Event|1|||
13374859|NCT00792935|26728728|FG000|Overall Study|Lost to Follow-up|0|||
13374860|NCT00792935|26728729|FG001|Overall Study|Lost to Follow-up|1|||
13374861|NCT00792935|26728728|FG000|Overall Study|Protocol Violation|2|||
13374862|NCT00792935|26728729|FG001|Overall Study|Protocol Violation|0|||
13374863|NCT00792935|26728728|FG000|Overall Study|Withdrawal by Subject|0|||
13374864|NCT00792935|26728729|FG001|Overall Study|Withdrawal by Subject|1|||
13374865|NCT00792909|26728792|FG000|Overall Study|Withdrawal by Subject|0|||
13360305|NCT00753545|26681850|FG000|Overall Study|Death|98|||
13360306|NCT00753545|26681851|FG001|Overall Study|Death|112|||
13360307|NCT00753545|26681850|FG000|Overall Study|Lost to Follow-up|2|||
13360308|NCT00753545|26681851|FG001|Overall Study|Lost to Follow-up|3|||
13360309|NCT00753545|26681850|FG000|Overall Study|Protocol Violation|1|||
13360310|NCT00753545|26681851|FG001|Overall Study|Protocol Violation|0|||
13360311|NCT00753545|26681850|FG000|Overall Study|Voluntary Discontinuation of Patient|7|||
13360312|NCT00753545|26681851|FG001|Overall Study|Voluntary Discontinuation of Patient|3|||
13360313|NCT00659334|26681910|FG000|Overall Study|Screen Failure|8|||
13360314|NCT00659334|26681911|FG001|Overall Study|Screen Failure|5|||
13360315|NCT00659334|26681912|FG002|Overall Study|Screen Failure|0|||
13360316|NCT00659334|26681913|FG003|Overall Study|Screen Failure|0|||
13360317|NCT00659334|26681914|FG004|Overall Study|Screen Failure|0|||
13360318|NCT00659334|26681915|FG005|Overall Study|Screen Failure|0|||
13360319|NCT00659334|26681916|FG006|Overall Study|Screen Failure|1|||
13360320|NCT00278915|26681951|FG000|Overall Study|Lack of Efficacy|1|||
13360321|NCT00099437|26681978|FG000|Overall Study|Lost to Follow-up|30|||
13360322|NCT00099437|26681979|FG001|Overall Study|Lost to Follow-up|33|||
13360323|NCT00099437|26681978|FG000|Overall Study|Death|293|||
13360324|NCT00099437|26681979|FG001|Overall Study|Death|261|||
13360325|NCT00099437|26681978|FG000|Overall Study|Withdrawal by Subject|6|||
13360326|NCT00099437|26681979|FG001|Overall Study|Withdrawal by Subject|10|||
13360327|NCT00099437|26681978|FG000|Overall Study|Ongoing in FU but not on treatment|37|||
13360328|NCT00099437|26681979|FG001|Overall Study|Ongoing in FU but not on treatment|45|||
13360329|NCT04968925|26682022|FG000|Phase I- Period 1|COVID-19 related|0|||
13360330|NCT04968925|26682023|FG001|Phase I- Period 1|COVID-19 related|1|||
13360331|NCT04968925|26682024|FG002|Phase I- Period 1|COVID-19 related|0|||
13360332|NCT04968925|26682025|FG003|Phase I- Period 1|COVID-19 related|0|||
13360333|NCT04968925|26682022|FG000|Phase I- Period 1|Subject enrolled in error|1|||
13360334|NCT04968925|26682023|FG001|Phase I- Period 1|Subject enrolled in error|1|||
13360335|NCT04968925|26682024|FG002|Phase I- Period 1|Subject enrolled in error|0|||
13360336|NCT04968925|26682025|FG003|Phase I- Period 1|Subject enrolled in error|0|||
13360337|NCT04968925|26682022|FG000|Phase II- Period 1|COVID-19 Related|0|||
13360338|NCT04968925|26682023|FG001|Phase II- Period 1|COVID-19 Related|0|||
13360339|NCT04968925|26682024|FG002|Phase II- Period 1|COVID-19 Related|6|||
13360340|NCT04968925|26682025|FG003|Phase II- Period 1|COVID-19 Related|6|||
13360341|NCT04968925|26682022|FG000|Phase II- Period 1|Subject enrolled in error|0|||
13360342|NCT04968925|26682023|FG001|Phase II- Period 1|Subject enrolled in error|0|||
13360343|NCT04968925|26682024|FG002|Phase II- Period 1|Subject enrolled in error|1|||
13360344|NCT04968925|26682025|FG003|Phase II- Period 1|Subject enrolled in error|0|||
13360345|NCT04968925|26682022|FG000|Phase II -Period 2|COVID-19 related|0|||
13360346|NCT04968925|26682023|FG001|Phase II -Period 2|COVID-19 related|0|||
13360347|NCT04968925|26682024|FG002|Phase II -Period 2|COVID-19 related|4|||
13360348|NCT04968925|26682025|FG003|Phase II -Period 2|COVID-19 related|3|||
13360349|NCT04968925|26682022|FG000|Phase II -Period 2|Incorrectly dispensed|0|||
13360350|NCT04968925|26682023|FG001|Phase II -Period 2|Incorrectly dispensed|0|||
13360351|NCT04968925|26682024|FG002|Phase II -Period 2|Incorrectly dispensed|0|||
13360352|NCT04968925|26682025|FG003|Phase II -Period 2|Incorrectly dispensed|1|||
13360353|NCT04713553|26682191|FG000|Primary Study (2 Months)|Withdrawal by Subject|2|||
13360354|NCT04713553|26682192|FG001|Primary Study (2 Months)|Withdrawal by Subject|3|||
13360355|NCT04713553|26682193|FG002|Primary Study (2 Months)|Withdrawal by Subject|0|||
13360356|NCT04713553|26682194|FG003|Primary Study (2 Months)|Withdrawal by Subject|0|||
13360357|NCT04713553|26682195|FG004|Primary Study (2 Months)|Withdrawal by Subject|1|||
13360358|NCT04713553|26682196|FG005|Primary Study (2 Months)|Withdrawal by Subject|0|||
13360359|NCT04713553|26682197|FG006|Primary Study (2 Months)|Withdrawal by Subject|0|||
13360360|NCT04713553|26682191|FG000|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
13360361|NCT04713553|26682192|FG001|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
13360362|NCT04713553|26682193|FG002|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
13360363|NCT04713553|26682194|FG003|Primary Study (2 Months)|Withdrawal by parent/guardian|1|||
13360364|NCT04713553|26682195|FG004|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
13360365|NCT04713553|26682196|FG005|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
13360366|NCT04713553|26682197|FG006|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
13360367|NCT04713553|26682191|FG000|Primary Study (2 Months)|Other|1|||
13360368|NCT04713553|26682192|FG001|Primary Study (2 Months)|Other|2|||
13360369|NCT04713553|26682193|FG002|Primary Study (2 Months)|Other|0|||
13360370|NCT04713553|26682194|FG003|Primary Study (2 Months)|Other|0|||
13360371|NCT04713553|26682195|FG004|Primary Study (2 Months)|Other|1|||
13360372|NCT04713553|26682196|FG005|Primary Study (2 Months)|Other|0|||
13360373|NCT04713553|26682197|FG006|Primary Study (2 Months)|Other|0|||
13360374|NCT04713553|26682191|FG000|Primary Study (2 Months)|Lost to Follow-up|1|||
13360375|NCT04713553|26682192|FG001|Primary Study (2 Months)|Lost to Follow-up|1|||
13360376|NCT04713553|26682193|FG002|Primary Study (2 Months)|Lost to Follow-up|2|||
13360377|NCT04713553|26682194|FG003|Primary Study (2 Months)|Lost to Follow-up|1|||
13360378|NCT04713553|26682195|FG004|Primary Study (2 Months)|Lost to Follow-up|0|||
13360379|NCT04713553|26682196|FG005|Primary Study (2 Months)|Lost to Follow-up|0|||
13360380|NCT04713553|26682197|FG006|Primary Study (2 Months)|Lost to Follow-up|0|||
13360381|NCT04713553|26682191|FG000|Primary Study (2 Months)|Inclusion criteria not met|0|||
13360382|NCT04713553|26682192|FG001|Primary Study (2 Months)|Inclusion criteria not met|0|||
13360383|NCT04713553|26682193|FG002|Primary Study (2 Months)|Inclusion criteria not met|1|||
13360384|NCT04713553|26682194|FG003|Primary Study (2 Months)|Inclusion criteria not met|0|||
13360385|NCT04713553|26682195|FG004|Primary Study (2 Months)|Inclusion criteria not met|0|||
13360386|NCT04713553|26682196|FG005|Primary Study (2 Months)|Inclusion criteria not met|0|||
13360387|NCT04713553|26682197|FG006|Primary Study (2 Months)|Inclusion criteria not met|0|||
13360388|NCT04631107|26682210|FG000|First Intervention (1 Night)|ineligible participant was inadvertently randomized but not treated|1|||
13360389|NCT04631107|26682210|FG000|Second Intervention (1 Night)|Adverse Event|1|||
13360390|NCT04631107|26682210|FG000|Second Intervention (1 Night)|Withdrawal by Subject|1|||
13360391|NCT04631107|26682210|FG000|Third Intervention (1 Night)|Withdrawal by Subject|2|||
13360392|NCT04515394|26682225|FG000|Overall Study|Participant did not receive treatment|1|||
13360393|NCT04359758|26682244|FG000|Overall Study|Lost to Follow-up|0|||
13360394|NCT04359758|26682245|FG001|Overall Study|Lost to Follow-up|2|||
13360395|NCT04249076|26682260|FG000|Overall Study|Adverse Event|1|||
13360396|NCT04249076|26682261|FG001|Overall Study|Adverse Event|1|||
13360397|NCT04249076|26682260|FG000|Overall Study|Protocol Violation|1|||
13360398|NCT04249076|26682261|FG001|Overall Study|Protocol Violation|2|||
13360399|NCT04249076|26682260|FG000|Overall Study|Lack of Efficacy|0|||
13360400|NCT04249076|26682261|FG001|Overall Study|Lack of Efficacy|1|||
13360401|NCT04249076|26682260|FG000|Overall Study|Withdrawal by Subject|0|||
13360402|NCT04249076|26682261|FG001|Overall Study|Withdrawal by Subject|1|||
13360403|NCT04246801|26682276|FG000|Overall Study|Adverse Event|1|||
13360404|NCT04246801|26682277|FG001|Overall Study|Adverse Event|1|||
13360405|NCT04246801|26682276|FG000|Overall Study|Protocol Violation|1|||
13360406|NCT04246801|26682277|FG001|Overall Study|Protocol Violation|1|||
13360407|NCT04246801|26682276|FG000|Overall Study|Lack of Efficacy|0|||
13360408|NCT04246801|26682277|FG001|Overall Study|Lack of Efficacy|2|||
13360409|NCT04246801|26682276|FG000|Overall Study|Lost to Follow-up|1|||
13360410|NCT04246801|26682277|FG001|Overall Study|Lost to Follow-up|1|||
13360411|NCT04246801|26682276|FG000|Overall Study|Withdrawal by Subject|2|||
13360412|NCT04246801|26682277|FG001|Overall Study|Withdrawal by Subject|1|||
13360413|NCT04173494|26682290|FG000|Randomized Double-Blind Treatment Period|Adverse Event|16|||
13360414|NCT04173494|26682291|FG001|Randomized Double-Blind Treatment Period|Adverse Event|11|||
13360415|NCT04173494|26682290|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|6|||
13360416|NCT04173494|26682291|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|5|||
13360417|NCT04173494|26682290|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|6|||
13360418|NCT04173494|26682291|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|3|||
13360419|NCT04173494|26682290|FG000|Randomized Double-Blind Treatment Period|Death|4|||
13360420|NCT04173494|26682291|FG001|Randomized Double-Blind Treatment Period|Death|3|||
13360421|NCT04173494|26682290|FG000|Randomized Double-Blind Treatment Period|Leukemic Transformation|2|||
13360422|NCT04173494|26682291|FG001|Randomized Double-Blind Treatment Period|Leukemic Transformation|2|||
13360423|NCT04173494|26682290|FG000|Randomized Double-Blind Treatment Period|Disease Progression|1|||
13360424|NCT04173494|26682291|FG001|Randomized Double-Blind Treatment Period|Disease Progression|2|||
13360425|NCT04173494|26682290|FG000|Randomized Double-Blind Treatment Period|Lost to Follow-up|1|||
13360426|NCT04173494|26682291|FG001|Randomized Double-Blind Treatment Period|Lost to Follow-up|0|||
13360427|NCT04173494|26682290|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
13360428|NCT04173494|26682291|FG001|Randomized Double-Blind Treatment Period|Physician Decision|1|||
13360429|NCT04173494|26682290|FG000|Open-Label Extended Treatment Period|Open-label treatment ongoing|52|||
13360430|NCT04173494|26682291|FG001|Open-Label Extended Treatment Period|Open-label treatment ongoing|22|||
13360431|NCT04173494|26682290|FG000|Open-Label Extended Treatment Period|Continuing in MMB extension study|24|||
13360432|NCT04173494|26682291|FG001|Open-Label Extended Treatment Period|Continuing in MMB extension study|9|||
13360433|NCT04173494|26682290|FG000|Open-Label Extended Treatment Period|Adverse Event|8|||
13360434|NCT04173494|26682291|FG001|Open-Label Extended Treatment Period|Adverse Event|1|||
13360435|NCT04173494|26682290|FG000|Open-Label Extended Treatment Period|Withdrawal by Subject|2|||
13360436|NCT04173494|26682291|FG001|Open-Label Extended Treatment Period|Withdrawal by Subject|3|||
13360437|NCT04173494|26682290|FG000|Open-Label Extended Treatment Period|Death|3|||
13360438|NCT04173494|26682291|FG001|Open-Label Extended Treatment Period|Death|1|||
13360439|NCT04173494|26682290|FG000|Open-Label Extended Treatment Period|Physician Decision|2|||
13360440|NCT04173494|26682291|FG001|Open-Label Extended Treatment Period|Physician Decision|2|||
13360441|NCT04173494|26682290|FG000|Open-Label Extended Treatment Period|Lack of Efficacy|1|||
13360442|NCT04173494|26682291|FG001|Open-Label Extended Treatment Period|Lack of Efficacy|1|||
13360443|NCT04173494|26682290|FG000|Open-Label Extended Treatment Period|Leukemic transformation|0|||
13360444|NCT04173494|26682291|FG001|Open-Label Extended Treatment Period|Leukemic transformation|1|||
13374866|NCT00792909|26728793|FG001|Overall Study|Withdrawal by Subject|1|||
13374867|NCT00792909|26728794|FG002|Overall Study|Withdrawal by Subject|0|||
13360445|NCT04010227|26682319|FG000|Overall Study|Death|1|||
13360446|NCT04010227|26682320|FG001|Overall Study|Death|2|||
13360447|NCT04010227|26682319|FG000|Overall Study|Medical Reasons|4|||
13360448|NCT04010227|26682320|FG001|Overall Study|Medical Reasons|3|||
13360449|NCT04010227|26682319|FG000|Overall Study|Withdrawal by Subject|2|||
13360450|NCT04010227|26682320|FG001|Overall Study|Withdrawal by Subject|0|||
13360451|NCT04010227|26682319|FG000|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
13360452|NCT04010227|26682320|FG001|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
13360453|NCT03842436|26682459|FG000|Overall Study|Lost to Follow-up|1|||
13360454|NCT03538756|26682558|FG000|Long-Term Follow-up|Adverse Event|0|||
13360455|NCT03538756|26682559|FG001|Long-Term Follow-up|Adverse Event|0|||
13360456|NCT03538756|26682560|FG002|Long-Term Follow-up|Adverse Event|6|||
13360457|NCT03538756|26682558|FG000|Long-Term Follow-up|Death|0|||
13360458|NCT03538756|26682559|FG001|Long-Term Follow-up|Death|0|||
13360459|NCT03538756|26682560|FG002|Long-Term Follow-up|Death|1|||
13360460|NCT03538756|26682558|FG000|Long-Term Follow-up|Withdrawal by Subject|0|||
13360461|NCT03538756|26682559|FG001|Long-Term Follow-up|Withdrawal by Subject|0|||
13360462|NCT03538756|26682560|FG002|Long-Term Follow-up|Withdrawal by Subject|5|||
13360463|NCT03538756|26682558|FG000|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
13360464|NCT03538756|26682559|FG001|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
13360465|NCT03538756|26682560|FG002|Long-Term Follow-up|COVID-19 Disruptions at Sites|13|||
13360466|NCT03538756|26682558|FG000|Long-Term Follow-up|Device Dissatisfaction|0|||
13360467|NCT03538756|26682559|FG001|Long-Term Follow-up|Device Dissatisfaction|0|||
13360468|NCT03538756|26682560|FG002|Long-Term Follow-up|Device Dissatisfaction|8|||
13360469|NCT03528551|26682612|FG000|Overall Study|Lost to Follow-up|0|||
13360470|NCT03528551|26682613|FG001|Overall Study|Lost to Follow-up|1|||
13360471|NCT03528551|26682614|FG002|Overall Study|Lost to Follow-up|0|||
13360472|NCT03528551|26682612|FG000|Overall Study|Transferred to other arm/group|2|||
13360473|NCT03528551|26682613|FG001|Overall Study|Transferred to other arm/group|3|||
13360474|NCT03528551|26682614|FG002|Overall Study|Transferred to other arm/group|0|||
13360475|NCT03528551|26682612|FG000|Overall Study|Withdrawal by parent/guardian|0|||
13360476|NCT03528551|26682613|FG001|Overall Study|Withdrawal by parent/guardian|5|||
13360477|NCT03528551|26682614|FG002|Overall Study|Withdrawal by parent/guardian|0|||
13360478|NCT03528551|26682612|FG000|Overall Study|Protocol Violation|0|||
13360479|NCT03528551|26682613|FG001|Overall Study|Protocol Violation|3|||
13360480|NCT03528551|26682614|FG002|Overall Study|Protocol Violation|0|||
13360481|NCT03528551|26682612|FG000|Overall Study|Withdrawal by Subject|0|||
13360482|NCT03528551|26682613|FG001|Overall Study|Withdrawal by Subject|7|||
13360483|NCT03528551|26682614|FG002|Overall Study|Withdrawal by Subject|0|||
13360484|NCT03459846|26682633|FG000|Overall Study|Death|52|||
13360485|NCT03459846|26682634|FG001|Overall Study|Death|46|||
13360486|NCT03459846|26682633|FG000|Overall Study|Study terminated by sponsor|24|||
13360487|NCT03459846|26682634|FG001|Overall Study|Study terminated by sponsor|28|||
13360488|NCT03459846|26682633|FG000|Overall Study|Withdrawal by Subject|2|||
13360489|NCT03459846|26682634|FG001|Overall Study|Withdrawal by Subject|2|||
13360490|NCT03258723|26682715|FG000|Overall Study|COVID Interruption of study|54|||
13360491|NCT03258723|26682715|FG000|Overall Study|Lost to Follow-up|8|||
13360492|NCT03158285|26683384|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4|||
13360493|NCT03158285|26683385|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2|||
13360494|NCT03158285|26683386|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6|||
13360495|NCT03158285|26683384|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0|||
13360496|NCT03158285|26683385|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
13360497|NCT03158285|26683386|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
13360498|NCT03158285|26683384|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
13360499|NCT03158285|26683385|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
13360500|NCT03158285|26683386|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
13360501|NCT03158285|26683384|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
13360502|NCT03158285|26683385|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1|||
13360503|NCT03158285|26683386|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
13360504|NCT03158285|26683384|FG000|Placebo-controlled Period: Week 0 - 24|Other|1|||
13360505|NCT03158285|26683385|FG001|Placebo-controlled Period: Week 0 - 24|Other|1|||
13360506|NCT03158285|26683386|FG002|Placebo-controlled Period: Week 0 - 24|Other|0|||
13360507|NCT03158285|26683384|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
13360508|NCT03158285|26683385|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
13360509|NCT03158285|26683386|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1|||
13360510|NCT03158285|26683384|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5|||
13360511|NCT03158285|26683385|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
13360512|NCT03158285|26683386|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
13360513|NCT03158285|26683384|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
13360514|NCT03158285|26683385|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
13360515|NCT03158285|26683386|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
13360516|NCT03158285|26683384|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
13360517|NCT03158285|26683385|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
13360518|NCT03158285|26683386|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1|||
13360519|NCT03158285|26683384|FG000|Active Treatment Period: Week 24 - 52|Other|1|||
13360520|NCT03158285|26683385|FG001|Active Treatment Period: Week 24 - 52|Other|1|||
13360521|NCT03158285|26683386|FG002|Active Treatment Period: Week 24 - 52|Other|0|||
13360522|NCT03158285|26683384|FG000|Active Treatment Period: Week 52-100|Adverse Event|7|||
13360523|NCT03158285|26683385|FG001|Active Treatment Period: Week 52-100|Adverse Event|5|||
13360524|NCT03158285|26683386|FG002|Active Treatment Period: Week 52-100|Adverse Event|3|||
13360525|NCT03158285|26683384|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
13360526|NCT03158285|26683385|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
13360527|NCT03158285|26683386|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3|||
13360528|NCT03158285|26683384|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5|||
13360529|NCT03158285|26683385|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2|||
13360530|NCT03158285|26683386|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1|||
13360531|NCT03158285|26683384|FG000|Active Treatment Period: Week 52-100|Pregnancy|0|||
13360532|NCT03158285|26683385|FG001|Active Treatment Period: Week 52-100|Pregnancy|0|||
13360533|NCT03158285|26683386|FG002|Active Treatment Period: Week 52-100|Pregnancy|1|||
13360534|NCT03158285|26683384|FG000|Active Treatment Period: Week 52-100|Death|1|||
13360535|NCT03158285|26683385|FG001|Active Treatment Period: Week 52-100|Death|0|||
13360536|NCT03158285|26683386|FG002|Active Treatment Period: Week 52-100|Death|0|||
13360537|NCT03158285|26683384|FG000|Active Treatment Period: Week 52-100|Other|4|||
13360538|NCT03158285|26683385|FG001|Active Treatment Period: Week 52-100|Other|1|||
13360539|NCT03158285|26683386|FG002|Active Treatment Period: Week 52-100|Other|0|||
13360540|NCT03084471|26683396|FG000|Overall Study|Development of study specific discontinuation criteria|2|||
13360541|NCT03084471|26683396|FG000|Overall Study|Condition under investigation worsened|84|||
13360542|NCT03084471|26683396|FG000|Overall Study|Lack of therapeutic response|2|||
13360543|NCT03084471|26683396|FG000|Overall Study|Protocol Violation|1|||
13360544|NCT03084471|26683396|FG000|Overall Study|Adverse Event|73|||
13360545|NCT03084471|26683396|FG000|Overall Study|Withdrawal by Subject|12|||
13360546|NCT03084471|26683396|FG000|Overall Study|Disease relapse|181|||
13360547|NCT03084471|26683396|FG000|Overall Study|Subjective disease progression|359|||
13360548|NCT03084471|26683396|FG000|Overall Study|Other (as recorded)|33|||
13360549|NCT03084471|26683396|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120|||
13374868|NCT00792805|26728812|FG000|Overall Study|Adverse Event|12|||
13374869|NCT00792805|26728813|FG001|Overall Study|Adverse Event|10|||
13374870|NCT00792805|26728814|FG002|Overall Study|Adverse Event|10|||
13374871|NCT00792805|26728812|FG000|Overall Study|Subject withdrew consent|5|||
13374872|NCT00792805|26728813|FG001|Overall Study|Subject withdrew consent|6|||
13374873|NCT00792805|26728814|FG002|Overall Study|Subject withdrew consent|5|||
13374874|NCT00792805|26728812|FG000|Overall Study|Administrative problems|2|||
13374875|NCT00792805|26728813|FG001|Overall Study|Administrative problems|0|||
13374876|NCT00792805|26728814|FG002|Overall Study|Administrative problems|4|||
13374877|NCT00792805|26728812|FG000|Overall Study|Abnormal test procedure result(s)|1|||
13374878|NCT00792805|26728813|FG001|Overall Study|Abnormal test procedure result(s)|2|||
13374879|NCT00792805|26728814|FG002|Overall Study|Abnormal test procedure result(s)|0|||
13374880|NCT00792805|26728812|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
13374881|NCT00792805|26728813|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
13374882|NCT00792805|26728814|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
13374883|NCT00792805|26728812|FG000|Overall Study|Lost to Follow-up|1|||
13374884|NCT00792805|26728813|FG001|Overall Study|Lost to Follow-up|1|||
13374885|NCT00792805|26728814|FG002|Overall Study|Lost to Follow-up|6|||
13374886|NCT00792805|26728812|FG000|Overall Study|Abnormal laboratory value(s)|0|||
13374887|NCT00792805|26728813|FG001|Overall Study|Abnormal laboratory value(s)|0|||
13374888|NCT00792805|26728814|FG002|Overall Study|Abnormal laboratory value(s)|1|||
13374889|NCT00792805|26728812|FG000|Overall Study|Protocol deviation|0|||
13374890|NCT00792805|26728813|FG001|Overall Study|Protocol deviation|1|||
13374891|NCT00792805|26728814|FG002|Overall Study|Protocol deviation|1|||
13374892|NCT00792701|26728832|FG000|Overall Study|Adverse Event|0|||
13374893|NCT00792701|26728833|FG001|Overall Study|Adverse Event|22|||
13374894|NCT00792701|26728832|FG000|Overall Study|Ineligible|1|||
13374895|NCT00792701|26728833|FG001|Overall Study|Ineligible|3|||
13374896|NCT00792701|26728832|FG000|Overall Study|Withdrawal by Subject|1|||
13374897|NCT00792701|26728833|FG001|Overall Study|Withdrawal by Subject|19|||
13374898|NCT00792701|26728832|FG000|Overall Study|Not protocol specified|17|||
13374899|NCT00792701|26728833|FG001|Overall Study|Not protocol specified|0|||
13374900|NCT00792636|26728880|FG000|Overall Study|Protocol Violation|17|||
13374901|NCT00792636|26728881|FG001|Overall Study|Protocol Violation|23|||
13374902|NCT00792636|26728882|FG002|Overall Study|Protocol Violation|20|||
13374903|NCT00792636|26728880|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19|||
13374904|NCT00792636|26728881|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20|||
13374905|NCT00792636|26728882|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20|||
13374906|NCT00792636|26728880|FG000|Overall Study|Lost to Follow-up|13|||
13360550|NCT02969915|26683469|FG000|Overall Study|Death|104|||
13360551|NCT02969915|26683470|FG001|Overall Study|Death|125|||
13360552|NCT02969915|26683469|FG000|Overall Study|Lost to Follow-up|108|||
13360553|NCT02969915|26683470|FG001|Overall Study|Lost to Follow-up|112|||
13360554|NCT02969915|26683469|FG000|Overall Study|Censored due to COVID-19|481|||
13360555|NCT02969915|26683470|FG001|Overall Study|Censored due to COVID-19|471|||
13360556|NCT02963831|26683521|FG000|Overall Study|Progressive Disease|3|||
13360557|NCT02963831|26683522|FG001|Overall Study|Progressive Disease|3|||
13360558|NCT02963831|26683523|FG002|Overall Study|Progressive Disease|16|||
13360559|NCT02963831|26683524|FG003|Overall Study|Progressive Disease|27|||
13360560|NCT02963831|26683521|FG000|Overall Study|Withdrawal by Subject|1|||
13360561|NCT02963831|26683522|FG001|Overall Study|Withdrawal by Subject|0|||
13360562|NCT02963831|26683523|FG002|Overall Study|Withdrawal by Subject|2|||
13360563|NCT02963831|26683524|FG003|Overall Study|Withdrawal by Subject|4|||
13360564|NCT02963831|26683521|FG000|Overall Study|Adverse Event|0|||
13360565|NCT02963831|26683522|FG001|Overall Study|Adverse Event|1|||
13360566|NCT02963831|26683523|FG002|Overall Study|Adverse Event|1|||
13360567|NCT02963831|26683524|FG003|Overall Study|Adverse Event|2|||
13360568|NCT02963831|26683521|FG000|Overall Study|Death|0|||
13360569|NCT02963831|26683522|FG001|Overall Study|Death|0|||
13360570|NCT02963831|26683523|FG002|Overall Study|Death|0|||
13360571|NCT02963831|26683524|FG003|Overall Study|Death|2|||
13360572|NCT02927301|26683532|FG000|Overall Study|Adverse Event|7|||
13360573|NCT02927301|26683532|FG000|Overall Study|Withdrawal by Subject|1|||
13360574|NCT02927301|26683532|FG000|Overall Study|Physician Decision|2|||
13360575|NCT02846545|26683567|FG000|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
13360576|NCT02846545|26683568|FG001|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
13360577|NCT02846545|26683567|FG000|Active Treatment Period: Week 0-52|Non-compliance with study drug|1|||
13360578|NCT02846545|26683568|FG001|Active Treatment Period: Week 0-52|Non-compliance with study drug|0|||
13360579|NCT02846545|26683567|FG000|Active Treatment Period: Week 0-52|Withdrawal by Subject|1|||
13360580|NCT02846545|26683568|FG001|Active Treatment Period: Week 0-52|Withdrawal by Subject|5|||
13360581|NCT02846545|26683567|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
13360582|NCT02846545|26683568|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
13360583|NCT02846545|26683567|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
13360584|NCT02846545|26683568|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
13360585|NCT02652949|26683583|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
13360586|NCT02652949|26683583|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
13360587|NCT02652949|26683583|FG000|6-Month Follow-up Secondary Endpoint|Death|5|||
13360588|NCT02652949|26683583|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
13360589|NCT02652949|26683583|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
13360590|NCT02652949|26683583|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
13360591|NCT02652949|26683583|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
13360592|NCT02652949|26683583|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
13360593|NCT02652949|26683583|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
13360594|NCT02652949|26683583|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|27|||
13360595|NCT02652949|26683583|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
13360596|NCT02652949|26683583|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
13360597|NCT02652949|26683583|FG000|36-Month Follow-up Secondary Endpoint|Subject declined extended follow up at 12 month timepoint. Data entry error-to be corrected by site|1|||
13360598|NCT02625324|26683598|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
13360599|NCT02625324|26683598|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
13360600|NCT02625324|26683598|FG000|6-Month Follow-up Subject Accountability|Death|5|||
13360601|NCT02625324|26683598|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2|||
13360602|NCT02625324|26683598|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1|||
13360603|NCT02625324|26683598|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
13360604|NCT02625324|26683598|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
13360605|NCT02625324|26683598|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
13360606|NCT02625324|26683598|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
13360607|NCT02625324|26683598|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|27|||
13360608|NCT02625324|26683598|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
13360609|NCT02625324|26683598|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
13360610|NCT02625324|26683598|FG000|36-Month Follow-up Secondary Endpoint|Subject declined extended follow up at 12 month timepoint. Data entry error to be corrected by site|1|||
13360611|NCT01924533|26683679|FG000|Overall Study|Death|181|||
13360612|NCT01924533|26683680|FG001|Overall Study|Death|200|||
13360613|NCT01924533|26683679|FG000|Overall Study|Lost to Follow-up|0|||
13360614|NCT01924533|26683680|FG001|Overall Study|Lost to Follow-up|1|||
13360615|NCT01924533|26683679|FG000|Overall Study|Withdrawal by Subject|7|||
13360616|NCT01924533|26683680|FG001|Overall Study|Withdrawal by Subject|3|||
13360617|NCT01924533|26683679|FG000|Overall Study|Other Eligibility criteria|1|||
13360618|NCT01924533|26683680|FG001|Overall Study|Other Eligibility criteria|1|||
13360619|NCT01385176|26683707|FG000|Randomization Phase|Death|1|||
13360620|NCT01385176|26683708|FG001|Randomization Phase|Death|2|||
13360621|NCT01385176|26683707|FG000|6-18 Month All VNS Active|Death|1|||
13360622|NCT01385176|26683708|FG001|6-18 Month All VNS Active|Death|2|||
13360623|NCT01385176|26683707|FG000|6-18 Month All VNS Active|Physician Decision|0|||
13360624|NCT01385176|26683708|FG001|6-18 Month All VNS Active|Physician Decision|1|||
13360625|NCT01385176|26683707|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2|||
13360626|NCT01385176|26683708|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0|||
13360627|NCT01385176|26683707|FG000|6-18 Month All VNS Active|Heart Transplant|1|||
13360628|NCT01385176|26683708|FG001|6-18 Month All VNS Active|Heart Transplant|0|||
13360629|NCT00887926|26683768|FG000|Overall Study|Withdrawal by Subject|0|||
13360630|NCT00887926|26683769|FG001|Overall Study|Withdrawal by Subject|1|||
13360631|NCT00887926|26683770|FG002|Overall Study|Withdrawal by Subject|0|||
13360632|NCT00887926|26683771|FG003|Overall Study|Withdrawal by Subject|0|||
13374907|NCT00792636|26728881|FG001|Overall Study|Lost to Follow-up|19|||
13374908|NCT00792636|26728882|FG002|Overall Study|Lost to Follow-up|14|||
13374909|NCT00792636|26728880|FG000|Overall Study|Withdrew Consent|10|||
13374910|NCT00792636|26728881|FG001|Overall Study|Withdrew Consent|13|||
13374911|NCT00792636|26728882|FG002|Overall Study|Withdrew Consent|9|||
13374912|NCT00792636|26728880|FG000|Overall Study|Lack of Efficacy|3|||
13374913|NCT00792636|26728881|FG001|Overall Study|Lack of Efficacy|4|||
13374914|NCT00792636|26728882|FG002|Overall Study|Lack of Efficacy|13|||
13374915|NCT00792636|26728880|FG000|Overall Study|Adverse Event|4|||
13374916|NCT00792636|26728881|FG001|Overall Study|Adverse Event|2|||
13374917|NCT00792636|26728882|FG002|Overall Study|Adverse Event|3|||
13374918|NCT00792636|26728880|FG000|Overall Study|Investigator Discretion|2|||
13374919|NCT00792636|26728881|FG001|Overall Study|Investigator Discretion|0|||
13374920|NCT00792636|26728882|FG002|Overall Study|Investigator Discretion|2|||
13374921|NCT00792623|26728897|FG000|Overall Study|Adverse Event|2|||
13374922|NCT00792623|26728897|FG000|Overall Study|Withdrawal by Subject|5|||
13374923|NCT00792571|26728908|FG000|Overall Study|Death|1|||
13374924|NCT00792571|26728908|FG000|Overall Study|Adverse Event|4|||
13374925|NCT00792571|26728908|FG000|Overall Study|Withdrawal by Subject|1|||
13374926|NCT00792571|26728908|FG000|Overall Study|Other|4|||
13374927|NCT00792467|26728923|FG000|Overall Study|progression of disease|17|||
13374928|NCT00792467|26728923|FG000|Overall Study|Adverse Event|1|||
13374929|NCT00792467|26728923|FG000|Overall Study|patient request|1|||
13374930|NCT00792467|26728923|FG000|Overall Study|Lost to Follow-up|1|||
13374931|NCT00792467|26728923|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1|||
13374932|NCT00792467|26728923|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1|||
13374933|NCT00792298|26728959|FG000|Treatment Period 1|Adverse Event|0|||
13374934|NCT00792298|26728960|FG001|Treatment Period 1|Adverse Event|1|||
13374935|NCT00792298|26728961|FG002|Treatment Period 1|Adverse Event|0|||
13374936|NCT00792298|26728962|FG003|Treatment Period 1|Adverse Event|1|||
13374937|NCT00792298|26728963|FG004|Treatment Period 1|Adverse Event|0|||
13374938|NCT00792298|26728964|FG005|Treatment Period 1|Adverse Event|1|||
13374939|NCT00792298|26728965|FG006|Treatment Period 1|Adverse Event|1|||
13374940|NCT00792298|26728966|FG007|Treatment Period 1|Adverse Event|0|||
13374941|NCT00792298|26728959|FG000|Treatment Period 1|Lack of Efficacy|0|||
13374942|NCT00792298|26728960|FG001|Treatment Period 1|Lack of Efficacy|0|||
13374943|NCT00792298|26728961|FG002|Treatment Period 1|Lack of Efficacy|1|||
13374944|NCT00792298|26728962|FG003|Treatment Period 1|Lack of Efficacy|0|||
13374945|NCT00792298|26728963|FG004|Treatment Period 1|Lack of Efficacy|0|||
13374946|NCT00792298|26728964|FG005|Treatment Period 1|Lack of Efficacy|0|||
13374947|NCT00792298|26728965|FG006|Treatment Period 1|Lack of Efficacy|0|||
13374948|NCT00792298|26728966|FG007|Treatment Period 1|Lack of Efficacy|0|||
13374949|NCT00792298|26728959|FG000|Treatment Period 1|Withdrawal by Subject|1|||
13374950|NCT00792298|26728960|FG001|Treatment Period 1|Withdrawal by Subject|0|||
13374951|NCT00792298|26728961|FG002|Treatment Period 1|Withdrawal by Subject|1|||
13374952|NCT00792298|26728962|FG003|Treatment Period 1|Withdrawal by Subject|2|||
13374953|NCT00792298|26728963|FG004|Treatment Period 1|Withdrawal by Subject|0|||
13374954|NCT00792298|26728964|FG005|Treatment Period 1|Withdrawal by Subject|2|||
13374955|NCT00792298|26728965|FG006|Treatment Period 1|Withdrawal by Subject|1|||
13374956|NCT00792298|26728966|FG007|Treatment Period 1|Withdrawal by Subject|0|||
13374957|NCT00792298|26728959|FG000|Treatment Period 1|Lost to Follow-up|0|||
13374958|NCT00792298|26728960|FG001|Treatment Period 1|Lost to Follow-up|0|||
13374959|NCT00792298|26728961|FG002|Treatment Period 1|Lost to Follow-up|0|||
13374960|NCT00792298|26728962|FG003|Treatment Period 1|Lost to Follow-up|0|||
13374961|NCT00792298|26728963|FG004|Treatment Period 1|Lost to Follow-up|0|||
13374962|NCT00792298|26728964|FG005|Treatment Period 1|Lost to Follow-up|0|||
13374963|NCT00792298|26728965|FG006|Treatment Period 1|Lost to Follow-up|1|||
13374964|NCT00792298|26728966|FG007|Treatment Period 1|Lost to Follow-up|0|||
13374965|NCT00792298|26728959|FG000|Treatment Period 1|Physician Decision|0|||
13374966|NCT00792298|26728960|FG001|Treatment Period 1|Physician Decision|0|||
13374967|NCT00792298|26728961|FG002|Treatment Period 1|Physician Decision|0|||
13374968|NCT00792298|26728962|FG003|Treatment Period 1|Physician Decision|1|||
13374969|NCT00792298|26728963|FG004|Treatment Period 1|Physician Decision|0|||
13360633|NCT04816669|26683846|FG000|Part 1|Adverse Event|1|||
13360634|NCT04816669|26683847|FG001|Part 1|Adverse Event|1|||
13360635|NCT04816669|26683848|FG002|Part 1|Adverse Event|0|||
13360636|NCT04816669|26683849|FG003|Part 1|Adverse Event|0|||
13360637|NCT04816669|26683846|FG000|Part 1|Lost to Follow-up|2|||
13360638|NCT04816669|26683847|FG001|Part 1|Lost to Follow-up|2|||
13360639|NCT04816669|26683848|FG002|Part 1|Lost to Follow-up|0|||
13360640|NCT04816669|26683849|FG003|Part 1|Lost to Follow-up|0|||
13360641|NCT04816669|26683846|FG000|Part 1|Protocol Violation|0|||
13360642|NCT04816669|26683847|FG001|Part 1|Protocol Violation|1|||
13360643|NCT04816669|26683848|FG002|Part 1|Protocol Violation|0|||
13360644|NCT04816669|26683849|FG003|Part 1|Protocol Violation|0|||
13360645|NCT04816669|26683846|FG000|Part 1|Withdrawal by Subject|1|||
13360646|NCT04816669|26683847|FG001|Part 1|Withdrawal by Subject|2|||
13360647|NCT04816669|26683848|FG002|Part 1|Withdrawal by Subject|0|||
13360648|NCT04816669|26683849|FG003|Part 1|Withdrawal by Subject|0|||
13360649|NCT04816669|26683846|FG000|Part 2|Other|0|||
13360650|NCT04816669|26683847|FG001|Part 2|Other|0|||
13360651|NCT04816669|26683848|FG002|Part 2|Other|1|||
13360652|NCT04816669|26683849|FG003|Part 2|Other|0|||
13360653|NCT04816669|26683846|FG000|Part 2|Withdrawal by Subject|0|||
13360654|NCT04816669|26683847|FG001|Part 2|Withdrawal by Subject|0|||
13360655|NCT04816669|26683848|FG002|Part 2|Withdrawal by Subject|0|||
13360656|NCT04816669|26683849|FG003|Part 2|Withdrawal by Subject|1|||
13360657|NCT04816669|26683846|FG000|Part 2|Lost to Follow-up|0|||
13360658|NCT04816669|26683847|FG001|Part 2|Lost to Follow-up|0|||
13360659|NCT04816669|26683848|FG002|Part 2|Lost to Follow-up|1|||
13360660|NCT04816669|26683849|FG003|Part 2|Lost to Follow-up|0|||
13360661|NCT03918109|26684081|FG000|Overall Study|Withdrawal by Subject|0|||
13360662|NCT03918109|26684082|FG001|Overall Study|Withdrawal by Subject|0|||
13360663|NCT03918109|26684083|FG002|Overall Study|Withdrawal by Subject|2|||
13360664|NCT03918109|26684084|FG003|Overall Study|Withdrawal by Subject|1|||
13360665|NCT03918109|26684081|FG000|Overall Study|Lost to Follow-up|0|||
13360666|NCT03918109|26684082|FG001|Overall Study|Lost to Follow-up|0|||
13360667|NCT03918109|26684083|FG002|Overall Study|Lost to Follow-up|0|||
13360668|NCT03918109|26684084|FG003|Overall Study|Lost to Follow-up|1|||
13360669|NCT03861078|26684099|FG000|Overall Study|COVID-19 shut down|4|||
13360670|NCT03861078|26684099|FG000|Overall Study|Lost to Follow-up|1|||
13360671|NCT03861078|26684099|FG000|Overall Study|Protocol Violation|2|||
13360672|NCT03861078|26684099|FG000|Overall Study|lack of venous access|1|||
13360673|NCT03848845|26684237|FG000|Overall Study|Lost to Follow-up|0|||
13360674|NCT03848845|26684238|FG001|Overall Study|Lost to Follow-up|1|||
13360675|NCT03848845|26684239|FG002|Overall Study|Lost to Follow-up|0|||
13360676|NCT03848845|26684237|FG000|Overall Study|Withdrawal by Subject|3|||
13360677|NCT03848845|26684238|FG001|Overall Study|Withdrawal by Subject|2|||
13360678|NCT03848845|26684239|FG002|Overall Study|Withdrawal by Subject|6|||
13360679|NCT03848845|26684237|FG000|Overall Study|In Follow-up|0|||
13360680|NCT03848845|26684238|FG001|Overall Study|In Follow-up|1|||
13360681|NCT03848845|26684239|FG002|Overall Study|In Follow-up|12|||
13360682|NCT03848845|26684237|FG000|Overall Study|On Study Treatment|0|||
13360683|NCT03848845|26684238|FG001|Overall Study|On Study Treatment|0|||
13360684|NCT03848845|26684239|FG002|Overall Study|On Study Treatment|4|||
13360685|NCT03848845|26684237|FG000|Overall Study|Physician Decision|0|||
13360686|NCT03848845|26684238|FG001|Overall Study|Physician Decision|0|||
13360687|NCT03848845|26684239|FG002|Overall Study|Physician Decision|1|||
13360688|NCT03836001|26684272|FG000|Blinded Phase (2 Months)|Adverse Event|0|||
13360689|NCT03836001|26684273|FG001|Blinded Phase (2 Months)|Adverse Event|1|||
13360690|NCT03836001|26684274|FG002|Blinded Phase (2 Months)|Adverse Event|0|||
13360691|NCT03836001|26684272|FG000|Blinded Phase (2 Months)|Physician Decision|0|||
13360692|NCT03836001|26684273|FG001|Blinded Phase (2 Months)|Physician Decision|1|||
13360693|NCT03836001|26684274|FG002|Blinded Phase (2 Months)|Physician Decision|0|||
13360694|NCT03836001|26684272|FG000|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
13360695|NCT03836001|26684273|FG001|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
13360696|NCT03836001|26684274|FG002|Open-label Extension (3 or 12 Months)|Lost to Follow-up|1|||
13360697|NCT03836001|26684272|FG000|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
13360698|NCT03836001|26684273|FG001|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
13360699|NCT03836001|26684274|FG002|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|1|||
13360700|NCT03778021|26684317|FG000|Overall Study|Student failed to respond to follow-up survey|28|||
13360701|NCT03778021|26684318|FG001|Overall Study|Student failed to respond to follow-up survey|53|||
13360702|NCT03766906|26684331|FG000|Overall Study|Withdrawal by Subject|6|||
13360703|NCT03608826|26684354|FG000|Overall Study|Death|3|||
13360704|NCT03608826|26684354|FG000|Overall Study|Heart Transplant|3|||
13360705|NCT03608826|26684354|FG000|Overall Study|Physician Decision|4|||
13360706|NCT03542266|26684360|FG000|Treatment Phase|Withdrawal by Subject|1|||
13360707|NCT03542266|26684360|FG000|Treatment Phase|Adverse Event|1|||
13360708|NCT03542266|26684360|FG000|Treatment Phase|PD|1|||
13360709|NCT03484117|26684381|FG000|Overall Study|Lost to Follow-up|1|||
13360710|NCT03484117|26684382|FG001|Overall Study|Lost to Follow-up|3|||
13360711|NCT03484117|26684381|FG000|Overall Study|Declined participation in exit assess|1|||
13360712|NCT03484117|26684382|FG001|Overall Study|Declined participation in exit assess|1|||
13360713|NCT03347422|26684461|FG000|Part A (26 Weeks)|Adverse Event|3|||
13360714|NCT03347422|26684462|FG001|Part A (26 Weeks)|Adverse Event|0|||
13360715|NCT03347422|26684461|FG000|Part B (149 Weeks)|Lack of Efficacy|1|||
13360716|NCT03347422|26684462|FG001|Part B (149 Weeks)|Lack of Efficacy|2|||
13360717|NCT03347422|26684461|FG000|Part B (149 Weeks)|Adverse Event|0|||
13360718|NCT03347422|26684462|FG001|Part B (149 Weeks)|Adverse Event|1|||
13360719|NCT03347422|26684461|FG000|Part B (149 Weeks)|Withdrawal by Subject|1|||
13360720|NCT03347422|26684462|FG001|Part B (149 Weeks)|Withdrawal by Subject|1|||
13360721|NCT03347422|26684461|FG000|Part B (149 Weeks)|Other|1|||
13360722|NCT03347422|26684462|FG001|Part B (149 Weeks)|Other|0|||
13360723|NCT03214250|26684518|FG000|Overall Study|Death|5|||
13360724|NCT03214250|26684519|FG001|Overall Study|Death|5|||
13360725|NCT03214250|26684520|FG002|Overall Study|Death|7|||
13360726|NCT03214250|26684521|FG003|Overall Study|Death|4|||
13360727|NCT03214250|26684522|FG004|Overall Study|Death|23|||
13360728|NCT03214250|26684523|FG005|Overall Study|Death|23|||
13360729|NCT03214250|26684524|FG006|Overall Study|Death|24|||
13360730|NCT03214250|26684518|FG000|Overall Study|Lost to Follow-up|0|||
13360731|NCT03214250|26684519|FG001|Overall Study|Lost to Follow-up|0|||
13360732|NCT03214250|26684520|FG002|Overall Study|Lost to Follow-up|0|||
13360733|NCT03214250|26684521|FG003|Overall Study|Lost to Follow-up|1|||
13360734|NCT03214250|26684522|FG004|Overall Study|Lost to Follow-up|1|||
13360735|NCT03214250|26684523|FG005|Overall Study|Lost to Follow-up|2|||
13360736|NCT03214250|26684524|FG006|Overall Study|Lost to Follow-up|0|||
13360737|NCT03214250|26684518|FG000|Overall Study|Other|0|||
13360738|NCT03214250|26684519|FG001|Overall Study|Other|0|||
13360739|NCT03214250|26684520|FG002|Overall Study|Other|0|||
13360740|NCT03214250|26684521|FG003|Overall Study|Other|0|||
13360741|NCT03214250|26684522|FG004|Overall Study|Other|1|||
13360742|NCT03214250|26684523|FG005|Overall Study|Other|1|||
13360743|NCT03214250|26684524|FG006|Overall Study|Other|2|||
13360744|NCT03214250|26684518|FG000|Overall Study|Remains on Study|2|||
13360745|NCT03214250|26684519|FG001|Overall Study|Remains on Study|2|||
13360746|NCT03214250|26684520|FG002|Overall Study|Remains on Study|0|||
13360747|NCT03214250|26684521|FG003|Overall Study|Remains on Study|1|||
13360748|NCT03214250|26684522|FG004|Overall Study|Remains on Study|7|||
13360749|NCT03214250|26684523|FG005|Overall Study|Remains on Study|5|||
13360750|NCT03214250|26684524|FG006|Overall Study|Remains on Study|3|||
13360751|NCT03214250|26684518|FG000|Overall Study|Withdrawal by Subject|0|||
13360752|NCT03214250|26684519|FG001|Overall Study|Withdrawal by Subject|0|||
13360753|NCT03214250|26684520|FG002|Overall Study|Withdrawal by Subject|1|||
13360754|NCT03214250|26684521|FG003|Overall Study|Withdrawal by Subject|2|||
13360755|NCT03214250|26684522|FG004|Overall Study|Withdrawal by Subject|5|||
13360756|NCT03214250|26684523|FG005|Overall Study|Withdrawal by Subject|0|||
13360757|NCT03214250|26684524|FG006|Overall Study|Withdrawal by Subject|2|||
13360758|NCT03201250|26684546|FG000|Overall Study|screen failures|3|||
13360759|NCT03201250|26684547|FG001|Overall Study|screen failures|0|||
13360760|NCT03201250|26684548|FG002|Overall Study|screen failures|0|||
13360761|NCT03107793|26684609|FG000|Induction Period (16 Weeks)|Adverse Event|5|||
13360762|NCT03107793|26684610|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
13360763|NCT03107793|26684611|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
13360764|NCT03107793|26684612|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
13360765|NCT03107793|26684613|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
13360766|NCT03107793|26684609|FG000|Induction Period (16 Weeks)|Physician Decision|1|||
13360767|NCT03107793|26684610|FG001|Induction Period (16 Weeks)|Physician Decision|0|||
13360768|NCT03107793|26684611|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
13360769|NCT03107793|26684612|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
13360770|NCT03107793|26684613|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
13360771|NCT03107793|26684609|FG000|Induction Period (16 Weeks)|Progressive disease|1|||
13360772|NCT03107793|26684610|FG001|Induction Period (16 Weeks)|Progressive disease|0|||
13360773|NCT03107793|26684611|FG002|Induction Period (16 Weeks)|Progressive disease|0|||
13360774|NCT03107793|26684612|FG003|Induction Period (16 Weeks)|Progressive disease|0|||
13360775|NCT03107793|26684613|FG004|Induction Period (16 Weeks)|Progressive disease|0|||
13360776|NCT03107793|26684609|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
13360777|NCT03107793|26684610|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
13360778|NCT03107793|26684611|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
13360779|NCT03107793|26684612|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
13360780|NCT03107793|26684613|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
13360781|NCT03107793|26684609|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
13360782|NCT03107793|26684610|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|6|||
13360783|NCT03107793|26684611|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|10|||
13360784|NCT03107793|26684612|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
13360785|NCT03107793|26684613|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
13360786|NCT03107793|26684609|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
13360787|NCT03107793|26684610|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
13124947|NCT02936037|25954513|FG000|Double-Blind Treatment Period|Lack of Efficacy|4|||
13360788|NCT03107793|26684611|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|2|||
13360789|NCT03107793|26684612|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
13360790|NCT03107793|26684613|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
13360791|NCT03107793|26684609|FG000|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
13360792|NCT03107793|26684610|FG001|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
13360793|NCT03107793|26684611|FG002|Maintenance Period (Week 16-Week 48)|Progressive disease|1|||
13360794|NCT03107793|26684612|FG003|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
13360795|NCT03107793|26684613|FG004|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
13360796|NCT03107793|26684609|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
13360797|NCT03107793|26684610|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|21|||
13360798|NCT03107793|26684611|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|8|||
13360799|NCT03107793|26684612|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
13360800|NCT03107793|26684613|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
13360801|NCT03107793|26684609|FG000|Maintenance Period (Week 16-Week 48)|Death|0|||
13360802|NCT03107793|26684610|FG001|Maintenance Period (Week 16-Week 48)|Death|2|||
13360803|NCT03107793|26684611|FG002|Maintenance Period (Week 16-Week 48)|Death|0|||
13360804|NCT03107793|26684612|FG003|Maintenance Period (Week 16-Week 48)|Death|0|||
13360805|NCT03107793|26684613|FG004|Maintenance Period (Week 16-Week 48)|Death|0|||
13360806|NCT03107793|26684609|FG000|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
13360807|NCT03107793|26684610|FG001|Maintenance Period (Week 16-Week 48)|Disease relapse|2|||
13360808|NCT03107793|26684611|FG002|Maintenance Period (Week 16-Week 48)|Disease relapse|1|||
13360809|NCT03107793|26684612|FG003|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
13360810|NCT03107793|26684613|FG004|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
13360811|NCT03107793|26684609|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
13360812|NCT03107793|26684610|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
13360813|NCT03107793|26684611|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
13360814|NCT03107793|26684612|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
13360815|NCT03107793|26684613|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
13360816|NCT03107793|26684609|FG000|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
13360817|NCT03107793|26684610|FG001|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
13360818|NCT03107793|26684611|FG002|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
13360819|NCT03107793|26684612|FG003|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
13360820|NCT03107793|26684613|FG004|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
13360821|NCT03107793|26684609|FG000|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
13360822|NCT03107793|26684610|FG001|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
13360823|NCT03107793|26684611|FG002|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|1|||
13360824|NCT03107793|26684612|FG003|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
13360825|NCT03107793|26684613|FG004|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
13360826|NCT03107793|26684609|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
13360827|NCT03107793|26684610|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|12|||
13360828|NCT03107793|26684611|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
13360829|NCT03107793|26684612|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
13360830|NCT03107793|26684613|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
13360831|NCT03107793|26684609|FG000|Extension Period (Week 48- Week 104)|Adverse Event|0|||
13360832|NCT03107793|26684610|FG001|Extension Period (Week 48- Week 104)|Adverse Event|0|||
13360833|NCT03107793|26684611|FG002|Extension Period (Week 48- Week 104)|Adverse Event|0|||
13360834|NCT03107793|26684612|FG003|Extension Period (Week 48- Week 104)|Adverse Event|10|||
13360835|NCT03107793|26684613|FG004|Extension Period (Week 48- Week 104)|Adverse Event|3|||
13360836|NCT03107793|26684609|FG000|Extension Period (Week 48- Week 104)|Physician Decision|0|||
13360837|NCT03107793|26684610|FG001|Extension Period (Week 48- Week 104)|Physician Decision|0|||
13360838|NCT03107793|26684611|FG002|Extension Period (Week 48- Week 104)|Physician Decision|0|||
13360839|NCT03107793|26684612|FG003|Extension Period (Week 48- Week 104)|Physician Decision|0|||
13360840|NCT03107793|26684613|FG004|Extension Period (Week 48- Week 104)|Physician Decision|2|||
13360841|NCT03107793|26684609|FG000|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
13360842|NCT03107793|26684610|FG001|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
13360843|NCT03107793|26684611|FG002|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
13360844|NCT03107793|26684612|FG003|Extension Period (Week 48- Week 104)|Lack of Efficacy|8|||
13360845|NCT03107793|26684613|FG004|Extension Period (Week 48- Week 104)|Lack of Efficacy|9|||
13360846|NCT03107793|26684609|FG000|Extension Period (Week 48- Week 104)|Death|0|||
13360847|NCT03107793|26684610|FG001|Extension Period (Week 48- Week 104)|Death|0|||
13360848|NCT03107793|26684611|FG002|Extension Period (Week 48- Week 104)|Death|0|||
13360849|NCT03107793|26684612|FG003|Extension Period (Week 48- Week 104)|Death|0|||
13360850|NCT03107793|26684613|FG004|Extension Period (Week 48- Week 104)|Death|1|||
13360851|NCT03107793|26684609|FG000|Extension Period (Week 48- Week 104)|Disease relapse|0|||
13360852|NCT03107793|26684610|FG001|Extension Period (Week 48- Week 104)|Disease relapse|0|||
13360853|NCT03107793|26684611|FG002|Extension Period (Week 48- Week 104)|Disease relapse|0|||
13360854|NCT03107793|26684612|FG003|Extension Period (Week 48- Week 104)|Disease relapse|0|||
13360855|NCT03107793|26684613|FG004|Extension Period (Week 48- Week 104)|Disease relapse|3|||
13360856|NCT03107793|26684609|FG000|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
13360857|NCT03107793|26684610|FG001|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
13360858|NCT03107793|26684611|FG002|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
13360859|NCT03107793|26684612|FG003|Extension Period (Week 48- Week 104)|Lost to Follow-up|1|||
13360860|NCT03107793|26684613|FG004|Extension Period (Week 48- Week 104)|Lost to Follow-up|2|||
13360861|NCT03107793|26684609|FG000|Extension Period (Week 48- Week 104)|Pregnancy|0|||
13360862|NCT03107793|26684610|FG001|Extension Period (Week 48- Week 104)|Pregnancy|0|||
13360863|NCT03107793|26684611|FG002|Extension Period (Week 48- Week 104)|Pregnancy|0|||
13360864|NCT03107793|26684612|FG003|Extension Period (Week 48- Week 104)|Pregnancy|2|||
13360865|NCT03107793|26684613|FG004|Extension Period (Week 48- Week 104)|Pregnancy|4|||
13360866|NCT03107793|26684609|FG000|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
13360867|NCT03107793|26684610|FG001|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
13360868|NCT03107793|26684611|FG002|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
13360869|NCT03107793|26684612|FG003|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
13360870|NCT03107793|26684613|FG004|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|1|||
13360871|NCT03107793|26684609|FG000|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
13360872|NCT03107793|26684610|FG001|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
13360873|NCT03107793|26684611|FG002|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
13360874|NCT03107793|26684612|FG003|Extension Period (Week 48- Week 104)|Non-compliance with study drug|1|||
13360875|NCT03107793|26684613|FG004|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
13360876|NCT03107793|26684609|FG000|Extension Period (Week 48- Week 104)|Other|0|||
13360877|NCT03107793|26684610|FG001|Extension Period (Week 48- Week 104)|Other|0|||
13360878|NCT03107793|26684611|FG002|Extension Period (Week 48- Week 104)|Other|0|||
13360879|NCT03107793|26684612|FG003|Extension Period (Week 48- Week 104)|Other|1|||
13360880|NCT03107793|26684613|FG004|Extension Period (Week 48- Week 104)|Other|3|||
13360881|NCT03107793|26684609|FG000|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
13360882|NCT03107793|26684610|FG001|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
13360883|NCT03107793|26684611|FG002|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
13360884|NCT03107793|26684612|FG003|Extension Period (Week 48- Week 104)|Withdrawal by Subject|5|||
13360885|NCT03107793|26684613|FG004|Extension Period (Week 48- Week 104)|Withdrawal by Subject|9|||
13360886|NCT02881151|26684785|FG000|Post-surgical Washout (65 to 93 Days)|Device explantation|1|||
13374970|NCT00792298|26728964|FG005|Treatment Period 1|Physician Decision|0|||
13374971|NCT00792298|26728965|FG006|Treatment Period 1|Physician Decision|1|||
13374972|NCT00792298|26728966|FG007|Treatment Period 1|Physician Decision|0|||
13374973|NCT00792298|26728959|FG000|Treatment Period 1|Protocol Violation|0|||
13374974|NCT00792298|26728960|FG001|Treatment Period 1|Protocol Violation|0|||
13374975|NCT00792298|26728961|FG002|Treatment Period 1|Protocol Violation|0|||
13374976|NCT00792298|26728962|FG003|Treatment Period 1|Protocol Violation|0|||
13374977|NCT00792298|26728963|FG004|Treatment Period 1|Protocol Violation|0|||
13374978|NCT00792298|26728964|FG005|Treatment Period 1|Protocol Violation|0|||
13374979|NCT00792298|26728965|FG006|Treatment Period 1|Protocol Violation|0|||
13374980|NCT00792298|26728966|FG007|Treatment Period 1|Protocol Violation|1|||
13374981|NCT00792298|26728959|FG000|Washout|Adverse Event|0|||
13374982|NCT00792298|26728960|FG001|Washout|Adverse Event|0|||
13374983|NCT00792298|26728961|FG002|Washout|Adverse Event|0|||
13374984|NCT00792298|26728962|FG003|Washout|Adverse Event|0|||
13374985|NCT00792298|26728963|FG004|Washout|Adverse Event|0|||
13374986|NCT00792298|26728964|FG005|Washout|Adverse Event|1|||
13374987|NCT00792298|26728965|FG006|Washout|Adverse Event|0|||
13374988|NCT00792298|26728966|FG007|Washout|Adverse Event|0|||
13374989|NCT00792298|26728959|FG000|Washout|Withdrawal by Subject|0|||
13374990|NCT00792298|26728960|FG001|Washout|Withdrawal by Subject|0|||
13374991|NCT00792298|26728961|FG002|Washout|Withdrawal by Subject|1|||
13374992|NCT00792298|26728962|FG003|Washout|Withdrawal by Subject|0|||
13374993|NCT00792298|26728963|FG004|Washout|Withdrawal by Subject|0|||
13374994|NCT00792298|26728964|FG005|Washout|Withdrawal by Subject|1|||
13374995|NCT00792298|26728965|FG006|Washout|Withdrawal by Subject|0|||
13374996|NCT00792298|26728966|FG007|Washout|Withdrawal by Subject|0|||
13374997|NCT00792298|26728959|FG000|Treatment Period 2|Lack of Efficacy|0|||
13374998|NCT00792298|26728960|FG001|Treatment Period 2|Lack of Efficacy|0|||
13374999|NCT00792298|26728961|FG002|Treatment Period 2|Lack of Efficacy|0|||
13375000|NCT00792298|26728962|FG003|Treatment Period 2|Lack of Efficacy|0|||
13375001|NCT00792298|26728963|FG004|Treatment Period 2|Lack of Efficacy|1|||
13375002|NCT00792298|26728964|FG005|Treatment Period 2|Lack of Efficacy|0|||
13375003|NCT00792298|26728965|FG006|Treatment Period 2|Lack of Efficacy|0|||
13375004|NCT00792298|26728966|FG007|Treatment Period 2|Lack of Efficacy|0|||
13375005|NCT00792298|26728959|FG000|Treatment Period 2|Physician Decision|0|||
13360887|NCT02731729|26684808|FG000|Overall Study|Death|2|||
13360888|NCT02731729|26684809|FG001|Overall Study|Death|2|||
13360889|NCT02731729|26684808|FG000|Overall Study|Study terminated by Sponsor|6|||
13360890|NCT02731729|26684809|FG001|Overall Study|Study terminated by Sponsor|6|||
13360891|NCT02731729|26684808|FG000|Overall Study|Withdrawal by Subject|1|||
13360892|NCT02731729|26684809|FG001|Overall Study|Withdrawal by Subject|0|||
13360893|NCT02242942|26684846|FG000|Overall Study|Death|17|||
13360894|NCT02242942|26684847|FG001|Overall Study|Death|20|||
13360895|NCT02242942|26684848|FG002|Overall Study|Death|2|||
13360896|NCT02242942|26684846|FG000|Overall Study|Physician Decision|1|||
13360897|NCT02242942|26684847|FG001|Overall Study|Physician Decision|0|||
13360898|NCT02242942|26684848|FG002|Overall Study|Physician Decision|0|||
13360899|NCT02242942|26684846|FG000|Overall Study|Withdrawal by Subject|8|||
13360900|NCT02242942|26684847|FG001|Overall Study|Withdrawal by Subject|10|||
13360901|NCT02242942|26684848|FG002|Overall Study|Withdrawal by Subject|0|||
13360902|NCT02242942|26684846|FG000|Overall Study|On-going in Study|190|||
13360903|NCT02242942|26684847|FG001|Overall Study|On-going in Study|186|||
13360904|NCT02242942|26684848|FG002|Overall Study|On-going in Study|11|||
13360905|NCT01933932|26684871|FG000|Overall Study|Death|173|||
13360906|NCT01933932|26684872|FG001|Overall Study|Death|163|||
13360907|NCT01933932|26684871|FG000|Overall Study|Withdrawal by Subject|11|||
13360908|NCT01933932|26684872|FG001|Overall Study|Withdrawal by Subject|14|||
13360909|NCT01933932|26684871|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
13360910|NCT01933932|26684872|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
13360911|NCT01874353|26684920|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2|||
13360912|NCT01874353|26684921|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
13360913|NCT01874353|26684922|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
13360914|NCT01874353|26684923|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
13360915|NCT01874353|26684920|FG000|Overall Study|Lost to Follow-up|2|||
13360916|NCT01874353|26684921|FG001|Overall Study|Lost to Follow-up|2|||
13360917|NCT01874353|26684922|FG002|Overall Study|Lost to Follow-up|2|||
13360918|NCT01874353|26684923|FG003|Overall Study|Lost to Follow-up|0|||
13360919|NCT01874353|26684920|FG000|Overall Study|Death|110|||
13360920|NCT01874353|26684921|FG001|Overall Study|Death|60|||
13360921|NCT01874353|26684922|FG002|Overall Study|Death|13|||
13360922|NCT01874353|26684923|FG003|Overall Study|Death|7|||
13360923|NCT01874353|26684920|FG000|Overall Study|Withdrawal by Subject|13|||
13360924|NCT01874353|26684921|FG001|Overall Study|Withdrawal by Subject|11|||
13360925|NCT01874353|26684922|FG002|Overall Study|Withdrawal by Subject|0|||
13360926|NCT01874353|26684923|FG003|Overall Study|Withdrawal by Subject|0|||
13360927|NCT01605253|26684976|FG000|Overall Study|Physician Decision|3|||
13360928|NCT01605253|26684977|FG001|Overall Study|Physician Decision|2|||
13360929|NCT01605253|26684976|FG000|Overall Study|Lost to Follow-up|3|||
13360930|NCT01605253|26684977|FG001|Overall Study|Lost to Follow-up|1|||
13360931|NCT00602667|26685175|FG000|Overall Study|Still on Therapy|0|||
13360932|NCT00602667|26685176|FG001|Overall Study|Still on Therapy|2|||
13360933|NCT00602667|26685177|FG002|Overall Study|Still on Therapy|2|||
13360934|NCT00602667|26685175|FG000|Overall Study|Death|0|||
13360935|NCT00602667|26685176|FG001|Overall Study|Death|1|||
13360936|NCT00602667|26685177|FG002|Overall Study|Death|1|||
13360937|NCT00602667|26685175|FG000|Overall Study|Family request|3|||
13360938|NCT00602667|26685176|FG001|Overall Study|Family request|25|||
13360939|NCT00602667|26685177|FG002|Overall Study|Family request|6|||
13360940|NCT00602667|26685175|FG000|Overall Study|Excessive toxicity|1|||
13360941|NCT00602667|26685176|FG001|Overall Study|Excessive toxicity|1|||
13360942|NCT00602667|26685177|FG002|Overall Study|Excessive toxicity|0|||
13360943|NCT00602667|26685175|FG000|Overall Study|Second malignancy|0|||
13360944|NCT00602667|26685176|FG001|Overall Study|Second malignancy|1|||
13360945|NCT00602667|26685177|FG002|Overall Study|Second malignancy|0|||
13360946|NCT00602667|26685175|FG000|Overall Study|Physician Decision|2|||
13360947|NCT00602667|26685176|FG001|Overall Study|Physician Decision|3|||
13360948|NCT00602667|26685177|FG002|Overall Study|Physician Decision|8|||
13360949|NCT00602667|26685175|FG000|Overall Study|Progressive disease|13|||
13360950|NCT00602667|26685176|FG001|Overall Study|Progressive disease|48|||
13360951|NCT00602667|26685177|FG002|Overall Study|Progressive disease|45|||
13360952|NCT00602667|26685175|FG000|Overall Study|Progressive disease prior to therapy|0|||
13360953|NCT00602667|26685176|FG001|Overall Study|Progressive disease prior to therapy|0|||
13360954|NCT00602667|26685177|FG002|Overall Study|Progressive disease prior to therapy|1|||
13360955|NCT00885755|26685261|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1|||
13360956|NCT00885755|26685262|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0|||
13360957|NCT00885755|26685263|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0|||
13360958|NCT00885755|26685261|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16|||
13360959|NCT00885755|26685262|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
13360960|NCT00885755|26685263|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
13360961|NCT00885755|26685261|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1|||
13360962|NCT00885755|26685262|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
13360963|NCT00885755|26685263|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
13360964|NCT00885755|26685261|FG000|Part I: Trastuzumab+Taxane|Death|0|||
13360965|NCT00885755|26685262|FG001|Part I: Trastuzumab+Taxane|Death|0|||
13360966|NCT00885755|26685263|FG002|Part I: Trastuzumab+Taxane|Death|1|||
13360967|NCT00885755|26685261|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5|||
13360968|NCT00885755|26685262|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
13360969|NCT00885755|26685263|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
13360970|NCT00885703|26685341|FG000|Overall Study|Death|9|||
13360971|NCT00885703|26685342|FG001|Overall Study|Death|7|||
13360972|NCT00885703|26685343|FG002|Overall Study|Death|8|||
13360973|NCT00885703|26685344|FG003|Overall Study|Death|7|||
13360974|NCT00885703|26685345|FG004|Overall Study|Death|7|||
13360975|NCT00885703|26685346|FG005|Overall Study|Death|8|||
13360976|NCT00885703|26685347|FG006|Overall Study|Death|4|||
13360977|NCT00885703|26685341|FG000|Overall Study|Lost to Follow-up|0|||
13360978|NCT00885703|26685342|FG001|Overall Study|Lost to Follow-up|0|||
13360979|NCT00885703|26685343|FG002|Overall Study|Lost to Follow-up|1|||
13360980|NCT00885703|26685344|FG003|Overall Study|Lost to Follow-up|0|||
13360981|NCT00885703|26685345|FG004|Overall Study|Lost to Follow-up|0|||
13360982|NCT00885703|26685346|FG005|Overall Study|Lost to Follow-up|1|||
13360983|NCT00885703|26685347|FG006|Overall Study|Lost to Follow-up|0|||
13360984|NCT00885703|26685341|FG000|Overall Study|Withdrawal by Subject|0|||
13360985|NCT00885703|26685342|FG001|Overall Study|Withdrawal by Subject|0|||
13360986|NCT00885703|26685343|FG002|Overall Study|Withdrawal by Subject|0|||
13360987|NCT00885703|26685344|FG003|Overall Study|Withdrawal by Subject|1|||
13360988|NCT00885703|26685345|FG004|Overall Study|Withdrawal by Subject|3|||
13360989|NCT00885703|26685346|FG005|Overall Study|Withdrawal by Subject|1|||
13360990|NCT00885703|26685347|FG006|Overall Study|Withdrawal by Subject|1|||
13360991|NCT00885703|26685341|FG000|Overall Study|Ineligible (no CM)|1|||
13360992|NCT00885703|26685342|FG001|Overall Study|Ineligible (no CM)|3|||
13360993|NCT00885703|26685343|FG002|Overall Study|Ineligible (no CM)|2|||
13360994|NCT00885703|26685344|FG003|Overall Study|Ineligible (no CM)|1|||
13360995|NCT00885703|26685345|FG004|Overall Study|Ineligible (no CM)|2|||
13360996|NCT00885703|26685346|FG005|Overall Study|Ineligible (no CM)|3|||
13360997|NCT00885703|26685347|FG006|Overall Study|Ineligible (no CM)|1|||
13360998|NCT00885677|26685362|FG000|Overall Study|Death|40|||
13360999|NCT00885677|26685363|FG001|Overall Study|Death|34|||
13361000|NCT00885677|26685362|FG000|Overall Study|Lost to Follow-up|15|||
13361001|NCT00885677|26685363|FG001|Overall Study|Lost to Follow-up|13|||
13361002|NCT00885677|26685362|FG000|Overall Study|Protocol Violation|54|||
13361003|NCT00885677|26685363|FG001|Overall Study|Protocol Violation|54|||
13361004|NCT00885677|26685362|FG000|Overall Study|premature study closure|41|||
13361005|NCT00885677|26685363|FG001|Overall Study|premature study closure|44|||
13361006|NCT00885677|26685362|FG000|Overall Study|device/lead revision or replacement|7|||
13361007|NCT00885677|26685363|FG001|Overall Study|device/lead revision or replacement|6|||
13361008|NCT00885677|26685362|FG000|Overall Study|Heart transplantation|1|||
13361009|NCT00885677|26685363|FG001|Overall Study|Heart transplantation|0|||
13361010|NCT00885677|26685362|FG000|Overall Study|Inclusion/exclusion not met|25|||
13361011|NCT00885677|26685363|FG001|Overall Study|Inclusion/exclusion not met|27|||
13361012|NCT00885534|26685369|FG000|Overall Study|Patient deemed ineligible|1|||
13361013|NCT00885495|26685389|FG000|Overall Study|Adverse Event|1|||
13361014|NCT00885495|26685390|FG001|Overall Study|Adverse Event|2|||
13361015|NCT00885495|26685389|FG000|Overall Study|Protocol Violation|0|||
13361016|NCT00885495|26685390|FG001|Overall Study|Protocol Violation|1|||
13361017|NCT00885495|26685389|FG000|Overall Study|Withdrawal by Subject|1|||
13361018|NCT00885495|26685390|FG001|Overall Study|Withdrawal by Subject|0|||
13361019|NCT00885482|26685396|FG000|Overall Study|Pregnancy|1|||
13361020|NCT00885482|26685396|FG000|Overall Study|Lack of Efficacy|1|||
13361021|NCT00885482|26685396|FG000|Overall Study|Death|1|||
13361022|NCT00885482|26685396|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1|||
13361023|NCT00885378|26685431|FG000|Overall Study|Lack of Efficacy|2|||
13361024|NCT00885378|26685432|FG001|Overall Study|Lack of Efficacy|2|||
13361025|NCT00885378|26685431|FG000|Overall Study|Withdrawal by Subject|1|||
13361026|NCT00885378|26685432|FG001|Overall Study|Withdrawal by Subject|2|||
13361027|NCT00885378|26685431|FG000|Overall Study|Lost to Follow-up|1|||
13361028|NCT00885378|26685432|FG001|Overall Study|Lost to Follow-up|2|||
13361029|NCT00885378|26685431|FG000|Overall Study|Poor/Noncompliance|2|||
13361030|NCT00885378|26685432|FG001|Overall Study|Poor/Noncompliance|2|||
13361031|NCT00885378|26685431|FG000|Overall Study|Protocol Violation|2|||
13361032|NCT00885378|26685432|FG001|Overall Study|Protocol Violation|0|||
13361033|NCT00885365|26685473|FG000|4 Weeks ON Treatment|Adverse Event|2|||
13361034|NCT00885365|26685474|FG001|4 Weeks ON Treatment|Adverse Event|4|||
13361035|NCT00885365|26685473|FG000|4 Weeks ON Treatment|Protocol Violation|1|||
13361036|NCT00885365|26685474|FG001|4 Weeks ON Treatment|Protocol Violation|2|||
13361037|NCT00885365|26685473|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1|||
13361038|NCT00885365|26685474|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0|||
13361039|NCT00885352|26685491|FG000|Overall Study|Adverse Event|2|||
13204470|NCT01972841|26229048|FG000|Overall Study|Miscellaneous|0|||
13361040|NCT00885352|26685492|FG001|Overall Study|Adverse Event|3|||
13361041|NCT00885352|26685491|FG000|Overall Study|Lost to Follow-up|2|||
13361042|NCT00885352|26685492|FG001|Overall Study|Lost to Follow-up|2|||
13361043|NCT00885352|26685491|FG000|Overall Study|Physician Decision|0|||
13361044|NCT00885352|26685492|FG001|Overall Study|Physician Decision|3|||
13361045|NCT00885352|26685491|FG000|Overall Study|Protocol Violation|0|||
13361046|NCT00885352|26685492|FG001|Overall Study|Protocol Violation|2|||
13361047|NCT00885352|26685491|FG000|Overall Study|Withdrawal by Subject|1|||
13361048|NCT00885352|26685492|FG001|Overall Study|Withdrawal by Subject|5|||
13361049|NCT00885352|26685491|FG000|Overall Study|Contradiction to study medication|0|||
13361050|NCT00885352|26685492|FG001|Overall Study|Contradiction to study medication|2|||
13361051|NCT00885352|26685491|FG000|Overall Study|Excluded medication|2|||
13361052|NCT00885352|26685492|FG001|Overall Study|Excluded medication|2|||
13361053|NCT00885352|26685491|FG000|Overall Study|Lab abnormalities|1|||
13361054|NCT00885352|26685492|FG001|Overall Study|Lab abnormalities|1|||
13361055|NCT00885170|26685553|FG000|Overall Study|Adverse Event|12|||
13361056|NCT00885170|26685554|FG001|Overall Study|Adverse Event|4|||
13361057|NCT00885170|26685553|FG000|Overall Study|Excessive bone loss|6|||
13361058|NCT00885170|26685554|FG001|Overall Study|Excessive bone loss|3|||
13361059|NCT00885170|26685553|FG000|Overall Study|Lost to Follow-up|2|||
13361060|NCT00885170|26685554|FG001|Overall Study|Lost to Follow-up|1|||
13361061|NCT00885170|26685553|FG000|Overall Study|Physician Decision|2|||
13361062|NCT00885170|26685554|FG001|Overall Study|Physician Decision|1|||
13361063|NCT00885170|26685553|FG000|Overall Study|Protocol Violation|3|||
13361064|NCT00885170|26685554|FG001|Overall Study|Protocol Violation|1|||
13361065|NCT00885170|26685553|FG000|Overall Study|Withdrawal by Subject|13|||
13361066|NCT00885170|26685554|FG001|Overall Study|Withdrawal by Subject|13|||
13361067|NCT00885118|26685707|FG000|Overall Study|Adverse Event|1|||
13361068|NCT00885118|26685708|FG001|Overall Study|Adverse Event|0|||
13361069|NCT00885118|26685709|FG002|Overall Study|Adverse Event|0|||
13361070|NCT00885118|26685710|FG003|Overall Study|Adverse Event|0|||
13361071|NCT00885118|26685711|FG004|Overall Study|Adverse Event|0|||
13361072|NCT00885118|26685707|FG000|Overall Study|Withdrawal by Subject|0|||
13361073|NCT00885118|26685708|FG001|Overall Study|Withdrawal by Subject|0|||
13361074|NCT00885118|26685709|FG002|Overall Study|Withdrawal by Subject|0|||
13361075|NCT00885118|26685710|FG003|Overall Study|Withdrawal by Subject|0|||
13361076|NCT00885118|26685711|FG004|Overall Study|Withdrawal by Subject|1|||
13361077|NCT00885118|26685707|FG000|Overall Study|Other reason not defined above|0|||
13361078|NCT00885118|26685708|FG001|Overall Study|Other reason not defined above|0|||
13361079|NCT00885118|26685709|FG002|Overall Study|Other reason not defined above|1|||
13361080|NCT00885118|26685710|FG003|Overall Study|Other reason not defined above|0|||
13361081|NCT00885118|26685711|FG004|Overall Study|Other reason not defined above|0|||
13361082|NCT00885105|26685734|FG000|Overall Study|Withdrawal by Subject|0|||
13361083|NCT00885105|26685735|FG001|Overall Study|Withdrawal by Subject|8|||
13361084|NCT00885105|26685734|FG000|Overall Study|Adverse Event|1|||
13361085|NCT00885105|26685735|FG001|Overall Study|Adverse Event|0|||
13361086|NCT00885105|26685734|FG000|Overall Study|Protocol Violation|0|||
13361087|NCT00885105|26685735|FG001|Overall Study|Protocol Violation|2|||
13361088|NCT00884949|26685754|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1|||
13361089|NCT00884949|26685754|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1|||
13361090|NCT00884832|26685791|FG000|Overall Study|Withdrawal by Subject|0|||
13361091|NCT00884832|26685792|FG001|Overall Study|Withdrawal by Subject|1|||
13361092|NCT00884793|26685801|FG000|Overall Study|Withdrawal by Subject|1|||
13361093|NCT00884741|26685823|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157|||
13361094|NCT00884741|26685824|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
13361095|NCT00884741|26685825|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
13361096|NCT00884741|26685826|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
13361097|NCT00884741|26685823|FG000|Step 1 Registration: Tissue Screening|Death|3|||
13361098|NCT00884741|26685824|FG001|Step 1 Registration: Tissue Screening|Death|0|||
13361099|NCT00884741|26685825|FG002|Step 1 Registration: Tissue Screening|Death|0|||
13361100|NCT00884741|26685826|FG003|Step 1 Registration: Tissue Screening|Death|0|||
13361101|NCT00884741|26685823|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3|||
13361102|NCT00884741|26685824|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0|||
13361103|NCT00884741|26685825|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0|||
13361104|NCT00884741|26685826|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0|||
13361105|NCT00884741|26685823|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105|||
13361106|NCT00884741|26685824|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
13361107|NCT00884741|26685825|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
13361108|NCT00884741|26685826|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
13361109|NCT00884741|26685823|FG000|Step 1 Registration: Tissue Screening|Disease progression|12|||
13361110|NCT00884741|26685824|FG001|Step 1 Registration: Tissue Screening|Disease progression|0|||
13361111|NCT00884741|26685825|FG002|Step 1 Registration: Tissue Screening|Disease progression|0|||
13361112|NCT00884741|26685826|FG003|Step 1 Registration: Tissue Screening|Disease progression|0|||
13361113|NCT00884741|26685823|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32|||
13361114|NCT00884741|26685824|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0|||
13361115|NCT00884741|26685825|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0|||
13361116|NCT00884741|26685826|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0|||
13361117|NCT00884741|26685823|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
13361118|NCT00884741|26685824|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15|||
13361119|NCT00884741|26685825|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
13361120|NCT00884741|26685826|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
13361121|NCT00884741|26685823|FG000|Step 2 Registration: Tissue Analysis|Death|0|||
13361122|NCT00884741|26685824|FG001|Step 2 Registration: Tissue Analysis|Death|1|||
13361123|NCT00884741|26685825|FG002|Step 2 Registration: Tissue Analysis|Death|0|||
13361124|NCT00884741|26685826|FG003|Step 2 Registration: Tissue Analysis|Death|0|||
13361125|NCT00884741|26685823|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
13361126|NCT00884741|26685824|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2|||
13361127|NCT00884741|26685825|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
13361128|NCT00884741|26685826|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
13361129|NCT00884741|26685823|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
13361130|NCT00884741|26685824|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7|||
13361131|NCT00884741|26685825|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
13361132|NCT00884741|26685826|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
13361133|NCT00884741|26685823|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
13361134|NCT00884741|26685824|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4|||
13361135|NCT00884741|26685825|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
13361136|NCT00884741|26685826|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
13361137|NCT00884741|26685823|FG000|Randomization|Protocol Violation|0|||
13361138|NCT00884741|26685824|FG001|Randomization|Protocol Violation|0|||
13361139|NCT00884741|26685825|FG002|Randomization|Protocol Violation|8|||
13361140|NCT00884741|26685826|FG003|Randomization|Protocol Violation|8|||
13361141|NCT00884650|26685842|FG000|Overall Study|Did not return complete pain diaries|7|||
13361142|NCT00884650|26685843|FG001|Overall Study|Did not return complete pain diaries|7|||
13361143|NCT00884650|26685842|FG000|Overall Study|Admitted Post-Op|1|||
13361144|NCT00884650|26685843|FG001|Overall Study|Admitted Post-Op|0|||
13361145|NCT00884650|26685842|FG000|Overall Study|Femoral Stress Fracture|1|||
13361146|NCT00884650|26685843|FG001|Overall Study|Femoral Stress Fracture|0|||
13361147|NCT00884650|26685842|FG000|Overall Study|Pain Pump Complication|0|||
13361148|NCT00884650|26685843|FG001|Overall Study|Pain Pump Complication|1|||
13361149|NCT00884390|26685866|FG000|Overall Study|Adverse Event|0|||
13361150|NCT00884390|26685867|FG001|Overall Study|Adverse Event|1|||
13361151|NCT00884390|26685866|FG000|Overall Study|Lost to Follow-up|0|||
13361152|NCT00884390|26685867|FG001|Overall Study|Lost to Follow-up|1|||
13361153|NCT00884390|26685866|FG000|Overall Study|Physician Decision|2|||
13361154|NCT00884390|26685867|FG001|Overall Study|Physician Decision|1|||
13361155|NCT00884390|26685866|FG000|Overall Study|Protocol Violation|4|||
13361156|NCT00884390|26685867|FG001|Overall Study|Protocol Violation|1|||
13361157|NCT00884390|26685866|FG000|Overall Study|Withdrawal by Subject|4|||
13361158|NCT00884390|26685867|FG001|Overall Study|Withdrawal by Subject|1|||
13361159|NCT00884390|26685866|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
13361160|NCT00884390|26685867|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
13361161|NCT00884390|26685866|FG000|Overall Study|Other|11|||
13361162|NCT00884390|26685867|FG001|Overall Study|Other|1|||
13361163|NCT00884377|26685894|FG000|Overall Study|Withdrawal by Subject|1|||
13361164|NCT00884377|26685895|FG001|Overall Study|Withdrawal by Subject|0|||
13361165|NCT00884377|26685894|FG000|Overall Study|Could not confirm diagnosis|1|||
13361166|NCT00884377|26685895|FG001|Overall Study|Could not confirm diagnosis|0|||
13361167|NCT00884377|26685894|FG000|Overall Study|Physician Decision|0|||
13361168|NCT00884377|26685895|FG001|Overall Study|Physician Decision|1|||
13361169|NCT00884325|26685910|FG000|Overall Study|Lost to Follow-up|1|||
13361170|NCT00884325|26685911|FG001|Overall Study|Lost to Follow-up|2|||
13361171|NCT00884325|26685910|FG000|Overall Study|Lack of Efficacy|0|||
13361172|NCT00884325|26685911|FG001|Overall Study|Lack of Efficacy|1|||
13361173|NCT00884325|26685910|FG000|Overall Study|Withdrawal by Subject|1|||
13361174|NCT00884325|26685911|FG001|Overall Study|Withdrawal by Subject|1|||
13361175|NCT00884325|26685910|FG000|Overall Study|Not provided|1|||
13361176|NCT00884325|26685911|FG001|Overall Study|Not provided|0|||
13361177|NCT00884312|26685932|FG000|Overall Study|Non-fatal Progressive Disease|0|||
13361178|NCT00884312|26685933|FG001|Overall Study|Non-fatal Progressive Disease|8|||
13361179|NCT00884312|26685932|FG000|Overall Study|Fatal Progressive Disease|0|||
13361180|NCT00884312|26685933|FG001|Overall Study|Fatal Progressive Disease|1|||
13361181|NCT00884312|26685932|FG000|Overall Study|Non-fatal Adverse Event|1|||
13361182|NCT00884312|26685933|FG001|Overall Study|Non-fatal Adverse Event|0|||
13361183|NCT00884312|26685932|FG000|Overall Study|Fatal Adverse Event|1|||
13361184|NCT00884312|26685933|FG001|Overall Study|Fatal Adverse Event|4|||
13361185|NCT00884312|26685932|FG000|Overall Study|Withdrawal by Subject|0|||
13361186|NCT00884312|26685933|FG001|Overall Study|Withdrawal by Subject|6|||
13361187|NCT00884312|26685932|FG000|Overall Study|Physician Decision|0|||
13361188|NCT00884312|26685933|FG001|Overall Study|Physician Decision|1|||
13361189|NCT00884312|26685932|FG000|Overall Study|Other|0|||
13361190|NCT00884312|26685933|FG001|Overall Study|Other|4|||
13361191|NCT00884312|26685932|FG000|Overall Study|Did Not Receive Study Drug|0|||
13361192|NCT00884312|26685933|FG001|Overall Study|Did Not Receive Study Drug|1|||
13361193|NCT00884286|26685952|FG000|Overall Study|Progressive disease|21|||
13361194|NCT00884286|26685953|FG001|Overall Study|Progressive disease|28|||
13361195|NCT00884286|26685952|FG000|Overall Study|Toxicity|4|||
13361196|NCT00884286|26685953|FG001|Overall Study|Toxicity|1|||
13361197|NCT00884286|26685952|FG000|Overall Study|Death|2|||
13361198|NCT00884286|26685953|FG001|Overall Study|Death|2|||
13361199|NCT00884286|26685952|FG000|Overall Study|Physician Decision|1|||
13361200|NCT00884286|26685953|FG001|Overall Study|Physician Decision|0|||
13361201|NCT00884286|26685952|FG000|Overall Study|Septic shock|1|||
13361202|NCT00884286|26685953|FG001|Overall Study|Septic shock|0|||
13361203|NCT00884286|26685952|FG000|Overall Study|Thrombus in right auricle|1|||
13361204|NCT00884286|26685953|FG001|Overall Study|Thrombus in right auricle|0|||
13361205|NCT00884286|26685952|FG000|Overall Study|Not treated|2|||
13361206|NCT00884286|26685953|FG001|Overall Study|Not treated|1|||
13361207|NCT00884286|26685952|FG000|Overall Study|Comprised lung carcinoma|0|||
13361208|NCT00884286|26685953|FG001|Overall Study|Comprised lung carcinoma|1|||
13361209|NCT00884273|26685984|FG000|Overall Study|Adverse Event|0|||
13361210|NCT00884273|26685985|FG001|Overall Study|Adverse Event|2|||
13361211|NCT00884273|26685984|FG000|Overall Study|Protocol Violation|1|||
13361212|NCT00884273|26685985|FG001|Overall Study|Protocol Violation|3|||
13361213|NCT00884273|26685984|FG000|Overall Study|Practical reasons|1|||
13361214|NCT00884273|26685985|FG001|Overall Study|Practical reasons|0|||
13361215|NCT00884221|26686028|FG000|Overall Study|Withdrawal by Subject|0|||
13361216|NCT00884221|26686029|FG001|Overall Study|Withdrawal by Subject|3|||
13361217|NCT00884221|26686028|FG000|Overall Study|Adverse Event|6|||
13361218|NCT00884221|26686029|FG001|Overall Study|Adverse Event|3|||
13361219|NCT00884221|26686028|FG000|Overall Study|Protocol Violation|16|||
13361220|NCT00884221|26686029|FG001|Overall Study|Protocol Violation|13|||
13361221|NCT00884221|26686028|FG000|Overall Study|Cancellation of Cycle and Other Reason|12|||
13361222|NCT00884221|26686029|FG001|Overall Study|Cancellation of Cycle and Other Reason|13|||
13361223|NCT00884117|26686073|FG000|Overall Study|Adverse Event|2|||
13361224|NCT00884117|26686073|FG000|Overall Study|Withdrawal by Subject|89|||
13361225|NCT00884117|26686073|FG000|Overall Study|Death|3|||
13361226|NCT00884117|26686073|FG000|Overall Study|Lost to Follow-up|143|||
13361227|NCT00884117|26686073|FG000|Overall Study|Other|12|||
13361228|NCT00884039|26686086|FG000|Overall Study|Withdrawal by Subject|0|||
13361229|NCT00884039|26686087|FG001|Overall Study|Withdrawal by Subject|1|||
13361230|NCT00884039|26686086|FG000|Overall Study|Lack of Efficacy|2|||
13361231|NCT00884039|26686087|FG001|Overall Study|Lack of Efficacy|0|||
13361232|NCT00883896|26686170|FG000|Overall Study|Lost to Follow-up|0|||
13361233|NCT00883896|26686171|FG001|Overall Study|Lost to Follow-up|0|||
13361234|NCT00883896|26686172|FG002|Overall Study|Lost to Follow-up|0|||
13361235|NCT00883896|26686173|FG003|Overall Study|Lost to Follow-up|2|||
13361236|NCT00883896|26686170|FG000|Overall Study|Withdrawal by Subject|5|||
13361237|NCT00883896|26686171|FG001|Overall Study|Withdrawal by Subject|0|||
13361238|NCT00883896|26686172|FG002|Overall Study|Withdrawal by Subject|1|||
13361239|NCT00883896|26686173|FG003|Overall Study|Withdrawal by Subject|3|||
13361240|NCT00883896|26686170|FG000|Overall Study|Lack of Efficacy|0|||
13361241|NCT00883896|26686171|FG001|Overall Study|Lack of Efficacy|0|||
13361242|NCT00883896|26686172|FG002|Overall Study|Lack of Efficacy|0|||
13361243|NCT00883896|26686173|FG003|Overall Study|Lack of Efficacy|2|||
13361244|NCT00883896|26686170|FG000|Overall Study|Other|1|||
13361245|NCT00883896|26686171|FG001|Overall Study|Other|0|||
13361246|NCT00883896|26686172|FG002|Overall Study|Other|0|||
13361247|NCT00883896|26686173|FG003|Overall Study|Other|0|||
13361248|NCT00883779|26686216|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
13361249|NCT00883779|26686217|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
13361250|NCT00883779|26686216|FG000|Primary Study Treatment Phase|Disease progression|75|||
13361251|NCT00883779|26686217|FG001|Primary Study Treatment Phase|Disease progression|59|||
13361252|NCT00883779|26686216|FG000|Primary Study Treatment Phase|Adverse Event|16|||
13361253|NCT00883779|26686217|FG001|Primary Study Treatment Phase|Adverse Event|16|||
13361254|NCT00883779|26686216|FG000|Primary Study Treatment Phase|Death|2|||
13361255|NCT00883779|26686217|FG001|Primary Study Treatment Phase|Death|3|||
13361256|NCT00883779|26686216|FG000|Primary Study Treatment Phase|Refused Treatment|5|||
13361257|NCT00883779|26686217|FG001|Primary Study Treatment Phase|Refused Treatment|4|||
13361258|NCT00883779|26686216|FG000|Primary Study Treatment Phase|Other|3|||
13361259|NCT00883779|26686217|FG001|Primary Study Treatment Phase|Other|0|||
13361260|NCT00883779|26686216|FG000|Post-Study Treatment Phase|Adverse Event|2|||
13361261|NCT00883779|26686217|FG001|Post-Study Treatment Phase|Adverse Event|3|||
13361262|NCT00883779|26686216|FG000|Post-Study Treatment Phase|Death|1|||
13361263|NCT00883779|26686217|FG001|Post-Study Treatment Phase|Death|3|||
13361264|NCT00883779|26686216|FG000|Post-Study Treatment Phase|Protocol Violation|0|||
13361265|NCT00883779|26686217|FG001|Post-Study Treatment Phase|Protocol Violation|1|||
13361266|NCT00883779|26686216|FG000|Post-Study Treatment Phase|Refused Treatment|3|||
13361267|NCT00883779|26686217|FG001|Post-Study Treatment Phase|Refused Treatment|0|||
13361268|NCT00883779|26686216|FG000|Post-Study Treatment Phase|Disease progression|103|||
13361269|NCT00883779|26686217|FG001|Post-Study Treatment Phase|Disease progression|122|||
13361270|NCT00883779|26686216|FG000|Post-Study Treatment Phase|Other|3|||
13361271|NCT00883779|26686217|FG001|Post-Study Treatment Phase|Other|0|||
13361272|NCT00883779|26686216|FG000|Post-Study Treatment Phase|Ongoing in the study|0|||
13361273|NCT00883779|26686217|FG001|Post-Study Treatment Phase|Ongoing in the study|6|||
13361274|NCT00883779|26686216|FG000|Off-study Phase|Death|185|||
13361275|NCT00883779|26686217|FG001|Off-study Phase|Death|174|||
13361276|NCT00883779|26686216|FG000|Off-study Phase|Refused treatment|1|||
13361277|NCT00883779|26686217|FG001|Off-study Phase|Refused treatment|1|||
13361278|NCT00883779|26686216|FG000|Off-study Phase|Failure to return|5|||
13361279|NCT00883779|26686217|FG001|Off-study Phase|Failure to return|6|||
13361280|NCT00883779|26686216|FG000|Off-study Phase|Other|18|||
13361281|NCT00883779|26686217|FG001|Off-study Phase|Other|21|||
13361282|NCT00883753|26686259|FG000|Overall Study|Adverse Event|37|||
13361283|NCT00883753|26686259|FG000|Overall Study|Death|2|||
13361284|NCT00883753|26686259|FG000|Overall Study|Insufficient therapeutic response|16|||
13361285|NCT00883753|26686259|FG000|Overall Study|Lost to Follow-up|4|||
13361286|NCT00883753|26686259|FG000|Overall Study|Violation of selection criteria at entry|7|||
13361287|NCT00883753|26686259|FG000|Overall Study|Protocol Violation|2|||
13361288|NCT00883753|26686259|FG000|Overall Study|Refused treatment|4|||
13361289|NCT00883753|26686259|FG000|Overall Study|Withdrew consent|10|||
13361290|NCT00883753|26686259|FG000|Overall Study|Investigator's decision|17|||
13361291|NCT00883753|26686259|FG000|Overall Study|Administrative/Other|8|||
13361292|NCT00883740|26686302|FG000|First Intervention|Lost to Follow-up|1|||
13361293|NCT00883740|26686303|FG001|First Intervention|Lost to Follow-up|0|||
13361294|NCT00883740|26686302|FG000|First Intervention|No longer willing to participate|2|||
13361295|NCT00883740|26686303|FG001|First Intervention|No longer willing to participate|0|||
13361296|NCT00883740|26686302|FG000|First Intervention|Protocol Violation|3|||
13361297|NCT00883740|26686303|FG001|First Intervention|Protocol Violation|6|||
13361298|NCT00883740|26686302|FG000|First Intervention|Adverse Event|1|||
13361299|NCT00883740|26686303|FG001|First Intervention|Adverse Event|2|||
13361300|NCT00883740|26686302|FG000|Second Intervention|Protocol Violation|1|||
13361301|NCT00883740|26686303|FG001|Second Intervention|Protocol Violation|0|||
13361302|NCT00883740|26686302|FG000|Second Intervention|No longer willing to participate|0|||
13361303|NCT00883740|26686303|FG001|Second Intervention|No longer willing to participate|1|||
13361304|NCT00883688|26686309|FG000|Overall Study|Ineligible|2|||
13361305|NCT00883558|26686323|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2|||
13361306|NCT00883558|26686324|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
13361307|NCT00883558|26686325|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
13361308|NCT00883558|26686323|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
13361309|NCT00883558|26686324|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1|||
13361310|NCT00883558|26686325|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
13361311|NCT00883558|26686323|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0|||
13361312|NCT00883558|26686324|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
13361313|NCT00883558|26686325|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
13361314|NCT00883558|26686323|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
13361315|NCT00883558|26686324|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1|||
13361316|NCT00883558|26686325|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
13361317|NCT00883558|26686323|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
13361318|NCT00883558|26686324|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
13361319|NCT00883558|26686325|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1|||
13361320|NCT00883493|26686356|FG000|Overall Study|Adverse Event|11|||
13361321|NCT00883493|26686357|FG001|Overall Study|Adverse Event|12|||
13361322|NCT00883493|26686356|FG000|Overall Study|Lack of Efficacy|4|||
13361323|NCT00883493|26686357|FG001|Overall Study|Lack of Efficacy|3|||
13361324|NCT00883493|26686356|FG000|Overall Study|Lost to Follow-up|7|||
13361325|NCT00883493|26686357|FG001|Overall Study|Lost to Follow-up|6|||
13361326|NCT00883493|26686356|FG000|Overall Study|Withdrawal by Subject|11|||
13361327|NCT00883493|26686357|FG001|Overall Study|Withdrawal by Subject|20|||
13361328|NCT00883493|26686356|FG000|Overall Study|Eligibility Criteria not fullfilled|6|||
13361329|NCT00883493|26686357|FG001|Overall Study|Eligibility Criteria not fullfilled|6|||
13361330|NCT00883493|26686356|FG000|Overall Study|Study specific disc. criteria|2|||
13361331|NCT00883493|26686357|FG001|Overall Study|Study specific disc. criteria|0|||
13361332|NCT00883493|26686356|FG000|Overall Study|Other|5|||
13361333|NCT00883493|26686357|FG001|Overall Study|Other|3|||
13361334|NCT00883337|26686399|FG000|Core Treatment Period|Adverse Event|9|||
13361335|NCT00883337|26686400|FG001|Core Treatment Period|Adverse Event|12|||
13361336|NCT00883337|26686401|FG002|Core Treatment Period|Adverse Event|22|||
13361337|NCT00883337|26686399|FG000|Core Treatment Period|Lack of Efficacy|7|||
13361338|NCT00883337|26686400|FG001|Core Treatment Period|Lack of Efficacy|4|||
13361339|NCT00883337|26686401|FG002|Core Treatment Period|Lack of Efficacy|2|||
13361340|NCT00883337|26686399|FG000|Core Treatment Period|Lost to Follow-up|1|||
13361341|NCT00883337|26686400|FG001|Core Treatment Period|Lost to Follow-up|1|||
13361342|NCT00883337|26686401|FG002|Core Treatment Period|Lost to Follow-up|0|||
13361343|NCT00883337|26686399|FG000|Core Treatment Period|Withdrawal by Subject|2|||
13361344|NCT00883337|26686400|FG001|Core Treatment Period|Withdrawal by Subject|2|||
13361345|NCT00883337|26686401|FG002|Core Treatment Period|Withdrawal by Subject|6|||
13361346|NCT00883337|26686399|FG000|Core Treatment Period|Wish to be pregnant|1|||
13361347|NCT00883337|26686400|FG001|Core Treatment Period|Wish to be pregnant|2|||
13361348|NCT00883337|26686401|FG002|Core Treatment Period|Wish to be pregnant|1|||
13361349|NCT00883337|26686399|FG000|Core Treatment Period|Poor compliance to protocol|0|||
13361350|NCT00883337|26686400|FG001|Core Treatment Period|Poor compliance to protocol|0|||
13361351|NCT00883337|26686401|FG002|Core Treatment Period|Poor compliance to protocol|1|||
13361352|NCT00883337|26686399|FG000|Core Treatment Period|Other than above|0|||
13361353|NCT00883337|26686400|FG001|Core Treatment Period|Other than above|1|||
13361354|NCT00883337|26686401|FG002|Core Treatment Period|Other than above|1|||
13361355|NCT00883337|26686399|FG000|Extension Treatment Period|Adverse Event|8|||
13361356|NCT00883337|26686400|FG001|Extension Treatment Period|Adverse Event|5|||
13361357|NCT00883337|26686401|FG002|Extension Treatment Period|Adverse Event|5|||
13361358|NCT00883337|26686399|FG000|Extension Treatment Period|Lack of Efficacy|8|||
13361359|NCT00883337|26686400|FG001|Extension Treatment Period|Lack of Efficacy|8|||
13361360|NCT00883337|26686401|FG002|Extension Treatment Period|Lack of Efficacy|8|||
13361361|NCT00883337|26686399|FG000|Extension Treatment Period|Poor compliance to protocol|1|||
13361362|NCT00883337|26686400|FG001|Extension Treatment Period|Poor compliance to protocol|1|||
13361363|NCT00883337|26686401|FG002|Extension Treatment Period|Poor compliance to protocol|1|||
13361364|NCT00883337|26686399|FG000|Extension Treatment Period|Lost to Follow-up|1|||
13361365|NCT00883337|26686400|FG001|Extension Treatment Period|Lost to Follow-up|0|||
13361366|NCT00883337|26686401|FG002|Extension Treatment Period|Lost to Follow-up|0|||
13361367|NCT00883337|26686399|FG000|Extension Treatment Period|Other than above|10|||
13361368|NCT00883337|26686400|FG001|Extension Treatment Period|Other than above|9|||
13361369|NCT00883337|26686401|FG002|Extension Treatment Period|Other than above|5|||
13361370|NCT00883181|26686612|FG000|Overall Study|Hematological Adverse Event|26|||
13361371|NCT00883181|26686612|FG000|Overall Study|Non-hematological Adverse Event|55|||
13361372|NCT00883181|26686612|FG000|Overall Study|Disease Progression|94|||
13361373|NCT00883181|26686612|FG000|Overall Study|Administrative Reason|24|||
13361374|NCT00883181|26686612|FG000|Overall Study|Withdrawal by Subject|4|||
13361375|NCT00883181|26686612|FG000|Overall Study|Death|31|||
13361376|NCT00883181|26686612|FG000|Overall Study|Other|38|||
13361377|NCT00883181|26686612|FG000|Overall Study|Protocol Deviation|3|||
13361378|NCT00883181|26686612|FG000|Overall Study|Noncompliance|3|||
13361379|NCT00883129|26686641|FG000|Overall Study|Adverse Event|7|||
13361380|NCT00883129|26686642|FG001|Overall Study|Adverse Event|15|||
13361381|NCT00883129|26686641|FG000|Overall Study|Withdrawal by Subject|8|||
13361382|NCT00883129|26686642|FG001|Overall Study|Withdrawal by Subject|9|||
13361383|NCT00883129|26686641|FG000|Overall Study|Non-compliance|3|||
13361384|NCT00883129|26686642|FG001|Overall Study|Non-compliance|6|||
13361385|NCT00883129|26686641|FG000|Overall Study|Lost to Follow-up|1|||
13361386|NCT00883129|26686642|FG001|Overall Study|Lost to Follow-up|2|||
13361387|NCT00883129|26686641|FG000|Overall Study|Death|1|||
13361388|NCT00883129|26686642|FG001|Overall Study|Death|2|||
13361389|NCT00883129|26686641|FG000|Overall Study|Defined Treatment Failure|0|||
13361390|NCT00883129|26686642|FG001|Overall Study|Defined Treatment Failure|2|||
13361391|NCT00883116|26686662|FG000|Overall Study|Adverse event unrelated to study drug|5|||
13361392|NCT00883116|26686663|FG001|Overall Study|Adverse event unrelated to study drug|10|||
13361393|NCT00883116|26686662|FG000|Overall Study|Death|6|||
13361394|NCT00883116|26686663|FG001|Overall Study|Death|2|||
13361395|NCT00883116|26686662|FG000|Overall Study|Disease progression|130|||
13361396|NCT00883116|26686663|FG001|Overall Study|Disease progression|128|||
13361397|NCT00883116|26686662|FG000|Overall Study|Lost to Follow-up|0|||
13361398|NCT00883116|26686663|FG001|Overall Study|Lost to Follow-up|1|||
13361399|NCT00883116|26686662|FG000|Overall Study|Maximum clinical benefit|13|||
13361400|NCT00883116|26686663|FG001|Overall Study|Maximum clinical benefit|46|||
13361401|NCT00883116|26686662|FG000|Overall Study|Not identified|3|||
13361402|NCT00883116|26686663|FG001|Overall Study|Not identified|6|||
13361403|NCT00883116|26686662|FG000|Overall Study|Study drug toxicity|36|||
13361404|NCT00883116|26686663|FG001|Overall Study|Study drug toxicity|16|||
13361405|NCT00883116|26686662|FG000|Overall Study|Withdrawal by Subject|14|||
13361406|NCT00883116|26686663|FG001|Overall Study|Withdrawal by Subject|8|||
13361407|NCT00883116|26686662|FG000|Overall Study|No longer meets study criteria|2|||
13361408|NCT00883116|26686663|FG001|Overall Study|No longer meets study criteria|2|||
13361409|NCT00883090|26686680|FG000|Overall Study|Sponsor's decision|1|||
13361410|NCT00883090|26686680|FG000|Overall Study|Withdrawal by Subject|1|||
13361411|NCT00883051|26686793|FG000|Overall Study|Lost to Follow-up|0|||
13361412|NCT00883051|26686794|FG001|Overall Study|Lost to Follow-up|0|||
13361413|NCT00883051|26686795|FG002|Overall Study|Lost to Follow-up|0|||
13361414|NCT00883051|26686796|FG003|Overall Study|Lost to Follow-up|0|||
13361415|NCT00883051|26686797|FG004|Overall Study|Lost to Follow-up|1|||
13361416|NCT00883051|26686793|FG000|Overall Study|Did not use study medication|24|||
13361417|NCT00883051|26686794|FG001|Overall Study|Did not use study medication|22|||
13361418|NCT00883051|26686795|FG002|Overall Study|Did not use study medication|29|||
13361419|NCT00883051|26686796|FG003|Overall Study|Did not use study medication|29|||
13361420|NCT00883051|26686797|FG004|Overall Study|Did not use study medication|17|||
13361421|NCT00882999|26686946|FG000|Overall Study|Adverse Event|0|||
13361422|NCT00882999|26686947|FG001|Overall Study|Adverse Event|0|||
13361423|NCT00882999|26686948|FG002|Overall Study|Adverse Event|0|||
13361424|NCT00882999|26686949|FG003|Overall Study|Adverse Event|0|||
13361425|NCT00882999|26686950|FG004|Overall Study|Adverse Event|1|||
13361426|NCT00882999|26686951|FG005|Overall Study|Adverse Event|0|||
13361427|NCT00882999|26686952|FG006|Overall Study|Adverse Event|0|||
13361428|NCT00882999|26686946|FG000|Overall Study|Death|0|||
13361429|NCT00882999|26686947|FG001|Overall Study|Death|1|||
13361430|NCT00882999|26686948|FG002|Overall Study|Death|0|||
13361431|NCT00882999|26686949|FG003|Overall Study|Death|0|||
13361432|NCT00882999|26686950|FG004|Overall Study|Death|0|||
13361433|NCT00882999|26686951|FG005|Overall Study|Death|0|||
13361434|NCT00882999|26686952|FG006|Overall Study|Death|0|||
13361435|NCT00882999|26686946|FG000|Overall Study|Withdrawal by Subject|7|||
13361436|NCT00882999|26686947|FG001|Overall Study|Withdrawal by Subject|6|||
13361437|NCT00882999|26686948|FG002|Overall Study|Withdrawal by Subject|3|||
13361438|NCT00882999|26686949|FG003|Overall Study|Withdrawal by Subject|3|||
13361439|NCT00882999|26686950|FG004|Overall Study|Withdrawal by Subject|6|||
13361440|NCT00882999|26686951|FG005|Overall Study|Withdrawal by Subject|5|||
13361441|NCT00882999|26686952|FG006|Overall Study|Withdrawal by Subject|5|||
13361442|NCT00882999|26686946|FG000|Overall Study|Lost to Follow-up|0|||
13361443|NCT00882999|26686947|FG001|Overall Study|Lost to Follow-up|1|||
13361444|NCT00882999|26686948|FG002|Overall Study|Lost to Follow-up|1|||
13361445|NCT00882999|26686949|FG003|Overall Study|Lost to Follow-up|2|||
13361446|NCT00882999|26686950|FG004|Overall Study|Lost to Follow-up|1|||
13361447|NCT00882999|26686951|FG005|Overall Study|Lost to Follow-up|1|||
13361448|NCT00882999|26686952|FG006|Overall Study|Lost to Follow-up|2|||
13361449|NCT00882999|26686946|FG000|Overall Study|Physician Decision|1|||
13361450|NCT00882999|26686947|FG001|Overall Study|Physician Decision|0|||
13361451|NCT00882999|26686948|FG002|Overall Study|Physician Decision|0|||
13361452|NCT00882999|26686949|FG003|Overall Study|Physician Decision|0|||
13361453|NCT00882999|26686950|FG004|Overall Study|Physician Decision|0|||
13361454|NCT00882999|26686951|FG005|Overall Study|Physician Decision|1|||
13361455|NCT00882999|26686952|FG006|Overall Study|Physician Decision|1|||
13361456|NCT00882921|26686959|FG000|Overall Study|Death|2|||
13361457|NCT00882921|26686959|FG000|Overall Study|Other|3|||
13361458|NCT00882921|26686959|FG000|Overall Study|Lost to Follow-up|2|||
13361459|NCT00882921|26686959|FG000|Overall Study|Termination By Investigator|3|||
13361460|NCT00882921|26686959|FG000|Overall Study|Withdrawal Of Consent|1|||
13361461|NCT00882908|26687050|FG000|Overall Study|Adverse Event|0|||
13361462|NCT00882908|26687051|FG001|Overall Study|Adverse Event|0|||
13361463|NCT00882908|26687052|FG002|Overall Study|Adverse Event|1|||
13361464|NCT00882908|26687053|FG003|Overall Study|Adverse Event|0|||
13361465|NCT00882908|26687054|FG004|Overall Study|Adverse Event|1|||
13361466|NCT00882908|26687050|FG000|Overall Study|Lost to Follow-up|3|||
13361467|NCT00882908|26687051|FG001|Overall Study|Lost to Follow-up|5|||
13361468|NCT00882908|26687052|FG002|Overall Study|Lost to Follow-up|3|||
13361469|NCT00882908|26687053|FG003|Overall Study|Lost to Follow-up|1|||
13361470|NCT00882908|26687054|FG004|Overall Study|Lost to Follow-up|2|||
13361471|NCT00882908|26687050|FG000|Overall Study|Protocol Violation|0|||
13361472|NCT00882908|26687051|FG001|Overall Study|Protocol Violation|1|||
13361473|NCT00882908|26687052|FG002|Overall Study|Protocol Violation|0|||
13361474|NCT00882908|26687053|FG003|Overall Study|Protocol Violation|0|||
13361475|NCT00882908|26687054|FG004|Overall Study|Protocol Violation|0|||
13361476|NCT00882908|26687050|FG000|Overall Study|Withdrawal by Subject|0|||
13361477|NCT00882908|26687051|FG001|Overall Study|Withdrawal by Subject|0|||
13361478|NCT00882908|26687052|FG002|Overall Study|Withdrawal by Subject|3|||
13361479|NCT00882908|26687053|FG003|Overall Study|Withdrawal by Subject|5|||
13361480|NCT00882908|26687054|FG004|Overall Study|Withdrawal by Subject|2|||
13361481|NCT00882908|26687050|FG000|Overall Study|Subject reached a virologic endpoint|0|||
13361482|NCT00882908|26687051|FG001|Overall Study|Subject reached a virologic endpoint|0|||
13361483|NCT00882908|26687052|FG002|Overall Study|Subject reached a virologic endpoint|0|||
13361484|NCT00882908|26687053|FG003|Overall Study|Subject reached a virologic endpoint|0|||
13361485|NCT00882908|26687054|FG004|Overall Study|Subject reached a virologic endpoint|1|||
13361486|NCT00882908|26687050|FG000|Overall Study|Study terminated in error|0|||
13361487|NCT00882908|26687051|FG001|Overall Study|Study terminated in error|0|||
13361488|NCT00882908|26687052|FG002|Overall Study|Study terminated in error|0|||
13361489|NCT00882908|26687053|FG003|Overall Study|Study terminated in error|1|||
13361490|NCT00882908|26687054|FG004|Overall Study|Study terminated in error|0|||
13361491|NCT00882713|26687078|FG000|Overall Study|Adverse Event|2|||
13361492|NCT00882713|26687078|FG000|Overall Study|Death|3|||
13361493|NCT00882713|26687078|FG000|Overall Study|Administrative reasons|4|||
13361494|NCT00882713|26687078|FG000|Overall Study|refused treatment/withdrew consent|4|||
13361495|NCT00882713|26687078|FG000|Overall Study|Blood transfusion|2|||
13361496|NCT00882713|26687078|FG000|Overall Study|Insufficient therapeutic response|3|||
13361497|NCT00882713|26687078|FG000|Overall Study|Failure to return|2|||
13361498|NCT00882713|26687078|FG000|Overall Study|Other - Reasons|2|||
13361499|NCT00882583|26687091|FG000|Overall Study|Physician Decision|1|||
13361500|NCT00882583|26687092|FG001|Overall Study|Physician Decision|0|||
13361501|NCT00882583|26687091|FG000|Overall Study|Adverse Event|0|||
13361502|NCT00882583|26687092|FG001|Overall Study|Adverse Event|1|||
13361503|NCT00882557|26687117|FG000|Overall Study|Withdrawal by Subject|1|||
13361504|NCT00882557|26687118|FG001|Overall Study|Withdrawal by Subject|0|||
13361505|NCT00882557|26687117|FG000|Overall Study|Trouble with Vein Access|1|||
13361506|NCT00882557|26687118|FG001|Overall Study|Trouble with Vein Access|0|||
13361507|NCT00882557|26687117|FG000|Overall Study|Randomized Not Treated|0|||
13361508|NCT00882557|26687118|FG001|Overall Study|Randomized Not Treated|1|||
13361509|NCT00882518|26687147|FG000|Overall Study|Adverse Event|9|||
13361510|NCT00882518|26687148|FG001|Overall Study|Adverse Event|18|||
13361511|NCT00882518|26687147|FG000|Overall Study|Withdrawal by Subject|9|||
13361512|NCT00882518|26687148|FG001|Overall Study|Withdrawal by Subject|13|||
13361513|NCT00882518|26687147|FG000|Overall Study|Lack of Efficacy|12|||
13361514|NCT00882518|26687148|FG001|Overall Study|Lack of Efficacy|9|||
13361515|NCT00882518|26687147|FG000|Overall Study|Severe non-compliance to protocol|3|||
13361516|NCT00882518|26687148|FG001|Overall Study|Severe non-compliance to protocol|1|||
13361517|NCT00882518|26687147|FG000|Overall Study|Incorrect enrolment|4|||
13361518|NCT00882518|26687148|FG001|Overall Study|Incorrect enrolment|2|||
13361519|NCT00882518|26687147|FG000|Overall Study|Central lab closure for National day|1|||
13361520|NCT00882518|26687148|FG001|Overall Study|Central lab closure for National day|0|||
13361521|NCT00882518|26687147|FG000|Overall Study|Allocating random number by mistake|0|||
13361522|NCT00882518|26687148|FG001|Overall Study|Allocating random number by mistake|1|||
13361523|NCT00882362|26687161|FG000|Overall Study|Adverse Event|13|||
13361524|NCT00882362|26687162|FG001|Overall Study|Adverse Event|10|||
13361525|NCT00882362|26687161|FG000|Overall Study|Withdrawal by Subject|13|||
13361526|NCT00882362|26687162|FG001|Overall Study|Withdrawal by Subject|10|||
13361527|NCT00882362|26687161|FG000|Overall Study|Lack of Efficacy|3|||
13361528|NCT00882362|26687162|FG001|Overall Study|Lack of Efficacy|0|||
13361529|NCT00882362|26687161|FG000|Overall Study|Protocol Violation|7|||
13361530|NCT00882362|26687162|FG001|Overall Study|Protocol Violation|2|||
13361531|NCT00882362|26687161|FG000|Overall Study|Pregnancy|1|||
13361532|NCT00882362|26687162|FG001|Overall Study|Pregnancy|0|||
13361533|NCT00882362|26687161|FG000|Overall Study|Physician Decision|5|||
13361534|NCT00882362|26687162|FG001|Overall Study|Physician Decision|1|||
13361535|NCT00882362|26687161|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2|||
13361536|NCT00882362|26687162|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
13361537|NCT00882362|26687161|FG000|Overall Study|change of residence or other commitments|5|||
13361538|NCT00882362|26687162|FG001|Overall Study|change of residence or other commitments|0|||
13361539|NCT00882310|26687170|FG000|Overall Study|Screen Failure|10|||
13361540|NCT00882310|26687170|FG000|Overall Study|Never received treatment|1|||
13361541|NCT00882310|26687170|FG000|Overall Study|Death|6|||
13361542|NCT00882310|26687170|FG000|Overall Study|Progression of disease|4|||
13361543|NCT00882310|26687170|FG000|Overall Study|Adverse Event|1|||
13361544|NCT00882115|26687176|FG000|Overall Study|Withdrawal by Subject|3|||
13361545|NCT00882115|26687176|FG000|Overall Study|did not respond to DEP challe|6|||
13361546|NCT00881959|26687189|FG000|Overall Study|Lost to Follow-up|2|||
13361547|NCT00881959|26687190|FG001|Overall Study|Lost to Follow-up|4|||
13361548|NCT00881894|26687227|FG000|Overall Study|Consent withdrawn|0|||
13361549|NCT00881894|26687228|FG001|Overall Study|Consent withdrawn|1|||
13361550|NCT00881894|26687227|FG000|Overall Study|Other reasons for premature termination|1|||
13361551|NCT00881894|26687228|FG001|Overall Study|Other reasons for premature termination|2|||
13361552|NCT00881868|26687247|FG000|Overall Study|Adverse Event|0|||
13361553|NCT00881868|26687248|FG001|Overall Study|Adverse Event|1|||
13361554|NCT00881868|26687247|FG000|Overall Study|Lost to Follow-up|2|||
13361555|NCT00881868|26687248|FG001|Overall Study|Lost to Follow-up|1|||
13361556|NCT00881868|26687247|FG000|Overall Study|Physician Decision|4|||
13361557|NCT00881868|26687248|FG001|Overall Study|Physician Decision|0|||
13361558|NCT00881868|26687247|FG000|Overall Study|Protocol Violation|2|||
13361559|NCT00881868|26687248|FG001|Overall Study|Protocol Violation|0|||
13375006|NCT00792298|26728960|FG001|Treatment Period 2|Physician Decision|0|||
13375007|NCT00792298|26728961|FG002|Treatment Period 2|Physician Decision|0|||
13375008|NCT00792298|26728962|FG003|Treatment Period 2|Physician Decision|0|||
13375009|NCT00792298|26728963|FG004|Treatment Period 2|Physician Decision|0|||
13375010|NCT00792298|26728964|FG005|Treatment Period 2|Physician Decision|0|||
13375011|NCT00792298|26728965|FG006|Treatment Period 2|Physician Decision|1|||
13375012|NCT00792298|26728966|FG007|Treatment Period 2|Physician Decision|0|||
13375013|NCT00792298|26728959|FG000|Treatment Period 2|Pregnancy|0|||
13375014|NCT00792298|26728960|FG001|Treatment Period 2|Pregnancy|0|||
13375015|NCT00792298|26728961|FG002|Treatment Period 2|Pregnancy|1|||
13375016|NCT00792298|26728962|FG003|Treatment Period 2|Pregnancy|0|||
13375017|NCT00792298|26728963|FG004|Treatment Period 2|Pregnancy|0|||
13375018|NCT00792298|26728964|FG005|Treatment Period 2|Pregnancy|0|||
13361560|NCT00881751|26687267|FG000|Overall Study|Physician Decision|0|||
13361561|NCT00881751|26687268|FG001|Overall Study|Physician Decision|1|||
13361562|NCT00881751|26687267|FG000|Overall Study|Adverse Event|0|||
13361563|NCT00881751|26687268|FG001|Overall Study|Adverse Event|2|||
13361564|NCT00881751|26687267|FG000|Overall Study|Withdrawal by Subject|0|||
13361565|NCT00881751|26687268|FG001|Overall Study|Withdrawal by Subject|2|||
13361566|NCT00881712|26687298|FG000|Overall Study|Death|1|||
13361567|NCT00881712|26687299|FG001|Overall Study|Death|0|||
13361568|NCT00881712|26687300|FG002|Overall Study|Death|0|||
13361569|NCT00881712|26687298|FG000|Overall Study|Withdrawal by Subject|1|||
13361570|NCT00881712|26687299|FG001|Overall Study|Withdrawal by Subject|0|||
13361571|NCT00881712|26687300|FG002|Overall Study|Withdrawal by Subject|0|||
13361572|NCT00881621|26687309|FG000|Overall Study|Physician Decision|34|||
13361573|NCT00881608|26687338|FG000|Overall Study|Study prematurely terminated|11|||
13361574|NCT00881569|26687355|FG000|Overall Study|Disease progression|1|||
13361575|NCT00881569|26687356|FG001|Overall Study|Disease progression|1|||
13361576|NCT00881530|26687431|FG000|Overall Study|Adverse Event|5|||
13361577|NCT00881530|26687432|FG001|Overall Study|Adverse Event|1|||
13361578|NCT00881530|26687433|FG002|Overall Study|Adverse Event|1|||
13361579|NCT00881530|26687434|FG003|Overall Study|Adverse Event|4|||
13361580|NCT00881530|26687435|FG004|Overall Study|Adverse Event|10|||
13361581|NCT00881530|26687436|FG005|Overall Study|Adverse Event|2|||
13361582|NCT00881530|26687431|FG000|Overall Study|Lack of Efficacy|1|||
13361583|NCT00881530|26687432|FG001|Overall Study|Lack of Efficacy|0|||
13361584|NCT00881530|26687433|FG002|Overall Study|Lack of Efficacy|0|||
13361585|NCT00881530|26687434|FG003|Overall Study|Lack of Efficacy|0|||
13361586|NCT00881530|26687435|FG004|Overall Study|Lack of Efficacy|1|||
13361587|NCT00881530|26687436|FG005|Overall Study|Lack of Efficacy|1|||
13361588|NCT00881530|26687431|FG000|Overall Study|Not compliant with the protocol|0|||
13361589|NCT00881530|26687432|FG001|Overall Study|Not compliant with the protocol|0|||
13361590|NCT00881530|26687433|FG002|Overall Study|Not compliant with the protocol|0|||
13361591|NCT00881530|26687434|FG003|Overall Study|Not compliant with the protocol|0|||
13361592|NCT00881530|26687435|FG004|Overall Study|Not compliant with the protocol|2|||
13361593|NCT00881530|26687436|FG005|Overall Study|Not compliant with the protocol|0|||
13361594|NCT00881530|26687431|FG000|Overall Study|Lost to Follow-up|0|||
13361595|NCT00881530|26687432|FG001|Overall Study|Lost to Follow-up|1|||
13361596|NCT00881530|26687433|FG002|Overall Study|Lost to Follow-up|1|||
13361597|NCT00881530|26687434|FG003|Overall Study|Lost to Follow-up|3|||
13361598|NCT00881530|26687435|FG004|Overall Study|Lost to Follow-up|1|||
13361599|NCT00881530|26687436|FG005|Overall Study|Lost to Follow-up|0|||
13361600|NCT00881530|26687431|FG000|Overall Study|Refused to continue medication|7|||
13361601|NCT00881530|26687432|FG001|Overall Study|Refused to continue medication|2|||
13361602|NCT00881530|26687433|FG002|Overall Study|Refused to continue medication|1|||
13361603|NCT00881530|26687434|FG003|Overall Study|Refused to continue medication|2|||
13361604|NCT00881530|26687435|FG004|Overall Study|Refused to continue medication|0|||
13361605|NCT00881530|26687436|FG005|Overall Study|Refused to continue medication|0|||
13361606|NCT00881530|26687431|FG000|Overall Study|Other reason not defined above|1|||
13361607|NCT00881530|26687432|FG001|Overall Study|Other reason not defined above|1|||
13361608|NCT00881530|26687433|FG002|Overall Study|Other reason not defined above|2|||
13361609|NCT00881530|26687434|FG003|Overall Study|Other reason not defined above|0|||
13361610|NCT00881530|26687435|FG004|Overall Study|Other reason not defined above|0|||
13361611|NCT00881530|26687436|FG005|Overall Study|Other reason not defined above|2|||
13361612|NCT00881504|26687443|FG000|Overall Study|Withdrawal by Subject|1|||
13361613|NCT00881361|26687464|FG000|Overall Study|Terminated prior to surgery|27|||
13361614|NCT00881361|26687465|FG001|Overall Study|Terminated prior to surgery|7|||
13361615|NCT00881361|26687466|FG002|Overall Study|Terminated prior to surgery|0|||
13361616|NCT00881361|26687464|FG000|Overall Study|Ineligible|17|||
13361617|NCT00881361|26687465|FG001|Overall Study|Ineligible|2|||
13361618|NCT00881361|26687466|FG002|Overall Study|Ineligible|2|||
13361619|NCT00881335|26687491|FG000|Overall Study|Lost to Follow-up|3|||
13361620|NCT00881335|26687492|FG001|Overall Study|Lost to Follow-up|2|||
13361621|NCT00881205|26687506|FG000|Overall Study|Adverse Event|8|||
13361622|NCT00881205|26687507|FG001|Overall Study|Adverse Event|3|||
13361623|NCT00881205|26687506|FG000|Overall Study|Withdrawal by Subject|1|||
13361624|NCT00881205|26687507|FG001|Overall Study|Withdrawal by Subject|2|||
13361625|NCT00881205|26687506|FG000|Overall Study|Lost to Follow-up|0|||
13361626|NCT00881205|26687507|FG001|Overall Study|Lost to Follow-up|1|||
13361627|NCT00881205|26687506|FG000|Overall Study|Administrative problems|1|||
13361628|NCT00881205|26687507|FG001|Overall Study|Administrative problems|1|||
13361629|NCT00881205|26687506|FG000|Overall Study|Condition no longer requires drug|1|||
13361630|NCT00881205|26687507|FG001|Overall Study|Condition no longer requires drug|0|||
13361631|NCT00880906|26687522|FG000|Overall Study|Lost to Follow-up|0|||
13361632|NCT00880906|26687523|FG001|Overall Study|Lost to Follow-up|1|||
13361633|NCT00880906|26687522|FG000|Overall Study|Did not meet criteria following patholog|12|||
13361634|NCT00880906|26687523|FG001|Overall Study|Did not meet criteria following patholog|6|||
13361635|NCT00880763|26687566|FG000|Extension Period (Part 2)|Adverse Event|0|||
13361636|NCT00880763|26687567|FG001|Extension Period (Part 2)|Adverse Event|0|||
13361637|NCT00880763|26687568|FG002|Extension Period (Part 2)|Adverse Event|1|||
13361638|NCT00880763|26687569|FG003|Extension Period (Part 2)|Adverse Event|1|||
13361639|NCT00880763|26687566|FG000|Extension Period (Part 2)|Withdrawal by Subject|0|||
13361640|NCT00880763|26687567|FG001|Extension Period (Part 2)|Withdrawal by Subject|2|||
13361641|NCT00880763|26687568|FG002|Extension Period (Part 2)|Withdrawal by Subject|1|||
13361642|NCT00880763|26687569|FG003|Extension Period (Part 2)|Withdrawal by Subject|1|||
13361643|NCT00880763|26687566|FG000|Extension Period (Part 2)|Physician Decision|0|||
13361644|NCT00880763|26687567|FG001|Extension Period (Part 2)|Physician Decision|1|||
13361645|NCT00880763|26687568|FG002|Extension Period (Part 2)|Physician Decision|1|||
13361646|NCT00880763|26687569|FG003|Extension Period (Part 2)|Physician Decision|0|||
13361647|NCT00880763|26687566|FG000|Extension Period (Part 2)|Lack of Efficacy|0|||
13361648|NCT00880763|26687567|FG001|Extension Period (Part 2)|Lack of Efficacy|0|||
13361649|NCT00880763|26687568|FG002|Extension Period (Part 2)|Lack of Efficacy|0|||
13361650|NCT00880763|26687569|FG003|Extension Period (Part 2)|Lack of Efficacy|1|||
13361651|NCT00880750|26687590|FG000|First Intervention|Adverse Event|1|||
13361652|NCT00880750|26687591|FG001|First Intervention|Adverse Event|0|||
13361653|NCT00880750|26687590|FG000|First Intervention|Unable to collect urine|4|||
13361654|NCT00880750|26687591|FG001|First Intervention|Unable to collect urine|0|||
13361655|NCT00880750|26687590|FG000|First Intervention|Non-compliance with meals|0|||
13361656|NCT00880750|26687591|FG001|First Intervention|Non-compliance with meals|1|||
13361657|NCT00880750|26687590|FG000|First Intervention|Withdrawal by Subject|2|||
13361658|NCT00880750|26687591|FG001|First Intervention|Withdrawal by Subject|0|||
13361659|NCT00880750|26687590|FG000|First Intervention|Lost to Follow-up|2|||
13361660|NCT00880750|26687591|FG001|First Intervention|Lost to Follow-up|0|||
13361661|NCT00880750|26687590|FG000|Second Intervention|Withdrawal by Subject|2|||
13361662|NCT00880750|26687591|FG001|Second Intervention|Withdrawal by Subject|2|||
13361663|NCT00880750|26687590|FG000|Second Intervention|Protocol Violation|1|||
13361664|NCT00880750|26687591|FG001|Second Intervention|Protocol Violation|0|||
13361665|NCT00880750|26687590|FG000|Second Intervention|Unable to collect urine|1|||
13361666|NCT00880750|26687591|FG001|Second Intervention|Unable to collect urine|0|||
13361667|NCT00880698|26687630|FG000|Overall Study|Death|0|||
13361668|NCT00880698|26687631|FG001|Overall Study|Death|0|||
13361669|NCT00880698|26687632|FG002|Overall Study|Death|1|||
13361670|NCT00880698|26687633|FG003|Overall Study|Death|2|||
13361671|NCT00880698|26687630|FG000|Overall Study|Lost to Follow-up|1|||
13361672|NCT00880698|26687631|FG001|Overall Study|Lost to Follow-up|3|||
13361673|NCT00880698|26687632|FG002|Overall Study|Lost to Follow-up|0|||
13361674|NCT00880698|26687633|FG003|Overall Study|Lost to Follow-up|1|||
13361675|NCT00880685|26687643|FG000|Memantine 10mg|Lost to Follow-up|2|||
13361676|NCT00880685|26687643|FG000|Memantine 20mg|Withdrawal by Subject|1|||
13361677|NCT00880620|26687670|FG000|Overall Study|Adverse Event|4|||
13361678|NCT00880620|26687671|FG001|Overall Study|Adverse Event|5|||
13361679|NCT00880620|26687672|FG002|Overall Study|Adverse Event|15|||
13361680|NCT00880620|26687673|FG003|Overall Study|Adverse Event|15|||
13361681|NCT00880620|26687670|FG000|Overall Study|Death|0|||
13361682|NCT00880620|26687671|FG001|Overall Study|Death|0|||
13361683|NCT00880620|26687672|FG002|Overall Study|Death|1|||
13361684|NCT00880620|26687673|FG003|Overall Study|Death|0|||
13361685|NCT00880620|26687670|FG000|Overall Study|Lack of Efficacy|12|||
13361686|NCT00880620|26687671|FG001|Overall Study|Lack of Efficacy|4|||
13361687|NCT00880620|26687672|FG002|Overall Study|Lack of Efficacy|0|||
13361688|NCT00880620|26687673|FG003|Overall Study|Lack of Efficacy|1|||
13361689|NCT00880620|26687670|FG000|Overall Study|Lost to Follow-up|0|||
13361690|NCT00880620|26687671|FG001|Overall Study|Lost to Follow-up|1|||
13361691|NCT00880620|26687672|FG002|Overall Study|Lost to Follow-up|1|||
13361692|NCT00880620|26687673|FG003|Overall Study|Lost to Follow-up|0|||
13361693|NCT00880620|26687670|FG000|Overall Study|Protocol Violation|0|||
13361694|NCT00880620|26687671|FG001|Overall Study|Protocol Violation|1|||
13361695|NCT00880620|26687672|FG002|Overall Study|Protocol Violation|0|||
13361696|NCT00880620|26687673|FG003|Overall Study|Protocol Violation|2|||
13361697|NCT00880620|26687670|FG000|Overall Study|Withdrawal by Subject|4|||
13361698|NCT00880620|26687671|FG001|Overall Study|Withdrawal by Subject|3|||
13361699|NCT00880620|26687672|FG002|Overall Study|Withdrawal by Subject|1|||
13361700|NCT00880620|26687673|FG003|Overall Study|Withdrawal by Subject|3|||
13361701|NCT00880620|26687670|FG000|Overall Study|Noncompliance|0|||
13361702|NCT00880620|26687671|FG001|Overall Study|Noncompliance|0|||
13361703|NCT00880620|26687672|FG002|Overall Study|Noncompliance|1|||
13361704|NCT00880620|26687673|FG003|Overall Study|Noncompliance|1|||
13361705|NCT00880620|26687670|FG000|Overall Study|Other|1|||
13361706|NCT00880620|26687671|FG001|Overall Study|Other|1|||
13361707|NCT00880620|26687672|FG002|Overall Study|Other|2|||
13361708|NCT00880620|26687673|FG003|Overall Study|Other|2|||
13361709|NCT00880607|26687698|FG000|Overall Study|Physician Decision|2|||
13361710|NCT00880607|26687699|FG001|Overall Study|Physician Decision|2|||
13361711|NCT00880607|26687698|FG000|Overall Study|Protocol Violation|2|||
13361712|NCT00880607|26687699|FG001|Overall Study|Protocol Violation|1|||
13361713|NCT00880607|26687698|FG000|Overall Study|surgery did not extend past L1 level|3|||
13361714|NCT00880607|26687699|FG001|Overall Study|surgery did not extend past L1 level|0|||
13361715|NCT00880568|26687770|FG000|Overall Study|Disease progression|3|||
13361716|NCT00880568|26687771|FG001|Overall Study|Disease progression|3|||
13361717|NCT00880568|26687772|FG002|Overall Study|Disease progression|3|||
13361718|NCT00880568|26687773|FG003|Overall Study|Disease progression|1|||
13361719|NCT00880568|26687774|FG004|Overall Study|Disease progression|3|||
13361720|NCT00880568|26687775|FG005|Overall Study|Disease progression|3|||
13361721|NCT00880568|26687776|FG006|Overall Study|Disease progression|5|||
13361722|NCT00880568|26687777|FG007|Overall Study|Disease progression|0|||
13361723|NCT00880568|26687778|FG008|Overall Study|Disease progression|3|||
13361724|NCT00880568|26687770|FG000|Overall Study|Adverse Event|0|||
13361725|NCT00880568|26687771|FG001|Overall Study|Adverse Event|0|||
13361726|NCT00880568|26687772|FG002|Overall Study|Adverse Event|0|||
13361727|NCT00880568|26687773|FG003|Overall Study|Adverse Event|0|||
13361728|NCT00880568|26687774|FG004|Overall Study|Adverse Event|0|||
13361729|NCT00880568|26687775|FG005|Overall Study|Adverse Event|0|||
13361730|NCT00880568|26687776|FG006|Overall Study|Adverse Event|1|||
13361731|NCT00880568|26687777|FG007|Overall Study|Adverse Event|1|||
13361732|NCT00880568|26687778|FG008|Overall Study|Adverse Event|0|||
13361733|NCT00880568|26687770|FG000|Overall Study|Withdrawal by Subject|0|||
13361734|NCT00880568|26687771|FG001|Overall Study|Withdrawal by Subject|0|||
13361735|NCT00880568|26687772|FG002|Overall Study|Withdrawal by Subject|0|||
13361736|NCT00880568|26687773|FG003|Overall Study|Withdrawal by Subject|0|||
13361737|NCT00880568|26687774|FG004|Overall Study|Withdrawal by Subject|0|||
13361738|NCT00880568|26687775|FG005|Overall Study|Withdrawal by Subject|0|||
13361739|NCT00880568|26687776|FG006|Overall Study|Withdrawal by Subject|0|||
13361740|NCT00880568|26687777|FG007|Overall Study|Withdrawal by Subject|1|||
13361741|NCT00880568|26687778|FG008|Overall Study|Withdrawal by Subject|0|||
13361742|NCT00880555|26687802|FG000|Overall Study|Physician Decision|0|||
13361743|NCT00880555|26687803|FG001|Overall Study|Physician Decision|8|||
13361744|NCT00880555|26687804|FG002|Overall Study|Physician Decision|0|||
13361745|NCT00880555|26687805|FG003|Overall Study|Physician Decision|2|||
13361746|NCT00880555|26687806|FG004|Overall Study|Physician Decision|1|||
13361747|NCT00880555|26687807|FG005|Overall Study|Physician Decision|0|||
13361748|NCT00880555|26687802|FG000|Overall Study|Withdrawal by Subject|1|||
13361749|NCT00880555|26687803|FG001|Overall Study|Withdrawal by Subject|1|||
13361750|NCT00880555|26687804|FG002|Overall Study|Withdrawal by Subject|0|||
13361751|NCT00880555|26687805|FG003|Overall Study|Withdrawal by Subject|0|||
13361752|NCT00880555|26687806|FG004|Overall Study|Withdrawal by Subject|0|||
13361753|NCT00880555|26687807|FG005|Overall Study|Withdrawal by Subject|0|||
13361754|NCT00880555|26687802|FG000|Overall Study|Lack of resources (hired rater)|9|||
13361755|NCT00880555|26687803|FG001|Overall Study|Lack of resources (hired rater)|7|||
13361756|NCT00880555|26687804|FG002|Overall Study|Lack of resources (hired rater)|5|||
13361757|NCT00880555|26687805|FG003|Overall Study|Lack of resources (hired rater)|0|||
13361758|NCT00880555|26687806|FG004|Overall Study|Lack of resources (hired rater)|0|||
13361759|NCT00880555|26687807|FG005|Overall Study|Lack of resources (hired rater)|0|||
13361760|NCT00880555|26687802|FG000|Overall Study|Death|0|||
13361761|NCT00880555|26687803|FG001|Overall Study|Death|0|||
13361762|NCT00880555|26687804|FG002|Overall Study|Death|0|||
13361763|NCT00880555|26687805|FG003|Overall Study|Death|0|||
13361764|NCT00880555|26687806|FG004|Overall Study|Death|0|||
13361765|NCT00880555|26687807|FG005|Overall Study|Death|1|||
13361766|NCT00880555|26687802|FG000|Overall Study|Lost to Follow-up|0|||
13361767|NCT00880555|26687803|FG001|Overall Study|Lost to Follow-up|1|||
13361768|NCT00880555|26687804|FG002|Overall Study|Lost to Follow-up|0|||
13361769|NCT00880555|26687805|FG003|Overall Study|Lost to Follow-up|0|||
13361770|NCT00880555|26687806|FG004|Overall Study|Lost to Follow-up|0|||
13361771|NCT00880555|26687807|FG005|Overall Study|Lost to Follow-up|0|||
13361772|NCT00880542|26687814|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1|||
13361773|NCT00880542|26687814|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2|||
13361774|NCT00880542|26687814|FG000|REP: Surgical Resection|progressive disease|1|||
13361775|NCT00880399|26687880|FG000|Overall Study|Adverse Event|4|||
13361776|NCT00880399|26687881|FG001|Overall Study|Adverse Event|6|||
13361777|NCT00880399|26687882|FG002|Overall Study|Adverse Event|5|||
13361778|NCT00880399|26687880|FG000|Overall Study|Lack of Efficacy|1|||
13361779|NCT00880399|26687881|FG001|Overall Study|Lack of Efficacy|4|||
13361780|NCT00880399|26687882|FG002|Overall Study|Lack of Efficacy|2|||
13361781|NCT00880399|26687880|FG000|Overall Study|Protocol Violation|4|||
13361782|NCT00880399|26687881|FG001|Overall Study|Protocol Violation|4|||
13361783|NCT00880399|26687882|FG002|Overall Study|Protocol Violation|6|||
13361784|NCT00880399|26687880|FG000|Overall Study|Study closed/terminated|3|||
13361785|NCT00880399|26687881|FG001|Overall Study|Study closed/terminated|7|||
13361786|NCT00880399|26687882|FG002|Overall Study|Study closed/terminated|4|||
13361787|NCT00880399|26687880|FG000|Overall Study|Lost to Follow-up|8|||
13361788|NCT00880399|26687881|FG001|Overall Study|Lost to Follow-up|5|||
13361789|NCT00880399|26687882|FG002|Overall Study|Lost to Follow-up|3|||
13361790|NCT00880399|26687880|FG000|Overall Study|Physician Decision|5|||
13361791|NCT00880399|26687881|FG001|Overall Study|Physician Decision|0|||
13361792|NCT00880399|26687882|FG002|Overall Study|Physician Decision|3|||
13375019|NCT00792298|26728965|FG006|Treatment Period 2|Pregnancy|0|||
13361793|NCT00880399|26687880|FG000|Overall Study|Withdrawal by Subject|6|||
13361794|NCT00880399|26687881|FG001|Overall Study|Withdrawal by Subject|3|||
13361795|NCT00880399|26687882|FG002|Overall Study|Withdrawal by Subject|3|||
13361796|NCT00880334|26687904|FG000|Randomized Phase|Physician Decision|1|||
13361797|NCT00880334|26687905|FG001|Randomized Phase|Physician Decision|0|||
13361798|NCT00880334|26687904|FG000|Randomized Phase|Withdrawal by Subject|2|||
13361799|NCT00880334|26687905|FG001|Randomized Phase|Withdrawal by Subject|1|||
13361800|NCT00880334|26687904|FG000|Randomized Phase|Inadequate Labs|1|||
13361801|NCT00880334|26687905|FG001|Randomized Phase|Inadequate Labs|1|||
13361802|NCT00880334|26687904|FG000|Randomized Phase|Brain Metastasis|0|||
13361803|NCT00880334|26687905|FG001|Randomized Phase|Brain Metastasis|1|||
13361804|NCT00880334|26687904|FG000|Randomized Phase|Crossover Participants|0|||
13361805|NCT00880334|26687905|FG001|Randomized Phase|Crossover Participants|37|||
13361806|NCT00880269|26687928|FG000|Overall Study|Protocol Violation|1|||
13361807|NCT00880269|26687929|FG001|Overall Study|Protocol Violation|0|||
13361808|NCT00880269|26687928|FG000|Overall Study|Disease Progression|13|||
13361809|NCT00880269|26687929|FG001|Overall Study|Disease Progression|11|||
13361810|NCT00880269|26687928|FG000|Overall Study|New Cancer Therapy|1|||
13361811|NCT00880269|26687929|FG001|Overall Study|New Cancer Therapy|0|||
13361812|NCT00880269|26687928|FG000|Overall Study|Death|4|||
13361813|NCT00880269|26687929|FG001|Overall Study|Death|2|||
13361814|NCT00880269|26687928|FG000|Overall Study|Lost to Follow-up|0|||
13361815|NCT00880269|26687929|FG001|Overall Study|Lost to Follow-up|1|||
13361816|NCT00880269|26687928|FG000|Overall Study|Withdrawal by Subject|3|||
13361817|NCT00880269|26687929|FG001|Overall Study|Withdrawal by Subject|4|||
13361818|NCT00880269|26687928|FG000|Overall Study|Adverse Event|10|||
13361819|NCT00880269|26687929|FG001|Overall Study|Adverse Event|9|||
13361820|NCT00880256|26687936|FG000|Overall Study|Lost to Follow-up|28|||
13361821|NCT00880191|26687961|FG000|Overall Study|Refused further treatment|4|||
13361822|NCT00880191|26687962|FG001|Overall Study|Refused further treatment|1|||
13361823|NCT00880191|26687961|FG000|Overall Study|Adverse Event|8|||
13361824|NCT00880191|26687962|FG001|Overall Study|Adverse Event|6|||
13361825|NCT00880191|26687961|FG000|Overall Study|Hospitalization/efficacy|1|||
13361826|NCT00880191|26687962|FG001|Overall Study|Hospitalization/efficacy|1|||
13361827|NCT00880165|26687979|FG000|Overall Study|Withdrawal by Subject|27|||
13361828|NCT00880165|26687980|FG001|Overall Study|Withdrawal by Subject|23|||
13361829|NCT00880165|26687979|FG000|Overall Study|Not diagnosed with OSA|14|||
13361830|NCT00880165|26687980|FG001|Overall Study|Not diagnosed with OSA|8|||
13361831|NCT00880165|26687979|FG000|Overall Study|Required BIPAP or oxygen treatment|12|||
13361832|NCT00880165|26687980|FG001|Overall Study|Required BIPAP or oxygen treatment|4|||
13361833|NCT00880165|26687979|FG000|Overall Study|Lost to follow|9|||
13361834|NCT00880165|26687980|FG001|Overall Study|Lost to follow|15|||
13361835|NCT00880100|26687993|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1|||
13361836|NCT00880100|26687993|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1|||
13361837|NCT00880100|26687993|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2|||
13361838|NCT00880087|26688012|FG000|Overall Study|Lost to Follow-up|0|||
13361839|NCT00880087|26688013|FG001|Overall Study|Lost to Follow-up|2|||
13361840|NCT00880048|26688079|FG000|Overall Study|Adverse Event|2|||
13361841|NCT00880048|26688080|FG001|Overall Study|Adverse Event|3|||
13361842|NCT00880048|26688081|FG002|Overall Study|Adverse Event|5|||
13361843|NCT00880048|26688079|FG000|Overall Study|Lack of Efficacy|1|||
13361844|NCT00880048|26688080|FG001|Overall Study|Lack of Efficacy|2|||
13361845|NCT00880048|26688081|FG002|Overall Study|Lack of Efficacy|2|||
13361846|NCT00880048|26688079|FG000|Overall Study|Protocol Violation|4|||
13361847|NCT00880048|26688080|FG001|Overall Study|Protocol Violation|6|||
13361848|NCT00880048|26688081|FG002|Overall Study|Protocol Violation|5|||
13361849|NCT00880048|26688079|FG000|Overall Study|Lost to Follow-up|6|||
13361850|NCT00880048|26688080|FG001|Overall Study|Lost to Follow-up|6|||
13361851|NCT00880048|26688081|FG002|Overall Study|Lost to Follow-up|5|||
13361852|NCT00880048|26688079|FG000|Overall Study|Physician Decision|1|||
13361853|NCT00880048|26688080|FG001|Overall Study|Physician Decision|1|||
13361854|NCT00880048|26688081|FG002|Overall Study|Physician Decision|7|||
13361855|NCT00880048|26688079|FG000|Overall Study|Withdrawal by Subject|5|||
13361856|NCT00880048|26688080|FG001|Overall Study|Withdrawal by Subject|8|||
13361857|NCT00880048|26688081|FG002|Overall Study|Withdrawal by Subject|5|||
13361858|NCT00880048|26688079|FG000|Overall Study|Study closed/terminated|9|||
13361859|NCT00880048|26688080|FG001|Overall Study|Study closed/terminated|7|||
13361860|NCT00880048|26688081|FG002|Overall Study|Study closed/terminated|6|||
13361861|NCT00880009|26688105|FG000|Overall Study|Study terminated by sponsor|14|||
13361862|NCT00880009|26688105|FG000|Overall Study|Withdrawal by Subject|1|||
13361863|NCT00880009|26688105|FG000|Overall Study|Protocol Violation|1|||
13361864|NCT00879996|26688124|FG000|Overall Study|Lost to Follow-up|7|||
13361865|NCT00879996|26688125|FG001|Overall Study|Lost to Follow-up|6|||
13361866|NCT00879996|26688124|FG000|Overall Study|non-compliance|6|||
13361867|NCT00879996|26688125|FG001|Overall Study|non-compliance|4|||
13361868|NCT00879996|26688124|FG000|Overall Study|Physician Decision|1|||
13361869|NCT00879996|26688125|FG001|Overall Study|Physician Decision|2|||
13361870|NCT00879996|26688124|FG000|Overall Study|psychiatric problem|0|||
13361871|NCT00879996|26688125|FG001|Overall Study|psychiatric problem|1|||
13361872|NCT00879996|26688124|FG000|Overall Study|put on parole|1|||
13361873|NCT00879996|26688125|FG001|Overall Study|put on parole|0|||
13361874|NCT00879970|26688219|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
13361875|NCT00879970|26688220|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
13361876|NCT00879970|26688221|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4|||
13361877|NCT00879970|26688222|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
13361878|NCT00879970|26688223|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
13361879|NCT00879970|26688219|FG000|Period 1 TZD Randomization|Lost to Follow-up|1|||
13361880|NCT00879970|26688220|FG001|Period 1 TZD Randomization|Lost to Follow-up|0|||
13361881|NCT00879970|26688221|FG002|Period 1 TZD Randomization|Lost to Follow-up|1|||
13361882|NCT00879970|26688222|FG003|Period 1 TZD Randomization|Lost to Follow-up|0|||
13361883|NCT00879970|26688223|FG004|Period 1 TZD Randomization|Lost to Follow-up|0|||
13361884|NCT00879970|26688219|FG000|Period 1 TZD Randomization|Death|2|||
13361885|NCT00879970|26688220|FG001|Period 1 TZD Randomization|Death|1|||
13361886|NCT00879970|26688221|FG002|Period 1 TZD Randomization|Death|0|||
13361887|NCT00879970|26688222|FG003|Period 1 TZD Randomization|Death|0|||
13361888|NCT00879970|26688223|FG004|Period 1 TZD Randomization|Death|0|||
13361889|NCT00879970|26688219|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2|||
13361890|NCT00879970|26688220|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
13361891|NCT00879970|26688221|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1|||
13361892|NCT00879970|26688222|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
13361893|NCT00879970|26688223|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
13361894|NCT00879970|26688219|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
13361895|NCT00879970|26688220|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
13361896|NCT00879970|26688221|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
13361897|NCT00879970|26688222|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2|||
13361898|NCT00879970|26688223|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6|||
13361899|NCT00879970|26688219|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
13361900|NCT00879970|26688220|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
13361901|NCT00879970|26688221|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
13361902|NCT00879970|26688222|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
13361903|NCT00879970|26688223|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1|||
13361904|NCT00879970|26688219|FG000|Period 2 Vitamin D Randomization|Death|0|||
13361905|NCT00879970|26688220|FG001|Period 2 Vitamin D Randomization|Death|0|||
13361906|NCT00879970|26688221|FG002|Period 2 Vitamin D Randomization|Death|0|||
13361907|NCT00879970|26688222|FG003|Period 2 Vitamin D Randomization|Death|2|||
13361908|NCT00879970|26688223|FG004|Period 2 Vitamin D Randomization|Death|0|||
13361909|NCT00879879|26688233|FG000|Overall Study|Death|1|||
13361910|NCT00879879|26688233|FG000|Overall Study|Withdrawal by Subject|1|||
13361911|NCT00879879|26688233|FG000|Overall Study|Physician Decision|1|||
13361912|NCT00879814|26688352|FG000|Overall Study|Adverse Event|0|||
13361913|NCT00879814|26688353|FG001|Overall Study|Adverse Event|1|||
13361914|NCT00879814|26688354|FG002|Overall Study|Adverse Event|0|||
13361915|NCT00879814|26688355|FG003|Overall Study|Adverse Event|0|||
13361916|NCT00879814|26688352|FG000|Overall Study|Lost to Follow-up|1|||
13361917|NCT00879814|26688353|FG001|Overall Study|Lost to Follow-up|0|||
13361918|NCT00879814|26688354|FG002|Overall Study|Lost to Follow-up|0|||
13361919|NCT00879814|26688355|FG003|Overall Study|Lost to Follow-up|2|||
13361920|NCT00879814|26688352|FG000|Overall Study|Participant Failed to Return|0|||
13361921|NCT00879814|26688353|FG001|Overall Study|Participant Failed to Return|0|||
13361922|NCT00879814|26688354|FG002|Overall Study|Participant Failed to Return|0|||
13361923|NCT00879814|26688355|FG003|Overall Study|Participant Failed to Return|1|||
13361924|NCT00879814|26688352|FG000|Overall Study|Withdrawal by Subject|3|||
13361925|NCT00879814|26688353|FG001|Overall Study|Withdrawal by Subject|1|||
13361926|NCT00879814|26688354|FG002|Overall Study|Withdrawal by Subject|1|||
13361927|NCT00879814|26688355|FG003|Overall Study|Withdrawal by Subject|2|||
13361928|NCT00879814|26688352|FG000|Overall Study|Physician Decision|0|||
13361929|NCT00879814|26688353|FG001|Overall Study|Physician Decision|0|||
13361930|NCT00879814|26688354|FG002|Overall Study|Physician Decision|1|||
13361931|NCT00879814|26688355|FG003|Overall Study|Physician Decision|0|||
13361932|NCT00879814|26688352|FG000|Overall Study|Other|0|||
13361933|NCT00879814|26688353|FG001|Overall Study|Other|0|||
13361934|NCT00879814|26688354|FG002|Overall Study|Other|1|||
13361935|NCT00879814|26688355|FG003|Overall Study|Other|0|||
13361936|NCT00879775|26688376|FG000|Overall Study|Lost to Follow-up|2|||
13361937|NCT00879775|26688377|FG001|Overall Study|Lost to Follow-up|1|||
13361938|NCT00879710|26688394|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2|||
13361939|NCT00879710|26688395|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3|||
13361940|NCT00879710|26688396|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1|||
13361941|NCT00879710|26688397|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4|||
13361942|NCT00879710|26688394|FG000|Phase 1 - 6 Weeks|Adverse Event|0|||
13361943|NCT00879710|26688395|FG001|Phase 1 - 6 Weeks|Adverse Event|0|||
13361944|NCT00879710|26688396|FG002|Phase 1 - 6 Weeks|Adverse Event|1|||
13361945|NCT00879710|26688397|FG003|Phase 1 - 6 Weeks|Adverse Event|0|||
13361946|NCT00879697|26688410|FG000|Overall Study|Physician Decision|2|||
13361947|NCT00879697|26688411|FG001|Overall Study|Physician Decision|2|||
13361948|NCT00879684|26688481|FG000|Stage 1: Dose Escalation|Adverse Event|1|||
13361949|NCT00879684|26688482|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
13361950|NCT00879684|26688483|FG002|Stage 1: Dose Escalation|Adverse Event|0|||
13361951|NCT00879684|26688484|FG003|Stage 1: Dose Escalation|Adverse Event|0|||
13361952|NCT00879684|26688485|FG004|Stage 1: Dose Escalation|Adverse Event|0|||
13361953|NCT00879684|26688486|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
13361954|NCT00879684|26688487|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
13361955|NCT00879684|26688481|FG000|Stage 1: Dose Escalation|Progressive Disease|2|||
13361956|NCT00879684|26688482|FG001|Stage 1: Dose Escalation|Progressive Disease|3|||
13361957|NCT00879684|26688483|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
13361958|NCT00879684|26688484|FG003|Stage 1: Dose Escalation|Progressive Disease|4|||
13361959|NCT00879684|26688485|FG004|Stage 1: Dose Escalation|Progressive Disease|3|||
13361960|NCT00879684|26688486|FG005|Stage 1: Dose Escalation|Progressive Disease|3|||
13361961|NCT00879684|26688487|FG006|Stage 1: Dose Escalation|Progressive Disease|0|||
13361962|NCT00879684|26688481|FG000|Stage 1: Dose Escalation|Investigator declined participation|0|||
13361963|NCT00879684|26688482|FG001|Stage 1: Dose Escalation|Investigator declined participation|0|||
13361964|NCT00879684|26688483|FG002|Stage 1: Dose Escalation|Investigator declined participation|2|||
13361965|NCT00879684|26688484|FG003|Stage 1: Dose Escalation|Investigator declined participation|2|||
13361966|NCT00879684|26688485|FG004|Stage 1: Dose Escalation|Investigator declined participation|0|||
13361967|NCT00879684|26688486|FG005|Stage 1: Dose Escalation|Investigator declined participation|0|||
13361968|NCT00879684|26688487|FG006|Stage 1: Dose Escalation|Investigator declined participation|0|||
13361969|NCT00879684|26688481|FG000|Stage 1: Dose Escalation|Death|0|||
13361970|NCT00879684|26688482|FG001|Stage 1: Dose Escalation|Death|0|||
13361971|NCT00879684|26688483|FG002|Stage 1: Dose Escalation|Death|1|||
13361972|NCT00879684|26688484|FG003|Stage 1: Dose Escalation|Death|0|||
13361973|NCT00879684|26688485|FG004|Stage 1: Dose Escalation|Death|0|||
13361974|NCT00879684|26688486|FG005|Stage 1: Dose Escalation|Death|0|||
13361975|NCT00879684|26688487|FG006|Stage 1: Dose Escalation|Death|0|||
13361976|NCT00879684|26688481|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
13361977|NCT00879684|26688482|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
13361978|NCT00879684|26688483|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
13361979|NCT00879684|26688484|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
13361980|NCT00879684|26688485|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
13361981|NCT00879684|26688486|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
13361982|NCT00879684|26688487|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1|||
13361983|NCT00879684|26688481|FG000|Stage 2: Expanded Cohort|Progressive Disease|0|||
13361984|NCT00879684|26688482|FG001|Stage 2: Expanded Cohort|Progressive Disease|0|||
13361985|NCT00879684|26688483|FG002|Stage 2: Expanded Cohort|Progressive Disease|0|||
13361986|NCT00879684|26688484|FG003|Stage 2: Expanded Cohort|Progressive Disease|0|||
13361987|NCT00879684|26688485|FG004|Stage 2: Expanded Cohort|Progressive Disease|0|||
13361988|NCT00879684|26688486|FG005|Stage 2: Expanded Cohort|Progressive Disease|0|||
13361989|NCT00879684|26688487|FG006|Stage 2: Expanded Cohort|Progressive Disease|11|||
13361990|NCT00879684|26688481|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0|||
13361991|NCT00879684|26688482|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0|||
13361992|NCT00879684|26688483|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0|||
13361993|NCT00879684|26688484|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0|||
13361994|NCT00879684|26688485|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0|||
13361995|NCT00879684|26688486|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0|||
13361996|NCT00879684|26688487|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1|||
13361997|NCT00879658|26688591|FG000|Overall Study|Abnormal laboratory value(s)|3|||
13361998|NCT00879658|26688592|FG001|Overall Study|Abnormal laboratory value(s)|0|||
13361999|NCT00879658|26688593|FG002|Overall Study|Abnormal laboratory value(s)|0|||
13362000|NCT00879658|26688594|FG003|Overall Study|Abnormal laboratory value(s)|1|||
13362001|NCT00879658|26688595|FG004|Overall Study|Abnormal laboratory value(s)|0|||
13362002|NCT00879658|26688596|FG005|Overall Study|Abnormal laboratory value(s)|0|||
13362003|NCT00879658|26688597|FG006|Overall Study|Abnormal laboratory value(s)|0|||
13362004|NCT00879658|26688591|FG000|Overall Study|Administrative problems|2|||
13362005|NCT00879658|26688592|FG001|Overall Study|Administrative problems|1|||
13362006|NCT00879658|26688593|FG002|Overall Study|Administrative problems|0|||
13362007|NCT00879658|26688594|FG003|Overall Study|Administrative problems|1|||
13362008|NCT00879658|26688595|FG004|Overall Study|Administrative problems|0|||
13362009|NCT00879658|26688596|FG005|Overall Study|Administrative problems|0|||
13362010|NCT00879658|26688597|FG006|Overall Study|Administrative problems|0|||
13362011|NCT00879658|26688591|FG000|Overall Study|Adverse Event|6|||
13362012|NCT00879658|26688592|FG001|Overall Study|Adverse Event|4|||
13362013|NCT00879658|26688593|FG002|Overall Study|Adverse Event|3|||
13362014|NCT00879658|26688594|FG003|Overall Study|Adverse Event|1|||
13362015|NCT00879658|26688595|FG004|Overall Study|Adverse Event|2|||
13362016|NCT00879658|26688596|FG005|Overall Study|Adverse Event|0|||
13362017|NCT00879658|26688597|FG006|Overall Study|Adverse Event|0|||
13362018|NCT00879658|26688591|FG000|Overall Study|Protocol Violation|1|||
13362019|NCT00879658|26688592|FG001|Overall Study|Protocol Violation|0|||
13362020|NCT00879658|26688593|FG002|Overall Study|Protocol Violation|0|||
13362021|NCT00879658|26688594|FG003|Overall Study|Protocol Violation|0|||
13362022|NCT00879658|26688595|FG004|Overall Study|Protocol Violation|0|||
13362023|NCT00879658|26688596|FG005|Overall Study|Protocol Violation|0|||
13362024|NCT00879658|26688597|FG006|Overall Study|Protocol Violation|0|||
13362025|NCT00879658|26688591|FG000|Overall Study|Withdrawal by Subject|3|||
13362026|NCT00879658|26688592|FG001|Overall Study|Withdrawal by Subject|0|||
13362027|NCT00879658|26688593|FG002|Overall Study|Withdrawal by Subject|2|||
13362028|NCT00879658|26688594|FG003|Overall Study|Withdrawal by Subject|0|||
13362029|NCT00879658|26688595|FG004|Overall Study|Withdrawal by Subject|0|||
13362030|NCT00879658|26688596|FG005|Overall Study|Withdrawal by Subject|1|||
13362031|NCT00879658|26688597|FG006|Overall Study|Withdrawal by Subject|0|||
13362032|NCT00879658|26688591|FG000|Overall Study|Lack of Efficacy|0|||
13362033|NCT00879658|26688592|FG001|Overall Study|Lack of Efficacy|0|||
13362034|NCT00879658|26688593|FG002|Overall Study|Lack of Efficacy|2|||
13362035|NCT00879658|26688594|FG003|Overall Study|Lack of Efficacy|0|||
13362036|NCT00879658|26688595|FG004|Overall Study|Lack of Efficacy|0|||
13362037|NCT00879658|26688596|FG005|Overall Study|Lack of Efficacy|0|||
13362038|NCT00879658|26688597|FG006|Overall Study|Lack of Efficacy|0|||
13362039|NCT00879658|26688591|FG000|Overall Study|misrandomized (never received study med)|0|||
13362040|NCT00879658|26688592|FG001|Overall Study|misrandomized (never received study med)|0|||
13362041|NCT00879658|26688593|FG002|Overall Study|misrandomized (never received study med)|0|||
13362042|NCT00879658|26688594|FG003|Overall Study|misrandomized (never received study med)|1|||
13362043|NCT00879658|26688595|FG004|Overall Study|misrandomized (never received study med)|0|||
13362044|NCT00879658|26688596|FG005|Overall Study|misrandomized (never received study med)|0|||
13362045|NCT00879658|26688597|FG006|Overall Study|misrandomized (never received study med)|0|||
13362046|NCT00879645|26688628|FG000|Overall Study|Adverse Event|1|||
13362047|NCT00879645|26688629|FG001|Overall Study|Adverse Event|0|||
13362048|NCT00879645|26688630|FG002|Overall Study|Adverse Event|0|||
13362049|NCT00879645|26688631|FG003|Overall Study|Adverse Event|0|||
13362050|NCT00879437|26688685|FG000|Overall Study|Protocol Violation|0|||
13362051|NCT00879437|26688686|FG001|Overall Study|Protocol Violation|1|||
13362052|NCT00879437|26688685|FG000|Overall Study|Death|1|||
13362053|NCT00879437|26688686|FG001|Overall Study|Death|0|||
13362054|NCT00879411|26688694|FG000|Overall Study|lost to follow-up (non-AE)|162|||
13362055|NCT00879398|26688706|FG000|Overall Study|Visit Stop|399|||
13362056|NCT00879398|26688706|FG000|Overall Study|Lack of Efficacy|64|||
13362057|NCT00879398|26688706|FG000|Overall Study|Adverse Event|41|||
13362058|NCT00879398|26688706|FG000|Overall Study|Other Reasons|171|||
13362059|NCT00879333|26688731|FG000|Overall Study|Adverse Event|94|||
13362060|NCT00879333|26688732|FG001|Overall Study|Adverse Event|34|||
13362061|NCT00879333|26688731|FG000|Overall Study|Abnormal Laboratory Value|1|||
13362062|NCT00879333|26688732|FG001|Overall Study|Abnormal Laboratory Value|0|||
13362063|NCT00879333|26688731|FG000|Overall Study|Withdrawal by Subject|20|||
13362064|NCT00879333|26688732|FG001|Overall Study|Withdrawal by Subject|7|||
13362065|NCT00879333|26688731|FG000|Overall Study|Lost to Follow-up|2|||
13362066|NCT00879333|26688732|FG001|Overall Study|Lost to Follow-up|1|||
13362067|NCT00879333|26688731|FG000|Overall Study|Administrative Problems|2|||
13362068|NCT00879333|26688732|FG001|Overall Study|Administrative Problems|0|||
13362069|NCT00879333|26688731|FG000|Overall Study|Death|16|||
13362070|NCT00879333|26688732|FG001|Overall Study|Death|5|||
13362071|NCT00879333|26688731|FG000|Overall Study|Disease Progression|292|||
13362072|NCT00879333|26688732|FG001|Overall Study|Disease Progression|169|||
13362073|NCT00879333|26688731|FG000|Overall Study|Protocol Violation|1|||
13362074|NCT00879333|26688732|FG001|Overall Study|Protocol Violation|1|||
13362075|NCT00879229|26688763|FG000|Overall Study|Study terminated by Sponsor|13|||
13362076|NCT00879229|26688764|FG001|Overall Study|Study terminated by Sponsor|12|||
13362077|NCT00879229|26688763|FG000|Overall Study|Death|4|||
13362078|NCT00879229|26688764|FG001|Overall Study|Death|2|||
13362079|NCT00879229|26688763|FG000|Overall Study|Adverse Event|2|||
13362080|NCT00879229|26688764|FG001|Overall Study|Adverse Event|0|||
13362081|NCT00879229|26688763|FG000|Overall Study|Withdrawal by Subject|1|||
13362082|NCT00879229|26688764|FG001|Overall Study|Withdrawal by Subject|0|||
13362083|NCT00879229|26688763|FG000|Overall Study|Clinical status did not improve|1|||
13362084|NCT00879229|26688764|FG001|Overall Study|Clinical status did not improve|0|||
13362085|NCT00879229|26688763|FG000|Overall Study|Other|1|||
13362086|NCT00879229|26688764|FG001|Overall Study|Other|0|||
13362087|NCT00879086|26688797|FG000|Overall Study|Adverse Event|3|||
13362088|NCT00879086|26688798|FG001|Overall Study|Adverse Event|15|||
13362089|NCT00879086|26688797|FG000|Overall Study|Participant choice|2|||
13362090|NCT00879086|26688798|FG001|Overall Study|Participant choice|2|||
13362091|NCT00879086|26688797|FG000|Overall Study|Progression of disease|40|||
13362092|NCT00879086|26688798|FG001|Overall Study|Progression of disease|26|||
13362093|NCT00879086|26688797|FG000|Overall Study|Withdrawal of consent|2|||
13362094|NCT00879086|26688798|FG001|Overall Study|Withdrawal of consent|1|||
13362095|NCT00879086|26688797|FG000|Overall Study|Other|4|||
13362096|NCT00879086|26688798|FG001|Overall Study|Other|6|||
13362097|NCT00879086|26688797|FG000|Overall Study|Death|1|||
13362098|NCT00879086|26688798|FG001|Overall Study|Death|2|||
13362099|NCT00878995|26688903|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0|||
13362100|NCT00878995|26688904|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2|||
13362101|NCT00878969|26688922|FG000|Overall Study|Physician Decision|5|||
13362102|NCT00878969|26688923|FG001|Overall Study|Physician Decision|3|||
13362103|NCT00878969|26688924|FG002|Overall Study|Physician Decision|2|||
13362104|NCT00878969|26688922|FG000|Overall Study|Withdrawal by Subject|1|||
13362105|NCT00878969|26688923|FG001|Overall Study|Withdrawal by Subject|6|||
13362106|NCT00878969|26688924|FG002|Overall Study|Withdrawal by Subject|3|||
13362107|NCT00878969|26688922|FG000|Overall Study|kidney transplant|2|||
13362108|NCT00878969|26688923|FG001|Overall Study|kidney transplant|3|||
13362109|NCT00878969|26688924|FG002|Overall Study|kidney transplant|2|||
13362110|NCT00878969|26688922|FG000|Overall Study|Adverse Event|3|||
13362111|NCT00878969|26688923|FG001|Overall Study|Adverse Event|1|||
13362112|NCT00878969|26688924|FG002|Overall Study|Adverse Event|2|||
13362113|NCT00878969|26688922|FG000|Overall Study|Lost to Follow-up|2|||
13362114|NCT00878969|26688923|FG001|Overall Study|Lost to Follow-up|1|||
13362115|NCT00878969|26688924|FG002|Overall Study|Lost to Follow-up|0|||
13362116|NCT00878969|26688922|FG000|Overall Study|Protocol Violation|2|||
13362117|NCT00878969|26688923|FG001|Overall Study|Protocol Violation|0|||
13362118|NCT00878969|26688924|FG002|Overall Study|Protocol Violation|0|||
13362119|NCT00878969|26688922|FG000|Overall Study|Death|0|||
13362120|NCT00878969|26688923|FG001|Overall Study|Death|0|||
13362121|NCT00878969|26688924|FG002|Overall Study|Death|2|||
13362122|NCT00878969|26688922|FG000|Overall Study|Pregnancy|0|||
13362123|NCT00878969|26688923|FG001|Overall Study|Pregnancy|1|||
13362124|NCT00878969|26688924|FG002|Overall Study|Pregnancy|0|||
13362125|NCT00878800|26688967|FG000|Overall Study|Adverse Event|0|||
13362126|NCT00878800|26688968|FG001|Overall Study|Adverse Event|0|||
13362127|NCT00878800|26688969|FG002|Overall Study|Adverse Event|2|||
13362128|NCT00878800|26688970|FG003|Overall Study|Adverse Event|0|||
13362129|NCT00878800|26688971|FG004|Overall Study|Adverse Event|1|||
13362130|NCT00878800|26688967|FG000|Overall Study|Progressive disease|1|||
13362131|NCT00878800|26688968|FG001|Overall Study|Progressive disease|5|||
13362132|NCT00878800|26688969|FG002|Overall Study|Progressive disease|6|||
13362133|NCT00878800|26688970|FG003|Overall Study|Progressive disease|5|||
13362134|NCT00878800|26688971|FG004|Overall Study|Progressive disease|13|||
13362135|NCT00878800|26688967|FG000|Overall Study|Withdrew consent|1|||
13362136|NCT00878800|26688968|FG001|Overall Study|Withdrew consent|1|||
13362137|NCT00878800|26688969|FG002|Overall Study|Withdrew consent|0|||
13362138|NCT00878800|26688970|FG003|Overall Study|Withdrew consent|1|||
13362139|NCT00878800|26688971|FG004|Overall Study|Withdrew consent|1|||
13362140|NCT00878800|26688967|FG000|Overall Study|Death|0|||
13362141|NCT00878800|26688968|FG001|Overall Study|Death|0|||
13362142|NCT00878800|26688969|FG002|Overall Study|Death|1|||
13362143|NCT00878800|26688970|FG003|Overall Study|Death|0|||
13362144|NCT00878800|26688971|FG004|Overall Study|Death|0|||
13362145|NCT00878800|26688967|FG000|Overall Study|Other|1|||
13362146|NCT00878800|26688968|FG001|Overall Study|Other|1|||
13362147|NCT00878800|26688969|FG002|Overall Study|Other|0|||
13362148|NCT00878800|26688970|FG003|Overall Study|Other|0|||
13362149|NCT00878800|26688971|FG004|Overall Study|Other|1|||
13362150|NCT00878722|26689079|FG000|Overall Study|Progressive disease|3|||
13362151|NCT00878722|26689080|FG001|Overall Study|Progressive disease|3|||
13362152|NCT00878722|26689081|FG002|Overall Study|Progressive disease|3|||
13362153|NCT00878722|26689082|FG003|Overall Study|Progressive disease|7|||
13362154|NCT00878722|26689083|FG004|Overall Study|Progressive disease|7|||
13362155|NCT00878722|26689084|FG005|Overall Study|Progressive disease|1|||
13362156|NCT00878722|26689085|FG006|Overall Study|Progressive disease|4|||
13362157|NCT00878722|26689086|FG007|Overall Study|Progressive disease|3|||
13362158|NCT00878722|26689079|FG000|Overall Study|Death|0|||
13362159|NCT00878722|26689080|FG001|Overall Study|Death|0|||
13362160|NCT00878722|26689081|FG002|Overall Study|Death|0|||
13362161|NCT00878722|26689082|FG003|Overall Study|Death|1|||
13362162|NCT00878722|26689083|FG004|Overall Study|Death|0|||
13362163|NCT00878722|26689084|FG005|Overall Study|Death|1|||
13362164|NCT00878722|26689085|FG006|Overall Study|Death|0|||
13362165|NCT00878722|26689086|FG007|Overall Study|Death|2|||
13362166|NCT00878722|26689079|FG000|Overall Study|Adverse Event|0|||
13362167|NCT00878722|26689080|FG001|Overall Study|Adverse Event|0|||
13362168|NCT00878722|26689081|FG002|Overall Study|Adverse Event|0|||
13362169|NCT00878722|26689082|FG003|Overall Study|Adverse Event|0|||
13362170|NCT00878722|26689083|FG004|Overall Study|Adverse Event|0|||
13204471|NCT01972841|26229049|FG001|Overall Study|Miscellaneous|0|||
13362171|NCT00878722|26689084|FG005|Overall Study|Adverse Event|0|||
13362172|NCT00878722|26689085|FG006|Overall Study|Adverse Event|2|||
13362173|NCT00878722|26689086|FG007|Overall Study|Adverse Event|0|||
13375020|NCT00792298|26728966|FG007|Treatment Period 2|Pregnancy|0|||
13362174|NCT00878722|26689079|FG000|Overall Study|Withdrawal by Subject|0|||
13362175|NCT00878722|26689080|FG001|Overall Study|Withdrawal by Subject|0|||
13362176|NCT00878722|26689081|FG002|Overall Study|Withdrawal by Subject|0|||
13362177|NCT00878722|26689082|FG003|Overall Study|Withdrawal by Subject|0|||
13362178|NCT00878722|26689083|FG004|Overall Study|Withdrawal by Subject|0|||
13362179|NCT00878722|26689084|FG005|Overall Study|Withdrawal by Subject|0|||
13362180|NCT00878722|26689085|FG006|Overall Study|Withdrawal by Subject|0|||
13362181|NCT00878722|26689086|FG007|Overall Study|Withdrawal by Subject|2|||
13362182|NCT00878722|26689079|FG000|Overall Study|Relapse|0|||
13362183|NCT00878722|26689080|FG001|Overall Study|Relapse|0|||
13362184|NCT00878722|26689081|FG002|Overall Study|Relapse|0|||
13362185|NCT00878722|26689082|FG003|Overall Study|Relapse|1|||
13362186|NCT00878722|26689083|FG004|Overall Study|Relapse|0|||
13362187|NCT00878722|26689084|FG005|Overall Study|Relapse|0|||
13362188|NCT00878722|26689085|FG006|Overall Study|Relapse|0|||
13362189|NCT00878722|26689086|FG007|Overall Study|Relapse|0|||
13362190|NCT00878709|26689131|FG000|Overall Study|Withdrawal by Subject|197|||
13362191|NCT00878709|26689132|FG001|Overall Study|Withdrawal by Subject|120|||
13362192|NCT00878709|26689131|FG000|Overall Study|Lost to Follow-up|35|||
13362193|NCT00878709|26689132|FG001|Overall Study|Lost to Follow-up|33|||
13362194|NCT00878709|26689131|FG000|Overall Study|Other Reasons|93|||
13362195|NCT00878709|26689132|FG001|Overall Study|Other Reasons|84|||
13362196|NCT00878553|26689202|FG000|Sleep Study|Withdrawal by Subject|2|||
13362197|NCT00878553|26689203|FG001|Sleep Study|Withdrawal by Subject|0|||
13362198|NCT00878553|26689204|FG002|Sleep Study|Withdrawal by Subject|0|||
13362199|NCT00878553|26689205|FG003|Sleep Study|Withdrawal by Subject|0|||
13362200|NCT00878553|26689206|FG004|Sleep Study|Withdrawal by Subject|0|||
13362201|NCT00878553|26689202|FG000|Sleep Study|Lost to Follow-up|1|||
13362202|NCT00878553|26689203|FG001|Sleep Study|Lost to Follow-up|0|||
13362203|NCT00878553|26689204|FG002|Sleep Study|Lost to Follow-up|0|||
13362204|NCT00878553|26689205|FG003|Sleep Study|Lost to Follow-up|0|||
13362205|NCT00878553|26689206|FG004|Sleep Study|Lost to Follow-up|0|||
13362206|NCT00878553|26689202|FG000|Sleep Study|car accident|1|||
13362207|NCT00878553|26689203|FG001|Sleep Study|car accident|0|||
13362208|NCT00878553|26689204|FG002|Sleep Study|car accident|0|||
13362209|NCT00878553|26689205|FG003|Sleep Study|car accident|0|||
13362210|NCT00878553|26689206|FG004|Sleep Study|car accident|0|||
13362211|NCT00878553|26689202|FG000|Sleep Study|family emergency|1|||
13362212|NCT00878553|26689203|FG001|Sleep Study|family emergency|0|||
13362213|NCT00878553|26689204|FG002|Sleep Study|family emergency|0|||
13362214|NCT00878553|26689205|FG003|Sleep Study|family emergency|0|||
13362215|NCT00878553|26689206|FG004|Sleep Study|family emergency|0|||
13362216|NCT00878553|26689202|FG000|PK Study|Withdrawal by Subject|0|||
13362217|NCT00878553|26689203|FG001|PK Study|Withdrawal by Subject|0|||
13362218|NCT00878553|26689204|FG002|PK Study|Withdrawal by Subject|0|||
13362219|NCT00878553|26689205|FG003|PK Study|Withdrawal by Subject|1|||
13362220|NCT00878553|26689206|FG004|PK Study|Withdrawal by Subject|0|||
13362221|NCT00878501|26689233|FG000|Overall Study|Adverse Event|11|||
13362222|NCT00878501|26689234|FG001|Overall Study|Adverse Event|3|||
13362223|NCT00878501|26689235|FG002|Overall Study|Adverse Event|3|||
13362224|NCT00878501|26689233|FG000|Overall Study|Lack of Efficacy|2|||
13362225|NCT00878501|26689234|FG001|Overall Study|Lack of Efficacy|1|||
13362226|NCT00878501|26689235|FG002|Overall Study|Lack of Efficacy|0|||
13362227|NCT00878501|26689233|FG000|Overall Study|Withdrawal by Subject|2|||
13362228|NCT00878501|26689234|FG001|Overall Study|Withdrawal by Subject|1|||
13362229|NCT00878501|26689235|FG002|Overall Study|Withdrawal by Subject|2|||
13362230|NCT00878501|26689233|FG000|Overall Study|Protocol Violation|0|||
13362231|NCT00878501|26689234|FG001|Overall Study|Protocol Violation|0|||
13362232|NCT00878501|26689235|FG002|Overall Study|Protocol Violation|1|||
13362233|NCT00878501|26689233|FG000|Overall Study|Incorrect enrolment|1|||
13362234|NCT00878501|26689234|FG001|Overall Study|Incorrect enrolment|2|||
13362235|NCT00878501|26689235|FG002|Overall Study|Incorrect enrolment|0|||
13362236|NCT00878501|26689233|FG000|Overall Study|Intake of prohibited concom. medication|0|||
13362237|NCT00878501|26689234|FG001|Overall Study|Intake of prohibited concom. medication|0|||
13362238|NCT00878501|26689235|FG002|Overall Study|Intake of prohibited concom. medication|1|||
13362239|NCT00878501|26689233|FG000|Overall Study|Mis-randomisation of patient|1|||
13362240|NCT00878501|26689234|FG001|Overall Study|Mis-randomisation of patient|0|||
13362241|NCT00878501|26689235|FG002|Overall Study|Mis-randomisation of patient|0|||
13362242|NCT00878501|26689233|FG000|Overall Study|Administrative|0|||
13362243|NCT00878501|26689234|FG001|Overall Study|Administrative|0|||
13362244|NCT00878501|26689235|FG002|Overall Study|Administrative|1|||
13362245|NCT00878215|26689258|FG000|Overall Study|Determined to be ineligible|0|||
13362246|NCT00878215|26689259|FG001|Overall Study|Determined to be ineligible|10|||
13362247|NCT00878215|26689260|FG002|Overall Study|Determined to be ineligible|0|||
13362248|NCT00878215|26689261|FG003|Overall Study|Determined to be ineligible|0|||
13362249|NCT00878189|26689541|FG000|Overall Study|Death|0|||
13362250|NCT00878189|26689542|FG001|Overall Study|Death|1|||
13362251|NCT00878189|26689543|FG002|Overall Study|Death|0|||
13362252|NCT00878189|26689544|FG003|Overall Study|Death|1|||
13362253|NCT00878189|26689545|FG004|Overall Study|Death|0|||
13362254|NCT00878189|26689546|FG005|Overall Study|Death|0|||
13362255|NCT00878189|26689547|FG006|Overall Study|Death|0|||
13362256|NCT00878189|26689548|FG007|Overall Study|Death|0|||
13362257|NCT00878189|26689549|FG008|Overall Study|Death|1|||
13362258|NCT00878189|26689541|FG000|Overall Study|Participant Refused to Follow-up|0|||
13362259|NCT00878189|26689542|FG001|Overall Study|Participant Refused to Follow-up|0|||
13362260|NCT00878189|26689543|FG002|Overall Study|Participant Refused to Follow-up|0|||
13362261|NCT00878189|26689544|FG003|Overall Study|Participant Refused to Follow-up|0|||
13362262|NCT00878189|26689545|FG004|Overall Study|Participant Refused to Follow-up|0|||
13362263|NCT00878189|26689546|FG005|Overall Study|Participant Refused to Follow-up|4|||
13362264|NCT00878189|26689547|FG006|Overall Study|Participant Refused to Follow-up|0|||
13362265|NCT00878189|26689548|FG007|Overall Study|Participant Refused to Follow-up|0|||
13362266|NCT00878189|26689549|FG008|Overall Study|Participant Refused to Follow-up|0|||
13362267|NCT00878189|26689541|FG000|Overall Study|Other|3|||
13362268|NCT00878189|26689542|FG001|Overall Study|Other|2|||
13362269|NCT00878189|26689543|FG002|Overall Study|Other|4|||
13362270|NCT00878189|26689544|FG003|Overall Study|Other|7|||
13362271|NCT00878189|26689545|FG004|Overall Study|Other|4|||
13362272|NCT00878189|26689546|FG005|Overall Study|Other|18|||
13362273|NCT00878189|26689547|FG006|Overall Study|Other|15|||
13362274|NCT00878189|26689548|FG007|Overall Study|Other|3|||
13362275|NCT00878189|26689549|FG008|Overall Study|Other|4|||
13362276|NCT00878189|26689541|FG000|Overall Study|Lost to Follow-up|0|||
13362277|NCT00878189|26689542|FG001|Overall Study|Lost to Follow-up|0|||
13362278|NCT00878189|26689543|FG002|Overall Study|Lost to Follow-up|0|||
13362279|NCT00878189|26689544|FG003|Overall Study|Lost to Follow-up|0|||
13362280|NCT00878189|26689545|FG004|Overall Study|Lost to Follow-up|0|||
13362281|NCT00878189|26689546|FG005|Overall Study|Lost to Follow-up|1|||
13362282|NCT00878189|26689547|FG006|Overall Study|Lost to Follow-up|1|||
13362283|NCT00878189|26689548|FG007|Overall Study|Lost to Follow-up|0|||
13362284|NCT00878189|26689549|FG008|Overall Study|Lost to Follow-up|0|||
13362285|NCT00878189|26689541|FG000|Overall Study|Objection Progression or Relapse|0|||
13362286|NCT00878189|26689542|FG001|Overall Study|Objection Progression or Relapse|0|||
13362287|NCT00878189|26689543|FG002|Overall Study|Objection Progression or Relapse|0|||
13362288|NCT00878189|26689544|FG003|Overall Study|Objection Progression or Relapse|0|||
13362289|NCT00878189|26689545|FG004|Overall Study|Objection Progression or Relapse|0|||
13362290|NCT00878189|26689546|FG005|Overall Study|Objection Progression or Relapse|0|||
13362291|NCT00878189|26689547|FG006|Overall Study|Objection Progression or Relapse|0|||
13362292|NCT00878189|26689548|FG007|Overall Study|Objection Progression or Relapse|0|||
13362293|NCT00878189|26689549|FG008|Overall Study|Objection Progression or Relapse|3|||
13362294|NCT00878072|26689571|FG000|Overall Study|Withdrew consent|2|||
13362295|NCT00877929|26689664|FG000|Overall Study|Adverse Event|11|||
13362296|NCT00877929|26689665|FG001|Overall Study|Adverse Event|20|||
13362297|NCT00877929|26689664|FG000|Overall Study|Protocol Violation|3|||
13362298|NCT00877929|26689665|FG001|Overall Study|Protocol Violation|3|||
13362299|NCT00877929|26689664|FG000|Overall Study|Lost to Follow-up|0|||
13362300|NCT00877929|26689665|FG001|Overall Study|Lost to Follow-up|1|||
13362301|NCT00877929|26689664|FG000|Overall Study|Withdrawal by Subject|4|||
13362302|NCT00877929|26689665|FG001|Overall Study|Withdrawal by Subject|4|||
13362303|NCT00877929|26689664|FG000|Overall Study|Lack of Efficacy|0|||
13362304|NCT00877929|26689665|FG001|Overall Study|Lack of Efficacy|1|||
13362305|NCT00877929|26689664|FG000|Overall Study|Other reason (not specified)|2|||
13362306|NCT00877929|26689665|FG001|Overall Study|Other reason (not specified)|6|||
13362307|NCT00877890|26689706|FG000|Overall Study|Adverse Event|6|||
13362308|NCT00877890|26689707|FG001|Overall Study|Adverse Event|6|||
13362309|NCT00877890|26689706|FG000|Overall Study|Lost to Follow-up|5|||
13362310|NCT00877890|26689707|FG001|Overall Study|Lost to Follow-up|5|||
13362311|NCT00877890|26689706|FG000|Overall Study|Protocol Violation|0|||
13362312|NCT00877890|26689707|FG001|Overall Study|Protocol Violation|1|||
13362313|NCT00877890|26689706|FG000|Overall Study|Withdrawal of Consent|6|||
13362314|NCT00877890|26689707|FG001|Overall Study|Withdrawal of Consent|12|||
13362315|NCT00877890|26689706|FG000|Overall Study|Investigator Decision|0|||
13362316|NCT00877890|26689707|FG001|Overall Study|Investigator Decision|2|||
13362317|NCT00877890|26689706|FG000|Overall Study|Loss of Glucose Control|3|||
13362318|NCT00877890|26689707|FG001|Overall Study|Loss of Glucose Control|4|||
13362319|NCT00877799|26689738|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2|||
13362320|NCT00877799|26689739|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
13362321|NCT00877799|26689740|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
13362322|NCT00877799|26689741|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
13362323|NCT00877799|26689742|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
13362324|NCT00877799|26689738|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
13362325|NCT00877799|26689739|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
13362326|NCT00877799|26689740|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2|||
13362327|NCT00877799|26689741|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
13204472|NCT01972841|26229050|FG002|Overall Study|Miscellaneous|4|||
13362328|NCT00877799|26689742|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
13362329|NCT00877799|26689738|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
13362330|NCT00877799|26689739|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3|||
13362331|NCT00877799|26689740|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
13362332|NCT00877799|26689741|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
13362333|NCT00877799|26689742|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
13362334|NCT00877799|26689738|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
13362335|NCT00877799|26689739|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
13362336|NCT00877799|26689740|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
13362337|NCT00877799|26689741|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1|||
13362338|NCT00877799|26689742|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
13362339|NCT00877799|26689738|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
13362340|NCT00877799|26689739|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
13362341|NCT00877799|26689740|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
13362342|NCT00877799|26689741|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
13362343|NCT00877799|26689742|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
13362344|NCT00877773|26689748|FG000|Overall Study|Disease Progression|44|||
13362345|NCT00877487|26689761|FG000|Open-label Treatment Phase|Adverse Event|1|||
13362346|NCT00877487|26689762|FG001|Open-label Treatment Phase|Adverse Event|0|||
13362347|NCT00877487|26689761|FG000|Open-label Treatment Phase|Protocol Violation|3|||
13362348|NCT00877487|26689762|FG001|Open-label Treatment Phase|Protocol Violation|0|||
13362349|NCT00877487|26689761|FG000|Open-label Treatment Phase|Withdrawal by Subject|1|||
13362350|NCT00877487|26689762|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
13362351|NCT00877487|26689761|FG000|Open-label Treatment Phase|Lost to Follow-up|1|||
13362352|NCT00877487|26689762|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
13362353|NCT00877487|26689761|FG000|Open-label Treatment Phase|Out of country for business|1|||
13362354|NCT00877487|26689762|FG001|Open-label Treatment Phase|Out of country for business|0|||
13362355|NCT00877487|26689761|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5|||
13362356|NCT00877487|26689762|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45|||
13362357|NCT00877487|26689761|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0|||
13362358|NCT00877487|26689762|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1|||
13362359|NCT00877487|26689761|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0|||
13362360|NCT00877487|26689762|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1|||
13362361|NCT00877487|26689761|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1|||
13362362|NCT00877487|26689762|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0|||
13362363|NCT00877383|26689785|FG000|Overall Study|Adverse Event|13|||
13362364|NCT00877383|26689786|FG001|Overall Study|Adverse Event|14|||
13362365|NCT00877383|26689785|FG000|Overall Study|Lost to Follow-up|5|||
13362366|NCT00877383|26689786|FG001|Overall Study|Lost to Follow-up|3|||
13362367|NCT00877383|26689785|FG000|Overall Study|Subject withdrew consent|3|||
13362368|NCT00877383|26689786|FG001|Overall Study|Subject withdrew consent|12|||
13362369|NCT00877383|26689785|FG000|Overall Study|Subject no longer requires study drug|2|||
13362370|NCT00877383|26689786|FG001|Overall Study|Subject no longer requires study drug|0|||
13362371|NCT00877383|26689785|FG000|Overall Study|Administrative problems|2|||
13362372|NCT00877383|26689786|FG001|Overall Study|Administrative problems|0|||
13362373|NCT00877383|26689785|FG000|Overall Study|Protocol deviation|2|||
13362374|NCT00877383|26689786|FG001|Overall Study|Protocol deviation|6|||
13362375|NCT00877383|26689785|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
13362376|NCT00877383|26689786|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
13362377|NCT00877383|26689785|FG000|Overall Study|Death|1|||
13362378|NCT00877383|26689786|FG001|Overall Study|Death|2|||
13362379|NCT00877071|26689795|FG000|Overall Study|disease progression|2|||
13362380|NCT00877032|26689916|FG000|Overall Study|Did not meet entrance criteria|0|||
13362381|NCT00877032|26689917|FG001|Overall Study|Did not meet entrance criteria|0|||
13362382|NCT00877032|26689918|FG002|Overall Study|Did not meet entrance criteria|0|||
13362383|NCT00877032|26689919|FG003|Overall Study|Did not meet entrance criteria|1|||
13362384|NCT00877032|26689920|FG004|Overall Study|Did not meet entrance criteria|0|||
13362385|NCT00877032|26689921|FG005|Overall Study|Did not meet entrance criteria|0|||
13362386|NCT00877032|26689922|FG006|Overall Study|Did not meet entrance criteria|2|||
13362387|NCT00877006|26689967|FG000|Treatment Period|Death|2|||
13362388|NCT00877006|26689968|FG001|Treatment Period|Death|1|||
13362389|NCT00877006|26689967|FG000|Treatment Period|Adverse Event|10|||
13362390|NCT00877006|26689968|FG001|Treatment Period|Adverse Event|3|||
13362391|NCT00877006|26689967|FG000|Treatment Period|Withdrawal by Subject|2|||
13362392|NCT00877006|26689968|FG001|Treatment Period|Withdrawal by Subject|3|||
13362393|NCT00877006|26689967|FG000|Treatment Period|Protocol Violation|1|||
13362394|NCT00877006|26689968|FG001|Treatment Period|Protocol Violation|0|||
13362395|NCT00877006|26689967|FG000|Treatment Period|Lost to Follow-up|0|||
13362396|NCT00877006|26689968|FG001|Treatment Period|Lost to Follow-up|1|||
13362397|NCT00877006|26689967|FG000|Treatment Period|Disease Progression|1|||
13362398|NCT00877006|26689968|FG001|Treatment Period|Disease Progression|2|||
13362399|NCT00877006|26689967|FG000|Treatment Period|Started New Treatment Regimen|2|||
13362400|NCT00877006|26689968|FG001|Treatment Period|Started New Treatment Regimen|5|||
13362401|NCT00877006|26689967|FG000|Treatment Period|Other|4|||
13362402|NCT00877006|26689968|FG001|Treatment Period|Other|4|||
13362403|NCT00877006|26689967|FG000|Treatment Period|Randomized but Not Treated|3|||
13362404|NCT00877006|26689968|FG001|Treatment Period|Randomized but Not Treated|8|||
13362405|NCT00877006|26689967|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12|||
13362406|NCT00877006|26689968|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19|||
13362407|NCT00877006|26689967|FG000|Long-Term Follow-up Period|Lost to Follow-up|8|||
13362408|NCT00877006|26689968|FG001|Long-Term Follow-up Period|Lost to Follow-up|9|||
13362409|NCT00877006|26689967|FG000|Long-Term Follow-up Period|Death|26|||
13362410|NCT00877006|26689968|FG001|Long-Term Follow-up Period|Death|18|||
13362411|NCT00877006|26689967|FG000|Long-Term Follow-up Period|Other|7|||
13362412|NCT00877006|26689968|FG001|Long-Term Follow-up Period|Other|9|||
13362413|NCT00876928|26689983|FG000|Overall Study|Lost to Follow-up|2|||
13362414|NCT00876928|26689984|FG001|Overall Study|Lost to Follow-up|5|||
13362415|NCT00876928|26689983|FG000|Overall Study|Hypokalemia-affects insulin secretion|1|||
13362416|NCT00876928|26689984|FG001|Overall Study|Hypokalemia-affects insulin secretion|0|||
13362417|NCT00876733|26690103|FG000|Overall Study|Adverse Event|34|||
13362418|NCT00876733|26690104|FG001|Overall Study|Adverse Event|20|||
13362419|NCT00876733|26690105|FG002|Overall Study|Adverse Event|10|||
13362420|NCT00876733|26690106|FG003|Overall Study|Adverse Event|3|||
13362421|NCT00876733|26690103|FG000|Overall Study|Lack of Efficacy|17|||
13362422|NCT00876733|26690104|FG001|Overall Study|Lack of Efficacy|9|||
13362423|NCT00876733|26690105|FG002|Overall Study|Lack of Efficacy|10|||
13362424|NCT00876733|26690106|FG003|Overall Study|Lack of Efficacy|1|||
13362425|NCT00876733|26690103|FG000|Overall Study|Lost to Follow-up|26|||
13362426|NCT00876733|26690104|FG001|Overall Study|Lost to Follow-up|10|||
13362427|NCT00876733|26690105|FG002|Overall Study|Lost to Follow-up|3|||
13362428|NCT00876733|26690106|FG003|Overall Study|Lost to Follow-up|2|||
13362429|NCT00876733|26690103|FG000|Overall Study|Data not available|14|||
13362430|NCT00876733|26690104|FG001|Overall Study|Data not available|3|||
13362431|NCT00876733|26690105|FG002|Overall Study|Data not available|7|||
13362432|NCT00876733|26690106|FG003|Overall Study|Data not available|1|||
13362433|NCT00876694|26690131|FG000|Overall Study|Adverse Event|10|||
13362434|NCT00876694|26690132|FG001|Overall Study|Adverse Event|7|||
13362435|NCT00876694|26690131|FG000|Overall Study|Subject withdrew consent|6|||
13362436|NCT00876694|26690132|FG001|Overall Study|Subject withdrew consent|4|||
13362437|NCT00876694|26690131|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
13362438|NCT00876694|26690132|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
13362439|NCT00876694|26690131|FG000|Overall Study|Abnormal test procedure result(s)|1|||
13362440|NCT00876694|26690132|FG001|Overall Study|Abnormal test procedure result(s)|0|||
13362441|NCT00876694|26690131|FG000|Overall Study|Administrative problems|1|||
13362442|NCT00876694|26690132|FG001|Overall Study|Administrative problems|1|||
13362443|NCT00876694|26690131|FG000|Overall Study|Death|1|||
13362444|NCT00876694|26690132|FG001|Overall Study|Death|0|||
13362445|NCT00876460|26690227|FG000|Combination Therapy Phase|Progressive disease|2|||
13362446|NCT00876460|26690228|FG001|Combination Therapy Phase|Progressive disease|3|||
13362447|NCT00876460|26690229|FG002|Combination Therapy Phase|Progressive disease|3|||
13362448|NCT00876460|26690230|FG003|Combination Therapy Phase|Progressive disease|3|||
13362449|NCT00876460|26690231|FG004|Combination Therapy Phase|Progressive disease|3|||
13362450|NCT00876460|26690232|FG005|Combination Therapy Phase|Progressive disease|1|||
13362451|NCT00876460|26690233|FG006|Combination Therapy Phase|Progressive disease|1|||
13362452|NCT00876460|26690234|FG007|Combination Therapy Phase|Progressive disease|1|||
13362453|NCT00876460|26690227|FG000|Combination Therapy Phase|Dose limiting toxicity|0|||
13362454|NCT00876460|26690228|FG001|Combination Therapy Phase|Dose limiting toxicity|1|||
13362455|NCT00876460|26690229|FG002|Combination Therapy Phase|Dose limiting toxicity|0|||
13362456|NCT00876460|26690230|FG003|Combination Therapy Phase|Dose limiting toxicity|1|||
13362457|NCT00876460|26690231|FG004|Combination Therapy Phase|Dose limiting toxicity|1|||
13362458|NCT00876460|26690232|FG005|Combination Therapy Phase|Dose limiting toxicity|2|||
13362459|NCT00876460|26690233|FG006|Combination Therapy Phase|Dose limiting toxicity|2|||
13362460|NCT00876460|26690234|FG007|Combination Therapy Phase|Dose limiting toxicity|1|||
13362461|NCT00876460|26690227|FG000|Combination Therapy Phase|Adverse Event|0|||
13362462|NCT00876460|26690228|FG001|Combination Therapy Phase|Adverse Event|2|||
13362463|NCT00876460|26690229|FG002|Combination Therapy Phase|Adverse Event|0|||
13362464|NCT00876460|26690230|FG003|Combination Therapy Phase|Adverse Event|2|||
13362465|NCT00876460|26690231|FG004|Combination Therapy Phase|Adverse Event|2|||
13362466|NCT00876460|26690232|FG005|Combination Therapy Phase|Adverse Event|0|||
13124948|NCT02936037|25954514|FG001|Double-Blind Treatment Period|Lack of Efficacy|12|||
13362467|NCT00876460|26690233|FG006|Combination Therapy Phase|Adverse Event|3|||
13362468|NCT00876460|26690234|FG007|Combination Therapy Phase|Adverse Event|2|||
13362469|NCT00876460|26690227|FG000|Combination Therapy Phase|Withdrawal by Subject|1|||
13362470|NCT00876460|26690228|FG001|Combination Therapy Phase|Withdrawal by Subject|1|||
13362471|NCT00876460|26690229|FG002|Combination Therapy Phase|Withdrawal by Subject|0|||
13362472|NCT00876460|26690230|FG003|Combination Therapy Phase|Withdrawal by Subject|0|||
13362473|NCT00876460|26690231|FG004|Combination Therapy Phase|Withdrawal by Subject|1|||
13362474|NCT00876460|26690232|FG005|Combination Therapy Phase|Withdrawal by Subject|0|||
13362475|NCT00876460|26690233|FG006|Combination Therapy Phase|Withdrawal by Subject|0|||
13362476|NCT00876460|26690234|FG007|Combination Therapy Phase|Withdrawal by Subject|0|||
13362477|NCT00876460|26690227|FG000|Combination Therapy Phase|Other reason not defined above|0|||
13362478|NCT00876460|26690228|FG001|Combination Therapy Phase|Other reason not defined above|0|||
13362479|NCT00876460|26690229|FG002|Combination Therapy Phase|Other reason not defined above|0|||
13362480|NCT00876460|26690230|FG003|Combination Therapy Phase|Other reason not defined above|0|||
13362481|NCT00876460|26690231|FG004|Combination Therapy Phase|Other reason not defined above|0|||
13362482|NCT00876460|26690232|FG005|Combination Therapy Phase|Other reason not defined above|0|||
13362483|NCT00876460|26690233|FG006|Combination Therapy Phase|Other reason not defined above|1|||
13362484|NCT00876460|26690234|FG007|Combination Therapy Phase|Other reason not defined above|2|||
13362485|NCT00876460|26690227|FG000|Combination Therapy Phase|Not treated|0|||
13362486|NCT00876460|26690228|FG001|Combination Therapy Phase|Not treated|0|||
13362487|NCT00876460|26690229|FG002|Combination Therapy Phase|Not treated|0|||
13362488|NCT00876460|26690230|FG003|Combination Therapy Phase|Not treated|0|||
13362489|NCT00876460|26690231|FG004|Combination Therapy Phase|Not treated|0|||
13362490|NCT00876460|26690232|FG005|Combination Therapy Phase|Not treated|0|||
13362491|NCT00876460|26690233|FG006|Combination Therapy Phase|Not treated|1|||
13362492|NCT00876460|26690234|FG007|Combination Therapy Phase|Not treated|0|||
13362493|NCT00876460|26690227|FG000|Mono Therapy Phase|Progressive disease|0|||
13362494|NCT00876460|26690228|FG001|Mono Therapy Phase|Progressive disease|0|||
13362495|NCT00876460|26690229|FG002|Mono Therapy Phase|Progressive disease|0|||
13362496|NCT00876460|26690230|FG003|Mono Therapy Phase|Progressive disease|0|||
13362497|NCT00876460|26690231|FG004|Mono Therapy Phase|Progressive disease|2|||
13362498|NCT00876460|26690232|FG005|Mono Therapy Phase|Progressive disease|0|||
13362499|NCT00876460|26690233|FG006|Mono Therapy Phase|Progressive disease|1|||
13362500|NCT00876460|26690234|FG007|Mono Therapy Phase|Progressive disease|3|||
13362501|NCT00876460|26690227|FG000|Mono Therapy Phase|Withdrawal by Subject|0|||
13362502|NCT00876460|26690228|FG001|Mono Therapy Phase|Withdrawal by Subject|1|||
13362503|NCT00876460|26690229|FG002|Mono Therapy Phase|Withdrawal by Subject|0|||
13362504|NCT00876460|26690230|FG003|Mono Therapy Phase|Withdrawal by Subject|0|||
13362505|NCT00876460|26690231|FG004|Mono Therapy Phase|Withdrawal by Subject|0|||
13362506|NCT00876460|26690232|FG005|Mono Therapy Phase|Withdrawal by Subject|0|||
13362507|NCT00876460|26690233|FG006|Mono Therapy Phase|Withdrawal by Subject|0|||
13362508|NCT00876460|26690234|FG007|Mono Therapy Phase|Withdrawal by Subject|0|||
13362509|NCT00876460|26690227|FG000|Mono Therapy Phase|Adverse Event|0|||
13362510|NCT00876460|26690228|FG001|Mono Therapy Phase|Adverse Event|0|||
13362511|NCT00876460|26690229|FG002|Mono Therapy Phase|Adverse Event|0|||
13362512|NCT00876460|26690230|FG003|Mono Therapy Phase|Adverse Event|1|||
13362513|NCT00876460|26690231|FG004|Mono Therapy Phase|Adverse Event|0|||
13362514|NCT00876460|26690232|FG005|Mono Therapy Phase|Adverse Event|0|||
13362515|NCT00876460|26690233|FG006|Mono Therapy Phase|Adverse Event|0|||
13362516|NCT00876460|26690234|FG007|Mono Therapy Phase|Adverse Event|0|||
13362517|NCT00876447|26690299|FG000|Overall Study|Other miscellaneous reasons|3|||
13362518|NCT00876447|26690300|FG001|Overall Study|Other miscellaneous reasons|8|||
13362519|NCT00876447|26690299|FG000|Overall Study|Site closure|19|||
13362520|NCT00876447|26690300|FG001|Overall Study|Site closure|14|||
13362521|NCT00876447|26690299|FG000|Overall Study|Protocol Violation|9|||
13362522|NCT00876447|26690300|FG001|Overall Study|Protocol Violation|3|||
13362523|NCT00876447|26690299|FG000|Overall Study|Personal reasons|30|||
13362524|NCT00876447|26690300|FG001|Overall Study|Personal reasons|28|||
13362525|NCT00876447|26690299|FG000|Overall Study|Lost to Follow-up|6|||
13362526|NCT00876447|26690300|FG001|Overall Study|Lost to Follow-up|15|||
13362527|NCT00876447|26690299|FG000|Overall Study|Pregnancy|4|||
13362528|NCT00876447|26690300|FG001|Overall Study|Pregnancy|2|||
13362529|NCT00876447|26690299|FG000|Overall Study|Lack of Efficacy|5|||
13362530|NCT00876447|26690300|FG001|Overall Study|Lack of Efficacy|3|||
13362531|NCT00876447|26690299|FG000|Overall Study|Adverse Event|4|||
13362532|NCT00876447|26690300|FG001|Overall Study|Adverse Event|8|||
13362533|NCT00876395|26690345|FG000|Overall Study|Untreated|8|||
13362534|NCT00876395|26690346|FG001|Overall Study|Untreated|1|||
13362535|NCT00876395|26690345|FG000|Overall Study|Adverse Event|63|||
13362536|NCT00876395|26690346|FG001|Overall Study|Adverse Event|11|||
13362537|NCT00876395|26690345|FG000|Overall Study|Abnormal test procedure result(s)|1|||
13362538|NCT00876395|26690346|FG001|Overall Study|Abnormal test procedure result(s)|0|||
13362539|NCT00876395|26690345|FG000|Overall Study|Disease progression|259|||
13362540|NCT00876395|26690346|FG001|Overall Study|Disease progression|162|||
13362541|NCT00876395|26690345|FG000|Overall Study|New cancer therapy|25|||
13362542|NCT00876395|26690346|FG001|Overall Study|New cancer therapy|7|||
13362543|NCT00876395|26690345|FG000|Overall Study|Protocol Violation|5|||
13362544|NCT00876395|26690346|FG001|Overall Study|Protocol Violation|2|||
13362545|NCT00876395|26690345|FG000|Overall Study|Withdrawal by Subject|66|||
13362546|NCT00876395|26690346|FG001|Overall Study|Withdrawal by Subject|33|||
13362547|NCT00876395|26690345|FG000|Overall Study|Lost to Follow-up|2|||
13362548|NCT00876395|26690346|FG001|Overall Study|Lost to Follow-up|0|||
13362549|NCT00876395|26690345|FG000|Overall Study|Administrative problems|39|||
13362550|NCT00876395|26690346|FG001|Overall Study|Administrative problems|23|||
13362551|NCT00876395|26690345|FG000|Overall Study|Death|12|||
13362552|NCT00876395|26690346|FG001|Overall Study|Death|0|||
13362553|NCT00876343|26690370|FG000|Overall Study|Adverse Event|7|||
13362554|NCT00876343|26690371|FG001|Overall Study|Adverse Event|8|||
13362555|NCT00876343|26690372|FG002|Overall Study|Adverse Event|2|||
13362556|NCT00876343|26690370|FG000|Overall Study|Withdrawal by Subject|4|||
13362557|NCT00876343|26690371|FG001|Overall Study|Withdrawal by Subject|4|||
13362558|NCT00876343|26690372|FG002|Overall Study|Withdrawal by Subject|3|||
13362559|NCT00876343|26690370|FG000|Overall Study|Lack of Efficacy|0|||
13362560|NCT00876343|26690371|FG001|Overall Study|Lack of Efficacy|0|||
13362561|NCT00876343|26690372|FG002|Overall Study|Lack of Efficacy|1|||
13362562|NCT00876343|26690370|FG000|Overall Study|Protocol Violation|4|||
13362563|NCT00876343|26690371|FG001|Overall Study|Protocol Violation|1|||
13362564|NCT00876343|26690372|FG002|Overall Study|Protocol Violation|1|||
13362565|NCT00876343|26690370|FG000|Overall Study|Physician Decision|0|||
13362566|NCT00876343|26690371|FG001|Overall Study|Physician Decision|1|||
13362567|NCT00876343|26690372|FG002|Overall Study|Physician Decision|1|||
13362568|NCT00876343|26690370|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
13362569|NCT00876343|26690371|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
13362570|NCT00876343|26690372|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
13362571|NCT00876343|26690370|FG000|Overall Study|Change of residence or other commitments|2|||
13362572|NCT00876343|26690371|FG001|Overall Study|Change of residence or other commitments|2|||
13362573|NCT00876343|26690372|FG002|Overall Study|Change of residence or other commitments|3|||
13362574|NCT00876265|26690380|FG000|Overall Study|Miscellaneous reasons|4|||
13362575|NCT00876265|26690380|FG000|Overall Study|Lost to Follow-up|6|||
13362576|NCT00876265|26690380|FG000|Overall Study|Withdrawal by Subject|2|||
13362577|NCT00876187|26690494|FG000|Overall Study|Adverse Event|14|||
13362578|NCT00876187|26690495|FG001|Overall Study|Adverse Event|12|||
13362579|NCT00876187|26690496|FG002|Overall Study|Adverse Event|19|||
13362580|NCT00876187|26690497|FG003|Overall Study|Adverse Event|29|||
13362581|NCT00876187|26690498|FG004|Overall Study|Adverse Event|10|||
13362582|NCT00876187|26690494|FG000|Overall Study|Lack of Efficacy|59|||
13362583|NCT00876187|26690495|FG001|Overall Study|Lack of Efficacy|34|||
13362584|NCT00876187|26690496|FG002|Overall Study|Lack of Efficacy|45|||
13362585|NCT00876187|26690497|FG003|Overall Study|Lack of Efficacy|34|||
13362586|NCT00876187|26690498|FG004|Overall Study|Lack of Efficacy|59|||
13362587|NCT00876187|26690494|FG000|Overall Study|Lost to Follow-up|9|||
13362588|NCT00876187|26690495|FG001|Overall Study|Lost to Follow-up|10|||
13362589|NCT00876187|26690496|FG002|Overall Study|Lost to Follow-up|8|||
13362590|NCT00876187|26690497|FG003|Overall Study|Lost to Follow-up|8|||
13362591|NCT00876187|26690498|FG004|Overall Study|Lost to Follow-up|11|||
13362592|NCT00876187|26690494|FG000|Overall Study|Protocol Violation|6|||
13362593|NCT00876187|26690495|FG001|Overall Study|Protocol Violation|7|||
13362594|NCT00876187|26690496|FG002|Overall Study|Protocol Violation|7|||
13362595|NCT00876187|26690497|FG003|Overall Study|Protocol Violation|6|||
13362596|NCT00876187|26690498|FG004|Overall Study|Protocol Violation|3|||
13362597|NCT00876187|26690494|FG000|Overall Study|Withdrawal by Subject|16|||
13362598|NCT00876187|26690495|FG001|Overall Study|Withdrawal by Subject|26|||
13362599|NCT00876187|26690496|FG002|Overall Study|Withdrawal by Subject|32|||
13362600|NCT00876187|26690497|FG003|Overall Study|Withdrawal by Subject|38|||
13362601|NCT00876187|26690498|FG004|Overall Study|Withdrawal by Subject|37|||
13362602|NCT00876187|26690494|FG000|Overall Study|Entered extension study|101|||
13362603|NCT00876187|26690495|FG001|Overall Study|Entered extension study|120|||
13362604|NCT00876187|26690496|FG002|Overall Study|Entered extension study|156|||
13362605|NCT00876187|26690497|FG003|Overall Study|Entered extension study|151|||
13362606|NCT00876187|26690498|FG004|Overall Study|Entered extension study|144|||
13362607|NCT00876187|26690494|FG000|Overall Study|Randomized but not treated|3|||
13362608|NCT00876187|26690495|FG001|Overall Study|Randomized but not treated|1|||
13362609|NCT00876187|26690496|FG002|Overall Study|Randomized but not treated|3|||
13362610|NCT00876187|26690497|FG003|Overall Study|Randomized but not treated|2|||
13362611|NCT00876187|26690498|FG004|Overall Study|Randomized but not treated|3|||
13362612|NCT00876187|26690494|FG000|Overall Study|Other|2|||
13362613|NCT00876187|26690495|FG001|Overall Study|Other|5|||
13362614|NCT00876187|26690496|FG002|Overall Study|Other|9|||
13362615|NCT00876187|26690497|FG003|Overall Study|Other|7|||
13362616|NCT00876187|26690498|FG004|Overall Study|Other|4|||
13362617|NCT00876018|26690561|FG000|Overall Study|Lost to Follow-up|0|||
13362618|NCT00876018|26690562|FG001|Overall Study|Lost to Follow-up|1|||
13362619|NCT00876018|26690563|FG002|Overall Study|Lost to Follow-up|1|||
13362620|NCT00876018|26690561|FG000|Overall Study|Withdrew Consent due to Adverse Event|5|||
13362621|NCT00876018|26690562|FG001|Overall Study|Withdrew Consent due to Adverse Event|4|||
13362622|NCT00876018|26690563|FG002|Overall Study|Withdrew Consent due to Adverse Event|2|||
13362623|NCT00875979|26690580|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1|||
13362624|NCT00875979|26690581|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0|||
13362625|NCT00875979|26690580|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1|||
13362626|NCT00875979|26690581|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0|||
13362627|NCT00875979|26690580|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1|||
13362628|NCT00875979|26690581|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0|||
13362629|NCT00875979|26690580|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0|||
13362630|NCT00875979|26690581|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6|||
13362631|NCT00875979|26690580|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0|||
13362632|NCT00875979|26690581|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37|||
13362633|NCT00875979|26690580|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0|||
13362634|NCT00875979|26690581|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3|||
13362635|NCT00875979|26690580|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0|||
13362636|NCT00875979|26690581|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3|||
13362637|NCT00875979|26690580|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0|||
13362638|NCT00875979|26690581|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3|||
13362639|NCT00875979|26690580|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0|||
13362640|NCT00875979|26690581|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1|||
13362641|NCT00875810|26690590|FG000|Overall Study|Withdrawal by Subject|1|||
13362642|NCT00875810|26690590|FG000|Overall Study|Physician Decision|3|||
13362643|NCT00875810|26690590|FG000|Overall Study|Lost to Follow-up|39|||
13362644|NCT00875810|26690590|FG000|Overall Study|Patient enroled but not implanted|2|||
13362645|NCT00875810|26690590|FG000|Overall Study|Device explanted|1|||
13362646|NCT00875797|26690607|FG000|Overall Study|Protocol Violation|6|||
13362647|NCT00875797|26690608|FG001|Overall Study|Protocol Violation|3|||
13362648|NCT00875706|26690635|FG000|Overall Study|Withdrawal by Subject|1|||
13362649|NCT00875706|26690636|FG001|Overall Study|Withdrawal by Subject|0|||
13362650|NCT00875706|26690637|FG002|Overall Study|Withdrawal by Subject|0|||
13362651|NCT00875667|26690742|FG000|Overall Study|Adverse Event|29|||
13362652|NCT00875667|26690743|FG001|Overall Study|Adverse Event|10|||
13362653|NCT00875667|26690742|FG000|Overall Study|Withdrawal by Subject|17|||
13362654|NCT00875667|26690743|FG001|Overall Study|Withdrawal by Subject|5|||
13362655|NCT00875667|26690742|FG000|Overall Study|Death|7|||
13362656|NCT00875667|26690743|FG001|Overall Study|Death|2|||
13362657|NCT00875667|26690742|FG000|Overall Study|Protocol Violation|2|||
13362658|NCT00875667|26690743|FG001|Overall Study|Protocol Violation|0|||
13362659|NCT00875667|26690742|FG000|Overall Study|Disease Progression|100|||
13362660|NCT00875667|26690743|FG001|Overall Study|Disease Progression|49|||
13362661|NCT00875667|26690742|FG000|Overall Study|Miscellaneous|12|||
13362662|NCT00875667|26690743|FG001|Overall Study|Miscellaneous|6|||
13362663|NCT00875667|26690742|FG000|Overall Study|Randomized but no Study Drug Given|3|||
13362664|NCT00875667|26690743|FG001|Overall Study|Randomized but no Study Drug Given|1|||
13362665|NCT00875615|26690750|FG000|Overall Study|Withdrawal by Subject|1|||
13362666|NCT00875563|26690756|FG000|Overall Study|Death|4|||
13362667|NCT00875563|26690756|FG000|Overall Study|Withdrawal by Subject|7|||
13362668|NCT00875563|26690756|FG000|Overall Study|No long-term (3-5 year) consent|6|||
13362669|NCT00875563|26690756|FG000|Overall Study|Still be eligible for follow-up|7|||
13362670|NCT00875524|26690779|FG000|Overall Study|Serious adverse event|0|||
13362671|NCT00875524|26690780|FG001|Overall Study|Serious adverse event|1|||
13362672|NCT00875524|26690779|FG000|Overall Study|Protocol Violation|4|||
13362673|NCT00875524|26690780|FG001|Overall Study|Protocol Violation|0|||
13204473|NCT01972841|26229051|FG003|Overall Study|Miscellaneous|1|||
13362674|NCT00875524|26690779|FG000|Overall Study|Lost to Follow-up|1|||
13362675|NCT00875524|26690780|FG001|Overall Study|Lost to Follow-up|0|||
13362676|NCT00875524|26690779|FG000|Overall Study|Withdrawal by Subject|3|||
13362677|NCT00875524|26690780|FG001|Overall Study|Withdrawal by Subject|5|||
13362678|NCT00875485|26690827|FG000|Challenge Dose Epoch|Pregnancy|1|||
13362679|NCT00875485|26690828|FG001|Challenge Dose Epoch|Pregnancy|0|||
13362680|NCT00875433|26690855|FG000|Overall Study|Progressive disease|41|||
13362681|NCT00875433|26690855|FG000|Overall Study|Other Adverse Event|14|||
13362682|NCT00875433|26690855|FG000|Overall Study|Withdrawal by Subject|2|||
13362683|NCT00875433|26690855|FG000|Overall Study|Other|3|||
13362684|NCT00875420|26690898|FG000|Overall Study|Adverse Event|0|||
13362685|NCT00875420|26690899|FG001|Overall Study|Adverse Event|1|||
13362686|NCT00875420|26690900|FG002|Overall Study|Adverse Event|1|||
13362687|NCT00875420|26690901|FG003|Overall Study|Adverse Event|0|||
13362688|NCT00875420|26690902|FG004|Overall Study|Adverse Event|0|||
13362689|NCT00875420|26690898|FG000|Overall Study|Inability to complete study procedures|1|||
13362690|NCT00875420|26690899|FG001|Overall Study|Inability to complete study procedures|0|||
13362691|NCT00875420|26690900|FG002|Overall Study|Inability to complete study procedures|1|||
13362692|NCT00875420|26690901|FG003|Overall Study|Inability to complete study procedures|1|||
13362693|NCT00875420|26690902|FG004|Overall Study|Inability to complete study procedures|1|||
13362694|NCT00875420|26690898|FG000|Overall Study|Lost to Follow-up|1|||
13362695|NCT00875420|26690899|FG001|Overall Study|Lost to Follow-up|0|||
13362696|NCT00875420|26690900|FG002|Overall Study|Lost to Follow-up|0|||
13362697|NCT00875420|26690901|FG003|Overall Study|Lost to Follow-up|0|||
13362698|NCT00875420|26690902|FG004|Overall Study|Lost to Follow-up|0|||
13362699|NCT00875420|26690898|FG000|Overall Study|Personal reason|0|||
13362700|NCT00875420|26690899|FG001|Overall Study|Personal reason|0|||
13362701|NCT00875420|26690900|FG002|Overall Study|Personal reason|0|||
13362702|NCT00875420|26690901|FG003|Overall Study|Personal reason|0|||
13362703|NCT00875420|26690902|FG004|Overall Study|Personal reason|1|||
13362704|NCT00875420|26690898|FG000|Overall Study|Prohibited medication|0|||
13362705|NCT00875420|26690899|FG001|Overall Study|Prohibited medication|0|||
13362706|NCT00875420|26690900|FG002|Overall Study|Prohibited medication|0|||
13362707|NCT00875420|26690901|FG003|Overall Study|Prohibited medication|1|||
13362708|NCT00875420|26690902|FG004|Overall Study|Prohibited medication|0|||
13362709|NCT00875420|26690898|FG000|Overall Study|Sponsor decision|0|||
13362710|NCT00875420|26690899|FG001|Overall Study|Sponsor decision|1|||
13362711|NCT00875420|26690900|FG002|Overall Study|Sponsor decision|0|||
13362712|NCT00875420|26690901|FG003|Overall Study|Sponsor decision|0|||
13362713|NCT00875420|26690902|FG004|Overall Study|Sponsor decision|0|||
13362714|NCT00875420|26690898|FG000|Overall Study|Withdrawal by Subject|0|||
13362715|NCT00875420|26690899|FG001|Overall Study|Withdrawal by Subject|0|||
13362716|NCT00875420|26690900|FG002|Overall Study|Withdrawal by Subject|1|||
13362717|NCT00875420|26690901|FG003|Overall Study|Withdrawal by Subject|0|||
13362718|NCT00875420|26690902|FG004|Overall Study|Withdrawal by Subject|0|||
13362719|NCT00875056|26690932|FG000|Overall Study|Adverse Event|6|||
13362720|NCT00875056|26690933|FG001|Overall Study|Adverse Event|1|||
13362721|NCT00875056|26690934|FG002|Overall Study|Adverse Event|2|||
13362722|NCT00875056|26690932|FG000|Overall Study|Progressive Disease|14|||
13362723|NCT00875056|26690933|FG001|Overall Study|Progressive Disease|8|||
13362724|NCT00875056|26690934|FG002|Overall Study|Progressive Disease|3|||
13362725|NCT00875056|26690932|FG000|Overall Study|Withdrawal by Subject|3|||
13362726|NCT00875056|26690933|FG001|Overall Study|Withdrawal by Subject|0|||
13362727|NCT00875056|26690934|FG002|Overall Study|Withdrawal by Subject|1|||
13362728|NCT00875017|26690967|FG000|First Intervention|Withdrawal by Subject|1|||
13362729|NCT00875017|26690968|FG001|First Intervention|Withdrawal by Subject|0|||
13362730|NCT00875017|26690969|FG002|First Intervention|Withdrawal by Subject|1|||
13362731|NCT00875017|26690970|FG003|First Intervention|Withdrawal by Subject|0|||
13362732|NCT00875017|26690971|FG004|First Intervention|Withdrawal by Subject|0|||
13362733|NCT00875017|26690972|FG005|First Intervention|Withdrawal by Subject|0|||
13362734|NCT00875017|26690967|FG000|First Intervention|Adverse Event|0|||
13362735|NCT00875017|26690968|FG001|First Intervention|Adverse Event|0|||
13362736|NCT00875017|26690969|FG002|First Intervention|Adverse Event|0|||
13362737|NCT00875017|26690970|FG003|First Intervention|Adverse Event|1|||
13362738|NCT00875017|26690971|FG004|First Intervention|Adverse Event|0|||
13362739|NCT00875017|26690972|FG005|First Intervention|Adverse Event|0|||
13362740|NCT00875017|26690967|FG000|First Intervention|Problems collecting rectal effluent|1|||
13362741|NCT00875017|26690968|FG001|First Intervention|Problems collecting rectal effluent|0|||
13362742|NCT00875017|26690969|FG002|First Intervention|Problems collecting rectal effluent|0|||
13362743|NCT00875017|26690970|FG003|First Intervention|Problems collecting rectal effluent|0|||
13362744|NCT00875017|26690971|FG004|First Intervention|Problems collecting rectal effluent|0|||
13362745|NCT00875017|26690972|FG005|First Intervention|Problems collecting rectal effluent|0|||
13362746|NCT00875017|26690967|FG000|First Intervention|Intolerance to nasogastric tube|0|||
13362747|NCT00875017|26690968|FG001|First Intervention|Intolerance to nasogastric tube|0|||
13362748|NCT00875017|26690969|FG002|First Intervention|Intolerance to nasogastric tube|0|||
13362749|NCT00875017|26690970|FG003|First Intervention|Intolerance to nasogastric tube|0|||
13362750|NCT00875017|26690971|FG004|First Intervention|Intolerance to nasogastric tube|1|||
13362751|NCT00875017|26690972|FG005|First Intervention|Intolerance to nasogastric tube|0|||
13362752|NCT00875017|26690967|FG000|Washout|Problem collecting rectal effluent|0|||
13362753|NCT00875017|26690968|FG001|Washout|Problem collecting rectal effluent|0|||
13362754|NCT00875017|26690969|FG002|Washout|Problem collecting rectal effluent|1|||
13362755|NCT00875017|26690970|FG003|Washout|Problem collecting rectal effluent|0|||
13362756|NCT00875017|26690971|FG004|Washout|Problem collecting rectal effluent|0|||
13362757|NCT00875017|26690972|FG005|Washout|Problem collecting rectal effluent|0|||
13362758|NCT00875017|26690967|FG000|Second Intervention|Adverse Event|0|||
13362759|NCT00875017|26690968|FG001|Second Intervention|Adverse Event|0|||
13362760|NCT00875017|26690969|FG002|Second Intervention|Adverse Event|0|||
13362761|NCT00875017|26690970|FG003|Second Intervention|Adverse Event|1|||
13362762|NCT00875017|26690971|FG004|Second Intervention|Adverse Event|0|||
13362763|NCT00875017|26690972|FG005|Second Intervention|Adverse Event|0|||
13362764|NCT00875017|26690967|FG000|Washout|Problems collecting rectal effluent|0|||
13362765|NCT00875017|26690968|FG001|Washout|Problems collecting rectal effluent|1|||
13362766|NCT00875017|26690969|FG002|Washout|Problems collecting rectal effluent|0|||
13362767|NCT00875017|26690970|FG003|Washout|Problems collecting rectal effluent|0|||
13362768|NCT00875017|26690971|FG004|Washout|Problems collecting rectal effluent|0|||
13362769|NCT00875017|26690972|FG005|Washout|Problems collecting rectal effluent|0|||
13362770|NCT00875017|26690967|FG000|Third Intervention|Adverse Event|0|||
13362771|NCT00875017|26690968|FG001|Third Intervention|Adverse Event|1|||
13362772|NCT00875017|26690969|FG002|Third Intervention|Adverse Event|1|||
13362773|NCT00875017|26690970|FG003|Third Intervention|Adverse Event|0|||
13362774|NCT00875017|26690971|FG004|Third Intervention|Adverse Event|0|||
13362775|NCT00875017|26690972|FG005|Third Intervention|Adverse Event|0|||
13362776|NCT00875017|26690967|FG000|Washout|Withdrawal by Subject|0|||
13362777|NCT00875017|26690968|FG001|Washout|Withdrawal by Subject|0|||
13362778|NCT00875017|26690969|FG002|Washout|Withdrawal by Subject|0|||
13362779|NCT00875017|26690970|FG003|Washout|Withdrawal by Subject|0|||
13362780|NCT00875017|26690971|FG004|Washout|Withdrawal by Subject|1|||
13362781|NCT00875017|26690972|FG005|Washout|Withdrawal by Subject|0|||
13362782|NCT00875017|26690967|FG000|Fourth Intervention|Inability to comply with fasting|0|||
13362783|NCT00875017|26690968|FG001|Fourth Intervention|Inability to comply with fasting|0|||
13362784|NCT00875017|26690969|FG002|Fourth Intervention|Inability to comply with fasting|0|||
13362785|NCT00875017|26690970|FG003|Fourth Intervention|Inability to comply with fasting|0|||
13362786|NCT00875017|26690971|FG004|Fourth Intervention|Inability to comply with fasting|0|||
13362787|NCT00875017|26690972|FG005|Fourth Intervention|Inability to comply with fasting|1|||
13362788|NCT00874939|26690988|FG000|Overall Study|Study terminated|4|||
13362789|NCT00874848|26691011|FG000|Overall Study|Adverse Event|13|||
13362790|NCT00874848|26691012|FG001|Overall Study|Adverse Event|2|||
13362791|NCT00874848|26691011|FG000|Overall Study|Progressive neoplastic disease|38|||
13362792|NCT00874848|26691012|FG001|Overall Study|Progressive neoplastic disease|18|||
13362793|NCT00874848|26691011|FG000|Overall Study|Withdrawal by Subject|7|||
13362794|NCT00874848|26691012|FG001|Overall Study|Withdrawal by Subject|4|||
13362795|NCT00874848|26691011|FG000|Overall Study|Noncompliance|1|||
13362796|NCT00874848|26691012|FG001|Overall Study|Noncompliance|1|||
13362797|NCT00874848|26691011|FG000|Overall Study|Failure to comply with protocol|0|||
13362798|NCT00874848|26691012|FG001|Overall Study|Failure to comply with protocol|1|||
13362799|NCT00874848|26691011|FG000|Overall Study|Physician Decision|0|||
13362800|NCT00874848|26691012|FG001|Overall Study|Physician Decision|2|||
13362801|NCT00874822|26691018|FG000|Overall Study|excluded by criteria|8|||
13362802|NCT00874770|26691065|FG000|Overall Study|Lack of Efficacy|2|||
13362803|NCT00874770|26691066|FG001|Overall Study|Lack of Efficacy|0|||
13362804|NCT00874770|26691067|FG002|Overall Study|Lack of Efficacy|0|||
13362805|NCT00874770|26691068|FG003|Overall Study|Lack of Efficacy|2|||
13362806|NCT00874770|26691065|FG000|Overall Study|Adverse Event|1|||
13362807|NCT00874770|26691066|FG001|Overall Study|Adverse Event|1|||
13362808|NCT00874770|26691067|FG002|Overall Study|Adverse Event|4|||
13362809|NCT00874770|26691068|FG003|Overall Study|Adverse Event|2|||
13362810|NCT00874770|26691065|FG000|Overall Study|Lost to Follow-up|1|||
13362811|NCT00874770|26691066|FG001|Overall Study|Lost to Follow-up|0|||
13362812|NCT00874770|26691067|FG002|Overall Study|Lost to Follow-up|0|||
13362813|NCT00874770|26691068|FG003|Overall Study|Lost to Follow-up|1|||
13362814|NCT00874770|26691065|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
13362815|NCT00874770|26691066|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
13362816|NCT00874770|26691067|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
13362817|NCT00874770|26691068|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
13362818|NCT00874731|26691101|FG000|Part 1, Day 1: Placebo|Disease Progression|1|||
13362819|NCT00874731|26691102|FG001|Part 1, Day 1: Placebo|Disease Progression|0|||
13362820|NCT00874731|26691103|FG002|Part 1, Day 1: Placebo|Disease Progression|0|||
13362821|NCT00874731|26691101|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
13362822|NCT00874731|26691102|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
13362823|NCT00874731|26691103|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3|||
13362824|NCT00874731|26691101|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
13362825|NCT00874731|26691102|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
13362826|NCT00874731|26691103|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19|||
13362827|NCT00874549|26691182|FG000|Overall Study|Adverse Event|0|||
13362828|NCT00874549|26691183|FG001|Overall Study|Adverse Event|0|||
13362829|NCT00874549|26691184|FG002|Overall Study|Adverse Event|1|||
13362830|NCT00874549|26691185|FG003|Overall Study|Adverse Event|0|||
13362831|NCT00874549|26691182|FG000|Overall Study|Protocol Violation|1|||
13362832|NCT00874549|26691183|FG001|Overall Study|Protocol Violation|0|||
13362833|NCT00874549|26691184|FG002|Overall Study|Protocol Violation|2|||
13362834|NCT00874549|26691185|FG003|Overall Study|Protocol Violation|1|||
13362835|NCT00874549|26691182|FG000|Overall Study|Lost to Follow-up|0|||
13362836|NCT00874549|26691183|FG001|Overall Study|Lost to Follow-up|0|||
13362837|NCT00874549|26691184|FG002|Overall Study|Lost to Follow-up|1|||
13362838|NCT00874549|26691185|FG003|Overall Study|Lost to Follow-up|0|||
13362839|NCT00874549|26691182|FG000|Overall Study|Withdrawal by Subject|0|||
13362840|NCT00874549|26691183|FG001|Overall Study|Withdrawal by Subject|1|||
13362841|NCT00874549|26691184|FG002|Overall Study|Withdrawal by Subject|0|||
13362842|NCT00874549|26691185|FG003|Overall Study|Withdrawal by Subject|1|||
13362843|NCT00874497|26691230|FG000|Overall Study|Lost to Follow-up|2|||
13362844|NCT00874497|26691231|FG001|Overall Study|Lost to Follow-up|4|||
13362845|NCT00874497|26691230|FG000|Overall Study|Adverse Event|9|||
13362846|NCT00874497|26691231|FG001|Overall Study|Adverse Event|4|||
13362847|NCT00874497|26691230|FG000|Overall Study|Sponsor Discontinued Trial|7|||
13362848|NCT00874497|26691231|FG001|Overall Study|Sponsor Discontinued Trial|3|||
13362849|NCT00874497|26691230|FG000|Overall Study|Met Withdrawal Criteria|4|||
13362850|NCT00874497|26691231|FG001|Overall Study|Met Withdrawal Criteria|2|||
13362851|NCT00874497|26691230|FG000|Overall Study|Physician Decision|1|||
13362852|NCT00874497|26691231|FG001|Overall Study|Physician Decision|1|||
13362853|NCT00874497|26691230|FG000|Overall Study|Withdrawal by Subject|5|||
13362854|NCT00874497|26691231|FG001|Overall Study|Withdrawal by Subject|4|||
13362855|NCT00874432|26691260|FG000|Overall Study|Withdrawal by Subject|1|||
13362856|NCT00874432|26691261|FG001|Overall Study|Withdrawal by Subject|0|||
13362857|NCT00874432|26691262|FG002|Overall Study|Withdrawal by Subject|0|||
13362858|NCT00874432|26691263|FG003|Overall Study|Withdrawal by Subject|0|||
13362859|NCT00874432|26691260|FG000|Overall Study|Physician Decision|1|||
13362860|NCT00874432|26691261|FG001|Overall Study|Physician Decision|0|||
13362861|NCT00874432|26691262|FG002|Overall Study|Physician Decision|0|||
13362862|NCT00874432|26691263|FG003|Overall Study|Physician Decision|0|||
13362863|NCT00874432|26691260|FG000|Overall Study|Other|1|||
13362864|NCT00874432|26691261|FG001|Overall Study|Other|2|||
13362865|NCT00874432|26691262|FG002|Overall Study|Other|8|||
13362866|NCT00874432|26691263|FG003|Overall Study|Other|3|||
13362867|NCT00874276|26691278|FG000|Overall Study|Withdrawal by Subject|1|||
13362868|NCT00874276|26691279|FG001|Overall Study|Withdrawal by Subject|1|||
13362869|NCT00874237|26691302|FG000|Overall Study|Physician Decision|0|||
13362870|NCT00874237|26691303|FG001|Overall Study|Physician Decision|1|||
13362871|NCT00874237|26691304|FG002|Overall Study|Physician Decision|0|||
13362872|NCT00874237|26691305|FG003|Overall Study|Physician Decision|0|||
13362873|NCT00874237|26691306|FG004|Overall Study|Physician Decision|0|||
13362874|NCT00874237|26691307|FG005|Overall Study|Physician Decision|0|||
13362875|NCT00874237|26691302|FG000|Overall Study|Withdrawal by Subject|0|||
13362876|NCT00874237|26691303|FG001|Overall Study|Withdrawal by Subject|0|||
13362877|NCT00874237|26691304|FG002|Overall Study|Withdrawal by Subject|1|||
13362878|NCT00874237|26691305|FG003|Overall Study|Withdrawal by Subject|0|||
13362879|NCT00874237|26691306|FG004|Overall Study|Withdrawal by Subject|0|||
13362880|NCT00874237|26691307|FG005|Overall Study|Withdrawal by Subject|0|||
13362881|NCT00874120|26691320|FG000|First Intervention|Adverse Event|0|||
13362882|NCT00874120|26691321|FG001|First Intervention|Adverse Event|1|||
13362883|NCT00874120|26691320|FG000|First Intervention|Withdrawal by Subject|2|||
13362884|NCT00874120|26691321|FG001|First Intervention|Withdrawal by Subject|0|||
13362885|NCT00874120|26691320|FG000|First Intervention|Lost to Follow-up|0|||
13362886|NCT00874120|26691321|FG001|First Intervention|Lost to Follow-up|1|||
13362887|NCT00874120|26691320|FG000|First Intervention|Protocol Violation|3|||
13362888|NCT00874120|26691321|FG001|First Intervention|Protocol Violation|0|||
13362889|NCT00874120|26691320|FG000|First Intervention|positive drug test|1|||
13362890|NCT00874120|26691321|FG001|First Intervention|positive drug test|0|||
13362891|NCT00874120|26691320|FG000|Second Intervention|Withdrawal by Subject|1|||
13362892|NCT00874120|26691321|FG001|Second Intervention|Withdrawal by Subject|0|||
13362893|NCT00874120|26691320|FG000|Second Intervention|Protocol Violation|1|||
13362894|NCT00874120|26691321|FG001|Second Intervention|Protocol Violation|0|||
13362895|NCT00874029|26691337|FG000|Overall Study|Withdrawal by Subject|10|||
13362896|NCT00874029|26691337|FG000|Overall Study|Pregnancy|4|||
13362897|NCT00874029|26691337|FG000|Overall Study|Physician Decision|1|||
13362898|NCT00874029|26691337|FG000|Overall Study|Adverse Event|1|||
13362899|NCT00874029|26691337|FG000|Overall Study|Lost to Follow-up|5|||
13375021|NCT00792298|26728959|FG000|Treatment Period 2|Withdrawal by Subject|1|||
13375022|NCT00792298|26728960|FG001|Treatment Period 2|Withdrawal by Subject|1|||
13375023|NCT00792298|26728961|FG002|Treatment Period 2|Withdrawal by Subject|0|||
13375024|NCT00792298|26728962|FG003|Treatment Period 2|Withdrawal by Subject|2|||
13375025|NCT00792298|26728963|FG004|Treatment Period 2|Withdrawal by Subject|1|||
13375026|NCT00792298|26728964|FG005|Treatment Period 2|Withdrawal by Subject|0|||
13375027|NCT00792298|26728965|FG006|Treatment Period 2|Withdrawal by Subject|0|||
13375028|NCT00792298|26728966|FG007|Treatment Period 2|Withdrawal by Subject|2|||
13375029|NCT00792259|26728984|FG000|Overall Study|Poor Quality Scans|1|||
13375030|NCT00792259|26728985|FG001|Overall Study|Poor Quality Scans|0|||
13375031|NCT00792259|26728986|FG002|Overall Study|Poor Quality Scans|0|||
13375032|NCT00792103|26728996|FG000|Overall Study|Enrolled, not treated|15|||
13375033|NCT00792103|26728996|FG000|Overall Study|Lost to Follow-up|17|||
13375034|NCT00792103|26728996|FG000|Overall Study|Adverse Event|25|||
13375035|NCT00792103|26728996|FG000|Overall Study|Withdrawal by Subject|52|||
13375036|NCT00792103|26728996|FG000|Overall Study|Protocol Violation|10|||
13375037|NCT00792103|26728996|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14|||
13375038|NCT00791999|26729023|FG000|Overall Study|Protocol planed withdrawal|14|||
13375039|NCT00791999|26729024|FG001|Overall Study|Protocol planed withdrawal|11|||
13375040|NCT00791999|26729025|FG002|Overall Study|Protocol planed withdrawal|11|||
13375041|NCT00791999|26729026|FG003|Overall Study|Protocol planed withdrawal|45|||
13375042|NCT00791999|26729023|FG000|Overall Study|Withdrawal by Subject|0|||
13375043|NCT00791999|26729024|FG001|Overall Study|Withdrawal by Subject|1|||
13375044|NCT00791999|26729025|FG002|Overall Study|Withdrawal by Subject|0|||
13375045|NCT00791999|26729026|FG003|Overall Study|Withdrawal by Subject|2|||
13375046|NCT00791999|26729023|FG000|Overall Study|Protocol Violation|3|||
13375047|NCT00791999|26729024|FG001|Overall Study|Protocol Violation|0|||
13375048|NCT00791999|26729025|FG002|Overall Study|Protocol Violation|1|||
13375049|NCT00791999|26729026|FG003|Overall Study|Protocol Violation|0|||
13362900|NCT00873912|26691358|FG000|Overall Study|Withdrawal by Subject|1|||
13362901|NCT00873912|26691359|FG001|Overall Study|Withdrawal by Subject|0|||
13362902|NCT00873912|26691358|FG000|Overall Study|Lost to Follow-up|2|||
13362903|NCT00873912|26691359|FG001|Overall Study|Lost to Follow-up|0|||
13362904|NCT00873860|26691441|FG000|Overall Study|Lost to Follow-up|1|||
13362905|NCT00873860|26691442|FG001|Overall Study|Lost to Follow-up|0|||
13362906|NCT00873860|26691443|FG002|Overall Study|Lost to Follow-up|0|||
13362907|NCT00873860|26691444|FG003|Overall Study|Lost to Follow-up|1|||
13362908|NCT00873860|26691441|FG000|Overall Study|Withdrawal by Subject|1|||
13362909|NCT00873860|26691442|FG001|Overall Study|Withdrawal by Subject|0|||
13362910|NCT00873860|26691443|FG002|Overall Study|Withdrawal by Subject|2|||
13362911|NCT00873860|26691444|FG003|Overall Study|Withdrawal by Subject|0|||
13362912|NCT00873860|26691441|FG000|Overall Study|Death|1|||
13362913|NCT00873860|26691442|FG001|Overall Study|Death|0|||
13362914|NCT00873860|26691443|FG002|Overall Study|Death|0|||
13362915|NCT00873860|26691444|FG003|Overall Study|Death|0|||
13362916|NCT00873860|26691441|FG000|Overall Study|Other|1|||
13362917|NCT00873860|26691442|FG001|Overall Study|Other|0|||
13362918|NCT00873860|26691443|FG002|Overall Study|Other|1|||
13362919|NCT00873860|26691444|FG003|Overall Study|Other|0|||
13362920|NCT00873730|26691487|FG000|Overall Study|Protocol Deviation|5|||
13362921|NCT00873730|26691488|FG001|Overall Study|Protocol Deviation|2|||
13362922|NCT00873730|26691487|FG000|Overall Study|Adverse Event|0|||
13362923|NCT00873730|26691488|FG001|Overall Study|Adverse Event|2|||
13362924|NCT00873730|26691487|FG000|Overall Study|Withdrawal by Subject|0|||
13362925|NCT00873730|26691488|FG001|Overall Study|Withdrawal by Subject|1|||
13362926|NCT00873730|26691487|FG000|Overall Study|Sponsor decision|1|||
13362927|NCT00873730|26691488|FG001|Overall Study|Sponsor decision|0|||
13362928|NCT00873366|26691509|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1|||
13362929|NCT00873366|26691509|FG000|Overall Study|Off tamoxifen due to side effects|2|||
13362930|NCT00873366|26691509|FG000|Overall Study|Refused to continue DM-BT testing|3|||
13362931|NCT00873119|26691532|FG000|Overall Study|Patient request|4|||
13362932|NCT00873119|26691533|FG001|Overall Study|Patient request|2|||
13362933|NCT00873119|26691532|FG000|Overall Study|Adverse Event|8|||
13362934|NCT00873119|26691533|FG001|Overall Study|Adverse Event|0|||
13362935|NCT00873119|26691532|FG000|Overall Study|Progressive disease|26|||
13362936|NCT00873119|26691533|FG001|Overall Study|Progressive disease|18|||
13362937|NCT00873119|26691532|FG000|Overall Study|Death|2|||
13362938|NCT00873119|26691533|FG001|Overall Study|Death|1|||
13362939|NCT00873119|26691532|FG000|Overall Study|Other|2|||
13362940|NCT00873119|26691533|FG001|Overall Study|Other|5|||
13362941|NCT00873119|26691532|FG000|Overall Study|Not treated|2|||
13362942|NCT00873119|26691533|FG001|Overall Study|Not treated|0|||
13362943|NCT00873093|26691603|FG000|Overall Study|Adverse Event|0|||
13362944|NCT00873093|26691604|FG001|Overall Study|Adverse Event|2|||
13362945|NCT00873093|26691605|FG002|Overall Study|Adverse Event|0|||
13362946|NCT00873093|26691606|FG003|Overall Study|Adverse Event|0|||
13362947|NCT00873093|26691607|FG004|Overall Study|Adverse Event|0|||
13362948|NCT00873093|26691603|FG000|Overall Study|Death|0|||
13362949|NCT00873093|26691604|FG001|Overall Study|Death|3|||
13362950|NCT00873093|26691605|FG002|Overall Study|Death|2|||
13362951|NCT00873093|26691606|FG003|Overall Study|Death|0|||
13362952|NCT00873093|26691607|FG004|Overall Study|Death|0|||
13362953|NCT00873093|26691603|FG000|Overall Study|Physician Decision|0|||
13362954|NCT00873093|26691604|FG001|Overall Study|Physician Decision|17|||
13362955|NCT00873093|26691605|FG002|Overall Study|Physician Decision|10|||
13362956|NCT00873093|26691606|FG003|Overall Study|Physician Decision|10|||
13362957|NCT00873093|26691607|FG004|Overall Study|Physician Decision|2|||
13362958|NCT00873093|26691603|FG000|Overall Study|Withdrawal by Subject|1|||
13362959|NCT00873093|26691604|FG001|Overall Study|Withdrawal by Subject|4|||
13362960|NCT00873093|26691605|FG002|Overall Study|Withdrawal by Subject|4|||
13362961|NCT00873093|26691606|FG003|Overall Study|Withdrawal by Subject|0|||
13362962|NCT00873093|26691607|FG004|Overall Study|Withdrawal by Subject|0|||
13362963|NCT00873093|26691603|FG000|Overall Study|Ineligible|0|||
13362964|NCT00873093|26691604|FG001|Overall Study|Ineligible|1|||
13362965|NCT00873093|26691605|FG002|Overall Study|Ineligible|0|||
13362966|NCT00873093|26691606|FG003|Overall Study|Ineligible|1|||
13362967|NCT00873093|26691607|FG004|Overall Study|Ineligible|0|||
13362968|NCT00873041|26691671|FG000|Core Study|Adverse Event|2|||
13362969|NCT00873041|26691672|FG001|Core Study|Adverse Event|3|||
13362970|NCT00873041|26691673|FG002|Core Study|Adverse Event|1|||
13362971|NCT00873041|26691671|FG000|Core Study|Withdrawal by Subject|1|||
13362972|NCT00873041|26691672|FG001|Core Study|Withdrawal by Subject|2|||
13362973|NCT00873041|26691673|FG002|Core Study|Withdrawal by Subject|2|||
13362974|NCT00873041|26691671|FG000|Core Study|Lost to Follow-up|3|||
13362975|NCT00873041|26691672|FG001|Core Study|Lost to Follow-up|1|||
13362976|NCT00873041|26691673|FG002|Core Study|Lost to Follow-up|0|||
13362977|NCT00873041|26691671|FG000|Core Study|Abnormal laboratory value|0|||
13362978|NCT00873041|26691672|FG001|Core Study|Abnormal laboratory value|0|||
13362979|NCT00873041|26691673|FG002|Core Study|Abnormal laboratory value|1|||
13362980|NCT00873041|26691671|FG000|Core Study|Protocol deviation|1|||
13362981|NCT00873041|26691672|FG001|Core Study|Protocol deviation|0|||
13362982|NCT00873041|26691673|FG002|Core Study|Protocol deviation|1|||
13362983|NCT00873041|26691671|FG000|Extension Study|Adverse Event|1|||
13362984|NCT00873041|26691672|FG001|Extension Study|Adverse Event|0|||
13362985|NCT00873041|26691673|FG002|Extension Study|Adverse Event|1|||
13362986|NCT00873041|26691671|FG000|Extension Study|Administrative reasons|0|||
13362987|NCT00873041|26691672|FG001|Extension Study|Administrative reasons|0|||
13362988|NCT00873041|26691673|FG002|Extension Study|Administrative reasons|1|||
13362989|NCT00873015|26691701|FG000|Overall Study|Withdrawal by Subject|0|||
13362990|NCT00873015|26691702|FG001|Overall Study|Withdrawal by Subject|1|||
13362991|NCT00873015|26691703|FG002|Overall Study|Withdrawal by Subject|0|||
13362992|NCT00873015|26691704|FG003|Overall Study|Withdrawal by Subject|0|||
13362993|NCT00872989|26691727|FG000|Overall Study|Adverse Event|7|||
13362994|NCT00872989|26691728|FG001|Overall Study|Adverse Event|15|||
13362995|NCT00872989|26691727|FG000|Overall Study|Withdrawal by Subject|8|||
13362996|NCT00872989|26691728|FG001|Overall Study|Withdrawal by Subject|5|||
13362997|NCT00872989|26691727|FG000|Overall Study|Progression/relapse|47|||
13362998|NCT00872989|26691728|FG001|Overall Study|Progression/relapse|35|||
13362999|NCT00872989|26691727|FG000|Overall Study|Not protocol specified|3|||
13363000|NCT00872989|26691728|FG001|Overall Study|Not protocol specified|8|||
13363001|NCT00872898|26691771|FG000|Part Two - Double Blind|Adverse Event|4|||
13363002|NCT00872898|26691772|FG001|Part Two - Double Blind|Adverse Event|3|||
13363003|NCT00872898|26691771|FG000|Part Two - Double Blind|Lack of Efficacy|1|||
13363004|NCT00872898|26691772|FG001|Part Two - Double Blind|Lack of Efficacy|0|||
13363005|NCT00872898|26691771|FG000|Part Two - Double Blind|Protocol Violation|1|||
13363006|NCT00872898|26691772|FG001|Part Two - Double Blind|Protocol Violation|0|||
13363007|NCT00872898|26691771|FG000|Part Two - Double Blind|Withdrawal by Subject|3|||
13363008|NCT00872898|26691772|FG001|Part Two - Double Blind|Withdrawal by Subject|1|||
13363009|NCT00872898|26691771|FG000|Part Two - Double Blind|Lost to Follow-up|0|||
13363010|NCT00872898|26691772|FG001|Part Two - Double Blind|Lost to Follow-up|2|||
13363011|NCT00872898|26691771|FG000|Part Two - Double Blind|Other reasons|2|||
13363012|NCT00872898|26691772|FG001|Part Two - Double Blind|Other reasons|0|||
13363013|NCT00872599|26691783|FG000|Second Washout Period|Adverse Event|1|||
13363014|NCT00872599|26691784|FG001|Second Washout Period|Adverse Event|1|||
13363015|NCT00872521|26691840|FG000|Completed PAD Induction|Patient choice|0|||
13363016|NCT00872521|26691841|FG001|Completed PAD Induction|Patient choice|1|||
13363017|NCT00872521|26691842|FG002|Completed PAD Induction|Patient choice|0|||
13363018|NCT00872521|26691840|FG000|Completed PAD Induction|Disease progression|0|||
13363019|NCT00872521|26691841|FG001|Completed PAD Induction|Disease progression|2|||
13363020|NCT00872521|26691842|FG002|Completed PAD Induction|Disease progression|0|||
13363021|NCT00872521|26691840|FG000|Completed PAD Induction|Adverse Event|4|||
13363022|NCT00872521|26691841|FG001|Completed PAD Induction|Adverse Event|0|||
13363023|NCT00872521|26691842|FG002|Completed PAD Induction|Adverse Event|0|||
13363024|NCT00872521|26691840|FG000|Completed PAD Induction|Death|1|||
13363025|NCT00872521|26691841|FG001|Completed PAD Induction|Death|1|||
13363026|NCT00872521|26691842|FG002|Completed PAD Induction|Death|0|||
13363027|NCT00872521|26691840|FG000|Primary Endpoint Analysis|Other|1|||
13363028|NCT00872521|26691841|FG001|Primary Endpoint Analysis|Other|2|||
13363029|NCT00872521|26691842|FG002|Primary Endpoint Analysis|Other|0|||
13363030|NCT00872521|26691840|FG000|Primary Endpoint Analysis|Patient choice|0|||
13363031|NCT00872521|26691841|FG001|Primary Endpoint Analysis|Patient choice|1|||
13363032|NCT00872521|26691842|FG002|Primary Endpoint Analysis|Patient choice|0|||
13363033|NCT00872521|26691840|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0|||
13363034|NCT00872521|26691841|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2|||
13363035|NCT00872521|26691842|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0|||
13363036|NCT00872521|26691840|FG000|Primary Endpoint Analysis|Patient response missing|0|||
13363037|NCT00872521|26691841|FG001|Primary Endpoint Analysis|Patient response missing|0|||
13363038|NCT00872521|26691842|FG002|Primary Endpoint Analysis|Patient response missing|1|||
13363039|NCT00872521|26691840|FG000|Completed 3-month Follow up|Other|0|||
13363040|NCT00872521|26691841|FG001|Completed 3-month Follow up|Other|2|||
13363041|NCT00872521|26691842|FG002|Completed 3-month Follow up|Other|0|||
13363042|NCT00872521|26691840|FG000|Completed 3-month Follow up|Physician Decision|0|||
13363043|NCT00872521|26691841|FG001|Completed 3-month Follow up|Physician Decision|1|||
13363044|NCT00872521|26691842|FG002|Completed 3-month Follow up|Physician Decision|0|||
13363045|NCT00872521|26691840|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0|||
13363046|NCT00872521|26691841|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2|||
13363047|NCT00872521|26691842|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1|||
13363048|NCT00872170|26691864|FG000|Overall Study|Adverse Event|1|||
13363049|NCT00872170|26691865|FG001|Overall Study|Adverse Event|0|||
13363050|NCT00872001|26691880|FG000|Overall Study|Adverse Event|34|||
13363051|NCT00872001|26691881|FG001|Overall Study|Adverse Event|23|||
13363052|NCT00872001|26691880|FG000|Overall Study|Protocol Defined Clinical Event|5|||
13363053|NCT00872001|26691881|FG001|Overall Study|Protocol Defined Clinical Event|7|||
13363054|NCT00872001|26691880|FG000|Overall Study|Lost to Follow-up|13|||
13363055|NCT00872001|26691881|FG001|Overall Study|Lost to Follow-up|12|||
13363056|NCT00872001|26691880|FG000|Overall Study|Withdrawal by Subject|18|||
13363057|NCT00872001|26691881|FG001|Overall Study|Withdrawal by Subject|30|||
13363058|NCT00872001|26691880|FG000|Overall Study|Protocol Violation|5|||
13363059|NCT00872001|26691881|FG001|Overall Study|Protocol Violation|8|||
13363060|NCT00872001|26691880|FG000|Overall Study|Did Not Meet Protocol Eligibility|38|||
13363061|NCT00872001|26691881|FG001|Overall Study|Did Not Meet Protocol Eligibility|36|||
13363062|NCT00872001|26691880|FG000|Overall Study|Administrative|23|||
13363063|NCT00872001|26691881|FG001|Overall Study|Administrative|15|||
13363064|NCT00871975|26691887|FG000|Overall Study|Technical difficulty w155-1ith equipment|3|||
13363065|NCT00871975|26691887|FG000|Overall Study|Catheters could not be inserted|1|||
13363066|NCT00871975|26691887|FG000|Overall Study|Patient unable to void/insufficient vol|13|||
13363067|NCT00871975|26691887|FG000|Overall Study|Motion artifact, tracing uninterpretable|5|||
13363068|NCT00871923|26691894|FG000|Overall Study|Death|1|||
13363069|NCT00871923|26691894|FG000|Overall Study|Withdrawal by Subject|1|||
13363070|NCT00871871|26691923|FG000|Part I|Adverse Event|0|||
13363071|NCT00871871|26691924|FG001|Part I|Adverse Event|2|||
13363072|NCT00871871|26691925|FG002|Part I|Adverse Event|0|||
13363073|NCT00871871|26691926|FG003|Part I|Adverse Event|0|||
13363074|NCT00871871|26691923|FG000|Part I|Withdrawal by Subject|3|||
13363075|NCT00871871|26691924|FG001|Part I|Withdrawal by Subject|0|||
13363076|NCT00871871|26691925|FG002|Part I|Withdrawal by Subject|0|||
13363077|NCT00871871|26691926|FG003|Part I|Withdrawal by Subject|0|||
13363078|NCT00871871|26691923|FG000|Part I|Laboratory abnormality|0|||
13363079|NCT00871871|26691924|FG001|Part I|Laboratory abnormality|1|||
13363080|NCT00871871|26691925|FG002|Part I|Laboratory abnormality|0|||
13363081|NCT00871871|26691926|FG003|Part I|Laboratory abnormality|0|||
13363082|NCT00871871|26691923|FG000|Part II|Lack of Efficacy|0|||
13363083|NCT00871871|26691924|FG001|Part II|Lack of Efficacy|0|||
13363084|NCT00871871|26691925|FG002|Part II|Lack of Efficacy|1|||
13363085|NCT00871871|26691926|FG003|Part II|Lack of Efficacy|0|||
13363086|NCT00871871|26691923|FG000|Part II|Withdrawal by Subject|0|||
13363087|NCT00871871|26691924|FG001|Part II|Withdrawal by Subject|0|||
13363088|NCT00871871|26691925|FG002|Part II|Withdrawal by Subject|2|||
13363089|NCT00871871|26691926|FG003|Part II|Withdrawal by Subject|1|||
13363090|NCT00871871|26691923|FG000|Part II|Adverse Event|0|||
13363091|NCT00871871|26691924|FG001|Part II|Adverse Event|0|||
13363092|NCT00871871|26691925|FG002|Part II|Adverse Event|1|||
13363093|NCT00871871|26691926|FG003|Part II|Adverse Event|2|||
13363094|NCT00871871|26691923|FG000|Part II|Protocol Violation|0|||
13363095|NCT00871871|26691924|FG001|Part II|Protocol Violation|0|||
13363096|NCT00871871|26691925|FG002|Part II|Protocol Violation|0|||
13363097|NCT00871871|26691926|FG003|Part II|Protocol Violation|1|||
13363098|NCT00871858|26691947|FG000|Overall Study|Protocol Violation|3|||
13363099|NCT00871858|26691948|FG001|Overall Study|Protocol Violation|4|||
13363100|NCT00871858|26691947|FG000|Overall Study|Adverse Event|1|||
13363101|NCT00871858|26691948|FG001|Overall Study|Adverse Event|1|||
13363102|NCT00871858|26691947|FG000|Overall Study|Withdrawal by Subject|1|||
13363103|NCT00871858|26691948|FG001|Overall Study|Withdrawal by Subject|1|||
13363104|NCT00871858|26691947|FG000|Overall Study|Lost to Follow-up|0|||
13363105|NCT00871858|26691948|FG001|Overall Study|Lost to Follow-up|1|||
13363106|NCT00871780|26691968|FG000|Overall Study|Enrolled But Not Treated|6|||
13363107|NCT00871780|26691968|FG000|Overall Study|Withdrawal by Subject|9|||
13363108|NCT00871780|26691968|FG000|Overall Study|Adverse Event|6|||
13363109|NCT00871780|26691968|FG000|Overall Study|Voluntary Discontinuation|4|||
13363110|NCT00871780|26691968|FG000|Overall Study|Death|1|||
13363111|NCT00871780|26691968|FG000|Overall Study|Physician Decision|1|||
13363112|NCT00871741|26691989|FG000|Overall Study|Premature study termination|9|||
13363113|NCT00871741|26691990|FG001|Overall Study|Premature study termination|7|||
13363114|NCT00871728|26692002|FG000|Overall Study|Adverse Event|1|||
13363115|NCT00871728|26692002|FG000|Overall Study|Protocol Violation|7|||
13363116|NCT00871728|26692002|FG000|Overall Study|Lost to Follow-up|2|||
13363117|NCT00871728|26692002|FG000|Overall Study|Failed to Visit Hospital|4|||
13363118|NCT00871728|26692002|FG000|Overall Study|Participant Non-compliance|1|||
13363119|NCT00871728|26692002|FG000|Overall Study|Withdrawal of Informed Consent|5|||
13363120|NCT00871715|26692063|FG000|Overall Study|Withdrawal by Subject|6|||
13363121|NCT00871715|26692064|FG001|Overall Study|Withdrawal by Subject|10|||
13363122|NCT00871715|26692065|FG002|Overall Study|Withdrawal by Subject|15|||
13363123|NCT00871715|26692063|FG000|Overall Study|Physician Decision|6|||
13363124|NCT00871715|26692064|FG001|Overall Study|Physician Decision|0|||
13363125|NCT00871715|26692065|FG002|Overall Study|Physician Decision|2|||
13363126|NCT00871715|26692063|FG000|Overall Study|Lost to Follow-up|3|||
13363127|NCT00871715|26692064|FG001|Overall Study|Lost to Follow-up|6|||
13363128|NCT00871715|26692065|FG002|Overall Study|Lost to Follow-up|9|||
13363129|NCT00871572|26692148|FG000|Overall Study|Adverse Event|0|||
13363130|NCT00871572|26692149|FG001|Overall Study|Adverse Event|2|||
13363131|NCT00871572|26692150|FG002|Overall Study|Adverse Event|0|||
13363132|NCT00871572|26692151|FG003|Overall Study|Adverse Event|3|||
13363133|NCT00871572|26692148|FG000|Overall Study|Investigator Decision|0|||
13363134|NCT00871572|26692149|FG001|Overall Study|Investigator Decision|1|||
13363135|NCT00871572|26692150|FG002|Overall Study|Investigator Decision|0|||
13363136|NCT00871572|26692151|FG003|Overall Study|Investigator Decision|1|||
13363137|NCT00871572|26692148|FG000|Overall Study|Lost to Follow-up|0|||
13363138|NCT00871572|26692149|FG001|Overall Study|Lost to Follow-up|1|||
13363139|NCT00871572|26692150|FG002|Overall Study|Lost to Follow-up|0|||
13363140|NCT00871572|26692151|FG003|Overall Study|Lost to Follow-up|1|||
13363141|NCT00871572|26692148|FG000|Overall Study|Protocol Violation|0|||
13363142|NCT00871572|26692149|FG001|Overall Study|Protocol Violation|0|||
13363143|NCT00871572|26692150|FG002|Overall Study|Protocol Violation|1|||
13363144|NCT00871572|26692151|FG003|Overall Study|Protocol Violation|1|||
13363145|NCT00871572|26692148|FG000|Overall Study|Sponsor Decision|1|||
13363146|NCT00871572|26692149|FG001|Overall Study|Sponsor Decision|0|||
13363147|NCT00871572|26692150|FG002|Overall Study|Sponsor Decision|0|||
13363148|NCT00871572|26692151|FG003|Overall Study|Sponsor Decision|0|||
13363149|NCT00871572|26692148|FG000|Overall Study|Withdrawal by Subject|1|||
13363150|NCT00871572|26692149|FG001|Overall Study|Withdrawal by Subject|2|||
13363151|NCT00871572|26692150|FG002|Overall Study|Withdrawal by Subject|3|||
13363152|NCT00871572|26692151|FG003|Overall Study|Withdrawal by Subject|1|||
13363153|NCT00871494|26692160|FG000|Overall Study|Protocol Violation|5|||
13363154|NCT00871494|26692160|FG000|Overall Study|Lack of Efficacy|4|||
13363155|NCT00871494|26692160|FG000|Overall Study|Adverse Event|4|||
13363156|NCT00871494|26692160|FG000|Overall Study|Lost to Follow-up|1|||
13363157|NCT00871429|26692170|FG000|Overall Study|Lost to Follow-up|6|||
13363158|NCT00871429|26692170|FG000|Overall Study|Withdrawal by Subject|17|||
13363159|NCT00871429|26692170|FG000|Overall Study|Questionnaire not completed|1|||
13363160|NCT00871403|26692193|FG000|Combination Treatment Phase|Randomized but Not Treated|1|||
13363161|NCT00871403|26692194|FG001|Combination Treatment Phase|Randomized but Not Treated|1|||
13363162|NCT00871403|26692195|FG002|Combination Treatment Phase|Randomized but Not Treated|1|||
13363163|NCT00871403|26692193|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8|||
13363164|NCT00871403|26692194|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19|||
13363165|NCT00871403|26692195|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0|||
13363166|NCT00871403|26692193|FG000|Combination Treatment Phase|Adverse Event|0|||
13363167|NCT00871403|26692194|FG001|Combination Treatment Phase|Adverse Event|17|||
13363168|NCT00871403|26692195|FG002|Combination Treatment Phase|Adverse Event|2|||
13363169|NCT00871403|26692193|FG000|Combination Treatment Phase|Disease Progression|0|||
13363170|NCT00871403|26692194|FG001|Combination Treatment Phase|Disease Progression|8|||
13363171|NCT00871403|26692195|FG002|Combination Treatment Phase|Disease Progression|5|||
13363172|NCT00871403|26692193|FG000|Combination Treatment Phase|Withdrawal by Subject|0|||
13363173|NCT00871403|26692194|FG001|Combination Treatment Phase|Withdrawal by Subject|3|||
13363174|NCT00871403|26692195|FG002|Combination Treatment Phase|Withdrawal by Subject|1|||
13363175|NCT00871403|26692193|FG000|Combination Treatment Phase|Physician Decision|0|||
13363176|NCT00871403|26692194|FG001|Combination Treatment Phase|Physician Decision|1|||
13363177|NCT00871403|26692195|FG002|Combination Treatment Phase|Physician Decision|3|||
13363178|NCT00871403|26692193|FG000|Monotherapy Treatment Phase|Disease Progression|0|||
13363179|NCT00871403|26692194|FG001|Monotherapy Treatment Phase|Disease Progression|9|||
13363180|NCT00871403|26692195|FG002|Monotherapy Treatment Phase|Disease Progression|1|||
13363181|NCT00871403|26692193|FG000|Monotherapy Treatment Phase|Adverse Event|0|||
13363182|NCT00871403|26692194|FG001|Monotherapy Treatment Phase|Adverse Event|4|||
13363183|NCT00871403|26692195|FG002|Monotherapy Treatment Phase|Adverse Event|0|||
13363184|NCT00871377|26692210|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
13363185|NCT00871377|26692211|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
13363186|NCT00871377|26692212|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1|||
13363187|NCT00871377|26692213|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
13363188|NCT00871377|26692214|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
13363189|NCT00871377|26692215|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
13363190|NCT00871377|26692210|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0|||
13363191|NCT00871377|26692211|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0|||
13363192|NCT00871377|26692212|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0|||
13363193|NCT00871377|26692213|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0|||
13363194|NCT00871377|26692214|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0|||
13363195|NCT00871377|26692215|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1|||
13363196|NCT00871377|26692210|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
13363197|NCT00871377|26692211|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
13363198|NCT00871377|26692212|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
13363199|NCT00871377|26692213|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
13363200|NCT00871377|26692214|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
13363201|NCT00871377|26692215|FG005|Washout (6 Weeks)|Withdrawal by Subject|0|||
13363202|NCT00871377|26692210|FG000|Washout (6 Weeks)|Withdrawal by Subject|0|||
13363203|NCT00871377|26692211|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
13363204|NCT00871377|26692212|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
13363205|NCT00871377|26692213|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
13363206|NCT00871377|26692214|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
13363207|NCT00871377|26692215|FG005|Washout (6 Weeks)|Withdrawal by Subject|1|||
13363208|NCT00871377|26692210|FG000|Third Intervention (10 Weeks)|Death|0|||
13204474|NCT01972841|26229052|FG004|Overall Study|Miscellaneous|0|||
13363209|NCT00871377|26692211|FG001|Third Intervention (10 Weeks)|Death|0|||
13363210|NCT00871377|26692212|FG002|Third Intervention (10 Weeks)|Death|0|||
13363211|NCT00871377|26692213|FG003|Third Intervention (10 Weeks)|Death|1|||
13363212|NCT00871377|26692214|FG004|Third Intervention (10 Weeks)|Death|0|||
13363213|NCT00871377|26692215|FG005|Third Intervention (10 Weeks)|Death|0|||
13363214|NCT00871338|26692300|FG000|Prior to Booster|Withdrawal by Subject|1|||
13363215|NCT00871338|26692301|FG001|Prior to Booster|Withdrawal by Subject|3|||
13363216|NCT00871338|26692300|FG000|Prior to Booster|Lost to Follow-up|1|||
13363217|NCT00871338|26692301|FG001|Prior to Booster|Lost to Follow-up|0|||
13363218|NCT00871234|26692307|FG000|Overall Study|Adverse Event|2|||
13363219|NCT00871234|26692307|FG000|Overall Study|Lost to Follow-up|3|||
13363220|NCT00871169|26692314|FG000|Overall Study|Protocol Violation|1|||
13363221|NCT00871169|26692314|FG000|Overall Study|Patient did not receive study treatment|2|||
13363222|NCT00871117|26692353|FG000|Overall Study|Lost to Follow-up|5|||
13363223|NCT00871117|26692354|FG001|Overall Study|Lost to Follow-up|6|||
13363224|NCT00871117|26692353|FG000|Overall Study|Other|0|||
13363225|NCT00871117|26692354|FG001|Overall Study|Other|4|||
13363226|NCT00871000|26692403|FG000|Overall Study|Withdrawal by Subject|1|||
13363227|NCT00871000|26692404|FG001|Overall Study|Withdrawal by Subject|0|||
13363228|NCT00870870|26692455|FG000|Overall Study|Withdrawal by Subject|0|||
13363229|NCT00870870|26692456|FG001|Overall Study|Withdrawal by Subject|1|||
13363230|NCT00870870|26692457|FG002|Overall Study|Withdrawal by Subject|1|||
13363231|NCT00870870|26692458|FG003|Overall Study|Withdrawal by Subject|3|||
13363232|NCT00870870|26692455|FG000|Overall Study|Adverse Event|0|||
13363233|NCT00870870|26692456|FG001|Overall Study|Adverse Event|0|||
13363234|NCT00870870|26692457|FG002|Overall Study|Adverse Event|2|||
13363235|NCT00870870|26692458|FG003|Overall Study|Adverse Event|2|||
13363236|NCT00870740|26692551|FG000|Overall Study|Adverse Event|2|||
13363237|NCT00870740|26692552|FG001|Overall Study|Adverse Event|1|||
13363238|NCT00870740|26692553|FG002|Overall Study|Adverse Event|3|||
13363239|NCT00870740|26692554|FG003|Overall Study|Adverse Event|2|||
13363240|NCT00870740|26692555|FG004|Overall Study|Adverse Event|1|||
13363241|NCT00870740|26692556|FG005|Overall Study|Adverse Event|6|||
13363242|NCT00870740|26692551|FG000|Overall Study|Consent Withdrawn|6|||
13363243|NCT00870740|26692552|FG001|Overall Study|Consent Withdrawn|3|||
13363244|NCT00870740|26692553|FG002|Overall Study|Consent Withdrawn|4|||
13363245|NCT00870740|26692554|FG003|Overall Study|Consent Withdrawn|6|||
13363246|NCT00870740|26692555|FG004|Overall Study|Consent Withdrawn|6|||
13363247|NCT00870740|26692556|FG005|Overall Study|Consent Withdrawn|5|||
13363248|NCT00870740|26692551|FG000|Overall Study|Investigator Decision|2|||
13363249|NCT00870740|26692552|FG001|Overall Study|Investigator Decision|0|||
13363250|NCT00870740|26692553|FG002|Overall Study|Investigator Decision|1|||
13363251|NCT00870740|26692554|FG003|Overall Study|Investigator Decision|0|||
13363252|NCT00870740|26692555|FG004|Overall Study|Investigator Decision|0|||
13363253|NCT00870740|26692556|FG005|Overall Study|Investigator Decision|0|||
13363254|NCT00870740|26692551|FG000|Overall Study|Subject Non-compliance|0|||
13363255|NCT00870740|26692552|FG001|Overall Study|Subject Non-compliance|0|||
13363256|NCT00870740|26692553|FG002|Overall Study|Subject Non-compliance|0|||
13363257|NCT00870740|26692554|FG003|Overall Study|Subject Non-compliance|0|||
13363258|NCT00870740|26692555|FG004|Overall Study|Subject Non-compliance|0|||
13363259|NCT00870740|26692556|FG005|Overall Study|Subject Non-compliance|1|||
13363260|NCT00870740|26692551|FG000|Overall Study|Death|0|||
13363261|NCT00870740|26692552|FG001|Overall Study|Death|0|||
13363262|NCT00870740|26692553|FG002|Overall Study|Death|0|||
13363263|NCT00870740|26692554|FG003|Overall Study|Death|0|||
13363264|NCT00870740|26692555|FG004|Overall Study|Death|1|||
13363265|NCT00870740|26692556|FG005|Overall Study|Death|0|||
13363266|NCT00870740|26692551|FG000|Overall Study|Other|2|||
13363267|NCT00870740|26692552|FG001|Overall Study|Other|5|||
13363268|NCT00870740|26692553|FG002|Overall Study|Other|2|||
13363269|NCT00870740|26692554|FG003|Overall Study|Other|4|||
13363270|NCT00870740|26692555|FG004|Overall Study|Other|3|||
13363271|NCT00870740|26692556|FG005|Overall Study|Other|5|||
13363272|NCT00870727|26692579|FG000|Overall Study|Lost to Follow-up|0|||
13363273|NCT00870727|26692580|FG001|Overall Study|Lost to Follow-up|1|||
13363274|NCT00870727|26692579|FG000|Overall Study|Lack of Efficacy|1|||
13363275|NCT00870727|26692580|FG001|Overall Study|Lack of Efficacy|3|||
13363276|NCT00870727|26692579|FG000|Overall Study|Adverse Event|0|||
13363277|NCT00870727|26692580|FG001|Overall Study|Adverse Event|1|||
13363278|NCT00870584|26692595|FG000|Overall Study|Adverse Event|3|||
13363279|NCT00870584|26692596|FG001|Overall Study|Adverse Event|3|||
13363280|NCT00870584|26692595|FG000|Overall Study|Withdrawal by Subject|6|||
13363281|NCT00870584|26692596|FG001|Overall Study|Withdrawal by Subject|7|||
13363282|NCT00870584|26692595|FG000|Overall Study|Lost to Follow-up|5|||
13363283|NCT00870584|26692596|FG001|Overall Study|Lost to Follow-up|1|||
13363284|NCT00870584|26692595|FG000|Overall Study|Protocol Deviation|2|||
13363285|NCT00870584|26692596|FG001|Overall Study|Protocol Deviation|2|||
13363286|NCT00870233|26692605|FG000|Overall Study|Withdrawal by Subject|18|||
13363287|NCT00870233|26692605|FG000|Overall Study|Did not undergo laparotomy|3|||
13375050|NCT00791999|26729023|FG000|Overall Study|Adverse Event|3|||
13363288|NCT00870233|26692605|FG000|Overall Study|Incompatible internet browser|2|||
13363289|NCT00870233|26692605|FG000|Overall Study|Death|1|||
13363290|NCT00870194|26692650|FG000|Overall Study|Adverse Event|10|||
13363291|NCT00870194|26692651|FG001|Overall Study|Adverse Event|5|||
13363292|NCT00870194|26692650|FG000|Overall Study|Lack of Efficacy|0|||
13363293|NCT00870194|26692651|FG001|Overall Study|Lack of Efficacy|1|||
13363294|NCT00870194|26692650|FG000|Overall Study|Lost to Follow-up|2|||
13363295|NCT00870194|26692651|FG001|Overall Study|Lost to Follow-up|0|||
13363296|NCT00870194|26692650|FG000|Overall Study|Physician Decision|3|||
13363297|NCT00870194|26692651|FG001|Overall Study|Physician Decision|1|||
13363298|NCT00870194|26692650|FG000|Overall Study|Protocol Violation|3|||
13363299|NCT00870194|26692651|FG001|Overall Study|Protocol Violation|3|||
13363300|NCT00870194|26692650|FG000|Overall Study|Entry Criteria Not Met|1|||
13363301|NCT00870194|26692651|FG001|Overall Study|Entry Criteria Not Met|2|||
13363302|NCT00870194|26692650|FG000|Overall Study|Subject Decision|7|||
13363303|NCT00870194|26692651|FG001|Overall Study|Subject Decision|2|||
13363304|NCT00870103|26692658|FG000|Overall Study|Physician Decision|2|||
13363305|NCT00870103|26692658|FG000|Overall Study|Lost to Follow-up|2|||
13363306|NCT00869999|26692666|FG000|Overall Study|Withdrawal by Subject|1|||
13363307|NCT00869999|26692666|FG000|Overall Study|removed prior to starting therapy|1|||
13363308|NCT00869960|26692679|FG000|Overall Study|Lost to Follow-up|2|||
13363309|NCT00869778|26692724|FG000|Overall Study|Adverse Event|2|||
13363310|NCT00869778|26692725|FG001|Overall Study|Adverse Event|0|||
13363311|NCT00869778|26692726|FG002|Overall Study|Adverse Event|0|||
13363312|NCT00869778|26692724|FG000|Overall Study|Withdrawal by Subject|3|||
13363313|NCT00869778|26692725|FG001|Overall Study|Withdrawal by Subject|4|||
13363314|NCT00869778|26692726|FG002|Overall Study|Withdrawal by Subject|5|||
13363315|NCT00869778|26692724|FG000|Overall Study|Pregnancy|1|||
13363316|NCT00869778|26692725|FG001|Overall Study|Pregnancy|0|||
13363317|NCT00869778|26692726|FG002|Overall Study|Pregnancy|0|||
13363318|NCT00869778|26692724|FG000|Overall Study|Protocol Violation|5|||
13363319|NCT00869778|26692725|FG001|Overall Study|Protocol Violation|3|||
13363320|NCT00869778|26692726|FG002|Overall Study|Protocol Violation|5|||
13363321|NCT00869778|26692724|FG000|Overall Study|Unblinding|1|||
13363322|NCT00869778|26692725|FG001|Overall Study|Unblinding|0|||
13363323|NCT00869778|26692726|FG002|Overall Study|Unblinding|0|||
13363324|NCT00869557|26692750|FG000|Randomized Phase|Lost to Follow-up|2|||
13363325|NCT00869557|26692751|FG001|Randomized Phase|Lost to Follow-up|1|||
13363326|NCT00869557|26692750|FG000|Randomized Phase|Investigator's Discretion|1|||
13363327|NCT00869557|26692751|FG001|Randomized Phase|Investigator's Discretion|0|||
13363328|NCT00869557|26692750|FG000|Randomized Phase|Withdrew Consent|0|||
13363329|NCT00869557|26692751|FG001|Randomized Phase|Withdrew Consent|1|||
13363330|NCT00869557|26692750|FG000|Extension Phase|Adverse Event|2|||
13363331|NCT00869557|26692751|FG001|Extension Phase|Adverse Event|2|||
13363332|NCT00869557|26692750|FG000|Extension Phase|Lack of Efficacy|1|||
13363333|NCT00869557|26692751|FG001|Extension Phase|Lack of Efficacy|0|||
13363334|NCT00869557|26692750|FG000|Extension Phase|Lost to Follow-up|3|||
13363335|NCT00869557|26692751|FG001|Extension Phase|Lost to Follow-up|1|||
13363336|NCT00869557|26692750|FG000|Extension Phase|Investigator's Discretion|2|||
13363337|NCT00869557|26692751|FG001|Extension Phase|Investigator's Discretion|0|||
13363338|NCT00869557|26692750|FG000|Extension Phase|Withdrew Consent|2|||
13363339|NCT00869557|26692751|FG001|Extension Phase|Withdrew Consent|0|||
13363340|NCT00869518|26692770|FG000|Overall Study|Lost to Follow-up|1|||
13363341|NCT00869518|26692771|FG001|Overall Study|Lost to Follow-up|1|||
13363342|NCT00869440|26692802|FG000|Overall Study|Withdrawal by Subject|1|||
13363343|NCT00869440|26692803|FG001|Overall Study|Withdrawal by Subject|0|||
13363344|NCT00869440|26692804|FG002|Overall Study|Withdrawal by Subject|0|||
13363345|NCT00869440|26692805|FG003|Overall Study|Withdrawal by Subject|0|||
13363346|NCT00869440|26692802|FG000|Overall Study|Physician Decision|1|||
13363347|NCT00869440|26692803|FG001|Overall Study|Physician Decision|1|||
13363348|NCT00869440|26692804|FG002|Overall Study|Physician Decision|0|||
13363349|NCT00869440|26692805|FG003|Overall Study|Physician Decision|0|||
13363350|NCT00869401|26692833|FG000|Overall Study|Withdrawal by Subject|0|||
13363351|NCT00869401|26692834|FG001|Overall Study|Withdrawal by Subject|0|||
13363352|NCT00869401|26692835|FG002|Overall Study|Withdrawal by Subject|0|||
13363353|NCT00869401|26692836|FG003|Overall Study|Withdrawal by Subject|5|||
13363354|NCT00869401|26692837|FG004|Overall Study|Withdrawal by Subject|3|||
13363355|NCT00869362|26692852|FG000|Overall Study|Death|0|||
13363356|NCT00869362|26692853|FG001|Overall Study|Death|2|||
13363357|NCT00869362|26692852|FG000|Overall Study|Lost to Follow-up|1|||
13363358|NCT00869362|26692853|FG001|Overall Study|Lost to Follow-up|3|||
13363359|NCT00869323|26692863|FG000|Maintenance Therapy|concurrent illness|1|||
13363360|NCT00869258|26692869|FG000|Overall Study|Physician Decision|1|||
13363361|NCT00869089|26692875|FG000|Overall Study|Lost to Follow-up|1|||
13363362|NCT00869089|26692875|FG000|Overall Study|Withdrawal by Subject|1|||
13363363|NCT00869089|26692875|FG000|Overall Study|Screen Fail|1|||
13363364|NCT00869050|26692882|FG000|Overall Study|Screen Failure|3|||
13363365|NCT00869024|26692905|FG000|Overall Study|Death|2|||
13363366|NCT00869024|26692906|FG001|Overall Study|Death|3|||
13363367|NCT00869024|26692905|FG000|Overall Study|Lost to Follow-up|0|||
13363368|NCT00869024|26692906|FG001|Overall Study|Lost to Follow-up|1|||
13363369|NCT00869024|26692905|FG000|Overall Study|Protocol Violation|0|||
13363370|NCT00869024|26692906|FG001|Overall Study|Protocol Violation|1|||
13363371|NCT00868998|26692913|FG000|Overall Study|Screen Failure|1|||
13363372|NCT00868998|26692913|FG000|Overall Study|Withdrawal by Subject|1|||
13363373|NCT00868998|26692913|FG000|Overall Study|Progression of disease|2|||
13363374|NCT00868998|26692913|FG000|Overall Study|Death|1|||
13363375|NCT00868790|26692965|FG000|Period 1|Adverse Event|1|||
13363376|NCT00868790|26692966|FG001|Period 1|Adverse Event|0|||
13363377|NCT00868790|26692967|FG002|Period 1|Adverse Event|0|||
13363378|NCT00868790|26692968|FG003|Period 1|Adverse Event|0|||
13363379|NCT00868790|26692969|FG004|Period 1|Adverse Event|0|||
13363380|NCT00868790|26692970|FG005|Period 1|Adverse Event|0|||
13363381|NCT00868790|26692971|FG006|Period 1|Adverse Event|0|||
13363382|NCT00868790|26692972|FG007|Period 1|Adverse Event|3|||
13363383|NCT00868790|26692973|FG008|Period 1|Adverse Event|1|||
13363384|NCT00868790|26692974|FG009|Period 1|Adverse Event|0|||
13363385|NCT00868790|26692975|FG010|Period 1|Adverse Event|0|||
13363386|NCT00868790|26692976|FG011|Period 1|Adverse Event|0|||
13363387|NCT00868790|26692977|FG012|Period 1|Adverse Event|0|||
13363388|NCT00868790|26692978|FG013|Period 1|Adverse Event|1|||
13363389|NCT00868790|26692965|FG000|Period 1|Protocol Violation|1|||
13363390|NCT00868790|26692966|FG001|Period 1|Protocol Violation|0|||
13363391|NCT00868790|26692967|FG002|Period 1|Protocol Violation|0|||
13363392|NCT00868790|26692968|FG003|Period 1|Protocol Violation|0|||
13363393|NCT00868790|26692969|FG004|Period 1|Protocol Violation|0|||
13363394|NCT00868790|26692970|FG005|Period 1|Protocol Violation|0|||
13363395|NCT00868790|26692971|FG006|Period 1|Protocol Violation|0|||
13363396|NCT00868790|26692972|FG007|Period 1|Protocol Violation|0|||
13363397|NCT00868790|26692973|FG008|Period 1|Protocol Violation|0|||
13363398|NCT00868790|26692974|FG009|Period 1|Protocol Violation|0|||
13363399|NCT00868790|26692975|FG010|Period 1|Protocol Violation|0|||
13363400|NCT00868790|26692976|FG011|Period 1|Protocol Violation|0|||
13363401|NCT00868790|26692977|FG012|Period 1|Protocol Violation|0|||
13363402|NCT00868790|26692978|FG013|Period 1|Protocol Violation|0|||
13363403|NCT00868790|26692965|FG000|Period 1|Withdrawal by Subject|0|||
13363404|NCT00868790|26692966|FG001|Period 1|Withdrawal by Subject|1|||
13363405|NCT00868790|26692967|FG002|Period 1|Withdrawal by Subject|0|||
13363406|NCT00868790|26692968|FG003|Period 1|Withdrawal by Subject|0|||
13363407|NCT00868790|26692969|FG004|Period 1|Withdrawal by Subject|0|||
13363408|NCT00868790|26692970|FG005|Period 1|Withdrawal by Subject|0|||
13363409|NCT00868790|26692971|FG006|Period 1|Withdrawal by Subject|0|||
13363410|NCT00868790|26692972|FG007|Period 1|Withdrawal by Subject|0|||
13363411|NCT00868790|26692973|FG008|Period 1|Withdrawal by Subject|0|||
13363412|NCT00868790|26692974|FG009|Period 1|Withdrawal by Subject|0|||
13363413|NCT00868790|26692975|FG010|Period 1|Withdrawal by Subject|0|||
13363414|NCT00868790|26692976|FG011|Period 1|Withdrawal by Subject|0|||
13363415|NCT00868790|26692977|FG012|Period 1|Withdrawal by Subject|0|||
13363416|NCT00868790|26692978|FG013|Period 1|Withdrawal by Subject|1|||
13363417|NCT00868790|26692965|FG000|Period 1|Abnormal Triglycerides|0|||
13363418|NCT00868790|26692966|FG001|Period 1|Abnormal Triglycerides|0|||
13363419|NCT00868790|26692967|FG002|Period 1|Abnormal Triglycerides|0|||
13363420|NCT00868790|26692968|FG003|Period 1|Abnormal Triglycerides|0|||
13363421|NCT00868790|26692969|FG004|Period 1|Abnormal Triglycerides|1|||
13363422|NCT00868790|26692970|FG005|Period 1|Abnormal Triglycerides|0|||
13363423|NCT00868790|26692971|FG006|Period 1|Abnormal Triglycerides|0|||
13363424|NCT00868790|26692972|FG007|Period 1|Abnormal Triglycerides|0|||
13363425|NCT00868790|26692973|FG008|Period 1|Abnormal Triglycerides|0|||
13363426|NCT00868790|26692974|FG009|Period 1|Abnormal Triglycerides|0|||
13363427|NCT00868790|26692975|FG010|Period 1|Abnormal Triglycerides|0|||
13363428|NCT00868790|26692976|FG011|Period 1|Abnormal Triglycerides|0|||
13363429|NCT00868790|26692977|FG012|Period 1|Abnormal Triglycerides|0|||
13363430|NCT00868790|26692978|FG013|Period 1|Abnormal Triglycerides|0|||
13363431|NCT00868790|26692965|FG000|Period 1|Lost to Follow-up|0|||
13363432|NCT00868790|26692966|FG001|Period 1|Lost to Follow-up|0|||
13363433|NCT00868790|26692967|FG002|Period 1|Lost to Follow-up|0|||
13363434|NCT00868790|26692968|FG003|Period 1|Lost to Follow-up|0|||
13363435|NCT00868790|26692969|FG004|Period 1|Lost to Follow-up|0|||
13363436|NCT00868790|26692970|FG005|Period 1|Lost to Follow-up|1|||
13363437|NCT00868790|26692971|FG006|Period 1|Lost to Follow-up|0|||
13363438|NCT00868790|26692972|FG007|Period 1|Lost to Follow-up|0|||
13363439|NCT00868790|26692973|FG008|Period 1|Lost to Follow-up|0|||
13363440|NCT00868790|26692974|FG009|Period 1|Lost to Follow-up|0|||
13363441|NCT00868790|26692975|FG010|Period 1|Lost to Follow-up|0|||
13363442|NCT00868790|26692976|FG011|Period 1|Lost to Follow-up|0|||
13363443|NCT00868790|26692977|FG012|Period 1|Lost to Follow-up|0|||
13363444|NCT00868790|26692978|FG013|Period 1|Lost to Follow-up|0|||
13363445|NCT00868790|26692965|FG000|Period 2|Adverse Event|0|||
13363446|NCT00868790|26692966|FG001|Period 2|Adverse Event|0|||
13363447|NCT00868790|26692967|FG002|Period 2|Adverse Event|0|||
13363448|NCT00868790|26692968|FG003|Period 2|Adverse Event|0|||
13363449|NCT00868790|26692969|FG004|Period 2|Adverse Event|0|||
13363450|NCT00868790|26692970|FG005|Period 2|Adverse Event|0|||
13363451|NCT00868790|26692971|FG006|Period 2|Adverse Event|0|||
13363452|NCT00868790|26692972|FG007|Period 2|Adverse Event|0|||
13363453|NCT00868790|26692973|FG008|Period 2|Adverse Event|1|||
13363454|NCT00868790|26692974|FG009|Period 2|Adverse Event|0|||
13363455|NCT00868790|26692975|FG010|Period 2|Adverse Event|0|||
13363456|NCT00868790|26692976|FG011|Period 2|Adverse Event|0|||
13363457|NCT00868790|26692977|FG012|Period 2|Adverse Event|0|||
13363458|NCT00868790|26692978|FG013|Period 2|Adverse Event|0|||
13363459|NCT00868790|26692965|FG000|Period 2|Lost to Follow-up|0|||
13363460|NCT00868790|26692966|FG001|Period 2|Lost to Follow-up|1|||
13363461|NCT00868790|26692967|FG002|Period 2|Lost to Follow-up|0|||
13363462|NCT00868790|26692968|FG003|Period 2|Lost to Follow-up|0|||
13363463|NCT00868790|26692969|FG004|Period 2|Lost to Follow-up|0|||
13363464|NCT00868790|26692970|FG005|Period 2|Lost to Follow-up|1|||
13363465|NCT00868790|26692971|FG006|Period 2|Lost to Follow-up|0|||
13363466|NCT00868790|26692972|FG007|Period 2|Lost to Follow-up|0|||
13363467|NCT00868790|26692973|FG008|Period 2|Lost to Follow-up|0|||
13363468|NCT00868790|26692974|FG009|Period 2|Lost to Follow-up|0|||
13363469|NCT00868790|26692975|FG010|Period 2|Lost to Follow-up|0|||
13363470|NCT00868790|26692976|FG011|Period 2|Lost to Follow-up|0|||
13363471|NCT00868790|26692977|FG012|Period 2|Lost to Follow-up|0|||
13363472|NCT00868790|26692978|FG013|Period 2|Lost to Follow-up|0|||
13363473|NCT00868790|26692965|FG000|Period 2|Withdrawal by Subject|0|||
13363474|NCT00868790|26692966|FG001|Period 2|Withdrawal by Subject|0|||
13363475|NCT00868790|26692967|FG002|Period 2|Withdrawal by Subject|0|||
13363476|NCT00868790|26692968|FG003|Period 2|Withdrawal by Subject|0|||
13363477|NCT00868790|26692969|FG004|Period 2|Withdrawal by Subject|0|||
13363478|NCT00868790|26692970|FG005|Period 2|Withdrawal by Subject|0|||
13363479|NCT00868790|26692971|FG006|Period 2|Withdrawal by Subject|0|||
13363480|NCT00868790|26692972|FG007|Period 2|Withdrawal by Subject|0|||
13363481|NCT00868790|26692973|FG008|Period 2|Withdrawal by Subject|1|||
13363482|NCT00868790|26692974|FG009|Period 2|Withdrawal by Subject|0|||
13363483|NCT00868790|26692975|FG010|Period 2|Withdrawal by Subject|0|||
13363484|NCT00868790|26692976|FG011|Period 2|Withdrawal by Subject|0|||
13363485|NCT00868790|26692977|FG012|Period 2|Withdrawal by Subject|0|||
13363486|NCT00868790|26692978|FG013|Period 2|Withdrawal by Subject|1|||
13363487|NCT00868790|26692965|FG000|Period 3|Adverse Event|0|||
13363488|NCT00868790|26692966|FG001|Period 3|Adverse Event|0|||
13363489|NCT00868790|26692967|FG002|Period 3|Adverse Event|0|||
13363490|NCT00868790|26692968|FG003|Period 3|Adverse Event|0|||
13363491|NCT00868790|26692969|FG004|Period 3|Adverse Event|0|||
13363492|NCT00868790|26692970|FG005|Period 3|Adverse Event|0|||
13363493|NCT00868790|26692971|FG006|Period 3|Adverse Event|0|||
13363494|NCT00868790|26692972|FG007|Period 3|Adverse Event|0|||
13363495|NCT00868790|26692973|FG008|Period 3|Adverse Event|0|||
13363496|NCT00868790|26692974|FG009|Period 3|Adverse Event|1|||
13363497|NCT00868790|26692975|FG010|Period 3|Adverse Event|0|||
13363498|NCT00868790|26692976|FG011|Period 3|Adverse Event|0|||
13363499|NCT00868790|26692977|FG012|Period 3|Adverse Event|0|||
13363500|NCT00868790|26692978|FG013|Period 3|Adverse Event|0|||
13363501|NCT00868790|26692965|FG000|Period 3|Protocol Violation|0|||
13363502|NCT00868790|26692966|FG001|Period 3|Protocol Violation|0|||
13363503|NCT00868790|26692967|FG002|Period 3|Protocol Violation|0|||
13363504|NCT00868790|26692968|FG003|Period 3|Protocol Violation|0|||
13363505|NCT00868790|26692969|FG004|Period 3|Protocol Violation|0|||
13363506|NCT00868790|26692970|FG005|Period 3|Protocol Violation|0|||
13363507|NCT00868790|26692971|FG006|Period 3|Protocol Violation|0|||
13363508|NCT00868790|26692972|FG007|Period 3|Protocol Violation|0|||
13363509|NCT00868790|26692973|FG008|Period 3|Protocol Violation|0|||
13363510|NCT00868790|26692974|FG009|Period 3|Protocol Violation|0|||
13363511|NCT00868790|26692975|FG010|Period 3|Protocol Violation|1|||
13363512|NCT00868790|26692976|FG011|Period 3|Protocol Violation|0|||
13363513|NCT00868790|26692977|FG012|Period 3|Protocol Violation|0|||
13363514|NCT00868790|26692978|FG013|Period 3|Protocol Violation|0|||
13363515|NCT00868790|26692965|FG000|Period 3|Study Terminated by Sponsor|0|||
13363516|NCT00868790|26692966|FG001|Period 3|Study Terminated by Sponsor|0|||
13363517|NCT00868790|26692967|FG002|Period 3|Study Terminated by Sponsor|0|||
13363518|NCT00868790|26692968|FG003|Period 3|Study Terminated by Sponsor|1|||
13363519|NCT00868790|26692969|FG004|Period 3|Study Terminated by Sponsor|0|||
13363520|NCT00868790|26692970|FG005|Period 3|Study Terminated by Sponsor|0|||
13363521|NCT00868790|26692971|FG006|Period 3|Study Terminated by Sponsor|0|||
13363522|NCT00868790|26692972|FG007|Period 3|Study Terminated by Sponsor|0|||
13363523|NCT00868790|26692973|FG008|Period 3|Study Terminated by Sponsor|0|||
13363524|NCT00868790|26692974|FG009|Period 3|Study Terminated by Sponsor|0|||
13363525|NCT00868790|26692975|FG010|Period 3|Study Terminated by Sponsor|0|||
13363526|NCT00868790|26692976|FG011|Period 3|Study Terminated by Sponsor|0|||
13363527|NCT00868790|26692977|FG012|Period 3|Study Terminated by Sponsor|0|||
13363528|NCT00868790|26692978|FG013|Period 3|Study Terminated by Sponsor|0|||
13363529|NCT00868790|26692965|FG000|Period 4|Adverse Event|0|||
13363530|NCT00868790|26692966|FG001|Period 4|Adverse Event|0|||
13363531|NCT00868790|26692967|FG002|Period 4|Adverse Event|0|||
13363532|NCT00868790|26692968|FG003|Period 4|Adverse Event|0|||
13363533|NCT00868790|26692969|FG004|Period 4|Adverse Event|0|||
13363534|NCT00868790|26692970|FG005|Period 4|Adverse Event|0|||
13363535|NCT00868790|26692971|FG006|Period 4|Adverse Event|0|||
13363536|NCT00868790|26692972|FG007|Period 4|Adverse Event|1|||
13363537|NCT00868790|26692973|FG008|Period 4|Adverse Event|0|||
13363538|NCT00868790|26692974|FG009|Period 4|Adverse Event|0|||
13363539|NCT00868790|26692975|FG010|Period 4|Adverse Event|1|||
13363540|NCT00868790|26692976|FG011|Period 4|Adverse Event|0|||
13363541|NCT00868790|26692977|FG012|Period 4|Adverse Event|1|||
13363542|NCT00868790|26692978|FG013|Period 4|Adverse Event|0|||
13363543|NCT00868790|26692965|FG000|Period 4|Lost to Follow-up|0|||
13363544|NCT00868790|26692966|FG001|Period 4|Lost to Follow-up|0|||
13363545|NCT00868790|26692967|FG002|Period 4|Lost to Follow-up|0|||
13363546|NCT00868790|26692968|FG003|Period 4|Lost to Follow-up|0|||
13363547|NCT00868790|26692969|FG004|Period 4|Lost to Follow-up|0|||
13363548|NCT00868790|26692970|FG005|Period 4|Lost to Follow-up|0|||
13363549|NCT00868790|26692971|FG006|Period 4|Lost to Follow-up|0|||
13363550|NCT00868790|26692972|FG007|Period 4|Lost to Follow-up|1|||
13363551|NCT00868790|26692973|FG008|Period 4|Lost to Follow-up|0|||
13363552|NCT00868790|26692974|FG009|Period 4|Lost to Follow-up|0|||
13363553|NCT00868790|26692975|FG010|Period 4|Lost to Follow-up|0|||
13363554|NCT00868790|26692976|FG011|Period 4|Lost to Follow-up|0|||
13363555|NCT00868790|26692977|FG012|Period 4|Lost to Follow-up|0|||
13363556|NCT00868790|26692978|FG013|Period 4|Lost to Follow-up|0|||
13363557|NCT00868790|26692965|FG000|Period 4|Study Terminated by Sponsor|2|||
13363558|NCT00868790|26692966|FG001|Period 4|Study Terminated by Sponsor|0|||
13363559|NCT00868790|26692967|FG002|Period 4|Study Terminated by Sponsor|0|||
13363560|NCT00868790|26692968|FG003|Period 4|Study Terminated by Sponsor|0|||
13363561|NCT00868790|26692969|FG004|Period 4|Study Terminated by Sponsor|0|||
13363562|NCT00868790|26692970|FG005|Period 4|Study Terminated by Sponsor|0|||
13363563|NCT00868790|26692971|FG006|Period 4|Study Terminated by Sponsor|0|||
13363564|NCT00868790|26692972|FG007|Period 4|Study Terminated by Sponsor|1|||
13363565|NCT00868790|26692973|FG008|Period 4|Study Terminated by Sponsor|2|||
13363566|NCT00868790|26692974|FG009|Period 4|Study Terminated by Sponsor|0|||
13363567|NCT00868790|26692975|FG010|Period 4|Study Terminated by Sponsor|2|||
13363568|NCT00868790|26692976|FG011|Period 4|Study Terminated by Sponsor|1|||
13363569|NCT00868790|26692977|FG012|Period 4|Study Terminated by Sponsor|0|||
13363570|NCT00868790|26692978|FG013|Period 4|Study Terminated by Sponsor|1|||
13363571|NCT00868790|26692965|FG000|Period 4|Abnormal ALT/AST|0|||
13363572|NCT00868790|26692966|FG001|Period 4|Abnormal ALT/AST|0|||
13363573|NCT00868790|26692967|FG002|Period 4|Abnormal ALT/AST|1|||
13363574|NCT00868790|26692968|FG003|Period 4|Abnormal ALT/AST|0|||
13363575|NCT00868790|26692969|FG004|Period 4|Abnormal ALT/AST|0|||
13363576|NCT00868790|26692970|FG005|Period 4|Abnormal ALT/AST|0|||
13363577|NCT00868790|26692971|FG006|Period 4|Abnormal ALT/AST|0|||
13363578|NCT00868790|26692972|FG007|Period 4|Abnormal ALT/AST|0|||
13363579|NCT00868790|26692973|FG008|Period 4|Abnormal ALT/AST|0|||
13363580|NCT00868790|26692974|FG009|Period 4|Abnormal ALT/AST|0|||
13363581|NCT00868790|26692975|FG010|Period 4|Abnormal ALT/AST|0|||
13363582|NCT00868790|26692976|FG011|Period 4|Abnormal ALT/AST|0|||
13363583|NCT00868790|26692977|FG012|Period 4|Abnormal ALT/AST|0|||
13363584|NCT00868790|26692978|FG013|Period 4|Abnormal ALT/AST|0|||
13363585|NCT00868790|26692965|FG000|Post-study|Withdrawal by Subject|0|||
13363586|NCT00868790|26692966|FG001|Post-study|Withdrawal by Subject|0|||
13363587|NCT00868790|26692967|FG002|Post-study|Withdrawal by Subject|0|||
13363588|NCT00868790|26692968|FG003|Post-study|Withdrawal by Subject|0|||
13363589|NCT00868790|26692969|FG004|Post-study|Withdrawal by Subject|1|||
13363590|NCT00868790|26692970|FG005|Post-study|Withdrawal by Subject|0|||
13363591|NCT00868790|26692971|FG006|Post-study|Withdrawal by Subject|0|||
13363592|NCT00868790|26692972|FG007|Post-study|Withdrawal by Subject|0|||
13363593|NCT00868790|26692973|FG008|Post-study|Withdrawal by Subject|0|||
13363594|NCT00868790|26692974|FG009|Post-study|Withdrawal by Subject|0|||
13363595|NCT00868790|26692975|FG010|Post-study|Withdrawal by Subject|0|||
13363596|NCT00868790|26692976|FG011|Post-study|Withdrawal by Subject|0|||
13363597|NCT00868790|26692977|FG012|Post-study|Withdrawal by Subject|0|||
13363598|NCT00868790|26692978|FG013|Post-study|Withdrawal by Subject|0|||
13363599|NCT00868790|26692965|FG000|Post-study|Excluded Medication|0|||
13363600|NCT00868790|26692966|FG001|Post-study|Excluded Medication|0|||
13363601|NCT00868790|26692967|FG002|Post-study|Excluded Medication|0|||
13363602|NCT00868790|26692968|FG003|Post-study|Excluded Medication|0|||
13363603|NCT00868790|26692969|FG004|Post-study|Excluded Medication|0|||
13363604|NCT00868790|26692970|FG005|Post-study|Excluded Medication|0|||
13363605|NCT00868790|26692971|FG006|Post-study|Excluded Medication|0|||
13363606|NCT00868790|26692972|FG007|Post-study|Excluded Medication|2|||
13363607|NCT00868790|26692973|FG008|Post-study|Excluded Medication|0|||
13363608|NCT00868790|26692974|FG009|Post-study|Excluded Medication|1|||
13363609|NCT00868790|26692975|FG010|Post-study|Excluded Medication|0|||
13363610|NCT00868790|26692976|FG011|Post-study|Excluded Medication|0|||
13363611|NCT00868790|26692977|FG012|Post-study|Excluded Medication|0|||
13363612|NCT00868790|26692978|FG013|Post-study|Excluded Medication|0|||
13363613|NCT00868608|26693012|FG000|Overall Study|Withdrawal by Subject|3|||
13363614|NCT00868608|26693013|FG001|Overall Study|Withdrawal by Subject|1|||
13363615|NCT00868608|26693014|FG002|Overall Study|Withdrawal by Subject|0|||
13363616|NCT00868608|26693012|FG000|Overall Study|Lost to Follow-up|3|||
13363617|NCT00868608|26693013|FG001|Overall Study|Lost to Follow-up|0|||
13363618|NCT00868608|26693014|FG002|Overall Study|Lost to Follow-up|1|||
13363619|NCT00868608|26693012|FG000|Overall Study|Death|16|||
13363620|NCT00868608|26693013|FG001|Overall Study|Death|2|||
13363621|NCT00868608|26693014|FG002|Overall Study|Death|4|||
13363622|NCT00868608|26693012|FG000|Overall Study|Other - Unspecified|1|||
13363623|NCT00868608|26693013|FG001|Overall Study|Other - Unspecified|0|||
13363624|NCT00868608|26693014|FG002|Overall Study|Other - Unspecified|0|||
13363625|NCT00868530|26693028|FG000|Overall Study|Adverse Event|3|||
13363626|NCT00868530|26693028|FG000|Overall Study|Lost to Follow-up|1|||
13363627|NCT00868517|26693061|FG000|Overall Study|Withdrawal by Subject|3|||
13363628|NCT00868517|26693062|FG001|Overall Study|Withdrawal by Subject|3|||
13363629|NCT00868517|26693063|FG002|Overall Study|Withdrawal by Subject|2|||
13363630|NCT00868517|26693061|FG000|Overall Study|Protocol Violation|1|||
13363631|NCT00868517|26693062|FG001|Overall Study|Protocol Violation|1|||
13363632|NCT00868517|26693063|FG002|Overall Study|Protocol Violation|0|||
13363633|NCT00868439|26693086|FG000|Overall Study|Adverse Event|4|||
13363634|NCT00868439|26693087|FG001|Overall Study|Adverse Event|3|||
13363635|NCT00868439|26693086|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2|||
13363636|NCT00868439|26693087|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3|||
13363637|NCT00868439|26693086|FG000|Overall Study|Death|0|||
13363638|NCT00868439|26693087|FG001|Overall Study|Death|1|||
13363639|NCT00868439|26693086|FG000|Overall Study|Protocol Violation|1|||
13363640|NCT00868439|26693087|FG001|Overall Study|Protocol Violation|1|||
13363641|NCT00868439|26693086|FG000|Overall Study|Physician Decision|1|||
13363642|NCT00868439|26693087|FG001|Overall Study|Physician Decision|0|||
13363643|NCT00868439|26693086|FG000|Overall Study|Withdrawal by Subject|0|||
13363644|NCT00868439|26693087|FG001|Overall Study|Withdrawal by Subject|1|||
13363645|NCT00868296|26693102|FG000|Overall Study|Adverse Event|0|||
13363646|NCT00868296|26693103|FG001|Overall Study|Adverse Event|2|||
13363647|NCT00868296|26693102|FG000|Overall Study|Withdrawal by Subject|0|||
13363648|NCT00868296|26693103|FG001|Overall Study|Withdrawal by Subject|1|||
13363649|NCT00868231|26693151|FG000|Treatment Period 1|Adverse Event|0|||
13363650|NCT00868231|26693152|FG001|Treatment Period 1|Adverse Event|0|||
13363651|NCT00868231|26693153|FG002|Treatment Period 1|Adverse Event|0|||
13363652|NCT00868231|26693154|FG003|Treatment Period 1|Adverse Event|0|||
13363653|NCT00868231|26693155|FG004|Treatment Period 1|Adverse Event|1|||
13363654|NCT00868231|26693156|FG005|Treatment Period 1|Adverse Event|0|||
13363655|NCT00868231|26693151|FG000|Treatment Period 2|Adverse Event|1|||
13363656|NCT00868231|26693152|FG001|Treatment Period 2|Adverse Event|0|||
13363657|NCT00868231|26693153|FG002|Treatment Period 2|Adverse Event|0|||
13363658|NCT00868231|26693154|FG003|Treatment Period 2|Adverse Event|0|||
13363659|NCT00868231|26693155|FG004|Treatment Period 2|Adverse Event|0|||
13363660|NCT00868231|26693156|FG005|Treatment Period 2|Adverse Event|0|||
13363661|NCT00868231|26693151|FG000|Treatment Period 3|Adverse Event|0|||
13363662|NCT00868231|26693152|FG001|Treatment Period 3|Adverse Event|0|||
13363663|NCT00868231|26693153|FG002|Treatment Period 3|Adverse Event|1|||
13363664|NCT00868231|26693154|FG003|Treatment Period 3|Adverse Event|0|||
13363665|NCT00868231|26693155|FG004|Treatment Period 3|Adverse Event|0|||
13363666|NCT00868231|26693156|FG005|Treatment Period 3|Adverse Event|0|||
13363667|NCT00868192|26693173|FG000|Overall Study|Ineligible|4|||
13363668|NCT00868166|26693200|FG000|Overall Study|Death|58|||
13363669|NCT00868166|26693201|FG001|Overall Study|Death|65|||
13363670|NCT00868166|26693200|FG000|Overall Study|Withdrawal by Subject|33|||
13363671|NCT00868166|26693201|FG001|Overall Study|Withdrawal by Subject|25|||
13363672|NCT00868166|26693200|FG000|Overall Study|Protocol Violation|1|||
13363673|NCT00868166|26693201|FG001|Overall Study|Protocol Violation|0|||
13363674|NCT00868166|26693200|FG000|Overall Study|Lost to Follow-up|1|||
13363675|NCT00868166|26693201|FG001|Overall Study|Lost to Follow-up|3|||
13363676|NCT00868166|26693200|FG000|Overall Study|Adverse Event|9|||
13363677|NCT00868166|26693201|FG001|Overall Study|Adverse Event|10|||
13363678|NCT00868166|26693200|FG000|Overall Study|Lack of efficacy, logistics, unwell|9|||
13363679|NCT00868166|26693201|FG001|Overall Study|Lack of efficacy, logistics, unwell|10|||
13363680|NCT00868166|26693200|FG000|Overall Study|Non-compliance with IMP|1|||
13363681|NCT00868166|26693201|FG001|Overall Study|Non-compliance with IMP|1|||
13363682|NCT00867815|26693209|FG000|Overall Study|Lost to Follow-up|1|||
13363683|NCT00867568|26693220|FG000|Overall Study|Lack of Efficacy|10|||
13363684|NCT00867568|26693220|FG000|Overall Study|Adverse Event|4|||
13363685|NCT00867568|26693220|FG000|Overall Study|Withdrawal by Subject|1|||
13363686|NCT00867503|26693228|FG000|Overall Study|Withdrawal by Subject|1|||
13363687|NCT00867490|26693247|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5|||
13363688|NCT00867490|26693247|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4|||
13363689|NCT00867490|26693247|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1|||
13363690|NCT00867490|26693247|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2|||
13363691|NCT00867490|26693247|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1|||
13363692|NCT00867360|26693264|FG000|Overall Study|Withdrawal by Subject|1|||
13363693|NCT00867360|26693265|FG001|Overall Study|Withdrawal by Subject|0|||
13363694|NCT00867360|26693264|FG000|Overall Study|Physician Decision|0|||
13363695|NCT00867360|26693265|FG001|Overall Study|Physician Decision|1|||
13363696|NCT00867334|26693280|FG000|Overall Study|Withdrawal by Subject|0|||
13363697|NCT00867334|26693281|FG001|Overall Study|Withdrawal by Subject|1|||
13363698|NCT00867334|26693280|FG000|Overall Study|Withdrawal by Subject|1|||
13363699|NCT00867334|26693281|FG001|Overall Study|Withdrawal by Subject|0|||
13363700|NCT00867334|26693280|FG000|Overall Study|Withdrawal by Subject|1|||
13363701|NCT00867334|26693281|FG001|Overall Study|Withdrawal by Subject|0|||
13363702|NCT00867308|26693296|FG000|Overall Study|Death|1|||
13363703|NCT00867308|26693297|FG001|Overall Study|Death|0|||
13363704|NCT00867308|26693296|FG000|Overall Study|Adverse Event|1|||
13363705|NCT00867308|26693297|FG001|Overall Study|Adverse Event|4|||
13363706|NCT00867308|26693296|FG000|Overall Study|Lack of Efficacy|6|||
13363707|NCT00867308|26693297|FG001|Overall Study|Lack of Efficacy|12|||
13363708|NCT00867308|26693296|FG000|Overall Study|Withdrawal by Subject|1|||
13363709|NCT00867308|26693297|FG001|Overall Study|Withdrawal by Subject|2|||
13363710|NCT00867165|26693406|FG000|Overall Study|Adverse Event|3|||
13363711|NCT00867165|26693407|FG001|Overall Study|Adverse Event|0|||
13363712|NCT00867165|26693406|FG000|Overall Study|Withdrawal by Subject|1|||
13363713|NCT00867165|26693407|FG001|Overall Study|Withdrawal by Subject|0|||
13363714|NCT00867113|26693416|FG000|Treatment Period|Adverse Event|15|||
13363715|NCT00867113|26693416|FG000|Treatment Period|Death|2|||
13363716|NCT00867113|26693416|FG000|Treatment Period|Withdrawal by Subject|19|||
13363717|NCT00867113|26693416|FG000|Treatment Period|Lost to Follow-up|3|||
13363718|NCT00867113|26693416|FG000|Treatment Period|Administrative problems|1|||
13363719|NCT00867113|26693416|FG000|Treatment Period|Disease progression/relapse|1|||
13363720|NCT00867113|26693416|FG000|Treatment Period|Protocol Violation|4|||
13363721|NCT00867113|26693416|FG000|Post Treatment After Survival Follow-up|Death|1|||
13363722|NCT00867113|26693416|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1|||
13363723|NCT00867113|26693416|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5|||
13363724|NCT00867113|26693416|FG000|Post Treatment After Survival Follow-up|Administrative problems|4|||
13363725|NCT00867087|26693432|FG000|Overall Study|Other|1|||
13363726|NCT00867087|26693432|FG000|Overall Study|Withdrawal by Subject|4|||
13363727|NCT00867087|26693432|FG000|Overall Study|Death|37|||
13363728|NCT00867035|26693465|FG000|Baseline to 1 Hour|Withdrawal by Subject|1|||
13363729|NCT00867035|26693466|FG001|Baseline to 1 Hour|Withdrawal by Subject|1|||
13363730|NCT00867035|26693465|FG000|Baseline to 1 Week|Withdrawal by Subject|1|||
13363731|NCT00867035|26693466|FG001|Baseline to 1 Week|Withdrawal by Subject|0|||
13363732|NCT00867009|26693475|FG000|Induction Period|Nonserious Adverse Event|5|||
13363733|NCT00867009|26693475|FG000|Induction Period|Serious Adverse Event|10|||
13363734|NCT00867009|26693475|FG000|Induction Period|Death due to serious adverse event|6|||
13363735|NCT00867009|26693475|FG000|Induction Period|Death due to Study Disease|4|||
13363736|NCT00867009|26693475|FG000|Induction Period|Protocol Violation|1|||
13363737|NCT00867009|26693475|FG000|Induction Period|Withdrawal by Subject|8|||
13363738|NCT00867009|26693475|FG000|Induction Period|Physician Decision|3|||
13363739|NCT00867009|26693475|FG000|Induction Period|Progressive Disease (PD)|25|||
13363740|NCT00867009|26693475|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4|||
13363741|NCT00866918|26693494|FG000|Overall Study|Death|1|||
13363742|NCT00866918|26693495|FG001|Overall Study|Death|5|||
13363743|NCT00866918|26693494|FG000|Overall Study|Lack of Efficacy|1|||
13363744|NCT00866918|26693495|FG001|Overall Study|Lack of Efficacy|1|||
13363745|NCT00866918|26693494|FG000|Overall Study|Physician Decision|10|||
13363746|NCT00866918|26693495|FG001|Overall Study|Physician Decision|2|||
13363747|NCT00866918|26693494|FG000|Overall Study|Ineligible|2|||
13363748|NCT00866918|26693495|FG001|Overall Study|Ineligible|4|||
13363749|NCT00866918|26693494|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1|||
13363750|NCT00866918|26693495|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0|||
13363751|NCT00866918|26693494|FG000|Overall Study|Secondary malignancy|1|||
13363752|NCT00866918|26693495|FG001|Overall Study|Secondary malignancy|0|||
13363753|NCT00866814|26693506|FG000|Overall Study|Lost to Follow-up|12|||
13363754|NCT00866814|26693506|FG000|Overall Study|Adverse Event|2|||
13363755|NCT00866814|26693506|FG000|Overall Study|Physician Decision|1|||
13363756|NCT00866814|26693506|FG000|Overall Study|Death|1|||
13363757|NCT00866814|26693506|FG000|Overall Study|No longer wished to participate|1|||
13363758|NCT00866814|26693506|FG000|Overall Study|Unable to meet follow-up requirements|2|||
13363759|NCT00866814|26693506|FG000|Overall Study|Moved to area without study site|1|||
13363760|NCT00866788|26693565|FG000|Overall Study|Adverse Event|0|||
13363761|NCT00866788|26693566|FG001|Overall Study|Adverse Event|2|||
13363762|NCT00866788|26693567|FG002|Overall Study|Adverse Event|0|||
13363763|NCT00866788|26693568|FG003|Overall Study|Adverse Event|1|||
13363764|NCT00866788|26693565|FG000|Overall Study|Lost to Follow-up|1|||
13363765|NCT00866788|26693566|FG001|Overall Study|Lost to Follow-up|1|||
13363766|NCT00866788|26693567|FG002|Overall Study|Lost to Follow-up|0|||
13363767|NCT00866788|26693568|FG003|Overall Study|Lost to Follow-up|2|||
13363768|NCT00866788|26693565|FG000|Overall Study|Withdrawal by Subject|2|||
13363769|NCT00866788|26693566|FG001|Overall Study|Withdrawal by Subject|1|||
13363770|NCT00866788|26693567|FG002|Overall Study|Withdrawal by Subject|0|||
13363771|NCT00866788|26693568|FG003|Overall Study|Withdrawal by Subject|1|||
13363772|NCT00866788|26693565|FG000|Overall Study|Pregnancy|0|||
13363773|NCT00866788|26693566|FG001|Overall Study|Pregnancy|1|||
13363774|NCT00866788|26693567|FG002|Overall Study|Pregnancy|0|||
13363775|NCT00866788|26693568|FG003|Overall Study|Pregnancy|0|||
13363776|NCT00866788|26693565|FG000|Overall Study|Disease progression|3|||
13363777|NCT00866788|26693566|FG001|Overall Study|Disease progression|1|||
13363778|NCT00866788|26693567|FG002|Overall Study|Disease progression|1|||
13363779|NCT00866788|26693568|FG003|Overall Study|Disease progression|0|||
13363780|NCT00866788|26693565|FG000|Overall Study|Physician Decision|0|||
13363781|NCT00866788|26693566|FG001|Overall Study|Physician Decision|0|||
13363782|NCT00866788|26693567|FG002|Overall Study|Physician Decision|1|||
13363783|NCT00866788|26693568|FG003|Overall Study|Physician Decision|1|||
13363784|NCT00866775|26693611|FG000|Overall Study|Adverse Event|5|||
13363785|NCT00866775|26693612|FG001|Overall Study|Adverse Event|19|||
13363786|NCT00866775|26693611|FG000|Overall Study|Death|1|||
13363787|NCT00866775|26693612|FG001|Overall Study|Death|0|||
13363788|NCT00866775|26693611|FG000|Overall Study|Lost to Follow-up|0|||
13363789|NCT00866775|26693612|FG001|Overall Study|Lost to Follow-up|4|||
13363790|NCT00866775|26693611|FG000|Overall Study|Physician Decision|0|||
13363791|NCT00866775|26693612|FG001|Overall Study|Physician Decision|3|||
13363792|NCT00866775|26693611|FG000|Overall Study|Protocol Violation|3|||
13363793|NCT00866775|26693612|FG001|Overall Study|Protocol Violation|4|||
13363794|NCT00866775|26693611|FG000|Overall Study|Withdrawal by Subject|4|||
13363795|NCT00866775|26693612|FG001|Overall Study|Withdrawal by Subject|4|||
13363796|NCT00866775|26693611|FG000|Overall Study|met exit criteria|23|||
13363797|NCT00866775|26693612|FG001|Overall Study|met exit criteria|17|||
13363798|NCT00866775|26693611|FG000|Overall Study|discontinued due to communication error|0|||
13363799|NCT00866775|26693612|FG001|Overall Study|discontinued due to communication error|1|||
13363800|NCT00866723|26693619|FG000|Overall Study|Withdrawal by Subject|1|||
13363801|NCT00866723|26693619|FG000|Overall Study|Disease Progression|4|||
13363802|NCT00866697|26693670|FG000|Overall Study|Study closed/terminated|156|||
13363803|NCT00866697|26693671|FG001|Overall Study|Study closed/terminated|138|||
13363804|NCT00866697|26693670|FG000|Overall Study|Lost to Follow-up|22|||
13363805|NCT00866697|26693671|FG001|Overall Study|Lost to Follow-up|28|||
13363806|NCT00866697|26693670|FG000|Overall Study|Physician Decision|3|||
13363807|NCT00866697|26693671|FG001|Overall Study|Physician Decision|5|||
13363808|NCT00866697|26693670|FG000|Overall Study|Withdrawal by Subject|33|||
13363809|NCT00866697|26693671|FG001|Overall Study|Withdrawal by Subject|57|||
13363810|NCT00866658|26693706|FG000|Overall Study|Adverse Event|5|||
13363811|NCT00866658|26693707|FG001|Overall Study|Adverse Event|14|||
13363812|NCT00866658|26693706|FG000|Overall Study|Lack of Efficacy|2|||
13363813|NCT00866658|26693707|FG001|Overall Study|Lack of Efficacy|1|||
13363814|NCT00866658|26693706|FG000|Overall Study|Withdrawal by Subject|1|||
13363815|NCT00866658|26693707|FG001|Overall Study|Withdrawal by Subject|0|||
13363816|NCT00866658|26693706|FG000|Overall Study|Protocol Violation|1|||
13363817|NCT00866658|26693707|FG001|Overall Study|Protocol Violation|1|||
13363818|NCT00866658|26693706|FG000|Overall Study|Familial and Personal Reasons|4|||
13363819|NCT00866658|26693707|FG001|Overall Study|Familial and Personal Reasons|5|||
13363820|NCT00866619|26694040|FG000|Overall Study|Adverse Event|112|||
13363821|NCT00866619|26694041|FG001|Overall Study|Adverse Event|106|||
13363822|NCT00866619|26694042|FG002|Overall Study|Adverse Event|47|||
13363823|NCT00866619|26694043|FG003|Overall Study|Adverse Event|44|||
13363824|NCT00866619|26694040|FG000|Overall Study|Protocol Violation|2|||
13363825|NCT00866619|26694041|FG001|Overall Study|Protocol Violation|39|||
13363826|NCT00866619|26694042|FG002|Overall Study|Protocol Violation|2|||
13363827|NCT00866619|26694043|FG003|Overall Study|Protocol Violation|17|||
13363828|NCT00866619|26694040|FG000|Overall Study|Withdrawal by Subject|587|||
13363829|NCT00866619|26694041|FG001|Overall Study|Withdrawal by Subject|295|||
13363830|NCT00866619|26694042|FG002|Overall Study|Withdrawal by Subject|272|||
13363831|NCT00866619|26694043|FG003|Overall Study|Withdrawal by Subject|144|||
13363832|NCT00866619|26694040|FG000|Overall Study|Lost to Follow-up|1145|||
13363833|NCT00866619|26694041|FG001|Overall Study|Lost to Follow-up|830|||
13363834|NCT00866619|26694042|FG002|Overall Study|Lost to Follow-up|568|||
13363835|NCT00866619|26694043|FG003|Overall Study|Lost to Follow-up|425|||
13363836|NCT00866606|26694057|FG000|Overall Study|Lost to Follow-up|3|||
13363837|NCT00866606|26694057|FG000|Overall Study|Adverse Event|1|||
13363838|NCT00866359|26694119|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5|||
13363839|NCT00866359|26694120|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4|||
13363840|NCT00866359|26694121|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
13363841|NCT00866359|26694122|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
13363842|NCT00866359|26694119|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3|||
13363843|NCT00866359|26694120|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
13363844|NCT00866359|26694121|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
13363845|NCT00866359|26694122|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
13363846|NCT00866359|26694119|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1|||
13363847|NCT00866359|26694120|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
13363848|NCT00866359|26694121|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
13363849|NCT00866359|26694122|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
13363850|NCT00866359|26694119|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
13363851|NCT00866359|26694120|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
13363852|NCT00866359|26694121|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
13363853|NCT00866359|26694122|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
13363854|NCT00866359|26694119|FG000|Treatment Phase (Days 1 to 85)|Other|1|||
13363855|NCT00866359|26694120|FG001|Treatment Phase (Days 1 to 85)|Other|0|||
13363856|NCT00866359|26694121|FG002|Treatment Phase (Days 1 to 85)|Other|0|||
13363857|NCT00866359|26694122|FG003|Treatment Phase (Days 1 to 85)|Other|0|||
13363858|NCT00866359|26694119|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0|||
13363859|NCT00866359|26694120|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0|||
13363860|NCT00866359|26694121|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1|||
13363861|NCT00866359|26694122|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3|||
13363862|NCT00866333|26694149|FG000|Overall Study|Withdrawal of consent|0|||
13363863|NCT00866333|26694150|FG001|Overall Study|Withdrawal of consent|1|||
13363864|NCT00866333|26694151|FG002|Overall Study|Withdrawal of consent|2|||
13363865|NCT00866333|26694149|FG000|Overall Study|Reason not Specified|3|||
13363866|NCT00866333|26694150|FG001|Overall Study|Reason not Specified|1|||
13363867|NCT00866333|26694151|FG002|Overall Study|Reason not Specified|1|||
13363868|NCT00866333|26694149|FG000|Overall Study|Study Terminated by Sponsor|2|||
13363869|NCT00866333|26694150|FG001|Overall Study|Study Terminated by Sponsor|5|||
13363870|NCT00866333|26694151|FG002|Overall Study|Study Terminated by Sponsor|9|||
13363871|NCT00866320|26694160|FG000|Overall Study|Withdrawal by Subject|4|||
13363872|NCT00866320|26694160|FG000|Overall Study|Death|2|||
13363873|NCT00866307|26694171|FG000|Induction|Adverse Event|5|||
13363874|NCT00866307|26694172|FG001|Induction|Adverse Event|0|||
13363875|NCT00866307|26694173|FG002|Induction|Adverse Event|0|||
13363876|NCT00866307|26694171|FG000|Induction|Death|2|||
13363877|NCT00866307|26694172|FG001|Induction|Death|0|||
13363878|NCT00866307|26694173|FG002|Induction|Death|0|||
13363879|NCT00866307|26694171|FG000|Induction|Physician Decision|5|||
13363880|NCT00866307|26694172|FG001|Induction|Physician Decision|0|||
13363881|NCT00866307|26694173|FG002|Induction|Physician Decision|0|||
13363882|NCT00866307|26694171|FG000|Induction|Progressive Disease|1|||
13363883|NCT00866307|26694172|FG001|Induction|Progressive Disease|0|||
13363884|NCT00866307|26694173|FG002|Induction|Progressive Disease|0|||
13363885|NCT00866307|26694171|FG000|Induction|Identification of Patients with Day 29 M|3|||
13363886|NCT00866307|26694172|FG001|Induction|Identification of Patients with Day 29 M|0|||
13363887|NCT00866307|26694173|FG002|Induction|Identification of Patients with Day 29 M|0|||
13363888|NCT00866307|26694171|FG000|Induction|Inadequate cytognetic samples th|1|||
13363889|NCT00866307|26694172|FG001|Induction|Inadequate cytognetic samples th|0|||
13363890|NCT00866307|26694173|FG002|Induction|Inadequate cytognetic samples th|0|||
13363891|NCT00866307|26694171|FG000|Induction|Improper post-induction consent|2|||
13363892|NCT00866307|26694172|FG001|Induction|Improper post-induction consent|0|||
13363893|NCT00866307|26694173|FG002|Induction|Improper post-induction consent|0|||
13363894|NCT00866307|26694171|FG000|Induction|Study was closed at the time|1|||
13363895|NCT00866307|26694172|FG001|Induction|Study was closed at the time|0|||
13363896|NCT00866307|26694173|FG002|Induction|Study was closed at the time|0|||
13363897|NCT00866307|26694171|FG000|Consolidation/Maintenance|Adverse Event|0|||
13363898|NCT00866307|26694172|FG001|Consolidation/Maintenance|Adverse Event|0|||
13363899|NCT00866307|26694173|FG002|Consolidation/Maintenance|Adverse Event|8|||
13363900|NCT00866307|26694171|FG000|Consolidation/Maintenance|Death|0|||
13363901|NCT00866307|26694172|FG001|Consolidation/Maintenance|Death|0|||
13363902|NCT00866307|26694173|FG002|Consolidation/Maintenance|Death|1|||
13363903|NCT00866307|26694171|FG000|Consolidation/Maintenance|Physician Decision|0|||
13363904|NCT00866307|26694172|FG001|Consolidation/Maintenance|Physician Decision|3|||
13363905|NCT00866307|26694173|FG002|Consolidation/Maintenance|Physician Decision|2|||
13363906|NCT00866307|26694171|FG000|Consolidation/Maintenance|Withdrawal by Subject|0|||
13363907|NCT00866307|26694172|FG001|Consolidation/Maintenance|Withdrawal by Subject|1|||
13363908|NCT00866307|26694173|FG002|Consolidation/Maintenance|Withdrawal by Subject|1|||
13363909|NCT00866307|26694171|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
13363910|NCT00866307|26694172|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
13363911|NCT00866307|26694173|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2|||
13363912|NCT00866307|26694171|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0|||
13363913|NCT00866307|26694172|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3|||
13363914|NCT00866307|26694173|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1|||
13363915|NCT00866307|26694171|FG000|Consolidation/Maintenance|Therapy error|0|||
13363916|NCT00866307|26694172|FG001|Consolidation/Maintenance|Therapy error|1|||
13363917|NCT00866307|26694173|FG002|Consolidation/Maintenance|Therapy error|0|||
13363918|NCT00866307|26694171|FG000|Consolidation/Maintenance|Non-compliance|0|||
13363919|NCT00866307|26694172|FG001|Consolidation/Maintenance|Non-compliance|0|||
13363920|NCT00866307|26694173|FG002|Consolidation/Maintenance|Non-compliance|1|||
13363921|NCT00866307|26694171|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
13375051|NCT00791999|26729024|FG001|Overall Study|Adverse Event|3|||
13363922|NCT00866307|26694172|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1|||
13363923|NCT00866307|26694173|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
13363924|NCT00866294|26694210|FG000|Overall Study|Adverse Event|12|||
13363925|NCT00866294|26694211|FG001|Overall Study|Adverse Event|13|||
13363926|NCT00866294|26694212|FG002|Overall Study|Adverse Event|9|||
13363927|NCT00866294|26694210|FG000|Overall Study|Lack of Efficacy|7|||
13363928|NCT00866294|26694211|FG001|Overall Study|Lack of Efficacy|1|||
13363929|NCT00866294|26694212|FG002|Overall Study|Lack of Efficacy|0|||
13363930|NCT00866294|26694210|FG000|Overall Study|Protocol Violation|2|||
13363931|NCT00866294|26694211|FG001|Overall Study|Protocol Violation|0|||
13363932|NCT00866294|26694212|FG002|Overall Study|Protocol Violation|0|||
13363933|NCT00866294|26694210|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5|||
13363934|NCT00866294|26694211|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
13363935|NCT00866294|26694212|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1|||
13363936|NCT00866294|26694210|FG000|Overall Study|Lost to Follow-up|1|||
13363937|NCT00866294|26694211|FG001|Overall Study|Lost to Follow-up|3|||
13363938|NCT00866294|26694212|FG002|Overall Study|Lost to Follow-up|0|||
13363939|NCT00866294|26694210|FG000|Overall Study|Physician Decision|6|||
13363940|NCT00866294|26694211|FG001|Overall Study|Physician Decision|2|||
13363941|NCT00866294|26694212|FG002|Overall Study|Physician Decision|1|||
13363942|NCT00866281|26694235|FG000|Overall Study|Adverse Event|1|||
13363943|NCT00866281|26694236|FG001|Overall Study|Adverse Event|0|||
13363944|NCT00866281|26694235|FG000|Overall Study|Withdrawal by participants|3|||
13363945|NCT00866281|26694236|FG001|Overall Study|Withdrawal by participants|0|||
13363946|NCT00866281|26694235|FG000|Overall Study|Disease progression|3|||
13363947|NCT00866281|26694236|FG001|Overall Study|Disease progression|11|||
13363948|NCT00866281|26694235|FG000|Overall Study|New cancer therapy|0|||
13363949|NCT00866281|26694236|FG001|Overall Study|New cancer therapy|4|||
13363950|NCT00866177|26694242|FG000|Overall Study|Withdrawal by Subject|1|||
13363951|NCT00866177|26694242|FG000|Overall Study|Not Treated|151|||
13363952|NCT00866047|26694260|FG000|Treatment Period|Progressive disease|13|||
13363953|NCT00866047|26694260|FG000|Treatment Period|Adverse Event|16|||
13363954|NCT00866047|26694260|FG000|Treatment Period|Physician Decision|14|||
13363955|NCT00866047|26694260|FG000|Treatment Period|Withdrawal by Subject|5|||
13363956|NCT00866047|26694260|FG000|Follow-up Period|Lost to Follow-up|5|||
13363957|NCT00865904|26694331|FG000|Overall Study|Randomized but not Treated|2|||
13363958|NCT00865904|26694332|FG001|Overall Study|Randomized but not Treated|0|||
13363959|NCT00865904|26694333|FG002|Overall Study|Randomized but not Treated|0|||
13363960|NCT00865904|26694334|FG003|Overall Study|Randomized but not Treated|1|||
13363961|NCT00865904|26694335|FG004|Overall Study|Randomized but not Treated|1|||
13363962|NCT00865709|26694358|FG000|Treatment|Adverse Event|9|||
13363963|NCT00865709|26694359|FG001|Treatment|Adverse Event|6|||
13363964|NCT00865709|26694358|FG000|Treatment|Withdrawal by Subject|10|||
13363965|NCT00865709|26694359|FG001|Treatment|Withdrawal by Subject|7|||
13363966|NCT00865709|26694358|FG000|Treatment|Physician Decision|3|||
13363967|NCT00865709|26694359|FG001|Treatment|Physician Decision|2|||
13363968|NCT00865709|26694358|FG000|Treatment|Surgery|8|||
13363969|NCT00865709|26694359|FG001|Treatment|Surgery|3|||
13363970|NCT00865566|26694386|FG000|Overall Study|Death|1|||
13363971|NCT00865566|26694387|FG001|Overall Study|Death|11|||
13363972|NCT00865566|26694386|FG000|Overall Study|Lost to Follow-up|314|||
13363973|NCT00865566|26694387|FG001|Overall Study|Lost to Follow-up|315|||
13363974|NCT00865566|26694386|FG000|Overall Study|Withdrawal by Subject|45|||
13363975|NCT00865566|26694387|FG001|Overall Study|Withdrawal by Subject|65|||
13363976|NCT00865566|26694386|FG000|Overall Study|Physician Decision|0|||
13363977|NCT00865566|26694387|FG001|Overall Study|Physician Decision|1|||
13363978|NCT00865566|26694386|FG000|Overall Study|Participant relocated|78|||
13363979|NCT00865566|26694387|FG001|Overall Study|Participant relocated|107|||
13363980|NCT00865566|26694386|FG000|Overall Study|Participant unable to adhere|27|||
13363981|NCT00865566|26694387|FG001|Overall Study|Participant unable to adhere|42|||
13363982|NCT00865566|26694386|FG000|Overall Study|Other; N=245 due to early study closure|154|||
13363983|NCT00865566|26694387|FG001|Overall Study|Other; N=245 due to early study closure|139|||
13363984|NCT00865566|26694386|FG000|Overall Study|HIV infection|5|||
13363985|NCT00865566|26694387|FG001|Overall Study|HIV infection|7|||
13363986|NCT00865514|26694394|FG000|Overall Study|Infusion cost exceeded funding|2|||
13363987|NCT00865345|26694401|FG000|Overall Study|Withdrawal by Subject|2|||
13363988|NCT00865306|26694418|FG000|Controlled Trial|Lost to Follow-up|1|||
13363989|NCT00865306|26694419|FG001|Controlled Trial|Lost to Follow-up|1|||
13363990|NCT00865306|26694418|FG000|Controlled Trial|Difficulty commuting|2|||
13363991|NCT00865306|26694419|FG001|Controlled Trial|Difficulty commuting|0|||
13363992|NCT00865306|26694418|FG000|Controlled Trial|Improved btw baseline and first session|1|||
13363993|NCT00865306|26694419|FG001|Controlled Trial|Improved btw baseline and first session|0|||
13363994|NCT00865306|26694418|FG000|Controlled Trial|Sought treatment for conduct disorder|1|||
13363995|NCT00865306|26694419|FG001|Controlled Trial|Sought treatment for conduct disorder|0|||
13363996|NCT00865306|26694418|FG000|Controlled Trial|Withdrawal by Subject|0|||
13363997|NCT00865306|26694419|FG001|Controlled Trial|Withdrawal by Subject|1|||
13363998|NCT00865280|26694444|FG000|Overall Study|Withdrawal by Subject|4|||
13363999|NCT00865280|26694445|FG001|Overall Study|Withdrawal by Subject|1|||
13364000|NCT00865280|26694444|FG000|Overall Study|End of Treatment/Lost to Follow-up|0|||
13364001|NCT00865280|26694445|FG001|Overall Study|End of Treatment/Lost to Follow-up|1|||
13364002|NCT00865280|26694444|FG000|Overall Study|Adverse Event/Lost to Follow-up|1|||
13364003|NCT00865280|26694445|FG001|Overall Study|Adverse Event/Lost to Follow-up|0|||
13364004|NCT00865280|26694444|FG000|Overall Study|Exclusion Condition|1|||
13364005|NCT00865280|26694445|FG001|Overall Study|Exclusion Condition|0|||
13364006|NCT00865280|26694444|FG000|Overall Study|Adverse Event|0|||
13364007|NCT00865280|26694445|FG001|Overall Study|Adverse Event|1|||
13364008|NCT00865189|26694477|FG000|Overall Study|Other|1|||
13364009|NCT00865189|26694478|FG001|Overall Study|Other|2|||
13364010|NCT00865189|26694477|FG000|Overall Study|Death|4|||
13364011|NCT00865189|26694478|FG001|Overall Study|Death|11|||
13364012|NCT00865189|26694477|FG000|Overall Study|Lost to Follow-up|6|||
13364013|NCT00865189|26694478|FG001|Overall Study|Lost to Follow-up|6|||
13364014|NCT00865189|26694477|FG000|Overall Study|Withdrawal by Subject|1|||
13364015|NCT00865189|26694478|FG001|Overall Study|Withdrawal by Subject|0|||
13364016|NCT00865124|26694505|FG000|Overall Study|Physician Decision|2|||
13364017|NCT00865124|26694506|FG001|Overall Study|Physician Decision|1|||
13364018|NCT00865124|26694507|FG002|Overall Study|Physician Decision|0|||
13364019|NCT00865124|26694505|FG000|Overall Study|Withdrawn consent|2|||
13364020|NCT00865124|26694506|FG001|Overall Study|Withdrawn consent|0|||
13364021|NCT00865124|26694507|FG002|Overall Study|Withdrawn consent|0|||
13375052|NCT00791999|26729025|FG002|Overall Study|Adverse Event|7|||
13375053|NCT00791999|26729026|FG003|Overall Study|Adverse Event|3|||
13375054|NCT00791999|26729023|FG000|Overall Study|Lack of Efficacy|0|||
13375055|NCT00791999|26729024|FG001|Overall Study|Lack of Efficacy|1|||
13375056|NCT00791999|26729025|FG002|Overall Study|Lack of Efficacy|0|||
13375057|NCT00791999|26729026|FG003|Overall Study|Lack of Efficacy|2|||
13375058|NCT00791999|26729023|FG000|Overall Study|Reason other than those above|1|||
13375059|NCT00791999|26729024|FG001|Overall Study|Reason other than those above|0|||
13375060|NCT00791999|26729025|FG002|Overall Study|Reason other than those above|1|||
13375061|NCT00791999|26729026|FG003|Overall Study|Reason other than those above|0|||
13375062|NCT00791934|26729036|FG000|Overall Study|Withdrawal by Subject|2|||
13375063|NCT00791934|26729036|FG000|Overall Study|Did not consent for extended follow-up|13|||
13375064|NCT00791921|26729051|FG000|Overall Study|Protocol planed|24|||
13375065|NCT00791921|26729052|FG001|Overall Study|Protocol planed|88|||
13375066|NCT00791921|26729051|FG000|Overall Study|Withdrawal by Subject|1|||
13375067|NCT00791921|26729052|FG001|Overall Study|Withdrawal by Subject|2|||
13375068|NCT00791921|26729051|FG000|Overall Study|Adverse Event|8|||
13375069|NCT00791921|26729052|FG001|Overall Study|Adverse Event|2|||
13375070|NCT00791921|26729051|FG000|Overall Study|Lack of Efficacy|0|||
13375071|NCT00791921|26729052|FG001|Overall Study|Lack of Efficacy|2|||
13375072|NCT00791921|26729051|FG000|Overall Study|Lack of study drug administration|1|||
13375073|NCT00791921|26729052|FG001|Overall Study|Lack of study drug administration|1|||
13375074|NCT00791921|26729051|FG000|Overall Study|Reason other than those above|0|||
13375075|NCT00791921|26729052|FG001|Overall Study|Reason other than those above|1|||
13375076|NCT00791778|26729111|FG000|Double-blind Treatment|Adverse Event|49|||
13375077|NCT00791778|26729112|FG001|Double-blind Treatment|Adverse Event|9|||
13375078|NCT00791778|26729111|FG000|Double-blind Treatment|Physician Decision|6|||
13375079|NCT00791778|26729112|FG001|Double-blind Treatment|Physician Decision|26|||
13375080|NCT00791778|26729111|FG000|Double-blind Treatment|Protocol Violation|0|||
13375081|NCT00791778|26729112|FG001|Double-blind Treatment|Protocol Violation|4|||
13375082|NCT00791778|26729111|FG000|Double-blind Treatment|Withdrawal by Subject|20|||
13375083|NCT00791778|26729112|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
13375084|NCT00791778|26729111|FG000|Double-blind Treatment|Non-compliant with study medication|2|||
13375085|NCT00791778|26729112|FG001|Double-blind Treatment|Non-compliant with study medication|0|||
13375086|NCT00791778|26729111|FG000|Follow-up|Withdrawal by Subject|3|||
13375087|NCT00791778|26729112|FG001|Follow-up|Withdrawal by Subject|0|||
13375088|NCT00791778|26729111|FG000|Follow-up|Lost to Follow-up|2|||
13375089|NCT00791778|26729112|FG001|Follow-up|Lost to Follow-up|1|||
13375090|NCT00791765|26729130|FG000|Weeks 1 to 12|Adverse Event|0|||
13375091|NCT00791765|26729131|FG001|Weeks 1 to 12|Adverse Event|1|||
13375092|NCT00791765|26729130|FG000|Weeks 1 to 12|Lost to Follow-up|1|||
13375093|NCT00791765|26729131|FG001|Weeks 1 to 12|Lost to Follow-up|0|||
13375094|NCT00791765|26729130|FG000|Weeks 1 to 12|Withdrawal by Subject|3|||
13375095|NCT00791765|26729131|FG001|Weeks 1 to 12|Withdrawal by Subject|0|||
13375096|NCT00791765|26729130|FG000|Weeks 1 to 12|Physician Decision|1|||
13375097|NCT00791765|26729131|FG001|Weeks 1 to 12|Physician Decision|0|||
13375098|NCT00791765|26729130|FG000|Weeks 1 to 12|Disease progression|3|||
13375099|NCT00791765|26729131|FG001|Weeks 1 to 12|Disease progression|0|||
13375100|NCT00791765|26729130|FG000|Weeks 1 to 12|Ineligibility determined|0|||
13375101|NCT00791765|26729131|FG001|Weeks 1 to 12|Ineligibility determined|3|||
13375102|NCT00791765|26729130|FG000|Weeks 13 to 24|Protocol deviation|2|||
13375103|NCT00791765|26729131|FG001|Weeks 13 to 24|Protocol deviation|0|||
13375104|NCT00791765|26729130|FG000|Weeks 13 to 24|Adverse Event|0|||
13375105|NCT00791765|26729131|FG001|Weeks 13 to 24|Adverse Event|3|||
13364022|NCT00865098|26694518|FG000|Overall Study|Progressive disease|1|||
13364023|NCT00865046|26694536|FG000|Overall Study|Lost to Follow-up|1|||
13364024|NCT00865046|26694537|FG001|Overall Study|Lost to Follow-up|4|||
13364025|NCT00865046|26694538|FG002|Overall Study|Lost to Follow-up|0|||
13364026|NCT00865046|26694536|FG000|Overall Study|Death|0|||
13364027|NCT00865046|26694537|FG001|Overall Study|Death|1|||
13364028|NCT00865046|26694538|FG002|Overall Study|Death|1|||
13364029|NCT00865046|26694536|FG000|Overall Study|Withdrawal by Subject|5|||
13364030|NCT00865046|26694537|FG001|Overall Study|Withdrawal by Subject|0|||
13364031|NCT00865046|26694538|FG002|Overall Study|Withdrawal by Subject|0|||
13364032|NCT00865020|26694559|FG000|Overall Study|Withdrawal by Subject|22|||
13364033|NCT00865020|26694560|FG001|Overall Study|Withdrawal by Subject|16|||
13364034|NCT00865020|26694559|FG000|Overall Study|Adverse Event|9|||
13364035|NCT00865020|26694560|FG001|Overall Study|Adverse Event|14|||
13364036|NCT00865020|26694559|FG000|Overall Study|Abnormal test procedure result(s)|6|||
13364037|NCT00865020|26694560|FG001|Overall Study|Abnormal test procedure result(s)|8|||
13364038|NCT00865020|26694559|FG000|Overall Study|Lost to Follow-up|6|||
13364039|NCT00865020|26694560|FG001|Overall Study|Lost to Follow-up|4|||
13364040|NCT00865020|26694559|FG000|Overall Study|Protocol deviation|4|||
13364041|NCT00865020|26694560|FG001|Overall Study|Protocol deviation|1|||
13364042|NCT00865020|26694559|FG000|Overall Study|Administrative problems|0|||
13364043|NCT00865020|26694560|FG001|Overall Study|Administrative problems|2|||
13364044|NCT00865020|26694559|FG000|Overall Study|Abnormal laboratory value(s)|0|||
13364045|NCT00865020|26694560|FG001|Overall Study|Abnormal laboratory value(s)|1|||
13364046|NCT00865020|26694559|FG000|Overall Study|Death|0|||
13364047|NCT00865020|26694560|FG001|Overall Study|Death|1|||
13364048|NCT00865020|26694559|FG000|Overall Study|Randomized but discontinued|2|||
13364049|NCT00865020|26694560|FG001|Overall Study|Randomized but discontinued|4|||
13364050|NCT00864916|26694573|FG000|Overall Study|Lost to Follow-up|4|||
13364051|NCT00864916|26694574|FG001|Overall Study|Lost to Follow-up|4|||
13364052|NCT00864916|26694573|FG000|Overall Study|Protocol Violation|1|||
13364053|NCT00864916|26694574|FG001|Overall Study|Protocol Violation|0|||
13364054|NCT00864916|26694573|FG000|Overall Study|Withdrawal by Subject|1|||
13364055|NCT00864916|26694574|FG001|Overall Study|Withdrawal by Subject|0|||
13364056|NCT00864851|26694618|FG000|Overall Study|Withdrawal by Subject|0|||
13364057|NCT00864851|26694619|FG001|Overall Study|Withdrawal by Subject|1|||
13364058|NCT00864851|26694620|FG002|Overall Study|Withdrawal by Subject|0|||
13364059|NCT00864851|26694618|FG000|Overall Study|Physician Decision|1|||
13364060|NCT00864851|26694619|FG001|Overall Study|Physician Decision|0|||
13364061|NCT00864851|26694620|FG002|Overall Study|Physician Decision|0|||
13364062|NCT00864851|26694618|FG000|Overall Study|Death|1|||
13364063|NCT00864851|26694619|FG001|Overall Study|Death|0|||
13364064|NCT00864851|26694620|FG002|Overall Study|Death|0|||
13364065|NCT00864851|26694618|FG000|Overall Study|Patient uncooperative|1|||
13364066|NCT00864851|26694619|FG001|Overall Study|Patient uncooperative|0|||
13364067|NCT00864851|26694620|FG002|Overall Study|Patient uncooperative|0|||
13364068|NCT00864721|26694630|FG000|Overall Study|Patient request|11|||
13364069|NCT00864721|26694630|FG000|Overall Study|Hospitalized|1|||
13364070|NCT00864721|26694630|FG000|Overall Study|Drug hold/delay more than 4 weeks|1|||
13364071|NCT00864721|26694630|FG000|Overall Study|Adverse Event|21|||
13364072|NCT00864682|26694654|FG000|Overall Study|Protocol Violation|2|||
13364073|NCT00864682|26694655|FG001|Overall Study|Protocol Violation|1|||
13364074|NCT00864682|26694656|FG002|Overall Study|Protocol Violation|2|||
13364075|NCT00864513|26694665|FG000|Overall Study|Withdrawal by Subject|3|||
13364076|NCT00864253|26694702|FG000|Overall Study|Adverse Event|56|||
13364077|NCT00864253|26694703|FG001|Overall Study|Adverse Event|11|||
13364078|NCT00864253|26694702|FG000|Overall Study|Unrelated Adverse Event|3|||
13364079|NCT00864253|26694703|FG001|Overall Study|Unrelated Adverse Event|1|||
13364080|NCT00864253|26694702|FG000|Overall Study|Physician Decision|11|||
13364081|NCT00864253|26694703|FG001|Overall Study|Physician Decision|15|||
13364082|NCT00864253|26694702|FG000|Overall Study|Protocol Violation|0|||
13364083|NCT00864253|26694703|FG001|Overall Study|Protocol Violation|2|||
13364084|NCT00864253|26694702|FG000|Overall Study|Lost to Follow-up|1|||
13364085|NCT00864253|26694703|FG001|Overall Study|Lost to Follow-up|1|||
13364086|NCT00864253|26694702|FG000|Overall Study|Withdrawal by Subject|18|||
13364087|NCT00864253|26694703|FG001|Overall Study|Withdrawal by Subject|18|||
13364088|NCT00864253|26694702|FG000|Overall Study|Death|1|||
13364089|NCT00864253|26694703|FG001|Overall Study|Death|0|||
13364090|NCT00864253|26694702|FG000|Overall Study|Ongoing|2|||
13364091|NCT00864253|26694703|FG001|Overall Study|Ongoing|3|||
13364092|NCT00864253|26694702|FG000|Overall Study|Untreated|7|||
13364093|NCT00864253|26694703|FG001|Overall Study|Untreated|7|||
13364094|NCT00864097|26694818|FG000|Overall Study|Death|0|||
13204475|NCT01972841|26229053|FG005|Overall Study|Miscellaneous|4|||
13364095|NCT00864097|26694819|FG001|Overall Study|Death|1|||
13364096|NCT00864097|26694820|FG002|Overall Study|Death|0|||
13364097|NCT00864097|26694821|FG003|Overall Study|Death|0|||
13364098|NCT00864097|26694818|FG000|Overall Study|Adverse Event|6|||
13364099|NCT00864097|26694819|FG001|Overall Study|Adverse Event|8|||
13364100|NCT00864097|26694820|FG002|Overall Study|Adverse Event|11|||
13364101|NCT00864097|26694821|FG003|Overall Study|Adverse Event|9|||
13364102|NCT00864097|26694818|FG000|Overall Study|Lack of Efficacy|9|||
13364103|NCT00864097|26694819|FG001|Overall Study|Lack of Efficacy|3|||
13364104|NCT00864097|26694820|FG002|Overall Study|Lack of Efficacy|7|||
13364105|NCT00864097|26694821|FG003|Overall Study|Lack of Efficacy|2|||
13364106|NCT00864097|26694818|FG000|Overall Study|Lost to Follow-up|0|||
13364107|NCT00864097|26694819|FG001|Overall Study|Lost to Follow-up|1|||
13364108|NCT00864097|26694820|FG002|Overall Study|Lost to Follow-up|0|||
13364109|NCT00864097|26694821|FG003|Overall Study|Lost to Follow-up|1|||
13364110|NCT00864097|26694818|FG000|Overall Study|Withdrawal by Subject|15|||
13364111|NCT00864097|26694819|FG001|Overall Study|Withdrawal by Subject|11|||
13364112|NCT00864097|26694820|FG002|Overall Study|Withdrawal by Subject|11|||
13364113|NCT00864097|26694821|FG003|Overall Study|Withdrawal by Subject|12|||
13364114|NCT00864097|26694818|FG000|Overall Study|Protocol Violation|2|||
13364115|NCT00864097|26694819|FG001|Overall Study|Protocol Violation|1|||
13364116|NCT00864097|26694820|FG002|Overall Study|Protocol Violation|0|||
13364117|NCT00864097|26694821|FG003|Overall Study|Protocol Violation|1|||
13364118|NCT00864097|26694818|FG000|Overall Study|Terminated by sponsor|105|||
13364119|NCT00864097|26694819|FG001|Overall Study|Terminated by sponsor|112|||
13364120|NCT00864097|26694820|FG002|Overall Study|Terminated by sponsor|102|||
13364121|NCT00864097|26694821|FG003|Overall Study|Terminated by sponsor|99|||
13364122|NCT00864097|26694818|FG000|Overall Study|Randomized but not treated|2|||
13364123|NCT00864097|26694819|FG001|Overall Study|Randomized but not treated|0|||
13364124|NCT00864097|26694820|FG002|Overall Study|Randomized but not treated|1|||
13364125|NCT00864097|26694821|FG003|Overall Study|Randomized but not treated|0|||
13364126|NCT00864097|26694818|FG000|Overall Study|Other|0|||
13364127|NCT00864097|26694819|FG001|Overall Study|Other|0|||
13364128|NCT00864097|26694820|FG002|Overall Study|Other|0|||
13364129|NCT00864097|26694821|FG003|Overall Study|Other|1|||
13364130|NCT00863928|26694834|FG000|Overall Study|Protocol Violation|26|||
13364131|NCT00863928|26694835|FG001|Overall Study|Protocol Violation|0|||
13364132|NCT00863928|26694834|FG000|Overall Study|Withdrawal by Subject|3|||
13364133|NCT00863928|26694835|FG001|Overall Study|Withdrawal by Subject|0|||
13364134|NCT00863928|26694834|FG000|Overall Study|surgery cancellation|4|||
13364135|NCT00863928|26694835|FG001|Overall Study|surgery cancellation|0|||
13364136|NCT00863928|26694834|FG000|Overall Study|medication allergy|3|||
13364137|NCT00863928|26694835|FG001|Overall Study|medication allergy|0|||
13364138|NCT00863798|26694895|FG000|Overall Study|Adverse Event|5|||
13364139|NCT00863798|26694896|FG001|Overall Study|Adverse Event|2|||
13364140|NCT00863798|26694897|FG002|Overall Study|Adverse Event|4|||
13364141|NCT00863798|26694895|FG000|Overall Study|Participant failed to return|2|||
13364142|NCT00863798|26694896|FG001|Overall Study|Participant failed to return|1|||
13364143|NCT00863798|26694897|FG002|Overall Study|Participant failed to return|0|||
13364144|NCT00863798|26694895|FG000|Overall Study|Investigator request|1|||
13364145|NCT00863798|26694896|FG001|Overall Study|Investigator request|2|||
13364146|NCT00863798|26694897|FG002|Overall Study|Investigator request|1|||
13364147|NCT00863798|26694895|FG000|Overall Study|Lack of Efficacy|4|||
13364148|NCT00863798|26694896|FG001|Overall Study|Lack of Efficacy|3|||
13364149|NCT00863798|26694897|FG002|Overall Study|Lack of Efficacy|6|||
13364150|NCT00863798|26694895|FG000|Overall Study|Lost to Follow-up|6|||
13364151|NCT00863798|26694896|FG001|Overall Study|Lost to Follow-up|9|||
13364152|NCT00863798|26694897|FG002|Overall Study|Lost to Follow-up|5|||
13364153|NCT00863798|26694895|FG000|Overall Study|Other|2|||
13364154|NCT00863798|26694896|FG001|Overall Study|Other|3|||
13364155|NCT00863798|26694897|FG002|Overall Study|Other|1|||
13364156|NCT00863798|26694895|FG000|Overall Study|Protocol Violation|0|||
13364157|NCT00863798|26694896|FG001|Overall Study|Protocol Violation|1|||
13364158|NCT00863798|26694897|FG002|Overall Study|Protocol Violation|1|||
13364159|NCT00863798|26694895|FG000|Overall Study|Withdrawal by Subject|8|||
13364160|NCT00863798|26694896|FG001|Overall Study|Withdrawal by Subject|7|||
13364161|NCT00863798|26694897|FG002|Overall Study|Withdrawal by Subject|4|||
13364162|NCT00863798|26694895|FG000|Overall Study|Randomized not treated|4|||
13364163|NCT00863798|26694896|FG001|Overall Study|Randomized not treated|2|||
13364164|NCT00863798|26694897|FG002|Overall Study|Randomized not treated|3|||
13364165|NCT00863772|26695033|FG000|Overall Study|Adverse Event|1|||
13364166|NCT00863772|26695034|FG001|Overall Study|Adverse Event|4|||
13364167|NCT00863772|26695035|FG002|Overall Study|Adverse Event|0|||
13364168|NCT00863772|26695033|FG000|Overall Study|Lack of Efficacy|4|||
13364169|NCT00863772|26695034|FG001|Overall Study|Lack of Efficacy|2|||
13364170|NCT00863772|26695035|FG002|Overall Study|Lack of Efficacy|4|||
13364171|NCT00863772|26695033|FG000|Overall Study|Lost to Follow-up|5|||
13364172|NCT00863772|26695034|FG001|Overall Study|Lost to Follow-up|1|||
13364173|NCT00863772|26695035|FG002|Overall Study|Lost to Follow-up|1|||
13364174|NCT00863772|26695033|FG000|Overall Study|Protocol Violation|2|||
13364175|NCT00863772|26695034|FG001|Overall Study|Protocol Violation|0|||
13364176|NCT00863772|26695035|FG002|Overall Study|Protocol Violation|2|||
13364177|NCT00863772|26695033|FG000|Overall Study|Withdrawal by Subject|4|||
13364178|NCT00863772|26695034|FG001|Overall Study|Withdrawal by Subject|7|||
13364179|NCT00863772|26695035|FG002|Overall Study|Withdrawal by Subject|5|||
13364180|NCT00863772|26695033|FG000|Overall Study|Study terminated by sponsor|44|||
13364181|NCT00863772|26695034|FG001|Overall Study|Study terminated by sponsor|45|||
13364182|NCT00863772|26695035|FG002|Overall Study|Study terminated by sponsor|36|||
13364183|NCT00863772|26695033|FG000|Overall Study|Entered extension study|6|||
13364184|NCT00863772|26695034|FG001|Overall Study|Entered extension study|4|||
13364185|NCT00863772|26695035|FG002|Overall Study|Entered extension study|9|||
13124949|NCT02936037|25954513|FG000|Double-Blind Treatment Period|Death|0|||
13364186|NCT00863772|26695033|FG000|Overall Study|Other|1|||
13364187|NCT00863772|26695034|FG001|Overall Study|Other|2|||
13364188|NCT00863772|26695035|FG002|Overall Study|Other|4|||
13364189|NCT00863772|26695033|FG000|Overall Study|Randomized but not Treated|1|||
13364190|NCT00863772|26695034|FG001|Overall Study|Randomized but not Treated|0|||
13364191|NCT00863772|26695035|FG002|Overall Study|Randomized but not Treated|0|||
13364192|NCT00863746|26695066|FG000|Treatment|Not treated|4|||
13364193|NCT00863746|26695067|FG001|Treatment|Not treated|2|||
13364194|NCT00863746|26695066|FG000|Treatment|Adverse Event|41|||
13364195|NCT00863746|26695067|FG001|Treatment|Adverse Event|16|||
13364196|NCT00863746|26695066|FG000|Treatment|non-compliant with study medication|4|||
13364197|NCT00863746|26695067|FG001|Treatment|non-compliant with study medication|0|||
13364198|NCT00863746|26695066|FG000|Treatment|Consent withdrawn|15|||
13364199|NCT00863746|26695067|FG001|Treatment|Consent withdrawn|14|||
13364200|NCT00863746|26695066|FG000|Treatment|Lost to Follow-up|1|||
13364201|NCT00863746|26695067|FG001|Treatment|Lost to Follow-up|0|||
13364202|NCT00863746|26695066|FG000|Treatment|Protocol Violation|5|||
13364203|NCT00863746|26695067|FG001|Treatment|Protocol Violation|3|||
13364204|NCT00863746|26695066|FG000|Treatment|Other|1|||
13364205|NCT00863746|26695067|FG001|Treatment|Other|0|||
13124950|NCT02936037|25954514|FG001|Double-Blind Treatment Period|Death|1|||
13124951|NCT02936037|25954513|FG000|Double-Blind Treatment Period|Adverse Event|11|||
13124952|NCT02936037|25954514|FG001|Double-Blind Treatment Period|Adverse Event|11|||
13124953|NCT02936037|25954513|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31|||
13124954|NCT02936037|25954514|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28|||
13124955|NCT02936037|25954513|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
13124956|NCT02936037|25954514|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
13124957|NCT02936037|25954513|FG000|Open Label Extension|Adverse Event|0|||
13124958|NCT02936037|25954514|FG001|Open Label Extension|Adverse Event|3|||
13124959|NCT02936037|25954513|FG000|Open Label Extension|Other|0|||
13124960|NCT02936037|25954514|FG001|Open Label Extension|Other|3|||
13124961|NCT02936037|25954513|FG000|Open Label Extension|Withdrawal by Subject|0|||
13124962|NCT02936037|25954514|FG001|Open Label Extension|Withdrawal by Subject|4|||
13124963|NCT02935894|25954527|FG000|Overall Study|Subject dismissed|1|||
13124964|NCT02935842|25954574|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2|||
13364206|NCT00863746|26695066|FG000|Survival Follow up|Death|244|||
13364207|NCT00863746|26695067|FG001|Survival Follow up|Death|271|||
13364208|NCT00863746|26695066|FG000|Survival Follow up|Lost to Follow-up|2|||
13364209|NCT00863746|26695067|FG001|Survival Follow up|Lost to Follow-up|1|||
13364210|NCT00863746|26695066|FG000|Survival Follow up|Consent Withdrawn|7|||
13364211|NCT00863746|26695067|FG001|Survival Follow up|Consent Withdrawn|8|||
13364212|NCT00863707|26695080|FG000|Overall Study|Randomized, but drug not received|4|||
13364213|NCT00863707|26695081|FG001|Overall Study|Randomized, but drug not received|3|||
13364214|NCT00863681|26695174|FG000|Overall Study|Other|2|||
13364215|NCT00863681|26695175|FG001|Overall Study|Other|0|||
13364216|NCT00863681|26695176|FG002|Overall Study|Other|0|||
13364217|NCT00863681|26695174|FG000|Overall Study|Missing|1|||
13364218|NCT00863681|26695175|FG001|Overall Study|Missing|0|||
13364219|NCT00863681|26695176|FG002|Overall Study|Missing|0|||
13364220|NCT00863681|26695174|FG000|Overall Study|Death|40|||
13364221|NCT00863681|26695175|FG001|Overall Study|Death|23|||
13364222|NCT00863681|26695176|FG002|Overall Study|Death|6|||
13364223|NCT00863681|26695174|FG000|Overall Study|Withdrawal by Subject|12|||
13364224|NCT00863681|26695175|FG001|Overall Study|Withdrawal by Subject|5|||
13364225|NCT00863681|26695176|FG002|Overall Study|Withdrawal by Subject|2|||
13364226|NCT00863681|26695174|FG000|Overall Study|Protocol Violation|2|||
13364227|NCT00863681|26695175|FG001|Overall Study|Protocol Violation|0|||
13364228|NCT00863681|26695176|FG002|Overall Study|Protocol Violation|0|||
13364229|NCT00863681|26695174|FG000|Overall Study|Lost to Follow-up|3|||
13364230|NCT00863681|26695175|FG001|Overall Study|Lost to Follow-up|0|||
13364231|NCT00863681|26695176|FG002|Overall Study|Lost to Follow-up|3|||
13364232|NCT00863681|26695174|FG000|Overall Study|Adverse Event|28|||
13364233|NCT00863681|26695175|FG001|Overall Study|Adverse Event|10|||
13364234|NCT00863681|26695176|FG002|Overall Study|Adverse Event|6|||
13364235|NCT00863681|26695174|FG000|Overall Study|Lack of Efficacy|2|||
13364236|NCT00863681|26695175|FG001|Overall Study|Lack of Efficacy|2|||
13364237|NCT00863681|26695176|FG002|Overall Study|Lack of Efficacy|1|||
13364238|NCT00863681|26695174|FG000|Overall Study|Non-compliance with study drug|1|||
13364239|NCT00863681|26695175|FG001|Overall Study|Non-compliance with study drug|3|||
13364240|NCT00863681|26695176|FG002|Overall Study|Non-compliance with study drug|0|||
13364241|NCT00863655|26695210|FG000|Overall Study|Protocol Violation|4|||
13364242|NCT00863655|26695211|FG001|Overall Study|Protocol Violation|0|||
13364243|NCT00863655|26695210|FG000|Overall Study|Adverse Event|52|||
13364244|NCT00863655|26695211|FG001|Overall Study|Adverse Event|8|||
13364245|NCT00863655|26695210|FG000|Overall Study|Withdrawal by Subject|47|||
13364246|NCT00863655|26695211|FG001|Overall Study|Withdrawal by Subject|7|||
13364247|NCT00863655|26695210|FG000|Overall Study|Administrative problems|1|||
13364248|NCT00863655|26695211|FG001|Overall Study|Administrative problems|0|||
13364249|NCT00863655|26695210|FG000|Overall Study|Death|7|||
13364250|NCT00863655|26695211|FG001|Overall Study|Death|1|||
13364251|NCT00863655|26695210|FG000|Overall Study|New cancer therapy|5|||
13364252|NCT00863655|26695211|FG001|Overall Study|New cancer therapy|1|||
13364253|NCT00863655|26695210|FG000|Overall Study|Disease progression|364|||
13364254|NCT00863655|26695211|FG001|Overall Study|Disease progression|221|||
13364255|NCT00863655|26695210|FG000|Overall Study|Treatment completed as per protocol|5|||
13364256|NCT00863655|26695211|FG001|Overall Study|Treatment completed as per protocol|1|||
13364257|NCT00863512|26695224|FG000|Overall Study|Adverse Event|2|||
13364258|NCT00863512|26695225|FG001|Overall Study|Adverse Event|0|||
13364259|NCT00863512|26695224|FG000|Overall Study|Withdrawal by Subject|11|||
13364260|NCT00863512|26695225|FG001|Overall Study|Withdrawal by Subject|0|||
13364261|NCT00863512|26695224|FG000|Overall Study|Physician Decision|1|||
13364262|NCT00863512|26695225|FG001|Overall Study|Physician Decision|0|||
13364263|NCT00863330|26695231|FG000|Overall Study|study terminated early due to administra|6|||
13364264|NCT00863317|26695244|FG000|Overall Study|Lost to Follow-up|8|||
13364265|NCT00863317|26695245|FG001|Overall Study|Lost to Follow-up|9|||
13364266|NCT00863304|26695406|FG000|Overall Study|Adverse Event|10|||
13364267|NCT00863304|26695407|FG001|Overall Study|Adverse Event|4|||
13364268|NCT00863304|26695408|FG002|Overall Study|Adverse Event|14|||
13364269|NCT00863304|26695409|FG003|Overall Study|Adverse Event|16|||
13364270|NCT00863304|26695406|FG000|Overall Study|Lost to Follow-up|1|||
13364271|NCT00863304|26695407|FG001|Overall Study|Lost to Follow-up|5|||
13364272|NCT00863304|26695408|FG002|Overall Study|Lost to Follow-up|4|||
13364273|NCT00863304|26695409|FG003|Overall Study|Lost to Follow-up|2|||
13364274|NCT00863304|26695406|FG000|Overall Study|Lack of Efficacy|57|||
13364275|NCT00863304|26695407|FG001|Overall Study|Lack of Efficacy|26|||
13364276|NCT00863304|26695408|FG002|Overall Study|Lack of Efficacy|30|||
13364277|NCT00863304|26695409|FG003|Overall Study|Lack of Efficacy|28|||
13364278|NCT00863304|26695406|FG000|Overall Study|Withdrawal by Subject|19|||
13364279|NCT00863304|26695407|FG001|Overall Study|Withdrawal by Subject|14|||
13364280|NCT00863304|26695408|FG002|Overall Study|Withdrawal by Subject|20|||
13364281|NCT00863304|26695409|FG003|Overall Study|Withdrawal by Subject|18|||
13364282|NCT00863304|26695406|FG000|Overall Study|Other|1|||
13364283|NCT00863304|26695407|FG001|Overall Study|Other|0|||
13364284|NCT00863304|26695408|FG002|Overall Study|Other|0|||
13364285|NCT00863304|26695409|FG003|Overall Study|Other|1|||
13364286|NCT00863304|26695406|FG000|Overall Study|Protocol Violation|2|||
13364287|NCT00863304|26695407|FG001|Overall Study|Protocol Violation|6|||
13364288|NCT00863304|26695408|FG002|Overall Study|Protocol Violation|2|||
13364289|NCT00863304|26695409|FG003|Overall Study|Protocol Violation|0|||
13364290|NCT00863304|26695406|FG000|Overall Study|Randomized, but not Treated|3|||
13364291|NCT00863304|26695407|FG001|Overall Study|Randomized, but not Treated|1|||
13364292|NCT00863304|26695408|FG002|Overall Study|Randomized, but not Treated|4|||
13364293|NCT00863304|26695409|FG003|Overall Study|Randomized, but not Treated|1|||
13364294|NCT00863304|26695406|FG000|Overall Study|Entered extension study|101|||
13364295|NCT00863304|26695407|FG001|Overall Study|Entered extension study|129|||
13364296|NCT00863304|26695408|FG002|Overall Study|Entered extension study|113|||
13364297|NCT00863304|26695409|FG003|Overall Study|Entered extension study|125|||
13364298|NCT00863057|26695478|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
13364299|NCT00863057|26695479|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
13364300|NCT00863057|26695480|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0|||
13364301|NCT00863057|26695481|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
13364302|NCT00863057|26695478|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
13364303|NCT00863057|26695479|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1|||
13364304|NCT00863057|26695480|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
13364305|NCT00863057|26695481|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
13364306|NCT00863057|26695478|FG000|Period 2 (Weeks 6-10)|Adverse Event|0|||
13364307|NCT00863057|26695479|FG001|Period 2 (Weeks 6-10)|Adverse Event|1|||
13364308|NCT00863057|26695480|FG002|Period 2 (Weeks 6-10)|Adverse Event|1|||
13364309|NCT00863057|26695481|FG003|Period 2 (Weeks 6-10)|Adverse Event|0|||
13364310|NCT00863057|26695478|FG000|Period 2 (Weeks 6-10)|Physician Decision|0|||
13364311|NCT00863057|26695479|FG001|Period 2 (Weeks 6-10)|Physician Decision|0|||
13364312|NCT00863057|26695480|FG002|Period 2 (Weeks 6-10)|Physician Decision|0|||
13364313|NCT00863057|26695481|FG003|Period 2 (Weeks 6-10)|Physician Decision|1|||
13364314|NCT00862992|26695517|FG000|Overall Study|Adverse Event|2|||
13364315|NCT00862992|26695518|FG001|Overall Study|Adverse Event|1|||
13364316|NCT00862992|26695519|FG002|Overall Study|Adverse Event|1|||
13364317|NCT00862992|26695517|FG000|Overall Study|Physician Decision|1|||
13364318|NCT00862992|26695518|FG001|Overall Study|Physician Decision|0|||
13364319|NCT00862992|26695519|FG002|Overall Study|Physician Decision|0|||
13364320|NCT00862992|26695517|FG000|Overall Study|Withdrawal by Subject|0|||
13364321|NCT00862992|26695518|FG001|Overall Study|Withdrawal by Subject|0|||
13364322|NCT00862992|26695519|FG002|Overall Study|Withdrawal by Subject|2|||
13364323|NCT00862979|26695542|FG000|Overall Study|Adverse Event|6|||
13364324|NCT00862979|26695543|FG001|Overall Study|Adverse Event|3|||
13364325|NCT00862979|26695542|FG000|Overall Study|Protocol Violation|0|||
13364326|NCT00862979|26695543|FG001|Overall Study|Protocol Violation|1|||
13364327|NCT00862979|26695542|FG000|Overall Study|Patient withdrew consent|2|||
13364328|NCT00862979|26695543|FG001|Overall Study|Patient withdrew consent|1|||
13364329|NCT00862979|26695542|FG000|Overall Study|Administrative problems|0|||
13364330|NCT00862979|26695543|FG001|Overall Study|Administrative problems|1|||
13364331|NCT00862979|26695542|FG000|Overall Study|Death|0|||
13364332|NCT00862979|26695543|FG001|Overall Study|Death|1|||
13364333|NCT00862940|26695562|FG000|Overall Study|Adverse Event|15|||
13364334|NCT00862940|26695563|FG001|Overall Study|Adverse Event|12|||
13364335|NCT00862940|26695562|FG000|Overall Study|Lack of Efficacy|1|||
13364336|NCT00862940|26695563|FG001|Overall Study|Lack of Efficacy|3|||
13364337|NCT00862940|26695562|FG000|Overall Study|Protocol Violation|2|||
13364338|NCT00862940|26695563|FG001|Overall Study|Protocol Violation|5|||
13364339|NCT00862940|26695562|FG000|Overall Study|Withdrawal by Subject|4|||
13364340|NCT00862940|26695563|FG001|Overall Study|Withdrawal by Subject|6|||
13364341|NCT00862940|26695562|FG000|Overall Study|Non-compliance|4|||
13364342|NCT00862940|26695563|FG001|Overall Study|Non-compliance|0|||
13364343|NCT00862940|26695562|FG000|Overall Study|Lost to Follow-up|0|||
13364344|NCT00862940|26695563|FG001|Overall Study|Lost to Follow-up|1|||
13364345|NCT00862940|26695562|FG000|Overall Study|Administrative or other reason(s)|4|||
13364346|NCT00862940|26695563|FG001|Overall Study|Administrative or other reason(s)|3|||
13364347|NCT00862849|26695593|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
13364348|NCT00862849|26695594|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1|||
13364349|NCT00862849|26695595|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
13364350|NCT00862849|26695596|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
13364351|NCT00862849|26695597|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
13364352|NCT00862849|26695598|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
13364353|NCT00862849|26695593|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
13364354|NCT00862849|26695594|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1|||
13364355|NCT00862849|26695595|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
13364356|NCT00862849|26695596|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
13364357|NCT00862849|26695597|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
13364358|NCT00862849|26695598|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
13364359|NCT00862836|26695611|FG000|Overall Study|Withdrawal by Subject|1|||
13364360|NCT00862823|26695621|FG000|First Intervention|Withdrawal by Subject|1|||
13364361|NCT00862823|26695622|FG001|First Intervention|Withdrawal by Subject|1|||
13364362|NCT00862719|26695654|FG000|Overall Study|Disease Progression|5|||
13364363|NCT00862719|26695655|FG001|Overall Study|Disease Progression|0|||
13364364|NCT00862719|26695656|FG002|Overall Study|Disease Progression|1|||
13364365|NCT00862719|26695657|FG003|Overall Study|Disease Progression|0|||
13364366|NCT00862719|26695654|FG000|Overall Study|Death|5|||
13364367|NCT00862719|26695655|FG001|Overall Study|Death|6|||
13364368|NCT00862719|26695656|FG002|Overall Study|Death|1|||
13364369|NCT00862719|26695657|FG003|Overall Study|Death|1|||
13364370|NCT00862719|26695654|FG000|Overall Study|Engraftment failure|0|||
13364371|NCT00862719|26695655|FG001|Overall Study|Engraftment failure|0|||
13364372|NCT00862719|26695656|FG002|Overall Study|Engraftment failure|1|||
13364373|NCT00862719|26695657|FG003|Overall Study|Engraftment failure|0|||
13364374|NCT00862719|26695654|FG000|Overall Study|Veno-Occlusive Disease|0|||
13364375|NCT00862719|26695655|FG001|Overall Study|Veno-Occlusive Disease|0|||
13364376|NCT00862719|26695656|FG002|Overall Study|Veno-Occlusive Disease|1|||
13364377|NCT00862719|26695657|FG003|Overall Study|Veno-Occlusive Disease|0|||
13364378|NCT00862654|26695680|FG000|Overall Study|Lack of Efficacy|1|||
13364379|NCT00862654|26695681|FG001|Overall Study|Lack of Efficacy|0|||
13364380|NCT00862654|26695682|FG002|Overall Study|Lack of Efficacy|1|||
13364381|NCT00862654|26695683|FG003|Overall Study|Lack of Efficacy|0|||
13364382|NCT00862654|26695680|FG000|Overall Study|Lost to Follow-up|1|||
13364383|NCT00862654|26695681|FG001|Overall Study|Lost to Follow-up|2|||
13364384|NCT00862654|26695682|FG002|Overall Study|Lost to Follow-up|1|||
13364385|NCT00862654|26695683|FG003|Overall Study|Lost to Follow-up|3|||
13364386|NCT00862654|26695680|FG000|Overall Study|Adverse Event|0|||
13364387|NCT00862654|26695681|FG001|Overall Study|Adverse Event|1|||
13364388|NCT00862654|26695682|FG002|Overall Study|Adverse Event|1|||
13364389|NCT00862654|26695683|FG003|Overall Study|Adverse Event|0|||
13364390|NCT00862654|26695680|FG000|Overall Study|Pregnancy|1|||
13364391|NCT00862654|26695681|FG001|Overall Study|Pregnancy|1|||
13364392|NCT00862654|26695682|FG002|Overall Study|Pregnancy|0|||
13364393|NCT00862654|26695683|FG003|Overall Study|Pregnancy|0|||
13364394|NCT00862654|26695680|FG000|Overall Study|Withdrawal by Subject|2|||
13364395|NCT00862654|26695681|FG001|Overall Study|Withdrawal by Subject|2|||
13364396|NCT00862654|26695682|FG002|Overall Study|Withdrawal by Subject|2|||
13364397|NCT00862654|26695683|FG003|Overall Study|Withdrawal by Subject|3|||
13364398|NCT00862654|26695680|FG000|Overall Study|Subject mistake|0|||
13364399|NCT00862654|26695681|FG001|Overall Study|Subject mistake|1|||
13364400|NCT00862654|26695682|FG002|Overall Study|Subject mistake|0|||
13364401|NCT00862654|26695683|FG003|Overall Study|Subject mistake|0|||
13364402|NCT00862654|26695680|FG000|Overall Study|Familly constraint|0|||
13364403|NCT00862654|26695681|FG001|Overall Study|Familly constraint|1|||
13364404|NCT00862654|26695682|FG002|Overall Study|Familly constraint|0|||
13364405|NCT00862654|26695683|FG003|Overall Study|Familly constraint|0|||
13364406|NCT00862654|26695680|FG000|Overall Study|Never used study drugs|1|||
13364407|NCT00862654|26695681|FG001|Overall Study|Never used study drugs|0|||
13364408|NCT00862654|26695682|FG002|Overall Study|Never used study drugs|0|||
13364409|NCT00862654|26695683|FG003|Overall Study|Never used study drugs|0|||
13364410|NCT00862654|26695680|FG000|Overall Study|Included after end of inclusions|0|||
13364411|NCT00862654|26695681|FG001|Overall Study|Included after end of inclusions|0|||
13364412|NCT00862654|26695682|FG002|Overall Study|Included after end of inclusions|1|||
13364413|NCT00862654|26695683|FG003|Overall Study|Included after end of inclusions|0|||
13364414|NCT00862641|26695738|FG000|Overall Study|Randomized, but drug not received|1|||
13364415|NCT00862641|26695739|FG001|Overall Study|Randomized, but drug not received|4|||
13364416|NCT00862641|26695740|FG002|Overall Study|Randomized, but drug not received|1|||
13364417|NCT00862641|26695741|FG003|Overall Study|Randomized, but drug not received|4|||
13364418|NCT00862459|26695895|FG000|Overall Study|Lost to Follow-up|1|||
13364419|NCT00862459|26695896|FG001|Overall Study|Lost to Follow-up|2|||
13364420|NCT00862459|26695897|FG002|Overall Study|Lost to Follow-up|2|||
13364421|NCT00862459|26695895|FG000|Overall Study|Protocol Violation|1|||
13364422|NCT00862459|26695896|FG001|Overall Study|Protocol Violation|0|||
13364423|NCT00862459|26695897|FG002|Overall Study|Protocol Violation|0|||
13364424|NCT00862459|26695895|FG000|Overall Study|Withdrawal by Subject|1|||
13364425|NCT00862459|26695896|FG001|Overall Study|Withdrawal by Subject|1|||
13364426|NCT00862459|26695897|FG002|Overall Study|Withdrawal by Subject|3|||
13364427|NCT00862459|26695895|FG000|Overall Study|Adverse Event|0|||
13364428|NCT00862459|26695896|FG001|Overall Study|Adverse Event|1|||
13364429|NCT00862459|26695897|FG002|Overall Study|Adverse Event|0|||
13364430|NCT00862459|26695895|FG000|Overall Study|Personal reasons|1|||
13364431|NCT00862459|26695896|FG001|Overall Study|Personal reasons|0|||
13364432|NCT00862459|26695897|FG002|Overall Study|Personal reasons|0|||
13364433|NCT00862459|26695895|FG000|Overall Study|Operation|1|||
13364434|NCT00862459|26695896|FG001|Overall Study|Operation|1|||
13364435|NCT00862459|26695897|FG002|Overall Study|Operation|0|||
13364436|NCT00862459|26695895|FG000|Overall Study|Intravenous (IV) site problems|1|||
13364437|NCT00862459|26695896|FG001|Overall Study|Intravenous (IV) site problems|0|||
13364438|NCT00862459|26695897|FG002|Overall Study|Intravenous (IV) site problems|1|||
13364439|NCT00862459|26695895|FG000|Overall Study|Unable to hold still for imaging|0|||
13364440|NCT00862459|26695896|FG001|Overall Study|Unable to hold still for imaging|1|||
13364441|NCT00862459|26695897|FG002|Overall Study|Unable to hold still for imaging|0|||
13364442|NCT00862459|26695895|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
13364443|NCT00862459|26695896|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
13364444|NCT00862459|26695897|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
13364445|NCT00862459|26695895|FG000|Overall Study|Administrative problems|0|||
13364446|NCT00862459|26695896|FG001|Overall Study|Administrative problems|1|||
13364447|NCT00862459|26695897|FG002|Overall Study|Administrative problems|0|||
13364448|NCT00862277|26695918|FG000|Overall Study|Protocol Violation|1|||
13364449|NCT00862277|26695919|FG001|Overall Study|Protocol Violation|2|||
13364450|NCT00862277|26695920|FG002|Overall Study|Protocol Violation|5|||
13364451|NCT00862134|26695937|FG000|Overall Study|Death|1|||
13364452|NCT00862134|26695938|FG001|Overall Study|Death|0|||
13364453|NCT00862134|26695937|FG000|Overall Study|Physician Decision|0|||
13364454|NCT00862134|26695938|FG001|Overall Study|Physician Decision|1|||
13364455|NCT00862134|26695937|FG000|Overall Study|Withdrawal by Subject|1|||
13364456|NCT00862134|26695938|FG001|Overall Study|Withdrawal by Subject|2|||
13364457|NCT00862134|26695937|FG000|Overall Study|Sponsor terminated study|5|||
13364458|NCT00862134|26695938|FG001|Overall Study|Sponsor terminated study|7|||
13364459|NCT00862134|26695937|FG000|Overall Study|Adverse Event|2|||
13364460|NCT00862134|26695938|FG001|Overall Study|Adverse Event|2|||
13364461|NCT00862134|26695937|FG000|Overall Study|Withdrew prior to dosing|2|||
13364462|NCT00862134|26695938|FG001|Overall Study|Withdrew prior to dosing|0|||
13364463|NCT00862121|26695961|FG000|Overall Study|Adverse Event|1|||
13364464|NCT00862121|26695962|FG001|Overall Study|Adverse Event|2|||
13364465|NCT00862121|26695961|FG000|Overall Study|Lack of Efficacy|0|||
13364466|NCT00862121|26695962|FG001|Overall Study|Lack of Efficacy|3|||
13364467|NCT00862121|26695961|FG000|Overall Study|Protocol Violation|0|||
13364468|NCT00862121|26695962|FG001|Overall Study|Protocol Violation|1|||
13364469|NCT00862121|26695961|FG000|Overall Study|Exclusion criterion violation|0|||
13364470|NCT00862121|26695962|FG001|Overall Study|Exclusion criterion violation|1|||
13364471|NCT00862121|26695961|FG000|Overall Study|Incorrect randomisation|0|||
13364472|NCT00862121|26695962|FG001|Overall Study|Incorrect randomisation|1|||
13364473|NCT00862082|26696012|FG000|Overall Study|Sponsor decision to terminate the study|5|||
13364474|NCT00862082|26696013|FG001|Overall Study|Sponsor decision to terminate the study|0|||
13364475|NCT00862082|26696012|FG000|Overall Study|Withdrawal by Subject|0|||
13364476|NCT00862082|26696013|FG001|Overall Study|Withdrawal by Subject|1|||
13364477|NCT00861757|26696080|FG000|Overall Study|Adverse Event|1|||
13364478|NCT00861757|26696081|FG001|Overall Study|Adverse Event|5|||
13364479|NCT00861757|26696082|FG002|Overall Study|Adverse Event|7|||
13364480|NCT00861757|26696083|FG003|Overall Study|Adverse Event|2|||
13364481|NCT00861757|26696080|FG000|Overall Study|Entry Criteria Not Met|1|||
13364482|NCT00861757|26696081|FG001|Overall Study|Entry Criteria Not Met|2|||
13364483|NCT00861757|26696082|FG002|Overall Study|Entry Criteria Not Met|1|||
13364484|NCT00861757|26696083|FG003|Overall Study|Entry Criteria Not Met|1|||
13364485|NCT00861757|26696080|FG000|Overall Study|Lack of Efficacy|3|||
13364486|NCT00861757|26696081|FG001|Overall Study|Lack of Efficacy|1|||
13364487|NCT00861757|26696082|FG002|Overall Study|Lack of Efficacy|0|||
13364488|NCT00861757|26696083|FG003|Overall Study|Lack of Efficacy|1|||
13364489|NCT00861757|26696080|FG000|Overall Study|Lost to Follow-up|1|||
13364490|NCT00861757|26696081|FG001|Overall Study|Lost to Follow-up|0|||
13364491|NCT00861757|26696082|FG002|Overall Study|Lost to Follow-up|1|||
13364492|NCT00861757|26696083|FG003|Overall Study|Lost to Follow-up|1|||
13364493|NCT00861757|26696080|FG000|Overall Study|Physician Decision|0|||
13364494|NCT00861757|26696081|FG001|Overall Study|Physician Decision|0|||
13364495|NCT00861757|26696082|FG002|Overall Study|Physician Decision|0|||
13364496|NCT00861757|26696083|FG003|Overall Study|Physician Decision|1|||
13364497|NCT00861757|26696080|FG000|Overall Study|Protocol Violation|2|||
13364498|NCT00861757|26696081|FG001|Overall Study|Protocol Violation|2|||
13364499|NCT00861757|26696082|FG002|Overall Study|Protocol Violation|4|||
13364500|NCT00861757|26696083|FG003|Overall Study|Protocol Violation|1|||
13364501|NCT00861757|26696080|FG000|Overall Study|Withdrawal by Subject|1|||
13364502|NCT00861757|26696081|FG001|Overall Study|Withdrawal by Subject|5|||
13364503|NCT00861757|26696082|FG002|Overall Study|Withdrawal by Subject|5|||
13364504|NCT00861757|26696083|FG003|Overall Study|Withdrawal by Subject|2|||
13364505|NCT00861744|26696274|FG000|Overall Study|Adverse Event|0|||
13364506|NCT00861744|26696275|FG001|Overall Study|Adverse Event|0|||
13364507|NCT00861744|26696276|FG002|Overall Study|Adverse Event|0|||
13364508|NCT00861744|26696277|FG003|Overall Study|Adverse Event|1|||
13364509|NCT00861744|26696274|FG000|Overall Study|Lost to Follow-up|7|||
13364510|NCT00861744|26696275|FG001|Overall Study|Lost to Follow-up|19|||
13364511|NCT00861744|26696276|FG002|Overall Study|Lost to Follow-up|17|||
13364512|NCT00861744|26696277|FG003|Overall Study|Lost to Follow-up|12|||
13364513|NCT00861744|26696274|FG000|Overall Study|Withdrawal by Subject|10|||
13364514|NCT00861744|26696275|FG001|Overall Study|Withdrawal by Subject|6|||
13364515|NCT00861744|26696276|FG002|Overall Study|Withdrawal by Subject|6|||
13364516|NCT00861744|26696277|FG003|Overall Study|Withdrawal by Subject|19|||
13364517|NCT00861744|26696274|FG000|Overall Study|Protocol Violation|0|||
13364518|NCT00861744|26696275|FG001|Overall Study|Protocol Violation|1|||
13364519|NCT00861744|26696276|FG002|Overall Study|Protocol Violation|0|||
13364520|NCT00861744|26696277|FG003|Overall Study|Protocol Violation|0|||
13364521|NCT00861744|26696274|FG000|Overall Study|Migration from study area|0|||
13364522|NCT00861744|26696275|FG001|Overall Study|Migration from study area|3|||
13364523|NCT00861744|26696276|FG002|Overall Study|Migration from study area|1|||
13364524|NCT00861744|26696277|FG003|Overall Study|Migration from study area|0|||
13364525|NCT00861744|26696274|FG000|Overall Study|Blood draws|0|||
13364526|NCT00861744|26696275|FG001|Overall Study|Blood draws|0|||
13364527|NCT00861744|26696276|FG002|Overall Study|Blood draws|0|||
13364528|NCT00861744|26696277|FG003|Overall Study|Blood draws|1|||
13364529|NCT00861692|26696289|FG000|Overall Study|Death|6|||
13364530|NCT00861614|26696326|FG000|Overall Study|Disease Progression|182|||
13364531|NCT00861614|26696327|FG001|Overall Study|Disease Progression|263|||
13364532|NCT00861614|26696326|FG000|Overall Study|Study Drug Toxicity|79|||
13364533|NCT00861614|26696327|FG001|Overall Study|Study Drug Toxicity|6|||
13364534|NCT00861614|26696326|FG000|Overall Study|Death|32|||
13364535|NCT00861614|26696327|FG001|Overall Study|Death|19|||
13364536|NCT00861614|26696326|FG000|Overall Study|Adverse Event|27|||
13364537|NCT00861614|26696327|FG001|Overall Study|Adverse Event|23|||
13364538|NCT00861614|26696326|FG000|Overall Study|Withdrawal by Subject|34|||
13364539|NCT00861614|26696327|FG001|Overall Study|Withdrawal by Subject|35|||
13364540|NCT00861614|26696326|FG000|Overall Study|Other|17|||
13364541|NCT00861614|26696327|FG001|Overall Study|Other|22|||
13364542|NCT00861471|26696337|FG000|Overall Study|Withdrawal by Subject|1|||
13364543|NCT00861471|26696337|FG000|Overall Study|Adverse Event|2|||
13364544|NCT00861471|26696337|FG000|Overall Study|Lack of Efficacy|3|||
13364545|NCT00861471|26696337|FG000|Overall Study|treatment for lumbar laminectomy|1|||
13364546|NCT00861471|26696337|FG000|Overall Study|Physician Decision|2|||
13364547|NCT00861380|26696455|FG000|Overall Study|Withdrawal Information not recorded|8427|||
13364548|NCT00861380|26696456|FG001|Overall Study|Withdrawal Information not recorded|9112|||
13364549|NCT00861380|26696457|FG002|Overall Study|Withdrawal Information not recorded|8872|||
13364550|NCT00861380|26696458|FG003|Overall Study|Withdrawal Information not recorded|3689|||
13364551|NCT00861380|26696459|FG004|Overall Study|Withdrawal Information not recorded|1812|||
13364552|NCT00861380|26696460|FG005|Overall Study|Withdrawal Information not recorded|6249|||
13364553|NCT00861380|26696461|FG006|Overall Study|Withdrawal Information not recorded|3020|||
13364554|NCT00861341|26696468|FG000|Overall Study|Withdrawal by Subject|2|||
13364555|NCT00861198|26696474|FG000|Overall Study|SpyGlass Failed|5|||
13364556|NCT00860951|26696482|FG000|Overall Study|Withdrawal by Subject|2|||
13364557|NCT00860951|26696482|FG000|Overall Study|Lost to Follow-up|5|||
13364558|NCT00860743|26696503|FG000|Overall Study|Withdrawal by Subject|3|||
13364559|NCT00860743|26696504|FG001|Overall Study|Withdrawal by Subject|0|||
13364560|NCT00860574|26696517|FG000|Overall Study|Death|2|||
13364561|NCT00860574|26696517|FG000|Overall Study|Relapse|1|||
13364562|NCT00860470|26696548|FG000|Overall Study|Death|6|||
13364563|NCT00860470|26696549|FG001|Overall Study|Death|10|||
13364564|NCT00860470|26696548|FG000|Overall Study|Moved away|8|||
13364565|NCT00860470|26696549|FG001|Overall Study|Moved away|10|||
13364566|NCT00860470|26696548|FG000|Overall Study|Lost to Follow-up|34|||
13364567|NCT00860470|26696549|FG001|Overall Study|Lost to Follow-up|39|||
13364568|NCT00860405|26696578|FG000|Overall Study|Main reason: Follow-up data not complete|5|||
13364569|NCT00860405|26696579|FG001|Overall Study|Main reason: Follow-up data not complete|4|||
13364570|NCT00860262|26696699|FG000|Overall Study|Adverse Event|9|||
13364571|NCT00860262|26696700|FG001|Overall Study|Adverse Event|6|||
13364572|NCT00860262|26696701|FG002|Overall Study|Adverse Event|7|||
13364573|NCT00860262|26696699|FG000|Overall Study|Protocol Violation|0|||
13364574|NCT00860262|26696700|FG001|Overall Study|Protocol Violation|1|||
13364575|NCT00860262|26696701|FG002|Overall Study|Protocol Violation|0|||
13364576|NCT00860262|26696699|FG000|Overall Study|Lost to Follow-up|2|||
13364577|NCT00860262|26696700|FG001|Overall Study|Lost to Follow-up|0|||
13364578|NCT00860262|26696701|FG002|Overall Study|Lost to Follow-up|1|||
13364579|NCT00860262|26696699|FG000|Overall Study|Withdrawal by Subject|4|||
13364580|NCT00860262|26696700|FG001|Overall Study|Withdrawal by Subject|8|||
13364581|NCT00860262|26696701|FG002|Overall Study|Withdrawal by Subject|6|||
13364582|NCT00860262|26696699|FG000|Overall Study|Lack of Efficacy|0|||
13364583|NCT00860262|26696700|FG001|Overall Study|Lack of Efficacy|4|||
13364584|NCT00860262|26696701|FG002|Overall Study|Lack of Efficacy|3|||
13364585|NCT00860262|26696699|FG000|Overall Study|Other|5|||
13364586|NCT00860262|26696700|FG001|Overall Study|Other|3|||
13364587|NCT00860262|26696701|FG002|Overall Study|Other|1|||
13364588|NCT00860249|26696722|FG000|Overall Study|trial was terminated prior to completion|21|||
13364589|NCT00860249|26696723|FG001|Overall Study|trial was terminated prior to completion|18|||
13364590|NCT00860249|26696724|FG002|Overall Study|trial was terminated prior to completion|21|||
13364591|NCT00860158|26696735|FG000|Overall Study|Study Terminated|1|||
13364592|NCT00860067|26696803|FG000|Overall Study|Lost to Follow-up|46|||
13364593|NCT00860067|26696804|FG001|Overall Study|Lost to Follow-up|9|||
13364594|NCT00860067|26696805|FG002|Overall Study|Lost to Follow-up|9|||
13364595|NCT00860067|26696803|FG000|Overall Study|Withdrawal by Subject|4|||
13364596|NCT00860067|26696804|FG001|Overall Study|Withdrawal by Subject|0|||
13364597|NCT00860067|26696805|FG002|Overall Study|Withdrawal by Subject|0|||
13364598|NCT00860067|26696803|FG000|Overall Study|Pregnancy|1|||
13364599|NCT00860067|26696804|FG001|Overall Study|Pregnancy|0|||
13364600|NCT00860067|26696805|FG002|Overall Study|Pregnancy|0|||
13364601|NCT00860028|26696822|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2|||
13364602|NCT00860028|26696823|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1|||
13364603|NCT00859937|26696842|FG000|Overall Study|Protocol Violation|1|||
13364604|NCT00859937|26696843|FG001|Overall Study|Protocol Violation|0|||
13364605|NCT00859898|26696894|FG000|Overall Study|Lack of Efficacy|0|||
13364606|NCT00859898|26696895|FG001|Overall Study|Lack of Efficacy|1|||
13364607|NCT00859898|26696896|FG002|Overall Study|Lack of Efficacy|1|||
13364608|NCT00859898|26696894|FG000|Overall Study|Adverse Event|4|||
13364609|NCT00859898|26696895|FG001|Overall Study|Adverse Event|9|||
13364610|NCT00859898|26696896|FG002|Overall Study|Adverse Event|8|||
13364611|NCT00859898|26696894|FG000|Overall Study|Withdrawal by Subject|11|||
13364612|NCT00859898|26696895|FG001|Overall Study|Withdrawal by Subject|8|||
13364613|NCT00859898|26696896|FG002|Overall Study|Withdrawal by Subject|11|||
13364614|NCT00859898|26696894|FG000|Overall Study|Death|0|||
13364615|NCT00859898|26696895|FG001|Overall Study|Death|0|||
13364616|NCT00859898|26696896|FG002|Overall Study|Death|1|||
13364617|NCT00859898|26696894|FG000|Overall Study|Lost to Follow-up|10|||
13364618|NCT00859898|26696895|FG001|Overall Study|Lost to Follow-up|11|||
13364619|NCT00859898|26696896|FG002|Overall Study|Lost to Follow-up|5|||
13364620|NCT00859898|26696894|FG000|Overall Study|poor/non-compliance|2|||
13364621|NCT00859898|26696895|FG001|Overall Study|poor/non-compliance|0|||
13364622|NCT00859898|26696896|FG002|Overall Study|poor/non-compliance|0|||
13364623|NCT00859898|26696894|FG000|Overall Study|No longer meets criteria|0|||
13364624|NCT00859898|26696895|FG001|Overall Study|No longer meets criteria|1|||
13364625|NCT00859898|26696896|FG002|Overall Study|No longer meets criteria|0|||
13364626|NCT00859898|26696894|FG000|Overall Study|non-specified|1|||
13364627|NCT00859898|26696895|FG001|Overall Study|non-specified|1|||
13364628|NCT00859898|26696896|FG002|Overall Study|non-specified|1|||
13364629|NCT00859638|26696909|FG000|Overall Study|Lost to Follow-up|6|||
13364630|NCT00859638|26696910|FG001|Overall Study|Lost to Follow-up|1|||
13364631|NCT00859638|26696909|FG000|Overall Study|Withdrawal by Subject|3|||
13364632|NCT00859638|26696910|FG001|Overall Study|Withdrawal by Subject|2|||
13364633|NCT00859638|26696909|FG000|Overall Study|Ill health|1|||
13364634|NCT00859638|26696910|FG001|Overall Study|Ill health|1|||
13364635|NCT00859586|26696926|FG000|Overall Study|Donors|4|||
13364636|NCT00859573|26696939|FG000|Overall Study|Withdrawal by Subject|4|||
13364637|NCT00859573|26696940|FG001|Overall Study|Withdrawal by Subject|1|||
13364638|NCT00859573|26696939|FG000|Overall Study|Physician Decision|1|||
13364639|NCT00859573|26696940|FG001|Overall Study|Physician Decision|1|||
13364640|NCT00859547|26696953|FG000|Overall Study|Lost to Follow-up|1|||
13364641|NCT00859547|26696953|FG000|Overall Study|Parent withdrew consent|1|||
13364642|NCT00859469|26696961|FG000|Overall Study|Adverse Event|2|||
13364643|NCT00859469|26696961|FG000|Overall Study|Lack of Efficacy|9|||
13364644|NCT00859469|26696961|FG000|Overall Study|Withdrawal by Subject|1|||
13364645|NCT00859469|26696961|FG000|Overall Study|Death|16|||
13364646|NCT00859456|26696967|FG000|Overall Study|Adverse Event|3|||
13364647|NCT00859456|26696967|FG000|Overall Study|Progressive disease|2|||
13364648|NCT00859456|26696967|FG000|Overall Study|Non-compliance|3|||
13364649|NCT00859313|26696973|FG000|Overall Study|Lack of Efficacy|2|||
13364650|NCT00859313|26696973|FG000|Overall Study|Adverse Event|1|||
13364651|NCT00859313|26696973|FG000|Overall Study|staff error|1|||
13364652|NCT00859222|26697010|FG000|Overall Study|Adverse Event|2|||
13364653|NCT00859222|26697011|FG001|Overall Study|Adverse Event|3|||
13364654|NCT00859222|26697012|FG002|Overall Study|Adverse Event|6|||
13364655|NCT00859222|26697013|FG003|Overall Study|Adverse Event|24|||
13364656|NCT00859222|26697014|FG004|Overall Study|Adverse Event|15|||
13364657|NCT00859222|26697010|FG000|Overall Study|DLT|1|||
13364658|NCT00859222|26697011|FG001|Overall Study|DLT|0|||
13364659|NCT00859222|26697012|FG002|Overall Study|DLT|0|||
13364660|NCT00859222|26697013|FG003|Overall Study|DLT|0|||
13364661|NCT00859222|26697014|FG004|Overall Study|DLT|0|||
13364662|NCT00859014|26697021|FG000|Overall Study|Death|4|||
13364663|NCT00859014|26697021|FG000|Overall Study|Lost to Follow-up|1|||
13364664|NCT00858988|26697034|FG000|Analysis|Lactulose unable to be detected in urine|2|||
13364665|NCT00858988|26697035|FG001|Analysis|Lactulose unable to be detected in urine|1|||
13364666|NCT00858845|26697052|FG000|Overall Study|Patient underwent heart transplant.|0|||
13364667|NCT00858845|26697053|FG001|Overall Study|Patient underwent heart transplant.|1|||
13364668|NCT00858832|26697066|FG000|Overall Study|became ineligible: delivered vaginally|1|||
13364669|NCT00858832|26697067|FG001|Overall Study|became ineligible: delivered vaginally|0|||
13364670|NCT00858832|26697066|FG000|Overall Study|Adverse Event|0|||
13364671|NCT00858832|26697067|FG001|Overall Study|Adverse Event|1|||
13364672|NCT00858780|26697146|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18|||
13364673|NCT00858780|26697147|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
13364674|NCT00858780|26697148|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
13364675|NCT00858780|26697149|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
13364676|NCT00858780|26697150|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
13364677|NCT00858780|26697146|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
13364678|NCT00858780|26697147|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
13364679|NCT00858780|26697148|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1|||
13364680|NCT00858780|26697149|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
13364681|NCT00858780|26697150|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
13364682|NCT00858780|26697146|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
13364683|NCT00858780|26697147|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
13364684|NCT00858780|26697148|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
13364685|NCT00858780|26697149|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
13364686|NCT00858780|26697150|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
13364687|NCT00858780|26697146|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
13364688|NCT00858780|26697147|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1|||
13364689|NCT00858780|26697148|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
13364690|NCT00858780|26697149|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
13364691|NCT00858780|26697150|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
13364692|NCT00858780|26697146|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
13364693|NCT00858780|26697147|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
13364694|NCT00858780|26697148|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
13364695|NCT00858780|26697149|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
13364696|NCT00858780|26697150|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1|||
13364697|NCT00858780|26697146|FG000|OL Re-Treatment (Failure to Week 48)|Other|0|||
13364698|NCT00858780|26697147|FG001|OL Re-Treatment (Failure to Week 48)|Other|0|||
13289374|NCT01680965|26478382|FG000|Overall Study|Death|0|||
13289375|NCT01680965|26478383|FG001|Overall Study|Death|0|||
13289376|NCT01680965|26478384|FG002|Overall Study|Death|0|||
13289377|NCT01680965|26478385|FG003|Overall Study|Death|6|||
13289378|NCT02277106|26478610|FG000|Stage 2|Adverse Event|0|||
13289379|NCT02277106|26478611|FG001|Stage 2|Adverse Event|0|||
13289380|NCT02277106|26478612|FG002|Stage 2|Adverse Event|1|||
13364699|NCT00858780|26697148|FG002|OL Re-Treatment (Failure to Week 48)|Other|0|||
13364700|NCT00858780|26697149|FG003|OL Re-Treatment (Failure to Week 48)|Other|0|||
13364701|NCT00858780|26697150|FG004|OL Re-Treatment (Failure to Week 48)|Other|1|||
13364702|NCT00858637|26697171|FG000|Active Comparison Phase|Adverse Event|14|||
13364703|NCT00858637|26697172|FG001|Active Comparison Phase|Adverse Event|0|||
13364704|NCT00858637|26697173|FG002|Active Comparison Phase|Adverse Event|0|||
13364705|NCT00858637|26697174|FG003|Active Comparison Phase|Adverse Event|9|||
13364706|NCT00858637|26697175|FG004|Active Comparison Phase|Adverse Event|0|||
13364707|NCT00858637|26697176|FG005|Active Comparison Phase|Adverse Event|0|||
13364708|NCT00858637|26697171|FG000|Active Comparison Phase|Death|1|||
13364709|NCT00858637|26697172|FG001|Active Comparison Phase|Death|0|||
13364710|NCT00858637|26697173|FG002|Active Comparison Phase|Death|0|||
13364711|NCT00858637|26697174|FG003|Active Comparison Phase|Death|1|||
13364712|NCT00858637|26697175|FG004|Active Comparison Phase|Death|0|||
13364713|NCT00858637|26697176|FG005|Active Comparison Phase|Death|0|||
13364714|NCT00858637|26697171|FG000|Active Comparison Phase|Physician Decision|1|||
13364715|NCT00858637|26697172|FG001|Active Comparison Phase|Physician Decision|0|||
13364716|NCT00858637|26697173|FG002|Active Comparison Phase|Physician Decision|0|||
13364717|NCT00858637|26697174|FG003|Active Comparison Phase|Physician Decision|1|||
13364718|NCT00858637|26697175|FG004|Active Comparison Phase|Physician Decision|0|||
13364719|NCT00858637|26697176|FG005|Active Comparison Phase|Physician Decision|0|||
13364720|NCT00858637|26697171|FG000|Active Comparison Phase|Withdrawal by Subject|7|||
13364721|NCT00858637|26697172|FG001|Active Comparison Phase|Withdrawal by Subject|0|||
13364722|NCT00858637|26697173|FG002|Active Comparison Phase|Withdrawal by Subject|0|||
13364723|NCT00858637|26697174|FG003|Active Comparison Phase|Withdrawal by Subject|6|||
13364724|NCT00858637|26697175|FG004|Active Comparison Phase|Withdrawal by Subject|0|||
13364725|NCT00858637|26697176|FG005|Active Comparison Phase|Withdrawal by Subject|0|||
13364726|NCT00858637|26697171|FG000|Active Comparison Phase|Other Reasons|1|||
13364727|NCT00858637|26697172|FG001|Active Comparison Phase|Other Reasons|0|||
13364728|NCT00858637|26697173|FG002|Active Comparison Phase|Other Reasons|0|||
13364729|NCT00858637|26697174|FG003|Active Comparison Phase|Other Reasons|1|||
13364730|NCT00858637|26697175|FG004|Active Comparison Phase|Other Reasons|0|||
13364731|NCT00858637|26697176|FG005|Active Comparison Phase|Other Reasons|0|||
13364732|NCT00858637|26697171|FG000|Placebo-controlled Withdrawal Phase|Death|0|||
13364733|NCT00858637|26697172|FG001|Placebo-controlled Withdrawal Phase|Death|0|||
13364734|NCT00858637|26697173|FG002|Placebo-controlled Withdrawal Phase|Death|1|||
13364735|NCT00858637|26697174|FG003|Placebo-controlled Withdrawal Phase|Death|0|||
13364736|NCT00858637|26697175|FG004|Placebo-controlled Withdrawal Phase|Death|1|||
13364737|NCT00858637|26697176|FG005|Placebo-controlled Withdrawal Phase|Death|0|||
13364738|NCT00858637|26697171|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
13364739|NCT00858637|26697172|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
13364740|NCT00858637|26697173|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
13364741|NCT00858637|26697174|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
13364742|NCT00858637|26697175|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
13364743|NCT00858637|26697176|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1|||
13364744|NCT00858442|26697193|FG000|Compression:Start to Finish|Lost to Follow-up|1|||
13364745|NCT00858442|26697194|FG001|Compression:Start to Finish|Lost to Follow-up|3|||
13364746|NCT00858403|26697206|FG000|Overall Study|Withdrawal by Subject|1|||
13364747|NCT00858403|26697206|FG000|Overall Study|Death|3|||
13364748|NCT00858403|26697206|FG000|Overall Study|Disease Progression|1|||
13364749|NCT00858247|26697229|FG000|Baseline Assessment|Withdrawal by Subject|1|||
13364750|NCT00858247|26697230|FG001|Baseline Assessment|Withdrawal by Subject|1|||
13364751|NCT00858247|26697229|FG000|Baseline Assessment|Poor IV access|1|||
13364752|NCT00858247|26697230|FG001|Baseline Assessment|Poor IV access|0|||
13364753|NCT00858247|26697229|FG000|Baseline Assessment|Protocol Violation|0|||
13364754|NCT00858247|26697230|FG001|Baseline Assessment|Protocol Violation|1|||
13364755|NCT00858247|26697229|FG000|Week 12 Follow-up|Withdrawal by Subject|0|||
13364756|NCT00858247|26697230|FG001|Week 12 Follow-up|Withdrawal by Subject|1|||
13364757|NCT00858234|26697238|FG000|Overall Study|Adverse Event|6|||
13364758|NCT00858234|26697238|FG000|Overall Study|Progressive disease|2|||
13364759|NCT00858234|26697238|FG000|Overall Study|Status unknown|1|||
13364760|NCT00858208|26697257|FG000|Overall Study|Adverse Event|3|||
13364761|NCT00858208|26697257|FG000|Overall Study|Lost to Follow-up|26|||
13364762|NCT00858208|26697257|FG000|Overall Study|Participant refused|40|||
13364763|NCT00858208|26697257|FG000|Overall Study|Other|10|||
13364764|NCT00858143|26697308|FG000|Overall Study|Adverse Event|16|||
13364765|NCT00858143|26697308|FG000|Overall Study|Lack of Efficacy|4|||
13364766|NCT00858143|26697308|FG000|Overall Study|Death|7|||
13364767|NCT00858143|26697308|FG000|Overall Study|Other|23|||
13364768|NCT00858117|26697318|FG000|Treatment on Study|Adverse Event|2|||
13364769|NCT00858117|26697318|FG000|Follow up for 5 Years|Death|4|||
13364770|NCT00858117|26697318|FG000|Follow up for 5 Years|No further data collected for study|9|||
13364771|NCT00857948|26697353|FG000|Overall Study|Withdrawal by Subject|2|||
13364772|NCT00857948|26697354|FG001|Overall Study|Withdrawal by Subject|0|||
13364773|NCT00857948|26697355|FG002|Overall Study|Withdrawal by Subject|0|||
13364774|NCT00857948|26697356|FG003|Overall Study|Withdrawal by Subject|0|||
13364775|NCT00857948|26697353|FG000|Overall Study|Protocol Violation|1|||
13364776|NCT00857948|26697354|FG001|Overall Study|Protocol Violation|0|||
13364777|NCT00857948|26697355|FG002|Overall Study|Protocol Violation|1|||
13364778|NCT00857948|26697356|FG003|Overall Study|Protocol Violation|0|||
13364779|NCT00857896|26697370|FG000|Baseline to Week 4|Withdrawal by Subject|1|||
13364780|NCT00857818|26697405|FG000|Overall Study|Lack of Efficacy|1|||
13364781|NCT00857818|26697406|FG001|Overall Study|Lack of Efficacy|0|||
13364782|NCT00857818|26697405|FG000|Overall Study|Adverse Event|3|||
13364783|NCT00857818|26697406|FG001|Overall Study|Adverse Event|0|||
13364784|NCT00857818|26697405|FG000|Overall Study|Withdrawal by Subject|0|||
13364785|NCT00857818|26697406|FG001|Overall Study|Withdrawal by Subject|4|||
13364786|NCT00857818|26697405|FG000|Overall Study|Sponsor terminated study|6|||
13364787|NCT00857818|26697406|FG001|Overall Study|Sponsor terminated study|4|||
13364788|NCT00857818|26697405|FG000|Overall Study|Investigator decision|1|||
13364789|NCT00857818|26697406|FG001|Overall Study|Investigator decision|0|||
13364790|NCT00857792|26697412|FG000|Overall Study|inadequate image quality for analysis|12|||
13364791|NCT00857766|26697429|FG000|Overall Study|Adverse Event|13|||
13364792|NCT00857766|26697430|FG001|Overall Study|Adverse Event|12|||
13364793|NCT00857766|26697429|FG000|Overall Study|Protocol Violation|11|||
13364794|NCT00857766|26697430|FG001|Overall Study|Protocol Violation|11|||
13364795|NCT00857766|26697429|FG000|Overall Study|Lost to Follow-up|1|||
13364796|NCT00857766|26697430|FG001|Overall Study|Lost to Follow-up|0|||
13364797|NCT00857766|26697429|FG000|Overall Study|Investigator Discretion|2|||
13364798|NCT00857766|26697430|FG001|Overall Study|Investigator Discretion|3|||
13364799|NCT00857766|26697429|FG000|Overall Study|Participant Withdrew Consent|4|||
13364800|NCT00857766|26697430|FG001|Overall Study|Participant Withdrew Consent|4|||
13364801|NCT00857649|26697451|FG000|Overall Study|Adverse Event|15|||
13364802|NCT00857649|26697452|FG001|Overall Study|Adverse Event|10|||
13364803|NCT00857649|26697451|FG000|Overall Study|Non-compliance|1|||
13364804|NCT00857649|26697452|FG001|Overall Study|Non-compliance|1|||
13364805|NCT00857649|26697451|FG000|Overall Study|Protocol Violation|2|||
13364806|NCT00857649|26697452|FG001|Overall Study|Protocol Violation|2|||
13364807|NCT00857649|26697451|FG000|Overall Study|Withdrawal of Consent|10|||
13364808|NCT00857649|26697452|FG001|Overall Study|Withdrawal of Consent|7|||
13364809|NCT00857649|26697451|FG000|Overall Study|Nursing Home Placement|2|||
13364810|NCT00857649|26697452|FG001|Overall Study|Nursing Home Placement|9|||
13364811|NCT00857649|26697451|FG000|Overall Study|Other Reasons|1|||
13364812|NCT00857649|26697452|FG001|Overall Study|Other Reasons|3|||
13364813|NCT00857623|26697481|FG000|Overall Study|Adverse Event|5|||
13364814|NCT00857623|26697482|FG001|Overall Study|Adverse Event|2|||
13364815|NCT00857623|26697481|FG000|Overall Study|Study-specific discontinuation criteria|5|||
13364816|NCT00857623|26697482|FG001|Overall Study|Study-specific discontinuation criteria|3|||
13364817|NCT00857623|26697481|FG000|Overall Study|Withdrawal by Subject|2|||
13364818|NCT00857623|26697482|FG001|Overall Study|Withdrawal by Subject|1|||
13364819|NCT00857623|26697481|FG000|Overall Study|Lack of Efficacy|1|||
13364820|NCT00857623|26697482|FG001|Overall Study|Lack of Efficacy|1|||
13364821|NCT00857623|26697481|FG000|Overall Study|Severe non-compliance to protocol|1|||
13364822|NCT00857623|26697482|FG001|Overall Study|Severe non-compliance to protocol|1|||
13364823|NCT00857623|26697481|FG000|Overall Study|Intake of prohibited medication|0|||
13364824|NCT00857623|26697482|FG001|Overall Study|Intake of prohibited medication|1|||
13364825|NCT00857623|26697481|FG000|Overall Study|Positive for HEP C|0|||
13364826|NCT00857623|26697482|FG001|Overall Study|Positive for HEP C|1|||
13364827|NCT00857584|26697529|FG000|Overall Study|Lack of Efficacy|1|||
13364828|NCT00857584|26697530|FG001|Overall Study|Lack of Efficacy|2|||
13364829|NCT00857584|26697529|FG000|Overall Study|Adverse Event|2|||
13364830|NCT00857584|26697530|FG001|Overall Study|Adverse Event|2|||
13364831|NCT00857584|26697529|FG000|Overall Study|Physician Decision|1|||
13364832|NCT00857584|26697530|FG001|Overall Study|Physician Decision|1|||
13364833|NCT00857454|26697543|FG000|Overall Study|Withdrawal by Subject|2|||
13364834|NCT00857454|26697543|FG000|Overall Study|Lost to Follow-up|1|||
13364835|NCT00857454|26697543|FG000|Overall Study|Adverse Event|2|||
13364836|NCT00857454|26697543|FG000|Overall Study|Total Testosterone >1050 ng/dL|1|||
13364837|NCT00857454|26697543|FG000|Overall Study|Total Testosterone <300 ng/dL|8|||
13364838|NCT00857454|26697543|FG000|Overall Study|MTE09 enrollment criteria not met|6|||
13364839|NCT00857415|26697557|FG000|Overall Study|Image acquisition failure|2|||
13364840|NCT00857415|26697558|FG001|Overall Study|Image acquisition failure|0|||
13364841|NCT00857415|26697557|FG000|Overall Study|Invalid image or not imaged|3|||
13364842|NCT00857415|26697558|FG001|Overall Study|Invalid image or not imaged|0|||
13364843|NCT00857415|26697557|FG000|Overall Study|Subject still living at end of study|110|||
13364844|NCT00857415|26697558|FG001|Overall Study|Subject still living at end of study|0|||
13364845|NCT00857415|26697557|FG000|Overall Study|Deceased with no autopsy|2|||
13364846|NCT00857415|26697558|FG001|Overall Study|Deceased with no autopsy|0|||
13364847|NCT00857389|26697570|FG000|Overall Study|Did not proceed to transplant|2|||
13364848|NCT00857311|26697593|FG000|Overall Study|Lost to Follow-up|1|||
13364849|NCT00857311|26697594|FG001|Overall Study|Lost to Follow-up|0|||
13364850|NCT00857311|26697595|FG002|Overall Study|Lost to Follow-up|0|||
13364851|NCT00857311|26697596|FG003|Overall Study|Lost to Follow-up|0|||
13364852|NCT00857259|26697616|FG000|Overall Study|Protocol Violation|1|||
13364853|NCT00857259|26697617|FG001|Overall Study|Protocol Violation|0|||
13364854|NCT00857259|26697618|FG002|Overall Study|Protocol Violation|1|||
13364855|NCT00857246|26697630|FG000|Induction Regimen|Adverse Event|1|||
13364856|NCT00857246|26697630|FG000|Induction Regimen|disease-related complications|1|||
13364857|NCT00857246|26697630|FG000|Induction Regimen|Withdrawal by Subject|1|||
13364858|NCT00857246|26697630|FG000|Surgery (Curative)|disease progression|6|||
13364859|NCT00857246|26697630|FG000|ChemoRT|Withdrawal by Subject|1|||
13364860|NCT00857246|26697630|FG000|ChemoRT|Adverse Event|2|||
13364861|NCT00857233|26697641|FG000|Overall Study|Adverse Event|24|||
13364862|NCT00857233|26697641|FG000|Overall Study|Lack of Efficacy|1|||
13364863|NCT00857233|26697641|FG000|Overall Study|Non-compliance|1|||
13364864|NCT00857233|26697641|FG000|Overall Study|Withdrawal of Consent|9|||
13364865|NCT00857233|26697641|FG000|Overall Study|Lost to Follow-up|4|||
13364866|NCT00857233|26697641|FG000|Overall Study|Nursing Home Placement|14|||
13364867|NCT00857233|26697641|FG000|Overall Study|Other Reasons|2|||
13364868|NCT00857220|26697660|FG000|Overall Study|Adverse Event|35|||
13364869|NCT00857220|26697660|FG000|Overall Study|Death|1|||
13364870|NCT00857220|26697660|FG000|Overall Study|Lack of Efficacy|11|||
13364871|NCT00857220|26697660|FG000|Overall Study|Lost to Follow-up|30|||
13364872|NCT00857220|26697660|FG000|Overall Study|Physician Decision|4|||
13364873|NCT00857220|26697660|FG000|Overall Study|Protocol Violation|16|||
13364874|NCT00857220|26697660|FG000|Overall Study|Withdrawal by Subject|67|||
13364875|NCT00857220|26697660|FG000|Overall Study|Clinical Hold|6|||
13364876|NCT00857220|26697660|FG000|Overall Study|Site Closed|5|||
13364877|NCT00857220|26697660|FG000|Overall Study|Miscellaneous|8|||
13364878|NCT00857207|26697677|FG000|Overall Study|Withdrawal by Subject|13|||
13364879|NCT00857207|26697678|FG001|Overall Study|Withdrawal by Subject|0|||
13364880|NCT00857207|26697677|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18|||
13364881|NCT00857207|26697678|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0|||
13364882|NCT00857207|26697677|FG000|Overall Study|Subject chose not to participate after signing consent|3|||
13364883|NCT00857207|26697678|FG001|Overall Study|Subject chose not to participate after signing consent|0|||
13364884|NCT00856999|26697685|FG000|Overall Study|Withdrawal by Subject|5|||
13364885|NCT00856986|26697868|FG000|Run-in Period, Weeks -12-0|Adverse Event|0|||
13364886|NCT00856986|26697869|FG001|Run-in Period, Weeks -12-0|Adverse Event|0|||
13364887|NCT00856986|26697870|FG002|Run-in Period, Weeks -12-0|Adverse Event|0|||
13364888|NCT00856986|26697871|FG003|Run-in Period, Weeks -12-0|Adverse Event|92|||
13364889|NCT00856986|26697872|FG004|Run-in Period, Weeks -12-0|Adverse Event|0|||
13364890|NCT00856986|26697868|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0|||
13364891|NCT00856986|26697869|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0|||
13364892|NCT00856986|26697870|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0|||
13364893|NCT00856986|26697871|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24|||
13364894|NCT00856986|26697872|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0|||
13364895|NCT00856986|26697868|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
13364896|NCT00856986|26697869|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
13364897|NCT00856986|26697870|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
13364898|NCT00856986|26697871|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10|||
13364899|NCT00856986|26697872|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
13364900|NCT00856986|26697868|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
13364901|NCT00856986|26697869|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
13364902|NCT00856986|26697870|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
13364903|NCT00856986|26697871|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11|||
13364904|NCT00856986|26697872|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
13364905|NCT00856986|26697868|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
13364906|NCT00856986|26697869|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
13364907|NCT00856986|26697870|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
13364908|NCT00856986|26697871|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6|||
13364909|NCT00856986|26697872|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
13364910|NCT00856986|26697868|FG000|Run-in Period, Weeks -12-0|Unclassified|0|||
13364911|NCT00856986|26697869|FG001|Run-in Period, Weeks -12-0|Unclassified|0|||
13364912|NCT00856986|26697870|FG002|Run-in Period, Weeks -12-0|Unclassified|0|||
13364913|NCT00856986|26697871|FG003|Run-in Period, Weeks -12-0|Unclassified|24|||
13364914|NCT00856986|26697872|FG004|Run-in Period, Weeks -12-0|Unclassified|0|||
13364915|NCT00856986|26697868|FG000|Main Period, Weeks 0-26|Adverse Event|6|||
13364916|NCT00856986|26697869|FG001|Main Period, Weeks 0-26|Adverse Event|4|||
13364917|NCT00856986|26697870|FG002|Main Period, Weeks 0-26|Adverse Event|9|||
13364918|NCT00856986|26697871|FG003|Main Period, Weeks 0-26|Adverse Event|0|||
13364919|NCT00856986|26697872|FG004|Main Period, Weeks 0-26|Adverse Event|0|||
13364920|NCT00856986|26697868|FG000|Main Period, Weeks 0-26|Protocol Violation|4|||
13364921|NCT00856986|26697869|FG001|Main Period, Weeks 0-26|Protocol Violation|5|||
13364922|NCT00856986|26697870|FG002|Main Period, Weeks 0-26|Protocol Violation|7|||
13364923|NCT00856986|26697871|FG003|Main Period, Weeks 0-26|Protocol Violation|0|||
13364924|NCT00856986|26697872|FG004|Main Period, Weeks 0-26|Protocol Violation|0|||
13364925|NCT00856986|26697868|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11|||
13364926|NCT00856986|26697869|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
13364927|NCT00856986|26697870|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3|||
13364928|NCT00856986|26697871|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
13364929|NCT00856986|26697872|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
13364930|NCT00856986|26697868|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1|||
13364931|NCT00856986|26697869|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1|||
13364932|NCT00856986|26697870|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2|||
13364933|NCT00856986|26697871|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0|||
13364934|NCT00856986|26697872|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0|||
13364935|NCT00856986|26697868|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5|||
13364936|NCT00856986|26697869|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2|||
13364937|NCT00856986|26697870|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0|||
13364938|NCT00856986|26697871|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0|||
13364939|NCT00856986|26697872|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0|||
13364940|NCT00856986|26697868|FG000|Main Period, Weeks 0-26|Unclassified|7|||
13364941|NCT00856986|26697869|FG001|Main Period, Weeks 0-26|Unclassified|6|||
13364942|NCT00856986|26697870|FG002|Main Period, Weeks 0-26|Unclassified|7|||
13364943|NCT00856986|26697871|FG003|Main Period, Weeks 0-26|Unclassified|0|||
13364944|NCT00856986|26697872|FG004|Main Period, Weeks 0-26|Unclassified|0|||
13364945|NCT00856986|26697868|FG000|Extension Period, Weeks 26-52|Adverse Event|3|||
13364946|NCT00856986|26697869|FG001|Extension Period, Weeks 26-52|Adverse Event|3|||
13364947|NCT00856986|26697870|FG002|Extension Period, Weeks 26-52|Adverse Event|10|||
13364948|NCT00856986|26697871|FG003|Extension Period, Weeks 26-52|Adverse Event|0|||
13364949|NCT00856986|26697872|FG004|Extension Period, Weeks 26-52|Adverse Event|0|||
13364950|NCT00856986|26697868|FG000|Extension Period, Weeks 26-52|Protocol Violation|6|||
13364951|NCT00856986|26697869|FG001|Extension Period, Weeks 26-52|Protocol Violation|2|||
13364952|NCT00856986|26697870|FG002|Extension Period, Weeks 26-52|Protocol Violation|5|||
13364953|NCT00856986|26697871|FG003|Extension Period, Weeks 26-52|Protocol Violation|0|||
13364954|NCT00856986|26697872|FG004|Extension Period, Weeks 26-52|Protocol Violation|0|||
13364955|NCT00856986|26697868|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2|||
13364956|NCT00856986|26697869|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
13364957|NCT00856986|26697870|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8|||
13364958|NCT00856986|26697871|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
13364959|NCT00856986|26697872|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
13364960|NCT00856986|26697868|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
13364961|NCT00856986|26697869|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5|||
13364962|NCT00856986|26697870|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2|||
13364963|NCT00856986|26697871|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
13364964|NCT00856986|26697872|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
13364965|NCT00856986|26697868|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4|||
13364966|NCT00856986|26697869|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
13364967|NCT00856986|26697870|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
13364968|NCT00856986|26697871|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
13364969|NCT00856986|26697872|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
13364970|NCT00856986|26697868|FG000|Extension Period, Weeks 26-52|Unclassified|4|||
13364971|NCT00856986|26697869|FG001|Extension Period, Weeks 26-52|Unclassified|2|||
13364972|NCT00856986|26697870|FG002|Extension Period, Weeks 26-52|Unclassified|11|||
13364973|NCT00856986|26697871|FG003|Extension Period, Weeks 26-52|Unclassified|0|||
13364974|NCT00856986|26697872|FG004|Extension Period, Weeks 26-52|Unclassified|0|||
13364975|NCT00856973|26697947|FG000|Overall Study|Adverse Event|5|||
13364976|NCT00856973|26697948|FG001|Overall Study|Adverse Event|5|||
13364977|NCT00856973|26697949|FG002|Overall Study|Adverse Event|3|||
13364978|NCT00856973|26697947|FG000|Overall Study|Lost to Follow-up|6|||
13364979|NCT00856973|26697948|FG001|Overall Study|Lost to Follow-up|3|||
13364980|NCT00856973|26697949|FG002|Overall Study|Lost to Follow-up|5|||
13364981|NCT00856973|26697947|FG000|Overall Study|Physician Decision|0|||
13364982|NCT00856973|26697948|FG001|Overall Study|Physician Decision|3|||
13364983|NCT00856973|26697949|FG002|Overall Study|Physician Decision|1|||
13364984|NCT00856973|26697947|FG000|Overall Study|Protocol Violation|1|||
13364985|NCT00856973|26697948|FG001|Overall Study|Protocol Violation|2|||
13364986|NCT00856973|26697949|FG002|Overall Study|Protocol Violation|1|||
13364987|NCT00856973|26697947|FG000|Overall Study|Withdrawal by Subject|13|||
13364988|NCT00856973|26697948|FG001|Overall Study|Withdrawal by Subject|16|||
13364989|NCT00856973|26697949|FG002|Overall Study|Withdrawal by Subject|15|||
13364990|NCT00856973|26697947|FG000|Overall Study|Other|11|||
13364991|NCT00856973|26697948|FG001|Overall Study|Other|12|||
13364992|NCT00856973|26697949|FG002|Overall Study|Other|13|||
13364993|NCT00856908|26697981|FG000|Overall Study|Lost to Follow-up|1|||
13364994|NCT00856908|26697982|FG001|Overall Study|Lost to Follow-up|0|||
13364995|NCT00856856|26698181|FG000|2-year Clinical Follow-up|Lost to Follow-up|1|||
13364996|NCT00856856|26698181|FG000|4-year Clinical Follow-up|Missed visit|1|||
13364997|NCT00856843|26698220|FG000|Overall Study|Withdrawal by Subject|1|||
13364998|NCT00856843|26698221|FG001|Overall Study|Withdrawal by Subject|5|||
13364999|NCT00856843|26698220|FG000|Overall Study|Lack of Efficacy|1|||
13365000|NCT00856843|26698221|FG001|Overall Study|Lack of Efficacy|0|||
13375106|NCT00791765|26729130|FG000|Weeks 13 to 24|Withdrawal by Subject|2|||
13375107|NCT00791765|26729131|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
13375108|NCT00791765|26729130|FG000|Weeks 13 to 24|Disease progression|0|||
13375109|NCT00791765|26729131|FG001|Weeks 13 to 24|Disease progression|1|||
13375110|NCT00791765|26729130|FG000|Weeks 13 to 24|Lost to Follow-up|1|||
13375111|NCT00791765|26729131|FG001|Weeks 13 to 24|Lost to Follow-up|2|||
13375112|NCT00791765|26729130|FG000|Weeks 13 to 24|Other|0|||
13375113|NCT00791765|26729131|FG001|Weeks 13 to 24|Other|1|||
13375114|NCT00791700|26729229|FG000|Overall Study|Insufficient clinical response|1|||
13375115|NCT00791700|26729230|FG001|Overall Study|Insufficient clinical response|4|||
13375116|NCT00791700|26729231|FG002|Overall Study|Insufficient clinical response|1|||
13375117|NCT00791700|26729232|FG003|Overall Study|Insufficient clinical response|8|||
13375118|NCT00791700|26729229|FG000|Overall Study|No longer willing to participate|1|||
13375119|NCT00791700|26729230|FG001|Overall Study|No longer willing to participate|1|||
13375120|NCT00791700|26729231|FG002|Overall Study|No longer willing to participate|0|||
13375121|NCT00791700|26729232|FG003|Overall Study|No longer willing to participate|8|||
13375122|NCT00791700|26729229|FG000|Overall Study|Non-compliance with study treatment|0|||
13375123|NCT00791700|26729230|FG001|Overall Study|Non-compliance with study treatment|2|||
13375124|NCT00791700|26729231|FG002|Overall Study|Non-compliance with study treatment|0|||
13375125|NCT00791700|26729232|FG003|Overall Study|Non-compliance with study treatment|4|||
13375126|NCT00791700|26729229|FG000|Overall Study|Withdrawn due to pregnancy|0|||
13375127|NCT00791700|26729230|FG001|Overall Study|Withdrawn due to pregnancy|0|||
13375128|NCT00791700|26729231|FG002|Overall Study|Withdrawn due to pregnancy|0|||
13375129|NCT00791700|26729232|FG003|Overall Study|Withdrawn due to pregnancy|1|||
13375130|NCT00791700|26729229|FG000|Overall Study|Other|0|||
13375131|NCT00791700|26729230|FG001|Overall Study|Other|1|||
13375132|NCT00791700|26729231|FG002|Overall Study|Other|0|||
13375133|NCT00791700|26729232|FG003|Overall Study|Other|1|||
13375134|NCT00791700|26729229|FG000|Overall Study|Death|0|||
13375135|NCT00791700|26729230|FG001|Overall Study|Death|0|||
13375136|NCT00791700|26729231|FG002|Overall Study|Death|0|||
13375137|NCT00791700|26729232|FG003|Overall Study|Death|1|||
13375138|NCT00791700|26729229|FG000|Overall Study|Lost to Follow-up|4|||
13375139|NCT00791700|26729230|FG001|Overall Study|Lost to Follow-up|3|||
13375140|NCT00791700|26729231|FG002|Overall Study|Lost to Follow-up|4|||
13375141|NCT00791700|26729232|FG003|Overall Study|Lost to Follow-up|6|||
13375142|NCT00791700|26729229|FG000|Overall Study|Adverse Event|0|||
13375143|NCT00791700|26729230|FG001|Overall Study|Adverse Event|0|||
13375144|NCT00791700|26729231|FG002|Overall Study|Adverse Event|1|||
13375145|NCT00791700|26729232|FG003|Overall Study|Adverse Event|1|||
13375146|NCT00791661|26729333|FG000|7 Day Wash-out|Adverse Event|0|||
13375147|NCT00791661|26729334|FG001|7 Day Wash-out|Adverse Event|0|||
13375148|NCT00791661|26729335|FG002|7 Day Wash-out|Adverse Event|1|||
13375149|NCT00791661|26729333|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
13375150|NCT00791661|26729334|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
13375151|NCT00791661|26729335|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1|||
13375152|NCT00791648|26729378|FG000|Overall Study|Physician Decision|0|||
13375153|NCT00791648|26729379|FG001|Overall Study|Physician Decision|1|||
13375154|NCT00791648|26729378|FG000|Overall Study|Withdrawal by Subject|0|||
13375155|NCT00791648|26729379|FG001|Overall Study|Withdrawal by Subject|1|||
13375156|NCT00791557|26729385|FG000|Overall Study|Adverse Event|1|||
13375157|NCT00791518|26729413|FG000|Overall Study|Protocol Violation|93|||
13375158|NCT00791492|26729462|FG000|Overall Study|Withdrawal by Subject|1|||
13375159|NCT00791492|26729463|FG001|Overall Study|Withdrawal by Subject|2|||
13375160|NCT00791492|26729462|FG000|Overall Study|Liver transplantation|5|||
13375161|NCT00791492|26729463|FG001|Overall Study|Liver transplantation|1|||
13375162|NCT00791479|26729576|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0|||
13375163|NCT00791479|26729577|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0|||
13375164|NCT00791479|26729578|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0|||
13375165|NCT00791479|26729579|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0|||
13375166|NCT00791479|26729580|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3|||
13375167|NCT00791479|26729581|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0|||
13375168|NCT00791479|26729576|FG000|Overall Study|Adverse Event|0|||
13375169|NCT00791479|26729577|FG001|Overall Study|Adverse Event|1|||
13375170|NCT00791479|26729578|FG002|Overall Study|Adverse Event|0|||
13375171|NCT00791479|26729579|FG003|Overall Study|Adverse Event|2|||
13375172|NCT00791479|26729580|FG004|Overall Study|Adverse Event|0|||
13375173|NCT00791479|26729581|FG005|Overall Study|Adverse Event|1|||
13375174|NCT00791479|26729576|FG000|Overall Study|Lost to Follow-up|0|||
13375175|NCT00791479|26729577|FG001|Overall Study|Lost to Follow-up|1|||
13375176|NCT00791479|26729578|FG002|Overall Study|Lost to Follow-up|0|||
13375177|NCT00791479|26729579|FG003|Overall Study|Lost to Follow-up|0|||
13375178|NCT00791479|26729580|FG004|Overall Study|Lost to Follow-up|0|||
13375179|NCT00791479|26729581|FG005|Overall Study|Lost to Follow-up|1|||
13365001|NCT00856830|26698240|FG000|Irinotecan & Bendamustine|Death|0|||
13365002|NCT00856830|26698241|FG001|Irinotecan & Bendamustine|Death|0|||
13365003|NCT00856830|26698242|FG002|Irinotecan & Bendamustine|Death|0|||
13365004|NCT00856830|26698243|FG003|Irinotecan & Bendamustine|Death|2|||
13365005|NCT00856830|26698240|FG000|Irinotecan & Bendamustine|Physician Decision|0|||
13365006|NCT00856830|26698241|FG001|Irinotecan & Bendamustine|Physician Decision|0|||
13365007|NCT00856830|26698242|FG002|Irinotecan & Bendamustine|Physician Decision|0|||
13365008|NCT00856830|26698243|FG003|Irinotecan & Bendamustine|Physician Decision|1|||
13365009|NCT00856778|26698261|FG000|Overall Study|Adverse Event|7|||
13365010|NCT00856778|26698261|FG000|Overall Study|Withdrawal by Subject|10|||
13365011|NCT00856778|26698261|FG000|Overall Study|Study deviation|2|||
13365012|NCT00856778|26698261|FG000|Overall Study|Lost to Follow-up|5|||
13365013|NCT00856661|26698280|FG000|Overall Study|Death|15|||
13365014|NCT00856661|26698281|FG001|Overall Study|Death|18|||
13365015|NCT00856661|26698280|FG000|Overall Study|Protocol Violation|2|||
13365016|NCT00856661|26698281|FG001|Overall Study|Protocol Violation|1|||
13365017|NCT00856661|26698280|FG000|Overall Study|Withdrawal by Subject|1|||
13365018|NCT00856661|26698281|FG001|Overall Study|Withdrawal by Subject|2|||
13365019|NCT00856661|26698280|FG000|Overall Study|Lost to Follow-up|1|||
13365020|NCT00856661|26698281|FG001|Overall Study|Lost to Follow-up|3|||
13365021|NCT00856661|26698280|FG000|Overall Study|Physician Judgement|8|||
13365022|NCT00856661|26698281|FG001|Overall Study|Physician Judgement|5|||
13365023|NCT00856635|26698296|FG000|Overall Study|Lost to Follow-up|2|||
13365024|NCT00856635|26698297|FG001|Overall Study|Lost to Follow-up|5|||
13365025|NCT00856635|26698296|FG000|Overall Study|Pregnancy|1|||
13365026|NCT00856635|26698297|FG001|Overall Study|Pregnancy|0|||
13365027|NCT00856635|26698296|FG000|Overall Study|Withdrawal by Subject|3|||
13365028|NCT00856635|26698297|FG001|Overall Study|Withdrawal by Subject|1|||
13365029|NCT00856635|26698296|FG000|Overall Study|Serious Adverse Event|1|||
13365030|NCT00856635|26698297|FG001|Overall Study|Serious Adverse Event|0|||
13365031|NCT00856635|26698296|FG000|Overall Study|Other|1|||
13365032|NCT00856635|26698297|FG001|Overall Study|Other|0|||
13365033|NCT00856635|26698296|FG000|Overall Study|Discontinued at Randomization|2|||
13365034|NCT00856635|26698297|FG001|Overall Study|Discontinued at Randomization|2|||
13365035|NCT00856609|26698314|FG000|Overall Study|Adverse Event|1|||
13365036|NCT00856609|26698315|FG001|Overall Study|Adverse Event|0|||
13365037|NCT00856583|26698350|FG000|Overall Study|Lack of Efficacy|389|||
13365038|NCT00856583|26698351|FG001|Overall Study|Lack of Efficacy|377|||
13365039|NCT00856583|26698350|FG000|Overall Study|Serious Adverse Event (SAE)|99|||
13365040|NCT00856583|26698351|FG001|Overall Study|Serious Adverse Event (SAE)|65|||
13365041|NCT00856583|26698350|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393|||
13365042|NCT00856583|26698351|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179|||
13365043|NCT00856583|26698350|FG000|Overall Study|Non-compliance|305|||
13365044|NCT00856583|26698351|FG001|Overall Study|Non-compliance|262|||
13365045|NCT00856583|26698350|FG000|Overall Study|Withdrawal by Subject|1092|||
13365046|NCT00856583|26698351|FG001|Overall Study|Withdrawal by Subject|919|||
13365047|NCT00856583|26698350|FG000|Overall Study|Physician Decision|59|||
13365048|NCT00856583|26698351|FG001|Overall Study|Physician Decision|82|||
13365049|NCT00856583|26698350|FG000|Overall Study|Pregnancy|14|||
13365050|NCT00856583|26698351|FG001|Overall Study|Pregnancy|5|||
13365051|NCT00856583|26698350|FG000|Overall Study|Other|92|||
13365052|NCT00856583|26698351|FG001|Overall Study|Other|104|||
13365053|NCT00856583|26698350|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694|||
13365054|NCT00856583|26698351|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604|||
13365055|NCT00856557|26698368|FG000|Overall Study|No patients with contextual flags|12|||
13365056|NCT00856557|26698369|FG001|Overall Study|No patients with contextual flags|16|||
13365057|NCT00856544|26698559|FG000|Overall Study|Randomized but not treated|3|||
13365058|NCT00856544|26698560|FG001|Overall Study|Randomized but not treated|0|||
13365059|NCT00856544|26698561|FG002|Overall Study|Randomized but not treated|0|||
13365060|NCT00856544|26698562|FG003|Overall Study|Randomized but not treated|0|||
13365061|NCT00856544|26698559|FG000|Overall Study|Death|0|||
13365062|NCT00856544|26698560|FG001|Overall Study|Death|2|||
13365063|NCT00856544|26698561|FG002|Overall Study|Death|0|||
13365064|NCT00856544|26698562|FG003|Overall Study|Death|0|||
13365065|NCT00856544|26698559|FG000|Overall Study|Adverse Event|20|||
13365066|NCT00856544|26698560|FG001|Overall Study|Adverse Event|29|||
13365067|NCT00856544|26698561|FG002|Overall Study|Adverse Event|2|||
13365068|NCT00856544|26698562|FG003|Overall Study|Adverse Event|3|||
13365069|NCT00856544|26698559|FG000|Overall Study|Lack of Efficacy|16|||
13365070|NCT00856544|26698560|FG001|Overall Study|Lack of Efficacy|12|||
13365071|NCT00856544|26698561|FG002|Overall Study|Lack of Efficacy|3|||
13365072|NCT00856544|26698562|FG003|Overall Study|Lack of Efficacy|3|||
13365073|NCT00856544|26698559|FG000|Overall Study|Other|9|||
13365074|NCT00856544|26698560|FG001|Overall Study|Other|16|||
13365075|NCT00856544|26698561|FG002|Overall Study|Other|1|||
13365076|NCT00856544|26698562|FG003|Overall Study|Other|6|||
13365077|NCT00856544|26698559|FG000|Overall Study|Lost to Follow-up|1|||
13365078|NCT00856544|26698560|FG001|Overall Study|Lost to Follow-up|2|||
13365079|NCT00856544|26698561|FG002|Overall Study|Lost to Follow-up|2|||
13365080|NCT00856544|26698562|FG003|Overall Study|Lost to Follow-up|0|||
13365081|NCT00856544|26698559|FG000|Overall Study|Withdrawal by Subject|8|||
13365082|NCT00856544|26698560|FG001|Overall Study|Withdrawal by Subject|5|||
13365083|NCT00856544|26698561|FG002|Overall Study|Withdrawal by Subject|0|||
13365084|NCT00856544|26698562|FG003|Overall Study|Withdrawal by Subject|1|||
13365085|NCT00856518|26698579|FG000|Overall Study|Lost to Follow-up|4|||
13365086|NCT00856518|26698580|FG001|Overall Study|Lost to Follow-up|2|||
13365087|NCT00856492|26698604|FG000|Overall Study|Ineligible or withdrew consent|1|||
13365088|NCT00856492|26698605|FG001|Overall Study|Ineligible or withdrew consent|1|||
13365089|NCT00856492|26698606|FG002|Overall Study|Ineligible or withdrew consent|2|||
13365090|NCT00856388|26698619|FG000|Overall Study|Other|1|||
13365091|NCT00856375|26698642|FG000|Overall Study|Other|0|||
13365092|NCT00856375|26698643|FG001|Overall Study|Other|1|||
13365093|NCT00856375|26698642|FG000|Overall Study|Death|32|||
13365094|NCT00856375|26698643|FG001|Overall Study|Death|30|||
13365095|NCT00856375|26698642|FG000|Overall Study|Sponsor Terminated Study|7|||
13365096|NCT00856375|26698643|FG001|Overall Study|Sponsor Terminated Study|7|||
13365097|NCT00856375|26698642|FG000|Overall Study|Withdrawal by Subject|2|||
13365098|NCT00856375|26698643|FG001|Overall Study|Withdrawal by Subject|1|||
13365099|NCT00856375|26698642|FG000|Overall Study|Lost to Follow-up|1|||
13365100|NCT00856375|26698643|FG001|Overall Study|Lost to Follow-up|2|||
13365101|NCT00856349|26698654|FG000|Overall Study|Death|418|||
13365102|NCT00856349|26698654|FG000|Overall Study|Withdrawal by Subject|116|||
13365103|NCT00856349|26698654|FG000|Overall Study|Lost to Follow-up|91|||
13365104|NCT00856349|26698654|FG000|Overall Study|Protocol Violation|38|||
13365105|NCT00856349|26698654|FG000|Overall Study|Physician Decision|13|||
13365106|NCT00856349|26698654|FG000|Overall Study|Subject relocation|104|||
13365107|NCT00856349|26698654|FG000|Overall Study|Device explant|33|||
13365108|NCT00856349|26698654|FG000|Overall Study|Site closure|78|||
13365109|NCT00856349|26698654|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130|||
13365110|NCT00856323|26698663|FG000|Overall Study|Withdrawal by Subject|2|||
13365111|NCT00856297|26698709|FG000|Overall Study|Unable to classify|2|||
13365112|NCT00856297|26698710|FG001|Overall Study|Unable to classify|0|||
13365113|NCT00856297|26698711|FG002|Overall Study|Unable to classify|0|||
13365114|NCT00856297|26698712|FG003|Overall Study|Unable to classify|0|||
13365115|NCT00856297|26698713|FG004|Overall Study|Unable to classify|0|||
13365116|NCT00856284|26698749|FG000|Overall Study|Hyperglycemic rescue|231|||
13365117|NCT00856284|26698750|FG001|Overall Study|Hyperglycemic rescue|201|||
13365118|NCT00856284|26698751|FG002|Overall Study|Hyperglycemic rescue|235|||
13365119|NCT00856284|26698749|FG000|Overall Study|Adverse Event|60|||
13365120|NCT00856284|26698750|FG001|Overall Study|Adverse Event|74|||
13365121|NCT00856284|26698751|FG002|Overall Study|Adverse Event|82|||
13365122|NCT00856284|26698749|FG000|Overall Study|Major protocol deviation|24|||
13365123|NCT00856284|26698750|FG001|Overall Study|Major protocol deviation|16|||
13365124|NCT00856284|26698751|FG002|Overall Study|Major protocol deviation|15|||
13365125|NCT00856284|26698749|FG000|Overall Study|Lost to Follow-up|20|||
13365126|NCT00856284|26698750|FG001|Overall Study|Lost to Follow-up|22|||
13365127|NCT00856284|26698751|FG002|Overall Study|Lost to Follow-up|28|||
13365128|NCT00856284|26698749|FG000|Overall Study|Voluntary withdrawal|48|||
13365129|NCT00856284|26698750|FG001|Overall Study|Voluntary withdrawal|52|||
13365130|NCT00856284|26698751|FG002|Overall Study|Voluntary withdrawal|62|||
13365131|NCT00856284|26698749|FG000|Overall Study|Pregnancy|1|||
13365132|NCT00856284|26698750|FG001|Overall Study|Pregnancy|2|||
13365133|NCT00856284|26698751|FG002|Overall Study|Pregnancy|0|||
13365134|NCT00856284|26698749|FG000|Overall Study|Investigator discretion|9|||
13365135|NCT00856284|26698750|FG001|Overall Study|Investigator discretion|8|||
13365136|NCT00856284|26698751|FG002|Overall Study|Investigator discretion|10|||
13365137|NCT00856284|26698749|FG000|Overall Study|Other|15|||
13365138|NCT00856284|26698750|FG001|Overall Study|Other|17|||
13365139|NCT00856284|26698751|FG002|Overall Study|Other|14|||
13365140|NCT00856284|26698749|FG000|Overall Study|Randomized in error|0|||
13365141|NCT00856284|26698750|FG001|Overall Study|Randomized in error|0|||
13365142|NCT00856284|26698751|FG002|Overall Study|Randomized in error|1|||
13365143|NCT00856245|26698758|FG000|Overall Study|Was not transplanted|5|||
13365144|NCT00856206|26698779|FG000|Overall Study|Protocol Violation|6|||
13365145|NCT00856206|26698780|FG001|Overall Study|Protocol Violation|18|||
13365146|NCT00856206|26698779|FG000|Overall Study|Adverse Event|10|||
13365147|NCT00856206|26698780|FG001|Overall Study|Adverse Event|46|||
13365148|NCT00856206|26698779|FG000|Overall Study|Lack of Efficacy|1|||
13365149|NCT00856206|26698780|FG001|Overall Study|Lack of Efficacy|2|||
13365150|NCT00856206|26698779|FG000|Overall Study|Withdrawal by Subject|15|||
13365151|NCT00856206|26698780|FG001|Overall Study|Withdrawal by Subject|36|||
13365152|NCT00856206|26698779|FG000|Overall Study|Lost to Follow-up|13|||
13365153|NCT00856206|26698780|FG001|Overall Study|Lost to Follow-up|39|||
13365154|NCT00856206|26698779|FG000|Overall Study|Death|2|||
13365155|NCT00856206|26698780|FG001|Overall Study|Death|2|||
13365156|NCT00856206|26698779|FG000|Overall Study|Decision by the Sponsor|4|||
13365157|NCT00856206|26698780|FG001|Overall Study|Decision by the Sponsor|8|||
13365158|NCT00856206|26698779|FG000|Overall Study|Other than specified above|3|||
13365159|NCT00856206|26698780|FG001|Overall Study|Other than specified above|10|||
13365160|NCT00856193|26698795|FG000|Period 2|Abnormal test procedure results|0|||
13365161|NCT00856193|26698796|FG001|Period 2|Abnormal test procedure results|1|||
13365162|NCT00856193|26698795|FG000|Period 2|Lost to Follow-up|0|||
13365163|NCT00856193|26698796|FG001|Period 2|Lost to Follow-up|1|||
13365164|NCT00856180|26698807|FG000|Overall Study|Adverse Event|4|||
13365165|NCT00856180|26698807|FG000|Overall Study|Progressive Disease|16|||
13365166|NCT00855959|26698824|FG000|Overall Study|Adverse Event|2|||
13365167|NCT00855959|26698824|FG000|Overall Study|Lost to Follow-up|2|||
13365168|NCT00855959|26698824|FG000|Overall Study|Withdrawal by Subject|3|||
13365169|NCT00855959|26698824|FG000|Overall Study|Pregnancy|1|||
13365170|NCT00855959|26698824|FG000|Overall Study|Incorrect enrolment|1|||
13365171|NCT00855933|26698837|FG000|Overall Study|Withdrawal by Subject|0|||
13365172|NCT00855933|26698838|FG001|Overall Study|Withdrawal by Subject|1|||
13365173|NCT00855920|26698865|FG000|Overall Study|Protocol Violation|0|||
13365174|NCT00855920|26698866|FG001|Overall Study|Protocol Violation|0|||
13365175|NCT00855920|26698867|FG002|Overall Study|Protocol Violation|2|||
13365176|NCT00855920|26698865|FG000|Overall Study|Adverse Event|2|||
13365177|NCT00855920|26698866|FG001|Overall Study|Adverse Event|1|||
13365178|NCT00855920|26698867|FG002|Overall Study|Adverse Event|1|||
13365179|NCT00855920|26698865|FG000|Overall Study|Lack of Efficacy|2|||
13365180|NCT00855920|26698866|FG001|Overall Study|Lack of Efficacy|2|||
13365181|NCT00855920|26698867|FG002|Overall Study|Lack of Efficacy|2|||
13365182|NCT00855920|26698865|FG000|Overall Study|Withdrawal by Subject|2|||
13365183|NCT00855920|26698866|FG001|Overall Study|Withdrawal by Subject|3|||
13365184|NCT00855920|26698867|FG002|Overall Study|Withdrawal by Subject|2|||
13365185|NCT00855920|26698865|FG000|Overall Study|Lost to Follow-up|1|||
13365186|NCT00855920|26698866|FG001|Overall Study|Lost to Follow-up|0|||
13365187|NCT00855920|26698867|FG002|Overall Study|Lost to Follow-up|2|||
13365188|NCT00855920|26698865|FG000|Overall Study|Death|0|||
13365189|NCT00855920|26698866|FG001|Overall Study|Death|1|||
13365190|NCT00855920|26698867|FG002|Overall Study|Death|0|||
13365191|NCT00855920|26698865|FG000|Overall Study|Decision by the sponsor|0|||
13365192|NCT00855920|26698866|FG001|Overall Study|Decision by the sponsor|1|||
13365193|NCT00855920|26698867|FG002|Overall Study|Decision by the sponsor|1|||
13365194|NCT00855920|26698865|FG000|Overall Study|Other than specified above|1|||
13365195|NCT00855920|26698866|FG001|Overall Study|Other than specified above|1|||
13365196|NCT00855920|26698867|FG002|Overall Study|Other than specified above|1|||
13365197|NCT00855894|26698877|FG000|Overall Study|Death|31|||
13365198|NCT00855894|26698877|FG000|Overall Study|Patient's decision|1|||
13365199|NCT00855894|26698877|FG000|Overall Study|Disease progression|1|||
13365200|NCT00855816|26698890|FG000|Overall Study|Withdrawal by Subject|22|||
13365201|NCT00855816|26698891|FG001|Overall Study|Withdrawal by Subject|15|||
13365202|NCT00855816|26698890|FG000|Overall Study|Lost to Follow-up|3|||
13365203|NCT00855816|26698891|FG001|Overall Study|Lost to Follow-up|5|||
13365204|NCT00855816|26698890|FG000|Overall Study|Death|1|||
13365205|NCT00855816|26698891|FG001|Overall Study|Death|0|||
13365206|NCT00855816|26698890|FG000|Overall Study|Became ineligible|0|||
13365207|NCT00855816|26698891|FG001|Overall Study|Became ineligible|1|||
13365208|NCT00855803|26698901|FG000|Overall Study|Death|2|||
13365209|NCT00855803|26698901|FG000|Overall Study|Lost to Follow-up|2|||
13365210|NCT00855803|26698901|FG000|Overall Study|Technical inability to undergo procedure|2|||
13365211|NCT00855803|26698901|FG000|Overall Study|Not evaluable at 3 month timepoint|2|||
13365212|NCT00855803|26698901|FG000|Overall Study|Withdrawal by Subject|3|||
13365213|NCT00855803|26698901|FG000|Overall Study|Physician Decision|3|||
13365214|NCT00855738|26698929|FG000|Overall Study|Lost to Follow-up|2|||
13365215|NCT00855738|26698929|FG000|Overall Study|Adverse Event|1|||
13365216|NCT00855738|26698929|FG000|Overall Study|Subject Defaulted|1|||
13365217|NCT00855738|26698929|FG000|Overall Study|Death|1|||
13365218|NCT00855595|26698972|FG000|Overall Study|Withdrawal by Subject|1|||
13365219|NCT00855595|26698973|FG001|Overall Study|Withdrawal by Subject|2|||
13365220|NCT00855595|26698972|FG000|Overall Study|Lost to Follow-up|3|||
13365221|NCT00855595|26698973|FG001|Overall Study|Lost to Follow-up|3|||
13365222|NCT00855595|26698972|FG000|Overall Study|Adverse Event|1|||
13365223|NCT00855595|26698973|FG001|Overall Study|Adverse Event|1|||
13365224|NCT00855595|26698972|FG000|Overall Study|patient moved out of state|1|||
13365225|NCT00855595|26698973|FG001|Overall Study|patient moved out of state|0|||
13365226|NCT00855595|26698972|FG000|Overall Study|patient left country|0|||
13365227|NCT00855595|26698973|FG001|Overall Study|patient left country|1|||
13365228|NCT00855582|26699070|FG000|Overall Study|Adverse Event|2|||
13365229|NCT00855582|26699071|FG001|Overall Study|Adverse Event|6|||
13365230|NCT00855582|26699072|FG002|Overall Study|Adverse Event|3|||
13365231|NCT00855582|26699070|FG000|Overall Study|Death|1|||
13365232|NCT00855582|26699071|FG001|Overall Study|Death|0|||
13365233|NCT00855582|26699072|FG002|Overall Study|Death|0|||
13365234|NCT00855582|26699070|FG000|Overall Study|Lack of Efficacy|1|||
13365235|NCT00855582|26699071|FG001|Overall Study|Lack of Efficacy|3|||
13365236|NCT00855582|26699072|FG002|Overall Study|Lack of Efficacy|8|||
13365237|NCT00855582|26699070|FG000|Overall Study|Lost to Follow-up|1|||
13365238|NCT00855582|26699071|FG001|Overall Study|Lost to Follow-up|3|||
13365239|NCT00855582|26699072|FG002|Overall Study|Lost to Follow-up|1|||
13365240|NCT00855582|26699070|FG000|Overall Study|Physician Decision|0|||
13365241|NCT00855582|26699071|FG001|Overall Study|Physician Decision|0|||
13365242|NCT00855582|26699072|FG002|Overall Study|Physician Decision|1|||
13365243|NCT00855582|26699070|FG000|Overall Study|Protocol Violation|6|||
13365244|NCT00855582|26699071|FG001|Overall Study|Protocol Violation|2|||
13365245|NCT00855582|26699072|FG002|Overall Study|Protocol Violation|6|||
13365246|NCT00855582|26699070|FG000|Overall Study|Entry Criteria Not Met|8|||
13365247|NCT00855582|26699071|FG001|Overall Study|Entry Criteria Not Met|6|||
13365248|NCT00855582|26699072|FG002|Overall Study|Entry Criteria Not Met|3|||
13365249|NCT00855582|26699070|FG000|Overall Study|Withdrawal by Subject|7|||
13365250|NCT00855582|26699071|FG001|Overall Study|Withdrawal by Subject|4|||
13365251|NCT00855582|26699072|FG002|Overall Study|Withdrawal by Subject|8|||
13365252|NCT00855465|26699167|FG000|Treatment Period|Adverse Event|4|||
13365253|NCT00855465|26699168|FG001|Treatment Period|Adverse Event|2|||
13365254|NCT00855465|26699167|FG000|Treatment Period|Death|2|||
13365255|NCT00855465|26699168|FG001|Treatment Period|Death|2|||
13365256|NCT00855465|26699167|FG000|Treatment Period|Lack of Efficacy|2|||
13365257|NCT00855465|26699168|FG001|Treatment Period|Lack of Efficacy|1|||
13365258|NCT00855465|26699167|FG000|Treatment Period|Non-compliance|1|||
13365259|NCT00855465|26699168|FG001|Treatment Period|Non-compliance|0|||
13365260|NCT00855465|26699167|FG000|Treatment Period|Protocol Violation|2|||
13365261|NCT00855465|26699168|FG001|Treatment Period|Protocol Violation|0|||
13365262|NCT00855465|26699167|FG000|Treatment Period|Withdrawal by Subject|2|||
13365263|NCT00855465|26699168|FG001|Treatment Period|Withdrawal by Subject|0|||
13365264|NCT00855465|26699167|FG000|Treatment Period|Not treated|1|||
13365265|NCT00855465|26699168|FG001|Treatment Period|Not treated|0|||
13365266|NCT00855465|26699167|FG000|Follow-up Period (FUP)|Adverse Event|0|||
13365267|NCT00855465|26699168|FG001|Follow-up Period (FUP)|Adverse Event|1|||
13365268|NCT00855465|26699167|FG000|Follow-up Period (FUP)|Death|0|||
13365269|NCT00855465|26699168|FG001|Follow-up Period (FUP)|Death|1|||
13365270|NCT00855465|26699167|FG000|Follow-up Period (FUP)|Lost to Follow-up|3|||
13365271|NCT00855465|26699168|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
13365272|NCT00855465|26699167|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4|||
13365273|NCT00855465|26699168|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0|||
13365274|NCT00855465|26699167|FG000|Follow-up Period (FUP)|Missing|1|||
13365275|NCT00855465|26699168|FG001|Follow-up Period (FUP)|Missing|0|||
13365276|NCT00855439|26699187|FG000|Overall Study|Withdrawal by Subject|2|||
13365277|NCT00855439|26699188|FG001|Overall Study|Withdrawal by Subject|0|||
13365278|NCT00855439|26699187|FG000|Overall Study|Pregnancy|1|||
13365279|NCT00855439|26699188|FG001|Overall Study|Pregnancy|0|||
13365280|NCT00855335|26699289|FG000|Overall Study|Lost to Follow-up|0|||
13365281|NCT00855335|26699290|FG001|Overall Study|Lost to Follow-up|0|||
13365282|NCT00855335|26699291|FG002|Overall Study|Lost to Follow-up|3|||
13365283|NCT00855335|26699292|FG003|Overall Study|Lost to Follow-up|1|||
13365284|NCT00855335|26699293|FG004|Overall Study|Lost to Follow-up|0|||
13365285|NCT00855335|26699289|FG000|Overall Study|Withdrawal by Subject|0|||
13365286|NCT00855335|26699290|FG001|Overall Study|Withdrawal by Subject|0|||
13365287|NCT00855335|26699291|FG002|Overall Study|Withdrawal by Subject|0|||
13365288|NCT00855335|26699292|FG003|Overall Study|Withdrawal by Subject|1|||
13365289|NCT00855335|26699293|FG004|Overall Study|Withdrawal by Subject|0|||
13365290|NCT00855335|26699289|FG000|Overall Study|Adverse Event|2|||
13365291|NCT00855335|26699290|FG001|Overall Study|Adverse Event|0|||
13365292|NCT00855335|26699291|FG002|Overall Study|Adverse Event|0|||
13365293|NCT00855335|26699292|FG003|Overall Study|Adverse Event|0|||
13365294|NCT00855335|26699293|FG004|Overall Study|Adverse Event|0|||
13365295|NCT00855335|26699289|FG000|Overall Study|Physician Decision|1|||
13365296|NCT00855335|26699290|FG001|Overall Study|Physician Decision|1|||
13365297|NCT00855335|26699291|FG002|Overall Study|Physician Decision|0|||
13365298|NCT00855335|26699292|FG003|Overall Study|Physician Decision|0|||
13365299|NCT00855335|26699293|FG004|Overall Study|Physician Decision|0|||
13365300|NCT00855335|26699289|FG000|Overall Study|Other|2|||
13365301|NCT00855335|26699290|FG001|Overall Study|Other|1|||
13365302|NCT00855335|26699291|FG002|Overall Study|Other|2|||
13365303|NCT00855335|26699292|FG003|Overall Study|Other|5|||
13365304|NCT00855335|26699293|FG004|Overall Study|Other|1|||
13365305|NCT00855309|26699306|FG000|Overall Study|patient never recieved drug|1|||
13365306|NCT00855309|26699307|FG001|Overall Study|patient never recieved drug|0|||
13365307|NCT00855218|26699330|FG000|Overall Study|Adverse Event|43|||
13365308|NCT00855218|26699331|FG001|Overall Study|Adverse Event|27|||
13365309|NCT00855218|26699330|FG000|Overall Study|Withdrawal by Subject|10|||
13365310|NCT00855218|26699331|FG001|Overall Study|Withdrawal by Subject|6|||
13365311|NCT00855218|26699330|FG000|Overall Study|Physician Decision|18|||
13365312|NCT00855218|26699331|FG001|Overall Study|Physician Decision|11|||
13365313|NCT00855218|26699330|FG000|Overall Study|Lost to Follow-up|0|||
13365314|NCT00855218|26699331|FG001|Overall Study|Lost to Follow-up|1|||
13365315|NCT00855218|26699330|FG000|Overall Study|Protocol Violation|5|||
13365316|NCT00855218|26699331|FG001|Overall Study|Protocol Violation|9|||
13365317|NCT00855218|26699330|FG000|Overall Study|non-compliant with study drug|3|||
13365318|NCT00855218|26699331|FG001|Overall Study|non-compliant with study drug|1|||
13365319|NCT00855218|26699330|FG000|Overall Study|patient convenience|2|||
13365320|NCT00855218|26699331|FG001|Overall Study|patient convenience|0|||
13365321|NCT00855218|26699330|FG000|Overall Study|technical problems|2|||
13365322|NCT00855218|26699331|FG001|Overall Study|technical problems|1|||
13365323|NCT00855218|26699330|FG000|Overall Study|Still treated with study medication|0|||
13365324|NCT00855218|26699331|FG001|Overall Study|Still treated with study medication|1|||
13365325|NCT00855218|26699330|FG000|Overall Study|Untreatable disease progression|54|||
13365326|NCT00855218|26699331|FG001|Overall Study|Untreatable disease progression|67|||
13365327|NCT00855218|26699330|FG000|Overall Study|Second malignancy|0|||
13365328|NCT00855218|26699331|FG001|Overall Study|Second malignancy|1|||
13365329|NCT00855218|26699330|FG000|Overall Study|Progression measurement proven|7|||
13365330|NCT00855218|26699331|FG001|Overall Study|Progression measurement proven|15|||
13365331|NCT00855218|26699330|FG000|Overall Study|Clinical endpoint reached|10|||
13365332|NCT00855218|26699331|FG001|Overall Study|Clinical endpoint reached|13|||
13365333|NCT00855166|26699356|FG000|Overall Study|Adverse Event|0|||
13365334|NCT00855166|26699357|FG001|Overall Study|Adverse Event|2|||
13365335|NCT00855166|26699356|FG000|Overall Study|Death|0|||
13365336|NCT00855166|26699357|FG001|Overall Study|Death|1|||
13365337|NCT00855166|26699356|FG000|Overall Study|Withdrawal by Subject|1|||
13365338|NCT00855166|26699357|FG001|Overall Study|Withdrawal by Subject|4|||
13365339|NCT00855166|26699356|FG000|Overall Study|Poor/non-compliance|2|||
13365340|NCT00855166|26699357|FG001|Overall Study|Poor/non-compliance|0|||
13365341|NCT00855166|26699356|FG000|Overall Study|Administrative reasons by sponsor|1|||
13365342|NCT00855166|26699357|FG001|Overall Study|Administrative reasons by sponsor|0|||
13365343|NCT00855166|26699356|FG000|Overall Study|Subject no longer meets study criteria|1|||
13365344|NCT00855166|26699357|FG001|Overall Study|Subject no longer meets study criteria|1|||
13365345|NCT00855062|26699388|FG000|Step1|Early Study Closure|5|||
13365346|NCT00855062|26699389|FG001|Step1|Early Study Closure|7|||
13365347|NCT00855062|26699388|FG000|Step1|Adverse Event|1|||
13365348|NCT00855062|26699389|FG001|Step1|Adverse Event|1|||
13365349|NCT00855062|26699388|FG000|Step1|Protocol Violation|1|||
13365350|NCT00855062|26699389|FG001|Step1|Protocol Violation|0|||
13365351|NCT00855062|26699388|FG000|Step1|Pregnancy|1|||
13365352|NCT00855062|26699389|FG001|Step1|Pregnancy|0|||
13365353|NCT00855062|26699388|FG000|Step1|Withdrawal by Subject|2|||
13365354|NCT00855062|26699389|FG001|Step1|Withdrawal by Subject|3|||
13365355|NCT00855062|26699388|FG000|Step2|Early Study Closure|6|||
13365356|NCT00855062|26699389|FG001|Step2|Early Study Closure|2|||
13365357|NCT00855062|26699388|FG000|Step2|Adverse Event|0|||
13365358|NCT00855062|26699389|FG001|Step2|Adverse Event|3|||
13365359|NCT00855062|26699388|FG000|Step2|Initiation of antiretroviral therapy/ART|0|||
13365360|NCT00855062|26699389|FG001|Step2|Initiation of antiretroviral therapy/ART|1|||
13365361|NCT00854906|26699398|FG000|Overall Study|One person had no ocular history|1|||
13365362|NCT00854828|26699423|FG000|Overall Study|Death|1|||
13365363|NCT00854828|26699424|FG001|Overall Study|Death|0|||
13365364|NCT00854828|26699425|FG002|Overall Study|Death|0|||
13365365|NCT00854828|26699426|FG003|Overall Study|Death|0|||
13365366|NCT00854828|26699423|FG000|Overall Study|Withdrawal by Subject|1|||
13365367|NCT00854828|26699424|FG001|Overall Study|Withdrawal by Subject|1|||
13365368|NCT00854828|26699425|FG002|Overall Study|Withdrawal by Subject|0|||
13365369|NCT00854828|26699426|FG003|Overall Study|Withdrawal by Subject|9|||
13365370|NCT00854828|26699423|FG000|Overall Study|Missed 24mo visit|1|||
13365371|NCT00854828|26699424|FG001|Overall Study|Missed 24mo visit|1|||
13365372|NCT00854828|26699425|FG002|Overall Study|Missed 24mo visit|8|||
13365373|NCT00854828|26699426|FG003|Overall Study|Missed 24mo visit|8|||
13365374|NCT00854724|26699439|FG000|First Intervention|Withdrawal by Subject|1|||
13365375|NCT00854724|26699440|FG001|First Intervention|Withdrawal by Subject|1|||
13365376|NCT00854724|26699439|FG000|Washout|Protocol Violation|1|||
13365377|NCT00854724|26699440|FG001|Washout|Protocol Violation|0|||
13365378|NCT00854724|26699439|FG000|Washout|Withdrawal by Subject|0|||
13365379|NCT00854724|26699440|FG001|Washout|Withdrawal by Subject|1|||
13365380|NCT00854724|26699439|FG000|Second Intervention|Protocol Violation|1|||
13365381|NCT00854724|26699440|FG001|Second Intervention|Protocol Violation|0|||
13365382|NCT00854724|26699439|FG000|Second Intervention|Physician Decision|0|||
13365383|NCT00854724|26699440|FG001|Second Intervention|Physician Decision|1|||
13365384|NCT00854620|26699446|FG000|Overall Study|Adverse Event|1|||
13365385|NCT00854607|26699481|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65|||
13365386|NCT00854581|26699496|FG000|Induction (Up to Day 21)|Lack of Efficacy|4|||
13365387|NCT00854581|26699496|FG000|Induction (Up to Day 21)|Death|1|||
13365388|NCT00854581|26699496|FG000|Induction (Up to Day 21)|Physician Decision|1|||
13365389|NCT00854581|26699496|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3|||
13365390|NCT00854373|26699513|FG000|Overall Study|Withdrawal by Subject|1|||
13365391|NCT00854373|26699514|FG001|Overall Study|Withdrawal by Subject|3|||
13365392|NCT00854373|26699513|FG000|Overall Study|Forgot to take study drug|1|||
13365393|NCT00854373|26699514|FG001|Overall Study|Forgot to take study drug|1|||
13365394|NCT00854360|26699557|FG000|Overall Study|Adverse Event|0|||
13365395|NCT00854360|26699558|FG001|Overall Study|Adverse Event|1|||
13365396|NCT00854360|26699559|FG002|Overall Study|Adverse Event|2|||
13365397|NCT00854360|26699560|FG003|Overall Study|Adverse Event|6|||
13365398|NCT00854360|26699557|FG000|Overall Study|Withdrawal by Subject|0|||
13365399|NCT00854360|26699558|FG001|Overall Study|Withdrawal by Subject|0|||
13365400|NCT00854360|26699559|FG002|Overall Study|Withdrawal by Subject|0|||
13365401|NCT00854360|26699560|FG003|Overall Study|Withdrawal by Subject|1|||
13365402|NCT00854360|26699557|FG000|Overall Study|Pregnancy|0|||
13365403|NCT00854360|26699558|FG001|Overall Study|Pregnancy|1|||
13365404|NCT00854360|26699559|FG002|Overall Study|Pregnancy|0|||
13365405|NCT00854360|26699560|FG003|Overall Study|Pregnancy|0|||
13365406|NCT00854360|26699557|FG000|Overall Study|Lack of Efficacy|2|||
13365407|NCT00854360|26699558|FG001|Overall Study|Lack of Efficacy|1|||
13365408|NCT00854360|26699559|FG002|Overall Study|Lack of Efficacy|0|||
13365409|NCT00854360|26699560|FG003|Overall Study|Lack of Efficacy|0|||
13365410|NCT00854360|26699557|FG000|Overall Study|Other|0|||
13365411|NCT00854360|26699558|FG001|Overall Study|Other|0|||
13365412|NCT00854360|26699559|FG002|Overall Study|Other|0|||
13365413|NCT00854360|26699560|FG003|Overall Study|Other|3|||
13365414|NCT00854308|26699581|FG000|Overall Study|Disease progression|42|||
13365415|NCT00854308|26699582|FG001|Overall Study|Disease progression|50|||
13365416|NCT00854308|26699581|FG000|Overall Study|Adverse Event|8|||
13365417|NCT00854308|26699582|FG001|Overall Study|Adverse Event|3|||
13365418|NCT00854308|26699581|FG000|Overall Study|Death|2|||
13365419|NCT00854308|26699582|FG001|Overall Study|Death|5|||
13365420|NCT00854308|26699581|FG000|Overall Study|Physician Decision|6|||
13365421|NCT00854308|26699582|FG001|Overall Study|Physician Decision|6|||
13365422|NCT00854308|26699581|FG000|Overall Study|Withdrawal by Subject|4|||
13365423|NCT00854308|26699582|FG001|Overall Study|Withdrawal by Subject|2|||
13365424|NCT00854308|26699581|FG000|Overall Study|Sponsor's decision to terminate study|0|||
13365425|NCT00854308|26699582|FG001|Overall Study|Sponsor's decision to terminate study|1|||
13365426|NCT00854113|26699717|FG000|Overall Study|Adverse Event|0|||
13365427|NCT00854113|26699718|FG001|Overall Study|Adverse Event|0|||
13365428|NCT00854113|26699719|FG002|Overall Study|Adverse Event|0|||
13365429|NCT00854113|26699720|FG003|Overall Study|Adverse Event|0|||
13365430|NCT00854113|26699721|FG004|Overall Study|Adverse Event|0|||
13365431|NCT00854113|26699722|FG005|Overall Study|Adverse Event|0|||
13365432|NCT00854113|26699723|FG006|Overall Study|Adverse Event|0|||
13365433|NCT00854113|26699724|FG007|Overall Study|Adverse Event|2|||
13365434|NCT00854113|26699725|FG008|Overall Study|Adverse Event|0|||
13365435|NCT00854113|26699726|FG009|Overall Study|Adverse Event|0|||
13365436|NCT00854113|26699727|FG010|Overall Study|Adverse Event|0|||
13365437|NCT00854113|26699717|FG000|Overall Study|Withdrawal by Subject|0|||
13365438|NCT00854113|26699718|FG001|Overall Study|Withdrawal by Subject|0|||
13365439|NCT00854113|26699719|FG002|Overall Study|Withdrawal by Subject|0|||
13365440|NCT00854113|26699720|FG003|Overall Study|Withdrawal by Subject|0|||
13365441|NCT00854113|26699721|FG004|Overall Study|Withdrawal by Subject|0|||
13365442|NCT00854113|26699722|FG005|Overall Study|Withdrawal by Subject|0|||
13365443|NCT00854113|26699723|FG006|Overall Study|Withdrawal by Subject|0|||
13365444|NCT00854113|26699724|FG007|Overall Study|Withdrawal by Subject|1|||
13365445|NCT00854113|26699725|FG008|Overall Study|Withdrawal by Subject|1|||
13365446|NCT00854113|26699726|FG009|Overall Study|Withdrawal by Subject|0|||
13365447|NCT00854113|26699727|FG010|Overall Study|Withdrawal by Subject|0|||
13365448|NCT00854100|26699749|FG000|Overall Study|Inability to complete the study visits|0|||
13365449|NCT00854100|26699750|FG001|Overall Study|Inability to complete the study visits|0|||
13365450|NCT00854100|26699751|FG002|Overall Study|Inability to complete the study visits|1|||
13365451|NCT00854100|26699749|FG000|Overall Study|Lost to Follow-up|2|||
13365452|NCT00854100|26699750|FG001|Overall Study|Lost to Follow-up|0|||
13365453|NCT00854100|26699751|FG002|Overall Study|Lost to Follow-up|3|||
13365454|NCT00854100|26699749|FG000|Overall Study|Withdrawal by Subject|3|||
13365455|NCT00854100|26699750|FG001|Overall Study|Withdrawal by Subject|1|||
13365456|NCT00854100|26699751|FG002|Overall Study|Withdrawal by Subject|2|||
13365457|NCT00854100|26699749|FG000|Overall Study|Protocol Violation|2|||
13365458|NCT00854100|26699750|FG001|Overall Study|Protocol Violation|4|||
13365459|NCT00854100|26699751|FG002|Overall Study|Protocol Violation|3|||
13365460|NCT00854100|26699749|FG000|Overall Study|Adverse Event|2|||
13365461|NCT00854100|26699750|FG001|Overall Study|Adverse Event|1|||
13365462|NCT00854100|26699751|FG002|Overall Study|Adverse Event|2|||
13365463|NCT00853970|26699766|FG000|Overall Study|Withdrawal by Subject|2|||
13365464|NCT00853970|26699767|FG001|Overall Study|Withdrawal by Subject|1|||
13365465|NCT00853970|26699766|FG000|Overall Study|Cancelled surgery|4|||
13365466|NCT00853970|26699767|FG001|Overall Study|Cancelled surgery|2|||
13289387|NCT02279745|26478805|FG000|Overall Study|Adverse Event|7|||
13289388|NCT02279745|26478805|FG000|Overall Study|Death|6|||
13365467|NCT00853957|26699790|FG000|Overall Study|Adverse Event|9|||
13365468|NCT00853957|26699791|FG001|Overall Study|Adverse Event|3|||
13365469|NCT00853957|26699790|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
13365470|NCT00853957|26699791|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
13365471|NCT00853957|26699790|FG000|Overall Study|Subject withdrew consent|4|||
13365472|NCT00853957|26699791|FG001|Overall Study|Subject withdrew consent|5|||
13365473|NCT00853957|26699790|FG000|Overall Study|Lost to Follow-up|1|||
13365474|NCT00853957|26699791|FG001|Overall Study|Lost to Follow-up|6|||
13365475|NCT00853957|26699790|FG000|Overall Study|Protocol deviation|0|||
13365476|NCT00853957|26699791|FG001|Overall Study|Protocol deviation|3|||
13365477|NCT00853905|26699812|FG000|Overall Study|Lost to Follow-up|1|||
13365478|NCT00853905|26699813|FG001|Overall Study|Lost to Follow-up|3|||
13365479|NCT00853905|26699812|FG000|Overall Study|Withdrawal by Subject|0|||
13365480|NCT00853905|26699813|FG001|Overall Study|Withdrawal by Subject|1|||
13365481|NCT00853905|26699812|FG000|Overall Study|never had surgery|1|||
13365482|NCT00853905|26699813|FG001|Overall Study|never had surgery|0|||
13365483|NCT00853827|26699832|FG000|Single Blind Period (1 Week)|Other|4|||
13365484|NCT00853827|26699833|FG001|Single Blind Period (1 Week)|Other|0|||
13365485|NCT00853827|26699832|FG000|Single Blind Period (1 Week)|Adverse Event|9|||
13365486|NCT00853827|26699833|FG001|Single Blind Period (1 Week)|Adverse Event|0|||
13365487|NCT00853827|26699832|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3|||
13365488|NCT00853827|26699833|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0|||
13365489|NCT00853827|26699832|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1|||
13365490|NCT00853827|26699833|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0|||
13365491|NCT00853827|26699832|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9|||
13365492|NCT00853827|26699833|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0|||
13365493|NCT00853827|26699832|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1|||
13365494|NCT00853827|26699833|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0|||
13365495|NCT00853827|26699832|FG000|Single Blind Period (1 Week)|Protocol Violation|12|||
13365496|NCT00853827|26699833|FG001|Single Blind Period (1 Week)|Protocol Violation|0|||
13365497|NCT00853827|26699832|FG000|Double Blind Period (103 Weeks)|Adverse Event|25|||
13365498|NCT00853827|26699833|FG001|Double Blind Period (103 Weeks)|Adverse Event|14|||
13365499|NCT00853827|26699832|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0|||
13365500|NCT00853827|26699833|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3|||
13365501|NCT00853827|26699832|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1|||
13365502|NCT00853827|26699833|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0|||
13365503|NCT00853827|26699832|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3|||
13365504|NCT00853827|26699833|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1|||
13365505|NCT00853827|26699832|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2|||
13365506|NCT00853827|26699833|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1|||
13365507|NCT00853827|26699832|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19|||
13365508|NCT00853827|26699833|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18|||
13365509|NCT00853827|26699832|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8|||
13365510|NCT00853827|26699833|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10|||
13365511|NCT00853827|26699832|FG000|Double Blind Period (103 Weeks)|Administrative problems|45|||
13365512|NCT00853827|26699833|FG001|Double Blind Period (103 Weeks)|Administrative problems|56|||
13365513|NCT00853827|26699832|FG000|Double Blind Period (103 Weeks)|Death|1|||
13365514|NCT00853827|26699833|FG001|Double Blind Period (103 Weeks)|Death|6|||
13365515|NCT00853762|26699912|FG000|Overall Study|Premature Termination|16|||
13365516|NCT00853762|26699913|FG001|Overall Study|Premature Termination|15|||
13365517|NCT00853762|26699914|FG002|Overall Study|Premature Termination|14|||
13365518|NCT00853762|26699915|FG003|Overall Study|Premature Termination|21|||
13365519|NCT00853762|26699912|FG000|Overall Study|Protocol Violation|0|||
13365520|NCT00853762|26699913|FG001|Overall Study|Protocol Violation|0|||
13365521|NCT00853762|26699914|FG002|Overall Study|Protocol Violation|0|||
13365522|NCT00853762|26699915|FG003|Overall Study|Protocol Violation|1|||
13365523|NCT00853762|26699912|FG000|Overall Study|Withdrawal by Subject|0|||
13365524|NCT00853762|26699913|FG001|Overall Study|Withdrawal by Subject|0|||
13365525|NCT00853762|26699914|FG002|Overall Study|Withdrawal by Subject|1|||
13365526|NCT00853762|26699915|FG003|Overall Study|Withdrawal by Subject|0|||
13365527|NCT00853762|26699912|FG000|Overall Study|Other|0|||
13365528|NCT00853762|26699913|FG001|Overall Study|Other|2|||
13365529|NCT00853762|26699914|FG002|Overall Study|Other|0|||
13365530|NCT00853762|26699915|FG003|Overall Study|Other|0|||
13365531|NCT00853762|26699912|FG000|Overall Study|Randomised but not Treated|0|||
13365532|NCT00853762|26699913|FG001|Overall Study|Randomised but not Treated|2|||
13365533|NCT00853762|26699914|FG002|Overall Study|Randomised but not Treated|2|||
13365534|NCT00853762|26699915|FG003|Overall Study|Randomised but not Treated|0|||
13365535|NCT00853749|26699940|FG000|Overall Study|Lost to Follow-up|0|||
13365536|NCT00853749|26699941|FG001|Overall Study|Lost to Follow-up|1|||
13365537|NCT00853723|26699995|FG000|Overall Study|Adverse Event|3|||
13365538|NCT00853723|26699996|FG001|Overall Study|Adverse Event|4|||
13365539|NCT00853723|26699997|FG002|Overall Study|Adverse Event|1|||
13365540|NCT00853723|26699995|FG000|Overall Study|Withdrawal by Subject|2|||
13365541|NCT00853723|26699996|FG001|Overall Study|Withdrawal by Subject|1|||
13365542|NCT00853723|26699997|FG002|Overall Study|Withdrawal by Subject|0|||
13365543|NCT00853723|26699995|FG000|Overall Study|Protocol Violation|1|||
13365544|NCT00853723|26699996|FG001|Overall Study|Protocol Violation|2|||
13365545|NCT00853723|26699997|FG002|Overall Study|Protocol Violation|1|||
13365546|NCT00853658|26700021|FG000|Overall Study|Death|713|||
13365547|NCT00853658|26700022|FG001|Overall Study|Death|768|||
13365548|NCT00853658|26700023|FG002|Overall Study|Death|753|||
13365549|NCT00853658|26700021|FG000|Overall Study|Lost to Follow-up|11|||
13365550|NCT00853658|26700022|FG001|Overall Study|Lost to Follow-up|6|||
13365551|NCT00853658|26700023|FG002|Overall Study|Lost to Follow-up|11|||
13365552|NCT00853658|26700021|FG000|Overall Study|H.A. Request|26|||
13365553|NCT00853658|26700022|FG001|Overall Study|H.A. Request|23|||
13365554|NCT00853658|26700023|FG002|Overall Study|H.A. Request|19|||
13365555|NCT00853658|26700021|FG000|Overall Study|IRB request|0|||
13365556|NCT00853658|26700022|FG001|Overall Study|IRB request|0|||
13365557|NCT00853658|26700023|FG002|Overall Study|IRB request|2|||
13365558|NCT00853658|26700021|FG000|Overall Study|Vital Status known (alive) at study end|2|||
13365559|NCT00853658|26700022|FG001|Overall Study|Vital Status known (alive) at study end|3|||
13365560|NCT00853658|26700023|FG002|Overall Study|Vital Status known (alive) at study end|3|||
13365561|NCT00853658|26700021|FG000|Overall Study|Vital Status unknown at study end|1|||
13365562|NCT00853658|26700022|FG001|Overall Study|Vital Status unknown at study end|1|||
13365563|NCT00853658|26700023|FG002|Overall Study|Vital Status unknown at study end|0|||
13365564|NCT00853658|26700021|FG000|Overall Study|Vital Status at study end N/A|8|||
13365565|NCT00853658|26700022|FG001|Overall Study|Vital Status at study end N/A|10|||
13365566|NCT00853658|26700023|FG002|Overall Study|Vital Status at study end N/A|10|||
13365567|NCT00853658|26700021|FG000|Overall Study|Patient's request|21|||
13365568|NCT00853658|26700022|FG001|Overall Study|Patient's request|17|||
13365569|NCT00853658|26700023|FG002|Overall Study|Patient's request|11|||
13365570|NCT00853658|26700021|FG000|Overall Study|Missing study completion information|5|||
13365571|NCT00853658|26700022|FG001|Overall Study|Missing study completion information|4|||
13365572|NCT00853658|26700023|FG002|Overall Study|Missing study completion information|6|||
13365573|NCT00853593|26700050|FG000|Overall Study|Subjects did not receive a 4396 lead|12|||
13365574|NCT00853593|26700050|FG000|Overall Study|Model 4396 lead not attempted|29|||
13365575|NCT00853593|26700050|FG000|Overall Study|Implant not attempted|4|||
13365576|NCT00853580|26700101|FG000|Overall Study|Lost to Follow-up|3|||
13365577|NCT00853580|26700102|FG001|Overall Study|Lost to Follow-up|5|||
13365578|NCT00853580|26700101|FG000|Overall Study|Protocol Violation|2|||
13365579|NCT00853580|26700102|FG001|Overall Study|Protocol Violation|1|||
13365580|NCT00853580|26700101|FG000|Overall Study|Withdrawal by Subject|2|||
13365581|NCT00853580|26700102|FG001|Overall Study|Withdrawal by Subject|8|||
13365582|NCT00853580|26700101|FG000|Overall Study|Commenced contraindicated therapy|0|||
13365583|NCT00853580|26700102|FG001|Overall Study|Commenced contraindicated therapy|2|||
13365584|NCT00853567|26700118|FG000|Overall Study|Study prematurely terminated|71|||
13365585|NCT00853489|26700135|FG000|Overall Study|Lost to Follow-up|5|||
13365586|NCT00853489|26700136|FG001|Overall Study|Lost to Follow-up|2|||
13365587|NCT00853385|26700365|FG000|Overall Study|Death|0|||
13365588|NCT00853385|26700366|FG001|Overall Study|Death|0|||
13365589|NCT00853385|26700367|FG002|Overall Study|Death|0|||
13365590|NCT00853385|26700368|FG003|Overall Study|Death|0|||
13365591|NCT00853385|26700369|FG004|Overall Study|Death|1|||
13365592|NCT00853385|26700365|FG000|Overall Study|Adverse Event|24|||
13365593|NCT00853385|26700366|FG001|Overall Study|Adverse Event|24|||
13365594|NCT00853385|26700367|FG002|Overall Study|Adverse Event|2|||
13365595|NCT00853385|26700368|FG003|Overall Study|Adverse Event|5|||
13365596|NCT00853385|26700369|FG004|Overall Study|Adverse Event|22|||
13365597|NCT00853385|26700365|FG000|Overall Study|Lack of Efficacy|6|||
13365598|NCT00853385|26700366|FG001|Overall Study|Lack of Efficacy|7|||
13365599|NCT00853385|26700367|FG002|Overall Study|Lack of Efficacy|3|||
13365600|NCT00853385|26700368|FG003|Overall Study|Lack of Efficacy|3|||
13365601|NCT00853385|26700369|FG004|Overall Study|Lack of Efficacy|6|||
13365602|NCT00853385|26700365|FG000|Overall Study|Lost to Follow-up|2|||
13365603|NCT00853385|26700366|FG001|Overall Study|Lost to Follow-up|1|||
13365604|NCT00853385|26700367|FG002|Overall Study|Lost to Follow-up|0|||
13365605|NCT00853385|26700368|FG003|Overall Study|Lost to Follow-up|0|||
13365606|NCT00853385|26700369|FG004|Overall Study|Lost to Follow-up|0|||
13365607|NCT00853385|26700365|FG000|Overall Study|Withdrawal by Subject|4|||
13365608|NCT00853385|26700366|FG001|Overall Study|Withdrawal by Subject|2|||
13365609|NCT00853385|26700367|FG002|Overall Study|Withdrawal by Subject|0|||
13365610|NCT00853385|26700368|FG003|Overall Study|Withdrawal by Subject|1|||
13365611|NCT00853385|26700369|FG004|Overall Study|Withdrawal by Subject|1|||
13365612|NCT00853385|26700365|FG000|Overall Study|Other|18|||
13365613|NCT00853385|26700366|FG001|Overall Study|Other|9|||
13365614|NCT00853385|26700367|FG002|Overall Study|Other|4|||
13365615|NCT00853385|26700368|FG003|Overall Study|Other|4|||
13365616|NCT00853385|26700369|FG004|Overall Study|Other|12|||
13365617|NCT00853372|26700410|FG000|Overall Study|Death|30|||
13365618|NCT00853372|26700411|FG001|Overall Study|Death|26|||
13365619|NCT00853372|26700410|FG000|Overall Study|Lost to Follow-up|1|||
13365620|NCT00853372|26700411|FG001|Overall Study|Lost to Follow-up|2|||
13365621|NCT00853372|26700410|FG000|Overall Study|Full Consent Withdrawn|1|||
13365622|NCT00853372|26700411|FG001|Overall Study|Full Consent Withdrawn|1|||
13365623|NCT00853307|26700438|FG000|Overall Study|Adverse Event|1|||
13365624|NCT00853307|26700439|FG001|Overall Study|Adverse Event|2|||
13365625|NCT00853307|26700438|FG000|Overall Study|Withdrawal by Subject|1|||
13365626|NCT00853307|26700439|FG001|Overall Study|Withdrawal by Subject|2|||
13365627|NCT00853307|26700438|FG000|Overall Study|Reason Not Specified|0|||
13365628|NCT00853307|26700439|FG001|Overall Study|Reason Not Specified|1|||
13365629|NCT00853242|26700501|FG000|Overall Study|Adverse Event|0|||
13365630|NCT00853242|26700502|FG001|Overall Study|Adverse Event|1|||
13365631|NCT00853242|26700503|FG002|Overall Study|Adverse Event|1|||
13365632|NCT00853242|26700504|FG003|Overall Study|Adverse Event|0|||
13365633|NCT00853242|26700505|FG004|Overall Study|Adverse Event|3|||
13365634|NCT00853242|26700506|FG005|Overall Study|Adverse Event|1|||
13365635|NCT00853242|26700507|FG006|Overall Study|Adverse Event|1|||
13365636|NCT00853242|26700501|FG000|Overall Study|Noncompliant|0|||
13365637|NCT00853242|26700502|FG001|Overall Study|Noncompliant|0|||
13365638|NCT00853242|26700503|FG002|Overall Study|Noncompliant|0|||
13365639|NCT00853242|26700504|FG003|Overall Study|Noncompliant|0|||
13365640|NCT00853242|26700505|FG004|Overall Study|Noncompliant|1|||
13365641|NCT00853242|26700506|FG005|Overall Study|Noncompliant|0|||
13365642|NCT00853242|26700507|FG006|Overall Study|Noncompliant|0|||
13365643|NCT00853242|26700501|FG000|Overall Study|Withdrawal by Subject|1|||
13365644|NCT00853242|26700502|FG001|Overall Study|Withdrawal by Subject|2|||
13365645|NCT00853242|26700503|FG002|Overall Study|Withdrawal by Subject|0|||
13365646|NCT00853242|26700504|FG003|Overall Study|Withdrawal by Subject|4|||
13365647|NCT00853242|26700505|FG004|Overall Study|Withdrawal by Subject|0|||
13365648|NCT00853242|26700506|FG005|Overall Study|Withdrawal by Subject|0|||
13365649|NCT00853242|26700507|FG006|Overall Study|Withdrawal by Subject|2|||
13365650|NCT00853242|26700501|FG000|Overall Study|Other|2|||
13365651|NCT00853242|26700502|FG001|Overall Study|Other|0|||
13365652|NCT00853242|26700503|FG002|Overall Study|Other|2|||
13365653|NCT00853242|26700504|FG003|Overall Study|Other|0|||
13365654|NCT00853242|26700505|FG004|Overall Study|Other|0|||
13365655|NCT00853242|26700506|FG005|Overall Study|Other|1|||
13365656|NCT00853242|26700507|FG006|Overall Study|Other|2|||
13365657|NCT00853229|26700522|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
13365658|NCT00853229|26700523|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
13365659|NCT00853151|26700678|FG000|Overall Study|Adverse Event|1|||
13365660|NCT00853151|26700679|FG001|Overall Study|Adverse Event|4|||
13365661|NCT00853151|26700680|FG002|Overall Study|Adverse Event|2|||
13365662|NCT00853151|26700681|FG003|Overall Study|Adverse Event|0|||
13365663|NCT00853151|26700678|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
13365664|NCT00853151|26700679|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
13365665|NCT00853151|26700680|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
13365666|NCT00853151|26700681|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
13365667|NCT00853151|26700678|FG000|Overall Study|Lost to Follow-up|2|||
13365668|NCT00853151|26700679|FG001|Overall Study|Lost to Follow-up|0|||
13365669|NCT00853151|26700680|FG002|Overall Study|Lost to Follow-up|3|||
13365670|NCT00853151|26700681|FG003|Overall Study|Lost to Follow-up|0|||
13365671|NCT00853151|26700678|FG000|Overall Study|Death|1|||
13365672|NCT00853151|26700679|FG001|Overall Study|Death|0|||
13365673|NCT00853151|26700680|FG002|Overall Study|Death|0|||
13365674|NCT00853151|26700681|FG003|Overall Study|Death|1|||
13365675|NCT00853151|26700678|FG000|Overall Study|Protocol Violation|0|||
13365676|NCT00853151|26700679|FG001|Overall Study|Protocol Violation|0|||
13365677|NCT00853151|26700680|FG002|Overall Study|Protocol Violation|0|||
13365678|NCT00853151|26700681|FG003|Overall Study|Protocol Violation|1|||
13365679|NCT00853151|26700678|FG000|Overall Study|Withdrawal by Subject|5|||
13365680|NCT00853151|26700679|FG001|Overall Study|Withdrawal by Subject|4|||
13365681|NCT00853151|26700680|FG002|Overall Study|Withdrawal by Subject|2|||
13365682|NCT00853151|26700681|FG003|Overall Study|Withdrawal by Subject|1|||
13365683|NCT00853151|26700678|FG000|Overall Study|Physician Decision|0|||
13365684|NCT00853151|26700679|FG001|Overall Study|Physician Decision|2|||
13365685|NCT00853151|26700680|FG002|Overall Study|Physician Decision|1|||
13365686|NCT00853151|26700681|FG003|Overall Study|Physician Decision|0|||
13365687|NCT00853151|26700678|FG000|Overall Study|Sponsor Decision|0|||
13365688|NCT00853151|26700679|FG001|Overall Study|Sponsor Decision|3|||
13365689|NCT00853151|26700680|FG002|Overall Study|Sponsor Decision|0|||
13365690|NCT00853151|26700681|FG003|Overall Study|Sponsor Decision|0|||
13365691|NCT00853125|26700688|FG000|Overall Study|Study participant's donor was CMV +|1|||
13365692|NCT00853112|26700817|FG000|Overall Study|Randomized but not treated|0|||
13365693|NCT00853112|26700818|FG001|Overall Study|Randomized but not treated|1|||
13365694|NCT00853112|26700819|FG002|Overall Study|Randomized but not treated|0|||
13365695|NCT00853112|26700820|FG003|Overall Study|Randomized but not treated|2|||
13375180|NCT00791479|26729576|FG000|Overall Study|Protocol Violation|2|||
13365696|NCT00853112|26700821|FG004|Overall Study|Randomized but not treated|0|||
13365697|NCT00853112|26700822|FG005|Overall Study|Randomized but not treated|0|||
13365698|NCT00853112|26700823|FG006|Overall Study|Randomized but not treated|1|||
13365699|NCT00853099|26700874|FG000|Double-blind Period|Adverse Event|7|||
13365700|NCT00853099|26700875|FG001|Double-blind Period|Adverse Event|9|||
13365701|NCT00853099|26700876|FG002|Double-blind Period|Adverse Event|13|||
13365702|NCT00853099|26700877|FG003|Double-blind Period|Adverse Event|0|||
13365703|NCT00853099|26700874|FG000|Double-blind Period|Withdrawal by Subject|2|||
13365704|NCT00853099|26700875|FG001|Double-blind Period|Withdrawal by Subject|3|||
13365705|NCT00853099|26700876|FG002|Double-blind Period|Withdrawal by Subject|0|||
13365706|NCT00853099|26700877|FG003|Double-blind Period|Withdrawal by Subject|0|||
13365707|NCT00853099|26700874|FG000|Double-blind Period|Lack of Efficacy|14|||
13365708|NCT00853099|26700875|FG001|Double-blind Period|Lack of Efficacy|17|||
13365709|NCT00853099|26700876|FG002|Double-blind Period|Lack of Efficacy|16|||
13365710|NCT00853099|26700877|FG003|Double-blind Period|Lack of Efficacy|0|||
13365711|NCT00853099|26700874|FG000|Double-blind Period|Other|0|||
13365712|NCT00853099|26700875|FG001|Double-blind Period|Other|0|||
13365713|NCT00853099|26700876|FG002|Double-blind Period|Other|1|||
13365714|NCT00853099|26700877|FG003|Double-blind Period|Other|0|||
13365715|NCT00853099|26700874|FG000|Double-blind Period|Mistreated with rescue study drug|0|||
13365716|NCT00853099|26700875|FG001|Double-blind Period|Mistreated with rescue study drug|0|||
13365717|NCT00853099|26700876|FG002|Double-blind Period|Mistreated with rescue study drug|1|||
13365718|NCT00853099|26700877|FG003|Double-blind Period|Mistreated with rescue study drug|0|||
13365719|NCT00853099|26700874|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0|||
13365720|NCT00853099|26700875|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0|||
13365721|NCT00853099|26700876|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0|||
13365722|NCT00853099|26700877|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74|||
13365723|NCT00853099|26700874|FG000|Double-blind + Open-label Periods|Adverse Event|0|||
13365724|NCT00853099|26700875|FG001|Double-blind + Open-label Periods|Adverse Event|0|||
13365725|NCT00853099|26700876|FG002|Double-blind + Open-label Periods|Adverse Event|0|||
13365726|NCT00853099|26700877|FG003|Double-blind + Open-label Periods|Adverse Event|47|||
13365727|NCT00853099|26700874|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
13365728|NCT00853099|26700875|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
13365729|NCT00853099|26700876|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
13365730|NCT00853099|26700877|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20|||
13365731|NCT00853099|26700874|FG000|Double-blind + Open-label Periods|Other|0|||
13365732|NCT00853099|26700875|FG001|Double-blind + Open-label Periods|Other|0|||
13365733|NCT00853099|26700876|FG002|Double-blind + Open-label Periods|Other|0|||
13365734|NCT00853099|26700877|FG003|Double-blind + Open-label Periods|Other|6|||
13365735|NCT00853073|26700892|FG000|Overall Study|Withdrawal by Subject|3|||
13365736|NCT00853073|26700893|FG001|Overall Study|Withdrawal by Subject|2|||
13365737|NCT00853047|26700976|FG000|Core Phase|Participant Request|0|||
13365738|NCT00853047|26700977|FG001|Core Phase|Participant Request|0|||
13365739|NCT00853047|26700978|FG002|Core Phase|Participant Request|0|||
13365740|NCT00853047|26700979|FG003|Core Phase|Participant Request|1|||
13365741|NCT00853047|26700980|FG004|Core Phase|Participant Request|0|||
13365742|NCT00853047|26700981|FG005|Core Phase|Participant Request|0|||
13365743|NCT00853047|26700976|FG000|Open-Label Extension Phase|Participant Request|0|||
13365744|NCT00853047|26700977|FG001|Open-Label Extension Phase|Participant Request|0|||
13365745|NCT00853047|26700978|FG002|Open-Label Extension Phase|Participant Request|0|||
13365746|NCT00853047|26700979|FG003|Open-Label Extension Phase|Participant Request|0|||
13365747|NCT00853047|26700980|FG004|Open-Label Extension Phase|Participant Request|0|||
13365748|NCT00853047|26700981|FG005|Open-Label Extension Phase|Participant Request|7|||
13365749|NCT00853047|26700976|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
13365750|NCT00853047|26700977|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
13365751|NCT00853047|26700978|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
13365752|NCT00853047|26700979|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
13365753|NCT00853047|26700980|FG004|Open-Label Extension Phase|Lost to Follow-up|0|||
13365754|NCT00853047|26700981|FG005|Open-Label Extension Phase|Lost to Follow-up|1|||
13365755|NCT00853047|26700976|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0|||
13365756|NCT00853047|26700977|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0|||
13365757|NCT00853047|26700978|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0|||
13365758|NCT00853047|26700979|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0|||
13365759|NCT00853047|26700980|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0|||
13365760|NCT00853047|26700981|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2|||
13365761|NCT00853047|26700976|FG000|Open-Label Extension Phase|Investigator Decision|0|||
13365762|NCT00853047|26700977|FG001|Open-Label Extension Phase|Investigator Decision|0|||
13365763|NCT00853047|26700978|FG002|Open-Label Extension Phase|Investigator Decision|0|||
13365764|NCT00853047|26700979|FG003|Open-Label Extension Phase|Investigator Decision|0|||
13365765|NCT00853047|26700980|FG004|Open-Label Extension Phase|Investigator Decision|0|||
13365766|NCT00853047|26700981|FG005|Open-Label Extension Phase|Investigator Decision|1|||
13365767|NCT00853047|26700976|FG000|Open-Label Extension Phase|Reason Not Specified|0|||
13375181|NCT00791479|26729577|FG001|Overall Study|Protocol Violation|1|||
13365768|NCT00853047|26700977|FG001|Open-Label Extension Phase|Reason Not Specified|0|||
13365769|NCT00853047|26700978|FG002|Open-Label Extension Phase|Reason Not Specified|0|||
13365770|NCT00853047|26700979|FG003|Open-Label Extension Phase|Reason Not Specified|0|||
13365771|NCT00853047|26700980|FG004|Open-Label Extension Phase|Reason Not Specified|0|||
13365772|NCT00853047|26700981|FG005|Open-Label Extension Phase|Reason Not Specified|6|||
13365773|NCT00853021|26700990|FG000|Overall Study|Adverse Event|2|||
13365774|NCT00853021|26700990|FG000|Overall Study|Withdrawal by Subject|2|||
13365775|NCT00853021|26700990|FG000|Overall Study|Death|1|||
13365776|NCT00852995|26701048|FG000|Overall Study|Adverse Event|1|||
13365777|NCT00852995|26701049|FG001|Overall Study|Adverse Event|0|||
13365778|NCT00852995|26701050|FG002|Overall Study|Adverse Event|4|||
13365779|NCT00852995|26701051|FG003|Overall Study|Adverse Event|0|||
13365780|NCT00852995|26701052|FG004|Overall Study|Adverse Event|0|||
13365781|NCT00852995|26701048|FG000|Overall Study|Lost to Follow-up|0|||
13365782|NCT00852995|26701049|FG001|Overall Study|Lost to Follow-up|1|||
13365783|NCT00852995|26701050|FG002|Overall Study|Lost to Follow-up|1|||
13365784|NCT00852995|26701051|FG003|Overall Study|Lost to Follow-up|0|||
13365785|NCT00852995|26701052|FG004|Overall Study|Lost to Follow-up|0|||
13365786|NCT00852995|26701048|FG000|Overall Study|Withdrawal by Subject|4|||
13365787|NCT00852995|26701049|FG001|Overall Study|Withdrawal by Subject|0|||
13365788|NCT00852995|26701050|FG002|Overall Study|Withdrawal by Subject|0|||
13365789|NCT00852995|26701051|FG003|Overall Study|Withdrawal by Subject|1|||
13365790|NCT00852995|26701052|FG004|Overall Study|Withdrawal by Subject|2|||
13365791|NCT00852995|26701048|FG000|Overall Study|Non-Compliance|0|||
13365792|NCT00852995|26701049|FG001|Overall Study|Non-Compliance|0|||
13365793|NCT00852995|26701050|FG002|Overall Study|Non-Compliance|0|||
13365794|NCT00852995|26701051|FG003|Overall Study|Non-Compliance|2|||
13365795|NCT00852995|26701052|FG004|Overall Study|Non-Compliance|0|||
13365796|NCT00852995|26701048|FG000|Overall Study|Progressive Disease|1|||
13365797|NCT00852995|26701049|FG001|Overall Study|Progressive Disease|0|||
13365798|NCT00852995|26701050|FG002|Overall Study|Progressive Disease|0|||
13365799|NCT00852995|26701051|FG003|Overall Study|Progressive Disease|2|||
13365800|NCT00852995|26701052|FG004|Overall Study|Progressive Disease|1|||
13365801|NCT00852995|26701048|FG000|Overall Study|Physician Decision|1|||
13365802|NCT00852995|26701049|FG001|Overall Study|Physician Decision|0|||
13365803|NCT00852995|26701050|FG002|Overall Study|Physician Decision|0|||
13365804|NCT00852995|26701051|FG003|Overall Study|Physician Decision|0|||
13365805|NCT00852995|26701052|FG004|Overall Study|Physician Decision|0|||
13365806|NCT00852995|26701048|FG000|Overall Study|Protocol Violation|0|||
13365807|NCT00852995|26701049|FG001|Overall Study|Protocol Violation|0|||
13365808|NCT00852995|26701050|FG002|Overall Study|Protocol Violation|0|||
13365809|NCT00852995|26701051|FG003|Overall Study|Protocol Violation|0|||
13365810|NCT00852995|26701052|FG004|Overall Study|Protocol Violation|1|||
13365811|NCT00852995|26701048|FG000|Overall Study|Moved Out of Area|1|||
13365812|NCT00852995|26701049|FG001|Overall Study|Moved Out of Area|0|||
13365813|NCT00852995|26701050|FG002|Overall Study|Moved Out of Area|0|||
13365814|NCT00852995|26701051|FG003|Overall Study|Moved Out of Area|0|||
13365815|NCT00852995|26701052|FG004|Overall Study|Moved Out of Area|0|||
13365816|NCT00852969|26701067|FG000|Overall Study|Adverse Event|0|||
13365817|NCT00852969|26701068|FG001|Overall Study|Adverse Event|1|||
13365818|NCT00852969|26701067|FG000|Overall Study|Lost to Follow-up|0|||
13365819|NCT00852969|26701068|FG001|Overall Study|Lost to Follow-up|1|||
13365820|NCT00852930|26701095|FG000|Overall Study|Withdrawal by Subject|1|||
13365821|NCT00852930|26701096|FG001|Overall Study|Withdrawal by Subject|1|||
13365822|NCT00852930|26701097|FG002|Overall Study|Withdrawal by Subject|1|||
13365823|NCT00852930|26701095|FG000|Overall Study|Physician Decision|0|||
13365824|NCT00852930|26701096|FG001|Overall Study|Physician Decision|0|||
13365825|NCT00852930|26701097|FG002|Overall Study|Physician Decision|1|||
13365826|NCT00852917|26701148|FG000|Overall Study|Adverse Event|13|||
13365827|NCT00852917|26701149|FG001|Overall Study|Adverse Event|20|||
13365828|NCT00852917|26701150|FG002|Overall Study|Adverse Event|35|||
13365829|NCT00852917|26701151|FG003|Overall Study|Adverse Event|17|||
13365830|NCT00852917|26701148|FG000|Overall Study|Lack of Efficacy|21|||
13365831|NCT00852917|26701149|FG001|Overall Study|Lack of Efficacy|11|||
13365832|NCT00852917|26701150|FG002|Overall Study|Lack of Efficacy|11|||
13365833|NCT00852917|26701151|FG003|Overall Study|Lack of Efficacy|47|||
13365834|NCT00852917|26701148|FG000|Overall Study|Withdrawal by Subject|4|||
13365835|NCT00852917|26701149|FG001|Overall Study|Withdrawal by Subject|8|||
13365836|NCT00852917|26701150|FG002|Overall Study|Withdrawal by Subject|10|||
13365837|NCT00852917|26701151|FG003|Overall Study|Withdrawal by Subject|9|||
13365838|NCT00852917|26701148|FG000|Overall Study|Physician Decision|6|||
13365839|NCT00852917|26701149|FG001|Overall Study|Physician Decision|7|||
13365840|NCT00852917|26701150|FG002|Overall Study|Physician Decision|2|||
13365841|NCT00852917|26701151|FG003|Overall Study|Physician Decision|19|||
13365842|NCT00852917|26701148|FG000|Overall Study|Death|0|||
13365843|NCT00852917|26701149|FG001|Overall Study|Death|0|||
13365844|NCT00852917|26701150|FG002|Overall Study|Death|0|||
13365845|NCT00852917|26701151|FG003|Overall Study|Death|1|||
13365846|NCT00852540|26701184|FG000|Overall Study|Adverse Event|10|||
13365847|NCT00852540|26701185|FG001|Overall Study|Adverse Event|3|||
13365848|NCT00852540|26701184|FG000|Overall Study|Lack of Efficacy|15|||
13365849|NCT00852540|26701185|FG001|Overall Study|Lack of Efficacy|3|||
13365850|NCT00852540|26701184|FG000|Overall Study|Protocol Violation|1|||
13365851|NCT00852540|26701185|FG001|Overall Study|Protocol Violation|2|||
13365852|NCT00852540|26701184|FG000|Overall Study|Lost to Follow-up|2|||
13365853|NCT00852540|26701185|FG001|Overall Study|Lost to Follow-up|3|||
13365854|NCT00852540|26701184|FG000|Overall Study|Investigator Discretion|2|||
13365855|NCT00852540|26701185|FG001|Overall Study|Investigator Discretion|3|||
13365856|NCT00852540|26701184|FG000|Overall Study|Withdrawal by Subject|3|||
13365857|NCT00852540|26701185|FG001|Overall Study|Withdrawal by Subject|1|||
13365858|NCT00852540|26701184|FG000|Overall Study|Did Not Receive Study Drug|3|||
13365859|NCT00852540|26701185|FG001|Overall Study|Did Not Receive Study Drug|3|||
13365860|NCT00852475|26701200|FG000|Overall Study|Lost to Follow-up|3|||
13365861|NCT00852475|26701201|FG001|Overall Study|Lost to Follow-up|4|||
13365862|NCT00852397|26701240|FG000|Overall Study|Adverse Event|4|||
13365863|NCT00852397|26701241|FG001|Overall Study|Adverse Event|6|||
13365864|NCT00852397|26701242|FG002|Overall Study|Adverse Event|4|||
13365865|NCT00852397|26701240|FG000|Overall Study|Death|0|||
13365866|NCT00852397|26701241|FG001|Overall Study|Death|0|||
13365867|NCT00852397|26701242|FG002|Overall Study|Death|1|||
13365868|NCT00852397|26701240|FG000|Overall Study|Withdrawal by Subject|4|||
13365869|NCT00852397|26701241|FG001|Overall Study|Withdrawal by Subject|1|||
13365870|NCT00852397|26701242|FG002|Overall Study|Withdrawal by Subject|2|||
13365871|NCT00852397|26701240|FG000|Overall Study|Study terminated by sponsor|2|||
13365872|NCT00852397|26701241|FG001|Overall Study|Study terminated by sponsor|1|||
13365873|NCT00852397|26701242|FG002|Overall Study|Study terminated by sponsor|6|||
13365874|NCT00852397|26701240|FG000|Overall Study|Difficulty in study site visit|1|||
13365875|NCT00852397|26701241|FG001|Overall Study|Difficulty in study site visit|0|||
13365876|NCT00852397|26701242|FG002|Overall Study|Difficulty in study site visit|0|||
13365877|NCT00852397|26701240|FG000|Overall Study|Protocol Violation|0|||
13365878|NCT00852397|26701241|FG001|Overall Study|Protocol Violation|0|||
13365879|NCT00852397|26701242|FG002|Overall Study|Protocol Violation|1|||
13365880|NCT00852241|26701248|FG000|Overall Study|Physician Decision|18|||
13365881|NCT00852202|26701269|FG000|Overall Study|Adverse Event|2|||
13365882|NCT00852202|26701270|FG001|Overall Study|Adverse Event|3|||
13365883|NCT00852202|26701271|FG002|Overall Study|Adverse Event|7|||
13365884|NCT00852202|26701269|FG000|Overall Study|Lack of Efficacy|4|||
13365885|NCT00852202|26701270|FG001|Overall Study|Lack of Efficacy|1|||
13365886|NCT00852202|26701271|FG002|Overall Study|Lack of Efficacy|2|||
13365887|NCT00852202|26701269|FG000|Overall Study|Protocol Violation|2|||
13365888|NCT00852202|26701270|FG001|Overall Study|Protocol Violation|2|||
13365889|NCT00852202|26701271|FG002|Overall Study|Protocol Violation|7|||
13365890|NCT00852202|26701269|FG000|Overall Study|Withdrawal by Subject|3|||
13365891|NCT00852202|26701270|FG001|Overall Study|Withdrawal by Subject|1|||
13365892|NCT00852202|26701271|FG002|Overall Study|Withdrawal by Subject|2|||
13365893|NCT00852202|26701269|FG000|Overall Study|Lost to Follow-up|5|||
13365894|NCT00852202|26701270|FG001|Overall Study|Lost to Follow-up|5|||
13365895|NCT00852202|26701271|FG002|Overall Study|Lost to Follow-up|6|||
13365896|NCT00852202|26701269|FG000|Overall Study|pregnancy,moving away and surgery|1|||
13365897|NCT00852202|26701270|FG001|Overall Study|pregnancy,moving away and surgery|0|||
13365898|NCT00852202|26701271|FG002|Overall Study|pregnancy,moving away and surgery|2|||
13365899|NCT00851903|26701283|FG000|Overall Study|Withdrawal by Subject|2|||
13365900|NCT00851890|26701353|FG000|Overall Study|Lost to Follow-up|0|||
13365901|NCT00851890|26701354|FG001|Overall Study|Lost to Follow-up|1|||
13365902|NCT00851890|26701355|FG002|Overall Study|Lost to Follow-up|0|||
13365903|NCT00851890|26701356|FG003|Overall Study|Lost to Follow-up|1|||
13365904|NCT00851877|26701367|FG000|Phase I-1|Death|1|||
13365905|NCT00851877|26701368|FG001|Phase I-1|Death|0|||
13365906|NCT00851877|26701369|FG002|Phase I-1|Death|0|||
13365907|NCT00851877|26701367|FG000|Phase II|Withdrawal by Subject|0|||
13365908|NCT00851877|26701368|FG001|Phase II|Withdrawal by Subject|0|||
13365909|NCT00851877|26701369|FG002|Phase II|Withdrawal by Subject|3|||
13365910|NCT00851799|26701465|FG000|Overall Study|Death|1|||
13365911|NCT00851799|26701466|FG001|Overall Study|Death|0|||
13365912|NCT00851799|26701467|FG002|Overall Study|Death|1|||
13365913|NCT00851799|26701465|FG000|Overall Study|Lost to Follow-up|5|||
13365914|NCT00851799|26701466|FG001|Overall Study|Lost to Follow-up|3|||
13365915|NCT00851799|26701467|FG002|Overall Study|Lost to Follow-up|10|||
13365916|NCT00851799|26701465|FG000|Overall Study|Not able to get to clinic|8|||
13365917|NCT00851799|26701466|FG001|Overall Study|Not able to get to clinic|5|||
13365918|NCT00851799|26701467|FG002|Overall Study|Not able to get to clinic|9|||
13365919|NCT00851799|26701465|FG000|Overall Study|Not willing to adhere to requirements|1|||
13365920|NCT00851799|26701466|FG001|Overall Study|Not willing to adhere to requirements|2|||
13365921|NCT00851799|26701467|FG002|Overall Study|Not willing to adhere to requirements|2|||
13365922|NCT00851799|26701465|FG000|Overall Study|Withdrew consent prior study completion|1|||
13365923|NCT00851799|26701466|FG001|Overall Study|Withdrew consent prior study completion|2|||
13365924|NCT00851799|26701467|FG002|Overall Study|Withdrew consent prior study completion|1|||
13365925|NCT00851799|26701465|FG000|Overall Study|Severe Debilitation|0|||
13365926|NCT00851799|26701466|FG001|Overall Study|Severe Debilitation|1|||
13365927|NCT00851799|26701467|FG002|Overall Study|Severe Debilitation|0|||
13365928|NCT00851799|26701465|FG000|Overall Study|Completed protocol due to pregnancy|0|||
13365929|NCT00851799|26701466|FG001|Overall Study|Completed protocol due to pregnancy|0|||
13365930|NCT00851799|26701467|FG002|Overall Study|Completed protocol due to pregnancy|1|||
13365931|NCT00851786|26701484|FG000|Overall Study|Withdrawal by Subject|0|||
13365932|NCT00851786|26701485|FG001|Overall Study|Withdrawal by Subject|1|||
13365933|NCT00851786|26701484|FG000|Overall Study|Protocol Violation|0|||
13365934|NCT00851786|26701485|FG001|Overall Study|Protocol Violation|1|||
13365935|NCT00851786|26701484|FG000|Overall Study|Lost to Follow-up|1|||
13365936|NCT00851786|26701485|FG001|Overall Study|Lost to Follow-up|0|||
13365937|NCT00851786|26701484|FG000|Overall Study|Incarceration|1|||
13365938|NCT00851786|26701485|FG001|Overall Study|Incarceration|0|||
13365939|NCT00851786|26701484|FG000|Overall Study|Site Closure|1|||
13365940|NCT00851786|26701485|FG001|Overall Study|Site Closure|0|||
13365941|NCT00851786|26701484|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2|||
13365942|NCT00851786|26701485|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0|||
13365943|NCT00851747|26701502|FG000|Overall Study|Physician Decision|6|||
13365944|NCT00851747|26701503|FG001|Overall Study|Physician Decision|6|||
13365945|NCT00851747|26701504|FG002|Overall Study|Physician Decision|6|||
13365946|NCT00851721|26701599|FG000|Overall Study|planned surgery|1|||
13365947|NCT00851721|26701600|FG001|Overall Study|planned surgery|0|||
13365948|NCT00851721|26701599|FG000|Overall Study|Death|1|||
13365949|NCT00851721|26701600|FG001|Overall Study|Death|0|||
13365950|NCT00851721|26701599|FG000|Overall Study|Adverse Event|0|||
13365951|NCT00851721|26701600|FG001|Overall Study|Adverse Event|1|||
13365952|NCT00851682|26701615|FG000|Overall Study|screen failure|5|||
13365953|NCT00851682|26701616|FG001|Overall Study|screen failure|0|||
13365954|NCT00851643|26701654|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1|||
13365955|NCT00851643|26701655|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
13365956|NCT00851643|26701656|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
13365957|NCT00851643|26701657|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
13365958|NCT00851643|26701658|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
13365959|NCT00851643|26701659|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
13365960|NCT00851643|26701654|FG000|Base Study (Up to 12 Months)|Other|0|||
13365961|NCT00851643|26701655|FG001|Base Study (Up to 12 Months)|Other|0|||
13365962|NCT00851643|26701656|FG002|Base Study (Up to 12 Months)|Other|0|||
13365963|NCT00851643|26701657|FG003|Base Study (Up to 12 Months)|Other|0|||
13365964|NCT00851643|26701658|FG004|Base Study (Up to 12 Months)|Other|0|||
13365965|NCT00851643|26701659|FG005|Base Study (Up to 12 Months)|Other|1|||
13365966|NCT00851643|26701654|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
13365967|NCT00851643|26701655|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
13365968|NCT00851643|26701656|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
13365969|NCT00851643|26701657|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1|||
13365970|NCT00851643|26701658|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
13365971|NCT00851643|26701659|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0|||
13365972|NCT00851643|26701654|FG000|Extension Study (Up to 36 Months)|Moved|0|||
13365973|NCT00851643|26701655|FG001|Extension Study (Up to 36 Months)|Moved|2|||
13365974|NCT00851643|26701656|FG002|Extension Study (Up to 36 Months)|Moved|1|||
13365975|NCT00851643|26701657|FG003|Extension Study (Up to 36 Months)|Moved|1|||
13365976|NCT00851643|26701658|FG004|Extension Study (Up to 36 Months)|Moved|0|||
13365977|NCT00851643|26701659|FG005|Extension Study (Up to 36 Months)|Moved|1|||
13365978|NCT00851630|26701678|FG000|Overall Study|Death|2|||
13365979|NCT00851630|26701679|FG001|Overall Study|Death|1|||
13365980|NCT00851630|26701678|FG000|Overall Study|Clinical failure|0|||
13365981|NCT00851630|26701679|FG001|Overall Study|Clinical failure|1|||
13365982|NCT00851591|26701692|FG000|Overall Study|Withdrawal by Subject|2|||
13365983|NCT00851591|26701693|FG001|Overall Study|Withdrawal by Subject|0|||
13365984|NCT00851552|26701700|FG000|Overall Study|Death|2|||
13365985|NCT00851552|26701700|FG000|Overall Study|Adverse Event|1|||
13365986|NCT00851552|26701700|FG000|Overall Study|Disease Progression|4|||
13365987|NCT00851318|26701743|FG000|Overall Study|Withdrawal by Subject|7|||
13365988|NCT00851318|26701744|FG001|Overall Study|Withdrawal by Subject|1|||
13365989|NCT00851318|26701745|FG002|Overall Study|Withdrawal by Subject|5|||
13365990|NCT00851318|26701746|FG003|Overall Study|Withdrawal by Subject|3|||
13365991|NCT00851318|26701743|FG000|Overall Study|Adverse Event|13|||
13365992|NCT00851318|26701744|FG001|Overall Study|Adverse Event|2|||
13365993|NCT00851318|26701745|FG002|Overall Study|Adverse Event|9|||
13365994|NCT00851318|26701746|FG003|Overall Study|Adverse Event|12|||
13365995|NCT00851318|26701743|FG000|Overall Study|Pregnancy|0|||
13365996|NCT00851318|26701744|FG001|Overall Study|Pregnancy|0|||
13365997|NCT00851318|26701745|FG002|Overall Study|Pregnancy|1|||
13365998|NCT00851318|26701746|FG003|Overall Study|Pregnancy|1|||
13365999|NCT00851318|26701743|FG000|Overall Study|Lack of Efficacy|8|||
13366000|NCT00851318|26701744|FG001|Overall Study|Lack of Efficacy|2|||
13366001|NCT00851318|26701745|FG002|Overall Study|Lack of Efficacy|4|||
13366002|NCT00851318|26701746|FG003|Overall Study|Lack of Efficacy|2|||
13366003|NCT00851318|26701743|FG000|Overall Study|Non-compliance with Study Procedures|2|||
13366004|NCT00851318|26701744|FG001|Overall Study|Non-compliance with Study Procedures|0|||
13366005|NCT00851318|26701745|FG002|Overall Study|Non-compliance with Study Procedures|1|||
13366006|NCT00851318|26701746|FG003|Overall Study|Non-compliance with Study Procedures|0|||
13366007|NCT00851318|26701743|FG000|Overall Study|Physician Decision|0|||
13366008|NCT00851318|26701744|FG001|Overall Study|Physician Decision|0|||
13366009|NCT00851318|26701745|FG002|Overall Study|Physician Decision|1|||
13366010|NCT00851318|26701746|FG003|Overall Study|Physician Decision|1|||
13366011|NCT00851253|26701761|FG000|Overall Study|Disease Progression|1|||
13366012|NCT00851253|26701762|FG001|Overall Study|Disease Progression|0|||
13366013|NCT00851084|26701785|FG000|Overall Study|Randomized but not treated|1|||
13366014|NCT00851084|26701786|FG001|Overall Study|Randomized but not treated|0|||
13366015|NCT00851084|26701785|FG000|Overall Study|Adverse Event|26|||
13366016|NCT00851084|26701786|FG001|Overall Study|Adverse Event|36|||
13366017|NCT00851084|26701785|FG000|Overall Study|Disease progression|52|||
13366018|NCT00851084|26701786|FG001|Overall Study|Disease progression|47|||
13366019|NCT00851084|26701785|FG000|Overall Study|Poor compliance to protocol|1|||
13366020|NCT00851084|26701786|FG001|Overall Study|Poor compliance to protocol|1|||
13366021|NCT00851084|26701785|FG000|Overall Study|Physician Decision|13|||
13366022|NCT00851084|26701786|FG001|Overall Study|Physician Decision|14|||
13366023|NCT00851084|26701785|FG000|Overall Study|Consent withdrawn|0|||
13366024|NCT00851084|26701786|FG001|Overall Study|Consent withdrawn|2|||
13366025|NCT00851084|26701785|FG000|Overall Study|Withdrawal by Subject|11|||
13366026|NCT00851084|26701786|FG001|Overall Study|Withdrawal by Subject|12|||
13366027|NCT00851084|26701785|FG000|Overall Study|Metastatic surgery|6|||
13366028|NCT00851084|26701786|FG001|Overall Study|Metastatic surgery|6|||
13366029|NCT00851084|26701785|FG000|Overall Study|Other|7|||
13366030|NCT00851084|26701786|FG001|Overall Study|Other|1|||
13366031|NCT00850993|26701813|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
13366032|NCT00850993|26701814|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
13366033|NCT00850993|26701815|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
13366034|NCT00850993|26701816|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
13366035|NCT00850759|26701839|FG000|Overall Study|Lost to Follow-up|7|||
13366036|NCT00850759|26701840|FG001|Overall Study|Lost to Follow-up|5|||
13366037|NCT00850759|26701841|FG002|Overall Study|Lost to Follow-up|5|||
13366038|NCT00850759|26701842|FG003|Overall Study|Lost to Follow-up|3|||
13366039|NCT00850564|26701849|FG000|Overall Study|Withdrawal by Subject|2|||
13366040|NCT00850538|26701855|FG000|Overall Study|unable/unwilling to complete MRI|13|||
13366041|NCT00850538|26701855|FG000|Overall Study|specimen missed due to scheduling error|14|||
13366042|NCT00850538|26701855|FG000|Overall Study|specimen unusable|7|||
13366043|NCT00850538|26701855|FG000|Overall Study|Withdrawal by Subject|3|||
13366044|NCT00850538|26701855|FG000|Overall Study|radiology error|2|||
13366045|NCT00850538|26701855|FG000|Overall Study|Protocol Violation|2|||
13366046|NCT00850499|26701870|FG000|Overall Study|Adverse Event|3|||
13366047|NCT00850499|26701871|FG001|Overall Study|Adverse Event|1|||
13366048|NCT00850499|26701870|FG000|Overall Study|Lack of Efficacy|0|||
13366049|NCT00850499|26701871|FG001|Overall Study|Lack of Efficacy|1|||
13375182|NCT00791479|26729578|FG002|Overall Study|Protocol Violation|0|||
13375183|NCT00791479|26729579|FG003|Overall Study|Protocol Violation|1|||
13375184|NCT00791479|26729580|FG004|Overall Study|Protocol Violation|0|||
13375185|NCT00791479|26729581|FG005|Overall Study|Protocol Violation|0|||
13375186|NCT00791479|26729576|FG000|Overall Study|Withdrawal by Subject|0|||
13375187|NCT00791479|26729577|FG001|Overall Study|Withdrawal by Subject|0|||
13375188|NCT00791479|26729578|FG002|Overall Study|Withdrawal by Subject|0|||
13375189|NCT00791479|26729579|FG003|Overall Study|Withdrawal by Subject|1|||
13375190|NCT00791479|26729580|FG004|Overall Study|Withdrawal by Subject|0|||
13375191|NCT00791479|26729581|FG005|Overall Study|Withdrawal by Subject|1|||
13375192|NCT00791388|26729624|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
13375193|NCT00791388|26729625|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1|||
13375194|NCT00791388|26729626|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
13375195|NCT00791388|26729627|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
13375196|NCT00791388|26729628|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
13375197|NCT00791388|26729624|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1|||
13375198|NCT00791388|26729625|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
13375199|NCT00791388|26729626|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
13375200|NCT00791388|26729627|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
13375201|NCT00791388|26729628|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
13375202|NCT00791388|26729624|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0|||
13375203|NCT00791388|26729625|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0|||
13375204|NCT00791388|26729626|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0|||
13375205|NCT00791388|26729627|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0|||
13375206|NCT00791388|26729628|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4|||
13375207|NCT00791258|26729692|FG000|Overall Study|Adverse Event|87|||
13375208|NCT00791258|26729692|FG000|Overall Study|Lost to Follow-up|18|||
13366050|NCT00850460|26701886|FG000|Overall Study|Lost to Follow-up|4|||
13366051|NCT00850460|26701887|FG001|Overall Study|Lost to Follow-up|4|||
13366052|NCT00850395|26701905|FG000|Overall Study|Death|1|||
13366053|NCT00850395|26701905|FG000|Overall Study|Adverse Event|1|||
13366054|NCT00850395|26701905|FG000|Overall Study|Insufficient clinical response|3|||
13366055|NCT00850395|26701905|FG000|Overall Study|Other|5|||
13366056|NCT00850343|26701948|FG000|Overall Study|Withdrawal by Subject|11|||
13366057|NCT00850343|26701949|FG001|Overall Study|Withdrawal by Subject|0|||
13366058|NCT00850343|26701950|FG002|Overall Study|Withdrawal by Subject|3|||
13366059|NCT00850343|26701951|FG003|Overall Study|Withdrawal by Subject|2|||
13366060|NCT00850343|26701948|FG000|Overall Study|Adverse Event|15|||
13366061|NCT00850343|26701949|FG001|Overall Study|Adverse Event|2|||
13366062|NCT00850343|26701950|FG002|Overall Study|Adverse Event|6|||
13366063|NCT00850343|26701951|FG003|Overall Study|Adverse Event|6|||
13366064|NCT00850343|26701948|FG000|Overall Study|Pregnancy|0|||
13366065|NCT00850343|26701949|FG001|Overall Study|Pregnancy|0|||
13366066|NCT00850343|26701950|FG002|Overall Study|Pregnancy|0|||
13366067|NCT00850343|26701951|FG003|Overall Study|Pregnancy|1|||
13366068|NCT00850343|26701948|FG000|Overall Study|Lack of Efficacy|17|||
13366069|NCT00850343|26701949|FG001|Overall Study|Lack of Efficacy|0|||
13366070|NCT00850343|26701950|FG002|Overall Study|Lack of Efficacy|3|||
13366071|NCT00850343|26701951|FG003|Overall Study|Lack of Efficacy|2|||
13366072|NCT00850343|26701948|FG000|Overall Study|Non-compliance with Study Procedures|1|||
13366073|NCT00850343|26701949|FG001|Overall Study|Non-compliance with Study Procedures|0|||
13366074|NCT00850343|26701950|FG002|Overall Study|Non-compliance with Study Procedures|1|||
13366075|NCT00850343|26701951|FG003|Overall Study|Non-compliance with Study Procedures|1|||
13366076|NCT00850343|26701948|FG000|Overall Study|Physician Decision|2|||
13366077|NCT00850343|26701949|FG001|Overall Study|Physician Decision|1|||
13366078|NCT00850343|26701950|FG002|Overall Study|Physician Decision|1|||
13366079|NCT00850343|26701951|FG003|Overall Study|Physician Decision|1|||
13366080|NCT00850200|26701961|FG000|Overall Study|Physician Decision|2|||
13366081|NCT00850200|26701961|FG000|Overall Study|Did not recieve treatment|2|||
13366082|NCT00850200|26701961|FG000|Overall Study|Withdrawal by Subject|1|||
13366083|NCT00850135|26701969|FG000|Overall Study|Physician Decision|1|||
13366084|NCT00850070|26702000|FG000|Overall Study|Lack of Efficacy|1|||
13366085|NCT00850070|26702001|FG001|Overall Study|Lack of Efficacy|1|||
13366086|NCT00850070|26702000|FG000|Overall Study|Adverse Event|2|||
13366087|NCT00850070|26702001|FG001|Overall Study|Adverse Event|0|||
13366088|NCT00849940|26702011|FG000|Overall Study|Physician Decision|4|||
13366089|NCT00849901|26702065|FG000|Acute Treatment Phase|Adverse Event|9|||
13366090|NCT00849901|26702066|FG001|Acute Treatment Phase|Adverse Event|1|||
13366091|NCT00849901|26702067|FG002|Acute Treatment Phase|Adverse Event|3|||
13366092|NCT00849901|26702065|FG000|Acute Treatment Phase|Lost to Follow-up|2|||
13366093|NCT00849901|26702066|FG001|Acute Treatment Phase|Lost to Follow-up|4|||
13366094|NCT00849901|26702067|FG002|Acute Treatment Phase|Lost to Follow-up|1|||
13366095|NCT00849901|26702065|FG000|Acute Treatment Phase|Protocol Violation|0|||
13366096|NCT00849901|26702066|FG001|Acute Treatment Phase|Protocol Violation|2|||
13366097|NCT00849901|26702067|FG002|Acute Treatment Phase|Protocol Violation|1|||
13366098|NCT00849901|26702065|FG000|Acute Treatment Phase|Withdrawal by Subject|4|||
13366099|NCT00849901|26702066|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
13366100|NCT00849901|26702067|FG002|Acute Treatment Phase|Withdrawal by Subject|4|||
13366101|NCT00849901|26702065|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11|||
13366102|NCT00849901|26702066|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5|||
13366103|NCT00849901|26702067|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4|||
13366104|NCT00849901|26702065|FG000|Acute Treatment Phase|Physician Decision|1|||
13366105|NCT00849901|26702066|FG001|Acute Treatment Phase|Physician Decision|1|||
13366106|NCT00849901|26702067|FG002|Acute Treatment Phase|Physician Decision|1|||
13366107|NCT00849901|26702065|FG000|Acute Treatment Phase|Sponsor Decision|1|||
13366108|NCT00849901|26702066|FG001|Acute Treatment Phase|Sponsor Decision|0|||
13366109|NCT00849901|26702067|FG002|Acute Treatment Phase|Sponsor Decision|0|||
13366110|NCT00849901|26702065|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
13366111|NCT00849901|26702066|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
13366112|NCT00849901|26702067|FG002|Acute Treatment Phase|Lack of Efficacy|2|||
13366113|NCT00849901|26702065|FG000|Extension Phase|Adverse Event|2|||
13366114|NCT00849901|26702066|FG001|Extension Phase|Adverse Event|8|||
13366115|NCT00849901|26702067|FG002|Extension Phase|Adverse Event|4|||
13366116|NCT00849901|26702065|FG000|Extension Phase|Lost to Follow-up|3|||
13366117|NCT00849901|26702066|FG001|Extension Phase|Lost to Follow-up|0|||
13366118|NCT00849901|26702067|FG002|Extension Phase|Lost to Follow-up|1|||
13366119|NCT00849901|26702065|FG000|Extension Phase|Protocol Violation|2|||
13366120|NCT00849901|26702066|FG001|Extension Phase|Protocol Violation|2|||
13366121|NCT00849901|26702067|FG002|Extension Phase|Protocol Violation|4|||
13366122|NCT00849901|26702065|FG000|Extension Phase|Withdrawal by Subject|7|||
13366123|NCT00849901|26702066|FG001|Extension Phase|Withdrawal by Subject|6|||
13366124|NCT00849901|26702067|FG002|Extension Phase|Withdrawal by Subject|3|||
13366125|NCT00849901|26702065|FG000|Extension Phase|Parent or Caregiver Decision|10|||
13366126|NCT00849901|26702066|FG001|Extension Phase|Parent or Caregiver Decision|4|||
13366127|NCT00849901|26702067|FG002|Extension Phase|Parent or Caregiver Decision|4|||
13366128|NCT00849901|26702065|FG000|Extension Phase|Physician Decision|1|||
13366129|NCT00849901|26702066|FG001|Extension Phase|Physician Decision|2|||
13366130|NCT00849901|26702067|FG002|Extension Phase|Physician Decision|0|||
13366131|NCT00849901|26702065|FG000|Extension Phase|Lack of Efficacy|2|||
13366132|NCT00849901|26702066|FG001|Extension Phase|Lack of Efficacy|4|||
13366133|NCT00849901|26702067|FG002|Extension Phase|Lack of Efficacy|1|||
13366134|NCT00849875|26702155|FG000|Overall Study|Death|28|||
13366135|NCT00849875|26702155|FG000|Overall Study|Ongoing (unknown completion status)|11|||
13366136|NCT00849875|26702155|FG000|Overall Study|Others|6|||
13366137|NCT00849875|26702155|FG000|Overall Study|Lost to Follow-up|2|||
13366138|NCT00849693|26702227|FG000|Acute Treatment Phase|Adverse Event|12|||
13366139|NCT00849693|26702228|FG001|Acute Treatment Phase|Adverse Event|7|||
13366140|NCT00849693|26702229|FG002|Acute Treatment Phase|Adverse Event|6|||
13366141|NCT00849693|26702230|FG003|Acute Treatment Phase|Adverse Event|4|||
13366142|NCT00849693|26702227|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
13366143|NCT00849693|26702228|FG001|Acute Treatment Phase|Lost to Follow-up|8|||
13366144|NCT00849693|26702229|FG002|Acute Treatment Phase|Lost to Follow-up|11|||
13366145|NCT00849693|26702230|FG003|Acute Treatment Phase|Lost to Follow-up|9|||
13366146|NCT00849693|26702227|FG000|Acute Treatment Phase|Protocol Violation|1|||
13366147|NCT00849693|26702228|FG001|Acute Treatment Phase|Protocol Violation|5|||
13366148|NCT00849693|26702229|FG002|Acute Treatment Phase|Protocol Violation|2|||
13366149|NCT00849693|26702230|FG003|Acute Treatment Phase|Protocol Violation|6|||
13366150|NCT00849693|26702227|FG000|Acute Treatment Phase|Withdrawal by Subject|5|||
13366151|NCT00849693|26702228|FG001|Acute Treatment Phase|Withdrawal by Subject|5|||
13366152|NCT00849693|26702229|FG002|Acute Treatment Phase|Withdrawal by Subject|3|||
13366153|NCT00849693|26702230|FG003|Acute Treatment Phase|Withdrawal by Subject|8|||
13366154|NCT00849693|26702227|FG000|Acute Treatment Phase|Parent or caregiver decision|7|||
13366155|NCT00849693|26702228|FG001|Acute Treatment Phase|Parent or caregiver decision|6|||
13366156|NCT00849693|26702229|FG002|Acute Treatment Phase|Parent or caregiver decision|7|||
13366157|NCT00849693|26702230|FG003|Acute Treatment Phase|Parent or caregiver decision|7|||
13366158|NCT00849693|26702227|FG000|Acute Treatment Phase|Physician Decision|2|||
13366159|NCT00849693|26702228|FG001|Acute Treatment Phase|Physician Decision|1|||
13366160|NCT00849693|26702229|FG002|Acute Treatment Phase|Physician Decision|2|||
13366161|NCT00849693|26702230|FG003|Acute Treatment Phase|Physician Decision|1|||
13366162|NCT00849693|26702227|FG000|Acute Treatment Phase|Sponsor decision|0|||
13366163|NCT00849693|26702228|FG001|Acute Treatment Phase|Sponsor decision|0|||
13366164|NCT00849693|26702229|FG002|Acute Treatment Phase|Sponsor decision|1|||
13366165|NCT00849693|26702230|FG003|Acute Treatment Phase|Sponsor decision|0|||
13366166|NCT00849693|26702227|FG000|Acute Treatment Phase|Lack of Efficacy|1|||
13366167|NCT00849693|26702228|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
13366168|NCT00849693|26702229|FG002|Acute Treatment Phase|Lack of Efficacy|1|||
13366169|NCT00849693|26702230|FG003|Acute Treatment Phase|Lack of Efficacy|2|||
13366170|NCT00849693|26702227|FG000|Extension Phase|Adverse Event|4|||
13366171|NCT00849693|26702228|FG001|Extension Phase|Adverse Event|6|||
13366172|NCT00849693|26702229|FG002|Extension Phase|Adverse Event|3|||
13366173|NCT00849693|26702230|FG003|Extension Phase|Adverse Event|7|||
13366174|NCT00849693|26702227|FG000|Extension Phase|Lost to Follow-up|7|||
13366175|NCT00849693|26702228|FG001|Extension Phase|Lost to Follow-up|5|||
13366176|NCT00849693|26702229|FG002|Extension Phase|Lost to Follow-up|6|||
13366177|NCT00849693|26702230|FG003|Extension Phase|Lost to Follow-up|6|||
13366178|NCT00849693|26702227|FG000|Extension Phase|Protocol Violation|0|||
13366179|NCT00849693|26702228|FG001|Extension Phase|Protocol Violation|3|||
13366180|NCT00849693|26702229|FG002|Extension Phase|Protocol Violation|2|||
13366181|NCT00849693|26702230|FG003|Extension Phase|Protocol Violation|3|||
13366182|NCT00849693|26702227|FG000|Extension Phase|Withdrawal by Subject|6|||
13366183|NCT00849693|26702228|FG001|Extension Phase|Withdrawal by Subject|9|||
13366184|NCT00849693|26702229|FG002|Extension Phase|Withdrawal by Subject|10|||
13366185|NCT00849693|26702230|FG003|Extension Phase|Withdrawal by Subject|15|||
13366186|NCT00849693|26702227|FG000|Extension Phase|Parent or caregiver decision|9|||
13366187|NCT00849693|26702228|FG001|Extension Phase|Parent or caregiver decision|4|||
13366188|NCT00849693|26702229|FG002|Extension Phase|Parent or caregiver decision|10|||
13366189|NCT00849693|26702230|FG003|Extension Phase|Parent or caregiver decision|5|||
13366190|NCT00849693|26702227|FG000|Extension Phase|Physician Decision|1|||
13366191|NCT00849693|26702228|FG001|Extension Phase|Physician Decision|1|||
13366192|NCT00849693|26702229|FG002|Extension Phase|Physician Decision|2|||
13366193|NCT00849693|26702230|FG003|Extension Phase|Physician Decision|0|||
13366194|NCT00849693|26702227|FG000|Extension Phase|Sponsor decision|1|||
13366195|NCT00849693|26702228|FG001|Extension Phase|Sponsor decision|0|||
13366196|NCT00849693|26702229|FG002|Extension Phase|Sponsor decision|0|||
13366197|NCT00849693|26702230|FG003|Extension Phase|Sponsor decision|1|||
13366198|NCT00849693|26702227|FG000|Extension Phase|Lack of Efficacy|2|||
13366199|NCT00849693|26702228|FG001|Extension Phase|Lack of Efficacy|2|||
13366200|NCT00849693|26702229|FG002|Extension Phase|Lack of Efficacy|2|||
13366201|NCT00849693|26702230|FG003|Extension Phase|Lack of Efficacy|1|||
13366202|NCT00849680|26702297|FG000|Overall Study|Adverse Event|0|||
13366203|NCT00849680|26702298|FG001|Overall Study|Adverse Event|0|||
13366204|NCT00849680|26702299|FG002|Overall Study|Adverse Event|0|||
13366205|NCT00849680|26702300|FG003|Overall Study|Adverse Event|0|||
13366206|NCT00849680|26702301|FG004|Overall Study|Adverse Event|0|||
13366207|NCT00849680|26702302|FG005|Overall Study|Adverse Event|0|||
13366208|NCT00849680|26702303|FG006|Overall Study|Adverse Event|2|||
13366209|NCT00849680|26702304|FG007|Overall Study|Adverse Event|0|||
13366210|NCT00849680|26702297|FG000|Overall Study|Lost to Follow-up|7|||
13366211|NCT00849680|26702298|FG001|Overall Study|Lost to Follow-up|3|||
13366212|NCT00849680|26702299|FG002|Overall Study|Lost to Follow-up|12|||
13366213|NCT00849680|26702300|FG003|Overall Study|Lost to Follow-up|11|||
13366214|NCT00849680|26702301|FG004|Overall Study|Lost to Follow-up|8|||
13366215|NCT00849680|26702302|FG005|Overall Study|Lost to Follow-up|11|||
13366216|NCT00849680|26702303|FG006|Overall Study|Lost to Follow-up|12|||
13366217|NCT00849680|26702304|FG007|Overall Study|Lost to Follow-up|5|||
13366218|NCT00849680|26702297|FG000|Overall Study|Subject moved|1|||
13366219|NCT00849680|26702298|FG001|Overall Study|Subject moved|0|||
13366220|NCT00849680|26702299|FG002|Overall Study|Subject moved|3|||
13366221|NCT00849680|26702300|FG003|Overall Study|Subject moved|1|||
13366222|NCT00849680|26702301|FG004|Overall Study|Subject moved|0|||
13366223|NCT00849680|26702302|FG005|Overall Study|Subject moved|2|||
13366224|NCT00849680|26702303|FG006|Overall Study|Subject moved|2|||
13366225|NCT00849680|26702304|FG007|Overall Study|Subject moved|2|||
13366226|NCT00849680|26702297|FG000|Overall Study|Withdrawal by Subject|2|||
13366227|NCT00849680|26702298|FG001|Overall Study|Withdrawal by Subject|0|||
13366228|NCT00849680|26702299|FG002|Overall Study|Withdrawal by Subject|0|||
13366229|NCT00849680|26702300|FG003|Overall Study|Withdrawal by Subject|2|||
13366230|NCT00849680|26702301|FG004|Overall Study|Withdrawal by Subject|2|||
13366231|NCT00849680|26702302|FG005|Overall Study|Withdrawal by Subject|2|||
13366232|NCT00849680|26702303|FG006|Overall Study|Withdrawal by Subject|1|||
13366233|NCT00849680|26702304|FG007|Overall Study|Withdrawal by Subject|1|||
13366234|NCT00849680|26702297|FG000|Overall Study|Subject unable to comply with protocol|1|||
13366235|NCT00849680|26702298|FG001|Overall Study|Subject unable to comply with protocol|0|||
13366236|NCT00849680|26702299|FG002|Overall Study|Subject unable to comply with protocol|0|||
13366237|NCT00849680|26702300|FG003|Overall Study|Subject unable to comply with protocol|0|||
13366238|NCT00849680|26702301|FG004|Overall Study|Subject unable to comply with protocol|0|||
13366239|NCT00849680|26702302|FG005|Overall Study|Subject unable to comply with protocol|0|||
13366240|NCT00849680|26702303|FG006|Overall Study|Subject unable to comply with protocol|0|||
13366241|NCT00849680|26702304|FG007|Overall Study|Subject unable to comply with protocol|0|||
13366242|NCT00849524|26702312|FG000|Overall Study|Lack of Efficacy|3|||
13366243|NCT00849472|26702328|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2|||
13366244|NCT00849472|26702328|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1|||
13366245|NCT00849472|26702328|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1|||
13366246|NCT00849472|26702328|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1|||
13366247|NCT00849472|26702328|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1|||
13366248|NCT00849472|26702328|FG000|Weekly Paclitaxel|Disease Progression|1|||
13366249|NCT00849472|26702328|FG000|Weekly Paclitaxel|Adverse Event|11|||
13366250|NCT00849472|26702328|FG000|Weekly Paclitaxel|Withdrawal by Subject|1|||
13366251|NCT00849472|26702328|FG000|Weekly Paclitaxel|Physician Decision|3|||
13366252|NCT00849472|26702328|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52|||
13366253|NCT00849472|26702328|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4|||
13366254|NCT00849472|26702328|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1|||
13366255|NCT00849472|26702328|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1|||
13366256|NCT00849472|26702328|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19|||
13366257|NCT00849472|26702328|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5|||
13366258|NCT00849472|26702328|FG000|Pazopanib Postsurgery Treatment|Moved|1|||
13366259|NCT00849472|26702328|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1|||
13366260|NCT00849381|26702336|FG000|Overall Study|Adverse Event|1|||
13366261|NCT00849381|26702336|FG000|Overall Study|Lost to Follow-up|129|||
13366262|NCT00849381|26702336|FG000|Overall Study|Protocol Violation|5|||
13366263|NCT00849381|26702336|FG000|Overall Study|Withdrawal by Subject|6|||
13366264|NCT00849381|26702336|FG000|Overall Study|Other|4|||
13366265|NCT00849290|26702342|FG000|Overall Study|Adverse Event|3|||
13366266|NCT00849290|26702342|FG000|Overall Study|Death|14|||
13366267|NCT00849290|26702342|FG000|Overall Study|Withdrawal by Subject|11|||
13366268|NCT00849290|26702342|FG000|Overall Study|Lost to Follow-up|2|||
13366269|NCT00849290|26702342|FG000|Overall Study|Protocol Violation|5|||
13366270|NCT00849290|26702342|FG000|Overall Study|Disease Progression|20|||
13366271|NCT00849212|26702349|FG000|Overall Study|Lack of Efficacy|1|||
13366272|NCT00849212|26702349|FG000|Overall Study|Withdrawal by Subject|3|||
13366273|NCT00849212|26702349|FG000|Overall Study|Adverse Event|2|||
13366274|NCT00849212|26702349|FG000|Overall Study|Miscellaneous|1|||
13366275|NCT00849186|26702357|FG000|Overall Study|Adverse Event|2|||
13366276|NCT00849186|26702357|FG000|Overall Study|Withdrawal by Subject|1|||
13366277|NCT00849186|26702357|FG000|Overall Study|not treated|6|||
13366278|NCT00849186|26702357|FG000|Overall Study|Other|1|||
13366279|NCT00849108|26702374|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1|||
13366280|NCT00849108|26702375|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0|||
13366281|NCT00849108|26702374|FG000|Cohort 2 Efficacy|Adverse Event|0|||
13366282|NCT00849108|26702375|FG001|Cohort 2 Efficacy|Adverse Event|1|||
13366283|NCT00849108|26702374|FG000|Cohort 2 Efficacy|Other|0|||
13366284|NCT00849108|26702375|FG001|Cohort 2 Efficacy|Other|9|||
13366285|NCT00849056|26702404|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13|||
13366286|NCT00849056|26702405|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
13366287|NCT00849056|26702404|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3|||
13366288|NCT00849056|26702405|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6|||
13366289|NCT00849056|26702404|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
13366290|NCT00849056|26702405|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
13366291|NCT00849056|26702404|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
13366292|NCT00849056|26702405|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5|||
13366293|NCT00849056|26702404|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31|||
13366294|NCT00849056|26702405|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18|||
13366295|NCT00849056|26702404|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
13366296|NCT00849056|26702405|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
13366297|NCT00849056|26702404|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1|||
13366298|NCT00849056|26702405|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4|||
13366299|NCT00849056|26702404|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1|||
13366300|NCT00849056|26702405|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0|||
13366301|NCT00849056|26702404|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
13366302|NCT00849056|26702405|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
13366303|NCT00849056|26702404|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
13366304|NCT00849056|26702405|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3|||
13366305|NCT00849056|26702404|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
13366306|NCT00849056|26702405|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
13366307|NCT00849056|26702404|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14|||
13366308|NCT00849056|26702405|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9|||
13366309|NCT00849056|26702404|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9|||
13366310|NCT00849056|26702405|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7|||
13366311|NCT00849056|26702404|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
13366312|NCT00849056|26702405|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
13366313|NCT00849056|26702404|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1|||
13366314|NCT00849056|26702405|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4|||
13366315|NCT00849056|26702404|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1|||
13366316|NCT00849056|26702405|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0|||
13366317|NCT00849017|26702458|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
13366318|NCT00849017|26702459|FG001|Treatment Period (156 Weeks)|Adverse Event|6|||
13366319|NCT00849017|26702460|FG002|Treatment Period (156 Weeks)|Adverse Event|15|||
13366320|NCT00849017|26702458|FG000|Treatment Period (156 Weeks)|Noncompliance|3|||
13366321|NCT00849017|26702459|FG001|Treatment Period (156 Weeks)|Noncompliance|3|||
13366322|NCT00849017|26702460|FG002|Treatment Period (156 Weeks)|Noncompliance|4|||
13366323|NCT00849017|26702458|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10|||
13366324|NCT00849017|26702459|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7|||
13366325|NCT00849017|26702460|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8|||
13366326|NCT00849017|26702458|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18|||
13366327|NCT00849017|26702459|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14|||
13366328|NCT00849017|26702460|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11|||
13366329|NCT00849017|26702458|FG000|Treatment Period (156 Weeks)|Physician Decision|0|||
13366330|NCT00849017|26702459|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
13366331|NCT00849017|26702460|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
13366332|NCT00849017|26702458|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3|||
13366333|NCT00849017|26702459|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
13366334|NCT00849017|26702460|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
13366335|NCT00849017|26702458|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1|||
13366336|NCT00849017|26702459|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
13366337|NCT00849017|26702460|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
13366338|NCT00849017|26702458|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1|||
13366339|NCT00849017|26702459|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
13366340|NCT00849017|26702460|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
13366341|NCT00849017|26702458|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1|||
13366342|NCT00849017|26702459|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
13366343|NCT00849017|26702460|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
13366344|NCT00849017|26702458|FG000|Treatment Period (156 Weeks)|Pregnancy|1|||
13366345|NCT00849017|26702459|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
13366346|NCT00849017|26702460|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
13366347|NCT00849017|26702458|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
13366348|NCT00849017|26702459|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
13366349|NCT00849017|26702460|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1|||
13366350|NCT00849017|26702458|FG000|Follow-up Period (8 Weeks)|Adverse Event|1|||
13366351|NCT00849017|26702459|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
13366352|NCT00849017|26702460|FG002|Follow-up Period (8 Weeks)|Adverse Event|0|||
13366353|NCT00849017|26702458|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
13366354|NCT00849017|26702459|FG001|Follow-up Period (8 Weeks)|Noncompliance|1|||
13366355|NCT00849017|26702460|FG002|Follow-up Period (8 Weeks)|Noncompliance|0|||
13366356|NCT00849017|26702458|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13|||
13366357|NCT00849017|26702459|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
13366358|NCT00849017|26702460|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16|||
13366359|NCT00849017|26702458|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
13366360|NCT00849017|26702459|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
13366361|NCT00849017|26702460|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4|||
13366362|NCT00849017|26702458|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
13366363|NCT00849017|26702459|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
13366364|NCT00849017|26702460|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
13366365|NCT00849017|26702458|FG000|Follow-up Period (8 Weeks)|Physician Decision|0|||
13366366|NCT00849017|26702459|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
13366367|NCT00849017|26702460|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
13366368|NCT00849017|26702458|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3|||
13366369|NCT00849017|26702459|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
13366370|NCT00849017|26702460|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
13366371|NCT00849017|26702458|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1|||
13366372|NCT00849017|26702459|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
13366373|NCT00849017|26702460|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
13366374|NCT00848965|26702504|FG000|Overall Study|Adverse Event|1|||
13366375|NCT00848965|26702504|FG000|Overall Study|Withdrawal by Subject|1|||
13366376|NCT00848926|26702522|FG000|Treatment Period|Progressive disease|45|||
13366377|NCT00848926|26702522|FG000|Treatment Period|Adverse Event|20|||
13366378|NCT00848926|26702522|FG000|Treatment Period|Physician Decision|12|||
13366379|NCT00848926|26702522|FG000|Treatment Period|Withdrawal by Subject|7|||
13366380|NCT00848926|26702522|FG000|Follow-up Period|Lost to Follow-up|7|||
13366381|NCT00848926|26702522|FG000|Follow-up Period|Withdrawal by Subject|3|||
13366382|NCT00848926|26702522|FG000|Follow-up Period|Other|2|||
13366383|NCT00848718|26702661|FG000|Overall Study|Adverse Event|2|||
13366384|NCT00848718|26702662|FG001|Overall Study|Adverse Event|2|||
13366385|NCT00848718|26702663|FG002|Overall Study|Adverse Event|1|||
13366386|NCT00848718|26702664|FG003|Overall Study|Adverse Event|1|||
13366387|NCT00848718|26702665|FG004|Overall Study|Adverse Event|1|||
13366388|NCT00848718|26702666|FG005|Overall Study|Adverse Event|0|||
13366389|NCT00848718|26702667|FG006|Overall Study|Adverse Event|0|||
13366390|NCT00848718|26702668|FG007|Overall Study|Adverse Event|1|||
13366391|NCT00848718|26702669|FG008|Overall Study|Adverse Event|1|||
13366392|NCT00848718|26702670|FG009|Overall Study|Adverse Event|0|||
13366393|NCT00848718|26702671|FG010|Overall Study|Adverse Event|0|||
13366394|NCT00848718|26702672|FG011|Overall Study|Adverse Event|0|||
13366395|NCT00848718|26702673|FG012|Overall Study|Adverse Event|2|||
13366396|NCT00848718|26702661|FG000|Overall Study|Lack of Efficacy|0|||
13366397|NCT00848718|26702662|FG001|Overall Study|Lack of Efficacy|0|||
13366398|NCT00848718|26702663|FG002|Overall Study|Lack of Efficacy|1|||
13366399|NCT00848718|26702664|FG003|Overall Study|Lack of Efficacy|0|||
13366400|NCT00848718|26702665|FG004|Overall Study|Lack of Efficacy|0|||
13366401|NCT00848718|26702666|FG005|Overall Study|Lack of Efficacy|0|||
13366402|NCT00848718|26702667|FG006|Overall Study|Lack of Efficacy|1|||
13366403|NCT00848718|26702668|FG007|Overall Study|Lack of Efficacy|0|||
13366404|NCT00848718|26702669|FG008|Overall Study|Lack of Efficacy|0|||
13366405|NCT00848718|26702670|FG009|Overall Study|Lack of Efficacy|0|||
13366406|NCT00848718|26702671|FG010|Overall Study|Lack of Efficacy|0|||
13366407|NCT00848718|26702672|FG011|Overall Study|Lack of Efficacy|0|||
13366408|NCT00848718|26702673|FG012|Overall Study|Lack of Efficacy|0|||
13366409|NCT00848718|26702661|FG000|Overall Study|Physician Decision|0|||
13366410|NCT00848718|26702662|FG001|Overall Study|Physician Decision|1|||
13366411|NCT00848718|26702663|FG002|Overall Study|Physician Decision|0|||
13366412|NCT00848718|26702664|FG003|Overall Study|Physician Decision|0|||
13366413|NCT00848718|26702665|FG004|Overall Study|Physician Decision|1|||
13366414|NCT00848718|26702666|FG005|Overall Study|Physician Decision|1|||
13366415|NCT00848718|26702667|FG006|Overall Study|Physician Decision|0|||
13366416|NCT00848718|26702668|FG007|Overall Study|Physician Decision|0|||
13366417|NCT00848718|26702669|FG008|Overall Study|Physician Decision|1|||
13204476|NCT01972841|26229048|FG000|Overall Study|Did not have end of treatment page|0|||
13366418|NCT00848718|26702670|FG009|Overall Study|Physician Decision|2|||
13366419|NCT00848718|26702671|FG010|Overall Study|Physician Decision|0|||
13366420|NCT00848718|26702672|FG011|Overall Study|Physician Decision|0|||
13366421|NCT00848718|26702673|FG012|Overall Study|Physician Decision|1|||
13366422|NCT00848718|26702661|FG000|Overall Study|Progressive disease before treatment|1|||
13366423|NCT00848718|26702662|FG001|Overall Study|Progressive disease before treatment|5|||
13366424|NCT00848718|26702663|FG002|Overall Study|Progressive disease before treatment|1|||
13366425|NCT00848718|26702664|FG003|Overall Study|Progressive disease before treatment|3|||
13366426|NCT00848718|26702665|FG004|Overall Study|Progressive disease before treatment|4|||
13366427|NCT00848718|26702666|FG005|Overall Study|Progressive disease before treatment|4|||
13366428|NCT00848718|26702667|FG006|Overall Study|Progressive disease before treatment|2|||
13366429|NCT00848718|26702668|FG007|Overall Study|Progressive disease before treatment|1|||
13366430|NCT00848718|26702669|FG008|Overall Study|Progressive disease before treatment|2|||
13366431|NCT00848718|26702670|FG009|Overall Study|Progressive disease before treatment|7|||
13366432|NCT00848718|26702671|FG010|Overall Study|Progressive disease before treatment|3|||
13366433|NCT00848718|26702672|FG011|Overall Study|Progressive disease before treatment|6|||
13366434|NCT00848718|26702673|FG012|Overall Study|Progressive disease before treatment|2|||
13366435|NCT00848718|26702661|FG000|Overall Study|Protocol Violation|0|||
13366436|NCT00848718|26702662|FG001|Overall Study|Protocol Violation|1|||
13366437|NCT00848718|26702663|FG002|Overall Study|Protocol Violation|0|||
13366438|NCT00848718|26702664|FG003|Overall Study|Protocol Violation|0|||
13366439|NCT00848718|26702665|FG004|Overall Study|Protocol Violation|0|||
13366440|NCT00848718|26702666|FG005|Overall Study|Protocol Violation|0|||
13366441|NCT00848718|26702667|FG006|Overall Study|Protocol Violation|0|||
13366442|NCT00848718|26702668|FG007|Overall Study|Protocol Violation|1|||
13366443|NCT00848718|26702669|FG008|Overall Study|Protocol Violation|0|||
13366444|NCT00848718|26702670|FG009|Overall Study|Protocol Violation|0|||
13366445|NCT00848718|26702671|FG010|Overall Study|Protocol Violation|0|||
13366446|NCT00848718|26702672|FG011|Overall Study|Protocol Violation|0|||
13366447|NCT00848718|26702673|FG012|Overall Study|Protocol Violation|1|||
13366448|NCT00848718|26702661|FG000|Overall Study|Withdrawal by Subject|1|||
13366449|NCT00848718|26702662|FG001|Overall Study|Withdrawal by Subject|0|||
13366450|NCT00848718|26702663|FG002|Overall Study|Withdrawal by Subject|0|||
13366451|NCT00848718|26702664|FG003|Overall Study|Withdrawal by Subject|1|||
13366452|NCT00848718|26702665|FG004|Overall Study|Withdrawal by Subject|0|||
13366453|NCT00848718|26702666|FG005|Overall Study|Withdrawal by Subject|0|||
13366454|NCT00848718|26702667|FG006|Overall Study|Withdrawal by Subject|0|||
13366455|NCT00848718|26702668|FG007|Overall Study|Withdrawal by Subject|0|||
13366456|NCT00848718|26702669|FG008|Overall Study|Withdrawal by Subject|0|||
13366457|NCT00848718|26702670|FG009|Overall Study|Withdrawal by Subject|0|||
13366458|NCT00848718|26702671|FG010|Overall Study|Withdrawal by Subject|1|||
13366459|NCT00848718|26702672|FG011|Overall Study|Withdrawal by Subject|0|||
13366460|NCT00848718|26702673|FG012|Overall Study|Withdrawal by Subject|0|||
13366461|NCT00848718|26702661|FG000|Overall Study|Progressive disease during treatment|3|||
13366462|NCT00848718|26702662|FG001|Overall Study|Progressive disease during treatment|0|||
13366463|NCT00848718|26702663|FG002|Overall Study|Progressive disease during treatment|3|||
13366464|NCT00848718|26702664|FG003|Overall Study|Progressive disease during treatment|0|||
13366465|NCT00848718|26702665|FG004|Overall Study|Progressive disease during treatment|0|||
13366466|NCT00848718|26702666|FG005|Overall Study|Progressive disease during treatment|0|||
13366467|NCT00848718|26702667|FG006|Overall Study|Progressive disease during treatment|0|||
13366468|NCT00848718|26702668|FG007|Overall Study|Progressive disease during treatment|2|||
13366469|NCT00848718|26702669|FG008|Overall Study|Progressive disease during treatment|0|||
13366470|NCT00848718|26702670|FG009|Overall Study|Progressive disease during treatment|0|||
13366471|NCT00848718|26702671|FG010|Overall Study|Progressive disease during treatment|0|||
13366472|NCT00848718|26702672|FG011|Overall Study|Progressive disease during treatment|0|||
13366473|NCT00848718|26702673|FG012|Overall Study|Progressive disease during treatment|2|||
13366474|NCT00848549|26702696|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31|||
13366475|NCT00848549|26702697|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35|||
13366476|NCT00848549|26702696|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35|||
13366477|NCT00848549|26702697|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24|||
13366478|NCT00848549|26702696|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
13366479|NCT00848549|26702697|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
13366480|NCT00848549|26702696|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3|||
13366481|NCT00848549|26702697|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8|||
13366482|NCT00848549|26702696|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4|||
13366483|NCT00848549|26702697|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5|||
13366484|NCT00848549|26702696|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21|||
13366485|NCT00848549|26702697|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11|||
13366486|NCT00848549|26702696|FG000|E2090-E044-310 (Base Study) Disposition|Other|4|||
13366487|NCT00848549|26702697|FG001|E2090-E044-310 (Base Study) Disposition|Other|3|||
13366488|NCT00848549|26702696|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24|||
13366489|NCT00848549|26702697|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34|||
13366490|NCT00848549|26702696|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2|||
13366491|NCT00848549|26702697|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1|||
13366492|NCT00848549|26702696|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1|||
13366493|NCT00848549|26702697|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2|||
13366494|NCT00848549|26702696|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8|||
13366495|NCT00848549|26702697|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12|||
13366496|NCT00848549|26702696|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
13366497|NCT00848549|26702697|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
13366498|NCT00848549|26702696|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0|||
13366499|NCT00848549|26702697|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2|||
13366500|NCT00848549|26702696|FG000|E2090-E044-314 (Extension Study)|Other|5|||
13366501|NCT00848549|26702697|FG001|E2090-E044-314 (Extension Study)|Other|6|||
13366502|NCT00848536|26702714|FG000|Overall Study|Adverse Event|2|||
13366503|NCT00848536|26702715|FG001|Overall Study|Adverse Event|2|||
13366504|NCT00848536|26702714|FG000|Overall Study|Withdrawal by Subject|0|||
13366505|NCT00848536|26702715|FG001|Overall Study|Withdrawal by Subject|1|||
13366506|NCT00848536|26702714|FG000|Overall Study|Protocol Violation|0|||
13366507|NCT00848536|26702715|FG001|Overall Study|Protocol Violation|1|||
13366508|NCT00848536|26702714|FG000|Overall Study|Noncompliance|1|||
13366509|NCT00848536|26702715|FG001|Overall Study|Noncompliance|0|||
13366510|NCT00848536|26702714|FG000|Overall Study|Inadequate Control of IOP|1|||
13366511|NCT00848536|26702715|FG001|Overall Study|Inadequate Control of IOP|1|||
13366512|NCT00848536|26702714|FG000|Overall Study|Patient Moved|0|||
13366513|NCT00848536|26702715|FG001|Overall Study|Patient Moved|2|||
13366514|NCT00848497|26702734|FG000|Overall Study|Screen failure|2|||
13366515|NCT00848497|26702735|FG001|Overall Study|Screen failure|0|||
13366516|NCT00848497|26702734|FG000|Overall Study|Withdrawal by Subject|0|||
13366517|NCT00848497|26702735|FG001|Overall Study|Withdrawal by Subject|1|||
13366518|NCT00848484|26702758|FG000|First Intervention (Treatment Period 1)|Adverse Event|2|||
13366519|NCT00848484|26702759|FG001|First Intervention (Treatment Period 1)|Adverse Event|1|||
13366520|NCT00848484|26702758|FG000|First Intervention (Treatment Period 1)|Physician Decision|0|||
13366521|NCT00848484|26702759|FG001|First Intervention (Treatment Period 1)|Physician Decision|1|||
13366522|NCT00848484|26702758|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0|||
13366523|NCT00848484|26702759|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1|||
13366524|NCT00848484|26702758|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0|||
13366525|NCT00848484|26702759|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3|||
13366526|NCT00848484|26702758|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0|||
13366527|NCT00848484|26702759|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1|||
13366528|NCT00848393|26702795|FG000|Overall Study|Protocol Violation|0|||
13366529|NCT00848393|26702796|FG001|Overall Study|Protocol Violation|0|||
13366530|NCT00848393|26702797|FG002|Overall Study|Protocol Violation|1|||
13366531|NCT00848393|26702795|FG000|Overall Study|surgical complications unrelated to stud|0|||
13366532|NCT00848393|26702796|FG001|Overall Study|surgical complications unrelated to stud|0|||
13366533|NCT00848393|26702797|FG002|Overall Study|surgical complications unrelated to stud|2|||
13366534|NCT00848354|26702954|FG000|Phase 1|Adverse Event|5|||
13366535|NCT00848354|26702955|FG001|Phase 1|Adverse Event|4|||
13366536|NCT00848354|26702954|FG000|Phase 1|Discontinuation of study by sponsor|2|||
13366537|NCT00848354|26702955|FG001|Phase 1|Discontinuation of study by sponsor|1|||
13366538|NCT00848354|26702954|FG000|Phase 1|Failed to return|0|||
13366539|NCT00848354|26702955|FG001|Phase 1|Failed to return|1|||
13366540|NCT00848354|26702954|FG000|Phase 1|Lost to Follow-up|1|||
13366541|NCT00848354|26702955|FG001|Phase 1|Lost to Follow-up|1|||
13366542|NCT00848354|26702954|FG000|Phase 1|Unspecified Reason|1|||
13366543|NCT00848354|26702955|FG001|Phase 1|Unspecified Reason|1|||
13366544|NCT00848354|26702954|FG000|Phase 1|Protocol Violation|1|||
13366545|NCT00848354|26702955|FG001|Phase 1|Protocol Violation|1|||
13366546|NCT00848354|26702954|FG000|Phase 1|Withdrawal by Subject|2|||
13366547|NCT00848354|26702955|FG001|Phase 1|Withdrawal by Subject|4|||
13366548|NCT00848354|26702954|FG000|Phase 1|Lack of Efficacy|0|||
13366549|NCT00848354|26702955|FG001|Phase 1|Lack of Efficacy|1|||
13366550|NCT00848354|26702954|FG000|Phase 2 Year 1|Adverse Event|7|||
13366551|NCT00848354|26702955|FG001|Phase 2 Year 1|Adverse Event|2|||
13366552|NCT00848354|26702954|FG000|Phase 2 Year 1|Death|1|||
13366553|NCT00848354|26702955|FG001|Phase 2 Year 1|Death|0|||
13366554|NCT00848354|26702954|FG000|Phase 2 Year 1|Failed to Return|1|||
13366555|NCT00848354|26702955|FG001|Phase 2 Year 1|Failed to Return|1|||
13366556|NCT00848354|26702954|FG000|Phase 2 Year 1|Lost to Follow-up|1|||
13366557|NCT00848354|26702955|FG001|Phase 2 Year 1|Lost to Follow-up|0|||
13366558|NCT00848354|26702954|FG000|Phase 2 Year 1|Unspecified Reason|3|||
13366559|NCT00848354|26702955|FG001|Phase 2 Year 1|Unspecified Reason|0|||
13366560|NCT00848354|26702954|FG000|Phase 2 Year 1|Protocol Violation|4|||
13366561|NCT00848354|26702955|FG001|Phase 2 Year 1|Protocol Violation|1|||
13366562|NCT00848354|26702954|FG000|Phase 2 Year 1|Subject Request|1|||
13366563|NCT00848354|26702955|FG001|Phase 2 Year 1|Subject Request|2|||
13366564|NCT00848354|26702954|FG000|Phase 2 Year 2|Adverse Event|12|||
13366565|NCT00848354|26702955|FG001|Phase 2 Year 2|Adverse Event|2|||
13366566|NCT00848354|26702954|FG000|Phase 2 Year 2|Death|2|||
13366567|NCT00848354|26702955|FG001|Phase 2 Year 2|Death|0|||
13366568|NCT00848354|26702954|FG000|Phase 2 Year 2|Failed to return|3|||
13366569|NCT00848354|26702955|FG001|Phase 2 Year 2|Failed to return|0|||
13366570|NCT00848354|26702954|FG000|Phase 2 Year 2|Lost to Follow-up|1|||
13366571|NCT00848354|26702955|FG001|Phase 2 Year 2|Lost to Follow-up|3|||
13366572|NCT00848354|26702954|FG000|Phase 2 Year 2|Unspecified Reason|1|||
13366573|NCT00848354|26702955|FG001|Phase 2 Year 2|Unspecified Reason|0|||
13366574|NCT00848354|26702954|FG000|Phase 2 Year 2|Protocol Violation|1|||
13366575|NCT00848354|26702955|FG001|Phase 2 Year 2|Protocol Violation|1|||
13366576|NCT00848354|26702954|FG000|Phase 2 Year 2|Subject Request|1|||
13366577|NCT00848354|26702955|FG001|Phase 2 Year 2|Subject Request|1|||
13366578|NCT00848354|26702954|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2|||
13366579|NCT00848354|26702955|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0|||
13366580|NCT00848250|26702980|FG000|Overall Study|surgery was completed without cardiopulm|0|||
13366581|NCT00848250|26702981|FG001|Overall Study|surgery was completed without cardiopulm|1|||
13366582|NCT00848211|26703012|FG000|Overall Study|Protocol Violation|0|||
13366583|NCT00848211|26703013|FG001|Overall Study|Protocol Violation|1|||
13366584|NCT00848211|26703014|FG002|Overall Study|Protocol Violation|1|||
13366585|NCT00848211|26703015|FG003|Overall Study|Protocol Violation|0|||
13366586|NCT00848211|26703012|FG000|Overall Study|Adverse Event|0|||
13366587|NCT00848211|26703013|FG001|Overall Study|Adverse Event|0|||
13366588|NCT00848211|26703014|FG002|Overall Study|Adverse Event|0|||
13366589|NCT00848211|26703015|FG003|Overall Study|Adverse Event|0|||
13366590|NCT00848198|26703055|FG000|Overall Study|Incomplete Case Report Forms|15|||
13366591|NCT00848120|26703069|FG000|Overall Study|Adverse Event|1|||
13366592|NCT00848107|26703079|FG000|Overall Study|Lost to Follow-up|2|||
13366593|NCT00848107|26703079|FG000|Overall Study|Withdrawal by Subject|8|||
13366594|NCT00848107|26703079|FG000|Overall Study|Adverse Event|9|||
13366595|NCT00848107|26703079|FG000|Overall Study|Death|1|||
13366596|NCT00848107|26703079|FG000|Overall Study|Pregnancy|1|||
13366597|NCT00848081|26703100|FG000|Overall Study|Adverse Event|6|||
13366598|NCT00848081|26703101|FG001|Overall Study|Adverse Event|7|||
13366599|NCT00848081|26703100|FG000|Overall Study|Protocol Violation|8|||
13366600|NCT00848081|26703101|FG001|Overall Study|Protocol Violation|5|||
13366601|NCT00848081|26703100|FG000|Overall Study|Lost to Follow-up|1|||
13366602|NCT00848081|26703101|FG001|Overall Study|Lost to Follow-up|0|||
13366603|NCT00848081|26703100|FG000|Overall Study|Physician Decision|0|||
13366604|NCT00848081|26703101|FG001|Overall Study|Physician Decision|3|||
13366605|NCT00848081|26703100|FG000|Overall Study|Withdrawal by Subject|5|||
13366606|NCT00848081|26703101|FG001|Overall Study|Withdrawal by Subject|3|||
13366607|NCT00848042|26703122|FG000|Overall Study|Death|1|||
13366608|NCT00848042|26703123|FG001|Overall Study|Death|2|||
13366609|NCT00848042|26703124|FG002|Overall Study|Death|0|||
13366610|NCT00848042|26703122|FG000|Overall Study|Other Therapy|3|||
13366611|NCT00848042|26703123|FG001|Overall Study|Other Therapy|0|||
13366612|NCT00848042|26703124|FG002|Overall Study|Other Therapy|0|||
13366613|NCT00847912|26703139|FG000|Overall Study|Protocol Violation|6|||
13366614|NCT00847912|26703140|FG001|Overall Study|Protocol Violation|7|||
13366615|NCT00847912|26703139|FG000|Overall Study|Withdrawal by Subject|3|||
13366616|NCT00847912|26703140|FG001|Overall Study|Withdrawal by Subject|6|||
13366617|NCT00847886|26703173|FG000|Overall Study|Adverse Event|0|||
13366618|NCT00847886|26703174|FG001|Overall Study|Adverse Event|1|||
13366619|NCT00847808|26703193|FG000|Overall Study|Adverse Event|7|||
13366620|NCT00847808|26703193|FG000|Overall Study|Protocol Violation|1|||
13366621|NCT00847808|26703193|FG000|Overall Study|Lost to Follow-up|1|||
13366622|NCT00847808|26703193|FG000|Overall Study|Withdrawal by Subject|4|||
13366623|NCT00847808|26703193|FG000|Overall Study|Participant Reported Lack of Efficacy|1|||
13366624|NCT00847808|26703193|FG000|Overall Study|Participant Took Excluded Medication|1|||
13366625|NCT00847730|26703199|FG000|Overall Study|Multiple interruptions in therapy|8|||
13366626|NCT00847704|26703210|FG000|Overall Study|Withdrawal by Subject|1|||
13366627|NCT00847665|26703229|FG000|Overall Study|Withdrawal by Subject|1|||
13366628|NCT00847665|26703230|FG001|Overall Study|Withdrawal by Subject|0|||
13366629|NCT00847626|26703459|FG000|Overall Study|Adverse Event|10|||
13366630|NCT00847626|26703460|FG001|Overall Study|Adverse Event|10|||
13366631|NCT00847626|26703461|FG002|Overall Study|Adverse Event|6|||
13366632|NCT00847626|26703462|FG003|Overall Study|Adverse Event|19|||
13366633|NCT00847626|26703463|FG004|Overall Study|Adverse Event|11|||
13366634|NCT00847626|26703464|FG005|Overall Study|Adverse Event|22|||
13366635|NCT00847626|26703465|FG006|Overall Study|Adverse Event|4|||
13366636|NCT00847626|26703466|FG007|Overall Study|Adverse Event|6|||
13366637|NCT00847626|26703467|FG008|Overall Study|Adverse Event|3|||
13366638|NCT00847626|26703468|FG009|Overall Study|Adverse Event|6|||
13366639|NCT00847626|26703469|FG010|Overall Study|Adverse Event|6|||
13366640|NCT00847626|26703459|FG000|Overall Study|Protocol Violation|2|||
13366641|NCT00847626|26703460|FG001|Overall Study|Protocol Violation|1|||
13366642|NCT00847626|26703461|FG002|Overall Study|Protocol Violation|2|||
13366643|NCT00847626|26703462|FG003|Overall Study|Protocol Violation|1|||
13366644|NCT00847626|26703463|FG004|Overall Study|Protocol Violation|1|||
13366645|NCT00847626|26703464|FG005|Overall Study|Protocol Violation|1|||
13366646|NCT00847626|26703465|FG006|Overall Study|Protocol Violation|1|||
13366647|NCT00847626|26703466|FG007|Overall Study|Protocol Violation|1|||
13366648|NCT00847626|26703467|FG008|Overall Study|Protocol Violation|0|||
13366649|NCT00847626|26703468|FG009|Overall Study|Protocol Violation|1|||
13366650|NCT00847626|26703469|FG010|Overall Study|Protocol Violation|1|||
13366651|NCT00847626|26703459|FG000|Overall Study|Lost to Follow-up|0|||
13366652|NCT00847626|26703460|FG001|Overall Study|Lost to Follow-up|1|||
13366653|NCT00847626|26703461|FG002|Overall Study|Lost to Follow-up|1|||
13366654|NCT00847626|26703462|FG003|Overall Study|Lost to Follow-up|1|||
13366655|NCT00847626|26703463|FG004|Overall Study|Lost to Follow-up|0|||
13366656|NCT00847626|26703464|FG005|Overall Study|Lost to Follow-up|3|||
13366657|NCT00847626|26703465|FG006|Overall Study|Lost to Follow-up|1|||
13366658|NCT00847626|26703466|FG007|Overall Study|Lost to Follow-up|3|||
13366659|NCT00847626|26703467|FG008|Overall Study|Lost to Follow-up|1|||
13366660|NCT00847626|26703468|FG009|Overall Study|Lost to Follow-up|0|||
13366661|NCT00847626|26703469|FG010|Overall Study|Lost to Follow-up|1|||
13366662|NCT00847626|26703459|FG000|Overall Study|Withdrawal by Subject|5|||
13366663|NCT00847626|26703460|FG001|Overall Study|Withdrawal by Subject|5|||
13366664|NCT00847626|26703461|FG002|Overall Study|Withdrawal by Subject|3|||
13366665|NCT00847626|26703462|FG003|Overall Study|Withdrawal by Subject|8|||
13366666|NCT00847626|26703463|FG004|Overall Study|Withdrawal by Subject|12|||
13366667|NCT00847626|26703464|FG005|Overall Study|Withdrawal by Subject|9|||
13366668|NCT00847626|26703465|FG006|Overall Study|Withdrawal by Subject|8|||
13366669|NCT00847626|26703466|FG007|Overall Study|Withdrawal by Subject|4|||
13366670|NCT00847626|26703467|FG008|Overall Study|Withdrawal by Subject|4|||
13366671|NCT00847626|26703468|FG009|Overall Study|Withdrawal by Subject|5|||
13366672|NCT00847626|26703469|FG010|Overall Study|Withdrawal by Subject|2|||
13366673|NCT00847626|26703459|FG000|Overall Study|Lack of Efficacy|3|||
13366674|NCT00847626|26703460|FG001|Overall Study|Lack of Efficacy|1|||
13366675|NCT00847626|26703461|FG002|Overall Study|Lack of Efficacy|0|||
13366676|NCT00847626|26703462|FG003|Overall Study|Lack of Efficacy|1|||
13366677|NCT00847626|26703463|FG004|Overall Study|Lack of Efficacy|2|||
13366678|NCT00847626|26703464|FG005|Overall Study|Lack of Efficacy|0|||
13366679|NCT00847626|26703465|FG006|Overall Study|Lack of Efficacy|6|||
13366680|NCT00847626|26703466|FG007|Overall Study|Lack of Efficacy|2|||
13366681|NCT00847626|26703467|FG008|Overall Study|Lack of Efficacy|5|||
13366682|NCT00847626|26703468|FG009|Overall Study|Lack of Efficacy|1|||
13366683|NCT00847626|26703469|FG010|Overall Study|Lack of Efficacy|7|||
13366684|NCT00847626|26703459|FG000|Overall Study|Other|1|||
13366685|NCT00847626|26703460|FG001|Overall Study|Other|5|||
13366686|NCT00847626|26703461|FG002|Overall Study|Other|4|||
13366687|NCT00847626|26703462|FG003|Overall Study|Other|1|||
13366688|NCT00847626|26703463|FG004|Overall Study|Other|2|||
13366689|NCT00847626|26703464|FG005|Overall Study|Other|2|||
13366690|NCT00847626|26703465|FG006|Overall Study|Other|2|||
13366691|NCT00847626|26703466|FG007|Overall Study|Other|3|||
13366692|NCT00847626|26703467|FG008|Overall Study|Other|1|||
13366693|NCT00847626|26703468|FG009|Overall Study|Other|1|||
13366694|NCT00847626|26703469|FG010|Overall Study|Other|3|||
13366695|NCT00847613|26703720|FG000|Overall Study|Ongoing at cut-off date|250|||
13366696|NCT00847613|26703721|FG001|Overall Study|Ongoing at cut-off date|265|||
13366697|NCT00847613|26703722|FG002|Overall Study|Ongoing at cut-off date|64|||
13366698|NCT00847613|26703723|FG003|Overall Study|Ongoing at cut-off date|64|||
13366699|NCT00847613|26703720|FG000|Overall Study|Death|1|||
13366700|NCT00847613|26703721|FG001|Overall Study|Death|1|||
13366701|NCT00847613|26703722|FG002|Overall Study|Death|0|||
13366702|NCT00847613|26703723|FG003|Overall Study|Death|0|||
13366703|NCT00847613|26703720|FG000|Overall Study|Adverse Event|36|||
13366704|NCT00847613|26703721|FG001|Overall Study|Adverse Event|26|||
13366705|NCT00847613|26703722|FG002|Overall Study|Adverse Event|5|||
13366706|NCT00847613|26703723|FG003|Overall Study|Adverse Event|6|||
13366707|NCT00847613|26703720|FG000|Overall Study|Lack of Efficacy|7|||
13366708|NCT00847613|26703721|FG001|Overall Study|Lack of Efficacy|3|||
13366709|NCT00847613|26703722|FG002|Overall Study|Lack of Efficacy|3|||
13366710|NCT00847613|26703723|FG003|Overall Study|Lack of Efficacy|1|||
13366711|NCT00847613|26703720|FG000|Overall Study|Study terminated by Sponsor|1|||
13366712|NCT00847613|26703721|FG001|Overall Study|Study terminated by Sponsor|0|||
13366713|NCT00847613|26703722|FG002|Overall Study|Study terminated by Sponsor|2|||
13366714|NCT00847613|26703723|FG003|Overall Study|Study terminated by Sponsor|1|||
13366715|NCT00847613|26703720|FG000|Overall Study|Lost to Follow-up|5|||
13366716|NCT00847613|26703721|FG001|Overall Study|Lost to Follow-up|0|||
13366717|NCT00847613|26703722|FG002|Overall Study|Lost to Follow-up|0|||
13366718|NCT00847613|26703723|FG003|Overall Study|Lost to Follow-up|3|||
13366719|NCT00847613|26703720|FG000|Overall Study|Protocol Violation|6|||
13366720|NCT00847613|26703721|FG001|Overall Study|Protocol Violation|6|||
13366721|NCT00847613|26703722|FG002|Overall Study|Protocol Violation|3|||
13366722|NCT00847613|26703723|FG003|Overall Study|Protocol Violation|1|||
13366723|NCT00847613|26703720|FG000|Overall Study|Pregnancy|1|||
13366724|NCT00847613|26703721|FG001|Overall Study|Pregnancy|1|||
13366725|NCT00847613|26703722|FG002|Overall Study|Pregnancy|0|||
13366726|NCT00847613|26703723|FG003|Overall Study|Pregnancy|0|||
13366727|NCT00847613|26703720|FG000|Overall Study|Site closure|1|||
13366728|NCT00847613|26703721|FG001|Overall Study|Site closure|0|||
13366729|NCT00847613|26703722|FG002|Overall Study|Site closure|0|||
13366730|NCT00847613|26703723|FG003|Overall Study|Site closure|1|||
13366731|NCT00847613|26703720|FG000|Overall Study|Withdrawal by Subject|8|||
13366732|NCT00847613|26703721|FG001|Overall Study|Withdrawal by Subject|11|||
13366733|NCT00847613|26703722|FG002|Overall Study|Withdrawal by Subject|2|||
13366734|NCT00847613|26703723|FG003|Overall Study|Withdrawal by Subject|2|||
13366735|NCT00847613|26703720|FG000|Overall Study|Participant moved|4|||
13366736|NCT00847613|26703721|FG001|Overall Study|Participant moved|1|||
13366737|NCT00847613|26703722|FG002|Overall Study|Participant moved|0|||
13366738|NCT00847613|26703723|FG003|Overall Study|Participant moved|0|||
13366739|NCT00847613|26703720|FG000|Overall Study|Sponsor request|0|||
13366740|NCT00847613|26703721|FG001|Overall Study|Sponsor request|1|||
13366741|NCT00847613|26703722|FG002|Overall Study|Sponsor request|0|||
13366742|NCT00847613|26703723|FG003|Overall Study|Sponsor request|0|||
13366743|NCT00847613|26703720|FG000|Overall Study|Randomized, but not treated|0|||
13366744|NCT00847613|26703721|FG001|Overall Study|Randomized, but not treated|3|||
13366745|NCT00847613|26703722|FG002|Overall Study|Randomized, but not treated|0|||
13366746|NCT00847613|26703723|FG003|Overall Study|Randomized, but not treated|0|||
13366747|NCT00847613|26703720|FG000|Overall Study|Other|1|||
13366748|NCT00847613|26703721|FG001|Overall Study|Other|1|||
13366749|NCT00847613|26703722|FG002|Overall Study|Other|2|||
13366750|NCT00847613|26703723|FG003|Overall Study|Other|0|||
13366751|NCT00847561|26703736|FG000|Overall Study|Withdrawal by Subject|4|||
13366752|NCT00847561|26703737|FG001|Overall Study|Withdrawal by Subject|3|||
13366753|NCT00847561|26703736|FG000|Overall Study|Unable to schedule|9|||
13366754|NCT00847561|26703737|FG001|Overall Study|Unable to schedule|1|||
13366755|NCT00847535|26703749|FG000|Overall Study|Withdrawal by Subject|2|||
13366756|NCT00847535|26703750|FG001|Overall Study|Withdrawal by Subject|1|||
13366757|NCT00847535|26703751|FG002|Overall Study|Withdrawal by Subject|1|||
13366758|NCT00847535|26703749|FG000|Overall Study|Lost to Follow-up|0|||
13366759|NCT00847535|26703750|FG001|Overall Study|Lost to Follow-up|1|||
13366760|NCT00847535|26703751|FG002|Overall Study|Lost to Follow-up|0|||
13366761|NCT00847405|26703766|FG000|First Intervention|Adverse Event|0|||
13366762|NCT00847405|26703767|FG001|First Intervention|Adverse Event|1|||
13366763|NCT00847405|26703766|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
13366764|NCT00847405|26703767|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
13366765|NCT00847379|26703875|FG000|Overall Study|Study terminated by Sponsor|59|||
13366766|NCT00847379|26703876|FG001|Overall Study|Study terminated by Sponsor|57|||
13366767|NCT00847379|26703877|FG002|Overall Study|Study terminated by Sponsor|57|||
13366768|NCT00847301|26703887|FG000|Overall Study|Adverse Event|35|||
13366769|NCT00847301|26703887|FG000|Overall Study|Switch to other anticoagulants|16|||
13366770|NCT00847301|26703887|FG000|Overall Study|Lost to Follow-up|1|||
13366771|NCT00847301|26703887|FG000|Overall Study|No prescription after hospital discharge|1|||
13366772|NCT00847301|26703887|FG000|Overall Study|Other reason not defined above|1|||
13366773|NCT00847197|26703904|FG000|Overall Study|Adverse Event|21|||
13366774|NCT00847197|26703905|FG001|Overall Study|Adverse Event|3|||
13366775|NCT00847197|26703904|FG000|Overall Study|Protocol Violation|0|||
13366776|NCT00847197|26703905|FG001|Overall Study|Protocol Violation|1|||
13366777|NCT00847197|26703904|FG000|Overall Study|Withdrawal by Subject|3|||
13366778|NCT00847197|26703905|FG001|Overall Study|Withdrawal by Subject|1|||
13366779|NCT00847145|26703978|FG000|Overall Study|AE or Death|0|||
13366780|NCT00847145|26703979|FG001|Overall Study|AE or Death|1|||
13366781|NCT00847145|26703980|FG002|Overall Study|AE or Death|1|||
13366782|NCT00847145|26703981|FG003|Overall Study|AE or Death|0|||
13366783|NCT00847145|26703982|FG004|Overall Study|AE or Death|0|||
13366784|NCT00847145|26703983|FG005|Overall Study|AE or Death|0|||
13366785|NCT00847145|26703984|FG006|Overall Study|AE or Death|0|||
13366786|NCT00847145|26703985|FG007|Overall Study|AE or Death|0|||
13366787|NCT00847145|26703978|FG000|Overall Study|Withdrawal by Subject|3|||
13366788|NCT00847145|26703979|FG001|Overall Study|Withdrawal by Subject|4|||
13366789|NCT00847145|26703980|FG002|Overall Study|Withdrawal by Subject|6|||
13366790|NCT00847145|26703981|FG003|Overall Study|Withdrawal by Subject|1|||
13366791|NCT00847145|26703982|FG004|Overall Study|Withdrawal by Subject|0|||
13366792|NCT00847145|26703983|FG005|Overall Study|Withdrawal by Subject|0|||
13366793|NCT00847145|26703984|FG006|Overall Study|Withdrawal by Subject|1|||
13366794|NCT00847145|26703985|FG007|Overall Study|Withdrawal by Subject|1|||
13366795|NCT00847145|26703978|FG000|Overall Study|Lost to Follow-up|3|||
13366796|NCT00847145|26703979|FG001|Overall Study|Lost to Follow-up|1|||
13366797|NCT00847145|26703980|FG002|Overall Study|Lost to Follow-up|1|||
13366798|NCT00847145|26703981|FG003|Overall Study|Lost to Follow-up|0|||
13366799|NCT00847145|26703982|FG004|Overall Study|Lost to Follow-up|4|||
13366800|NCT00847145|26703983|FG005|Overall Study|Lost to Follow-up|4|||
13366801|NCT00847145|26703984|FG006|Overall Study|Lost to Follow-up|8|||
13366802|NCT00847145|26703985|FG007|Overall Study|Lost to Follow-up|2|||
13366803|NCT00847145|26703978|FG000|Overall Study|Inappropriate enrollment|0|||
13366804|NCT00847145|26703979|FG001|Overall Study|Inappropriate enrollment|0|||
13366805|NCT00847145|26703980|FG002|Overall Study|Inappropriate enrollment|0|||
13366806|NCT00847145|26703981|FG003|Overall Study|Inappropriate enrollment|0|||
13366807|NCT00847145|26703982|FG004|Overall Study|Inappropriate enrollment|1|||
13366808|NCT00847145|26703983|FG005|Overall Study|Inappropriate enrollment|0|||
13366809|NCT00847145|26703984|FG006|Overall Study|Inappropriate enrollment|0|||
13366810|NCT00847145|26703985|FG007|Overall Study|Inappropriate enrollment|0|||
13366811|NCT00847145|26703978|FG000|Overall Study|Protocol Violation|0|||
13366812|NCT00847145|26703979|FG001|Overall Study|Protocol Violation|0|||
13366813|NCT00847145|26703980|FG002|Overall Study|Protocol Violation|3|||
13366814|NCT00847145|26703981|FG003|Overall Study|Protocol Violation|0|||
13366815|NCT00847145|26703982|FG004|Overall Study|Protocol Violation|1|||
13366816|NCT00847145|26703983|FG005|Overall Study|Protocol Violation|0|||
13366817|NCT00847145|26703984|FG006|Overall Study|Protocol Violation|0|||
13366818|NCT00847145|26703985|FG007|Overall Study|Protocol Violation|1|||
13366819|NCT00847132|26704000|FG000|Overall Study|Death|1|||
13366820|NCT00847132|26704001|FG001|Overall Study|Death|1|||
13366821|NCT00847015|26704009|FG000|Overall Study|Withdrawal by Subject|1|||
13366822|NCT00847015|26704009|FG000|Overall Study|declined any surgery|1|||
13366823|NCT00847015|26704009|FG000|Overall Study|partial cystectomy vs radical cystectomy|1|||
13366824|NCT00846846|26704016|FG000|Overall Study|Death|56|||
13366825|NCT00846846|26704016|FG000|Overall Study|Withdrawal by Subject|19|||
13366826|NCT00846807|26704026|FG000|Overall Study|Adverse Event|270|||
13366827|NCT00846807|26704026|FG000|Overall Study|Lost to Follow-up|94|||
13366828|NCT00846807|26704026|FG000|Overall Study|Withdrawal by Subject|56|||
13366829|NCT00846807|26704026|FG000|Overall Study|Non compliant with European label|7|||
13366830|NCT00846807|26704026|FG000|Overall Study|Switch to other anticoagulants|89|||
13366831|NCT00846807|26704026|FG000|Overall Study|No prescription after hospital discharge|56|||
13366832|NCT00846807|26704026|FG000|Overall Study|Other|60|||
13366833|NCT00846768|26704101|FG000|Overall Study|Adverse Event|0|||
13366834|NCT00846768|26704102|FG001|Overall Study|Adverse Event|1|||
13366835|NCT00846768|26704103|FG002|Overall Study|Adverse Event|0|||
13366836|NCT00846768|26704104|FG003|Overall Study|Adverse Event|0|||
13366837|NCT00846742|26704112|FG000|Overall Study|Withdrawal by Subject|1|||
13366838|NCT00846586|26704135|FG000|Overall Study|Adverse Event|20|||
13366839|NCT00846586|26704136|FG001|Overall Study|Adverse Event|10|||
13366840|NCT00846586|26704135|FG000|Overall Study|Subject withdrew consent|8|||
13366841|NCT00846586|26704136|FG001|Overall Study|Subject withdrew consent|10|||
13366842|NCT00846586|26704135|FG000|Overall Study|Administrative problems|5|||
13366843|NCT00846586|26704136|FG001|Overall Study|Administrative problems|4|||
13366844|NCT00846586|26704135|FG000|Overall Study|Death|2|||
13366845|NCT00846586|26704136|FG001|Overall Study|Death|0|||
13366846|NCT00846586|26704135|FG000|Overall Study|Protocol deviation|2|||
13366847|NCT00846586|26704136|FG001|Overall Study|Protocol deviation|6|||
13366848|NCT00846586|26704135|FG000|Overall Study|Abnormal test procedure result(s)|1|||
13366849|NCT00846586|26704136|FG001|Overall Study|Abnormal test procedure result(s)|0|||
13366850|NCT00846586|26704135|FG000|Overall Study|Lost to Follow-up|1|||
13366851|NCT00846586|26704136|FG001|Overall Study|Lost to Follow-up|4|||
13366852|NCT00846586|26704135|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
13366853|NCT00846586|26704136|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
13366854|NCT00846521|26704143|FG000|Overall Study|Withdrawal by Subject|5|||
13366855|NCT00846521|26704143|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5|||
13366856|NCT00846521|26704143|FG000|Overall Study|Protocol Violation|1|||
13366857|NCT00846495|26704170|FG000|Overall Study|Lost to Follow-up|1|||
13366858|NCT00846495|26704171|FG001|Overall Study|Lost to Follow-up|0|||
13366859|NCT00846495|26704170|FG000|Overall Study|Adverse Event|5|||
13366860|NCT00846495|26704171|FG001|Overall Study|Adverse Event|1|||
13366861|NCT00846495|26704170|FG000|Overall Study|Lack of Efficacy|1|||
13366862|NCT00846495|26704171|FG001|Overall Study|Lack of Efficacy|2|||
13366863|NCT00846495|26704170|FG000|Overall Study|Physician Decision|1|||
13366864|NCT00846495|26704171|FG001|Overall Study|Physician Decision|0|||
13366865|NCT00846391|26704189|FG000|Overall Study|Physician Decision|0|||
13366866|NCT00846391|26704190|FG001|Overall Study|Physician Decision|0|||
13366867|NCT00846391|26704191|FG002|Overall Study|Physician Decision|1|||
13366868|NCT00846391|26704189|FG000|Overall Study|Study Terminated by Sponsor|1|||
13366869|NCT00846391|26704190|FG001|Overall Study|Study Terminated by Sponsor|2|||
13366870|NCT00846391|26704191|FG002|Overall Study|Study Terminated by Sponsor|2|||
13366871|NCT00846365|26704254|FG000|Overall Study|Adverse Event|20|||
13366872|NCT00846365|26704255|FG001|Overall Study|Adverse Event|30|||
13366873|NCT00846365|26704256|FG002|Overall Study|Adverse Event|11|||
13366874|NCT00846365|26704254|FG000|Overall Study|Protocol Violation|5|||
13366875|NCT00846365|26704255|FG001|Overall Study|Protocol Violation|4|||
13366876|NCT00846365|26704256|FG002|Overall Study|Protocol Violation|0|||
13204477|NCT01972841|26229049|FG001|Overall Study|Did not have end of treatment page|0|||
13366877|NCT00846365|26704254|FG000|Overall Study|Lost to Follow-up|8|||
13366878|NCT00846365|26704255|FG001|Overall Study|Lost to Follow-up|2|||
13366879|NCT00846365|26704256|FG002|Overall Study|Lost to Follow-up|5|||
13366880|NCT00846365|26704254|FG000|Overall Study|Withdrawal by Subject|11|||
13366881|NCT00846365|26704255|FG001|Overall Study|Withdrawal by Subject|11|||
13366882|NCT00846365|26704256|FG002|Overall Study|Withdrawal by Subject|9|||
13366883|NCT00846365|26704254|FG000|Overall Study|Pregnancy|1|||
13366884|NCT00846365|26704255|FG001|Overall Study|Pregnancy|0|||
13366885|NCT00846365|26704256|FG002|Overall Study|Pregnancy|0|||
13366886|NCT00846365|26704254|FG000|Overall Study|Lack of Efficacy|1|||
13366887|NCT00846365|26704255|FG001|Overall Study|Lack of Efficacy|1|||
13366888|NCT00846365|26704256|FG002|Overall Study|Lack of Efficacy|2|||
13366889|NCT00846365|26704254|FG000|Overall Study|Other|9|||
13366890|NCT00846365|26704255|FG001|Overall Study|Other|1|||
13366891|NCT00846365|26704256|FG002|Overall Study|Other|6|||
13366892|NCT00846053|26704271|FG000|Overall Study|Physician Decision|3|||
13366893|NCT00846053|26704272|FG001|Overall Study|Physician Decision|0|||
13366894|NCT00846040|26704299|FG000|Baseline: Days 1-5|Withdrawal by Subject|1|||
13366895|NCT00846040|26704300|FG001|Baseline: Days 1-5|Withdrawal by Subject|0|||
13366896|NCT00846040|26704301|FG002|Baseline: Days 1-5|Withdrawal by Subject|0|||
13366897|NCT00846040|26704299|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
13366898|NCT00846040|26704300|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2|||
13366899|NCT00846040|26704301|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
13366900|NCT00846027|26704310|FG000|Overall Study|Death|3|||
13366901|NCT00846027|26704310|FG000|Overall Study|Disease Progression|30|||
13366902|NCT00846027|26704310|FG000|Overall Study|Toxicity|12|||
13366903|NCT00846027|26704310|FG000|Overall Study|Patient Decision|7|||
13366904|NCT00846027|26704310|FG000|Overall Study|Investigator Discretion|29|||
13366905|NCT00846027|26704310|FG000|Overall Study|Protocol Violation|2|||
13366906|NCT00846027|26704310|FG000|Overall Study|Subject Not Treated|7|||
13366907|NCT00845897|26704331|FG000|Overall Study|Lost to Follow-up|1|||
13366908|NCT00845897|26704332|FG001|Overall Study|Lost to Follow-up|1|||
13366909|NCT00845897|26704333|FG002|Overall Study|Lost to Follow-up|0|||
13366910|NCT00845897|26704331|FG000|Overall Study|Withdrawal by Subject|0|||
13366911|NCT00845897|26704332|FG001|Overall Study|Withdrawal by Subject|3|||
13366912|NCT00845897|26704333|FG002|Overall Study|Withdrawal by Subject|2|||
13366913|NCT00845897|26704331|FG000|Overall Study|Ulcer did not heal|1|||
13366914|NCT00845897|26704332|FG001|Overall Study|Ulcer did not heal|0|||
13366915|NCT00845897|26704333|FG002|Overall Study|Ulcer did not heal|1|||
13366916|NCT00845897|26704331|FG000|Overall Study|Too ill to participate|0|||
13366917|NCT00845897|26704332|FG001|Overall Study|Too ill to participate|1|||
13366918|NCT00845897|26704333|FG002|Overall Study|Too ill to participate|0|||
13366919|NCT00845871|26704360|FG000|Assessment Period|Adverse Event|2|||
13366920|NCT00845871|26704360|FG000|Assessment Period|Abnormal laboratory values|1|||
13366921|NCT00845871|26704360|FG000|Assessment Period|Abnormal test procedure results|1|||
13366922|NCT00845871|26704360|FG000|Assessment Period|Patient withdrew consent|3|||
13366923|NCT00845858|26704381|FG000|Overall Study|Withdrawal by Subject|5|||
13366924|NCT00845858|26704382|FG001|Overall Study|Withdrawal by Subject|1|||
13366925|NCT00845858|26704383|FG002|Overall Study|Withdrawal by Subject|1|||
13366926|NCT00845858|26704381|FG000|Overall Study|Adverse Event|3|||
13366927|NCT00845858|26704382|FG001|Overall Study|Adverse Event|8|||
13366928|NCT00845858|26704383|FG002|Overall Study|Adverse Event|4|||
13366929|NCT00845858|26704381|FG000|Overall Study|Protocol Violation|0|||
13366930|NCT00845858|26704382|FG001|Overall Study|Protocol Violation|0|||
13366931|NCT00845858|26704383|FG002|Overall Study|Protocol Violation|1|||
13366932|NCT00845858|26704381|FG000|Overall Study|not eligible|0|||
13366933|NCT00845858|26704382|FG001|Overall Study|not eligible|3|||
13366934|NCT00845858|26704383|FG002|Overall Study|not eligible|2|||
13366935|NCT00845845|26704398|FG000|Overall Study|Lost to Follow-up|0|||
13366936|NCT00845845|26704399|FG001|Overall Study|Lost to Follow-up|4|||
13366937|NCT00845832|26704453|FG000|Treatment Period|Adverse Event|0|||
13366938|NCT00845832|26704454|FG001|Treatment Period|Adverse Event|2|||
13366939|NCT00845832|26704455|FG002|Treatment Period|Adverse Event|0|||
13366940|NCT00845832|26704453|FG000|Treatment Period|Protocol Violation|1|||
13366941|NCT00845832|26704454|FG001|Treatment Period|Protocol Violation|1|||
13366942|NCT00845832|26704455|FG002|Treatment Period|Protocol Violation|0|||
13366943|NCT00845832|26704453|FG000|Safety Follow-Up|Withdrawal by Subject|1|||
13366944|NCT00845832|26704454|FG001|Safety Follow-Up|Withdrawal by Subject|0|||
13366945|NCT00845832|26704455|FG002|Safety Follow-Up|Withdrawal by Subject|0|||
13366946|NCT00845832|26704453|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0|||
13366947|NCT00845832|26704454|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0|||
13366948|NCT00845832|26704455|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7|||
13366949|NCT00845728|26704470|FG000|Overall Study|Abnormal laboratory value (s)|2|||
13366950|NCT00845728|26704471|FG001|Overall Study|Abnormal laboratory value (s)|2|||
13366951|NCT00845728|26704470|FG000|Overall Study|Patient's inability to use the device|4|||
13366952|NCT00845728|26704471|FG001|Overall Study|Patient's inability to use the device|6|||
13366953|NCT00845728|26704470|FG000|Overall Study|Abnormal test procedure result (s)|7|||
13366954|NCT00845728|26704471|FG001|Overall Study|Abnormal test procedure result (s)|2|||
13366955|NCT00845728|26704470|FG000|Overall Study|Lost to Follow-up|22|||
13366956|NCT00845728|26704471|FG001|Overall Study|Lost to Follow-up|13|||
13366957|NCT00845728|26704470|FG000|Overall Study|Death|24|||
13366958|NCT00845728|26704471|FG001|Overall Study|Death|26|||
13366959|NCT00845728|26704470|FG000|Overall Study|Administrative Problems|34|||
13366960|NCT00845728|26704471|FG001|Overall Study|Administrative Problems|26|||
13366961|NCT00845728|26704470|FG000|Overall Study|Protocol Violation|36|||
13366962|NCT00845728|26704471|FG001|Overall Study|Protocol Violation|24|||
13366963|NCT00845728|26704470|FG000|Overall Study|Lack of Efficacy|51|||
13366964|NCT00845728|26704471|FG001|Overall Study|Lack of Efficacy|39|||
13366965|NCT00845728|26704470|FG000|Overall Study|Adverse Event|101|||
13366966|NCT00845728|26704471|FG001|Overall Study|Adverse Event|96|||
13366967|NCT00845728|26704470|FG000|Overall Study|Withdrawal by Subject|105|||
13366968|NCT00845728|26704471|FG001|Overall Study|Withdrawal by Subject|108|||
13366969|NCT00845676|26704479|FG000|Overall Study|Virologic breakthrough at week 20|1|||
13366970|NCT00845676|26704479|FG000|Overall Study|Adverse Event|1|||
13366971|NCT00845650|26704533|FG000|Overall Study|Withdrawal by Subject|0|||
13366972|NCT00845650|26704534|FG001|Overall Study|Withdrawal by Subject|0|||
13366973|NCT00845650|26704535|FG002|Overall Study|Withdrawal by Subject|0|||
13366974|NCT00845650|26704536|FG003|Overall Study|Withdrawal by Subject|0|||
13366975|NCT00845650|26704537|FG004|Overall Study|Withdrawal by Subject|2|||
13366976|NCT00845650|26704538|FG005|Overall Study|Withdrawal by Subject|0|||
13366977|NCT00845650|26704533|FG000|Overall Study|Lost to Follow-up|0|||
13366978|NCT00845650|26704534|FG001|Overall Study|Lost to Follow-up|0|||
13366979|NCT00845650|26704535|FG002|Overall Study|Lost to Follow-up|3|||
13366980|NCT00845650|26704536|FG003|Overall Study|Lost to Follow-up|1|||
13366981|NCT00845650|26704537|FG004|Overall Study|Lost to Follow-up|0|||
13366982|NCT00845650|26704538|FG005|Overall Study|Lost to Follow-up|1|||
13366983|NCT00845650|26704533|FG000|Overall Study|Sponsor hold on dosing|0|||
13366984|NCT00845650|26704534|FG001|Overall Study|Sponsor hold on dosing|0|||
13366985|NCT00845650|26704535|FG002|Overall Study|Sponsor hold on dosing|0|||
13366986|NCT00845650|26704536|FG003|Overall Study|Sponsor hold on dosing|0|||
13366987|NCT00845650|26704537|FG004|Overall Study|Sponsor hold on dosing|1|||
13366988|NCT00845650|26704538|FG005|Overall Study|Sponsor hold on dosing|1|||
13366989|NCT00845650|26704533|FG000|Overall Study|Unable to access IV line|1|||
13366990|NCT00845650|26704534|FG001|Overall Study|Unable to access IV line|0|||
13366991|NCT00845650|26704535|FG002|Overall Study|Unable to access IV line|0|||
13366992|NCT00845650|26704536|FG003|Overall Study|Unable to access IV line|0|||
13366993|NCT00845650|26704537|FG004|Overall Study|Unable to access IV line|0|||
13366994|NCT00845650|26704538|FG005|Overall Study|Unable to access IV line|0|||
13366995|NCT00845520|26704562|FG000|Overall Study|Death|1|||
13366996|NCT00845520|26704563|FG001|Overall Study|Death|2|||
13366997|NCT00845520|26704564|FG002|Overall Study|Death|0|||
13366998|NCT00845520|26704562|FG000|Overall Study|Lost to Follow-up|1|||
13366999|NCT00845520|26704563|FG001|Overall Study|Lost to Follow-up|0|||
13367000|NCT00845520|26704564|FG002|Overall Study|Lost to Follow-up|0|||
13367001|NCT00845520|26704562|FG000|Overall Study|Adverse Event|0|||
13367002|NCT00845520|26704563|FG001|Overall Study|Adverse Event|0|||
13367003|NCT00845520|26704564|FG002|Overall Study|Adverse Event|1|||
13367004|NCT00845429|26704591|FG000|Overall Study|Protocol Violation|5|||
13367005|NCT00845429|26704592|FG001|Overall Study|Protocol Violation|4|||
13367006|NCT00845429|26704593|FG002|Overall Study|Protocol Violation|7|||
13367007|NCT00845429|26704591|FG000|Overall Study|Lost to Follow-up|7|||
13367008|NCT00845429|26704592|FG001|Overall Study|Lost to Follow-up|9|||
13367009|NCT00845429|26704593|FG002|Overall Study|Lost to Follow-up|10|||
13367010|NCT00845429|26704591|FG000|Overall Study|Withdrawal by Subject|2|||
13367011|NCT00845429|26704592|FG001|Overall Study|Withdrawal by Subject|2|||
13367012|NCT00845429|26704593|FG002|Overall Study|Withdrawal by Subject|2|||
13367013|NCT00845429|26704591|FG000|Overall Study|Serious adverse event|0|||
13367014|NCT00845429|26704592|FG001|Overall Study|Serious adverse event|0|||
13367015|NCT00845429|26704593|FG002|Overall Study|Serious adverse event|1|||
13367016|NCT00845182|26704615|FG000|Overall Study|Lost to Follow-up|3|||
13367017|NCT00845182|26704616|FG001|Overall Study|Lost to Follow-up|3|||
13367018|NCT00845182|26704617|FG002|Overall Study|Lost to Follow-up|4|||
13367019|NCT00845182|26704615|FG000|Overall Study|Adverse Event|0|||
13367020|NCT00845182|26704616|FG001|Overall Study|Adverse Event|1|||
13367021|NCT00845182|26704617|FG002|Overall Study|Adverse Event|1|||
13367022|NCT00845182|26704615|FG000|Overall Study|Physician Decision|0|||
13367023|NCT00845182|26704616|FG001|Overall Study|Physician Decision|0|||
13367024|NCT00845182|26704617|FG002|Overall Study|Physician Decision|1|||
13367025|NCT00845065|26704638|FG000|Overall Study|Adverse Event|3|||
13367026|NCT00845065|26704639|FG001|Overall Study|Adverse Event|23|||
13367027|NCT00845065|26704638|FG000|Overall Study|Lack of Efficacy|43|||
13367028|NCT00845065|26704639|FG001|Overall Study|Lack of Efficacy|21|||
13367029|NCT00845065|26704638|FG000|Overall Study|Non-Medical Reasons|1|||
13367030|NCT00845065|26704639|FG001|Overall Study|Non-Medical Reasons|11|||
13367031|NCT00844896|26704668|FG000|Overall Study|Lost to Follow-up|12|||
13367032|NCT00844896|26704669|FG001|Overall Study|Lost to Follow-up|16|||
13367033|NCT00844896|26704668|FG000|Overall Study|Parents did not have time to complete|0|||
13367034|NCT00844896|26704669|FG001|Overall Study|Parents did not have time to complete|1|||
13367035|NCT00844883|26704684|FG000|Overall Study|Bridged to liver transplant|3|||
13367036|NCT00844883|26704684|FG000|Overall Study|Bridged to resection|1|||
13367037|NCT00844857|26704735|FG000|Overall Study|Adverse Event|24|||
13367038|NCT00844857|26704736|FG001|Overall Study|Adverse Event|5|||
13367039|NCT00844857|26704735|FG000|Overall Study|Sponsor Decision|1|||
13367040|NCT00844857|26704736|FG001|Overall Study|Sponsor Decision|1|||
13367041|NCT00844857|26704735|FG000|Overall Study|Physician Decision|2|||
13367042|NCT00844857|26704736|FG001|Overall Study|Physician Decision|0|||
13367043|NCT00844857|26704735|FG000|Overall Study|Parent/Caregiver Decision|6|||
13367044|NCT00844857|26704736|FG001|Overall Study|Parent/Caregiver Decision|2|||
13367045|NCT00844857|26704735|FG000|Overall Study|Withdrawal by Subject|8|||
13367046|NCT00844857|26704736|FG001|Overall Study|Withdrawal by Subject|7|||
13367047|NCT00844857|26704735|FG000|Overall Study|Protocol Violation|6|||
13367048|NCT00844857|26704736|FG001|Overall Study|Protocol Violation|0|||
13367049|NCT00844857|26704735|FG000|Overall Study|Lack of Efficacy|5|||
13367050|NCT00844857|26704736|FG001|Overall Study|Lack of Efficacy|5|||
13367051|NCT00844857|26704735|FG000|Overall Study|Clinical Relapse|0|||
13367052|NCT00844857|26704736|FG001|Overall Study|Clinical Relapse|1|||
13367053|NCT00844857|26704735|FG000|Overall Study|Entry Criteria Not Met|0|||
13367054|NCT00844857|26704736|FG001|Overall Study|Entry Criteria Not Met|1|||
13367055|NCT00844857|26704735|FG000|Overall Study|Lost to Follow-up|2|||
13367056|NCT00844857|26704736|FG001|Overall Study|Lost to Follow-up|3|||
13367057|NCT00844857|26704735|FG000|Overall Study|Did Not Take Study Drug|3|||
13367058|NCT00844857|26704736|FG001|Overall Study|Did Not Take Study Drug|1|||
13367059|NCT00844857|26704735|FG000|Overall Study|Good Clinical Practice Violations|21|||
13367060|NCT00844857|26704736|FG001|Overall Study|Good Clinical Practice Violations|11|||
13367061|NCT00844844|26704752|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
13367062|NCT00844844|26704752|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
13367063|NCT00844844|26704752|FG000|Extension Treatment Period|Adverse Event|2|||
13367064|NCT00844844|26704752|FG000|Post Treatment Period|Withdrawal by Subject|1|||
13367065|NCT00844831|26704762|FG000|Overall Study|Withdrawal by Subject|4|||
13367066|NCT00844831|26704762|FG000|Overall Study|Adverse Event|1|||
13367067|NCT00844831|26704762|FG000|Overall Study|Physician Decision|1|||
13367068|NCT00844805|26704811|FG000|Treatment Phase|Adverse Event|5|||
13367069|NCT00844805|26704812|FG001|Treatment Phase|Adverse Event|1|||
13367070|NCT00844805|26704813|FG002|Treatment Phase|Adverse Event|0|||
13367071|NCT00844805|26704814|FG003|Treatment Phase|Adverse Event|0|||
13367072|NCT00844805|26704811|FG000|Treatment Phase|Withdrawal by Subject|3|||
13367073|NCT00844805|26704812|FG001|Treatment Phase|Withdrawal by Subject|4|||
13367074|NCT00844805|26704813|FG002|Treatment Phase|Withdrawal by Subject|0|||
13367075|NCT00844805|26704814|FG003|Treatment Phase|Withdrawal by Subject|0|||
13367076|NCT00844805|26704811|FG000|Treatment Phase|Noncompliance With Protocol|1|||
13367077|NCT00844805|26704812|FG001|Treatment Phase|Noncompliance With Protocol|0|||
13367078|NCT00844805|26704813|FG002|Treatment Phase|Noncompliance With Protocol|0|||
13367079|NCT00844805|26704814|FG003|Treatment Phase|Noncompliance With Protocol|0|||
13367080|NCT00844805|26704811|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1|||
13367081|NCT00844805|26704812|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2|||
13367082|NCT00844805|26704813|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
13367083|NCT00844805|26704814|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
13367084|NCT00844805|26704811|FG000|Follow-Up Phase|Adverse Event|0|||
13367085|NCT00844805|26704812|FG001|Follow-Up Phase|Adverse Event|0|||
13367086|NCT00844805|26704813|FG002|Follow-Up Phase|Adverse Event|1|||
13367087|NCT00844805|26704814|FG003|Follow-Up Phase|Adverse Event|0|||
13367088|NCT00844805|26704811|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
13367089|NCT00844805|26704812|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
13367090|NCT00844805|26704813|FG002|Follow-Up Phase|Withdrawal by Subject|6|||
13367091|NCT00844805|26704814|FG003|Follow-Up Phase|Withdrawal by Subject|3|||
13367092|NCT00844805|26704811|FG000|Follow-Up Phase|Noncompliance With Protocol|0|||
13367093|NCT00844805|26704812|FG001|Follow-Up Phase|Noncompliance With Protocol|0|||
13367094|NCT00844805|26704813|FG002|Follow-Up Phase|Noncompliance With Protocol|0|||
13367095|NCT00844805|26704814|FG003|Follow-Up Phase|Noncompliance With Protocol|1|||
13367096|NCT00844805|26704811|FG000|Follow-Up Phase|Relapse/Recurrence|0|||
13367097|NCT00844805|26704812|FG001|Follow-Up Phase|Relapse/Recurrence|0|||
13367098|NCT00844805|26704813|FG002|Follow-Up Phase|Relapse/Recurrence|2|||
13367099|NCT00844805|26704814|FG003|Follow-Up Phase|Relapse/Recurrence|4|||
13367100|NCT00844805|26704811|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
13367101|NCT00844805|26704812|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
13367102|NCT00844805|26704813|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
13367103|NCT00844805|26704814|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1|||
13367104|NCT00844753|26704839|FG000|Overall Study|Lack of Efficacy|1|||
13367105|NCT00844753|26704840|FG001|Overall Study|Lack of Efficacy|0|||
13367106|NCT00844753|26704841|FG002|Overall Study|Lack of Efficacy|2|||
13367107|NCT00844753|26704842|FG003|Overall Study|Lack of Efficacy|2|||
13367108|NCT00844753|26704839|FG000|Overall Study|Adverse Event|3|||
13367109|NCT00844753|26704840|FG001|Overall Study|Adverse Event|2|||
13367110|NCT00844753|26704841|FG002|Overall Study|Adverse Event|5|||
13367111|NCT00844753|26704842|FG003|Overall Study|Adverse Event|5|||
13367112|NCT00844753|26704839|FG000|Overall Study|Lost to Follow-up|1|||
13367113|NCT00844753|26704840|FG001|Overall Study|Lost to Follow-up|1|||
13367114|NCT00844753|26704841|FG002|Overall Study|Lost to Follow-up|0|||
13367115|NCT00844753|26704842|FG003|Overall Study|Lost to Follow-up|1|||
13367116|NCT00844753|26704839|FG000|Overall Study|could not swallow medication|2|||
13367117|NCT00844753|26704840|FG001|Overall Study|could not swallow medication|0|||
13367118|NCT00844753|26704841|FG002|Overall Study|could not swallow medication|0|||
13367119|NCT00844753|26704842|FG003|Overall Study|could not swallow medication|0|||
13367120|NCT00844753|26704839|FG000|Overall Study|Withdrawal by Subject|1|||
13367121|NCT00844753|26704840|FG001|Overall Study|Withdrawal by Subject|0|||
13367122|NCT00844753|26704841|FG002|Overall Study|Withdrawal by Subject|0|||
13367123|NCT00844753|26704842|FG003|Overall Study|Withdrawal by Subject|3|||
13367124|NCT00844649|26704867|FG000|Overall Study|Progressive Disease|196|||
13367125|NCT00844649|26704868|FG001|Overall Study|Progressive Disease|245|||
13367126|NCT00844649|26704867|FG000|Overall Study|Adverse Event|128|||
13367127|NCT00844649|26704868|FG001|Overall Study|Adverse Event|73|||
13367128|NCT00844649|26704867|FG000|Overall Study|Physician Decision|25|||
13367129|NCT00844649|26704868|FG001|Overall Study|Physician Decision|18|||
13367130|NCT00844649|26704867|FG000|Overall Study|Protocol Violation|10|||
13367131|NCT00844649|26704868|FG001|Overall Study|Protocol Violation|6|||
13367132|NCT00844649|26704867|FG000|Overall Study|Withdrawal by Subject|28|||
13367133|NCT00844649|26704868|FG001|Overall Study|Withdrawal by Subject|39|||
13367134|NCT00844649|26704867|FG000|Overall Study|Other|7|||
13367135|NCT00844649|26704868|FG001|Overall Study|Other|10|||
13367136|NCT00844649|26704867|FG000|Overall Study|Withdrew prior to starting treatment|11|||
13367137|NCT00844649|26704868|FG001|Overall Study|Withdrew prior to starting treatment|27|||
13367138|NCT00844597|26704905|FG000|Overall Study|Adverse Event|0|||
13367139|NCT00844597|26704906|FG001|Overall Study|Adverse Event|0|||
13367140|NCT00844597|26704907|FG002|Overall Study|Adverse Event|0|||
13367141|NCT00844597|26704908|FG003|Overall Study|Adverse Event|1|||
13367142|NCT00844597|26704909|FG004|Overall Study|Adverse Event|0|||
13367143|NCT00844597|26704910|FG005|Overall Study|Adverse Event|0|||
13367144|NCT00844558|26704933|FG000|Overall Study|Withdrawal by Subject|9|||
13367145|NCT00844558|26704934|FG001|Overall Study|Withdrawal by Subject|2|||
13367146|NCT00844558|26704933|FG000|Overall Study|Death|1|||
13367147|NCT00844558|26704934|FG001|Overall Study|Death|0|||
13367148|NCT00844558|26704933|FG000|Overall Study|Protocol Violation|1|||
13367149|NCT00844558|26704934|FG001|Overall Study|Protocol Violation|1|||
13367150|NCT00844558|26704933|FG000|Overall Study|Lost to Follow-up|0|||
13367151|NCT00844558|26704934|FG001|Overall Study|Lost to Follow-up|1|||
13367152|NCT00844558|26704933|FG000|Overall Study|Physician Decision|1|||
13367153|NCT00844558|26704934|FG001|Overall Study|Physician Decision|0|||
13367154|NCT00844545|26704950|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
13367155|NCT00844545|26704950|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
13367156|NCT00844545|26704950|FG000|Extension Treatment Period|Adverse Event|2|||
13367157|NCT00844545|26704950|FG000|Post Treatment Period|Withdrawal by Subject|1|||
13367158|NCT00844532|26705036|FG000|Overall Study|Death|16|||
13367159|NCT00844532|26705036|FG000|Overall Study|Withdrawal by Subject|16|||
13367160|NCT00844532|26705036|FG000|Overall Study|Lost to Follow-up|7|||
13367161|NCT00844519|26705049|FG000|Overall Study|Withdrawal by Subject|1|||
13367162|NCT00844519|26705050|FG001|Overall Study|Withdrawal by Subject|1|||
13367163|NCT00844519|26705049|FG000|Overall Study|Adverse Event|1|||
13367164|NCT00844519|26705050|FG001|Overall Study|Adverse Event|0|||
13367165|NCT00844480|26705065|FG000|Overall Study|Withdrawal by Subject|2|||
13367166|NCT00844480|26705066|FG001|Overall Study|Withdrawal by Subject|3|||
13367167|NCT00844428|26705084|FG000|Screening Period|Screen Failure|3|||
13367168|NCT00844428|26705084|FG000|Extension Treatment Period|Death|1|||
13367169|NCT00844428|26705084|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
13367170|NCT00844415|26705100|FG000|Overall Study|Withdrawal by Subject|1|||
13367171|NCT00844376|26705121|FG000|Period 1: First Intervention|Withdrawal by Subject|1|||
13367172|NCT00844376|26705122|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
13367173|NCT00844194|26705333|FG000|Overall Study|Adverse Event|17|||
13367174|NCT00844194|26705334|FG001|Overall Study|Adverse Event|5|||
13367175|NCT00844194|26705333|FG000|Overall Study|Protocol Violation|1|||
13367176|NCT00844194|26705334|FG001|Overall Study|Protocol Violation|1|||
13367177|NCT00844194|26705333|FG000|Overall Study|Lost to Follow-up|1|||
13367178|NCT00844194|26705334|FG001|Overall Study|Lost to Follow-up|1|||
13367179|NCT00844194|26705333|FG000|Overall Study|Withdrawal by Subject|2|||
13367180|NCT00844194|26705334|FG001|Overall Study|Withdrawal by Subject|1|||
13367181|NCT00844194|26705333|FG000|Overall Study|Lack of Efficacy|3|||
13367182|NCT00844194|26705334|FG001|Overall Study|Lack of Efficacy|0|||
13367183|NCT00844194|26705333|FG000|Overall Study|Other reason (not specified)|1|||
13367184|NCT00844194|26705334|FG001|Overall Study|Other reason (not specified)|0|||
13367185|NCT00843856|26705349|FG000|Overall Study|Lost to Follow-up|1|||
13367186|NCT00843856|26705350|FG001|Overall Study|Lost to Follow-up|2|||
13367187|NCT00843843|26705365|FG000|Overall Study|Physician Decision|1|||
13367188|NCT00843843|26705366|FG001|Overall Study|Physician Decision|1|||
13367189|NCT00843843|26705365|FG000|Overall Study|Protocol Violation|1|||
13367190|NCT00843843|26705366|FG001|Overall Study|Protocol Violation|1|||
13367191|NCT00843778|26705401|FG000|Overall Study|Adverse Event|15|||
13367192|NCT00843778|26705401|FG000|Overall Study|Lack of Efficacy|14|||
13367193|NCT00843778|26705401|FG000|Overall Study|Loss of efficacy|2|||
13367194|NCT00843778|26705401|FG000|Overall Study|Withdrawal by Subject|4|||
13367195|NCT00843726|26705418|FG000|Overall Study|Death|1|||
13367196|NCT00843726|26705419|FG001|Overall Study|Death|0|||
13367197|NCT00843726|26705418|FG000|Overall Study|Withdrawal by Subject|0|||
13367198|NCT00843726|26705419|FG001|Overall Study|Withdrawal by Subject|1|||
13367199|NCT00843635|26705447|FG000|Overall Study|Adverse Event|2|||
13367200|NCT00843635|26705448|FG001|Overall Study|Adverse Event|2|||
13367201|NCT00843635|26705449|FG002|Overall Study|Adverse Event|0|||
13375209|NCT00791258|26729692|FG000|Overall Study|Protocol Violation|109|||
13375210|NCT00791258|26729692|FG000|Overall Study|Withdrawal by Subject|40|||
13375211|NCT00791258|26729692|FG000|Overall Study|Did not take medication for >3 days|1|||
13375212|NCT00791258|26729692|FG000|Overall Study|subject left area|2|||
13375213|NCT00791258|26729692|FG000|Overall Study|non-compliance|3|||
13375214|NCT00791258|26729692|FG000|Overall Study|Subject incarcerated|1|||
13375215|NCT00791258|26729692|FG000|Overall Study|Subject required restricted medication|1|||
13375216|NCT00791258|26729692|FG000|Overall Study|Lack of Efficacy|1|||
13375217|NCT00791128|26729699|FG000|Overall Study|Adverse Event|4|||
13375218|NCT00791128|26729699|FG000|Overall Study|Device migration|2|||
13375219|NCT00791128|26729699|FG000|Overall Study|non-compliance by subject|2|||
13375220|NCT00791128|26729699|FG000|Overall Study|abdominal tumor, unrelated to device|1|||
13375221|NCT00791076|26729709|FG000|Overall Study|Study was terminated,PI left institution|8|||
13375222|NCT00790907|26729740|FG000|Overall Study|Adverse Event|9|||
13375223|NCT00790907|26729741|FG001|Overall Study|Adverse Event|7|||
13375224|NCT00790907|26729742|FG002|Overall Study|Adverse Event|6|||
13375225|NCT00790907|26729740|FG000|Overall Study|Physician Decision|304|||
13375226|NCT00790907|26729741|FG001|Overall Study|Physician Decision|271|||
13375227|NCT00790907|26729742|FG002|Overall Study|Physician Decision|255|||
13375228|NCT00790907|26729740|FG000|Overall Study|Withdrawal by Subject|1|||
13375229|NCT00790907|26729741|FG001|Overall Study|Withdrawal by Subject|7|||
13375230|NCT00790907|26729742|FG002|Overall Study|Withdrawal by Subject|5|||
13375231|NCT00790907|26729740|FG000|Overall Study|Bleeding Event|11|||
13375232|NCT00790907|26729741|FG001|Overall Study|Bleeding Event|16|||
13375233|NCT00790907|26729742|FG002|Overall Study|Bleeding Event|21|||
13375234|NCT00790907|26729740|FG000|Overall Study|Required Protocol-prohibited Therapy|17|||
13375235|NCT00790907|26729741|FG001|Overall Study|Required Protocol-prohibited Therapy|5|||
13375236|NCT00790907|26729742|FG002|Overall Study|Required Protocol-prohibited Therapy|7|||
13375237|NCT00790907|26729740|FG000|Overall Study|Qualifying Condition Not Present|29|||
13375238|NCT00790907|26729741|FG001|Overall Study|Qualifying Condition Not Present|14|||
13375239|NCT00790907|26729742|FG002|Overall Study|Qualifying Condition Not Present|16|||
13375240|NCT00790907|26729740|FG000|Overall Study|Verbatim Reason on the Case Report Form|74|||
13375241|NCT00790907|26729741|FG001|Overall Study|Verbatim Reason on the Case Report Form|20|||
13375242|NCT00790907|26729742|FG002|Overall Study|Verbatim Reason on the Case Report Form|29|||
13375243|NCT00790907|26729740|FG000|Overall Study|Did Not Receive Study Drug|10|||
13375244|NCT00790907|26729741|FG001|Overall Study|Did Not Receive Study Drug|0|||
13375245|NCT00790907|26729742|FG002|Overall Study|Did Not Receive Study Drug|0|||
13375246|NCT00790868|26729763|FG000|Overall Study|Withdrawal by Subject|4|||
13375247|NCT00790868|26729764|FG001|Overall Study|Withdrawal by Subject|5|||
13375248|NCT00790868|26729763|FG000|Overall Study|Lost to Follow-up|2|||
13375249|NCT00790868|26729764|FG001|Overall Study|Lost to Follow-up|12|||
13375250|NCT00790842|26729839|FG000|Dose Level 1|Adverse Event|1|||
13375251|NCT00790842|26729840|FG001|Dose Level 1|Adverse Event|0|||
13375252|NCT00790842|26729841|FG002|Dose Level 1|Adverse Event|0|||
13375253|NCT00790842|26729842|FG003|Dose Level 1|Adverse Event|2|||
13375254|NCT00790842|26729843|FG004|Dose Level 1|Adverse Event|0|||
13375255|NCT00790842|26729844|FG005|Dose Level 1|Adverse Event|0|||
13375256|NCT00790842|26729845|FG006|Dose Level 1|Adverse Event|0|||
13375257|NCT00790842|26729846|FG007|Dose Level 1|Adverse Event|1|||
13375258|NCT00790842|26729847|FG008|Dose Level 1|Adverse Event|0|||
13375259|NCT00790842|26729848|FG009|Dose Level 1|Adverse Event|0|||
13375260|NCT00790842|26729849|FG010|Dose Level 1|Adverse Event|0|||
13375261|NCT00790842|26729839|FG000|Dose Level 1|Physician Decision|1|||
13375262|NCT00790842|26729840|FG001|Dose Level 1|Physician Decision|0|||
13375263|NCT00790842|26729841|FG002|Dose Level 1|Physician Decision|0|||
13375264|NCT00790842|26729842|FG003|Dose Level 1|Physician Decision|0|||
13375265|NCT00790842|26729843|FG004|Dose Level 1|Physician Decision|0|||
13375266|NCT00790842|26729844|FG005|Dose Level 1|Physician Decision|0|||
13375267|NCT00790842|26729845|FG006|Dose Level 1|Physician Decision|0|||
13375268|NCT00790842|26729846|FG007|Dose Level 1|Physician Decision|1|||
13375269|NCT00790842|26729847|FG008|Dose Level 1|Physician Decision|0|||
13375270|NCT00790842|26729848|FG009|Dose Level 1|Physician Decision|0|||
13375271|NCT00790842|26729849|FG010|Dose Level 1|Physician Decision|0|||
13375272|NCT00790842|26729839|FG000|Dose Level 1|Withdrawal by Subject|1|||
13375273|NCT00790842|26729840|FG001|Dose Level 1|Withdrawal by Subject|0|||
13367202|NCT00843518|26705484|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5|||
13367203|NCT00843518|26705485|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3|||
13367204|NCT00843518|26705484|FG000|Period 2 (Double-blind Treatment)|Death|0|||
13367205|NCT00843518|26705485|FG001|Period 2 (Double-blind Treatment)|Death|1|||
13367206|NCT00843518|26705484|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2|||
13367207|NCT00843518|26705485|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3|||
13367208|NCT00843518|26705484|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2|||
13367209|NCT00843518|26705485|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1|||
13367210|NCT00843518|26705484|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2|||
13367211|NCT00843518|26705485|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5|||
13367212|NCT00843518|26705484|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2|||
13367213|NCT00843518|26705485|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0|||
13367214|NCT00843518|26705484|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
13367215|NCT00843518|26705485|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
13367216|NCT00843492|26705510|FG000|Overall Study|Adverse Event|0|||
13367217|NCT00843492|26705511|FG001|Overall Study|Adverse Event|3|||
13367218|NCT00843492|26705510|FG000|Overall Study|Lost to Follow-up|4|||
13367219|NCT00843492|26705511|FG001|Overall Study|Lost to Follow-up|4|||
13367220|NCT00843492|26705510|FG000|Overall Study|Withdrawal by Subject|0|||
13367221|NCT00843492|26705511|FG001|Overall Study|Withdrawal by Subject|4|||
13367222|NCT00843492|26705510|FG000|Overall Study|Immobilization Stopped|1|||
13367223|NCT00843492|26705511|FG001|Overall Study|Immobilization Stopped|0|||
13367224|NCT00843492|26705510|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
13367225|NCT00843492|26705511|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
13367226|NCT00843492|26705510|FG000|Overall Study|Orthopedic Surgery|0|||
13367227|NCT00843492|26705511|FG001|Overall Study|Orthopedic Surgery|2|||
13367228|NCT00843492|26705510|FG000|Overall Study|Visit Not Performed|1|||
13367229|NCT00843492|26705511|FG001|Overall Study|Visit Not Performed|0|||
13367230|NCT00843492|26705510|FG000|Overall Study|Deep-vein Thrombosis|1|||
13367231|NCT00843492|26705511|FG001|Overall Study|Deep-vein Thrombosis|0|||
13367232|NCT00843284|26705521|FG000|Overall Study|Adverse Event|39|||
13367233|NCT00843284|26705521|FG000|Overall Study|Lack of Efficacy|5|||
13367234|NCT00843284|26705521|FG000|Overall Study|Lost to Follow-up|11|||
13367235|NCT00843284|26705521|FG000|Overall Study|Other|10|||
13367236|NCT00843284|26705521|FG000|Overall Study|Withdrawal by Subject|4|||
13367237|NCT00843284|26705521|FG000|Overall Study|Death|3|||
13367238|NCT00843193|26705562|FG000|Overall Study|Adverse Event|2|||
13367239|NCT00843193|26705563|FG001|Overall Study|Adverse Event|4|||
13367240|NCT00843193|26705562|FG000|Overall Study|Lack of Efficacy|1|||
13367241|NCT00843193|26705563|FG001|Overall Study|Lack of Efficacy|1|||
13367242|NCT00843193|26705562|FG000|Overall Study|Protocol Violation|1|||
13367243|NCT00843193|26705563|FG001|Overall Study|Protocol Violation|2|||
13367244|NCT00843193|26705562|FG000|Overall Study|Lost to Follow-up|1|||
13367245|NCT00843193|26705563|FG001|Overall Study|Lost to Follow-up|0|||
13367246|NCT00843193|26705562|FG000|Overall Study|Physician Decision|0|||
13367247|NCT00843193|26705563|FG001|Overall Study|Physician Decision|1|||
13367248|NCT00843193|26705562|FG000|Overall Study|Withdrawal by Subject|3|||
13367249|NCT00843193|26705563|FG001|Overall Study|Withdrawal by Subject|3|||
13367250|NCT00843167|26705583|FG000|Treatment Period|Adverse Event|1|||
13367251|NCT00843167|26705584|FG001|Treatment Period|Adverse Event|5|||
13367252|NCT00843167|26705583|FG000|Treatment Period|Withdrawal by Subject|2|||
13367253|NCT00843167|26705584|FG001|Treatment Period|Withdrawal by Subject|3|||
13367254|NCT00843115|26705632|FG000|Overall Study|Death|4|||
13367255|NCT00843115|26705632|FG000|Overall Study|Adverse Event|30|||
13367256|NCT00843115|26705632|FG000|Overall Study|Lost to Follow-up|4|||
13367257|NCT00843115|26705632|FG000|Overall Study|Withdrawal by Subject|17|||
13367258|NCT00843115|26705632|FG000|Overall Study|Family wanted meds stopped|1|||
13367259|NCT00843115|26705632|FG000|Overall Study|Family does not want continuation|1|||
13367260|NCT00843115|26705632|FG000|Overall Study|Patient forgot to take meds|1|||
13367261|NCT00843115|26705632|FG000|Overall Study|Does not meet entrance criteria|1|||
13367262|NCT00843115|26705632|FG000|Overall Study|Physician Decision|1|||
13367263|NCT00843115|26705632|FG000|Overall Study|Family discontinued meds|1|||
13367264|NCT00843115|26705632|FG000|Overall Study|patient took for 2 days then stopped|1|||
13124965|NCT02935842|25954575|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0|||
13367265|NCT00843115|26705632|FG000|Overall Study|patient never took the medication|1|||
13367266|NCT00843115|26705632|FG000|Overall Study|hospitalized due to deterioration|1|||
13367267|NCT00843115|26705632|FG000|Overall Study|week 12 not done|1|||
13367268|NCT00843115|26705632|FG000|Overall Study|Syndrome De Glissement|1|||
13367269|NCT00843024|26705712|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79|||
13367270|NCT00843024|26705713|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74|||
13367271|NCT00843024|26705714|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
13367272|NCT00843024|26705715|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
13367273|NCT00843024|26705716|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
13367274|NCT00843024|26705717|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
13367275|NCT00843024|26705712|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36|||
13367276|NCT00843024|26705713|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31|||
13367277|NCT00843024|26705714|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
13367278|NCT00843024|26705715|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
13367279|NCT00843024|26705716|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
13367280|NCT00843024|26705717|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
13367281|NCT00843024|26705712|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19|||
13367282|NCT00843024|26705713|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18|||
13367283|NCT00843024|26705714|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
13367284|NCT00843024|26705715|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
13367285|NCT00843024|26705716|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
13367286|NCT00843024|26705717|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
13367287|NCT00843024|26705712|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4|||
13367288|NCT00843024|26705713|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5|||
13367289|NCT00843024|26705714|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
13367290|NCT00843024|26705715|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
13367291|NCT00843024|26705716|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
13367292|NCT00843024|26705717|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
13367293|NCT00843024|26705712|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2|||
13367294|NCT00843024|26705713|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6|||
13367295|NCT00843024|26705714|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0|||
13367296|NCT00843024|26705715|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0|||
13367297|NCT00843024|26705716|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0|||
13367298|NCT00843024|26705717|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0|||
13367299|NCT00843024|26705712|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0|||
13367300|NCT00843024|26705713|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1|||
13367301|NCT00843024|26705714|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0|||
13367302|NCT00843024|26705715|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0|||
13367303|NCT00843024|26705716|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0|||
13367304|NCT00843024|26705717|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0|||
13367305|NCT00843024|26705712|FG000|Single-blind Placebo Run-In Phase|Other|0|||
13367306|NCT00843024|26705713|FG001|Single-blind Placebo Run-In Phase|Other|1|||
13367307|NCT00843024|26705714|FG002|Single-blind Placebo Run-In Phase|Other|0|||
13367308|NCT00843024|26705715|FG003|Single-blind Placebo Run-In Phase|Other|0|||
13367309|NCT00843024|26705716|FG004|Single-blind Placebo Run-In Phase|Other|0|||
13367310|NCT00843024|26705717|FG005|Single-blind Placebo Run-In Phase|Other|0|||
13367311|NCT00843024|26705712|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
13367312|NCT00843024|26705713|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
13367313|NCT00843024|26705714|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20|||
13367314|NCT00843024|26705715|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10|||
13367315|NCT00843024|26705716|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13|||
13367316|NCT00843024|26705717|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14|||
13367317|NCT00843024|26705712|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
13367318|NCT00843024|26705713|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
13367319|NCT00843024|26705714|FG002|Double-blind Treatment Phase|Lost to Follow-up|8|||
13367320|NCT00843024|26705715|FG003|Double-blind Treatment Phase|Lost to Follow-up|4|||
13367321|NCT00843024|26705716|FG004|Double-blind Treatment Phase|Lost to Follow-up|4|||
13367322|NCT00843024|26705717|FG005|Double-blind Treatment Phase|Lost to Follow-up|4|||
13367323|NCT00843024|26705712|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
13367324|NCT00843024|26705713|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
13367325|NCT00843024|26705714|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
13367326|NCT00843024|26705715|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6|||
13367327|NCT00843024|26705716|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
13367328|NCT00843024|26705717|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2|||
13367329|NCT00843024|26705712|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
13367330|NCT00843024|26705713|FG001|Double-blind Treatment Phase|Protocol Violation|0|||
13367331|NCT00843024|26705714|FG002|Double-blind Treatment Phase|Protocol Violation|3|||
13367332|NCT00843024|26705715|FG003|Double-blind Treatment Phase|Protocol Violation|0|||
13367333|NCT00843024|26705716|FG004|Double-blind Treatment Phase|Protocol Violation|0|||
13367334|NCT00843024|26705717|FG005|Double-blind Treatment Phase|Protocol Violation|3|||
13367335|NCT00843024|26705712|FG000|Double-blind Treatment Phase|Physician Decision|0|||
13367336|NCT00843024|26705713|FG001|Double-blind Treatment Phase|Physician Decision|0|||
13367337|NCT00843024|26705714|FG002|Double-blind Treatment Phase|Physician Decision|0|||
13367338|NCT00843024|26705715|FG003|Double-blind Treatment Phase|Physician Decision|3|||
13367339|NCT00843024|26705716|FG004|Double-blind Treatment Phase|Physician Decision|1|||
13367340|NCT00843024|26705717|FG005|Double-blind Treatment Phase|Physician Decision|1|||
13367341|NCT00843024|26705712|FG000|Double-blind Treatment Phase|Adverse Event|0|||
13367342|NCT00843024|26705713|FG001|Double-blind Treatment Phase|Adverse Event|0|||
13367343|NCT00843024|26705714|FG002|Double-blind Treatment Phase|Adverse Event|0|||
13367344|NCT00843024|26705715|FG003|Double-blind Treatment Phase|Adverse Event|0|||
13367345|NCT00843024|26705716|FG004|Double-blind Treatment Phase|Adverse Event|1|||
13367346|NCT00843024|26705717|FG005|Double-blind Treatment Phase|Adverse Event|1|||
13367347|NCT00843024|26705712|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
13367348|NCT00843024|26705713|FG001|Double-blind Treatment Phase|Lack of Efficacy|0|||
13367349|NCT00843024|26705714|FG002|Double-blind Treatment Phase|Lack of Efficacy|0|||
13367350|NCT00843024|26705715|FG003|Double-blind Treatment Phase|Lack of Efficacy|0|||
13367351|NCT00843024|26705716|FG004|Double-blind Treatment Phase|Lack of Efficacy|1|||
13367352|NCT00843024|26705717|FG005|Double-blind Treatment Phase|Lack of Efficacy|0|||
13367353|NCT00842985|26705726|FG000|Screening|Did not meet entrance requirements|27|||
13367354|NCT00842985|26705726|FG000|First Intervention|Withdrawal by Subject|3|||
13367355|NCT00842985|26705726|FG000|First Intervention|Protocol Violation|3|||
13367356|NCT00842985|26705726|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
13367357|NCT00842985|26705726|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
13367358|NCT00842829|26705768|FG000|Dose Titration Period|Adverse Event|11|||
13367359|NCT00842829|26705769|FG001|Dose Titration Period|Adverse Event|10|||
13367360|NCT00842829|26705770|FG002|Dose Titration Period|Adverse Event|0|||
13367361|NCT00842829|26705768|FG000|Dose Titration Period|Lack of Efficacy|4|||
13367362|NCT00842829|26705769|FG001|Dose Titration Period|Lack of Efficacy|1|||
13367363|NCT00842829|26705770|FG002|Dose Titration Period|Lack of Efficacy|0|||
13367364|NCT00842829|26705768|FG000|Dose Titration Period|Unstable persistent cancer pain|1|||
13367365|NCT00842829|26705769|FG001|Dose Titration Period|Unstable persistent cancer pain|0|||
13367366|NCT00842829|26705770|FG002|Dose Titration Period|Unstable persistent cancer pain|0|||
13367367|NCT00842829|26705768|FG000|Dose Titration Period|Withdrawal by Subject|2|||
13367368|NCT00842829|26705769|FG001|Dose Titration Period|Withdrawal by Subject|6|||
13367369|NCT00842829|26705770|FG002|Dose Titration Period|Withdrawal by Subject|0|||
13367370|NCT00842829|26705768|FG000|Dose Titration Period|Other|5|||
13367371|NCT00842829|26705769|FG001|Dose Titration Period|Other|4|||
13367372|NCT00842829|26705770|FG002|Dose Titration Period|Other|0|||
13367373|NCT00842829|26705768|FG000|Dose Titration Period|Non-compliance to study procedures|1|||
13367374|NCT00842829|26705769|FG001|Dose Titration Period|Non-compliance to study procedures|1|||
13367375|NCT00842829|26705770|FG002|Dose Titration Period|Non-compliance to study procedures|0|||
13367376|NCT00842829|26705768|FG000|Dose Titration Period|Non-compliance to study drug|2|||
13367377|NCT00842829|26705769|FG001|Dose Titration Period|Non-compliance to study drug|1|||
13367378|NCT00842829|26705770|FG002|Dose Titration Period|Non-compliance to study drug|0|||
13367379|NCT00842829|26705768|FG000|Treatment Period|Adverse Event|0|||
13367380|NCT00842829|26705769|FG001|Treatment Period|Adverse Event|0|||
13367381|NCT00842829|26705770|FG002|Treatment Period|Adverse Event|15|||
13367382|NCT00842829|26705768|FG000|Treatment Period|Lack of Efficacy|0|||
13367383|NCT00842829|26705769|FG001|Treatment Period|Lack of Efficacy|0|||
13367384|NCT00842829|26705770|FG002|Treatment Period|Lack of Efficacy|6|||
13367385|NCT00842829|26705768|FG000|Treatment Period|Unstable persistent cancer pain|0|||
13367386|NCT00842829|26705769|FG001|Treatment Period|Unstable persistent cancer pain|0|||
13367387|NCT00842829|26705770|FG002|Treatment Period|Unstable persistent cancer pain|5|||
13367388|NCT00842829|26705768|FG000|Treatment Period|Withdrawal by Subject|0|||
13367389|NCT00842829|26705769|FG001|Treatment Period|Withdrawal by Subject|0|||
13367390|NCT00842829|26705770|FG002|Treatment Period|Withdrawal by Subject|11|||
13367391|NCT00842829|26705768|FG000|Treatment Period|Consistently >4 BTP episodes daily|0|||
13367392|NCT00842829|26705769|FG001|Treatment Period|Consistently >4 BTP episodes daily|0|||
13367393|NCT00842829|26705770|FG002|Treatment Period|Consistently >4 BTP episodes daily|1|||
13367394|NCT00842829|26705768|FG000|Treatment Period|Protocol Violation|0|||
13367395|NCT00842829|26705769|FG001|Treatment Period|Protocol Violation|0|||
13367396|NCT00842829|26705770|FG002|Treatment Period|Protocol Violation|2|||
13367397|NCT00842829|26705768|FG000|Treatment Period|Other|0|||
13367398|NCT00842829|26705769|FG001|Treatment Period|Other|0|||
13367399|NCT00842829|26705770|FG002|Treatment Period|Other|18|||
13367400|NCT00842829|26705768|FG000|Treatment Period|Non-compliance to study procedures|0|||
13367401|NCT00842829|26705769|FG001|Treatment Period|Non-compliance to study procedures|0|||
13367402|NCT00842829|26705770|FG002|Treatment Period|Non-compliance to study procedures|4|||
13367403|NCT00842829|26705768|FG000|Treatment Period|Unclear completion status|0|||
13367404|NCT00842829|26705769|FG001|Treatment Period|Unclear completion status|0|||
13367405|NCT00842829|26705770|FG002|Treatment Period|Unclear completion status|1|||
13367406|NCT00842829|26705768|FG000|Continuation Period|Adverse Event|0|||
13367407|NCT00842829|26705769|FG001|Continuation Period|Adverse Event|0|||
13367408|NCT00842829|26705770|FG002|Continuation Period|Adverse Event|32|||
13367409|NCT00842829|26705768|FG000|Continuation Period|Lack of Efficacy|0|||
13367410|NCT00842829|26705769|FG001|Continuation Period|Lack of Efficacy|0|||
13367411|NCT00842829|26705770|FG002|Continuation Period|Lack of Efficacy|6|||
13367412|NCT00842829|26705768|FG000|Continuation Period|Unstable persistent cancer pain|0|||
13367413|NCT00842829|26705769|FG001|Continuation Period|Unstable persistent cancer pain|0|||
13367414|NCT00842829|26705770|FG002|Continuation Period|Unstable persistent cancer pain|3|||
13367415|NCT00842829|26705768|FG000|Continuation Period|Withdrawal by Subject|0|||
13367416|NCT00842829|26705769|FG001|Continuation Period|Withdrawal by Subject|0|||
13367417|NCT00842829|26705770|FG002|Continuation Period|Withdrawal by Subject|10|||
13367418|NCT00842829|26705768|FG000|Continuation Period|Other|0|||
13367419|NCT00842829|26705769|FG001|Continuation Period|Other|0|||
13367420|NCT00842829|26705770|FG002|Continuation Period|Other|7|||
13367421|NCT00842829|26705768|FG000|Continuation Period|Non-compliance to study procedures|0|||
13367422|NCT00842829|26705769|FG001|Continuation Period|Non-compliance to study procedures|0|||
13367423|NCT00842829|26705770|FG002|Continuation Period|Non-compliance to study procedures|2|||
13367424|NCT00842829|26705768|FG000|Continuation Period|Non-compliance to study drug|0|||
13367425|NCT00842829|26705769|FG001|Continuation Period|Non-compliance to study drug|0|||
13367426|NCT00842829|26705770|FG002|Continuation Period|Non-compliance to study drug|1|||
13367427|NCT00842712|26705820|FG000|Safety Run-in Part|Adverse Event|0|||
13367428|NCT00842712|26705821|FG001|Safety Run-in Part|Adverse Event|1|||
13367429|NCT00842712|26705822|FG002|Safety Run-in Part|Adverse Event|0|||
13367430|NCT00842712|26705823|FG003|Safety Run-in Part|Adverse Event|0|||
13367431|NCT00842712|26705824|FG004|Safety Run-in Part|Adverse Event|0|||
13367432|NCT00842712|26705825|FG005|Safety Run-in Part|Adverse Event|0|||
13367433|NCT00842712|26705826|FG006|Safety Run-in Part|Adverse Event|0|||
13367434|NCT00842712|26705820|FG000|Safety Run-in Part|Progressive disease|3|||
13367435|NCT00842712|26705821|FG001|Safety Run-in Part|Progressive disease|1|||
13367436|NCT00842712|26705822|FG002|Safety Run-in Part|Progressive disease|0|||
13367437|NCT00842712|26705823|FG003|Safety Run-in Part|Progressive disease|1|||
13367438|NCT00842712|26705824|FG004|Safety Run-in Part|Progressive disease|0|||
13367439|NCT00842712|26705825|FG005|Safety Run-in Part|Progressive disease|0|||
13367440|NCT00842712|26705826|FG006|Safety Run-in Part|Progressive disease|0|||
13367441|NCT00842712|26705820|FG000|Randomized Part|Randomized but not treated|0|||
13367442|NCT00842712|26705821|FG001|Randomized Part|Randomized but not treated|0|||
13367443|NCT00842712|26705822|FG002|Randomized Part|Randomized but not treated|0|||
13367444|NCT00842712|26705823|FG003|Randomized Part|Randomized but not treated|0|||
13367445|NCT00842712|26705824|FG004|Randomized Part|Randomized but not treated|0|||
13367446|NCT00842712|26705825|FG005|Randomized Part|Randomized but not treated|1|||
13367447|NCT00842712|26705826|FG006|Randomized Part|Randomized but not treated|4|||
13367448|NCT00842712|26705820|FG000|Randomized Part|Ongoing at cut-off date|0|||
13367449|NCT00842712|26705821|FG001|Randomized Part|Ongoing at cut-off date|0|||
13367450|NCT00842712|26705822|FG002|Randomized Part|Ongoing at cut-off date|0|||
13367451|NCT00842712|26705823|FG003|Randomized Part|Ongoing at cut-off date|0|||
13367452|NCT00842712|26705824|FG004|Randomized Part|Ongoing at cut-off date|0|||
13367453|NCT00842712|26705825|FG005|Randomized Part|Ongoing at cut-off date|0|||
13367454|NCT00842712|26705826|FG006|Randomized Part|Ongoing at cut-off date|2|||
13367455|NCT00842543|26705851|FG000|Overall Study|Withdrawal by Subject|2|||
13367456|NCT00842543|26705852|FG001|Overall Study|Withdrawal by Subject|0|||
13367457|NCT00842543|26705853|FG002|Overall Study|Withdrawal by Subject|3|||
13367458|NCT00842543|26705854|FG003|Overall Study|Withdrawal by Subject|4|||
13367459|NCT00842530|26705889|FG000|Overall Study|Serious adverse event|0|||
13367460|NCT00842530|26705890|FG001|Overall Study|Serious adverse event|6|||
13367461|NCT00842530|26705889|FG000|Overall Study|Other adverse event|6|||
13367462|NCT00842530|26705890|FG001|Overall Study|Other adverse event|1|||
13367463|NCT00842530|26705889|FG000|Overall Study|Protocol Violation|32|||
13367464|NCT00842530|26705890|FG001|Overall Study|Protocol Violation|14|||
13367465|NCT00842530|26705889|FG000|Overall Study|Lost to Follow-up|6|||
13367466|NCT00842530|26705890|FG001|Overall Study|Lost to Follow-up|8|||
13367467|NCT00842530|26705889|FG000|Overall Study|Withdrawal by Subject|73|||
13367468|NCT00842530|26705890|FG001|Overall Study|Withdrawal by Subject|28|||
13367469|NCT00842361|26705915|FG000|Overall Study|Protocol Violation|1|||
13367470|NCT00842361|26705916|FG001|Overall Study|Protocol Violation|0|||
13367471|NCT00842361|26705915|FG000|Overall Study|Unclassified|0|||
13367472|NCT00842361|26705916|FG001|Overall Study|Unclassified|2|||
13367473|NCT00842309|26705931|FG000|Overall Study|Withdrawal by Subject|3|||
13367474|NCT00842309|26705932|FG001|Overall Study|Withdrawal by Subject|1|||
13367475|NCT00842257|26705941|FG000|Overall Study|Adverse Event|1|||
13367476|NCT00842244|26705962|FG000|Overall Study|Death|3|||
13367477|NCT00842244|26705962|FG000|Overall Study|Withdrawal by Subject|1|||
13367478|NCT00842244|26705962|FG000|Overall Study|Other|17|||
13367479|NCT00842153|26706007|FG000|Overall Study|Adverse Event|0|||
13367480|NCT00842153|26706008|FG001|Overall Study|Adverse Event|1|||
13367481|NCT00842153|26706007|FG000|Overall Study|Lost to Follow-up|1|||
13367482|NCT00842153|26706008|FG001|Overall Study|Lost to Follow-up|2|||
13367483|NCT00841906|26706027|FG000|Overall Study|Withdrawal by Subject|2|||
13367484|NCT00841906|26706028|FG001|Overall Study|Withdrawal by Subject|0|||
13367485|NCT00841776|26706051|FG000|Overall Study|Lack of Efficacy|0|||
13367486|NCT00841776|26706052|FG001|Overall Study|Lack of Efficacy|1|||
13367487|NCT00841776|26706051|FG000|Overall Study|Lost to Follow-up|2|||
13367488|NCT00841776|26706052|FG001|Overall Study|Lost to Follow-up|1|||
13367489|NCT00841776|26706051|FG000|Overall Study|Withdrawal by Subject|0|||
13367490|NCT00841776|26706052|FG001|Overall Study|Withdrawal by Subject|1|||
13367491|NCT00841763|26706129|FG000|Overall Study|Withdrawal by Subject|60|||
13367492|NCT00841763|26706130|FG001|Overall Study|Withdrawal by Subject|17|||
13367493|NCT00841763|26706131|FG002|Overall Study|Withdrawal by Subject|4|||
13367494|NCT00841763|26706132|FG003|Overall Study|Withdrawal by Subject|1|||
13367495|NCT00841763|26706129|FG000|Overall Study|Adverse Event|9|||
13367496|NCT00841763|26706130|FG001|Overall Study|Adverse Event|10|||
13367497|NCT00841763|26706131|FG002|Overall Study|Adverse Event|3|||
13367498|NCT00841763|26706132|FG003|Overall Study|Adverse Event|2|||
13367499|NCT00841763|26706129|FG000|Overall Study|Lost to Follow-up|63|||
13367500|NCT00841763|26706130|FG001|Overall Study|Lost to Follow-up|25|||
13367501|NCT00841763|26706131|FG002|Overall Study|Lost to Follow-up|0|||
13367502|NCT00841763|26706132|FG003|Overall Study|Lost to Follow-up|0|||
13367503|NCT00841763|26706129|FG000|Overall Study|Protocol Violation|20|||
13367504|NCT00841763|26706130|FG001|Overall Study|Protocol Violation|3|||
13367505|NCT00841763|26706131|FG002|Overall Study|Protocol Violation|1|||
13367506|NCT00841763|26706132|FG003|Overall Study|Protocol Violation|0|||
13367507|NCT00841763|26706129|FG000|Overall Study|Administrative Reasons|3|||
13367508|NCT00841763|26706130|FG001|Overall Study|Administrative Reasons|1|||
13367509|NCT00841763|26706131|FG002|Overall Study|Administrative Reasons|0|||
13367510|NCT00841763|26706132|FG003|Overall Study|Administrative Reasons|0|||
13367511|NCT00841763|26706129|FG000|Overall Study|Unable to Classify|7|||
13367512|NCT00841763|26706130|FG001|Overall Study|Unable to Classify|1|||
13367513|NCT00841763|26706131|FG002|Overall Study|Unable to Classify|0|||
13367514|NCT00841763|26706132|FG003|Overall Study|Unable to Classify|0|||
13367515|NCT00841672|26706153|FG000|Overall Study|Adverse Event|7|||
13367516|NCT00841672|26706154|FG001|Overall Study|Adverse Event|16|||
13367517|NCT00841672|26706153|FG000|Overall Study|Abnormal test procedure result(s)|0|||
13367518|NCT00841672|26706154|FG001|Overall Study|Abnormal test procedure result(s)|1|||
13367519|NCT00841672|26706153|FG000|Overall Study|Subject withdrew consent|2|||
13367520|NCT00841672|26706154|FG001|Overall Study|Subject withdrew consent|4|||
13367521|NCT00841672|26706153|FG000|Overall Study|Lost to Follow-up|1|||
13367522|NCT00841672|26706154|FG001|Overall Study|Lost to Follow-up|1|||
13367523|NCT00841672|26706153|FG000|Overall Study|Administrative problems|9|||
13367524|NCT00841672|26706154|FG001|Overall Study|Administrative problems|9|||
13367525|NCT00841672|26706153|FG000|Overall Study|Misrandomized|1|||
13367526|NCT00841672|26706154|FG001|Overall Study|Misrandomized|0|||
13367527|NCT00841672|26706153|FG000|Overall Study|Protocol Deviation|0|||
13367528|NCT00841672|26706154|FG001|Overall Study|Protocol Deviation|1|||
13367529|NCT00841568|26706169|FG000|Overall Study|Adverse Event|1|||
13367530|NCT00841568|26706169|FG000|Overall Study|Death|1|||
13367531|NCT00841568|26706169|FG000|Overall Study|Withdrawal by Subject|2|||
13367532|NCT00841568|26706169|FG000|Overall Study|Creatinine over the withdrawal criteria|1|||
13367533|NCT00841321|26706188|FG000|Overall Study|Lost to Follow-up|1|||
13367534|NCT00841321|26706189|FG001|Overall Study|Lost to Follow-up|1|||
13367535|NCT00841321|26706188|FG000|Overall Study|Adverse Event|0|||
13367536|NCT00841321|26706189|FG001|Overall Study|Adverse Event|2|||
13367537|NCT00841100|26706195|FG000|Phase 1 (28 Days)|Adverse Event|1|||
13367538|NCT00841100|26706195|FG000|Phase 1 (28 Days)|Participant non-compliance|2|||
13367539|NCT00841035|26706202|FG000|Phase 1 Overall Study|Physician Decision|13|||
13367540|NCT00840996|26706227|FG000|Overall Study|Withdrawal by Subject|1|||
13367541|NCT00840996|26706228|FG001|Overall Study|Withdrawal by Subject|0|||
13367542|NCT00840970|26706250|FG000|Overall Study|Adverse Event|0|||
13367543|NCT00840970|26706251|FG001|Overall Study|Adverse Event|0|||
13367544|NCT00840970|26706252|FG002|Overall Study|Adverse Event|1|||
13367545|NCT00840827|26706267|FG000|Overall Study|Adverse Event|1|||
13367546|NCT00840827|26706267|FG000|Overall Study|Lack of Efficacy|4|||
13367547|NCT00840827|26706267|FG000|Overall Study|Physician Decision|1|||
13367548|NCT00840749|26706282|FG000|Overall Study|Death|1|||
13367549|NCT00840749|26706283|FG001|Overall Study|Death|2|||
13367550|NCT00840749|26706282|FG000|Overall Study|not treated on study arm|11|||
13367551|NCT00840749|26706283|FG001|Overall Study|not treated on study arm|11|||
13367552|NCT00840749|26706282|FG000|Overall Study|study closed|19|||
13367553|NCT00840749|26706283|FG001|Overall Study|study closed|14|||
13367554|NCT00840658|26706312|FG000|Overall Study|Death|2|||
13367555|NCT00840658|26706313|FG001|Overall Study|Death|2|||
13367556|NCT00840658|26706314|FG002|Overall Study|Death|3|||
13367557|NCT00840658|26706315|FG003|Overall Study|Death|3|||
13367558|NCT00840658|26706312|FG000|Overall Study|Lost to Follow-up|3|||
13367559|NCT00840658|26706313|FG001|Overall Study|Lost to Follow-up|1|||
13367560|NCT00840658|26706314|FG002|Overall Study|Lost to Follow-up|2|||
13367561|NCT00840658|26706315|FG003|Overall Study|Lost to Follow-up|1|||
13367562|NCT00840463|26706336|FG000|Overall Study|Adverse Event|1|||
13367563|NCT00840463|26706337|FG001|Overall Study|Adverse Event|0|||
13367564|NCT00840450|26706345|FG000|Overall Study|Adverse Event|1|||
13367565|NCT00840450|26706345|FG000|Overall Study|Lack of Efficacy|2|||
13367566|NCT00840294|26706360|FG000|Overall Study|Withdrawal by Subject|2|||
13367567|NCT00840294|26706361|FG001|Overall Study|Withdrawal by Subject|1|||
13367568|NCT00840294|26706360|FG000|Overall Study|Protocol Violation|1|||
13367569|NCT00840294|26706361|FG001|Overall Study|Protocol Violation|3|||
13367570|NCT00840294|26706360|FG000|Overall Study|Illness|0|||
13367571|NCT00840294|26706361|FG001|Overall Study|Illness|1|||
13367572|NCT00840086|26706370|FG000|Overall Study|Adverse Event|1|||
13367573|NCT00840086|26706370|FG000|Overall Study|Protocol Violation|2|||
13367574|NCT00840086|26706370|FG000|Overall Study|Lost to Follow-up|1|||
13367575|NCT00840060|26706385|FG000|Overall Study|Withdrawal by Subject|1|||
13367576|NCT00840060|26706386|FG001|Overall Study|Withdrawal by Subject|0|||
13367577|NCT00840060|26706385|FG000|Overall Study|Change in emotional/behavioral status|0|||
13367578|NCT00840060|26706386|FG001|Overall Study|Change in emotional/behavioral status|1|||
13367579|NCT00840034|26706429|FG000|Acute Treatment Phase|Adverse Event|6|||
13367580|NCT00840034|26706430|FG001|Acute Treatment Phase|Adverse Event|8|||
13367581|NCT00840034|26706429|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
13367582|NCT00840034|26706430|FG001|Acute Treatment Phase|Lack of Efficacy|0|||
13367583|NCT00840034|26706429|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
13367584|NCT00840034|26706430|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
13367585|NCT00840034|26706429|FG000|Acute Treatment Phase|Physician Decision|0|||
13367586|NCT00840034|26706430|FG001|Acute Treatment Phase|Physician Decision|1|||
13367587|NCT00840034|26706429|FG000|Acute Treatment Phase|Protocol Violation|2|||
13367588|NCT00840034|26706430|FG001|Acute Treatment Phase|Protocol Violation|4|||
13367589|NCT00840034|26706429|FG000|Acute Treatment Phase|Withdrawal by Subject|6|||
13367590|NCT00840034|26706430|FG001|Acute Treatment Phase|Withdrawal by Subject|11|||
13367591|NCT00840034|26706429|FG000|Taper Phase|Adverse Event|1|||
13367592|NCT00840034|26706430|FG001|Taper Phase|Adverse Event|0|||
13367593|NCT00840034|26706429|FG000|Taper Phase|Lost to Follow-up|1|||
13367594|NCT00840034|26706430|FG001|Taper Phase|Lost to Follow-up|1|||
13367595|NCT00840034|26706429|FG000|Taper Phase|Withdrawal by Subject|1|||
13367596|NCT00840034|26706430|FG001|Taper Phase|Withdrawal by Subject|1|||
13367597|NCT00839956|26706439|FG000|Overall Study|Adverse Event|2|||
13367598|NCT00839956|26706439|FG000|Overall Study|Lack of Efficacy|6|||
13367599|NCT00839956|26706439|FG000|Overall Study|Physician Decision|1|||
13367600|NCT00839956|26706439|FG000|Overall Study|Withdrawal by Subject|3|||
13367601|NCT00839917|26706482|FG000|Overall Study|Lost to Follow-up|1|||
13367602|NCT00839917|26706483|FG001|Overall Study|Lost to Follow-up|0|||
13367603|NCT00839917|26706482|FG000|Overall Study|Did not receive vaccine|0|||
13367604|NCT00839917|26706483|FG001|Overall Study|Did not receive vaccine|1|||
13367605|NCT00839852|26706490|FG000|Overall Study|Adverse Event|10|||
13367606|NCT00839852|26706490|FG000|Overall Study|Insufficient Therapeutic Response|3|||
13367607|NCT00839852|26706490|FG000|Overall Study|Protocol Violation|9|||
13367608|NCT00839852|26706490|FG000|Overall Study|Withdrawal of Consent|16|||
13367609|NCT00839852|26706490|FG000|Overall Study|Lost to Follow-up|7|||
13367610|NCT00839852|26706490|FG000|Overall Study|Lack of Compliance While in Jail|1|||
13367611|NCT00839852|26706490|FG000|Overall Study|Pregnancy|1|||
13367612|NCT00839800|26706527|FG000|Overall Study|Adverse Event|8|||
13367613|NCT00839800|26706528|FG001|Overall Study|Adverse Event|12|||
13367614|NCT00839800|26706527|FG000|Overall Study|Lost to Follow-up|31|||
13367615|NCT00839800|26706528|FG001|Overall Study|Lost to Follow-up|26|||
13367616|NCT00839800|26706527|FG000|Overall Study|Withdrawal by Subject|28|||
13367617|NCT00839800|26706528|FG001|Overall Study|Withdrawal by Subject|34|||
13367618|NCT00839800|26706527|FG000|Overall Study|Incorrect Enrolment|3|||
13367619|NCT00839800|26706528|FG001|Overall Study|Incorrect Enrolment|3|||
13367620|NCT00839800|26706527|FG000|Overall Study|Study-Specific Discontinuation Criteria|6|||
13367621|NCT00839800|26706528|FG001|Overall Study|Study-Specific Discontinuation Criteria|13|||
13367622|NCT00839800|26706527|FG000|Overall Study|Safety Reasons|2|||
13367623|NCT00839800|26706528|FG001|Overall Study|Safety Reasons|1|||
13367624|NCT00839800|26706527|FG000|Overall Study|Other|8|||
13367625|NCT00839800|26706528|FG001|Overall Study|Other|14|||
13367626|NCT00839800|26706527|FG000|Overall Study|Severe Non-Compliance to Protocol|7|||
13367627|NCT00839800|26706528|FG001|Overall Study|Severe Non-Compliance to Protocol|7|||
13367628|NCT00839527|26706570|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
13367629|NCT00839527|26706571|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29|||
13367630|NCT00839527|26706572|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22|||
13367631|NCT00839527|26706570|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4|||
13367632|NCT00839527|26706571|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7|||
13367633|NCT00839527|26706572|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1|||
13367634|NCT00839527|26706570|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5|||
13367635|NCT00839527|26706571|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6|||
13367636|NCT00839527|26706572|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16|||
13367637|NCT00839527|26706570|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3|||
13367638|NCT00839527|26706571|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12|||
13367639|NCT00839527|26706572|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
13367640|NCT00839527|26706570|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32|||
13367641|NCT00839527|26706571|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46|||
13367642|NCT00839527|26706572|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64|||
13367643|NCT00839527|26706570|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
13367644|NCT00839527|26706571|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6|||
13367645|NCT00839527|26706572|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
13367646|NCT00839527|26706570|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3|||
13367647|NCT00839527|26706571|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8|||
13367648|NCT00839527|26706572|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5|||
13367649|NCT00839527|26706570|FG000|Treatment Period (TP) (156 Weeks)|Missing|0|||
13367650|NCT00839527|26706571|FG001|Treatment Period (TP) (156 Weeks)|Missing|1|||
13367651|NCT00839527|26706572|FG002|Treatment Period (TP) (156 Weeks)|Missing|0|||
13367652|NCT00839527|26706570|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
13367653|NCT00839527|26706571|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
13367654|NCT00839527|26706572|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1|||
13367655|NCT00839527|26706570|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
13367656|NCT00839527|26706571|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
13367657|NCT00839527|26706572|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
13367658|NCT00839527|26706570|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1|||
13367659|NCT00839527|26706571|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2|||
13367660|NCT00839527|26706572|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0|||
13367661|NCT00839527|26706570|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
13367662|NCT00839527|26706571|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
13367663|NCT00839527|26706572|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1|||
13367664|NCT00839527|26706570|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
13367665|NCT00839527|26706571|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2|||
13367666|NCT00839527|26706572|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
13367667|NCT00839527|26706570|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
13367668|NCT00839527|26706571|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
13367669|NCT00839527|26706572|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5|||
13367670|NCT00839527|26706570|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8|||
13367671|NCT00839527|26706571|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20|||
13367672|NCT00839527|26706572|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29|||
13367673|NCT00839527|26706570|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12|||
13367674|NCT00839527|26706571|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21|||
13367675|NCT00839527|26706572|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19|||
13367676|NCT00839527|26706570|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
13367677|NCT00839527|26706571|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
13367678|NCT00839527|26706572|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
13367679|NCT00839527|26706570|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3|||
13367680|NCT00839527|26706571|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10|||
13367681|NCT00839527|26706572|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5|||
13367682|NCT00839527|26706570|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1|||
13367683|NCT00839527|26706571|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
13367684|NCT00839527|26706572|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
13367685|NCT00839527|26706570|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1|||
13367686|NCT00839527|26706571|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
13367687|NCT00839527|26706572|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
13367688|NCT00839527|26706570|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
13367689|NCT00839527|26706571|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1|||
13367690|NCT00839527|26706572|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
13367691|NCT00839527|26706570|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
13367692|NCT00839527|26706571|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0|||
13367693|NCT00839527|26706572|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
13367694|NCT00839527|26706570|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
13367695|NCT00839527|26706571|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1|||
13367696|NCT00839527|26706572|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
13367697|NCT00839527|26706570|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0|||
13367698|NCT00839527|26706571|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
13367699|NCT00839527|26706572|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
13367700|NCT00839436|26706590|FG000|Overall Study|Developed exclusionary condition|1|||
13367701|NCT00839436|26706591|FG001|Overall Study|Developed exclusionary condition|0|||
13367702|NCT00839436|26706592|FG002|Overall Study|Developed exclusionary condition|0|||
13367703|NCT00839436|26706590|FG000|Overall Study|Withdrawal by Subject|0|||
13367704|NCT00839436|26706591|FG001|Overall Study|Withdrawal by Subject|1|||
13367705|NCT00839436|26706592|FG002|Overall Study|Withdrawal by Subject|0|||
13367706|NCT00839436|26706590|FG000|Overall Study|Study drug no longer available|0|||
13367707|NCT00839436|26706591|FG001|Overall Study|Study drug no longer available|0|||
13367708|NCT00839436|26706592|FG002|Overall Study|Study drug no longer available|1|||
13367709|NCT00839423|26706643|FG000|Overall Study|Adverse Event|4|||
13367710|NCT00839423|26706644|FG001|Overall Study|Adverse Event|3|||
13367711|NCT00839423|26706645|FG002|Overall Study|Adverse Event|7|||
13367712|NCT00839423|26706646|FG003|Overall Study|Adverse Event|16|||
13367713|NCT00839423|26706643|FG000|Overall Study|Lack of Efficacy|6|||
13367714|NCT00839423|26706644|FG001|Overall Study|Lack of Efficacy|6|||
13367715|NCT00839423|26706645|FG002|Overall Study|Lack of Efficacy|3|||
13367716|NCT00839423|26706646|FG003|Overall Study|Lack of Efficacy|2|||
13367717|NCT00839423|26706643|FG000|Overall Study|Non-compliance|0|||
13367718|NCT00839423|26706644|FG001|Overall Study|Non-compliance|0|||
13367719|NCT00839423|26706645|FG002|Overall Study|Non-compliance|0|||
13367720|NCT00839423|26706646|FG003|Overall Study|Non-compliance|1|||
13367721|NCT00839423|26706643|FG000|Overall Study|Protocol Violation|0|||
13367722|NCT00839423|26706644|FG001|Overall Study|Protocol Violation|1|||
13367723|NCT00839423|26706645|FG002|Overall Study|Protocol Violation|2|||
13367724|NCT00839423|26706646|FG003|Overall Study|Protocol Violation|0|||
13367725|NCT00839423|26706643|FG000|Overall Study|Withdrawal of consent|4|||
13367726|NCT00839423|26706644|FG001|Overall Study|Withdrawal of consent|0|||
13367727|NCT00839423|26706645|FG002|Overall Study|Withdrawal of consent|4|||
13367728|NCT00839423|26706646|FG003|Overall Study|Withdrawal of consent|1|||
13367729|NCT00839423|26706643|FG000|Overall Study|Lost to Follow-up|1|||
13367730|NCT00839423|26706644|FG001|Overall Study|Lost to Follow-up|0|||
13367731|NCT00839423|26706645|FG002|Overall Study|Lost to Follow-up|1|||
13367732|NCT00839423|26706646|FG003|Overall Study|Lost to Follow-up|0|||
13367733|NCT00839423|26706643|FG000|Overall Study|Administrative or other reasons|3|||
13367734|NCT00839423|26706644|FG001|Overall Study|Administrative or other reasons|0|||
13367735|NCT00839423|26706645|FG002|Overall Study|Administrative or other reasons|1|||
13367736|NCT00839423|26706646|FG003|Overall Study|Administrative or other reasons|0|||
13367737|NCT00839332|26706679|FG000|Phase 1|Disease Progression|38|||
13367738|NCT00839332|26706680|FG001|Phase 1|Disease Progression|0|||
13367739|NCT00839332|26706681|FG002|Phase 1|Disease Progression|0|||
13367740|NCT00839332|26706679|FG000|Phase 1|Adverse Event|6|||
13367741|NCT00839332|26706680|FG001|Phase 1|Adverse Event|0|||
13367742|NCT00839332|26706681|FG002|Phase 1|Adverse Event|0|||
13367743|NCT00839332|26706679|FG000|Phase 1|Withdrawal by Subject|4|||
13367744|NCT00839332|26706680|FG001|Phase 1|Withdrawal by Subject|0|||
13367745|NCT00839332|26706681|FG002|Phase 1|Withdrawal by Subject|0|||
13367746|NCT00839332|26706679|FG000|Phase 1|Physician Decision|2|||
13367747|NCT00839332|26706680|FG001|Phase 1|Physician Decision|0|||
13367748|NCT00839332|26706681|FG002|Phase 1|Physician Decision|0|||
13367749|NCT00839332|26706679|FG000|Phase 2|Protocol Violation|0|||
13367750|NCT00839332|26706680|FG001|Phase 2|Protocol Violation|1|||
13367751|NCT00839332|26706681|FG002|Phase 2|Protocol Violation|0|||
13367752|NCT00839332|26706679|FG000|Phase 2|Disease Progression|0|||
13367753|NCT00839332|26706680|FG001|Phase 2|Disease Progression|46|||
13367754|NCT00839332|26706681|FG002|Phase 2|Disease Progression|21|||
13367755|NCT00839332|26706679|FG000|Phase 2|Adverse Event|0|||
13367756|NCT00839332|26706680|FG001|Phase 2|Adverse Event|8|||
13367757|NCT00839332|26706681|FG002|Phase 2|Adverse Event|6|||
13367758|NCT00839332|26706679|FG000|Phase 2|Death|0|||
13367759|NCT00839332|26706680|FG001|Phase 2|Death|4|||
13367760|NCT00839332|26706681|FG002|Phase 2|Death|2|||
13367761|NCT00839332|26706679|FG000|Phase 2|Withdrawal by Subject|0|||
13367762|NCT00839332|26706680|FG001|Phase 2|Withdrawal by Subject|5|||
13367763|NCT00839332|26706681|FG002|Phase 2|Withdrawal by Subject|8|||
13367764|NCT00839332|26706679|FG000|Phase 2|Physician Decision|0|||
13367765|NCT00839332|26706680|FG001|Phase 2|Physician Decision|4|||
13367766|NCT00839332|26706681|FG002|Phase 2|Physician Decision|1|||
13367767|NCT00839332|26706679|FG000|Phase 2|Lost to Follow-up|0|||
13367768|NCT00839332|26706680|FG001|Phase 2|Lost to Follow-up|0|||
13367769|NCT00839332|26706681|FG002|Phase 2|Lost to Follow-up|1|||
13367770|NCT00839306|26706696|FG000|Overall Study|Adverse Event|3|||
13367771|NCT00839306|26706697|FG001|Overall Study|Adverse Event|5|||
13367772|NCT00839306|26706696|FG000|Overall Study|Lost to Follow-up|6|||
13367773|NCT00839306|26706697|FG001|Overall Study|Lost to Follow-up|9|||
13367774|NCT00839306|26706696|FG000|Overall Study|Withdrawal by Subject|5|||
13367775|NCT00839306|26706697|FG001|Overall Study|Withdrawal by Subject|7|||
13367776|NCT00839306|26706696|FG000|Overall Study|Lack of Efficacy|5|||
13367777|NCT00839306|26706697|FG001|Overall Study|Lack of Efficacy|4|||
13367778|NCT00839306|26706696|FG000|Overall Study|Other|6|||
13367779|NCT00839306|26706697|FG001|Overall Study|Other|18|||
13367780|NCT00839254|26706956|FG000|Overall Study|Protocol Violation|0|||
13367781|NCT00839254|26706957|FG001|Overall Study|Protocol Violation|1|||
13367782|NCT00839254|26706958|FG002|Overall Study|Protocol Violation|1|||
13367783|NCT00839254|26706959|FG003|Overall Study|Protocol Violation|1|||
13367784|NCT00839254|26706960|FG004|Overall Study|Protocol Violation|0|||
13367785|NCT00839254|26706961|FG005|Overall Study|Protocol Violation|0|||
13367786|NCT00839254|26706962|FG006|Overall Study|Protocol Violation|1|||
13367787|NCT00839254|26706963|FG007|Overall Study|Protocol Violation|2|||
13367788|NCT00839254|26706956|FG000|Overall Study|Physician Decision|0|||
13367789|NCT00839254|26706957|FG001|Overall Study|Physician Decision|1|||
13367790|NCT00839254|26706958|FG002|Overall Study|Physician Decision|0|||
13367791|NCT00839254|26706959|FG003|Overall Study|Physician Decision|0|||
13367792|NCT00839254|26706960|FG004|Overall Study|Physician Decision|0|||
13367793|NCT00839254|26706961|FG005|Overall Study|Physician Decision|0|||
13367794|NCT00839254|26706962|FG006|Overall Study|Physician Decision|0|||
13367795|NCT00839254|26706963|FG007|Overall Study|Physician Decision|1|||
13367796|NCT00839254|26706956|FG000|Overall Study|Wrong treatment number allocation|0|||
13367797|NCT00839254|26706957|FG001|Overall Study|Wrong treatment number allocation|1|||
13367798|NCT00839254|26706958|FG002|Overall Study|Wrong treatment number allocation|0|||
13367799|NCT00839254|26706959|FG003|Overall Study|Wrong treatment number allocation|0|||
13367800|NCT00839254|26706960|FG004|Overall Study|Wrong treatment number allocation|0|||
13367801|NCT00839254|26706961|FG005|Overall Study|Wrong treatment number allocation|1|||
13367802|NCT00839254|26706962|FG006|Overall Study|Wrong treatment number allocation|0|||
13367803|NCT00839254|26706963|FG007|Overall Study|Wrong treatment number allocation|0|||
13367804|NCT00839254|26706956|FG000|Overall Study|Adverse Event|12|||
13367805|NCT00839254|26706957|FG001|Overall Study|Adverse Event|6|||
13367806|NCT00839254|26706958|FG002|Overall Study|Adverse Event|3|||
13367807|NCT00839254|26706959|FG003|Overall Study|Adverse Event|5|||
13367808|NCT00839254|26706960|FG004|Overall Study|Adverse Event|2|||
13367809|NCT00839254|26706961|FG005|Overall Study|Adverse Event|1|||
13367810|NCT00839254|26706962|FG006|Overall Study|Adverse Event|0|||
13367811|NCT00839254|26706963|FG007|Overall Study|Adverse Event|1|||
13367812|NCT00839254|26706956|FG000|Overall Study|Withdrawal by Subject|87|||
13367813|NCT00839254|26706957|FG001|Overall Study|Withdrawal by Subject|53|||
13367814|NCT00839254|26706958|FG002|Overall Study|Withdrawal by Subject|54|||
13367815|NCT00839254|26706959|FG003|Overall Study|Withdrawal by Subject|32|||
13367816|NCT00839254|26706960|FG004|Overall Study|Withdrawal by Subject|27|||
13367817|NCT00839254|26706961|FG005|Overall Study|Withdrawal by Subject|15|||
13367818|NCT00839254|26706962|FG006|Overall Study|Withdrawal by Subject|22|||
13367819|NCT00839254|26706963|FG007|Overall Study|Withdrawal by Subject|9|||
13367820|NCT00839254|26706956|FG000|Overall Study|Wrong group allocation|0|||
13367821|NCT00839254|26706957|FG001|Overall Study|Wrong group allocation|0|||
13367822|NCT00839254|26706958|FG002|Overall Study|Wrong group allocation|0|||
13367823|NCT00839254|26706959|FG003|Overall Study|Wrong group allocation|0|||
13367824|NCT00839254|26706960|FG004|Overall Study|Wrong group allocation|0|||
13367825|NCT00839254|26706961|FG005|Overall Study|Wrong group allocation|0|||
13367826|NCT00839254|26706962|FG006|Overall Study|Wrong group allocation|1|||
13367827|NCT00839254|26706963|FG007|Overall Study|Wrong group allocation|0|||
13367828|NCT00839254|26706956|FG000|Overall Study|Parents wanted pneumococcal vaccine|1|||
13367829|NCT00839254|26706957|FG001|Overall Study|Parents wanted pneumococcal vaccine|0|||
13367830|NCT00839254|26706958|FG002|Overall Study|Parents wanted pneumococcal vaccine|0|||
13367831|NCT00839254|26706959|FG003|Overall Study|Parents wanted pneumococcal vaccine|0|||
13367832|NCT00839254|26706960|FG004|Overall Study|Parents wanted pneumococcal vaccine|0|||
13367833|NCT00839254|26706961|FG005|Overall Study|Parents wanted pneumococcal vaccine|1|||
13367834|NCT00839254|26706962|FG006|Overall Study|Parents wanted pneumococcal vaccine|0|||
13367835|NCT00839254|26706963|FG007|Overall Study|Parents wanted pneumococcal vaccine|0|||
13367836|NCT00839254|26706956|FG000|Overall Study|Withdrawn due to non-compliance|2|||
13367837|NCT00839254|26706957|FG001|Overall Study|Withdrawn due to non-compliance|0|||
13486421|NCT03181529|27036165|FG000|Overall Study|Withdrawal by Subject|1|||
13486422|NCT03181529|27036166|FG001|Overall Study|Withdrawal by Subject|1|||
13486423|NCT03181529|27036165|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1|||
13486424|NCT03181529|27036166|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0|||
13486425|NCT02779556|27036185|FG000|Baseline|Partial baseline interview completed|1|||
13486426|NCT02779556|27036186|FG001|Baseline|Partial baseline interview completed|0|||
13486427|NCT02779556|27036185|FG000|3 Months|Lost to Follow-up|40|||
13486428|NCT02779556|27036186|FG001|3 Months|Lost to Follow-up|29|||
13486429|NCT02779556|27036185|FG000|3 Months|Missed 3 month clinic visit|27|||
13486430|NCT02779556|27036186|FG001|3 Months|Missed 3 month clinic visit|19|||
13486431|NCT02779556|27036185|FG000|6 Month|Lost to Follow-up|33|||
13486432|NCT02779556|27036186|FG001|6 Month|Lost to Follow-up|39|||
13486433|NCT02779556|27036185|FG000|6 Month HbA1c|No value collected during window|69|||
13486434|NCT02779556|27036186|FG001|6 Month HbA1c|No value collected during window|50|||
13486435|NCT02779556|27036185|FG000|12 Month HbA1c|No value collected during window|138|||
13486436|NCT02779556|27036186|FG001|12 Month HbA1c|No value collected during window|102|||
13486437|NCT02675751|27036220|FG000|Overall Study|Lost to Follow-up|16|||
13486438|NCT02334722|27036261|FG000|Overall Study|Lost to Follow-up|4|||
13486439|NCT02334722|27036262|FG001|Overall Study|Lost to Follow-up|0|||
13367838|NCT00839254|26706958|FG002|Overall Study|Withdrawn due to non-compliance|0|||
13367839|NCT00839254|26706959|FG003|Overall Study|Withdrawn due to non-compliance|0|||
13367840|NCT00839254|26706960|FG004|Overall Study|Withdrawn due to non-compliance|0|||
13367841|NCT00839254|26706961|FG005|Overall Study|Withdrawn due to non-compliance|0|||
13367842|NCT00839254|26706962|FG006|Overall Study|Withdrawn due to non-compliance|0|||
13486440|NCT02334722|27036261|FG000|Overall Study|6 week questionnaire not completed|2|||
13486441|NCT02334722|27036262|FG001|Overall Study|6 week questionnaire not completed|0|||
13486442|NCT02334722|27036261|FG000|Overall Study|Unable to obtain medication|1|||
13486443|NCT02334722|27036262|FG001|Overall Study|Unable to obtain medication|1|||
13486444|NCT02334722|27036261|FG000|Overall Study|Withdrawal by Subject|0|||
13486445|NCT02334722|27036262|FG001|Overall Study|Withdrawal by Subject|3|||
13486446|NCT02334722|27036261|FG000|Overall Study|Adverse Event|0|||
13486447|NCT02334722|27036262|FG001|Overall Study|Adverse Event|2|||
13486448|NCT02334722|27036261|FG000|Overall Study|Physician Decision|0|||
13486449|NCT02334722|27036262|FG001|Overall Study|Physician Decision|1|||
13486450|NCT00812708|27036323|FG000|Overall Study|Device could not be implanted|2|||
13486451|NCT00812708|27036323|FG000|Overall Study|Lack of medical insurance|1|||
13486452|NCT00812708|27036323|FG000|Overall Study|Switched to another study|1|||
13486453|NCT00812708|27036323|FG000|Overall Study|Surgery cancelled due to uveitis|1|||
13486454|NCT00812708|27036323|FG000|Overall Study|Signed consent but later withdrew|3|||
13486455|NCT00741988|27036342|FG000|Overall Study|Adverse Event|2|||
13486456|NCT00741988|27036343|FG001|Overall Study|Adverse Event|4|||
13486457|NCT00741988|27036342|FG000|Overall Study|Lack of Efficacy|2|||
13486458|NCT00741988|27036343|FG001|Overall Study|Lack of Efficacy|0|||
13486459|NCT00515671|27036378|FG000|Overall Study|Lost to Follow-up|13|||
13486460|NCT00515671|27036379|FG001|Overall Study|Lost to Follow-up|10|||
13486461|NCT00515671|27036378|FG000|Overall Study|Withdrawal by Subject|3|||
13486462|NCT00515671|27036379|FG001|Overall Study|Withdrawal by Subject|5|||
13486463|NCT00515671|27036378|FG000|Overall Study|incarcerated|1|||
13486464|NCT00515671|27036379|FG001|Overall Study|incarcerated|2|||
13486465|NCT00455403|27036392|FG000|Overall Study|Lost to Follow-up|2|||
13486466|NCT00455403|27036393|FG001|Overall Study|Lost to Follow-up|1|||
13486467|NCT00455403|27036392|FG000|Overall Study|Withdrawal by Subject|1|||
13486468|NCT00455403|27036393|FG001|Overall Study|Withdrawal by Subject|3|||
13367843|NCT00839254|26706963|FG007|Overall Study|Withdrawn due to non-compliance|0|||
13367844|NCT00839254|26706956|FG000|Overall Study|Lost to Follow-up|51|||
13367845|NCT00839254|26706957|FG001|Overall Study|Lost to Follow-up|30|||
13367846|NCT00839254|26706958|FG002|Overall Study|Lost to Follow-up|32|||
13367847|NCT00839254|26706959|FG003|Overall Study|Lost to Follow-up|24|||
13367848|NCT00839254|26706960|FG004|Overall Study|Lost to Follow-up|8|||
13367849|NCT00839254|26706961|FG005|Overall Study|Lost to Follow-up|8|||
13367850|NCT00839254|26706962|FG006|Overall Study|Lost to Follow-up|4|||
13367851|NCT00839254|26706963|FG007|Overall Study|Lost to Follow-up|2|||
13367852|NCT00839098|26706999|FG000|Overall Study|Withdrawal by Subject|2|||
13367853|NCT00839098|26707000|FG001|Overall Study|Withdrawal by Subject|1|||
13367854|NCT00839098|26707001|FG002|Overall Study|Withdrawal by Subject|7|||
13367855|NCT00839072|26707020|FG000|First Intervention Period|Withdrawal by Subject|1|||
13367856|NCT00839072|26707021|FG001|First Intervention Period|Withdrawal by Subject|0|||
13367857|NCT00839072|26707020|FG000|First Intervention Period|Adverse Event|1|||
13367858|NCT00839072|26707021|FG001|First Intervention Period|Adverse Event|1|||
13367859|NCT00839072|26707020|FG000|Second Intervention Period|Withdrawal by Subject|1|||
13367860|NCT00839072|26707021|FG001|Second Intervention Period|Withdrawal by Subject|0|||
13367861|NCT00838929|26707037|FG000|Overall Study|Protocol Violation|0|||
13367862|NCT00838929|26707038|FG001|Overall Study|Protocol Violation|1|||
13367863|NCT00838929|26707039|FG002|Overall Study|Protocol Violation|0|||
13367864|NCT00838929|26707037|FG000|Overall Study|Disease progression|0|||
13486469|NCT00455403|27036392|FG000|Overall Study|Protocol Violation|0|||
13486470|NCT00455403|27036393|FG001|Overall Study|Protocol Violation|2|||
13486471|NCT05159362|27036410|FG000|Field Testing (4 Weeks)|Withdrawal by Subject|1|||
13486472|NCT05159362|27036411|FG001|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
13486473|NCT05159362|27036412|FG002|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
13488122|NCT03858634|27042764|FG000|Overall Study|Other, Not Specified|1|||
13488123|NCT03858634|27042765|FG001|Overall Study|Other, Not Specified|1|||
13488124|NCT03819114|27042826|FG000|Overall Study|Protocol Violation|0|||
13488125|NCT03819114|27042827|FG001|Overall Study|Protocol Violation|1|||
13488126|NCT03819114|27042828|FG002|Overall Study|Protocol Violation|1|||
13488127|NCT03819114|27042829|FG003|Overall Study|Protocol Violation|0|||
13488128|NCT03819114|27042826|FG000|Overall Study|Lost to Follow-up|0|||
13488129|NCT03819114|27042827|FG001|Overall Study|Lost to Follow-up|0|||
13488130|NCT03819114|27042828|FG002|Overall Study|Lost to Follow-up|1|||
13488131|NCT03819114|27042829|FG003|Overall Study|Lost to Follow-up|0|||
13488378|NCT02959918|27043328|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1|||
13488379|NCT02959918|27043329|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0|||
13367865|NCT00838929|26707038|FG001|Overall Study|Disease progression|2|||
13488380|NCT02959918|27043330|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0|||
13488381|NCT02959918|27043331|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0|||
13488382|NCT02959918|27043332|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0|||
13488383|NCT02959918|27043333|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0|||
13488384|NCT02959918|27043320|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
13488385|NCT02959918|27043321|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
13486474|NCT03761810|27036465|FG000|Overall Study|Adverse Event|12|||
13486475|NCT03761810|27036466|FG001|Overall Study|Adverse Event|0|||
13486476|NCT03761810|27036465|FG000|Overall Study|Lost to Follow-up|15|||
13486477|NCT03761810|27036466|FG001|Overall Study|Lost to Follow-up|7|||
13486478|NCT03761810|27036465|FG000|Overall Study|Pregnancy|1|||
13486479|NCT03761810|27036466|FG001|Overall Study|Pregnancy|0|||
13486480|NCT03761810|27036465|FG000|Overall Study|Withdrawal by Subject|14|||
13486481|NCT03761810|27036466|FG001|Overall Study|Withdrawal by Subject|5|||
13486482|NCT03761810|27036465|FG000|Overall Study|Physician Decision|1|||
13486483|NCT03761810|27036466|FG001|Overall Study|Physician Decision|0|||
13486484|NCT03761810|27036465|FG000|Overall Study|Withdrawal by Parent/Guardian|4|||
13486485|NCT03761810|27036466|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
13486486|NCT03761810|27036465|FG000|Overall Study|Other Than Specified|1|||
13486487|NCT03761810|27036466|FG001|Overall Study|Other Than Specified|0|||
13486488|NCT03761784|27036499|FG000|Overall Study|Adverse Event|4|||
13486489|NCT03761784|27036500|FG001|Overall Study|Adverse Event|0|||
13486490|NCT03761784|27036499|FG000|Overall Study|Lost to Follow-up|10|||
13486491|NCT03761784|27036500|FG001|Overall Study|Lost to Follow-up|7|||
13486492|NCT03761784|27036499|FG000|Overall Study|Pregnancy|1|||
13486493|NCT03761784|27036500|FG001|Overall Study|Pregnancy|0|||
13486494|NCT03761784|27036499|FG000|Overall Study|Protocol Violation|2|||
13486495|NCT03761784|27036500|FG001|Overall Study|Protocol Violation|0|||
13486496|NCT03761784|27036499|FG000|Overall Study|Withdrawal by Parent or Guardian|4|||
13486497|NCT03761784|27036500|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
13486498|NCT03761784|27036499|FG000|Overall Study|Withdrawal by Subject|9|||
13486499|NCT03761784|27036500|FG001|Overall Study|Withdrawal by Subject|4|||
13486500|NCT03761784|27036499|FG000|Overall Study|Physician Decision|1|||
13486501|NCT03761784|27036500|FG001|Overall Study|Physician Decision|0|||
13486502|NCT03761784|27036499|FG000|Overall Study|Other Than Specified|1|||
13486503|NCT03761784|27036500|FG001|Overall Study|Other Than Specified|0|||
13486504|NCT03361865|27036518|FG000|Overall Study|Death|17|||
13486505|NCT03361865|27036519|FG001|Overall Study|Death|18|||
13486506|NCT03361865|27036518|FG000|Overall Study|Physician Decision|1|||
13486507|NCT03361865|27036519|FG001|Overall Study|Physician Decision|9|||
13486508|NCT03361865|27036518|FG000|Overall Study|Withdrawal by Subject|1|||
13486509|NCT03361865|27036519|FG001|Overall Study|Withdrawal by Subject|0|||
13486510|NCT02929056|27036571|FG000|Overall Study|Lost to Follow-up|0|||
13486511|NCT02929056|27036572|FG001|Overall Study|Lost to Follow-up|1|||
13486512|NCT02896855|27036615|FG000|Overall Study|Death|50|||
13124966|NCT02935842|25954576|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0|||
13124967|NCT02935842|25954577|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0|||
13124968|NCT02935842|25954574|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1|||
13124969|NCT02935842|25954575|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
13124970|NCT02935842|25954576|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
13124971|NCT02935842|25954577|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0|||
13124972|NCT02935842|25954574|FG000|Testing and Therapy Period 3|Accident prior to treatment|2|||
13124973|NCT02935842|25954575|FG001|Testing and Therapy Period 3|Accident prior to treatment|2|||
13124974|NCT02935842|25954576|FG002|Testing and Therapy Period 3|Accident prior to treatment|0|||
13124975|NCT02935842|25954577|FG003|Testing and Therapy Period 3|Accident prior to treatment|0|||
13486513|NCT02896855|27036616|FG001|Overall Study|Death|40|||
13486514|NCT02896855|27036615|FG000|Overall Study|Lost to Follow-up|15|||
13486515|NCT02896855|27036616|FG001|Overall Study|Lost to Follow-up|9|||
13486516|NCT02896855|27036615|FG000|Overall Study|Withdrawal by Subject|7|||
13486517|NCT02896855|27036616|FG001|Overall Study|Withdrawal by Subject|4|||
13486518|NCT02871778|27036687|FG000|Part A: Treatment Period 1|Adverse Event|1|||
13486519|NCT02871778|27036688|FG001|Part A: Treatment Period 1|Adverse Event|1|||
13486520|NCT02871778|27036689|FG002|Part A: Treatment Period 1|Adverse Event|1|||
13486521|NCT02871778|27036690|FG003|Part A: Treatment Period 1|Adverse Event|0|||
13486522|NCT02871778|27036691|FG004|Part A: Treatment Period 1|Adverse Event|0|||
13486523|NCT02871778|27036692|FG005|Part A: Treatment Period 1|Adverse Event|0|||
13486524|NCT02871778|27036693|FG006|Part A: Treatment Period 1|Adverse Event|0|||
13486525|NCT02871778|27036694|FG007|Part A: Treatment Period 1|Adverse Event|0|||
13486526|NCT02871778|27036687|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
13486527|NCT02871778|27036688|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
13486528|NCT02871778|27036689|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
13486529|NCT02871778|27036690|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
13486530|NCT02871778|27036691|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
13486531|NCT02871778|27036692|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
13486532|NCT02871778|27036693|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
13486533|NCT02871778|27036694|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
13486534|NCT02871778|27036687|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0|||
13486535|NCT02871778|27036688|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0|||
13486536|NCT02871778|27036689|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1|||
13486537|NCT02871778|27036690|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0|||
13124976|NCT02935842|25954574|FG000|Testing and Therapy Period 3|Lost to Follow-up|0|||
13124977|NCT02935842|25954575|FG001|Testing and Therapy Period 3|Lost to Follow-up|0|||
13124978|NCT02935842|25954576|FG002|Testing and Therapy Period 3|Lost to Follow-up|0|||
13124979|NCT02935842|25954577|FG003|Testing and Therapy Period 3|Lost to Follow-up|1|||
13124980|NCT02935842|25954574|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0|||
13124981|NCT02935842|25954575|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0|||
13124982|NCT02935842|25954576|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3|||
13124983|NCT02935842|25954577|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0|||
13124984|NCT02935673|25954709|FG000|Overall Study|Adverse Event|0|||
13486538|NCT02871778|27036691|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0|||
13486539|NCT02871778|27036692|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0|||
13486540|NCT02871778|27036693|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0|||
13486541|NCT02871778|27036694|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0|||
13486542|NCT02871778|27036687|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
13486543|NCT02871778|27036688|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
13486544|NCT02871778|27036689|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1|||
13486545|NCT02871778|27036690|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
13486546|NCT02871778|27036691|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
13486547|NCT02871778|27036692|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
13486548|NCT02871778|27036693|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
13486549|NCT02871778|27036694|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
13486550|NCT02871778|27036687|FG000|Part A: Treatment Period 1|Wrong drug shipment|0|||
13486551|NCT02871778|27036688|FG001|Part A: Treatment Period 1|Wrong drug shipment|1|||
13486552|NCT02871778|27036689|FG002|Part A: Treatment Period 1|Wrong drug shipment|0|||
13486553|NCT02871778|27036690|FG003|Part A: Treatment Period 1|Wrong drug shipment|0|||
13486554|NCT02871778|27036691|FG004|Part A: Treatment Period 1|Wrong drug shipment|0|||
13486555|NCT02871778|27036692|FG005|Part A: Treatment Period 1|Wrong drug shipment|0|||
13486556|NCT02871778|27036693|FG006|Part A: Treatment Period 1|Wrong drug shipment|0|||
13486557|NCT02871778|27036694|FG007|Part A: Treatment Period 1|Wrong drug shipment|0|||
13486558|NCT02871778|27036687|FG000|Part A: Treatment Period 2|Adverse Event|2|||
13486559|NCT02871778|27036688|FG001|Part A: Treatment Period 2|Adverse Event|2|||
13486560|NCT02871778|27036689|FG002|Part A: Treatment Period 2|Adverse Event|0|||
13486561|NCT02871778|27036690|FG003|Part A: Treatment Period 2|Adverse Event|0|||
13486562|NCT02871778|27036691|FG004|Part A: Treatment Period 2|Adverse Event|0|||
13486563|NCT02871778|27036692|FG005|Part A: Treatment Period 2|Adverse Event|0|||
13486564|NCT02871778|27036693|FG006|Part A: Treatment Period 2|Adverse Event|0|||
13486565|NCT02871778|27036694|FG007|Part A: Treatment Period 2|Adverse Event|0|||
13486566|NCT02871778|27036687|FG000|Part A: Treatment Period 2|Lost to Follow-up|0|||
13486567|NCT02871778|27036688|FG001|Part A: Treatment Period 2|Lost to Follow-up|0|||
13486568|NCT02871778|27036689|FG002|Part A: Treatment Period 2|Lost to Follow-up|0|||
13486569|NCT02871778|27036690|FG003|Part A: Treatment Period 2|Lost to Follow-up|1|||
13486570|NCT02871778|27036691|FG004|Part A: Treatment Period 2|Lost to Follow-up|0|||
13486571|NCT02871778|27036692|FG005|Part A: Treatment Period 2|Lost to Follow-up|0|||
13486572|NCT02871778|27036693|FG006|Part A: Treatment Period 2|Lost to Follow-up|0|||
13486573|NCT02871778|27036694|FG007|Part A: Treatment Period 2|Lost to Follow-up|0|||
13486574|NCT02871778|27036687|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
13486575|NCT02871778|27036688|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
13486576|NCT02871778|27036689|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
13486577|NCT02871778|27036690|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
13486578|NCT02871778|27036691|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
13486579|NCT02871778|27036692|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
13486580|NCT02871778|27036693|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
13486581|NCT02871778|27036694|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
13486582|NCT02871778|27036687|FG000|Part B: Treatment Period 3|Adverse Event|0|||
13486583|NCT02871778|27036688|FG001|Part B: Treatment Period 3|Adverse Event|0|||
13486584|NCT02871778|27036689|FG002|Part B: Treatment Period 3|Adverse Event|0|||
13486585|NCT02871778|27036690|FG003|Part B: Treatment Period 3|Adverse Event|0|||
13486586|NCT02871778|27036691|FG004|Part B: Treatment Period 3|Adverse Event|1|||
13486587|NCT02871778|27036692|FG005|Part B: Treatment Period 3|Adverse Event|1|||
13486588|NCT02871778|27036693|FG006|Part B: Treatment Period 3|Adverse Event|1|||
13486589|NCT02871778|27036694|FG007|Part B: Treatment Period 3|Adverse Event|0|||
13488132|NCT04435808|27042842|FG000|Overall Study|Study stopped by DSMB|0|||
13488133|NCT04435808|27042843|FG001|Overall Study|Study stopped by DSMB|1|||
13488134|NCT04409262|27042892|FG000|Overall Study|Adverse Event|0|||
13488135|NCT04409262|27042893|FG001|Overall Study|Adverse Event|2|||
13488136|NCT04409262|27042892|FG000|Overall Study|Death|55|||
13488137|NCT04409262|27042893|FG001|Overall Study|Death|97|||
13488138|NCT04409262|27042892|FG000|Overall Study|Lost to Follow-up|12|||
13486590|NCT02149121|27036773|FG000|Main Study Period|Lack of Efficacy|2|||
13486591|NCT02149121|27036774|FG001|Main Study Period|Lack of Efficacy|2|||
13486592|NCT02149121|27036775|FG002|Main Study Period|Lack of Efficacy|1|||
13367866|NCT00838929|26707039|FG002|Overall Study|Disease progression|1|||
13367867|NCT00838916|26707071|FG000|Treatment Period (156 Weeks)|Adverse Event|50|||
13367868|NCT00838916|26707072|FG001|Treatment Period (156 Weeks)|Adverse Event|11|||
13367869|NCT00838916|26707071|FG000|Treatment Period (156 Weeks)|Protocol Violation|12|||
13367870|NCT00838916|26707072|FG001|Treatment Period (156 Weeks)|Protocol Violation|3|||
13367871|NCT00838916|26707071|FG000|Treatment Period (156 Weeks)|Noncompliance|21|||
13367872|NCT00838916|26707072|FG001|Treatment Period (156 Weeks)|Noncompliance|14|||
13367873|NCT00838916|26707071|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
13367874|NCT00838916|26707072|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
13486593|NCT02149121|27036776|FG003|Main Study Period|Lack of Efficacy|0|||
13486594|NCT02149121|27036777|FG004|Main Study Period|Lack of Efficacy|0|||
13486595|NCT02149121|27036778|FG005|Main Study Period|Lack of Efficacy|0|||
13486596|NCT02149121|27036779|FG006|Main Study Period|Lack of Efficacy|0|||
13486597|NCT02149121|27036773|FG000|Main Study Period|Withdrawal by Subject|9|||
13486598|NCT02149121|27036774|FG001|Main Study Period|Withdrawal by Subject|5|||
13486599|NCT02149121|27036775|FG002|Main Study Period|Withdrawal by Subject|1|||
13486600|NCT02149121|27036776|FG003|Main Study Period|Withdrawal by Subject|0|||
13486601|NCT02149121|27036777|FG004|Main Study Period|Withdrawal by Subject|0|||
13486602|NCT02149121|27036778|FG005|Main Study Period|Withdrawal by Subject|0|||
13486603|NCT02149121|27036779|FG006|Main Study Period|Withdrawal by Subject|0|||
13486604|NCT02149121|27036773|FG000|Main Study Period|Adverse Event|2|||
13486605|NCT02149121|27036774|FG001|Main Study Period|Adverse Event|5|||
13486606|NCT02149121|27036775|FG002|Main Study Period|Adverse Event|1|||
13486607|NCT02149121|27036776|FG003|Main Study Period|Adverse Event|0|||
13486608|NCT02149121|27036777|FG004|Main Study Period|Adverse Event|0|||
13486609|NCT02149121|27036778|FG005|Main Study Period|Adverse Event|0|||
13486610|NCT02149121|27036779|FG006|Main Study Period|Adverse Event|0|||
13486611|NCT02149121|27036773|FG000|Main Study Period|Protocol Violation|2|||
13486612|NCT02149121|27036774|FG001|Main Study Period|Protocol Violation|0|||
13486613|NCT02149121|27036775|FG002|Main Study Period|Protocol Violation|0|||
13124985|NCT02935673|25954710|FG001|Overall Study|Adverse Event|1|||
13124986|NCT02935673|25954711|FG002|Overall Study|Adverse Event|0|||
13124987|NCT02935673|25954709|FG000|Overall Study|Withdrawal by Subject|1|||
13486614|NCT02149121|27036776|FG003|Main Study Period|Protocol Violation|0|||
13486615|NCT02149121|27036777|FG004|Main Study Period|Protocol Violation|0|||
13486616|NCT02149121|27036778|FG005|Main Study Period|Protocol Violation|0|||
13486617|NCT02149121|27036779|FG006|Main Study Period|Protocol Violation|0|||
13486618|NCT02149121|27036773|FG000|Main Study Period|Lost to Follow-up|2|||
13486619|NCT02149121|27036774|FG001|Main Study Period|Lost to Follow-up|1|||
13486620|NCT02149121|27036775|FG002|Main Study Period|Lost to Follow-up|0|||
13486621|NCT02149121|27036776|FG003|Main Study Period|Lost to Follow-up|0|||
13486622|NCT02149121|27036777|FG004|Main Study Period|Lost to Follow-up|0|||
13486623|NCT02149121|27036778|FG005|Main Study Period|Lost to Follow-up|0|||
13486624|NCT02149121|27036779|FG006|Main Study Period|Lost to Follow-up|0|||
13486625|NCT02149121|27036773|FG000|Main Study Period|Death|1|||
13486626|NCT02149121|27036774|FG001|Main Study Period|Death|0|||
13486627|NCT02149121|27036775|FG002|Main Study Period|Death|0|||
13486628|NCT02149121|27036776|FG003|Main Study Period|Death|0|||
13486629|NCT02149121|27036777|FG004|Main Study Period|Death|0|||
13486630|NCT02149121|27036778|FG005|Main Study Period|Death|0|||
13367875|NCT00838916|26707071|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19|||
13367876|NCT00838916|26707072|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18|||
13367877|NCT00838916|26707071|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81|||
13367878|NCT00838916|26707072|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29|||
13367879|NCT00838916|26707071|FG000|Treatment Period (156 Weeks)|Physician Decision|6|||
13367880|NCT00838916|26707072|FG001|Treatment Period (156 Weeks)|Physician Decision|1|||
13367881|NCT00838916|26707071|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1|||
13367882|NCT00838916|26707072|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0|||
13367883|NCT00838916|26707071|FG000|Treatment Period (156 Weeks)|Missing|3|||
13486631|NCT02149121|27036779|FG006|Main Study Period|Death|0|||
13486632|NCT02149121|27036773|FG000|Main Study Period|Physician Decision|1|||
13486633|NCT02149121|27036774|FG001|Main Study Period|Physician Decision|0|||
13486634|NCT02149121|27036775|FG002|Main Study Period|Physician Decision|0|||
13486635|NCT02149121|27036776|FG003|Main Study Period|Physician Decision|0|||
13486636|NCT02149121|27036777|FG004|Main Study Period|Physician Decision|0|||
13486637|NCT02149121|27036778|FG005|Main Study Period|Physician Decision|0|||
13486638|NCT02149121|27036779|FG006|Main Study Period|Physician Decision|0|||
13486639|NCT02149121|27036773|FG000|Main Study Period|Developed any malignancy|0|||
13486640|NCT02149121|27036774|FG001|Main Study Period|Developed any malignancy|1|||
13486641|NCT02149121|27036775|FG002|Main Study Period|Developed any malignancy|1|||
13486642|NCT02149121|27036776|FG003|Main Study Period|Developed any malignancy|0|||
13486643|NCT02149121|27036777|FG004|Main Study Period|Developed any malignancy|0|||
13124988|NCT02935673|25954710|FG001|Overall Study|Withdrawal by Subject|2|||
13124989|NCT02935673|25954711|FG002|Overall Study|Withdrawal by Subject|0|||
13124990|NCT02935452|25954730|FG000|Overall Study|work and life commintment|3|||
13124991|NCT02935452|25954731|FG001|Overall Study|work and life commintment|1|||
13133523|NCT02769065|25988345|FG004|Overall Study|Pre-treatment Event/Adverse Event|0|||
13133524|NCT02769065|25988346|FG005|Overall Study|Pre-treatment Event/Adverse Event|0|||
13133525|NCT02769065|25988347|FG006|Overall Study|Pre-treatment Event/Adverse Event|0|||
13133526|NCT02769065|25988348|FG007|Overall Study|Pre-treatment Event/Adverse Event|0|||
13133527|NCT02769065|25988349|FG008|Overall Study|Pre-treatment Event/Adverse Event|0|||
13367884|NCT00838916|26707072|FG001|Treatment Period (156 Weeks)|Missing|1|||
13367885|NCT00838916|26707071|FG000|Treatment Period (156 Weeks)|Pregnancy|2|||
13367886|NCT00838916|26707072|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
13367887|NCT00838916|26707071|FG000|Follow-up Period (8 Weeks)|Adverse Event|10|||
13367888|NCT00838916|26707072|FG001|Follow-up Period (8 Weeks)|Adverse Event|5|||
13367889|NCT00838916|26707071|FG000|Follow-up Period (8 Weeks)|Noncompliance|6|||
13367890|NCT00838916|26707072|FG001|Follow-up Period (8 Weeks)|Noncompliance|5|||
13367891|NCT00838916|26707071|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38|||
13367892|NCT00838916|26707072|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
13367893|NCT00838916|26707071|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
13367894|NCT00838916|26707072|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
13367895|NCT00838916|26707071|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26|||
13367896|NCT00838916|26707072|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12|||
13367897|NCT00838916|26707071|FG000|Follow-up Period (8 Weeks)|Physician Decision|2|||
13367898|NCT00838916|26707072|FG001|Follow-up Period (8 Weeks)|Physician Decision|0|||
13367899|NCT00838916|26707071|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2|||
13367900|NCT00838916|26707072|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
13367901|NCT00838916|26707071|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
13367902|NCT00838916|26707072|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0|||
13367903|NCT00838916|26707071|FG000|Follow-up Period (8 Weeks)|Missing|3|||
13367904|NCT00838916|26707072|FG001|Follow-up Period (8 Weeks)|Missing|0|||
13367905|NCT00838903|26707127|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
13367906|NCT00838903|26707128|FG001|Treatment Period (156 Weeks)|Adverse Event|13|||
13367907|NCT00838903|26707129|FG002|Treatment Period (156 Weeks)|Adverse Event|17|||
13367908|NCT00838903|26707130|FG003|Treatment Period (156 Weeks)|Adverse Event|25|||
13367909|NCT00838903|26707127|FG000|Treatment Period (156 Weeks)|Protocol Violation|1|||
13367910|NCT00838903|26707128|FG001|Treatment Period (156 Weeks)|Protocol Violation|6|||
13367911|NCT00838903|26707129|FG002|Treatment Period (156 Weeks)|Protocol Violation|6|||
13367912|NCT00838903|26707130|FG003|Treatment Period (156 Weeks)|Protocol Violation|5|||
13367913|NCT00838903|26707127|FG000|Treatment Period (156 Weeks)|Noncompliance|9|||
13367914|NCT00838903|26707128|FG001|Treatment Period (156 Weeks)|Noncompliance|13|||
13367915|NCT00838903|26707129|FG002|Treatment Period (156 Weeks)|Noncompliance|12|||
13367916|NCT00838903|26707130|FG003|Treatment Period (156 Weeks)|Noncompliance|6|||
13367917|NCT00838903|26707127|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
13367918|NCT00838903|26707128|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
13367919|NCT00838903|26707129|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
13367920|NCT00838903|26707130|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
13367921|NCT00838903|26707127|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4|||
13367922|NCT00838903|26707128|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16|||
13367923|NCT00838903|26707129|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15|||
13367924|NCT00838903|26707130|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13|||
13367925|NCT00838903|26707127|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20|||
13367926|NCT00838903|26707128|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55|||
13367927|NCT00838903|26707129|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56|||
13367928|NCT00838903|26707130|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53|||
13367929|NCT00838903|26707127|FG000|Treatment Period (156 Weeks)|Physician Decision|1|||
13367930|NCT00838903|26707128|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
13367931|NCT00838903|26707129|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
13367932|NCT00838903|26707130|FG003|Treatment Period (156 Weeks)|Physician Decision|2|||
13367933|NCT00838903|26707127|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3|||
13367934|NCT00838903|26707128|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
13367935|NCT00838903|26707129|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
13367936|NCT00838903|26707130|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4|||
13367937|NCT00838903|26707127|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
13367938|NCT00838903|26707128|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1|||
13367939|NCT00838903|26707129|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
13367940|NCT00838903|26707130|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
13367941|NCT00838903|26707127|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
13367942|NCT00838903|26707128|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
13367943|NCT00838903|26707129|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
13367944|NCT00838903|26707130|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1|||
13367945|NCT00838903|26707127|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1|||
13367946|NCT00838903|26707128|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
13367947|NCT00838903|26707129|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
13367948|NCT00838903|26707130|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
13367949|NCT00838903|26707127|FG000|Treatment Period (156 Weeks)|Pregnancy|0|||
13367950|NCT00838903|26707128|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
13367951|NCT00838903|26707129|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
13367952|NCT00838903|26707130|FG003|Treatment Period (156 Weeks)|Pregnancy|0|||
13367953|NCT00838903|26707127|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
13367954|NCT00838903|26707128|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
13367955|NCT00838903|26707129|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1|||
13204478|NCT01972841|26229050|FG002|Overall Study|Did not have end of treatment page|0|||
13204479|NCT01972841|26229051|FG003|Overall Study|Did not have end of treatment page|0|||
13204480|NCT01972841|26229052|FG004|Overall Study|Did not have end of treatment page|1|||
13204481|NCT01972841|26229053|FG005|Overall Study|Did not have end of treatment page|0|||
13204482|NCT01972789|26229088|FG000|Overall Study|Adverse Event|11|||
13204483|NCT01972789|26229089|FG001|Overall Study|Adverse Event|4|||
13204484|NCT01972789|26229088|FG000|Overall Study|Subject withdrew consent|14|||
13204485|NCT01972789|26229089|FG001|Overall Study|Subject withdrew consent|12|||
13367956|NCT00838903|26707130|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
13367957|NCT00838903|26707127|FG000|Treatment Period (156 Weeks)|Site closed|0|||
13367958|NCT00838903|26707128|FG001|Treatment Period (156 Weeks)|Site closed|0|||
13367959|NCT00838903|26707129|FG002|Treatment Period (156 Weeks)|Site closed|1|||
13367960|NCT00838903|26707130|FG003|Treatment Period (156 Weeks)|Site closed|0|||
13367961|NCT00838903|26707127|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1|||
13367962|NCT00838903|26707128|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
13367963|NCT00838903|26707129|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
13367964|NCT00838903|26707130|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
13367965|NCT00838903|26707127|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
13367966|NCT00838903|26707128|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
13367967|NCT00838903|26707129|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
13367968|NCT00838903|26707130|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
13367969|NCT00838903|26707127|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1|||
13367970|NCT00838903|26707128|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
13367971|NCT00838903|26707129|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
13367972|NCT00838903|26707130|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
13367973|NCT00838903|26707127|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
13367974|NCT00838903|26707128|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
13367975|NCT00838903|26707129|FG002|Follow-up Period (8 Weeks)|Adverse Event|3|||
13367976|NCT00838903|26707130|FG003|Follow-up Period (8 Weeks)|Adverse Event|1|||
13367977|NCT00838903|26707127|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
13367978|NCT00838903|26707128|FG001|Follow-up Period (8 Weeks)|Noncompliance|8|||
13367979|NCT00838903|26707129|FG002|Follow-up Period (8 Weeks)|Noncompliance|5|||
13367980|NCT00838903|26707130|FG003|Follow-up Period (8 Weeks)|Noncompliance|5|||
13367981|NCT00838903|26707127|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6|||
13367982|NCT00838903|26707128|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28|||
13367983|NCT00838903|26707129|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
13367984|NCT00838903|26707130|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24|||
13367985|NCT00838903|26707127|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5|||
13367986|NCT00838903|26707128|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
13367987|NCT00838903|26707129|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12|||
13367988|NCT00838903|26707130|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
13367989|NCT00838903|26707127|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8|||
13367990|NCT00838903|26707128|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13|||
13367991|NCT00838903|26707129|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
13367992|NCT00838903|26707130|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
13367993|NCT00838903|26707127|FG000|Follow-up Period (8 Weeks)|Physician Decision|1|||
13367994|NCT00838903|26707128|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
13367995|NCT00838903|26707129|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
13367996|NCT00838903|26707130|FG003|Follow-up Period (8 Weeks)|Physician Decision|1|||
13367997|NCT00838903|26707127|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3|||
13367998|NCT00838903|26707128|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
13367999|NCT00838903|26707129|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6|||
13368000|NCT00838903|26707130|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
13204486|NCT01972789|26229088|FG000|Overall Study|Lost to Follow-up|4|||
13368001|NCT00838903|26707127|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
13368002|NCT00838903|26707128|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1|||
13368003|NCT00838903|26707129|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
13368004|NCT00838903|26707130|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
13368005|NCT00838903|26707127|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
13368006|NCT00838903|26707128|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1|||
13368007|NCT00838903|26707129|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
13368008|NCT00838903|26707130|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
13368009|NCT00838903|26707127|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
13368010|NCT00838903|26707128|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
13368011|NCT00838903|26707129|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
13368012|NCT00838903|26707130|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1|||
13368013|NCT00838903|26707127|FG000|Follow-up Period (8 Weeks)|Missing|1|||
13368014|NCT00838903|26707128|FG001|Follow-up Period (8 Weeks)|Missing|2|||
13368015|NCT00838903|26707129|FG002|Follow-up Period (8 Weeks)|Missing|1|||
13368016|NCT00838903|26707130|FG003|Follow-up Period (8 Weeks)|Missing|1|||
13368017|NCT00838682|26707153|FG000|Overall Study|Lost to Follow-up|21|||
13368018|NCT00838682|26707154|FG001|Overall Study|Lost to Follow-up|14|||
13368019|NCT00838682|26707153|FG000|Overall Study|detection of exclusion criteria|4|||
13368020|NCT00838682|26707154|FG001|Overall Study|detection of exclusion criteria|3|||
13368021|NCT00838682|26707153|FG000|Overall Study|Protocol Violation|0|||
13368022|NCT00838682|26707154|FG001|Overall Study|Protocol Violation|1|||
13368023|NCT00838682|26707153|FG000|Overall Study|Withdrawal by Subject|0|||
13368024|NCT00838682|26707154|FG001|Overall Study|Withdrawal by Subject|1|||
13368025|NCT00838578|26707164|FG000|Overall Study|Protocol Violation|2|||
13368026|NCT00838565|26707276|FG000|Overall Study|Withdrawal by Subject|0|||
13368027|NCT00838565|26707277|FG001|Overall Study|Withdrawal by Subject|0|||
13368028|NCT00838565|26707278|FG002|Overall Study|Withdrawal by Subject|1|||
13368029|NCT00838565|26707279|FG003|Overall Study|Withdrawal by Subject|0|||
13368030|NCT00838565|26707280|FG004|Overall Study|Withdrawal by Subject|0|||
13368031|NCT00838565|26707281|FG005|Overall Study|Withdrawal by Subject|2|||
13368032|NCT00838565|26707276|FG000|Overall Study|Other|0|||
13368033|NCT00838565|26707277|FG001|Overall Study|Other|2|||
13368034|NCT00838565|26707278|FG002|Overall Study|Other|0|||
13368035|NCT00838565|26707279|FG003|Overall Study|Other|0|||
13368036|NCT00838565|26707280|FG004|Overall Study|Other|0|||
13368037|NCT00838565|26707281|FG005|Overall Study|Other|0|||
13368038|NCT00838565|26707276|FG000|Overall Study|Randomized but not Treated|0|||
13368039|NCT00838565|26707277|FG001|Overall Study|Randomized but not Treated|1|||
13368040|NCT00838565|26707278|FG002|Overall Study|Randomized but not Treated|0|||
13368041|NCT00838565|26707279|FG003|Overall Study|Randomized but not Treated|0|||
13368042|NCT00838565|26707280|FG004|Overall Study|Randomized but not Treated|0|||
13368043|NCT00838565|26707281|FG005|Overall Study|Randomized but not Treated|0|||
13368044|NCT00838539|26707366|FG000|Overall Study|Disease Progression|2|||
13368045|NCT00838539|26707367|FG001|Overall Study|Disease Progression|4|||
13368046|NCT00838539|26707368|FG002|Overall Study|Disease Progression|3|||
13368047|NCT00838539|26707369|FG003|Overall Study|Disease Progression|2|||
13368048|NCT00838539|26707370|FG004|Overall Study|Disease Progression|4|||
13368049|NCT00838539|26707371|FG005|Overall Study|Disease Progression|2|||
13368050|NCT00838539|26707372|FG006|Overall Study|Disease Progression|3|||
13368051|NCT00838539|26707373|FG007|Overall Study|Disease Progression|4|||
13368052|NCT00838539|26707374|FG008|Overall Study|Disease Progression|4|||
13368053|NCT00838539|26707375|FG009|Overall Study|Disease Progression|5|||
13368054|NCT00838539|26707376|FG010|Overall Study|Disease Progression|1|||
13368055|NCT00838539|26707377|FG011|Overall Study|Disease Progression|4|||
13368056|NCT00838539|26707366|FG000|Overall Study|Adverse Event|1|||
13368057|NCT00838539|26707367|FG001|Overall Study|Adverse Event|1|||
13368058|NCT00838539|26707368|FG002|Overall Study|Adverse Event|1|||
13368059|NCT00838539|26707369|FG003|Overall Study|Adverse Event|1|||
13368060|NCT00838539|26707370|FG004|Overall Study|Adverse Event|2|||
13368061|NCT00838539|26707371|FG005|Overall Study|Adverse Event|1|||
13368062|NCT00838539|26707372|FG006|Overall Study|Adverse Event|0|||
13368063|NCT00838539|26707373|FG007|Overall Study|Adverse Event|2|||
13368064|NCT00838539|26707374|FG008|Overall Study|Adverse Event|0|||
13368065|NCT00838539|26707375|FG009|Overall Study|Adverse Event|1|||
13368066|NCT00838539|26707376|FG010|Overall Study|Adverse Event|2|||
13368067|NCT00838539|26707377|FG011|Overall Study|Adverse Event|0|||
13368068|NCT00838539|26707366|FG000|Overall Study|Withdrawal by Subject|0|||
13368069|NCT00838539|26707367|FG001|Overall Study|Withdrawal by Subject|1|||
13368070|NCT00838539|26707368|FG002|Overall Study|Withdrawal by Subject|0|||
13368071|NCT00838539|26707369|FG003|Overall Study|Withdrawal by Subject|0|||
13368072|NCT00838539|26707370|FG004|Overall Study|Withdrawal by Subject|0|||
13368073|NCT00838539|26707371|FG005|Overall Study|Withdrawal by Subject|0|||
13368074|NCT00838539|26707372|FG006|Overall Study|Withdrawal by Subject|0|||
13368075|NCT00838539|26707373|FG007|Overall Study|Withdrawal by Subject|0|||
13368076|NCT00838539|26707374|FG008|Overall Study|Withdrawal by Subject|0|||
13368077|NCT00838539|26707375|FG009|Overall Study|Withdrawal by Subject|1|||
13368078|NCT00838539|26707376|FG010|Overall Study|Withdrawal by Subject|2|||
13368079|NCT00838539|26707377|FG011|Overall Study|Withdrawal by Subject|0|||
13368080|NCT00838539|26707366|FG000|Overall Study|Death|0|||
13368081|NCT00838539|26707367|FG001|Overall Study|Death|0|||
13368082|NCT00838539|26707368|FG002|Overall Study|Death|0|||
13368083|NCT00838539|26707369|FG003|Overall Study|Death|0|||
13368084|NCT00838539|26707370|FG004|Overall Study|Death|0|||
13368085|NCT00838539|26707371|FG005|Overall Study|Death|0|||
13368086|NCT00838539|26707372|FG006|Overall Study|Death|1|||
13368087|NCT00838539|26707373|FG007|Overall Study|Death|0|||
13368088|NCT00838539|26707374|FG008|Overall Study|Death|0|||
13368089|NCT00838539|26707375|FG009|Overall Study|Death|0|||
13368090|NCT00838539|26707376|FG010|Overall Study|Death|0|||
13368091|NCT00838539|26707377|FG011|Overall Study|Death|0|||
13368092|NCT00838539|26707366|FG000|Overall Study|Physician Decision|0|||
13368093|NCT00838539|26707367|FG001|Overall Study|Physician Decision|0|||
13368094|NCT00838539|26707368|FG002|Overall Study|Physician Decision|0|||
13368095|NCT00838539|26707369|FG003|Overall Study|Physician Decision|0|||
13368096|NCT00838539|26707370|FG004|Overall Study|Physician Decision|0|||
13368097|NCT00838539|26707371|FG005|Overall Study|Physician Decision|0|||
13368098|NCT00838539|26707372|FG006|Overall Study|Physician Decision|0|||
13368099|NCT00838539|26707373|FG007|Overall Study|Physician Decision|0|||
13368100|NCT00838539|26707374|FG008|Overall Study|Physician Decision|1|||
13368101|NCT00838539|26707375|FG009|Overall Study|Physician Decision|0|||
13368102|NCT00838539|26707376|FG010|Overall Study|Physician Decision|0|||
13368103|NCT00838539|26707377|FG011|Overall Study|Physician Decision|0|||
13368104|NCT00838539|26707366|FG000|Overall Study|Clinical Progression|0|||
13368105|NCT00838539|26707367|FG001|Overall Study|Clinical Progression|0|||
13368106|NCT00838539|26707368|FG002|Overall Study|Clinical Progression|0|||
13368107|NCT00838539|26707369|FG003|Overall Study|Clinical Progression|0|||
13368108|NCT00838539|26707370|FG004|Overall Study|Clinical Progression|0|||
13368109|NCT00838539|26707371|FG005|Overall Study|Clinical Progression|0|||
13368110|NCT00838539|26707372|FG006|Overall Study|Clinical Progression|1|||
13368111|NCT00838539|26707373|FG007|Overall Study|Clinical Progression|0|||
13368112|NCT00838539|26707374|FG008|Overall Study|Clinical Progression|0|||
13368113|NCT00838539|26707375|FG009|Overall Study|Clinical Progression|0|||
13368114|NCT00838539|26707376|FG010|Overall Study|Clinical Progression|0|||
13368115|NCT00838539|26707377|FG011|Overall Study|Clinical Progression|0|||
13368116|NCT00838539|26707366|FG000|Overall Study|Symptomatic Deterioration|0|||
13368117|NCT00838539|26707367|FG001|Overall Study|Symptomatic Deterioration|0|||
13368118|NCT00838539|26707368|FG002|Overall Study|Symptomatic Deterioration|1|||
13368119|NCT00838539|26707369|FG003|Overall Study|Symptomatic Deterioration|1|||
13368120|NCT00838539|26707370|FG004|Overall Study|Symptomatic Deterioration|0|||
13368121|NCT00838539|26707371|FG005|Overall Study|Symptomatic Deterioration|1|||
13368122|NCT00838539|26707372|FG006|Overall Study|Symptomatic Deterioration|0|||
13368123|NCT00838539|26707373|FG007|Overall Study|Symptomatic Deterioration|0|||
13368124|NCT00838539|26707374|FG008|Overall Study|Symptomatic Deterioration|0|||
13368125|NCT00838539|26707375|FG009|Overall Study|Symptomatic Deterioration|1|||
13368126|NCT00838539|26707376|FG010|Overall Study|Symptomatic Deterioration|0|||
13368127|NCT00838539|26707377|FG011|Overall Study|Symptomatic Deterioration|0|||
13368128|NCT00838526|26707394|FG000|Overall Study|Adverse Event|3|||
13368129|NCT00838526|26707395|FG001|Overall Study|Adverse Event|12|||
13368130|NCT00838526|26707394|FG000|Overall Study|Lost to Follow-up|4|||
13368131|NCT00838526|26707395|FG001|Overall Study|Lost to Follow-up|12|||
13368132|NCT00838526|26707394|FG000|Overall Study|Withdrawal by Subject|4|||
13368133|NCT00838526|26707395|FG001|Overall Study|Withdrawal by Subject|5|||
13368134|NCT00838526|26707394|FG000|Overall Study|Lack of Efficacy|2|||
13368135|NCT00838526|26707395|FG001|Overall Study|Lack of Efficacy|3|||
13368136|NCT00838526|26707394|FG000|Overall Study|Other|11|||
13368137|NCT00838526|26707395|FG001|Overall Study|Other|7|||
13368138|NCT00838513|26707413|FG000|Screening Period|Screen Failure|3|||
13368139|NCT00838513|26707413|FG000|Extension Treatment Period|Death|1|||
13368140|NCT00838513|26707413|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
13368141|NCT00838435|26707428|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1|||
13368142|NCT00838435|26707428|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2|||
13368143|NCT00838435|26707428|FG000|Part 2 (7 Years)|Adverse Event|2|||
13368144|NCT00838435|26707428|FG000|Part 2 (7 Years)|Lost to Follow-up|2|||
13368145|NCT00838435|26707428|FG000|Part 2 (7 Years)|Physician Decision|1|||
13368146|NCT00838435|26707428|FG000|Part 2 (7 Years)|Sponsor Decision|6|||
13368147|NCT00838435|26707428|FG000|Part 2 (7 Years)|Withdrawal by Subject|5|||
13368148|NCT00838331|26707434|FG000|Aged Blood Transfusion|Withdrawal by Subject|9|||
13368149|NCT00838201|26707447|FG000|Overall Study|Investigator decision, or other reasons|2|||
13368150|NCT00838201|26707448|FG001|Overall Study|Investigator decision, or other reasons|3|||
13368151|NCT00838201|26707447|FG000|Overall Study|Noncompliance|0|||
13368152|NCT00838201|26707448|FG001|Overall Study|Noncompliance|1|||
13368153|NCT00838201|26707447|FG000|Overall Study|Administrative decision|1|||
13368154|NCT00838201|26707448|FG001|Overall Study|Administrative decision|2|||
13368155|NCT00838201|26707447|FG000|Overall Study|Disease progression|3|||
13368156|NCT00838201|26707448|FG001|Overall Study|Disease progression|3|||
13368157|NCT00838201|26707447|FG000|Overall Study|Consent withdrawn|16|||
13368158|NCT00838201|26707448|FG001|Overall Study|Consent withdrawn|19|||
13368159|NCT00838201|26707447|FG000|Overall Study|Lost to Follow-up|4|||
13368160|NCT00838201|26707448|FG001|Overall Study|Lost to Follow-up|3|||
13368161|NCT00838201|26707447|FG000|Overall Study|Adverse Event|5|||
13368162|NCT00838201|26707448|FG001|Overall Study|Adverse Event|9|||
13368163|NCT00838201|26707447|FG000|Overall Study|Death|11|||
13368164|NCT00838201|26707448|FG001|Overall Study|Death|13|||
13368165|NCT00838110|26707477|FG000|Overall Study|Death|0|||
13368166|NCT00838110|26707478|FG001|Overall Study|Death|0|||
13368167|NCT00838110|26707479|FG002|Overall Study|Death|1|||
13368168|NCT00838110|26707480|FG003|Overall Study|Death|2|||
13368169|NCT00838110|26707477|FG000|Overall Study|Adverse Event|11|||
13368170|NCT00838110|26707478|FG001|Overall Study|Adverse Event|10|||
13368171|NCT00838110|26707479|FG002|Overall Study|Adverse Event|8|||
13368172|NCT00838110|26707480|FG003|Overall Study|Adverse Event|7|||
13368173|NCT00838110|26707477|FG000|Overall Study|Withdrawal by Subject|5|||
13368174|NCT00838110|26707478|FG001|Overall Study|Withdrawal by Subject|6|||
13368175|NCT00838110|26707479|FG002|Overall Study|Withdrawal by Subject|3|||
13368176|NCT00838110|26707480|FG003|Overall Study|Withdrawal by Subject|4|||
13368177|NCT00838110|26707477|FG000|Overall Study|Other|3|||
13368178|NCT00838110|26707478|FG001|Overall Study|Other|3|||
13368179|NCT00838110|26707479|FG002|Overall Study|Other|3|||
13368180|NCT00838110|26707480|FG003|Overall Study|Other|2|||
13368181|NCT00838110|26707477|FG000|Overall Study|Protocol Violation|0|||
13368182|NCT00838110|26707478|FG001|Overall Study|Protocol Violation|2|||
13368183|NCT00838110|26707479|FG002|Overall Study|Protocol Violation|1|||
13368184|NCT00838110|26707480|FG003|Overall Study|Protocol Violation|1|||
13368185|NCT00838110|26707477|FG000|Overall Study|Lost to Follow-up|3|||
13368186|NCT00838110|26707478|FG001|Overall Study|Lost to Follow-up|0|||
13368187|NCT00838110|26707479|FG002|Overall Study|Lost to Follow-up|0|||
13368188|NCT00838110|26707480|FG003|Overall Study|Lost to Follow-up|0|||
13368189|NCT00838110|26707477|FG000|Overall Study|Did not meet eligibility criteria|0|||
13368190|NCT00838110|26707478|FG001|Overall Study|Did not meet eligibility criteria|0|||
13368191|NCT00838110|26707479|FG002|Overall Study|Did not meet eligibility criteria|1|||
13368192|NCT00838110|26707480|FG003|Overall Study|Did not meet eligibility criteria|2|||
13368193|NCT00838110|26707477|FG000|Overall Study|Randomized but not treated|0|||
13368194|NCT00838110|26707478|FG001|Overall Study|Randomized but not treated|1|||
13368195|NCT00838110|26707479|FG002|Overall Study|Randomized but not treated|0|||
13368196|NCT00838110|26707480|FG003|Overall Study|Randomized but not treated|0|||
13368197|NCT00838097|26707490|FG000|Overall Study|Ineligibility determined|6|||
13368198|NCT00838097|26707490|FG000|Overall Study|Adverse Event|2|||
13368199|NCT00838097|26707490|FG000|Overall Study|Withdrawal by Subject|3|||
13368200|NCT00838097|26707490|FG000|Overall Study|Requirement for alternative therapy|2|||
13368201|NCT00838097|26707490|FG000|Overall Study|Physician Decision|4|||
13368202|NCT00838097|26707490|FG000|Overall Study|Lost to Follow-up|11|||
13368203|NCT00838097|26707490|FG000|Overall Study|Death|6|||
13368204|NCT00838097|26707490|FG000|Overall Study|Protocol-specified criteria|142|||
13368205|NCT00837967|26707509|FG000|Washout Period of 7 - 14 Days|Adverse Event|2|||
13368206|NCT00837967|26707510|FG001|Washout Period of 7 - 14 Days|Adverse Event|0|||
13368207|NCT00837876|26707519|FG000|Overall Study|Death|2|||
13368208|NCT00837876|26707519|FG000|Overall Study|Adverse Event|7|||
13368209|NCT00837876|26707519|FG000|Overall Study|Physician Decision|1|||
13368210|NCT00837876|26707519|FG000|Overall Study|Withdrawal by Subject|3|||
13368211|NCT00837876|26707519|FG000|Overall Study|disease progression|24|||
13368212|NCT00837811|26707614|FG000|Overall Study|Adverse Event|4|||
13368213|NCT00837811|26707615|FG001|Overall Study|Adverse Event|6|||
13368214|NCT00837811|26707616|FG002|Overall Study|Adverse Event|0|||
13368215|NCT00837811|26707614|FG000|Overall Study|Death|1|||
13368216|NCT00837811|26707615|FG001|Overall Study|Death|1|||
13368217|NCT00837811|26707616|FG002|Overall Study|Death|0|||
13368218|NCT00837811|26707614|FG000|Overall Study|Lack of Efficacy|0|||
13368219|NCT00837811|26707615|FG001|Overall Study|Lack of Efficacy|11|||
13368220|NCT00837811|26707616|FG002|Overall Study|Lack of Efficacy|0|||
13368221|NCT00837811|26707614|FG000|Overall Study|Lost to Follow-up|1|||
13368222|NCT00837811|26707615|FG001|Overall Study|Lost to Follow-up|3|||
13368223|NCT00837811|26707616|FG002|Overall Study|Lost to Follow-up|0|||
13368224|NCT00837811|26707614|FG000|Overall Study|Physician Decision|0|||
13368225|NCT00837811|26707615|FG001|Overall Study|Physician Decision|2|||
13368226|NCT00837811|26707616|FG002|Overall Study|Physician Decision|1|||
13368227|NCT00837811|26707614|FG000|Overall Study|Withdrawal by Subject|1|||
13368228|NCT00837811|26707615|FG001|Overall Study|Withdrawal by Subject|9|||
13368229|NCT00837811|26707616|FG002|Overall Study|Withdrawal by Subject|0|||
13368230|NCT00837811|26707614|FG000|Overall Study|Sponsor Decision|0|||
13368231|NCT00837811|26707615|FG001|Overall Study|Sponsor Decision|2|||
13368232|NCT00837811|26707616|FG002|Overall Study|Sponsor Decision|0|||
13368233|NCT00837759|26707627|FG000|Overall Study|Protocol Violation|3|||
13368234|NCT00837759|26707627|FG000|Overall Study|Lost to Follow-up|1|||
13368235|NCT00837694|26707660|FG000|Overall Study|Lost to Follow-up|2|||
13368236|NCT00837694|26707661|FG001|Overall Study|Lost to Follow-up|0|||
13368237|NCT00837694|26707662|FG002|Overall Study|Lost to Follow-up|2|||
13368238|NCT00837694|26707663|FG003|Overall Study|Lost to Follow-up|1|||
13368239|NCT00837694|26707664|FG004|Overall Study|Lost to Follow-up|1|||
13368240|NCT00837694|26707665|FG005|Overall Study|Lost to Follow-up|1|||
13368241|NCT00837616|26707696|FG000|Overall Study|Withdrawal by Subject|0|||
13368242|NCT00837616|26707697|FG001|Overall Study|Withdrawal by Subject|1|||
13486644|NCT02149121|27036778|FG005|Main Study Period|Developed any malignancy|0|||
13486645|NCT02149121|27036779|FG006|Main Study Period|Developed any malignancy|0|||
13368243|NCT00837577|26707715|FG000|Double-blind Period|Clinical Adverse Event|1|||
13368244|NCT00837577|26707716|FG001|Double-blind Period|Clinical Adverse Event|0|||
13368245|NCT00837577|26707715|FG000|Double-blind Period|Withdrawal by Subject|1|||
13368246|NCT00837577|26707716|FG001|Double-blind Period|Withdrawal by Subject|0|||
13368247|NCT00837577|26707715|FG000|Open-label Period|Clinical Adverse Event|2|||
13368248|NCT00837577|26707716|FG001|Open-label Period|Clinical Adverse Event|2|||
13368249|NCT00837577|26707715|FG000|Open-label Period|Laboratory Adverse Event|0|||
13368250|NCT00837577|26707716|FG001|Open-label Period|Laboratory Adverse Event|1|||
13368251|NCT00837577|26707715|FG000|Open-label Period|Lack of Efficacy|4|||
13368252|NCT00837577|26707716|FG001|Open-label Period|Lack of Efficacy|3|||
13368253|NCT00837577|26707715|FG000|Open-label Period|Withdrawal by Subject|1|||
13368254|NCT00837577|26707716|FG001|Open-label Period|Withdrawal by Subject|2|||
13368255|NCT00837577|26707715|FG000|Open-label Period|Other Reason|1|||
13368256|NCT00837577|26707716|FG001|Open-label Period|Other Reason|1|||
13368257|NCT00837486|26707735|FG000|Blinded-treatment Phase|Physician Decision|1|||
13368258|NCT00837486|26707736|FG001|Blinded-treatment Phase|Physician Decision|0|||
13368259|NCT00837486|26707735|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2|||
13368260|NCT00837486|26707736|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0|||
13368261|NCT00837486|26707735|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2|||
13368262|NCT00837486|26707736|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0|||
13368263|NCT00837486|26707735|FG000|Long-term Follow-up Phase - Open Label|Death|1|||
13368264|NCT00837486|26707736|FG001|Long-term Follow-up Phase - Open Label|Death|0|||
13368265|NCT00837473|26707751|FG000|Overall Study|Lost to Follow-up|1|||
13368266|NCT00837473|26707751|FG000|Overall Study|Withdrawal by Subject|2|||
13368267|NCT00837434|26707776|FG000|Overall Study|Physician Decision|3|||
13368268|NCT00837434|26707777|FG001|Overall Study|Physician Decision|0|||
13368269|NCT00837434|26707776|FG000|Overall Study|Lost to Follow-up|1|||
13368270|NCT00837434|26707777|FG001|Overall Study|Lost to Follow-up|1|||
13368271|NCT00837434|26707776|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1|||
13368272|NCT00837434|26707777|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0|||
13368273|NCT00837434|26707776|FG000|Overall Study|Noncompliant|2|||
13368274|NCT00837434|26707777|FG001|Overall Study|Noncompliant|0|||
13368275|NCT00837434|26707776|FG000|Overall Study|Baseline assessments not done in time|1|||
13368276|NCT00837434|26707777|FG001|Overall Study|Baseline assessments not done in time|0|||
13368277|NCT00837434|26707776|FG000|Overall Study|Unable to obtain study drug|1|||
13368278|NCT00837434|26707777|FG001|Overall Study|Unable to obtain study drug|0|||
13368279|NCT00837330|26707790|FG000|Overall Study|Lost to Follow-up|1|||
13368280|NCT00837330|26707791|FG001|Overall Study|Lost to Follow-up|3|||
13368281|NCT00837213|26707818|FG000|Overall Study|Lost to Follow-up|3|||
13368282|NCT00837213|26707819|FG001|Overall Study|Lost to Follow-up|2|||
13368283|NCT00837213|26707818|FG000|Overall Study|Withdrawal by Subject|2|||
13368284|NCT00837213|26707819|FG001|Overall Study|Withdrawal by Subject|2|||
13368285|NCT00837213|26707818|FG000|Overall Study|not stated|1|||
13368286|NCT00837213|26707819|FG001|Overall Study|not stated|1|||
13368287|NCT00837161|26707829|FG000|Overall Study|refused hysterectomy|2|||
13368288|NCT00837148|26707835|FG000|Overall Study|Adverse Event|1|||
13368289|NCT00837148|26707835|FG000|Overall Study|Death|1|||
13368290|NCT00837096|26707848|FG000|Overall Study|Physician Decision|1|||
13368291|NCT00837096|26707849|FG001|Overall Study|Physician Decision|1|||
13368292|NCT00837096|26707848|FG000|Overall Study|Not reported|9|||
13368293|NCT00837096|26707849|FG001|Overall Study|Not reported|8|||
13368294|NCT00836953|26707857|FG000|Overall Study|Withdrawal by Subject|1|||
13368295|NCT00836953|26707857|FG000|Overall Study|Lost to Follow-up|1|||
13368296|NCT00836927|26707907|FG000|Overall Study|Progressive disease|2|||
13368297|NCT00836927|26707908|FG001|Overall Study|Progressive disease|0|||
13368298|NCT00836927|26707909|FG002|Overall Study|Progressive disease|0|||
13368299|NCT00836927|26707910|FG003|Overall Study|Progressive disease|1|||
13368300|NCT00836927|26707911|FG004|Overall Study|Progressive disease|1|||
13368301|NCT00836927|26707907|FG000|Overall Study|Withdrawal by Subject|1|||
13368302|NCT00836927|26707908|FG001|Overall Study|Withdrawal by Subject|0|||
13368303|NCT00836927|26707909|FG002|Overall Study|Withdrawal by Subject|0|||
13368304|NCT00836927|26707910|FG003|Overall Study|Withdrawal by Subject|0|||
13368305|NCT00836927|26707911|FG004|Overall Study|Withdrawal by Subject|0|||
13368306|NCT00836875|26707932|FG000|Overall Study|Death|3|||
13368307|NCT00836875|26707933|FG001|Overall Study|Death|2|||
13368308|NCT00836875|26707932|FG000|Overall Study|Withdrawal by Subject|0|||
13368309|NCT00836875|26707933|FG001|Overall Study|Withdrawal by Subject|1|||
13368310|NCT00836810|26707956|FG000|Overall Study|New diagnosis|1|||
13368311|NCT00836810|26707957|FG001|Overall Study|New diagnosis|0|||
13368312|NCT00836745|26707966|FG000|Overall Study|Death|2|||
13368313|NCT00836745|26707966|FG000|Overall Study|Lost to Follow-up|10|||
13368314|NCT00836745|26707966|FG000|Overall Study|Adverse Event|3|||
13368315|NCT00836745|26707966|FG000|Overall Study|Objective progression or relapse|4|||
13368316|NCT00836745|26707966|FG000|Overall Study|Other|2|||
13368317|NCT00836693|26708013|FG000|Overall Study|Adverse Event|4|||
13368318|NCT00836693|26708014|FG001|Overall Study|Adverse Event|1|||
13368319|NCT00836693|26708013|FG000|Overall Study|Sponsor Decision|0|||
13368320|NCT00836693|26708014|FG001|Overall Study|Sponsor Decision|1|||
13368321|NCT00836693|26708013|FG000|Overall Study|Physician Decision|2|||
13368322|NCT00836693|26708014|FG001|Overall Study|Physician Decision|0|||
13368323|NCT00836693|26708013|FG000|Overall Study|Withdrawal by Subject|9|||
13368324|NCT00836693|26708014|FG001|Overall Study|Withdrawal by Subject|4|||
13368325|NCT00836693|26708013|FG000|Overall Study|Protocol Violation|1|||
13368326|NCT00836693|26708014|FG001|Overall Study|Protocol Violation|0|||
13368327|NCT00836693|26708013|FG000|Overall Study|Lost to Follow-up|1|||
13368328|NCT00836693|26708014|FG001|Overall Study|Lost to Follow-up|0|||
13368329|NCT00836589|26708047|FG000|Overall Study|Lost to Follow-up|246|||
13368330|NCT00836589|26708047|FG000|Overall Study|Death|429|||
13368331|NCT00836589|26708047|FG000|Overall Study|Withdrawal by Subject or Physician|591|||
13368332|NCT00836498|26708084|FG000|Overall Study|Adverse Event|1|||
13368333|NCT00836498|26708085|FG001|Overall Study|Adverse Event|0|||
13368334|NCT00836498|26708084|FG000|Overall Study|Lost to Follow-up|1|||
13368335|NCT00836498|26708085|FG001|Overall Study|Lost to Follow-up|0|||
13368336|NCT00836498|26708084|FG000|Overall Study|Withdrawal by Subject|2|||
13368337|NCT00836498|26708085|FG001|Overall Study|Withdrawal by Subject|1|||
13368338|NCT00836277|26708095|FG000|Overall Study|Not evaluable for response|6|||
13368339|NCT00836186|26708103|FG000|Overall Study|Blood could not be drawn|1|||
13368340|NCT00836095|26708118|FG000|Overall Study|Physician Decision|0|||
13368341|NCT00836095|26708119|FG001|Overall Study|Physician Decision|3|||
13368342|NCT00835978|26708190|FG000|Overall Study|Death|33|||
13368343|NCT00835978|26708191|FG001|Overall Study|Death|40|||
13368344|NCT00835978|26708192|FG002|Overall Study|Death|49|||
13368345|NCT00835978|26708193|FG003|Overall Study|Death|4|||
13368346|NCT00835978|26708190|FG000|Overall Study|Lost to Follow-up|3|||
13368347|NCT00835978|26708191|FG001|Overall Study|Lost to Follow-up|4|||
13368348|NCT00835978|26708192|FG002|Overall Study|Lost to Follow-up|2|||
13368349|NCT00835978|26708193|FG003|Overall Study|Lost to Follow-up|1|||
13368350|NCT00835978|26708190|FG000|Overall Study|Other|5|||
13368351|NCT00835978|26708191|FG001|Overall Study|Other|1|||
13368352|NCT00835978|26708192|FG002|Overall Study|Other|8|||
13368353|NCT00835978|26708193|FG003|Overall Study|Other|0|||
13368354|NCT00835978|26708190|FG000|Overall Study|Objective progression or relapse|2|||
13368355|NCT00835978|26708191|FG001|Overall Study|Objective progression or relapse|0|||
13368356|NCT00835978|26708192|FG002|Overall Study|Objective progression or relapse|1|||
13368357|NCT00835978|26708193|FG003|Overall Study|Objective progression or relapse|0|||
13368358|NCT00835978|26708190|FG000|Overall Study|Adverse Event|1|||
13368359|NCT00835978|26708191|FG001|Overall Study|Adverse Event|0|||
13368360|NCT00835978|26708192|FG002|Overall Study|Adverse Event|1|||
13368361|NCT00835978|26708193|FG003|Overall Study|Adverse Event|0|||
13368362|NCT00835978|26708190|FG000|Overall Study|Withdrawal by Subject|0|||
13368363|NCT00835978|26708191|FG001|Overall Study|Withdrawal by Subject|3|||
13368364|NCT00835978|26708192|FG002|Overall Study|Withdrawal by Subject|0|||
13368365|NCT00835978|26708193|FG003|Overall Study|Withdrawal by Subject|5|||
13368366|NCT00835978|26708190|FG000|Overall Study|Study terminated by sponsor|12|||
13368367|NCT00835978|26708191|FG001|Overall Study|Study terminated by sponsor|8|||
13368368|NCT00835978|26708192|FG002|Overall Study|Study terminated by sponsor|30|||
13368369|NCT00835978|26708193|FG003|Overall Study|Study terminated by sponsor|0|||
13368370|NCT00835770|26708296|FG000|Overall Study|MS Relapse|17|||
13368371|NCT00835770|26708297|FG001|Overall Study|MS Relapse|23|||
13368372|NCT00835770|26708296|FG000|Overall Study|MS Progression|14|||
13368373|NCT00835770|26708297|FG001|Overall Study|MS Progression|9|||
13368374|NCT00835770|26708296|FG000|Overall Study|Adverse Event|113|||
13368375|NCT00835770|26708297|FG001|Overall Study|Adverse Event|124|||
13368376|NCT00835770|26708296|FG000|Overall Study|Lost to Follow-up|22|||
13368377|NCT00835770|26708297|FG001|Overall Study|Lost to Follow-up|19|||
13368378|NCT00835770|26708296|FG000|Overall Study|Consent Withdrawn|144|||
13368379|NCT00835770|26708297|FG001|Overall Study|Consent Withdrawn|156|||
13368380|NCT00835770|26708296|FG000|Overall Study|Investigator Decision|42|||
13368381|NCT00835770|26708297|FG001|Overall Study|Investigator Decision|42|||
13368382|NCT00835770|26708296|FG000|Overall Study|Participant Non-Compliance|11|||
13368383|NCT00835770|26708297|FG001|Overall Study|Participant Non-Compliance|9|||
13368384|NCT00835770|26708296|FG000|Overall Study|Death|4|||
13368385|NCT00835770|26708297|FG001|Overall Study|Death|6|||
13368386|NCT00835770|26708296|FG000|Overall Study|Other|115|||
13368387|NCT00835770|26708297|FG001|Overall Study|Other|104|||
13368388|NCT00835770|26708296|FG000|Overall Study|Other|2|||
13368389|NCT00835770|26708297|FG001|Overall Study|Other|1|||
13368390|NCT00835731|26708322|FG000|Overall Study|Withdrawal by Subject|1|||
13368391|NCT00835731|26708323|FG001|Overall Study|Withdrawal by Subject|0|||
13368392|NCT00835731|26708322|FG000|Overall Study|Physician Decision|1|||
13368393|NCT00835731|26708323|FG001|Overall Study|Physician Decision|1|||
13368394|NCT00835679|26708358|FG000|Overall Study|Withdrawal by Subject|1|||
13368395|NCT00835679|26708359|FG001|Overall Study|Withdrawal by Subject|0|||
13368396|NCT00835679|26708360|FG002|Overall Study|Withdrawal by Subject|0|||
13368397|NCT00835679|26708361|FG003|Overall Study|Withdrawal by Subject|0|||
13368398|NCT00835380|26708368|FG000|Overall Study|Withdrawal by Subject|2|||
13368399|NCT00835341|26708381|FG000|Overall Study|Lost to Follow-up|3|||
13368400|NCT00835341|26708382|FG001|Overall Study|Lost to Follow-up|12|||
13368401|NCT00835237|26708413|FG000|Overall Study|Lost to Follow-up|4|||
13368402|NCT00835237|26708414|FG001|Overall Study|Lost to Follow-up|0|||
13368403|NCT00835237|26708413|FG000|Overall Study|Withdrawal by Subject|2|||
13368404|NCT00835237|26708414|FG001|Overall Study|Withdrawal by Subject|0|||
13368405|NCT00835120|26708424|FG000|Overall Study|Lack of Efficacy|1|||
13368406|NCT00835120|26708424|FG000|Overall Study|Lost to Follow-up|3|||
13368407|NCT00835120|26708424|FG000|Overall Study|Adverse Event|2|||
13368408|NCT00835120|26708424|FG000|Overall Study|Withdrawal by Subject|2|||
13368409|NCT00835068|26708449|FG000|Overall Study|Death|1|||
13368410|NCT00835068|26708450|FG001|Overall Study|Death|0|||
13368411|NCT00835068|26708449|FG000|Overall Study|Adverse Event|0|||
13368412|NCT00835068|26708450|FG001|Overall Study|Adverse Event|1|||
13368413|NCT00835068|26708449|FG000|Overall Study|Other|8|||
13368414|NCT00835068|26708450|FG001|Overall Study|Other|0|||
13368415|NCT00835068|26708449|FG000|Overall Study|Withdrawal by Subject|1|||
13368416|NCT00835068|26708450|FG001|Overall Study|Withdrawal by Subject|0|||
13368417|NCT00834912|26708489|FG000|Treatment Period 1|Adverse Event|0|||
13368418|NCT00834912|26708490|FG001|Treatment Period 1|Adverse Event|1|||
13368419|NCT00834912|26708491|FG002|Treatment Period 1|Adverse Event|0|||
13368420|NCT00834912|26708492|FG003|Treatment Period 1|Adverse Event|1|||
13368421|NCT00834912|26708493|FG004|Treatment Period 1|Adverse Event|0|||
13368422|NCT00834912|26708494|FG005|Treatment Period 1|Adverse Event|0|||
13368423|NCT00834912|26708489|FG000|Treatment Period 2|Withdrawal by Subject|0|||
13368424|NCT00834912|26708490|FG001|Treatment Period 2|Withdrawal by Subject|0|||
13368425|NCT00834912|26708491|FG002|Treatment Period 2|Withdrawal by Subject|1|||
13368426|NCT00834912|26708492|FG003|Treatment Period 2|Withdrawal by Subject|0|||
13368427|NCT00834912|26708493|FG004|Treatment Period 2|Withdrawal by Subject|1|||
13368428|NCT00834912|26708494|FG005|Treatment Period 2|Withdrawal by Subject|0|||
13368429|NCT00834899|26708513|FG000|Overall Study|Withdrawal by Subject|1|||
13368430|NCT00834899|26708514|FG001|Overall Study|Withdrawal by Subject|1|||
13368431|NCT00834834|26708529|FG000|Overall Study|Withdrawal by Subject|4|||
13368432|NCT00834834|26708530|FG001|Overall Study|Withdrawal by Subject|3|||
13375274|NCT00790842|26729841|FG002|Dose Level 1|Withdrawal by Subject|0|||
13375275|NCT00790842|26729842|FG003|Dose Level 1|Withdrawal by Subject|0|||
13375276|NCT00790842|26729843|FG004|Dose Level 1|Withdrawal by Subject|0|||
13375277|NCT00790842|26729844|FG005|Dose Level 1|Withdrawal by Subject|0|||
13375278|NCT00790842|26729845|FG006|Dose Level 1|Withdrawal by Subject|0|||
13375279|NCT00790842|26729846|FG007|Dose Level 1|Withdrawal by Subject|0|||
13375280|NCT00790842|26729847|FG008|Dose Level 1|Withdrawal by Subject|0|||
13375281|NCT00790842|26729848|FG009|Dose Level 1|Withdrawal by Subject|0|||
13375282|NCT00790842|26729849|FG010|Dose Level 1|Withdrawal by Subject|0|||
13375283|NCT00790842|26729839|FG000|Dose Level 2|Death|0|||
13375284|NCT00790842|26729840|FG001|Dose Level 2|Death|1|||
13375285|NCT00790842|26729841|FG002|Dose Level 2|Death|0|||
13375286|NCT00790842|26729842|FG003|Dose Level 2|Death|0|||
13375287|NCT00790842|26729843|FG004|Dose Level 2|Death|1|||
13375288|NCT00790842|26729844|FG005|Dose Level 2|Death|0|||
13375289|NCT00790842|26729845|FG006|Dose Level 2|Death|0|||
13375290|NCT00790842|26729846|FG007|Dose Level 2|Death|0|||
13375291|NCT00790842|26729847|FG008|Dose Level 2|Death|0|||
13375292|NCT00790842|26729848|FG009|Dose Level 2|Death|0|||
13375293|NCT00790842|26729849|FG010|Dose Level 2|Death|0|||
13375294|NCT00790842|26729839|FG000|Dose Level 2|Physician Decision|0|||
13375295|NCT00790842|26729840|FG001|Dose Level 2|Physician Decision|1|||
13375296|NCT00790842|26729841|FG002|Dose Level 2|Physician Decision|0|||
13375297|NCT00790842|26729842|FG003|Dose Level 2|Physician Decision|0|||
13375298|NCT00790842|26729843|FG004|Dose Level 2|Physician Decision|0|||
13375299|NCT00790842|26729844|FG005|Dose Level 2|Physician Decision|0|||
13375300|NCT00790842|26729845|FG006|Dose Level 2|Physician Decision|0|||
13375301|NCT00790842|26729846|FG007|Dose Level 2|Physician Decision|0|||
13375302|NCT00790842|26729847|FG008|Dose Level 2|Physician Decision|0|||
13375303|NCT00790842|26729848|FG009|Dose Level 2|Physician Decision|0|||
13375304|NCT00790842|26729849|FG010|Dose Level 2|Physician Decision|0|||
13375305|NCT00790842|26729839|FG000|Dose Level 2|Withdrawal by Subject|0|||
13375306|NCT00790842|26729840|FG001|Dose Level 2|Withdrawal by Subject|1|||
13375307|NCT00790842|26729841|FG002|Dose Level 2|Withdrawal by Subject|0|||
13375308|NCT00790842|26729842|FG003|Dose Level 2|Withdrawal by Subject|0|||
13375309|NCT00790842|26729843|FG004|Dose Level 2|Withdrawal by Subject|0|||
13488139|NCT04409262|27042893|FG001|Overall Study|Lost to Follow-up|23|||
13368433|NCT00834366|26708551|FG000|Treatment Period 1|Adverse Event|1|||
13368434|NCT00834366|26708552|FG001|Treatment Period 1|Adverse Event|1|||
13368435|NCT00834080|26708558|FG000|Overall Study|Adverse Event|7|||
13368436|NCT00834080|26708558|FG000|Overall Study|Lost to Follow-up|7|||
13368437|NCT00834080|26708558|FG000|Overall Study|Withdrawal by Subject|5|||
13368438|NCT00834080|26708558|FG000|Overall Study|Other - Pregnancy|1|||
13368439|NCT00834080|26708558|FG000|Overall Study|Other - False positive tests of the UDS|1|||
13368440|NCT00834080|26708558|FG000|Overall Study|Physician Decision|1|||
13368441|NCT00834080|26708558|FG000|Overall Study|Subject Relocated|1|||
13368442|NCT00834041|26708579|FG000|Overall Study|Withdrawal by Subject|1|||
13368443|NCT00834041|26708580|FG001|Overall Study|Withdrawal by Subject|0|||
13368444|NCT00834041|26708579|FG000|Overall Study|Lost to Follow-up|0|||
13368445|NCT00834041|26708580|FG001|Overall Study|Lost to Follow-up|1|||
13368446|NCT00833989|26708697|FG000|Overall Study|Physician Decision|0|||
13368447|NCT00833989|26708698|FG001|Overall Study|Physician Decision|0|||
13368448|NCT00833989|26708699|FG002|Overall Study|Physician Decision|0|||
13368449|NCT00833989|26708700|FG003|Overall Study|Physician Decision|1|||
13368450|NCT00833989|26708697|FG000|Overall Study|Withdrawal by Subject|3|||
13368451|NCT00833989|26708698|FG001|Overall Study|Withdrawal by Subject|0|||
13368452|NCT00833989|26708699|FG002|Overall Study|Withdrawal by Subject|1|||
13368453|NCT00833989|26708700|FG003|Overall Study|Withdrawal by Subject|1|||
13368454|NCT00833976|26708708|FG000|Overall Study|Withdrawal by Subject|5|||
13368455|NCT00833976|26708708|FG000|Overall Study|Lost to Follow-up|4|||
13368456|NCT00833976|26708708|FG000|Overall Study|Did not meet eligibility criteria|41|||
13368457|NCT00833976|26708708|FG000|Overall Study|Physician Decision|1|||
13368458|NCT00833924|26708715|FG000|Overall Study|Death|21|||
13368459|NCT00833924|26708715|FG000|Overall Study|Conversion|2|||
13368460|NCT00833924|26708715|FG000|Overall Study|Lost to Follow-up|2|||
13368461|NCT00833924|26708715|FG000|Overall Study|Withdrawal by Subject|13|||
13368462|NCT00833924|26708715|FG000|Overall Study|In study follow-up|71|||
13368463|NCT00833911|26708725|FG000|Titration|Adverse Event|18|||
13368464|NCT00833911|26708725|FG000|Titration|Withdrawal by Subject|3|||
13368465|NCT00833911|26708725|FG000|Maintenance Phase I|Adverse Event|73|||
13368466|NCT00833911|26708725|FG000|Maintenance Phase I|Withdrawal by Subject|11|||
13368467|NCT00833911|26708725|FG000|Maintenance Phase I|Physician Decision|10|||
13368468|NCT00833911|26708725|FG000|Maintenance Phase I|Lack of Efficacy|4|||
13368469|NCT00833911|26708725|FG000|Maintenance Phase II|Adverse Event|6|||
13368470|NCT00833911|26708725|FG000|Maintenance Phase II|Physician Decision|2|||
13368471|NCT00833911|26708725|FG000|Maintenance Phase II|Withdrawal by Subject|1|||
13368472|NCT00833911|26708725|FG000|Maintenance Phase II|Lack of Efficacy|1|||
13368473|NCT00833898|26708778|FG000|Overall Study|Withdrawal by Subject|33|||
13368474|NCT00833898|26708779|FG001|Overall Study|Withdrawal by Subject|27|||
13368475|NCT00833898|26708778|FG000|Overall Study|Lost to Follow-up|7|||
13368476|NCT00833898|26708779|FG001|Overall Study|Lost to Follow-up|7|||
13368477|NCT00833898|26708778|FG000|Overall Study|Patient did not receive transplant|0|||
13368478|NCT00833898|26708779|FG001|Overall Study|Patient did not receive transplant|2|||
13368479|NCT00833833|26708836|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0|||
13368480|NCT00833833|26708837|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0|||
13368481|NCT00833833|26708838|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2|||
13368482|NCT00833833|26708839|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2|||
13368483|NCT00833833|26708840|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0|||
13368484|NCT00833833|26708841|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0|||
13368485|NCT00833833|26708836|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
13368486|NCT00833833|26708837|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
13368487|NCT00833833|26708838|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
13368488|NCT00833833|26708839|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
13368489|NCT00833833|26708840|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
13368490|NCT00833833|26708841|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
13368491|NCT00833833|26708836|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
13368492|NCT00833833|26708837|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
13368493|NCT00833833|26708838|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2|||
13368494|NCT00833833|26708839|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
13368495|NCT00833833|26708840|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
13368496|NCT00833833|26708841|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
13368497|NCT00833833|26708836|FG000|Phase 1 (as of 01 April 2011)|Death|0|||
13368498|NCT00833833|26708837|FG001|Phase 1 (as of 01 April 2011)|Death|1|||
13368499|NCT00833833|26708838|FG002|Phase 1 (as of 01 April 2011)|Death|2|||
13368500|NCT00833833|26708839|FG003|Phase 1 (as of 01 April 2011)|Death|0|||
13368501|NCT00833833|26708840|FG004|Phase 1 (as of 01 April 2011)|Death|0|||
13368502|NCT00833833|26708841|FG005|Phase 1 (as of 01 April 2011)|Death|0|||
13368503|NCT00833833|26708836|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
13368504|NCT00833833|26708837|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
13368505|NCT00833833|26708838|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
13368506|NCT00833833|26708839|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
13368507|NCT00833833|26708840|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
13368508|NCT00833833|26708841|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
13368509|NCT00833833|26708836|FG000|Phase 1 (as of 01 April 2011)|Other|1|||
13368510|NCT00833833|26708837|FG001|Phase 1 (as of 01 April 2011)|Other|3|||
13368511|NCT00833833|26708838|FG002|Phase 1 (as of 01 April 2011)|Other|0|||
13368512|NCT00833833|26708839|FG003|Phase 1 (as of 01 April 2011)|Other|1|||
13368513|NCT00833833|26708840|FG004|Phase 1 (as of 01 April 2011)|Other|0|||
13368514|NCT00833833|26708841|FG005|Phase 1 (as of 01 April 2011)|Other|0|||
13368515|NCT00833833|26708836|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0|||
13368516|NCT00833833|26708837|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0|||
13368517|NCT00833833|26708838|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0|||
13368518|NCT00833833|26708839|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0|||
13368519|NCT00833833|26708840|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23|||
13368520|NCT00833833|26708841|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22|||
13368521|NCT00833833|26708836|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
13368522|NCT00833833|26708837|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
13368523|NCT00833833|26708838|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
13368524|NCT00833833|26708839|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
13368525|NCT00833833|26708840|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8|||
13368526|NCT00833833|26708841|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13|||
13368527|NCT00833833|26708836|FG000|Phase 2 (as of 01 April 2011)|Death|0|||
13368528|NCT00833833|26708837|FG001|Phase 2 (as of 01 April 2011)|Death|0|||
13368529|NCT00833833|26708838|FG002|Phase 2 (as of 01 April 2011)|Death|0|||
13368530|NCT00833833|26708839|FG003|Phase 2 (as of 01 April 2011)|Death|0|||
13368531|NCT00833833|26708840|FG004|Phase 2 (as of 01 April 2011)|Death|8|||
13368532|NCT00833833|26708841|FG005|Phase 2 (as of 01 April 2011)|Death|9|||
13368533|NCT00833833|26708836|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
13368534|NCT00833833|26708837|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
13368535|NCT00833833|26708838|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
13368536|NCT00833833|26708839|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
13368537|NCT00833833|26708840|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7|||
13368538|NCT00833833|26708841|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6|||
13368539|NCT00833833|26708836|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
13368540|NCT00833833|26708837|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
13368541|NCT00833833|26708838|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
13368542|NCT00833833|26708839|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
13368543|NCT00833833|26708840|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5|||
13486646|NCT02149121|27036773|FG000|Main Study Period|Unmet predefined eligibility criteria|2|||
13204487|NCT01972789|26229089|FG001|Overall Study|Lost to Follow-up|7|||
13368544|NCT00833833|26708841|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7|||
13368545|NCT00833833|26708836|FG000|Phase 2 (as of 01 April 2011)|Other|0|||
13368546|NCT00833833|26708837|FG001|Phase 2 (as of 01 April 2011)|Other|0|||
13368547|NCT00833833|26708838|FG002|Phase 2 (as of 01 April 2011)|Other|0|||
13368548|NCT00833833|26708839|FG003|Phase 2 (as of 01 April 2011)|Other|0|||
13368549|NCT00833833|26708840|FG004|Phase 2 (as of 01 April 2011)|Other|4|||
13368550|NCT00833833|26708841|FG005|Phase 2 (as of 01 April 2011)|Other|3|||
13368551|NCT00833833|26708836|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
13368552|NCT00833833|26708837|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
13368553|NCT00833833|26708838|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
13368554|NCT00833833|26708839|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
13368555|NCT00833833|26708840|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
13368556|NCT00833833|26708841|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1|||
13368557|NCT00833794|26708874|FG000|Open-label Phase|Adverse Event|225|||
13368558|NCT00833794|26708875|FG001|Open-label Phase|Adverse Event|0|||
13368559|NCT00833794|26708874|FG000|Open-label Phase|Lack of Efficacy|28|||
13368560|NCT00833794|26708875|FG001|Open-label Phase|Lack of Efficacy|0|||
13368561|NCT00833794|26708874|FG000|Open-label Phase|Withdrawal by Subject|48|||
13368562|NCT00833794|26708875|FG001|Open-label Phase|Withdrawal by Subject|0|||
13368563|NCT00833794|26708874|FG000|Open-label Phase|Physician Decision|20|||
13368564|NCT00833794|26708875|FG001|Open-label Phase|Physician Decision|0|||
13368565|NCT00833794|26708874|FG000|Open-label Phase|Administrative reason|1|||
13368566|NCT00833794|26708875|FG001|Open-label Phase|Administrative reason|0|||
13368567|NCT00833794|26708874|FG000|Open-label Phase|Protocol Violation|47|||
13368568|NCT00833794|26708875|FG001|Open-label Phase|Protocol Violation|0|||
13368569|NCT00833794|26708874|FG000|Open-label Phase|Did not complete wash-out period|12|||
13368570|NCT00833794|26708875|FG001|Open-label Phase|Did not complete wash-out period|0|||
13368571|NCT00833794|26708874|FG000|Open-label Phase|enrolled in error (immediately D/C)|1|||
13368572|NCT00833794|26708875|FG001|Open-label Phase|enrolled in error (immediately D/C)|0|||
13368573|NCT00833794|26708874|FG000|Double-blind Phase|Adverse Event|44|||
13368574|NCT00833794|26708875|FG001|Double-blind Phase|Adverse Event|11|||
13368575|NCT00833794|26708874|FG000|Double-blind Phase|Lack of Efficacy|34|||
13368576|NCT00833794|26708875|FG001|Double-blind Phase|Lack of Efficacy|22|||
13368577|NCT00833794|26708874|FG000|Double-blind Phase|Withdrawal by Subject|23|||
13368578|NCT00833794|26708875|FG001|Double-blind Phase|Withdrawal by Subject|6|||
13368579|NCT00833794|26708874|FG000|Double-blind Phase|Physician Decision|4|||
13368580|NCT00833794|26708875|FG001|Double-blind Phase|Physician Decision|7|||
13368581|NCT00833794|26708874|FG000|Double-blind Phase|Administrative reason|1|||
13368582|NCT00833794|26708875|FG001|Double-blind Phase|Administrative reason|3|||
13368583|NCT00833755|26708906|FG000|Overall Study|Physician Decision|4|||
13368584|NCT00833755|26708907|FG001|Overall Study|Physician Decision|4|||
13368585|NCT00833755|26708908|FG002|Overall Study|Physician Decision|2|||
13368586|NCT00833755|26708909|FG003|Overall Study|Physician Decision|6|||
13368587|NCT00833755|26708906|FG000|Overall Study|Subject had scheduling issues|0|||
13368588|NCT00833755|26708907|FG001|Overall Study|Subject had scheduling issues|1|||
13368589|NCT00833755|26708908|FG002|Overall Study|Subject had scheduling issues|0|||
13368590|NCT00833755|26708909|FG003|Overall Study|Subject had scheduling issues|0|||
13368591|NCT00833703|26708926|FG000|Overall Study|Parent(s)/guardian(s)'s request|0|||
13368592|NCT00833703|26708927|FG001|Overall Study|Parent(s)/guardian(s)'s request|1|||
13368593|NCT00833690|26709059|FG000|Overall Study|Withdrawal by Subject|1|||
13368594|NCT00833690|26709060|FG001|Overall Study|Withdrawal by Subject|0|||
13368595|NCT00833690|26709061|FG002|Overall Study|Withdrawal by Subject|0|||
13368596|NCT00833690|26709059|FG000|Overall Study|Discontinued study drug|3|||
13368597|NCT00833690|26709060|FG001|Overall Study|Discontinued study drug|2|||
13368598|NCT00833690|26709061|FG002|Overall Study|Discontinued study drug|0|||
13368599|NCT00833638|26709111|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1|||
13368600|NCT00833638|26709112|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2|||
13368601|NCT00833638|26709113|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0|||
13368602|NCT00833638|26709111|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3|||
13368603|NCT00833638|26709112|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2|||
13368604|NCT00833638|26709113|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1|||
13368605|NCT00833638|26709111|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
13368606|NCT00833638|26709112|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2|||
13368607|NCT00833638|26709113|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
13368608|NCT00833638|26709111|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1|||
13368609|NCT00833638|26709112|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
13368610|NCT00833638|26709113|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
13368611|NCT00833638|26709111|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
13368612|NCT00833638|26709112|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
13368613|NCT00833638|26709113|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
13368614|NCT00833638|26709111|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
13368615|NCT00833638|26709112|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
13368616|NCT00833638|26709113|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2|||
13368617|NCT00833638|26709111|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
13368618|NCT00833638|26709112|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
13368619|NCT00833638|26709113|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2|||
13368620|NCT00833638|26709111|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1|||
13368621|NCT00833638|26709112|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2|||
13368622|NCT00833638|26709113|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0|||
13368623|NCT00833638|26709111|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0|||
13368624|NCT00833638|26709112|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1|||
13368625|NCT00833638|26709113|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2|||
13368626|NCT00833560|26709122|FG000|Overall Study|Toxicity|13|||
13368627|NCT00833560|26709122|FG000|Overall Study|Adverse Event|11|||
13368628|NCT00833560|26709122|FG000|Overall Study|Protocol Violation|6|||
13368629|NCT00833560|26709122|FG000|Overall Study|Lack of Efficacy|4|||
13368630|NCT00833560|26709122|FG000|Overall Study|Death|2|||
13368631|NCT00833560|26709122|FG000|Overall Study|Pregression of other disease|1|||
13368632|NCT00833560|26709122|FG000|Overall Study|Other|5|||
13368633|NCT00833547|26709137|FG000|Overall Study|Withdrawal by Subject|2|||
13368634|NCT00833547|26709138|FG001|Overall Study|Withdrawal by Subject|2|||
13368635|NCT00833482|26709205|FG000|Days 11-20|Adverse Event|0|||
13368636|NCT00833482|26709206|FG001|Days 11-20|Adverse Event|2|||
13368637|NCT00833482|26709207|FG002|Days 11-20|Adverse Event|0|||
13368638|NCT00833482|26709208|FG003|Days 11-20|Adverse Event|0|||
13368639|NCT00833482|26709209|FG004|Days 11-20|Adverse Event|0|||
13368640|NCT00833482|26709210|FG005|Days 11-20|Adverse Event|0|||
13368641|NCT00833482|26709205|FG000|Days 11-20|Withdrawal by Subject|0|||
13368642|NCT00833482|26709206|FG001|Days 11-20|Withdrawal by Subject|1|||
13368643|NCT00833482|26709207|FG002|Days 11-20|Withdrawal by Subject|0|||
13368644|NCT00833482|26709208|FG003|Days 11-20|Withdrawal by Subject|0|||
13368645|NCT00833482|26709209|FG004|Days 11-20|Withdrawal by Subject|0|||
13368646|NCT00833482|26709210|FG005|Days 11-20|Withdrawal by Subject|0|||
13368647|NCT00833482|26709205|FG000|Days 21-30|Adverse Event|0|||
13368648|NCT00833482|26709206|FG001|Days 21-30|Adverse Event|0|||
13368649|NCT00833482|26709207|FG002|Days 21-30|Adverse Event|1|||
13368650|NCT00833482|26709208|FG003|Days 21-30|Adverse Event|0|||
13368651|NCT00833482|26709209|FG004|Days 21-30|Adverse Event|0|||
13368652|NCT00833482|26709210|FG005|Days 21-30|Adverse Event|0|||
13368653|NCT00833482|26709205|FG000|Days 21-30|Withdrawal by Subject|0|||
13368654|NCT00833482|26709206|FG001|Days 21-30|Withdrawal by Subject|0|||
13368655|NCT00833482|26709207|FG002|Days 21-30|Withdrawal by Subject|0|||
13368656|NCT00833482|26709208|FG003|Days 21-30|Withdrawal by Subject|0|||
13368657|NCT00833482|26709209|FG004|Days 21-30|Withdrawal by Subject|1|||
13368658|NCT00833482|26709210|FG005|Days 21-30|Withdrawal by Subject|0|||
13368659|NCT00833469|26709218|FG000|Overall Study|Withdrawal by Subject|1|||
13368660|NCT00833469|26709218|FG000|Overall Study|Lost to Follow-up|1|||
13368661|NCT00833417|26709238|FG000|Overall Study|Adverse Event|5|||
13368662|NCT00833417|26709239|FG001|Overall Study|Adverse Event|16|||
13368663|NCT00833417|26709238|FG000|Overall Study|Death|1|||
13368664|NCT00833417|26709239|FG001|Overall Study|Death|3|||
13368665|NCT00833417|26709238|FG000|Overall Study|Lost to Follow-up|1|||
13368666|NCT00833417|26709239|FG001|Overall Study|Lost to Follow-up|2|||
13368667|NCT00833417|26709238|FG000|Overall Study|Physician Decision to Withdraw Patient|3|||
13368668|NCT00833417|26709239|FG001|Overall Study|Physician Decision to Withdraw Patient|7|||
13368669|NCT00833417|26709238|FG000|Overall Study|Patient Decision to Withdraw|4|||
13368670|NCT00833417|26709239|FG001|Overall Study|Patient Decision to Withdraw|23|||
13368671|NCT00833417|26709238|FG000|Overall Study|Sponsor Decision to Terminate Study|1|||
13368672|NCT00833417|26709239|FG001|Overall Study|Sponsor Decision to Terminate Study|2|||
13368673|NCT00833417|26709238|FG000|Overall Study|Disease Progression|18|||
13368674|NCT00833417|26709239|FG001|Overall Study|Disease Progression|17|||
13368675|NCT00833417|26709238|FG000|Overall Study|Reason Not Specified|0|||
13368676|NCT00833417|26709239|FG001|Overall Study|Reason Not Specified|1|||
13368677|NCT00833261|26709246|FG000|Overall Study|Withdrawal by Subject|4|||
13368678|NCT00833248|26709275|FG000|Overall Study|Adverse Event|3|||
13368679|NCT00833248|26709276|FG001|Overall Study|Adverse Event|0|||
13368680|NCT00833248|26709275|FG000|Overall Study|Protocol Violation|1|||
13368681|NCT00833248|26709276|FG001|Overall Study|Protocol Violation|2|||
13368682|NCT00833248|26709275|FG000|Overall Study|Withdrawal by Subject|0|||
13368683|NCT00833248|26709276|FG001|Overall Study|Withdrawal by Subject|1|||
13368684|NCT00833105|26709294|FG000|Overall Study|Withdrawal by Subject|1|||
13368685|NCT00833105|26709294|FG000|Overall Study|Adverse Event|2|||
13368686|NCT00833092|26709307|FG000|Overall Study|Withdrawal by Subject|2|||
13368687|NCT00833092|26709308|FG001|Overall Study|Withdrawal by Subject|3|||
13368688|NCT00833092|26709307|FG000|Overall Study|Protocol Violation|2|||
13368689|NCT00833092|26709308|FG001|Overall Study|Protocol Violation|1|||
13368690|NCT00833092|26709307|FG000|Overall Study|Diarrhea|0|||
13368691|NCT00833092|26709308|FG001|Overall Study|Diarrhea|2|||
13368692|NCT00833092|26709307|FG000|Overall Study|constipation|0|||
13368693|NCT00833092|26709308|FG001|Overall Study|constipation|1|||
13368694|NCT00833053|26709333|FG000|Overall Study|Adverse Event|4|||
13368695|NCT00833053|26709334|FG001|Overall Study|Adverse Event|0|||
13368696|NCT00833053|26709333|FG000|Overall Study|Treatment Failure|3|||
13368697|NCT00833053|26709334|FG001|Overall Study|Treatment Failure|1|||
13368698|NCT00833053|26709333|FG000|Overall Study|Withdrawal by Subject|0|||
13368699|NCT00833053|26709334|FG001|Overall Study|Withdrawal by Subject|1|||
13368700|NCT00833053|26709333|FG000|Overall Study|Protocol Violation|2|||
13368701|NCT00833053|26709334|FG001|Overall Study|Protocol Violation|1|||
13368702|NCT00833040|26709346|FG000|Overall Study|Adverse Event|0|||
13368703|NCT00833040|26709347|FG001|Overall Study|Adverse Event|0|||
13368704|NCT00833040|26709348|FG002|Overall Study|Adverse Event|0|||
13368705|NCT00833040|26709349|FG003|Overall Study|Adverse Event|0|||
13368706|NCT00833040|26709350|FG004|Overall Study|Adverse Event|0|||
13368707|NCT00833040|26709351|FG005|Overall Study|Adverse Event|1|||
13368708|NCT00833027|26709358|FG000|Overall Study|Adverse Event|33|||
13368709|NCT00833027|26709358|FG000|Overall Study|Death|1|||
13368710|NCT00833027|26709358|FG000|Overall Study|Lack of Efficacy|12|||
13368711|NCT00833027|26709358|FG000|Overall Study|Lost to Follow-up|24|||
13368712|NCT00833027|26709358|FG000|Overall Study|Protocol Violation|115|||
13368713|NCT00833027|26709358|FG000|Overall Study|Withdrawal by Subject|16|||
13368714|NCT00833027|26709358|FG000|Overall Study|Missing|10|||
13368715|NCT00832975|26709365|FG000|Overall Study|Lost to Follow-up|7|||
13368716|NCT00832975|26709365|FG000|Overall Study|Protocol Violation|6|||
13368717|NCT00832975|26709365|FG000|Overall Study|Death|5|||
13368718|NCT00832975|26709365|FG000|Overall Study|Physician Decision|4|||
13368719|NCT00832975|26709365|FG000|Overall Study|Withdrawal by Subject|3|||
13368720|NCT00832975|26709365|FG000|Overall Study|Other reasons|14|||
13368721|NCT00832819|26709381|FG000|Overall Study|Adverse Event|0|||
13368722|NCT00832819|26709382|FG001|Overall Study|Adverse Event|1|||
13368723|NCT00832819|26709383|FG002|Overall Study|Adverse Event|0|||
13368724|NCT00832819|26709381|FG000|Overall Study|Protocol Violation|0|||
13368725|NCT00832819|26709382|FG001|Overall Study|Protocol Violation|0|||
13368726|NCT00832819|26709383|FG002|Overall Study|Protocol Violation|1|||
13368727|NCT00832780|26709393|FG000|Overall Study|Death|16|||
13368728|NCT00832780|26709393|FG000|Overall Study|Lost to Follow-up|4|||
13368729|NCT00832780|26709393|FG000|Overall Study|no reason given|2|||
13368730|NCT00832780|26709393|FG000|Overall Study|other complicating condition|2|||
13368731|NCT00832780|26709393|FG000|Overall Study|Physician Decision|1|||
13368732|NCT00832650|26709435|FG000|Overall Study|Randomized but not treated|0|||
13368733|NCT00832650|26709436|FG001|Overall Study|Randomized but not treated|0|||
13368734|NCT00832650|26709437|FG002|Overall Study|Randomized but not treated|1|||
13368735|NCT00832624|26709443|FG000|Overall Study|Study Terminated|10|||
13368736|NCT00832585|26709450|FG000|Overall Study|Withdrawal by Subject|1|||
13368737|NCT00832585|26709450|FG000|Overall Study|Lost to Follow-up|1|||
13368738|NCT00832416|26709501|FG000|Overall Study|Lack of Efficacy|17|||
13368739|NCT00832416|26709502|FG001|Overall Study|Lack of Efficacy|15|||
13368740|NCT00832416|26709503|FG002|Overall Study|Lack of Efficacy|13|||
13368741|NCT00832416|26709504|FG003|Overall Study|Lack of Efficacy|52|||
13368742|NCT00832416|26709501|FG000|Overall Study|Withdrawal by Subject|5|||
13368743|NCT00832416|26709502|FG001|Overall Study|Withdrawal by Subject|7|||
13368744|NCT00832416|26709503|FG002|Overall Study|Withdrawal by Subject|2|||
13368745|NCT00832416|26709504|FG003|Overall Study|Withdrawal by Subject|10|||
13368746|NCT00832416|26709501|FG000|Overall Study|Physician Decision|2|||
13368747|NCT00832416|26709502|FG001|Overall Study|Physician Decision|12|||
13368748|NCT00832416|26709503|FG002|Overall Study|Physician Decision|5|||
13368749|NCT00832416|26709504|FG003|Overall Study|Physician Decision|10|||
13368750|NCT00832416|26709501|FG000|Overall Study|Administrative|0|||
13368751|NCT00832416|26709502|FG001|Overall Study|Administrative|0|||
13368752|NCT00832416|26709503|FG002|Overall Study|Administrative|0|||
13368753|NCT00832416|26709504|FG003|Overall Study|Administrative|1|||
13368754|NCT00832416|26709501|FG000|Overall Study|Adverse Event|21|||
13368755|NCT00832416|26709502|FG001|Overall Study|Adverse Event|19|||
13368756|NCT00832416|26709503|FG002|Overall Study|Adverse Event|41|||
13368757|NCT00832416|26709504|FG003|Overall Study|Adverse Event|10|||
13368758|NCT00832416|26709501|FG000|Overall Study|Death|1|||
13368759|NCT00832416|26709502|FG001|Overall Study|Death|0|||
13368760|NCT00832416|26709503|FG002|Overall Study|Death|0|||
13368761|NCT00832416|26709504|FG003|Overall Study|Death|0|||
13368762|NCT00832377|26709513|FG000|Overall Study|Protocol Violation|1|||
13368763|NCT00832117|26709536|FG000|Overall Study|Death|1|||
13368764|NCT00832117|26709536|FG000|Overall Study|Disease Progression|11|||
13368765|NCT00832091|26709551|FG000|Overall Study|Adverse Event|1|||
13368766|NCT00832091|26709552|FG001|Overall Study|Adverse Event|1|||
13368767|NCT00832091|26709551|FG000|Overall Study|Protocol Violation|1|||
13368768|NCT00832091|26709552|FG001|Overall Study|Protocol Violation|0|||
13368769|NCT00832091|26709551|FG000|Overall Study|Withdrawal by Subject|2|||
13368770|NCT00832091|26709552|FG001|Overall Study|Withdrawal by Subject|1|||
13368771|NCT00832091|26709551|FG000|Overall Study|Prohibited Medication|1|||
13368772|NCT00832091|26709552|FG001|Overall Study|Prohibited Medication|0|||
13368773|NCT00832078|26709561|FG000|Test Day 1-2 Period|Lack of Efficacy|0|||
13368774|NCT00832078|26709562|FG001|Test Day 1-2 Period|Lack of Efficacy|2|||
13368775|NCT00832078|26709561|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1|||
13368776|NCT00832078|26709562|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0|||
13368777|NCT00832000|26709601|FG000|Overall Study|Adverse Event|2|||
13368778|NCT00832000|26709602|FG001|Overall Study|Adverse Event|0|||
13368779|NCT00832000|26709601|FG000|Overall Study|Withdrawal by Subject|1|||
13368780|NCT00832000|26709602|FG001|Overall Study|Withdrawal by Subject|0|||
13368781|NCT00832000|26709601|FG000|Overall Study|No calls to IVR in either period|1|||
13368782|NCT00832000|26709602|FG001|Overall Study|No calls to IVR in either period|1|||
13368783|NCT00832000|26709601|FG000|Overall Study|No calls to IVR in period 2|2|||
13368784|NCT00832000|26709602|FG001|Overall Study|No calls to IVR in period 2|0|||
13368785|NCT00831844|26709655|FG000|Overall Study|Adverse Event|2|||
13368786|NCT00831844|26709656|FG001|Overall Study|Adverse Event|0|||
13368787|NCT00831844|26709657|FG002|Overall Study|Adverse Event|0|||
13368788|NCT00831844|26709658|FG003|Overall Study|Adverse Event|0|||
13368789|NCT00831844|26709659|FG004|Overall Study|Adverse Event|1|||
13368790|NCT00831844|26709660|FG005|Overall Study|Adverse Event|1|||
13368791|NCT00831844|26709661|FG006|Overall Study|Adverse Event|2|||
13368792|NCT00831844|26709662|FG007|Overall Study|Adverse Event|0|||
13368793|NCT00831844|26709663|FG008|Overall Study|Adverse Event|0|||
13368794|NCT00831844|26709664|FG009|Overall Study|Adverse Event|0|||
13368795|NCT00831844|26709655|FG000|Overall Study|Death|0|||
13368796|NCT00831844|26709656|FG001|Overall Study|Death|0|||
13368797|NCT00831844|26709657|FG002|Overall Study|Death|0|||
13368798|NCT00831844|26709658|FG003|Overall Study|Death|1|||
13368799|NCT00831844|26709659|FG004|Overall Study|Death|0|||
13368800|NCT00831844|26709660|FG005|Overall Study|Death|0|||
13368801|NCT00831844|26709661|FG006|Overall Study|Death|0|||
13368802|NCT00831844|26709662|FG007|Overall Study|Death|0|||
13368803|NCT00831844|26709663|FG008|Overall Study|Death|0|||
13368804|NCT00831844|26709664|FG009|Overall Study|Death|0|||
13368805|NCT00831844|26709655|FG000|Overall Study|Lack of Efficacy|8|||
13368806|NCT00831844|26709656|FG001|Overall Study|Lack of Efficacy|10|||
13368807|NCT00831844|26709657|FG002|Overall Study|Lack of Efficacy|15|||
13368808|NCT00831844|26709658|FG003|Overall Study|Lack of Efficacy|8|||
13368809|NCT00831844|26709659|FG004|Overall Study|Lack of Efficacy|11|||
13368810|NCT00831844|26709660|FG005|Overall Study|Lack of Efficacy|17|||
13368811|NCT00831844|26709661|FG006|Overall Study|Lack of Efficacy|8|||
13368812|NCT00831844|26709662|FG007|Overall Study|Lack of Efficacy|9|||
13368813|NCT00831844|26709663|FG008|Overall Study|Lack of Efficacy|7|||
13368814|NCT00831844|26709664|FG009|Overall Study|Lack of Efficacy|0|||
13368815|NCT00831844|26709655|FG000|Overall Study|Physician Decision|0|||
13368816|NCT00831844|26709656|FG001|Overall Study|Physician Decision|1|||
13368817|NCT00831844|26709657|FG002|Overall Study|Physician Decision|3|||
13368818|NCT00831844|26709658|FG003|Overall Study|Physician Decision|1|||
13368819|NCT00831844|26709659|FG004|Overall Study|Physician Decision|1|||
13368820|NCT00831844|26709660|FG005|Overall Study|Physician Decision|1|||
13368821|NCT00831844|26709661|FG006|Overall Study|Physician Decision|0|||
13368822|NCT00831844|26709662|FG007|Overall Study|Physician Decision|0|||
13368823|NCT00831844|26709663|FG008|Overall Study|Physician Decision|1|||
13368824|NCT00831844|26709664|FG009|Overall Study|Physician Decision|0|||
13368825|NCT00831844|26709655|FG000|Overall Study|Withdrawal by Subject|0|||
13368826|NCT00831844|26709656|FG001|Overall Study|Withdrawal by Subject|0|||
13368827|NCT00831844|26709657|FG002|Overall Study|Withdrawal by Subject|1|||
13368828|NCT00831844|26709658|FG003|Overall Study|Withdrawal by Subject|0|||
13368829|NCT00831844|26709659|FG004|Overall Study|Withdrawal by Subject|0|||
13368830|NCT00831844|26709660|FG005|Overall Study|Withdrawal by Subject|0|||
13368831|NCT00831844|26709661|FG006|Overall Study|Withdrawal by Subject|0|||
13368832|NCT00831844|26709662|FG007|Overall Study|Withdrawal by Subject|1|||
13368833|NCT00831844|26709663|FG008|Overall Study|Withdrawal by Subject|1|||
13368834|NCT00831844|26709664|FG009|Overall Study|Withdrawal by Subject|0|||
13368835|NCT00831844|26709655|FG000|Overall Study|Ineligible|0|||
13368836|NCT00831844|26709656|FG001|Overall Study|Ineligible|1|||
13368837|NCT00831844|26709657|FG002|Overall Study|Ineligible|1|||
13368838|NCT00831844|26709658|FG003|Overall Study|Ineligible|0|||
13368839|NCT00831844|26709659|FG004|Overall Study|Ineligible|1|||
13368840|NCT00831844|26709660|FG005|Overall Study|Ineligible|0|||
13368841|NCT00831844|26709661|FG006|Overall Study|Ineligible|0|||
13368842|NCT00831844|26709662|FG007|Overall Study|Ineligible|0|||
13368843|NCT00831844|26709663|FG008|Overall Study|Ineligible|0|||
13368844|NCT00831844|26709664|FG009|Overall Study|Ineligible|0|||
13368845|NCT00831792|26709670|FG000|Overall Study|Not Eligible|3|||
13368846|NCT00831792|26709670|FG000|Overall Study|Adverse Event|1|||
13368847|NCT00831792|26709670|FG000|Overall Study|Death|1|||
13368848|NCT00831792|26709670|FG000|Overall Study|Lack of Efficacy|1|||
13368849|NCT00831779|26709685|FG000|Overall Study|Lost to Follow-up|1|||
13368850|NCT00831779|26709686|FG001|Overall Study|Lost to Follow-up|0|||
13368851|NCT00831779|26709685|FG000|Overall Study|No longer met criteria|0|||
13368852|NCT00831779|26709686|FG001|Overall Study|No longer met criteria|1|||
13368853|NCT00831701|26709707|FG000|Overall Study|Withdrawal by Subject|2|||
13368854|NCT00831701|26709708|FG001|Overall Study|Withdrawal by Subject|0|||
13368855|NCT00831701|26709707|FG000|Overall Study|Stone expulsion before first medication|2|||
13368856|NCT00831701|26709708|FG001|Overall Study|Stone expulsion before first medication|2|||
13368857|NCT00831701|26709707|FG000|Overall Study|Lost to Follow-up|1|||
13368858|NCT00831701|26709708|FG001|Overall Study|Lost to Follow-up|3|||
13368859|NCT00831493|26709714|FG000|Overall Study|Intractable nausea and vomiting|1|||
13368860|NCT00831441|26709749|FG000|Randomized|Death|82|||
13368861|NCT00831441|26709750|FG001|Randomized|Death|81|||
13368862|NCT00831441|26709749|FG000|Randomized|Adverse Event|248|||
13368863|NCT00831441|26709750|FG001|Randomized|Adverse Event|321|||
13368864|NCT00831441|26709749|FG000|Randomized|Emergency procedure|2|||
13368865|NCT00831441|26709750|FG001|Randomized|Emergency procedure|2|||
13368866|NCT00831441|26709749|FG000|Randomized|Elective procedure|26|||
13368867|NCT00831441|26709750|FG001|Randomized|Elective procedure|25|||
13368868|NCT00831441|26709749|FG000|Randomized|Physician Decision|26|||
13368869|NCT00831441|26709750|FG001|Randomized|Physician Decision|35|||
13368870|NCT00831441|26709749|FG000|Randomized|No longer met criteria|13|||
13368871|NCT00831441|26709750|FG001|Randomized|No longer met criteria|19|||
13368872|NCT00831441|26709749|FG000|Randomized|Withdrawal by Subject|178|||
13368873|NCT00831441|26709750|FG001|Randomized|Withdrawal by Subject|212|||
13368874|NCT00831441|26709749|FG000|Randomized|Lost to Follow-up|26|||
13368875|NCT00831441|26709750|FG001|Randomized|Lost to Follow-up|35|||
13368876|NCT00831441|26709749|FG000|Randomized|Administrative reason by sponsor|2780|||
13368877|NCT00831441|26709750|FG001|Randomized|Administrative reason by sponsor|2671|||
13368878|NCT00831441|26709749|FG000|Randomized|poor/non-compliance|30|||
13368879|NCT00831441|26709750|FG001|Randomized|poor/non-compliance|38|||
13368880|NCT00831441|26709749|FG000|Randomized|non-specified|276|||
13368881|NCT00831441|26709750|FG001|Randomized|non-specified|266|||
13368882|NCT00831441|26709749|FG000|Follow Up (30 Days)|Withdrawal by Subject|41|||
13368883|NCT00831441|26709750|FG001|Follow Up (30 Days)|Withdrawal by Subject|34|||
13368884|NCT00831441|26709749|FG000|Follow Up (30 Days)|Lost to Follow-up|13|||
13368885|NCT00831441|26709750|FG001|Follow Up (30 Days)|Lost to Follow-up|27|||
13368886|NCT00831441|26709749|FG000|Follow Up (30 Days)|Death|63|||
13368887|NCT00831441|26709750|FG001|Follow Up (30 Days)|Death|86|||
13368888|NCT00831441|26709749|FG000|Follow Up (30 Days)|non-specified|16|||
13368889|NCT00831441|26709750|FG001|Follow Up (30 Days)|non-specified|26|||
13368890|NCT00831441|26709749|FG000|Follow Up (30 Days)|missing end of study status|0|||
13368891|NCT00831441|26709750|FG001|Follow Up (30 Days)|missing end of study status|1|||
13368892|NCT00831415|26709759|FG000|Overall Study|Adverse Event|14|||
13368893|NCT00831415|26709759|FG000|Overall Study|Failed to return|3|||
13368894|NCT00831415|26709759|FG000|Overall Study|Physician Decision|6|||
13368895|NCT00831415|26709759|FG000|Overall Study|Lost to Follow-up|9|||
13368896|NCT00831415|26709759|FG000|Overall Study|Protocol Violation|3|||
13368897|NCT00831415|26709759|FG000|Overall Study|Withdrawal by Subject|35|||
13368898|NCT00831415|26709759|FG000|Overall Study|Unsatisfactory response - Efficacy|4|||
13368899|NCT00831415|26709759|FG000|Overall Study|Death|1|||
13368900|NCT00831389|26709790|FG000|Overall Study|Withdrawal by Subject|0|||
13368901|NCT00831389|26709791|FG001|Overall Study|Withdrawal by Subject|1|||
13368902|NCT00831311|26709816|FG000|Overall Study|Definitive Contraindication|3|||
13368903|NCT00831311|26709817|FG001|Overall Study|Definitive Contraindication|3|||
13368904|NCT00831311|26709816|FG000|Overall Study|Lost to Follow-up|3|||
13368905|NCT00831311|26709817|FG001|Overall Study|Lost to Follow-up|0|||
13368906|NCT00831311|26709816|FG000|Overall Study|Physician Decision|0|||
13368907|NCT00831311|26709817|FG001|Overall Study|Physician Decision|1|||
13368908|NCT00831311|26709816|FG000|Overall Study|Withdrawal by Subject|6|||
13368909|NCT00831311|26709817|FG001|Overall Study|Withdrawal by Subject|4|||
13368910|NCT00831233|26709848|FG000|Overall Study|Adverse Event|0|||
13368911|NCT00831233|26709849|FG001|Overall Study|Adverse Event|1|||
13368912|NCT00831233|26709848|FG000|Overall Study|Protocol Violation|1|||
13368913|NCT00831233|26709849|FG001|Overall Study|Protocol Violation|0|||
13368914|NCT00831233|26709848|FG000|Overall Study|Selection Criteria Not Met|2|||
13368915|NCT00831233|26709849|FG001|Overall Study|Selection Criteria Not Met|0|||
13368916|NCT00831181|26709862|FG000|Overall Study|Adverse Event|12|||
13368917|NCT00831129|26709905|FG000|Overall Study|Adverse Event|0|||
13368918|NCT00831129|26709906|FG001|Overall Study|Adverse Event|1|||
13368919|NCT00831129|26709905|FG000|Overall Study|9 lost to follow-up reasons uknown|0|||
13368920|NCT00831129|26709906|FG001|Overall Study|9 lost to follow-up reasons uknown|9|||
13368921|NCT00830960|26710039|FG000|Overall Study|Death|5|||
13368922|NCT00830960|26710040|FG001|Overall Study|Death|4|||
13368923|NCT00830960|26710041|FG002|Overall Study|Death|3|||
13368924|NCT00830960|26710042|FG003|Overall Study|Death|2|||
13368925|NCT00830960|26710043|FG004|Overall Study|Death|6|||
13368926|NCT00830960|26710044|FG005|Overall Study|Death|1|||
13368927|NCT00830960|26710039|FG000|Overall Study|Lost to Follow-up|1|||
13368928|NCT00830960|26710040|FG001|Overall Study|Lost to Follow-up|1|||
13368929|NCT00830960|26710041|FG002|Overall Study|Lost to Follow-up|1|||
13368930|NCT00830960|26710042|FG003|Overall Study|Lost to Follow-up|0|||
13368931|NCT00830960|26710043|FG004|Overall Study|Lost to Follow-up|0|||
13368932|NCT00830960|26710044|FG005|Overall Study|Lost to Follow-up|1|||
13368933|NCT00830960|26710039|FG000|Overall Study|Withdrawal by Subject|19|||
13368934|NCT00830960|26710040|FG001|Overall Study|Withdrawal by Subject|19|||
13368935|NCT00830960|26710041|FG002|Overall Study|Withdrawal by Subject|18|||
13368936|NCT00830960|26710042|FG003|Overall Study|Withdrawal by Subject|23|||
13368937|NCT00830960|26710043|FG004|Overall Study|Withdrawal by Subject|16|||
13368938|NCT00830960|26710044|FG005|Overall Study|Withdrawal by Subject|21|||
13368939|NCT00830960|26710039|FG000|Overall Study|Sponsor Decision|1|||
13368940|NCT00830960|26710040|FG001|Overall Study|Sponsor Decision|2|||
13368941|NCT00830960|26710041|FG002|Overall Study|Sponsor Decision|3|||
13368942|NCT00830960|26710042|FG003|Overall Study|Sponsor Decision|4|||
13368943|NCT00830960|26710043|FG004|Overall Study|Sponsor Decision|5|||
13368944|NCT00830960|26710044|FG005|Overall Study|Sponsor Decision|7|||
13368945|NCT00830960|26710039|FG000|Overall Study|No study drug received|7|||
13368946|NCT00830960|26710040|FG001|Overall Study|No study drug received|2|||
13368947|NCT00830960|26710041|FG002|Overall Study|No study drug received|4|||
13368948|NCT00830960|26710042|FG003|Overall Study|No study drug received|3|||
13368949|NCT00830960|26710043|FG004|Overall Study|No study drug received|5|||
13368950|NCT00830960|26710044|FG005|Overall Study|No study drug received|7|||
13368951|NCT00830947|26710057|FG000|Overall Study|Lost to Follow-up|4|||
13368952|NCT00830947|26710058|FG001|Overall Study|Lost to Follow-up|4|||
13368953|NCT00830869|26710231|FG000|Period 1: Part 1|Symptomatic deterioration|0|||
13368954|NCT00830869|26710232|FG001|Period 1: Part 1|Symptomatic deterioration|0|||
13368955|NCT00830869|26710233|FG002|Period 1: Part 1|Symptomatic deterioration|0|||
13368956|NCT00830869|26710234|FG003|Period 1: Part 1|Symptomatic deterioration|1|||
13368957|NCT00830869|26710235|FG004|Period 1: Part 1|Symptomatic deterioration|0|||
13368958|NCT00830869|26710236|FG005|Period 1: Part 1|Symptomatic deterioration|1|||
13368959|NCT00830869|26710237|FG006|Period 1: Part 1|Symptomatic deterioration|1|||
13368960|NCT00830869|26710238|FG007|Period 1: Part 1|Symptomatic deterioration|0|||
13368961|NCT00830869|26710239|FG008|Period 1: Part 1|Symptomatic deterioration|0|||
13368962|NCT00830869|26710240|FG009|Period 1: Part 1|Symptomatic deterioration|0|||
13368963|NCT00830869|26710241|FG010|Period 1: Part 1|Symptomatic deterioration|0|||
13368964|NCT00830869|26710242|FG011|Period 1: Part 1|Symptomatic deterioration|0|||
13368965|NCT00830869|26710231|FG000|Period 1: Part 1|Withdrawal by Subject|0|||
13368966|NCT00830869|26710232|FG001|Period 1: Part 1|Withdrawal by Subject|1|||
13368967|NCT00830869|26710233|FG002|Period 1: Part 1|Withdrawal by Subject|0|||
13368968|NCT00830869|26710234|FG003|Period 1: Part 1|Withdrawal by Subject|0|||
13368969|NCT00830869|26710235|FG004|Period 1: Part 1|Withdrawal by Subject|0|||
13368970|NCT00830869|26710236|FG005|Period 1: Part 1|Withdrawal by Subject|0|||
13368971|NCT00830869|26710237|FG006|Period 1: Part 1|Withdrawal by Subject|0|||
13368972|NCT00830869|26710238|FG007|Period 1: Part 1|Withdrawal by Subject|0|||
13368973|NCT00830869|26710239|FG008|Period 1: Part 1|Withdrawal by Subject|0|||
13368974|NCT00830869|26710240|FG009|Period 1: Part 1|Withdrawal by Subject|0|||
13368975|NCT00830869|26710241|FG010|Period 1: Part 1|Withdrawal by Subject|0|||
13368976|NCT00830869|26710242|FG011|Period 1: Part 1|Withdrawal by Subject|0|||
13368977|NCT00830869|26710231|FG000|Period 1: Part 1|Adverse Event|0|||
13368978|NCT00830869|26710232|FG001|Period 1: Part 1|Adverse Event|0|||
13368979|NCT00830869|26710233|FG002|Period 1: Part 1|Adverse Event|0|||
13368980|NCT00830869|26710234|FG003|Period 1: Part 1|Adverse Event|0|||
13368981|NCT00830869|26710235|FG004|Period 1: Part 1|Adverse Event|0|||
13368982|NCT00830869|26710236|FG005|Period 1: Part 1|Adverse Event|1|||
13368983|NCT00830869|26710237|FG006|Period 1: Part 1|Adverse Event|1|||
13368984|NCT00830869|26710238|FG007|Period 1: Part 1|Adverse Event|0|||
13368985|NCT00830869|26710239|FG008|Period 1: Part 1|Adverse Event|0|||
13368986|NCT00830869|26710240|FG009|Period 1: Part 1|Adverse Event|0|||
13368987|NCT00830869|26710241|FG010|Period 1: Part 1|Adverse Event|0|||
13368988|NCT00830869|26710242|FG011|Period 1: Part 1|Adverse Event|0|||
13368989|NCT00830869|26710231|FG000|Period 1: Part 1|Progressive disease|1|||
13368990|NCT00830869|26710232|FG001|Period 1: Part 1|Progressive disease|0|||
13368991|NCT00830869|26710233|FG002|Period 1: Part 1|Progressive disease|1|||
13368992|NCT00830869|26710234|FG003|Period 1: Part 1|Progressive disease|6|||
13368993|NCT00830869|26710235|FG004|Period 1: Part 1|Progressive disease|4|||
13368994|NCT00830869|26710236|FG005|Period 1: Part 1|Progressive disease|4|||
13368995|NCT00830869|26710237|FG006|Period 1: Part 1|Progressive disease|1|||
13368996|NCT00830869|26710238|FG007|Period 1: Part 1|Progressive disease|0|||
13368997|NCT00830869|26710239|FG008|Period 1: Part 1|Progressive disease|0|||
13368998|NCT00830869|26710240|FG009|Period 1: Part 1|Progressive disease|0|||
13368999|NCT00830869|26710241|FG010|Period 1: Part 1|Progressive disease|0|||
13369000|NCT00830869|26710242|FG011|Period 1: Part 1|Progressive disease|0|||
13369001|NCT00830869|26710231|FG000|Period 2: Part 2|Protocol Violation|0|||
13369002|NCT00830869|26710232|FG001|Period 2: Part 2|Protocol Violation|0|||
13369003|NCT00830869|26710233|FG002|Period 2: Part 2|Protocol Violation|0|||
13369004|NCT00830869|26710234|FG003|Period 2: Part 2|Protocol Violation|0|||
13369005|NCT00830869|26710235|FG004|Period 2: Part 2|Protocol Violation|0|||
13369006|NCT00830869|26710236|FG005|Period 2: Part 2|Protocol Violation|0|||
13369007|NCT00830869|26710237|FG006|Period 2: Part 2|Protocol Violation|0|||
13369008|NCT00830869|26710238|FG007|Period 2: Part 2|Protocol Violation|1|||
13369009|NCT00830869|26710239|FG008|Period 2: Part 2|Protocol Violation|0|||
13369010|NCT00830869|26710240|FG009|Period 2: Part 2|Protocol Violation|1|||
13369011|NCT00830869|26710241|FG010|Period 2: Part 2|Protocol Violation|0|||
13369012|NCT00830869|26710242|FG011|Period 2: Part 2|Protocol Violation|0|||
13369013|NCT00830869|26710231|FG000|Period 2: Part 2|Withdrawal by Subject|0|||
13369014|NCT00830869|26710232|FG001|Period 2: Part 2|Withdrawal by Subject|0|||
13369015|NCT00830869|26710233|FG002|Period 2: Part 2|Withdrawal by Subject|0|||
13369016|NCT00830869|26710234|FG003|Period 2: Part 2|Withdrawal by Subject|0|||
13369017|NCT00830869|26710235|FG004|Period 2: Part 2|Withdrawal by Subject|0|||
13369018|NCT00830869|26710236|FG005|Period 2: Part 2|Withdrawal by Subject|0|||
13369019|NCT00830869|26710237|FG006|Period 2: Part 2|Withdrawal by Subject|0|||
13369020|NCT00830869|26710238|FG007|Period 2: Part 2|Withdrawal by Subject|1|||
13369021|NCT00830869|26710239|FG008|Period 2: Part 2|Withdrawal by Subject|2|||
13369022|NCT00830869|26710240|FG009|Period 2: Part 2|Withdrawal by Subject|1|||
13369023|NCT00830869|26710241|FG010|Period 2: Part 2|Withdrawal by Subject|0|||
13369024|NCT00830869|26710242|FG011|Period 2: Part 2|Withdrawal by Subject|1|||
13369025|NCT00830869|26710231|FG000|Period 2: Part 2|Adverse Event|0|||
13369026|NCT00830869|26710232|FG001|Period 2: Part 2|Adverse Event|0|||
13369027|NCT00830869|26710233|FG002|Period 2: Part 2|Adverse Event|0|||
13369028|NCT00830869|26710234|FG003|Period 2: Part 2|Adverse Event|0|||
13369029|NCT00830869|26710235|FG004|Period 2: Part 2|Adverse Event|0|||
13369030|NCT00830869|26710236|FG005|Period 2: Part 2|Adverse Event|0|||
13369031|NCT00830869|26710237|FG006|Period 2: Part 2|Adverse Event|0|||
13369032|NCT00830869|26710238|FG007|Period 2: Part 2|Adverse Event|4|||
13369033|NCT00830869|26710239|FG008|Period 2: Part 2|Adverse Event|3|||
13369034|NCT00830869|26710240|FG009|Period 2: Part 2|Adverse Event|2|||
13369035|NCT00830869|26710241|FG010|Period 2: Part 2|Adverse Event|2|||
13369036|NCT00830869|26710242|FG011|Period 2: Part 2|Adverse Event|0|||
13369037|NCT00830869|26710231|FG000|Period 2: Part 2|Symptomatic Deterioration|0|||
13369038|NCT00830869|26710232|FG001|Period 2: Part 2|Symptomatic Deterioration|0|||
13369039|NCT00830869|26710233|FG002|Period 2: Part 2|Symptomatic Deterioration|0|||
13369040|NCT00830869|26710234|FG003|Period 2: Part 2|Symptomatic Deterioration|0|||
13369041|NCT00830869|26710235|FG004|Period 2: Part 2|Symptomatic Deterioration|0|||
13488140|NCT04409262|27042892|FG000|Overall Study|Lack of Staff|0|||
13369042|NCT00830869|26710236|FG005|Period 2: Part 2|Symptomatic Deterioration|0|||
13369043|NCT00830869|26710237|FG006|Period 2: Part 2|Symptomatic Deterioration|0|||
13369044|NCT00830869|26710238|FG007|Period 2: Part 2|Symptomatic Deterioration|0|||
13369045|NCT00830869|26710239|FG008|Period 2: Part 2|Symptomatic Deterioration|6|||
13369046|NCT00830869|26710240|FG009|Period 2: Part 2|Symptomatic Deterioration|3|||
13369047|NCT00830869|26710241|FG010|Period 2: Part 2|Symptomatic Deterioration|1|||
13369048|NCT00830869|26710242|FG011|Period 2: Part 2|Symptomatic Deterioration|4|||
13369049|NCT00830869|26710231|FG000|Period 2: Part 2|Progressive disease|0|||
13369050|NCT00830869|26710232|FG001|Period 2: Part 2|Progressive disease|0|||
13369051|NCT00830869|26710233|FG002|Period 2: Part 2|Progressive disease|0|||
13369052|NCT00830869|26710234|FG003|Period 2: Part 2|Progressive disease|0|||
13369053|NCT00830869|26710235|FG004|Period 2: Part 2|Progressive disease|0|||
13369054|NCT00830869|26710236|FG005|Period 2: Part 2|Progressive disease|0|||
13369055|NCT00830869|26710237|FG006|Period 2: Part 2|Progressive disease|0|||
13369056|NCT00830869|26710238|FG007|Period 2: Part 2|Progressive disease|14|||
13369057|NCT00830869|26710239|FG008|Period 2: Part 2|Progressive disease|11|||
13369058|NCT00830869|26710240|FG009|Period 2: Part 2|Progressive disease|12|||
13369059|NCT00830869|26710241|FG010|Period 2: Part 2|Progressive disease|8|||
13369060|NCT00830869|26710242|FG011|Period 2: Part 2|Progressive disease|15|||
13369061|NCT00830869|26710231|FG000|Period 2: Part 2|Other|0|||
13369062|NCT00830869|26710232|FG001|Period 2: Part 2|Other|0|||
13369063|NCT00830869|26710233|FG002|Period 2: Part 2|Other|0|||
13369064|NCT00830869|26710234|FG003|Period 2: Part 2|Other|0|||
13369065|NCT00830869|26710235|FG004|Period 2: Part 2|Other|0|||
13369066|NCT00830869|26710236|FG005|Period 2: Part 2|Other|0|||
13369067|NCT00830869|26710237|FG006|Period 2: Part 2|Other|0|||
13369068|NCT00830869|26710238|FG007|Period 2: Part 2|Other|0|||
13369069|NCT00830869|26710239|FG008|Period 2: Part 2|Other|0|||
13369070|NCT00830869|26710240|FG009|Period 2: Part 2|Other|1|||
13369071|NCT00830869|26710241|FG010|Period 2: Part 2|Other|0|||
13369072|NCT00830869|26710242|FG011|Period 2: Part 2|Other|0|||
13369073|NCT00830804|26710264|FG000|Overall Study|Lost to Follow-up|4|||
13369074|NCT00830804|26710264|FG000|Overall Study|Death|1|||
13369075|NCT00830804|26710264|FG000|Overall Study|Unable to get to clinic|7|||
13369076|NCT00830804|26710264|FG000|Overall Study|Consent withdrawn|2|||
13369077|NCT00830804|26710264|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
13369078|NCT00830765|26710277|FG000|Overall Study|Protocol Violation|3|||
13369079|NCT00830765|26710278|FG001|Overall Study|Protocol Violation|2|||
13369080|NCT00830518|26710302|FG000|Overall Study|Progressive Disease|18|||
13369081|NCT00830518|26710303|FG001|Overall Study|Progressive Disease|8|||
13369082|NCT00830518|26710302|FG000|Overall Study|Symptomatic Deterioration|4|||
13369083|NCT00830518|26710303|FG001|Overall Study|Symptomatic Deterioration|1|||
13369084|NCT00830518|26710302|FG000|Overall Study|Adverse Event|14|||
13369085|NCT00830518|26710303|FG001|Overall Study|Adverse Event|1|||
13369086|NCT00830518|26710302|FG000|Overall Study|Withdrawal by Patient|2|||
13369087|NCT00830518|26710303|FG001|Overall Study|Withdrawal by Patient|0|||
13369088|NCT00830518|26710302|FG000|Overall Study|Reason not Specified|8|||
13369089|NCT00830518|26710303|FG001|Overall Study|Reason not Specified|1|||
13369090|NCT00830440|26710320|FG000|Overall Study|Protocol Violation|1|||
13369091|NCT00830440|26710321|FG001|Overall Study|Protocol Violation|0|||
13369092|NCT00830440|26710320|FG000|Overall Study|Withdrawal by Subject|1|||
13369093|NCT00830440|26710321|FG001|Overall Study|Withdrawal by Subject|0|||
13369094|NCT00830440|26710320|FG000|Overall Study|unsuccessful procedure|4|||
13369095|NCT00830440|26710321|FG001|Overall Study|unsuccessful procedure|0|||
13369096|NCT00830440|26710320|FG000|Overall Study|Adverse Event|2|||
13369097|NCT00830440|26710321|FG001|Overall Study|Adverse Event|0|||
13369098|NCT00830375|26710327|FG000|Overall Study|Lost to Follow-up|1|||
13369099|NCT00830180|26710350|FG000|Overall Study|Adverse Event|6|||
13369100|NCT00830180|26710350|FG000|Overall Study|Death|11|||
13369101|NCT00830180|26710350|FG000|Overall Study|Insufficient clinical response|1|||
13369102|NCT00830180|26710350|FG000|Overall Study|Withdrawal by Subject|5|||
13369103|NCT00830180|26710350|FG000|Overall Study|Progressive disease|2|||
13369104|NCT00830180|26710350|FG000|Overall Study|Other - Unspecified|1|||
13369105|NCT00830167|26710427|FG000|Overall Study|Lack of Efficacy|26|||
13369106|NCT00830167|26710428|FG001|Overall Study|Lack of Efficacy|10|||
13369107|NCT00830167|26710427|FG000|Overall Study|Adverse Event|8|||
13369108|NCT00830167|26710428|FG001|Overall Study|Adverse Event|24|||
13369109|NCT00830167|26710427|FG000|Overall Study|Not meeting entrance criteria|2|||
13369110|NCT00830167|26710428|FG001|Overall Study|Not meeting entrance criteria|5|||
13369111|NCT00830167|26710427|FG000|Overall Study|Withdrawal by Subject|2|||
13369112|NCT00830167|26710428|FG001|Overall Study|Withdrawal by Subject|0|||
13369113|NCT00830167|26710427|FG000|Overall Study|Lost to Follow-up|0|||
13369114|NCT00830167|26710428|FG001|Overall Study|Lost to Follow-up|1|||
13369115|NCT00830167|26710427|FG000|Overall Study|Protocol Violation|0|||
13369116|NCT00830167|26710428|FG001|Overall Study|Protocol Violation|1|||
13369117|NCT00830167|26710427|FG000|Overall Study|Other|2|||
13369118|NCT00830167|26710428|FG001|Overall Study|Other|2|||
13369119|NCT00830128|26710445|FG000|Overall Study|Adverse Event|5|||
13369120|NCT00830128|26710445|FG000|Overall Study|Lack of Efficacy|7|||
13369121|NCT00830128|26710445|FG000|Overall Study|Protocol Violation|1|||
13369122|NCT00830128|26710445|FG000|Overall Study|Withdrawal by Subject|2|||
13369123|NCT00830128|26710445|FG000|Overall Study|Family obligation|1|||
13369124|NCT00830128|26710445|FG000|Overall Study|Relocation|1|||
13369125|NCT00830128|26710445|FG000|Overall Study|Work obligation|1|||
13369126|NCT00830128|26710445|FG000|Overall Study|Operating a vehicle|1|||
13369127|NCT00830115|26710463|FG000|Overall Study|Adverse Event|2|||
13369128|NCT00830115|26710463|FG000|Overall Study|Improvement/recovery|1|||
13369129|NCT00830063|26710636|FG000|Overall Study|Adverse Event|7|||
13369130|NCT00830063|26710637|FG001|Overall Study|Adverse Event|13|||
13369131|NCT00830063|26710638|FG002|Overall Study|Adverse Event|16|||
13369132|NCT00830063|26710639|FG003|Overall Study|Adverse Event|13|||
13369133|NCT00830063|26710636|FG000|Overall Study|Death|1|||
13369134|NCT00830063|26710637|FG001|Overall Study|Death|0|||
13369135|NCT00830063|26710638|FG002|Overall Study|Death|0|||
13369136|NCT00830063|26710639|FG003|Overall Study|Death|0|||
13369137|NCT00830063|26710636|FG000|Overall Study|Lost to Follow-up|0|||
13369138|NCT00830063|26710637|FG001|Overall Study|Lost to Follow-up|0|||
13369139|NCT00830063|26710638|FG002|Overall Study|Lost to Follow-up|3|||
13369140|NCT00830063|26710639|FG003|Overall Study|Lost to Follow-up|1|||
13369141|NCT00830063|26710636|FG000|Overall Study|Preferred Time Entry in Extension Study|119|||
13369142|NCT00830063|26710637|FG001|Overall Study|Preferred Time Entry in Extension Study|139|||
13369143|NCT00830063|26710638|FG002|Overall Study|Preferred Time Entry in Extension Study|127|||
13369144|NCT00830063|26710639|FG003|Overall Study|Preferred Time Entry in Extension Study|126|||
13369145|NCT00830063|26710636|FG000|Overall Study|Lack of Efficacy|51|||
13369146|NCT00830063|26710637|FG001|Overall Study|Lack of Efficacy|23|||
13369147|NCT00830063|26710638|FG002|Overall Study|Lack of Efficacy|25|||
13369148|NCT00830063|26710639|FG003|Overall Study|Lack of Efficacy|32|||
13369149|NCT00830063|26710636|FG000|Overall Study|Other|5|||
13369150|NCT00830063|26710637|FG001|Overall Study|Other|5|||
13369151|NCT00830063|26710638|FG002|Overall Study|Other|8|||
13369152|NCT00830063|26710639|FG003|Overall Study|Other|6|||
13369153|NCT00830063|26710636|FG000|Overall Study|Withdrawal by Subject|16|||
13369154|NCT00830063|26710637|FG001|Overall Study|Withdrawal by Subject|10|||
13369155|NCT00830063|26710638|FG002|Overall Study|Withdrawal by Subject|16|||
13369156|NCT00830063|26710639|FG003|Overall Study|Withdrawal by Subject|13|||
13369157|NCT00830063|26710636|FG000|Overall Study|Protocol Violation|1|||
13369158|NCT00830063|26710637|FG001|Overall Study|Protocol Violation|0|||
13369159|NCT00830063|26710638|FG002|Overall Study|Protocol Violation|3|||
13369160|NCT00830063|26710639|FG003|Overall Study|Protocol Violation|2|||
13369161|NCT00830063|26710636|FG000|Overall Study|Randomized But Not Treated|0|||
13369162|NCT00830063|26710637|FG001|Overall Study|Randomized But Not Treated|2|||
13369163|NCT00830063|26710638|FG002|Overall Study|Randomized But Not Treated|0|||
13369164|NCT00830063|26710639|FG003|Overall Study|Randomized But Not Treated|2|||
13369165|NCT00830037|26710654|FG000|Overall Study|Withdrawal by Subject|2|||
13369166|NCT00830037|26710655|FG001|Overall Study|Withdrawal by Subject|3|||
13369167|NCT00830037|26710654|FG000|Overall Study|Lost to Follow-up|1|||
13369168|NCT00830037|26710655|FG001|Overall Study|Lost to Follow-up|2|||
13369169|NCT00830037|26710654|FG000|Overall Study|Active when terminated by DSMB|15|||
13369170|NCT00830037|26710655|FG001|Overall Study|Active when terminated by DSMB|14|||
13369171|NCT00829933|26710678|FG000|Overall Study|Adverse Event|2|||
13369172|NCT00829933|26710679|FG001|Overall Study|Adverse Event|3|||
13369173|NCT00829933|26710680|FG002|Overall Study|Adverse Event|2|||
13369174|NCT00829933|26710681|FG003|Overall Study|Adverse Event|1|||
13369175|NCT00829933|26710678|FG000|Overall Study|Death|0|||
13369176|NCT00829933|26710679|FG001|Overall Study|Death|0|||
13369177|NCT00829933|26710680|FG002|Overall Study|Death|1|||
13369178|NCT00829933|26710681|FG003|Overall Study|Death|1|||
13369179|NCT00829933|26710678|FG000|Overall Study|Lack of Efficacy|0|||
13369180|NCT00829933|26710679|FG001|Overall Study|Lack of Efficacy|1|||
13369181|NCT00829933|26710680|FG002|Overall Study|Lack of Efficacy|0|||
13369182|NCT00829933|26710681|FG003|Overall Study|Lack of Efficacy|0|||
13369183|NCT00829933|26710678|FG000|Overall Study|Physician Decision|5|||
13369184|NCT00829933|26710679|FG001|Overall Study|Physician Decision|7|||
13369185|NCT00829933|26710680|FG002|Overall Study|Physician Decision|8|||
13369186|NCT00829933|26710681|FG003|Overall Study|Physician Decision|1|||
13369187|NCT00829933|26710678|FG000|Overall Study|Pregnancy|0|||
13369188|NCT00829933|26710679|FG001|Overall Study|Pregnancy|0|||
13369189|NCT00829933|26710680|FG002|Overall Study|Pregnancy|0|||
13369190|NCT00829933|26710681|FG003|Overall Study|Pregnancy|2|||
13369191|NCT00829933|26710678|FG000|Overall Study|Protocol Violation|2|||
13369192|NCT00829933|26710679|FG001|Overall Study|Protocol Violation|1|||
13369193|NCT00829933|26710680|FG002|Overall Study|Protocol Violation|0|||
13369194|NCT00829933|26710681|FG003|Overall Study|Protocol Violation|0|||
13369195|NCT00829933|26710678|FG000|Overall Study|withdrew before treatment started|5|||
13369196|NCT00829933|26710679|FG001|Overall Study|withdrew before treatment started|1|||
13369197|NCT00829933|26710680|FG002|Overall Study|withdrew before treatment started|2|||
13369198|NCT00829933|26710681|FG003|Overall Study|withdrew before treatment started|9|||
13369199|NCT00829829|26710714|FG000|Overall Study|Protocol Violation|0|||
13369200|NCT00829829|26710715|FG001|Overall Study|Protocol Violation|3|||
13369201|NCT00829829|26710716|FG002|Overall Study|Protocol Violation|0|||
13369202|NCT00829829|26710714|FG000|Overall Study|Adverse Event|4|||
13369203|NCT00829829|26710715|FG001|Overall Study|Adverse Event|4|||
13369204|NCT00829829|26710716|FG002|Overall Study|Adverse Event|3|||
13369205|NCT00829829|26710714|FG000|Overall Study|Withdrawal by Subject|8|||
13369206|NCT00829829|26710715|FG001|Overall Study|Withdrawal by Subject|4|||
13369207|NCT00829829|26710716|FG002|Overall Study|Withdrawal by Subject|2|||
13369208|NCT00829829|26710714|FG000|Overall Study|Decision by the Sponsor|1|||
13369209|NCT00829829|26710715|FG001|Overall Study|Decision by the Sponsor|0|||
13369210|NCT00829829|26710716|FG002|Overall Study|Decision by the Sponsor|2|||
13369211|NCT00829829|26710714|FG000|Overall Study|Lost to Follow-up|7|||
13369212|NCT00829829|26710715|FG001|Overall Study|Lost to Follow-up|3|||
13369213|NCT00829829|26710716|FG002|Overall Study|Lost to Follow-up|3|||
13369214|NCT00829829|26710714|FG000|Overall Study|Other than specified above|2|||
13369215|NCT00829829|26710715|FG001|Overall Study|Other than specified above|2|||
13369216|NCT00829829|26710716|FG002|Overall Study|Other than specified above|1|||
13369217|NCT00829621|26710729|FG000|Overall Study|Death|1|||
13369218|NCT00829621|26710730|FG001|Overall Study|Death|0|||
13369219|NCT00829621|26710729|FG000|Overall Study|Lost to Follow-up|3|||
13369220|NCT00829621|26710730|FG001|Overall Study|Lost to Follow-up|4|||
13369221|NCT00829439|26710739|FG000|Overall Study|Adverse Event|0|||
13369222|NCT00829439|26710740|FG001|Overall Study|Adverse Event|0|||
13369223|NCT00829439|26710741|FG002|Overall Study|Adverse Event|1|||
13369224|NCT00829439|26710742|FG003|Overall Study|Adverse Event|0|||
13369225|NCT00829413|26710791|FG000|Overall Study|No study drug admimnistered|13|||
13369226|NCT00829413|26710791|FG000|Overall Study|Training Patients|67|||
13369227|NCT00829413|26710791|FG000|Overall Study|No truth standard procedure available|9|||
13369228|NCT00829413|26710791|FG000|Overall Study|Technically inadequate truth standard|2|||
13369229|NCT00829413|26710791|FG000|Overall Study|Indeterminate diagnosis from truth stand|3|||
13369230|NCT00829387|26710814|FG000|Overall Study|Withdrawal by Subject|2|||
13369231|NCT00829387|26710815|FG001|Overall Study|Withdrawal by Subject|3|||
13369232|NCT00829387|26710814|FG000|Overall Study|Disqualified by PI|1|||
13369233|NCT00829387|26710815|FG001|Overall Study|Disqualified by PI|0|||
13369234|NCT00829296|26710834|FG000|Overall Study|Adverse Event|5|||
13369235|NCT00829296|26710835|FG001|Overall Study|Adverse Event|4|||
13369236|NCT00829283|26710850|FG000|Overall Study|Lost to Follow-up|7|||
13369237|NCT00829283|26710851|FG001|Overall Study|Lost to Follow-up|25|||
13369238|NCT00829244|26710888|FG000|Overall Study|Adverse Event|1|||
13369239|NCT00829244|26710889|FG001|Overall Study|Adverse Event|3|||
13369240|NCT00829244|26710888|FG000|Overall Study|Protocol Violation|1|||
13369241|NCT00829244|26710889|FG001|Overall Study|Protocol Violation|0|||
13369242|NCT00829244|26710888|FG000|Overall Study|Lack of ovarian response to stimulation|9|||
13369243|NCT00829244|26710889|FG001|Overall Study|Lack of ovarian response to stimulation|5|||
13369244|NCT00829244|26710888|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1|||
13369245|NCT00829244|26710889|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6|||
13369246|NCT00829244|26710888|FG000|Overall Study|No fertilization|2|||
13369247|NCT00829244|26710889|FG001|Overall Study|No fertilization|2|||
13369248|NCT00829244|26710888|FG000|Overall Study|All embryos discarded|0|||
13369249|NCT00829244|26710889|FG001|Overall Study|All embryos discarded|3|||
13369250|NCT00829244|26710888|FG000|Overall Study|No embryo cleavage|0|||
13369251|NCT00829244|26710889|FG001|Overall Study|No embryo cleavage|2|||
13369252|NCT00829179|26710895|FG000|Overall Study|Withdrawal by Subject|1|||
13369253|NCT00829166|26710941|FG000|Overall Study|Death|305|||
13369254|NCT00829166|26710942|FG001|Overall Study|Death|333|||
13369255|NCT00829166|26710941|FG000|Overall Study|Lost to Follow-up|5|||
13369256|NCT00829166|26710942|FG001|Overall Study|Lost to Follow-up|4|||
13369257|NCT00829166|26710941|FG000|Overall Study|Physician's Decision|4|||
13369258|NCT00829166|26710942|FG001|Overall Study|Physician's Decision|3|||
13369259|NCT00829166|26710941|FG000|Overall Study|Subject's Decision|41|||
13369260|NCT00829166|26710942|FG001|Overall Study|Subject's Decision|55|||
13369261|NCT00829166|26710941|FG000|Overall Study|Sponsor's Decision|137|||
13369262|NCT00829166|26710942|FG001|Overall Study|Sponsor's Decision|98|||
13369263|NCT00829166|26710941|FG000|Overall Study|Reason Not Specified|3|||
13369264|NCT00829166|26710942|FG001|Overall Study|Reason Not Specified|3|||
13369265|NCT00829010|26711120|FG000|Overall Study|Adverse Event|1|||
13369266|NCT00829010|26711121|FG001|Overall Study|Adverse Event|0|||
13369267|NCT00829010|26711122|FG002|Overall Study|Adverse Event|0|||
13369268|NCT00829010|26711123|FG003|Overall Study|Adverse Event|0|||
13369269|NCT00829010|26711124|FG004|Overall Study|Adverse Event|0|||
13369270|NCT00829010|26711120|FG000|Overall Study|Withdrawal by Subject|0|||
13369271|NCT00829010|26711121|FG001|Overall Study|Withdrawal by Subject|1|||
13369272|NCT00829010|26711122|FG002|Overall Study|Withdrawal by Subject|1|||
13369273|NCT00829010|26711123|FG003|Overall Study|Withdrawal by Subject|0|||
13369274|NCT00829010|26711124|FG004|Overall Study|Withdrawal by Subject|2|||
13369275|NCT00829010|26711120|FG000|Overall Study|Lost to Follow-up|1|||
13369276|NCT00829010|26711121|FG001|Overall Study|Lost to Follow-up|0|||
13369277|NCT00829010|26711122|FG002|Overall Study|Lost to Follow-up|2|||
13369278|NCT00829010|26711123|FG003|Overall Study|Lost to Follow-up|0|||
13369279|NCT00829010|26711124|FG004|Overall Study|Lost to Follow-up|0|||
13369280|NCT00829010|26711120|FG000|Overall Study|Fatality|5|||
13369281|NCT00829010|26711121|FG001|Overall Study|Fatality|4|||
13369282|NCT00829010|26711122|FG002|Overall Study|Fatality|0|||
13369283|NCT00829010|26711123|FG003|Overall Study|Fatality|3|||
13369284|NCT00829010|26711124|FG004|Overall Study|Fatality|0|||
13369285|NCT00829010|26711120|FG000|Overall Study|Migrated/Moved from study area|3|||
13369286|NCT00829010|26711121|FG001|Overall Study|Migrated/Moved from study area|4|||
13369287|NCT00829010|26711122|FG002|Overall Study|Migrated/Moved from study area|0|||
13369288|NCT00829010|26711123|FG003|Overall Study|Migrated/Moved from study area|5|||
13369289|NCT00829010|26711124|FG004|Overall Study|Migrated/Moved from study area|0|||
13369290|NCT00828984|26711157|FG000|Overall Study|Adverse Event|2|||
13369291|NCT00828984|26711158|FG001|Overall Study|Adverse Event|3|||
13369292|NCT00828984|26711159|FG002|Overall Study|Adverse Event|0|||
13369293|NCT00828984|26711157|FG000|Overall Study|Lost to Follow-up|5|||
13369294|NCT00828984|26711158|FG001|Overall Study|Lost to Follow-up|3|||
13369295|NCT00828984|26711159|FG002|Overall Study|Lost to Follow-up|1|||
13369296|NCT00828984|26711157|FG000|Overall Study|Withdrawal by Subject|4|||
13369297|NCT00828984|26711158|FG001|Overall Study|Withdrawal by Subject|4|||
13369298|NCT00828984|26711159|FG002|Overall Study|Withdrawal by Subject|4|||
13369299|NCT00828984|26711157|FG000|Overall Study|Ineligable|1|||
13369300|NCT00828984|26711158|FG001|Overall Study|Ineligable|2|||
13369301|NCT00828984|26711159|FG002|Overall Study|Ineligable|0|||
13369302|NCT00828984|26711157|FG000|Overall Study|Medical Contraindication|0|||
13369303|NCT00828984|26711158|FG001|Overall Study|Medical Contraindication|1|||
13369304|NCT00828984|26711159|FG002|Overall Study|Medical Contraindication|0|||
13369305|NCT00828984|26711157|FG000|Overall Study|Noncompliant|1|||
13369306|NCT00828984|26711158|FG001|Overall Study|Noncompliant|2|||
13369307|NCT00828984|26711159|FG002|Overall Study|Noncompliant|3|||
13369308|NCT00828984|26711157|FG000|Overall Study|ConMed|1|||
13369309|NCT00828984|26711158|FG001|Overall Study|ConMed|1|||
13369310|NCT00828984|26711159|FG002|Overall Study|ConMed|1|||
13369311|NCT00828945|26711175|FG000|Overall Study|Death|4|||
13369312|NCT00828945|26711175|FG000|Overall Study|Participant was missing|1|||
13369313|NCT00828945|26711175|FG000|Overall Study|Other|36|||
13369314|NCT00828750|26711188|FG000|Overall Study|Lack of Efficacy|3|||
13369315|NCT00828750|26711188|FG000|Overall Study|Normal PC Remained While No Treatment|1|||
13369316|NCT00828711|26711227|FG000|Overall Study|Lost to Follow-up|1|||
13369317|NCT00828711|26711228|FG001|Overall Study|Lost to Follow-up|0|||
13369318|NCT00828711|26711229|FG002|Overall Study|Lost to Follow-up|0|||
13369319|NCT00828672|26711254|FG000|Study Treatment|Lost to Follow-up|1|||
13369320|NCT00828672|26711255|FG001|Study Treatment|Lost to Follow-up|0|||
13369321|NCT00828672|26711254|FG000|Study Treatment|Adverse Event|0|||
13369322|NCT00828672|26711255|FG001|Study Treatment|Adverse Event|1|||
13369323|NCT00828672|26711254|FG000|Study Treatment|Complete response, no surgery|1|||
13369324|NCT00828672|26711255|FG001|Study Treatment|Complete response, no surgery|1|||
13369325|NCT00828672|26711254|FG000|Post-surgery (<30 Days)|No central review materials|0|||
13369326|NCT00828672|26711255|FG001|Post-surgery (<30 Days)|No central review materials|1|||
13369327|NCT00828568|26711278|FG000|Randomized|Withdrawal by Subject|1|||
13369328|NCT00828568|26711279|FG001|Randomized|Withdrawal by Subject|0|||
13369329|NCT00828568|26711280|FG002|Randomized|Withdrawal by Subject|2|||
13369330|NCT00828568|26711278|FG000|Treated - Received at Least One Dose|Adverse Event|11|||
13369331|NCT00828568|26711279|FG001|Treated - Received at Least One Dose|Adverse Event|8|||
13369332|NCT00828568|26711280|FG002|Treated - Received at Least One Dose|Adverse Event|1|||
13369333|NCT00828568|26711278|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9|||
13369334|NCT00828568|26711279|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11|||
13369335|NCT00828568|26711280|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0|||
13369336|NCT00828568|26711278|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1|||
13369337|NCT00828568|26711279|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5|||
13369338|NCT00828568|26711280|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1|||
13369339|NCT00828568|26711278|FG000|Treated - Received at Least One Dose|Protocol Violation|9|||
13369340|NCT00828568|26711279|FG001|Treated - Received at Least One Dose|Protocol Violation|5|||
13369341|NCT00828568|26711280|FG002|Treated - Received at Least One Dose|Protocol Violation|3|||
13369342|NCT00828516|26711287|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2|||
13369343|NCT00828464|26711306|FG000|Overall Study|Withdrawal by Subject|1|||
13369344|NCT00828451|26711314|FG000|Overall Study|Death|2|||
13369345|NCT00828451|26711314|FG000|Overall Study|Lack of intravenous line|7|||
13369346|NCT00828451|26711314|FG000|Overall Study|Withdrawal by Subject|1|||
13369347|NCT00828451|26711314|FG000|Overall Study|Deterioration in clinical status|1|||
13369348|NCT00828204|26711338|FG000|Main Study: Prior to Study Suspension|Adverse Event|1|||
13369349|NCT00828204|26711339|FG001|Main Study: Prior to Study Suspension|Adverse Event|0|||
13369350|NCT00828204|26711338|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2|||
13369351|NCT00828204|26711339|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0|||
13369352|NCT00828204|26711338|FG000|Main Study: Prior to Study Suspension|Study Suspension|11|||
13369353|NCT00828204|26711339|FG001|Main Study: Prior to Study Suspension|Study Suspension|0|||
13369354|NCT00828204|26711338|FG000|Main Study: After Study Restart|Adverse Event|0|||
13369355|NCT00828204|26711339|FG001|Main Study: After Study Restart|Adverse Event|2|||
13369356|NCT00828204|26711338|FG000|Main Study: After Study Restart|Noncompliance|0|||
13369357|NCT00828204|26711339|FG001|Main Study: After Study Restart|Noncompliance|1|||
13369358|NCT00828204|26711338|FG000|Extension Study|Lost to Follow-up|0|||
13369359|NCT00828204|26711339|FG001|Extension Study|Lost to Follow-up|1|||
13369360|NCT00828204|26711338|FG000|Extension Study|Physician Decision|0|||
13369361|NCT00828204|26711339|FG001|Extension Study|Physician Decision|2|||
13369362|NCT00828139|26711370|FG000|Overall Study|Adverse Event|8|||
13369363|NCT00828139|26711371|FG001|Overall Study|Adverse Event|1|||
13369364|NCT00828139|26711372|FG002|Overall Study|Adverse Event|10|||
13369365|NCT00828139|26711373|FG003|Overall Study|Adverse Event|5|||
13369366|NCT00828139|26711370|FG000|Overall Study|Death|2|||
13369367|NCT00828139|26711371|FG001|Overall Study|Death|1|||
13369368|NCT00828139|26711372|FG002|Overall Study|Death|0|||
13369369|NCT00828139|26711373|FG003|Overall Study|Death|2|||
13369370|NCT00828139|26711370|FG000|Overall Study|Refusal unrelated to toxicity|3|||
13369371|NCT00828139|26711371|FG001|Overall Study|Refusal unrelated to toxicity|4|||
13369372|NCT00828139|26711372|FG002|Overall Study|Refusal unrelated to toxicity|5|||
13369373|NCT00828139|26711373|FG003|Overall Study|Refusal unrelated to toxicity|3|||
13369374|NCT00828139|26711370|FG000|Overall Study|Disease Progression|24|||
13369375|NCT00828139|26711371|FG001|Overall Study|Disease Progression|33|||
13369376|NCT00828139|26711372|FG002|Overall Study|Disease Progression|35|||
13369377|NCT00828139|26711373|FG003|Overall Study|Disease Progression|39|||
13369378|NCT00828139|26711370|FG000|Overall Study|Other|4|||
13369379|NCT00828139|26711371|FG001|Overall Study|Other|2|||
13369380|NCT00828139|26711372|FG002|Overall Study|Other|5|||
13369381|NCT00828139|26711373|FG003|Overall Study|Other|2|||
13369382|NCT00828113|26711386|FG000|Overall Study|Withdrawal by Subject|27|||
13369383|NCT00828113|26711387|FG001|Overall Study|Withdrawal by Subject|26|||
13369384|NCT00828113|26711386|FG000|Overall Study|Lost to Follow-up|3|||
13369385|NCT00828113|26711387|FG001|Overall Study|Lost to Follow-up|5|||
13369386|NCT00828009|26711396|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10|||
13369387|NCT00828009|26711396|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2|||
13369388|NCT00828009|26711396|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3|||
13369389|NCT00828009|26711396|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11|||
13369390|NCT00828009|26711396|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1|||
13369391|NCT00828009|26711396|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2|||
13369392|NCT00828009|26711396|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2|||
13369393|NCT00828009|26711396|FG000|Step 2 - Maintenance Therapy|Progressive disease|12|||
13369394|NCT00828009|26711396|FG000|Step 2 - Maintenance Therapy|Adverse Event|13|||
13369395|NCT00828009|26711396|FG000|Step 2 - Maintenance Therapy|Death|1|||
13369396|NCT00828009|26711396|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4|||
13369397|NCT00828009|26711396|FG000|Step 2 - Maintenance Therapy|Complicating disease|2|||
13369398|NCT00828009|26711396|FG000|Step 2 - Maintenance Therapy|Other|1|||
13369399|NCT00827931|26711421|FG000|Overall Study|Death|3|||
13369400|NCT00827931|26711422|FG001|Overall Study|Death|5|||
13369401|NCT00827931|26711421|FG000|Overall Study|Adverse Event|1|||
13369402|NCT00827931|26711422|FG001|Overall Study|Adverse Event|0|||
13369403|NCT00827931|26711421|FG000|Overall Study|Lost to Follow-up|1|||
13369404|NCT00827931|26711422|FG001|Overall Study|Lost to Follow-up|0|||
13369405|NCT00827931|26711421|FG000|Overall Study|Withdrawal by Subject|0|||
13369406|NCT00827931|26711422|FG001|Overall Study|Withdrawal by Subject|1|||
13369407|NCT00827931|26711421|FG000|Overall Study|Other|1|||
13369408|NCT00827931|26711422|FG001|Overall Study|Other|0|||
13369409|NCT00827918|26711458|FG000|Overall Study|Adverse Event|4|||
13369410|NCT00827918|26711459|FG001|Overall Study|Adverse Event|0|||
13369411|NCT00827918|26711460|FG002|Overall Study|Adverse Event|0|||
13369412|NCT00827918|26711458|FG000|Overall Study|Lack of Efficacy|16|||
13369413|NCT00827918|26711459|FG001|Overall Study|Lack of Efficacy|4|||
13369414|NCT00827918|26711460|FG002|Overall Study|Lack of Efficacy|15|||
13369415|NCT00827918|26711458|FG000|Overall Study|Physician Decision|1|||
13369416|NCT00827918|26711459|FG001|Overall Study|Physician Decision|0|||
13369417|NCT00827918|26711460|FG002|Overall Study|Physician Decision|0|||
13369418|NCT00827918|26711458|FG000|Overall Study|Pregnancy|0|||
13369419|NCT00827918|26711459|FG001|Overall Study|Pregnancy|1|||
13369420|NCT00827918|26711460|FG002|Overall Study|Pregnancy|0|||
13369421|NCT00827918|26711458|FG000|Overall Study|Progressive Disease|1|||
13369422|NCT00827918|26711459|FG001|Overall Study|Progressive Disease|1|||
13369423|NCT00827918|26711460|FG002|Overall Study|Progressive Disease|0|||
13369424|NCT00827918|26711458|FG000|Overall Study|Protocol Violation|0|||
13369425|NCT00827918|26711459|FG001|Overall Study|Protocol Violation|1|||
13369426|NCT00827918|26711460|FG002|Overall Study|Protocol Violation|0|||
13369427|NCT00827918|26711458|FG000|Overall Study|Withdrawal by Subject|6|||
13369428|NCT00827918|26711459|FG001|Overall Study|Withdrawal by Subject|2|||
13369429|NCT00827918|26711460|FG002|Overall Study|Withdrawal by Subject|6|||
13369430|NCT00827827|26711509|FG000|Overall Study|Lost to Follow-up|3|||
13369431|NCT00827827|26711510|FG001|Overall Study|Lost to Follow-up|0|||
13369432|NCT00827827|26711509|FG000|Overall Study|Fall at home- hospitalization|1|||
13369433|NCT00827827|26711510|FG001|Overall Study|Fall at home- hospitalization|0|||
13369434|NCT00827827|26711509|FG000|Overall Study|Another cerebrovascular accident (CVA)|1|||
13369435|NCT00827827|26711510|FG001|Overall Study|Another cerebrovascular accident (CVA)|0|||
13369436|NCT00827827|26711509|FG000|Overall Study|Gout|1|||
13369437|NCT00827827|26711510|FG001|Overall Study|Gout|0|||
13369438|NCT00827827|26711509|FG000|Overall Study|Transportation issues|1|||
13369439|NCT00827827|26711510|FG001|Overall Study|Transportation issues|0|||
13369440|NCT00827827|26711509|FG000|Overall Study|Burned with water at home|1|||
13369441|NCT00827827|26711510|FG001|Overall Study|Burned with water at home|0|||
13369442|NCT00827775|26711525|FG000|Overall Study|Withdrawal by Subject|0|||
13369443|NCT00827775|26711526|FG001|Overall Study|Withdrawal by Subject|5|||
13369444|NCT00827632|26711543|FG000|Overall Study|Lost to Follow-up|8|||
13369445|NCT00827632|26711544|FG001|Overall Study|Lost to Follow-up|12|||
13369446|NCT00827632|26711543|FG000|Overall Study|Early withdrawal|14|||
13369447|NCT00827632|26711544|FG001|Overall Study|Early withdrawal|11|||
13369448|NCT00827606|26711612|FG000|Overall Study|Protocol Violation|4|||
13369449|NCT00827606|26711613|FG001|Overall Study|Protocol Violation|3|||
13369450|NCT00827606|26711612|FG000|Overall Study|Lost to Follow-up|3|||
13369451|NCT00827606|26711613|FG001|Overall Study|Lost to Follow-up|1|||
13369452|NCT00827606|26711612|FG000|Overall Study|Withdrawal by Subject|7|||
13369453|NCT00827606|26711613|FG001|Overall Study|Withdrawal by Subject|6|||
13369454|NCT00827606|26711612|FG000|Overall Study|Pregnancy|0|||
13369455|NCT00827606|26711613|FG001|Overall Study|Pregnancy|1|||
13369456|NCT00827606|26711612|FG000|Overall Study|Other|5|||
13369457|NCT00827606|26711613|FG001|Overall Study|Other|13|||
13369458|NCT00827606|26711612|FG000|Overall Study|LDL below 2.59 mmol/L|4|||
13369459|NCT00827606|26711613|FG001|Overall Study|LDL below 2.59 mmol/L|12|||
13369460|NCT00827606|26711612|FG000|Overall Study|Adverse Event|4|||
13369461|NCT00827606|26711613|FG001|Overall Study|Adverse Event|2|||
13369462|NCT00827567|26711619|FG000|Overall Study|Progression of Disease/Screen Failure|4|||
13369463|NCT00827541|26711638|FG000|Overall Study|Exitus|1|||
13369464|NCT00827541|26711639|FG001|Overall Study|Exitus|8|||
13369465|NCT00827541|26711638|FG000|Overall Study|Other|1|||
13369466|NCT00827541|26711639|FG001|Overall Study|Other|3|||
13369467|NCT00827541|26711638|FG000|Overall Study|Pathogen not susceptible|1|||
13369468|NCT00827541|26711639|FG001|Overall Study|Pathogen not susceptible|0|||
13369469|NCT00827541|26711638|FG000|Overall Study|Lack of effectiveness|1|||
13369470|NCT00827541|26711639|FG001|Overall Study|Lack of effectiveness|0|||
13369471|NCT00827502|26711647|FG000|Overall Study|randomized but not treated|11|||
13369472|NCT00827502|26711647|FG000|Overall Study|Adverse Event|1|||
13369473|NCT00827502|26711647|FG000|Overall Study|Lost to Follow-up|4|||
13369474|NCT00827502|26711647|FG000|Overall Study|Withdrawal by Subject|5|||
13369475|NCT00827372|26711657|FG000|Overall Study|Adverse Event|5|||
13369476|NCT00827372|26711657|FG000|Overall Study|Lack of Efficacy|3|||
13369477|NCT00827359|26711666|FG000|Overall Study|Progressive Diseas|19|||
13369478|NCT00827359|26711666|FG000|Overall Study|Unacceptable Toxicity|5|||
13369479|NCT00827359|26711666|FG000|Overall Study|Ineligible|1|||
13375310|NCT00790842|26729844|FG005|Dose Level 2|Withdrawal by Subject|0|||
13375311|NCT00790842|26729845|FG006|Dose Level 2|Withdrawal by Subject|0|||
13375312|NCT00790842|26729846|FG007|Dose Level 2|Withdrawal by Subject|0|||
13375313|NCT00790842|26729847|FG008|Dose Level 2|Withdrawal by Subject|0|||
13375314|NCT00790842|26729848|FG009|Dose Level 2|Withdrawal by Subject|0|||
13375315|NCT00790842|26729849|FG010|Dose Level 2|Withdrawal by Subject|0|||
13375316|NCT00790842|26729839|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
13375317|NCT00790842|26729840|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
13375318|NCT00790842|26729841|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
13486647|NCT02149121|27036774|FG001|Main Study Period|Unmet predefined eligibility criteria|2|||
13486648|NCT02149121|27036775|FG002|Main Study Period|Unmet predefined eligibility criteria|0|||
13486649|NCT02149121|27036776|FG003|Main Study Period|Unmet predefined eligibility criteria|0|||
13486650|NCT02149121|27036777|FG004|Main Study Period|Unmet predefined eligibility criteria|0|||
13486651|NCT02149121|27036778|FG005|Main Study Period|Unmet predefined eligibility criteria|0|||
13486652|NCT02149121|27036779|FG006|Main Study Period|Unmet predefined eligibility criteria|0|||
13486653|NCT02149121|27036773|FG000|Main Study Period|Disease progression|0|||
13486654|NCT02149121|27036774|FG001|Main Study Period|Disease progression|1|||
13375319|NCT00790842|26729842|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
13375320|NCT00790842|26729843|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
13375321|NCT00790842|26729844|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
13375322|NCT00790842|26729845|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
13375323|NCT00790842|26729846|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
13375324|NCT00790842|26729847|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2|||
13375325|NCT00790842|26729848|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
13375326|NCT00790842|26729849|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
13375327|NCT00790842|26729839|FG000|Dose Level 3|Adverse Event|0|||
13375328|NCT00790842|26729840|FG001|Dose Level 3|Adverse Event|0|||
13375329|NCT00790842|26729841|FG002|Dose Level 3|Adverse Event|1|||
13486655|NCT02149121|27036775|FG002|Main Study Period|Disease progression|0|||
13486656|NCT02149121|27036776|FG003|Main Study Period|Disease progression|0|||
13486657|NCT02149121|27036777|FG004|Main Study Period|Disease progression|0|||
13486658|NCT02149121|27036778|FG005|Main Study Period|Disease progression|0|||
13486659|NCT02149121|27036779|FG006|Main Study Period|Disease progression|0|||
13486660|NCT02149121|27036773|FG000|Extension Study Period|Withdrawal by Subject|0|||
13486661|NCT02149121|27036774|FG001|Extension Study Period|Withdrawal by Subject|0|||
13486662|NCT02149121|27036775|FG002|Extension Study Period|Withdrawal by Subject|0|||
13486663|NCT02149121|27036776|FG003|Extension Study Period|Withdrawal by Subject|1|||
13486664|NCT02149121|27036777|FG004|Extension Study Period|Withdrawal by Subject|0|||
13486665|NCT02149121|27036778|FG005|Extension Study Period|Withdrawal by Subject|2|||
13486666|NCT02149121|27036779|FG006|Extension Study Period|Withdrawal by Subject|0|||
13486667|NCT01889186|27036813|FG000|Overall Study|Adverse event- not related to progression|18|||
13486668|NCT01889186|27036814|FG001|Overall Study|Adverse event- not related to progression|5|||
13486669|NCT01889186|27036813|FG000|Overall Study|Adverse event- related to progression|7|||
13486670|NCT01889186|27036814|FG001|Overall Study|Adverse event- related to progression|2|||
13486671|NCT01889186|27036813|FG000|Overall Study|COVID-19 logistical restrictions|1|||
13486672|NCT01889186|27036814|FG001|Overall Study|COVID-19 logistical restrictions|0|||
13486673|NCT01889186|27036813|FG000|Overall Study|Investigator request|1|||
13488141|NCT04409262|27042893|FG001|Overall Study|Lack of Staff|1|||
13369480|NCT00827242|26711709|FG000|Overall Study|Withdrawal by Subject|2|||
13369481|NCT00827242|26711710|FG001|Overall Study|Withdrawal by Subject|4|||
13369482|NCT00827242|26711709|FG000|Overall Study|Protocol Violation|1|||
13369483|NCT00827242|26711710|FG001|Overall Study|Protocol Violation|3|||
13369484|NCT00827242|26711709|FG000|Overall Study|Lost to Follow-up|0|||
13369485|NCT00827242|26711710|FG001|Overall Study|Lost to Follow-up|3|||
13369486|NCT00827242|26711709|FG000|Overall Study|Adverse Event Excluding Death|2|||
13369487|NCT00827242|26711710|FG001|Overall Study|Adverse Event Excluding Death|1|||
13369488|NCT00827242|26711709|FG000|Overall Study|Entry Criteria Not Met|4|||
13369489|NCT00827242|26711710|FG001|Overall Study|Entry Criteria Not Met|1|||
13369490|NCT00827242|26711709|FG000|Overall Study|Physician Decision|2|||
13369491|NCT00827242|26711710|FG001|Overall Study|Physician Decision|0|||
13369492|NCT00827242|26711709|FG000|Overall Study|Death|1|||
13369493|NCT00827242|26711710|FG001|Overall Study|Death|0|||
13369494|NCT00827242|26711709|FG000|Overall Study|Lack of Efficacy|1|||
13369495|NCT00827242|26711710|FG001|Overall Study|Lack of Efficacy|0|||
13369496|NCT00827112|26711750|FG000|Overall Study|Adverse Event|2|||
13369497|NCT00827112|26711751|FG001|Overall Study|Adverse Event|0|||
13369498|NCT00827112|26711750|FG000|Overall Study|Lack of Efficacy|2|||
13369499|NCT00827112|26711751|FG001|Overall Study|Lack of Efficacy|0|||
13369500|NCT00827112|26711750|FG000|Overall Study|Lost to Follow-up|3|||
13369501|NCT00827112|26711751|FG001|Overall Study|Lost to Follow-up|2|||
13369502|NCT00827112|26711750|FG000|Overall Study|Pregnancy|0|||
13369503|NCT00827112|26711751|FG001|Overall Study|Pregnancy|1|||
13369504|NCT00827112|26711750|FG000|Overall Study|Protocol Violation|0|||
13369505|NCT00827112|26711751|FG001|Overall Study|Protocol Violation|2|||
13369506|NCT00827112|26711750|FG000|Overall Study|Withdrawal by Subject|2|||
13369507|NCT00827112|26711751|FG001|Overall Study|Withdrawal by Subject|1|||
13369508|NCT00827112|26711750|FG000|Overall Study|Randomized but not treated|5|||
13369509|NCT00827112|26711751|FG001|Overall Study|Randomized but not treated|3|||
13369510|NCT00827112|26711750|FG000|Overall Study|Other|1|||
13369511|NCT00827112|26711751|FG001|Overall Study|Other|3|||
13369512|NCT00826943|26711772|FG000|Overall Study|Withdrawal by Subject|0|||
13369513|NCT00826943|26711773|FG001|Overall Study|Withdrawal by Subject|0|||
13369514|NCT00826943|26711774|FG002|Overall Study|Withdrawal by Subject|0|||
13369515|NCT00826943|26711775|FG003|Overall Study|Withdrawal by Subject|0|||
13369516|NCT00826943|26711776|FG004|Overall Study|Withdrawal by Subject|1|||
13369517|NCT00826943|26711777|FG005|Overall Study|Withdrawal by Subject|0|||
13369518|NCT00826748|26711795|FG000|Overall Study|Withdrawal by Subject|0|||
13369519|NCT00826748|26711796|FG001|Overall Study|Withdrawal by Subject|0|||
13369520|NCT00826748|26711797|FG002|Overall Study|Withdrawal by Subject|2|||
13369521|NCT00826748|26711795|FG000|Overall Study|Physician Decision|0|||
13369522|NCT00826748|26711796|FG001|Overall Study|Physician Decision|0|||
13369523|NCT00826748|26711797|FG002|Overall Study|Physician Decision|1|||
13369524|NCT00826748|26711795|FG000|Overall Study|Samples Did Not pass QC|0|||
13369525|NCT00826748|26711796|FG001|Overall Study|Samples Did Not pass QC|0|||
13369526|NCT00826748|26711797|FG002|Overall Study|Samples Did Not pass QC|1|||
13369527|NCT00826618|26711803|FG000|Overall Study|Withdrawal by Subject|1|||
13369528|NCT00826540|26711809|FG000|Overall Study|ineligible|3|||
13369529|NCT00826540|26711809|FG000|Overall Study|Withdrawal by Subject|1|||
13369530|NCT00826514|26711863|FG000|Overall Study|Adverse Event|1|||
13369531|NCT00826514|26711864|FG001|Overall Study|Adverse Event|1|||
13369532|NCT00826514|26711863|FG000|Overall Study|Lack of Efficacy|0|||
13369533|NCT00826514|26711864|FG001|Overall Study|Lack of Efficacy|1|||
13369534|NCT00826514|26711863|FG000|Overall Study|Withdrawal by Subject|2|||
13369535|NCT00826514|26711864|FG001|Overall Study|Withdrawal by Subject|3|||
13369536|NCT00826449|26711876|FG000|Overall Study|Disease Progression|4|||
13369537|NCT00826449|26711876|FG000|Overall Study|Withdrawal by Subject|1|||
13369538|NCT00826280|26711912|FG000|Overall Study|Randomized but drug not received|1|||
13369539|NCT00826280|26711913|FG001|Overall Study|Randomized but drug not received|0|||
13369540|NCT00826280|26711914|FG002|Overall Study|Randomized but drug not received|1|||
13369541|NCT00826280|26711912|FG000|Overall Study|Adverse Event|1|||
13369542|NCT00826280|26711913|FG001|Overall Study|Adverse Event|3|||
13369543|NCT00826280|26711914|FG002|Overall Study|Adverse Event|0|||
13369544|NCT00826280|26711912|FG000|Overall Study|Lost to Follow-up|0|||
13369545|NCT00826280|26711913|FG001|Overall Study|Lost to Follow-up|1|||
13369546|NCT00826280|26711914|FG002|Overall Study|Lost to Follow-up|0|||
13369547|NCT00826280|26711912|FG000|Overall Study|Sponsor discontinued subject or study|1|||
13369548|NCT00826280|26711913|FG001|Overall Study|Sponsor discontinued subject or study|0|||
13369549|NCT00826280|26711914|FG002|Overall Study|Sponsor discontinued subject or study|0|||
13369550|NCT00826280|26711912|FG000|Overall Study|Reversible ischemic defect not present|43|||
13369551|NCT00826280|26711913|FG001|Overall Study|Reversible ischemic defect not present|40|||
13369552|NCT00826280|26711914|FG002|Overall Study|Reversible ischemic defect not present|44|||
13369553|NCT00826280|26711912|FG000|Overall Study|Interpretation Failure|1|||
13369554|NCT00826280|26711913|FG001|Overall Study|Interpretation Failure|0|||
13369555|NCT00826280|26711914|FG002|Overall Study|Interpretation Failure|0|||
13369556|NCT00826280|26711912|FG000|Overall Study|Machine Failure|1|||
13369557|NCT00826280|26711913|FG001|Overall Study|Machine Failure|1|||
13369558|NCT00826280|26711914|FG002|Overall Study|Machine Failure|0|||
13369559|NCT00826280|26711912|FG000|Overall Study|One or more non-interpretable scan|0|||
13369560|NCT00826280|26711913|FG001|Overall Study|One or more non-interpretable scan|1|||
13369561|NCT00826280|26711914|FG002|Overall Study|One or more non-interpretable scan|1|||
13369562|NCT00826267|26711942|FG000|Overall Study|Other Adverse Event|1|||
13369563|NCT00826267|26711943|FG001|Overall Study|Other Adverse Event|0|||
13369564|NCT00826267|26711944|FG002|Overall Study|Other Adverse Event|0|||
13369565|NCT00826241|26711952|FG000|Overall Study|Withdrawal from Follow-up|1|||
13369566|NCT00826241|26711952|FG000|Overall Study|Withdrew consent|2|||
13369567|NCT00826241|26711952|FG000|Overall Study|Death|4|||
13369568|NCT00826241|26711952|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1|||
13369569|NCT00826241|26711952|FG000|Overall Study|Non-compliance|1|||
13369570|NCT00826241|26711952|FG000|Overall Study|Progression of disease|1|||
13369571|NCT00826241|26711952|FG000|Overall Study|Patient refused follow-up|3|||
13369572|NCT00826241|26711952|FG000|Overall Study|Lost to Follow-up|9|||
13369573|NCT00826241|26711952|FG000|Overall Study|Could not obtain records|1|||
13369574|NCT00826241|26711952|FG000|Overall Study|Screen failure|2|||
13369575|NCT00826241|26711952|FG000|Overall Study|Pt unable to proceed to registration|1|||
13369576|NCT00826241|26711952|FG000|Overall Study|Pt opt not to proceed w/trmt|1|||
13369577|NCT00826228|26711959|FG000|Overall Study|Withdrawal by Subject|1|||
13369578|NCT00826176|26711976|FG000|Overall Study|Lost to Follow-up|1|||
13369579|NCT00826176|26711977|FG001|Overall Study|Lost to Follow-up|0|||
13369580|NCT00826176|26711976|FG000|Overall Study|Subject Withdrew Consent|3|||
13369581|NCT00826176|26711977|FG001|Overall Study|Subject Withdrew Consent|0|||
13369582|NCT00826176|26711976|FG000|Overall Study|Administrative|9|||
13369583|NCT00826176|26711977|FG001|Overall Study|Administrative|0|||
13369584|NCT00826111|26712006|FG000|Overall Study|Lost to Follow-up|0|||
13369585|NCT00826111|26712007|FG001|Overall Study|Lost to Follow-up|1|||
13369586|NCT00826111|26712006|FG000|Overall Study|Protocol Violation|1|||
13369587|NCT00826111|26712007|FG001|Overall Study|Protocol Violation|0|||
13369588|NCT00826111|26712006|FG000|Overall Study|Withdrawal by Subject|5|||
13369589|NCT00826111|26712007|FG001|Overall Study|Withdrawal by Subject|0|||
13369590|NCT00826111|26712006|FG000|Overall Study|Physician Decision|1|||
13369591|NCT00826111|26712007|FG001|Overall Study|Physician Decision|1|||
13369592|NCT00825994|26712014|FG000|Overall Study|Withdrawal by Subject|2|||
13369593|NCT00825994|26712014|FG000|Overall Study|Lost to Follow-up|1|||
13369594|NCT00825994|26712014|FG000|Overall Study|Protocol Violation|1|||
13369595|NCT00825994|26712014|FG000|Overall Study|Placebo Responder at V2|1|||
13369596|NCT00825916|26712065|FG000|Overall Study|Lost to Follow-up|4|||
13369597|NCT00825916|26712066|FG001|Overall Study|Lost to Follow-up|2|||
13369598|NCT00825916|26712067|FG002|Overall Study|Lost to Follow-up|1|||
13369599|NCT00825825|26712086|FG000|First Medication Period (14 Days)|Adverse Event|1|||
13369600|NCT00825825|26712087|FG001|First Medication Period (14 Days)|Adverse Event|0|||
13369601|NCT00825825|26712088|FG002|First Medication Period (14 Days)|Adverse Event|0|||
13369602|NCT00825825|26712089|FG003|First Medication Period (14 Days)|Adverse Event|0|||
13369603|NCT00825825|26712090|FG004|First Medication Period (14 Days)|Adverse Event|0|||
13369604|NCT00825825|26712091|FG005|First Medication Period (14 Days)|Adverse Event|1|||
13369605|NCT00825825|26712086|FG000|First Medication Period (14 Days)|Physician Decision|2|||
13369606|NCT00825825|26712087|FG001|First Medication Period (14 Days)|Physician Decision|0|||
13369607|NCT00825825|26712088|FG002|First Medication Period (14 Days)|Physician Decision|1|||
13369608|NCT00825825|26712089|FG003|First Medication Period (14 Days)|Physician Decision|0|||
13369609|NCT00825825|26712090|FG004|First Medication Period (14 Days)|Physician Decision|0|||
13369610|NCT00825825|26712091|FG005|First Medication Period (14 Days)|Physician Decision|1|||
13375330|NCT00790842|26729842|FG003|Dose Level 3|Adverse Event|0|||
13369611|NCT00825825|26712086|FG000|Second Medication Period (14 Days)|Physician Decision|1|||
13369612|NCT00825825|26712087|FG001|Second Medication Period (14 Days)|Physician Decision|0|||
13369613|NCT00825825|26712088|FG002|Second Medication Period (14 Days)|Physician Decision|0|||
13369614|NCT00825825|26712089|FG003|Second Medication Period (14 Days)|Physician Decision|2|||
13369615|NCT00825825|26712090|FG004|Second Medication Period (14 Days)|Physician Decision|0|||
13369616|NCT00825825|26712091|FG005|Second Medication Period (14 Days)|Physician Decision|0|||
13369617|NCT00825825|26712086|FG000|Second Medication Period (14 Days)|Protocol Violation|1|||
13369618|NCT00825825|26712087|FG001|Second Medication Period (14 Days)|Protocol Violation|0|||
13369619|NCT00825825|26712088|FG002|Second Medication Period (14 Days)|Protocol Violation|0|||
13369620|NCT00825825|26712089|FG003|Second Medication Period (14 Days)|Protocol Violation|0|||
13369621|NCT00825825|26712090|FG004|Second Medication Period (14 Days)|Protocol Violation|1|||
13369622|NCT00825825|26712091|FG005|Second Medication Period (14 Days)|Protocol Violation|0|||
13369623|NCT00825825|26712086|FG000|Third Medication Period (14 Days)|Adverse Event|0|||
13369624|NCT00825825|26712087|FG001|Third Medication Period (14 Days)|Adverse Event|1|||
13369625|NCT00825825|26712088|FG002|Third Medication Period (14 Days)|Adverse Event|0|||
13369626|NCT00825825|26712089|FG003|Third Medication Period (14 Days)|Adverse Event|0|||
13369627|NCT00825825|26712090|FG004|Third Medication Period (14 Days)|Adverse Event|0|||
13369628|NCT00825825|26712091|FG005|Third Medication Period (14 Days)|Adverse Event|0|||
13369629|NCT00825825|26712086|FG000|Third Medication Period (14 Days)|Protocol Violation|0|||
13369630|NCT00825825|26712087|FG001|Third Medication Period (14 Days)|Protocol Violation|0|||
13369631|NCT00825825|26712088|FG002|Third Medication Period (14 Days)|Protocol Violation|0|||
13369632|NCT00825825|26712089|FG003|Third Medication Period (14 Days)|Protocol Violation|0|||
13369633|NCT00825825|26712090|FG004|Third Medication Period (14 Days)|Protocol Violation|0|||
13369634|NCT00825825|26712091|FG005|Third Medication Period (14 Days)|Protocol Violation|2|||
13369635|NCT00825825|26712086|FG000|Third Medication Period (14 Days)|poor data quality|0|||
13369636|NCT00825825|26712087|FG001|Third Medication Period (14 Days)|poor data quality|1|||
13369637|NCT00825825|26712088|FG002|Third Medication Period (14 Days)|poor data quality|0|||
13369638|NCT00825825|26712089|FG003|Third Medication Period (14 Days)|poor data quality|0|||
13369639|NCT00825825|26712090|FG004|Third Medication Period (14 Days)|poor data quality|0|||
13369640|NCT00825825|26712091|FG005|Third Medication Period (14 Days)|poor data quality|0|||
13369641|NCT00825812|26712118|FG000|Overall Study|Never entered follow up|0|||
13369642|NCT00825812|26712119|FG001|Overall Study|Never entered follow up|0|||
13369643|NCT00825812|26712120|FG002|Overall Study|Never entered follow up|0|||
13369644|NCT00825812|26712121|FG003|Overall Study|Never entered follow up|1|||
13369645|NCT00825812|26712118|FG000|Overall Study|Adverse Event|0|||
13369646|NCT00825812|26712119|FG001|Overall Study|Adverse Event|0|||
13369647|NCT00825812|26712120|FG002|Overall Study|Adverse Event|0|||
13369648|NCT00825812|26712121|FG003|Overall Study|Adverse Event|1|||
13369649|NCT00825812|26712118|FG000|Overall Study|Subject withdrew consent|0|||
13369650|NCT00825812|26712119|FG001|Overall Study|Subject withdrew consent|0|||
13369651|NCT00825812|26712120|FG002|Overall Study|Subject withdrew consent|3|||
13369652|NCT00825812|26712121|FG003|Overall Study|Subject withdrew consent|2|||
13369653|NCT00825812|26712118|FG000|Overall Study|Non-compliance with protocol|0|||
13369654|NCT00825812|26712119|FG001|Overall Study|Non-compliance with protocol|0|||
13369655|NCT00825812|26712120|FG002|Overall Study|Non-compliance with protocol|0|||
13369656|NCT00825812|26712121|FG003|Overall Study|Non-compliance with protocol|1|||
13369657|NCT00825812|26712118|FG000|Overall Study|Administrative|0|||
13369658|NCT00825812|26712119|FG001|Overall Study|Administrative|1|||
13369659|NCT00825812|26712120|FG002|Overall Study|Administrative|3|||
13369660|NCT00825812|26712121|FG003|Overall Study|Administrative|5|||
13369661|NCT00825682|26712138|FG000|Overall Study|personal reasons/ inconvenience|13|||
13369662|NCT00825682|26712139|FG001|Overall Study|personal reasons/ inconvenience|5|||
13369663|NCT00825305|26712158|FG000|Overall Study|Adverse Event|1|||
13369664|NCT00825305|26712159|FG001|Overall Study|Adverse Event|1|||
13369665|NCT00825305|26712158|FG000|Overall Study|Withdrawal by Subject|6|||
13369666|NCT00825305|26712159|FG001|Overall Study|Withdrawal by Subject|12|||
13369667|NCT00825305|26712158|FG000|Overall Study|Inappropriate inclusion|1|||
13369668|NCT00825305|26712159|FG001|Overall Study|Inappropriate inclusion|0|||
13369669|NCT00825305|26712158|FG000|Overall Study|Protocol Violation|9|||
13369670|NCT00825305|26712159|FG001|Overall Study|Protocol Violation|9|||
13369671|NCT00825305|26712158|FG000|Overall Study|Can not be classified|0|||
13369672|NCT00825305|26712159|FG001|Overall Study|Can not be classified|1|||
13369673|NCT00825175|26712172|FG000|Overall Study|Withdrawal by Subject|0|||
13369674|NCT00825175|26712173|FG001|Overall Study|Withdrawal by Subject|5|||
13369675|NCT00825162|26712207|FG000|Overall Study|Withdrawal by Subject|11|||
13369676|NCT00825162|26712208|FG001|Overall Study|Withdrawal by Subject|13|||
13369677|NCT00825162|26712209|FG002|Overall Study|Withdrawal by Subject|3|||
13369678|NCT00825162|26712207|FG000|Overall Study|Lost to Follow-up|9|||
13369679|NCT00825162|26712208|FG001|Overall Study|Lost to Follow-up|6|||
13369680|NCT00825162|26712209|FG002|Overall Study|Lost to Follow-up|3|||
13369681|NCT00825162|26712207|FG000|Overall Study|Physician Decision|2|||
13369682|NCT00825162|26712208|FG001|Overall Study|Physician Decision|0|||
13369683|NCT00825162|26712209|FG002|Overall Study|Physician Decision|0|||
13369684|NCT00825162|26712207|FG000|Overall Study|Move away from the study area|1|||
13369685|NCT00825162|26712208|FG001|Overall Study|Move away from the study area|0|||
13369686|NCT00825162|26712209|FG002|Overall Study|Move away from the study area|0|||
13369687|NCT00825162|26712207|FG000|Overall Study|Unable to attend the study visit|5|||
13369688|NCT00825162|26712208|FG001|Overall Study|Unable to attend the study visit|2|||
13369689|NCT00825162|26712209|FG002|Overall Study|Unable to attend the study visit|0|||
13369690|NCT00824993|26712222|FG000|Overall Study|Withdrawal by Subject|1|||
13369691|NCT00824993|26712223|FG001|Overall Study|Withdrawal by Subject|1|||
13369692|NCT00824993|26712222|FG000|Overall Study|Malignancy Relapse|9|||
13369693|NCT00824993|26712223|FG001|Overall Study|Malignancy Relapse|10|||
13369694|NCT00824993|26712222|FG000|Overall Study|Rapid Bone Loss|0|||
13369695|NCT00824993|26712223|FG001|Overall Study|Rapid Bone Loss|1|||
13369696|NCT00824993|26712222|FG000|Overall Study|Non-Compliant|2|||
13369697|NCT00824993|26712223|FG001|Overall Study|Non-Compliant|1|||
13369698|NCT00824993|26712222|FG000|Overall Study|Insurance Issue|2|||
13369699|NCT00824993|26712223|FG001|Overall Study|Insurance Issue|1|||
13369700|NCT00824993|26712222|FG000|Overall Study|Death|0|||
13369701|NCT00824993|26712223|FG001|Overall Study|Death|3|||
13369702|NCT00824850|26712274|FG000|Overall Study|Withdrawal by Subject|0|||
13369703|NCT00824850|26712275|FG001|Overall Study|Withdrawal by Subject|1|||
13369704|NCT00824772|26712282|FG000|Overall Study|Withdrawal by Subject|8|||
13369705|NCT00824720|26712306|FG000|Overall Study|failed plug insertion|3|||
13369706|NCT00824720|26712307|FG001|Overall Study|failed plug insertion|1|||
13369707|NCT00824720|26712308|FG002|Overall Study|failed plug insertion|0|||
13369708|NCT00824720|26712306|FG000|Overall Study|Protocol Violation|0|||
13369709|NCT00824720|26712307|FG001|Overall Study|Protocol Violation|0|||
13369710|NCT00824720|26712308|FG002|Overall Study|Protocol Violation|1|||
13369711|NCT00824655|26712333|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1|||
13369712|NCT00824655|26712334|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0|||
13369713|NCT00824655|26712333|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1|||
13369714|NCT00824655|26712334|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0|||
13369715|NCT00824616|26712349|FG000|Overall Study|Adverse Event|2|||
13369716|NCT00824616|26712350|FG001|Overall Study|Adverse Event|1|||
13369717|NCT00824616|26712349|FG000|Overall Study|Creatinine/Creatinine Clearance|0|||
13369718|NCT00824616|26712350|FG001|Overall Study|Creatinine/Creatinine Clearance|2|||
13369719|NCT00824616|26712349|FG000|Overall Study|Hyperglycemia|1|||
13369720|NCT00824616|26712350|FG001|Overall Study|Hyperglycemia|1|||
13369721|NCT00824616|26712349|FG000|Overall Study|Lack of Efficacy|2|||
13369722|NCT00824616|26712350|FG001|Overall Study|Lack of Efficacy|1|||
13369723|NCT00824616|26712349|FG000|Overall Study|Lost to Follow-up|0|||
13369724|NCT00824616|26712350|FG001|Overall Study|Lost to Follow-up|1|||
13369725|NCT00824616|26712349|FG000|Overall Study|Withdrawal by Subject|1|||
13369726|NCT00824616|26712350|FG001|Overall Study|Withdrawal by Subject|1|||
13369727|NCT00824564|26712375|FG000|Overall Study|Lost to Follow-up|5|||
13369728|NCT00824564|26712376|FG001|Overall Study|Lost to Follow-up|7|||
13369729|NCT00824564|26712375|FG000|Overall Study|Withdrawal by Subject|1|||
13369730|NCT00824564|26712376|FG001|Overall Study|Withdrawal by Subject|1|||
13369731|NCT00824564|26712375|FG000|Overall Study|Other|1|||
13369732|NCT00824564|26712376|FG001|Overall Study|Other|2|||
13369733|NCT00824564|26712375|FG000|Overall Study|Randomized, but not treated|1|||
13369734|NCT00824564|26712376|FG001|Overall Study|Randomized, but not treated|0|||
13369735|NCT00824473|26712399|FG000|Overall Study|Adverse Event|4|||
13369736|NCT00824473|26712400|FG001|Overall Study|Adverse Event|5|||
13369737|NCT00824473|26712399|FG000|Overall Study|Lack of Efficacy|2|||
13369738|NCT00824473|26712400|FG001|Overall Study|Lack of Efficacy|2|||
13369739|NCT00824473|26712399|FG000|Overall Study|Protocol Violation|2|||
13369740|NCT00824473|26712400|FG001|Overall Study|Protocol Violation|0|||
13369741|NCT00824473|26712399|FG000|Overall Study|Non-Compliance|4|||
13369742|NCT00824473|26712400|FG001|Overall Study|Non-Compliance|2|||
13369743|NCT00824473|26712399|FG000|Overall Study|Withdrawal by Subject|2|||
13369744|NCT00824473|26712400|FG001|Overall Study|Withdrawal by Subject|3|||
13369745|NCT00824473|26712399|FG000|Overall Study|Other|1|||
13369746|NCT00824473|26712400|FG001|Overall Study|Other|1|||
13369747|NCT00824421|26712456|FG000|Overall Study|Adverse Event|6|||
13369748|NCT00824421|26712457|FG001|Overall Study|Adverse Event|6|||
13369749|NCT00824421|26712458|FG002|Overall Study|Adverse Event|6|||
13369750|NCT00824421|26712456|FG000|Overall Study|Death|0|||
13369751|NCT00824421|26712457|FG001|Overall Study|Death|1|||
13369752|NCT00824421|26712458|FG002|Overall Study|Death|0|||
13369753|NCT00824421|26712456|FG000|Overall Study|Lack of Efficacy|5|||
13369754|NCT00824421|26712457|FG001|Overall Study|Lack of Efficacy|7|||
13369755|NCT00824421|26712458|FG002|Overall Study|Lack of Efficacy|4|||
13369756|NCT00824421|26712456|FG000|Overall Study|Lost to Follow-up|2|||
13369757|NCT00824421|26712457|FG001|Overall Study|Lost to Follow-up|3|||
13369758|NCT00824421|26712458|FG002|Overall Study|Lost to Follow-up|0|||
13369759|NCT00824421|26712456|FG000|Overall Study|Pregnancy|1|||
13369760|NCT00824421|26712457|FG001|Overall Study|Pregnancy|0|||
13369761|NCT00824421|26712458|FG002|Overall Study|Pregnancy|1|||
13369762|NCT00824421|26712456|FG000|Overall Study|Withdrawal by Subject|2|||
13369763|NCT00824421|26712457|FG001|Overall Study|Withdrawal by Subject|3|||
13369764|NCT00824421|26712458|FG002|Overall Study|Withdrawal by Subject|3|||
13369765|NCT00824421|26712456|FG000|Overall Study|Randomized but not Treated|1|||
13369766|NCT00824421|26712457|FG001|Overall Study|Randomized but not Treated|1|||
13369767|NCT00824421|26712458|FG002|Overall Study|Randomized but not Treated|0|||
13369768|NCT00824421|26712456|FG000|Overall Study|Other|0|||
13369769|NCT00824421|26712457|FG001|Overall Study|Other|1|||
13369770|NCT00824421|26712458|FG002|Overall Study|Other|0|||
13369771|NCT00824408|26712522|FG000|Run-in Phase|Progressive disease|4|||
13369772|NCT00824408|26712523|FG001|Run-in Phase|Progressive disease|4|||
13369773|NCT00824408|26712524|FG002|Run-in Phase|Progressive disease|0|||
13369774|NCT00824408|26712525|FG003|Run-in Phase|Progressive disease|0|||
13369775|NCT00824408|26712526|FG004|Run-in Phase|Progressive disease|0|||
13369776|NCT00824408|26712522|FG000|Run-in Phase|Adverse Event|1|||
13369777|NCT00824408|26712523|FG001|Run-in Phase|Adverse Event|1|||
13369778|NCT00824408|26712524|FG002|Run-in Phase|Adverse Event|0|||
13369779|NCT00824408|26712525|FG003|Run-in Phase|Adverse Event|0|||
13369780|NCT00824408|26712526|FG004|Run-in Phase|Adverse Event|0|||
13369781|NCT00824408|26712522|FG000|Run-in Phase|Refused to continue medication|1|||
13369782|NCT00824408|26712523|FG001|Run-in Phase|Refused to continue medication|0|||
13369783|NCT00824408|26712524|FG002|Run-in Phase|Refused to continue medication|0|||
13369784|NCT00824408|26712525|FG003|Run-in Phase|Refused to continue medication|0|||
13369785|NCT00824408|26712526|FG004|Run-in Phase|Refused to continue medication|0|||
13369786|NCT00824408|26712522|FG000|Run-in Phase|Other reason not defined above|0|||
13369787|NCT00824408|26712523|FG001|Run-in Phase|Other reason not defined above|1|||
13369788|NCT00824408|26712524|FG002|Run-in Phase|Other reason not defined above|0|||
13369789|NCT00824408|26712525|FG003|Run-in Phase|Other reason not defined above|0|||
13369790|NCT00824408|26712526|FG004|Run-in Phase|Other reason not defined above|0|||
13369791|NCT00824408|26712522|FG000|Randomized Phase|Not treated|0|||
13369792|NCT00824408|26712523|FG001|Randomized Phase|Not treated|0|||
13369793|NCT00824408|26712524|FG002|Randomized Phase|Not treated|1|||
13369794|NCT00824408|26712525|FG003|Randomized Phase|Not treated|1|||
13369795|NCT00824408|26712526|FG004|Randomized Phase|Not treated|1|||
13369796|NCT00824408|26712522|FG000|Randomized Phase|Progressive disease|0|||
13369797|NCT00824408|26712523|FG001|Randomized Phase|Progressive disease|0|||
13369798|NCT00824408|26712524|FG002|Randomized Phase|Progressive disease|25|||
13369799|NCT00824408|26712525|FG003|Randomized Phase|Progressive disease|36|||
13369800|NCT00824408|26712526|FG004|Randomized Phase|Progressive disease|34|||
13369801|NCT00824408|26712522|FG000|Randomized Phase|Adverse Event|0|||
13369802|NCT00824408|26712523|FG001|Randomized Phase|Adverse Event|0|||
13369803|NCT00824408|26712524|FG002|Randomized Phase|Adverse Event|4|||
13369804|NCT00824408|26712525|FG003|Randomized Phase|Adverse Event|5|||
13369805|NCT00824408|26712526|FG004|Randomized Phase|Adverse Event|5|||
13369806|NCT00824408|26712522|FG000|Randomized Phase|Refused to continue medication|0|||
13369807|NCT00824408|26712523|FG001|Randomized Phase|Refused to continue medication|0|||
13369808|NCT00824408|26712524|FG002|Randomized Phase|Refused to continue medication|2|||
13369809|NCT00824408|26712525|FG003|Randomized Phase|Refused to continue medication|2|||
13369810|NCT00824408|26712526|FG004|Randomized Phase|Refused to continue medication|2|||
13369811|NCT00824408|26712522|FG000|Randomized Phase|Other reason not defined above|0|||
13369812|NCT00824408|26712523|FG001|Randomized Phase|Other reason not defined above|0|||
13369813|NCT00824408|26712524|FG002|Randomized Phase|Other reason not defined above|4|||
13369814|NCT00824408|26712525|FG003|Randomized Phase|Other reason not defined above|2|||
13369815|NCT00824408|26712526|FG004|Randomized Phase|Other reason not defined above|4|||
13369816|NCT00824382|26712609|FG000|Overall Study|Adverse Event|4|||
13369817|NCT00824382|26712610|FG001|Overall Study|Adverse Event|1|||
13369818|NCT00824382|26712611|FG002|Overall Study|Adverse Event|1|||
13369819|NCT00824382|26712612|FG003|Overall Study|Adverse Event|4|||
13369820|NCT00824382|26712609|FG000|Overall Study|Protocol Violation|1|||
13369821|NCT00824382|26712610|FG001|Overall Study|Protocol Violation|0|||
13369822|NCT00824382|26712611|FG002|Overall Study|Protocol Violation|0|||
13369823|NCT00824382|26712612|FG003|Overall Study|Protocol Violation|1|||
13369824|NCT00824382|26712609|FG000|Overall Study|Investigator's decision|0|||
13369825|NCT00824382|26712610|FG001|Overall Study|Investigator's decision|1|||
13369826|NCT00824382|26712611|FG002|Overall Study|Investigator's decision|2|||
13369827|NCT00824382|26712612|FG003|Overall Study|Investigator's decision|0|||
13369828|NCT00824369|26712669|FG000|Overall Study|Nolonger willing to participate in study|1|||
13369829|NCT00824369|26712670|FG001|Overall Study|Nolonger willing to participate in study|0|||
13369830|NCT00824369|26712671|FG002|Overall Study|Nolonger willing to participate in study|1|||
13369831|NCT00824369|26712672|FG003|Overall Study|Nolonger willing to participate in study|2|||
13369832|NCT00824369|26712673|FG004|Overall Study|Nolonger willing to participate in study|0|||
13369833|NCT00824369|26712674|FG005|Overall Study|Nolonger willing to participate in study|1|||
13369834|NCT00824369|26712669|FG000|Overall Study|Lost to Follow-up|0|||
13369835|NCT00824369|26712670|FG001|Overall Study|Lost to Follow-up|0|||
13486674|NCT01889186|27036814|FG001|Overall Study|Investigator request|1|||
13488142|NCT04409262|27042892|FG000|Overall Study|Protocol Violation|3|||
13369836|NCT00824369|26712671|FG002|Overall Study|Lost to Follow-up|0|||
13369837|NCT00824369|26712672|FG003|Overall Study|Lost to Follow-up|0|||
13369838|NCT00824369|26712673|FG004|Overall Study|Lost to Follow-up|1|||
13369839|NCT00824369|26712674|FG005|Overall Study|Lost to Follow-up|0|||
13369840|NCT00824291|26712701|FG000|Overall Study|Adverse Event|15|||
13369841|NCT00824291|26712702|FG001|Overall Study|Adverse Event|6|||
13369842|NCT00824291|26712701|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
13369843|NCT00824291|26712702|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
13369844|NCT00824291|26712701|FG000|Overall Study|Lost to Follow-up|11|||
13369845|NCT00824291|26712702|FG001|Overall Study|Lost to Follow-up|9|||
13369846|NCT00824291|26712701|FG000|Overall Study|Non-compliance|1|||
13369847|NCT00824291|26712702|FG001|Overall Study|Non-compliance|1|||
13369848|NCT00824291|26712701|FG000|Overall Study|Protocol Violation|4|||
13369849|NCT00824291|26712702|FG001|Overall Study|Protocol Violation|1|||
13369850|NCT00824291|26712701|FG000|Overall Study|Withdrawal by Subject|14|||
13369851|NCT00824291|26712702|FG001|Overall Study|Withdrawal by Subject|8|||
13369852|NCT00824291|26712701|FG000|Overall Study|Lack of Efficacy|7|||
13369853|NCT00824291|26712702|FG001|Overall Study|Lack of Efficacy|8|||
13369854|NCT00824291|26712701|FG000|Overall Study|Participant on prohibited medication|1|||
13369855|NCT00824291|26712702|FG001|Overall Study|Participant on prohibited medication|0|||
13369856|NCT00824265|26712770|FG000|Treatment Phase|Adverse Event,non-fatal|50|||
13369857|NCT00824265|26712771|FG001|Treatment Phase|Adverse Event,non-fatal|52|||
13369858|NCT00824265|26712770|FG000|Treatment Phase|Protocol Violation|1|||
13369859|NCT00824265|26712771|FG001|Treatment Phase|Protocol Violation|0|||
13369860|NCT00824265|26712770|FG000|Treatment Phase|Lost to Follow-up|1|||
13369861|NCT00824265|26712771|FG001|Treatment Phase|Lost to Follow-up|1|||
13369862|NCT00824265|26712770|FG000|Treatment Phase|Physician Decision|6|||
13369863|NCT00824265|26712771|FG001|Treatment Phase|Physician Decision|12|||
13369864|NCT00824265|26712770|FG000|Treatment Phase|Withdrawal by Subject|6|||
13369865|NCT00824265|26712771|FG001|Treatment Phase|Withdrawal by Subject|15|||
13369866|NCT00824265|26712770|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18|||
13369867|NCT00824265|26712771|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31|||
13369868|NCT00824265|26712770|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9|||
13369869|NCT00824265|26712771|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16|||
13369870|NCT00824161|26712779|FG000|Overall Study|Withdrawal by Subject|1|||
13369871|NCT00824161|26712779|FG000|Overall Study|Screen Failure|1|||
13369872|NCT00824005|26712818|FG000|Overall Study|Death|0|||
13369873|NCT00824005|26712819|FG001|Overall Study|Death|1|||
13369874|NCT00824005|26712818|FG000|Overall Study|Lost to Follow-up|0|||
13369875|NCT00824005|26712819|FG001|Overall Study|Lost to Follow-up|1|||
13369876|NCT00823979|26712867|FG000|Overall Study|Lack of Efficacy|13|||
13369877|NCT00823979|26712868|FG001|Overall Study|Lack of Efficacy|16|||
13369878|NCT00823979|26712869|FG002|Overall Study|Lack of Efficacy|9|||
13369879|NCT00823979|26712867|FG000|Overall Study|Lost to Follow-up|2|||
13369880|NCT00823979|26712868|FG001|Overall Study|Lost to Follow-up|1|||
13369881|NCT00823979|26712869|FG002|Overall Study|Lost to Follow-up|0|||
13369882|NCT00823979|26712867|FG000|Overall Study|Withdrawal by Subject|2|||
13369883|NCT00823979|26712868|FG001|Overall Study|Withdrawal by Subject|3|||
13369884|NCT00823979|26712869|FG002|Overall Study|Withdrawal by Subject|2|||
13369885|NCT00823979|26712867|FG000|Overall Study|Protocol Violation|1|||
13369886|NCT00823979|26712868|FG001|Overall Study|Protocol Violation|1|||
13369887|NCT00823979|26712869|FG002|Overall Study|Protocol Violation|0|||
13369888|NCT00823979|26712867|FG000|Overall Study|Pregnancy|0|||
13369889|NCT00823979|26712868|FG001|Overall Study|Pregnancy|1|||
13369890|NCT00823979|26712869|FG002|Overall Study|Pregnancy|0|||
13369891|NCT00823979|26712867|FG000|Overall Study|Adverse Event|0|||
13369892|NCT00823979|26712868|FG001|Overall Study|Adverse Event|2|||
13369893|NCT00823979|26712869|FG002|Overall Study|Adverse Event|4|||
13369894|NCT00823979|26712867|FG000|Overall Study|Other|2|||
13369895|NCT00823979|26712868|FG001|Overall Study|Other|0|||
13369896|NCT00823979|26712869|FG002|Overall Study|Other|1|||
13369897|NCT00823979|26712867|FG000|Overall Study|Randomized but not Treated|4|||
13369898|NCT00823979|26712868|FG001|Overall Study|Randomized but not Treated|3|||
13369899|NCT00823979|26712869|FG002|Overall Study|Randomized but not Treated|1|||
13369900|NCT00823979|26712867|FG000|Overall Study|Study Terminated by Sponsor|5|||
13369901|NCT00823979|26712868|FG001|Overall Study|Study Terminated by Sponsor|5|||
13369902|NCT00823979|26712869|FG002|Overall Study|Study Terminated by Sponsor|7|||
13369903|NCT00823901|26712882|FG000|Overall Study|Adverse Event|1|||
13369904|NCT00823901|26712883|FG001|Overall Study|Adverse Event|1|||
13369905|NCT00823901|26712882|FG000|Overall Study|Lack of Efficacy|1|||
13369906|NCT00823901|26712883|FG001|Overall Study|Lack of Efficacy|0|||
13369907|NCT00823901|26712882|FG000|Overall Study|Lost to Follow-up|2|||
13369908|NCT00823901|26712883|FG001|Overall Study|Lost to Follow-up|1|||
13369909|NCT00823836|26712994|FG000|NV and PR/XR Switching Phases|Adverse Event|22|||
13369910|NCT00823836|26712995|FG001|NV and PR/XR Switching Phases|Adverse Event|21|||
13369911|NCT00823836|26712994|FG000|NV and PR/XR Switching Phases|Protocol Violation|1|||
13369912|NCT00823836|26712995|FG001|NV and PR/XR Switching Phases|Protocol Violation|1|||
13369913|NCT00823836|26712994|FG000|NV and PR/XR Switching Phases|Physician Decision|5|||
13369914|NCT00823836|26712995|FG001|NV and PR/XR Switching Phases|Physician Decision|2|||
13369915|NCT00823836|26712994|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4|||
13369916|NCT00823836|26712995|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5|||
13369917|NCT00823836|26712994|FG000|Long-term Phase|Adverse Event|3|||
13369918|NCT00823836|26712995|FG001|Long-term Phase|Adverse Event|2|||
13369919|NCT00823836|26712994|FG000|Long-term Phase|Physician Decision|1|||
13369920|NCT00823836|26712995|FG001|Long-term Phase|Physician Decision|2|||
13369921|NCT00823836|26712994|FG000|Long-term Phase|Withdrawal by Subject|1|||
13369922|NCT00823836|26712995|FG001|Long-term Phase|Withdrawal by Subject|1|||
13369923|NCT00823823|26713010|FG000|Overall Study|Lost to Follow-up|3|||
13369924|NCT00823823|26713011|FG001|Overall Study|Lost to Follow-up|1|||
13369925|NCT00823823|26713010|FG000|Overall Study|Protocol Violation|5|||
13369926|NCT00823823|26713011|FG001|Overall Study|Protocol Violation|5|||
13369927|NCT00823719|26713071|FG000|Overall Study|Adverse Event|1|||
13369928|NCT00823719|26713072|FG001|Overall Study|Adverse Event|2|||
13369929|NCT00823719|26713071|FG000|Overall Study|Physician Decision|1|||
13369930|NCT00823719|26713072|FG001|Overall Study|Physician Decision|4|||
13369931|NCT00823719|26713071|FG000|Overall Study|Withdrawal by Subject|0|||
13369932|NCT00823719|26713072|FG001|Overall Study|Withdrawal by Subject|1|||
13369933|NCT00823719|26713071|FG000|Overall Study|Disease Progression|4|||
13369934|NCT00823719|26713072|FG001|Overall Study|Disease Progression|4|||
13369935|NCT00823615|26713083|FG000|Period 2|Lost to Follow-up|2|||
13369936|NCT00823615|26713084|FG001|Period 2|Lost to Follow-up|0|||
13369937|NCT00823615|26713083|FG000|Period 2|Time/Job Conflict|1|||
13369938|NCT00823615|26713084|FG001|Period 2|Time/Job Conflict|2|||
13369939|NCT00823472|26713099|FG000|Overall Study|Physician Decision|24|||
13369940|NCT00823472|26713100|FG001|Overall Study|Physician Decision|28|||
13369941|NCT00823264|26713113|FG000|Overall Study|Protocol Violation|2|||
13369942|NCT00823264|26713114|FG001|Overall Study|Protocol Violation|0|||
13369943|NCT00823212|26713203|FG000|Overall Study|Death|8|||
13369944|NCT00823212|26713204|FG001|Overall Study|Death|10|||
13369945|NCT00823212|26713203|FG000|Overall Study|Withdrawal by Subject|6|||
13369946|NCT00823212|26713204|FG001|Overall Study|Withdrawal by Subject|1|||
13369947|NCT00823212|26713203|FG000|Overall Study|Incarcerated|0|||
13369948|NCT00823212|26713204|FG001|Overall Study|Incarcerated|1|||
13369949|NCT00823212|26713203|FG000|Overall Study|Missed 12-month visit|21|||
13369950|NCT00823212|26713204|FG001|Overall Study|Missed 12-month visit|21|||
13369951|NCT00823199|26713212|FG000|Overall Study|Withdrawal by Subject|2|||
13369952|NCT00823134|26713224|FG000|Overall Study|Invalid measurement|1|||
13369953|NCT00822926|26713243|FG000|Second Injection Visit|Lost to Follow-up|1|||
13369954|NCT00822926|26713244|FG001|Second Injection Visit|Lost to Follow-up|0|||
13369955|NCT00822926|26713243|FG000|Second Injection Visit|Withdrawal by Subject|0|||
13369956|NCT00822926|26713244|FG001|Second Injection Visit|Withdrawal by Subject|1|||
13369957|NCT00822900|26713279|FG000|Overall Study|Withdrawal by Subject|14|||
13369958|NCT00822900|26713280|FG001|Overall Study|Withdrawal by Subject|14|||
13369959|NCT00822900|26713279|FG000|Overall Study|Lost to Follow-up|9|||
13369960|NCT00822900|26713280|FG001|Overall Study|Lost to Follow-up|9|||
13369961|NCT00822900|26713279|FG000|Overall Study|Death|83|||
13369962|NCT00822900|26713280|FG001|Overall Study|Death|69|||
13369963|NCT00822900|26713279|FG000|Overall Study|Became a ward of the state|2|||
13369964|NCT00822900|26713280|FG001|Overall Study|Became a ward of the state|1|||
13369965|NCT00822770|26713294|FG000|Overall Study|Not treated|1|||
13369966|NCT00822770|26713295|FG001|Overall Study|Not treated|0|||
13369967|NCT00822770|26713294|FG000|Overall Study|Complication/Incomplete treatment|1|||
13369968|NCT00822770|26713295|FG001|Overall Study|Complication/Incomplete treatment|0|||
13369969|NCT00822770|26713294|FG000|Overall Study|Death|1|||
13369970|NCT00822770|26713295|FG001|Overall Study|Death|1|||
13369971|NCT00822692|26713308|FG000|Overall Study|Lost to Follow-up|17|||
13369972|NCT00822692|26713309|FG001|Overall Study|Lost to Follow-up|25|||
13369973|NCT00822237|26713321|FG000|Dose 1 Vaccination|Not vaccinated|3|||
13369974|NCT00822237|26713322|FG001|Dose 1 Vaccination|Not vaccinated|0|||
13369975|NCT00822237|26713321|FG000|Dose 1 Vaccination|Withdrawal by Subject|13|||
13369976|NCT00822237|26713322|FG001|Dose 1 Vaccination|Withdrawal by Subject|14|||
13369977|NCT00822237|26713321|FG000|Dose 1 Vaccination|Lost to Follow-up|9|||
13369978|NCT00822237|26713322|FG001|Dose 1 Vaccination|Lost to Follow-up|12|||
13369979|NCT00822237|26713321|FG000|Dose 2 Vaccination|Withdrawal by Subject|2|||
13369980|NCT00822237|26713322|FG001|Dose 2 Vaccination|Withdrawal by Subject|2|||
13369981|NCT00822237|26713321|FG000|Dose 2 Vaccination|Lost to Follow-up|2|||
13369982|NCT00822237|26713322|FG001|Dose 2 Vaccination|Lost to Follow-up|9|||
13369983|NCT00822172|26713347|FG000|Overall Study|Adverse Event|10|||
13369984|NCT00822172|26713348|FG001|Overall Study|Adverse Event|12|||
13369985|NCT00822172|26713347|FG000|Overall Study|Death|1|||
13369986|NCT00822172|26713348|FG001|Overall Study|Death|0|||
13369987|NCT00822172|26713347|FG000|Overall Study|Lost to Follow-up|3|||
13369988|NCT00822172|26713348|FG001|Overall Study|Lost to Follow-up|1|||
13369989|NCT00822172|26713347|FG000|Overall Study|Withdrawal by Subject|1|||
13369990|NCT00822172|26713348|FG001|Overall Study|Withdrawal by Subject|4|||
13369991|NCT00822172|26713347|FG000|Overall Study|site closed|0|||
13369992|NCT00822172|26713348|FG001|Overall Study|site closed|1|||
13369993|NCT00822172|26713347|FG000|Overall Study|Other|0|||
13369994|NCT00822172|26713348|FG001|Overall Study|Other|1|||
13369995|NCT00822120|26713382|FG000|Initial Registration|Adverse Event|1|||
13369996|NCT00822120|26713383|FG001|Initial Registration|Adverse Event|0|||
13369997|NCT00822120|26713384|FG002|Initial Registration|Adverse Event|0|||
13369998|NCT00822120|26713385|FG003|Initial Registration|Adverse Event|0|||
13369999|NCT00822120|26713386|FG004|Initial Registration|Adverse Event|0|||
13370000|NCT00822120|26713387|FG005|Initial Registration|Adverse Event|0|||
13370001|NCT00822120|26713382|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1|||
13370002|NCT00822120|26713383|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
13370003|NCT00822120|26713384|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0|||
13370004|NCT00822120|26713385|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0|||
13370005|NCT00822120|26713386|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0|||
13370006|NCT00822120|26713387|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0|||
13370007|NCT00822120|26713382|FG000|Initial Registration|Reasons not Protocol Specified|2|||
13370008|NCT00822120|26713383|FG001|Initial Registration|Reasons not Protocol Specified|0|||
13370009|NCT00822120|26713384|FG002|Initial Registration|Reasons not Protocol Specified|0|||
13370010|NCT00822120|26713385|FG003|Initial Registration|Reasons not Protocol Specified|0|||
13370011|NCT00822120|26713386|FG004|Initial Registration|Reasons not Protocol Specified|0|||
13370012|NCT00822120|26713387|FG005|Initial Registration|Reasons not Protocol Specified|0|||
13370013|NCT00822120|26713382|FG000|Initial Registration|Ineligible|22|||
13370014|NCT00822120|26713383|FG001|Initial Registration|Ineligible|1|||
13370015|NCT00822120|26713384|FG002|Initial Registration|Ineligible|0|||
13370016|NCT00822120|26713385|FG003|Initial Registration|Ineligible|0|||
13370017|NCT00822120|26713386|FG004|Initial Registration|Ineligible|0|||
13370018|NCT00822120|26713387|FG005|Initial Registration|Ineligible|0|||
13370019|NCT00822120|26713382|FG000|PET-directed Therapy|Adverse Event|0|||
13370020|NCT00822120|26713383|FG001|PET-directed Therapy|Adverse Event|0|||
13370021|NCT00822120|26713384|FG002|PET-directed Therapy|Adverse Event|0|||
13370022|NCT00822120|26713385|FG003|PET-directed Therapy|Adverse Event|1|||
13370023|NCT00822120|26713386|FG004|PET-directed Therapy|Adverse Event|0|||
13370024|NCT00822120|26713387|FG005|PET-directed Therapy|Adverse Event|0|||
13370025|NCT00822120|26713382|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
13370026|NCT00822120|26713383|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
13370027|NCT00822120|26713384|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
13370028|NCT00822120|26713385|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1|||
13370029|NCT00822120|26713386|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
13370030|NCT00822120|26713387|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
13370031|NCT00822120|26713382|FG000|PET-directed Therapy|Death|0|||
13370032|NCT00822120|26713383|FG001|PET-directed Therapy|Death|0|||
13370033|NCT00822120|26713384|FG002|PET-directed Therapy|Death|0|||
13370034|NCT00822120|26713385|FG003|PET-directed Therapy|Death|2|||
13370035|NCT00822120|26713386|FG004|PET-directed Therapy|Death|0|||
13370036|NCT00822120|26713387|FG005|PET-directed Therapy|Death|0|||
13370037|NCT00822120|26713382|FG000|PET-directed Therapy|Protocol Violation|0|||
13370038|NCT00822120|26713383|FG001|PET-directed Therapy|Protocol Violation|0|||
13370039|NCT00822120|26713384|FG002|PET-directed Therapy|Protocol Violation|0|||
13370040|NCT00822120|26713385|FG003|PET-directed Therapy|Protocol Violation|6|||
13370041|NCT00822120|26713386|FG004|PET-directed Therapy|Protocol Violation|0|||
13370042|NCT00822120|26713387|FG005|PET-directed Therapy|Protocol Violation|0|||
13370043|NCT00821873|26713393|FG000|Overall Study|Lost to Follow-up|4|||
13370044|NCT00821678|26713420|FG000|Overall Study|Withdrawal by Subject|8|||
13370045|NCT00821678|26713421|FG001|Overall Study|Withdrawal by Subject|0|||
13370046|NCT00821678|26713420|FG000|Overall Study|Lost to Follow-up|13|||
13370047|NCT00821678|26713421|FG001|Overall Study|Lost to Follow-up|12|||
13370048|NCT00821678|26713420|FG000|Overall Study|Death|0|||
13370049|NCT00821678|26713421|FG001|Overall Study|Death|2|||
13370050|NCT00821509|26713442|FG000|Overall Study|Withdrawal by Subject|12|||
13370051|NCT00821509|26713443|FG001|Overall Study|Withdrawal by Subject|11|||
13370052|NCT00821509|26713444|FG002|Overall Study|Withdrawal by Subject|34|||
13370053|NCT00821431|26713459|FG000|Overall Study|Adverse Event|6|||
13370054|NCT00821431|26713460|FG001|Overall Study|Adverse Event|3|||
13370055|NCT00821431|26713459|FG000|Overall Study|Withdrawal by Subject|5|||
13370056|NCT00821431|26713460|FG001|Overall Study|Withdrawal by Subject|0|||
13370057|NCT00821431|26713459|FG000|Overall Study|Lost to Follow-up|1|||
13370058|NCT00821431|26713460|FG001|Overall Study|Lost to Follow-up|0|||
13370059|NCT00821431|26713459|FG000|Overall Study|Protocol Violation|3|||
13370060|NCT00821431|26713460|FG001|Overall Study|Protocol Violation|1|||
13370061|NCT00821431|26713459|FG000|Overall Study|Physician Decision|0|||
13370062|NCT00821431|26713460|FG001|Overall Study|Physician Decision|1|||
13370063|NCT00821327|26713468|FG000|Overall Study|Adverse Event|13|||
13370064|NCT00821327|26713468|FG000|Overall Study|Patient Request|1|||
13370065|NCT00821327|26713468|FG000|Overall Study|Investigator Request|2|||
13370066|NCT00821327|26713468|FG000|Overall Study|Sponsor Request|1|||
13370067|NCT00821327|26713468|FG000|Overall Study|Disease Progression|13|||
13370068|NCT00821327|26713468|FG000|Overall Study|Other/Unknown|5|||
13370069|NCT00821236|26713490|FG000|Overall Study|Lost to Follow-up|3|||
13370070|NCT00821093|26713505|FG000|Overall Study|Adverse Event|20|||
13370071|NCT00821093|26713506|FG001|Overall Study|Adverse Event|12|||
13370072|NCT00821093|26713505|FG000|Overall Study|Withdrawal by Subject|9|||
13370073|NCT00821093|26713506|FG001|Overall Study|Withdrawal by Subject|13|||
13370074|NCT00821093|26713505|FG000|Overall Study|Lost to Follow-up|9|||
13370075|NCT00821093|26713506|FG001|Overall Study|Lost to Follow-up|3|||
13370076|NCT00821093|26713505|FG000|Overall Study|Protocol deviation|3|||
13370077|NCT00821093|26713506|FG001|Overall Study|Protocol deviation|6|||
13370078|NCT00821093|26713505|FG000|Overall Study|Abnormal laboratory value(s)|2|||
13370079|NCT00821093|26713506|FG001|Overall Study|Abnormal laboratory value(s)|0|||
13370080|NCT00821093|26713505|FG000|Overall Study|Lack of Efficacy|2|||
13370081|NCT00821093|26713506|FG001|Overall Study|Lack of Efficacy|2|||
13370082|NCT00821093|26713505|FG000|Overall Study|Death|2|||
13370083|NCT00821093|26713506|FG001|Overall Study|Death|1|||
13370084|NCT00821093|26713505|FG000|Overall Study|Abnormal test procedure result(s)|1|||
13370085|NCT00821093|26713506|FG001|Overall Study|Abnormal test procedure result(s)|1|||
13370086|NCT00821093|26713505|FG000|Overall Study|Administrative problems|1|||
13370087|NCT00821093|26713506|FG001|Overall Study|Administrative problems|2|||
13370088|NCT00821015|26713519|FG000|Overall Study|Lost to Follow-up|12|||
13370089|NCT00820950|26713593|FG000|Overall Study|Scheduling Conflict|0|||
13370090|NCT00820950|26713594|FG001|Overall Study|Scheduling Conflict|0|||
13370091|NCT00820950|26713595|FG002|Overall Study|Scheduling Conflict|0|||
13370092|NCT00820950|26713596|FG003|Overall Study|Scheduling Conflict|0|||
13370093|NCT00820950|26713597|FG004|Overall Study|Scheduling Conflict|0|||
13370094|NCT00820950|26713598|FG005|Overall Study|Scheduling Conflict|0|||
13370095|NCT00820950|26713599|FG006|Overall Study|Scheduling Conflict|1|||
13370096|NCT00820950|26713600|FG007|Overall Study|Scheduling Conflict|1|||
13370097|NCT00820950|26713601|FG008|Overall Study|Scheduling Conflict|0|||
13370098|NCT00820950|26713602|FG009|Overall Study|Scheduling Conflict|0|||
13370099|NCT00820950|26713593|FG000|Overall Study|Protocol Violation|1|||
13370100|NCT00820950|26713594|FG001|Overall Study|Protocol Violation|1|||
13370101|NCT00820950|26713595|FG002|Overall Study|Protocol Violation|0|||
13370102|NCT00820950|26713596|FG003|Overall Study|Protocol Violation|0|||
13370103|NCT00820950|26713597|FG004|Overall Study|Protocol Violation|0|||
13370104|NCT00820950|26713598|FG005|Overall Study|Protocol Violation|0|||
13370105|NCT00820950|26713599|FG006|Overall Study|Protocol Violation|0|||
13370106|NCT00820950|26713600|FG007|Overall Study|Protocol Violation|0|||
13370107|NCT00820950|26713601|FG008|Overall Study|Protocol Violation|0|||
13370108|NCT00820950|26713602|FG009|Overall Study|Protocol Violation|0|||
13370109|NCT00820898|26713614|FG000|Overall Study|Inelgible - wrong primary site|1|||
13370110|NCT00820755|26713639|FG000|Period 1: Combination Therapy Phase|Adverse Event|77|||
13370111|NCT00820755|26713640|FG001|Period 1: Combination Therapy Phase|Adverse Event|0|||
13370112|NCT00820755|26713641|FG002|Period 1: Combination Therapy Phase|Adverse Event|0|||
13370113|NCT00820755|26713639|FG000|Period 1: Combination Therapy Phase|Death|28|||
13370114|NCT00820755|26713640|FG001|Period 1: Combination Therapy Phase|Death|0|||
13370115|NCT00820755|26713641|FG002|Period 1: Combination Therapy Phase|Death|0|||
13370116|NCT00820755|26713639|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4|||
13370117|NCT00820755|26713640|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0|||
13370118|NCT00820755|26713641|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0|||
13370119|NCT00820755|26713639|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1|||
13370120|NCT00820755|26713640|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
13370121|NCT00820755|26713641|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
13370122|NCT00820755|26713639|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21|||
13370123|NCT00820755|26713640|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
13370124|NCT00820755|26713641|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
13370125|NCT00820755|26713639|FG000|Period 1: Combination Therapy Phase|Progressive disease|114|||
13370126|NCT00820755|26713640|FG001|Period 1: Combination Therapy Phase|Progressive disease|0|||
13370127|NCT00820755|26713641|FG002|Period 1: Combination Therapy Phase|Progressive disease|0|||
13370128|NCT00820755|26713639|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14|||
13370129|NCT00820755|26713640|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
13370130|NCT00820755|26713641|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
13370131|NCT00820755|26713639|FG000|Period 1: Combination Therapy Phase|Other|11|||
13370132|NCT00820755|26713640|FG001|Period 1: Combination Therapy Phase|Other|0|||
13370133|NCT00820755|26713641|FG002|Period 1: Combination Therapy Phase|Other|0|||
13370134|NCT00820755|26713639|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0|||
13370135|NCT00820755|26713640|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
13370136|NCT00820755|26713641|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
13370137|NCT00820599|26713648|FG000|Overall Study|Death|129|||
13370138|NCT00820599|26713648|FG000|Overall Study|Withdrawal by Subject|2|||
13370139|NCT00820248|26713663|FG000|Overall Study|No treated|4|||
13370140|NCT00820248|26713664|FG001|Overall Study|No treated|1|||
13370141|NCT00820222|26713697|FG000|Overall Study|Lost to Follow-up|10|||
13370142|NCT00820222|26713698|FG001|Overall Study|Lost to Follow-up|9|||
13370143|NCT00820222|26713697|FG000|Overall Study|Withdrawal by Subject|19|||
13370144|NCT00820222|26713698|FG001|Overall Study|Withdrawal by Subject|21|||
13370145|NCT00820222|26713697|FG000|Overall Study|Physician Decision|93|||
13370146|NCT00820222|26713698|FG001|Overall Study|Physician Decision|88|||
13370147|NCT00820222|26713697|FG000|Overall Study|Sponsor Terminated Study|43|||
13370148|NCT00820222|26713698|FG001|Overall Study|Sponsor Terminated Study|65|||
13370149|NCT00820222|26713697|FG000|Overall Study|Unkown|11|||
13370150|NCT00820222|26713698|FG001|Overall Study|Unkown|7|||
13370151|NCT00820170|26713762|FG000|Overall Study|Adverse Event|0|||
13370152|NCT00820170|26713763|FG001|Overall Study|Adverse Event|0|||
13370153|NCT00820170|26713764|FG002|Overall Study|Adverse Event|0|||
13370154|NCT00820170|26713765|FG003|Overall Study|Adverse Event|0|||
13370155|NCT00820170|26713766|FG004|Overall Study|Adverse Event|2|||
13370156|NCT00820170|26713762|FG000|Overall Study|Progressive Disease|0|||
13370157|NCT00820170|26713763|FG001|Overall Study|Progressive Disease|0|||
13370158|NCT00820170|26713764|FG002|Overall Study|Progressive Disease|0|||
13370159|NCT00820170|26713765|FG003|Overall Study|Progressive Disease|0|||
13370160|NCT00820170|26713766|FG004|Overall Study|Progressive Disease|2|||
13370161|NCT00820040|26713776|FG000|Overall Study|Death|1|||
13370162|NCT00820040|26713776|FG000|Overall Study|Sponsor terminated study|1|||
13370163|NCT00820040|26713776|FG000|Overall Study|Screen failure|1|||
13370164|NCT00820027|26713827|FG000|Overall Study|Adverse Event|15|||
13370165|NCT00820027|26713828|FG001|Overall Study|Adverse Event|8|||
13370166|NCT00820027|26713829|FG002|Overall Study|Adverse Event|10|||
13370167|NCT00820027|26713830|FG003|Overall Study|Adverse Event|5|||
13370168|NCT00820027|26713827|FG000|Overall Study|Lack of Efficacy|2|||
13370169|NCT00820027|26713828|FG001|Overall Study|Lack of Efficacy|1|||
13370170|NCT00820027|26713829|FG002|Overall Study|Lack of Efficacy|2|||
13370171|NCT00820027|26713830|FG003|Overall Study|Lack of Efficacy|2|||
13370172|NCT00820027|26713827|FG000|Overall Study|Physician Decision|0|||
13370173|NCT00820027|26713828|FG001|Overall Study|Physician Decision|1|||
13370174|NCT00820027|26713829|FG002|Overall Study|Physician Decision|1|||
13370175|NCT00820027|26713830|FG003|Overall Study|Physician Decision|0|||
13370176|NCT00820027|26713827|FG000|Overall Study|Protocol Violation|3|||
13370177|NCT00820027|26713828|FG001|Overall Study|Protocol Violation|0|||
13370178|NCT00820027|26713829|FG002|Overall Study|Protocol Violation|4|||
13370179|NCT00820027|26713830|FG003|Overall Study|Protocol Violation|0|||
13370180|NCT00820027|26713827|FG000|Overall Study|Withdrawal by Subject|6|||
13370181|NCT00820027|26713828|FG001|Overall Study|Withdrawal by Subject|4|||
13370182|NCT00820027|26713829|FG002|Overall Study|Withdrawal by Subject|4|||
13370183|NCT00820027|26713830|FG003|Overall Study|Withdrawal by Subject|6|||
13370184|NCT00819910|26713869|FG000|Overall Study|Adverse Event|0|||
13370185|NCT00819910|26713870|FG001|Overall Study|Adverse Event|0|||
13370186|NCT00819910|26713871|FG002|Overall Study|Adverse Event|2|||
13370187|NCT00819910|26713872|FG003|Overall Study|Adverse Event|1|||
13370188|NCT00819910|26713869|FG000|Overall Study|Withdrawal by Subject|1|||
13370189|NCT00819910|26713870|FG001|Overall Study|Withdrawal by Subject|1|||
13370190|NCT00819910|26713871|FG002|Overall Study|Withdrawal by Subject|1|||
13370191|NCT00819910|26713872|FG003|Overall Study|Withdrawal by Subject|0|||
13370192|NCT00819910|26713869|FG000|Overall Study|Lost to Follow-up|1|||
13370193|NCT00819910|26713870|FG001|Overall Study|Lost to Follow-up|0|||
13370194|NCT00819910|26713871|FG002|Overall Study|Lost to Follow-up|0|||
13370195|NCT00819910|26713872|FG003|Overall Study|Lost to Follow-up|0|||
13370196|NCT00819832|26713905|FG000|Overall Study|Sponsor Termination of Study|3|||
13370197|NCT00819832|26713906|FG001|Overall Study|Sponsor Termination of Study|0|||
13370198|NCT00819832|26713907|FG002|Overall Study|Sponsor Termination of Study|0|||
13370199|NCT00819832|26713908|FG003|Overall Study|Sponsor Termination of Study|0|||
13370200|NCT00819832|26713909|FG004|Overall Study|Sponsor Termination of Study|0|||
13370201|NCT00819832|26713910|FG005|Overall Study|Sponsor Termination of Study|0|||
13370202|NCT00819767|26713927|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
13370203|NCT00819767|26713928|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
13370204|NCT00819741|26713969|FG000|Overall Study|Adverse Event|5|||
13370205|NCT00819741|26713970|FG001|Overall Study|Adverse Event|2|||
13370206|NCT00819741|26713969|FG000|Overall Study|Lack of Efficacy|0|||
13370207|NCT00819741|26713970|FG001|Overall Study|Lack of Efficacy|2|||
13370208|NCT00819741|26713969|FG000|Overall Study|Lost to Follow-up|3|||
13370209|NCT00819741|26713970|FG001|Overall Study|Lost to Follow-up|1|||
13370210|NCT00819741|26713969|FG000|Overall Study|Protocol Violation|3|||
13370211|NCT00819741|26713970|FG001|Overall Study|Protocol Violation|4|||
13370212|NCT00819741|26713969|FG000|Overall Study|Withdrawal by Subject|2|||
13370213|NCT00819741|26713970|FG001|Overall Study|Withdrawal by Subject|2|||
13370214|NCT00819741|26713969|FG000|Overall Study|Unclassified|6|||
13370215|NCT00819741|26713970|FG001|Overall Study|Unclassified|0|||
13370216|NCT00819741|26713969|FG000|Overall Study|Reasons unknown|3|||
13370217|NCT00819741|26713970|FG001|Overall Study|Reasons unknown|3|||
13370218|NCT00819585|26714067|FG000|Core Study|Adverse Event|2|||
13370219|NCT00819585|26714068|FG001|Core Study|Adverse Event|1|||
13370220|NCT00819585|26714069|FG002|Core Study|Adverse Event|1|||
13370221|NCT00819585|26714070|FG003|Core Study|Adverse Event|4|||
13370222|NCT00819585|26714071|FG004|Core Study|Adverse Event|1|||
13370223|NCT00819585|26714072|FG005|Core Study|Adverse Event|0|||
13370224|NCT00819585|26714073|FG006|Core Study|Adverse Event|2|||
13370225|NCT00819585|26714074|FG007|Core Study|Adverse Event|0|||
13370226|NCT00819585|26714075|FG008|Core Study|Adverse Event|0|||
13370227|NCT00819585|26714076|FG009|Core Study|Adverse Event|0|||
13370228|NCT00819585|26714077|FG010|Core Study|Adverse Event|0|||
13370229|NCT00819585|26714067|FG000|Core Study|Abnormal Laboratory Value(s)|2|||
13370230|NCT00819585|26714068|FG001|Core Study|Abnormal Laboratory Value(s)|0|||
13370231|NCT00819585|26714069|FG002|Core Study|Abnormal Laboratory Value(s)|0|||
13370232|NCT00819585|26714070|FG003|Core Study|Abnormal Laboratory Value(s)|0|||
13370233|NCT00819585|26714071|FG004|Core Study|Abnormal Laboratory Value(s)|0|||
13370234|NCT00819585|26714072|FG005|Core Study|Abnormal Laboratory Value(s)|0|||
13370235|NCT00819585|26714073|FG006|Core Study|Abnormal Laboratory Value(s)|0|||
13370236|NCT00819585|26714074|FG007|Core Study|Abnormal Laboratory Value(s)|0|||
13370237|NCT00819585|26714075|FG008|Core Study|Abnormal Laboratory Value(s)|0|||
13370238|NCT00819585|26714076|FG009|Core Study|Abnormal Laboratory Value(s)|0|||
13370239|NCT00819585|26714077|FG010|Core Study|Abnormal Laboratory Value(s)|0|||
13370240|NCT00819585|26714067|FG000|Core Study|Unsatisfactory Therapeutic Effect|0|||
13370241|NCT00819585|26714068|FG001|Core Study|Unsatisfactory Therapeutic Effect|1|||
13370242|NCT00819585|26714069|FG002|Core Study|Unsatisfactory Therapeutic Effect|0|||
13370243|NCT00819585|26714070|FG003|Core Study|Unsatisfactory Therapeutic Effect|0|||
13370244|NCT00819585|26714071|FG004|Core Study|Unsatisfactory Therapeutic Effect|0|||
13370245|NCT00819585|26714072|FG005|Core Study|Unsatisfactory Therapeutic Effect|0|||
13370246|NCT00819585|26714073|FG006|Core Study|Unsatisfactory Therapeutic Effect|1|||
13370247|NCT00819585|26714074|FG007|Core Study|Unsatisfactory Therapeutic Effect|0|||
13370248|NCT00819585|26714075|FG008|Core Study|Unsatisfactory Therapeutic Effect|0|||
13370249|NCT00819585|26714076|FG009|Core Study|Unsatisfactory Therapeutic Effect|0|||
13370250|NCT00819585|26714077|FG010|Core Study|Unsatisfactory Therapeutic Effect|0|||
13370251|NCT00819585|26714067|FG000|Core Study|Subject No Longer Requires Study Drug|0|||
13370252|NCT00819585|26714068|FG001|Core Study|Subject No Longer Requires Study Drug|0|||
13370253|NCT00819585|26714069|FG002|Core Study|Subject No Longer Requires Study Drug|0|||
13370254|NCT00819585|26714070|FG003|Core Study|Subject No Longer Requires Study Drug|0|||
13370255|NCT00819585|26714071|FG004|Core Study|Subject No Longer Requires Study Drug|1|||
13370256|NCT00819585|26714072|FG005|Core Study|Subject No Longer Requires Study Drug|0|||
13370257|NCT00819585|26714073|FG006|Core Study|Subject No Longer Requires Study Drug|0|||
13370258|NCT00819585|26714074|FG007|Core Study|Subject No Longer Requires Study Drug|0|||
13370259|NCT00819585|26714075|FG008|Core Study|Subject No Longer Requires Study Drug|0|||
13370260|NCT00819585|26714076|FG009|Core Study|Subject No Longer Requires Study Drug|0|||
13370261|NCT00819585|26714077|FG010|Core Study|Subject No Longer Requires Study Drug|0|||
13370262|NCT00819585|26714067|FG000|Core Study|Subject Withdrew Consent|0|||
13370263|NCT00819585|26714068|FG001|Core Study|Subject Withdrew Consent|3|||
13370264|NCT00819585|26714069|FG002|Core Study|Subject Withdrew Consent|2|||
13370265|NCT00819585|26714070|FG003|Core Study|Subject Withdrew Consent|1|||
13370266|NCT00819585|26714071|FG004|Core Study|Subject Withdrew Consent|0|||
13370267|NCT00819585|26714072|FG005|Core Study|Subject Withdrew Consent|0|||
13370268|NCT00819585|26714073|FG006|Core Study|Subject Withdrew Consent|3|||
13370269|NCT00819585|26714074|FG007|Core Study|Subject Withdrew Consent|0|||
13370270|NCT00819585|26714075|FG008|Core Study|Subject Withdrew Consent|0|||
13370271|NCT00819585|26714076|FG009|Core Study|Subject Withdrew Consent|0|||
13370272|NCT00819585|26714077|FG010|Core Study|Subject Withdrew Consent|0|||
13370273|NCT00819585|26714067|FG000|Core Study|Lost to Follow-up|2|||
13370274|NCT00819585|26714068|FG001|Core Study|Lost to Follow-up|1|||
13370275|NCT00819585|26714069|FG002|Core Study|Lost to Follow-up|2|||
13370276|NCT00819585|26714070|FG003|Core Study|Lost to Follow-up|0|||
13370277|NCT00819585|26714071|FG004|Core Study|Lost to Follow-up|1|||
13370278|NCT00819585|26714072|FG005|Core Study|Lost to Follow-up|1|||
13370279|NCT00819585|26714073|FG006|Core Study|Lost to Follow-up|1|||
13370280|NCT00819585|26714074|FG007|Core Study|Lost to Follow-up|0|||
13370281|NCT00819585|26714075|FG008|Core Study|Lost to Follow-up|0|||
13370282|NCT00819585|26714076|FG009|Core Study|Lost to Follow-up|0|||
13370283|NCT00819585|26714077|FG010|Core Study|Lost to Follow-up|0|||
13370284|NCT00819585|26714067|FG000|Core Study|Administrative Problems|0|||
13370285|NCT00819585|26714068|FG001|Core Study|Administrative Problems|0|||
13370286|NCT00819585|26714069|FG002|Core Study|Administrative Problems|0|||
13370287|NCT00819585|26714070|FG003|Core Study|Administrative Problems|0|||
13370288|NCT00819585|26714071|FG004|Core Study|Administrative Problems|0|||
13370289|NCT00819585|26714072|FG005|Core Study|Administrative Problems|0|||
13370290|NCT00819585|26714073|FG006|Core Study|Administrative Problems|2|||
13370291|NCT00819585|26714074|FG007|Core Study|Administrative Problems|0|||
13370292|NCT00819585|26714075|FG008|Core Study|Administrative Problems|0|||
13370293|NCT00819585|26714076|FG009|Core Study|Administrative Problems|0|||
13370294|NCT00819585|26714077|FG010|Core Study|Administrative Problems|0|||
13370295|NCT00819585|26714067|FG000|Core Study|Death|0|||
13370296|NCT00819585|26714068|FG001|Core Study|Death|0|||
13370297|NCT00819585|26714069|FG002|Core Study|Death|0|||
13370298|NCT00819585|26714070|FG003|Core Study|Death|0|||
13370299|NCT00819585|26714071|FG004|Core Study|Death|0|||
13370300|NCT00819585|26714072|FG005|Core Study|Death|0|||
13370301|NCT00819585|26714073|FG006|Core Study|Death|1|||
13370302|NCT00819585|26714074|FG007|Core Study|Death|0|||
13370303|NCT00819585|26714075|FG008|Core Study|Death|0|||
13370304|NCT00819585|26714076|FG009|Core Study|Death|0|||
13370305|NCT00819585|26714077|FG010|Core Study|Death|0|||
13370306|NCT00819585|26714067|FG000|Core Study|Protocol Violation|0|||
13370307|NCT00819585|26714068|FG001|Core Study|Protocol Violation|0|||
13370308|NCT00819585|26714069|FG002|Core Study|Protocol Violation|1|||
13370309|NCT00819585|26714070|FG003|Core Study|Protocol Violation|0|||
13370310|NCT00819585|26714071|FG004|Core Study|Protocol Violation|0|||
13370311|NCT00819585|26714072|FG005|Core Study|Protocol Violation|1|||
13370312|NCT00819585|26714073|FG006|Core Study|Protocol Violation|3|||
13370313|NCT00819585|26714074|FG007|Core Study|Protocol Violation|0|||
13370314|NCT00819585|26714075|FG008|Core Study|Protocol Violation|0|||
13370315|NCT00819585|26714076|FG009|Core Study|Protocol Violation|0|||
13370316|NCT00819585|26714077|FG010|Core Study|Protocol Violation|0|||
13370317|NCT00819585|26714067|FG000|Extension Study|Abnormal Laboratory Value(s)|0|||
13370318|NCT00819585|26714068|FG001|Extension Study|Abnormal Laboratory Value(s)|0|||
13370319|NCT00819585|26714069|FG002|Extension Study|Abnormal Laboratory Value(s)|0|||
13370320|NCT00819585|26714070|FG003|Extension Study|Abnormal Laboratory Value(s)|0|||
13370321|NCT00819585|26714071|FG004|Extension Study|Abnormal Laboratory Value(s)|0|||
13370322|NCT00819585|26714072|FG005|Extension Study|Abnormal Laboratory Value(s)|0|||
13370323|NCT00819585|26714073|FG006|Extension Study|Abnormal Laboratory Value(s)|0|||
13370324|NCT00819585|26714074|FG007|Extension Study|Abnormal Laboratory Value(s)|0|||
13370325|NCT00819585|26714075|FG008|Extension Study|Abnormal Laboratory Value(s)|1|||
13370326|NCT00819585|26714076|FG009|Extension Study|Abnormal Laboratory Value(s)|0|||
13370327|NCT00819585|26714077|FG010|Extension Study|Abnormal Laboratory Value(s)|0|||
13370328|NCT00819585|26714067|FG000|Extension Study|Subject Withdrew Consent|0|||
13370329|NCT00819585|26714068|FG001|Extension Study|Subject Withdrew Consent|0|||
13370330|NCT00819585|26714069|FG002|Extension Study|Subject Withdrew Consent|0|||
13370331|NCT00819585|26714070|FG003|Extension Study|Subject Withdrew Consent|0|||
13370332|NCT00819585|26714071|FG004|Extension Study|Subject Withdrew Consent|0|||
13370333|NCT00819585|26714072|FG005|Extension Study|Subject Withdrew Consent|0|||
13370334|NCT00819585|26714073|FG006|Extension Study|Subject Withdrew Consent|0|||
13370335|NCT00819585|26714074|FG007|Extension Study|Subject Withdrew Consent|0|||
13370336|NCT00819585|26714075|FG008|Extension Study|Subject Withdrew Consent|3|||
13370337|NCT00819585|26714076|FG009|Extension Study|Subject Withdrew Consent|0|||
13370338|NCT00819585|26714077|FG010|Extension Study|Subject Withdrew Consent|1|||
13370339|NCT00819585|26714067|FG000|Extension Study|Lost to Follow-up|0|||
13370340|NCT00819585|26714068|FG001|Extension Study|Lost to Follow-up|0|||
13370341|NCT00819585|26714069|FG002|Extension Study|Lost to Follow-up|0|||
13370342|NCT00819585|26714070|FG003|Extension Study|Lost to Follow-up|0|||
13370343|NCT00819585|26714071|FG004|Extension Study|Lost to Follow-up|0|||
13370344|NCT00819585|26714072|FG005|Extension Study|Lost to Follow-up|0|||
13370345|NCT00819585|26714073|FG006|Extension Study|Lost to Follow-up|0|||
13370346|NCT00819585|26714074|FG007|Extension Study|Lost to Follow-up|0|||
13370347|NCT00819585|26714075|FG008|Extension Study|Lost to Follow-up|2|||
13370348|NCT00819585|26714076|FG009|Extension Study|Lost to Follow-up|1|||
13370349|NCT00819585|26714077|FG010|Extension Study|Lost to Follow-up|1|||
13370350|NCT00819585|26714067|FG000|Extension Study|Death|0|||
13370351|NCT00819585|26714068|FG001|Extension Study|Death|0|||
13370352|NCT00819585|26714069|FG002|Extension Study|Death|0|||
13370353|NCT00819585|26714070|FG003|Extension Study|Death|0|||
13370354|NCT00819585|26714071|FG004|Extension Study|Death|0|||
13370355|NCT00819585|26714072|FG005|Extension Study|Death|0|||
13370356|NCT00819585|26714073|FG006|Extension Study|Death|0|||
13370357|NCT00819585|26714074|FG007|Extension Study|Death|0|||
13370358|NCT00819585|26714075|FG008|Extension Study|Death|2|||
13370359|NCT00819585|26714076|FG009|Extension Study|Death|0|||
13370360|NCT00819585|26714077|FG010|Extension Study|Death|0|||
13370361|NCT00819390|26714200|FG000|Overall Study|Lost to Follow-up|1|||
13370362|NCT00819390|26714201|FG001|Overall Study|Lost to Follow-up|1|||
13370363|NCT00819390|26714202|FG002|Overall Study|Lost to Follow-up|0|||
13370364|NCT00819390|26714203|FG003|Overall Study|Lost to Follow-up|0|||
13370365|NCT00819390|26714200|FG000|Overall Study|Withdrawal by Subject|2|||
13370366|NCT00819390|26714201|FG001|Overall Study|Withdrawal by Subject|0|||
13370367|NCT00819390|26714202|FG002|Overall Study|Withdrawal by Subject|0|||
13370368|NCT00819390|26714203|FG003|Overall Study|Withdrawal by Subject|0|||
13370369|NCT00819390|26714200|FG000|Overall Study|Adverse Event|0|||
13370370|NCT00819390|26714201|FG001|Overall Study|Adverse Event|0|||
13370371|NCT00819390|26714202|FG002|Overall Study|Adverse Event|1|||
13370372|NCT00819390|26714203|FG003|Overall Study|Adverse Event|0|||
13370373|NCT00819247|26714239|FG000|Overall Study|Adverse Event|0|||
13370374|NCT00819247|26714240|FG001|Overall Study|Adverse Event|5|||
13370375|NCT00819247|26714241|FG002|Overall Study|Adverse Event|3|||
13370376|NCT00819247|26714239|FG000|Overall Study|Insufficient testosterone response|5|||
13370377|NCT00819247|26714240|FG001|Overall Study|Insufficient testosterone response|8|||
13370378|NCT00819247|26714241|FG002|Overall Study|Insufficient testosterone response|10|||
13370379|NCT00819247|26714239|FG000|Overall Study|Withdrawal by Subject|1|||
13370380|NCT00819247|26714240|FG001|Overall Study|Withdrawal by Subject|0|||
13370381|NCT00819247|26714241|FG002|Overall Study|Withdrawal by Subject|0|||
13370382|NCT00819247|26714239|FG000|Overall Study|Protocol Violation|1|||
13370383|NCT00819247|26714240|FG001|Overall Study|Protocol Violation|0|||
13370384|NCT00819247|26714241|FG002|Overall Study|Protocol Violation|1|||
13370385|NCT00819247|26714239|FG000|Overall Study|Mistakenly withdrawn|0|||
13370386|NCT00819247|26714240|FG001|Overall Study|Mistakenly withdrawn|1|||
13370387|NCT00819247|26714241|FG002|Overall Study|Mistakenly withdrawn|0|||
13370388|NCT00819247|26714239|FG000|Overall Study|Bad prostate-specific antigen response|3|||
13370389|NCT00819247|26714240|FG001|Overall Study|Bad prostate-specific antigen response|2|||
13370390|NCT00819247|26714241|FG002|Overall Study|Bad prostate-specific antigen response|0|||
13370391|NCT00819247|26714239|FG000|Overall Study|Other|1|||
13370392|NCT00819247|26714240|FG001|Overall Study|Other|0|||
13370393|NCT00819247|26714241|FG002|Overall Study|Other|0|||
13370394|NCT00819234|26714410|FG000|Overall Study|Withdrawal by Subject|8|||
13370395|NCT00819234|26714411|FG001|Overall Study|Withdrawal by Subject|13|||
13370396|NCT00819234|26714412|FG002|Overall Study|Withdrawal by Subject|6|||
13370397|NCT00819234|26714413|FG003|Overall Study|Withdrawal by Subject|3|||
13370398|NCT00819234|26714414|FG004|Overall Study|Withdrawal by Subject|0|||
13370399|NCT00819234|26714415|FG005|Overall Study|Withdrawal by Subject|4|||
13370400|NCT00819234|26714416|FG006|Overall Study|Withdrawal by Subject|4|||
13370401|NCT00819234|26714417|FG007|Overall Study|Withdrawal by Subject|8|||
13370402|NCT00819234|26714418|FG008|Overall Study|Withdrawal by Subject|5|||
13370403|NCT00819234|26714419|FG009|Overall Study|Withdrawal by Subject|3|||
13370404|NCT00819234|26714410|FG000|Overall Study|Adverse Event|0|||
13370405|NCT00819234|26714411|FG001|Overall Study|Adverse Event|0|||
13370406|NCT00819234|26714412|FG002|Overall Study|Adverse Event|1|||
13370407|NCT00819234|26714413|FG003|Overall Study|Adverse Event|0|||
13370408|NCT00819234|26714414|FG004|Overall Study|Adverse Event|0|||
13370409|NCT00819234|26714415|FG005|Overall Study|Adverse Event|2|||
13370410|NCT00819234|26714416|FG006|Overall Study|Adverse Event|0|||
13370411|NCT00819234|26714417|FG007|Overall Study|Adverse Event|0|||
13370412|NCT00819234|26714418|FG008|Overall Study|Adverse Event|0|||
13370413|NCT00819234|26714419|FG009|Overall Study|Adverse Event|0|||
13370414|NCT00819234|26714410|FG000|Overall Study|Physician Decision|0|||
13370415|NCT00819234|26714411|FG001|Overall Study|Physician Decision|0|||
13370416|NCT00819234|26714412|FG002|Overall Study|Physician Decision|0|||
13370417|NCT00819234|26714413|FG003|Overall Study|Physician Decision|1|||
13370418|NCT00819234|26714414|FG004|Overall Study|Physician Decision|0|||
13370419|NCT00819234|26714415|FG005|Overall Study|Physician Decision|0|||
13370420|NCT00819234|26714416|FG006|Overall Study|Physician Decision|0|||
13370421|NCT00819234|26714417|FG007|Overall Study|Physician Decision|0|||
13370422|NCT00819234|26714418|FG008|Overall Study|Physician Decision|0|||
13370423|NCT00819234|26714419|FG009|Overall Study|Physician Decision|2|||
13370424|NCT00819234|26714410|FG000|Overall Study|Protocol Violation|0|||
13370425|NCT00819234|26714411|FG001|Overall Study|Protocol Violation|0|||
13370426|NCT00819234|26714412|FG002|Overall Study|Protocol Violation|1|||
13370427|NCT00819234|26714413|FG003|Overall Study|Protocol Violation|0|||
13370428|NCT00819234|26714414|FG004|Overall Study|Protocol Violation|0|||
13370429|NCT00819234|26714415|FG005|Overall Study|Protocol Violation|0|||
13370430|NCT00819234|26714416|FG006|Overall Study|Protocol Violation|0|||
13370431|NCT00819234|26714417|FG007|Overall Study|Protocol Violation|0|||
13370432|NCT00819234|26714418|FG008|Overall Study|Protocol Violation|0|||
13370433|NCT00819234|26714419|FG009|Overall Study|Protocol Violation|0|||
13370434|NCT00819234|26714410|FG000|Overall Study|Lost to Follow-up|2|||
13370435|NCT00819234|26714411|FG001|Overall Study|Lost to Follow-up|2|||
13370436|NCT00819234|26714412|FG002|Overall Study|Lost to Follow-up|0|||
13370437|NCT00819234|26714413|FG003|Overall Study|Lost to Follow-up|2|||
13370438|NCT00819234|26714414|FG004|Overall Study|Lost to Follow-up|1|||
13370439|NCT00819234|26714415|FG005|Overall Study|Lost to Follow-up|1|||
13370440|NCT00819234|26714416|FG006|Overall Study|Lost to Follow-up|1|||
13370441|NCT00819234|26714417|FG007|Overall Study|Lost to Follow-up|1|||
13370442|NCT00819234|26714418|FG008|Overall Study|Lost to Follow-up|1|||
13370443|NCT00819234|26714419|FG009|Overall Study|Lost to Follow-up|2|||
13370444|NCT00819156|26714526|FG000|Overall Study|Adverse Event|1|||
13370445|NCT00819156|26714527|FG001|Overall Study|Adverse Event|4|||
13370446|NCT00819156|26714528|FG002|Overall Study|Adverse Event|2|||
13370447|NCT00819156|26714529|FG003|Overall Study|Adverse Event|1|||
13370448|NCT00819156|26714530|FG004|Overall Study|Adverse Event|2|||
13370449|NCT00819156|26714531|FG005|Overall Study|Adverse Event|3|||
13370450|NCT00819156|26714526|FG000|Overall Study|Withdrawal by Subject|0|||
13370451|NCT00819156|26714527|FG001|Overall Study|Withdrawal by Subject|3|||
13370452|NCT00819156|26714528|FG002|Overall Study|Withdrawal by Subject|2|||
13370453|NCT00819156|26714529|FG003|Overall Study|Withdrawal by Subject|0|||
13370454|NCT00819156|26714530|FG004|Overall Study|Withdrawal by Subject|1|||
13370455|NCT00819156|26714531|FG005|Overall Study|Withdrawal by Subject|0|||
13370456|NCT00819156|26714526|FG000|Overall Study|Protocol Violation|1|||
13370457|NCT00819156|26714527|FG001|Overall Study|Protocol Violation|0|||
13370458|NCT00819156|26714528|FG002|Overall Study|Protocol Violation|1|||
13370459|NCT00819156|26714529|FG003|Overall Study|Protocol Violation|0|||
13370460|NCT00819156|26714530|FG004|Overall Study|Protocol Violation|0|||
13370461|NCT00819156|26714531|FG005|Overall Study|Protocol Violation|1|||
13370462|NCT00819156|26714526|FG000|Overall Study|Lost to Follow-up|0|||
13370463|NCT00819156|26714527|FG001|Overall Study|Lost to Follow-up|1|||
13370464|NCT00819156|26714528|FG002|Overall Study|Lost to Follow-up|0|||
13370465|NCT00819156|26714529|FG003|Overall Study|Lost to Follow-up|0|||
13370466|NCT00819156|26714530|FG004|Overall Study|Lost to Follow-up|0|||
13370467|NCT00819156|26714531|FG005|Overall Study|Lost to Follow-up|2|||
13370468|NCT00819156|26714526|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5|||
13370469|NCT00819156|26714527|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
13370470|NCT00819156|26714528|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
13370471|NCT00819156|26714529|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
13370472|NCT00819156|26714530|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
13370473|NCT00819156|26714531|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
13370474|NCT00819156|26714526|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3|||
13370475|NCT00819156|26714527|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
13370476|NCT00819156|26714528|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
13370477|NCT00819156|26714529|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
13370478|NCT00819156|26714530|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1|||
13370479|NCT00819156|26714531|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
13370480|NCT00819156|26714526|FG000|Overall Study|Prostate-specific antigen progression|0|||
13370481|NCT00819156|26714527|FG001|Overall Study|Prostate-specific antigen progression|0|||
13370482|NCT00819156|26714528|FG002|Overall Study|Prostate-specific antigen progression|0|||
13370483|NCT00819156|26714529|FG003|Overall Study|Prostate-specific antigen progression|0|||
13370484|NCT00819156|26714530|FG004|Overall Study|Prostate-specific antigen progression|1|||
13370485|NCT00819156|26714531|FG005|Overall Study|Prostate-specific antigen progression|0|||
13370486|NCT00819091|26714562|FG000|Overall Study|Adverse Event|3|||
13370487|NCT00819091|26714563|FG001|Overall Study|Adverse Event|5|||
13370488|NCT00819091|26714562|FG000|Overall Study|Protocol Violation|0|||
13370489|NCT00819091|26714563|FG001|Overall Study|Protocol Violation|1|||
13370490|NCT00819091|26714562|FG000|Overall Study|Lost to Follow-up|2|||
13370491|NCT00819091|26714563|FG001|Overall Study|Lost to Follow-up|0|||
13370492|NCT00819091|26714562|FG000|Overall Study|Withdrawal by Subject|1|||
13370493|NCT00819091|26714563|FG001|Overall Study|Withdrawal by Subject|2|||
13370494|NCT00819091|26714562|FG000|Overall Study|Other|1|||
13370495|NCT00819091|26714563|FG001|Overall Study|Other|2|||
13370496|NCT00819052|26714682|FG000|Overall Study|Adverse Event|0|||
13370497|NCT00819052|26714683|FG001|Overall Study|Adverse Event|5|||
13370498|NCT00819052|26714682|FG000|Overall Study|Protocol Violation|1|||
13370499|NCT00819052|26714683|FG001|Overall Study|Protocol Violation|2|||
13370500|NCT00819052|26714682|FG000|Overall Study|Lost to Follow-up|1|||
13370501|NCT00819052|26714683|FG001|Overall Study|Lost to Follow-up|2|||
13370502|NCT00819052|26714682|FG000|Overall Study|Withdrawal by Subject|1|||
13370503|NCT00819052|26714683|FG001|Overall Study|Withdrawal by Subject|2|||
13370504|NCT00819052|26714682|FG000|Overall Study|Lack of Efficacy|1|||
13370505|NCT00819052|26714683|FG001|Overall Study|Lack of Efficacy|1|||
13370506|NCT00819052|26714682|FG000|Overall Study|Pregnancy|1|||
13370507|NCT00819052|26714683|FG001|Overall Study|Pregnancy|2|||
13370508|NCT00819052|26714682|FG000|Overall Study|Death or events leading to death|1|||
13370509|NCT00819052|26714683|FG001|Overall Study|Death or events leading to death|0|||
13370510|NCT00819039|26714719|FG000|Overall Study|Physician Decision|1|||
13370511|NCT00819039|26714720|FG001|Overall Study|Physician Decision|0|||
13370512|NCT00819039|26714721|FG002|Overall Study|Physician Decision|1|||
13370513|NCT00819039|26714719|FG000|Overall Study|Protocol Violation|1|||
13370514|NCT00819039|26714720|FG001|Overall Study|Protocol Violation|0|||
13370515|NCT00819039|26714721|FG002|Overall Study|Protocol Violation|0|||
13370516|NCT00819013|26714784|FG000|Overall Study|Not meeting continuing study eligibility|2|||
13370517|NCT00819013|26714785|FG001|Overall Study|Not meeting continuing study eligibility|1|||
13370518|NCT00819013|26714786|FG002|Overall Study|Not meeting continuing study eligibility|2|||
13370519|NCT00819013|26714787|FG003|Overall Study|Not meeting continuing study eligibility|1|||
13370520|NCT00819013|26714784|FG000|Overall Study|Adverse Event|0|||
13370521|NCT00819013|26714785|FG001|Overall Study|Adverse Event|0|||
13370522|NCT00819013|26714786|FG002|Overall Study|Adverse Event|1|||
13370523|NCT00819013|26714787|FG003|Overall Study|Adverse Event|0|||
13370524|NCT00819013|26714784|FG000|Overall Study|Withdrawal by Subject|1|||
13370525|NCT00819013|26714785|FG001|Overall Study|Withdrawal by Subject|0|||
13370526|NCT00819013|26714786|FG002|Overall Study|Withdrawal by Subject|1|||
13370527|NCT00819013|26714787|FG003|Overall Study|Withdrawal by Subject|0|||
13370528|NCT00819013|26714784|FG000|Overall Study|Lost to Follow-up|0|||
13370529|NCT00819013|26714785|FG001|Overall Study|Lost to Follow-up|0|||
13370530|NCT00819013|26714786|FG002|Overall Study|Lost to Follow-up|1|||
13370531|NCT00819013|26714787|FG003|Overall Study|Lost to Follow-up|2|||
13370532|NCT00819013|26714784|FG000|Overall Study|Death|0|||
13370533|NCT00819013|26714785|FG001|Overall Study|Death|0|||
13370534|NCT00819013|26714786|FG002|Overall Study|Death|0|||
13370535|NCT00819013|26714787|FG003|Overall Study|Death|1|||
13370536|NCT00818883|26714828|FG000|Overall Study|Adverse Event|28|||
13370537|NCT00818883|26714829|FG001|Overall Study|Adverse Event|19|||
13370538|NCT00818883|26714828|FG000|Overall Study|Protocol Violation|2|||
13370539|NCT00818883|26714829|FG001|Overall Study|Protocol Violation|2|||
13370540|NCT00818883|26714828|FG000|Overall Study|Lost to Follow-up|3|||
13370541|NCT00818883|26714829|FG001|Overall Study|Lost to Follow-up|2|||
13370542|NCT00818883|26714828|FG000|Overall Study|Withdrawal by Subject|16|||
13370543|NCT00818883|26714829|FG001|Overall Study|Withdrawal by Subject|14|||
13370544|NCT00818883|26714828|FG000|Overall Study|Lack of Efficacy|0|||
13370545|NCT00818883|26714829|FG001|Overall Study|Lack of Efficacy|2|||
13370546|NCT00818883|26714828|FG000|Overall Study|Other|2|||
13370547|NCT00818883|26714829|FG001|Overall Study|Other|7|||
13370548|NCT00818779|26714850|FG000|Overall Study|Protocol Violation|1|||
13370549|NCT00818779|26714851|FG001|Overall Study|Protocol Violation|0|||
13370550|NCT00818779|26714850|FG000|Overall Study|Lost to Follow-up|1|||
13370551|NCT00818779|26714851|FG001|Overall Study|Lost to Follow-up|0|||
13370552|NCT00818779|26714850|FG000|Overall Study|Adverse Event|4|||
13370553|NCT00818779|26714851|FG001|Overall Study|Adverse Event|1|||
13370554|NCT00818766|26714884|FG000|Overall Study|Could not be Contacted on Day 28|11|||
13370555|NCT00818766|26714885|FG001|Overall Study|Could not be Contacted on Day 28|10|||
13370556|NCT00818766|26714884|FG000|Overall Study|Death|1|||
13370557|NCT00818766|26714885|FG001|Overall Study|Death|0|||
13370558|NCT00818766|26714884|FG000|Overall Study|Did not Receive Allocated Intervention|3|||
13370559|NCT00818766|26714885|FG001|Overall Study|Did not Receive Allocated Intervention|0|||
13370560|NCT00818753|26714915|FG000|Overall Study|Protocol Violation|1|||
13370561|NCT00818753|26714916|FG001|Overall Study|Protocol Violation|0|||
13370562|NCT00818753|26714917|FG002|Overall Study|Protocol Violation|0|||
13370563|NCT00818753|26714915|FG000|Overall Study|Other reason (not specified)|0|||
13370564|NCT00818753|26714916|FG001|Overall Study|Other reason (not specified)|0|||
13370565|NCT00818753|26714917|FG002|Overall Study|Other reason (not specified)|1|||
13370566|NCT00818753|26714915|FG000|Overall Study|Randomised and not treated|2|||
13370567|NCT00818753|26714916|FG001|Overall Study|Randomised and not treated|0|||
13370568|NCT00818753|26714917|FG002|Overall Study|Randomised and not treated|0|||
13370569|NCT00818662|26715016|FG000|Overall Study|Adverse Event|5|||
13370570|NCT00818662|26715017|FG001|Overall Study|Adverse Event|14|||
13370571|NCT00818662|26715018|FG002|Overall Study|Adverse Event|4|||
13370572|NCT00818662|26715019|FG003|Overall Study|Adverse Event|3|||
13370573|NCT00818662|26715016|FG000|Overall Study|Withdrawal by Subject|5|||
13370574|NCT00818662|26715017|FG001|Overall Study|Withdrawal by Subject|4|||
13370575|NCT00818662|26715018|FG002|Overall Study|Withdrawal by Subject|2|||
13370576|NCT00818662|26715019|FG003|Overall Study|Withdrawal by Subject|2|||
13370577|NCT00818662|26715016|FG000|Overall Study|Death|1|||
13370578|NCT00818662|26715017|FG001|Overall Study|Death|3|||
13370579|NCT00818662|26715018|FG002|Overall Study|Death|0|||
13370580|NCT00818662|26715019|FG003|Overall Study|Death|0|||
13370581|NCT00818662|26715016|FG000|Overall Study|Physician Decision|1|||
13370582|NCT00818662|26715017|FG001|Overall Study|Physician Decision|0|||
13370583|NCT00818662|26715018|FG002|Overall Study|Physician Decision|0|||
13370584|NCT00818662|26715019|FG003|Overall Study|Physician Decision|0|||
13370585|NCT00818662|26715016|FG000|Overall Study|Lost to Follow-up|0|||
13370586|NCT00818662|26715017|FG001|Overall Study|Lost to Follow-up|0|||
13370587|NCT00818662|26715018|FG002|Overall Study|Lost to Follow-up|0|||
13370588|NCT00818662|26715019|FG003|Overall Study|Lost to Follow-up|1|||
13370589|NCT00818662|26715016|FG000|Overall Study|Unwilling or Unable to Participate|4|||
13370590|NCT00818662|26715017|FG001|Overall Study|Unwilling or Unable to Participate|6|||
13370591|NCT00818662|26715018|FG002|Overall Study|Unwilling or Unable to Participate|2|||
13370592|NCT00818662|26715019|FG003|Overall Study|Unwilling or Unable to Participate|4|||
13370593|NCT00818662|26715016|FG000|Overall Study|Protocol Violation|1|||
13370594|NCT00818662|26715017|FG001|Overall Study|Protocol Violation|1|||
13370595|NCT00818662|26715018|FG002|Overall Study|Protocol Violation|0|||
13370596|NCT00818662|26715019|FG003|Overall Study|Protocol Violation|0|||
13370597|NCT00818662|26715016|FG000|Overall Study|Requires a Prohibited Medication|1|||
13370598|NCT00818662|26715017|FG001|Overall Study|Requires a Prohibited Medication|0|||
13370599|NCT00818662|26715018|FG002|Overall Study|Requires a Prohibited Medication|0|||
13370600|NCT00818662|26715019|FG003|Overall Study|Requires a Prohibited Medication|0|||
13370601|NCT00818662|26715016|FG000|Overall Study|Safety Risk|1|||
13370602|NCT00818662|26715017|FG001|Overall Study|Safety Risk|1|||
13370603|NCT00818662|26715018|FG002|Overall Study|Safety Risk|0|||
13370604|NCT00818662|26715019|FG003|Overall Study|Safety Risk|1|||
13370605|NCT00818662|26715016|FG000|Overall Study|Study Partner Unwilling or Unable|3|||
13370606|NCT00818662|26715017|FG001|Overall Study|Study Partner Unwilling or Unable|2|||
13370607|NCT00818662|26715018|FG002|Overall Study|Study Partner Unwilling or Unable|1|||
13370608|NCT00818662|26715019|FG003|Overall Study|Study Partner Unwilling or Unable|1|||
13370609|NCT00818662|26715016|FG000|Overall Study|Participant's health declined|0|||
13370610|NCT00818662|26715017|FG001|Overall Study|Participant's health declined|0|||
13370611|NCT00818662|26715018|FG002|Overall Study|Participant's health declined|0|||
13370612|NCT00818662|26715019|FG003|Overall Study|Participant's health declined|1|||
13370613|NCT00818662|26715016|FG000|Overall Study|Caregiver to pursue other treatment|0|||
13370614|NCT00818662|26715017|FG001|Overall Study|Caregiver to pursue other treatment|1|||
13370615|NCT00818662|26715018|FG002|Overall Study|Caregiver to pursue other treatment|0|||
13370616|NCT00818662|26715019|FG003|Overall Study|Caregiver to pursue other treatment|0|||
13370617|NCT00818662|26715016|FG000|Overall Study|Moving out of state|0|||
13370618|NCT00818662|26715017|FG001|Overall Study|Moving out of state|0|||
13370619|NCT00818662|26715018|FG002|Overall Study|Moving out of state|0|||
13370620|NCT00818662|26715019|FG003|Overall Study|Moving out of state|1|||
13370621|NCT00818662|26715016|FG000|Overall Study|Declined move to another study site|1|||
13370622|NCT00818662|26715017|FG001|Overall Study|Declined move to another study site|0|||
13370623|NCT00818662|26715018|FG002|Overall Study|Declined move to another study site|0|||
13370624|NCT00818662|26715019|FG003|Overall Study|Declined move to another study site|0|||
13370625|NCT00818662|26715016|FG000|Overall Study|Change in living situation|0|||
13370626|NCT00818662|26715017|FG001|Overall Study|Change in living situation|0|||
13370627|NCT00818662|26715018|FG002|Overall Study|Change in living situation|0|||
13370628|NCT00818662|26715019|FG003|Overall Study|Change in living situation|1|||
13370629|NCT00818662|26715016|FG000|Overall Study|Study partner decision|0|||
13370630|NCT00818662|26715017|FG001|Overall Study|Study partner decision|0|||
13370631|NCT00818662|26715018|FG002|Overall Study|Study partner decision|0|||
13370632|NCT00818662|26715019|FG003|Overall Study|Study partner decision|1|||
13370633|NCT00818662|26715016|FG000|Overall Study|Admitted to long term nursing care|0|||
13370634|NCT00818662|26715017|FG001|Overall Study|Admitted to long term nursing care|1|||
13370635|NCT00818662|26715018|FG002|Overall Study|Admitted to long term nursing care|0|||
13370636|NCT00818662|26715019|FG003|Overall Study|Admitted to long term nursing care|0|||
13370637|NCT00818649|26715027|FG000|Overall Study|Declining performance status|2|||
13370638|NCT00818649|26715027|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1|||
13370639|NCT00818649|26715027|FG000|Overall Study|Adverse Event|1|||
13370640|NCT00818623|26715126|FG000|Overall Study|Adverse Event|1|||
13370641|NCT00818623|26715127|FG001|Overall Study|Adverse Event|0|||
13370642|NCT00818623|26715128|FG002|Overall Study|Adverse Event|1|||
13370643|NCT00818623|26715129|FG003|Overall Study|Adverse Event|0|||
13370644|NCT00818623|26715130|FG004|Overall Study|Adverse Event|0|||
13370645|NCT00818623|26715131|FG005|Overall Study|Adverse Event|1|||
13370646|NCT00818623|26715132|FG006|Overall Study|Adverse Event|0|||
13370647|NCT00818623|26715133|FG007|Overall Study|Adverse Event|0|||
13370648|NCT00818623|26715126|FG000|Overall Study|Bad prostate specific antigen response|0|||
13370649|NCT00818623|26715127|FG001|Overall Study|Bad prostate specific antigen response|3|||
13370650|NCT00818623|26715128|FG002|Overall Study|Bad prostate specific antigen response|2|||
13370651|NCT00818623|26715129|FG003|Overall Study|Bad prostate specific antigen response|5|||
13370652|NCT00818623|26715130|FG004|Overall Study|Bad prostate specific antigen response|0|||
13370653|NCT00818623|26715131|FG005|Overall Study|Bad prostate specific antigen response|1|||
13370654|NCT00818623|26715132|FG006|Overall Study|Bad prostate specific antigen response|0|||
13370655|NCT00818623|26715133|FG007|Overall Study|Bad prostate specific antigen response|0|||
13370656|NCT00818623|26715126|FG000|Overall Study|Withdrawal by Subject|0|||
13370657|NCT00818623|26715127|FG001|Overall Study|Withdrawal by Subject|1|||
13370658|NCT00818623|26715128|FG002|Overall Study|Withdrawal by Subject|1|||
13370659|NCT00818623|26715129|FG003|Overall Study|Withdrawal by Subject|0|||
13370660|NCT00818623|26715130|FG004|Overall Study|Withdrawal by Subject|0|||
13370661|NCT00818623|26715131|FG005|Overall Study|Withdrawal by Subject|1|||
13370662|NCT00818623|26715132|FG006|Overall Study|Withdrawal by Subject|1|||
13370663|NCT00818623|26715133|FG007|Overall Study|Withdrawal by Subject|1|||
13370664|NCT00818623|26715126|FG000|Overall Study|Protocol Violation|1|||
13370665|NCT00818623|26715127|FG001|Overall Study|Protocol Violation|0|||
13370666|NCT00818623|26715128|FG002|Overall Study|Protocol Violation|0|||
13370667|NCT00818623|26715129|FG003|Overall Study|Protocol Violation|0|||
13370668|NCT00818623|26715130|FG004|Overall Study|Protocol Violation|1|||
13370669|NCT00818623|26715131|FG005|Overall Study|Protocol Violation|0|||
13370670|NCT00818623|26715132|FG006|Overall Study|Protocol Violation|1|||
13370671|NCT00818623|26715133|FG007|Overall Study|Protocol Violation|0|||
13370672|NCT00818623|26715126|FG000|Overall Study|Need of additional treatment|0|||
13370673|NCT00818623|26715127|FG001|Overall Study|Need of additional treatment|0|||
13370674|NCT00818623|26715128|FG002|Overall Study|Need of additional treatment|0|||
13370675|NCT00818623|26715129|FG003|Overall Study|Need of additional treatment|0|||
13370676|NCT00818623|26715130|FG004|Overall Study|Need of additional treatment|1|||
13370677|NCT00818623|26715131|FG005|Overall Study|Need of additional treatment|0|||
13370678|NCT00818623|26715132|FG006|Overall Study|Need of additional treatment|0|||
13370679|NCT00818623|26715133|FG007|Overall Study|Need of additional treatment|0|||
13370680|NCT00818623|26715126|FG000|Overall Study|Lack of trial drug at site|0|||
13370681|NCT00818623|26715127|FG001|Overall Study|Lack of trial drug at site|0|||
13370682|NCT00818623|26715128|FG002|Overall Study|Lack of trial drug at site|0|||
13370683|NCT00818623|26715129|FG003|Overall Study|Lack of trial drug at site|0|||
13370684|NCT00818623|26715130|FG004|Overall Study|Lack of trial drug at site|2|||
13370685|NCT00818623|26715131|FG005|Overall Study|Lack of trial drug at site|0|||
13370686|NCT00818623|26715132|FG006|Overall Study|Lack of trial drug at site|1|||
13370687|NCT00818623|26715133|FG007|Overall Study|Lack of trial drug at site|0|||
13370688|NCT00818623|26715126|FG000|Overall Study|Disease progression|0|||
13370689|NCT00818623|26715127|FG001|Overall Study|Disease progression|0|||
13370690|NCT00818623|26715128|FG002|Overall Study|Disease progression|0|||
13370691|NCT00818623|26715129|FG003|Overall Study|Disease progression|0|||
13370692|NCT00818623|26715130|FG004|Overall Study|Disease progression|0|||
13370693|NCT00818623|26715131|FG005|Overall Study|Disease progression|0|||
13370694|NCT00818623|26715132|FG006|Overall Study|Disease progression|1|||
13370695|NCT00818623|26715133|FG007|Overall Study|Disease progression|0|||
13370696|NCT00818519|26715170|FG000|Overall Study|Adverse Event|2|||
13370697|NCT00818519|26715171|FG001|Overall Study|Adverse Event|2|||
13370698|NCT00818519|26715170|FG000|Overall Study|Lost to Follow-up|4|||
13370699|NCT00818519|26715171|FG001|Overall Study|Lost to Follow-up|6|||
13370700|NCT00818519|26715170|FG000|Overall Study|Protocol Violation|2|||
13370701|NCT00818519|26715171|FG001|Overall Study|Protocol Violation|1|||
13370702|NCT00818519|26715170|FG000|Overall Study|Pregnancy|0|||
13370703|NCT00818519|26715171|FG001|Overall Study|Pregnancy|1|||
13370704|NCT00818519|26715170|FG000|Overall Study|Withdrawal by Subject|4|||
13370705|NCT00818519|26715171|FG001|Overall Study|Withdrawal by Subject|9|||
13370706|NCT00818519|26715170|FG000|Overall Study|participant recovered completely|1|||
13370707|NCT00818519|26715171|FG001|Overall Study|participant recovered completely|0|||
13370708|NCT00818519|26715170|FG000|Overall Study|participant will leave for long tme|1|||
13370709|NCT00818519|26715171|FG001|Overall Study|participant will leave for long tme|0|||
13370710|NCT00818454|26715202|FG000|Treatment Period 1|Adverse Event|0|||
13370711|NCT00818454|26715203|FG001|Treatment Period 1|Adverse Event|1|||
13370712|NCT00818454|26715204|FG002|Treatment Period 1|Adverse Event|0|||
13370713|NCT00818454|26715205|FG003|Treatment Period 1|Adverse Event|0|||
13370714|NCT00818454|26715202|FG000|Treatment Period 1|Other|3|||
13370715|NCT00818454|26715203|FG001|Treatment Period 1|Other|0|||
13370716|NCT00818454|26715204|FG002|Treatment Period 1|Other|0|||
13370717|NCT00818454|26715205|FG003|Treatment Period 1|Other|0|||
13370718|NCT00818454|26715202|FG000|Washout Period of 1 Week|Adverse Event|1|||
13370719|NCT00818454|26715203|FG001|Washout Period of 1 Week|Adverse Event|1|||
13370720|NCT00818454|26715204|FG002|Washout Period of 1 Week|Adverse Event|0|||
13370721|NCT00818454|26715205|FG003|Washout Period of 1 Week|Adverse Event|0|||
13370722|NCT00818454|26715202|FG000|Washout Period of 1 Week|Protocol Violation|2|||
13370723|NCT00818454|26715203|FG001|Washout Period of 1 Week|Protocol Violation|0|||
13370724|NCT00818454|26715204|FG002|Washout Period of 1 Week|Protocol Violation|0|||
13370725|NCT00818454|26715205|FG003|Washout Period of 1 Week|Protocol Violation|0|||
13370726|NCT00818454|26715202|FG000|Washout Period of 1 Week|Other|1|||
13370727|NCT00818454|26715203|FG001|Washout Period of 1 Week|Other|2|||
13370728|NCT00818454|26715204|FG002|Washout Period of 1 Week|Other|0|||
13370729|NCT00818454|26715205|FG003|Washout Period of 1 Week|Other|0|||
13370730|NCT00818454|26715202|FG000|Treatment Period 2|Other|2|||
13370731|NCT00818454|26715203|FG001|Treatment Period 2|Other|1|||
13370732|NCT00818454|26715204|FG002|Treatment Period 2|Other|0|||
13370733|NCT00818454|26715205|FG003|Treatment Period 2|Other|0|||
13370734|NCT00818454|26715202|FG000|Treatment Period 3|Adverse Event|0|||
13370735|NCT00818454|26715203|FG001|Treatment Period 3|Adverse Event|0|||
13370736|NCT00818454|26715204|FG002|Treatment Period 3|Adverse Event|0|||
13370737|NCT00818454|26715205|FG003|Treatment Period 3|Adverse Event|1|||
13370738|NCT00818441|26715232|FG000|Overall Study|Death|69|||
13370739|NCT00818441|26715233|FG001|Overall Study|Death|26|||
13370740|NCT00818441|26715232|FG000|Overall Study|Other|5|||
13370741|NCT00818441|26715233|FG001|Overall Study|Other|0|||
13370742|NCT00818441|26715232|FG000|Overall Study|Lost to Follow-up|2|||
13370743|NCT00818441|26715233|FG001|Overall Study|Lost to Follow-up|1|||
13370744|NCT00818441|26715232|FG000|Overall Study|Withdrawal by Subject|2|||
13370745|NCT00818441|26715233|FG001|Overall Study|Withdrawal by Subject|0|||
13370746|NCT00818441|26715232|FG000|Overall Study|Adverse Event|0|||
13370747|NCT00818441|26715233|FG001|Overall Study|Adverse Event|1|||
13370748|NCT00818441|26715232|FG000|Overall Study|Study terminated by sponsor|11|||
13370749|NCT00818441|26715233|FG001|Overall Study|Study terminated by sponsor|2|||
13370750|NCT00818389|26715250|FG000|Overall Study|Death|1|||
13370751|NCT00818389|26715251|FG001|Overall Study|Death|3|||
13370752|NCT00818389|26715250|FG000|Overall Study|ALS Disease Progression|1|||
13370753|NCT00818389|26715251|FG001|Overall Study|ALS Disease Progression|0|||
13370754|NCT00818389|26715250|FG000|Overall Study|Withdrawal by Subject|2|||
13370755|NCT00818389|26715251|FG001|Overall Study|Withdrawal by Subject|2|||
13370756|NCT00818389|26715250|FG000|Overall Study|Adverse Event|0|||
13370757|NCT00818389|26715251|FG001|Overall Study|Adverse Event|1|||
13370758|NCT00818259|26715347|FG000|Part I|Withdrawal by Subject|1|||
13370759|NCT00818259|26715348|FG001|Part I|Withdrawal by Subject|0|||
13370760|NCT00818259|26715349|FG002|Part I|Withdrawal by Subject|0|||
13370761|NCT00818259|26715350|FG003|Part I|Withdrawal by Subject|0|||
13370762|NCT00818259|26715351|FG004|Part I|Withdrawal by Subject|0|||
13370763|NCT00818259|26715352|FG005|Part I|Withdrawal by Subject|0|||
13370764|NCT00818259|26715353|FG006|Part I|Withdrawal by Subject|0|||
13370765|NCT00818259|26715354|FG007|Part I|Withdrawal by Subject|0|||
13370766|NCT00818259|26715355|FG008|Part I|Withdrawal by Subject|0|||
13370767|NCT00818259|26715347|FG000|Part II|Physician Decision|0|||
13370768|NCT00818259|26715348|FG001|Part II|Physician Decision|0|||
13370769|NCT00818259|26715349|FG002|Part II|Physician Decision|1|||
13370770|NCT00818259|26715350|FG003|Part II|Physician Decision|0|||
13370771|NCT00818259|26715351|FG004|Part II|Physician Decision|0|||
13370772|NCT00818259|26715352|FG005|Part II|Physician Decision|0|||
13370773|NCT00818259|26715353|FG006|Part II|Physician Decision|0|||
13370774|NCT00818259|26715354|FG007|Part II|Physician Decision|0|||
13370775|NCT00818259|26715355|FG008|Part II|Physician Decision|0|||
13370776|NCT00818259|26715347|FG000|Part II|Lack of Efficacy|0|||
13370777|NCT00818259|26715348|FG001|Part II|Lack of Efficacy|0|||
13370778|NCT00818259|26715349|FG002|Part II|Lack of Efficacy|0|||
13370779|NCT00818259|26715350|FG003|Part II|Lack of Efficacy|1|||
13370780|NCT00818259|26715351|FG004|Part II|Lack of Efficacy|0|||
13370781|NCT00818259|26715352|FG005|Part II|Lack of Efficacy|0|||
13370782|NCT00818259|26715353|FG006|Part II|Lack of Efficacy|0|||
13370783|NCT00818259|26715354|FG007|Part II|Lack of Efficacy|0|||
13370784|NCT00818259|26715355|FG008|Part II|Lack of Efficacy|0|||
13370785|NCT00818259|26715347|FG000|Part II|Not Treated|0|||
13370786|NCT00818259|26715348|FG001|Part II|Not Treated|0|||
13370787|NCT00818259|26715349|FG002|Part II|Not Treated|0|||
13370788|NCT00818259|26715350|FG003|Part II|Not Treated|1|||
13370789|NCT00818259|26715351|FG004|Part II|Not Treated|0|||
13370790|NCT00818259|26715352|FG005|Part II|Not Treated|0|||
13370791|NCT00818259|26715353|FG006|Part II|Not Treated|0|||
13370792|NCT00818259|26715354|FG007|Part II|Not Treated|0|||
13370793|NCT00818259|26715355|FG008|Part II|Not Treated|0|||
13370794|NCT00818259|26715347|FG000|Part IV|Physician Decision|0|||
13370795|NCT00818259|26715348|FG001|Part IV|Physician Decision|0|||
13370796|NCT00818259|26715349|FG002|Part IV|Physician Decision|0|||
13370797|NCT00818259|26715350|FG003|Part IV|Physician Decision|0|||
13370798|NCT00818259|26715351|FG004|Part IV|Physician Decision|0|||
13370799|NCT00818259|26715352|FG005|Part IV|Physician Decision|1|||
13370800|NCT00818259|26715353|FG006|Part IV|Physician Decision|0|||
13370801|NCT00818259|26715354|FG007|Part IV|Physician Decision|0|||
13370802|NCT00818259|26715355|FG008|Part IV|Physician Decision|0|||
13370803|NCT00818259|26715347|FG000|Part V|Adverse Event|0|||
13370804|NCT00818259|26715348|FG001|Part V|Adverse Event|0|||
13370805|NCT00818259|26715349|FG002|Part V|Adverse Event|0|||
13370806|NCT00818259|26715350|FG003|Part V|Adverse Event|0|||
13370807|NCT00818259|26715351|FG004|Part V|Adverse Event|0|||
13370808|NCT00818259|26715352|FG005|Part V|Adverse Event|0|||
13370809|NCT00818259|26715353|FG006|Part V|Adverse Event|0|||
13370810|NCT00818259|26715354|FG007|Part V|Adverse Event|1|||
13370811|NCT00818259|26715355|FG008|Part V|Adverse Event|0|||
13370812|NCT00818246|26715364|FG000|Overall Study|Impossible to match pictures|5|||
13370813|NCT00818207|26715385|FG000|Overall Study|Adverse Event|6|||
13370814|NCT00818207|26715386|FG001|Overall Study|Adverse Event|0|||
13370815|NCT00818207|26715385|FG000|Overall Study|Lost to Follow-up|160|||
13370816|NCT00818207|26715386|FG001|Overall Study|Lost to Follow-up|146|||
13370817|NCT00818207|26715385|FG000|Overall Study|Multiple reasons|11|||
13370818|NCT00818207|26715386|FG001|Overall Study|Multiple reasons|12|||
13370819|NCT00818207|26715385|FG000|Overall Study|Withdrawal by Subject|42|||
13370820|NCT00818207|26715386|FG001|Overall Study|Withdrawal by Subject|104|||
13370821|NCT00818207|26715385|FG000|Overall Study|Death|3|||
13370822|NCT00818207|26715386|FG001|Overall Study|Death|5|||
13375331|NCT00790842|26729843|FG004|Dose Level 3|Adverse Event|0|||
13375332|NCT00790842|26729844|FG005|Dose Level 3|Adverse Event|0|||
13375333|NCT00790842|26729845|FG006|Dose Level 3|Adverse Event|0|||
13375334|NCT00790842|26729846|FG007|Dose Level 3|Adverse Event|0|||
13375335|NCT00790842|26729847|FG008|Dose Level 3|Adverse Event|0|||
13375336|NCT00790842|26729848|FG009|Dose Level 3|Adverse Event|0|||
13375337|NCT00790842|26729849|FG010|Dose Level 3|Adverse Event|0|||
13375338|NCT00790842|26729839|FG000|Dose Level 3|Withdrawal by Subject|0|||
13375339|NCT00790842|26729840|FG001|Dose Level 3|Withdrawal by Subject|0|||
13375340|NCT00790842|26729841|FG002|Dose Level 3|Withdrawal by Subject|3|||
13375341|NCT00790842|26729842|FG003|Dose Level 3|Withdrawal by Subject|0|||
13375342|NCT00790842|26729843|FG004|Dose Level 3|Withdrawal by Subject|0|||
13375343|NCT00790842|26729844|FG005|Dose Level 3|Withdrawal by Subject|0|||
13375344|NCT00790842|26729845|FG006|Dose Level 3|Withdrawal by Subject|0|||
13375345|NCT00790842|26729846|FG007|Dose Level 3|Withdrawal by Subject|0|||
13375346|NCT00790842|26729847|FG008|Dose Level 3|Withdrawal by Subject|0|||
13375347|NCT00790842|26729848|FG009|Dose Level 3|Withdrawal by Subject|2|||
13375348|NCT00790842|26729849|FG010|Dose Level 3|Withdrawal by Subject|0|||
13375349|NCT00790842|26729839|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
13375350|NCT00790842|26729840|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
13375351|NCT00790842|26729841|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
13375352|NCT00790842|26729842|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
13370823|NCT00818168|26715396|FG000|Overall Study|Lack of Efficacy|18|||
13370824|NCT00818168|26715396|FG000|Overall Study|Pregnancy|2|||
13370825|NCT00818168|26715396|FG000|Overall Study|Withdrawal by Subject|16|||
13370826|NCT00818168|26715396|FG000|Overall Study|Lost to Follow-up|7|||
13370827|NCT00818168|26715396|FG000|Overall Study|Adverse Event|19|||
13370828|NCT00818168|26715396|FG000|Overall Study|Reason for Non-completion Not reported|6|||
13370829|NCT00818168|26715396|FG000|Overall Study|Participant Moved|2|||
13370830|NCT00817778|26715428|FG000|Overall Study|Adverse Event|1|||
13370831|NCT00817778|26715429|FG001|Overall Study|Adverse Event|0|||
13370832|NCT00817778|26715428|FG000|Overall Study|Withdrawal by Subject|1|||
13370833|NCT00817778|26715429|FG001|Overall Study|Withdrawal by Subject|1|||
13370834|NCT00817778|26715428|FG000|Overall Study|Protocol Violation|0|||
13370835|NCT00817778|26715429|FG001|Overall Study|Protocol Violation|1|||
13370836|NCT00817778|26715428|FG000|Overall Study|Study-specific discontinuation criteria|0|||
13370837|NCT00817778|26715429|FG001|Overall Study|Study-specific discontinuation criteria|1|||
13370838|NCT00817778|26715428|FG000|Overall Study|Poor venous access|1|||
13370839|NCT00817778|26715429|FG001|Overall Study|Poor venous access|0|||
13370840|NCT00817635|26715518|FG000|Overall Study|Adverse Event|1|||
13370841|NCT00817635|26715519|FG001|Overall Study|Adverse Event|0|||
13370842|NCT00817635|26715520|FG002|Overall Study|Adverse Event|0|||
13370843|NCT00817635|26715521|FG003|Overall Study|Adverse Event|1|||
13370844|NCT00817635|26715522|FG004|Overall Study|Adverse Event|1|||
13370845|NCT00817635|26715518|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
13370846|NCT00817635|26715519|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
13370847|NCT00817635|26715520|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
13370848|NCT00817635|26715521|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
13370849|NCT00817635|26715522|FG004|Overall Study|Abnormal Laboratory Value(s)|1|||
13370850|NCT00817635|26715518|FG000|Overall Study|Withdrawal by Subject|2|||
13370851|NCT00817635|26715519|FG001|Overall Study|Withdrawal by Subject|1|||
13370852|NCT00817635|26715520|FG002|Overall Study|Withdrawal by Subject|0|||
13370853|NCT00817635|26715521|FG003|Overall Study|Withdrawal by Subject|1|||
13370854|NCT00817635|26715522|FG004|Overall Study|Withdrawal by Subject|2|||
13370855|NCT00817635|26715518|FG000|Overall Study|Lost to Follow-up|0|||
13370856|NCT00817635|26715519|FG001|Overall Study|Lost to Follow-up|1|||
13370857|NCT00817635|26715520|FG002|Overall Study|Lost to Follow-up|0|||
13370858|NCT00817635|26715521|FG003|Overall Study|Lost to Follow-up|1|||
13370859|NCT00817635|26715522|FG004|Overall Study|Lost to Follow-up|0|||
13370860|NCT00817635|26715518|FG000|Overall Study|Administrative Problems|0|||
13370861|NCT00817635|26715519|FG001|Overall Study|Administrative Problems|0|||
13370862|NCT00817635|26715520|FG002|Overall Study|Administrative Problems|0|||
13370863|NCT00817635|26715521|FG003|Overall Study|Administrative Problems|0|||
13370864|NCT00817635|26715522|FG004|Overall Study|Administrative Problems|1|||
13370865|NCT00817635|26715518|FG000|Overall Study|Protocol Violation|5|||
13370866|NCT00817635|26715519|FG001|Overall Study|Protocol Violation|1|||
13370867|NCT00817635|26715520|FG002|Overall Study|Protocol Violation|3|||
13370868|NCT00817635|26715521|FG003|Overall Study|Protocol Violation|2|||
13370869|NCT00817635|26715522|FG004|Overall Study|Protocol Violation|3|||
13370870|NCT00817531|26715528|FG000|Overall Study|Adverse Event|1|||
13370871|NCT00817531|26715528|FG000|Overall Study|Lack of Efficacy|1|||
13370872|NCT00817479|26715543|FG000|Overall Study|Physician Decision|1|||
13370873|NCT00817479|26715544|FG001|Overall Study|Physician Decision|1|||
13370874|NCT00817414|26715612|FG000|Overall Study|Adverse Event|1|||
13370875|NCT00817414|26715613|FG001|Overall Study|Adverse Event|1|||
13370876|NCT00817414|26715614|FG002|Overall Study|Adverse Event|1|||
13370877|NCT00817414|26715615|FG003|Overall Study|Adverse Event|0|||
13370878|NCT00817414|26715616|FG004|Overall Study|Adverse Event|0|||
13370879|NCT00817414|26715612|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
13370880|NCT00817414|26715613|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1|||
13370881|NCT00817414|26715614|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2|||
13370882|NCT00817414|26715615|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4|||
13370883|NCT00817414|26715616|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
13370884|NCT00817414|26715612|FG000|Overall Study|Withdrawal by Subject|1|||
13370885|NCT00817414|26715613|FG001|Overall Study|Withdrawal by Subject|1|||
13370886|NCT00817414|26715614|FG002|Overall Study|Withdrawal by Subject|0|||
13370887|NCT00817414|26715615|FG003|Overall Study|Withdrawal by Subject|0|||
13370888|NCT00817414|26715616|FG004|Overall Study|Withdrawal by Subject|0|||
13370889|NCT00817414|26715612|FG000|Overall Study|Lost to Follow-up|0|||
13370890|NCT00817414|26715613|FG001|Overall Study|Lost to Follow-up|0|||
13370891|NCT00817414|26715614|FG002|Overall Study|Lost to Follow-up|1|||
13370892|NCT00817414|26715615|FG003|Overall Study|Lost to Follow-up|1|||
13370893|NCT00817414|26715616|FG004|Overall Study|Lost to Follow-up|1|||
13370894|NCT00817414|26715612|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
13370895|NCT00817414|26715613|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
13370896|NCT00817414|26715614|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
13370897|NCT00817414|26715615|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7|||
13370898|NCT00817414|26715616|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
13370899|NCT00817414|26715612|FG000|Overall Study|Protocol Violation|0|||
13370900|NCT00817414|26715613|FG001|Overall Study|Protocol Violation|0|||
13370901|NCT00817414|26715614|FG002|Overall Study|Protocol Violation|0|||
13370902|NCT00817414|26715615|FG003|Overall Study|Protocol Violation|0|||
13370903|NCT00817414|26715616|FG004|Overall Study|Protocol Violation|1|||
13370904|NCT00817336|26715634|FG000|Overall Study|Withdrawal by Subject|1|||
13370905|NCT00817336|26715635|FG001|Overall Study|Withdrawal by Subject|1|||
13370906|NCT00817206|26715648|FG000|Overall Study|Adverse Event|10|||
13370907|NCT00817206|26715649|FG001|Overall Study|Adverse Event|3|||
13370908|NCT00817206|26715648|FG000|Overall Study|Protocol Violation|0|||
13370909|NCT00817206|26715649|FG001|Overall Study|Protocol Violation|2|||
13370910|NCT00817206|26715648|FG000|Overall Study|Lost to Follow-up|0|||
13370911|NCT00817206|26715649|FG001|Overall Study|Lost to Follow-up|1|||
13370912|NCT00817206|26715648|FG000|Overall Study|Death|2|||
13370913|NCT00817206|26715649|FG001|Overall Study|Death|0|||
13370914|NCT00817206|26715648|FG000|Overall Study|Withdrawal by Subject|7|||
13370915|NCT00817206|26715649|FG001|Overall Study|Withdrawal by Subject|3|||
13370916|NCT00817206|26715648|FG000|Overall Study|Physician Decision|2|||
13370917|NCT00817206|26715649|FG001|Overall Study|Physician Decision|0|||
13370918|NCT00817089|26715676|FG000|First Alcohol Challenge|Lost to Follow-up|0|||
13370919|NCT00817089|26715677|FG001|First Alcohol Challenge|Lost to Follow-up|0|||
13370920|NCT00817089|26715678|FG002|First Alcohol Challenge|Lost to Follow-up|0|||
13370921|NCT00817089|26715679|FG003|First Alcohol Challenge|Lost to Follow-up|1|||
13370922|NCT00817089|26715676|FG000|Second Alcohol Challenge|Lost to Follow-up|0|||
13370923|NCT00817089|26715677|FG001|Second Alcohol Challenge|Lost to Follow-up|1|||
13370924|NCT00817089|26715678|FG002|Second Alcohol Challenge|Lost to Follow-up|0|||
13370925|NCT00817089|26715679|FG003|Second Alcohol Challenge|Lost to Follow-up|0|||
13370926|NCT00817063|26715728|FG000|Overall Study|Adverse Event|32|||
13370927|NCT00817063|26715729|FG001|Overall Study|Adverse Event|13|||
13370928|NCT00817063|26715728|FG000|Overall Study|Death|1|||
13370929|NCT00817063|26715729|FG001|Overall Study|Death|1|||
13370930|NCT00817063|26715728|FG000|Overall Study|Lack of Efficacy|33|||
13370931|NCT00817063|26715729|FG001|Overall Study|Lack of Efficacy|86|||
13370932|NCT00817063|26715728|FG000|Overall Study|Failure to Return|13|||
13370933|NCT00817063|26715729|FG001|Overall Study|Failure to Return|12|||
13370934|NCT00817063|26715728|FG000|Overall Study|Violation of Selection at Entry|7|||
13370935|NCT00817063|26715729|FG001|Overall Study|Violation of Selection at Entry|4|||
13370936|NCT00817063|26715728|FG000|Overall Study|Protocol Violation|3|||
13370937|NCT00817063|26715729|FG001|Overall Study|Protocol Violation|8|||
13370938|NCT00817063|26715728|FG000|Overall Study|Withdrawal by Subject|17|||
13370939|NCT00817063|26715729|FG001|Overall Study|Withdrawal by Subject|37|||
13370940|NCT00817063|26715728|FG000|Overall Study|Early Improvement|19|||
13370941|NCT00817063|26715729|FG001|Overall Study|Early Improvement|4|||
13370942|NCT00817063|26715728|FG000|Overall Study|Administrative|10|||
13370943|NCT00817063|26715729|FG001|Overall Study|Administrative|4|||
13370944|NCT00817063|26715728|FG000|Overall Study|Abnormality of Laboratory Test|2|||
13370945|NCT00817063|26715729|FG001|Overall Study|Abnormality of Laboratory Test|1|||
13370946|NCT00816595|26715746|FG000|Overall Study|Withdrawal by Subject|2|||
13370947|NCT00816595|26715747|FG001|Overall Study|Withdrawal by Subject|0|||
13370948|NCT00816556|26715771|FG000|Overall Study|Adverse Event|1|||
13370949|NCT00816556|26715772|FG001|Overall Study|Adverse Event|1|||
13370950|NCT00816556|26715773|FG002|Overall Study|Adverse Event|1|||
13370951|NCT00816556|26715771|FG000|Overall Study|Withdrawal by Subject|1|||
13370952|NCT00816556|26715772|FG001|Overall Study|Withdrawal by Subject|1|||
13370953|NCT00816556|26715773|FG002|Overall Study|Withdrawal by Subject|1|||
13370954|NCT00816556|26715771|FG000|Overall Study|Lost to Follow-up|0|||
13370955|NCT00816556|26715772|FG001|Overall Study|Lost to Follow-up|0|||
13370956|NCT00816556|26715773|FG002|Overall Study|Lost to Follow-up|1|||
13370957|NCT00816400|26715985|FG000|Overall Study|Death|2|||
13370958|NCT00816400|26715986|FG001|Overall Study|Death|3|||
13370959|NCT00816400|26715987|FG002|Overall Study|Death|3|||
13370960|NCT00816400|26715988|FG003|Overall Study|Death|3|||
13370961|NCT00816400|26715989|FG004|Overall Study|Death|2|||
13370962|NCT00816400|26715990|FG005|Overall Study|Death|3|||
13370963|NCT00816400|26715991|FG006|Overall Study|Death|2|||
13370964|NCT00816400|26715992|FG007|Overall Study|Death|5|||
13370965|NCT00816400|26715993|FG008|Overall Study|Death|6|||
13370966|NCT00816400|26715985|FG000|Overall Study|In hospice care at the end of the study|0|||
13370967|NCT00816400|26715986|FG001|Overall Study|In hospice care at the end of the study|0|||
13370968|NCT00816400|26715987|FG002|Overall Study|In hospice care at the end of the study|2|||
13370969|NCT00816400|26715988|FG003|Overall Study|In hospice care at the end of the study|0|||
13370970|NCT00816400|26715989|FG004|Overall Study|In hospice care at the end of the study|0|||
13370971|NCT00816400|26715990|FG005|Overall Study|In hospice care at the end of the study|0|||
13370972|NCT00816400|26715991|FG006|Overall Study|In hospice care at the end of the study|0|||
13370973|NCT00816400|26715992|FG007|Overall Study|In hospice care at the end of the study|0|||
13370974|NCT00816400|26715993|FG008|Overall Study|In hospice care at the end of the study|0|||
13370975|NCT00816361|26716170|FG000|Overall Study|Withdrawal by Subject|0|||
13370976|NCT00816361|26716171|FG001|Overall Study|Withdrawal by Subject|0|||
13370977|NCT00816361|26716172|FG002|Overall Study|Withdrawal by Subject|0|||
13204488|NCT01972789|26229088|FG000|Overall Study|Death|7|||
13204489|NCT01972789|26229089|FG001|Overall Study|Death|5|||
13204490|NCT01972789|26229088|FG000|Overall Study|Protocol deviation|1|||
13204491|NCT01972789|26229089|FG001|Overall Study|Protocol deviation|0|||
13204492|NCT01972789|26229088|FG000|Overall Study|Physician Decision|3|||
13204493|NCT01972789|26229089|FG001|Overall Study|Physician Decision|2|||
13204494|NCT01972776|26229176|FG000|Part 1|Withdrawal by Subject|0|||
13204495|NCT01972776|26229177|FG001|Part 1|Withdrawal by Subject|0|||
13204496|NCT01972776|26229178|FG002|Part 1|Withdrawal by Subject|1|||
13204497|NCT01972776|26229179|FG003|Part 1|Withdrawal by Subject|0|||
13204498|NCT01972776|26229180|FG004|Part 1|Withdrawal by Subject|0|||
13204499|NCT01972776|26229181|FG005|Part 1|Withdrawal by Subject|0|||
13204500|NCT01972776|26229176|FG000|Part 1|Adverse Event|0|||
13204501|NCT01972776|26229177|FG001|Part 1|Adverse Event|0|||
13204502|NCT01972776|26229178|FG002|Part 1|Adverse Event|1|||
13204503|NCT01972776|26229179|FG003|Part 1|Adverse Event|1|||
13204504|NCT01972776|26229180|FG004|Part 1|Adverse Event|0|||
13204505|NCT01972776|26229181|FG005|Part 1|Adverse Event|0|||
13204506|NCT01972776|26229176|FG000|Part 2|Adverse Event|0|||
13204507|NCT01972776|26229177|FG001|Part 2|Adverse Event|0|||
13204508|NCT01972776|26229178|FG002|Part 2|Adverse Event|0|||
13204509|NCT01972776|26229179|FG003|Part 2|Adverse Event|0|||
13370978|NCT00816361|26716173|FG003|Overall Study|Withdrawal by Subject|0|||
13370979|NCT00816361|26716174|FG004|Overall Study|Withdrawal by Subject|1|||
13370980|NCT00816361|26716175|FG005|Overall Study|Withdrawal by Subject|2|||
13370981|NCT00816361|26716176|FG006|Overall Study|Withdrawal by Subject|0|||
13370982|NCT00816361|26716177|FG007|Overall Study|Withdrawal by Subject|2|||
13370983|NCT00816361|26716178|FG008|Overall Study|Withdrawal by Subject|1|||
13370984|NCT00816361|26716170|FG000|Overall Study|Death|4|||
13370985|NCT00816361|26716171|FG001|Overall Study|Death|3|||
13370986|NCT00816361|26716172|FG002|Overall Study|Death|3|||
13370987|NCT00816361|26716173|FG003|Overall Study|Death|3|||
13370988|NCT00816361|26716174|FG004|Overall Study|Death|1|||
13370989|NCT00816361|26716175|FG005|Overall Study|Death|1|||
13370990|NCT00816361|26716176|FG006|Overall Study|Death|3|||
13370991|NCT00816361|26716177|FG007|Overall Study|Death|7|||
13370992|NCT00816361|26716178|FG008|Overall Study|Death|8|||
13370993|NCT00816361|26716170|FG000|Overall Study|Other|0|||
13370994|NCT00816361|26716171|FG001|Overall Study|Other|0|||
13370995|NCT00816361|26716172|FG002|Overall Study|Other|0|||
13370996|NCT00816361|26716173|FG003|Overall Study|Other|0|||
13370997|NCT00816361|26716174|FG004|Overall Study|Other|0|||
13370998|NCT00816361|26716175|FG005|Overall Study|Other|0|||
13370999|NCT00816361|26716176|FG006|Overall Study|Other|0|||
13371000|NCT00816361|26716177|FG007|Overall Study|Other|0|||
13371001|NCT00816361|26716178|FG008|Overall Study|Other|1|||
13371002|NCT00816166|26716191|FG000|Overall Study|Lost to Follow-up|6|||
13371003|NCT00816166|26716192|FG001|Overall Study|Lost to Follow-up|10|||
13371004|NCT00816166|26716191|FG000|Overall Study|Death|4|||
13371005|NCT00816166|26716192|FG001|Overall Study|Death|2|||
13371006|NCT00816036|26716209|FG000|Overall Study|Death|47|||
13371007|NCT00816036|26716210|FG001|Overall Study|Death|28|||
13371008|NCT00816036|26716209|FG000|Overall Study|Lost to Follow-up|75|||
13371009|NCT00816036|26716210|FG001|Overall Study|Lost to Follow-up|57|||
13371010|NCT00816036|26716209|FG000|Overall Study|Withdrawal by Subject|54|||
13371011|NCT00816036|26716210|FG001|Overall Study|Withdrawal by Subject|23|||
13371012|NCT00816023|26716237|FG000|Overall Study|Lost to Follow-up|1|||
13371013|NCT00816023|26716238|FG001|Overall Study|Lost to Follow-up|1|||
13371014|NCT00816023|26716239|FG002|Overall Study|Lost to Follow-up|0|||
13371015|NCT00816023|26716240|FG003|Overall Study|Lost to Follow-up|0|||
13371016|NCT00816023|26716237|FG000|Overall Study|Withdrawal by Subject|1|||
13371017|NCT00816023|26716238|FG001|Overall Study|Withdrawal by Subject|0|||
13371018|NCT00816023|26716239|FG002|Overall Study|Withdrawal by Subject|0|||
13371019|NCT00816023|26716240|FG003|Overall Study|Withdrawal by Subject|0|||
13371020|NCT00816023|26716237|FG000|Overall Study|Physician Decision|0|||
13371021|NCT00816023|26716238|FG001|Overall Study|Physician Decision|0|||
13371022|NCT00816023|26716239|FG002|Overall Study|Physician Decision|1|||
13371023|NCT00816023|26716240|FG003|Overall Study|Physician Decision|0|||
13371024|NCT00816023|26716237|FG000|Overall Study|assessments complete prior to window|1|||
13371025|NCT00816023|26716238|FG001|Overall Study|assessments complete prior to window|1|||
13204510|NCT01972776|26229180|FG004|Part 2|Adverse Event|3|||
13204511|NCT01972776|26229181|FG005|Part 2|Adverse Event|0|||
13204512|NCT01972776|26229176|FG000|Part 2|Administrative problems|0|||
13204513|NCT01972776|26229177|FG001|Part 2|Administrative problems|0|||
13204514|NCT01972776|26229178|FG002|Part 2|Administrative problems|0|||
13204515|NCT01972776|26229179|FG003|Part 2|Administrative problems|0|||
13371026|NCT00816023|26716239|FG002|Overall Study|assessments complete prior to window|2|||
13371027|NCT00816023|26716240|FG003|Overall Study|assessments complete prior to window|1|||
13371028|NCT00816023|26716237|FG000|Overall Study|Randomized Not Treated|6|||
13371029|NCT00816023|26716238|FG001|Overall Study|Randomized Not Treated|4|||
13371030|NCT00816023|26716239|FG002|Overall Study|Randomized Not Treated|6|||
13371031|NCT00816023|26716240|FG003|Overall Study|Randomized Not Treated|11|||
13371032|NCT00815919|26716250|FG000|Overall Study|Unrelated Fungal Infection|1|||
13371033|NCT00815919|26716250|FG000|Overall Study|AML Relapse|1|||
13371034|NCT00815919|26716250|FG000|Overall Study|Lack of Efficacy|2|||
13371035|NCT00815659|26716295|FG000|Overall Study|Adverse Event|9|||
13371036|NCT00815659|26716295|FG000|Overall Study|Withdrawal by Subject|9|||
13371037|NCT00815659|26716295|FG000|Overall Study|Lost to Follow-up|4|||
13371038|NCT00815659|26716295|FG000|Overall Study|Protocol Violation|1|||
13371039|NCT00815633|26716302|FG000|Overall Study|study terminated|1|||
13371040|NCT00815516|26716338|FG000|Overall Study|Death|3|||
13371041|NCT00815516|26716339|FG001|Overall Study|Death|1|||
13371042|NCT00815516|26716338|FG000|Overall Study|Physician Decision|1|||
13371043|NCT00815516|26716339|FG001|Overall Study|Physician Decision|0|||
13371044|NCT00815308|26716347|FG000|Overall Study|Adverse Event|4|||
13371045|NCT00815308|26716347|FG000|Overall Study|Withdrawal by Subject|0|||
13371046|NCT00815308|26716347|FG000|Overall Study|Protocol Violation|6|||
13371047|NCT00815295|26716367|FG000|Overall Study|Cetuximab hypersensitivity reaction|0|||
13371048|NCT00815295|26716368|FG001|Overall Study|Cetuximab hypersensitivity reaction|1|||
13371049|NCT00815295|26716369|FG002|Overall Study|Cetuximab hypersensitivity reaction|3|||
13371050|NCT00815191|26716382|FG000|Overall Study|Protocol Violation|1|||
13371051|NCT00815191|26716383|FG001|Overall Study|Protocol Violation|1|||
13371052|NCT00814983|26716400|FG000|Overall Study|Screen failure|1|||
13371053|NCT00814983|26716401|FG001|Overall Study|Screen failure|0|||
13371054|NCT00814983|26716400|FG000|Overall Study|Withdrawal by Subject|1|||
13371055|NCT00814983|26716401|FG001|Overall Study|Withdrawal by Subject|0|||
13371056|NCT00814983|26716400|FG000|Overall Study|Graft failure|1|||
13371057|NCT00814983|26716401|FG001|Overall Study|Graft failure|0|||
13371058|NCT00814892|26716413|FG000|Overall Study|Disease Progression|1|||
13371059|NCT00814892|26716413|FG000|Overall Study|Study Termination|1|||
13371060|NCT00814879|26716436|FG000|By Week 24|Cancer Diagnosis|1|||
13371061|NCT00814879|26716437|FG001|By Week 24|Cancer Diagnosis|0|||
13371062|NCT00814879|26716436|FG000|By Week 24|Incarceration|0|||
13371063|NCT00814879|26716437|FG001|By Week 24|Incarceration|1|||
13371064|NCT00814879|26716436|FG000|By Week 48|Lost to Follow-up|2|||
13371065|NCT00814879|26716437|FG001|By Week 48|Lost to Follow-up|2|||
13371066|NCT00814879|26716436|FG000|By Week 48|Death|0|||
13371067|NCT00814879|26716437|FG001|By Week 48|Death|1|||
13371068|NCT00814801|26716467|FG000|Overall Study|Adverse Event|15|||
13371069|NCT00814801|26716468|FG001|Overall Study|Adverse Event|16|||
13371070|NCT00814801|26716469|FG002|Overall Study|Adverse Event|19|||
13371071|NCT00814801|26716467|FG000|Overall Study|Withdrawal by Subject|9|||
13371072|NCT00814801|26716468|FG001|Overall Study|Withdrawal by Subject|11|||
13371073|NCT00814801|26716469|FG002|Overall Study|Withdrawal by Subject|14|||
13371074|NCT00814801|26716467|FG000|Overall Study|Inappropriate as a subject|1|||
13371075|NCT00814801|26716468|FG001|Overall Study|Inappropriate as a subject|1|||
13371076|NCT00814801|26716469|FG002|Overall Study|Inappropriate as a subject|1|||
13371077|NCT00814801|26716467|FG000|Overall Study|Change of patients for CIBIC plus-J|1|||
13371078|NCT00814801|26716468|FG001|Overall Study|Change of patients for CIBIC plus-J|1|||
13371079|NCT00814801|26716469|FG002|Overall Study|Change of patients for CIBIC plus-J|0|||
13371080|NCT00814801|26716467|FG000|Overall Study|Missing or change of caregiver|6|||
13371081|NCT00814801|26716468|FG001|Overall Study|Missing or change of caregiver|2|||
13371082|NCT00814801|26716469|FG002|Overall Study|Missing or change of caregiver|4|||
13371083|NCT00814801|26716467|FG000|Overall Study|Non-compliance|0|||
13371084|NCT00814801|26716468|FG001|Overall Study|Non-compliance|1|||
13371085|NCT00814801|26716469|FG002|Overall Study|Non-compliance|1|||
13371086|NCT00814801|26716467|FG000|Overall Study|Other|2|||
13371087|NCT00814801|26716468|FG001|Overall Study|Other|6|||
13371088|NCT00814801|26716469|FG002|Overall Study|Other|4|||
13371089|NCT00814710|26716514|FG000|Overall Study|Adverse Event|1|||
13371090|NCT00814710|26716515|FG001|Overall Study|Adverse Event|0|||
13371091|NCT00814710|26716514|FG000|Overall Study|Lost to Follow-up|7|||
13371092|NCT00814710|26716515|FG001|Overall Study|Lost to Follow-up|3|||
13371093|NCT00814658|26716588|FG000|Overall Study|Lost to Follow-up|0|||
13371094|NCT00814658|26716589|FG001|Overall Study|Lost to Follow-up|1|||
13371095|NCT00814658|26716588|FG000|Overall Study|Physician Decision|1|||
13371096|NCT00814658|26716589|FG001|Overall Study|Physician Decision|0|||
13371097|NCT00814658|26716588|FG000|Overall Study|Adverse Event|3|||
13371098|NCT00814658|26716589|FG001|Overall Study|Adverse Event|3|||
13371099|NCT00814632|26716595|FG000|Overall Study|Lack of Efficacy|2|||
13371100|NCT00814580|26716730|FG000|Overall Study|Adverse Event|6|||
13371101|NCT00814580|26716731|FG001|Overall Study|Adverse Event|15|||
13371102|NCT00814580|26716730|FG000|Overall Study|Lack of Efficacy|18|||
13371103|NCT00814580|26716731|FG001|Overall Study|Lack of Efficacy|25|||
13371104|NCT00814580|26716730|FG000|Overall Study|Protocol Violation|2|||
13371105|NCT00814580|26716731|FG001|Overall Study|Protocol Violation|0|||
13371106|NCT00814580|26716730|FG000|Overall Study|Withdrawal by Subject|2|||
13371107|NCT00814580|26716731|FG001|Overall Study|Withdrawal by Subject|2|||
13371108|NCT00814580|26716730|FG000|Overall Study|Other|1|||
13371109|NCT00814580|26716731|FG001|Overall Study|Other|3|||
13371110|NCT00814580|26716730|FG000|Overall Study|Did Not Take Drug|2|||
13371111|NCT00814580|26716731|FG001|Overall Study|Did Not Take Drug|2|||
13371112|NCT00814502|26716748|FG000|Overall Study|Adverse Event|1|||
13371113|NCT00814502|26716749|FG001|Overall Study|Adverse Event|0|||
13371114|NCT00814502|26716748|FG000|Overall Study|Withdrawal by Subject|0|||
13371115|NCT00814502|26716749|FG001|Overall Study|Withdrawal by Subject|2|||
13371116|NCT00814489|26716791|FG000|Overall Study|Other|2|||
13371117|NCT00814489|26716792|FG001|Overall Study|Other|0|||
13371118|NCT00814489|26716793|FG002|Overall Study|Other|1|||
13371119|NCT00814463|26716806|FG000|Overall Study|Lost to Follow-up|1|||
13371120|NCT00814346|26716877|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0|||
13371121|NCT00814346|26716878|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1|||
13371122|NCT00814346|26716877|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0|||
13371123|NCT00814346|26716878|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2|||
13371124|NCT00814346|26716877|FG000|Open Phase (17 Months)|Adverse Event|5|||
13371125|NCT00814346|26716878|FG001|Open Phase (17 Months)|Adverse Event|0|||
13371126|NCT00814346|26716877|FG000|Open Phase (17 Months)|Consent|2|||
13371127|NCT00814346|26716878|FG001|Open Phase (17 Months)|Consent|0|||
13371128|NCT00814346|26716877|FG000|Open Phase (17 Months)|Lost to Follow-up|2|||
13371129|NCT00814346|26716878|FG001|Open Phase (17 Months)|Lost to Follow-up|0|||
13371130|NCT00814346|26716877|FG000|Open Phase (17 Months)|Not otherwise specified|1|||
13371131|NCT00814346|26716878|FG001|Open Phase (17 Months)|Not otherwise specified|0|||
13371132|NCT00814333|26716891|FG000|Enrollment|Lost to Follow-up|1|||
13371133|NCT00814333|26716892|FG001|Enrollment|Lost to Follow-up|0|||
13371134|NCT00814320|26717027|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1|||
13371135|NCT00814320|26717028|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0|||
13371136|NCT00814320|26717027|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0|||
13371137|NCT00814320|26717028|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2|||
13371138|NCT00814320|26717027|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0|||
13371139|NCT00814320|26717028|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1|||
13371140|NCT00814320|26717027|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1|||
13371141|NCT00814320|26717028|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0|||
13371142|NCT00814320|26717027|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1|||
13371143|NCT00814320|26717028|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0|||
13371144|NCT00814320|26717027|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1|||
13371145|NCT00814320|26717028|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4|||
13371146|NCT00814320|26717027|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2|||
13371147|NCT00814320|26717028|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1|||
13371148|NCT00814320|26717027|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0|||
13371149|NCT00814320|26717028|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1|||
13371150|NCT00814320|26717027|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0|||
13371151|NCT00814320|26717028|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1|||
13371152|NCT00814320|26717027|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0|||
13371153|NCT00814320|26717028|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3|||
13371154|NCT00814307|26717203|FG000|Overall Study|Randomized but not treated|1|||
13371155|NCT00814307|26717204|FG001|Overall Study|Randomized but not treated|0|||
13371156|NCT00814307|26717205|FG002|Overall Study|Randomized but not treated|0|||
13371157|NCT00814307|26717206|FG003|Overall Study|Randomized but not treated|0|||
13371158|NCT00814307|26717203|FG000|Overall Study|Adverse Event|3|||
13371159|NCT00814307|26717204|FG001|Overall Study|Adverse Event|9|||
13371160|NCT00814307|26717205|FG002|Overall Study|Adverse Event|3|||
13371161|NCT00814307|26717206|FG003|Overall Study|Adverse Event|2|||
13371162|NCT00814307|26717203|FG000|Overall Study|Lack of Efficacy|1|||
13371163|NCT00814307|26717204|FG001|Overall Study|Lack of Efficacy|1|||
13371164|NCT00814307|26717205|FG002|Overall Study|Lack of Efficacy|3|||
13371165|NCT00814307|26717206|FG003|Overall Study|Lack of Efficacy|4|||
13371166|NCT00814307|26717203|FG000|Overall Study|Other|1|||
13371167|NCT00814307|26717204|FG001|Overall Study|Other|2|||
13371168|NCT00814307|26717205|FG002|Overall Study|Other|0|||
13371169|NCT00814307|26717206|FG003|Overall Study|Other|1|||
13371170|NCT00814307|26717203|FG000|Overall Study|Protocol Violation|2|||
13371171|NCT00814307|26717204|FG001|Overall Study|Protocol Violation|8|||
13371172|NCT00814307|26717205|FG002|Overall Study|Protocol Violation|1|||
13371173|NCT00814307|26717206|FG003|Overall Study|Protocol Violation|1|||
13371174|NCT00814307|26717203|FG000|Overall Study|Withdrawal by Subject|4|||
13371175|NCT00814307|26717204|FG001|Overall Study|Withdrawal by Subject|6|||
13371176|NCT00814307|26717205|FG002|Overall Study|Withdrawal by Subject|0|||
13371177|NCT00814307|26717206|FG003|Overall Study|Withdrawal by Subject|2|||
13371178|NCT00814307|26717203|FG000|Overall Study|Death|0|||
13371179|NCT00814307|26717204|FG001|Overall Study|Death|1|||
13371180|NCT00814307|26717205|FG002|Overall Study|Death|0|||
13371181|NCT00814307|26717206|FG003|Overall Study|Death|0|||
13371182|NCT00814164|26717219|FG000|Overall Study|Progression|7|||
13371183|NCT00814164|26717219|FG000|Overall Study|not stated|7|||
13371184|NCT00814164|26717219|FG000|Overall Study|Death|5|||
13371185|NCT00813995|26717240|FG000|Overall Study|Clinical adverse event|9|||
13371186|NCT00813995|26717241|FG001|Overall Study|Clinical adverse event|3|||
13371187|NCT00813995|26717240|FG000|Overall Study|Laboratory adverse event|0|||
13371188|NCT00813995|26717241|FG001|Overall Study|Laboratory adverse event|2|||
13371189|NCT00813995|26717240|FG000|Overall Study|Lack of Efficacy|1|||
13371190|NCT00813995|26717241|FG001|Overall Study|Lack of Efficacy|0|||
13371191|NCT00813995|26717240|FG000|Overall Study|Lost to Follow-up|4|||
13371192|NCT00813995|26717241|FG001|Overall Study|Lost to Follow-up|2|||
13371193|NCT00813995|26717240|FG000|Overall Study|Other reason|2|||
13371194|NCT00813995|26717241|FG001|Overall Study|Other reason|2|||
13371195|NCT00813995|26717240|FG000|Overall Study|Protocol Violation|3|||
13371196|NCT00813995|26717241|FG001|Overall Study|Protocol Violation|2|||
13371197|NCT00813995|26717240|FG000|Overall Study|Subject moved|4|||
13371198|NCT00813995|26717241|FG001|Overall Study|Subject moved|0|||
13371199|NCT00813995|26717240|FG000|Overall Study|Withdrawal by Subject|0|||
13371200|NCT00813995|26717241|FG001|Overall Study|Withdrawal by Subject|5|||
13371201|NCT00813943|26717279|FG000|Overall Study|Ongoing at cut-off date|5|||
13371202|NCT00813943|26717280|FG001|Overall Study|Ongoing at cut-off date|5|||
13371203|NCT00813943|26717281|FG002|Overall Study|Ongoing at cut-off date|3|||
13371204|NCT00813917|26717294|FG000|Overall Study|Adverse Event|0|||
13371205|NCT00813917|26717295|FG001|Overall Study|Adverse Event|1|||
13371206|NCT00813917|26717294|FG000|Overall Study|Withdrawal by Subject|3|||
13371207|NCT00813917|26717295|FG001|Overall Study|Withdrawal by Subject|4|||
13371208|NCT00813917|26717294|FG000|Overall Study|Lost to Follow-up|3|||
13371209|NCT00813917|26717295|FG001|Overall Study|Lost to Follow-up|1|||
13371210|NCT00813904|26717303|FG000|Overall Study|Death|1|||
13371211|NCT00813865|26717311|FG000|Overall Study|Failure to Respond|3|||
13371212|NCT00813865|26717311|FG000|Overall Study|Lost to Follow-up|3|||
13371213|NCT00813865|26717311|FG000|Overall Study|Withdrawal by Subject|1|||
13371214|NCT00813813|26717334|FG000|Overall Study|Withdrawal by Subject|1|||
13371215|NCT00813813|26717335|FG001|Overall Study|Withdrawal by Subject|1|||
13371216|NCT00813813|26717334|FG000|Overall Study|Lost to Follow-up|2|||
13371217|NCT00813813|26717335|FG001|Overall Study|Lost to Follow-up|7|||
13371218|NCT00813813|26717334|FG000|Overall Study|Other|0|||
13371219|NCT00813813|26717335|FG001|Overall Study|Other|1|||
13371220|NCT00813800|26717343|FG000|Overall Study|Screen Failure after Consent|2|||
13371221|NCT00813800|26717343|FG000|Overall Study|Adverse Event|1|||
13371222|NCT00813800|26717343|FG000|Overall Study|Worsening of depression|2|||
13371223|NCT00813800|26717343|FG000|Overall Study|Physician Decision|1|||
13371224|NCT00813761|26717400|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2|||
13371225|NCT00813761|26717401|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
13371226|NCT00813761|26717402|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
13371227|NCT00813761|26717403|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
13371228|NCT00813761|26717400|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
13371229|NCT00813761|26717401|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
13371230|NCT00813761|26717402|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3|||
13371231|NCT00813761|26717403|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1|||
13371232|NCT00813761|26717400|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
13371233|NCT00813761|26717401|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
13371234|NCT00813761|26717402|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
13371235|NCT00813761|26717403|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0|||
13371236|NCT00813761|26717400|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
13371237|NCT00813761|26717401|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
13371238|NCT00813761|26717402|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3|||
13371239|NCT00813761|26717403|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
13371240|NCT00813761|26717400|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
13371241|NCT00813761|26717401|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
13371242|NCT00813761|26717402|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5|||
13371243|NCT00813761|26717403|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
13371244|NCT00813761|26717400|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
13371245|NCT00813761|26717401|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1|||
13371246|NCT00813761|26717402|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
13371247|NCT00813761|26717403|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
13371248|NCT00813761|26717400|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2|||
13371249|NCT00813761|26717401|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3|||
13371250|NCT00813761|26717402|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
13371251|NCT00813761|26717403|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
13371252|NCT00813761|26717400|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3|||
13371253|NCT00813761|26717401|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0|||
13371254|NCT00813761|26717402|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2|||
13371255|NCT00813761|26717403|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1|||
13371256|NCT00813761|26717400|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
13371257|NCT00813761|26717401|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
13371258|NCT00813761|26717402|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
13371259|NCT00813761|26717403|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
13371260|NCT00813761|26717400|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
13371261|NCT00813761|26717401|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
13371262|NCT00813761|26717402|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
13371263|NCT00813761|26717403|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0|||
13371264|NCT00813761|26717400|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1|||
13371265|NCT00813761|26717401|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4|||
13371266|NCT00813761|26717402|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0|||
13371267|NCT00813761|26717403|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3|||
13371268|NCT00813761|26717400|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9|||
13371269|NCT00813761|26717401|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
13371270|NCT00813761|26717402|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6|||
13371271|NCT00813761|26717403|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
13371272|NCT00813748|26717436|FG000|Skin Test Substudy|Physician Decision|0|||
13371273|NCT00813748|26717437|FG001|Skin Test Substudy|Physician Decision|1|||
13371274|NCT00813709|26717530|FG000|Double Blind Period|Adverse Event|4|||
13371275|NCT00813709|26717531|FG001|Double Blind Period|Adverse Event|1|||
13371276|NCT00813709|26717532|FG002|Double Blind Period|Adverse Event|4|||
13371277|NCT00813709|26717533|FG003|Double Blind Period|Adverse Event|0|||
13371278|NCT00813709|26717534|FG004|Double Blind Period|Adverse Event|0|||
13371279|NCT00813709|26717535|FG005|Double Blind Period|Adverse Event|0|||
13371280|NCT00813709|26717530|FG000|Double Blind Period|Lost to Follow-up|3|||
13371281|NCT00813709|26717531|FG001|Double Blind Period|Lost to Follow-up|2|||
13371282|NCT00813709|26717532|FG002|Double Blind Period|Lost to Follow-up|2|||
13371283|NCT00813709|26717533|FG003|Double Blind Period|Lost to Follow-up|0|||
13371284|NCT00813709|26717534|FG004|Double Blind Period|Lost to Follow-up|0|||
13371285|NCT00813709|26717535|FG005|Double Blind Period|Lost to Follow-up|0|||
13371286|NCT00813709|26717530|FG000|Double Blind Period|Switched to open label phase|9|||
13371287|NCT00813709|26717531|FG001|Double Blind Period|Switched to open label phase|26|||
13371288|NCT00813709|26717532|FG002|Double Blind Period|Switched to open label phase|18|||
13371289|NCT00813709|26717533|FG003|Double Blind Period|Switched to open label phase|0|||
13371290|NCT00813709|26717534|FG004|Double Blind Period|Switched to open label phase|0|||
13371291|NCT00813709|26717535|FG005|Double Blind Period|Switched to open label phase|0|||
13371292|NCT00813709|26717530|FG000|Double Blind Period|Randomized but not treated|1|||
13371293|NCT00813709|26717531|FG001|Double Blind Period|Randomized but not treated|3|||
13371294|NCT00813709|26717532|FG002|Double Blind Period|Randomized but not treated|1|||
13371295|NCT00813709|26717533|FG003|Double Blind Period|Randomized but not treated|0|||
13371296|NCT00813709|26717534|FG004|Double Blind Period|Randomized but not treated|0|||
13371297|NCT00813709|26717535|FG005|Double Blind Period|Randomized but not treated|0|||
13371298|NCT00813709|26717530|FG000|Double Blind Period|Other|14|||
13371299|NCT00813709|26717531|FG001|Double Blind Period|Other|9|||
13371300|NCT00813709|26717532|FG002|Double Blind Period|Other|6|||
13371301|NCT00813709|26717533|FG003|Double Blind Period|Other|0|||
13371302|NCT00813709|26717534|FG004|Double Blind Period|Other|0|||
13371303|NCT00813709|26717535|FG005|Double Blind Period|Other|0|||
13371304|NCT00813709|26717530|FG000|Open Label Period|Adverse Event|0|||
13371305|NCT00813709|26717531|FG001|Open Label Period|Adverse Event|0|||
13371306|NCT00813709|26717532|FG002|Open Label Period|Adverse Event|0|||
13371307|NCT00813709|26717533|FG003|Open Label Period|Adverse Event|5|||
13371308|NCT00813709|26717534|FG004|Open Label Period|Adverse Event|4|||
13371309|NCT00813709|26717535|FG005|Open Label Period|Adverse Event|3|||
13371310|NCT00813709|26717530|FG000|Open Label Period|Lack of Efficacy|0|||
13371311|NCT00813709|26717531|FG001|Open Label Period|Lack of Efficacy|0|||
13371312|NCT00813709|26717532|FG002|Open Label Period|Lack of Efficacy|0|||
13371313|NCT00813709|26717533|FG003|Open Label Period|Lack of Efficacy|3|||
13371314|NCT00813709|26717534|FG004|Open Label Period|Lack of Efficacy|1|||
13371315|NCT00813709|26717535|FG005|Open Label Period|Lack of Efficacy|1|||
13371316|NCT00813709|26717530|FG000|Open Label Period|Randomized but not treated|0|||
13371317|NCT00813709|26717531|FG001|Open Label Period|Randomized but not treated|0|||
13371318|NCT00813709|26717532|FG002|Open Label Period|Randomized but not treated|0|||
13371319|NCT00813709|26717533|FG003|Open Label Period|Randomized but not treated|1|||
13371320|NCT00813709|26717534|FG004|Open Label Period|Randomized but not treated|0|||
13371321|NCT00813709|26717535|FG005|Open Label Period|Randomized but not treated|1|||
13371322|NCT00813709|26717530|FG000|Open Label Period|Other|0|||
13371323|NCT00813709|26717531|FG001|Open Label Period|Other|0|||
13371324|NCT00813709|26717532|FG002|Open Label Period|Other|0|||
13371325|NCT00813709|26717533|FG003|Open Label Period|Other|11|||
13371326|NCT00813709|26717534|FG004|Open Label Period|Other|5|||
13371327|NCT00813709|26717535|FG005|Open Label Period|Other|6|||
13371328|NCT00813592|26717546|FG000|Overall Study|Disease assessment was not completed per|2|||
13371329|NCT00813488|26717645|FG000|Titration Period 1|Adverse Event|6|||
13371330|NCT00813488|26717646|FG001|Titration Period 1|Adverse Event|1|||
13371331|NCT00813488|26717645|FG000|Titration Period 1|Lack of Efficacy|9|||
13371332|NCT00813488|26717646|FG001|Titration Period 1|Lack of Efficacy|7|||
13371333|NCT00813488|26717645|FG000|Titration Period 1|Withdrawal by Subject|2|||
13371334|NCT00813488|26717646|FG001|Titration Period 1|Withdrawal by Subject|2|||
13371335|NCT00813488|26717645|FG000|Titration Period 1|Protocol Violation|4|||
13371336|NCT00813488|26717646|FG001|Titration Period 1|Protocol Violation|3|||
13371337|NCT00813488|26717645|FG000|Titration Period 1|Non-compliance to study medication|4|||
13371338|NCT00813488|26717646|FG001|Titration Period 1|Non-compliance to study medication|1|||
13371339|NCT00813488|26717645|FG000|Titration Period 1|Non-compliance to study procedures|2|||
13371340|NCT00813488|26717646|FG001|Titration Period 1|Non-compliance to study procedures|2|||
13371341|NCT00813488|26717645|FG000|Titration Period 1|Technical Difficulties|0|||
13371342|NCT00813488|26717646|FG001|Titration Period 1|Technical Difficulties|1|||
13371343|NCT00813488|26717645|FG000|Titration Period 2|Adverse Event|2|||
13371344|NCT00813488|26717646|FG001|Titration Period 2|Adverse Event|3|||
13371345|NCT00813488|26717645|FG000|Titration Period 2|Lack of Efficacy|8|||
13371346|NCT00813488|26717646|FG001|Titration Period 2|Lack of Efficacy|4|||
13371347|NCT00813488|26717645|FG000|Titration Period 2|Protocol Violation|3|||
13371348|NCT00813488|26717646|FG001|Titration Period 2|Protocol Violation|2|||
13371349|NCT00813488|26717645|FG000|Titration Period 2|Lost to Follow-up|1|||
13371350|NCT00813488|26717646|FG001|Titration Period 2|Lost to Follow-up|0|||
13371351|NCT00813488|26717645|FG000|Titration Period 2|Non-compliance with study procedures|2|||
13371352|NCT00813488|26717646|FG001|Titration Period 2|Non-compliance with study procedures|1|||
13371353|NCT00813488|26717645|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
13371354|NCT00813488|26717646|FG001|Double-blind Treatment Period 1|Adverse Event|1|||
13371355|NCT00813488|26717645|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0|||
13371356|NCT00813488|26717646|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1|||
13371357|NCT00813488|26717645|FG000|Double-blind Treatment Period 1|Protocol Violation|0|||
13371358|NCT00813488|26717646|FG001|Double-blind Treatment Period 1|Protocol Violation|2|||
13371359|NCT00813488|26717645|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0|||
13371360|NCT00813488|26717646|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1|||
13371361|NCT00813488|26717645|FG000|Double-blind Treatment Period 2|Adverse Event|1|||
13371362|NCT00813488|26717646|FG001|Double-blind Treatment Period 2|Adverse Event|0|||
13371363|NCT00813488|26717645|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
13371364|NCT00813488|26717646|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
13371365|NCT00813488|26717645|FG000|Double-blind Treatment Period 2|Protocol Violation|2|||
13371366|NCT00813488|26717646|FG001|Double-blind Treatment Period 2|Protocol Violation|0|||
13371367|NCT00813488|26717645|FG000|Double-blind Treatment Period 2|Other|1|||
13371368|NCT00813488|26717646|FG001|Double-blind Treatment Period 2|Other|0|||
13371369|NCT00813488|26717645|FG000|Open-label Extension|Adverse Event|1|||
13371370|NCT00813488|26717646|FG001|Open-label Extension|Adverse Event|2|||
13371371|NCT00813488|26717645|FG000|Open-label Extension|Lack of Efficacy|3|||
13371372|NCT00813488|26717646|FG001|Open-label Extension|Lack of Efficacy|0|||
13371373|NCT00813488|26717645|FG000|Open-label Extension|Withdrawal by Subject|0|||
13371374|NCT00813488|26717646|FG001|Open-label Extension|Withdrawal by Subject|2|||
13371375|NCT00813488|26717645|FG000|Open-label Extension|Protocol Violation|1|||
13371376|NCT00813488|26717646|FG001|Open-label Extension|Protocol Violation|2|||
13371377|NCT00813488|26717645|FG000|Open-label Extension|Non-compliance study medication|4|||
13371378|NCT00813488|26717646|FG001|Open-label Extension|Non-compliance study medication|0|||
13371379|NCT00813488|26717645|FG000|Open-label Extension|Non-compliance study procedures|2|||
13371380|NCT00813488|26717646|FG001|Open-label Extension|Non-compliance study procedures|1|||
13371381|NCT00813488|26717645|FG000|Open-label Extension|Other|1|||
13371382|NCT00813488|26717646|FG001|Open-label Extension|Other|0|||
13371383|NCT00813358|26717652|FG000|Overall Study|Death|32|||
13371384|NCT00813358|26717652|FG000|Overall Study|Lost to Follow-up|12|||
13371385|NCT00813358|26717652|FG000|Overall Study|other endpoints|5|||
13371386|NCT00813358|26717652|FG000|Overall Study|Withdrawal by Subject|20|||
13371387|NCT00813293|26717677|FG000|Overall Study|Intercurrent illness|1|||
13371388|NCT00813293|26717678|FG001|Overall Study|Intercurrent illness|0|||
13371389|NCT00813293|26717677|FG000|Overall Study|Adverse Event|0|||
13371390|NCT00813293|26717678|FG001|Overall Study|Adverse Event|1|||
13371391|NCT00813150|26717697|FG000|Treatment Period|Adverse Event|16|||
13371392|NCT00813150|26717698|FG001|Treatment Period|Adverse Event|15|||
13371393|NCT00813150|26717697|FG000|Treatment Period|Death|2|||
13371394|NCT00813150|26717698|FG001|Treatment Period|Death|0|||
13371395|NCT00813150|26717697|FG000|Treatment Period|Progressive disease|1|||
13371396|NCT00813150|26717698|FG001|Treatment Period|Progressive disease|0|||
13371397|NCT00813150|26717697|FG000|Treatment Period|Complete response|0|||
13371398|NCT00813150|26717698|FG001|Treatment Period|Complete response|1|||
13371399|NCT00813150|26717697|FG000|Treatment Period|Stable disease|1|||
13371400|NCT00813150|26717698|FG001|Treatment Period|Stable disease|2|||
13371401|NCT00813150|26717697|FG000|Treatment Period|Protocol Violation|3|||
13371402|NCT00813150|26717698|FG001|Treatment Period|Protocol Violation|4|||
13371403|NCT00813150|26717697|FG000|Treatment Period|Withdrawal by Subject|5|||
13371404|NCT00813150|26717698|FG001|Treatment Period|Withdrawal by Subject|3|||
13371405|NCT00813150|26717697|FG000|Treatment Period|Non compliance|0|||
13371406|NCT00813150|26717698|FG001|Treatment Period|Non compliance|1|||
13371407|NCT00813150|26717697|FG000|Treatment Period|Reason not specified|3|||
13371408|NCT00813150|26717698|FG001|Treatment Period|Reason not specified|4|||
13371409|NCT00813150|26717697|FG000|Treatment Period|Data not available|1|||
13371410|NCT00813150|26717698|FG001|Treatment Period|Data not available|2|||
13371411|NCT00813150|26717697|FG000|Long Term Follow-up|Death|0|||
13371412|NCT00813150|26717698|FG001|Long Term Follow-up|Death|4|||
13371413|NCT00813150|26717697|FG000|Long Term Follow-up|Other|0|||
13371414|NCT00813150|26717698|FG001|Long Term Follow-up|Other|3|||
13371415|NCT00813150|26717697|FG000|Long Term Follow-up|Lost to Follow-up|2|||
13371416|NCT00813150|26717698|FG001|Long Term Follow-up|Lost to Follow-up|0|||
13371417|NCT00813150|26717697|FG000|Long Term Follow-up|Progression/Relapse|22|||
13371418|NCT00813150|26717698|FG001|Long Term Follow-up|Progression/Relapse|24|||
13371419|NCT00813124|26717704|FG000|Overall Study|Death|2|||
13371420|NCT00813124|26717704|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9|||
13371421|NCT00813124|26717704|FG000|Overall Study|Withdrawal by Subject|1|||
13371422|NCT00813098|26717737|FG000|Overall Study|Adverse Event|2|||
13371423|NCT00813098|26717738|FG001|Overall Study|Adverse Event|4|||
13371424|NCT00813098|26717739|FG002|Overall Study|Adverse Event|1|||
13371425|NCT00813098|26717737|FG000|Overall Study|Withdrawal by Subject|0|||
13371426|NCT00813098|26717738|FG001|Overall Study|Withdrawal by Subject|1|||
13371427|NCT00813098|26717739|FG002|Overall Study|Withdrawal by Subject|0|||
13371428|NCT00813098|26717737|FG000|Overall Study|Inability to complete study procedures|1|||
13371429|NCT00813098|26717738|FG001|Overall Study|Inability to complete study procedures|0|||
13371430|NCT00813098|26717739|FG002|Overall Study|Inability to complete study procedures|0|||
13371431|NCT00813098|26717737|FG000|Overall Study|Lost to Follow-up|0|||
13371432|NCT00813098|26717738|FG001|Overall Study|Lost to Follow-up|1|||
13371433|NCT00813098|26717739|FG002|Overall Study|Lost to Follow-up|0|||
13371434|NCT00813098|26717737|FG000|Overall Study|Protocol Violation|0|||
13371435|NCT00813098|26717738|FG001|Overall Study|Protocol Violation|0|||
13371436|NCT00813098|26717739|FG002|Overall Study|Protocol Violation|1|||
13371437|NCT00813098|26717737|FG000|Overall Study|Principal Investigator decision|0|||
13371438|NCT00813098|26717738|FG001|Overall Study|Principal Investigator decision|1|||
13371439|NCT00813098|26717739|FG002|Overall Study|Principal Investigator decision|0|||
13371440|NCT00813098|26717737|FG000|Overall Study|Withdrew Consent|0|||
13371441|NCT00813098|26717738|FG001|Overall Study|Withdrew Consent|1|||
13371442|NCT00813098|26717739|FG002|Overall Study|Withdrew Consent|0|||
13371443|NCT00812981|26717784|FG000|Overall Study|Other|0|||
13371444|NCT00812981|26717785|FG001|Overall Study|Other|1|||
13371445|NCT00812968|26717818|FG000|Overall Study|Relapse after erythroid response|6|||
13371446|NCT00812968|26717818|FG000|Overall Study|Disease progression|1|||
13371447|NCT00812968|26717818|FG000|Overall Study|No further treatment required|1|||
13371448|NCT00812968|26717818|FG000|Overall Study|Study closed due to marketing approval|3|||
13371449|NCT00812955|26717851|FG000|Overall Study|Adverse Event|7|||
13371450|NCT00812955|26717852|FG001|Overall Study|Adverse Event|6|||
13371451|NCT00812955|26717853|FG002|Overall Study|Adverse Event|3|||
13371452|NCT00812955|26717854|FG003|Overall Study|Adverse Event|4|||
13371453|NCT00812955|26717851|FG000|Overall Study|Lost to Follow-up|2|||
13371454|NCT00812955|26717852|FG001|Overall Study|Lost to Follow-up|1|||
13371455|NCT00812955|26717853|FG002|Overall Study|Lost to Follow-up|1|||
13371456|NCT00812955|26717854|FG003|Overall Study|Lost to Follow-up|2|||
13371457|NCT00812955|26717851|FG000|Overall Study|Withdrawal by Subject|1|||
13371458|NCT00812955|26717852|FG001|Overall Study|Withdrawal by Subject|0|||
13371459|NCT00812955|26717853|FG002|Overall Study|Withdrawal by Subject|1|||
13371460|NCT00812955|26717854|FG003|Overall Study|Withdrawal by Subject|2|||
13371461|NCT00812955|26717851|FG000|Overall Study|randomized in error|0|||
13371462|NCT00812955|26717852|FG001|Overall Study|randomized in error|0|||
13371463|NCT00812955|26717853|FG002|Overall Study|randomized in error|1|||
13371464|NCT00812955|26717854|FG003|Overall Study|randomized in error|0|||
13371465|NCT00812929|26717981|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
13371466|NCT00812929|26717982|FG001|Washout Period 1 (7 Days)|Physician Decision|0|||
13371467|NCT00812929|26717983|FG002|Washout Period 1 (7 Days)|Physician Decision|1|||
13371468|NCT00812929|26717984|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
13371469|NCT00812929|26717985|FG004|Washout Period 1 (7 Days)|Physician Decision|0|||
13371470|NCT00812929|26717986|FG005|Washout Period 1 (7 Days)|Physician Decision|0|||
13371471|NCT00812929|26717987|FG006|Washout Period 1 (7 Days)|Physician Decision|0|||
13371472|NCT00812929|26717988|FG007|Washout Period 1 (7 Days)|Physician Decision|0|||
13371473|NCT00812929|26717989|FG008|Washout Period 1 (7 Days)|Physician Decision|0|||
13371474|NCT00812929|26717990|FG009|Washout Period 1 (7 Days)|Physician Decision|0|||
13371475|NCT00812929|26717981|FG000|Washout Period 2 (7 Days)|Physician Decision|0|||
13371476|NCT00812929|26717982|FG001|Washout Period 2 (7 Days)|Physician Decision|0|||
13371477|NCT00812929|26717983|FG002|Washout Period 2 (7 Days)|Physician Decision|0|||
13371478|NCT00812929|26717984|FG003|Washout Period 2 (7 Days)|Physician Decision|0|||
13371479|NCT00812929|26717985|FG004|Washout Period 2 (7 Days)|Physician Decision|0|||
13371480|NCT00812929|26717986|FG005|Washout Period 2 (7 Days)|Physician Decision|0|||
13371481|NCT00812929|26717987|FG006|Washout Period 2 (7 Days)|Physician Decision|0|||
13371482|NCT00812929|26717988|FG007|Washout Period 2 (7 Days)|Physician Decision|0|||
13488143|NCT04409262|27042893|FG001|Overall Study|Protocol Violation|1|||
13371483|NCT00812929|26717989|FG008|Washout Period 2 (7 Days)|Physician Decision|0|||
13371484|NCT00812929|26717990|FG009|Washout Period 2 (7 Days)|Physician Decision|1|||
13371485|NCT00812929|26717981|FG000|Washout Period 3 (7 Days)|Adverse Event|0|||
13371486|NCT00812929|26717982|FG001|Washout Period 3 (7 Days)|Adverse Event|0|||
13371487|NCT00812929|26717983|FG002|Washout Period 3 (7 Days)|Adverse Event|0|||
13371488|NCT00812929|26717984|FG003|Washout Period 3 (7 Days)|Adverse Event|0|||
13371489|NCT00812929|26717985|FG004|Washout Period 3 (7 Days)|Adverse Event|0|||
13371490|NCT00812929|26717986|FG005|Washout Period 3 (7 Days)|Adverse Event|1|||
13371491|NCT00812929|26717987|FG006|Washout Period 3 (7 Days)|Adverse Event|0|||
13371492|NCT00812929|26717988|FG007|Washout Period 3 (7 Days)|Adverse Event|0|||
13371493|NCT00812929|26717989|FG008|Washout Period 3 (7 Days)|Adverse Event|0|||
13371494|NCT00812929|26717990|FG009|Washout Period 3 (7 Days)|Adverse Event|0|||
13371495|NCT00812812|26718010|FG000|Overall Study|Adverse Event|2|||
13371496|NCT00812812|26718011|FG001|Overall Study|Adverse Event|1|||
13371497|NCT00812812|26718010|FG000|Overall Study|Lack of Efficacy|1|||
13371498|NCT00812812|26718011|FG001|Overall Study|Lack of Efficacy|0|||
13371499|NCT00812812|26718010|FG000|Overall Study|Lost to Follow-up|0|||
13371500|NCT00812812|26718011|FG001|Overall Study|Lost to Follow-up|1|||
13371501|NCT00812812|26718010|FG000|Overall Study|Withdrawal by Subject|0|||
13371502|NCT00812812|26718011|FG001|Overall Study|Withdrawal by Subject|2|||
13371503|NCT00812565|26718158|FG000|Overall Study|Did Not Receive Study Medication|1|||
13371504|NCT00812565|26718159|FG001|Overall Study|Did Not Receive Study Medication|1|||
13371505|NCT00812565|26718160|FG002|Overall Study|Did Not Receive Study Medication|0|||
13371506|NCT00812565|26718161|FG003|Overall Study|Did Not Receive Study Medication|0|||
13371507|NCT00812565|26718162|FG004|Overall Study|Did Not Receive Study Medication|0|||
13371508|NCT00812565|26718163|FG005|Overall Study|Did Not Receive Study Medication|0|||
13371509|NCT00812565|26718164|FG006|Overall Study|Did Not Receive Study Medication|0|||
13371510|NCT00812565|26718165|FG007|Overall Study|Did Not Receive Study Medication|0|||
13371511|NCT00812565|26718158|FG000|Overall Study|Adverse Event|0|||
13371512|NCT00812565|26718159|FG001|Overall Study|Adverse Event|0|||
13371513|NCT00812565|26718160|FG002|Overall Study|Adverse Event|0|||
13371514|NCT00812565|26718161|FG003|Overall Study|Adverse Event|2|||
13371515|NCT00812565|26718162|FG004|Overall Study|Adverse Event|0|||
13371516|NCT00812565|26718163|FG005|Overall Study|Adverse Event|0|||
13371517|NCT00812565|26718164|FG006|Overall Study|Adverse Event|0|||
13371518|NCT00812565|26718165|FG007|Overall Study|Adverse Event|1|||
13371519|NCT00812565|26718158|FG000|Overall Study|Did Not Come to Study Visit|1|||
13371520|NCT00812565|26718159|FG001|Overall Study|Did Not Come to Study Visit|0|||
13371521|NCT00812565|26718160|FG002|Overall Study|Did Not Come to Study Visit|0|||
13371522|NCT00812565|26718161|FG003|Overall Study|Did Not Come to Study Visit|0|||
13371523|NCT00812565|26718162|FG004|Overall Study|Did Not Come to Study Visit|0|||
13371524|NCT00812565|26718163|FG005|Overall Study|Did Not Come to Study Visit|0|||
13371525|NCT00812565|26718164|FG006|Overall Study|Did Not Come to Study Visit|0|||
13371526|NCT00812565|26718165|FG007|Overall Study|Did Not Come to Study Visit|0|||
13371527|NCT00812565|26718158|FG000|Overall Study|Withdrawal of Consent|1|||
13371528|NCT00812565|26718159|FG001|Overall Study|Withdrawal of Consent|0|||
13371529|NCT00812565|26718160|FG002|Overall Study|Withdrawal of Consent|0|||
13371530|NCT00812565|26718161|FG003|Overall Study|Withdrawal of Consent|0|||
13371531|NCT00812565|26718162|FG004|Overall Study|Withdrawal of Consent|1|||
13371532|NCT00812565|26718163|FG005|Overall Study|Withdrawal of Consent|0|||
13371533|NCT00812565|26718164|FG006|Overall Study|Withdrawal of Consent|0|||
13371534|NCT00812565|26718165|FG007|Overall Study|Withdrawal of Consent|0|||
13371535|NCT00812565|26718158|FG000|Overall Study|Reason Not Specified|0|||
13371536|NCT00812565|26718159|FG001|Overall Study|Reason Not Specified|0|||
13371537|NCT00812565|26718160|FG002|Overall Study|Reason Not Specified|0|||
13371538|NCT00812565|26718161|FG003|Overall Study|Reason Not Specified|0|||
13371539|NCT00812565|26718162|FG004|Overall Study|Reason Not Specified|0|||
13371540|NCT00812565|26718163|FG005|Overall Study|Reason Not Specified|1|||
13371541|NCT00812565|26718164|FG006|Overall Study|Reason Not Specified|0|||
13371542|NCT00812565|26718165|FG007|Overall Study|Reason Not Specified|0|||
13371543|NCT00812487|26718196|FG000|Overall Study|Lost to Follow-up|2|||
13371544|NCT00812487|26718197|FG001|Overall Study|Lost to Follow-up|0|||
13371545|NCT00812487|26718196|FG000|Overall Study|Withdrawal by Subject|3|||
13371546|NCT00812487|26718197|FG001|Overall Study|Withdrawal by Subject|2|||
13371547|NCT00812487|26718196|FG000|Overall Study|Transfer to ICU prior to intervention|1|||
13371548|NCT00812487|26718197|FG001|Overall Study|Transfer to ICU prior to intervention|0|||
13371549|NCT00812487|26718196|FG000|Overall Study|Protocol Violation|0|||
13371550|NCT00812487|26718197|FG001|Overall Study|Protocol Violation|1|||
13371551|NCT00812461|26718222|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23|||
13371552|NCT00812461|26718223|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17|||
13371553|NCT00812461|26718222|FG000|All Treated Patients|Adverse Event|8|||
13371554|NCT00812461|26718223|FG001|All Treated Patients|Adverse Event|15|||
13371555|NCT00812461|26718222|FG000|All Treated Patients|Lack of Efficacy|13|||
13371556|NCT00812461|26718223|FG001|All Treated Patients|Lack of Efficacy|7|||
13371557|NCT00812461|26718222|FG000|All Treated Patients|Non-compliance|6|||
13371558|NCT00812461|26718223|FG001|All Treated Patients|Non-compliance|9|||
13371559|NCT00812461|26718222|FG000|All Treated Patients|Protocol Violation|36|||
13371560|NCT00812461|26718223|FG001|All Treated Patients|Protocol Violation|27|||
13371561|NCT00812461|26718222|FG000|All Treated Patients|Withdrawal by Subject|45|||
13371562|NCT00812461|26718223|FG001|All Treated Patients|Withdrawal by Subject|54|||
13371563|NCT00812461|26718222|FG000|All Treated Patients|Lost to Follow-up|11|||
13371564|NCT00812461|26718223|FG001|All Treated Patients|Lost to Follow-up|14|||
13371565|NCT00812461|26718222|FG000|All Treated Patients|Other Reason|13|||
13371566|NCT00812461|26718223|FG001|All Treated Patients|Other Reason|21|||
13371567|NCT00812331|26718312|FG000|Overall Study|Adverse Event|1|||
13371568|NCT00812331|26718313|FG001|Overall Study|Adverse Event|0|||
13371569|NCT00812331|26718314|FG002|Overall Study|Adverse Event|0|||
13371570|NCT00812331|26718315|FG003|Overall Study|Adverse Event|0|||
13371571|NCT00812331|26718316|FG004|Overall Study|Adverse Event|0|||
13371572|NCT00812253|26718339|FG000|Overall Study|Withdrawal by Subject|3|||
13371573|NCT00812253|26718340|FG001|Overall Study|Withdrawal by Subject|2|||
13371574|NCT00812253|26718339|FG000|Overall Study|Protocol Violation|1|||
13371575|NCT00812253|26718340|FG001|Overall Study|Protocol Violation|1|||
13371576|NCT00812253|26718339|FG000|Overall Study|Lost to Follow-up|2|||
13371577|NCT00812253|26718340|FG001|Overall Study|Lost to Follow-up|0|||
13371578|NCT00812097|26718379|FG000|Overall Study|Death|3|||
13371579|NCT00812097|26718380|FG001|Overall Study|Death|10|||
13371580|NCT00812097|26718381|FG002|Overall Study|Death|3|||
13371581|NCT00812097|26718382|FG003|Overall Study|Death|3|||
13371582|NCT00812097|26718379|FG000|Overall Study|Withdrawal by Subject|14|||
13371583|NCT00812097|26718380|FG001|Overall Study|Withdrawal by Subject|12|||
13371584|NCT00812097|26718381|FG002|Overall Study|Withdrawal by Subject|8|||
13371585|NCT00812097|26718382|FG003|Overall Study|Withdrawal by Subject|2|||
13371586|NCT00812097|26718379|FG000|Overall Study|Lost to Follow-up|90|||
13371587|NCT00812097|26718380|FG001|Overall Study|Lost to Follow-up|14|||
13371588|NCT00812097|26718381|FG002|Overall Study|Lost to Follow-up|17|||
13371589|NCT00812097|26718382|FG003|Overall Study|Lost to Follow-up|5|||
13371590|NCT00812097|26718379|FG000|Overall Study|Explantation of study device(s)|27|||
13371591|NCT00812097|26718380|FG001|Overall Study|Explantation of study device(s)|29|||
13371592|NCT00812097|26718381|FG002|Overall Study|Explantation of study device(s)|14|||
13371593|NCT00812097|26718382|FG003|Overall Study|Explantation of study device(s)|20|||
13371594|NCT00812097|26718379|FG000|Overall Study|Unknown reasons and patient/doctor moves|111|||
13371595|NCT00812097|26718380|FG001|Overall Study|Unknown reasons and patient/doctor moves|24|||
13371596|NCT00812097|26718381|FG002|Overall Study|Unknown reasons and patient/doctor moves|15|||
13371597|NCT00812097|26718382|FG003|Overall Study|Unknown reasons and patient/doctor moves|5|||
13371598|NCT00811954|26718454|FG000|Overall Study|Death|10|||
13371599|NCT00811954|26718455|FG001|Overall Study|Death|6|||
13371600|NCT00811954|26718456|FG002|Overall Study|Death|13|||
13371601|NCT00811954|26718454|FG000|Overall Study|Lost to Follow-up|29|||
13371602|NCT00811954|26718455|FG001|Overall Study|Lost to Follow-up|23|||
13371603|NCT00811954|26718456|FG002|Overall Study|Lost to Follow-up|34|||
13371604|NCT00811954|26718454|FG000|Overall Study|Not able to get to clinic|28|||
13371605|NCT00811954|26718455|FG001|Overall Study|Not able to get to clinic|35|||
13371606|NCT00811954|26718456|FG002|Overall Study|Not able to get to clinic|30|||
13371607|NCT00811954|26718454|FG000|Overall Study|Not willing to adhere to requirements|12|||
13371608|NCT00811954|26718455|FG001|Overall Study|Not willing to adhere to requirements|2|||
13371609|NCT00811954|26718456|FG002|Overall Study|Not willing to adhere to requirements|16|||
13371610|NCT00811954|26718454|FG000|Overall Study|Withdraw consent prior study completion|4|||
13371611|NCT00811954|26718455|FG001|Overall Study|Withdraw consent prior study completion|6|||
13371612|NCT00811954|26718456|FG002|Overall Study|Withdraw consent prior study completion|5|||
13371613|NCT00811954|26718454|FG000|Overall Study|Site Closure|4|||
13371614|NCT00811954|26718455|FG001|Overall Study|Site Closure|0|||
13371615|NCT00811954|26718456|FG002|Overall Study|Site Closure|1|||
13371616|NCT00811954|26718454|FG000|Overall Study|Severe Debilitation|2|||
13371617|NCT00811954|26718455|FG001|Overall Study|Severe Debilitation|0|||
13371618|NCT00811954|26718456|FG002|Overall Study|Severe Debilitation|1|||
13371619|NCT00811954|26718454|FG000|Overall Study|Complete Protocol: No follow-up|0|||
13371620|NCT00811954|26718455|FG001|Overall Study|Complete Protocol: No follow-up|0|||
13371621|NCT00811954|26718456|FG002|Overall Study|Complete Protocol: No follow-up|1|||
13371622|NCT00811941|26718499|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
13371623|NCT00811941|26718500|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8|||
13371624|NCT00811941|26718499|FG000|All Treated Patients|Adverse Event|2|||
13371625|NCT00811941|26718500|FG001|All Treated Patients|Adverse Event|43|||
13371626|NCT00811941|26718499|FG000|All Treated Patients|Lack of Efficacy|2|||
13371627|NCT00811941|26718500|FG001|All Treated Patients|Lack of Efficacy|3|||
13371628|NCT00811941|26718499|FG000|All Treated Patients|Non-compliance|1|||
13371629|NCT00811941|26718500|FG001|All Treated Patients|Non-compliance|8|||
13371630|NCT00811941|26718499|FG000|All Treated Patients|Protocol Violation|5|||
13371631|NCT00811941|26718500|FG001|All Treated Patients|Protocol Violation|17|||
13371632|NCT00811941|26718499|FG000|All Treated Patients|Withdrawal by Subject|35|||
13371633|NCT00811941|26718500|FG001|All Treated Patients|Withdrawal by Subject|94|||
13371634|NCT00811941|26718499|FG000|All Treated Patients|Lost to Follow-up|3|||
13371635|NCT00811941|26718500|FG001|All Treated Patients|Lost to Follow-up|12|||
13371636|NCT00811941|26718499|FG000|All Treated Patients|Other Reason|4|||
13371637|NCT00811941|26718500|FG001|All Treated Patients|Other Reason|14|||
13371638|NCT00811928|26718525|FG000|Overall Study|AEs and SAEs Including Death|7|||
13371639|NCT00811928|26718526|FG001|Overall Study|AEs and SAEs Including Death|11|||
13371640|NCT00811928|26718525|FG000|Overall Study|Withdrawal by Subject|18|||
13371641|NCT00811928|26718526|FG001|Overall Study|Withdrawal by Subject|12|||
13371642|NCT00811928|26718525|FG000|Overall Study|Did Not Take Study Drug|3|||
13371643|NCT00811928|26718526|FG001|Overall Study|Did Not Take Study Drug|0|||
13371644|NCT00811928|26718525|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7|||
13371645|NCT00811928|26718526|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4|||
13371646|NCT00811928|26718525|FG000|Overall Study|Investigator Decision|2|||
13371647|NCT00811928|26718526|FG001|Overall Study|Investigator Decision|1|||
13371648|NCT00811928|26718525|FG000|Overall Study|Poor Compliance|2|||
13371649|NCT00811928|26718526|FG001|Overall Study|Poor Compliance|5|||
13371650|NCT00811733|26718579|FG000|Overall Study|Investigator Discretion|10|||
13371651|NCT00811733|26718580|FG001|Overall Study|Investigator Discretion|8|||
13371652|NCT00811733|26718579|FG000|Overall Study|Withdrawal by Subject|1|||
13371653|NCT00811733|26718580|FG001|Overall Study|Withdrawal by Subject|2|||
13371654|NCT00811720|26718605|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
13371655|NCT00811720|26718606|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4|||
13371656|NCT00811720|26718605|FG000|All Treated Patients|Adverse Event|20|||
13371657|NCT00811720|26718606|FG001|All Treated Patients|Adverse Event|62|||
13371658|NCT00811720|26718605|FG000|All Treated Patients|Lack of Efficacy|22|||
13371659|NCT00811720|26718606|FG001|All Treated Patients|Lack of Efficacy|18|||
13371660|NCT00811720|26718605|FG000|All Treated Patients|Non-compliance|0|||
13371661|NCT00811720|26718606|FG001|All Treated Patients|Non-compliance|14|||
13371662|NCT00811720|26718605|FG000|All Treated Patients|Protocol Violation|9|||
13371663|NCT00811720|26718606|FG001|All Treated Patients|Protocol Violation|16|||
13371664|NCT00811720|26718605|FG000|All Treated Patients|Withdrawal by Subject|28|||
13371665|NCT00811720|26718606|FG001|All Treated Patients|Withdrawal by Subject|34|||
13371666|NCT00811720|26718605|FG000|All Treated Patients|Lost to Follow-up|10|||
13371667|NCT00811720|26718606|FG001|All Treated Patients|Lost to Follow-up|16|||
13371668|NCT00811720|26718605|FG000|All Treated Patients|Other Reason|7|||
13371669|NCT00811720|26718606|FG001|All Treated Patients|Other Reason|4|||
13371670|NCT00811655|26718620|FG000|Overall Study|Physician Decision|1|||
13371671|NCT00811642|26718632|FG000|Overall Study|Adverse Event|3|||
13371672|NCT00811642|26718632|FG000|Overall Study|Protocol Violation|1|||
13371673|NCT00811642|26718632|FG000|Overall Study|Death|2|||
13371674|NCT00811642|26718632|FG000|Overall Study|Withdrawal by Subject|7|||
13371675|NCT00811642|26718632|FG000|Overall Study|Cumulative use of antifungal agent|2|||
13371676|NCT00811577|26718688|FG000|Overall Study|Lost to Follow-up|7|||
13371677|NCT00811577|26718689|FG001|Overall Study|Lost to Follow-up|1|||
13371678|NCT00811577|26718688|FG000|Overall Study|Withdrawal by Subject|3|||
13371679|NCT00811577|26718689|FG001|Overall Study|Withdrawal by Subject|0|||
13371680|NCT00811473|26718712|FG000|Overall Study|Adverse Event|3|||
13371681|NCT00811473|26718713|FG001|Overall Study|Adverse Event|12|||
13371682|NCT00811473|26718712|FG000|Overall Study|Lost to Follow-up|5|||
13371683|NCT00811473|26718713|FG001|Overall Study|Lost to Follow-up|1|||
13371684|NCT00811473|26718712|FG000|Overall Study|Withdrawal by Subject|2|||
13371685|NCT00811473|26718713|FG001|Overall Study|Withdrawal by Subject|4|||
13371686|NCT00811473|26718712|FG000|Overall Study|Severe non-compliance to protocol|2|||
13371687|NCT00811473|26718713|FG001|Overall Study|Severe non-compliance to protocol|4|||
13371688|NCT00811473|26718712|FG000|Overall Study|Lack of therapeutic response|4|||
13371689|NCT00811473|26718713|FG001|Overall Study|Lack of therapeutic response|1|||
13371690|NCT00811473|26718712|FG000|Overall Study|Condition under investigation worsened|1|||
13371691|NCT00811473|26718713|FG001|Overall Study|Condition under investigation worsened|3|||
13371692|NCT00811473|26718712|FG000|Overall Study|Other 2|4|||
13371693|NCT00811473|26718713|FG001|Overall Study|Other 2|1|||
13371694|NCT00811473|26718712|FG000|Overall Study|Incorrect Enrollment|1|||
13371695|NCT00811473|26718713|FG001|Overall Study|Incorrect Enrollment|0|||
13371696|NCT00811473|26718712|FG000|Overall Study|Safety Reasons|1|||
13371697|NCT00811473|26718713|FG001|Overall Study|Safety Reasons|0|||
13371698|NCT00811395|26718794|FG000|Extension Treatment|Adverse Event|1|||
13371699|NCT00811395|26718795|FG001|Extension Treatment|Adverse Event|2|||
13371700|NCT00811395|26718796|FG002|Extension Treatment|Adverse Event|2|||
13371701|NCT00811395|26718797|FG003|Extension Treatment|Adverse Event|2|||
13371702|NCT00811395|26718798|FG004|Extension Treatment|Adverse Event|0|||
13371703|NCT00811395|26718799|FG005|Extension Treatment|Adverse Event|1|||
13371704|NCT00811395|26718794|FG000|Extension Treatment|Progressive disease|1|||
13371705|NCT00811395|26718795|FG001|Extension Treatment|Progressive disease|1|||
13371706|NCT00811395|26718796|FG002|Extension Treatment|Progressive disease|0|||
13371707|NCT00811395|26718797|FG003|Extension Treatment|Progressive disease|0|||
13371708|NCT00811395|26718798|FG004|Extension Treatment|Progressive disease|0|||
13371709|NCT00811395|26718799|FG005|Extension Treatment|Progressive disease|0|||
13371710|NCT00811395|26718794|FG000|Extension Treatment|Participant did not wish to continue|0|||
13371711|NCT00811395|26718795|FG001|Extension Treatment|Participant did not wish to continue|3|||
13371712|NCT00811395|26718796|FG002|Extension Treatment|Participant did not wish to continue|0|||
13371713|NCT00811395|26718797|FG003|Extension Treatment|Participant did not wish to continue|1|||
13371714|NCT00811395|26718798|FG004|Extension Treatment|Participant did not wish to continue|0|||
13371715|NCT00811395|26718799|FG005|Extension Treatment|Participant did not wish to continue|1|||
13371716|NCT00811395|26718794|FG000|Extension Treatment|Other than above|0|||
13371717|NCT00811395|26718795|FG001|Extension Treatment|Other than above|0|||
13371718|NCT00811395|26718796|FG002|Extension Treatment|Other than above|1|||
13371719|NCT00811395|26718797|FG003|Extension Treatment|Other than above|0|||
13371720|NCT00811395|26718798|FG004|Extension Treatment|Other than above|0|||
13371721|NCT00811395|26718799|FG005|Extension Treatment|Other than above|0|||
13371722|NCT00811252|26718853|FG000|Overall Study|Adverse Event|6|||
13371723|NCT00811252|26718854|FG001|Overall Study|Adverse Event|10|||
13371724|NCT00811252|26718855|FG002|Overall Study|Adverse Event|15|||
13371725|NCT00811252|26718853|FG000|Overall Study|Lack of Efficacy|7|||
13371726|NCT00811252|26718854|FG001|Overall Study|Lack of Efficacy|2|||
13371727|NCT00811252|26718855|FG002|Overall Study|Lack of Efficacy|0|||
13371728|NCT00811252|26718853|FG000|Overall Study|Protocol Violation|3|||
13371729|NCT00811252|26718854|FG001|Overall Study|Protocol Violation|3|||
13371730|NCT00811252|26718855|FG002|Overall Study|Protocol Violation|2|||
13371731|NCT00811252|26718853|FG000|Overall Study|Withdrawal of Consent|1|||
13371732|NCT00811252|26718854|FG001|Overall Study|Withdrawal of Consent|2|||
13371733|NCT00811252|26718855|FG002|Overall Study|Withdrawal of Consent|2|||
13371734|NCT00811252|26718853|FG000|Overall Study|Lost to Follow-up|0|||
13371735|NCT00811252|26718854|FG001|Overall Study|Lost to Follow-up|0|||
13371736|NCT00811252|26718855|FG002|Overall Study|Lost to Follow-up|2|||
13371737|NCT00811252|26718853|FG000|Overall Study|Administrative or Other Reasons|0|||
13371738|NCT00811252|26718854|FG001|Overall Study|Administrative or Other Reasons|3|||
13371739|NCT00811252|26718855|FG002|Overall Study|Administrative or Other Reasons|2|||
13371740|NCT00811187|26718868|FG000|Overall Study|Unable to place device / procedure abort|3|||
13371741|NCT00811187|26718869|FG001|Overall Study|Unable to place device / procedure abort|3|||
13375353|NCT00790842|26729843|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
13375354|NCT00790842|26729844|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1|||
13375355|NCT00790842|26729845|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
13375356|NCT00790842|26729846|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
13375357|NCT00790842|26729847|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
13375358|NCT00790842|26729848|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
13375359|NCT00790842|26729849|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
13375360|NCT00790842|26729839|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
13375361|NCT00790842|26729840|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
13375362|NCT00790842|26729841|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1|||
13375363|NCT00790842|26729842|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
13375364|NCT00790842|26729843|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
13375365|NCT00790842|26729844|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
13375366|NCT00790842|26729845|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
13375367|NCT00790842|26729846|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
13375368|NCT00790842|26729847|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
13375369|NCT00790842|26729848|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
13375370|NCT00790842|26729849|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
13375371|NCT00790842|26729839|FG000|Dose Level 4|Adverse Event|0|||
13375372|NCT00790842|26729840|FG001|Dose Level 4|Adverse Event|0|||
13375373|NCT00790842|26729841|FG002|Dose Level 4|Adverse Event|0|||
13375374|NCT00790842|26729842|FG003|Dose Level 4|Adverse Event|0|||
13375375|NCT00790842|26729843|FG004|Dose Level 4|Adverse Event|0|||
13375376|NCT00790842|26729844|FG005|Dose Level 4|Adverse Event|0|||
13375377|NCT00790842|26729845|FG006|Dose Level 4|Adverse Event|1|||
13375378|NCT00790842|26729846|FG007|Dose Level 4|Adverse Event|0|||
13375379|NCT00790842|26729847|FG008|Dose Level 4|Adverse Event|0|||
13375380|NCT00790842|26729848|FG009|Dose Level 4|Adverse Event|0|||
13375381|NCT00790842|26729849|FG010|Dose Level 4|Adverse Event|0|||
13375382|NCT00790842|26729839|FG000|Dose Level 4|Physician Decision|0|||
13375383|NCT00790842|26729840|FG001|Dose Level 4|Physician Decision|0|||
13375384|NCT00790842|26729841|FG002|Dose Level 4|Physician Decision|0|||
13375385|NCT00790842|26729842|FG003|Dose Level 4|Physician Decision|0|||
13375386|NCT00790842|26729843|FG004|Dose Level 4|Physician Decision|0|||
13375387|NCT00790842|26729844|FG005|Dose Level 4|Physician Decision|0|||
13375388|NCT00790842|26729845|FG006|Dose Level 4|Physician Decision|1|||
13375389|NCT00790842|26729846|FG007|Dose Level 4|Physician Decision|0|||
13375390|NCT00790842|26729847|FG008|Dose Level 4|Physician Decision|0|||
13375391|NCT00790842|26729848|FG009|Dose Level 4|Physician Decision|0|||
13375392|NCT00790842|26729849|FG010|Dose Level 4|Physician Decision|1|||
13375393|NCT00790842|26729839|FG000|Dose Level 4|Withdrawal by Subject|0|||
13371742|NCT00811174|26718882|FG000|Overall Study|Protocol Violation|2|||
13371743|NCT00811174|26718882|FG000|Overall Study|Sponsors Decision|1|||
13371744|NCT00811135|26718896|FG000|Overall Study|Adverse Event/Intercurrent Illness|8|||
13371745|NCT00811135|26718896|FG000|Overall Study|Death|3|||
13371746|NCT00811135|26718896|FG000|Overall Study|Protocol Violation|2|||
13371747|NCT00811135|26718896|FG000|Overall Study|Violation of Selection Criteria|1|||
13371748|NCT00811135|26718896|FG000|Overall Study|Refused Treatment|1|||
13371749|NCT00811135|26718896|FG000|Overall Study|Withdrawal by Subject|3|||
13371750|NCT00811135|26718896|FG000|Overall Study|Administrative/Other Unspecified|11|||
13371751|NCT00811135|26718896|FG000|Overall Study|Ongoing|59|||
13371752|NCT00811070|26718972|FG000|Overall Study|Death|0|||
13371753|NCT00811070|26718973|FG001|Overall Study|Death|0|||
13371754|NCT00811070|26718974|FG002|Overall Study|Death|0|||
13371755|NCT00811070|26718975|FG003|Overall Study|Death|2|||
13371756|NCT00811070|26718976|FG004|Overall Study|Death|5|||
13371757|NCT00811070|26718977|FG005|Overall Study|Death|0|||
13371758|NCT00811070|26718972|FG000|Overall Study|Other|1|||
13371759|NCT00811070|26718973|FG001|Overall Study|Other|0|||
13371760|NCT00811070|26718974|FG002|Overall Study|Other|0|||
13371761|NCT00811070|26718975|FG003|Overall Study|Other|0|||
13371762|NCT00811070|26718976|FG004|Overall Study|Other|0|||
13371763|NCT00811070|26718977|FG005|Overall Study|Other|0|||
13371764|NCT00811070|26718972|FG000|Overall Study|Withdrawal by Subject|0|||
13371765|NCT00811070|26718973|FG001|Overall Study|Withdrawal by Subject|1|||
13371766|NCT00811070|26718974|FG002|Overall Study|Withdrawal by Subject|0|||
13371767|NCT00811070|26718975|FG003|Overall Study|Withdrawal by Subject|0|||
13371768|NCT00811070|26718976|FG004|Overall Study|Withdrawal by Subject|0|||
13371769|NCT00811070|26718977|FG005|Overall Study|Withdrawal by Subject|0|||
13371770|NCT00811070|26718972|FG000|Overall Study|Physician Decision|0|||
13371771|NCT00811070|26718973|FG001|Overall Study|Physician Decision|0|||
13371772|NCT00811070|26718974|FG002|Overall Study|Physician Decision|0|||
13371773|NCT00811070|26718975|FG003|Overall Study|Physician Decision|0|||
13371774|NCT00811070|26718976|FG004|Overall Study|Physician Decision|0|||
13371775|NCT00811070|26718977|FG005|Overall Study|Physician Decision|1|||
13371776|NCT00811057|26718998|FG000|Overall Study|Protocol Violation|5|||
13371777|NCT00811057|26718999|FG001|Overall Study|Protocol Violation|10|||
13371778|NCT00811057|26719000|FG002|Overall Study|Protocol Violation|10|||
13371779|NCT00811018|26719018|FG000|Overall Study|Additional Chronic Treatment|31|||
13371780|NCT00811018|26719018|FG000|Overall Study|Adverse Event|79|||
13371781|NCT00811018|26719018|FG000|Overall Study|Death|147|||
13371782|NCT00811018|26719018|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4|||
13371783|NCT00811018|26719018|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70|||
13371784|NCT00811018|26719018|FG000|Overall Study|Investigator Decision|57|||
13371785|NCT00811018|26719018|FG000|Overall Study|Lost to Follow-up|19|||
13371786|NCT00811018|26719018|FG000|Overall Study|Pregnancy|6|||
13371787|NCT00811018|26719018|FG000|Overall Study|Sponsor Decision|450|||
13371788|NCT00811018|26719018|FG000|Overall Study|Withdrawal by Subject|70|||
13371789|NCT00811018|26719018|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9|||
13371790|NCT00811018|26719018|FG000|Overall Study|Other|26|||
13371791|NCT00810901|26719033|FG000|Overall Study|Lost to Follow-up|88|||
13371792|NCT00810901|26719034|FG001|Overall Study|Lost to Follow-up|58|||
13371793|NCT00810810|26719061|FG000|Overall Study|Withdrawal by Subject|0|||
13371794|NCT00810810|26719062|FG001|Overall Study|Withdrawal by Subject|8|||
13371795|NCT00810810|26719063|FG002|Overall Study|Withdrawal by Subject|10|||
13371796|NCT00810810|26719064|FG003|Overall Study|Withdrawal by Subject|8|||
13371797|NCT00810810|26719061|FG000|Overall Study|Physician Decision|0|||
13371798|NCT00810810|26719062|FG001|Overall Study|Physician Decision|3|||
13371799|NCT00810810|26719063|FG002|Overall Study|Physician Decision|1|||
13371800|NCT00810810|26719064|FG003|Overall Study|Physician Decision|5|||
13371801|NCT00810693|26719103|FG000|Treatment Period|Adverse Event|8|||
13371802|NCT00810693|26719104|FG001|Treatment Period|Adverse Event|1|||
13371803|NCT00810693|26719105|FG002|Treatment Period|Adverse Event|7|||
13371804|NCT00810693|26719103|FG000|Treatment Period|Death|0|||
13371805|NCT00810693|26719104|FG001|Treatment Period|Death|1|||
13371806|NCT00810693|26719105|FG002|Treatment Period|Death|2|||
13371807|NCT00810693|26719103|FG000|Treatment Period|Lack of Efficacy|0|||
13371808|NCT00810693|26719104|FG001|Treatment Period|Lack of Efficacy|0|||
13371809|NCT00810693|26719105|FG002|Treatment Period|Lack of Efficacy|1|||
13371810|NCT00810693|26719103|FG000|Treatment Period|Lost to Follow-up|1|||
13371811|NCT00810693|26719104|FG001|Treatment Period|Lost to Follow-up|0|||
13371812|NCT00810693|26719105|FG002|Treatment Period|Lost to Follow-up|0|||
13371813|NCT00810693|26719103|FG000|Treatment Period|Non-compliance|1|||
13371814|NCT00810693|26719104|FG001|Treatment Period|Non-compliance|0|||
13371815|NCT00810693|26719105|FG002|Treatment Period|Non-compliance|0|||
13371816|NCT00810693|26719103|FG000|Treatment Period|Protocol Violation|1|||
13371817|NCT00810693|26719104|FG001|Treatment Period|Protocol Violation|2|||
13371818|NCT00810693|26719105|FG002|Treatment Period|Protocol Violation|2|||
13371819|NCT00810693|26719103|FG000|Treatment Period|Withdrawal by Subject|6|||
13371820|NCT00810693|26719104|FG001|Treatment Period|Withdrawal by Subject|2|||
13371821|NCT00810693|26719105|FG002|Treatment Period|Withdrawal by Subject|3|||
13371822|NCT00810693|26719103|FG000|Treatment Period|Not treated|0|||
13371823|NCT00810693|26719104|FG001|Treatment Period|Not treated|1|||
13371824|NCT00810693|26719105|FG002|Treatment Period|Not treated|1|||
13371825|NCT00810693|26719103|FG000|Follow-up Period (FUP)|Adverse Event|3|||
13371826|NCT00810693|26719104|FG001|Follow-up Period (FUP)|Adverse Event|1|||
13371827|NCT00810693|26719105|FG002|Follow-up Period (FUP)|Adverse Event|1|||
13371828|NCT00810693|26719103|FG000|Follow-up Period (FUP)|Death|2|||
13371829|NCT00810693|26719104|FG001|Follow-up Period (FUP)|Death|0|||
13371830|NCT00810693|26719105|FG002|Follow-up Period (FUP)|Death|1|||
13371831|NCT00810693|26719103|FG000|Follow-up Period (FUP)|Lost to Follow-up|1|||
13371832|NCT00810693|26719104|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
13371833|NCT00810693|26719105|FG002|Follow-up Period (FUP)|Lost to Follow-up|2|||
13371834|NCT00810693|26719103|FG000|Follow-up Period (FUP)|Protocol Violation|0|||
13371835|NCT00810693|26719104|FG001|Follow-up Period (FUP)|Protocol Violation|1|||
13371836|NCT00810693|26719105|FG002|Follow-up Period (FUP)|Protocol Violation|0|||
13371837|NCT00810693|26719103|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2|||
13371838|NCT00810693|26719104|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1|||
13371839|NCT00810693|26719105|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0|||
13371840|NCT00810641|26719123|FG000|Overall Study|Withdrawal by Subject|0|||
13371841|NCT00810641|26719124|FG001|Overall Study|Withdrawal by Subject|1|||
13371842|NCT00810641|26719125|FG002|Overall Study|Withdrawal by Subject|2|||
13371843|NCT00810615|26719182|FG000|Overall Study|Withdrawal by Subject|1|||
13371844|NCT00810615|26719183|FG001|Overall Study|Withdrawal by Subject|1|||
13371845|NCT00810602|26719193|FG000|Overall Study|Withdrawal by Subject|8|||
13371846|NCT00810602|26719194|FG001|Overall Study|Withdrawal by Subject|3|||
13371847|NCT00810511|26719207|FG000|Overall Study|Protocol Violation|0|||
13371848|NCT00810511|26719208|FG001|Overall Study|Protocol Violation|1|||
13371849|NCT00810511|26719207|FG000|Overall Study|Lack of Efficacy|9|||
13371850|NCT00810511|26719208|FG001|Overall Study|Lack of Efficacy|1|||
13371851|NCT00810511|26719207|FG000|Overall Study|death in the family|0|||
13371852|NCT00810511|26719208|FG001|Overall Study|death in the family|1|||
13371853|NCT00810511|26719207|FG000|Overall Study|Lost to Follow-up|1|||
13371854|NCT00810511|26719208|FG001|Overall Study|Lost to Follow-up|0|||
13371855|NCT00810511|26719207|FG000|Overall Study|deposits on contact lens|0|||
13371856|NCT00810511|26719208|FG001|Overall Study|deposits on contact lens|1|||
13371857|NCT00810407|26719222|FG000|Overall Study|Protocol Violation|3|||
13371858|NCT00810407|26719222|FG000|Overall Study|No Visit After First Day of Treatment|3|||
13371859|NCT00810394|26719230|FG000|Overall Study|Withdrawal by Subject|3|||
13371860|NCT00810368|26719255|FG000|Overall Study|Lost to Follow-up|4|||
13371861|NCT00810368|26719256|FG001|Overall Study|Lost to Follow-up|2|||
13371862|NCT00810368|26719255|FG000|Overall Study|Lack of Efficacy|2|||
13371863|NCT00810368|26719256|FG001|Overall Study|Lack of Efficacy|0|||
13371864|NCT00810355|26719280|FG000|Overall Study|Lost to Follow-up|13|||
13371865|NCT00810355|26719281|FG001|Overall Study|Lost to Follow-up|17|||
13371866|NCT00810355|26719282|FG002|Overall Study|Lost to Follow-up|11|||
13371867|NCT00810355|26719280|FG000|Overall Study|Withdrawal by Subject|1|||
13371868|NCT00810355|26719281|FG001|Overall Study|Withdrawal by Subject|0|||
13371869|NCT00810355|26719282|FG002|Overall Study|Withdrawal by Subject|0|||
13371870|NCT00810342|26719297|FG000|Month 1 Follow-up|Lost to Follow-up|4|||
13371871|NCT00810342|26719298|FG001|Month 1 Follow-up|Lost to Follow-up|2|||
13371872|NCT00810342|26719297|FG000|Month 1 Follow-up|Pregnancy|1|||
13371873|NCT00810342|26719298|FG001|Month 1 Follow-up|Pregnancy|0|||
13371874|NCT00810342|26719297|FG000|6-month Follow-up|Lost to Follow-up|18|||
13371875|NCT00810342|26719298|FG001|6-month Follow-up|Lost to Follow-up|6|||
13371876|NCT00810342|26719297|FG000|6-month Follow-up|Pregnancy|6|||
13371877|NCT00810342|26719298|FG001|6-month Follow-up|Pregnancy|2|||
13371878|NCT00810342|26719297|FG000|12-month Followup|Pregnancy|9|||
13371879|NCT00810342|26719298|FG001|12-month Followup|Pregnancy|10|||
13371880|NCT00810342|26719297|FG000|12-month Followup|Lost to Follow-up|3|||
13371881|NCT00810342|26719298|FG001|12-month Followup|Lost to Follow-up|1|||
13371882|NCT00810277|26719313|FG000|Overall Study|Adverse Event|1|||
13371883|NCT00810264|26719340|FG000|Overall Study|Lost to Follow-up|191|||
13371884|NCT00810264|26719340|FG000|Overall Study|Withdrawal by subject or physician|721|||
13371885|NCT00810264|26719340|FG000|Overall Study|Death|641|||
13371886|NCT00810199|26719423|FG000|Overall Study|Adverse Event|24|||
13371887|NCT00810199|26719424|FG001|Overall Study|Adverse Event|26|||
13371888|NCT00810199|26719423|FG000|Overall Study|Death|4|||
13371889|NCT00810199|26719424|FG001|Overall Study|Death|6|||
13371890|NCT00810199|26719423|FG000|Overall Study|Withdrew consent|9|||
13371891|NCT00810199|26719424|FG001|Overall Study|Withdrew consent|12|||
13371892|NCT00810199|26719423|FG000|Overall Study|Insufficient therapeutic response|5|||
13371893|NCT00810199|26719424|FG001|Overall Study|Insufficient therapeutic response|14|||
13371894|NCT00810199|26719423|FG000|Overall Study|Refused treatment/Did not cooperate|7|||
13371895|NCT00810199|26719424|FG001|Overall Study|Refused treatment/Did not cooperate|7|||
13371896|NCT00810199|26719423|FG000|Overall Study|Administrative/Other|5|||
13371897|NCT00810199|26719424|FG001|Overall Study|Administrative/Other|6|||
13371898|NCT00810199|26719423|FG000|Overall Study|Protocol Violation|2|||
13371899|NCT00810199|26719424|FG001|Overall Study|Protocol Violation|6|||
13371900|NCT00810199|26719423|FG000|Overall Study|Failure to return|1|||
13371901|NCT00810199|26719424|FG001|Overall Study|Failure to return|4|||
13371902|NCT00810199|26719423|FG000|Overall Study|Did not receive study drug|2|||
13371903|NCT00810199|26719424|FG001|Overall Study|Did not receive study drug|1|||
13375394|NCT00790842|26729840|FG001|Dose Level 4|Withdrawal by Subject|0|||
13375395|NCT00790842|26729841|FG002|Dose Level 4|Withdrawal by Subject|0|||
13375396|NCT00790842|26729842|FG003|Dose Level 4|Withdrawal by Subject|0|||
13375397|NCT00790842|26729843|FG004|Dose Level 4|Withdrawal by Subject|0|||
13375398|NCT00790842|26729844|FG005|Dose Level 4|Withdrawal by Subject|0|||
13375399|NCT00790842|26729845|FG006|Dose Level 4|Withdrawal by Subject|0|||
13375400|NCT00790842|26729846|FG007|Dose Level 4|Withdrawal by Subject|0|||
13375401|NCT00790842|26729847|FG008|Dose Level 4|Withdrawal by Subject|0|||
13375402|NCT00790842|26729848|FG009|Dose Level 4|Withdrawal by Subject|0|||
13375403|NCT00790842|26729849|FG010|Dose Level 4|Withdrawal by Subject|1|||
13375404|NCT00790842|26729839|FG000|Expansion Cohort|Adverse Event|0|||
13375405|NCT00790842|26729840|FG001|Expansion Cohort|Adverse Event|0|||
13375406|NCT00790842|26729841|FG002|Expansion Cohort|Adverse Event|0|||
13375407|NCT00790842|26729842|FG003|Expansion Cohort|Adverse Event|0|||
13375408|NCT00790842|26729843|FG004|Expansion Cohort|Adverse Event|0|||
13375409|NCT00790842|26729844|FG005|Expansion Cohort|Adverse Event|0|||
13375410|NCT00790842|26729845|FG006|Expansion Cohort|Adverse Event|1|||
13375411|NCT00790842|26729846|FG007|Expansion Cohort|Adverse Event|0|||
13375412|NCT00790842|26729847|FG008|Expansion Cohort|Adverse Event|0|||
13375413|NCT00790842|26729848|FG009|Expansion Cohort|Adverse Event|0|||
13375414|NCT00790842|26729849|FG010|Expansion Cohort|Adverse Event|0|||
13375415|NCT00790842|26729839|FG000|Expansion Cohort|Death|0|||
13375416|NCT00790842|26729840|FG001|Expansion Cohort|Death|0|||
13375417|NCT00790842|26729841|FG002|Expansion Cohort|Death|2|||
13375418|NCT00790842|26729842|FG003|Expansion Cohort|Death|0|||
13375419|NCT00790842|26729843|FG004|Expansion Cohort|Death|0|||
13375420|NCT00790842|26729844|FG005|Expansion Cohort|Death|0|||
13375421|NCT00790842|26729845|FG006|Expansion Cohort|Death|0|||
13375422|NCT00790842|26729846|FG007|Expansion Cohort|Death|0|||
13375423|NCT00790842|26729847|FG008|Expansion Cohort|Death|0|||
13375424|NCT00790842|26729848|FG009|Expansion Cohort|Death|0|||
13375425|NCT00790842|26729849|FG010|Expansion Cohort|Death|0|||
13375426|NCT00790842|26729839|FG000|Expansion Cohort|Physician Decision|0|||
13375427|NCT00790842|26729840|FG001|Expansion Cohort|Physician Decision|0|||
13375428|NCT00790842|26729841|FG002|Expansion Cohort|Physician Decision|1|||
13375429|NCT00790842|26729842|FG003|Expansion Cohort|Physician Decision|0|||
13375430|NCT00790842|26729843|FG004|Expansion Cohort|Physician Decision|0|||
13375431|NCT00790842|26729844|FG005|Expansion Cohort|Physician Decision|0|||
13375432|NCT00790842|26729845|FG006|Expansion Cohort|Physician Decision|0|||
13375433|NCT00790842|26729846|FG007|Expansion Cohort|Physician Decision|0|||
13375434|NCT00790842|26729847|FG008|Expansion Cohort|Physician Decision|0|||
13375435|NCT00790842|26729848|FG009|Expansion Cohort|Physician Decision|0|||
13375436|NCT00790842|26729849|FG010|Expansion Cohort|Physician Decision|0|||
13375437|NCT00790842|26729839|FG000|Expansion Cohort|Withdrawal by Subject|0|||
13375438|NCT00790842|26729840|FG001|Expansion Cohort|Withdrawal by Subject|0|||
13375439|NCT00790842|26729841|FG002|Expansion Cohort|Withdrawal by Subject|3|||
13375440|NCT00790842|26729842|FG003|Expansion Cohort|Withdrawal by Subject|0|||
13375441|NCT00790842|26729843|FG004|Expansion Cohort|Withdrawal by Subject|0|||
13375442|NCT00790842|26729844|FG005|Expansion Cohort|Withdrawal by Subject|0|||
13375443|NCT00790842|26729845|FG006|Expansion Cohort|Withdrawal by Subject|0|||
13375444|NCT00790842|26729846|FG007|Expansion Cohort|Withdrawal by Subject|0|||
13375445|NCT00790842|26729847|FG008|Expansion Cohort|Withdrawal by Subject|0|||
13375446|NCT00790842|26729848|FG009|Expansion Cohort|Withdrawal by Subject|0|||
13375447|NCT00790842|26729849|FG010|Expansion Cohort|Withdrawal by Subject|0|||
13375448|NCT00790842|26729839|FG000|Expansion Cohort|Study Closure|0|||
13375449|NCT00790842|26729840|FG001|Expansion Cohort|Study Closure|0|||
13375450|NCT00790842|26729841|FG002|Expansion Cohort|Study Closure|1|||
13375451|NCT00790842|26729842|FG003|Expansion Cohort|Study Closure|0|||
13375452|NCT00790842|26729843|FG004|Expansion Cohort|Study Closure|0|||
13375453|NCT00790842|26729844|FG005|Expansion Cohort|Study Closure|0|||
13375454|NCT00790842|26729845|FG006|Expansion Cohort|Study Closure|0|||
13375455|NCT00790842|26729846|FG007|Expansion Cohort|Study Closure|0|||
13375456|NCT00790842|26729847|FG008|Expansion Cohort|Study Closure|0|||
13375457|NCT00790842|26729848|FG009|Expansion Cohort|Study Closure|0|||
13375458|NCT00790842|26729849|FG010|Expansion Cohort|Study Closure|0|||
13375459|NCT00790790|26729932|FG000|Study Period 2: Therapy Phase|Adverse Event|3|||
13375460|NCT00790790|26729933|FG001|Study Period 2: Therapy Phase|Adverse Event|16|||
13375461|NCT00790790|26729934|FG002|Study Period 2: Therapy Phase|Adverse Event|16|||
13375462|NCT00790790|26729932|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
13375463|NCT00790790|26729933|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
13375464|NCT00790790|26729934|FG002|Study Period 2: Therapy Phase|Protocol Violation|0|||
13375465|NCT00790790|26729932|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7|||
13375466|NCT00790790|26729933|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
13375467|NCT00790790|26729934|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
13371904|NCT00810108|26719436|FG000|Overall Study|Withdrawal by Subject|1|||
13371905|NCT00810108|26719437|FG001|Overall Study|Withdrawal by Subject|0|||
13371906|NCT00810082|26719450|FG000|Overall Study|Lost to Follow-up|0|||
13371907|NCT00810082|26719451|FG001|Overall Study|Lost to Follow-up|4|||
13371908|NCT00810069|26719502|FG000|Lead-in Period I|Adverse Event|43|||
13371909|NCT00810069|26719503|FG001|Lead-in Period I|Adverse Event|0|||
13371910|NCT00810069|26719504|FG002|Lead-in Period I|Adverse Event|0|||
13371911|NCT00810069|26719502|FG000|Lead-in Period I|Lack of Efficacy|1|||
13371912|NCT00810069|26719503|FG001|Lead-in Period I|Lack of Efficacy|0|||
13371913|NCT00810069|26719504|FG002|Lead-in Period I|Lack of Efficacy|0|||
13371914|NCT00810069|26719502|FG000|Lead-in Period I|Lost to Follow-up|19|||
13371915|NCT00810069|26719503|FG001|Lead-in Period I|Lost to Follow-up|0|||
13371916|NCT00810069|26719504|FG002|Lead-in Period I|Lost to Follow-up|0|||
13371917|NCT00810069|26719502|FG000|Lead-in Period I|Physician Decision|1|||
13371918|NCT00810069|26719503|FG001|Lead-in Period I|Physician Decision|0|||
13371919|NCT00810069|26719504|FG002|Lead-in Period I|Physician Decision|0|||
13371920|NCT00810069|26719502|FG000|Lead-in Period I|Protocol Violation|1|||
13371921|NCT00810069|26719503|FG001|Lead-in Period I|Protocol Violation|0|||
13371922|NCT00810069|26719504|FG002|Lead-in Period I|Protocol Violation|0|||
13371923|NCT00810069|26719502|FG000|Lead-in Period I|Withdrawal by Subject|46|||
13371924|NCT00810069|26719503|FG001|Lead-in Period I|Withdrawal by Subject|0|||
13371925|NCT00810069|26719504|FG002|Lead-in Period I|Withdrawal by Subject|0|||
13371926|NCT00810069|26719502|FG000|Lead-in Period I|Protocol entry criterion not met|5|||
13371927|NCT00810069|26719503|FG001|Lead-in Period I|Protocol entry criterion not met|0|||
13371928|NCT00810069|26719504|FG002|Lead-in Period I|Protocol entry criterion not met|0|||
13371929|NCT00810069|26719502|FG000|Lead-in Period I|Randomization criteria not met|158|||
13371930|NCT00810069|26719503|FG001|Lead-in Period I|Randomization criteria not met|0|||
13371931|NCT00810069|26719504|FG002|Lead-in Period I|Randomization criteria not met|0|||
13371932|NCT00810069|26719502|FG000|Double-Blind Period II|Adverse Event|0|||
13371933|NCT00810069|26719503|FG001|Double-Blind Period II|Adverse Event|9|||
13371934|NCT00810069|26719504|FG002|Double-Blind Period II|Adverse Event|8|||
13371935|NCT00810069|26719502|FG000|Double-Blind Period II|Lack of Efficacy|0|||
13371936|NCT00810069|26719503|FG001|Double-Blind Period II|Lack of Efficacy|7|||
13371937|NCT00810069|26719504|FG002|Double-Blind Period II|Lack of Efficacy|12|||
13371938|NCT00810069|26719502|FG000|Double-Blind Period II|Lost to Follow-up|0|||
13371939|NCT00810069|26719503|FG001|Double-Blind Period II|Lost to Follow-up|9|||
13371940|NCT00810069|26719504|FG002|Double-Blind Period II|Lost to Follow-up|9|||
13371941|NCT00810069|26719502|FG000|Double-Blind Period II|Physician Decision|0|||
13371942|NCT00810069|26719503|FG001|Double-Blind Period II|Physician Decision|0|||
13371943|NCT00810069|26719504|FG002|Double-Blind Period II|Physician Decision|1|||
13371944|NCT00810069|26719502|FG000|Double-Blind Period II|Withdrawal by Subject|0|||
13371945|NCT00810069|26719503|FG001|Double-Blind Period II|Withdrawal by Subject|21|||
13371946|NCT00810069|26719504|FG002|Double-Blind Period II|Withdrawal by Subject|35|||
13371947|NCT00810069|26719502|FG000|Double-Blind Period II|Protocol entry criterion not met|0|||
13371948|NCT00810069|26719503|FG001|Double-Blind Period II|Protocol entry criterion not met|0|||
13371949|NCT00810069|26719504|FG002|Double-Blind Period II|Protocol entry criterion not met|1|||
13371950|NCT00810069|26719502|FG000|Double-Blind Period II|Clinical relapse|0|||
13371951|NCT00810069|26719503|FG001|Double-Blind Period II|Clinical relapse|3|||
13371952|NCT00810069|26719504|FG002|Double-Blind Period II|Clinical relapse|0|||
13371953|NCT00810069|26719502|FG000|Double-Blind Period II|Protocol Violation|0|||
13371954|NCT00810069|26719503|FG001|Double-Blind Period II|Protocol Violation|7|||
13371955|NCT00810069|26719504|FG002|Double-Blind Period II|Protocol Violation|6|||
13371956|NCT00810043|26719531|FG000|Overall Study|Withdrawal by Subject|1|||
13371957|NCT00810043|26719532|FG001|Overall Study|Withdrawal by Subject|0|||
13371958|NCT00810043|26719533|FG002|Overall Study|Withdrawal by Subject|2|||
13371959|NCT00810043|26719531|FG000|Overall Study|Lost to Follow-up|1|||
13371960|NCT00810043|26719532|FG001|Overall Study|Lost to Follow-up|0|||
13371961|NCT00810043|26719533|FG002|Overall Study|Lost to Follow-up|0|||
13371962|NCT00810043|26719531|FG000|Overall Study|Physician Decision|0|||
13371963|NCT00810043|26719532|FG001|Overall Study|Physician Decision|0|||
13371964|NCT00810043|26719533|FG002|Overall Study|Physician Decision|2|||
13371965|NCT00810043|26719531|FG000|Overall Study|Death|2|||
13371966|NCT00810043|26719532|FG001|Overall Study|Death|0|||
13371967|NCT00810043|26719533|FG002|Overall Study|Death|0|||
13371968|NCT00810043|26719531|FG000|Overall Study|Unrelated medical problem|0|||
13371969|NCT00810043|26719532|FG001|Overall Study|Unrelated medical problem|1|||
13371970|NCT00810043|26719533|FG002|Overall Study|Unrelated medical problem|0|||
13371971|NCT00810043|26719531|FG000|Overall Study|Non-medical problem|0|||
13371972|NCT00810043|26719532|FG001|Overall Study|Non-medical problem|0|||
13371973|NCT00810043|26719533|FG002|Overall Study|Non-medical problem|1|||
13371974|NCT00810043|26719531|FG000|Overall Study|No longer met enrollment criteria|0|||
13371975|NCT00810043|26719532|FG001|Overall Study|No longer met enrollment criteria|0|||
13371976|NCT00810043|26719533|FG002|Overall Study|No longer met enrollment criteria|3|||
13371977|NCT00809965|26719563|FG000|Overall Study|Death|194|||
13371978|NCT00809965|26719564|FG001|Overall Study|Death|147|||
13371979|NCT00809965|26719565|FG002|Overall Study|Death|196|||
13371980|NCT00809965|26719563|FG000|Overall Study|Lost to Follow-up|17|||
13371981|NCT00809965|26719564|FG001|Overall Study|Lost to Follow-up|10|||
13371982|NCT00809965|26719565|FG002|Overall Study|Lost to Follow-up|18|||
13371983|NCT00809965|26719563|FG000|Overall Study|Withdrawal by Subject|405|||
13371984|NCT00809965|26719564|FG001|Overall Study|Withdrawal by Subject|448|||
13371985|NCT00809965|26719565|FG002|Overall Study|Withdrawal by Subject|441|||
13371986|NCT00809965|26719563|FG000|Overall Study|Other Reason|167|||
13371987|NCT00809965|26719564|FG001|Overall Study|Other Reason|170|||
13371988|NCT00809965|26719565|FG002|Overall Study|Other Reason|189|||
13371989|NCT00809926|26719596|FG000|Overall Study|Adverse Event|18|||
13371990|NCT00809926|26719597|FG001|Overall Study|Adverse Event|10|||
13371991|NCT00809926|26719596|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
13371992|NCT00809926|26719597|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
13371993|NCT00809926|26719596|FG000|Overall Study|Patient withdrew consent|8|||
13371994|NCT00809926|26719597|FG001|Overall Study|Patient withdrew consent|6|||
13371995|NCT00809926|26719596|FG000|Overall Study|Lost to Follow-up|2|||
13371996|NCT00809926|26719597|FG001|Overall Study|Lost to Follow-up|1|||
13371997|NCT00809926|26719596|FG000|Overall Study|Administrative Problems|0|||
13371998|NCT00809926|26719597|FG001|Overall Study|Administrative Problems|1|||
13371999|NCT00809926|26719596|FG000|Overall Study|Protocol deviation|0|||
13372000|NCT00809926|26719597|FG001|Overall Study|Protocol deviation|2|||
13372001|NCT00809835|26719628|FG000|Overall Study|Lost to Follow-up|7|||
13372002|NCT00809835|26719629|FG001|Overall Study|Lost to Follow-up|6|||
13372003|NCT00809835|26719630|FG002|Overall Study|Lost to Follow-up|10|||
13372004|NCT00809835|26719631|FG003|Overall Study|Lost to Follow-up|2|||
13372005|NCT00809835|26719628|FG000|Overall Study|Withdrawal by Subject|1|||
13372006|NCT00809835|26719629|FG001|Overall Study|Withdrawal by Subject|1|||
13372007|NCT00809835|26719630|FG002|Overall Study|Withdrawal by Subject|1|||
13372008|NCT00809835|26719631|FG003|Overall Study|Withdrawal by Subject|0|||
13372009|NCT00809783|26719709|FG000|Overall Study|Death|1|||
13372010|NCT00809783|26719710|FG001|Overall Study|Death|0|||
13372011|NCT00809783|26719711|FG002|Overall Study|Death|0|||
13372012|NCT00809783|26719709|FG000|Overall Study|Adverse Event|34|||
13372013|NCT00809783|26719710|FG001|Overall Study|Adverse Event|52|||
13372014|NCT00809783|26719711|FG002|Overall Study|Adverse Event|71|||
13372015|NCT00809783|26719709|FG000|Overall Study|Lack of Efficacy|39|||
13372016|NCT00809783|26719710|FG001|Overall Study|Lack of Efficacy|52|||
13372017|NCT00809783|26719711|FG002|Overall Study|Lack of Efficacy|63|||
13372018|NCT00809783|26719709|FG000|Overall Study|Lost to Follow-up|0|||
13372019|NCT00809783|26719710|FG001|Overall Study|Lost to Follow-up|3|||
13372020|NCT00809783|26719711|FG002|Overall Study|Lost to Follow-up|4|||
13372021|NCT00809783|26719709|FG000|Overall Study|Withdrawal by Subject|47|||
13372022|NCT00809783|26719710|FG001|Overall Study|Withdrawal by Subject|72|||
13372023|NCT00809783|26719711|FG002|Overall Study|Withdrawal by Subject|64|||
13372024|NCT00809783|26719709|FG000|Overall Study|Protocol Violation|2|||
13372025|NCT00809783|26719710|FG001|Overall Study|Protocol Violation|6|||
13372026|NCT00809783|26719711|FG002|Overall Study|Protocol Violation|5|||
13372027|NCT00809783|26719709|FG000|Overall Study|Randomized, but not treated|3|||
13372028|NCT00809783|26719710|FG001|Overall Study|Randomized, but not treated|0|||
13372029|NCT00809783|26719711|FG002|Overall Study|Randomized, but not treated|2|||
13372030|NCT00809783|26719709|FG000|Overall Study|Study Terminated by Sponsor|378|||
13372031|NCT00809783|26719710|FG001|Overall Study|Study Terminated by Sponsor|626|||
13372032|NCT00809783|26719711|FG002|Overall Study|Study Terminated by Sponsor|565|||
13372033|NCT00809783|26719709|FG000|Overall Study|Other|21|||
13372034|NCT00809783|26719710|FG001|Overall Study|Other|21|||
13372035|NCT00809783|26719711|FG002|Overall Study|Other|16|||
13372036|NCT00809757|26719804|FG000|Overall Study|Adverse Event|2|||
13372037|NCT00809757|26719805|FG001|Overall Study|Adverse Event|3|||
13372038|NCT00809757|26719806|FG002|Overall Study|Adverse Event|3|||
13372039|NCT00809757|26719804|FG000|Overall Study|Lost to Follow-up|0|||
13372040|NCT00809757|26719805|FG001|Overall Study|Lost to Follow-up|0|||
13372041|NCT00809757|26719806|FG002|Overall Study|Lost to Follow-up|1|||
13372042|NCT00809757|26719804|FG000|Overall Study|Protocol Violation|1|||
13372043|NCT00809757|26719805|FG001|Overall Study|Protocol Violation|1|||
13372044|NCT00809757|26719806|FG002|Overall Study|Protocol Violation|1|||
13372045|NCT00809757|26719804|FG000|Overall Study|Withdrawal by Subject|2|||
13372046|NCT00809757|26719805|FG001|Overall Study|Withdrawal by Subject|1|||
13372047|NCT00809757|26719806|FG002|Overall Study|Withdrawal by Subject|3|||
13372048|NCT00809757|26719804|FG000|Overall Study|Subject Uncooperative|1|||
13372049|NCT00809757|26719805|FG001|Overall Study|Subject Uncooperative|0|||
13372050|NCT00809757|26719806|FG002|Overall Study|Subject Uncooperative|2|||
13372051|NCT00809757|26719804|FG000|Overall Study|Noncompliance with Medication|0|||
13372052|NCT00809757|26719805|FG001|Overall Study|Noncompliance with Medication|0|||
13372053|NCT00809757|26719806|FG002|Overall Study|Noncompliance with Medication|1|||
13372054|NCT00809614|26719841|FG000|Overall Study|Lack of Efficacy|2|||
13372055|NCT00809614|26719842|FG001|Overall Study|Lack of Efficacy|3|||
13372056|NCT00809614|26719841|FG000|Overall Study|Withdrawal by Subject|1|||
13372057|NCT00809614|26719842|FG001|Overall Study|Withdrawal by Subject|1|||
13372058|NCT00809471|26719866|FG000|Overall Study|Protocol non-compliance|15|||
13372059|NCT00809471|26719867|FG001|Overall Study|Protocol non-compliance|15|||
13372060|NCT00809471|26719868|FG002|Overall Study|Protocol non-compliance|6|||
13372061|NCT00809471|26719866|FG000|Overall Study|Lost to Follow-up|4|||
13372062|NCT00809471|26719867|FG001|Overall Study|Lost to Follow-up|2|||
13372063|NCT00809471|26719868|FG002|Overall Study|Lost to Follow-up|9|||
13372064|NCT00809471|26719866|FG000|Overall Study|Adverse Event|0|||
13372065|NCT00809471|26719867|FG001|Overall Study|Adverse Event|2|||
13372066|NCT00809471|26719868|FG002|Overall Study|Adverse Event|2|||
13372067|NCT00809471|26719866|FG000|Overall Study|Requirement for restricted medication|1|||
13372068|NCT00809471|26719867|FG001|Overall Study|Requirement for restricted medication|1|||
13372069|NCT00809471|26719868|FG002|Overall Study|Requirement for restricted medication|0|||
13372070|NCT00809445|26719895|FG000|1 Month Follow-up|Lost contact|1|||
13372071|NCT00809445|26719896|FG001|1 Month Follow-up|Lost contact|2|||
13372072|NCT00809445|26719897|FG002|1 Month Follow-up|Lost contact|1|||
13372073|NCT00809445|26719895|FG000|1 Month Follow-up|Withdrew consent|1|||
13372074|NCT00809445|26719896|FG001|1 Month Follow-up|Withdrew consent|1|||
13372075|NCT00809445|26719897|FG002|1 Month Follow-up|Withdrew consent|1|||
13372076|NCT00809445|26719895|FG000|1 Month Follow-up|Death|0|||
13372077|NCT00809445|26719896|FG001|1 Month Follow-up|Death|1|||
13372078|NCT00809445|26719897|FG002|1 Month Follow-up|Death|1|||
13372079|NCT00809445|26719895|FG000|1 Month Follow-up|Incarcerated|0|||
13372080|NCT00809445|26719896|FG001|1 Month Follow-up|Incarcerated|0|||
13372081|NCT00809445|26719897|FG002|1 Month Follow-up|Incarcerated|1|||
13372082|NCT00809445|26719895|FG000|6 Month Follow-up|Lost contact|16|||
13372083|NCT00809445|26719896|FG001|6 Month Follow-up|Lost contact|14|||
13372084|NCT00809445|26719897|FG002|6 Month Follow-up|Lost contact|14|||
13372085|NCT00809445|26719895|FG000|6 Month Follow-up|Death|2|||
13372086|NCT00809445|26719896|FG001|6 Month Follow-up|Death|1|||
13372087|NCT00809445|26719897|FG002|6 Month Follow-up|Death|1|||
13372088|NCT00809445|26719895|FG000|6 Month Follow-up|Incarcerated|6|||
13372089|NCT00809445|26719896|FG001|6 Month Follow-up|Incarcerated|8|||
13372090|NCT00809445|26719897|FG002|6 Month Follow-up|Incarcerated|8|||
13372091|NCT00809445|26719895|FG000|6 Month Follow-up|Withdrew consent|0|||
13372092|NCT00809445|26719896|FG001|6 Month Follow-up|Withdrew consent|0|||
13372093|NCT00809445|26719897|FG002|6 Month Follow-up|Withdrew consent|1|||
13372094|NCT00809354|26720408|FG000|Overall Study|Adverse Event|32|||
13372095|NCT00809354|26720409|FG001|Overall Study|Adverse Event|45|||
13372096|NCT00809354|26720410|FG002|Overall Study|Adverse Event|37|||
13372097|NCT00809354|26720411|FG003|Overall Study|Adverse Event|53|||
13372098|NCT00809354|26720412|FG004|Overall Study|Adverse Event|26|||
13372099|NCT00809354|26720413|FG005|Overall Study|Adverse Event|33|||
13372100|NCT00809354|26720414|FG006|Overall Study|Adverse Event|44|||
13372101|NCT00809354|26720415|FG007|Overall Study|Adverse Event|40|||
13372102|NCT00809354|26720416|FG008|Overall Study|Adverse Event|46|||
13372103|NCT00809354|26720417|FG009|Overall Study|Adverse Event|26|||
13372104|NCT00809354|26720408|FG000|Overall Study|Lack of Efficacy|23|||
13372105|NCT00809354|26720409|FG001|Overall Study|Lack of Efficacy|23|||
13372106|NCT00809354|26720410|FG002|Overall Study|Lack of Efficacy|22|||
13372107|NCT00809354|26720411|FG003|Overall Study|Lack of Efficacy|15|||
13372108|NCT00809354|26720412|FG004|Overall Study|Lack of Efficacy|40|||
13372109|NCT00809354|26720413|FG005|Overall Study|Lack of Efficacy|19|||
13372110|NCT00809354|26720414|FG006|Overall Study|Lack of Efficacy|21|||
13372111|NCT00809354|26720415|FG007|Overall Study|Lack of Efficacy|15|||
13372112|NCT00809354|26720416|FG008|Overall Study|Lack of Efficacy|18|||
13372113|NCT00809354|26720417|FG009|Overall Study|Lack of Efficacy|38|||
13372114|NCT00809354|26720408|FG000|Overall Study|Lost to Follow-up|10|||
13372115|NCT00809354|26720409|FG001|Overall Study|Lost to Follow-up|11|||
13372116|NCT00809354|26720410|FG002|Overall Study|Lost to Follow-up|8|||
13372117|NCT00809354|26720411|FG003|Overall Study|Lost to Follow-up|13|||
13372118|NCT00809354|26720412|FG004|Overall Study|Lost to Follow-up|6|||
13372119|NCT00809354|26720413|FG005|Overall Study|Lost to Follow-up|2|||
13372120|NCT00809354|26720414|FG006|Overall Study|Lost to Follow-up|0|||
13372121|NCT00809354|26720415|FG007|Overall Study|Lost to Follow-up|5|||
13372122|NCT00809354|26720416|FG008|Overall Study|Lost to Follow-up|4|||
13372123|NCT00809354|26720417|FG009|Overall Study|Lost to Follow-up|0|||
13372124|NCT00809354|26720408|FG000|Overall Study|Protocol Violation|7|||
13372125|NCT00809354|26720409|FG001|Overall Study|Protocol Violation|14|||
13372126|NCT00809354|26720410|FG002|Overall Study|Protocol Violation|14|||
13372127|NCT00809354|26720411|FG003|Overall Study|Protocol Violation|12|||
13372128|NCT00809354|26720412|FG004|Overall Study|Protocol Violation|14|||
13372129|NCT00809354|26720413|FG005|Overall Study|Protocol Violation|6|||
13372130|NCT00809354|26720414|FG006|Overall Study|Protocol Violation|4|||
13372131|NCT00809354|26720415|FG007|Overall Study|Protocol Violation|6|||
13372132|NCT00809354|26720416|FG008|Overall Study|Protocol Violation|9|||
13372133|NCT00809354|26720417|FG009|Overall Study|Protocol Violation|3|||
13372134|NCT00809354|26720408|FG000|Overall Study|Withdrawal by Subject|32|||
13372135|NCT00809354|26720409|FG001|Overall Study|Withdrawal by Subject|27|||
13372136|NCT00809354|26720410|FG002|Overall Study|Withdrawal by Subject|31|||
13372137|NCT00809354|26720411|FG003|Overall Study|Withdrawal by Subject|33|||
13372138|NCT00809354|26720412|FG004|Overall Study|Withdrawal by Subject|34|||
13372139|NCT00809354|26720413|FG005|Overall Study|Withdrawal by Subject|29|||
13372140|NCT00809354|26720414|FG006|Overall Study|Withdrawal by Subject|27|||
13372141|NCT00809354|26720415|FG007|Overall Study|Withdrawal by Subject|19|||
13372142|NCT00809354|26720416|FG008|Overall Study|Withdrawal by Subject|18|||
13372143|NCT00809354|26720417|FG009|Overall Study|Withdrawal by Subject|20|||
13372144|NCT00809354|26720408|FG000|Overall Study|Other|10|||
13372145|NCT00809354|26720409|FG001|Overall Study|Other|2|||
13372146|NCT00809354|26720410|FG002|Overall Study|Other|7|||
13372147|NCT00809354|26720411|FG003|Overall Study|Other|10|||
13372148|NCT00809354|26720412|FG004|Overall Study|Other|5|||
13372149|NCT00809354|26720413|FG005|Overall Study|Other|3|||
13372150|NCT00809354|26720414|FG006|Overall Study|Other|2|||
13372151|NCT00809354|26720415|FG007|Overall Study|Other|3|||
13372152|NCT00809354|26720416|FG008|Overall Study|Other|4|||
13372153|NCT00809354|26720417|FG009|Overall Study|Other|3|||
13372154|NCT00809354|26720408|FG000|Overall Study|Study terminated by sponsor|138|||
13372155|NCT00809354|26720409|FG001|Overall Study|Study terminated by sponsor|134|||
13372156|NCT00809354|26720410|FG002|Overall Study|Study terminated by sponsor|129|||
13372157|NCT00809354|26720411|FG003|Overall Study|Study terminated by sponsor|120|||
13372158|NCT00809354|26720412|FG004|Overall Study|Study terminated by sponsor|126|||
13372159|NCT00809354|26720413|FG005|Overall Study|Study terminated by sponsor|133|||
13372160|NCT00809354|26720414|FG006|Overall Study|Study terminated by sponsor|124|||
13372161|NCT00809354|26720415|FG007|Overall Study|Study terminated by sponsor|148|||
13372162|NCT00809354|26720416|FG008|Overall Study|Study terminated by sponsor|127|||
13372163|NCT00809354|26720417|FG009|Overall Study|Study terminated by sponsor|135|||
13372164|NCT00809354|26720408|FG000|Overall Study|Withdrawn due to pregnancy|0|||
13372165|NCT00809354|26720409|FG001|Overall Study|Withdrawn due to pregnancy|1|||
13372166|NCT00809354|26720410|FG002|Overall Study|Withdrawn due to pregnancy|0|||
13372167|NCT00809354|26720411|FG003|Overall Study|Withdrawn due to pregnancy|0|||
13372168|NCT00809354|26720412|FG004|Overall Study|Withdrawn due to pregnancy|0|||
13372169|NCT00809354|26720413|FG005|Overall Study|Withdrawn due to pregnancy|0|||
13372170|NCT00809354|26720414|FG006|Overall Study|Withdrawn due to pregnancy|0|||
13372171|NCT00809354|26720415|FG007|Overall Study|Withdrawn due to pregnancy|0|||
13372172|NCT00809354|26720416|FG008|Overall Study|Withdrawn due to pregnancy|0|||
13372173|NCT00809354|26720417|FG009|Overall Study|Withdrawn due to pregnancy|0|||
13372174|NCT00809354|26720408|FG000|Overall Study|Randomized but not Treated|3|||
13372175|NCT00809354|26720409|FG001|Overall Study|Randomized but not Treated|1|||
13372176|NCT00809354|26720410|FG002|Overall Study|Randomized but not Treated|6|||
13372177|NCT00809354|26720411|FG003|Overall Study|Randomized but not Treated|0|||
13372178|NCT00809354|26720412|FG004|Overall Study|Randomized but not Treated|5|||
13372179|NCT00809354|26720413|FG005|Overall Study|Randomized but not Treated|0|||
13372180|NCT00809354|26720414|FG006|Overall Study|Randomized but not Treated|1|||
13372181|NCT00809354|26720415|FG007|Overall Study|Randomized but not Treated|1|||
13372182|NCT00809354|26720416|FG008|Overall Study|Randomized but not Treated|2|||
13372183|NCT00809354|26720417|FG009|Overall Study|Randomized but not Treated|1|||
13372184|NCT00809354|26720408|FG000|Overall Study|Death|0|||
13372185|NCT00809354|26720409|FG001|Overall Study|Death|0|||
13372186|NCT00809354|26720410|FG002|Overall Study|Death|0|||
13372187|NCT00809354|26720411|FG003|Overall Study|Death|0|||
13372188|NCT00809354|26720412|FG004|Overall Study|Death|0|||
13372189|NCT00809354|26720413|FG005|Overall Study|Death|0|||
13372190|NCT00809354|26720414|FG006|Overall Study|Death|0|||
13372191|NCT00809354|26720415|FG007|Overall Study|Death|1|||
13372192|NCT00809354|26720416|FG008|Overall Study|Death|0|||
13372193|NCT00809354|26720417|FG009|Overall Study|Death|0|||
13372194|NCT00809341|26720432|FG000|Overall Study|Physician Decision|0|||
13372195|NCT00809341|26720433|FG001|Overall Study|Physician Decision|1|||
13372196|NCT00809328|26720443|FG000|Overall Study|Lack of Efficacy|18|||
13372197|NCT00809328|26720443|FG000|Overall Study|Adverse Event|6|||
13372198|NCT00809328|26720443|FG000|Overall Study|Protocol Violation|3|||
13372199|NCT00809328|26720443|FG000|Overall Study|Withdrawal by Subject|2|||
13372200|NCT00809159|26720522|FG000|Part 1|Adverse Event|1|||
13372201|NCT00809159|26720523|FG001|Part 1|Adverse Event|1|||
13372202|NCT00809159|26720524|FG002|Part 1|Adverse Event|0|||
13372203|NCT00809159|26720525|FG003|Part 1|Adverse Event|0|||
13372204|NCT00809159|26720526|FG004|Part 1|Adverse Event|0|||
13372205|NCT00809159|26720527|FG005|Part 1|Adverse Event|0|||
13372206|NCT00809159|26720522|FG000|Part 1|Lost to Follow-up|1|||
13372207|NCT00809159|26720523|FG001|Part 1|Lost to Follow-up|0|||
13372208|NCT00809159|26720524|FG002|Part 1|Lost to Follow-up|0|||
13372209|NCT00809159|26720525|FG003|Part 1|Lost to Follow-up|0|||
13372210|NCT00809159|26720526|FG004|Part 1|Lost to Follow-up|0|||
13372211|NCT00809159|26720527|FG005|Part 1|Lost to Follow-up|0|||
13372212|NCT00809159|26720522|FG000|Part 1|Withdrawal by Subject|3|||
13372213|NCT00809159|26720523|FG001|Part 1|Withdrawal by Subject|1|||
13372214|NCT00809159|26720524|FG002|Part 1|Withdrawal by Subject|0|||
13372215|NCT00809159|26720525|FG003|Part 1|Withdrawal by Subject|0|||
13372216|NCT00809159|26720526|FG004|Part 1|Withdrawal by Subject|0|||
13372217|NCT00809159|26720527|FG005|Part 1|Withdrawal by Subject|0|||
13372218|NCT00809159|26720522|FG000|Part 1|Unsatisfactory therapeutic effect|3|||
13372219|NCT00809159|26720523|FG001|Part 1|Unsatisfactory therapeutic effect|1|||
13372220|NCT00809159|26720524|FG002|Part 1|Unsatisfactory therapeutic effect|0|||
13372221|NCT00809159|26720525|FG003|Part 1|Unsatisfactory therapeutic effect|0|||
13372222|NCT00809159|26720526|FG004|Part 1|Unsatisfactory therapeutic effect|0|||
13372223|NCT00809159|26720527|FG005|Part 1|Unsatisfactory therapeutic effect|0|||
13372224|NCT00809159|26720522|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
13372225|NCT00809159|26720523|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
13372226|NCT00809159|26720524|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4|||
13372227|NCT00809159|26720525|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3|||
13372228|NCT00809159|26720526|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5|||
13372229|NCT00809159|26720527|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1|||
13372230|NCT00809159|26720522|FG000|Part 1 and 2|Administrative problems|0|||
13372231|NCT00809159|26720523|FG001|Part 1 and 2|Administrative problems|0|||
13372232|NCT00809159|26720524|FG002|Part 1 and 2|Administrative problems|0|||
13372233|NCT00809159|26720525|FG003|Part 1 and 2|Administrative problems|1|||
13372234|NCT00809159|26720526|FG004|Part 1 and 2|Administrative problems|0|||
13372235|NCT00809159|26720527|FG005|Part 1 and 2|Administrative problems|0|||
13372236|NCT00809159|26720522|FG000|Part 1 and 2|Adverse Event|0|||
13372237|NCT00809159|26720523|FG001|Part 1 and 2|Adverse Event|0|||
13372238|NCT00809159|26720524|FG002|Part 1 and 2|Adverse Event|1|||
13372239|NCT00809159|26720525|FG003|Part 1 and 2|Adverse Event|0|||
13372240|NCT00809159|26720526|FG004|Part 1 and 2|Adverse Event|1|||
13372241|NCT00809159|26720527|FG005|Part 1 and 2|Adverse Event|1|||
13372242|NCT00809159|26720522|FG000|Part 1 and 2|Lost to Follow-up|0|||
13372243|NCT00809159|26720523|FG001|Part 1 and 2|Lost to Follow-up|0|||
13372244|NCT00809159|26720524|FG002|Part 1 and 2|Lost to Follow-up|1|||
13372245|NCT00809159|26720525|FG003|Part 1 and 2|Lost to Follow-up|1|||
13372246|NCT00809159|26720526|FG004|Part 1 and 2|Lost to Follow-up|0|||
13372247|NCT00809159|26720527|FG005|Part 1 and 2|Lost to Follow-up|0|||
13372248|NCT00809159|26720522|FG000|Part 1 and 2|Withdrawal by Subject|0|||
13372249|NCT00809159|26720523|FG001|Part 1 and 2|Withdrawal by Subject|0|||
13372250|NCT00809159|26720524|FG002|Part 1 and 2|Withdrawal by Subject|4|||
13372251|NCT00809159|26720525|FG003|Part 1 and 2|Withdrawal by Subject|0|||
13372252|NCT00809159|26720526|FG004|Part 1 and 2|Withdrawal by Subject|0|||
13372253|NCT00809159|26720527|FG005|Part 1 and 2|Withdrawal by Subject|1|||
13372254|NCT00809133|26720722|FG000|Overall Study|Progressive disease|2|||
13372255|NCT00809133|26720723|FG001|Overall Study|Progressive disease|5|||
13372256|NCT00809133|26720724|FG002|Overall Study|Progressive disease|5|||
13372257|NCT00809133|26720725|FG003|Overall Study|Progressive disease|3|||
13372258|NCT00809133|26720726|FG004|Overall Study|Progressive disease|4|||
13372259|NCT00809133|26720727|FG005|Overall Study|Progressive disease|1|||
13372260|NCT00809133|26720728|FG006|Overall Study|Progressive disease|3|||
13372261|NCT00809133|26720729|FG007|Overall Study|Progressive disease|3|||
13372262|NCT00809133|26720730|FG008|Overall Study|Progressive disease|3|||
13372263|NCT00809133|26720731|FG009|Overall Study|Progressive disease|9|||
13372264|NCT00809133|26720732|FG010|Overall Study|Progressive disease|5|||
13372265|NCT00809133|26720733|FG011|Overall Study|Progressive disease|7|||
13372266|NCT00809133|26720734|FG012|Overall Study|Progressive disease|5|||
13372267|NCT00809133|26720735|FG013|Overall Study|Progressive disease|4|||
13372268|NCT00809133|26720722|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
13372269|NCT00809133|26720723|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
13372270|NCT00809133|26720724|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
13372271|NCT00809133|26720725|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
13372272|NCT00809133|26720726|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
13372273|NCT00809133|26720727|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1|||
13372274|NCT00809133|26720728|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1|||
13372275|NCT00809133|26720729|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1|||
13372276|NCT00809133|26720730|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
13372277|NCT00809133|26720731|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
13372278|NCT00809133|26720732|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
13372279|NCT00809133|26720733|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
13372280|NCT00809133|26720734|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
13372281|NCT00809133|26720735|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2|||
13372282|NCT00809133|26720722|FG000|Overall Study|Other adverse event|1|||
13372283|NCT00809133|26720723|FG001|Overall Study|Other adverse event|1|||
13372284|NCT00809133|26720724|FG002|Overall Study|Other adverse event|1|||
13372285|NCT00809133|26720725|FG003|Overall Study|Other adverse event|0|||
13372286|NCT00809133|26720726|FG004|Overall Study|Other adverse event|0|||
13372287|NCT00809133|26720727|FG005|Overall Study|Other adverse event|3|||
13372288|NCT00809133|26720728|FG006|Overall Study|Other adverse event|2|||
13372289|NCT00809133|26720729|FG007|Overall Study|Other adverse event|4|||
13372290|NCT00809133|26720730|FG008|Overall Study|Other adverse event|0|||
13372291|NCT00809133|26720731|FG009|Overall Study|Other adverse event|0|||
13372292|NCT00809133|26720732|FG010|Overall Study|Other adverse event|1|||
13372293|NCT00809133|26720733|FG011|Overall Study|Other adverse event|1|||
13372294|NCT00809133|26720734|FG012|Overall Study|Other adverse event|0|||
13372295|NCT00809133|26720735|FG013|Overall Study|Other adverse event|1|||
13372296|NCT00809133|26720722|FG000|Overall Study|Lost to Follow-up|0|||
13372297|NCT00809133|26720723|FG001|Overall Study|Lost to Follow-up|0|||
13372298|NCT00809133|26720724|FG002|Overall Study|Lost to Follow-up|0|||
13372299|NCT00809133|26720725|FG003|Overall Study|Lost to Follow-up|0|||
13372300|NCT00809133|26720726|FG004|Overall Study|Lost to Follow-up|0|||
13372301|NCT00809133|26720727|FG005|Overall Study|Lost to Follow-up|1|||
13372302|NCT00809133|26720728|FG006|Overall Study|Lost to Follow-up|0|||
13372303|NCT00809133|26720729|FG007|Overall Study|Lost to Follow-up|0|||
13372304|NCT00809133|26720730|FG008|Overall Study|Lost to Follow-up|0|||
13372305|NCT00809133|26720731|FG009|Overall Study|Lost to Follow-up|0|||
13372306|NCT00809133|26720732|FG010|Overall Study|Lost to Follow-up|0|||
13372307|NCT00809133|26720733|FG011|Overall Study|Lost to Follow-up|0|||
13372308|NCT00809133|26720734|FG012|Overall Study|Lost to Follow-up|0|||
13372309|NCT00809133|26720735|FG013|Overall Study|Lost to Follow-up|0|||
13372310|NCT00809133|26720722|FG000|Overall Study|Consent withdrawn|0|||
13372311|NCT00809133|26720723|FG001|Overall Study|Consent withdrawn|0|||
13372312|NCT00809133|26720724|FG002|Overall Study|Consent withdrawn|0|||
13372313|NCT00809133|26720725|FG003|Overall Study|Consent withdrawn|0|||
13372314|NCT00809133|26720726|FG004|Overall Study|Consent withdrawn|1|||
13372315|NCT00809133|26720727|FG005|Overall Study|Consent withdrawn|0|||
13372316|NCT00809133|26720728|FG006|Overall Study|Consent withdrawn|0|||
13372317|NCT00809133|26720729|FG007|Overall Study|Consent withdrawn|0|||
13372318|NCT00809133|26720730|FG008|Overall Study|Consent withdrawn|0|||
13372319|NCT00809133|26720731|FG009|Overall Study|Consent withdrawn|0|||
13372320|NCT00809133|26720732|FG010|Overall Study|Consent withdrawn|0|||
13372321|NCT00809133|26720733|FG011|Overall Study|Consent withdrawn|0|||
13372322|NCT00809133|26720734|FG012|Overall Study|Consent withdrawn|0|||
13372323|NCT00809133|26720735|FG013|Overall Study|Consent withdrawn|0|||
13372324|NCT00809133|26720722|FG000|Overall Study|Other not mentioned above|0|||
13372325|NCT00809133|26720723|FG001|Overall Study|Other not mentioned above|1|||
13372326|NCT00809133|26720724|FG002|Overall Study|Other not mentioned above|0|||
13372327|NCT00809133|26720725|FG003|Overall Study|Other not mentioned above|0|||
13372328|NCT00809133|26720726|FG004|Overall Study|Other not mentioned above|0|||
13372329|NCT00809133|26720727|FG005|Overall Study|Other not mentioned above|1|||
13372330|NCT00809133|26720728|FG006|Overall Study|Other not mentioned above|0|||
13372331|NCT00809133|26720729|FG007|Overall Study|Other not mentioned above|0|||
13372332|NCT00809133|26720730|FG008|Overall Study|Other not mentioned above|0|||
13372333|NCT00809133|26720731|FG009|Overall Study|Other not mentioned above|0|||
13372334|NCT00809133|26720732|FG010|Overall Study|Other not mentioned above|0|||
13372335|NCT00809133|26720733|FG011|Overall Study|Other not mentioned above|0|||
13372336|NCT00809133|26720734|FG012|Overall Study|Other not mentioned above|0|||
13372337|NCT00809133|26720735|FG013|Overall Study|Other not mentioned above|0|||
13372338|NCT00809094|26720760|FG000|Overall Study|Lost to Follow-up|0|||
13372339|NCT00809094|26720761|FG001|Overall Study|Lost to Follow-up|1|||
13372340|NCT00808899|26720767|FG000|Overall Study|Death|1|||
13372341|NCT00808899|26720767|FG000|Overall Study|Physician Decision|3|||
13372342|NCT00808808|26720803|FG000|Overall Study|Vaccinated; survey not completed|131|||
13372343|NCT00808808|26720804|FG001|Overall Study|Vaccinated; survey not completed|169|||
13372344|NCT00808808|26720805|FG002|Overall Study|Vaccinated; survey not completed|302|||
13372345|NCT00808808|26720803|FG000|Overall Study|Employee was not vaccinated.|2686|||
13372346|NCT00808808|26720804|FG001|Overall Study|Employee was not vaccinated.|2268|||
13372347|NCT00808808|26720805|FG002|Overall Study|Employee was not vaccinated.|2255|||
13372348|NCT00808665|26720818|FG000|Overall Study|Withdrawal by Subject|1|||
13372349|NCT00808665|26720819|FG001|Overall Study|Withdrawal by Subject|0|||
13372350|NCT00808665|26720818|FG000|Overall Study|only required minimally invasive surgery|1|||
13372351|NCT00808665|26720819|FG001|Overall Study|only required minimally invasive surgery|0|||
13372352|NCT00808665|26720818|FG000|Overall Study|surgery cancelled|1|||
13372353|NCT00808665|26720819|FG001|Overall Study|surgery cancelled|0|||
13372354|NCT00808665|26720818|FG000|Overall Study|required an additional procedure|0|||
13372355|NCT00808665|26720819|FG001|Overall Study|required an additional procedure|1|||
13372356|NCT00808665|26720818|FG000|Overall Study|Physician Decision|3|||
13372357|NCT00808665|26720819|FG001|Overall Study|Physician Decision|1|||
13372358|NCT00808665|26720818|FG000|Overall Study|Medication stopped by resident|0|||
13372359|NCT00808665|26720819|FG001|Overall Study|Medication stopped by resident|1|||
13372360|NCT00808639|26720827|FG000|Overall Study|Disease progression before surgery.|1|||
13372361|NCT00808509|26720930|FG000|Randomized Phase|Did not meet eligibility criteria|1|||
13372362|NCT00808509|26720931|FG001|Randomized Phase|Did not meet eligibility criteria|0|||
13372363|NCT00808509|26720930|FG000|Randomized Phase|Reduced methotrexate dose|1|||
13372364|NCT00808509|26720931|FG001|Randomized Phase|Reduced methotrexate dose|2|||
13372365|NCT00808509|26720930|FG000|Randomized Phase|Patient refused rescue therapy|0|||
13372366|NCT00808509|26720931|FG001|Randomized Phase|Patient refused rescue therapy|3|||
13372367|NCT00808483|26720958|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
13372368|NCT00808483|26720959|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
13372369|NCT00808483|26720958|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1|||
13372370|NCT00808483|26720959|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0|||
13372371|NCT00808483|26720958|FG000|From 5 Months to 12 Months|Lack of Efficacy|1|||
13372372|NCT00808483|26720959|FG001|From 5 Months to 12 Months|Lack of Efficacy|0|||
13372373|NCT00808444|26721004|FG000|Overall Study|Withdrawal by Subject|1|||
13372374|NCT00808444|26721005|FG001|Overall Study|Withdrawal by Subject|0|||
13372375|NCT00808444|26721004|FG000|Overall Study|Lost to Follow-up|0|||
13372376|NCT00808444|26721005|FG001|Overall Study|Lost to Follow-up|1|||
13486675|NCT01889186|27036813|FG000|Overall Study|Progressive disease- Richter's|12|||
13486676|NCT01889186|27036814|FG001|Overall Study|Progressive disease- Richter's|7|||
13486677|NCT01889186|27036813|FG000|Overall Study|Progressive disease per protocol|46|||
13486678|NCT01889186|27036814|FG001|Overall Study|Progressive disease per protocol|17|||
13486679|NCT01889186|27036813|FG000|Overall Study|Stem cell transplant|2|||
13486680|NCT01889186|27036814|FG001|Overall Study|Stem cell transplant|1|||
13486681|NCT01889186|27036813|FG000|Overall Study|Withdrew consent|2|||
13486682|NCT01889186|27036814|FG001|Overall Study|Withdrew consent|3|||
13486683|NCT01889186|27036813|FG000|Overall Study|Other, not specified|18|||
13486684|NCT01889186|27036814|FG001|Overall Study|Other, not specified|15|||
13486685|NCT01510184|27036833|FG000|Overall Study|Sponsor discretion|28|||
13486686|NCT01510184|27036834|FG001|Overall Study|Sponsor discretion|28|||
13486687|NCT01510184|27036833|FG000|Overall Study|Death|1|||
13486688|NCT01510184|27036834|FG001|Overall Study|Death|2|||
13486689|NCT01510184|27036833|FG000|Overall Study|Withdrawal by Subject|1|||
13486690|NCT01510184|27036834|FG001|Overall Study|Withdrawal by Subject|4|||
13486691|NCT01510184|27036833|FG000|Overall Study|Other|0|||
13486692|NCT01510184|27036834|FG001|Overall Study|Other|1|||
13372377|NCT00808249|26721044|FG000|Overall Study|Adverse Event|4|||
13372378|NCT00808249|26721045|FG001|Overall Study|Adverse Event|7|||
13372379|NCT00808249|26721046|FG002|Overall Study|Adverse Event|10|||
13372380|NCT00808249|26721047|FG003|Overall Study|Adverse Event|6|||
13372381|NCT00808249|26721044|FG000|Overall Study|Lost to Follow-up|2|||
13372382|NCT00808249|26721045|FG001|Overall Study|Lost to Follow-up|3|||
13372383|NCT00808249|26721046|FG002|Overall Study|Lost to Follow-up|3|||
13372384|NCT00808249|26721047|FG003|Overall Study|Lost to Follow-up|5|||
13372385|NCT00808249|26721044|FG000|Overall Study|Withdrawal by Subject|4|||
13372386|NCT00808249|26721045|FG001|Overall Study|Withdrawal by Subject|0|||
13372387|NCT00808249|26721046|FG002|Overall Study|Withdrawal by Subject|2|||
13372388|NCT00808249|26721047|FG003|Overall Study|Withdrawal by Subject|4|||
13372389|NCT00808249|26721044|FG000|Overall Study|Protocol Violation|3|||
13372390|NCT00808249|26721045|FG001|Overall Study|Protocol Violation|3|||
13372391|NCT00808249|26721046|FG002|Overall Study|Protocol Violation|3|||
13372392|NCT00808249|26721047|FG003|Overall Study|Protocol Violation|0|||
13372393|NCT00808249|26721044|FG000|Overall Study|Lack of Efficacy|1|||
13372394|NCT00808249|26721045|FG001|Overall Study|Lack of Efficacy|1|||
13372395|NCT00808249|26721046|FG002|Overall Study|Lack of Efficacy|0|||
13372396|NCT00808249|26721047|FG003|Overall Study|Lack of Efficacy|0|||
13372397|NCT00808249|26721044|FG000|Overall Study|study specific discontinuation criteria|1|||
13372398|NCT00808249|26721045|FG001|Overall Study|study specific discontinuation criteria|0|||
13372399|NCT00808249|26721046|FG002|Overall Study|study specific discontinuation criteria|1|||
13372400|NCT00808249|26721047|FG003|Overall Study|study specific discontinuation criteria|0|||
13372401|NCT00808249|26721044|FG000|Overall Study|All other reasons|2|||
13372402|NCT00808249|26721045|FG001|Overall Study|All other reasons|1|||
13372403|NCT00808249|26721046|FG002|Overall Study|All other reasons|3|||
13372404|NCT00808249|26721047|FG003|Overall Study|All other reasons|1|||
13372405|NCT00808236|26721082|FG000|Overall Study|Was not resuscitated|50|||
13372406|NCT00808236|26721083|FG001|Overall Study|Was not resuscitated|56|||
13372407|NCT00808236|26721082|FG000|Overall Study|Pre-defined exclusion|13|||
13372408|NCT00808236|26721083|FG001|Overall Study|Pre-defined exclusion|3|||
13372409|NCT00808236|26721082|FG000|Overall Study|Lost to Follow-up|1|||
13372410|NCT00808236|26721083|FG001|Overall Study|Lost to Follow-up|1|||
13372411|NCT00808236|26721082|FG000|Overall Study|Physician Decision|0|||
13372412|NCT00808236|26721083|FG001|Overall Study|Physician Decision|1|||
13372413|NCT00808236|26721082|FG000|Overall Study|Death|18|||
13372414|NCT00808236|26721083|FG001|Overall Study|Death|30|||
13372415|NCT00808210|26721110|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3|||
13372416|NCT00808210|26721111|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7|||
13372417|NCT00808210|26721110|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6|||
13372418|NCT00808210|26721111|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2|||
13372419|NCT00808210|26721110|FG000|Double-Blind TX Period|Adverse Event|0|||
13372420|NCT00808210|26721111|FG001|Double-Blind TX Period|Adverse Event|1|||
13372421|NCT00808210|26721110|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1|||
13372422|NCT00808210|26721111|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1|||
13372423|NCT00808210|26721110|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
13486693|NCT01471444|27036853|FG000|Overall Study|Physician Decision|3|||
13486694|NCT01471444|27036854|FG001|Overall Study|Physician Decision|2|||
13204516|NCT01972776|26229180|FG004|Part 2|Administrative problems|10|||
13372424|NCT00808210|26721111|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
13372425|NCT00808210|26721110|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9|||
13375468|NCT00790790|26729932|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
13372426|NCT00808210|26721111|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4|||
13372427|NCT00808132|26721199|FG000|Overall Study|Adverse Event|34|||
13372428|NCT00808132|26721200|FG001|Overall Study|Adverse Event|33|||
13372429|NCT00808132|26721201|FG002|Overall Study|Adverse Event|16|||
13372430|NCT00808132|26721202|FG003|Overall Study|Adverse Event|31|||
13372431|NCT00808132|26721203|FG004|Overall Study|Adverse Event|33|||
13372432|NCT00808132|26721199|FG000|Overall Study|Death|0|||
13372433|NCT00808132|26721200|FG001|Overall Study|Death|0|||
13372434|NCT00808132|26721201|FG002|Overall Study|Death|0|||
13372435|NCT00808132|26721202|FG003|Overall Study|Death|0|||
13372436|NCT00808132|26721203|FG004|Overall Study|Death|1|||
13372437|NCT00808132|26721199|FG000|Overall Study|Physician Decision|0|||
13372438|NCT00808132|26721200|FG001|Overall Study|Physician Decision|1|||
13372439|NCT00808132|26721201|FG002|Overall Study|Physician Decision|0|||
13372440|NCT00808132|26721202|FG003|Overall Study|Physician Decision|0|||
13372441|NCT00808132|26721203|FG004|Overall Study|Physician Decision|0|||
13372442|NCT00808132|26721199|FG000|Overall Study|Lost to Follow-up|8|||
13372443|NCT00808132|26721200|FG001|Overall Study|Lost to Follow-up|10|||
13372444|NCT00808132|26721201|FG002|Overall Study|Lost to Follow-up|11|||
13372445|NCT00808132|26721202|FG003|Overall Study|Lost to Follow-up|8|||
13372446|NCT00808132|26721203|FG004|Overall Study|Lost to Follow-up|9|||
13372447|NCT00808132|26721199|FG000|Overall Study|Protocol Violation|8|||
13372448|NCT00808132|26721200|FG001|Overall Study|Protocol Violation|9|||
13372449|NCT00808132|26721201|FG002|Overall Study|Protocol Violation|4|||
13372450|NCT00808132|26721202|FG003|Overall Study|Protocol Violation|9|||
13372451|NCT00808132|26721203|FG004|Overall Study|Protocol Violation|5|||
13372452|NCT00808132|26721199|FG000|Overall Study|Withdrawal by Subject|27|||
13372453|NCT00808132|26721200|FG001|Overall Study|Withdrawal by Subject|18|||
13372454|NCT00808132|26721201|FG002|Overall Study|Withdrawal by Subject|2|||
13372455|NCT00808132|26721202|FG003|Overall Study|Withdrawal by Subject|7|||
13372456|NCT00808132|26721203|FG004|Overall Study|Withdrawal by Subject|16|||
13372457|NCT00808132|26721199|FG000|Overall Study|Other|6|||
13372458|NCT00808132|26721200|FG001|Overall Study|Other|4|||
13372459|NCT00808132|26721201|FG002|Overall Study|Other|6|||
13372460|NCT00808132|26721202|FG003|Overall Study|Other|2|||
13372461|NCT00808132|26721203|FG004|Overall Study|Other|15|||
13372462|NCT00808132|26721199|FG000|Overall Study|Randomized, but not treated|10|||
13372463|NCT00808132|26721200|FG001|Overall Study|Randomized, but not treated|7|||
13372464|NCT00808132|26721201|FG002|Overall Study|Randomized, but not treated|9|||
13372465|NCT00808132|26721202|FG003|Overall Study|Randomized, but not treated|8|||
13372466|NCT00808132|26721203|FG004|Overall Study|Randomized, but not treated|9|||
13372467|NCT00808132|26721199|FG000|Overall Study|Unsatisfactory response|5|||
13372468|NCT00808132|26721200|FG001|Overall Study|Unsatisfactory response|6|||
13372469|NCT00808132|26721201|FG002|Overall Study|Unsatisfactory response|6|||
13372470|NCT00808132|26721202|FG003|Overall Study|Unsatisfactory response|4|||
13372471|NCT00808132|26721203|FG004|Overall Study|Unsatisfactory response|12|||
13372472|NCT00808080|26721210|FG000|Overall Study|Patients Became Ineligible for infusion|6|||
13372473|NCT00808067|26721249|FG000|Overall Study|Major/minor bleed|30|||
13372474|NCT00808067|26721250|FG001|Overall Study|Major/minor bleed|44|||
13372475|NCT00808067|26721249|FG000|Overall Study|Outcome event - other|33|||
13372476|NCT00808067|26721250|FG001|Overall Study|Outcome event - other|25|||
13372477|NCT00808067|26721249|FG000|Overall Study|Adverse Event|111|||
13372478|NCT00808067|26721250|FG001|Overall Study|Adverse Event|121|||
13372479|NCT00808067|26721249|FG000|Overall Study|Hospitalization (not including surgery)|18|||
13372480|NCT00808067|26721250|FG001|Overall Study|Hospitalization (not including surgery)|17|||
13372481|NCT00808067|26721249|FG000|Overall Study|Hospitalization due to surgery|37|||
13372482|NCT00808067|26721250|FG001|Overall Study|Hospitalization due to surgery|40|||
13372483|NCT00808067|26721249|FG000|Overall Study|Reduced creatinine clearance|53|||
13372484|NCT00808067|26721250|FG001|Overall Study|Reduced creatinine clearance|55|||
13372485|NCT00808067|26721249|FG000|Overall Study|Elevated LFT results|7|||
13372486|NCT00808067|26721250|FG001|Overall Study|Elevated LFT results|3|||
13372487|NCT00808067|26721249|FG000|Overall Study|Patient refused to take study medication|65|||
13372488|NCT00808067|26721250|FG001|Overall Study|Patient refused to take study medication|76|||
13372489|NCT00808067|26721249|FG000|Overall Study|Missing|1|||
13372490|NCT00808067|26721250|FG001|Overall Study|Missing|0|||
13372491|NCT00808067|26721249|FG000|Overall Study|Death|1|||
13372492|NCT00808067|26721250|FG001|Overall Study|Death|1|||
13372493|NCT00808067|26721249|FG000|Overall Study|Procedure|6|||
13372494|NCT00808067|26721250|FG001|Overall Study|Procedure|7|||
13372495|NCT00808067|26721249|FG000|Overall Study|Withdrawal by Subject|21|||
13372496|NCT00808067|26721250|FG001|Overall Study|Withdrawal by Subject|25|||
13372497|NCT00808067|26721249|FG000|Overall Study|Site closed|4|||
13372498|NCT00808067|26721250|FG001|Overall Study|Site closed|3|||
13372499|NCT00808067|26721249|FG000|Overall Study|Physician Decision|47|||
13372500|NCT00808067|26721250|FG001|Overall Study|Physician Decision|38|||
13372501|NCT00808067|26721249|FG000|Overall Study|Protocol Violation|3|||
13372502|NCT00808067|26721250|FG001|Overall Study|Protocol Violation|11|||
13372503|NCT00808067|26721249|FG000|Overall Study|Patient elected|7|||
13372504|NCT00808067|26721250|FG001|Overall Study|Patient elected|9|||
13372505|NCT00808067|26721249|FG000|Overall Study|Site closed for cause|19|||
13372506|NCT00808067|26721250|FG001|Overall Study|Site closed for cause|19|||
13372507|NCT00808067|26721249|FG000|Overall Study|Other reason not defined above|5|||
13372508|NCT00808067|26721250|FG001|Overall Study|Other reason not defined above|5|||
13372509|NCT00808067|26721249|FG000|Overall Study|Excluded from analysis|13|||
13372510|NCT00808067|26721250|FG001|Overall Study|Excluded from analysis|19|||
13372511|NCT00808028|26721299|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3|||
13372512|NCT00808028|26721300|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0|||
13372513|NCT00808028|26721301|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2|||
13372514|NCT00808028|26721302|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5|||
13372515|NCT00808028|26721299|FG000|Stage 1 (6 Months)|Other|1|||
13372516|NCT00808028|26721300|FG001|Stage 1 (6 Months)|Other|0|||
13372517|NCT00808028|26721301|FG002|Stage 1 (6 Months)|Other|2|||
13372518|NCT00808028|26721302|FG003|Stage 1 (6 Months)|Other|4|||
13372519|NCT00808028|26721299|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0|||
13372520|NCT00808028|26721300|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1|||
13372521|NCT00808028|26721301|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1|||
13372522|NCT00808028|26721302|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3|||
13372523|NCT00808028|26721299|FG000|Stage 1 (6 Months)|Adverse Event|0|||
13372524|NCT00808028|26721300|FG001|Stage 1 (6 Months)|Adverse Event|0|||
13372525|NCT00808028|26721301|FG002|Stage 1 (6 Months)|Adverse Event|1|||
13372526|NCT00808028|26721302|FG003|Stage 1 (6 Months)|Adverse Event|2|||
13372527|NCT00808028|26721299|FG000|Stage 1 (6 Months)|Lost to Follow-up|1|||
13372528|NCT00808028|26721300|FG001|Stage 1 (6 Months)|Lost to Follow-up|0|||
13372529|NCT00808028|26721301|FG002|Stage 1 (6 Months)|Lost to Follow-up|1|||
13372530|NCT00808028|26721302|FG003|Stage 1 (6 Months)|Lost to Follow-up|0|||
13372531|NCT00808028|26721299|FG000|Stage 1 (6 Months)|Protocol Violation|0|||
13372532|NCT00808028|26721300|FG001|Stage 1 (6 Months)|Protocol Violation|0|||
13372533|NCT00808028|26721301|FG002|Stage 1 (6 Months)|Protocol Violation|0|||
13372534|NCT00808028|26721302|FG003|Stage 1 (6 Months)|Protocol Violation|1|||
13372535|NCT00808028|26721299|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6|||
13372536|NCT00808028|26721300|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0|||
13372537|NCT00808028|26721301|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9|||
13372538|NCT00808028|26721302|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11|||
13372539|NCT00808028|26721299|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
13372540|NCT00808028|26721300|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
13372541|NCT00808028|26721301|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1|||
13372542|NCT00808028|26721302|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
13372543|NCT00808028|26721299|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2|||
13372544|NCT00808028|26721300|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0|||
13372545|NCT00808028|26721301|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8|||
13372546|NCT00808028|26721302|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7|||
13372547|NCT00808028|26721299|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2|||
13372548|NCT00808028|26721300|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0|||
13372549|NCT00808028|26721301|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5|||
13372550|NCT00808028|26721302|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4|||
13372551|NCT00808028|26721299|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
13372552|NCT00808028|26721300|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
13372553|NCT00808028|26721301|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
13372554|NCT00808028|26721302|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
13372555|NCT00808028|26721299|FG000|Stage 2 (Followed up to 48 Months )|Other|0|||
13372556|NCT00808028|26721300|FG001|Stage 2 (Followed up to 48 Months )|Other|0|||
13372557|NCT00808028|26721301|FG002|Stage 2 (Followed up to 48 Months )|Other|1|||
13372558|NCT00808028|26721302|FG003|Stage 2 (Followed up to 48 Months )|Other|1|||
13372559|NCT00808028|26721299|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
13372560|NCT00808028|26721300|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
13372561|NCT00808028|26721301|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2|||
13372562|NCT00808028|26721302|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
13372563|NCT00808028|26721299|FG000|Stage 2 (Followed up to 48 Months )|Death|0|||
13372564|NCT00808028|26721300|FG001|Stage 2 (Followed up to 48 Months )|Death|0|||
13372565|NCT00808028|26721301|FG002|Stage 2 (Followed up to 48 Months )|Death|1|||
13372566|NCT00808028|26721302|FG003|Stage 2 (Followed up to 48 Months )|Death|0|||
13372567|NCT00808028|26721299|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
13372568|NCT00808028|26721300|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
13372569|NCT00808028|26721301|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1|||
13372570|NCT00808028|26721302|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
13372571|NCT00808015|26721316|FG000|Overall Study|Death|1|||
13372572|NCT00808015|26721316|FG000|Overall Study|Lack of Efficacy|58|||
13372573|NCT00808015|26721316|FG000|Overall Study|Lost to Follow-up|76|||
13372574|NCT00808015|26721316|FG000|Overall Study|Participants not willing to participate|158|||
13372575|NCT00808015|26721316|FG000|Overall Study|Adverse Event|22|||
13372576|NCT00808015|26721316|FG000|Overall Study|Other|25|||
13372577|NCT00808015|26721316|FG000|Overall Study|Enrolled but not treated|4|||
13372578|NCT00807937|26721355|FG000|Overall Study|Adverse Event|12|||
13372579|NCT00807937|26721356|FG001|Overall Study|Adverse Event|12|||
13372580|NCT00807937|26721357|FG002|Overall Study|Adverse Event|5|||
13372581|NCT00807937|26721358|FG003|Overall Study|Adverse Event|4|||
13372582|NCT00807937|26721355|FG000|Overall Study|Protocol Violation|4|||
13372583|NCT00807937|26721356|FG001|Overall Study|Protocol Violation|5|||
13372584|NCT00807937|26721357|FG002|Overall Study|Protocol Violation|3|||
13372585|NCT00807937|26721358|FG003|Overall Study|Protocol Violation|3|||
13372586|NCT00807937|26721355|FG000|Overall Study|Withdrawal by Subject|5|||
13372587|NCT00807937|26721356|FG001|Overall Study|Withdrawal by Subject|4|||
13372588|NCT00807937|26721357|FG002|Overall Study|Withdrawal by Subject|1|||
13372589|NCT00807937|26721358|FG003|Overall Study|Withdrawal by Subject|4|||
13372590|NCT00807937|26721355|FG000|Overall Study|Lost to Follow-up|4|||
13372591|NCT00807937|26721356|FG001|Overall Study|Lost to Follow-up|0|||
13372592|NCT00807937|26721357|FG002|Overall Study|Lost to Follow-up|2|||
13372593|NCT00807937|26721358|FG003|Overall Study|Lost to Follow-up|1|||
13372594|NCT00807937|26721355|FG000|Overall Study|Lack of Efficacy|0|||
13372595|NCT00807937|26721356|FG001|Overall Study|Lack of Efficacy|0|||
13372596|NCT00807937|26721357|FG002|Overall Study|Lack of Efficacy|1|||
13372597|NCT00807937|26721358|FG003|Overall Study|Lack of Efficacy|2|||
13372598|NCT00807937|26721355|FG000|Overall Study|Intake of prohibited medicine|0|||
13372599|NCT00807937|26721356|FG001|Overall Study|Intake of prohibited medicine|0|||
13372600|NCT00807937|26721357|FG002|Overall Study|Intake of prohibited medicine|2|||
13372601|NCT00807937|26721358|FG003|Overall Study|Intake of prohibited medicine|0|||
13372602|NCT00807937|26721355|FG000|Overall Study|All other reasons (not provided)|2|||
13372603|NCT00807937|26721356|FG001|Overall Study|All other reasons (not provided)|4|||
13372604|NCT00807937|26721357|FG002|Overall Study|All other reasons (not provided)|0|||
13372605|NCT00807937|26721358|FG003|Overall Study|All other reasons (not provided)|1|||
13372606|NCT00807885|26721433|FG000|Overall Study|Lost to Follow-up|0|||
13372607|NCT00807885|26721434|FG001|Overall Study|Lost to Follow-up|0|||
13372608|NCT00807885|26721435|FG002|Overall Study|Lost to Follow-up|0|||
13372609|NCT00807885|26721436|FG003|Overall Study|Lost to Follow-up|0|||
13372610|NCT00807885|26721437|FG004|Overall Study|Lost to Follow-up|0|||
13372611|NCT00807885|26721438|FG005|Overall Study|Lost to Follow-up|1|||
13372612|NCT00807885|26721439|FG006|Overall Study|Lost to Follow-up|0|||
13372613|NCT00807885|26721440|FG007|Overall Study|Lost to Follow-up|0|||
13372614|NCT00807885|26721441|FG008|Overall Study|Lost to Follow-up|0|||
13372615|NCT00807846|26721480|FG000|Overall Study|Adverse Event|5|||
13372616|NCT00807846|26721481|FG001|Overall Study|Adverse Event|0|||
13372617|NCT00807846|26721480|FG000|Overall Study|Lack of Efficacy|2|||
13372618|NCT00807846|26721481|FG001|Overall Study|Lack of Efficacy|0|||
13372619|NCT00807846|26721480|FG000|Overall Study|Protocol Violation|2|||
13372620|NCT00807846|26721481|FG001|Overall Study|Protocol Violation|1|||
13372621|NCT00807846|26721480|FG000|Overall Study|Withdrawal by Subject|2|||
13372622|NCT00807846|26721481|FG001|Overall Study|Withdrawal by Subject|1|||
13372623|NCT00807846|26721480|FG000|Overall Study|Other|1|||
13372624|NCT00807846|26721481|FG001|Overall Study|Other|2|||
13372625|NCT00807742|26721532|FG000|Overall Study|Death|9|||
13372626|NCT00807742|26721533|FG001|Overall Study|Death|2|||
13372627|NCT00807742|26721532|FG000|Overall Study|Withdrawal by Subject|2|||
13372628|NCT00807742|26721533|FG001|Overall Study|Withdrawal by Subject|1|||
13372629|NCT00807742|26721532|FG000|Overall Study|Lost to Follow-up|35|||
13372630|NCT00807742|26721533|FG001|Overall Study|Lost to Follow-up|51|||
13372631|NCT00807599|26721553|FG000|Overall Study|Not treated on protocol study|0|||
13372632|NCT00807599|26721554|FG001|Overall Study|Not treated on protocol study|0|||
13372633|NCT00807599|26721555|FG002|Overall Study|Not treated on protocol study|2|||
13372634|NCT00807599|26721553|FG000|Overall Study|Adverse Event|0|||
13372635|NCT00807599|26721554|FG001|Overall Study|Adverse Event|0|||
13372636|NCT00807599|26721555|FG002|Overall Study|Adverse Event|5|||
13372637|NCT00807599|26721553|FG000|Overall Study|Inadequate response to induction|0|||
13372638|NCT00807599|26721554|FG001|Overall Study|Inadequate response to induction|0|||
13372639|NCT00807599|26721555|FG002|Overall Study|Inadequate response to induction|9|||
13372640|NCT00807599|26721553|FG000|Overall Study|Withdrawal by Subject|0|||
13372641|NCT00807599|26721554|FG001|Overall Study|Withdrawal by Subject|0|||
13372642|NCT00807599|26721555|FG002|Overall Study|Withdrawal by Subject|1|||
13372643|NCT00807573|26721561|FG000|Overall Study|Withdrawal by Subject|1|||
13372644|NCT00807573|26721561|FG000|Overall Study|Adverse Event|1|||
13372645|NCT00807495|26721619|FG000|Overall Study|Adverse Event|6|||
13372646|NCT00807495|26721620|FG001|Overall Study|Adverse Event|3|||
13372647|NCT00807495|26721621|FG002|Overall Study|Adverse Event|1|||
13372648|NCT00807495|26721622|FG003|Overall Study|Adverse Event|1|||
13372649|NCT00807495|26721623|FG004|Overall Study|Adverse Event|2|||
13372650|NCT00807495|26721619|FG000|Overall Study|Withdrawal by Patient|2|||
13372651|NCT00807495|26721620|FG001|Overall Study|Withdrawal by Patient|0|||
13372652|NCT00807495|26721621|FG002|Overall Study|Withdrawal by Patient|1|||
13372653|NCT00807495|26721622|FG003|Overall Study|Withdrawal by Patient|0|||
13372654|NCT00807495|26721623|FG004|Overall Study|Withdrawal by Patient|0|||
13372655|NCT00807495|26721619|FG000|Overall Study|Reason Not Specified|0|||
13372656|NCT00807495|26721620|FG001|Overall Study|Reason Not Specified|3|||
13372657|NCT00807495|26721621|FG002|Overall Study|Reason Not Specified|2|||
13372658|NCT00807495|26721622|FG003|Overall Study|Reason Not Specified|0|||
13372659|NCT00807495|26721623|FG004|Overall Study|Reason Not Specified|3|||
13372660|NCT00807365|26721629|FG000|Overall Study|Study Terminated|5|||
13372661|NCT00807248|26721684|FG000|Overall Study|Adverse Event|1|||
13372662|NCT00807248|26721685|FG001|Overall Study|Adverse Event|2|||
13372663|NCT00807248|26721686|FG002|Overall Study|Adverse Event|2|||
13372664|NCT00807248|26721687|FG003|Overall Study|Adverse Event|6|||
13372665|NCT00807248|26721684|FG000|Overall Study|Lack of Efficacy|14|||
13372666|NCT00807248|26721685|FG001|Overall Study|Lack of Efficacy|4|||
13372667|NCT00807248|26721686|FG002|Overall Study|Lack of Efficacy|8|||
13372668|NCT00807248|26721687|FG003|Overall Study|Lack of Efficacy|3|||
13372669|NCT00807248|26721684|FG000|Overall Study|Protocol Violation|0|||
13372670|NCT00807248|26721685|FG001|Overall Study|Protocol Violation|1|||
13372671|NCT00807248|26721686|FG002|Overall Study|Protocol Violation|1|||
13372672|NCT00807248|26721687|FG003|Overall Study|Protocol Violation|0|||
13372673|NCT00807248|26721684|FG000|Overall Study|Withdrawal of Consent|5|||
13372674|NCT00807248|26721685|FG001|Overall Study|Withdrawal of Consent|5|||
13372675|NCT00807248|26721686|FG002|Overall Study|Withdrawal of Consent|5|||
13372676|NCT00807248|26721687|FG003|Overall Study|Withdrawal of Consent|5|||
13372677|NCT00807248|26721684|FG000|Overall Study|Lost to Follow-up|1|||
13372678|NCT00807248|26721685|FG001|Overall Study|Lost to Follow-up|0|||
13372679|NCT00807248|26721686|FG002|Overall Study|Lost to Follow-up|0|||
13372680|NCT00807248|26721687|FG003|Overall Study|Lost to Follow-up|0|||
13372681|NCT00807248|26721684|FG000|Overall Study|Other Reason|0|||
13372682|NCT00807248|26721685|FG001|Overall Study|Other Reason|0|||
13372683|NCT00807248|26721686|FG002|Overall Study|Other Reason|2|||
13372684|NCT00807248|26721687|FG003|Overall Study|Other Reason|0|||
13372685|NCT00807235|26721724|FG000|Overall Study|Adverse Event|1|||
13372686|NCT00807235|26721725|FG001|Overall Study|Adverse Event|0|||
13372687|NCT00807144|26721742|FG000|Overall Study|Lost to Follow-up|0|||
13372688|NCT00807144|26721743|FG001|Overall Study|Lost to Follow-up|1|||
13372689|NCT00807092|26721778|FG000|Overall Study|Adverse Event|0|||
13372690|NCT00807092|26721779|FG001|Overall Study|Adverse Event|1|||
13372691|NCT00807092|26721778|FG000|Overall Study|Protocol Violation|0|||
13372692|NCT00807092|26721779|FG001|Overall Study|Protocol Violation|2|||
13372693|NCT00807092|26721778|FG000|Overall Study|Withdrawal by Subject|1|||
13372694|NCT00807092|26721779|FG001|Overall Study|Withdrawal by Subject|0|||
13372695|NCT00807092|26721778|FG000|Overall Study|CGMS data collection failed|0|||
13372696|NCT00807092|26721779|FG001|Overall Study|CGMS data collection failed|1|||
13372697|NCT00807040|26721794|FG000|Overall Study|Death|24|||
13372698|NCT00807040|26721795|FG001|Overall Study|Death|29|||
13372699|NCT00807040|26721794|FG000|Overall Study|Withdrawal by Subject|8|||
13372700|NCT00807040|26721795|FG001|Overall Study|Withdrawal by Subject|6|||
13372701|NCT00807040|26721794|FG000|Overall Study|Lost to Follow-up|4|||
13372702|NCT00807040|26721795|FG001|Overall Study|Lost to Follow-up|6|||
13372703|NCT00807014|26721828|FG000|Overall Study|Participant Considered Disease Cured|13|||
13372704|NCT00807014|26721829|FG001|Overall Study|Participant Considered Disease Cured|2|||
13372705|NCT00807014|26721828|FG000|Overall Study|Participant Considered Disease Not Cured|2|||
13372706|NCT00807014|26721829|FG001|Overall Study|Participant Considered Disease Not Cured|7|||
13372707|NCT00807014|26721828|FG000|Overall Study|Protocol Violation|2|||
13372708|NCT00807014|26721829|FG001|Overall Study|Protocol Violation|8|||
13372709|NCT00807014|26721828|FG000|Overall Study|Adverse Event|0|||
13372710|NCT00807014|26721829|FG001|Overall Study|Adverse Event|2|||
13372711|NCT00807014|26721828|FG000|Overall Study|Lost to Follow-up|9|||
13372712|NCT00807014|26721829|FG001|Overall Study|Lost to Follow-up|7|||
13372713|NCT00807014|26721828|FG000|Overall Study|Recovery|1|||
13372714|NCT00807014|26721829|FG001|Overall Study|Recovery|0|||
13372715|NCT00807014|26721828|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0|||
13372716|NCT00807014|26721829|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1|||
13372717|NCT00807001|26721862|FG000|Overall Study|Non-compliance|0|||
13372718|NCT00807001|26721863|FG001|Overall Study|Non-compliance|1|||
13372719|NCT00807001|26721864|FG002|Overall Study|Non-compliance|0|||
13372720|NCT00807001|26721865|FG003|Overall Study|Non-compliance|0|||
13372721|NCT00807001|26721866|FG004|Overall Study|Non-compliance|0|||
13372722|NCT00806988|26721881|FG000|Overall Study|Death|15|||
13372723|NCT00806988|26721882|FG001|Overall Study|Death|16|||
13372724|NCT00806988|26721881|FG000|Overall Study|Withdrawal by Subject|8|||
13372725|NCT00806988|26721882|FG001|Overall Study|Withdrawal by Subject|8|||
13372726|NCT00806988|26721881|FG000|Overall Study|Lost to Follow-up|4|||
13372727|NCT00806988|26721882|FG001|Overall Study|Lost to Follow-up|19|||
13372728|NCT00806819|26721921|FG000|Overall Study|progressive disease (modified RECIST )|217|||
13372729|NCT00806819|26721922|FG001|Overall Study|progressive disease (modified RECIST )|216|||
13372730|NCT00806819|26721921|FG000|Overall Study|Worsening or AE of underlying disease|18|||
13372731|NCT00806819|26721922|FG001|Overall Study|Worsening or AE of underlying disease|25|||
13372732|NCT00806819|26721921|FG000|Overall Study|Other AE|38|||
13372733|NCT00806819|26721922|FG001|Overall Study|Other AE|40|||
13372734|NCT00806819|26721921|FG000|Overall Study|Protocol Violation|9|||
13372735|NCT00806819|26721922|FG001|Overall Study|Protocol Violation|4|||
13372736|NCT00806819|26721921|FG000|Overall Study|Lost to Follow-up|1|||
13372737|NCT00806819|26721922|FG001|Overall Study|Lost to Follow-up|0|||
13372738|NCT00806819|26721921|FG000|Overall Study|Withdrawal by Subject|32|||
13372739|NCT00806819|26721922|FG001|Overall Study|Withdrawal by Subject|29|||
13372740|NCT00806819|26721921|FG000|Overall Study|Not treated|6|||
13372741|NCT00806819|26721922|FG001|Overall Study|Not treated|3|||
13372742|NCT00806819|26721921|FG000|Overall Study|Reasons other than stated above|25|||
13372743|NCT00806819|26721922|FG001|Overall Study|Reasons other than stated above|41|||
13372744|NCT00806624|26721940|FG000|Overall Study|Adverse Event|2|||
13372745|NCT00806624|26721941|FG001|Overall Study|Adverse Event|8|||
13372746|NCT00806624|26721942|FG002|Overall Study|Adverse Event|0|||
13372747|NCT00806624|26721940|FG000|Overall Study|Death|0|||
13372748|NCT00806624|26721941|FG001|Overall Study|Death|1|||
13372749|NCT00806624|26721942|FG002|Overall Study|Death|1|||
13372750|NCT00806624|26721940|FG000|Overall Study|Lost to Follow-up|1|||
13372751|NCT00806624|26721941|FG001|Overall Study|Lost to Follow-up|0|||
13372752|NCT00806624|26721942|FG002|Overall Study|Lost to Follow-up|1|||
13372753|NCT00806624|26721940|FG000|Overall Study|Withdrawal by Subject|6|||
13372754|NCT00806624|26721941|FG001|Overall Study|Withdrawal by Subject|3|||
13372755|NCT00806624|26721942|FG002|Overall Study|Withdrawal by Subject|3|||
13372756|NCT00806624|26721940|FG000|Overall Study|discontinued before start of treatment|0|||
13372757|NCT00806624|26721941|FG001|Overall Study|discontinued before start of treatment|0|||
13372758|NCT00806624|26721942|FG002|Overall Study|discontinued before start of treatment|1|||
13372759|NCT00806585|26721990|FG000|Overall Study|Study terminated by Sponsor|0|||
13372760|NCT00806585|26721991|FG001|Overall Study|Study terminated by Sponsor|0|||
13372761|NCT00806585|26721992|FG002|Overall Study|Study terminated by Sponsor|1|||
13372762|NCT00806585|26721993|FG003|Overall Study|Study terminated by Sponsor|2|||
13372763|NCT00806585|26721994|FG004|Overall Study|Study terminated by Sponsor|0|||
13372764|NCT00806585|26721990|FG000|Overall Study|Protocol Violation|3|||
13372765|NCT00806585|26721991|FG001|Overall Study|Protocol Violation|1|||
13372766|NCT00806585|26721992|FG002|Overall Study|Protocol Violation|2|||
13372767|NCT00806585|26721993|FG003|Overall Study|Protocol Violation|0|||
13372768|NCT00806585|26721994|FG004|Overall Study|Protocol Violation|0|||
13372769|NCT00806585|26721990|FG000|Overall Study|Physician Decision|0|||
13372770|NCT00806585|26721991|FG001|Overall Study|Physician Decision|2|||
13372771|NCT00806585|26721992|FG002|Overall Study|Physician Decision|3|||
13372772|NCT00806585|26721993|FG003|Overall Study|Physician Decision|0|||
13372773|NCT00806585|26721994|FG004|Overall Study|Physician Decision|1|||
13372774|NCT00806585|26721990|FG000|Overall Study|Lost to Follow-up|2|||
13372775|NCT00806585|26721991|FG001|Overall Study|Lost to Follow-up|1|||
13372776|NCT00806585|26721992|FG002|Overall Study|Lost to Follow-up|2|||
13372777|NCT00806585|26721993|FG003|Overall Study|Lost to Follow-up|2|||
13372778|NCT00806585|26721994|FG004|Overall Study|Lost to Follow-up|5|||
13372779|NCT00806585|26721990|FG000|Overall Study|Lack of Efficacy|1|||
13372780|NCT00806585|26721991|FG001|Overall Study|Lack of Efficacy|0|||
13372781|NCT00806585|26721992|FG002|Overall Study|Lack of Efficacy|0|||
13372782|NCT00806585|26721993|FG003|Overall Study|Lack of Efficacy|0|||
13372783|NCT00806585|26721994|FG004|Overall Study|Lack of Efficacy|0|||
13372784|NCT00806585|26721990|FG000|Overall Study|Adverse Event|1|||
13372785|NCT00806585|26721991|FG001|Overall Study|Adverse Event|5|||
13372786|NCT00806585|26721992|FG002|Overall Study|Adverse Event|3|||
13372787|NCT00806585|26721993|FG003|Overall Study|Adverse Event|4|||
13372788|NCT00806585|26721994|FG004|Overall Study|Adverse Event|2|||
13372789|NCT00806585|26721990|FG000|Overall Study|Withdrawal by Subject|10|||
13372790|NCT00806585|26721991|FG001|Overall Study|Withdrawal by Subject|8|||
13372791|NCT00806585|26721992|FG002|Overall Study|Withdrawal by Subject|9|||
13372792|NCT00806585|26721993|FG003|Overall Study|Withdrawal by Subject|3|||
13372793|NCT00806585|26721994|FG004|Overall Study|Withdrawal by Subject|11|||
13372794|NCT00806585|26721990|FG000|Overall Study|Completion status unknown|15|||
13372795|NCT00806585|26721991|FG001|Overall Study|Completion status unknown|14|||
13372796|NCT00806585|26721992|FG002|Overall Study|Completion status unknown|12|||
13372797|NCT00806585|26721993|FG003|Overall Study|Completion status unknown|4|||
13372798|NCT00806585|26721994|FG004|Overall Study|Completion status unknown|12|||
13372799|NCT00806546|26722000|FG000|Overall Study|Enrolled, not treated|35|||
13372800|NCT00806546|26722000|FG000|Overall Study|Lost to Follow-up|32|||
13372801|NCT00806546|26722000|FG000|Overall Study|Adverse Event|74|||
13372802|NCT00806546|26722000|FG000|Overall Study|Withdrawal by Subject|75|||
13372803|NCT00806546|26722000|FG000|Overall Study|Protocol Violation|49|||
13372804|NCT00806546|26722000|FG000|Overall Study|Various|42|||
13372805|NCT00806494|26722026|FG000|Overall Study|Adverse Event|29|||
13372806|NCT00806494|26722026|FG000|Overall Study|Lack of Efficacy|6|||
13372807|NCT00806494|26722026|FG000|Overall Study|Lost to Follow-up|10|||
13372808|NCT00806494|26722026|FG000|Overall Study|Other|30|||
13372809|NCT00806494|26722026|FG000|Overall Study|Withdrawal by Subject|5|||
13372810|NCT00806442|26722049|FG000|Overall Study|Lost to Follow-up|3|||
13372811|NCT00806442|26722050|FG001|Overall Study|Lost to Follow-up|2|||
13375505|NCT00790582|26729992|FG000|Overall Study|Withdrawal by Subject|7|||
13375506|NCT00790582|26729993|FG001|Overall Study|Withdrawal by Subject|51|||
13375507|NCT00790569|26730044|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
13375508|NCT00790569|26730045|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8|||
13375509|NCT00790569|26730046|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
13375510|NCT00790569|26730044|FG000|End of Treatment (6 Month Interview)|Death|0|||
13375511|NCT00790569|26730045|FG001|End of Treatment (6 Month Interview)|Death|2|||
13375512|NCT00790569|26730046|FG002|End of Treatment (6 Month Interview)|Death|1|||
13375513|NCT00790569|26730044|FG000|End of Treatment (6 Month Interview)|Hospitalized|2|||
13375514|NCT00790569|26730045|FG001|End of Treatment (6 Month Interview)|Hospitalized|0|||
13375515|NCT00790569|26730046|FG002|End of Treatment (6 Month Interview)|Hospitalized|0|||
13375516|NCT00790569|26730044|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0|||
13375517|NCT00790569|26730045|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0|||
13375518|NCT00790569|26730046|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2|||
13375519|NCT00790569|26730044|FG000|End of Treatment (6 Month Interview)|Incarcerated|0|||
13375520|NCT00790569|26730045|FG001|End of Treatment (6 Month Interview)|Incarcerated|0|||
13375521|NCT00790569|26730046|FG002|End of Treatment (6 Month Interview)|Incarcerated|3|||
13375522|NCT00790569|26730044|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66|||
13375523|NCT00790569|26730045|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19|||
13375524|NCT00790569|26730046|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50|||
13375525|NCT00790556|26730059|FG000|Treatment Period 1|Physician Decision|1|||
13375526|NCT00790556|26730060|FG001|Treatment Period 1|Physician Decision|0|||
13375527|NCT00790556|26730059|FG000|Treatment Period 1|Withdrawal by Subject|1|||
13375528|NCT00790556|26730060|FG001|Treatment Period 1|Withdrawal by Subject|0|||
13375529|NCT00790452|26730073|FG000|Overall Study|Drug supply issue|1|||
13375530|NCT00790452|26730074|FG001|Overall Study|Drug supply issue|0|||
13375531|NCT00790400|26730108|FG000|Double-blind Period (Core Phase)|Protocol Violation|1|||
13375532|NCT00790400|26730109|FG001|Double-blind Period (Core Phase)|Protocol Violation|0|||
13375533|NCT00790400|26730108|FG000|Double-blind Period (Core Phase)|Progressive disease|0|||
13375534|NCT00790400|26730109|FG001|Double-blind Period (Core Phase)|Progressive disease|9|||
13375535|NCT00790400|26730108|FG000|Double-blind Period (Core Phase)|Adverse Event|2|||
13375536|NCT00790400|26730109|FG001|Double-blind Period (Core Phase)|Adverse Event|4|||
13375537|NCT00790400|26730108|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1|||
13375538|NCT00790400|26730109|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0|||
13375539|NCT00790400|26730108|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1|||
13375540|NCT00790400|26730109|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0|||
13375541|NCT00790400|26730108|FG000|Double-blind Period (Core Phase)|Administrative problems|1|||
13375542|NCT00790400|26730109|FG001|Double-blind Period (Core Phase)|Administrative problems|0|||
13375543|NCT00790400|26730108|FG000|Double-blind Period (Core Phase)|Death|1|||
13375544|NCT00790400|26730109|FG001|Double-blind Period (Core Phase)|Death|0|||
13375545|NCT00790400|26730108|FG000|Everolimus Period (Core or Extension)|Adverse Event|9|||
13375546|NCT00790400|26730109|FG001|Everolimus Period (Core or Extension)|Adverse Event|0|||
13375547|NCT00790400|26730108|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1|||
13375548|NCT00790400|26730109|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0|||
13375549|NCT00790400|26730108|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7|||
13375550|NCT00790400|26730109|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0|||
13375551|NCT00790400|26730108|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1|||
13375552|NCT00790400|26730109|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0|||
13375553|NCT00790400|26730108|FG000|Everolimus Period (Core or Extension)|Administrative problems|2|||
13375554|NCT00790400|26730109|FG001|Everolimus Period (Core or Extension)|Administrative problems|0|||
13375555|NCT00790400|26730108|FG000|Everolimus Period (Core or Extension)|Death|1|||
13375556|NCT00790400|26730109|FG001|Everolimus Period (Core or Extension)|Death|0|||
13375557|NCT00790400|26730108|FG000|Everolimus Period (Core or Extension)|Disease progression|5|||
13375558|NCT00790400|26730109|FG001|Everolimus Period (Core or Extension)|Disease progression|0|||
13375559|NCT00790400|26730108|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1|||
13375560|NCT00790400|26730109|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0|||
13375561|NCT00790400|26730108|FG000|Everolimus Period (Core or Extension)|New treatment|2|||
13375562|NCT00790400|26730109|FG001|Everolimus Period (Core or Extension)|New treatment|0|||
13375563|NCT00790296|26730122|FG000|Overall Study|Did not meet study eligibility criteria|1|||
13375564|NCT00790296|26730123|FG001|Overall Study|Did not meet study eligibility criteria|1|||
13375565|NCT00790296|26730122|FG000|Overall Study|Adverse Event|0|||
13375566|NCT00790296|26730123|FG001|Overall Study|Adverse Event|1|||
13375567|NCT00790205|26730170|FG000|Overall Study|Lost to Follow-up|61|||
13375568|NCT00790205|26730171|FG001|Overall Study|Lost to Follow-up|71|||
13375569|NCT00790205|26730170|FG000|Overall Study|Withdrawal by Subject|299|||
13375570|NCT00790205|26730171|FG001|Overall Study|Withdrawal by Subject|363|||
13375571|NCT00790088|26730183|FG000|Overall Study|Protocol Violation|11|||
13393698|NCT00662792|26784674|FG000|Period 4|Worsening of disease under study (AE)|0|||
13375572|NCT00790088|26730183|FG000|Overall Study|Withdrawal by Subject|17|||
13375573|NCT00790088|26730183|FG000|Overall Study|Lost to Follow-up|7|||
13375574|NCT00790088|26730183|FG000|Overall Study|Physician Decision|4|||
13375575|NCT00790036|26730201|FG000|Overall Study|Abnormal lab values|3|||
13375576|NCT00790036|26730202|FG001|Overall Study|Abnormal lab values|2|||
13375577|NCT00790036|26730201|FG000|Overall Study|Administrative problems|5|||
13375578|NCT00790036|26730202|FG001|Overall Study|Administrative problems|9|||
13375579|NCT00790036|26730201|FG000|Overall Study|Adverse Event|113|||
13375580|NCT00790036|26730202|FG001|Overall Study|Adverse Event|44|||
13375581|NCT00790036|26730201|FG000|Overall Study|Death|1|||
13375582|NCT00790036|26730202|FG001|Overall Study|Death|0|||
13375583|NCT00790036|26730201|FG000|Overall Study|Disease progression|24|||
13375584|NCT00790036|26730202|FG001|Overall Study|Disease progression|48|||
13375585|NCT00790036|26730201|FG000|Overall Study|Lost to Follow-up|1|||
13375586|NCT00790036|26730202|FG001|Overall Study|Lost to Follow-up|2|||
13375587|NCT00790036|26730201|FG000|Overall Study|Protocol Violation|10|||
13375588|NCT00790036|26730202|FG001|Overall Study|Protocol Violation|2|||
13375589|NCT00790036|26730201|FG000|Overall Study|Withdrawal by Subject|18|||
13375590|NCT00790036|26730202|FG001|Overall Study|Withdrawal by Subject|7|||
13375591|NCT00790036|26730201|FG000|Overall Study|Subject/guardian decision|20|||
13375592|NCT00790036|26730202|FG001|Overall Study|Subject/guardian decision|7|||
13375593|NCT00790023|26730300|FG000|Overall Study|Adverse Event|2|||
13375594|NCT00790023|26730301|FG001|Overall Study|Adverse Event|1|||
13375595|NCT00790023|26730302|FG002|Overall Study|Adverse Event|4|||
13375596|NCT00790023|26730300|FG000|Overall Study|Protocol Violation|2|||
13375597|NCT00790023|26730301|FG001|Overall Study|Protocol Violation|4|||
13375598|NCT00790023|26730302|FG002|Overall Study|Protocol Violation|2|||
13375599|NCT00790023|26730300|FG000|Overall Study|Withdrawal by Subject|2|||
13375600|NCT00790023|26730301|FG001|Overall Study|Withdrawal by Subject|0|||
13375601|NCT00790023|26730302|FG002|Overall Study|Withdrawal by Subject|6|||
13375602|NCT00790023|26730300|FG000|Overall Study|Lost to Follow-up|0|||
13375603|NCT00790023|26730301|FG001|Overall Study|Lost to Follow-up|0|||
13375604|NCT00790023|26730302|FG002|Overall Study|Lost to Follow-up|1|||
13375605|NCT00790023|26730300|FG000|Overall Study|Other|5|||
13375606|NCT00790023|26730301|FG001|Overall Study|Other|5|||
13375607|NCT00790023|26730302|FG002|Overall Study|Other|8|||
13375608|NCT00789958|26730317|FG000|Overall Study|Adverse Event|3|||
13375609|NCT00789958|26730317|FG000|Overall Study|Withdrawal by Subject|4|||
13375610|NCT00789958|26730317|FG000|Overall Study|Progression|3|||
13375611|NCT00789958|26730317|FG000|Overall Study|not protocol specified|1|||
13375612|NCT00789958|26730317|FG000|Overall Study|Not eligible/not analyzable|26|||
13375613|NCT00789880|26730362|FG000|Overall Study|Adverse Event|0|||
13375614|NCT00789880|26730363|FG001|Overall Study|Adverse Event|0|||
13375615|NCT00789880|26730364|FG002|Overall Study|Adverse Event|0|||
13375616|NCT00789880|26730365|FG003|Overall Study|Adverse Event|0|||
13375617|NCT00789880|26730366|FG004|Overall Study|Adverse Event|1|||
13375618|NCT00789880|26730367|FG005|Overall Study|Adverse Event|0|||
13375619|NCT00789880|26730362|FG000|Overall Study|Protocol Violation|0|||
13375620|NCT00789880|26730363|FG001|Overall Study|Protocol Violation|1|||
13375621|NCT00789880|26730364|FG002|Overall Study|Protocol Violation|0|||
13375622|NCT00789880|26730365|FG003|Overall Study|Protocol Violation|1|||
13375623|NCT00789880|26730366|FG004|Overall Study|Protocol Violation|0|||
13375624|NCT00789880|26730367|FG005|Overall Study|Protocol Violation|0|||
13375625|NCT00789880|26730362|FG000|Overall Study|Withdrawal by Subject|1|||
13375626|NCT00789880|26730363|FG001|Overall Study|Withdrawal by Subject|0|||
13375627|NCT00789880|26730364|FG002|Overall Study|Withdrawal by Subject|0|||
13375628|NCT00789880|26730365|FG003|Overall Study|Withdrawal by Subject|0|||
13375629|NCT00789880|26730366|FG004|Overall Study|Withdrawal by Subject|2|||
13375630|NCT00789880|26730367|FG005|Overall Study|Withdrawal by Subject|0|||
13375631|NCT00789854|26730472|FG000|Overall Study|Adverse Event|28|||
13375632|NCT00789854|26730473|FG001|Overall Study|Adverse Event|23|||
13375633|NCT00789854|26730474|FG002|Overall Study|Adverse Event|18|||
13375634|NCT00789854|26730472|FG000|Overall Study|Lost to Follow-up|1|||
13375635|NCT00789854|26730473|FG001|Overall Study|Lost to Follow-up|1|||
13375636|NCT00789854|26730474|FG002|Overall Study|Lost to Follow-up|4|||
13375637|NCT00789854|26730472|FG000|Overall Study|Withdrawal by Subject|9|||
13375638|NCT00789854|26730473|FG001|Overall Study|Withdrawal by Subject|6|||
13375639|NCT00789854|26730474|FG002|Overall Study|Withdrawal by Subject|17|||
13375640|NCT00789854|26730472|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
13375641|NCT00789854|26730473|FG001|Overall Study|Eligibility criteria not fulfilled|5|||
13375642|NCT00789854|26730474|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
13375643|NCT00789854|26730472|FG000|Overall Study|Severe non-compliance to the protocol|3|||
13375644|NCT00789854|26730473|FG001|Overall Study|Severe non-compliance to the protocol|0|||
13375645|NCT00789854|26730474|FG002|Overall Study|Severe non-compliance to the protocol|0|||
13375646|NCT00789854|26730472|FG000|Overall Study|Safety reasons|0|||
13375647|NCT00789854|26730473|FG001|Overall Study|Safety reasons|0|||
13375648|NCT00789854|26730474|FG002|Overall Study|Safety reasons|2|||
13375649|NCT00789854|26730472|FG000|Overall Study|Other|6|||
13375650|NCT00789854|26730473|FG001|Overall Study|Other|0|||
13375651|NCT00789854|26730474|FG002|Overall Study|Other|5|||
13375652|NCT00789828|26730513|FG000|Core Period (48 Weeks)|Administrative problems|0|||
13375653|NCT00789828|26730514|FG001|Core Period (48 Weeks)|Administrative problems|1|||
13375654|NCT00789828|26730513|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0|||
13375655|NCT00789828|26730514|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4|||
13375656|NCT00789828|26730513|FG000|Core Period (48 Weeks)|Lost to Follow-up|0|||
13375657|NCT00789828|26730514|FG001|Core Period (48 Weeks)|Lost to Follow-up|1|||
13375658|NCT00789828|26730513|FG000|Open-label Extension Period (4 Years)|Adverse Event|10|||
13375659|NCT00789828|26730514|FG001|Open-label Extension Period (4 Years)|Adverse Event|0|||
13375660|NCT00789828|26730513|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6|||
13375661|NCT00789828|26730514|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0|||
13375662|NCT00789828|26730513|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3|||
13375663|NCT00789828|26730514|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0|||
13375664|NCT00789828|26730513|FG000|Open-label Extension Period (4 Years)|Administrative problems|7|||
13375665|NCT00789828|26730514|FG001|Open-label Extension Period (4 Years)|Administrative problems|0|||
13375666|NCT00789828|26730513|FG000|Open-label Extension Period (4 Years)|Death|1|||
13375667|NCT00789828|26730514|FG001|Open-label Extension Period (4 Years)|Death|0|||
13375668|NCT00789828|26730513|FG000|Open-label Extension Period (4 Years)|Disease progression|1|||
13375669|NCT00789828|26730514|FG001|Open-label Extension Period (4 Years)|Disease progression|0|||
13375670|NCT00789828|26730513|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1|||
13375671|NCT00789828|26730514|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0|||
13375672|NCT00789815|26730541|FG000|Overall Study|Protocol Violation|6|||
13375673|NCT00789815|26730542|FG001|Overall Study|Protocol Violation|1|||
13375674|NCT00789815|26730541|FG000|Overall Study|Intubation due to massive bleeding|1|||
13375675|NCT00789815|26730542|FG001|Overall Study|Intubation due to massive bleeding|0|||
13375676|NCT00789737|26730579|FG000|Overall Study|Withdrawal by Subject|13|||
13375677|NCT00789737|26730580|FG001|Overall Study|Withdrawal by Subject|22|||
13375678|NCT00789737|26730579|FG000|Overall Study|Lost to Follow-up|10|||
13375679|NCT00789737|26730580|FG001|Overall Study|Lost to Follow-up|14|||
13375680|NCT00789737|26730579|FG000|Overall Study|Adverse Event|8|||
13375681|NCT00789737|26730580|FG001|Overall Study|Adverse Event|8|||
13375682|NCT00789737|26730579|FG000|Overall Study|Protocol Violation|3|||
13375683|NCT00789737|26730580|FG001|Overall Study|Protocol Violation|0|||
13375684|NCT00789737|26730579|FG000|Overall Study|Lack of Efficacy|3|||
13375685|NCT00789737|26730580|FG001|Overall Study|Lack of Efficacy|0|||
13375686|NCT00789737|26730579|FG000|Overall Study|hyperglycemia that met protocol-specifie|0|||
13375687|NCT00789737|26730580|FG001|Overall Study|hyperglycemia that met protocol-specifie|4|||
13375688|NCT00789737|26730579|FG000|Overall Study|Other|11|||
13375689|NCT00789737|26730580|FG001|Overall Study|Other|7|||
13375690|NCT00789698|26730607|FG000|Overall Study|Lack of Efficacy|10|||
13375691|NCT00789698|26730608|FG001|Overall Study|Lack of Efficacy|4|||
13375692|NCT00789698|26730609|FG002|Overall Study|Lack of Efficacy|5|||
13375693|NCT00789698|26730610|FG003|Overall Study|Lack of Efficacy|18|||
13375694|NCT00789698|26730607|FG000|Overall Study|Adverse Event|5|||
13375695|NCT00789698|26730608|FG001|Overall Study|Adverse Event|5|||
13375696|NCT00789698|26730609|FG002|Overall Study|Adverse Event|3|||
13375697|NCT00789698|26730610|FG003|Overall Study|Adverse Event|4|||
13375698|NCT00789698|26730607|FG000|Overall Study|Lost to Follow-up|5|||
13375699|NCT00789698|26730608|FG001|Overall Study|Lost to Follow-up|5|||
13375700|NCT00789698|26730609|FG002|Overall Study|Lost to Follow-up|2|||
13375701|NCT00789698|26730610|FG003|Overall Study|Lost to Follow-up|9|||
13375702|NCT00789698|26730607|FG000|Overall Study|Protocol Violation|6|||
13375703|NCT00789698|26730608|FG001|Overall Study|Protocol Violation|1|||
13375704|NCT00789698|26730609|FG002|Overall Study|Protocol Violation|2|||
13375705|NCT00789698|26730610|FG003|Overall Study|Protocol Violation|1|||
13375706|NCT00789698|26730607|FG000|Overall Study|Withdrawal by Subject|14|||
13375707|NCT00789698|26730608|FG001|Overall Study|Withdrawal by Subject|15|||
13375708|NCT00789698|26730609|FG002|Overall Study|Withdrawal by Subject|12|||
13375709|NCT00789698|26730610|FG003|Overall Study|Withdrawal by Subject|19|||
13375710|NCT00789698|26730607|FG000|Overall Study|Administrative|0|||
13375711|NCT00789698|26730608|FG001|Overall Study|Administrative|3|||
13375712|NCT00789698|26730609|FG002|Overall Study|Administrative|3|||
13375713|NCT00789698|26730610|FG003|Overall Study|Administrative|1|||
13375714|NCT00789581|26730625|FG000|AC Therapy|Adverse Event|2|||
13375715|NCT00789581|26730626|FG001|AC Therapy|Adverse Event|3|||
13375716|NCT00789581|26730625|FG000|AC Therapy|Withdrawal by Subject|4|||
13375717|NCT00789581|26730626|FG001|AC Therapy|Withdrawal by Subject|7|||
13375718|NCT00789581|26730625|FG000|AC Therapy|Disease recurrence|3|||
13375719|NCT00789581|26730626|FG001|AC Therapy|Disease recurrence|1|||
13375720|NCT00789581|26730625|FG000|AC Therapy|Intercurrent Illness|1|||
13375721|NCT00789581|26730626|FG001|AC Therapy|Intercurrent Illness|0|||
13375722|NCT00789581|26730625|FG000|AC Therapy|Never Treated|1|||
13375723|NCT00789581|26730626|FG001|AC Therapy|Never Treated|4|||
13375724|NCT00789581|26730625|FG000|AC Therapy|Other|0|||
13375725|NCT00789581|26730626|FG001|AC Therapy|Other|2|||
13375726|NCT00789581|26730625|FG000|Adjuvant Therapy|Never treated|2|||
13375727|NCT00789581|26730626|FG001|Adjuvant Therapy|Never treated|2|||
13375728|NCT00789581|26730625|FG000|Adjuvant Therapy|Adverse Event|20|||
13375729|NCT00789581|26730626|FG001|Adjuvant Therapy|Adverse Event|44|||
13375730|NCT00789581|26730625|FG000|Adjuvant Therapy|Withdrawal by Subject|14|||
13375731|NCT00789581|26730626|FG001|Adjuvant Therapy|Withdrawal by Subject|5|||
13375732|NCT00789581|26730625|FG000|Adjuvant Therapy|Disease recurrence|2|||
13375733|NCT00789581|26730626|FG001|Adjuvant Therapy|Disease recurrence|1|||
13375734|NCT00789581|26730625|FG000|Adjuvant Therapy|Intercurrent Illness|1|||
13375735|NCT00789581|26730626|FG001|Adjuvant Therapy|Intercurrent Illness|3|||
13375736|NCT00789581|26730625|FG000|Adjuvant Therapy|Protocol Violation|1|||
13375737|NCT00789581|26730626|FG001|Adjuvant Therapy|Protocol Violation|1|||
13375738|NCT00789581|26730625|FG000|Adjuvant Therapy|Other|0|||
13375739|NCT00789581|26730626|FG001|Adjuvant Therapy|Other|1|||
13375740|NCT00789555|26730659|FG000|Overall Study|Protocol Amendment|78|||
13375741|NCT00789555|26730660|FG001|Overall Study|Protocol Amendment|76|||
13375742|NCT00789555|26730661|FG002|Overall Study|Protocol Amendment|80|||
13375743|NCT00789555|26730659|FG000|Overall Study|Adverse Event|17|||
13375744|NCT00789555|26730660|FG001|Overall Study|Adverse Event|7|||
13375745|NCT00789555|26730661|FG002|Overall Study|Adverse Event|10|||
13375746|NCT00789555|26730659|FG000|Overall Study|Lost to Follow-up|9|||
13375747|NCT00789555|26730660|FG001|Overall Study|Lost to Follow-up|10|||
13375748|NCT00789555|26730661|FG002|Overall Study|Lost to Follow-up|18|||
13375749|NCT00789555|26730659|FG000|Overall Study|Patient decision unnrelated to adv event|38|||
13375750|NCT00789555|26730660|FG001|Overall Study|Patient decision unnrelated to adv event|29|||
13375751|NCT00789555|26730661|FG002|Overall Study|Patient decision unnrelated to adv event|26|||
13375752|NCT00789555|26730659|FG000|Overall Study|Treatment failure|11|||
13375753|NCT00789555|26730660|FG001|Overall Study|Treatment failure|8|||
13375754|NCT00789555|26730661|FG002|Overall Study|Treatment failure|12|||
13375755|NCT00789555|26730659|FG000|Overall Study|Protocol Violation|6|||
13375756|NCT00789555|26730660|FG001|Overall Study|Protocol Violation|9|||
13375757|NCT00789555|26730661|FG002|Overall Study|Protocol Violation|13|||
13375758|NCT00789529|26730676|FG000|Overall Study|Withdrawal by Subject|0|||
13375759|NCT00789529|26730677|FG001|Overall Study|Withdrawal by Subject|1|||
13375760|NCT00789529|26730676|FG000|Overall Study|Other Reason|1|||
13375761|NCT00789529|26730677|FG001|Overall Study|Other Reason|0|||
13375762|NCT00789477|26730725|FG000|Overall Study|Withdrawal by Subject|2|||
13375763|NCT00789477|26730726|FG001|Overall Study|Withdrawal by Subject|1|||
13375764|NCT00789477|26730727|FG002|Overall Study|Withdrawal by Subject|3|||
13375765|NCT00789477|26730728|FG003|Overall Study|Withdrawal by Subject|2|||
13375766|NCT00789477|26730729|FG004|Overall Study|Withdrawal by Subject|3|||
13375767|NCT00789477|26730725|FG000|Overall Study|Protocol Violation|1|||
13375768|NCT00789477|26730726|FG001|Overall Study|Protocol Violation|0|||
13375769|NCT00789477|26730727|FG002|Overall Study|Protocol Violation|0|||
13375770|NCT00789477|26730728|FG003|Overall Study|Protocol Violation|1|||
13375771|NCT00789477|26730729|FG004|Overall Study|Protocol Violation|0|||
13375772|NCT00789477|26730725|FG000|Overall Study|Adverse Event|3|||
13375773|NCT00789477|26730726|FG001|Overall Study|Adverse Event|3|||
13375774|NCT00789477|26730727|FG002|Overall Study|Adverse Event|1|||
13375775|NCT00789477|26730728|FG003|Overall Study|Adverse Event|0|||
13375776|NCT00789477|26730729|FG004|Overall Study|Adverse Event|0|||
13375777|NCT00789477|26730725|FG000|Overall Study|Death|1|||
13375778|NCT00789477|26730726|FG001|Overall Study|Death|1|||
13375779|NCT00789477|26730727|FG002|Overall Study|Death|2|||
13375780|NCT00789477|26730728|FG003|Overall Study|Death|2|||
13375781|NCT00789477|26730729|FG004|Overall Study|Death|0|||
13375782|NCT00789477|26730725|FG000|Overall Study|Lost to Follow-up|0|||
13375783|NCT00789477|26730726|FG001|Overall Study|Lost to Follow-up|1|||
13375784|NCT00789477|26730727|FG002|Overall Study|Lost to Follow-up|4|||
13375785|NCT00789477|26730728|FG003|Overall Study|Lost to Follow-up|2|||
13375786|NCT00789477|26730729|FG004|Overall Study|Lost to Follow-up|4|||
13375787|NCT00789477|26730725|FG000|Overall Study|Lack of Efficacy|2|||
13375788|NCT00789477|26730726|FG001|Overall Study|Lack of Efficacy|0|||
13375789|NCT00789477|26730727|FG002|Overall Study|Lack of Efficacy|0|||
13375790|NCT00789477|26730728|FG003|Overall Study|Lack of Efficacy|0|||
13375791|NCT00789477|26730729|FG004|Overall Study|Lack of Efficacy|0|||
13375792|NCT00789477|26730725|FG000|Overall Study|Other|2|||
13375793|NCT00789477|26730726|FG001|Overall Study|Other|0|||
13375794|NCT00789477|26730727|FG002|Overall Study|Other|1|||
13375795|NCT00789477|26730728|FG003|Overall Study|Other|3|||
13375796|NCT00789477|26730729|FG004|Overall Study|Other|0|||
13375797|NCT00789373|26730758|FG000|Induction|Adverse Event|64|||
13375798|NCT00789373|26730759|FG001|Induction|Adverse Event|0|||
13375799|NCT00789373|26730760|FG002|Induction|Adverse Event|0|||
13375800|NCT00789373|26730758|FG000|Induction|Death Due to study disease|24|||
13375801|NCT00789373|26730759|FG001|Induction|Death Due to study disease|0|||
13375802|NCT00789373|26730760|FG002|Induction|Death Due to study disease|0|||
13375803|NCT00789373|26730758|FG000|Induction|Death due to adverse event|19|||
13375804|NCT00789373|26730759|FG001|Induction|Death due to adverse event|0|||
13375805|NCT00789373|26730760|FG002|Induction|Death due to adverse event|0|||
13375806|NCT00789373|26730758|FG000|Induction|Death due to toxicity|11|||
13375807|NCT00789373|26730759|FG001|Induction|Death due to toxicity|0|||
13375808|NCT00789373|26730760|FG002|Induction|Death due to toxicity|0|||
13375809|NCT00789373|26730758|FG000|Induction|Death due to procedure|1|||
13375810|NCT00789373|26730759|FG001|Induction|Death due to procedure|0|||
13375811|NCT00789373|26730760|FG002|Induction|Death due to procedure|0|||
13375812|NCT00789373|26730758|FG000|Induction|Investigator decision|7|||
13375813|NCT00789373|26730759|FG001|Induction|Investigator decision|0|||
13375814|NCT00789373|26730760|FG002|Induction|Investigator decision|0|||
13375815|NCT00789373|26730758|FG000|Induction|Protocol entry criteria not met|9|||
13393699|NCT00662792|26784675|FG001|Period 4|Worsening of disease under study (AE)|0|||
13393700|NCT00662792|26784676|FG002|Period 4|Worsening of disease under study (AE)|0|||
13393701|NCT00662792|26784677|FG003|Period 4|Worsening of disease under study (AE)|1|||
13393702|NCT00662649|26784729|FG000|Core Study (24 Months)|Withdrawal by Subject|31|||
13393703|NCT00662649|26784730|FG001|Core Study (24 Months)|Withdrawal by Subject|17|||
13393704|NCT00662649|26784731|FG002|Core Study (24 Months)|Withdrawal by Subject|28|||
13393705|NCT00662649|26784732|FG003|Core Study (24 Months)|Withdrawal by Subject|0|||
13393706|NCT00662649|26784733|FG004|Core Study (24 Months)|Withdrawal by Subject|0|||
13393707|NCT00662649|26784729|FG000|Core Study (24 Months)|Adverse Event|22|||
13393708|NCT00662649|26784730|FG001|Core Study (24 Months)|Adverse Event|13|||
13393709|NCT00662649|26784731|FG002|Core Study (24 Months)|Adverse Event|18|||
13393710|NCT00662649|26784732|FG003|Core Study (24 Months)|Adverse Event|0|||
13393711|NCT00662649|26784733|FG004|Core Study (24 Months)|Adverse Event|0|||
13393712|NCT00662649|26784729|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13|||
13393713|NCT00662649|26784730|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6|||
13393714|NCT00662649|26784731|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25|||
13393715|NCT00662649|26784732|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
13393716|NCT00662649|26784733|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
13393717|NCT00662649|26784729|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20|||
13393718|NCT00662649|26784730|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9|||
13393719|NCT00662649|26784731|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1|||
13393720|NCT00662649|26784732|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
13393721|NCT00662649|26784733|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
13393722|NCT00662649|26784729|FG000|Core Study (24 Months)|Lost to Follow-up|3|||
13393723|NCT00662649|26784730|FG001|Core Study (24 Months)|Lost to Follow-up|5|||
13393724|NCT00662649|26784731|FG002|Core Study (24 Months)|Lost to Follow-up|7|||
13393725|NCT00662649|26784732|FG003|Core Study (24 Months)|Lost to Follow-up|0|||
13393726|NCT00662649|26784733|FG004|Core Study (24 Months)|Lost to Follow-up|0|||
13393727|NCT00662649|26784729|FG000|Core Study (24 Months)|Protocol Violation|5|||
13393728|NCT00662649|26784730|FG001|Core Study (24 Months)|Protocol Violation|5|||
13393729|NCT00662649|26784731|FG002|Core Study (24 Months)|Protocol Violation|4|||
13393730|NCT00662649|26784732|FG003|Core Study (24 Months)|Protocol Violation|0|||
13393731|NCT00662649|26784733|FG004|Core Study (24 Months)|Protocol Violation|0|||
13393732|NCT00662649|26784729|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2|||
13393733|NCT00662649|26784730|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
13393734|NCT00662649|26784731|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
13393735|NCT00662649|26784732|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
13393736|NCT00662649|26784733|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
13393737|NCT00662649|26784729|FG000|Core Study (24 Months)|Death|1|||
13393738|NCT00662649|26784730|FG001|Core Study (24 Months)|Death|0|||
13393739|NCT00662649|26784731|FG002|Core Study (24 Months)|Death|2|||
13393740|NCT00662649|26784732|FG003|Core Study (24 Months)|Death|0|||
13393741|NCT00662649|26784733|FG004|Core Study (24 Months)|Death|0|||
13393742|NCT00662649|26784729|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10|||
13393743|NCT00662649|26784730|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5|||
13393744|NCT00662649|26784731|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0|||
13393745|NCT00662649|26784732|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8|||
13393746|NCT00662649|26784733|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3|||
13393747|NCT00662649|26784729|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
13393748|NCT00662649|26784730|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
13393749|NCT00662649|26784731|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0|||
13393750|NCT00662649|26784732|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
13393751|NCT00662649|26784733|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
13393752|NCT00662649|26784729|FG000|Extension Study (Month 24 to 60)|Administrative problems|0|||
13393753|NCT00662649|26784730|FG001|Extension Study (Month 24 to 60)|Administrative problems|0|||
13393754|NCT00662649|26784731|FG002|Extension Study (Month 24 to 60)|Administrative problems|0|||
13393755|NCT00662649|26784732|FG003|Extension Study (Month 24 to 60)|Administrative problems|1|||
13393756|NCT00662649|26784733|FG004|Extension Study (Month 24 to 60)|Administrative problems|0|||
13393757|NCT00662649|26784729|FG000|Extension Study (Month 24 to 60)|Adverse Event|6|||
13393758|NCT00662649|26784730|FG001|Extension Study (Month 24 to 60)|Adverse Event|9|||
13393759|NCT00662649|26784731|FG002|Extension Study (Month 24 to 60)|Adverse Event|0|||
13375816|NCT00789373|26730759|FG001|Induction|Protocol entry criteria not met|0|||
13375817|NCT00789373|26730760|FG002|Induction|Protocol entry criteria not met|0|||
13375818|NCT00789373|26730758|FG000|Induction|Lost to Follow-up|6|||
13375819|NCT00789373|26730759|FG001|Induction|Lost to Follow-up|0|||
13375820|NCT00789373|26730760|FG002|Induction|Lost to Follow-up|0|||
13375821|NCT00789373|26730758|FG000|Induction|Protocol Violation|1|||
13375822|NCT00789373|26730759|FG001|Induction|Protocol Violation|0|||
13375823|NCT00789373|26730760|FG002|Induction|Protocol Violation|0|||
13375824|NCT00789373|26730758|FG000|Induction|Progressive Disease|220|||
13375825|NCT00789373|26730759|FG001|Induction|Progressive Disease|0|||
13375826|NCT00789373|26730760|FG002|Induction|Progressive Disease|0|||
13375827|NCT00789373|26730758|FG000|Induction|Withdrawal by Subject|37|||
13375828|NCT00789373|26730759|FG001|Induction|Withdrawal by Subject|0|||
13375829|NCT00789373|26730760|FG002|Induction|Withdrawal by Subject|0|||
13375830|NCT00789373|26730758|FG000|Maintenance|Adverse Event|0|||
13375831|NCT00789373|26730759|FG001|Maintenance|Adverse Event|65|||
13375832|NCT00789373|26730760|FG002|Maintenance|Adverse Event|12|||
13375833|NCT00789373|26730758|FG000|Maintenance|Death due to study disease|0|||
13375834|NCT00789373|26730759|FG001|Maintenance|Death due to study disease|3|||
13375835|NCT00789373|26730760|FG002|Maintenance|Death due to study disease|1|||
13375836|NCT00789373|26730758|FG000|Maintenance|Death due to adverse event|0|||
13375837|NCT00789373|26730759|FG001|Maintenance|Death due to adverse event|4|||
13375838|NCT00789373|26730760|FG002|Maintenance|Death due to adverse event|1|||
13375839|NCT00789373|26730758|FG000|Maintenance|Death due to toxicity|0|||
13375840|NCT00789373|26730759|FG001|Maintenance|Death due to toxicity|1|||
13375841|NCT00789373|26730760|FG002|Maintenance|Death due to toxicity|2|||
13375842|NCT00789373|26730758|FG000|Maintenance|Investigator Decision|0|||
13375843|NCT00789373|26730759|FG001|Maintenance|Investigator Decision|4|||
13375844|NCT00789373|26730760|FG002|Maintenance|Investigator Decision|2|||
13375845|NCT00789373|26730758|FG000|Maintenance|Protocol entry criteria not met|0|||
13375846|NCT00789373|26730759|FG001|Maintenance|Protocol entry criteria not met|2|||
13375847|NCT00789373|26730760|FG002|Maintenance|Protocol entry criteria not met|0|||
13375848|NCT00789373|26730758|FG000|Maintenance|Lost to Follow-up|0|||
13375849|NCT00789373|26730759|FG001|Maintenance|Lost to Follow-up|2|||
13375850|NCT00789373|26730760|FG002|Maintenance|Lost to Follow-up|0|||
13375851|NCT00789373|26730758|FG000|Maintenance|Progressive Disease|0|||
13375852|NCT00789373|26730759|FG001|Maintenance|Progressive Disease|253|||
13375853|NCT00789373|26730760|FG002|Maintenance|Progressive Disease|152|||
13375854|NCT00789373|26730758|FG000|Maintenance|Withdrawal by Subject|0|||
13375855|NCT00789373|26730759|FG001|Maintenance|Withdrawal by Subject|21|||
13375856|NCT00789373|26730760|FG002|Maintenance|Withdrawal by Subject|8|||
13375857|NCT00789373|26730758|FG000|Maintenance|Sponsor Decision|0|||
13375858|NCT00789373|26730759|FG001|Maintenance|Sponsor Decision|0|||
13375859|NCT00789373|26730760|FG002|Maintenance|Sponsor Decision|2|||
13375860|NCT00789373|26730758|FG000|Maintenance|Participants On-Going at Data Cut-Off|0|||
13375861|NCT00789373|26730759|FG001|Maintenance|Participants On-Going at Data Cut-Off|4|||
13375862|NCT00789373|26730760|FG002|Maintenance|Participants On-Going at Data Cut-Off|0|||
13375863|NCT00789360|26730775|FG000|Overall Study|Protocol Violation|3|||
13375864|NCT00789360|26730776|FG001|Overall Study|Protocol Violation|1|||
13375865|NCT00789321|26730791|FG000|Overall Study|Adverse Event|0|||
13375866|NCT00789321|26730792|FG001|Overall Study|Adverse Event|1|||
13375867|NCT00789191|26730827|FG000|Overall Study|Adverse Event|2|||
13375868|NCT00789191|26730828|FG001|Overall Study|Adverse Event|4|||
13375869|NCT00789191|26730827|FG000|Overall Study|Lack of Efficacy|0|||
13375870|NCT00789191|26730828|FG001|Overall Study|Lack of Efficacy|5|||
13375871|NCT00789191|26730827|FG000|Overall Study|Protocol Violation|5|||
13375872|NCT00789191|26730828|FG001|Overall Study|Protocol Violation|3|||
13375873|NCT00789191|26730827|FG000|Overall Study|Withdrawal Criteria|2|||
13375874|NCT00789191|26730828|FG001|Overall Study|Withdrawal Criteria|4|||
13375875|NCT00789191|26730827|FG000|Overall Study|Unclassified|5|||
13488409|NCT02472964|27043347|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2|||
13375876|NCT00789191|26730828|FG001|Overall Study|Unclassified|3|||
13375877|NCT00789035|26730899|FG000|Overall Study|Adverse Event|0|||
13375878|NCT00789035|26730900|FG001|Overall Study|Adverse Event|2|||
13375879|NCT00789035|26730901|FG002|Overall Study|Adverse Event|0|||
13375880|NCT00789035|26730902|FG003|Overall Study|Adverse Event|1|||
13375881|NCT00789035|26730903|FG004|Overall Study|Adverse Event|3|||
13375882|NCT00789035|26730899|FG000|Overall Study|Lack of Efficacy|3|||
13375883|NCT00789035|26730900|FG001|Overall Study|Lack of Efficacy|0|||
13375884|NCT00789035|26730901|FG002|Overall Study|Lack of Efficacy|0|||
13375885|NCT00789035|26730902|FG003|Overall Study|Lack of Efficacy|0|||
13375886|NCT00789035|26730903|FG004|Overall Study|Lack of Efficacy|2|||
13375887|NCT00789035|26730899|FG000|Overall Study|Protocol Violation|1|||
13375888|NCT00789035|26730900|FG001|Overall Study|Protocol Violation|0|||
13375889|NCT00789035|26730901|FG002|Overall Study|Protocol Violation|0|||
13375890|NCT00789035|26730902|FG003|Overall Study|Protocol Violation|0|||
13375891|NCT00789035|26730903|FG004|Overall Study|Protocol Violation|0|||
13375892|NCT00789035|26730899|FG000|Overall Study|Withdrawal by Subject|0|||
13375893|NCT00789035|26730900|FG001|Overall Study|Withdrawal by Subject|2|||
13488410|NCT02472964|27043346|FG000|Part 1 (up to Week 24)|Other|2|||
13375894|NCT00789035|26730901|FG002|Overall Study|Withdrawal by Subject|0|||
13375895|NCT00789035|26730902|FG003|Overall Study|Withdrawal by Subject|0|||
13375896|NCT00789035|26730903|FG004|Overall Study|Withdrawal by Subject|0|||
13375897|NCT00789035|26730899|FG000|Overall Study|Other reason not defined above|2|||
13375898|NCT00789035|26730900|FG001|Overall Study|Other reason not defined above|3|||
13375899|NCT00789035|26730901|FG002|Overall Study|Other reason not defined above|1|||
13375900|NCT00789035|26730902|FG003|Overall Study|Other reason not defined above|0|||
13375901|NCT00789035|26730903|FG004|Overall Study|Other reason not defined above|1|||
13375902|NCT00788957|26730972|FG000|Part 1|Death|8|||
13375903|NCT00788957|26730973|FG001|Part 1|Death|0|||
13375904|NCT00788957|26730974|FG002|Part 1|Death|0|||
13375905|NCT00788957|26730975|FG003|Part 1|Death|0|||
13375906|NCT00788957|26730976|FG004|Part 1|Death|0|||
13375907|NCT00788957|26730977|FG005|Part 1|Death|0|||
13375908|NCT00788957|26730972|FG000|Part 1|Lost to Follow-up|1|||
13375909|NCT00788957|26730973|FG001|Part 1|Lost to Follow-up|0|||
13375910|NCT00788957|26730974|FG002|Part 1|Lost to Follow-up|0|||
13375911|NCT00788957|26730975|FG003|Part 1|Lost to Follow-up|0|||
13375912|NCT00788957|26730976|FG004|Part 1|Lost to Follow-up|0|||
13375913|NCT00788957|26730977|FG005|Part 1|Lost to Follow-up|0|||
13375914|NCT00788957|26730972|FG000|Part 2|Withdrawal by Subject|0|||
13375915|NCT00788957|26730973|FG001|Part 2|Withdrawal by Subject|9|||
13375916|NCT00788957|26730974|FG002|Part 2|Withdrawal by Subject|5|||
13375917|NCT00788957|26730975|FG003|Part 2|Withdrawal by Subject|3|||
13375918|NCT00788957|26730976|FG004|Part 2|Withdrawal by Subject|0|||
13375919|NCT00788957|26730977|FG005|Part 2|Withdrawal by Subject|0|||
13375920|NCT00788957|26730972|FG000|Part 2|Death|0|||
13375921|NCT00788957|26730973|FG001|Part 2|Death|32|||
13375922|NCT00788957|26730974|FG002|Part 2|Death|35|||
13375923|NCT00788957|26730975|FG003|Part 2|Death|37|||
13375924|NCT00788957|26730976|FG004|Part 2|Death|0|||
13375925|NCT00788957|26730977|FG005|Part 2|Death|0|||
13375926|NCT00788957|26730972|FG000|Part 2|Lost to Follow-up|0|||
13375927|NCT00788957|26730973|FG001|Part 2|Lost to Follow-up|0|||
13375928|NCT00788957|26730974|FG002|Part 2|Lost to Follow-up|3|||
13375929|NCT00788957|26730975|FG003|Part 2|Lost to Follow-up|0|||
13375930|NCT00788957|26730976|FG004|Part 2|Lost to Follow-up|0|||
13375931|NCT00788957|26730977|FG005|Part 2|Lost to Follow-up|0|||
13375932|NCT00788957|26730972|FG000|Part 2|On-study at time of data cut-off|0|||
13375933|NCT00788957|26730973|FG001|Part 2|On-study at time of data cut-off|1|||
13375934|NCT00788957|26730974|FG002|Part 2|On-study at time of data cut-off|1|||
13375935|NCT00788957|26730975|FG003|Part 2|On-study at time of data cut-off|1|||
13375936|NCT00788957|26730976|FG004|Part 2|On-study at time of data cut-off|0|||
13375937|NCT00788957|26730977|FG005|Part 2|On-study at time of data cut-off|0|||
13375938|NCT00788957|26730972|FG000|Part 3|Withdrawal by Subject|0|||
13375939|NCT00788957|26730973|FG001|Part 3|Withdrawal by Subject|0|||
13375940|NCT00788957|26730974|FG002|Part 3|Withdrawal by Subject|0|||
13375941|NCT00788957|26730975|FG003|Part 3|Withdrawal by Subject|0|||
13375942|NCT00788957|26730976|FG004|Part 3|Withdrawal by Subject|0|||
13375943|NCT00788957|26730977|FG005|Part 3|Withdrawal by Subject|2|||
13375944|NCT00788957|26730972|FG000|Part 3|Death|0|||
13375945|NCT00788957|26730973|FG001|Part 3|Death|0|||
13375946|NCT00788957|26730974|FG002|Part 3|Death|0|||
13375947|NCT00788957|26730975|FG003|Part 3|Death|0|||
13375948|NCT00788957|26730976|FG004|Part 3|Death|8|||
13375949|NCT00788957|26730977|FG005|Part 3|Death|9|||
13375950|NCT00788957|26730972|FG000|Part 3|On-study at time of data cut-off|0|||
13375951|NCT00788957|26730973|FG001|Part 3|On-study at time of data cut-off|0|||
13375952|NCT00788957|26730974|FG002|Part 3|On-study at time of data cut-off|0|||
13375953|NCT00788957|26730975|FG003|Part 3|On-study at time of data cut-off|0|||
13375954|NCT00788957|26730976|FG004|Part 3|On-study at time of data cut-off|1|||
13375955|NCT00788957|26730977|FG005|Part 3|On-study at time of data cut-off|0|||
13375956|NCT00788827|26730991|FG000|Overall Study|Lack of Efficacy|2|||
13375957|NCT00788775|26731010|FG000|Overall Study|Progressive Disease|8|||
13375958|NCT00788775|26731011|FG001|Overall Study|Progressive Disease|6|||
13375959|NCT00788775|26731010|FG000|Overall Study|Withdrawal by Subject|0|||
13375960|NCT00788775|26731011|FG001|Overall Study|Withdrawal by Subject|2|||
13375961|NCT00788775|26731010|FG000|Overall Study|Patient Non-Compliance|1|||
13375962|NCT00788775|26731011|FG001|Overall Study|Patient Non-Compliance|0|||
13375963|NCT00788775|26731010|FG000|Overall Study|Patient's measurable disease resected.|1|||
13375964|NCT00788775|26731011|FG001|Overall Study|Patient's measurable disease resected.|0|||
13375965|NCT00788710|26731035|FG000|Overall Study|Adverse Event|1|||
13375966|NCT00788710|26731036|FG001|Overall Study|Adverse Event|3|||
13375967|NCT00788710|26731037|FG002|Overall Study|Adverse Event|4|||
13375968|NCT00788710|26731035|FG000|Overall Study|Lack of Efficacy|0|||
13375969|NCT00788710|26731036|FG001|Overall Study|Lack of Efficacy|0|||
13375970|NCT00788710|26731037|FG002|Overall Study|Lack of Efficacy|1|||
13375971|NCT00788710|26731035|FG000|Overall Study|Lost to Follow-up|0|||
13375972|NCT00788710|26731036|FG001|Overall Study|Lost to Follow-up|1|||
13375973|NCT00788710|26731037|FG002|Overall Study|Lost to Follow-up|0|||
13375974|NCT00788710|26731035|FG000|Overall Study|Physician Decision|2|||
13375975|NCT00788710|26731036|FG001|Overall Study|Physician Decision|1|||
13375976|NCT00788710|26731037|FG002|Overall Study|Physician Decision|0|||
13375977|NCT00788710|26731035|FG000|Overall Study|Protocol Violation|0|||
13375978|NCT00788710|26731036|FG001|Overall Study|Protocol Violation|1|||
13375979|NCT00788710|26731037|FG002|Overall Study|Protocol Violation|1|||
13375980|NCT00788710|26731035|FG000|Overall Study|Withdrawal by Subject|2|||
13375981|NCT00788710|26731036|FG001|Overall Study|Withdrawal by Subject|2|||
13375982|NCT00788710|26731037|FG002|Overall Study|Withdrawal by Subject|0|||
13375983|NCT00788697|26731086|FG000|Overall Study|No study drug administered|12|||
13375984|NCT00788697|26731086|FG000|Overall Study|Training Patients|74|||
13375985|NCT00788697|26731086|FG000|Overall Study|no truth standard procedure available|5|||
13375986|NCT00788697|26731086|FG000|Overall Study|Technically inadequate truth standard|1|||
13375987|NCT00788697|26731086|FG000|Overall Study|Indeterminate diagnosis from truth stand|17|||
13375988|NCT00788593|26731107|FG000|Placebo Run-in Phase|Adverse Event|2|||
13375989|NCT00788593|26731108|FG001|Placebo Run-in Phase|Adverse Event|0|||
13375990|NCT00788593|26731109|FG002|Placebo Run-in Phase|Adverse Event|0|||
13375991|NCT00788593|26731107|FG000|Placebo Run-in Phase|Withdrawal by Subject|2|||
13375992|NCT00788593|26731108|FG001|Placebo Run-in Phase|Withdrawal by Subject|0|||
13375993|NCT00788593|26731109|FG002|Placebo Run-in Phase|Withdrawal by Subject|0|||
13375994|NCT00788593|26731107|FG000|Placebo Run-in Phase|Protocol Violation|2|||
13375995|NCT00788593|26731108|FG001|Placebo Run-in Phase|Protocol Violation|0|||
13375996|NCT00788593|26731109|FG002|Placebo Run-in Phase|Protocol Violation|0|||
13375997|NCT00788593|26731107|FG000|First Intervention Period|Adverse Event|0|||
13375998|NCT00788593|26731108|FG001|First Intervention Period|Adverse Event|1|||
13375999|NCT00788593|26731109|FG002|First Intervention Period|Adverse Event|0|||
13376000|NCT00788593|26731107|FG000|Second Intervention Period|Lost to Follow-up|0|||
13376001|NCT00788593|26731108|FG001|Second Intervention Period|Lost to Follow-up|1|||
13376002|NCT00788593|26731109|FG002|Second Intervention Period|Lost to Follow-up|0|||
13376003|NCT00788593|26731107|FG000|Second Intervention Period|Other|0|||
13376004|NCT00788593|26731108|FG001|Second Intervention Period|Other|0|||
13376005|NCT00788593|26731109|FG002|Second Intervention Period|Other|1|||
13376006|NCT00788372|26731125|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18|||
13376007|NCT00788372|26731125|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9|||
13376008|NCT00788372|26731125|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4|||
13376009|NCT00788372|26731125|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13|||
13376010|NCT00788372|26731125|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9|||
13376011|NCT00788372|26731125|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9|||
13376012|NCT00788372|26731125|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1|||
13376013|NCT00788151|26731174|FG000|Overall Study|Other adverse event|0|||
13376014|NCT00788151|26731175|FG001|Overall Study|Other adverse event|2|||
13376015|NCT00788151|26731174|FG000|Overall Study|Protocol Violation|0|||
13376016|NCT00788151|26731175|FG001|Overall Study|Protocol Violation|1|||
13376017|NCT00788151|26731174|FG000|Overall Study|Withdrawal by Subject|13|||
13376018|NCT00788151|26731175|FG001|Overall Study|Withdrawal by Subject|6|||
13376019|NCT00788151|26731174|FG000|Overall Study|Enrolled but not treated|1|||
13376020|NCT00788151|26731175|FG001|Overall Study|Enrolled but not treated|1|||
13376021|NCT00788125|26731181|FG000|Overall Study|Death|6|||
13376022|NCT00788073|26731196|FG000|STX209 Then Placebo|Adverse Event|1|||
13376023|NCT00788073|26731197|FG001|STX209 Then Placebo|Adverse Event|0|||
13376024|NCT00788073|26731196|FG000|STX209 Then Placebo|Lost to Follow-up|0|||
13376025|NCT00788073|26731197|FG001|STX209 Then Placebo|Lost to Follow-up|1|||
13376026|NCT00788073|26731196|FG000|STX209 Then Placebo|Withdrawal by Subject|0|||
13376027|NCT00788073|26731197|FG001|STX209 Then Placebo|Withdrawal by Subject|1|||
13376028|NCT00788073|26731196|FG000|STX209 Then Placebo|unable to return due to travel|0|||
13376029|NCT00788073|26731197|FG001|STX209 Then Placebo|unable to return due to travel|1|||
13376030|NCT00788073|26731196|FG000|Placebo Then STX209|Adverse Event|2|||
13376031|NCT00788073|26731197|FG001|Placebo Then STX209|Adverse Event|0|||
13376032|NCT00788073|26731196|FG000|Placebo Then STX209|Protocol Violation|0|||
13376033|NCT00788073|26731197|FG001|Placebo Then STX209|Protocol Violation|1|||
13376034|NCT00787930|26731212|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3|||
13376035|NCT00787917|26731236|FG000|Blinded Treatment|Adverse Event|1|||
13376036|NCT00787917|26731237|FG001|Blinded Treatment|Adverse Event|0|||
13376037|NCT00787917|26731236|FG000|Blinded Treatment|Lack of Efficacy|1|||
13376038|NCT00787917|26731237|FG001|Blinded Treatment|Lack of Efficacy|0|||
13376039|NCT00787917|26731236|FG000|Blinded Treatment|Administrative problems|3|||
13376040|NCT00787917|26731237|FG001|Blinded Treatment|Administrative problems|2|||
13376041|NCT00787917|26731236|FG000|Open Label|Unsatisfactory therapeutic effect|1|||
13376042|NCT00787917|26731237|FG001|Open Label|Unsatisfactory therapeutic effect|0|||
13376043|NCT00787917|26731236|FG000|Open Label|Administrative problems|3|||
13376044|NCT00787917|26731237|FG001|Open Label|Administrative problems|0|||
13376045|NCT00787891|26731262|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1|||
13376046|NCT00787891|26731263|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2|||
13376047|NCT00787891|26731262|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
13376048|NCT00787891|26731263|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
13376049|NCT00787891|26731262|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0|||
13376050|NCT00787891|26731263|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1|||
13376051|NCT00787891|26731262|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1|||
13376052|NCT00787891|26731263|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0|||
13376053|NCT00787891|26731262|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6|||
13376054|NCT00787891|26731263|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2|||
13376055|NCT00787891|26731262|FG000|Short-term Double-blind Phase (Part 1)|Other|0|||
13376056|NCT00787891|26731263|FG001|Short-term Double-blind Phase (Part 1)|Other|2|||
13376057|NCT00787891|26731262|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0|||
13376058|NCT00787891|26731263|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1|||
13376059|NCT00787891|26731262|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
13376060|NCT00787891|26731263|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
13376061|NCT00787891|26731262|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1|||
13376062|NCT00787891|26731263|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3|||
13376063|NCT00787891|26731262|FG000|Maintenance Double-blind Phase (Part 2)|Other|5|||
13376064|NCT00787891|26731263|FG001|Maintenance Double-blind Phase (Part 2)|Other|2|||
13376065|NCT00787839|26731286|FG000|Overall Study|Failure to have the OGTT was most common|404|||
13376066|NCT00787800|26731309|FG000|Overall Study|Withdrawal by Subject|3|||
13376067|NCT00787800|26731310|FG001|Overall Study|Withdrawal by Subject|5|||
13376068|NCT00787800|26731309|FG000|Overall Study|Death|0|||
13376069|NCT00787800|26731310|FG001|Overall Study|Death|2|||
13376070|NCT00787787|26731318|FG000|Overall Study|Lack of Efficacy|4|||
13376071|NCT00787787|26731318|FG000|Overall Study|Adverse Event|3|||
13376072|NCT00787644|26731331|FG000|Overall Study|Lost to Follow-up|1|||
13376073|NCT00787644|26731332|FG001|Overall Study|Lost to Follow-up|1|||
13376074|NCT00787644|26731331|FG000|Overall Study|Withdrawal by Subject|1|||
13376075|NCT00787644|26731332|FG001|Overall Study|Withdrawal by Subject|1|||
13376076|NCT00787605|26731355|FG000|Overall Study|Administrative Problems|3|||
13376077|NCT00787605|26731356|FG001|Overall Study|Administrative Problems|0|||
13376078|NCT00787605|26731355|FG000|Overall Study|Adverse Event|14|||
13376079|NCT00787605|26731356|FG001|Overall Study|Adverse Event|25|||
13376080|NCT00787605|26731355|FG000|Overall Study|Lost to Follow-up|3|||
13376081|NCT00787605|26731356|FG001|Overall Study|Lost to Follow-up|6|||
13376082|NCT00787605|26731355|FG000|Overall Study|Protocol Violation|7|||
13376083|NCT00787605|26731356|FG001|Overall Study|Protocol Violation|3|||
13376084|NCT00787605|26731355|FG000|Overall Study|Withdrawal by Subject|6|||
13376085|NCT00787605|26731356|FG001|Overall Study|Withdrawal by Subject|13|||
13376086|NCT00787605|26731355|FG000|Overall Study|Lack of Efficacy|13|||
13376087|NCT00787605|26731356|FG001|Overall Study|Lack of Efficacy|9|||
13376088|NCT00787566|26731374|FG000|Overall Study|AE related to chemotherapy|0|||
13376089|NCT00787566|26731375|FG001|Overall Study|AE related to chemotherapy|1|||
13376090|NCT00787566|26731376|FG002|Overall Study|AE related to chemotherapy|0|||
13376091|NCT00787527|26731386|FG000|Overall Study|Toxicity|3|||
13376092|NCT00787319|26731400|FG000|Overall Study|Lost to Follow-up|2|||
13376093|NCT00787319|26731400|FG000|Overall Study|Withdrawal by Subject|15|||
13376094|NCT00787319|26731400|FG000|Overall Study|Adverse Event|3|||
13376095|NCT00787319|26731400|FG000|Overall Study|Objective progression or relapse|30|||
13376096|NCT00787319|26731400|FG000|Overall Study|Lack of Efficacy|1|||
13376097|NCT00787319|26731400|FG000|Overall Study|Budget exhausted/exceeded|1|||
13376098|NCT00787319|26731400|FG000|Overall Study|Unresponsiveness to visit invitation|1|||
13376099|NCT00787319|26731400|FG000|Overall Study|No health insurance reimbursement|2|||
13376100|NCT00787319|26731400|FG000|Overall Study|Stabilized disease findings|3|||
13376101|NCT00787319|26731400|FG000|Overall Study|Inactive disease|5|||
13393760|NCT00662649|26784732|FG003|Extension Study (Month 24 to 60)|Adverse Event|6|||
13393761|NCT00662649|26784733|FG004|Extension Study (Month 24 to 60)|Adverse Event|10|||
13393762|NCT00662649|26784729|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2|||
13393763|NCT00662649|26784730|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
13393764|NCT00662649|26784731|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
13393765|NCT00662649|26784732|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
13393766|NCT00662649|26784733|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
13393767|NCT00662649|26784729|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1|||
13393768|NCT00662649|26784730|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1|||
13393769|NCT00662649|26784731|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0|||
13393770|NCT00662649|26784732|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0|||
13393771|NCT00662649|26784733|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0|||
13393772|NCT00662649|26784729|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19|||
13393773|NCT00662649|26784730|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23|||
13393774|NCT00662649|26784731|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0|||
13393775|NCT00662649|26784732|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15|||
13393776|NCT00662649|26784733|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9|||
13393777|NCT00662649|26784729|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
13393778|NCT00662649|26784730|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1|||
13376102|NCT00787267|26731410|FG000|Overall Study|Screen failure/Ineligible|10|||
13376103|NCT00787267|26731410|FG000|Overall Study|No Reason Provided|1|||
13376104|NCT00787267|26731410|FG000|Overall Study|Withdrawal by Subject|1|||
13376105|NCT00787254|26731517|FG000|Overall Study|Adverse Event|24|||
13376106|NCT00787254|26731518|FG001|Overall Study|Adverse Event|23|||
13376107|NCT00787254|26731517|FG000|Overall Study|Protocol Violation|26|||
13376108|NCT00787254|26731518|FG001|Overall Study|Protocol Violation|23|||
13376109|NCT00787254|26731517|FG000|Overall Study|Withdrawal by Subject|16|||
13376110|NCT00787254|26731518|FG001|Overall Study|Withdrawal by Subject|11|||
13376111|NCT00787254|26731517|FG000|Overall Study|Lack of Efficacy|4|||
13376112|NCT00787254|26731518|FG001|Overall Study|Lack of Efficacy|15|||
13376113|NCT00787254|26731517|FG000|Overall Study|NSAIDs discontinuation|1|||
13376114|NCT00787254|26731518|FG001|Overall Study|NSAIDs discontinuation|2|||
13376115|NCT00787254|26731517|FG000|Overall Study|Institution closed|1|||
13376116|NCT00787254|26731518|FG001|Overall Study|Institution closed|0|||
13376117|NCT00787254|26731517|FG000|Overall Study|Physician Decision|4|||
13376118|NCT00787254|26731518|FG001|Overall Study|Physician Decision|8|||
13376119|NCT00787202|26731585|FG000|Overall Study|Adverse Event|3|||
13376120|NCT00787202|26731586|FG001|Overall Study|Adverse Event|2|||
13376121|NCT00787202|26731587|FG002|Overall Study|Adverse Event|0|||
13376122|NCT00787202|26731588|FG003|Overall Study|Adverse Event|0|||
13376123|NCT00787202|26731589|FG004|Overall Study|Adverse Event|2|||
13376124|NCT00787202|26731585|FG000|Overall Study|Lack of Efficacy|5|||
13376125|NCT00787202|26731586|FG001|Overall Study|Lack of Efficacy|6|||
13376126|NCT00787202|26731587|FG002|Overall Study|Lack of Efficacy|5|||
13376127|NCT00787202|26731588|FG003|Overall Study|Lack of Efficacy|2|||
13376128|NCT00787202|26731589|FG004|Overall Study|Lack of Efficacy|1|||
13376129|NCT00787202|26731585|FG000|Overall Study|Lost to Follow-up|1|||
13376130|NCT00787202|26731586|FG001|Overall Study|Lost to Follow-up|0|||
13376131|NCT00787202|26731587|FG002|Overall Study|Lost to Follow-up|0|||
13376132|NCT00787202|26731588|FG003|Overall Study|Lost to Follow-up|0|||
13376133|NCT00787202|26731589|FG004|Overall Study|Lost to Follow-up|0|||
13376134|NCT00787202|26731585|FG000|Overall Study|Withdrawal by Subject|2|||
13376135|NCT00787202|26731586|FG001|Overall Study|Withdrawal by Subject|2|||
13376136|NCT00787202|26731587|FG002|Overall Study|Withdrawal by Subject|2|||
13376137|NCT00787202|26731588|FG003|Overall Study|Withdrawal by Subject|0|||
13376138|NCT00787202|26731589|FG004|Overall Study|Withdrawal by Subject|0|||
13376139|NCT00787202|26731585|FG000|Overall Study|Protocol Violation|2|||
13376140|NCT00787202|26731586|FG001|Overall Study|Protocol Violation|1|||
13376141|NCT00787202|26731587|FG002|Overall Study|Protocol Violation|0|||
13376142|NCT00787202|26731588|FG003|Overall Study|Protocol Violation|0|||
13376143|NCT00787202|26731589|FG004|Overall Study|Protocol Violation|1|||
13376144|NCT00787202|26731585|FG000|Overall Study|Randomized, not treated|1|||
13376145|NCT00787202|26731586|FG001|Overall Study|Randomized, not treated|0|||
13376146|NCT00787202|26731587|FG002|Overall Study|Randomized, not treated|0|||
13376147|NCT00787202|26731588|FG003|Overall Study|Randomized, not treated|0|||
13376148|NCT00787202|26731589|FG004|Overall Study|Randomized, not treated|0|||
13376149|NCT00787189|26731602|FG000|Overall Study|Lost to Follow-up|2|||
13376150|NCT00787189|26731603|FG001|Overall Study|Lost to Follow-up|2|||
13376151|NCT00787150|26731655|FG000|Overall Study|Adverse Event|4|||
13376152|NCT00787150|26731656|FG001|Overall Study|Adverse Event|4|||
13376153|NCT00787150|26731657|FG002|Overall Study|Adverse Event|4|||
13376154|NCT00787150|26731655|FG000|Overall Study|Physician Decision|1|||
13376155|NCT00787150|26731656|FG001|Overall Study|Physician Decision|2|||
13376156|NCT00787150|26731657|FG002|Overall Study|Physician Decision|1|||
13376157|NCT00787150|26731655|FG000|Overall Study|Withdrawal by Subject|2|||
13376158|NCT00787150|26731656|FG001|Overall Study|Withdrawal by Subject|1|||
13376159|NCT00787150|26731657|FG002|Overall Study|Withdrawal by Subject|0|||
13376160|NCT00787150|26731655|FG000|Overall Study|Dosing incorrect study durg|2|||
13376161|NCT00787150|26731656|FG001|Overall Study|Dosing incorrect study durg|0|||
13376162|NCT00787150|26731657|FG002|Overall Study|Dosing incorrect study durg|0|||
13376163|NCT00787137|26731687|FG000|Overall Study|Study Termination|0|||
13376164|NCT00787137|26731688|FG001|Overall Study|Study Termination|0|||
13376165|NCT00787137|26731689|FG002|Overall Study|Study Termination|1|||
13376166|NCT00786864|26731708|FG000|Overall Study|Lost to Follow-up|0|||
13376167|NCT00786864|26731709|FG001|Overall Study|Lost to Follow-up|1|||
13376168|NCT00786864|26731708|FG000|Overall Study|Sustained serious back injury|1|||
13376169|NCT00786864|26731709|FG001|Overall Study|Sustained serious back injury|0|||
13376170|NCT00786838|26731736|FG000|Overall Study|Physician Decision|4|||
13376171|NCT00786838|26731736|FG000|Overall Study|Death|4|||
13376172|NCT00786838|26731736|FG000|Overall Study|Adverse Event|6|||
13376173|NCT00786838|26731736|FG000|Overall Study|Progressive disease|31|||
13376174|NCT00786838|26731736|FG000|Overall Study|Withdrawal by Subject|4|||
13376175|NCT00786799|26731754|FG000|Overall Study|Lost to Follow-up|1|||
13376176|NCT00786799|26731755|FG001|Overall Study|Lost to Follow-up|1|||
13376177|NCT00786565|26731795|FG000|Enrollment Prior to Surgery|Site Closed|3|||
13376178|NCT00786565|26731795|FG000|Enrollment Prior to Surgery|Protocol Violation|3|||
13376179|NCT00786565|26731795|FG000|Post Surgery|Abnormal macular pucker|1|||
13376180|NCT00786565|26731795|FG000|Post Surgery|Adapt AO implanted posterior side up|1|||
13376181|NCT00786474|26731814|FG000|Overall Study|Death|5|||
13376182|NCT00786474|26731815|FG001|Overall Study|Death|4|||
13376183|NCT00786474|26731814|FG000|Overall Study|Withdrawal by Subject|23|||
13376184|NCT00786474|26731815|FG001|Overall Study|Withdrawal by Subject|31|||
13376185|NCT00786474|26731814|FG000|Overall Study|Lost to Follow-up|3|||
13376186|NCT00786474|26731815|FG001|Overall Study|Lost to Follow-up|3|||
13376187|NCT00786474|26731814|FG000|Overall Study|Physician Decision|2|||
13376188|NCT00786474|26731815|FG001|Overall Study|Physician Decision|1|||
13376189|NCT00786474|26731814|FG000|Overall Study|Other|4|||
13376190|NCT00786474|26731815|FG001|Overall Study|Other|4|||
13376191|NCT00786422|26731833|FG000|Rivaroxaban Treatment|Death|2|||
13376192|NCT00786422|26731833|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3|||
13376193|NCT00786422|26731833|FG000|Rivaroxaban Treatment|Lack of Efficacy|1|||
13376194|NCT00786422|26731833|FG000|Rivaroxaban Treatment|Physician Decision|1|||
13376195|NCT00786422|26731833|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1|||
13376196|NCT00786422|26731833|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1|||
13376197|NCT00786422|26731833|FG000|Rivaroxaban Treatment|Adverse Event|2|||
13376198|NCT00786422|26731833|FG000|Follow-up Period|Death|1|||
13376199|NCT00786422|26731833|FG000|Follow-up Period|End-of-study done up to 4 days early|2|||
13376200|NCT00786409|26731850|FG000|Overall Study|Withdrawal by Subject|2|||
13376201|NCT00786409|26731850|FG000|Overall Study|Adverse Event|2|||
13376202|NCT00786409|26731850|FG000|Overall Study|Pregnancy|2|||
13376203|NCT00786409|26731850|FG000|Overall Study|Lost to Follow-up|1|||
13376204|NCT00786188|26731883|FG000|Overall Study|Adverse Event|3|||
13376205|NCT00786188|26731884|FG001|Overall Study|Adverse Event|1|||
13376206|NCT00786188|26731883|FG000|Overall Study|Withdrawal by Subject|2|||
13376207|NCT00786188|26731884|FG001|Overall Study|Withdrawal by Subject|0|||
13376208|NCT00786032|26731896|FG000|Overall Study|Death|4|||
13376209|NCT00786032|26731896|FG000|Overall Study|Withdrawal by Subject|14|||
13376210|NCT00786032|26731896|FG000|Overall Study|Did not complete in the timeframe|6|||
13376211|NCT00785980|26731909|FG000|7 Day Washout Period|Protocol Violation|3|||
13376212|NCT00785928|26732071|FG000|Treatment Phase|Adverse Event|1|||
13376213|NCT00785928|26732072|FG001|Treatment Phase|Adverse Event|1|||
13376214|NCT00785928|26732073|FG002|Treatment Phase|Adverse Event|2|||
13376215|NCT00785928|26732074|FG003|Treatment Phase|Adverse Event|0|||
13376216|NCT00785928|26732075|FG004|Treatment Phase|Adverse Event|0|||
13376217|NCT00785928|26732076|FG005|Treatment Phase|Adverse Event|0|||
13376218|NCT00785928|26732077|FG006|Treatment Phase|Adverse Event|2|||
13376219|NCT00785928|26732071|FG000|Treatment Phase|Inadequate Response|0|||
13376220|NCT00785928|26732072|FG001|Treatment Phase|Inadequate Response|1|||
13376221|NCT00785928|26732073|FG002|Treatment Phase|Inadequate Response|0|||
13376222|NCT00785928|26732074|FG003|Treatment Phase|Inadequate Response|0|||
13376223|NCT00785928|26732075|FG004|Treatment Phase|Inadequate Response|0|||
13376224|NCT00785928|26732076|FG005|Treatment Phase|Inadequate Response|0|||
13376225|NCT00785928|26732077|FG006|Treatment Phase|Inadequate Response|0|||
13376226|NCT00785928|26732071|FG000|Treatment Phase|Lack of Efficacy|0|||
13376227|NCT00785928|26732072|FG001|Treatment Phase|Lack of Efficacy|1|||
13376228|NCT00785928|26732073|FG002|Treatment Phase|Lack of Efficacy|1|||
13376229|NCT00785928|26732074|FG003|Treatment Phase|Lack of Efficacy|0|||
13376230|NCT00785928|26732075|FG004|Treatment Phase|Lack of Efficacy|0|||
13376231|NCT00785928|26732076|FG005|Treatment Phase|Lack of Efficacy|0|||
13376232|NCT00785928|26732077|FG006|Treatment Phase|Lack of Efficacy|0|||
13376233|NCT00785928|26732071|FG000|Treatment Phase|Physician Decision|0|||
13376234|NCT00785928|26732072|FG001|Treatment Phase|Physician Decision|0|||
13376235|NCT00785928|26732073|FG002|Treatment Phase|Physician Decision|0|||
13376236|NCT00785928|26732074|FG003|Treatment Phase|Physician Decision|0|||
13376237|NCT00785928|26732075|FG004|Treatment Phase|Physician Decision|1|||
13376238|NCT00785928|26732076|FG005|Treatment Phase|Physician Decision|0|||
13376239|NCT00785928|26732077|FG006|Treatment Phase|Physician Decision|0|||
13376240|NCT00785928|26732071|FG000|Treatment Phase|Sponsor Decision|1|||
13376241|NCT00785928|26732072|FG001|Treatment Phase|Sponsor Decision|0|||
13376242|NCT00785928|26732073|FG002|Treatment Phase|Sponsor Decision|0|||
13376243|NCT00785928|26732074|FG003|Treatment Phase|Sponsor Decision|0|||
13376244|NCT00785928|26732075|FG004|Treatment Phase|Sponsor Decision|0|||
13376245|NCT00785928|26732076|FG005|Treatment Phase|Sponsor Decision|0|||
13376246|NCT00785928|26732077|FG006|Treatment Phase|Sponsor Decision|1|||
13376247|NCT00785928|26732071|FG000|Treatment Phase|Withdrawal by Subject|1|||
13376248|NCT00785928|26732072|FG001|Treatment Phase|Withdrawal by Subject|2|||
13376249|NCT00785928|26732073|FG002|Treatment Phase|Withdrawal by Subject|0|||
13376250|NCT00785928|26732074|FG003|Treatment Phase|Withdrawal by Subject|0|||
13393779|NCT00662649|26784731|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
13376251|NCT00785928|26732075|FG004|Treatment Phase|Withdrawal by Subject|1|||
13376252|NCT00785928|26732076|FG005|Treatment Phase|Withdrawal by Subject|0|||
13376253|NCT00785928|26732077|FG006|Treatment Phase|Withdrawal by Subject|0|||
13376254|NCT00785785|26732092|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3|||
13376255|NCT00785785|26732093|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4|||
13376256|NCT00785785|26732092|FG000|Core Phase up to 36 Months|Adverse Event|31|||
13376257|NCT00785785|26732093|FG001|Core Phase up to 36 Months|Adverse Event|21|||
13376258|NCT00785785|26732092|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1|||
13376259|NCT00785785|26732093|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0|||
13376260|NCT00785785|26732092|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2|||
13376261|NCT00785785|26732093|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2|||
13376262|NCT00785785|26732092|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16|||
13376263|NCT00785785|26732093|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17|||
13376264|NCT00785785|26732092|FG000|Core Phase up to 36 Months|Lost to Follow-up|3|||
13376265|NCT00785785|26732093|FG001|Core Phase up to 36 Months|Lost to Follow-up|7|||
13376266|NCT00785785|26732092|FG000|Core Phase up to 36 Months|Administrative problems|3|||
13376267|NCT00785785|26732093|FG001|Core Phase up to 36 Months|Administrative problems|3|||
13376268|NCT00785785|26732092|FG000|Core Phase up to 36 Months|Death|5|||
13376269|NCT00785785|26732093|FG001|Core Phase up to 36 Months|Death|8|||
13376270|NCT00785785|26732092|FG000|Core Phase up to 36 Months|Disease progression|139|||
13376271|NCT00785785|26732093|FG001|Core Phase up to 36 Months|Disease progression|119|||
13376272|NCT00785785|26732092|FG000|Core Phase up to 36 Months|Protocol deviation|5|||
13376273|NCT00785785|26732093|FG001|Core Phase up to 36 Months|Protocol deviation|6|||
13376274|NCT00785785|26732092|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116|||
13376275|NCT00785785|26732093|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133|||
13376276|NCT00785785|26732092|FG000|Optional Extension Phase|Adverse Event|4|||
13376277|NCT00785785|26732093|FG001|Optional Extension Phase|Adverse Event|5|||
13376278|NCT00785785|26732092|FG000|Optional Extension Phase|Withdrawal by Subject|6|||
13376279|NCT00785785|26732093|FG001|Optional Extension Phase|Withdrawal by Subject|6|||
13376280|NCT00785785|26732092|FG000|Optional Extension Phase|Lost to Follow-up|1|||
13376281|NCT00785785|26732093|FG001|Optional Extension Phase|Lost to Follow-up|0|||
13376282|NCT00785785|26732092|FG000|Optional Extension Phase|Administrative problems|2|||
13376283|NCT00785785|26732093|FG001|Optional Extension Phase|Administrative problems|0|||
13376284|NCT00785785|26732092|FG000|Optional Extension Phase|Death|1|||
13376285|NCT00785785|26732093|FG001|Optional Extension Phase|Death|5|||
13376286|NCT00785785|26732092|FG000|Optional Extension Phase|Disease progression|22|||
13376287|NCT00785785|26732093|FG001|Optional Extension Phase|Disease progression|70|||
13376288|NCT00785785|26732092|FG000|Optional Extension Phase|Protocol deviation|0|||
13376289|NCT00785785|26732093|FG001|Optional Extension Phase|Protocol deviation|2|||
13376290|NCT00785785|26732092|FG000|Optional Extension Phase|Study terminated by sponsor|3|||
13376291|NCT00785785|26732093|FG001|Optional Extension Phase|Study terminated by sponsor|37|||
13376292|NCT00785707|26732100|FG000|Overall Study|Lost to Follow-up|7|||
13376293|NCT00785629|26732121|FG000|Overall Study|Adverse Event|2|||
13376294|NCT00785629|26732122|FG001|Overall Study|Adverse Event|1|||
13376295|NCT00785629|26732123|FG002|Overall Study|Adverse Event|1|||
13376296|NCT00785629|26732124|FG003|Overall Study|Adverse Event|5|||
13376297|NCT00785629|26732121|FG000|Overall Study|Protocol Violation|1|||
13376298|NCT00785629|26732122|FG001|Overall Study|Protocol Violation|2|||
13376299|NCT00785629|26732123|FG002|Overall Study|Protocol Violation|4|||
13376300|NCT00785629|26732124|FG003|Overall Study|Protocol Violation|5|||
13376301|NCT00785629|26732121|FG000|Overall Study|administrative decision|5|||
13376302|NCT00785629|26732122|FG001|Overall Study|administrative decision|1|||
13376303|NCT00785629|26732123|FG002|Overall Study|administrative decision|3|||
13376304|NCT00785629|26732124|FG003|Overall Study|administrative decision|4|||
13376305|NCT00785629|26732121|FG000|Overall Study|Withdrawal by Subject|0|||
13376306|NCT00785629|26732122|FG001|Overall Study|Withdrawal by Subject|1|||
13376307|NCT00785629|26732123|FG002|Overall Study|Withdrawal by Subject|2|||
13376308|NCT00785629|26732124|FG003|Overall Study|Withdrawal by Subject|2|||
13376309|NCT00785577|26732276|FG000|Study Period 2: Therapy Phase|Adverse Event|5|||
13376310|NCT00785577|26732277|FG001|Study Period 2: Therapy Phase|Adverse Event|7|||
13376311|NCT00785577|26732278|FG002|Study Period 2: Therapy Phase|Adverse Event|14|||
13376312|NCT00785577|26732279|FG003|Study Period 2: Therapy Phase|Adverse Event|10|||
13376313|NCT00785577|26732280|FG004|Study Period 2: Therapy Phase|Adverse Event|17|||
13376314|NCT00785577|26732276|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
13376315|NCT00785577|26732277|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
13376316|NCT00785577|26732278|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
13376317|NCT00785577|26732279|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
13376318|NCT00785577|26732280|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
13376319|NCT00785577|26732276|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
13376320|NCT00785577|26732277|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
13376321|NCT00785577|26732278|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
13376322|NCT00785577|26732279|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1|||
13376323|NCT00785577|26732280|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
13376324|NCT00785577|26732276|FG000|Study Period 2: Therapy Phase|Physician Decision|1|||
13376325|NCT00785577|26732277|FG001|Study Period 2: Therapy Phase|Physician Decision|0|||
13376326|NCT00785577|26732278|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
13376327|NCT00785577|26732279|FG003|Study Period 2: Therapy Phase|Physician Decision|0|||
13488411|NCT02472964|27043347|FG001|Part 1 (up to Week 24)|Other|1|||
13376328|NCT00785577|26732280|FG004|Study Period 2: Therapy Phase|Physician Decision|0|||
13376329|NCT00785577|26732276|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
13376330|NCT00785577|26732277|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
13376331|NCT00785577|26732278|FG002|Study Period 2: Therapy Phase|Protocol Violation|1|||
13376332|NCT00785577|26732279|FG003|Study Period 2: Therapy Phase|Protocol Violation|0|||
13376333|NCT00785577|26732280|FG004|Study Period 2: Therapy Phase|Protocol Violation|1|||
13376334|NCT00785577|26732276|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
13376335|NCT00785577|26732277|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
13376336|NCT00785577|26732278|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
13376337|NCT00785577|26732279|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
13393780|NCT00662649|26784732|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
13393781|NCT00662649|26784733|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
13393782|NCT00662649|26784729|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
13393783|NCT00662649|26784730|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
13393784|NCT00662649|26784731|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0|||
13393785|NCT00662649|26784732|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
13393786|NCT00662649|26784733|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
13393787|NCT00662558|26784772|FG000|Overall Study|Adverse Event|21|||
13393788|NCT00662558|26784773|FG001|Overall Study|Adverse Event|59|||
13393789|NCT00662558|26784772|FG000|Overall Study|Lack of Efficacy|4|||
13393790|NCT00662558|26784773|FG001|Overall Study|Lack of Efficacy|7|||
13393791|NCT00662558|26784772|FG000|Overall Study|Lost to Follow-up|13|||
13393792|NCT00662558|26784773|FG001|Overall Study|Lost to Follow-up|10|||
13393793|NCT00662558|26784772|FG000|Overall Study|Other|9|||
13393794|NCT00662558|26784773|FG001|Overall Study|Other|14|||
13393795|NCT00662558|26784772|FG000|Overall Study|Withdrawal by Subject|7|||
13393796|NCT00662558|26784773|FG001|Overall Study|Withdrawal by Subject|12|||
13393797|NCT00662558|26784772|FG000|Overall Study|Randomized But Did Not Receive Treatment|2|||
13393798|NCT00662558|26784773|FG001|Overall Study|Randomized But Did Not Receive Treatment|8|||
13393799|NCT00662532|26784790|FG000|Overall Study|Adverse Event|0|||
13393800|NCT00662532|26784791|FG001|Overall Study|Adverse Event|1|||
13393801|NCT00662532|26784790|FG000|Overall Study|Lost to Follow-up|0|||
13393802|NCT00662532|26784791|FG001|Overall Study|Lost to Follow-up|1|||
13393803|NCT00662363|26784806|FG000|Overall Study|Withdrawal by Subject|6|||
13393804|NCT00662363|26784807|FG001|Overall Study|Withdrawal by Subject|5|||
13393805|NCT00662363|26784806|FG000|Overall Study|Adverse Event|0|||
13393806|NCT00662363|26784807|FG001|Overall Study|Adverse Event|3|||
13393807|NCT00662363|26784806|FG000|Overall Study|Discharged early from rehab|4|||
13393808|NCT00662363|26784807|FG001|Overall Study|Discharged early from rehab|1|||
13393809|NCT00662363|26784806|FG000|Overall Study|Protocol Violation|1|||
13393810|NCT00662363|26784807|FG001|Overall Study|Protocol Violation|1|||
13393811|NCT00662311|26784840|FG000|Overall Study|Respiratory Infection|1|||
13393812|NCT00662311|26784841|FG001|Overall Study|Respiratory Infection|0|||
13393813|NCT00662311|26784842|FG002|Overall Study|Respiratory Infection|0|||
13393814|NCT00662259|26784863|FG000|Overall Study|Adverse Event|2|||
13393815|NCT00662259|26784864|FG001|Overall Study|Adverse Event|0|||
13393816|NCT00662129|26784876|FG000|Overall Study|Protocol Violation|1|||
13393817|NCT00662129|26784876|FG000|Overall Study|Cancel prior to beginning treatment|1|||
13393818|NCT00662129|26784876|FG000|Overall Study|Ineligible|1|||
13393819|NCT00662038|26784882|FG000|Overall Study|Reason not specified|3|||
13393820|NCT00662038|26784882|FG000|Overall Study|Withdrawn consent|22|||
13393821|NCT00662038|26784882|FG000|Overall Study|Withdrawal by Subject|83|||
13393822|NCT00662038|26784882|FG000|Overall Study|Sponsor decision|1|||
13393823|NCT00662038|26784882|FG000|Overall Study|Physician Decision|19|||
13393824|NCT00662038|26784882|FG000|Overall Study|Lung transplantation|44|||
13393825|NCT00662038|26784882|FG000|Overall Study|Lost to Follow-up|1|||
13393826|NCT00662038|26784882|FG000|Overall Study|Death|95|||
13393827|NCT00662038|26784882|FG000|Overall Study|Adverse Event|358|||
13393828|NCT00662038|26784882|FG000|Overall Study|Continued treatment|5|||
13393829|NCT00662025|26784904|FG000|Overall Study|Objective progression or relapse|51|||
13393830|NCT00662025|26784904|FG000|Overall Study|Adverse Event|7|||
13393831|NCT00662025|26784904|FG000|Overall Study|Withdrawal by Subject|1|||
13393832|NCT00662025|26784904|FG000|Overall Study|Results of other clinical study|2|||
13393833|NCT00662025|26784904|FG000|Overall Study|Target lesion cannot be evaluated|1|||
13393834|NCT00662025|26784904|FG000|Overall Study|Domestic circumstances|1|||
13393835|NCT00662012|26784911|FG000|Overall Study|Lost to Follow-up|85|||
13393836|NCT00662012|26784911|FG000|Overall Study|Death|1|||
13393837|NCT00662012|26784911|FG000|Overall Study|Withdrawal by Subject|1|||
13393838|NCT00661999|26784974|FG000|Overall Study|Adverse Event|11|||
13393839|NCT00661999|26784975|FG001|Overall Study|Adverse Event|5|||
13393840|NCT00661999|26784976|FG002|Overall Study|Adverse Event|8|||
13393841|NCT00661999|26784974|FG000|Overall Study|Death|8|||
13393842|NCT00661999|26784975|FG001|Overall Study|Death|6|||
13393843|NCT00661999|26784976|FG002|Overall Study|Death|3|||
13393844|NCT00661999|26784974|FG000|Overall Study|Other Reasons|5|||
13376338|NCT00785577|26732280|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
13376339|NCT00785577|26732276|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
13376340|NCT00785577|26732277|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
13376341|NCT00785577|26732278|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
13376342|NCT00785577|26732279|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
13376343|NCT00785577|26732280|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
13376344|NCT00785577|26732276|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1|||
13376345|NCT00785577|26732277|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0|||
13376346|NCT00785577|26732278|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1|||
13376347|NCT00785577|26732279|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1|||
13376348|NCT00785577|26732280|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0|||
13376349|NCT00785577|26732276|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
13376350|NCT00785577|26732277|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
13376351|NCT00785577|26732278|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
13376352|NCT00785577|26732279|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1|||
13376353|NCT00785577|26732280|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
13376354|NCT00785577|26732276|FG000|Study Period 3: 1-Week Washout Phase|Death|0|||
13376355|NCT00785577|26732277|FG001|Study Period 3: 1-Week Washout Phase|Death|0|||
13376356|NCT00785577|26732278|FG002|Study Period 3: 1-Week Washout Phase|Death|0|||
13376357|NCT00785577|26732279|FG003|Study Period 3: 1-Week Washout Phase|Death|0|||
13376358|NCT00785577|26732280|FG004|Study Period 3: 1-Week Washout Phase|Death|1|||
13376359|NCT00785538|26732339|FG000|Treatment Period|Adverse Event|1|||
13376360|NCT00785538|26732340|FG001|Treatment Period|Adverse Event|2|||
13376361|NCT00785538|26732341|FG002|Treatment Period|Adverse Event|2|||
13376362|NCT00785538|26732342|FG003|Treatment Period|Adverse Event|0|||
13376363|NCT00785538|26732339|FG000|Treatment Period|Withdrawal by Subject|0|||
13376364|NCT00785538|26732340|FG001|Treatment Period|Withdrawal by Subject|0|||
13376365|NCT00785538|26732341|FG002|Treatment Period|Withdrawal by Subject|0|||
13376366|NCT00785538|26732342|FG003|Treatment Period|Withdrawal by Subject|1|||
13376367|NCT00785512|26732358|FG000|Overall Study|Inclusion/Exclusion not meet|0|||
13376368|NCT00785512|26732359|FG001|Overall Study|Inclusion/Exclusion not meet|0|||
13376369|NCT00785512|26732358|FG000|Overall Study|Adverse Event|0|||
13376370|NCT00785512|26732359|FG001|Overall Study|Adverse Event|0|||
13376371|NCT00785512|26732358|FG000|Overall Study|Lack of Efficacy|0|||
13376372|NCT00785512|26732359|FG001|Overall Study|Lack of Efficacy|2|||
13376373|NCT00785512|26732358|FG000|Overall Study|Withdrawal by Subject|0|||
13376374|NCT00785512|26732359|FG001|Overall Study|Withdrawal by Subject|1|||
13376375|NCT00785512|26732358|FG000|Overall Study|Lost to Follow-up|3|||
13376376|NCT00785512|26732359|FG001|Overall Study|Lost to Follow-up|0|||
13376377|NCT00785512|26732358|FG000|Overall Study|Precedure Refused|0|||
13376378|NCT00785512|26732359|FG001|Overall Study|Precedure Refused|0|||
13376379|NCT00785512|26732358|FG000|Overall Study|IVRS Programing Error|0|||
13376380|NCT00785512|26732359|FG001|Overall Study|IVRS Programing Error|0|||
13376381|NCT00785512|26732358|FG000|Overall Study|Physician Decision|0|||
13376382|NCT00785512|26732359|FG001|Overall Study|Physician Decision|0|||
13376383|NCT00785512|26732358|FG000|Overall Study|Lack of compliance|0|||
13376384|NCT00785512|26732359|FG001|Overall Study|Lack of compliance|1|||
13376385|NCT00785486|26732382|FG000|Midazolam Alone|Withdrawal by Subject|1|||
13376386|NCT00785356|26732398|FG000|Overall Study|Study prematurely terminated|8|||
13376387|NCT00785291|26732428|FG000|Overall Study|Never began treatment|8|||
13376388|NCT00785291|26732429|FG001|Overall Study|Never began treatment|4|||
13376389|NCT00785291|26732430|FG002|Overall Study|Never began treatment|4|||
13376390|NCT00785291|26732428|FG000|Overall Study|Adverse Event|39|||
13376391|NCT00785291|26732429|FG001|Overall Study|Adverse Event|70|||
13376392|NCT00785291|26732430|FG002|Overall Study|Adverse Event|56|||
13376393|NCT00785291|26732428|FG000|Overall Study|Death|7|||
13376394|NCT00785291|26732429|FG001|Overall Study|Death|4|||
13376395|NCT00785291|26732430|FG002|Overall Study|Death|3|||
13376396|NCT00785291|26732428|FG000|Overall Study|Withdrawal by Subject|35|||
13376397|NCT00785291|26732429|FG001|Overall Study|Withdrawal by Subject|36|||
13376398|NCT00785291|26732430|FG002|Overall Study|Withdrawal by Subject|17|||
13376399|NCT00785291|26732428|FG000|Overall Study|Alternative Therapy|12|||
13376400|NCT00785291|26732429|FG001|Overall Study|Alternative Therapy|6|||
13376401|NCT00785291|26732430|FG002|Overall Study|Alternative Therapy|7|||
13376402|NCT00785291|26732428|FG000|Overall Study|Complicating illness|6|||
13376403|NCT00785291|26732429|FG001|Overall Study|Complicating illness|4|||
13376404|NCT00785291|26732430|FG002|Overall Study|Complicating illness|4|||
13376405|NCT00785291|26732428|FG000|Overall Study|Other Medical Reasons|29|||
13376406|NCT00785291|26732429|FG001|Overall Study|Other Medical Reasons|25|||
13376407|NCT00785291|26732430|FG002|Overall Study|Other Medical Reasons|15|||
13376408|NCT00785213|26732443|FG000|Quinine Sulfate Alone|Adverse Event|4|||
13376409|NCT00785213|26732443|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1|||
13376410|NCT00785044|26732450|FG000|Overall Study|Dosed at non-participating sites|152|||
13376411|NCT00785044|26732450|FG000|Overall Study|Death|77|||
13376412|NCT00785044|26732450|FG000|Overall Study|Lost to Follow-up|266|||
13376413|NCT00785044|26732450|FG000|Overall Study|Withdrawal by Subject|1|||
13376414|NCT00784979|26732456|FG000|Overall Study|incomplete data|6|||
13376415|NCT00784927|26732466|FG000|Overall Study|Cancel Prior to Initiating Treatment|1|||
13376416|NCT00784927|26732466|FG000|Overall Study|Protocol Violation|1|||
13376417|NCT00784927|26732466|FG000|Overall Study|Ineligible|1|||
13376418|NCT00784875|26732593|FG000|Period A - Baseline|Entry Criteria Not Met|0|||
13376419|NCT00784875|26732594|FG001|Period A - Baseline|Entry Criteria Not Met|0|||
13376420|NCT00784875|26732595|FG002|Period A - Baseline|Entry Criteria Not Met|0|||
13376421|NCT00784875|26732596|FG003|Period A - Baseline|Entry Criteria Not Met|5|||
13376422|NCT00784875|26732593|FG000|Period A - Baseline|Adverse Event|0|||
13376423|NCT00784875|26732594|FG001|Period A - Baseline|Adverse Event|0|||
13376424|NCT00784875|26732595|FG002|Period A - Baseline|Adverse Event|0|||
13376425|NCT00784875|26732596|FG003|Period A - Baseline|Adverse Event|8|||
13376426|NCT00784875|26732593|FG000|Period A - Baseline|Protocol Violation|0|||
13376427|NCT00784875|26732594|FG001|Period A - Baseline|Protocol Violation|0|||
13376428|NCT00784875|26732595|FG002|Period A - Baseline|Protocol Violation|0|||
13376429|NCT00784875|26732596|FG003|Period A - Baseline|Protocol Violation|25|||
13376430|NCT00784875|26732593|FG000|Period A - Baseline|Withdrawal by Subject|0|||
13376431|NCT00784875|26732594|FG001|Period A - Baseline|Withdrawal by Subject|0|||
13376432|NCT00784875|26732595|FG002|Period A - Baseline|Withdrawal by Subject|0|||
13376433|NCT00784875|26732596|FG003|Period A - Baseline|Withdrawal by Subject|27|||
13376434|NCT00784875|26732593|FG000|Period A - Baseline|Physician Decision|0|||
13376435|NCT00784875|26732594|FG001|Period A - Baseline|Physician Decision|0|||
13376436|NCT00784875|26732595|FG002|Period A - Baseline|Physician Decision|0|||
13376437|NCT00784875|26732596|FG003|Period A - Baseline|Physician Decision|2|||
13393845|NCT00661999|26784975|FG001|Overall Study|Other Reasons|12|||
13393846|NCT00661999|26784976|FG002|Overall Study|Other Reasons|23|||
13393847|NCT00661999|26784974|FG000|Overall Study|Withdrawal by Subject|30|||
13393848|NCT00661999|26784975|FG001|Overall Study|Withdrawal by Subject|23|||
13393849|NCT00661999|26784976|FG002|Overall Study|Withdrawal by Subject|14|||
13393850|NCT00661999|26784974|FG000|Overall Study|Alternative Treatment|1|||
13393851|NCT00661999|26784975|FG001|Overall Study|Alternative Treatment|0|||
13393852|NCT00661999|26784976|FG002|Overall Study|Alternative Treatment|0|||
13393853|NCT00661999|26784974|FG000|Overall Study|Other Medical Problems|4|||
13393854|NCT00661999|26784975|FG001|Overall Study|Other Medical Problems|4|||
13393855|NCT00661999|26784976|FG002|Overall Study|Other Medical Problems|9|||
13393856|NCT00661830|26784995|FG000|Overall Study|Death|37|||
13393857|NCT00661830|26784996|FG001|Overall Study|Death|33|||
13393858|NCT00661830|26784995|FG000|Overall Study|Lost to Follow-up|1|||
13393859|NCT00661830|26784996|FG001|Overall Study|Lost to Follow-up|3|||
13393860|NCT00661830|26784995|FG000|Overall Study|Withdrawal by Subject|1|||
13393861|NCT00661830|26784996|FG001|Overall Study|Withdrawal by Subject|1|||
13393862|NCT00661830|26784995|FG000|Overall Study|Other reason|1|||
13393863|NCT00661830|26784996|FG001|Overall Study|Other reason|5|||
13393864|NCT00661778|26785005|FG000|Overall Study|Disease Progression|23|||
13393865|NCT00661778|26785005|FG000|Overall Study|Adverse Event|18|||
13393866|NCT00661778|26785005|FG000|Overall Study|Reason not Specified|6|||
13393867|NCT00661778|26785005|FG000|Overall Study|Protocol Violation|2|||
13393868|NCT00661778|26785005|FG000|Overall Study|Withdrawal of Consent|1|||
13393869|NCT00661726|26785022|FG000|Overall Study|Adverse Event|1|||
13393870|NCT00661713|26785139|FG000|Overall Study|Death|1|||
13393871|NCT00661713|26785140|FG001|Overall Study|Death|0|||
13393872|NCT00661713|26785141|FG002|Overall Study|Death|0|||
13393873|NCT00661713|26785142|FG003|Overall Study|Death|0|||
13393874|NCT00661713|26785143|FG004|Overall Study|Death|1|||
13393875|NCT00661713|26785144|FG005|Overall Study|Death|0|||
13393876|NCT00661713|26785145|FG006|Overall Study|Death|0|||
13393877|NCT00661713|26785146|FG007|Overall Study|Death|0|||
13393878|NCT00661713|26785139|FG000|Overall Study|Unable to Classify|1|||
13393879|NCT00661713|26785140|FG001|Overall Study|Unable to Classify|0|||
13393880|NCT00661713|26785141|FG002|Overall Study|Unable to Classify|0|||
13393881|NCT00661713|26785142|FG003|Overall Study|Unable to Classify|0|||
13393882|NCT00661713|26785143|FG004|Overall Study|Unable to Classify|0|||
13393883|NCT00661713|26785144|FG005|Overall Study|Unable to Classify|0|||
13393884|NCT00661713|26785145|FG006|Overall Study|Unable to Classify|0|||
13393885|NCT00661713|26785146|FG007|Overall Study|Unable to Classify|0|||
13393886|NCT00661713|26785139|FG000|Overall Study|Protocol Violation|1|||
13393887|NCT00661713|26785140|FG001|Overall Study|Protocol Violation|6|||
13393888|NCT00661713|26785141|FG002|Overall Study|Protocol Violation|3|||
13393889|NCT00661713|26785142|FG003|Overall Study|Protocol Violation|3|||
13393890|NCT00661713|26785143|FG004|Overall Study|Protocol Violation|0|||
13393891|NCT00661713|26785144|FG005|Overall Study|Protocol Violation|2|||
13393892|NCT00661713|26785145|FG006|Overall Study|Protocol Violation|2|||
13393893|NCT00661713|26785146|FG007|Overall Study|Protocol Violation|1|||
13393894|NCT00661713|26785139|FG000|Overall Study|Withdrawal by Subject|11|||
13393895|NCT00661713|26785140|FG001|Overall Study|Withdrawal by Subject|25|||
13393896|NCT00661713|26785141|FG002|Overall Study|Withdrawal by Subject|12|||
13393897|NCT00661713|26785142|FG003|Overall Study|Withdrawal by Subject|21|||
13376438|NCT00784875|26732593|FG000|Period A - Baseline|Sponsor Decision|0|||
13376439|NCT00784875|26732594|FG001|Period A - Baseline|Sponsor Decision|0|||
13376440|NCT00784875|26732595|FG002|Period A - Baseline|Sponsor Decision|0|||
13376441|NCT00784875|26732596|FG003|Period A - Baseline|Sponsor Decision|113|||
13376442|NCT00784875|26732593|FG000|Period A - Baseline|Lost to Follow-up|0|||
13376443|NCT00784875|26732594|FG001|Period A - Baseline|Lost to Follow-up|0|||
13376444|NCT00784875|26732595|FG002|Period A - Baseline|Lost to Follow-up|0|||
13376445|NCT00784875|26732596|FG003|Period A - Baseline|Lost to Follow-up|2|||
13376446|NCT00784875|26732593|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
13376447|NCT00784875|26732594|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
13376448|NCT00784875|26732595|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2|||
13376449|NCT00784875|26732596|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1|||
13376450|NCT00784875|26732593|FG000|Period B - Efficacy Endpoint|Adverse Event|0|||
13376451|NCT00784875|26732594|FG001|Period B - Efficacy Endpoint|Adverse Event|3|||
13376452|NCT00784875|26732595|FG002|Period B - Efficacy Endpoint|Adverse Event|2|||
13376453|NCT00784875|26732596|FG003|Period B - Efficacy Endpoint|Adverse Event|1|||
13376454|NCT00784875|26732593|FG000|Period B - Efficacy Endpoint|Protocol Violation|1|||
13376455|NCT00784875|26732594|FG001|Period B - Efficacy Endpoint|Protocol Violation|1|||
13376456|NCT00784875|26732595|FG002|Period B - Efficacy Endpoint|Protocol Violation|2|||
13376457|NCT00784875|26732596|FG003|Period B - Efficacy Endpoint|Protocol Violation|3|||
13376458|NCT00784875|26732593|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
13376459|NCT00784875|26732594|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1|||
13376460|NCT00784875|26732595|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
13376461|NCT00784875|26732596|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
13376462|NCT00784875|26732593|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4|||
13376463|NCT00784875|26732594|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
13376464|NCT00784875|26732595|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
13376465|NCT00784875|26732596|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2|||
13376466|NCT00784875|26732593|FG000|Period B - Efficacy Endpoint|Physician Decision|0|||
13376467|NCT00784875|26732594|FG001|Period B - Efficacy Endpoint|Physician Decision|0|||
13376468|NCT00784875|26732595|FG002|Period B - Efficacy Endpoint|Physician Decision|1|||
13376469|NCT00784875|26732596|FG003|Period B - Efficacy Endpoint|Physician Decision|0|||
13376470|NCT00784875|26732593|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9|||
13376471|NCT00784875|26732594|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6|||
13376472|NCT00784875|26732595|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12|||
13376473|NCT00784875|26732596|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12|||
13376474|NCT00784875|26732593|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
13376475|NCT00784875|26732594|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
13376476|NCT00784875|26732595|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1|||
13376477|NCT00784875|26732596|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
13376478|NCT00784875|26732593|FG000|Period C|Adverse Event|1|||
13376479|NCT00784875|26732594|FG001|Period C|Adverse Event|0|||
13376480|NCT00784875|26732595|FG002|Period C|Adverse Event|4|||
13376481|NCT00784875|26732596|FG003|Period C|Adverse Event|2|||
13376482|NCT00784875|26732593|FG000|Period C|Protocol Violation|0|||
13376483|NCT00784875|26732594|FG001|Period C|Protocol Violation|0|||
13376484|NCT00784875|26732595|FG002|Period C|Protocol Violation|1|||
13376485|NCT00784875|26732596|FG003|Period C|Protocol Violation|2|||
13376486|NCT00784875|26732593|FG000|Period C|Lack of Efficacy|0|||
13376487|NCT00784875|26732594|FG001|Period C|Lack of Efficacy|0|||
13376488|NCT00784875|26732595|FG002|Period C|Lack of Efficacy|1|||
13376489|NCT00784875|26732596|FG003|Period C|Lack of Efficacy|0|||
13376490|NCT00784875|26732593|FG000|Period C|Withdrawal by Subject|1|||
13376491|NCT00784875|26732594|FG001|Period C|Withdrawal by Subject|1|||
13376492|NCT00784875|26732595|FG002|Period C|Withdrawal by Subject|2|||
13376493|NCT00784875|26732596|FG003|Period C|Withdrawal by Subject|0|||
13376494|NCT00784875|26732593|FG000|Period C|Physician Decision|0|||
13376495|NCT00784875|26732594|FG001|Period C|Physician Decision|0|||
13376496|NCT00784875|26732595|FG002|Period C|Physician Decision|1|||
13376497|NCT00784875|26732596|FG003|Period C|Physician Decision|1|||
13376498|NCT00784875|26732593|FG000|Period C|Sponsor Decision|5|||
13376499|NCT00784875|26732594|FG001|Period C|Sponsor Decision|5|||
13376500|NCT00784875|26732595|FG002|Period C|Sponsor Decision|4|||
13376501|NCT00784875|26732596|FG003|Period C|Sponsor Decision|2|||
13376502|NCT00784875|26732593|FG000|Period D|Adverse Event|0|||
13488412|NCT02472964|27043346|FG000|Part 2 (Week 24-week 48)|Adverse Event|4|||
13376503|NCT00784875|26732594|FG001|Period D|Adverse Event|2|||
13376504|NCT00784875|26732595|FG002|Period D|Adverse Event|2|||
13376505|NCT00784875|26732596|FG003|Period D|Adverse Event|0|||
13376506|NCT00784875|26732593|FG000|Period D|Protocol Violation|1|||
13376507|NCT00784875|26732594|FG001|Period D|Protocol Violation|0|||
13376508|NCT00784875|26732595|FG002|Period D|Protocol Violation|0|||
13376509|NCT00784875|26732596|FG003|Period D|Protocol Violation|0|||
13376510|NCT00784875|26732593|FG000|Period D|Withdrawal by Subject|2|||
13376511|NCT00784875|26732594|FG001|Period D|Withdrawal by Subject|0|||
13376512|NCT00784875|26732595|FG002|Period D|Withdrawal by Subject|2|||
13376513|NCT00784875|26732596|FG003|Period D|Withdrawal by Subject|0|||
13376514|NCT00784875|26732593|FG000|Period D|Physician Decision|0|||
13376515|NCT00784875|26732594|FG001|Period D|Physician Decision|1|||
13376516|NCT00784875|26732595|FG002|Period D|Physician Decision|0|||
13376517|NCT00784875|26732596|FG003|Period D|Physician Decision|0|||
13376518|NCT00784875|26732593|FG000|Period D|Sponsor Decision|1|||
13376519|NCT00784875|26732594|FG001|Period D|Sponsor Decision|1|||
13376520|NCT00784875|26732595|FG002|Period D|Sponsor Decision|1|||
13376521|NCT00784875|26732596|FG003|Period D|Sponsor Decision|0|||
13376522|NCT00784875|26732593|FG000|Period D|Lost to Follow-up|1|||
13376523|NCT00784875|26732594|FG001|Period D|Lost to Follow-up|0|||
13376524|NCT00784875|26732595|FG002|Period D|Lost to Follow-up|1|||
13376525|NCT00784875|26732596|FG003|Period D|Lost to Follow-up|1|||
13376526|NCT00784836|26732603|FG000|Overall Study|Early Study Termination|3|||
13376527|NCT00784810|26732618|FG000|Overall Study|Adverse Event|32|||
13376528|NCT00784810|26732619|FG001|Overall Study|Adverse Event|20|||
13376529|NCT00784810|26732618|FG000|Overall Study|Lack of Efficacy|14|||
13376530|NCT00784810|26732619|FG001|Overall Study|Lack of Efficacy|11|||
13376531|NCT00784810|26732618|FG000|Overall Study|Withdrawal by Subject|11|||
13376532|NCT00784810|26732619|FG001|Overall Study|Withdrawal by Subject|9|||
13376533|NCT00784810|26732618|FG000|Overall Study|Administrative|5|||
13376534|NCT00784810|26732619|FG001|Overall Study|Administrative|8|||
13376535|NCT00784810|26732618|FG000|Overall Study|Lost to Follow-up|1|||
13376536|NCT00784810|26732619|FG001|Overall Study|Lost to Follow-up|1|||
13376537|NCT00784784|26732634|FG000|Overall Study|Withdrawal by Subject|2|||
13376538|NCT00784784|26732635|FG001|Overall Study|Withdrawal by Subject|2|||
13376539|NCT00784758|26732684|FG000|Overall Study|Withdrawal by Subject|3|||
13376540|NCT00784758|26732685|FG001|Overall Study|Withdrawal by Subject|0|||
13376541|NCT00784758|26732684|FG000|Overall Study|Adverse Event|1|||
13376542|NCT00784758|26732685|FG001|Overall Study|Adverse Event|0|||
13376543|NCT00784719|26732877|FG000|Overall Study|Adverse Event|0|||
13376544|NCT00784719|26732878|FG001|Overall Study|Adverse Event|2|||
13376545|NCT00784719|26732879|FG002|Overall Study|Adverse Event|0|||
13376546|NCT00784719|26732880|FG003|Overall Study|Adverse Event|0|||
13376547|NCT00784719|26732881|FG004|Overall Study|Adverse Event|1|||
13376548|NCT00784719|26732882|FG005|Overall Study|Adverse Event|1|||
13376549|NCT00784719|26732883|FG006|Overall Study|Adverse Event|1|||
13376550|NCT00784719|26732877|FG000|Overall Study|Lost to Follow-up|0|||
13376551|NCT00784719|26732878|FG001|Overall Study|Lost to Follow-up|0|||
13376552|NCT00784719|26732879|FG002|Overall Study|Lost to Follow-up|0|||
13376553|NCT00784719|26732880|FG003|Overall Study|Lost to Follow-up|0|||
13376554|NCT00784719|26732881|FG004|Overall Study|Lost to Follow-up|1|||
13376555|NCT00784719|26732882|FG005|Overall Study|Lost to Follow-up|1|||
13376556|NCT00784719|26732883|FG006|Overall Study|Lost to Follow-up|0|||
13376557|NCT00784719|26732877|FG000|Overall Study|Other|2|||
13376558|NCT00784719|26732878|FG001|Overall Study|Other|1|||
13376559|NCT00784719|26732879|FG002|Overall Study|Other|1|||
13376560|NCT00784719|26732880|FG003|Overall Study|Other|0|||
13376561|NCT00784719|26732881|FG004|Overall Study|Other|2|||
13376562|NCT00784719|26732882|FG005|Overall Study|Other|1|||
13376563|NCT00784719|26732883|FG006|Overall Study|Other|3|||
13376564|NCT00784719|26732877|FG000|Overall Study|Withdrawal by Subject|1|||
13376565|NCT00784719|26732878|FG001|Overall Study|Withdrawal by Subject|0|||
13376566|NCT00784719|26732879|FG002|Overall Study|Withdrawal by Subject|0|||
13376567|NCT00784719|26732880|FG003|Overall Study|Withdrawal by Subject|0|||
13376568|NCT00784719|26732881|FG004|Overall Study|Withdrawal by Subject|2|||
13376569|NCT00784719|26732882|FG005|Overall Study|Withdrawal by Subject|0|||
13376570|NCT00784719|26732883|FG006|Overall Study|Withdrawal by Subject|1|||
13376571|NCT00784693|26732933|FG000|Overall Study|Lost to Follow-up|0|||
13376572|NCT00784693|26732934|FG001|Overall Study|Lost to Follow-up|1|||
13376573|NCT00784693|26732933|FG000|Overall Study|Lack of Efficacy|1|||
13376574|NCT00784693|26732934|FG001|Overall Study|Lack of Efficacy|1|||
13376575|NCT00784693|26732933|FG000|Overall Study|Withdrawal by Subject|0|||
13376576|NCT00784693|26732934|FG001|Overall Study|Withdrawal by Subject|4|||
13376577|NCT00784693|26732933|FG000|Overall Study|Randomized but not Treated|1|||
13376578|NCT00784693|26732934|FG001|Overall Study|Randomized but not Treated|0|||
13376579|NCT00784693|26732933|FG000|Overall Study|Other|1|||
13376580|NCT00784693|26732934|FG001|Overall Study|Other|0|||
13376581|NCT00784654|26732970|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44|||
13376582|NCT00784654|26732971|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0|||
13376583|NCT00784654|26732972|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0|||
13376584|NCT00784654|26732970|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22|||
13376585|NCT00784654|26732971|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
13376586|NCT00784654|26732972|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
13376587|NCT00784654|26732970|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21|||
13376588|NCT00784654|26732971|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
13376589|NCT00784654|26732972|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
13376590|NCT00784654|26732970|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11|||
13376591|NCT00784654|26732971|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
13376592|NCT00784654|26732972|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
13376593|NCT00784654|26732970|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7|||
13376594|NCT00784654|26732971|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
13376595|NCT00784654|26732972|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
13376596|NCT00784654|26732970|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1|||
13376597|NCT00784654|26732971|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
13376598|NCT00784654|26732972|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
13376599|NCT00784654|26732970|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1|||
13376600|NCT00784654|26732971|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
13376601|NCT00784654|26732972|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
13376602|NCT00784654|26732970|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1|||
13376603|NCT00784654|26732971|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
13376604|NCT00784654|26732972|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
13376605|NCT00784654|26732970|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1|||
13376606|NCT00784654|26732971|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
13376607|NCT00784654|26732972|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
13376608|NCT00784654|26732970|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1|||
13376609|NCT00784654|26732971|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
13376610|NCT00784654|26732972|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
13376611|NCT00784654|26732970|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1|||
13376612|NCT00784654|26732971|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
13376613|NCT00784654|26732972|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
13376614|NCT00784654|26732970|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0|||
13376615|NCT00784654|26732971|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8|||
13376616|NCT00784654|26732972|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35|||
13376617|NCT00784654|26732970|FG000|Randomized Withdrawal Period|Lack of Efficacy|0|||
13376618|NCT00784654|26732971|FG001|Randomized Withdrawal Period|Lack of Efficacy|5|||
13376619|NCT00784654|26732972|FG002|Randomized Withdrawal Period|Lack of Efficacy|18|||
13376620|NCT00784654|26732970|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
13376621|NCT00784654|26732971|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1|||
13376622|NCT00784654|26732972|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7|||
13376623|NCT00784654|26732970|FG000|Randomized Withdrawal Period|Protocol Violation|0|||
13376624|NCT00784654|26732971|FG001|Randomized Withdrawal Period|Protocol Violation|2|||
13376625|NCT00784654|26732972|FG002|Randomized Withdrawal Period|Protocol Violation|1|||
13376626|NCT00784654|26732970|FG000|Randomized Withdrawal Period|Adverse Event|0|||
13376627|NCT00784654|26732971|FG001|Randomized Withdrawal Period|Adverse Event|1|||
13376628|NCT00784654|26732972|FG002|Randomized Withdrawal Period|Adverse Event|1|||
13376629|NCT00784654|26732970|FG000|Randomized Withdrawal Period|Did not complete a visit|0|||
13376630|NCT00784654|26732971|FG001|Randomized Withdrawal Period|Did not complete a visit|1|||
13376631|NCT00784654|26732972|FG002|Randomized Withdrawal Period|Did not complete a visit|0|||
13376632|NCT00784654|26732970|FG000|Randomized Withdrawal Period|Family reasons|0|||
13376633|NCT00784654|26732971|FG001|Randomized Withdrawal Period|Family reasons|0|||
13376634|NCT00784654|26732972|FG002|Randomized Withdrawal Period|Family reasons|1|||
13376635|NCT00784563|26732998|FG000|Years 1 & 2|Withdrawal by Subject|3|||
13376636|NCT00784563|26732999|FG001|Years 1 & 2|Withdrawal by Subject|2|||
13376637|NCT00784563|26733000|FG002|Years 1 & 2|Withdrawal by Subject|0|||
13376638|NCT00784563|26732998|FG000|Years 1 & 2|Adverse Event|0|||
13376639|NCT00784563|26732999|FG001|Years 1 & 2|Adverse Event|3|||
13376640|NCT00784563|26733000|FG002|Years 1 & 2|Adverse Event|0|||
13376641|NCT00784563|26732998|FG000|Year 3|Withdrawal by Subject|0|||
13376642|NCT00784563|26732999|FG001|Year 3|Withdrawal by Subject|0|||
13376643|NCT00784563|26733000|FG002|Year 3|Withdrawal by Subject|2|||
13376644|NCT00784563|26732998|FG000|Year 3|Adverse Event|0|||
13376645|NCT00784563|26732999|FG001|Year 3|Adverse Event|0|||
13376646|NCT00784563|26733000|FG002|Year 3|Adverse Event|1|||
13292378|NCT00706654|26485249|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
13292379|NCT00706654|26485250|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12|||
13292380|NCT00706654|26485251|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8|||
13292381|NCT00706654|26485248|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
13292382|NCT00706654|26485249|FG001|Depot Maintenance Phase|Withdrew Consent|21|||
13292383|NCT00706654|26485250|FG002|Depot Maintenance Phase|Withdrew Consent|29|||
13292384|NCT00706654|26485251|FG003|Depot Maintenance Phase|Withdrew Consent|14|||
13292385|NCT00706654|26485248|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
13292386|NCT00706654|26485249|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
13292387|NCT00706654|26485250|FG002|Depot Maintenance Phase|Protocol Deviation|3|||
13292388|NCT00706654|26485251|FG003|Depot Maintenance Phase|Protocol Deviation|1|||
13376647|NCT00784550|26733023|FG000|Overall Study|Adverse Event|12|||
13376648|NCT00784550|26733024|FG001|Overall Study|Adverse Event|10|||
13376649|NCT00784550|26733023|FG000|Overall Study|Lack of Efficacy|0|||
13376650|NCT00784550|26733024|FG001|Overall Study|Lack of Efficacy|1|||
13376651|NCT00784550|26733023|FG000|Overall Study|Protocol Violation|10|||
13376652|NCT00784550|26733024|FG001|Overall Study|Protocol Violation|10|||
13376653|NCT00784550|26733023|FG000|Overall Study|Lost to Follow-up|8|||
13376654|NCT00784550|26733024|FG001|Overall Study|Lost to Follow-up|5|||
13376655|NCT00784550|26733023|FG000|Overall Study|Physician Decision|2|||
13376656|NCT00784550|26733024|FG001|Overall Study|Physician Decision|3|||
13376657|NCT00784550|26733023|FG000|Overall Study|Withdrawal by Subject|4|||
13488413|NCT02472964|27043347|FG001|Part 2 (Week 24-week 48)|Adverse Event|2|||
13488414|NCT02472964|27043346|FG000|Part 2 (Week 24-week 48)|Disease Progression|52|||
13488415|NCT02472964|27043347|FG001|Part 2 (Week 24-week 48)|Disease Progression|56|||
13488416|NCT02472964|27043346|FG000|Part 2 (Week 24-week 48)|Death|0|||
13488417|NCT02472964|27043347|FG001|Part 2 (Week 24-week 48)|Death|1|||
13488418|NCT02472964|27043346|FG000|Part 2 (Week 24-week 48)|Physician Decision|1|||
13488419|NCT02472964|27043347|FG001|Part 2 (Week 24-week 48)|Physician Decision|1|||
13488420|NCT02472964|27043346|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2|||
13488421|NCT02472964|27043347|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1|||
13488422|NCT02472964|27043346|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3|||
13488423|NCT02472964|27043347|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1|||
13488424|NCT02472964|27043346|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3|||
13488425|NCT02472964|27043347|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1|||
13488426|NCT02178722|27043382|FG000|Overall Study|Withdrawal by Subject|0|||
13488427|NCT02178722|27043383|FG001|Overall Study|Withdrawal by Subject|0|||
13488428|NCT02178722|27043384|FG002|Overall Study|Withdrawal by Subject|0|||
13488429|NCT02178722|27043385|FG003|Overall Study|Withdrawal by Subject|2|||
13488430|NCT02178722|27043386|FG004|Overall Study|Withdrawal by Subject|33|||
13488431|NCT02178722|27043382|FG000|Overall Study|Death|2|||
13488432|NCT02178722|27043383|FG001|Overall Study|Death|13|||
13488433|NCT02178722|27043384|FG002|Overall Study|Death|12|||
13488434|NCT02178722|27043385|FG003|Overall Study|Death|12|||
13488435|NCT02178722|27043386|FG004|Overall Study|Death|205|||
13488436|NCT02178722|27043382|FG000|Overall Study|Lost to Follow-up|0|||
13488437|NCT02178722|27043383|FG001|Overall Study|Lost to Follow-up|0|||
13488438|NCT02178722|27043384|FG002|Overall Study|Lost to Follow-up|0|||
13488439|NCT02178722|27043385|FG003|Overall Study|Lost to Follow-up|2|||
13488440|NCT02178722|27043386|FG004|Overall Study|Lost to Follow-up|11|||
13488441|NCT02178722|27043382|FG000|Overall Study|Study terminated by Sponsor|2|||
13488442|NCT02178722|27043383|FG001|Overall Study|Study terminated by Sponsor|7|||
13488443|NCT02178722|27043384|FG002|Overall Study|Study terminated by Sponsor|6|||
13488444|NCT02178722|27043385|FG003|Overall Study|Study terminated by Sponsor|4|||
13488445|NCT02178722|27043386|FG004|Overall Study|Study terminated by Sponsor|128|||
13488446|NCT02178722|27043382|FG000|Overall Study|Physician Decision|0|||
13488447|NCT02178722|27043383|FG001|Overall Study|Physician Decision|0|||
13488448|NCT02178722|27043384|FG002|Overall Study|Physician Decision|0|||
13488449|NCT02178722|27043385|FG003|Overall Study|Physician Decision|0|||
13488450|NCT02178722|27043386|FG004|Overall Study|Physician Decision|3|||
13488451|NCT02178722|27043382|FG000|Overall Study|Other|0|||
13488452|NCT02178722|27043383|FG001|Overall Study|Other|0|||
13488453|NCT02178722|27043384|FG002|Overall Study|Other|0|||
13488454|NCT02178722|27043385|FG003|Overall Study|Other|0|||
13488455|NCT02178722|27043386|FG004|Overall Study|Other|2|||
13488456|NCT01258803|27043419|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
13488457|NCT01258803|27043420|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
13488458|NCT01258803|27043421|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
13488459|NCT01258803|27043422|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
13488460|NCT01258803|27043423|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
13488461|NCT01258803|27043424|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
13488462|NCT01258803|27043419|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
13488463|NCT01258803|27043420|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1|||
13488464|NCT01258803|27043421|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
13488465|NCT01258803|27043422|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
13488466|NCT01258803|27043423|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
13488467|NCT01258803|27043424|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
13488468|NCT01258803|27043419|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
13488469|NCT01258803|27043420|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
13488470|NCT01258803|27043421|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1|||
13376658|NCT00784550|26733024|FG001|Overall Study|Withdrawal by Subject|13|||
13376659|NCT00784459|26733039|FG000|Overall Study|Adverse Event|0|||
13376660|NCT00784459|26733040|FG001|Overall Study|Adverse Event|2|||
13488471|NCT01258803|27043422|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
13488472|NCT01258803|27043423|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
13488473|NCT01258803|27043424|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
13488474|NCT00862251|27043501|FG000|Overall Study|Adverse Event|8|||
13488475|NCT00862251|27043502|FG001|Overall Study|Adverse Event|3|||
13488476|NCT00862251|27043503|FG002|Overall Study|Adverse Event|1|||
13488477|NCT00862251|27043501|FG000|Overall Study|Lost to Follow-up|0|||
13488478|NCT00862251|27043502|FG001|Overall Study|Lost to Follow-up|0|||
13488479|NCT00862251|27043503|FG002|Overall Study|Lost to Follow-up|1|||
13488480|NCT00862251|27043501|FG000|Overall Study|Protocol Violation|2|||
13488481|NCT00862251|27043502|FG001|Overall Study|Protocol Violation|0|||
13488482|NCT00862251|27043503|FG002|Overall Study|Protocol Violation|1|||
13488483|NCT00862251|27043501|FG000|Overall Study|Withdrawal by Subject|9|||
13488484|NCT00862251|27043502|FG001|Overall Study|Withdrawal by Subject|2|||
13488485|NCT00862251|27043503|FG002|Overall Study|Withdrawal by Subject|6|||
13488486|NCT00783263|27043542|FG000|Overall Study|Adverse Event|3|||
13488487|NCT00783263|27043543|FG001|Overall Study|Adverse Event|0|||
13488488|NCT00783263|27043544|FG002|Overall Study|Adverse Event|2|||
13488489|NCT00783263|27043545|FG003|Overall Study|Adverse Event|1|||
13488490|NCT00783263|27043542|FG000|Overall Study|Lost to Follow-up|1|||
13488491|NCT00783263|27043543|FG001|Overall Study|Lost to Follow-up|1|||
13488492|NCT00783263|27043544|FG002|Overall Study|Lost to Follow-up|0|||
13488493|NCT00783263|27043545|FG003|Overall Study|Lost to Follow-up|0|||
13488494|NCT00783263|27043542|FG000|Overall Study|Withdrawal by Subject|0|||
13488495|NCT00783263|27043543|FG001|Overall Study|Withdrawal by Subject|1|||
13488496|NCT00783263|27043544|FG002|Overall Study|Withdrawal by Subject|1|||
13488497|NCT00783263|27043545|FG003|Overall Study|Withdrawal by Subject|2|||
13488498|NCT00782184|27043587|FG000|Overall Study|Adverse Event|1|||
13488499|NCT00782184|27043588|FG001|Overall Study|Adverse Event|2|||
13488500|NCT00782184|27043587|FG000|Overall Study|Protocol Violation|0|||
13488501|NCT00782184|27043588|FG001|Overall Study|Protocol Violation|1|||
13488502|NCT00782184|27043587|FG000|Overall Study|Withdrawal by Subject|3|||
13488503|NCT00782184|27043588|FG001|Overall Study|Withdrawal by Subject|2|||
13488504|NCT00535405|27043655|FG000|Overall Study|Adverse Event|6|||
13488505|NCT00535405|27043656|FG001|Overall Study|Adverse Event|8|||
13488506|NCT00535405|27043657|FG002|Overall Study|Adverse Event|3|||
13488507|NCT00535405|27043658|FG003|Overall Study|Adverse Event|8|||
13488508|NCT00535405|27043659|FG004|Overall Study|Adverse Event|6|||
13488509|NCT00535405|27043655|FG000|Overall Study|Lost to Follow-up|1|||
13488510|NCT00535405|27043656|FG001|Overall Study|Lost to Follow-up|3|||
13488511|NCT00535405|27043657|FG002|Overall Study|Lost to Follow-up|3|||
13488512|NCT00535405|27043658|FG003|Overall Study|Lost to Follow-up|2|||
13488513|NCT00535405|27043659|FG004|Overall Study|Lost to Follow-up|1|||
13488514|NCT00535405|27043655|FG000|Overall Study|Physician Decision|3|||
13488515|NCT00535405|27043656|FG001|Overall Study|Physician Decision|2|||
13488516|NCT00535405|27043657|FG002|Overall Study|Physician Decision|0|||
13488517|NCT00535405|27043658|FG003|Overall Study|Physician Decision|1|||
13488518|NCT00535405|27043659|FG004|Overall Study|Physician Decision|1|||
13488519|NCT00535405|27043655|FG000|Overall Study|Protocol Violation|2|||
13488520|NCT00535405|27043656|FG001|Overall Study|Protocol Violation|2|||
13488521|NCT00535405|27043657|FG002|Overall Study|Protocol Violation|2|||
13488522|NCT00535405|27043658|FG003|Overall Study|Protocol Violation|1|||
13488523|NCT00535405|27043659|FG004|Overall Study|Protocol Violation|0|||
13488524|NCT00535405|27043655|FG000|Overall Study|Withdrawal by Subject|5|||
13488525|NCT00535405|27043656|FG001|Overall Study|Withdrawal by Subject|11|||
13488526|NCT00535405|27043657|FG002|Overall Study|Withdrawal by Subject|10|||
13488527|NCT00535405|27043658|FG003|Overall Study|Withdrawal by Subject|10|||
13488528|NCT00535405|27043659|FG004|Overall Study|Withdrawal by Subject|8|||
13488529|NCT00496730|27043676|FG000|Overall Study|Lost to Follow-up|4|||
13488530|NCT00496730|27043677|FG001|Overall Study|Lost to Follow-up|3|||
13488531|NCT00496730|27043676|FG000|Overall Study|Withdrawal by Subject|2|||
13488532|NCT00496730|27043677|FG001|Overall Study|Withdrawal by Subject|2|||
13488533|NCT00462748|27043695|FG000|Overall Study|Adverse Event|7|||
13488534|NCT00462748|27043696|FG001|Overall Study|Adverse Event|5|||
13488535|NCT00462748|27043697|FG002|Overall Study|Adverse Event|9|||
13488536|NCT00462748|27043695|FG000|Overall Study|Protocol Violation|0|||
13488537|NCT00462748|27043696|FG001|Overall Study|Protocol Violation|2|||
13488538|NCT00462748|27043697|FG002|Overall Study|Protocol Violation|1|||
13488539|NCT00462748|27043695|FG000|Overall Study|Withdrew consent|3|||
13488540|NCT00462748|27043696|FG001|Overall Study|Withdrew consent|3|||
13488541|NCT00462748|27043697|FG002|Overall Study|Withdrew consent|0|||
13488542|NCT00462748|27043695|FG000|Overall Study|Lost to Follow-up|1|||
13488543|NCT00462748|27043696|FG001|Overall Study|Lost to Follow-up|1|||
13488544|NCT00462748|27043697|FG002|Overall Study|Lost to Follow-up|1|||
13488545|NCT00462748|27043695|FG000|Overall Study|Discontinued after 41 days Rx|1|||
13488546|NCT00462748|27043696|FG001|Overall Study|Discontinued after 41 days Rx|0|||
13488547|NCT00462748|27043697|FG002|Overall Study|Discontinued after 41 days Rx|0|||
13488548|NCT00418834|27043764|FG000|Overall Study|Adverse Event|16|||
13488549|NCT00418834|27043765|FG001|Overall Study|Adverse Event|9|||
13488550|NCT00418834|27043764|FG000|Overall Study|Lost to Follow-up|0|||
13488551|NCT00418834|27043765|FG001|Overall Study|Lost to Follow-up|1|||
13488552|NCT00418834|27043764|FG000|Overall Study|Protocol Violation|4|||
13488553|NCT00418834|27043765|FG001|Overall Study|Protocol Violation|3|||
13488554|NCT00418834|27043764|FG000|Overall Study|Withdrawal by Subject|3|||
13488555|NCT00418834|27043765|FG001|Overall Study|Withdrawal by Subject|7|||
13488556|NCT00409773|27043863|FG000|Overall Study|Adverse Event|3|||
13488557|NCT00409773|27043864|FG001|Overall Study|Adverse Event|4|||
13488558|NCT00409773|27043865|FG002|Overall Study|Adverse Event|4|||
13488559|NCT00409773|27043866|FG003|Overall Study|Adverse Event|2|||
13292389|NCT00706654|26485248|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
13292390|NCT00706654|26485249|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8|||
13292391|NCT00706654|26485250|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
13292392|NCT00706654|26485251|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
13292393|NCT00706654|26485248|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
13292394|NCT00706654|26485249|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
13292395|NCT00706654|26485250|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12|||
13292396|NCT00706654|26485251|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17|||
13292397|NCT00706654|26485248|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
13292398|NCT00706654|26485249|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
13292399|NCT00706654|26485250|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
13292400|NCT00706654|26485251|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12|||
13292401|NCT00706641|26485263|FG000|Dasatinib Administration|Withdrawal by Subject|1|||
13292402|NCT00706641|26485263|FG000|Dasatinib Administration|Ineligible after start of therapy|1|||
13292403|NCT00706641|26485263|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1|||
13292404|NCT00706628|26485324|FG000|Overall Study|Other Adverse Event|16|||
13292405|NCT00706628|26485325|FG001|Overall Study|Other Adverse Event|5|||
13292406|NCT00706628|26485326|FG002|Overall Study|Other Adverse Event|5|||
13292407|NCT00706628|26485327|FG003|Overall Study|Other Adverse Event|2|||
13292408|NCT00706628|26485324|FG000|Overall Study|Non compliant with protocol|0|||
13292409|NCT00706628|26485325|FG001|Overall Study|Non compliant with protocol|1|||
13292410|NCT00706628|26485326|FG002|Overall Study|Non compliant with protocol|0|||
13292411|NCT00706628|26485327|FG003|Overall Study|Non compliant with protocol|0|||
13292412|NCT00706628|26485324|FG000|Overall Study|Consent withdrawn|6|||
13292413|NCT00706628|26485325|FG001|Overall Study|Consent withdrawn|1|||
13292414|NCT00706628|26485326|FG002|Overall Study|Consent withdrawn|3|||
13292415|NCT00706628|26485327|FG003|Overall Study|Consent withdrawn|0|||
13292416|NCT00706628|26485324|FG000|Overall Study|Progressive disease|20|||
13292417|NCT00706628|26485325|FG001|Overall Study|Progressive disease|13|||
13292418|NCT00706628|26485326|FG002|Overall Study|Progressive disease|8|||
13292419|NCT00706628|26485327|FG003|Overall Study|Progressive disease|1|||
13292420|NCT00706628|26485324|FG000|Overall Study|Other than those stated above|4|||
13292421|NCT00706628|26485325|FG001|Overall Study|Other than those stated above|0|||
13292422|NCT00706628|26485326|FG002|Overall Study|Other than those stated above|0|||
13292423|NCT00706628|26485327|FG003|Overall Study|Other than those stated above|0|||
13292424|NCT00706628|26485324|FG000|Overall Study|Not treated|1|||
13292425|NCT00706628|26485325|FG001|Overall Study|Not treated|1|||
13292426|NCT00706628|26485326|FG002|Overall Study|Not treated|0|||
13292427|NCT00706628|26485327|FG003|Overall Study|Not treated|0|||
13292428|NCT00706433|26485654|FG000|Overall Study|Lost to Follow-up|3|||
13292429|NCT00706433|26485655|FG001|Overall Study|Lost to Follow-up|1|||
13292430|NCT00706433|26485656|FG002|Overall Study|Lost to Follow-up|6|||
13292431|NCT00706433|26485657|FG003|Overall Study|Lost to Follow-up|0|||
13292432|NCT00706433|26485654|FG000|Overall Study|Withdrawal by Subject|1|||
13292433|NCT00706433|26485655|FG001|Overall Study|Withdrawal by Subject|2|||
13292434|NCT00706433|26485656|FG002|Overall Study|Withdrawal by Subject|3|||
13292435|NCT00706433|26485657|FG003|Overall Study|Withdrawal by Subject|1|||
13292436|NCT00706433|26485654|FG000|Overall Study|Adverse Event|0|||
13292437|NCT00706433|26485655|FG001|Overall Study|Adverse Event|0|||
13292438|NCT00706433|26485656|FG002|Overall Study|Adverse Event|1|||
13292439|NCT00706433|26485657|FG003|Overall Study|Adverse Event|0|||
13292440|NCT00706433|26485654|FG000|Overall Study|Protocol Violation|1|||
13292441|NCT00706433|26485655|FG001|Overall Study|Protocol Violation|0|||
13292442|NCT00706433|26485656|FG002|Overall Study|Protocol Violation|0|||
13292443|NCT00706433|26485657|FG003|Overall Study|Protocol Violation|0|||
13292444|NCT00706433|26485654|FG000|Overall Study|new job|0|||
13292445|NCT00706433|26485655|FG001|Overall Study|new job|0|||
13292446|NCT00706433|26485656|FG002|Overall Study|new job|0|||
13292447|NCT00706433|26485657|FG003|Overall Study|new job|1|||
13292448|NCT00706342|26485668|FG000|Overall Study|Adverse Event|3|||
13376661|NCT00784368|26733084|FG000|Overall Study|Physician Decision|0|||
13488560|NCT00409773|27043867|FG004|Overall Study|Adverse Event|6|||
13292449|NCT00706342|26485668|FG000|Overall Study|Not responding to treatment|2|||
13488561|NCT00409773|27043863|FG000|Overall Study|Lost to Follow-up|6|||
13292450|NCT00706342|26485668|FG000|Overall Study|Withdrawn due to failure to respond|1|||
13292451|NCT00706342|26485668|FG000|Overall Study|Death|1|||
13292452|NCT00706342|26485668|FG000|Overall Study|Withdrew from the study on his own.|1|||
13292453|NCT00706342|26485668|FG000|Overall Study|Investigator discretion|2|||
13292454|NCT00706342|26485668|FG000|Overall Study|Non-responder Week 12|1|||
13292455|NCT00706342|26485668|FG000|Overall Study|Ongoing|6|||
13292456|NCT00706342|26485668|FG000|Overall Study|WIthdrawal of consent|1|||
13292457|NCT00706238|26485683|FG000|Overall Study|Disease progression|4|||
13292458|NCT00706238|26485683|FG000|Overall Study|Other|1|||
13292459|NCT00706134|26485726|FG000|Overall Study|Adverse Event|8|||
13292460|NCT00706134|26485727|FG001|Overall Study|Adverse Event|7|||
13292461|NCT00706134|26485728|FG002|Overall Study|Adverse Event|2|||
13292462|NCT00706134|26485729|FG003|Overall Study|Adverse Event|3|||
13292463|NCT00706134|26485726|FG000|Overall Study|Lost to Follow-up|0|||
13292464|NCT00706134|26485727|FG001|Overall Study|Lost to Follow-up|1|||
13292465|NCT00706134|26485728|FG002|Overall Study|Lost to Follow-up|0|||
13292466|NCT00706134|26485729|FG003|Overall Study|Lost to Follow-up|0|||
13292467|NCT00706134|26485726|FG000|Overall Study|Protocol Violation|0|||
13292468|NCT00706134|26485727|FG001|Overall Study|Protocol Violation|6|||
13292469|NCT00706134|26485728|FG002|Overall Study|Protocol Violation|0|||
13292470|NCT00706134|26485729|FG003|Overall Study|Protocol Violation|3|||
13292471|NCT00706134|26485726|FG000|Overall Study|Withdrawal by Subject|1|||
13292472|NCT00706134|26485727|FG001|Overall Study|Withdrawal by Subject|2|||
13292473|NCT00706134|26485728|FG002|Overall Study|Withdrawal by Subject|1|||
13292474|NCT00706134|26485729|FG003|Overall Study|Withdrawal by Subject|0|||
13292475|NCT00706134|26485726|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
13292476|NCT00706134|26485727|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
13292477|NCT00706134|26485728|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
13292478|NCT00706134|26485729|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
13292479|NCT00706134|26485726|FG000|Overall Study|Did not meet study criteria|2|||
13292480|NCT00706134|26485727|FG001|Overall Study|Did not meet study criteria|0|||
13292481|NCT00706134|26485728|FG002|Overall Study|Did not meet study criteria|0|||
13292482|NCT00706134|26485729|FG003|Overall Study|Did not meet study criteria|0|||
13292483|NCT00706095|26485753|FG000|Overall Study|Progressive Disease|4|||
13292484|NCT00706095|26485754|FG001|Overall Study|Progressive Disease|5|||
13292485|NCT00706095|26485755|FG002|Overall Study|Progressive Disease|3|||
13292486|NCT00706095|26485753|FG000|Overall Study|Clinical Progression|1|||
13292487|NCT00706095|26485754|FG001|Overall Study|Clinical Progression|2|||
13292488|NCT00706095|26485755|FG002|Overall Study|Clinical Progression|2|||
13292489|NCT00706095|26485753|FG000|Overall Study|Withdrawal by Subject|1|||
13292490|NCT00706095|26485754|FG001|Overall Study|Withdrawal by Subject|0|||
13292491|NCT00706095|26485755|FG002|Overall Study|Withdrawal by Subject|0|||
13376662|NCT00784368|26733085|FG001|Overall Study|Physician Decision|0|||
13376663|NCT00784368|26733086|FG002|Overall Study|Physician Decision|6|||
13376664|NCT00784368|26733084|FG000|Overall Study|Lack of Efficacy|2|||
13376665|NCT00784368|26733085|FG001|Overall Study|Lack of Efficacy|0|||
13376666|NCT00784368|26733086|FG002|Overall Study|Lack of Efficacy|1|||
13376667|NCT00784368|26733084|FG000|Overall Study|Adverse Event|6|||
13376668|NCT00784368|26733085|FG001|Overall Study|Adverse Event|9|||
13376669|NCT00784368|26733086|FG002|Overall Study|Adverse Event|2|||
13376670|NCT00784368|26733084|FG000|Overall Study|Diagnosis of fever|0|||
13376671|NCT00784368|26733085|FG001|Overall Study|Diagnosis of fever|0|||
13376672|NCT00784368|26733086|FG002|Overall Study|Diagnosis of fever|1|||
13393898|NCT00661713|26785143|FG004|Overall Study|Withdrawal by Subject|12|||
13393899|NCT00661713|26785144|FG005|Overall Study|Withdrawal by Subject|26|||
13393900|NCT00661713|26785145|FG006|Overall Study|Withdrawal by Subject|45|||
13393901|NCT00661713|26785146|FG007|Overall Study|Withdrawal by Subject|9|||
13393902|NCT00661713|26785139|FG000|Overall Study|Lost to Follow-up|2|||
13393903|NCT00661713|26785140|FG001|Overall Study|Lost to Follow-up|7|||
13393904|NCT00661713|26785141|FG002|Overall Study|Lost to Follow-up|2|||
13393905|NCT00661713|26785142|FG003|Overall Study|Lost to Follow-up|2|||
13393906|NCT00661713|26785143|FG004|Overall Study|Lost to Follow-up|5|||
13393907|NCT00661713|26785144|FG005|Overall Study|Lost to Follow-up|7|||
13393908|NCT00661713|26785145|FG006|Overall Study|Lost to Follow-up|14|||
13393909|NCT00661713|26785146|FG007|Overall Study|Lost to Follow-up|1|||
13393910|NCT00661713|26785139|FG000|Overall Study|Administrative Reason|0|||
13488562|NCT00409773|27043864|FG001|Overall Study|Lost to Follow-up|1|||
13376673|NCT00784368|26733084|FG000|Overall Study|Worsening of complications|0|||
13376674|NCT00784368|26733085|FG001|Overall Study|Worsening of complications|0|||
13376675|NCT00784368|26733086|FG002|Overall Study|Worsening of complications|1|||
13376676|NCT00784368|26733084|FG000|Overall Study|Worsening of symptoms|0|||
13376677|NCT00784368|26733085|FG001|Overall Study|Worsening of symptoms|1|||
13376678|NCT00784368|26733086|FG002|Overall Study|Worsening of symptoms|0|||
13376679|NCT00784368|26733084|FG000|Overall Study|Withdrawal of informed consent|0|||
13376680|NCT00784368|26733085|FG001|Overall Study|Withdrawal of informed consent|1|||
13376681|NCT00784368|26733086|FG002|Overall Study|Withdrawal of informed consent|0|||
13393911|NCT00661713|26785140|FG001|Overall Study|Administrative Reason|1|||
13393912|NCT00661713|26785141|FG002|Overall Study|Administrative Reason|0|||
13292492|NCT00706030|26485783|FG000|Overall Study|Disease Progression|4|||
13292493|NCT00706030|26485784|FG001|Overall Study|Disease Progression|6|||
13292494|NCT00706030|26485785|FG002|Overall Study|Disease Progression|46|||
13292495|NCT00706030|26485786|FG003|Overall Study|Disease Progression|12|||
13292496|NCT00706030|26485783|FG000|Overall Study|Adverse Event|1|||
13292497|NCT00706030|26485784|FG001|Overall Study|Adverse Event|0|||
13292498|NCT00706030|26485785|FG002|Overall Study|Adverse Event|4|||
13292499|NCT00706030|26485786|FG003|Overall Study|Adverse Event|2|||
13292500|NCT00706030|26485783|FG000|Overall Study|Withdrawal by Subject|1|||
13292501|NCT00706030|26485784|FG001|Overall Study|Withdrawal by Subject|0|||
13292502|NCT00706030|26485785|FG002|Overall Study|Withdrawal by Subject|2|||
13292503|NCT00706030|26485786|FG003|Overall Study|Withdrawal by Subject|0|||
13292504|NCT00706030|26485783|FG000|Overall Study|Physician Decision|0|||
13292505|NCT00706030|26485784|FG001|Overall Study|Physician Decision|0|||
13292506|NCT00706030|26485785|FG002|Overall Study|Physician Decision|2|||
13292507|NCT00706030|26485786|FG003|Overall Study|Physician Decision|0|||
13292508|NCT00706030|26485783|FG000|Overall Study|Not recorded|0|||
13292509|NCT00706030|26485784|FG001|Overall Study|Not recorded|0|||
13292510|NCT00706030|26485785|FG002|Overall Study|Not recorded|2|||
13292511|NCT00706030|26485786|FG003|Overall Study|Not recorded|0|||
13292512|NCT00706030|26485783|FG000|Overall Study|Protocol Violation|0|||
13292513|NCT00706030|26485784|FG001|Overall Study|Protocol Violation|0|||
13292514|NCT00706030|26485785|FG002|Overall Study|Protocol Violation|1|||
13292515|NCT00706030|26485786|FG003|Overall Study|Protocol Violation|1|||
13292516|NCT00706030|26485783|FG000|Overall Study|Failed to return|0|||
13292517|NCT00706030|26485784|FG001|Overall Study|Failed to return|0|||
13292518|NCT00706030|26485785|FG002|Overall Study|Failed to return|1|||
13292519|NCT00706030|26485786|FG003|Overall Study|Failed to return|0|||
13292520|NCT00706030|26485783|FG000|Overall Study|Symptomatic Deterioration|0|||
13292521|NCT00706030|26485784|FG001|Overall Study|Symptomatic Deterioration|0|||
13292522|NCT00706030|26485785|FG002|Overall Study|Symptomatic Deterioration|1|||
13292523|NCT00706030|26485786|FG003|Overall Study|Symptomatic Deterioration|0|||
13292524|NCT00706030|26485783|FG000|Overall Study|No treatment received|0|||
13292525|NCT00706030|26485784|FG001|Overall Study|No treatment received|0|||
13292526|NCT00706030|26485785|FG002|Overall Study|No treatment received|0|||
13292527|NCT00706030|26485786|FG003|Overall Study|No treatment received|1|||
13292528|NCT00706030|26485783|FG000|Overall Study|Death|0|||
13292529|NCT00706030|26485784|FG001|Overall Study|Death|0|||
13292530|NCT00706030|26485785|FG002|Overall Study|Death|1|||
13292531|NCT00706030|26485786|FG003|Overall Study|Death|0|||
13292532|NCT00706004|26485813|FG000|Overall Study|Did not meet eligibility criteria|2|||
13292533|NCT00705718|26485836|FG000|Overall Study|Death|6|||
13292534|NCT00705718|26485837|FG001|Overall Study|Death|6|||
13292535|NCT00705718|26485836|FG000|Overall Study|Not due for Visit|0|||
13292536|NCT00705718|26485837|FG001|Overall Study|Not due for Visit|12|||
13292537|NCT00705718|26485836|FG000|Overall Study|Follow up not done|1|||
13292538|NCT00705718|26485837|FG001|Overall Study|Follow up not done|4|||
13292539|NCT00705666|26485843|FG000|Overall Study|No post-treatment questionnaire|279|||
13292540|NCT00705666|26485843|FG000|Overall Study|Withdrawal by Subject|21|||
13292541|NCT00705666|26485843|FG000|Overall Study|Physician Decision|7|||
13292542|NCT00705666|26485843|FG000|Overall Study|Lost to Follow-up|5|||
13292543|NCT00705666|26485843|FG000|Overall Study|Death|1|||
13292544|NCT00705666|26485843|FG000|Overall Study|Adverse Event|4|||
13292545|NCT00705666|26485843|FG000|Overall Study|Other|12|||
13292546|NCT00705666|26485843|FG000|Overall Study|Other|2|||
13292547|NCT00705666|26485843|FG000|Overall Study|Lack of data|3|||
13292548|NCT00705666|26485843|FG000|Overall Study|Untreated|5|||
13292549|NCT00705575|26485862|FG000|Overall Study|Abnormal laboratory value(s)|0|||
13292550|NCT00705575|26485863|FG001|Overall Study|Abnormal laboratory value(s)|3|||
13292551|NCT00705575|26485862|FG000|Overall Study|Abnormal test procedure result(s)|2|||
13292552|NCT00705575|26485863|FG001|Overall Study|Abnormal test procedure result(s)|12|||
13292553|NCT00705575|26485862|FG000|Overall Study|Adverse Event|11|||
13292554|NCT00705575|26485863|FG001|Overall Study|Adverse Event|15|||
13292555|NCT00705575|26485862|FG000|Overall Study|Lost to Follow-up|3|||
13292556|NCT00705575|26485863|FG001|Overall Study|Lost to Follow-up|4|||
13292557|NCT00705575|26485862|FG000|Overall Study|Protocol Violation|2|||
13292558|NCT00705575|26485863|FG001|Overall Study|Protocol Violation|2|||
13292559|NCT00705575|26485862|FG000|Overall Study|Withdrawal by Subject|5|||
13292560|NCT00705575|26485863|FG001|Overall Study|Withdrawal by Subject|10|||
13292561|NCT00705536|26485931|FG000|Start Period 1|Withdrawal by Subject|0|||
13292562|NCT00705536|26485932|FG001|Start Period 1|Withdrawal by Subject|0|||
13292563|NCT00705536|26485933|FG002|Start Period 1|Withdrawal by Subject|0|||
13292564|NCT00705536|26485934|FG003|Start Period 1|Withdrawal by Subject|1|||
13292565|NCT00705523|26485949|FG000|Overall Study|Lost to Follow-up|2|||
13292566|NCT00705523|26485950|FG001|Overall Study|Lost to Follow-up|3|||
13292567|NCT00705484|26485965|FG000|Overall Study|Adverse Event|28|||
13292568|NCT00705484|26485966|FG001|Overall Study|Adverse Event|27|||
13292569|NCT00705484|26485965|FG000|Overall Study|Lost to Follow-up|169|||
13292570|NCT00705484|26485966|FG001|Overall Study|Lost to Follow-up|250|||
13292571|NCT00705484|26485965|FG000|Overall Study|Withdrawal by Subject|96|||
13292572|NCT00705484|26485966|FG001|Overall Study|Withdrawal by Subject|72|||
13292573|NCT00705484|26485965|FG000|Overall Study|Administrative|89|||
13292574|NCT00705484|26485966|FG001|Overall Study|Administrative|59|||
13292575|NCT00705432|26486020|FG000|Treatment Period|Adverse Event|45|||
13292576|NCT00705432|26486021|FG001|Treatment Period|Adverse Event|37|||
13292577|NCT00705432|26486022|FG002|Treatment Period|Adverse Event|51|||
13292578|NCT00705432|26486023|FG003|Treatment Period|Adverse Event|12|||
13292579|NCT00705432|26486024|FG004|Treatment Period|Adverse Event|8|||
13292580|NCT00705432|26486025|FG005|Treatment Period|Adverse Event|9|||
13292581|NCT00705432|26486020|FG000|Treatment Period|Treatment failure|92|||
13292582|NCT00705432|26486021|FG001|Treatment Period|Treatment failure|42|||
13292583|NCT00705432|26486022|FG002|Treatment Period|Treatment failure|33|||
13292584|NCT00705432|26486023|FG003|Treatment Period|Treatment failure|25|||
13292585|NCT00705432|26486024|FG004|Treatment Period|Treatment failure|13|||
13292586|NCT00705432|26486025|FG005|Treatment Period|Treatment failure|14|||
13292587|NCT00705432|26486020|FG000|Treatment Period|Non medical reason|26|||
13292588|NCT00705432|26486021|FG001|Treatment Period|Non medical reason|32|||
13292589|NCT00705432|26486022|FG002|Treatment Period|Non medical reason|37|||
13292590|NCT00705432|26486023|FG003|Treatment Period|Non medical reason|4|||
13292591|NCT00705432|26486024|FG004|Treatment Period|Non medical reason|7|||
13292592|NCT00705432|26486025|FG005|Treatment Period|Non medical reason|7|||
13292593|NCT00705432|26486020|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2|||
13292594|NCT00705432|26486021|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1|||
13292595|NCT00705432|26486022|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1|||
13292596|NCT00705432|26486023|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0|||
13292597|NCT00705432|26486024|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0|||
13292598|NCT00705432|26486025|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0|||
13292599|NCT00705432|26486020|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69|||
13292600|NCT00705432|26486021|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42|||
13292601|NCT00705432|26486022|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24|||
13292602|NCT00705432|26486023|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14|||
13292603|NCT00705432|26486024|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6|||
13292604|NCT00705432|26486025|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7|||
13292605|NCT00705406|26486054|FG000|Overall Study|Lost to Follow-up|3|||
13292606|NCT00705406|26486055|FG001|Overall Study|Lost to Follow-up|3|||
13292607|NCT00705406|26486054|FG000|Overall Study|Did not receive study drug|1|||
13292608|NCT00705406|26486055|FG001|Overall Study|Did not receive study drug|2|||
13292609|NCT00705367|26486087|FG000|Long-term Extension Period|Adverse Event|2|||
13292610|NCT00705367|26486088|FG001|Long-term Extension Period|Adverse Event|0|||
13292611|NCT00705367|26486087|FG000|Long-term Extension Period|Withdrawal by Subject|2|||
13292612|NCT00705367|26486088|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
13292613|NCT00705367|26486087|FG000|Long-term Extension Period|Lack of Efficacy|1|||
13292614|NCT00705367|26486088|FG001|Long-term Extension Period|Lack of Efficacy|0|||
13292615|NCT00705367|26486087|FG000|Long-term Extension Period|No longer met study criteria|1|||
13292616|NCT00705367|26486088|FG001|Long-term Extension Period|No longer met study criteria|0|||
13292617|NCT00705367|26486087|FG000|Long-term Extension Period|Administrative reason by sponsor|3|||
13292618|NCT00705367|26486088|FG001|Long-term Extension Period|Administrative reason by sponsor|0|||
13292619|NCT00705341|26486105|FG000|Phase 2: Trial|Withdrawal by Subject|0|||
13292620|NCT00705341|26486106|FG001|Phase 2: Trial|Withdrawal by Subject|0|||
13292621|NCT00705341|26486107|FG002|Phase 2: Trial|Withdrawal by Subject|6|||
13292622|NCT00705341|26486108|FG003|Phase 2: Trial|Withdrawal by Subject|4|||
13292623|NCT00705341|26486105|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0|||
13292624|NCT00705341|26486106|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0|||
13292625|NCT00705341|26486107|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1|||
13292626|NCT00705341|26486108|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0|||
13292627|NCT00705289|26486134|FG000|Overall Study|Subject or treating physician's choice|131|||
13292628|NCT00705263|26486140|FG000|Overall Study|Withdrawal by Subject|2|||
13292629|NCT00705250|26486146|FG000|Overall Study|Withdrawal by Subject|1|||
13292630|NCT00705250|26486146|FG000|Overall Study|Patient died in car accident|1|||
13292631|NCT00705224|26486160|FG000|Overall Study|Adverse Event|1|||
13292632|NCT00705224|26486160|FG000|Overall Study|Lack of Efficacy|2|||
13292633|NCT00705224|26486160|FG000|Overall Study|Withdrawal by Subject|3|||
13292634|NCT00705224|26486160|FG000|Overall Study|Lost to Follow-up|5|||
13292635|NCT00705159|26486191|FG000|Overall Study|Withdrawal by Subject|0|||
13292636|NCT00705159|26486192|FG001|Overall Study|Withdrawal by Subject|1|||
13292637|NCT00705159|26486193|FG002|Overall Study|Withdrawal by Subject|1|||
13292638|NCT00705159|26486194|FG003|Overall Study|Withdrawal by Subject|1|||
13292639|NCT00705159|26486191|FG000|Overall Study|Protocol Violation|0|||
13292640|NCT00705159|26486192|FG001|Overall Study|Protocol Violation|1|||
13292641|NCT00705159|26486193|FG002|Overall Study|Protocol Violation|0|||
13292642|NCT00705159|26486194|FG003|Overall Study|Protocol Violation|0|||
13292643|NCT00705159|26486191|FG000|Overall Study|Adverse Event|0|||
13292644|NCT00705159|26486192|FG001|Overall Study|Adverse Event|0|||
13292645|NCT00705159|26486193|FG002|Overall Study|Adverse Event|1|||
13292646|NCT00705159|26486194|FG003|Overall Study|Adverse Event|0|||
13292647|NCT00705159|26486191|FG000|Overall Study|Lost to Follow-up|0|||
13292648|NCT00705159|26486192|FG001|Overall Study|Lost to Follow-up|0|||
13292649|NCT00705159|26486193|FG002|Overall Study|Lost to Follow-up|3|||
13292650|NCT00705159|26486194|FG003|Overall Study|Lost to Follow-up|2|||
13292651|NCT00705159|26486191|FG000|Overall Study|Screen Failure|0|||
13292652|NCT00705159|26486192|FG001|Overall Study|Screen Failure|0|||
13292653|NCT00705159|26486193|FG002|Overall Study|Screen Failure|0|||
13292654|NCT00705159|26486194|FG003|Overall Study|Screen Failure|1|||
13292655|NCT00705146|26486209|FG000|Overall Study|Lost to Follow-up|1|||
13292656|NCT00705146|26486210|FG001|Overall Study|Lost to Follow-up|1|||
13292657|NCT00704964|26486217|FG000|Overall Study|Not completed on time|328|||
13292658|NCT00704808|26486223|FG000|Overall Study|Discontinued prior to starting treatment|14|||
13292659|NCT00704808|26486223|FG000|Overall Study|Death|7|||
13292660|NCT00704808|26486223|FG000|Overall Study|Tumor progression|80|||
13292661|NCT00704808|26486223|FG000|Overall Study|Patient's decision|11|||
13292662|NCT00704808|26486223|FG000|Overall Study|Early therapy discontinuation|16|||
13292663|NCT00704808|26486223|FG000|Overall Study|Adverse Event|1|||
13292664|NCT00704808|26486223|FG000|Overall Study|Lost to Follow-up|1|||
13292665|NCT00704808|26486223|FG000|Overall Study|Treatment change|1|||
13292666|NCT00704535|26486236|FG000|Overall Study|Adverse Event|2|||
13292667|NCT00704535|26486236|FG000|Overall Study|Death|2|||
13292668|NCT00704535|26486236|FG000|Overall Study|Lost to Follow-up|8|||
13292669|NCT00704535|26486236|FG000|Overall Study|Protocol Violation|10|||
13292670|NCT00704535|26486236|FG000|Overall Study|Completed status not on Case Report Form|124|||
13292671|NCT00704522|26486250|FG000|Overall Study|Lack of Efficacy|65|||
13292672|NCT00704522|26486251|FG001|Overall Study|Lack of Efficacy|17|||
13292673|NCT00704522|26486250|FG000|Overall Study|Failure to appear again at hospital|56|||
13292674|NCT00704522|26486251|FG001|Overall Study|Failure to appear again at hospital|10|||
13292675|NCT00704522|26486250|FG000|Overall Study|Withdrawal by Subject|17|||
13292676|NCT00704522|26486251|FG001|Overall Study|Withdrawal by Subject|8|||
13292677|NCT00704522|26486250|FG000|Overall Study|Adverse Event|9|||
13292678|NCT00704522|26486251|FG001|Overall Study|Adverse Event|1|||
13292679|NCT00704522|26486250|FG000|Overall Study|Undefined causes|9|||
13292680|NCT00704522|26486251|FG001|Overall Study|Undefined causes|7|||
13292681|NCT00704522|26486250|FG000|Overall Study|No information on therapy end|27|||
13292682|NCT00704522|26486251|FG001|Overall Study|No information on therapy end|2|||
13292683|NCT00704418|26486266|FG000|Overall Study|Withdrawal by Subject|2|||
13292684|NCT00704418|26486267|FG001|Overall Study|Withdrawal by Subject|0|||
13292685|NCT00704418|26486266|FG000|Overall Study|Over-enrolled/surgery postponed|3|||
13292686|NCT00704418|26486267|FG001|Overall Study|Over-enrolled/surgery postponed|6|||
13292687|NCT00704405|26486311|FG000|Overall Study (NC Population)|Adverse Event|1|||
13292688|NCT00704405|26486312|FG001|Overall Study (NC Population)|Adverse Event|0|||
13292689|NCT00704405|26486313|FG002|Overall Study (NC Population)|Adverse Event|0|||
13292690|NCT00704405|26486314|FG003|Overall Study (NC Population)|Adverse Event|0|||
13292691|NCT00704405|26486315|FG004|Overall Study (NC Population)|Adverse Event|0|||
13292692|NCT00704405|26486311|FG000|Overall Study (NC Population)|Lost to Follow-up|2|||
13292693|NCT00704405|26486312|FG001|Overall Study (NC Population)|Lost to Follow-up|1|||
13292694|NCT00704405|26486313|FG002|Overall Study (NC Population)|Lost to Follow-up|1|||
13292695|NCT00704405|26486314|FG003|Overall Study (NC Population)|Lost to Follow-up|2|||
13292696|NCT00704405|26486315|FG004|Overall Study (NC Population)|Lost to Follow-up|2|||
13292697|NCT00704405|26486311|FG000|Overall Study (NC Population)|Withdrawal by Subject|2|||
13292698|NCT00704405|26486312|FG001|Overall Study (NC Population)|Withdrawal by Subject|3|||
13292699|NCT00704405|26486313|FG002|Overall Study (NC Population)|Withdrawal by Subject|2|||
13292700|NCT00704405|26486314|FG003|Overall Study (NC Population)|Withdrawal by Subject|2|||
13292701|NCT00704405|26486315|FG004|Overall Study (NC Population)|Withdrawal by Subject|2|||
13292702|NCT00704405|26486311|FG000|Overall Study (NC Population)|Other|0|||
13292703|NCT00704405|26486312|FG001|Overall Study (NC Population)|Other|0|||
13292704|NCT00704405|26486313|FG002|Overall Study (NC Population)|Other|0|||
13292705|NCT00704405|26486314|FG003|Overall Study (NC Population)|Other|0|||
13292706|NCT00704405|26486315|FG004|Overall Study (NC Population)|Other|1|||
13292707|NCT00704405|26486311|FG000|Overall Study (C Population)|Withdrawal by Subject|1|||
13292708|NCT00704405|26486312|FG001|Overall Study (C Population)|Withdrawal by Subject|1|||
13292709|NCT00704405|26486313|FG002|Overall Study (C Population)|Withdrawal by Subject|1|||
13292710|NCT00704405|26486314|FG003|Overall Study (C Population)|Withdrawal by Subject|1|||
13292711|NCT00704405|26486315|FG004|Overall Study (C Population)|Withdrawal by Subject|0|||
13292712|NCT00704405|26486311|FG000|Overall Study (C Population)|Lost to Follow-up|0|||
13292713|NCT00704405|26486312|FG001|Overall Study (C Population)|Lost to Follow-up|2|||
13292714|NCT00704405|26486313|FG002|Overall Study (C Population)|Lost to Follow-up|0|||
13292715|NCT00704405|26486314|FG003|Overall Study (C Population)|Lost to Follow-up|0|||
13292716|NCT00704405|26486315|FG004|Overall Study (C Population)|Lost to Follow-up|0|||
13292717|NCT00704340|26486332|FG000|Overall Study|Lost to Follow-up|2|||
13292718|NCT00704340|26486333|FG001|Overall Study|Lost to Follow-up|1|||
13292719|NCT00704340|26486332|FG000|Overall Study|Death|0|||
13292720|NCT00704340|26486333|FG001|Overall Study|Death|1|||
13292721|NCT00704171|26486356|FG000|Overall Study|Withdrawal by Subject|1|||
13292722|NCT00704171|26486357|FG001|Overall Study|Withdrawal by Subject|0|||
13292723|NCT00704132|26486370|FG000|Overall Study|Clinical Adverse Experience|1|||
13292724|NCT00704132|26486371|FG001|Overall Study|Clinical Adverse Experience|0|||
13292725|NCT00704132|26486370|FG000|Overall Study|Lack of Efficacy|0|||
13292726|NCT00704132|26486371|FG001|Overall Study|Lack of Efficacy|1|||
13292727|NCT00704132|26486370|FG000|Overall Study|Withdrawal by Subject|0|||
13292728|NCT00704132|26486371|FG001|Overall Study|Withdrawal by Subject|1|||
13292729|NCT00703963|26486388|FG000|Overall Study|Withdrawal by Subject|7|||
13292730|NCT00703963|26486389|FG001|Overall Study|Withdrawal by Subject|13|||
13292731|NCT00703963|26486388|FG000|Overall Study|Physician Decision|0|||
13292732|NCT00703963|26486389|FG001|Overall Study|Physician Decision|1|||
13292733|NCT00703924|26486412|FG000|Overall Study|Withdrawal by Subject|1|||
13376682|NCT00784277|26733119|FG000|IR Treatment|Adverse Event|4|||
13376683|NCT00784277|26733120|FG001|IR Treatment|Adverse Event|8|||
13376684|NCT00784277|26733121|FG002|IR Treatment|Adverse Event|19|||
13376685|NCT00784277|26733122|FG003|IR Treatment|Adverse Event|35|||
13376686|NCT00784277|26733123|FG004|IR Treatment|Adverse Event|0|||
13376687|NCT00784277|26733124|FG005|IR Treatment|Adverse Event|0|||
13376688|NCT00784277|26733125|FG006|IR Treatment|Adverse Event|0|||
13376689|NCT00784277|26733119|FG000|IR Treatment|Lack of Efficacy|4|||
13376690|NCT00784277|26733120|FG001|IR Treatment|Lack of Efficacy|4|||
13376691|NCT00784277|26733121|FG002|IR Treatment|Lack of Efficacy|1|||
13376692|NCT00784277|26733122|FG003|IR Treatment|Lack of Efficacy|0|||
13376693|NCT00784277|26733123|FG004|IR Treatment|Lack of Efficacy|0|||
13376694|NCT00784277|26733124|FG005|IR Treatment|Lack of Efficacy|0|||
13376695|NCT00784277|26733125|FG006|IR Treatment|Lack of Efficacy|0|||
13376696|NCT00784277|26733119|FG000|IR Treatment|Lost to Follow-up|1|||
13376697|NCT00784277|26733120|FG001|IR Treatment|Lost to Follow-up|0|||
13376698|NCT00784277|26733121|FG002|IR Treatment|Lost to Follow-up|1|||
13376699|NCT00784277|26733122|FG003|IR Treatment|Lost to Follow-up|0|||
13376700|NCT00784277|26733123|FG004|IR Treatment|Lost to Follow-up|0|||
13376701|NCT00784277|26733124|FG005|IR Treatment|Lost to Follow-up|0|||
13376702|NCT00784277|26733125|FG006|IR Treatment|Lost to Follow-up|0|||
13376703|NCT00784277|26733119|FG000|IR Treatment|Withdrawal by Subject|5|||
13376704|NCT00784277|26733120|FG001|IR Treatment|Withdrawal by Subject|1|||
13376705|NCT00784277|26733121|FG002|IR Treatment|Withdrawal by Subject|4|||
13376706|NCT00784277|26733122|FG003|IR Treatment|Withdrawal by Subject|6|||
13376707|NCT00784277|26733123|FG004|IR Treatment|Withdrawal by Subject|0|||
13376708|NCT00784277|26733124|FG005|IR Treatment|Withdrawal by Subject|0|||
13376709|NCT00784277|26733125|FG006|IR Treatment|Withdrawal by Subject|0|||
13376710|NCT00784277|26733119|FG000|IR Treatment|Resolution Of Pain|0|||
13376711|NCT00784277|26733120|FG001|IR Treatment|Resolution Of Pain|1|||
13376712|NCT00784277|26733121|FG002|IR Treatment|Resolution Of Pain|0|||
13376713|NCT00784277|26733122|FG003|IR Treatment|Resolution Of Pain|0|||
13376714|NCT00784277|26733123|FG004|IR Treatment|Resolution Of Pain|0|||
13376715|NCT00784277|26733124|FG005|IR Treatment|Resolution Of Pain|0|||
13376716|NCT00784277|26733125|FG006|IR Treatment|Resolution Of Pain|0|||
13376717|NCT00784277|26733119|FG000|IR Treatment|Other|2|||
13376718|NCT00784277|26733120|FG001|IR Treatment|Other|3|||
13376719|NCT00784277|26733121|FG002|IR Treatment|Other|3|||
13376720|NCT00784277|26733122|FG003|IR Treatment|Other|2|||
13376721|NCT00784277|26733123|FG004|IR Treatment|Other|0|||
13376722|NCT00784277|26733124|FG005|IR Treatment|Other|0|||
13376723|NCT00784277|26733125|FG006|IR Treatment|Other|0|||
13376724|NCT00784277|26733119|FG000|ER Treatment|Adverse Event|0|||
13376725|NCT00784277|26733120|FG001|ER Treatment|Adverse Event|0|||
13376726|NCT00784277|26733121|FG002|ER Treatment|Adverse Event|0|||
13376727|NCT00784277|26733122|FG003|ER Treatment|Adverse Event|0|||
13376728|NCT00784277|26733123|FG004|ER Treatment|Adverse Event|1|||
13376729|NCT00784277|26733124|FG005|ER Treatment|Adverse Event|7|||
13376730|NCT00784277|26733125|FG006|ER Treatment|Adverse Event|7|||
13376731|NCT00784277|26733119|FG000|ER Treatment|Lack of Efficacy|0|||
13376732|NCT00784277|26733120|FG001|ER Treatment|Lack of Efficacy|0|||
13376733|NCT00784277|26733121|FG002|ER Treatment|Lack of Efficacy|0|||
13376734|NCT00784277|26733122|FG003|ER Treatment|Lack of Efficacy|0|||
13376735|NCT00784277|26733123|FG004|ER Treatment|Lack of Efficacy|3|||
13376736|NCT00784277|26733124|FG005|ER Treatment|Lack of Efficacy|4|||
13376737|NCT00784277|26733125|FG006|ER Treatment|Lack of Efficacy|0|||
13376738|NCT00784277|26733119|FG000|ER Treatment|Lost to Follow-up|0|||
13376739|NCT00784277|26733120|FG001|ER Treatment|Lost to Follow-up|0|||
13376740|NCT00784277|26733121|FG002|ER Treatment|Lost to Follow-up|0|||
13376741|NCT00784277|26733122|FG003|ER Treatment|Lost to Follow-up|0|||
13376742|NCT00784277|26733123|FG004|ER Treatment|Lost to Follow-up|0|||
13376743|NCT00784277|26733124|FG005|ER Treatment|Lost to Follow-up|2|||
13376744|NCT00784277|26733125|FG006|ER Treatment|Lost to Follow-up|0|||
13376745|NCT00784277|26733119|FG000|ER Treatment|Withdrawal by Subject|0|||
13488563|NCT00409773|27043865|FG002|Overall Study|Lost to Follow-up|2|||
13292734|NCT00703924|26486413|FG001|Overall Study|Withdrawal by Subject|1|||
13292735|NCT00703911|26486443|FG000|Overall Study|Death|1|||
13292736|NCT00703911|26486443|FG000|Overall Study|Physician Decision|6|||
13292737|NCT00703911|26486443|FG000|Overall Study|Lost to Follow-up|1|||
13292738|NCT00703911|26486443|FG000|Overall Study|Withdrawal by Subject|2|||
13292739|NCT00703846|26486459|FG000|Overall Study|Adverse Event|8|||
13292740|NCT00703846|26486459|FG000|Overall Study|Lost to Follow-up|55|||
13292741|NCT00703846|26486459|FG000|Overall Study|Lack of Efficacy|15|||
13292742|NCT00703846|26486459|FG000|Overall Study|Noncompliance with Study Treatment|2|||
13292743|NCT00703846|26486459|FG000|Overall Study|Withdrawal by Subject|40|||
13292744|NCT00703846|26486459|FG000|Overall Study|Death|1|||
13292745|NCT00703846|26486459|FG000|Overall Study|Other|14|||
13292746|NCT00703846|26486459|FG000|Overall Study|Did Not Receive Study Drug|2|||
13292747|NCT00703781|26486474|FG000|Overall Study|Withdrawal by Subject|1|||
13292748|NCT00703781|26486475|FG001|Overall Study|Withdrawal by Subject|2|||
13292749|NCT00703781|26486474|FG000|Overall Study|Cancelled surgery|1|||
13292750|NCT00703781|26486475|FG001|Overall Study|Cancelled surgery|0|||
13292751|NCT00703677|26486490|FG000|Overall Study|Dropout-withdrawal not related to drug|3|||
13292752|NCT00703157|26486528|FG000|Overall Study|Lost to Follow-up|0|||
13292753|NCT00703157|26486529|FG001|Overall Study|Lost to Follow-up|1|||
13292754|NCT00703157|26486528|FG000|Overall Study|source data permanently lost/ other|4|||
13292755|NCT00703157|26486529|FG001|Overall Study|source data permanently lost/ other|1|||
13292756|NCT00703118|26486570|FG000|Overall Study|Adverse Event|1|||
13292757|NCT00703118|26486571|FG001|Overall Study|Adverse Event|2|||
13292758|NCT00703118|26486572|FG002|Overall Study|Adverse Event|2|||
13292759|NCT00703118|26486570|FG000|Overall Study|Subject Ineligible To Continue The Trial|6|||
13292760|NCT00703118|26486571|FG001|Overall Study|Subject Ineligible To Continue The Trial|3|||
13292761|NCT00703118|26486572|FG002|Overall Study|Subject Ineligible To Continue The Trial|2|||
13292762|NCT00703118|26486570|FG000|Overall Study|Lost to Follow-up|6|||
13292763|NCT00703118|26486571|FG001|Overall Study|Lost to Follow-up|4|||
13292764|NCT00703118|26486572|FG002|Overall Study|Lost to Follow-up|4|||
13292765|NCT00703118|26486570|FG000|Overall Study|Withdrawal by Subject|8|||
13292766|NCT00703118|26486571|FG001|Overall Study|Withdrawal by Subject|7|||
13292767|NCT00703118|26486572|FG002|Overall Study|Withdrawal by Subject|13|||
13292768|NCT00703118|26486570|FG000|Overall Study|Other|0|||
13292769|NCT00703118|26486571|FG001|Overall Study|Other|0|||
13292770|NCT00703118|26486572|FG002|Overall Study|Other|1|||
13292771|NCT00703092|26486579|FG000|Overall Study|Withdrawal by Subject|2|||
13292772|NCT00702962|26486594|FG000|Overall Study|Progressive disease|0|||
13292773|NCT00702962|26486595|FG001|Overall Study|Progressive disease|1|||
13292774|NCT00702962|26486594|FG000|Overall Study|Hospitalized for other health disorder|1|||
13292775|NCT00702962|26486595|FG001|Overall Study|Hospitalized for other health disorder|0|||
13292776|NCT00702949|26486630|FG000|Overall Study|Refusal|3|||
13292777|NCT00702949|26486631|FG001|Overall Study|Refusal|2|||
13292778|NCT00702949|26486632|FG002|Overall Study|Refusal|2|||
13292779|NCT00702949|26486630|FG000|Overall Study|Adverse Event|1|||
13292780|NCT00702949|26486631|FG001|Overall Study|Adverse Event|6|||
13292781|NCT00702949|26486632|FG002|Overall Study|Adverse Event|3|||
13292782|NCT00702949|26486630|FG000|Overall Study|Other Medical Reason/unknown|1|||
13292783|NCT00702949|26486631|FG001|Overall Study|Other Medical Reason/unknown|1|||
13292784|NCT00702949|26486632|FG002|Overall Study|Other Medical Reason/unknown|3|||
13292785|NCT00702923|26486643|FG000|Overall Study|Adverse Event|1|||
13292786|NCT00702715|26486660|FG000|Overall Study|Lost to Follow-up|1|||
13292787|NCT00702715|26486661|FG001|Overall Study|Lost to Follow-up|0|||
13292788|NCT00702702|26486677|FG000|Overall Study|Study prematurely terminated|56|||
13292789|NCT00702650|26486697|FG000|Overall Study|Withdrawal by Subject|9|||
13292790|NCT00702650|26486697|FG000|Overall Study|Non-Compliance of Study Drug|3|||
13292791|NCT00702650|26486697|FG000|Overall Study|Lost to Follow-up|2|||
13292792|NCT00702650|26486697|FG000|Overall Study|Non-Compliance with Site Directives|1|||
13292793|NCT00702650|26486697|FG000|Overall Study|Sponsor Request|1|||
13292794|NCT00702650|26486697|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1|||
13292795|NCT00702650|26486697|FG000|Overall Study|Adverse Event|3|||
13292796|NCT00702507|26486711|FG000|Initial Treatment Phase|Adverse Event|2|||
13292797|NCT00702507|26486711|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3|||
13292798|NCT00702507|26486711|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
13292799|NCT00702507|26486711|FG000|Initial Treatment Phase|Negative Candida Culture|34|||
13292800|NCT00702507|26486711|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1|||
13292801|NCT00702507|26486711|FG000|Follow-up Phase|Protocol Violation|2|||
13292802|NCT00702507|26486711|FG000|Follow-up Phase|Lost to Follow-up|23|||
13292803|NCT00702507|26486711|FG000|Follow-up Phase|Late Enrollment|1|||
13292804|NCT00702403|26486721|FG000|From Consent to Engraftment|Progressive leukemia|6|||
13292805|NCT00702403|26486721|FG000|From Consent to Engraftment|Critically ill|2|||
13292806|NCT00702403|26486721|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2|||
13292807|NCT00702403|26486721|FG000|From Consent to Engraftment|Myocardial infarction|1|||
13292808|NCT00702403|26486721|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4|||
13488564|NCT00409773|27043866|FG003|Overall Study|Lost to Follow-up|3|||
13292809|NCT00702403|26486721|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2|||
13292810|NCT00702403|26486721|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11|||
13292811|NCT00702403|26486721|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4|||
13292812|NCT00702403|26486721|FG000|From Engraftment to Study Completion|Non-compliance|2|||
13292813|NCT00702403|26486721|FG000|From Engraftment to Study Completion|Adenocarcinoma|1|||
13292814|NCT00702403|26486721|FG000|From Engraftment to Study Completion|Liver GVHD|1|||
13292815|NCT00702403|26486721|FG000|From Engraftment to Study Completion|Suicide|1|||
13292816|NCT00702403|26486721|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1|||
13292817|NCT00702403|26486721|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1|||
13292818|NCT00702403|26486721|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5|||
13292819|NCT00702325|26486780|FG000|Overall Study|Adverse Event|1|||
13292820|NCT00702325|26486781|FG001|Overall Study|Adverse Event|0|||
13292821|NCT00702325|26486780|FG000|Overall Study|Withdrawal by Subject|7|||
13292822|NCT00702325|26486781|FG001|Overall Study|Withdrawal by Subject|7|||
13292823|NCT00702325|26486780|FG000|Overall Study|Lost to Follow-up|3|||
13292824|NCT00702325|26486781|FG001|Overall Study|Lost to Follow-up|4|||
13292825|NCT00702325|26486780|FG000|Overall Study|Incorrect enrollment|5|||
13292826|NCT00702325|26486781|FG001|Overall Study|Incorrect enrollment|7|||
13292827|NCT00702325|26486780|FG000|Overall Study|Developed study discontinuation criteria|18|||
13292828|NCT00702325|26486781|FG001|Overall Study|Developed study discontinuation criteria|28|||
13292829|NCT00702325|26486780|FG000|Overall Study|Severe noncompliance to protocol|3|||
13292830|NCT00702325|26486781|FG001|Overall Study|Severe noncompliance to protocol|3|||
13292831|NCT00702325|26486780|FG000|Overall Study|Termination due to lab results|1|||
13292832|NCT00702325|26486781|FG001|Overall Study|Termination due to lab results|0|||
13292833|NCT00702325|26486780|FG000|Overall Study|Didn't follow study medication dosage|0|||
13292834|NCT00702325|26486781|FG001|Overall Study|Didn't follow study medication dosage|2|||
13292835|NCT00702325|26486780|FG000|Overall Study|Withdrew consent|0|||
13292836|NCT00702325|26486781|FG001|Overall Study|Withdrew consent|1|||
13292837|NCT00702325|26486780|FG000|Overall Study|Incorrectly Discontinued|0|||
13292838|NCT00702325|26486781|FG001|Overall Study|Incorrectly Discontinued|1|||
13292839|NCT00702221|26486794|FG000|Overall Study|Adverse Event|4|||
13292840|NCT00702221|26486795|FG001|Overall Study|Adverse Event|3|||
13292841|NCT00702208|26486803|FG000|Overall Study|Lost to Follow-up|28|||
13292842|NCT00702208|26486803|FG000|Overall Study|Did not self-lavage|1|||
13292843|NCT00702208|26486803|FG000|Overall Study|Unsatisfactory colposcopy|2|||
13292844|NCT00702143|26486825|FG000|Overall Study|Lost to Follow-up|0|||
13292845|NCT00702143|26486826|FG001|Overall Study|Lost to Follow-up|0|||
13292846|NCT00702143|26486827|FG002|Overall Study|Lost to Follow-up|1|||
13292847|NCT00702052|26486838|FG000|Overall Study|Adverse Event|23|||
13292848|NCT00702052|26486838|FG000|Overall Study|Disease Progression|30|||
13292849|NCT00702052|26486838|FG000|Overall Study|Withdrawal by Subject|5|||
13292850|NCT00701805|26486901|FG000|Overall Study|Withdrawal by Subject|3|||
13292851|NCT00701805|26486902|FG001|Overall Study|Withdrawal by Subject|1|||
13292852|NCT00701805|26486903|FG002|Overall Study|Withdrawal by Subject|4|||
13292853|NCT00701805|26486904|FG003|Overall Study|Withdrawal by Subject|3|||
13292854|NCT00701805|26486901|FG000|Overall Study|Adverse Event|0|||
13292855|NCT00701805|26486902|FG001|Overall Study|Adverse Event|1|||
13292856|NCT00701805|26486903|FG002|Overall Study|Adverse Event|1|||
13292857|NCT00701805|26486904|FG003|Overall Study|Adverse Event|0|||
13292858|NCT00701805|26486901|FG000|Overall Study|Missed 7 consecutive doses|0|||
13292859|NCT00701805|26486902|FG001|Overall Study|Missed 7 consecutive doses|1|||
13292860|NCT00701805|26486903|FG002|Overall Study|Missed 7 consecutive doses|0|||
13292861|NCT00701805|26486904|FG003|Overall Study|Missed 7 consecutive doses|0|||
13292862|NCT00701805|26486901|FG000|Overall Study|Admitted to hospital for 2 weeks|0|||
13292863|NCT00701805|26486902|FG001|Overall Study|Admitted to hospital for 2 weeks|0|||
13292864|NCT00701805|26486903|FG002|Overall Study|Admitted to hospital for 2 weeks|1|||
13292865|NCT00701805|26486904|FG003|Overall Study|Admitted to hospital for 2 weeks|0|||
13292866|NCT00701805|26486901|FG000|Overall Study|Physician decision, change of therapy|0|||
13292867|NCT00701805|26486902|FG001|Overall Study|Physician decision, change of therapy|0|||
13292868|NCT00701805|26486903|FG002|Overall Study|Physician decision, change of therapy|0|||
13292869|NCT00701805|26486904|FG003|Overall Study|Physician decision, change of therapy|1|||
13292870|NCT00701805|26486901|FG000|Overall Study|Difficult to travel to dialysis site|0|||
13292871|NCT00701805|26486902|FG001|Overall Study|Difficult to travel to dialysis site|0|||
13292872|NCT00701805|26486903|FG002|Overall Study|Difficult to travel to dialysis site|1|||
13292873|NCT00701805|26486904|FG003|Overall Study|Difficult to travel to dialysis site|0|||
13292874|NCT00701805|26486901|FG000|Overall Study|Resumption criteria were not met|0|||
13292875|NCT00701805|26486902|FG001|Overall Study|Resumption criteria were not met|1|||
13292876|NCT00701805|26486903|FG002|Overall Study|Resumption criteria were not met|0|||
13292877|NCT00701805|26486904|FG003|Overall Study|Resumption criteria were not met|0|||
13292878|NCT00701779|26486918|FG000|Overall Study|Adverse Event|6|||
13292879|NCT00701779|26486918|FG000|Overall Study|Lost to Follow-up|1|||
13292880|NCT00701779|26486918|FG000|Overall Study|Withdrawal by Subject|2|||
13292881|NCT00701727|26486939|FG000|First Treatment Period|Adverse Event|0|||
13292882|NCT00701727|26486940|FG001|First Treatment Period|Adverse Event|0|||
13292883|NCT00701727|26486939|FG000|First Treatment Period|Withdrawal by Subject|1|||
13292884|NCT00701727|26486940|FG001|First Treatment Period|Withdrawal by Subject|0|||
13292885|NCT00701727|26486939|FG000|First Treatment Period|sponsor decision|0|||
13292886|NCT00701727|26486940|FG001|First Treatment Period|sponsor decision|1|||
13292887|NCT00701727|26486939|FG000|First Treatment Period|Lost to Follow-up|0|||
13292888|NCT00701727|26486940|FG001|First Treatment Period|Lost to Follow-up|1|||
13292889|NCT00701727|26486939|FG000|Second Treatment Period|Withdrawal by Subject|2|||
13292890|NCT00701727|26486940|FG001|Second Treatment Period|Withdrawal by Subject|0|||
13292891|NCT00701662|26486959|FG000|Overall Study|Lack of Efficacy|1|||
13292892|NCT00701558|26486967|FG000|Overall Study|Death|7|||
13292893|NCT00701558|26486967|FG000|Overall Study|Lost to Follow-up|8|||
13292894|NCT00701441|26486984|FG000|Overall Study|failure in cpap compliance|0|||
13292895|NCT00701441|26486985|FG001|Overall Study|failure in cpap compliance|4|||
13292896|NCT00701363|26487038|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4|||
13292897|NCT00701363|26487039|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
13292898|NCT00701363|26487040|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
13292899|NCT00701363|26487041|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
13292900|NCT00701363|26487038|FG000|Treatment Phase 1|Does not meet entry Criteria|1|||
13292901|NCT00701363|26487039|FG001|Treatment Phase 1|Does not meet entry Criteria|0|||
13292902|NCT00701363|26487040|FG002|Treatment Phase 1|Does not meet entry Criteria|0|||
13292903|NCT00701363|26487041|FG003|Treatment Phase 1|Does not meet entry Criteria|0|||
13292904|NCT00701363|26487038|FG000|Treatment Phase 1|Adverse Event|7|||
13292905|NCT00701363|26487039|FG001|Treatment Phase 1|Adverse Event|0|||
13292906|NCT00701363|26487040|FG002|Treatment Phase 1|Adverse Event|0|||
13292907|NCT00701363|26487041|FG003|Treatment Phase 1|Adverse Event|0|||
13292908|NCT00701363|26487038|FG000|Treatment Phase 1|Protocol Violation|1|||
13292909|NCT00701363|26487039|FG001|Treatment Phase 1|Protocol Violation|0|||
13292910|NCT00701363|26487040|FG002|Treatment Phase 1|Protocol Violation|0|||
13292911|NCT00701363|26487041|FG003|Treatment Phase 1|Protocol Violation|0|||
13292912|NCT00701363|26487038|FG000|Treatment Phase 1|Withdrawal by Subject|5|||
13292913|NCT00701363|26487039|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
13292914|NCT00701363|26487040|FG002|Treatment Phase 1|Withdrawal by Subject|0|||
13292915|NCT00701363|26487041|FG003|Treatment Phase 1|Withdrawal by Subject|0|||
13292916|NCT00701363|26487038|FG000|Treatment Phase 1|Lack of Efficacy|1|||
13292917|NCT00701363|26487039|FG001|Treatment Phase 1|Lack of Efficacy|0|||
13292918|NCT00701363|26487040|FG002|Treatment Phase 1|Lack of Efficacy|0|||
13292919|NCT00701363|26487041|FG003|Treatment Phase 1|Lack of Efficacy|0|||
13292920|NCT00701363|26487038|FG000|Treatment Phase 2|Adverse Event|0|||
13292921|NCT00701363|26487039|FG001|Treatment Phase 2|Adverse Event|0|||
13292922|NCT00701363|26487040|FG002|Treatment Phase 2|Adverse Event|1|||
13292923|NCT00701363|26487041|FG003|Treatment Phase 2|Adverse Event|0|||
13292924|NCT00701363|26487038|FG000|Treatment Phase 2|Withdrawal by Subject|0|||
13292925|NCT00701363|26487039|FG001|Treatment Phase 2|Withdrawal by Subject|0|||
13292926|NCT00701363|26487040|FG002|Treatment Phase 2|Withdrawal by Subject|1|||
13292927|NCT00701363|26487041|FG003|Treatment Phase 2|Withdrawal by Subject|0|||
13292928|NCT00701311|26487047|FG000|Overall Study|Lack of Efficacy|3|||
13292929|NCT00701311|26487047|FG000|Overall Study|Adverse Event|3|||
13292930|NCT00701311|26487047|FG000|Overall Study|Withdrawal by Subject|2|||
13292931|NCT00701129|26487060|FG000|Overall Study|Death|2|||
13292932|NCT00701103|26487198|FG000|Overall Study|Adverse Event|0|||
13292933|NCT00701103|26487199|FG001|Overall Study|Adverse Event|0|||
13292934|NCT00701103|26487200|FG002|Overall Study|Adverse Event|1|||
13292935|NCT00701103|26487201|FG003|Overall Study|Adverse Event|1|||
13292936|NCT00701103|26487202|FG004|Overall Study|Adverse Event|0|||
13292937|NCT00701103|26487203|FG005|Overall Study|Adverse Event|1|||
13292938|NCT00701103|26487204|FG006|Overall Study|Adverse Event|1|||
13292939|NCT00701103|26487205|FG007|Overall Study|Adverse Event|0|||
13292940|NCT00701103|26487206|FG008|Overall Study|Adverse Event|0|||
13292941|NCT00701103|26487207|FG009|Overall Study|Adverse Event|2|||
13292942|NCT00701103|26487208|FG010|Overall Study|Adverse Event|0|||
13292943|NCT00701103|26487198|FG000|Overall Study|Progressive Disease|5|||
13292944|NCT00701103|26487199|FG001|Overall Study|Progressive Disease|2|||
13292945|NCT00701103|26487200|FG002|Overall Study|Progressive Disease|6|||
13292946|NCT00701103|26487201|FG003|Overall Study|Progressive Disease|5|||
13292947|NCT00701103|26487202|FG004|Overall Study|Progressive Disease|6|||
13292948|NCT00701103|26487203|FG005|Overall Study|Progressive Disease|5|||
13292949|NCT00701103|26487204|FG006|Overall Study|Progressive Disease|7|||
13292950|NCT00701103|26487205|FG007|Overall Study|Progressive Disease|7|||
13292951|NCT00701103|26487206|FG008|Overall Study|Progressive Disease|8|||
13292952|NCT00701103|26487207|FG009|Overall Study|Progressive Disease|8|||
13292953|NCT00701103|26487208|FG010|Overall Study|Progressive Disease|11|||
13292954|NCT00701103|26487198|FG000|Overall Study|Withdrawal by Subject|0|||
13292955|NCT00701103|26487199|FG001|Overall Study|Withdrawal by Subject|1|||
13292956|NCT00701103|26487200|FG002|Overall Study|Withdrawal by Subject|1|||
13488565|NCT00409773|27043867|FG004|Overall Study|Lost to Follow-up|1|||
13292957|NCT00701103|26487201|FG003|Overall Study|Withdrawal by Subject|0|||
13292958|NCT00701103|26487202|FG004|Overall Study|Withdrawal by Subject|0|||
13292959|NCT00701103|26487203|FG005|Overall Study|Withdrawal by Subject|0|||
13292960|NCT00701103|26487204|FG006|Overall Study|Withdrawal by Subject|0|||
13292961|NCT00701103|26487205|FG007|Overall Study|Withdrawal by Subject|0|||
13292962|NCT00701103|26487206|FG008|Overall Study|Withdrawal by Subject|0|||
13292963|NCT00701103|26487207|FG009|Overall Study|Withdrawal by Subject|0|||
13292964|NCT00701103|26487208|FG010|Overall Study|Withdrawal by Subject|0|||
13292965|NCT00701103|26487198|FG000|Overall Study|Other|0|||
13292966|NCT00701103|26487199|FG001|Overall Study|Other|0|||
13292967|NCT00701103|26487200|FG002|Overall Study|Other|0|||
13292968|NCT00701103|26487201|FG003|Overall Study|Other|0|||
13292969|NCT00701103|26487202|FG004|Overall Study|Other|0|||
13292970|NCT00701103|26487203|FG005|Overall Study|Other|0|||
13292971|NCT00701103|26487204|FG006|Overall Study|Other|0|||
13292972|NCT00701103|26487205|FG007|Overall Study|Other|0|||
13292973|NCT00701103|26487206|FG008|Overall Study|Other|1|||
13292974|NCT00701103|26487207|FG009|Overall Study|Other|1|||
13292975|NCT00701103|26487208|FG010|Overall Study|Other|0|||
13292976|NCT00701090|26487231|FG000|Overall Study|Adverse Event|11|||
13292977|NCT00701090|26487232|FG001|Overall Study|Adverse Event|2|||
13292978|NCT00701090|26487231|FG000|Overall Study|Death|0|||
13292979|NCT00701090|26487232|FG001|Overall Study|Death|1|||
13292980|NCT00701090|26487231|FG000|Overall Study|Lack of Efficacy|5|||
13292981|NCT00701090|26487232|FG001|Overall Study|Lack of Efficacy|4|||
13292982|NCT00701090|26487231|FG000|Overall Study|Lost to Follow-up|9|||
13292983|NCT00701090|26487232|FG001|Overall Study|Lost to Follow-up|9|||
13292984|NCT00701090|26487231|FG000|Overall Study|Physician Decision|3|||
13292985|NCT00701090|26487232|FG001|Overall Study|Physician Decision|4|||
13292986|NCT00701090|26487231|FG000|Overall Study|Protocol Violation|2|||
13292987|NCT00701090|26487232|FG001|Overall Study|Protocol Violation|3|||
13292988|NCT00701090|26487231|FG000|Overall Study|Withdrawal by Subject|11|||
13292989|NCT00701090|26487232|FG001|Overall Study|Withdrawal by Subject|16|||
13292990|NCT00701090|26487231|FG000|Overall Study|Other|7|||
13292991|NCT00701090|26487232|FG001|Overall Study|Other|12|||
13292992|NCT00701064|26487249|FG000|Overall Study|Protocol Violation|1|||
13292993|NCT00701064|26487250|FG001|Overall Study|Protocol Violation|1|||
13292994|NCT00701064|26487249|FG000|Overall Study|Withdrawal by Subject|1|||
13292995|NCT00701064|26487250|FG001|Overall Study|Withdrawal by Subject|1|||
13292996|NCT00701064|26487249|FG000|Overall Study|initiated other PTSD treatment|2|||
13292997|NCT00701064|26487250|FG001|Overall Study|initiated other PTSD treatment|2|||
13292998|NCT00701051|26487274|FG000|Screening|Failed Screening|40|||
13292999|NCT00701051|26487275|FG001|Screening|Failed Screening|0|||
13293000|NCT00701051|26487276|FG002|Screening|Failed Screening|0|||
13293001|NCT00701051|26487274|FG000|Screening|Time conflicts|19|||
13293002|NCT00701051|26487275|FG001|Screening|Time conflicts|0|||
13293003|NCT00701051|26487276|FG002|Screening|Time conflicts|0|||
13293004|NCT00701051|26487274|FG000|Exercise Intervention|time conflict; non-study related illness|0|||
13293005|NCT00701051|26487275|FG001|Exercise Intervention|time conflict; non-study related illness|5|||
13293006|NCT00701051|26487276|FG002|Exercise Intervention|time conflict; non-study related illness|3|||
13293007|NCT00700999|26487289|FG000|Overall Study|Lost to Follow-up|7|||
13293008|NCT00700999|26487290|FG001|Overall Study|Lost to Follow-up|7|||
13293009|NCT00700999|26487289|FG000|Overall Study|Excluded - did not meet study criteria|0|||
13293010|NCT00700999|26487290|FG001|Overall Study|Excluded - did not meet study criteria|1|||
13293011|NCT00700999|26487289|FG000|Overall Study|Withdrawal by Subject|8|||
13293012|NCT00700999|26487290|FG001|Overall Study|Withdrawal by Subject|1|||
13293013|NCT00700817|26487686|FG000|Week 0-26 (Main Period)|Adverse Event|14|||
13293014|NCT00700817|26487687|FG001|Week 0-26 (Main Period)|Adverse Event|15|||
13293015|NCT00700817|26487688|FG002|Week 0-26 (Main Period)|Adverse Event|4|||
13293016|NCT00700817|26487689|FG003|Week 0-26 (Main Period)|Adverse Event|0|||
13293017|NCT00700817|26487690|FG004|Week 0-26 (Main Period)|Adverse Event|0|||
13293018|NCT00700817|26487686|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4|||
13293019|NCT00700817|26487687|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0|||
13293020|NCT00700817|26487688|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4|||
13293021|NCT00700817|26487689|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0|||
13293022|NCT00700817|26487690|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0|||
13293023|NCT00700817|26487686|FG000|Week 0-26 (Main Period)|Protocol Violation|14|||
13293024|NCT00700817|26487687|FG001|Week 0-26 (Main Period)|Protocol Violation|4|||
13293025|NCT00700817|26487688|FG002|Week 0-26 (Main Period)|Protocol Violation|4|||
13293026|NCT00700817|26487689|FG003|Week 0-26 (Main Period)|Protocol Violation|0|||
13293027|NCT00700817|26487690|FG004|Week 0-26 (Main Period)|Protocol Violation|0|||
13293028|NCT00700817|26487686|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10|||
13293029|NCT00700817|26487687|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7|||
13293030|NCT00700817|26487688|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5|||
13293031|NCT00700817|26487689|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0|||
13293032|NCT00700817|26487690|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0|||
13293033|NCT00700817|26487686|FG000|Week 0-26 (Main Period)|Unclassified|14|||
13293034|NCT00700817|26487687|FG001|Week 0-26 (Main Period)|Unclassified|4|||
13293035|NCT00700817|26487688|FG002|Week 0-26 (Main Period)|Unclassified|8|||
13293036|NCT00700817|26487689|FG003|Week 0-26 (Main Period)|Unclassified|0|||
13293037|NCT00700817|26487690|FG004|Week 0-26 (Main Period)|Unclassified|0|||
13293038|NCT00700817|26487686|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5|||
13293039|NCT00700817|26487687|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10|||
13293040|NCT00700817|26487688|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3|||
13293041|NCT00700817|26487689|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0|||
13293042|NCT00700817|26487690|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0|||
13293043|NCT00700817|26487686|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3|||
13293044|NCT00700817|26487687|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
13293045|NCT00700817|26487688|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
13293046|NCT00700817|26487689|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
13293047|NCT00700817|26487690|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
13293048|NCT00700817|26487686|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2|||
13293049|NCT00700817|26487687|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3|||
13293050|NCT00700817|26487688|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7|||
13293051|NCT00700817|26487689|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
13293052|NCT00700817|26487690|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
13293053|NCT00700817|26487686|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6|||
13293054|NCT00700817|26487687|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8|||
13293055|NCT00700817|26487688|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2|||
13293056|NCT00700817|26487689|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
13293057|NCT00700817|26487690|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
13293058|NCT00700817|26487686|FG000|Week 26-52 (Extension Period 1)|Unclassified|4|||
13293059|NCT00700817|26487687|FG001|Week 26-52 (Extension Period 1)|Unclassified|3|||
13293060|NCT00700817|26487688|FG002|Week 26-52 (Extension Period 1)|Unclassified|1|||
13293061|NCT00700817|26487689|FG003|Week 26-52 (Extension Period 1)|Unclassified|0|||
13293062|NCT00700817|26487690|FG004|Week 26-52 (Extension Period 1)|Unclassified|0|||
13293063|NCT00700817|26487686|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0|||
13293064|NCT00700817|26487687|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3|||
13293065|NCT00700817|26487688|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0|||
13293066|NCT00700817|26487689|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6|||
13293067|NCT00700817|26487690|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0|||
13293068|NCT00700817|26487686|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
13293069|NCT00700817|26487687|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2|||
13293070|NCT00700817|26487688|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0|||
13293071|NCT00700817|26487689|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
13293072|NCT00700817|26487690|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
13293073|NCT00700817|26487686|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
13293074|NCT00700817|26487687|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
13293075|NCT00700817|26487688|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
13293076|NCT00700817|26487689|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
13293077|NCT00700817|26487690|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
13293078|NCT00700817|26487686|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4|||
13293079|NCT00700817|26487687|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
13293080|NCT00700817|26487688|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0|||
13293081|NCT00700817|26487689|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1|||
13293082|NCT00700817|26487690|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
13293083|NCT00700817|26487686|FG000|Week 52-78 (Extension Period 2)|Unclassified|2|||
13293084|NCT00700817|26487687|FG001|Week 52-78 (Extension Period 2)|Unclassified|4|||
13293085|NCT00700817|26487688|FG002|Week 52-78 (Extension Period 2)|Unclassified|0|||
13293086|NCT00700817|26487689|FG003|Week 52-78 (Extension Period 2)|Unclassified|0|||
13293087|NCT00700817|26487690|FG004|Week 52-78 (Extension Period 2)|Unclassified|1|||
13293088|NCT00700804|26487705|FG000|Overall Study|Withdrawal by Subject|1|||
13293089|NCT00700804|26487706|FG001|Overall Study|Withdrawal by Subject|2|||
13293090|NCT00700804|26487705|FG000|Overall Study|Protocol Violation|1|||
13293091|NCT00700804|26487706|FG001|Overall Study|Protocol Violation|1|||
13293092|NCT00700804|26487705|FG000|Overall Study|Loose Stools|1|||
13293093|NCT00700804|26487706|FG001|Overall Study|Loose Stools|1|||
13293094|NCT00700778|26487712|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2|||
13293095|NCT00700752|26487721|FG000|First Intervention|Withdrawal by Subject|0|||
13293096|NCT00700752|26487722|FG001|First Intervention|Withdrawal by Subject|2|||
13293097|NCT00700739|26487765|FG000|Overall Study|Lost to Follow-up|4|||
13293098|NCT00700739|26487766|FG001|Overall Study|Lost to Follow-up|4|||
13293099|NCT00700713|26487790|FG000|Overall Study|Protocol Violation|1|||
13293100|NCT00700713|26487791|FG001|Overall Study|Protocol Violation|0|||
13293101|NCT00700713|26487792|FG002|Overall Study|Protocol Violation|1|||
13293102|NCT00700713|26487790|FG000|Overall Study|Withdrawal by Subject|0|||
13293103|NCT00700713|26487791|FG001|Overall Study|Withdrawal by Subject|0|||
13293104|NCT00700713|26487792|FG002|Overall Study|Withdrawal by Subject|1|||
13293105|NCT00700622|26487805|FG000|Overall Study|Adverse Event|4|||
13293106|NCT00700622|26487806|FG001|Overall Study|Adverse Event|0|||
13293107|NCT00700622|26487805|FG000|Overall Study|Lost to Follow-up|0|||
13293108|NCT00700622|26487806|FG001|Overall Study|Lost to Follow-up|1|||
13293109|NCT00700622|26487805|FG000|Overall Study|Physician Decision|2|||
13293110|NCT00700622|26487806|FG001|Overall Study|Physician Decision|1|||
13293111|NCT00700622|26487805|FG000|Overall Study|Protocol Violation|0|||
13293112|NCT00700622|26487806|FG001|Overall Study|Protocol Violation|1|||
13293113|NCT00700622|26487805|FG000|Overall Study|Withdrawal by Subject|4|||
13293114|NCT00700622|26487806|FG001|Overall Study|Withdrawal by Subject|1|||
13293115|NCT00700622|26487805|FG000|Overall Study|Other|3|||
13293116|NCT00700622|26487806|FG001|Overall Study|Other|1|||
13293117|NCT00700570|26487825|FG000|Overall Study|Adverse Event|2|||
13293118|NCT00700570|26487826|FG001|Overall Study|Adverse Event|6|||
13293119|NCT00700570|26487825|FG000|Overall Study|Discretion of Investigator or Sponsor|0|||
13293120|NCT00700570|26487826|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
13293121|NCT00700570|26487825|FG000|Overall Study|Disease Progression|8|||
13293122|NCT00700570|26487826|FG001|Overall Study|Disease Progression|11|||
13293123|NCT00700570|26487825|FG000|Overall Study|Withdrawal by Subject|1|||
13293124|NCT00700570|26487826|FG001|Overall Study|Withdrawal by Subject|6|||
13293125|NCT00700427|26487854|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298|||
13293126|NCT00700427|26487855|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
13293127|NCT00700427|26487856|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
13293128|NCT00700427|26487857|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
13293129|NCT00700427|26487858|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
13293130|NCT00700427|26487854|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173|||
13293131|NCT00700427|26487855|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
13293132|NCT00700427|26487856|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
13293133|NCT00700427|26487857|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
13293134|NCT00700427|26487858|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
13293135|NCT00700427|26487854|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164|||
13293136|NCT00700427|26487855|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
13293137|NCT00700427|26487856|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
13293138|NCT00700427|26487857|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
13293139|NCT00700427|26487858|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
13293140|NCT00700427|26487854|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161|||
13293141|NCT00700427|26487855|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
13293142|NCT00700427|26487856|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
13293143|NCT00700427|26487857|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
13293144|NCT00700427|26487858|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
13293145|NCT00700427|26487854|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108|||
13293146|NCT00700427|26487855|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
13293147|NCT00700427|26487856|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
13293148|NCT00700427|26487857|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
13293149|NCT00700427|26487858|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
13293150|NCT00700427|26487854|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90|||
13293151|NCT00700427|26487855|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
13293152|NCT00700427|26487856|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
13293153|NCT00700427|26487857|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
13293154|NCT00700427|26487858|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
13293155|NCT00700427|26487854|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8|||
13293156|NCT00700427|26487855|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
13293157|NCT00700427|26487856|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
13293158|NCT00700427|26487857|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
13293159|NCT00700427|26487858|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
13293160|NCT00700427|26487854|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7|||
13293161|NCT00700427|26487855|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
13293162|NCT00700427|26487856|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
13293163|NCT00700427|26487857|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
13293164|NCT00700427|26487858|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
13293165|NCT00700427|26487854|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2|||
13293166|NCT00700427|26487855|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
13293167|NCT00700427|26487856|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
13293168|NCT00700427|26487857|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
13293169|NCT00700427|26487858|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
13293170|NCT00700427|26487854|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
13293171|NCT00700427|26487855|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50|||
13293172|NCT00700427|26487856|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
13293173|NCT00700427|26487857|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
13293174|NCT00700427|26487858|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
13293175|NCT00700427|26487854|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
13293176|NCT00700427|26487855|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162|||
13293177|NCT00700427|26487856|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
13293178|NCT00700427|26487857|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
13293179|NCT00700427|26487858|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
13293180|NCT00700427|26487854|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
13293181|NCT00700427|26487855|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81|||
13293182|NCT00700427|26487856|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
13293183|NCT00700427|26487857|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
13293184|NCT00700427|26487858|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
13293185|NCT00700427|26487854|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
13293186|NCT00700427|26487855|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56|||
13293187|NCT00700427|26487856|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
13293188|NCT00700427|26487857|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
13293189|NCT00700427|26487858|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
13293190|NCT00700427|26487854|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
13293191|NCT00700427|26487855|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49|||
13293192|NCT00700427|26487856|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
13293193|NCT00700427|26487857|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
13293194|NCT00700427|26487858|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
13293195|NCT00700427|26487854|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
13293196|NCT00700427|26487855|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41|||
13206809|NCT01954082|26235554|FG001|Overall Study|Miscalculation of Final Dose Day|3|||
13206810|NCT01954082|26235553|FG000|Overall Study|Comfort Care|0|||
13206811|NCT01954082|26235554|FG001|Overall Study|Comfort Care|1|||
13206812|NCT01954082|26235553|FG000|Overall Study|Infant Moved|0|||
13206813|NCT01954082|26235554|FG001|Overall Study|Infant Moved|1|||
13206814|NCT01954082|26235553|FG000|Overall Study|Randomized not Treated|4|||
13206815|NCT01954082|26235554|FG001|Overall Study|Randomized not Treated|2|||
13206816|NCT01954056|26235603|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1|||
13206817|NCT01954056|26235604|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0|||
13206818|NCT01954017|26235840|FG000|Overall Study|Adverse Event|0|||
13206819|NCT01954017|26235841|FG001|Overall Study|Adverse Event|0|||
13206820|NCT01954017|26235842|FG002|Overall Study|Adverse Event|1|||
13206821|NCT01954017|26235840|FG000|Overall Study|Death|2|||
13206822|NCT01954017|26235841|FG001|Overall Study|Death|1|||
13206823|NCT01954017|26235842|FG002|Overall Study|Death|1|||
13206824|NCT01954017|26235840|FG000|Overall Study|Withdrawal by Subject|0|||
13206825|NCT01954017|26235841|FG001|Overall Study|Withdrawal by Subject|1|||
13206826|NCT01954017|26235842|FG002|Overall Study|Withdrawal by Subject|0|||
13206827|NCT01954017|26235840|FG000|Overall Study|Protocol Violation|0|||
13206828|NCT01954017|26235841|FG001|Overall Study|Protocol Violation|3|||
13206829|NCT01954017|26235842|FG002|Overall Study|Protocol Violation|2|||
13206830|NCT01954017|26235840|FG000|Overall Study|Necrotizing enterocolitis|1|||
13206831|NCT01954017|26235841|FG001|Overall Study|Necrotizing enterocolitis|0|||
13206832|NCT01954017|26235842|FG002|Overall Study|Necrotizing enterocolitis|1|||
13206833|NCT01954017|26235840|FG000|Overall Study|Enteral intake stopped >7 days|0|||
13206834|NCT01954017|26235841|FG001|Overall Study|Enteral intake stopped >7 days|1|||
13206835|NCT01954017|26235842|FG002|Overall Study|Enteral intake stopped >7 days|1|||
13206836|NCT01954017|26235840|FG000|Overall Study|All other reasons|2|||
13206837|NCT01954017|26235841|FG001|Overall Study|All other reasons|2|||
13206838|NCT01954017|26235842|FG002|Overall Study|All other reasons|7|||
13206839|NCT01953913|26235850|FG000|Overall Study|Disease Progression|349|||
13206840|NCT01953913|26235850|FG000|Overall Study|Worsening of underlying cancer|22|||
13206841|NCT01953913|26235850|FG000|Overall Study|Adverse Event|20|||
13206842|NCT01953913|26235850|FG000|Overall Study|Protocol Violation|6|||
13206843|NCT01953913|26235850|FG000|Overall Study|Lost to Follow-up|4|||
13206844|NCT01953913|26235850|FG000|Overall Study|Withdrawal by Subject|32|||
13206845|NCT01953913|26235850|FG000|Overall Study|Other than listed|108|||
13206846|NCT01953913|26235850|FG000|Overall Study|Not Treated|1|||
13293197|NCT00700427|26487856|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
13293198|NCT00700427|26487857|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
13293199|NCT00700427|26487858|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
13293200|NCT00700427|26487854|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
13293201|NCT00700427|26487855|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32|||
13293202|NCT00700427|26487856|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
13293203|NCT00700427|26487857|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
13488566|NCT00409773|27043863|FG000|Overall Study|Physician Decision|0|||
13206847|NCT01953783|26235874|FG000|Overall Study|Progressive disease|2|||
13206848|NCT01953692|26236003|FG000|Overall Study|Adverse Event|5|||
13206849|NCT01953692|26236004|FG001|Overall Study|Adverse Event|2|||
13206850|NCT01953692|26236005|FG002|Overall Study|Adverse Event|4|||
13206851|NCT01953692|26236006|FG003|Overall Study|Adverse Event|2|||
13206852|NCT01953692|26236007|FG004|Overall Study|Adverse Event|1|||
13206853|NCT01953692|26236008|FG005|Overall Study|Adverse Event|2|||
13206854|NCT01953692|26236009|FG006|Overall Study|Adverse Event|0|||
13293204|NCT00700427|26487858|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
13293205|NCT00700427|26487854|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
13293206|NCT00700427|26487855|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3|||
13293207|NCT00700427|26487856|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
13293208|NCT00700427|26487857|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
13293209|NCT00700427|26487858|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
13293210|NCT00700427|26487854|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
13293211|NCT00700427|26487855|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2|||
13293212|NCT00700427|26487856|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
13293213|NCT00700427|26487857|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
13293214|NCT00700427|26487858|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
13293215|NCT00700427|26487854|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
13293216|NCT00700427|26487855|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5|||
13293217|NCT00700427|26487856|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
13293218|NCT00700427|26487857|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
13293219|NCT00700427|26487858|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
13293220|NCT00700427|26487854|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
13293221|NCT00700427|26487855|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
13293222|NCT00700427|26487856|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8|||
13293223|NCT00700427|26487857|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5|||
13293224|NCT00700427|26487858|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
13293225|NCT00700427|26487854|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
13293226|NCT00700427|26487855|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
13293227|NCT00700427|26487856|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25|||
13293228|NCT00700427|26487857|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34|||
13293229|NCT00700427|26487858|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
13293230|NCT00700427|26487854|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
13293231|NCT00700427|26487855|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
13293232|NCT00700427|26487856|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23|||
13293233|NCT00700427|26487857|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25|||
13293234|NCT00700427|26487858|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
13293235|NCT00700427|26487854|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
13293236|NCT00700427|26487855|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
13293237|NCT00700427|26487856|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19|||
13293238|NCT00700427|26487857|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9|||
13293239|NCT00700427|26487858|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
13293240|NCT00700427|26487854|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
13293241|NCT00700427|26487855|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
13293242|NCT00700427|26487856|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3|||
13293243|NCT00700427|26487857|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11|||
13293244|NCT00700427|26487858|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
13293245|NCT00700427|26487854|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
13293246|NCT00700427|26487855|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
13293247|NCT00700427|26487856|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
13293248|NCT00700427|26487857|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5|||
13293249|NCT00700427|26487858|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
13293250|NCT00700427|26487854|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
13293251|NCT00700427|26487855|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
13293252|NCT00700427|26487856|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
13293253|NCT00700427|26487857|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3|||
13293254|NCT00700427|26487858|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
13293255|NCT00700427|26487854|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0|||
13293256|NCT00700427|26487855|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0|||
13293257|NCT00700427|26487856|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1|||
13488567|NCT00409773|27043864|FG001|Overall Study|Physician Decision|0|||
13488568|NCT00409773|27043865|FG002|Overall Study|Physician Decision|0|||
13206855|NCT01953692|26236010|FG007|Overall Study|Adverse Event|0|||
13206856|NCT01953692|26236011|FG008|Overall Study|Adverse Event|0|||
13293258|NCT00700427|26487857|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1|||
13293259|NCT00700427|26487858|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0|||
13293260|NCT00700427|26487854|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
13293261|NCT00700427|26487855|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
13293262|NCT00700427|26487856|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2|||
13293263|NCT00700427|26487857|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
13293264|NCT00700427|26487858|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
13293265|NCT00700427|26487854|FG000|Study Period 3B (Randomized Withdrawal)|Death|0|||
13293266|NCT00700427|26487855|FG001|Study Period 3B (Randomized Withdrawal)|Death|0|||
13293267|NCT00700427|26487856|FG002|Study Period 3B (Randomized Withdrawal)|Death|1|||
13293268|NCT00700427|26487857|FG003|Study Period 3B (Randomized Withdrawal)|Death|0|||
13293269|NCT00700427|26487858|FG004|Study Period 3B (Randomized Withdrawal)|Death|0|||
13293270|NCT00700427|26487854|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
13293271|NCT00700427|26487855|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
13293272|NCT00700427|26487856|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
13293273|NCT00700427|26487857|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
13293274|NCT00700427|26487858|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16|||
13293275|NCT00700427|26487854|FG000|Study Period 4 (Open-Label Extension)|Death|0|||
13293276|NCT00700427|26487855|FG001|Study Period 4 (Open-Label Extension)|Death|0|||
13293277|NCT00700427|26487856|FG002|Study Period 4 (Open-Label Extension)|Death|0|||
13293278|NCT00700427|26487857|FG003|Study Period 4 (Open-Label Extension)|Death|0|||
13293279|NCT00700427|26487858|FG004|Study Period 4 (Open-Label Extension)|Death|1|||
13293280|NCT00700427|26487854|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
13293281|NCT00700427|26487855|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
13293282|NCT00700427|26487856|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
13293283|NCT00700427|26487857|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
13293284|NCT00700427|26487858|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12|||
13293285|NCT00700427|26487854|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
13293286|NCT00700427|26487855|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
13293287|NCT00700427|26487856|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
13293288|NCT00700427|26487857|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
13293289|NCT00700427|26487858|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38|||
13293290|NCT00700427|26487854|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
13293291|NCT00700427|26487855|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
13293292|NCT00700427|26487856|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
13293293|NCT00700427|26487857|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
13293294|NCT00700427|26487858|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2|||
13293295|NCT00700427|26487854|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
13293296|NCT00700427|26487855|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
13293297|NCT00700427|26487856|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
13293298|NCT00700427|26487857|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
13293299|NCT00700427|26487858|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2|||
13293300|NCT00700427|26487854|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
13293301|NCT00700427|26487855|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
13293302|NCT00700427|26487856|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
13293303|NCT00700427|26487857|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
13293304|NCT00700427|26487858|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1|||
13293305|NCT00700427|26487854|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
13293306|NCT00700427|26487855|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
13293307|NCT00700427|26487856|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
13293308|NCT00700427|26487857|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
13293309|NCT00700427|26487858|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11|||
13293310|NCT00700427|26487854|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
13293311|NCT00700427|26487855|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
13293312|NCT00700427|26487856|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
13293313|NCT00700427|26487857|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
13293314|NCT00700427|26487858|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1|||
13293315|NCT00700401|26487871|FG000|Overall Study|Detectable HCV RNA after Week 4|82|||
13293316|NCT00700401|26487871|FG000|Overall Study|Adverse Event|5|||
13293317|NCT00700401|26487871|FG000|Overall Study|Refused Treatment|2|||
13293318|NCT00700401|26487871|FG000|Overall Study|Lost to Follow-up|1|||
13293319|NCT00700401|26487871|FG000|Overall Study|Treatment never started|1|||
13293320|NCT00700401|26487871|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1|||
13293321|NCT00700401|26487871|FG000|Overall Study|Withdrawal by Subject|2|||
13293322|NCT00700310|26487902|FG000|Overall Study|Adverse Event|6|||
13293323|NCT00700310|26487903|FG001|Overall Study|Adverse Event|10|||
13293324|NCT00700310|26487904|FG002|Overall Study|Adverse Event|5|||
13293325|NCT00700310|26487905|FG003|Overall Study|Adverse Event|11|||
13293326|NCT00700310|26487902|FG000|Overall Study|Lost to Follow-up|4|||
13293327|NCT00700310|26487903|FG001|Overall Study|Lost to Follow-up|1|||
13293328|NCT00700310|26487904|FG002|Overall Study|Lost to Follow-up|0|||
13293329|NCT00700310|26487905|FG003|Overall Study|Lost to Follow-up|1|||
13293330|NCT00700310|26487902|FG000|Overall Study|Withdrawal by Subject|8|||
13293331|NCT00700310|26487903|FG001|Overall Study|Withdrawal by Subject|9|||
13293332|NCT00700310|26487904|FG002|Overall Study|Withdrawal by Subject|8|||
13293333|NCT00700310|26487905|FG003|Overall Study|Withdrawal by Subject|8|||
13293334|NCT00700310|26487902|FG000|Overall Study|Lack of Efficacy|0|||
13293335|NCT00700310|26487903|FG001|Overall Study|Lack of Efficacy|3|||
13293336|NCT00700310|26487904|FG002|Overall Study|Lack of Efficacy|0|||
13293337|NCT00700310|26487905|FG003|Overall Study|Lack of Efficacy|1|||
13293338|NCT00700310|26487902|FG000|Overall Study|Administrative/Other|1|||
13293339|NCT00700310|26487903|FG001|Overall Study|Administrative/Other|3|||
13293340|NCT00700310|26487904|FG002|Overall Study|Administrative/Other|1|||
13393913|NCT00661713|26785142|FG003|Overall Study|Administrative Reason|2|||
13393914|NCT00661713|26785143|FG004|Overall Study|Administrative Reason|2|||
13393915|NCT00661713|26785144|FG005|Overall Study|Administrative Reason|2|||
13393916|NCT00661713|26785145|FG006|Overall Study|Administrative Reason|1|||
13393917|NCT00661713|26785146|FG007|Overall Study|Administrative Reason|0|||
13393918|NCT00661713|26785139|FG000|Overall Study|Adverse Event|0|||
13393919|NCT00661713|26785140|FG001|Overall Study|Adverse Event|0|||
13488569|NCT00409773|27043866|FG003|Overall Study|Physician Decision|2|||
13488570|NCT00409773|27043867|FG004|Overall Study|Physician Decision|0|||
13293341|NCT00700310|26487905|FG003|Overall Study|Administrative/Other|3|||
13293342|NCT00700310|26487902|FG000|Overall Study|Randomized, Not Treated|2|||
13293343|NCT00700310|26487903|FG001|Overall Study|Randomized, Not Treated|0|||
13293344|NCT00700310|26487904|FG002|Overall Study|Randomized, Not Treated|2|||
13293345|NCT00700310|26487905|FG003|Overall Study|Randomized, Not Treated|2|||
13293346|NCT00700271|26487938|FG000|Overall Study|Adverse Event|4|||
13293347|NCT00700271|26487939|FG001|Overall Study|Adverse Event|6|||
13293348|NCT00700271|26487938|FG000|Overall Study|Protocol Violation|1|||
13293349|NCT00700271|26487939|FG001|Overall Study|Protocol Violation|0|||
13293350|NCT00700271|26487938|FG000|Overall Study|Administrative Reasons|1|||
13293351|NCT00700271|26487939|FG001|Overall Study|Administrative Reasons|0|||
13293352|NCT00700271|26487938|FG000|Overall Study|Withdrawal by Subject|6|||
13293353|NCT00700271|26487939|FG001|Overall Study|Withdrawal by Subject|4|||
13293354|NCT00700271|26487938|FG000|Overall Study|Lost to Follow-up|2|||
13293355|NCT00700271|26487939|FG001|Overall Study|Lost to Follow-up|2|||
13293356|NCT00700180|26487968|FG000|Overall Study|Death|99|||
13293357|NCT00700180|26487969|FG001|Overall Study|Death|114|||
13293358|NCT00700180|26487968|FG000|Overall Study|Alive on treatment|5|||
13293359|NCT00700180|26487969|FG001|Overall Study|Alive on treatment|3|||
13293360|NCT00700180|26487968|FG000|Overall Study|Alive in follow-up|46|||
13293361|NCT00700180|26487969|FG001|Overall Study|Alive in follow-up|27|||
13293362|NCT00700180|26487968|FG000|Overall Study|Lost to Follow-up|4|||
13293363|NCT00700180|26487969|FG001|Overall Study|Lost to Follow-up|5|||
13293364|NCT00703326|26487998|FG000|Overall Study|Lost to Follow-up|47|||
13293365|NCT00703326|26487999|FG001|Overall Study|Lost to Follow-up|18|||
13293366|NCT00703326|26487998|FG000|Overall Study|Withdrawal by Subject|54|||
13293367|NCT00703326|26487999|FG001|Overall Study|Withdrawal by Subject|20|||
13293368|NCT00703326|26487998|FG000|Overall Study|Adverse Event|1|||
13293369|NCT00703326|26487999|FG001|Overall Study|Adverse Event|0|||
13293370|NCT00703014|26488042|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33|||
13293371|NCT00703014|26488043|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32|||
13293372|NCT00703014|26488044|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
13293373|NCT00703014|26488045|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
13293374|NCT00703014|26488042|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
13293375|NCT00703014|26488043|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
13293376|NCT00703014|26488044|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47|||
13293377|NCT00703014|26488045|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42|||
13293378|NCT00702520|26488124|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
13293379|NCT00702520|26488125|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1|||
13293380|NCT00702520|26488126|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
13293381|NCT00702520|26488127|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
13293382|NCT00702520|26488124|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3|||
13293383|NCT00702520|26488125|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6|||
13293384|NCT00702520|26488126|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
13293385|NCT00702520|26488127|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
13293386|NCT00702520|26488124|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15|||
13393920|NCT00661713|26785141|FG002|Overall Study|Adverse Event|0|||
13393921|NCT00661713|26785142|FG003|Overall Study|Adverse Event|0|||
13293387|NCT00702520|26488125|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10|||
13293388|NCT00702520|26488126|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
13293389|NCT00702520|26488127|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
13376746|NCT00784277|26733120|FG001|ER Treatment|Withdrawal by Subject|0|||
13376747|NCT00784277|26733121|FG002|ER Treatment|Withdrawal by Subject|0|||
13376748|NCT00784277|26733122|FG003|ER Treatment|Withdrawal by Subject|0|||
13376749|NCT00784277|26733123|FG004|ER Treatment|Withdrawal by Subject|2|||
13376750|NCT00784277|26733124|FG005|ER Treatment|Withdrawal by Subject|5|||
13376751|NCT00784277|26733125|FG006|ER Treatment|Withdrawal by Subject|3|||
13376752|NCT00784277|26733119|FG000|ER Treatment|Study Medication Non-Compliant|0|||
13376753|NCT00784277|26733120|FG001|ER Treatment|Study Medication Non-Compliant|0|||
13376754|NCT00784277|26733121|FG002|ER Treatment|Study Medication Non-Compliant|0|||
13376755|NCT00784277|26733122|FG003|ER Treatment|Study Medication Non-Compliant|0|||
13376756|NCT00784277|26733123|FG004|ER Treatment|Study Medication Non-Compliant|2|||
13376757|NCT00784277|26733124|FG005|ER Treatment|Study Medication Non-Compliant|3|||
13376758|NCT00784277|26733125|FG006|ER Treatment|Study Medication Non-Compliant|3|||
13376759|NCT00784277|26733119|FG000|ER Treatment|Other|0|||
13376760|NCT00784277|26733120|FG001|ER Treatment|Other|0|||
13376761|NCT00784277|26733121|FG002|ER Treatment|Other|0|||
13376762|NCT00784277|26733122|FG003|ER Treatment|Other|0|||
13376763|NCT00784277|26733123|FG004|ER Treatment|Other|1|||
13376764|NCT00784277|26733124|FG005|ER Treatment|Other|3|||
13376765|NCT00784277|26733125|FG006|ER Treatment|Other|2|||
13376766|NCT00784238|26733168|FG000|Overall Study|Adverse Event|14|||
13376767|NCT00784238|26733168|FG000|Overall Study|Death|2|||
13376768|NCT00784238|26733168|FG000|Overall Study|Lack of Efficacy|33|||
13376769|NCT00784238|26733168|FG000|Overall Study|Lost to Follow-up|29|||
13376770|NCT00784238|26733168|FG000|Overall Study|Pregnancy|1|||
13376771|NCT00784238|26733168|FG000|Overall Study|Withdrawal by Subject|26|||
13376772|NCT00784238|26733168|FG000|Overall Study|Other|14|||
13376773|NCT00784147|26733193|FG000|Overall Study|Lost to Follow-up|2|||
13376774|NCT00784147|26733194|FG001|Overall Study|Lost to Follow-up|4|||
13376775|NCT00784147|26733193|FG000|Overall Study|Withdrawal by Subject|1|||
13376776|NCT00784147|26733194|FG001|Overall Study|Withdrawal by Subject|3|||
13376777|NCT00784147|26733193|FG000|Overall Study|Physician Decision|2|||
13376778|NCT00784147|26733194|FG001|Overall Study|Physician Decision|1|||
13376779|NCT00784147|26733193|FG000|Overall Study|Protocol Violation|1|||
13376780|NCT00784147|26733194|FG001|Overall Study|Protocol Violation|1|||
13376781|NCT00784147|26733193|FG000|Overall Study|Death|2|||
13376782|NCT00784147|26733194|FG001|Overall Study|Death|0|||
13376783|NCT00784134|26733297|FG000|Overall Study|Lost to Follow-up|3|||
13376784|NCT00784134|26733298|FG001|Overall Study|Lost to Follow-up|6|||
13376785|NCT00784043|26733315|FG000|Overall Study|Withdrawal by Subject|8|||
13376786|NCT00784043|26733316|FG001|Overall Study|Withdrawal by Subject|5|||
13376787|NCT00784043|26733315|FG000|Overall Study|Protocol Terminated|23|||
13376788|NCT00784043|26733316|FG001|Overall Study|Protocol Terminated|1|||
13376789|NCT00783835|26733330|FG000|Overall Study|Adverse Event|3|||
13376790|NCT00783835|26733330|FG000|Overall Study|Medical Criteria|1|||
13376791|NCT00783835|26733330|FG000|Overall Study|Withdrawal by Subject|2|||
13376792|NCT00783835|26733330|FG000|Overall Study|Lost to Follow-up|1|||
13376793|NCT00783835|26733330|FG000|Overall Study|Participant not Adherent|3|||
13376794|NCT00783796|26733434|FG000|Overall Study|Did not receive any stent|4|||
13376795|NCT00783796|26733434|FG000|Overall Study|Received non-XIENCE V stent|1|||
13376796|NCT00783796|26733434|FG000|Overall Study|Received commercial XIENCE V stent|1|||
13376797|NCT00783718|26733474|FG000|Induction Phase|Adverse Event|4|||
13376798|NCT00783718|26733475|FG001|Induction Phase|Adverse Event|0|||
13376799|NCT00783718|26733476|FG002|Induction Phase|Adverse Event|7|||
13376800|NCT00783718|26733477|FG003|Induction Phase|Adverse Event|0|||
13376801|NCT00783718|26733478|FG004|Induction Phase|Adverse Event|0|||
13376802|NCT00783718|26733479|FG005|Induction Phase|Adverse Event|0|||
13376803|NCT00783718|26733480|FG006|Induction Phase|Adverse Event|0|||
13376804|NCT00783718|26733474|FG000|Induction Phase|Protocol Violation|1|||
13376805|NCT00783718|26733475|FG001|Induction Phase|Protocol Violation|1|||
13376806|NCT00783718|26733476|FG002|Induction Phase|Protocol Violation|6|||
13376807|NCT00783718|26733477|FG003|Induction Phase|Protocol Violation|0|||
13376808|NCT00783718|26733478|FG004|Induction Phase|Protocol Violation|0|||
13376809|NCT00783718|26733479|FG005|Induction Phase|Protocol Violation|0|||
13376810|NCT00783718|26733480|FG006|Induction Phase|Protocol Violation|0|||
13376811|NCT00783718|26733474|FG000|Induction Phase|Lack of Efficacy|5|||
13376812|NCT00783718|26733475|FG001|Induction Phase|Lack of Efficacy|2|||
13376813|NCT00783718|26733476|FG002|Induction Phase|Lack of Efficacy|14|||
13376814|NCT00783718|26733477|FG003|Induction Phase|Lack of Efficacy|0|||
13376815|NCT00783718|26733478|FG004|Induction Phase|Lack of Efficacy|0|||
13376816|NCT00783718|26733479|FG005|Induction Phase|Lack of Efficacy|0|||
13376817|NCT00783718|26733480|FG006|Induction Phase|Lack of Efficacy|0|||
13376818|NCT00783718|26733474|FG000|Induction Phase|Withdrawal by Subject|3|||
13376819|NCT00783718|26733475|FG001|Induction Phase|Withdrawal by Subject|4|||
13376820|NCT00783718|26733476|FG002|Induction Phase|Withdrawal by Subject|8|||
13293390|NCT00703820|26488204|FG000|Overall Study|Adverse Event|12|||
13293391|NCT00703820|26488205|FG001|Overall Study|Adverse Event|17|||
13293392|NCT00703820|26488204|FG000|Overall Study|Death|5|||
13293393|NCT00703820|26488205|FG001|Overall Study|Death|0|||
13293394|NCT00703820|26488204|FG000|Overall Study|Lack of Efficacy|11|||
13293395|NCT00703820|26488205|FG001|Overall Study|Lack of Efficacy|11|||
13293396|NCT00703820|26488204|FG000|Overall Study|Received non-protocol therapy|1|||
13293397|NCT00703820|26488205|FG001|Overall Study|Received non-protocol therapy|0|||
13293398|NCT00703820|26488204|FG000|Overall Study|Physician Decision|4|||
13293399|NCT00703820|26488205|FG001|Overall Study|Physician Decision|5|||
13293400|NCT00703820|26488204|FG000|Overall Study|Withdrawal by Subject|2|||
13293401|NCT00703820|26488205|FG001|Overall Study|Withdrawal by Subject|1|||
13293402|NCT00702689|26488218|FG000|Overall Study|Withdrawal by Subject|4|||
13293403|NCT00702689|26488218|FG000|Overall Study|Recurrent malignancy|1|||
13293404|NCT00702689|26488218|FG000|Overall Study|Adverse Event|1|||
13293405|NCT00701701|26488247|FG000|Overall Study|Withdrawal by Subject|0|||
13293406|NCT00701701|26488248|FG001|Overall Study|Withdrawal by Subject|1|||
13293407|NCT00701701|26488247|FG000|Overall Study|Adverse Event|0|||
13293408|NCT00701701|26488248|FG001|Overall Study|Adverse Event|1|||
13293409|NCT00708305|26488285|FG000|Period 1|Protocol Violation|1|||
13293410|NCT00708305|26488286|FG001|Period 1|Protocol Violation|0|||
13293411|NCT00708305|26488287|FG002|Period 1|Protocol Violation|1|||
13293412|NCT00708305|26488288|FG003|Period 1|Protocol Violation|0|||
13293413|NCT00708305|26488285|FG000|Period 1|Other Reason|0|||
13293414|NCT00708305|26488286|FG001|Period 1|Other Reason|0|||
13293415|NCT00708305|26488287|FG002|Period 1|Other Reason|0|||
13293416|NCT00708305|26488288|FG003|Period 1|Other Reason|2|||
13293417|NCT00708305|26488285|FG000|Period 2|Lost to Follow-up|0|||
13293418|NCT00708305|26488286|FG001|Period 2|Lost to Follow-up|1|||
13293419|NCT00708305|26488287|FG002|Period 2|Lost to Follow-up|0|||
13293420|NCT00708305|26488288|FG003|Period 2|Lost to Follow-up|0|||
13293421|NCT00708305|26488285|FG000|Period 2|Protocol Violation|0|||
13293422|NCT00708305|26488286|FG001|Period 2|Protocol Violation|1|||
13293423|NCT00708305|26488287|FG002|Period 2|Protocol Violation|0|||
13293424|NCT00708305|26488288|FG003|Period 2|Protocol Violation|0|||
13293425|NCT00708305|26488285|FG000|Period 2|Other Reason|1|||
13293426|NCT00708305|26488286|FG001|Period 2|Other Reason|0|||
13293427|NCT00708305|26488287|FG002|Period 2|Other Reason|0|||
13293428|NCT00708305|26488288|FG003|Period 2|Other Reason|1|||
13293429|NCT00708305|26488285|FG000|Period 3|Protocol Violation|0|||
13293430|NCT00708305|26488286|FG001|Period 3|Protocol Violation|2|||
13293431|NCT00708305|26488287|FG002|Period 3|Protocol Violation|0|||
13293432|NCT00708305|26488288|FG003|Period 3|Protocol Violation|0|||
13293433|NCT00708305|26488285|FG000|Period 3|Other Reason|1|||
13293434|NCT00708305|26488286|FG001|Period 3|Other Reason|0|||
13293435|NCT00708305|26488287|FG002|Period 3|Other Reason|0|||
13293436|NCT00708305|26488288|FG003|Period 3|Other Reason|0|||
13293437|NCT00708123|26488314|FG000|Period 1|Protocol Violation|0|||
13293438|NCT00708123|26488315|FG001|Period 1|Protocol Violation|1|||
13293439|NCT00708123|26488316|FG002|Period 1|Protocol Violation|0|||
13293440|NCT00708123|26488317|FG003|Period 1|Protocol Violation|1|||
13293441|NCT00708123|26488318|FG004|Period 1|Protocol Violation|0|||
13293442|NCT00708123|26488314|FG000|Period 1|Adverse Event|0|||
13293443|NCT00708123|26488315|FG001|Period 1|Adverse Event|0|||
13293444|NCT00708123|26488316|FG002|Period 1|Adverse Event|1|||
13293445|NCT00708123|26488317|FG003|Period 1|Adverse Event|0|||
13293446|NCT00708123|26488318|FG004|Period 1|Adverse Event|0|||
13293447|NCT00708123|26488314|FG000|Period 2|Protocol Violation|0|||
13293448|NCT00708123|26488315|FG001|Period 2|Protocol Violation|0|||
13293449|NCT00708123|26488316|FG002|Period 2|Protocol Violation|0|||
13293450|NCT00708123|26488317|FG003|Period 2|Protocol Violation|1|||
13293451|NCT00708123|26488318|FG004|Period 2|Protocol Violation|0|||
13293452|NCT00708123|26488314|FG000|Period 2|Other Reason|1|||
13293453|NCT00708123|26488315|FG001|Period 2|Other Reason|0|||
13293454|NCT00708123|26488316|FG002|Period 2|Other Reason|0|||
13293455|NCT00708123|26488317|FG003|Period 2|Other Reason|0|||
13293456|NCT00708123|26488318|FG004|Period 2|Other Reason|0|||
13293457|NCT00708123|26488314|FG000|Period 3|Lost to Follow-up|0|||
13293458|NCT00708123|26488315|FG001|Period 3|Lost to Follow-up|0|||
13293459|NCT00708123|26488316|FG002|Period 3|Lost to Follow-up|1|||
13293460|NCT00708123|26488317|FG003|Period 3|Lost to Follow-up|1|||
13293461|NCT00708123|26488318|FG004|Period 3|Lost to Follow-up|0|||
13293462|NCT00708123|26488314|FG000|Period 4|Protocol Violation|0|||
13293463|NCT00708123|26488315|FG001|Period 4|Protocol Violation|1|||
13293464|NCT00708123|26488316|FG002|Period 4|Protocol Violation|0|||
13293465|NCT00708123|26488317|FG003|Period 4|Protocol Violation|0|||
13293466|NCT00708123|26488318|FG004|Period 4|Protocol Violation|0|||
13293467|NCT00708097|26488354|FG000|Period 1|Protocol Violation|0|||
13293468|NCT00708097|26488355|FG001|Period 1|Protocol Violation|1|||
13293469|NCT00708097|26488356|FG002|Period 1|Protocol Violation|0|||
13293470|NCT00708097|26488357|FG003|Period 1|Protocol Violation|2|||
13293471|NCT00708097|26488358|FG004|Period 1|Protocol Violation|0|||
13293472|NCT00708097|26488354|FG000|Period 1|Other Reason|0|||
13293473|NCT00708097|26488355|FG001|Period 1|Other Reason|0|||
13293474|NCT00708097|26488356|FG002|Period 1|Other Reason|0|||
13293475|NCT00708097|26488357|FG003|Period 1|Other Reason|0|||
13293476|NCT00708097|26488358|FG004|Period 1|Other Reason|1|||
13293477|NCT00708097|26488354|FG000|Period 2|Protocol Violation|0|||
13293478|NCT00708097|26488355|FG001|Period 2|Protocol Violation|1|||
13293479|NCT00708097|26488356|FG002|Period 2|Protocol Violation|1|||
13293480|NCT00708097|26488357|FG003|Period 2|Protocol Violation|1|||
13293481|NCT00708097|26488358|FG004|Period 2|Protocol Violation|0|||
13293482|NCT00705783|26488393|FG000|Conversion Phase|Sponsor Discontinued Study|54|||
13293483|NCT00705783|26488394|FG001|Conversion Phase|Sponsor Discontinued Study|0|||
13293484|NCT00705783|26488395|FG002|Conversion Phase|Sponsor Discontinued Study|0|||
13293485|NCT00705783|26488393|FG000|Conversion Phase|Lost to Follow-up|13|||
13293486|NCT00705783|26488394|FG001|Conversion Phase|Lost to Follow-up|0|||
13293487|NCT00705783|26488395|FG002|Conversion Phase|Lost to Follow-up|0|||
13293488|NCT00705783|26488393|FG000|Conversion Phase|Met Withdrawal Criteria|4|||
13293489|NCT00705783|26488394|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
13293490|NCT00705783|26488395|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
13293491|NCT00705783|26488393|FG000|Conversion Phase|Withdrawn by Investigator|4|||
13293492|NCT00705783|26488394|FG001|Conversion Phase|Withdrawn by Investigator|0|||
13293493|NCT00705783|26488395|FG002|Conversion Phase|Withdrawn by Investigator|0|||
13293494|NCT00705783|26488393|FG000|Conversion Phase|Withdrew Consent|24|||
13293495|NCT00705783|26488394|FG001|Conversion Phase|Withdrew Consent|0|||
13293496|NCT00705783|26488395|FG002|Conversion Phase|Withdrew Consent|0|||
13293497|NCT00705783|26488393|FG000|Conversion Phase|Protocol Deviation|2|||
13293498|NCT00705783|26488394|FG001|Conversion Phase|Protocol Deviation|0|||
13293499|NCT00705783|26488395|FG002|Conversion Phase|Protocol Deviation|0|||
13293500|NCT00705783|26488393|FG000|Conversion Phase|Adverse Event|11|||
13293501|NCT00705783|26488394|FG001|Conversion Phase|Adverse Event|0|||
13293502|NCT00705783|26488395|FG002|Conversion Phase|Adverse Event|0|||
13293503|NCT00705783|26488393|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13|||
13293504|NCT00705783|26488394|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
13293505|NCT00705783|26488395|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
13293506|NCT00705783|26488393|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8|||
13293507|NCT00705783|26488394|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
13293508|NCT00705783|26488395|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
13293509|NCT00705783|26488393|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42|||
13293510|NCT00705783|26488394|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
13293511|NCT00705783|26488395|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
13293512|NCT00705783|26488393|FG000|Oral Stabilization Phase|Lost to Follow-up|7|||
13293513|NCT00705783|26488394|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
13293514|NCT00705783|26488395|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
13293515|NCT00705783|26488393|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19|||
13293516|NCT00705783|26488394|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
13293517|NCT00705783|26488395|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
13293518|NCT00705783|26488393|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12|||
13293519|NCT00705783|26488394|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
13293520|NCT00705783|26488395|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
13293521|NCT00705783|26488393|FG000|Oral Stabilization Phase|Withdrew Consent|29|||
13293522|NCT00705783|26488394|FG001|Oral Stabilization Phase|Withdrew Consent|0|||
13293523|NCT00705783|26488395|FG002|Oral Stabilization Phase|Withdrew Consent|0|||
13293524|NCT00705783|26488393|FG000|Oral Stabilization Phase|Adverse Event|14|||
13293525|NCT00705783|26488394|FG001|Oral Stabilization Phase|Adverse Event|0|||
13293526|NCT00705783|26488395|FG002|Oral Stabilization Phase|Adverse Event|0|||
13293527|NCT00705783|26488393|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7|||
13293528|NCT00705783|26488394|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
13293529|NCT00705783|26488395|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
13293530|NCT00705783|26488393|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4|||
13293531|NCT00705783|26488394|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
13293532|NCT00705783|26488395|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
13293533|NCT00705783|26488393|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86|||
13293534|NCT00705783|26488394|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
13293535|NCT00705783|26488395|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
13293536|NCT00705783|26488393|FG000|Depot Stabilization Phase|Lost to Follow-up|11|||
13293537|NCT00705783|26488394|FG001|Depot Stabilization Phase|Lost to Follow-up|0|||
13293538|NCT00705783|26488395|FG002|Depot Stabilization Phase|Lost to Follow-up|0|||
13293539|NCT00705783|26488393|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8|||
13293540|NCT00705783|26488394|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
13293541|NCT00705783|26488395|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
13293542|NCT00705783|26488393|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9|||
13293543|NCT00705783|26488394|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0|||
13293544|NCT00705783|26488395|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0|||
13293545|NCT00705783|26488393|FG000|Depot Stabilization Phase|Withdrew Consent|29|||
13293546|NCT00705783|26488394|FG001|Depot Stabilization Phase|Withdrew Consent|0|||
13293547|NCT00705783|26488395|FG002|Depot Stabilization Phase|Withdrew Consent|0|||
13293548|NCT00705783|26488393|FG000|Depot Stabilization Phase|Adverse Event|17|||
13293549|NCT00705783|26488394|FG001|Depot Stabilization Phase|Adverse Event|0|||
13293550|NCT00705783|26488395|FG002|Depot Stabilization Phase|Adverse Event|0|||
13293551|NCT00705783|26488393|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12|||
13293552|NCT00705783|26488394|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
13293553|NCT00705783|26488395|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
13293554|NCT00705783|26488393|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1|||
13293555|NCT00705783|26488394|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
13293556|NCT00705783|26488395|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
13293557|NCT00705783|26488393|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0|||
13293558|NCT00705783|26488394|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179|||
13293559|NCT00705783|26488395|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58|||
13293560|NCT00705783|26488393|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
13293561|NCT00705783|26488394|FG001|Depot Maintenance Phase|Lost to Follow-up|5|||
13293562|NCT00705783|26488395|FG002|Depot Maintenance Phase|Lost to Follow-up|3|||
13293563|NCT00705783|26488393|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
13293564|NCT00705783|26488394|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
13293565|NCT00705783|26488395|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
13293566|NCT00705783|26488393|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
13293567|NCT00705783|26488394|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
13293568|NCT00705783|26488395|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6|||
13293569|NCT00705783|26488393|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
13293570|NCT00705783|26488394|FG001|Depot Maintenance Phase|Withdrew Consent|14|||
13293571|NCT00705783|26488395|FG002|Depot Maintenance Phase|Withdrew Consent|4|||
13293572|NCT00705783|26488393|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
13293573|NCT00705783|26488394|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
13293574|NCT00705783|26488395|FG002|Depot Maintenance Phase|Protocol Deviation|0|||
13293575|NCT00705783|26488393|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
13293576|NCT00705783|26488394|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9|||
13293577|NCT00705783|26488395|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5|||
13293578|NCT00705783|26488393|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
13293579|NCT00705783|26488394|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11|||
13293580|NCT00705783|26488395|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
13293581|NCT00705783|26488393|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
13293582|NCT00705783|26488394|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16|||
13293583|NCT00705783|26488395|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40|||
13293584|NCT00700635|26488425|FG000|Overall Study|Adverse Event|1|||
13293585|NCT00700635|26488426|FG001|Overall Study|Adverse Event|0|||
13293586|NCT00700635|26488427|FG002|Overall Study|Adverse Event|0|||
13293587|NCT00700635|26488425|FG000|Overall Study|Lost to Follow-up|1|||
13293588|NCT00700635|26488426|FG001|Overall Study|Lost to Follow-up|3|||
13293589|NCT00700635|26488427|FG002|Overall Study|Lost to Follow-up|0|||
13293590|NCT00700635|26488425|FG000|Overall Study|Protocol Violation|2|||
13293591|NCT00700635|26488426|FG001|Overall Study|Protocol Violation|2|||
13293592|NCT00700635|26488427|FG002|Overall Study|Protocol Violation|0|||
13293593|NCT00700635|26488425|FG000|Overall Study|Withdrawal by Subject|7|||
13293594|NCT00700635|26488426|FG001|Overall Study|Withdrawal by Subject|3|||
13293595|NCT00700635|26488427|FG002|Overall Study|Withdrawal by Subject|1|||
13376821|NCT00783718|26733477|FG003|Induction Phase|Withdrawal by Subject|0|||
13376822|NCT00783718|26733478|FG004|Induction Phase|Withdrawal by Subject|0|||
13376823|NCT00783718|26733479|FG005|Induction Phase|Withdrawal by Subject|0|||
13376824|NCT00783718|26733480|FG006|Induction Phase|Withdrawal by Subject|0|||
13376825|NCT00783718|26733474|FG000|Induction Phase|Lost to Follow-up|1|||
13376826|NCT00783718|26733475|FG001|Induction Phase|Lost to Follow-up|0|||
13376827|NCT00783718|26733476|FG002|Induction Phase|Lost to Follow-up|1|||
13376828|NCT00783718|26733477|FG003|Induction Phase|Lost to Follow-up|0|||
13376829|NCT00783718|26733478|FG004|Induction Phase|Lost to Follow-up|0|||
13376830|NCT00783718|26733479|FG005|Induction Phase|Lost to Follow-up|0|||
13376831|NCT00783718|26733480|FG006|Induction Phase|Lost to Follow-up|0|||
13376832|NCT00783718|26733474|FG000|Maintenance Phase|Adverse Event|12|||
13376833|NCT00783718|26733475|FG001|Maintenance Phase|Adverse Event|0|||
13376834|NCT00783718|26733476|FG002|Maintenance Phase|Adverse Event|0|||
13376835|NCT00783718|26733477|FG003|Maintenance Phase|Adverse Event|15|||
13376836|NCT00783718|26733478|FG004|Maintenance Phase|Adverse Event|7|||
13376837|NCT00783718|26733479|FG005|Maintenance Phase|Adverse Event|6|||
13376838|NCT00783718|26733480|FG006|Maintenance Phase|Adverse Event|16|||
13376839|NCT00783718|26733474|FG000|Maintenance Phase|Protocol Violation|1|||
13376840|NCT00783718|26733475|FG001|Maintenance Phase|Protocol Violation|0|||
13293596|NCT04056299|26488442|FG000|Overall Study|Sponsor discontinued study|3|||
13293597|NCT04056299|26488443|FG001|Overall Study|Sponsor discontinued study|3|||
13293598|NCT04057937|26488485|FG000|Placebo-controlled Phase|Adverse Event|3|||
13293599|NCT04057937|26488486|FG001|Placebo-controlled Phase|Adverse Event|0|||
13293600|NCT04057937|26488485|FG000|Active-treatment Phase|Withdrawal by Subject|1|||
13293601|NCT04057937|26488486|FG001|Active-treatment Phase|Withdrawal by Subject|0|||
13293602|NCT04057937|26488485|FG000|Active-treatment Phase|Pregnancy|0|||
13293603|NCT04057937|26488486|FG001|Active-treatment Phase|Pregnancy|1|||
13293604|NCT04057937|26488485|FG000|Active-treatment Phase|Physician Decision|0|||
13293605|NCT04057937|26488486|FG001|Active-treatment Phase|Physician Decision|1|||
13293606|NCT01069939|26488539|FG000|Randomised and Included in the Analyses|Adverse Event|17|||
13293607|NCT01069939|26488540|FG001|Randomised and Included in the Analyses|Adverse Event|22|||
13293608|NCT01069939|26488539|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15|||
13293609|NCT01069939|26488540|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12|||
13293610|NCT01069939|26488539|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1|||
13293611|NCT01069939|26488540|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1|||
13293612|NCT01069939|26488539|FG000|Randomised and Included in the Analyses|Protocol Violation|0|||
13293613|NCT01069939|26488540|FG001|Randomised and Included in the Analyses|Protocol Violation|1|||
13293614|NCT01069939|26488539|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0|||
13293615|NCT01069939|26488540|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1|||
13293616|NCT01069939|26488539|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7|||
13293617|NCT01069939|26488540|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33|||
13293618|NCT01069939|26488539|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4|||
13293619|NCT01069939|26488540|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3|||
13293620|NCT01069939|26488539|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4|||
13293621|NCT01069939|26488540|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2|||
13293622|NCT01069939|26488539|FG000|Randomised and Included in the Analyses|Physician Decision|0|||
13293623|NCT01069939|26488540|FG001|Randomised and Included in the Analyses|Physician Decision|2|||
13293624|NCT01069939|26488539|FG000|Randomised and Included in the Analyses|Removal|1|||
13293625|NCT01069939|26488540|FG001|Randomised and Included in the Analyses|Removal|0|||
13293626|NCT01069900|26488591|FG000|Overall Study|Technical problems|0|||
13293627|NCT01069900|26488592|FG001|Overall Study|Technical problems|1|||
13293628|NCT01069900|26488591|FG000|Overall Study|Lost to Follow-up|7|||
13293629|NCT01069900|26488592|FG001|Overall Study|Lost to Follow-up|1|||
13293630|NCT01069900|26488591|FG000|Overall Study|Withdrawal by Subject|6|||
13293631|NCT01069900|26488592|FG001|Overall Study|Withdrawal by Subject|1|||
13293632|NCT01069900|26488591|FG000|Overall Study|Protocol Violation|4|||
13293633|NCT01069900|26488592|FG001|Overall Study|Protocol Violation|1|||
13293634|NCT01069900|26488591|FG000|Overall Study|Insufficient Therapeutic effect|1|||
13293635|NCT01069900|26488592|FG001|Overall Study|Insufficient Therapeutic effect|0|||
13293636|NCT01069705|26488609|FG000|Overall Study|Adverse Event|1|||
13293637|NCT01069705|26488609|FG000|Overall Study|Withdrawal by Subject|2|||
13293638|NCT01069627|26488632|FG000|Overall Study|Disease progression|7|||
13293639|NCT01069627|26488632|FG000|Overall Study|Adverse Event|12|||
13293640|NCT01069627|26488632|FG000|Overall Study|Protocol Violation|1|||
13293641|NCT01069523|26488647|FG000|Overall Study|Withdrawal by Subject|4|||
13293642|NCT01069523|26488648|FG001|Overall Study|Withdrawal by Subject|7|||
13293643|NCT01069419|26488657|FG000|Overall Study|Adverse Event|233|||
13293644|NCT01069419|26488657|FG000|Overall Study|Lack of Efficacy|332|||
13293645|NCT01069419|26488657|FG000|Overall Study|Lost to Follow-up|49|||
13293646|NCT01069419|26488657|FG000|Overall Study|Remission of disease|11|||
13293647|NCT01069419|26488657|FG000|Overall Study|Withdrawal by Subject|34|||
13293648|NCT01069419|26488657|FG000|Overall Study|Other Reason|43|||
13293649|NCT01069419|26488657|FG000|Overall Study|Missing termination information|13|||
13293650|NCT01069341|26488670|FG000|Overall Study|Lost to Follow-up|1|||
13376841|NCT00783718|26733476|FG002|Maintenance Phase|Protocol Violation|0|||
13376842|NCT00783718|26733477|FG003|Maintenance Phase|Protocol Violation|0|||
13376843|NCT00783718|26733478|FG004|Maintenance Phase|Protocol Violation|0|||
13376844|NCT00783718|26733479|FG005|Maintenance Phase|Protocol Violation|0|||
13376845|NCT00783718|26733480|FG006|Maintenance Phase|Protocol Violation|2|||
13376846|NCT00783718|26733474|FG000|Maintenance Phase|Lack of Efficacy|83|||
13376847|NCT00783718|26733475|FG001|Maintenance Phase|Lack of Efficacy|0|||
13376848|NCT00783718|26733476|FG002|Maintenance Phase|Lack of Efficacy|0|||
13376849|NCT00783718|26733477|FG003|Maintenance Phase|Lack of Efficacy|61|||
13376850|NCT00783718|26733478|FG004|Maintenance Phase|Lack of Efficacy|31|||
13376851|NCT00783718|26733479|FG005|Maintenance Phase|Lack of Efficacy|33|||
13376852|NCT00783718|26733480|FG006|Maintenance Phase|Lack of Efficacy|155|||
13376853|NCT00783718|26733474|FG000|Maintenance Phase|Withdrawal by Subject|6|||
13376854|NCT00783718|26733475|FG001|Maintenance Phase|Withdrawal by Subject|0|||
13376855|NCT00783718|26733476|FG002|Maintenance Phase|Withdrawal by Subject|0|||
13376856|NCT00783718|26733477|FG003|Maintenance Phase|Withdrawal by Subject|2|||
13393922|NCT00661713|26785143|FG004|Overall Study|Adverse Event|0|||
13293651|NCT01069289|26488715|FG000|Overall Study|Withdrawal by Subject|15|||
13293652|NCT01069289|26488716|FG001|Overall Study|Withdrawal by Subject|26|||
13293653|NCT01069289|26488715|FG000|Overall Study|Adverse Event|21|||
13293654|NCT01069289|26488716|FG001|Overall Study|Adverse Event|28|||
13293655|NCT01069289|26488715|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
13293656|NCT01069289|26488716|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
13293657|NCT01069289|26488715|FG000|Overall Study|Severe non-compliance to protocol|3|||
13293658|NCT01069289|26488716|FG001|Overall Study|Severe non-compliance to protocol|2|||
13293659|NCT01069289|26488715|FG000|Overall Study|Due to deteriorating health condition|1|||
13293660|NCT01069289|26488716|FG001|Overall Study|Due to deteriorating health condition|0|||
13293661|NCT01069172|26488727|FG000|Overall Study|Withdrawal by Subject|1|||
13293662|NCT01069172|26488728|FG001|Overall Study|Withdrawal by Subject|0|||
13293663|NCT01069120|26488740|FG000|Overall Study|Study prematurely terminated|27|||
13293664|NCT01068912|26488758|FG000|Overall Study|Adverse Event|2|||
13293665|NCT01068912|26488759|FG001|Overall Study|Adverse Event|3|||
13293666|NCT01068912|26488760|FG002|Overall Study|Adverse Event|2|||
13293667|NCT01068912|26488758|FG000|Overall Study|Withdrawal by Subject|5|||
13293668|NCT01068912|26488759|FG001|Overall Study|Withdrawal by Subject|6|||
13293669|NCT01068912|26488760|FG002|Overall Study|Withdrawal by Subject|6|||
13293670|NCT01068912|26488758|FG000|Overall Study|Lost to Follow-up|3|||
13293671|NCT01068912|26488759|FG001|Overall Study|Lost to Follow-up|7|||
13293672|NCT01068912|26488760|FG002|Overall Study|Lost to Follow-up|3|||
13293673|NCT01068912|26488758|FG000|Overall Study|Protocol Violation|0|||
13293674|NCT01068912|26488759|FG001|Overall Study|Protocol Violation|2|||
13293675|NCT01068912|26488760|FG002|Overall Study|Protocol Violation|0|||
13293676|NCT01068912|26488758|FG000|Overall Study|aggravation influenza|1|||
13293677|NCT01068912|26488759|FG001|Overall Study|aggravation influenza|1|||
13293678|NCT01068912|26488760|FG002|Overall Study|aggravation influenza|1|||
13293679|NCT01068912|26488758|FG000|Overall Study|other underlying illness|0|||
13293680|NCT01068912|26488759|FG001|Overall Study|other underlying illness|3|||
13293681|NCT01068912|26488760|FG002|Overall Study|other underlying illness|3|||
13293682|NCT01068860|26488963|FG000|Overall Study|Withdrawal by Subject|0|||
13293683|NCT01068860|26488964|FG001|Overall Study|Withdrawal by Subject|0|||
13293684|NCT01068860|26488965|FG002|Overall Study|Withdrawal by Subject|0|||
13293685|NCT01068860|26488966|FG003|Overall Study|Withdrawal by Subject|0|||
13293686|NCT01068860|26488967|FG004|Overall Study|Withdrawal by Subject|0|||
13293687|NCT01068860|26488968|FG005|Overall Study|Withdrawal by Subject|2|||
13293688|NCT01068860|26488969|FG006|Overall Study|Withdrawal by Subject|0|||
13293689|NCT01068860|26488970|FG007|Overall Study|Withdrawal by Subject|0|||
13293690|NCT01068860|26488971|FG008|Overall Study|Withdrawal by Subject|0|||
13293691|NCT01068860|26488972|FG009|Overall Study|Withdrawal by Subject|3|||
13293692|NCT01068860|26488963|FG000|Overall Study|Administrative problems; misrandomized|0|||
13293693|NCT01068860|26488964|FG001|Overall Study|Administrative problems; misrandomized|0|||
13293694|NCT01068860|26488965|FG002|Overall Study|Administrative problems; misrandomized|0|||
13293695|NCT01068860|26488966|FG003|Overall Study|Administrative problems; misrandomized|1|||
13293696|NCT01068860|26488967|FG004|Overall Study|Administrative problems; misrandomized|0|||
13293697|NCT01068860|26488968|FG005|Overall Study|Administrative problems; misrandomized|0|||
13293698|NCT01068860|26488969|FG006|Overall Study|Administrative problems; misrandomized|0|||
13293699|NCT01068860|26488970|FG007|Overall Study|Administrative problems; misrandomized|0|||
13293700|NCT01068860|26488971|FG008|Overall Study|Administrative problems; misrandomized|0|||
13293701|NCT01068860|26488972|FG009|Overall Study|Administrative problems; misrandomized|1|||
13293702|NCT01068860|26488963|FG000|Overall Study|Lost to Follow-up|0|||
13293703|NCT01068860|26488964|FG001|Overall Study|Lost to Follow-up|1|||
13293704|NCT01068860|26488965|FG002|Overall Study|Lost to Follow-up|0|||
13293705|NCT01068860|26488966|FG003|Overall Study|Lost to Follow-up|0|||
13293706|NCT01068860|26488967|FG004|Overall Study|Lost to Follow-up|0|||
13293707|NCT01068860|26488968|FG005|Overall Study|Lost to Follow-up|0|||
13293708|NCT01068860|26488969|FG006|Overall Study|Lost to Follow-up|0|||
13293709|NCT01068860|26488970|FG007|Overall Study|Lost to Follow-up|0|||
13293710|NCT01068860|26488971|FG008|Overall Study|Lost to Follow-up|0|||
13293711|NCT01068860|26488972|FG009|Overall Study|Lost to Follow-up|0|||
13293712|NCT01068769|26488979|FG000|Overall Study|Ineligible|1|||
13293713|NCT01068743|26489058|FG000|Period 3|Adverse Event|0|||
13293714|NCT01068743|26489059|FG001|Period 3|Adverse Event|1|||
13293715|NCT01068743|26489060|FG002|Period 3|Adverse Event|0|||
13293716|NCT01068743|26489061|FG003|Period 3|Adverse Event|0|||
13293717|NCT01068730|26489120|FG000|Period 3|Personal reason|1|||
13293718|NCT01068730|26489121|FG001|Period 3|Personal reason|0|||
13293719|NCT01068730|26489122|FG002|Period 3|Personal reason|0|||
13293720|NCT01068730|26489123|FG003|Period 3|Personal reason|0|||
13293721|NCT01068730|26489120|FG000|Period 4|Family emergency|0|||
13293722|NCT01068730|26489121|FG001|Period 4|Family emergency|1|||
13293723|NCT01068730|26489122|FG002|Period 4|Family emergency|0|||
13293724|NCT01068730|26489123|FG003|Period 4|Family emergency|0|||
13293725|NCT01068717|26489182|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1|||
13293726|NCT01068717|26489183|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
13293727|NCT01068717|26489184|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
13293728|NCT01068717|26489185|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
13293729|NCT01068678|26489200|FG000|Overall Study|Lack of Efficacy|3|||
13293730|NCT01068678|26489201|FG001|Overall Study|Lack of Efficacy|2|||
13293731|NCT01068678|26489200|FG000|Overall Study|Protocol Violation|5|||
13293732|NCT01068678|26489201|FG001|Overall Study|Protocol Violation|1|||
13293733|NCT01068678|26489200|FG000|Overall Study|Withdrawal criteria|12|||
13293734|NCT01068678|26489201|FG001|Overall Study|Withdrawal criteria|6|||
13293735|NCT01068678|26489200|FG000|Overall Study|Unclassified|18|||
13293736|NCT01068678|26489201|FG001|Overall Study|Unclassified|15|||
13293737|NCT01068652|26489246|FG000|Overall Study|Adverse Event|4|||
13293738|NCT01068652|26489247|FG001|Overall Study|Adverse Event|0|||
13293739|NCT01068652|26489246|FG000|Overall Study|Lack of Efficacy|0|||
13293740|NCT01068652|26489247|FG001|Overall Study|Lack of Efficacy|2|||
13293741|NCT01068652|26489246|FG000|Overall Study|Lost to Follow-up|2|||
13293742|NCT01068652|26489247|FG001|Overall Study|Lost to Follow-up|1|||
13293743|NCT01068652|26489246|FG000|Overall Study|Protocol Violation|3|||
13293744|NCT01068652|26489247|FG001|Overall Study|Protocol Violation|6|||
13293745|NCT01068652|26489246|FG000|Overall Study|Withdrawal criteria|1|||
13293746|NCT01068652|26489247|FG001|Overall Study|Withdrawal criteria|2|||
13293747|NCT01068652|26489246|FG000|Overall Study|Patient was not eligible|1|||
13293748|NCT01068652|26489247|FG001|Overall Study|Patient was not eligible|0|||
13293749|NCT01068652|26489246|FG000|Overall Study|Unclassified|7|||
13293750|NCT01068652|26489247|FG001|Overall Study|Unclassified|4|||
13293751|NCT01068626|26489270|FG000|Overall Study|Adverse Event|3|||
13293752|NCT01068626|26489271|FG001|Overall Study|Adverse Event|0|||
13293753|NCT01068626|26489270|FG000|Overall Study|Withdrawal by Subject|0|||
13293754|NCT01068626|26489271|FG001|Overall Study|Withdrawal by Subject|2|||
13293755|NCT01068600|26489286|FG000|Overall Study|Withdrawal by Subject|5|||
13293756|NCT01068600|26489287|FG001|Overall Study|Withdrawal by Subject|6|||
13293757|NCT01068600|26489286|FG000|Overall Study|Adverse Event|3|||
13293758|NCT01068600|26489287|FG001|Overall Study|Adverse Event|3|||
13293759|NCT01068600|26489286|FG000|Overall Study|Abnormal laboratory value(s)|1|||
13293760|NCT01068600|26489287|FG001|Overall Study|Abnormal laboratory value(s)|0|||
13293761|NCT01068600|26489286|FG000|Overall Study|Lost to Follow-up|1|||
13293762|NCT01068600|26489287|FG001|Overall Study|Lost to Follow-up|2|||
13293763|NCT01068600|26489286|FG000|Overall Study|Protocol deviation|1|||
13293764|NCT01068600|26489287|FG001|Overall Study|Protocol deviation|1|||
13293765|NCT01068600|26489286|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
13293766|NCT01068600|26489287|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
13293767|NCT01068600|26489286|FG000|Overall Study|Administrative problems|0|||
13293768|NCT01068600|26489287|FG001|Overall Study|Administrative problems|1|||
13293769|NCT01068418|26489294|FG000|Overall Study|Physician Decision|12|||
13293770|NCT01068262|26489335|FG000|Overall Study|Adverse Event|2|||
13293771|NCT01068262|26489336|FG001|Overall Study|Adverse Event|0|||
13293772|NCT01068262|26489337|FG002|Overall Study|Adverse Event|1|||
13293773|NCT01068262|26489338|FG003|Overall Study|Adverse Event|0|||
13293774|NCT01068262|26489335|FG000|Overall Study|Protocol Violation|1|||
13293775|NCT01068262|26489336|FG001|Overall Study|Protocol Violation|0|||
13293776|NCT01068262|26489337|FG002|Overall Study|Protocol Violation|0|||
13293777|NCT01068262|26489338|FG003|Overall Study|Protocol Violation|0|||
13293778|NCT01068262|26489335|FG000|Overall Study|Withdrawal by Subject|0|||
13293779|NCT01068262|26489336|FG001|Overall Study|Withdrawal by Subject|1|||
13293780|NCT01068262|26489337|FG002|Overall Study|Withdrawal by Subject|0|||
13293781|NCT01068262|26489338|FG003|Overall Study|Withdrawal by Subject|0|||
13293782|NCT01068158|26489357|FG000|Overall Study|Withdrawal by Subject|1|||
13293783|NCT01068158|26489358|FG001|Overall Study|Withdrawal by Subject|2|||
13293784|NCT01068158|26489357|FG000|Overall Study|Lost to Follow-up|7|||
13293785|NCT01068158|26489358|FG001|Overall Study|Lost to Follow-up|0|||
13293786|NCT01068158|26489357|FG000|Overall Study|Protocol Violation|0|||
13293787|NCT01068158|26489358|FG001|Overall Study|Protocol Violation|2|||
13293788|NCT01067976|26489419|FG000|Overall Study|Study drug never administered|20|||
13293789|NCT01067976|26489419|FG000|Overall Study|Study prematurely discontinued|2|||
13293790|NCT01067846|26489434|FG000|Overall Study|Lost to Follow-up|17|||
13293791|NCT01067846|26489435|FG001|Overall Study|Lost to Follow-up|19|||
13293792|NCT01067846|26489434|FG000|Overall Study|Withdrawal by Subject|1|||
13293793|NCT01067846|26489435|FG001|Overall Study|Withdrawal by Subject|0|||
13293794|NCT01067846|26489434|FG000|Overall Study|participation in other tx study|1|||
13293795|NCT01067846|26489435|FG001|Overall Study|participation in other tx study|0|||
13293796|NCT01067508|26489448|FG000|Overall Study|Physician Decision|0|||
13293797|NCT01067508|26489449|FG001|Overall Study|Physician Decision|1|||
13293798|NCT01067508|26489448|FG000|Overall Study|Withdrawal by Subject|0|||
13293799|NCT01067508|26489449|FG001|Overall Study|Withdrawal by Subject|1|||
13293800|NCT01067469|26489472|FG000|Overall Study|Withdrawal by Subject|0|||
13293801|NCT01067469|26489473|FG001|Overall Study|Withdrawal by Subject|1|||
13293802|NCT01067469|26489472|FG000|Overall Study|Disease Progression|0|||
13293803|NCT01067469|26489473|FG001|Overall Study|Disease Progression|1|||
13293804|NCT01067352|26489497|FG000|Overall Study|Withdrawal by Subject|1|||
13293805|NCT01067352|26489498|FG001|Overall Study|Withdrawal by Subject|2|||
13293806|NCT01067352|26489499|FG002|Overall Study|Withdrawal by Subject|1|||
13293807|NCT01067352|26489497|FG000|Overall Study|Physician Decision|0|||
13293808|NCT01067352|26489498|FG001|Overall Study|Physician Decision|1|||
13293809|NCT01067352|26489499|FG002|Overall Study|Physician Decision|0|||
13293810|NCT01067339|26489514|FG000|Overall Study|Withdrawal by Subject|6|||
13293811|NCT01067339|26489515|FG001|Overall Study|Withdrawal by Subject|5|||
13293812|NCT01067105|26489534|FG000|Overall Study|Adverse Event|14|||
13293813|NCT01067105|26489534|FG000|Overall Study|Protocol Violation|48|||
13293814|NCT01067105|26489534|FG000|Overall Study|Withdrawal by Subject|36|||
13293815|NCT01067105|26489534|FG000|Overall Study|Lost to Follow-up|6|||
13293816|NCT01067105|26489534|FG000|Overall Study|Physician Decision|6|||
13293817|NCT01067105|26489534|FG000|Overall Study|Other|31|||
13293818|NCT01066936|26489568|FG000|Overall Study|Death|2|||
13293819|NCT01066936|26489568|FG000|Overall Study|Device revised/removed|1|||
13293820|NCT01066936|26489568|FG000|Overall Study|Lost to Follow-up|3|||
13293821|NCT01066936|26489568|FG000|Overall Study|Withdrawal by Subject|4|||
13293822|NCT01066923|26489603|FG000|Overall Study|Withdrawal by Subject|3|||
13293823|NCT01066923|26489604|FG001|Overall Study|Withdrawal by Subject|3|||
13293824|NCT01066923|26489605|FG002|Overall Study|Withdrawal by Subject|8|||
13293825|NCT01066923|26489606|FG003|Overall Study|Withdrawal by Subject|8|||
13293826|NCT01066897|26489623|FG000|Overall Study|Withdrawal by Subject|1|||
13293827|NCT01066897|26489624|FG001|Overall Study|Withdrawal by Subject|0|||
13293828|NCT01066897|26489623|FG000|Overall Study|stopped study after developing the flu.|1|||
13293829|NCT01066897|26489624|FG001|Overall Study|stopped study after developing the flu.|0|||
13293830|NCT01066871|26489695|FG000|Overall Study|Lost to Follow-up|0|||
13293831|NCT01066871|26489696|FG001|Overall Study|Lost to Follow-up|2|||
13293832|NCT01066871|26489697|FG002|Overall Study|Lost to Follow-up|2|||
13293833|NCT01066871|26489698|FG003|Overall Study|Lost to Follow-up|0|||
13293834|NCT01066871|26489695|FG000|Overall Study|Protocol Violation|1|||
13293835|NCT01066871|26489696|FG001|Overall Study|Protocol Violation|0|||
13293836|NCT01066871|26489697|FG002|Overall Study|Protocol Violation|3|||
13293837|NCT01066871|26489698|FG003|Overall Study|Protocol Violation|2|||
13293838|NCT01066871|26489695|FG000|Overall Study|Lack of Efficacy|0|||
13293839|NCT01066871|26489696|FG001|Overall Study|Lack of Efficacy|0|||
13293840|NCT01066871|26489697|FG002|Overall Study|Lack of Efficacy|0|||
13293841|NCT01066871|26489698|FG003|Overall Study|Lack of Efficacy|1|||
13293842|NCT01066871|26489695|FG000|Overall Study|Withdrawal by Subject|3|||
13293843|NCT01066871|26489696|FG001|Overall Study|Withdrawal by Subject|1|||
13293844|NCT01066871|26489697|FG002|Overall Study|Withdrawal by Subject|0|||
13293845|NCT01066871|26489698|FG003|Overall Study|Withdrawal by Subject|0|||
13293846|NCT01066871|26489695|FG000|Overall Study|Other|0|||
13293847|NCT01066871|26489696|FG001|Overall Study|Other|2|||
13293848|NCT01066871|26489697|FG002|Overall Study|Other|1|||
13293849|NCT01066871|26489698|FG003|Overall Study|Other|2|||
13293850|NCT01066819|26489852|FG000|Overall Study|Adverse Event|18|||
13293851|NCT01066819|26489853|FG001|Overall Study|Adverse Event|1|||
13293852|NCT01066819|26489854|FG002|Overall Study|Adverse Event|6|||
13293853|NCT01066819|26489855|FG003|Overall Study|Adverse Event|0|||
13293854|NCT01066819|26489856|FG004|Overall Study|Adverse Event|0|||
13293855|NCT01066819|26489857|FG005|Overall Study|Adverse Event|0|||
13293856|NCT01066819|26489852|FG000|Overall Study|Death|5|||
13293857|NCT01066819|26489853|FG001|Overall Study|Death|0|||
13293858|NCT01066819|26489854|FG002|Overall Study|Death|1|||
13293859|NCT01066819|26489855|FG003|Overall Study|Death|0|||
13293860|NCT01066819|26489856|FG004|Overall Study|Death|0|||
13293861|NCT01066819|26489857|FG005|Overall Study|Death|0|||
13293862|NCT01066819|26489852|FG000|Overall Study|Lack of Efficacy|22|||
13293863|NCT01066819|26489853|FG001|Overall Study|Lack of Efficacy|1|||
13293864|NCT01066819|26489854|FG002|Overall Study|Lack of Efficacy|2|||
13293865|NCT01066819|26489855|FG003|Overall Study|Lack of Efficacy|1|||
13293866|NCT01066819|26489856|FG004|Overall Study|Lack of Efficacy|0|||
13293867|NCT01066819|26489857|FG005|Overall Study|Lack of Efficacy|0|||
13293868|NCT01066819|26489852|FG000|Overall Study|Physician Decision|6|||
13293869|NCT01066819|26489853|FG001|Overall Study|Physician Decision|2|||
13293870|NCT01066819|26489854|FG002|Overall Study|Physician Decision|3|||
13293871|NCT01066819|26489855|FG003|Overall Study|Physician Decision|0|||
13293872|NCT01066819|26489856|FG004|Overall Study|Physician Decision|0|||
13293873|NCT01066819|26489857|FG005|Overall Study|Physician Decision|0|||
13293874|NCT01066819|26489852|FG000|Overall Study|Protocol Violation|12|||
13293875|NCT01066819|26489853|FG001|Overall Study|Protocol Violation|6|||
13293876|NCT01066819|26489854|FG002|Overall Study|Protocol Violation|0|||
13293877|NCT01066819|26489855|FG003|Overall Study|Protocol Violation|0|||
13293878|NCT01066819|26489856|FG004|Overall Study|Protocol Violation|0|||
13293879|NCT01066819|26489857|FG005|Overall Study|Protocol Violation|0|||
13293880|NCT01066819|26489852|FG000|Overall Study|Withdrawal by Subject|29|||
13293881|NCT01066819|26489853|FG001|Overall Study|Withdrawal by Subject|11|||
13293882|NCT01066819|26489854|FG002|Overall Study|Withdrawal by Subject|6|||
13293883|NCT01066819|26489855|FG003|Overall Study|Withdrawal by Subject|0|||
13293884|NCT01066819|26489856|FG004|Overall Study|Withdrawal by Subject|0|||
13293885|NCT01066819|26489857|FG005|Overall Study|Withdrawal by Subject|0|||
13293886|NCT01066819|26489852|FG000|Overall Study|Administrative|6|||
13293887|NCT01066819|26489853|FG001|Overall Study|Administrative|4|||
13293888|NCT01066819|26489854|FG002|Overall Study|Administrative|2|||
13293889|NCT01066819|26489855|FG003|Overall Study|Administrative|0|||
13293890|NCT01066819|26489856|FG004|Overall Study|Administrative|0|||
13293891|NCT01066819|26489857|FG005|Overall Study|Administrative|0|||
13293892|NCT01066819|26489852|FG000|Overall Study|Not met inclusion/exclusion criteria|1|||
13293893|NCT01066819|26489853|FG001|Overall Study|Not met inclusion/exclusion criteria|0|||
13293894|NCT01066819|26489854|FG002|Overall Study|Not met inclusion/exclusion criteria|0|||
13293895|NCT01066819|26489855|FG003|Overall Study|Not met inclusion/exclusion criteria|0|||
13293896|NCT01066819|26489856|FG004|Overall Study|Not met inclusion/exclusion criteria|0|||
13293897|NCT01066819|26489857|FG005|Overall Study|Not met inclusion/exclusion criteria|0|||
13293898|NCT01066819|26489852|FG000|Overall Study|Early termination|2|||
13293899|NCT01066819|26489853|FG001|Overall Study|Early termination|0|||
13293900|NCT01066819|26489854|FG002|Overall Study|Early termination|0|||
13293901|NCT01066819|26489855|FG003|Overall Study|Early termination|0|||
13293902|NCT01066819|26489856|FG004|Overall Study|Early termination|0|||
13293903|NCT01066819|26489857|FG005|Overall Study|Early termination|0|||
13293904|NCT01066819|26489852|FG000|Overall Study|Failed to return|298|||
13293905|NCT01066819|26489853|FG001|Overall Study|Failed to return|107|||
13293906|NCT01066819|26489854|FG002|Overall Study|Failed to return|68|||
13293907|NCT01066819|26489855|FG003|Overall Study|Failed to return|7|||
13293908|NCT01066819|26489856|FG004|Overall Study|Failed to return|2|||
13293909|NCT01066819|26489857|FG005|Overall Study|Failed to return|3|||
13293910|NCT01066819|26489852|FG000|Overall Study|Lab test not done|9|||
13293911|NCT01066819|26489853|FG001|Overall Study|Lab test not done|0|||
13293912|NCT01066819|26489854|FG002|Overall Study|Lab test not done|2|||
13293913|NCT01066819|26489855|FG003|Overall Study|Lab test not done|1|||
13293914|NCT01066819|26489856|FG004|Overall Study|Lab test not done|0|||
13293915|NCT01066819|26489857|FG005|Overall Study|Lab test not done|0|||
13293916|NCT01066819|26489852|FG000|Overall Study|Miscellaneous|28|||
13293917|NCT01066819|26489853|FG001|Overall Study|Miscellaneous|10|||
13293918|NCT01066819|26489854|FG002|Overall Study|Miscellaneous|18|||
13293919|NCT01066819|26489855|FG003|Overall Study|Miscellaneous|1|||
13293920|NCT01066819|26489856|FG004|Overall Study|Miscellaneous|0|||
13293921|NCT01066819|26489857|FG005|Overall Study|Miscellaneous|0|||
13293922|NCT01066819|26489852|FG000|Overall Study|Non responders|123|||
13293923|NCT01066819|26489853|FG001|Overall Study|Non responders|2|||
13293924|NCT01066819|26489854|FG002|Overall Study|Non responders|7|||
13293925|NCT01066819|26489855|FG003|Overall Study|Non responders|2|||
13293926|NCT01066819|26489856|FG004|Overall Study|Non responders|0|||
13293927|NCT01066819|26489857|FG005|Overall Study|Non responders|1|||
13293928|NCT01066819|26489852|FG000|Overall Study|Not categorised|9|||
13293929|NCT01066819|26489853|FG001|Overall Study|Not categorised|2|||
13293930|NCT01066819|26489854|FG002|Overall Study|Not categorised|6|||
13293931|NCT01066819|26489855|FG003|Overall Study|Not categorised|1|||
13293932|NCT01066819|26489856|FG004|Overall Study|Not categorised|0|||
13293933|NCT01066819|26489857|FG005|Overall Study|Not categorised|0|||
13293934|NCT01066819|26489852|FG000|Overall Study|Relapse|16|||
13293935|NCT01066819|26489853|FG001|Overall Study|Relapse|4|||
13293936|NCT01066819|26489854|FG002|Overall Study|Relapse|3|||
13293937|NCT01066819|26489855|FG003|Overall Study|Relapse|0|||
13293938|NCT01066819|26489856|FG004|Overall Study|Relapse|0|||
13293939|NCT01066819|26489857|FG005|Overall Study|Relapse|0|||
13293940|NCT01066819|26489852|FG000|Overall Study|Results not available|1|||
13293941|NCT01066819|26489853|FG001|Overall Study|Results not available|0|||
13293942|NCT01066819|26489854|FG002|Overall Study|Results not available|0|||
13293943|NCT01066819|26489855|FG003|Overall Study|Results not available|0|||
13293944|NCT01066819|26489856|FG004|Overall Study|Results not available|0|||
13293945|NCT01066819|26489857|FG005|Overall Study|Results not available|0|||
13293946|NCT01066819|26489852|FG000|Overall Study|Screen failure|1|||
13293947|NCT01066819|26489853|FG001|Overall Study|Screen failure|0|||
13293948|NCT01066819|26489854|FG002|Overall Study|Screen failure|0|||
13293949|NCT01066819|26489855|FG003|Overall Study|Screen failure|0|||
13293950|NCT01066819|26489856|FG004|Overall Study|Screen failure|0|||
13293951|NCT01066819|26489857|FG005|Overall Study|Screen failure|0|||
13293952|NCT01066819|26489852|FG000|Overall Study|Spontaneous cure|1|||
13293953|NCT01066819|26489853|FG001|Overall Study|Spontaneous cure|0|||
13293954|NCT01066819|26489854|FG002|Overall Study|Spontaneous cure|0|||
13293955|NCT01066819|26489855|FG003|Overall Study|Spontaneous cure|0|||
13293956|NCT01066819|26489856|FG004|Overall Study|Spontaneous cure|0|||
13293957|NCT01066819|26489857|FG005|Overall Study|Spontaneous cure|0|||
13293958|NCT01066819|26489852|FG000|Overall Study|Treatment never started|85|||
13293959|NCT01066819|26489853|FG001|Overall Study|Treatment never started|19|||
13293960|NCT01066819|26489854|FG002|Overall Study|Treatment never started|19|||
13293961|NCT01066819|26489855|FG003|Overall Study|Treatment never started|3|||
13293962|NCT01066819|26489856|FG004|Overall Study|Treatment never started|2|||
13293963|NCT01066819|26489857|FG005|Overall Study|Treatment never started|2|||
13293964|NCT01066819|26489852|FG000|Overall Study|Treatment stopped|12|||
13293965|NCT01066819|26489853|FG001|Overall Study|Treatment stopped|1|||
13293966|NCT01066819|26489854|FG002|Overall Study|Treatment stopped|2|||
13293967|NCT01066819|26489855|FG003|Overall Study|Treatment stopped|1|||
13293968|NCT01066819|26489856|FG004|Overall Study|Treatment stopped|0|||
13293969|NCT01066819|26489857|FG005|Overall Study|Treatment stopped|0|||
13293970|NCT01066819|26489852|FG000|Overall Study|Other|5|||
13293971|NCT01066819|26489853|FG001|Overall Study|Other|1|||
13293972|NCT01066819|26489854|FG002|Overall Study|Other|1|||
13293973|NCT01066819|26489855|FG003|Overall Study|Other|0|||
13293974|NCT01066819|26489856|FG004|Overall Study|Other|0|||
13293975|NCT01066819|26489857|FG005|Overall Study|Other|0|||
13293976|NCT01066793|26490016|FG000|Overall Study|Death|4|||
13293977|NCT01066793|26490017|FG001|Overall Study|Death|1|||
13293978|NCT01066793|26490018|FG002|Overall Study|Death|1|||
13293979|NCT01066793|26490019|FG003|Overall Study|Death|0|||
13293980|NCT01066793|26490020|FG004|Overall Study|Death|0|||
13293981|NCT01066793|26490021|FG005|Overall Study|Death|0|||
13293982|NCT01066793|26490016|FG000|Overall Study|Lack of Efficacy|2|||
13293983|NCT01066793|26490017|FG001|Overall Study|Lack of Efficacy|1|||
13293984|NCT01066793|26490018|FG002|Overall Study|Lack of Efficacy|0|||
13293985|NCT01066793|26490019|FG003|Overall Study|Lack of Efficacy|0|||
13293986|NCT01066793|26490020|FG004|Overall Study|Lack of Efficacy|0|||
13293987|NCT01066793|26490021|FG005|Overall Study|Lack of Efficacy|0|||
13293988|NCT01066793|26490016|FG000|Overall Study|Lost to Follow-up|180|||
13293989|NCT01066793|26490017|FG001|Overall Study|Lost to Follow-up|39|||
13293990|NCT01066793|26490018|FG002|Overall Study|Lost to Follow-up|82|||
13293991|NCT01066793|26490019|FG003|Overall Study|Lost to Follow-up|16|||
13293992|NCT01066793|26490020|FG004|Overall Study|Lost to Follow-up|0|||
13293993|NCT01066793|26490021|FG005|Overall Study|Lost to Follow-up|1|||
13293994|NCT01066793|26490016|FG000|Overall Study|Physician Decision|3|||
13293995|NCT01066793|26490017|FG001|Overall Study|Physician Decision|0|||
13293996|NCT01066793|26490018|FG002|Overall Study|Physician Decision|0|||
13293997|NCT01066793|26490019|FG003|Overall Study|Physician Decision|0|||
13293998|NCT01066793|26490020|FG004|Overall Study|Physician Decision|0|||
13293999|NCT01066793|26490021|FG005|Overall Study|Physician Decision|0|||
13294000|NCT01066793|26490016|FG000|Overall Study|Protocol Violation|3|||
13294001|NCT01066793|26490017|FG001|Overall Study|Protocol Violation|2|||
13294002|NCT01066793|26490018|FG002|Overall Study|Protocol Violation|2|||
13294003|NCT01066793|26490019|FG003|Overall Study|Protocol Violation|0|||
13294004|NCT01066793|26490020|FG004|Overall Study|Protocol Violation|0|||
13294005|NCT01066793|26490021|FG005|Overall Study|Protocol Violation|0|||
13294006|NCT01066793|26490016|FG000|Overall Study|Withdrawal by Subject|7|||
13294007|NCT01066793|26490017|FG001|Overall Study|Withdrawal by Subject|4|||
13294008|NCT01066793|26490018|FG002|Overall Study|Withdrawal by Subject|1|||
13294009|NCT01066793|26490019|FG003|Overall Study|Withdrawal by Subject|0|||
13294010|NCT01066793|26490020|FG004|Overall Study|Withdrawal by Subject|0|||
13294011|NCT01066793|26490021|FG005|Overall Study|Withdrawal by Subject|0|||
13294012|NCT01066793|26490016|FG000|Overall Study|Early Termination|3|||
13294013|NCT01066793|26490017|FG001|Overall Study|Early Termination|0|||
13294014|NCT01066793|26490018|FG002|Overall Study|Early Termination|0|||
13294015|NCT01066793|26490019|FG003|Overall Study|Early Termination|0|||
13294016|NCT01066793|26490020|FG004|Overall Study|Early Termination|0|||
13294017|NCT01066793|26490021|FG005|Overall Study|Early Termination|0|||
13294018|NCT01066793|26490016|FG000|Overall Study|Lab test not done|7|||
13294019|NCT01066793|26490017|FG001|Overall Study|Lab test not done|0|||
13294020|NCT01066793|26490018|FG002|Overall Study|Lab test not done|0|||
13294021|NCT01066793|26490019|FG003|Overall Study|Lab test not done|1|||
13294022|NCT01066793|26490020|FG004|Overall Study|Lab test not done|0|||
13294023|NCT01066793|26490021|FG005|Overall Study|Lab test not done|0|||
13294024|NCT01066793|26490016|FG000|Overall Study|Miscellaneous|4|||
13294025|NCT01066793|26490017|FG001|Overall Study|Miscellaneous|5|||
13294026|NCT01066793|26490018|FG002|Overall Study|Miscellaneous|6|||
13294027|NCT01066793|26490019|FG003|Overall Study|Miscellaneous|0|||
13294028|NCT01066793|26490020|FG004|Overall Study|Miscellaneous|0|||
13294029|NCT01066793|26490021|FG005|Overall Study|Miscellaneous|0|||
13294030|NCT01066793|26490016|FG000|Overall Study|Non-responders|104|||
13294031|NCT01066793|26490017|FG001|Overall Study|Non-responders|5|||
13294032|NCT01066793|26490018|FG002|Overall Study|Non-responders|11|||
13294033|NCT01066793|26490019|FG003|Overall Study|Non-responders|25|||
13294034|NCT01066793|26490020|FG004|Overall Study|Non-responders|0|||
13294035|NCT01066793|26490021|FG005|Overall Study|Non-responders|0|||
13376857|NCT00783718|26733478|FG004|Maintenance Phase|Withdrawal by Subject|5|||
13294036|NCT01066793|26490016|FG000|Overall Study|Other|15|||
13294037|NCT01066793|26490017|FG001|Overall Study|Other|5|||
13294038|NCT01066793|26490018|FG002|Overall Study|Other|6|||
13294039|NCT01066793|26490019|FG003|Overall Study|Other|2|||
13294040|NCT01066793|26490020|FG004|Overall Study|Other|0|||
13294041|NCT01066793|26490021|FG005|Overall Study|Other|0|||
13294042|NCT01066793|26490016|FG000|Overall Study|Relapse|20|||
13294043|NCT01066793|26490017|FG001|Overall Study|Relapse|8|||
13294044|NCT01066793|26490018|FG002|Overall Study|Relapse|2|||
13294045|NCT01066793|26490019|FG003|Overall Study|Relapse|3|||
13294046|NCT01066793|26490020|FG004|Overall Study|Relapse|0|||
13294047|NCT01066793|26490021|FG005|Overall Study|Relapse|0|||
13294048|NCT01066793|26490016|FG000|Overall Study|Result Not Available|1|||
13294049|NCT01066793|26490017|FG001|Overall Study|Result Not Available|0|||
13294050|NCT01066793|26490018|FG002|Overall Study|Result Not Available|0|||
13294051|NCT01066793|26490019|FG003|Overall Study|Result Not Available|0|||
13294052|NCT01066793|26490020|FG004|Overall Study|Result Not Available|0|||
13294053|NCT01066793|26490021|FG005|Overall Study|Result Not Available|0|||
13294054|NCT01066793|26490016|FG000|Overall Study|Treatment Interrupted|1|||
13294055|NCT01066793|26490017|FG001|Overall Study|Treatment Interrupted|1|||
13294056|NCT01066793|26490018|FG002|Overall Study|Treatment Interrupted|0|||
13294057|NCT01066793|26490019|FG003|Overall Study|Treatment Interrupted|0|||
13294058|NCT01066793|26490020|FG004|Overall Study|Treatment Interrupted|0|||
13294059|NCT01066793|26490021|FG005|Overall Study|Treatment Interrupted|0|||
13294060|NCT01066793|26490016|FG000|Overall Study|Treatment Never Started|18|||
13294061|NCT01066793|26490017|FG001|Overall Study|Treatment Never Started|5|||
13294062|NCT01066793|26490018|FG002|Overall Study|Treatment Never Started|4|||
13294063|NCT01066793|26490019|FG003|Overall Study|Treatment Never Started|1|||
13294064|NCT01066793|26490020|FG004|Overall Study|Treatment Never Started|0|||
13294065|NCT01066793|26490021|FG005|Overall Study|Treatment Never Started|0|||
13294066|NCT01066793|26490016|FG000|Overall Study|Treatment Stopped|2|||
13294067|NCT01066793|26490017|FG001|Overall Study|Treatment Stopped|1|||
13294068|NCT01066793|26490018|FG002|Overall Study|Treatment Stopped|0|||
13294069|NCT01066793|26490019|FG003|Overall Study|Treatment Stopped|1|||
13294070|NCT01066793|26490020|FG004|Overall Study|Treatment Stopped|0|||
13294071|NCT01066793|26490021|FG005|Overall Study|Treatment Stopped|0|||
13294072|NCT01066780|26490028|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
13294073|NCT01066780|26490029|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
13294074|NCT01066585|26490048|FG000|Overall Study|Protocol Violation|1|||
13294075|NCT01066585|26490049|FG001|Overall Study|Protocol Violation|0|||
13294076|NCT01066585|26490048|FG000|Overall Study|Withdrawal by Subject|0|||
13294077|NCT01066585|26490049|FG001|Overall Study|Withdrawal by Subject|3|||
13294078|NCT01066156|26490055|FG000|Overall Study|ineligible|2|||
13294079|NCT01066156|26490055|FG000|Overall Study|Lost to Follow-up|7|||
13294080|NCT01066156|26490055|FG000|Overall Study|Withdrawal by Subject|1|||
13294081|NCT01066143|26490061|FG000|Overall Study|ineligible for the study|8|||
13294082|NCT01066104|26490076|FG000|Overall Study|Adverse Event|1|||
13294083|NCT01066104|26490077|FG001|Overall Study|Adverse Event|1|||
13294084|NCT01066104|26490076|FG000|Overall Study|Protocol Violation|1|||
13294085|NCT01066104|26490077|FG001|Overall Study|Protocol Violation|0|||
13294086|NCT01066052|26490095|FG000|Overall Study|Enrolled But Not Treated|3|||
13294087|NCT01066052|26490096|FG001|Overall Study|Enrolled But Not Treated|0|||
13294088|NCT01066039|26490111|FG000|Overall Study|Adverse Event|6|||
13294089|NCT01066039|26490111|FG000|Overall Study|Withdrawal by Subject|17|||
13294090|NCT01066039|26490111|FG000|Overall Study|Protocol Violation|2|||
13294091|NCT01066039|26490111|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9|||
13294092|NCT01066039|26490111|FG000|Overall Study|Investigator's Request|1|||
13294093|NCT01066039|26490111|FG000|Overall Study|Dropout due to Insulin Administration|1|||
13294094|NCT01066039|26490111|FG000|Overall Study|Additional Antihypertensive Required|4|||
13294095|NCT01066039|26490111|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2|||
13294096|NCT01066039|26490111|FG000|Overall Study|Failure to Control Blood Pressure|1|||
13294097|NCT01066039|26490111|FG000|Overall Study|Drug/Dose Adjustment Required|1|||
13294098|NCT01066000|26490124|FG000|Overall Study|Protocol Violation|4|||
13294099|NCT01066000|26490124|FG000|Overall Study|Death|3|||
13294100|NCT01066000|26490124|FG000|Overall Study|Withdrawal by Subject|1|||
13294101|NCT01066000|26490124|FG000|Overall Study|Adverse Event|1|||
13294102|NCT01065844|26490130|FG000|Overall Study|Adverse Event|5|||
13294103|NCT01065818|26490136|FG000|Overall Study|Withdrawal by Subject|1|||
13294104|NCT01065818|26490136|FG000|Overall Study|Not a candidate for surgery|1|||
13294105|NCT01065766|26490150|FG000|Overall Study|Assessed before the contracted date|1|||
13294106|NCT01065766|26490150|FG000|Overall Study|Contraindication to administration|6|||
13294107|NCT01065766|26490150|FG000|Overall Study|Violated dosage/administration|25|||
13294108|NCT01065597|26490159|FG000|Overall Study|Adverse Event|1|||
13294109|NCT01065350|26490198|FG000|Overall Study|Received incorrect drug allocation|0|||
13294110|NCT01065350|26490199|FG001|Overall Study|Received incorrect drug allocation|1|||
13294111|NCT01064947|26490209|FG000|Overall Study|negative culture|41|||
13294112|NCT01064817|26490228|FG000|Study Completion|Physician Decision|1|||
13294113|NCT01064817|26490229|FG001|Study Completion|Physician Decision|0|||
13294114|NCT01064817|26490228|FG000|Study Completion|Withdrawal by Subject|1|||
13294115|NCT01064817|26490229|FG001|Study Completion|Withdrawal by Subject|0|||
13294116|NCT01064739|26490287|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1|||
13294117|NCT01064687|26490477|FG000|Overall Study|Adverse Event|9|||
13294118|NCT01064687|26490478|FG001|Overall Study|Adverse Event|4|||
13294119|NCT01064687|26490479|FG002|Overall Study|Adverse Event|10|||
13294120|NCT01064687|26490480|FG003|Overall Study|Adverse Event|3|||
13294121|NCT01064687|26490477|FG000|Overall Study|Death|1|||
13294122|NCT01064687|26490478|FG001|Overall Study|Death|1|||
13294123|NCT01064687|26490479|FG002|Overall Study|Death|0|||
13294124|NCT01064687|26490480|FG003|Overall Study|Death|0|||
13294125|NCT01064687|26490477|FG000|Overall Study|Entry Criteria Not Met|3|||
13294126|NCT01064687|26490478|FG001|Overall Study|Entry Criteria Not Met|0|||
13294127|NCT01064687|26490479|FG002|Overall Study|Entry Criteria Not Met|0|||
13294128|NCT01064687|26490480|FG003|Overall Study|Entry Criteria Not Met|0|||
13294129|NCT01064687|26490477|FG000|Overall Study|Lack of Efficacy|1|||
13294130|NCT01064687|26490478|FG001|Overall Study|Lack of Efficacy|0|||
13294131|NCT01064687|26490479|FG002|Overall Study|Lack of Efficacy|2|||
13294132|NCT01064687|26490480|FG003|Overall Study|Lack of Efficacy|3|||
13294133|NCT01064687|26490477|FG000|Overall Study|Lost to Follow-up|7|||
13294134|NCT01064687|26490478|FG001|Overall Study|Lost to Follow-up|10|||
13294135|NCT01064687|26490479|FG002|Overall Study|Lost to Follow-up|13|||
13294136|NCT01064687|26490480|FG003|Overall Study|Lost to Follow-up|5|||
13294137|NCT01064687|26490477|FG000|Overall Study|Physician Decision|2|||
13294138|NCT01064687|26490478|FG001|Overall Study|Physician Decision|2|||
13294139|NCT01064687|26490479|FG002|Overall Study|Physician Decision|0|||
13294140|NCT01064687|26490480|FG003|Overall Study|Physician Decision|0|||
13294141|NCT01064687|26490477|FG000|Overall Study|Protocol Violation|1|||
13294142|NCT01064687|26490478|FG001|Overall Study|Protocol Violation|1|||
13294143|NCT01064687|26490479|FG002|Overall Study|Protocol Violation|0|||
13294144|NCT01064687|26490480|FG003|Overall Study|Protocol Violation|1|||
13294145|NCT01064687|26490477|FG000|Overall Study|Sponsor Decision|0|||
13294146|NCT01064687|26490478|FG001|Overall Study|Sponsor Decision|0|||
13294147|NCT01064687|26490479|FG002|Overall Study|Sponsor Decision|3|||
13294148|NCT01064687|26490480|FG003|Overall Study|Sponsor Decision|0|||
13294149|NCT01064687|26490477|FG000|Overall Study|Withdrawal by Subject|9|||
13294150|NCT01064687|26490478|FG001|Overall Study|Withdrawal by Subject|7|||
13294151|NCT01064687|26490479|FG002|Overall Study|Withdrawal by Subject|12|||
13294152|NCT01064687|26490480|FG003|Overall Study|Withdrawal by Subject|5|||
13294153|NCT01064687|26490477|FG000|Overall Study|Treatment Noncompliance|1|||
13294154|NCT01064687|26490478|FG001|Overall Study|Treatment Noncompliance|1|||
13294155|NCT01064687|26490479|FG002|Overall Study|Treatment Noncompliance|1|||
13294156|NCT01064687|26490480|FG003|Overall Study|Treatment Noncompliance|0|||
13294157|NCT01064622|26490510|FG000|Randomized Phase II|Withdrawal by Subject|2|||
13294158|NCT01064622|26490511|FG001|Randomized Phase II|Withdrawal by Subject|2|||
13294159|NCT01064622|26490510|FG000|Randomized Phase II|Protocol Violation|0|||
13294160|NCT01064622|26490511|FG001|Randomized Phase II|Protocol Violation|1|||
13294161|NCT01064531|26490562|FG000|Overall Study|Lost to Follow-up|0|||
13294162|NCT01064531|26490563|FG001|Overall Study|Lost to Follow-up|2|||
13294163|NCT01064531|26490562|FG000|Overall Study|Physician Decision|0|||
13294164|NCT01064531|26490563|FG001|Overall Study|Physician Decision|1|||
13294165|NCT01064531|26490562|FG000|Overall Study|Withdrawal by Subject|2|||
13294166|NCT01064531|26490563|FG001|Overall Study|Withdrawal by Subject|2|||
13294167|NCT01064531|26490562|FG000|Overall Study|Revision due to femoral stem loosening|1|||
13294168|NCT01064531|26490563|FG001|Overall Study|Revision due to femoral stem loosening|0|||
13294169|NCT01064531|26490562|FG000|Overall Study|Revision due to dislocation|0|||
13294170|NCT01064531|26490563|FG001|Overall Study|Revision due to dislocation|1|||
13294171|NCT01064531|26490562|FG000|Overall Study|Death|0|||
13294172|NCT01064531|26490563|FG001|Overall Study|Death|1|||
13294173|NCT01064414|26490590|FG000|Core Period: Baseline to Week 26|Adverse Event|4|||
13294174|NCT01064414|26490591|FG001|Core Period: Baseline to Week 26|Adverse Event|4|||
13294175|NCT01064414|26490592|FG002|Core Period: Baseline to Week 26|Adverse Event|2|||
13294176|NCT01064414|26490590|FG000|Core Period: Baseline to Week 26|Death|0|||
13294177|NCT01064414|26490591|FG001|Core Period: Baseline to Week 26|Death|1|||
13294178|NCT01064414|26490592|FG002|Core Period: Baseline to Week 26|Death|0|||
13294179|NCT01064414|26490590|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
13294180|NCT01064414|26490591|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
13294181|NCT01064414|26490592|FG002|Core Period: Baseline to Week 26|Protocol Violation|1|||
13294182|NCT01064414|26490590|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
13294183|NCT01064414|26490591|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
13294184|NCT01064414|26490592|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
13294185|NCT01064414|26490590|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
13294186|NCT01064414|26490591|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
13294187|NCT01064414|26490592|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
13294188|NCT01064414|26490590|FG000|Core Period: Baseline to Week 26|Other|4|||
13294189|NCT01064414|26490591|FG001|Core Period: Baseline to Week 26|Other|7|||
13294190|NCT01064414|26490592|FG002|Core Period: Baseline to Week 26|Other|2|||
13294191|NCT01064414|26490590|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
13294192|NCT01064414|26490591|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
13294193|NCT01064414|26490592|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2|||
13294194|NCT01064414|26490590|FG000|Extension Period: Week 26 to Week 52|Death|0|||
13294195|NCT01064414|26490591|FG001|Extension Period: Week 26 to Week 52|Death|1|||
13294196|NCT01064414|26490592|FG002|Extension Period: Week 26 to Week 52|Death|0|||
13294197|NCT01064414|26490590|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
13294198|NCT01064414|26490591|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
13294199|NCT01064414|26490592|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
13294200|NCT01064414|26490590|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1|||
13294201|NCT01064414|26490591|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
13294202|NCT01064414|26490592|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
13294203|NCT01064414|26490590|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
13294204|NCT01064414|26490591|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
13294205|NCT01064414|26490592|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
13294206|NCT01064414|26490590|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
13294207|NCT01064414|26490591|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
13294208|NCT01064414|26490592|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
13294209|NCT01064414|26490590|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
13294210|NCT01064414|26490591|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
13294211|NCT01064414|26490592|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
13294212|NCT01064414|26490590|FG000|Extension Period: Week 26 to Week 52|Other|5|||
13294213|NCT01064414|26490591|FG001|Extension Period: Week 26 to Week 52|Other|2|||
13294214|NCT01064414|26490592|FG002|Extension Period: Week 26 to Week 52|Other|1|||
13294215|NCT01064167|26490607|FG000|Overall Study|Protocol Violation|14|||
13294216|NCT01064167|26490608|FG001|Overall Study|Protocol Violation|15|||
13376858|NCT00783718|26733479|FG005|Maintenance Phase|Withdrawal by Subject|2|||
13376859|NCT00783718|26733480|FG006|Maintenance Phase|Withdrawal by Subject|20|||
13376860|NCT00783718|26733474|FG000|Maintenance Phase|Lost to Follow-up|3|||
13376861|NCT00783718|26733475|FG001|Maintenance Phase|Lost to Follow-up|0|||
13376862|NCT00783718|26733476|FG002|Maintenance Phase|Lost to Follow-up|0|||
13376863|NCT00783718|26733477|FG003|Maintenance Phase|Lost to Follow-up|0|||
13376864|NCT00783718|26733478|FG004|Maintenance Phase|Lost to Follow-up|2|||
13376865|NCT00783718|26733479|FG005|Maintenance Phase|Lost to Follow-up|0|||
13376866|NCT00783718|26733480|FG006|Maintenance Phase|Lost to Follow-up|2|||
13376867|NCT00783705|26733531|FG000|Overall Study|Adverse Event|2|||
13376868|NCT00783705|26733532|FG001|Overall Study|Adverse Event|0|||
13376869|NCT00783705|26733531|FG000|Overall Study|Withdrawal by Subject|3|||
13376870|NCT00783705|26733532|FG001|Overall Study|Withdrawal by Subject|2|||
13376871|NCT00783705|26733531|FG000|Overall Study|Lost to Follow-up|1|||
13376872|NCT00783705|26733532|FG001|Overall Study|Lost to Follow-up|3|||
13206857|NCT01953692|26236003|FG000|Overall Study|Clinical Progression|0|||
13206858|NCT01953692|26236004|FG001|Overall Study|Clinical Progression|15|||
13206859|NCT01953692|26236005|FG002|Overall Study|Clinical Progression|7|||
13206860|NCT01953692|26236006|FG003|Overall Study|Clinical Progression|5|||
13206861|NCT01953692|26236007|FG004|Overall Study|Clinical Progression|0|||
13376873|NCT00783692|26733569|FG000|Induction Phase|Adverse Event|7|||
13376874|NCT00783692|26733570|FG001|Induction Phase|Adverse Event|9|||
13376875|NCT00783692|26733571|FG002|Induction Phase|Adverse Event|24|||
13376876|NCT00783692|26733572|FG003|Induction Phase|Adverse Event|0|||
13376877|NCT00783692|26733573|FG004|Induction Phase|Adverse Event|0|||
13376878|NCT00783692|26733574|FG005|Induction Phase|Adverse Event|0|||
13376879|NCT00783692|26733575|FG006|Induction Phase|Adverse Event|0|||
13376880|NCT00783692|26733569|FG000|Induction Phase|Protocol Violation|0|||
13376881|NCT00783692|26733570|FG001|Induction Phase|Protocol Violation|0|||
13376882|NCT00783692|26733571|FG002|Induction Phase|Protocol Violation|1|||
13376883|NCT00783692|26733572|FG003|Induction Phase|Protocol Violation|0|||
13376884|NCT00783692|26733573|FG004|Induction Phase|Protocol Violation|0|||
13376885|NCT00783692|26733574|FG005|Induction Phase|Protocol Violation|0|||
13376886|NCT00783692|26733575|FG006|Induction Phase|Protocol Violation|0|||
13376887|NCT00783692|26733569|FG000|Induction Phase|Lack of Efficacy|1|||
13376888|NCT00783692|26733570|FG001|Induction Phase|Lack of Efficacy|3|||
13376889|NCT00783692|26733571|FG002|Induction Phase|Lack of Efficacy|28|||
13376890|NCT00783692|26733572|FG003|Induction Phase|Lack of Efficacy|0|||
13376891|NCT00783692|26733573|FG004|Induction Phase|Lack of Efficacy|0|||
13376892|NCT00783692|26733574|FG005|Induction Phase|Lack of Efficacy|0|||
13376893|NCT00783692|26733575|FG006|Induction Phase|Lack of Efficacy|0|||
13376894|NCT00783692|26733569|FG000|Induction Phase|Withdrawal by Subject|3|||
13376895|NCT00783692|26733570|FG001|Induction Phase|Withdrawal by Subject|9|||
13376896|NCT00783692|26733571|FG002|Induction Phase|Withdrawal by Subject|16|||
13376897|NCT00783692|26733572|FG003|Induction Phase|Withdrawal by Subject|0|||
13376898|NCT00783692|26733573|FG004|Induction Phase|Withdrawal by Subject|0|||
13376899|NCT00783692|26733574|FG005|Induction Phase|Withdrawal by Subject|0|||
13376900|NCT00783692|26733575|FG006|Induction Phase|Withdrawal by Subject|0|||
13376901|NCT00783692|26733569|FG000|Induction Phase|Lost to Follow-up|0|||
13376902|NCT00783692|26733570|FG001|Induction Phase|Lost to Follow-up|0|||
13376903|NCT00783692|26733571|FG002|Induction Phase|Lost to Follow-up|3|||
13488571|NCT00409773|27043863|FG000|Overall Study|Protocol Violation|0|||
13376904|NCT00783692|26733572|FG003|Induction Phase|Lost to Follow-up|0|||
13376905|NCT00783692|26733573|FG004|Induction Phase|Lost to Follow-up|0|||
13376906|NCT00783692|26733574|FG005|Induction Phase|Lost to Follow-up|0|||
13376907|NCT00783692|26733575|FG006|Induction Phase|Lost to Follow-up|0|||
13376908|NCT00783692|26733569|FG000|Induction Phase|Other|0|||
13376909|NCT00783692|26733570|FG001|Induction Phase|Other|0|||
13376910|NCT00783692|26733571|FG002|Induction Phase|Other|2|||
13376911|NCT00783692|26733572|FG003|Induction Phase|Other|0|||
13376912|NCT00783692|26733573|FG004|Induction Phase|Other|0|||
13376913|NCT00783692|26733574|FG005|Induction Phase|Other|0|||
13376914|NCT00783692|26733575|FG006|Induction Phase|Other|0|||
13376915|NCT00783692|26733569|FG000|Maintenance Phase|Adverse Event|7|||
13376916|NCT00783692|26733570|FG001|Maintenance Phase|Adverse Event|0|||
13376917|NCT00783692|26733571|FG002|Maintenance Phase|Adverse Event|0|||
13376918|NCT00783692|26733572|FG003|Maintenance Phase|Adverse Event|15|||
13376919|NCT00783692|26733573|FG004|Maintenance Phase|Adverse Event|12|||
13376920|NCT00783692|26733574|FG005|Maintenance Phase|Adverse Event|9|||
13376921|NCT00783692|26733575|FG006|Maintenance Phase|Adverse Event|38|||
13376922|NCT00783692|26733569|FG000|Maintenance Phase|Protocol Violation|0|||
13376923|NCT00783692|26733570|FG001|Maintenance Phase|Protocol Violation|0|||
13376924|NCT00783692|26733571|FG002|Maintenance Phase|Protocol Violation|0|||
13376925|NCT00783692|26733572|FG003|Maintenance Phase|Protocol Violation|1|||
13376926|NCT00783692|26733573|FG004|Maintenance Phase|Protocol Violation|2|||
13376927|NCT00783692|26733574|FG005|Maintenance Phase|Protocol Violation|3|||
13376928|NCT00783692|26733575|FG006|Maintenance Phase|Protocol Violation|4|||
13376929|NCT00783692|26733569|FG000|Maintenance Phase|Lack of Efficacy|79|||
13376930|NCT00783692|26733570|FG001|Maintenance Phase|Lack of Efficacy|0|||
13376931|NCT00783692|26733571|FG002|Maintenance Phase|Lack of Efficacy|0|||
13376932|NCT00783692|26733572|FG003|Maintenance Phase|Lack of Efficacy|64|||
13376933|NCT00783692|26733573|FG004|Maintenance Phase|Lack of Efficacy|58|||
13376934|NCT00783692|26733574|FG005|Maintenance Phase|Lack of Efficacy|48|||
13376935|NCT00783692|26733575|FG006|Maintenance Phase|Lack of Efficacy|177|||
13376936|NCT00783692|26733569|FG000|Maintenance Phase|Withdrawal by Subject|7|||
13376937|NCT00783692|26733570|FG001|Maintenance Phase|Withdrawal by Subject|0|||
13376938|NCT00783692|26733571|FG002|Maintenance Phase|Withdrawal by Subject|0|||
13376939|NCT00783692|26733572|FG003|Maintenance Phase|Withdrawal by Subject|7|||
13376940|NCT00783692|26733573|FG004|Maintenance Phase|Withdrawal by Subject|6|||
13376941|NCT00783692|26733574|FG005|Maintenance Phase|Withdrawal by Subject|9|||
13376942|NCT00783692|26733575|FG006|Maintenance Phase|Withdrawal by Subject|24|||
13376943|NCT00783692|26733569|FG000|Maintenance Phase|Lost to Follow-up|2|||
13376944|NCT00783692|26733570|FG001|Maintenance Phase|Lost to Follow-up|0|||
13376945|NCT00783692|26733571|FG002|Maintenance Phase|Lost to Follow-up|0|||
13376946|NCT00783692|26733572|FG003|Maintenance Phase|Lost to Follow-up|1|||
13376947|NCT00783692|26733573|FG004|Maintenance Phase|Lost to Follow-up|3|||
13376948|NCT00783692|26733574|FG005|Maintenance Phase|Lost to Follow-up|2|||
13376949|NCT00783692|26733575|FG006|Maintenance Phase|Lost to Follow-up|5|||
13376950|NCT00783692|26733569|FG000|Maintenance Phase|Other|0|||
13376951|NCT00783692|26733570|FG001|Maintenance Phase|Other|0|||
13376952|NCT00783692|26733571|FG002|Maintenance Phase|Other|0|||
13376953|NCT00783692|26733572|FG003|Maintenance Phase|Other|1|||
13376954|NCT00783692|26733573|FG004|Maintenance Phase|Other|0|||
13376955|NCT00783692|26733574|FG005|Maintenance Phase|Other|1|||
13376956|NCT00783692|26733575|FG006|Maintenance Phase|Other|1|||
13376957|NCT00783432|26733592|FG000|Overall Study|Adverse Event|22|||
13376958|NCT00783432|26733593|FG001|Overall Study|Adverse Event|17|||
13376959|NCT00783432|26733592|FG000|Overall Study|Lack of Efficacy|20|||
13376960|NCT00783432|26733593|FG001|Overall Study|Lack of Efficacy|21|||
13376961|NCT00783432|26733592|FG000|Overall Study|Lost to Follow-up|11|||
13376962|NCT00783432|26733593|FG001|Overall Study|Lost to Follow-up|6|||
13376963|NCT00783432|26733592|FG000|Overall Study|Withdrawal by Subject|23|||
13376964|NCT00783432|26733593|FG001|Overall Study|Withdrawal by Subject|20|||
13376965|NCT00783432|26733592|FG000|Overall Study|subject moved|3|||
13376966|NCT00783432|26733593|FG001|Overall Study|subject moved|5|||
13376967|NCT00783432|26733592|FG000|Overall Study|Protocol Violation|6|||
13376968|NCT00783432|26733593|FG001|Overall Study|Protocol Violation|9|||
13376969|NCT00783302|26733613|FG000|Overall Study|Lost to Follow-up|17|||
13376970|NCT00783302|26733613|FG000|Overall Study|Technical Problems|11|||
13376971|NCT00783302|26733613|FG000|Overall Study|Protocol Violation|3|||
13376972|NCT00783302|26733613|FG000|Overall Study|Physician Decision|1|||
13376973|NCT00783302|26733613|FG000|Overall Study|Withdrawal by Subject|3|||
13376974|NCT00783289|26733652|FG000|Overall Study|Protocol Violation|0|||
13376975|NCT00783289|26733653|FG001|Overall Study|Protocol Violation|1|||
13376976|NCT00783289|26733654|FG002|Overall Study|Protocol Violation|0|||
13376977|NCT00783289|26733655|FG003|Overall Study|Protocol Violation|0|||
13376978|NCT00783224|26733677|FG000|Overall Study|Adverse Event|0|||
13376979|NCT00783224|26733678|FG001|Overall Study|Adverse Event|0|||
13376980|NCT00783224|26733679|FG002|Overall Study|Adverse Event|1|||
13376981|NCT00783224|26733680|FG003|Overall Study|Adverse Event|0|||
13376982|NCT00783224|26733677|FG000|Overall Study|Discarded the Investigational Drug Used|0|||
13393923|NCT00661713|26785144|FG005|Overall Study|Adverse Event|0|||
13376983|NCT00783224|26733678|FG001|Overall Study|Discarded the Investigational Drug Used|0|||
13376984|NCT00783224|26733679|FG002|Overall Study|Discarded the Investigational Drug Used|0|||
13376985|NCT00783224|26733680|FG003|Overall Study|Discarded the Investigational Drug Used|1|||
13376986|NCT00783224|26733677|FG000|Overall Study|Inappropriate as a study subject|0|||
13376987|NCT00783224|26733678|FG001|Overall Study|Inappropriate as a study subject|0|||
13376988|NCT00783224|26733679|FG002|Overall Study|Inappropriate as a study subject|0|||
13376989|NCT00783224|26733680|FG003|Overall Study|Inappropriate as a study subject|1|||
13376990|NCT00783198|26733710|FG000|Overall Study|Adverse Event|15|||
13376991|NCT00783198|26733711|FG001|Overall Study|Adverse Event|19|||
13376992|NCT00783198|26733712|FG002|Overall Study|Adverse Event|3|||
13376993|NCT00783198|26733710|FG000|Overall Study|Lost to Follow-up|11|||
13376994|NCT00783198|26733711|FG001|Overall Study|Lost to Follow-up|1|||
13376995|NCT00783198|26733712|FG002|Overall Study|Lost to Follow-up|7|||
13376996|NCT00783198|26733710|FG000|Overall Study|Withdrawal by Subject|22|||
13376997|NCT00783198|26733711|FG001|Overall Study|Withdrawal by Subject|14|||
13376998|NCT00783198|26733712|FG002|Overall Study|Withdrawal by Subject|20|||
13376999|NCT00783198|26733710|FG000|Overall Study|Noncompliance with protocol|7|||
13377000|NCT00783198|26733711|FG001|Overall Study|Noncompliance with protocol|7|||
13377001|NCT00783198|26733712|FG002|Overall Study|Noncompliance with protocol|10|||
13377002|NCT00783198|26733710|FG000|Overall Study|Did not meet protocol eligibility|0|||
13377003|NCT00783198|26733711|FG001|Overall Study|Did not meet protocol eligibility|1|||
13377004|NCT00783198|26733712|FG002|Overall Study|Did not meet protocol eligibility|0|||
13377005|NCT00783198|26733710|FG000|Overall Study|Administrative|2|||
13377006|NCT00783198|26733711|FG001|Overall Study|Administrative|1|||
13377007|NCT00783198|26733712|FG002|Overall Study|Administrative|2|||
13377008|NCT00783094|26733798|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4|||
13377009|NCT00783094|26733799|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5|||
13377010|NCT00783094|26733800|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5|||
13377011|NCT00783094|26733798|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0|||
13377012|NCT00783094|26733799|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2|||
13377013|NCT00783094|26733800|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1|||
13377014|NCT00783094|26733798|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
13377015|NCT00783094|26733799|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2|||
13377016|NCT00783094|26733800|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0|||
13377017|NCT00783094|26733798|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
13377018|NCT00783094|26733799|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2|||
13377019|NCT00783094|26733800|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
13377020|NCT00783094|26733798|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
13377021|NCT00783094|26733799|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1|||
13377022|NCT00783094|26733800|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
13377023|NCT00783094|26733798|FG000|Open-Label Extension Period|Adverse Event|12|||
13377024|NCT00783094|26733799|FG001|Open-Label Extension Period|Adverse Event|7|||
13377025|NCT00783094|26733800|FG002|Open-Label Extension Period|Adverse Event|16|||
13377026|NCT00783094|26733798|FG000|Open-Label Extension Period|Death|0|||
13377027|NCT00783094|26733799|FG001|Open-Label Extension Period|Death|0|||
13377028|NCT00783094|26733800|FG002|Open-Label Extension Period|Death|1|||
13377029|NCT00783094|26733798|FG000|Open-Label Extension Period|Protocol Violation|4|||
13377030|NCT00783094|26733799|FG001|Open-Label Extension Period|Protocol Violation|5|||
13377031|NCT00783094|26733800|FG002|Open-Label Extension Period|Protocol Violation|7|||
13377032|NCT00783094|26733798|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
13377033|NCT00783094|26733799|FG001|Open-Label Extension Period|Withdrawal by Subject|1|||
13377034|NCT00783094|26733800|FG002|Open-Label Extension Period|Withdrawal by Subject|3|||
13377035|NCT00783094|26733798|FG000|Open-Label Extension Period|Physician Decision|4|||
13377036|NCT00783094|26733799|FG001|Open-Label Extension Period|Physician Decision|2|||
13377037|NCT00783094|26733800|FG002|Open-Label Extension Period|Physician Decision|3|||
13377038|NCT00783094|26733798|FG000|Open-Label Extension Period|Lack of Efficacy|1|||
13377039|NCT00783094|26733799|FG001|Open-Label Extension Period|Lack of Efficacy|4|||
13377040|NCT00783094|26733800|FG002|Open-Label Extension Period|Lack of Efficacy|0|||
13377041|NCT00782834|26733807|FG000|Treatment Phase|fibrous tumor not GIST|1|||
13377042|NCT00782795|26733846|FG000|Overall Study|Withdrawal by Subject|1|||
13377043|NCT00782795|26733847|FG001|Overall Study|Withdrawal by Subject|2|||
13377044|NCT00782717|26733862|FG000|Overall Study|Adverse Event|2|||
13377045|NCT00782717|26733863|FG001|Overall Study|Adverse Event|5|||
13377046|NCT00782717|26733862|FG000|Overall Study|Patient decision unrelated to AE|6|||
13377047|NCT00782717|26733863|FG001|Overall Study|Patient decision unrelated to AE|3|||
13377048|NCT00782717|26733862|FG000|Overall Study|Noncompliance|2|||
13377049|NCT00782717|26733863|FG001|Overall Study|Noncompliance|1|||
13377050|NCT00782717|26733862|FG000|Overall Study|Treatment failure|3|||
13377051|NCT00782717|26733863|FG001|Overall Study|Treatment failure|14|||
13377052|NCT00782717|26733862|FG000|Overall Study|Enrollment close prior to surgery|1|||
13377053|NCT00782717|26733863|FG001|Overall Study|Enrollment close prior to surgery|0|||
13393924|NCT00661713|26785145|FG006|Overall Study|Adverse Event|1|||
13377054|NCT00782717|26733862|FG000|Overall Study|Did not meet entrance criteria|1|||
13377055|NCT00782717|26733863|FG001|Overall Study|Did not meet entrance criteria|3|||
13377056|NCT00782717|26733862|FG000|Overall Study|Exited in error|0|||
13377057|NCT00782717|26733863|FG001|Overall Study|Exited in error|2|||
13377058|NCT00782626|26733869|FG000|Overall Study|Adverse Event|1|||
13377059|NCT00782626|26733869|FG000|Overall Study|Progressive Disease|5|||
13377060|NCT00782626|26733869|FG000|Overall Study|Other Complicating Disease|1|||
13377061|NCT00782509|26734070|FG000|Overall Study|Adverse Event|20|||
13377062|NCT00782509|26734071|FG001|Overall Study|Adverse Event|10|||
13377063|NCT00782509|26734072|FG002|Overall Study|Adverse Event|20|||
13377064|NCT00782509|26734070|FG000|Overall Study|Lost to Follow-up|1|||
13377065|NCT00782509|26734071|FG001|Overall Study|Lost to Follow-up|2|||
13377066|NCT00782509|26734072|FG002|Overall Study|Lost to Follow-up|3|||
13377067|NCT00782509|26734070|FG000|Overall Study|Withdrawal by Subject|3|||
13377068|NCT00782509|26734071|FG001|Overall Study|Withdrawal by Subject|5|||
13377069|NCT00782509|26734072|FG002|Overall Study|Withdrawal by Subject|8|||
13377070|NCT00782509|26734070|FG000|Overall Study|Non compliance with protocol|2|||
13377071|NCT00782509|26734071|FG001|Overall Study|Non compliance with protocol|0|||
13377072|NCT00782509|26734072|FG002|Overall Study|Non compliance with protocol|0|||
13377073|NCT00782509|26734070|FG000|Overall Study|Other reasons not stated above|5|||
13377074|NCT00782509|26734071|FG001|Overall Study|Other reasons not stated above|2|||
13377075|NCT00782509|26734072|FG002|Overall Study|Other reasons not stated above|3|||
13377076|NCT00782509|26734070|FG000|Overall Study|Lack of Efficacy|10|||
13377077|NCT00782509|26734071|FG001|Overall Study|Lack of Efficacy|5|||
13377078|NCT00782509|26734072|FG002|Overall Study|Lack of Efficacy|2|||
13377079|NCT00782496|26734086|FG000|Overall Study|Lost to Follow-up|14|||
13377080|NCT00782496|26734087|FG001|Overall Study|Lost to Follow-up|15|||
13377081|NCT00782483|26734093|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6|||
13377082|NCT00782418|26734121|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1|||
13393925|NCT00661713|26785146|FG007|Overall Study|Adverse Event|0|||
13393926|NCT00661713|26785139|FG000|Overall Study|Inappropriate Enrollment|0|||
13393927|NCT00661713|26785140|FG001|Overall Study|Inappropriate Enrollment|0|||
13393928|NCT00661713|26785141|FG002|Overall Study|Inappropriate Enrollment|0|||
13393929|NCT00661713|26785142|FG003|Overall Study|Inappropriate Enrollment|0|||
13393930|NCT00661713|26785143|FG004|Overall Study|Inappropriate Enrollment|0|||
13393931|NCT00661713|26785144|FG005|Overall Study|Inappropriate Enrollment|0|||
13393932|NCT00661713|26785145|FG006|Overall Study|Inappropriate Enrollment|1|||
13393933|NCT00661713|26785146|FG007|Overall Study|Inappropriate Enrollment|0|||
13393934|NCT00661687|26785158|FG000|Overall Study|Study related symptoms and complaints|5|||
13393935|NCT00661687|26785158|FG000|Overall Study|Positive slit lamp findings|4|||
13393936|NCT00661687|26785158|FG000|Overall Study|Inability to maintain wearing schedule|3|||
13393937|NCT00661687|26785158|FG000|Overall Study|Physician Decision|1|||
13393938|NCT00661687|26785158|FG000|Overall Study|Adverse Event|2|||
13393939|NCT00661661|26785239|FG000|Overall Study|Adverse Event|99|||
13393940|NCT00661661|26785240|FG001|Overall Study|Adverse Event|24|||
13393941|NCT00661661|26785239|FG000|Overall Study|Lack of Efficacy|3|||
13393942|NCT00661661|26785240|FG001|Overall Study|Lack of Efficacy|2|||
13393943|NCT00661661|26785239|FG000|Overall Study|Lost to Follow-up|0|||
13393944|NCT00661661|26785240|FG001|Overall Study|Lost to Follow-up|1|||
13393945|NCT00661661|26785239|FG000|Overall Study|Withdrawal by Subject|15|||
13393946|NCT00661661|26785240|FG001|Overall Study|Withdrawal by Subject|5|||
13393947|NCT00661661|26785239|FG000|Overall Study|Other|22|||
13393948|NCT00661661|26785240|FG001|Overall Study|Other|7|||
13393949|NCT00661661|26785239|FG000|Overall Study|Not assigned treatment|1|||
13393950|NCT00661661|26785240|FG001|Overall Study|Not assigned treatment|0|||
13393951|NCT00661622|26785261|FG000|Overall Study|Protocol Violation|1|||
13393952|NCT00661622|26785262|FG001|Overall Study|Protocol Violation|0|||
13393953|NCT00661609|26785271|FG000|Overall Study|Adverse Event|4|||
13393954|NCT00661609|26785271|FG000|Overall Study|Death|20|||
13393955|NCT00661609|26785271|FG000|Overall Study|Withdrawal by Subject|2|||
13393956|NCT00661609|26785271|FG000|Overall Study|PI Decision|1|||
13393957|NCT00661609|26785271|FG000|Overall Study|Survival follow up stage discontinued|11|||
13393958|NCT00661609|26785271|FG000|Overall Study|Disease progression|3|||
13393959|NCT00661531|26785278|FG000|Overall Study|Withdrawal by Subject|3|||
13393960|NCT00661505|26785306|FG000|Overall Study|Adverse Event|3|||
13393961|NCT00661505|26785306|FG000|Overall Study|Protocol Violation|14|||
13393962|NCT00661505|26785306|FG000|Overall Study|Withdrawal by Subject|8|||
13393963|NCT00661505|26785306|FG000|Overall Study|Lost to Follow-up|3|||
13393964|NCT00661505|26785306|FG000|Overall Study|Other|2|||
13393965|NCT00661492|26785333|FG000|Overall Study|Adverse Event|16|||
13393966|NCT00661492|26785334|FG001|Overall Study|Adverse Event|13|||
13393967|NCT00661492|26785333|FG000|Overall Study|Disease Progression|44|||
13393968|NCT00661492|26785334|FG001|Overall Study|Disease Progression|14|||
13393969|NCT00661492|26785333|FG000|Overall Study|Patient Request|6|||
13393970|NCT00661492|26785334|FG001|Overall Study|Patient Request|1|||
13393971|NCT00661492|26785333|FG000|Overall Study|Investigator Request|1|||
13393972|NCT00661492|26785334|FG001|Overall Study|Investigator Request|0|||
13377083|NCT00782418|26734122|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
13377084|NCT00782418|26734123|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
13377085|NCT00782418|26734124|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
13377086|NCT00782418|26734125|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
13377087|NCT00782418|26734126|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
13377088|NCT00782418|26734127|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
13377089|NCT00782418|26734121|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
13377090|NCT00782418|26734122|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
13377091|NCT00782418|26734123|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
13377092|NCT00782418|26734124|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
13377093|NCT00782418|26734125|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
13377094|NCT00782418|26734126|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
13377095|NCT00782418|26734127|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
13377096|NCT00782340|26734160|FG000|Open Label Titration|Adverse Event|12|||
13377097|NCT00782340|26734161|FG001|Open Label Titration|Adverse Event|0|||
13377098|NCT00782340|26734162|FG002|Open Label Titration|Adverse Event|0|||
13377099|NCT00782340|26734160|FG000|Open Label Titration|Treatment failure|50|||
13377100|NCT00782340|26734161|FG001|Open Label Titration|Treatment failure|0|||
13377101|NCT00782340|26734162|FG002|Open Label Titration|Treatment failure|0|||
13377102|NCT00782340|26734160|FG000|Open Label Titration|Protocol Violation|5|||
13377103|NCT00782340|26734161|FG001|Open Label Titration|Protocol Violation|0|||
13377104|NCT00782340|26734162|FG002|Open Label Titration|Protocol Violation|0|||
13377105|NCT00782340|26734160|FG000|Open Label Titration|Withdrawal by Subject|5|||
13377106|NCT00782340|26734161|FG001|Open Label Titration|Withdrawal by Subject|0|||
13377107|NCT00782340|26734162|FG002|Open Label Titration|Withdrawal by Subject|0|||
13377108|NCT00782340|26734160|FG000|Open Label Titration|Enrollment capped|16|||
13377109|NCT00782340|26734161|FG001|Open Label Titration|Enrollment capped|0|||
13377110|NCT00782340|26734162|FG002|Open Label Titration|Enrollment capped|0|||
13377111|NCT00782340|26734160|FG000|Open Label Titration|Did not meet responder criteria|2|||
13377112|NCT00782340|26734161|FG001|Open Label Titration|Did not meet responder criteria|0|||
13377113|NCT00782340|26734162|FG002|Open Label Titration|Did not meet responder criteria|0|||
13377114|NCT00782340|26734160|FG000|Open Label Titration|Lost to Follow-up|5|||
13377115|NCT00782340|26734161|FG001|Open Label Titration|Lost to Follow-up|0|||
13377116|NCT00782340|26734162|FG002|Open Label Titration|Lost to Follow-up|0|||
13377117|NCT00782340|26734160|FG000|Open Label Titration|Randomized in error|6|||
13377118|NCT00782340|26734161|FG001|Open Label Titration|Randomized in error|0|||
13377119|NCT00782340|26734162|FG002|Open Label Titration|Randomized in error|0|||
13377120|NCT00782275|26734170|FG000|Overall Study|Adverse Event|11|||
13377121|NCT00782275|26734170|FG000|Overall Study|Withdrawal by Subject|1|||
13377122|NCT00782275|26734170|FG000|Overall Study|Progressive Disease|21|||
13377123|NCT00782275|26734170|FG000|Overall Study|Physician Decision|4|||
13377124|NCT00782275|26734170|FG000|Overall Study|Not started treatment|1|||
13377125|NCT00782275|26734170|FG000|Overall Study|Other|3|||
13377126|NCT00782210|26734371|FG000|Overall Study|Adverse Event|21|||
13377127|NCT00782210|26734372|FG001|Overall Study|Adverse Event|17|||
13377128|NCT00782210|26734373|FG002|Overall Study|Adverse Event|16|||
13377129|NCT00782210|26734371|FG000|Overall Study|Lost to Follow-up|2|||
13377130|NCT00782210|26734372|FG001|Overall Study|Lost to Follow-up|1|||
13377131|NCT00782210|26734373|FG002|Overall Study|Lost to Follow-up|2|||
13377132|NCT00782210|26734371|FG000|Overall Study|Withdrawal by Subject|11|||
13377133|NCT00782210|26734372|FG001|Overall Study|Withdrawal by Subject|8|||
13377134|NCT00782210|26734373|FG002|Overall Study|Withdrawal by Subject|11|||
13377135|NCT00782210|26734371|FG000|Overall Study|Non compliance with protocol|0|||
13377136|NCT00782210|26734372|FG001|Overall Study|Non compliance with protocol|3|||
13377137|NCT00782210|26734373|FG002|Overall Study|Non compliance with protocol|2|||
13377138|NCT00782210|26734371|FG000|Overall Study|Lack of Efficacy|13|||
13377139|NCT00782210|26734372|FG001|Overall Study|Lack of Efficacy|4|||
13377140|NCT00782210|26734373|FG002|Overall Study|Lack of Efficacy|1|||
13377141|NCT00782210|26734371|FG000|Overall Study|Other reason not described above|3|||
13377142|NCT00782210|26734372|FG001|Overall Study|Other reason not described above|2|||
13377143|NCT00782210|26734373|FG002|Overall Study|Other reason not described above|3|||
13377144|NCT00782171|26734412|FG000|Overall Study|Lost to Follow-up|2|||
13377145|NCT00782171|26734413|FG001|Overall Study|Lost to Follow-up|2|||
13377146|NCT00782171|26734412|FG000|Overall Study|Withdrawal by Subject|2|||
13377147|NCT00782171|26734413|FG001|Overall Study|Withdrawal by Subject|1|||
13377148|NCT00782171|26734412|FG000|Overall Study|complications|3|||
13377149|NCT00782171|26734413|FG001|Overall Study|complications|1|||
13377150|NCT00782171|26734412|FG000|Overall Study|others|7|||
13377151|NCT00782171|26734413|FG001|Overall Study|others|9|||
13377152|NCT00782171|26734412|FG000|Overall Study|not eligible|8|||
13377153|NCT00782171|26734413|FG001|Overall Study|not eligible|6|||
13377154|NCT00782067|26734425|FG000|Overall Study|Adverse Event|35|||
13377155|NCT00782067|26734425|FG000|Overall Study|Subject withdrew consent|11|||
13377156|NCT00782067|26734425|FG000|Overall Study|Lost to Follow-up|2|||
13377157|NCT00782067|26734425|FG000|Overall Study|Administrative problems|14|||
13377158|NCT00782067|26734425|FG000|Overall Study|Death|9|||
13377159|NCT00782067|26734425|FG000|Overall Study|Disease progression|43|||
13377160|NCT00782067|26734425|FG000|Overall Study|Protocol deviation|2|||
13377161|NCT00781963|26734448|FG000|Overall Study|Death|3|||
13377162|NCT00781963|26734449|FG001|Overall Study|Death|0|||
13377163|NCT00781963|26734448|FG000|Overall Study|Lost to Follow-up|2|||
13377164|NCT00781963|26734449|FG001|Overall Study|Lost to Follow-up|1|||
13377165|NCT00781963|26734448|FG000|Overall Study|Withdrawal by Subject|3|||
13377166|NCT00781963|26734449|FG001|Overall Study|Withdrawal by Subject|1|||
13377167|NCT00781963|26734448|FG000|Overall Study|Refused follow-up|9|||
13377168|NCT00781963|26734449|FG001|Overall Study|Refused follow-up|0|||
13377169|NCT00781937|26734512|FG000|Main Trial Period Through Week 56|Adverse Event|18|||
13377170|NCT00781937|26734513|FG001|Main Trial Period Through Week 56|Adverse Event|18|||
13377171|NCT00781937|26734512|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0|||
13377172|NCT00781937|26734513|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2|||
13377173|NCT00781937|26734512|FG000|Main Trial Period Through Week 56|Protocol Violation|8|||
13377174|NCT00781937|26734513|FG001|Main Trial Period Through Week 56|Protocol Violation|5|||
13377175|NCT00781937|26734512|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17|||
13377176|NCT00781937|26734513|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24|||
13377177|NCT00781937|26734512|FG000|Main Trial Period Through Week 56|Unclassified|10|||
13377178|NCT00781937|26734513|FG001|Main Trial Period Through Week 56|Unclassified|15|||
13377179|NCT00781937|26734512|FG000|Follow up Period (Week 56-68)|Protocol Violation|1|||
13377180|NCT00781937|26734513|FG001|Follow up Period (Week 56-68)|Protocol Violation|1|||
13377181|NCT00781937|26734512|FG000|Follow up Period (Week 56-68)|Unclassified|5|||
13377182|NCT00781937|26734513|FG001|Follow up Period (Week 56-68)|Unclassified|4|||
13377183|NCT00781911|26734546|FG000|Overall Study|Adverse Event|4|||
13377184|NCT00781911|26734547|FG001|Overall Study|Adverse Event|4|||
13377185|NCT00781911|26734546|FG000|Overall Study|Withdrawal by Subject|1|||
13377186|NCT00781911|26734547|FG001|Overall Study|Withdrawal by Subject|2|||
13377187|NCT00781911|26734546|FG000|Overall Study|Physician Decision|0|||
13377188|NCT00781911|26734547|FG001|Overall Study|Physician Decision|2|||
13377189|NCT00781911|26734546|FG000|Overall Study|Sponsor Decision|1|||
13377190|NCT00781911|26734547|FG001|Overall Study|Sponsor Decision|0|||
13377191|NCT00781885|26734564|FG000|Overall Study|Physician Decision|1|||
13377192|NCT00781859|26734579|FG000|Overall Study|Adverse Event|2|||
13377193|NCT00781859|26734580|FG001|Overall Study|Adverse Event|2|||
13377194|NCT00781859|26734579|FG000|Overall Study|Withdrawal by Subject|8|||
13377195|NCT00781859|26734580|FG001|Overall Study|Withdrawal by Subject|4|||
13377196|NCT00781859|26734579|FG000|Overall Study|Lost to Follow-up|6|||
13377197|NCT00781859|26734580|FG001|Overall Study|Lost to Follow-up|3|||
13377198|NCT00781859|26734579|FG000|Overall Study|Death|3|||
13377199|NCT00781859|26734580|FG001|Overall Study|Death|0|||
13377200|NCT00781768|26734593|FG000|Overall Study|Not transplanted.|0|||
13377201|NCT00781768|26734594|FG001|Overall Study|Not transplanted.|2|||
13377202|NCT00781599|26734613|FG000|Overall Study|Lost to Follow-up|7|||
13377203|NCT00781599|26734614|FG001|Overall Study|Lost to Follow-up|4|||
13377204|NCT00781456|26734641|FG000|Overall Study|Adverse Event|3|||
13377205|NCT00781456|26734642|FG001|Overall Study|Adverse Event|3|||
13377206|NCT00781456|26734641|FG000|Overall Study|Withdrawal by Subject|3|||
13377207|NCT00781456|26734642|FG001|Overall Study|Withdrawal by Subject|5|||
13377208|NCT00781456|26734641|FG000|Overall Study|Protocol Violation|4|||
13377209|NCT00781456|26734642|FG001|Overall Study|Protocol Violation|1|||
13377210|NCT00781456|26734641|FG000|Overall Study|Noncompliance With Protocol|1|||
13377211|NCT00781456|26734642|FG001|Overall Study|Noncompliance With Protocol|1|||
13377212|NCT00781456|26734641|FG000|Overall Study|Lost to Follow-up|10|||
13377213|NCT00781456|26734642|FG001|Overall Study|Lost to Follow-up|5|||
13377214|NCT00781456|26734641|FG000|Overall Study|Other Reason, Unknown|0|||
13377215|NCT00781456|26734642|FG001|Overall Study|Other Reason, Unknown|1|||
13377216|NCT00781391|26734684|FG000|Overall Study|never received study drug|24|||
13377217|NCT00781391|26734685|FG001|Overall Study|never received study drug|23|||
13377218|NCT00781391|26734686|FG002|Overall Study|never received study drug|32|||
13377219|NCT00781391|26734684|FG000|Overall Study|Protocol Violation|19|||
13377220|NCT00781391|26734685|FG001|Overall Study|Protocol Violation|17|||
13377221|NCT00781391|26734686|FG002|Overall Study|Protocol Violation|20|||
13377222|NCT00781391|26734684|FG000|Overall Study|Death|789|||
13377223|NCT00781391|26734685|FG001|Overall Study|Death|730|||
13377224|NCT00781391|26734686|FG002|Overall Study|Death|706|||
13377225|NCT00781391|26734684|FG000|Overall Study|Withdrawal by Subject|47|||
13377226|NCT00781391|26734685|FG001|Overall Study|Withdrawal by Subject|37|||
13377227|NCT00781391|26734686|FG002|Overall Study|Withdrawal by Subject|25|||
13377228|NCT00781391|26734684|FG000|Overall Study|Lost to Follow-up|0|||
13377229|NCT00781391|26734685|FG001|Overall Study|Lost to Follow-up|0|||
13377230|NCT00781391|26734686|FG002|Overall Study|Lost to Follow-up|1|||
13377231|NCT00781365|26734703|FG000|Overall Study|Withdrawal by Subject|13|||
13377232|NCT00781365|26734704|FG001|Overall Study|Withdrawal by Subject|8|||
13377233|NCT00781365|26734703|FG000|Overall Study|Did Not Attend Visit|20|||
13377234|NCT00781365|26734704|FG001|Overall Study|Did Not Attend Visit|28|||
13377235|NCT00781365|26734703|FG000|Overall Study|Language barrier|1|||
13377236|NCT00781365|26734704|FG001|Overall Study|Language barrier|0|||
13377237|NCT00781326|26734710|FG000|Phase I|Adverse Event|1|||
13377238|NCT00781326|26734710|FG000|Phase I|Withdrawal by Subject|1|||
13377239|NCT00781326|26734710|FG000|Phase I|Physician Decision|2|||
13377240|NCT00781274|26734716|FG000|Overall Study|Withdrawal by Subject|2|||
13377241|NCT00780975|26734727|FG000|Overall Study|Progressive disease|3|||
13377242|NCT00780975|26734727|FG000|Overall Study|Toxicity|5|||
13377243|NCT00780910|26734733|FG000|Overall Study|Adverse Event|2|||
13377244|NCT00780559|26734754|FG000|Overall Study|Lost to Follow-up|2|||
13377245|NCT00780559|26734755|FG001|Overall Study|Lost to Follow-up|7|||
13377246|NCT00780559|26734754|FG000|Overall Study|Death|1|||
13377247|NCT00780559|26734755|FG001|Overall Study|Death|0|||
13377248|NCT00780416|26734768|FG000|Overall Study|Physician Decision|3|||
13377249|NCT00780416|26734769|FG001|Overall Study|Physician Decision|3|||
13377250|NCT00780416|26734768|FG000|Overall Study|Protocol Violation|1|||
13377251|NCT00780416|26734769|FG001|Overall Study|Protocol Violation|0|||
13377252|NCT00780416|26734768|FG000|Overall Study|Withdrawal by Subject|8|||
13377253|NCT00780416|26734769|FG001|Overall Study|Withdrawal by Subject|6|||
13377254|NCT00780273|26734780|FG000|Overall Study|Death|1|||
13377255|NCT00780273|26734780|FG000|Overall Study|Lost to Follow-up|1|||
13377256|NCT00780143|26734788|FG000|Overall Study|Progressive disease|1|||
13377257|NCT00780143|26734788|FG000|Overall Study|Toxicity|1|||
13377258|NCT00780143|26734788|FG000|Overall Study|Adverse Event|1|||
13377259|NCT00779909|26734843|FG000|Overall Study|Lost to Follow-up|1|||
13377260|NCT00779909|26734844|FG001|Overall Study|Lost to Follow-up|0|||
13377261|NCT00779909|26734845|FG002|Overall Study|Lost to Follow-up|0|||
13377262|NCT00779909|26734846|FG003|Overall Study|Lost to Follow-up|1|||
13377263|NCT00779909|26734843|FG000|Overall Study|Withdrawal by Subject|0|||
13377264|NCT00779909|26734844|FG001|Overall Study|Withdrawal by Subject|1|||
13377265|NCT00779909|26734845|FG002|Overall Study|Withdrawal by Subject|0|||
13377266|NCT00779909|26734846|FG003|Overall Study|Withdrawal by Subject|0|||
13377267|NCT00779857|26734853|FG000|Overall Study|Death|1|||
13377268|NCT00779857|26734853|FG000|Overall Study|Withdrawal by Subject|3|||
13377269|NCT00779857|26734853|FG000|Overall Study|Missed Visit|2|||
13377270|NCT00779779|26734862|FG000|Overall Study|Adverse Event|1|||
13377271|NCT00779779|26734862|FG000|Overall Study|Protocol Violation|14|||
13377272|NCT00779779|26734862|FG000|Overall Study|Withdrawal by Subject|4|||
13377273|NCT00779779|26734862|FG000|Overall Study|Lost to Follow-up|5|||
13377274|NCT00779766|26734953|FG000|Month 24|Serious Adverse Event|2|||
13377275|NCT00779766|26734954|FG001|Month 24|Serious Adverse Event|3|||
13377276|NCT00779766|26734953|FG000|Month 24|Adverse Event|3|||
13377277|NCT00779766|26734954|FG001|Month 24|Adverse Event|3|||
13377278|NCT00779766|26734953|FG000|Month 24|Protocol Violation|3|||
13377279|NCT00779766|26734954|FG001|Month 24|Protocol Violation|1|||
13377280|NCT00779766|26734953|FG000|Month 24|Withdrawal by Subject|159|||
13377281|NCT00779766|26734954|FG001|Month 24|Withdrawal by Subject|127|||
13377282|NCT00779766|26734953|FG000|Month 24|Migrated/moved from study area|138|||
13377283|NCT00779766|26734954|FG001|Month 24|Migrated/moved from study area|162|||
13377284|NCT00779766|26734953|FG000|Month 24|Lost to Follow-up|9|||
13377285|NCT00779766|26734954|FG001|Month 24|Lost to Follow-up|9|||
13377286|NCT00779766|26734953|FG000|Month 24|Other|18|||
13377287|NCT00779766|26734954|FG001|Month 24|Other|27|||
13377288|NCT00779766|26734953|FG000|Month 48|Withdrawal by Subject|68|||
13377289|NCT00779766|26734954|FG001|Month 48|Withdrawal by Subject|63|||
13377290|NCT00779766|26734953|FG000|Month 48|Migrated/moved from study area|76|||
13377291|NCT00779766|26734954|FG001|Month 48|Migrated/moved from study area|75|||
13377292|NCT00779766|26734953|FG000|Month 48|Lost to Follow-up|29|||
13377293|NCT00779766|26734954|FG001|Month 48|Lost to Follow-up|30|||
13377294|NCT00779766|26734953|FG000|Month 48|Other|1|||
13377295|NCT00779766|26734954|FG001|Month 48|Other|0|||
13377296|NCT00779766|26734953|FG000|Month 72|Withdrawal by Subject|55|||
13377297|NCT00779766|26734954|FG001|Month 72|Withdrawal by Subject|71|||
13377298|NCT00779766|26734953|FG000|Month 72|Migrated/moved from study area|124|||
13377299|NCT00779766|26734954|FG001|Month 72|Migrated/moved from study area|109|||
13377300|NCT00779766|26734953|FG000|Month 72|Lost to Follow-up|6|||
13377301|NCT00779766|26734954|FG001|Month 72|Lost to Follow-up|8|||
13377302|NCT00779766|26734953|FG000|Month 72|Other|0|||
13377303|NCT00779766|26734954|FG001|Month 72|Other|1|||
13488572|NCT00409773|27043864|FG001|Overall Study|Protocol Violation|2|||
13377304|NCT00779675|26734975|FG000|Treatment Period|Adverse Event|87|||
13377305|NCT00779675|26734975|FG000|Treatment Period|Treatment Failure|80|||
13377306|NCT00779675|26734975|FG000|Treatment Period|Transferred to Another Study|38|||
13377307|NCT00779675|26734975|FG000|Treatment Period|Lost to Follow-up|23|||
13377308|NCT00779675|26734975|FG000|Treatment Period|Withdrawal by Subject|46|||
13377309|NCT00779675|26734975|FG000|Treatment Period|Protocol Violation|54|||
13377310|NCT00779675|26734975|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1|||
13377311|NCT00779675|26734975|FG000|Treatment Period|Administrative|3|||
13393973|NCT00661492|26785333|FG000|Overall Study|Lost to Follow-up|0|||
13377312|NCT00779675|26734975|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9|||
13377313|NCT00779675|26734975|FG000|Extended Treatment Period|Protocol Violation|13|||
13377314|NCT00779675|26734975|FG000|Extended Treatment Period|Adverse Event|6|||
13377315|NCT00779675|26734975|FG000|Extended Treatment Period|Treatment Failure|11|||
13377316|NCT00779675|26734975|FG000|Extended Treatment Period|Protocol defined clinical event|1|||
13377317|NCT00779675|26734975|FG000|Extended Treatment Period|Lost to Follow-up|6|||
13377318|NCT00779584|26735077|FG000|Overall Study|Protocol Violation|0|||
13377319|NCT00779584|26735078|FG001|Overall Study|Protocol Violation|0|||
13377320|NCT00779584|26735079|FG002|Overall Study|Protocol Violation|0|||
13377321|NCT00779584|26735080|FG003|Overall Study|Protocol Violation|0|||
13377322|NCT00779584|26735081|FG004|Overall Study|Protocol Violation|0|||
13377323|NCT00779584|26735082|FG005|Overall Study|Protocol Violation|1|||
13377324|NCT00779584|26735083|FG006|Overall Study|Protocol Violation|0|||
13377325|NCT00779584|26735084|FG007|Overall Study|Protocol Violation|0|||
13377326|NCT00779584|26735085|FG008|Overall Study|Protocol Violation|0|||
13377327|NCT00779584|26735077|FG000|Overall Study|Withdrawal by Subject|1|||
13377328|NCT00779584|26735078|FG001|Overall Study|Withdrawal by Subject|1|||
13377329|NCT00779584|26735079|FG002|Overall Study|Withdrawal by Subject|2|||
13377330|NCT00779584|26735080|FG003|Overall Study|Withdrawal by Subject|0|||
13377331|NCT00779584|26735081|FG004|Overall Study|Withdrawal by Subject|0|||
13377332|NCT00779584|26735082|FG005|Overall Study|Withdrawal by Subject|2|||
13377333|NCT00779584|26735083|FG006|Overall Study|Withdrawal by Subject|1|||
13377334|NCT00779584|26735084|FG007|Overall Study|Withdrawal by Subject|0|||
13377335|NCT00779584|26735085|FG008|Overall Study|Withdrawal by Subject|0|||
13377336|NCT00779584|26735077|FG000|Overall Study|Lost to Follow-up|0|||
13377337|NCT00779584|26735078|FG001|Overall Study|Lost to Follow-up|0|||
13377338|NCT00779584|26735079|FG002|Overall Study|Lost to Follow-up|0|||
13377339|NCT00779584|26735080|FG003|Overall Study|Lost to Follow-up|0|||
13377340|NCT00779584|26735081|FG004|Overall Study|Lost to Follow-up|1|||
13377341|NCT00779584|26735082|FG005|Overall Study|Lost to Follow-up|0|||
13377342|NCT00779584|26735083|FG006|Overall Study|Lost to Follow-up|0|||
13377343|NCT00779584|26735084|FG007|Overall Study|Lost to Follow-up|0|||
13377344|NCT00779584|26735085|FG008|Overall Study|Lost to Follow-up|0|||
13377345|NCT00779584|26735077|FG000|Overall Study|Progression of Disease|0|||
13377346|NCT00779584|26735078|FG001|Overall Study|Progression of Disease|1|||
13377347|NCT00779584|26735079|FG002|Overall Study|Progression of Disease|2|||
13377348|NCT00779584|26735080|FG003|Overall Study|Progression of Disease|6|||
13377349|NCT00779584|26735081|FG004|Overall Study|Progression of Disease|5|||
13377350|NCT00779584|26735082|FG005|Overall Study|Progression of Disease|1|||
13377351|NCT00779584|26735083|FG006|Overall Study|Progression of Disease|4|||
13377352|NCT00779584|26735084|FG007|Overall Study|Progression of Disease|2|||
13377353|NCT00779584|26735085|FG008|Overall Study|Progression of Disease|1|||
13377354|NCT00779584|26735077|FG000|Overall Study|Adverse Event|1|||
13377355|NCT00779584|26735078|FG001|Overall Study|Adverse Event|0|||
13377356|NCT00779584|26735079|FG002|Overall Study|Adverse Event|2|||
13377357|NCT00779584|26735080|FG003|Overall Study|Adverse Event|0|||
13377358|NCT00779584|26735081|FG004|Overall Study|Adverse Event|0|||
13377359|NCT00779584|26735082|FG005|Overall Study|Adverse Event|0|||
13377360|NCT00779584|26735083|FG006|Overall Study|Adverse Event|2|||
13377361|NCT00779584|26735084|FG007|Overall Study|Adverse Event|1|||
13377362|NCT00779584|26735085|FG008|Overall Study|Adverse Event|1|||
13377363|NCT00779584|26735077|FG000|Overall Study|Symptomatic Deterioration|1|||
13377364|NCT00779584|26735078|FG001|Overall Study|Symptomatic Deterioration|1|||
13377365|NCT00779584|26735079|FG002|Overall Study|Symptomatic Deterioration|1|||
13377366|NCT00779584|26735080|FG003|Overall Study|Symptomatic Deterioration|0|||
13377367|NCT00779584|26735081|FG004|Overall Study|Symptomatic Deterioration|0|||
13377368|NCT00779584|26735082|FG005|Overall Study|Symptomatic Deterioration|1|||
13377369|NCT00779584|26735083|FG006|Overall Study|Symptomatic Deterioration|1|||
13377370|NCT00779584|26735084|FG007|Overall Study|Symptomatic Deterioration|0|||
13377371|NCT00779584|26735085|FG008|Overall Study|Symptomatic Deterioration|0|||
13377372|NCT00779584|26735077|FG000|Overall Study|Ongoing in Study|0|||
13377373|NCT00779584|26735078|FG001|Overall Study|Ongoing in Study|0|||
13377374|NCT00779584|26735079|FG002|Overall Study|Ongoing in Study|0|||
13377375|NCT00779584|26735080|FG003|Overall Study|Ongoing in Study|0|||
13377376|NCT00779584|26735081|FG004|Overall Study|Ongoing in Study|1|||
13488573|NCT00409773|27043865|FG002|Overall Study|Protocol Violation|3|||
13377377|NCT00779584|26735082|FG005|Overall Study|Ongoing in Study|1|||
13377378|NCT00779584|26735083|FG006|Overall Study|Ongoing in Study|0|||
13377379|NCT00779584|26735084|FG007|Overall Study|Ongoing in Study|0|||
13377380|NCT00779584|26735085|FG008|Overall Study|Ongoing in Study|0|||
13377381|NCT00779506|26735097|FG000|Overall Study|Screening Failed|2|||
13377382|NCT00779506|26735097|FG000|Overall Study|Adverse Event|4|||
13377383|NCT00779506|26735097|FG000|Overall Study|Lack of Efficacy|11|||
13377384|NCT00779506|26735097|FG000|Overall Study|Protocol Violation|5|||
13377385|NCT00779506|26735097|FG000|Overall Study|Withdrawal by Subject|6|||
13377386|NCT00779506|26735097|FG000|Overall Study|Lost to Follow-up|1|||
13377387|NCT00779467|26735148|FG000|Overall Study|Lack of Efficacy|11|||
13377388|NCT00779467|26735149|FG001|Overall Study|Lack of Efficacy|2|||
13377389|NCT00779467|26735150|FG002|Overall Study|Lack of Efficacy|6|||
13377390|NCT00779467|26735151|FG003|Overall Study|Lack of Efficacy|11|||
13377391|NCT00779467|26735148|FG000|Overall Study|failed inclusion criteria|3|||
13377392|NCT00779467|26735149|FG001|Overall Study|failed inclusion criteria|3|||
13377393|NCT00779467|26735150|FG002|Overall Study|failed inclusion criteria|1|||
13377394|NCT00779467|26735151|FG003|Overall Study|failed inclusion criteria|2|||
13377395|NCT00779467|26735148|FG000|Overall Study|missing data|1|||
13377396|NCT00779467|26735149|FG001|Overall Study|missing data|0|||
13377397|NCT00779467|26735150|FG002|Overall Study|missing data|1|||
13377398|NCT00779467|26735151|FG003|Overall Study|missing data|4|||
13377399|NCT00779467|26735148|FG000|Overall Study|technical issue|0|||
13377400|NCT00779467|26735149|FG001|Overall Study|technical issue|0|||
13377401|NCT00779467|26735150|FG002|Overall Study|technical issue|2|||
13377402|NCT00779467|26735151|FG003|Overall Study|technical issue|1|||
13377403|NCT00779467|26735148|FG000|Overall Study|unavailable research staff|0|||
13377404|NCT00779467|26735149|FG001|Overall Study|unavailable research staff|0|||
13377405|NCT00779467|26735150|FG002|Overall Study|unavailable research staff|0|||
13377406|NCT00779467|26735151|FG003|Overall Study|unavailable research staff|1|||
13377407|NCT00779402|26735166|FG000|Treatment Phase 1|Disease Progression|1|||
13377408|NCT00779402|26735167|FG001|Treatment Phase 1|Disease Progression|0|||
13377409|NCT00779402|26735166|FG000|Treatment Phase 1|Adverse Event|2|||
13377410|NCT00779402|26735167|FG001|Treatment Phase 1|Adverse Event|0|||
13377411|NCT00779402|26735166|FG000|Treatment Phase 1|Protocol Violation|1|||
13377412|NCT00779402|26735167|FG001|Treatment Phase 1|Protocol Violation|0|||
13377413|NCT00779402|26735166|FG000|Treatment Phase 1|Patient Refused to Continue|17|||
13377414|NCT00779402|26735167|FG001|Treatment Phase 1|Patient Refused to Continue|2|||
13377415|NCT00779402|26735166|FG000|Treatment Phase 1|Lost to Follow-up|0|||
13377416|NCT00779402|26735167|FG001|Treatment Phase 1|Lost to Follow-up|1|||
13377417|NCT00779402|26735166|FG000|Treatment Phase 1|Death|0|||
13377418|NCT00779402|26735167|FG001|Treatment Phase 1|Death|1|||
13377419|NCT00779402|26735166|FG000|Treatment Phase 1|Intercurrent Illness|1|||
13377420|NCT00779402|26735167|FG001|Treatment Phase 1|Intercurrent Illness|1|||
13377421|NCT00779402|26735166|FG000|Treatment Phase 1|Withdrawal by Subject|1|||
13377422|NCT00779402|26735167|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
13377423|NCT00779402|26735166|FG000|Treatment Phase 1|Other|4|||
13377424|NCT00779402|26735167|FG001|Treatment Phase 1|Other|2|||
13377425|NCT00779402|26735166|FG000|Treatment Phase 1|Closure of Study|3|||
13377426|NCT00779402|26735167|FG001|Treatment Phase 1|Closure of Study|2|||
13377427|NCT00779402|26735166|FG000|Treatment Phase 1|Completed Protocol Visits|3|||
13377428|NCT00779402|26735167|FG001|Treatment Phase 1|Completed Protocol Visits|6|||
13377429|NCT00779402|26735166|FG000|Surveillance Phase|Protocol Violation|0|||
13377430|NCT00779402|26735167|FG001|Surveillance Phase|Protocol Violation|1|||
13377431|NCT00779402|26735166|FG000|Surveillance Phase|Patient refused to continue|22|||
13377432|NCT00779402|26735167|FG001|Surveillance Phase|Patient refused to continue|14|||
13377433|NCT00779402|26735166|FG000|Surveillance Phase|Lost to Follow-up|2|||
13377434|NCT00779402|26735167|FG001|Surveillance Phase|Lost to Follow-up|1|||
13377435|NCT00779402|26735166|FG000|Surveillance Phase|Death|0|||
13377436|NCT00779402|26735167|FG001|Surveillance Phase|Death|1|||
13377437|NCT00779402|26735166|FG000|Surveillance Phase|Intercurrent Illness|2|||
13377438|NCT00779402|26735167|FG001|Surveillance Phase|Intercurrent Illness|0|||
13377439|NCT00779402|26735166|FG000|Surveillance Phase|Other|5|||
13377440|NCT00779402|26735167|FG001|Surveillance Phase|Other|5|||
13377441|NCT00779402|26735166|FG000|Surveillance Phase|Withdrawal by Subject|4|||
13377442|NCT00779402|26735167|FG001|Surveillance Phase|Withdrawal by Subject|1|||
13377443|NCT00779402|26735166|FG000|Surveillance Phase|Closure of study|5|||
13377444|NCT00779402|26735167|FG001|Surveillance Phase|Closure of study|6|||
13377445|NCT00779402|26735166|FG000|Surveillance Phase|Completed Protocol Visits|3|||
13377446|NCT00779402|26735167|FG001|Surveillance Phase|Completed Protocol Visits|2|||
13377447|NCT00779402|26735166|FG000|Long-term Follow-up|Patient refused to continue|2|||
13377448|NCT00779402|26735167|FG001|Long-term Follow-up|Patient refused to continue|0|||
13377449|NCT00779402|26735166|FG000|Long-term Follow-up|Other|5|||
13377450|NCT00779402|26735167|FG001|Long-term Follow-up|Other|0|||
13377451|NCT00779402|26735166|FG000|Long-term Follow-up|Closure of Study|8|||
13377452|NCT00779402|26735167|FG001|Long-term Follow-up|Closure of Study|4|||
13377453|NCT00779402|26735166|FG000|Long-term Follow-up|Completed Protocol Visits|6|||
13377454|NCT00779402|26735167|FG001|Long-term Follow-up|Completed Protocol Visits|2|||
13377455|NCT00779324|26735198|FG000|Overall Study|Lost to Follow-up|2|||
13377456|NCT00779324|26735199|FG001|Overall Study|Lost to Follow-up|1|||
13377457|NCT00779324|26735198|FG000|Overall Study|Withdrawal by Subject|4|||
13377458|NCT00779324|26735199|FG001|Overall Study|Withdrawal by Subject|2|||
13377459|NCT00779324|26735198|FG000|Overall Study|Missed visit|1|||
13377460|NCT00779324|26735199|FG001|Overall Study|Missed visit|1|||
13377461|NCT00779259|26735220|FG000|Quinine Alone|Adverse Event|2|||
13393974|NCT00661492|26785334|FG001|Overall Study|Lost to Follow-up|1|||
13393975|NCT00661492|26785333|FG000|Overall Study|Other|1|||
13393976|NCT00661492|26785334|FG001|Overall Study|Other|0|||
13393977|NCT00661427|26785349|FG000|Overall Study|Adverse Event|5|||
13393978|NCT00661427|26785350|FG001|Overall Study|Adverse Event|5|||
13377462|NCT00779246|26735237|FG000|Overall Study|Missing sufficient data for analysis|33|||
13377463|NCT00779246|26735238|FG001|Overall Study|Missing sufficient data for analysis|53|||
13377464|NCT00779142|26735246|FG000|Overall Study|Screen Failures|3|||
13377465|NCT00779038|26735257|FG000|Overall Study|Study Prematurely Terminated|13|||
13377466|NCT00779025|26735268|FG000|Overall Study|Withdrawal by Subject|1|||
13377467|NCT00778921|26735292|FG000|Overall Study|Adverse Event|9|||
13377468|NCT00778921|26735293|FG001|Overall Study|Adverse Event|10|||
13377469|NCT00778921|26735294|FG002|Overall Study|Adverse Event|14|||
13377470|NCT00778921|26735292|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
13377471|NCT00778921|26735293|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
13377472|NCT00778921|26735294|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
13377473|NCT00778921|26735292|FG000|Overall Study|Abnormal Test Procedure Result(s)|0|||
13377474|NCT00778921|26735293|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
13377475|NCT00778921|26735294|FG002|Overall Study|Abnormal Test Procedure Result(s)|2|||
13377476|NCT00778921|26735292|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
13377477|NCT00778921|26735293|FG001|Overall Study|Unsatisfactory therapeutic response|1|||
13377478|NCT00778921|26735294|FG002|Overall Study|Unsatisfactory therapeutic response|1|||
13377479|NCT00778921|26735292|FG000|Overall Study|Patient No Longer Requires Study Drug|0|||
13377480|NCT00778921|26735293|FG001|Overall Study|Patient No Longer Requires Study Drug|1|||
13377481|NCT00778921|26735294|FG002|Overall Study|Patient No Longer Requires Study Drug|0|||
13377482|NCT00778921|26735292|FG000|Overall Study|Patient withdrew request|3|||
13377483|NCT00778921|26735293|FG001|Overall Study|Patient withdrew request|1|||
13377484|NCT00778921|26735294|FG002|Overall Study|Patient withdrew request|6|||
13377485|NCT00778921|26735292|FG000|Overall Study|Lost to Follow-up|0|||
13377486|NCT00778921|26735293|FG001|Overall Study|Lost to Follow-up|2|||
13377487|NCT00778921|26735294|FG002|Overall Study|Lost to Follow-up|1|||
13377488|NCT00778921|26735292|FG000|Overall Study|Administrative Problems|1|||
13377489|NCT00778921|26735293|FG001|Overall Study|Administrative Problems|2|||
13377490|NCT00778921|26735294|FG002|Overall Study|Administrative Problems|0|||
13377491|NCT00778921|26735292|FG000|Overall Study|Protocol Violation|3|||
13377492|NCT00778921|26735293|FG001|Overall Study|Protocol Violation|0|||
13377493|NCT00778921|26735294|FG002|Overall Study|Protocol Violation|2|||
13377494|NCT00778921|26735292|FG000|Overall Study|Not treated|0|||
13377495|NCT00778921|26735293|FG001|Overall Study|Not treated|2|||
13377496|NCT00778921|26735294|FG002|Overall Study|Not treated|2|||
13377497|NCT00778895|26735342|FG000|Active Phase|Adverse Event|3|||
13377498|NCT00778895|26735343|FG001|Active Phase|Adverse Event|1|||
13377499|NCT00778895|26735344|FG002|Active Phase|Adverse Event|0|||
13377500|NCT00778895|26735342|FG000|Active Phase|Withdrawal by Subject|1|||
13377501|NCT00778895|26735343|FG001|Active Phase|Withdrawal by Subject|4|||
13377502|NCT00778895|26735344|FG002|Active Phase|Withdrawal by Subject|0|||
13377503|NCT00778895|26735342|FG000|Active Phase|Lost to Follow-up|1|||
13377504|NCT00778895|26735343|FG001|Active Phase|Lost to Follow-up|1|||
13377505|NCT00778895|26735344|FG002|Active Phase|Lost to Follow-up|0|||
13377506|NCT00778895|26735342|FG000|Active Phase|Other|2|||
13377507|NCT00778895|26735343|FG001|Active Phase|Other|0|||
13377508|NCT00778895|26735344|FG002|Active Phase|Other|0|||
13377509|NCT00778895|26735342|FG000|ESFU Phase|Adverse Event|2|||
13377510|NCT00778895|26735343|FG001|ESFU Phase|Adverse Event|1|||
13377511|NCT00778895|26735344|FG002|ESFU Phase|Adverse Event|0|||
13377512|NCT00778895|26735342|FG000|ESFU Phase|Withdrawal by Subject|1|||
13377513|NCT00778895|26735343|FG001|ESFU Phase|Withdrawal by Subject|4|||
13377514|NCT00778895|26735344|FG002|ESFU Phase|Withdrawal by Subject|0|||
13377515|NCT00778895|26735342|FG000|ESFU Phase|Lost to Follow-up|6|||
13377516|NCT00778895|26735343|FG001|ESFU Phase|Lost to Follow-up|7|||
13377517|NCT00778895|26735344|FG002|ESFU Phase|Lost to Follow-up|2|||
13377518|NCT00778895|26735342|FG000|ESFU Phase|Other|2|||
13377519|NCT00778895|26735343|FG001|ESFU Phase|Other|0|||
13377520|NCT00778895|26735344|FG002|ESFU Phase|Other|0|||
13377521|NCT00778830|26735363|FG000|Overall Study|Ongoing at data cut-off|0|||
13377522|NCT00778830|26735364|FG001|Overall Study|Ongoing at data cut-off|1|||
13377523|NCT00778817|26735381|FG000|Overall Study|Adverse Event|2|||
13377524|NCT00778817|26735381|FG000|Overall Study|Withdrawal by Subject|2|||
13377525|NCT00778700|26735472|FG000|Overall Study|Adverse Event|6|||
13377526|NCT00778700|26735473|FG001|Overall Study|Adverse Event|1|||
13377527|NCT00778700|26735474|FG002|Overall Study|Adverse Event|3|||
13377528|NCT00778700|26735475|FG003|Overall Study|Adverse Event|5|||
13377529|NCT00778700|26735472|FG000|Overall Study|Protocol Violation|1|||
13377530|NCT00778700|26735473|FG001|Overall Study|Protocol Violation|1|||
13377531|NCT00778700|26735474|FG002|Overall Study|Protocol Violation|0|||
13377532|NCT00778700|26735475|FG003|Overall Study|Protocol Violation|0|||
13377533|NCT00778700|26735472|FG000|Overall Study|Subject Withdrew Consent|6|||
13377534|NCT00778700|26735473|FG001|Overall Study|Subject Withdrew Consent|4|||
13377535|NCT00778700|26735474|FG002|Overall Study|Subject Withdrew Consent|1|||
13377536|NCT00778700|26735475|FG003|Overall Study|Subject Withdrew Consent|4|||
13377537|NCT00778700|26735472|FG000|Overall Study|Lost to Follow-up|3|||
13377538|NCT00778700|26735473|FG001|Overall Study|Lost to Follow-up|1|||
13377539|NCT00778700|26735474|FG002|Overall Study|Lost to Follow-up|0|||
13377540|NCT00778700|26735475|FG003|Overall Study|Lost to Follow-up|1|||
13377541|NCT00778700|26735472|FG000|Overall Study|Reason not Specified|2|||
13377542|NCT00778700|26735473|FG001|Overall Study|Reason not Specified|0|||
13377543|NCT00778700|26735474|FG002|Overall Study|Reason not Specified|1|||
13377544|NCT00778700|26735475|FG003|Overall Study|Reason not Specified|3|||
13377545|NCT00778700|26735472|FG000|Overall Study|Other|0|||
13377546|NCT00778700|26735473|FG001|Overall Study|Other|0|||
13377547|NCT00778700|26735474|FG002|Overall Study|Other|1|||
13377548|NCT00778700|26735475|FG003|Overall Study|Other|0|||
13377549|NCT00778622|26735538|FG000|Overall Study|Adverse Event|5|||
13377550|NCT00778622|26735539|FG001|Overall Study|Adverse Event|4|||
13377551|NCT00778622|26735540|FG002|Overall Study|Adverse Event|7|||
13377552|NCT00778622|26735538|FG000|Overall Study|Withdrawal by Subject|4|||
13377553|NCT00778622|26735539|FG001|Overall Study|Withdrawal by Subject|5|||
13377554|NCT00778622|26735540|FG002|Overall Study|Withdrawal by Subject|5|||
13377555|NCT00778622|26735538|FG000|Overall Study|Lost to Follow-up|3|||
13377556|NCT00778622|26735539|FG001|Overall Study|Lost to Follow-up|3|||
13377557|NCT00778622|26735540|FG002|Overall Study|Lost to Follow-up|2|||
13377558|NCT00778622|26735538|FG000|Overall Study|Protocol Violation|0|||
13377559|NCT00778622|26735539|FG001|Overall Study|Protocol Violation|3|||
13377560|NCT00778622|26735540|FG002|Overall Study|Protocol Violation|0|||
13377561|NCT00778622|26735538|FG000|Overall Study|Lack of Efficacy|2|||
13377562|NCT00778622|26735539|FG001|Overall Study|Lack of Efficacy|0|||
13377563|NCT00778622|26735540|FG002|Overall Study|Lack of Efficacy|0|||
13377564|NCT00778622|26735538|FG000|Overall Study|immigration|1|||
13377565|NCT00778622|26735539|FG001|Overall Study|immigration|0|||
13377566|NCT00778622|26735540|FG002|Overall Study|immigration|0|||
13377567|NCT00778622|26735538|FG000|Overall Study|Other|1|||
13377568|NCT00778622|26735539|FG001|Overall Study|Other|0|||
13377569|NCT00778622|26735540|FG002|Overall Study|Other|1|||
13377570|NCT00778375|26735552|FG000|Overall Study|Ineligible|3|||
13377571|NCT00778336|26735583|FG000|Index Procedure-Discharge|Death|6|||
13377572|NCT00778336|26735584|FG001|Index Procedure-Discharge|Death|3|||
13377573|NCT00778336|26735585|FG002|Index Procedure-Discharge|Death|2|||
13377574|NCT00778336|26735586|FG003|Index Procedure-Discharge|Death|0|||
13377575|NCT00778336|26735583|FG000|3 Month Follow Up|Lost to Follow-up|15|||
13377576|NCT00778336|26735584|FG001|3 Month Follow Up|Lost to Follow-up|20|||
13377577|NCT00778336|26735585|FG002|3 Month Follow Up|Lost to Follow-up|3|||
13377578|NCT00778336|26735586|FG003|3 Month Follow Up|Lost to Follow-up|0|||
13377579|NCT00778336|26735583|FG000|3 Month Follow Up|Death|8|||
13377580|NCT00778336|26735584|FG001|3 Month Follow Up|Death|3|||
13377581|NCT00778336|26735585|FG002|3 Month Follow Up|Death|2|||
13377582|NCT00778336|26735586|FG003|3 Month Follow Up|Death|0|||
13377583|NCT00778258|26735666|FG000|Overall Study|Adverse Event|1|||
13377584|NCT00778258|26735667|FG001|Overall Study|Adverse Event|0|||
13377585|NCT00778258|26735668|FG002|Overall Study|Adverse Event|0|||
13377586|NCT00778258|26735669|FG003|Overall Study|Adverse Event|0|||
13377587|NCT00778258|26735670|FG004|Overall Study|Adverse Event|0|||
13377588|NCT00778258|26735671|FG005|Overall Study|Adverse Event|1|||
13377589|NCT00778258|26735672|FG006|Overall Study|Adverse Event|0|||
13377590|NCT00778258|26735673|FG007|Overall Study|Adverse Event|0|||
13377591|NCT00778258|26735674|FG008|Overall Study|Adverse Event|0|||
13377592|NCT00778258|26735666|FG000|Overall Study|Lost to Follow-up|0|||
13377593|NCT00778258|26735667|FG001|Overall Study|Lost to Follow-up|0|||
13377594|NCT00778258|26735668|FG002|Overall Study|Lost to Follow-up|2|||
13377595|NCT00778258|26735669|FG003|Overall Study|Lost to Follow-up|0|||
13377596|NCT00778258|26735670|FG004|Overall Study|Lost to Follow-up|0|||
13377597|NCT00778258|26735671|FG005|Overall Study|Lost to Follow-up|3|||
13377598|NCT00778258|26735672|FG006|Overall Study|Lost to Follow-up|2|||
13377599|NCT00778258|26735673|FG007|Overall Study|Lost to Follow-up|2|||
13377600|NCT00778258|26735674|FG008|Overall Study|Lost to Follow-up|0|||
13377601|NCT00778258|26735666|FG000|Overall Study|Withdrawal by Subject|6|||
13377602|NCT00778258|26735667|FG001|Overall Study|Withdrawal by Subject|2|||
13377603|NCT00778258|26735668|FG002|Overall Study|Withdrawal by Subject|8|||
13377604|NCT00778258|26735669|FG003|Overall Study|Withdrawal by Subject|2|||
13377605|NCT00778258|26735670|FG004|Overall Study|Withdrawal by Subject|0|||
13377606|NCT00778258|26735671|FG005|Overall Study|Withdrawal by Subject|6|||
13377607|NCT00778258|26735672|FG006|Overall Study|Withdrawal by Subject|12|||
13377608|NCT00778258|26735673|FG007|Overall Study|Withdrawal by Subject|12|||
13377609|NCT00778258|26735674|FG008|Overall Study|Withdrawal by Subject|4|||
13377610|NCT00778258|26735666|FG000|Overall Study|New Contraindication|0|||
13377611|NCT00778258|26735667|FG001|Overall Study|New Contraindication|0|||
13377612|NCT00778258|26735668|FG002|Overall Study|New Contraindication|0|||
13377613|NCT00778258|26735669|FG003|Overall Study|New Contraindication|0|||
13377614|NCT00778258|26735670|FG004|Overall Study|New Contraindication|0|||
13377615|NCT00778258|26735671|FG005|Overall Study|New Contraindication|0|||
13377616|NCT00778258|26735672|FG006|Overall Study|New Contraindication|0|||
13377617|NCT00778258|26735673|FG007|Overall Study|New Contraindication|1|||
13377618|NCT00778258|26735674|FG008|Overall Study|New Contraindication|0|||
13377619|NCT00778258|26735666|FG000|Overall Study|Non-compliance|0|||
13377620|NCT00778258|26735667|FG001|Overall Study|Non-compliance|0|||
13377621|NCT00778258|26735668|FG002|Overall Study|Non-compliance|0|||
13377622|NCT00778258|26735669|FG003|Overall Study|Non-compliance|1|||
13377623|NCT00778258|26735670|FG004|Overall Study|Non-compliance|0|||
13377624|NCT00778258|26735671|FG005|Overall Study|Non-compliance|0|||
13377625|NCT00778258|26735672|FG006|Overall Study|Non-compliance|0|||
13377626|NCT00778258|26735673|FG007|Overall Study|Non-compliance|0|||
13377627|NCT00778258|26735674|FG008|Overall Study|Non-compliance|0|||
13377628|NCT00778258|26735666|FG000|Overall Study|Other|0|||
13377629|NCT00778258|26735667|FG001|Overall Study|Other|0|||
13377630|NCT00778258|26735668|FG002|Overall Study|Other|0|||
13377631|NCT00778258|26735669|FG003|Overall Study|Other|0|||
13377632|NCT00778258|26735670|FG004|Overall Study|Other|0|||
13377633|NCT00778258|26735671|FG005|Overall Study|Other|0|||
13377634|NCT00778258|26735672|FG006|Overall Study|Other|1|||
13377635|NCT00778258|26735673|FG007|Overall Study|Other|0|||
13377636|NCT00778258|26735674|FG008|Overall Study|Other|0|||
13377637|NCT00778102|26735713|FG000|Overall Study|Adverse Event|8|||
13377638|NCT00778102|26735714|FG001|Overall Study|Adverse Event|5|||
13377639|NCT00778102|26735713|FG000|Overall Study|Death|1|||
13377640|NCT00778102|26735714|FG001|Overall Study|Death|1|||
13377641|NCT00778102|26735713|FG000|Overall Study|Lost to Follow-up|1|||
13377642|NCT00778102|26735714|FG001|Overall Study|Lost to Follow-up|0|||
13377643|NCT00778102|26735713|FG000|Overall Study|Violation of Selection Criteria|1|||
13377644|NCT00778102|26735714|FG001|Overall Study|Violation of Selection Criteria|1|||
13377645|NCT00778102|26735713|FG000|Overall Study|Protocol Violation|0|||
13377646|NCT00778102|26735714|FG001|Overall Study|Protocol Violation|1|||
13377647|NCT00778102|26735713|FG000|Overall Study|Refused Treatment|2|||
13377648|NCT00778102|26735714|FG001|Overall Study|Refused Treatment|3|||
13377649|NCT00778102|26735713|FG000|Overall Study|Withdrawal by Subject|1|||
13377650|NCT00778102|26735714|FG001|Overall Study|Withdrawal by Subject|1|||
13377651|NCT00778102|26735713|FG000|Overall Study|Administrative Reason|7|||
13377652|NCT00778102|26735714|FG001|Overall Study|Administrative Reason|10|||
13377653|NCT00777946|26735747|FG000|Overall Study|Adverse Event|11|||
13377654|NCT00777946|26735748|FG001|Overall Study|Adverse Event|1|||
13377655|NCT00777946|26735749|FG002|Overall Study|Adverse Event|3|||
13377656|NCT00777946|26735747|FG000|Overall Study|Lack of Efficacy|0|||
13377657|NCT00777946|26735748|FG001|Overall Study|Lack of Efficacy|0|||
13377658|NCT00777946|26735749|FG002|Overall Study|Lack of Efficacy|9|||
13377659|NCT00777946|26735747|FG000|Overall Study|Condition no longer required study drug|1|||
13377660|NCT00777946|26735748|FG001|Overall Study|Condition no longer required study drug|0|||
13377661|NCT00777946|26735749|FG002|Overall Study|Condition no longer required study drug|0|||
13377662|NCT00777946|26735747|FG000|Overall Study|Patient withdrew consent|3|||
13377663|NCT00777946|26735748|FG001|Overall Study|Patient withdrew consent|2|||
13377664|NCT00777946|26735749|FG002|Overall Study|Patient withdrew consent|3|||
13377665|NCT00777946|26735747|FG000|Overall Study|Lost to Follow-up|3|||
13377666|NCT00777946|26735748|FG001|Overall Study|Lost to Follow-up|1|||
13377667|NCT00777946|26735749|FG002|Overall Study|Lost to Follow-up|0|||
13377668|NCT00777946|26735747|FG000|Overall Study|Protocol deviation|2|||
13377669|NCT00777946|26735748|FG001|Overall Study|Protocol deviation|1|||
13377670|NCT00777946|26735749|FG002|Overall Study|Protocol deviation|1|||
13377671|NCT00777946|26735747|FG000|Overall Study|Randomized in error|1|||
13377672|NCT00777946|26735748|FG001|Overall Study|Randomized in error|1|||
13377673|NCT00777946|26735749|FG002|Overall Study|Randomized in error|0|||
13377674|NCT00777920|26735755|FG000|Overall Study|Adverse Event|39|||
13377675|NCT00777920|26735755|FG000|Overall Study|Withdrawal of Consent|4|||
13377676|NCT00777920|26735755|FG000|Overall Study|Lost to Follow-up|1|||
13377677|NCT00777920|26735755|FG000|Overall Study|Investigator's discretion|1|||
13377678|NCT00777920|26735755|FG000|Overall Study|Clinical status did not improve|1|||
13377679|NCT00777920|26735755|FG000|Overall Study|Other, not specified|4|||
13377680|NCT00777829|26735766|FG000|Overall Study|Withdrawal by Subject|0|||
13377681|NCT00777829|26735767|FG001|Overall Study|Withdrawal by Subject|2|||
13377682|NCT00777803|26735806|FG000|Overall Study|Lost to Follow-up|12|||
13377683|NCT00777803|26735807|FG001|Overall Study|Lost to Follow-up|5|||
13377684|NCT00777803|26735806|FG000|Overall Study|Adverse Event|1|||
13377685|NCT00777803|26735807|FG001|Overall Study|Adverse Event|0|||
13377686|NCT00777803|26735806|FG000|Overall Study|Non-compliance|2|||
13377687|NCT00777803|26735807|FG001|Overall Study|Non-compliance|2|||
13377688|NCT00777608|26735824|FG000|Overall Study|Lost to Follow-up|1|||
13377689|NCT00777608|26735825|FG001|Overall Study|Lost to Follow-up|1|||
13377690|NCT00777608|26735824|FG000|Overall Study|Withdrawal by Subject|1|||
13377691|NCT00777608|26735825|FG001|Overall Study|Withdrawal by Subject|3|||
13377692|NCT00777608|26735824|FG000|Overall Study|Protocol Violation|1|||
13377693|NCT00777608|26735825|FG001|Overall Study|Protocol Violation|0|||
13377694|NCT00777608|26735824|FG000|Overall Study|Investigator Decision|1|||
13377695|NCT00777608|26735825|FG001|Overall Study|Investigator Decision|2|||
13377696|NCT00777556|26735834|FG000|Overall Study|Inappropriate self-selection|34|||
13377697|NCT00777556|26735834|FG000|Overall Study|Dispensed but did not use product|12|||
13377698|NCT00777556|26735834|FG000|Overall Study|Did not complete all 3 follow-up visits|20|||
13377699|NCT00777296|26735886|FG000|Overall Study|Adverse Event|0|||
13377700|NCT00777296|26735887|FG001|Overall Study|Adverse Event|1|||
13377701|NCT00777296|26735888|FG002|Overall Study|Adverse Event|0|||
13377702|NCT00777296|26735889|FG003|Overall Study|Adverse Event|1|||
13377703|NCT00777296|26735886|FG000|Overall Study|Withdrawal by Subject|1|||
13377704|NCT00777296|26735887|FG001|Overall Study|Withdrawal by Subject|0|||
13377705|NCT00777296|26735888|FG002|Overall Study|Withdrawal by Subject|0|||
13377706|NCT00777296|26735889|FG003|Overall Study|Withdrawal by Subject|0|||
13377707|NCT00777296|26735886|FG000|Overall Study|CRF form not completed|0|||
13377708|NCT00777296|26735887|FG001|Overall Study|CRF form not completed|0|||
13377709|NCT00777296|26735888|FG002|Overall Study|CRF form not completed|2|||
13377710|NCT00777296|26735889|FG003|Overall Study|CRF form not completed|0|||
13377711|NCT00777257|26735916|FG000|Overall Study|Adverse Event|3|||
13377712|NCT00777257|26735917|FG001|Overall Study|Adverse Event|1|||
13377713|NCT00777257|26735918|FG002|Overall Study|Adverse Event|0|||
13377714|NCT00777257|26735916|FG000|Overall Study|Lost to Follow-up|3|||
13377715|NCT00777257|26735917|FG001|Overall Study|Lost to Follow-up|3|||
13377716|NCT00777257|26735918|FG002|Overall Study|Lost to Follow-up|2|||
13377717|NCT00777257|26735916|FG000|Overall Study|Protocol Violation|2|||
13377718|NCT00777257|26735917|FG001|Overall Study|Protocol Violation|2|||
13377719|NCT00777257|26735918|FG002|Overall Study|Protocol Violation|2|||
13377720|NCT00777257|26735916|FG000|Overall Study|Withdrawal by Subject|3|||
13377721|NCT00777257|26735917|FG001|Overall Study|Withdrawal by Subject|6|||
13377722|NCT00777257|26735918|FG002|Overall Study|Withdrawal by Subject|5|||
13377723|NCT00777205|26735939|FG000|Overall Study|Lost to Follow-up|25|||
13377724|NCT00777205|26735940|FG001|Overall Study|Lost to Follow-up|9|||
13377725|NCT00777205|26735939|FG000|Overall Study|Withdrawal by Subject|6|||
13393979|NCT00661427|26785349|FG000|Overall Study|Patient not treated|0|||
13393980|NCT00661427|26785350|FG001|Overall Study|Patient not treated|2|||
13393981|NCT00661388|26785373|FG000|Overall Study|Adverse Event|14|||
13393982|NCT00661388|26785373|FG000|Overall Study|Protocol Violation|7|||
13393983|NCT00661388|26785373|FG000|Overall Study|Renal transplantation|1|||
13393984|NCT00661388|26785373|FG000|Overall Study|Dialysis initiation|1|||
13393985|NCT00661388|26785373|FG000|Overall Study|Administrative reasons|1|||
13393986|NCT00661362|26785396|FG000|Overall Study|Adverse Event|5|||
13393987|NCT00661362|26785397|FG001|Overall Study|Adverse Event|4|||
13393988|NCT00661362|26785396|FG000|Overall Study|Incorrect enrollment|2|||
13393989|NCT00661362|26785397|FG001|Overall Study|Incorrect enrollment|0|||
13393990|NCT00661362|26785396|FG000|Overall Study|Study specific discontinuation criteria|4|||
13393991|NCT00661362|26785397|FG001|Overall Study|Study specific discontinuation criteria|11|||
13393992|NCT00661362|26785396|FG000|Overall Study|Withdrawal by Subject|13|||
13393993|NCT00661362|26785397|FG001|Overall Study|Withdrawal by Subject|23|||
13393994|NCT00661362|26785396|FG000|Overall Study|Lost to Follow-up|3|||
13393995|NCT00661362|26785397|FG001|Overall Study|Lost to Follow-up|1|||
13393996|NCT00661362|26785396|FG000|Overall Study|Severe non-compliance to protocol|0|||
13393997|NCT00661362|26785397|FG001|Overall Study|Severe non-compliance to protocol|1|||
13393998|NCT00661362|26785396|FG000|Overall Study|Safety reasons|1|||
13393999|NCT00661362|26785397|FG001|Overall Study|Safety reasons|0|||
13394000|NCT00661362|26785396|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1|||
13394001|NCT00661362|26785397|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0|||
13394002|NCT00661271|26785412|FG000|Overall Study|Lost to Follow-up|28|||
13394003|NCT00661271|26785413|FG001|Overall Study|Lost to Follow-up|25|||
13394004|NCT00661258|26785428|FG000|Overall Study|Death|1|||
13394005|NCT00661258|26785429|FG001|Overall Study|Death|0|||
13394006|NCT00661258|26785428|FG000|Overall Study|caught by police and in detox center|2|||
13394007|NCT00661258|26785429|FG001|Overall Study|caught by police and in detox center|1|||
13394008|NCT00661193|26785444|FG000|Overall Study|Adverse Event|2|||
13394009|NCT00661193|26785445|FG001|Overall Study|Adverse Event|1|||
13394010|NCT00661193|26785444|FG000|Overall Study|Withdrawal by Subject|3|||
13394011|NCT00661193|26785445|FG001|Overall Study|Withdrawal by Subject|1|||
13394012|NCT00661193|26785444|FG000|Overall Study|Progression|27|||
13394013|NCT00661193|26785445|FG001|Overall Study|Progression|24|||
13394014|NCT00661193|26785444|FG000|Overall Study|Not protocol specified|1|||
13394015|NCT00661193|26785445|FG001|Overall Study|Not protocol specified|0|||
13394016|NCT00661089|26785460|FG000|Overall Study|1 subject withdrawal|0|||
13394017|NCT00661089|26785461|FG001|Overall Study|1 subject withdrawal|1|||
13394018|NCT00661089|26785460|FG000|Overall Study|death at 8 weeks due to new stroke|0|||
13394019|NCT00661089|26785461|FG001|Overall Study|death at 8 weeks due to new stroke|1|||
13377726|NCT00777205|26735940|FG001|Overall Study|Withdrawal by Subject|4|||
13377727|NCT00777205|26735939|FG000|Overall Study|Death|0|||
13377728|NCT00777205|26735940|FG001|Overall Study|Death|2|||
13394020|NCT00660907|26785480|FG000|Overall Study|Incorrect Enrollment|1|||
13394021|NCT00660907|26785481|FG001|Overall Study|Incorrect Enrollment|1|||
13394022|NCT00660907|26785480|FG000|Overall Study|Adverse Event|33|||
13394023|NCT00660907|26785481|FG001|Overall Study|Adverse Event|19|||
13394024|NCT00660907|26785480|FG000|Overall Study|Subject No Longer Meets Study Criteria|6|||
13394025|NCT00660907|26785481|FG001|Overall Study|Subject No Longer Meets Study Criteria|27|||
13377729|NCT00777205|26735939|FG000|Overall Study|Protocol Violation|0|||
13377730|NCT00777205|26735940|FG001|Overall Study|Protocol Violation|56|||
13377731|NCT00777153|26735973|FG000|Overall Study|Lost to Follow-up|1|||
13377732|NCT00777153|26735974|FG001|Overall Study|Lost to Follow-up|1|||
13377733|NCT00777153|26735975|FG002|Overall Study|Lost to Follow-up|0|||
13377734|NCT00777153|26735973|FG000|Overall Study|Death|85|||
13377735|NCT00777153|26735974|FG001|Overall Study|Death|73|||
13377736|NCT00777153|26735975|FG002|Overall Study|Death|33|||
13377737|NCT00777153|26735973|FG000|Overall Study|Withdrawal by Subject|3|||
13377738|NCT00777153|26735974|FG001|Overall Study|Withdrawal by Subject|4|||
13377739|NCT00777153|26735975|FG002|Overall Study|Withdrawal by Subject|3|||
13377740|NCT00777153|26735973|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
13377741|NCT00777153|26735974|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5|||
13377742|NCT00777153|26735975|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
13377743|NCT00777101|26736000|FG000|Overall Study|Death|48|||
13377744|NCT00777101|26736001|FG001|Overall Study|Death|43|||
13377745|NCT00777101|26736000|FG000|Overall Study|Withdrawal by Subject|11|||
13377746|NCT00777101|26736001|FG001|Overall Study|Withdrawal by Subject|6|||
13377747|NCT00777101|26736000|FG000|Overall Study|Lost to Follow-up|2|||
13377748|NCT00777101|26736001|FG001|Overall Study|Lost to Follow-up|1|||
13377749|NCT00777101|26736000|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
13377750|NCT00777101|26736001|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
13377751|NCT00777101|26736000|FG000|Overall Study|Failed to Return|0|||
13377752|NCT00777101|26736001|FG001|Overall Study|Failed to Return|1|||
13377753|NCT00777088|26736015|FG000|Overall Study|PED Treatment not attempted|1|||
13377754|NCT00777049|26736028|FG000|Overall Study|Withdrawal by Subject|1|||
13377755|NCT00777049|26736029|FG001|Overall Study|Withdrawal by Subject|0|||
13377756|NCT00777049|26736028|FG000|Overall Study|No treatment (elevated liver enzymes)|0|||
13377757|NCT00777049|26736029|FG001|Overall Study|No treatment (elevated liver enzymes)|1|||
13377758|NCT00777023|26736056|FG000|Overall Study|Adverse Event|15|||
13377759|NCT00777023|26736057|FG001|Overall Study|Adverse Event|21|||
13377760|NCT00777023|26736058|FG002|Overall Study|Adverse Event|8|||
13377761|NCT00777023|26736056|FG000|Overall Study|Lack of Efficacy|1|||
13377762|NCT00777023|26736057|FG001|Overall Study|Lack of Efficacy|0|||
13377763|NCT00777023|26736058|FG002|Overall Study|Lack of Efficacy|14|||
13377764|NCT00777023|26736056|FG000|Overall Study|Protocol Violation|2|||
13377765|NCT00777023|26736057|FG001|Overall Study|Protocol Violation|1|||
13377766|NCT00777023|26736058|FG002|Overall Study|Protocol Violation|1|||
13377767|NCT00777023|26736056|FG000|Overall Study|Lost to Follow-up|2|||
13377768|NCT00777023|26736057|FG001|Overall Study|Lost to Follow-up|3|||
13377769|NCT00777023|26736058|FG002|Overall Study|Lost to Follow-up|3|||
13377770|NCT00777023|26736056|FG000|Overall Study|Death|0|||
13377771|NCT00777023|26736057|FG001|Overall Study|Death|1|||
13377772|NCT00777023|26736058|FG002|Overall Study|Death|0|||
13377773|NCT00777023|26736056|FG000|Overall Study|Withdrawal by Subject|7|||
13377774|NCT00777023|26736057|FG001|Overall Study|Withdrawal by Subject|7|||
13377775|NCT00777023|26736058|FG002|Overall Study|Withdrawal by Subject|8|||
13377776|NCT00777023|26736056|FG000|Overall Study|Missing data|1|||
13377777|NCT00777023|26736057|FG001|Overall Study|Missing data|1|||
13377778|NCT00777023|26736058|FG002|Overall Study|Missing data|0|||
13377779|NCT00777023|26736056|FG000|Overall Study|Reasons not specified|4|||
13377780|NCT00777023|26736057|FG001|Overall Study|Reasons not specified|4|||
13377781|NCT00777023|26736058|FG002|Overall Study|Reasons not specified|2|||
13377782|NCT00777023|26736056|FG000|Overall Study|Last dose date unknown|3|||
13377783|NCT00777023|26736057|FG001|Overall Study|Last dose date unknown|3|||
13377784|NCT00777023|26736058|FG002|Overall Study|Last dose date unknown|1|||
13377785|NCT00776997|26736067|FG000|Overall Study|Adverse Event|2|||
13377786|NCT00776984|26736144|FG000|Overall Study|Adverse Event|8|||
13377787|NCT00776984|26736145|FG001|Overall Study|Adverse Event|2|||
13377788|NCT00776984|26736144|FG000|Overall Study|Protocol Violation|4|||
13377789|NCT00776984|26736145|FG001|Overall Study|Protocol Violation|2|||
13377790|NCT00776984|26736144|FG000|Overall Study|Lost to Follow-up|2|||
13377791|NCT00776984|26736145|FG001|Overall Study|Lost to Follow-up|0|||
13377792|NCT00776984|26736144|FG000|Overall Study|Withdrawal by Subject|12|||
13377793|NCT00776984|26736145|FG001|Overall Study|Withdrawal by Subject|7|||
13377794|NCT00776984|26736144|FG000|Overall Study|Lack of Efficacy|0|||
13377795|NCT00776984|26736145|FG001|Overall Study|Lack of Efficacy|1|||
13377796|NCT00776984|26736144|FG000|Overall Study|Other|5|||
13377797|NCT00776984|26736145|FG001|Overall Study|Other|9|||
13377798|NCT00776919|26736220|FG000|Overall Study|Withdrawal by Subject|16|||
13377799|NCT00776919|26736221|FG001|Overall Study|Withdrawal by Subject|14|||
13377800|NCT00776919|26736222|FG002|Overall Study|Withdrawal by Subject|15|||
13377801|NCT00776919|26736223|FG003|Overall Study|Withdrawal by Subject|26|||
13377802|NCT00776919|26736220|FG000|Overall Study|Lost to Follow-up|8|||
13377803|NCT00776919|26736221|FG001|Overall Study|Lost to Follow-up|12|||
13377804|NCT00776919|26736222|FG002|Overall Study|Lost to Follow-up|11|||
13377805|NCT00776919|26736223|FG003|Overall Study|Lost to Follow-up|8|||
13377806|NCT00776919|26736220|FG000|Overall Study|Adverse Event|1|||
13377807|NCT00776919|26736221|FG001|Overall Study|Adverse Event|0|||
13377808|NCT00776919|26736222|FG002|Overall Study|Adverse Event|2|||
13377809|NCT00776919|26736223|FG003|Overall Study|Adverse Event|2|||
13377810|NCT00776919|26736220|FG000|Overall Study|Protocol Violation|1|||
13377811|NCT00776919|26736221|FG001|Overall Study|Protocol Violation|2|||
13377812|NCT00776919|26736222|FG002|Overall Study|Protocol Violation|0|||
13377813|NCT00776919|26736223|FG003|Overall Study|Protocol Violation|1|||
13377814|NCT00776919|26736220|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1|||
13377815|NCT00776919|26736221|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5|||
13377816|NCT00776919|26736222|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4|||
13377817|NCT00776919|26736223|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2|||
13377818|NCT00776789|26736242|FG000|Overall Study|Consent refusal|2|||
13377819|NCT00776789|26736243|FG001|Overall Study|Consent refusal|2|||
13377820|NCT00776789|26736242|FG000|Overall Study|Poor quality video|1|||
13377821|NCT00776789|26736243|FG001|Overall Study|Poor quality video|1|||
13377822|NCT00776659|26736255|FG000|Overall Study|Lost to Follow-up|15|||
13377823|NCT00776659|26736255|FG000|Overall Study|Withdrawal by Subject|10|||
13377824|NCT00776659|26736255|FG000|Overall Study|Study Terminated by Sponsor|1|||
13377825|NCT00776555|26736272|FG000|Overall Study|Study terminated|3|||
13377826|NCT00776555|26736273|FG001|Overall Study|Study terminated|0|||
13377827|NCT00776230|26736291|FG000|Overall Study|Lost to Follow-up|2|||
13377828|NCT00776230|26736292|FG001|Overall Study|Lost to Follow-up|1|||
13377829|NCT00776230|26736293|FG002|Overall Study|Lost to Follow-up|5|||
13377830|NCT00776230|26736291|FG000|Overall Study|Not vaccinated at Day 0|1|||
13377831|NCT00776230|26736292|FG001|Overall Study|Not vaccinated at Day 0|0|||
13377832|NCT00776230|26736293|FG002|Overall Study|Not vaccinated at Day 0|0|||
13377833|NCT00776230|26736291|FG000|Overall Study|Withdrawal by Subject|0|||
13377834|NCT00776230|26736292|FG001|Overall Study|Withdrawal by Subject|1|||
13377835|NCT00776230|26736293|FG002|Overall Study|Withdrawal by Subject|0|||
13377836|NCT00776230|26736291|FG000|Overall Study|Subject missed Visit 4|0|||
13377837|NCT00776230|26736292|FG001|Overall Study|Subject missed Visit 4|1|||
13377838|NCT00776230|26736293|FG002|Overall Study|Subject missed Visit 4|0|||
13377839|NCT00776100|26736316|FG000|Overall Study|Disease Progression|1|||
13377840|NCT00776100|26736317|FG001|Overall Study|Disease Progression|0|||
13377841|NCT00776009|26736356|FG000|Period 1: First Intervention|Withdrawal by Subject|0|||
13377842|NCT00776009|26736357|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
13377843|NCT00776009|26736358|FG002|Period 1: First Intervention|Withdrawal by Subject|1|||
13377844|NCT00776009|26736359|FG003|Period 1: First Intervention|Withdrawal by Subject|0|||
13377845|NCT00776009|26736360|FG004|Period 1: First Intervention|Withdrawal by Subject|1|||
13377846|NCT00776009|26736361|FG005|Period 1: First Intervention|Withdrawal by Subject|0|||
13377847|NCT00776009|26736356|FG000|Period 1: First Intervention|Protocol Violation|0|||
13377848|NCT00776009|26736357|FG001|Period 1: First Intervention|Protocol Violation|1|||
13377849|NCT00776009|26736358|FG002|Period 1: First Intervention|Protocol Violation|0|||
13377850|NCT00776009|26736359|FG003|Period 1: First Intervention|Protocol Violation|0|||
13377851|NCT00776009|26736360|FG004|Period 1: First Intervention|Protocol Violation|1|||
13377852|NCT00776009|26736361|FG005|Period 1: First Intervention|Protocol Violation|0|||
13377853|NCT00776009|26736356|FG000|Period 2: Second Intervention|Withdrawal by Subject|0|||
13377854|NCT00776009|26736357|FG001|Period 2: Second Intervention|Withdrawal by Subject|0|||
13377855|NCT00776009|26736358|FG002|Period 2: Second Intervention|Withdrawal by Subject|0|||
13377856|NCT00776009|26736359|FG003|Period 2: Second Intervention|Withdrawal by Subject|0|||
13377857|NCT00776009|26736360|FG004|Period 2: Second Intervention|Withdrawal by Subject|0|||
13377858|NCT00776009|26736361|FG005|Period 2: Second Intervention|Withdrawal by Subject|1|||
13377859|NCT00776009|26736356|FG000|Period 2: Second Intervention|Protocol Violation|1|||
13377860|NCT00776009|26736357|FG001|Period 2: Second Intervention|Protocol Violation|0|||
13377861|NCT00776009|26736358|FG002|Period 2: Second Intervention|Protocol Violation|1|||
13377862|NCT00776009|26736359|FG003|Period 2: Second Intervention|Protocol Violation|0|||
13377863|NCT00776009|26736360|FG004|Period 2: Second Intervention|Protocol Violation|0|||
13377864|NCT00776009|26736361|FG005|Period 2: Second Intervention|Protocol Violation|0|||
13377865|NCT00776009|26736356|FG000|Period 3: Third Intervention|Withdrawal by Subject|1|||
13377866|NCT00776009|26736357|FG001|Period 3: Third Intervention|Withdrawal by Subject|0|||
13377867|NCT00776009|26736358|FG002|Period 3: Third Intervention|Withdrawal by Subject|0|||
13377868|NCT00776009|26736359|FG003|Period 3: Third Intervention|Withdrawal by Subject|0|||
13377869|NCT00776009|26736360|FG004|Period 3: Third Intervention|Withdrawal by Subject|0|||
13377870|NCT00776009|26736361|FG005|Period 3: Third Intervention|Withdrawal by Subject|0|||
13377871|NCT00775983|26736376|FG000|Overall Study|Protocol Violation|1|||
13377872|NCT00775983|26736377|FG001|Overall Study|Protocol Violation|2|||
13377873|NCT00775606|26736394|FG000|Overall Study|Study sponsor terminated funding|3|||
13377874|NCT00775606|26736395|FG001|Overall Study|Study sponsor terminated funding|0|||
13377875|NCT00775593|26736404|FG000|Overall Study|Unmet eligibility criteria|6|||
13377876|NCT00775593|26736404|FG000|Overall Study|Death|1|||
13377877|NCT00775528|26736413|FG000|Overall Study|Protocol Violation|1|||
13377878|NCT00775463|26736452|FG000|Overall Study|Withdrawal by Subject|0|||
13377879|NCT00775463|26736453|FG001|Overall Study|Withdrawal by Subject|1|||
13377880|NCT00775463|26736452|FG000|Overall Study|Adverse Event|7|||
13377881|NCT00775463|26736453|FG001|Overall Study|Adverse Event|9|||
13377882|NCT00775463|26736452|FG000|Overall Study|Protocol Violation|2|||
13377883|NCT00775463|26736453|FG001|Overall Study|Protocol Violation|2|||
13377884|NCT00775463|26736452|FG000|Overall Study|Lost to Follow-up|1|||
13377885|NCT00775463|26736453|FG001|Overall Study|Lost to Follow-up|0|||
13377886|NCT00775463|26736452|FG000|Overall Study|Lack of Efficacy|1|||
13377887|NCT00775463|26736453|FG001|Overall Study|Lack of Efficacy|1|||
13377888|NCT00775450|26736496|FG000|Overall Study|Serious Adverse Event|2|||
13377889|NCT00775450|26736497|FG001|Overall Study|Serious Adverse Event|0|||
13377890|NCT00775450|26736498|FG002|Overall Study|Serious Adverse Event|0|||
13377891|NCT00775450|26736499|FG003|Overall Study|Serious Adverse Event|0|||
13377892|NCT00775450|26736500|FG004|Overall Study|Serious Adverse Event|0|||
13377893|NCT00775450|26736496|FG000|Overall Study|Protocol Violation|0|||
13377894|NCT00775450|26736497|FG001|Overall Study|Protocol Violation|0|||
13377895|NCT00775450|26736498|FG002|Overall Study|Protocol Violation|0|||
13377896|NCT00775450|26736499|FG003|Overall Study|Protocol Violation|0|||
13377897|NCT00775450|26736500|FG004|Overall Study|Protocol Violation|1|||
13377898|NCT00775450|26736496|FG000|Overall Study|Withdrawal by Subject|1|||
13377899|NCT00775450|26736497|FG001|Overall Study|Withdrawal by Subject|0|||
13377900|NCT00775450|26736498|FG002|Overall Study|Withdrawal by Subject|0|||
13377901|NCT00775450|26736499|FG003|Overall Study|Withdrawal by Subject|0|||
13377902|NCT00775450|26736500|FG004|Overall Study|Withdrawal by Subject|1|||
13377903|NCT00775437|26736552|FG000|Overall Study|Loss of efficacy|2|||
13377904|NCT00775437|26736552|FG000|Overall Study|Withdrawal by Subject|3|||
13377905|NCT00775437|26736552|FG000|Overall Study|Lost to Follow-up|1|||
13377906|NCT00775268|26736576|FG000|Baseline|Drug not synthesize dose|1|||
13377907|NCT00775268|26736577|FG001|Baseline|Drug not synthesize dose|0|||
13377908|NCT00775268|26736576|FG000|Baseline|Not treated-ineligible per CT|0|||
13377909|NCT00775268|26736577|FG001|Baseline|Not treated-ineligible per CT|1|||
13377910|NCT00775268|26736576|FG000|After 2 Cycles|Participant refused to be scanned further|1|||
13377911|NCT00775268|26736577|FG001|After 2 Cycles|Participant refused to be scanned further|0|||
13377912|NCT00775268|26736576|FG000|After Completion|Participant missed scan appointment|1|||
13377913|NCT00775268|26736577|FG001|After Completion|Participant missed scan appointment|0|||
13377914|NCT00775203|26736616|FG000|Overall Study|Adverse Event|25|||
13377915|NCT00775203|26736617|FG001|Overall Study|Adverse Event|6|||
13377916|NCT00775203|26736616|FG000|Overall Study|Lack of Efficacy|8|||
13377917|NCT00775203|26736617|FG001|Overall Study|Lack of Efficacy|9|||
13377918|NCT00775203|26736616|FG000|Overall Study|Withdrawal by Subject|11|||
13377919|NCT00775203|26736617|FG001|Overall Study|Withdrawal by Subject|9|||
13377920|NCT00775203|26736616|FG000|Overall Study|Lost to Follow-up|11|||
13377921|NCT00775203|26736617|FG001|Overall Study|Lost to Follow-up|15|||
13377922|NCT00775203|26736616|FG000|Overall Study|Administrative reason|2|||
13377923|NCT00775203|26736617|FG001|Overall Study|Administrative reason|0|||
13377924|NCT00775203|26736616|FG000|Overall Study|Noncompliance|4|||
13377925|NCT00775203|26736617|FG001|Overall Study|Noncompliance|2|||
13377926|NCT00775203|26736616|FG000|Overall Study|Protocol Violation|0|||
13377927|NCT00775203|26736617|FG001|Overall Study|Protocol Violation|1|||
13377928|NCT00775203|26736616|FG000|Overall Study|Entered other study|1|||
13377929|NCT00775203|26736617|FG001|Overall Study|Entered other study|0|||
13377930|NCT00775203|26736616|FG000|Overall Study|Physician Decision|0|||
13377931|NCT00775203|26736617|FG001|Overall Study|Physician Decision|1|||
13377932|NCT00775190|26736646|FG000|Overall Study|Lost to Follow-up|2|||
13377933|NCT00775190|26736647|FG001|Overall Study|Lost to Follow-up|3|||
13377934|NCT00775190|26736646|FG000|Overall Study|Withdrawal by Subject|1|||
13377935|NCT00775190|26736647|FG001|Overall Study|Withdrawal by Subject|2|||
13377936|NCT00775190|26736646|FG000|Overall Study|Protocol Violation|1|||
13377937|NCT00775190|26736647|FG001|Overall Study|Protocol Violation|0|||
13377938|NCT00775138|26736706|FG000|Overall Study|Withdrawal by Subject|0|||
13377939|NCT00775138|26736707|FG001|Overall Study|Withdrawal by Subject|0|||
13377940|NCT00775138|26736708|FG002|Overall Study|Withdrawal by Subject|2|||
13377941|NCT00775138|26736709|FG003|Overall Study|Withdrawal by Subject|2|||
13377942|NCT00775138|26736706|FG000|Overall Study|Adverse Event|0|||
13377943|NCT00775138|26736707|FG001|Overall Study|Adverse Event|0|||
13377944|NCT00775138|26736708|FG002|Overall Study|Adverse Event|1|||
13377945|NCT00775138|26736709|FG003|Overall Study|Adverse Event|0|||
13377946|NCT00775021|26736726|FG000|First Intervention|Lost to Follow-up|1|||
13377947|NCT00775021|26736727|FG001|First Intervention|Lost to Follow-up|0|||
13377948|NCT00775021|26736726|FG000|Second Intervention|Adverse Event|0|||
13377949|NCT00775021|26736727|FG001|Second Intervention|Adverse Event|1|||
13377950|NCT00774995|26736778|FG000|Overall Study|Protocol Violation|0|||
13377951|NCT00774995|26736779|FG001|Overall Study|Protocol Violation|0|||
13377952|NCT00774995|26736780|FG002|Overall Study|Protocol Violation|1|||
13377953|NCT00774995|26736781|FG003|Overall Study|Protocol Violation|0|||
13377954|NCT00774852|26736836|FG000|Overall Study|Adverse Event|9|||
13377955|NCT00774852|26736837|FG001|Overall Study|Adverse Event|6|||
13377956|NCT00774852|26736836|FG000|Overall Study|Death|2|||
13377957|NCT00774852|26736837|FG001|Overall Study|Death|1|||
13377958|NCT00774852|26736836|FG000|Overall Study|Lack of Efficacy|3|||
13377959|NCT00774852|26736837|FG001|Overall Study|Lack of Efficacy|7|||
13377960|NCT00774852|26736836|FG000|Overall Study|Lost to Follow-up|9|||
13377961|NCT00774852|26736837|FG001|Overall Study|Lost to Follow-up|5|||
13377962|NCT00774852|26736836|FG000|Overall Study|Physician Decision|2|||
13377963|NCT00774852|26736837|FG001|Overall Study|Physician Decision|6|||
13377964|NCT00774852|26736836|FG000|Overall Study|Pregnancy|1|||
13377965|NCT00774852|26736837|FG001|Overall Study|Pregnancy|2|||
13377966|NCT00774852|26736836|FG000|Overall Study|Withdrawal by Subject|2|||
13377967|NCT00774852|26736837|FG001|Overall Study|Withdrawal by Subject|2|||
13377968|NCT00774852|26736836|FG000|Overall Study|Non-responder|15|||
13377969|NCT00774852|26736837|FG001|Overall Study|Non-responder|11|||
13377970|NCT00774852|26736836|FG000|Overall Study|Subject non-compliance|0|||
13377971|NCT00774852|26736837|FG001|Overall Study|Subject non-compliance|1|||
13377972|NCT00774852|26736836|FG000|Overall Study|Protocol Violation|1|||
13377973|NCT00774852|26736837|FG001|Overall Study|Protocol Violation|0|||
13377974|NCT00774852|26736836|FG000|Overall Study|Subject received prohibited medication|1|||
13377975|NCT00774852|26736837|FG001|Overall Study|Subject received prohibited medication|0|||
13377976|NCT00774800|26736861|FG000|Intervention 4|Withdrawal by Subject|1|||
13377977|NCT00774787|26736870|FG000|Overall Study|Lost to Follow-up|1|||
13377978|NCT00774748|26736880|FG000|Overall Study|Lost to Follow-up|3|||
13377979|NCT00774566|26736905|FG000|Overall Study|Protocol Violation|18|||
13377980|NCT00774566|26736906|FG001|Overall Study|Protocol Violation|15|||
13377981|NCT00774397|26737160|FG000|Overall Study|Adverse Event|1|||
13377982|NCT00774397|26737161|FG001|Overall Study|Adverse Event|3|||
13377983|NCT00774397|26737162|FG002|Overall Study|Adverse Event|16|||
13377984|NCT00774397|26737163|FG003|Overall Study|Adverse Event|8|||
13377985|NCT00774397|26737164|FG004|Overall Study|Adverse Event|8|||
13377986|NCT00774397|26737165|FG005|Overall Study|Adverse Event|3|||
13377987|NCT00774397|26737166|FG006|Overall Study|Adverse Event|16|||
13377988|NCT00774397|26737160|FG000|Overall Study|Lack of Efficacy|11|||
13377989|NCT00774397|26737161|FG001|Overall Study|Lack of Efficacy|4|||
13377990|NCT00774397|26737162|FG002|Overall Study|Lack of Efficacy|5|||
13377991|NCT00774397|26737163|FG003|Overall Study|Lack of Efficacy|3|||
13377992|NCT00774397|26737164|FG004|Overall Study|Lack of Efficacy|27|||
13377993|NCT00774397|26737165|FG005|Overall Study|Lack of Efficacy|15|||
13377994|NCT00774397|26737166|FG006|Overall Study|Lack of Efficacy|9|||
13377995|NCT00774397|26737160|FG000|Overall Study|Protocol Violation|0|||
13377996|NCT00774397|26737161|FG001|Overall Study|Protocol Violation|1|||
13377997|NCT00774397|26737162|FG002|Overall Study|Protocol Violation|3|||
13377998|NCT00774397|26737163|FG003|Overall Study|Protocol Violation|1|||
13377999|NCT00774397|26737164|FG004|Overall Study|Protocol Violation|2|||
13378000|NCT00774397|26737165|FG005|Overall Study|Protocol Violation|1|||
13378001|NCT00774397|26737166|FG006|Overall Study|Protocol Violation|0|||
13378002|NCT00774397|26737160|FG000|Overall Study|Lost to Follow-up|0|||
13378003|NCT00774397|26737161|FG001|Overall Study|Lost to Follow-up|1|||
13378004|NCT00774397|26737162|FG002|Overall Study|Lost to Follow-up|1|||
13378005|NCT00774397|26737163|FG003|Overall Study|Lost to Follow-up|1|||
13378006|NCT00774397|26737164|FG004|Overall Study|Lost to Follow-up|0|||
13378007|NCT00774397|26737165|FG005|Overall Study|Lost to Follow-up|1|||
13378008|NCT00774397|26737166|FG006|Overall Study|Lost to Follow-up|0|||
13378009|NCT00774397|26737160|FG000|Overall Study|Refused to continue trial medication|1|||
13378010|NCT00774397|26737161|FG001|Overall Study|Refused to continue trial medication|3|||
13378011|NCT00774397|26737162|FG002|Overall Study|Refused to continue trial medication|2|||
13378012|NCT00774397|26737163|FG003|Overall Study|Refused to continue trial medication|2|||
13378013|NCT00774397|26737164|FG004|Overall Study|Refused to continue trial medication|6|||
13378014|NCT00774397|26737165|FG005|Overall Study|Refused to continue trial medication|2|||
13378015|NCT00774397|26737166|FG006|Overall Study|Refused to continue trial medication|3|||
13378016|NCT00774397|26737160|FG000|Overall Study|Not treated|0|||
13378017|NCT00774397|26737161|FG001|Overall Study|Not treated|0|||
13378018|NCT00774397|26737162|FG002|Overall Study|Not treated|0|||
13378019|NCT00774397|26737163|FG003|Overall Study|Not treated|0|||
13378020|NCT00774397|26737164|FG004|Overall Study|Not treated|1|||
13378021|NCT00774397|26737165|FG005|Overall Study|Not treated|0|||
13378022|NCT00774397|26737166|FG006|Overall Study|Not treated|1|||
13378023|NCT00774397|26737160|FG000|Overall Study|Other than those stated above|1|||
13378024|NCT00774397|26737161|FG001|Overall Study|Other than those stated above|1|||
13378025|NCT00774397|26737162|FG002|Overall Study|Other than those stated above|3|||
13378026|NCT00774397|26737163|FG003|Overall Study|Other than those stated above|2|||
13378027|NCT00774397|26737164|FG004|Overall Study|Other than those stated above|2|||
13378028|NCT00774397|26737165|FG005|Overall Study|Other than those stated above|0|||
13378029|NCT00774397|26737166|FG006|Overall Study|Other than those stated above|1|||
13378030|NCT00774345|26737183|FG000|Pre-treatment|Other reasons|2|||
13378031|NCT00774345|26737184|FG001|Pre-treatment|Other reasons|0|||
13378032|NCT00774345|26737183|FG000|Treatment|Adverse Event|61|||
13378033|NCT00774345|26737184|FG001|Treatment|Adverse Event|15|||
13378034|NCT00774345|26737183|FG000|Treatment|Progressive Disease without histologic transformation|51|||
13378035|NCT00774345|26737184|FG001|Treatment|Progressive Disease without histologic transformation|111|||
13488574|NCT00409773|27043866|FG003|Overall Study|Protocol Violation|3|||
13378036|NCT00774345|26737183|FG000|Treatment|Progressive Disease with histologic transformation|4|||
13378037|NCT00774345|26737184|FG001|Treatment|Progressive Disease with histologic transformation|2|||
13378038|NCT00774345|26737183|FG000|Treatment|Withdrawal by Subject|5|||
13378039|NCT00774345|26737184|FG001|Treatment|Withdrawal by Subject|2|||
13378040|NCT00774345|26737183|FG000|Treatment|Lost to Follow-up|1|||
13378041|NCT00774345|26737184|FG001|Treatment|Lost to Follow-up|1|||
13378042|NCT00774345|26737183|FG000|Treatment|Death|4|||
13378043|NCT00774345|26737184|FG001|Treatment|Death|0|||
13378044|NCT00774345|26737183|FG000|Treatment|Other Reasons|32|||
13378045|NCT00774345|26737184|FG001|Treatment|Other Reasons|26|||
13378046|NCT00774306|26737207|FG000|Overall Study|Adverse Event|3|||
13378047|NCT00774306|26737208|FG001|Overall Study|Adverse Event|0|||
13378048|NCT00774306|26737209|FG002|Overall Study|Adverse Event|0|||
13378049|NCT00774306|26737210|FG003|Overall Study|Adverse Event|0|||
13378050|NCT00774306|26737207|FG000|Overall Study|Protocol Violation|2|||
13378051|NCT00774306|26737208|FG001|Overall Study|Protocol Violation|0|||
13378052|NCT00774306|26737209|FG002|Overall Study|Protocol Violation|3|||
13378053|NCT00774306|26737210|FG003|Overall Study|Protocol Violation|0|||
13378054|NCT00774306|26737207|FG000|Overall Study|Withdrawal by Subject|6|||
13378055|NCT00774306|26737208|FG001|Overall Study|Withdrawal by Subject|1|||
13378056|NCT00774306|26737209|FG002|Overall Study|Withdrawal by Subject|1|||
13378057|NCT00774306|26737210|FG003|Overall Study|Withdrawal by Subject|0|||
13378058|NCT00774306|26737207|FG000|Overall Study|Lost to Follow-up|6|||
13378059|NCT00774306|26737208|FG001|Overall Study|Lost to Follow-up|0|||
13378060|NCT00774306|26737209|FG002|Overall Study|Lost to Follow-up|4|||
13378061|NCT00774306|26737210|FG003|Overall Study|Lost to Follow-up|5|||
13378062|NCT00774306|26737207|FG000|Overall Study|Death|1|||
13378063|NCT00774306|26737208|FG001|Overall Study|Death|1|||
13378064|NCT00774306|26737209|FG002|Overall Study|Death|0|||
13378065|NCT00774306|26737210|FG003|Overall Study|Death|0|||
13378066|NCT00774046|26737222|FG000|Screening|Not eligible|56|||
13378067|NCT00774046|26737222|FG000|Enrollment|Desired other therapy/refused|28|||
13378068|NCT00774046|26737222|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3|||
13378069|NCT00773968|26737233|FG000|Overall Study|Adverse Event|2|||
13378070|NCT00773968|26737233|FG000|Overall Study|Death|1|||
13378071|NCT00773968|26737233|FG000|Overall Study|Failure to Return|2|||
13378072|NCT00773968|26737233|FG000|Overall Study|Lack of Efficacy|3|||
13378073|NCT00773968|26737233|FG000|Overall Study|Protocol Violation|1|||
13378074|NCT00773968|26737233|FG000|Overall Study|Withdrawal by Subject|11|||
13378075|NCT00773968|26737233|FG000|Overall Study|Screen Failure|17|||
13378076|NCT00773968|26737233|FG000|Overall Study|Other|8|||
13378077|NCT00773838|26737246|FG000|Overall Study|Adverse Event|29|||
13378078|NCT00773838|26737246|FG000|Overall Study|Lost to Follow-up|1|||
13378079|NCT00773838|26737246|FG000|Overall Study|Physician Decision|8|||
13378080|NCT00773838|26737246|FG000|Overall Study|Progressive Disease|82|||
13378081|NCT00773838|26737246|FG000|Overall Study|Protocol Violation|2|||
13378082|NCT00773838|26737246|FG000|Overall Study|Withdrawal by Subject|21|||
13378083|NCT00773747|26737267|FG000|Overall Study|Lack of Efficacy|112|||
13378084|NCT00773747|26737268|FG001|Overall Study|Lack of Efficacy|144|||
13378085|NCT00773747|26737267|FG000|Overall Study|Physician Decision|26|||
13378086|NCT00773747|26737268|FG001|Overall Study|Physician Decision|18|||
13378087|NCT00773747|26737267|FG000|Overall Study|Lost to Follow-up|0|||
13378088|NCT00773747|26737268|FG001|Overall Study|Lost to Follow-up|1|||
13378089|NCT00773747|26737267|FG000|Overall Study|Protocol Violation|2|||
13378090|NCT00773747|26737268|FG001|Overall Study|Protocol Violation|2|||
13378091|NCT00773747|26737267|FG000|Overall Study|Withdrawal by Subject|89|||
13378092|NCT00773747|26737268|FG001|Overall Study|Withdrawal by Subject|61|||
13378093|NCT00773747|26737267|FG000|Overall Study|Adverse Event|61|||
13378094|NCT00773747|26737268|FG001|Overall Study|Adverse Event|62|||
13378095|NCT00773747|26737267|FG000|Overall Study|Death|5|||
13378096|NCT00773747|26737268|FG001|Overall Study|Death|8|||
13378097|NCT00773747|26737267|FG000|Overall Study|Not Treated|2|||
13378098|NCT00773747|26737268|FG001|Overall Study|Not Treated|0|||
13378099|NCT00773734|26737845|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5|||
13378100|NCT00773734|26737846|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1|||
13378101|NCT00773734|26737847|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8|||
13378102|NCT00773734|26737848|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10|||
13378103|NCT00773734|26737849|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
13378104|NCT00773734|26737850|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
13378105|NCT00773734|26737845|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4|||
13378106|NCT00773734|26737846|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3|||
13378107|NCT00773734|26737847|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
13378108|NCT00773734|26737848|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
13378109|NCT00773734|26737849|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
13378110|NCT00773734|26737850|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
13378111|NCT00773734|26737845|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
13378112|NCT00773734|26737846|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
13378113|NCT00773734|26737847|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6|||
13378114|NCT00773734|26737848|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4|||
13378115|NCT00773734|26737849|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
13378116|NCT00773734|26737850|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
13378117|NCT00773734|26737845|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1|||
13378118|NCT00773734|26737846|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0|||
13378119|NCT00773734|26737847|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0|||
13378120|NCT00773734|26737848|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0|||
13378121|NCT00773734|26737849|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0|||
13378122|NCT00773734|26737850|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0|||
13378123|NCT00773734|26737845|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2|||
13378124|NCT00773734|26737846|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
13378125|NCT00773734|26737847|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
13378126|NCT00773734|26737848|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1|||
13378127|NCT00773734|26737849|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
13378128|NCT00773734|26737850|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
13378129|NCT00773734|26737845|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1|||
13378130|NCT00773734|26737846|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3|||
13378131|NCT00773734|26737847|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4|||
13378132|NCT00773734|26737848|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
13378133|NCT00773734|26737849|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
13378134|NCT00773734|26737850|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
13378135|NCT00773734|26737845|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1|||
13378136|NCT00773734|26737846|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1|||
13378137|NCT00773734|26737847|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1|||
13378138|NCT00773734|26737848|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1|||
13378139|NCT00773734|26737849|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0|||
13378140|NCT00773734|26737850|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0|||
13378141|NCT00773734|26737845|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
13378142|NCT00773734|26737846|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4|||
13394026|NCT00660907|26785480|FG000|Overall Study|Withdrawal by Subject|23|||
13394027|NCT00660907|26785481|FG001|Overall Study|Withdrawal by Subject|32|||
13394028|NCT00660907|26785480|FG000|Overall Study|Lost to Follow-up|3|||
13394029|NCT00660907|26785481|FG001|Overall Study|Lost to Follow-up|3|||
13394030|NCT00660907|26785480|FG000|Overall Study|Poor/Non-Compliance|5|||
13394031|NCT00660907|26785481|FG001|Overall Study|Poor/Non-Compliance|1|||
13394032|NCT00660907|26785480|FG000|Overall Study|Safety|1|||
13394033|NCT00660907|26785481|FG001|Overall Study|Safety|0|||
13394034|NCT00660907|26785480|FG000|Overall Study|Death|1|||
13394035|NCT00660907|26785481|FG001|Overall Study|Death|3|||
13394036|NCT00660907|26785480|FG000|Overall Study|Various|11|||
13394037|NCT00660907|26785481|FG001|Overall Study|Various|8|||
13394038|NCT00660829|26785504|FG000|Overall Study|Adverse Event|3|||
13394039|NCT00660829|26785505|FG001|Overall Study|Adverse Event|4|||
13394040|NCT00660829|26785504|FG000|Overall Study|Lack of Efficacy|2|||
13394041|NCT00660829|26785505|FG001|Overall Study|Lack of Efficacy|3|||
13394042|NCT00660829|26785504|FG000|Overall Study|Non-Compliance|0|||
13394043|NCT00660829|26785505|FG001|Overall Study|Non-Compliance|4|||
13394044|NCT00660829|26785504|FG000|Overall Study|Withdrawal by Subject|1|||
13394045|NCT00660829|26785505|FG001|Overall Study|Withdrawal by Subject|2|||
13394046|NCT00660829|26785504|FG000|Overall Study|Lost to Follow-up|3|||
13394047|NCT00660829|26785505|FG001|Overall Study|Lost to Follow-up|2|||
13394048|NCT00660829|26785504|FG000|Overall Study|Other|9|||
13394049|NCT00660829|26785505|FG001|Overall Study|Other|4|||
13394050|NCT00660816|26785524|FG000|Overall Study|Adverse Event|1|||
13394051|NCT00660816|26785525|FG001|Overall Study|Adverse Event|2|||
13394052|NCT00660816|26785524|FG000|Overall Study|Withdrawal by Subject|1|||
13394053|NCT00660816|26785525|FG001|Overall Study|Withdrawal by Subject|0|||
13394054|NCT00660816|26785524|FG000|Overall Study|Death|0|||
13394055|NCT00660816|26785525|FG001|Overall Study|Death|2|||
13394056|NCT00660816|26785524|FG000|Overall Study|Lack of Efficacy|1|||
13394057|NCT00660816|26785525|FG001|Overall Study|Lack of Efficacy|0|||
13394058|NCT00660816|26785524|FG000|Overall Study|Physician Decision|0|||
13394059|NCT00660816|26785525|FG001|Overall Study|Physician Decision|2|||
13394060|NCT00660816|26785524|FG000|Overall Study|Protocol Violation|1|||
13394061|NCT00660816|26785525|FG001|Overall Study|Protocol Violation|0|||
13394062|NCT00660816|26785524|FG000|Overall Study|Disease Progression|16|||
13394063|NCT00660816|26785525|FG001|Overall Study|Disease Progression|12|||
13394064|NCT00660816|26785524|FG000|Overall Study|Complicating Disease|0|||
13394065|NCT00660816|26785525|FG001|Overall Study|Complicating Disease|1|||
13394066|NCT00660790|26785531|FG000|Baseline to 3 Months|Death|1|||
13394067|NCT00660790|26785531|FG000|Baseline to 3 Months|Withdrawal by Subject|2|||
13394068|NCT00660790|26785531|FG000|3 Months to 2 Years|Withdrawal by Subject|17|||
13394069|NCT00660699|26785547|FG000|Overall Study|Withdrawal by Subject|2|||
13378143|NCT00773734|26737847|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
13378144|NCT00773734|26737848|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
13378145|NCT00773734|26737849|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1|||
13378146|NCT00773734|26737850|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2|||
13378147|NCT00773734|26737845|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
13378148|NCT00773734|26737846|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
13378149|NCT00773734|26737847|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
13378150|NCT00773734|26737848|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1|||
13378151|NCT00773734|26737849|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
13378152|NCT00773734|26737850|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
13378153|NCT00773734|26737845|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
13378154|NCT00773734|26737846|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
13378155|NCT00773734|26737847|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
13378156|NCT00773734|26737848|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
13378157|NCT00773734|26737849|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
13378158|NCT00773734|26737850|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2|||
13378159|NCT00773734|26737845|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
13378160|NCT00773734|26737846|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
13378161|NCT00773734|26737847|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
13378162|NCT00773734|26737848|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
13378163|NCT00773734|26737849|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
13378164|NCT00773734|26737850|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
13378165|NCT00773734|26737845|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
13378166|NCT00773734|26737846|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
13378167|NCT00773734|26737847|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
13378168|NCT00773734|26737848|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
13378169|NCT00773734|26737849|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
13378170|NCT00773734|26737850|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
13378171|NCT00773734|26737845|FG000|Core: Active Treatment Phase Week 16-24|Other|0|||
13378172|NCT00773734|26737846|FG001|Core: Active Treatment Phase Week 16-24|Other|1|||
13378173|NCT00773734|26737847|FG002|Core: Active Treatment Phase Week 16-24|Other|0|||
13378174|NCT00773734|26737848|FG003|Core: Active Treatment Phase Week 16-24|Other|0|||
13378175|NCT00773734|26737849|FG004|Core: Active Treatment Phase Week 16-24|Other|0|||
13378176|NCT00773734|26737850|FG005|Core: Active Treatment Phase Week 16-24|Other|0|||
13378177|NCT00773734|26737845|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0|||
13378178|NCT00773734|26737846|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0|||
13378179|NCT00773734|26737847|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0|||
13378180|NCT00773734|26737848|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0|||
13378181|NCT00773734|26737849|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2|||
13378182|NCT00773734|26737850|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1|||
13378183|NCT00773734|26737845|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0|||
13378184|NCT00773734|26737846|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8|||
13378185|NCT00773734|26737847|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10|||
13378186|NCT00773734|26737848|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3|||
13378187|NCT00773734|26737849|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1|||
13378188|NCT00773734|26737850|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2|||
13378189|NCT00773734|26737845|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0|||
13378190|NCT00773734|26737846|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
13378191|NCT00773734|26737847|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1|||
13378192|NCT00773734|26737848|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
13378193|NCT00773734|26737849|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
13378194|NCT00773734|26737850|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
13378195|NCT00773734|26737845|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
13378196|NCT00773734|26737846|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2|||
13378197|NCT00773734|26737847|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5|||
13378198|NCT00773734|26737848|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3|||
13378199|NCT00773734|26737849|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
13378200|NCT00773734|26737850|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1|||
13378201|NCT00773734|26737845|FG000|Extension: Active Treatment Week 24-52|Other|0|||
13378202|NCT00773734|26737846|FG001|Extension: Active Treatment Week 24-52|Other|0|||
13378203|NCT00773734|26737847|FG002|Extension: Active Treatment Week 24-52|Other|1|||
13378204|NCT00773734|26737848|FG003|Extension: Active Treatment Week 24-52|Other|2|||
13378205|NCT00773734|26737849|FG004|Extension: Active Treatment Week 24-52|Other|0|||
13378206|NCT00773734|26737850|FG005|Extension: Active Treatment Week 24-52|Other|1|||
13378207|NCT00773734|26737845|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
13378208|NCT00773734|26737846|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
13378209|NCT00773734|26737847|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
13378210|NCT00773734|26737848|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1|||
13378211|NCT00773734|26737849|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
13206862|NCT01953692|26236008|FG005|Overall Study|Clinical Progression|7|||
13206863|NCT01953692|26236009|FG006|Overall Study|Clinical Progression|20|||
13206864|NCT01953692|26236010|FG007|Overall Study|Clinical Progression|3|||
13206865|NCT01953692|26236011|FG008|Overall Study|Clinical Progression|3|||
13206866|NCT01953692|26236003|FG000|Overall Study|Death|5|||
13206867|NCT01953692|26236004|FG001|Overall Study|Death|0|||
13206868|NCT01953692|26236005|FG002|Overall Study|Death|2|||
13206869|NCT01953692|26236006|FG003|Overall Study|Death|2|||
13206870|NCT01953692|26236007|FG004|Overall Study|Death|1|||
13206871|NCT01953692|26236008|FG005|Overall Study|Death|3|||
13206872|NCT01953692|26236009|FG006|Overall Study|Death|6|||
13206873|NCT01953692|26236010|FG007|Overall Study|Death|2|||
13206874|NCT01953692|26236011|FG008|Overall Study|Death|1|||
13206875|NCT01953692|26236003|FG000|Overall Study|Excluded Medication|1|||
13206876|NCT01953692|26236004|FG001|Overall Study|Excluded Medication|0|||
13206877|NCT01953692|26236005|FG002|Overall Study|Excluded Medication|0|||
13206878|NCT01953692|26236006|FG003|Overall Study|Excluded Medication|0|||
13206879|NCT01953692|26236007|FG004|Overall Study|Excluded Medication|0|||
13206880|NCT01953692|26236008|FG005|Overall Study|Excluded Medication|0|||
13206881|NCT01953692|26236009|FG006|Overall Study|Excluded Medication|0|||
13206882|NCT01953692|26236010|FG007|Overall Study|Excluded Medication|0|||
13206883|NCT01953692|26236011|FG008|Overall Study|Excluded Medication|0|||
13206884|NCT01953692|26236003|FG000|Overall Study|Lost to Follow-up|1|||
13206885|NCT01953692|26236004|FG001|Overall Study|Lost to Follow-up|0|||
13206886|NCT01953692|26236005|FG002|Overall Study|Lost to Follow-up|3|||
13206887|NCT01953692|26236006|FG003|Overall Study|Lost to Follow-up|1|||
13206888|NCT01953692|26236007|FG004|Overall Study|Lost to Follow-up|0|||
13206889|NCT01953692|26236008|FG005|Overall Study|Lost to Follow-up|1|||
13206890|NCT01953692|26236009|FG006|Overall Study|Lost to Follow-up|0|||
13206891|NCT01953692|26236010|FG007|Overall Study|Lost to Follow-up|0|||
13206892|NCT01953692|26236011|FG008|Overall Study|Lost to Follow-up|0|||
13206893|NCT01953692|26236003|FG000|Overall Study|Physician Decision|11|||
13206894|NCT01953692|26236004|FG001|Overall Study|Physician Decision|4|||
13206895|NCT01953692|26236005|FG002|Overall Study|Physician Decision|2|||
13206896|NCT01953692|26236006|FG003|Overall Study|Physician Decision|2|||
13206897|NCT01953692|26236007|FG004|Overall Study|Physician Decision|1|||
13206898|NCT01953692|26236008|FG005|Overall Study|Physician Decision|2|||
13206899|NCT01953692|26236009|FG006|Overall Study|Physician Decision|4|||
13206900|NCT01953692|26236010|FG007|Overall Study|Physician Decision|1|||
13294217|NCT01063972|26490631|FG000|Overall Study|Death|12|||
13294218|NCT01063972|26490632|FG001|Overall Study|Death|11|||
13294219|NCT01063972|26490631|FG000|Overall Study|Incarcerated|2|||
13294220|NCT01063972|26490632|FG001|Overall Study|Incarcerated|1|||
13294221|NCT01063881|26490664|FG000|Overall Study|Adverse Event|12|||
13294222|NCT01063881|26490665|FG001|Overall Study|Adverse Event|2|||
13294223|NCT01063881|26490666|FG002|Overall Study|Adverse Event|0|||
13294224|NCT01063881|26490664|FG000|Overall Study|Lost to Follow-up|13|||
13294225|NCT01063881|26490665|FG001|Overall Study|Lost to Follow-up|7|||
13294226|NCT01063881|26490666|FG002|Overall Study|Lost to Follow-up|1|||
13294227|NCT01063881|26490664|FG000|Overall Study|Withdrawal by Subject|25|||
13294228|NCT01063881|26490665|FG001|Overall Study|Withdrawal by Subject|1|||
13294229|NCT01063881|26490666|FG002|Overall Study|Withdrawal by Subject|0|||
13294230|NCT01063881|26490664|FG000|Overall Study|Reason for not completed not specified|5|||
13294231|NCT01063881|26490665|FG001|Overall Study|Reason for not completed not specified|1|||
13294232|NCT01063881|26490666|FG002|Overall Study|Reason for not completed not specified|0|||
13294233|NCT01063868|26490679|FG000|Overall Study|Adverse Event|9|||
13294234|NCT01063868|26490680|FG001|Overall Study|Adverse Event|7|||
13294235|NCT01063868|26490679|FG000|Overall Study|Withdrawal by Subject|3|||
13294236|NCT01063868|26490680|FG001|Overall Study|Withdrawal by Subject|1|||
13294237|NCT01063868|26490679|FG000|Overall Study|Study Terminated By Sponsor|23|||
13294238|NCT01063868|26490680|FG001|Overall Study|Study Terminated By Sponsor|4|||
13294239|NCT01063855|26490709|FG000|Overall Study|Adverse Event|4|||
13294240|NCT01063855|26490710|FG001|Overall Study|Adverse Event|4|||
13294241|NCT01063855|26490709|FG000|Overall Study|Death|0|||
13294242|NCT01063855|26490710|FG001|Overall Study|Death|1|||
13294243|NCT01063855|26490709|FG000|Overall Study|Lost to Follow-up|8|||
13294244|NCT01063855|26490710|FG001|Overall Study|Lost to Follow-up|4|||
13294245|NCT01063855|26490709|FG000|Overall Study|Pregnancy|1|||
13294246|NCT01063855|26490710|FG001|Overall Study|Pregnancy|0|||
13294247|NCT01063855|26490709|FG000|Overall Study|Lack of Efficacy|0|||
13294248|NCT01063855|26490710|FG001|Overall Study|Lack of Efficacy|1|||
13294249|NCT01063855|26490709|FG000|Overall Study|Withdrawal by Subject|11|||
13294250|NCT01063855|26490710|FG001|Overall Study|Withdrawal by Subject|8|||
13294251|NCT01063855|26490709|FG000|Overall Study|Reason not specified|13|||
13294252|NCT01063855|26490710|FG001|Overall Study|Reason not specified|11|||
13294253|NCT01063764|26490726|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4|||
13294254|NCT01063764|26490726|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6|||
13294255|NCT01063764|26490726|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1|||
13294256|NCT01063764|26490726|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3|||
13294257|NCT01063764|26490726|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9|||
13294258|NCT01063764|26490726|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7|||
13294259|NCT01063764|26490726|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1|||
13294260|NCT01063595|26490739|FG000|Enrolled in Study and Randomized|Reason not Specified|1|||
13294261|NCT01063595|26490740|FG001|Enrolled in Study and Randomized|Reason not Specified|0|||
13294262|NCT01063595|26490739|FG000|Enrolled in Study and Randomized|Adverse Event|0|||
13294263|NCT01063595|26490740|FG001|Enrolled in Study and Randomized|Adverse Event|1|||
13294264|NCT01063595|26490739|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0|||
13294265|NCT01063595|26490740|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1|||
13294266|NCT01063595|26490739|FG000|First Intervention|Adverse Event|1|||
13294267|NCT01063595|26490740|FG001|First Intervention|Adverse Event|4|||
13294268|NCT01063595|26490739|FG000|First Intervention|Withdrawal by Subject|1|||
13294269|NCT01063595|26490740|FG001|First Intervention|Withdrawal by Subject|0|||
13294270|NCT01063595|26490739|FG000|First Intervention|Reason not Specified|0|||
13294271|NCT01063595|26490740|FG001|First Intervention|Reason not Specified|1|||
13294272|NCT01063348|26490755|FG000|Overall Study|Lost to Follow-up|3|||
13294273|NCT01063348|26490756|FG001|Overall Study|Lost to Follow-up|10|||
13294274|NCT01063283|26490776|FG000|Cycle 1|Adverse Event|2|||
13294275|NCT01063283|26490777|FG001|Cycle 1|Adverse Event|0|||
13294276|NCT01063283|26490778|FG002|Cycle 1|Adverse Event|0|||
13294277|NCT01063283|26490776|FG000|Cycle 1|Technical failure in data collection|1|||
13294278|NCT01063283|26490777|FG001|Cycle 1|Technical failure in data collection|0|||
13294279|NCT01063283|26490778|FG002|Cycle 1|Technical failure in data collection|0|||
13294280|NCT01063153|26490795|FG000|Overall Study|Found Ineligible During Screening|2|||
13294281|NCT01063153|26490796|FG001|Overall Study|Found Ineligible During Screening|0|||
13294282|NCT01063153|26490795|FG000|Overall Study|Lost to Follow-up|0|||
13294283|NCT01063153|26490796|FG001|Overall Study|Lost to Follow-up|7|||
13294284|NCT01063153|26490795|FG000|Overall Study|Withdrawal by Subject|0|||
13294285|NCT01063153|26490796|FG001|Overall Study|Withdrawal by Subject|1|||
13294286|NCT01063153|26490795|FG000|Overall Study|Physician Decision|0|||
13294287|NCT01063153|26490796|FG001|Overall Study|Physician Decision|4|||
13294288|NCT01063062|26490841|FG000|Overall Study|Patient withdrew consent|0|||
13294289|NCT01063062|26490842|FG001|Overall Study|Patient withdrew consent|1|||
13294290|NCT01063062|26490841|FG000|Overall Study|Adverse Event|2|||
13294291|NCT01063062|26490842|FG001|Overall Study|Adverse Event|4|||
13294292|NCT01063062|26490841|FG000|Overall Study|Protocol Violation|5|||
13294293|NCT01063062|26490842|FG001|Overall Study|Protocol Violation|4|||
13294294|NCT01063062|26490841|FG000|Overall Study|Investigator's request|1|||
13294295|NCT01063062|26490842|FG001|Overall Study|Investigator's request|0|||
13294296|NCT01063062|26490841|FG000|Overall Study|Lost to Follow-up|0|||
13294297|NCT01063062|26490842|FG001|Overall Study|Lost to Follow-up|2|||
13294298|NCT01063062|26490841|FG000|Overall Study|Miscellaneous reason|0|||
13294299|NCT01063062|26490842|FG001|Overall Study|Miscellaneous reason|1|||
13294300|NCT01063036|26490858|FG000|Participants Treated With Study Drug|Adverse Event|1|||
13294301|NCT01063036|26490858|FG000|Participants Treated With Study Drug|Protocol Violation|1|||
13294302|NCT01063036|26490858|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2|||
13294303|NCT01063036|26490858|FG000|Participants Treated With Study Drug|Lost to Follow-up|1|||
13294304|NCT01063036|26490858|FG000|Participants Treated With Study Drug|Pregnancy|1|||
13294305|NCT01063036|26490858|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1|||
13294306|NCT01063036|26490858|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6|||
13294307|NCT01063036|26490858|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32|||
13294308|NCT01062971|26490873|FG000|Overall Study|Protocol Violation|1|||
13294309|NCT01062971|26490874|FG001|Overall Study|Protocol Violation|3|||
13294310|NCT01062971|26490873|FG000|Overall Study|Lost to Follow-up|3|||
13294311|NCT01062971|26490874|FG001|Overall Study|Lost to Follow-up|4|||
13294312|NCT01062841|26490909|FG000|Overall Study|Indwelling Device Removed|41|||
13294313|NCT01062841|26490910|FG001|Overall Study|Indwelling Device Removed|48|||
13294314|NCT01062841|26490909|FG000|Overall Study|Death|3|||
13294315|NCT01062841|26490910|FG001|Overall Study|Death|5|||
13294316|NCT01062841|26490909|FG000|Overall Study|Withdrawal by Subject|2|||
13294317|NCT01062841|26490910|FG001|Overall Study|Withdrawal by Subject|0|||
13294318|NCT01062841|26490909|FG000|Overall Study|Withdrawal by Study|3|||
13294319|NCT01062841|26490910|FG001|Overall Study|Withdrawal by Study|0|||
13294320|NCT01062555|26490937|FG000|Phase 1|Death|10|||
13294321|NCT01062555|26490938|FG001|Phase 1|Death|17|||
13294322|NCT01062555|26490939|FG002|Phase 1|Death|0|||
13294323|NCT01062555|26490940|FG003|Phase 1|Death|0|||
13294324|NCT01062555|26490937|FG000|Phase 1|Graft Failure|12|||
13294325|NCT01062555|26490938|FG001|Phase 1|Graft Failure|8|||
13294326|NCT01062555|26490939|FG002|Phase 1|Graft Failure|0|||
13294327|NCT01062555|26490940|FG003|Phase 1|Graft Failure|0|||
13294328|NCT01062555|26490937|FG000|Phase 1|Withdrawal by Subject|1|||
13294329|NCT01062555|26490938|FG001|Phase 1|Withdrawal by Subject|1|||
13294330|NCT01062555|26490939|FG002|Phase 1|Withdrawal by Subject|0|||
13294331|NCT01062555|26490940|FG003|Phase 1|Withdrawal by Subject|0|||
13294332|NCT01062555|26490937|FG000|Phase 2|Death|0|||
13294333|NCT01062555|26490938|FG001|Phase 2|Death|0|||
13294334|NCT01062555|26490939|FG002|Phase 2|Death|8|||
13294335|NCT01062555|26490940|FG003|Phase 2|Death|3|||
13294336|NCT01062555|26490937|FG000|Phase 2|Graft failure|0|||
13294337|NCT01062555|26490938|FG001|Phase 2|Graft failure|0|||
13294338|NCT01062555|26490939|FG002|Phase 2|Graft failure|7|||
13294339|NCT01062555|26490940|FG003|Phase 2|Graft failure|4|||
13294340|NCT01062555|26490937|FG000|Phase 2|Withdrawal by Subject|0|||
13294341|NCT01062555|26490938|FG001|Phase 2|Withdrawal by Subject|0|||
13294342|NCT01062555|26490939|FG002|Phase 2|Withdrawal by Subject|0|||
13294343|NCT01062555|26490940|FG003|Phase 2|Withdrawal by Subject|7|||
13294344|NCT01062555|26490937|FG000|Phase 2|Protocol Violation|0|||
13294345|NCT01062555|26490938|FG001|Phase 2|Protocol Violation|0|||
13294346|NCT01062555|26490939|FG002|Phase 2|Protocol Violation|0|||
13294347|NCT01062555|26490940|FG003|Phase 2|Protocol Violation|3|||
13294348|NCT01062555|26490937|FG000|Phase 2|Physician Decision|0|||
13294349|NCT01062555|26490938|FG001|Phase 2|Physician Decision|0|||
13294350|NCT01062555|26490939|FG002|Phase 2|Physician Decision|0|||
13294351|NCT01062555|26490940|FG003|Phase 2|Physician Decision|17|||
13294352|NCT01062425|26490959|FG000|Overall Study|Protocol Violation|3|||
13294353|NCT01062425|26490960|FG001|Overall Study|Protocol Violation|6|||
13294354|NCT01062126|26490966|FG000|Overall Study|Death|209|||
13294355|NCT01062126|26490966|FG000|Overall Study|All Withdrawals|324|||
13294356|NCT01062061|26490982|FG000|Overall Study|Enrolled more than once|2|||
13294357|NCT01062061|26490982|FG000|Overall Study|Investigated before study start|13|||
13294358|NCT01062061|26490982|FG000|Overall Study|Outside chief indications|10|||
13294359|NCT01062061|26490982|FG000|Overall Study|Failed to meet inclusion criteria|2|||
13294360|NCT01061866|26490988|FG000|Overall Study|Adverse Event|2|||
13294361|NCT01061775|26490997|FG000|Overall Study|Physician Decision|2|||
13294362|NCT01061775|26490997|FG000|Overall Study|Lost to Follow-up|1|||
13294363|NCT01061723|26491096|FG000|Overall Study|Adverse Event|0|||
13294364|NCT01061723|26491097|FG001|Overall Study|Adverse Event|2|||
13294365|NCT01061723|26491098|FG002|Overall Study|Adverse Event|5|||
13294366|NCT01061723|26491099|FG003|Overall Study|Adverse Event|5|||
13294367|NCT01061723|26491100|FG004|Overall Study|Adverse Event|2|||
13294368|NCT01061723|26491101|FG005|Overall Study|Adverse Event|6|||
13294369|NCT01061723|26491096|FG000|Overall Study|Lack of Efficacy|2|||
13294370|NCT01061723|26491097|FG001|Overall Study|Lack of Efficacy|3|||
13294371|NCT01061723|26491098|FG002|Overall Study|Lack of Efficacy|4|||
13294372|NCT01061723|26491099|FG003|Overall Study|Lack of Efficacy|2|||
13294373|NCT01061723|26491100|FG004|Overall Study|Lack of Efficacy|1|||
13294374|NCT01061723|26491101|FG005|Overall Study|Lack of Efficacy|1|||
13294375|NCT01061723|26491096|FG000|Overall Study|Randomized but not treated|0|||
13294376|NCT01061723|26491097|FG001|Overall Study|Randomized but not treated|0|||
13294377|NCT01061723|26491098|FG002|Overall Study|Randomized but not treated|0|||
13294378|NCT01061723|26491099|FG003|Overall Study|Randomized but not treated|0|||
13294379|NCT01061723|26491100|FG004|Overall Study|Randomized but not treated|0|||
13294380|NCT01061723|26491101|FG005|Overall Study|Randomized but not treated|1|||
13294381|NCT01061723|26491096|FG000|Overall Study|Other than specified above|2|||
13294382|NCT01061723|26491097|FG001|Overall Study|Other than specified above|1|||
13294383|NCT01061723|26491098|FG002|Overall Study|Other than specified above|1|||
13294384|NCT01061723|26491099|FG003|Overall Study|Other than specified above|1|||
13294385|NCT01061723|26491100|FG004|Overall Study|Other than specified above|0|||
13294386|NCT01061723|26491101|FG005|Overall Study|Other than specified above|1|||
13294387|NCT01061671|26491120|FG000|Overall Study|Withdrawal by Subject|16|||
13294388|NCT01061671|26491121|FG001|Overall Study|Withdrawal by Subject|20|||
13294389|NCT01061671|26491120|FG000|Overall Study|Lost to Follow-up|3|||
13294390|NCT01061671|26491121|FG001|Overall Study|Lost to Follow-up|5|||
13294391|NCT01061671|26491120|FG000|Overall Study|Death|28|||
13294392|NCT01061671|26491121|FG001|Overall Study|Death|30|||
13294393|NCT01061606|26491132|FG000|Overall Study|Adverse Event|1|||
13294394|NCT01061606|26491132|FG000|Overall Study|Death|1|||
13294395|NCT01061606|26491132|FG000|Overall Study|Disease Progression|4|||
13294396|NCT01061606|26491132|FG000|Overall Study|alternative therapy|2|||
13294397|NCT01061567|26491143|FG000|Overall Study|Adverse Event|32|||
13294398|NCT01061567|26491143|FG000|Overall Study|Death|2|||
13294399|NCT01061567|26491143|FG000|Overall Study|Lack of Efficacy|3|||
13294400|NCT01061567|26491143|FG000|Overall Study|Lost to Follow-up|24|||
13294401|NCT01061567|26491143|FG000|Overall Study|Protocol Violation|1|||
13294402|NCT01061567|26491143|FG000|Overall Study|Withdrawal by Subject|11|||
13294403|NCT01061567|26491143|FG000|Overall Study|Other reason than stated above|3|||
13294404|NCT01061385|26491158|FG000|Overall Study|Lost to Follow-up|1|||
13294405|NCT01061385|26491159|FG001|Overall Study|Lost to Follow-up|0|||
13294406|NCT01061385|26491158|FG000|Overall Study|subject decision not related to AE|0|||
13294407|NCT01061385|26491159|FG001|Overall Study|subject decision not related to AE|1|||
13294408|NCT01061333|26491200|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0|||
13294409|NCT01061333|26491201|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1|||
13294410|NCT01061177|26491222|FG000|Overall Study|Adverse Event|117|||
13294411|NCT01061177|26491222|FG000|Overall Study|Withdrawal by Subject|27|||
13294412|NCT01061177|26491222|FG000|Overall Study|Disease progression|17|||
13294413|NCT01061177|26491222|FG000|Overall Study|Protocol Violation|11|||
13294414|NCT01061177|26491222|FG000|Overall Study|Lost to Follow-up|9|||
13294415|NCT01061177|26491222|FG000|Overall Study|New cancer therapy|9|||
13294416|NCT01061177|26491222|FG000|Overall Study|Abnormal laboratory values|6|||
13294417|NCT01061177|26491222|FG000|Overall Study|Abnormal test procedure results|4|||
13294418|NCT01061177|26491222|FG000|Overall Study|Administratie problems|4|||
13294419|NCT01061177|26491222|FG000|Overall Study|Death|4|||
13294420|NCT01061008|26491235|FG000|Overall Study|Badiocephalic fistula failed|3|||
13294421|NCT01061008|26491236|FG001|Overall Study|Badiocephalic fistula failed|2|||
13294422|NCT01061008|26491235|FG000|Overall Study|Death|1|||
13294423|NCT01061008|26491236|FG001|Overall Study|Death|0|||
13294424|NCT01061008|26491235|FG000|Overall Study|Withdrawal by Subject|1|||
13294425|NCT01061008|26491236|FG001|Overall Study|Withdrawal by Subject|3|||
13294426|NCT01061008|26491235|FG000|Overall Study|Unable to exercise following surgery|1|||
13294427|NCT01061008|26491236|FG001|Overall Study|Unable to exercise following surgery|0|||
13294428|NCT01061008|26491235|FG000|Overall Study|Adverse Event|0|||
13294429|NCT01061008|26491236|FG001|Overall Study|Adverse Event|1|||
13294430|NCT01060670|26491261|FG000|Run In|screen failure|0|||
13294431|NCT01060670|26491262|FG001|Run In|screen failure|238|||
13294432|NCT01060553|26491270|FG000|Overall Study|Lost to Follow-up|3|||
13294433|NCT01060553|26491271|FG001|Overall Study|Lost to Follow-up|5|||
13294434|NCT01060553|26491270|FG000|Overall Study|Withdrawal by Subject|5|||
13294435|NCT01060553|26491271|FG001|Overall Study|Withdrawal by Subject|5|||
13294436|NCT01060553|26491270|FG000|Overall Study|Lack of Efficacy|1|||
13294437|NCT01060553|26491271|FG001|Overall Study|Lack of Efficacy|0|||
13294438|NCT01060540|26491292|FG000|Overall Study|Withdrawal by Subject|10|||
13294439|NCT01060540|26491293|FG001|Overall Study|Withdrawal by Subject|20|||
13294440|NCT01060540|26491292|FG000|Overall Study|Lost to Follow-up|52|||
13294441|NCT01060540|26491293|FG001|Overall Study|Lost to Follow-up|43|||
13294442|NCT01060540|26491292|FG000|Overall Study|Death|2|||
13294443|NCT01060540|26491293|FG001|Overall Study|Death|1|||
13294444|NCT01060540|26491292|FG000|Overall Study|Physician Decision|0|||
13294445|NCT01060540|26491293|FG001|Overall Study|Physician Decision|1|||
13294446|NCT01060384|26491308|FG000|Overall Study|Withdrawal by Subject|0|||
13294447|NCT01060384|26491309|FG001|Overall Study|Withdrawal by Subject|1|||
13294448|NCT01060384|26491310|FG002|Overall Study|Withdrawal by Subject|0|||
13294449|NCT01060384|26491311|FG003|Overall Study|Withdrawal by Subject|0|||
13294450|NCT01060384|26491312|FG004|Overall Study|Withdrawal by Subject|0|||
13294451|NCT01060384|26491308|FG000|Overall Study|Death|0|||
13294452|NCT01060384|26491309|FG001|Overall Study|Death|0|||
13294453|NCT01060384|26491310|FG002|Overall Study|Death|0|||
13294454|NCT01060384|26491311|FG003|Overall Study|Death|0|||
13294455|NCT01060384|26491312|FG004|Overall Study|Death|1|||
13294456|NCT01060384|26491308|FG000|Overall Study|Intercurrent illness|0|||
13294457|NCT01060384|26491309|FG001|Overall Study|Intercurrent illness|0|||
13294458|NCT01060384|26491310|FG002|Overall Study|Intercurrent illness|0|||
13294459|NCT01060384|26491311|FG003|Overall Study|Intercurrent illness|0|||
13294460|NCT01060384|26491312|FG004|Overall Study|Intercurrent illness|1|||
13294461|NCT01060150|26491329|FG000|Overall Study|Adverse Event|6|||
13294462|NCT01060150|26491329|FG000|Overall Study|Lost to Follow-up|1|||
13294463|NCT01060150|26491329|FG000|Overall Study|Protocol Violation|6|||
13294464|NCT01060150|26491329|FG000|Overall Study|Withdrawal by Subject|8|||
13294465|NCT01060150|26491329|FG000|Overall Study|Enrolled, but not treated|2|||
13294466|NCT01060124|26491339|FG000|Overall Study|Other|16|||
13294467|NCT01060124|26491339|FG000|Overall Study|Adverse Event|14|||
13294468|NCT01060124|26491339|FG000|Overall Study|Withdrawal by Subject|7|||
13294469|NCT01060111|26491366|FG000|Overall Study|Adverse Event|9|||
13294470|NCT01060111|26491367|FG001|Overall Study|Adverse Event|5|||
13294471|NCT01060111|26491368|FG002|Overall Study|Adverse Event|18|||
13294472|NCT01060111|26491366|FG000|Overall Study|Lack of Efficacy|2|||
13294473|NCT01060111|26491367|FG001|Overall Study|Lack of Efficacy|1|||
13294474|NCT01060111|26491368|FG002|Overall Study|Lack of Efficacy|0|||
13294475|NCT01060111|26491366|FG000|Overall Study|Inappropriate participant|5|||
13294476|NCT01060111|26491367|FG001|Overall Study|Inappropriate participant|4|||
13294477|NCT01060111|26491368|FG002|Overall Study|Inappropriate participant|5|||
13294478|NCT01060111|26491366|FG000|Overall Study|Participants' evasion for hospital visit|0|||
13294479|NCT01060111|26491367|FG001|Overall Study|Participants' evasion for hospital visit|3|||
13294480|NCT01060111|26491368|FG002|Overall Study|Participants' evasion for hospital visit|2|||
13294481|NCT01060111|26491366|FG000|Overall Study|Participants' non-cooperation|8|||
13294482|NCT01060111|26491367|FG001|Overall Study|Participants' non-cooperation|6|||
13294483|NCT01060111|26491368|FG002|Overall Study|Participants' non-cooperation|6|||
13294484|NCT01060111|26491366|FG000|Overall Study|Adverse event and insufficient effect|0|||
13294485|NCT01060111|26491367|FG001|Overall Study|Adverse event and insufficient effect|1|||
13294486|NCT01060111|26491368|FG002|Overall Study|Adverse event and insufficient effect|0|||
13294487|NCT01060111|26491366|FG000|Overall Study|Participants' non-cooperation|1|||
13294488|NCT01060111|26491367|FG001|Overall Study|Participants' non-cooperation|0|||
13294489|NCT01060111|26491368|FG002|Overall Study|Participants' non-cooperation|0|||
13294490|NCT01060111|26491366|FG000|Overall Study|Other|2|||
13294491|NCT01060111|26491367|FG001|Overall Study|Other|3|||
13294492|NCT01060111|26491368|FG002|Overall Study|Other|4|||
13294493|NCT01060072|26491389|FG000|Overall Study|Adverse Event|1|||
13294494|NCT01060072|26491390|FG001|Overall Study|Adverse Event|1|||
13294495|NCT01060072|26491389|FG000|Overall Study|Physician Decision|0|||
13294496|NCT01060072|26491390|FG001|Overall Study|Physician Decision|2|||
13294497|NCT01060072|26491389|FG000|Overall Study|Protocol Violation|0|||
13294498|NCT01060072|26491390|FG001|Overall Study|Protocol Violation|1|||
13294499|NCT01060072|26491389|FG000|Overall Study|Acute cholecystitis|1|||
13294500|NCT01060072|26491390|FG001|Overall Study|Acute cholecystitis|0|||
13294501|NCT01060072|26491389|FG000|Overall Study|Excluded Medications|0|||
13294502|NCT01060072|26491390|FG001|Overall Study|Excluded Medications|1|||
13294503|NCT01060059|26491447|FG000|Overall Study|Adverse Event|1|||
13294504|NCT01060059|26491448|FG001|Overall Study|Adverse Event|1|||
13294505|NCT01060059|26491447|FG000|Overall Study|Death|2|||
13294506|NCT01060059|26491448|FG001|Overall Study|Death|3|||
13294507|NCT01060059|26491447|FG000|Overall Study|Lost to Follow-up|18|||
13294508|NCT01060059|26491448|FG001|Overall Study|Lost to Follow-up|34|||
13294509|NCT01060059|26491447|FG000|Overall Study|entry criteria not met|4|||
13294510|NCT01060059|26491448|FG001|Overall Study|entry criteria not met|3|||
13294511|NCT01060059|26491447|FG000|Overall Study|Withdrawal by Subject|35|||
13294512|NCT01060059|26491448|FG001|Overall Study|Withdrawal by Subject|23|||
13294513|NCT01060059|26491447|FG000|Overall Study|lack of glycemic control|2|||
13294514|NCT01060059|26491448|FG001|Overall Study|lack of glycemic control|1|||
13294515|NCT01060059|26491447|FG000|Overall Study|lack of compliance|5|||
13294516|NCT01060059|26491448|FG001|Overall Study|lack of compliance|2|||
13294517|NCT01060007|26491464|FG000|Overall Study|Withdrawal by Subject|1|||
13294518|NCT01060007|26491464|FG000|Overall Study|Inevaluable for response at surgery|3|||
13294519|NCT01062399|26491499|FG000|Overall Study|Protocol Violation|0|||
13294520|NCT01062399|26491500|FG001|Overall Study|Protocol Violation|1|||
13294521|NCT01062399|26491501|FG002|Overall Study|Protocol Violation|0|||
13294522|NCT01062399|26491502|FG003|Overall Study|Protocol Violation|6|||
13294523|NCT01062399|26491503|FG004|Overall Study|Protocol Violation|4|||
13294524|NCT01067521|26491534|FG000|Double-Blind Placebo-Controlled Period|Death|0|||
13294525|NCT01067521|26491535|FG001|Double-Blind Placebo-Controlled Period|Death|1|||
13294526|NCT01067521|26491534|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29|||
13294527|NCT01067521|26491535|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6|||
13294528|NCT01067521|26491534|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34|||
13294529|NCT01067521|26491535|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17|||
13294530|NCT01067521|26491534|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
13294531|NCT01067521|26491535|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
13294532|NCT01067521|26491534|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4|||
13294533|NCT01067521|26491535|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1|||
13294534|NCT01067521|26491534|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2|||
13294535|NCT01067521|26491535|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0|||
13294536|NCT01067521|26491534|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2|||
13294537|NCT01067521|26491535|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
13294538|NCT01067521|26491534|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7|||
13294539|NCT01067521|26491535|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4|||
13294540|NCT01067521|26491534|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5|||
13294541|NCT01067521|26491535|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1|||
13294542|NCT01067521|26491534|FG000|Open-Label Period|Death|3|||
13294543|NCT01067521|26491535|FG001|Open-Label Period|Death|1|||
13294544|NCT01067521|26491534|FG000|Open-Label Period|Adverse Event|30|||
13294545|NCT01067521|26491535|FG001|Open-Label Period|Adverse Event|28|||
13294546|NCT01067521|26491534|FG000|Open-Label Period|Withdrawal by Subject|160|||
13294547|NCT01067521|26491535|FG001|Open-Label Period|Withdrawal by Subject|88|||
13294548|NCT01067521|26491534|FG000|Open-Label Period|Physician Decision|13|||
13294549|NCT01067521|26491535|FG001|Open-Label Period|Physician Decision|11|||
13294550|NCT01067521|26491534|FG000|Open-Label Period|Non-compliance with study drug|5|||
13294551|NCT01067521|26491535|FG001|Open-Label Period|Non-compliance with study drug|0|||
13294552|NCT01067521|26491534|FG000|Open-Label Period|Protocol Violation|3|||
13294553|NCT01067521|26491535|FG001|Open-Label Period|Protocol Violation|0|||
13294554|NCT01067521|26491534|FG000|Open-Label Period|Pregnancy|14|||
13294555|NCT01067521|26491535|FG001|Open-Label Period|Pregnancy|8|||
13294556|NCT01067521|26491534|FG000|Open-Label Period|Teva requested subject to be withdrawn|5|||
13294557|NCT01067521|26491535|FG001|Open-Label Period|Teva requested subject to be withdrawn|2|||
13294558|NCT01067521|26491534|FG000|Open-Label Period|Lost to Follow-up|21|||
13294559|NCT01067521|26491535|FG001|Open-Label Period|Lost to Follow-up|20|||
13294560|NCT01065779|26491548|FG000|Overall Study|Duplicate Investigation|1|||
13294561|NCT01065779|26491548|FG000|Overall Study|Investigation Before Contract Date|37|||
13294562|NCT01065779|26491548|FG000|Overall Study|Non-enrollment Period Administration|10|||
13294563|NCT01065779|26491548|FG000|Overall Study|Not Administered With Study Drug|17|||
13294564|NCT01065779|26491548|FG000|Overall Study|Failed to Follow-up|10|||
13294565|NCT01065779|26491548|FG000|Overall Study|Inclusion Criteria Violation|7|||
13294566|NCT01064479|26491569|FG000|Overall Study|Death|10|||
13294567|NCT01064479|26491570|FG001|Overall Study|Death|11|||
13294568|NCT01064479|26491569|FG000|Overall Study|Withdrawal by Subject|2|||
13294569|NCT01064479|26491570|FG001|Overall Study|Withdrawal by Subject|2|||
13294570|NCT01064479|26491569|FG000|Overall Study|Disease progression|1|||
13294571|NCT01064479|26491570|FG001|Overall Study|Disease progression|1|||
13294572|NCT01064479|26491569|FG000|Overall Study|Toxicity|1|||
13294573|NCT01064479|26491570|FG001|Overall Study|Toxicity|1|||
13294574|NCT01064479|26491569|FG000|Overall Study|Other|1|||
13294575|NCT01064479|26491570|FG001|Overall Study|Other|2|||
13294576|NCT01066663|26491593|FG000|Overall Study|Adverse Event|0|||
13294577|NCT01066663|26491594|FG001|Overall Study|Adverse Event|0|||
13294578|NCT01066663|26491595|FG002|Overall Study|Adverse Event|1|||
13378212|NCT00773734|26737850|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
13378213|NCT00773734|26737845|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
13378214|NCT00773734|26737846|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
13378215|NCT00773734|26737847|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2|||
13378216|NCT00773734|26737848|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4|||
13378217|NCT00773734|26737849|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
13378218|NCT00773734|26737850|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
13378219|NCT00773734|26737845|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
13378220|NCT00773734|26737846|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
13378221|NCT00773734|26737847|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6|||
13378222|NCT00773734|26737848|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3|||
13378223|NCT00773734|26737849|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
13378224|NCT00773734|26737850|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
13378225|NCT00773734|26737845|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
13378226|NCT00773734|26737846|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
13378227|NCT00773734|26737847|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
13378228|NCT00773734|26737848|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
13378229|NCT00773734|26737849|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
13378230|NCT00773734|26737850|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
13378231|NCT00773513|26737877|FG000|Overall Study|Renal Transplant|254|||
13378232|NCT00773513|26737878|FG001|Overall Study|Renal Transplant|263|||
13378233|NCT00773513|26737877|FG000|Overall Study|Adverse Event / Intercurrent Illness|40|||
13378234|NCT00773513|26737878|FG001|Overall Study|Adverse Event / Intercurrent Illness|48|||
13378235|NCT00773513|26737877|FG000|Overall Study|Withdrew Consent|68|||
13378236|NCT00773513|26737878|FG001|Overall Study|Withdrew Consent|69|||
13378237|NCT00773513|26737877|FG000|Overall Study|Refused Treatment / Did not Cooperate|26|||
13378238|NCT00773513|26737878|FG001|Overall Study|Refused Treatment / Did not Cooperate|32|||
13378239|NCT00773513|26737877|FG000|Overall Study|Failure to Return|22|||
13378240|NCT00773513|26737878|FG001|Overall Study|Failure to Return|8|||
13378241|NCT00773513|26737877|FG000|Overall Study|Insufficient Therapeutic Response|1|||
13378242|NCT00773513|26737878|FG001|Overall Study|Insufficient Therapeutic Response|18|||
13378243|NCT00773513|26737877|FG000|Overall Study|Reason Not Specified|159|||
13378244|NCT00773513|26737878|FG001|Overall Study|Reason Not Specified|126|||
13378245|NCT00773513|26737877|FG000|Overall Study|Death|531|||
13378246|NCT00773513|26737878|FG001|Overall Study|Death|545|||
13378247|NCT00773461|26737923|FG000|Overall Study|Adverse Event|1|||
13378248|NCT00773461|26737924|FG001|Overall Study|Adverse Event|3|||
13378249|NCT00773461|26737923|FG000|Overall Study|Withdrawal by Subject|4|||
13378250|NCT00773461|26737924|FG001|Overall Study|Withdrawal by Subject|1|||
13378251|NCT00773383|26737946|FG000|Overall Study|Adverse Event|4|||
13378252|NCT00773383|26737946|FG000|Overall Study|Death|1|||
13378253|NCT00773383|26737946|FG000|Overall Study|Progression of Disease|23|||
13378254|NCT00773383|26737946|FG000|Overall Study|Other|2|||
13378255|NCT00773383|26737946|FG000|Overall Study|No study dose received|1|||
13378256|NCT00773292|26737953|FG000|Treatment 48 Weeks|Adverse Event|1|||
13378257|NCT00773292|26737953|FG000|Treatment 48 Weeks|Lack of Efficacy|1|||
13378258|NCT00773279|26737975|FG000|Period 1|Adverse Event|2|||
13378259|NCT00773279|26737976|FG001|Period 1|Adverse Event|1|||
13378260|NCT00773279|26737975|FG000|Period 1|Lack of Efficacy|0|||
13378261|NCT00773279|26737976|FG001|Period 1|Lack of Efficacy|2|||
13378262|NCT00773279|26737975|FG000|Period 1|Unclassified|5|||
13378263|NCT00773279|26737976|FG001|Period 1|Unclassified|1|||
13378264|NCT00773279|26737975|FG000|Period 2|Adverse Event|0|||
13378265|NCT00773279|26737976|FG001|Period 2|Adverse Event|1|||
13378266|NCT00773279|26737975|FG000|Period 2|Lack of Efficacy|1|||
13378267|NCT00773279|26737976|FG001|Period 2|Lack of Efficacy|0|||
13378268|NCT00773279|26737975|FG000|Period 2|Protocol Violation|0|||
13294579|NCT01319994|26491610|FG000|Overall Study|Protocol Violation|7|||
13294580|NCT01319994|26491611|FG001|Overall Study|Protocol Violation|6|||
13294581|NCT01319929|26491648|FG000|First Treatment Period (4 Weeks)|Adverse Event|2|||
13294582|NCT01319929|26491649|FG001|First Treatment Period (4 Weeks)|Adverse Event|0|||
13294583|NCT01319929|26491648|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
13294584|NCT01319929|26491649|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
13294585|NCT01319929|26491648|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0|||
13294586|NCT01319929|26491649|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1|||
13294587|NCT01319929|26491648|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1|||
13294588|NCT01319929|26491649|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0|||
13294589|NCT01319929|26491648|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0|||
13294590|NCT01319929|26491649|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1|||
13294591|NCT01319877|26491691|FG000|Overall Study|Lost to Follow-up|100|||
13294592|NCT01319877|26491692|FG001|Overall Study|Lost to Follow-up|37|||
13294593|NCT01319877|26491691|FG000|Overall Study|Physician Decision|2|||
13294594|NCT01319877|26491692|FG001|Overall Study|Physician Decision|0|||
13294595|NCT01319877|26491691|FG000|Overall Study|Disease Progression|2|||
13294596|NCT01319877|26491692|FG001|Overall Study|Disease Progression|2|||
13294597|NCT01319877|26491691|FG000|Overall Study|Withdrawal by Subject|0|||
13294598|NCT01319877|26491692|FG001|Overall Study|Withdrawal by Subject|1|||
13294599|NCT01319877|26491691|FG000|Overall Study|Reason Not Specified|4|||
13294600|NCT01319877|26491692|FG001|Overall Study|Reason Not Specified|5|||
13294601|NCT01319721|26491713|FG000|Overall Study|Lost to Follow-up|1|||
13294602|NCT01319721|26491714|FG001|Overall Study|Lost to Follow-up|6|||
13294603|NCT01319422|26491735|FG000|Overall Study|Withdrawal by Subject|1|||
13294604|NCT01319422|26491736|FG001|Overall Study|Withdrawal by Subject|0|||
13294605|NCT01318915|26491763|FG000|Overall Study|Lost to Follow-up|1|||
13294606|NCT01318876|26491770|FG000|Day 8 Survey|email address invalid|96|||
13294607|NCT01318876|26491770|FG000|Day 8 Survey|survey not completed-don't know why|1724|||
13294608|NCT01318876|26491770|FG000|Day 29 Survey|survey not completed-don't know why|1825|||
13294609|NCT01318512|26491788|FG000|Maintenance Period (6 Months)|Death|2|||
13294610|NCT01318512|26491788|FG000|Maintenance Period (6 Months)|Protocol Violation|9|||
13294611|NCT01318499|26491816|FG000|Overall Study|Adverse Event|16|||
13294612|NCT01318499|26491817|FG001|Overall Study|Adverse Event|11|||
13294613|NCT01318499|26491818|FG002|Overall Study|Adverse Event|6|||
13294614|NCT01318499|26491816|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
13294615|NCT01318499|26491817|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
13294616|NCT01318499|26491818|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2|||
13294617|NCT01318499|26491816|FG000|Overall Study|Noncompliance|2|||
13294618|NCT01318499|26491817|FG001|Overall Study|Noncompliance|3|||
13294619|NCT01318499|26491818|FG002|Overall Study|Noncompliance|0|||
13294620|NCT01318499|26491816|FG000|Overall Study|Treatment Failure|19|||
13294621|NCT01318499|26491817|FG001|Overall Study|Treatment Failure|19|||
13294622|NCT01318499|26491818|FG002|Overall Study|Treatment Failure|101|||
13294623|NCT01318499|26491816|FG000|Overall Study|Protocol Violation|2|||
13294624|NCT01318499|26491817|FG001|Overall Study|Protocol Violation|4|||
13294625|NCT01318499|26491818|FG002|Overall Study|Protocol Violation|2|||
13294626|NCT01318499|26491816|FG000|Overall Study|Patient Did Not Use Study Medication|18|||
13294627|NCT01318499|26491817|FG001|Overall Study|Patient Did Not Use Study Medication|28|||
13294628|NCT01318499|26491818|FG002|Overall Study|Patient Did Not Use Study Medication|14|||
13294629|NCT01318499|26491816|FG000|Overall Study|Other|7|||
13294630|NCT01318499|26491817|FG001|Overall Study|Other|10|||
13294631|NCT01318499|26491818|FG002|Overall Study|Other|22|||
13294632|NCT01318382|26491827|FG000|Overall Study|Physician Decision|2|||
13294633|NCT01318382|26491827|FG000|Overall Study|Device Malfunction|10|||
13294634|NCT01318382|26491827|FG000|Overall Study|Protocol Violation|1|||
13294635|NCT01318135|26491974|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1|||
13294636|NCT01318135|26491975|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
13294637|NCT01318135|26491976|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
13294638|NCT01318135|26491977|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0|||
13294639|NCT01318135|26491978|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0|||
13294640|NCT01318135|26491979|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
13294641|NCT01318135|26491980|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
13378269|NCT00773279|26737976|FG001|Period 2|Protocol Violation|3|||
13294642|NCT01318135|26491981|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
13294643|NCT01318135|26491974|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1|||
13294644|NCT01318135|26491975|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
13294645|NCT01318135|26491976|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
13294646|NCT01318135|26491977|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
13294647|NCT01318135|26491978|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
13294648|NCT01318135|26491979|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
13294649|NCT01318135|26491980|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
13378270|NCT00773279|26737975|FG000|Period 2|Unclassified|2|||
13294650|NCT01318135|26491981|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
13294651|NCT01318135|26491974|FG000|Entered - Long-Term Extension Study|Adverse Event|9|||
13294652|NCT01318135|26491975|FG001|Entered - Long-Term Extension Study|Adverse Event|3|||
13294653|NCT01318135|26491976|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
13294654|NCT01318135|26491977|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
13294655|NCT01318135|26491978|FG004|Entered - Long-Term Extension Study|Adverse Event|4|||
13294656|NCT01318135|26491979|FG005|Entered - Long-Term Extension Study|Adverse Event|2|||
13294657|NCT01318135|26491980|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
13294658|NCT01318135|26491981|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
13294659|NCT01318135|26491974|FG000|Entered - Long-Term Extension Study|Protocol Violation|1|||
13294660|NCT01318135|26491975|FG001|Entered - Long-Term Extension Study|Protocol Violation|1|||
13294661|NCT01318135|26491976|FG002|Entered - Long-Term Extension Study|Protocol Violation|0|||
13294662|NCT01318135|26491977|FG003|Entered - Long-Term Extension Study|Protocol Violation|0|||
13294663|NCT01318135|26491978|FG004|Entered - Long-Term Extension Study|Protocol Violation|1|||
13294664|NCT01318135|26491979|FG005|Entered - Long-Term Extension Study|Protocol Violation|0|||
13294665|NCT01318135|26491980|FG006|Entered - Long-Term Extension Study|Protocol Violation|0|||
13294666|NCT01318135|26491981|FG007|Entered - Long-Term Extension Study|Protocol Violation|0|||
13294667|NCT01318135|26491974|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
13294668|NCT01318135|26491975|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
13294669|NCT01318135|26491976|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
13294670|NCT01318135|26491977|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
13294671|NCT01318135|26491978|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
13294672|NCT01318135|26491979|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
13294673|NCT01318135|26491980|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
13294674|NCT01318135|26491981|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
13294675|NCT01318135|26491974|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
13294676|NCT01318135|26491975|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7|||
13294677|NCT01318135|26491976|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
13294678|NCT01318135|26491977|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
13294679|NCT01318135|26491978|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
13294680|NCT01318135|26491979|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
13294681|NCT01318135|26491980|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
13294682|NCT01318135|26491981|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
13294683|NCT01318135|26491974|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
13294684|NCT01318135|26491975|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
13294685|NCT01318135|26491976|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
13294686|NCT01318135|26491977|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
13294687|NCT01318135|26491978|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
13294688|NCT01318135|26491979|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
13294689|NCT01318135|26491980|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
13294690|NCT01318135|26491981|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1|||
13294691|NCT01318122|26492056|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
13294692|NCT01318122|26492057|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
13294693|NCT01318122|26492058|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2|||
13294694|NCT01318122|26492059|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
13294695|NCT01318122|26492056|FG000|Enrolled - Long-Term Extension Study|Other|1|||
13294696|NCT01318122|26492057|FG001|Enrolled - Long-Term Extension Study|Other|0|||
13294697|NCT01318122|26492058|FG002|Enrolled - Long-Term Extension Study|Other|0|||
13294698|NCT01318122|26492059|FG003|Enrolled - Long-Term Extension Study|Other|0|||
13294699|NCT01318122|26492056|FG000|Entered - Long-Term Extension Study|Adverse Event|6|||
13294700|NCT01318122|26492057|FG001|Entered - Long-Term Extension Study|Adverse Event|6|||
13294701|NCT01318122|26492058|FG002|Entered - Long-Term Extension Study|Adverse Event|2|||
13294702|NCT01318122|26492059|FG003|Entered - Long-Term Extension Study|Adverse Event|4|||
13294703|NCT01318122|26492056|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1|||
13294704|NCT01318122|26492057|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
13294705|NCT01318122|26492058|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
13294706|NCT01318122|26492059|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
13294707|NCT01318122|26492056|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
13294708|NCT01318122|26492057|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3|||
13294709|NCT01318122|26492058|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
13294710|NCT01318122|26492059|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
13294711|NCT01318122|26492056|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
13294712|NCT01318122|26492057|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
13294713|NCT01318122|26492058|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
13294714|NCT01318122|26492059|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
13294715|NCT01318109|26492101|FG000|Overall Study|Adverse Event|0|||
13294716|NCT01318109|26492102|FG001|Overall Study|Adverse Event|2|||
13294717|NCT01318109|26492103|FG002|Overall Study|Adverse Event|0|||
13294718|NCT01318109|26492101|FG000|Overall Study|Withdrawal by Subject|1|||
13294719|NCT01318109|26492102|FG001|Overall Study|Withdrawal by Subject|0|||
13294720|NCT01318109|26492103|FG002|Overall Study|Withdrawal by Subject|0|||
13294721|NCT01318109|26492101|FG000|Overall Study|Schedule Conflict|0|||
13294722|NCT01318109|26492102|FG001|Overall Study|Schedule Conflict|1|||
13294723|NCT01318109|26492103|FG002|Overall Study|Schedule Conflict|0|||
13294724|NCT01318083|26492145|FG000|Overall Study|Adverse Event|4|||
13294725|NCT01318083|26492146|FG001|Overall Study|Adverse Event|1|||
13294726|NCT01318083|26492147|FG002|Overall Study|Adverse Event|2|||
13294727|NCT01318083|26492145|FG000|Overall Study|Withdrawal by Subject|1|||
13294728|NCT01318083|26492146|FG001|Overall Study|Withdrawal by Subject|0|||
13294729|NCT01318083|26492147|FG002|Overall Study|Withdrawal by Subject|2|||
13294730|NCT01318083|26492145|FG000|Overall Study|Lack of Efficacy|0|||
13294731|NCT01318083|26492146|FG001|Overall Study|Lack of Efficacy|0|||
13294732|NCT01318083|26492147|FG002|Overall Study|Lack of Efficacy|1|||
13294733|NCT01318083|26492145|FG000|Overall Study|Treatment Complications|1|||
13294734|NCT01318083|26492146|FG001|Overall Study|Treatment Complications|0|||
13294735|NCT01318083|26492147|FG002|Overall Study|Treatment Complications|0|||
13294736|NCT01318083|26492145|FG000|Overall Study|Lack of Study Medication Compliance|0|||
13294737|NCT01318083|26492146|FG001|Overall Study|Lack of Study Medication Compliance|1|||
13294738|NCT01318083|26492147|FG002|Overall Study|Lack of Study Medication Compliance|0|||
13294739|NCT01318070|26492189|FG000|Overall Study|Adverse Event|1|||
13294740|NCT01318070|26492190|FG001|Overall Study|Adverse Event|1|||
13294741|NCT01318070|26492191|FG002|Overall Study|Adverse Event|5|||
13294742|NCT01318070|26492189|FG000|Overall Study|Withdrawal by Subject|0|||
13294743|NCT01318070|26492190|FG001|Overall Study|Withdrawal by Subject|1|||
13294744|NCT01318070|26492191|FG002|Overall Study|Withdrawal by Subject|1|||
13294745|NCT01318070|26492189|FG000|Overall Study|Lack of Efficacy|0|||
13294746|NCT01318070|26492190|FG001|Overall Study|Lack of Efficacy|0|||
13294747|NCT01318070|26492191|FG002|Overall Study|Lack of Efficacy|1|||
13294748|NCT01318070|26492189|FG000|Overall Study|Principal Investigator Discretion|1|||
13294749|NCT01318070|26492190|FG001|Overall Study|Principal Investigator Discretion|0|||
13294750|NCT01318070|26492191|FG002|Overall Study|Principal Investigator Discretion|0|||
13294751|NCT01317940|26492229|FG000|Overall Study|Death|1|||
13294752|NCT01317940|26492230|FG001|Overall Study|Death|0|||
13294753|NCT01317940|26492231|FG002|Overall Study|Death|1|||
13294754|NCT01317940|26492232|FG003|Overall Study|Death|0|||
13294755|NCT01317940|26492233|FG004|Overall Study|Death|0|||
13294756|NCT01317940|26492234|FG005|Overall Study|Death|0|||
13294757|NCT01317940|26492229|FG000|Overall Study|Lost to Follow-up|0|||
13294758|NCT01317940|26492230|FG001|Overall Study|Lost to Follow-up|0|||
13294759|NCT01317940|26492231|FG002|Overall Study|Lost to Follow-up|1|||
13294760|NCT01317940|26492232|FG003|Overall Study|Lost to Follow-up|1|||
13294761|NCT01317940|26492233|FG004|Overall Study|Lost to Follow-up|1|||
13294762|NCT01317940|26492234|FG005|Overall Study|Lost to Follow-up|0|||
13294763|NCT01317940|26492229|FG000|Overall Study|Change in therapy plan|0|||
13294764|NCT01317940|26492230|FG001|Overall Study|Change in therapy plan|0|||
13294765|NCT01317940|26492231|FG002|Overall Study|Change in therapy plan|3|||
13294766|NCT01317940|26492232|FG003|Overall Study|Change in therapy plan|0|||
13294767|NCT01317940|26492233|FG004|Overall Study|Change in therapy plan|0|||
13294768|NCT01317940|26492234|FG005|Overall Study|Change in therapy plan|0|||
13294769|NCT01317797|26492296|FG000|Overall Study|Other|0|||
13294770|NCT01317797|26492297|FG001|Overall Study|Other|1|||
13294771|NCT01317797|26492298|FG002|Overall Study|Other|0|||
13294772|NCT01317797|26492296|FG000|Overall Study|Withdrawal of Patient|0|||
13294773|NCT01317797|26492297|FG001|Overall Study|Withdrawal of Patient|0|||
13294774|NCT01317797|26492298|FG002|Overall Study|Withdrawal of Patient|1|||
13294775|NCT01317641|26492428|FG000|Overall Study|Not treated|0|||
13294776|NCT01317641|26492429|FG001|Overall Study|Not treated|0|||
13294777|NCT01317641|26492430|FG002|Overall Study|Not treated|0|||
13294778|NCT01317641|26492431|FG003|Overall Study|Not treated|0|||
13294779|NCT01317641|26492432|FG004|Overall Study|Not treated|0|||
13294780|NCT01317641|26492433|FG005|Overall Study|Not treated|0|||
13294781|NCT01317641|26492434|FG006|Overall Study|Not treated|0|||
13294782|NCT01317641|26492435|FG007|Overall Study|Not treated|1|||
13135108|NCT02745145|25993631|FG002|Overall Study|Adverse Event|0|||
13294783|NCT01317641|26492436|FG008|Overall Study|Not treated|1|||
13294784|NCT01317641|26492428|FG000|Overall Study|Adverse Event|0|||
13294785|NCT01317641|26492429|FG001|Overall Study|Adverse Event|1|||
13294786|NCT01317641|26492430|FG002|Overall Study|Adverse Event|0|||
13294787|NCT01317641|26492431|FG003|Overall Study|Adverse Event|1|||
13294788|NCT01317641|26492432|FG004|Overall Study|Adverse Event|0|||
13294789|NCT01317641|26492433|FG005|Overall Study|Adverse Event|0|||
13294790|NCT01317641|26492434|FG006|Overall Study|Adverse Event|2|||
13294791|NCT01317641|26492435|FG007|Overall Study|Adverse Event|1|||
13294792|NCT01317641|26492436|FG008|Overall Study|Adverse Event|0|||
13294793|NCT01317641|26492428|FG000|Overall Study|Protocol Violation|1|||
13294794|NCT01317641|26492429|FG001|Overall Study|Protocol Violation|0|||
13294795|NCT01317641|26492430|FG002|Overall Study|Protocol Violation|0|||
13294796|NCT01317641|26492431|FG003|Overall Study|Protocol Violation|0|||
13294797|NCT01317641|26492432|FG004|Overall Study|Protocol Violation|0|||
13294798|NCT01317641|26492433|FG005|Overall Study|Protocol Violation|0|||
13294799|NCT01317641|26492434|FG006|Overall Study|Protocol Violation|0|||
13294800|NCT01317641|26492435|FG007|Overall Study|Protocol Violation|0|||
13294801|NCT01317641|26492436|FG008|Overall Study|Protocol Violation|0|||
13294802|NCT01317641|26492428|FG000|Overall Study|Disease progression|0|||
13294803|NCT01317641|26492429|FG001|Overall Study|Disease progression|0|||
13294804|NCT01317641|26492430|FG002|Overall Study|Disease progression|0|||
13294805|NCT01317641|26492431|FG003|Overall Study|Disease progression|0|||
13294806|NCT01317641|26492432|FG004|Overall Study|Disease progression|0|||
13294807|NCT01317641|26492433|FG005|Overall Study|Disease progression|0|||
13294808|NCT01317641|26492434|FG006|Overall Study|Disease progression|0|||
13294809|NCT01317641|26492435|FG007|Overall Study|Disease progression|3|||
13294810|NCT01317641|26492436|FG008|Overall Study|Disease progression|4|||
13294811|NCT01317641|26492428|FG000|Overall Study|Withdrawal by Subject|0|||
13294812|NCT01317641|26492429|FG001|Overall Study|Withdrawal by Subject|0|||
13294813|NCT01317641|26492430|FG002|Overall Study|Withdrawal by Subject|0|||
13294814|NCT01317641|26492431|FG003|Overall Study|Withdrawal by Subject|0|||
13294815|NCT01317641|26492432|FG004|Overall Study|Withdrawal by Subject|0|||
13294816|NCT01317641|26492433|FG005|Overall Study|Withdrawal by Subject|0|||
13294817|NCT01317641|26492434|FG006|Overall Study|Withdrawal by Subject|1|||
13294818|NCT01317641|26492435|FG007|Overall Study|Withdrawal by Subject|0|||
13294819|NCT01317641|26492436|FG008|Overall Study|Withdrawal by Subject|0|||
13294820|NCT01317550|26492459|FG000|Overall Study|Withdrawal by Subject|1|||
13294821|NCT01317550|26492460|FG001|Overall Study|Withdrawal by Subject|0|||
13294822|NCT01317550|26492461|FG002|Overall Study|Withdrawal by Subject|0|||
13294823|NCT01317550|26492462|FG003|Overall Study|Withdrawal by Subject|0|||
13294824|NCT01317550|26492459|FG000|Overall Study|Lack of compliance study med|1|||
13294825|NCT01317550|26492460|FG001|Overall Study|Lack of compliance study med|0|||
13294826|NCT01317550|26492461|FG002|Overall Study|Lack of compliance study med|0|||
13294827|NCT01317550|26492462|FG003|Overall Study|Lack of compliance study med|0|||
13294828|NCT01317472|26492475|FG000|Overall Study|Withdrawal by Subject|1|||
13294829|NCT01317472|26492476|FG001|Overall Study|Withdrawal by Subject|0|||
13294830|NCT01317472|26492475|FG000|Overall Study|Unrelated hospitalization|1|||
13294831|NCT01317472|26492476|FG001|Overall Study|Unrelated hospitalization|0|||
13294832|NCT01317277|26492493|FG000|Overall Study|Lost to Follow-up|3|||
13294833|NCT01317277|26492494|FG001|Overall Study|Lost to Follow-up|1|||
13294834|NCT01317277|26492493|FG000|Overall Study|Lost MEMS|1|||
13294835|NCT01317277|26492494|FG001|Overall Study|Lost MEMS|1|||
13294836|NCT01317277|26492493|FG000|Overall Study|Unable to comply with intervention|1|||
13294837|NCT01317277|26492494|FG001|Overall Study|Unable to comply with intervention|0|||
13294838|NCT01317277|26492493|FG000|Overall Study|Withdrawal by Subject|1|||
13294839|NCT01317277|26492494|FG001|Overall Study|Withdrawal by Subject|0|||
13294840|NCT01317277|26492493|FG000|Overall Study|Adverse Event|1|||
13294841|NCT01317277|26492494|FG001|Overall Study|Adverse Event|0|||
13294842|NCT01317199|26492534|FG000|Dose-escalation Phase 1|Physician Decision|5|||
13294843|NCT01317199|26492535|FG001|Dose-escalation Phase 1|Physician Decision|0|||
13294844|NCT01317199|26492536|FG002|Dose-escalation Phase 1|Physician Decision|0|||
13294845|NCT01317199|26492537|FG003|Dose-escalation Phase 1|Physician Decision|0|||
13294846|NCT01317199|26492534|FG000|Dose-escalation Phase 1|Disease progression|1|||
13294847|NCT01317199|26492535|FG001|Dose-escalation Phase 1|Disease progression|0|||
13294848|NCT01317199|26492536|FG002|Dose-escalation Phase 1|Disease progression|0|||
13294849|NCT01317199|26492537|FG003|Dose-escalation Phase 1|Disease progression|0|||
13294850|NCT01317199|26492534|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1|||
13294851|NCT01317199|26492535|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
13294852|NCT01317199|26492536|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
13294853|NCT01317199|26492537|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
13294854|NCT01317199|26492534|FG000|Randomized Phase 2|Disease progression|0|||
13294855|NCT01317199|26492535|FG001|Randomized Phase 2|Disease progression|3|||
13294856|NCT01317199|26492536|FG002|Randomized Phase 2|Disease progression|7|||
13294857|NCT01317199|26492537|FG003|Randomized Phase 2|Disease progression|5|||
13294858|NCT01317199|26492534|FG000|Randomized Phase 2|Withdrawal by Subject|0|||
13294859|NCT01317199|26492535|FG001|Randomized Phase 2|Withdrawal by Subject|3|||
13294860|NCT01317199|26492536|FG002|Randomized Phase 2|Withdrawal by Subject|5|||
13294861|NCT01317199|26492537|FG003|Randomized Phase 2|Withdrawal by Subject|4|||
13294862|NCT01317199|26492534|FG000|Randomized Phase 2|Adverse Event|0|||
13294863|NCT01317199|26492535|FG001|Randomized Phase 2|Adverse Event|0|||
13294864|NCT01317199|26492536|FG002|Randomized Phase 2|Adverse Event|0|||
13294865|NCT01317199|26492537|FG003|Randomized Phase 2|Adverse Event|1|||
13294866|NCT01317199|26492534|FG000|Randomized Phase 2|Comorbidities|0|||
13294867|NCT01317199|26492535|FG001|Randomized Phase 2|Comorbidities|2|||
13294868|NCT01317199|26492536|FG002|Randomized Phase 2|Comorbidities|2|||
13294869|NCT01317199|26492537|FG003|Randomized Phase 2|Comorbidities|2|||
13294870|NCT01317199|26492534|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0|||
13294871|NCT01317199|26492535|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
13294872|NCT01317199|26492536|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5|||
13294873|NCT01317199|26492537|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
13294874|NCT01317199|26492534|FG000|Randomized Phase 2|Disenrolled before treatment|0|||
13294875|NCT01317199|26492535|FG001|Randomized Phase 2|Disenrolled before treatment|1|||
13294876|NCT01317199|26492536|FG002|Randomized Phase 2|Disenrolled before treatment|1|||
13294877|NCT01317199|26492537|FG003|Randomized Phase 2|Disenrolled before treatment|2|||
13294878|NCT01317199|26492534|FG000|Randomized Phase 2|Patient stopped taking study drug|0|||
13294879|NCT01317199|26492535|FG001|Randomized Phase 2|Patient stopped taking study drug|0|||
13294880|NCT01317199|26492536|FG002|Randomized Phase 2|Patient stopped taking study drug|0|||
13294881|NCT01317199|26492537|FG003|Randomized Phase 2|Patient stopped taking study drug|1|||
13294882|NCT01317199|26492534|FG000|Randomized Phase 2|Patient transferred to other facility|0|||
13294883|NCT01317199|26492535|FG001|Randomized Phase 2|Patient transferred to other facility|0|||
13294884|NCT01317199|26492536|FG002|Randomized Phase 2|Patient transferred to other facility|1|||
13294885|NCT01317199|26492537|FG003|Randomized Phase 2|Patient transferred to other facility|0|||
13294886|NCT01317160|26492560|FG000|Overall Study|Incorrect inclusion|1|||
13294887|NCT01317160|26492561|FG001|Overall Study|Incorrect inclusion|1|||
13294888|NCT01317160|26492560|FG000|Overall Study|Lost to Follow-up|3|||
13294889|NCT01317160|26492561|FG001|Overall Study|Lost to Follow-up|3|||
13294890|NCT01317160|26492560|FG000|Overall Study|Withdrawal by Subject|0|||
13294891|NCT01317160|26492561|FG001|Overall Study|Withdrawal by Subject|2|||
13294892|NCT01317004|26492586|FG000|Overall Study|Withdrawal by Subject|1|||
13294893|NCT01317004|26492587|FG001|Overall Study|Withdrawal by Subject|4|||
13294894|NCT01317004|26492586|FG000|Overall Study|Protocol Violation|0|||
13294895|NCT01317004|26492587|FG001|Overall Study|Protocol Violation|2|||
13294896|NCT01317004|26492586|FG000|Overall Study|Adverse Event|3|||
13294897|NCT01317004|26492587|FG001|Overall Study|Adverse Event|3|||
13294898|NCT01316939|26492677|FG000|Overall Study|Study closed/terminated|26|||
13294899|NCT01316939|26492678|FG001|Overall Study|Study closed/terminated|25|||
13294900|NCT01316939|26492679|FG002|Overall Study|Study closed/terminated|23|||
13294901|NCT01316939|26492677|FG000|Overall Study|Lack of Efficacy|24|||
13294902|NCT01316939|26492678|FG001|Overall Study|Lack of Efficacy|25|||
13294903|NCT01316939|26492679|FG002|Overall Study|Lack of Efficacy|25|||
13294904|NCT01316939|26492677|FG000|Overall Study|Adverse Event|9|||
13294905|NCT01316939|26492678|FG001|Overall Study|Adverse Event|12|||
13294906|NCT01316939|26492679|FG002|Overall Study|Adverse Event|11|||
13294907|NCT01316939|26492677|FG000|Overall Study|Withdrawal by Subject|1|||
13294908|NCT01316939|26492678|FG001|Overall Study|Withdrawal by Subject|3|||
13294909|NCT01316939|26492679|FG002|Overall Study|Withdrawal by Subject|6|||
13294910|NCT01316939|26492677|FG000|Overall Study|Physician Decision|2|||
13294911|NCT01316939|26492678|FG001|Overall Study|Physician Decision|2|||
13294912|NCT01316939|26492679|FG002|Overall Study|Physician Decision|1|||
13294913|NCT01316939|26492677|FG000|Overall Study|Lost to Follow-up|0|||
13294914|NCT01316939|26492678|FG001|Overall Study|Lost to Follow-up|0|||
13294915|NCT01316939|26492679|FG002|Overall Study|Lost to Follow-up|2|||
13294916|NCT01316939|26492677|FG000|Overall Study|Met Liver chemistry stopping criteria|1|||
13294917|NCT01316939|26492678|FG001|Overall Study|Met Liver chemistry stopping criteria|0|||
13294918|NCT01316939|26492679|FG002|Overall Study|Met Liver chemistry stopping criteria|1|||
13294919|NCT01316939|26492677|FG000|Overall Study|Protocol Violation|0|||
13294920|NCT01316939|26492678|FG001|Overall Study|Protocol Violation|1|||
13294921|NCT01316939|26492679|FG002|Overall Study|Protocol Violation|0|||
13294922|NCT01316913|26492710|FG000|Overall Study|Adverse Event|17|||
13294923|NCT01316913|26492711|FG001|Overall Study|Adverse Event|20|||
13294924|NCT01316913|26492712|FG002|Overall Study|Adverse Event|15|||
13294925|NCT01316913|26492713|FG003|Overall Study|Adverse Event|11|||
13294926|NCT01316913|26492710|FG000|Overall Study|Lack of Efficacy|22|||
13294927|NCT01316913|26492711|FG001|Overall Study|Lack of Efficacy|12|||
13294928|NCT01316913|26492712|FG002|Overall Study|Lack of Efficacy|9|||
13294929|NCT01316913|26492713|FG003|Overall Study|Lack of Efficacy|13|||
13294930|NCT01316913|26492710|FG000|Overall Study|Protocol Violation|1|||
13294931|NCT01316913|26492711|FG001|Overall Study|Protocol Violation|4|||
13294932|NCT01316913|26492712|FG002|Overall Study|Protocol Violation|4|||
13294933|NCT01316913|26492713|FG003|Overall Study|Protocol Violation|1|||
13294934|NCT01316913|26492710|FG000|Overall Study|Protocol-defined Stopping Criteria|7|||
13294935|NCT01316913|26492711|FG001|Overall Study|Protocol-defined Stopping Criteria|8|||
13294936|NCT01316913|26492712|FG002|Overall Study|Protocol-defined Stopping Criteria|11|||
13294937|NCT01316913|26492713|FG003|Overall Study|Protocol-defined Stopping Criteria|6|||
13294938|NCT01316913|26492710|FG000|Overall Study|Lost to Follow-up|0|||
13294939|NCT01316913|26492711|FG001|Overall Study|Lost to Follow-up|1|||
13294940|NCT01316913|26492712|FG002|Overall Study|Lost to Follow-up|0|||
13294941|NCT01316913|26492713|FG003|Overall Study|Lost to Follow-up|2|||
13294942|NCT01316913|26492710|FG000|Overall Study|Withdrawal by Subject|10|||
13294943|NCT01316913|26492711|FG001|Overall Study|Withdrawal by Subject|9|||
13294944|NCT01316913|26492712|FG002|Overall Study|Withdrawal by Subject|10|||
13294945|NCT01316913|26492713|FG003|Overall Study|Withdrawal by Subject|6|||
13294946|NCT01316900|26492744|FG000|Overall Study|Adverse Event|10|||
13294947|NCT01316900|26492745|FG001|Overall Study|Adverse Event|10|||
13294948|NCT01316900|26492746|FG002|Overall Study|Adverse Event|15|||
13294949|NCT01316900|26492747|FG003|Overall Study|Adverse Event|9|||
13294950|NCT01316900|26492744|FG000|Overall Study|Lack of Efficacy|17|||
13294951|NCT01316900|26492745|FG001|Overall Study|Lack of Efficacy|9|||
13294952|NCT01316900|26492746|FG002|Overall Study|Lack of Efficacy|5|||
13294953|NCT01316900|26492747|FG003|Overall Study|Lack of Efficacy|7|||
13294954|NCT01316900|26492744|FG000|Overall Study|Protocol Violation|7|||
13294955|NCT01316900|26492745|FG001|Overall Study|Protocol Violation|1|||
13294956|NCT01316900|26492746|FG002|Overall Study|Protocol Violation|4|||
13294957|NCT01316900|26492747|FG003|Overall Study|Protocol Violation|0|||
13294958|NCT01316900|26492744|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
13294959|NCT01316900|26492745|FG001|Overall Study|Protocol-defined Stopping Criteria|3|||
13294960|NCT01316900|26492746|FG002|Overall Study|Protocol-defined Stopping Criteria|10|||
13294961|NCT01316900|26492747|FG003|Overall Study|Protocol-defined Stopping Criteria|5|||
13294962|NCT01316900|26492744|FG000|Overall Study|Lost to Follow-up|1|||
13294963|NCT01316900|26492745|FG001|Overall Study|Lost to Follow-up|0|||
13294964|NCT01316900|26492746|FG002|Overall Study|Lost to Follow-up|1|||
13294965|NCT01316900|26492747|FG003|Overall Study|Lost to Follow-up|1|||
13294966|NCT01316900|26492744|FG000|Overall Study|Withdrawal by Subject|7|||
13294967|NCT01316900|26492745|FG001|Overall Study|Withdrawal by Subject|8|||
13294968|NCT01316900|26492746|FG002|Overall Study|Withdrawal by Subject|6|||
13294969|NCT01316900|26492747|FG003|Overall Study|Withdrawal by Subject|9|||
13294970|NCT01316887|26492819|FG000|Overall Study|Adverse Event|13|||
13294971|NCT01316887|26492820|FG001|Overall Study|Adverse Event|21|||
13294972|NCT01316887|26492821|FG002|Overall Study|Adverse Event|17|||
13294973|NCT01316887|26492819|FG000|Overall Study|Lack of Efficacy|9|||
13294974|NCT01316887|26492820|FG001|Overall Study|Lack of Efficacy|3|||
13294975|NCT01316887|26492821|FG002|Overall Study|Lack of Efficacy|1|||
13294976|NCT01316887|26492819|FG000|Overall Study|Protocol Violation|2|||
13294977|NCT01316887|26492820|FG001|Overall Study|Protocol Violation|6|||
13294978|NCT01316887|26492821|FG002|Overall Study|Protocol Violation|6|||
13294979|NCT01316887|26492819|FG000|Overall Study|Protocol-defined Stopping Criteria|8|||
13294980|NCT01316887|26492820|FG001|Overall Study|Protocol-defined Stopping Criteria|37|||
13294981|NCT01316887|26492821|FG002|Overall Study|Protocol-defined Stopping Criteria|36|||
13294982|NCT01316887|26492819|FG000|Overall Study|Study Closed/Terminated|2|||
13294983|NCT01316887|26492820|FG001|Overall Study|Study Closed/Terminated|4|||
13294984|NCT01316887|26492821|FG002|Overall Study|Study Closed/Terminated|3|||
13294985|NCT01316887|26492819|FG000|Overall Study|Lost to Follow-up|1|||
13294986|NCT01316887|26492820|FG001|Overall Study|Lost to Follow-up|7|||
13294987|NCT01316887|26492821|FG002|Overall Study|Lost to Follow-up|5|||
13294988|NCT01316887|26492819|FG000|Overall Study|Withdrawal by Subject|8|||
13294989|NCT01316887|26492820|FG001|Overall Study|Withdrawal by Subject|16|||
13294990|NCT01316887|26492821|FG002|Overall Study|Withdrawal by Subject|15|||
13294991|NCT01316692|26492832|FG000|Overall Study|Adverse Event|5|||
13294992|NCT01316692|26492832|FG000|Overall Study|Disease Progression|7|||
13294993|NCT01316419|26492857|FG000|Overall Study|Not treated|103|||
13294994|NCT01316419|26492857|FG000|Overall Study|Violated inclusion/exclusion criterion|143|||
13294995|NCT01316419|26492857|FG000|Overall Study|Lost to Follow-up|19|||
13294996|NCT01316380|26492905|FG000|Overall Study|Adverse Event|0|||
13294997|NCT01316380|26492906|FG001|Overall Study|Adverse Event|2|||
13378271|NCT00773279|26737976|FG001|Period 2|Unclassified|2|||
13378272|NCT00773253|26737991|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0|||
13378273|NCT00773253|26737992|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1|||
13378274|NCT00773175|26738091|FG000|Overall Study|Adverse Event|2|||
13378275|NCT00773175|26738092|FG001|Overall Study|Adverse Event|0|||
13378276|NCT00773175|26738091|FG000|Overall Study|Consent Withdrawn|0|||
13378277|NCT00773175|26738092|FG001|Overall Study|Consent Withdrawn|2|||
13378278|NCT00773136|26738099|FG000|Overall Study|Physician Decision|2|||
13378279|NCT00773097|26738107|FG000|Overall Study|Withdrawal by Subject|1|||
13378280|NCT00773097|26738107|FG000|Overall Study|Physician Decision|6|||
13378281|NCT00772967|26738131|FG000|Crossover Treatment 1|Adverse Event (Pain)|0|||
13378282|NCT00772967|26738132|FG001|Crossover Treatment 1|Adverse Event (Pain)|0|||
13378283|NCT00772967|26738133|FG002|Crossover Treatment 1|Adverse Event (Pain)|0|||
13378284|NCT00772967|26738134|FG003|Crossover Treatment 1|Adverse Event (Pain)|1|||
13378285|NCT00772967|26738135|FG004|Crossover Treatment 1|Adverse Event (Pain)|0|||
13378286|NCT00772967|26738136|FG005|Crossover Treatment 1|Adverse Event (Pain)|0|||
13378287|NCT00772967|26738131|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
13378288|NCT00772967|26738132|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1|||
13378289|NCT00772967|26738133|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
13378290|NCT00772967|26738134|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
13378291|NCT00772967|26738135|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
13378292|NCT00772967|26738136|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
13378293|NCT00772967|26738131|FG000|Crossover Treatment 3|Adverse Event|0|||
13378294|NCT00772967|26738132|FG001|Crossover Treatment 3|Adverse Event|0|||
13378295|NCT00772967|26738133|FG002|Crossover Treatment 3|Adverse Event|0|||
13294998|NCT01316380|26492907|FG002|Overall Study|Adverse Event|1|||
13294999|NCT01316380|26492905|FG000|Overall Study|Protocol Violation|0|||
13295000|NCT01316380|26492906|FG001|Overall Study|Protocol Violation|0|||
13295001|NCT01316380|26492907|FG002|Overall Study|Protocol Violation|1|||
13295002|NCT01316380|26492905|FG000|Overall Study|Withdrawal by Subject|1|||
13295003|NCT01316380|26492906|FG001|Overall Study|Withdrawal by Subject|2|||
13295004|NCT01316380|26492907|FG002|Overall Study|Withdrawal by Subject|0|||
13295005|NCT01316380|26492905|FG000|Overall Study|Other|0|||
13295006|NCT01316380|26492906|FG001|Overall Study|Other|1|||
13295007|NCT01316380|26492907|FG002|Overall Study|Other|1|||
13295008|NCT01316380|26492905|FG000|Overall Study|Not treated|1|||
13295009|NCT01316380|26492906|FG001|Overall Study|Not treated|0|||
13295010|NCT01316380|26492907|FG002|Overall Study|Not treated|0|||
13295011|NCT01316276|26492928|FG000|Overall Study|Death|1|||
13295012|NCT01316276|26492928|FG000|Overall Study|Adverse Event|19|||
13295013|NCT01316276|26492928|FG000|Overall Study|Withdrawal of consent|24|||
13295014|NCT01316276|26492928|FG000|Overall Study|Lost to Follow-up|1|||
13295015|NCT01316276|26492928|FG000|Overall Study|Other|22|||
13295016|NCT01316224|26492944|FG000|Overall Study|Protocol Violation|3|||
13295017|NCT01316224|26492944|FG000|Overall Study|Adverse Event|3|||
13295018|NCT01316224|26492944|FG000|Overall Study|Lack of Efficacy|1|||
13295019|NCT01316224|26492944|FG000|Overall Study|Withdrawal by Subject|1|||
13295020|NCT01316224|26492944|FG000|Overall Study|Adverse Event With Treatment Failure|1|||
13295021|NCT01316224|26492944|FG000|Overall Study|Other|1|||
13295022|NCT01316055|26492968|FG000|Overall Study|Lost to Follow-up|1|||
13295023|NCT01316055|26492969|FG001|Overall Study|Lost to Follow-up|0|||
13295024|NCT01316055|26492970|FG002|Overall Study|Lost to Follow-up|0|||
13295025|NCT01315236|26492999|FG000|Double-blind Phase|Death|1|||
13295026|NCT01315236|26493000|FG001|Double-blind Phase|Death|0|||
13295027|NCT01315236|26492999|FG000|Double-blind Phase|Adverse Event|1|||
13295028|NCT01315236|26493000|FG001|Double-blind Phase|Adverse Event|0|||
13295029|NCT01315236|26492999|FG000|Double-blind Phase|Withdrawal of Consent|1|||
13295030|NCT01315236|26493000|FG001|Double-blind Phase|Withdrawal of Consent|0|||
13295031|NCT01315236|26492999|FG000|Double-blind Phase|Lost to Follow-up|1|||
13295032|NCT01315236|26493000|FG001|Double-blind Phase|Lost to Follow-up|0|||
13295033|NCT01315236|26492999|FG000|Open-label Phase|Death|1|||
13295034|NCT01315236|26493000|FG001|Open-label Phase|Death|0|||
13295035|NCT01315236|26492999|FG000|Open-label Phase|Adverse Event|0|||
13295036|NCT01315236|26493000|FG001|Open-label Phase|Adverse Event|1|||
13295037|NCT01315236|26492999|FG000|Open-label Phase|Other|0|||
13295038|NCT01315236|26493000|FG001|Open-label Phase|Other|1|||
13295039|NCT01315236|26492999|FG000|12-Month Follow-up Period|Death|0|||
13295040|NCT01315236|26493000|FG001|12-Month Follow-up Period|Death|1|||
13295041|NCT01315236|26492999|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1|||
13295042|NCT01315236|26493000|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0|||
13295043|NCT01315028|26493019|FG000|Overall Study|Lost to Follow-up|1|||
13295044|NCT01315028|26493020|FG001|Overall Study|Lost to Follow-up|0|||
13295045|NCT01315028|26493019|FG000|Overall Study|Death|0|||
13295046|NCT01315028|26493020|FG001|Overall Study|Death|1|||
13295047|NCT01314872|26493149|FG000|Treatment Period 1|Protocol Violation|2|||
13295048|NCT01314872|26493150|FG001|Treatment Period 1|Protocol Violation|1|||
13295049|NCT01314872|26493151|FG002|Treatment Period 1|Protocol Violation|1|||
13295050|NCT01314872|26493152|FG003|Treatment Period 1|Protocol Violation|0|||
13295051|NCT01314872|26493153|FG004|Treatment Period 1|Protocol Violation|1|||
13295052|NCT01314872|26493154|FG005|Treatment Period 1|Protocol Violation|0|||
13295053|NCT01314872|26493155|FG006|Treatment Period 1|Protocol Violation|0|||
13295054|NCT01314872|26493156|FG007|Treatment Period 1|Protocol Violation|0|||
13295055|NCT01314872|26493157|FG008|Treatment Period 1|Protocol Violation|0|||
13295056|NCT01314872|26493158|FG009|Treatment Period 1|Protocol Violation|1|||
13295057|NCT01314872|26493159|FG010|Treatment Period 1|Protocol Violation|1|||
13295058|NCT01314872|26493160|FG011|Treatment Period 1|Protocol Violation|0|||
13295059|NCT01314872|26493161|FG012|Treatment Period 1|Protocol Violation|0|||
13295060|NCT01314872|26493162|FG013|Treatment Period 1|Protocol Violation|0|||
13295061|NCT01314872|26493163|FG014|Treatment Period 1|Protocol Violation|0|||
13295062|NCT01314872|26493149|FG000|Treatment Period 1|Physician Decision|0|||
13295063|NCT01314872|26493150|FG001|Treatment Period 1|Physician Decision|1|||
13295064|NCT01314872|26493151|FG002|Treatment Period 1|Physician Decision|0|||
13295065|NCT01314872|26493152|FG003|Treatment Period 1|Physician Decision|1|||
13295066|NCT01314872|26493153|FG004|Treatment Period 1|Physician Decision|0|||
13295067|NCT01314872|26493154|FG005|Treatment Period 1|Physician Decision|0|||
13295068|NCT01314872|26493155|FG006|Treatment Period 1|Physician Decision|0|||
13295069|NCT01314872|26493156|FG007|Treatment Period 1|Physician Decision|0|||
13295070|NCT01314872|26493157|FG008|Treatment Period 1|Physician Decision|0|||
13295071|NCT01314872|26493158|FG009|Treatment Period 1|Physician Decision|1|||
13295072|NCT01314872|26493159|FG010|Treatment Period 1|Physician Decision|0|||
13295073|NCT01314872|26493160|FG011|Treatment Period 1|Physician Decision|0|||
13295074|NCT01314872|26493161|FG012|Treatment Period 1|Physician Decision|0|||
13295075|NCT01314872|26493162|FG013|Treatment Period 1|Physician Decision|0|||
13295076|NCT01314872|26493163|FG014|Treatment Period 1|Physician Decision|0|||
13295077|NCT01314872|26493149|FG000|Treatment Period 1|Lack of Efficacy|1|||
13295078|NCT01314872|26493150|FG001|Treatment Period 1|Lack of Efficacy|0|||
13295079|NCT01314872|26493151|FG002|Treatment Period 1|Lack of Efficacy|0|||
13295080|NCT01314872|26493152|FG003|Treatment Period 1|Lack of Efficacy|0|||
13295081|NCT01314872|26493153|FG004|Treatment Period 1|Lack of Efficacy|0|||
13295082|NCT01314872|26493154|FG005|Treatment Period 1|Lack of Efficacy|1|||
13295083|NCT01314872|26493155|FG006|Treatment Period 1|Lack of Efficacy|0|||
13295084|NCT01314872|26493156|FG007|Treatment Period 1|Lack of Efficacy|2|||
13295085|NCT01314872|26493157|FG008|Treatment Period 1|Lack of Efficacy|0|||
13295086|NCT01314872|26493158|FG009|Treatment Period 1|Lack of Efficacy|0|||
13295087|NCT01314872|26493159|FG010|Treatment Period 1|Lack of Efficacy|0|||
13295088|NCT01314872|26493160|FG011|Treatment Period 1|Lack of Efficacy|0|||
13295089|NCT01314872|26493161|FG012|Treatment Period 1|Lack of Efficacy|0|||
13295090|NCT01314872|26493162|FG013|Treatment Period 1|Lack of Efficacy|0|||
13295091|NCT01314872|26493163|FG014|Treatment Period 1|Lack of Efficacy|0|||
13295092|NCT01314872|26493149|FG000|Treatment Period 1|Adverse event, non-fatal|4|||
13295093|NCT01314872|26493150|FG001|Treatment Period 1|Adverse event, non-fatal|2|||
13295094|NCT01314872|26493151|FG002|Treatment Period 1|Adverse event, non-fatal|3|||
13295095|NCT01314872|26493152|FG003|Treatment Period 1|Adverse event, non-fatal|2|||
13295096|NCT01314872|26493153|FG004|Treatment Period 1|Adverse event, non-fatal|2|||
13295097|NCT01314872|26493154|FG005|Treatment Period 1|Adverse event, non-fatal|4|||
13295098|NCT01314872|26493155|FG006|Treatment Period 1|Adverse event, non-fatal|4|||
13295099|NCT01314872|26493156|FG007|Treatment Period 1|Adverse event, non-fatal|2|||
13295100|NCT01314872|26493157|FG008|Treatment Period 1|Adverse event, non-fatal|3|||
13295101|NCT01314872|26493158|FG009|Treatment Period 1|Adverse event, non-fatal|0|||
13295102|NCT01314872|26493159|FG010|Treatment Period 1|Adverse event, non-fatal|1|||
13295103|NCT01314872|26493160|FG011|Treatment Period 1|Adverse event, non-fatal|0|||
13295104|NCT01314872|26493161|FG012|Treatment Period 1|Adverse event, non-fatal|0|||
13295105|NCT01314872|26493162|FG013|Treatment Period 1|Adverse event, non-fatal|0|||
13295106|NCT01314872|26493163|FG014|Treatment Period 1|Adverse event, non-fatal|0|||
13295107|NCT01314872|26493149|FG000|Treatment Period 1|Withdrawal by Subject|3|||
13295108|NCT01314872|26493150|FG001|Treatment Period 1|Withdrawal by Subject|1|||
13295109|NCT01314872|26493151|FG002|Treatment Period 1|Withdrawal by Subject|0|||
13295110|NCT01314872|26493152|FG003|Treatment Period 1|Withdrawal by Subject|2|||
13295111|NCT01314872|26493153|FG004|Treatment Period 1|Withdrawal by Subject|3|||
13295112|NCT01314872|26493154|FG005|Treatment Period 1|Withdrawal by Subject|1|||
13295113|NCT01314872|26493155|FG006|Treatment Period 1|Withdrawal by Subject|3|||
13295114|NCT01314872|26493156|FG007|Treatment Period 1|Withdrawal by Subject|2|||
13295115|NCT01314872|26493157|FG008|Treatment Period 1|Withdrawal by Subject|2|||
13295116|NCT01314872|26493158|FG009|Treatment Period 1|Withdrawal by Subject|2|||
13295117|NCT01314872|26493159|FG010|Treatment Period 1|Withdrawal by Subject|1|||
13295118|NCT01314872|26493160|FG011|Treatment Period 1|Withdrawal by Subject|0|||
13295119|NCT01314872|26493161|FG012|Treatment Period 1|Withdrawal by Subject|0|||
13295120|NCT01314872|26493162|FG013|Treatment Period 1|Withdrawal by Subject|0|||
13295121|NCT01314872|26493163|FG014|Treatment Period 1|Withdrawal by Subject|0|||
13295122|NCT01314872|26493149|FG000|Treatment Period 1|Lost to Follow-up|0|||
13295123|NCT01314872|26493150|FG001|Treatment Period 1|Lost to Follow-up|1|||
13295124|NCT01314872|26493151|FG002|Treatment Period 1|Lost to Follow-up|2|||
13295125|NCT01314872|26493152|FG003|Treatment Period 1|Lost to Follow-up|2|||
13295126|NCT01314872|26493153|FG004|Treatment Period 1|Lost to Follow-up|1|||
13295127|NCT01314872|26493154|FG005|Treatment Period 1|Lost to Follow-up|1|||
13295128|NCT01314872|26493155|FG006|Treatment Period 1|Lost to Follow-up|1|||
13295129|NCT01314872|26493156|FG007|Treatment Period 1|Lost to Follow-up|1|||
13295130|NCT01314872|26493157|FG008|Treatment Period 1|Lost to Follow-up|1|||
13295131|NCT01314872|26493158|FG009|Treatment Period 1|Lost to Follow-up|0|||
13295132|NCT01314872|26493159|FG010|Treatment Period 1|Lost to Follow-up|0|||
13295133|NCT01314872|26493160|FG011|Treatment Period 1|Lost to Follow-up|0|||
13295134|NCT01314872|26493161|FG012|Treatment Period 1|Lost to Follow-up|0|||
13295135|NCT01314872|26493162|FG013|Treatment Period 1|Lost to Follow-up|0|||
13295136|NCT01314872|26493163|FG014|Treatment Period 1|Lost to Follow-up|0|||
13295137|NCT01314872|26493149|FG000|Period 2|Protocol Violation|0|||
13295138|NCT01314872|26493150|FG001|Period 2|Protocol Violation|0|||
13295139|NCT01314872|26493151|FG002|Period 2|Protocol Violation|0|||
13295140|NCT01314872|26493152|FG003|Period 2|Protocol Violation|0|||
13295141|NCT01314872|26493153|FG004|Period 2|Protocol Violation|0|||
13295142|NCT01314872|26493154|FG005|Period 2|Protocol Violation|0|||
13295143|NCT01314872|26493155|FG006|Period 2|Protocol Violation|0|||
13295144|NCT01314872|26493156|FG007|Period 2|Protocol Violation|0|||
13394070|NCT00660660|26785652|FG000|Overall Study|Adverse Event|1|||
13295145|NCT01314872|26493157|FG008|Period 2|Protocol Violation|0|||
13295146|NCT01314872|26493158|FG009|Period 2|Protocol Violation|0|||
13295147|NCT01314872|26493159|FG010|Period 2|Protocol Violation|0|||
13295148|NCT01314872|26493160|FG011|Period 2|Protocol Violation|3|||
13295149|NCT01314872|26493161|FG012|Period 2|Protocol Violation|3|||
13295150|NCT01314872|26493162|FG013|Period 2|Protocol Violation|2|||
13295151|NCT01314872|26493163|FG014|Period 2|Protocol Violation|0|||
13295152|NCT01314872|26493149|FG000|Period 2|Non-compliance with study drug|0|||
13295153|NCT01314872|26493150|FG001|Period 2|Non-compliance with study drug|0|||
13295154|NCT01314872|26493151|FG002|Period 2|Non-compliance with study drug|0|||
13295155|NCT01314872|26493152|FG003|Period 2|Non-compliance with study drug|0|||
13295156|NCT01314872|26493153|FG004|Period 2|Non-compliance with study drug|0|||
13295157|NCT01314872|26493154|FG005|Period 2|Non-compliance with study drug|0|||
13295158|NCT01314872|26493155|FG006|Period 2|Non-compliance with study drug|0|||
13295159|NCT01314872|26493156|FG007|Period 2|Non-compliance with study drug|0|||
13295160|NCT01314872|26493157|FG008|Period 2|Non-compliance with study drug|0|||
13295161|NCT01314872|26493158|FG009|Period 2|Non-compliance with study drug|0|||
13295162|NCT01314872|26493159|FG010|Period 2|Non-compliance with study drug|0|||
13295163|NCT01314872|26493160|FG011|Period 2|Non-compliance with study drug|3|||
13295164|NCT01314872|26493161|FG012|Period 2|Non-compliance with study drug|3|||
13295165|NCT01314872|26493162|FG013|Period 2|Non-compliance with study drug|1|||
13295166|NCT01314872|26493163|FG014|Period 2|Non-compliance with study drug|2|||
13295167|NCT01314872|26493149|FG000|Period 2|Lack of Efficacy|0|||
13295168|NCT01314872|26493150|FG001|Period 2|Lack of Efficacy|0|||
13295169|NCT01314872|26493151|FG002|Period 2|Lack of Efficacy|0|||
13295170|NCT01314872|26493152|FG003|Period 2|Lack of Efficacy|0|||
13295171|NCT01314872|26493153|FG004|Period 2|Lack of Efficacy|0|||
13295172|NCT01314872|26493154|FG005|Period 2|Lack of Efficacy|0|||
13295173|NCT01314872|26493155|FG006|Period 2|Lack of Efficacy|0|||
13295174|NCT01314872|26493156|FG007|Period 2|Lack of Efficacy|0|||
13295175|NCT01314872|26493157|FG008|Period 2|Lack of Efficacy|0|||
13295176|NCT01314872|26493158|FG009|Period 2|Lack of Efficacy|0|||
13295177|NCT01314872|26493159|FG010|Period 2|Lack of Efficacy|0|||
13295178|NCT01314872|26493160|FG011|Period 2|Lack of Efficacy|7|||
13295179|NCT01314872|26493161|FG012|Period 2|Lack of Efficacy|12|||
13295180|NCT01314872|26493162|FG013|Period 2|Lack of Efficacy|9|||
13295181|NCT01314872|26493163|FG014|Period 2|Lack of Efficacy|2|||
13295182|NCT01314872|26493149|FG000|Period 2|Pregnancy|0|||
13295183|NCT01314872|26493150|FG001|Period 2|Pregnancy|0|||
13295184|NCT01314872|26493151|FG002|Period 2|Pregnancy|0|||
13295185|NCT01314872|26493152|FG003|Period 2|Pregnancy|0|||
13295186|NCT01314872|26493153|FG004|Period 2|Pregnancy|0|||
13295187|NCT01314872|26493154|FG005|Period 2|Pregnancy|0|||
13295188|NCT01314872|26493155|FG006|Period 2|Pregnancy|0|||
13295189|NCT01314872|26493156|FG007|Period 2|Pregnancy|0|||
13295190|NCT01314872|26493157|FG008|Period 2|Pregnancy|0|||
13295191|NCT01314872|26493158|FG009|Period 2|Pregnancy|0|||
13295192|NCT01314872|26493159|FG010|Period 2|Pregnancy|0|||
13295193|NCT01314872|26493160|FG011|Period 2|Pregnancy|0|||
13295194|NCT01314872|26493161|FG012|Period 2|Pregnancy|0|||
13295195|NCT01314872|26493162|FG013|Period 2|Pregnancy|0|||
13295196|NCT01314872|26493163|FG014|Period 2|Pregnancy|1|||
13295197|NCT01314872|26493149|FG000|Period 2|Study terminated by Sponsor|0|||
13295198|NCT01314872|26493150|FG001|Period 2|Study terminated by Sponsor|0|||
13295199|NCT01314872|26493151|FG002|Period 2|Study terminated by Sponsor|0|||
13295200|NCT01314872|26493152|FG003|Period 2|Study terminated by Sponsor|0|||
13295201|NCT01314872|26493153|FG004|Period 2|Study terminated by Sponsor|0|||
13295202|NCT01314872|26493154|FG005|Period 2|Study terminated by Sponsor|0|||
13295203|NCT01314872|26493155|FG006|Period 2|Study terminated by Sponsor|0|||
13295204|NCT01314872|26493156|FG007|Period 2|Study terminated by Sponsor|0|||
13295205|NCT01314872|26493157|FG008|Period 2|Study terminated by Sponsor|0|||
13295206|NCT01314872|26493158|FG009|Period 2|Study terminated by Sponsor|0|||
13295207|NCT01314872|26493159|FG010|Period 2|Study terminated by Sponsor|0|||
13295208|NCT01314872|26493160|FG011|Period 2|Study terminated by Sponsor|2|||
13295209|NCT01314872|26493161|FG012|Period 2|Study terminated by Sponsor|2|||
13295210|NCT01314872|26493162|FG013|Period 2|Study terminated by Sponsor|3|||
13295211|NCT01314872|26493163|FG014|Period 2|Study terminated by Sponsor|0|||
13295212|NCT01314872|26493149|FG000|Period 2|Adverse event, non-fatal|0|||
13295213|NCT01314872|26493150|FG001|Period 2|Adverse event, non-fatal|0|||
13295214|NCT01314872|26493151|FG002|Period 2|Adverse event, non-fatal|0|||
13295215|NCT01314872|26493152|FG003|Period 2|Adverse event, non-fatal|0|||
13295216|NCT01314872|26493153|FG004|Period 2|Adverse event, non-fatal|0|||
13295217|NCT01314872|26493154|FG005|Period 2|Adverse event, non-fatal|0|||
13295218|NCT01314872|26493155|FG006|Period 2|Adverse event, non-fatal|0|||
13295219|NCT01314872|26493156|FG007|Period 2|Adverse event, non-fatal|0|||
13295220|NCT01314872|26493157|FG008|Period 2|Adverse event, non-fatal|0|||
13295221|NCT01314872|26493158|FG009|Period 2|Adverse event, non-fatal|0|||
13295222|NCT01314872|26493159|FG010|Period 2|Adverse event, non-fatal|0|||
13295223|NCT01314872|26493160|FG011|Period 2|Adverse event, non-fatal|13|||
13295224|NCT01314872|26493161|FG012|Period 2|Adverse event, non-fatal|16|||
13295225|NCT01314872|26493162|FG013|Period 2|Adverse event, non-fatal|24|||
13295226|NCT01314872|26493163|FG014|Period 2|Adverse event, non-fatal|9|||
13295227|NCT01314872|26493149|FG000|Period 2|Withdrawal by Subject|0|||
13295228|NCT01314872|26493150|FG001|Period 2|Withdrawal by Subject|0|||
13295229|NCT01314872|26493151|FG002|Period 2|Withdrawal by Subject|0|||
13295230|NCT01314872|26493152|FG003|Period 2|Withdrawal by Subject|0|||
13295231|NCT01314872|26493153|FG004|Period 2|Withdrawal by Subject|0|||
13295232|NCT01314872|26493154|FG005|Period 2|Withdrawal by Subject|0|||
13295233|NCT01314872|26493155|FG006|Period 2|Withdrawal by Subject|0|||
13295234|NCT01314872|26493156|FG007|Period 2|Withdrawal by Subject|0|||
13295235|NCT01314872|26493157|FG008|Period 2|Withdrawal by Subject|0|||
13295236|NCT01314872|26493158|FG009|Period 2|Withdrawal by Subject|0|||
13295237|NCT01314872|26493159|FG010|Period 2|Withdrawal by Subject|0|||
13295238|NCT01314872|26493160|FG011|Period 2|Withdrawal by Subject|14|||
13295239|NCT01314872|26493161|FG012|Period 2|Withdrawal by Subject|17|||
13295240|NCT01314872|26493162|FG013|Period 2|Withdrawal by Subject|12|||
13295241|NCT01314872|26493163|FG014|Period 2|Withdrawal by Subject|4|||
13295242|NCT01314872|26493149|FG000|Period 2|Lost to Follow-up|0|||
13295243|NCT01314872|26493150|FG001|Period 2|Lost to Follow-up|0|||
13295244|NCT01314872|26493151|FG002|Period 2|Lost to Follow-up|0|||
13295245|NCT01314872|26493152|FG003|Period 2|Lost to Follow-up|0|||
13295246|NCT01314872|26493153|FG004|Period 2|Lost to Follow-up|0|||
13295247|NCT01314872|26493154|FG005|Period 2|Lost to Follow-up|0|||
13295248|NCT01314872|26493155|FG006|Period 2|Lost to Follow-up|0|||
13295249|NCT01314872|26493156|FG007|Period 2|Lost to Follow-up|0|||
13295250|NCT01314872|26493157|FG008|Period 2|Lost to Follow-up|0|||
13295251|NCT01314872|26493158|FG009|Period 2|Lost to Follow-up|0|||
13295252|NCT01314872|26493159|FG010|Period 2|Lost to Follow-up|0|||
13295253|NCT01314872|26493160|FG011|Period 2|Lost to Follow-up|6|||
13295254|NCT01314872|26493161|FG012|Period 2|Lost to Follow-up|7|||
13295255|NCT01314872|26493162|FG013|Period 2|Lost to Follow-up|2|||
13295256|NCT01314872|26493163|FG014|Period 2|Lost to Follow-up|6|||
13295257|NCT01314716|26493182|FG000|Double-Blind Phase|Randomized but not treated|1|||
13295258|NCT01314716|26493183|FG001|Double-Blind Phase|Randomized but not treated|1|||
13295259|NCT01314716|26493182|FG000|Double-Blind Phase|Adverse Event|10|||
13295260|NCT01314716|26493183|FG001|Double-Blind Phase|Adverse Event|4|||
13295261|NCT01314716|26493182|FG000|Double-Blind Phase|Withdrawal by Subject|5|||
13295262|NCT01314716|26493183|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
13295263|NCT01314716|26493182|FG000|Double-Blind Phase|Lost to Follow-up|0|||
13295264|NCT01314716|26493183|FG001|Double-Blind Phase|Lost to Follow-up|1|||
13295265|NCT01314716|26493182|FG000|Double-Blind Phase|Sponsor request|1|||
13295266|NCT01314716|26493183|FG001|Double-Blind Phase|Sponsor request|2|||
13295267|NCT01314716|26493182|FG000|Double-Blind Phase|Physician Decision|0|||
13295268|NCT01314716|26493183|FG001|Double-Blind Phase|Physician Decision|1|||
13295269|NCT01314716|26493182|FG000|Open-Label Phase|Adverse Event|4|||
13295270|NCT01314716|26493183|FG001|Open-Label Phase|Adverse Event|6|||
13295271|NCT01314716|26493182|FG000|Open-Label Phase|Withdrawal by Subject|1|||
13295272|NCT01314716|26493183|FG001|Open-Label Phase|Withdrawal by Subject|2|||
13295273|NCT01314716|26493182|FG000|Open-Label Phase|Physician Decision|5|||
13295274|NCT01314716|26493183|FG001|Open-Label Phase|Physician Decision|4|||
13295275|NCT01314703|26493190|FG000|Overall Study|screen failure and closed enrollment|8|||
13295276|NCT01314443|26493221|FG000|Overall Study|Withdrawal by Subject|2|||
13295277|NCT01314443|26493222|FG001|Overall Study|Withdrawal by Subject|1|||
13295278|NCT01314443|26493223|FG002|Overall Study|Withdrawal by Subject|1|||
13295279|NCT01314443|26493224|FG003|Overall Study|Withdrawal by Subject|1|||
13295280|NCT01314443|26493221|FG000|Overall Study|Protocol Violation|2|||
13295281|NCT01314443|26493222|FG001|Overall Study|Protocol Violation|2|||
13295282|NCT01314443|26493223|FG002|Overall Study|Protocol Violation|1|||
13295283|NCT01314443|26493224|FG003|Overall Study|Protocol Violation|1|||
13295284|NCT01314105|26493273|FG000|Overall Study|Progressive Disease|6|||
13295285|NCT01314105|26493274|FG001|Overall Study|Progressive Disease|10|||
13295286|NCT01314105|26493273|FG000|Overall Study|Refused to continue taking medication|0|||
13295287|NCT01314105|26493274|FG001|Overall Study|Refused to continue taking medication|1|||
13295288|NCT01314105|26493273|FG000|Overall Study|Other Adverse Event|1|||
13295289|NCT01314105|26493274|FG001|Overall Study|Other Adverse Event|1|||
13378296|NCT00772967|26738134|FG003|Crossover Treatment 3|Adverse Event|0|||
13378297|NCT00772967|26738135|FG004|Crossover Treatment 3|Adverse Event|1|||
13378298|NCT00772967|26738136|FG005|Crossover Treatment 3|Adverse Event|0|||
13378299|NCT00772954|26738154|FG000|Overall Study|Adverse Event|0|||
13378300|NCT00772954|26738155|FG001|Overall Study|Adverse Event|0|||
13378301|NCT00772954|26738156|FG002|Overall Study|Adverse Event|1|||
13378302|NCT00772941|26738187|FG000|Overall Study|CRFs not available|195|||
13378303|NCT00772941|26738187|FG000|Overall Study|Study not completed|16|||
13378304|NCT00772941|26738187|FG000|Overall Study|Missed Visits|374|||
13378305|NCT00772941|26738187|FG000|Overall Study|Poor Compliance|7|||
13378306|NCT00772941|26738187|FG000|Overall Study|GPSP Violation|90|||
13378307|NCT00772928|26738204|FG000|Overall Study|Lost to Follow-up|9|||
13378308|NCT00772928|26738205|FG001|Overall Study|Lost to Follow-up|6|||
13378309|NCT00772928|26738204|FG000|Overall Study|Protocol Violation|10|||
13378310|NCT00772928|26738205|FG001|Overall Study|Protocol Violation|12|||
13378311|NCT00772928|26738204|FG000|Overall Study|Withdrawal by Subject|25|||
13378312|NCT00772928|26738205|FG001|Overall Study|Withdrawal by Subject|22|||
13378313|NCT00772928|26738204|FG000|Overall Study|Did not receive vaccine|0|||
13378314|NCT00772928|26738205|FG001|Overall Study|Did not receive vaccine|1|||
13378315|NCT00772889|26738268|FG000|Overall Study|Adverse Event|7|||
13295290|NCT01380093|26493574|FG000|Naloxone Challenge Phase|Screen failures|21|||
13295291|NCT01380093|26493575|FG001|Naloxone Challenge Phase|Screen failures|0|||
13295292|NCT01380093|26493576|FG002|Naloxone Challenge Phase|Screen failures|0|||
13295293|NCT01380093|26493577|FG003|Naloxone Challenge Phase|Screen failures|0|||
13295294|NCT01380093|26493578|FG004|Naloxone Challenge Phase|Screen failures|0|||
13295295|NCT01380093|26493579|FG005|Naloxone Challenge Phase|Screen failures|0|||
13295296|NCT01380093|26493580|FG006|Naloxone Challenge Phase|Screen failures|0|||
13295297|NCT01380093|26493581|FG007|Naloxone Challenge Phase|Screen failures|0|||
13295298|NCT01380093|26493582|FG008|Naloxone Challenge Phase|Screen failures|0|||
13295299|NCT01380093|26493574|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
13295300|NCT01380093|26493575|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1|||
13295301|NCT01380093|26493576|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
13295302|NCT01380093|26493577|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
13295303|NCT01380093|26493578|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
13295304|NCT01380093|26493579|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
13295305|NCT01380093|26493580|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
13295306|NCT01380093|26493581|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
13295307|NCT01380093|26493582|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
13295308|NCT01380093|26493574|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0|||
13295309|NCT01380093|26493575|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3|||
13295310|NCT01380093|26493576|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1|||
13295311|NCT01380093|26493577|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0|||
13295312|NCT01380093|26493578|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0|||
13295313|NCT01380093|26493579|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0|||
13295314|NCT01380093|26493580|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0|||
13295315|NCT01380093|26493581|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0|||
13295316|NCT01380093|26493582|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0|||
13295317|NCT01380093|26493574|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
13295318|NCT01380093|26493575|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1|||
13295319|NCT01380093|26493576|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
13295320|NCT01380093|26493577|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
13295321|NCT01380093|26493578|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
13295322|NCT01380093|26493579|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
13295323|NCT01380093|26493580|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
13295324|NCT01380093|26493581|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
13295325|NCT01380093|26493582|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
13295326|NCT01380093|26493574|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
13295327|NCT01380093|26493575|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4|||
13295328|NCT01380093|26493576|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9|||
13295329|NCT01380093|26493577|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
13295330|NCT01380093|26493578|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
13295331|NCT01380093|26493579|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
13295332|NCT01380093|26493580|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
13295333|NCT01380093|26493581|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
13295334|NCT01380093|26493582|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
13295335|NCT01380093|26493574|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
13295336|NCT01380093|26493575|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
13295337|NCT01380093|26493576|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
13295338|NCT01380093|26493577|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
13295339|NCT01380093|26493578|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
13295340|NCT01380093|26493579|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
13295341|NCT01380093|26493580|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
13295342|NCT01380093|26493581|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
13295343|NCT01380093|26493582|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
13295344|NCT01380093|26493574|FG000|Drug Discrimination Phase: Day 2|Backup participant|0|||
13295345|NCT01380093|26493575|FG001|Drug Discrimination Phase: Day 2|Backup participant|0|||
13295346|NCT01380093|26493576|FG002|Drug Discrimination Phase: Day 2|Backup participant|1|||
13295347|NCT01380093|26493577|FG003|Drug Discrimination Phase: Day 2|Backup participant|0|||
13295348|NCT01380093|26493578|FG004|Drug Discrimination Phase: Day 2|Backup participant|0|||
13295349|NCT01380093|26493579|FG005|Drug Discrimination Phase: Day 2|Backup participant|0|||
13295350|NCT01380093|26493580|FG006|Drug Discrimination Phase: Day 2|Backup participant|0|||
13295351|NCT01380093|26493581|FG007|Drug Discrimination Phase: Day 2|Backup participant|0|||
13295352|NCT01380093|26493582|FG008|Drug Discrimination Phase: Day 2|Backup participant|0|||
13295353|NCT01380093|26493574|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
13295354|NCT01380093|26493575|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
13135109|NCT02745145|25993629|FG000|Overall Study|Death|0|||
13295355|NCT01380093|26493576|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1|||
13295356|NCT01380093|26493577|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
13295357|NCT01380093|26493578|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
13295358|NCT01380093|26493579|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
13295359|NCT01380093|26493580|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
13295360|NCT01380093|26493581|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
13295361|NCT01380093|26493582|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
13295362|NCT01380093|26493574|FG000|Treatment Phase: Second Intervention|Other|0|||
13295363|NCT01380093|26493575|FG001|Treatment Phase: Second Intervention|Other|0|||
13295364|NCT01380093|26493576|FG002|Treatment Phase: Second Intervention|Other|0|||
13295365|NCT01380093|26493577|FG003|Treatment Phase: Second Intervention|Other|1|||
13295366|NCT01380093|26493578|FG004|Treatment Phase: Second Intervention|Other|0|||
13295367|NCT01380093|26493579|FG005|Treatment Phase: Second Intervention|Other|0|||
13295368|NCT01380093|26493580|FG006|Treatment Phase: Second Intervention|Other|0|||
13295369|NCT01380093|26493581|FG007|Treatment Phase: Second Intervention|Other|0|||
13295370|NCT01380093|26493582|FG008|Treatment Phase: Second Intervention|Other|0|||
13295371|NCT01380093|26493574|FG000|Treatment Phase: Third Intervention|Non-compliance|0|||
13295372|NCT01380093|26493575|FG001|Treatment Phase: Third Intervention|Non-compliance|0|||
13295373|NCT01380093|26493576|FG002|Treatment Phase: Third Intervention|Non-compliance|0|||
13295374|NCT01380093|26493577|FG003|Treatment Phase: Third Intervention|Non-compliance|0|||
13295375|NCT01380093|26493578|FG004|Treatment Phase: Third Intervention|Non-compliance|0|||
13295376|NCT01380093|26493579|FG005|Treatment Phase: Third Intervention|Non-compliance|0|||
13295377|NCT01380093|26493580|FG006|Treatment Phase: Third Intervention|Non-compliance|0|||
13295378|NCT01380093|26493581|FG007|Treatment Phase: Third Intervention|Non-compliance|0|||
13295379|NCT01380093|26493582|FG008|Treatment Phase: Third Intervention|Non-compliance|1|||
13295380|NCT01380093|26493574|FG000|Treatment Phase: Third Intervention|Other|0|||
13295381|NCT01380093|26493575|FG001|Treatment Phase: Third Intervention|Other|0|||
13295382|NCT01380093|26493576|FG002|Treatment Phase: Third Intervention|Other|0|||
13295383|NCT01380093|26493577|FG003|Treatment Phase: Third Intervention|Other|0|||
13295384|NCT01380093|26493578|FG004|Treatment Phase: Third Intervention|Other|0|||
13295385|NCT01380093|26493579|FG005|Treatment Phase: Third Intervention|Other|0|||
13295386|NCT01380093|26493580|FG006|Treatment Phase: Third Intervention|Other|0|||
13295387|NCT01380093|26493581|FG007|Treatment Phase: Third Intervention|Other|0|||
13295388|NCT01380093|26493582|FG008|Treatment Phase: Third Intervention|Other|1|||
13295389|NCT01380080|26493625|FG000|Overall Study|Death|36|||
13295390|NCT01380080|26493626|FG001|Overall Study|Death|44|||
13295391|NCT01380080|26493625|FG000|Overall Study|Site is closing|28|||
13295392|NCT01380080|26493626|FG001|Overall Study|Site is closing|31|||
13295393|NCT01380080|26493625|FG000|Overall Study|Not able to get to clinic|7|||
13295394|NCT01380080|26493626|FG001|Overall Study|Not able to get to clinic|1|||
13295395|NCT01380080|26493625|FG000|Overall Study|Not willing to adhere to requirements|6|||
13295396|NCT01380080|26493626|FG001|Overall Study|Not willing to adhere to requirements|2|||
13295397|NCT01380080|26493625|FG000|Overall Study|Withdrawal by Subject|5|||
13295398|NCT01380080|26493626|FG001|Overall Study|Withdrawal by Subject|2|||
13295399|NCT01380080|26493625|FG000|Overall Study|Lost to Follow-up|3|||
13295400|NCT01380080|26493626|FG001|Overall Study|Lost to Follow-up|3|||
13295401|NCT01379937|26493719|FG000|Overall Study|Protocol Violation|0|||
13295402|NCT01379937|26493720|FG001|Overall Study|Protocol Violation|0|||
13295403|NCT01379937|26493721|FG002|Overall Study|Protocol Violation|0|||
13295404|NCT01379937|26493722|FG003|Overall Study|Protocol Violation|1|||
13295405|NCT01379937|26493719|FG000|Overall Study|Consent withdrawal|0|||
13295406|NCT01379937|26493720|FG001|Overall Study|Consent withdrawal|1|||
13295407|NCT01379937|26493721|FG002|Overall Study|Consent withdrawal|0|||
13295408|NCT01379937|26493722|FG003|Overall Study|Consent withdrawal|0|||
13295409|NCT01379937|26493719|FG000|Overall Study|Lost to Follow-up|1|||
13378316|NCT00772889|26738269|FG001|Overall Study|Adverse Event|4|||
13378317|NCT00772889|26738270|FG002|Overall Study|Adverse Event|0|||
13378318|NCT00772889|26738268|FG000|Overall Study|Withdrawal by Subject|9|||
13378319|NCT00772889|26738269|FG001|Overall Study|Withdrawal by Subject|8|||
13378320|NCT00772889|26738270|FG002|Overall Study|Withdrawal by Subject|9|||
13378321|NCT00772889|26738268|FG000|Overall Study|Lost to Follow-up|6|||
13378322|NCT00772889|26738269|FG001|Overall Study|Lost to Follow-up|6|||
13378323|NCT00772889|26738270|FG002|Overall Study|Lost to Follow-up|7|||
13378324|NCT00772707|26738277|FG000|Overall Study|Withdrawn|3|||
13378325|NCT00772668|26738286|FG000|Overall Study|Physician Decision|3|||
13378326|NCT00772629|26738299|FG000|Overall Study|Subject was not vaccinated|1|||
13378327|NCT00772629|26738300|FG001|Overall Study|Subject was not vaccinated|0|||
13378328|NCT00772603|26738330|FG000|Overall Study|Withdrawal by Subject|11|||
13378329|NCT00772603|26738331|FG001|Overall Study|Withdrawal by Subject|10|||
13378330|NCT00772603|26738332|FG002|Overall Study|Withdrawal by Subject|6|||
13295410|NCT01379937|26493720|FG001|Overall Study|Lost to Follow-up|2|||
13295411|NCT01379937|26493721|FG002|Overall Study|Lost to Follow-up|2|||
13295412|NCT01379937|26493722|FG003|Overall Study|Lost to Follow-up|0|||
13378331|NCT00772603|26738330|FG000|Overall Study|Adverse Event|37|||
13295413|NCT01379781|26493735|FG000|Overall Study|Lost to Follow-up|11|||
13378332|NCT00772603|26738331|FG001|Overall Study|Adverse Event|18|||
13378333|NCT00772603|26738332|FG002|Overall Study|Adverse Event|10|||
13378334|NCT00772603|26738330|FG000|Overall Study|Subject Non-compliance|1|||
13378335|NCT00772603|26738331|FG001|Overall Study|Subject Non-compliance|6|||
13378336|NCT00772603|26738332|FG002|Overall Study|Subject Non-compliance|4|||
13378337|NCT00772603|26738330|FG000|Overall Study|Protocol Violation|0|||
13378338|NCT00772603|26738331|FG001|Overall Study|Protocol Violation|1|||
13378339|NCT00772603|26738332|FG002|Overall Study|Protocol Violation|1|||
13378340|NCT00772603|26738330|FG000|Overall Study|Lost to Follow-up|1|||
13378341|NCT00772603|26738331|FG001|Overall Study|Lost to Follow-up|5|||
13378342|NCT00772603|26738332|FG002|Overall Study|Lost to Follow-up|2|||
13378343|NCT00772603|26738330|FG000|Overall Study|Physician Decision|0|||
13378344|NCT00772603|26738331|FG001|Overall Study|Physician Decision|0|||
13378345|NCT00772603|26738332|FG002|Overall Study|Physician Decision|1|||
13378346|NCT00772603|26738330|FG000|Overall Study|Other|2|||
13378347|NCT00772603|26738331|FG001|Overall Study|Other|0|||
13378348|NCT00772603|26738332|FG002|Overall Study|Other|2|||
13378349|NCT00772577|26738353|FG000|Overall Study|Adverse Event|6|||
13378350|NCT00772577|26738354|FG001|Overall Study|Adverse Event|3|||
13378351|NCT00772577|26738353|FG000|Overall Study|Abnormal laboratory values|0|||
13378352|NCT00772577|26738354|FG001|Overall Study|Abnormal laboratory values|1|||
13378353|NCT00772577|26738353|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
13378354|NCT00772577|26738354|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
13378355|NCT00772577|26738353|FG000|Overall Study|Patient withdrew consent|8|||
13378356|NCT00772577|26738354|FG001|Overall Study|Patient withdrew consent|5|||
13378357|NCT00772577|26738353|FG000|Overall Study|Lost to Follow-up|4|||
13378358|NCT00772577|26738354|FG001|Overall Study|Lost to Follow-up|3|||
13378359|NCT00772577|26738353|FG000|Overall Study|Administrative problems|2|||
13378360|NCT00772577|26738354|FG001|Overall Study|Administrative problems|1|||
13378361|NCT00772577|26738353|FG000|Overall Study|Protocol Deviation|3|||
13378362|NCT00772577|26738354|FG001|Overall Study|Protocol Deviation|2|||
13378363|NCT00772538|26738431|FG000|Overall Study|Adverse Event|6|||
13378364|NCT00772538|26738432|FG001|Overall Study|Adverse Event|6|||
13378365|NCT00772538|26738431|FG000|Overall Study|Protocol Violation|3|||
13378366|NCT00772538|26738432|FG001|Overall Study|Protocol Violation|3|||
13378367|NCT00772538|26738431|FG000|Overall Study|Lost to Follow-up|1|||
13378368|NCT00772538|26738432|FG001|Overall Study|Lost to Follow-up|1|||
13378369|NCT00772538|26738431|FG000|Overall Study|Withdrawal by Subject|3|||
13378370|NCT00772538|26738432|FG001|Overall Study|Withdrawal by Subject|8|||
13378371|NCT00772538|26738431|FG000|Overall Study|Lack of Efficacy|0|||
13378372|NCT00772538|26738432|FG001|Overall Study|Lack of Efficacy|1|||
13378373|NCT00772538|26738431|FG000|Overall Study|Other|7|||
13378374|NCT00772538|26738432|FG001|Overall Study|Other|7|||
13378375|NCT00772447|26738467|FG000|Overall Study|Withdrawal by Subject|9|||
13378376|NCT00772447|26738468|FG001|Overall Study|Withdrawal by Subject|5|||
13378377|NCT00772447|26738467|FG000|Overall Study|Physician Decision|4|||
13378378|NCT00772447|26738468|FG001|Overall Study|Physician Decision|8|||
13378379|NCT00772447|26738467|FG000|Overall Study|Lost to Follow-up|2|||
13378380|NCT00772447|26738468|FG001|Overall Study|Lost to Follow-up|4|||
13378381|NCT00772447|26738467|FG000|Overall Study|incorrect enrolment|3|||
13378382|NCT00772447|26738468|FG001|Overall Study|incorrect enrolment|4|||
13378383|NCT00772447|26738467|FG000|Overall Study|Protocol Violation|0|||
13378384|NCT00772447|26738468|FG001|Overall Study|Protocol Violation|1|||
13378385|NCT00772447|26738467|FG000|Overall Study|all others|2|||
13378386|NCT00772447|26738468|FG001|Overall Study|all others|2|||
13378387|NCT00772382|26738475|FG000|Overall Study|Adverse Event|19|||
13378388|NCT00772382|26738475|FG000|Overall Study|Death|6|||
13378389|NCT00772382|26738475|FG000|Overall Study|Lack of Efficacy|4|||
13378390|NCT00772382|26738475|FG000|Overall Study|Physician Decision|5|||
13378391|NCT00772382|26738475|FG000|Overall Study|Protocol Violation|1|||
13378392|NCT00772382|26738475|FG000|Overall Study|Withdrawal by Subject|10|||
13378393|NCT00772382|26738475|FG000|Overall Study|Other Reasons|10|||
13378394|NCT00772369|26738482|FG000|Overall Study|Did not return record release form|1|||
13378395|NCT00772330|26738494|FG000|Overall Study|Lost to Follow-up|3|||
13378396|NCT00772148|26738517|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3|||
13378397|NCT00772148|26738518|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1|||
13378398|NCT00772148|26738517|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3|||
13378399|NCT00772148|26738518|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5|||
13378400|NCT00772148|26738517|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2|||
13378401|NCT00772148|26738518|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0|||
13378402|NCT00772148|26738517|FG000|Maintenance Phase (Week 52)|Death|2|||
13378403|NCT00772148|26738518|FG001|Maintenance Phase (Week 52)|Death|2|||
13378404|NCT00772148|26738517|FG000|Maintenance Phase (Week 52)|Adverse Event|1|||
13378405|NCT00772148|26738518|FG001|Maintenance Phase (Week 52)|Adverse Event|0|||
13378406|NCT00772148|26738517|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0|||
13378407|NCT00772148|26738518|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1|||
13378408|NCT00772148|26738517|FG000|Maintenance Phase (Week 52)|Administrative/other|1|||
13378409|NCT00772148|26738518|FG001|Maintenance Phase (Week 52)|Administrative/other|2|||
13378410|NCT00772109|26738553|FG000|Overall Study|Serious adverse event|1|||
13378411|NCT00772109|26738554|FG001|Overall Study|Serious adverse event|0|||
13378412|NCT00772109|26738555|FG002|Overall Study|Serious adverse event|1|||
13378413|NCT00772109|26738556|FG003|Overall Study|Serious adverse event|0|||
13378414|NCT00772109|26738553|FG000|Overall Study|Protocol Violation|5|||
13378415|NCT00772109|26738554|FG001|Overall Study|Protocol Violation|8|||
13378416|NCT00772109|26738555|FG002|Overall Study|Protocol Violation|7|||
13378417|NCT00772109|26738556|FG003|Overall Study|Protocol Violation|6|||
13378418|NCT00772109|26738553|FG000|Overall Study|Lost to Follow-up|7|||
13378419|NCT00772109|26738554|FG001|Overall Study|Lost to Follow-up|3|||
13378420|NCT00772109|26738555|FG002|Overall Study|Lost to Follow-up|5|||
13378421|NCT00772109|26738556|FG003|Overall Study|Lost to Follow-up|9|||
13378422|NCT00772109|26738553|FG000|Overall Study|Withdrawal by Subject|8|||
13378423|NCT00772109|26738554|FG001|Overall Study|Withdrawal by Subject|8|||
13378424|NCT00772109|26738555|FG002|Overall Study|Withdrawal by Subject|6|||
13378425|NCT00772109|26738556|FG003|Overall Study|Withdrawal by Subject|16|||
13378426|NCT00772070|26738573|FG000|Overall Study|Lost to Follow-up|0|||
13378427|NCT00772070|26738574|FG001|Overall Study|Lost to Follow-up|8|||
13378428|NCT00772070|26738573|FG000|Overall Study|Withdrawal by Subject|0|||
13378429|NCT00772070|26738574|FG001|Overall Study|Withdrawal by Subject|2|||
13378430|NCT00772070|26738573|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2|||
13378431|NCT00772070|26738574|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0|||
13378432|NCT00772031|26738603|FG000|Overall Study|Early termination of trial|12|||
13378433|NCT00772031|26738604|FG001|Overall Study|Early termination of trial|10|||
13378434|NCT00772031|26738603|FG000|Overall Study|Lost to Follow-up|20|||
13378435|NCT00772031|26738604|FG001|Overall Study|Lost to Follow-up|33|||
13378436|NCT00772005|26739303|FG000|Overall Study|Adverse Event|9|||
13378437|NCT00772005|26739304|FG001|Overall Study|Adverse Event|14|||
13378438|NCT00772005|26739305|FG002|Overall Study|Adverse Event|10|||
13378439|NCT00772005|26739306|FG003|Overall Study|Adverse Event|13|||
13378440|NCT00772005|26739303|FG000|Overall Study|Lack of Efficacy|0|||
13378441|NCT00772005|26739304|FG001|Overall Study|Lack of Efficacy|1|||
13378442|NCT00772005|26739305|FG002|Overall Study|Lack of Efficacy|0|||
13378443|NCT00772005|26739306|FG003|Overall Study|Lack of Efficacy|0|||
13378444|NCT00772005|26739303|FG000|Overall Study|Withdrawal by Subject|3|||
13378445|NCT00772005|26739304|FG001|Overall Study|Withdrawal by Subject|7|||
13378446|NCT00772005|26739305|FG002|Overall Study|Withdrawal by Subject|10|||
13378447|NCT00772005|26739306|FG003|Overall Study|Withdrawal by Subject|2|||
13378448|NCT00772005|26739303|FG000|Overall Study|Protocol Violation|2|||
13378449|NCT00772005|26739304|FG001|Overall Study|Protocol Violation|4|||
13378450|NCT00772005|26739305|FG002|Overall Study|Protocol Violation|1|||
13378451|NCT00772005|26739306|FG003|Overall Study|Protocol Violation|6|||
13378452|NCT00772005|26739303|FG000|Overall Study|Lost to Follow-up|7|||
13378453|NCT00772005|26739304|FG001|Overall Study|Lost to Follow-up|3|||
13378454|NCT00772005|26739305|FG002|Overall Study|Lost to Follow-up|6|||
13378455|NCT00772005|26739306|FG003|Overall Study|Lost to Follow-up|3|||
13378456|NCT00772005|26739303|FG000|Overall Study|Non-compliance with study procedures|1|||
13378457|NCT00772005|26739304|FG001|Overall Study|Non-compliance with study procedures|1|||
13378458|NCT00772005|26739305|FG002|Overall Study|Non-compliance with study procedures|0|||
13378459|NCT00772005|26739306|FG003|Overall Study|Non-compliance with study procedures|1|||
13378460|NCT00772005|26739303|FG000|Overall Study|Non-compliance with drug administration|3|||
13378461|NCT00772005|26739304|FG001|Overall Study|Non-compliance with drug administration|0|||
13378462|NCT00772005|26739305|FG002|Overall Study|Non-compliance with drug administration|1|||
13378463|NCT00772005|26739306|FG003|Overall Study|Non-compliance with drug administration|1|||
13378464|NCT00771953|26739321|FG000|Overall Study|Adverse Event|5|||
13378465|NCT00771953|26739322|FG001|Overall Study|Adverse Event|3|||
13378466|NCT00771953|26739321|FG000|Overall Study|Death|2|||
13378467|NCT00771953|26739322|FG001|Overall Study|Death|2|||
13378468|NCT00771953|26739321|FG000|Overall Study|Progression before active Tx|1|||
13378469|NCT00771953|26739322|FG001|Overall Study|Progression before active Tx|2|||
13378470|NCT00771953|26739321|FG000|Overall Study|Sponsor decision|1|||
13378471|NCT00771953|26739322|FG001|Overall Study|Sponsor decision|0|||
13378472|NCT00771953|26739321|FG000|Overall Study|Other complicating disease|1|||
13378473|NCT00771953|26739322|FG001|Overall Study|Other complicating disease|0|||
13378474|NCT00771953|26739321|FG000|Overall Study|Withdrawal by Subject|0|||
13378475|NCT00771953|26739322|FG001|Overall Study|Withdrawal by Subject|3|||
13378476|NCT00771927|26739337|FG000|Overall Study|Adverse Event|100|||
13378477|NCT00771927|26739338|FG001|Overall Study|Adverse Event|105|||
13378478|NCT00771927|26739337|FG000|Overall Study|Lack of Efficacy|70|||
13378479|NCT00771927|26739338|FG001|Overall Study|Lack of Efficacy|42|||
13378480|NCT00771927|26739337|FG000|Overall Study|Lost to Follow-up|46|||
13378481|NCT00771927|26739338|FG001|Overall Study|Lost to Follow-up|46|||
13378482|NCT00771927|26739337|FG000|Overall Study|Withdrawal by Subject|16|||
13378483|NCT00771927|26739338|FG001|Overall Study|Withdrawal by Subject|17|||
13378484|NCT00771927|26739337|FG000|Overall Study|Other reason|23|||
13378485|NCT00771927|26739338|FG001|Overall Study|Other reason|27|||
13378486|NCT00771914|26739361|FG000|Overall Study|Physician Decision|0|||
13378487|NCT00771914|26739362|FG001|Overall Study|Physician Decision|0|||
13378488|NCT00771914|26739363|FG002|Overall Study|Physician Decision|0|||
13378489|NCT00771914|26739364|FG003|Overall Study|Physician Decision|1|||
13378490|NCT00771914|26739361|FG000|Overall Study|Lost to Follow-up|0|||
13378491|NCT00771914|26739362|FG001|Overall Study|Lost to Follow-up|0|||
13378492|NCT00771914|26739363|FG002|Overall Study|Lost to Follow-up|0|||
13378493|NCT00771914|26739364|FG003|Overall Study|Lost to Follow-up|1|||
13378494|NCT00771901|26739388|FG000|Overall Study|Dissat w/# of study medication (40/day)|0|||
13378495|NCT00771901|26739389|FG001|Overall Study|Dissat w/# of study medication (40/day)|0|||
13378496|NCT00771901|26739390|FG002|Overall Study|Dissat w/# of study medication (40/day)|4|||
13378497|NCT00771849|26739405|FG000|Overall Study|Lost to Follow-up|1|||
13378498|NCT00771849|26739406|FG001|Overall Study|Lost to Follow-up|2|||
13378499|NCT00771849|26739405|FG000|Overall Study|Withdrawal by Subject|1|||
13378500|NCT00771849|26739406|FG001|Overall Study|Withdrawal by Subject|1|||
13378501|NCT00771849|26739405|FG000|Overall Study|Not vaccinated|0|||
13378502|NCT00771849|26739406|FG001|Overall Study|Not vaccinated|1|||
13378503|NCT00771810|26739451|FG000|Overall Study|Adverse Event|3|||
13378504|NCT00771810|26739452|FG001|Overall Study|Adverse Event|0|||
13378505|NCT00771810|26739453|FG002|Overall Study|Adverse Event|2|||
13378506|NCT00771810|26739451|FG000|Overall Study|Lost to Follow-up|0|||
13378507|NCT00771810|26739452|FG001|Overall Study|Lost to Follow-up|0|||
13378508|NCT00771810|26739453|FG002|Overall Study|Lost to Follow-up|1|||
13378509|NCT00771810|26739451|FG000|Overall Study|Physician Decision|1|||
13378510|NCT00771810|26739452|FG001|Overall Study|Physician Decision|2|||
13378511|NCT00771810|26739453|FG002|Overall Study|Physician Decision|2|||
13378512|NCT00771810|26739451|FG000|Overall Study|Protocol Violation|0|||
13378513|NCT00771810|26739452|FG001|Overall Study|Protocol Violation|1|||
13378514|NCT00771810|26739453|FG002|Overall Study|Protocol Violation|1|||
13378515|NCT00771810|26739451|FG000|Overall Study|Withdrawal by Subject|1|||
13378516|NCT00771810|26739452|FG001|Overall Study|Withdrawal by Subject|2|||
13378517|NCT00771810|26739453|FG002|Overall Study|Withdrawal by Subject|0|||
13378518|NCT00771810|26739451|FG000|Overall Study|Other|0|||
13378519|NCT00771810|26739452|FG001|Overall Study|Other|0|||
13378520|NCT00771810|26739453|FG002|Overall Study|Other|1|||
13378521|NCT00771758|26739611|FG000|Overall Study|Adverse Event|2|||
13378522|NCT00771758|26739612|FG001|Overall Study|Adverse Event|8|||
13378523|NCT00771758|26739613|FG002|Overall Study|Adverse Event|1|||
13378524|NCT00771758|26739611|FG000|Overall Study|Lack of Efficacy|0|||
13378525|NCT00771758|26739612|FG001|Overall Study|Lack of Efficacy|2|||
13378526|NCT00771758|26739613|FG002|Overall Study|Lack of Efficacy|1|||
13378527|NCT00771758|26739611|FG000|Overall Study|Lost to Follow-up|1|||
13378528|NCT00771758|26739612|FG001|Overall Study|Lost to Follow-up|0|||
13378529|NCT00771758|26739613|FG002|Overall Study|Lost to Follow-up|0|||
13378530|NCT00771758|26739611|FG000|Overall Study|Protocol Violation|1|||
13378531|NCT00771758|26739612|FG001|Overall Study|Protocol Violation|0|||
13378532|NCT00771758|26739613|FG002|Overall Study|Protocol Violation|0|||
13378533|NCT00771758|26739611|FG000|Overall Study|Withdrawal by Subject|1|||
13378534|NCT00771758|26739612|FG001|Overall Study|Withdrawal by Subject|0|||
13378535|NCT00771758|26739613|FG002|Overall Study|Withdrawal by Subject|0|||
13378536|NCT00771758|26739611|FG000|Overall Study|Other|3|||
13378537|NCT00771758|26739612|FG001|Overall Study|Other|2|||
13378538|NCT00771758|26739613|FG002|Overall Study|Other|0|||
13378539|NCT00771667|26739668|FG000|Induction Phase|Adverse Event|5|||
13378540|NCT00771667|26739669|FG001|Induction Phase|Adverse Event|2|||
13378541|NCT00771667|26739670|FG002|Induction Phase|Adverse Event|4|||
13378542|NCT00771667|26739671|FG003|Induction Phase|Adverse Event|1|||
13378543|NCT00771667|26739672|FG004|Induction Phase|Adverse Event|0|||
13378544|NCT00771667|26739673|FG005|Induction Phase|Adverse Event|0|||
13378545|NCT00771667|26739674|FG006|Induction Phase|Adverse Event|0|||
13378546|NCT00771667|26739675|FG007|Induction Phase|Adverse Event|0|||
13378547|NCT00771667|26739676|FG008|Induction Phase|Adverse Event|0|||
13378548|NCT00771667|26739677|FG009|Induction Phase|Adverse Event|0|||
13378549|NCT00771667|26739668|FG000|Induction Phase|Lack of Efficacy|9|||
13378550|NCT00771667|26739669|FG001|Induction Phase|Lack of Efficacy|2|||
13378551|NCT00771667|26739670|FG002|Induction Phase|Lack of Efficacy|4|||
13378552|NCT00771667|26739671|FG003|Induction Phase|Lack of Efficacy|3|||
13378553|NCT00771667|26739672|FG004|Induction Phase|Lack of Efficacy|0|||
13378554|NCT00771667|26739673|FG005|Induction Phase|Lack of Efficacy|0|||
13378555|NCT00771667|26739674|FG006|Induction Phase|Lack of Efficacy|0|||
13378556|NCT00771667|26739675|FG007|Induction Phase|Lack of Efficacy|0|||
13378557|NCT00771667|26739676|FG008|Induction Phase|Lack of Efficacy|0|||
13378558|NCT00771667|26739677|FG009|Induction Phase|Lack of Efficacy|0|||
13378559|NCT00771667|26739668|FG000|Induction Phase|Lost to Follow-up|1|||
13378560|NCT00771667|26739669|FG001|Induction Phase|Lost to Follow-up|0|||
13378561|NCT00771667|26739670|FG002|Induction Phase|Lost to Follow-up|1|||
13378562|NCT00771667|26739671|FG003|Induction Phase|Lost to Follow-up|0|||
13378563|NCT00771667|26739672|FG004|Induction Phase|Lost to Follow-up|0|||
13378564|NCT00771667|26739673|FG005|Induction Phase|Lost to Follow-up|0|||
13378565|NCT00771667|26739674|FG006|Induction Phase|Lost to Follow-up|0|||
13378566|NCT00771667|26739675|FG007|Induction Phase|Lost to Follow-up|0|||
13378567|NCT00771667|26739676|FG008|Induction Phase|Lost to Follow-up|0|||
13378568|NCT00771667|26739677|FG009|Induction Phase|Lost to Follow-up|0|||
13378569|NCT00771667|26739668|FG000|Induction Phase|Other|4|||
13378570|NCT00771667|26739669|FG001|Induction Phase|Other|6|||
13378571|NCT00771667|26739670|FG002|Induction Phase|Other|3|||
13378572|NCT00771667|26739671|FG003|Induction Phase|Other|4|||
13378573|NCT00771667|26739672|FG004|Induction Phase|Other|0|||
13378574|NCT00771667|26739673|FG005|Induction Phase|Other|0|||
13378575|NCT00771667|26739674|FG006|Induction Phase|Other|0|||
13378576|NCT00771667|26739675|FG007|Induction Phase|Other|0|||
13378577|NCT00771667|26739676|FG008|Induction Phase|Other|0|||
13378578|NCT00771667|26739677|FG009|Induction Phase|Other|0|||
13378579|NCT00771667|26739668|FG000|Maintenance Phase|Adverse Event|0|||
13378580|NCT00771667|26739669|FG001|Maintenance Phase|Adverse Event|0|||
13378581|NCT00771667|26739670|FG002|Maintenance Phase|Adverse Event|0|||
13378582|NCT00771667|26739671|FG003|Maintenance Phase|Adverse Event|0|||
13378583|NCT00771667|26739672|FG004|Maintenance Phase|Adverse Event|1|||
13378584|NCT00771667|26739673|FG005|Maintenance Phase|Adverse Event|3|||
13378585|NCT00771667|26739674|FG006|Maintenance Phase|Adverse Event|5|||
13378586|NCT00771667|26739675|FG007|Maintenance Phase|Adverse Event|1|||
13378587|NCT00771667|26739676|FG008|Maintenance Phase|Adverse Event|8|||
13378588|NCT00771667|26739677|FG009|Maintenance Phase|Adverse Event|7|||
13378589|NCT00771667|26739668|FG000|Maintenance Phase|Lack of Efficacy|0|||
13378590|NCT00771667|26739669|FG001|Maintenance Phase|Lack of Efficacy|0|||
13378591|NCT00771667|26739670|FG002|Maintenance Phase|Lack of Efficacy|0|||
13378592|NCT00771667|26739671|FG003|Maintenance Phase|Lack of Efficacy|0|||
13378593|NCT00771667|26739672|FG004|Maintenance Phase|Lack of Efficacy|1|||
13378594|NCT00771667|26739673|FG005|Maintenance Phase|Lack of Efficacy|3|||
13378595|NCT00771667|26739674|FG006|Maintenance Phase|Lack of Efficacy|3|||
13378596|NCT00771667|26739675|FG007|Maintenance Phase|Lack of Efficacy|2|||
13378597|NCT00771667|26739676|FG008|Maintenance Phase|Lack of Efficacy|11|||
13378598|NCT00771667|26739677|FG009|Maintenance Phase|Lack of Efficacy|7|||
13378599|NCT00771667|26739668|FG000|Maintenance Phase|Other|0|||
13378600|NCT00771667|26739669|FG001|Maintenance Phase|Other|0|||
13378601|NCT00771667|26739670|FG002|Maintenance Phase|Other|0|||
13378602|NCT00771667|26739671|FG003|Maintenance Phase|Other|0|||
13378603|NCT00771667|26739672|FG004|Maintenance Phase|Other|0|||
13378604|NCT00771667|26739673|FG005|Maintenance Phase|Other|1|||
13378605|NCT00771667|26739674|FG006|Maintenance Phase|Other|2|||
13378606|NCT00771667|26739675|FG007|Maintenance Phase|Other|2|||
13378607|NCT00771667|26739676|FG008|Maintenance Phase|Other|3|||
13378608|NCT00771667|26739677|FG009|Maintenance Phase|Other|3|||
13394071|NCT00660660|26785653|FG001|Overall Study|Adverse Event|0|||
13394072|NCT00660660|26785652|FG000|Overall Study|Lost to Follow-up|0|||
13394073|NCT00660660|26785653|FG001|Overall Study|Lost to Follow-up|6|||
13394074|NCT00660660|26785652|FG000|Overall Study|Lack of Efficacy|0|||
13394075|NCT00660660|26785653|FG001|Overall Study|Lack of Efficacy|2|||
13394076|NCT00660660|26785652|FG000|Overall Study|Withdrawal by Subject|3|||
13394077|NCT00660660|26785653|FG001|Overall Study|Withdrawal by Subject|0|||
13394078|NCT00660660|26785652|FG000|Overall Study|Incorrect enrollment and other|0|||
13394079|NCT00660660|26785653|FG001|Overall Study|Incorrect enrollment and other|1|||
13394080|NCT00660660|26785652|FG000|Overall Study|New medication after randomization|1|||
13394081|NCT00660660|26785653|FG001|Overall Study|New medication after randomization|0|||
13394082|NCT00660595|26785672|FG000|Overall Study|Lost to Follow-up|0|||
13394083|NCT00660595|26785673|FG001|Overall Study|Lost to Follow-up|1|||
13394084|NCT00660595|26785672|FG000|Overall Study|Did not consent to participate in study|12|||
13394085|NCT00660595|26785673|FG001|Overall Study|Did not consent to participate in study|8|||
13394086|NCT00660595|26785672|FG000|Overall Study|Participant left hospital|1|||
13394087|NCT00660595|26785673|FG001|Overall Study|Participant left hospital|0|||
13394088|NCT00660595|26785672|FG000|Overall Study|Non Specified reasons|5|||
13394089|NCT00660595|26785673|FG001|Overall Study|Non Specified reasons|0|||
13394090|NCT00660400|26785682|FG000|Overall Study|Lack of insurance approval|1|||
13394091|NCT00660400|26785682|FG000|Overall Study|Suboptimal organ function|1|||
13394092|NCT00660400|26785682|FG000|Overall Study|Intracranial hemorrhage|1|||
13394093|NCT00660400|26785682|FG000|Overall Study|Withdrawal by Subject|1|||
13394094|NCT00660387|26785741|FG000|Overall Study|Adverse Event|1|||
13394095|NCT00660387|26785742|FG001|Overall Study|Adverse Event|2|||
13394096|NCT00660387|26785741|FG000|Overall Study|Lack of Efficacy|0|||
13394097|NCT00660387|26785742|FG001|Overall Study|Lack of Efficacy|1|||
13394098|NCT00660387|26785741|FG000|Overall Study|Protocol Violation|1|||
13394099|NCT00660387|26785742|FG001|Overall Study|Protocol Violation|0|||
13394100|NCT00660348|26785755|FG000|Overall Study|Withdrawal by Subject|1|||
13394101|NCT00660348|26785756|FG001|Overall Study|Withdrawal by Subject|0|||
13394102|NCT00660309|26785802|FG000|Overall Study|Adverse Event|2|||
13394103|NCT00660309|26785803|FG001|Overall Study|Adverse Event|0|||
13394104|NCT00660309|26785802|FG000|Overall Study|Withdrawal by Subject|0|||
13394105|NCT00660309|26785803|FG001|Overall Study|Withdrawal by Subject|3|||
13394106|NCT00660192|26785818|FG000|Overall Study|Lost to Follow-up|2|||
13394107|NCT00660192|26785819|FG001|Overall Study|Lost to Follow-up|3|||
13394108|NCT00660179|26785861|FG000|Overall Study|Death|44|||
13378609|NCT00771615|26739896|FG000|Overall Study|Withdrawal by Subject|0|||
13378610|NCT00771615|26739897|FG001|Overall Study|Withdrawal by Subject|1|||
13378611|NCT00771615|26739898|FG002|Overall Study|Withdrawal by Subject|0|||
13378612|NCT00771615|26739899|FG003|Overall Study|Withdrawal by Subject|0|||
13378613|NCT00771615|26739900|FG004|Overall Study|Withdrawal by Subject|0|||
13378614|NCT00771615|26739901|FG005|Overall Study|Withdrawal by Subject|0|||
13378615|NCT00771615|26739902|FG006|Overall Study|Withdrawal by Subject|0|||
13378616|NCT00771615|26739903|FG007|Overall Study|Withdrawal by Subject|1|||
13378617|NCT00771615|26739904|FG008|Overall Study|Withdrawal by Subject|0|||
13378618|NCT00771615|26739896|FG000|Overall Study|Lost to Follow-up|1|||
13378619|NCT00771615|26739897|FG001|Overall Study|Lost to Follow-up|1|||
13378620|NCT00771615|26739898|FG002|Overall Study|Lost to Follow-up|1|||
13378621|NCT00771615|26739899|FG003|Overall Study|Lost to Follow-up|1|||
13378622|NCT00771615|26739900|FG004|Overall Study|Lost to Follow-up|0|||
13378623|NCT00771615|26739901|FG005|Overall Study|Lost to Follow-up|1|||
13378624|NCT00771615|26739902|FG006|Overall Study|Lost to Follow-up|1|||
13378625|NCT00771615|26739903|FG007|Overall Study|Lost to Follow-up|0|||
13378626|NCT00771615|26739904|FG008|Overall Study|Lost to Follow-up|0|||
13378627|NCT00771472|26739916|FG000|Overall Study|Physician Decision|2|||
13378628|NCT00771472|26739917|FG001|Overall Study|Physician Decision|3|||
13378629|NCT00771472|26739916|FG000|Overall Study|Progressive Disease|3|||
13378630|NCT00771472|26739917|FG001|Overall Study|Progressive Disease|1|||
13378631|NCT00771472|26739916|FG000|Overall Study|Protocol Violation|1|||
13378632|NCT00771472|26739917|FG001|Overall Study|Protocol Violation|0|||
13378633|NCT00771316|26739934|FG000|Overall Study|Adverse Event|0|||
13378634|NCT00771316|26739935|FG001|Overall Study|Adverse Event|1|||
13378635|NCT00771316|26739934|FG000|Overall Study|Patient withdrew consent|1|||
13378636|NCT00771316|26739935|FG001|Overall Study|Patient withdrew consent|0|||
13378637|NCT00771316|26739934|FG000|Overall Study|Discontinued due to early termination|1|||
13378638|NCT00771316|26739935|FG001|Overall Study|Discontinued due to early termination|0|||
13378639|NCT00771030|26740014|FG000|Overall Study|Adverse Event|0|||
13378640|NCT00771030|26740015|FG001|Overall Study|Adverse Event|1|||
13378641|NCT00771030|26740016|FG002|Overall Study|Adverse Event|0|||
13378642|NCT00771030|26740017|FG003|Overall Study|Adverse Event|0|||
13378643|NCT00771030|26740018|FG004|Overall Study|Adverse Event|0|||
13378644|NCT00771030|26740019|FG005|Overall Study|Adverse Event|0|||
13378645|NCT00771030|26740020|FG006|Overall Study|Adverse Event|0|||
13378646|NCT00770991|26740039|FG000|Overall Study|Physician Decision|2|||
13378647|NCT00770991|26740040|FG001|Overall Study|Physician Decision|0|||
13378648|NCT00770991|26740039|FG000|Overall Study|Withdrawal by Subject|1|||
13378649|NCT00770991|26740040|FG001|Overall Study|Withdrawal by Subject|0|||
13378650|NCT00770991|26740039|FG000|Overall Study|Adverse Event|1|||
13378651|NCT00770991|26740040|FG001|Overall Study|Adverse Event|5|||
13378652|NCT00770991|26740039|FG000|Overall Study|Pregnancy|1|||
13378653|NCT00770991|26740040|FG001|Overall Study|Pregnancy|0|||
13378654|NCT00770965|26740071|FG000|Safety Set|Withdrawal by Subject|0|||
13378655|NCT00770965|26740072|FG001|Safety Set|Withdrawal by Subject|0|||
13378656|NCT00770965|26740073|FG002|Safety Set|Withdrawal by Subject|0|||
13378657|NCT00770965|26740074|FG003|Safety Set|Withdrawal by Subject|1|||
13378658|NCT00770965|26740071|FG000|Safety Set|Protocol deviation|0|||
13378659|NCT00770965|26740072|FG001|Safety Set|Protocol deviation|0|||
13378660|NCT00770965|26740073|FG002|Safety Set|Protocol deviation|1|||
13378661|NCT00770965|26740074|FG003|Safety Set|Protocol deviation|0|||
13378662|NCT00770965|26740071|FG000|Excluded Set|Administrative problems|14|||
13378663|NCT00770965|26740072|FG001|Excluded Set|Administrative problems|12|||
13378664|NCT00770965|26740073|FG002|Excluded Set|Administrative problems|12|||
13378665|NCT00770965|26740074|FG003|Excluded Set|Administrative problems|10|||
13378666|NCT00770965|26740071|FG000|Excluded Set|Withdrawal by Subject|1|||
13378667|NCT00770965|26740072|FG001|Excluded Set|Withdrawal by Subject|1|||
13378668|NCT00770965|26740073|FG002|Excluded Set|Withdrawal by Subject|2|||
13378669|NCT00770965|26740074|FG003|Excluded Set|Withdrawal by Subject|3|||
13378670|NCT00770913|26740092|FG000|Overall Study|Adverse Event|1|||
13378671|NCT00770913|26740093|FG001|Overall Study|Adverse Event|3|||
13378672|NCT00770913|26740094|FG002|Overall Study|Adverse Event|6|||
13378673|NCT00770913|26740092|FG000|Overall Study|Refusal to continue participation|6|||
13378674|NCT00770913|26740093|FG001|Overall Study|Refusal to continue participation|4|||
13378675|NCT00770913|26740094|FG002|Overall Study|Refusal to continue participation|5|||
13378676|NCT00770913|26740092|FG000|Overall Study|Physician Decision|0|||
13378677|NCT00770913|26740093|FG001|Overall Study|Physician Decision|1|||
13378678|NCT00770913|26740094|FG002|Overall Study|Physician Decision|1|||
13378679|NCT00770913|26740092|FG000|Overall Study|Protocol Violation|3|||
13378680|NCT00770913|26740093|FG001|Overall Study|Protocol Violation|0|||
13378681|NCT00770913|26740094|FG002|Overall Study|Protocol Violation|1|||
13378682|NCT00770913|26740092|FG000|Overall Study|Incorrect drug was allocated|1|||
13378683|NCT00770913|26740093|FG001|Overall Study|Incorrect drug was allocated|0|||
13378684|NCT00770913|26740094|FG002|Overall Study|Incorrect drug was allocated|0|||
13378685|NCT00770770|26740107|FG000|Overall Study|Lost to Follow-up|1|||
13378686|NCT00770770|26740108|FG001|Overall Study|Lost to Follow-up|0|||
13378687|NCT00770770|26740107|FG000|Overall Study|Withdrawal by Subject|1|||
13378688|NCT00770770|26740108|FG001|Overall Study|Withdrawal by Subject|0|||
13378689|NCT00770770|26740107|FG000|Overall Study|Death|0|||
13378690|NCT00770770|26740108|FG001|Overall Study|Death|1|||
13378691|NCT00770770|26740107|FG000|Overall Study|Study Terminated|8|||
13378692|NCT00770770|26740108|FG001|Overall Study|Study Terminated|0|||
13378693|NCT00770692|26740147|FG000|Overall Study|Withdrawal by Subject|7|||
13378694|NCT00770692|26740148|FG001|Overall Study|Withdrawal by Subject|9|||
13378695|NCT00770692|26740149|FG002|Overall Study|Withdrawal by Subject|9|||
13378696|NCT00770692|26740150|FG003|Overall Study|Withdrawal by Subject|6|||
13378697|NCT00770692|26740147|FG000|Overall Study|Adverse Event|3|||
13378698|NCT00770692|26740148|FG001|Overall Study|Adverse Event|0|||
13378699|NCT00770692|26740149|FG002|Overall Study|Adverse Event|4|||
13378700|NCT00770692|26740150|FG003|Overall Study|Adverse Event|4|||
13378701|NCT00770692|26740147|FG000|Overall Study|Investigator judgment|2|||
13378702|NCT00770692|26740148|FG001|Overall Study|Investigator judgment|0|||
13378703|NCT00770692|26740149|FG002|Overall Study|Investigator judgment|1|||
13378704|NCT00770692|26740150|FG003|Overall Study|Investigator judgment|1|||
13378705|NCT00770679|26740158|FG000|Overall Study|Lost to Follow-up|3|||
13378706|NCT00770679|26740158|FG000|Overall Study|Follow-up LDL measurement not collected|3|||
13378707|NCT00770653|26740233|FG000|Overall Study|Adverse Event|13|||
13378708|NCT00770653|26740234|FG001|Overall Study|Adverse Event|5|||
13378709|NCT00770653|26740233|FG000|Overall Study|Protocol Violation|8|||
13378710|NCT00770653|26740234|FG001|Overall Study|Protocol Violation|6|||
13378711|NCT00770653|26740233|FG000|Overall Study|Withdrawal by Subject|4|||
13378712|NCT00770653|26740234|FG001|Overall Study|Withdrawal by Subject|7|||
13378713|NCT00770653|26740233|FG000|Overall Study|Lack of Compliance|1|||
13378714|NCT00770653|26740234|FG001|Overall Study|Lack of Compliance|4|||
13378715|NCT00770653|26740233|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
13378716|NCT00770653|26740234|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
13378717|NCT00770653|26740233|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2|||
13378718|NCT00770653|26740234|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1|||
13378719|NCT00770653|26740233|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0|||
13378720|NCT00770653|26740234|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2|||
13378721|NCT00770653|26740233|FG000|Overall Study|Lost to Follow-up|1|||
13378722|NCT00770653|26740234|FG001|Overall Study|Lost to Follow-up|2|||
13378723|NCT00770653|26740233|FG000|Overall Study|Physician Decision|1|||
13378724|NCT00770653|26740234|FG001|Overall Study|Physician Decision|0|||
13378725|NCT00770601|26740240|FG000|Overall Study|Withdrawal by Subject|1|||
13378726|NCT00770588|26740261|FG000|Overall Study|Adverse Event|9|||
13378727|NCT00770588|26740262|FG001|Overall Study|Adverse Event|2|||
13378728|NCT00770588|26740261|FG000|Overall Study|Death caused by progression of disease|70|||
13378729|NCT00770588|26740262|FG001|Overall Study|Death caused by progression of disease|91|||
13378730|NCT00770588|26740261|FG000|Overall Study|Lost to Follow-up|1|||
13378731|NCT00770588|26740262|FG001|Overall Study|Lost to Follow-up|1|||
13378732|NCT00770588|26740261|FG000|Overall Study|Withdrawal by Subject|1|||
13378733|NCT00770588|26740262|FG001|Overall Study|Withdrawal by Subject|1|||
13378734|NCT00770562|26740280|FG000|Overall Study|Did not take treatment|1|||
13378735|NCT00770562|26740281|FG001|Overall Study|Did not take treatment|1|||
13378736|NCT00770510|26740320|FG000|Overall Study|Lost to Follow-up|2|||
13378737|NCT00770510|26740320|FG000|Overall Study|Pregnancy|1|||
13378738|NCT00770510|26740320|FG000|Overall Study|Withdrawal by Subject|2|||
13378739|NCT00770484|26740333|FG000|Overall Study|Withdrawal by Subject|1|||
13378740|NCT00770484|26740334|FG001|Overall Study|Withdrawal by Subject|0|||
13378741|NCT00770432|26740347|FG000|Overall Study|Other|4|||
13378742|NCT00770432|26740348|FG001|Overall Study|Other|6|||
13378743|NCT00770432|26740347|FG000|Overall Study|Non-compliance|0|||
13378744|NCT00770432|26740348|FG001|Overall Study|Non-compliance|1|||
13378745|NCT00770367|26740363|FG000|First Intervention|Withdrawal by Subject|0|||
13378746|NCT00770367|26740364|FG001|First Intervention|Withdrawal by Subject|2|||
13378747|NCT00770367|26740363|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0|||
13378748|NCT00770367|26740364|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1|||
13378749|NCT00770367|26740363|FG000|Second Intervention|Lost to Follow-up|2|||
13378750|NCT00770367|26740364|FG001|Second Intervention|Lost to Follow-up|0|||
13378751|NCT00770341|26740398|FG000|Overall Study|Did not meet eligibility criteria|1|||
13378752|NCT00770341|26740399|FG001|Overall Study|Did not meet eligibility criteria|0|||
13378753|NCT00770341|26740400|FG002|Overall Study|Did not meet eligibility criteria|0|||
13378754|NCT00770341|26740398|FG000|Overall Study|Withdrawal by Subject|0|||
13378755|NCT00770341|26740399|FG001|Overall Study|Withdrawal by Subject|1|||
13378756|NCT00770341|26740400|FG002|Overall Study|Withdrawal by Subject|0|||
13378757|NCT00770341|26740398|FG000|Overall Study|Clinical Adverse Event|3|||
13378758|NCT00770341|26740399|FG001|Overall Study|Clinical Adverse Event|1|||
13378759|NCT00770341|26740400|FG002|Overall Study|Clinical Adverse Event|2|||
13378760|NCT00770341|26740398|FG000|Overall Study|Laboratory adverse event|3|||
13378761|NCT00770341|26740399|FG001|Overall Study|Laboratory adverse event|3|||
13378762|NCT00770341|26740400|FG002|Overall Study|Laboratory adverse event|0|||
13378763|NCT00770341|26740398|FG000|Overall Study|Lack of Efficacy|3|||
13378764|NCT00770341|26740399|FG001|Overall Study|Lack of Efficacy|0|||
13378765|NCT00770341|26740400|FG002|Overall Study|Lack of Efficacy|1|||
13378766|NCT00770341|26740398|FG000|Overall Study|Other|1|||
13378767|NCT00770341|26740399|FG001|Overall Study|Other|0|||
13378768|NCT00770341|26740400|FG002|Overall Study|Other|0|||
13378769|NCT00770341|26740398|FG000|Overall Study|Not treated|1|||
13378770|NCT00770341|26740399|FG001|Overall Study|Not treated|0|||
13378771|NCT00770341|26740400|FG002|Overall Study|Not treated|0|||
13378772|NCT00770328|26740419|FG000|Overall Study|Adverse Event|11|||
13378773|NCT00770328|26740420|FG001|Overall Study|Adverse Event|2|||
13378774|NCT00770328|26740419|FG000|Overall Study|Lost to Follow-up|2|||
13378775|NCT00770328|26740420|FG001|Overall Study|Lost to Follow-up|2|||
13378776|NCT00770315|26740459|FG000|Overall Study|Adverse Event|11|||
13378777|NCT00770315|26740460|FG001|Overall Study|Adverse Event|17|||
13378778|NCT00770315|26740461|FG002|Overall Study|Adverse Event|16|||
13378779|NCT00770315|26740462|FG003|Overall Study|Adverse Event|6|||
13378780|NCT00770315|26740459|FG000|Overall Study|Lost to Follow-up|9|||
13378781|NCT00770315|26740460|FG001|Overall Study|Lost to Follow-up|5|||
13378782|NCT00770315|26740461|FG002|Overall Study|Lost to Follow-up|10|||
13378783|NCT00770315|26740462|FG003|Overall Study|Lost to Follow-up|3|||
13378784|NCT00770315|26740459|FG000|Overall Study|Withdrawal by Subject|13|||
13378785|NCT00770315|26740460|FG001|Overall Study|Withdrawal by Subject|17|||
13378786|NCT00770315|26740461|FG002|Overall Study|Withdrawal by Subject|24|||
13378787|NCT00770315|26740462|FG003|Overall Study|Withdrawal by Subject|20|||
13378788|NCT00770315|26740459|FG000|Overall Study|Noncompliance with Protocol|7|||
13378789|NCT00770315|26740460|FG001|Overall Study|Noncompliance with Protocol|4|||
13378790|NCT00770315|26740461|FG002|Overall Study|Noncompliance with Protocol|7|||
13378791|NCT00770315|26740462|FG003|Overall Study|Noncompliance with Protocol|9|||
13378792|NCT00770289|26740473|FG000|Overall Study|Other|6|||
13378793|NCT00770224|26740486|FG000|Step 1: Induction|Adverse Event|3|||
13378794|NCT00770224|26740487|FG001|Step 1: Induction|Adverse Event|0|||
13378795|NCT00770224|26740486|FG000|Step 1: Induction|Refusal unrelated to adverse event|6|||
13378796|NCT00770224|26740487|FG001|Step 1: Induction|Refusal unrelated to adverse event|0|||
13378797|NCT00770224|26740486|FG000|Step 1: Induction|Other reason not protocol specified|2|||
13378798|NCT00770224|26740487|FG001|Step 1: Induction|Other reason not protocol specified|0|||
13378799|NCT00770224|26740486|FG000|Step 1: Induction|Ineligible|2|||
13378800|NCT00770224|26740487|FG001|Step 1: Induction|Ineligible|0|||
13378801|NCT00770224|26740486|FG000|Step 1: Induction|No protocol treatment given|1|||
13378802|NCT00770224|26740487|FG001|Step 1: Induction|No protocol treatment given|0|||
13378803|NCT00770224|26740486|FG000|Step 2: Maintenance|Adverse Event|0|||
13378804|NCT00770224|26740487|FG001|Step 2: Maintenance|Adverse Event|10|||
13378805|NCT00770224|26740486|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0|||
13378806|NCT00770224|26740487|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8|||
13378807|NCT00770224|26740486|FG000|Step 2: Maintenance|Progression/relapse|0|||
13378808|NCT00770224|26740487|FG001|Step 2: Maintenance|Progression/relapse|1|||
13378809|NCT00770224|26740486|FG000|Step 2: Maintenance|Death|0|||
13378810|NCT00770224|26740487|FG001|Step 2: Maintenance|Death|2|||
13378811|NCT00770224|26740486|FG000|Step 2: Maintenance|Other reason not protocol specified|0|||
13378812|NCT00770224|26740487|FG001|Step 2: Maintenance|Other reason not protocol specified|7|||
13378813|NCT00770224|26740486|FG000|Step 2: Maintenance|Ineligible|0|||
13378814|NCT00770224|26740487|FG001|Step 2: Maintenance|Ineligible|2|||
13378815|NCT00770211|26740508|FG000|Overall Study|Lost to Follow-up|1|||
13378816|NCT00770211|26740509|FG001|Overall Study|Lost to Follow-up|0|||
13378817|NCT00770211|26740508|FG000|Overall Study|Withdrawal by Subject|0|||
13378818|NCT00770211|26740509|FG001|Overall Study|Withdrawal by Subject|2|||
13378819|NCT00770146|26740560|FG000|Treatment Period|Withdrawal by Subject|6|||
13378820|NCT00770146|26740561|FG001|Treatment Period|Withdrawal by Subject|13|||
13378821|NCT00770146|26740560|FG000|Treatment Period|Adverse Event|2|||
13378822|NCT00770146|26740561|FG001|Treatment Period|Adverse Event|26|||
13378823|NCT00770146|26740560|FG000|Treatment Period|Other|1|||
13378824|NCT00770146|26740561|FG001|Treatment Period|Other|5|||
13378825|NCT00770146|26740560|FG000|Treatment Period|Protocol non-compliance|0|||
13378826|NCT00770146|26740561|FG001|Treatment Period|Protocol non-compliance|1|||
13378827|NCT00770146|26740560|FG000|Follow-up Period|Withdrawal by Subject|7|||
13378828|NCT00770146|26740561|FG001|Follow-up Period|Withdrawal by Subject|13|||
13378829|NCT00770146|26740560|FG000|Follow-up Period|Adverse Event|0|||
13378830|NCT00770146|26740561|FG001|Follow-up Period|Adverse Event|2|||
13378831|NCT00770146|26740560|FG000|Follow-up Period|Other|4|||
13378832|NCT00770146|26740561|FG001|Follow-up Period|Other|5|||
13378833|NCT00770120|26740570|FG000|Overall Study|Progression|31|||
13378834|NCT00770120|26740570|FG000|Overall Study|Adverse Event|11|||
13378835|NCT00770120|26740570|FG000|Overall Study|Not Protocol Specified|11|||
13378836|NCT00770120|26740570|FG000|Overall Study|Death|3|||
13378837|NCT00770120|26740570|FG000|Overall Study|Withdrawal by Subject|2|||
13378838|NCT00770120|26740570|FG000|Overall Study|Ineligible|1|||
13378839|NCT00770120|26740570|FG000|Overall Study|Never Received Treatment/Not Analyzable|1|||
13378840|NCT00770120|26740570|FG000|Overall Study|Reason under Review|1|||
13378841|NCT00770029|26740591|FG000|Overall Study|Lost to Follow-up|2|||
13378842|NCT00770029|26740592|FG001|Overall Study|Lost to Follow-up|0|||
13378843|NCT00770029|26740591|FG000|Overall Study|Withdrawal by Subject|3|||
13378844|NCT00770029|26740592|FG001|Overall Study|Withdrawal by Subject|3|||
13378845|NCT00770029|26740591|FG000|Overall Study|Adverse Event|1|||
13378846|NCT00770029|26740592|FG001|Overall Study|Adverse Event|0|||
13378847|NCT00769860|26740625|FG000|Overall Study|Withdrawal by Subject|2|||
13378848|NCT00769860|26740626|FG001|Overall Study|Withdrawal by Subject|0|||
13378849|NCT00769704|26740651|FG000|Overall Study|Lost to Follow-up|3|||
13378850|NCT00769704|26740652|FG001|Overall Study|Lost to Follow-up|2|||
13378851|NCT00769704|26740651|FG000|Overall Study|Death|95|||
13378852|NCT00769704|26740652|FG001|Overall Study|Death|190|||
13378853|NCT00769704|26740651|FG000|Overall Study|Withdrawal by Subject|12|||
13378854|NCT00769704|26740652|FG001|Overall Study|Withdrawal by Subject|5|||
13378855|NCT00769704|26740651|FG000|Overall Study|Other|1|||
13378856|NCT00769704|26740652|FG001|Overall Study|Other|2|||
13378857|NCT00769561|26740679|FG000|Overall Study|Withdrawal by Subject|2|||
13378858|NCT00769561|26740680|FG001|Overall Study|Withdrawal by Subject|2|||
13378859|NCT00769561|26740679|FG000|Overall Study|Lost to Follow-up|1|||
13378860|NCT00769561|26740680|FG001|Overall Study|Lost to Follow-up|3|||
13378861|NCT00769483|26740737|FG000|Overall Study|Withdrawal by Subject|0|||
13378862|NCT00769483|26740738|FG001|Overall Study|Withdrawal by Subject|1|||
13378863|NCT00769483|26740739|FG002|Overall Study|Withdrawal by Subject|0|||
13378864|NCT00769483|26740740|FG003|Overall Study|Withdrawal by Subject|0|||
13378865|NCT00769483|26740741|FG004|Overall Study|Withdrawal by Subject|1|||
13378866|NCT00769483|26740742|FG005|Overall Study|Withdrawal by Subject|0|||
13378867|NCT00769184|26740753|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1|||
13378868|NCT00769184|26740754|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0|||
13378869|NCT00769184|26740753|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0|||
13378870|NCT00769184|26740754|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1|||
13378871|NCT00769184|26740753|FG000|No Treatment (6 Weeks)|Adverse Event|1|||
13378872|NCT00769184|26740754|FG001|No Treatment (6 Weeks)|Adverse Event|1|||
13378873|NCT00769132|26740773|FG000|Period 1|Adverse Event|1|||
13378874|NCT00769132|26740774|FG001|Period 1|Adverse Event|0|||
13378875|NCT00769132|26740775|FG002|Period 1|Adverse Event|0|||
13378876|NCT00769132|26740776|FG003|Period 1|Adverse Event|1|||
13378877|NCT00769132|26740773|FG000|Period 2|Withdrawal by Subject|0|||
13378878|NCT00769132|26740774|FG001|Period 2|Withdrawal by Subject|0|||
13378879|NCT00769132|26740775|FG002|Period 2|Withdrawal by Subject|0|||
13378880|NCT00769132|26740776|FG003|Period 2|Withdrawal by Subject|1|||
13378881|NCT00769132|26740773|FG000|Period 3|Withdrawal by Subject|1|||
13378882|NCT00769132|26740774|FG001|Period 3|Withdrawal by Subject|0|||
13378883|NCT00769132|26740775|FG002|Period 3|Withdrawal by Subject|0|||
13378884|NCT00769132|26740776|FG003|Period 3|Withdrawal by Subject|0|||
13378885|NCT00769132|26740773|FG000|Period 4|Withdrawal by Subject|0|||
13378886|NCT00769132|26740774|FG001|Period 4|Withdrawal by Subject|1|||
13378887|NCT00769132|26740775|FG002|Period 4|Withdrawal by Subject|0|||
13378888|NCT00769132|26740776|FG003|Period 4|Withdrawal by Subject|0|||
13378889|NCT00769119|26740827|FG000|Overall Study|Voluntary discontinuation|0|||
13378890|NCT00769119|26740828|FG001|Overall Study|Voluntary discontinuation|2|||
13378891|NCT00769119|26740827|FG000|Overall Study|Adverse Event|1|||
13378892|NCT00769119|26740828|FG001|Overall Study|Adverse Event|1|||
13378893|NCT00769119|26740827|FG000|Overall Study|Disallowed medication|1|||
13378894|NCT00769119|26740828|FG001|Overall Study|Disallowed medication|0|||
13378895|NCT00769067|26740860|FG000|Overall Study|Death|89|||
13378896|NCT00769067|26740861|FG001|Overall Study|Death|86|||
13378897|NCT00769067|26740860|FG000|Overall Study|Lost to Follow-up|3|||
13378898|NCT00769067|26740861|FG001|Overall Study|Lost to Follow-up|1|||
13378899|NCT00769067|26740860|FG000|Overall Study|Study terminated by sponsor|1|||
13378900|NCT00769067|26740861|FG001|Overall Study|Study terminated by sponsor|3|||
13378901|NCT00769067|26740860|FG000|Overall Study|Other|1|||
13378902|NCT00769067|26740861|FG001|Overall Study|Other|3|||
13378903|NCT00769067|26740860|FG000|Overall Study|Withdrawal by Subject|0|||
13378904|NCT00769067|26740861|FG001|Overall Study|Withdrawal by Subject|1|||
13378905|NCT00769002|26740877|FG000|Overall Study|Study was not completed, no data|9|||
13378906|NCT00769002|26740878|FG001|Overall Study|Study was not completed, no data|9|||
13378907|NCT00768989|26740933|FG000|Prior to Week 24|Withdrawal by Subject|1|||
13378908|NCT00768989|26740934|FG001|Prior to Week 24|Withdrawal by Subject|0|||
13378909|NCT00768989|26740933|FG000|Prior to Week 24|Adverse Event|3|||
13378910|NCT00768989|26740934|FG001|Prior to Week 24|Adverse Event|0|||
13378911|NCT00768989|26740933|FG000|Prior to Week 24|Lost to Follow-up|0|||
13378912|NCT00768989|26740934|FG001|Prior to Week 24|Lost to Follow-up|1|||
13378913|NCT00768989|26740933|FG000|Prior to Week 24|Protocol Violation|0|||
13378914|NCT00768989|26740934|FG001|Prior to Week 24|Protocol Violation|2|||
13378915|NCT00768989|26740933|FG000|Week 24 to Prior to Week 36|Adverse Event|1|||
13378916|NCT00768989|26740934|FG001|Week 24 to Prior to Week 36|Adverse Event|0|||
13378917|NCT00768989|26740933|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6|||
13378918|NCT00768989|26740934|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0|||
13378919|NCT00768989|26740933|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1|||
13378920|NCT00768989|26740934|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0|||
13378921|NCT00768989|26740933|FG000|On or After Week 36|Lack of Efficacy|1|||
13378922|NCT00768989|26740934|FG001|On or After Week 36|Lack of Efficacy|0|||
13378923|NCT00768989|26740933|FG000|On or After Week 36|Adverse Event|0|||
13378924|NCT00768989|26740934|FG001|On or After Week 36|Adverse Event|1|||
13378925|NCT00768989|26740933|FG000|On or After Week 36|Lost to Follow-up|1|||
13378926|NCT00768989|26740934|FG001|On or After Week 36|Lost to Follow-up|0|||
13378927|NCT00768989|26740933|FG000|On or After Week 36|Poor Compliance|1|||
13378928|NCT00768989|26740934|FG001|On or After Week 36|Poor Compliance|0|||
13378929|NCT00768989|26740933|FG000|On or After Week 36|Protocol Violation|1|||
13378930|NCT00768989|26740934|FG001|On or After Week 36|Protocol Violation|0|||
13378931|NCT00768989|26740933|FG000|On or After Week 36|Did not attend termination visit|2|||
13378932|NCT00768989|26740934|FG001|On or After Week 36|Did not attend termination visit|0|||
13378933|NCT00768989|26740933|FG000|On or After Week 36|Sponsor Termination|45|||
13378934|NCT00768989|26740934|FG001|On or After Week 36|Sponsor Termination|26|||
13378935|NCT00768898|26740956|FG000|Overall Study|Unrelated injury|1|||
13378936|NCT00768898|26740956|FG000|Overall Study|Headache|1|||
13378937|NCT00768755|26740993|FG000|Phase 1|Death|6|||
13378938|NCT00768755|26740994|FG001|Phase 1|Death|0|||
13378939|NCT00768755|26740995|FG002|Phase 1|Death|0|||
13378940|NCT00768755|26740996|FG003|Phase 1|Death|0|||
13378941|NCT00768755|26740993|FG000|Phase 1|Other|4|||
13378942|NCT00768755|26740994|FG001|Phase 1|Other|0|||
13378943|NCT00768755|26740995|FG002|Phase 1|Other|0|||
13378944|NCT00768755|26740996|FG003|Phase 1|Other|0|||
13378945|NCT00768755|26740993|FG000|Phase 2|Death|0|||
13378946|NCT00768755|26740994|FG001|Phase 2|Death|37|||
13378947|NCT00768755|26740995|FG002|Phase 2|Death|48|||
13378948|NCT00768755|26740996|FG003|Phase 2|Death|31|||
13378949|NCT00768755|26740993|FG000|Phase 2|Protocol Violation|0|||
13378950|NCT00768755|26740994|FG001|Phase 2|Protocol Violation|2|||
13378951|NCT00768755|26740995|FG002|Phase 2|Protocol Violation|0|||
13378952|NCT00768755|26740996|FG003|Phase 2|Protocol Violation|1|||
13378953|NCT00768755|26740993|FG000|Phase 2|Lost to Follow-up|0|||
13378954|NCT00768755|26740994|FG001|Phase 2|Lost to Follow-up|1|||
13378955|NCT00768755|26740995|FG002|Phase 2|Lost to Follow-up|1|||
13378956|NCT00768755|26740996|FG003|Phase 2|Lost to Follow-up|4|||
13378957|NCT00768755|26740993|FG000|Phase 2|Withdrawal by Subject|0|||
13378958|NCT00768755|26740994|FG001|Phase 2|Withdrawal by Subject|1|||
13378959|NCT00768755|26740995|FG002|Phase 2|Withdrawal by Subject|0|||
13378960|NCT00768755|26740996|FG003|Phase 2|Withdrawal by Subject|1|||
13378961|NCT00768755|26740993|FG000|Phase 2|Other|0|||
13378962|NCT00768755|26740994|FG001|Phase 2|Other|1|||
13378963|NCT00768755|26740995|FG002|Phase 2|Other|2|||
13378964|NCT00768755|26740996|FG003|Phase 2|Other|4|||
13378965|NCT00768755|26740993|FG000|Phase 2|Study Terminated by Sponsor|0|||
13378966|NCT00768755|26740994|FG001|Phase 2|Study Terminated by Sponsor|13|||
13378967|NCT00768755|26740995|FG002|Phase 2|Study Terminated by Sponsor|7|||
13378968|NCT00768755|26740996|FG003|Phase 2|Study Terminated by Sponsor|14|||
13378969|NCT00768755|26740993|FG000|Phase 2|Randomized but not treated|0|||
13378970|NCT00768755|26740994|FG001|Phase 2|Randomized but not treated|0|||
13378971|NCT00768755|26740995|FG002|Phase 2|Randomized but not treated|0|||
13378972|NCT00768755|26740996|FG003|Phase 2|Randomized but not treated|2|||
13378973|NCT00768664|26741017|FG000|Overall Study|Death|57|||
13378974|NCT00768664|26741017|FG000|Overall Study|Lost to Follow-up|2|||
13378975|NCT00768664|26741017|FG000|Overall Study|Other|9|||
13378976|NCT00768664|26741017|FG000|Overall Study|Participant refused|1|||
13378977|NCT00768651|26741024|FG000|Overall Study|Withdrawal by Subject|1|||
13378978|NCT00768560|26741069|FG000|Intervention Set 1|Adverse Event|0|||
13378979|NCT00768560|26741070|FG001|Intervention Set 1|Adverse Event|1|||
13378980|NCT00768560|26741071|FG002|Intervention Set 1|Adverse Event|0|||
13378981|NCT00768560|26741072|FG003|Intervention Set 1|Adverse Event|0|||
13378982|NCT00768560|26741073|FG004|Intervention Set 1|Adverse Event|0|||
13378983|NCT00768560|26741074|FG005|Intervention Set 1|Adverse Event|0|||
13378984|NCT00768469|26741094|FG000|Overall Study|Adverse Event|0|||
13378985|NCT00768469|26741095|FG001|Overall Study|Adverse Event|2|||
13378986|NCT00768469|26741094|FG000|Overall Study|Disease Progression|3|||
13378987|NCT00768469|26741095|FG001|Overall Study|Disease Progression|4|||
13378988|NCT00768469|26741094|FG000|Overall Study|Withdrawal by Subject|0|||
13378989|NCT00768469|26741095|FG001|Overall Study|Withdrawal by Subject|1|||
13378990|NCT00768430|26741108|FG000|7 Day Endpoint|Withdrawal by Subject|2|||
13378991|NCT00768430|26741109|FG001|7 Day Endpoint|Withdrawal by Subject|3|||
13378992|NCT00768300|26741138|FG000|Overall Study|Randomized but not treated|1|||
13378993|NCT00768300|26741139|FG001|Overall Study|Randomized but not treated|1|||
13378994|NCT00768300|26741138|FG000|Overall Study|Adverse Event|10|||
13378995|NCT00768300|26741139|FG001|Overall Study|Adverse Event|2|||
13378996|NCT00768300|26741138|FG000|Overall Study|Protocol Violation|6|||
13378997|NCT00768300|26741139|FG001|Overall Study|Protocol Violation|1|||
13378998|NCT00768300|26741138|FG000|Overall Study|Withdrawal by Subject|13|||
13378999|NCT00768300|26741139|FG001|Overall Study|Withdrawal by Subject|7|||
13379000|NCT00768300|26741138|FG000|Overall Study|Physician Decision|2|||
13379001|NCT00768300|26741139|FG001|Overall Study|Physician Decision|3|||
13379002|NCT00768300|26741138|FG000|Overall Study|Study discontinued by Sponsor|271|||
13379003|NCT00768300|26741139|FG001|Overall Study|Study discontinued by Sponsor|140|||
13379004|NCT00768300|26741138|FG000|Overall Study|Death|21|||
13379005|NCT00768300|26741139|FG001|Overall Study|Death|5|||
13379006|NCT00768300|26741138|FG000|Overall Study|Subject moved to pursue lung transplant|1|||
13379007|NCT00768300|26741139|FG001|Overall Study|Subject moved to pursue lung transplant|1|||
13379008|NCT00768300|26741138|FG000|Overall Study|Screen failure following randomization|1|||
13379009|NCT00768300|26741139|FG001|Overall Study|Screen failure following randomization|0|||
13379010|NCT00768300|26741138|FG000|Overall Study|Received lung transplant|1|||
13379011|NCT00768300|26741139|FG001|Overall Study|Received lung transplant|1|||
13379012|NCT00768300|26741138|FG000|Overall Study|Lost to Follow-up|0|||
13379013|NCT00768300|26741139|FG001|Overall Study|Lost to Follow-up|1|||
13379014|NCT00768300|26741138|FG000|Overall Study|Began prohibited concomitant medication|0|||
13379015|NCT00768300|26741139|FG001|Overall Study|Began prohibited concomitant medication|1|||
13379016|NCT00768300|26741138|FG000|Overall Study|Treated but never dosed with Study drug|1|||
13379017|NCT00768300|26741139|FG001|Overall Study|Treated but never dosed with Study drug|0|||
13379018|NCT00768300|26741138|FG000|Overall Study|Missing data|1|||
13379019|NCT00768300|26741139|FG001|Overall Study|Missing data|0|||
13379020|NCT00768248|26741160|FG000|Overall Study|Research coordinator didn't collect data|1|||
13379021|NCT00768248|26741161|FG001|Overall Study|Research coordinator didn't collect data|1|||
13379022|NCT00768222|26741190|FG000|Overall Study|Lost to Follow-up|1|||
13379023|NCT00768222|26741191|FG001|Overall Study|Lost to Follow-up|1|||
13379024|NCT00768222|26741190|FG000|Overall Study|Withdrawal by Subject|3|||
13379025|NCT00768222|26741191|FG001|Overall Study|Withdrawal by Subject|1|||
13379026|NCT00768222|26741190|FG000|Overall Study|Protocol Violation|0|||
13379027|NCT00768222|26741191|FG001|Overall Study|Protocol Violation|2|||
13379028|NCT00768144|26741199|FG000|Overall Study|Adverse Event|13|||
13379029|NCT00768144|26741199|FG000|Overall Study|Progressive Disease|21|||
13379030|NCT00768144|26741199|FG000|Overall Study|Patient or MD Decision to End Treatment|1|||
13379031|NCT00768144|26741199|FG000|Overall Study|Pt Withdrew Consent|1|||
13379032|NCT00768079|26741263|FG000|Overall Study|Lost to Follow-up|2|||
13379033|NCT00768079|26741264|FG001|Overall Study|Lost to Follow-up|0|||
13379034|NCT00768079|26741265|FG002|Overall Study|Lost to Follow-up|4|||
13379035|NCT00768079|26741263|FG000|Overall Study|Participant incarcerated|0|||
13379036|NCT00768079|26741264|FG001|Overall Study|Participant incarcerated|1|||
13379037|NCT00768079|26741265|FG002|Overall Study|Participant incarcerated|0|||
13379038|NCT00768066|26741307|FG000|Overall Study|Did not receive study product injection.|3|||
13379039|NCT00768066|26741308|FG001|Overall Study|Did not receive study product injection.|3|||
13379040|NCT00768066|26741309|FG002|Overall Study|Did not receive study product injection.|0|||
13379041|NCT00768053|26741340|FG000|Overall Study|Adverse Event|10|||
13379042|NCT00768053|26741340|FG000|Overall Study|Lost to Follow-up|1|||
13379043|NCT00768040|26741353|FG000|Overall Study|Adverse Event|3|||
13379044|NCT00768040|26741354|FG001|Overall Study|Adverse Event|2|||
13379045|NCT00768040|26741353|FG000|Overall Study|Abnormal laboratory value|1|||
13379046|NCT00768040|26741354|FG001|Overall Study|Abnormal laboratory value|1|||
13379047|NCT00767819|26741387|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
13379048|NCT00767819|26741388|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
13379049|NCT00767819|26741389|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
13379050|NCT00767819|26741387|FG000|Overall Study|Withdrawal by Subject|1|||
13379051|NCT00767819|26741388|FG001|Overall Study|Withdrawal by Subject|1|||
13379052|NCT00767819|26741389|FG002|Overall Study|Withdrawal by Subject|0|||
13379053|NCT00767819|26741387|FG000|Overall Study|Administrative problems|0|||
13379054|NCT00767819|26741388|FG001|Overall Study|Administrative problems|1|||
13379055|NCT00767819|26741389|FG002|Overall Study|Administrative problems|0|||
13379056|NCT00767819|26741387|FG000|Overall Study|Death|2|||
13379057|NCT00767819|26741388|FG001|Overall Study|Death|3|||
13379058|NCT00767819|26741389|FG002|Overall Study|Death|0|||
13379059|NCT00767819|26741387|FG000|Overall Study|Adverse Event|2|||
13379060|NCT00767819|26741388|FG001|Overall Study|Adverse Event|0|||
13379061|NCT00767819|26741389|FG002|Overall Study|Adverse Event|0|||
13379062|NCT00767819|26741387|FG000|Overall Study|Abnormal lab values|1|||
13379063|NCT00767819|26741388|FG001|Overall Study|Abnormal lab values|0|||
13379064|NCT00767819|26741389|FG002|Overall Study|Abnormal lab values|0|||
13379065|NCT00767819|26741387|FG000|Overall Study|Lost to Follow-up|1|||
13379066|NCT00767819|26741388|FG001|Overall Study|Lost to Follow-up|0|||
13379067|NCT00767819|26741389|FG002|Overall Study|Lost to Follow-up|0|||
13379068|NCT00767806|26741452|FG000|Overall Study|Adverse Event|30|||
13379069|NCT00767806|26741453|FG001|Overall Study|Adverse Event|11|||
13379070|NCT00767806|26741452|FG000|Overall Study|Withdrawal by Subject|8|||
13379071|NCT00767806|26741453|FG001|Overall Study|Withdrawal by Subject|13|||
13379072|NCT00767806|26741452|FG000|Overall Study|Protocol Violation|6|||
13379073|NCT00767806|26741453|FG001|Overall Study|Protocol Violation|5|||
13379074|NCT00767806|26741452|FG000|Overall Study|Lack of Efficacy|1|||
13379075|NCT00767806|26741453|FG001|Overall Study|Lack of Efficacy|9|||
13379076|NCT00767806|26741452|FG000|Overall Study|Physician Decision|4|||
13379077|NCT00767806|26741453|FG001|Overall Study|Physician Decision|3|||
13379078|NCT00767806|26741452|FG000|Overall Study|Lost to Follow-up|1|||
13379079|NCT00767806|26741453|FG001|Overall Study|Lost to Follow-up|4|||
13379080|NCT00767806|26741452|FG000|Overall Study|Entry Criteria Not Met|1|||
13379081|NCT00767806|26741453|FG001|Overall Study|Entry Criteria Not Met|1|||
13379082|NCT00767806|26741452|FG000|Overall Study|Sponsor Decision|0|||
13379083|NCT00767806|26741453|FG001|Overall Study|Sponsor Decision|1|||
13379084|NCT00767676|26741459|FG000|Overall Study|Investigator error|54|||
13379085|NCT00767520|26741488|FG000|Overall Study|Participants still on treatment|11|||
13379086|NCT00767520|26741489|FG001|Overall Study|Participants still on treatment|15|||
13379087|NCT00767520|26741488|FG000|Overall Study|Randomized in error and Never treated|0|||
13379088|NCT00767520|26741489|FG001|Overall Study|Randomized in error and Never treated|2|||
13379089|NCT00767455|26741497|FG000|Overall Study|Investigator error|19|||
13379090|NCT00767325|26741508|FG000|Overall Study|Lack of Efficacy|2|||
13379091|NCT00767325|26741508|FG000|Overall Study|Adverse Event|7|||
13379092|NCT00767325|26741508|FG000|Overall Study|Lost to Follow-up|3|||
13379093|NCT00767325|26741508|FG000|Overall Study|No longer met study criteria|2|||
13379094|NCT00767325|26741508|FG000|Overall Study|Missed visit due to family reasons|1|||
13379095|NCT00767104|26741523|FG000|Overall Study|Lost to Follow-up|1|||
13379096|NCT00767104|26741524|FG001|Overall Study|Lost to Follow-up|2|||
13379097|NCT00767039|26741557|FG000|Overall Study|Death|5|||
13379098|NCT00767039|26741558|FG001|Overall Study|Death|2|||
13379099|NCT00767000|26741616|FG000|54-week Study|Adverse Event|4|||
13379100|NCT00767000|26741617|FG001|54-week Study|Adverse Event|6|||
13379101|NCT00767000|26741618|FG002|54-week Study|Adverse Event|6|||
13379102|NCT00767000|26741619|FG003|54-week Study|Adverse Event|8|||
13379103|NCT00767000|26741620|FG004|54-week Study|Adverse Event|4|||
13379104|NCT00767000|26741616|FG000|54-week Study|Creaninine/creatinine clearance|2|||
13379105|NCT00767000|26741617|FG001|54-week Study|Creaninine/creatinine clearance|1|||
13379106|NCT00767000|26741618|FG002|54-week Study|Creaninine/creatinine clearance|2|||
13379107|NCT00767000|26741619|FG003|54-week Study|Creaninine/creatinine clearance|2|||
13379108|NCT00767000|26741620|FG004|54-week Study|Creaninine/creatinine clearance|4|||
13379109|NCT00767000|26741616|FG000|54-week Study|Hyperglycemia|0|||
13379110|NCT00767000|26741617|FG001|54-week Study|Hyperglycemia|0|||
13379111|NCT00767000|26741618|FG002|54-week Study|Hyperglycemia|1|||
13379112|NCT00767000|26741619|FG003|54-week Study|Hyperglycemia|0|||
13379113|NCT00767000|26741620|FG004|54-week Study|Hyperglycemia|1|||
13379114|NCT00767000|26741616|FG000|54-week Study|Hypoglycemia|0|||
13379115|NCT00767000|26741617|FG001|54-week Study|Hypoglycemia|1|||
13379116|NCT00767000|26741618|FG002|54-week Study|Hypoglycemia|0|||
13379117|NCT00767000|26741619|FG003|54-week Study|Hypoglycemia|0|||
13379118|NCT00767000|26741620|FG004|54-week Study|Hypoglycemia|0|||
13379119|NCT00767000|26741616|FG000|54-week Study|Interruption of study medication|0|||
13379120|NCT00767000|26741617|FG001|54-week Study|Interruption of study medication|0|||
13379121|NCT00767000|26741618|FG002|54-week Study|Interruption of study medication|1|||
13379122|NCT00767000|26741619|FG003|54-week Study|Interruption of study medication|0|||
13379123|NCT00767000|26741620|FG004|54-week Study|Interruption of study medication|0|||
13379124|NCT00767000|26741616|FG000|54-week Study|Lack of Efficacy|2|||
13379125|NCT00767000|26741617|FG001|54-week Study|Lack of Efficacy|0|||
13379126|NCT00767000|26741618|FG002|54-week Study|Lack of Efficacy|1|||
13379127|NCT00767000|26741619|FG003|54-week Study|Lack of Efficacy|0|||
13379128|NCT00767000|26741620|FG004|54-week Study|Lack of Efficacy|5|||
13379129|NCT00767000|26741616|FG000|54-week Study|Lost to Follow-up|4|||
13379130|NCT00767000|26741617|FG001|54-week Study|Lost to Follow-up|0|||
13379131|NCT00767000|26741618|FG002|54-week Study|Lost to Follow-up|1|||
13379132|NCT00767000|26741619|FG003|54-week Study|Lost to Follow-up|4|||
13379133|NCT00767000|26741620|FG004|54-week Study|Lost to Follow-up|2|||
13379134|NCT00767000|26741616|FG000|54-week Study|Physician Decision|4|||
13379135|NCT00767000|26741617|FG001|54-week Study|Physician Decision|0|||
13379136|NCT00767000|26741618|FG002|54-week Study|Physician Decision|1|||
13379137|NCT00767000|26741619|FG003|54-week Study|Physician Decision|1|||
13379138|NCT00767000|26741620|FG004|54-week Study|Physician Decision|1|||
13394109|NCT00660179|26785862|FG001|Overall Study|Death|47|||
13379139|NCT00767000|26741616|FG000|54-week Study|Progressive disease|0|||
13379140|NCT00767000|26741617|FG001|54-week Study|Progressive disease|0|||
13379141|NCT00767000|26741618|FG002|54-week Study|Progressive disease|1|||
13379142|NCT00767000|26741619|FG003|54-week Study|Progressive disease|0|||
13379143|NCT00767000|26741620|FG004|54-week Study|Progressive disease|0|||
13379144|NCT00767000|26741616|FG000|54-week Study|Protocol Violation|0|||
13379145|NCT00767000|26741617|FG001|54-week Study|Protocol Violation|0|||
13379146|NCT00767000|26741618|FG002|54-week Study|Protocol Violation|1|||
13379147|NCT00767000|26741619|FG003|54-week Study|Protocol Violation|2|||
13379148|NCT00767000|26741620|FG004|54-week Study|Protocol Violation|0|||
13379149|NCT00767000|26741616|FG000|54-week Study|Withdrawal by Subject|2|||
13379150|NCT00767000|26741617|FG001|54-week Study|Withdrawal by Subject|3|||
13379151|NCT00767000|26741618|FG002|54-week Study|Withdrawal by Subject|5|||
13379152|NCT00767000|26741619|FG003|54-week Study|Withdrawal by Subject|11|||
13379153|NCT00767000|26741620|FG004|54-week Study|Withdrawal by Subject|13|||
13379154|NCT00767000|26741616|FG000|54-week Study|Study terminated by sponsor|90|||
13379155|NCT00767000|26741617|FG001|54-week Study|Study terminated by sponsor|102|||
13379156|NCT00767000|26741618|FG002|54-week Study|Study terminated by sponsor|89|||
13379157|NCT00767000|26741619|FG003|54-week Study|Study terminated by sponsor|196|||
13379158|NCT00767000|26741620|FG004|54-week Study|Study terminated by sponsor|194|||
13379159|NCT00767000|26741616|FG000|54-week Study|Reason not reported|0|||
13379160|NCT00767000|26741617|FG001|54-week Study|Reason not reported|0|||
13379161|NCT00767000|26741618|FG002|54-week Study|Reason not reported|0|||
13379162|NCT00767000|26741619|FG003|54-week Study|Reason not reported|1|||
13379163|NCT00767000|26741620|FG004|54-week Study|Reason not reported|0|||
13379164|NCT00767000|26741616|FG000|Optional 104-week Extension|Study terminated by sponsor|7|||
13379165|NCT00767000|26741617|FG001|Optional 104-week Extension|Study terminated by sponsor|3|||
13379166|NCT00767000|26741618|FG002|Optional 104-week Extension|Study terminated by sponsor|7|||
13379167|NCT00767000|26741619|FG003|Optional 104-week Extension|Study terminated by sponsor|2|||
13379168|NCT00767000|26741620|FG004|Optional 104-week Extension|Study terminated by sponsor|4|||
13379169|NCT00766831|26741638|FG000|Overall Study|Withdrawal by Subject|4|||
13379170|NCT00766831|26741638|FG000|Overall Study|Lost to Follow-up|3|||
13379171|NCT00766831|26741638|FG000|Overall Study|Adverse Event|20|||
13379172|NCT00766831|26741638|FG000|Overall Study|Protocol Violation|15|||
13379173|NCT00766831|26741638|FG000|Overall Study|Physician Decision|5|||
13379174|NCT00766831|26741638|FG000|Overall Study|Withdrawal of consent|26|||
13379175|NCT00766831|26741638|FG000|Overall Study|Non cooperation by participants|14|||
13379176|NCT00766831|26741638|FG000|Overall Study|Other|28|||
13379177|NCT00766675|26741653|FG000|Overall Study|Adverse Event|16|||
13379178|NCT00766675|26741653|FG000|Overall Study|Lost to Follow-up|2|||
13379179|NCT00766675|26741653|FG000|Overall Study|Withdrawal by Subject|11|||
13379180|NCT00766675|26741653|FG000|Overall Study|Protocol Violation|8|||
13379181|NCT00766675|26741653|FG000|Overall Study|Participant took prohibited medication|1|||
13379182|NCT00766675|26741653|FG000|Overall Study|Receive other anti-neoplastic treatment|1|||
13379183|NCT00766675|26741653|FG000|Overall Study|Insufficient therapy|1|||
13379184|NCT00766636|26741666|FG000|Overall Study|Withdrawal by Subject|1|||
13379185|NCT00766636|26741667|FG001|Overall Study|Withdrawal by Subject|1|||
13379186|NCT00766636|26741666|FG000|Overall Study|Incomplete Treatment|0|||
13379187|NCT00766636|26741667|FG001|Overall Study|Incomplete Treatment|1|||
13379188|NCT00766636|26741666|FG000|Overall Study|Adverse Event|1|||
13379189|NCT00766636|26741667|FG001|Overall Study|Adverse Event|0|||
13379190|NCT00766636|26741666|FG000|Overall Study|Disease Progression|1|||
13379191|NCT00766636|26741667|FG001|Overall Study|Disease Progression|0|||
13379192|NCT00766597|26741681|FG000|Overall Study|Unexpected closure of study|4|||
13379193|NCT00766597|26741681|FG000|Overall Study|Without CCR5-tropic virus|5|||
13379194|NCT00766532|26741687|FG000|Overall Study|Protocol Violation|2|||
13379195|NCT00766506|26741718|FG000|Overall Study|Use rescue medication after 3 hours|3|||
13379196|NCT00766506|26741719|FG001|Overall Study|Use rescue medication after 3 hours|0|||
13379197|NCT00766506|26741718|FG000|Overall Study|Other|2|||
13379198|NCT00766506|26741719|FG001|Overall Study|Other|2|||
13379199|NCT00766493|26741729|FG000|30 Days Post-Procedure|Discontinued|7|||
13379200|NCT00766493|26741729|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4|||
13379201|NCT00766493|26741729|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1|||
13379202|NCT00766467|26741746|FG000|Overall Study|Withdrawal by Subject|7|||
13379203|NCT00766467|26741747|FG001|Overall Study|Withdrawal by Subject|2|||
13379204|NCT00766467|26741746|FG000|Overall Study|Adverse Event|1|||
13379205|NCT00766467|26741747|FG001|Overall Study|Adverse Event|1|||
13379206|NCT00766467|26741746|FG000|Overall Study|Protocol Violation|2|||
13379207|NCT00766467|26741747|FG001|Overall Study|Protocol Violation|4|||
13379208|NCT00766467|26741746|FG000|Overall Study|Tumor Progression on Study|0|||
13379209|NCT00766467|26741747|FG001|Overall Study|Tumor Progression on Study|1|||
13379210|NCT00766467|26741746|FG000|Overall Study|Physician Decision|1|||
13379211|NCT00766467|26741747|FG001|Overall Study|Physician Decision|0|||
13379212|NCT00766415|26741802|FG000|Overall Study|Withdrawal by Subject|0|||
13379213|NCT00766415|26741803|FG001|Overall Study|Withdrawal by Subject|1|||
13379214|NCT00766376|26741810|FG000|Overall Study|Withdrawal by Subject|27|||
13379215|NCT00766363|26741860|FG000|Overall Study|Withdrawal by Subject|1|||
13379216|NCT00766363|26741861|FG001|Overall Study|Withdrawal by Subject|0|||
13379217|NCT00766363|26741862|FG002|Overall Study|Withdrawal by Subject|0|||
13379218|NCT00766363|26741863|FG003|Overall Study|Withdrawal by Subject|0|||
13379219|NCT00766363|26741860|FG000|Overall Study|Adverse Event Prior to Randomization|0|||
13379220|NCT00766363|26741861|FG001|Overall Study|Adverse Event Prior to Randomization|1|||
13379221|NCT00766363|26741862|FG002|Overall Study|Adverse Event Prior to Randomization|0|||
13379222|NCT00766363|26741863|FG003|Overall Study|Adverse Event Prior to Randomization|0|||
13379223|NCT00766142|26741872|FG000|Overall Study|Protocol Violation|4|||
13379224|NCT00766090|26741928|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
13379225|NCT00766090|26741929|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
13379226|NCT00766090|26741930|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
13379227|NCT00766090|26741931|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
13379228|NCT00766090|26741932|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
13379229|NCT00766090|26741933|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
13379230|NCT00766090|26741934|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
13379231|NCT00766090|26741935|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
13379232|NCT00766090|26741936|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
13379233|NCT00766090|26741937|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
13379234|NCT00766090|26741938|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
13379235|NCT00766090|26741939|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
13379236|NCT00766090|26741928|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2|||
13379237|NCT00766090|26741929|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
13379238|NCT00766090|26741930|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
13379239|NCT00766090|26741931|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
13379240|NCT00766090|26741932|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
13379241|NCT00766090|26741933|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
13379242|NCT00766090|26741934|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
13379243|NCT00766090|26741935|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
13379244|NCT00766090|26741936|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
13379245|NCT00766090|26741937|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
13379246|NCT00766090|26741938|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
13379247|NCT00766090|26741939|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
13379248|NCT00766090|26741928|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
13379249|NCT00766090|26741929|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
13379250|NCT00766090|26741930|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
13379251|NCT00766090|26741931|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
13379252|NCT00766090|26741932|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
13379253|NCT00766090|26741933|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
13379254|NCT00766090|26741934|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
13379255|NCT00766090|26741935|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
13379256|NCT00766090|26741936|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
13379257|NCT00766090|26741937|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
13379258|NCT00766090|26741938|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
13379259|NCT00766090|26741939|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
13379260|NCT00766090|26741928|FG000|Washout Period 1 (14 Days)|Protocol Violation|0|||
13379261|NCT00766090|26741929|FG001|Washout Period 1 (14 Days)|Protocol Violation|0|||
13379262|NCT00766090|26741930|FG002|Washout Period 1 (14 Days)|Protocol Violation|1|||
13379263|NCT00766090|26741931|FG003|Washout Period 1 (14 Days)|Protocol Violation|0|||
13379264|NCT00766090|26741932|FG004|Washout Period 1 (14 Days)|Protocol Violation|0|||
13379265|NCT00766090|26741933|FG005|Washout Period 1 (14 Days)|Protocol Violation|0|||
13379266|NCT00766090|26741934|FG006|Washout Period 1 (14 Days)|Protocol Violation|0|||
13379267|NCT00766090|26741935|FG007|Washout Period 1 (14 Days)|Protocol Violation|0|||
13379268|NCT00766090|26741936|FG008|Washout Period 1 (14 Days)|Protocol Violation|0|||
13379269|NCT00766090|26741937|FG009|Washout Period 1 (14 Days)|Protocol Violation|0|||
13379270|NCT00766090|26741938|FG010|Washout Period 1 (14 Days)|Protocol Violation|0|||
13379271|NCT00766090|26741939|FG011|Washout Period 1 (14 Days)|Protocol Violation|0|||
13379272|NCT00766090|26741928|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
13379273|NCT00766090|26741929|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
13379274|NCT00766090|26741930|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
13379275|NCT00766090|26741931|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
13379276|NCT00766090|26741932|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2|||
13379277|NCT00766090|26741933|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
13379278|NCT00766090|26741934|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
13379279|NCT00766090|26741935|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
13379280|NCT00766090|26741936|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
13379281|NCT00766090|26741937|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
13379282|NCT00766090|26741938|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
13379283|NCT00766090|26741939|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
13379284|NCT00766090|26741928|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
13379285|NCT00766090|26741929|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
13379286|NCT00766090|26741930|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1|||
13379287|NCT00766090|26741931|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
13379288|NCT00766090|26741932|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
13379289|NCT00766090|26741933|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
13379290|NCT00766090|26741934|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
13379291|NCT00766090|26741935|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
13379292|NCT00766090|26741936|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
13379293|NCT00766090|26741937|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
13379294|NCT00766090|26741938|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
13379295|NCT00766090|26741939|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
13379296|NCT00766090|26741928|FG000|Washout Period 2 (14 Days)|Physician Decision|0|||
13379297|NCT00766090|26741929|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
13379298|NCT00766090|26741930|FG002|Washout Period 2 (14 Days)|Physician Decision|1|||
13379299|NCT00766090|26741931|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
13379300|NCT00766090|26741932|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
13379301|NCT00766090|26741933|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
13379302|NCT00766090|26741934|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
13379303|NCT00766090|26741935|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
13379304|NCT00766090|26741936|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
13379305|NCT00766090|26741937|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
13379306|NCT00766090|26741938|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
13379307|NCT00766090|26741939|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
13379308|NCT00766090|26741928|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0|||
13379309|NCT00766090|26741929|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0|||
13379310|NCT00766090|26741930|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0|||
13379311|NCT00766090|26741931|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0|||
13379312|NCT00766090|26741932|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0|||
13379313|NCT00766090|26741933|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1|||
13379314|NCT00766090|26741934|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0|||
13379315|NCT00766090|26741935|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0|||
13379316|NCT00766090|26741936|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0|||
13379317|NCT00766090|26741937|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0|||
13379318|NCT00766090|26741938|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0|||
13379319|NCT00766090|26741939|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0|||
13379320|NCT00766090|26741928|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
13379321|NCT00766090|26741929|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
13379322|NCT00766090|26741930|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
13379323|NCT00766090|26741931|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
13379324|NCT00766090|26741932|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
13379325|NCT00766090|26741933|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
13379326|NCT00766090|26741934|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
13379327|NCT00766090|26741935|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
13379328|NCT00766090|26741936|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
13379329|NCT00766090|26741937|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
13379330|NCT00766090|26741938|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
13379331|NCT00766090|26741939|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
13379332|NCT00766090|26741928|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
13379333|NCT00766090|26741929|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
13379334|NCT00766090|26741930|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
13379335|NCT00766090|26741931|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
13379336|NCT00766090|26741932|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1|||
13379337|NCT00766090|26741933|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
13379338|NCT00766090|26741934|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
13379339|NCT00766090|26741935|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
13379340|NCT00766090|26741936|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
13379341|NCT00766090|26741937|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
13379342|NCT00766090|26741938|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
13379343|NCT00766090|26741939|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
13379344|NCT00766051|26741956|FG000|Overall Study|Withdrawal by Subject|2|||
13394110|NCT00660179|26785863|FG002|Overall Study|Death|34|||
13394111|NCT00660179|26785861|FG000|Overall Study|Withdrawal of consent|4|||
13394112|NCT00660179|26785862|FG001|Overall Study|Withdrawal of consent|6|||
13394113|NCT00660179|26785863|FG002|Overall Study|Withdrawal of consent|4|||
13394114|NCT00660179|26785861|FG000|Overall Study|Lost to Follow-up|7|||
13394115|NCT00660179|26785862|FG001|Overall Study|Lost to Follow-up|5|||
13394116|NCT00660179|26785863|FG002|Overall Study|Lost to Follow-up|2|||
13394117|NCT00660179|26785861|FG000|Overall Study|Administrative reason|0|||
13394118|NCT00660179|26785862|FG001|Overall Study|Administrative reason|0|||
13394119|NCT00660179|26785863|FG002|Overall Study|Administrative reason|1|||
13394120|NCT00660179|26785861|FG000|Overall Study|Incorrect randomization|1|||
13394121|NCT00660179|26785862|FG001|Overall Study|Incorrect randomization|0|||
13394122|NCT00660179|26785863|FG002|Overall Study|Incorrect randomization|0|||
13394123|NCT00660023|26785876|FG000|Overall Study|Adverse Event|2|||
13394124|NCT00660023|26785876|FG000|Overall Study|Death|8|||
13394125|NCT00660023|26785876|FG000|Overall Study|Blood Transfusion|5|||
13394126|NCT00660023|26785876|FG000|Overall Study|Renal Transplantation|3|||
13394127|NCT00660023|26785876|FG000|Overall Study|Withdrawal by Subject|1|||
13394128|NCT00660023|26785876|FG000|Overall Study|Missed Pregnancy Test|1|||
13394129|NCT00660023|26785876|FG000|Overall Study|Other Screening Failure|9|||
13394130|NCT00660010|26785892|FG000|Overall Study|Withdrawal by Subject|2|||
13394131|NCT00660010|26785892|FG000|Overall Study|Lost to Follow-up|3|||
13394132|NCT00660010|26785892|FG000|Overall Study|Adverse Event|1|||
13394133|NCT00660010|26785892|FG000|Overall Study|Noncompliance with visit schedule|3|||
13379345|NCT00766051|26741957|FG001|Overall Study|Withdrawal by Subject|0|||
13379346|NCT00766038|26741980|FG000|Overall Study|Lost to Follow-up|15|||
13379347|NCT00766038|26741981|FG001|Overall Study|Lost to Follow-up|14|||
13379348|NCT00765999|26741989|FG000|Overall Study|Adverse Event|203|||
13379349|NCT00765999|26741989|FG000|Overall Study|Insufficient Therapeutic Response|100|||
13379350|NCT00765999|26741989|FG000|Overall Study|Protocol Violation|95|||
13379351|NCT00765999|26741989|FG000|Overall Study|Consent Withdrawn|202|||
13379352|NCT00765999|26741989|FG000|Overall Study|Lost to Follow-up|131|||
13379353|NCT00765999|26741989|FG000|Overall Study|Study Terminated by Sponsor|2|||
13379354|NCT00765999|26741989|FG000|Overall Study|Other Miscellaneous Reasons|51|||
13379355|NCT00765882|26742028|FG000|Overall Study|Adverse Event|10|||
13379356|NCT00765882|26742029|FG001|Overall Study|Adverse Event|21|||
13379357|NCT00765882|26742030|FG002|Overall Study|Adverse Event|20|||
13379358|NCT00765882|26742028|FG000|Overall Study|Lack of Efficacy|4|||
13379359|NCT00765882|26742029|FG001|Overall Study|Lack of Efficacy|0|||
13379360|NCT00765882|26742030|FG002|Overall Study|Lack of Efficacy|1|||
13379361|NCT00765882|26742028|FG000|Overall Study|Protocol Violation|4|||
13379362|NCT00765882|26742029|FG001|Overall Study|Protocol Violation|3|||
13379363|NCT00765882|26742030|FG002|Overall Study|Protocol Violation|1|||
13379364|NCT00765882|26742028|FG000|Overall Study|Withdrawal by Subject|2|||
13379365|NCT00765882|26742029|FG001|Overall Study|Withdrawal by Subject|6|||
13379366|NCT00765882|26742030|FG002|Overall Study|Withdrawal by Subject|6|||
13379367|NCT00765882|26742028|FG000|Overall Study|Lost to Follow-up|1|||
13379368|NCT00765882|26742029|FG001|Overall Study|Lost to Follow-up|9|||
13379369|NCT00765882|26742030|FG002|Overall Study|Lost to Follow-up|6|||
13379370|NCT00765882|26742028|FG000|Overall Study|Other Reason|3|||
13379371|NCT00765882|26742029|FG001|Overall Study|Other Reason|1|||
13379372|NCT00765882|26742030|FG002|Overall Study|Other Reason|2|||
13379373|NCT00765843|26742048|FG000|Overall Study|Lost to Follow-up|1|||
13379374|NCT00765843|26742049|FG001|Overall Study|Lost to Follow-up|3|||
13379375|NCT00765843|26742050|FG002|Overall Study|Lost to Follow-up|2|||
13379376|NCT00765843|26742048|FG000|Overall Study|did not return to receive intervention|0|||
13379377|NCT00765843|26742049|FG001|Overall Study|did not return to receive intervention|1|||
13379378|NCT00765843|26742050|FG002|Overall Study|did not return to receive intervention|0|||
13379379|NCT00765843|26742048|FG000|Overall Study|Adverse Event|0|||
13379380|NCT00765843|26742049|FG001|Overall Study|Adverse Event|0|||
13379381|NCT00765843|26742050|FG002|Overall Study|Adverse Event|1|||
13379382|NCT00765817|26742095|FG000|Overall Study|Adverse Event|13|||
13379383|NCT00765817|26742096|FG001|Overall Study|Adverse Event|1|||
13379384|NCT00765817|26742095|FG000|Overall Study|Death|0|||
13379385|NCT00765817|26742096|FG001|Overall Study|Death|1|||
13379386|NCT00765817|26742095|FG000|Overall Study|Entry criteria not met|2|||
13379387|NCT00765817|26742096|FG001|Overall Study|Entry criteria not met|2|||
13379388|NCT00765817|26742095|FG000|Overall Study|Loss of glucose control|0|||
13379389|NCT00765817|26742096|FG001|Overall Study|Loss of glucose control|2|||
13379390|NCT00765817|26742095|FG000|Overall Study|Lost to Follow-up|1|||
13379391|NCT00765817|26742096|FG001|Overall Study|Lost to Follow-up|3|||
13379392|NCT00765817|26742095|FG000|Overall Study|Physician Decision|2|||
13379393|NCT00765817|26742096|FG001|Overall Study|Physician Decision|1|||
13379394|NCT00765817|26742095|FG000|Overall Study|Protocol Violation|1|||
13379395|NCT00765817|26742096|FG001|Overall Study|Protocol Violation|1|||
13379396|NCT00765817|26742095|FG000|Overall Study|Subject decision|7|||
13379397|NCT00765817|26742096|FG001|Overall Study|Subject decision|11|||
13379398|NCT00765726|26742102|FG000|Overall Study|Withdrawal by Subject|1|||
13379399|NCT00765726|26742102|FG000|Overall Study|Discontinuation of study by sponsor|8|||
13379400|NCT00765674|26742137|FG000|Overall Study|Adverse Event|7|||
13379401|NCT00765674|26742138|FG001|Overall Study|Adverse Event|2|||
13379402|NCT00765674|26742139|FG002|Overall Study|Adverse Event|8|||
13379403|NCT00765674|26742140|FG003|Overall Study|Adverse Event|11|||
13379404|NCT00765674|26742137|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
13379405|NCT00765674|26742138|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
13379406|NCT00765674|26742139|FG002|Overall Study|Abnormal Laboratory Value(s)|1|||
13379407|NCT00765674|26742140|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
13379408|NCT00765674|26742137|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
13379409|NCT00765674|26742138|FG001|Overall Study|Abnormal Test Procedure Result(s)|3|||
13379410|NCT00765674|26742139|FG002|Overall Study|Abnormal Test Procedure Result(s)|1|||
13379411|NCT00765674|26742140|FG003|Overall Study|Abnormal Test Procedure Result(s)|2|||
13379412|NCT00765674|26742137|FG000|Overall Study|Lack of Efficacy|2|||
13379413|NCT00765674|26742138|FG001|Overall Study|Lack of Efficacy|3|||
13379414|NCT00765674|26742139|FG002|Overall Study|Lack of Efficacy|1|||
13379415|NCT00765674|26742140|FG003|Overall Study|Lack of Efficacy|2|||
13379416|NCT00765674|26742137|FG000|Overall Study|Protocol Violation|2|||
13379417|NCT00765674|26742138|FG001|Overall Study|Protocol Violation|0|||
13379418|NCT00765674|26742139|FG002|Overall Study|Protocol Violation|1|||
13379419|NCT00765674|26742140|FG003|Overall Study|Protocol Violation|0|||
13379420|NCT00765674|26742137|FG000|Overall Study|Withdrawal by Subject|5|||
13379421|NCT00765674|26742138|FG001|Overall Study|Withdrawal by Subject|7|||
13135110|NCT02745145|25993630|FG001|Overall Study|Death|1|||
13379422|NCT00765674|26742139|FG002|Overall Study|Withdrawal by Subject|3|||
13379423|NCT00765674|26742140|FG003|Overall Study|Withdrawal by Subject|8|||
13379424|NCT00765674|26742137|FG000|Overall Study|Lost to Follow-up|4|||
13379425|NCT00765674|26742138|FG001|Overall Study|Lost to Follow-up|6|||
13379426|NCT00765674|26742139|FG002|Overall Study|Lost to Follow-up|2|||
13379427|NCT00765674|26742140|FG003|Overall Study|Lost to Follow-up|1|||
13379428|NCT00765674|26742137|FG000|Overall Study|Randomized in Error - No Study Drug|0|||
13379429|NCT00765674|26742138|FG001|Overall Study|Randomized in Error - No Study Drug|1|||
13379430|NCT00765674|26742139|FG002|Overall Study|Randomized in Error - No Study Drug|0|||
13379431|NCT00765674|26742140|FG003|Overall Study|Randomized in Error - No Study Drug|1|||
13379432|NCT00765388|26742171|FG000|Period 1|Lack of Efficacy|1|||
13379433|NCT00765388|26742172|FG001|Period 1|Lack of Efficacy|2|||
13379434|NCT00765388|26742171|FG000|Period 1|Lost to Follow-up|0|||
13379435|NCT00765388|26742172|FG001|Period 1|Lost to Follow-up|1|||
13379436|NCT00765388|26742171|FG000|Period 1|Herpes Zoster|0|||
13379437|NCT00765388|26742172|FG001|Period 1|Herpes Zoster|1|||
13379438|NCT00765388|26742171|FG000|Period 1|Hip operation|0|||
13379439|NCT00765388|26742172|FG001|Period 1|Hip operation|1|||
13379440|NCT00765362|26742180|FG000|Overall Study|Death|9|||
13379441|NCT00765362|26742180|FG000|Overall Study|Adverse Event|2|||
13379442|NCT00765362|26742180|FG000|Overall Study|Protocol Violation|18|||
13379443|NCT00765362|26742180|FG000|Overall Study|Withdrawal by Subject|13|||
13379444|NCT00765362|26742180|FG000|Overall Study|Lost to Follow-up|95|||
13379445|NCT00765336|26742193|FG000|Overall Study|Protocol Violation|4|||
13379446|NCT00765336|26742194|FG001|Overall Study|Protocol Violation|2|||
13379447|NCT00765336|26742193|FG000|Overall Study|Withdrawal by Subject|6|||
13379448|NCT00765336|26742194|FG001|Overall Study|Withdrawal by Subject|4|||
13379449|NCT00765336|26742193|FG000|Overall Study|Lost to Follow-up|7|||
13379450|NCT00765336|26742194|FG001|Overall Study|Lost to Follow-up|9|||
13379451|NCT00765336|26742193|FG000|Overall Study|Adverse Event|2|||
13379452|NCT00765336|26742194|FG001|Overall Study|Adverse Event|1|||
13379453|NCT00765245|26742211|FG000|Overall Study|disease progression|3|||
13379454|NCT00765245|26742212|FG001|Overall Study|disease progression|2|||
13379455|NCT00765245|26742211|FG000|Overall Study|Withdrawal by Subject|3|||
13379456|NCT00765245|26742212|FG001|Overall Study|Withdrawal by Subject|0|||
13379457|NCT00765245|26742211|FG000|Overall Study|Adverse Event|5|||
13379458|NCT00765245|26742212|FG001|Overall Study|Adverse Event|0|||
13379459|NCT00765245|26742211|FG000|Overall Study|Physician Decision|1|||
13379460|NCT00765245|26742212|FG001|Overall Study|Physician Decision|0|||
13379461|NCT00765245|26742211|FG000|Overall Study|Death|1|||
13379462|NCT00765245|26742212|FG001|Overall Study|Death|0|||
13379463|NCT00765102|26742236|FG000|Overall Study|Progressive disease|18|||
13379464|NCT00765102|26742236|FG000|Overall Study|Adverse Event|6|||
13379465|NCT00765102|26742236|FG000|Overall Study|Physician Decision|4|||
13379466|NCT00765102|26742236|FG000|Overall Study|Withdrawal by Subject|2|||
13379467|NCT00765102|26742236|FG000|Overall Study|Protocol Violation|1|||
13379468|NCT00765076|26742299|FG000|Overall Study|Adverse Event|1|||
13379469|NCT00765076|26742300|FG001|Overall Study|Adverse Event|0|||
13379470|NCT00765076|26742301|FG002|Overall Study|Adverse Event|0|||
13379471|NCT00765076|26742299|FG000|Overall Study|Withdrawal by Subject|0|||
13379472|NCT00765076|26742300|FG001|Overall Study|Withdrawal by Subject|0|||
13379473|NCT00765076|26742301|FG002|Overall Study|Withdrawal by Subject|1|||
13379474|NCT00765063|26742319|FG000|Overall Study|Lack of Efficacy|5|||
13379475|NCT00765063|26742319|FG000|Overall Study|Withdrawal by Subject|1|||
13379476|NCT00765063|26742319|FG000|Overall Study|Other|16|||
13379477|NCT00765063|26742319|FG000|Overall Study|Protocol Violation|6|||
13379478|NCT00765063|26742319|FG000|Overall Study|Adverse Event|4|||
13379479|NCT00765037|26742325|FG000|Overall Study|Lost to Follow-up|5|||
13379480|NCT00765037|26742325|FG000|Overall Study|Adverse Event|1|||
13379481|NCT00764946|26742361|FG000|Overall Study|Lack of Efficacy|1|||
13379482|NCT00764946|26742362|FG001|Overall Study|Lack of Efficacy|0|||
13379483|NCT00764946|26742363|FG002|Overall Study|Lack of Efficacy|0|||
13379484|NCT00764946|26742361|FG000|Overall Study|Lost to Follow-up|3|||
13379485|NCT00764946|26742362|FG001|Overall Study|Lost to Follow-up|4|||
13379486|NCT00764946|26742363|FG002|Overall Study|Lost to Follow-up|0|||
13379487|NCT00764946|26742361|FG000|Overall Study|Physician Decision|2|||
13379488|NCT00764946|26742362|FG001|Overall Study|Physician Decision|4|||
13379489|NCT00764946|26742363|FG002|Overall Study|Physician Decision|0|||
13379490|NCT00764946|26742361|FG000|Overall Study|Adverse Event|3|||
13379491|NCT00764946|26742362|FG001|Overall Study|Adverse Event|2|||
13379492|NCT00764946|26742363|FG002|Overall Study|Adverse Event|1|||
13379493|NCT00764946|26742361|FG000|Overall Study|Withdrawal by Subject|3|||
13379494|NCT00764946|26742362|FG001|Overall Study|Withdrawal by Subject|6|||
13379495|NCT00764946|26742363|FG002|Overall Study|Withdrawal by Subject|2|||
13379496|NCT00764946|26742361|FG000|Overall Study|Never Treated|1|||
13379497|NCT00764946|26742362|FG001|Overall Study|Never Treated|1|||
13379498|NCT00764946|26742363|FG002|Overall Study|Never Treated|1|||
13379499|NCT00764881|26742594|FG000|Overall Study|Adverse Event|5|||
13379500|NCT00764881|26742595|FG001|Overall Study|Adverse Event|1|||
13379501|NCT00764881|26742594|FG000|Overall Study|Withdrawal by Subject|1|||
13379502|NCT00764881|26742595|FG001|Overall Study|Withdrawal by Subject|3|||
13379503|NCT00764881|26742594|FG000|Overall Study|Protocol Violation|2|||
13379504|NCT00764881|26742595|FG001|Overall Study|Protocol Violation|2|||
13379505|NCT00764881|26742594|FG000|Overall Study|Lost to Follow-up|2|||
13379506|NCT00764881|26742595|FG001|Overall Study|Lost to Follow-up|0|||
13379507|NCT00764881|26742594|FG000|Overall Study|Noncompliant|1|||
13379508|NCT00764881|26742595|FG001|Overall Study|Noncompliant|0|||
13379509|NCT00764881|26742594|FG000|Overall Study|Accidentally discontinued study drug|1|||
13379510|NCT00764881|26742595|FG001|Overall Study|Accidentally discontinued study drug|0|||
13379511|NCT00764881|26742594|FG000|Overall Study|Wished to become pregnant|1|||
13379512|NCT00764881|26742595|FG001|Overall Study|Wished to become pregnant|0|||
13379513|NCT00764881|26742594|FG000|Overall Study|Carcinoma detected|1|||
13379514|NCT00764881|26742595|FG001|Overall Study|Carcinoma detected|0|||
13379515|NCT00764881|26742594|FG000|Overall Study|Possibly noncompliant (study drug)|0|||
13379516|NCT00764881|26742595|FG001|Overall Study|Possibly noncompliant (study drug)|2|||
13379517|NCT00764881|26742594|FG000|Overall Study|no treatment or no observation|2|||
13379518|NCT00764881|26742595|FG001|Overall Study|no treatment or no observation|2|||
13379519|NCT00764868|26742603|FG000|Overall Study|Adverse Event|18|||
13379520|NCT00764868|26742603|FG000|Overall Study|Withdrawal by Subject|31|||
13394134|NCT00659984|26785905|FG000|Overall Study|Adverse Event|1|||
13394135|NCT00659880|26785912|FG000|Overall Study|Lost to Follow-up|5|||
13394136|NCT00659815|26785929|FG000|Overall Study|Study related symptoms and complaints|2|||
13394137|NCT00659815|26785930|FG001|Overall Study|Study related symptoms and complaints|1|||
13394138|NCT00659815|26785929|FG000|Overall Study|Inability to maintain wearing schedule|1|||
13394139|NCT00659815|26785930|FG001|Overall Study|Inability to maintain wearing schedule|2|||
13394140|NCT00659815|26785929|FG000|Overall Study|Withdrawal by Subject|1|||
13394141|NCT00659815|26785930|FG001|Overall Study|Withdrawal by Subject|1|||
13394142|NCT00659607|26785950|FG000|Overall Study|No blood pressure recorded|147|||
13394143|NCT00659607|26785950|FG000|Overall Study|Unknown measuring date of blood pressure|85|||
13394144|NCT00659607|26785950|FG000|Overall Study|'Unable to evaluate' for the final asses|67|||
13394145|NCT00659607|26785950|FG000|Overall Study|No recorded efficacy data|15|||
13394146|NCT00659607|26785950|FG000|Overall Study|Inconsistent BP measuring date|2|||
13394147|NCT00659581|26785964|FG000|Overall Study|Adverse Event|1006|||
13394148|NCT00659581|26785964|FG000|Overall Study|Lack of Efficacy|1183|||
13394149|NCT00659581|26785964|FG000|Overall Study|Other|6393|||
13394150|NCT00659529|26785970|FG000|Overall Study|Withdrawal by Subject|4|||
13394151|NCT00659529|26785970|FG000|Overall Study|Protocol Violation|3|||
13394152|NCT00659529|26785970|FG000|Overall Study|Screen failure|9|||
13394153|NCT00659490|26786051|FG000|Overall Study|Lost to Follow-up|2|||
13394154|NCT00659490|26786052|FG001|Overall Study|Lost to Follow-up|0|||
13394155|NCT00659490|26786053|FG002|Overall Study|Lost to Follow-up|1|||
13394156|NCT00659438|26786082|FG000|Overall Study|Withdrawal by Subject|2|||
13394157|NCT00659438|26786083|FG001|Overall Study|Withdrawal by Subject|2|||
13394158|NCT00659438|26786082|FG000|Overall Study|Death|11|||
13394159|NCT00659438|26786083|FG001|Overall Study|Death|6|||
13394160|NCT00659438|26786082|FG000|Overall Study|Lost to Follow-up|1|||
13394161|NCT00659438|26786083|FG001|Overall Study|Lost to Follow-up|0|||
13394162|NCT00659425|26786343|FG000|Overall Study|Disease progression|1|||
13394163|NCT00659425|26786344|FG001|Overall Study|Disease progression|0|||
13394164|NCT00659425|26786345|FG002|Overall Study|Disease progression|0|||
13394165|NCT00659425|26786346|FG003|Overall Study|Disease progression|1|||
13394166|NCT00659425|26786347|FG004|Overall Study|Disease progression|0|||
13394167|NCT00659425|26786348|FG005|Overall Study|Disease progression|2|||
13394168|NCT00659425|26786349|FG006|Overall Study|Disease progression|4|||
13394169|NCT00659425|26786350|FG007|Overall Study|Disease progression|3|||
13394170|NCT00659425|26786351|FG008|Overall Study|Disease progression|5|||
13394171|NCT00659425|26786352|FG009|Overall Study|Disease progression|3|||
13394172|NCT00659425|26786343|FG000|Overall Study|Death|0|||
13394173|NCT00659425|26786344|FG001|Overall Study|Death|0|||
13394174|NCT00659425|26786345|FG002|Overall Study|Death|0|||
13394175|NCT00659425|26786346|FG003|Overall Study|Death|1|||
13394176|NCT00659425|26786347|FG004|Overall Study|Death|0|||
13394177|NCT00659425|26786348|FG005|Overall Study|Death|0|||
13394178|NCT00659425|26786349|FG006|Overall Study|Death|1|||
13394179|NCT00659425|26786350|FG007|Overall Study|Death|0|||
13394180|NCT00659425|26786351|FG008|Overall Study|Death|0|||
13394181|NCT00659425|26786352|FG009|Overall Study|Death|0|||
13394182|NCT00659425|26786343|FG000|Overall Study|Adverse Event|0|||
13394183|NCT00659425|26786344|FG001|Overall Study|Adverse Event|0|||
13394184|NCT00659425|26786345|FG002|Overall Study|Adverse Event|0|||
13394185|NCT00659425|26786346|FG003|Overall Study|Adverse Event|0|||
13394186|NCT00659425|26786347|FG004|Overall Study|Adverse Event|0|||
13394187|NCT00659425|26786348|FG005|Overall Study|Adverse Event|1|||
13394188|NCT00659425|26786349|FG006|Overall Study|Adverse Event|0|||
13394189|NCT00659425|26786350|FG007|Overall Study|Adverse Event|3|||
13394190|NCT00659425|26786351|FG008|Overall Study|Adverse Event|1|||
13394191|NCT00659425|26786352|FG009|Overall Study|Adverse Event|4|||
13394192|NCT00659425|26786343|FG000|Overall Study|Investigator Discretion|0|||
13379521|NCT00764868|26742603|FG000|Overall Study|Non-compliance|16|||
13379522|NCT00764868|26742603|FG000|Overall Study|Lost to Follow-up|25|||
13379523|NCT00764868|26742603|FG000|Overall Study|Lack of Efficacy|5|||
13394193|NCT00659425|26786344|FG001|Overall Study|Investigator Discretion|0|||
13394194|NCT00659425|26786345|FG002|Overall Study|Investigator Discretion|0|||
13394195|NCT00659425|26786346|FG003|Overall Study|Investigator Discretion|0|||
13394196|NCT00659425|26786347|FG004|Overall Study|Investigator Discretion|0|||
13394197|NCT00659425|26786348|FG005|Overall Study|Investigator Discretion|1|||
13394198|NCT00659425|26786349|FG006|Overall Study|Investigator Discretion|0|||
13394199|NCT00659425|26786350|FG007|Overall Study|Investigator Discretion|3|||
13394200|NCT00659425|26786351|FG008|Overall Study|Investigator Discretion|0|||
13394201|NCT00659425|26786352|FG009|Overall Study|Investigator Discretion|0|||
13394202|NCT00659425|26786343|FG000|Overall Study|Other|0|||
13394203|NCT00659425|26786344|FG001|Overall Study|Other|1|||
13394204|NCT00659425|26786345|FG002|Overall Study|Other|1|||
13394205|NCT00659425|26786346|FG003|Overall Study|Other|2|||
13394206|NCT00659425|26786347|FG004|Overall Study|Other|4|||
13394207|NCT00659425|26786348|FG005|Overall Study|Other|0|||
13394208|NCT00659425|26786349|FG006|Overall Study|Other|3|||
13394209|NCT00659425|26786350|FG007|Overall Study|Other|2|||
13394210|NCT00659425|26786351|FG008|Overall Study|Other|0|||
13394211|NCT00659425|26786352|FG009|Overall Study|Other|6|||
13394212|NCT00659373|26786365|FG000|Overall Study|Withdrawal by Subject|3|||
13394213|NCT00659373|26786366|FG001|Overall Study|Withdrawal by Subject|5|||
13394214|NCT00659373|26786365|FG000|Overall Study|Assessment Missed|2|||
13394215|NCT00659373|26786366|FG001|Overall Study|Assessment Missed|2|||
13394216|NCT00659269|26786401|FG000|Overall Study|Physician Decision|1|||
13394217|NCT00659269|26786402|FG001|Overall Study|Physician Decision|1|||
13394218|NCT00659230|26786421|FG000|Overall Study|Lost to Follow-up|2|||
13394219|NCT00659230|26786422|FG001|Overall Study|Lost to Follow-up|5|||
13394220|NCT00659230|26786421|FG000|Overall Study|Lost source documentation|5|||
13394221|NCT00659230|26786422|FG001|Overall Study|Lost source documentation|4|||
13394222|NCT00659230|26786421|FG000|Overall Study|Did not return post-randomization|2|||
13394223|NCT00659230|26786422|FG001|Overall Study|Did not return post-randomization|3|||
13394224|NCT00658996|26786435|FG000|First Intervention|Positive slit lamp finding|1|||
13394225|NCT00658996|26786436|FG001|First Intervention|Positive slit lamp finding|0|||
13394226|NCT00658996|26786435|FG000|First Intervention|Lack of lenses|0|||
13394227|NCT00658996|26786436|FG001|First Intervention|Lack of lenses|1|||
13394228|NCT00658996|26786435|FG000|Crossover Period|Physician Decision|1|||
13394229|NCT00658996|26786436|FG001|Crossover Period|Physician Decision|0|||
13394230|NCT00658996|26786435|FG000|Crossover Period|Ineligible|1|||
13394231|NCT00658996|26786436|FG001|Crossover Period|Ineligible|1|||
13394232|NCT00658996|26786435|FG000|Second Intervention|Developed a stye on upper lid|1|||
13394233|NCT00658996|26786436|FG001|Second Intervention|Developed a stye on upper lid|0|||
13379524|NCT00764868|26742603|FG000|Overall Study|Subject moved|7|||
13379525|NCT00764868|26742603|FG000|Overall Study|Pregnancy|3|||
13379526|NCT00764868|26742603|FG000|Overall Study|Prohibited medication|1|||
13379527|NCT00764868|26742603|FG000|Overall Study|Out of town|1|||
13379528|NCT00764868|26742603|FG000|Overall Study|Misuse and compliance of study drug|1|||
13379529|NCT00764868|26742603|FG000|Overall Study|Subject sent to boarding school|1|||
13379530|NCT00764868|26742603|FG000|Overall Study|Met an exclusion criteria|1|||
13379531|NCT00764868|26742603|FG000|Overall Study|Positive drug screen|2|||
13379532|NCT00764868|26742603|FG000|Overall Study|Sponsor requested withdrawal|1|||
13379533|NCT00764790|26742645|FG000|Overall Study|Protocol Violation|0|||
13379534|NCT00764790|26742646|FG001|Overall Study|Protocol Violation|0|||
13379535|NCT00764790|26742647|FG002|Overall Study|Protocol Violation|1|||
13379536|NCT00764790|26742645|FG000|Overall Study|Withdrawal by Subject|10|||
13379537|NCT00764790|26742646|FG001|Overall Study|Withdrawal by Subject|12|||
13379538|NCT00764790|26742647|FG002|Overall Study|Withdrawal by Subject|6|||
13379539|NCT00764790|26742645|FG000|Overall Study|Lost to Follow-up|28|||
13379540|NCT00764790|26742646|FG001|Overall Study|Lost to Follow-up|29|||
13379541|NCT00764790|26742647|FG002|Overall Study|Lost to Follow-up|23|||
13379542|NCT00764751|26742688|FG000|Overall Study|Adverse Event|1|||
13379543|NCT00764751|26742689|FG001|Overall Study|Adverse Event|1|||
13379544|NCT00764751|26742688|FG000|Overall Study|Psoriasis flare up on the scalp|1|||
13379545|NCT00764751|26742689|FG001|Overall Study|Psoriasis flare up on the scalp|0|||
13379546|NCT00764699|26742695|FG000|Overall Study|PI left and study terminated|3|||
13379547|NCT00764673|26742705|FG000|Overall Study|Death|1|||
13379548|NCT00764673|26742705|FG000|Overall Study|Lost to Follow-up|3|||
13379549|NCT00764673|26742705|FG000|Overall Study|Withdrawal by Subject|6|||
13379550|NCT00764673|26742705|FG000|Overall Study|Revision of Device|2|||
13379551|NCT00764660|26742744|FG000|Overall Study|Adverse Event|6|||
13379552|NCT00764660|26742745|FG001|Overall Study|Adverse Event|3|||
13379553|NCT00764660|26742744|FG000|Overall Study|Lost to Follow-up|3|||
13379554|NCT00764660|26742745|FG001|Overall Study|Lost to Follow-up|4|||
13379555|NCT00764660|26742744|FG000|Overall Study|Withdrawal by Subject|7|||
13379556|NCT00764660|26742745|FG001|Overall Study|Withdrawal by Subject|3|||
13379557|NCT00764660|26742744|FG000|Overall Study|Noncompliance With Protocol|5|||
13379558|NCT00764660|26742745|FG001|Overall Study|Noncompliance With Protocol|1|||
13379559|NCT00764660|26742744|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
13379560|NCT00764660|26742745|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
13379561|NCT00764517|26742770|FG000|Overall Study|Adverse Event|9|||
13379562|NCT00764517|26742771|FG001|Overall Study|Adverse Event|3|||
13379563|NCT00764517|26742770|FG000|Overall Study|Death|3|||
13379564|NCT00764517|26742771|FG001|Overall Study|Death|11|||
13379565|NCT00764517|26742770|FG000|Overall Study|Physician Decision|3|||
13379566|NCT00764517|26742771|FG001|Overall Study|Physician Decision|0|||
13379567|NCT00764504|26742807|FG000|Overall Study|Death|12|||
13379568|NCT00764504|26742808|FG001|Overall Study|Death|6|||
13379569|NCT00764504|26742809|FG002|Overall Study|Death|13|||
13379570|NCT00764504|26742807|FG000|Overall Study|Revision of Device|12|||
13379571|NCT00764504|26742808|FG001|Overall Study|Revision of Device|23|||
13379572|NCT00764504|26742809|FG002|Overall Study|Revision of Device|14|||
13379573|NCT00764504|26742807|FG000|Overall Study|Physician Decision|1|||
13379574|NCT00764504|26742808|FG001|Overall Study|Physician Decision|0|||
13379575|NCT00764504|26742809|FG002|Overall Study|Physician Decision|0|||
13379576|NCT00764504|26742807|FG000|Overall Study|Withdrawal by Subject|1|||
13379577|NCT00764504|26742808|FG001|Overall Study|Withdrawal by Subject|7|||
13379578|NCT00764504|26742809|FG002|Overall Study|Withdrawal by Subject|4|||
13379579|NCT00764504|26742807|FG000|Overall Study|Lost to Follow-up|40|||
13379580|NCT00764504|26742808|FG001|Overall Study|Lost to Follow-up|34|||
13379581|NCT00764504|26742809|FG002|Overall Study|Lost to Follow-up|72|||
13394234|NCT00658996|26786435|FG000|Second Intervention|Positive slit lamp finding|0|||
13394235|NCT00658996|26786436|FG001|Second Intervention|Positive slit lamp finding|1|||
13394236|NCT00658879|26786453|FG000|Overall Study|Protocol Violation|1|||
13394259|NCT00658788|26786530|FG000|Overall Study|Adverse Event|11|||
13394260|NCT00658788|26786530|FG000|Overall Study|Withdrawal by Subject|13|||
13394261|NCT00658788|26786530|FG000|Overall Study|Lost to Follow-up|18|||
13394262|NCT00658788|26786530|FG000|Overall Study|Treatment Discontinuation|32|||
13394263|NCT00658775|26786547|FG000|Overall Study|Adverse Event|4|||
13394264|NCT00658775|26786548|FG001|Overall Study|Adverse Event|6|||
13394265|NCT00658775|26786547|FG000|Overall Study|Lost to Follow-up|17|||
13394266|NCT00658775|26786548|FG001|Overall Study|Lost to Follow-up|18|||
13394267|NCT00658775|26786547|FG000|Overall Study|Withdrawal by Subject|6|||
13394268|NCT00658775|26786548|FG001|Overall Study|Withdrawal by Subject|4|||
13394269|NCT00658775|26786547|FG000|Overall Study|Withdrawal of consent|8|||
13394270|NCT00658775|26786548|FG001|Overall Study|Withdrawal of consent|7|||
13394271|NCT00658775|26786547|FG000|Overall Study|Other|7|||
13394272|NCT00658775|26786548|FG001|Overall Study|Other|8|||
13394273|NCT00658723|26786583|FG000|Overall Study|Lost to Follow-up|0|||
13394274|NCT00658723|26786584|FG001|Overall Study|Lost to Follow-up|2|||
13394275|NCT00658723|26786585|FG002|Overall Study|Lost to Follow-up|2|||
13394276|NCT00658723|26786583|FG000|Overall Study|Death|2|||
13394277|NCT00658723|26786584|FG001|Overall Study|Death|1|||
13394278|NCT00658723|26786585|FG002|Overall Study|Death|4|||
13394279|NCT00658723|26786583|FG000|Overall Study|Scheduling Issue|1|||
13394280|NCT00658723|26786584|FG001|Overall Study|Scheduling Issue|1|||
13394281|NCT00658723|26786585|FG002|Overall Study|Scheduling Issue|0|||
13394282|NCT00658723|26786583|FG000|Overall Study|Withdrawal by Subject|1|||
13394283|NCT00658723|26786584|FG001|Overall Study|Withdrawal by Subject|0|||
13394284|NCT00658723|26786585|FG002|Overall Study|Withdrawal by Subject|1|||
13475825|NCT03137173|27001105|FG000|Overall Study|Withdrawal by Subject|8|||
13475826|NCT03137173|27001106|FG001|Overall Study|Withdrawal by Subject|13|||
13379582|NCT00764491|26742834|FG000|Overall Study|Lost to Follow-up|35|||
13379583|NCT00764491|26742835|FG001|Overall Study|Lost to Follow-up|17|||
13379584|NCT00764478|26742919|FG000|Overall Study|Adverse Event|1|||
13379585|NCT00764478|26742920|FG001|Overall Study|Adverse Event|1|||
13379586|NCT00764478|26742921|FG002|Overall Study|Adverse Event|1|||
13379587|NCT00764478|26742919|FG000|Overall Study|Withdrawal by Subject|7|||
13379588|NCT00764478|26742920|FG001|Overall Study|Withdrawal by Subject|12|||
13379589|NCT00764478|26742921|FG002|Overall Study|Withdrawal by Subject|1|||
13379590|NCT00764478|26742919|FG000|Overall Study|Lost to Follow-up|7|||
13379591|NCT00764478|26742920|FG001|Overall Study|Lost to Follow-up|8|||
13379592|NCT00764478|26742921|FG002|Overall Study|Lost to Follow-up|5|||
13379593|NCT00764478|26742919|FG000|Overall Study|Protocol Violation|0|||
13379594|NCT00764478|26742920|FG001|Overall Study|Protocol Violation|1|||
13379595|NCT00764478|26742921|FG002|Overall Study|Protocol Violation|1|||
13379596|NCT00764465|26742966|FG000|Overall Study|Adverse Event|2|||
13379597|NCT00764465|26742967|FG001|Overall Study|Adverse Event|0|||
13379598|NCT00764465|26742968|FG002|Overall Study|Adverse Event|0|||
13379599|NCT00764465|26742969|FG003|Overall Study|Adverse Event|1|||
13379600|NCT00764465|26742970|FG004|Overall Study|Adverse Event|1|||
13379601|NCT00764465|26742971|FG005|Overall Study|Adverse Event|1|||
13379602|NCT00764465|26742966|FG000|Overall Study|Withdrawal by Subject|0|||
13379603|NCT00764465|26742967|FG001|Overall Study|Withdrawal by Subject|1|||
13379604|NCT00764465|26742968|FG002|Overall Study|Withdrawal by Subject|1|||
13379605|NCT00764465|26742969|FG003|Overall Study|Withdrawal by Subject|0|||
13379606|NCT00764465|26742970|FG004|Overall Study|Withdrawal by Subject|0|||
13379607|NCT00764465|26742971|FG005|Overall Study|Withdrawal by Subject|0|||
13379608|NCT00764361|26742984|FG000|Overall Study|Withdrawal by Subject|2|||
13379609|NCT00764361|26742985|FG001|Overall Study|Withdrawal by Subject|3|||
13379610|NCT00764361|26742984|FG000|Overall Study|Adverse Event|0|||
13379611|NCT00764361|26742985|FG001|Overall Study|Adverse Event|1|||
13379612|NCT00764322|26743008|FG000|Overall Study|Withdrawal by Subject|11|||
13379613|NCT00764322|26743008|FG000|Overall Study|No CYP2D6 genotyping|9|||
13379614|NCT00763971|26743047|FG000|Overall Study|Adverse Event|5|||
13379615|NCT00763971|26743048|FG001|Overall Study|Adverse Event|2|||
13379616|NCT00763971|26743049|FG002|Overall Study|Adverse Event|4|||
13379617|NCT00763971|26743047|FG000|Overall Study|Protocol Violation|3|||
13379618|NCT00763971|26743048|FG001|Overall Study|Protocol Violation|3|||
13379619|NCT00763971|26743049|FG002|Overall Study|Protocol Violation|2|||
13379620|NCT00763971|26743047|FG000|Overall Study|Withdrawal by Subject|4|||
13379621|NCT00763971|26743048|FG001|Overall Study|Withdrawal by Subject|5|||
13379622|NCT00763971|26743049|FG002|Overall Study|Withdrawal by Subject|5|||
13379623|NCT00763971|26743047|FG000|Overall Study|Lost to Follow-up|0|||
13379624|NCT00763971|26743048|FG001|Overall Study|Lost to Follow-up|1|||
13379625|NCT00763971|26743049|FG002|Overall Study|Lost to Follow-up|0|||
13379626|NCT00763971|26743047|FG000|Overall Study|Lack of Efficacy|11|||
13379627|NCT00763971|26743048|FG001|Overall Study|Lack of Efficacy|22|||
13379628|NCT00763971|26743049|FG002|Overall Study|Lack of Efficacy|54|||
13379629|NCT00763971|26743047|FG000|Overall Study|Unable to swallow capsule|2|||
13379630|NCT00763971|26743048|FG001|Overall Study|Unable to swallow capsule|1|||
13379631|NCT00763971|26743049|FG002|Overall Study|Unable to swallow capsule|1|||
13379632|NCT00763971|26743047|FG000|Overall Study|Personal reason|3|||
13379633|NCT00763971|26743048|FG001|Overall Study|Personal reason|0|||
13379634|NCT00763971|26743049|FG002|Overall Study|Personal reason|0|||
13379635|NCT00763971|26743047|FG000|Overall Study|Exclusion criteria met|1|||
13379636|NCT00763971|26743048|FG001|Overall Study|Exclusion criteria met|0|||
13379637|NCT00763971|26743049|FG002|Overall Study|Exclusion criteria met|0|||
13379638|NCT00763971|26743047|FG000|Overall Study|Sponsor decision|1|||
13379639|NCT00763971|26743048|FG001|Overall Study|Sponsor decision|0|||
13379640|NCT00763971|26743049|FG002|Overall Study|Sponsor decision|0|||
13379641|NCT00763971|26743047|FG000|Overall Study|Due to holiday season|2|||
13379642|NCT00763971|26743048|FG001|Overall Study|Due to holiday season|0|||
13379643|NCT00763971|26743049|FG002|Overall Study|Due to holiday season|1|||
13379644|NCT00763971|26743047|FG000|Overall Study|Randomization error|0|||
13379645|NCT00763971|26743048|FG001|Overall Study|Randomization error|0|||
13379646|NCT00763971|26743049|FG002|Overall Study|Randomization error|1|||
13379647|NCT00763971|26743047|FG000|Overall Study|Medical monitor decision|0|||
13379648|NCT00763971|26743048|FG001|Overall Study|Medical monitor decision|0|||
13379649|NCT00763971|26743049|FG002|Overall Study|Medical monitor decision|1|||
13379650|NCT00763971|26743047|FG000|Overall Study|Moved to another country|0|||
13379651|NCT00763971|26743048|FG001|Overall Study|Moved to another country|1|||
13379652|NCT00763971|26743049|FG002|Overall Study|Moved to another country|0|||
13379653|NCT00763971|26743047|FG000|Overall Study|Subject wanted dose reduction|0|||
13379654|NCT00763971|26743048|FG001|Overall Study|Subject wanted dose reduction|1|||
13379655|NCT00763971|26743049|FG002|Overall Study|Subject wanted dose reduction|0|||
13379656|NCT00763971|26743047|FG000|Overall Study|Lack of availability|0|||
13379657|NCT00763971|26743048|FG001|Overall Study|Lack of availability|1|||
13379658|NCT00763971|26743049|FG002|Overall Study|Lack of availability|0|||
13379659|NCT00763971|26743047|FG000|Overall Study|Performed final visit on phone|0|||
13379660|NCT00763971|26743048|FG001|Overall Study|Performed final visit on phone|1|||
13379661|NCT00763971|26743049|FG002|Overall Study|Performed final visit on phone|0|||
13379662|NCT00763971|26743047|FG000|Overall Study|Participation in 489-326 required|1|||
13379663|NCT00763971|26743048|FG001|Overall Study|Participation in 489-326 required|0|||
13379664|NCT00763971|26743049|FG002|Overall Study|Participation in 489-326 required|0|||
13379665|NCT00763958|26743066|FG000|Overall Study|did not meet final criteria|4|||
13379666|NCT00763958|26743067|FG001|Overall Study|did not meet final criteria|4|||
13379667|NCT00763958|26743066|FG000|Overall Study|Lost to Follow-up|10|||
13379668|NCT00763958|26743067|FG001|Overall Study|Lost to Follow-up|2|||
13379669|NCT00763958|26743066|FG000|Overall Study|Believed they were receiving placebo|0|||
13379670|NCT00763958|26743067|FG001|Overall Study|Believed they were receiving placebo|5|||
13379671|NCT00763815|26743098|FG000|Overall Study|Adverse Event|14|||
13379672|NCT00763815|26743099|FG001|Overall Study|Adverse Event|29|||
13379673|NCT00763815|26743098|FG000|Overall Study|Lack of Efficacy|10|||
13379674|NCT00763815|26743099|FG001|Overall Study|Lack of Efficacy|11|||
13379675|NCT00763815|26743098|FG000|Overall Study|Poor Compliance to Protocol|6|||
13379676|NCT00763815|26743099|FG001|Overall Study|Poor Compliance to Protocol|6|||
13379677|NCT00763815|26743098|FG000|Overall Study|Lost to Follow-up|2|||
13379678|NCT00763815|26743099|FG001|Overall Study|Lost to Follow-up|4|||
13379679|NCT00763815|26743098|FG000|Overall Study|Early Termination|1|||
13379680|NCT00763815|26743099|FG001|Overall Study|Early Termination|0|||
13379681|NCT00763815|26743098|FG000|Overall Study|Familial and Personal Reasons|9|||
13379682|NCT00763815|26743099|FG001|Overall Study|Familial and Personal Reasons|16|||
13379683|NCT00763815|26743098|FG000|Overall Study|Physician Decision|1|||
13379684|NCT00763815|26743099|FG001|Overall Study|Physician Decision|0|||
13379685|NCT00763815|26743098|FG000|Overall Study|Withdrawal by Subject|7|||
13379686|NCT00763815|26743099|FG001|Overall Study|Withdrawal by Subject|12|||
13379687|NCT00763815|26743098|FG000|Overall Study|Protocol Violation|2|||
13379688|NCT00763815|26743099|FG001|Overall Study|Protocol Violation|5|||
13379689|NCT00763815|26743098|FG000|Overall Study|Sponsor's Decision|0|||
13379690|NCT00763815|26743099|FG001|Overall Study|Sponsor's Decision|1|||
13379691|NCT00763698|26743107|FG000|Overall Study|Unsuccessful Implant|5|||
13379692|NCT00763698|26743107|FG000|Overall Study|Death|4|||
13379693|NCT00763698|26743107|FG000|Overall Study|Withdrawal by Subject|1|||
13379694|NCT00763555|26743150|FG000|Overall Study|Adverse Event|2|||
13379695|NCT00763555|26743151|FG001|Overall Study|Adverse Event|1|||
13379696|NCT00763555|26743150|FG000|Overall Study|Withdrawal by Subject|2|||
13379697|NCT00763555|26743151|FG001|Overall Study|Withdrawal by Subject|6|||
13379698|NCT00763555|26743150|FG000|Overall Study|Lost to Follow-up|0|||
13379699|NCT00763555|26743151|FG001|Overall Study|Lost to Follow-up|3|||
13379700|NCT00763451|26743196|FG000|Overall Study|Adverse Event|4|||
13379701|NCT00763451|26743197|FG001|Overall Study|Adverse Event|6|||
13379702|NCT00763451|26743198|FG002|Overall Study|Adverse Event|19|||
13379703|NCT00763451|26743199|FG003|Overall Study|Adverse Event|14|||
13379704|NCT00763451|26743196|FG000|Overall Study|Lack of Efficacy|1|||
13379705|NCT00763451|26743197|FG001|Overall Study|Lack of Efficacy|4|||
13379706|NCT00763451|26743198|FG002|Overall Study|Lack of Efficacy|3|||
13379707|NCT00763451|26743199|FG003|Overall Study|Lack of Efficacy|2|||
13379708|NCT00763451|26743196|FG000|Overall Study|Withdrawal by Subject|1|||
13379709|NCT00763451|26743197|FG001|Overall Study|Withdrawal by Subject|6|||
13379710|NCT00763451|26743198|FG002|Overall Study|Withdrawal by Subject|9|||
13379711|NCT00763451|26743199|FG003|Overall Study|Withdrawal by Subject|7|||
13379712|NCT00763451|26743196|FG000|Overall Study|Protocol Violation|0|||
13379713|NCT00763451|26743197|FG001|Overall Study|Protocol Violation|0|||
13379714|NCT00763451|26743198|FG002|Overall Study|Protocol Violation|1|||
13379715|NCT00763451|26743199|FG003|Overall Study|Protocol Violation|0|||
13379716|NCT00763451|26743196|FG000|Overall Study|Poor Compliance to Protocol|1|||
13379717|NCT00763451|26743197|FG001|Overall Study|Poor Compliance to Protocol|1|||
13379718|NCT00763451|26743198|FG002|Overall Study|Poor Compliance to Protocol|2|||
13379719|NCT00763451|26743199|FG003|Overall Study|Poor Compliance to Protocol|2|||
13379720|NCT00763451|26743196|FG000|Overall Study|Familial and Personal Reasons|5|||
13379721|NCT00763451|26743197|FG001|Overall Study|Familial and Personal Reasons|3|||
13379722|NCT00763451|26743198|FG002|Overall Study|Familial and Personal Reasons|5|||
13379723|NCT00763451|26743199|FG003|Overall Study|Familial and Personal Reasons|4|||
13379724|NCT00763451|26743196|FG000|Overall Study|Randomized but not Treated|1|||
13379725|NCT00763451|26743197|FG001|Overall Study|Randomized but not Treated|1|||
13379726|NCT00763451|26743198|FG002|Overall Study|Randomized but not Treated|0|||
13379727|NCT00763451|26743199|FG003|Overall Study|Randomized but not Treated|0|||
13379728|NCT00763451|26743196|FG000|Overall Study|Study Site Reason|0|||
13379729|NCT00763451|26743197|FG001|Overall Study|Study Site Reason|1|||
13379730|NCT00763451|26743198|FG002|Overall Study|Study Site Reason|1|||
13379731|NCT00763451|26743199|FG003|Overall Study|Study Site Reason|1|||
13379732|NCT00763386|26743214|FG000|Overall Study|Adverse Event|43|||
13379733|NCT00763386|26743215|FG001|Overall Study|Adverse Event|33|||
13379734|NCT00763386|26743214|FG000|Overall Study|Death|1|||
13379735|NCT00763386|26743215|FG001|Overall Study|Death|2|||
13379736|NCT00763386|26743214|FG000|Overall Study|Lost to Follow-up|3|||
13379737|NCT00763386|26743215|FG001|Overall Study|Lost to Follow-up|3|||
13379738|NCT00763386|26743214|FG000|Overall Study|Withdrawal by Subject|0|||
13379739|NCT00763386|26743215|FG001|Overall Study|Withdrawal by Subject|1|||
13379740|NCT00763386|26743214|FG000|Overall Study|CRF missing|0|||
13379741|NCT00763386|26743215|FG001|Overall Study|CRF missing|1|||
13379742|NCT00763386|26743214|FG000|Overall Study|Study Prosthesis Removed|1|||
13379743|NCT00763386|26743215|FG001|Overall Study|Study Prosthesis Removed|0|||
13379744|NCT00763321|26743234|FG000|Open-label Period|Adverse Event|24|||
13379745|NCT00763321|26743235|FG001|Open-label Period|Adverse Event|0|||
13379746|NCT00763321|26743236|FG002|Open-label Period|Adverse Event|0|||
13379747|NCT00763321|26743234|FG000|Open-label Period|Lost to Follow-up|14|||
13379748|NCT00763321|26743235|FG001|Open-label Period|Lost to Follow-up|0|||
13379749|NCT00763321|26743236|FG002|Open-label Period|Lost to Follow-up|0|||
13379750|NCT00763321|26743234|FG000|Open-label Period|Withdrawal by Subject|7|||
13379751|NCT00763321|26743235|FG001|Open-label Period|Withdrawal by Subject|0|||
13379752|NCT00763321|26743236|FG002|Open-label Period|Withdrawal by Subject|0|||
13379753|NCT00763321|26743234|FG000|Open-label Period|Subject noncompliant|7|||
13379754|NCT00763321|26743235|FG001|Open-label Period|Subject noncompliant|0|||
13379755|NCT00763321|26743236|FG002|Open-label Period|Subject noncompliant|0|||
13379756|NCT00763321|26743234|FG000|Open-label Period|Did not meet DB randomization criteria|5|||
13379757|NCT00763321|26743235|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
13379758|NCT00763321|26743236|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
13379759|NCT00763321|26743234|FG000|Open-label Period|Lack of Efficacy|2|||
13379760|NCT00763321|26743235|FG001|Open-label Period|Lack of Efficacy|0|||
13379761|NCT00763321|26743236|FG002|Open-label Period|Lack of Efficacy|0|||
13379762|NCT00763321|26743234|FG000|Open-label Period|Other|4|||
13379763|NCT00763321|26743235|FG001|Open-label Period|Other|0|||
13379764|NCT00763321|26743236|FG002|Open-label Period|Other|0|||
13379765|NCT00763321|26743234|FG000|Double-blind Period|Lack of Efficacy|0|||
13379766|NCT00763321|26743235|FG001|Double-blind Period|Lack of Efficacy|9|||
13379767|NCT00763321|26743236|FG002|Double-blind Period|Lack of Efficacy|17|||
13379768|NCT00763321|26743234|FG000|Double-blind Period|Adverse Event|0|||
13379769|NCT00763321|26743235|FG001|Double-blind Period|Adverse Event|4|||
13379770|NCT00763321|26743236|FG002|Double-blind Period|Adverse Event|4|||
13379771|NCT00763321|26743234|FG000|Double-blind Period|Lost to Follow-up|0|||
13379772|NCT00763321|26743235|FG001|Double-blind Period|Lost to Follow-up|4|||
13379773|NCT00763321|26743236|FG002|Double-blind Period|Lost to Follow-up|2|||
13379774|NCT00763321|26743234|FG000|Double-blind Period|Withdrawal by Subject|0|||
13379775|NCT00763321|26743235|FG001|Double-blind Period|Withdrawal by Subject|2|||
13379776|NCT00763321|26743236|FG002|Double-blind Period|Withdrawal by Subject|3|||
13379777|NCT00763321|26743234|FG000|Double-blind Period|Other|0|||
13379778|NCT00763321|26743235|FG001|Double-blind Period|Other|2|||
13379779|NCT00763321|26743236|FG002|Double-blind Period|Other|3|||
13379780|NCT00763282|26743257|FG000|Overall Study|Withdrawal by Subject|6|||
13379781|NCT00763282|26743258|FG001|Overall Study|Withdrawal by Subject|5|||
13379782|NCT00763282|26743257|FG000|Overall Study|Death|4|||
13379783|NCT00763282|26743258|FG001|Overall Study|Death|3|||
13379784|NCT00763282|26743257|FG000|Overall Study|Lost to Follow-up|22|||
13379785|NCT00763282|26743258|FG001|Overall Study|Lost to Follow-up|26|||
13379786|NCT00763269|26743277|FG000|Overall Study|Lost to Follow-up|12|||
13379787|NCT00763269|26743278|FG001|Overall Study|Lost to Follow-up|13|||
13379788|NCT00763256|26743299|FG000|Overall Study|Didn't return for appointments|7|||
13379789|NCT00763256|26743300|FG001|Overall Study|Didn't return for appointments|10|||
13379790|NCT00763139|26743323|FG000|Overall Study|Adverse Event|4|||
13379791|NCT00763139|26743324|FG001|Overall Study|Adverse Event|2|||
13379792|NCT00763139|26743323|FG000|Overall Study|Withdrawal by Subject|0|||
13379793|NCT00763139|26743324|FG001|Overall Study|Withdrawal by Subject|1|||
13379794|NCT00763139|26743323|FG000|Overall Study|med change not allowed by protocol|1|||
13379795|NCT00763139|26743324|FG001|Overall Study|med change not allowed by protocol|0|||
13379796|NCT00763035|26743345|FG000|First Intervention|Did not meeting inclusion/exclusion|1|||
13379797|NCT00763035|26743346|FG001|First Intervention|Did not meeting inclusion/exclusion|0|||
13379798|NCT00763035|26743345|FG000|First Intervention|Adverse Event|0|||
13379799|NCT00763035|26743346|FG001|First Intervention|Adverse Event|1|||
13379800|NCT00763035|26743345|FG000|Second Intervention|Adverse Event|1|||
13379801|NCT00763035|26743346|FG001|Second Intervention|Adverse Event|0|||
13379802|NCT00763035|26743345|FG000|Second Intervention|Physician Decision|2|||
13379803|NCT00763035|26743346|FG001|Second Intervention|Physician Decision|0|||
13379804|NCT00763009|26743353|FG000|Overall Study|Coronary Anatomy unsuitable|1|||
13379805|NCT00762996|26743368|FG000|Period One|Protocol Violation|0|||
13379806|NCT00762996|26743369|FG001|Period One|Protocol Violation|0|||
13379807|NCT00762996|26743370|FG002|Period One|Protocol Violation|1|||
13379808|NCT00762996|26743371|FG003|Period One|Protocol Violation|0|||
13379809|NCT00762996|26743368|FG000|Period One|ineligible|0|||
13379810|NCT00762996|26743369|FG001|Period One|ineligible|0|||
13379811|NCT00762996|26743370|FG002|Period One|ineligible|1|||
13379812|NCT00762996|26743371|FG003|Period One|ineligible|1|||
13379813|NCT00762996|26743368|FG000|Period One|Adverse Event|0|||
13379814|NCT00762996|26743369|FG001|Period One|Adverse Event|0|||
13379815|NCT00762996|26743370|FG002|Period One|Adverse Event|1|||
13379816|NCT00762996|26743371|FG003|Period One|Adverse Event|0|||
13379817|NCT00762996|26743368|FG000|Period One|Withdrawal by Subject|0|||
13379818|NCT00762996|26743369|FG001|Period One|Withdrawal by Subject|0|||
13379819|NCT00762996|26743370|FG002|Period One|Withdrawal by Subject|1|||
13379820|NCT00762996|26743371|FG003|Period One|Withdrawal by Subject|0|||
13379821|NCT00762970|26743392|FG000|Overall Study|Withdrawal by Subject|7|||
13379822|NCT00762970|26743393|FG001|Overall Study|Withdrawal by Subject|4|||
13379823|NCT00762970|26743394|FG002|Overall Study|Withdrawal by Subject|0|||
13379824|NCT00762970|26743392|FG000|Overall Study|Protocol Violation|3|||
13379825|NCT00762970|26743393|FG001|Overall Study|Protocol Violation|1|||
13379826|NCT00762970|26743394|FG002|Overall Study|Protocol Violation|1|||
13379827|NCT00762970|26743392|FG000|Overall Study|Lost to Follow-up|1|||
13379828|NCT00762970|26743393|FG001|Overall Study|Lost to Follow-up|2|||
13379829|NCT00762970|26743394|FG002|Overall Study|Lost to Follow-up|0|||
13379830|NCT00762970|26743392|FG000|Overall Study|Difficulty of handling lens|1|||
13379831|NCT00762970|26743393|FG001|Overall Study|Difficulty of handling lens|2|||
13379832|NCT00762970|26743394|FG002|Overall Study|Difficulty of handling lens|0|||
13379833|NCT00762892|26743415|FG000|Overall Study|Lost to Follow-up|2|||
13379834|NCT00762892|26743416|FG001|Overall Study|Lost to Follow-up|5|||
13379835|NCT00762892|26743415|FG000|Overall Study|Withdrawal by Subject|0|||
13379836|NCT00762892|26743416|FG001|Overall Study|Withdrawal by Subject|1|||
13379837|NCT00762892|26743415|FG000|Overall Study|Death|1|||
13379838|NCT00762892|26743416|FG001|Overall Study|Death|0|||
13379839|NCT00762892|26743415|FG000|Overall Study|Pregnancy|1|||
13379840|NCT00762892|26743416|FG001|Overall Study|Pregnancy|0|||
13379841|NCT00762892|26743415|FG000|Overall Study|Incarceration|1|||
13379842|NCT00762892|26743416|FG001|Overall Study|Incarceration|0|||
13379843|NCT00762788|26743455|FG000|Overall Study|Lost to Follow-up|26|||
13379844|NCT00762788|26743456|FG001|Overall Study|Lost to Follow-up|37|||
13379845|NCT00762788|26743457|FG002|Overall Study|Lost to Follow-up|21|||
13379846|NCT00762788|26743458|FG003|Overall Study|Lost to Follow-up|26|||
13379847|NCT00762788|26743459|FG004|Overall Study|Lost to Follow-up|13|||
13379848|NCT00762788|26743460|FG005|Overall Study|Lost to Follow-up|21|||
13379849|NCT00762762|26743481|FG000|Overall Study|Did not report for appointments|8|||
13379850|NCT00762762|26743482|FG001|Overall Study|Did not report for appointments|10|||
13379851|NCT00762723|26743500|FG000|Overall Study|Study Terminated slow enrollement|5|||
13379852|NCT00762723|26743501|FG001|Overall Study|Study Terminated slow enrollement|5|||
13379853|NCT00762723|26743502|FG002|Overall Study|Study Terminated slow enrollement|3|||
13379854|NCT00762606|26743517|FG000|Overall Study|Lost to Follow-up|18|||
13379855|NCT00762606|26743518|FG001|Overall Study|Lost to Follow-up|13|||
13379856|NCT00762502|26743540|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4|||
13379857|NCT00762502|26743541|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3|||
13379858|NCT00762502|26743542|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6|||
13379859|NCT00762502|26743540|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6|||
13379860|NCT00762502|26743541|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3|||
13379861|NCT00762502|26743542|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13|||
13379862|NCT00762502|26743540|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
13379863|NCT00762502|26743541|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1|||
13379864|NCT00762502|26743542|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
13379865|NCT00762476|26743559|FG000|Overall Study|Adverse Event|7|||
13379866|NCT00762476|26743560|FG001|Overall Study|Adverse Event|1|||
13379867|NCT00762476|26743559|FG000|Overall Study|Lost to Follow-up|2|||
13379868|NCT00762476|26743560|FG001|Overall Study|Lost to Follow-up|0|||
13379869|NCT00762476|26743559|FG000|Overall Study|Protocol Violation|5|||
13379870|NCT00762476|26743560|FG001|Overall Study|Protocol Violation|6|||
13379871|NCT00762476|26743559|FG000|Overall Study|Physician Decision|2|||
13379872|NCT00762476|26743560|FG001|Overall Study|Physician Decision|14|||
13379873|NCT00762476|26743559|FG000|Overall Study|Withdrawal by Subject|6|||
13379874|NCT00762476|26743560|FG001|Overall Study|Withdrawal by Subject|12|||
13379875|NCT00762476|26743559|FG000|Overall Study|antibiotic use|0|||
13379876|NCT00762476|26743560|FG001|Overall Study|antibiotic use|1|||
13379877|NCT00762476|26743559|FG000|Overall Study|non-compliance with study visits|0|||
13379878|NCT00762476|26743560|FG001|Overall Study|non-compliance with study visits|2|||
13379879|NCT00762476|26743559|FG000|Overall Study|Seasonal allergies|1|||
13379880|NCT00762476|26743560|FG001|Overall Study|Seasonal allergies|0|||
13379881|NCT00762463|26743651|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
13379882|NCT00762463|26743652|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
13379883|NCT00762463|26743653|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
13379884|NCT00762463|26743654|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
13379885|NCT00762463|26743651|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3|||
13379886|NCT00762463|26743652|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4|||
13379887|NCT00762463|26743653|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
13379888|NCT00762463|26743654|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
13379889|NCT00762463|26743651|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2|||
13379890|NCT00762463|26743652|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4|||
13379891|NCT00762463|26743653|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
13379892|NCT00762463|26743654|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
13379893|NCT00762463|26743651|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4|||
13379894|NCT00762463|26743652|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1|||
13379895|NCT00762463|26743653|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
13379896|NCT00762463|26743654|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
13379897|NCT00762463|26743651|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
13379898|NCT00762463|26743652|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
13379899|NCT00762463|26743653|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
13379900|NCT00762463|26743654|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
13379901|NCT00762463|26743651|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
13379902|NCT00762463|26743652|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
13379903|NCT00762463|26743653|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0|||
13379904|NCT00762463|26743654|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
13379905|NCT00762463|26743651|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1|||
13379906|NCT00762463|26743652|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
13379907|NCT00762463|26743653|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3|||
13379908|NCT00762463|26743654|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
13379909|NCT00762463|26743651|FG000|Extension Phase (Week 6 to Week 12)|Other|0|||
13379910|NCT00762463|26743652|FG001|Extension Phase (Week 6 to Week 12)|Other|0|||
13379911|NCT00762463|26743653|FG002|Extension Phase (Week 6 to Week 12)|Other|0|||
13379912|NCT00762463|26743654|FG003|Extension Phase (Week 6 to Week 12)|Other|1|||
13379913|NCT00762411|26743725|FG000|Initial Treatment|Death|7|||
13379914|NCT00762411|26743726|FG001|Initial Treatment|Death|6|||
13379915|NCT00762411|26743725|FG000|Initial Treatment|Adverse Event|132|||
13379916|NCT00762411|26743726|FG001|Initial Treatment|Adverse Event|40|||
13379917|NCT00762411|26743725|FG000|Initial Treatment|Protocol Violation|4|||
13379918|NCT00762411|26743726|FG001|Initial Treatment|Protocol Violation|1|||
13379919|NCT00762411|26743725|FG000|Initial Treatment|Withdrawal by Subject|65|||
13379920|NCT00762411|26743726|FG001|Initial Treatment|Withdrawal by Subject|52|||
13379921|NCT00762411|26743725|FG000|Initial Treatment|Physician Decision|1|||
13379922|NCT00762411|26743726|FG001|Initial Treatment|Physician Decision|0|||
13379923|NCT00762411|26743725|FG000|Initial Treatment|Sponsor Decision|293|||
13379924|NCT00762411|26743726|FG001|Initial Treatment|Sponsor Decision|401|||
13379925|NCT00762411|26743725|FG000|Initial Treatment|Lost to Follow-up|5|||
13379926|NCT00762411|26743726|FG001|Initial Treatment|Lost to Follow-up|0|||
13379927|NCT00762411|26743725|FG000|Initial Treatment|Caregiver Decision|21|||
13379928|NCT00762411|26743726|FG001|Initial Treatment|Caregiver Decision|16|||
13379929|NCT00762411|26743725|FG000|Initial Treatment|Abnormal Lab/ECG Result|6|||
13379930|NCT00762411|26743726|FG001|Initial Treatment|Abnormal Lab/ECG Result|4|||
13379931|NCT00762411|26743725|FG000|Initial Treatment|Entry Criteria Exclusion|0|||
13379932|NCT00762411|26743726|FG001|Initial Treatment|Entry Criteria Exclusion|1|||
13379933|NCT00762411|26743725|FG000|Delayed Start|Adverse Event|0|||
13379934|NCT00762411|26743726|FG001|Delayed Start|Adverse Event|4|||
13379935|NCT00762411|26743725|FG000|Delayed Start|Protocol Violation|0|||
13379936|NCT00762411|26743726|FG001|Delayed Start|Protocol Violation|1|||
13379937|NCT00762411|26743725|FG000|Delayed Start|Sponsor Decision|16|||
13379938|NCT00762411|26743726|FG001|Delayed Start|Sponsor Decision|20|||
13379939|NCT00762411|26743725|FG000|Delayed Start|Caregiver Decision|1|||
13379940|NCT00762411|26743726|FG001|Delayed Start|Caregiver Decision|1|||
13379941|NCT00762411|26743725|FG000|Safety Follow Up (SFU)-Optional|Death|1|||
13379942|NCT00762411|26743726|FG001|Safety Follow Up (SFU)-Optional|Death|8|||
13379943|NCT00762411|26743725|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
13379944|NCT00762411|26743726|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1|||
13379945|NCT00762411|26743725|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21|||
13379946|NCT00762411|26743726|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46|||
13379947|NCT00762411|26743725|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6|||
13379948|NCT00762411|26743726|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
13379949|NCT00762411|26743725|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
13379950|NCT00762411|26743726|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
13379951|NCT00762411|26743725|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48|||
13379952|NCT00762411|26743726|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54|||
13379953|NCT00762385|26743739|FG000|First Intervention|Lens Issue|1|||
13379954|NCT00762385|26743740|FG001|First Intervention|Lens Issue|1|||
13379955|NCT00762385|26743739|FG000|First Intervention|Lost to Follow-up|0|||
13379956|NCT00762385|26743740|FG001|First Intervention|Lost to Follow-up|2|||
13379957|NCT00762385|26743739|FG000|First Intervention|Ineligible|1|||
13379958|NCT00762385|26743740|FG001|First Intervention|Ineligible|0|||
13379959|NCT00762385|26743739|FG000|First Intervention|Protocol Violation|0|||
13379960|NCT00762385|26743740|FG001|First Intervention|Protocol Violation|1|||
13379961|NCT00762385|26743739|FG000|Second Intervention|Protocol Violation|3|||
13379962|NCT00762385|26743740|FG001|Second Intervention|Protocol Violation|3|||
13379963|NCT00762372|26743824|FG000|Overall Study|Adverse Event|1|||
13379964|NCT00762372|26743825|FG001|Overall Study|Adverse Event|0|||
13379965|NCT00762372|26743826|FG002|Overall Study|Adverse Event|0|||
13379966|NCT00762359|26743933|FG000|Overall Study|Adverse Event|20|||
13379967|NCT00762359|26743934|FG001|Overall Study|Adverse Event|23|||
13379968|NCT00762359|26743933|FG000|Overall Study|Protocol Violation|21|||
13379969|NCT00762359|26743934|FG001|Overall Study|Protocol Violation|13|||
13379970|NCT00762359|26743933|FG000|Overall Study|Withdrawal by Subject|13|||
13379971|NCT00762359|26743934|FG001|Overall Study|Withdrawal by Subject|10|||
13379972|NCT00762359|26743933|FG000|Overall Study|Lack of Efficacy|0|||
13379973|NCT00762359|26743934|FG001|Overall Study|Lack of Efficacy|4|||
13379974|NCT00762359|26743933|FG000|Overall Study|Institution closed|2|||
13379975|NCT00762359|26743934|FG001|Overall Study|Institution closed|3|||
13379976|NCT00762359|26743933|FG000|Overall Study|Physician Decision|2|||
13379977|NCT00762359|26743934|FG001|Overall Study|Physician Decision|3|||
13379978|NCT00762359|26743933|FG000|Overall Study|Removal|0|||
13379979|NCT00762359|26743934|FG001|Overall Study|Removal|1|||
13379980|NCT00762359|26743933|FG000|Overall Study|Withdrew consent|1|||
13379981|NCT00762359|26743934|FG001|Overall Study|Withdrew consent|0|||
13379982|NCT00762268|26743951|FG000|Overall Study|Withdrawal by Subject|3|||
13379983|NCT00762268|26743952|FG001|Overall Study|Withdrawal by Subject|3|||
13379984|NCT00762229|26743967|FG000|Overall Study|Lost to Follow-up|1|||
13379985|NCT00762229|26743968|FG001|Overall Study|Lost to Follow-up|1|||
13379986|NCT00762229|26743967|FG000|Overall Study|did not recveive intervention|0|||
13379987|NCT00762229|26743968|FG001|Overall Study|did not recveive intervention|1|||
13379988|NCT00762164|26743983|FG000|Overall Study|Lost to Follow-up|1|||
13379989|NCT00762164|26743984|FG001|Overall Study|Lost to Follow-up|1|||
13379990|NCT00762164|26743983|FG000|Overall Study|Discontinued medication|2|||
13379991|NCT00762164|26743984|FG001|Overall Study|Discontinued medication|0|||
13379992|NCT00762164|26743983|FG000|Overall Study|Withdrawal by Subject|0|||
13379993|NCT00762164|26743984|FG001|Overall Study|Withdrawal by Subject|1|||
13379994|NCT00762086|26743997|FG000|Overall Study|Adverse Event|2|||
13379995|NCT00762086|26743998|FG001|Overall Study|Adverse Event|0|||
13379996|NCT00762086|26743997|FG000|Overall Study|Lost to Follow-up|0|||
13379997|NCT00762086|26743998|FG001|Overall Study|Lost to Follow-up|2|||
13379998|NCT00762086|26743997|FG000|Overall Study|Non compliance|1|||
13379999|NCT00762086|26743998|FG001|Overall Study|Non compliance|0|||
13295414|NCT01379781|26493736|FG001|Overall Study|Lost to Follow-up|8|||
13295415|NCT01379768|26493769|FG000|Overall Study|Adverse Event|1|||
13295416|NCT01379768|26493770|FG001|Overall Study|Adverse Event|1|||
13380000|NCT00762086|26743997|FG000|Overall Study|Withdrawal by Subject|2|||
13380001|NCT00762086|26743998|FG001|Overall Study|Withdrawal by Subject|2|||
13380002|NCT00762086|26743997|FG000|Overall Study|Ineligible to participate in the study|1|||
13380003|NCT00762086|26743998|FG001|Overall Study|Ineligible to participate in the study|0|||
13380004|NCT00762073|26744073|FG000|Overall Study|Lack of Efficacy|1|||
13380005|NCT00762073|26744074|FG001|Overall Study|Lack of Efficacy|1|||
13380006|NCT00762073|26744075|FG002|Overall Study|Lack of Efficacy|0|||
13380007|NCT00762073|26744076|FG003|Overall Study|Lack of Efficacy|0|||
13380008|NCT00762073|26744073|FG000|Overall Study|Adverse Event|1|||
13380009|NCT00762073|26744074|FG001|Overall Study|Adverse Event|0|||
13380010|NCT00762073|26744075|FG002|Overall Study|Adverse Event|1|||
13380011|NCT00762073|26744076|FG003|Overall Study|Adverse Event|1|||
13380012|NCT00762073|26744073|FG000|Overall Study|Significant Subject Noncompliance|0|||
13380013|NCT00762073|26744074|FG001|Overall Study|Significant Subject Noncompliance|1|||
13380014|NCT00762073|26744075|FG002|Overall Study|Significant Subject Noncompliance|0|||
13380015|NCT00762073|26744076|FG003|Overall Study|Significant Subject Noncompliance|1|||
13380016|NCT00762073|26744073|FG000|Overall Study|Withdrawal by Subject|1|||
13380017|NCT00762073|26744074|FG001|Overall Study|Withdrawal by Subject|2|||
13380018|NCT00762073|26744075|FG002|Overall Study|Withdrawal by Subject|1|||
13380019|NCT00762073|26744076|FG003|Overall Study|Withdrawal by Subject|1|||
13380020|NCT00762073|26744073|FG000|Overall Study|Not on treatment for >/= 77 days|1|||
13380021|NCT00762073|26744074|FG001|Overall Study|Not on treatment for >/= 77 days|0|||
13380022|NCT00762073|26744075|FG002|Overall Study|Not on treatment for >/= 77 days|0|||
13380023|NCT00762073|26744076|FG003|Overall Study|Not on treatment for >/= 77 days|0|||
13380024|NCT00762034|26744140|FG000|Induction Period|Protocol Violation|1|||
13380025|NCT00762034|26744141|FG001|Induction Period|Protocol Violation|2|||
13380026|NCT00762034|26744140|FG000|Induction Period|Entry Criterion Not Met|12|||
13380027|NCT00762034|26744141|FG001|Induction Period|Entry Criterion Not Met|11|||
13295417|NCT01379768|26493771|FG002|Overall Study|Adverse Event|0|||
13295418|NCT01379768|26493769|FG000|Overall Study|Lost to Follow-up|2|||
13295419|NCT01379768|26493770|FG001|Overall Study|Lost to Follow-up|0|||
13295420|NCT01379768|26493771|FG002|Overall Study|Lost to Follow-up|0|||
13295421|NCT01379703|26493836|FG000|Study Start Through 9 Months|Lost to Follow-up|2|||
13295422|NCT01379703|26493837|FG001|Study Start Through 9 Months|Lost to Follow-up|61|||
13380028|NCT00762034|26744140|FG000|Induction Period|Adverse Event|27|||
13380029|NCT00762034|26744141|FG001|Induction Period|Adverse Event|38|||
13380030|NCT00762034|26744140|FG000|Induction Period|Lost to Follow-up|1|||
13380031|NCT00762034|26744141|FG001|Induction Period|Lost to Follow-up|1|||
13380032|NCT00762034|26744140|FG000|Induction Period|Progressive Disease|73|||
13380033|NCT00762034|26744141|FG001|Induction Period|Progressive Disease|55|||
13380034|NCT00762034|26744140|FG000|Induction Period|Physician Decision|21|||
13380035|NCT00762034|26744141|FG001|Induction Period|Physician Decision|20|||
13380036|NCT00762034|26744140|FG000|Induction Period|Withdrawal by Subject|15|||
13380037|NCT00762034|26744141|FG001|Induction Period|Withdrawal by Subject|19|||
13380038|NCT00762034|26744140|FG000|Induction Period|Deaths Not Due to Study Disease|19|||
13380039|NCT00762034|26744141|FG001|Induction Period|Deaths Not Due to Study Disease|14|||
13380040|NCT00762034|26744140|FG000|Induction Period|Deaths Due to Study Disease|9|||
13380041|NCT00762034|26744141|FG001|Induction Period|Deaths Due to Study Disease|9|||
13380042|NCT00762034|26744140|FG000|Maintenance Period|Protocol Violation|1|||
13380043|NCT00762034|26744141|FG001|Maintenance Period|Protocol Violation|3|||
13380044|NCT00762034|26744140|FG000|Maintenance Period|Entry Criterion Not Met|0|||
13380045|NCT00762034|26744141|FG001|Maintenance Period|Entry Criterion Not Met|2|||
13380046|NCT00762034|26744140|FG000|Maintenance Period|Adverse Event|42|||
13380047|NCT00762034|26744141|FG001|Maintenance Period|Adverse Event|26|||
13380048|NCT00762034|26744140|FG000|Maintenance Period|Progressive Disease|186|||
13380049|NCT00762034|26744141|FG001|Maintenance Period|Progressive Disease|224|||
13380050|NCT00762034|26744140|FG000|Maintenance Period|Physician Decision|25|||
13380051|NCT00762034|26744141|FG001|Maintenance Period|Physician Decision|20|||
13380052|NCT00762034|26744140|FG000|Maintenance Period|Withdrawal by Subject|34|||
13380053|NCT00762034|26744141|FG001|Maintenance Period|Withdrawal by Subject|14|||
13380054|NCT00762034|26744140|FG000|Maintenance Period|Death not due to study disease|2|||
13380055|NCT00762034|26744141|FG001|Maintenance Period|Death not due to study disease|5|||
13380056|NCT00762034|26744140|FG000|Maintenance Period|Death due to study disease|3|||
13380057|NCT00762034|26744141|FG001|Maintenance Period|Death due to study disease|3|||
13380058|NCT00762034|26744140|FG000|Maintenance Period|Other|1|||
13380059|NCT00762034|26744141|FG001|Maintenance Period|Other|1|||
13380060|NCT00761969|26744156|FG000|Overall Study|Death|112|||
13380061|NCT00761969|26744157|FG001|Overall Study|Death|47|||
13380062|NCT00761969|26744156|FG000|Overall Study|Lost to Follow-up|88|||
13380063|NCT00761969|26744157|FG001|Overall Study|Lost to Follow-up|93|||
13380064|NCT00761956|26744172|FG000|Overall Study|Lost to Follow-up|6|||
13380065|NCT00761956|26744173|FG001|Overall Study|Lost to Follow-up|11|||
13380066|NCT00761956|26744172|FG000|Overall Study|Withdrawal by Subject|3|||
13380067|NCT00761956|26744173|FG001|Overall Study|Withdrawal by Subject|8|||
13380068|NCT00761956|26744172|FG000|Overall Study|Death|0|||
13380069|NCT00761956|26744173|FG001|Overall Study|Death|1|||
13380070|NCT00761956|26744172|FG000|Overall Study|Adverse Event|26|||
13380071|NCT00761956|26744173|FG001|Overall Study|Adverse Event|34|||
13380072|NCT00761891|26744180|FG000|Overall Study|Withdrawal by Subject|10|||
13380073|NCT00761865|26744195|FG000|Overall Study|Lost to Follow-up|8|||
13380074|NCT00761865|26744196|FG001|Overall Study|Lost to Follow-up|7|||
13380075|NCT00761774|26744207|FG000|Overall Study|Adverse Event|17|||
13380076|NCT00761774|26744207|FG000|Overall Study|Lack of Efficacy|37|||
13380077|NCT00761774|26744207|FG000|Overall Study|Lost to Follow-up|2|||
13380078|NCT00761774|26744207|FG000|Overall Study|Withdrawal by Subject|9|||
13380079|NCT00761774|26744207|FG000|Overall Study|Non-compliance|4|||
13380080|NCT00761774|26744207|FG000|Overall Study|End of study|2|||
13380081|NCT00761774|26744207|FG000|Overall Study|Reclassification of seizures|1|||
13380082|NCT00761774|26744207|FG000|Overall Study|Medical decision to read SUSAR reports|1|||
13380083|NCT00761774|26744207|FG000|Overall Study|Sponsor decision|1|||
13380084|NCT00761774|26744207|FG000|Overall Study|Investigator clinical judgement|1|||
13380085|NCT00761774|26744207|FG000|Overall Study|Patient moved out of study area|1|||
13380086|NCT00761774|26744207|FG000|Overall Study|Coordinator leaving site|1|||
13380087|NCT00761774|26744207|FG000|Overall Study|Subject IP non-compliance|1|||
13380088|NCT00761774|26744207|FG000|Overall Study|IP stopped by hospital physician|1|||
13380089|NCT00761761|26744226|FG000|Overall Study|Lost to Follow-up|3|||
13380090|NCT00761761|26744227|FG001|Overall Study|Lost to Follow-up|1|||
13380091|NCT00761761|26744226|FG000|Overall Study|Withdrawal by Subject|3|||
13380092|NCT00761761|26744227|FG001|Overall Study|Withdrawal by Subject|0|||
13380093|NCT00761748|26744236|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3|||
13380094|NCT00761748|26744237|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0|||
13380095|NCT00761748|26744236|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0|||
13380096|NCT00761748|26744237|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3|||
13380097|NCT00761735|26744251|FG000|Overall Study|Lost to Follow-up|6|||
13380098|NCT00761735|26744251|FG000|Overall Study|Withdrawal by Subject|6|||
13380099|NCT00761735|26744251|FG000|Overall Study|Non-compliance with protocol|1|||
13380100|NCT00761735|26744251|FG000|Overall Study|Administrative|1|||
13380101|NCT00761657|26744344|FG000|Part 1 (up to Day 57)|Adverse Event|0|||
13380102|NCT00761657|26744345|FG001|Part 1 (up to Day 57)|Adverse Event|0|||
13380103|NCT00761657|26744346|FG002|Part 1 (up to Day 57)|Adverse Event|0|||
13380104|NCT00761657|26744347|FG003|Part 1 (up to Day 57)|Adverse Event|1|||
13380105|NCT00761657|26744348|FG004|Part 1 (up to Day 57)|Adverse Event|0|||
13380106|NCT00761657|26744349|FG005|Part 1 (up to Day 57)|Adverse Event|0|||
13380107|NCT00761657|26744350|FG006|Part 1 (up to Day 57)|Adverse Event|0|||
13380108|NCT00761657|26744351|FG007|Part 1 (up to Day 57)|Adverse Event|0|||
13380109|NCT00761657|26744352|FG008|Part 1 (up to Day 57)|Adverse Event|0|||
13380110|NCT00761657|26744344|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
13380111|NCT00761657|26744345|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
13380112|NCT00761657|26744346|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
13380113|NCT00761657|26744347|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
13380114|NCT00761657|26744348|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
13380115|NCT00761657|26744349|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
13380116|NCT00761657|26744350|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
13380117|NCT00761657|26744351|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
13380118|NCT00761657|26744352|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
13380119|NCT00761657|26744344|FG000|Part 1 (up to Day 57)|Sponsor Decision|0|||
13380120|NCT00761657|26744345|FG001|Part 1 (up to Day 57)|Sponsor Decision|0|||
13380121|NCT00761657|26744346|FG002|Part 1 (up to Day 57)|Sponsor Decision|3|||
13380122|NCT00761657|26744347|FG003|Part 1 (up to Day 57)|Sponsor Decision|4|||
13380123|NCT00761657|26744348|FG004|Part 1 (up to Day 57)|Sponsor Decision|0|||
13380124|NCT00761657|26744349|FG005|Part 1 (up to Day 57)|Sponsor Decision|0|||
13380125|NCT00761657|26744350|FG006|Part 1 (up to Day 57)|Sponsor Decision|1|||
13380126|NCT00761657|26744351|FG007|Part 1 (up to Day 57)|Sponsor Decision|1|||
13380127|NCT00761657|26744352|FG008|Part 1 (up to Day 57)|Sponsor Decision|1|||
13380128|NCT00761657|26744344|FG000|Part 2 (up to Day 114)|Adverse Event|0|||
13380129|NCT00761657|26744345|FG001|Part 2 (up to Day 114)|Adverse Event|0|||
13380130|NCT00761657|26744346|FG002|Part 2 (up to Day 114)|Adverse Event|0|||
13380131|NCT00761657|26744347|FG003|Part 2 (up to Day 114)|Adverse Event|0|||
13380132|NCT00761657|26744348|FG004|Part 2 (up to Day 114)|Adverse Event|0|||
13380133|NCT00761657|26744349|FG005|Part 2 (up to Day 114)|Adverse Event|0|||
13380134|NCT00761657|26744350|FG006|Part 2 (up to Day 114)|Adverse Event|0|||
13380135|NCT00761657|26744351|FG007|Part 2 (up to Day 114)|Adverse Event|0|||
13380136|NCT00761657|26744352|FG008|Part 2 (up to Day 114)|Adverse Event|1|||
13380137|NCT00761631|26744402|FG000|Overall Study|Parent/legal guardian request|8|||
13380138|NCT00761631|26744403|FG001|Overall Study|Parent/legal guardian request|3|||
13380139|NCT00761631|26744404|FG002|Overall Study|Parent/legal guardian request|8|||
13380140|NCT00761631|26744405|FG003|Overall Study|Parent/legal guardian request|0|||
13380141|NCT00761631|26744406|FG004|Overall Study|Parent/legal guardian request|5|||
13380142|NCT00761631|26744407|FG005|Overall Study|Parent/legal guardian request|0|||
13380143|NCT00761631|26744402|FG000|Overall Study|Lost to Follow-up|2|||
13380144|NCT00761631|26744403|FG001|Overall Study|Lost to Follow-up|4|||
13380145|NCT00761631|26744404|FG002|Overall Study|Lost to Follow-up|7|||
13380146|NCT00761631|26744405|FG003|Overall Study|Lost to Follow-up|1|||
13380147|NCT00761631|26744406|FG004|Overall Study|Lost to Follow-up|6|||
13380148|NCT00761631|26744407|FG005|Overall Study|Lost to Follow-up|1|||
13380149|NCT00761631|26744402|FG000|Overall Study|Protocol Violation|2|||
13380150|NCT00761631|26744403|FG001|Overall Study|Protocol Violation|0|||
13380151|NCT00761631|26744404|FG002|Overall Study|Protocol Violation|0|||
13380152|NCT00761631|26744405|FG003|Overall Study|Protocol Violation|1|||
13380153|NCT00761631|26744406|FG004|Overall Study|Protocol Violation|5|||
13380154|NCT00761631|26744407|FG005|Overall Study|Protocol Violation|1|||
13380155|NCT00761631|26744402|FG000|Overall Study|Randomized, not treated|1|||
13380156|NCT00761631|26744403|FG001|Overall Study|Randomized, not treated|0|||
13380157|NCT00761631|26744404|FG002|Overall Study|Randomized, not treated|0|||
13380158|NCT00761631|26744405|FG003|Overall Study|Randomized, not treated|0|||
13380159|NCT00761631|26744406|FG004|Overall Study|Randomized, not treated|0|||
13380160|NCT00761631|26744407|FG005|Overall Study|Randomized, not treated|0|||
13380161|NCT00761631|26744402|FG000|Overall Study|Failed to return|1|||
13380162|NCT00761631|26744403|FG001|Overall Study|Failed to return|0|||
13380163|NCT00761631|26744404|FG002|Overall Study|Failed to return|1|||
13380164|NCT00761631|26744405|FG003|Overall Study|Failed to return|1|||
13380165|NCT00761631|26744406|FG004|Overall Study|Failed to return|5|||
13380166|NCT00761631|26744407|FG005|Overall Study|Failed to return|2|||
13380167|NCT00761631|26744402|FG000|Overall Study|Physician Decision|1|||
13380168|NCT00761631|26744403|FG001|Overall Study|Physician Decision|0|||
13380169|NCT00761631|26744404|FG002|Overall Study|Physician Decision|0|||
13380170|NCT00761631|26744405|FG003|Overall Study|Physician Decision|0|||
13380171|NCT00761631|26744406|FG004|Overall Study|Physician Decision|0|||
13380172|NCT00761631|26744407|FG005|Overall Study|Physician Decision|0|||
13380173|NCT00761631|26744402|FG000|Overall Study|Other|0|||
13380174|NCT00761631|26744403|FG001|Overall Study|Other|0|||
13380175|NCT00761631|26744404|FG002|Overall Study|Other|0|||
13380176|NCT00761631|26744405|FG003|Overall Study|Other|0|||
13380177|NCT00761631|26744406|FG004|Overall Study|Other|1|||
13380178|NCT00761631|26744407|FG005|Overall Study|Other|1|||
13380179|NCT00761605|26744436|FG000|Overall Study|Adverse Event|26|||
13380180|NCT00761605|26744436|FG000|Overall Study|Death|2|||
13380181|NCT00761605|26744436|FG000|Overall Study|Lack of Efficacy|26|||
13380182|NCT00761605|26744436|FG000|Overall Study|Lost to Follow-up|29|||
13380183|NCT00761605|26744436|FG000|Overall Study|Withdrawal by Subject|37|||
13380184|NCT00761605|26744436|FG000|Overall Study|Other|21|||
13380185|NCT00761579|26744471|FG000|Overall Study|Adverse Event|10|||
13380186|NCT00761579|26744471|FG000|Overall Study|Death|2|||
13380187|NCT00761579|26744471|FG000|Overall Study|Lack of Efficacy|21|||
13380188|NCT00761579|26744471|FG000|Overall Study|Lost to Follow-up|16|||
13380189|NCT00761579|26744471|FG000|Overall Study|Pregnancy|1|||
13380190|NCT00761579|26744471|FG000|Overall Study|Withdrawal by Subject|34|||
13380191|NCT00761579|26744471|FG000|Overall Study|Lack of compliance|2|||
13380192|NCT00761579|26744471|FG000|Overall Study|Protocol deviation|1|||
13380193|NCT00761579|26744471|FG000|Overall Study|Drug overdose|1|||
13380194|NCT00761579|26744471|FG000|Overall Study|Aggravation of depression|1|||
13380195|NCT00761579|26744471|FG000|Overall Study|Aggravation of symptoms by changing drug|1|||
13380196|NCT00761579|26744471|FG000|Overall Study|Lost survey form|1|||
13380197|NCT00761579|26744471|FG000|Overall Study|Intake of prohibited concomitant drug|1|||
13380198|NCT00761527|26744480|FG000|Overall Study|Adverse Event|3|||
13380199|NCT00761527|26744480|FG000|Overall Study|Poor Compliance|8|||
13380200|NCT00761527|26744480|FG000|Overall Study|Lost to Follow-up|9|||
13380201|NCT00761527|26744480|FG000|Overall Study|Unknown reason|2|||
13380202|NCT00761514|26744487|FG000|Overall Study|Adverse Event|1|||
13380203|NCT00761514|26744487|FG000|Overall Study|Withdrawal by Subject|2|||
13380204|NCT00761514|26744487|FG000|Overall Study|Lost to Follow-up|1|||
13380205|NCT00761514|26744487|FG000|Overall Study|Health insurance didn't cover study drug|1|||
13380206|NCT00761514|26744487|FG000|Overall Study|Problem complying with study visit|1|||
13380207|NCT00761514|26744487|FG000|Overall Study|Unable to pay for medications|1|||
13380208|NCT00761462|26744502|FG000|Treatment|Subjects never received study medication|23|||
13380209|NCT00761462|26744503|FG001|Treatment|Subjects never received study medication|12|||
13380210|NCT00761462|26744502|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4|||
13380211|NCT00761462|26744503|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0|||
13380212|NCT00761462|26744502|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75|||
13380213|NCT00761462|26744503|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30|||
13380214|NCT00761462|26744502|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75|||
13380215|NCT00761462|26744503|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21|||
13380216|NCT00761319|26744518|FG000|Overall Study|Protocol Violation|21|||
13380217|NCT00761319|26744519|FG001|Overall Study|Protocol Violation|14|||
13380218|NCT00761319|26744518|FG000|Overall Study|Adverse Event|11|||
13380219|NCT00761319|26744519|FG001|Overall Study|Adverse Event|7|||
13380220|NCT00761319|26744518|FG000|Overall Study|Withdrawal by Subject|8|||
13380221|NCT00761319|26744519|FG001|Overall Study|Withdrawal by Subject|7|||
13380222|NCT00761319|26744518|FG000|Overall Study|Noncompliance|4|||
13380223|NCT00761319|26744519|FG001|Overall Study|Noncompliance|3|||
13380224|NCT00761319|26744518|FG000|Overall Study|Lost to Follow-up|1|||
13380225|NCT00761319|26744519|FG001|Overall Study|Lost to Follow-up|1|||
13380226|NCT00761319|26744518|FG000|Overall Study|Nonspecified|2|||
13380227|NCT00761319|26744519|FG001|Overall Study|Nonspecified|2|||
13380228|NCT00761319|26744518|FG000|Overall Study|Missing|1|||
13380229|NCT00761319|26744519|FG001|Overall Study|Missing|0|||
13380230|NCT00761306|26744530|FG000|Overall Study|Adverse Event|5|||
13380231|NCT00761306|26744530|FG000|Overall Study|Lack of Efficacy|4|||
13380232|NCT00761306|26744530|FG000|Overall Study|Protocol Violation|2|||
13380233|NCT00761306|26744530|FG000|Overall Study|Withdrawal of Consent|3|||
13380234|NCT00761306|26744530|FG000|Overall Study|Lost to Follow-up|1|||
13380235|NCT00761306|26744530|FG000|Overall Study|Administrative or Other Reasons|5|||
13380236|NCT00761280|26744565|FG000|Randomization to First Dose|Withdrawal by Subject|0|||
13380237|NCT00761280|26744566|FG001|Randomization to First Dose|Withdrawal by Subject|2|||
13380238|NCT00761280|26744565|FG000|Randomization to First Dose|Sponsor decision|1|||
13380239|NCT00761280|26744566|FG001|Randomization to First Dose|Sponsor decision|0|||
13380240|NCT00761280|26744565|FG000|Randomization to First Dose|Other|1|||
13380241|NCT00761280|26744566|FG001|Randomization to First Dose|Other|0|||
13380242|NCT00761280|26744565|FG000|First Dose to End of Study|End of trial|5|||
13380243|NCT00761280|26744566|FG001|First Dose to End of Study|End of trial|5|||
13380244|NCT00761280|26744565|FG000|First Dose to End of Study|Progressive disease|5|||
13380245|NCT00761280|26744566|FG001|First Dose to End of Study|Progressive disease|3|||
13380246|NCT00761280|26744565|FG000|First Dose to End of Study|Sponsor decision|1|||
13380247|NCT00761280|26744566|FG001|First Dose to End of Study|Sponsor decision|2|||
13380248|NCT00761280|26744565|FG000|First Dose to End of Study|Death|1|||
13380249|NCT00761280|26744566|FG001|First Dose to End of Study|Death|0|||
13380250|NCT00761280|26744565|FG000|First Dose to End of Study|Lost to Follow-up|0|||
13380251|NCT00761280|26744566|FG001|First Dose to End of Study|Lost to Follow-up|1|||
13380252|NCT00761267|26744624|FG000|Overall Study|Death|1|||
13380253|NCT00761267|26744625|FG001|Overall Study|Death|2|||
13380254|NCT00761267|26744626|FG002|Overall Study|Death|5|||
13380255|NCT00761267|26744624|FG000|Overall Study|Lost to Follow-up|0|||
13394285|NCT00658684|26786646|FG000|Overall Study|Adverse Event|10|||
13380256|NCT00761267|26744625|FG001|Overall Study|Lost to Follow-up|0|||
13380257|NCT00761267|26744626|FG002|Overall Study|Lost to Follow-up|1|||
13380258|NCT00761267|26744624|FG000|Overall Study|Randomized but not treated|1|||
13380259|NCT00761267|26744625|FG001|Overall Study|Randomized but not treated|1|||
13380260|NCT00761267|26744626|FG002|Overall Study|Randomized but not treated|0|||
13380261|NCT00761267|26744624|FG000|Overall Study|Withdrawal by Subject|0|||
13380262|NCT00761267|26744625|FG001|Overall Study|Withdrawal by Subject|1|||
13380263|NCT00761267|26744626|FG002|Overall Study|Withdrawal by Subject|0|||
13380264|NCT00761215|26744659|FG000|Overall Study|Randomized but didn't receive drug|1|||
13380265|NCT00761215|26744660|FG001|Overall Study|Randomized but didn't receive drug|1|||
13380266|NCT00761215|26744661|FG002|Overall Study|Randomized but didn't receive drug|2|||
13380267|NCT00761215|26744659|FG000|Overall Study|Lost to Follow-up|6|||
13380268|NCT00761215|26744660|FG001|Overall Study|Lost to Follow-up|3|||
13380269|NCT00761215|26744661|FG002|Overall Study|Lost to Follow-up|6|||
13380270|NCT00761215|26744659|FG000|Overall Study|Withdrawal by Subject|1|||
13380271|NCT00761215|26744660|FG001|Overall Study|Withdrawal by Subject|0|||
13380272|NCT00761215|26744661|FG002|Overall Study|Withdrawal by Subject|0|||
13380273|NCT00761215|26744659|FG000|Overall Study|Bacteremia|1|||
13380274|NCT00761215|26744660|FG001|Overall Study|Bacteremia|0|||
13380275|NCT00761215|26744661|FG002|Overall Study|Bacteremia|0|||
13380276|NCT00761189|26744678|FG000|Overall Study|Adverse Event|42|||
13380277|NCT00761189|26744678|FG000|Overall Study|Lack of Efficacy|45|||
13380278|NCT00761189|26744678|FG000|Overall Study|Lost to Follow-up|36|||
13380279|NCT00761189|26744678|FG000|Overall Study|Withdrawal by Subject|49|||
13380280|NCT00761189|26744678|FG000|Overall Study|Other|13|||
13380281|NCT00761176|26744691|FG000|Overall Study|Death|1|||
13380282|NCT00761176|26744692|FG001|Overall Study|Death|0|||
13380283|NCT00761176|26744691|FG000|Overall Study|Withdrawal by Subject|1|||
13380284|NCT00761176|26744692|FG001|Overall Study|Withdrawal by Subject|1|||
13380285|NCT00761150|26744711|FG000|Open-label Period|Adverse Event|36|||
13380286|NCT00761150|26744712|FG001|Open-label Period|Adverse Event|0|||
13380287|NCT00761150|26744713|FG002|Open-label Period|Adverse Event|0|||
13380288|NCT00761150|26744711|FG000|Open-label Period|Did not meet DB randomization criteria|11|||
13380289|NCT00761150|26744712|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
13380290|NCT00761150|26744713|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
13380291|NCT00761150|26744711|FG000|Open-label Period|Lost to Follow-up|7|||
13380292|NCT00761150|26744712|FG001|Open-label Period|Lost to Follow-up|0|||
13380293|NCT00761150|26744713|FG002|Open-label Period|Lost to Follow-up|0|||
13380294|NCT00761150|26744711|FG000|Open-label Period|Lack of Efficacy|4|||
13380295|NCT00761150|26744712|FG001|Open-label Period|Lack of Efficacy|0|||
13380296|NCT00761150|26744713|FG002|Open-label Period|Lack of Efficacy|0|||
13380297|NCT00761150|26744711|FG000|Open-label Period|Withdrawal by Subject|5|||
13380298|NCT00761150|26744712|FG001|Open-label Period|Withdrawal by Subject|0|||
13380299|NCT00761150|26744713|FG002|Open-label Period|Withdrawal by Subject|0|||
13394286|NCT00658684|26786647|FG001|Overall Study|Adverse Event|8|||
13394287|NCT00658684|26786648|FG002|Overall Study|Adverse Event|2|||
13394288|NCT00658684|26786649|FG003|Overall Study|Adverse Event|0|||
13394289|NCT00658684|26786646|FG000|Overall Study|Withdrawal by Subject|6|||
13394290|NCT00658684|26786647|FG001|Overall Study|Withdrawal by Subject|4|||
13394291|NCT00658684|26786648|FG002|Overall Study|Withdrawal by Subject|1|||
13394292|NCT00658684|26786649|FG003|Overall Study|Withdrawal by Subject|1|||
13394293|NCT00658684|26786646|FG000|Overall Study|Lack of Efficacy|1|||
13394294|NCT00658684|26786647|FG001|Overall Study|Lack of Efficacy|1|||
13394295|NCT00658684|26786648|FG002|Overall Study|Lack of Efficacy|0|||
13394296|NCT00658684|26786649|FG003|Overall Study|Lack of Efficacy|0|||
13394297|NCT00658684|26786646|FG000|Overall Study|Protocol Violation|1|||
13394298|NCT00658684|26786647|FG001|Overall Study|Protocol Violation|1|||
13394299|NCT00658684|26786648|FG002|Overall Study|Protocol Violation|0|||
13394300|NCT00658684|26786649|FG003|Overall Study|Protocol Violation|0|||
13394301|NCT00658684|26786646|FG000|Overall Study|Pregnancy|1|||
13394302|NCT00658684|26786647|FG001|Overall Study|Pregnancy|1|||
13394303|NCT00658684|26786648|FG002|Overall Study|Pregnancy|0|||
13394304|NCT00658684|26786649|FG003|Overall Study|Pregnancy|0|||
13394305|NCT00658658|26786722|FG000|Overall Study|Withdrawal by Subject|0|||
13394306|NCT00658658|26786723|FG001|Overall Study|Withdrawal by Subject|1|||
13394307|NCT00658658|26786724|FG002|Overall Study|Withdrawal by Subject|0|||
13394308|NCT00658658|26786725|FG003|Overall Study|Withdrawal by Subject|0|||
13394309|NCT00658658|26786726|FG004|Overall Study|Withdrawal by Subject|0|||
13394310|NCT00658658|26786722|FG000|Overall Study|Death|4|||
13394311|NCT00658658|26786723|FG001|Overall Study|Death|0|||
13394312|NCT00658658|26786724|FG002|Overall Study|Death|0|||
13394313|NCT00658658|26786725|FG003|Overall Study|Death|1|||
13394314|NCT00658658|26786726|FG004|Overall Study|Death|1|||
13394315|NCT00658658|26786722|FG000|Overall Study|Disease Progression|0|||
13394316|NCT00658658|26786723|FG001|Overall Study|Disease Progression|1|||
13394317|NCT00658658|26786724|FG002|Overall Study|Disease Progression|0|||
13394318|NCT00658658|26786725|FG003|Overall Study|Disease Progression|1|||
13394319|NCT00658658|26786726|FG004|Overall Study|Disease Progression|3|||
13394320|NCT00658658|26786722|FG000|Overall Study|Protocol-specified Criteria|1|||
13380300|NCT00761150|26744711|FG000|Open-label Period|Noncompliance|2|||
13394321|NCT00658658|26786723|FG001|Overall Study|Protocol-specified Criteria|0|||
13394322|NCT00658658|26786724|FG002|Overall Study|Protocol-specified Criteria|0|||
13394323|NCT00658658|26786725|FG003|Overall Study|Protocol-specified Criteria|0|||
13394324|NCT00658658|26786726|FG004|Overall Study|Protocol-specified Criteria|0|||
13394325|NCT00658658|26786722|FG000|Overall Study|Other|0|||
13394326|NCT00658658|26786723|FG001|Overall Study|Other|0|||
13394327|NCT00658658|26786724|FG002|Overall Study|Other|0|||
13394328|NCT00658658|26786725|FG003|Overall Study|Other|0|||
13394329|NCT00658658|26786726|FG004|Overall Study|Other|1|||
13394330|NCT00658632|26786743|FG000|Overall Study|Adverse Event|13|||
13394331|NCT00658632|26786744|FG001|Overall Study|Adverse Event|11|||
13394332|NCT00658632|26786743|FG000|Overall Study|Lost to Follow-up|25|||
13394333|NCT00658632|26786744|FG001|Overall Study|Lost to Follow-up|23|||
13394334|NCT00658632|26786743|FG000|Overall Study|Withdrawal by Subject|10|||
13135111|NCT02745145|25993631|FG002|Overall Study|Death|0|||
13380301|NCT00761150|26744712|FG001|Open-label Period|Noncompliance|0|||
13380302|NCT00761150|26744713|FG002|Open-label Period|Noncompliance|0|||
13380303|NCT00761150|26744711|FG000|Open-label Period|Other|5|||
13380304|NCT00761150|26744712|FG001|Open-label Period|Other|0|||
13380305|NCT00761150|26744713|FG002|Open-label Period|Other|0|||
13380306|NCT00761150|26744711|FG000|Double-blind Period|Lack of Efficacy|0|||
13380307|NCT00761150|26744712|FG001|Double-blind Period|Lack of Efficacy|2|||
13380308|NCT00761150|26744713|FG002|Double-blind Period|Lack of Efficacy|19|||
13380309|NCT00761150|26744711|FG000|Double-blind Period|Adverse Event|0|||
13380310|NCT00761150|26744712|FG001|Double-blind Period|Adverse Event|3|||
13380311|NCT00761150|26744713|FG002|Double-blind Period|Adverse Event|3|||
13380312|NCT00761150|26744711|FG000|Double-blind Period|Withdrawal by Subject|0|||
13380313|NCT00761150|26744712|FG001|Double-blind Period|Withdrawal by Subject|3|||
13380314|NCT00761150|26744713|FG002|Double-blind Period|Withdrawal by Subject|2|||
13380315|NCT00761150|26744711|FG000|Double-blind Period|Lost to Follow-up|0|||
13380316|NCT00761150|26744712|FG001|Double-blind Period|Lost to Follow-up|2|||
13380317|NCT00761150|26744713|FG002|Double-blind Period|Lost to Follow-up|1|||
13380318|NCT00761150|26744711|FG000|Double-blind Period|Did not meet DB randomization criteria|0|||
13380319|NCT00761150|26744712|FG001|Double-blind Period|Did not meet DB randomization criteria|0|||
13380320|NCT00761150|26744713|FG002|Double-blind Period|Did not meet DB randomization criteria|1|||
13380321|NCT00761150|26744711|FG000|Double-blind Period|Noncompliance|0|||
13380322|NCT00761150|26744712|FG001|Double-blind Period|Noncompliance|1|||
13380323|NCT00761150|26744713|FG002|Double-blind Period|Noncompliance|0|||
13380324|NCT00761150|26744711|FG000|Double-blind Period|Other|0|||
13380325|NCT00761150|26744712|FG001|Double-blind Period|Other|3|||
13380326|NCT00761150|26744713|FG002|Double-blind Period|Other|3|||
13380327|NCT00760994|26744734|FG000|Overall Study|Lost to Follow-up|4|||
13380328|NCT00760994|26744735|FG001|Overall Study|Lost to Follow-up|4|||
13380329|NCT00760994|26744736|FG002|Overall Study|Lost to Follow-up|3|||
13380330|NCT00760929|26744770|FG000|Overall Study|Adverse Event|2|||
13380331|NCT00760929|26744771|FG001|Overall Study|Adverse Event|0|||
13380332|NCT00760929|26744772|FG002|Overall Study|Adverse Event|6|||
13380333|NCT00760929|26744773|FG003|Overall Study|Adverse Event|10|||
13380334|NCT00760929|26744770|FG000|Overall Study|Lack of Efficacy|0|||
13380335|NCT00760929|26744771|FG001|Overall Study|Lack of Efficacy|2|||
13380336|NCT00760929|26744772|FG002|Overall Study|Lack of Efficacy|1|||
13380337|NCT00760929|26744773|FG003|Overall Study|Lack of Efficacy|0|||
13380338|NCT00760929|26744770|FG000|Overall Study|Withdrawal by Subject|1|||
13380339|NCT00760929|26744771|FG001|Overall Study|Withdrawal by Subject|0|||
13380340|NCT00760929|26744772|FG002|Overall Study|Withdrawal by Subject|9|||
13380341|NCT00760929|26744773|FG003|Overall Study|Withdrawal by Subject|1|||
13380342|NCT00760929|26744770|FG000|Overall Study|Lost to Follow-up|0|||
13380343|NCT00760929|26744771|FG001|Overall Study|Lost to Follow-up|0|||
13380344|NCT00760929|26744772|FG002|Overall Study|Lost to Follow-up|1|||
13380345|NCT00760929|26744773|FG003|Overall Study|Lost to Follow-up|0|||
13380346|NCT00760929|26744770|FG000|Overall Study|Progression of Disease|21|||
13380347|NCT00760929|26744771|FG001|Overall Study|Progression of Disease|26|||
13380348|NCT00760929|26744772|FG002|Overall Study|Progression of Disease|38|||
13380349|NCT00760929|26744773|FG003|Overall Study|Progression of Disease|42|||
13380350|NCT00760929|26744770|FG000|Overall Study|Other|2|||
13380351|NCT00760929|26744771|FG001|Overall Study|Other|0|||
13380352|NCT00760929|26744772|FG002|Overall Study|Other|2|||
13380353|NCT00760929|26744773|FG003|Overall Study|Other|1|||
13380354|NCT00760929|26744770|FG000|Overall Study|Death|0|||
13380355|NCT00760929|26744771|FG001|Overall Study|Death|0|||
13380356|NCT00760929|26744772|FG002|Overall Study|Death|1|||
13380357|NCT00760929|26744773|FG003|Overall Study|Death|0|||
13380358|NCT00760929|26744770|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
13380359|NCT00760929|26744771|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
13380360|NCT00760929|26744772|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
13380361|NCT00760929|26744773|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
13380362|NCT00760877|26744796|FG000|Overall Study|Protocol Violation|1|||
13394335|NCT00658632|26786744|FG001|Overall Study|Withdrawal by Subject|7|||
13380363|NCT00760877|26744797|FG001|Overall Study|Protocol Violation|0|||
13380364|NCT00760877|26744796|FG000|Overall Study|Non-compliance with protocol treatment|2|||
13380365|NCT00760877|26744797|FG001|Overall Study|Non-compliance with protocol treatment|1|||
13380366|NCT00760877|26744796|FG000|Overall Study|Pregnancy|1|||
13380367|NCT00760877|26744797|FG001|Overall Study|Pregnancy|4|||
13380368|NCT00760877|26744796|FG000|Overall Study|Death|2|||
13380369|NCT00760877|26744797|FG001|Overall Study|Death|1|||
13380370|NCT00760877|26744796|FG000|Overall Study|Withdrawal by Subject|7|||
13380371|NCT00760877|26744797|FG001|Overall Study|Withdrawal by Subject|3|||
13380372|NCT00760877|26744796|FG000|Overall Study|Adverse Event|19|||
13380373|NCT00760877|26744797|FG001|Overall Study|Adverse Event|12|||
13380374|NCT00760877|26744796|FG000|Overall Study|Participant diagnosed with AML|0|||
13380375|NCT00760877|26744797|FG001|Overall Study|Participant diagnosed with AML|1|||
13380376|NCT00760877|26744796|FG000|Overall Study|Participant not eligible to cross-over|0|||
13380377|NCT00760877|26744797|FG001|Overall Study|Participant not eligible to cross-over|1|||
13380378|NCT00760877|26744796|FG000|Overall Study|Physician Decision|1|||
13380379|NCT00760877|26744797|FG001|Overall Study|Physician Decision|2|||
13380380|NCT00760877|26744796|FG000|Overall Study|Participants transferred to AMN107A2408|11|||
13380381|NCT00760877|26744797|FG001|Overall Study|Participants transferred to AMN107A2408|1|||
13380382|NCT00760877|26744796|FG000|Overall Study|Treatment failure|1|||
13380383|NCT00760877|26744797|FG001|Overall Study|Treatment failure|0|||
13380384|NCT00760838|26744820|FG000|Overall Study|Adverse Event|1|||
13380385|NCT00760838|26744821|FG001|Overall Study|Adverse Event|1|||
13380386|NCT00760838|26744820|FG000|Overall Study|Lack of Efficacy|1|||
13380387|NCT00760838|26744821|FG001|Overall Study|Lack of Efficacy|0|||
13380388|NCT00760838|26744820|FG000|Overall Study|Lost to Follow-up|2|||
13380389|NCT00760838|26744821|FG001|Overall Study|Lost to Follow-up|0|||
13380390|NCT00760838|26744820|FG000|Overall Study|Withdrawal by Subject|1|||
13380391|NCT00760838|26744821|FG001|Overall Study|Withdrawal by Subject|1|||
13380392|NCT00760747|26744856|FG000|Study Period II|Adverse Event|3|||
13380393|NCT00760747|26744857|FG001|Study Period II|Adverse Event|4|||
13380394|NCT00760747|26744856|FG000|Study Period II|Lack of Efficacy|0|||
13380395|NCT00760747|26744857|FG001|Study Period II|Lack of Efficacy|6|||
13380396|NCT00760747|26744856|FG000|Study Period II|Parent/Caregiver Decision|3|||
13380397|NCT00760747|26744857|FG001|Study Period II|Parent/Caregiver Decision|0|||
13380398|NCT00760747|26744856|FG000|Study Period II|Protocol Violation|6|||
13380399|NCT00760747|26744857|FG001|Study Period II|Protocol Violation|3|||
13380400|NCT00760747|26744856|FG000|Study Period II|Withdrawal by Subject|1|||
13380401|NCT00760747|26744857|FG001|Study Period II|Withdrawal by Subject|0|||
13380402|NCT00760747|26744856|FG000|Study Period II|No drug administered|0|||
13380403|NCT00760747|26744857|FG001|Study Period II|No drug administered|1|||
13380404|NCT00760747|26744856|FG000|Study Period III|Adverse Event|1|||
13380405|NCT00760747|26744857|FG001|Study Period III|Adverse Event|0|||
13380406|NCT00760747|26744856|FG000|Study Period III|Lack of Efficacy|1|||
13380407|NCT00760747|26744857|FG001|Study Period III|Lack of Efficacy|0|||
13380408|NCT00760747|26744856|FG000|Study Period III|Parent/Caregiver Decision|0|||
13380409|NCT00760747|26744857|FG001|Study Period III|Parent/Caregiver Decision|1|||
13380410|NCT00760747|26744856|FG000|Study Period III|Protocol Violation|1|||
13380411|NCT00760747|26744857|FG001|Study Period III|Protocol Violation|1|||
13380412|NCT00760747|26744856|FG000|Study Period III|Physician Decision|0|||
13380413|NCT00760747|26744857|FG001|Study Period III|Physician Decision|1|||
13380414|NCT00760669|26744873|FG000|Overall Study|Not assessed for overall improvement|18|||
13380415|NCT00760669|26744873|FG000|Overall Study|Participants missing efficacy assessment|6|||
13380416|NCT00760669|26744873|FG000|Overall Study|Participants with overlapping cases|1|||
13380417|NCT00760669|26744873|FG000|Overall Study|Took drug before entering in contract|5|||
13380418|NCT00760617|26744954|FG000|Overall Study|Adverse Event|5|||
13380419|NCT00760617|26744955|FG001|Overall Study|Adverse Event|2|||
13380420|NCT00760617|26744956|FG002|Overall Study|Adverse Event|0|||
13380421|NCT00760617|26744954|FG000|Overall Study|Lost to Follow-up|0|||
13380422|NCT00760617|26744955|FG001|Overall Study|Lost to Follow-up|0|||
13380423|NCT00760617|26744956|FG002|Overall Study|Lost to Follow-up|5|||
13380424|NCT00760552|26744969|FG000|Overall Study|Death|2|||
13380425|NCT00760552|26744970|FG001|Overall Study|Death|0|||
13380426|NCT00760552|26744969|FG000|Overall Study|Lost to Follow-up|11|||
13380427|NCT00760552|26744970|FG001|Overall Study|Lost to Follow-up|10|||
13380428|NCT00760513|26744987|FG000|Overall Study|Withdrawal by Subject|5|||
13380429|NCT00760513|26744988|FG001|Overall Study|Withdrawal by Subject|7|||
13380430|NCT00760487|26744996|FG000|Overall Study|Unilateral implantation|3|||
13380431|NCT00760474|26745035|FG000|Period 1 (P1)|Discontinued then re-entered|1|||
13380432|NCT00760474|26745036|FG001|Period 1 (P1)|Discontinued then re-entered|1|||
13380433|NCT00760474|26745035|FG000|Placebo Washout Period|Other|0|||
13380434|NCT00760474|26745036|FG001|Placebo Washout Period|Other|1|||
13380435|NCT00760474|26745035|FG000|Period 2 (P2)|Lost to Follow-up|1|||
13380436|NCT00760474|26745036|FG001|Period 2 (P2)|Lost to Follow-up|0|||
13380437|NCT00760474|26745035|FG000|Period 2 (P2)|Adverse Event|0|||
13380438|NCT00760474|26745036|FG001|Period 2 (P2)|Adverse Event|1|||
13380439|NCT00760383|26745053|FG000|Overall Study|moved away; withdrew; medical reasons|5|||
13380440|NCT00760383|26745054|FG001|Overall Study|moved away; withdrew; medical reasons|7|||
13380441|NCT00760266|26745075|FG000|Overall Study|Adverse Event|13|||
13380442|NCT00760266|26745076|FG001|Overall Study|Adverse Event|7|||
13380443|NCT00760266|26745075|FG000|Overall Study|Abnormal laboratory value(s)|1|||
13380444|NCT00760266|26745076|FG001|Overall Study|Abnormal laboratory value(s)|0|||
13380445|NCT00760266|26745075|FG000|Overall Study|Abnormal test procedure result(s)|1|||
13380446|NCT00760266|26745076|FG001|Overall Study|Abnormal test procedure result(s)|0|||
13380447|NCT00760266|26745075|FG000|Overall Study|Lack of Efficacy|2|||
13380448|NCT00760266|26745076|FG001|Overall Study|Lack of Efficacy|2|||
13380449|NCT00760266|26745075|FG000|Overall Study|Protocol deviation|2|||
13380450|NCT00760266|26745076|FG001|Overall Study|Protocol deviation|4|||
13380451|NCT00760266|26745075|FG000|Overall Study|Patient withdrew consent|3|||
13380452|NCT00760266|26745076|FG001|Overall Study|Patient withdrew consent|3|||
13380453|NCT00760266|26745075|FG000|Overall Study|Lost to Follow-up|2|||
13380454|NCT00760266|26745076|FG001|Overall Study|Lost to Follow-up|1|||
13380455|NCT00760266|26745075|FG000|Overall Study|Administrative Problems|0|||
13380456|NCT00760266|26745076|FG001|Overall Study|Administrative Problems|1|||
13380457|NCT00760214|26745127|FG000|Overall Study|Adverse Event|8|||
13380458|NCT00760214|26745128|FG001|Overall Study|Adverse Event|9|||
13380459|NCT00760214|26745129|FG002|Overall Study|Adverse Event|12|||
13380460|NCT00760214|26745127|FG000|Overall Study|Protocol Violation|3|||
13380461|NCT00760214|26745128|FG001|Overall Study|Protocol Violation|0|||
13380462|NCT00760214|26745129|FG002|Overall Study|Protocol Violation|3|||
13380463|NCT00760214|26745127|FG000|Overall Study|Lost to Follow-up|0|||
13380464|NCT00760214|26745128|FG001|Overall Study|Lost to Follow-up|0|||
13380465|NCT00760214|26745129|FG002|Overall Study|Lost to Follow-up|1|||
13380466|NCT00760214|26745127|FG000|Overall Study|Withdrawal by Subject|12|||
13380467|NCT00760214|26745128|FG001|Overall Study|Withdrawal by Subject|14|||
13380468|NCT00760214|26745129|FG002|Overall Study|Withdrawal by Subject|13|||
13380469|NCT00760214|26745127|FG000|Overall Study|Lack of Efficacy|3|||
13380470|NCT00760214|26745128|FG001|Overall Study|Lack of Efficacy|2|||
13380471|NCT00760214|26745129|FG002|Overall Study|Lack of Efficacy|4|||
13380472|NCT00760214|26745127|FG000|Overall Study|Pregnancy|0|||
13380473|NCT00760214|26745128|FG001|Overall Study|Pregnancy|0|||
13380474|NCT00760214|26745129|FG002|Overall Study|Pregnancy|1|||
13380475|NCT00760214|26745127|FG000|Overall Study|Physician Decision|1|||
13380476|NCT00760214|26745128|FG001|Overall Study|Physician Decision|1|||
13380477|NCT00760214|26745129|FG002|Overall Study|Physician Decision|1|||
13380478|NCT00760214|26745127|FG000|Overall Study|Other|3|||
13380479|NCT00760214|26745128|FG001|Overall Study|Other|4|||
13394336|NCT00658632|26786743|FG000|Overall Study|Lack of Efficacy|0|||
13394337|NCT00658632|26786744|FG001|Overall Study|Lack of Efficacy|1|||
13394338|NCT00658632|26786743|FG000|Overall Study|Withdrawal of consent|8|||
13394339|NCT00658632|26786744|FG001|Overall Study|Withdrawal of consent|14|||
13394340|NCT00658632|26786743|FG000|Overall Study|Pregnancy|1|||
13394341|NCT00658632|26786744|FG001|Overall Study|Pregnancy|1|||
13394342|NCT00658632|26786743|FG000|Overall Study|Other|7|||
13394343|NCT00658632|26786744|FG001|Overall Study|Other|8|||
13394344|NCT00658606|26786777|FG000|Overall Study|Adverse Event|2|||
13394345|NCT00658606|26786778|FG001|Overall Study|Adverse Event|1|||
13394346|NCT00658606|26786777|FG000|Overall Study|Lack of Efficacy|6|||
13394347|NCT00658606|26786778|FG001|Overall Study|Lack of Efficacy|3|||
13394348|NCT00658606|26786777|FG000|Overall Study|Lost to Follow-up|1|||
13394349|NCT00658606|26786778|FG001|Overall Study|Lost to Follow-up|0|||
13394350|NCT00658606|26786777|FG000|Overall Study|Withdrawal by Subject|7|||
13394351|NCT00658606|26786778|FG001|Overall Study|Withdrawal by Subject|16|||
13394352|NCT00658606|26786777|FG000|Overall Study|Lack of Compliance|0|||
13394353|NCT00658606|26786778|FG001|Overall Study|Lack of Compliance|3|||
13394354|NCT00658567|26786799|FG000|Overall Study|Adverse Event|5|||
13394355|NCT00658567|26786800|FG001|Overall Study|Adverse Event|2|||
13394356|NCT00658567|26786801|FG002|Overall Study|Adverse Event|3|||
13394357|NCT00658567|26786799|FG000|Overall Study|Voluntary Withdrawal of Consent|2|||
13394358|NCT00658567|26786800|FG001|Overall Study|Voluntary Withdrawal of Consent|0|||
13394359|NCT00658567|26786801|FG002|Overall Study|Voluntary Withdrawal of Consent|2|||
13394360|NCT00658567|26786799|FG000|Overall Study|Physician Decision|0|||
13394361|NCT00658567|26786800|FG001|Overall Study|Physician Decision|1|||
13394362|NCT00658567|26786801|FG002|Overall Study|Physician Decision|0|||
13394363|NCT00658567|26786799|FG000|Overall Study|At Discretion of Sponsor|1|||
13394364|NCT00658567|26786800|FG001|Overall Study|At Discretion of Sponsor|1|||
13394365|NCT00658567|26786801|FG002|Overall Study|At Discretion of Sponsor|1|||
13394366|NCT00658541|26786814|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
13394367|NCT00658541|26786815|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
13394368|NCT00658541|26786814|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
13394369|NCT00658541|26786815|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
13394370|NCT00658528|26786832|FG000|Overall Study|Adverse Event|5|||
13135112|NCT02745145|25993629|FG000|Overall Study|Progressive disease|0|||
13380480|NCT00760214|26745129|FG002|Overall Study|Other|6|||
13394371|NCT00658528|26786833|FG001|Overall Study|Adverse Event|7|||
13394372|NCT00658528|26786832|FG000|Overall Study|Lost to Follow-up|14|||
13380481|NCT00760084|26745135|FG000|Overall Study|Physician Decision|5|||
13380482|NCT00760084|26745135|FG000|Overall Study|Withdrawal by Subject|2|||
13380483|NCT00760084|26745135|FG000|Overall Study|Progressive Disease|3|||
13380484|NCT00759954|26745154|FG000|Overall Study|Personal reason|1|||
13380485|NCT00759954|26745155|FG001|Overall Study|Personal reason|0|||
13380486|NCT00759954|26745154|FG000|Overall Study|Adverse Event|1|||
13380487|NCT00759954|26745155|FG001|Overall Study|Adverse Event|2|||
13380488|NCT00759941|26745174|FG000|Overall Study|Use of medication|1|||
13380489|NCT00759941|26745175|FG001|Overall Study|Use of medication|0|||
13380490|NCT00759941|26745174|FG000|Overall Study|Adverse Event|1|||
13380491|NCT00759941|26745175|FG001|Overall Study|Adverse Event|0|||
13380492|NCT00759941|26745174|FG000|Overall Study|Exited in error by site|1|||
13380493|NCT00759941|26745175|FG001|Overall Study|Exited in error by site|1|||
13380494|NCT00759915|26745194|FG000|Overall Study|Withdrawal by Subject|1|||
13380495|NCT00759915|26745195|FG001|Overall Study|Withdrawal by Subject|0|||
13380496|NCT00759915|26745194|FG000|Overall Study|Adverse Event|0|||
13380497|NCT00759915|26745195|FG001|Overall Study|Adverse Event|1|||
13380498|NCT00759902|26745214|FG000|Overall Study|Adverse Event|0|||
13380499|NCT00759902|26745215|FG001|Overall Study|Adverse Event|1|||
13380500|NCT00759876|26745239|FG000|Overall Study|Sponsor terminated study early|36|||
13380501|NCT00759863|26745256|FG000|Overall Study|Death, moved, or lost contact|20|||
13380502|NCT00759863|26745257|FG001|Overall Study|Death, moved, or lost contact|18|||
13380503|NCT00759785|26745276|FG000|Overall Study|Participant sample not evaluable|11|||
13380504|NCT00759785|26745277|FG001|Overall Study|Participant sample not evaluable|2|||
13380505|NCT00759785|26745276|FG000|Overall Study|Participant sample lost|0|||
13380506|NCT00759785|26745277|FG001|Overall Study|Participant sample lost|1|||
13380507|NCT00759785|26745276|FG000|Overall Study|Protocol Violation|1|||
13380508|NCT00759785|26745277|FG001|Overall Study|Protocol Violation|0|||
13380509|NCT00759785|26745276|FG000|Overall Study|Physician Decision|0|||
13380510|NCT00759785|26745277|FG001|Overall Study|Physician Decision|1|||
13380511|NCT00759785|26745276|FG000|Overall Study|Withdrawal by Subject|0|||
13380512|NCT00759785|26745277|FG001|Overall Study|Withdrawal by Subject|1|||
13380513|NCT00759759|26745296|FG000|Overall Study|didn't return for period 2|1|||
13380514|NCT00759759|26745297|FG001|Overall Study|didn't return for period 2|0|||
13380515|NCT00759759|26745296|FG000|Overall Study|Didn't receive drug in period 2|1|||
13380516|NCT00759759|26745297|FG001|Overall Study|Didn't receive drug in period 2|0|||
13380517|NCT00759759|26745296|FG000|Overall Study|Withdrawal by Subject|2|||
13380518|NCT00759759|26745297|FG001|Overall Study|Withdrawal by Subject|1|||
13380519|NCT00759681|26745312|FG000|Overall Study|Death|2|||
13380520|NCT00759681|26745313|FG001|Overall Study|Death|5|||
13380521|NCT00759681|26745312|FG000|Overall Study|Lost to Follow-up|8|||
13380522|NCT00759681|26745313|FG001|Overall Study|Lost to Follow-up|5|||
13380523|NCT00759564|26745469|FG000|Washout Period (at Least 14 Days)|Adverse Event|0|||
13380524|NCT00759564|26745470|FG001|Washout Period (at Least 14 Days)|Adverse Event|0|||
13380525|NCT00759564|26745471|FG002|Washout Period (at Least 14 Days)|Adverse Event|0|||
13380526|NCT00759564|26745472|FG003|Washout Period (at Least 14 Days)|Adverse Event|0|||
13380527|NCT00759564|26745473|FG004|Washout Period (at Least 14 Days)|Adverse Event|1|||
13380528|NCT00759395|26745494|FG000|Overall Study|Adverse Event|1|||
13380529|NCT00759395|26745495|FG001|Overall Study|Adverse Event|0|||
13380530|NCT00759395|26745494|FG000|Overall Study|Withdrawal by Subject|1|||
13380531|NCT00759395|26745495|FG001|Overall Study|Withdrawal by Subject|0|||
13380532|NCT00759395|26745494|FG000|Overall Study|Lack of Efficacy|0|||
13380533|NCT00759395|26745495|FG001|Overall Study|Lack of Efficacy|2|||
13380534|NCT00759356|26745514|FG000|Overall Study|Adverse Event|0|||
13380535|NCT00759356|26745515|FG001|Overall Study|Adverse Event|1|||
13380536|NCT00759356|26745514|FG000|Overall Study|Withdrawal by Subject|0|||
13394373|NCT00658528|26786833|FG001|Overall Study|Lost to Follow-up|22|||
13394374|NCT00658528|26786832|FG000|Overall Study|Withdrawal by Subject|8|||
13394375|NCT00658528|26786833|FG001|Overall Study|Withdrawal by Subject|6|||
13394376|NCT00658528|26786832|FG000|Overall Study|Withdrawal of consent|5|||
13394377|NCT00658528|26786833|FG001|Overall Study|Withdrawal of consent|6|||
13394378|NCT00658528|26786832|FG000|Overall Study|Other|8|||
13394379|NCT00658528|26786833|FG001|Overall Study|Other|4|||
13394380|NCT00658359|26786929|FG000|Overall Study|Death|3|||
13394381|NCT00658359|26786930|FG001|Overall Study|Death|1|||
13394382|NCT00658359|26786931|FG002|Overall Study|Death|2|||
13394383|NCT00658359|26786929|FG000|Overall Study|Adverse Event|13|||
13394384|NCT00658359|26786930|FG001|Overall Study|Adverse Event|6|||
13394385|NCT00658359|26786931|FG002|Overall Study|Adverse Event|9|||
13394386|NCT00658359|26786929|FG000|Overall Study|Protocol Violation|1|||
13394387|NCT00658359|26786930|FG001|Overall Study|Protocol Violation|0|||
13394388|NCT00658359|26786931|FG002|Overall Study|Protocol Violation|0|||
13394389|NCT00658359|26786929|FG000|Overall Study|Includes protocol Amendments 3 and 4|2|||
13394390|NCT00658359|26786930|FG001|Overall Study|Includes protocol Amendments 3 and 4|31|||
13394391|NCT00658359|26786931|FG002|Overall Study|Includes protocol Amendments 3 and 4|29|||
13394392|NCT00658359|26786929|FG000|Overall Study|Withdrawal by Subject|7|||
13380537|NCT00759356|26745515|FG001|Overall Study|Withdrawal by Subject|2|||
13380538|NCT00759356|26745514|FG000|Overall Study|Subject was unable to return|1|||
13380539|NCT00759356|26745515|FG001|Overall Study|Subject was unable to return|0|||
13380540|NCT00759174|26745531|FG000|Overall Study|Other|0|||
13380541|NCT00759174|26745532|FG001|Overall Study|Other|2|||
13380542|NCT00759148|26745547|FG000|Overall Study|Adverse Event|1|||
13380543|NCT00759148|26745548|FG001|Overall Study|Adverse Event|6|||
13380544|NCT00759148|26745547|FG000|Overall Study|Withdrawal by Subject|3|||
13380545|NCT00759148|26745548|FG001|Overall Study|Withdrawal by Subject|7|||
13380546|NCT00759148|26745547|FG000|Overall Study|Lost to Follow-up|3|||
13380547|NCT00759148|26745548|FG001|Overall Study|Lost to Follow-up|9|||
13380548|NCT00759148|26745547|FG000|Overall Study|Treatment Failure|6|||
13380549|NCT00759148|26745548|FG001|Overall Study|Treatment Failure|10|||
13380550|NCT00759148|26745547|FG000|Overall Study|Reason not given|1|||
13380551|NCT00759148|26745548|FG001|Overall Study|Reason not given|0|||
13380552|NCT00759109|26745571|FG000|Overall Study|Adverse Event|17|||
13380553|NCT00759109|26745572|FG001|Overall Study|Adverse Event|12|||
13380554|NCT00759109|26745571|FG000|Overall Study|Inability to comply|1|||
13380555|NCT00759109|26745572|FG001|Overall Study|Inability to comply|1|||
13380556|NCT00759109|26745571|FG000|Overall Study|Withdrawal by Subject|9|||
13380557|NCT00759109|26745572|FG001|Overall Study|Withdrawal by Subject|5|||
13380558|NCT00759109|26745571|FG000|Overall Study|Death|4|||
13380559|NCT00759109|26745572|FG001|Overall Study|Death|3|||
13380560|NCT00759109|26745571|FG000|Overall Study|Lost to Follow-up|4|||
13380561|NCT00759109|26745572|FG001|Overall Study|Lost to Follow-up|6|||
13380562|NCT00759109|26745571|FG000|Overall Study|Started new therapy|2|||
13380563|NCT00759109|26745572|FG001|Overall Study|Started new therapy|6|||
13380564|NCT00759109|26745571|FG000|Overall Study|HCV RNA negative|1|||
13380565|NCT00759109|26745572|FG001|Overall Study|HCV RNA negative|0|||
13380566|NCT00759109|26745571|FG000|Overall Study|Participant moved to a different city|0|||
13380567|NCT00759109|26745572|FG001|Overall Study|Participant moved to a different city|1|||
13380568|NCT00759109|26745571|FG000|Overall Study|Participant had a liver transplant|0|||
13380569|NCT00759109|26745572|FG001|Overall Study|Participant had a liver transplant|1|||
13380570|NCT00759109|26745571|FG000|Overall Study|Lost during study|1|||
13380571|NCT00759109|26745572|FG001|Overall Study|Lost during study|0|||
13380572|NCT00759031|26745585|FG000|First Intervention (1 Day)|Physician Decision|1|||
13380573|NCT00759031|26745586|FG001|First Intervention (1 Day)|Physician Decision|0|||
13380574|NCT00759031|26745585|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
13380575|NCT00759031|26745586|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
13380576|NCT00759031|26745585|FG000|First Intervention (1 Day)|Screening failure|1|||
13380577|NCT00759031|26745586|FG001|First Intervention (1 Day)|Screening failure|0|||
13380578|NCT00758771|26745599|FG000|Overall Study|Withdrawal by Subject|1|||
13380579|NCT00758771|26745600|FG001|Overall Study|Withdrawal by Subject|1|||
13380580|NCT00758771|26745599|FG000|Overall Study|Did not meet eligibility criteria|2|||
13380581|NCT00758771|26745600|FG001|Overall Study|Did not meet eligibility criteria|4|||
13380582|NCT00758706|26745643|FG000|Overall Study|Adverse Event|4|||
13380583|NCT00758706|26745644|FG001|Overall Study|Adverse Event|4|||
13380584|NCT00758680|26745695|FG000|Overall Study|Adverse Event|0|||
13380585|NCT00758680|26745696|FG001|Overall Study|Adverse Event|0|||
13380586|NCT00758680|26745697|FG002|Overall Study|Adverse Event|0|||
13380587|NCT00758680|26745698|FG003|Overall Study|Adverse Event|0|||
13380588|NCT00758680|26745699|FG004|Overall Study|Adverse Event|0|||
13380589|NCT00758680|26745700|FG005|Overall Study|Adverse Event|0|||
13380590|NCT00758680|26745701|FG006|Overall Study|Adverse Event|0|||
13380591|NCT00758680|26745702|FG007|Overall Study|Adverse Event|1|||
13380592|NCT00758680|26745703|FG008|Overall Study|Adverse Event|0|||
13380593|NCT00758680|26745704|FG009|Overall Study|Adverse Event|1|||
13380594|NCT00758680|26745695|FG000|Overall Study|Laboratory Adverse Event|0|||
13380595|NCT00758680|26745696|FG001|Overall Study|Laboratory Adverse Event|0|||
13380596|NCT00758680|26745697|FG002|Overall Study|Laboratory Adverse Event|0|||
13380597|NCT00758680|26745698|FG003|Overall Study|Laboratory Adverse Event|0|||
13380598|NCT00758680|26745699|FG004|Overall Study|Laboratory Adverse Event|0|||
13380599|NCT00758680|26745700|FG005|Overall Study|Laboratory Adverse Event|0|||
13380600|NCT00758680|26745701|FG006|Overall Study|Laboratory Adverse Event|0|||
13380601|NCT00758680|26745702|FG007|Overall Study|Laboratory Adverse Event|0|||
13380602|NCT00758680|26745703|FG008|Overall Study|Laboratory Adverse Event|1|||
13380603|NCT00758680|26745704|FG009|Overall Study|Laboratory Adverse Event|0|||
13380604|NCT00758680|26745695|FG000|Overall Study|Withdrawal by Subject|0|||
13380605|NCT00758680|26745696|FG001|Overall Study|Withdrawal by Subject|0|||
13380606|NCT00758680|26745697|FG002|Overall Study|Withdrawal by Subject|0|||
13380607|NCT00758680|26745698|FG003|Overall Study|Withdrawal by Subject|0|||
13380608|NCT00758680|26745699|FG004|Overall Study|Withdrawal by Subject|0|||
13380609|NCT00758680|26745700|FG005|Overall Study|Withdrawal by Subject|0|||
13380610|NCT00758680|26745701|FG006|Overall Study|Withdrawal by Subject|1|||
13380611|NCT00758680|26745702|FG007|Overall Study|Withdrawal by Subject|0|||
13380612|NCT00758680|26745703|FG008|Overall Study|Withdrawal by Subject|1|||
13380613|NCT00758680|26745704|FG009|Overall Study|Withdrawal by Subject|0|||
13380614|NCT00758602|26745733|FG000|Overall Study|Adverse Event|11|||
13380615|NCT00758602|26745734|FG001|Overall Study|Adverse Event|10|||
13380616|NCT00758602|26745733|FG000|Overall Study|Lost to Follow-up|4|||
13380617|NCT00758602|26745734|FG001|Overall Study|Lost to Follow-up|3|||
13380618|NCT00758602|26745733|FG000|Overall Study|Withdrawal by Subject|1|||
13380619|NCT00758602|26745734|FG001|Overall Study|Withdrawal by Subject|3|||
13380620|NCT00758602|26745733|FG000|Overall Study|Protocol Violation|0|||
13380621|NCT00758602|26745734|FG001|Overall Study|Protocol Violation|2|||
13380622|NCT00758602|26745733|FG000|Overall Study|Death|0|||
13380623|NCT00758602|26745734|FG001|Overall Study|Death|1|||
13380624|NCT00758602|26745733|FG000|Overall Study|Reason not specified|3|||
13380625|NCT00758602|26745734|FG001|Overall Study|Reason not specified|3|||
13380626|NCT00758589|26745813|FG000|Overall Study|Adverse Event|3|||
13380627|NCT00758589|26745814|FG001|Overall Study|Adverse Event|2|||
13380628|NCT00758589|26745815|FG002|Overall Study|Adverse Event|5|||
13380629|NCT00758589|26745816|FG003|Overall Study|Adverse Event|4|||
13380630|NCT00758589|26745813|FG000|Overall Study|Withdrawal by Subject|0|||
13380631|NCT00758589|26745814|FG001|Overall Study|Withdrawal by Subject|1|||
13380632|NCT00758589|26745815|FG002|Overall Study|Withdrawal by Subject|1|||
13380633|NCT00758589|26745816|FG003|Overall Study|Withdrawal by Subject|1|||
13380634|NCT00758589|26745813|FG000|Overall Study|Palm stopped to work|0|||
13380635|NCT00758589|26745814|FG001|Overall Study|Palm stopped to work|0|||
13380636|NCT00758589|26745815|FG002|Overall Study|Palm stopped to work|0|||
13380637|NCT00758589|26745816|FG003|Overall Study|Palm stopped to work|1|||
13380638|NCT00758524|26745961|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
13380639|NCT00758524|26745962|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2|||
13380640|NCT00758524|26745963|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4|||
13380641|NCT00758524|26745964|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
13380642|NCT00758524|26745965|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
13380643|NCT00758524|26745966|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5|||
13380644|NCT00758524|26745967|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
13380645|NCT00758524|26745968|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
13380646|NCT00758524|26745969|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
13380647|NCT00758524|26745970|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
13380648|NCT00758524|26745971|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
13380649|NCT00758524|26745972|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
13380650|NCT00758524|26745973|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
13380651|NCT00758524|26745974|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
13380652|NCT00758524|26745975|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
13380653|NCT00758524|26745976|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
13380654|NCT00758524|26745977|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
13380655|NCT00758524|26745961|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
13380656|NCT00758524|26745962|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
13380657|NCT00758524|26745963|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2|||
13380658|NCT00758524|26745964|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
13380659|NCT00758524|26745965|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1|||
13380660|NCT00758524|26745966|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
13380661|NCT00758524|26745967|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
13380662|NCT00758524|26745968|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
13380663|NCT00758524|26745969|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
13380664|NCT00758524|26745970|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
13380665|NCT00758524|26745971|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
13380666|NCT00758524|26745972|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
13380667|NCT00758524|26745973|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
13380668|NCT00758524|26745974|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
13380669|NCT00758524|26745975|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
13380670|NCT00758524|26745976|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
13380671|NCT00758524|26745977|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
13380672|NCT00758524|26745961|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2|||
13380673|NCT00758524|26745962|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1|||
13380674|NCT00758524|26745963|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1|||
13380675|NCT00758524|26745964|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3|||
13380676|NCT00758524|26745965|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2|||
13380677|NCT00758524|26745966|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1|||
13380678|NCT00758524|26745967|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0|||
13380679|NCT00758524|26745968|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0|||
13380680|NCT00758524|26745969|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0|||
13380681|NCT00758524|26745970|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0|||
13380682|NCT00758524|26745971|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0|||
13380683|NCT00758524|26745972|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0|||
13380684|NCT00758524|26745973|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0|||
13380685|NCT00758524|26745974|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0|||
13380686|NCT00758524|26745975|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0|||
13380687|NCT00758524|26745976|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0|||
13380688|NCT00758524|26745977|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0|||
13380689|NCT00758524|26745961|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
13380690|NCT00758524|26745962|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
13380691|NCT00758524|26745963|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
13380692|NCT00758524|26745964|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
13380693|NCT00758524|26745965|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
13380694|NCT00758524|26745966|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
13380695|NCT00758524|26745967|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
13380696|NCT00758524|26745968|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
13380697|NCT00758524|26745969|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
13380698|NCT00758524|26745970|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
13380699|NCT00758524|26745971|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
13380700|NCT00758524|26745972|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
13380701|NCT00758524|26745973|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
13380702|NCT00758524|26745974|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
13380703|NCT00758524|26745975|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
13380704|NCT00758524|26745976|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
13380705|NCT00758524|26745977|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
13380706|NCT00758524|26745961|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
13380707|NCT00758524|26745962|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
13380708|NCT00758524|26745963|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
13380709|NCT00758524|26745964|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
13380710|NCT00758524|26745965|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
13380711|NCT00758524|26745966|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
13380712|NCT00758524|26745967|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
13380713|NCT00758524|26745968|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
13380714|NCT00758524|26745969|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
13380715|NCT00758524|26745970|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
13380716|NCT00758524|26745971|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
13380717|NCT00758524|26745972|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
13380718|NCT00758524|26745973|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
13380719|NCT00758524|26745974|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
13380720|NCT00758524|26745975|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
13380721|NCT00758524|26745976|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
13380722|NCT00758524|26745977|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
13380723|NCT00758524|26745961|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
13380724|NCT00758524|26745962|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
13380725|NCT00758524|26745963|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
13380726|NCT00758524|26745964|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
13380727|NCT00758524|26745965|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1|||
13380728|NCT00758524|26745966|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
13380729|NCT00758524|26745967|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
13380730|NCT00758524|26745968|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
13380731|NCT00758524|26745969|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
13380732|NCT00758524|26745970|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
13380733|NCT00758524|26745971|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
13380734|NCT00758524|26745972|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
13380735|NCT00758524|26745973|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
13380736|NCT00758524|26745974|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
13380737|NCT00758524|26745975|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
13380738|NCT00758524|26745976|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
13380739|NCT00758524|26745977|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
13380740|NCT00758524|26745961|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
13380741|NCT00758524|26745962|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1|||
13380742|NCT00758524|26745963|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
13380743|NCT00758524|26745964|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
13380744|NCT00758524|26745965|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
13380745|NCT00758524|26745966|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
13380746|NCT00758524|26745967|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
13380747|NCT00758524|26745968|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
13380748|NCT00758524|26745969|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
13380749|NCT00758524|26745970|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
13380750|NCT00758524|26745971|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
13394393|NCT00658359|26786930|FG001|Overall Study|Withdrawal by Subject|4|||
13380751|NCT00758524|26745972|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
13380752|NCT00758524|26745973|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
13380753|NCT00758524|26745974|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
13380754|NCT00758524|26745975|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
13380755|NCT00758524|26745976|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
13380756|NCT00758524|26745977|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
13380757|NCT00758524|26745961|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
13380758|NCT00758524|26745962|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1|||
13380759|NCT00758524|26745963|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
13380760|NCT00758524|26745964|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
13380761|NCT00758524|26745965|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
13380762|NCT00758524|26745966|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
13380763|NCT00758524|26745967|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
13380764|NCT00758524|26745968|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
13380765|NCT00758524|26745969|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
13380766|NCT00758524|26745970|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
13380767|NCT00758524|26745971|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
13380768|NCT00758524|26745972|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
13380769|NCT00758524|26745973|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
13380770|NCT00758524|26745974|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
13380771|NCT00758524|26745975|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
13380772|NCT00758524|26745976|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
13380773|NCT00758524|26745977|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
13380774|NCT00758524|26745961|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
13380775|NCT00758524|26745962|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
13380776|NCT00758524|26745963|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
13380777|NCT00758524|26745964|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
13380778|NCT00758524|26745965|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
13380779|NCT00758524|26745966|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
13380780|NCT00758524|26745967|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
13380781|NCT00758524|26745968|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
13380782|NCT00758524|26745969|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2|||
13380783|NCT00758524|26745970|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
13380784|NCT00758524|26745971|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
13380785|NCT00758524|26745972|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
13380786|NCT00758524|26745973|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
13380787|NCT00758524|26745974|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
13380788|NCT00758524|26745975|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
13380789|NCT00758524|26745976|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
13380790|NCT00758524|26745977|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
13380791|NCT00758524|26745961|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
13380792|NCT00758524|26745962|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
13380793|NCT00758524|26745963|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
13380794|NCT00758524|26745964|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
13380795|NCT00758524|26745965|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
13380796|NCT00758524|26745966|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
13380797|NCT00758524|26745967|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1|||
13380798|NCT00758524|26745968|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
13380799|NCT00758524|26745969|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
13380800|NCT00758524|26745970|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
13380801|NCT00758524|26745971|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
13380802|NCT00758524|26745972|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
13380803|NCT00758524|26745973|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
13380804|NCT00758524|26745974|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
13380805|NCT00758524|26745975|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
13380806|NCT00758524|26745976|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
13380807|NCT00758524|26745977|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
13380808|NCT00758498|26746070|FG000|Overall Study|Adverse Event|2|||
13380809|NCT00758498|26746071|FG001|Overall Study|Adverse Event|2|||
13380810|NCT00758498|26746072|FG002|Overall Study|Adverse Event|3|||
13380811|NCT00758498|26746070|FG000|Overall Study|Subject legally detained out of state|1|||
13380812|NCT00758498|26746071|FG001|Overall Study|Subject legally detained out of state|0|||
13380813|NCT00758498|26746072|FG002|Overall Study|Subject legally detained out of state|0|||
13380814|NCT00758498|26746070|FG000|Overall Study|Withdrawal by Subject|0|||
13380815|NCT00758498|26746071|FG001|Overall Study|Withdrawal by Subject|0|||
13380816|NCT00758498|26746072|FG002|Overall Study|Withdrawal by Subject|1|||
13380817|NCT00758498|26746070|FG000|Overall Study|Noncompliance to study procedures|0|||
13380818|NCT00758498|26746071|FG001|Overall Study|Noncompliance to study procedures|0|||
13380819|NCT00758498|26746072|FG002|Overall Study|Noncompliance to study procedures|1|||
13394394|NCT00658359|26786931|FG002|Overall Study|Withdrawal by Subject|2|||
13394395|NCT00658359|26786929|FG000|Overall Study|Lost to Follow-up|2|||
13394396|NCT00658359|26786930|FG001|Overall Study|Lost to Follow-up|2|||
13394397|NCT00658359|26786931|FG002|Overall Study|Lost to Follow-up|4|||
13394398|NCT00658359|26786929|FG000|Overall Study|Lack of Efficacy|0|||
13394399|NCT00658359|26786930|FG001|Overall Study|Lack of Efficacy|1|||
13394400|NCT00658359|26786931|FG002|Overall Study|Lack of Efficacy|0|||
13394401|NCT00658333|26786946|FG000|Overall Study|Adverse Event|2|||
13394402|NCT00658333|26786947|FG001|Overall Study|Adverse Event|1|||
13394403|NCT00658320|26786977|FG000|Core Study: 12 Months|Subject withdrew consent|5|||
13394404|NCT00658320|26786978|FG001|Core Study: 12 Months|Subject withdrew consent|3|||
13394405|NCT00658320|26786977|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3|||
13394406|NCT00658320|26786978|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0|||
13394407|NCT00658320|26786977|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3|||
13394408|NCT00658320|26786978|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7|||
13394409|NCT00658320|26786977|FG000|Extension Study: After Month 24|Subject withdrew consent|2|||
13394410|NCT00658320|26786978|FG001|Extension Study: After Month 24|Subject withdrew consent|0|||
13394411|NCT00658021|26787012|FG000|28-Week Treatment Period|Adverse Event|3|||
13394412|NCT00658021|26787013|FG001|28-Week Treatment Period|Adverse Event|1|||
13394413|NCT00658021|26787014|FG002|28-Week Treatment Period|Adverse Event|0|||
13394414|NCT00658021|26787012|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0|||
13394415|NCT00658021|26787013|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2|||
13394416|NCT00658021|26787014|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0|||
13394417|NCT00658021|26787012|FG000|28-Week Treatment Period|Protocol Violation|0|||
13394418|NCT00658021|26787013|FG001|28-Week Treatment Period|Protocol Violation|2|||
13394419|NCT00658021|26787014|FG002|28-Week Treatment Period|Protocol Violation|1|||
13394420|NCT00658021|26787012|FG000|28-Week Treatment Period|Withdrawal by Subject|1|||
13394421|NCT00658021|26787013|FG001|28-Week Treatment Period|Withdrawal by Subject|1|||
13394422|NCT00658021|26787014|FG002|28-Week Treatment Period|Withdrawal by Subject|3|||
13394423|NCT00658021|26787012|FG000|28-Week Treatment Period|Physician Decision|1|||
13394424|NCT00658021|26787013|FG001|28-Week Treatment Period|Physician Decision|2|||
13394425|NCT00658021|26787014|FG002|28-Week Treatment Period|Physician Decision|1|||
13394426|NCT00658021|26787012|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
13394427|NCT00658021|26787013|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
13394428|NCT00658021|26787014|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
13394429|NCT00658021|26787012|FG000|28-Week Treatment Period|Loss of glucose control|1|||
13394430|NCT00658021|26787013|FG001|28-Week Treatment Period|Loss of glucose control|1|||
13394431|NCT00658021|26787014|FG002|28-Week Treatment Period|Loss of glucose control|10|||
13394432|NCT00658021|26787012|FG000|28-Week Treatment Period|Other|2|||
13394433|NCT00658021|26787013|FG001|28-Week Treatment Period|Other|3|||
13394434|NCT00658021|26787014|FG002|28-Week Treatment Period|Other|1|||
13394435|NCT00658021|26787012|FG000|28-Week Treatment Period|Did not receive treatment|2|||
13394436|NCT00658021|26787013|FG001|28-Week Treatment Period|Did not receive treatment|0|||
13394437|NCT00658021|26787014|FG002|28-Week Treatment Period|Did not receive treatment|0|||
13394438|NCT00658021|26787012|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
13394439|NCT00658021|26787013|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1|||
13394440|NCT00658021|26787014|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
13394441|NCT00658021|26787012|FG000|Long-term Safety Follow-up Period|Physician Decision|0|||
13394442|NCT00658021|26787013|FG001|Long-term Safety Follow-up Period|Physician Decision|2|||
13394443|NCT00658021|26787014|FG002|Long-term Safety Follow-up Period|Physician Decision|0|||
13394444|NCT00657709|26787071|FG000|Overall Study|AE or Death|7|||
13394445|NCT00657709|26787072|FG001|Overall Study|AE or Death|7|||
13394446|NCT00657709|26787073|FG002|Overall Study|AE or Death|6|||
13394447|NCT00657709|26787074|FG003|Overall Study|AE or Death|7|||
13394448|NCT00657709|26787075|FG004|Overall Study|AE or Death|1|||
13394449|NCT00657709|26787071|FG000|Overall Study|Withdrawal by Subject|7|||
13394450|NCT00657709|26787072|FG001|Overall Study|Withdrawal by Subject|15|||
13394451|NCT00657709|26787073|FG002|Overall Study|Withdrawal by Subject|15|||
13394452|NCT00657709|26787074|FG003|Overall Study|Withdrawal by Subject|5|||
13394453|NCT00657709|26787075|FG004|Overall Study|Withdrawal by Subject|9|||
13394454|NCT00657709|26787071|FG000|Overall Study|Lost to Follow-up|9|||
13394455|NCT00657709|26787072|FG001|Overall Study|Lost to Follow-up|9|||
13394456|NCT00657709|26787073|FG002|Overall Study|Lost to Follow-up|7|||
13394457|NCT00657709|26787074|FG003|Overall Study|Lost to Follow-up|1|||
13394458|NCT00657709|26787075|FG004|Overall Study|Lost to Follow-up|21|||
13394459|NCT00657709|26787071|FG000|Overall Study|Protocol Violation|0|||
13394460|NCT00657709|26787072|FG001|Overall Study|Protocol Violation|2|||
13380820|NCT00758485|26746089|FG000|Overall Study|Lost to Follow-up|0|||
13380821|NCT00758485|26746090|FG001|Overall Study|Lost to Follow-up|1|||
13380822|NCT00758485|26746089|FG000|Overall Study|Not Treated|1|||
13380823|NCT00758485|26746090|FG001|Overall Study|Not Treated|2|||
13380824|NCT00758459|26746129|FG000|Overall Study|Adverse Event|3|||
13380825|NCT00758459|26746130|FG001|Overall Study|Adverse Event|2|||
13380826|NCT00758459|26746129|FG000|Overall Study|Protocol Violation|0|||
13380827|NCT00758459|26746130|FG001|Overall Study|Protocol Violation|1|||
13380828|NCT00758459|26746129|FG000|Overall Study|Withdrawal by Subject|0|||
13380829|NCT00758459|26746130|FG001|Overall Study|Withdrawal by Subject|1|||
13380830|NCT00758394|26746153|FG000|2nd Intervention Order|Lost to Follow-up|0|||
13380831|NCT00758394|26746154|FG001|2nd Intervention Order|Lost to Follow-up|1|||
13380832|NCT00758394|26746155|FG002|2nd Intervention Order|Lost to Follow-up|0|||
13380833|NCT00758394|26746156|FG003|2nd Intervention Order|Lost to Follow-up|0|||
13380834|NCT00758394|26746153|FG000|3rd Intervention|Lost to Follow-up|1|||
13380835|NCT00758394|26746154|FG001|3rd Intervention|Lost to Follow-up|0|||
13380836|NCT00758394|26746155|FG002|3rd Intervention|Lost to Follow-up|0|||
13380837|NCT00758394|26746156|FG003|3rd Intervention|Lost to Follow-up|1|||
13380838|NCT00758264|26746225|FG000|Active Phase|Withdrawal by Subject|0|||
13380839|NCT00758264|26746226|FG001|Active Phase|Withdrawal by Subject|0|||
13380840|NCT00758264|26746227|FG002|Active Phase|Withdrawal by Subject|1|||
13380841|NCT00758264|26746225|FG000|Active Phase|Lost to Follow-up|1|||
13380842|NCT00758264|26746226|FG001|Active Phase|Lost to Follow-up|0|||
13380843|NCT00758264|26746227|FG002|Active Phase|Lost to Follow-up|0|||
13380844|NCT00758264|26746225|FG000|Active Phase|Other|0|||
13380845|NCT00758264|26746226|FG001|Active Phase|Other|0|||
13380846|NCT00758264|26746227|FG002|Active Phase|Other|4|||
13380847|NCT00758160|26746247|FG000|Overall Study|No Longer Requires Study Medication|4|||
13380848|NCT00758160|26746247|FG000|Overall Study|Administration Problems|3|||
13380849|NCT00758160|26746247|FG000|Overall Study|Adverse Event|15|||
13380850|NCT00758160|26746247|FG000|Overall Study|Lack of Efficacy|10|||
13380851|NCT00758160|26746247|FG000|Overall Study|Lost to Follow-up|14|||
13380852|NCT00758160|26746247|FG000|Overall Study|Protocol Violation|12|||
13380853|NCT00758160|26746247|FG000|Overall Study|Withdrawal by Subject|8|||
13380854|NCT00758069|26746268|FG000|Overall Study|Lack of Efficacy|0|||
13380855|NCT00758069|26746269|FG001|Overall Study|Lack of Efficacy|0|||
13380856|NCT00758069|26746270|FG002|Overall Study|Lack of Efficacy|1|||
13380857|NCT00758069|26746268|FG000|Overall Study|Incorrect Study Drug|1|||
13380858|NCT00758069|26746269|FG001|Overall Study|Incorrect Study Drug|0|||
13380859|NCT00758069|26746270|FG002|Overall Study|Incorrect Study Drug|0|||
13380860|NCT00758043|26746321|FG000|Overall Study|Adverse Event|1|||
13380861|NCT00758043|26746322|FG001|Overall Study|Adverse Event|20|||
13380862|NCT00758043|26746323|FG002|Overall Study|Adverse Event|12|||
13380863|NCT00758043|26746324|FG003|Overall Study|Adverse Event|62|||
13380864|NCT00758043|26746321|FG000|Overall Study|Lack of Efficacy|0|||
13380865|NCT00758043|26746322|FG001|Overall Study|Lack of Efficacy|6|||
13380866|NCT00758043|26746323|FG002|Overall Study|Lack of Efficacy|18|||
13380867|NCT00758043|26746324|FG003|Overall Study|Lack of Efficacy|12|||
13380868|NCT00758043|26746321|FG000|Overall Study|Refused Further Treatment|0|||
13380869|NCT00758043|26746322|FG001|Overall Study|Refused Further Treatment|11|||
13380870|NCT00758043|26746323|FG002|Overall Study|Refused Further Treatment|5|||
13380871|NCT00758043|26746324|FG003|Overall Study|Refused Further Treatment|8|||
13380872|NCT00758043|26746321|FG000|Overall Study|Lost to Follow-up|0|||
13380873|NCT00758043|26746322|FG001|Overall Study|Lost to Follow-up|2|||
13380874|NCT00758043|26746323|FG002|Overall Study|Lost to Follow-up|2|||
13380875|NCT00758043|26746324|FG003|Overall Study|Lost to Follow-up|5|||
13380876|NCT00758043|26746321|FG000|Overall Study|Withdrawal by Subject|0|||
13380877|NCT00758043|26746322|FG001|Overall Study|Withdrawal by Subject|1|||
13380878|NCT00758043|26746323|FG002|Overall Study|Withdrawal by Subject|1|||
13380879|NCT00758043|26746324|FG003|Overall Study|Withdrawal by Subject|4|||
13380880|NCT00758043|26746321|FG000|Overall Study|Required Prohibited Medication|0|||
13380881|NCT00758043|26746322|FG001|Overall Study|Required Prohibited Medication|0|||
13380882|NCT00758043|26746323|FG002|Overall Study|Required Prohibited Medication|1|||
13380883|NCT00758043|26746324|FG003|Overall Study|Required Prohibited Medication|3|||
13380884|NCT00758043|26746321|FG000|Overall Study|Non-Compliant With study Drug|0|||
13380885|NCT00758043|26746322|FG001|Overall Study|Non-Compliant With study Drug|0|||
13380886|NCT00758043|26746323|FG002|Overall Study|Non-Compliant With study Drug|0|||
13380887|NCT00758043|26746324|FG003|Overall Study|Non-Compliant With study Drug|1|||
13380888|NCT00758043|26746321|FG000|Overall Study|Other Reasons|0|||
13380889|NCT00758043|26746322|FG001|Overall Study|Other Reasons|1|||
13380890|NCT00758043|26746323|FG002|Overall Study|Other Reasons|0|||
13380891|NCT00758043|26746324|FG003|Overall Study|Other Reasons|5|||
13380892|NCT00757848|26746375|FG000|Overall Study|Voluntary discontinuation|1|||
13380893|NCT00757848|26746376|FG001|Overall Study|Voluntary discontinuation|0|||
13380894|NCT00757848|26746375|FG000|Overall Study|Adverse Event|1|||
13380895|NCT00757848|26746376|FG001|Overall Study|Adverse Event|2|||
13380896|NCT00757848|26746375|FG000|Overall Study|Incorrect enrolment|1|||
13380897|NCT00757848|26746376|FG001|Overall Study|Incorrect enrolment|0|||
13380898|NCT00757783|26746419|FG000|Overall Study|Adverse Event|0|||
13380899|NCT00757783|26746420|FG001|Overall Study|Adverse Event|2|||
13380900|NCT00757783|26746419|FG000|Overall Study|Lost to Follow-up|1|||
13380901|NCT00757783|26746420|FG001|Overall Study|Lost to Follow-up|1|||
13380902|NCT00757783|26746419|FG000|Overall Study|Protocol Violation|1|||
13380903|NCT00757783|26746420|FG001|Overall Study|Protocol Violation|0|||
13380904|NCT00757783|26746419|FG000|Overall Study|Withdrawal by Subject|2|||
13380905|NCT00757783|26746420|FG001|Overall Study|Withdrawal by Subject|1|||
13380906|NCT00757783|26746419|FG000|Overall Study|Other|1|||
13380907|NCT00757783|26746420|FG001|Overall Study|Other|2|||
13380908|NCT00757705|26746434|FG000|Overall Study|Adverse Event|19|||
13380909|NCT00757705|26746434|FG000|Overall Study|Lost to Follow-up|16|||
13380910|NCT00757705|26746434|FG000|Overall Study|Withdrawal by Subject|25|||
13380911|NCT00757705|26746434|FG000|Overall Study|Insufficient Response|26|||
13380912|NCT00757705|26746434|FG000|Overall Study|Ineligible to continue|8|||
13380913|NCT00757705|26746434|FG000|Overall Study|Non-compliant|9|||
13380914|NCT00757705|26746434|FG000|Overall Study|Other|18|||
13380915|NCT00757627|26746449|FG000|Overall Study|Adverse Event|15|||
13380916|NCT00757627|26746449|FG000|Overall Study|Lack of Efficacy|10|||
13380917|NCT00757627|26746449|FG000|Overall Study|Lost to Follow-up|28|||
13380918|NCT00757627|26746449|FG000|Overall Study|Withdrawal by Subject|27|||
13380919|NCT00757627|26746449|FG000|Overall Study|Other|1|||
13380920|NCT00757588|26746488|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3|||
13380921|NCT00757588|26746489|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2|||
13380922|NCT00757588|26746488|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6|||
13380923|NCT00757588|26746489|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3|||
13380924|NCT00757588|26746488|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13|||
13380925|NCT00757588|26746489|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5|||
13380926|NCT00757588|26746488|FG000|Period 1: Short-term (24-week) Phase|Death|1|||
13380927|NCT00757588|26746489|FG001|Period 1: Short-term (24-week) Phase|Death|0|||
13380928|NCT00757588|26746488|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3|||
13380929|NCT00757588|26746489|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5|||
13380930|NCT00757588|26746488|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5|||
13380931|NCT00757588|26746489|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1|||
13380932|NCT00757588|26746488|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5|||
13380933|NCT00757588|26746489|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0|||
13380934|NCT00757588|26746488|FG000|Period 1: Short-term (24-week) Phase|Other|0|||
13380935|NCT00757588|26746489|FG001|Period 1: Short-term (24-week) Phase|Other|1|||
13380936|NCT00757588|26746488|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1|||
13380937|NCT00757588|26746489|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0|||
13380938|NCT00757588|26746488|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4|||
13380939|NCT00757588|26746489|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0|||
13380940|NCT00757588|26746488|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4|||
13380941|NCT00757588|26746489|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2|||
13380942|NCT00757588|26746488|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
13380943|NCT00757588|26746489|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
13380944|NCT00757588|26746488|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5|||
13380945|NCT00757588|26746489|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2|||
13380946|NCT00757588|26746488|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1|||
13380947|NCT00757588|26746489|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0|||
13380948|NCT00757588|26746488|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5|||
13380949|NCT00757588|26746489|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4|||
13380950|NCT00757588|26746488|FG000|Period 2: Long-term (52-week) Phase|Other|1|||
13380951|NCT00757588|26746489|FG001|Period 2: Long-term (52-week) Phase|Other|0|||
13380952|NCT00757237|26746524|FG000|Overall Study|Lost to Follow-up|0|||
13380953|NCT00757237|26746525|FG001|Overall Study|Lost to Follow-up|1|||
13380954|NCT00757237|26746524|FG000|Overall Study|Protocol Violation|0|||
13380955|NCT00757237|26746525|FG001|Overall Study|Protocol Violation|2|||
13380956|NCT00757237|26746524|FG000|Overall Study|Physician Decision|2|||
13380957|NCT00757237|26746525|FG001|Overall Study|Physician Decision|3|||
13380958|NCT00757237|26746524|FG000|Overall Study|Withdrawal by Subject|8|||
13380959|NCT00757237|26746525|FG001|Overall Study|Withdrawal by Subject|12|||
13380960|NCT00757237|26746524|FG000|Overall Study|Safety or Tolerability|3|||
13380961|NCT00757237|26746525|FG001|Overall Study|Safety or Tolerability|5|||
13380962|NCT00757237|26746524|FG000|Overall Study|Other|0|||
13380963|NCT00757237|26746525|FG001|Overall Study|Other|2|||
13380964|NCT00757172|26746535|FG000|Overall Study|Withdrawal by Subject|4|||
13380965|NCT00757172|26746535|FG000|Overall Study|Physician Decision|3|||
13380966|NCT00757172|26746535|FG000|Overall Study|Progression|4|||
13380967|NCT00757042|26746659|FG000|Overall Study|Lost to Follow-up|0|||
13380968|NCT00757042|26746660|FG001|Overall Study|Lost to Follow-up|0|||
13380969|NCT00757042|26746661|FG002|Overall Study|Lost to Follow-up|0|||
13380970|NCT00757042|26746662|FG003|Overall Study|Lost to Follow-up|0|||
13380971|NCT00757042|26746663|FG004|Overall Study|Lost to Follow-up|0|||
13380972|NCT00757042|26746664|FG005|Overall Study|Lost to Follow-up|0|||
13380973|NCT00757042|26746665|FG006|Overall Study|Lost to Follow-up|0|||
13380974|NCT00757042|26746666|FG007|Overall Study|Lost to Follow-up|0|||
13380975|NCT00757042|26746667|FG008|Overall Study|Lost to Follow-up|1|||
13380976|NCT00757042|26746668|FG009|Overall Study|Lost to Follow-up|0|||
13380977|NCT00757042|26746669|FG010|Overall Study|Lost to Follow-up|0|||
13380978|NCT00757042|26746659|FG000|Overall Study|Ineligibility Determined|0|||
13380979|NCT00757042|26746660|FG001|Overall Study|Ineligibility Determined|0|||
13380980|NCT00757042|26746661|FG002|Overall Study|Ineligibility Determined|0|||
13380981|NCT00757042|26746662|FG003|Overall Study|Ineligibility Determined|0|||
13380982|NCT00757042|26746663|FG004|Overall Study|Ineligibility Determined|0|||
13380983|NCT00757042|26746664|FG005|Overall Study|Ineligibility Determined|0|||
13380984|NCT00757042|26746665|FG006|Overall Study|Ineligibility Determined|0|||
13380985|NCT00757042|26746666|FG007|Overall Study|Ineligibility Determined|0|||
13380986|NCT00757042|26746667|FG008|Overall Study|Ineligibility Determined|0|||
13380987|NCT00757042|26746668|FG009|Overall Study|Ineligibility Determined|0|||
13380988|NCT00757042|26746669|FG010|Overall Study|Ineligibility Determined|1|||
13380989|NCT00757042|26746659|FG000|Overall Study|Withdrawal by Subject|0|||
13380990|NCT00757042|26746660|FG001|Overall Study|Withdrawal by Subject|0|||
13380991|NCT00757042|26746661|FG002|Overall Study|Withdrawal by Subject|0|||
13380992|NCT00757042|26746662|FG003|Overall Study|Withdrawal by Subject|0|||
13380993|NCT00757042|26746663|FG004|Overall Study|Withdrawal by Subject|0|||
13380994|NCT00757042|26746664|FG005|Overall Study|Withdrawal by Subject|0|||
13380995|NCT00757042|26746665|FG006|Overall Study|Withdrawal by Subject|0|||
13380996|NCT00757042|26746666|FG007|Overall Study|Withdrawal by Subject|0|||
13380997|NCT00757042|26746667|FG008|Overall Study|Withdrawal by Subject|0|||
13380998|NCT00757042|26746668|FG009|Overall Study|Withdrawal by Subject|1|||
13380999|NCT00757042|26746669|FG010|Overall Study|Withdrawal by Subject|0|||
13381000|NCT00757003|26746677|FG000|Overall Study|Death|33|||
13381001|NCT00757003|26746677|FG000|Overall Study|Lost to Follow-up|9|||
13381002|NCT00757003|26746677|FG000|Overall Study|Withdrawal by Subject|4|||
13381003|NCT00757003|26746677|FG000|Overall Study|Surgically explanted|2|||
13381004|NCT00757003|26746677|FG000|Overall Study|Not implanted|1|||
13381005|NCT00756938|26746714|FG000|12-week Base Study|Protocol-specific Criteria Met|1|||
13381006|NCT00756938|26746715|FG001|12-week Base Study|Protocol-specific Criteria Met|0|||
13381007|NCT00756938|26746716|FG002|12-week Base Study|Protocol-specific Criteria Met|1|||
13381008|NCT00756938|26746717|FG003|12-week Base Study|Protocol-specific Criteria Met|0|||
13381009|NCT00756938|26746714|FG000|12-week Base Study|Protocol Violation|0|||
13381010|NCT00756938|26746715|FG001|12-week Base Study|Protocol Violation|0|||
13381011|NCT00756938|26746716|FG002|12-week Base Study|Protocol Violation|1|||
13381012|NCT00756938|26746717|FG003|12-week Base Study|Protocol Violation|0|||
13381013|NCT00756938|26746714|FG000|12-week Base Study|Lost to Follow-up|1|||
13381014|NCT00756938|26746715|FG001|12-week Base Study|Lost to Follow-up|0|||
13381015|NCT00756938|26746716|FG002|12-week Base Study|Lost to Follow-up|0|||
13381016|NCT00756938|26746717|FG003|12-week Base Study|Lost to Follow-up|0|||
13381017|NCT00756938|26746714|FG000|Optional Extension|Lack of Efficacy|0|||
13381018|NCT00756938|26746715|FG001|Optional Extension|Lack of Efficacy|0|||
13381019|NCT00756938|26746716|FG002|Optional Extension|Lack of Efficacy|0|||
13381020|NCT00756938|26746717|FG003|Optional Extension|Lack of Efficacy|1|||
13381021|NCT00756938|26746714|FG000|Optional Extension|End of Study|0|||
13381022|NCT00756938|26746715|FG001|Optional Extension|End of Study|0|||
13381023|NCT00756938|26746716|FG002|Optional Extension|End of Study|0|||
13381024|NCT00756938|26746717|FG003|Optional Extension|End of Study|11|||
13381025|NCT00756938|26746714|FG000|Optional Extension|Protocol-specific criteria met|0|||
13381026|NCT00756938|26746715|FG001|Optional Extension|Protocol-specific criteria met|0|||
13381027|NCT00756938|26746716|FG002|Optional Extension|Protocol-specific criteria met|0|||
13381028|NCT00756938|26746717|FG003|Optional Extension|Protocol-specific criteria met|9|||
13381029|NCT00756938|26746714|FG000|Optional Extension|Physician Decision|0|||
13381030|NCT00756938|26746715|FG001|Optional Extension|Physician Decision|0|||
13381031|NCT00756938|26746716|FG002|Optional Extension|Physician Decision|0|||
13381032|NCT00756938|26746717|FG003|Optional Extension|Physician Decision|3|||
13381033|NCT00756938|26746714|FG000|Optional Extension|Lost to Follow-up|0|||
13381034|NCT00756938|26746715|FG001|Optional Extension|Lost to Follow-up|0|||
13381035|NCT00756938|26746716|FG002|Optional Extension|Lost to Follow-up|0|||
13381036|NCT00756938|26746717|FG003|Optional Extension|Lost to Follow-up|1|||
13381037|NCT00756938|26746714|FG000|Optional Extension|Protocol Violation|0|||
13381038|NCT00756938|26746715|FG001|Optional Extension|Protocol Violation|0|||
13381039|NCT00756938|26746716|FG002|Optional Extension|Protocol Violation|0|||
13381040|NCT00756938|26746717|FG003|Optional Extension|Protocol Violation|1|||
13381041|NCT00756938|26746714|FG000|Optional Extension|Withdrawal by Subject|0|||
13381042|NCT00756938|26746715|FG001|Optional Extension|Withdrawal by Subject|0|||
13381043|NCT00756938|26746716|FG002|Optional Extension|Withdrawal by Subject|0|||
13381044|NCT00756938|26746717|FG003|Optional Extension|Withdrawal by Subject|10|||
13381045|NCT00756938|26746714|FG000|Optional Extension|Adverse Event|0|||
13381046|NCT00756938|26746715|FG001|Optional Extension|Adverse Event|0|||
13381047|NCT00756938|26746716|FG002|Optional Extension|Adverse Event|0|||
13381048|NCT00756938|26746717|FG003|Optional Extension|Adverse Event|1|||
13381049|NCT00756886|26746730|FG000|Overall Study|Lost to Follow-up|1|||
13381050|NCT00756886|26746731|FG001|Overall Study|Lost to Follow-up|0|||
13381051|NCT00756886|26746730|FG000|Overall Study|Adverse Event|0|||
13381052|NCT00756886|26746731|FG001|Overall Study|Adverse Event|3|||
13381053|NCT00756886|26746730|FG000|Overall Study|Lack of Efficacy|1|||
13381054|NCT00756886|26746731|FG001|Overall Study|Lack of Efficacy|0|||
13381055|NCT00756886|26746730|FG000|Overall Study|Ineligible|9|||
13381056|NCT00756886|26746731|FG001|Overall Study|Ineligible|4|||
13381057|NCT00756730|26746758|FG000|Overall Study|discontinued due to rash prior to week 4|0|||
13381058|NCT00756730|26746759|FG001|Overall Study|discontinued due to rash prior to week 4|1|||
13381059|NCT00756730|26746758|FG000|Overall Study|persistent low-level viremmia|0|||
13381060|NCT00756730|26746759|FG001|Overall Study|persistent low-level viremmia|1|||
13381061|NCT00756717|26746765|FG000|Overall Study|Withdrawal by Subject|2|||
13381062|NCT00756652|26746778|FG000|Original Phase|Withdrawal by Subject|864|||
13381063|NCT00756652|26746779|FG001|Original Phase|Withdrawal by Subject|23|||
13381064|NCT00756652|26746778|FG000|Original Phase|Lost to Follow-up|601|||
13381065|NCT00756652|26746779|FG001|Original Phase|Lost to Follow-up|0|||
13381066|NCT00756652|26746778|FG000|Original Phase|Other Discontinuation|797|||
13381067|NCT00756652|26746779|FG001|Original Phase|Other Discontinuation|5|||
13381068|NCT00756652|26746778|FG000|Original Phase|Participant Noncompliance|18622|||
13381069|NCT00756652|26746779|FG001|Original Phase|Participant Noncompliance|424|||
13381070|NCT00756652|26746778|FG000|Original Phase|Unknown Discontinuation Reason|2|||
13381071|NCT00756652|26746779|FG001|Original Phase|Unknown Discontinuation Reason|0|||
13381072|NCT00756652|26746778|FG000|Original Phase|Participants without data|3259|||
13381073|NCT00756652|26746779|FG001|Original Phase|Participants without data|466|||
13381074|NCT00756652|26746778|FG000|Original Phase|Death|168|||
13381075|NCT00756652|26746779|FG001|Original Phase|Death|1|||
13381076|NCT00756652|26746778|FG000|Original Phase|Not due for F/U at Phase One closure|11076|||
13381077|NCT00756652|26746779|FG001|Original Phase|Not due for F/U at Phase One closure|2|||
13381078|NCT00756652|26746778|FG000|Re-Op Phase|Withdrawal by Subject|62|||
13381079|NCT00756652|26746779|FG001|Re-Op Phase|Withdrawal by Subject|0|||
13381080|NCT00756652|26746778|FG000|Re-Op Phase|Death|6|||
13381081|NCT00756652|26746779|FG001|Re-Op Phase|Death|0|||
13381082|NCT00756652|26746778|FG000|Re-Op Phase|Lost to Follow-up|340|||
13381083|NCT00756652|26746779|FG001|Re-Op Phase|Lost to Follow-up|0|||
13381084|NCT00756652|26746778|FG000|Re-Op Phase|Site Closed|2454|||
13381085|NCT00756652|26746779|FG001|Re-Op Phase|Site Closed|0|||
13381086|NCT00756652|26746778|FG000|Re-Op Phase|Withdrawn after explant|14|||
13381087|NCT00756652|26746779|FG001|Re-Op Phase|Withdrawn after explant|0|||
13381088|NCT00756470|26746786|FG000|Overall Study|Withdrawal by Subject|1|||
13381089|NCT00756470|26746786|FG000|Overall Study|Adverse Event|4|||
13381090|NCT00756457|26746821|FG000|Overall Study|Lost to Follow-up|1|||
13381091|NCT00756457|26746822|FG001|Overall Study|Lost to Follow-up|2|||
13381092|NCT00756444|26746838|FG000|Overall Study|Adverse Event|1|||
13381093|NCT00756444|26746839|FG001|Overall Study|Adverse Event|1|||
13381094|NCT00756444|26746838|FG000|Overall Study|Withdrawal by Subject|6|||
13381095|NCT00756444|26746839|FG001|Overall Study|Withdrawal by Subject|8|||
13394461|NCT00657709|26787073|FG002|Overall Study|Protocol Violation|0|||
13394462|NCT00657709|26787074|FG003|Overall Study|Protocol Violation|1|||
13394463|NCT00657709|26787075|FG004|Overall Study|Protocol Violation|2|||
13394464|NCT00657618|26787082|FG000|Overall Study|Adverse Event|32|||
13394465|NCT00657618|26787082|FG000|Overall Study|Withdrawal by Subject|8|||
13394466|NCT00657618|26787082|FG000|Overall Study|negative for leishmaniasis|2|||
13394467|NCT00657618|26787082|FG000|Overall Study|didn't start due to schedule conflicts|1|||
13394468|NCT00657553|26787095|FG000|Overall Study|low accrual, no analysis run|5|||
13394469|NCT00657553|26787096|FG001|Overall Study|low accrual, no analysis run|5|||
13394470|NCT00657540|26787117|FG000|Overall Study|Lost to Follow-up|1|||
13394471|NCT00657540|26787118|FG001|Overall Study|Lost to Follow-up|4|||
13394472|NCT00657371|26787125|FG000|Overall Study|Poor bowel preparation|15|||
13394473|NCT00657371|26787125|FG000|Overall Study|Unable to intubate the cecum|5|||
13394474|NCT00657371|26787125|FG000|Overall Study|Protocol Violation|2|||
13394475|NCT00657371|26787125|FG000|Overall Study|Device- related reasons|13|||
13394476|NCT00657371|26787125|FG000|Overall Study|Pre-existing medical condition|4|||
13394477|NCT00657358|26787135|FG000|Overall Study|Lack of Efficacy|6|||
13394478|NCT00657267|26787145|FG000|Overall Study|Progressive disease|45|||
13394479|NCT00657267|26787145|FG000|Overall Study|Adverse Event|9|||
13394480|NCT00657150|26787180|FG000|Overall Study|Adverse Event|19|||
13394481|NCT00657150|26787181|FG001|Overall Study|Adverse Event|10|||
13394482|NCT00657150|26787180|FG000|Overall Study|Non-compliant with protocol|5|||
13394483|NCT00657150|26787181|FG001|Overall Study|Non-compliant with protocol|9|||
13394484|NCT00657150|26787180|FG000|Overall Study|Lost to Follow-up|2|||
13394485|NCT00657150|26787181|FG001|Overall Study|Lost to Follow-up|0|||
13394486|NCT00657150|26787180|FG000|Overall Study|Withdrawal by Subject|51|||
13394487|NCT00657150|26787181|FG001|Overall Study|Withdrawal by Subject|36|||
13394488|NCT00657150|26787180|FG000|Overall Study|Other|38|||
13394489|NCT00657150|26787181|FG001|Overall Study|Other|38|||
13381096|NCT00756444|26746838|FG000|Overall Study|Lost to Follow-up|0|||
13381097|NCT00756444|26746839|FG001|Overall Study|Lost to Follow-up|1|||
13381098|NCT00756444|26746838|FG000|Overall Study|Death|5|||
13381099|NCT00756444|26746839|FG001|Overall Study|Death|4|||
13381100|NCT00756444|26746838|FG000|Overall Study|Disease Progression|2|||
13381101|NCT00756444|26746839|FG001|Overall Study|Disease Progression|7|||
13381102|NCT00756444|26746838|FG000|Overall Study|Ineligibility Determined|1|||
13381103|NCT00756444|26746839|FG001|Overall Study|Ineligibility Determined|0|||
13381104|NCT00756314|26746860|FG000|Overall Study|Lost to Follow-up|2|||
13381105|NCT00756314|26746861|FG001|Overall Study|Lost to Follow-up|59|||
13381106|NCT00756275|26746892|FG000|Overall Study|Lost to Follow-up|25|||
13381107|NCT00756275|26746893|FG001|Overall Study|Lost to Follow-up|21|||
13381108|NCT00756275|26746892|FG000|Overall Study|Withdrawal by Subject|4|||
13381109|NCT00756275|26746893|FG001|Overall Study|Withdrawal by Subject|7|||
13381110|NCT00756002|26746994|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
13381111|NCT00756002|26746995|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
13381112|NCT00756002|26746994|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
13381113|NCT00756002|26746995|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
13381114|NCT00756002|26746994|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6|||
13381115|NCT00756002|26746995|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6|||
13381116|NCT00756002|26746994|FG000|Double-Blind Treatment Period|Protocol Violation|6|||
13381117|NCT00756002|26746995|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
13381118|NCT00756002|26746994|FG000|Double-Blind Treatment Period|Other|2|||
13381119|NCT00756002|26746995|FG001|Double-Blind Treatment Period|Other|2|||
13381120|NCT00755937|26747007|FG000|Recruitment|Unknown if infliximab received|164|||
13381121|NCT00755937|26747007|FG000|Observational Follow-up|Lost to Follow-up|148|||
13381122|NCT00755846|26747124|FG000|Overall Study|Adverse Event|0|||
13381123|NCT00755846|26747125|FG001|Overall Study|Adverse Event|0|||
13381124|NCT00755846|26747126|FG002|Overall Study|Adverse Event|0|||
13381125|NCT00755846|26747127|FG003|Overall Study|Adverse Event|1|||
13381126|NCT00755846|26747128|FG004|Overall Study|Adverse Event|3|||
13381127|NCT00755846|26747129|FG005|Overall Study|Adverse Event|2|||
13381128|NCT00755846|26747124|FG000|Overall Study|Protocol Violation|1|||
13381129|NCT00755846|26747125|FG001|Overall Study|Protocol Violation|1|||
13381130|NCT00755846|26747126|FG002|Overall Study|Protocol Violation|1|||
13381131|NCT00755846|26747127|FG003|Overall Study|Protocol Violation|1|||
13381132|NCT00755846|26747128|FG004|Overall Study|Protocol Violation|1|||
13381133|NCT00755846|26747129|FG005|Overall Study|Protocol Violation|1|||
13381134|NCT00755846|26747124|FG000|Overall Study|Lost to Follow-up|0|||
13381135|NCT00755846|26747125|FG001|Overall Study|Lost to Follow-up|2|||
13381136|NCT00755846|26747126|FG002|Overall Study|Lost to Follow-up|1|||
13381137|NCT00755846|26747127|FG003|Overall Study|Lost to Follow-up|0|||
13381138|NCT00755846|26747128|FG004|Overall Study|Lost to Follow-up|4|||
13381139|NCT00755846|26747129|FG005|Overall Study|Lost to Follow-up|2|||
13381140|NCT00755846|26747124|FG000|Overall Study|Withdrawal by Subject|2|||
13381141|NCT00755846|26747125|FG001|Overall Study|Withdrawal by Subject|3|||
13381142|NCT00755846|26747126|FG002|Overall Study|Withdrawal by Subject|5|||
13381143|NCT00755846|26747127|FG003|Overall Study|Withdrawal by Subject|2|||
13381144|NCT00755846|26747128|FG004|Overall Study|Withdrawal by Subject|0|||
13381145|NCT00755846|26747129|FG005|Overall Study|Withdrawal by Subject|1|||
13381146|NCT00755846|26747124|FG000|Overall Study|Hyperglycemic Rescue|21|||
13381147|NCT00755846|26747125|FG001|Overall Study|Hyperglycemic Rescue|7|||
13381148|NCT00755846|26747126|FG002|Overall Study|Hyperglycemic Rescue|5|||
13381149|NCT00755846|26747127|FG003|Overall Study|Hyperglycemic Rescue|8|||
13381150|NCT00755846|26747128|FG004|Overall Study|Hyperglycemic Rescue|8|||
13381151|NCT00755846|26747129|FG005|Overall Study|Hyperglycemic Rescue|7|||
13381152|NCT00755846|26747124|FG000|Overall Study|Physician Decision|1|||
13381153|NCT00755846|26747125|FG001|Overall Study|Physician Decision|3|||
13381154|NCT00755846|26747126|FG002|Overall Study|Physician Decision|0|||
13381155|NCT00755846|26747127|FG003|Overall Study|Physician Decision|1|||
13381156|NCT00755846|26747128|FG004|Overall Study|Physician Decision|0|||
13381157|NCT00755846|26747129|FG005|Overall Study|Physician Decision|1|||
13381158|NCT00755846|26747124|FG000|Overall Study|Administrative Error|0|||
13381159|NCT00755846|26747125|FG001|Overall Study|Administrative Error|1|||
13381160|NCT00755846|26747126|FG002|Overall Study|Administrative Error|0|||
13381161|NCT00755846|26747127|FG003|Overall Study|Administrative Error|0|||
13381162|NCT00755846|26747128|FG004|Overall Study|Administrative Error|0|||
13381163|NCT00755846|26747129|FG005|Overall Study|Administrative Error|0|||
13381164|NCT00755846|26747124|FG000|Overall Study|Participant Non-compliance|0|||
13381165|NCT00755846|26747125|FG001|Overall Study|Participant Non-compliance|0|||
13381166|NCT00755846|26747126|FG002|Overall Study|Participant Non-compliance|0|||
13381167|NCT00755846|26747127|FG003|Overall Study|Participant Non-compliance|0|||
13381168|NCT00755846|26747128|FG004|Overall Study|Participant Non-compliance|1|||
13381169|NCT00755846|26747129|FG005|Overall Study|Participant Non-compliance|0|||
13381170|NCT00755807|26747197|FG000|Acute Phase|Adverse Event|16|||
13381171|NCT00755807|26747198|FG001|Acute Phase|Adverse Event|5|||
13381172|NCT00755807|26747197|FG000|Acute Phase|Protocol Violation|1|||
13381173|NCT00755807|26747198|FG001|Acute Phase|Protocol Violation|3|||
13381174|NCT00755807|26747197|FG000|Acute Phase|Withdrawal by Subject|1|||
13381175|NCT00755807|26747198|FG001|Acute Phase|Withdrawal by Subject|2|||
13381176|NCT00755807|26747197|FG000|Acute Phase|Lack of Efficacy|0|||
13381177|NCT00755807|26747198|FG001|Acute Phase|Lack of Efficacy|1|||
13381178|NCT00755807|26747197|FG000|Acute Phase|Physician Decision|0|||
13381179|NCT00755807|26747198|FG001|Acute Phase|Physician Decision|1|||
13381180|NCT00755807|26747197|FG000|Open-label Extension Phase|Adverse Event|7|||
13381181|NCT00755807|26747198|FG001|Open-label Extension Phase|Adverse Event|7|||
13381182|NCT00755807|26747197|FG000|Open-label Extension Phase|Protocol Violation|5|||
13381183|NCT00755807|26747198|FG001|Open-label Extension Phase|Protocol Violation|2|||
13381184|NCT00755807|26747197|FG000|Open-label Extension Phase|Lack of Efficacy|3|||
13381185|NCT00755807|26747198|FG001|Open-label Extension Phase|Lack of Efficacy|3|||
13381186|NCT00755807|26747197|FG000|Open-label Extension Phase|Withdrawal by Subject|1|||
13381187|NCT00755807|26747198|FG001|Open-label Extension Phase|Withdrawal by Subject|3|||
13381188|NCT00755807|26747197|FG000|Open-label Extension Phase|Lost to Follow-up|2|||
13381189|NCT00755807|26747198|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
13381190|NCT00755807|26747197|FG000|Open-label Extension Phase|Sponsor Decision|0|||
13381191|NCT00755807|26747198|FG001|Open-label Extension Phase|Sponsor Decision|1|||
13381192|NCT00755716|26747219|FG000|Overall Study|Adverse Event|1|||
13381193|NCT00755716|26747220|FG001|Overall Study|Adverse Event|4|||
13381194|NCT00755716|26747221|FG002|Overall Study|Adverse Event|1|||
13381195|NCT00755716|26747219|FG000|Overall Study|Lack of Efficacy|2|||
13381196|NCT00755716|26747220|FG001|Overall Study|Lack of Efficacy|0|||
13206901|NCT01953692|26236011|FG008|Overall Study|Physician Decision|0|||
13206902|NCT01953692|26236003|FG000|Overall Study|Protocol Violation|0|||
13206903|NCT01953692|26236004|FG001|Overall Study|Protocol Violation|2|||
13206904|NCT01953692|26236005|FG002|Overall Study|Protocol Violation|1|||
13206905|NCT01953692|26236006|FG003|Overall Study|Protocol Violation|0|||
13206906|NCT01953692|26236007|FG004|Overall Study|Protocol Violation|0|||
13206907|NCT01953692|26236008|FG005|Overall Study|Protocol Violation|0|||
13206908|NCT01953692|26236009|FG006|Overall Study|Protocol Violation|0|||
13206909|NCT01953692|26236010|FG007|Overall Study|Protocol Violation|1|||
13206910|NCT01953692|26236011|FG008|Overall Study|Protocol Violation|0|||
13206911|NCT01953692|26236003|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
13206912|NCT01953692|26236004|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
13206913|NCT01953692|26236005|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
13206914|NCT01953692|26236006|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
13206915|NCT01953692|26236007|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
13206916|NCT01953692|26236008|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
13206917|NCT01953692|26236009|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
13206918|NCT01953692|26236010|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2|||
13206919|NCT01953692|26236011|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
13206920|NCT01953692|26236003|FG000|Overall Study|Withdrawal by Subject|4|||
13206921|NCT01953692|26236004|FG001|Overall Study|Withdrawal by Subject|2|||
13206922|NCT01953692|26236005|FG002|Overall Study|Withdrawal by Subject|1|||
13206923|NCT01953692|26236006|FG003|Overall Study|Withdrawal by Subject|2|||
13206924|NCT01953692|26236007|FG004|Overall Study|Withdrawal by Subject|0|||
13206925|NCT01953692|26236008|FG005|Overall Study|Withdrawal by Subject|3|||
13206926|NCT01953692|26236009|FG006|Overall Study|Withdrawal by Subject|2|||
13206927|NCT01953692|26236010|FG007|Overall Study|Withdrawal by Subject|1|||
13206928|NCT01953692|26236011|FG008|Overall Study|Withdrawal by Subject|1|||
13206929|NCT01953601|26236068|FG000|Part 1 (Base Study)|Adverse Event|24|||
13206930|NCT01953601|26236069|FG001|Part 1 (Base Study)|Adverse Event|37|||
13206931|NCT01953601|26236070|FG002|Part 1 (Base Study)|Adverse Event|15|||
13206932|NCT01953601|26236068|FG000|Part 1 (Base Study)|Death|2|||
13206933|NCT01953601|26236069|FG001|Part 1 (Base Study)|Death|0|||
13206934|NCT01953601|26236070|FG002|Part 1 (Base Study)|Death|3|||
13206935|NCT01953601|26236068|FG000|Part 1 (Base Study)|Lack of Efficacy|3|||
13206936|NCT01953601|26236069|FG001|Part 1 (Base Study)|Lack of Efficacy|1|||
13206937|NCT01953601|26236070|FG002|Part 1 (Base Study)|Lack of Efficacy|4|||
13206938|NCT01953601|26236068|FG000|Part 1 (Base Study)|Lost to Follow-up|1|||
13206939|NCT01953601|26236069|FG001|Part 1 (Base Study)|Lost to Follow-up|3|||
13206940|NCT01953601|26236070|FG002|Part 1 (Base Study)|Lost to Follow-up|6|||
13206941|NCT01953601|26236068|FG000|Part 1 (Base Study)|Non-compliance with study drug|0|||
13206942|NCT01953601|26236069|FG001|Part 1 (Base Study)|Non-compliance with study drug|3|||
13206943|NCT01953601|26236070|FG002|Part 1 (Base Study)|Non-compliance with study drug|1|||
13206944|NCT01953601|26236068|FG000|Part 1 (Base Study)|Physician Decision|3|||
13206945|NCT01953601|26236069|FG001|Part 1 (Base Study)|Physician Decision|7|||
13206946|NCT01953601|26236070|FG002|Part 1 (Base Study)|Physician Decision|4|||
13206947|NCT01953601|26236068|FG000|Part 1 (Base Study)|Screen failure|1|||
13206948|NCT01953601|26236069|FG001|Part 1 (Base Study)|Screen failure|0|||
13381197|NCT00755716|26747221|FG002|Overall Study|Lack of Efficacy|0|||
13381198|NCT00755716|26747219|FG000|Overall Study|Lost to Follow-up|5|||
13381199|NCT00755716|26747220|FG001|Overall Study|Lost to Follow-up|3|||
13206949|NCT01953601|26236070|FG002|Part 1 (Base Study)|Screen failure|1|||
13206950|NCT01953601|26236068|FG000|Part 1 (Base Study)|Site discontinued study participation|2|||
13206951|NCT01953601|26236069|FG001|Part 1 (Base Study)|Site discontinued study participation|0|||
13206952|NCT01953601|26236070|FG002|Part 1 (Base Study)|Site discontinued study participation|0|||
13206953|NCT01953601|26236068|FG000|Part 1 (Base Study)|Study terminated by sponsor|174|||
13206954|NCT01953601|26236069|FG001|Part 1 (Base Study)|Study terminated by sponsor|169|||
13206955|NCT01953601|26236070|FG002|Part 1 (Base Study)|Study terminated by sponsor|179|||
13206956|NCT01953601|26236068|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7|||
13206957|NCT01953601|26236069|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8|||
13206958|NCT01953601|26236070|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10|||
13206959|NCT01953601|26236068|FG000|Part 1 (Base Study)|Subject moved|2|||
13206960|NCT01953601|26236069|FG001|Part 1 (Base Study)|Subject moved|2|||
13206961|NCT01953601|26236070|FG002|Part 1 (Base Study)|Subject moved|1|||
13206962|NCT01953601|26236068|FG000|Part 1 (Base Study)|Withdrawal by Subject|32|||
13206963|NCT01953601|26236069|FG001|Part 1 (Base Study)|Withdrawal by Subject|23|||
13206964|NCT01953601|26236070|FG002|Part 1 (Base Study)|Withdrawal by Subject|22|||
13206965|NCT01953601|26236068|FG000|Part 2 (Extension Study)|Adverse Event|1|||
13206966|NCT01953601|26236069|FG001|Part 2 (Extension Study)|Adverse Event|1|||
13206967|NCT01953601|26236070|FG002|Part 2 (Extension Study)|Adverse Event|10|||
13206968|NCT01953601|26236068|FG000|Part 2 (Extension Study)|Death|0|||
13206969|NCT01953601|26236069|FG001|Part 2 (Extension Study)|Death|3|||
13206970|NCT01953601|26236070|FG002|Part 2 (Extension Study)|Death|0|||
13206971|NCT01953601|26236068|FG000|Part 2 (Extension Study)|Lack of Efficacy|2|||
13206972|NCT01953601|26236069|FG001|Part 2 (Extension Study)|Lack of Efficacy|0|||
13206973|NCT01953601|26236070|FG002|Part 2 (Extension Study)|Lack of Efficacy|0|||
13206974|NCT01953601|26236068|FG000|Part 2 (Extension Study)|Lost to Follow-up|2|||
13206975|NCT01953601|26236069|FG001|Part 2 (Extension Study)|Lost to Follow-up|1|||
13206976|NCT01953601|26236070|FG002|Part 2 (Extension Study)|Lost to Follow-up|1|||
13206977|NCT01953601|26236068|FG000|Part 2 (Extension Study)|Physician Decision|2|||
13206978|NCT01953601|26236069|FG001|Part 2 (Extension Study)|Physician Decision|0|||
13206979|NCT01953601|26236070|FG002|Part 2 (Extension Study)|Physician Decision|2|||
13206980|NCT01953601|26236068|FG000|Part 2 (Extension Study)|Site discontinued study participation|0|||
13206981|NCT01953601|26236069|FG001|Part 2 (Extension Study)|Site discontinued study participation|1|||
13206982|NCT01953601|26236070|FG002|Part 2 (Extension Study)|Site discontinued study participation|1|||
13206983|NCT01953601|26236068|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185|||
13206984|NCT01953601|26236069|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178|||
13206985|NCT01953601|26236070|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187|||
13206986|NCT01953601|26236068|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1|||
13206987|NCT01953601|26236069|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3|||
13206988|NCT01953601|26236070|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0|||
13206989|NCT01953601|26236068|FG000|Part 2 (Extension Study)|Subject moved|0|||
13206990|NCT01953601|26236069|FG001|Part 2 (Extension Study)|Subject moved|0|||
13206991|NCT01953601|26236070|FG002|Part 2 (Extension Study)|Subject moved|1|||
13206992|NCT01953601|26236068|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5|||
13206993|NCT01953601|26236069|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4|||
13206994|NCT01953601|26236070|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2|||
13295423|NCT01379703|26493838|FG002|Study Start Through 9 Months|Lost to Follow-up|104|||
13295424|NCT01379703|26493836|FG000|Study Start Through 9 Months|Adverse Event|0|||
13295425|NCT01379703|26493837|FG001|Study Start Through 9 Months|Adverse Event|14|||
13295426|NCT01379703|26493838|FG002|Study Start Through 9 Months|Adverse Event|10|||
13295427|NCT01379703|26493836|FG000|Study Start Through 9 Months|Withdrawal by Subject|0|||
13295428|NCT01379703|26493837|FG001|Study Start Through 9 Months|Withdrawal by Subject|6|||
13295429|NCT01379703|26493838|FG002|Study Start Through 9 Months|Withdrawal by Subject|1|||
13295430|NCT01379703|26493836|FG000|Study Start Through 9 Months|Treatment Failure|0|||
13295431|NCT01379703|26493837|FG001|Study Start Through 9 Months|Treatment Failure|2|||
13295432|NCT01379703|26493838|FG002|Study Start Through 9 Months|Treatment Failure|2|||
13295433|NCT01379703|26493836|FG000|Study Start Through 9 Months|Patient Noncompliance|0|||
13295434|NCT01379703|26493837|FG001|Study Start Through 9 Months|Patient Noncompliance|0|||
13295435|NCT01379703|26493838|FG002|Study Start Through 9 Months|Patient Noncompliance|1|||
13295436|NCT01379703|26493836|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
13295437|NCT01379703|26493837|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4|||
13295438|NCT01379703|26493838|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
13295439|NCT01379703|26493836|FG000|Study Start Through 9 Months|Medication not available|0|||
13295440|NCT01379703|26493837|FG001|Study Start Through 9 Months|Medication not available|2|||
13295441|NCT01379703|26493838|FG002|Study Start Through 9 Months|Medication not available|1|||
13295442|NCT01379703|26493836|FG000|Study Start Through 9 Months|Poor general condition|0|||
13295443|NCT01379703|26493837|FG001|Study Start Through 9 Months|Poor general condition|1|||
13295444|NCT01379703|26493838|FG002|Study Start Through 9 Months|Poor general condition|0|||
13295445|NCT01379703|26493836|FG000|Study Start Through 9 Months|Increased triglycerides|0|||
13295446|NCT01379703|26493837|FG001|Study Start Through 9 Months|Increased triglycerides|1|||
13295447|NCT01379703|26493838|FG002|Study Start Through 9 Months|Increased triglycerides|0|||
13295448|NCT01379703|26493836|FG000|Study Start Through 9 Months|Reason unknown|2|||
13295449|NCT01379703|26493837|FG001|Study Start Through 9 Months|Reason unknown|31|||
13295450|NCT01379703|26493838|FG002|Study Start Through 9 Months|Reason unknown|24|||
13295451|NCT01379703|26493836|FG000|9 Months Through 18 Months|Lost to Follow-up|0|||
13295452|NCT01379703|26493837|FG001|9 Months Through 18 Months|Lost to Follow-up|178|||
13295453|NCT01379703|26493838|FG002|9 Months Through 18 Months|Lost to Follow-up|0|||
13295454|NCT01379703|26493836|FG000|9 Months Through 18 Months|Withdrawal by Subject|0|||
13295455|NCT01379703|26493837|FG001|9 Months Through 18 Months|Withdrawal by Subject|11|||
13295456|NCT01379703|26493838|FG002|9 Months Through 18 Months|Withdrawal by Subject|0|||
13295457|NCT01379703|26493836|FG000|9 Months Through 18 Months|Adverse Event|0|||
13295458|NCT01379703|26493837|FG001|9 Months Through 18 Months|Adverse Event|6|||
13295459|NCT01379703|26493838|FG002|9 Months Through 18 Months|Adverse Event|0|||
13295460|NCT01379703|26493836|FG000|9 Months Through 18 Months|Treatment failure|0|||
13295461|NCT01379703|26493837|FG001|9 Months Through 18 Months|Treatment failure|5|||
13295462|NCT01379703|26493838|FG002|9 Months Through 18 Months|Treatment failure|0|||
13295463|NCT01379703|26493836|FG000|9 Months Through 18 Months|Patient Noncompliance|0|||
13295464|NCT01379703|26493837|FG001|9 Months Through 18 Months|Patient Noncompliance|4|||
13295465|NCT01379703|26493838|FG002|9 Months Through 18 Months|Patient Noncompliance|0|||
13295466|NCT01379703|26493836|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
13295467|NCT01379703|26493837|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2|||
13295468|NCT01379703|26493838|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
13295469|NCT01379703|26493836|FG000|9 Months Through 18 Months|Fatigue|0|||
13295470|NCT01379703|26493837|FG001|9 Months Through 18 Months|Fatigue|1|||
13295471|NCT01379703|26493838|FG002|9 Months Through 18 Months|Fatigue|0|||
13295472|NCT01379703|26493836|FG000|9 Months Through 18 Months|Reason Unknown|0|||
13295473|NCT01379703|26493837|FG001|9 Months Through 18 Months|Reason Unknown|23|||
13295474|NCT01379703|26493838|FG002|9 Months Through 18 Months|Reason Unknown|0|||
13295475|NCT01379573|26493852|FG000|Overall Study|Lost to Follow-up|1|||
13295476|NCT01379573|26493852|FG000|Overall Study|Screen Failure|10|||
13295477|NCT01379534|26493877|FG000|Treatment Phase|Withdrawal by Subject|2|||
13295478|NCT01379534|26493878|FG001|Treatment Phase|Withdrawal by Subject|2|||
13295479|NCT01379534|26493877|FG000|Treatment Phase|Progressive disease|13|||
13295480|NCT01379534|26493878|FG001|Treatment Phase|Progressive disease|22|||
13295481|NCT01379534|26493877|FG000|Treatment Phase|Adverse Event|7|||
13295482|NCT01379534|26493878|FG001|Treatment Phase|Adverse Event|7|||
13295483|NCT01379534|26493877|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0|||
13295484|NCT01379534|26493878|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1|||
13295485|NCT01379534|26493877|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3|||
13295486|NCT01379534|26493878|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0|||
13295487|NCT01379534|26493877|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0|||
13295488|NCT01379534|26493878|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1|||
13295489|NCT01379534|26493877|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1|||
13295490|NCT01379534|26493878|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0|||
13295491|NCT01379521|26493903|FG000|Overall Study -Treatment Period|Adverse Event|3|||
13295492|NCT01379521|26493904|FG001|Overall Study -Treatment Period|Adverse Event|0|||
13295493|NCT01379521|26493903|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0|||
13295494|NCT01379521|26493904|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1|||
13295495|NCT01379521|26493903|FG000|Overall Study -Treatment Period|Disease Progression|23|||
13295496|NCT01379521|26493904|FG001|Overall Study -Treatment Period|Disease Progression|22|||
13295497|NCT01379521|26493903|FG000|Overall Study -Treatment Period|New Cancer Therapy|1|||
13295498|NCT01379521|26493904|FG001|Overall Study -Treatment Period|New Cancer Therapy|0|||
13295499|NCT01379521|26493903|FG000|Overall Study -Treatment Period|Protocol Deviation|0|||
13295500|NCT01379521|26493904|FG001|Overall Study -Treatment Period|Protocol Deviation|2|||
13295501|NCT01379521|26493903|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3|||
13295502|NCT01379521|26493904|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0|||
13295503|NCT01379521|26493903|FG000|Overall Study -Treatment Period|Administrative Problems|1|||
13295504|NCT01379521|26493904|FG001|Overall Study -Treatment Period|Administrative Problems|0|||
13295505|NCT01379521|26493903|FG000|Overall Study -Treatment Period|Death|2|||
13295506|NCT01379521|26493904|FG001|Overall Study -Treatment Period|Death|1|||
13295507|NCT01379521|26493903|FG000|Post-Treatment Evaluations|Disease Progression|22|||
13295508|NCT01379521|26493904|FG001|Post-Treatment Evaluations|Disease Progression|20|||
13295509|NCT01379521|26493903|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2|||
13295510|NCT01379521|26493904|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1|||
13295511|NCT01379521|26493903|FG000|Post-Treatment Evaluations|Death|1|||
13295512|NCT01379521|26493904|FG001|Post-Treatment Evaluations|Death|0|||
13295513|NCT01379508|26493943|FG000|Treatment to Week 104|Adverse Event|2|||
13295514|NCT01379508|26493944|FG001|Treatment to Week 104|Adverse Event|0|||
13295515|NCT01379508|26493945|FG002|Treatment to Week 104|Adverse Event|5|||
13295516|NCT01379508|26493946|FG003|Treatment to Week 104|Adverse Event|0|||
13295517|NCT01379508|26493943|FG000|Treatment to Week 104|Abnormal lab value|1|||
13295518|NCT01379508|26493944|FG001|Treatment to Week 104|Abnormal lab value|0|||
13295519|NCT01379508|26493945|FG002|Treatment to Week 104|Abnormal lab value|0|||
13295520|NCT01379508|26493946|FG003|Treatment to Week 104|Abnormal lab value|0|||
13295521|NCT01379508|26493943|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1|||
13295522|NCT01379508|26493944|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0|||
13295523|NCT01379508|26493945|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0|||
13295524|NCT01379508|26493946|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0|||
13295525|NCT01379508|26493943|FG000|Treatment to Week 104|Withdrawal by Subject|6|||
13295526|NCT01379508|26493944|FG001|Treatment to Week 104|Withdrawal by Subject|1|||
13295527|NCT01379508|26493945|FG002|Treatment to Week 104|Withdrawal by Subject|4|||
13295528|NCT01379508|26493946|FG003|Treatment to Week 104|Withdrawal by Subject|0|||
13295529|NCT01379508|26493943|FG000|Treatment to Week 104|Lost to Follow-up|5|||
13295530|NCT01379508|26493944|FG001|Treatment to Week 104|Lost to Follow-up|0|||
13295531|NCT01379508|26493945|FG002|Treatment to Week 104|Lost to Follow-up|3|||
13295532|NCT01379508|26493946|FG003|Treatment to Week 104|Lost to Follow-up|0|||
13295533|NCT01379508|26493943|FG000|Treatment to Week 104|Administrative problems|3|||
13295534|NCT01379508|26493944|FG001|Treatment to Week 104|Administrative problems|1|||
13295535|NCT01379508|26493945|FG002|Treatment to Week 104|Administrative problems|0|||
13295536|NCT01379508|26493946|FG003|Treatment to Week 104|Administrative problems|0|||
13295537|NCT01379508|26493943|FG000|Treatment to Week 104|Protocol Violation|1|||
13295538|NCT01379508|26493944|FG001|Treatment to Week 104|Protocol Violation|1|||
13295539|NCT01379508|26493945|FG002|Treatment to Week 104|Protocol Violation|1|||
13295540|NCT01379508|26493946|FG003|Treatment to Week 104|Protocol Violation|0|||
13295541|NCT01379508|26493943|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
13295542|NCT01379508|26493944|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1|||
13295543|NCT01379508|26493945|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
13295544|NCT01379508|26493946|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0|||
13295545|NCT01379508|26493943|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6|||
13295546|NCT01379508|26493944|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1|||
13295547|NCT01379508|26493945|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5|||
13295548|NCT01379508|26493946|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0|||
13295549|NCT01379508|26493943|FG000|Extension Period Weeks 109-156|Administrative problems|3|||
13295550|NCT01379508|26493944|FG001|Extension Period Weeks 109-156|Administrative problems|0|||
13295551|NCT01379508|26493945|FG002|Extension Period Weeks 109-156|Administrative problems|1|||
13295552|NCT01379508|26493946|FG003|Extension Period Weeks 109-156|Administrative problems|0|||
13295553|NCT01379508|26493943|FG000|Extension Period Weeks 109-156|Protocol Violation|2|||
13295554|NCT01379508|26493944|FG001|Extension Period Weeks 109-156|Protocol Violation|1|||
13295555|NCT01379508|26493945|FG002|Extension Period Weeks 109-156|Protocol Violation|0|||
13295556|NCT01379508|26493946|FG003|Extension Period Weeks 109-156|Protocol Violation|0|||
13295557|NCT01379274|26493952|FG000|Overall Study|funding withdrawn|1|||
13295558|NCT01378975|26493985|FG000|Overall Study|Death|77|||
13295559|NCT01378975|26493986|FG001|Overall Study|Death|46|||
13295560|NCT01378975|26493985|FG000|Overall Study|Investigator Request|1|||
13295561|NCT01378975|26493986|FG001|Overall Study|Investigator Request|0|||
13295562|NCT01378975|26493985|FG000|Overall Study|Lost to Follow-up|4|||
13295563|NCT01378975|26493986|FG001|Overall Study|Lost to Follow-up|1|||
13295564|NCT01378975|26493985|FG000|Overall Study|Withdrew Consent|4|||
13295565|NCT01378975|26493986|FG001|Overall Study|Withdrew Consent|3|||
13295566|NCT01378962|26494001|FG000|Overall Study|Death|14|||
13295567|NCT01378962|26494001|FG000|Overall Study|Lost to Follow-up|1|||
13295568|NCT01378962|26494001|FG000|Overall Study|Other|2|||
13295569|NCT01378858|26494018|FG000|Overall Study|Withdrawal by Subject|4|||
13295570|NCT01378858|26494019|FG001|Overall Study|Withdrawal by Subject|4|||
13295571|NCT01378429|26494058|FG000|Overall Study|Noncompliance with study drug|1|||
13295572|NCT01378429|26494059|FG001|Overall Study|Noncompliance with study drug|0|||
13295573|NCT01378325|26494072|FG000|Overall Study|Protocol Violation|0|||
13295574|NCT01378325|26494073|FG001|Overall Study|Protocol Violation|1|||
13295575|NCT01378195|26494090|FG000|Overall Study|Lost to Follow-up|29|||
13295576|NCT01378195|26494091|FG001|Overall Study|Lost to Follow-up|18|||
13295577|NCT01378117|26494133|FG000|Overall Study|withdrawal|2|||
13295578|NCT01378117|26494134|FG001|Overall Study|withdrawal|1|||
13295579|NCT01378117|26494135|FG002|Overall Study|withdrawal|2|||
13295580|NCT01378117|26494133|FG000|Overall Study|discharged before med given|2|||
13295581|NCT01378117|26494134|FG001|Overall Study|discharged before med given|0|||
13295582|NCT01378117|26494135|FG002|Overall Study|discharged before med given|1|||
13295583|NCT01378104|26494150|FG000|Overall Study|Adverse Event|8|||
13295584|NCT01378104|26494151|FG001|Overall Study|Adverse Event|8|||
13295585|NCT01378104|26494150|FG000|Overall Study|Lack of Efficacy|7|||
13295586|NCT01378104|26494151|FG001|Overall Study|Lack of Efficacy|5|||
13295587|NCT01378104|26494150|FG000|Overall Study|Withdrawal by Subject|12|||
13295588|NCT01378104|26494151|FG001|Overall Study|Withdrawal by Subject|13|||
13381200|NCT00755716|26747221|FG002|Overall Study|Lost to Follow-up|1|||
13295589|NCT01377987|26494170|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
13295590|NCT01377987|26494171|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
13295591|NCT01377922|26494190|FG000|Overall Study|rescue tx after part 2, entered part 4|1|||
13295592|NCT01377922|26494191|FG001|Overall Study|rescue tx after part 2, entered part 4|0|||
13295593|NCT01377844|26494214|FG000|Overall Study|Withdrawal by Subject|25|||
13295594|NCT01377844|26494215|FG001|Overall Study|Withdrawal by Subject|28|||
13295595|NCT01377844|26494214|FG000|Overall Study|Protocol Violation|2|||
13295596|NCT01377844|26494215|FG001|Overall Study|Protocol Violation|3|||
13295597|NCT01377844|26494214|FG000|Overall Study|Adverse Event|3|||
13295598|NCT01377844|26494215|FG001|Overall Study|Adverse Event|0|||
13295599|NCT01377844|26494214|FG000|Overall Study|Physician Decision|6|||
13295600|NCT01377844|26494215|FG001|Overall Study|Physician Decision|3|||
13295601|NCT01377844|26494214|FG000|Overall Study|Study terminated by Sponsor|0|||
13295602|NCT01377844|26494215|FG001|Overall Study|Study terminated by Sponsor|1|||
13295603|NCT01377480|26494238|FG000|Overall Study|Protocol Violation|0|||
13295604|NCT01377480|26494239|FG001|Overall Study|Protocol Violation|0|||
13295605|NCT01377480|26494240|FG002|Overall Study|Protocol Violation|0|||
13295606|NCT01377480|26494241|FG003|Overall Study|Protocol Violation|4|||
13295607|NCT01377480|26494238|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
13295608|NCT01377480|26494239|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
13295609|NCT01377480|26494240|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
13295610|NCT01377480|26494241|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
13295611|NCT01377480|26494238|FG000|Overall Study|Withdrawal by Subject|0|||
13295612|NCT01377480|26494239|FG001|Overall Study|Withdrawal by Subject|0|||
13295613|NCT01377480|26494240|FG002|Overall Study|Withdrawal by Subject|1|||
13295614|NCT01377480|26494241|FG003|Overall Study|Withdrawal by Subject|0|||
13295615|NCT01377480|26494238|FG000|Overall Study|Serious adverse event|0|||
13295616|NCT01377480|26494239|FG001|Overall Study|Serious adverse event|0|||
13295617|NCT01377480|26494240|FG002|Overall Study|Serious adverse event|1|||
13295618|NCT01377480|26494241|FG003|Overall Study|Serious adverse event|1|||
13295619|NCT01377480|26494238|FG000|Overall Study|Other|0|||
13295620|NCT01377480|26494239|FG001|Overall Study|Other|0|||
13295621|NCT01377480|26494240|FG002|Overall Study|Other|7|||
13295622|NCT01377480|26494241|FG003|Overall Study|Other|6|||
13295623|NCT01377389|26494252|FG000|Overall Study|Withdrawal by Subject|1|||
13295624|NCT01377389|26494252|FG000|Overall Study|Screen failure|2|||
13295625|NCT01377233|26494292|FG000|Open-label|Adverse Event|1|||
13295626|NCT01377233|26494293|FG001|Open-label|Adverse Event|0|||
13295627|NCT01377233|26494294|FG002|Open-label|Adverse Event|0|||
13295628|NCT01377233|26494295|FG003|Open-label|Adverse Event|0|||
13295629|NCT01377233|26494296|FG004|Open-label|Adverse Event|0|||
13295630|NCT01377233|26494292|FG000|Open-label|Withdrawal by Subject|3|||
13295631|NCT01377233|26494293|FG001|Open-label|Withdrawal by Subject|0|||
13295632|NCT01377233|26494294|FG002|Open-label|Withdrawal by Subject|0|||
13295633|NCT01377233|26494295|FG003|Open-label|Withdrawal by Subject|0|||
13295634|NCT01377233|26494296|FG004|Open-label|Withdrawal by Subject|0|||
13295635|NCT01377233|26494292|FG000|Double-blind|Adverse Event|0|||
13295636|NCT01377233|26494293|FG001|Double-blind|Adverse Event|1|||
13295637|NCT01377233|26494294|FG002|Double-blind|Adverse Event|2|||
13295638|NCT01377233|26494295|FG003|Double-blind|Adverse Event|2|||
13295639|NCT01377233|26494296|FG004|Double-blind|Adverse Event|0|||
13295640|NCT01377233|26494292|FG000|Double-blind|Protocol Violation|0|||
13295641|NCT01377233|26494293|FG001|Double-blind|Protocol Violation|0|||
13295642|NCT01377233|26494294|FG002|Double-blind|Protocol Violation|0|||
13295643|NCT01377233|26494295|FG003|Double-blind|Protocol Violation|0|||
13295644|NCT01377233|26494296|FG004|Double-blind|Protocol Violation|1|||
13295645|NCT01377233|26494292|FG000|Double-blind|Withdrawal by Subject|0|||
13295646|NCT01377233|26494293|FG001|Double-blind|Withdrawal by Subject|0|||
13295647|NCT01377233|26494294|FG002|Double-blind|Withdrawal by Subject|0|||
13295648|NCT01377233|26494295|FG003|Double-blind|Withdrawal by Subject|1|||
13295649|NCT01377233|26494296|FG004|Double-blind|Withdrawal by Subject|0|||
13295650|NCT01377233|26494292|FG000|Double-blind|Administrative or other|0|||
13295651|NCT01377233|26494293|FG001|Double-blind|Administrative or other|0|||
13295652|NCT01377233|26494294|FG002|Double-blind|Administrative or other|0|||
13295653|NCT01377233|26494295|FG003|Double-blind|Administrative or other|1|||
13295654|NCT01377233|26494296|FG004|Double-blind|Administrative or other|1|||
13295655|NCT01377194|26494317|FG000|Overall Study|Adverse Event|3|||
13295656|NCT01377194|26494318|FG001|Overall Study|Adverse Event|12|||
13295657|NCT01377194|26494319|FG002|Overall Study|Adverse Event|19|||
13295658|NCT01377194|26494317|FG000|Overall Study|Lack of Efficacy|3|||
13295659|NCT01377194|26494318|FG001|Overall Study|Lack of Efficacy|3|||
13295660|NCT01377194|26494319|FG002|Overall Study|Lack of Efficacy|3|||
13295661|NCT01377194|26494317|FG000|Overall Study|Protocol Violation|4|||
13295662|NCT01377194|26494318|FG001|Overall Study|Protocol Violation|10|||
13295663|NCT01377194|26494319|FG002|Overall Study|Protocol Violation|6|||
13295664|NCT01377194|26494317|FG000|Overall Study|Withdrawal by Subject|8|||
13295665|NCT01377194|26494318|FG001|Overall Study|Withdrawal by Subject|10|||
13295666|NCT01377194|26494319|FG002|Overall Study|Withdrawal by Subject|7|||
13295667|NCT01377194|26494317|FG000|Overall Study|Lost to Follow-up|14|||
13295668|NCT01377194|26494318|FG001|Overall Study|Lost to Follow-up|8|||
13295669|NCT01377194|26494319|FG002|Overall Study|Lost to Follow-up|11|||
13295670|NCT01377012|26494364|FG000|Core Study|Study terminated by Sponsor|47|||
13295671|NCT01377012|26494365|FG001|Core Study|Study terminated by Sponsor|54|||
13295672|NCT01377012|26494366|FG002|Core Study|Study terminated by Sponsor|46|||
13295673|NCT01377012|26494364|FG000|Core Study|Technical problems|1|||
13295674|NCT01377012|26494365|FG001|Core Study|Technical problems|0|||
13295675|NCT01377012|26494366|FG002|Core Study|Technical problems|0|||
13295676|NCT01377012|26494364|FG000|Core Study|Withdrawal by Subject|15|||
13295677|NCT01377012|26494365|FG001|Core Study|Withdrawal by Subject|23|||
13295678|NCT01377012|26494366|FG002|Core Study|Withdrawal by Subject|18|||
13295679|NCT01377012|26494364|FG000|Core Study|Protocol Violation|7|||
13295680|NCT01377012|26494365|FG001|Core Study|Protocol Violation|3|||
13295681|NCT01377012|26494366|FG002|Core Study|Protocol Violation|2|||
13295682|NCT01377012|26494364|FG000|Core Study|Pregnancy|0|||
13295683|NCT01377012|26494365|FG001|Core Study|Pregnancy|0|||
13295684|NCT01377012|26494366|FG002|Core Study|Pregnancy|1|||
13295685|NCT01377012|26494364|FG000|Core Study|Physician Decision|5|||
13295686|NCT01377012|26494365|FG001|Core Study|Physician Decision|4|||
13295687|NCT01377012|26494366|FG002|Core Study|Physician Decision|10|||
13295688|NCT01377012|26494364|FG000|Core Study|Non-Compliant with study treatment|0|||
13295689|NCT01377012|26494365|FG001|Core Study|Non-Compliant with study treatment|0|||
13295690|NCT01377012|26494366|FG002|Core Study|Non-Compliant with study treatment|1|||
13295691|NCT01377012|26494364|FG000|Core Study|No Longer require treatment|0|||
13295692|NCT01377012|26494365|FG001|Core Study|No Longer require treatment|0|||
13295693|NCT01377012|26494366|FG002|Core Study|No Longer require treatment|1|||
13295694|NCT01377012|26494364|FG000|Core Study|Lost to Follow-up|7|||
13295695|NCT01377012|26494365|FG001|Core Study|Lost to Follow-up|5|||
13295696|NCT01377012|26494366|FG002|Core Study|Lost to Follow-up|4|||
13295697|NCT01377012|26494364|FG000|Core Study|Lack of Efficacy|41|||
13295698|NCT01377012|26494365|FG001|Core Study|Lack of Efficacy|28|||
13295699|NCT01377012|26494366|FG002|Core Study|Lack of Efficacy|37|||
13295700|NCT01377012|26494364|FG000|Core Study|Death|1|||
13295701|NCT01377012|26494365|FG001|Core Study|Death|1|||
13295702|NCT01377012|26494366|FG002|Core Study|Death|1|||
13295703|NCT01377012|26494364|FG000|Core Study|Adverse Event|10|||
13295704|NCT01377012|26494365|FG001|Core Study|Adverse Event|14|||
13295705|NCT01377012|26494366|FG002|Core Study|Adverse Event|13|||
13295706|NCT01377012|26494364|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3|||
13295707|NCT01377012|26494365|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
13295708|NCT01377012|26494366|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
13295709|NCT01377012|26494364|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52|||
13295710|NCT01377012|26494365|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69|||
13295711|NCT01377012|26494366|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63|||
13295712|NCT01377012|26494364|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1|||
13295713|NCT01377012|26494365|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0|||
13295714|NCT01377012|26494366|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3|||
13295715|NCT01377012|26494364|FG000|Extension Study, Weeks 104-260|Physician Decision|1|||
13295716|NCT01377012|26494365|FG001|Extension Study, Weeks 104-260|Physician Decision|0|||
13295717|NCT01377012|26494366|FG002|Extension Study, Weeks 104-260|Physician Decision|0|||
13295718|NCT01377012|26494364|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
13295719|NCT01377012|26494365|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
13295720|NCT01377012|26494366|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1|||
13295721|NCT01377012|26494364|FG000|Extension Study, Weeks 104-260|Adverse Event|0|||
13295722|NCT01377012|26494365|FG001|Extension Study, Weeks 104-260|Adverse Event|2|||
13295723|NCT01377012|26494366|FG002|Extension Study, Weeks 104-260|Adverse Event|1|||
13295724|NCT01376908|26494406|FG000|Overall Study|Protocol Violation|1|||
13295725|NCT01376908|26494407|FG001|Overall Study|Protocol Violation|1|||
13295726|NCT01376908|26494406|FG000|Overall Study|Withdrawal by Subject|1|||
13295727|NCT01376908|26494407|FG001|Overall Study|Withdrawal by Subject|2|||
13295728|NCT01376804|26494420|FG000|Treatment Period|Withdrawal by Subject|1|||
13295729|NCT01376804|26494420|FG000|Treatment Period|Adverse Event|6|||
13295730|NCT01376804|26494420|FG000|Treatment Period|Patient did not receive study drug|1|||
13295731|NCT01376700|26494438|FG000|Overall Study|Sponsor terminated study early|8|||
13295732|NCT01376700|26494438|FG000|Overall Study|Low or high titer inhibitor|8|||
13295733|NCT01376388|26494455|FG000|Overall Study|Adverse Event|13|||
13295734|NCT01376388|26494455|FG000|Overall Study|Lack of Efficacy|2|||
13295735|NCT01376388|26494455|FG000|Overall Study|Withdrawal by Subject|3|||
13295736|NCT01376349|26494474|FG000|Raondomized Treatment|Withdrawal by Subject|10|||
13295737|NCT01376349|26494475|FG001|Raondomized Treatment|Withdrawal by Subject|16|||
13295738|NCT01376349|26494476|FG002|Raondomized Treatment|Withdrawal by Subject|13|||
13295739|NCT01376349|26494474|FG000|Raondomized Treatment|Adverse Event|13|||
13295740|NCT01376349|26494475|FG001|Raondomized Treatment|Adverse Event|17|||
13295741|NCT01376349|26494476|FG002|Raondomized Treatment|Adverse Event|14|||
13295742|NCT01376349|26494474|FG000|Raondomized Treatment|Unkown|1|||
13295743|NCT01376349|26494475|FG001|Raondomized Treatment|Unkown|2|||
13295744|NCT01376349|26494476|FG002|Raondomized Treatment|Unkown|1|||
13295745|NCT01376349|26494474|FG000|Raondomized Treatment|Alternative Treatment|0|||
13295746|NCT01376349|26494475|FG001|Raondomized Treatment|Alternative Treatment|0|||
13295747|NCT01376349|26494476|FG002|Raondomized Treatment|Alternative Treatment|1|||
13295748|NCT01376310|26494489|FG000|Overall Study|Study closed/terminated|1|||
13295749|NCT01376310|26494490|FG001|Overall Study|Study closed/terminated|2|||
13295750|NCT01376310|26494489|FG000|Overall Study|Withdrawal by Subject|8|||
13295751|NCT01376310|26494490|FG001|Overall Study|Withdrawal by Subject|2|||
13295752|NCT01376310|26494489|FG000|Overall Study|Physician Decision|26|||
13295753|NCT01376310|26494490|FG001|Overall Study|Physician Decision|7|||
13295754|NCT01376310|26494489|FG000|Overall Study|Lost to Follow-up|1|||
13295755|NCT01376310|26494490|FG001|Overall Study|Lost to Follow-up|0|||
13295756|NCT01376245|26494518|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66|||
13295757|NCT01376245|26494519|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
13295758|NCT01376245|26494520|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
13295759|NCT01376245|26494521|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
13295760|NCT01376245|26494522|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
13295761|NCT01376245|26494518|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4|||
13295762|NCT01376245|26494519|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
13295763|NCT01376245|26494520|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
13295764|NCT01376245|26494521|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
13295765|NCT01376245|26494522|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
13295766|NCT01376245|26494518|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1|||
13295767|NCT01376245|26494519|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
13295768|NCT01376245|26494520|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
13295769|NCT01376245|26494521|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
13295770|NCT01376245|26494522|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
13295771|NCT01376245|26494518|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2|||
13295772|NCT01376245|26494519|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
13295773|NCT01376245|26494520|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
13295774|NCT01376245|26494521|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
13295775|NCT01376245|26494522|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
13295776|NCT01376245|26494518|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28|||
13295777|NCT01376245|26494519|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
13295778|NCT01376245|26494520|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
13295779|NCT01376245|26494521|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
13295780|NCT01376245|26494522|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
13295781|NCT01376245|26494518|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
13295782|NCT01376245|26494519|FG001|24-week, Double-blind Treatment Period|Adverse Event|16|||
13295783|NCT01376245|26494520|FG002|24-week, Double-blind Treatment Period|Adverse Event|7|||
13295784|NCT01376245|26494521|FG003|24-week, Double-blind Treatment Period|Adverse Event|8|||
13295785|NCT01376245|26494522|FG004|24-week, Double-blind Treatment Period|Adverse Event|18|||
13295786|NCT01376245|26494518|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0|||
13295787|NCT01376245|26494519|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
13295788|NCT01376245|26494520|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5|||
13295789|NCT01376245|26494521|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
13295790|NCT01376245|26494522|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3|||
13295791|NCT01376245|26494518|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
13295792|NCT01376245|26494519|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2|||
13295793|NCT01376245|26494520|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0|||
13295794|NCT01376245|26494521|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
13295795|NCT01376245|26494522|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
13295796|NCT01376245|26494518|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
13295797|NCT01376245|26494519|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2|||
13295798|NCT01376245|26494520|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3|||
13295799|NCT01376245|26494521|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1|||
13295800|NCT01376245|26494522|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
13295801|NCT01376245|26494518|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
13295802|NCT01376245|26494519|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
13295803|NCT01376245|26494520|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
13295804|NCT01376245|26494521|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
13295805|NCT01376245|26494522|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
13295806|NCT01376245|26494518|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
13295807|NCT01376245|26494519|FG001|24-week, Double-blind Treatment Period|Physician Decision|0|||
13295808|NCT01376245|26494520|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
13295809|NCT01376245|26494521|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
13295810|NCT01376245|26494522|FG004|24-week, Double-blind Treatment Period|Physician Decision|0|||
13295811|NCT01376245|26494518|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
13295812|NCT01376245|26494519|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
13295813|NCT01376245|26494520|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
13295814|NCT01376245|26494521|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
13295815|NCT01376245|26494522|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
13295816|NCT01376167|26494601|FG000|Overall Study|Lost to Follow-up|2|||
13295817|NCT01376167|26494602|FG001|Overall Study|Lost to Follow-up|4|||
13295818|NCT01376167|26494603|FG002|Overall Study|Lost to Follow-up|2|||
13295819|NCT01376167|26494601|FG000|Overall Study|Physician Decision|1|||
13295820|NCT01376167|26494602|FG001|Overall Study|Physician Decision|1|||
13295821|NCT01376167|26494603|FG002|Overall Study|Physician Decision|0|||
13295822|NCT01376167|26494601|FG000|Overall Study|Withdrawal by Subject|1|||
13295823|NCT01376167|26494602|FG001|Overall Study|Withdrawal by Subject|5|||
13295824|NCT01376167|26494603|FG002|Overall Study|Withdrawal by Subject|4|||
13295825|NCT01376089|26494620|FG000|Overall Study|Patient received no contrast media|3|||
13295826|NCT01376089|26494621|FG001|Overall Study|Patient received no contrast media|4|||
13295827|NCT01376037|26494634|FG000|Overall Study|Lost to Follow-up|0|||
13295828|NCT01376037|26494635|FG001|Overall Study|Lost to Follow-up|2|||
13295829|NCT01375959|26494656|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
13295830|NCT01375959|26494657|FG001|First Intervention (6 Weeks)|Adverse Event|3|||
13295831|NCT01375959|26494656|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
13295832|NCT01375959|26494657|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
13295833|NCT01375959|26494656|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
13295834|NCT01375959|26494657|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
13295835|NCT01375751|26494690|FG000|Overall Study|Other|0|||
13295836|NCT01375751|26494691|FG001|Overall Study|Other|1|||
13295837|NCT01375751|26494692|FG002|Overall Study|Other|0|||
13295838|NCT01375673|26494709|FG000|Overall Study|Withdrawal by Subject|0|||
13295839|NCT01375673|26494710|FG001|Overall Study|Withdrawal by Subject|1|||
13295840|NCT01375608|26494716|FG000|Overall Study|Withdrawal by Subject|2|||
13295841|NCT01375374|26494725|FG000|Overall Study|Adverse Event|1|||
13295842|NCT01375205|26494752|FG000|Overall Study|Lost to Follow-up|15|||
13295843|NCT01375205|26494753|FG001|Overall Study|Lost to Follow-up|12|||
13295844|NCT01375205|26494752|FG000|Overall Study|Withdrawal by Subject|6|||
13295845|NCT01375205|26494753|FG001|Overall Study|Withdrawal by Subject|1|||
13295846|NCT01375075|26494856|FG000|Overall Study|Adverse Event|0|||
13295847|NCT01375075|26494857|FG001|Overall Study|Adverse Event|0|||
13295848|NCT01375075|26494858|FG002|Overall Study|Adverse Event|3|||
13295849|NCT01375075|26494859|FG003|Overall Study|Adverse Event|1|||
13295850|NCT01375075|26494860|FG004|Overall Study|Adverse Event|0|||
13295851|NCT01375075|26494861|FG005|Overall Study|Adverse Event|1|||
13295852|NCT01375075|26494856|FG000|Overall Study|Entry Criterion Not Met|1|||
13295853|NCT01375075|26494857|FG001|Overall Study|Entry Criterion Not Met|0|||
13295854|NCT01375075|26494858|FG002|Overall Study|Entry Criterion Not Met|0|||
13295855|NCT01375075|26494859|FG003|Overall Study|Entry Criterion Not Met|0|||
13295856|NCT01375075|26494860|FG004|Overall Study|Entry Criterion Not Met|0|||
13295857|NCT01375075|26494861|FG005|Overall Study|Entry Criterion Not Met|1|||
13295858|NCT01375075|26494856|FG000|Overall Study|Withdrawal by Subject|0|||
13295859|NCT01375075|26494857|FG001|Overall Study|Withdrawal by Subject|1|||
13295860|NCT01375075|26494858|FG002|Overall Study|Withdrawal by Subject|0|||
13295861|NCT01375075|26494859|FG003|Overall Study|Withdrawal by Subject|0|||
13295862|NCT01375075|26494860|FG004|Overall Study|Withdrawal by Subject|0|||
13295863|NCT01375075|26494861|FG005|Overall Study|Withdrawal by Subject|1|||
13295864|NCT01375049|26494878|FG000|Overall Study|Adverse Event|2|||
13295865|NCT01375049|26494878|FG000|Overall Study|Lost to Follow-up|1|||
13295866|NCT01375049|26494878|FG000|Overall Study|Withdrawal by Subject|2|||
13295867|NCT01375049|26494878|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45|||
13295868|NCT01375010|26494899|FG000|Overall Study|Lost to Follow-up|8|||
13295869|NCT01375010|26494900|FG001|Overall Study|Lost to Follow-up|2|||
13295870|NCT01375010|26494899|FG000|Overall Study|Withdrawal by Subject|4|||
13295871|NCT01375010|26494900|FG001|Overall Study|Withdrawal by Subject|2|||
13295872|NCT01374971|26494907|FG000|Overall Study|Withdrawal by Subject|1|||
13295873|NCT01374919|26494914|FG000|Overall Study|Withdrawal by Subject|2|||
13295874|NCT01374906|26494988|FG000|Overall Study|Abnormal laboratory value(s)|0|||
13295875|NCT01374906|26494989|FG001|Overall Study|Abnormal laboratory value(s)|3|||
13295876|NCT01374906|26494988|FG000|Overall Study|Administrative problems|2|||
13295877|NCT01374906|26494989|FG001|Overall Study|Administrative problems|2|||
13295878|NCT01374906|26494988|FG000|Overall Study|Adverse Event|10|||
13295879|NCT01374906|26494989|FG001|Overall Study|Adverse Event|11|||
13295880|NCT01374906|26494988|FG000|Overall Study|Death|0|||
13295881|NCT01374906|26494989|FG001|Overall Study|Death|2|||
13295882|NCT01374906|26494988|FG000|Overall Study|Protocol Violation|2|||
13295883|NCT01374906|26494989|FG001|Overall Study|Protocol Violation|2|||
13295884|NCT01374906|26494988|FG000|Overall Study|Withdrawal by Subject|15|||
13295885|NCT01374906|26494989|FG001|Overall Study|Withdrawal by Subject|9|||
13295886|NCT01374906|26494988|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
13295887|NCT01374906|26494989|FG001|Overall Study|Unsatisfactory therapeutic effect|19|||
13295888|NCT01374568|26495004|FG000|Overall Study|Lab unable to analyze BTM|0|||
13295889|NCT01374568|26495005|FG001|Overall Study|Lab unable to analyze BTM|2|||
13295890|NCT01374451|26495039|FG000|Overall Study|Administrative problems|1|||
13295891|NCT01374451|26495040|FG001|Overall Study|Administrative problems|0|||
13295892|NCT01374425|26495125|FG000|Overall Study|Radiographic Disease Progression|86|||
13295893|NCT01374425|26495126|FG001|Overall Study|Radiographic Disease Progression|81|||
13295894|NCT01374425|26495125|FG000|Overall Study|Clinical Disease Progression|9|||
13295895|NCT01374425|26495126|FG001|Overall Study|Clinical Disease Progression|6|||
13295896|NCT01374425|26495125|FG000|Overall Study|Adverse Event|29|||
13295897|NCT01374425|26495126|FG001|Overall Study|Adverse Event|18|||
13295898|NCT01374425|26495125|FG000|Overall Study|Death (Progression of Disease)|1|||
13295899|NCT01374425|26495126|FG001|Overall Study|Death (Progression of Disease)|0|||
13295900|NCT01374425|26495125|FG000|Overall Study|Death (Adverse Event)|2|||
13295901|NCT01374425|26495126|FG001|Overall Study|Death (Adverse Event)|4|||
13295902|NCT01374425|26495125|FG000|Overall Study|Withdrawal by Subject|6|||
13295903|NCT01374425|26495126|FG001|Overall Study|Withdrawal by Subject|7|||
13295904|NCT01374425|26495125|FG000|Overall Study|Refused Treatment|10|||
13295905|NCT01374425|26495126|FG001|Overall Study|Refused Treatment|24|||
13295906|NCT01374425|26495125|FG000|Overall Study|Protocol Violation|2|||
13295907|NCT01374425|26495126|FG001|Overall Study|Protocol Violation|3|||
13295908|NCT01374425|26495125|FG000|Overall Study|Sponsor Decision|0|||
13295909|NCT01374425|26495126|FG001|Overall Study|Sponsor Decision|1|||
13295910|NCT01374425|26495125|FG000|Overall Study|Lost to Follow-up|2|||
13295911|NCT01374425|26495126|FG001|Overall Study|Lost to Follow-up|1|||
13295912|NCT01374425|26495125|FG000|Overall Study|Other|41|||
13295913|NCT01374425|26495126|FG001|Overall Study|Other|43|||
13295914|NCT01374269|26495261|FG000|Overall Study|Withdrawal by Subject|4|||
13295915|NCT01374269|26495262|FG001|Overall Study|Withdrawal by Subject|0|||
13295916|NCT01374269|26495261|FG000|Overall Study|Lost to Follow-up|1|||
13295917|NCT01374269|26495262|FG001|Overall Study|Lost to Follow-up|3|||
13295918|NCT01374269|26495261|FG000|Overall Study|closed research|1|||
13295919|NCT01374269|26495262|FG001|Overall Study|closed research|2|||
13295920|NCT01374217|26495272|FG000|Overall Study|Lack of Efficacy|13|||
13295921|NCT01374178|26495291|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1|||
13295922|NCT01374178|26495292|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0|||
13295923|NCT01374178|26495291|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2|||
13295924|NCT01374178|26495292|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0|||
13295925|NCT01374087|26495317|FG000|Overall Study|Adverse Event|1|||
13295926|NCT01374087|26495318|FG001|Overall Study|Adverse Event|0|||
13295927|NCT01374087|26495317|FG000|Overall Study|Disease progression|2|||
13295928|NCT01374087|26495318|FG001|Overall Study|Disease progression|2|||
13295929|NCT01374087|26495317|FG000|Overall Study|Study discontinued|13|||
13295930|NCT01374087|26495318|FG001|Overall Study|Study discontinued|13|||
13295931|NCT01373931|26495336|FG000|Lead-in Period|Adverse Event|2|||
13295932|NCT01373931|26495337|FG001|Lead-in Period|Adverse Event|0|||
13295933|NCT01373931|26495336|FG000|Period 1|Adverse Event|2|||
13295934|NCT01373931|26495337|FG001|Period 1|Adverse Event|0|||
13295935|NCT01373931|26495336|FG000|Period 1|Withdrawal by Subject|0|||
13295936|NCT01373931|26495337|FG001|Period 1|Withdrawal by Subject|2|||
13295937|NCT01373918|26495356|FG000|Overall Study|Physician Decision|0|||
13295938|NCT01373918|26495357|FG001|Overall Study|Physician Decision|1|||
13295939|NCT01373346|26495380|FG000|Overall Study|Death|1|||
13295940|NCT01373294|26495394|FG000|Overall Study|Adverse Event|1|||
13295941|NCT01373294|26495395|FG001|Overall Study|Adverse Event|0|||
13295942|NCT01373229|26495406|FG000|Overall Study|Death|3|||
13295943|NCT01373229|26495406|FG000|Overall Study|Physician Decision|3|||
13295944|NCT01373164|26495453|FG000|Overall Study|Lost to Follow-up|0|||
13295945|NCT01373164|26495454|FG001|Overall Study|Lost to Follow-up|0|||
13295946|NCT01373164|26495455|FG002|Overall Study|Lost to Follow-up|1|||
13295947|NCT01373164|26495456|FG003|Overall Study|Lost to Follow-up|2|||
13295948|NCT01373164|26495457|FG004|Overall Study|Lost to Follow-up|0|||
13295949|NCT01373164|26495453|FG000|Overall Study|Withdrawal by Subject|0|||
13295950|NCT01373164|26495454|FG001|Overall Study|Withdrawal by Subject|1|||
13295951|NCT01373164|26495455|FG002|Overall Study|Withdrawal by Subject|0|||
13295952|NCT01373164|26495456|FG003|Overall Study|Withdrawal by Subject|10|||
13295953|NCT01373164|26495457|FG004|Overall Study|Withdrawal by Subject|2|||
13295954|NCT01372995|26495514|FG000|Overall Study|Spouse withdrew participant from study|0|||
13295955|NCT01372995|26495515|FG001|Overall Study|Spouse withdrew participant from study|1|||
13295956|NCT01372995|26495516|FG002|Overall Study|Spouse withdrew participant from study|0|||
13295957|NCT01372995|26495514|FG000|Overall Study|Physician Decision|0|||
13295958|NCT01372995|26495515|FG001|Overall Study|Physician Decision|0|||
13295959|NCT01372995|26495516|FG002|Overall Study|Physician Decision|1|||
13295960|NCT01372878|26495523|FG000|Overall Study|Withdrawal by Subject|63|||
13295961|NCT01372878|26495523|FG000|Overall Study|Protocol Violation|17|||
13295962|NCT01372878|26495523|FG000|Overall Study|incomplete study procedure|104|||
13295963|NCT01372774|26495544|FG000|Overall Study|Withdrawal prior to treatment|4|||
13295964|NCT01372774|26495545|FG001|Overall Study|Withdrawal prior to treatment|5|||
13295965|NCT01372748|26495560|FG000|Overall Study|Lost to Follow-up|16|||
13295966|NCT01372748|26495561|FG001|Overall Study|Lost to Follow-up|34|||
13295967|NCT01372748|26495560|FG000|Overall Study|Withdrawal by Subject|7|||
13295968|NCT01372748|26495561|FG001|Overall Study|Withdrawal by Subject|5|||
13295969|NCT01372618|26495569|FG000|Overall Study|PI Died. Study Terminated|9|||
13295970|NCT01372605|26495602|FG000|Overall Study|Death|1|||
13295971|NCT01372605|26495603|FG001|Overall Study|Death|2|||
13295972|NCT01372605|26495602|FG000|Overall Study|Lost to Follow-up|2|||
13295973|NCT01372605|26495603|FG001|Overall Study|Lost to Follow-up|1|||
13295974|NCT01372605|26495602|FG000|Overall Study|Withdrawal by Subject|4|||
13295975|NCT01372605|26495603|FG001|Overall Study|Withdrawal by Subject|7|||
13295976|NCT01372605|26495602|FG000|Overall Study|Moved|3|||
13295977|NCT01372605|26495603|FG001|Overall Study|Moved|0|||
13295978|NCT01372605|26495602|FG000|Overall Study|Changed medical home|2|||
13295979|NCT01372605|26495603|FG001|Overall Study|Changed medical home|0|||
13295980|NCT01372501|26495610|FG000|Overall Study|Adverse Event|4|||
13295981|NCT01372501|26495610|FG000|Overall Study|Device migration|1|||
13295982|NCT01372410|26495656|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
13295983|NCT01372410|26495657|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
13295984|NCT01372410|26495658|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
13295985|NCT01372410|26495659|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
13295986|NCT01372410|26495660|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
13295987|NCT01372410|26495661|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
13295988|NCT01372410|26495662|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
13381201|NCT00755716|26747219|FG000|Overall Study|work schedule issues|0|||
13381202|NCT00755716|26747220|FG001|Overall Study|work schedule issues|1|||
13381203|NCT00755716|26747221|FG002|Overall Study|work schedule issues|1|||
13381204|NCT00755417|26747248|FG000|Overall Study|Adverse Event|28|||
13381205|NCT00755417|26747249|FG001|Overall Study|Adverse Event|20|||
13381206|NCT00755417|26747250|FG002|Overall Study|Adverse Event|7|||
13381207|NCT00755417|26747248|FG000|Overall Study|Lack of Efficacy|8|||
13381208|NCT00755417|26747249|FG001|Overall Study|Lack of Efficacy|4|||
13381209|NCT00755417|26747250|FG002|Overall Study|Lack of Efficacy|9|||
13381210|NCT00755417|26747248|FG000|Overall Study|Protocol Violation|2|||
13381211|NCT00755417|26747249|FG001|Overall Study|Protocol Violation|1|||
13381212|NCT00755417|26747250|FG002|Overall Study|Protocol Violation|1|||
13381213|NCT00755417|26747248|FG000|Overall Study|Lost to Follow-up|3|||
13381214|NCT00755417|26747249|FG001|Overall Study|Lost to Follow-up|0|||
13381215|NCT00755417|26747250|FG002|Overall Study|Lost to Follow-up|1|||
13381216|NCT00755417|26747248|FG000|Overall Study|Withdrawal by Subject|12|||
13381217|NCT00755417|26747249|FG001|Overall Study|Withdrawal by Subject|12|||
13381218|NCT00755417|26747250|FG002|Overall Study|Withdrawal by Subject|12|||
13381219|NCT00755417|26747248|FG000|Overall Study|Not specified or missing data|9|||
13381220|NCT00755417|26747249|FG001|Overall Study|Not specified or missing data|18|||
13381221|NCT00755417|26747250|FG002|Overall Study|Not specified or missing data|12|||
13381222|NCT00755326|26747267|FG000|Overall Study|Lost to Follow-up|2|||
13381223|NCT00755326|26747268|FG001|Overall Study|Lost to Follow-up|3|||
13381224|NCT00755222|26747289|FG000|Overall Study|Withdrawal by Subject|4|||
13381225|NCT00755222|26747290|FG001|Overall Study|Withdrawal by Subject|2|||
13381226|NCT00755222|26747289|FG000|Overall Study|Adverse Event|2|||
13381227|NCT00755222|26747290|FG001|Overall Study|Adverse Event|0|||
13381228|NCT00755222|26747289|FG000|Overall Study|Protocol Violation|2|||
13381229|NCT00755222|26747290|FG001|Overall Study|Protocol Violation|0|||
13381230|NCT00755196|26747297|FG000|Overall Study|Lost to Follow-up|1|||
13381231|NCT00755196|26747297|FG000|Overall Study|Lack of Efficiency|1|||
13381232|NCT00755183|26747312|FG000|Overall Study|Adverse Event|5|||
13381233|NCT00755183|26747313|FG001|Overall Study|Adverse Event|2|||
13381234|NCT00755183|26747312|FG000|Overall Study|Protocol Violation|0|||
13381235|NCT00755183|26747313|FG001|Overall Study|Protocol Violation|1|||
13381236|NCT00755183|26747312|FG000|Overall Study|Withdrawal by Subject|0|||
13381237|NCT00755183|26747313|FG001|Overall Study|Withdrawal by Subject|2|||
13381238|NCT00755183|26747312|FG000|Overall Study|Administrative|2|||
13381239|NCT00755183|26747313|FG001|Overall Study|Administrative|1|||
13381240|NCT00755105|26747331|FG000|Overall Study|Withdrawal by Subject|9|||
13394490|NCT00657150|26787180|FG000|Treatment|Adverse Event|60|||
13394491|NCT00657150|26787181|FG001|Treatment|Adverse Event|53|||
13394492|NCT00657150|26787180|FG000|Treatment|Non-compliant with protocol|10|||
13394493|NCT00657150|26787181|FG001|Treatment|Non-compliant with protocol|9|||
13394494|NCT00657150|26787180|FG000|Treatment|Lost to Follow-up|1|||
13394495|NCT00657150|26787181|FG001|Treatment|Lost to Follow-up|0|||
13394496|NCT00657150|26787180|FG000|Treatment|Withdrawal by Subject|23|||
13394497|NCT00657150|26787181|FG001|Treatment|Withdrawal by Subject|20|||
13394498|NCT00657150|26787180|FG000|Treatment|Other|13|||
13295989|NCT01372410|26495663|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
13295990|NCT01372410|26495656|FG000|Treatment Period 1 (7 Days)|Adverse Event|0|||
13295991|NCT01372410|26495657|FG001|Treatment Period 1 (7 Days)|Adverse Event|1|||
13295992|NCT01372410|26495658|FG002|Treatment Period 1 (7 Days)|Adverse Event|0|||
13295993|NCT01372410|26495659|FG003|Treatment Period 1 (7 Days)|Adverse Event|0|||
13295994|NCT01372410|26495660|FG004|Treatment Period 1 (7 Days)|Adverse Event|0|||
13295995|NCT01372410|26495661|FG005|Treatment Period 1 (7 Days)|Adverse Event|0|||
13295996|NCT01372410|26495662|FG006|Treatment Period 1 (7 Days)|Adverse Event|1|||
13295997|NCT01372410|26495663|FG007|Treatment Period 1 (7 Days)|Adverse Event|0|||
13295998|NCT01372410|26495656|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
13295999|NCT01372410|26495657|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
13296000|NCT01372410|26495658|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
13296001|NCT01372410|26495659|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
13296002|NCT01372410|26495660|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
13296003|NCT01372410|26495661|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
13296004|NCT01372410|26495662|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
13296005|NCT01372410|26495663|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
13296006|NCT01372410|26495656|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
13296007|NCT01372410|26495657|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
13296008|NCT01372410|26495658|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
13296009|NCT01372410|26495659|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
13296010|NCT01372410|26495660|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
13296011|NCT01372410|26495661|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
13296012|NCT01372410|26495662|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1|||
13296013|NCT01372410|26495663|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
13296014|NCT01372410|26495656|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
13296015|NCT01372410|26495657|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
13296016|NCT01372410|26495658|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
13296017|NCT01372410|26495659|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
13296018|NCT01372410|26495660|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
13296019|NCT01372410|26495661|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
13296020|NCT01372410|26495662|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
13296021|NCT01372410|26495663|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
13296022|NCT01372410|26495656|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0|||
13296023|NCT01372410|26495657|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0|||
13296024|NCT01372410|26495658|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0|||
13296025|NCT01372410|26495659|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0|||
13296026|NCT01372410|26495660|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1|||
13296027|NCT01372410|26495661|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0|||
13296028|NCT01372410|26495662|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0|||
13296029|NCT01372410|26495663|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0|||
13296030|NCT01372410|26495656|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
13296031|NCT01372410|26495657|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
13296032|NCT01372410|26495658|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
13296033|NCT01372410|26495659|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
13296034|NCT01372410|26495660|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
13296035|NCT01372410|26495661|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
13296036|NCT01372410|26495662|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
13296037|NCT01372410|26495663|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
13296038|NCT01372410|26495656|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
13296039|NCT01372410|26495657|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
13296040|NCT01372410|26495658|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
13296041|NCT01372410|26495659|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
13296042|NCT01372410|26495660|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
13296043|NCT01372410|26495661|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
13296044|NCT01372410|26495662|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
13296045|NCT01372410|26495663|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1|||
13296046|NCT01372410|26495656|FG000|Treatment Period 3 (7 Days)|Adverse Event|0|||
13296047|NCT01372410|26495657|FG001|Treatment Period 3 (7 Days)|Adverse Event|0|||
13296048|NCT01372410|26495658|FG002|Treatment Period 3 (7 Days)|Adverse Event|1|||
13296049|NCT01372410|26495659|FG003|Treatment Period 3 (7 Days)|Adverse Event|0|||
13296050|NCT01372410|26495660|FG004|Treatment Period 3 (7 Days)|Adverse Event|0|||
13296051|NCT01372410|26495661|FG005|Treatment Period 3 (7 Days)|Adverse Event|0|||
13296052|NCT01372410|26495662|FG006|Treatment Period 3 (7 Days)|Adverse Event|0|||
13296053|NCT01372410|26495663|FG007|Treatment Period 3 (7 Days)|Adverse Event|0|||
13296054|NCT01372410|26495656|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
13296055|NCT01372410|26495657|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
13296056|NCT01372410|26495658|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
13296057|NCT01372410|26495659|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
13296058|NCT01372410|26495660|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
13296059|NCT01372410|26495661|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1|||
13296060|NCT01372410|26495662|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
13296061|NCT01372410|26495663|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
13296062|NCT01372384|26495672|FG000|Overall Study|Progression of disease|3|||
13296063|NCT01372150|26495699|FG000|Overall Study|Lack of Efficacy|3|||
13296064|NCT01372150|26495700|FG001|Overall Study|Lack of Efficacy|0|||
13296065|NCT01372150|26495701|FG002|Overall Study|Lack of Efficacy|1|||
13296066|NCT01372150|26495699|FG000|Overall Study|Lost to Follow-up|4|||
13296067|NCT01372150|26495700|FG001|Overall Study|Lost to Follow-up|5|||
13296068|NCT01372150|26495701|FG002|Overall Study|Lost to Follow-up|6|||
13296069|NCT01372150|26495699|FG000|Overall Study|Protocol Violation|1|||
13296070|NCT01372150|26495700|FG001|Overall Study|Protocol Violation|0|||
13296071|NCT01372150|26495701|FG002|Overall Study|Protocol Violation|3|||
13296072|NCT01372150|26495699|FG000|Overall Study|Withdrawal by Subject|2|||
13296073|NCT01372150|26495700|FG001|Overall Study|Withdrawal by Subject|7|||
13296074|NCT01372150|26495701|FG002|Overall Study|Withdrawal by Subject|2|||
13296075|NCT01372150|26495699|FG000|Overall Study|Other|1|||
13296076|NCT01372150|26495700|FG001|Overall Study|Other|0|||
13296077|NCT01372150|26495701|FG002|Overall Study|Other|2|||
13296078|NCT01372150|26495699|FG000|Overall Study|Adverse Event|2|||
13296079|NCT01372150|26495700|FG001|Overall Study|Adverse Event|1|||
13296080|NCT01372150|26495701|FG002|Overall Study|Adverse Event|2|||
13296081|NCT01372150|26495699|FG000|Overall Study|Randomized but not treated|0|||
13296082|NCT01372150|26495700|FG001|Overall Study|Randomized but not treated|1|||
13296083|NCT01372150|26495701|FG002|Overall Study|Randomized but not treated|0|||
13296084|NCT01372085|26495762|FG000|Washout Period 2|Physician Decision|0|||
13296085|NCT01372085|26495763|FG001|Washout Period 2|Physician Decision|0|||
13296086|NCT01372085|26495764|FG002|Washout Period 2|Physician Decision|0|||
13296087|NCT01372085|26495765|FG003|Washout Period 2|Physician Decision|0|||
13296088|NCT01372085|26495766|FG004|Washout Period 2|Physician Decision|1|||
13296089|NCT01372085|26495767|FG005|Washout Period 2|Physician Decision|0|||
13296090|NCT01372085|26495768|FG006|Washout Period 2|Physician Decision|0|||
13296091|NCT01372085|26495769|FG007|Washout Period 2|Physician Decision|0|||
13296092|NCT01372085|26495770|FG008|Washout Period 2|Physician Decision|0|||
13296093|NCT01372085|26495771|FG009|Washout Period 2|Physician Decision|0|||
13296094|NCT01372085|26495762|FG000|Washout Period 3|Withdrawal by Subject|0|||
13296095|NCT01372085|26495763|FG001|Washout Period 3|Withdrawal by Subject|0|||
13296096|NCT01372085|26495764|FG002|Washout Period 3|Withdrawal by Subject|0|||
13296097|NCT01372085|26495765|FG003|Washout Period 3|Withdrawal by Subject|0|||
13296098|NCT01372085|26495766|FG004|Washout Period 3|Withdrawal by Subject|0|||
13296099|NCT01372085|26495767|FG005|Washout Period 3|Withdrawal by Subject|2|||
13296100|NCT01372085|26495768|FG006|Washout Period 3|Withdrawal by Subject|0|||
13296101|NCT01372085|26495769|FG007|Washout Period 3|Withdrawal by Subject|0|||
13296102|NCT01372085|26495770|FG008|Washout Period 3|Withdrawal by Subject|0|||
13296103|NCT01372085|26495771|FG009|Washout Period 3|Withdrawal by Subject|0|||
13296104|NCT01371994|26495820|FG000|Overall Study|Adverse Event|3|||
13296105|NCT01371994|26495821|FG001|Overall Study|Adverse Event|6|||
13296106|NCT01371994|26495820|FG000|Overall Study|Lack of Efficacy|3|||
13296107|NCT01371994|26495821|FG001|Overall Study|Lack of Efficacy|0|||
13296108|NCT01371994|26495820|FG000|Overall Study|Withdrawal by Subject|13|||
13296109|NCT01371994|26495821|FG001|Overall Study|Withdrawal by Subject|7|||
13296110|NCT01371994|26495820|FG000|Overall Study|Lost to Follow-up|1|||
13296111|NCT01371994|26495821|FG001|Overall Study|Lost to Follow-up|1|||
13296112|NCT01371994|26495820|FG000|Overall Study|Protocol Violation|24|||
13296113|NCT01371994|26495821|FG001|Overall Study|Protocol Violation|17|||
13296114|NCT01371994|26495820|FG000|Overall Study|Randomized but Never Received Study Drug|6|||
13296115|NCT01371994|26495821|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
13296116|NCT01371994|26495820|FG000|Overall Study|Physician Decision|1|||
13296117|NCT01371994|26495821|FG001|Overall Study|Physician Decision|1|||
13296118|NCT01371994|26495820|FG000|Overall Study|Miscellaneous Reasons|6|||
13296119|NCT01371994|26495821|FG001|Overall Study|Miscellaneous Reasons|4|||
13296120|NCT01371877|26495838|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0|||
13296121|NCT01371877|26495839|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4|||
13296122|NCT01371851|26495852|FG000|Overall Study|Lost to Follow-up|5|||
13296123|NCT01371851|26495853|FG001|Overall Study|Lost to Follow-up|8|||
13296124|NCT01371851|26495852|FG000|Overall Study|was arrested and put in jail|0|||
13296125|NCT01371851|26495853|FG001|Overall Study|was arrested and put in jail|1|||
13296126|NCT01371851|26495852|FG000|Overall Study|non study related adverse event|1|||
13296127|NCT01371851|26495853|FG001|Overall Study|non study related adverse event|0|||
13296128|NCT01371851|26495852|FG000|Overall Study|Blood Pressure outside study parameters|2|||
13296129|NCT01371851|26495853|FG001|Overall Study|Blood Pressure outside study parameters|0|||
13296130|NCT01371838|26495896|FG000|Overall Study|Withdrawal by Subject|27|||
13296131|NCT01371838|26495897|FG001|Overall Study|Withdrawal by Subject|33|||
13296132|NCT01371838|26495896|FG000|Overall Study|Lost to Follow-up|10|||
13296133|NCT01371838|26495897|FG001|Overall Study|Lost to Follow-up|20|||
13296134|NCT01371838|26495896|FG000|Overall Study|Death|3|||
13296135|NCT01371838|26495897|FG001|Overall Study|Death|4|||
13296136|NCT01371838|26495896|FG000|Overall Study|Protocol Violation|3|||
13296137|NCT01371838|26495897|FG001|Overall Study|Protocol Violation|0|||
13296138|NCT01371838|26495896|FG000|Overall Study|Investigator Decision|3|||
13296139|NCT01371838|26495897|FG001|Overall Study|Investigator Decision|8|||
13296140|NCT01371838|26495896|FG000|Overall Study|Last follow-up visit not conducted|2|||
13296141|NCT01371838|26495897|FG001|Overall Study|Last follow-up visit not conducted|0|||
13296142|NCT01371838|26495896|FG000|Overall Study|Lack of therapeutic response|0|||
13296143|NCT01371838|26495897|FG001|Overall Study|Lack of therapeutic response|1|||
13296144|NCT01371838|26495896|FG000|Overall Study|Surgery|1|||
13296145|NCT01371838|26495897|FG001|Overall Study|Surgery|0|||
13296146|NCT01371825|26495910|FG000|Overall Study|Death|4|||
13296147|NCT01371747|26495991|FG000|Overall Study|Adverse Event|4|||
13296148|NCT01371747|26495992|FG001|Overall Study|Adverse Event|2|||
13296149|NCT01371747|26495993|FG002|Overall Study|Adverse Event|7|||
13296150|NCT01371747|26495994|FG003|Overall Study|Adverse Event|2|||
13296151|NCT01371747|26495995|FG004|Overall Study|Adverse Event|2|||
13296152|NCT01371747|26495996|FG005|Overall Study|Adverse Event|2|||
13296153|NCT01371747|26495991|FG000|Overall Study|Death|1|||
13296154|NCT01371747|26495992|FG001|Overall Study|Death|0|||
13296155|NCT01371747|26495993|FG002|Overall Study|Death|4|||
13206995|NCT01953354|26236097|FG000|Overall Study|Withdrawal by Subject|0|||
13206996|NCT01953354|26236098|FG001|Overall Study|Withdrawal by Subject|1|||
13206997|NCT01953354|26236097|FG000|Overall Study|Decision of Sponsor|0|||
13206998|NCT01953354|26236098|FG001|Overall Study|Decision of Sponsor|1|||
13206999|NCT01953354|26236097|FG000|Overall Study|Disease Exacerbation|1|||
13207000|NCT01953354|26236098|FG001|Overall Study|Disease Exacerbation|0|||
13207001|NCT01953328|26236325|FG000|Overall Study|Withdrawal by Subject|0|||
13207002|NCT01953328|26236326|FG001|Overall Study|Withdrawal by Subject|0|||
13207003|NCT01953328|26236327|FG002|Overall Study|Withdrawal by Subject|0|||
13207004|NCT01953328|26236328|FG003|Overall Study|Withdrawal by Subject|0|||
13207005|NCT01953328|26236329|FG004|Overall Study|Withdrawal by Subject|1|||
13207006|NCT01953328|26236330|FG005|Overall Study|Withdrawal by Subject|0|||
13207007|NCT01953328|26236331|FG006|Overall Study|Withdrawal by Subject|0|||
13207008|NCT01953328|26236332|FG007|Overall Study|Withdrawal by Subject|0|||
13207009|NCT01953328|26236325|FG000|Overall Study|Lost to Follow-up|0|||
13207010|NCT01953328|26236326|FG001|Overall Study|Lost to Follow-up|0|||
13207011|NCT01953328|26236327|FG002|Overall Study|Lost to Follow-up|0|||
13207012|NCT01953328|26236328|FG003|Overall Study|Lost to Follow-up|0|||
13207013|NCT01953328|26236329|FG004|Overall Study|Lost to Follow-up|1|||
13207014|NCT01953328|26236330|FG005|Overall Study|Lost to Follow-up|0|||
13207015|NCT01953328|26236331|FG006|Overall Study|Lost to Follow-up|0|||
13207016|NCT01953328|26236332|FG007|Overall Study|Lost to Follow-up|0|||
13207017|NCT01953224|26236355|FG000|Overall Study|Lost to Follow-up|1|||
13207018|NCT01953224|26236356|FG001|Overall Study|Lost to Follow-up|1|||
13207019|NCT01953224|26236355|FG000|Overall Study|Withdrawal by Subject|1|||
13207020|NCT01953224|26236356|FG001|Overall Study|Withdrawal by Subject|2|||
13207021|NCT01953003|26236369|FG000|Overall Study|Not treated|0|||
13207022|NCT01953003|26236370|FG001|Overall Study|Not treated|1|||
13207023|NCT01953003|26236369|FG000|Overall Study|Progressive disease|35|||
13296156|NCT01371747|26495994|FG003|Overall Study|Death|1|||
13296157|NCT01371747|26495995|FG004|Overall Study|Death|2|||
13296158|NCT01371747|26495996|FG005|Overall Study|Death|0|||
13296159|NCT01371747|26495991|FG000|Overall Study|Abnormal Renal Function|0|||
13296160|NCT01371747|26495992|FG001|Overall Study|Abnormal Renal Function|2|||
13296161|NCT01371747|26495993|FG002|Overall Study|Abnormal Renal Function|0|||
13296162|NCT01371747|26495994|FG003|Overall Study|Abnormal Renal Function|1|||
13296163|NCT01371747|26495995|FG004|Overall Study|Abnormal Renal Function|0|||
13296164|NCT01371747|26495996|FG005|Overall Study|Abnormal Renal Function|1|||
13296165|NCT01371747|26495991|FG000|Overall Study|High Serum Potassium Results|1|||
13296166|NCT01371747|26495992|FG001|Overall Study|High Serum Potassium Results|1|||
13296167|NCT01371747|26495993|FG002|Overall Study|High Serum Potassium Results|1|||
13296168|NCT01371747|26495994|FG003|Overall Study|High Serum Potassium Results|2|||
13296169|NCT01371747|26495995|FG004|Overall Study|High Serum Potassium Results|0|||
13296170|NCT01371747|26495996|FG005|Overall Study|High Serum Potassium Results|2|||
13296171|NCT01371747|26495991|FG000|Overall Study|Low Serum Potassium Results|1|||
13296172|NCT01371747|26495992|FG001|Overall Study|Low Serum Potassium Results|1|||
13296173|NCT01371747|26495993|FG002|Overall Study|Low Serum Potassium Results|1|||
13296174|NCT01371747|26495994|FG003|Overall Study|Low Serum Potassium Results|1|||
13296175|NCT01371747|26495995|FG004|Overall Study|Low Serum Potassium Results|0|||
13296176|NCT01371747|26495996|FG005|Overall Study|Low Serum Potassium Results|3|||
13296177|NCT01371747|26495991|FG000|Overall Study|Protocol Violation|0|||
13296178|NCT01371747|26495992|FG001|Overall Study|Protocol Violation|0|||
13296179|NCT01371747|26495993|FG002|Overall Study|Protocol Violation|1|||
13296180|NCT01371747|26495994|FG003|Overall Study|Protocol Violation|0|||
13207024|NCT01953003|26236370|FG001|Overall Study|Progressive disease|45|||
13207025|NCT01953003|26236369|FG000|Overall Study|Related Adverse events|7|||
13207026|NCT01953003|26236370|FG001|Overall Study|Related Adverse events|2|||
13207027|NCT01953003|26236369|FG000|Overall Study|Non-related adverse events|0|||
13207028|NCT01953003|26236370|FG001|Overall Study|Non-related adverse events|2|||
13207029|NCT01953003|26236369|FG000|Overall Study|Protocol Violation|0|||
13207030|NCT01953003|26236370|FG001|Overall Study|Protocol Violation|1|||
13207031|NCT01953003|26236369|FG000|Overall Study|Withdrawal by Subject|14|||
13207032|NCT01953003|26236370|FG001|Overall Study|Withdrawal by Subject|4|||
13207033|NCT01952834|26236379|FG000|Overall Study|Adverse Event|1|||
13207034|NCT01952691|26236387|FG000|Overall Study|Lost to Follow-up|2|||
13207035|NCT01952665|26236532|FG000|Overall Study|Physician Decision|3|||
13207036|NCT01952665|26236533|FG001|Overall Study|Physician Decision|2|||
13207037|NCT01952665|26236532|FG000|Overall Study|Lost to Follow-up|1|||
13207038|NCT01952665|26236533|FG001|Overall Study|Lost to Follow-up|2|||
13207039|NCT01952665|26236532|FG000|Overall Study|Adverse Event|2|||
13207040|NCT01952665|26236533|FG001|Overall Study|Adverse Event|1|||
13207041|NCT01952665|26236532|FG000|Overall Study|Protocol Violation|0|||
13207042|NCT01952665|26236533|FG001|Overall Study|Protocol Violation|1|||
13207043|NCT01952366|26236542|FG000|Overall Study|Death|22|||
13207044|NCT01952366|26236542|FG000|Overall Study|Withdrawal by Subject|9|||
13207045|NCT01952145|26236559|FG000|Overall Study|Protocol Violation|2|||
13207046|NCT01952145|26236560|FG001|Overall Study|Protocol Violation|1|||
13207047|NCT01952145|26236559|FG000|Overall Study|Death|0|||
13207048|NCT01952145|26236560|FG001|Overall Study|Death|1|||
13207049|NCT01952145|26236559|FG000|Overall Study|Adverse Event|9|||
13207050|NCT01952145|26236560|FG001|Overall Study|Adverse Event|0|||
13207051|NCT01952145|26236559|FG000|Overall Study|Withdrawal Criteria|16|||
13207052|NCT01952145|26236560|FG001|Overall Study|Withdrawal Criteria|11|||
13207053|NCT01952145|26236559|FG000|Overall Study|Unclassified|1|||
13207054|NCT01952145|26236560|FG001|Overall Study|Unclassified|1|||
13207055|NCT01952080|26236619|FG000|Overall Study|Withdrawal by Subject|0|||
13207056|NCT01952080|26236620|FG001|Overall Study|Withdrawal by Subject|0|||
13207057|NCT01952080|26236621|FG002|Overall Study|Withdrawal by Subject|0|||
13207058|NCT01952080|26236622|FG003|Overall Study|Withdrawal by Subject|1|||
13207059|NCT01952080|26236619|FG000|Overall Study|Protocol Non-compliance|0|||
13207060|NCT01952080|26236620|FG001|Overall Study|Protocol Non-compliance|1|||
13207061|NCT01952080|26236621|FG002|Overall Study|Protocol Non-compliance|0|||
13207062|NCT01952080|26236622|FG003|Overall Study|Protocol Non-compliance|0|||
13207063|NCT01952054|26236630|FG000|Overall Study|Physician Decision|1|||
13207064|NCT01952041|26236651|FG000|Overall Study|Lost to Follow-up|9|||
13207065|NCT01952041|26236652|FG001|Overall Study|Lost to Follow-up|16|||
13207066|NCT01952041|26236651|FG000|Overall Study|Withdrawal by Subject|7|||
13207067|NCT01952041|26236652|FG001|Overall Study|Withdrawal by Subject|5|||
13207068|NCT01952041|26236651|FG000|Overall Study|Death|1|||
13207069|NCT01952041|26236652|FG001|Overall Study|Death|0|||
13207070|NCT01952015|26236675|FG000|Induction|Protocol Violation|1|||
13207071|NCT01952015|26236675|FG000|Maintenance|Adverse Event|2|||
13207072|NCT01952015|26236675|FG000|Treatment Period 3|Physician Decision|9|||
13207073|NCT01951703|26236690|FG000|First Intervention|Withdrawal by Subject|1|||
13207074|NCT01951703|26236691|FG001|First Intervention|Withdrawal by Subject|0|||
13207075|NCT01951703|26236690|FG000|First Intervention|Subject was not compliant|1|||
13207076|NCT01951703|26236691|FG001|First Intervention|Subject was not compliant|1|||
13207077|NCT01951703|26236690|FG000|First Intervention|Physician Decision|1|||
13207078|NCT01951703|26236691|FG001|First Intervention|Physician Decision|0|||
13207079|NCT01951703|26236690|FG000|Second Intervention|Protocol Violation|0|||
13207080|NCT01951703|26236691|FG001|Second Intervention|Protocol Violation|1|||
13381241|NCT00755105|26747332|FG001|Overall Study|Withdrawal by Subject|11|||
13381242|NCT00755105|26747333|FG002|Overall Study|Withdrawal by Subject|4|||
13381243|NCT00755079|26747348|FG000|Overall Study|Lost to Follow-up|1|||
13381244|NCT00755079|26747349|FG001|Overall Study|Lost to Follow-up|3|||
13381245|NCT00755079|26747348|FG000|Overall Study|Adverse Event|0|||
13381246|NCT00755079|26747349|FG001|Overall Study|Adverse Event|1|||
13381247|NCT00755079|26747348|FG000|Overall Study|Withdrawal by Subject|0|||
13381248|NCT00755079|26747349|FG001|Overall Study|Withdrawal by Subject|2|||
13381249|NCT00754936|26747356|FG000|Overall Study|Lost to Follow-up|3|||
13381250|NCT00754936|26747356|FG000|Overall Study|Physician Decision|1|||
13381251|NCT00754936|26747356|FG000|Overall Study|Withdrawal by Subject|2|||
13381252|NCT00754936|26747356|FG000|Overall Study|Side Effects|3|||
13381253|NCT00754936|26747356|FG000|Overall Study|Inter-current medical events|3|||
13394499|NCT00657150|26787181|FG001|Treatment|Other|15|||
13207081|NCT01951703|26236690|FG000|Second Intervention|Unsatisfactory Lens fitting|0|||
13207082|NCT01951703|26236691|FG001|Second Intervention|Unsatisfactory Lens fitting|1|||
13207083|NCT01951638|26236739|FG000|Treatment Period|Protocol Violation|0|||
13207084|NCT01951638|26236740|FG001|Treatment Period|Protocol Violation|0|||
13207085|NCT01951638|26236741|FG002|Treatment Period|Protocol Violation|0|||
13207086|NCT01951638|26236742|FG003|Treatment Period|Protocol Violation|2|||
13381254|NCT00754793|26747369|FG000|Overall Study|voluntary withdrawn from study|0|||
13381255|NCT00754793|26747370|FG001|Overall Study|voluntary withdrawn from study|1|||
13207087|NCT01951638|26236743|FG004|Treatment Period|Protocol Violation|0|||
13207088|NCT01951638|26236739|FG000|Treatment Period|Protocol-driven decision point|1|||
13207089|NCT01951638|26236740|FG001|Treatment Period|Protocol-driven decision point|3|||
13207090|NCT01951638|26236741|FG002|Treatment Period|Protocol-driven decision point|0|||
13207091|NCT01951638|26236742|FG003|Treatment Period|Protocol-driven decision point|0|||
13207092|NCT01951638|26236743|FG004|Treatment Period|Protocol-driven decision point|0|||
13207093|NCT01951638|26236739|FG000|Treatment Period|Logistical difficulties|0|||
13207094|NCT01951638|26236740|FG001|Treatment Period|Logistical difficulties|1|||
13207095|NCT01951638|26236741|FG002|Treatment Period|Logistical difficulties|1|||
13207096|NCT01951638|26236742|FG003|Treatment Period|Logistical difficulties|0|||
13207097|NCT01951638|26236743|FG004|Treatment Period|Logistical difficulties|0|||
13207098|NCT01951638|26236739|FG000|Treatment Period|Withdrawal by Subject|9|||
13207099|NCT01951638|26236740|FG001|Treatment Period|Withdrawal by Subject|6|||
13207100|NCT01951638|26236741|FG002|Treatment Period|Withdrawal by Subject|4|||
13207101|NCT01951638|26236742|FG003|Treatment Period|Withdrawal by Subject|5|||
13207102|NCT01951638|26236743|FG004|Treatment Period|Withdrawal by Subject|4|||
13207103|NCT01951638|26236739|FG000|Treatment Period|Death|0|||
13207104|NCT01951638|26236740|FG001|Treatment Period|Death|0|||
13207105|NCT01951638|26236741|FG002|Treatment Period|Death|0|||
13207106|NCT01951638|26236742|FG003|Treatment Period|Death|3|||
13207107|NCT01951638|26236743|FG004|Treatment Period|Death|1|||
13207108|NCT01951638|26236739|FG000|Treatment Period|Adverse Event|3|||
13207109|NCT01951638|26236740|FG001|Treatment Period|Adverse Event|4|||
13207110|NCT01951638|26236741|FG002|Treatment Period|Adverse Event|8|||
13207111|NCT01951638|26236742|FG003|Treatment Period|Adverse Event|6|||
13207112|NCT01951638|26236743|FG004|Treatment Period|Adverse Event|5|||
13207113|NCT01951638|26236739|FG000|Follow-up Period|Protocol Violation|0|||
13207114|NCT01951638|26236740|FG001|Follow-up Period|Protocol Violation|0|||
13207115|NCT01951638|26236741|FG002|Follow-up Period|Protocol Violation|0|||
13207116|NCT01951638|26236742|FG003|Follow-up Period|Protocol Violation|1|||
13207117|NCT01951638|26236743|FG004|Follow-up Period|Protocol Violation|0|||
13207118|NCT01951638|26236739|FG000|Follow-up Period|Logistical difficulties|0|||
13207119|NCT01951638|26236740|FG001|Follow-up Period|Logistical difficulties|2|||
13207120|NCT01951638|26236741|FG002|Follow-up Period|Logistical difficulties|0|||
13207121|NCT01951638|26236742|FG003|Follow-up Period|Logistical difficulties|0|||
13207122|NCT01951638|26236743|FG004|Follow-up Period|Logistical difficulties|1|||
13207123|NCT01951638|26236739|FG000|Follow-up Period|Withdrawal by Subject|1|||
13207124|NCT01951638|26236740|FG001|Follow-up Period|Withdrawal by Subject|5|||
13207125|NCT01951638|26236741|FG002|Follow-up Period|Withdrawal by Subject|2|||
13207126|NCT01951638|26236742|FG003|Follow-up Period|Withdrawal by Subject|1|||
13207127|NCT01951638|26236743|FG004|Follow-up Period|Withdrawal by Subject|2|||
13207128|NCT01951638|26236739|FG000|Follow-up Period|Lost to Follow-up|0|||
13207129|NCT01951638|26236740|FG001|Follow-up Period|Lost to Follow-up|1|||
13207130|NCT01951638|26236741|FG002|Follow-up Period|Lost to Follow-up|0|||
13207131|NCT01951638|26236742|FG003|Follow-up Period|Lost to Follow-up|1|||
13207132|NCT01951638|26236743|FG004|Follow-up Period|Lost to Follow-up|0|||
13207133|NCT01951638|26236739|FG000|Follow-up Period|Death|1|||
13207134|NCT01951638|26236740|FG001|Follow-up Period|Death|0|||
13207135|NCT01951638|26236741|FG002|Follow-up Period|Death|1|||
13207136|NCT01951638|26236742|FG003|Follow-up Period|Death|4|||
13207137|NCT01951638|26236743|FG004|Follow-up Period|Death|1|||
13207138|NCT01951638|26236739|FG000|Follow-up Period|Adverse Event|0|||
13207139|NCT01951638|26236740|FG001|Follow-up Period|Adverse Event|1|||
13207140|NCT01951638|26236741|FG002|Follow-up Period|Adverse Event|2|||
13207141|NCT01951638|26236742|FG003|Follow-up Period|Adverse Event|1|||
13207142|NCT01951638|26236743|FG004|Follow-up Period|Adverse Event|1|||
13207143|NCT01951625|26236842|FG000|Treatment Period|Protocol Violation|2|||
13207144|NCT01951625|26236843|FG001|Treatment Period|Protocol Violation|0|||
13207145|NCT01951625|26236844|FG002|Treatment Period|Protocol Violation|1|||
13207146|NCT01951625|26236845|FG003|Treatment Period|Protocol Violation|3|||
13207147|NCT01951625|26236846|FG004|Treatment Period|Protocol Violation|2|||
13207148|NCT01951625|26236842|FG000|Treatment Period|Physician Decision|0|||
13207149|NCT01951625|26236843|FG001|Treatment Period|Physician Decision|0|||
13207150|NCT01951625|26236844|FG002|Treatment Period|Physician Decision|0|||
13207151|NCT01951625|26236845|FG003|Treatment Period|Physician Decision|0|||
13207152|NCT01951625|26236846|FG004|Treatment Period|Physician Decision|1|||
13207153|NCT01951625|26236842|FG000|Treatment Period|Protocol driven decision point|0|||
13207154|NCT01951625|26236843|FG001|Treatment Period|Protocol driven decision point|5|||
13207155|NCT01951625|26236844|FG002|Treatment Period|Protocol driven decision point|0|||
13207156|NCT01951625|26236845|FG003|Treatment Period|Protocol driven decision point|2|||
13207157|NCT01951625|26236846|FG004|Treatment Period|Protocol driven decision point|1|||
13207158|NCT01951625|26236842|FG000|Treatment Period|Non compliance with study drug|1|||
13207159|NCT01951625|26236843|FG001|Treatment Period|Non compliance with study drug|2|||
13207160|NCT01951625|26236844|FG002|Treatment Period|Non compliance with study drug|2|||
13207161|NCT01951625|26236845|FG003|Treatment Period|Non compliance with study drug|0|||
13207162|NCT01951625|26236846|FG004|Treatment Period|Non compliance with study drug|0|||
13207163|NCT01951625|26236842|FG000|Treatment Period|Death|3|||
13207164|NCT01951625|26236843|FG001|Treatment Period|Death|2|||
13207165|NCT01951625|26236844|FG002|Treatment Period|Death|2|||
13207166|NCT01951625|26236845|FG003|Treatment Period|Death|1|||
13207167|NCT01951625|26236846|FG004|Treatment Period|Death|2|||
13207168|NCT01951625|26236842|FG000|Treatment Period|Adverse Event|7|||
13207169|NCT01951625|26236843|FG001|Treatment Period|Adverse Event|10|||
13207170|NCT01951625|26236844|FG002|Treatment Period|Adverse Event|9|||
13207171|NCT01951625|26236845|FG003|Treatment Period|Adverse Event|8|||
13207172|NCT01951625|26236846|FG004|Treatment Period|Adverse Event|8|||
13207173|NCT01951625|26236842|FG000|Treatment Period|Withdrawal by Subject|5|||
13207174|NCT01951625|26236843|FG001|Treatment Period|Withdrawal by Subject|2|||
13207175|NCT01951625|26236844|FG002|Treatment Period|Withdrawal by Subject|1|||
13207176|NCT01951625|26236845|FG003|Treatment Period|Withdrawal by Subject|7|||
13207177|NCT01951625|26236846|FG004|Treatment Period|Withdrawal by Subject|3|||
13207178|NCT01951625|26236842|FG000|Treatment Period|Lost to Follow-up|1|||
13207179|NCT01951625|26236843|FG001|Treatment Period|Lost to Follow-up|0|||
13207180|NCT01951625|26236844|FG002|Treatment Period|Lost to Follow-up|0|||
13207181|NCT01951625|26236845|FG003|Treatment Period|Lost to Follow-up|1|||
13207182|NCT01951625|26236846|FG004|Treatment Period|Lost to Follow-up|0|||
13207183|NCT01951625|26236842|FG000|Follow Up Period|Non-compliance with study drug|1|||
13207184|NCT01951625|26236843|FG001|Follow Up Period|Non-compliance with study drug|0|||
13207185|NCT01951625|26236844|FG002|Follow Up Period|Non-compliance with study drug|0|||
13207186|NCT01951625|26236845|FG003|Follow Up Period|Non-compliance with study drug|0|||
13207187|NCT01951625|26236846|FG004|Follow Up Period|Non-compliance with study drug|0|||
13207188|NCT01951625|26236842|FG000|Follow Up Period|Death|1|||
13207189|NCT01951625|26236843|FG001|Follow Up Period|Death|3|||
13207190|NCT01951625|26236844|FG002|Follow Up Period|Death|2|||
13207191|NCT01951625|26236845|FG003|Follow Up Period|Death|2|||
13207192|NCT01951625|26236846|FG004|Follow Up Period|Death|1|||
13207193|NCT01951625|26236842|FG000|Follow Up Period|Logistical difficulties|1|||
13207194|NCT01951625|26236843|FG001|Follow Up Period|Logistical difficulties|2|||
13207195|NCT01951625|26236844|FG002|Follow Up Period|Logistical difficulties|0|||
13207196|NCT01951625|26236845|FG003|Follow Up Period|Logistical difficulties|0|||
13207197|NCT01951625|26236846|FG004|Follow Up Period|Logistical difficulties|0|||
13207198|NCT01951625|26236842|FG000|Follow Up Period|Adverse Event|0|||
13207199|NCT01951625|26236843|FG001|Follow Up Period|Adverse Event|3|||
13207200|NCT01951625|26236844|FG002|Follow Up Period|Adverse Event|2|||
13207201|NCT01951625|26236845|FG003|Follow Up Period|Adverse Event|3|||
13207202|NCT01951625|26236846|FG004|Follow Up Period|Adverse Event|5|||
13207203|NCT01951625|26236842|FG000|Follow Up Period|Withdrawal by Subject|4|||
13207204|NCT01951625|26236843|FG001|Follow Up Period|Withdrawal by Subject|1|||
13207205|NCT01951625|26236844|FG002|Follow Up Period|Withdrawal by Subject|0|||
13207206|NCT01951625|26236845|FG003|Follow Up Period|Withdrawal by Subject|5|||
13207207|NCT01951625|26236846|FG004|Follow Up Period|Withdrawal by Subject|3|||
13207208|NCT01951625|26236842|FG000|Follow Up Period|Lost to Follow-up|1|||
13207209|NCT01951625|26236843|FG001|Follow Up Period|Lost to Follow-up|0|||
13207210|NCT01951625|26236844|FG002|Follow Up Period|Lost to Follow-up|0|||
13207211|NCT01951625|26236845|FG003|Follow Up Period|Lost to Follow-up|1|||
13207212|NCT01951625|26236846|FG004|Follow Up Period|Lost to Follow-up|1|||
13207213|NCT01951586|26236877|FG000|Overall Study|Death|61|||
13207214|NCT01951586|26236878|FG001|Overall Study|Death|120|||
13207215|NCT01951586|26236877|FG000|Overall Study|Withdrawal by Subject|8|||
13207216|NCT01951586|26236878|FG001|Overall Study|Withdrawal by Subject|17|||
13207217|NCT01951586|26236877|FG000|Overall Study|Lost to Follow-up|0|||
13207218|NCT01951586|26236878|FG001|Overall Study|Lost to Follow-up|1|||
13207219|NCT01951586|26236877|FG000|Overall Study|Sponsor Decision|9|||
13207220|NCT01951586|26236878|FG001|Overall Study|Sponsor Decision|10|||
13207221|NCT01951573|26236891|FG000|Washout Period|Adverse Event|0|||
13207222|NCT01951573|26236892|FG001|Washout Period|Adverse Event|1|||
13207223|NCT01951417|26236917|FG000|Overall Study|Withdrawal by Subject|1|||
13207224|NCT01951417|26236917|FG000|Overall Study|Protocol Violation|2|||
13207225|NCT01951417|26236917|FG000|Overall Study|Lost to Follow-up|6|||
13207226|NCT01951378|26236932|FG000|Overall Study|Study Terminated-Not completed|23|||
13207227|NCT01951378|26236933|FG001|Overall Study|Study Terminated-Not completed|17|||
13207228|NCT01951261|26236958|FG000|Overall Study|Death|1|||
13207229|NCT01951261|26236959|FG001|Overall Study|Death|0|||
13207230|NCT01951261|26236958|FG000|Overall Study|Lost to Follow-up|4|||
13207231|NCT01951261|26236959|FG001|Overall Study|Lost to Follow-up|3|||
13207232|NCT01951261|26236958|FG000|Overall Study|Protocol Violation|4|||
13207233|NCT01951261|26236959|FG001|Overall Study|Protocol Violation|3|||
13207234|NCT01951170|26236984|FG000|Overall Study|Investigator decision|1|||
13207235|NCT01951157|26237023|FG000|Overall Study|Progressive Disease|12|||
13207236|NCT01951157|26237024|FG001|Overall Study|Progressive Disease|13|||
13207237|NCT01951157|26237025|FG002|Overall Study|Progressive Disease|10|||
13207238|NCT01951157|26237023|FG000|Overall Study|Treatment-unrelated AE|1|||
13207239|NCT01951157|26237024|FG001|Overall Study|Treatment-unrelated AE|0|||
13207240|NCT01951157|26237025|FG002|Overall Study|Treatment-unrelated AE|3|||
13207241|NCT01951157|26237023|FG000|Overall Study|Study Termination|0|||
13207242|NCT01951157|26237024|FG001|Overall Study|Study Termination|0|||
13207243|NCT01951157|26237025|FG002|Overall Study|Study Termination|1|||
13207244|NCT01951157|26237023|FG000|Overall Study|Physician Decision|5|||
13207245|NCT01951157|26237024|FG001|Overall Study|Physician Decision|3|||
13207246|NCT01951157|26237025|FG002|Overall Study|Physician Decision|2|||
13207247|NCT01951157|26237023|FG000|Overall Study|Non-treatmentrelated death|2|||
13207248|NCT01951157|26237024|FG001|Overall Study|Non-treatmentrelated death|2|||
13207249|NCT01951157|26237025|FG002|Overall Study|Non-treatmentrelated death|2|||
13207250|NCT01951157|26237023|FG000|Overall Study|No treated|0|||
13207251|NCT01951157|26237024|FG001|Overall Study|No treated|1|||
13207252|NCT01951157|26237025|FG002|Overall Study|No treated|0|||
13207253|NCT01951157|26237023|FG000|Overall Study|Treatment-related AE|2|||
13207254|NCT01951157|26237024|FG001|Overall Study|Treatment-related AE|0|||
13207255|NCT01951157|26237025|FG002|Overall Study|Treatment-related AE|4|||
13207256|NCT01951157|26237023|FG000|Overall Study|Consent withdrawn by subject|0|||
13207257|NCT01951157|26237024|FG001|Overall Study|Consent withdrawn by subject|1|||
13207258|NCT01951157|26237025|FG002|Overall Study|Consent withdrawn by subject|3|||
13207259|NCT01951157|26237023|FG000|Overall Study|Treatment-related death|0|||
13207260|NCT01951157|26237024|FG001|Overall Study|Treatment-related death|2|||
13207261|NCT01951157|26237025|FG002|Overall Study|Treatment-related death|0|||
13207262|NCT01951105|26237049|FG000|Overall Study|Adverse Event|0|||
13207263|NCT01951105|26237050|FG001|Overall Study|Adverse Event|5|||
13207264|NCT01951105|26237051|FG002|Overall Study|Adverse Event|0|||
13207265|NCT01951105|26237049|FG000|Overall Study|Lost to Follow-up|0|||
13207266|NCT01951105|26237050|FG001|Overall Study|Lost to Follow-up|1|||
13207267|NCT01951105|26237051|FG002|Overall Study|Lost to Follow-up|0|||
13207268|NCT01951105|26237049|FG000|Overall Study|Protocol Violation|1|||
13207269|NCT01951105|26237050|FG001|Overall Study|Protocol Violation|1|||
13207270|NCT01951105|26237051|FG002|Overall Study|Protocol Violation|1|||
13207271|NCT01951105|26237049|FG000|Overall Study|Withdrawal by Subject|0|||
13207272|NCT01951105|26237050|FG001|Overall Study|Withdrawal by Subject|3|||
13207273|NCT01951105|26237051|FG002|Overall Study|Withdrawal by Subject|1|||
13207274|NCT01951092|26237058|FG000|Overall Study|Lost to Follow-up|10|||
13207275|NCT01951092|26237058|FG000|Overall Study|Incarceration|1|||
13207276|NCT01951092|26237058|FG000|Overall Study|Transfer of Care|1|||
13207277|NCT01950819|26237113|FG000|Overall Study|Graft Loss|35|||
13207278|NCT01950819|26237114|FG001|Overall Study|Graft Loss|30|||
13207279|NCT01950819|26237113|FG000|Overall Study|Death|29|||
13207280|NCT01950819|26237114|FG001|Overall Study|Death|34|||
13207281|NCT01950819|26237113|FG000|Overall Study|Subject / Gardian decision|54|||
13207282|NCT01950819|26237114|FG001|Overall Study|Subject / Gardian decision|51|||
13207283|NCT01950819|26237113|FG000|Overall Study|technical problems|2|||
13207284|NCT01950819|26237114|FG001|Overall Study|technical problems|0|||
13207285|NCT01950819|26237113|FG000|Overall Study|Pregnancy|0|||
13207286|NCT01950819|26237114|FG001|Overall Study|Pregnancy|2|||
13207287|NCT01950819|26237113|FG000|Overall Study|Lost to Follow-up|9|||
13207288|NCT01950819|26237114|FG001|Overall Study|Lost to Follow-up|17|||
13207289|NCT01950741|26237125|FG000|Overall Study|Lost to Follow-up|1|||
13207290|NCT01950741|26237125|FG000|Overall Study|Death|1|||
13207291|NCT01950741|26237125|FG000|Overall Study|Withdrawal by Subject|1|||
13207292|NCT01950364|26237230|FG000|Overall Study|Adverse Event|3|||
13207293|NCT01950364|26237231|FG001|Overall Study|Adverse Event|0|||
13207294|NCT01950364|26237230|FG000|Overall Study|Stem Cell Transplant|2|||
13207295|NCT01950364|26237231|FG001|Overall Study|Stem Cell Transplant|6|||
13207296|NCT01950364|26237230|FG000|Overall Study|Disease Progression|5|||
13207297|NCT01950364|26237231|FG001|Overall Study|Disease Progression|2|||
13207298|NCT01950364|26237230|FG000|Overall Study|Withdrawal by Subject|0|||
13207299|NCT01950364|26237231|FG001|Overall Study|Withdrawal by Subject|1|||
13207300|NCT01950364|26237230|FG000|Overall Study|Protocol Violation|0|||
13207301|NCT01950364|26237231|FG001|Overall Study|Protocol Violation|1|||
13207302|NCT01950273|26237258|FG000|Overall Study|Protocol Violation|1|||
13207303|NCT01950273|26237259|FG001|Overall Study|Protocol Violation|0|||
13381256|NCT00754741|26747427|FG000|Overall Study|Died or disenrolled|57|||
13381257|NCT00754741|26747428|FG001|Overall Study|Died or disenrolled|69|||
13381258|NCT00754741|26747429|FG002|Overall Study|Died or disenrolled|54|||
13381259|NCT00754650|26747436|FG000|Overall Study|Disease Progression|2|||
13381260|NCT00754624|26747448|FG000|Overall Study|Adverse Event|16|||
13381261|NCT00754624|26747448|FG000|Overall Study|Death|1|||
13381262|NCT00754624|26747448|FG000|Overall Study|Physician Decision|8|||
13381263|NCT00754624|26747448|FG000|Overall Study|Protocol Violation|1|||
13381264|NCT00754624|26747448|FG000|Overall Study|Withdrawal by Subject|28|||
13381265|NCT00754624|26747448|FG000|Overall Study|Various|12|||
13381266|NCT00754624|26747448|FG000|Overall Study|Lost to Follow-up|3|||
13394500|NCT00657046|26787223|FG000|Overall Study|Adverse Event|1|||
13207304|NCT01950273|26237258|FG000|Overall Study|Withdrawal by Subject|2|||
13207305|NCT01950273|26237259|FG001|Overall Study|Withdrawal by Subject|0|||
13207306|NCT01950273|26237258|FG000|Overall Study|Other not defined above|1|||
13381267|NCT00754572|26747477|FG000|Overall Study|Adverse Event|19|||
13381268|NCT00754572|26747477|FG000|Overall Study|Other|39|||
13381269|NCT00754572|26747477|FG000|Overall Study|Protocol Violation|3|||
13381270|NCT00754572|26747477|FG000|Overall Study|Withdrawal by Subject|3|||
13381271|NCT00754572|26747477|FG000|Overall Study|Lack of Efficacy|2|||
13381272|NCT00754572|26747477|FG000|Overall Study|Death|1|||
13207307|NCT01950273|26237259|FG001|Overall Study|Other not defined above|0|||
13207308|NCT01950169|26237286|FG000|Overall Study|Withdrawal by Subject|2|||
13207309|NCT01950169|26237287|FG001|Overall Study|Withdrawal by Subject|8|||
13207310|NCT01950169|26237288|FG002|Overall Study|Withdrawal by Subject|1|||
13207311|NCT01950169|26237286|FG000|Overall Study|Death|1|||
13207312|NCT01950169|26237287|FG001|Overall Study|Death|0|||
13381273|NCT00754572|26747477|FG000|Overall Study|Administrative Reason|3|||
13381274|NCT00754572|26747477|FG000|Overall Study|Lost to Follow-up|1|||
13381275|NCT00754559|26747503|FG000|Overall Study|Adverse Event|15|||
13381276|NCT00754559|26747503|FG000|Overall Study|Protocol Violation|11|||
13381277|NCT00754559|26747503|FG000|Overall Study|Lack of Efficacy|10|||
13381278|NCT00754559|26747503|FG000|Overall Study|Lost to Follow-up|2|||
13381279|NCT00754559|26747503|FG000|Overall Study|Administrative reason|1|||
13381280|NCT00754559|26747503|FG000|Overall Study|Other|5|||
13381281|NCT00754559|26747503|FG000|Overall Study|Withdrawal by Subject|3|||
13381282|NCT00754442|26747517|FG000|Overall Study|Withdrawal by Subject|5|||
13381283|NCT00754442|26747518|FG001|Overall Study|Withdrawal by Subject|3|||
13381284|NCT00754390|26747527|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3|||
13381285|NCT00754390|26747527|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2|||
13381286|NCT00754390|26747527|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1|||
13381287|NCT00754390|26747527|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1|||
13381288|NCT00754338|26747570|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
13381289|NCT00754338|26747571|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
13381290|NCT00754338|26747572|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
13207313|NCT01950169|26237288|FG002|Overall Study|Death|0|||
13207314|NCT01950013|26237309|FG000|Overall Study|Withdrawal by Subject|0|||
13207315|NCT01950013|26237310|FG001|Overall Study|Withdrawal by Subject|2|||
13207316|NCT01950013|26237311|FG002|Overall Study|Withdrawal by Subject|0|||
13207317|NCT01949870|26237317|FG000|Overall Study|Lack of Efficacy|2|||
13207318|NCT01949870|26237317|FG000|Overall Study|Adverse Event|1|||
13207319|NCT01949870|26237317|FG000|Overall Study|Study termination|1|||
13207320|NCT01949870|26237317|FG000|Overall Study|Eligibility requirements not fulfilled|2|||
13207321|NCT01949662|26237336|FG000|Overall Study|Death|9|||
13207322|NCT01949662|26237337|FG001|Overall Study|Death|7|||
13207323|NCT01949662|26237336|FG000|Overall Study|Discharged before an agitation event|8|||
13207324|NCT01949662|26237337|FG001|Overall Study|Discharged before an agitation event|3|||
13207325|NCT01949662|26237336|FG000|Overall Study|Dropped out|1|||
13207326|NCT01949662|26237337|FG001|Overall Study|Dropped out|3|||
13207327|NCT01949662|26237336|FG000|Overall Study|Ineligible|0|||
13207328|NCT01949662|26237337|FG001|Overall Study|Ineligible|1|||
13207329|NCT01949532|26237412|FG000|Overall Study|On-study at the Data Cut-off Date|3|||
13207330|NCT01949532|26237413|FG001|Overall Study|On-study at the Data Cut-off Date|3|||
13207331|NCT01949480|26237448|FG000|Overall Study|Physician Decision|5|||
13207332|NCT01949480|26237449|FG001|Overall Study|Physician Decision|8|||
13207333|NCT01949155|26237466|FG000|Overall Study|Lost to Follow-up|1|||
13207334|NCT01949155|26237467|FG001|Overall Study|Lost to Follow-up|0|||
13207335|NCT01949155|26237466|FG000|Overall Study|Protocol Violation|1|||
13207336|NCT01949155|26237467|FG001|Overall Study|Protocol Violation|0|||
13207337|NCT01949142|26237484|FG000|Overall Study|Withdrawal of consent|1|||
13207338|NCT01949142|26237485|FG001|Overall Study|Withdrawal of consent|0|||
13207339|NCT01949142|26237484|FG000|Overall Study|Lost to Follow-up|1|||
13207340|NCT01949142|26237485|FG001|Overall Study|Lost to Follow-up|1|||
13207341|NCT01949142|26237484|FG000|Overall Study|Parent changed their mind|1|||
13207342|NCT01949142|26237485|FG001|Overall Study|Parent changed their mind|0|||
13207343|NCT01949116|26237524|FG000|Overall Study|Death|2|||
13207344|NCT01949116|26237525|FG001|Overall Study|Death|0|||
13381291|NCT00754338|26747573|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
13381292|NCT00754338|26747570|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
13381293|NCT00754338|26747571|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
13207345|NCT01949116|26237524|FG000|Overall Study|Lost to Follow-up|1|||
13207346|NCT01949116|26237525|FG001|Overall Study|Lost to Follow-up|3|||
13207347|NCT01949116|26237524|FG000|Overall Study|Withdrawal by Subject|5|||
13207348|NCT01949116|26237525|FG001|Overall Study|Withdrawal by Subject|3|||
13207349|NCT01949090|26237718|FG000|Overall Study|Serious Adverse Event|0|||
13207350|NCT01949090|26237719|FG001|Overall Study|Serious Adverse Event|1|||
13207351|NCT01949090|26237720|FG002|Overall Study|Serious Adverse Event|2|||
13207352|NCT01949090|26237721|FG003|Overall Study|Serious Adverse Event|0|||
13207353|NCT01949090|26237722|FG004|Overall Study|Serious Adverse Event|1|||
13207354|NCT01949090|26237718|FG000|Overall Study|Withdrawal by Subject|2|||
13207355|NCT01949090|26237719|FG001|Overall Study|Withdrawal by Subject|0|||
13207356|NCT01949090|26237720|FG002|Overall Study|Withdrawal by Subject|0|||
13207357|NCT01949090|26237721|FG003|Overall Study|Withdrawal by Subject|0|||
13381294|NCT00754338|26747572|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
13381295|NCT00754338|26747573|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
13381296|NCT00754325|26747599|FG000|Initial Treatment|Continuing Active Treatment|4|||
13381297|NCT00754325|26747600|FG001|Initial Treatment|Continuing Active Treatment|5|||
13381298|NCT00754325|26747599|FG000|Initial Treatment|Adverse Event|7|||
13381299|NCT00754325|26747600|FG001|Initial Treatment|Adverse Event|6|||
13381300|NCT00754325|26747599|FG000|Initial Treatment|Withdrawal by Subject|2|||
13381301|NCT00754325|26747600|FG001|Initial Treatment|Withdrawal by Subject|2|||
13381302|NCT00754325|26747599|FG000|Initial Treatment|Physician Decision|2|||
13381303|NCT00754325|26747600|FG001|Initial Treatment|Physician Decision|0|||
13381304|NCT00754325|26747599|FG000|Initial Treatment|Sponsor Request|0|||
13207358|NCT01949090|26237722|FG004|Overall Study|Withdrawal by Subject|1|||
13207359|NCT01949090|26237718|FG000|Overall Study|Protocol non-compliance|0|||
13207360|NCT01949090|26237719|FG001|Overall Study|Protocol non-compliance|0|||
13207361|NCT01949090|26237720|FG002|Overall Study|Protocol non-compliance|0|||
13207362|NCT01949090|26237721|FG003|Overall Study|Protocol non-compliance|0|||
13207363|NCT01949090|26237722|FG004|Overall Study|Protocol non-compliance|1|||
13207364|NCT01949090|26237718|FG000|Overall Study|Lost to Follow-up|2|||
13207365|NCT01949090|26237719|FG001|Overall Study|Lost to Follow-up|1|||
13207366|NCT01949090|26237720|FG002|Overall Study|Lost to Follow-up|0|||
13207367|NCT01949090|26237721|FG003|Overall Study|Lost to Follow-up|1|||
13207368|NCT01949090|26237722|FG004|Overall Study|Lost to Follow-up|1|||
13207369|NCT01949051|26237740|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1|||
13207370|NCT01949051|26237741|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0|||
13207371|NCT01949051|26237742|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0|||
13207372|NCT01949051|26237743|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1|||
13207373|NCT01949051|26237744|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0|||
13207374|NCT01949051|26237745|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0|||
13207375|NCT01949051|26237740|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
13207376|NCT01949051|26237741|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
13207377|NCT01949051|26237742|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
13207378|NCT01949051|26237743|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
13207379|NCT01949051|26237744|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
13207380|NCT01949051|26237745|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
13207381|NCT01949051|26237740|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0|||
13207382|NCT01949051|26237741|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0|||
13207383|NCT01949051|26237742|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0|||
13207384|NCT01949051|26237743|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0|||
13207385|NCT01949051|26237744|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0|||
13207386|NCT01949051|26237745|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1|||
13207387|NCT01949051|26237740|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
13207388|NCT01949051|26237741|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1|||
13207389|NCT01949051|26237742|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
13207390|NCT01949051|26237743|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
13207391|NCT01949051|26237744|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
13207392|NCT01949051|26237745|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
13207393|NCT01949051|26237740|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
13207394|NCT01949051|26237741|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
13207395|NCT01949051|26237742|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1|||
13207396|NCT01949051|26237743|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
13207397|NCT01949051|26237744|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
13207398|NCT01949051|26237745|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
13207399|NCT01948908|26237769|FG000|Overall Study|Protocol Violation|1|||
13207400|NCT01948908|26237770|FG001|Overall Study|Protocol Violation|0|||
13207401|NCT01948908|26237771|FG002|Overall Study|Protocol Violation|2|||
13207402|NCT01948830|26237810|FG000|Overall Study|Physician Decision|1|||
13207403|NCT01948830|26237811|FG001|Overall Study|Physician Decision|3|||
13207404|NCT01948830|26237810|FG000|Overall Study|Protocol deviation|1|||
13207405|NCT01948830|26237811|FG001|Overall Study|Protocol deviation|2|||
13207406|NCT01948830|26237810|FG000|Overall Study|Lost to Follow-up|5|||
13207407|NCT01948830|26237811|FG001|Overall Study|Lost to Follow-up|4|||
13207408|NCT01948830|26237810|FG000|Overall Study|Withdrawal by Subject|14|||
13207409|NCT01948830|26237811|FG001|Overall Study|Withdrawal by Subject|17|||
13207410|NCT01948830|26237810|FG000|Overall Study|Adverse Event|9|||
13207411|NCT01948830|26237811|FG001|Overall Study|Adverse Event|2|||
13207412|NCT01948830|26237810|FG000|Overall Study|Death|3|||
13207413|NCT01948830|26237811|FG001|Overall Study|Death|4|||
13296181|NCT01371747|26495995|FG004|Overall Study|Protocol Violation|0|||
13296182|NCT01371747|26495996|FG005|Overall Study|Protocol Violation|0|||
13296183|NCT01371747|26495991|FG000|Overall Study|Non-Compliance|3|||
13296184|NCT01371747|26495992|FG001|Overall Study|Non-Compliance|4|||
13296185|NCT01371747|26495993|FG002|Overall Study|Non-Compliance|3|||
13296186|NCT01371747|26495994|FG003|Overall Study|Non-Compliance|0|||
13296187|NCT01371747|26495995|FG004|Overall Study|Non-Compliance|0|||
13296188|NCT01371747|26495996|FG005|Overall Study|Non-Compliance|1|||
13296189|NCT01371747|26495991|FG000|Overall Study|Physician Decision|0|||
13381305|NCT00754325|26747600|FG001|Initial Treatment|Sponsor Request|1|||
13381306|NCT00754325|26747599|FG000|Initial Treatment|Disease Progression|35|||
13381307|NCT00754325|26747600|FG001|Initial Treatment|Disease Progression|35|||
13381308|NCT00754234|26747606|FG000|Overall Study|Withdrawal by Subject|3|||
13381309|NCT00754065|26747851|FG000|Overall Study|Never received treatment|12|||
13381310|NCT00754065|26747852|FG001|Overall Study|Never received treatment|2|||
13381311|NCT00754065|26747851|FG000|Overall Study|Adverse Event|19|||
13381312|NCT00754065|26747852|FG001|Overall Study|Adverse Event|25|||
13381313|NCT00754065|26747851|FG000|Overall Study|Lost to Follow-up|7|||
13207414|NCT01948791|26237821|FG000|Overall Study|Adverse Event|12|||
13207415|NCT01948791|26237821|FG000|Overall Study|Lack of Efficacy|3|||
13207416|NCT01948791|26237821|FG000|Overall Study|Protocol Violation|2|||
13207417|NCT01948791|26237821|FG000|Overall Study|Withdrawal by Subject|5|||
13207418|NCT01948791|26237821|FG000|Overall Study|Lost to Follow-up|6|||
13207419|NCT01948791|26237821|FG000|Overall Study|Management issues|1|||
13207420|NCT01948791|26237821|FG000|Overall Study|Others|7|||
13207421|NCT01948791|26237821|FG000|Overall Study|Screening failure|35|||
13207422|NCT01948427|26237869|FG000|Overall Study|Serious Adverse Event|3|||
13207423|NCT01948427|26237870|FG001|Overall Study|Serious Adverse Event|0|||
13207424|NCT01948427|26237871|FG002|Overall Study|Serious Adverse Event|0|||
13207425|NCT01948427|26237872|FG003|Overall Study|Serious Adverse Event|0|||
13207426|NCT01948427|26237873|FG004|Overall Study|Serious Adverse Event|1|||
13207427|NCT01948427|26237869|FG000|Overall Study|Investigator Request|0|||
13207428|NCT01948427|26237870|FG001|Overall Study|Investigator Request|8|||
13207429|NCT01948427|26237871|FG002|Overall Study|Investigator Request|0|||
13207430|NCT01948427|26237872|FG003|Overall Study|Investigator Request|0|||
13207431|NCT01948427|26237873|FG004|Overall Study|Investigator Request|6|||
13207432|NCT01948427|26237869|FG000|Overall Study|Lost to Follow-up|1|||
13207433|NCT01948427|26237870|FG001|Overall Study|Lost to Follow-up|0|||
13207434|NCT01948427|26237871|FG002|Overall Study|Lost to Follow-up|0|||
13207435|NCT01948427|26237872|FG003|Overall Study|Lost to Follow-up|0|||
13207436|NCT01948427|26237873|FG004|Overall Study|Lost to Follow-up|4|||
13207437|NCT01948427|26237869|FG000|Overall Study|Withdrawal by Subject|2|||
13207438|NCT01948427|26237870|FG001|Overall Study|Withdrawal by Subject|0|||
13207439|NCT01948427|26237871|FG002|Overall Study|Withdrawal by Subject|0|||
13207440|NCT01948427|26237872|FG003|Overall Study|Withdrawal by Subject|0|||
13207441|NCT01948427|26237873|FG004|Overall Study|Withdrawal by Subject|1|||
13207442|NCT01948427|26237869|FG000|Overall Study|Other, Not Specified|1|||
13207443|NCT01948427|26237870|FG001|Overall Study|Other, Not Specified|9|||
13207444|NCT01948427|26237871|FG002|Overall Study|Other, Not Specified|0|||
13207445|NCT01948427|26237872|FG003|Overall Study|Other, Not Specified|0|||
13207446|NCT01948427|26237873|FG004|Overall Study|Other, Not Specified|2|||
13207447|NCT01948258|26237881|FG000|Overall Study|Pregnancy|41|||
13207448|NCT01948258|26237881|FG000|Overall Study|Did not complete by cut-off date|35|||
13207449|NCT01948258|26237881|FG000|Overall Study|Lost to Follow-up|27|||
13207450|NCT01948258|26237881|FG000|Overall Study|Withdrawal by SPD|8|||
13207451|NCT01948258|26237881|FG000|Overall Study|Withdrawal by Subject|6|||
13207452|NCT01948258|26237881|FG000|Overall Study|Health Care Professional|43|||
13207453|NCT01948258|26237881|FG000|Overall Study|Removed from statistical analysis|2|||
13207454|NCT01948193|26237892|FG000|Overall Study|Serious event|2|||
13207455|NCT01948193|26237892|FG000|Overall Study|Lost to Follow-up|7|||
13207456|NCT01948076|26237907|FG000|Overall Study|Withdrawal by Subject|0|||
13207457|NCT01948076|26237908|FG001|Overall Study|Withdrawal by Subject|1|||
13207458|NCT01948063|26237921|FG000|Overall Study|Boston MCI halted research protocol|0|||
13207459|NCT01948063|26237922|FG001|Overall Study|Boston MCI halted research protocol|1|||
13207460|NCT01948063|26237921|FG000|Overall Study|Discovered an enrollment in other study|0|||
13207461|NCT01948063|26237922|FG001|Overall Study|Discovered an enrollment in other study|1|||
13207462|NCT01948063|26237921|FG000|Overall Study|Blood samples were accidentally thawed|1|||
13207463|NCT01948063|26237922|FG001|Overall Study|Blood samples were accidentally thawed|0|||
13207464|NCT01948050|26237935|FG000|Overall Study|Withdrawal by Subject|0|||
13207465|NCT01948050|26237936|FG001|Overall Study|Withdrawal by Subject|1|||
13207466|NCT01947894|26238008|FG000|Overall Study|Other|3|||
13207467|NCT01947894|26238009|FG001|Overall Study|Other|4|||
13207468|NCT01947894|26238010|FG002|Overall Study|Other|3|||
13207469|NCT01947894|26238008|FG000|Overall Study|Withdrawal by Subject|12|||
13207470|NCT01947894|26238009|FG001|Overall Study|Withdrawal by Subject|4|||
13207471|NCT01947894|26238010|FG002|Overall Study|Withdrawal by Subject|1|||
13207472|NCT01947894|26238008|FG000|Overall Study|Death|12|||
13207473|NCT01947894|26238009|FG001|Overall Study|Death|1|||
13207474|NCT01947894|26238010|FG002|Overall Study|Death|0|||
13207475|NCT01947894|26238008|FG000|Overall Study|Physician Decision|2|||
13207476|NCT01947894|26238009|FG001|Overall Study|Physician Decision|0|||
13207477|NCT01947894|26238010|FG002|Overall Study|Physician Decision|0|||
13207478|NCT01947894|26238008|FG000|Overall Study|Adverse Event|5|||
13207479|NCT01947894|26238009|FG001|Overall Study|Adverse Event|1|||
13207480|NCT01947894|26238010|FG002|Overall Study|Adverse Event|0|||
13381314|NCT00754065|26747852|FG001|Overall Study|Lost to Follow-up|11|||
13207481|NCT01947894|26238008|FG000|Overall Study|Switched to other growth hormone brand|53|||
13207482|NCT01947894|26238009|FG001|Overall Study|Switched to other growth hormone brand|8|||
13207483|NCT01947894|26238010|FG002|Overall Study|Switched to other growth hormone brand|23|||
13207484|NCT01947855|26238028|FG000|Overall Study|Withdrawal by Subject|1|||
13207485|NCT01947855|26238029|FG001|Overall Study|Withdrawal by Subject|0|||
13207486|NCT01947855|26238030|FG002|Overall Study|Withdrawal by Subject|0|||
13207487|NCT01947582|26238039|FG000|Overall Study|Withdrawal by Subject|1|||
13207488|NCT01947517|26238060|FG000|Overall Study|Withdrawal by Subject|1|||
13207489|NCT01947517|26238061|FG001|Overall Study|Withdrawal by Subject|1|||
13207490|NCT01947491|26238084|FG000|Overall Study|Lost to Follow-up|5|||
13207491|NCT01947491|26238085|FG001|Overall Study|Lost to Follow-up|3|||
13207492|NCT01947491|26238086|FG002|Overall Study|Lost to Follow-up|1|||
13207493|NCT01947491|26238087|FG003|Overall Study|Lost to Follow-up|2|||
13207494|NCT01947491|26238084|FG000|Overall Study|Lack of Efficacy|1|||
13207495|NCT01947491|26238085|FG001|Overall Study|Lack of Efficacy|0|||
13207496|NCT01947491|26238086|FG002|Overall Study|Lack of Efficacy|0|||
13207497|NCT01947491|26238087|FG003|Overall Study|Lack of Efficacy|1|||
13207498|NCT01947491|26238084|FG000|Overall Study|Protocol Violation|1|||
13207499|NCT01947491|26238085|FG001|Overall Study|Protocol Violation|0|||
13207500|NCT01947491|26238086|FG002|Overall Study|Protocol Violation|0|||
13296190|NCT01371747|26495992|FG001|Overall Study|Physician Decision|0|||
13296191|NCT01371747|26495993|FG002|Overall Study|Physician Decision|0|||
13381315|NCT00754065|26747851|FG000|Overall Study|Protocol Violation|12|||
13381316|NCT00754065|26747852|FG001|Overall Study|Protocol Violation|10|||
13381317|NCT00754065|26747851|FG000|Overall Study|Withdrawal by Subject|4|||
13381318|NCT00754065|26747852|FG001|Overall Study|Withdrawal by Subject|5|||
13381319|NCT00754065|26747851|FG000|Overall Study|Pregnancy|6|||
13381320|NCT00754065|26747852|FG001|Overall Study|Pregnancy|0|||
13381321|NCT00754065|26747851|FG000|Overall Study|Reason not specified or unknown, etc.|21|||
13381322|NCT00754065|26747852|FG001|Overall Study|Reason not specified or unknown, etc.|27|||
13381323|NCT00754052|26747871|FG000|Overall Study|Study terminated by Sponsor|5|||
13381324|NCT00754052|26747872|FG001|Overall Study|Study terminated by Sponsor|3|||
13381325|NCT00754013|26747887|FG000|Overall Study|Lost to Follow-up|1|||
13381326|NCT00754013|26747888|FG001|Overall Study|Lost to Follow-up|1|||
13381327|NCT00754013|26747887|FG000|Overall Study|didn't return after study termed|3|||
13381328|NCT00754013|26747888|FG001|Overall Study|didn't return after study termed|4|||
13381329|NCT00753922|26747931|FG000|Overall Study|Lost to Follow-up|155|||
13381330|NCT00753922|26747932|FG001|Overall Study|Lost to Follow-up|24|||
13381331|NCT00753922|26747933|FG002|Overall Study|Lost to Follow-up|28|||
13381332|NCT00753922|26747934|FG003|Overall Study|Lost to Follow-up|5|||
13381333|NCT00753922|26747931|FG000|Overall Study|Withdrawal by Subject|9|||
13381334|NCT00753922|26747932|FG001|Overall Study|Withdrawal by Subject|11|||
13381335|NCT00753922|26747933|FG002|Overall Study|Withdrawal by Subject|4|||
13381336|NCT00753922|26747934|FG003|Overall Study|Withdrawal by Subject|2|||
13381337|NCT00753922|26747931|FG000|Overall Study|Patient Non-compliance|55|||
13381338|NCT00753922|26747932|FG001|Overall Study|Patient Non-compliance|22|||
13381339|NCT00753922|26747933|FG002|Overall Study|Patient Non-compliance|14|||
13207501|NCT01947491|26238087|FG003|Overall Study|Protocol Violation|0|||
13207502|NCT01947491|26238084|FG000|Overall Study|Withdrawal by Subject|1|||
13296192|NCT01371747|26495994|FG003|Overall Study|Physician Decision|0|||
13296193|NCT01371747|26495995|FG004|Overall Study|Physician Decision|1|||
13296194|NCT01371747|26495996|FG005|Overall Study|Physician Decision|0|||
13296195|NCT01371747|26495991|FG000|Overall Study|Withdrawal by Subject|6|||
13296196|NCT01371747|26495992|FG001|Overall Study|Withdrawal by Subject|12|||
13296197|NCT01371747|26495993|FG002|Overall Study|Withdrawal by Subject|5|||
13296198|NCT01371747|26495994|FG003|Overall Study|Withdrawal by Subject|2|||
13296199|NCT01371747|26495995|FG004|Overall Study|Withdrawal by Subject|2|||
13207503|NCT01947491|26238085|FG001|Overall Study|Withdrawal by Subject|1|||
13207504|NCT01947491|26238086|FG002|Overall Study|Withdrawal by Subject|1|||
13207505|NCT01947491|26238087|FG003|Overall Study|Withdrawal by Subject|0|||
13207506|NCT01947491|26238084|FG000|Overall Study|Worsening of condition|0|||
13207507|NCT01947491|26238085|FG001|Overall Study|Worsening of condition|1|||
13207508|NCT01947491|26238086|FG002|Overall Study|Worsening of condition|0|||
13207509|NCT01947491|26238087|FG003|Overall Study|Worsening of condition|0|||
13207510|NCT01947491|26238084|FG000|Overall Study|Adverse Event|0|||
13296200|NCT01371747|26495996|FG005|Overall Study|Withdrawal by Subject|4|||
13296201|NCT01371747|26495991|FG000|Overall Study|Other Reasons|2|||
13381340|NCT00753922|26747934|FG003|Overall Study|Patient Non-compliance|11|||
13207511|NCT01947491|26238085|FG001|Overall Study|Adverse Event|1|||
13207512|NCT01947491|26238086|FG002|Overall Study|Adverse Event|0|||
13207513|NCT01947491|26238087|FG003|Overall Study|Adverse Event|2|||
13207514|NCT01947283|26238160|FG000|Overall Study|Death|1|||
13207515|NCT01947283|26238161|FG001|Overall Study|Death|1|||
13207516|NCT01947283|26238162|FG002|Overall Study|Death|1|||
13207517|NCT01947283|26238163|FG003|Overall Study|Death|0|||
13381341|NCT00753922|26747931|FG000|Overall Study|Patients Not Completing Visit|11|||
13381342|NCT00753922|26747932|FG001|Overall Study|Patients Not Completing Visit|0|||
13207518|NCT01947283|26238164|FG004|Overall Study|Death|0|||
13488575|NCT00409773|27043867|FG004|Overall Study|Protocol Violation|1|||
13488576|NCT00409773|27043863|FG000|Overall Study|Withdrawal by Subject|0|||
13488577|NCT00409773|27043864|FG001|Overall Study|Withdrawal by Subject|0|||
13488578|NCT00409773|27043865|FG002|Overall Study|Withdrawal by Subject|0|||
13488579|NCT00409773|27043866|FG003|Overall Study|Withdrawal by Subject|2|||
13488580|NCT00409773|27043867|FG004|Overall Study|Withdrawal by Subject|1|||
13488581|NCT00409773|27043863|FG000|Overall Study|Lack of Eligibility|0|||
13488582|NCT00409773|27043864|FG001|Overall Study|Lack of Eligibility|0|||
13488583|NCT00409773|27043865|FG002|Overall Study|Lack of Eligibility|0|||
13488584|NCT00409773|27043866|FG003|Overall Study|Lack of Eligibility|0|||
13488585|NCT00409773|27043867|FG004|Overall Study|Lack of Eligibility|1|||
13488586|NCT00271817|27043904|FG000|Part 1|Adverse Event|68|||
13488587|NCT00271817|27043905|FG001|Part 1|Adverse Event|25|||
13488588|NCT00271817|27043906|FG002|Part 1|Adverse Event|156|||
13488589|NCT00271817|27043904|FG000|Part 1|Lost to Follow-up|6|||
13488590|NCT00271817|27043905|FG001|Part 1|Lost to Follow-up|8|||
13488591|NCT00271817|27043906|FG002|Part 1|Lost to Follow-up|24|||
13488592|NCT00271817|27043904|FG000|Part 1|Protocol Violation|5|||
13488593|NCT00271817|27043905|FG001|Part 1|Protocol Violation|4|||
13488594|NCT00271817|27043906|FG002|Part 1|Protocol Violation|7|||
13488595|NCT00271817|27043904|FG000|Part 1|Patient Moved|3|||
13488596|NCT00271817|27043905|FG001|Part 1|Patient Moved|1|||
13488597|NCT00271817|27043906|FG002|Part 1|Patient Moved|5|||
13488598|NCT00271817|27043904|FG000|Part 1|Withdrawal by Subject|23|||
13488599|NCT00271817|27043905|FG001|Part 1|Withdrawal by Subject|17|||
13488600|NCT00271817|27043906|FG002|Part 1|Withdrawal by Subject|45|||
13488601|NCT00271817|27043904|FG000|Part 1|LDL < 50 mg/dL|1|||
13488602|NCT00271817|27043905|FG001|Part 1|LDL < 50 mg/dL|4|||
13488603|NCT00271817|27043906|FG002|Part 1|LDL < 50 mg/dL|48|||
13488604|NCT00271817|27043904|FG000|Part 2|Adverse Event|0|||
13488605|NCT00271817|27043905|FG001|Part 2|Adverse Event|17|||
13488606|NCT00271817|27043906|FG002|Part 2|Adverse Event|33|||
13488607|NCT00271817|27043904|FG000|Part 2|Lack of Efficacy|0|||
13488608|NCT00271817|27043905|FG001|Part 2|Lack of Efficacy|1|||
13488609|NCT00271817|27043906|FG002|Part 2|Lack of Efficacy|6|||
13488610|NCT00271817|27043904|FG000|Part 2|Lost to Follow-up|0|||
13488611|NCT00271817|27043905|FG001|Part 2|Lost to Follow-up|6|||
13488612|NCT00271817|27043906|FG002|Part 2|Lost to Follow-up|18|||
13488613|NCT00271817|27043904|FG000|Part 2|Protocol Violation|0|||
13488614|NCT00271817|27043905|FG001|Part 2|Protocol Violation|3|||
13488615|NCT00271817|27043906|FG002|Part 2|Protocol Violation|5|||
13488616|NCT00271817|27043904|FG000|Part 2|Patient Moved|0|||
13488617|NCT00271817|27043905|FG001|Part 2|Patient Moved|0|||
13488618|NCT00271817|27043906|FG002|Part 2|Patient Moved|5|||
13488619|NCT00271817|27043904|FG000|Part 2|Withdrawal by Subject|0|||
13488620|NCT00271817|27043905|FG001|Part 2|Withdrawal by Subject|2|||
13488621|NCT00271817|27043906|FG002|Part 2|Withdrawal by Subject|13|||
13488622|NCT00271817|27043904|FG000|Part 2|LDL < 50 mg/dL|0|||
13488623|NCT00271817|27043905|FG001|Part 2|LDL < 50 mg/dL|3|||
13488624|NCT00271817|27043906|FG002|Part 2|LDL < 50 mg/dL|4|||
13488625|NCT03420781|27044020|FG000|Treatment Period (40 Weeks)|Adverse Event|1|||
13488626|NCT03420781|27044021|FG001|Treatment Period (40 Weeks)|Adverse Event|6|||
13488627|NCT03420781|27044022|FG002|Treatment Period (40 Weeks)|Adverse Event|0|||
13488628|NCT03420781|27044023|FG003|Treatment Period (40 Weeks)|Adverse Event|0|||
13488629|NCT03420781|27044024|FG004|Treatment Period (40 Weeks)|Adverse Event|0|||
13488630|NCT03420781|27044020|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
13488631|NCT03420781|27044021|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
13488632|NCT03420781|27044022|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
13488633|NCT03420781|27044023|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
13488634|NCT03420781|27044024|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
13488635|NCT03420781|27044020|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22|||
13488636|NCT03420781|27044021|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16|||
13488637|NCT03420781|27044022|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
13488638|NCT03420781|27044023|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
13488639|NCT03420781|27044024|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
13488640|NCT03420781|27044020|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10|||
13488641|NCT03420781|27044021|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6|||
13488642|NCT03420781|27044022|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
13488643|NCT03420781|27044023|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
13488644|NCT03420781|27044024|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
13488645|NCT03420781|27044020|FG000|Treatment Period (40 Weeks)|Death|2|||
13488646|NCT03420781|27044021|FG001|Treatment Period (40 Weeks)|Death|2|||
13488647|NCT03420781|27044022|FG002|Treatment Period (40 Weeks)|Death|0|||
13488648|NCT03420781|27044023|FG003|Treatment Period (40 Weeks)|Death|0|||
13488649|NCT03420781|27044024|FG004|Treatment Period (40 Weeks)|Death|0|||
13488650|NCT03420781|27044020|FG000|Treatment Period (40 Weeks)|Physician Decision|3|||
13488651|NCT03420781|27044021|FG001|Treatment Period (40 Weeks)|Physician Decision|4|||
13488652|NCT03420781|27044022|FG002|Treatment Period (40 Weeks)|Physician Decision|0|||
13207519|NCT01947283|26238165|FG005|Overall Study|Death|0|||
13488653|NCT03420781|27044023|FG003|Treatment Period (40 Weeks)|Physician Decision|0|||
13488654|NCT03420781|27044024|FG004|Treatment Period (40 Weeks)|Physician Decision|0|||
13488655|NCT03420781|27044020|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0|||
13488656|NCT03420781|27044021|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2|||
13488657|NCT03420781|27044022|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0|||
13488658|NCT03420781|27044023|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0|||
13488659|NCT03420781|27044024|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0|||
13488660|NCT03420781|27044020|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101|||
13488661|NCT03420781|27044021|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89|||
13488662|NCT03420781|27044022|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
13488663|NCT03420781|27044023|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
13488664|NCT03420781|27044024|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
13488665|NCT03420781|27044020|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1|||
13488666|NCT03420781|27044021|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
13488667|NCT03420781|27044022|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
13488668|NCT03420781|27044023|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
13488669|NCT03420781|27044024|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
13488670|NCT03420781|27044020|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3|||
13488671|NCT03420781|27044021|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0|||
13488672|NCT03420781|27044022|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0|||
13488673|NCT03420781|27044023|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0|||
13488674|NCT03420781|27044024|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0|||
13488675|NCT03420781|27044020|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
13488676|NCT03420781|27044021|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
13488677|NCT03420781|27044022|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
13488678|NCT03420781|27044023|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2|||
13488679|NCT03420781|27044024|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
13488680|NCT03420781|27044020|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
13488681|NCT03420781|27044021|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
13488682|NCT03420781|27044022|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
13488683|NCT03420781|27044023|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
13488684|NCT03420781|27044024|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2|||
13488685|NCT03420781|27044020|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
13488686|NCT03420781|27044021|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
13488687|NCT03420781|27044022|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6|||
13488688|NCT03420781|27044023|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
13488689|NCT03420781|27044024|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
13488690|NCT03316586|27044034|FG000|Overall Study|Adverse Event|2|||
13488691|NCT03316586|27044034|FG000|Overall Study|Physician Decision|3|||
13488692|NCT03316586|27044034|FG000|Overall Study|Lack of Efficacy|10|||
13488693|NCT03316586|27044034|FG000|Overall Study|still on treatment|1|||
13488694|NCT03316586|27044034|FG000|Overall Study|Patient needed radiation therapy|1|||
13488695|NCT03316586|27044034|FG000|Overall Study|Physician Decision to send patient for breast surgery|1|||
13488696|NCT03269695|27044079|FG000|Overall Study|Adverse Event|2|||
13488697|NCT03269695|27044080|FG001|Overall Study|Adverse Event|1|||
13488698|NCT03269695|27044079|FG000|Overall Study|Lack of Efficacy|0|||
13488699|NCT03269695|27044080|FG001|Overall Study|Lack of Efficacy|1|||
13488700|NCT03269695|27044079|FG000|Overall Study|Withdrawal by Subject|0|||
13488701|NCT03269695|27044080|FG001|Overall Study|Withdrawal by Subject|1|||
13488702|NCT03268811|27044175|FG000|Overall Study|Adverse Event|0|||
13488703|NCT03268811|27044176|FG001|Overall Study|Adverse Event|1|||
13488704|NCT03142334|27044189|FG000|Overall Study|Death|18|||
13488705|NCT03142334|27044190|FG001|Overall Study|Death|33|||
13488706|NCT03142334|27044189|FG000|Overall Study|Withdrawal by Subject|15|||
13488707|NCT03142334|27044190|FG001|Overall Study|Withdrawal by Subject|11|||
13488708|NCT03142334|27044189|FG000|Overall Study|Ongoing on trial follow up|463|||
13488709|NCT03142334|27044190|FG001|Overall Study|Ongoing on trial follow up|454|||
13488710|NCT02857426|27044333|FG000|Overall Study|Disease progression|34|||
13488711|NCT02857426|27044334|FG001|Overall Study|Disease progression|13|||
13488712|NCT02857426|27044333|FG000|Overall Study|Study drug toxicity|4|||
13488713|NCT02857426|27044334|FG001|Overall Study|Study drug toxicity|1|||
13488714|NCT02857426|27044333|FG000|Overall Study|Death|1|||
13488715|NCT02857426|27044334|FG001|Overall Study|Death|0|||
13488716|NCT02857426|27044333|FG000|Overall Study|Adverse event unrelated to study drug|6|||
13488717|NCT02857426|27044334|FG001|Overall Study|Adverse event unrelated to study drug|2|||
13488718|NCT02857426|27044333|FG000|Overall Study|Participant withdrew consent|1|||
13488719|NCT02857426|27044334|FG001|Overall Study|Participant withdrew consent|1|||
13488720|NCT02857426|27044333|FG000|Overall Study|Maximum clinical benefit|1|||
13488721|NCT02857426|27044334|FG001|Overall Study|Maximum clinical benefit|0|||
13488722|NCT02857426|27044333|FG000|Overall Study|Completed treatment|0|||
13488723|NCT02857426|27044334|FG001|Overall Study|Completed treatment|2|||
13488724|NCT02855125|27044357|FG000|Overall Study|Withdrawal by Subject|2|||
13488725|NCT02855125|27044358|FG001|Overall Study|Withdrawal by Subject|2|||
13488726|NCT02855125|27044357|FG000|Overall Study|Clinical Disease Progression|5|||
13488727|NCT02855125|27044358|FG001|Overall Study|Clinical Disease Progression|4|||
13488728|NCT02855125|27044357|FG000|Overall Study|Radiologic Disease Progression|36|||
13488729|NCT02855125|27044358|FG001|Overall Study|Radiologic Disease Progression|39|||
13488730|NCT02855125|27044357|FG000|Overall Study|Adverse Event|11|||
13488731|NCT02855125|27044358|FG001|Overall Study|Adverse Event|7|||
13488732|NCT02855125|27044357|FG000|Overall Study|Physician Decision|1|||
13488733|NCT02855125|27044358|FG001|Overall Study|Physician Decision|0|||
13488734|NCT02855125|27044357|FG000|Overall Study|On Treatment|9|||
13488735|NCT02855125|27044358|FG001|Overall Study|On Treatment|11|||
13488736|NCT02855125|27044357|FG000|Overall Study|Randomized but not treated|0|||
13488737|NCT02855125|27044358|FG001|Overall Study|Randomized but not treated|1|||
13296202|NCT01371747|26495992|FG001|Overall Study|Other Reasons|1|||
13394501|NCT00657046|26787224|FG001|Overall Study|Adverse Event|1|||
13488738|NCT02527798|27044503|FG000|Overall Study|Physician Decision|1|||
13488739|NCT02527798|27044504|FG001|Overall Study|Physician Decision|0|||
13488740|NCT02527798|27044505|FG002|Overall Study|Physician Decision|1|||
13488741|NCT02527798|27044506|FG003|Overall Study|Physician Decision|1|||
13488742|NCT02527798|27044507|FG004|Overall Study|Physician Decision|0|||
13488743|NCT02527798|27044508|FG005|Overall Study|Physician Decision|0|||
13488744|NCT02527798|27044503|FG000|Overall Study|Death|0|||
13488745|NCT02527798|27044504|FG001|Overall Study|Death|0|||
13488746|NCT02527798|27044505|FG002|Overall Study|Death|1|||
13488747|NCT02527798|27044506|FG003|Overall Study|Death|0|||
13488748|NCT02527798|27044507|FG004|Overall Study|Death|0|||
13488749|NCT02527798|27044508|FG005|Overall Study|Death|0|||
13488750|NCT02527798|27044503|FG000|Overall Study|Withdrawal by Subject|0|||
13488751|NCT02527798|27044504|FG001|Overall Study|Withdrawal by Subject|1|||
13488752|NCT02527798|27044505|FG002|Overall Study|Withdrawal by Subject|2|||
13488753|NCT02527798|27044506|FG003|Overall Study|Withdrawal by Subject|0|||
13488754|NCT02527798|27044507|FG004|Overall Study|Withdrawal by Subject|0|||
13488755|NCT02527798|27044508|FG005|Overall Study|Withdrawal by Subject|0|||
13488756|NCT02527798|27044503|FG000|Overall Study|Reason undisclosed|1|||
13488757|NCT02527798|27044504|FG001|Overall Study|Reason undisclosed|0|||
13488758|NCT02527798|27044505|FG002|Overall Study|Reason undisclosed|1|||
13488759|NCT02527798|27044506|FG003|Overall Study|Reason undisclosed|0|||
13488760|NCT02527798|27044507|FG004|Overall Study|Reason undisclosed|0|||
13488761|NCT02527798|27044508|FG005|Overall Study|Reason undisclosed|0|||
13488762|NCT02527798|27044503|FG000|Overall Study|Did not receive intervention|1|||
13488763|NCT02527798|27044504|FG001|Overall Study|Did not receive intervention|1|||
13488764|NCT02527798|27044505|FG002|Overall Study|Did not receive intervention|0|||
13488765|NCT02527798|27044506|FG003|Overall Study|Did not receive intervention|0|||
13488766|NCT02527798|27044507|FG004|Overall Study|Did not receive intervention|0|||
13488767|NCT02527798|27044508|FG005|Overall Study|Did not receive intervention|0|||
13488768|NCT02006147|27044610|FG000|Overall Study|Protocol Violation|1|||
13488769|NCT02006147|27044611|FG001|Overall Study|Protocol Violation|1|||
13488770|NCT02006147|27044612|FG002|Overall Study|Protocol Violation|0|||
13488771|NCT02006147|27044613|FG003|Overall Study|Protocol Violation|0|||
13488772|NCT02006147|27044610|FG000|Overall Study|Withdrawal by Subject|0|||
13488773|NCT02006147|27044611|FG001|Overall Study|Withdrawal by Subject|1|||
13488774|NCT02006147|27044612|FG002|Overall Study|Withdrawal by Subject|0|||
13488775|NCT02006147|27044613|FG003|Overall Study|Withdrawal by Subject|0|||
13488776|NCT02006147|27044610|FG000|Overall Study|Withdrawal by Sponsor|1|||
13488777|NCT02006147|27044611|FG001|Overall Study|Withdrawal by Sponsor|0|||
13488778|NCT02006147|27044612|FG002|Overall Study|Withdrawal by Sponsor|0|||
13488779|NCT02006147|27044613|FG003|Overall Study|Withdrawal by Sponsor|0|||
13488780|NCT01849250|27044685|FG000|Overall Study|Withdrawal by Subject|1|||
13488781|NCT01849250|27044686|FG001|Overall Study|Withdrawal by Subject|0|||
13488782|NCT01849250|27044685|FG000|Overall Study|Not Evaluable|5|||
13488783|NCT01849250|27044686|FG001|Overall Study|Not Evaluable|3|||
13488784|NCT01849250|27044685|FG000|Overall Study|Screen Failure|1|||
13488785|NCT01849250|27044686|FG001|Overall Study|Screen Failure|0|||
13488786|NCT01441115|27044707|FG000|Overall Study|Taken off study - Principal Investigator discretion|1|||
13488787|NCT01199302|27044751|FG000|Overall Study|Adverse Event|1|||
13488788|NCT01199302|27044752|FG001|Overall Study|Adverse Event|1|||
13488789|NCT01199302|27044753|FG002|Overall Study|Adverse Event|2|||
13488790|NCT01199302|27044754|FG003|Overall Study|Adverse Event|0|||
13488791|NCT01199302|27044751|FG000|Overall Study|Withdrawal by Subject|2|||
13488792|NCT01199302|27044752|FG001|Overall Study|Withdrawal by Subject|2|||
13488793|NCT01199302|27044753|FG002|Overall Study|Withdrawal by Subject|3|||
13488794|NCT01199302|27044754|FG003|Overall Study|Withdrawal by Subject|0|||
13488795|NCT01199302|27044751|FG000|Overall Study|Disease Progression|3|||
13488796|NCT01199302|27044752|FG001|Overall Study|Disease Progression|4|||
13488797|NCT01199302|27044753|FG002|Overall Study|Disease Progression|4|||
13488798|NCT01199302|27044754|FG003|Overall Study|Disease Progression|2|||
13488799|NCT01199302|27044751|FG000|Overall Study|Study Termination|13|||
13488800|NCT01199302|27044752|FG001|Overall Study|Study Termination|8|||
13488801|NCT01199302|27044753|FG002|Overall Study|Study Termination|11|||
13488802|NCT01199302|27044754|FG003|Overall Study|Study Termination|9|||
13488803|NCT01199302|27044751|FG000|Overall Study|Lost to Follow-up|0|||
13488804|NCT01199302|27044752|FG001|Overall Study|Lost to Follow-up|1|||
13488805|NCT01199302|27044753|FG002|Overall Study|Lost to Follow-up|0|||
13488806|NCT01199302|27044754|FG003|Overall Study|Lost to Follow-up|0|||
13488807|NCT01199302|27044751|FG000|Overall Study|Other|1|||
13488808|NCT01199302|27044752|FG001|Overall Study|Other|0|||
13488809|NCT01199302|27044753|FG002|Overall Study|Other|0|||
13488810|NCT01199302|27044754|FG003|Overall Study|Other|0|||
13488811|NCT01123707|27044849|FG000|Overall Study|Lost to Follow-up|3|||
13488812|NCT01123707|27044850|FG001|Overall Study|Lost to Follow-up|1|||
13488813|NCT01123707|27044851|FG002|Overall Study|Lost to Follow-up|3|||
13488814|NCT01123707|27044852|FG003|Overall Study|Lost to Follow-up|2|||
13488815|NCT01123707|27044849|FG000|Overall Study|Adverse Event|5|||
13488816|NCT01123707|27044850|FG001|Overall Study|Adverse Event|7|||
13488817|NCT01123707|27044851|FG002|Overall Study|Adverse Event|5|||
13488818|NCT01123707|27044852|FG003|Overall Study|Adverse Event|3|||
13488819|NCT01123707|27044849|FG000|Overall Study|Sponsor Discontinued Study|30|||
13488820|NCT01123707|27044850|FG001|Overall Study|Sponsor Discontinued Study|24|||
13488821|NCT01123707|27044851|FG002|Overall Study|Sponsor Discontinued Study|25|||
13488822|NCT01123707|27044852|FG003|Overall Study|Sponsor Discontinued Study|40|||
13488823|NCT01123707|27044849|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
13488824|NCT01123707|27044850|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
13488825|NCT01123707|27044851|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
13488826|NCT01123707|27044852|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
13488827|NCT01123707|27044849|FG000|Overall Study|Investigator Withdrew Participant|0|||
13488828|NCT01123707|27044850|FG001|Overall Study|Investigator Withdrew Participant|1|||
13488829|NCT01123707|27044851|FG002|Overall Study|Investigator Withdrew Participant|1|||
13488830|NCT01123707|27044852|FG003|Overall Study|Investigator Withdrew Participant|1|||
13488831|NCT01123707|27044849|FG000|Overall Study|Subject Withdrew Consent|4|||
13488832|NCT01123707|27044850|FG001|Overall Study|Subject Withdrew Consent|5|||
13488833|NCT01123707|27044851|FG002|Overall Study|Subject Withdrew Consent|1|||
13488834|NCT01123707|27044852|FG003|Overall Study|Subject Withdrew Consent|2|||
13488835|NCT01123707|27044849|FG000|Overall Study|Lack of Efficacy|1|||
13488836|NCT01123707|27044850|FG001|Overall Study|Lack of Efficacy|2|||
13488837|NCT01123707|27044851|FG002|Overall Study|Lack of Efficacy|1|||
13488838|NCT01123707|27044852|FG003|Overall Study|Lack of Efficacy|0|||
13488839|NCT01123707|27044849|FG000|Overall Study|Subject Met Exclusion Criteria|0|||
13488840|NCT01123707|27044850|FG001|Overall Study|Subject Met Exclusion Criteria|0|||
13488841|NCT01123707|27044851|FG002|Overall Study|Subject Met Exclusion Criteria|2|||
13488842|NCT01123707|27044852|FG003|Overall Study|Subject Met Exclusion Criteria|1|||
13488843|NCT00462943|27044935|FG000|Overall Study|Failure to achieve a response|5|||
13488844|NCT00462943|27044936|FG001|Overall Study|Failure to achieve a response|5|||
13488845|NCT00462943|27044937|FG002|Overall Study|Failure to achieve a response|1|||
13488846|NCT00462943|27044935|FG000|Overall Study|Adverse Event|6|||
13488847|NCT00462943|27044936|FG001|Overall Study|Adverse Event|4|||
13488848|NCT00462943|27044937|FG002|Overall Study|Adverse Event|1|||
13488849|NCT00462943|27044935|FG000|Overall Study|Protocol Violation|1|||
13488850|NCT00462943|27044936|FG001|Overall Study|Protocol Violation|0|||
13488851|NCT00462943|27044937|FG002|Overall Study|Protocol Violation|0|||
13488852|NCT00462943|27044935|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8|||
13488853|NCT00462943|27044936|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2|||
13488854|NCT00462943|27044937|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4|||
13488855|NCT00462943|27044935|FG000|Overall Study|Disease Progression|15|||
13488856|NCT00462943|27044936|FG001|Overall Study|Disease Progression|15|||
13488857|NCT00462943|27044937|FG002|Overall Study|Disease Progression|9|||
13488858|NCT00462943|27044935|FG000|Overall Study|Death|5|||
13488859|NCT00462943|27044936|FG001|Overall Study|Death|2|||
13488860|NCT00462943|27044937|FG002|Overall Study|Death|7|||
13488861|NCT00462943|27044935|FG000|Overall Study|Stem Cell Transplant|1|||
13488862|NCT00462943|27044936|FG001|Overall Study|Stem Cell Transplant|1|||
13488863|NCT00462943|27044937|FG002|Overall Study|Stem Cell Transplant|0|||
13488864|NCT00462943|27044935|FG000|Overall Study|Bone Marrow Transplant|1|||
13488865|NCT00462943|27044936|FG001|Overall Study|Bone Marrow Transplant|0|||
13488866|NCT00462943|27044937|FG002|Overall Study|Bone Marrow Transplant|0|||
13488867|NCT00462943|27044935|FG000|Overall Study|Required Lymphocyte Infusion|1|||
13488868|NCT00462943|27044936|FG001|Overall Study|Required Lymphocyte Infusion|0|||
13488869|NCT00462943|27044937|FG002|Overall Study|Required Lymphocyte Infusion|0|||
13488870|NCT00462943|27044935|FG000|Overall Study|Transplant - not specified|1|||
13488871|NCT00462943|27044936|FG001|Overall Study|Transplant - not specified|0|||
13488872|NCT00462943|27044937|FG002|Overall Study|Transplant - not specified|1|||
13488873|NCT00462943|27044935|FG000|Overall Study|Physician Decision|1|||
13488874|NCT00462943|27044936|FG001|Overall Study|Physician Decision|0|||
13488875|NCT00462943|27044937|FG002|Overall Study|Physician Decision|0|||
13488876|NCT00462943|27044935|FG000|Overall Study|Withdrawal by Subject|0|||
13488877|NCT00462943|27044936|FG001|Overall Study|Withdrawal by Subject|1|||
13488878|NCT00462943|27044937|FG002|Overall Study|Withdrawal by Subject|0|||
13488879|NCT00105560|27044962|FG000|Overall Study|Lost to Follow-up|1|||
13488880|NCT04569786|27045079|FG000|Overall Study|Lost to Follow-up|1|||
13488881|NCT04569786|27045080|FG001|Overall Study|Lost to Follow-up|0|||
13488882|NCT04569786|27045081|FG002|Overall Study|Lost to Follow-up|4|||
13488883|NCT04569786|27045082|FG003|Overall Study|Lost to Follow-up|1|||
13488884|NCT04569786|27045083|FG004|Overall Study|Lost to Follow-up|0|||
13488885|NCT04569786|27045079|FG000|Overall Study|Withdrawal by Subject|0|||
13488886|NCT04569786|27045080|FG001|Overall Study|Withdrawal by Subject|0|||
13488887|NCT04569786|27045081|FG002|Overall Study|Withdrawal by Subject|0|||
13488888|NCT04569786|27045082|FG003|Overall Study|Withdrawal by Subject|5|||
13488889|NCT04569786|27045083|FG004|Overall Study|Withdrawal by Subject|1|||
13488890|NCT04569786|27045079|FG000|Overall Study|Physician Decision|0|||
13488891|NCT04569786|27045080|FG001|Overall Study|Physician Decision|0|||
13488892|NCT04569786|27045081|FG002|Overall Study|Physician Decision|0|||
13488893|NCT04569786|27045082|FG003|Overall Study|Physician Decision|1|||
13488894|NCT04569786|27045083|FG004|Overall Study|Physician Decision|0|||
13488895|NCT03857542|27045147|FG000|Overall Study|Adverse Event|1|||
13488896|NCT03857542|27045148|FG001|Overall Study|Adverse Event|3|||
13488897|NCT03857542|27045147|FG000|Overall Study|Withdrawal by Subject|2|||
13488898|NCT03857542|27045148|FG001|Overall Study|Withdrawal by Subject|1|||
13488899|NCT03857542|27045147|FG000|Overall Study|Lost to Follow-up|2|||
13488900|NCT03857542|27045148|FG001|Overall Study|Lost to Follow-up|1|||
13488901|NCT03857542|27045147|FG000|Overall Study|Reason not Specified|1|||
13488902|NCT03857542|27045148|FG001|Overall Study|Reason not Specified|0|||
13488903|NCT03656744|27045253|FG000|Overall Study|Adverse Event|1|||
13488904|NCT03656744|27045254|FG001|Overall Study|Adverse Event|4|||
13488905|NCT03656744|27045255|FG002|Overall Study|Adverse Event|1|||
13488906|NCT03656744|27045253|FG000|Overall Study|Protocol Violation|1|||
13488907|NCT03656744|27045254|FG001|Overall Study|Protocol Violation|0|||
13488908|NCT03656744|27045255|FG002|Overall Study|Protocol Violation|0|||
13488909|NCT03656744|27045253|FG000|Overall Study|Lost to Follow-up|2|||
13488910|NCT03656744|27045254|FG001|Overall Study|Lost to Follow-up|2|||
13488911|NCT03656744|27045255|FG002|Overall Study|Lost to Follow-up|0|||
13488912|NCT03656744|27045253|FG000|Overall Study|Withdrawal by Subject|0|||
13488913|NCT03656744|27045254|FG001|Overall Study|Withdrawal by Subject|1|||
13488914|NCT03656744|27045255|FG002|Overall Study|Withdrawal by Subject|0|||
13488915|NCT03656744|27045253|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1|||
13488916|NCT03656744|27045254|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
13488917|NCT03656744|27045255|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
13488918|NCT03510598|27045265|FG000|Overall Study|Withdrawal by Subject|1|||
13488919|NCT03487796|27045294|FG000|Overall Study|Lost to Follow-up|18|||
13488920|NCT03487796|27045295|FG001|Overall Study|Lost to Follow-up|6|||
13488921|NCT03446612|27045400|FG000|Overall Study|Protocol defined stopping criteria|0|||
13488922|NCT03446612|27045401|FG001|Overall Study|Protocol defined stopping criteria|1|||
13488923|NCT03370120|27045432|FG000|Overall Study|Adverse event, non-fatal|24|||
13488924|NCT03370120|27045432|FG000|Overall Study|Withdrawal by Subject|6|||
13488925|NCT03370120|27045432|FG000|Overall Study|Lost to Follow-up|1|||
13488926|NCT03370120|27045432|FG000|Overall Study|Lack of Efficacy|37|||
13488927|NCT03370120|27045432|FG000|Overall Study|Per sponsor's instructions|1|||
13488928|NCT03370120|27045432|FG000|Overall Study|Study was terminated by parent company UCB|2|||
13488929|NCT03370120|27045432|FG000|Overall Study|The study was ended by the promoter|3|||
13488930|NCT03370120|27045432|FG000|Overall Study|Discontinuation of drug development|3|||
13488931|NCT03370120|27045432|FG000|Overall Study|End of project|2|||
13488932|NCT03370120|27045432|FG000|Overall Study|Premature study closure|2|||
13488933|NCT03370120|27045432|FG000|Overall Study|Premature program termination|1|||
13488934|NCT03370120|27045432|FG000|Overall Study|Premature study termination|7|||
13488935|NCT03370120|27045432|FG000|Overall Study|Trial terminated by sponsor|2|||
13488936|NCT03370120|27045432|FG000|Overall Study|Trial discontinued by sponsor|2|||
13488937|NCT03370120|27045432|FG000|Overall Study|Study ended|15|||
13488938|NCT03370120|27045432|FG000|Overall Study|Clinical trial has been cancelled|1|||
13488939|NCT03370120|27045432|FG000|Overall Study|End of study per sponsor decision|2|||
13488940|NCT03370120|27045432|FG000|Overall Study|Promoter's decision|2|||
13488941|NCT03370120|27045432|FG000|Overall Study|The trial has been suspended|3|||
13488942|NCT03370120|27045432|FG000|Overall Study|Sponsor stopped PSL development based on data|3|||
13488943|NCT03370120|27045432|FG000|Overall Study|Early termination by order of sponsor|2|||
13488944|NCT03370120|27045432|FG000|Overall Study|Discontinuation of the study|5|||
13488945|NCT03370120|27045432|FG000|Overall Study|End of clinical trial discontinuation|1|||
13488946|NCT03370120|27045432|FG000|Overall Study|Because the clinical trial ended halfway|4|||
13488947|NCT03370120|27045432|FG000|Overall Study|Development discontinued|5|||
13488948|NCT03370120|27045432|FG000|Overall Study|Padsenovil program closed|3|||
13488949|NCT03370120|27045432|FG000|Overall Study|End of project|2|||
13488950|NCT03370120|27045432|FG000|Overall Study|Termination of project|1|||
13488951|NCT03370120|27045432|FG000|Overall Study|The study was interrupted by sponsor|4|||
13488952|NCT03370120|27045432|FG000|Overall Study|The protocol was interrupted by sponsor|1|||
13135113|NCT02745145|25993630|FG001|Overall Study|Progressive disease|0|||
13488953|NCT03370120|27045432|FG000|Overall Study|End of sponsor decision|1|||
13488954|NCT03370120|27045432|FG000|Overall Study|The study was terminated prematurely by study lead|1|||
13488955|NCT03370120|27045432|FG000|Overall Study|Early termination of studies|5|||
13488956|NCT03370120|27045432|FG000|Overall Study|This study is ended early|1|||
13488957|NCT03370120|27045432|FG000|Overall Study|End of padsevonil program|2|||
13488958|NCT03370120|27045432|FG000|Overall Study|Decision of sponsor|6|||
13488959|NCT03370120|27045432|FG000|Overall Study|Asked by the sponsor|3|||
13488960|NCT03370120|27045432|FG000|Overall Study|Sponsor decision to stop the protocol|1|||
13488961|NCT03370120|27045432|FG000|Overall Study|PI decision poor compliance from participant|1|||
13488962|NCT03370120|27045432|FG000|Overall Study|Promoter ended the study|3|||
13488963|NCT03370120|27045432|FG000|Overall Study|Premature study close by sponsor's decision|4|||
13488964|NCT03370120|27045432|FG000|Overall Study|Study terminated by sponsor|33|||
13488965|NCT03370120|27045432|FG000|Overall Study|Sponsor prematurely terminated this study|2|||
13488966|NCT03370120|27045432|FG000|Overall Study|Sponsor decision to terminate study|63|||
13488967|NCT03370120|27045432|FG000|Overall Study|Program closure|3|||
13488968|NCT03370120|27045432|FG000|Overall Study|Study ended prematurely|1|||
13488969|NCT03370120|27045432|FG000|Overall Study|Study stopped by sponsor|2|||
13488970|NCT03370120|27045432|FG000|Overall Study|Program termination|55|||
13488971|NCT03370120|27045432|FG000|Overall Study|Sponsor decision|62|||
13488972|NCT03370120|27045432|FG000|Overall Study|Sponsor study closure|10|||
13296203|NCT01371747|26495993|FG002|Overall Study|Other Reasons|2|||
13296204|NCT01371747|26495994|FG003|Overall Study|Other Reasons|0|||
13296205|NCT01371747|26495995|FG004|Overall Study|Other Reasons|0|||
13296206|NCT01371747|26495996|FG005|Overall Study|Other Reasons|1|||
13296207|NCT01371734|26496023|FG000|Overall Study|Other|2|||
13296208|NCT01371734|26496024|FG001|Overall Study|Other|1|||
13296209|NCT01371734|26496025|FG002|Overall Study|Other|2|||
13296210|NCT01371734|26496023|FG000|Overall Study|Withdrawal by Subject|3|||
13394502|NCT00657046|26787225|FG002|Overall Study|Adverse Event|0|||
13488973|NCT03143829|27045475|FG000|Overall Study|Withdrawal by Subject|2|||
13488974|NCT03143829|27045476|FG001|Overall Study|Withdrawal by Subject|5|||
13488975|NCT03143829|27045475|FG000|Overall Study|Lost to Follow-up|0|||
13488976|NCT03143829|27045476|FG001|Overall Study|Lost to Follow-up|2|||
13488977|NCT03143829|27045475|FG000|Overall Study|Death|1|||
13488978|NCT03143829|27045476|FG001|Overall Study|Death|1|||
13488979|NCT03143829|27045475|FG000|Overall Study|changed treatment, no longer eligible|2|||
13488980|NCT03143829|27045476|FG001|Overall Study|changed treatment, no longer eligible|2|||
13488981|NCT02963610|27045506|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3|||
13488982|NCT02766335|27045536|FG000|Initial Registration|Adverse Event|6|||
13488983|NCT02766335|27045537|FG001|Initial Registration|Adverse Event|3|||
13488984|NCT02766335|27045538|FG002|Initial Registration|Adverse Event|0|||
13488985|NCT02766335|27045536|FG000|Initial Registration|Refusal unrelated to adverse event|1|||
13488986|NCT02766335|27045537|FG001|Initial Registration|Refusal unrelated to adverse event|0|||
13296211|NCT01371734|26496024|FG001|Overall Study|Withdrawal by Subject|4|||
13488987|NCT02766335|27045538|FG002|Initial Registration|Refusal unrelated to adverse event|0|||
13488988|NCT02766335|27045536|FG000|Initial Registration|Progression/relapse|49|||
13488989|NCT02766335|27045537|FG001|Initial Registration|Progression/relapse|15|||
13488990|NCT02766335|27045538|FG002|Initial Registration|Progression/relapse|0|||
13488991|NCT02766335|27045536|FG000|Initial Registration|Death|1|||
13488992|NCT02766335|27045537|FG001|Initial Registration|Death|3|||
13488993|NCT02766335|27045538|FG002|Initial Registration|Death|0|||
13488994|NCT02766335|27045536|FG000|Initial Registration|not protocol specified|1|||
13488995|NCT02766335|27045537|FG001|Initial Registration|not protocol specified|9|||
13488996|NCT02766335|27045538|FG002|Initial Registration|not protocol specified|0|||
13488997|NCT02766335|27045536|FG000|Re-registration of Arm I to MEDI4738|Death|0|||
13488998|NCT02766335|27045537|FG001|Re-registration of Arm I to MEDI4738|Death|0|||
13488999|NCT02766335|27045538|FG002|Re-registration of Arm I to MEDI4738|Death|1|||
13489000|NCT02766335|27045536|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
13489001|NCT02766335|27045537|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
13489002|NCT02766335|27045538|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1|||
13489003|NCT02606136|27045553|FG000|Overall Study|Participant/Legal Guardian Decision|5|||
13489004|NCT02606136|27045553|FG000|Overall Study|Withdrawal by Subject|1|||
13489005|NCT02228382|27045634|FG000|Overall Study|Death|5|||
13489006|NCT02228382|27045635|FG001|Overall Study|Death|7|||
13489007|NCT02228382|27045636|FG002|Overall Study|Death|5|||
13489008|NCT02228382|27045637|FG003|Overall Study|Death|0|||
13489009|NCT02228382|27045638|FG004|Overall Study|Death|2|||
13489010|NCT02228382|27045634|FG000|Overall Study|Participant refused further follow-up|0|||
13489011|NCT02228382|27045635|FG001|Overall Study|Participant refused further follow-up|0|||
13381343|NCT00753922|26747933|FG002|Overall Study|Patients Not Completing Visit|1|||
13381344|NCT00753922|26747934|FG003|Overall Study|Patients Not Completing Visit|0|||
13489012|NCT02228382|27045636|FG002|Overall Study|Participant refused further follow-up|1|||
13489013|NCT02228382|27045637|FG003|Overall Study|Participant refused further follow-up|0|||
13489014|NCT02228382|27045638|FG004|Overall Study|Participant refused further follow-up|0|||
13489015|NCT02228382|27045634|FG000|Overall Study|Study terminated by sponsor|3|||
13489016|NCT02228382|27045635|FG001|Overall Study|Study terminated by sponsor|5|||
13489017|NCT02228382|27045636|FG002|Overall Study|Study terminated by sponsor|7|||
13489018|NCT02228382|27045637|FG003|Overall Study|Study terminated by sponsor|0|||
13489019|NCT02228382|27045638|FG004|Overall Study|Study terminated by sponsor|0|||
13296212|NCT01371734|26496025|FG002|Overall Study|Withdrawal by Subject|9|||
13296213|NCT01371734|26496023|FG000|Overall Study|Lost to Follow-up|5|||
13296214|NCT01371734|26496024|FG001|Overall Study|Lost to Follow-up|3|||
13296215|NCT01371734|26496025|FG002|Overall Study|Lost to Follow-up|1|||
13296216|NCT01371734|26496023|FG000|Overall Study|Protocol Violation|3|||
13296217|NCT01371734|26496024|FG001|Overall Study|Protocol Violation|1|||
13296218|NCT01371734|26496025|FG002|Overall Study|Protocol Violation|2|||
13296219|NCT01371734|26496023|FG000|Overall Study|Adverse Event|8|||
13296220|NCT01371734|26496024|FG001|Overall Study|Adverse Event|8|||
13296221|NCT01371734|26496025|FG002|Overall Study|Adverse Event|3|||
13296222|NCT01371734|26496023|FG000|Overall Study|Lack of Efficacy|2|||
13296223|NCT01371734|26496024|FG001|Overall Study|Lack of Efficacy|2|||
13296224|NCT01371734|26496025|FG002|Overall Study|Lack of Efficacy|0|||
13296225|NCT01371721|26496065|FG000|Overall Study|Adverse Event|5|||
13296226|NCT01371721|26496066|FG001|Overall Study|Adverse Event|4|||
13489020|NCT02228382|27045634|FG000|Overall Study|Lost to Follow-up|0|||
13489021|NCT02228382|27045635|FG001|Overall Study|Lost to Follow-up|0|||
13489022|NCT02228382|27045636|FG002|Overall Study|Lost to Follow-up|3|||
13489023|NCT02228382|27045637|FG003|Overall Study|Lost to Follow-up|1|||
13489024|NCT02228382|27045638|FG004|Overall Study|Lost to Follow-up|0|||
13489025|NCT02228382|27045634|FG000|Overall Study|Withdrawal by Subject|0|||
13489026|NCT02228382|27045635|FG001|Overall Study|Withdrawal by Subject|3|||
13489027|NCT02228382|27045636|FG002|Overall Study|Withdrawal by Subject|2|||
13135114|NCT02745145|25993631|FG002|Overall Study|Progressive disease|1|||
13296227|NCT01371721|26496067|FG002|Overall Study|Adverse Event|5|||
13489028|NCT02228382|27045637|FG003|Overall Study|Withdrawal by Subject|1|||
13489029|NCT02228382|27045638|FG004|Overall Study|Withdrawal by Subject|0|||
13489030|NCT02228382|27045634|FG000|Overall Study|Other|2|||
13489031|NCT02228382|27045635|FG001|Overall Study|Other|3|||
13489032|NCT02228382|27045636|FG002|Overall Study|Other|3|||
13489033|NCT02228382|27045637|FG003|Overall Study|Other|0|||
13489034|NCT02228382|27045638|FG004|Overall Study|Other|0|||
13489035|NCT02001623|27046033|FG000|Overall Study|Disease Progression|2|||
13489036|NCT02001623|27046034|FG001|Overall Study|Disease Progression|2|||
13489037|NCT02001623|27046035|FG002|Overall Study|Disease Progression|3|||
13489038|NCT02001623|27046036|FG003|Overall Study|Disease Progression|2|||
13489039|NCT02001623|27046037|FG004|Overall Study|Disease Progression|3|||
13489040|NCT02001623|27046038|FG005|Overall Study|Disease Progression|2|||
13489041|NCT02001623|27046039|FG006|Overall Study|Disease Progression|3|||
13489042|NCT02001623|27046040|FG007|Overall Study|Disease Progression|3|||
13489043|NCT02001623|27046041|FG008|Overall Study|Disease Progression|7|||
13489044|NCT02001623|27046042|FG009|Overall Study|Disease Progression|40|||
13489045|NCT02001623|27046043|FG010|Overall Study|Disease Progression|5|||
13489046|NCT02001623|27046044|FG011|Overall Study|Disease Progression|9|||
13489047|NCT02001623|27046045|FG012|Overall Study|Disease Progression|9|||
13489048|NCT02001623|27046046|FG013|Overall Study|Disease Progression|20|||
13489049|NCT02001623|27046047|FG014|Overall Study|Disease Progression|9|||
13489050|NCT02001623|27046033|FG000|Overall Study|Physician Decision|0|||
13489051|NCT02001623|27046034|FG001|Overall Study|Physician Decision|0|||
13489052|NCT02001623|27046035|FG002|Overall Study|Physician Decision|0|||
13489053|NCT02001623|27046036|FG003|Overall Study|Physician Decision|0|||
13489054|NCT02001623|27046037|FG004|Overall Study|Physician Decision|0|||
13489055|NCT02001623|27046038|FG005|Overall Study|Physician Decision|0|||
13489056|NCT02001623|27046039|FG006|Overall Study|Physician Decision|0|||
13489057|NCT02001623|27046040|FG007|Overall Study|Physician Decision|0|||
13489058|NCT02001623|27046041|FG008|Overall Study|Physician Decision|3|||
13489059|NCT02001623|27046042|FG009|Overall Study|Physician Decision|2|||
13489060|NCT02001623|27046043|FG010|Overall Study|Physician Decision|3|||
13489061|NCT02001623|27046044|FG011|Overall Study|Physician Decision|3|||
13489062|NCT02001623|27046045|FG012|Overall Study|Physician Decision|1|||
13489063|NCT02001623|27046046|FG013|Overall Study|Physician Decision|2|||
13489064|NCT02001623|27046047|FG014|Overall Study|Physician Decision|1|||
13489065|NCT02001623|27046033|FG000|Overall Study|Death|0|||
13489066|NCT02001623|27046034|FG001|Overall Study|Death|1|||
13489067|NCT02001623|27046035|FG002|Overall Study|Death|0|||
13489068|NCT02001623|27046036|FG003|Overall Study|Death|0|||
13489069|NCT02001623|27046037|FG004|Overall Study|Death|0|||
13489070|NCT02001623|27046038|FG005|Overall Study|Death|0|||
13489071|NCT02001623|27046039|FG006|Overall Study|Death|0|||
13489072|NCT02001623|27046040|FG007|Overall Study|Death|0|||
13489073|NCT02001623|27046041|FG008|Overall Study|Death|0|||
13489074|NCT02001623|27046042|FG009|Overall Study|Death|0|||
13489075|NCT02001623|27046043|FG010|Overall Study|Death|0|||
13489076|NCT02001623|27046044|FG011|Overall Study|Death|0|||
13489077|NCT02001623|27046045|FG012|Overall Study|Death|0|||
13489078|NCT02001623|27046046|FG013|Overall Study|Death|0|||
13489079|NCT02001623|27046047|FG014|Overall Study|Death|0|||
13489080|NCT02001623|27046033|FG000|Overall Study|Adverse Event|0|||
13489081|NCT02001623|27046034|FG001|Overall Study|Adverse Event|0|||
13489082|NCT02001623|27046035|FG002|Overall Study|Adverse Event|0|||
13489083|NCT02001623|27046036|FG003|Overall Study|Adverse Event|0|||
13489084|NCT02001623|27046037|FG004|Overall Study|Adverse Event|0|||
13489085|NCT02001623|27046038|FG005|Overall Study|Adverse Event|1|||
13489086|NCT02001623|27046039|FG006|Overall Study|Adverse Event|0|||
13489087|NCT02001623|27046040|FG007|Overall Study|Adverse Event|3|||
13489088|NCT02001623|27046041|FG008|Overall Study|Adverse Event|4|||
13489089|NCT02001623|27046042|FG009|Overall Study|Adverse Event|6|||
13489090|NCT02001623|27046043|FG010|Overall Study|Adverse Event|4|||
13489091|NCT02001623|27046044|FG011|Overall Study|Adverse Event|0|||
13489092|NCT02001623|27046045|FG012|Overall Study|Adverse Event|3|||
13489093|NCT02001623|27046046|FG013|Overall Study|Adverse Event|5|||
13489094|NCT02001623|27046047|FG014|Overall Study|Adverse Event|6|||
13489095|NCT02001623|27046033|FG000|Overall Study|Other - Miscellaneous|0|||
13489096|NCT02001623|27046034|FG001|Overall Study|Other - Miscellaneous|0|||
13489097|NCT02001623|27046035|FG002|Overall Study|Other - Miscellaneous|0|||
13489098|NCT02001623|27046036|FG003|Overall Study|Other - Miscellaneous|0|||
13489099|NCT02001623|27046037|FG004|Overall Study|Other - Miscellaneous|0|||
13489100|NCT02001623|27046038|FG005|Overall Study|Other - Miscellaneous|0|||
13489101|NCT02001623|27046039|FG006|Overall Study|Other - Miscellaneous|0|||
13489102|NCT02001623|27046040|FG007|Overall Study|Other - Miscellaneous|0|||
13489103|NCT02001623|27046041|FG008|Overall Study|Other - Miscellaneous|0|||
13489104|NCT02001623|27046042|FG009|Overall Study|Other - Miscellaneous|1|||
13296228|NCT01371721|26496065|FG000|Overall Study|Protocol Violation|6|||
13489105|NCT02001623|27046043|FG010|Overall Study|Other - Miscellaneous|0|||
13489106|NCT02001623|27046044|FG011|Overall Study|Other - Miscellaneous|0|||
13489107|NCT02001623|27046045|FG012|Overall Study|Other - Miscellaneous|0|||
13489108|NCT02001623|27046046|FG013|Overall Study|Other - Miscellaneous|1|||
13489109|NCT02001623|27046047|FG014|Overall Study|Other - Miscellaneous|0|||
13489110|NCT02001623|27046033|FG000|Overall Study|Withdrawal by Subject|1|||
13489111|NCT02001623|27046034|FG001|Overall Study|Withdrawal by Subject|0|||
13489112|NCT02001623|27046035|FG002|Overall Study|Withdrawal by Subject|0|||
13489113|NCT02001623|27046036|FG003|Overall Study|Withdrawal by Subject|0|||
13489114|NCT02001623|27046037|FG004|Overall Study|Withdrawal by Subject|0|||
13489115|NCT02001623|27046038|FG005|Overall Study|Withdrawal by Subject|0|||
13489116|NCT02001623|27046039|FG006|Overall Study|Withdrawal by Subject|0|||
13489117|NCT02001623|27046040|FG007|Overall Study|Withdrawal by Subject|0|||
13489118|NCT02001623|27046041|FG008|Overall Study|Withdrawal by Subject|1|||
13489119|NCT02001623|27046042|FG009|Overall Study|Withdrawal by Subject|3|||
13489120|NCT02001623|27046043|FG010|Overall Study|Withdrawal by Subject|2|||
13489121|NCT02001623|27046044|FG011|Overall Study|Withdrawal by Subject|2|||
13489122|NCT02001623|27046045|FG012|Overall Study|Withdrawal by Subject|1|||
13489123|NCT02001623|27046046|FG013|Overall Study|Withdrawal by Subject|5|||
13489124|NCT02001623|27046047|FG014|Overall Study|Withdrawal by Subject|2|||
13489125|NCT02001623|27046033|FG000|Overall Study|Lost to Follow-up|0|||
13489126|NCT02001623|27046034|FG001|Overall Study|Lost to Follow-up|0|||
13489127|NCT02001623|27046035|FG002|Overall Study|Lost to Follow-up|0|||
13489128|NCT02001623|27046036|FG003|Overall Study|Lost to Follow-up|0|||
13489129|NCT02001623|27046037|FG004|Overall Study|Lost to Follow-up|0|||
13489130|NCT02001623|27046038|FG005|Overall Study|Lost to Follow-up|0|||
13489131|NCT02001623|27046039|FG006|Overall Study|Lost to Follow-up|0|||
13489132|NCT02001623|27046040|FG007|Overall Study|Lost to Follow-up|0|||
13489133|NCT02001623|27046041|FG008|Overall Study|Lost to Follow-up|0|||
13489134|NCT02001623|27046042|FG009|Overall Study|Lost to Follow-up|1|||
13489135|NCT02001623|27046043|FG010|Overall Study|Lost to Follow-up|0|||
13489136|NCT02001623|27046044|FG011|Overall Study|Lost to Follow-up|0|||
13489137|NCT02001623|27046045|FG012|Overall Study|Lost to Follow-up|0|||
13489138|NCT02001623|27046046|FG013|Overall Study|Lost to Follow-up|0|||
13489139|NCT02001623|27046047|FG014|Overall Study|Lost to Follow-up|0|||
13489140|NCT02001623|27046033|FG000|Overall Study|Start of New Anti-cancer Treatment|0|||
13489141|NCT02001623|27046034|FG001|Overall Study|Start of New Anti-cancer Treatment|0|||
13489142|NCT02001623|27046035|FG002|Overall Study|Start of New Anti-cancer Treatment|0|||
13296229|NCT01371721|26496066|FG001|Overall Study|Protocol Violation|4|||
13296230|NCT01371721|26496067|FG002|Overall Study|Protocol Violation|5|||
13296231|NCT01371721|26496065|FG000|Overall Study|Lost to Follow-up|8|||
13296232|NCT01371721|26496066|FG001|Overall Study|Lost to Follow-up|2|||
13296233|NCT01371721|26496067|FG002|Overall Study|Lost to Follow-up|6|||
13296234|NCT01371721|26496065|FG000|Overall Study|Withdrawal by Subject|5|||
13296235|NCT01371721|26496066|FG001|Overall Study|Withdrawal by Subject|7|||
13296236|NCT01371721|26496067|FG002|Overall Study|Withdrawal by Subject|11|||
13296237|NCT01371721|26496065|FG000|Overall Study|Other|2|||
13296238|NCT01371721|26496066|FG001|Overall Study|Other|3|||
13296239|NCT01371721|26496067|FG002|Overall Study|Other|0|||
13296240|NCT01371721|26496065|FG000|Overall Study|Lack of Efficacy|2|||
13296241|NCT01371721|26496066|FG001|Overall Study|Lack of Efficacy|4|||
13296242|NCT01371721|26496067|FG002|Overall Study|Lack of Efficacy|3|||
13296243|NCT01371721|26496065|FG000|Overall Study|Randomized but not treated|1|||
13296244|NCT01371721|26496066|FG001|Overall Study|Randomized but not treated|0|||
13296245|NCT01371721|26496067|FG002|Overall Study|Randomized but not treated|0|||
13296246|NCT01371708|26496107|FG000|Overall Study|Insufficient clinical response|3|||
13296247|NCT01371708|26496108|FG001|Overall Study|Insufficient clinical response|2|||
13296248|NCT01371708|26496109|FG002|Overall Study|Insufficient clinical response|0|||
13489143|NCT02001623|27046036|FG003|Overall Study|Start of New Anti-cancer Treatment|0|||
13489144|NCT02001623|27046037|FG004|Overall Study|Start of New Anti-cancer Treatment|0|||
13489145|NCT02001623|27046038|FG005|Overall Study|Start of New Anti-cancer Treatment|0|||
13489146|NCT02001623|27046039|FG006|Overall Study|Start of New Anti-cancer Treatment|0|||
13489147|NCT02001623|27046040|FG007|Overall Study|Start of New Anti-cancer Treatment|0|||
13489148|NCT02001623|27046041|FG008|Overall Study|Start of New Anti-cancer Treatment|0|||
13489149|NCT02001623|27046042|FG009|Overall Study|Start of New Anti-cancer Treatment|0|||
13489150|NCT02001623|27046043|FG010|Overall Study|Start of New Anti-cancer Treatment|0|||
13489151|NCT02001623|27046044|FG011|Overall Study|Start of New Anti-cancer Treatment|1|||
13489152|NCT02001623|27046045|FG012|Overall Study|Start of New Anti-cancer Treatment|0|||
13489153|NCT02001623|27046046|FG013|Overall Study|Start of New Anti-cancer Treatment|1|||
13489154|NCT02001623|27046047|FG014|Overall Study|Start of New Anti-cancer Treatment|0|||
13489155|NCT02001623|27046033|FG000|Overall Study|Dose Delay Due to Toxicity|0|||
13489156|NCT02001623|27046034|FG001|Overall Study|Dose Delay Due to Toxicity|0|||
13489157|NCT02001623|27046035|FG002|Overall Study|Dose Delay Due to Toxicity|0|||
13489158|NCT02001623|27046036|FG003|Overall Study|Dose Delay Due to Toxicity|0|||
13489159|NCT02001623|27046037|FG004|Overall Study|Dose Delay Due to Toxicity|0|||
13489160|NCT02001623|27046038|FG005|Overall Study|Dose Delay Due to Toxicity|0|||
13489161|NCT02001623|27046039|FG006|Overall Study|Dose Delay Due to Toxicity|0|||
13489162|NCT02001623|27046040|FG007|Overall Study|Dose Delay Due to Toxicity|0|||
13296249|NCT01371708|26496107|FG000|Overall Study|Lost to Follow-up|5|||
13296250|NCT01371708|26496108|FG001|Overall Study|Lost to Follow-up|9|||
13489163|NCT02001623|27046041|FG008|Overall Study|Dose Delay Due to Toxicity|0|||
13489164|NCT02001623|27046042|FG009|Overall Study|Dose Delay Due to Toxicity|0|||
13489165|NCT02001623|27046043|FG010|Overall Study|Dose Delay Due to Toxicity|0|||
13489166|NCT02001623|27046044|FG011|Overall Study|Dose Delay Due to Toxicity|0|||
13489167|NCT02001623|27046045|FG012|Overall Study|Dose Delay Due to Toxicity|0|||
13489168|NCT02001623|27046046|FG013|Overall Study|Dose Delay Due to Toxicity|1|||
13489169|NCT02001623|27046047|FG014|Overall Study|Dose Delay Due to Toxicity|0|||
13489170|NCT01900002|27046055|FG000|Overall Study|Withdrawal by Subject|2|||
13489171|NCT01900002|27046055|FG000|Overall Study|ineligible for Y-90|4|||
13489172|NCT01595061|27046064|FG000|Overall Study|Never Treated|3|||
13489173|NCT01595061|27046064|FG000|Overall Study|Inadequate Pathology|1|||
13489174|NCT04502212|27046107|FG000|Overall Study|Unevaluable data; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
13489175|NCT04502212|27046107|FG000|Overall Study|Clamp protocol deviation; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
13489176|NCT04794803|27046174|FG000|Overall Study|Death|1|||
13489177|NCT04794803|27046175|FG001|Overall Study|Death|3|||
13489178|NCT04794803|27046174|FG000|Overall Study|Lost to Follow-up|2|||
13489179|NCT04794803|27046175|FG001|Overall Study|Lost to Follow-up|2|||
13489180|NCT04794803|27046174|FG000|Overall Study|Withdrawal by Subject|1|||
13489181|NCT04794803|27046175|FG001|Overall Study|Withdrawal by Subject|0|||
13489182|NCT04794803|27046174|FG000|Overall Study|Physician Decision|1|||
13489183|NCT04794803|27046175|FG001|Overall Study|Physician Decision|1|||
13489184|NCT04794803|27046174|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4|||
13489185|NCT04794803|27046175|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1|||
13489186|NCT04794803|27046174|FG000|Overall Study|Refused to continue the treatment|1|||
13489187|NCT04794803|27046175|FG001|Overall Study|Refused to continue the treatment|0|||
13489188|NCT04794803|27046174|FG000|Overall Study|Patient admitted to ICU|0|||
13489189|NCT04794803|27046175|FG001|Overall Study|Patient admitted to ICU|1|||
13489190|NCT04706403|27046203|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
13489191|NCT04706403|27046204|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
13489192|NCT04706403|27046205|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
13489193|NCT04706403|27046206|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
13489194|NCT04706403|27046207|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2|||
13489195|NCT04440449|27046227|FG000|Overall Study|Lost to Follow-up|2|||
13489196|NCT04440449|27046228|FG001|Overall Study|Lost to Follow-up|0|||
13489197|NCT04369469|27046258|FG000|Overall Study|Lost to Follow-up|2|||
13489198|NCT04369469|27046259|FG001|Overall Study|Lost to Follow-up|4|||
13489199|NCT04369469|27046258|FG000|Overall Study|Physician Decision|2|||
13489200|NCT04369469|27046259|FG001|Overall Study|Physician Decision|1|||
13489201|NCT04369469|27046258|FG000|Overall Study|Withdrawal by Subject|2|||
13489202|NCT04369469|27046259|FG001|Overall Study|Withdrawal by Subject|3|||
13489203|NCT04369469|27046258|FG000|Overall Study|Adverse Event|1|||
13489204|NCT04369469|27046259|FG001|Overall Study|Adverse Event|0|||
13489205|NCT04369469|27046258|FG000|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|2|||
13489206|NCT04369469|27046259|FG001|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|0|||
13489207|NCT04369469|27046258|FG000|Overall Study|Not Qualified due to History of Anaphylaxis|1|||
13489208|NCT04369469|27046259|FG001|Overall Study|Not Qualified due to History of Anaphylaxis|0|||
13489209|NCT04369469|27046258|FG000|Overall Study|Unable to Provide Consent|0|||
13489210|NCT04369469|27046259|FG001|Overall Study|Unable to Provide Consent|1|||
13489211|NCT03772574|27046307|FG000|Overall Study|Protocol Violation|2|||
13489212|NCT03772574|27046308|FG001|Overall Study|Protocol Violation|0|||
13489213|NCT03772574|27046309|FG002|Overall Study|Protocol Violation|0|||
13489214|NCT03772574|27046307|FG000|Overall Study|Discomfort|0|||
13489215|NCT03772574|27046308|FG001|Overall Study|Discomfort|5|||
13489216|NCT03772574|27046309|FG002|Overall Study|Discomfort|4|||
13489217|NCT03548220|27046370|FG000|Overall Study|Lost to Follow-up|1|||
13489218|NCT03548220|27046371|FG001|Overall Study|Lost to Follow-up|0|||
13489219|NCT03548220|27046372|FG002|Overall Study|Lost to Follow-up|0|||
13489220|NCT03548220|27046373|FG003|Overall Study|Lost to Follow-up|0|||
13489221|NCT03434041|27046410|FG000|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
13489222|NCT03434041|27046411|FG001|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
13489223|NCT03434041|27046410|FG000|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|2|||
13489224|NCT03434041|27046411|FG001|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|1|||
13489225|NCT03434041|27046410|FG000|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|3|||
13489226|NCT03434041|27046411|FG001|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|14|||
13489227|NCT03434041|27046410|FG000|Double Blind Treatment Phase (4 Weeks)|Adverse Event|7|||
13489228|NCT03434041|27046411|FG001|Double Blind Treatment Phase (4 Weeks)|Adverse Event|2|||
13489229|NCT03434041|27046410|FG000|Double Blind Treatment Phase (4 Weeks)|Death|1|||
13489230|NCT03434041|27046411|FG001|Double Blind Treatment Phase (4 Weeks)|Death|0|||
13489231|NCT03434041|27046410|FG000|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
13489232|NCT03434041|27046411|FG001|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
13489233|NCT03434041|27046410|FG000|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|0|||
13489234|NCT03434041|27046411|FG001|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|1|||
13489235|NCT03434041|27046410|FG000|Double Blind Treatment Phase (4 Weeks)|Other|2|||
13489236|NCT03434041|27046411|FG001|Double Blind Treatment Phase (4 Weeks)|Other|0|||
13489237|NCT03434041|27046410|FG000|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|4|||
13489238|NCT03434041|27046411|FG001|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|3|||
13489239|NCT03434041|27046410|FG000|Follow-up Phase (Up to 8 Weeks)|Adverse Event|2|||
13489240|NCT03434041|27046411|FG001|Follow-up Phase (Up to 8 Weeks)|Adverse Event|0|||
13489241|NCT03434041|27046410|FG000|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|1|||
13296251|NCT01371708|26496109|FG002|Overall Study|Lost to Follow-up|7|||
13296252|NCT01371708|26496107|FG000|Overall Study|Protocol Violation|2|||
13296253|NCT01371708|26496108|FG001|Overall Study|Protocol Violation|1|||
13296254|NCT01371708|26496109|FG002|Overall Study|Protocol Violation|2|||
13296255|NCT01371708|26496107|FG000|Overall Study|No longer willing to participate|7|||
13296256|NCT01371708|26496108|FG001|Overall Study|No longer willing to participate|7|||
13489242|NCT03434041|27046411|FG001|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|0|||
13489243|NCT03420222|27046456|FG000|Overall Study|Withdrawal by Subject|5|||
13489244|NCT03420222|27046457|FG001|Overall Study|Withdrawal by Subject|0|||
13489245|NCT03420222|27046456|FG000|Overall Study|Physician Decision|0|||
13489246|NCT03420222|27046457|FG001|Overall Study|Physician Decision|1|||
13489247|NCT03093350|27046515|FG000|Overall Study|Death|1|||
13489248|NCT03093350|27046515|FG000|Overall Study|Signed consent, never began treartment|1|||
13489249|NCT02839343|27046536|FG000|Overall Study|Withdrawal by Subject|3|||
13489250|NCT02839343|27046537|FG001|Overall Study|Withdrawal by Subject|1|||
13489251|NCT02839343|27046536|FG000|Overall Study|Disease Progression Prior to Treatment|1|||
13489252|NCT02839343|27046537|FG001|Overall Study|Disease Progression Prior to Treatment|0|||
13489253|NCT02839343|27046536|FG000|Overall Study|Adverse Event|1|||
13489254|NCT02839343|27046537|FG001|Overall Study|Adverse Event|0|||
13489255|NCT02819479|27046550|FG000|Overall Study|Adverse Event|2|||
13489256|NCT02004691|27046627|FG000|PAP: Up to 52 Weeks|Poor compliance|1|||
13489257|NCT02004691|27046628|FG001|PAP: Up to 52 Weeks|Poor compliance|0|||
13489258|NCT02004691|27046627|FG000|ETP: Ongoing From Week 52|Related to Coronavirus Disease (COVID-19)|1|||
13489259|NCT02004691|27046628|FG001|ETP: Ongoing From Week 52|Related to Coronavirus Disease (COVID-19)|0|||
13489260|NCT02004691|27046627|FG000|ETP: Ongoing From Week 52|Withdrawal by Subject|0|||
13489261|NCT02004691|27046628|FG001|ETP: Ongoing From Week 52|Withdrawal by Subject|1|||
13489262|NCT02004691|27046627|FG000|ETP: Ongoing From Week 52|Other|0|||
13489263|NCT02004691|27046628|FG001|ETP: Ongoing From Week 52|Other|1|||
13489264|NCT02004691|27046627|FG000|ETP: Ongoing From Week 52|Ongoing|16|||
13489265|NCT02004691|27046628|FG001|ETP: Ongoing From Week 52|Ongoing|16|||
13489266|NCT01668719|27046652|FG000|Phase I|On treatment|1|||
13489267|NCT01668719|27046653|FG001|Phase I|On treatment|0|||
13489268|NCT01668719|27046654|FG002|Phase I|On treatment|0|||
13489269|NCT01668719|27046652|FG000|Phase I|Adverse Event|2|||
13489270|NCT01668719|27046653|FG001|Phase I|Adverse Event|0|||
13489271|NCT01668719|27046654|FG002|Phase I|Adverse Event|0|||
13489272|NCT01668719|27046652|FG000|Phase I|Progression/relapse|1|||
13489273|NCT01668719|27046653|FG001|Phase I|Progression/relapse|0|||
13489274|NCT01668719|27046654|FG002|Phase I|Progression/relapse|0|||
13489275|NCT01668719|27046652|FG000|Phase I|not protocol specified|2|||
13489276|NCT01668719|27046653|FG001|Phase I|not protocol specified|0|||
13489277|NCT01668719|27046654|FG002|Phase I|not protocol specified|0|||
13489278|NCT01668719|27046652|FG000|Phase II|On treatment|0|||
13489279|NCT01668719|27046653|FG001|Phase II|On treatment|4|||
13489280|NCT01668719|27046654|FG002|Phase II|On treatment|3|||
13489281|NCT01668719|27046652|FG000|Phase II|Adverse Event|0|||
13489282|NCT01668719|27046653|FG001|Phase II|Adverse Event|18|||
13489283|NCT01668719|27046654|FG002|Phase II|Adverse Event|18|||
13489284|NCT01668719|27046652|FG000|Phase II|Refusal unrelated to adverse event|0|||
13489285|NCT01668719|27046653|FG001|Phase II|Refusal unrelated to adverse event|4|||
13489286|NCT01668719|27046654|FG002|Phase II|Refusal unrelated to adverse event|1|||
13489287|NCT01668719|27046652|FG000|Phase II|Progression/relapse|0|||
13489288|NCT01668719|27046653|FG001|Phase II|Progression/relapse|13|||
13489289|NCT01668719|27046654|FG002|Phase II|Progression/relapse|17|||
13489290|NCT01668719|27046652|FG000|Phase II|Death|0|||
13489291|NCT01668719|27046653|FG001|Phase II|Death|0|||
13489292|NCT01668719|27046654|FG002|Phase II|Death|2|||
13489293|NCT01668719|27046652|FG000|Phase II|not protocol specified|0|||
13489294|NCT01668719|27046653|FG001|Phase II|not protocol specified|13|||
13489295|NCT01668719|27046654|FG002|Phase II|not protocol specified|7|||
13489296|NCT01515748|27046682|FG000|Overall Study|Withdrawal by Subject|32|||
13489297|NCT01515748|27046683|FG001|Overall Study|Withdrawal by Subject|41|||
13489298|NCT01515748|27046682|FG000|Overall Study|Lost to Follow-up|2|||
13489299|NCT01515748|27046683|FG001|Overall Study|Lost to Follow-up|4|||
13489300|NCT01515748|27046682|FG000|Overall Study|Ongoing|86|||
13489301|NCT01515748|27046683|FG001|Overall Study|Ongoing|90|||
13489302|NCT01261247|27046692|FG000|Overall Study|Ineligible|2|||
13489303|NCT00790933|27047366|FG000|Overall Study|Adverse Event|94|||
13489304|NCT00790933|27047367|FG001|Overall Study|Adverse Event|119|||
13489305|NCT00790933|27047368|FG002|Overall Study|Adverse Event|65|||
13489306|NCT00790933|27047369|FG003|Overall Study|Adverse Event|5|||
13489307|NCT00790933|27047370|FG004|Overall Study|Adverse Event|69|||
13489308|NCT00790933|27047366|FG000|Overall Study|Protocol Violation(s)|8|||
13489309|NCT00790933|27047367|FG001|Overall Study|Protocol Violation(s)|18|||
13489310|NCT00790933|27047368|FG002|Overall Study|Protocol Violation(s)|7|||
13489311|NCT00790933|27047369|FG003|Overall Study|Protocol Violation(s)|0|||
13489312|NCT00790933|27047370|FG004|Overall Study|Protocol Violation(s)|12|||
13489313|NCT00790933|27047366|FG000|Overall Study|Lack of Efficacy|192|||
13489314|NCT00790933|27047367|FG001|Overall Study|Lack of Efficacy|176|||
13489315|NCT00790933|27047368|FG002|Overall Study|Lack of Efficacy|130|||
13489316|NCT00790933|27047369|FG003|Overall Study|Lack of Efficacy|1|||
13489317|NCT00790933|27047370|FG004|Overall Study|Lack of Efficacy|121|||
13489318|NCT00790933|27047366|FG000|Overall Study|Study Terminated by Sponsor|0|||
13489319|NCT00790933|27047367|FG001|Overall Study|Study Terminated by Sponsor|0|||
13489320|NCT00790933|27047368|FG002|Overall Study|Study Terminated by Sponsor|1|||
13489321|NCT00790933|27047369|FG003|Overall Study|Study Terminated by Sponsor|0|||
13489322|NCT00790933|27047370|FG004|Overall Study|Study Terminated by Sponsor|0|||
13489323|NCT00790933|27047366|FG000|Overall Study|Withdrawal by Subject|123|||
13489324|NCT00790933|27047367|FG001|Overall Study|Withdrawal by Subject|120|||
13489325|NCT00790933|27047368|FG002|Overall Study|Withdrawal by Subject|52|||
13489326|NCT00790933|27047369|FG003|Overall Study|Withdrawal by Subject|6|||
13489327|NCT00790933|27047370|FG004|Overall Study|Withdrawal by Subject|50|||
13489328|NCT00790933|27047366|FG000|Overall Study|Lost to Follow-up|13|||
13489329|NCT00790933|27047367|FG001|Overall Study|Lost to Follow-up|31|||
13489330|NCT00790933|27047368|FG002|Overall Study|Lost to Follow-up|10|||
13489331|NCT00790933|27047369|FG003|Overall Study|Lost to Follow-up|1|||
13489332|NCT00790933|27047370|FG004|Overall Study|Lost to Follow-up|15|||
13489333|NCT00790933|27047366|FG000|Overall Study|Reason Not Specified|8|||
13489334|NCT00790933|27047367|FG001|Overall Study|Reason Not Specified|16|||
13489335|NCT00790933|27047368|FG002|Overall Study|Reason Not Specified|4|||
13489336|NCT00790933|27047369|FG003|Overall Study|Reason Not Specified|1|||
13489337|NCT00790933|27047370|FG004|Overall Study|Reason Not Specified|9|||
13489338|NCT04388527|27047477|FG000|Overall Study|Death|14|||
13489339|NCT04388527|27047477|FG000|Overall Study|Withdrawal by Subject|2|||
13489340|NCT04388527|27047477|FG000|Overall Study|Lost to Follow-up|1|||
13489341|NCT04280081|27047534|FG000|Overall Study|Adverse Event|4|||
13489342|NCT04280081|27047534|FG000|Overall Study|Death|2|||
13489343|NCT04280081|27047534|FG000|Overall Study|Progressive Disease|6|||
13489344|NCT03444038|27047983|FG000|Overall Study|Adverse Event|12|||
13489345|NCT03444038|27047983|FG000|Overall Study|Withdrawal by Subject|7|||
13489346|NCT03444038|27047983|FG000|Overall Study|Lost to Follow-up|1|||
13489347|NCT03444038|27047983|FG000|Overall Study|Physician Decision|2|||
13489348|NCT03444038|27047983|FG000|Overall Study|Lack of Efficacy|7|||
13489349|NCT03265665|27048021|FG000|24-week Data Collection|Withdrawal by Subject|2|||
13489350|NCT03265665|27048022|FG001|24-week Data Collection|Withdrawal by Subject|2|||
13489351|NCT03265665|27048021|FG000|24-week Data Collection|Lost to Follow-up|4|||
13489352|NCT03265665|27048022|FG001|24-week Data Collection|Lost to Follow-up|5|||
13489353|NCT03265665|27048021|FG000|36-week Data Collection|Lost to Follow-up|6|||
13489354|NCT03265665|27048022|FG001|36-week Data Collection|Lost to Follow-up|8|||
13489355|NCT02725593|27048047|FG000|Blinded Treatment Period|Withdrawal by Subject|4|||
13489356|NCT02725593|27048048|FG001|Blinded Treatment Period|Withdrawal by Subject|3|||
13489357|NCT02725593|27048047|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0|||
13489358|NCT02725593|27048048|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2|||
13489359|NCT02725593|27048047|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
13489360|NCT02725593|27048048|FG001|Blinded Treatment Period|Lost to Follow-up|1|||
13489361|NCT02725593|27048047|FG000|Long Term Extension|Withdrawal by Subject|1|||
13489362|NCT02725593|27048048|FG001|Long Term Extension|Withdrawal by Subject|3|||
13489363|NCT02716675|27048118|FG000|Overall Study|Death|2|||
13489364|NCT02716675|27048119|FG001|Overall Study|Death|3|||
13489365|NCT02716675|27048120|FG002|Overall Study|Death|0|||
13489366|NCT02716675|27048118|FG000|Overall Study|Physician Decision|2|||
13489367|NCT02716675|27048119|FG001|Overall Study|Physician Decision|1|||
13489368|NCT02716675|27048120|FG002|Overall Study|Physician Decision|1|||
13489369|NCT02716675|27048118|FG000|Overall Study|Lost to Follow-up|100|||
13489370|NCT02716675|27048119|FG001|Overall Study|Lost to Follow-up|87|||
13489371|NCT02716675|27048120|FG002|Overall Study|Lost to Follow-up|99|||
13489372|NCT02716675|27048118|FG000|Overall Study|Withdrawal by Subject|22|||
13489373|NCT02716675|27048119|FG001|Overall Study|Withdrawal by Subject|25|||
13489374|NCT02716675|27048120|FG002|Overall Study|Withdrawal by Subject|20|||
13489375|NCT02716675|27048118|FG000|Overall Study|Protocol Violation|0|||
13489376|NCT02716675|27048119|FG001|Overall Study|Protocol Violation|3|||
13489377|NCT02716675|27048120|FG002|Overall Study|Protocol Violation|1|||
13489378|NCT02716675|27048118|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36|||
13489379|NCT02716675|27048119|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31|||
13489380|NCT02716675|27048120|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42|||
13489381|NCT02716675|27048118|FG000|Overall Study|Other|38|||
13489382|NCT02716675|27048119|FG001|Overall Study|Other|47|||
13489383|NCT02716675|27048120|FG002|Overall Study|Other|48|||
13489384|NCT02636946|27048145|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0|||
13489385|NCT02636946|27048146|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1|||
13489386|NCT02636946|27048145|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
13489387|NCT02636946|27048146|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
13489388|NCT02636946|27048145|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0|||
13489389|NCT02636946|27048146|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1|||
13489390|NCT02636946|27048145|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0|||
13489391|NCT02636946|27048146|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1|||
13489392|NCT02636946|27048145|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
13489393|NCT02636946|27048146|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2|||
13489394|NCT02636946|27048145|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2|||
13489395|NCT02636946|27048146|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1|||
13489396|NCT02631941|27048243|FG000|Overall Study|Physician Decision|0|||
13489397|NCT02631941|27048244|FG001|Overall Study|Physician Decision|1|||
13489398|NCT02631941|27048245|FG002|Overall Study|Physician Decision|0|||
13489399|NCT02631941|27048246|FG003|Overall Study|Physician Decision|0|||
13489400|NCT02631941|27048247|FG004|Overall Study|Physician Decision|0|||
13489401|NCT02631941|27048248|FG005|Overall Study|Physician Decision|0|||
13489402|NCT02631941|27048249|FG006|Overall Study|Physician Decision|0|||
13489403|NCT02631941|27048250|FG007|Overall Study|Physician Decision|0|||
13489404|NCT02631941|27048251|FG008|Overall Study|Physician Decision|0|||
13489405|NCT02631941|27048252|FG009|Overall Study|Physician Decision|0|||
13489406|NCT02631941|27048243|FG000|Overall Study|Adverse Event|0|||
13489407|NCT02631941|27048244|FG001|Overall Study|Adverse Event|1|||
13489408|NCT02631941|27048245|FG002|Overall Study|Adverse Event|0|||
13489409|NCT02631941|27048246|FG003|Overall Study|Adverse Event|0|||
13489410|NCT02631941|27048247|FG004|Overall Study|Adverse Event|0|||
13489411|NCT02631941|27048248|FG005|Overall Study|Adverse Event|0|||
13489412|NCT02631941|27048249|FG006|Overall Study|Adverse Event|0|||
13489413|NCT02631941|27048250|FG007|Overall Study|Adverse Event|0|||
13489414|NCT02631941|27048251|FG008|Overall Study|Adverse Event|0|||
13489415|NCT02631941|27048252|FG009|Overall Study|Adverse Event|0|||
13489416|NCT02631941|27048243|FG000|Overall Study|Withdrawal by Subject|0|||
13489417|NCT02631941|27048244|FG001|Overall Study|Withdrawal by Subject|0|||
13489418|NCT02631941|27048245|FG002|Overall Study|Withdrawal by Subject|0|||
13489419|NCT02631941|27048246|FG003|Overall Study|Withdrawal by Subject|0|||
13489420|NCT02631941|27048247|FG004|Overall Study|Withdrawal by Subject|1|||
13489421|NCT02631941|27048248|FG005|Overall Study|Withdrawal by Subject|0|||
13489422|NCT02631941|27048249|FG006|Overall Study|Withdrawal by Subject|0|||
13489423|NCT02631941|27048250|FG007|Overall Study|Withdrawal by Subject|1|||
13489424|NCT02631941|27048251|FG008|Overall Study|Withdrawal by Subject|0|||
13489425|NCT02631941|27048252|FG009|Overall Study|Withdrawal by Subject|0|||
13489426|NCT02631941|27048243|FG000|Overall Study|Lost to Follow-up|0|||
13489427|NCT02631941|27048244|FG001|Overall Study|Lost to Follow-up|0|||
13489428|NCT02631941|27048245|FG002|Overall Study|Lost to Follow-up|0|||
13489429|NCT02631941|27048246|FG003|Overall Study|Lost to Follow-up|0|||
13489430|NCT02631941|27048247|FG004|Overall Study|Lost to Follow-up|0|||
13489431|NCT02631941|27048248|FG005|Overall Study|Lost to Follow-up|0|||
13489432|NCT02631941|27048249|FG006|Overall Study|Lost to Follow-up|0|||
13489433|NCT02631941|27048250|FG007|Overall Study|Lost to Follow-up|0|||
13489434|NCT02631941|27048251|FG008|Overall Study|Lost to Follow-up|1|||
13489435|NCT02631941|27048252|FG009|Overall Study|Lost to Follow-up|0|||
13489436|NCT02568215|27048322|FG000|Overall Study|Death|1|||
13489437|NCT02568215|27048323|FG001|Overall Study|Death|2|||
13489438|NCT02568215|27048324|FG002|Overall Study|Death|0|||
13489439|NCT02568215|27048322|FG000|Overall Study|Physician Decision|2|||
13489440|NCT02568215|27048323|FG001|Overall Study|Physician Decision|2|||
13489441|NCT02568215|27048324|FG002|Overall Study|Physician Decision|2|||
13489442|NCT02568215|27048322|FG000|Overall Study|Lost to Follow-up|29|||
13489443|NCT02568215|27048323|FG001|Overall Study|Lost to Follow-up|32|||
13489444|NCT02568215|27048324|FG002|Overall Study|Lost to Follow-up|41|||
13489445|NCT02568215|27048322|FG000|Overall Study|Withdrawal by Subject|21|||
13489446|NCT02568215|27048323|FG001|Overall Study|Withdrawal by Subject|19|||
13489447|NCT02568215|27048324|FG002|Overall Study|Withdrawal by Subject|22|||
13489448|NCT02568215|27048322|FG000|Overall Study|Protocol Violation|1|||
13489449|NCT02568215|27048323|FG001|Overall Study|Protocol Violation|1|||
13489450|NCT02568215|27048324|FG002|Overall Study|Protocol Violation|0|||
13489451|NCT02568215|27048322|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25|||
13489452|NCT02568215|27048323|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23|||
13489453|NCT02568215|27048324|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
13489454|NCT02568215|27048322|FG000|Overall Study|Other|0|||
13489455|NCT02568215|27048323|FG001|Overall Study|Other|1|||
13489456|NCT02568215|27048324|FG002|Overall Study|Other|4|||
13489457|NCT02528643|27048421|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5|||
13489458|NCT02528643|27048422|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8|||
13489459|NCT02528643|27048421|FG000|DB (Median Duration up to 14.65 Months)|Death|1|||
13489460|NCT02528643|27048422|FG001|DB (Median Duration up to 14.65 Months)|Death|6|||
13489461|NCT02528643|27048421|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0|||
13489462|NCT02528643|27048422|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1|||
13489463|NCT02528643|27048421|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44|||
13489464|NCT02528643|27048422|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82|||
13489465|NCT02528643|27048421|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2|||
13489466|NCT02528643|27048422|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8|||
13489467|NCT02528643|27048421|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3|||
13489468|NCT02528643|27048422|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5|||
13489469|NCT02528643|27048421|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0|||
13489470|NCT02528643|27048422|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1|||
13489471|NCT02237508|27048552|FG000|Overall Study|Withdrawal by Subject|0|||
13489472|NCT02237508|27048553|FG001|Overall Study|Withdrawal by Subject|2|||
13381345|NCT00753922|26747931|FG000|Overall Study|Death|2|||
13381346|NCT00753922|26747932|FG001|Overall Study|Death|23|||
13381347|NCT00753922|26747933|FG002|Overall Study|Death|2|||
13381348|NCT00753922|26747934|FG003|Overall Study|Death|1|||
13381349|NCT00753922|26747931|FG000|Overall Study|Discontinuation Due to Explantation|14|||
13381350|NCT00753922|26747932|FG001|Overall Study|Discontinuation Due to Explantation|14|||
13394503|NCT00657046|26787223|FG000|Overall Study|Protocol Violation|2|||
13489473|NCT02237508|27048554|FG002|Overall Study|Withdrawal by Subject|0|||
13489474|NCT02237508|27048555|FG003|Overall Study|Withdrawal by Subject|1|||
13489475|NCT02237508|27048556|FG004|Overall Study|Withdrawal by Subject|0|||
13489476|NCT02237508|27048557|FG005|Overall Study|Withdrawal by Subject|1|||
13489477|NCT02237508|27048558|FG006|Overall Study|Withdrawal by Subject|1|||
13489478|NCT02237508|27048559|FG007|Overall Study|Withdrawal by Subject|0|||
13489479|NCT02237508|27048560|FG008|Overall Study|Withdrawal by Subject|1|||
13489480|NCT02237508|27048561|FG009|Overall Study|Withdrawal by Subject|0|||
13489481|NCT02237508|27048552|FG000|Overall Study|Physician Decision|0|||
13489482|NCT02237508|27048553|FG001|Overall Study|Physician Decision|1|||
13489483|NCT02237508|27048554|FG002|Overall Study|Physician Decision|0|||
13489484|NCT02237508|27048555|FG003|Overall Study|Physician Decision|0|||
13489485|NCT02237508|27048556|FG004|Overall Study|Physician Decision|0|||
13489486|NCT02237508|27048557|FG005|Overall Study|Physician Decision|0|||
13489487|NCT02237508|27048558|FG006|Overall Study|Physician Decision|0|||
13489488|NCT02237508|27048559|FG007|Overall Study|Physician Decision|0|||
13489489|NCT02237508|27048560|FG008|Overall Study|Physician Decision|0|||
13489490|NCT02237508|27048561|FG009|Overall Study|Physician Decision|0|||
13489491|NCT02237508|27048552|FG000|Overall Study|Protocol Violation|0|||
13489492|NCT02237508|27048553|FG001|Overall Study|Protocol Violation|0|||
13489493|NCT02237508|27048554|FG002|Overall Study|Protocol Violation|1|||
13489494|NCT02237508|27048555|FG003|Overall Study|Protocol Violation|0|||
13489495|NCT02237508|27048556|FG004|Overall Study|Protocol Violation|0|||
13489496|NCT02237508|27048557|FG005|Overall Study|Protocol Violation|0|||
13489497|NCT02237508|27048558|FG006|Overall Study|Protocol Violation|0|||
13489498|NCT02237508|27048559|FG007|Overall Study|Protocol Violation|0|||
13489499|NCT02237508|27048560|FG008|Overall Study|Protocol Violation|0|||
13489500|NCT02237508|27048561|FG009|Overall Study|Protocol Violation|0|||
13489501|NCT04862065|27048577|FG000|Screening|Protocol Violation|54|||
13489502|NCT04862065|27048578|FG001|Screening|Protocol Violation|0|||
13489503|NCT04862065|27048579|FG002|Screening|Protocol Violation|0|||
13489504|NCT04862065|27048577|FG000|Screening|Insufficient Sample|1|||
13489505|NCT04862065|27048578|FG001|Screening|Insufficient Sample|0|||
13489506|NCT04862065|27048579|FG002|Screening|Insufficient Sample|0|||
13489507|NCT04862065|27048577|FG000|Follow-Up|Lost to Follow-up|3|||
13489508|NCT04862065|27048578|FG001|Follow-Up|Lost to Follow-up|0|||
13489509|NCT04862065|27048579|FG002|Follow-Up|Lost to Follow-up|0|||
13489510|NCT03369236|27048650|FG000|Double-blind Treatment Period|Accidental unblinding|0|||
13489511|NCT03369236|27048651|FG001|Double-blind Treatment Period|Accidental unblinding|1|||
13489512|NCT03369236|27048650|FG000|Open-label Extension Period|Lack of Efficacy|2|||
13489513|NCT03369236|27048651|FG001|Open-label Extension Period|Lack of Efficacy|1|||
13489514|NCT03369236|27048650|FG000|Open-label Extension Period|Adverse Event|0|||
13489515|NCT03369236|27048651|FG001|Open-label Extension Period|Adverse Event|1|||
13489516|NCT03369236|27048650|FG000|Open-label Extension Period|Sponsor decision to close study|3|||
13489517|NCT03369236|27048651|FG001|Open-label Extension Period|Sponsor decision to close study|4|||
13489591|NCT00774930|27049086|FG000|LTOLE Phase|Sponsor decision|2|||
13489592|NCT00774930|27049087|FG001|LTOLE Phase|Sponsor decision|1|||
13489593|NCT00774930|27049086|FG000|LTOLE Phase|Disease Progression|2|||
13489594|NCT00774930|27049087|FG001|LTOLE Phase|Disease Progression|5|||
13489595|NCT00774930|27049086|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0|||
13489596|NCT00774930|27049087|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1|||
13489597|NCT00774930|27049086|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0|||
13489598|NCT00774930|27049087|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1|||
13489599|NCT00690898|27049103|FG000|SCREENING|Screen failure|18|||
13489600|NCT00690898|27049103|FG000|TREATMENT|Adverse Event|3|||
13489601|NCT00690898|27049103|FG000|TREATMENT|Lack of Efficacy|18|||
13489602|NCT00690898|27049103|FG000|TREATMENT|Withdrawal by Subject|4|||
13489603|NCT00690898|27049103|FG000|TREATMENT|Other (not otherwise specified)|1|||
13489604|NCT01706705|27049131|FG000|Overall Study|Death|1|||
13489605|NCT01706705|27049131|FG000|Overall Study|Lack of Efficacy|13|||
13489606|NCT01706705|27049131|FG000|Overall Study|Non-clinical|6|||
13489607|NCT01609842|27049166|FG000|Concurrent Intervention Control|pharmacy data not available|2|||
13489608|NCT01609842|27049167|FG001|Concurrent Intervention Control|pharmacy data not available|0|||
13489609|NCT00003479|27049203|FG000|Overall Study|Not evaluable|3|||
13489518|NCT02987959|27048735|FG000|Overall Study|Grantor stopped supply of drugs|6|||
13489519|NCT02382406|27049002|FG000|Study Treatment|Disease Progression|8|||
13489520|NCT02382406|27049003|FG001|Study Treatment|Disease Progression|0|||
13489521|NCT02382406|27049004|FG002|Study Treatment|Disease Progression|20|||
13489522|NCT02382406|27049002|FG000|Study Treatment|AE/ Side Effects/ Complications|4|||
13489523|NCT02382406|27049003|FG001|Study Treatment|AE/ Side Effects/ Complications|0|||
13489524|NCT02382406|27049004|FG002|Study Treatment|AE/ Side Effects/ Complications|6|||
13381351|NCT00753922|26747933|FG002|Overall Study|Discontinuation Due to Explantation|14|||
13381352|NCT00753922|26747934|FG003|Overall Study|Discontinuation Due to Explantation|4|||
13381353|NCT00753896|26747950|FG000|Overall Study|Adverse Event|4|||
13381354|NCT00753896|26747950|FG000|Overall Study|Death|1|||
13489525|NCT02382406|27049002|FG000|Study Treatment|Patient withdrawal after therapy start|1|||
13489526|NCT02382406|27049003|FG001|Study Treatment|Patient withdrawal after therapy start|0|||
13489527|NCT02382406|27049004|FG002|Study Treatment|Patient withdrawal after therapy start|1|||
13489528|NCT02382406|27049002|FG000|Study Treatment|symptomatic deterioration|1|||
13489529|NCT02382406|27049003|FG001|Study Treatment|symptomatic deterioration|0|||
13489530|NCT02382406|27049004|FG002|Study Treatment|symptomatic deterioration|1|||
13489531|NCT02382406|27049002|FG000|Study Treatment|Death|0|||
13489532|NCT02382406|27049003|FG001|Study Treatment|Death|0|||
13489533|NCT02382406|27049004|FG002|Study Treatment|Death|2|||
13489534|NCT02382406|27049002|FG000|Follow up|Death|11|||
13489535|NCT02382406|27049003|FG001|Follow up|Death|0|||
13489536|NCT02382406|27049004|FG002|Follow up|Death|19|||
13489537|NCT02382406|27049002|FG000|Follow up|Symptomatic deterioration|1|||
13489538|NCT02382406|27049003|FG001|Follow up|Symptomatic deterioration|0|||
13489539|NCT02382406|27049004|FG002|Follow up|Symptomatic deterioration|1|||
13489540|NCT02382406|27049002|FG000|Follow up|Patient Refused Follow-up|1|||
13489541|NCT02382406|27049003|FG001|Follow up|Patient Refused Follow-up|0|||
13489542|NCT02382406|27049004|FG002|Follow up|Patient Refused Follow-up|0|||
13489543|NCT02382406|27049002|FG000|Follow up|Study Terminated|1|||
13489544|NCT02382406|27049003|FG001|Follow up|Study Terminated|0|||
13489545|NCT02382406|27049004|FG002|Follow up|Study Terminated|8|||
13489546|NCT02382406|27049002|FG000|Follow up|Withdrawal by Subject|0|||
13489547|NCT02382406|27049003|FG001|Follow up|Withdrawal by Subject|0|||
13489548|NCT02382406|27049004|FG002|Follow up|Withdrawal by Subject|2|||
13489549|NCT02297516|27049052|FG000|Single Treatment Phase (6 Months)|Medical reason|1|||
13489550|NCT02297516|27049053|FG001|Single Treatment Phase (6 Months)|Medical reason|0|||
13489551|NCT02297516|27049052|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0|||
13489552|NCT02297516|27049053|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2|||
13489553|NCT02297516|27049052|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0|||
13489554|NCT02297516|27049053|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1|||
13489555|NCT00774930|27049086|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11|||
13489556|NCT00774930|27049087|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12|||
13489557|NCT00774930|27049086|FG000|DB Phase|Adverse Event|1|||
13489558|NCT00774930|27049087|FG001|DB Phase|Adverse Event|2|||
13489559|NCT00774930|27049086|FG000|DB Phase|Subject Decision|1|||
13489560|NCT00774930|27049087|FG001|DB Phase|Subject Decision|5|||
13489561|NCT00774930|27049086|FG000|DB Phase|Sponsor Decision|0|||
13489562|NCT00774930|27049087|FG001|DB Phase|Sponsor Decision|1|||
13489563|NCT00774930|27049086|FG000|DB Phase|Disease Progression|1|||
13489564|NCT00774930|27049087|FG001|DB Phase|Disease Progression|1|||
13489565|NCT00774930|27049086|FG000|DB Phase|Started Nonprotocol Radiation therapy|0|||
13489566|NCT00774930|27049087|FG001|DB Phase|Started Nonprotocol Radiation therapy|1|||
13489567|NCT00774930|27049086|FG000|IOL Phase|Adverse Event|1|||
13489568|NCT00774930|27049087|FG001|IOL Phase|Adverse Event|1|||
13489569|NCT00774930|27049086|FG000|IOL Phase|Subject Decision|4|||
13489570|NCT00774930|27049087|FG001|IOL Phase|Subject Decision|3|||
13489571|NCT00774930|27049086|FG000|IOL Phase|Physician Decision|3|||
13489572|NCT00774930|27049087|FG001|IOL Phase|Physician Decision|2|||
13489573|NCT00774930|27049086|FG000|IOL Phase|Sponsor Decision|1|||
13489574|NCT00774930|27049087|FG001|IOL Phase|Sponsor Decision|0|||
13489575|NCT00774930|27049086|FG000|IOL Phase|Disease Progression|2|||
13489576|NCT00774930|27049087|FG001|IOL Phase|Disease Progression|1|||
13489577|NCT00774930|27049086|FG000|IOL Phase|Subject Consumed Prohibited Medication|1|||
13489578|NCT00774930|27049087|FG001|IOL Phase|Subject Consumed Prohibited Medication|0|||
13489579|NCT00774930|27049086|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0|||
13489580|NCT00774930|27049087|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1|||
13489581|NCT00774930|27049086|FG000|IOL Phase|Other|1|||
13489582|NCT00774930|27049087|FG001|IOL Phase|Other|0|||
13489583|NCT00774930|27049086|FG000|IOL Phase|Brain radiation|0|||
13489584|NCT00774930|27049087|FG001|IOL Phase|Brain radiation|1|||
13489585|NCT00774930|27049086|FG000|LTOLE Phase|Adverse Event|7|||
13489586|NCT00774930|27049087|FG001|LTOLE Phase|Adverse Event|3|||
13489587|NCT00774930|27049086|FG000|LTOLE Phase|Subject decision|0|||
13489588|NCT00774930|27049087|FG001|LTOLE Phase|Subject decision|5|||
13489589|NCT00774930|27049086|FG000|LTOLE Phase|Physician Decision|4|||
13489590|NCT00774930|27049087|FG001|LTOLE Phase|Physician Decision|1|||
13381355|NCT00753896|26747950|FG000|Overall Study|Lost to Follow-up|2|||
13489610|NCT04223778|27049276|FG000|Overall Study|Ongoing|322|||
13489611|NCT04223778|27049277|FG001|Overall Study|Ongoing|326|||
13489612|NCT04223778|27049276|FG000|Overall Study|Death|0|||
13489613|NCT04223778|27049277|FG001|Overall Study|Death|1|||
13489614|NCT04223778|27049276|FG000|Overall Study|Lost to Follow-up|1|||
13489615|NCT04223778|27049277|FG001|Overall Study|Lost to Follow-up|5|||
13489616|NCT04223778|27049276|FG000|Overall Study|Physician Decision|3|||
13489617|NCT04223778|27049277|FG001|Overall Study|Physician Decision|1|||
13489618|NCT04223778|27049276|FG000|Overall Study|Withdrawal by Subject|10|||
13489619|NCT04223778|27049277|FG001|Overall Study|Withdrawal by Subject|1|||
13489620|NCT04223778|27049276|FG000|Overall Study|Lack of Efficacy|0|||
13489621|NCT04223778|27049277|FG001|Overall Study|Lack of Efficacy|2|||
13489622|NCT04153929|27049360|FG000|Overall Study|Other than listed|2|||
13489623|NCT04153929|27049361|FG001|Overall Study|Other than listed|2|||
13489624|NCT04153929|27049362|FG002|Overall Study|Other than listed|0|||
13489625|NCT04153929|27049363|FG003|Overall Study|Other than listed|1|||
13489626|NCT04153929|27049364|FG004|Overall Study|Other than listed|0|||
13489627|NCT04153929|27049365|FG005|Overall Study|Other than listed|2|||
13489628|NCT04153929|27049366|FG006|Overall Study|Other than listed|2|||
13489629|NCT04153929|27049367|FG007|Overall Study|Other than listed|1|||
13489630|NCT04153929|27049360|FG000|Overall Study|Lost to Follow-up|2|||
13489631|NCT04153929|27049361|FG001|Overall Study|Lost to Follow-up|1|||
13489632|NCT04153929|27049362|FG002|Overall Study|Lost to Follow-up|0|||
13489633|NCT04153929|27049363|FG003|Overall Study|Lost to Follow-up|1|||
13489634|NCT04153929|27049364|FG004|Overall Study|Lost to Follow-up|1|||
13489635|NCT04153929|27049365|FG005|Overall Study|Lost to Follow-up|0|||
13489636|NCT04153929|27049366|FG006|Overall Study|Lost to Follow-up|0|||
13489637|NCT04153929|27049367|FG007|Overall Study|Lost to Follow-up|0|||
13489638|NCT04153929|27049360|FG000|Overall Study|Withdrawal by Subject|3|||
13489639|NCT04153929|27049361|FG001|Overall Study|Withdrawal by Subject|1|||
13489640|NCT04153929|27049362|FG002|Overall Study|Withdrawal by Subject|0|||
13489641|NCT04153929|27049363|FG003|Overall Study|Withdrawal by Subject|3|||
13489642|NCT04153929|27049364|FG004|Overall Study|Withdrawal by Subject|1|||
13489643|NCT04153929|27049365|FG005|Overall Study|Withdrawal by Subject|0|||
13489644|NCT04153929|27049366|FG006|Overall Study|Withdrawal by Subject|1|||
13489645|NCT04153929|27049367|FG007|Overall Study|Withdrawal by Subject|0|||
13489646|NCT04153929|27049360|FG000|Overall Study|Protocol Violation|0|||
13489647|NCT04153929|27049361|FG001|Overall Study|Protocol Violation|0|||
13489648|NCT04153929|27049362|FG002|Overall Study|Protocol Violation|0|||
13489649|NCT04153929|27049363|FG003|Overall Study|Protocol Violation|0|||
13489650|NCT04153929|27049364|FG004|Overall Study|Protocol Violation|0|||
13489651|NCT04153929|27049365|FG005|Overall Study|Protocol Violation|0|||
13489652|NCT04153929|27049366|FG006|Overall Study|Protocol Violation|1|||
13489653|NCT04153929|27049367|FG007|Overall Study|Protocol Violation|2|||
13489654|NCT04153929|27049360|FG000|Overall Study|Adverse Event|3|||
13489655|NCT04153929|27049361|FG001|Overall Study|Adverse Event|5|||
13489656|NCT04153929|27049362|FG002|Overall Study|Adverse Event|5|||
13489657|NCT04153929|27049363|FG003|Overall Study|Adverse Event|11|||
13489658|NCT04153929|27049364|FG004|Overall Study|Adverse Event|15|||
13489659|NCT04153929|27049365|FG005|Overall Study|Adverse Event|4|||
13489660|NCT04153929|27049366|FG006|Overall Study|Adverse Event|8|||
13489661|NCT04153929|27049367|FG007|Overall Study|Adverse Event|2|||
13489662|NCT04153929|27049360|FG000|Overall Study|Not treated|1|||
13489663|NCT04153929|27049361|FG001|Overall Study|Not treated|0|||
13489664|NCT04153929|27049362|FG002|Overall Study|Not treated|0|||
13489665|NCT04153929|27049363|FG003|Overall Study|Not treated|0|||
13489666|NCT04153929|27049364|FG004|Overall Study|Not treated|0|||
13489667|NCT04153929|27049365|FG005|Overall Study|Not treated|0|||
13489668|NCT04153929|27049366|FG006|Overall Study|Not treated|1|||
13489669|NCT04153929|27049367|FG007|Overall Study|Not treated|0|||
13489670|NCT03478956|27049454|FG000|Overall Study|Adverse Event|1|||
13207520|NCT01947283|26238166|FG006|Overall Study|Death|0|||
13394504|NCT00657046|26787224|FG001|Overall Study|Protocol Violation|2|||
13489671|NCT03478956|27049455|FG001|Overall Study|Adverse Event|0|||
13489672|NCT03478956|27049454|FG000|Overall Study|Withdrawal by Subject|0|||
13489673|NCT03478956|27049455|FG001|Overall Study|Withdrawal by Subject|1|||
13489674|NCT03478956|27049454|FG000|Overall Study|Ongoing in the Study|11|||
13489675|NCT03478956|27049455|FG001|Overall Study|Ongoing in the Study|11|||
13489676|NCT03326193|27049490|FG000|Overall Study|Treatment ongoing at the time of analysis|26|||
13489677|NCT03326193|27049490|FG000|Overall Study|Death|19|||
13489678|NCT03326193|27049490|FG000|Overall Study|Withdrawal by Subject|8|||
13489679|NCT02960763|27049616|FG000|Step 1|Withdrawal by Subject|10|||
13489680|NCT02960763|27049617|FG001|Step 1|Withdrawal by Subject|8|||
13489681|NCT02960763|27049618|FG002|Step 1|Withdrawal by Subject|13|||
13489682|NCT02960763|27049619|FG003|Step 1|Withdrawal by Subject|0|||
13489683|NCT02960763|27049620|FG004|Step 1|Withdrawal by Subject|0|||
13489684|NCT02960763|27049616|FG000|Step 1|Lost to Follow-up|7|||
13489685|NCT02960763|27049617|FG001|Step 1|Lost to Follow-up|9|||
13489686|NCT02960763|27049618|FG002|Step 1|Lost to Follow-up|12|||
13207521|NCT01947283|26238160|FG000|Overall Study|Lost to Follow-up|4|||
13489687|NCT02960763|27049619|FG003|Step 1|Lost to Follow-up|0|||
13296257|NCT01371708|26496109|FG002|Overall Study|No longer willing to participate|13|||
13296258|NCT01371708|26496107|FG000|Overall Study|Medication error/not related to AE|0|||
13489688|NCT02960763|27049620|FG004|Step 1|Lost to Follow-up|0|||
13489689|NCT02960763|27049616|FG000|Step 1|Death|1|||
13489690|NCT02960763|27049617|FG001|Step 1|Death|1|||
13489691|NCT02960763|27049618|FG002|Step 1|Death|1|||
13489692|NCT02960763|27049619|FG003|Step 1|Death|0|||
13489693|NCT02960763|27049620|FG004|Step 1|Death|0|||
13489694|NCT02960763|27049616|FG000|Step 1|Investigator discretion|1|||
13489695|NCT02960763|27049617|FG001|Step 1|Investigator discretion|0|||
13489696|NCT02960763|27049618|FG002|Step 1|Investigator discretion|1|||
13489697|NCT02960763|27049619|FG003|Step 1|Investigator discretion|0|||
13489698|NCT02960763|27049620|FG004|Step 1|Investigator discretion|0|||
13489699|NCT02960763|27049616|FG000|Step 1|Other|0|||
13489700|NCT02960763|27049617|FG001|Step 1|Other|0|||
13489701|NCT02960763|27049618|FG002|Step 1|Other|1|||
13489702|NCT02960763|27049619|FG003|Step 1|Other|0|||
13489703|NCT02960763|27049620|FG004|Step 1|Other|0|||
13296259|NCT01371708|26496108|FG001|Overall Study|Medication error/not related to AE|1|||
13296260|NCT01371708|26496109|FG002|Overall Study|Medication error/not related to AE|0|||
13296261|NCT01371708|26496107|FG000|Overall Study|Other|3|||
13296262|NCT01371708|26496108|FG001|Overall Study|Other|2|||
13296263|NCT01371708|26496109|FG002|Overall Study|Other|4|||
13296264|NCT01371708|26496107|FG000|Overall Study|Adverse Event|5|||
13296265|NCT01371708|26496108|FG001|Overall Study|Adverse Event|8|||
13296266|NCT01371708|26496109|FG002|Overall Study|Adverse Event|12|||
13296267|NCT01371708|26496107|FG000|Overall Study|Started but did not receive treatment|1|||
13296268|NCT01371708|26496108|FG001|Overall Study|Started but did not receive treatment|0|||
13296269|NCT01371708|26496109|FG002|Overall Study|Started but did not receive treatment|1|||
13296270|NCT01371656|26496134|FG000|Overall Study|Death|7|||
13296271|NCT01371656|26496135|FG001|Overall Study|Death|4|||
13394505|NCT00657046|26787225|FG002|Overall Study|Protocol Violation|0|||
13489704|NCT02960763|27049616|FG000|Step 2|Withdrawal by Subject|0|||
13489705|NCT02960763|27049617|FG001|Step 2|Withdrawal by Subject|0|||
13489706|NCT02960763|27049618|FG002|Step 2|Withdrawal by Subject|0|||
13489707|NCT02960763|27049619|FG003|Step 2|Withdrawal by Subject|7|||
13489708|NCT02960763|27049620|FG004|Step 2|Withdrawal by Subject|3|||
13489709|NCT02960763|27049616|FG000|Step 2|Lost to Follow-up|0|||
13489710|NCT02960763|27049617|FG001|Step 2|Lost to Follow-up|0|||
13489711|NCT02960763|27049618|FG002|Step 2|Lost to Follow-up|0|||
13489712|NCT02960763|27049619|FG003|Step 2|Lost to Follow-up|4|||
13489713|NCT02960763|27049620|FG004|Step 2|Lost to Follow-up|1|||
13489714|NCT02960763|27049616|FG000|Step 2|Investigator discretion|0|||
13489715|NCT02960763|27049617|FG001|Step 2|Investigator discretion|0|||
13489716|NCT02960763|27049618|FG002|Step 2|Investigator discretion|0|||
13489717|NCT02960763|27049619|FG003|Step 2|Investigator discretion|0|||
13489718|NCT02960763|27049620|FG004|Step 2|Investigator discretion|1|||
13489719|NCT02770716|27049643|FG000|Overall Study|Death|101|||
13489720|NCT02770716|27049644|FG001|Overall Study|Death|45|||
13489721|NCT02770716|27049643|FG000|Overall Study|Withdrawal by Subject|4|||
13489722|NCT02770716|27049644|FG001|Overall Study|Withdrawal by Subject|2|||
13489723|NCT02770716|27049643|FG000|Overall Study|Lost to Follow-up|1|||
13489724|NCT02770716|27049644|FG001|Overall Study|Lost to Follow-up|0|||
13489725|NCT02770716|27049643|FG000|Overall Study|Various reasons|6|||
13489726|NCT02770716|27049644|FG001|Overall Study|Various reasons|2|||
13489727|NCT02732210|27049667|FG000|Overall Study|Site Closed|0|||
13489728|NCT02732210|27049668|FG001|Overall Study|Site Closed|11|||
13489729|NCT02732210|27049667|FG000|Overall Study|Study Ended|13|||
13489730|NCT02732210|27049668|FG001|Overall Study|Study Ended|13|||
13489731|NCT02732210|27049667|FG000|Overall Study|Withdrawal by Subject|28|||
13489732|NCT02732210|27049668|FG001|Overall Study|Withdrawal by Subject|87|||
13489733|NCT02732210|27049667|FG000|Overall Study|Lost to Follow-up|5|||
13489734|NCT02732210|27049668|FG001|Overall Study|Lost to Follow-up|57|||
13489735|NCT02732210|27049667|FG000|Overall Study|Death|4|||
13489736|NCT02732210|27049668|FG001|Overall Study|Death|15|||
13489737|NCT02732210|27049667|FG000|Overall Study|Other|35|||
13489738|NCT02732210|27049668|FG001|Overall Study|Other|103|||
13489739|NCT02732210|27049667|FG000|Overall Study|Missing|0|||
13489740|NCT02732210|27049668|FG001|Overall Study|Missing|8|||
13489741|NCT02680587|27049713|FG000|Overall Study|Withdrawal by Subject|1|||
13489742|NCT02680587|27049714|FG001|Overall Study|Withdrawal by Subject|0|||
13489743|NCT02655016|27049753|FG000|Overall Study|Disease progression|6|||
13489744|NCT02655016|27049754|FG001|Overall Study|Disease progression|4|||
13489745|NCT02655016|27049753|FG000|Overall Study|Site closed|0|||
13489746|NCT02655016|27049754|FG001|Overall Study|Site closed|1|||
13489747|NCT02655016|27049753|FG000|Overall Study|Death|30|||
13489748|NCT02655016|27049754|FG001|Overall Study|Death|48|||
13296272|NCT01371656|26496134|FG000|Overall Study|Physician Decision|46|||
13296273|NCT01371656|26496135|FG001|Overall Study|Physician Decision|7|||
13296274|NCT01371656|26496134|FG000|Overall Study|Withdrawal by Subject|7|||
13489749|NCT02655016|27049753|FG000|Overall Study|Lost to Follow-up|1|||
13489750|NCT02655016|27049754|FG001|Overall Study|Lost to Follow-up|1|||
13489751|NCT02655016|27049753|FG000|Overall Study|Withdrawal by Subject|18|||
13489752|NCT02655016|27049754|FG001|Overall Study|Withdrawal by Subject|36|||
13489753|NCT02243605|27049813|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
13489754|NCT02243605|27049814|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
13489755|NCT02243605|27049813|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1|||
13489756|NCT02243605|27049814|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0|||
13489757|NCT02243605|27049813|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5|||
13489758|NCT02243605|27049814|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1|||
13489759|NCT02243605|27049813|FG000|Stage 2 - Final Analysis Population|Adverse Event|1|||
13489760|NCT02243605|27049814|FG001|Stage 2 - Final Analysis Population|Adverse Event|1|||
13489761|NCT02243605|27049813|FG000|Stage 2 - Final Analysis Population|Progression|0|||
13489762|NCT02243605|27049814|FG001|Stage 2 - Final Analysis Population|Progression|1|||
13489763|NCT01995175|27049848|FG000|Period 1 - From 0 up to 2 Years of Age|Withdrawal by Subject|35|||
13489764|NCT01995175|27049848|FG000|Period 1 - From 0 up to 2 Years of Age|Lost to Follow-up|102|||
13489765|NCT01995175|27049848|FG000|Period 1 - From 0 up to 2 Years of Age|Other|67|||
13489766|NCT01995175|27049848|FG000|Period 1 - From 0 up to 2 Years of Age|Migrated / moved from the study area|49|||
13489767|NCT01995175|27049848|FG000|Period 2 - From 2 up to 6 Years of Age|Other|21|||
13489768|NCT01995175|27049848|FG000|Period 2 - From 2 up to 6 Years of Age|Lost to Follow-up|22|||
13489769|NCT01995175|27049848|FG000|Period 2 - From 2 up to 6 Years of Age|Migrated/moved from the study area|6|||
13489770|NCT01995175|27049848|FG000|Period 2 - From 2 up to 6 Years of Age|Consent withdrawal, not due to a Serious Adverse Event|7|||
13489771|NCT01995175|27049848|FG000|Period 2 - From 2 up to 6 Years of Age|Protocol Violation|1|||
13489772|NCT01752907|27049873|FG000|Overall Study|Withdrawal by Subject|4|||
13489773|NCT01752907|27049874|FG001|Overall Study|Withdrawal by Subject|10|||
13489774|NCT01752907|27049873|FG000|Overall Study|Lost to Follow-up|2|||
13489775|NCT01752907|27049874|FG001|Overall Study|Lost to Follow-up|1|||
13489776|NCT01752907|27049873|FG000|Overall Study|Decision by Sponsor|6|||
13489777|NCT01752907|27049874|FG001|Overall Study|Decision by Sponsor|9|||
13489778|NCT01705977|27049899|FG000|Overall Study|Withdrawal by Subject|128|||
13489779|NCT01705977|27049900|FG001|Overall Study|Withdrawal by Subject|128|||
13489780|NCT01705977|27049899|FG000|Overall Study|Adverse Event|57|||
13489781|NCT01705977|27049900|FG001|Overall Study|Adverse Event|49|||
13489782|NCT01705977|27049899|FG000|Overall Study|Protocol Violation|2|||
13489783|NCT01705977|27049900|FG001|Overall Study|Protocol Violation|4|||
13489784|NCT01705977|27049899|FG000|Overall Study|Site closure|3|||
13489785|NCT01705977|27049900|FG001|Overall Study|Site closure|2|||
13489786|NCT01705977|27049899|FG000|Overall Study|Lost to Follow-up|33|||
13489787|NCT01705977|27049900|FG001|Overall Study|Lost to Follow-up|37|||
13489788|NCT01705977|27049899|FG000|Overall Study|Physician Decision|48|||
13489789|NCT01705977|27049900|FG001|Overall Study|Physician Decision|38|||
13489790|NCT01705977|27049899|FG000|Overall Study|Missing study conclusion form|2|||
13489791|NCT01705977|27049900|FG001|Overall Study|Missing study conclusion form|2|||
13489792|NCT01143246|27049921|FG000|Overall Study|Adverse Event|24|||
13489793|NCT01143246|27049922|FG001|Overall Study|Adverse Event|28|||
13489794|NCT01143246|27049921|FG000|Overall Study|Participant Withdrew Informed Consent|2|||
13489795|NCT01143246|27049922|FG001|Overall Study|Participant Withdrew Informed Consent|2|||
13489796|NCT01143246|27049921|FG000|Overall Study|Lost to Follow-up|0|||
13489797|NCT01143246|27049922|FG001|Overall Study|Lost to Follow-up|1|||
13489798|NCT01143246|27049921|FG000|Overall Study|Death|16|||
13489799|NCT01143246|27049922|FG001|Overall Study|Death|15|||
13489800|NCT01143246|27049921|FG000|Overall Study|Reason not Specified|3|||
13489801|NCT01143246|27049922|FG001|Overall Study|Reason not Specified|5|||
13489802|NCT00436748|27050030|FG000|Overall Study|Ineligibility Determined|1|||
13489803|NCT00436748|27050031|FG001|Overall Study|Ineligibility Determined|1|||
13489804|NCT00436748|27050030|FG000|Overall Study|Adverse Event|0|||
13489805|NCT00436748|27050031|FG001|Overall Study|Adverse Event|2|||
13489806|NCT00436748|27050030|FG000|Overall Study|Consent Withdrawn|1|||
13489807|NCT00436748|27050031|FG001|Overall Study|Consent Withdrawn|4|||
13489808|NCT00436748|27050030|FG000|Overall Study|Administrative Decision|1|||
13489809|NCT00436748|27050031|FG001|Overall Study|Administrative Decision|0|||
13489810|NCT00436748|27050030|FG000|Overall Study|Lost to Follow-up|0|||
13489811|NCT00436748|27050031|FG001|Overall Study|Lost to Follow-up|1|||
13489812|NCT00436748|27050030|FG000|Overall Study|Protocol-specified Criteria|5|||
13489813|NCT00436748|27050031|FG001|Overall Study|Protocol-specified Criteria|4|||
13489814|NCT00436748|27050030|FG000|Overall Study|Other|3|||
13489815|NCT00436748|27050031|FG001|Overall Study|Other|0|||
13489816|NCT04160195|27050103|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1|||
13489817|NCT04160195|27050104|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0|||
13489818|NCT04159701|27050130|FG000|Period 1: Treatment Period|Pregnancy|1|||
13489819|NCT04159701|27050131|FG001|Period 1: Treatment Period|Pregnancy|0|||
13489820|NCT04159701|27050130|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4|||
13489821|NCT04159701|27050131|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1|||
13489822|NCT04159701|27050130|FG000|Period 1: Treatment Period|Withdrawal by Subject|3|||
13489823|NCT04159701|27050131|FG001|Period 1: Treatment Period|Withdrawal by Subject|0|||
13489824|NCT04159701|27050130|FG000|Washout Period|site terminated by sponsor|0|||
13489825|NCT04159701|27050131|FG001|Washout Period|site terminated by sponsor|1|||
13489826|NCT04159701|27050130|FG000|Washout Period|study terminated by sponsor|10|||
13489827|NCT04159701|27050131|FG001|Washout Period|study terminated by sponsor|3|||
13489828|NCT04159701|27050130|FG000|Washout Period|Withdrawal by Subject|1|||
13489829|NCT04159701|27050131|FG001|Washout Period|Withdrawal by Subject|0|||
13489830|NCT04159701|27050130|FG000|Washout Period|Inadvertent Enrollment|1|||
13489831|NCT04159701|27050131|FG001|Washout Period|Inadvertent Enrollment|0|||
13489832|NCT04159701|27050130|FG000|Washout Period|Miscellaneous|1|||
13489833|NCT04159701|27050131|FG001|Washout Period|Miscellaneous|0|||
13489834|NCT04159701|27050130|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0|||
13489835|NCT04159701|27050131|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2|||
13489836|NCT04159701|27050130|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0|||
13489837|NCT04159701|27050131|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1|||
13489838|NCT04159701|27050130|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6|||
13489839|NCT04159701|27050131|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3|||
13489840|NCT04159701|27050130|FG000|Post-treatment Follow-up|Withdrawal by Subject|3|||
13489841|NCT04159701|27050131|FG001|Post-treatment Follow-up|Withdrawal by Subject|0|||
13489842|NCT04159701|27050130|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1|||
13489843|NCT04159701|27050131|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0|||
13489844|NCT04152447|27050148|FG000|Overall Study|Lost to Follow-up|1|||
13489845|NCT04152447|27050149|FG001|Overall Study|Lost to Follow-up|0|||
13489846|NCT04152447|27050148|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1|||
13489847|NCT04152447|27050149|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1|||
13489848|NCT04152447|27050148|FG000|Overall Study|Withdrawal by Subject|0|||
13489849|NCT04152447|27050149|FG001|Overall Study|Withdrawal by Subject|1|||
13489850|NCT04152447|27050148|FG000|Overall Study|Found ineligible after enrolling|1|||
13489851|NCT04152447|27050149|FG001|Overall Study|Found ineligible after enrolling|1|||
13489852|NCT04152447|27050148|FG000|Overall Study|Did not receive VR headset in time.|0|||
13489853|NCT04152447|27050149|FG001|Overall Study|Did not receive VR headset in time.|2|||
13489854|NCT04150107|27050179|FG000|Period 3 Crossover-Treatment B or A|Adverse Event|2|||
13489855|NCT04150107|27050180|FG001|Period 3 Crossover-Treatment B or A|Adverse Event|0|||
13489856|NCT04150107|27050179|FG000|Period 3 Crossover-Treatment B or A|Patient non-compliance|0|||
13489857|NCT04150107|27050180|FG001|Period 3 Crossover-Treatment B or A|Patient non-compliance|1|||
13489858|NCT04450394|27050209|FG000|Overall Study|Adverse Event|2|||
13489859|NCT04450394|27050210|FG001|Overall Study|Adverse Event|0|||
13489860|NCT04450394|27050211|FG002|Overall Study|Adverse Event|0|||
13489861|NCT04450394|27050209|FG000|Overall Study|Death|0|||
13489862|NCT04450394|27050210|FG001|Overall Study|Death|1|||
13489863|NCT04450394|27050211|FG002|Overall Study|Death|0|||
13489864|NCT04450394|27050209|FG000|Overall Study|Lost to Follow-up|0|||
13489865|NCT04450394|27050210|FG001|Overall Study|Lost to Follow-up|3|||
13489866|NCT04450394|27050211|FG002|Overall Study|Lost to Follow-up|0|||
13489867|NCT04450394|27050209|FG000|Overall Study|Physician Decision|0|||
13489868|NCT04450394|27050210|FG001|Overall Study|Physician Decision|1|||
13489869|NCT04450394|27050211|FG002|Overall Study|Physician Decision|0|||
13489870|NCT04450394|27050209|FG000|Overall Study|Protocol Violation|2|||
13489871|NCT04450394|27050210|FG001|Overall Study|Protocol Violation|0|||
13489872|NCT04450394|27050211|FG002|Overall Study|Protocol Violation|0|||
13489873|NCT04450394|27050209|FG000|Overall Study|Withdrawal by Subject|6|||
13489874|NCT04450394|27050210|FG001|Overall Study|Withdrawal by Subject|9|||
13489875|NCT04450394|27050211|FG002|Overall Study|Withdrawal by Subject|0|||
13489922|NCT03553836|27050455|FG000|Overall Study|Ongoing in Study|460|||
13489923|NCT03553836|27050456|FG001|Overall Study|Ongoing in Study|459|||
13489924|NCT03553836|27050455|FG000|Overall Study|Withdrawal by Subject|9|||
13489925|NCT03553836|27050456|FG001|Overall Study|Withdrawal by Subject|10|||
13489926|NCT03553836|27050455|FG000|Overall Study|Lost to Follow-up|1|||
13489927|NCT03553836|27050456|FG001|Overall Study|Lost to Follow-up|3|||
13489928|NCT03553836|27050455|FG000|Overall Study|Death|17|||
13489929|NCT03553836|27050456|FG001|Overall Study|Death|17|||
13489930|NCT03307785|27050788|FG000|Part A: Up to 28.5 Months|Disease progression|2|||
13489931|NCT03307785|27050789|FG001|Part A: Up to 28.5 Months|Disease progression|0|||
13489932|NCT03307785|27050790|FG002|Part A: Up to 28.5 Months|Disease progression|0|||
13489933|NCT03307785|27050791|FG003|Part A: Up to 28.5 Months|Disease progression|0|||
13489876|NCT04167462|27050244|FG000|Overall Study|Other reasons|1|||
13489877|NCT04167462|27050245|FG001|Overall Study|Other reasons|0|||
13489878|NCT04167462|27050244|FG000|Overall Study|Adverse Event|2|||
13489879|NCT04167462|27050245|FG001|Overall Study|Adverse Event|0|||
13489880|NCT04167462|27050244|FG000|Overall Study|Withdrawal by Subject|2|||
13489881|NCT04167462|27050245|FG001|Overall Study|Withdrawal by Subject|6|||
13489882|NCT04060212|27050253|FG000|Overall Study|Withdrawal by Subject|7|||
13489883|NCT04033367|27050296|FG000|DB Period (Up to Week 12)|Adverse Event|1|||
13489884|NCT04033367|27050297|FG001|DB Period (Up to Week 12)|Adverse Event|1|||
13489885|NCT04033367|27050296|FG000|DB Period (Up to Week 12)|Withdrawal by Subject|4|||
13489886|NCT04033367|27050297|FG001|DB Period (Up to Week 12)|Withdrawal by Subject|0|||
13489887|NCT04033367|27050296|FG000|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|4|||
13489888|NCT04033367|27050297|FG001|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|1|||
13489889|NCT04033367|27050296|FG000|OLE Period (Week 12 to Week 24)|Other-unspecified|1|||
13489890|NCT04033367|27050297|FG001|OLE Period (Week 12 to Week 24)|Other-unspecified|0|||
13489891|NCT03927105|27050313|FG000|Overall Study|Death|1|||
13489892|NCT03927105|27050313|FG000|Overall Study|In observation for potential re-treatment|2|||
13489893|NCT03927105|27050313|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1|||
13489894|NCT03920254|27050331|FG000|Overall Study|Adverse Event|1|||
13489895|NCT03920254|27050332|FG001|Overall Study|Adverse Event|0|||
13489896|NCT03920254|27050333|FG002|Overall Study|Adverse Event|0|||
13489897|NCT03920254|27050331|FG000|Overall Study|Physician Decision|0|||
13489898|NCT03920254|27050332|FG001|Overall Study|Physician Decision|1|||
13489899|NCT03920254|27050333|FG002|Overall Study|Physician Decision|2|||
13489900|NCT03920254|27050331|FG000|Overall Study|Study Terminated By Sponsor|12|||
13489901|NCT03920254|27050332|FG001|Overall Study|Study Terminated By Sponsor|17|||
13489902|NCT03920254|27050333|FG002|Overall Study|Study Terminated By Sponsor|12|||
13489903|NCT03920254|27050331|FG000|Overall Study|Withdrawal by Subject|0|||
13489904|NCT03920254|27050332|FG001|Overall Study|Withdrawal by Subject|0|||
13489905|NCT03920254|27050333|FG002|Overall Study|Withdrawal by Subject|1|||
13489906|NCT03704064|27050416|FG000|Overall Study|Lost to Follow-up|8|||
13489907|NCT03704064|27050417|FG001|Overall Study|Lost to Follow-up|4|||
13489908|NCT03704064|27050416|FG000|Overall Study|Withdrawal by Subject|1|||
13489909|NCT03704064|27050417|FG001|Overall Study|Withdrawal by Subject|1|||
13489910|NCT03704064|27050416|FG000|Overall Study|No longer available for study visits|0|||
13489911|NCT03704064|27050417|FG001|Overall Study|No longer available for study visits|1|||
13489912|NCT03704064|27050416|FG000|Overall Study|Censoring event|1|||
13489913|NCT03704064|27050417|FG001|Overall Study|Censoring event|0|||
13489914|NCT03631784|27050436|FG000|Overall Study|Death|48|||
13489915|NCT03631784|27050437|FG001|Overall Study|Death|28|||
13489916|NCT03631784|27050436|FG000|Overall Study|Lost to Follow-up|1|||
13489917|NCT03631784|27050437|FG001|Overall Study|Lost to Follow-up|0|||
13489918|NCT03631784|27050436|FG000|Overall Study|Withdrawal by Subject|0|||
13489919|NCT03631784|27050437|FG001|Overall Study|Withdrawal by Subject|3|||
13489920|NCT03631784|27050436|FG000|Overall Study|Participants Ongoing|63|||
13489921|NCT03631784|27050437|FG001|Overall Study|Participants Ongoing|71|||
13489934|NCT03307785|27050792|FG004|Part A: Up to 28.5 Months|Disease progression|0|||
13489935|NCT03307785|27050793|FG005|Part A: Up to 28.5 Months|Disease progression|0|||
13489936|NCT03307785|27050794|FG006|Part A: Up to 28.5 Months|Disease progression|0|||
13489937|NCT03307785|27050795|FG007|Part A: Up to 28.5 Months|Disease progression|0|||
13489938|NCT03307785|27050796|FG008|Part A: Up to 28.5 Months|Disease progression|0|||
13489939|NCT03307785|27050797|FG009|Part A: Up to 28.5 Months|Disease progression|0|||
13489940|NCT03307785|27050798|FG010|Part A: Up to 28.5 Months|Disease progression|0|||
13489941|NCT03307785|27050788|FG000|Part A: Up to 28.5 Months|Withdrawal by Subject|7|||
13489942|NCT03307785|27050789|FG001|Part A: Up to 28.5 Months|Withdrawal by Subject|1|||
13489943|NCT03307785|27050790|FG002|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
13489944|NCT03307785|27050791|FG003|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
13489945|NCT03307785|27050792|FG004|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
13489946|NCT03307785|27050793|FG005|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
13489947|NCT03307785|27050794|FG006|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
13489948|NCT03307785|27050795|FG007|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
13489949|NCT03307785|27050796|FG008|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
13489950|NCT03307785|27050797|FG009|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
13489951|NCT03307785|27050798|FG010|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
13489952|NCT03307785|27050788|FG000|Part A: Up to 28.5 Months|Death|4|||
13489953|NCT03307785|27050789|FG001|Part A: Up to 28.5 Months|Death|4|||
13489954|NCT03307785|27050790|FG002|Part A: Up to 28.5 Months|Death|0|||
13489955|NCT03307785|27050791|FG003|Part A: Up to 28.5 Months|Death|0|||
13489956|NCT03307785|27050792|FG004|Part A: Up to 28.5 Months|Death|0|||
13489957|NCT03307785|27050793|FG005|Part A: Up to 28.5 Months|Death|0|||
13489958|NCT03307785|27050794|FG006|Part A: Up to 28.5 Months|Death|0|||
13489959|NCT03307785|27050795|FG007|Part A: Up to 28.5 Months|Death|0|||
13489960|NCT03307785|27050796|FG008|Part A: Up to 28.5 Months|Death|0|||
13489961|NCT03307785|27050797|FG009|Part A: Up to 28.5 Months|Death|0|||
13489962|NCT03307785|27050798|FG010|Part A: Up to 28.5 Months|Death|0|||
13489963|NCT03307785|27050788|FG000|Part A: Up to 28.5 Months|Physician Decision|3|||
13489964|NCT03307785|27050789|FG001|Part A: Up to 28.5 Months|Physician Decision|1|||
13489965|NCT03307785|27050790|FG002|Part A: Up to 28.5 Months|Physician Decision|0|||
13489966|NCT03307785|27050791|FG003|Part A: Up to 28.5 Months|Physician Decision|0|||
13489967|NCT03307785|27050792|FG004|Part A: Up to 28.5 Months|Physician Decision|0|||
13489968|NCT03307785|27050793|FG005|Part A: Up to 28.5 Months|Physician Decision|0|||
13489969|NCT03307785|27050794|FG006|Part A: Up to 28.5 Months|Physician Decision|0|||
13489970|NCT03307785|27050795|FG007|Part A: Up to 28.5 Months|Physician Decision|0|||
13489971|NCT03307785|27050796|FG008|Part A: Up to 28.5 Months|Physician Decision|0|||
13489972|NCT03307785|27050797|FG009|Part A: Up to 28.5 Months|Physician Decision|0|||
13489973|NCT03307785|27050798|FG010|Part A: Up to 28.5 Months|Physician Decision|0|||
13489974|NCT03307785|27050788|FG000|Part B: Up to 28.5 Months|Disease progression|0|||
13489975|NCT03307785|27050789|FG001|Part B: Up to 28.5 Months|Disease progression|0|||
13489976|NCT03307785|27050790|FG002|Part B: Up to 28.5 Months|Disease progression|1|||
13489977|NCT03307785|27050791|FG003|Part B: Up to 28.5 Months|Disease progression|0|||
13489978|NCT03307785|27050792|FG004|Part B: Up to 28.5 Months|Disease progression|0|||
13489979|NCT03307785|27050793|FG005|Part B: Up to 28.5 Months|Disease progression|0|||
13489980|NCT03307785|27050794|FG006|Part B: Up to 28.5 Months|Disease progression|0|||
13489981|NCT03307785|27050795|FG007|Part B: Up to 28.5 Months|Disease progression|0|||
13489982|NCT03307785|27050796|FG008|Part B: Up to 28.5 Months|Disease progression|0|||
13489983|NCT03307785|27050797|FG009|Part B: Up to 28.5 Months|Disease progression|0|||
13489984|NCT03307785|27050798|FG010|Part B: Up to 28.5 Months|Disease progression|0|||
13489985|NCT03307785|27050788|FG000|Part B: Up to 28.5 Months|Physician Decision|0|||
13489986|NCT03307785|27050789|FG001|Part B: Up to 28.5 Months|Physician Decision|0|||
13489987|NCT03307785|27050790|FG002|Part B: Up to 28.5 Months|Physician Decision|1|||
13489988|NCT03307785|27050791|FG003|Part B: Up to 28.5 Months|Physician Decision|0|||
13489989|NCT03307785|27050792|FG004|Part B: Up to 28.5 Months|Physician Decision|0|||
13489990|NCT03307785|27050793|FG005|Part B: Up to 28.5 Months|Physician Decision|0|||
13489991|NCT03307785|27050794|FG006|Part B: Up to 28.5 Months|Physician Decision|0|||
13489992|NCT03307785|27050795|FG007|Part B: Up to 28.5 Months|Physician Decision|0|||
13489993|NCT03307785|27050796|FG008|Part B: Up to 28.5 Months|Physician Decision|0|||
13489994|NCT03307785|27050797|FG009|Part B: Up to 28.5 Months|Physician Decision|0|||
13489995|NCT03307785|27050798|FG010|Part B: Up to 28.5 Months|Physician Decision|0|||
13489996|NCT03307785|27050788|FG000|Part B: Up to 28.5 Months|Death|0|||
13489997|NCT03307785|27050789|FG001|Part B: Up to 28.5 Months|Death|0|||
13489998|NCT03307785|27050790|FG002|Part B: Up to 28.5 Months|Death|7|||
13489999|NCT03307785|27050791|FG003|Part B: Up to 28.5 Months|Death|0|||
13490000|NCT03307785|27050792|FG004|Part B: Up to 28.5 Months|Death|0|||
13490001|NCT03307785|27050793|FG005|Part B: Up to 28.5 Months|Death|0|||
13490002|NCT03307785|27050794|FG006|Part B: Up to 28.5 Months|Death|0|||
13490003|NCT03307785|27050795|FG007|Part B: Up to 28.5 Months|Death|0|||
13490004|NCT03307785|27050796|FG008|Part B: Up to 28.5 Months|Death|0|||
13490005|NCT03307785|27050797|FG009|Part B: Up to 28.5 Months|Death|0|||
13490006|NCT03307785|27050798|FG010|Part B: Up to 28.5 Months|Death|0|||
13490007|NCT03307785|27050788|FG000|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
13490008|NCT03307785|27050789|FG001|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
13296275|NCT01371656|26496135|FG001|Overall Study|Withdrawal by Subject|0|||
13296276|NCT01371656|26496134|FG000|Overall Study|Ineligible|4|||
13381356|NCT00753896|26747950|FG000|Overall Study|Protocol Violation|1|||
13490009|NCT03307785|27050790|FG002|Part B: Up to 28.5 Months|Withdrawal by Subject|1|||
13490010|NCT03307785|27050791|FG003|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
13490011|NCT03307785|27050792|FG004|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
13490012|NCT03307785|27050793|FG005|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
13490013|NCT03307785|27050794|FG006|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
13207522|NCT01947283|26238161|FG001|Overall Study|Lost to Follow-up|6|||
13207523|NCT01947283|26238162|FG002|Overall Study|Lost to Follow-up|5|||
13207524|NCT01947283|26238163|FG003|Overall Study|Lost to Follow-up|5|||
13207525|NCT01947283|26238164|FG004|Overall Study|Lost to Follow-up|0|||
13207526|NCT01947283|26238165|FG005|Overall Study|Lost to Follow-up|2|||
13207527|NCT01947283|26238166|FG006|Overall Study|Lost to Follow-up|5|||
13207528|NCT01947283|26238160|FG000|Overall Study|Withdrawal by Subject|10|||
13207529|NCT01947283|26238161|FG001|Overall Study|Withdrawal by Subject|8|||
13381357|NCT00753896|26747950|FG000|Overall Study|Withdrawal by Subject|4|||
13381358|NCT00753896|26747950|FG000|Overall Study|Entry Criteria Not Met|4|||
13490014|NCT03307785|27050795|FG007|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
13490015|NCT03307785|27050796|FG008|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
13490016|NCT03307785|27050797|FG009|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
13490017|NCT03307785|27050798|FG010|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
13490018|NCT03307785|27050788|FG000|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
13490019|NCT03307785|27050789|FG001|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
13207530|NCT01947283|26238162|FG002|Overall Study|Withdrawal by Subject|4|||
13207531|NCT01947283|26238163|FG003|Overall Study|Withdrawal by Subject|1|||
13296277|NCT01371656|26496135|FG001|Overall Study|Ineligible|3|||
13490020|NCT03307785|27050790|FG002|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|4|||
13490021|NCT03307785|27050791|FG003|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
13490022|NCT03307785|27050792|FG004|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
13490023|NCT03307785|27050793|FG005|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
13490024|NCT03307785|27050794|FG006|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
13490025|NCT03307785|27050795|FG007|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
13490026|NCT03307785|27050796|FG008|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
13490027|NCT03307785|27050797|FG009|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
13490028|NCT03307785|27050798|FG010|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
13490029|NCT03307785|27050788|FG000|Part C: Up to 22.5 Months|Disease progression|0|||
13490030|NCT03307785|27050789|FG001|Part C: Up to 22.5 Months|Disease progression|0|||
13490031|NCT03307785|27050790|FG002|Part C: Up to 22.5 Months|Disease progression|0|||
13490032|NCT03307785|27050791|FG003|Part C: Up to 22.5 Months|Disease progression|0|||
13490033|NCT03307785|27050792|FG004|Part C: Up to 22.5 Months|Disease progression|1|||
13490034|NCT03307785|27050793|FG005|Part C: Up to 22.5 Months|Disease progression|0|||
13490035|NCT03307785|27050794|FG006|Part C: Up to 22.5 Months|Disease progression|0|||
13490036|NCT03307785|27050795|FG007|Part C: Up to 22.5 Months|Disease progression|0|||
13490037|NCT03307785|27050796|FG008|Part C: Up to 22.5 Months|Disease progression|0|||
13490038|NCT03307785|27050797|FG009|Part C: Up to 22.5 Months|Disease progression|0|||
13490039|NCT03307785|27050798|FG010|Part C: Up to 22.5 Months|Disease progression|0|||
13490040|NCT03307785|27050788|FG000|Part C: Up to 22.5 Months|Physician Decision|0|||
13490041|NCT03307785|27050789|FG001|Part C: Up to 22.5 Months|Physician Decision|0|||
13490042|NCT03307785|27050790|FG002|Part C: Up to 22.5 Months|Physician Decision|0|||
13490043|NCT03307785|27050791|FG003|Part C: Up to 22.5 Months|Physician Decision|3|||
13490044|NCT03307785|27050792|FG004|Part C: Up to 22.5 Months|Physician Decision|1|||
13490045|NCT03307785|27050793|FG005|Part C: Up to 22.5 Months|Physician Decision|0|||
13490046|NCT03307785|27050794|FG006|Part C: Up to 22.5 Months|Physician Decision|0|||
13490047|NCT03307785|27050795|FG007|Part C: Up to 22.5 Months|Physician Decision|0|||
13490048|NCT03307785|27050796|FG008|Part C: Up to 22.5 Months|Physician Decision|0|||
13490049|NCT03307785|27050797|FG009|Part C: Up to 22.5 Months|Physician Decision|0|||
13490050|NCT03307785|27050798|FG010|Part C: Up to 22.5 Months|Physician Decision|0|||
13490051|NCT03307785|27050788|FG000|Part C: Up to 22.5 Months|Death|0|||
13490052|NCT03307785|27050789|FG001|Part C: Up to 22.5 Months|Death|0|||
13490053|NCT03307785|27050790|FG002|Part C: Up to 22.5 Months|Death|0|||
13490054|NCT03307785|27050791|FG003|Part C: Up to 22.5 Months|Death|1|||
13490055|NCT03307785|27050792|FG004|Part C: Up to 22.5 Months|Death|4|||
13490056|NCT03307785|27050793|FG005|Part C: Up to 22.5 Months|Death|0|||
13490057|NCT03307785|27050794|FG006|Part C: Up to 22.5 Months|Death|0|||
13490058|NCT03307785|27050795|FG007|Part C: Up to 22.5 Months|Death|0|||
13490059|NCT03307785|27050796|FG008|Part C: Up to 22.5 Months|Death|0|||
13490060|NCT03307785|27050797|FG009|Part C: Up to 22.5 Months|Death|0|||
13490061|NCT03307785|27050798|FG010|Part C: Up to 22.5 Months|Death|0|||
13490062|NCT03307785|27050788|FG000|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
13490063|NCT03307785|27050789|FG001|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
13490064|NCT03307785|27050790|FG002|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
13490065|NCT03307785|27050791|FG003|Part C: Up to 22.5 Months|Withdrawal by Subject|1|||
13490066|NCT03307785|27050792|FG004|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
13490067|NCT03307785|27050793|FG005|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
13490068|NCT03307785|27050794|FG006|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
13490069|NCT03307785|27050795|FG007|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
13490070|NCT03307785|27050796|FG008|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
13490071|NCT03307785|27050797|FG009|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
13490072|NCT03307785|27050798|FG010|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
13490073|NCT03307785|27050788|FG000|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
13490074|NCT03307785|27050789|FG001|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
13490075|NCT03307785|27050790|FG002|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
13490076|NCT03307785|27050791|FG003|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|1|||
13490077|NCT03307785|27050792|FG004|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|1|||
13490078|NCT03307785|27050793|FG005|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
13490079|NCT03307785|27050794|FG006|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
13490080|NCT03307785|27050795|FG007|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
13490081|NCT03307785|27050796|FG008|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
13490082|NCT03307785|27050797|FG009|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
13490083|NCT03307785|27050798|FG010|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
13490084|NCT03307785|27050788|FG000|Part D: Up to 9.5 Months|Physician Decision|0|||
13490085|NCT03307785|27050789|FG001|Part D: Up to 9.5 Months|Physician Decision|0|||
13490086|NCT03307785|27050790|FG002|Part D: Up to 9.5 Months|Physician Decision|0|||
13490087|NCT03307785|27050791|FG003|Part D: Up to 9.5 Months|Physician Decision|0|||
13490088|NCT03307785|27050792|FG004|Part D: Up to 9.5 Months|Physician Decision|0|||
13490089|NCT03307785|27050793|FG005|Part D: Up to 9.5 Months|Physician Decision|1|||
13490090|NCT03307785|27050794|FG006|Part D: Up to 9.5 Months|Physician Decision|0|||
13490091|NCT03307785|27050795|FG007|Part D: Up to 9.5 Months|Physician Decision|0|||
13490092|NCT03307785|27050796|FG008|Part D: Up to 9.5 Months|Physician Decision|0|||
13490093|NCT03307785|27050797|FG009|Part D: Up to 9.5 Months|Physician Decision|0|||
13490094|NCT03307785|27050798|FG010|Part D: Up to 9.5 Months|Physician Decision|0|||
13490095|NCT03307785|27050788|FG000|Part D: Up to 9.5 Months|Death|0|||
13490096|NCT03307785|27050789|FG001|Part D: Up to 9.5 Months|Death|0|||
13490097|NCT03307785|27050790|FG002|Part D: Up to 9.5 Months|Death|0|||
13490098|NCT03307785|27050791|FG003|Part D: Up to 9.5 Months|Death|0|||
13490099|NCT03307785|27050792|FG004|Part D: Up to 9.5 Months|Death|0|||
13490100|NCT03307785|27050793|FG005|Part D: Up to 9.5 Months|Death|1|||
13490101|NCT03307785|27050794|FG006|Part D: Up to 9.5 Months|Death|0|||
13490102|NCT03307785|27050795|FG007|Part D: Up to 9.5 Months|Death|0|||
13490103|NCT03307785|27050796|FG008|Part D: Up to 9.5 Months|Death|0|||
13490104|NCT03307785|27050797|FG009|Part D: Up to 9.5 Months|Death|0|||
13490105|NCT03307785|27050798|FG010|Part D: Up to 9.5 Months|Death|0|||
13490106|NCT03307785|27050788|FG000|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
13490107|NCT03307785|27050789|FG001|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
13490108|NCT03307785|27050790|FG002|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
13490109|NCT03307785|27050791|FG003|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
13490110|NCT03307785|27050792|FG004|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
13490111|NCT03307785|27050793|FG005|Part D: Up to 9.5 Months|Withdrawal by Subject|1|||
13490112|NCT03307785|27050794|FG006|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
13490113|NCT03307785|27050795|FG007|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
13490114|NCT03307785|27050796|FG008|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
13490115|NCT03307785|27050797|FG009|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
13490116|NCT03307785|27050798|FG010|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
13490117|NCT03307785|27050788|FG000|Part E: Up to 4.4 Months|Death|0|||
13490118|NCT03307785|27050789|FG001|Part E: Up to 4.4 Months|Death|0|||
13490119|NCT03307785|27050790|FG002|Part E: Up to 4.4 Months|Death|0|||
13490120|NCT03307785|27050791|FG003|Part E: Up to 4.4 Months|Death|0|||
13490121|NCT03307785|27050792|FG004|Part E: Up to 4.4 Months|Death|0|||
13490122|NCT03307785|27050793|FG005|Part E: Up to 4.4 Months|Death|0|||
13490123|NCT03307785|27050794|FG006|Part E: Up to 4.4 Months|Death|1|||
13490124|NCT03307785|27050795|FG007|Part E: Up to 4.4 Months|Death|0|||
13490125|NCT03307785|27050796|FG008|Part E: Up to 4.4 Months|Death|0|||
13490126|NCT03307785|27050797|FG009|Part E: Up to 4.4 Months|Death|0|||
13490127|NCT03307785|27050798|FG010|Part E: Up to 4.4 Months|Death|0|||
13490128|NCT03307785|27050788|FG000|Part E: Up to 4.4 Months|Physician Decision|0|||
13490129|NCT03307785|27050789|FG001|Part E: Up to 4.4 Months|Physician Decision|0|||
13490130|NCT03307785|27050790|FG002|Part E: Up to 4.4 Months|Physician Decision|0|||
13490131|NCT03307785|27050791|FG003|Part E: Up to 4.4 Months|Physician Decision|0|||
13490132|NCT03307785|27050792|FG004|Part E: Up to 4.4 Months|Physician Decision|0|||
13490133|NCT03307785|27050793|FG005|Part E: Up to 4.4 Months|Physician Decision|0|||
13490134|NCT03307785|27050794|FG006|Part E: Up to 4.4 Months|Physician Decision|1|||
13490135|NCT03307785|27050795|FG007|Part E: Up to 4.4 Months|Physician Decision|0|||
13490136|NCT03307785|27050796|FG008|Part E: Up to 4.4 Months|Physician Decision|0|||
13490137|NCT03307785|27050797|FG009|Part E: Up to 4.4 Months|Physician Decision|0|||
13490138|NCT03307785|27050798|FG010|Part E: Up to 4.4 Months|Physician Decision|0|||
13490139|NCT03307785|27050788|FG000|Part F: Up to 3.5 Months|Physician Decision|0|||
13490140|NCT03307785|27050789|FG001|Part F: Up to 3.5 Months|Physician Decision|0|||
13490141|NCT03307785|27050790|FG002|Part F: Up to 3.5 Months|Physician Decision|0|||
13490142|NCT03307785|27050791|FG003|Part F: Up to 3.5 Months|Physician Decision|0|||
13490143|NCT03307785|27050792|FG004|Part F: Up to 3.5 Months|Physician Decision|0|||
13490144|NCT03307785|27050793|FG005|Part F: Up to 3.5 Months|Physician Decision|0|||
13490145|NCT03307785|27050794|FG006|Part F: Up to 3.5 Months|Physician Decision|0|||
13490146|NCT03307785|27050795|FG007|Part F: Up to 3.5 Months|Physician Decision|1|||
13490147|NCT03307785|27050796|FG008|Part F: Up to 3.5 Months|Physician Decision|0|||
13490148|NCT03307785|27050797|FG009|Part F: Up to 3.5 Months|Physician Decision|0|||
13490149|NCT03307785|27050798|FG010|Part F: Up to 3.5 Months|Physician Decision|0|||
13490150|NCT03253627|27050823|FG000|Overall Study|Lost to Follow-up|1|||
13490151|NCT03253627|27050824|FG001|Overall Study|Lost to Follow-up|2|||
13490152|NCT03253627|27050823|FG000|Overall Study|Withdrawal by Subject|0|||
13490153|NCT03253627|27050824|FG001|Overall Study|Withdrawal by Subject|2|||
13490154|NCT03253627|27050823|FG000|Overall Study|Inability to complete MRI|1|||
13490155|NCT03253627|27050824|FG001|Overall Study|Inability to complete MRI|0|||
13490156|NCT02864394|27050933|FG000|Overall Study|Death|135|||
13490157|NCT02864394|27050934|FG001|Overall Study|Death|150|||
13490158|NCT02864394|27050933|FG000|Overall Study|Withdrawal by Subject|1|||
13490159|NCT02864394|27050934|FG001|Overall Study|Withdrawal by Subject|9|||
13296278|NCT01371643|26496152|FG000|Overall Study|Withdrawal by Subject|3|||
13490160|NCT02864394|27050933|FG000|Overall Study|Ongoing In Study|77|||
13490161|NCT02864394|27050934|FG001|Overall Study|Ongoing In Study|53|||
13490162|NCT02842086|27050977|FG000|Overall Study|Randomized but Never Treated|6|||
13490163|NCT02842086|27050978|FG001|Overall Study|Randomized but Never Treated|6|||
13490164|NCT02842086|27050977|FG000|Overall Study|Still in Double-Blind Phase|7|||
13490165|NCT02842086|27050978|FG001|Overall Study|Still in Double-Blind Phase|3|||
13490166|NCT02842086|27050977|FG000|Overall Study|Adverse Event|18|||
13490167|NCT02842086|27050978|FG001|Overall Study|Adverse Event|20|||
13490168|NCT02842086|27050977|FG000|Overall Study|Death|3|||
13490169|NCT02842086|27050978|FG001|Overall Study|Death|3|||
13490170|NCT02842086|27050977|FG000|Overall Study|Investigator's Discretion|9|||
13490171|NCT02842086|27050978|FG001|Overall Study|Investigator's Discretion|13|||
13490172|NCT02842086|27050977|FG000|Overall Study|Non-Compliance with Study Drug|9|||
13490173|NCT02842086|27050978|FG001|Overall Study|Non-Compliance with Study Drug|8|||
13490174|NCT02842086|27050977|FG000|Overall Study|Protocol Violation|8|||
13490175|NCT02842086|27050978|FG001|Overall Study|Protocol Violation|4|||
13490176|NCT02842086|27050977|FG000|Overall Study|Withdrew Consent|205|||
13490177|NCT02842086|27050978|FG001|Overall Study|Withdrew Consent|194|||
13490178|NCT02842086|27050977|FG000|Overall Study|Lost to Follow-up|274|||
13490179|NCT02842086|27050978|FG001|Overall Study|Lost to Follow-up|236|||
13490180|NCT02842086|27050977|FG000|Overall Study|HIV-1 Infection|5|||
13490181|NCT02842086|27050978|FG001|Overall Study|HIV-1 Infection|6|||
13490182|NCT02281084|27051069|FG000|Overall Study|Adverse Event|1|||
13490183|NCT02281084|27051070|FG001|Overall Study|Adverse Event|0|||
13490184|NCT02281084|27051071|FG002|Overall Study|Adverse Event|0|||
13490185|NCT02281084|27051072|FG003|Overall Study|Adverse Event|0|||
13490186|NCT02281084|27051069|FG000|Overall Study|Withdrawal by Subject|1|||
13490187|NCT02281084|27051070|FG001|Overall Study|Withdrawal by Subject|2|||
13490188|NCT02281084|27051071|FG002|Overall Study|Withdrawal by Subject|0|||
13490189|NCT02281084|27051072|FG003|Overall Study|Withdrawal by Subject|0|||
13490190|NCT02281084|27051069|FG000|Overall Study|Death|20|||
13490191|NCT02281084|27051070|FG001|Overall Study|Death|16|||
13490192|NCT02281084|27051071|FG002|Overall Study|Death|3|||
13490193|NCT02281084|27051072|FG003|Overall Study|Death|5|||
13490194|NCT02281084|27051069|FG000|Overall Study|Physician Decision|0|||
13490195|NCT02281084|27051070|FG001|Overall Study|Physician Decision|0|||
13490196|NCT02281084|27051071|FG002|Overall Study|Physician Decision|1|||
13490197|NCT02281084|27051072|FG003|Overall Study|Physician Decision|0|||
13490198|NCT02207569|27051092|FG000|1-Month|Death|6|||
13490199|NCT02207569|27051092|FG000|1-Month|Withdrawal by Subject|2|||
13490200|NCT02207569|27051092|FG000|1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1|||
13490201|NCT02207569|27051092|FG000|6-Month|Death|8|||
13490202|NCT02207569|27051092|FG000|6-Month|Withdrawal by Subject|2|||
13490203|NCT02207569|27051092|FG000|12-Month|Death|14|||
13490204|NCT02207569|27051092|FG000|12-Month|Withdrawal by Subject|2|||
13490205|NCT02207569|27051092|FG000|24-Month|Death|23|||
13490206|NCT02207569|27051092|FG000|24-Month|Withdrawal by Subject|3|||
13490207|NCT02207569|27051092|FG000|36-Month|Death|23|||
13490208|NCT02207569|27051092|FG000|36-Month|Withdrawal by Subject|4|||
13490209|NCT02207569|27051092|FG000|48-Month|Death|25|||
13490210|NCT02207569|27051092|FG000|48-Month|Withdrawal by Subject|2|||
13490211|NCT02207569|27051092|FG000|48-Month|Lost to Follow-up|4|||
13490212|NCT02207569|27051092|FG000|60-Month|Death|1|||
13490213|NCT02207569|27051092|FG000|60-Month|Lost to Follow-up|1|||
13490214|NCT02207569|27051092|FG000|60-Month|pt 103 years old no longer traveling for MD visits|1|||
13490215|NCT02207569|27051092|FG000|60-Month|Covid-19 pt not willing to be seen|1|||
13490216|NCT01602380|27051151|FG000|Overall Study|Death|63|||
13490217|NCT01602380|27051152|FG001|Overall Study|Death|68|||
13490218|NCT01602380|27051151|FG000|Overall Study|Withdrawal by Subject|22|||
13490219|NCT01602380|27051152|FG001|Overall Study|Withdrawal by Subject|29|||
13490220|NCT01602380|27051151|FG000|Overall Study|Lost to Follow-up|6|||
13490221|NCT01602380|27051152|FG001|Overall Study|Lost to Follow-up|1|||
13490222|NCT01602380|27051151|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
13490223|NCT01602380|27051152|FG001|Overall Study|Eligibility criteria not fulfilled|3|||
13490224|NCT01558115|27051164|FG000|Overall Study|Withdrawal by Subject|3|||
13490225|NCT01558115|27051164|FG000|Overall Study|Study closed due to poor enrollment|4|||
13490226|NCT04006847|27051183|FG000|Overall Study|Product issue|1|||
13490227|NCT03928028|27051288|FG000|Overall Study|Physician Decision|9|||
13490228|NCT03928028|27051289|FG001|Overall Study|Physician Decision|6|||
13490229|NCT03928028|27051290|FG002|Overall Study|Physician Decision|3|||
13490230|NCT03928028|27051288|FG000|Overall Study|Withdrawal by Subject|12|||
13490231|NCT03928028|27051289|FG001|Overall Study|Withdrawal by Subject|3|||
13490232|NCT03928028|27051290|FG002|Overall Study|Withdrawal by Subject|3|||
13490233|NCT03922711|27051323|FG000|Overall Study|Adverse Event|3|||
13490234|NCT03922711|27051324|FG001|Overall Study|Adverse Event|2|||
13490235|NCT03922711|27051325|FG002|Overall Study|Adverse Event|2|||
13490236|NCT03922711|27051323|FG000|Overall Study|Protocol Violation|1|||
13490237|NCT03922711|27051324|FG001|Overall Study|Protocol Violation|0|||
13490238|NCT03922711|27051325|FG002|Overall Study|Protocol Violation|0|||
13490239|NCT03922711|27051323|FG000|Overall Study|Withdrawal by Subject|0|||
13490240|NCT03922711|27051324|FG001|Overall Study|Withdrawal by Subject|3|||
13490241|NCT03922711|27051325|FG002|Overall Study|Withdrawal by Subject|1|||
13490242|NCT03922711|27051323|FG000|Overall Study|Not further specified|0|||
13490243|NCT03922711|27051324|FG001|Overall Study|Not further specified|0|||
13490244|NCT03922711|27051325|FG002|Overall Study|Not further specified|1|||
13490245|NCT04246996|27051433|FG000|Overall Study|Physician Decision|1|||
13490246|NCT04246996|27051434|FG001|Overall Study|Physician Decision|1|||
13490247|NCT04246996|27051433|FG000|Overall Study|Did not meet eligibility criteria|1|||
13490248|NCT04246996|27051434|FG001|Overall Study|Did not meet eligibility criteria|4|||
13490328|NCT03352557|27051772|FG003|PC Period: Day 1 to Week 78|Adverse Event|0|||
13490329|NCT03352557|27051773|FG004|PC Period: Day 1 to Week 78|Adverse Event|5|||
13490330|NCT03352557|27051774|FG005|PC Period: Day 1 to Week 78|Adverse Event|0|||
13490331|NCT03352557|27051775|FG006|PC Period: Day 1 to Week 78|Adverse Event|0|||
13490332|NCT03352557|27051776|FG007|PC Period: Day 1 to Week 78|Adverse Event|0|||
13490333|NCT03352557|27051777|FG008|PC Period: Day 1 to Week 78|Adverse Event|0|||
13490334|NCT03352557|27051778|FG009|PC Period: Day 1 to Week 78|Adverse Event|0|||
13490335|NCT03352557|27051769|FG000|PC Period: Day 1 to Week 78|Progressive Disease|0|||
13490336|NCT03352557|27051770|FG001|PC Period: Day 1 to Week 78|Progressive Disease|0|||
13490337|NCT03352557|27051771|FG002|PC Period: Day 1 to Week 78|Progressive Disease|0|||
13490338|NCT03352557|27051772|FG003|PC Period: Day 1 to Week 78|Progressive Disease|0|||
13490339|NCT03352557|27051773|FG004|PC Period: Day 1 to Week 78|Progressive Disease|1|||
13490340|NCT03352557|27051774|FG005|PC Period: Day 1 to Week 78|Progressive Disease|0|||
13490341|NCT03352557|27051775|FG006|PC Period: Day 1 to Week 78|Progressive Disease|0|||
13490342|NCT03352557|27051776|FG007|PC Period: Day 1 to Week 78|Progressive Disease|0|||
13490343|NCT03352557|27051777|FG008|PC Period: Day 1 to Week 78|Progressive Disease|0|||
13490344|NCT03352557|27051778|FG009|PC Period: Day 1 to Week 78|Progressive Disease|0|||
13490345|NCT03352557|27051769|FG000|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|1|||
13490346|NCT03352557|27051770|FG001|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
13490347|NCT03352557|27051771|FG002|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
13490348|NCT03352557|27051772|FG003|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
13490349|NCT03352557|27051773|FG004|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
13490350|NCT03352557|27051774|FG005|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
13490351|NCT03352557|27051775|FG006|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
13490352|NCT03352557|27051776|FG007|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
13490353|NCT03352557|27051777|FG008|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
13490354|NCT03352557|27051778|FG009|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
13490355|NCT03352557|27051769|FG000|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
13490356|NCT03352557|27051770|FG001|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
13490357|NCT03352557|27051771|FG002|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
13490358|NCT03352557|27051772|FG003|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
13490359|NCT03352557|27051773|FG004|PC Period: Day 1 to Week 78|Protocol Deviation|2|||
13490360|NCT03352557|27051774|FG005|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
13490361|NCT03352557|27051775|FG006|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
13490362|NCT03352557|27051776|FG007|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
13490363|NCT03352557|27051777|FG008|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
13490364|NCT03352557|27051778|FG009|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
13296279|NCT01371643|26496153|FG001|Overall Study|Withdrawal by Subject|0|||
13490365|NCT03352557|27051769|FG000|PC Period: Day 1 to Week 78|Randomized by Mistake|2|||
13490366|NCT03352557|27051770|FG001|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
13490249|NCT03812224|27051491|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
13490250|NCT03812224|27051492|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
13490251|NCT03812224|27051491|FG000|Double-blind Treatment Period|Decision by Sponsor|0|||
13490252|NCT03812224|27051492|FG001|Double-blind Treatment Period|Decision by Sponsor|1|||
13490253|NCT03812224|27051491|FG000|Open-label Treatment Period|Withdrawal by Subject|2|||
13490254|NCT03812224|27051492|FG001|Open-label Treatment Period|Withdrawal by Subject|2|||
13490255|NCT03812224|27051491|FG000|Open-label Treatment Period|Decision by Sponsor|0|||
13490256|NCT03812224|27051492|FG001|Open-label Treatment Period|Decision by Sponsor|1|||
13490257|NCT03559270|27051609|FG000|Overall Study|Adverse Event|6|||
13490258|NCT03559270|27051610|FG001|Overall Study|Adverse Event|5|||
13490259|NCT03559270|27051611|FG002|Overall Study|Adverse Event|3|||
13490260|NCT03559270|27051612|FG003|Overall Study|Adverse Event|0|||
13490261|NCT03559270|27051609|FG000|Overall Study|Lack of Efficacy|34|||
13490262|NCT03559270|27051610|FG001|Overall Study|Lack of Efficacy|52|||
13490263|NCT03559270|27051611|FG002|Overall Study|Lack of Efficacy|37|||
13490264|NCT03559270|27051612|FG003|Overall Study|Lack of Efficacy|2|||
13490265|NCT03559270|27051609|FG000|Overall Study|Death|0|||
13490266|NCT03559270|27051610|FG001|Overall Study|Death|2|||
13490267|NCT03559270|27051611|FG002|Overall Study|Death|0|||
13490268|NCT03559270|27051612|FG003|Overall Study|Death|0|||
13490269|NCT03559270|27051609|FG000|Overall Study|Lost to Follow-up|16|||
13490270|NCT03559270|27051610|FG001|Overall Study|Lost to Follow-up|4|||
13490271|NCT03559270|27051611|FG002|Overall Study|Lost to Follow-up|12|||
13490272|NCT03559270|27051612|FG003|Overall Study|Lost to Follow-up|3|||
13490273|NCT03559270|27051609|FG000|Overall Study|Sponsor Decision|38|||
13490274|NCT03559270|27051610|FG001|Overall Study|Sponsor Decision|31|||
13490275|NCT03559270|27051611|FG002|Overall Study|Sponsor Decision|35|||
13490276|NCT03559270|27051612|FG003|Overall Study|Sponsor Decision|18|||
13490277|NCT03559270|27051609|FG000|Overall Study|Withdrawal by Subject|19|||
13490278|NCT03559270|27051610|FG001|Overall Study|Withdrawal by Subject|21|||
13490279|NCT03559270|27051611|FG002|Overall Study|Withdrawal by Subject|18|||
13490280|NCT03559270|27051612|FG003|Overall Study|Withdrawal by Subject|7|||
13490281|NCT03559270|27051609|FG000|Overall Study|Physician Decision|3|||
13490282|NCT03559270|27051610|FG001|Overall Study|Physician Decision|2|||
13490283|NCT03559270|27051611|FG002|Overall Study|Physician Decision|1|||
13490284|NCT03559270|27051612|FG003|Overall Study|Physician Decision|0|||
13490285|NCT03559270|27051609|FG000|Overall Study|Pregnancy|0|||
13490286|NCT03559270|27051610|FG001|Overall Study|Pregnancy|1|||
13490287|NCT03559270|27051611|FG002|Overall Study|Pregnancy|0|||
13490288|NCT03559270|27051612|FG003|Overall Study|Pregnancy|0|||
13490289|NCT03559270|27051609|FG000|Overall Study|Protocol Violation|1|||
13490290|NCT03559270|27051610|FG001|Overall Study|Protocol Violation|0|||
13490291|NCT03559270|27051611|FG002|Overall Study|Protocol Violation|2|||
13490292|NCT03559270|27051612|FG003|Overall Study|Protocol Violation|0|||
13490293|NCT03532451|27051627|FG000|Overall Study|Withdrawal by Subject|0|||
13490294|NCT03532451|27051628|FG001|Overall Study|Withdrawal by Subject|1|||
13490295|NCT03532451|27051627|FG000|Overall Study|Progression prior to the surgery|1|||
13490296|NCT03532451|27051628|FG001|Overall Study|Progression prior to the surgery|0|||
13490297|NCT03445533|27051716|FG000|Overall Study|Progressive Disease|48|||
13490298|NCT03445533|27051717|FG001|Overall Study|Progressive Disease|81|||
13490299|NCT03445533|27051716|FG000|Overall Study|Adverse Event|60|||
13490300|NCT03445533|27051717|FG001|Overall Study|Adverse Event|64|||
13490301|NCT03445533|27051716|FG000|Overall Study|Death|9|||
13490302|NCT03445533|27051717|FG001|Overall Study|Death|19|||
13490303|NCT03445533|27051716|FG000|Overall Study|Miscellaneous|0|||
13490304|NCT03445533|27051717|FG001|Overall Study|Miscellaneous|16|||
13490305|NCT03445533|27051716|FG000|Overall Study|Withdrawal by Subject|3|||
13490306|NCT03445533|27051717|FG001|Overall Study|Withdrawal by Subject|4|||
13490307|NCT03445533|27051716|FG000|Overall Study|Physician Decision|1|||
13490308|NCT03445533|27051717|FG001|Overall Study|Physician Decision|3|||
13490309|NCT03445533|27051716|FG000|Overall Study|Sponsor Decision|0|||
13490310|NCT03445533|27051717|FG001|Overall Study|Sponsor Decision|1|||
13490311|NCT03445533|27051716|FG000|Overall Study|Lost to Follow-up|0|||
13490312|NCT03445533|27051717|FG001|Overall Study|Lost to Follow-up|1|||
13490313|NCT03445533|27051716|FG000|Overall Study|Never Received any Study Treatment|7|||
13490314|NCT03445533|27051717|FG001|Overall Study|Never Received any Study Treatment|4|||
13490315|NCT03352557|27051769|FG000|PC Period: Day 1 to Week 78|Death|1|||
13490316|NCT03352557|27051770|FG001|PC Period: Day 1 to Week 78|Death|1|||
13490317|NCT03352557|27051771|FG002|PC Period: Day 1 to Week 78|Death|0|||
13490318|NCT03352557|27051772|FG003|PC Period: Day 1 to Week 78|Death|0|||
13490319|NCT03352557|27051773|FG004|PC Period: Day 1 to Week 78|Death|1|||
13490320|NCT03352557|27051774|FG005|PC Period: Day 1 to Week 78|Death|0|||
13490321|NCT03352557|27051775|FG006|PC Period: Day 1 to Week 78|Death|0|||
13490322|NCT03352557|27051776|FG007|PC Period: Day 1 to Week 78|Death|0|||
13490323|NCT03352557|27051777|FG008|PC Period: Day 1 to Week 78|Death|0|||
13490324|NCT03352557|27051778|FG009|PC Period: Day 1 to Week 78|Death|0|||
13490325|NCT03352557|27051769|FG000|PC Period: Day 1 to Week 78|Adverse Event|10|||
13490326|NCT03352557|27051770|FG001|PC Period: Day 1 to Week 78|Adverse Event|1|||
13490327|NCT03352557|27051771|FG002|PC Period: Day 1 to Week 78|Adverse Event|1|||
13490367|NCT03352557|27051771|FG002|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
13490368|NCT03352557|27051772|FG003|PC Period: Day 1 to Week 78|Randomized by Mistake|1|||
13490369|NCT03352557|27051773|FG004|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
13490370|NCT03352557|27051774|FG005|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
13490371|NCT03352557|27051775|FG006|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
13490372|NCT03352557|27051776|FG007|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
13490373|NCT03352557|27051777|FG008|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
13490374|NCT03352557|27051778|FG009|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
13490375|NCT03352557|27051769|FG000|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
13490376|NCT03352557|27051770|FG001|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
13490377|NCT03352557|27051771|FG002|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
13490378|NCT03352557|27051772|FG003|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
13490379|NCT03352557|27051773|FG004|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
13490380|NCT03352557|27051774|FG005|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
13490381|NCT03352557|27051775|FG006|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
13490382|NCT03352557|27051776|FG007|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
13490383|NCT03352557|27051777|FG008|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
13490384|NCT03352557|27051778|FG009|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
13490385|NCT03352557|27051769|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|7|||
13490386|NCT03352557|27051770|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
13490387|NCT03352557|27051771|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
13490388|NCT03352557|27051772|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
13490389|NCT03352557|27051773|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
13490390|NCT03352557|27051774|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
13490391|NCT03352557|27051775|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
13490392|NCT03352557|27051776|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
13490393|NCT03352557|27051777|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
13490394|NCT03352557|27051778|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
13490395|NCT03352557|27051769|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
13490396|NCT03352557|27051770|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
13490397|NCT03352557|27051771|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
13490398|NCT03352557|27051772|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
13490399|NCT03352557|27051773|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|2|||
13490400|NCT03352557|27051774|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
13490401|NCT03352557|27051775|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
13490402|NCT03352557|27051776|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
13490403|NCT03352557|27051777|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
13490404|NCT03352557|27051778|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
13490405|NCT03352557|27051769|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
13490406|NCT03352557|27051770|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
13490407|NCT03352557|27051771|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
13490408|NCT03352557|27051772|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
13490409|NCT03352557|27051773|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
13490410|NCT03352557|27051774|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
13490411|NCT03352557|27051775|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
13490412|NCT03352557|27051776|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
13490413|NCT03352557|27051777|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
13490414|NCT03352557|27051778|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
13490415|NCT03352557|27051769|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
13490416|NCT03352557|27051770|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
13490417|NCT03352557|27051771|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
13490418|NCT03352557|27051772|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
13490419|NCT03352557|27051773|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
13490420|NCT03352557|27051774|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
13490421|NCT03352557|27051775|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
13490422|NCT03352557|27051776|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
13490423|NCT03352557|27051777|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
13490424|NCT03352557|27051778|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
13490425|NCT03352557|27051769|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|6|||
13490426|NCT03352557|27051770|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
13490427|NCT03352557|27051771|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
13490428|NCT03352557|27051772|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|5|||
13490429|NCT03352557|27051773|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|7|||
13490430|NCT03352557|27051774|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
13490431|NCT03352557|27051775|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
13490432|NCT03352557|27051776|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
13490433|NCT03352557|27051777|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
13490434|NCT03352557|27051778|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
13490435|NCT03352557|27051769|FG000|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
13381359|NCT00753766|26747977|FG000|Overall Study|Physician Decision|1|||
13490436|NCT03352557|27051770|FG001|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
13490437|NCT03352557|27051771|FG002|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
13490438|NCT03352557|27051772|FG003|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
13490439|NCT03352557|27051773|FG004|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|3|||
13490440|NCT03352557|27051774|FG005|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
13490441|NCT03352557|27051775|FG006|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
13490442|NCT03352557|27051776|FG007|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
13490443|NCT03352557|27051777|FG008|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
13490444|NCT03352557|27051778|FG009|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
13490445|NCT03352557|27051769|FG000|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
13490446|NCT03352557|27051770|FG001|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
13490447|NCT03352557|27051771|FG002|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
13490448|NCT03352557|27051772|FG003|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
13490449|NCT03352557|27051773|FG004|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
13490450|NCT03352557|27051774|FG005|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
13490451|NCT03352557|27051775|FG006|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
13490452|NCT03352557|27051776|FG007|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
13490453|NCT03352557|27051777|FG008|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
13490454|NCT03352557|27051778|FG009|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
13490455|NCT03352557|27051769|FG000|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
13490456|NCT03352557|27051770|FG001|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
13490457|NCT03352557|27051771|FG002|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
13490458|NCT03352557|27051772|FG003|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
13490459|NCT03352557|27051773|FG004|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
13490460|NCT03352557|27051774|FG005|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
13490461|NCT03352557|27051775|FG006|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
13490462|NCT03352557|27051776|FG007|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
13490463|NCT03352557|27051777|FG008|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
13490464|NCT03352557|27051778|FG009|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
13490465|NCT03352557|27051769|FG000|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
13490466|NCT03352557|27051770|FG001|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
13490467|NCT03352557|27051771|FG002|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
13490468|NCT03352557|27051772|FG003|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
13490469|NCT03352557|27051773|FG004|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
13490470|NCT03352557|27051774|FG005|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
13381360|NCT00753766|26747978|FG001|Overall Study|Physician Decision|0|||
13381361|NCT00753714|26747999|FG000|Overall Study|Lack of Efficacy|21|||
13381362|NCT00753714|26748000|FG001|Overall Study|Lack of Efficacy|34|||
13490471|NCT03352557|27051775|FG006|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
13490472|NCT03352557|27051776|FG007|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
13490473|NCT03352557|27051777|FG008|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
13490474|NCT03352557|27051778|FG009|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
13490475|NCT03352557|27051769|FG000|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
13490476|NCT03352557|27051770|FG001|PC Period: Day 1 to Week 78|WBP/G-Other|2|||
13490477|NCT03352557|27051771|FG002|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
13490478|NCT03352557|27051772|FG003|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
13490479|NCT03352557|27051773|FG004|PC Period: Day 1 to Week 78|WBP/G-Other|3|||
13490480|NCT03352557|27051774|FG005|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
13490481|NCT03352557|27051775|FG006|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
13490482|NCT03352557|27051776|FG007|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
13490483|NCT03352557|27051777|FG008|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
13490484|NCT03352557|27051778|FG009|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
13490485|NCT03352557|27051769|FG000|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|2|||
13490486|NCT03352557|27051770|FG001|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
13490487|NCT03352557|27051771|FG002|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
13490488|NCT03352557|27051772|FG003|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
13490489|NCT03352557|27051773|FG004|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|1|||
13490490|NCT03352557|27051774|FG005|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
13490491|NCT03352557|27051775|FG006|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
13490492|NCT03352557|27051776|FG007|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
13490493|NCT03352557|27051777|FG008|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
13490494|NCT03352557|27051778|FG009|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
13490495|NCT03352557|27051769|FG000|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
13490496|NCT03352557|27051770|FG001|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
13490497|NCT03352557|27051771|FG002|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
13490498|NCT03352557|27051772|FG003|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
13490499|NCT03352557|27051773|FG004|PC Period: Day 1 to Week 78|Lost to Follow-up|2|||
13490500|NCT03352557|27051774|FG005|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
13490501|NCT03352557|27051775|FG006|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
13490502|NCT03352557|27051776|FG007|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
13490503|NCT03352557|27051777|FG008|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
13490504|NCT03352557|27051778|FG009|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
13490505|NCT03352557|27051769|FG000|PC Period: Day 1 to Week 78|Other|5|||
13490506|NCT03352557|27051770|FG001|PC Period: Day 1 to Week 78|Other|1|||
13490507|NCT03352557|27051771|FG002|PC Period: Day 1 to Week 78|Other|0|||
13490508|NCT03352557|27051772|FG003|PC Period: Day 1 to Week 78|Other|3|||
13490509|NCT03352557|27051773|FG004|PC Period: Day 1 to Week 78|Other|0|||
13490510|NCT03352557|27051774|FG005|PC Period: Day 1 to Week 78|Other|0|||
13490511|NCT03352557|27051775|FG006|PC Period: Day 1 to Week 78|Other|0|||
13490512|NCT03352557|27051776|FG007|PC Period: Day 1 to Week 78|Other|0|||
13490513|NCT03352557|27051777|FG008|PC Period: Day 1 to Week 78|Other|0|||
13490514|NCT03352557|27051778|FG009|PC Period: Day 1 to Week 78|Other|0|||
13490515|NCT03352557|27051769|FG000|PC Period: Day 1 to Week 78|Not Dosed|0|||
13490516|NCT03352557|27051770|FG001|PC Period: Day 1 to Week 78|Not Dosed|0|||
13490517|NCT03352557|27051771|FG002|PC Period: Day 1 to Week 78|Not Dosed|0|||
13490518|NCT03352557|27051772|FG003|PC Period: Day 1 to Week 78|Not Dosed|0|||
13490519|NCT03352557|27051773|FG004|PC Period: Day 1 to Week 78|Not Dosed|4|||
13490520|NCT03352557|27051774|FG005|PC Period: Day 1 to Week 78|Not Dosed|0|||
13490521|NCT03352557|27051775|FG006|PC Period: Day 1 to Week 78|Not Dosed|0|||
13490522|NCT03352557|27051776|FG007|PC Period: Day 1 to Week 78|Not Dosed|0|||
13490523|NCT03352557|27051777|FG008|PC Period: Day 1 to Week 78|Not Dosed|0|||
13490524|NCT03352557|27051778|FG009|PC Period: Day 1 to Week 78|Not Dosed|0|||
13490525|NCT03352557|27051769|FG000|LTE Period: Week 80 to Week 173|Death|0|||
13490526|NCT03352557|27051770|FG001|LTE Period: Week 80 to Week 173|Death|0|||
13490527|NCT03352557|27051771|FG002|LTE Period: Week 80 to Week 173|Death|0|||
13490528|NCT03352557|27051772|FG003|LTE Period: Week 80 to Week 173|Death|0|||
13381363|NCT00753714|26747999|FG000|Overall Study|Adverse Event|26|||
13490529|NCT03352557|27051773|FG004|LTE Period: Week 80 to Week 173|Death|0|||
13490530|NCT03352557|27051774|FG005|LTE Period: Week 80 to Week 173|Death|1|||
13490531|NCT03352557|27051775|FG006|LTE Period: Week 80 to Week 173|Death|0|||
13490532|NCT03352557|27051776|FG007|LTE Period: Week 80 to Week 173|Death|1|||
13490533|NCT03352557|27051777|FG008|LTE Period: Week 80 to Week 173|Death|1|||
13490534|NCT03352557|27051778|FG009|LTE Period: Week 80 to Week 173|Death|1|||
13490535|NCT03352557|27051769|FG000|LTE Period: Week 80 to Week 173|Adverse Event|0|||
13490536|NCT03352557|27051770|FG001|LTE Period: Week 80 to Week 173|Adverse Event|0|||
13490537|NCT03352557|27051771|FG002|LTE Period: Week 80 to Week 173|Adverse Event|0|||
13381364|NCT00753714|26748000|FG001|Overall Study|Adverse Event|18|||
13490538|NCT03352557|27051772|FG003|LTE Period: Week 80 to Week 173|Adverse Event|0|||
13490539|NCT03352557|27051773|FG004|LTE Period: Week 80 to Week 173|Adverse Event|0|||
13490540|NCT03352557|27051774|FG005|LTE Period: Week 80 to Week 173|Adverse Event|3|||
13490541|NCT03352557|27051775|FG006|LTE Period: Week 80 to Week 173|Adverse Event|0|||
13490542|NCT03352557|27051776|FG007|LTE Period: Week 80 to Week 173|Adverse Event|0|||
13490543|NCT03352557|27051777|FG008|LTE Period: Week 80 to Week 173|Adverse Event|0|||
13490544|NCT03352557|27051778|FG009|LTE Period: Week 80 to Week 173|Adverse Event|0|||
13490545|NCT03352557|27051769|FG000|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
13490546|NCT03352557|27051770|FG001|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
13490547|NCT03352557|27051771|FG002|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
13490548|NCT03352557|27051772|FG003|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
13490549|NCT03352557|27051773|FG004|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
13490550|NCT03352557|27051774|FG005|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
13490551|NCT03352557|27051775|FG006|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
13490552|NCT03352557|27051776|FG007|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
13490553|NCT03352557|27051777|FG008|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|2|||
13490554|NCT03352557|27051778|FG009|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
13490555|NCT03352557|27051769|FG000|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
13490556|NCT03352557|27051770|FG001|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
13490557|NCT03352557|27051771|FG002|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
13490558|NCT03352557|27051772|FG003|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
13490559|NCT03352557|27051773|FG004|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
13490560|NCT03352557|27051774|FG005|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|38|||
13490561|NCT03352557|27051775|FG006|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|49|||
13490562|NCT03352557|27051776|FG007|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|75|||
13490563|NCT03352557|27051777|FG008|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|151|||
13490564|NCT03352557|27051778|FG009|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|154|||
13490565|NCT03352557|27051769|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
13490566|NCT03352557|27051770|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
13490567|NCT03352557|27051771|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
13490568|NCT03352557|27051772|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
13490569|NCT03352557|27051773|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
13490570|NCT03352557|27051774|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
13490571|NCT03352557|27051775|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
13490572|NCT03352557|27051776|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
13490573|NCT03352557|27051777|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
13490574|NCT03352557|27051778|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
13490575|NCT03352557|27051769|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
13490576|NCT03352557|27051770|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
13490577|NCT03352557|27051771|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
13490578|NCT03352557|27051772|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
13490579|NCT03352557|27051773|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
13490580|NCT03352557|27051774|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
13490581|NCT03352557|27051775|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
13490582|NCT03352557|27051776|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
13490583|NCT03352557|27051777|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
13490584|NCT03352557|27051778|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
13490585|NCT03352557|27051769|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
13490586|NCT03352557|27051770|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
13490587|NCT03352557|27051771|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
13490588|NCT03352557|27051772|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
13490589|NCT03352557|27051773|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
13490590|NCT03352557|27051774|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
13490591|NCT03352557|27051775|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
13490592|NCT03352557|27051776|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
13490593|NCT03352557|27051777|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
13490594|NCT03352557|27051778|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|4|||
13490595|NCT03352557|27051769|FG000|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
13490596|NCT03352557|27051770|FG001|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
13490597|NCT03352557|27051771|FG002|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
13490598|NCT03352557|27051772|FG003|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
13490599|NCT03352557|27051773|FG004|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
13490600|NCT03352557|27051774|FG005|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
13490601|NCT03352557|27051775|FG006|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
13490602|NCT03352557|27051776|FG007|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
13490603|NCT03352557|27051777|FG008|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|2|||
13490604|NCT03352557|27051778|FG009|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
13490605|NCT03352557|27051769|FG000|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
13490606|NCT03352557|27051770|FG001|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
13490607|NCT03352557|27051771|FG002|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
13490608|NCT03352557|27051772|FG003|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
13490609|NCT03352557|27051773|FG004|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
13490610|NCT03352557|27051774|FG005|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
13490611|NCT03352557|27051775|FG006|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
13381365|NCT00753714|26747999|FG000|Overall Study|Protocol Violation|1|||
13381366|NCT00753714|26748000|FG001|Overall Study|Protocol Violation|0|||
13381367|NCT00753714|26747999|FG000|Overall Study|Lost to Follow-up|0|||
13381368|NCT00753714|26748000|FG001|Overall Study|Lost to Follow-up|1|||
13381369|NCT00753714|26747999|FG000|Overall Study|Withdrawal by Subject|2|||
13381370|NCT00753714|26748000|FG001|Overall Study|Withdrawal by Subject|1|||
13381371|NCT00753714|26747999|FG000|Overall Study|Death|3|||
13381372|NCT00753714|26748000|FG001|Overall Study|Death|3|||
13381373|NCT00753714|26747999|FG000|Overall Study|Other|7|||
13381374|NCT00753714|26748000|FG001|Overall Study|Other|5|||
13381375|NCT00753688|26748033|FG000|Overall Study|Death|102|||
13381376|NCT00753688|26748034|FG001|Overall Study|Death|203|||
13381377|NCT00753688|26748033|FG000|Overall Study|Missing|4|||
13381378|NCT00753688|26748034|FG001|Overall Study|Missing|9|||
13381379|NCT00753688|26748033|FG000|Overall Study|Participant Withdrew Consent|2|||
13490612|NCT03352557|27051776|FG007|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
13296280|NCT01371565|26496159|FG000|Overall Study|Withdrawal by Subject|1|||
13296281|NCT01371565|26496159|FG000|Overall Study|Death|1|||
13296282|NCT01371565|26496159|FG000|Overall Study|Resection of neuroendocrine tumor|1|||
13296283|NCT01371552|26496193|FG000|Part 1, First 3 Days|Inconvenience|0|||
13296284|NCT01371552|26496194|FG001|Part 1, First 3 Days|Inconvenience|0|||
13296285|NCT01371552|26496195|FG002|Part 1, First 3 Days|Inconvenience|1|||
13296286|NCT01371552|26496196|FG003|Part 1, First 3 Days|Inconvenience|0|||
13296287|NCT01371552|26496197|FG004|Part 1, First 3 Days|Inconvenience|0|||
13296288|NCT01371552|26496198|FG005|Part 1, First 3 Days|Inconvenience|0|||
13296289|NCT01371539|26496209|FG000|Period One: One Week|Lost to Follow-up|0|||
13296290|NCT01371539|26496210|FG001|Period One: One Week|Lost to Follow-up|1|||
13296291|NCT01371539|26496209|FG000|Period Two: One Week|Lost to Follow-up|0|||
13296292|NCT01371539|26496210|FG001|Period Two: One Week|Lost to Follow-up|1|||
13296293|NCT01371539|26496209|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0|||
13296294|NCT01371539|26496210|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1|||
13296295|NCT01371539|26496209|FG000|Period Two: One Week|Time/job conflict|0|||
13490613|NCT03352557|27051777|FG008|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
13490614|NCT03352557|27051778|FG009|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
13490615|NCT03352557|27051769|FG000|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
13490616|NCT03352557|27051770|FG001|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
13490617|NCT03352557|27051771|FG002|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
13490618|NCT03352557|27051772|FG003|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
13490619|NCT03352557|27051773|FG004|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
13490620|NCT03352557|27051774|FG005|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
13490621|NCT03352557|27051775|FG006|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
13296296|NCT01371539|26496210|FG001|Period Two: One Week|Time/job conflict|1|||
13296297|NCT01371006|26496256|FG000|Overall Study|Adverse Event|1|||
13296298|NCT01371006|26496257|FG001|Overall Study|Adverse Event|0|||
13381380|NCT00753688|26748034|FG001|Overall Study|Participant Withdrew Consent|2|||
13381381|NCT00753688|26748033|FG000|Overall Study|Ongoing - in Follow-up|15|||
13381382|NCT00753688|26748034|FG001|Overall Study|Ongoing - in Follow-up|31|||
13381383|NCT00753688|26748033|FG000|Overall Study|Adverse Event|0|||
13490622|NCT03352557|27051776|FG007|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|2|||
13490623|NCT03352557|27051777|FG008|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
13490624|NCT03352557|27051778|FG009|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
13490625|NCT03352557|27051769|FG000|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
13490626|NCT03352557|27051770|FG001|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
13490627|NCT03352557|27051771|FG002|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
13490628|NCT03352557|27051772|FG003|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
13490629|NCT03352557|27051773|FG004|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
13490630|NCT03352557|27051774|FG005|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
13490631|NCT03352557|27051775|FG006|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
13490632|NCT03352557|27051776|FG007|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|2|||
13490633|NCT03352557|27051777|FG008|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
13490634|NCT03352557|27051778|FG009|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
13490635|NCT03352557|27051769|FG000|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
13490636|NCT03352557|27051770|FG001|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
13490637|NCT03352557|27051771|FG002|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
13490638|NCT03352557|27051772|FG003|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
13490639|NCT03352557|27051773|FG004|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
13490640|NCT03352557|27051774|FG005|LTE Period: Week 80 to Week 173|WBP/G-Other|1|||
13490641|NCT03352557|27051775|FG006|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
13490642|NCT03352557|27051776|FG007|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
13490643|NCT03352557|27051777|FG008|LTE Period: Week 80 to Week 173|WBP/G-Other|2|||
13490644|NCT03352557|27051778|FG009|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
13490645|NCT03352557|27051769|FG000|LTE Period: Week 80 to Week 173|Physician Decision|0|||
13490646|NCT03352557|27051770|FG001|LTE Period: Week 80 to Week 173|Physician Decision|0|||
13490647|NCT03352557|27051771|FG002|LTE Period: Week 80 to Week 173|Physician Decision|0|||
13490648|NCT03352557|27051772|FG003|LTE Period: Week 80 to Week 173|Physician Decision|0|||
13490649|NCT03352557|27051773|FG004|LTE Period: Week 80 to Week 173|Physician Decision|0|||
13490650|NCT03352557|27051774|FG005|LTE Period: Week 80 to Week 173|Physician Decision|0|||
13490651|NCT03352557|27051775|FG006|LTE Period: Week 80 to Week 173|Physician Decision|0|||
13490652|NCT03352557|27051776|FG007|LTE Period: Week 80 to Week 173|Physician Decision|0|||
13490653|NCT03352557|27051777|FG008|LTE Period: Week 80 to Week 173|Physician Decision|0|||
13490654|NCT03352557|27051778|FG009|LTE Period: Week 80 to Week 173|Physician Decision|3|||
13490655|NCT03352557|27051769|FG000|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
13490656|NCT03352557|27051770|FG001|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
13490657|NCT03352557|27051771|FG002|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
13490658|NCT03352557|27051772|FG003|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
13490659|NCT03352557|27051773|FG004|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
13490660|NCT03352557|27051774|FG005|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
13490661|NCT03352557|27051775|FG006|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
13490662|NCT03352557|27051776|FG007|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
13490663|NCT03352557|27051777|FG008|LTE Period: Week 80 to Week 173|Lost to Follow-up|3|||
13490664|NCT03352557|27051778|FG009|LTE Period: Week 80 to Week 173|Lost to Follow-up|1|||
13490665|NCT03352557|27051769|FG000|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
13490666|NCT03352557|27051770|FG001|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
13490667|NCT03352557|27051771|FG002|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
13490668|NCT03352557|27051772|FG003|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
13490669|NCT03352557|27051773|FG004|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
13490670|NCT03352557|27051774|FG005|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
13490671|NCT03352557|27051775|FG006|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
13490672|NCT03352557|27051776|FG007|LTE Period: Week 80 to Week 173|Progressive Disease|1|||
13490673|NCT03352557|27051777|FG008|LTE Period: Week 80 to Week 173|Progressive Disease|2|||
13490674|NCT03352557|27051778|FG009|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
13490675|NCT03352557|27051769|FG000|LTE Period: Week 80 to Week 173|Other|0|||
13490676|NCT03352557|27051770|FG001|LTE Period: Week 80 to Week 173|Other|0|||
13490677|NCT03352557|27051771|FG002|LTE Period: Week 80 to Week 173|Other|0|||
13490678|NCT03352557|27051772|FG003|LTE Period: Week 80 to Week 173|Other|0|||
13490679|NCT03352557|27051773|FG004|LTE Period: Week 80 to Week 173|Other|0|||
13490680|NCT03352557|27051774|FG005|LTE Period: Week 80 to Week 173|Other|0|||
13490681|NCT03352557|27051775|FG006|LTE Period: Week 80 to Week 173|Other|0|||
13490682|NCT03352557|27051776|FG007|LTE Period: Week 80 to Week 173|Other|1|||
13296299|NCT01370863|26496274|FG000|Overall Study|Adverse Event|1|||
13490683|NCT03352557|27051777|FG008|LTE Period: Week 80 to Week 173|Other|0|||
13490684|NCT03352557|27051778|FG009|LTE Period: Week 80 to Week 173|Other|0|||
13381384|NCT00753688|26748034|FG001|Overall Study|Adverse Event|1|||
13381385|NCT00753675|26748064|FG000|Overall Study|other reason|11|||
13381386|NCT00753675|26748065|FG001|Overall Study|other reason|12|||
13381387|NCT00753675|26748066|FG002|Overall Study|other reason|13|||
13381388|NCT00753675|26748064|FG000|Overall Study|Death|1|||
13381389|NCT00753675|26748065|FG001|Overall Study|Death|2|||
13381390|NCT00753675|26748066|FG002|Overall Study|Death|4|||
13296300|NCT01370863|26496275|FG001|Overall Study|Adverse Event|1|||
13296301|NCT01370863|26496274|FG000|Overall Study|Did not want second pH/MII monitoring|1|||
13296302|NCT01370863|26496275|FG001|Overall Study|Did not want second pH/MII monitoring|1|||
13296303|NCT01370863|26496274|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
13490685|NCT03301415|27051813|FG000|Overall Study|Lost to Follow-up|2|||
13490686|NCT03301415|27051813|FG000|Overall Study|Unable to comply with visit schedule|2|||
13490687|NCT03263923|27051834|FG000|Overall Study|Withdrawal by Subject|10|||
13490688|NCT03263923|27051835|FG001|Overall Study|Withdrawal by Subject|8|||
13490689|NCT03263923|27051834|FG000|Overall Study|Lost to Follow-up|15|||
13490690|NCT03263923|27051835|FG001|Overall Study|Lost to Follow-up|13|||
13490691|NCT03237325|27051848|FG000|Overall Study|Lost to Follow-up|3|||
13490692|NCT03237325|27051849|FG001|Overall Study|Lost to Follow-up|5|||
13490693|NCT03237325|27051848|FG000|Overall Study|Physician Decision|2|||
13490694|NCT03237325|27051849|FG001|Overall Study|Physician Decision|4|||
13490695|NCT03237325|27051848|FG000|Overall Study|Withdrawal by Subject|9|||
13490696|NCT03237325|27051849|FG001|Overall Study|Withdrawal by Subject|12|||
13490697|NCT03237325|27051848|FG000|Overall Study|Noncompliance with Study Procedures|1|||
13490698|NCT03237325|27051849|FG001|Overall Study|Noncompliance with Study Procedures|1|||
13490699|NCT03237325|27051848|FG000|Overall Study|Termination by Sponsor|0|||
13490700|NCT03237325|27051849|FG001|Overall Study|Termination by Sponsor|1|||
13490701|NCT03237325|27051848|FG000|Overall Study|Reason other than described|0|||
13490702|NCT03237325|27051849|FG001|Overall Study|Reason other than described|2|||
13490703|NCT03113383|27051884|FG000|Overall Study|Death|4|||
13490704|NCT03113383|27051885|FG001|Overall Study|Death|0|||
13490705|NCT03038438|27051987|FG000|Overall Study|Death|3|||
13490706|NCT03038438|27051987|FG000|Overall Study|Lost to Follow-up|8|||
13490707|NCT03038438|27051987|FG000|Overall Study|Subject Incarcerated, Moved, or Refused|4|||
13490708|NCT03038438|27051987|FG000|Overall Study|Withdrawal by Subject|5|||
13490709|NCT03038438|27051987|FG000|Overall Study|No 36-Month Follow-Up|18|||
13490710|NCT02903420|27052009|FG000|Overall Study|Death|3|||
13490711|NCT02713529|27052117|FG000|Overall Study|Withdrawal by Subject|3|||
13490712|NCT02713529|27052118|FG001|Overall Study|Withdrawal by Subject|1|||
13490713|NCT02713529|27052119|FG002|Overall Study|Withdrawal by Subject|4|||
13490714|NCT02713529|27052120|FG003|Overall Study|Withdrawal by Subject|2|||
13490715|NCT02713529|27052121|FG004|Overall Study|Withdrawal by Subject|0|||
13490716|NCT02713529|27052122|FG005|Overall Study|Withdrawal by Subject|1|||
13490717|NCT02713529|27052123|FG006|Overall Study|Withdrawal by Subject|1|||
13490718|NCT02713529|27052117|FG000|Overall Study|Lost to Follow-up|1|||
13490719|NCT02713529|27052118|FG001|Overall Study|Lost to Follow-up|0|||
13490720|NCT02713529|27052119|FG002|Overall Study|Lost to Follow-up|1|||
13490721|NCT02713529|27052120|FG003|Overall Study|Lost to Follow-up|0|||
13490722|NCT02713529|27052121|FG004|Overall Study|Lost to Follow-up|0|||
13296304|NCT01370863|26496275|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
13296305|NCT01370733|26496304|FG000|Overall Study|Withdrawal by Subject|8|||
13490723|NCT02713529|27052122|FG005|Overall Study|Lost to Follow-up|0|||
13490724|NCT02713529|27052123|FG006|Overall Study|Lost to Follow-up|0|||
13490725|NCT02713529|27052117|FG000|Overall Study|Death|3|||
13490726|NCT02713529|27052118|FG001|Overall Study|Death|3|||
13490727|NCT02713529|27052119|FG002|Overall Study|Death|26|||
13490728|NCT02713529|27052120|FG003|Overall Study|Death|27|||
13490729|NCT02713529|27052121|FG004|Overall Study|Death|3|||
13490730|NCT02713529|27052122|FG005|Overall Study|Death|13|||
13490731|NCT02713529|27052123|FG006|Overall Study|Death|3|||
13490732|NCT02685826|27052216|FG000|Overall Study|Adverse Event|2|||
13490733|NCT02685826|27052217|FG001|Overall Study|Adverse Event|0|||
13490734|NCT02685826|27052218|FG002|Overall Study|Adverse Event|1|||
13490735|NCT02685826|27052216|FG000|Overall Study|Progressive Disease|2|||
13296306|NCT01370733|26496305|FG001|Overall Study|Withdrawal by Subject|8|||
13296307|NCT01370733|26496304|FG000|Overall Study|Lost to Follow-up|3|||
13296308|NCT01370733|26496305|FG001|Overall Study|Lost to Follow-up|0|||
13296309|NCT01370733|26496304|FG000|Overall Study|Adverse Event|2|||
13381391|NCT00753675|26748064|FG000|Overall Study|Adverse Event|11|||
13490736|NCT02685826|27052217|FG001|Overall Study|Progressive Disease|1|||
13490737|NCT02685826|27052218|FG002|Overall Study|Progressive Disease|0|||
13490738|NCT02685826|27052216|FG000|Overall Study|Withdrawal by Subject|2|||
13490739|NCT02685826|27052217|FG001|Overall Study|Withdrawal by Subject|0|||
13490740|NCT02685826|27052218|FG002|Overall Study|Withdrawal by Subject|0|||
13490741|NCT02685826|27052216|FG000|Overall Study|Full Clinical Hold by FDA|19|||
13490742|NCT02685826|27052217|FG001|Overall Study|Full Clinical Hold by FDA|9|||
13296310|NCT01370733|26496305|FG001|Overall Study|Adverse Event|4|||
13296311|NCT01370733|26496304|FG000|Overall Study|Lack of Efficacy|3|||
13296312|NCT01370733|26496305|FG001|Overall Study|Lack of Efficacy|5|||
13296313|NCT01370733|26496304|FG000|Overall Study|Physician Decision|0|||
13296314|NCT01370733|26496305|FG001|Overall Study|Physician Decision|2|||
13296315|NCT01370733|26496304|FG000|Overall Study|Protocol Violation|1|||
13296316|NCT01370733|26496305|FG001|Overall Study|Protocol Violation|3|||
13296317|NCT01370694|26496317|FG000|Overall Study|Switched to rituximab|4|||
13296318|NCT01370694|26496317|FG000|Overall Study|Progressive disease|2|||
13296319|NCT01370655|26496388|FG000|Period 1|Adverse Event|2|||
13296320|NCT01370655|26496389|FG001|Period 1|Adverse Event|0|||
13296321|NCT01370655|26496390|FG002|Period 1|Adverse Event|0|||
13296322|NCT01370655|26496391|FG003|Period 1|Adverse Event|0|||
13296323|NCT01370655|26496392|FG004|Period 1|Adverse Event|0|||
13296324|NCT01370655|26496393|FG005|Period 1|Adverse Event|0|||
13296325|NCT01370655|26496394|FG006|Period 1|Adverse Event|1|||
13296326|NCT01370655|26496395|FG007|Period 1|Adverse Event|0|||
13296327|NCT01370655|26496396|FG008|Period 1|Adverse Event|0|||
13296328|NCT01370655|26496397|FG009|Period 1|Adverse Event|0|||
13296329|NCT01370655|26496398|FG010|Period 1|Adverse Event|0|||
13296330|NCT01370655|26496399|FG011|Period 1|Adverse Event|0|||
13296331|NCT01370655|26496388|FG000|Period 2|Adverse Event|0|||
13296332|NCT01370655|26496389|FG001|Period 2|Adverse Event|0|||
13296333|NCT01370655|26496390|FG002|Period 2|Adverse Event|1|||
13296334|NCT01370655|26496391|FG003|Period 2|Adverse Event|0|||
13296335|NCT01370655|26496392|FG004|Period 2|Adverse Event|1|||
13296336|NCT01370655|26496393|FG005|Period 2|Adverse Event|0|||
13296337|NCT01370655|26496394|FG006|Period 2|Adverse Event|0|||
13296338|NCT01370655|26496395|FG007|Period 2|Adverse Event|1|||
13296339|NCT01370655|26496396|FG008|Period 2|Adverse Event|0|||
13296340|NCT01370655|26496397|FG009|Period 2|Adverse Event|0|||
13296341|NCT01370655|26496398|FG010|Period 2|Adverse Event|0|||
13296342|NCT01370655|26496399|FG011|Period 2|Adverse Event|0|||
13296343|NCT01370655|26496388|FG000|Period 2|met protocol specified stopping criteria|0|||
13296344|NCT01370655|26496389|FG001|Period 2|met protocol specified stopping criteria|0|||
13296345|NCT01370655|26496390|FG002|Period 2|met protocol specified stopping criteria|1|||
13296346|NCT01370655|26496391|FG003|Period 2|met protocol specified stopping criteria|0|||
13296347|NCT01370655|26496392|FG004|Period 2|met protocol specified stopping criteria|0|||
13296348|NCT01370655|26496393|FG005|Period 2|met protocol specified stopping criteria|0|||
13296349|NCT01370655|26496394|FG006|Period 2|met protocol specified stopping criteria|1|||
13296350|NCT01370655|26496395|FG007|Period 2|met protocol specified stopping criteria|0|||
13296351|NCT01370655|26496396|FG008|Period 2|met protocol specified stopping criteria|1|||
13296352|NCT01370655|26496397|FG009|Period 2|met protocol specified stopping criteria|0|||
13296353|NCT01370655|26496398|FG010|Period 2|met protocol specified stopping criteria|1|||
13296354|NCT01370655|26496399|FG011|Period 2|met protocol specified stopping criteria|0|||
13296355|NCT01370655|26496388|FG000|Period 2|Withdrawal by Subject|0|||
13296356|NCT01370655|26496389|FG001|Period 2|Withdrawal by Subject|0|||
13296357|NCT01370655|26496390|FG002|Period 2|Withdrawal by Subject|0|||
13296358|NCT01370655|26496391|FG003|Period 2|Withdrawal by Subject|0|||
13296359|NCT01370655|26496392|FG004|Period 2|Withdrawal by Subject|0|||
13296360|NCT01370655|26496393|FG005|Period 2|Withdrawal by Subject|0|||
13296361|NCT01370655|26496394|FG006|Period 2|Withdrawal by Subject|0|||
13296362|NCT01370655|26496395|FG007|Period 2|Withdrawal by Subject|0|||
13296363|NCT01370655|26496396|FG008|Period 2|Withdrawal by Subject|1|||
13296364|NCT01370655|26496397|FG009|Period 2|Withdrawal by Subject|0|||
13296365|NCT01370655|26496398|FG010|Period 2|Withdrawal by Subject|0|||
13296366|NCT01370655|26496399|FG011|Period 2|Withdrawal by Subject|0|||
13296367|NCT01370642|26496438|FG000|Overall Study|Adverse Event|2|||
13296368|NCT01370642|26496439|FG001|Overall Study|Adverse Event|1|||
13296369|NCT01370642|26496440|FG002|Overall Study|Adverse Event|1|||
13296370|NCT01370642|26496438|FG000|Overall Study|Detectable HCV RNA|0|||
13296371|NCT01370642|26496439|FG001|Overall Study|Detectable HCV RNA|0|||
13296372|NCT01370642|26496440|FG002|Overall Study|Detectable HCV RNA|22|||
13296373|NCT01370642|26496438|FG000|Overall Study|Lost to Follow-up|0|||
13296374|NCT01370642|26496439|FG001|Overall Study|Lost to Follow-up|0|||
13296375|NCT01370642|26496440|FG002|Overall Study|Lost to Follow-up|1|||
13490743|NCT02685826|27052218|FG002|Overall Study|Full Clinical Hold by FDA|20|||
13490744|NCT02572167|27052251|FG000|Overall Study|Withdrawal by Subject|0|||
13296376|NCT01370642|26496438|FG000|Overall Study|Physician Decision|4|||
13296377|NCT01370642|26496439|FG001|Overall Study|Physician Decision|1|||
13296378|NCT01370642|26496440|FG002|Overall Study|Physician Decision|2|||
13296379|NCT01370642|26496438|FG000|Overall Study|Withdrawal by Subject|2|||
13296380|NCT01370642|26496439|FG001|Overall Study|Withdrawal by Subject|4|||
13296381|NCT01370642|26496440|FG002|Overall Study|Withdrawal by Subject|3|||
13296382|NCT01370616|26496469|FG000|Overall Study|Adverse Event|11|||
13296383|NCT01370616|26496470|FG001|Overall Study|Adverse Event|16|||
13296384|NCT01370616|26496469|FG000|Overall Study|Death|1|||
13296385|NCT01370616|26496470|FG001|Overall Study|Death|0|||
13296386|NCT01370616|26496469|FG000|Overall Study|Lack of Efficacy|6|||
13296387|NCT01370616|26496470|FG001|Overall Study|Lack of Efficacy|2|||
13296388|NCT01370616|26496469|FG000|Overall Study|Lost to Follow-up|0|||
13296389|NCT01370616|26496470|FG001|Overall Study|Lost to Follow-up|3|||
13296390|NCT01370616|26496469|FG000|Overall Study|Physician Decision|6|||
13296391|NCT01370616|26496470|FG001|Overall Study|Physician Decision|6|||
13296392|NCT01370616|26496469|FG000|Overall Study|Progressive Disease|0|||
13296393|NCT01370616|26496470|FG001|Overall Study|Progressive Disease|1|||
13296394|NCT01370616|26496469|FG000|Overall Study|Recovery|1|||
13296395|NCT01370616|26496470|FG001|Overall Study|Recovery|0|||
13296396|NCT01370616|26496469|FG000|Overall Study|Technical Problems|3|||
13296397|NCT01370616|26496470|FG001|Overall Study|Technical Problems|5|||
13296398|NCT01370616|26496469|FG000|Overall Study|Withdrawal by Subject|34|||
13296399|NCT01370616|26496470|FG001|Overall Study|Withdrawal by Subject|34|||
13296400|NCT01370603|26496493|FG000|Period 1|Adverse Event|5|||
13296401|NCT01370603|26496494|FG001|Period 1|Adverse Event|3|||
13296402|NCT01370603|26496493|FG000|Period 1|Lost to Follow-up|2|||
13490745|NCT02572167|27052252|FG001|Overall Study|Withdrawal by Subject|3|||
13490746|NCT02572167|27052253|FG002|Overall Study|Withdrawal by Subject|0|||
13490747|NCT02572167|27052251|FG000|Overall Study|Lost to Follow-up|2|||
13490748|NCT02572167|27052252|FG001|Overall Study|Lost to Follow-up|5|||
13490749|NCT02572167|27052253|FG002|Overall Study|Lost to Follow-up|3|||
13490750|NCT02572167|27052251|FG000|Overall Study|Death|0|||
13490751|NCT02572167|27052252|FG001|Overall Study|Death|8|||
13490752|NCT02572167|27052253|FG002|Overall Study|Death|3|||
13490753|NCT02572167|27052251|FG000|Overall Study|Did not meet inclusion criteria|0|||
13490754|NCT02572167|27052252|FG001|Overall Study|Did not meet inclusion criteria|0|||
13381392|NCT00753675|26748065|FG001|Overall Study|Adverse Event|9|||
13381393|NCT00753675|26748066|FG002|Overall Study|Adverse Event|4|||
13381394|NCT00753675|26748064|FG000|Overall Study|Objective progression of disease|35|||
13490755|NCT02572167|27052253|FG002|Overall Study|Did not meet inclusion criteria|1|||
13490756|NCT02572167|27052251|FG000|Overall Study|Study closure by Sponsor|4|||
13490757|NCT02572167|27052252|FG001|Overall Study|Study closure by Sponsor|40|||
13490758|NCT02572167|27052253|FG002|Overall Study|Study closure by Sponsor|24|||
13490759|NCT02561273|27052272|FG000|Overall Study|Protocol Violation|1|||
13490760|NCT02561273|27052273|FG001|Overall Study|Protocol Violation|0|||
13490761|NCT02392559|27052311|FG000|Overall Study|Withdrawal by Subject|0|||
13490762|NCT02392559|27052312|FG001|Overall Study|Withdrawal by Subject|1|||
13490763|NCT02258451|27052345|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|88|||
13490764|NCT02258451|27052346|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|95|||
13490765|NCT02258451|27052345|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|6|||
13490766|NCT02258451|27052346|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
13490767|NCT02258451|27052345|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8|||
13490768|NCT02258451|27052346|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1|||
13490769|NCT02258451|27052345|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8|||
13490770|NCT02258451|27052346|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6|||
13490771|NCT02258451|27052345|FG000|Overall Study|Death|4|||
13490772|NCT02258451|27052346|FG001|Overall Study|Death|3|||
13490773|NCT02258451|27052345|FG000|Overall Study|Withdrawal by Subject|21|||
13490774|NCT02258451|27052346|FG001|Overall Study|Withdrawal by Subject|12|||
13490775|NCT02258451|27052345|FG000|Overall Study|Discontinuation all treatment due to TS-1 started|1|||
13490776|NCT02258451|27052346|FG001|Overall Study|Discontinuation all treatment due to TS-1 started|0|||
13490777|NCT02258451|27052345|FG000|Overall Study|Discontinuation all treatment due to event point reached|1|||
13490778|NCT02258451|27052346|FG001|Overall Study|Discontinuation all treatment due to event point reached|1|||
13490779|NCT02258451|27052345|FG000|Overall Study|Physician Decision|0|||
13490780|NCT02258451|27052346|FG001|Overall Study|Physician Decision|2|||
13490781|NCT02258451|27052345|FG000|Overall Study|Never treated|2|||
13490782|NCT02258451|27052346|FG001|Overall Study|Never treated|3|||
13490783|NCT02258451|27052345|FG000|Overall Study|Ongoing with any Treatment of radium 223 or placebo, exemestane, or everolimus|3|||
13296403|NCT01370603|26496494|FG001|Period 1|Lost to Follow-up|0|||
13296404|NCT01370603|26496493|FG000|Period 1|Protocol Violation|2|||
13296405|NCT01370603|26496494|FG001|Period 1|Protocol Violation|2|||
13296406|NCT01370603|26496493|FG000|Period 1|Withdrawal by Subject|5|||
13296407|NCT01370603|26496494|FG001|Period 1|Withdrawal by Subject|5|||
13296408|NCT01370603|26496493|FG000|Crossover Washout|Adverse Event|2|||
13296409|NCT01370603|26496494|FG001|Crossover Washout|Adverse Event|1|||
13296410|NCT01370603|26496493|FG000|Crossover Washout|Lost to Follow-up|2|||
13296411|NCT01370603|26496494|FG001|Crossover Washout|Lost to Follow-up|0|||
13296412|NCT01370603|26496493|FG000|Crossover Washout|Protocol Violation|1|||
13475827|NCT03137173|27001105|FG000|Overall Study|Death|1|||
13296413|NCT01370603|26496494|FG001|Crossover Washout|Protocol Violation|0|||
13296414|NCT01370603|26496493|FG000|Crossover Washout|Withdrawal by Subject|4|||
13475828|NCT03137173|27001106|FG001|Overall Study|Death|3|||
13475829|NCT03137173|27001105|FG000|Overall Study|Physician Decision|1|||
13475830|NCT03137173|27001106|FG001|Overall Study|Physician Decision|0|||
13475831|NCT03137173|27001105|FG000|Overall Study|Lost to Follow-up|13|||
13475832|NCT03137173|27001106|FG001|Overall Study|Lost to Follow-up|18|||
13475833|NCT03137173|27001105|FG000|Overall Study|Other reasons|3|||
13475834|NCT03137173|27001106|FG001|Overall Study|Other reasons|2|||
13475835|NCT02998476|27001263|FG000|Overall Study|Lost to Follow-up|1|||
13475836|NCT02998476|27001264|FG001|Overall Study|Lost to Follow-up|0|||
13475837|NCT02998476|27001263|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2|||
13475838|NCT02998476|27001264|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0|||
13475839|NCT02998476|27001263|FG000|Overall Study|Withdrawal by Subject|1|||
13475840|NCT02998476|27001264|FG001|Overall Study|Withdrawal by Subject|2|||
13475841|NCT02998476|27001263|FG000|Overall Study|Death|45|||
13475842|NCT02998476|27001264|FG001|Overall Study|Death|2|||
13490784|NCT02258451|27052346|FG001|Overall Study|Ongoing with any Treatment of radium 223 or placebo, exemestane, or everolimus|11|||
13490785|NCT02115139|27052360|FG000|Overall Study|Protocol Violation|1|||
13490786|NCT02115139|27052360|FG000|Overall Study|treatment discontinuation|6|||
13490787|NCT02061293|27052413|FG000|Overall Study|Elevated Blood Pressure|1|||
13490788|NCT02061293|27052414|FG001|Overall Study|Elevated Blood Pressure|1|||
13490789|NCT01982955|27052556|FG000|Overall Study|Randomized but not treated|0|||
13490790|NCT01982955|27052557|FG001|Overall Study|Randomized but not treated|0|||
13490791|NCT01982955|27052558|FG002|Overall Study|Randomized but not treated|0|||
13490792|NCT01982955|27052559|FG003|Overall Study|Randomized but not treated|1|||
13490793|NCT01982955|27052560|FG004|Overall Study|Randomized but not treated|0|||
13490794|NCT01763866|27053187|FG000|Overall Study|Withdrawal by Subject|2|||
13490795|NCT01763866|27053188|FG001|Overall Study|Withdrawal by Subject|1|||
13490796|NCT01763866|27053189|FG002|Overall Study|Withdrawal by Subject|4|||
13490797|NCT01763866|27053190|FG003|Overall Study|Withdrawal by Subject|0|||
13490798|NCT01763866|27053191|FG004|Overall Study|Withdrawal by Subject|0|||
13490799|NCT01763866|27053192|FG005|Overall Study|Withdrawal by Subject|3|||
13490800|NCT01763866|27053193|FG006|Overall Study|Withdrawal by Subject|4|||
13490801|NCT01763866|27053194|FG007|Overall Study|Withdrawal by Subject|0|||
13490802|NCT01763866|27053195|FG008|Overall Study|Withdrawal by Subject|1|||
13490803|NCT01763866|27053196|FG009|Overall Study|Withdrawal by Subject|1|||
13490804|NCT01763866|27053197|FG010|Overall Study|Withdrawal by Subject|2|||
13490805|NCT01763866|27053198|FG011|Overall Study|Withdrawal by Subject|2|||
13490806|NCT01763866|27053199|FG012|Overall Study|Withdrawal by Subject|2|||
13490807|NCT01763866|27053200|FG013|Overall Study|Withdrawal by Subject|0|||
13490808|NCT01763866|27053201|FG014|Overall Study|Withdrawal by Subject|6|||
13490809|NCT01763866|27053202|FG015|Overall Study|Withdrawal by Subject|3|||
13490810|NCT01763866|27053203|FG016|Overall Study|Withdrawal by Subject|0|||
13490811|NCT01763866|27053204|FG017|Overall Study|Withdrawal by Subject|1|||
13490812|NCT01763866|27053205|FG018|Overall Study|Withdrawal by Subject|1|||
13490813|NCT01763866|27053206|FG019|Overall Study|Withdrawal by Subject|1|||
13490814|NCT01763866|27053207|FG020|Overall Study|Withdrawal by Subject|2|||
13490815|NCT01763866|27053208|FG021|Overall Study|Withdrawal by Subject|1|||
13490816|NCT01763866|27053209|FG022|Overall Study|Withdrawal by Subject|2|||
13490817|NCT01763866|27053210|FG023|Overall Study|Withdrawal by Subject|1|||
13490818|NCT01763866|27053187|FG000|Overall Study|Decision by sponsor|0|||
13490819|NCT01763866|27053188|FG001|Overall Study|Decision by sponsor|0|||
13490820|NCT01763866|27053189|FG002|Overall Study|Decision by sponsor|1|||
13490821|NCT01763866|27053190|FG003|Overall Study|Decision by sponsor|0|||
13490822|NCT01763866|27053191|FG004|Overall Study|Decision by sponsor|2|||
13490823|NCT01763866|27053192|FG005|Overall Study|Decision by sponsor|0|||
13490824|NCT01763866|27053193|FG006|Overall Study|Decision by sponsor|2|||
13490825|NCT01763866|27053194|FG007|Overall Study|Decision by sponsor|0|||
13490826|NCT01763866|27053195|FG008|Overall Study|Decision by sponsor|2|||
13490827|NCT01763866|27053196|FG009|Overall Study|Decision by sponsor|0|||
13490828|NCT01763866|27053197|FG010|Overall Study|Decision by sponsor|6|||
13490829|NCT01763866|27053198|FG011|Overall Study|Decision by sponsor|0|||
13490830|NCT01763866|27053199|FG012|Overall Study|Decision by sponsor|1|||
13490831|NCT01763866|27053200|FG013|Overall Study|Decision by sponsor|0|||
13490832|NCT01763866|27053201|FG014|Overall Study|Decision by sponsor|5|||
13490833|NCT01763866|27053202|FG015|Overall Study|Decision by sponsor|0|||
13490834|NCT01763866|27053203|FG016|Overall Study|Decision by sponsor|0|||
13490835|NCT01763866|27053204|FG017|Overall Study|Decision by sponsor|0|||
13490836|NCT01763866|27053205|FG018|Overall Study|Decision by sponsor|4|||
13490837|NCT01763866|27053206|FG019|Overall Study|Decision by sponsor|0|||
13490838|NCT01763866|27053207|FG020|Overall Study|Decision by sponsor|2|||
13490839|NCT01763866|27053208|FG021|Overall Study|Decision by sponsor|0|||
13490840|NCT01763866|27053209|FG022|Overall Study|Decision by sponsor|1|||
13490841|NCT01763866|27053210|FG023|Overall Study|Decision by sponsor|0|||
13490842|NCT01763866|27053187|FG000|Overall Study|Lost to Follow-up|0|||
13490843|NCT01763866|27053188|FG001|Overall Study|Lost to Follow-up|0|||
13207532|NCT01947283|26238164|FG004|Overall Study|Withdrawal by Subject|0|||
13207533|NCT01947283|26238165|FG005|Overall Study|Withdrawal by Subject|0|||
13207534|NCT01947283|26238166|FG006|Overall Study|Withdrawal by Subject|2|||
13207535|NCT01947283|26238160|FG000|Overall Study|No Clinical Recording|12|||
13490844|NCT01763866|27053189|FG002|Overall Study|Lost to Follow-up|0|||
13490845|NCT01763866|27053190|FG003|Overall Study|Lost to Follow-up|0|||
13490846|NCT01763866|27053191|FG004|Overall Study|Lost to Follow-up|0|||
13490847|NCT01763866|27053192|FG005|Overall Study|Lost to Follow-up|0|||
13490848|NCT01763866|27053193|FG006|Overall Study|Lost to Follow-up|1|||
13490849|NCT01763866|27053194|FG007|Overall Study|Lost to Follow-up|0|||
13490850|NCT01763866|27053195|FG008|Overall Study|Lost to Follow-up|0|||
13490851|NCT01763866|27053196|FG009|Overall Study|Lost to Follow-up|0|||
13490852|NCT01763866|27053197|FG010|Overall Study|Lost to Follow-up|0|||
13490853|NCT01763866|27053198|FG011|Overall Study|Lost to Follow-up|0|||
13490854|NCT01763866|27053199|FG012|Overall Study|Lost to Follow-up|1|||
13490855|NCT01763866|27053200|FG013|Overall Study|Lost to Follow-up|0|||
13207536|NCT01947283|26238161|FG001|Overall Study|No Clinical Recording|6|||
13490856|NCT01763866|27053201|FG014|Overall Study|Lost to Follow-up|1|||
13490857|NCT01763866|27053202|FG015|Overall Study|Lost to Follow-up|0|||
13490858|NCT01763866|27053203|FG016|Overall Study|Lost to Follow-up|0|||
13490859|NCT01763866|27053204|FG017|Overall Study|Lost to Follow-up|0|||
13490860|NCT01763866|27053205|FG018|Overall Study|Lost to Follow-up|1|||
13490861|NCT01763866|27053206|FG019|Overall Study|Lost to Follow-up|1|||
13490862|NCT01763866|27053207|FG020|Overall Study|Lost to Follow-up|0|||
13490863|NCT01763866|27053208|FG021|Overall Study|Lost to Follow-up|0|||
13490864|NCT01763866|27053209|FG022|Overall Study|Lost to Follow-up|0|||
13490865|NCT01763866|27053210|FG023|Overall Study|Lost to Follow-up|1|||
13490866|NCT01763866|27053187|FG000|Overall Study|Death|0|||
13490867|NCT01763866|27053188|FG001|Overall Study|Death|0|||
13490868|NCT01763866|27053189|FG002|Overall Study|Death|0|||
13490869|NCT01763866|27053190|FG003|Overall Study|Death|0|||
13490870|NCT01763866|27053191|FG004|Overall Study|Death|0|||
13490871|NCT01763866|27053192|FG005|Overall Study|Death|0|||
13490872|NCT01763866|27053193|FG006|Overall Study|Death|0|||
13490873|NCT01763866|27053194|FG007|Overall Study|Death|0|||
13490874|NCT01763866|27053195|FG008|Overall Study|Death|0|||
13490875|NCT01763866|27053196|FG009|Overall Study|Death|0|||
13490876|NCT01763866|27053197|FG010|Overall Study|Death|0|||
13490877|NCT01763866|27053198|FG011|Overall Study|Death|0|||
13490878|NCT01763866|27053199|FG012|Overall Study|Death|0|||
13490879|NCT01763866|27053200|FG013|Overall Study|Death|0|||
13490880|NCT01763866|27053201|FG014|Overall Study|Death|0|||
13490881|NCT01763866|27053202|FG015|Overall Study|Death|0|||
13490882|NCT01763866|27053203|FG016|Overall Study|Death|1|||
13490883|NCT01763866|27053204|FG017|Overall Study|Death|0|||
13490884|NCT01763866|27053205|FG018|Overall Study|Death|0|||
13490885|NCT01763866|27053206|FG019|Overall Study|Death|0|||
13490886|NCT01763866|27053207|FG020|Overall Study|Death|0|||
13490887|NCT01763866|27053208|FG021|Overall Study|Death|0|||
13490888|NCT01763866|27053209|FG022|Overall Study|Death|0|||
13490889|NCT01763866|27053210|FG023|Overall Study|Death|0|||
13490890|NCT01763827|27053369|FG000|Overall Study|Withdrawal by Subject|1|||
13490891|NCT01763827|27053370|FG001|Overall Study|Withdrawal by Subject|0|||
13490892|NCT01763827|27053371|FG002|Overall Study|Withdrawal by Subject|0|||
13490893|NCT01763827|27053372|FG003|Overall Study|Withdrawal by Subject|0|||
13490894|NCT01763827|27053373|FG004|Overall Study|Withdrawal by Subject|2|||
13490895|NCT01763827|27053374|FG005|Overall Study|Withdrawal by Subject|0|||
13490896|NCT01763827|27053369|FG000|Overall Study|Decision by sponsor|2|||
13490897|NCT01763827|27053370|FG001|Overall Study|Decision by sponsor|0|||
13490898|NCT01763827|27053371|FG002|Overall Study|Decision by sponsor|3|||
13490899|NCT01763827|27053372|FG003|Overall Study|Decision by sponsor|0|||
13490900|NCT01763827|27053373|FG004|Overall Study|Decision by sponsor|2|||
13490901|NCT01763827|27053374|FG005|Overall Study|Decision by sponsor|1|||
13490902|NCT01763827|27053369|FG000|Overall Study|Lost to Follow-up|0|||
13490903|NCT01763827|27053370|FG001|Overall Study|Lost to Follow-up|1|||
13490904|NCT01763827|27053371|FG002|Overall Study|Lost to Follow-up|1|||
13490905|NCT01763827|27053372|FG003|Overall Study|Lost to Follow-up|1|||
13490906|NCT01763827|27053373|FG004|Overall Study|Lost to Follow-up|2|||
13490907|NCT01763827|27053374|FG005|Overall Study|Lost to Follow-up|1|||
13490908|NCT01732783|27053446|FG000|Overall Study|Discontinued Panitumumab Treatment|106|||
13490909|NCT01732783|27053447|FG001|Overall Study|Discontinued Panitumumab Treatment|25|||
13490910|NCT01732783|27053448|FG002|Overall Study|Discontinued Panitumumab Treatment|7|||
13490911|NCT01732783|27053446|FG000|Overall Study|Death|13|||
13490912|NCT01732783|27053447|FG001|Overall Study|Death|4|||
13490913|NCT01732783|27053448|FG002|Overall Study|Death|1|||
13490914|NCT01732783|27053446|FG000|Overall Study|Lost to Follow-up|7|||
13490915|NCT01732783|27053447|FG001|Overall Study|Lost to Follow-up|1|||
13490916|NCT01732783|27053448|FG002|Overall Study|Lost to Follow-up|1|||
13490917|NCT01732783|27053446|FG000|Overall Study|Administrative Decision|8|||
13490918|NCT01732783|27053447|FG001|Overall Study|Administrative Decision|2|||
13490919|NCT01732783|27053448|FG002|Overall Study|Administrative Decision|1|||
13490920|NCT01732783|27053446|FG000|Overall Study|Withdrawal by Subject|1|||
13490921|NCT01732783|27053447|FG001|Overall Study|Withdrawal by Subject|0|||
13490922|NCT01732783|27053448|FG002|Overall Study|Withdrawal by Subject|0|||
13490923|NCT01631214|27053530|FG000|Overall Study|Withdrawal by Subject|276|||
13490924|NCT01631214|27053531|FG001|Overall Study|Withdrawal by Subject|290|||
13490925|NCT01631214|27053530|FG000|Overall Study|Death|113|||
13490926|NCT01631214|27053531|FG001|Overall Study|Death|106|||
13490927|NCT01631214|27053530|FG000|Overall Study|Lost to Follow-up|54|||
13490928|NCT01631214|27053531|FG001|Overall Study|Lost to Follow-up|40|||
13490929|NCT01631214|27053530|FG000|Overall Study|Adverse Event|45|||
13490930|NCT01631214|27053531|FG001|Overall Study|Adverse Event|45|||
13490931|NCT01631214|27053530|FG000|Overall Study|Other|22|||
13490932|NCT01631214|27053531|FG001|Overall Study|Other|19|||
13490933|NCT01631214|27053530|FG000|Overall Study|Noncompliance|16|||
13490934|NCT01631214|27053531|FG001|Overall Study|Noncompliance|15|||
13490935|NCT01631214|27053530|FG000|Overall Study|Requirement for Alternative Therapy|8|||
13490936|NCT01631214|27053531|FG001|Overall Study|Requirement for Alternative Therapy|3|||
13490937|NCT01631214|27053530|FG000|Overall Study|Protocol Deviation|4|||
13490938|NCT01631214|27053531|FG001|Overall Study|Protocol Deviation|3|||
13490939|NCT01631214|27053530|FG000|Overall Study|Ineligibility determined|5|||
13490940|NCT01631214|27053531|FG001|Overall Study|Ineligibility determined|2|||
13490941|NCT01631214|27053530|FG000|Overall Study|Administrative Decision|1|||
13490942|NCT01631214|27053531|FG001|Overall Study|Administrative Decision|0|||
13490943|NCT01375777|27053624|FG000|Overall Study|Withdrawal by Subject|0|||
13490944|NCT01375777|27053625|FG001|Overall Study|Withdrawal by Subject|2|||
13490945|NCT01375777|27053626|FG002|Overall Study|Withdrawal by Subject|1|||
13490946|NCT01375777|27053627|FG003|Overall Study|Withdrawal by Subject|0|||
13490947|NCT01375777|27053628|FG004|Overall Study|Withdrawal by Subject|1|||
13490948|NCT01375777|27053629|FG005|Overall Study|Withdrawal by Subject|1|||
13490949|NCT01375777|27053630|FG006|Overall Study|Withdrawal by Subject|1|||
13490950|NCT01375777|27053631|FG007|Overall Study|Withdrawal by Subject|2|||
13490951|NCT01375777|27053632|FG008|Overall Study|Withdrawal by Subject|1|||
13490952|NCT01375777|27053624|FG000|Overall Study|Lost to Follow-up|1|||
13490953|NCT01375777|27053625|FG001|Overall Study|Lost to Follow-up|0|||
13490954|NCT01375777|27053626|FG002|Overall Study|Lost to Follow-up|0|||
13490955|NCT01375777|27053627|FG003|Overall Study|Lost to Follow-up|0|||
13490956|NCT01375777|27053628|FG004|Overall Study|Lost to Follow-up|0|||
13490957|NCT01375777|27053629|FG005|Overall Study|Lost to Follow-up|0|||
13490958|NCT01375777|27053630|FG006|Overall Study|Lost to Follow-up|1|||
13490959|NCT01375777|27053631|FG007|Overall Study|Lost to Follow-up|0|||
13490960|NCT01375777|27053632|FG008|Overall Study|Lost to Follow-up|0|||
13490961|NCT01375777|27053624|FG000|Overall Study|Other|1|||
13490962|NCT01375777|27053625|FG001|Overall Study|Other|1|||
13490963|NCT01375777|27053626|FG002|Overall Study|Other|0|||
13490964|NCT01375777|27053627|FG003|Overall Study|Other|0|||
13490965|NCT01375777|27053628|FG004|Overall Study|Other|0|||
13490966|NCT01375777|27053629|FG005|Overall Study|Other|0|||
13490967|NCT01375777|27053630|FG006|Overall Study|Other|0|||
13490968|NCT01375777|27053631|FG007|Overall Study|Other|0|||
13490969|NCT01375777|27053632|FG008|Overall Study|Other|1|||
13490970|NCT01345019|27053661|FG000|Blinded Treatment Phase|Death|147|||
13490971|NCT01345019|27053662|FG001|Blinded Treatment Phase|Death|137|||
13490972|NCT01345019|27053661|FG000|Blinded Treatment Phase|Withdrawal by Subject|103|||
13490973|NCT01345019|27053662|FG001|Blinded Treatment Phase|Withdrawal by Subject|112|||
13490974|NCT01345019|27053661|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21|||
13490975|NCT01345019|27053662|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9|||
13490976|NCT01345019|27053661|FG000|Blinded Treatment Phase|Disease Progression|12|||
13490977|NCT01345019|27053662|FG001|Blinded Treatment Phase|Disease Progression|10|||
13490978|NCT01345019|27053661|FG000|Blinded Treatment Phase|Adverse Event|6|||
13490979|NCT01345019|27053662|FG001|Blinded Treatment Phase|Adverse Event|13|||
13490980|NCT01345019|27053661|FG000|Blinded Treatment Phase|Administrative Decision|10|||
13490981|NCT01345019|27053662|FG001|Blinded Treatment Phase|Administrative Decision|8|||
13490982|NCT01345019|27053661|FG000|Blinded Treatment Phase|Noncompliance|5|||
13490983|NCT01345019|27053662|FG001|Blinded Treatment Phase|Noncompliance|3|||
13490984|NCT01345019|27053661|FG000|Blinded Treatment Phase|Ineligibility Determined|1|||
13490985|NCT01345019|27053662|FG001|Blinded Treatment Phase|Ineligibility Determined|6|||
13490986|NCT01345019|27053661|FG000|Blinded Treatment Phase|Protocol Deviation|5|||
13490987|NCT01345019|27053662|FG001|Blinded Treatment Phase|Protocol Deviation|0|||
13490988|NCT01345019|27053661|FG000|Blinded Treatment Phase|Other, Not Specified|2|||
13490989|NCT01345019|27053662|FG001|Blinded Treatment Phase|Other, Not Specified|3|||
13490990|NCT01345019|27053661|FG000|Blinded Treatment Phase|Lost to Follow-up|6|||
13490991|NCT01345019|27053662|FG001|Blinded Treatment Phase|Lost to Follow-up|3|||
13490992|NCT01345019|27053661|FG000|Open Label Treatment Phase|Death|49|||
13490993|NCT01345019|27053662|FG001|Open Label Treatment Phase|Death|48|||
13490994|NCT01345019|27053661|FG000|Open Label Treatment Phase|Withdrawal by Subject|49|||
13490995|NCT01345019|27053662|FG001|Open Label Treatment Phase|Withdrawal by Subject|47|||
13490996|NCT01345019|27053661|FG000|Open Label Treatment Phase|Adverse Event|30|||
13490997|NCT01345019|27053662|FG001|Open Label Treatment Phase|Adverse Event|51|||
13490998|NCT01345019|27053661|FG000|Open Label Treatment Phase|Administrative Decision|30|||
13490999|NCT01345019|27053662|FG001|Open Label Treatment Phase|Administrative Decision|15|||
13491000|NCT01345019|27053661|FG000|Open Label Treatment Phase|Disease Progression|17|||
13491001|NCT01345019|27053662|FG001|Open Label Treatment Phase|Disease Progression|18|||
13491002|NCT01345019|27053661|FG000|Open Label Treatment Phase|Noncompliance|5|||
13491003|NCT01345019|27053662|FG001|Open Label Treatment Phase|Noncompliance|4|||
13491004|NCT01345019|27053661|FG000|Open Label Treatment Phase|Lost to Follow-up|1|||
13491005|NCT01345019|27053662|FG001|Open Label Treatment Phase|Lost to Follow-up|2|||
13491006|NCT01345019|27053661|FG000|Open Label Treatment Phase|Pregnancy|1|||
13491007|NCT01345019|27053662|FG001|Open Label Treatment Phase|Pregnancy|0|||
13491008|NCT01345019|27053661|FG000|Open Label Treatment Phase|Other, Not Specified|9|||
13491009|NCT01345019|27053662|FG001|Open Label Treatment Phase|Other, Not Specified|7|||
13491010|NCT01345019|27053661|FG000|Open Label Treatment Phase|Protocol Violation|0|||
13491011|NCT01345019|27053662|FG001|Open Label Treatment Phase|Protocol Violation|1|||
13491012|NCT01265537|27053697|FG000|Overall Study|Adverse Event|2|||
13491013|NCT01265537|27053698|FG001|Overall Study|Adverse Event|1|||
13491014|NCT01265537|27053697|FG000|Overall Study|Physician Decision|0|||
13491015|NCT01265537|27053698|FG001|Overall Study|Physician Decision|1|||
13491016|NCT00911820|27053762|FG000|Overall Study|RECIST progression|12|||
13491017|NCT00911820|27053763|FG001|Overall Study|RECIST progression|8|||
13491018|NCT00911820|27053762|FG000|Overall Study|Adverse Event|8|||
13491019|NCT00911820|27053763|FG001|Overall Study|Adverse Event|8|||
13491020|NCT00911820|27053762|FG000|Overall Study|Clinical Progression|7|||
13491021|NCT00911820|27053763|FG001|Overall Study|Clinical Progression|5|||
13491022|NCT00911820|27053762|FG000|Overall Study|Physician Decision|5|||
13491023|NCT00911820|27053763|FG001|Overall Study|Physician Decision|9|||
13491024|NCT00911820|27053762|FG000|Overall Study|Decline in Performance Status|4|||
13491025|NCT00911820|27053763|FG001|Overall Study|Decline in Performance Status|2|||
13491026|NCT00911820|27053762|FG000|Overall Study|Withdrawal by Subject|3|||
13491027|NCT00911820|27053763|FG001|Overall Study|Withdrawal by Subject|4|||
13491028|NCT00911820|27053762|FG000|Overall Study|Death|1|||
13491029|NCT00911820|27053763|FG001|Overall Study|Death|2|||
13491030|NCT00911820|27053762|FG000|Overall Study|Pursue surgery|1|||
13491031|NCT00911820|27053763|FG001|Overall Study|Pursue surgery|1|||
13491032|NCT00911820|27053762|FG000|Overall Study|Pursue Radiation|1|||
13491033|NCT00911820|27053763|FG001|Overall Study|Pursue Radiation|0|||
13491034|NCT00911820|27053762|FG000|Overall Study|Still on Therapy|2|||
13491035|NCT00911820|27053763|FG001|Overall Study|Still on Therapy|2|||
13491036|NCT00911820|27053762|FG000|Overall Study|Pathology Not Confirmed|1|||
13491037|NCT00911820|27053763|FG001|Overall Study|Pathology Not Confirmed|0|||
13491038|NCT00911820|27053762|FG000|Overall Study|Withdraw before Receive Treatment|0|||
13491039|NCT00911820|27053763|FG001|Overall Study|Withdraw before Receive Treatment|2|||
13491040|NCT00845026|27053828|FG000|Study Period III|Adverse Event|23|||
13491041|NCT00845026|27053829|FG001|Study Period III|Adverse Event|19|||
13491042|NCT00845026|27053828|FG000|Study Period III|Perceived lack of efficacy|27|||
13491043|NCT00845026|27053829|FG001|Study Period III|Perceived lack of efficacy|15|||
13491044|NCT00845026|27053828|FG000|Study Period III|Withdrawal by Subject|19|||
13491045|NCT00845026|27053829|FG001|Study Period III|Withdrawal by Subject|15|||
13491046|NCT00845026|27053828|FG000|Study Period III|Entry Criteria not met|8|||
13491047|NCT00845026|27053829|FG001|Study Period III|Entry Criteria not met|11|||
13491048|NCT00845026|27053828|FG000|Study Period III|Lost to Follow-up|4|||
13491049|NCT00845026|27053829|FG001|Study Period III|Lost to Follow-up|5|||
13491050|NCT00845026|27053828|FG000|Study Period III|Protocol Violation|8|||
13491051|NCT00845026|27053829|FG001|Study Period III|Protocol Violation|1|||
13491052|NCT00845026|27053828|FG000|Study Period III|Scheduled conflict|3|||
13491053|NCT00845026|27053829|FG001|Study Period III|Scheduled conflict|1|||
13491054|NCT00845026|27053828|FG000|Study Period III|Subject is moving or has moved|2|||
13491055|NCT00845026|27053829|FG001|Study Period III|Subject is moving or has moved|4|||
13491056|NCT00845026|27053828|FG000|Study Period III|Transportation issues|1|||
13491057|NCT00845026|27053829|FG001|Study Period III|Transportation issues|1|||
13491058|NCT00845026|27053828|FG000|Study Period IV|Adverse Event|4|||
13491059|NCT00845026|27053829|FG001|Study Period IV|Adverse Event|0|||
13491060|NCT00845026|27053828|FG000|Study Period IV|Perceived lack of efficacy|2|||
13491061|NCT00845026|27053829|FG001|Study Period IV|Perceived lack of efficacy|1|||
13491062|NCT00845026|27053828|FG000|Study Period IV|Protocol Violation|3|||
13491063|NCT00845026|27053829|FG001|Study Period IV|Protocol Violation|1|||
13491064|NCT00845026|27053828|FG000|Study Period IV|Lost to Follow-up|1|||
13491065|NCT00845026|27053829|FG001|Study Period IV|Lost to Follow-up|0|||
13491066|NCT00845026|27053828|FG000|Study Period IV|Withdrawal by Subject|4|||
13491067|NCT00845026|27053829|FG001|Study Period IV|Withdrawal by Subject|1|||
13296415|NCT01370603|26496494|FG001|Crossover Washout|Withdrawal by Subject|1|||
13296416|NCT01370603|26496493|FG000|Crossover Washout|Non-compliance with Study Drug|0|||
13296417|NCT01370603|26496494|FG001|Crossover Washout|Non-compliance with Study Drug|2|||
13296418|NCT01370603|26496493|FG000|Period 2|Adverse Event|1|||
13296419|NCT01370603|26496494|FG001|Period 2|Adverse Event|4|||
13296420|NCT01370603|26496493|FG000|Period 2|Lost to Follow-up|1|||
13296421|NCT01370603|26496494|FG001|Period 2|Lost to Follow-up|0|||
13296422|NCT01370603|26496493|FG000|Period 2|Withdrawal by Subject|1|||
13296423|NCT01370603|26496494|FG001|Period 2|Withdrawal by Subject|0|||
13296424|NCT01370590|26496517|FG000|Period 1|Adverse Event|8|||
13296425|NCT01370590|26496518|FG001|Period 1|Adverse Event|4|||
13491068|NCT00845026|27053828|FG000|Study Period IV|Entry Criteria Not Met|1|||
13491069|NCT00845026|27053829|FG001|Study Period IV|Entry Criteria Not Met|0|||
13491070|NCT00845026|27053828|FG000|Study Period IV|Subject is moving or has moved|0|||
13491071|NCT00845026|27053829|FG001|Study Period IV|Subject is moving or has moved|1|||
13491072|NCT00845026|27053828|FG000|Study Period IV|Scheduling conflict|1|||
13491073|NCT00845026|27053829|FG001|Study Period IV|Scheduling conflict|0|||
13491074|NCT00691678|27053835|FG000|Overall Study|Adverse Event|5|||
13491075|NCT00691678|27053835|FG000|Overall Study|life events, pain|11|||
13491076|NCT00415532|27053884|FG000|Treatment Period|Adverse Event|2|||
13296426|NCT01370590|26496517|FG000|Period 1|Lost to Follow-up|2|||
13296427|NCT01370590|26496518|FG001|Period 1|Lost to Follow-up|2|||
13491077|NCT00415532|27053885|FG001|Treatment Period|Adverse Event|3|||
13491078|NCT00415532|27053884|FG000|Treatment Period|Death|2|||
13491079|NCT00415532|27053885|FG001|Treatment Period|Death|1|||
13491080|NCT00415532|27053884|FG000|Treatment Period|Lost to Follow-up|1|||
13491081|NCT00415532|27053885|FG001|Treatment Period|Lost to Follow-up|1|||
13491082|NCT00415532|27053884|FG000|Treatment Period|Protocol Violation|1|||
13491083|NCT00415532|27053885|FG001|Treatment Period|Protocol Violation|0|||
13491084|NCT00415532|27053884|FG000|Treatment Period|Withdrawal by Subject|6|||
13491085|NCT00415532|27053885|FG001|Treatment Period|Withdrawal by Subject|6|||
13491086|NCT00415532|27053884|FG000|Treatment Period|Other|2|||
13491087|NCT00415532|27053885|FG001|Treatment Period|Other|2|||
13491088|NCT00415532|27053884|FG000|Treatment Period|Ineligibility determined|1|||
13491089|NCT00415532|27053885|FG001|Treatment Period|Ineligibility determined|1|||
13491090|NCT00415532|27053884|FG000|Treatment Period|Noncompliance|1|||
13491091|NCT00415532|27053885|FG001|Treatment Period|Noncompliance|1|||
13491092|NCT00415532|27053884|FG000|Treatment Period|Requirement for alternative therapy|1|||
13491093|NCT00415532|27053885|FG001|Treatment Period|Requirement for alternative therapy|0|||
13491094|NCT00415532|27053884|FG000|Safety Follow Up Period|Adverse Event|1|||
13491095|NCT00415532|27053885|FG001|Safety Follow Up Period|Adverse Event|3|||
13491096|NCT00415532|27053884|FG000|Safety Follow Up Period|Death|3|||
13491097|NCT00415532|27053885|FG001|Safety Follow Up Period|Death|0|||
13491098|NCT00415532|27053884|FG000|Safety Follow Up Period|Withdrawal by Subject|2|||
13491099|NCT00415532|27053885|FG001|Safety Follow Up Period|Withdrawal by Subject|3|||
13491100|NCT00415532|27053884|FG000|Safety Follow Up Period|Other|1|||
13491101|NCT00415532|27053885|FG001|Safety Follow Up Period|Other|4|||
13491102|NCT00415532|27053884|FG000|Safety Follow Up Period|Ineligibility determined|1|||
13491103|NCT00415532|27053885|FG001|Safety Follow Up Period|Ineligibility determined|1|||
13491104|NCT00415532|27053884|FG000|Safety Follow Up Period|Noncompliance|1|||
13491105|NCT00415532|27053885|FG001|Safety Follow Up Period|Noncompliance|0|||
13491106|NCT00415532|27053884|FG000|Safety Follow Up Period|Requirement for alternative therapy|0|||
13491107|NCT00415532|27053885|FG001|Safety Follow Up Period|Requirement for alternative therapy|1|||
13491108|NCT00396279|27053896|FG000|Overall Study|Ongoing in study|26|||
13491109|NCT00396279|27053896|FG000|Overall Study|Disease progression|2|||
13491110|NCT00396279|27053896|FG000|Overall Study|Withdrawal by Subject|1|||
13491111|NCT00396279|27053896|FG000|Overall Study|Physician Decision|1|||
13491112|NCT00358215|27053917|FG000|Overall Study|Ineligibility determined|4|||
13491113|NCT00358215|27053918|FG001|Overall Study|Ineligibility determined|3|||
13491114|NCT00358215|27053917|FG000|Overall Study|Adverse Event|83|||
13491115|NCT00358215|27053918|FG001|Overall Study|Adverse Event|65|||
13491116|NCT00358215|27053917|FG000|Overall Study|Withdrawal by Subject|111|||
13491117|NCT00358215|27053918|FG001|Overall Study|Withdrawal by Subject|102|||
13491118|NCT00358215|27053917|FG000|Overall Study|Participant request|65|||
13491119|NCT00358215|27053918|FG001|Overall Study|Participant request|64|||
13491120|NCT00358215|27053917|FG000|Overall Study|Physician Decision|47|||
13491121|NCT00358215|27053918|FG001|Overall Study|Physician Decision|39|||
13491122|NCT00358215|27053917|FG000|Overall Study|Lost to Follow-up|16|||
13491123|NCT00358215|27053918|FG001|Overall Study|Lost to Follow-up|22|||
13491124|NCT00358215|27053917|FG000|Overall Study|Death|265|||
13491125|NCT00358215|27053918|FG001|Overall Study|Death|281|||
13491126|NCT00358215|27053917|FG000|Overall Study|Protocol Violation|64|||
13491127|NCT00358215|27053918|FG001|Overall Study|Protocol Violation|59|||
13491128|NCT00358215|27053917|FG000|Overall Study|Pregnancy|1|||
13491129|NCT00358215|27053918|FG001|Overall Study|Pregnancy|0|||
13491130|NCT00358215|27053917|FG000|Overall Study|Other|21|||
13491131|NCT00358215|27053918|FG001|Overall Study|Other|14|||
13491132|NCT00358215|27053917|FG000|Overall Study|Did not receive investigational product|2|||
13491133|NCT00358215|27053918|FG001|Overall Study|Did not receive investigational product|3|||
13491134|NCT00321464|27053935|FG000|Overall Study|Death|169|||
13491135|NCT00321464|27053936|FG001|Overall Study|Death|174|||
13491136|NCT00321464|27053935|FG000|Overall Study|Disease progression|124|||
13491137|NCT00321464|27053936|FG001|Overall Study|Disease progression|124|||
13491138|NCT00321464|27053935|FG000|Overall Study|Withdrawal by Subject|117|||
13491139|NCT00321464|27053936|FG001|Overall Study|Withdrawal by Subject|118|||
13491140|NCT00321464|27053935|FG000|Overall Study|Participant request|57|||
13491141|NCT00321464|27053936|FG001|Overall Study|Participant request|61|||
13491142|NCT00321464|27053935|FG000|Overall Study|Adverse Event|43|||
13491143|NCT00321464|27053936|FG001|Overall Study|Adverse Event|28|||
13491144|NCT00321464|27053935|FG000|Overall Study|Physician Decision|15|||
13491145|NCT00321464|27053936|FG001|Overall Study|Physician Decision|14|||
13491146|NCT00321464|27053935|FG000|Overall Study|Noncompliance|4|||
13491147|NCT00321464|27053936|FG001|Overall Study|Noncompliance|10|||
13491148|NCT00321464|27053935|FG000|Overall Study|Lost to Follow-up|7|||
13491149|NCT00321464|27053936|FG001|Overall Study|Lost to Follow-up|8|||
13491150|NCT00321464|27053935|FG000|Overall Study|Protocol deviation|0|||
13491151|NCT00321464|27053936|FG001|Overall Study|Protocol deviation|2|||
13491152|NCT00321464|27053935|FG000|Overall Study|Ineligibility determined|2|||
13491153|NCT00321464|27053936|FG001|Overall Study|Ineligibility determined|1|||
13491154|NCT00321464|27053935|FG000|Overall Study|Other|21|||
13296428|NCT01370590|26496517|FG000|Period 1|Protocol Violation|2|||
13296429|NCT01370590|26496518|FG001|Period 1|Protocol Violation|2|||
13296430|NCT01370590|26496517|FG000|Period 1|Withdrawal by Subject|4|||
13296431|NCT01370590|26496518|FG001|Period 1|Withdrawal by Subject|2|||
13296432|NCT01370590|26496517|FG000|Period 1|Could not access randomization system|0|||
13296433|NCT01370590|26496518|FG001|Period 1|Could not access randomization system|1|||
13296434|NCT01370590|26496517|FG000|Crossover Washout Period|Adverse Event|1|||
13296435|NCT01370590|26496518|FG001|Crossover Washout Period|Adverse Event|4|||
13296436|NCT01370590|26496517|FG000|Crossover Washout Period|Lost to Follow-up|2|||
13296437|NCT01370590|26496518|FG001|Crossover Washout Period|Lost to Follow-up|0|||
13491155|NCT00321464|27053936|FG001|Overall Study|Other|18|||
13491156|NCT00246324|27053943|FG000|Overall Study|Withdrawal by Subject|1|||
13491157|NCT00093015|27053976|FG000|Overall Study|Withdrawal by Subject|194|||
13491158|NCT00093015|27053977|FG001|Overall Study|Withdrawal by Subject|171|||
13491159|NCT00093015|27053976|FG000|Overall Study|Lost to Follow-up|96|||
13491160|NCT00093015|27053977|FG001|Overall Study|Lost to Follow-up|108|||
13491161|NCT00093015|27053976|FG000|Overall Study|Death|375|||
13491162|NCT00093015|27053977|FG001|Overall Study|Death|385|||
13491163|NCT00089791|27053994|FG000|Overall Study|Physician Decision|6|||
13491164|NCT00089791|27053995|FG001|Overall Study|Physician Decision|3|||
13491165|NCT00089791|27053994|FG000|Overall Study|Adverse Event|81|||
13491166|NCT00089791|27053995|FG001|Overall Study|Adverse Event|93|||
13491167|NCT00089791|27053994|FG000|Overall Study|Withdrawal by Subject|403|||
13491168|NCT00089791|27053995|FG001|Overall Study|Withdrawal by Subject|344|||
13491169|NCT00089791|27053994|FG000|Overall Study|Death|78|||
13491170|NCT00089791|27053995|FG001|Overall Study|Death|62|||
13491171|NCT00089791|27053994|FG000|Overall Study|Disease progression|7|||
13491172|NCT00089791|27053995|FG001|Overall Study|Disease progression|3|||
13491173|NCT00089791|27053994|FG000|Overall Study|Ineligibility determined|12|||
13491174|NCT00089791|27053995|FG001|Overall Study|Ineligibility determined|9|||
13491175|NCT00089791|27053994|FG000|Overall Study|Lost to Follow-up|57|||
13491176|NCT00089791|27053995|FG001|Overall Study|Lost to Follow-up|57|||
13491177|NCT00089791|27053994|FG000|Overall Study|Noncompliance|17|||
13491178|NCT00089791|27053995|FG001|Overall Study|Noncompliance|13|||
13491179|NCT00089791|27053994|FG000|Overall Study|Other|20|||
13491180|NCT00089791|27053995|FG001|Overall Study|Other|32|||
13491181|NCT00089791|27053994|FG000|Overall Study|Protocol deviation|12|||
13491182|NCT00089791|27053995|FG001|Overall Study|Protocol deviation|10|||
13491183|NCT00089791|27053994|FG000|Overall Study|Requirement for alternative therapy|7|||
13491184|NCT00089791|27053995|FG001|Overall Study|Requirement for alternative therapy|4|||
13491185|NCT00003838|27054012|FG000|Overall Study|Death|0|||
13491186|NCT00003838|27054013|FG001|Overall Study|Death|12|||
13491187|NCT00003838|27054014|FG002|Overall Study|Death|7|||
13491188|NCT00003838|27054012|FG000|Overall Study|Lost to Follow-up|0|||
13491189|NCT00003838|27054013|FG001|Overall Study|Lost to Follow-up|1|||
13491190|NCT00003838|27054014|FG002|Overall Study|Lost to Follow-up|1|||
13491191|NCT00003838|27054012|FG000|Overall Study|Disease Progression|0|||
13491192|NCT00003838|27054013|FG001|Overall Study|Disease Progression|12|||
13491193|NCT00003838|27054014|FG002|Overall Study|Disease Progression|0|||
13296438|NCT01370590|26496517|FG000|Crossover Washout Period|Non-compliance with Study Drug|1|||
13491194|NCT04460183|27054047|FG000|Overall Study|Lost to Follow-up|3|||
13491195|NCT04460183|27054048|FG001|Overall Study|Lost to Follow-up|1|||
13491196|NCT04460183|27054047|FG000|Overall Study|Withdrawal by Subject|1|||
13491197|NCT04460183|27054048|FG001|Overall Study|Withdrawal by Subject|0|||
13491198|NCT03543046|27054061|FG000|Overall Study|Adverse Event|1|||
13491199|NCT03543046|27054062|FG001|Overall Study|Adverse Event|1|||
13491200|NCT03543046|27054061|FG000|Overall Study|Physician Decision|1|||
13491201|NCT03543046|27054062|FG001|Overall Study|Physician Decision|1|||
13491202|NCT03543046|27054061|FG000|Overall Study|Protocol Violation|1|||
13491203|NCT03543046|27054062|FG001|Overall Study|Protocol Violation|0|||
13491204|NCT03063203|27054152|FG000|Overall Study|Chose alternative therapy|3|||
13491205|NCT03063203|27054152|FG000|Overall Study|Death|2|||
13491206|NCT03063203|27054152|FG000|Overall Study|Disease progression|4|||
13491207|NCT03063203|27054152|FG000|Overall Study|Physician Decision|5|||
13491208|NCT00999804|27054318|FG000|Overall Study|Lack of Efficacy|9|||
13491209|NCT00999804|27054319|FG001|Overall Study|Lack of Efficacy|2|||
13491210|NCT00999804|27054318|FG000|Overall Study|Adverse Event|4|||
13491211|NCT00999804|27054319|FG001|Overall Study|Adverse Event|3|||
13491212|NCT00999804|27054318|FG000|Overall Study|Withdrawal by Subject|4|||
13491213|NCT00999804|27054319|FG001|Overall Study|Withdrawal by Subject|0|||
13491214|NCT00999804|27054318|FG000|Overall Study|Death|1|||
13381395|NCT00753675|26748065|FG001|Overall Study|Objective progression of disease|35|||
13381396|NCT00753675|26748066|FG002|Overall Study|Objective progression of disease|35|||
13381397|NCT00753675|26748064|FG000|Overall Study|Withdrawal by Subject|0|||
13381398|NCT00753675|26748065|FG001|Overall Study|Withdrawal by Subject|1|||
13381399|NCT00753675|26748066|FG002|Overall Study|Withdrawal by Subject|0|||
13381400|NCT00753675|26748064|FG000|Overall Study|Lost to Follow-up|1|||
13381401|NCT00753675|26748065|FG001|Overall Study|Lost to Follow-up|0|||
13381402|NCT00753675|26748066|FG002|Overall Study|Lost to Follow-up|0|||
13381403|NCT00753649|26748093|FG000|Overall Study|Migrated/moved from study area|1|||
13381404|NCT00753649|26748094|FG001|Overall Study|Migrated/moved from study area|0|||
13381405|NCT00753649|26748093|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3|||
13381406|NCT00753649|26748094|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0|||
13381407|NCT00753649|26748093|FG000|Overall Study|Lost to follow-up-complete vaccination|1|||
13381408|NCT00753649|26748094|FG001|Overall Study|Lost to follow-up-complete vaccination|0|||
13381409|NCT00753649|26748093|FG000|Overall Study|Protocol Violation|2|||
13381410|NCT00753649|26748094|FG001|Overall Study|Protocol Violation|0|||
13381411|NCT00753623|26748107|FG000|Phase I (14 Days)|Withdrawal by Subject|1|||
13381412|NCT00753623|26748108|FG001|Phase I (14 Days)|Withdrawal by Subject|1|||
13491215|NCT00999804|27054319|FG001|Overall Study|Death|0|||
13491216|NCT00999804|27054318|FG000|Overall Study|Ineligible|3|||
13491217|NCT00999804|27054319|FG001|Overall Study|Ineligible|0|||
13491218|NCT00458003|27054336|FG000|Overall Study|Non protocol spinal anesthesia|1|||
13491219|NCT00458003|27054337|FG001|Overall Study|Non protocol spinal anesthesia|1|||
13491220|NCT03794544|27054425|FG000|Overall Study|Withdrawal by Subject|1|||
13491221|NCT03794544|27054426|FG001|Overall Study|Withdrawal by Subject|1|||
13491222|NCT03794544|27054427|FG002|Overall Study|Withdrawal by Subject|0|||
13491223|NCT03794544|27054428|FG003|Overall Study|Withdrawal by Subject|0|||
13491224|NCT03794544|27054425|FG000|Overall Study|Death|0|||
13491225|NCT03794544|27054426|FG001|Overall Study|Death|0|||
13491226|NCT03794544|27054427|FG002|Overall Study|Death|0|||
13491227|NCT03794544|27054428|FG003|Overall Study|Death|1|||
13491228|NCT03794544|27054425|FG000|Overall Study|Lost to Follow-up|0|||
13491229|NCT03794544|27054426|FG001|Overall Study|Lost to Follow-up|1|||
13491230|NCT03794544|27054427|FG002|Overall Study|Lost to Follow-up|1|||
13491231|NCT03794544|27054428|FG003|Overall Study|Lost to Follow-up|0|||
13491232|NCT03794544|27054425|FG000|Overall Study|Other|0|||
13491233|NCT03794544|27054426|FG001|Overall Study|Other|1|||
13491234|NCT03794544|27054427|FG002|Overall Study|Other|0|||
13491235|NCT03794544|27054428|FG003|Overall Study|Other|0|||
13491236|NCT03770000|27054469|FG000|Overall Study|Premature discontinuation due to PD|0|||
13491237|NCT03770000|27054470|FG001|Overall Study|Premature discontinuation due to PD|0|||
13491238|NCT03770000|27054471|FG002|Overall Study|Premature discontinuation due to PD|1|||
13491239|NCT03770000|27054472|FG003|Overall Study|Premature discontinuation due to PD|3|||
13491240|NCT03770000|27054473|FG004|Overall Study|Premature discontinuation due to PD|2|||
13491241|NCT04839965|27054501|FG000|Overall Study|Death|6|||
13491242|NCT04839965|27054502|FG001|Overall Study|Death|6|||
13491243|NCT04839965|27054501|FG000|Overall Study|Lost to Follow-up|1|||
13491244|NCT04839965|27054502|FG001|Overall Study|Lost to Follow-up|0|||
13491245|NCT04230486|27054650|FG000|Overall Study|Screen Failure|1|||
13491246|NCT04228445|27054681|FG000|Overall Study|Lost to Follow-up|1|||
13491247|NCT04228445|27054682|FG001|Overall Study|Lost to Follow-up|1|||
13381413|NCT00753623|26748107|FG000|Phase I (14 Days)|Physician Decision|1|||
13491248|NCT04228445|27054681|FG000|Overall Study|Physician Decision|1|||
13491249|NCT04228445|27054682|FG001|Overall Study|Physician Decision|2|||
13491250|NCT04228445|27054681|FG000|Overall Study|Withdrawal by Subject|0|||
13491251|NCT04228445|27054682|FG001|Overall Study|Withdrawal by Subject|1|||
13491252|NCT04228445|27054681|FG000|Overall Study|Planned procedure not performed after randomization, study drug not administered|1|||
13491253|NCT04228445|27054682|FG001|Overall Study|Planned procedure not performed after randomization, study drug not administered|0|||
13491254|NCT04095793|27054688|FG000|Overall Study|Adverse Event|3|||
13491255|NCT04095793|27054688|FG000|Overall Study|Study Terminated by Sponsor|103|||
13491256|NCT04095793|27054688|FG000|Overall Study|Withdrawal by Subject|4|||
13491257|NCT03848403|27054720|FG000|Period 2 (Day 8)|Adverse Event|1|||
13491258|NCT03848403|27054721|FG001|Period 2 (Day 8)|Adverse Event|2|||
13491259|NCT03848403|27054722|FG002|Period 2 (Day 8)|Adverse Event|2|||
13491260|NCT03848403|27054720|FG000|Period 2 (Day 8)|Physician Decision|0|||
13491261|NCT03848403|27054721|FG001|Period 2 (Day 8)|Physician Decision|1|||
13491262|NCT03848403|27054722|FG002|Period 2 (Day 8)|Physician Decision|0|||
13491263|NCT03848403|27054720|FG000|Period 2 (Day 8)|Sponsor Decision|8|||
13491264|NCT03848403|27054721|FG001|Period 2 (Day 8)|Sponsor Decision|6|||
13491265|NCT03848403|27054722|FG002|Period 2 (Day 8)|Sponsor Decision|5|||
13394506|NCT00657046|26787223|FG000|Overall Study|Withdrawal by Subject|1|||
13207537|NCT01947283|26238162|FG002|Overall Study|No Clinical Recording|8|||
13207538|NCT01947283|26238163|FG003|Overall Study|No Clinical Recording|10|||
13207539|NCT01947283|26238164|FG004|Overall Study|No Clinical Recording|0|||
13394507|NCT00657046|26787224|FG001|Overall Study|Withdrawal by Subject|0|||
13207540|NCT01947283|26238165|FG005|Overall Study|No Clinical Recording|0|||
13491266|NCT03636542|27054743|FG000|Overall Study|Lost to Follow-up|1|||
13491267|NCT03636542|27054744|FG001|Overall Study|Lost to Follow-up|1|||
13491268|NCT03636542|27054743|FG000|Overall Study|Physician Decision|0|||
13491269|NCT03636542|27054744|FG001|Overall Study|Physician Decision|1|||
13491270|NCT03636542|27054743|FG000|Overall Study|Withdrawal by Subject|1|||
13491271|NCT03636542|27054744|FG001|Overall Study|Withdrawal by Subject|0|||
13491272|NCT03634033|27054807|FG000|Overall Study|Did not have a post-assessment|384|||
13491273|NCT03634033|27054808|FG001|Overall Study|Did not have a post-assessment|291|||
13491274|NCT03634033|27054809|FG002|Overall Study|Did not have a post-assessment|114|||
13491275|NCT03634033|27054810|FG003|Overall Study|Did not have a post-assessment|161|||
13491276|NCT03634033|27054811|FG004|Overall Study|Did not have a post-assessment|5|||
13491277|NCT03634033|27054812|FG005|Overall Study|Did not have a post-assessment|0|||
13491278|NCT03634033|27054813|FG006|Overall Study|Did not have a post-assessment|0|||
13491279|NCT03634033|27054807|FG000|Overall Study|Death|0|||
13491280|NCT03634033|27054808|FG001|Overall Study|Death|0|||
13491281|NCT03634033|27054809|FG002|Overall Study|Death|0|||
13491282|NCT03634033|27054810|FG003|Overall Study|Death|0|||
13491283|NCT03634033|27054811|FG004|Overall Study|Death|0|||
13491284|NCT03634033|27054812|FG005|Overall Study|Death|7|||
13491285|NCT03634033|27054813|FG006|Overall Study|Death|7|||
13491286|NCT03634033|27054807|FG000|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
13491287|NCT03634033|27054808|FG001|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
13491288|NCT03634033|27054809|FG002|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
13491289|NCT03634033|27054810|FG003|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
13491290|NCT03634033|27054811|FG004|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
13491291|NCT03634033|27054812|FG005|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
13491292|NCT03634033|27054813|FG006|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
13491293|NCT03634033|27054807|FG000|Overall Study|Lost to Follow-up|0|||
13491294|NCT03634033|27054808|FG001|Overall Study|Lost to Follow-up|0|||
13491295|NCT03634033|27054809|FG002|Overall Study|Lost to Follow-up|0|||
13491296|NCT03634033|27054810|FG003|Overall Study|Lost to Follow-up|0|||
13491297|NCT03634033|27054811|FG004|Overall Study|Lost to Follow-up|0|||
13491298|NCT03634033|27054812|FG005|Overall Study|Lost to Follow-up|1|||
13491299|NCT03634033|27054813|FG006|Overall Study|Lost to Follow-up|2|||
13491300|NCT03634033|27054807|FG000|Overall Study|Withdrawal by Subject|0|||
13491301|NCT03634033|27054808|FG001|Overall Study|Withdrawal by Subject|0|||
13491302|NCT03634033|27054809|FG002|Overall Study|Withdrawal by Subject|0|||
13491303|NCT03634033|27054810|FG003|Overall Study|Withdrawal by Subject|0|||
13491304|NCT03634033|27054811|FG004|Overall Study|Withdrawal by Subject|0|||
13491305|NCT03634033|27054812|FG005|Overall Study|Withdrawal by Subject|0|||
13491306|NCT03634033|27054813|FG006|Overall Study|Withdrawal by Subject|1|||
13491307|NCT03617172|27054830|FG000|Overall Study|Lost to Follow-up|1|||
13491308|NCT03617172|27054831|FG001|Overall Study|Lost to Follow-up|0|||
13491309|NCT03606512|27054870|FG000|Overall Study|Lost to Follow-up|0|||
13491310|NCT03606512|27054871|FG001|Overall Study|Lost to Follow-up|1|||
13491311|NCT03606512|27054870|FG000|Overall Study|'moved from study area|0|||
13491312|NCT03606512|27054871|FG001|Overall Study|'moved from study area|1|||
13491313|NCT02918292|27055162|FG000|Study Enrollment Prior to Transplant|Death|1|||
13491314|NCT02918292|27055162|FG000|Study Follow up After Transplant|Death|6|||
13491315|NCT02542293|27055252|FG000|Overall Study|Death|367|||
13491316|NCT02542293|27055253|FG001|Overall Study|Death|377|||
13491317|NCT02542293|27055252|FG000|Overall Study|Withdrawal by Subject|8|||
13491318|NCT02542293|27055253|FG001|Overall Study|Withdrawal by Subject|19|||
13491319|NCT02296125|27055314|FG000|Overall Study|Withdrawal by Subject|18|||
13491320|NCT02296125|27055315|FG001|Overall Study|Withdrawal by Subject|8|||
13491321|NCT02296125|27055316|FG002|Overall Study|Withdrawal by Subject|6|||
13491322|NCT02296125|27055317|FG003|Overall Study|Withdrawal by Subject|2|||
13491323|NCT02296125|27055314|FG000|Overall Study|Adverse Event|41|||
13491324|NCT02296125|27055315|FG001|Overall Study|Adverse Event|52|||
13491325|NCT02296125|27055316|FG002|Overall Study|Adverse Event|9|||
13491326|NCT02296125|27055317|FG003|Overall Study|Adverse Event|4|||
13491327|NCT02296125|27055314|FG000|Overall Study|Severe non-compliance to protocol|0|||
13491328|NCT02296125|27055315|FG001|Overall Study|Severe non-compliance to protocol|1|||
13491329|NCT02296125|27055316|FG002|Overall Study|Severe non-compliance to protocol|0|||
13491330|NCT02296125|27055317|FG003|Overall Study|Severe non-compliance to protocol|0|||
13491331|NCT02296125|27055314|FG000|Overall Study|Condition under investigation worsened|153|||
13491332|NCT02296125|27055315|FG001|Overall Study|Condition under investigation worsened|199|||
13491333|NCT02296125|27055316|FG002|Overall Study|Condition under investigation worsened|39|||
13491334|NCT02296125|27055317|FG003|Overall Study|Condition under investigation worsened|56|||
13491335|NCT02296125|27055314|FG000|Overall Study|Any reason not specifically recorded|6|||
13491336|NCT02296125|27055315|FG001|Overall Study|Any reason not specifically recorded|4|||
13491337|NCT02296125|27055316|FG002|Overall Study|Any reason not specifically recorded|2|||
13491338|NCT02296125|27055317|FG003|Overall Study|Any reason not specifically recorded|0|||
13491339|NCT01879319|27055332|FG000|Overall Study|Withdrawal by Subject|1|||
13491340|NCT01879319|27055333|FG001|Overall Study|Withdrawal by Subject|0|||
13491341|NCT01879319|27055332|FG000|Overall Study|Lost to Follow-up|1|||
13491342|NCT01879319|27055333|FG001|Overall Study|Lost to Follow-up|5|||
13491343|NCT00858364|27055405|FG000|Overall Study|Administrative Decision|3|||
13491344|NCT00858364|27055406|FG001|Overall Study|Administrative Decision|2|||
13491345|NCT00858364|27055405|FG000|Overall Study|Adverse Event|5|||
13491346|NCT00858364|27055406|FG001|Overall Study|Adverse Event|2|||
13491347|NCT00858364|27055405|FG000|Overall Study|Withdrawal by Subject|44|||
13491348|NCT00858364|27055406|FG001|Overall Study|Withdrawal by Subject|118|||
13491349|NCT00858364|27055405|FG000|Overall Study|Ineligibility Determined|1|||
13491350|NCT00858364|27055406|FG001|Overall Study|Ineligibility Determined|10|||
13491351|NCT00858364|27055405|FG000|Overall Study|Lost to Follow-up|24|||
13491352|NCT00858364|27055406|FG001|Overall Study|Lost to Follow-up|54|||
13491353|NCT00858364|27055405|FG000|Overall Study|Noncompliance|3|||
13491354|NCT00858364|27055406|FG001|Overall Study|Noncompliance|4|||
13491355|NCT00858364|27055405|FG000|Overall Study|Protocol Deviation|0|||
13491356|NCT00858364|27055406|FG001|Overall Study|Protocol Deviation|2|||
13491357|NCT00858364|27055405|FG000|Overall Study|Other|9|||
13491358|NCT00858364|27055406|FG001|Overall Study|Other|17|||
13491359|NCT00858364|27055405|FG000|Overall Study|Missing|1|||
13491360|NCT00858364|27055406|FG001|Overall Study|Missing|1|||
13491361|NCT00858364|27055405|FG000|Overall Study|Still on-study|114|||
13491362|NCT00858364|27055406|FG001|Overall Study|Still on-study|247|||
13296439|NCT01370590|26496518|FG001|Crossover Washout Period|Non-compliance with Study Drug|0|||
13296440|NCT01370590|26496517|FG000|Crossover Washout Period|Withdrawal by Subject|2|||
13475843|NCT02998476|27001263|FG000|Overall Study|Other|6|||
13491363|NCT03732807|27055588|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
13491364|NCT03732807|27055589|FG001|Treatment Period (up to Week 24)|Adverse Event|0|||
13491365|NCT03732807|27055590|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
13491366|NCT03732807|27055591|FG003|Treatment Period (up to Week 24)|Adverse Event|4|||
13491367|NCT03732807|27055592|FG004|Treatment Period (up to Week 24)|Adverse Event|2|||
13491368|NCT03732807|27055593|FG005|Treatment Period (up to Week 24)|Adverse Event|0|||
13491369|NCT03732807|27055594|FG006|Treatment Period (up to Week 24)|Adverse Event|1|||
13491370|NCT03732807|27055588|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
13491371|NCT03732807|27055589|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
13491372|NCT03732807|27055590|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
13491373|NCT03732807|27055591|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
13491374|NCT03732807|27055592|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
13491375|NCT03732807|27055593|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
13491376|NCT03732807|27055594|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
13491377|NCT03732807|27055588|FG000|Treatment Period (up to Week 24)|Physician Decision|0|||
13491378|NCT03732807|27055589|FG001|Treatment Period (up to Week 24)|Physician Decision|1|||
13491379|NCT03732807|27055590|FG002|Treatment Period (up to Week 24)|Physician Decision|2|||
13491380|NCT03732807|27055591|FG003|Treatment Period (up to Week 24)|Physician Decision|5|||
13491381|NCT03732807|27055592|FG004|Treatment Period (up to Week 24)|Physician Decision|0|||
13491382|NCT03732807|27055593|FG005|Treatment Period (up to Week 24)|Physician Decision|0|||
13491383|NCT03732807|27055594|FG006|Treatment Period (up to Week 24)|Physician Decision|1|||
13491384|NCT03732807|27055588|FG000|Treatment Period (up to Week 24)|Pregnancy|1|||
13491385|NCT03732807|27055589|FG001|Treatment Period (up to Week 24)|Pregnancy|0|||
13491386|NCT03732807|27055590|FG002|Treatment Period (up to Week 24)|Pregnancy|0|||
13491387|NCT03732807|27055591|FG003|Treatment Period (up to Week 24)|Pregnancy|0|||
13491388|NCT03732807|27055592|FG004|Treatment Period (up to Week 24)|Pregnancy|1|||
13491389|NCT03732807|27055593|FG005|Treatment Period (up to Week 24)|Pregnancy|0|||
13491390|NCT03732807|27055594|FG006|Treatment Period (up to Week 24)|Pregnancy|1|||
13491391|NCT03732807|27055588|FG000|Treatment Period (up to Week 24)|Protocol Violation|1|||
13491392|NCT03732807|27055589|FG001|Treatment Period (up to Week 24)|Protocol Violation|1|||
13491393|NCT03732807|27055590|FG002|Treatment Period (up to Week 24)|Protocol Violation|0|||
13491394|NCT03732807|27055591|FG003|Treatment Period (up to Week 24)|Protocol Violation|0|||
13491395|NCT03732807|27055592|FG004|Treatment Period (up to Week 24)|Protocol Violation|0|||
13491396|NCT03732807|27055593|FG005|Treatment Period (up to Week 24)|Protocol Violation|0|||
13491397|NCT03732807|27055594|FG006|Treatment Period (up to Week 24)|Protocol Violation|0|||
13491398|NCT03732807|27055588|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
13491399|NCT03732807|27055589|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
13491400|NCT03732807|27055590|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
13491401|NCT03732807|27055591|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
13491402|NCT03732807|27055592|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
13491403|NCT03732807|27055593|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
13491404|NCT03732807|27055594|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2|||
13491405|NCT03732807|27055588|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
13491406|NCT03732807|27055589|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
13491407|NCT03732807|27055590|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
13491408|NCT03732807|27055591|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
13491409|NCT03732807|27055592|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
13491410|NCT03732807|27055593|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
13491411|NCT03732807|27055594|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
13491412|NCT03732807|27055588|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
13491413|NCT03732807|27055589|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
13491414|NCT03732807|27055590|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
13491415|NCT03732807|27055591|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1|||
13491416|NCT03732807|27055592|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
13491417|NCT03732807|27055593|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
13491418|NCT03732807|27055594|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
13491419|NCT03732807|27055588|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2|||
13491420|NCT03732807|27055589|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
13491421|NCT03732807|27055590|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
13491422|NCT03732807|27055591|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
13296441|NCT01370590|26496518|FG001|Crossover Washout Period|Withdrawal by Subject|2|||
13296442|NCT01370590|26496517|FG000|Period 2|Adverse Event|0|||
13491423|NCT03732807|27055592|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
13491424|NCT03732807|27055593|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
13491425|NCT03732807|27055594|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
13491426|NCT03732807|27055588|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
13491427|NCT03732807|27055589|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
13491428|NCT03732807|27055590|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
13491429|NCT03732807|27055591|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
13491430|NCT03732807|27055592|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
13491431|NCT03732807|27055593|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
13491432|NCT03732807|27055594|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
13491433|NCT03732807|27055588|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
13491434|NCT03732807|27055589|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1|||
13491435|NCT03732807|27055590|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
13491436|NCT03732807|27055591|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
13491437|NCT03732807|27055592|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
13491438|NCT03732807|27055593|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
13491439|NCT03732807|27055594|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
13491440|NCT03732807|27055588|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
13491441|NCT03732807|27055589|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
13491442|NCT03732807|27055590|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
13491443|NCT03732807|27055591|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
13491444|NCT03732807|27055592|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
13491445|NCT03732807|27055593|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
13491446|NCT03732807|27055594|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
13491447|NCT03732807|27055588|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3|||
13491448|NCT03732807|27055589|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2|||
13491449|NCT03732807|27055590|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
13491450|NCT03732807|27055591|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
13491451|NCT03732807|27055592|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0|||
13491452|NCT03732807|27055593|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
13491453|NCT03732807|27055594|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
13491454|NCT03732807|27055588|FG000|Treatment Extension (Week 25 up to 48)|Other|1|||
13296443|NCT01370590|26496518|FG001|Period 2|Adverse Event|1|||
13296444|NCT01370590|26496517|FG000|Period 2|Withdrawal by Subject|1|||
13491455|NCT03732807|27055589|FG001|Treatment Extension (Week 25 up to 48)|Other|4|||
13491456|NCT03732807|27055590|FG002|Treatment Extension (Week 25 up to 48)|Other|0|||
13491457|NCT03732807|27055591|FG003|Treatment Extension (Week 25 up to 48)|Other|2|||
13491458|NCT03732807|27055592|FG004|Treatment Extension (Week 25 up to 48)|Other|0|||
13491459|NCT03732807|27055593|FG005|Treatment Extension (Week 25 up to 48)|Other|0|||
13491460|NCT03732807|27055594|FG006|Treatment Extension (Week 25 up to 48)|Other|0|||
13491461|NCT03731364|27055637|FG000|Overall Study|Adverse Event|0|||
13491462|NCT03731364|27055638|FG001|Overall Study|Adverse Event|0|||
13491463|NCT03731364|27055639|FG002|Overall Study|Adverse Event|1|||
13491464|NCT03731364|27055640|FG003|Overall Study|Adverse Event|2|||
13491465|NCT03731364|27055641|FG004|Overall Study|Adverse Event|1|||
13491466|NCT04598152|27055749|FG000|Overall Study|Lost to Follow-up|0|||
13491467|NCT04598152|27055750|FG001|Overall Study|Lost to Follow-up|1|||
13491468|NCT04546581|27055823|FG000|Overall Study|Adverse Event|9|||
13491469|NCT04546581|27055824|FG001|Overall Study|Adverse Event|3|||
13491470|NCT04546581|27055823|FG000|Overall Study|Physician Decision|0|||
13491471|NCT04546581|27055824|FG001|Overall Study|Physician Decision|1|||
13491472|NCT04546581|27055823|FG000|Overall Study|Protocol Violation|1|||
13491473|NCT04546581|27055824|FG001|Overall Study|Protocol Violation|2|||
13491474|NCT04546581|27055823|FG000|Overall Study|Withdrawal by Subject|3|||
13491475|NCT04546581|27055824|FG001|Overall Study|Withdrawal by Subject|7|||
13491476|NCT03915626|27055863|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1|||
13491477|NCT03698279|27055976|FG000|Overall Study|Withdrawal by parent/guardian|1|||
13491478|NCT03698279|27055977|FG001|Overall Study|Withdrawal by parent/guardian|1|||
13491479|NCT03698279|27055978|FG002|Overall Study|Withdrawal by parent/guardian|1|||
13491480|NCT03698279|27055979|FG003|Overall Study|Withdrawal by parent/guardian|1|||
13491481|NCT03698279|27055980|FG004|Overall Study|Withdrawal by parent/guardian|0|||
13491482|NCT03698279|27055981|FG005|Overall Study|Withdrawal by parent/guardian|0|||
13491483|NCT03698279|27055976|FG000|Overall Study|Protocol deviation|1|||
13491484|NCT03698279|27055977|FG001|Overall Study|Protocol deviation|0|||
13491485|NCT03698279|27055978|FG002|Overall Study|Protocol deviation|1|||
13491486|NCT03698279|27055979|FG003|Overall Study|Protocol deviation|0|||
13491487|NCT03698279|27055980|FG004|Overall Study|Protocol deviation|0|||
13491488|NCT03698279|27055981|FG005|Overall Study|Protocol deviation|0|||
13491489|NCT03698279|27055976|FG000|Overall Study|Withdrawal by Subject|0|||
13491490|NCT03698279|27055977|FG001|Overall Study|Withdrawal by Subject|0|||
13491491|NCT03698279|27055978|FG002|Overall Study|Withdrawal by Subject|1|||
13491492|NCT03698279|27055979|FG003|Overall Study|Withdrawal by Subject|0|||
13491493|NCT03698279|27055980|FG004|Overall Study|Withdrawal by Subject|0|||
13491494|NCT03698279|27055981|FG005|Overall Study|Withdrawal by Subject|0|||
13491495|NCT03698279|27055976|FG000|Overall Study|Lost to Follow-up|3|||
13491496|NCT03698279|27055977|FG001|Overall Study|Lost to Follow-up|1|||
13491497|NCT03698279|27055978|FG002|Overall Study|Lost to Follow-up|4|||
13491498|NCT03698279|27055979|FG003|Overall Study|Lost to Follow-up|5|||
13491499|NCT03698279|27055980|FG004|Overall Study|Lost to Follow-up|0|||
13491500|NCT03698279|27055981|FG005|Overall Study|Lost to Follow-up|0|||
13491501|NCT03478930|27056047|FG000|Overall Study|Adverse Event|0|||
13491502|NCT03478930|27056048|FG001|Overall Study|Adverse Event|1|||
13491503|NCT03478930|27056047|FG000|Overall Study|Lack of Efficacy|3|||
13491504|NCT03478930|27056048|FG001|Overall Study|Lack of Efficacy|3|||
13491505|NCT03478930|27056047|FG000|Overall Study|Withdrawal by Subject|6|||
13491506|NCT03478930|27056048|FG001|Overall Study|Withdrawal by Subject|5|||
13491507|NCT03434353|27056105|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10|||
13491508|NCT03434353|27056106|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3|||
13491509|NCT03434353|27056107|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11|||
13491510|NCT03434353|27056108|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3|||
13491511|NCT03434353|27056109|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17|||
13491512|NCT03434353|27056105|FG000|Overall Study|Withdrew consent|1|||
13491513|NCT03434353|27056106|FG001|Overall Study|Withdrew consent|0|||
13491514|NCT03434353|27056107|FG002|Overall Study|Withdrew consent|3|||
13491515|NCT03434353|27056108|FG003|Overall Study|Withdrew consent|0|||
13491516|NCT03434353|27056109|FG004|Overall Study|Withdrew consent|0|||
13491517|NCT03434353|27056105|FG000|Overall Study|Adverse Event|1|||
13491518|NCT03434353|27056106|FG001|Overall Study|Adverse Event|0|||
13491519|NCT03434353|27056107|FG002|Overall Study|Adverse Event|0|||
13491520|NCT03434353|27056108|FG003|Overall Study|Adverse Event|0|||
13491521|NCT03434353|27056109|FG004|Overall Study|Adverse Event|1|||
13491522|NCT03434353|27056105|FG000|Overall Study|Lost to Follow-up|2|||
13491523|NCT03434353|27056106|FG001|Overall Study|Lost to Follow-up|0|||
13491524|NCT03434353|27056107|FG002|Overall Study|Lost to Follow-up|0|||
13491525|NCT03434353|27056108|FG003|Overall Study|Lost to Follow-up|0|||
13491526|NCT03434353|27056109|FG004|Overall Study|Lost to Follow-up|0|||
13491527|NCT03415022|27056136|FG000|Overall Study|Withdrawal by Subject|1|||
13491528|NCT03415022|27056137|FG001|Overall Study|Withdrawal by Subject|2|||
13491529|NCT03415022|27056136|FG000|Overall Study|COVID-19 Suspension|2|||
13491530|NCT03415022|27056137|FG001|Overall Study|COVID-19 Suspension|3|||
13491531|NCT03415022|27056136|FG000|Overall Study|Lost to Follow-up|2|||
13491532|NCT03415022|27056137|FG001|Overall Study|Lost to Follow-up|0|||
13491533|NCT03283670|27056147|FG000|Placebo Gas|Withdrawal by Subject|2|||
13491534|NCT03283670|27056147|FG000|25% Nitrous Oxide|Withdrawal by Subject|4|||
13491535|NCT03283670|27056147|FG000|50% Nitrous Oxide|Withdrawal by Subject|1|||
13491536|NCT03073733|27056411|FG000|Overall Study|Lost to Follow-up|1|||
13491537|NCT03073733|27056412|FG001|Overall Study|Lost to Follow-up|0|||
13491538|NCT03073733|27056413|FG002|Overall Study|Lost to Follow-up|0|||
13491539|NCT03073733|27056411|FG000|Overall Study|Physician Decision|0|||
13491540|NCT03073733|27056412|FG001|Overall Study|Physician Decision|1|||
13491541|NCT03073733|27056413|FG002|Overall Study|Physician Decision|0|||
13491542|NCT03073733|27056411|FG000|Overall Study|Withdrawal by Subject|0|||
13491543|NCT03073733|27056412|FG001|Overall Study|Withdrawal by Subject|0|||
13491544|NCT03073733|27056413|FG002|Overall Study|Withdrawal by Subject|1|||
13491545|NCT02420795|27056531|FG000|Overall Study|Withdrawal by Subject|1|||
13491546|NCT02420795|27056532|FG001|Overall Study|Withdrawal by Subject|0|||
13491547|NCT02420795|27056533|FG002|Overall Study|Withdrawal by Subject|0|||
13491548|NCT02420795|27056531|FG000|Overall Study|Adverse Event|1|||
13491549|NCT02420795|27056532|FG001|Overall Study|Adverse Event|0|||
13491550|NCT02420795|27056533|FG002|Overall Study|Adverse Event|0|||
13491551|NCT02420795|27056531|FG000|Overall Study|Progressive disease|2|||
13491552|NCT02420795|27056532|FG001|Overall Study|Progressive disease|2|||
13491553|NCT02420795|27056533|FG002|Overall Study|Progressive disease|4|||
13491554|NCT02420795|27056531|FG000|Overall Study|Death|0|||
13491555|NCT02420795|27056532|FG001|Overall Study|Death|0|||
13491556|NCT02420795|27056533|FG002|Overall Study|Death|1|||
13491557|NCT02199691|27056566|FG000|Overall Study|Protocol Violation|3|||
13491558|NCT02199691|27056567|FG001|Overall Study|Protocol Violation|3|||
13491559|NCT02199691|27056568|FG002|Overall Study|Protocol Violation|6|||
13491560|NCT02199691|27056569|FG003|Overall Study|Protocol Violation|7|||
13491561|NCT02199691|27056566|FG000|Overall Study|Withdrawal by Subject|5|||
13491562|NCT02199691|27056567|FG001|Overall Study|Withdrawal by Subject|3|||
13491563|NCT02199691|27056568|FG002|Overall Study|Withdrawal by Subject|12|||
13491564|NCT02199691|27056569|FG003|Overall Study|Withdrawal by Subject|13|||
13491565|NCT02199691|27056566|FG000|Overall Study|Lost to Follow-up|2|||
13491566|NCT02199691|27056567|FG001|Overall Study|Lost to Follow-up|1|||
13491567|NCT02199691|27056568|FG002|Overall Study|Lost to Follow-up|9|||
13491568|NCT02199691|27056569|FG003|Overall Study|Lost to Follow-up|10|||
13491569|NCT01751984|27056642|FG000|Overall Study|Adverse Event|5|||
13207541|NCT01947283|26238166|FG006|Overall Study|No Clinical Recording|0|||
13207542|NCT01947283|26238160|FG000|Overall Study|Non-coding Clinical Recording language|0|||
13491570|NCT01751984|27056643|FG001|Overall Study|Adverse Event|3|||
13491571|NCT01751984|27056642|FG000|Overall Study|Withdrawal by Subject|0|||
13491572|NCT01751984|27056643|FG001|Overall Study|Withdrawal by Subject|1|||
13491573|NCT01751984|27056642|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
13491574|NCT01751984|27056643|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
13207543|NCT01947283|26238161|FG001|Overall Study|Non-coding Clinical Recording language|0|||
13207544|NCT01947283|26238162|FG002|Overall Study|Non-coding Clinical Recording language|0|||
13207545|NCT01947283|26238163|FG003|Overall Study|Non-coding Clinical Recording language|1|||
13207546|NCT01947283|26238164|FG004|Overall Study|Non-coding Clinical Recording language|0|||
13207547|NCT01947283|26238165|FG005|Overall Study|Non-coding Clinical Recording language|0|||
13207548|NCT01947283|26238166|FG006|Overall Study|Non-coding Clinical Recording language|0|||
13207549|NCT01947283|26238160|FG000|Overall Study|Missing Follow-up Assessment|2|||
13207550|NCT01947283|26238161|FG001|Overall Study|Missing Follow-up Assessment|2|||
13207551|NCT01947283|26238162|FG002|Overall Study|Missing Follow-up Assessment|3|||
13207552|NCT01947283|26238163|FG003|Overall Study|Missing Follow-up Assessment|0|||
13207553|NCT01947283|26238164|FG004|Overall Study|Missing Follow-up Assessment|0|||
13207554|NCT01947283|26238165|FG005|Overall Study|Missing Follow-up Assessment|2|||
13207555|NCT01947283|26238166|FG006|Overall Study|Missing Follow-up Assessment|0|||
13207556|NCT01947283|26238160|FG000|Overall Study|No patients were enrolled in study|0|||
13207557|NCT01947283|26238161|FG001|Overall Study|No patients were enrolled in study|0|||
13207558|NCT01947283|26238162|FG002|Overall Study|No patients were enrolled in study|0|||
13207559|NCT01947283|26238163|FG003|Overall Study|No patients were enrolled in study|0|||
13207560|NCT01947283|26238164|FG004|Overall Study|No patients were enrolled in study|0|||
13207561|NCT01947283|26238165|FG005|Overall Study|No patients were enrolled in study|3|||
13207562|NCT01947283|26238166|FG006|Overall Study|No patients were enrolled in study|1|||
13207563|NCT01947127|26238183|FG000|Overall Study|Protocol Violation|18|||
13207564|NCT01947127|26238184|FG001|Overall Study|Protocol Violation|38|||
13491575|NCT01732627|27056680|FG000|Overall Study|Withdrawal by Subject|1|||
13491576|NCT01732627|27056681|FG001|Overall Study|Withdrawal by Subject|0|||
13491577|NCT01702571|27056714|FG000|Overall Study|Death|1067|||
13491578|NCT01702571|27056715|FG001|Overall Study|Death|76|||
13491579|NCT01702571|27056714|FG000|Overall Study|Lost to Follow-up|144|||
13491580|NCT01702571|27056715|FG001|Overall Study|Lost to Follow-up|10|||
13491581|NCT01702571|27056714|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4|||
13491582|NCT01702571|27056715|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0|||
13491583|NCT01702571|27056714|FG000|Overall Study|Investigator Decision|5|||
13207565|NCT01947127|26238183|FG000|Overall Study|Withdrawal by Subject|1|||
13207566|NCT01947127|26238184|FG001|Overall Study|Withdrawal by Subject|1|||
13207567|NCT01947127|26238183|FG000|Overall Study|Data loss|4|||
13207568|NCT01947127|26238184|FG001|Overall Study|Data loss|4|||
13207569|NCT01946880|26238267|FG000|Overall Study|Lost to Follow-up|1|||
13207570|NCT01946880|26238268|FG001|Overall Study|Lost to Follow-up|0|||
13207571|NCT01946880|26238267|FG000|Overall Study|Physician Decision|1|||
13207572|NCT01946880|26238268|FG001|Overall Study|Physician Decision|1|||
13491584|NCT01702571|27056715|FG001|Overall Study|Investigator Decision|0|||
13491585|NCT01702571|27056714|FG000|Overall Study|Not Classifiable|1|||
13207573|NCT01946880|26238267|FG000|Overall Study|Withdrawal by Subject|3|||
13207574|NCT01946880|26238268|FG001|Overall Study|Withdrawal by Subject|2|||
13491586|NCT01702571|27056715|FG001|Overall Study|Not Classifiable|0|||
13207575|NCT01946880|26238267|FG000|Overall Study|Met Primary Endpoint|1|||
13207576|NCT01946880|26238268|FG001|Overall Study|Met Primary Endpoint|0|||
13207577|NCT01946880|26238267|FG000|Overall Study|Personal and Family Issues|1|||
13207578|NCT01946880|26238268|FG001|Overall Study|Personal and Family Issues|0|||
13207579|NCT01946802|26238279|FG000|Overall Study|Death|1|||
13207580|NCT01946802|26238279|FG000|Overall Study|Withdrawal by Subject|2|||
13207581|NCT01946802|26238279|FG000|Overall Study|Combined septic shock|1|||
13207582|NCT01946802|26238279|FG000|Overall Study|Protocol Violation|1|||
13207583|NCT01946529|26238296|FG000|End of Window Therapy (2 Courses)|Physician Decision|0|||
13491587|NCT01702571|27056714|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93|||
13491588|NCT01702571|27056715|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0|||
13491589|NCT01702571|27056714|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0|||
13491590|NCT01702571|27056715|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1|||
13491591|NCT01702571|27056714|FG000|Overall Study|Progressive Disease|3|||
13491592|NCT01702571|27056715|FG001|Overall Study|Progressive Disease|0|||
13491593|NCT01702571|27056714|FG000|Overall Study|Protocol Violation|2|||
13491594|NCT01702571|27056715|FG001|Overall Study|Protocol Violation|0|||
13491595|NCT01702571|27056714|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9|||
13491596|NCT01702571|27056715|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1|||
13491597|NCT01702571|27056714|FG000|Overall Study|Termination By Sponsor|4|||
13491598|NCT01702571|27056715|FG001|Overall Study|Termination By Sponsor|0|||
13491599|NCT01702571|27056714|FG000|Overall Study|Withdrawal by Subject|177|||
13491600|NCT01702571|27056715|FG001|Overall Study|Withdrawal by Subject|29|||
13491601|NCT01578239|27056744|FG000|Treatment Period|Progressive Disease|19|||
13491602|NCT01578239|27056745|FG001|Treatment Period|Progressive Disease|64|||
13491603|NCT01578239|27056744|FG000|Treatment Period|Physician Decision|17|||
13491604|NCT01578239|27056745|FG001|Treatment Period|Physician Decision|17|||
13491605|NCT01578239|27056744|FG000|Treatment Period|Adverse Event|13|||
13491606|NCT01578239|27056745|FG001|Treatment Period|Adverse Event|10|||
13491607|NCT01578239|27056744|FG000|Treatment Period|Non-compliance|2|||
13491608|NCT01578239|27056745|FG001|Treatment Period|Non-compliance|0|||
13491609|NCT01578239|27056744|FG000|Treatment Period|Withdrawal by Subject|10|||
13491610|NCT01578239|27056745|FG001|Treatment Period|Withdrawal by Subject|9|||
13491611|NCT01578239|27056744|FG000|Treatment Period|Other|6|||
13491612|NCT01578239|27056745|FG001|Treatment Period|Other|1|||
13491613|NCT01578239|27056744|FG000|Long-term Follow-Up Period|Death|69|||
13491614|NCT01578239|27056745|FG001|Long-term Follow-Up Period|Death|64|||
13491615|NCT01578239|27056744|FG000|Long-term Follow-Up Period|Consent withdrawal|4|||
13491616|NCT01578239|27056745|FG001|Long-term Follow-Up Period|Consent withdrawal|10|||
13491617|NCT01578239|27056744|FG000|Long-term Follow-Up Period|Lost to Follow-up|2|||
13491618|NCT01578239|27056745|FG001|Long-term Follow-Up Period|Lost to Follow-up|4|||
13491619|NCT01578239|27056744|FG000|Long-term Follow-Up Period|Other|2|||
13491620|NCT01578239|27056745|FG001|Long-term Follow-Up Period|Other|2|||
13491621|NCT01336634|27056846|FG000|Overall Study|Study closed/terminated|5|||
13491622|NCT01336634|27056847|FG001|Overall Study|Study closed/terminated|6|||
13491623|NCT01336634|27056848|FG002|Overall Study|Study closed/terminated|6|||
13491624|NCT01336634|27056846|FG000|Overall Study|Lost to Follow-up|2|||
13491625|NCT01336634|27056847|FG001|Overall Study|Lost to Follow-up|1|||
13491626|NCT01336634|27056848|FG002|Overall Study|Lost to Follow-up|1|||
13491627|NCT01336634|27056846|FG000|Overall Study|Physician Decision|1|||
13491628|NCT01336634|27056847|FG001|Overall Study|Physician Decision|1|||
13491629|NCT01336634|27056848|FG002|Overall Study|Physician Decision|0|||
13491630|NCT01336634|27056846|FG000|Overall Study|Withdrawal by Subject|6|||
13491631|NCT01336634|27056847|FG001|Overall Study|Withdrawal by Subject|0|||
13491632|NCT01336634|27056848|FG002|Overall Study|Withdrawal by Subject|2|||
13491633|NCT01155375|27056863|FG000|Overall Study|Adverse Event|1|||
13491634|NCT01155375|27056864|FG001|Overall Study|Adverse Event|0|||
13491635|NCT00628095|27056909|FG000|Overall Study|Adverse Event|5|||
13491636|NCT00628095|27056910|FG001|Overall Study|Adverse Event|3|||
13491637|NCT00628095|27056909|FG000|Overall Study|Lack of Efficacy|0|||
13491638|NCT00628095|27056910|FG001|Overall Study|Lack of Efficacy|3|||
13491639|NCT00628095|27056909|FG000|Overall Study|Withdrawal by Subject|2|||
13491640|NCT00628095|27056910|FG001|Overall Study|Withdrawal by Subject|0|||
13491641|NCT00628095|27056909|FG000|Overall Study|Other|0|||
13491642|NCT00628095|27056910|FG001|Overall Study|Other|1|||
13491643|NCT03945825|27057273|FG000|Overall Study|Enrolled but treatment not administered|0|||
13491644|NCT03945825|27057274|FG001|Overall Study|Enrolled but treatment not administered|0|||
13491645|NCT03945825|27057275|FG002|Overall Study|Enrolled but treatment not administered|0|||
13491646|NCT03945825|27057276|FG003|Overall Study|Enrolled but treatment not administered|0|||
13491647|NCT03945825|27057277|FG004|Overall Study|Enrolled but treatment not administered|1|||
13491648|NCT03945825|27057278|FG005|Overall Study|Enrolled but treatment not administered|0|||
13491649|NCT03945825|27057273|FG000|Overall Study|Lost to Follow-up|1|||
13491650|NCT03945825|27057274|FG001|Overall Study|Lost to Follow-up|5|||
13491651|NCT03945825|27057275|FG002|Overall Study|Lost to Follow-up|0|||
13207584|NCT01946529|26238297|FG001|End of Window Therapy (2 Courses)|Physician Decision|1|||
13296445|NCT01370590|26496518|FG001|Period 2|Withdrawal by Subject|1|||
13491652|NCT03945825|27057276|FG003|Overall Study|Lost to Follow-up|1|||
13491653|NCT03945825|27057277|FG004|Overall Study|Lost to Follow-up|2|||
13491654|NCT03945825|27057278|FG005|Overall Study|Lost to Follow-up|2|||
13491655|NCT03945825|27057273|FG000|Overall Study|Withdrawal by Subject|1|||
13491656|NCT03945825|27057274|FG001|Overall Study|Withdrawal by Subject|0|||
13491657|NCT03945825|27057275|FG002|Overall Study|Withdrawal by Subject|1|||
13491658|NCT03945825|27057276|FG003|Overall Study|Withdrawal by Subject|1|||
13491659|NCT03945825|27057277|FG004|Overall Study|Withdrawal by Subject|0|||
13491660|NCT03945825|27057278|FG005|Overall Study|Withdrawal by Subject|1|||
13207585|NCT01946529|26238298|FG002|End of Window Therapy (2 Courses)|Physician Decision|0|||
13207586|NCT01946529|26238296|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1|||
13207587|NCT01946529|26238297|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16|||
13207588|NCT01946529|26238298|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6|||
13207589|NCT01946438|26238337|FG000|Overall Study|Adverse Event|0|||
13207590|NCT01946438|26238338|FG001|Overall Study|Adverse Event|0|||
13207591|NCT01946438|26238339|FG002|Overall Study|Adverse Event|0|||
13207592|NCT01946438|26238340|FG003|Overall Study|Adverse Event|1|||
13207593|NCT01946438|26238337|FG000|Overall Study|Serious Adverse event|1|||
13207594|NCT01946438|26238338|FG001|Overall Study|Serious Adverse event|0|||
13207595|NCT01946438|26238339|FG002|Overall Study|Serious Adverse event|0|||
13207596|NCT01946438|26238340|FG003|Overall Study|Serious Adverse event|0|||
13207597|NCT01946438|26238337|FG000|Overall Study|Protocol Violation|0|||
13207598|NCT01946438|26238338|FG001|Overall Study|Protocol Violation|0|||
13207599|NCT01946438|26238339|FG002|Overall Study|Protocol Violation|1|||
13207600|NCT01946438|26238340|FG003|Overall Study|Protocol Violation|0|||
13207601|NCT01946438|26238337|FG000|Overall Study|Withdrawal by Subject|1|||
13207602|NCT01946438|26238338|FG001|Overall Study|Withdrawal by Subject|0|||
13207603|NCT01946438|26238339|FG002|Overall Study|Withdrawal by Subject|0|||
13207604|NCT01946438|26238340|FG003|Overall Study|Withdrawal by Subject|0|||
13207605|NCT01946425|26238361|FG000|Overall Study|Protocol Violation|1|||
13207606|NCT01946425|26238362|FG001|Overall Study|Protocol Violation|0|||
13207607|NCT01946425|26238361|FG000|Overall Study|Withdrawal by Subject|1|||
13207608|NCT01946425|26238362|FG001|Overall Study|Withdrawal by Subject|0|||
13207609|NCT01946412|26238386|FG000|Overall Study|Adverse Event|1|||
13207610|NCT01946412|26238386|FG000|Overall Study|Non-Compliance|1|||
13207611|NCT01946412|26238386|FG000|Overall Study|Continued with commercial Kalydeco|2|||
13207612|NCT01946412|26238386|FG000|Overall Study|Difficulty in swallowing|1|||
13207613|NCT01946282|26238406|FG000|Year 1|Did not return FIT kit|4186|||
13207614|NCT01946282|26238407|FG001|Year 1|Did not return FIT kit|608|||
13207615|NCT01946282|26238408|FG002|Year 1|Did not return FIT kit|654|||
13207616|NCT01946282|26238406|FG000|Year 2|Did not return FIT kit|803|||
13207617|NCT01946282|26238407|FG001|Year 2|Did not return FIT kit|131|||
13207618|NCT01946282|26238408|FG002|Year 2|Did not return FIT kit|115|||
13207619|NCT01946282|26238406|FG000|Year 3|Did not return FIT kit|288|||
13207620|NCT01946282|26238407|FG001|Year 3|Did not return FIT kit|43|||
13207621|NCT01946282|26238408|FG002|Year 3|Did not return FIT kit|30|||
13207622|NCT01946191|26238441|FG000|Allocation|Did not complete orientation|1|||
13207623|NCT01946191|26238442|FG001|Allocation|Did not complete orientation|1|||
13207624|NCT01946191|26238441|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4|||
13207625|NCT01946191|26238442|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2|||
13207626|NCT01946191|26238441|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0|||
13207627|NCT01946191|26238442|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1|||
13207628|NCT01946191|26238441|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13|||
13207629|NCT01946191|26238442|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15|||
13207630|NCT01946178|26238452|FG000|Overall Study|Pregnancy|1|||
13207631|NCT01946178|26238452|FG000|Overall Study|Lost to Follow-up|1|||
13207632|NCT01946165|26238467|FG000|Overall Study|Physician Decision|2|||
13207633|NCT01946165|26238468|FG001|Overall Study|Physician Decision|0|||
13475844|NCT02998476|27001264|FG001|Overall Study|Other|1|||
13207634|NCT01946165|26238467|FG000|Overall Study|Withdrawal by Subject|0|||
13207635|NCT01946165|26238468|FG001|Overall Study|Withdrawal by Subject|2|||
13207636|NCT01946152|26238494|FG000|Overall Study|Adverse Event|1|||
13475845|NCT02924064|27001310|FG000|Overall Study|Adverse Event|2|||
13475846|NCT02924064|27001311|FG001|Overall Study|Adverse Event|2|||
13475847|NCT02924064|27001310|FG000|Overall Study|Lost to Follow-up|0|||
13475848|NCT02924064|27001311|FG001|Overall Study|Lost to Follow-up|2|||
13475849|NCT02924064|27001310|FG000|Overall Study|Physician Decision|0|||
13475850|NCT02924064|27001311|FG001|Overall Study|Physician Decision|2|||
13475851|NCT02924064|27001310|FG000|Overall Study|Protocol Violation|1|||
13475852|NCT02924064|27001311|FG001|Overall Study|Protocol Violation|3|||
13207637|NCT01946152|26238495|FG001|Overall Study|Adverse Event|0|||
13207638|NCT01946152|26238496|FG002|Overall Study|Adverse Event|0|||
13207639|NCT01946152|26238497|FG003|Overall Study|Adverse Event|0|||
13207640|NCT01946152|26238494|FG000|Overall Study|Withdrawal by Subject|0|||
13207641|NCT01946152|26238495|FG001|Overall Study|Withdrawal by Subject|2|||
13207642|NCT01946152|26238496|FG002|Overall Study|Withdrawal by Subject|0|||
13207643|NCT01946152|26238497|FG003|Overall Study|Withdrawal by Subject|0|||
13207644|NCT01946152|26238494|FG000|Overall Study|Progression|0|||
13207645|NCT01946152|26238495|FG001|Overall Study|Progression|1|||
13207646|NCT01946152|26238496|FG002|Overall Study|Progression|4|||
13207647|NCT01946152|26238497|FG003|Overall Study|Progression|7|||
13207648|NCT01946152|26238494|FG000|Overall Study|Physician Decision|0|||
13207649|NCT01946152|26238495|FG001|Overall Study|Physician Decision|0|||
13207650|NCT01946152|26238496|FG002|Overall Study|Physician Decision|1|||
13207651|NCT01946152|26238497|FG003|Overall Study|Physician Decision|0|||
13207652|NCT01946152|26238494|FG000|Overall Study|Second malignancy|0|||
13207653|NCT01946152|26238495|FG001|Overall Study|Second malignancy|0|||
13207654|NCT01946152|26238496|FG002|Overall Study|Second malignancy|1|||
13207655|NCT01946152|26238497|FG003|Overall Study|Second malignancy|0|||
13207656|NCT01946152|26238494|FG000|Overall Study|Adverse Event|0|||
13207657|NCT01946152|26238495|FG001|Overall Study|Adverse Event|0|||
13207658|NCT01946152|26238496|FG002|Overall Study|Adverse Event|0|||
13207659|NCT01946152|26238497|FG003|Overall Study|Adverse Event|1|||
13207660|NCT01946139|26238507|FG000|Overall Study|Withdrawal by Subject|8|||
13207661|NCT01946139|26238507|FG000|Overall Study|ineligible|8|||
13207662|NCT01946139|26238507|FG000|Overall Study|Specimens not available|4|||
13207663|NCT01945996|26238546|FG000|Overall Study|Lost to Follow-up|3|||
13207664|NCT01945996|26238547|FG001|Overall Study|Lost to Follow-up|5|||
13207665|NCT01945944|26238576|FG000|Overall Study|Adverse Event|0|||
13207666|NCT01945944|26238577|FG001|Overall Study|Adverse Event|2|||
13207667|NCT01945944|26238576|FG000|Overall Study|Physician Decision|1|||
13207668|NCT01945944|26238577|FG001|Overall Study|Physician Decision|0|||
13207669|NCT01945944|26238576|FG000|Overall Study|Withdrawal by Subject|0|||
13207670|NCT01945944|26238577|FG001|Overall Study|Withdrawal by Subject|1|||
13207671|NCT01945866|26238603|FG000|Overall Study|Eyes did not complete or were dropped|2|||
13207672|NCT01945866|26238604|FG001|Overall Study|Eyes did not complete or were dropped|0|||
13207673|NCT01945710|26238741|FG000|Overall Study|Progressive Disease|5|||
13207674|NCT01945710|26238742|FG001|Overall Study|Progressive Disease|4|||
13207675|NCT01945710|26238743|FG002|Overall Study|Progressive Disease|3|||
13207676|NCT01945710|26238744|FG003|Overall Study|Progressive Disease|2|||
13207677|NCT01945710|26238745|FG004|Overall Study|Progressive Disease|7|||
13207678|NCT01945710|26238746|FG005|Overall Study|Progressive Disease|3|||
13491661|NCT03733925|27057295|FG000|Overall Study|Lost to Follow-up|1|||
13491662|NCT03733925|27057295|FG000|Overall Study|Withdrawal by Subject|2|||
13491663|NCT03733925|27057295|FG000|Overall Study|Adverse Event|2|||
13491664|NCT03733925|27057295|FG000|Overall Study|Non-Compliance with Study Drug|1|||
13491665|NCT03562767|27057356|FG000|Overall Study|Physician Decision|2|||
13491666|NCT03562767|27057357|FG001|Overall Study|Physician Decision|0|||
13491667|NCT03562767|27057358|FG002|Overall Study|Physician Decision|0|||
13491668|NCT03562767|27057356|FG000|Overall Study|Logistic Reason|1|||
13491669|NCT03562767|27057357|FG001|Overall Study|Logistic Reason|3|||
13491670|NCT03562767|27057358|FG002|Overall Study|Logistic Reason|0|||
13491671|NCT03559699|27057369|FG000|Overall Study|Withdrawal by Subject|6|||
13491672|NCT03559699|27057369|FG000|Overall Study|Lost to Follow-up|1|||
13491673|NCT03305016|27057399|FG000|Overall Study|Withdrawal by Subject|2|||
13491674|NCT03291067|27057472|FG000|Overall Study|Adverse Event|0|||
13491675|NCT03291067|27057473|FG001|Overall Study|Adverse Event|2|||
13491676|NCT03291067|27057474|FG002|Overall Study|Adverse Event|17|||
13491677|NCT03291067|27057475|FG003|Overall Study|Adverse Event|3|||
13491678|NCT03291067|27057472|FG000|Overall Study|Lost to Follow-up|2|||
13491679|NCT03291067|27057473|FG001|Overall Study|Lost to Follow-up|1|||
13491680|NCT03291067|27057474|FG002|Overall Study|Lost to Follow-up|0|||
13491681|NCT03291067|27057475|FG003|Overall Study|Lost to Follow-up|1|||
13491682|NCT03291067|27057472|FG000|Overall Study|Physician Decision|0|||
13491683|NCT03291067|27057473|FG001|Overall Study|Physician Decision|0|||
13491684|NCT03291067|27057474|FG002|Overall Study|Physician Decision|1|||
13491685|NCT03291067|27057475|FG003|Overall Study|Physician Decision|0|||
13491686|NCT03291067|27057472|FG000|Overall Study|Protocol Violation|5|||
13491687|NCT03291067|27057473|FG001|Overall Study|Protocol Violation|3|||
13491688|NCT03291067|27057474|FG002|Overall Study|Protocol Violation|4|||
13207679|NCT01945710|26238747|FG006|Overall Study|Progressive Disease|19|||
13207680|NCT01945710|26238741|FG000|Overall Study|Adverse Event|0|||
13207681|NCT01945710|26238742|FG001|Overall Study|Adverse Event|1|||
13207682|NCT01945710|26238743|FG002|Overall Study|Adverse Event|0|||
13207683|NCT01945710|26238744|FG003|Overall Study|Adverse Event|0|||
13207684|NCT01945710|26238745|FG004|Overall Study|Adverse Event|0|||
13207685|NCT01945710|26238746|FG005|Overall Study|Adverse Event|0|||
13491689|NCT03291067|27057475|FG003|Overall Study|Protocol Violation|2|||
13491690|NCT03291067|27057472|FG000|Overall Study|Withdrawal by Subject|3|||
13491691|NCT03291067|27057473|FG001|Overall Study|Withdrawal by Subject|4|||
13491692|NCT03291067|27057474|FG002|Overall Study|Withdrawal by Subject|7|||
13491693|NCT03291067|27057475|FG003|Overall Study|Withdrawal by Subject|5|||
13491694|NCT03291067|27057472|FG000|Overall Study|Other|0|||
13491695|NCT03291067|27057473|FG001|Overall Study|Other|4|||
13491696|NCT03291067|27057474|FG002|Overall Study|Other|4|||
13491697|NCT03291067|27057475|FG003|Overall Study|Other|6|||
13491698|NCT03257436|27057482|FG000|Overall Study|Withdrawal by Subject|76|||
13491699|NCT03257436|27057482|FG000|Overall Study|Death|19|||
13207686|NCT01945710|26238747|FG006|Overall Study|Adverse Event|0|||
13207687|NCT01945710|26238741|FG000|Overall Study|Other|2|||
13207688|NCT01945710|26238742|FG001|Overall Study|Other|0|||
13207689|NCT01945710|26238743|FG002|Overall Study|Other|3|||
13207690|NCT01945710|26238744|FG003|Overall Study|Other|1|||
13491700|NCT04723173|27057512|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1|||
13491701|NCT03683823|27057557|FG000|Post-treatment Assessment|Withdrawal by Subject|1|||
13491702|NCT03683823|27057558|FG001|Post-treatment Assessment|Withdrawal by Subject|1|||
13491703|NCT03683823|27057557|FG000|Post-treatment Assessment|Lost to Follow-up|0|||
13491704|NCT03683823|27057558|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
13491705|NCT03683823|27057557|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
13491706|NCT03683823|27057558|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
13491707|NCT03515551|27057707|FG000|Overall Study|Death|4|||
13491708|NCT03515551|27057708|FG001|Overall Study|Death|1|||
13491709|NCT03515551|27057709|FG002|Overall Study|Death|2|||
13491710|NCT03515551|27057710|FG003|Overall Study|Death|2|||
13491711|NCT03515551|27057711|FG004|Overall Study|Death|2|||
13207691|NCT01945710|26238745|FG004|Overall Study|Other|1|||
13207692|NCT01945710|26238746|FG005|Overall Study|Other|0|||
13207693|NCT01945710|26238747|FG006|Overall Study|Other|4|||
13207694|NCT01945710|26238741|FG000|Overall Study|Withdrawal by Subject|0|||
13207695|NCT01945710|26238742|FG001|Overall Study|Withdrawal by Subject|1|||
13207696|NCT01945710|26238743|FG002|Overall Study|Withdrawal by Subject|1|||
13207697|NCT01945710|26238744|FG003|Overall Study|Withdrawal by Subject|0|||
13207698|NCT01945710|26238745|FG004|Overall Study|Withdrawal by Subject|1|||
13207699|NCT01945710|26238746|FG005|Overall Study|Withdrawal by Subject|0|||
13207700|NCT01945710|26238747|FG006|Overall Study|Withdrawal by Subject|0|||
13207701|NCT01945593|26238840|FG000|Overall Study|Adverse Event|0|||
13207702|NCT01945593|26238841|FG001|Overall Study|Adverse Event|0|||
13207703|NCT01945593|26238842|FG002|Overall Study|Adverse Event|0|||
13207704|NCT01945593|26238843|FG003|Overall Study|Adverse Event|5|||
13207705|NCT01945593|26238840|FG000|Overall Study|Physician Decision|0|||
13207706|NCT01945593|26238841|FG001|Overall Study|Physician Decision|0|||
13207707|NCT01945593|26238842|FG002|Overall Study|Physician Decision|1|||
13207708|NCT01945593|26238843|FG003|Overall Study|Physician Decision|1|||
13207709|NCT01945593|26238840|FG000|Overall Study|Withdrawal by Subject|0|||
13207710|NCT01945593|26238841|FG001|Overall Study|Withdrawal by Subject|2|||
13207711|NCT01945593|26238842|FG002|Overall Study|Withdrawal by Subject|0|||
13207712|NCT01945593|26238843|FG003|Overall Study|Withdrawal by Subject|4|||
13207713|NCT01945593|26238840|FG000|Overall Study|Protocol Violation|0|||
13207714|NCT01945593|26238841|FG001|Overall Study|Protocol Violation|2|||
13207715|NCT01945593|26238842|FG002|Overall Study|Protocol Violation|1|||
13207716|NCT01945593|26238843|FG003|Overall Study|Protocol Violation|3|||
13207717|NCT01945593|26238840|FG000|Overall Study|Death|0|||
13207718|NCT01945593|26238841|FG001|Overall Study|Death|0|||
13207719|NCT01945593|26238842|FG002|Overall Study|Death|1|||
13207720|NCT01945593|26238843|FG003|Overall Study|Death|0|||
13207721|NCT01945593|26238840|FG000|Overall Study|Other: Terminated|0|||
13207722|NCT01945593|26238841|FG001|Overall Study|Other: Terminated|0|||
13207723|NCT01945593|26238842|FG002|Overall Study|Other: Terminated|0|||
13207724|NCT01945593|26238843|FG003|Overall Study|Other: Terminated|1|||
13491712|NCT03515551|27057712|FG005|Overall Study|Death|4|||
13491713|NCT03515551|27057713|FG006|Overall Study|Death|1|||
13491714|NCT03515551|27057707|FG000|Overall Study|Lost to Follow-up|0|||
13491715|NCT03515551|27057708|FG001|Overall Study|Lost to Follow-up|0|||
13491716|NCT03515551|27057709|FG002|Overall Study|Lost to Follow-up|1|||
13491717|NCT03515551|27057710|FG003|Overall Study|Lost to Follow-up|0|||
13491718|NCT03515551|27057711|FG004|Overall Study|Lost to Follow-up|0|||
13491719|NCT03515551|27057712|FG005|Overall Study|Lost to Follow-up|0|||
13491720|NCT03515551|27057713|FG006|Overall Study|Lost to Follow-up|0|||
13491721|NCT03515551|27057707|FG000|Overall Study|Withdrawal by Subject|0|||
13491722|NCT03515551|27057708|FG001|Overall Study|Withdrawal by Subject|1|||
13491723|NCT03515551|27057709|FG002|Overall Study|Withdrawal by Subject|0|||
13491724|NCT03515551|27057710|FG003|Overall Study|Withdrawal by Subject|0|||
13491725|NCT03515551|27057711|FG004|Overall Study|Withdrawal by Subject|0|||
13491726|NCT03515551|27057712|FG005|Overall Study|Withdrawal by Subject|0|||
13207725|NCT01945593|26238840|FG000|Overall Study|Other: Surgical Procedure|0|||
13207726|NCT01945593|26238841|FG001|Overall Study|Other: Surgical Procedure|2|||
13207727|NCT01945593|26238842|FG002|Overall Study|Other: Surgical Procedure|0|||
13491727|NCT03515551|27057713|FG006|Overall Study|Withdrawal by Subject|1|||
13491728|NCT03515551|27057707|FG000|Overall Study|Study ended by sponsor|0|||
13491729|NCT03515551|27057708|FG001|Overall Study|Study ended by sponsor|0|||
13491730|NCT03515551|27057709|FG002|Overall Study|Study ended by sponsor|2|||
13207728|NCT01945593|26238843|FG003|Overall Study|Other: Surgical Procedure|6|||
13207729|NCT01945593|26238840|FG000|Overall Study|Other: Screen Failure|0|||
13207730|NCT01945593|26238841|FG001|Overall Study|Other: Screen Failure|2|||
13207731|NCT01945593|26238842|FG002|Overall Study|Other: Screen Failure|0|||
13207732|NCT01945593|26238843|FG003|Overall Study|Other: Screen Failure|0|||
13491731|NCT03515551|27057710|FG003|Overall Study|Study ended by sponsor|1|||
13491732|NCT03515551|27057711|FG004|Overall Study|Study ended by sponsor|3|||
13491733|NCT03515551|27057712|FG005|Overall Study|Study ended by sponsor|0|||
13491734|NCT03515551|27057713|FG006|Overall Study|Study ended by sponsor|3|||
13491735|NCT03515551|27057707|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
13491736|NCT03515551|27057708|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1|||
13491737|NCT03515551|27057709|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
13491738|NCT03515551|27057710|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
13491739|NCT03515551|27057711|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
13491740|NCT03515551|27057712|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
13491741|NCT03515551|27057713|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
13491742|NCT03385265|27057750|FG000|Overall Study|Withdrawal by Subject|5|||
13491743|NCT03385265|27057751|FG001|Overall Study|Withdrawal by Subject|2|||
13491744|NCT03385265|27057752|FG002|Overall Study|Withdrawal by Subject|5|||
13491745|NCT03385265|27057753|FG003|Overall Study|Withdrawal by Subject|2|||
13491746|NCT02919306|27058020|FG000|Overall Study|Withdrawal by Subject|1|||
13491747|NCT02919306|27058021|FG001|Overall Study|Withdrawal by Subject|0|||
13491748|NCT02919306|27058020|FG000|Overall Study|Protocol Violation|1|||
13491749|NCT02919306|27058021|FG001|Overall Study|Protocol Violation|0|||
13491750|NCT02763189|27058036|FG000|Overall Study|Device failure|0|||
13491751|NCT02763189|27058037|FG001|Overall Study|Device failure|2|||
13491752|NCT02659514|27058062|FG000|Overall Study|Adverse Event|3|||
13491753|NCT02659514|27058063|FG001|Overall Study|Adverse Event|12|||
13491754|NCT02659514|27058062|FG000|Overall Study|Disease Progression|23|||
13491755|NCT02659514|27058063|FG001|Overall Study|Disease Progression|13|||
13491756|NCT02659514|27058062|FG000|Overall Study|Withdrawal by Subject|0|||
13491757|NCT02659514|27058063|FG001|Overall Study|Withdrawal by Subject|4|||
13491758|NCT02659514|27058062|FG000|Overall Study|Lost to Follow-up|0|||
13491759|NCT02659514|27058063|FG001|Overall Study|Lost to Follow-up|1|||
13491760|NCT02659514|27058062|FG000|Overall Study|Death|6|||
13491761|NCT02659514|27058063|FG001|Overall Study|Death|1|||
13491762|NCT02659514|27058062|FG000|Overall Study|Reason Unspecified|0|||
13491763|NCT02659514|27058063|FG001|Overall Study|Reason Unspecified|3|||
13207733|NCT01945580|26238884|FG000|Overall Study|Withdrawal by Subject|13|||
13207734|NCT01945580|26238885|FG001|Overall Study|Withdrawal by Subject|35|||
13207735|NCT01945580|26238884|FG000|Overall Study|Physician Decision|3|||
13491764|NCT01673867|27058096|FG000|Randomization|AE unrelated to study drug|1|||
13491765|NCT01673867|27058097|FG001|Randomization|AE unrelated to study drug|0|||
13491766|NCT01673867|27058096|FG000|Randomization|Requested treatment discontinuation|0|||
13491767|NCT01673867|27058097|FG001|Randomization|Requested treatment discontinuation|4|||
13491768|NCT01673867|27058096|FG000|Randomization|Withdrawal by Subject|0|||
13491769|NCT01673867|27058097|FG001|Randomization|Withdrawal by Subject|12|||
13491770|NCT01673867|27058096|FG000|Randomization|Lost to Follow-up|0|||
13491771|NCT01673867|27058097|FG001|Randomization|Lost to Follow-up|1|||
13491772|NCT01673867|27058096|FG000|Randomization|No longer meets criteria|4|||
13491773|NCT01673867|27058097|FG001|Randomization|No longer meets criteria|5|||
13491774|NCT01673867|27058096|FG000|Treatment|Disease Progression|194|||
13491775|NCT01673867|27058097|FG001|Treatment|Disease Progression|179|||
13491776|NCT01673867|27058096|FG000|Treatment|Study Drug Toxicity|17|||
13491777|NCT01673867|27058097|FG001|Treatment|Study Drug Toxicity|42|||
13491778|NCT01673867|27058096|FG000|Treatment|Death|1|||
13491779|NCT01673867|27058097|FG001|Treatment|Death|1|||
13491780|NCT01673867|27058096|FG000|Treatment|AE unrelated to study drug|19|||
13491781|NCT01673867|27058097|FG001|Treatment|AE unrelated to study drug|11|||
13491782|NCT01673867|27058096|FG000|Treatment|Requested treatment discontinuation|5|||
13491783|NCT01673867|27058097|FG001|Treatment|Requested treatment discontinuation|16|||
13491784|NCT01673867|27058096|FG000|Treatment|Withdrawal by Subject|4|||
13491785|NCT01673867|27058097|FG001|Treatment|Withdrawal by Subject|6|||
13491786|NCT01673867|27058096|FG000|Treatment|Maximum clinical benefit|0|||
13491787|NCT01673867|27058097|FG001|Treatment|Maximum clinical benefit|10|||
13491788|NCT01673867|27058096|FG000|Treatment|No longer meets criteria|2|||
13491789|NCT01673867|27058097|FG001|Treatment|No longer meets criteria|0|||
13491790|NCT01673867|27058096|FG000|Treatment|Required steroid therapy|1|||
13491791|NCT01673867|27058097|FG001|Treatment|Required steroid therapy|0|||
13491792|NCT01673867|27058096|FG000|Treatment|Health status not improved|1|||
13491793|NCT01673867|27058097|FG001|Treatment|Health status not improved|0|||
13491794|NCT01673867|27058096|FG000|Treatment|Required prolonged hospitalization|0|||
13491795|NCT01673867|27058097|FG001|Treatment|Required prolonged hospitalization|1|||
13491796|NCT01673867|27058096|FG000|Treatment|Symptomatic deterioration|0|||
13491797|NCT01673867|27058097|FG001|Treatment|Symptomatic deterioration|1|||
13491798|NCT01673867|27058096|FG000|Treatment|Physician Decision|0|||
13491799|NCT01673867|27058097|FG001|Treatment|Physician Decision|1|||
13491800|NCT00335777|27058112|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5|||
13491801|NCT00335777|27058112|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6|||
13491802|NCT00335777|27058112|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18|||
13491803|NCT00335777|27058112|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1|||
13491804|NCT00335777|27058112|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12|||
13491805|NCT00159588|27058133|FG000|5 Month Follow-up|Withdrawal by Subject|2|||
13491806|NCT00159588|27058134|FG001|5 Month Follow-up|Withdrawal by Subject|4|||
13491807|NCT00159588|27058135|FG002|5 Month Follow-up|Withdrawal by Subject|2|||
13491808|NCT03051217|27058178|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2|||
13491809|NCT03051217|27058179|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
13491810|NCT03051217|27058180|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
13491811|NCT03051217|27058181|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
13491812|NCT03051217|27058182|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
13491813|NCT03051217|27058183|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
13491814|NCT03051217|27058184|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
13491815|NCT03051217|27058178|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
13491816|NCT03051217|27058179|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1|||
13491817|NCT03051217|27058180|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
13491818|NCT03051217|27058181|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
13491819|NCT03051217|27058182|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
13491820|NCT03051217|27058183|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
13491821|NCT03051217|27058184|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
13491822|NCT03051217|27058178|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
13491823|NCT03051217|27058179|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
13491824|NCT03051217|27058180|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
13491825|NCT03051217|27058181|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
13491826|NCT03051217|27058182|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
13207736|NCT01945580|26238885|FG001|Overall Study|Physician Decision|2|||
13491827|NCT03051217|27058183|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
13491828|NCT03051217|27058184|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
13491829|NCT03051217|27058178|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
13491830|NCT03051217|27058179|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
13491831|NCT03051217|27058180|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
13491832|NCT03051217|27058181|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
13491833|NCT03051217|27058182|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2|||
13491834|NCT03051217|27058183|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
13491835|NCT03051217|27058184|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
13491836|NCT03051217|27058178|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
13491837|NCT03051217|27058179|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
13491838|NCT03051217|27058180|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
13491839|NCT03051217|27058181|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1|||
13491840|NCT03051217|27058182|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
13491841|NCT03051217|27058183|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
13491842|NCT03051217|27058184|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
13491843|NCT03051217|27058178|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
13491844|NCT03051217|27058179|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
13491845|NCT03051217|27058180|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
13491846|NCT03051217|27058181|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1|||
13491847|NCT03051217|27058182|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
13491848|NCT03051217|27058183|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
13491849|NCT03051217|27058184|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
13491850|NCT03051217|27058178|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
13491851|NCT03051217|27058179|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
13491852|NCT03051217|27058180|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
13491853|NCT03051217|27058181|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
13491854|NCT03051217|27058182|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1|||
13491855|NCT03051217|27058183|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
13491856|NCT03051217|27058184|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
13491857|NCT03051217|27058178|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
13491858|NCT03051217|27058179|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
13491859|NCT03051217|27058180|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
13491860|NCT03051217|27058181|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
13491861|NCT03051217|27058182|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
13491862|NCT03051217|27058183|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1|||
13491863|NCT03051217|27058184|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
13491864|NCT02889809|27058223|FG000|Overall Study|Withdrawal by Subject|30|||
13491865|NCT02889809|27058224|FG001|Overall Study|Withdrawal by Subject|21|||
13491866|NCT02889809|27058223|FG000|Overall Study|Lost to Follow-up|1|||
13491867|NCT02889809|27058224|FG001|Overall Study|Lost to Follow-up|1|||
13491868|NCT02889809|27058223|FG000|Overall Study|Site Closed|12|||
13491869|NCT02889809|27058224|FG001|Overall Study|Site Closed|11|||
13491870|NCT02849587|27058281|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
13491871|NCT02849587|27058282|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3|||
13491872|NCT02849587|27058283|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
13491873|NCT02849587|27058281|FG000|Overall Study|Withdrawal by Subject|0|||
13491874|NCT02849587|27058282|FG001|Overall Study|Withdrawal by Subject|1|||
13491875|NCT02849587|27058283|FG002|Overall Study|Withdrawal by Subject|0|||
13491876|NCT02781727|27058357|FG000|Pre-dosing Period|Withdrawal by Subject|1|||
13491877|NCT02781727|27058358|FG001|Pre-dosing Period|Withdrawal by Subject|0|||
13491878|NCT02781727|27058357|FG000|Treatment Period|Withdrawal by Subject|1|||
13491879|NCT02781727|27058358|FG001|Treatment Period|Withdrawal by Subject|0|||
13491880|NCT02781727|27058357|FG000|Treatment Period|Lost to Follow-up|0|||
13491881|NCT02781727|27058358|FG001|Treatment Period|Lost to Follow-up|1|||
13491882|NCT02778204|27058415|FG000|Overall Study|Adverse Event|1|||
13491883|NCT02778204|27058416|FG001|Overall Study|Adverse Event|0|||
13491884|NCT02778204|27058417|FG002|Overall Study|Adverse Event|0|||
13491885|NCT02778204|27058418|FG003|Overall Study|Adverse Event|0|||
13491886|NCT02778204|27058415|FG000|Overall Study|Withdrawal by Subject|0|||
13491887|NCT02778204|27058416|FG001|Overall Study|Withdrawal by Subject|0|||
13491888|NCT02778204|27058417|FG002|Overall Study|Withdrawal by Subject|1|||
13491889|NCT02778204|27058418|FG003|Overall Study|Withdrawal by Subject|2|||
13491890|NCT02778204|27058415|FG000|Overall Study|Lost to Follow-up|1|||
13491891|NCT02778204|27058416|FG001|Overall Study|Lost to Follow-up|0|||
13491892|NCT02778204|27058417|FG002|Overall Study|Lost to Follow-up|2|||
13207737|NCT01945580|26238884|FG000|Overall Study|Lost to Follow-up|26|||
13207738|NCT01945580|26238885|FG001|Overall Study|Lost to Follow-up|39|||
13207739|NCT01945580|26238884|FG000|Overall Study|Death|7|||
13207740|NCT01945580|26238885|FG001|Overall Study|Death|2|||
13207741|NCT01945580|26238884|FG000|Overall Study|Patient moved out of state|0|||
13207742|NCT01945580|26238885|FG001|Overall Study|Patient moved out of state|1|||
13207743|NCT01945580|26238884|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1|||
13491893|NCT02778204|27058418|FG003|Overall Study|Lost to Follow-up|1|||
13491894|NCT02778204|27058415|FG000|Overall Study|Protocol Violation|0|||
13491895|NCT02778204|27058416|FG001|Overall Study|Protocol Violation|0|||
13207744|NCT01945580|26238885|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0|||
13207745|NCT01945580|26238884|FG000|Overall Study|Family illness - unable to return|0|||
13207746|NCT01945580|26238885|FG001|Overall Study|Family illness - unable to return|1|||
13207747|NCT01945580|26238884|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0|||
13207748|NCT01945580|26238885|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1|||
13207749|NCT01945580|26238884|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0|||
13207750|NCT01945580|26238885|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1|||
13207751|NCT01945580|26238884|FG000|Overall Study|Noncompliance with 36 month visit|1|||
13296446|NCT01370538|26496539|FG000|Overall Study|Voluntary Discontinuation by Subject|3|||
13491896|NCT02778204|27058417|FG002|Overall Study|Protocol Violation|1|||
13491897|NCT02778204|27058418|FG003|Overall Study|Protocol Violation|0|||
13491898|NCT02778204|27058415|FG000|Overall Study|Eligibility Violation|0|||
13491899|NCT02778204|27058416|FG001|Overall Study|Eligibility Violation|0|||
13491900|NCT02778204|27058417|FG002|Overall Study|Eligibility Violation|0|||
13491901|NCT02778204|27058418|FG003|Overall Study|Eligibility Violation|1|||
13491902|NCT02496611|27058432|FG000|Overall Study|Lost to Follow-up|2|||
13491903|NCT02496611|27058433|FG001|Overall Study|Lost to Follow-up|1|||
13491904|NCT02496611|27058432|FG000|Overall Study|Withdrawal by Subject|5|||
13491905|NCT02496611|27058433|FG001|Overall Study|Withdrawal by Subject|2|||
13491906|NCT01988571|27058497|FG000|Overall Study|Death|3|||
13491907|NCT01988571|27058498|FG001|Overall Study|Death|1|||
13491908|NCT01988571|27058497|FG000|Overall Study|Physician Decision|2|||
13491909|NCT01988571|27058498|FG001|Overall Study|Physician Decision|1|||
13491910|NCT01988571|27058497|FG000|Overall Study|Lost to Follow-up|3|||
13491911|NCT01988571|27058498|FG001|Overall Study|Lost to Follow-up|0|||
13491912|NCT01988571|27058497|FG000|Overall Study|Withdrawal by Subject|31|||
13491913|NCT01988571|27058498|FG001|Overall Study|Withdrawal by Subject|33|||
13491914|NCT01332266|27058545|FG000|Phase 1b|Death|3|||
13491915|NCT01332266|27058546|FG001|Phase 1b|Death|3|||
13491916|NCT01332266|27058547|FG002|Phase 1b|Death|2|||
13491917|NCT01332266|27058548|FG003|Phase 1b|Death|0|||
13491918|NCT01332266|27058549|FG004|Phase 1b|Death|0|||
13491919|NCT01332266|27058545|FG000|Phase 1b|Lost to Follow-up|0|||
13491920|NCT01332266|27058546|FG001|Phase 1b|Lost to Follow-up|1|||
13491921|NCT01332266|27058547|FG002|Phase 1b|Lost to Follow-up|0|||
13491922|NCT01332266|27058548|FG003|Phase 1b|Lost to Follow-up|0|||
13491923|NCT01332266|27058549|FG004|Phase 1b|Lost to Follow-up|0|||
13491924|NCT01332266|27058545|FG000|Phase 1b|Withdrawal by Subject|1|||
13491925|NCT01332266|27058546|FG001|Phase 1b|Withdrawal by Subject|1|||
13491926|NCT01332266|27058547|FG002|Phase 1b|Withdrawal by Subject|1|||
13491927|NCT01332266|27058548|FG003|Phase 1b|Withdrawal by Subject|0|||
13491928|NCT01332266|27058549|FG004|Phase 1b|Withdrawal by Subject|0|||
13491929|NCT01332266|27058545|FG000|Phase 2|Death|0|||
13491930|NCT01332266|27058546|FG001|Phase 2|Death|0|||
13491931|NCT01332266|27058547|FG002|Phase 2|Death|0|||
13491932|NCT01332266|27058548|FG003|Phase 2|Death|33|||
13491933|NCT01332266|27058549|FG004|Phase 2|Death|36|||
13491934|NCT01332266|27058545|FG000|Phase 2|Lost to Follow-up|0|||
13491935|NCT01332266|27058546|FG001|Phase 2|Lost to Follow-up|0|||
13491936|NCT01332266|27058547|FG002|Phase 2|Lost to Follow-up|0|||
13491937|NCT01332266|27058548|FG003|Phase 2|Lost to Follow-up|2|||
13491938|NCT01332266|27058549|FG004|Phase 2|Lost to Follow-up|0|||
13491939|NCT01332266|27058545|FG000|Phase 2|Physician Decision|0|||
13491940|NCT01332266|27058546|FG001|Phase 2|Physician Decision|0|||
13491941|NCT01332266|27058547|FG002|Phase 2|Physician Decision|0|||
13491942|NCT01332266|27058548|FG003|Phase 2|Physician Decision|3|||
13491943|NCT01332266|27058549|FG004|Phase 2|Physician Decision|1|||
13491944|NCT01332266|27058545|FG000|Phase 2|Symptomatic deterioration|0|||
13491945|NCT01332266|27058546|FG001|Phase 2|Symptomatic deterioration|0|||
13491946|NCT01332266|27058547|FG002|Phase 2|Symptomatic deterioration|0|||
13491947|NCT01332266|27058548|FG003|Phase 2|Symptomatic deterioration|0|||
13491948|NCT01332266|27058549|FG004|Phase 2|Symptomatic deterioration|1|||
13491949|NCT01332266|27058545|FG000|Phase 2|Progression Disease|0|||
13491950|NCT01332266|27058546|FG001|Phase 2|Progression Disease|0|||
13491951|NCT01332266|27058547|FG002|Phase 2|Progression Disease|0|||
13491952|NCT01332266|27058548|FG003|Phase 2|Progression Disease|2|||
13491953|NCT01332266|27058549|FG004|Phase 2|Progression Disease|1|||
13491954|NCT01332266|27058545|FG000|Phase 2|Withdrawal by Subject|0|||
13491955|NCT01332266|27058546|FG001|Phase 2|Withdrawal by Subject|0|||
13491956|NCT01332266|27058547|FG002|Phase 2|Withdrawal by Subject|0|||
13491957|NCT01332266|27058548|FG003|Phase 2|Withdrawal by Subject|2|||
13491958|NCT01332266|27058549|FG004|Phase 2|Withdrawal by Subject|2|||
13491959|NCT01150890|27058596|FG000|Overall Study|Other|0|||
13491960|NCT01150890|27058597|FG001|Overall Study|Other|1|||
13491961|NCT01150890|27058598|FG002|Overall Study|Other|0|||
13491962|NCT01150890|27058599|FG003|Overall Study|Other|2|||
13491963|NCT01150890|27058596|FG000|Overall Study|Pregnancy|0|||
13491964|NCT01150890|27058597|FG001|Overall Study|Pregnancy|0|||
13491965|NCT01150890|27058598|FG002|Overall Study|Pregnancy|0|||
13491966|NCT01150890|27058599|FG003|Overall Study|Pregnancy|1|||
13491967|NCT01150890|27058596|FG000|Overall Study|Administrative Decision|4|||
13491968|NCT01150890|27058597|FG001|Overall Study|Administrative Decision|4|||
13491969|NCT01150890|27058598|FG002|Overall Study|Administrative Decision|5|||
13491970|NCT01150890|27058599|FG003|Overall Study|Administrative Decision|6|||
13491971|NCT01150890|27058596|FG000|Overall Study|Ineligibility determined|0|||
13491972|NCT01150890|27058597|FG001|Overall Study|Ineligibility determined|1|||
13491973|NCT01150890|27058598|FG002|Overall Study|Ineligibility determined|0|||
13491974|NCT01150890|27058599|FG003|Overall Study|Ineligibility determined|0|||
13491975|NCT01150890|27058596|FG000|Overall Study|Adverse Event|0|||
13491976|NCT01150890|27058597|FG001|Overall Study|Adverse Event|0|||
13491977|NCT01150890|27058598|FG002|Overall Study|Adverse Event|2|||
13491978|NCT01150890|27058599|FG003|Overall Study|Adverse Event|0|||
13491979|NCT01150890|27058596|FG000|Overall Study|Withdrawal by Subject|0|||
13491980|NCT01150890|27058597|FG001|Overall Study|Withdrawal by Subject|0|||
13491981|NCT01150890|27058598|FG002|Overall Study|Withdrawal by Subject|2|||
13491982|NCT01150890|27058599|FG003|Overall Study|Withdrawal by Subject|1|||
13491983|NCT01150890|27058596|FG000|Overall Study|Disease progression|0|||
13491984|NCT01150890|27058597|FG001|Overall Study|Disease progression|7|||
13491985|NCT01150890|27058598|FG002|Overall Study|Disease progression|3|||
13491986|NCT01150890|27058599|FG003|Overall Study|Disease progression|7|||
13491987|NCT01140867|27058608|FG000|Overall Study|Adverse Event|22|||
13491988|NCT01140867|27058608|FG000|Overall Study|Lack of Efficacy|3|||
13491989|NCT01140867|27058608|FG000|Overall Study|Lost to Follow-up|2|||
13491990|NCT01140867|27058608|FG000|Overall Study|Withdrawal by Subject|1|||
13491991|NCT01140867|27058608|FG000|Overall Study|Protocol Violation|1|||
13491992|NCT01140867|27058608|FG000|Overall Study|Uncooperative patient|2|||
13491993|NCT01140867|27058608|FG000|Overall Study|Medication Noncompliance|2|||
13491994|NCT01137773|27058623|FG000|Overall Study|Death|3|||
13491995|NCT01137773|27058624|FG001|Overall Study|Death|3|||
13491996|NCT01137773|27058623|FG000|Overall Study|Lost to Follow-up|6|||
13491997|NCT01137773|27058624|FG001|Overall Study|Lost to Follow-up|0|||
13491998|NCT01127256|27058641|FG000|Overall Study|Adverse Event|13|||
13491999|NCT01127256|27058642|FG001|Overall Study|Adverse Event|13|||
13492000|NCT01127256|27058641|FG000|Overall Study|Lack of Efficacy|4|||
13492001|NCT01127256|27058642|FG001|Overall Study|Lack of Efficacy|0|||
13492002|NCT01127256|27058641|FG000|Overall Study|Lost to Follow-up|16|||
13492003|NCT01127256|27058642|FG001|Overall Study|Lost to Follow-up|17|||
13492004|NCT01127256|27058641|FG000|Overall Study|Withdrawal by Subject|5|||
13492005|NCT01127256|27058642|FG001|Overall Study|Withdrawal by Subject|9|||
13492006|NCT01127256|27058641|FG000|Overall Study|Protocol Violation|1|||
13492007|NCT01127256|27058642|FG001|Overall Study|Protocol Violation|0|||
13492008|NCT01004861|27058746|FG000|Overall Study|Disease progression|3|||
13492009|NCT01004861|27058747|FG001|Overall Study|Disease progression|4|||
13492010|NCT01004861|27058748|FG002|Overall Study|Disease progression|5|||
13492011|NCT01004861|27058749|FG003|Overall Study|Disease progression|4|||
13492012|NCT01004861|27058750|FG004|Overall Study|Disease progression|4|||
13492013|NCT01004861|27058751|FG005|Overall Study|Disease progression|4|||
13492014|NCT01004861|27058752|FG006|Overall Study|Disease progression|5|||
13492015|NCT01004861|27058753|FG007|Overall Study|Disease progression|1|||
13492016|NCT01004861|27058754|FG008|Overall Study|Disease progression|4|||
13492017|NCT01004861|27058755|FG009|Overall Study|Disease progression|7|||
13492018|NCT01004861|27058756|FG010|Overall Study|Disease progression|6|||
13492019|NCT01004861|27058757|FG011|Overall Study|Disease progression|3|||
13492020|NCT01004861|27058758|FG012|Overall Study|Disease progression|8|||
13492021|NCT01004861|27058746|FG000|Overall Study|Physician Decision|0|||
13207752|NCT01945580|26238885|FG001|Overall Study|Noncompliance with 36 month visit|0|||
13207753|NCT01945580|26238884|FG000|Overall Study|The patient moved.|1|||
13207754|NCT01945580|26238885|FG001|Overall Study|The patient moved.|0|||
13207755|NCT01945580|26238884|FG000|Overall Study|No data available|0|||
13207756|NCT01945580|26238885|FG001|Overall Study|No data available|2|||
13207757|NCT01945489|26238909|FG000|Cycle 1|Adverse Event|2|||
13207758|NCT01945489|26238910|FG001|Cycle 1|Adverse Event|0|||
13207759|NCT01945489|26238909|FG000|Cycle 1|Lost to Follow-up|4|||
13492022|NCT01004861|27058747|FG001|Overall Study|Physician Decision|2|||
13492023|NCT01004861|27058748|FG002|Overall Study|Physician Decision|1|||
13492024|NCT01004861|27058749|FG003|Overall Study|Physician Decision|1|||
13492025|NCT01004861|27058750|FG004|Overall Study|Physician Decision|1|||
13492026|NCT01004861|27058751|FG005|Overall Study|Physician Decision|0|||
13492027|NCT01004861|27058752|FG006|Overall Study|Physician Decision|0|||
13492028|NCT01004861|27058753|FG007|Overall Study|Physician Decision|1|||
13492029|NCT01004861|27058754|FG008|Overall Study|Physician Decision|0|||
13492030|NCT01004861|27058755|FG009|Overall Study|Physician Decision|0|||
13492031|NCT01004861|27058756|FG010|Overall Study|Physician Decision|0|||
13492032|NCT01004861|27058757|FG011|Overall Study|Physician Decision|0|||
13207760|NCT01945489|26238910|FG001|Cycle 1|Lost to Follow-up|0|||
13207761|NCT01945489|26238909|FG000|Cycle 1|Personal Reasons|4|||
13492033|NCT01004861|27058758|FG012|Overall Study|Physician Decision|3|||
13492034|NCT01004861|27058746|FG000|Overall Study|Adverse Event|0|||
13492035|NCT01004861|27058747|FG001|Overall Study|Adverse Event|0|||
13207762|NCT01945489|26238910|FG001|Cycle 1|Personal Reasons|2|||
13207763|NCT01945489|26238909|FG000|Cycle 1|Protocol Violation|0|||
13207764|NCT01945489|26238910|FG001|Cycle 1|Protocol Violation|1|||
13207765|NCT01945489|26238909|FG000|Cycle 1|Other Miscellaneous Reasons|3|||
13207766|NCT01945489|26238910|FG001|Cycle 1|Other Miscellaneous Reasons|1|||
13207767|NCT01945489|26238909|FG000|Cycle 2|Adverse Event|1|||
13207768|NCT01945489|26238910|FG001|Cycle 2|Adverse Event|0|||
13207769|NCT01945489|26238909|FG000|Cycle 2|Lost to Follow-up|0|||
13207770|NCT01945489|26238910|FG001|Cycle 2|Lost to Follow-up|1|||
13492036|NCT01004861|27058748|FG002|Overall Study|Adverse Event|0|||
13492037|NCT01004861|27058749|FG003|Overall Study|Adverse Event|1|||
13492038|NCT01004861|27058750|FG004|Overall Study|Adverse Event|0|||
13492039|NCT01004861|27058751|FG005|Overall Study|Adverse Event|2|||
13492040|NCT01004861|27058752|FG006|Overall Study|Adverse Event|1|||
13492041|NCT01004861|27058753|FG007|Overall Study|Adverse Event|1|||
13492042|NCT01004861|27058754|FG008|Overall Study|Adverse Event|13|||
13492043|NCT01004861|27058755|FG009|Overall Study|Adverse Event|1|||
13492044|NCT01004861|27058756|FG010|Overall Study|Adverse Event|1|||
13492045|NCT01004861|27058757|FG011|Overall Study|Adverse Event|0|||
13492046|NCT01004861|27058758|FG012|Overall Study|Adverse Event|2|||
13492047|NCT01004861|27058746|FG000|Overall Study|Protocol Violation|0|||
13492048|NCT01004861|27058747|FG001|Overall Study|Protocol Violation|0|||
13492049|NCT01004861|27058748|FG002|Overall Study|Protocol Violation|0|||
13492050|NCT01004861|27058749|FG003|Overall Study|Protocol Violation|0|||
13492051|NCT01004861|27058750|FG004|Overall Study|Protocol Violation|1|||
13492052|NCT01004861|27058751|FG005|Overall Study|Protocol Violation|0|||
13492053|NCT01004861|27058752|FG006|Overall Study|Protocol Violation|0|||
13492054|NCT01004861|27058753|FG007|Overall Study|Protocol Violation|0|||
13492055|NCT01004861|27058754|FG008|Overall Study|Protocol Violation|0|||
13492056|NCT01004861|27058755|FG009|Overall Study|Protocol Violation|0|||
13492057|NCT01004861|27058756|FG010|Overall Study|Protocol Violation|0|||
13492058|NCT01004861|27058757|FG011|Overall Study|Protocol Violation|0|||
13492059|NCT01004861|27058758|FG012|Overall Study|Protocol Violation|0|||
13492060|NCT01004861|27058746|FG000|Overall Study|Lost to Follow-up|0|||
13492061|NCT01004861|27058747|FG001|Overall Study|Lost to Follow-up|0|||
13492062|NCT01004861|27058748|FG002|Overall Study|Lost to Follow-up|0|||
13492063|NCT01004861|27058749|FG003|Overall Study|Lost to Follow-up|0|||
13492064|NCT01004861|27058750|FG004|Overall Study|Lost to Follow-up|0|||
13492065|NCT01004861|27058751|FG005|Overall Study|Lost to Follow-up|0|||
13492066|NCT01004861|27058752|FG006|Overall Study|Lost to Follow-up|0|||
13492067|NCT01004861|27058753|FG007|Overall Study|Lost to Follow-up|1|||
13492068|NCT01004861|27058754|FG008|Overall Study|Lost to Follow-up|3|||
13492069|NCT01004861|27058755|FG009|Overall Study|Lost to Follow-up|0|||
13492070|NCT01004861|27058756|FG010|Overall Study|Lost to Follow-up|0|||
13492071|NCT01004861|27058757|FG011|Overall Study|Lost to Follow-up|1|||
13492072|NCT01004861|27058758|FG012|Overall Study|Lost to Follow-up|0|||
13492073|NCT01004861|27058746|FG000|Overall Study|Non-compliance|0|||
13492074|NCT01004861|27058747|FG001|Overall Study|Non-compliance|0|||
13492075|NCT01004861|27058748|FG002|Overall Study|Non-compliance|0|||
13492076|NCT01004861|27058749|FG003|Overall Study|Non-compliance|0|||
13492077|NCT01004861|27058750|FG004|Overall Study|Non-compliance|0|||
13492078|NCT01004861|27058751|FG005|Overall Study|Non-compliance|0|||
13492079|NCT01004861|27058752|FG006|Overall Study|Non-compliance|0|||
13492080|NCT01004861|27058753|FG007|Overall Study|Non-compliance|0|||
13492081|NCT01004861|27058754|FG008|Overall Study|Non-compliance|5|||
13492082|NCT01004861|27058755|FG009|Overall Study|Non-compliance|0|||
13492083|NCT01004861|27058756|FG010|Overall Study|Non-compliance|0|||
13492084|NCT01004861|27058757|FG011|Overall Study|Non-compliance|0|||
13492085|NCT01004861|27058758|FG012|Overall Study|Non-compliance|1|||
13492086|NCT01004861|27058746|FG000|Overall Study|Other|0|||
13492087|NCT01004861|27058747|FG001|Overall Study|Other|0|||
13492088|NCT01004861|27058748|FG002|Overall Study|Other|0|||
13492089|NCT01004861|27058749|FG003|Overall Study|Other|0|||
13492090|NCT01004861|27058750|FG004|Overall Study|Other|0|||
13492091|NCT01004861|27058751|FG005|Overall Study|Other|0|||
13492092|NCT01004861|27058752|FG006|Overall Study|Other|0|||
13492093|NCT01004861|27058753|FG007|Overall Study|Other|0|||
13492094|NCT01004861|27058754|FG008|Overall Study|Other|0|||
13492095|NCT01004861|27058755|FG009|Overall Study|Other|2|||
13492096|NCT01004861|27058756|FG010|Overall Study|Other|1|||
13492097|NCT01004861|27058757|FG011|Overall Study|Other|2|||
13492098|NCT01004861|27058758|FG012|Overall Study|Other|3|||
13492099|NCT01004861|27058746|FG000|Overall Study|Patient decision|0|||
13492100|NCT01004861|27058747|FG001|Overall Study|Patient decision|0|||
13492101|NCT01004861|27058748|FG002|Overall Study|Patient decision|0|||
13207771|NCT01945281|26238927|FG000|Overall Study|Adverse Event|1|||
13207772|NCT01945281|26238928|FG001|Overall Study|Adverse Event|0|||
13492102|NCT01004861|27058749|FG003|Overall Study|Patient decision|0|||
13492103|NCT01004861|27058750|FG004|Overall Study|Patient decision|1|||
13492104|NCT01004861|27058751|FG005|Overall Study|Patient decision|0|||
13492105|NCT01004861|27058752|FG006|Overall Study|Patient decision|1|||
13492106|NCT01004861|27058753|FG007|Overall Study|Patient decision|0|||
13492107|NCT01004861|27058754|FG008|Overall Study|Patient decision|7|||
13492108|NCT01004861|27058755|FG009|Overall Study|Patient decision|1|||
13492109|NCT01004861|27058756|FG010|Overall Study|Patient decision|1|||
13492110|NCT01004861|27058757|FG011|Overall Study|Patient decision|2|||
13492111|NCT01004861|27058758|FG012|Overall Study|Patient decision|3|||
13492112|NCT01004861|27058746|FG000|Overall Study|Transitioned to Phase 4 study|0|||
13492113|NCT01004861|27058747|FG001|Overall Study|Transitioned to Phase 4 study|0|||
13492114|NCT01004861|27058748|FG002|Overall Study|Transitioned to Phase 4 study|0|||
13492115|NCT01004861|27058749|FG003|Overall Study|Transitioned to Phase 4 study|0|||
13492116|NCT01004861|27058750|FG004|Overall Study|Transitioned to Phase 4 study|0|||
13492117|NCT01004861|27058751|FG005|Overall Study|Transitioned to Phase 4 study|0|||
13492118|NCT01004861|27058752|FG006|Overall Study|Transitioned to Phase 4 study|0|||
13492119|NCT01004861|27058753|FG007|Overall Study|Transitioned to Phase 4 study|0|||
13492120|NCT01004861|27058754|FG008|Overall Study|Transitioned to Phase 4 study|2|||
13492121|NCT01004861|27058755|FG009|Overall Study|Transitioned to Phase 4 study|0|||
13492122|NCT01004861|27058756|FG010|Overall Study|Transitioned to Phase 4 study|0|||
13492123|NCT01004861|27058757|FG011|Overall Study|Transitioned to Phase 4 study|0|||
13492124|NCT01004861|27058758|FG012|Overall Study|Transitioned to Phase 4 study|0|||
13492125|NCT01004861|27058746|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
13492126|NCT01004861|27058747|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
13492127|NCT01004861|27058748|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
13492128|NCT01004861|27058749|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
13492129|NCT01004861|27058750|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
13492130|NCT01004861|27058751|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
13492131|NCT01004861|27058752|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
13492132|NCT01004861|27058753|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
13492133|NCT01004861|27058754|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1|||
13207773|NCT01945281|26238927|FG000|Overall Study|Death|3|||
13207774|NCT01945281|26238928|FG001|Overall Study|Death|3|||
13207775|NCT01945281|26238927|FG000|Overall Study|Physician Decision|1|||
13207776|NCT01945281|26238928|FG001|Overall Study|Physician Decision|1|||
13207777|NCT01945281|26238927|FG000|Overall Study|Technical Problems|1|||
13207778|NCT01945281|26238928|FG001|Overall Study|Technical Problems|0|||
13207779|NCT01945242|26238947|FG000|Overall Study|Physician Decision|3|||
13207780|NCT01945242|26238948|FG001|Overall Study|Physician Decision|3|||
13207781|NCT01945216|26238968|FG000|Overall Study|Case report forms (CRF) uncollected|52|||
13207782|NCT01945216|26238968|FG000|Overall Study|Protocol Violation|42|||
13207783|NCT01945216|26238968|FG000|Overall Study|CRF not assured by investigators|5|||
13207784|NCT01945086|26239019|FG000|Overall Study|Withdrawal by Subject|1|||
13207785|NCT01945086|26239020|FG001|Overall Study|Withdrawal by Subject|0|||
13207786|NCT01945086|26239021|FG002|Overall Study|Withdrawal by Subject|1|||
13207787|NCT01945086|26239019|FG000|Overall Study|Adverse Event|0|||
13207788|NCT01945086|26239020|FG001|Overall Study|Adverse Event|0|||
13207789|NCT01945086|26239021|FG002|Overall Study|Adverse Event|1|||
13207790|NCT01945034|26239081|FG000|Overall Study|Medication Error|0|||
13207791|NCT01945034|26239082|FG001|Overall Study|Medication Error|1|||
13207792|NCT01945034|26239083|FG002|Overall Study|Medication Error|0|||
13207793|NCT01945034|26239081|FG000|Overall Study|Withdrawal by Subject|0|||
13207794|NCT01945034|26239082|FG001|Overall Study|Withdrawal by Subject|3|||
13207795|NCT01945034|26239083|FG002|Overall Study|Withdrawal by Subject|1|||
13207796|NCT01945034|26239081|FG000|Overall Study|Other|0|||
13207797|NCT01945034|26239082|FG001|Overall Study|Other|1|||
13207798|NCT01945034|26239083|FG002|Overall Study|Other|3|||
13207799|NCT01945034|26239081|FG000|Overall Study|Lost to Follow-up|0|||
13207800|NCT01945034|26239082|FG001|Overall Study|Lost to Follow-up|0|||
13207801|NCT01945034|26239083|FG002|Overall Study|Lost to Follow-up|2|||
13207802|NCT01945034|26239081|FG000|Overall Study|Protocol Violation|1|||
13207803|NCT01945034|26239082|FG001|Overall Study|Protocol Violation|0|||
13207804|NCT01945034|26239083|FG002|Overall Study|Protocol Violation|1|||
13207805|NCT01944969|26239096|FG000|Overall Study|Adverse Event|1|||
13207806|NCT01944969|26239096|FG000|Overall Study|Lack of Efficacy|1|||
13492134|NCT01004861|27058755|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
13492135|NCT01004861|27058756|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
13492136|NCT01004861|27058757|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
13492137|NCT01004861|27058758|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
13492138|NCT01004861|27058746|FG000|Overall Study|Patient withdrew|0|||
13492139|NCT01004861|27058747|FG001|Overall Study|Patient withdrew|0|||
13492140|NCT01004861|27058748|FG002|Overall Study|Patient withdrew|0|||
13492141|NCT01004861|27058749|FG003|Overall Study|Patient withdrew|0|||
13207807|NCT01944969|26239096|FG000|Overall Study|Non-compliance with IMP|1|||
13492142|NCT01004861|27058750|FG004|Overall Study|Patient withdrew|0|||
13492143|NCT01004861|27058751|FG005|Overall Study|Patient withdrew|0|||
13492144|NCT01004861|27058752|FG006|Overall Study|Patient withdrew|0|||
13492145|NCT01004861|27058753|FG007|Overall Study|Patient withdrew|0|||
13492146|NCT01004861|27058754|FG008|Overall Study|Patient withdrew|1|||
13492147|NCT01004861|27058755|FG009|Overall Study|Patient withdrew|0|||
13492148|NCT01004861|27058756|FG010|Overall Study|Patient withdrew|0|||
13492149|NCT01004861|27058757|FG011|Overall Study|Patient withdrew|0|||
13492150|NCT01004861|27058758|FG012|Overall Study|Patient withdrew|0|||
13492151|NCT01004861|27058746|FG000|Overall Study|Surgical resection|0|||
13492152|NCT01004861|27058747|FG001|Overall Study|Surgical resection|0|||
13492153|NCT01004861|27058748|FG002|Overall Study|Surgical resection|0|||
13492154|NCT01004861|27058749|FG003|Overall Study|Surgical resection|0|||
13492155|NCT01004861|27058750|FG004|Overall Study|Surgical resection|0|||
13492156|NCT01004861|27058751|FG005|Overall Study|Surgical resection|0|||
13492157|NCT01004861|27058752|FG006|Overall Study|Surgical resection|0|||
13492158|NCT01004861|27058753|FG007|Overall Study|Surgical resection|0|||
13492159|NCT01004861|27058754|FG008|Overall Study|Surgical resection|1|||
13492160|NCT01004861|27058755|FG009|Overall Study|Surgical resection|0|||
13492161|NCT01004861|27058756|FG010|Overall Study|Surgical resection|0|||
13492162|NCT01004861|27058757|FG011|Overall Study|Surgical resection|0|||
13492163|NCT01004861|27058758|FG012|Overall Study|Surgical resection|0|||
13492164|NCT01004861|27058746|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
13492165|NCT01004861|27058747|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
13492166|NCT01004861|27058748|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
13492167|NCT01004861|27058749|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
13207808|NCT01944969|26239096|FG000|Overall Study|Administrative or other reasons|23|||
13207809|NCT01944839|26239109|FG000|Overall Study|Physician Decision|2|||
13207810|NCT01944839|26239110|FG001|Overall Study|Physician Decision|2|||
13207811|NCT01944839|26239109|FG000|Overall Study|Protocol Violation|0|||
13207812|NCT01944839|26239110|FG001|Overall Study|Protocol Violation|1|||
13207813|NCT01944839|26239109|FG000|Overall Study|Adverse Event|10|||
13207814|NCT01944839|26239110|FG001|Overall Study|Adverse Event|5|||
13207815|NCT01944839|26239109|FG000|Overall Study|Withdrawal by Subject|9|||
13207816|NCT01944839|26239110|FG001|Overall Study|Withdrawal by Subject|17|||
13207817|NCT01944839|26239109|FG000|Overall Study|Lost to Follow-up|1|||
13207818|NCT01944839|26239110|FG001|Overall Study|Lost to Follow-up|0|||
13207819|NCT01944839|26239109|FG000|Overall Study|Subject non-compliance|0|||
13207820|NCT01944839|26239110|FG001|Overall Study|Subject non-compliance|3|||
13207821|NCT01944774|26239161|FG000|Overall Study|Withdrawal by Subject|2|||
13207822|NCT01944774|26239162|FG001|Overall Study|Withdrawal by Subject|3|||
13207823|NCT01944774|26239163|FG002|Overall Study|Withdrawal by Subject|3|||
13207824|NCT01944774|26239161|FG000|Overall Study|Adverse Event|3|||
13207825|NCT01944774|26239162|FG001|Overall Study|Adverse Event|2|||
13207826|NCT01944774|26239163|FG002|Overall Study|Adverse Event|3|||
13207827|NCT01944774|26239161|FG000|Overall Study|Lack of Efficacy|1|||
13207828|NCT01944774|26239162|FG001|Overall Study|Lack of Efficacy|2|||
13207829|NCT01944774|26239163|FG002|Overall Study|Lack of Efficacy|2|||
13207830|NCT01944774|26239161|FG000|Overall Study|Lost to Follow-up|0|||
13207831|NCT01944774|26239162|FG001|Overall Study|Lost to Follow-up|1|||
13207832|NCT01944774|26239163|FG002|Overall Study|Lost to Follow-up|0|||
13207833|NCT01944722|26239203|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171|||
13207834|NCT01944722|26239203|FG000|Overall Study|Specimen Shipping Issues|34|||
13207835|NCT01944722|26239203|FG000|Overall Study|Improper Storage/Transport|5|||
13207836|NCT01944722|26239203|FG000|Overall Study|Insufficient Volume for Test|1|||
13207837|NCT01944722|26239203|FG000|Overall Study|Missing Specimens|3|||
13207838|NCT01944722|26239203|FG000|Overall Study|Specimens Mislabeled|2|||
13207839|NCT01944722|26239203|FG000|Overall Study|Withdrawal by Subject|8|||
13207840|NCT01944722|26239203|FG000|Overall Study|NILM Subjects <30 years old|8106|||
13207841|NCT01944722|26239203|FG000|Overall Study|Unsatisfactory Cytology Result|63|||
13207842|NCT01944722|26239203|FG000|Overall Study|>ASCUS Cytology|1122|||
13207843|NCT01944670|26239210|FG000|Overall Study|Lost to Follow-up|2|||
13207844|NCT01944631|26239233|FG000|Overall Study|Adverse Event|1|||
13207845|NCT01944631|26239234|FG001|Overall Study|Adverse Event|0|||
13207846|NCT01944631|26239233|FG000|Overall Study|Lost to Follow-up|3|||
13207847|NCT01944631|26239234|FG001|Overall Study|Lost to Follow-up|1|||
13207848|NCT01944631|26239233|FG000|Overall Study|Withdrawal by Subject|0|||
13207849|NCT01944631|26239234|FG001|Overall Study|Withdrawal by Subject|1|||
13207850|NCT01944462|26239245|FG000|PPPP Educational Program|Lost to Follow-up|60|||
13207851|NCT01944098|26239264|FG000|Overall Study|Physician Decision|1|||
13207852|NCT01944098|26239265|FG001|Overall Study|Physician Decision|0|||
13207853|NCT01944059|26239276|FG000|Overall Study|Lost to Follow-up|1|||
13492168|NCT01004861|27058750|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
13492169|NCT01004861|27058751|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
13492170|NCT01004861|27058752|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
13207854|NCT01944059|26239276|FG000|Overall Study|Physician Decision|3|||
13207855|NCT01944059|26239276|FG000|Overall Study|Withdrawal by Subject|1|||
13207856|NCT01944059|26239276|FG000|Overall Study|Adverse Event|2|||
13207857|NCT01944046|26239321|FG000|Randomized to DB|Adverse Event|5|||
13207858|NCT01944046|26239322|FG001|Randomized to DB|Adverse Event|2|||
13207859|NCT01944046|26239321|FG000|Randomized to DB|Clinical Worsening|3|||
13207860|NCT01944046|26239322|FG001|Randomized to DB|Clinical Worsening|2|||
13207861|NCT01944046|26239321|FG000|Randomized to DB|Lost to Follow-up|3|||
13207862|NCT01944046|26239322|FG001|Randomized to DB|Lost to Follow-up|3|||
13207863|NCT01944046|26239321|FG000|Randomized to DB|Withdrawal by Subject|2|||
13207864|NCT01944046|26239322|FG001|Randomized to DB|Withdrawal by Subject|4|||
13207865|NCT01944046|26239321|FG000|Randomized to DB|Physician Decision|1|||
13207866|NCT01944046|26239322|FG001|Randomized to DB|Physician Decision|2|||
13207867|NCT01944046|26239321|FG000|Randomized to DB|Did not have baseline ABC-SW|2|||
13207868|NCT01944046|26239322|FG001|Randomized to DB|Did not have baseline ABC-SW|0|||
13207869|NCT01944046|26239321|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5|||
13207870|NCT01944046|26239322|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6|||
13207871|NCT01944046|26239321|FG000|Open Label Eligible and Consented|Lost to Follow-up|3|||
13207872|NCT01944046|26239322|FG001|Open Label Eligible and Consented|Lost to Follow-up|5|||
13207873|NCT01944046|26239321|FG000|Open Label Eligible and Consented|Adverse Event|6|||
13207874|NCT01944046|26239322|FG001|Open Label Eligible and Consented|Adverse Event|1|||
13207875|NCT01944046|26239321|FG000|Open Label Eligible and Consented|Clinical Worsening|4|||
13207876|NCT01944046|26239322|FG001|Open Label Eligible and Consented|Clinical Worsening|2|||
13207877|NCT01944046|26239321|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1|||
13207878|NCT01944046|26239322|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0|||
13207879|NCT01944020|26239337|FG000|Overall Study|Withdrawal by Subject|5|||
13207880|NCT01944020|26239338|FG001|Overall Study|Withdrawal by Subject|0|||
13207881|NCT01943916|26239351|FG000|Overall Study|Technically invalid images|10|||
13296447|NCT01370538|26496540|FG001|Overall Study|Voluntary Discontinuation by Subject|2|||
13296448|NCT01370538|26496539|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
13296449|NCT01370538|26496540|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
13296450|NCT01370538|26496539|FG000|Overall Study|Adverse Event|1|||
13296451|NCT01370538|26496540|FG001|Overall Study|Adverse Event|0|||
13296452|NCT01370538|26496539|FG000|Overall Study|Protocol Violation|8|||
13296453|NCT01370538|26496540|FG001|Overall Study|Protocol Violation|5|||
13296454|NCT01370538|26496539|FG000|Overall Study|Development of study specific withdrawal|1|||
13296455|NCT01370538|26496540|FG001|Overall Study|Development of study specific withdrawal|1|||
13296456|NCT01370538|26496539|FG000|Overall Study|Lost to follow up|6|||
13296457|NCT01370538|26496540|FG001|Overall Study|Lost to follow up|10|||
13296458|NCT01370525|26496561|FG000|Overall Study|Voluntary Discontinuation by Subject|2|||
13296459|NCT01370525|26496562|FG001|Overall Study|Voluntary Discontinuation by Subject|3|||
13296460|NCT01370525|26496561|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
13296461|NCT01370525|26496562|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
13296462|NCT01370525|26496561|FG000|Overall Study|Adverse Event|0|||
13296463|NCT01370525|26496562|FG001|Overall Study|Adverse Event|1|||
13296464|NCT01370525|26496561|FG000|Overall Study|Protocol Violation|2|||
13296465|NCT01370525|26496562|FG001|Overall Study|Protocol Violation|1|||
13296466|NCT01370525|26496561|FG000|Overall Study|Lost to follow up|2|||
13296467|NCT01370525|26496562|FG001|Overall Study|Lost to follow up|6|||
13296468|NCT01370499|26496601|FG000|Overall Study|Adverse Event|38|||
13296469|NCT01370499|26496602|FG001|Overall Study|Adverse Event|12|||
13296470|NCT01370499|26496601|FG000|Overall Study|Lack of Efficacy|4|||
13296471|NCT01370499|26496602|FG001|Overall Study|Lack of Efficacy|2|||
13296472|NCT01370499|26496601|FG000|Overall Study|Lost to Follow-up|2|||
13296473|NCT01370499|26496602|FG001|Overall Study|Lost to Follow-up|1|||
13296474|NCT01370499|26496601|FG000|Overall Study|Physician Decision|3|||
13296475|NCT01370499|26496602|FG001|Overall Study|Physician Decision|3|||
13296476|NCT01370499|26496601|FG000|Overall Study|Protocol Violation|5|||
13296477|NCT01370499|26496602|FG001|Overall Study|Protocol Violation|4|||
13296478|NCT01370499|26496601|FG000|Overall Study|Withdrawal by Subject|18|||
13296479|NCT01370499|26496602|FG001|Overall Study|Withdrawal by Subject|7|||
13296480|NCT01370499|26496601|FG000|Overall Study|Sponsor Decision|41|||
13296481|NCT01370499|26496602|FG001|Overall Study|Sponsor Decision|15|||
13296482|NCT01370408|26496615|FG000|Overall Study|treatment failure|9|||
13296483|NCT01370356|26496636|FG000|Overall Study|Death|1|||
13492171|NCT01004861|27058753|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
13296484|NCT01370356|26496637|FG001|Overall Study|Death|0|||
13296485|NCT01370356|26496636|FG000|Overall Study|Lack of Efficacy|6|||
13296486|NCT01370356|26496637|FG001|Overall Study|Lack of Efficacy|28|||
13296487|NCT01370356|26496636|FG000|Overall Study|Lost to Follow-up|76|||
13296488|NCT01370356|26496637|FG001|Overall Study|Lost to Follow-up|81|||
13296489|NCT01370356|26496636|FG000|Overall Study|Withdrawal by Subject|54|||
13296490|NCT01370356|26496637|FG001|Overall Study|Withdrawal by Subject|59|||
13296491|NCT01370356|26496636|FG000|Overall Study|Reason not specified|39|||
13296492|NCT01370356|26496637|FG001|Overall Study|Reason not specified|43|||
13296493|NCT01370356|26496636|FG000|Overall Study|Protocol Violation|3|||
13207882|NCT01943916|26239351|FG000|Overall Study|Enrollment Failure|23|||
13207883|NCT01943916|26239351|FG000|Overall Study|Pilot Phase exclusion|100|||
13207884|NCT01943916|26239351|FG000|Overall Study|Quality Assurance Reader Fail|130|||
13207885|NCT01943916|26239351|FG000|Overall Study|Technical Failure|39|||
13207886|NCT01943916|26239351|FG000|Overall Study|Protocol Deviation No Biopsy|25|||
13207887|NCT01943916|26239351|FG000|Overall Study|No Truth Panel Review|38|||
13207888|NCT01943916|26239351|FG000|Overall Study|Protocol Deviation|1|||
13207889|NCT01943851|26240040|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
13207890|NCT01943851|26240041|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
13207891|NCT01943851|26240042|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
13207892|NCT01943851|26240043|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
13207893|NCT01943851|26240044|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
13207894|NCT01943851|26240045|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
13207895|NCT01943851|26240046|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
13207896|NCT01943851|26240047|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
13207897|NCT01943851|26240048|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
13207898|NCT01943851|26240049|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
13207899|NCT01943851|26240050|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
13207900|NCT01943851|26240051|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
13207901|NCT01943851|26240052|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
13207902|NCT01943851|26240053|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
13207903|NCT01943851|26240054|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
13207904|NCT01943851|26240055|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
13207905|NCT01943851|26240056|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
13207906|NCT01943851|26240057|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
13207907|NCT01943851|26240040|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
13207908|NCT01943851|26240041|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
13207909|NCT01943851|26240042|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
13207910|NCT01943851|26240043|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
13207911|NCT01943851|26240044|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
13207912|NCT01943851|26240045|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
13207913|NCT01943851|26240046|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
13207914|NCT01943851|26240047|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
13207915|NCT01943851|26240048|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
13207916|NCT01943851|26240049|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
13207917|NCT01943851|26240050|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
13207918|NCT01943851|26240051|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
13207919|NCT01943851|26240052|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
13207920|NCT01943851|26240053|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
13207921|NCT01943851|26240054|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
13207922|NCT01943851|26240055|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
13207923|NCT01943851|26240056|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
13207924|NCT01943851|26240057|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
13207925|NCT01943851|26240040|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
13207926|NCT01943851|26240041|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
13207927|NCT01943851|26240042|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
13207928|NCT01943851|26240043|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
13207929|NCT01943851|26240044|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
13207930|NCT01943851|26240045|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
13207931|NCT01943851|26240046|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
13207932|NCT01943851|26240047|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
13135115|NCT02745145|25993629|FG000|Overall Study|Withdrew consent|1|||
13135116|NCT02745145|25993630|FG001|Overall Study|Withdrew consent|1|||
13135117|NCT02745145|25993631|FG002|Overall Study|Withdrew consent|1|||
13135118|NCT02745145|25993629|FG000|Overall Study|Study Termination|8|||
13135119|NCT02745145|25993630|FG001|Overall Study|Study Termination|3|||
13135120|NCT02745145|25993631|FG002|Overall Study|Study Termination|7|||
13135121|NCT02745119|25993666|FG000|Overall Study|Adverse Event|1|||
13135122|NCT02745119|25993667|FG001|Overall Study|Adverse Event|0|||
13135123|NCT02745119|25993668|FG002|Overall Study|Adverse Event|1|||
13135124|NCT02745119|25993669|FG003|Overall Study|Adverse Event|3|||
13135125|NCT02745119|25993666|FG000|Overall Study|Death|3|||
13135126|NCT02745119|25993667|FG001|Overall Study|Death|3|||
13135127|NCT02745119|25993668|FG002|Overall Study|Death|0|||
13135128|NCT02745119|25993669|FG003|Overall Study|Death|4|||
13135129|NCT02745119|25993666|FG000|Overall Study|Lost to Follow-up|0|||
13135130|NCT02745119|25993667|FG001|Overall Study|Lost to Follow-up|0|||
13135131|NCT02745119|25993668|FG002|Overall Study|Lost to Follow-up|0|||
13135132|NCT02745119|25993669|FG003|Overall Study|Lost to Follow-up|1|||
13135133|NCT02745119|25993666|FG000|Overall Study|Protocol Deviation|0|||
13135134|NCT02745119|25993667|FG001|Overall Study|Protocol Deviation|0|||
13135135|NCT02745119|25993668|FG002|Overall Study|Protocol Deviation|0|||
13135136|NCT02745119|25993669|FG003|Overall Study|Protocol Deviation|1|||
13207933|NCT01943851|26240048|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
13207934|NCT01943851|26240049|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
13207935|NCT01943851|26240050|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
13207936|NCT01943851|26240051|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
13207937|NCT01943851|26240052|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
13207938|NCT01943851|26240053|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1|||
13207939|NCT01943851|26240054|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
13207940|NCT01943851|26240055|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
13207941|NCT01943851|26240056|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
13207942|NCT01943851|26240057|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
13207943|NCT01943851|26240040|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
13207944|NCT01943851|26240041|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
13207945|NCT01943851|26240042|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
13207946|NCT01943851|26240043|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
13207947|NCT01943851|26240044|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
13207948|NCT01943851|26240045|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
13207949|NCT01943851|26240046|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
13207950|NCT01943851|26240047|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
13207951|NCT01943851|26240048|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
13207952|NCT01943851|26240049|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
13207953|NCT01943851|26240050|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
13207954|NCT01943851|26240051|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
13207955|NCT01943851|26240052|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
13207956|NCT01943851|26240053|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
13207957|NCT01943851|26240054|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
13207958|NCT01943851|26240055|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2|||
13207959|NCT01943851|26240056|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
13207960|NCT01943851|26240057|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
13207961|NCT01943851|26240040|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
13207962|NCT01943851|26240041|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
13207963|NCT01943851|26240042|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
13207964|NCT01943851|26240043|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
13207965|NCT01943851|26240044|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
13207966|NCT01943851|26240045|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
13207967|NCT01943851|26240046|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
13207968|NCT01943851|26240047|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
13207969|NCT01943851|26240048|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
13207970|NCT01943851|26240049|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
13207971|NCT01943851|26240050|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
13207972|NCT01943851|26240051|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
13207973|NCT01943851|26240052|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
13207974|NCT01943851|26240053|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
13207975|NCT01943851|26240054|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
13207976|NCT01943851|26240055|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4|||
13207977|NCT01943851|26240056|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3|||
13207978|NCT01943851|26240057|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1|||
13207979|NCT01943799|26240108|FG000|Overall Study|Lost to Follow-up|0|||
13207980|NCT01943799|26240109|FG001|Overall Study|Lost to Follow-up|1|||
13207981|NCT01943799|26240110|FG002|Overall Study|Lost to Follow-up|1|||
13207982|NCT01943799|26240111|FG003|Overall Study|Lost to Follow-up|0|||
13207983|NCT01943799|26240108|FG000|Overall Study|Protocol Violation|1|||
13207984|NCT01943799|26240109|FG001|Overall Study|Protocol Violation|0|||
13207985|NCT01943799|26240110|FG002|Overall Study|Protocol Violation|0|||
13207986|NCT01943799|26240111|FG003|Overall Study|Protocol Violation|0|||
13207987|NCT01943799|26240108|FG000|Overall Study|Withdrawal by Subject|4|||
13207988|NCT01943799|26240109|FG001|Overall Study|Withdrawal by Subject|2|||
13207989|NCT01943799|26240110|FG002|Overall Study|Withdrawal by Subject|1|||
13207990|NCT01943799|26240111|FG003|Overall Study|Withdrawal by Subject|0|||
13207991|NCT01943591|26240140|FG000|Overall Study|Lost to Follow-up|3|||
13207992|NCT01943591|26240141|FG001|Overall Study|Lost to Follow-up|4|||
13207993|NCT01943591|26240140|FG000|Overall Study|Death|2|||
13207994|NCT01943591|26240141|FG001|Overall Study|Death|7|||
13207995|NCT01943552|26240164|FG000|Overall Study|Adverse Event|3|||
13207996|NCT01943552|26240165|FG001|Overall Study|Adverse Event|2|||
13207997|NCT01943552|26240164|FG000|Overall Study|Withdrawal by Subject|6|||
13207998|NCT01943552|26240165|FG001|Overall Study|Withdrawal by Subject|6|||
13207999|NCT01943552|26240164|FG000|Overall Study|Other Reasons|16|||
13208000|NCT01943552|26240165|FG001|Overall Study|Other Reasons|17|||
13208001|NCT01943539|26240177|FG000|Overall Study|Non-compliance with at-home intervention|4|||
13208002|NCT01943539|26240178|FG001|Overall Study|Non-compliance with at-home intervention|0|||
13208003|NCT01943435|26240202|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4|||
13208004|NCT01943435|26240203|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12|||
13208005|NCT01943435|26240204|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3|||
13208006|NCT01943435|26240202|FG000|Intervention Period|Withdrawal by Subject|3|||
13208007|NCT01943435|26240203|FG001|Intervention Period|Withdrawal by Subject|3|||
13208008|NCT01943435|26240204|FG002|Intervention Period|Withdrawal by Subject|4|||
13208009|NCT01943435|26240202|FG000|2 Month Follow up|Lost to Follow-up|2|||
13208010|NCT01943435|26240203|FG001|2 Month Follow up|Lost to Follow-up|3|||
13208011|NCT01943435|26240204|FG002|2 Month Follow up|Lost to Follow-up|0|||
13208012|NCT01943435|26240202|FG000|6 Month Follow up|Lost to Follow-up|12|||
13208013|NCT01943435|26240203|FG001|6 Month Follow up|Lost to Follow-up|7|||
13208014|NCT01943435|26240204|FG002|6 Month Follow up|Lost to Follow-up|15|||
13208015|NCT01943292|26240225|FG000|Overall Study|Withdrawal by Subject|1|||
13208016|NCT01943292|26240226|FG001|Overall Study|Withdrawal by Subject|0|||
13208017|NCT01943292|26240227|FG002|Overall Study|Withdrawal by Subject|0|||
13208018|NCT01942993|26240246|FG000|Overall Study|Lost to Follow-up|1|||
13208019|NCT01942993|26240246|FG000|Overall Study|Physician Decision|1|||
13208020|NCT01942837|26240260|FG000|Overall Study|Death|1|||
13208021|NCT01942837|26240260|FG000|Overall Study|Symptomatic or radiographic progression|49|||
13208022|NCT01942837|26240260|FG000|Overall Study|Adverse Event|6|||
13208023|NCT01942837|26240260|FG000|Overall Study|Physician Decision|3|||
13208024|NCT01942837|26240260|FG000|Overall Study|Withdrawal by Subject|2|||
13208025|NCT01942837|26240260|FG000|Overall Study|Intercurrent Illness|1|||
13208026|NCT01942837|26240260|FG000|Overall Study|On treatment|3|||
13208027|NCT01942837|26240260|FG000|Overall Study|Never initiate the treatment|2|||
13208028|NCT01942785|26240291|FG000|Overall Study|Adverse Event|2|||
13208029|NCT01942785|26240291|FG000|Overall Study|Withdrawal by Subject|1|||
13208030|NCT01942785|26240291|FG000|Overall Study|Protocol Violation|1|||
13208031|NCT01942733|26240322|FG000|Overall Study|Lost to Follow-up|1|||
13208032|NCT01942733|26240322|FG000|Overall Study|Non-compliance with IMP|1|||
13208033|NCT01942733|26240322|FG000|Overall Study|Administrative|1|||
13208034|NCT01942590|26240359|FG000|Overall Study|Withdrawal by Subject|0|||
13208035|NCT01942590|26240360|FG001|Overall Study|Withdrawal by Subject|1|||
13208036|NCT01942590|26240359|FG000|Overall Study|Adverse Event|1|||
13208037|NCT01942590|26240360|FG001|Overall Study|Adverse Event|0|||
13208038|NCT01942486|26240366|FG000|Overall Study|Lost to Follow-up|27|||
13208039|NCT01942161|26240396|FG000|Overall Study|Adverse Event|1|||
13208040|NCT01942161|26240397|FG001|Overall Study|Adverse Event|2|||
13208041|NCT01942161|26240398|FG002|Overall Study|Adverse Event|5|||
13208042|NCT01942161|26240396|FG000|Overall Study|Physician Decision|3|||
13208043|NCT01942161|26240397|FG001|Overall Study|Physician Decision|1|||
13208044|NCT01942161|26240398|FG002|Overall Study|Physician Decision|0|||
13208045|NCT01942161|26240396|FG000|Overall Study|Protocol Violation|1|||
13208046|NCT01942161|26240397|FG001|Overall Study|Protocol Violation|0|||
13208047|NCT01942161|26240398|FG002|Overall Study|Protocol Violation|0|||
13208048|NCT01942161|26240396|FG000|Overall Study|Withdrawal by Subject|3|||
13208049|NCT01942161|26240397|FG001|Overall Study|Withdrawal by Subject|3|||
13208050|NCT01942161|26240398|FG002|Overall Study|Withdrawal by Subject|1|||
13208051|NCT01942148|26240406|FG000|Overall Study|Adverse Event|4|||
13208052|NCT01942148|26240406|FG000|Overall Study|Lack of Efficacy|2|||
13208053|NCT01942148|26240406|FG000|Overall Study|Physician Decision|11|||
13208054|NCT01942148|26240406|FG000|Overall Study|Protocol Violation|1|||
13208055|NCT01942148|26240406|FG000|Overall Study|Withdrawal by Subject|8|||
13208056|NCT01942148|26240406|FG000|Overall Study|Use of the prohibition medicine|1|||
13208057|NCT01941940|26240448|FG000|Overall Study|Adverse Event|11|||
13208058|NCT01941940|26240448|FG000|Overall Study|Lost to Follow-up|2|||
13208059|NCT01941940|26240448|FG000|Overall Study|Physician Decision|2|||
13208060|NCT01941940|26240448|FG000|Overall Study|Withdrawal by Subject|15|||
13208061|NCT01941940|26240448|FG000|Overall Study|Death|1|||
13208062|NCT01941940|26240448|FG000|Overall Study|Other|1|||
13208063|NCT01941940|26240448|FG000|Overall Study|Other|1|||
13208064|NCT01941537|26240467|FG000|Overall Study|Lack of Efficacy|1|||
13208065|NCT01941537|26240468|FG001|Overall Study|Lack of Efficacy|2|||
13208066|NCT01941537|26240467|FG000|Overall Study|Lost to Follow-up|1|||
13208067|NCT01941537|26240468|FG001|Overall Study|Lost to Follow-up|0|||
13208068|NCT01941537|26240467|FG000|Overall Study|Pregnancy|1|||
13208069|NCT01941537|26240468|FG001|Overall Study|Pregnancy|0|||
13208070|NCT01941537|26240467|FG000|Overall Study|Adverse Event|1|||
13208071|NCT01941537|26240468|FG001|Overall Study|Adverse Event|0|||
13208072|NCT01941537|26240467|FG000|Overall Study|Withdrawal by Subject|0|||
13208073|NCT01941537|26240468|FG001|Overall Study|Withdrawal by Subject|1|||
13208074|NCT01941498|26240516|FG000|Overall Study|Relocated out of state|1|||
13208075|NCT01941186|26240549|FG000|Follow-up|Lost to Follow-up|1|||
13208076|NCT01941186|26240550|FG001|Follow-up|Lost to Follow-up|0|||
13208077|NCT01941095|26240575|FG000|Overall Study|Insufficient therapeutic response|13|||
13208078|NCT01941095|26240575|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2|||
13208079|NCT01941095|26240575|FG000|Overall Study|Adverse Event|11|||
13208080|NCT01941095|26240575|FG000|Overall Study|Physician Decision|3|||
13208081|NCT01941095|26240575|FG000|Overall Study|Withdrawal by Subject|17|||
13208082|NCT01941095|26240575|FG000|Overall Study|Lost to Follow-up|10|||
13208083|NCT01941030|26240602|FG000|Overall Study|Death|3|||
13208084|NCT01941030|26240603|FG001|Overall Study|Death|2|||
13208085|NCT01941030|26240602|FG000|Overall Study|Lost to Follow-up|6|||
13208086|NCT01941030|26240603|FG001|Overall Study|Lost to Follow-up|5|||
13208087|NCT01941030|26240602|FG000|Overall Study|Withdrawal by Subject|4|||
13208088|NCT01941030|26240603|FG001|Overall Study|Withdrawal by Subject|6|||
13208089|NCT01940939|26240620|FG000|Overall Study|Withdrawal by Subject|2|||
13208090|NCT01940939|26240621|FG001|Overall Study|Withdrawal by Subject|8|||
13208091|NCT01940900|26240634|FG000|Overall Study|Physician Decision|4|||
13208092|NCT01940900|26240635|FG001|Overall Study|Physician Decision|0|||
13208093|NCT01940900|26240634|FG000|Overall Study|Adverse Event|10|||
13208094|NCT01940900|26240635|FG001|Overall Study|Adverse Event|15|||
13208095|NCT01940900|26240634|FG000|Overall Study|Withdrawal by Subject|11|||
13208096|NCT01940900|26240635|FG001|Overall Study|Withdrawal by Subject|15|||
13208097|NCT01940900|26240634|FG000|Overall Study|Lost to Follow-up|1|||
13208098|NCT01940900|26240635|FG001|Overall Study|Lost to Follow-up|0|||
13208099|NCT01940900|26240634|FG000|Overall Study|Sponsor Decision|1|||
13208100|NCT01940900|26240635|FG001|Overall Study|Sponsor Decision|0|||
13208101|NCT01940900|26240634|FG000|Overall Study|subject non-compliance|1|||
13208102|NCT01940900|26240635|FG001|Overall Study|subject non-compliance|1|||
13208103|NCT01940900|26240634|FG000|Overall Study|other|1|||
13208104|NCT01940900|26240635|FG001|Overall Study|other|0|||
13208105|NCT01940887|26240648|FG000|Year 1|Protocol Violation|0|||
13208106|NCT01940887|26240649|FG001|Year 1|Protocol Violation|1|||
13208107|NCT01940887|26240648|FG000|Year 1|Physician Decision|7|||
13208108|NCT01940887|26240649|FG001|Year 1|Physician Decision|3|||
13208109|NCT01940887|26240648|FG000|Year 1|Death|5|||
13208110|NCT01940887|26240649|FG001|Year 1|Death|3|||
13208111|NCT01940887|26240648|FG000|Year 1|Adverse Event|7|||
13208112|NCT01940887|26240649|FG001|Year 1|Adverse Event|6|||
13208113|NCT01940887|26240648|FG000|Year 1|Withdrawal by Subject|18|||
13208114|NCT01940887|26240649|FG001|Year 1|Withdrawal by Subject|9|||
13208115|NCT01940887|26240648|FG000|Year 1|Lost to Follow-up|2|||
13208116|NCT01940887|26240649|FG001|Year 1|Lost to Follow-up|1|||
13208117|NCT01940887|26240648|FG000|Year 2|Physician Decision|8|||
13208118|NCT01940887|26240649|FG001|Year 2|Physician Decision|1|||
13208119|NCT01940887|26240648|FG000|Year 2|Death|0|||
13208120|NCT01940887|26240649|FG001|Year 2|Death|2|||
13208121|NCT01940887|26240648|FG000|Year 2|Sponsor Decision, early termination|192|||
13208122|NCT01940887|26240649|FG001|Year 2|Sponsor Decision, early termination|203|||
13208123|NCT01940887|26240648|FG000|Year 2|Adverse Event|8|||
13208124|NCT01940887|26240649|FG001|Year 2|Adverse Event|2|||
13208125|NCT01940887|26240648|FG000|Year 2|Withdrawal by Subject|8|||
13208126|NCT01940887|26240649|FG001|Year 2|Withdrawal by Subject|8|||
13208127|NCT01940887|26240648|FG000|Year 2|Lost to Follow-up|1|||
13208128|NCT01940887|26240649|FG001|Year 2|Lost to Follow-up|6|||
13208129|NCT01940705|26240680|FG000|Overall Study|Lost to Follow-up|1|||
13208130|NCT01940705|26240681|FG001|Overall Study|Lost to Follow-up|3|||
13208131|NCT01940705|26240682|FG002|Overall Study|Lost to Follow-up|2|||
13208132|NCT01940705|26240683|FG003|Overall Study|Lost to Follow-up|2|||
13208133|NCT01940705|26240680|FG000|Overall Study|Withdrawal by Subject|2|||
13208134|NCT01940705|26240681|FG001|Overall Study|Withdrawal by Subject|2|||
13208135|NCT01940705|26240682|FG002|Overall Study|Withdrawal by Subject|3|||
13208136|NCT01940705|26240683|FG003|Overall Study|Withdrawal by Subject|2|||
13208137|NCT01940705|26240680|FG000|Overall Study|Intervention not given|0|||
13208138|NCT01940705|26240681|FG001|Overall Study|Intervention not given|3|||
13208139|NCT01940705|26240682|FG002|Overall Study|Intervention not given|3|||
13208140|NCT01940705|26240683|FG003|Overall Study|Intervention not given|0|||
13208141|NCT01940705|26240680|FG000|Overall Study|Withdrawal by team - hearing aid change|1|||
13208142|NCT01940705|26240681|FG001|Overall Study|Withdrawal by team - hearing aid change|0|||
13208143|NCT01940705|26240682|FG002|Overall Study|Withdrawal by team - hearing aid change|0|||
13208144|NCT01940705|26240683|FG003|Overall Study|Withdrawal by team - hearing aid change|0|||
13208145|NCT01940497|26240731|FG000|Overall Study|Adverse Event/Intercurrent Illness|11|||
13208146|NCT01940497|26240732|FG001|Overall Study|Adverse Event/Intercurrent Illness|8|||
13208147|NCT01940497|26240731|FG000|Overall Study|Recurrence of Disease Postsurgery|1|||
13208148|NCT01940497|26240732|FG001|Overall Study|Recurrence of Disease Postsurgery|3|||
13208149|NCT01940497|26240731|FG000|Overall Study|Violation of Entry Criteria|1|||
13208150|NCT01940497|26240732|FG001|Overall Study|Violation of Entry Criteria|1|||
13208151|NCT01940497|26240731|FG000|Overall Study|Refused Treatment|1|||
13208152|NCT01940497|26240732|FG001|Overall Study|Refused Treatment|3|||
13208153|NCT01940497|26240731|FG000|Overall Study|Withdrew Consent|6|||
13208154|NCT01940497|26240732|FG001|Overall Study|Withdrew Consent|2|||
13208155|NCT01940497|26240731|FG000|Overall Study|Administrative/Other|1|||
13208156|NCT01940497|26240732|FG001|Overall Study|Administrative/Other|1|||
13208157|NCT01940484|26240752|FG000|Overall Study|Withdrawal by Subject|3|||
13208158|NCT01940484|26240752|FG000|Overall Study|Underwent transplantation|4|||
13208159|NCT01940484|26240752|FG000|Overall Study|Death|2|||
13208160|NCT01940484|26240752|FG000|Overall Study|Adverse Event|1|||
13208161|NCT01940354|26240769|FG000|Overall Study|Withdrawal by Subject|4|||
13208162|NCT01940354|26240770|FG001|Overall Study|Withdrawal by Subject|2|||
13208163|NCT01940120|26240926|FG000|Overall Study|Death|40|||
13208164|NCT01940120|26240926|FG000|Overall Study|Withdrawal by Subject|8|||
13208165|NCT01939977|26240969|FG000|Overall Study|Adverse Event|4|||
13208166|NCT01939977|26240970|FG001|Overall Study|Adverse Event|3|||
13208167|NCT01939977|26240969|FG000|Overall Study|Lack of Efficacy|3|||
13208168|NCT01939977|26240970|FG001|Overall Study|Lack of Efficacy|0|||
13208169|NCT01939977|26240969|FG000|Overall Study|Physician Decision|1|||
13208170|NCT01939977|26240970|FG001|Overall Study|Physician Decision|1|||
13208171|NCT01939977|26240969|FG000|Overall Study|Withdrawal by Subject|0|||
13208172|NCT01939977|26240970|FG001|Overall Study|Withdrawal by Subject|2|||
13208173|NCT01939977|26240969|FG000|Overall Study|Did not meet inclusion criteria|1|||
13208174|NCT01939977|26240970|FG001|Overall Study|Did not meet inclusion criteria|0|||
13208175|NCT01939977|26240969|FG000|Overall Study|Did not receive study medication|0|||
13208176|NCT01939977|26240970|FG001|Overall Study|Did not receive study medication|1|||
13208177|NCT01939899|26241030|FG000|Lead-in Dose Finding Phase|Death|0|||
13208178|NCT01939899|26241031|FG001|Lead-in Dose Finding Phase|Death|3|||
13208179|NCT01939899|26241032|FG002|Lead-in Dose Finding Phase|Death|1|||
13208180|NCT01939899|26241033|FG003|Lead-in Dose Finding Phase|Death|0|||
13208181|NCT01939899|26241034|FG004|Lead-in Dose Finding Phase|Death|0|||
13208182|NCT01939899|26241030|FG000|Lead-in Dose Finding Phase|Disease Progression|2|||
13208183|NCT01939899|26241031|FG001|Lead-in Dose Finding Phase|Disease Progression|4|||
13208184|NCT01939899|26241032|FG002|Lead-in Dose Finding Phase|Disease Progression|3|||
13208185|NCT01939899|26241033|FG003|Lead-in Dose Finding Phase|Disease Progression|0|||
13208186|NCT01939899|26241034|FG004|Lead-in Dose Finding Phase|Disease Progression|0|||
13208187|NCT01939899|26241030|FG000|Lead-in Dose Finding Phase|Other|0|||
13208188|NCT01939899|26241031|FG001|Lead-in Dose Finding Phase|Other|0|||
13208189|NCT01939899|26241032|FG002|Lead-in Dose Finding Phase|Other|1|||
13208190|NCT01939899|26241033|FG003|Lead-in Dose Finding Phase|Other|0|||
13208191|NCT01939899|26241034|FG004|Lead-in Dose Finding Phase|Other|0|||
13208192|NCT01939899|26241030|FG000|Phase 2|Withdrawal by Subject|0|||
13208193|NCT01939899|26241031|FG001|Phase 2|Withdrawal by Subject|0|||
13208194|NCT01939899|26241032|FG002|Phase 2|Withdrawal by Subject|0|||
13208195|NCT01939899|26241033|FG003|Phase 2|Withdrawal by Subject|2|||
13208196|NCT01939899|26241034|FG004|Phase 2|Withdrawal by Subject|0|||
13208197|NCT01939899|26241030|FG000|Phase 2|Disease Progression|0|||
13208198|NCT01939899|26241031|FG001|Phase 2|Disease Progression|0|||
13208199|NCT01939899|26241032|FG002|Phase 2|Disease Progression|0|||
13208200|NCT01939899|26241033|FG003|Phase 2|Disease Progression|9|||
13208201|NCT01939899|26241034|FG004|Phase 2|Disease Progression|1|||
13208202|NCT01939548|26241115|FG000|Overall Study|Non compliance|0|||
13208203|NCT01939548|26241116|FG001|Overall Study|Non compliance|2|||
13208204|NCT01939548|26241117|FG002|Overall Study|Non compliance|0|||
13208205|NCT01939548|26241115|FG000|Overall Study|Study Terminated by Sponsor|17|||
13208206|NCT01939548|26241116|FG001|Overall Study|Study Terminated by Sponsor|19|||
13208207|NCT01939548|26241117|FG002|Overall Study|Study Terminated by Sponsor|12|||
13208208|NCT01939548|26241115|FG000|Overall Study|Insufficient Clinical Response|1|||
13208209|NCT01939548|26241116|FG001|Overall Study|Insufficient Clinical Response|0|||
13208210|NCT01939548|26241117|FG002|Overall Study|Insufficient Clinical Response|0|||
13208211|NCT01939548|26241115|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
13208212|NCT01939548|26241116|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
13208213|NCT01939548|26241117|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
13208214|NCT01939548|26241115|FG000|Overall Study|Withdrawal by Subject|4|||
13208215|NCT01939548|26241116|FG001|Overall Study|Withdrawal by Subject|4|||
13208216|NCT01939548|26241117|FG002|Overall Study|Withdrawal by Subject|1|||
13208217|NCT01939548|26241115|FG000|Overall Study|Protocol Violation|7|||
13208218|NCT01939548|26241116|FG001|Overall Study|Protocol Violation|6|||
13208219|NCT01939548|26241117|FG002|Overall Study|Protocol Violation|5|||
13208220|NCT01939548|26241115|FG000|Overall Study|Lost to Follow-up|5|||
13208221|NCT01939548|26241116|FG001|Overall Study|Lost to Follow-up|5|||
13208222|NCT01939548|26241117|FG002|Overall Study|Lost to Follow-up|3|||
13208223|NCT01939548|26241115|FG000|Overall Study|Adverse Event|2|||
13208224|NCT01939548|26241116|FG001|Overall Study|Adverse Event|9|||
13208225|NCT01939548|26241117|FG002|Overall Study|Adverse Event|7|||
13208226|NCT01939548|26241115|FG000|Overall Study|Death|0|||
13208227|NCT01939548|26241116|FG001|Overall Study|Death|0|||
13208228|NCT01939548|26241117|FG002|Overall Study|Death|1|||
13208229|NCT01939548|26241115|FG000|Overall Study|Participant dropped|0|||
13208230|NCT01939548|26241116|FG001|Overall Study|Participant dropped|0|||
13208231|NCT01939548|26241117|FG002|Overall Study|Participant dropped|1|||
13208232|NCT01939548|26241115|FG000|Overall Study|Participant unwilling to continue|0|||
13208233|NCT01939548|26241116|FG001|Overall Study|Participant unwilling to continue|1|||
13208234|NCT01939548|26241117|FG002|Overall Study|Participant unwilling to continue|0|||
13208235|NCT01939548|26241115|FG000|Overall Study|Participant withdrew consent|0|||
13208236|NCT01939548|26241116|FG001|Overall Study|Participant withdrew consent|2|||
13208237|NCT01939548|26241117|FG002|Overall Study|Participant withdrew consent|0|||
13208238|NCT01939548|26241115|FG000|Overall Study|Did not complete follow-up|0|||
13208239|NCT01939548|26241116|FG001|Overall Study|Did not complete follow-up|1|||
13208240|NCT01939548|26241117|FG002|Overall Study|Did not complete follow-up|0|||
13208241|NCT01939496|26241177|FG000|Overall Study|Adverse Event|2|||
13208242|NCT01939496|26241178|FG001|Overall Study|Adverse Event|0|||
13208243|NCT01939496|26241179|FG002|Overall Study|Adverse Event|0|||
13208244|NCT01939496|26241177|FG000|Overall Study|Lost to Follow-up|1|||
13208245|NCT01939496|26241178|FG001|Overall Study|Lost to Follow-up|1|||
13208246|NCT01939496|26241179|FG002|Overall Study|Lost to Follow-up|0|||
13208247|NCT01939496|26241177|FG000|Overall Study|Physician Decision|1|||
13208248|NCT01939496|26241178|FG001|Overall Study|Physician Decision|0|||
13208249|NCT01939496|26241179|FG002|Overall Study|Physician Decision|0|||
13208250|NCT01939496|26241177|FG000|Overall Study|Protocol Violation|3|||
13208251|NCT01939496|26241178|FG001|Overall Study|Protocol Violation|0|||
13208252|NCT01939496|26241179|FG002|Overall Study|Protocol Violation|0|||
13208253|NCT01939496|26241177|FG000|Overall Study|Withdrawal by Subject|0|||
13208254|NCT01939496|26241178|FG001|Overall Study|Withdrawal by Subject|1|||
13208255|NCT01939496|26241179|FG002|Overall Study|Withdrawal by Subject|1|||
13208256|NCT01939496|26241177|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0|||
13208257|NCT01939496|26241178|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1|||
13208258|NCT01939496|26241179|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0|||
13208259|NCT01939496|26241177|FG000|Overall Study|Other|2|||
13208260|NCT01939496|26241178|FG001|Overall Study|Other|0|||
13208261|NCT01939496|26241179|FG002|Overall Study|Other|1|||
13208262|NCT01939366|26241207|FG000|Overall Study|Adverse Event|8|||
13208263|NCT01939366|26241208|FG001|Overall Study|Adverse Event|17|||
13208264|NCT01939366|26241209|FG002|Overall Study|Adverse Event|30|||
13208265|NCT01939366|26241210|FG003|Overall Study|Adverse Event|8|||
13208266|NCT01939366|26241211|FG004|Overall Study|Adverse Event|5|||
13208267|NCT01939366|26241207|FG000|Overall Study|Lack of Efficacy|2|||
13208268|NCT01939366|26241208|FG001|Overall Study|Lack of Efficacy|1|||
13208269|NCT01939366|26241209|FG002|Overall Study|Lack of Efficacy|1|||
13208270|NCT01939366|26241210|FG003|Overall Study|Lack of Efficacy|1|||
13492172|NCT01004861|27058754|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1|||
13492173|NCT01004861|27058755|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
13492174|NCT01004861|27058756|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
13492175|NCT01004861|27058757|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
13492176|NCT01004861|27058758|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
13492177|NCT01004861|27058746|FG000|Overall Study|Study termination by Sponsor|0|||
13492178|NCT01004861|27058747|FG001|Overall Study|Study termination by Sponsor|0|||
13492179|NCT01004861|27058748|FG002|Overall Study|Study termination by Sponsor|0|||
13492180|NCT01004861|27058749|FG003|Overall Study|Study termination by Sponsor|0|||
13492181|NCT01004861|27058750|FG004|Overall Study|Study termination by Sponsor|0|||
13492182|NCT01004861|27058751|FG005|Overall Study|Study termination by Sponsor|0|||
13492183|NCT01004861|27058752|FG006|Overall Study|Study termination by Sponsor|0|||
13492184|NCT01004861|27058753|FG007|Overall Study|Study termination by Sponsor|0|||
13492185|NCT01004861|27058754|FG008|Overall Study|Study termination by Sponsor|1|||
13492186|NCT01004861|27058755|FG009|Overall Study|Study termination by Sponsor|0|||
13492187|NCT01004861|27058756|FG010|Overall Study|Study termination by Sponsor|0|||
13492188|NCT01004861|27058757|FG011|Overall Study|Study termination by Sponsor|0|||
13492189|NCT01004861|27058758|FG012|Overall Study|Study termination by Sponsor|0|||
13492190|NCT00381381|27058767|FG000|Overall Study|Adverse Event|3|||
13492191|NCT00381381|27058767|FG000|Overall Study|Lost to Follow-up|52|||
13492192|NCT00381381|27058767|FG000|Overall Study|Withdrawal by Subject|9|||
13208271|NCT01939366|26241211|FG004|Overall Study|Lack of Efficacy|3|||
13208272|NCT01939366|26241207|FG000|Overall Study|Lost to Follow-up|1|||
13208273|NCT01939366|26241208|FG001|Overall Study|Lost to Follow-up|1|||
13208274|NCT01939366|26241209|FG002|Overall Study|Lost to Follow-up|0|||
13492193|NCT03712124|27058822|FG000|Overall Study|Protocol Violation|1|||
13492194|NCT03712124|27058823|FG001|Overall Study|Protocol Violation|0|||
13492195|NCT02896257|27058904|FG000|Providers|Without eligible patients|21|||
13492196|NCT02896257|27058905|FG001|Providers|Without eligible patients|28|||
13492197|NCT02896257|27058904|FG000|Patients|PFT entry criteria not met|43|||
13492198|NCT02896257|27058905|FG001|Patients|PFT entry criteria not met|50|||
13492199|NCT02896257|27058904|FG000|Patients|No capacity to review|8|||
13492200|NCT02896257|27058905|FG001|Patients|No capacity to review|11|||
13492201|NCT02896257|27058904|FG000|Patients|Appointment rescheduled/cancelled|5|||
13492202|NCT02896257|27058905|FG001|Patients|Appointment rescheduled/cancelled|7|||
13492203|NCT02896257|27058904|FG000|Patients|PCP not assigned a clinic|4|||
13492204|NCT02896257|27058905|FG001|Patients|PCP not assigned a clinic|0|||
13492205|NCT02896257|27058904|FG000|Patients|No history of COPD|0|||
13492206|NCT02896257|27058905|FG001|Patients|No history of COPD|1|||
13492207|NCT02896257|27058904|FG000|Patients|Deceased between review and index date|0|||
13492208|NCT02896257|27058905|FG001|Patients|Deceased between review and index date|1|||
13492209|NCT02896257|27058904|FG000|Patients|No ICS Rx upon review|1|||
13492210|NCT02896257|27058905|FG001|Patients|No ICS Rx upon review|1|||
13492211|NCT02896257|27058904|FG000|Patients|Protocol Violation|2|||
13492212|NCT02896257|27058905|FG001|Patients|Protocol Violation|1|||
13492213|NCT02896257|27058904|FG000|Patients|Hospice care|0|||
13492214|NCT02896257|27058905|FG001|Patients|Hospice care|1|||
13492215|NCT02736617|27058931|FG000|Treatment|Adverse Event|1|||
13492216|NCT02736617|27058931|FG000|Treatment|Lack of Efficacy|1|||
13492217|NCT02736617|27058931|FG000|Treatment|Withdrawal by Subject|1|||
13492218|NCT02736617|27058931|FG000|Maintenance|Lack of Efficacy|4|||
13492219|NCT02736617|27058931|FG000|Maintenance|Physician Decision|1|||
13492220|NCT02579265|27058986|FG000|Overall Study|Weaned off earlier than 28 days|44|||
13492221|NCT02579265|27058987|FG001|Overall Study|Weaned off earlier than 28 days|43|||
13492222|NCT02579265|27058986|FG000|Overall Study|Adverse Event|2|||
13492223|NCT02579265|27058987|FG001|Overall Study|Adverse Event|0|||
13492224|NCT02579265|27058986|FG000|Overall Study|Any other reason not specified|0|||
13492225|NCT02579265|27058987|FG001|Overall Study|Any other reason not specified|2|||
13492226|NCT02579265|27058986|FG000|Overall Study|Withdrawal by Subject|2|||
13492227|NCT02579265|27058987|FG001|Overall Study|Withdrawal by Subject|0|||
13492228|NCT02579265|27058986|FG000|Overall Study|Physician Decision|1|||
13492229|NCT02579265|27058987|FG001|Overall Study|Physician Decision|0|||
13492230|NCT02579265|27058986|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1|||
13492231|NCT02579265|27058987|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0|||
13492232|NCT04502589|27059028|FG000|Overall Study|Physician Decision|1|||
13492233|NCT04502589|27059029|FG001|Overall Study|Physician Decision|0|||
13492234|NCT04480424|27059066|FG000|Overall Study|Withdrawal by Subject|0|||
13492235|NCT04480424|27059067|FG001|Overall Study|Withdrawal by Subject|2|||
13492236|NCT04480424|27059066|FG000|Overall Study|Lost to Follow-up|3|||
13492237|NCT04480424|27059067|FG001|Overall Study|Lost to Follow-up|3|||
13492238|NCT04480424|27059066|FG000|Overall Study|Death|14|||
13492239|NCT04480424|27059067|FG001|Overall Study|Death|16|||
13492240|NCT04480424|27059066|FG000|Overall Study|Reason not Specified|5|||
13492241|NCT04480424|27059067|FG001|Overall Study|Reason not Specified|5|||
13492242|NCT04472494|27059094|FG000|Pre-treatment|Other reasons|2|||
13492243|NCT04472494|27059095|FG001|Pre-treatment|Other reasons|0|||
13492244|NCT04472494|27059094|FG000|Treatment|Death|5|||
13492245|NCT04472494|27059095|FG001|Treatment|Death|2|||
13492246|NCT04472494|27059094|FG000|Treatment|Hospital discharge|1|||
13492247|NCT04472494|27059095|FG001|Treatment|Hospital discharge|1|||
13492248|NCT04428333|27059166|FG000|Overall Study|Physician Decision|2|||
13492249|NCT04428333|27059167|FG001|Overall Study|Physician Decision|0|||
13492250|NCT04428333|27059166|FG000|Overall Study|Withdrawal by Subject|0|||
13492251|NCT04428333|27059167|FG001|Overall Study|Withdrawal by Subject|1|||
13492252|NCT04428333|27059166|FG000|Overall Study|In Follow-Up|5|||
13492253|NCT04428333|27059167|FG001|Overall Study|In Follow-Up|10|||
13492254|NCT04428333|27059166|FG000|Overall Study|On Study Treatment (pembrolizumab) All participants discontinued feladilimab/placebo|47|||
13492255|NCT04428333|27059167|FG001|Overall Study|On Study Treatment (pembrolizumab) All participants discontinued feladilimab/placebo|47|||
13492256|NCT04237584|27059242|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
13492257|NCT04237584|27059243|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
13492258|NCT04237584|27059244|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
13492259|NCT04237584|27059245|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
13492260|NCT04237584|27059242|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
13492261|NCT04237584|27059243|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
13492262|NCT04237584|27059244|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|0|||
13492263|NCT04237584|27059245|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
13492264|NCT04237584|27059242|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
13492265|NCT04237584|27059243|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
13492266|NCT04237584|27059244|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|2|||
13492267|NCT04237584|27059245|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
13492268|NCT04237584|27059242|FG000|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
13492269|NCT04237584|27059243|FG001|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
13492270|NCT04237584|27059244|FG002|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|2|||
13492271|NCT04237584|27059245|FG003|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|3|||
13492272|NCT04237584|27059242|FG000|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
13492273|NCT04237584|27059243|FG001|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
13492274|NCT04237584|27059244|FG002|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|1|||
13492275|NCT04237584|27059245|FG003|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
13492276|NCT03847896|27059314|FG000|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
13492277|NCT03847896|27059315|FG001|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
13492278|NCT03847896|27059316|FG002|Overall Study|Randomized in error and did not receive randomized study treatment|1|||
13492279|NCT03847896|27059317|FG003|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
13492280|NCT03847896|27059318|FG004|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
13492281|NCT03847896|27059314|FG000|Overall Study|Withdrawal by Subject|2|||
13492282|NCT03847896|27059315|FG001|Overall Study|Withdrawal by Subject|10|||
13492283|NCT03847896|27059316|FG002|Overall Study|Withdrawal by Subject|5|||
13492284|NCT03847896|27059317|FG003|Overall Study|Withdrawal by Subject|9|||
13492285|NCT03847896|27059318|FG004|Overall Study|Withdrawal by Subject|8|||
13492286|NCT03847896|27059314|FG000|Overall Study|Withdrawal by parent/guardian|0|||
13492287|NCT03847896|27059315|FG001|Overall Study|Withdrawal by parent/guardian|0|||
13492288|NCT03847896|27059316|FG002|Overall Study|Withdrawal by parent/guardian|1|||
13492289|NCT03847896|27059317|FG003|Overall Study|Withdrawal by parent/guardian|0|||
13492290|NCT03847896|27059318|FG004|Overall Study|Withdrawal by parent/guardian|0|||
13492291|NCT03847896|27059314|FG000|Overall Study|Adverse Event|2|||
13492292|NCT03847896|27059315|FG001|Overall Study|Adverse Event|1|||
13492293|NCT03847896|27059316|FG002|Overall Study|Adverse Event|3|||
13492294|NCT03847896|27059317|FG003|Overall Study|Adverse Event|2|||
13492295|NCT03847896|27059318|FG004|Overall Study|Adverse Event|4|||
13492296|NCT03847896|27059314|FG000|Overall Study|A severe exacerbation event|0|||
13492297|NCT03847896|27059315|FG001|Overall Study|A severe exacerbation event|0|||
13492298|NCT03847896|27059316|FG002|Overall Study|A severe exacerbation event|0|||
13492299|NCT03847896|27059317|FG003|Overall Study|A severe exacerbation event|0|||
13492300|NCT03847896|27059318|FG004|Overall Study|A severe exacerbation event|3|||
13492301|NCT03847896|27059314|FG000|Overall Study|Protocol Violation|0|||
13381414|NCT00753623|26748108|FG001|Phase I (14 Days)|Physician Decision|2|||
13381415|NCT00753623|26748107|FG000|Phase I (14 Days)|Adverse Event|0|||
13381416|NCT00753623|26748108|FG001|Phase I (14 Days)|Adverse Event|1|||
13381417|NCT00753623|26748107|FG000|Washout (7 Days)|Physician Decision|1|||
13381418|NCT00753623|26748108|FG001|Washout (7 Days)|Physician Decision|0|||
13381419|NCT00753623|26748107|FG000|Phase II (14 Days)|Physician Decision|0|||
13381420|NCT00753623|26748108|FG001|Phase II (14 Days)|Physician Decision|1|||
13492302|NCT03847896|27059315|FG001|Overall Study|Protocol Violation|2|||
13492303|NCT03847896|27059316|FG002|Overall Study|Protocol Violation|1|||
13492304|NCT03847896|27059317|FG003|Overall Study|Protocol Violation|0|||
13492305|NCT03847896|27059318|FG004|Overall Study|Protocol Violation|2|||
13492306|NCT03847896|27059314|FG000|Overall Study|Lost to Follow-up|0|||
13492307|NCT03847896|27059315|FG001|Overall Study|Lost to Follow-up|0|||
13492308|NCT03847896|27059316|FG002|Overall Study|Lost to Follow-up|0|||
13492309|NCT03847896|27059317|FG003|Overall Study|Lost to Follow-up|1|||
13492310|NCT03847896|27059318|FG004|Overall Study|Lost to Follow-up|0|||
13492311|NCT03847896|27059314|FG000|Overall Study|Condition under investigation worsened|0|||
13492312|NCT03847896|27059315|FG001|Overall Study|Condition under investigation worsened|0|||
13492313|NCT03847896|27059316|FG002|Overall Study|Condition under investigation worsened|0|||
13492314|NCT03847896|27059317|FG003|Overall Study|Condition under investigation worsened|1|||
13492315|NCT03847896|27059318|FG004|Overall Study|Condition under investigation worsened|1|||
13492316|NCT03847896|27059314|FG000|Overall Study|Lack of Efficacy|0|||
13492317|NCT03847896|27059315|FG001|Overall Study|Lack of Efficacy|0|||
13492318|NCT03847896|27059316|FG002|Overall Study|Lack of Efficacy|0|||
13492319|NCT03847896|27059317|FG003|Overall Study|Lack of Efficacy|2|||
13492320|NCT03847896|27059318|FG004|Overall Study|Lack of Efficacy|2|||
13492321|NCT03847896|27059314|FG000|Overall Study|Other reasons|3|||
13492322|NCT03847896|27059315|FG001|Overall Study|Other reasons|3|||
13492323|NCT03847896|27059316|FG002|Overall Study|Other reasons|1|||
13492324|NCT03847896|27059317|FG003|Overall Study|Other reasons|2|||
13492325|NCT03847896|27059318|FG004|Overall Study|Other reasons|1|||
13492326|NCT03773978|27059365|FG000|PK/Safety and OLLI Period|Adverse Event|1|||
13492327|NCT03773978|27059366|FG001|PK/Safety and OLLI Period|Adverse Event|0|||
13492328|NCT03773978|27059365|FG000|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|39|||
13492329|NCT03773978|27059366|FG001|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|0|||
13492330|NCT03773978|27059365|FG000|PK/Safety and OLLI Period|Lost to Follow-up|1|||
13381421|NCT00753519|26748135|FG000|Overall Study|Withdrawal by Subject|0|||
13492331|NCT03773978|27059366|FG001|PK/Safety and OLLI Period|Lost to Follow-up|0|||
13492332|NCT03773978|27059365|FG000|PK/Safety and OLLI Period|Withdrawal by Subject|3|||
13492333|NCT03773978|27059366|FG001|PK/Safety and OLLI Period|Withdrawal by Subject|0|||
13492334|NCT03773978|27059365|FG000|PK/Safety and OLLI Period|Due to epidemic or pandemic|6|||
13492335|NCT03773978|27059366|FG001|PK/Safety and OLLI Period|Due to epidemic or pandemic|0|||
13492336|NCT03773978|27059365|FG000|PK/Safety and OLLI Period|unexplainable flare disease|1|||
13492337|NCT03773978|27059366|FG001|PK/Safety and OLLI Period|unexplainable flare disease|0|||
13492338|NCT03773978|27059365|FG000|PK/Safety and OLLI Period|Protocol Violation|4|||
13492339|NCT03773978|27059366|FG001|PK/Safety and OLLI Period|Protocol Violation|0|||
13492340|NCT03773978|27059365|FG000|PK/Safety and OLLI Period|Participant transitioned to JAHX|1|||
13492341|NCT03773978|27059366|FG001|PK/Safety and OLLI Period|Participant transitioned to JAHX|0|||
13492342|NCT03773978|27059365|FG000|PK/Safety and OLLI Period|Investigational product was not delivered to the site|1|||
13492343|NCT03773978|27059366|FG001|PK/Safety and OLLI Period|Investigational product was not delivered to the site|0|||
13381422|NCT00753519|26748136|FG001|Overall Study|Withdrawal by Subject|2|||
13381423|NCT00753506|26748149|FG000|Overall Study|Withdrawal by Subject|4|||
13381424|NCT00753506|26748150|FG001|Overall Study|Withdrawal by Subject|1|||
13381425|NCT00753506|26748149|FG000|Overall Study|Lost to Follow-up|2|||
13381426|NCT00753506|26748150|FG001|Overall Study|Lost to Follow-up|0|||
13381427|NCT00753506|26748149|FG000|Overall Study|Other reason|1|||
13381428|NCT00753506|26748150|FG001|Overall Study|Other reason|1|||
13381429|NCT00753454|26748181|FG000|Overall Study|Adverse Event|4|||
13381430|NCT00753454|26748181|FG000|Overall Study|Lack of Efficacy|1|||
13381431|NCT00753454|26748181|FG000|Overall Study|Lost to Follow-up|3|||
13381432|NCT00753454|26748181|FG000|Overall Study|Withdrawal by Subject|5|||
13381433|NCT00753454|26748181|FG000|Overall Study|Investigator Decision|1|||
13381434|NCT00753415|26748244|FG000|Part A|Disease progression|1|||
13381435|NCT00753415|26748245|FG001|Part A|Disease progression|0|||
13492344|NCT03773978|27059365|FG000|DBW Period|Adverse Event|2|||
13492345|NCT03773978|27059366|FG001|DBW Period|Adverse Event|2|||
13492346|NCT03773978|27059365|FG000|DBW Period|Failure to Meet Continuation Criteria|16|||
13492347|NCT03773978|27059366|FG001|DBW Period|Failure to Meet Continuation Criteria|40|||
13492348|NCT03773978|27059365|FG000|DBW Period|Withdrawal by Subject|2|||
13492349|NCT03773978|27059366|FG001|DBW Period|Withdrawal by Subject|1|||
13492350|NCT03773978|27059365|FG000|DBW Period|Due to epidemic or pandemic|5|||
13492351|NCT03773978|27059366|FG001|DBW Period|Due to epidemic or pandemic|6|||
13492352|NCT03773978|27059365|FG000|DBW Period|Study team decision|1|||
13492353|NCT03773978|27059366|FG001|DBW Period|Study team decision|0|||
13492354|NCT03713034|27059417|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5|||
13492355|NCT03713034|27059418|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4|||
13492356|NCT03688919|27059447|FG000|Overall Study|Lost to Follow-up|2|||
13492357|NCT03688919|27059448|FG001|Overall Study|Lost to Follow-up|1|||
13492358|NCT03688919|27059447|FG000|Overall Study|withdrawn by study team due to poor data validity|1|||
13492359|NCT03688919|27059448|FG001|Overall Study|withdrawn by study team due to poor data validity|0|||
13492360|NCT03673046|27059469|FG000|Overall Study|Adverse Event|1|||
13492361|NCT03673046|27059470|FG001|Overall Study|Adverse Event|1|||
13492362|NCT03673046|27059469|FG000|Overall Study|Withdrawal by Subject|8|||
13492363|NCT03673046|27059470|FG001|Overall Study|Withdrawal by Subject|2|||
13492364|NCT03364738|27059510|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6|||
13492365|NCT03364738|27059510|FG000|Overall Study|Withdrawal by Subject|1|||
13492366|NCT03364738|27059510|FG000|Overall Study|Adverse Event|1|||
13492367|NCT03338790|27059557|FG000|Overall Study|Disease Progression|65|||
13492368|NCT03338790|27059558|FG001|Overall Study|Disease Progression|43|||
13492369|NCT03338790|27059559|FG002|Overall Study|Disease Progression|50|||
13492370|NCT03338790|27059560|FG003|Overall Study|Disease Progression|37|||
13492371|NCT03338790|27059557|FG000|Overall Study|Study Drug Toxicity|9|||
13492372|NCT03338790|27059558|FG001|Overall Study|Study Drug Toxicity|8|||
13492373|NCT03338790|27059559|FG002|Overall Study|Study Drug Toxicity|15|||
13492374|NCT03338790|27059560|FG003|Overall Study|Study Drug Toxicity|0|||
13492375|NCT03338790|27059557|FG000|Overall Study|Death|1|||
13492376|NCT03338790|27059558|FG001|Overall Study|Death|1|||
13492377|NCT03338790|27059559|FG002|Overall Study|Death|1|||
13492378|NCT03338790|27059560|FG003|Overall Study|Death|0|||
13492379|NCT03338790|27059557|FG000|Overall Study|Adverse Event unrelated to Study Drug|4|||
13492380|NCT03338790|27059558|FG001|Overall Study|Adverse Event unrelated to Study Drug|4|||
13492381|NCT03338790|27059559|FG002|Overall Study|Adverse Event unrelated to Study Drug|6|||
13492382|NCT03338790|27059560|FG003|Overall Study|Adverse Event unrelated to Study Drug|4|||
13492383|NCT03338790|27059557|FG000|Overall Study|Participant request to discontinue study treatment|3|||
13492384|NCT03338790|27059558|FG001|Overall Study|Participant request to discontinue study treatment|3|||
13492385|NCT03338790|27059559|FG002|Overall Study|Participant request to discontinue study treatment|2|||
13492386|NCT03338790|27059560|FG003|Overall Study|Participant request to discontinue study treatment|1|||
13492387|NCT03338790|27059557|FG000|Overall Study|Poor/non-compliance|0|||
13492388|NCT03338790|27059558|FG001|Overall Study|Poor/non-compliance|1|||
13135520|NCT02739997|25995229|FG000|Overall Study|Death|1|||
13492389|NCT03338790|27059559|FG002|Overall Study|Poor/non-compliance|0|||
13492390|NCT03338790|27059560|FG003|Overall Study|Poor/non-compliance|0|||
13492391|NCT03338790|27059557|FG000|Overall Study|Participant withdrew consent|1|||
13492392|NCT03338790|27059558|FG001|Overall Study|Participant withdrew consent|0|||
13492393|NCT03338790|27059559|FG002|Overall Study|Participant withdrew consent|1|||
13492394|NCT03338790|27059560|FG003|Overall Study|Participant withdrew consent|1|||
13492395|NCT03338790|27059557|FG000|Overall Study|Other reasons|0|||
13492396|NCT03338790|27059558|FG001|Overall Study|Other reasons|5|||
13492397|NCT03338790|27059559|FG002|Overall Study|Other reasons|0|||
13492398|NCT03338790|27059560|FG003|Overall Study|Other reasons|2|||
13492399|NCT03338790|27059557|FG000|Overall Study|Not reported|0|||
13492400|NCT03338790|27059558|FG001|Overall Study|Not reported|0|||
13492401|NCT03338790|27059559|FG002|Overall Study|Not reported|1|||
13492402|NCT03338790|27059560|FG003|Overall Study|Not reported|0|||
13492403|NCT03338790|27059557|FG000|Overall Study|Completed treatment period|1|||
13492404|NCT03338790|27059558|FG001|Overall Study|Completed treatment period|2|||
13492405|NCT03338790|27059559|FG002|Overall Study|Completed treatment period|0|||
13492406|NCT03338790|27059560|FG003|Overall Study|Completed treatment period|0|||
13208275|NCT01939366|26241210|FG003|Overall Study|Lost to Follow-up|0|||
13208276|NCT01939366|26241211|FG004|Overall Study|Lost to Follow-up|0|||
13208277|NCT01939366|26241207|FG000|Overall Study|Withdrawal by Subject|1|||
13208278|NCT01939366|26241208|FG001|Overall Study|Withdrawal by Subject|0|||
13208279|NCT01939366|26241209|FG002|Overall Study|Withdrawal by Subject|2|||
13208280|NCT01939366|26241210|FG003|Overall Study|Withdrawal by Subject|2|||
13208281|NCT01939366|26241211|FG004|Overall Study|Withdrawal by Subject|3|||
13208282|NCT01939366|26241207|FG000|Overall Study|Inclusion criteria not met|0|||
13208283|NCT01939366|26241208|FG001|Overall Study|Inclusion criteria not met|1|||
13208284|NCT01939366|26241209|FG002|Overall Study|Inclusion criteria not met|1|||
13208285|NCT01939366|26241210|FG003|Overall Study|Inclusion criteria not met|0|||
13208286|NCT01939366|26241211|FG004|Overall Study|Inclusion criteria not met|1|||
13208287|NCT01939366|26241207|FG000|Overall Study|Other|0|||
13208288|NCT01939366|26241208|FG001|Overall Study|Other|0|||
13208289|NCT01939366|26241209|FG002|Overall Study|Other|2|||
13208290|NCT01939366|26241210|FG003|Overall Study|Other|2|||
13208291|NCT01939366|26241211|FG004|Overall Study|Other|1|||
13208292|NCT01939366|26241207|FG000|Overall Study|Protocol Violation|0|||
13208293|NCT01939366|26241208|FG001|Overall Study|Protocol Violation|0|||
13208294|NCT01939366|26241209|FG002|Overall Study|Protocol Violation|0|||
13208295|NCT01939366|26241210|FG003|Overall Study|Protocol Violation|1|||
13208296|NCT01939366|26241211|FG004|Overall Study|Protocol Violation|0|||
13208297|NCT01939366|26241207|FG000|Overall Study|Sponsor decision|0|||
13208298|NCT01939366|26241208|FG001|Overall Study|Sponsor decision|0|||
13208299|NCT01939366|26241209|FG002|Overall Study|Sponsor decision|0|||
13208300|NCT01939366|26241210|FG003|Overall Study|Sponsor decision|0|||
13208301|NCT01939366|26241211|FG004|Overall Study|Sponsor decision|2|||
13208302|NCT01939366|26241207|FG000|Overall Study|GCP non-compliance at site|2|||
13208303|NCT01939366|26241208|FG001|Overall Study|GCP non-compliance at site|3|||
13208304|NCT01939366|26241209|FG002|Overall Study|GCP non-compliance at site|2|||
13208305|NCT01939366|26241210|FG003|Overall Study|GCP non-compliance at site|3|||
13208306|NCT01939366|26241211|FG004|Overall Study|GCP non-compliance at site|3|||
13208307|NCT01939353|26241230|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3|||
13208308|NCT01939353|26241230|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1|||
13208309|NCT01939353|26241230|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2|||
13208310|NCT01939353|26241230|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
13208311|NCT01939353|26241230|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1|||
13208312|NCT01939314|26241247|FG000|Overall Study|Withdrawal by Subject|3|||
13208313|NCT01939314|26241248|FG001|Overall Study|Withdrawal by Subject|1|||
13208314|NCT01939314|26241247|FG000|Overall Study|Protocol Violation|1|||
13208315|NCT01939314|26241248|FG001|Overall Study|Protocol Violation|0|||
13208316|NCT01939314|26241247|FG000|Overall Study|Pregnancy|0|||
13208317|NCT01939314|26241248|FG001|Overall Study|Pregnancy|1|||
13208318|NCT01939314|26241247|FG000|Overall Study|Lost to Follow-up|5|||
13208319|NCT01939314|26241248|FG001|Overall Study|Lost to Follow-up|6|||
13208320|NCT01939223|26241263|FG000|Overall Study|AE not assoc. with disease recurrence|1|||
13208321|NCT01939223|26241264|FG001|Overall Study|AE not assoc. with disease recurrence|1|||
13208322|NCT01939223|26241263|FG000|Overall Study|Disease recurrence (radiological)|1|||
13208323|NCT01939223|26241264|FG001|Overall Study|Disease recurrence (radiological)|3|||
13208324|NCT01939223|26241263|FG000|Overall Study|Study stopped by Sponsor|5|||
13296494|NCT01370356|26496637|FG001|Overall Study|Protocol Violation|3|||
13208325|NCT01939223|26241264|FG001|Overall Study|Study stopped by Sponsor|7|||
13492407|NCT03106987|27059615|FG000|Overall Study|Death|37|||
13492408|NCT03106987|27059616|FG001|Overall Study|Death|22|||
13492409|NCT03106987|27059617|FG002|Overall Study|Death|12|||
13492410|NCT03106987|27059618|FG003|Overall Study|Death|8|||
13492411|NCT03106987|27059615|FG000|Overall Study|Lost to Follow-up|2|||
13492412|NCT03106987|27059616|FG001|Overall Study|Lost to Follow-up|0|||
13492413|NCT03106987|27059617|FG002|Overall Study|Lost to Follow-up|2|||
13492414|NCT03106987|27059618|FG003|Overall Study|Lost to Follow-up|2|||
13492415|NCT03106987|27059615|FG000|Overall Study|Withdrawal by Subject|5|||
13492416|NCT03106987|27059616|FG001|Overall Study|Withdrawal by Subject|1|||
13492417|NCT03106987|27059617|FG002|Overall Study|Withdrawal by Subject|4|||
13492418|NCT03106987|27059618|FG003|Overall Study|Withdrawal by Subject|1|||
13492419|NCT02973815|27059645|FG000|Post Intervention|Death|1|||
13492420|NCT02973815|27059646|FG001|Post Intervention|Death|0|||
13492421|NCT02973815|27059645|FG000|Post Intervention|Lost to Follow-up|7|||
13492422|NCT02973815|27059646|FG001|Post Intervention|Lost to Follow-up|24|||
13492423|NCT02973815|27059645|FG000|Follow-up|Lost to Follow-up|2|||
13492424|NCT02973815|27059646|FG001|Follow-up|Lost to Follow-up|0|||
13492425|NCT02736227|27059663|FG000|Overall Study|Withdrawal by Subject|0|||
13492426|NCT02736227|27059664|FG001|Overall Study|Withdrawal by Subject|0|||
13492427|NCT02736227|27059665|FG002|Overall Study|Withdrawal by Subject|1|||
13492428|NCT02736227|27059663|FG000|Overall Study|Physician Decision|0|||
13492429|NCT02736227|27059664|FG001|Overall Study|Physician Decision|0|||
13492430|NCT02736227|27059665|FG002|Overall Study|Physician Decision|5|||
13492431|NCT02736227|27059663|FG000|Overall Study|Non Compliant|0|||
13492432|NCT02736227|27059664|FG001|Overall Study|Non Compliant|0|||
13492433|NCT02736227|27059665|FG002|Overall Study|Non Compliant|2|||
13492434|NCT02499328|27059968|FG000|Overall Study|Withdrawal by Subject|1|||
13492435|NCT02499328|27059969|FG001|Overall Study|Withdrawal by Subject|1|||
13492436|NCT02499328|27059970|FG002|Overall Study|Withdrawal by Subject|5|||
13492437|NCT02499328|27059971|FG003|Overall Study|Withdrawal by Subject|3|||
13492438|NCT02499328|27059972|FG004|Overall Study|Withdrawal by Subject|5|||
13492439|NCT02499328|27059973|FG005|Overall Study|Withdrawal by Subject|0|||
13492440|NCT02499328|27059974|FG006|Overall Study|Withdrawal by Subject|0|||
13492441|NCT02499328|27059975|FG007|Overall Study|Withdrawal by Subject|0|||
13492442|NCT02499328|27059976|FG008|Overall Study|Withdrawal by Subject|2|||
13492443|NCT02499328|27059977|FG009|Overall Study|Withdrawal by Subject|2|||
13492444|NCT02499328|27059978|FG010|Overall Study|Withdrawal by Subject|0|||
13492445|NCT02499328|27059979|FG011|Overall Study|Withdrawal by Subject|3|||
13492446|NCT02499328|27059980|FG012|Overall Study|Withdrawal by Subject|7|||
13492447|NCT02499328|27059981|FG013|Overall Study|Withdrawal by Subject|3|||
13492448|NCT02499328|27059982|FG014|Overall Study|Withdrawal by Subject|1|||
13492449|NCT02499328|27059983|FG015|Overall Study|Withdrawal by Subject|0|||
13492450|NCT02499328|27059984|FG016|Overall Study|Withdrawal by Subject|0|||
13492451|NCT02499328|27059985|FG017|Overall Study|Withdrawal by Subject|3|||
13492452|NCT02499328|27059986|FG018|Overall Study|Withdrawal by Subject|0|||
13492453|NCT02499328|27059968|FG000|Overall Study|Lost to Follow-up|0|||
13492454|NCT02499328|27059969|FG001|Overall Study|Lost to Follow-up|1|||
13492455|NCT02499328|27059970|FG002|Overall Study|Lost to Follow-up|1|||
13492456|NCT02499328|27059971|FG003|Overall Study|Lost to Follow-up|2|||
13492457|NCT02499328|27059972|FG004|Overall Study|Lost to Follow-up|0|||
13492458|NCT02499328|27059973|FG005|Overall Study|Lost to Follow-up|0|||
13492459|NCT02499328|27059974|FG006|Overall Study|Lost to Follow-up|0|||
13208326|NCT01939223|26241263|FG000|Overall Study|Withdrawal by Subject|6|||
13208327|NCT01939223|26241264|FG001|Overall Study|Withdrawal by Subject|0|||
13208328|NCT01939197|26241344|FG000|Overall Study|Withdrawal by Subject|1|||
13208329|NCT01939197|26241345|FG001|Overall Study|Withdrawal by Subject|0|||
13208330|NCT01939197|26241346|FG002|Overall Study|Withdrawal by Subject|0|||
13208331|NCT01939197|26241347|FG003|Overall Study|Withdrawal by Subject|0|||
13208332|NCT01939197|26241348|FG004|Overall Study|Withdrawal by Subject|1|||
13208333|NCT01939197|26241349|FG005|Overall Study|Withdrawal by Subject|0|||
13208334|NCT01939197|26241350|FG006|Overall Study|Withdrawal by Subject|0|||
13208335|NCT01939197|26241344|FG000|Overall Study|Lost to Follow-up|0|||
13208336|NCT01939197|26241345|FG001|Overall Study|Lost to Follow-up|1|||
13208337|NCT01939197|26241346|FG002|Overall Study|Lost to Follow-up|0|||
13208338|NCT01939197|26241347|FG003|Overall Study|Lost to Follow-up|1|||
13208339|NCT01939197|26241348|FG004|Overall Study|Lost to Follow-up|3|||
13208340|NCT01939197|26241349|FG005|Overall Study|Lost to Follow-up|1|||
13492460|NCT02499328|27059975|FG007|Overall Study|Lost to Follow-up|2|||
13492461|NCT02499328|27059976|FG008|Overall Study|Lost to Follow-up|3|||
13492462|NCT02499328|27059977|FG009|Overall Study|Lost to Follow-up|0|||
13492463|NCT02499328|27059978|FG010|Overall Study|Lost to Follow-up|0|||
13492464|NCT02499328|27059979|FG011|Overall Study|Lost to Follow-up|0|||
13492465|NCT02499328|27059980|FG012|Overall Study|Lost to Follow-up|0|||
13492466|NCT02499328|27059981|FG013|Overall Study|Lost to Follow-up|0|||
13492467|NCT02499328|27059982|FG014|Overall Study|Lost to Follow-up|0|||
13492468|NCT02499328|27059983|FG015|Overall Study|Lost to Follow-up|0|||
13492469|NCT02499328|27059984|FG016|Overall Study|Lost to Follow-up|0|||
13208341|NCT01939197|26241350|FG006|Overall Study|Lost to Follow-up|2|||
13208342|NCT01939158|26241439|FG000|Overall Study|Adverse Event|1|||
13208343|NCT01939158|26241440|FG001|Overall Study|Adverse Event|0|||
13208344|NCT01939158|26241441|FG002|Overall Study|Adverse Event|0|||
13208345|NCT01939158|26241442|FG003|Overall Study|Adverse Event|0|||
13208346|NCT01939158|26241439|FG000|Overall Study|Withdrawal by Subject|22|||
13208347|NCT01939158|26241440|FG001|Overall Study|Withdrawal by Subject|25|||
13208348|NCT01939158|26241441|FG002|Overall Study|Withdrawal by Subject|15|||
13208349|NCT01939158|26241442|FG003|Overall Study|Withdrawal by Subject|17|||
13208350|NCT01939158|26241439|FG000|Overall Study|Migrated/moved from study area|5|||
13208351|NCT01939158|26241440|FG001|Overall Study|Migrated/moved from study area|7|||
13208352|NCT01939158|26241441|FG002|Overall Study|Migrated/moved from study area|3|||
13208353|NCT01939158|26241442|FG003|Overall Study|Migrated/moved from study area|6|||
13208354|NCT01939158|26241439|FG000|Overall Study|Lost to Follow-up|18|||
13208355|NCT01939158|26241440|FG001|Overall Study|Lost to Follow-up|17|||
13208356|NCT01939158|26241441|FG002|Overall Study|Lost to Follow-up|17|||
13492470|NCT02499328|27059985|FG017|Overall Study|Lost to Follow-up|0|||
13492471|NCT02499328|27059986|FG018|Overall Study|Lost to Follow-up|1|||
13492472|NCT02499328|27059968|FG000|Overall Study|Death|0|||
13492473|NCT02499328|27059969|FG001|Overall Study|Death|3|||
13492474|NCT02499328|27059970|FG002|Overall Study|Death|3|||
13492475|NCT02499328|27059971|FG003|Overall Study|Death|2|||
13492476|NCT02499328|27059972|FG004|Overall Study|Death|4|||
13492477|NCT02499328|27059973|FG005|Overall Study|Death|7|||
13492478|NCT02499328|27059974|FG006|Overall Study|Death|3|||
13492479|NCT02499328|27059975|FG007|Overall Study|Death|0|||
13492480|NCT02499328|27059976|FG008|Overall Study|Death|2|||
13492481|NCT02499328|27059977|FG009|Overall Study|Death|6|||
13492482|NCT02499328|27059978|FG010|Overall Study|Death|6|||
13492483|NCT02499328|27059979|FG011|Overall Study|Death|20|||
13492484|NCT02499328|27059980|FG012|Overall Study|Death|9|||
13492485|NCT02499328|27059981|FG013|Overall Study|Death|7|||
13492486|NCT02499328|27059982|FG014|Overall Study|Death|3|||
13492487|NCT02499328|27059983|FG015|Overall Study|Death|1|||
13492488|NCT02499328|27059984|FG016|Overall Study|Death|1|||
13492489|NCT02499328|27059985|FG017|Overall Study|Death|16|||
13492490|NCT02499328|27059986|FG018|Overall Study|Death|5|||
13492491|NCT02499328|27059968|FG000|Overall Study|"Other"|2|||
13492492|NCT02499328|27059969|FG001|Overall Study|"Other"|2|||
13492493|NCT02499328|27059970|FG002|Overall Study|"Other"|1|||
13492494|NCT02499328|27059971|FG003|Overall Study|"Other"|3|||
13492495|NCT02499328|27059972|FG004|Overall Study|"Other"|6|||
13492496|NCT02499328|27059973|FG005|Overall Study|"Other"|2|||
13492497|NCT02499328|27059974|FG006|Overall Study|"Other"|3|||
13492498|NCT02499328|27059975|FG007|Overall Study|"Other"|4|||
13492499|NCT02499328|27059976|FG008|Overall Study|"Other"|6|||
13492500|NCT02499328|27059977|FG009|Overall Study|"Other"|16|||
13492501|NCT02499328|27059978|FG010|Overall Study|"Other"|13|||
13492502|NCT02499328|27059979|FG011|Overall Study|"Other"|31|||
13492503|NCT02499328|27059980|FG012|Overall Study|"Other"|8|||
13492504|NCT02499328|27059981|FG013|Overall Study|"Other"|7|||
13492505|NCT02499328|27059982|FG014|Overall Study|"Other"|6|||
13492506|NCT02499328|27059983|FG015|Overall Study|"Other"|0|||
13492507|NCT02499328|27059984|FG016|Overall Study|"Other"|0|||
13492508|NCT02499328|27059985|FG017|Overall Study|"Other"|34|||
13492509|NCT02499328|27059986|FG018|Overall Study|"Other"|43|||
13492510|NCT02499328|27059968|FG000|Overall Study|Disease Progression|0|||
13492511|NCT02499328|27059969|FG001|Overall Study|Disease Progression|0|||
13492512|NCT02499328|27059970|FG002|Overall Study|Disease Progression|0|||
13492513|NCT02499328|27059971|FG003|Overall Study|Disease Progression|0|||
13492514|NCT02499328|27059972|FG004|Overall Study|Disease Progression|0|||
13492515|NCT02499328|27059973|FG005|Overall Study|Disease Progression|0|||
13492516|NCT02499328|27059974|FG006|Overall Study|Disease Progression|1|||
13492517|NCT02499328|27059975|FG007|Overall Study|Disease Progression|0|||
13492518|NCT02499328|27059976|FG008|Overall Study|Disease Progression|1|||
13492519|NCT02499328|27059977|FG009|Overall Study|Disease Progression|0|||
13492520|NCT02499328|27059978|FG010|Overall Study|Disease Progression|1|||
13492521|NCT02499328|27059979|FG011|Overall Study|Disease Progression|0|||
13492522|NCT02499328|27059980|FG012|Overall Study|Disease Progression|0|||
13492523|NCT02499328|27059981|FG013|Overall Study|Disease Progression|0|||
13492524|NCT02499328|27059982|FG014|Overall Study|Disease Progression|0|||
13492525|NCT02499328|27059983|FG015|Overall Study|Disease Progression|0|||
13492526|NCT02499328|27059984|FG016|Overall Study|Disease Progression|0|||
13492527|NCT02499328|27059985|FG017|Overall Study|Disease Progression|2|||
13492528|NCT02499328|27059986|FG018|Overall Study|Disease Progression|0|||
13208357|NCT01939158|26241442|FG003|Overall Study|Lost to Follow-up|17|||
13492529|NCT02499328|27059968|FG000|Overall Study|Adverse Event|1|||
13492530|NCT02499328|27059969|FG001|Overall Study|Adverse Event|0|||
13492531|NCT02499328|27059970|FG002|Overall Study|Adverse Event|0|||
13492532|NCT02499328|27059971|FG003|Overall Study|Adverse Event|1|||
13492533|NCT02499328|27059972|FG004|Overall Study|Adverse Event|0|||
13492534|NCT02499328|27059973|FG005|Overall Study|Adverse Event|0|||
13492535|NCT02499328|27059974|FG006|Overall Study|Adverse Event|0|||
13492536|NCT02499328|27059975|FG007|Overall Study|Adverse Event|0|||
13492537|NCT02499328|27059976|FG008|Overall Study|Adverse Event|0|||
13492538|NCT02499328|27059977|FG009|Overall Study|Adverse Event|0|||
13492539|NCT02499328|27059978|FG010|Overall Study|Adverse Event|0|||
13492540|NCT02499328|27059979|FG011|Overall Study|Adverse Event|0|||
13492541|NCT02499328|27059980|FG012|Overall Study|Adverse Event|1|||
13492542|NCT02499328|27059981|FG013|Overall Study|Adverse Event|0|||
13492543|NCT02499328|27059982|FG014|Overall Study|Adverse Event|0|||
13492544|NCT02499328|27059983|FG015|Overall Study|Adverse Event|0|||
13492545|NCT02499328|27059984|FG016|Overall Study|Adverse Event|0|||
13492546|NCT02499328|27059985|FG017|Overall Study|Adverse Event|0|||
13492547|NCT02499328|27059986|FG018|Overall Study|Adverse Event|0|||
13492548|NCT00688870|27060025|FG000|Infant Series|Parent or legal guardian request|4|||
13492549|NCT00688870|27060026|FG001|Infant Series|Parent or legal guardian request|0|||
13492550|NCT00004445|27060041|FG000|Overall Study|Physician Decision|2|||
13492551|NCT00004445|27060041|FG000|Overall Study|Withdrawal by Subject|1|||
13492552|NCT02013167|27060075|FG000|Overall Study|Withdrawal by Subject|15|||
13492553|NCT02013167|27060076|FG001|Overall Study|Withdrawal by Subject|14|||
13492554|NCT02013167|27060075|FG000|Overall Study|Sponsor Decision|1|||
13492555|NCT02013167|27060076|FG001|Overall Study|Sponsor Decision|3|||
13492556|NCT02013167|27060075|FG000|Overall Study|Lost to Follow-up|0|||
13492557|NCT02013167|27060076|FG001|Overall Study|Lost to Follow-up|1|||
13492558|NCT02013167|27060075|FG000|Overall Study|Death|85|||
13492559|NCT02013167|27060076|FG001|Overall Study|Death|160|||
13492560|NCT01981850|27060204|FG000|Main Phase Stage 1|Death|2|||
13492561|NCT01981850|27060205|FG001|Main Phase Stage 1|Death|0|||
13492562|NCT01981850|27060206|FG002|Main Phase Stage 1|Death|0|||
13492563|NCT01981850|27060207|FG003|Main Phase Stage 1|Death|0|||
13492564|NCT01981850|27060208|FG004|Main Phase Stage 1|Death|0|||
13492565|NCT01981850|27060209|FG005|Main Phase Stage 1|Death|0|||
13492566|NCT01981850|27060210|FG006|Main Phase Stage 1|Death|0|||
13492567|NCT01981850|27060211|FG007|Main Phase Stage 1|Death|0|||
13492568|NCT01981850|27060212|FG008|Main Phase Stage 1|Death|0|||
13492569|NCT01981850|27060213|FG009|Main Phase Stage 1|Death|0|||
13492570|NCT01981850|27060204|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1|||
13492571|NCT01981850|27060205|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0|||
13492572|NCT01981850|27060206|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0|||
13492573|NCT01981850|27060207|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0|||
13492574|NCT01981850|27060208|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0|||
13492575|NCT01981850|27060209|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0|||
13492576|NCT01981850|27060210|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0|||
13492577|NCT01981850|27060211|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0|||
13492578|NCT01981850|27060212|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0|||
13492579|NCT01981850|27060213|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0|||
13492580|NCT01981850|27060204|FG000|Main Phase Stage 1|Lack of Efficacy|0|||
13492581|NCT01981850|27060205|FG001|Main Phase Stage 1|Lack of Efficacy|2|||
13492582|NCT01981850|27060206|FG002|Main Phase Stage 1|Lack of Efficacy|0|||
13492583|NCT01981850|27060207|FG003|Main Phase Stage 1|Lack of Efficacy|0|||
13492584|NCT01981850|27060208|FG004|Main Phase Stage 1|Lack of Efficacy|0|||
13492585|NCT01981850|27060209|FG005|Main Phase Stage 1|Lack of Efficacy|0|||
13492586|NCT01981850|27060210|FG006|Main Phase Stage 1|Lack of Efficacy|0|||
13492587|NCT01981850|27060211|FG007|Main Phase Stage 1|Lack of Efficacy|0|||
13492588|NCT01981850|27060212|FG008|Main Phase Stage 1|Lack of Efficacy|0|||
13492589|NCT01981850|27060213|FG009|Main Phase Stage 1|Lack of Efficacy|0|||
13492590|NCT01981850|27060204|FG000|Main Phase Stage 1|Various reasons|0|||
13492591|NCT01981850|27060205|FG001|Main Phase Stage 1|Various reasons|0|||
13492592|NCT01981850|27060206|FG002|Main Phase Stage 1|Various reasons|2|||
13492593|NCT01981850|27060207|FG003|Main Phase Stage 1|Various reasons|0|||
13492594|NCT01981850|27060208|FG004|Main Phase Stage 1|Various reasons|0|||
13492595|NCT01981850|27060209|FG005|Main Phase Stage 1|Various reasons|0|||
13492596|NCT01981850|27060210|FG006|Main Phase Stage 1|Various reasons|0|||
13492597|NCT01981850|27060211|FG007|Main Phase Stage 1|Various reasons|0|||
13492598|NCT01981850|27060212|FG008|Main Phase Stage 1|Various reasons|0|||
13492599|NCT01981850|27060213|FG009|Main Phase Stage 1|Various reasons|0|||
13492600|NCT01981850|27060204|FG000|Main Phase Stage 2|Adverse Event|0|||
13492601|NCT01981850|27060205|FG001|Main Phase Stage 2|Adverse Event|0|||
13492602|NCT01981850|27060206|FG002|Main Phase Stage 2|Adverse Event|0|||
13492603|NCT01981850|27060207|FG003|Main Phase Stage 2|Adverse Event|0|||
13135653|NCT02738138|25995883|FG000|Overall Study|Adverse Event|0|||
13492604|NCT01981850|27060208|FG004|Main Phase Stage 2|Adverse Event|6|||
13492605|NCT01981850|27060209|FG005|Main Phase Stage 2|Adverse Event|5|||
13492606|NCT01981850|27060210|FG006|Main Phase Stage 2|Adverse Event|7|||
13492607|NCT01981850|27060211|FG007|Main Phase Stage 2|Adverse Event|0|||
13492608|NCT01981850|27060212|FG008|Main Phase Stage 2|Adverse Event|0|||
13492609|NCT01981850|27060213|FG009|Main Phase Stage 2|Adverse Event|0|||
13492610|NCT01981850|27060204|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0|||
13492611|NCT01981850|27060205|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0|||
13492612|NCT01981850|27060206|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0|||
13492613|NCT01981850|27060207|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0|||
13492614|NCT01981850|27060208|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4|||
13492615|NCT01981850|27060209|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3|||
13492616|NCT01981850|27060210|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3|||
13492617|NCT01981850|27060211|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0|||
13492618|NCT01981850|27060212|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0|||
13492619|NCT01981850|27060213|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0|||
13492620|NCT01981850|27060204|FG000|Main Phase Stage 2|Lack of Efficacy|0|||
13492621|NCT01981850|27060205|FG001|Main Phase Stage 2|Lack of Efficacy|0|||
13492622|NCT01981850|27060206|FG002|Main Phase Stage 2|Lack of Efficacy|0|||
13492623|NCT01981850|27060207|FG003|Main Phase Stage 2|Lack of Efficacy|0|||
13492624|NCT01981850|27060208|FG004|Main Phase Stage 2|Lack of Efficacy|1|||
13492625|NCT01981850|27060209|FG005|Main Phase Stage 2|Lack of Efficacy|2|||
13492626|NCT01981850|27060210|FG006|Main Phase Stage 2|Lack of Efficacy|0|||
13492627|NCT01981850|27060211|FG007|Main Phase Stage 2|Lack of Efficacy|0|||
13492628|NCT01981850|27060212|FG008|Main Phase Stage 2|Lack of Efficacy|0|||
13492629|NCT01981850|27060213|FG009|Main Phase Stage 2|Lack of Efficacy|0|||
13492630|NCT01981850|27060204|FG000|Main Phase Stage 2|Various reasons|0|||
13492631|NCT01981850|27060205|FG001|Main Phase Stage 2|Various reasons|0|||
13492632|NCT01981850|27060206|FG002|Main Phase Stage 2|Various reasons|0|||
13492633|NCT01981850|27060207|FG003|Main Phase Stage 2|Various reasons|0|||
13492634|NCT01981850|27060208|FG004|Main Phase Stage 2|Various reasons|2|||
13492635|NCT01981850|27060209|FG005|Main Phase Stage 2|Various reasons|0|||
13492636|NCT01981850|27060210|FG006|Main Phase Stage 2|Various reasons|1|||
13492637|NCT01981850|27060211|FG007|Main Phase Stage 2|Various reasons|0|||
13492638|NCT01981850|27060212|FG008|Main Phase Stage 2|Various reasons|0|||
13492639|NCT01981850|27060213|FG009|Main Phase Stage 2|Various reasons|0|||
13492640|NCT01981850|27060204|FG000|Main Phase Stage 2|Progressive Disease|0|||
13492641|NCT01981850|27060205|FG001|Main Phase Stage 2|Progressive Disease|0|||
13492642|NCT01981850|27060206|FG002|Main Phase Stage 2|Progressive Disease|0|||
13492643|NCT01981850|27060207|FG003|Main Phase Stage 2|Progressive Disease|0|||
13492644|NCT01981850|27060208|FG004|Main Phase Stage 2|Progressive Disease|0|||
13492645|NCT01981850|27060209|FG005|Main Phase Stage 2|Progressive Disease|6|||
13492646|NCT01981850|27060210|FG006|Main Phase Stage 2|Progressive Disease|6|||
13492647|NCT01981850|27060211|FG007|Main Phase Stage 2|Progressive Disease|0|||
13492648|NCT01981850|27060212|FG008|Main Phase Stage 2|Progressive Disease|0|||
13492649|NCT01981850|27060213|FG009|Main Phase Stage 2|Progressive Disease|0|||
13492650|NCT01981850|27060204|FG000|Open Label Extension (OLE)|Adverse Event|0|||
13492651|NCT01981850|27060205|FG001|Open Label Extension (OLE)|Adverse Event|0|||
13492652|NCT01981850|27060206|FG002|Open Label Extension (OLE)|Adverse Event|0|||
13492653|NCT01981850|27060207|FG003|Open Label Extension (OLE)|Adverse Event|0|||
13492654|NCT01981850|27060208|FG004|Open Label Extension (OLE)|Adverse Event|0|||
13492655|NCT01981850|27060209|FG005|Open Label Extension (OLE)|Adverse Event|0|||
13492656|NCT01981850|27060210|FG006|Open Label Extension (OLE)|Adverse Event|0|||
13492657|NCT01981850|27060211|FG007|Open Label Extension (OLE)|Adverse Event|2|||
13492658|NCT01981850|27060212|FG008|Open Label Extension (OLE)|Adverse Event|1|||
13492659|NCT01981850|27060213|FG009|Open Label Extension (OLE)|Adverse Event|8|||
13492660|NCT01981850|27060204|FG000|Open Label Extension (OLE)|Lack of Efficacy|0|||
13492661|NCT01981850|27060205|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
13492662|NCT01981850|27060206|FG002|Open Label Extension (OLE)|Lack of Efficacy|0|||
13492663|NCT01981850|27060207|FG003|Open Label Extension (OLE)|Lack of Efficacy|0|||
13492664|NCT01981850|27060208|FG004|Open Label Extension (OLE)|Lack of Efficacy|0|||
13492665|NCT01981850|27060209|FG005|Open Label Extension (OLE)|Lack of Efficacy|0|||
13492666|NCT01981850|27060210|FG006|Open Label Extension (OLE)|Lack of Efficacy|0|||
13492667|NCT01981850|27060211|FG007|Open Label Extension (OLE)|Lack of Efficacy|4|||
13492668|NCT01981850|27060212|FG008|Open Label Extension (OLE)|Lack of Efficacy|1|||
13492669|NCT01981850|27060213|FG009|Open Label Extension (OLE)|Lack of Efficacy|19|||
13492670|NCT01981850|27060204|FG000|Open Label Extension (OLE)|Various reasons|0|||
13492671|NCT01981850|27060205|FG001|Open Label Extension (OLE)|Various reasons|0|||
13492672|NCT01981850|27060206|FG002|Open Label Extension (OLE)|Various reasons|0|||
13492673|NCT01981850|27060207|FG003|Open Label Extension (OLE)|Various reasons|0|||
13492674|NCT01981850|27060208|FG004|Open Label Extension (OLE)|Various reasons|0|||
13492675|NCT01981850|27060209|FG005|Open Label Extension (OLE)|Various reasons|0|||
13492676|NCT01981850|27060210|FG006|Open Label Extension (OLE)|Various reasons|0|||
13492677|NCT01981850|27060211|FG007|Open Label Extension (OLE)|Various reasons|3|||
13492678|NCT01981850|27060212|FG008|Open Label Extension (OLE)|Various reasons|1|||
13492679|NCT01981850|27060213|FG009|Open Label Extension (OLE)|Various reasons|3|||
13492680|NCT01981850|27060204|FG000|Open Label Extension (OLE)|Progressive Disease|0|||
13492681|NCT01981850|27060205|FG001|Open Label Extension (OLE)|Progressive Disease|0|||
13492682|NCT01981850|27060206|FG002|Open Label Extension (OLE)|Progressive Disease|0|||
13492683|NCT01981850|27060207|FG003|Open Label Extension (OLE)|Progressive Disease|0|||
13492684|NCT01981850|27060208|FG004|Open Label Extension (OLE)|Progressive Disease|0|||
13492685|NCT01981850|27060209|FG005|Open Label Extension (OLE)|Progressive Disease|0|||
13492686|NCT01981850|27060210|FG006|Open Label Extension (OLE)|Progressive Disease|0|||
13492687|NCT01981850|27060211|FG007|Open Label Extension (OLE)|Progressive Disease|3|||
13492688|NCT01981850|27060212|FG008|Open Label Extension (OLE)|Progressive Disease|2|||
13492689|NCT01981850|27060213|FG009|Open Label Extension (OLE)|Progressive Disease|9|||
13492690|NCT01981850|27060204|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
13492691|NCT01981850|27060205|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
13492692|NCT01981850|27060206|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
13492693|NCT01981850|27060207|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
13492694|NCT01981850|27060208|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
13492695|NCT01981850|27060209|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
13492696|NCT01981850|27060210|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
13492697|NCT01981850|27060211|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
13492698|NCT01981850|27060212|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
13492699|NCT01981850|27060213|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8|||
13492700|NCT01981850|27060204|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
13492701|NCT01981850|27060205|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
13492702|NCT01981850|27060206|FG002|Open Label Extension (OLE)|Lost to Follow-up|0|||
13492703|NCT01981850|27060207|FG003|Open Label Extension (OLE)|Lost to Follow-up|0|||
13492704|NCT01981850|27060208|FG004|Open Label Extension (OLE)|Lost to Follow-up|0|||
13492705|NCT01981850|27060209|FG005|Open Label Extension (OLE)|Lost to Follow-up|0|||
13492706|NCT01981850|27060210|FG006|Open Label Extension (OLE)|Lost to Follow-up|0|||
13492707|NCT01981850|27060211|FG007|Open Label Extension (OLE)|Lost to Follow-up|0|||
13492708|NCT01981850|27060212|FG008|Open Label Extension (OLE)|Lost to Follow-up|0|||
13492709|NCT01981850|27060213|FG009|Open Label Extension (OLE)|Lost to Follow-up|1|||
13492710|NCT00688376|27060274|FG000|Double-Blind Phase|Adverse Event|4|||
13492711|NCT00688376|27060275|FG001|Double-Blind Phase|Adverse Event|4|||
13492712|NCT00688376|27060274|FG000|Double-Blind Phase|Protocol Violation|1|||
13492713|NCT00688376|27060275|FG001|Double-Blind Phase|Protocol Violation|2|||
13492714|NCT00688376|27060274|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
13492715|NCT00688376|27060275|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
13492716|NCT00688376|27060274|FG000|Double-Blind Phase|Not treated|0|||
13492717|NCT00688376|27060275|FG001|Double-Blind Phase|Not treated|1|||
13492718|NCT00688376|27060274|FG000|Blinded Extension Phase|Adverse Event|3|||
13492719|NCT00688376|27060275|FG001|Blinded Extension Phase|Adverse Event|4|||
13492720|NCT00688376|27060274|FG000|Blinded Extension Phase|Withdrawal by Subject|0|||
13492721|NCT00688376|27060275|FG001|Blinded Extension Phase|Withdrawal by Subject|1|||
13492722|NCT00688376|27060274|FG000|Blinded Extension Phase|Physician Decision|1|||
13492723|NCT00688376|27060275|FG001|Blinded Extension Phase|Physician Decision|0|||
13492724|NCT00688376|27060274|FG000|Blinded Extension Phase|Other|1|||
13492725|NCT00688376|27060275|FG001|Blinded Extension Phase|Other|0|||
13492726|NCT00121108|27060351|FG000|Overall Study|Lost to Follow-up|10|||
13492727|NCT00121108|27060352|FG001|Overall Study|Lost to Follow-up|22|||
13492728|NCT00121108|27060351|FG000|Overall Study|Withdrawal by Subject|106|||
13492729|NCT00121108|27060352|FG001|Overall Study|Withdrawal by Subject|195|||
13492730|NCT00121108|27060351|FG000|Overall Study|Death|5|||
13492731|NCT00121108|27060352|FG001|Overall Study|Death|8|||
13492732|NCT04633837|27060373|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5|||
13492733|NCT04633837|27060374|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0|||
13492734|NCT03032510|27060398|FG000|Overall Study|Adverse Event|5|||
13492735|NCT03032510|27060399|FG001|Overall Study|Adverse Event|2|||
13492736|NCT03032510|27060398|FG000|Overall Study|Lost to Follow-up|8|||
13492737|NCT03032510|27060399|FG001|Overall Study|Lost to Follow-up|7|||
13492738|NCT03032510|27060398|FG000|Overall Study|Withdrawal by Subject|8|||
13492739|NCT03032510|27060399|FG001|Overall Study|Withdrawal by Subject|7|||
13492740|NCT03032510|27060398|FG000|Overall Study|Subject noncompliance|4|||
13492741|NCT03032510|27060399|FG001|Overall Study|Subject noncompliance|2|||
13492742|NCT03032510|27060398|FG000|Overall Study|Physician Decision|2|||
13492743|NCT03032510|27060399|FG001|Overall Study|Physician Decision|0|||
13492744|NCT02946047|27060488|FG000|Overall Study|Adverse Event|1|||
13492745|NCT02946047|27060489|FG001|Overall Study|Adverse Event|0|||
13492746|NCT02946047|27060490|FG002|Overall Study|Adverse Event|0|||
13492747|NCT02946047|27060491|FG003|Overall Study|Adverse Event|0|||
13492748|NCT02784704|27060518|FG000|Overall Study|Adverse Event|4|||
13492749|NCT02784704|27060519|FG001|Overall Study|Adverse Event|2|||
13492750|NCT02784704|27060518|FG000|Overall Study|Lost to Follow-up|6|||
13492751|NCT02784704|27060519|FG001|Overall Study|Lost to Follow-up|4|||
13492752|NCT02784704|27060518|FG000|Overall Study|Withdrawal by Subject|1|||
13492753|NCT02784704|27060519|FG001|Overall Study|Withdrawal by Subject|3|||
13492754|NCT02784704|27060518|FG000|Overall Study|Subject Non Compliance|2|||
13492755|NCT02784704|27060519|FG001|Overall Study|Subject Non Compliance|0|||
13492756|NCT04831515|27060532|FG000|First Intervention|Adverse Event|0|||
13492757|NCT04831515|27060533|FG001|First Intervention|Adverse Event|1|||
13492758|NCT04634409|27060762|FG000|Overall Study|Death|0|||
13492759|NCT04634409|27060763|FG001|Overall Study|Death|0|||
13492760|NCT04634409|27060764|FG002|Overall Study|Death|0|||
13492761|NCT04634409|27060765|FG003|Overall Study|Death|0|||
13492762|NCT04634409|27060766|FG004|Overall Study|Death|0|||
13492763|NCT04634409|27060767|FG005|Overall Study|Death|0|||
13492764|NCT04634409|27060768|FG006|Overall Study|Death|0|||
13492765|NCT04634409|27060769|FG007|Overall Study|Death|0|||
13492766|NCT04634409|27060770|FG008|Overall Study|Death|0|||
13492767|NCT04634409|27060771|FG009|Overall Study|Death|0|||
13492768|NCT04634409|27060772|FG010|Overall Study|Death|1|||
13492769|NCT04634409|27060773|FG011|Overall Study|Death|0|||
13492770|NCT04634409|27060774|FG012|Overall Study|Death|1|||
13492771|NCT04634409|27060775|FG013|Overall Study|Death|0|||
13492772|NCT04634409|27060776|FG014|Overall Study|Death|0|||
13492773|NCT04634409|27060777|FG015|Overall Study|Death|0|||
13492774|NCT04634409|27060778|FG016|Overall Study|Death|0|||
13492775|NCT04634409|27060779|FG017|Overall Study|Death|0|||
13492776|NCT04634409|27060780|FG018|Overall Study|Death|0|||
13492777|NCT04634409|27060781|FG019|Overall Study|Death|0|||
13492778|NCT04634409|27060782|FG020|Overall Study|Death|0|||
13492779|NCT04634409|27060783|FG021|Overall Study|Death|0|||
13492780|NCT04634409|27060784|FG022|Overall Study|Death|0|||
13492781|NCT04634409|27060785|FG023|Overall Study|Death|0|||
13492782|NCT04634409|27060786|FG024|Overall Study|Death|0|||
13492783|NCT04634409|27060787|FG025|Overall Study|Death|0|||
13492784|NCT04634409|27060788|FG026|Overall Study|Death|0|||
13492785|NCT04634409|27060762|FG000|Overall Study|Adverse Event|0|||
13492786|NCT04634409|27060763|FG001|Overall Study|Adverse Event|0|||
13492787|NCT04634409|27060764|FG002|Overall Study|Adverse Event|1|||
13492788|NCT04634409|27060765|FG003|Overall Study|Adverse Event|0|||
13492789|NCT04634409|27060766|FG004|Overall Study|Adverse Event|0|||
13492790|NCT04634409|27060767|FG005|Overall Study|Adverse Event|1|||
13492791|NCT04634409|27060768|FG006|Overall Study|Adverse Event|0|||
13492792|NCT04634409|27060769|FG007|Overall Study|Adverse Event|0|||
13492793|NCT04634409|27060770|FG008|Overall Study|Adverse Event|0|||
13492794|NCT04634409|27060771|FG009|Overall Study|Adverse Event|0|||
13492795|NCT04634409|27060772|FG010|Overall Study|Adverse Event|0|||
13492796|NCT04634409|27060773|FG011|Overall Study|Adverse Event|0|||
13492797|NCT04634409|27060774|FG012|Overall Study|Adverse Event|0|||
13492798|NCT04634409|27060775|FG013|Overall Study|Adverse Event|0|||
13492799|NCT04634409|27060776|FG014|Overall Study|Adverse Event|0|||
13492800|NCT04634409|27060777|FG015|Overall Study|Adverse Event|0|||
13492801|NCT04634409|27060778|FG016|Overall Study|Adverse Event|0|||
13492802|NCT04634409|27060779|FG017|Overall Study|Adverse Event|0|||
13492803|NCT04634409|27060780|FG018|Overall Study|Adverse Event|0|||
13492804|NCT04634409|27060781|FG019|Overall Study|Adverse Event|0|||
13492805|NCT04634409|27060782|FG020|Overall Study|Adverse Event|0|||
13492806|NCT04634409|27060783|FG021|Overall Study|Adverse Event|0|||
13492807|NCT04634409|27060784|FG022|Overall Study|Adverse Event|0|||
13492808|NCT04634409|27060785|FG023|Overall Study|Adverse Event|0|||
13492809|NCT04634409|27060786|FG024|Overall Study|Adverse Event|0|||
13492810|NCT04634409|27060787|FG025|Overall Study|Adverse Event|0|||
13492811|NCT04634409|27060788|FG026|Overall Study|Adverse Event|0|||
13492812|NCT04634409|27060762|FG000|Overall Study|Lost to Follow-up|3|||
13492813|NCT04634409|27060763|FG001|Overall Study|Lost to Follow-up|1|||
13492814|NCT04634409|27060764|FG002|Overall Study|Lost to Follow-up|1|||
13492815|NCT04634409|27060765|FG003|Overall Study|Lost to Follow-up|3|||
13492816|NCT04634409|27060766|FG004|Overall Study|Lost to Follow-up|1|||
13492817|NCT04634409|27060767|FG005|Overall Study|Lost to Follow-up|1|||
13492818|NCT04634409|27060768|FG006|Overall Study|Lost to Follow-up|1|||
13492819|NCT04634409|27060769|FG007|Overall Study|Lost to Follow-up|3|||
13492820|NCT04634409|27060770|FG008|Overall Study|Lost to Follow-up|3|||
13492821|NCT04634409|27060771|FG009|Overall Study|Lost to Follow-up|11|||
13492822|NCT04634409|27060772|FG010|Overall Study|Lost to Follow-up|8|||
13492823|NCT04634409|27060773|FG011|Overall Study|Lost to Follow-up|15|||
13492824|NCT04634409|27060774|FG012|Overall Study|Lost to Follow-up|3|||
13492825|NCT04634409|27060775|FG013|Overall Study|Lost to Follow-up|2|||
13492826|NCT04634409|27060776|FG014|Overall Study|Lost to Follow-up|7|||
13492827|NCT04634409|27060777|FG015|Overall Study|Lost to Follow-up|0|||
13492828|NCT04634409|27060778|FG016|Overall Study|Lost to Follow-up|0|||
13492829|NCT04634409|27060779|FG017|Overall Study|Lost to Follow-up|0|||
13492830|NCT04634409|27060780|FG018|Overall Study|Lost to Follow-up|0|||
13492831|NCT04634409|27060781|FG019|Overall Study|Lost to Follow-up|0|||
13492832|NCT04634409|27060782|FG020|Overall Study|Lost to Follow-up|0|||
13492833|NCT04634409|27060783|FG021|Overall Study|Lost to Follow-up|0|||
13492834|NCT04634409|27060784|FG022|Overall Study|Lost to Follow-up|0|||
13492835|NCT04634409|27060785|FG023|Overall Study|Lost to Follow-up|0|||
13492836|NCT04634409|27060786|FG024|Overall Study|Lost to Follow-up|0|||
13492837|NCT04634409|27060787|FG025|Overall Study|Lost to Follow-up|0|||
13492838|NCT04634409|27060788|FG026|Overall Study|Lost to Follow-up|0|||
13492839|NCT04634409|27060762|FG000|Overall Study|Withdrawal by Subject|3|||
13492840|NCT04634409|27060763|FG001|Overall Study|Withdrawal by Subject|1|||
13492841|NCT04634409|27060764|FG002|Overall Study|Withdrawal by Subject|6|||
13492842|NCT04634409|27060765|FG003|Overall Study|Withdrawal by Subject|4|||
13492843|NCT04634409|27060766|FG004|Overall Study|Withdrawal by Subject|2|||
13492844|NCT04634409|27060767|FG005|Overall Study|Withdrawal by Subject|0|||
13492845|NCT04634409|27060768|FG006|Overall Study|Withdrawal by Subject|0|||
13492846|NCT04634409|27060769|FG007|Overall Study|Withdrawal by Subject|2|||
13492847|NCT04634409|27060770|FG008|Overall Study|Withdrawal by Subject|3|||
13492848|NCT04634409|27060771|FG009|Overall Study|Withdrawal by Subject|2|||
13492849|NCT04634409|27060772|FG010|Overall Study|Withdrawal by Subject|3|||
13492850|NCT04634409|27060773|FG011|Overall Study|Withdrawal by Subject|2|||
13492851|NCT04634409|27060774|FG012|Overall Study|Withdrawal by Subject|2|||
13492852|NCT04634409|27060775|FG013|Overall Study|Withdrawal by Subject|1|||
13492853|NCT04634409|27060776|FG014|Overall Study|Withdrawal by Subject|5|||
13492854|NCT04634409|27060777|FG015|Overall Study|Withdrawal by Subject|0|||
13492855|NCT04634409|27060778|FG016|Overall Study|Withdrawal by Subject|0|||
13492856|NCT04634409|27060779|FG017|Overall Study|Withdrawal by Subject|1|||
13492857|NCT04634409|27060780|FG018|Overall Study|Withdrawal by Subject|0|||
13492858|NCT04634409|27060781|FG019|Overall Study|Withdrawal by Subject|0|||
13492859|NCT04634409|27060782|FG020|Overall Study|Withdrawal by Subject|0|||
13492860|NCT04634409|27060783|FG021|Overall Study|Withdrawal by Subject|0|||
13492861|NCT04634409|27060784|FG022|Overall Study|Withdrawal by Subject|0|||
13492862|NCT04634409|27060785|FG023|Overall Study|Withdrawal by Subject|1|||
13492863|NCT04634409|27060786|FG024|Overall Study|Withdrawal by Subject|0|||
13492864|NCT04634409|27060787|FG025|Overall Study|Withdrawal by Subject|0|||
13492865|NCT04634409|27060788|FG026|Overall Study|Withdrawal by Subject|0|||
13492866|NCT04634409|27060762|FG000|Overall Study|Other - As reported by Investigator|1|||
13492867|NCT04634409|27060763|FG001|Overall Study|Other - As reported by Investigator|0|||
13492868|NCT04634409|27060764|FG002|Overall Study|Other - As reported by Investigator|0|||
13492869|NCT04634409|27060765|FG003|Overall Study|Other - As reported by Investigator|0|||
13492870|NCT04634409|27060766|FG004|Overall Study|Other - As reported by Investigator|0|||
13492871|NCT04634409|27060767|FG005|Overall Study|Other - As reported by Investigator|0|||
13492872|NCT04634409|27060768|FG006|Overall Study|Other - As reported by Investigator|0|||
13492873|NCT04634409|27060769|FG007|Overall Study|Other - As reported by Investigator|6|||
13492874|NCT04634409|27060770|FG008|Overall Study|Other - As reported by Investigator|4|||
13492875|NCT04634409|27060771|FG009|Overall Study|Other - As reported by Investigator|0|||
13492876|NCT04634409|27060772|FG010|Overall Study|Other - As reported by Investigator|1|||
13492877|NCT04634409|27060773|FG011|Overall Study|Other - As reported by Investigator|2|||
13492878|NCT04634409|27060774|FG012|Overall Study|Other - As reported by Investigator|2|||
13492879|NCT04634409|27060775|FG013|Overall Study|Other - As reported by Investigator|1|||
13492880|NCT04634409|27060776|FG014|Overall Study|Other - As reported by Investigator|0|||
13492881|NCT04634409|27060777|FG015|Overall Study|Other - As reported by Investigator|0|||
13492882|NCT04634409|27060778|FG016|Overall Study|Other - As reported by Investigator|0|||
13492883|NCT04634409|27060779|FG017|Overall Study|Other - As reported by Investigator|0|||
13492884|NCT04634409|27060780|FG018|Overall Study|Other - As reported by Investigator|0|||
13492885|NCT04634409|27060781|FG019|Overall Study|Other - As reported by Investigator|0|||
13492886|NCT04634409|27060782|FG020|Overall Study|Other - As reported by Investigator|0|||
13492887|NCT04634409|27060783|FG021|Overall Study|Other - As reported by Investigator|0|||
13492888|NCT04634409|27060784|FG022|Overall Study|Other - As reported by Investigator|0|||
13492889|NCT04634409|27060785|FG023|Overall Study|Other - As reported by Investigator|0|||
13492890|NCT04634409|27060786|FG024|Overall Study|Other - As reported by Investigator|0|||
13492891|NCT04634409|27060787|FG025|Overall Study|Other - As reported by Investigator|0|||
13492892|NCT04634409|27060788|FG026|Overall Study|Other - As reported by Investigator|0|||
13492893|NCT03502681|27060842|FG000|Overall Study|Adverse Event|1|||
13492894|NCT03502681|27060843|FG001|Overall Study|Adverse Event|1|||
13492895|NCT03502681|27060842|FG000|Overall Study|Disease Progression|2|||
13492896|NCT03502681|27060843|FG001|Overall Study|Disease Progression|1|||
13492897|NCT03405662|27060874|FG000|Overall Study|COVID-19 restriction|1|||
13492898|NCT03405662|27060875|FG001|Overall Study|COVID-19 restriction|0|||
13492899|NCT03405662|27060874|FG000|Overall Study|unblinding|0|||
13492900|NCT03405662|27060875|FG001|Overall Study|unblinding|1|||
13492901|NCT03405662|27060874|FG000|Overall Study|placement in memory care facility|0|||
13492902|NCT03405662|27060875|FG001|Overall Study|placement in memory care facility|2|||
13492903|NCT03334435|27060981|FG000|Overall Study|Ongoing as of Week 52|70|||
13492904|NCT03334435|27060982|FG001|Overall Study|Ongoing as of Week 52|32|||
13492905|NCT03334435|27060983|FG002|Overall Study|Ongoing as of Week 52|379|||
13492906|NCT03334435|27060984|FG003|Overall Study|Ongoing as of Week 52|519|||
13492907|NCT03334435|27060985|FG004|Overall Study|Ongoing as of Week 52|146|||
13492908|NCT03334435|27060981|FG000|Overall Study|Lack of Efficacy|3|||
13492909|NCT03334435|27060982|FG001|Overall Study|Lack of Efficacy|5|||
13492910|NCT03334435|27060983|FG002|Overall Study|Lack of Efficacy|76|||
13492911|NCT03334435|27060984|FG003|Overall Study|Lack of Efficacy|140|||
13492912|NCT03334435|27060985|FG004|Overall Study|Lack of Efficacy|61|||
13492913|NCT03334435|27060981|FG000|Overall Study|Adverse Event|2|||
13492914|NCT03334435|27060982|FG001|Overall Study|Adverse Event|1|||
13492915|NCT03334435|27060983|FG002|Overall Study|Adverse Event|9|||
13492916|NCT03334435|27060984|FG003|Overall Study|Adverse Event|23|||
13492917|NCT03334435|27060985|FG004|Overall Study|Adverse Event|13|||
13492918|NCT03334435|27060981|FG000|Overall Study|Withdrawal by Subject|11|||
13492919|NCT03334435|27060982|FG001|Overall Study|Withdrawal by Subject|4|||
13492920|NCT03334435|27060983|FG002|Overall Study|Withdrawal by Subject|38|||
13492921|NCT03334435|27060984|FG003|Overall Study|Withdrawal by Subject|42|||
13492922|NCT03334435|27060985|FG004|Overall Study|Withdrawal by Subject|20|||
13492923|NCT03334435|27060981|FG000|Overall Study|Lost to Follow-up|3|||
13492924|NCT03334435|27060982|FG001|Overall Study|Lost to Follow-up|0|||
13492925|NCT03334435|27060983|FG002|Overall Study|Lost to Follow-up|2|||
13492926|NCT03334435|27060984|FG003|Overall Study|Lost to Follow-up|1|||
13492927|NCT03334435|27060985|FG004|Overall Study|Lost to Follow-up|1|||
13492928|NCT03334435|27060981|FG000|Overall Study|Death|0|||
13492929|NCT03334435|27060982|FG001|Overall Study|Death|0|||
13492930|NCT03334435|27060983|FG002|Overall Study|Death|0|||
13492931|NCT03334435|27060984|FG003|Overall Study|Death|1|||
13492932|NCT03334435|27060985|FG004|Overall Study|Death|0|||
13492933|NCT03334435|27060981|FG000|Overall Study|Other|0|||
13492934|NCT03334435|27060982|FG001|Overall Study|Other|1|||
13492935|NCT03334435|27060983|FG002|Overall Study|Other|3|||
13492936|NCT03334435|27060984|FG003|Overall Study|Other|2|||
13492937|NCT03334435|27060985|FG004|Overall Study|Other|1|||
13492938|NCT03284424|27060997|FG000|Overall Study|Death|56|||
13492939|NCT03284424|27060998|FG001|Overall Study|Death|13|||
13492940|NCT03284424|27060997|FG000|Overall Study|Lost to Follow-up|1|||
13492941|NCT03284424|27060998|FG001|Overall Study|Lost to Follow-up|0|||
13492942|NCT03284424|27060997|FG000|Overall Study|Physician Decision|1|||
13492943|NCT03284424|27060998|FG001|Overall Study|Physician Decision|0|||
13492944|NCT03284424|27060997|FG000|Overall Study|Withdrawal by Subject|3|||
13492945|NCT03284424|27060998|FG001|Overall Study|Withdrawal by Subject|2|||
13492946|NCT03284424|27060997|FG000|Overall Study|Ongoing in study|44|||
13492947|NCT03284424|27060998|FG001|Overall Study|Ongoing in study|39|||
13492948|NCT02963766|27061071|FG000|Double-Blind Period|Adverse Event|1|||
13492949|NCT02963766|27061072|FG001|Double-Blind Period|Adverse Event|0|||
13492950|NCT02963766|27061073|FG002|Double-Blind Period|Adverse Event|1|||
13492951|NCT02963766|27061071|FG000|Double-Blind Period|Physician Decision|1|||
13492952|NCT02963766|27061072|FG001|Double-Blind Period|Physician Decision|0|||
13492953|NCT02963766|27061073|FG002|Double-Blind Period|Physician Decision|0|||
13492954|NCT02963766|27061071|FG000|Double-Blind Period|Withdrawal by Subject|1|||
13492955|NCT02963766|27061072|FG001|Double-Blind Period|Withdrawal by Subject|1|||
13492956|NCT02963766|27061073|FG002|Double-Blind Period|Withdrawal by Subject|0|||
13492957|NCT02963766|27061071|FG000|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
13492958|NCT02963766|27061072|FG001|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
13492959|NCT02963766|27061073|FG002|Double-Blind Period|Withdrawal by Parent or Guardian|1|||
13492960|NCT02963766|27061071|FG000|Double-Blind Period|Protocol Violation|1|||
13492961|NCT02963766|27061072|FG001|Double-Blind Period|Protocol Violation|0|||
13492962|NCT02963766|27061073|FG002|Double-Blind Period|Protocol Violation|0|||
13492963|NCT02963766|27061071|FG000|Double-Blind Period|Lost to Follow-up|0|||
13492964|NCT02963766|27061072|FG001|Double-Blind Period|Lost to Follow-up|1|||
13492965|NCT02963766|27061073|FG002|Double-Blind Period|Lost to Follow-up|0|||
13492966|NCT02963766|27061071|FG000|Open Label Extension (OLE)|Physician Decision|1|||
13492967|NCT02963766|27061072|FG001|Open Label Extension (OLE)|Physician Decision|2|||
13492968|NCT02963766|27061073|FG002|Open Label Extension (OLE)|Physician Decision|2|||
13492969|NCT02963766|27061071|FG000|Open Label Extension (OLE)|Withdrawal by Subject|1|||
13492970|NCT02963766|27061072|FG001|Open Label Extension (OLE)|Withdrawal by Subject|1|||
13492971|NCT02963766|27061073|FG002|Open Label Extension (OLE)|Withdrawal by Subject|0|||
13492972|NCT02795182|27061120|FG000|Overall Study|Death|5|||
13492973|NCT02795182|27061121|FG001|Overall Study|Death|4|||
13492974|NCT02795182|27061122|FG002|Overall Study|Death|4|||
13492975|NCT02795182|27061123|FG003|Overall Study|Death|18|||
13492976|NCT02795182|27061120|FG000|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
13492977|NCT02795182|27061121|FG001|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
13492978|NCT02795182|27061122|FG002|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
13492979|NCT02795182|27061123|FG003|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|1|||
13492980|NCT02795182|27061120|FG000|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
13492981|NCT02795182|27061121|FG001|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
13492982|NCT02795182|27061122|FG002|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
13492983|NCT02795182|27061123|FG003|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|2|||
13492984|NCT02795182|27061120|FG000|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|3|||
13492985|NCT02795182|27061121|FG001|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|2|||
13492986|NCT02795182|27061122|FG002|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|0|||
13492987|NCT02795182|27061123|FG003|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|8|||
13492988|NCT02795182|27061120|FG000|Overall Study|Withdrawal by Subject|4|||
13492989|NCT02795182|27061121|FG001|Overall Study|Withdrawal by Subject|0|||
13492990|NCT02795182|27061122|FG002|Overall Study|Withdrawal by Subject|0|||
13492991|NCT02795182|27061123|FG003|Overall Study|Withdrawal by Subject|3|||
13492992|NCT02795182|27061120|FG000|Overall Study|Lost to Follow-up|0|||
13492993|NCT02795182|27061121|FG001|Overall Study|Lost to Follow-up|0|||
13492994|NCT02795182|27061122|FG002|Overall Study|Lost to Follow-up|1|||
13492995|NCT02795182|27061123|FG003|Overall Study|Lost to Follow-up|1|||
13492996|NCT02795182|27061120|FG000|Overall Study|Roll Over to Long Term Extension|3|||
13492997|NCT02795182|27061121|FG001|Overall Study|Roll Over to Long Term Extension|3|||
13492998|NCT02795182|27061122|FG002|Overall Study|Roll Over to Long Term Extension|2|||
13492999|NCT02795182|27061123|FG003|Overall Study|Roll Over to Long Term Extension|5|||
13493000|NCT02795182|27061120|FG000|Overall Study|Progressive Disease|0|||
13493001|NCT02795182|27061121|FG001|Overall Study|Progressive Disease|1|||
13493002|NCT02795182|27061122|FG002|Overall Study|Progressive Disease|0|||
13493003|NCT02795182|27061123|FG003|Overall Study|Progressive Disease|4|||
13493004|NCT02795182|27061120|FG000|Overall Study|Physician Decision|0|||
13493005|NCT02795182|27061121|FG001|Overall Study|Physician Decision|0|||
13493006|NCT02795182|27061122|FG002|Overall Study|Physician Decision|0|||
13493007|NCT02795182|27061123|FG003|Overall Study|Physician Decision|1|||
13493008|NCT02674464|27061192|FG000|Overall Study|Death|10|||
13493009|NCT02674464|27061193|FG001|Overall Study|Death|21|||
13493010|NCT02674464|27061192|FG000|Overall Study|Withdrawal by Subject|24|||
13493011|NCT02674464|27061193|FG001|Overall Study|Withdrawal by Subject|44|||
13493012|NCT02674464|27061192|FG000|Overall Study|Lost to Follow-up|97|||
13493013|NCT02674464|27061193|FG001|Overall Study|Lost to Follow-up|92|||
13493014|NCT02674464|27061192|FG000|Overall Study|Outside survey window|6|||
13493015|NCT02674464|27061193|FG001|Overall Study|Outside survey window|3|||
13493016|NCT02318784|27061202|FG000|Overall Study|Adverse Event|13|||
13493017|NCT02318784|27061202|FG000|Overall Study|Death|2|||
13493018|NCT02318784|27061202|FG000|Overall Study|Progressive Disease|37|||
13493019|NCT02318784|27061202|FG000|Overall Study|Withdrawal by Subject|10|||
13493020|NCT02317991|27061212|FG000|Overall Study|Adverse Event|12|||
13493021|NCT02317991|27061212|FG000|Overall Study|Death|4|||
13493022|NCT02317991|27061212|FG000|Overall Study|Withdrawal by Subject|8|||
13493023|NCT02317991|27061212|FG000|Overall Study|Progressive Disease|41|||
13493024|NCT02260193|27061312|FG000|Overall Study|Lack of Efficacy|0|||
13493025|NCT02260193|27061313|FG001|Overall Study|Lack of Efficacy|1|||
13493026|NCT02260193|27061314|FG002|Overall Study|Lack of Efficacy|6|||
13493027|NCT02260193|27061312|FG000|Overall Study|Adverse Event|3|||
13493028|NCT02260193|27061313|FG001|Overall Study|Adverse Event|4|||
13493029|NCT02260193|27061314|FG002|Overall Study|Adverse Event|1|||
13493030|NCT02260193|27061312|FG000|Overall Study|Protocol Violation|0|||
13493031|NCT02260193|27061313|FG001|Overall Study|Protocol Violation|4|||
13493032|NCT02260193|27061314|FG002|Overall Study|Protocol Violation|0|||
13493033|NCT02260193|27061312|FG000|Overall Study|Withdrawal by Subject|3|||
13493034|NCT02260193|27061313|FG001|Overall Study|Withdrawal by Subject|0|||
13493035|NCT02260193|27061314|FG002|Overall Study|Withdrawal by Subject|2|||
13493036|NCT02260193|27061312|FG000|Overall Study|Kidney Transplantation|0|||
13493037|NCT02260193|27061313|FG001|Overall Study|Kidney Transplantation|0|||
13493038|NCT02260193|27061314|FG002|Overall Study|Kidney Transplantation|1|||
13493039|NCT01468922|27061384|FG000|Overall Study|Screening failure|0|||
13493040|NCT01468922|27061385|FG001|Overall Study|Screening failure|0|||
13493041|NCT01468922|27061386|FG002|Overall Study|Screening failure|0|||
13493042|NCT01468922|27061387|FG003|Overall Study|Screening failure|0|||
13493043|NCT01468922|27061388|FG004|Overall Study|Screening failure|0|||
13493044|NCT01468922|27061389|FG005|Overall Study|Screening failure|0|||
13493045|NCT01468922|27061390|FG006|Overall Study|Screening failure|0|||
13493046|NCT01468922|27061391|FG007|Overall Study|Screening failure|0|||
13493047|NCT01468922|27061392|FG008|Overall Study|Screening failure|1|||
13493048|NCT01468922|27061384|FG000|Overall Study|Per patient choice|1|||
13493049|NCT01468922|27061385|FG001|Overall Study|Per patient choice|0|||
13493050|NCT01468922|27061386|FG002|Overall Study|Per patient choice|0|||
13493051|NCT01468922|27061387|FG003|Overall Study|Per patient choice|0|||
13493052|NCT01468922|27061388|FG004|Overall Study|Per patient choice|0|||
13493053|NCT01468922|27061389|FG005|Overall Study|Per patient choice|0|||
13493054|NCT01468922|27061390|FG006|Overall Study|Per patient choice|0|||
13493055|NCT01468922|27061391|FG007|Overall Study|Per patient choice|0|||
13493056|NCT01468922|27061392|FG008|Overall Study|Per patient choice|0|||
13493057|NCT01468922|27061384|FG000|Overall Study|Switched to alternative treatment|1|||
13493058|NCT01468922|27061385|FG001|Overall Study|Switched to alternative treatment|0|||
13493059|NCT01468922|27061386|FG002|Overall Study|Switched to alternative treatment|0|||
13493060|NCT01468922|27061387|FG003|Overall Study|Switched to alternative treatment|0|||
13493061|NCT01468922|27061388|FG004|Overall Study|Switched to alternative treatment|1|||
13493062|NCT01468922|27061389|FG005|Overall Study|Switched to alternative treatment|0|||
13493063|NCT01468922|27061390|FG006|Overall Study|Switched to alternative treatment|0|||
13493064|NCT01468922|27061391|FG007|Overall Study|Switched to alternative treatment|0|||
13493065|NCT01468922|27061392|FG008|Overall Study|Switched to alternative treatment|0|||
13493066|NCT01468922|27061384|FG000|Overall Study|Enrolled on new protocol|0|||
13493067|NCT01468922|27061385|FG001|Overall Study|Enrolled on new protocol|0|||
13493068|NCT01468922|27061386|FG002|Overall Study|Enrolled on new protocol|0|||
13493069|NCT01468922|27061387|FG003|Overall Study|Enrolled on new protocol|0|||
13493070|NCT01468922|27061388|FG004|Overall Study|Enrolled on new protocol|1|||
13493071|NCT01468922|27061389|FG005|Overall Study|Enrolled on new protocol|0|||
13493072|NCT01468922|27061390|FG006|Overall Study|Enrolled on new protocol|0|||
13493073|NCT01468922|27061391|FG007|Overall Study|Enrolled on new protocol|0|||
13493074|NCT01468922|27061392|FG008|Overall Study|Enrolled on new protocol|0|||
13493075|NCT01468922|27061384|FG000|Overall Study|Adverse Event|0|||
13493076|NCT01468922|27061385|FG001|Overall Study|Adverse Event|0|||
13493077|NCT01468922|27061386|FG002|Overall Study|Adverse Event|0|||
13493078|NCT01468922|27061387|FG003|Overall Study|Adverse Event|0|||
13493079|NCT01468922|27061388|FG004|Overall Study|Adverse Event|0|||
13493080|NCT01468922|27061389|FG005|Overall Study|Adverse Event|0|||
13493081|NCT01468922|27061390|FG006|Overall Study|Adverse Event|0|||
13493082|NCT01468922|27061391|FG007|Overall Study|Adverse Event|1|||
13493083|NCT01468922|27061392|FG008|Overall Study|Adverse Event|0|||
13493084|NCT01468922|27061384|FG000|Overall Study|Infection of blood|0|||
13493085|NCT01468922|27061385|FG001|Overall Study|Infection of blood|0|||
13493086|NCT01468922|27061386|FG002|Overall Study|Infection of blood|0|||
13493087|NCT01468922|27061387|FG003|Overall Study|Infection of blood|0|||
13493088|NCT01468922|27061388|FG004|Overall Study|Infection of blood|0|||
13493089|NCT01468922|27061389|FG005|Overall Study|Infection of blood|0|||
13493090|NCT01468922|27061390|FG006|Overall Study|Infection of blood|0|||
13493091|NCT01468922|27061391|FG007|Overall Study|Infection of blood|1|||
13493092|NCT01468922|27061392|FG008|Overall Study|Infection of blood|0|||
13493093|NCT01468922|27061384|FG000|Overall Study|Patient choice - surgery|0|||
13493094|NCT01468922|27061385|FG001|Overall Study|Patient choice - surgery|0|||
13493095|NCT01468922|27061386|FG002|Overall Study|Patient choice - surgery|0|||
13493096|NCT01468922|27061387|FG003|Overall Study|Patient choice - surgery|0|||
13493097|NCT01468922|27061388|FG004|Overall Study|Patient choice - surgery|0|||
13493098|NCT01468922|27061389|FG005|Overall Study|Patient choice - surgery|0|||
13493099|NCT01468922|27061390|FG006|Overall Study|Patient choice - surgery|0|||
13493100|NCT01468922|27061391|FG007|Overall Study|Patient choice - surgery|1|||
13493101|NCT01468922|27061392|FG008|Overall Study|Patient choice - surgery|0|||
13493102|NCT01468922|27061384|FG000|Overall Study|Refused further treatment|0|||
13493103|NCT01468922|27061385|FG001|Overall Study|Refused further treatment|0|||
13493104|NCT01468922|27061386|FG002|Overall Study|Refused further treatment|0|||
13493105|NCT01468922|27061387|FG003|Overall Study|Refused further treatment|0|||
13493106|NCT01468922|27061388|FG004|Overall Study|Refused further treatment|0|||
13493107|NCT01468922|27061389|FG005|Overall Study|Refused further treatment|0|||
13493108|NCT01468922|27061390|FG006|Overall Study|Refused further treatment|0|||
13493109|NCT01468922|27061391|FG007|Overall Study|Refused further treatment|1|||
13493110|NCT01468922|27061392|FG008|Overall Study|Refused further treatment|0|||
13493111|NCT01381094|27061558|FG000|Overall Study|Adverse Event|1|||
13493112|NCT01381094|27061559|FG001|Overall Study|Adverse Event|2|||
13493113|NCT01381094|27061560|FG002|Overall Study|Adverse Event|0|||
13493114|NCT01381094|27061561|FG003|Overall Study|Adverse Event|1|||
13493115|NCT01381094|27061562|FG004|Overall Study|Adverse Event|0|||
13493116|NCT01381094|27061558|FG000|Overall Study|Lost to Follow-up|0|||
13493117|NCT01381094|27061559|FG001|Overall Study|Lost to Follow-up|0|||
13493118|NCT01381094|27061560|FG002|Overall Study|Lost to Follow-up|0|||
13493119|NCT01381094|27061561|FG003|Overall Study|Lost to Follow-up|0|||
13493120|NCT01381094|27061562|FG004|Overall Study|Lost to Follow-up|1|||
13493121|NCT01381094|27061558|FG000|Overall Study|Withdrawal of informed consent|0|||
13493122|NCT01381094|27061559|FG001|Overall Study|Withdrawal of informed consent|1|||
13493123|NCT01381094|27061560|FG002|Overall Study|Withdrawal of informed consent|0|||
13493124|NCT01381094|27061561|FG003|Overall Study|Withdrawal of informed consent|0|||
13493125|NCT01381094|27061562|FG004|Overall Study|Withdrawal of informed consent|0|||
13493126|NCT01381094|27061558|FG000|Overall Study|Participant given Aranesp injection|1|||
13493127|NCT01381094|27061559|FG001|Overall Study|Participant given Aranesp injection|0|||
13493128|NCT01381094|27061560|FG002|Overall Study|Participant given Aranesp injection|0|||
13493129|NCT01381094|27061561|FG003|Overall Study|Participant given Aranesp injection|0|||
13493130|NCT01381094|27061562|FG004|Overall Study|Participant given Aranesp injection|0|||
13493131|NCT00788671|27061603|FG000|Overall Study|Death|2|||
13493132|NCT00788671|27061603|FG000|Overall Study|Unable to biopsy|1|||
13493133|NCT00788671|27061603|FG000|Overall Study|Withdrawal by Subject|4|||
13493134|NCT00788671|27061603|FG000|Overall Study|IUD expulsed|1|||
13493135|NCT00788671|27061603|FG000|Overall Study|Lost to follow up|2|||
13493136|NCT03881059|27061765|FG000|Treatment Period - Part A|Adverse Event|1|||
13493137|NCT03881059|27061766|FG001|Treatment Period - Part A|Adverse Event|3|||
13493138|NCT03881059|27061767|FG002|Treatment Period - Part A|Adverse Event|4|||
13493139|NCT03881059|27061765|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0|||
13493140|NCT03881059|27061766|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
13493141|NCT03881059|27061767|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
13493142|NCT03881059|27061765|FG000|Treatment Period - Part A|Withdrawal by Subject|5|||
13493143|NCT03881059|27061766|FG001|Treatment Period - Part A|Withdrawal by Subject|2|||
13493144|NCT03881059|27061767|FG002|Treatment Period - Part A|Withdrawal by Subject|3|||
13493145|NCT03881059|27061765|FG000|Treatment Period - Part A|Other reasons|2|||
13493146|NCT03881059|27061766|FG001|Treatment Period - Part A|Other reasons|1|||
13493147|NCT03881059|27061767|FG002|Treatment Period - Part A|Other reasons|0|||
13493148|NCT03881059|27061765|FG000|Treatment Period - Part B|Adverse Event|0|||
13493149|NCT03881059|27061766|FG001|Treatment Period - Part B|Adverse Event|0|||
13493150|NCT03881059|27061767|FG002|Treatment Period - Part B|Adverse Event|3|||
13493151|NCT03881059|27061765|FG000|Treatment Period - Part B|Death|0|||
13493152|NCT03881059|27061766|FG001|Treatment Period - Part B|Death|1|||
13493153|NCT03881059|27061767|FG002|Treatment Period - Part B|Death|1|||
13493154|NCT03881059|27061765|FG000|Treatment Period - Part B|Lack of Efficacy|1|||
13493155|NCT03881059|27061766|FG001|Treatment Period - Part B|Lack of Efficacy|1|||
13493156|NCT03881059|27061767|FG002|Treatment Period - Part B|Lack of Efficacy|0|||
13493157|NCT03881059|27061765|FG000|Treatment Period - Part B|Lost to Follow-up|1|||
13493158|NCT03881059|27061766|FG001|Treatment Period - Part B|Lost to Follow-up|1|||
13493159|NCT03881059|27061767|FG002|Treatment Period - Part B|Lost to Follow-up|0|||
13493160|NCT03881059|27061765|FG000|Treatment Period - Part B|Site terminated by sponsor|1|||
13493161|NCT03881059|27061766|FG001|Treatment Period - Part B|Site terminated by sponsor|0|||
13493162|NCT03881059|27061767|FG002|Treatment Period - Part B|Site terminated by sponsor|3|||
13493163|NCT03881059|27061765|FG000|Treatment Period - Part B|Withdrawal by Subject|1|||
13493164|NCT03881059|27061766|FG001|Treatment Period - Part B|Withdrawal by Subject|0|||
13493165|NCT03881059|27061767|FG002|Treatment Period - Part B|Withdrawal by Subject|1|||
13493166|NCT03881059|27061765|FG000|Treatment Period - Part B|Other reasons|4|||
13493167|NCT03881059|27061766|FG001|Treatment Period - Part B|Other reasons|3|||
13493168|NCT03881059|27061767|FG002|Treatment Period - Part B|Other reasons|3|||
13493169|NCT03286426|27061785|FG000|Overall Study|Physician Decision|3|||
13493170|NCT02809677|27062344|FG000|Overall Study|Withdrawal by Subject|8|||
13493171|NCT02554253|27062371|FG000|Overall Study|ineligible after enrollment|1|||
13493172|NCT02554253|27062372|FG001|Overall Study|ineligible after enrollment|0|||
13493173|NCT02554253|27062371|FG000|Overall Study|converted to transcatheter procedure|0|||
13493174|NCT02554253|27062372|FG001|Overall Study|converted to transcatheter procedure|1|||
13493175|NCT02554253|27062371|FG000|Overall Study|received both drugs|0|||
13493176|NCT02554253|27062372|FG001|Overall Study|received both drugs|1|||
13493177|NCT01307046|27062420|FG000|Overall Study|Adverse Event|3|||
13493178|NCT01307046|27062421|FG001|Overall Study|Adverse Event|3|||
13493179|NCT01307046|27062420|FG000|Overall Study|Lack of Efficacy|0|||
13493180|NCT01307046|27062421|FG001|Overall Study|Lack of Efficacy|2|||
13493181|NCT01307046|27062420|FG000|Overall Study|Physician Decision|2|||
13493182|NCT01307046|27062421|FG001|Overall Study|Physician Decision|0|||
13493183|NCT01307046|27062420|FG000|Overall Study|Withdrawal by Subject|1|||
13493184|NCT01307046|27062421|FG001|Overall Study|Withdrawal by Subject|1|||
13493185|NCT01307046|27062420|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4|||
13493186|NCT01307046|27062421|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2|||
13493187|NCT01307046|27062420|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2|||
13493188|NCT01307046|27062421|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3|||
13493189|NCT01307033|27062442|FG000|8-week Double-blind Period|Adverse Event|2|||
13493190|NCT01307033|27062443|FG001|8-week Double-blind Period|Adverse Event|0|||
13493191|NCT01307033|27062444|FG002|8-week Double-blind Period|Adverse Event|0|||
13493192|NCT01307033|27062445|FG003|8-week Double-blind Period|Adverse Event|0|||
13493193|NCT01307033|27062442|FG000|8-week Double-blind Period|Withdrawal by Subject|4|||
13493194|NCT01307033|27062443|FG001|8-week Double-blind Period|Withdrawal by Subject|1|||
13493195|NCT01307033|27062444|FG002|8-week Double-blind Period|Withdrawal by Subject|0|||
13493196|NCT01307033|27062445|FG003|8-week Double-blind Period|Withdrawal by Subject|0|||
13493197|NCT01307033|27062442|FG000|8-week Double-blind Period|Lack of Efficacy|1|||
13493198|NCT01307033|27062443|FG001|8-week Double-blind Period|Lack of Efficacy|0|||
13493199|NCT01307033|27062444|FG002|8-week Double-blind Period|Lack of Efficacy|0|||
13493200|NCT01307033|27062445|FG003|8-week Double-blind Period|Lack of Efficacy|0|||
13493201|NCT01307033|27062442|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
13493202|NCT01307033|27062443|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3|||
13493203|NCT01307033|27062444|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
13493204|NCT01307033|27062445|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
13493205|NCT01307033|27062442|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6|||
13493206|NCT01307033|27062443|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3|||
13493207|NCT01307033|27062444|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
13493208|NCT01307033|27062445|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
13493209|NCT01307033|27062442|FG000|44-week Open-label Extension|Adverse Event|0|||
13493210|NCT01307033|27062443|FG001|44-week Open-label Extension|Adverse Event|0|||
13493211|NCT01307033|27062444|FG002|44-week Open-label Extension|Adverse Event|2|||
13493212|NCT01307033|27062445|FG003|44-week Open-label Extension|Adverse Event|1|||
13493213|NCT01307033|27062442|FG000|44-week Open-label Extension|Withdrawal by Subject|0|||
13493214|NCT01307033|27062443|FG001|44-week Open-label Extension|Withdrawal by Subject|0|||
13493215|NCT01307033|27062444|FG002|44-week Open-label Extension|Withdrawal by Subject|2|||
13493216|NCT01307033|27062445|FG003|44-week Open-label Extension|Withdrawal by Subject|1|||
13493217|NCT01307033|27062442|FG000|44-week Open-label Extension|Physician Decision|0|||
13493218|NCT01307033|27062443|FG001|44-week Open-label Extension|Physician Decision|0|||
13493219|NCT01307033|27062444|FG002|44-week Open-label Extension|Physician Decision|1|||
13493220|NCT01307033|27062445|FG003|44-week Open-label Extension|Physician Decision|0|||
13493221|NCT01307033|27062442|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
13493222|NCT01307033|27062443|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
13493223|NCT01307033|27062444|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
13493224|NCT01307033|27062445|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2|||
13493225|NCT01307033|27062442|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
13493226|NCT01307033|27062443|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
13493227|NCT01307033|27062444|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6|||
13493228|NCT01307033|27062445|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7|||
13493229|NCT01307033|27062442|FG000|44-week Open-label Extension|Death|0|||
13493230|NCT01307033|27062443|FG001|44-week Open-label Extension|Death|0|||
13493231|NCT01307033|27062444|FG002|44-week Open-label Extension|Death|0|||
13493232|NCT01307033|27062445|FG003|44-week Open-label Extension|Death|1|||
13493233|NCT00739674|27062478|FG000|Overall Study|Screening failures|19|||
13493234|NCT00739674|27062479|FG001|Overall Study|Screening failures|17|||
13493235|NCT00739674|27062478|FG000|Overall Study|Site 212 removal|19|||
13493236|NCT00739674|27062479|FG001|Overall Study|Site 212 removal|13|||
13493237|NCT00739674|27062478|FG000|Overall Study|No follow-up data|33|||
13493238|NCT00739674|27062479|FG001|Overall Study|No follow-up data|18|||
13493239|NCT00739674|27062478|FG000|Overall Study|Dietician consultation >30 days|1|||
13493240|NCT00739674|27062479|FG001|Overall Study|Dietician consultation >30 days|9|||
13493241|NCT00739674|27062478|FG000|Overall Study|Adverse Event|22|||
13493242|NCT00739674|27062479|FG001|Overall Study|Adverse Event|13|||
13493243|NCT00739674|27062478|FG000|Overall Study|Death|1|||
13493244|NCT00739674|27062479|FG001|Overall Study|Death|0|||
13493245|NCT00739674|27062478|FG000|Overall Study|Lack of Efficacy|1|||
13493246|NCT00739674|27062479|FG001|Overall Study|Lack of Efficacy|0|||
13493247|NCT00739674|27062478|FG000|Overall Study|Lost to Follow-up|52|||
13493248|NCT00739674|27062479|FG001|Overall Study|Lost to Follow-up|30|||
13493249|NCT00739674|27062478|FG000|Overall Study|Protocol Violation|5|||
13493250|NCT00739674|27062479|FG001|Overall Study|Protocol Violation|5|||
13493251|NCT00739674|27062478|FG000|Overall Study|Withdrawal by Subject|9|||
13493252|NCT00739674|27062479|FG001|Overall Study|Withdrawal by Subject|9|||
13493253|NCT00739674|27062478|FG000|Overall Study|Reason missing|2|||
13493254|NCT00739674|27062479|FG001|Overall Study|Reason missing|0|||
13493255|NCT00739674|27062478|FG000|Overall Study|Clinic closed|6|||
13493256|NCT00739674|27062479|FG001|Overall Study|Clinic closed|4|||
13493257|NCT00739674|27062478|FG000|Overall Study|Patient moved|3|||
13493258|NCT00739674|27062479|FG001|Overall Study|Patient moved|2|||
13493259|NCT00739674|27062478|FG000|Overall Study|Non compliant|4|||
13493260|NCT00739674|27062479|FG001|Overall Study|Non compliant|0|||
13493261|NCT00739674|27062478|FG000|Overall Study|Unable to attend visit|3|||
13493262|NCT00739674|27062479|FG001|Overall Study|Unable to attend visit|1|||
13493263|NCT00739674|27062478|FG000|Overall Study|Home monitoring off meds|1|||
13493264|NCT00739674|27062479|FG001|Overall Study|Home monitoring off meds|0|||
13493265|NCT00739674|27062478|FG000|Overall Study|Erectile dysfunction|0|||
13493266|NCT00739674|27062479|FG001|Overall Study|Erectile dysfunction|1|||
13493267|NCT00546754|27062516|FG000|Overall Study|Serious Adverse Event|1|||
13493268|NCT00546754|27062517|FG001|Overall Study|Serious Adverse Event|1|||
13493269|NCT00546754|27062516|FG000|Overall Study|Adverse Event|11|||
13493270|NCT00546754|27062517|FG001|Overall Study|Adverse Event|16|||
13493271|NCT00546754|27062516|FG000|Overall Study|Lack of Efficacy|1|||
13493272|NCT00546754|27062517|FG001|Overall Study|Lack of Efficacy|1|||
13493273|NCT00546754|27062516|FG000|Overall Study|Lost to Follow-up|9|||
13493274|NCT00546754|27062517|FG001|Overall Study|Lost to Follow-up|15|||
13493275|NCT00546754|27062516|FG000|Overall Study|Protocol Violation|3|||
13493276|NCT00546754|27062517|FG001|Overall Study|Protocol Violation|0|||
13493277|NCT00546754|27062516|FG000|Overall Study|Withdrawal by Subject|6|||
13493278|NCT00546754|27062517|FG001|Overall Study|Withdrawal by Subject|7|||
13493279|NCT00546754|27062516|FG000|Overall Study|Dyspnea|1|||
13493280|NCT00546754|27062517|FG001|Overall Study|Dyspnea|0|||
13493281|NCT00546754|27062516|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1|||
13493282|NCT00546754|27062517|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0|||
13493283|NCT00546754|27062516|FG000|Overall Study|Hip Replacement|1|||
13493284|NCT00546754|27062517|FG001|Overall Study|Hip Replacement|0|||
13493285|NCT00546754|27062516|FG000|Overall Study|Suicide|1|||
13493286|NCT00546754|27062517|FG001|Overall Study|Suicide|0|||
13493287|NCT00546754|27062516|FG000|Overall Study|Missing Cooperation|1|||
13493288|NCT00546754|27062517|FG001|Overall Study|Missing Cooperation|0|||
13493289|NCT00546754|27062516|FG000|Overall Study|Elevated Creatinine and Potassium levels|0|||
13493290|NCT00546754|27062517|FG001|Overall Study|Elevated Creatinine and Potassium levels|1|||
13493291|NCT00546754|27062516|FG000|Overall Study|Patient's Decision|0|||
13493292|NCT00546754|27062517|FG001|Overall Study|Patient's Decision|1|||
13493293|NCT00546754|27062516|FG000|Overall Study|Missing|14|||
13493294|NCT00546754|27062517|FG001|Overall Study|Missing|7|||
13493295|NCT00406783|27062536|FG000|Overall Study|Adverse Event|4|||
13493296|NCT00406783|27062537|FG001|Overall Study|Adverse Event|4|||
13493297|NCT00406783|27062536|FG000|Overall Study|Treatment Failure|2|||
13493298|NCT00406783|27062537|FG001|Overall Study|Treatment Failure|3|||
13493299|NCT00406783|27062536|FG000|Overall Study|Lost to Follow-up|3|||
13493300|NCT00406783|27062537|FG001|Overall Study|Lost to Follow-up|0|||
13493301|NCT00406783|27062536|FG000|Overall Study|Withdrawal by Subject|1|||
13493302|NCT00406783|27062537|FG001|Overall Study|Withdrawal by Subject|4|||
13493303|NCT00406783|27062536|FG000|Overall Study|Protocol Violation|4|||
13493304|NCT00406783|27062537|FG001|Overall Study|Protocol Violation|4|||
13493305|NCT00405964|27062554|FG000|Overall Study|Treatment Failure|17|||
13493306|NCT00405964|27062555|FG001|Overall Study|Treatment Failure|45|||
13493307|NCT00405964|27062554|FG000|Overall Study|Adverse Event|7|||
13493308|NCT00405964|27062555|FG001|Overall Study|Adverse Event|16|||
13493309|NCT00405964|27062554|FG000|Overall Study|Lost to Follow-up|5|||
13493310|NCT00405964|27062555|FG001|Overall Study|Lost to Follow-up|5|||
13493311|NCT00405964|27062554|FG000|Overall Study|Withdrawal by Subject|19|||
13493312|NCT00405964|27062555|FG001|Overall Study|Withdrawal by Subject|23|||
13493313|NCT00405964|27062554|FG000|Overall Study|Protocol Violation|11|||
13493314|NCT00405964|27062555|FG001|Overall Study|Protocol Violation|6|||
13493315|NCT00383721|27062608|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11|||
13493316|NCT00383721|27062609|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5|||
13493317|NCT00383721|27062610|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7|||
13493318|NCT00383721|27062611|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14|||
13493319|NCT00383721|27062612|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13|||
13493320|NCT00383721|27062608|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1|||
13493321|NCT00383721|27062609|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
13493322|NCT00383721|27062610|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
13493323|NCT00383721|27062611|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
13493324|NCT00383721|27062612|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
13493325|NCT00383721|27062608|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
13493326|NCT00383721|27062609|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
13493327|NCT00383721|27062610|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
13493328|NCT00383721|27062611|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
13493329|NCT00383721|27062612|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4|||
13493330|NCT00383721|27062608|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4|||
13493331|NCT00383721|27062609|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
13493332|NCT00383721|27062610|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15|||
13493333|NCT00383721|27062611|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
13493334|NCT00383721|27062612|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11|||
13493335|NCT00383721|27062608|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5|||
13493336|NCT00383721|27062609|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
13493337|NCT00383721|27062610|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6|||
13493338|NCT00383721|27062611|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8|||
13493339|NCT00383721|27062612|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9|||
13493340|NCT00383721|27062608|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7|||
13493341|NCT00383721|27062609|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
13493342|NCT00383721|27062610|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
13493343|NCT00383721|27062611|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
13493344|NCT00383721|27062612|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
13493345|NCT00383721|27062608|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
13493346|NCT00383721|27062609|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
13493347|NCT00383721|27062610|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11|||
13493348|NCT00383721|27062611|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4|||
13493349|NCT00383721|27062612|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13|||
13493350|NCT00383721|27062608|FG000|26-Week Double-Blind Treatment Period|Administrative|1|||
13493351|NCT00383721|27062609|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
13493352|NCT00383721|27062610|FG002|26-Week Double-Blind Treatment Period|Administrative|3|||
13493353|NCT00383721|27062611|FG003|26-Week Double-Blind Treatment Period|Administrative|3|||
13493354|NCT00383721|27062612|FG004|26-Week Double-Blind Treatment Period|Administrative|3|||
13493355|NCT00383721|27062608|FG000|26-Week Double-Blind Treatment Period|Ongoing|1|||
13493356|NCT00383721|27062609|FG001|26-Week Double-Blind Treatment Period|Ongoing|0|||
13493357|NCT00383721|27062610|FG002|26-Week Double-Blind Treatment Period|Ongoing|0|||
13493358|NCT00383721|27062611|FG003|26-Week Double-Blind Treatment Period|Ongoing|0|||
13493359|NCT00383721|27062612|FG004|26-Week Double-Blind Treatment Period|Ongoing|0|||
13493360|NCT00383721|27062608|FG000|26-Week Treatment Safety Extension|Adverse Event|6|||
13493361|NCT00383721|27062609|FG001|26-Week Treatment Safety Extension|Adverse Event|7|||
13493362|NCT00383721|27062610|FG002|26-Week Treatment Safety Extension|Adverse Event|10|||
13493363|NCT00383721|27062611|FG003|26-Week Treatment Safety Extension|Adverse Event|1|||
13493364|NCT00383721|27062612|FG004|26-Week Treatment Safety Extension|Adverse Event|0|||
13493365|NCT00383721|27062608|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
13493366|NCT00383721|27062609|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2|||
13493367|NCT00383721|27062610|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4|||
13493368|NCT00383721|27062611|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
13493369|NCT00383721|27062612|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
13493370|NCT00383721|27062608|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
13493371|NCT00383721|27062609|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
13493372|NCT00383721|27062610|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
13493373|NCT00383721|27062611|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
13493374|NCT00383721|27062612|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
13493375|NCT00383721|27062608|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
13493376|NCT00383721|27062609|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4|||
13493377|NCT00383721|27062610|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
13493378|NCT00383721|27062611|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7|||
13493379|NCT00383721|27062612|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
13493380|NCT00383721|27062608|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
13493381|NCT00383721|27062609|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
13493382|NCT00383721|27062610|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
13493383|NCT00383721|27062611|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
13493384|NCT00383721|27062612|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
13493385|NCT00383721|27062608|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2|||
13493386|NCT00383721|27062609|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
13493387|NCT00383721|27062610|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
13493388|NCT00383721|27062611|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
13493389|NCT00383721|27062612|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
13493390|NCT00383721|27062608|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
13493391|NCT00383721|27062609|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
13493392|NCT00383721|27062610|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
13493393|NCT00383721|27062611|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
13493394|NCT00383721|27062612|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
13493395|NCT00383721|27062608|FG000|26-Week Treatment Safety Extension|Administrative|1|||
13493396|NCT00383721|27062609|FG001|26-Week Treatment Safety Extension|Administrative|2|||
13493397|NCT00383721|27062610|FG002|26-Week Treatment Safety Extension|Administrative|3|||
13493398|NCT00383721|27062611|FG003|26-Week Treatment Safety Extension|Administrative|1|||
13493399|NCT00383721|27062612|FG004|26-Week Treatment Safety Extension|Administrative|0|||
13493400|NCT00383552|27062664|FG000|Overall Study|Adverse Event|7|||
13493401|NCT00383552|27062665|FG001|Overall Study|Adverse Event|6|||
13493402|NCT00383552|27062666|FG002|Overall Study|Adverse Event|9|||
13493403|NCT00383552|27062667|FG003|Overall Study|Adverse Event|6|||
13493404|NCT00383552|27062664|FG000|Overall Study|Lack of Efficacy|4|||
13493405|NCT00383552|27062665|FG001|Overall Study|Lack of Efficacy|13|||
13493406|NCT00383552|27062666|FG002|Overall Study|Lack of Efficacy|29|||
13493407|NCT00383552|27062667|FG003|Overall Study|Lack of Efficacy|42|||
13493408|NCT00383552|27062664|FG000|Overall Study|Lost to Follow-up|0|||
13493409|NCT00383552|27062665|FG001|Overall Study|Lost to Follow-up|1|||
13493410|NCT00383552|27062666|FG002|Overall Study|Lost to Follow-up|5|||
13493411|NCT00383552|27062667|FG003|Overall Study|Lost to Follow-up|1|||
13493412|NCT00383552|27062664|FG000|Overall Study|Did not wish to continue (unrelated)|4|||
13493413|NCT00383552|27062665|FG001|Overall Study|Did not wish to continue (unrelated)|9|||
13493414|NCT00383552|27062666|FG002|Overall Study|Did not wish to continue (unrelated)|5|||
13493415|NCT00383552|27062667|FG003|Overall Study|Did not wish to continue (unrelated)|6|||
13493416|NCT00383552|27062664|FG000|Overall Study|Did not wish to continue (related)|1|||
13493417|NCT00383552|27062665|FG001|Overall Study|Did not wish to continue (related)|0|||
13493418|NCT00383552|27062666|FG002|Overall Study|Did not wish to continue (related)|2|||
13493419|NCT00383552|27062667|FG003|Overall Study|Did not wish to continue (related)|3|||
13493420|NCT00383552|27062664|FG000|Overall Study|Noncompliance with the protocol|11|||
13493421|NCT00383552|27062665|FG001|Overall Study|Noncompliance with the protocol|6|||
13493422|NCT00383552|27062666|FG002|Overall Study|Noncompliance with the protocol|8|||
13493423|NCT00383552|27062667|FG003|Overall Study|Noncompliance with the protocol|10|||
13493424|NCT00383552|27062664|FG000|Overall Study|Did not meet protocol eligibility|8|||
13493425|NCT00383552|27062665|FG001|Overall Study|Did not meet protocol eligibility|6|||
13493426|NCT00383552|27062666|FG002|Overall Study|Did not meet protocol eligibility|2|||
13493427|NCT00383552|27062667|FG003|Overall Study|Did not meet protocol eligibility|3|||
13493428|NCT00383552|27062664|FG000|Overall Study|Administrative|1|||
13493429|NCT00383552|27062665|FG001|Overall Study|Administrative|0|||
13493430|NCT00383552|27062666|FG002|Overall Study|Administrative|1|||
13493431|NCT00383552|27062667|FG003|Overall Study|Administrative|1|||
13493432|NCT00383435|27062720|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10|||
13493433|NCT00383435|27062721|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2|||
13493434|NCT00383435|27062722|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8|||
13493435|NCT00383435|27062723|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6|||
13493436|NCT00383435|27062724|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8|||
13493437|NCT00383435|27062720|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
13493438|NCT00383435|27062721|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2|||
13493439|NCT00383435|27062722|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
13493440|NCT00383435|27062723|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5|||
13493441|NCT00383435|27062724|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
13493442|NCT00383435|27062720|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
13493443|NCT00383435|27062721|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
13493444|NCT00383435|27062722|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
13493445|NCT00383435|27062723|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
13493446|NCT00383435|27062724|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
13493447|NCT00383435|27062720|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7|||
13493448|NCT00383435|27062721|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
13493449|NCT00383435|27062722|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14|||
13493450|NCT00383435|27062723|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
13493451|NCT00383435|27062724|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17|||
13493452|NCT00383435|27062720|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2|||
13493453|NCT00383435|27062721|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
13493454|NCT00383435|27062722|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
13493455|NCT00383435|27062723|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
13493456|NCT00383435|27062724|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
13493457|NCT00383435|27062720|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1|||
13493458|NCT00383435|27062721|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
13493459|NCT00383435|27062722|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3|||
13493460|NCT00383435|27062723|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
13493461|NCT00383435|27062724|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
13493462|NCT00383435|27062720|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10|||
13493463|NCT00383435|27062721|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8|||
13493464|NCT00383435|27062722|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9|||
13493465|NCT00383435|27062723|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
13493466|NCT00383435|27062724|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
13493467|NCT00383435|27062720|FG000|26-Week Double-Blind Treatment Period|Administrative|5|||
13493468|NCT00383435|27062721|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
13493469|NCT00383435|27062722|FG002|26-Week Double-Blind Treatment Period|Administrative|1|||
13493470|NCT00383435|27062723|FG003|26-Week Double-Blind Treatment Period|Administrative|1|||
13493471|NCT00383435|27062724|FG004|26-Week Double-Blind Treatment Period|Administrative|1|||
13493472|NCT00383435|27062720|FG000|26-Week Treatment Safety Extension|Adverse Event|4|||
13493473|NCT00383435|27062721|FG001|26-Week Treatment Safety Extension|Adverse Event|2|||
13493474|NCT00383435|27062722|FG002|26-Week Treatment Safety Extension|Adverse Event|5|||
13493475|NCT00383435|27062723|FG003|26-Week Treatment Safety Extension|Adverse Event|5|||
13493476|NCT00383435|27062724|FG004|26-Week Treatment Safety Extension|Adverse Event|1|||
13493477|NCT00383435|27062720|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
13493478|NCT00383435|27062721|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
13493479|NCT00383435|27062722|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
13493480|NCT00383435|27062723|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
13493481|NCT00383435|27062724|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
13493482|NCT00383435|27062720|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
13493483|NCT00383435|27062721|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
13493484|NCT00383435|27062722|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
13493485|NCT00383435|27062723|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
13493486|NCT00383435|27062724|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
13493487|NCT00383435|27062720|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
13493488|NCT00383435|27062721|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
13493489|NCT00383435|27062722|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
13493490|NCT00383435|27062723|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
13493491|NCT00383435|27062724|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
13493492|NCT00383435|27062720|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
13493493|NCT00383435|27062721|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
13493494|NCT00383435|27062722|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2|||
13493495|NCT00383435|27062723|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
13493496|NCT00383435|27062724|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
13493497|NCT00383435|27062720|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
13493498|NCT00383435|27062721|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
13493499|NCT00383435|27062722|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
13493500|NCT00383435|27062723|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
13493501|NCT00383435|27062724|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
13493502|NCT00383435|27062720|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
13493503|NCT00383435|27062721|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
13493504|NCT00383435|27062722|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
13493505|NCT00383435|27062723|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
13493506|NCT00383435|27062724|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
13493507|NCT00383435|27062720|FG000|26-Week Treatment Safety Extension|Administrative|1|||
13493508|NCT00383435|27062721|FG001|26-Week Treatment Safety Extension|Administrative|1|||
13493509|NCT00383435|27062722|FG002|26-Week Treatment Safety Extension|Administrative|0|||
13493510|NCT00383435|27062723|FG003|26-Week Treatment Safety Extension|Administrative|1|||
13493511|NCT00383435|27062724|FG004|26-Week Treatment Safety Extension|Administrative|0|||
13493512|NCT00381485|27062753|FG000|Open-Label Run-In Period|Adverse Event|9|||
13493513|NCT00381485|27062754|FG001|Open-Label Run-In Period|Adverse Event|0|||
13493514|NCT00381485|27062755|FG002|Open-Label Run-In Period|Adverse Event|0|||
13493515|NCT00381485|27062756|FG003|Open-Label Run-In Period|Adverse Event|0|||
13493516|NCT00381485|27062753|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76|||
13493517|NCT00381485|27062754|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
13493518|NCT00381485|27062755|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
13493519|NCT00381485|27062756|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
13493520|NCT00381485|27062753|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16|||
13493521|NCT00381485|27062754|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
13493522|NCT00381485|27062755|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
13493523|NCT00381485|27062756|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
13493524|NCT00381485|27062753|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1|||
13493525|NCT00381485|27062754|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
13493526|NCT00381485|27062755|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
13493527|NCT00381485|27062756|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
13493528|NCT00381485|27062753|FG000|Open-Label Run-In Period|Lost to Follow-up|3|||
13493529|NCT00381485|27062754|FG001|Open-Label Run-In Period|Lost to Follow-up|0|||
13493530|NCT00381485|27062755|FG002|Open-Label Run-In Period|Lost to Follow-up|0|||
13493531|NCT00381485|27062756|FG003|Open-Label Run-In Period|Lost to Follow-up|0|||
13493532|NCT00381485|27062753|FG000|Open-Label Run-In Period|Treatment failure|1|||
13493533|NCT00381485|27062754|FG001|Open-Label Run-In Period|Treatment failure|0|||
13493534|NCT00381485|27062755|FG002|Open-Label Run-In Period|Treatment failure|0|||
13493535|NCT00381485|27062756|FG003|Open-Label Run-In Period|Treatment failure|0|||
13493536|NCT00381485|27062753|FG000|Double-Blind Treatment Period|Adverse Event|0|||
13493537|NCT00381485|27062754|FG001|Double-Blind Treatment Period|Adverse Event|2|||
13493538|NCT00381485|27062755|FG002|Double-Blind Treatment Period|Adverse Event|2|||
13493539|NCT00381485|27062756|FG003|Double-Blind Treatment Period|Adverse Event|5|||
13493540|NCT00381485|27062753|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
13493541|NCT00381485|27062754|FG001|Double-Blind Treatment Period|Lack of Efficacy|8|||
13493542|NCT00381485|27062755|FG002|Double-Blind Treatment Period|Lack of Efficacy|11|||
13493543|NCT00381485|27062756|FG003|Double-Blind Treatment Period|Lack of Efficacy|13|||
13493544|NCT00381485|27062753|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
13493545|NCT00381485|27062754|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
13493546|NCT00381485|27062755|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
13493547|NCT00381485|27062756|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
13493548|NCT00381485|27062753|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0|||
13493549|NCT00381485|27062754|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9|||
13493550|NCT00381485|27062755|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3|||
13493551|NCT00381485|27062756|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3|||
13493552|NCT00381485|27062753|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0|||
13493553|NCT00381485|27062754|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
13493554|NCT00381485|27062755|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7|||
13493555|NCT00381485|27062756|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
13493556|NCT00381485|27062753|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0|||
13493557|NCT00381485|27062754|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2|||
13493558|NCT00381485|27062755|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1|||
13493559|NCT00381485|27062756|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4|||
13493560|NCT00381485|27062753|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
13493561|NCT00381485|27062754|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
13493562|NCT00381485|27062755|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
13493563|NCT00381485|27062756|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1|||
13493564|NCT00381485|27062753|FG000|Double-Blind Treatment Period|Administrative|0|||
13493565|NCT00381485|27062754|FG001|Double-Blind Treatment Period|Administrative|1|||
13493566|NCT00381485|27062755|FG002|Double-Blind Treatment Period|Administrative|0|||
13493567|NCT00381485|27062756|FG003|Double-Blind Treatment Period|Administrative|1|||
13493568|NCT00379288|27062779|FG000|Overall Study|Adverse Event|5|||
13493569|NCT00379288|27062780|FG001|Overall Study|Adverse Event|6|||
13493570|NCT00379288|27062781|FG002|Overall Study|Adverse Event|2|||
13493571|NCT00379288|27062782|FG003|Overall Study|Adverse Event|0|||
13493572|NCT00379288|27062779|FG000|Overall Study|Treatment Failure|0|||
13493573|NCT00379288|27062780|FG001|Overall Study|Treatment Failure|1|||
13493574|NCT00379288|27062781|FG002|Overall Study|Treatment Failure|0|||
13493575|NCT00379288|27062782|FG003|Overall Study|Treatment Failure|1|||
13493576|NCT00379288|27062779|FG000|Overall Study|Lost to Follow-up|3|||
13493577|NCT00379288|27062780|FG001|Overall Study|Lost to Follow-up|3|||
13493578|NCT00379288|27062781|FG002|Overall Study|Lost to Follow-up|2|||
13493579|NCT00379288|27062782|FG003|Overall Study|Lost to Follow-up|0|||
13493580|NCT00379288|27062779|FG000|Overall Study|Subject withdrew-unrelated to study drug|0|||
13493581|NCT00379288|27062780|FG001|Overall Study|Subject withdrew-unrelated to study drug|3|||
13493582|NCT00379288|27062781|FG002|Overall Study|Subject withdrew-unrelated to study drug|4|||
13493583|NCT00379288|27062782|FG003|Overall Study|Subject withdrew-unrelated to study drug|2|||
13493584|NCT00379288|27062779|FG000|Overall Study|Subject withdrew-related to study drug|1|||
13493585|NCT00379288|27062780|FG001|Overall Study|Subject withdrew-related to study drug|0|||
13493586|NCT00379288|27062781|FG002|Overall Study|Subject withdrew-related to study drug|0|||
13493587|NCT00379288|27062782|FG003|Overall Study|Subject withdrew-related to study drug|1|||
13493588|NCT00379288|27062779|FG000|Overall Study|Noncompliance with protocol|8|||
13493589|NCT00379288|27062780|FG001|Overall Study|Noncompliance with protocol|6|||
13493590|NCT00379288|27062781|FG002|Overall Study|Noncompliance with protocol|2|||
13493591|NCT00379288|27062782|FG003|Overall Study|Noncompliance with protocol|1|||
13493592|NCT00379288|27062779|FG000|Overall Study|Did not meet protocol eligibility|0|||
13493593|NCT00379288|27062780|FG001|Overall Study|Did not meet protocol eligibility|1|||
13493594|NCT00379288|27062781|FG002|Overall Study|Did not meet protocol eligibility|0|||
13493595|NCT00379288|27062782|FG003|Overall Study|Did not meet protocol eligibility|2|||
13493596|NCT00379288|27062779|FG000|Overall Study|Administrative|2|||
13493597|NCT00379288|27062780|FG001|Overall Study|Administrative|2|||
13493598|NCT00379288|27062781|FG002|Overall Study|Administrative|0|||
13493599|NCT00379288|27062782|FG003|Overall Study|Administrative|1|||
13493600|NCT00378378|27062803|FG000|Overall Study|Withdrawal by Subject|0|||
13493601|NCT00378378|27062804|FG001|Overall Study|Withdrawal by Subject|1|||
13493602|NCT00378378|27062805|FG002|Overall Study|Withdrawal by Subject|0|||
13493603|NCT00378378|27062803|FG000|Overall Study|Treatment Failure|0|||
13493604|NCT00378378|27062804|FG001|Overall Study|Treatment Failure|0|||
13493605|NCT00378378|27062805|FG002|Overall Study|Treatment Failure|1|||
13493606|NCT00378378|27062803|FG000|Overall Study|Non-compliance with protocol|0|||
13493607|NCT00378378|27062804|FG001|Overall Study|Non-compliance with protocol|0|||
13493608|NCT00378378|27062805|FG002|Overall Study|Non-compliance with protocol|1|||
13493609|NCT00089895|27062820|FG000|Overall Study|Consent Withdrawn|11|||
13493610|NCT00089895|27062821|FG001|Overall Study|Consent Withdrawn|14|||
13493611|NCT00089895|27062820|FG000|Overall Study|Technical reason|7|||
13493612|NCT00089895|27062821|FG001|Overall Study|Technical reason|2|||
13493613|NCT00089895|27062820|FG000|Overall Study|Surgery|0|||
13493614|NCT00089895|27062821|FG001|Overall Study|Surgery|1|||
13493615|NCT00089895|27062820|FG000|Overall Study|Bleeding|0|||
13493616|NCT00089895|27062821|FG001|Overall Study|Bleeding|2|||
13493617|NCT00089895|27062820|FG000|Overall Study|Physician Decision|3|||
13493618|NCT00089895|27062821|FG001|Overall Study|Physician Decision|7|||
13493619|NCT00089895|27062820|FG000|Overall Study|Exclusion criteria met|6|||
13493620|NCT00089895|27062821|FG001|Overall Study|Exclusion criteria met|6|||
13493621|NCT00089895|27062820|FG000|Overall Study|Not otherwise specified|4|||
13493622|NCT00089895|27062821|FG001|Overall Study|Not otherwise specified|8|||
13493623|NCT00089895|27062820|FG000|Overall Study|Missing|4|||
13493624|NCT00089895|27062821|FG001|Overall Study|Missing|2|||
13493625|NCT02577354|27062886|FG000|Overall Study|Lack of Efficacy|4|||
13493626|NCT02577354|27062887|FG001|Overall Study|Lack of Efficacy|4|||
13493627|NCT02577354|27062886|FG000|Overall Study|Lost to Follow-up|3|||
13493628|NCT02577354|27062887|FG001|Overall Study|Lost to Follow-up|1|||
13493629|NCT02577354|27062886|FG000|Overall Study|Missed Visit|4|||
13493630|NCT02577354|27062887|FG001|Overall Study|Missed Visit|3|||
13493631|NCT02577354|27062886|FG000|Overall Study|Adverse Event|4|||
13493632|NCT02577354|27062887|FG001|Overall Study|Adverse Event|5|||
13493633|NCT02471807|27062896|FG000|Overall Study|Death|14|||
13493634|NCT02471807|27062896|FG000|Overall Study|Withdrawal by Subject|1|||
13493635|NCT02471807|27062896|FG000|Overall Study|Explant|5|||
13493636|NCT02471807|27062896|FG000|Overall Study|Visits not yet due|2|||
13493637|NCT02471807|27062896|FG000|Overall Study|Missed Visit|1|||
13208358|NCT01939158|26241439|FG000|Overall Study|Death|0|||
13493638|NCT01444092|27062938|FG000|Overall Study|Adverse Event|8|||
13493639|NCT01444092|27062938|FG000|Overall Study|Protocol Violation|1|||
13493640|NCT01444092|27062938|FG000|Overall Study|Withdrawal by Subject|1|||
13493641|NCT01444092|27062938|FG000|Overall Study|Other Eligibility criteria|7|||
13493642|NCT01265784|27063014|FG000|Overall Study|Lost to Follow-up|5|||
13493643|NCT01265784|27063015|FG001|Overall Study|Lost to Follow-up|3|||
13493644|NCT01265784|27063016|FG002|Overall Study|Lost to Follow-up|2|||
13493645|NCT01265784|27063014|FG000|Overall Study|Withdrawal by Subject|0|||
13493646|NCT01265784|27063015|FG001|Overall Study|Withdrawal by Subject|5|||
13493647|NCT01265784|27063016|FG002|Overall Study|Withdrawal by Subject|0|||
13493648|NCT01265784|27063014|FG000|Overall Study|Physician Decision|1|||
13493649|NCT01265784|27063015|FG001|Overall Study|Physician Decision|0|||
13493650|NCT01265784|27063016|FG002|Overall Study|Physician Decision|1|||
13493651|NCT01265784|27063014|FG000|Overall Study|Adverse Event|1|||
13493652|NCT01265784|27063015|FG001|Overall Study|Adverse Event|0|||
13493653|NCT01265784|27063016|FG002|Overall Study|Adverse Event|0|||
13493654|NCT01265784|27063014|FG000|Overall Study|Death|3|||
13493655|NCT01265784|27063015|FG001|Overall Study|Death|0|||
13493656|NCT01265784|27063016|FG002|Overall Study|Death|0|||
13493657|NCT01265784|27063014|FG000|Overall Study|Protocol Violation|2|||
13493658|NCT01265784|27063015|FG001|Overall Study|Protocol Violation|0|||
13493659|NCT01265784|27063016|FG002|Overall Study|Protocol Violation|0|||
13493660|NCT01265784|27063014|FG000|Overall Study|Incorrectly Randomized|0|||
13493661|NCT01265784|27063015|FG001|Overall Study|Incorrectly Randomized|0|||
13493662|NCT01265784|27063016|FG002|Overall Study|Incorrectly Randomized|1|||
13493663|NCT00577577|27063091|FG000|Overall Study|Adverse Event|3|||
13493664|NCT00577577|27063092|FG001|Overall Study|Adverse Event|2|||
13493665|NCT00577577|27063091|FG000|Overall Study|Lost to Follow-up|1|||
13493666|NCT00577577|27063092|FG001|Overall Study|Lost to Follow-up|0|||
13493667|NCT00577577|27063091|FG000|Overall Study|Protocol Violation|0|||
13493668|NCT00577577|27063092|FG001|Overall Study|Protocol Violation|3|||
13493669|NCT00577577|27063091|FG000|Overall Study|Transportation|1|||
13493670|NCT00577577|27063092|FG001|Overall Study|Transportation|0|||
13493671|NCT00392327|27063183|FG000|Overall Study|Death|1|||
13493672|NCT00392327|27063184|FG001|Overall Study|Death|0|||
13493673|NCT00392327|27063185|FG002|Overall Study|Death|1|||
13493674|NCT00392327|27063186|FG003|Overall Study|Death|0|||
13493675|NCT00392327|27063187|FG004|Overall Study|Death|0|||
13493676|NCT00392327|27063188|FG005|Overall Study|Death|0|||
13493677|NCT00392327|27063189|FG006|Overall Study|Death|0|||
13493678|NCT00392327|27063190|FG007|Overall Study|Death|0|||
13493679|NCT00392327|27063183|FG000|Overall Study|Lack of Efficacy|8|||
13493680|NCT00392327|27063184|FG001|Overall Study|Lack of Efficacy|8|||
13493681|NCT00392327|27063185|FG002|Overall Study|Lack of Efficacy|9|||
13493682|NCT00392327|27063186|FG003|Overall Study|Lack of Efficacy|6|||
13493683|NCT00392327|27063187|FG004|Overall Study|Lack of Efficacy|3|||
13493684|NCT00392327|27063188|FG005|Overall Study|Lack of Efficacy|3|||
13493685|NCT00392327|27063189|FG006|Overall Study|Lack of Efficacy|3|||
13493686|NCT00392327|27063190|FG007|Overall Study|Lack of Efficacy|3|||
13493687|NCT00392327|27063183|FG000|Overall Study|Physician Decision|3|||
13493688|NCT00392327|27063184|FG001|Overall Study|Physician Decision|5|||
13493689|NCT00392327|27063185|FG002|Overall Study|Physician Decision|2|||
13493690|NCT00392327|27063186|FG003|Overall Study|Physician Decision|2|||
13493691|NCT00392327|27063187|FG004|Overall Study|Physician Decision|0|||
13493692|NCT00392327|27063188|FG005|Overall Study|Physician Decision|1|||
13493693|NCT00392327|27063189|FG006|Overall Study|Physician Decision|5|||
13493694|NCT00392327|27063190|FG007|Overall Study|Physician Decision|3|||
13493695|NCT00392327|27063183|FG000|Overall Study|Protocol Violation|0|||
13493696|NCT00392327|27063184|FG001|Overall Study|Protocol Violation|0|||
13493697|NCT00392327|27063185|FG002|Overall Study|Protocol Violation|1|||
13493698|NCT00392327|27063186|FG003|Overall Study|Protocol Violation|0|||
13493699|NCT00392327|27063187|FG004|Overall Study|Protocol Violation|0|||
13493700|NCT00392327|27063188|FG005|Overall Study|Protocol Violation|0|||
13493701|NCT00392327|27063189|FG006|Overall Study|Protocol Violation|0|||
13493702|NCT00392327|27063190|FG007|Overall Study|Protocol Violation|0|||
13493703|NCT00392327|27063183|FG000|Overall Study|Withdrawal by Subject|3|||
13493704|NCT00392327|27063184|FG001|Overall Study|Withdrawal by Subject|2|||
13493705|NCT00392327|27063185|FG002|Overall Study|Withdrawal by Subject|4|||
13493706|NCT00392327|27063186|FG003|Overall Study|Withdrawal by Subject|6|||
13493707|NCT00392327|27063187|FG004|Overall Study|Withdrawal by Subject|0|||
13493708|NCT00392327|27063188|FG005|Overall Study|Withdrawal by Subject|1|||
13493709|NCT00392327|27063189|FG006|Overall Study|Withdrawal by Subject|1|||
13493710|NCT00392327|27063190|FG007|Overall Study|Withdrawal by Subject|5|||
13493711|NCT00392327|27063183|FG000|Overall Study|Ineligible|0|||
13493712|NCT00392327|27063184|FG001|Overall Study|Ineligible|4|||
13493713|NCT00392327|27063185|FG002|Overall Study|Ineligible|3|||
13493714|NCT00392327|27063186|FG003|Overall Study|Ineligible|2|||
13493715|NCT00392327|27063187|FG004|Overall Study|Ineligible|0|||
13493716|NCT00392327|27063188|FG005|Overall Study|Ineligible|0|||
13493717|NCT00392327|27063189|FG006|Overall Study|Ineligible|0|||
13493718|NCT00392327|27063190|FG007|Overall Study|Ineligible|0|||
13493719|NCT04386616|27063416|FG000|Overall Study|Death|22|||
13493720|NCT04386616|27063417|FG001|Overall Study|Death|22|||
13493721|NCT04386616|27063418|FG002|Overall Study|Death|21|||
13493722|NCT04386616|27063416|FG000|Overall Study|Lost to Follow-up|5|||
13493723|NCT04386616|27063417|FG001|Overall Study|Lost to Follow-up|8|||
13493724|NCT04386616|27063418|FG002|Overall Study|Lost to Follow-up|6|||
13493725|NCT04386616|27063416|FG000|Overall Study|Withdrawal by Subject|2|||
13493726|NCT04386616|27063417|FG001|Overall Study|Withdrawal by Subject|4|||
13493727|NCT04386616|27063418|FG002|Overall Study|Withdrawal by Subject|1|||
13493728|NCT04386616|27063416|FG000|Overall Study|Adverse Event|1|||
13493729|NCT04386616|27063417|FG001|Overall Study|Adverse Event|1|||
13493730|NCT04386616|27063418|FG002|Overall Study|Adverse Event|0|||
13493731|NCT04296942|27063479|FG000|Overall Study|Study closure by sponsor|1|||
13493732|NCT04296942|27063480|FG001|Overall Study|Study closure by sponsor|0|||
13493733|NCT04296942|27063481|FG002|Overall Study|Study closure by sponsor|0|||
13493734|NCT04213807|27063510|FG000|Overall Study|Physician Decision|0|||
13493735|NCT04213807|27063511|FG001|Overall Study|Physician Decision|0|||
13493736|NCT04213807|27063512|FG002|Overall Study|Physician Decision|1|||
13493737|NCT03721107|27063683|FG000|Overall Study|Adverse Event|1|||
13493738|NCT03721107|27063684|FG001|Overall Study|Adverse Event|1|||
13493739|NCT03721107|27063685|FG002|Overall Study|Adverse Event|6|||
13493740|NCT03721107|27063686|FG003|Overall Study|Adverse Event|5|||
13493741|NCT03721107|27063683|FG000|Overall Study|Lost to Follow-up|2|||
13493742|NCT03721107|27063684|FG001|Overall Study|Lost to Follow-up|0|||
13493743|NCT03721107|27063685|FG002|Overall Study|Lost to Follow-up|3|||
13493744|NCT03721107|27063686|FG003|Overall Study|Lost to Follow-up|0|||
13493745|NCT03721107|27063683|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
13493746|NCT03721107|27063684|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
13493747|NCT03721107|27063685|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
13493748|NCT03721107|27063686|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1|||
13493749|NCT03721107|27063683|FG000|Overall Study|Physician Decision|0|||
13493750|NCT03721107|27063684|FG001|Overall Study|Physician Decision|1|||
13493751|NCT03721107|27063685|FG002|Overall Study|Physician Decision|0|||
13493752|NCT03721107|27063686|FG003|Overall Study|Physician Decision|0|||
13493753|NCT03721107|27063683|FG000|Overall Study|Pregnancy|0|||
13493754|NCT03721107|27063684|FG001|Overall Study|Pregnancy|0|||
13493755|NCT03721107|27063685|FG002|Overall Study|Pregnancy|1|||
13493756|NCT03721107|27063686|FG003|Overall Study|Pregnancy|0|||
13493757|NCT03721107|27063683|FG000|Overall Study|Withdrawal by Subject|1|||
13493758|NCT03721107|27063684|FG001|Overall Study|Withdrawal by Subject|1|||
13493759|NCT03721107|27063685|FG002|Overall Study|Withdrawal by Subject|5|||
13493760|NCT03721107|27063686|FG003|Overall Study|Withdrawal by Subject|5|||
13493761|NCT03721107|27063683|FG000|Overall Study|Other|1|||
13493762|NCT03721107|27063684|FG001|Overall Study|Other|0|||
13493763|NCT03721107|27063685|FG002|Overall Study|Other|0|||
13493764|NCT03721107|27063686|FG003|Overall Study|Other|1|||
13493765|NCT03644849|27063755|FG000|Overall Study|Lost to Follow-up|1|||
13493766|NCT03644849|27063756|FG001|Overall Study|Lost to Follow-up|3|||
13493767|NCT03604159|27063783|FG000|Overall Study|Lost to Follow-up|6|||
13493768|NCT03604159|27063784|FG001|Overall Study|Lost to Follow-up|7|||
13493769|NCT03602885|27063811|FG000|Overall Study|Lost to Follow-up|3|||
13493770|NCT03602885|27063812|FG001|Overall Study|Lost to Follow-up|0|||
13493771|NCT03539601|27063951|FG000|Overall Study|Withdraw by parent/guardian|1|||
13493772|NCT03539601|27063952|FG001|Overall Study|Withdraw by parent/guardian|0|||
13493773|NCT03539601|27063953|FG002|Overall Study|Withdraw by parent/guardian|1|||
13493774|NCT03539601|27063954|FG003|Overall Study|Withdraw by parent/guardian|0|||
13493775|NCT03539601|27063951|FG000|Overall Study|Adverse Event|0|||
13493776|NCT03539601|27063952|FG001|Overall Study|Adverse Event|2|||
13493777|NCT03539601|27063953|FG002|Overall Study|Adverse Event|0|||
13493778|NCT03539601|27063954|FG003|Overall Study|Adverse Event|0|||
13493779|NCT03539601|27063951|FG000|Overall Study|Lost to Follow-up|2|||
13493780|NCT03539601|27063952|FG001|Overall Study|Lost to Follow-up|4|||
13493781|NCT03539601|27063953|FG002|Overall Study|Lost to Follow-up|5|||
13493782|NCT03539601|27063954|FG003|Overall Study|Lost to Follow-up|0|||
13493783|NCT03539601|27063951|FG000|Overall Study|Withdrawal by Subject|2|||
13493784|NCT03539601|27063952|FG001|Overall Study|Withdrawal by Subject|0|||
13493785|NCT03539601|27063953|FG002|Overall Study|Withdrawal by Subject|0|||
13493786|NCT03539601|27063954|FG003|Overall Study|Withdrawal by Subject|1|||
13493787|NCT03539601|27063951|FG000|Overall Study|Randomized but not treated|1|||
13493788|NCT03539601|27063952|FG001|Overall Study|Randomized but not treated|1|||
13493789|NCT03539601|27063953|FG002|Overall Study|Randomized but not treated|0|||
13493790|NCT03539601|27063954|FG003|Overall Study|Randomized but not treated|0|||
13493791|NCT03539458|27063960|FG000|Overall Study|Death|1|||
13493792|NCT03439657|27064016|FG000|Overall Study|Adverse Event|2|||
13493793|NCT03439657|27064017|FG001|Overall Study|Adverse Event|3|||
13493794|NCT03439657|27064016|FG000|Overall Study|Lost to Follow-up|1|||
13493795|NCT03439657|27064017|FG001|Overall Study|Lost to Follow-up|0|||
13493796|NCT03439657|27064016|FG000|Overall Study|Protocol Violation|1|||
13493797|NCT03439657|27064017|FG001|Overall Study|Protocol Violation|1|||
13493798|NCT03439657|27064016|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3|||
13493799|NCT03439657|27064017|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0|||
13493800|NCT03377790|27064048|FG000|Overall Study|Withdrawal by Subject|1|||
13493801|NCT03377790|27064049|FG001|Overall Study|Withdrawal by Subject|0|||
13493802|NCT03377790|27064048|FG000|Overall Study|Adverse Event|1|||
13493803|NCT03377790|27064049|FG001|Overall Study|Adverse Event|0|||
13493804|NCT03377790|27064048|FG000|Overall Study|Lost to Follow-up|0|||
13493805|NCT03377790|27064049|FG001|Overall Study|Lost to Follow-up|2|||
13493806|NCT03377790|27064048|FG000|Overall Study|Randomized but not treated|1|||
13493807|NCT03377790|27064049|FG001|Overall Study|Randomized but not treated|0|||
13493808|NCT03377790|27064048|FG000|Overall Study|Withdrawn by Parent/Guardian|7|||
13493809|NCT03377790|27064049|FG001|Overall Study|Withdrawn by Parent/Guardian|4|||
13493810|NCT03353675|27064060|FG000|Overall Study|Adverse Event|4|||
13493811|NCT03294109|27064083|FG000|Overall Study|Withdrawal by Subject|6|||
13493812|NCT03294109|27064084|FG001|Overall Study|Withdrawal by Subject|5|||
13493813|NCT03268005|27064199|FG000|Overall Study|Death|2|||
13493814|NCT03268005|27064200|FG001|Overall Study|Death|1|||
13493815|NCT03268005|27064199|FG000|Overall Study|Lost to Follow-up|2|||
13493816|NCT03268005|27064200|FG001|Overall Study|Lost to Follow-up|2|||
13493817|NCT03268005|27064199|FG000|Overall Study|Withdrawal by Subject|11|||
13493818|NCT03268005|27064200|FG001|Overall Study|Withdrawal by Subject|11|||
13493819|NCT03225170|27064250|FG000|Overall Study|Lost to Follow-up|4|||
13493820|NCT03225170|27064251|FG001|Overall Study|Lost to Follow-up|4|||
13493821|NCT03225170|27064252|FG002|Overall Study|Lost to Follow-up|0|||
13493822|NCT03225170|27064250|FG000|Overall Study|Did not complete intervention/control writing exercise|0|||
13493823|NCT03225170|27064251|FG001|Overall Study|Did not complete intervention/control writing exercise|1|||
13493824|NCT03225170|27064252|FG002|Overall Study|Did not complete intervention/control writing exercise|0|||
13493825|NCT03168438|27064329|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0|||
13493826|NCT03168438|27064330|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1|||
13493827|NCT03110380|27064351|FG000|Double-Blind Treatment Phase|Withdrew Consent|10|||
13493828|NCT03110380|27064352|FG001|Double-Blind Treatment Phase|Withdrew Consent|16|||
13493829|NCT03110380|27064353|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
13493830|NCT03110380|27064354|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
13493831|NCT03110380|27064351|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
13493832|NCT03110380|27064352|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3|||
13493833|NCT03110380|27064353|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
13493834|NCT03110380|27064354|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
13493835|NCT03110380|27064351|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
13493836|NCT03110380|27064352|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
13493837|NCT03110380|27064353|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
13493838|NCT03110380|27064354|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
13493839|NCT03110380|27064351|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1|||
13493840|NCT03110380|27064352|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3|||
13493841|NCT03110380|27064353|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
13493842|NCT03110380|27064354|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
13493843|NCT03110380|27064351|FG000|Double-Blind Treatment Phase|Death|2|||
13493844|NCT03110380|27064352|FG001|Double-Blind Treatment Phase|Death|1|||
13493845|NCT03110380|27064353|FG002|Double-Blind Treatment Phase|Death|0|||
13493846|NCT03110380|27064354|FG003|Double-Blind Treatment Phase|Death|0|||
13493847|NCT03110380|27064351|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
13493848|NCT03110380|27064352|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
13493849|NCT03110380|27064353|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
13493850|NCT03110380|27064354|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
13493851|NCT03110380|27064351|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
13493852|NCT03110380|27064352|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
13493853|NCT03110380|27064353|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
13493854|NCT03110380|27064354|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
13493855|NCT03110380|27064351|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0|||
13493856|NCT03110380|27064352|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2|||
13493857|NCT03110380|27064353|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0|||
13493858|NCT03110380|27064354|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0|||
13493859|NCT03110380|27064351|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
13493860|NCT03110380|27064352|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
13493861|NCT03110380|27064353|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3|||
13493862|NCT03110380|27064354|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1|||
13493863|NCT03110380|27064351|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
13493864|NCT03110380|27064352|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
13493865|NCT03110380|27064353|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
13493866|NCT03110380|27064354|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
13493867|NCT03110380|27064351|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
13493868|NCT03110380|27064352|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
13493869|NCT03110380|27064353|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
13493870|NCT03110380|27064354|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1|||
13493871|NCT03078478|27064405|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
13493872|NCT03078478|27064406|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
13493873|NCT03078478|27064405|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7|||
13493874|NCT03078478|27064406|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4|||
13493875|NCT03078478|27064405|FG000|Maintenance Period 1 (36 Weeks)|Death|3|||
13493876|NCT03078478|27064406|FG001|Maintenance Period 1 (36 Weeks)|Death|3|||
13493877|NCT03078478|27064405|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1|||
13493878|NCT03078478|27064406|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0|||
13493879|NCT03078478|27064405|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18|||
13493880|NCT03078478|27064406|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13|||
13493881|NCT03078478|27064405|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3|||
13493882|NCT03078478|27064406|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6|||
13493883|NCT03078478|27064405|FG000|Maintencance Period 2 (36 Weeks)|Death|4|||
13493884|NCT03078478|27064406|FG001|Maintencance Period 2 (36 Weeks)|Death|6|||
13493885|NCT03078478|27064405|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0|||
13493886|NCT03078478|27064406|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2|||
13493887|NCT02873195|27064480|FG000|Overall Study|Ineligible|5|||
13493888|NCT02873195|27064481|FG001|Overall Study|Ineligible|0|||
13493889|NCT02785952|27064516|FG000|Overall Study|Adverse Event|31|||
13493890|NCT02785952|27064517|FG001|Overall Study|Adverse Event|19|||
13493891|NCT02785952|27064516|FG000|Overall Study|Refusal unrelated to adverse events|10|||
13493892|NCT02785952|27064517|FG001|Overall Study|Refusal unrelated to adverse events|5|||
13493893|NCT02785952|27064516|FG000|Overall Study|Disease progression/relapse|61|||
13493894|NCT02785952|27064517|FG001|Overall Study|Disease progression/relapse|89|||
13493895|NCT02785952|27064516|FG000|Overall Study|Death|11|||
13493896|NCT02785952|27064517|FG001|Overall Study|Death|7|||
13493897|NCT02785952|27064516|FG000|Overall Study|Other- not protocol specified|6|||
13493898|NCT02785952|27064517|FG001|Overall Study|Other- not protocol specified|4|||
13493899|NCT02785952|27064516|FG000|Overall Study|On protocol treatment|6|||
13493900|NCT02785952|27064517|FG001|Overall Study|On protocol treatment|3|||
13493901|NCT02748616|27064523|FG000|Overall Study|Lost to Follow-up|1|||
13493902|NCT02748616|27064523|FG000|Overall Study|Withdrawal by Subject|2|||
13493903|NCT02748616|27064523|FG000|Overall Study|Physician Decision|2|||
13493904|NCT02748616|27064523|FG000|Overall Study|Did Not Complete Ursodial Course|2|||
13493905|NCT02719522|27064533|FG000|Overall Study|Implant Failure|4|||
13493906|NCT02719522|27064533|FG000|Overall Study|Death|2|||
13493907|NCT02719522|27064533|FG000|Overall Study|Lost to Follow-up|5|||
13493908|NCT02585232|27064554|FG000|Overall Study|Lost to Follow-up|8|||
13493909|NCT02585232|27064555|FG001|Overall Study|Lost to Follow-up|8|||
13493910|NCT02585232|27064554|FG000|Overall Study|Withdrawal by Subject|4|||
13493911|NCT02585232|27064555|FG001|Overall Study|Withdrawal by Subject|8|||
13493912|NCT02545283|27064682|FG000|Overall Study|Lost to Follow-up|2|||
13493913|NCT02545283|27064683|FG001|Overall Study|Lost to Follow-up|4|||
13493914|NCT02545283|27064682|FG000|Overall Study|Withdrawal by Subject|5|||
13493915|NCT02545283|27064683|FG001|Overall Study|Withdrawal by Subject|9|||
13493916|NCT02545283|27064682|FG000|Overall Study|Death|109|||
13493917|NCT02545283|27064683|FG001|Overall Study|Death|211|||
13493918|NCT02545283|27064682|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0|||
13493919|NCT02545283|27064683|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3|||
13493920|NCT02545283|27064682|FG000|Overall Study|Study Terminated By Sponsor|33|||
13493921|NCT02545283|27064683|FG001|Overall Study|Study Terminated By Sponsor|71|||
13493922|NCT02524171|27064726|FG000|6-month Follow-up|Lost to Follow-up|53|||
13493923|NCT02524171|27064727|FG001|6-month Follow-up|Lost to Follow-up|45|||
13493924|NCT02524171|27064726|FG000|12-month Follow-up Interview|Lost to Follow-up|45|||
13493925|NCT02524171|27064727|FG001|12-month Follow-up Interview|Lost to Follow-up|41|||
13493926|NCT02306122|27064779|FG000|Initial Physician Randomization|Physician Decision|0|||
13493927|NCT02306122|27064780|FG001|Initial Physician Randomization|Physician Decision|0|||
13493928|NCT02306122|27064781|FG002|Initial Physician Randomization|Physician Decision|0|||
13493929|NCT02306122|27064782|FG003|Initial Physician Randomization|Physician Decision|0|||
13493930|NCT02306122|27064783|FG004|Initial Physician Randomization|Physician Decision|0|||
13493931|NCT02306122|27064784|FG005|Initial Physician Randomization|Physician Decision|0|||
13493932|NCT02306122|27064785|FG006|Initial Physician Randomization|Physician Decision|0|||
13493933|NCT02306122|27064786|FG007|Initial Physician Randomization|Physician Decision|0|||
13493934|NCT02306122|27064787|FG008|Initial Physician Randomization|Physician Decision|1|||
13493935|NCT02306122|27064788|FG009|Initial Physician Randomization|Physician Decision|0|||
13493936|NCT02306122|27064789|FG010|Initial Physician Randomization|Physician Decision|0|||
13493937|NCT02147184|27064852|FG000|Overall Study|Lost to Follow-up|28|||
13493938|NCT02147184|27064853|FG001|Overall Study|Lost to Follow-up|15|||
13493939|NCT02147184|27064852|FG000|Overall Study|Study Burden|11|||
13493940|NCT02147184|27064853|FG001|Overall Study|Study Burden|7|||
13493941|NCT02147184|27064852|FG000|Overall Study|Pregnancy|6|||
13493942|NCT02147184|27064853|FG001|Overall Study|Pregnancy|0|||
13493943|NCT02147184|27064852|FG000|Overall Study|Moved out of state|3|||
13493944|NCT02147184|27064853|FG001|Overall Study|Moved out of state|3|||
13493945|NCT02147184|27064852|FG000|Overall Study|Physician Decision|0|||
13493946|NCT02147184|27064853|FG001|Overall Study|Physician Decision|2|||
13493947|NCT02147184|27064852|FG000|Overall Study|Other|1|||
13493948|NCT02147184|27064853|FG001|Overall Study|Other|0|||
13493949|NCT02000219|27064921|FG000|14-Week Study Period|Physician Decision|1|||
13493950|NCT02000219|27064921|FG000|14-Week Study Period|Adverse Event|1|||
13493951|NCT02000219|27064921|FG000|14-Week Study Period|Underwent transplantation|1|||
13493952|NCT02000219|27064921|FG000|Continuation Period|Withdrawal by Subject|1|||
13493953|NCT02000219|27064921|FG000|Continuation Period|Had liver transplant|2|||
13493954|NCT02000219|27064921|FG000|Continuation Period|Non-compliance with study drug|2|||
13493955|NCT01978938|27064938|FG000|Overall Study|Lost to Follow-up|12|||
13493956|NCT01978938|27064939|FG001|Overall Study|Lost to Follow-up|6|||
13493957|NCT01978938|27064938|FG000|Overall Study|Withdrawal by Subject|8|||
13493958|NCT01978938|27064939|FG001|Overall Study|Withdrawal by Subject|4|||
13493959|NCT01978938|27064938|FG000|Overall Study|Adverse Event, non-fatal|2|||
13493960|NCT01978938|27064939|FG001|Overall Study|Adverse Event, non-fatal|1|||
13493961|NCT01978938|27064938|FG000|Overall Study|Participant noncompliance|1|||
13493962|NCT01978938|27064939|FG001|Overall Study|Participant noncompliance|1|||
13493963|NCT01978938|27064938|FG000|Overall Study|Did not meet inclusion criteria|0|||
13493964|NCT01978938|27064939|FG001|Overall Study|Did not meet inclusion criteria|1|||
13493965|NCT01978938|27064938|FG000|Overall Study|Previously scheduled procedure|0|||
13493966|NCT01978938|27064939|FG001|Overall Study|Previously scheduled procedure|1|||
13493967|NCT01854385|27064948|FG000|Pre-Treatment|Withdrawal by Subject|4|||
13493968|NCT01854385|27064948|FG000|Pre-Treatment|Did not meet criteria based on headache number|15|||
13493969|NCT01854385|27064948|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3|||
13493970|NCT01854385|27064948|FG000|Pre-Treatment|Unable to come for study visits|1|||
13493971|NCT01854385|27064948|FG000|Treatment|Lost to Follow-up|1|||
13493972|NCT01844856|27064965|FG000|Overall Study|Lost to Follow-up|15|||
13493973|NCT01844856|27064966|FG001|Overall Study|Lost to Follow-up|3|||
13493974|NCT01844856|27064965|FG000|Overall Study|Adverse Event|3|||
13493975|NCT01844856|27064966|FG001|Overall Study|Adverse Event|6|||
13493976|NCT01844856|27064965|FG000|Overall Study|Withdrawal by Subject|3|||
13493977|NCT01844856|27064966|FG001|Overall Study|Withdrawal by Subject|2|||
13493978|NCT01844856|27064965|FG000|Overall Study|Noncompliance|2|||
13493979|NCT01844856|27064966|FG001|Overall Study|Noncompliance|3|||
13493980|NCT01844856|27064965|FG000|Overall Study|Enterococcus Resistant|0|||
13493981|NCT01844856|27064966|FG001|Overall Study|Enterococcus Resistant|1|||
13493982|NCT01844856|27064965|FG000|Overall Study|Inadvertently Not Scheduled|1|||
13493983|NCT01844856|27064966|FG001|Overall Study|Inadvertently Not Scheduled|0|||
13493984|NCT01844856|27064965|FG000|Overall Study|Randomized but was a Screen Failure|0|||
13493985|NCT01844856|27064966|FG001|Overall Study|Randomized but was a Screen Failure|1|||
13493986|NCT01712789|27065101|FG000|Overall Study|Lack of Efficacy|2|||
13493987|NCT01712789|27065101|FG000|Overall Study|Lost to Follow-up|1|||
13493988|NCT01712789|27065101|FG000|Overall Study|Progressive Disease|504|||
13493989|NCT01712789|27065101|FG000|Overall Study|Death|57|||
13493990|NCT01712789|27065101|FG000|Overall Study|Adverse Event|52|||
13493991|NCT01712789|27065101|FG000|Overall Study|Miscellaneous|31|||
13493992|NCT01712789|27065101|FG000|Overall Study|Withdrawal by Subject|21|||
13493993|NCT01712789|27065101|FG000|Overall Study|Transition to Commercial Treatment|8|||
13493994|NCT01712789|27065101|FG000|Overall Study|Participants Did Not Receive Study Drug|6|||
13493995|NCT01542736|27065117|FG000|Overall Study|Death|1|||
13493996|NCT01147666|27065369|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
13493997|NCT01147666|27065370|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
13493998|NCT01147666|27065371|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
13493999|NCT01147666|27065372|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
13494000|NCT01147666|27065373|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
13494001|NCT01147666|27065374|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
13494002|NCT01147666|27065375|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
13494003|NCT01147666|27065376|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
13494004|NCT01147666|27065377|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
13494005|NCT01147666|27065378|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
13494006|NCT01147666|27065379|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
13494007|NCT01147666|27065380|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
13494008|NCT01147666|27065381|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
13494009|NCT01147666|27065382|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
13494010|NCT01147666|27065383|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
13494011|NCT01147666|27065369|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
13494012|NCT01147666|27065370|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
13494013|NCT01147666|27065371|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
13494014|NCT01147666|27065372|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
13494015|NCT01147666|27065373|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
13494016|NCT01147666|27065374|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
13494017|NCT01147666|27065375|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
13494018|NCT01147666|27065376|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
13494019|NCT01147666|27065377|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
13494020|NCT01147666|27065378|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
13494021|NCT01147666|27065379|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
13494022|NCT01147666|27065380|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
13494023|NCT01147666|27065381|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
13494024|NCT01147666|27065382|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
13494025|NCT01147666|27065383|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
13494026|NCT01147666|27065369|FG000|Dosing Period 1: 6-Week Treatment|Death|0|||
13494027|NCT01147666|27065370|FG001|Dosing Period 1: 6-Week Treatment|Death|0|||
13494028|NCT01147666|27065371|FG002|Dosing Period 1: 6-Week Treatment|Death|0|||
13494029|NCT01147666|27065372|FG003|Dosing Period 1: 6-Week Treatment|Death|0|||
13494030|NCT01147666|27065373|FG004|Dosing Period 1: 6-Week Treatment|Death|1|||
13494031|NCT01147666|27065374|FG005|Dosing Period 1: 6-Week Treatment|Death|1|||
13494032|NCT01147666|27065375|FG006|Dosing Period 1: 6-Week Treatment|Death|1|||
13494033|NCT01147666|27065376|FG007|Dosing Period 1: 6-Week Treatment|Death|0|||
13494034|NCT01147666|27065377|FG008|Dosing Period 1: 6-Week Treatment|Death|0|||
13494035|NCT01147666|27065378|FG009|Dosing Period 1: 6-Week Treatment|Death|0|||
13494036|NCT01147666|27065379|FG010|Dosing Period 1: 6-Week Treatment|Death|0|||
13494037|NCT01147666|27065380|FG011|Dosing Period 1: 6-Week Treatment|Death|0|||
13494038|NCT01147666|27065381|FG012|Dosing Period 1: 6-Week Treatment|Death|1|||
13494039|NCT01147666|27065382|FG013|Dosing Period 1: 6-Week Treatment|Death|0|||
13494040|NCT01147666|27065383|FG014|Dosing Period 1: 6-Week Treatment|Death|0|||
13494041|NCT01147666|27065369|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
13494042|NCT01147666|27065370|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
13494043|NCT01147666|27065371|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
13494044|NCT01147666|27065372|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
13494045|NCT01147666|27065373|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
13494046|NCT01147666|27065374|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
13494047|NCT01147666|27065375|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
13494048|NCT01147666|27065376|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
13494049|NCT01147666|27065377|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
13494050|NCT01147666|27065378|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
13494051|NCT01147666|27065379|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
13494052|NCT01147666|27065380|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
13494053|NCT01147666|27065381|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
13494054|NCT01147666|27065382|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
13494055|NCT01147666|27065383|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
13494056|NCT01147666|27065369|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
13494057|NCT01147666|27065370|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
13494058|NCT01147666|27065371|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
13494059|NCT01147666|27065372|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
13494060|NCT01147666|27065373|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
13494061|NCT01147666|27065374|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
13494062|NCT01147666|27065375|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
13494063|NCT01147666|27065376|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
13494064|NCT01147666|27065377|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
13494065|NCT01147666|27065378|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
13494066|NCT01147666|27065379|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
13494067|NCT01147666|27065380|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
13494068|NCT01147666|27065381|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
13494069|NCT01147666|27065382|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
13494070|NCT01147666|27065383|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
13494071|NCT01147666|27065369|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
13494072|NCT01147666|27065370|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
13494073|NCT01147666|27065371|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
13494074|NCT01147666|27065372|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1|||
13494075|NCT01147666|27065373|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
13494076|NCT01147666|27065374|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
13494077|NCT01147666|27065375|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
13494078|NCT01147666|27065376|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
13494079|NCT01147666|27065377|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
13494080|NCT01147666|27065378|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
13494081|NCT01147666|27065379|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2|||
13494082|NCT01147666|27065380|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
13494083|NCT01147666|27065381|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
13494084|NCT01147666|27065382|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
13494085|NCT01147666|27065383|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
13494086|NCT01147666|27065369|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
13494087|NCT01147666|27065370|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
13494088|NCT01147666|27065371|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
13494089|NCT01147666|27065372|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
13494090|NCT01147666|27065373|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
13494091|NCT01147666|27065374|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
13494092|NCT01147666|27065375|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
13494093|NCT01147666|27065376|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
13494094|NCT01147666|27065377|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
13494095|NCT01147666|27065378|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
13494096|NCT01147666|27065379|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
13494097|NCT01147666|27065380|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
13494098|NCT01147666|27065381|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
13494099|NCT01147666|27065382|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
13494100|NCT01147666|27065383|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
13494101|NCT01147666|27065369|FG000|Dosing Period 2: 19-Week Treatment|Death|0|||
13494102|NCT01147666|27065370|FG001|Dosing Period 2: 19-Week Treatment|Death|0|||
13494103|NCT01147666|27065371|FG002|Dosing Period 2: 19-Week Treatment|Death|0|||
13494104|NCT01147666|27065372|FG003|Dosing Period 2: 19-Week Treatment|Death|0|||
13494105|NCT01147666|27065373|FG004|Dosing Period 2: 19-Week Treatment|Death|1|||
13494106|NCT01147666|27065374|FG005|Dosing Period 2: 19-Week Treatment|Death|1|||
13494107|NCT01147666|27065375|FG006|Dosing Period 2: 19-Week Treatment|Death|1|||
13494108|NCT01147666|27065376|FG007|Dosing Period 2: 19-Week Treatment|Death|0|||
13494109|NCT01147666|27065377|FG008|Dosing Period 2: 19-Week Treatment|Death|0|||
13494110|NCT01147666|27065378|FG009|Dosing Period 2: 19-Week Treatment|Death|0|||
13494111|NCT01147666|27065379|FG010|Dosing Period 2: 19-Week Treatment|Death|0|||
13494112|NCT01147666|27065380|FG011|Dosing Period 2: 19-Week Treatment|Death|0|||
13494113|NCT01147666|27065381|FG012|Dosing Period 2: 19-Week Treatment|Death|1|||
13494114|NCT01147666|27065382|FG013|Dosing Period 2: 19-Week Treatment|Death|0|||
13494115|NCT01147666|27065383|FG014|Dosing Period 2: 19-Week Treatment|Death|0|||
13494116|NCT01147666|27065369|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
13494117|NCT01147666|27065370|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
13494118|NCT01147666|27065371|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
13494119|NCT01147666|27065372|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
13494120|NCT01147666|27065373|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3|||
13494121|NCT01147666|27065374|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
13494122|NCT01147666|27065375|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
13494123|NCT01147666|27065376|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
13494124|NCT01147666|27065377|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
13494125|NCT01147666|27065378|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
13494126|NCT01147666|27065379|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
13494127|NCT01147666|27065380|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
13494128|NCT01147666|27065381|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
13494129|NCT01147666|27065382|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
13494130|NCT01147666|27065383|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
13494131|NCT01147666|27065369|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
13494132|NCT01147666|27065370|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
13494133|NCT01147666|27065371|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
13494134|NCT01147666|27065372|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1|||
13494135|NCT01147666|27065373|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
13494136|NCT01147666|27065374|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
13494137|NCT01147666|27065375|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
13494138|NCT01147666|27065376|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
13494139|NCT01147666|27065377|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
13494140|NCT01147666|27065378|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
13494141|NCT01147666|27065379|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
13494142|NCT01147666|27065380|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
13494143|NCT01147666|27065381|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
13494144|NCT01147666|27065382|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
13494145|NCT01147666|27065383|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
13494146|NCT01147666|27065369|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
13494147|NCT01147666|27065370|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
13494148|NCT01147666|27065371|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
13494149|NCT01147666|27065372|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
13494150|NCT01147666|27065373|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
13494151|NCT01147666|27065374|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
13494152|NCT01147666|27065375|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
13494153|NCT01147666|27065376|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
13494154|NCT01147666|27065377|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
13494155|NCT01147666|27065378|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
13494156|NCT01147666|27065379|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
13494157|NCT01147666|27065380|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
13494158|NCT01147666|27065381|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
13494159|NCT01147666|27065382|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
13494160|NCT01147666|27065383|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
13494161|NCT01147666|27065369|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
13494162|NCT01147666|27065370|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
13494163|NCT01147666|27065371|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
13494164|NCT01147666|27065372|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1|||
13494165|NCT01147666|27065373|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
13494166|NCT01147666|27065374|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
13494167|NCT01147666|27065375|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
13494168|NCT01147666|27065376|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
13494169|NCT01147666|27065377|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
13494170|NCT01147666|27065378|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
13494171|NCT01147666|27065379|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2|||
13494172|NCT01147666|27065380|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
13494173|NCT01147666|27065381|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
13494174|NCT01147666|27065382|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
13494175|NCT01147666|27065383|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
13494176|NCT01147666|27065369|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
13494177|NCT01147666|27065370|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
13494178|NCT01147666|27065371|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
13494179|NCT01147666|27065372|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
13494180|NCT01147666|27065373|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
13494181|NCT01147666|27065374|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
13494182|NCT01147666|27065375|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
13494183|NCT01147666|27065376|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
13494184|NCT01147666|27065377|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
13494185|NCT01147666|27065378|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
13494186|NCT01147666|27065379|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
13494187|NCT01147666|27065380|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
13494188|NCT01147666|27065381|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1|||
13494189|NCT01147666|27065382|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
13494190|NCT01147666|27065383|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
13494191|NCT01147666|27065369|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
13494192|NCT01147666|27065370|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
13494193|NCT01147666|27065371|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
13494194|NCT01147666|27065372|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
13494195|NCT01147666|27065373|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
13494196|NCT01147666|27065374|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
13494197|NCT01147666|27065375|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
13494198|NCT01147666|27065376|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
13494199|NCT01147666|27065377|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
13494200|NCT01147666|27065378|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
13494201|NCT01147666|27065379|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
13494202|NCT01147666|27065380|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
13494203|NCT01147666|27065381|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
13494204|NCT01147666|27065382|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
13494205|NCT01147666|27065383|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
13494206|NCT00982111|27065412|FG000|Overall Study|Adverse Event|1|||
13494207|NCT00982111|27065413|FG001|Overall Study|Adverse Event|1|||
13494208|NCT00982111|27065412|FG000|Overall Study|Progressive Disease|46|||
13494209|NCT00982111|27065413|FG001|Overall Study|Progressive Disease|39|||
13494210|NCT00982111|27065412|FG000|Overall Study|Lost to Follow-up|9|||
13494211|NCT00982111|27065413|FG001|Overall Study|Lost to Follow-up|6|||
13494212|NCT00982111|27065412|FG000|Overall Study|New Anti-Cancer Therapy|5|||
13494213|NCT00982111|27065413|FG001|Overall Study|New Anti-Cancer Therapy|5|||
13494214|NCT00982111|27065412|FG000|Overall Study|Medical Decision|1|||
13494215|NCT00982111|27065413|FG001|Overall Study|Medical Decision|0|||
13494216|NCT00982111|27065412|FG000|Overall Study|Withdrawal by Subject|17|||
13494217|NCT00982111|27065413|FG001|Overall Study|Withdrawal by Subject|19|||
13494218|NCT00982111|27065412|FG000|Overall Study|Global Study End|0|||
13494219|NCT00982111|27065413|FG001|Overall Study|Global Study End|1|||
13494220|NCT00982111|27065412|FG000|Overall Study|Sponsor's Decision|0|||
13494221|NCT00982111|27065413|FG001|Overall Study|Sponsor's Decision|1|||
13494222|NCT00116142|27065434|FG000|Overall Study|Adverse Event|8|||
13494223|NCT00116142|27065435|FG001|Overall Study|Adverse Event|7|||
13494224|NCT00116142|27065434|FG000|Overall Study|Protocol Violation|2|||
13494225|NCT00116142|27065435|FG001|Overall Study|Protocol Violation|1|||
13494226|NCT00116142|27065434|FG000|Overall Study|Withdrawal by Subject|5|||
13494227|NCT00116142|27065435|FG001|Overall Study|Withdrawal by Subject|5|||
13494228|NCT00116142|27065434|FG000|Overall Study|Physician Decision|3|||
13494229|NCT00116142|27065435|FG001|Overall Study|Physician Decision|1|||
13494230|NCT00116142|27065434|FG000|Overall Study|Delayed Radiation Therapy|1|||
13494231|NCT00116142|27065435|FG001|Overall Study|Delayed Radiation Therapy|0|||
13494232|NCT00116142|27065434|FG000|Overall Study|Patient could not tolerate docetaxel|0|||
13494233|NCT00116142|27065435|FG001|Overall Study|Patient could not tolerate docetaxel|2|||
13494234|NCT00116142|27065434|FG000|Overall Study|Patient stopped due to depression|0|||
13494235|NCT00116142|27065435|FG001|Overall Study|Patient stopped due to depression|1|||
13494236|NCT00116142|27065434|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0|||
13494237|NCT00116142|27065435|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1|||
13494238|NCT00116142|27065434|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0|||
13494239|NCT00116142|27065435|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1|||
13494240|NCT00116142|27065434|FG000|Overall Study|Patient didn't start due to low platelet counts|0|||
13494241|NCT00116142|27065435|FG001|Overall Study|Patient didn't start due to low platelet counts|1|||
13494242|NCT00070018|27065441|FG000|Overall Study|Adverse Event|2|||
13494243|NCT00070018|27065441|FG000|Overall Study|Lack of Efficacy|1|||
13494244|NCT00070018|27065441|FG000|Overall Study|Withdrawal by Subject|1|||
13494245|NCT04447287|27065529|FG000|Period 1: Run-in Period|Adverse Event|3|||
13494246|NCT04447287|27065530|FG001|Period 1: Run-in Period|Adverse Event|0|||
13494247|NCT04447287|27065531|FG002|Period 1: Run-in Period|Adverse Event|0|||
13494248|NCT04447287|27065529|FG000|Period 1: Run-in Period|Withdrawal by Subject|1|||
13494249|NCT04447287|27065530|FG001|Period 1: Run-in Period|Withdrawal by Subject|0|||
13494250|NCT04447287|27065531|FG002|Period 1: Run-in Period|Withdrawal by Subject|0|||
13494251|NCT04447287|27065529|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1|||
13494252|NCT04447287|27065530|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
13494253|NCT04447287|27065531|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
13494254|NCT04039503|27065666|FG000|Overall Study|Adverse Event|3|||
13494255|NCT04039503|27065667|FG001|Overall Study|Adverse Event|0|||
13494256|NCT04039503|27065668|FG002|Overall Study|Adverse Event|2|||
13494257|NCT04039503|27065669|FG003|Overall Study|Adverse Event|0|||
13494258|NCT04039503|27065666|FG000|Overall Study|Lost to Follow-up|0|||
13494259|NCT04039503|27065667|FG001|Overall Study|Lost to Follow-up|0|||
13494260|NCT04039503|27065668|FG002|Overall Study|Lost to Follow-up|1|||
13494261|NCT04039503|27065669|FG003|Overall Study|Lost to Follow-up|0|||
13494262|NCT04039503|27065666|FG000|Overall Study|Protocol Violation|0|||
13494263|NCT04039503|27065667|FG001|Overall Study|Protocol Violation|1|||
13494264|NCT04039503|27065668|FG002|Overall Study|Protocol Violation|2|||
13494265|NCT04039503|27065669|FG003|Overall Study|Protocol Violation|1|||
13494266|NCT04039503|27065666|FG000|Overall Study|Withdrawal by Subject|4|||
13494267|NCT04039503|27065667|FG001|Overall Study|Withdrawal by Subject|3|||
13494268|NCT04039503|27065668|FG002|Overall Study|Withdrawal by Subject|5|||
13494269|NCT04039503|27065669|FG003|Overall Study|Withdrawal by Subject|2|||
13494270|NCT03695172|27065735|FG000|Overall Study|Withdrawal by Subject|1|||
13494271|NCT03695172|27065736|FG001|Overall Study|Withdrawal by Subject|1|||
13494272|NCT03695172|27065737|FG002|Overall Study|Withdrawal by Subject|0|||
13494273|NCT03170869|27065805|FG000|Overall Study|Protocol Violation|5|||
13494274|NCT03170869|27065805|FG000|Overall Study|Early study termination|3|||
13494275|NCT03066622|27065822|FG000|Overall Study|Lost to Follow-up|24|||
13494276|NCT03066622|27065823|FG001|Overall Study|Lost to Follow-up|25|||
13494277|NCT03066622|27065822|FG000|Overall Study|Withdrawal by Subject|2|||
13494278|NCT03066622|27065823|FG001|Overall Study|Withdrawal by Subject|1|||
13494279|NCT03052920|27065843|FG000|Overall Study|Withdrawal by Subject|1|||
13494280|NCT02722434|27065888|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
13494281|NCT02722434|27065889|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
13494282|NCT02722434|27065888|FG000|Overall Study|Withdrawal After Beginning Treatment|0|||
13494283|NCT02722434|27065889|FG001|Overall Study|Withdrawal After Beginning Treatment|3|||
13494284|NCT01164228|27066004|FG000|Overall Study|Progression|24|||
13494285|NCT01164228|27066005|FG001|Overall Study|Progression|25|||
13494286|NCT01164228|27066004|FG000|Overall Study|Adverse Event|13|||
13494287|NCT01164228|27066005|FG001|Overall Study|Adverse Event|7|||
13494288|NCT01164228|27066004|FG000|Overall Study|Death|1|||
13494289|NCT01164228|27066005|FG001|Overall Study|Death|1|||
13494290|NCT01164228|27066004|FG000|Overall Study|Withdrawal by Subject|2|||
13494291|NCT01164228|27066005|FG001|Overall Study|Withdrawal by Subject|0|||
13494292|NCT01164228|27066004|FG000|Overall Study|Physician Decision|1|||
13494293|NCT01164228|27066005|FG001|Overall Study|Physician Decision|2|||
13494294|NCT01164228|27066004|FG000|Overall Study|Symptomatic deterioration|1|||
13494295|NCT01164228|27066005|FG001|Overall Study|Symptomatic deterioration|0|||
13494296|NCT01164228|27066004|FG000|Overall Study|Never started treatment|1|||
13494297|NCT01164228|27066005|FG001|Overall Study|Never started treatment|3|||
13494298|NCT01164228|27066004|FG000|Overall Study|Ineligible|1|||
13494299|NCT01164228|27066005|FG001|Overall Study|Ineligible|0|||
13494300|NCT04534517|27066371|FG000|Overall Study|Adverse Event|1|||
13494301|NCT04534517|27066371|FG000|Overall Study|Withdrawal by Subject|1|||
13494302|NCT04534517|27066371|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
13494303|NCT04534517|27066371|FG000|Overall Study|COVID-19 Related|1|||
13494304|NCT04494646|27066384|FG000|Overall Study|Adverse Event|0|||
13494305|NCT04494646|27066385|FG001|Overall Study|Adverse Event|1|||
13494306|NCT04494646|27066384|FG000|Overall Study|Withdrawal by Subject|0|||
13494307|NCT04494646|27066385|FG001|Overall Study|Withdrawal by Subject|1|||
13494308|NCT04258020|27066410|FG000|Overall Study|Withdrawal by Subject|1|||
13494309|NCT04258020|27066411|FG001|Overall Study|Withdrawal by Subject|0|||
13494310|NCT04234464|27066426|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1|||
13494311|NCT04234464|27066427|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0|||
13494312|NCT03852316|27066441|FG000|Overall Study|Protocol Violation|1|||
13494313|NCT03852316|27066441|FG000|Overall Study|Withdrawal by Subject|2|||
13494314|NCT03852316|27066441|FG000|Overall Study|Enrolled but Device not Utilized|1|||
13494315|NCT03789318|27066489|FG000|Overall Study|Adverse Event|0|||
13494316|NCT03789318|27066490|FG001|Overall Study|Adverse Event|0|||
13494317|NCT03789318|27066491|FG002|Overall Study|Adverse Event|1|||
13494318|NCT03789318|27066492|FG003|Overall Study|Adverse Event|1|||
13494319|NCT03789318|27066493|FG004|Overall Study|Adverse Event|0|||
13494320|NCT03789318|27066489|FG000|Overall Study|Lost to Follow-up|0|||
13494321|NCT03789318|27066490|FG001|Overall Study|Lost to Follow-up|0|||
13494322|NCT03789318|27066491|FG002|Overall Study|Lost to Follow-up|1|||
13494323|NCT03789318|27066492|FG003|Overall Study|Lost to Follow-up|0|||
13494324|NCT03789318|27066493|FG004|Overall Study|Lost to Follow-up|0|||
13494325|NCT03789318|27066489|FG000|Overall Study|Withdrawal by Subject|0|||
13494326|NCT03789318|27066490|FG001|Overall Study|Withdrawal by Subject|0|||
13494327|NCT03789318|27066491|FG002|Overall Study|Withdrawal by Subject|1|||
13494328|NCT03789318|27066492|FG003|Overall Study|Withdrawal by Subject|0|||
13494329|NCT03789318|27066493|FG004|Overall Study|Withdrawal by Subject|0|||
13494330|NCT03103321|27066582|FG000|Overall Study|Protocol Violation|1|||
13494331|NCT03103321|27066583|FG001|Overall Study|Protocol Violation|1|||
13494332|NCT03103321|27066584|FG002|Overall Study|Protocol Violation|1|||
13494333|NCT03103321|27066585|FG003|Overall Study|Protocol Violation|0|||
13494334|NCT03079869|27066604|FG000|Overall Study|Adverse Event|6|||
13494335|NCT03079869|27066605|FG001|Overall Study|Adverse Event|8|||
13494336|NCT03079869|27066604|FG000|Overall Study|Withdrawal by Subject|4|||
13494337|NCT03079869|27066605|FG001|Overall Study|Withdrawal by Subject|1|||
13494338|NCT03079869|27066604|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3|||
13494339|NCT03079869|27066605|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2|||
13494340|NCT03033875|27066641|FG000|Overall Study|Withdrawal by Subject|5|||
13494341|NCT03033875|27066642|FG001|Overall Study|Withdrawal by Subject|9|||
13494342|NCT03033875|27066643|FG002|Overall Study|Withdrawal by Subject|4|||
13494343|NCT03033875|27066641|FG000|Overall Study|Other|14|||
13494344|NCT03033875|27066642|FG001|Overall Study|Other|15|||
13494345|NCT03033875|27066643|FG002|Overall Study|Other|8|||
13494346|NCT02887248|27066666|FG000|Overall Study|Withdrawal by Subject|1|||
13494347|NCT02887248|27066666|FG000|Overall Study|Adverse Event|1|||
13494348|NCT02887248|27066666|FG000|Overall Study|Progressive Disease|1|||
13494349|NCT02849990|27066680|FG000|Overall Study|Adverse Event|1|||
13494350|NCT02849990|27066680|FG000|Overall Study|Withdrawal by Subject|1|||
13494351|NCT02452554|27066759|FG000|Overall Study|Death|2|||
13494352|NCT02452554|27066760|FG001|Overall Study|Death|1|||
13494353|NCT02452554|27066761|FG002|Overall Study|Death|0|||
13494354|NCT02452554|27066762|FG003|Overall Study|Death|0|||
13494355|NCT02452554|27066763|FG004|Overall Study|Death|0|||
13494356|NCT02452554|27066764|FG005|Overall Study|Death|0|||
13494357|NCT02452554|27066759|FG000|Overall Study|Lack of Efficacy|13|||
13494358|NCT02452554|27066760|FG001|Overall Study|Lack of Efficacy|14|||
13494359|NCT02452554|27066761|FG002|Overall Study|Lack of Efficacy|9|||
13494360|NCT02452554|27066762|FG003|Overall Study|Lack of Efficacy|1|||
13494361|NCT02452554|27066763|FG004|Overall Study|Lack of Efficacy|5|||
13494362|NCT02452554|27066764|FG005|Overall Study|Lack of Efficacy|8|||
13494363|NCT02452554|27066759|FG000|Overall Study|Physician Decision|0|||
13494364|NCT02452554|27066760|FG001|Overall Study|Physician Decision|1|||
13494365|NCT02452554|27066761|FG002|Overall Study|Physician Decision|0|||
13208359|NCT01939158|26241440|FG001|Overall Study|Death|0|||
13208360|NCT01939158|26241441|FG002|Overall Study|Death|1|||
13208361|NCT01939158|26241442|FG003|Overall Study|Death|1|||
13208362|NCT01939158|26241439|FG000|Overall Study|No longer meets eligibility criteria|0|||
13208363|NCT01939158|26241440|FG001|Overall Study|No longer meets eligibility criteria|0|||
13494366|NCT02452554|27066762|FG003|Overall Study|Physician Decision|0|||
13494367|NCT02452554|27066763|FG004|Overall Study|Physician Decision|0|||
13494368|NCT02452554|27066764|FG005|Overall Study|Physician Decision|0|||
13494369|NCT02452554|27066759|FG000|Overall Study|Withdrawal by Subject|1|||
13494370|NCT02452554|27066760|FG001|Overall Study|Withdrawal by Subject|0|||
13494371|NCT02452554|27066761|FG002|Overall Study|Withdrawal by Subject|2|||
13494372|NCT02452554|27066762|FG003|Overall Study|Withdrawal by Subject|0|||
13494373|NCT02452554|27066763|FG004|Overall Study|Withdrawal by Subject|0|||
13494374|NCT02452554|27066764|FG005|Overall Study|Withdrawal by Subject|1|||
13494375|NCT02452554|27066759|FG000|Overall Study|Ineligible|0|||
13494376|NCT02452554|27066760|FG001|Overall Study|Ineligible|1|||
13494377|NCT02452554|27066761|FG002|Overall Study|Ineligible|0|||
13494378|NCT02452554|27066762|FG003|Overall Study|Ineligible|0|||
13494379|NCT02452554|27066763|FG004|Overall Study|Ineligible|0|||
13494380|NCT02452554|27066764|FG005|Overall Study|Ineligible|0|||
13494381|NCT02452554|27066759|FG000|Overall Study|Never Received Treatment|1|||
13494382|NCT02452554|27066760|FG001|Overall Study|Never Received Treatment|0|||
13494383|NCT02452554|27066761|FG002|Overall Study|Never Received Treatment|0|||
13494384|NCT02452554|27066762|FG003|Overall Study|Never Received Treatment|0|||
13494385|NCT02452554|27066763|FG004|Overall Study|Never Received Treatment|0|||
13494386|NCT02452554|27066764|FG005|Overall Study|Never Received Treatment|0|||
13494387|NCT02318277|27066860|FG000|Overall Study|Physician Decision|0|||
13494388|NCT02318277|27066861|FG001|Overall Study|Physician Decision|0|||
13494389|NCT02318277|27066862|FG002|Overall Study|Physician Decision|0|||
13494390|NCT02318277|27066863|FG003|Overall Study|Physician Decision|0|||
13494391|NCT02318277|27066864|FG004|Overall Study|Physician Decision|0|||
13494392|NCT02318277|27066865|FG005|Overall Study|Physician Decision|0|||
13494393|NCT02318277|27066866|FG006|Overall Study|Physician Decision|0|||
13494394|NCT02318277|27066867|FG007|Overall Study|Physician Decision|1|||
13494395|NCT02318277|27066860|FG000|Overall Study|Other|0|||
13494396|NCT02318277|27066861|FG001|Overall Study|Other|0|||
13494397|NCT02318277|27066862|FG002|Overall Study|Other|0|||
13494398|NCT02318277|27066863|FG003|Overall Study|Other|0|||
13494399|NCT02318277|27066864|FG004|Overall Study|Other|0|||
13494400|NCT02318277|27066865|FG005|Overall Study|Other|0|||
13494401|NCT02318277|27066866|FG006|Overall Study|Other|1|||
13208364|NCT01939158|26241441|FG002|Overall Study|No longer meets eligibility criteria|1|||
13494402|NCT02318277|27066867|FG007|Overall Study|Other|0|||
13494403|NCT02318277|27066860|FG000|Overall Study|Withdrawal by Subject|0|||
13494404|NCT02318277|27066861|FG001|Overall Study|Withdrawal by Subject|0|||
13494405|NCT02318277|27066862|FG002|Overall Study|Withdrawal by Subject|1|||
13494406|NCT02318277|27066863|FG003|Overall Study|Withdrawal by Subject|0|||
13494407|NCT02318277|27066864|FG004|Overall Study|Withdrawal by Subject|1|||
13494408|NCT02318277|27066865|FG005|Overall Study|Withdrawal by Subject|1|||
13494409|NCT02318277|27066866|FG006|Overall Study|Withdrawal by Subject|6|||
13494410|NCT02318277|27066867|FG007|Overall Study|Withdrawal by Subject|14|||
13494411|NCT02318277|27066860|FG000|Overall Study|Participant trial terminated by sponsor|0|||
13494412|NCT02318277|27066861|FG001|Overall Study|Participant trial terminated by sponsor|0|||
13494413|NCT02318277|27066862|FG002|Overall Study|Participant trial terminated by sponsor|1|||
13494414|NCT02318277|27066863|FG003|Overall Study|Participant trial terminated by sponsor|0|||
13494415|NCT02318277|27066864|FG004|Overall Study|Participant trial terminated by sponsor|1|||
13494416|NCT02318277|27066865|FG005|Overall Study|Participant trial terminated by sponsor|2|||
13494417|NCT02318277|27066866|FG006|Overall Study|Participant trial terminated by sponsor|5|||
13494418|NCT02318277|27066867|FG007|Overall Study|Participant trial terminated by sponsor|16|||
13494419|NCT02318277|27066860|FG000|Overall Study|Lost to Follow-up|1|||
13494420|NCT02318277|27066861|FG001|Overall Study|Lost to Follow-up|0|||
13494421|NCT02318277|27066862|FG002|Overall Study|Lost to Follow-up|1|||
13494422|NCT02318277|27066863|FG003|Overall Study|Lost to Follow-up|0|||
13494423|NCT02318277|27066864|FG004|Overall Study|Lost to Follow-up|0|||
13494424|NCT02318277|27066865|FG005|Overall Study|Lost to Follow-up|0|||
13494425|NCT02318277|27066866|FG006|Overall Study|Lost to Follow-up|3|||
13494426|NCT02318277|27066867|FG007|Overall Study|Lost to Follow-up|4|||
13494427|NCT02318277|27066860|FG000|Overall Study|Death|5|||
13494428|NCT02318277|27066861|FG001|Overall Study|Death|3|||
13494429|NCT02318277|27066862|FG002|Overall Study|Death|1|||
13494430|NCT02318277|27066863|FG003|Overall Study|Death|4|||
13494431|NCT02318277|27066864|FG004|Overall Study|Death|6|||
13494432|NCT02318277|27066865|FG005|Overall Study|Death|5|||
13494433|NCT02318277|27066866|FG006|Overall Study|Death|34|||
13494434|NCT02318277|27066867|FG007|Overall Study|Death|58|||
13494435|NCT02318277|27066860|FG000|Overall Study|Transitioned to Hospice|0|||
13494436|NCT02318277|27066861|FG001|Overall Study|Transitioned to Hospice|0|||
13494437|NCT02318277|27066862|FG002|Overall Study|Transitioned to Hospice|0|||
13494438|NCT02318277|27066863|FG003|Overall Study|Transitioned to Hospice|0|||
13494439|NCT02318277|27066864|FG004|Overall Study|Transitioned to Hospice|0|||
13494440|NCT02318277|27066865|FG005|Overall Study|Transitioned to Hospice|1|||
13494441|NCT02318277|27066866|FG006|Overall Study|Transitioned to Hospice|0|||
13494442|NCT02318277|27066867|FG007|Overall Study|Transitioned to Hospice|0|||
13494443|NCT02143063|27066928|FG000|Overall Study|Lost to Follow-up|16|||
13494444|NCT02143063|27066929|FG001|Overall Study|Lost to Follow-up|28|||
13494445|NCT02143063|27066930|FG002|Overall Study|Lost to Follow-up|29|||
13494446|NCT02143063|27066928|FG000|Overall Study|Withdrawal by Subject|0|||
13494447|NCT02143063|27066929|FG001|Overall Study|Withdrawal by Subject|1|||
13494448|NCT02143063|27066930|FG002|Overall Study|Withdrawal by Subject|0|||
13494449|NCT02143063|27066928|FG000|Overall Study|Death|0|||
13494450|NCT02143063|27066929|FG001|Overall Study|Death|1|||
13494451|NCT02143063|27066930|FG002|Overall Study|Death|1|||
13494452|NCT02017964|27066940|FG000|Overall Study|Patient deemed ineligible|1|||
13494453|NCT01968785|27066967|FG000|Overall Study|Withdrawal by Subject|1|||
13494454|NCT01968785|27066968|FG001|Overall Study|Withdrawal by Subject|0|||
13494455|NCT01956110|27067025|FG000|Overall Study|Protocol Violation|25|||
13494456|NCT01956110|27067026|FG001|Overall Study|Protocol Violation|11|||
13494457|NCT01956110|27067025|FG000|Overall Study|Adverse Event|9|||
13494458|NCT01956110|27067026|FG001|Overall Study|Adverse Event|10|||
13494459|NCT01956110|27067025|FG000|Overall Study|Personal reasons|1|||
13494460|NCT01956110|27067026|FG001|Overall Study|Personal reasons|1|||
13494461|NCT01083433|27067079|FG000|Overall Study|Lost to Follow-up|2|||
13494462|NCT01083433|27067080|FG001|Overall Study|Lost to Follow-up|1|||
13494463|NCT01083433|27067081|FG002|Overall Study|Lost to Follow-up|1|||
13494464|NCT01083433|27067079|FG000|Overall Study|Withdrawal by Subject|0|||
13494465|NCT01083433|27067080|FG001|Overall Study|Withdrawal by Subject|5|||
13494466|NCT01083433|27067081|FG002|Overall Study|Withdrawal by Subject|3|||
13494467|NCT01083433|27067079|FG000|Overall Study|Pregnancy|0|||
13494468|NCT01083433|27067080|FG001|Overall Study|Pregnancy|0|||
13494469|NCT01083433|27067081|FG002|Overall Study|Pregnancy|1|||
13494470|NCT00787176|27067109|FG000|Overall Study|Low quality fetal heart rate tracing|7|||
13494471|NCT00787176|27067110|FG001|Overall Study|Low quality fetal heart rate tracing|3|||
13494472|NCT00787176|27067111|FG002|Overall Study|Low quality fetal heart rate tracing|6|||
13494473|NCT00787176|27067112|FG003|Overall Study|Low quality fetal heart rate tracing|5|||
13494474|NCT00352534|27067139|FG000|Initial Staging|Ineligible|8|||
13494475|NCT00352534|27067140|FG001|Initial Staging|Ineligible|9|||
13494476|NCT00352534|27067141|FG002|Initial Staging|Ineligible|0|||
13494477|NCT00352534|27067142|FG003|Initial Staging|Ineligible|0|||
13494478|NCT00352534|27067143|FG004|Initial Staging|Ineligible|0|||
13494479|NCT00352534|27067144|FG005|Initial Staging|Ineligible|0|||
13494480|NCT00352534|27067145|FG006|Initial Staging|Ineligible|0|||
13494481|NCT00352534|27067139|FG000|Final Risk Group Assignment|Lack of Efficacy|0|||
13494482|NCT00352534|27067140|FG001|Final Risk Group Assignment|Lack of Efficacy|0|||
13494483|NCT00352534|27067141|FG002|Final Risk Group Assignment|Lack of Efficacy|0|||
13494484|NCT00352534|27067142|FG003|Final Risk Group Assignment|Lack of Efficacy|2|||
13494485|NCT00352534|27067143|FG004|Final Risk Group Assignment|Lack of Efficacy|1|||
13494486|NCT00352534|27067144|FG005|Final Risk Group Assignment|Lack of Efficacy|19|||
13494487|NCT00352534|27067145|FG006|Final Risk Group Assignment|Lack of Efficacy|0|||
13494488|NCT00352534|27067139|FG000|Final Risk Group Assignment|Physician Decision|0|||
13494489|NCT00352534|27067140|FG001|Final Risk Group Assignment|Physician Decision|0|||
13494490|NCT00352534|27067141|FG002|Final Risk Group Assignment|Physician Decision|0|||
13494491|NCT00352534|27067142|FG003|Final Risk Group Assignment|Physician Decision|0|||
13494492|NCT00352534|27067143|FG004|Final Risk Group Assignment|Physician Decision|0|||
13494493|NCT00352534|27067144|FG005|Final Risk Group Assignment|Physician Decision|8|||
13494494|NCT00352534|27067145|FG006|Final Risk Group Assignment|Physician Decision|0|||
13494495|NCT00352534|27067139|FG000|Final Risk Group Assignment|Withdrawal by Subject|0|||
13494496|NCT00352534|27067140|FG001|Final Risk Group Assignment|Withdrawal by Subject|0|||
13494497|NCT00352534|27067141|FG002|Final Risk Group Assignment|Withdrawal by Subject|0|||
13494498|NCT00352534|27067142|FG003|Final Risk Group Assignment|Withdrawal by Subject|0|||
13494499|NCT00352534|27067143|FG004|Final Risk Group Assignment|Withdrawal by Subject|0|||
13494500|NCT00352534|27067144|FG005|Final Risk Group Assignment|Withdrawal by Subject|3|||
13494501|NCT00352534|27067145|FG006|Final Risk Group Assignment|Withdrawal by Subject|0|||
13494502|NCT00352534|27067139|FG000|Final Risk Group Assignment|Ineligible|0|||
13494503|NCT00352534|27067140|FG001|Final Risk Group Assignment|Ineligible|0|||
13494504|NCT00352534|27067141|FG002|Final Risk Group Assignment|Ineligible|3|||
13494505|NCT00352534|27067142|FG003|Final Risk Group Assignment|Ineligible|1|||
13494506|NCT00352534|27067143|FG004|Final Risk Group Assignment|Ineligible|0|||
13494507|NCT00352534|27067144|FG005|Final Risk Group Assignment|Ineligible|13|||
13494508|NCT00352534|27067145|FG006|Final Risk Group Assignment|Ineligible|0|||
13494509|NCT00352534|27067139|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0|||
13494510|NCT00352534|27067140|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0|||
13494511|NCT00352534|27067141|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0|||
13494512|NCT00352534|27067142|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0|||
13494513|NCT00352534|27067143|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0|||
13494514|NCT00352534|27067144|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0|||
13494515|NCT00352534|27067145|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28|||
13494516|NCT00352534|27067139|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
13494517|NCT00352534|27067140|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
13494518|NCT00352534|27067141|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
13494519|NCT00352534|27067142|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
13494520|NCT00352534|27067143|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
13494521|NCT00352534|27067144|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
13494522|NCT00352534|27067145|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11|||
13494523|NCT00352534|27067139|FG000|Final Risk Group Assignment|Death|0|||
13494524|NCT00352534|27067140|FG001|Final Risk Group Assignment|Death|0|||
13494525|NCT00352534|27067141|FG002|Final Risk Group Assignment|Death|0|||
13494526|NCT00352534|27067142|FG003|Final Risk Group Assignment|Death|0|||
13494527|NCT00352534|27067143|FG004|Final Risk Group Assignment|Death|0|||
13494528|NCT00352534|27067144|FG005|Final Risk Group Assignment|Death|2|||
13494529|NCT00352534|27067145|FG006|Final Risk Group Assignment|Death|0|||
13494530|NCT00033293|27067170|FG000|Overall Study|Death|0|||
13494531|NCT00033293|27067171|FG001|Overall Study|Death|1|||
13494532|NCT00033293|27067170|FG000|Overall Study|Lack of Efficacy|5|||
13494533|NCT00033293|27067171|FG001|Overall Study|Lack of Efficacy|8|||
13494534|NCT00033293|27067170|FG000|Overall Study|Lost to Follow-up|0|||
13494535|NCT00033293|27067171|FG001|Overall Study|Lost to Follow-up|1|||
13494536|NCT00033293|27067170|FG000|Overall Study|Physician Decision|3|||
13494537|NCT00033293|27067171|FG001|Overall Study|Physician Decision|1|||
13494538|NCT00033293|27067170|FG000|Overall Study|Withdrawal by Subject|1|||
13494539|NCT00033293|27067171|FG001|Overall Study|Withdrawal by Subject|0|||
13494540|NCT00033293|27067170|FG000|Overall Study|Could not be weaned from steroid therapy|1|||
13494541|NCT00033293|27067171|FG001|Overall Study|Could not be weaned from steroid therapy|1|||
13494542|NCT00033293|27067170|FG000|Overall Study|Treatment refused|0|||
13494543|NCT00033293|27067171|FG001|Overall Study|Treatment refused|6|||
13494544|NCT04497415|27067192|FG000|Overall Study|Lost to Follow-up|43|||
13494545|NCT04497415|27067193|FG001|Overall Study|Lost to Follow-up|27|||
13494546|NCT04594759|27067265|FG000|Overall Study|Lost to Follow-up|3|||
13494547|NCT04463069|27067288|FG000|Overall Study|Withdrawal by Subject|2|||
13494548|NCT04463069|27067289|FG001|Overall Study|Withdrawal by Subject|10|||
13494549|NCT04463069|27067288|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0|||
13494550|NCT04463069|27067289|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13|||
13494551|NCT04250337|27067362|FG000|Overall Study|Adverse Event|0|||
13494552|NCT04250337|27067363|FG001|Overall Study|Adverse Event|3|||
13494553|NCT04250337|27067362|FG000|Overall Study|Lack of Efficacy|1|||
13494554|NCT04250337|27067363|FG001|Overall Study|Lack of Efficacy|3|||
13494555|NCT04250337|27067362|FG000|Overall Study|Physician Decision|1|||
13494556|NCT04250337|27067363|FG001|Overall Study|Physician Decision|0|||
13494557|NCT04250337|27067362|FG000|Overall Study|Protocol Deviation|2|||
13494558|NCT04250337|27067363|FG001|Overall Study|Protocol Deviation|2|||
13494559|NCT04250337|27067362|FG000|Overall Study|Withdrawal by Subject|4|||
13494560|NCT04250337|27067363|FG001|Overall Study|Withdrawal by Subject|3|||
13494561|NCT03575572|27067422|FG000|Overall Study|Withdrawal by Subject|2|||
13494562|NCT03575572|27067422|FG000|Overall Study|Physician Decision|2|||
13494563|NCT03521687|27067434|FG000|Overall Study|Adverse Event|4|||
13494564|NCT03521687|27067434|FG000|Overall Study|Physician Decision|1|||
13494565|NCT02966301|27067477|FG000|Overall Study|Death|2|||
13494566|NCT02966301|27067477|FG000|Overall Study|Withdrawal by Subject|1|||
13494567|NCT02832167|27067510|FG000|Treatment Period 1|Disease progression|90|||
13494568|NCT02832167|27067510|FG000|Treatment Period 1|Adverse event unrelated to study drug|12|||
13494569|NCT02832167|27067510|FG000|Treatment Period 1|Death|2|||
13494570|NCT02832167|27067510|FG000|Treatment Period 1|Study Drug Toxicity|6|||
13494571|NCT02832167|27067510|FG000|Treatment Period 1|Participant request to discontinue|9|||
13494572|NCT02832167|27067510|FG000|Treatment Period 1|No longer meet study criteria|1|||
13494573|NCT02832167|27067510|FG000|Treatment Period 1|Participant withdrew consent|3|||
13494574|NCT02832167|27067510|FG000|Treatment Period 1|Other reasons|6|||
13494575|NCT02832167|27067510|FG000|Transition From Period 1 to Period 2|Other reasons|1|||
13494576|NCT02832167|27067510|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1|||
13494577|NCT02832167|27067510|FG000|Transition From Period 1 to Period 2|Death|2|||
13494578|NCT02832167|27067510|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3|||
13494579|NCT02832167|27067510|FG000|Treatment Period 2|Disease progression|69|||
13494580|NCT02832167|27067510|FG000|Treatment Period 2|Adverse event unrelated to study drug|1|||
13494581|NCT02832167|27067510|FG000|Treatment Period 2|Maximum clinical benefit|1|||
13494582|NCT02832167|27067510|FG000|Treatment Period 2|Study Drug Toxicity|5|||
13494583|NCT02832167|27067510|FG000|Treatment Period 2|Participant request to discontinue|2|||
13494584|NCT02832167|27067510|FG000|Treatment Period 2|Participant withdrew consent|3|||
13494585|NCT02832167|27067510|FG000|Treatment Period 2|Other reasons|3|||
13494586|NCT02728804|27067528|FG000|Overall Study|Ineligible|3|||
13494587|NCT02728804|27067528|FG000|Overall Study|Did not complete baseline questionnaire|9|||
13494588|NCT02728804|27067528|FG000|Overall Study|Death|99|||
13494589|NCT02699554|27067537|FG000|Overall Study|Lost to Follow-up|9|||
13494590|NCT02674529|27067553|FG000|Overall Study|Lost to Follow-up|1|||
13494591|NCT02674529|27067554|FG001|Overall Study|Lost to Follow-up|2|||
13494592|NCT02674529|27067553|FG000|Overall Study|Withdrawal by Subject|2|||
13494593|NCT02674529|27067554|FG001|Overall Study|Withdrawal by Subject|1|||
13494594|NCT02674529|27067553|FG000|Overall Study|Physician Decision|0|||
13494595|NCT02674529|27067554|FG001|Overall Study|Physician Decision|1|||
13494596|NCT02674529|27067553|FG000|Overall Study|Protocol Violation|0|||
13494597|NCT02674529|27067554|FG001|Overall Study|Protocol Violation|1|||
13494598|NCT02659020|27067642|FG000|Overall Study|Adverse Event|0|||
13494599|NCT02659020|27067643|FG001|Overall Study|Adverse Event|0|||
13494600|NCT02659020|27067644|FG002|Overall Study|Adverse Event|0|||
13494601|NCT02659020|27067645|FG003|Overall Study|Adverse Event|2|||
13494602|NCT02659020|27067646|FG004|Overall Study|Adverse Event|0|||
13494603|NCT02659020|27067647|FG005|Overall Study|Adverse Event|0|||
13494604|NCT02659020|27067648|FG006|Overall Study|Adverse Event|2|||
13494605|NCT02659020|27067642|FG000|Overall Study|Lost to Follow-up|1|||
13494606|NCT02659020|27067643|FG001|Overall Study|Lost to Follow-up|2|||
13494607|NCT02659020|27067644|FG002|Overall Study|Lost to Follow-up|1|||
13494608|NCT02659020|27067645|FG003|Overall Study|Lost to Follow-up|6|||
13494609|NCT02659020|27067646|FG004|Overall Study|Lost to Follow-up|1|||
13494610|NCT02659020|27067647|FG005|Overall Study|Lost to Follow-up|5|||
13494611|NCT02659020|27067648|FG006|Overall Study|Lost to Follow-up|0|||
13494612|NCT02659020|27067642|FG000|Overall Study|Physician Decision|0|||
13494613|NCT02659020|27067643|FG001|Overall Study|Physician Decision|0|||
13494614|NCT02659020|27067644|FG002|Overall Study|Physician Decision|0|||
13494615|NCT02659020|27067645|FG003|Overall Study|Physician Decision|1|||
13494616|NCT02659020|27067646|FG004|Overall Study|Physician Decision|1|||
13494617|NCT02659020|27067647|FG005|Overall Study|Physician Decision|0|||
13494618|NCT02659020|27067648|FG006|Overall Study|Physician Decision|1|||
13494619|NCT02659020|27067642|FG000|Overall Study|Withdrawal by Subject|2|||
13494620|NCT02659020|27067643|FG001|Overall Study|Withdrawal by Subject|1|||
13494621|NCT02659020|27067644|FG002|Overall Study|Withdrawal by Subject|0|||
13494622|NCT02659020|27067645|FG003|Overall Study|Withdrawal by Subject|3|||
13494623|NCT02659020|27067646|FG004|Overall Study|Withdrawal by Subject|3|||
13494624|NCT02659020|27067647|FG005|Overall Study|Withdrawal by Subject|6|||
13494625|NCT02659020|27067648|FG006|Overall Study|Withdrawal by Subject|3|||
13494626|NCT02659020|27067642|FG000|Overall Study|Progressive Disease|0|||
13494627|NCT02659020|27067643|FG001|Overall Study|Progressive Disease|0|||
13494628|NCT02659020|27067644|FG002|Overall Study|Progressive Disease|0|||
13494629|NCT02659020|27067645|FG003|Overall Study|Progressive Disease|4|||
13494630|NCT02659020|27067646|FG004|Overall Study|Progressive Disease|1|||
13494631|NCT02659020|27067647|FG005|Overall Study|Progressive Disease|0|||
13494632|NCT02659020|27067648|FG006|Overall Study|Progressive Disease|2|||
13494633|NCT02626949|27067671|FG000|Randomization, Pre-Enrollment|did not attend the baseline interview|15|||
13494634|NCT02626949|27067672|FG001|Randomization, Pre-Enrollment|did not attend the baseline interview|11|||
13494635|NCT02626949|27067671|FG000|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|1|||
13494636|NCT02626949|27067672|FG001|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|3|||
13494637|NCT02626949|27067671|FG000|Enrolled|Lost to Follow-up|7|||
13494638|NCT02626949|27067672|FG001|Enrolled|Lost to Follow-up|6|||
13494639|NCT02626949|27067671|FG000|Enrolled|Withdrawal by Subject|3|||
13494640|NCT02626949|27067672|FG001|Enrolled|Withdrawal by Subject|2|||
13494641|NCT02565914|27067728|FG000|Overall Study|Adverse Event|17|||
13494642|NCT02565914|27067728|FG000|Overall Study|Withdrawal of consent (not due to AE)|25|||
13494643|NCT02565914|27067728|FG000|Overall Study|Lost to Follow-up|12|||
13494644|NCT02565914|27067728|FG000|Overall Study|Death (not treatment emergent)|1|||
13494645|NCT02565914|27067728|FG000|Overall Study|Other noncompliance|6|||
13494646|NCT02565914|27067728|FG000|Overall Study|Physician Decision|6|||
13494647|NCT02565914|27067728|FG000|Overall Study|Parent study termination by sponsor|1|||
13494648|NCT02565914|27067728|FG000|Overall Study|Commercial drug available|5|||
13494649|NCT02565914|27067728|FG000|Overall Study|Other|18|||
13494650|NCT02565914|27067728|FG000|Overall Study|Enrolled, but did not receive study drug|2|||
13494651|NCT02385045|27067734|FG000|Overall Study|Endoscopy could not be completed|4|||
13494652|NCT01845649|27067785|FG000|Overall Study|Adverse Event|7|||
13494653|NCT01845649|27067786|FG001|Overall Study|Adverse Event|10|||
13494654|NCT01845649|27067785|FG000|Overall Study|Lack of Efficacy|1|||
13494655|NCT01845649|27067786|FG001|Overall Study|Lack of Efficacy|1|||
13494656|NCT01845649|27067785|FG000|Overall Study|Lost to Follow-up|2|||
13494657|NCT01845649|27067786|FG001|Overall Study|Lost to Follow-up|2|||
13494658|NCT01845649|27067785|FG000|Overall Study|Withdrew Consent|12|||
13494659|NCT01845649|27067786|FG001|Overall Study|Withdrew Consent|4|||
13494660|NCT01845649|27067785|FG000|Overall Study|Protocol Deviation|7|||
13494661|NCT01845649|27067786|FG001|Overall Study|Protocol Deviation|4|||
13494662|NCT01845649|27067785|FG000|Overall Study|Reason not Specified|2|||
13494663|NCT01845649|27067786|FG001|Overall Study|Reason not Specified|1|||
13494664|NCT01816139|27067817|FG000|Overall Study|Adverse Event|6|||
13494665|NCT01816139|27067818|FG001|Overall Study|Adverse Event|8|||
13494666|NCT01816139|27067817|FG000|Overall Study|Lack of Efficacy|1|||
13494667|NCT01816139|27067818|FG001|Overall Study|Lack of Efficacy|2|||
13494668|NCT01816139|27067817|FG000|Overall Study|Lost to Follow-up|5|||
13494669|NCT01816139|27067818|FG001|Overall Study|Lost to Follow-up|3|||
13494670|NCT01816139|27067817|FG000|Overall Study|Withdrew Consent|6|||
13494671|NCT01816139|27067818|FG001|Overall Study|Withdrew Consent|4|||
13494672|NCT01816139|27067817|FG000|Overall Study|Protocol Violation|6|||
13494673|NCT01816139|27067818|FG001|Overall Study|Protocol Violation|3|||
13494674|NCT01816139|27067817|FG000|Overall Study|Reason not Specified|4|||
13494675|NCT01816139|27067818|FG001|Overall Study|Reason not Specified|2|||
13494676|NCT01400776|27067905|FG000|Overall Study|Adverse Event|7|||
13494677|NCT01400776|27067906|FG001|Overall Study|Adverse Event|2|||
13494678|NCT01400776|27067907|FG002|Overall Study|Adverse Event|9|||
13494679|NCT01400776|27067908|FG003|Overall Study|Adverse Event|2|||
13494680|NCT01400776|27067905|FG000|Overall Study|Lost to Follow-up|1|||
13494681|NCT01400776|27067906|FG001|Overall Study|Lost to Follow-up|0|||
13494682|NCT01400776|27067907|FG002|Overall Study|Lost to Follow-up|4|||
13494683|NCT01400776|27067908|FG003|Overall Study|Lost to Follow-up|1|||
13494684|NCT01400776|27067905|FG000|Overall Study|Withdrew Consent|4|||
13494685|NCT01400776|27067906|FG001|Overall Study|Withdrew Consent|2|||
13494686|NCT01400776|27067907|FG002|Overall Study|Withdrew Consent|6|||
13494687|NCT01400776|27067908|FG003|Overall Study|Withdrew Consent|1|||
13494688|NCT01400776|27067905|FG000|Overall Study|Protocol Deviation|6|||
13494689|NCT01400776|27067906|FG001|Overall Study|Protocol Deviation|1|||
13494690|NCT01400776|27067907|FG002|Overall Study|Protocol Deviation|5|||
13494691|NCT01400776|27067908|FG003|Overall Study|Protocol Deviation|2|||
13494692|NCT01400776|27067905|FG000|Overall Study|Reason not Specified|3|||
13494693|NCT01400776|27067906|FG001|Overall Study|Reason not Specified|0|||
13494694|NCT01400776|27067907|FG002|Overall Study|Reason not Specified|4|||
13494695|NCT01400776|27067908|FG003|Overall Study|Reason not Specified|3|||
13494696|NCT00511134|27067923|FG000|Overall Study|Withdrawal by Subject|0|||
13494697|NCT00511134|27067924|FG001|Overall Study|Withdrawal by Subject|2|||
13494698|NCT03725293|27067971|FG000|Overall Study|Physician Decision|9|||
13494699|NCT03725293|27067972|FG001|Overall Study|Physician Decision|6|||
13494700|NCT03725293|27067971|FG000|Overall Study|alternative vascular access needs|1|||
13494701|NCT03725293|27067972|FG001|Overall Study|alternative vascular access needs|2|||
13494702|NCT03725293|27067971|FG000|Overall Study|venous anatomy screen failures|2|||
13494703|NCT03725293|27067972|FG001|Overall Study|venous anatomy screen failures|1|||
13494704|NCT03702231|27067996|FG000|Overall Study|Withdrawal by Subject|1|||
13494705|NCT03702231|27067997|FG001|Overall Study|Withdrawal by Subject|0|||
13494706|NCT03702231|27067998|FG002|Overall Study|Withdrawal by Subject|0|||
13494707|NCT03702231|27067996|FG000|Overall Study|Protocol Violation|0|||
13494708|NCT03702231|27067997|FG001|Overall Study|Protocol Violation|0|||
13494709|NCT03702231|27067998|FG002|Overall Study|Protocol Violation|1|||
13494710|NCT03702231|27067996|FG000|Overall Study|COVID Pandemic|3|||
13494711|NCT03702231|27067997|FG001|Overall Study|COVID Pandemic|4|||
13494712|NCT03702231|27067998|FG002|Overall Study|COVID Pandemic|1|||
13494713|NCT03556358|27068053|FG000|Overall Study|Subjects Randomized that did not Treat|3|||
13494714|NCT03556358|27068054|FG001|Overall Study|Subjects Randomized that did not Treat|0|||
13494715|NCT03556358|27068053|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7|||
13494716|NCT03556358|27068054|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5|||
13494717|NCT03556358|27068053|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0|||
13494718|NCT03556358|27068054|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1|||
13494719|NCT03556358|27068053|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0|||
13494720|NCT03556358|27068054|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1|||
13494721|NCT03556358|27068053|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0|||
13494722|NCT03556358|27068054|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2|||
13494723|NCT03556358|27068053|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0|||
13494724|NCT03556358|27068054|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1|||
13494725|NCT03556358|27068053|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1|||
13494726|NCT03556358|27068054|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2|||
13494727|NCT03290781|27068143|FG000|Overall Study|Adverse Event|5|||
13494728|NCT03290781|27068144|FG001|Overall Study|Adverse Event|7|||
13494729|NCT03290781|27068145|FG002|Overall Study|Adverse Event|4|||
13494730|NCT03290781|27068146|FG003|Overall Study|Adverse Event|1|||
13494731|NCT03290781|27068147|FG004|Overall Study|Adverse Event|0|||
13494732|NCT03290781|27068148|FG005|Overall Study|Adverse Event|0|||
13494733|NCT03290781|27068149|FG006|Overall Study|Adverse Event|0|||
13494734|NCT03290781|27068143|FG000|Overall Study|Death|0|||
13494735|NCT03290781|27068144|FG001|Overall Study|Death|0|||
13494736|NCT03290781|27068145|FG002|Overall Study|Death|1|||
13494737|NCT03290781|27068146|FG003|Overall Study|Death|0|||
13494738|NCT03290781|27068147|FG004|Overall Study|Death|1|||
13494739|NCT03290781|27068148|FG005|Overall Study|Death|0|||
13494740|NCT03290781|27068149|FG006|Overall Study|Death|0|||
13494741|NCT03290781|27068143|FG000|Overall Study|Withdrawal by Subject|6|||
13494742|NCT03290781|27068144|FG001|Overall Study|Withdrawal by Subject|5|||
13494743|NCT03290781|27068145|FG002|Overall Study|Withdrawal by Subject|9|||
13494744|NCT03290781|27068146|FG003|Overall Study|Withdrawal by Subject|10|||
13494745|NCT03290781|27068147|FG004|Overall Study|Withdrawal by Subject|1|||
13494746|NCT03290781|27068148|FG005|Overall Study|Withdrawal by Subject|2|||
13494747|NCT03290781|27068149|FG006|Overall Study|Withdrawal by Subject|0|||
13494748|NCT03290781|27068143|FG000|Overall Study|Physician Decision|0|||
13494749|NCT03290781|27068144|FG001|Overall Study|Physician Decision|1|||
13494750|NCT03290781|27068145|FG002|Overall Study|Physician Decision|0|||
13494751|NCT03290781|27068146|FG003|Overall Study|Physician Decision|0|||
13494752|NCT03290781|27068147|FG004|Overall Study|Physician Decision|0|||
13494753|NCT03290781|27068148|FG005|Overall Study|Physician Decision|0|||
13494754|NCT03290781|27068149|FG006|Overall Study|Physician Decision|0|||
13494755|NCT03290781|27068143|FG000|Overall Study|Site Terminated by Sponsor|1|||
13494756|NCT03290781|27068144|FG001|Overall Study|Site Terminated by Sponsor|0|||
13494757|NCT03290781|27068145|FG002|Overall Study|Site Terminated by Sponsor|2|||
13494758|NCT03290781|27068146|FG003|Overall Study|Site Terminated by Sponsor|1|||
13494759|NCT03290781|27068147|FG004|Overall Study|Site Terminated by Sponsor|0|||
13494760|NCT03290781|27068148|FG005|Overall Study|Site Terminated by Sponsor|0|||
13494761|NCT03290781|27068149|FG006|Overall Study|Site Terminated by Sponsor|0|||
13494762|NCT03290781|27068143|FG000|Overall Study|Lost to Follow-up|0|||
13494763|NCT03290781|27068144|FG001|Overall Study|Lost to Follow-up|0|||
13494764|NCT03290781|27068145|FG002|Overall Study|Lost to Follow-up|0|||
13494765|NCT03290781|27068146|FG003|Overall Study|Lost to Follow-up|1|||
13494766|NCT03290781|27068147|FG004|Overall Study|Lost to Follow-up|0|||
13494767|NCT03290781|27068148|FG005|Overall Study|Lost to Follow-up|0|||
13494768|NCT03290781|27068149|FG006|Overall Study|Lost to Follow-up|0|||
13494769|NCT03290781|27068143|FG000|Overall Study|Protocol Deviation|2|||
13494770|NCT03290781|27068144|FG001|Overall Study|Protocol Deviation|0|||
13494771|NCT03290781|27068145|FG002|Overall Study|Protocol Deviation|0|||
13494772|NCT03290781|27068146|FG003|Overall Study|Protocol Deviation|1|||
13494773|NCT03290781|27068147|FG004|Overall Study|Protocol Deviation|0|||
13494774|NCT03290781|27068148|FG005|Overall Study|Protocol Deviation|0|||
13494775|NCT03290781|27068149|FG006|Overall Study|Protocol Deviation|0|||
13494776|NCT03290781|27068143|FG000|Overall Study|Disease Relapse|32|||
13494777|NCT03290781|27068144|FG001|Overall Study|Disease Relapse|5|||
13494778|NCT03290781|27068145|FG002|Overall Study|Disease Relapse|38|||
13494779|NCT03290781|27068146|FG003|Overall Study|Disease Relapse|7|||
13494780|NCT03290781|27068147|FG004|Overall Study|Disease Relapse|3|||
13494781|NCT03290781|27068148|FG005|Overall Study|Disease Relapse|1|||
13494782|NCT03290781|27068149|FG006|Overall Study|Disease Relapse|4|||
13494783|NCT03290781|27068143|FG000|Overall Study|Other|3|||
13494784|NCT03290781|27068144|FG001|Overall Study|Other|0|||
13494785|NCT03290781|27068145|FG002|Overall Study|Other|2|||
13494786|NCT03290781|27068146|FG003|Overall Study|Other|2|||
13494787|NCT03290781|27068147|FG004|Overall Study|Other|0|||
13494788|NCT03290781|27068148|FG005|Overall Study|Other|0|||
13494789|NCT03290781|27068149|FG006|Overall Study|Other|0|||
13494790|NCT03228680|27068313|FG000|Overall Study|Adverse Event|13|||
13494791|NCT03228680|27068314|FG001|Overall Study|Adverse Event|18|||
13494792|NCT03228680|27068313|FG000|Overall Study|Randomization failure|0|||
13494793|NCT03228680|27068314|FG001|Overall Study|Randomization failure|1|||
13494794|NCT03228680|27068313|FG000|Overall Study|Withdrawal by Subject|1|||
13494795|NCT03228680|27068314|FG001|Overall Study|Withdrawal by Subject|0|||
13494796|NCT03228680|27068313|FG000|Overall Study|Other|9|||
13494797|NCT03228680|27068314|FG001|Overall Study|Other|16|||
13494798|NCT02679781|27068410|FG000|Overall Study|Lost to Follow-up|1|||
13494799|NCT02679781|27068411|FG001|Overall Study|Lost to Follow-up|2|||
13494800|NCT02679781|27068410|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6|||
13494801|NCT02679781|27068411|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1|||
13494802|NCT02624869|27068486|FG000|Overall Study|Lost to Follow-up|0|||
13494803|NCT02624869|27068487|FG001|Overall Study|Lost to Follow-up|0|||
13494804|NCT02624869|27068488|FG002|Overall Study|Lost to Follow-up|1|||
13494805|NCT02624869|27068486|FG000|Overall Study|Withdrawal by Subject|1|||
13494806|NCT02624869|27068487|FG001|Overall Study|Withdrawal by Subject|3|||
13494807|NCT02624869|27068488|FG002|Overall Study|Withdrawal by Subject|1|||
13494808|NCT02435433|27068604|FG000|Overall Study|Withdrawal by Subject|2|||
13494809|NCT02435433|27068605|FG001|Overall Study|Withdrawal by Subject|3|||
13494810|NCT02435433|27068606|FG002|Overall Study|Withdrawal by Subject|1|||
13494811|NCT02435433|27068607|FG003|Overall Study|Withdrawal by Subject|0|||
13494812|NCT02435433|27068608|FG004|Overall Study|Withdrawal by Subject|0|||
13494813|NCT02435433|27068604|FG000|Overall Study|Lost to Follow-up|2|||
13494814|NCT02435433|27068605|FG001|Overall Study|Lost to Follow-up|2|||
13494815|NCT02435433|27068606|FG002|Overall Study|Lost to Follow-up|4|||
13494816|NCT02435433|27068607|FG003|Overall Study|Lost to Follow-up|1|||
13494817|NCT02435433|27068608|FG004|Overall Study|Lost to Follow-up|0|||
13494818|NCT02368886|27068655|FG000|Overall Study|Cancel|1|||
13494819|NCT02368886|27068656|FG001|Overall Study|Cancel|1|||
13494820|NCT02368886|27068657|FG002|Overall Study|Cancel|1|||
13494821|NCT02368886|27068658|FG003|Overall Study|Cancel|3|||
13494822|NCT02368886|27068655|FG000|Overall Study|Ineligible|0|||
13494823|NCT02368886|27068656|FG001|Overall Study|Ineligible|0|||
13494824|NCT02368886|27068657|FG002|Overall Study|Ineligible|0|||
13494825|NCT02368886|27068658|FG003|Overall Study|Ineligible|1|||
13494826|NCT02354703|27068689|FG000|Overall Study|Withdrawal by Subject|1|||
13494827|NCT02354703|27068690|FG001|Overall Study|Withdrawal by Subject|1|||
13494828|NCT02354703|27068691|FG002|Overall Study|Withdrawal by Subject|1|||
13494829|NCT02354703|27068692|FG003|Overall Study|Withdrawal by Subject|1|||
13494830|NCT02354703|27068689|FG000|Overall Study|Lost to Follow-up|2|||
13494831|NCT02354703|27068690|FG001|Overall Study|Lost to Follow-up|7|||
13494832|NCT02354703|27068691|FG002|Overall Study|Lost to Follow-up|9|||
13494833|NCT02354703|27068692|FG003|Overall Study|Lost to Follow-up|2|||
13494834|NCT02354703|27068689|FG000|Overall Study|Adverse Event|0|||
13494835|NCT02354703|27068690|FG001|Overall Study|Adverse Event|0|||
13494836|NCT02354703|27068691|FG002|Overall Study|Adverse Event|1|||
13494837|NCT02354703|27068692|FG003|Overall Study|Adverse Event|0|||
13494838|NCT00468130|27068713|FG000|Overall Study|Adverse Event|2|||
13494839|NCT00468130|27068714|FG001|Overall Study|Adverse Event|1|||
13494840|NCT00468130|27068713|FG000|Overall Study|Withdrawal by Subject|0|||
13494841|NCT00468130|27068714|FG001|Overall Study|Withdrawal by Subject|1|||
13494842|NCT00384111|27068721|FG000|Overall Study|Disease Progression|3|||
13494843|NCT00384111|27068721|FG000|Overall Study|Adverse Event|1|||
13494844|NCT00384111|27068721|FG000|Overall Study|Investigator Decision|3|||
13494845|NCT00384111|27068721|FG000|Overall Study|Study Terminated by the Sponsor|19|||
13494846|NCT04854642|27068761|FG000|Overall Study|Adverse Event|1|||
13494847|NCT04854642|27068762|FG001|Overall Study|Adverse Event|2|||
13494848|NCT04854642|27068761|FG000|Overall Study|Withdrawal by Subject|0|||
13494849|NCT04854642|27068762|FG001|Overall Study|Withdrawal by Subject|1|||
13494850|NCT04495816|27068842|FG000|Overall Study|Lost to Follow-up|10|||
13494851|NCT04495816|27068843|FG001|Overall Study|Lost to Follow-up|4|||
13494852|NCT04495816|27068842|FG000|Overall Study|Withdrawal by Subject|3|||
13494853|NCT04495816|27068843|FG001|Overall Study|Withdrawal by Subject|5|||
13494854|NCT04421131|27068862|FG000|Overall Study|Lost to Follow-up|1|||
13494855|NCT04421131|27068862|FG000|Overall Study|Protocol Violation|2|||
13494856|NCT04421131|27068862|FG000|Overall Study|App crashed|5|||
13494857|NCT04388787|27068875|FG000|Blinded Period|Patient could not follow instructions|1|||
13494858|NCT04388787|27068875|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9|||
13494859|NCT04377620|27068952|FG000|Overall Study|Death|42|||
13494860|NCT04377620|27068953|FG001|Overall Study|Death|48|||
13494861|NCT04377620|27068954|FG002|Overall Study|Death|36|||
13494862|NCT04377620|27068952|FG000|Overall Study|Withdrawal by Subject|0|||
13494863|NCT04377620|27068953|FG001|Overall Study|Withdrawal by Subject|2|||
13494864|NCT04377620|27068954|FG002|Overall Study|Withdrawal by Subject|0|||
13494865|NCT04310566|27069018|FG000|Period 1|Study Termination due to COVID-19|15|||
13494866|NCT04310566|27069019|FG001|Period 1|Study Termination due to COVID-19|17|||
13494867|NCT04310566|27069018|FG000|Period 1|Protocol Violation|0|||
13494868|NCT04310566|27069019|FG001|Period 1|Protocol Violation|1|||
13494869|NCT04310566|27069018|FG000|Period 1|Subject no longer meets eligbility criteria|0|||
13494870|NCT04310566|27069019|FG001|Period 1|Subject no longer meets eligbility criteria|1|||
13494871|NCT04310566|27069018|FG000|Period 1|Lost to Follow-up|1|||
13494872|NCT04310566|27069019|FG001|Period 1|Lost to Follow-up|0|||
13494873|NCT04310566|27069018|FG000|Period 1|Withdrawal by Subject|0|||
13494874|NCT04310566|27069019|FG001|Period 1|Withdrawal by Subject|1|||
13494875|NCT04310566|27069018|FG000|Period 2|Study Termination|7|||
13494876|NCT04310566|27069019|FG001|Period 2|Study Termination|5|||
13494877|NCT04206020|27069034|FG000|Overall Study|Adverse Event|1|||
13494878|NCT04206020|27069035|FG001|Overall Study|Adverse Event|4|||
13494879|NCT04206020|27069034|FG000|Overall Study|Protocol Violation|2|||
13494880|NCT04206020|27069035|FG001|Overall Study|Protocol Violation|0|||
13494881|NCT04206020|27069034|FG000|Overall Study|Withdrawal by Subject|2|||
13494882|NCT04206020|27069035|FG001|Overall Study|Withdrawal by Subject|0|||
13494883|NCT04206020|27069034|FG000|Overall Study|Lost to Follow-up|2|||
13494884|NCT04206020|27069035|FG001|Overall Study|Lost to Follow-up|0|||
13494885|NCT04206020|27069034|FG000|Overall Study|Pregnancy|0|||
13494886|NCT04206020|27069035|FG001|Overall Study|Pregnancy|1|||
13494887|NCT04206020|27069034|FG000|Overall Study|Unable to attend visits|1|||
13494888|NCT04206020|27069035|FG001|Overall Study|Unable to attend visits|2|||
13494889|NCT04097301|27069056|FG000|Overall Study|Death|1|||
13494890|NCT04097301|27069056|FG000|Overall Study|Withdrawal by Subject|1|||
13494891|NCT04097301|27069056|FG000|Overall Study|Screening Failure|5|||
13494892|NCT03953079|27069108|FG000|Core Study|Withdrawal by Subject|1|||
13494893|NCT03953079|27069109|FG001|Core Study|Withdrawal by Subject|2|||
13494894|NCT03953079|27069110|FG002|Core Study|Withdrawal by Subject|1|||
13494895|NCT03953079|27069108|FG000|Core Study|COVID-19|0|||
13494896|NCT03953079|27069109|FG001|Core Study|COVID-19|1|||
13494897|NCT03953079|27069110|FG002|Core Study|COVID-19|0|||
13494898|NCT03953079|27069108|FG000|Core Study|Difficulties leaving the house|0|||
13494899|NCT03953079|27069109|FG001|Core Study|Difficulties leaving the house|1|||
13494900|NCT03953079|27069110|FG002|Core Study|Difficulties leaving the house|0|||
13494901|NCT03953079|27069108|FG000|Extension Study|Withdrawal by Subject|1|||
13494902|NCT03953079|27069109|FG001|Extension Study|Withdrawal by Subject|0|||
13494903|NCT03953079|27069110|FG002|Extension Study|Withdrawal by Subject|0|||
13494904|NCT03953079|27069108|FG000|Extension Study|Received Rescue Treatment|5|||
13494905|NCT03953079|27069109|FG001|Extension Study|Received Rescue Treatment|6|||
13494906|NCT03953079|27069110|FG002|Extension Study|Received Rescue Treatment|5|||
13494907|NCT03922750|27069152|FG000|Overall Study|Unclassified|0|||
13494908|NCT03922750|27069153|FG001|Overall Study|Unclassified|0|||
13494909|NCT03922750|27069154|FG002|Overall Study|Unclassified|1|||
13494910|NCT03922750|27069152|FG000|Overall Study|Adverse Event|0|||
13494911|NCT03922750|27069153|FG001|Overall Study|Adverse Event|1|||
13494912|NCT03922750|27069154|FG002|Overall Study|Adverse Event|0|||
13494913|NCT03910673|27069189|FG000|Overall Study|Adverse Event|0|||
13494914|NCT03910673|27069190|FG001|Overall Study|Adverse Event|0|||
13494915|NCT03910673|27069191|FG002|Overall Study|Adverse Event|0|||
13494916|NCT03910673|27069192|FG003|Overall Study|Adverse Event|2|||
13494917|NCT03910673|27069193|FG004|Overall Study|Adverse Event|0|||
13494918|NCT03885999|27069199|FG000|Overall Study|Adverse Event|1|||
13494919|NCT03882970|27069251|FG000|Overall Study|Adverse Event|5|||
13494920|NCT03882970|27069252|FG001|Overall Study|Adverse Event|7|||
13494921|NCT03882970|27069253|FG002|Overall Study|Adverse Event|3|||
13494922|NCT03882970|27069254|FG003|Overall Study|Adverse Event|1|||
13494923|NCT03882970|27069251|FG000|Overall Study|Death|1|||
13494924|NCT03882970|27069252|FG001|Overall Study|Death|2|||
13494925|NCT03882970|27069253|FG002|Overall Study|Death|1|||
13494926|NCT03882970|27069254|FG003|Overall Study|Death|1|||
13494927|NCT03882970|27069251|FG000|Overall Study|Lost to Follow-up|8|||
13494928|NCT03882970|27069252|FG001|Overall Study|Lost to Follow-up|9|||
13494929|NCT03882970|27069253|FG002|Overall Study|Lost to Follow-up|5|||
13494930|NCT03882970|27069254|FG003|Overall Study|Lost to Follow-up|5|||
13494931|NCT03882970|27069251|FG000|Overall Study|Physician Decision|0|||
13494932|NCT03882970|27069252|FG001|Overall Study|Physician Decision|2|||
13494933|NCT03882970|27069253|FG002|Overall Study|Physician Decision|2|||
13494934|NCT03882970|27069254|FG003|Overall Study|Physician Decision|2|||
13494935|NCT03882970|27069251|FG000|Overall Study|Protocol Violation|2|||
13494936|NCT03882970|27069252|FG001|Overall Study|Protocol Violation|0|||
13494937|NCT03882970|27069253|FG002|Overall Study|Protocol Violation|0|||
13494938|NCT03882970|27069254|FG003|Overall Study|Protocol Violation|0|||
13494939|NCT03882970|27069251|FG000|Overall Study|Withdrawal by Subject|8|||
13494940|NCT03882970|27069252|FG001|Overall Study|Withdrawal by Subject|17|||
13494941|NCT03882970|27069253|FG002|Overall Study|Withdrawal by Subject|7|||
13494942|NCT03882970|27069254|FG003|Overall Study|Withdrawal by Subject|22|||
13494943|NCT03882970|27069251|FG000|Overall Study|Personal Reason|2|||
13494944|NCT03882970|27069252|FG001|Overall Study|Personal Reason|3|||
13494945|NCT03882970|27069253|FG002|Overall Study|Personal Reason|1|||
13494946|NCT03882970|27069254|FG003|Overall Study|Personal Reason|3|||
13494947|NCT03867734|27069296|FG000|Overall Study|Lost to Follow-up|2|||
13494948|NCT03730480|27069326|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1|||
13494949|NCT03567057|27069505|FG000|Overall Study|Adverse Event|56|||
13494950|NCT03567057|27069506|FG001|Overall Study|Adverse Event|53|||
13494951|NCT03567057|27069507|FG002|Overall Study|Adverse Event|28|||
13494952|NCT03567057|27069505|FG000|Overall Study|Withdrawal by Subject|22|||
13494953|NCT03567057|27069506|FG001|Overall Study|Withdrawal by Subject|24|||
13494954|NCT03567057|27069507|FG002|Overall Study|Withdrawal by Subject|13|||
13494955|NCT03567057|27069505|FG000|Overall Study|Lost to Follow-up|3|||
13494956|NCT03567057|27069506|FG001|Overall Study|Lost to Follow-up|5|||
13494957|NCT03567057|27069507|FG002|Overall Study|Lost to Follow-up|2|||
13494958|NCT03567057|27069505|FG000|Overall Study|COVID-19 pandemic|4|||
13494959|NCT03567057|27069506|FG001|Overall Study|COVID-19 pandemic|3|||
13494960|NCT03567057|27069507|FG002|Overall Study|COVID-19 pandemic|0|||
13494961|NCT03567057|27069505|FG000|Overall Study|Non-compliance with study drug|4|||
13494962|NCT03567057|27069506|FG001|Overall Study|Non-compliance with study drug|2|||
13494963|NCT03567057|27069507|FG002|Overall Study|Non-compliance with study drug|0|||
13494964|NCT03567057|27069505|FG000|Overall Study|Lack of Efficacy|3|||
13494965|NCT03567057|27069506|FG001|Overall Study|Lack of Efficacy|0|||
13494966|NCT03567057|27069507|FG002|Overall Study|Lack of Efficacy|1|||
13494967|NCT03567057|27069505|FG000|Overall Study|Death|1|||
13494968|NCT03567057|27069506|FG001|Overall Study|Death|0|||
13494969|NCT03567057|27069507|FG002|Overall Study|Death|0|||
13494970|NCT03567057|27069505|FG000|Overall Study|Physician Decision|1|||
13494971|NCT03567057|27069506|FG001|Overall Study|Physician Decision|0|||
13494972|NCT03567057|27069507|FG002|Overall Study|Physician Decision|0|||
13494973|NCT03567057|27069505|FG000|Overall Study|Unstable medical condition|1|||
13494974|NCT03567057|27069506|FG001|Overall Study|Unstable medical condition|0|||
13494975|NCT03567057|27069507|FG002|Overall Study|Unstable medical condition|0|||
13494976|NCT03567057|27069505|FG000|Overall Study|Medical history event|0|||
13494977|NCT03567057|27069506|FG001|Overall Study|Medical history event|0|||
13494978|NCT03567057|27069507|FG002|Overall Study|Medical history event|1|||
13494979|NCT03567057|27069505|FG000|Overall Study|Other|0|||
13494980|NCT03567057|27069506|FG001|Overall Study|Other|0|||
13494981|NCT03567057|27069507|FG002|Overall Study|Other|1|||
13494982|NCT03548987|27069593|FG000|Run-in Period (Week 0 to Week 20)|Other|9|||
13494983|NCT03548987|27069594|FG001|Run-in Period (Week 0 to Week 20)|Other|0|||
13494984|NCT03548987|27069593|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8|||
13494985|NCT03548987|27069594|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0|||
13494986|NCT03548987|27069593|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11|||
13494987|NCT03548987|27069594|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0|||
13494988|NCT03548987|27069593|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2|||
13494989|NCT03548987|27069594|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0|||
13494990|NCT03548987|27069593|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19|||
13494991|NCT03548987|27069594|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0|||
13494992|NCT03548987|27069593|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1|||
13494993|NCT03548987|27069594|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0|||
13494994|NCT03548987|27069593|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1|||
13494995|NCT03548987|27069594|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0|||
13494996|NCT03548987|27069593|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48|||
13494997|NCT03548987|27069594|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0|||
13494998|NCT03548987|27069593|FG000|Maintenance Period (Week 20 to Week 68)|other|12|||
13494999|NCT03548987|27069594|FG001|Maintenance Period (Week 20 to Week 68)|other|23|||
13495000|NCT03548987|27069593|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2|||
13495001|NCT03548987|27069594|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1|||
13495002|NCT03548987|27069593|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
13495003|NCT03548987|27069594|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
13495004|NCT03548987|27069593|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2|||
13495005|NCT03548987|27069594|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0|||
13495006|NCT03548987|27069593|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1|||
13495007|NCT03548987|27069594|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0|||
13495008|NCT03548987|27069593|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13|||
13495009|NCT03548987|27069594|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6|||
13495010|NCT03548064|27069741|FG000|Overall Study|Withdrawal by Subject|0|||
13495011|NCT03548064|27069742|FG001|Overall Study|Withdrawal by Subject|0|||
13495012|NCT03548064|27069743|FG002|Overall Study|Withdrawal by Subject|0|||
13495013|NCT03548064|27069744|FG003|Overall Study|Withdrawal by Subject|1|||
13495014|NCT03548064|27069745|FG004|Overall Study|Withdrawal by Subject|0|||
13495015|NCT03548064|27069746|FG005|Overall Study|Withdrawal by Subject|0|||
13495016|NCT03548064|27069747|FG006|Overall Study|Withdrawal by Subject|0|||
13495017|NCT03548064|27069748|FG007|Overall Study|Withdrawal by Subject|0|||
13495018|NCT03548064|27069741|FG000|Overall Study|Lost to Follow-up|0|||
13495019|NCT03548064|27069742|FG001|Overall Study|Lost to Follow-up|0|||
13495020|NCT03548064|27069743|FG002|Overall Study|Lost to Follow-up|0|||
13495021|NCT03548064|27069744|FG003|Overall Study|Lost to Follow-up|0|||
13495022|NCT03548064|27069745|FG004|Overall Study|Lost to Follow-up|2|||
13495023|NCT03548064|27069746|FG005|Overall Study|Lost to Follow-up|0|||
13495024|NCT03548064|27069747|FG006|Overall Study|Lost to Follow-up|0|||
13495025|NCT03548064|27069748|FG007|Overall Study|Lost to Follow-up|0|||
13495026|NCT03548064|27069741|FG000|Overall Study|Covid-19 Pandemic|0|||
13495027|NCT03548064|27069742|FG001|Overall Study|Covid-19 Pandemic|0|||
13495028|NCT03548064|27069743|FG002|Overall Study|Covid-19 Pandemic|0|||
13495029|NCT03548064|27069744|FG003|Overall Study|Covid-19 Pandemic|0|||
13495030|NCT03548064|27069745|FG004|Overall Study|Covid-19 Pandemic|10|||
13495031|NCT03548064|27069746|FG005|Overall Study|Covid-19 Pandemic|3|||
13495032|NCT03548064|27069747|FG006|Overall Study|Covid-19 Pandemic|0|||
13495033|NCT03548064|27069748|FG007|Overall Study|Covid-19 Pandemic|0|||
13495034|NCT03446456|27069767|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
13495035|NCT03446456|27069768|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
13495036|NCT03446456|27069767|FG000|Overall Study|Lost to Follow-up|1|||
13495037|NCT03446456|27069768|FG001|Overall Study|Lost to Follow-up|3|||
13495038|NCT03446456|27069767|FG000|Overall Study|Participant failed the toxicology test|1|||
13495039|NCT03446456|27069768|FG001|Overall Study|Participant failed the toxicology test|0|||
13495040|NCT03446456|27069767|FG000|Overall Study|Break down of the experimental equipment|1|||
13495041|NCT03446456|27069768|FG001|Overall Study|Break down of the experimental equipment|0|||
13495042|NCT03382834|27069787|FG000|Overall Study|Lost to Follow-up|1|||
13495043|NCT03382834|27069788|FG001|Overall Study|Lost to Follow-up|0|||
13495044|NCT03382834|27069787|FG000|Overall Study|Withdrawal by Subject|0|||
13495045|NCT03382834|27069788|FG001|Overall Study|Withdrawal by Subject|1|||
13495046|NCT03371823|27069803|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1|||
13495047|NCT03371823|27069804|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0|||
13495048|NCT03353350|27069859|FG000|30-week Core Treatment Period|Protocol Violation|1|||
13495049|NCT03353350|27069860|FG001|30-week Core Treatment Period|Protocol Violation|1|||
13495050|NCT03353350|27069861|FG002|30-week Core Treatment Period|Protocol Violation|1|||
13495051|NCT03353350|27069862|FG003|30-week Core Treatment Period|Protocol Violation|0|||
13495052|NCT03353350|27069859|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
13495053|NCT03353350|27069860|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
13495054|NCT03353350|27069861|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
13495055|NCT03353350|27069862|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0|||
13495056|NCT03353350|27069859|FG000|30-week Core Treatment Period|Adverse Event|0|||
13495057|NCT03353350|27069860|FG001|30-week Core Treatment Period|Adverse Event|4|||
13495058|NCT03353350|27069861|FG002|30-week Core Treatment Period|Adverse Event|2|||
13495059|NCT03353350|27069862|FG003|30-week Core Treatment Period|Adverse Event|3|||
13495060|NCT03353350|27069859|FG000|30-week Core Treatment Period|Withdrawal by Subject|19|||
13495061|NCT03353350|27069860|FG001|30-week Core Treatment Period|Withdrawal by Subject|12|||
13495062|NCT03353350|27069861|FG002|30-week Core Treatment Period|Withdrawal by Subject|19|||
13495063|NCT03353350|27069862|FG003|30-week Core Treatment Period|Withdrawal by Subject|19|||
13495064|NCT03353350|27069859|FG000|26-week Treatment Extension Period|Protocol Violation|2|||
13495065|NCT03353350|27069860|FG001|26-week Treatment Extension Period|Protocol Violation|0|||
13495066|NCT03353350|27069861|FG002|26-week Treatment Extension Period|Protocol Violation|0|||
13495067|NCT03353350|27069862|FG003|26-week Treatment Extension Period|Protocol Violation|0|||
13495068|NCT03353350|27069859|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
13495069|NCT03353350|27069860|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
13495070|NCT03353350|27069861|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
13495071|NCT03353350|27069862|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
13495072|NCT03353350|27069859|FG000|26-week Treatment Extension Period|Adverse Event|1|||
13495073|NCT03353350|27069860|FG001|26-week Treatment Extension Period|Adverse Event|0|||
13495074|NCT03353350|27069861|FG002|26-week Treatment Extension Period|Adverse Event|0|||
13495075|NCT03353350|27069862|FG003|26-week Treatment Extension Period|Adverse Event|1|||
13495076|NCT03353350|27069859|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2|||
13495077|NCT03353350|27069860|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3|||
13495078|NCT03353350|27069861|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3|||
13381436|NCT00753415|26748246|FG002|Part A|Disease progression|1|||
13381437|NCT00753415|26748247|FG003|Part A|Disease progression|2|||
13381438|NCT00753415|26748248|FG004|Part A|Disease progression|0|||
13381439|NCT00753415|26748249|FG005|Part A|Disease progression|0|||
13381440|NCT00753415|26748250|FG006|Part A|Disease progression|0|||
13381441|NCT00753415|26748251|FG007|Part A|Disease progression|0|||
13381442|NCT00753415|26748252|FG008|Part A|Disease progression|0|||
13381443|NCT00753415|26748253|FG009|Part A|Disease progression|0|||
13495079|NCT03353350|27069862|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12|||
13495080|NCT03282565|27069907|FG000|Overall Study|COVID-19 Research Shutdown|0|||
13495081|NCT03282565|27069908|FG001|Overall Study|COVID-19 Research Shutdown|2|||
13495082|NCT03282565|27069909|FG002|Overall Study|COVID-19 Research Shutdown|2|||
13495083|NCT03255083|27069972|FG000|Overall Study|Clinical progression|1|||
13495084|NCT03255083|27069973|FG001|Overall Study|Clinical progression|0|||
13495085|NCT03255083|27069974|FG002|Overall Study|Clinical progression|0|||
13495086|NCT03255083|27069975|FG003|Overall Study|Clinical progression|0|||
13495087|NCT03255083|27069972|FG000|Overall Study|Adverse Event|0|||
13495088|NCT03255083|27069973|FG001|Overall Study|Adverse Event|1|||
13495089|NCT03255083|27069974|FG002|Overall Study|Adverse Event|0|||
13495090|NCT03255083|27069975|FG003|Overall Study|Adverse Event|0|||
13495091|NCT03255083|27069972|FG000|Overall Study|Progressive disease by RECIST version 1.1|4|||
13495092|NCT03255083|27069973|FG001|Overall Study|Progressive disease by RECIST version 1.1|1|||
13495093|NCT03255083|27069974|FG002|Overall Study|Progressive disease by RECIST version 1.1|2|||
13495094|NCT03255083|27069975|FG003|Overall Study|Progressive disease by RECIST version 1.1|1|||
13495095|NCT03255083|27069972|FG000|Overall Study|Withdrawal by Subject|1|||
13495096|NCT03255083|27069973|FG001|Overall Study|Withdrawal by Subject|1|||
13495097|NCT03255083|27069974|FG002|Overall Study|Withdrawal by Subject|1|||
13495098|NCT03255083|27069975|FG003|Overall Study|Withdrawal by Subject|0|||
13495099|NCT03227471|27070135|FG000|Overall Study|Withdrawal by Subject|0|||
13495100|NCT03227471|27070136|FG001|Overall Study|Withdrawal by Subject|0|||
13495101|NCT03227471|27070137|FG002|Overall Study|Withdrawal by Subject|0|||
13495102|NCT03227471|27070138|FG003|Overall Study|Withdrawal by Subject|0|||
13495103|NCT03227471|27070139|FG004|Overall Study|Withdrawal by Subject|1|||
13381444|NCT00753415|26748244|FG000|Part A|Withdrawal by Subject|0|||
13495104|NCT03227471|27070140|FG005|Overall Study|Withdrawal by Subject|0|||
13495105|NCT03227471|27070141|FG006|Overall Study|Withdrawal by Subject|0|||
13495106|NCT03227471|27070142|FG007|Overall Study|Withdrawal by Subject|0|||
13495107|NCT03227471|27070143|FG008|Overall Study|Withdrawal by Subject|0|||
13495108|NCT03227471|27070144|FG009|Overall Study|Withdrawal by Subject|0|||
13495109|NCT03227471|27070145|FG010|Overall Study|Withdrawal by Subject|0|||
13495110|NCT03227471|27070146|FG011|Overall Study|Withdrawal by Subject|0|||
13495111|NCT03227471|27070147|FG012|Overall Study|Withdrawal by Subject|1|||
13495112|NCT03227471|27070148|FG013|Overall Study|Withdrawal by Subject|0|||
13495113|NCT03227471|27070149|FG014|Overall Study|Withdrawal by Subject|0|||
13495114|NCT03227471|27070135|FG000|Overall Study|Randomized, Never Dosed|0|||
13495115|NCT03227471|27070136|FG001|Overall Study|Randomized, Never Dosed|0|||
13495116|NCT03227471|27070137|FG002|Overall Study|Randomized, Never Dosed|0|||
13495117|NCT03227471|27070138|FG003|Overall Study|Randomized, Never Dosed|0|||
13495118|NCT03227471|27070139|FG004|Overall Study|Randomized, Never Dosed|0|||
13495119|NCT03227471|27070140|FG005|Overall Study|Randomized, Never Dosed|0|||
13495120|NCT03227471|27070141|FG006|Overall Study|Randomized, Never Dosed|0|||
13495121|NCT03227471|27070142|FG007|Overall Study|Randomized, Never Dosed|0|||
13495122|NCT03227471|27070143|FG008|Overall Study|Randomized, Never Dosed|0|||
13495123|NCT03227471|27070144|FG009|Overall Study|Randomized, Never Dosed|0|||
13495124|NCT03227471|27070145|FG010|Overall Study|Randomized, Never Dosed|0|||
13495125|NCT03227471|27070146|FG011|Overall Study|Randomized, Never Dosed|0|||
13495126|NCT03227471|27070147|FG012|Overall Study|Randomized, Never Dosed|0|||
13495127|NCT03227471|27070148|FG013|Overall Study|Randomized, Never Dosed|0|||
13495128|NCT03227471|27070149|FG014|Overall Study|Randomized, Never Dosed|1|||
13495129|NCT03194321|27070157|FG000|Overall Study|Withdrawal by Subject|1|||
13495130|NCT03194321|27070157|FG000|Overall Study|Lost to Follow-up|1|||
13495131|NCT03194321|27070157|FG000|Overall Study|Travel for Follow-up|1|||
13495132|NCT03085095|27070222|FG000|Overall Study|Adverse Event|23|||
13495133|NCT03085095|27070223|FG001|Overall Study|Adverse Event|8|||
13495134|NCT03085095|27070222|FG000|Overall Study|Protocol Violation|0|||
13495135|NCT03085095|27070223|FG001|Overall Study|Protocol Violation|1|||
13495136|NCT03085095|27070222|FG000|Overall Study|Lost to Follow-up|2|||
13495137|NCT03085095|27070223|FG001|Overall Study|Lost to Follow-up|1|||
13495138|NCT03085095|27070222|FG000|Overall Study|Withdrawal by Subject|17|||
13495139|NCT03085095|27070223|FG001|Overall Study|Withdrawal by Subject|6|||
13495140|NCT03085095|27070222|FG000|Overall Study|Physician Decision|9|||
13495141|NCT03085095|27070223|FG001|Overall Study|Physician Decision|3|||
13495142|NCT03085095|27070222|FG000|Overall Study|Testosterone Suppression Level Not Met|7|||
13495143|NCT03085095|27070223|FG001|Overall Study|Testosterone Suppression Level Not Met|13|||
13495144|NCT03085095|27070222|FG000|Overall Study|Did not Receive Study Drug|2|||
13495145|NCT03085095|27070223|FG001|Overall Study|Did not Receive Study Drug|2|||
13495146|NCT03085095|27070222|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1|||
13495147|NCT03085095|27070223|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0|||
13495148|NCT03032068|27070236|FG000|Overall Study|Adverse Event|1|||
13495149|NCT02828982|27070255|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
13495150|NCT02828982|27070256|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
13495151|NCT02815280|27070288|FG000|Double-Blind Phase|Adverse Event|1|||
13495152|NCT02815280|27070289|FG001|Double-Blind Phase|Adverse Event|1|||
13495153|NCT02815280|27070288|FG000|Double-Blind Phase|Lost to Follow-up|10|||
13495154|NCT02815280|27070289|FG001|Double-Blind Phase|Lost to Follow-up|9|||
13495155|NCT02815280|27070288|FG000|Double-Blind Phase|Withdrawal by Subject|20|||
13495156|NCT02815280|27070289|FG001|Double-Blind Phase|Withdrawal by Subject|11|||
13495157|NCT02815280|27070288|FG000|Double-Blind Phase|Protocol Violation|2|||
13495158|NCT02815280|27070289|FG001|Double-Blind Phase|Protocol Violation|2|||
13495159|NCT02815280|27070288|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3|||
13495160|NCT02815280|27070289|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2|||
13495161|NCT02815280|27070288|FG000|Open-Label Phase|Adverse Event|2|||
13495162|NCT02815280|27070289|FG001|Open-Label Phase|Adverse Event|3|||
13495163|NCT02815280|27070288|FG000|Open-Label Phase|Lost to Follow-up|18|||
13495164|NCT02815280|27070289|FG001|Open-Label Phase|Lost to Follow-up|9|||
13495165|NCT02815280|27070288|FG000|Open-Label Phase|Withdrawal by Subject|33|||
13495166|NCT02815280|27070289|FG001|Open-Label Phase|Withdrawal by Subject|18|||
13495167|NCT02815280|27070288|FG000|Open-Label Phase|Protocol Violation|3|||
13495168|NCT02815280|27070289|FG001|Open-Label Phase|Protocol Violation|0|||
13495169|NCT02815280|27070288|FG000|Open-Label Phase|Administrative|26|||
13495170|NCT02815280|27070289|FG001|Open-Label Phase|Administrative|12|||
13495171|NCT02815280|27070288|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5|||
13495172|NCT02815280|27070289|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2|||
13495173|NCT02815267|27070314|FG000|Double-Blind Phase|Adverse Event|0|||
13495174|NCT02815267|27070315|FG001|Double-Blind Phase|Adverse Event|3|||
13495175|NCT02815267|27070314|FG000|Double-Blind Phase|Lost to Follow-up|17|||
13495176|NCT02815267|27070315|FG001|Double-Blind Phase|Lost to Follow-up|9|||
13495177|NCT02815267|27070314|FG000|Double-Blind Phase|Withdrawal by Subject|11|||
13495178|NCT02815267|27070315|FG001|Double-Blind Phase|Withdrawal by Subject|10|||
13495179|NCT02815267|27070314|FG000|Double-Blind Phase|Protocol Violation|3|||
13495180|NCT02815267|27070315|FG001|Double-Blind Phase|Protocol Violation|2|||
13495181|NCT02815267|27070314|FG000|Double-Blind Phase|Site withdrawal|1|||
13495182|NCT02815267|27070315|FG001|Double-Blind Phase|Site withdrawal|6|||
13495183|NCT02815267|27070314|FG000|Double-Blind Phase|Received a disallowed medication|1|||
13495184|NCT02815267|27070315|FG001|Double-Blind Phase|Received a disallowed medication|1|||
13495185|NCT02815267|27070314|FG000|Open-Label Phase|Adverse Event|1|||
13495186|NCT02815267|27070315|FG001|Open-Label Phase|Adverse Event|1|||
13495187|NCT02815267|27070314|FG000|Open-Label Phase|Lost to Follow-up|23|||
13495188|NCT02815267|27070315|FG001|Open-Label Phase|Lost to Follow-up|9|||
13495189|NCT02815267|27070314|FG000|Open-Label Phase|Withdrawal by Subject|24|||
13495190|NCT02815267|27070315|FG001|Open-Label Phase|Withdrawal by Subject|13|||
13495191|NCT02815267|27070314|FG000|Open-Label Phase|Protocol Violation|0|||
13495192|NCT02815267|27070315|FG001|Open-Label Phase|Protocol Violation|1|||
13495193|NCT02815267|27070314|FG000|Open-Label Phase|Administrative|21|||
13495194|NCT02815267|27070315|FG001|Open-Label Phase|Administrative|12|||
13495195|NCT02815267|27070314|FG000|Open-Label Phase|Other|2|||
13495196|NCT02815267|27070315|FG001|Open-Label Phase|Other|5|||
13495197|NCT02802228|27070340|FG000|Overall Study|Withdrawal by Subject|2|||
13495198|NCT02802228|27070341|FG001|Overall Study|Withdrawal by Subject|0|||
13495199|NCT02802228|27070340|FG000|Overall Study|Lost to Follow-up|1|||
13495200|NCT02802228|27070341|FG001|Overall Study|Lost to Follow-up|0|||
13495201|NCT02802228|27070340|FG000|Overall Study|Adverse Event|1|||
13495202|NCT02802228|27070341|FG001|Overall Study|Adverse Event|0|||
13495203|NCT02802228|27070340|FG000|Overall Study|Physician Decision|1|||
13495204|NCT02802228|27070341|FG001|Overall Study|Physician Decision|0|||
13495205|NCT02674516|27070354|FG000|Overall Study|Lost to Follow-up|3|||
13495206|NCT02674516|27070355|FG001|Overall Study|Lost to Follow-up|0|||
13495207|NCT02674516|27070354|FG000|Overall Study|Protocol Violation|0|||
13495208|NCT02674516|27070355|FG001|Overall Study|Protocol Violation|4|||
13495209|NCT02674516|27070354|FG000|Overall Study|Knowledge of study hypothesis|1|||
13495210|NCT02674516|27070355|FG001|Overall Study|Knowledge of study hypothesis|0|||
13495211|NCT02505425|27070494|FG000|Overall Study|Lost to Follow-up|41|||
13495212|NCT02505425|27070495|FG001|Overall Study|Lost to Follow-up|61|||
13495213|NCT02505425|27070496|FG002|Overall Study|Lost to Follow-up|31|||
13495214|NCT02505425|27070497|FG003|Overall Study|Lost to Follow-up|19|||
13495215|NCT02505425|27070494|FG000|Overall Study|Withdrawal by Subject|39|||
13495216|NCT02505425|27070495|FG001|Overall Study|Withdrawal by Subject|9|||
13495217|NCT02505425|27070496|FG002|Overall Study|Withdrawal by Subject|19|||
13495218|NCT02505425|27070497|FG003|Overall Study|Withdrawal by Subject|7|||
13495219|NCT02505425|27070494|FG000|Overall Study|Death|8|||
13495220|NCT02505425|27070495|FG001|Overall Study|Death|12|||
13495221|NCT02505425|27070496|FG002|Overall Study|Death|0|||
13495222|NCT02505425|27070497|FG003|Overall Study|Death|0|||
13495223|NCT02487979|27070509|FG000|Overall Study|Physician Decision|2|||
13495224|NCT02487979|27070509|FG000|Overall Study|Withdrawal by Subject|2|||
13495225|NCT02487979|27070509|FG000|Overall Study|Progressive Disease|17|||
13495226|NCT02463448|27070525|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3|||
13495227|NCT02463448|27070525|FG000|6 Months Through 12 Months|Lost to Follow-up|1|||
13495228|NCT02463448|27070525|FG000|6 Months Through 12 Months|Withdrawal by Subject|1|||
13495229|NCT02463448|27070525|FG000|12 Months Through End of Study|Lost to Follow-up|1|||
13495230|NCT02276547|27070555|FG000|Overall Study|Death|2|||
13495231|NCT02276547|27070555|FG000|Overall Study|Explant|2|||
13495232|NCT02263885|27070566|FG000|Overall Study|Withdrawal by Subject|7|||
13495233|NCT02263885|27070566|FG000|Overall Study|Alternative Treatment|3|||
13495234|NCT01804270|27070600|FG000|Overall Study|Withdrawal by Subject|1|||
13495235|NCT01804270|27070601|FG001|Overall Study|Withdrawal by Subject|1|||
13495236|NCT01338636|27070614|FG000|Overall Study|Withdrawn due to lack of improvement|8|||
13495237|NCT00938912|27070627|FG000|Overall Study|Withdrawal by Subject|28|||
13495238|NCT00938912|27070627|FG000|Overall Study|Lost to Follow-up|4|||
13495239|NCT00938912|27070627|FG000|Overall Study|Lack of Efficacy|43|||
13495240|NCT00938912|27070627|FG000|Overall Study|Adverse event, non-fatal|24|||
13495241|NCT00938912|27070627|FG000|Overall Study|Adverse event, fatal|1|||
13495242|NCT00938912|27070627|FG000|Overall Study|Participant self adjusted antiepileptic medication|1|||
13495243|NCT00938912|27070627|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1|||
13495244|NCT00938912|27070627|FG000|Overall Study|Participant needed prohibit medication|1|||
13495245|NCT00938912|27070627|FG000|Overall Study|Participant was scheduled for lobal resection|1|||
13495246|NCT00938912|27070627|FG000|Overall Study|Did not meet Eligibility criteria|1|||
13495247|NCT00938912|27070627|FG000|Overall Study|Participant relocated not related to AE|1|||
13495248|NCT00938912|27070627|FG000|Overall Study|Participant moved to another city|1|||
13495249|NCT00938912|27070627|FG000|Overall Study|Participant experienced break through seizures|1|||
13495250|NCT00938912|27070627|FG000|Overall Study|No longer wished to participate in the study|1|||
13495251|NCT00938912|27070627|FG000|Overall Study|Protocol Deviation|2|||
13495252|NCT00579826|27070702|FG000|Overall Study|Withdrawal by Subject|5|||
13495253|NCT00579826|27070703|FG001|Overall Study|Withdrawal by Subject|3|||
13495254|NCT00322218|27070720|FG000|Overall Study|Death|3|||
13495255|NCT00322218|27070721|FG001|Overall Study|Death|6|||
13495256|NCT03259425|27070959|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1|||
13495257|NCT03129100|27071106|FG000|Lead-In Period (Period 1)|Adverse Event|2|||
13495258|NCT03129100|27071107|FG001|Lead-In Period (Period 1)|Adverse Event|6|||
13495259|NCT03129100|27071108|FG002|Lead-In Period (Period 1)|Adverse Event|0|||
13495260|NCT03129100|27071109|FG003|Lead-In Period (Period 1)|Adverse Event|0|||
13495261|NCT03129100|27071110|FG004|Lead-In Period (Period 1)|Adverse Event|0|||
13495262|NCT03129100|27071111|FG005|Lead-In Period (Period 1)|Adverse Event|0|||
13495263|NCT03129100|27071112|FG006|Lead-In Period (Period 1)|Adverse Event|0|||
13495264|NCT03129100|27071113|FG007|Lead-In Period (Period 1)|Adverse Event|0|||
13495265|NCT03129100|27071114|FG008|Lead-In Period (Period 1)|Adverse Event|0|||
13495266|NCT03129100|27071115|FG009|Lead-In Period (Period 1)|Adverse Event|0|||
13495267|NCT03129100|27071116|FG010|Lead-In Period (Period 1)|Adverse Event|0|||
13495268|NCT03129100|27071117|FG011|Lead-In Period (Period 1)|Adverse Event|0|||
13495269|NCT03129100|27071118|FG012|Lead-In Period (Period 1)|Adverse Event|0|||
13495270|NCT03129100|27071119|FG013|Lead-In Period (Period 1)|Adverse Event|0|||
13495271|NCT03129100|27071120|FG014|Lead-In Period (Period 1)|Adverse Event|0|||
13495272|NCT03129100|27071121|FG015|Lead-In Period (Period 1)|Adverse Event|0|||
13495273|NCT03129100|27071122|FG016|Lead-In Period (Period 1)|Adverse Event|0|||
13495274|NCT03129100|27071123|FG017|Lead-In Period (Period 1)|Adverse Event|0|||
13495275|NCT03129100|27071124|FG018|Lead-In Period (Period 1)|Adverse Event|0|||
13495276|NCT03129100|27071125|FG019|Lead-In Period (Period 1)|Adverse Event|0|||
13495277|NCT03129100|27071126|FG020|Lead-In Period (Period 1)|Adverse Event|0|||
13495278|NCT03129100|27071127|FG021|Lead-In Period (Period 1)|Adverse Event|0|||
13495279|NCT03129100|27071128|FG022|Lead-In Period (Period 1)|Adverse Event|0|||
13495280|NCT03129100|27071129|FG023|Lead-In Period (Period 1)|Adverse Event|0|||
13495281|NCT03129100|27071130|FG024|Lead-In Period (Period 1)|Adverse Event|0|||
13495282|NCT03129100|27071131|FG025|Lead-In Period (Period 1)|Adverse Event|0|||
13495283|NCT03129100|27071106|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2|||
13495284|NCT03129100|27071107|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0|||
13495285|NCT03129100|27071108|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0|||
13495286|NCT03129100|27071109|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0|||
13495287|NCT03129100|27071110|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0|||
13495288|NCT03129100|27071111|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0|||
13495289|NCT03129100|27071112|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0|||
13495290|NCT03129100|27071113|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0|||
13495291|NCT03129100|27071114|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0|||
13495292|NCT03129100|27071115|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0|||
13495293|NCT03129100|27071116|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0|||
13495294|NCT03129100|27071117|FG011|Lead-In Period (Period 1)|Lost to Follow-up|0|||
13495295|NCT03129100|27071118|FG012|Lead-In Period (Period 1)|Lost to Follow-up|0|||
13495296|NCT03129100|27071119|FG013|Lead-In Period (Period 1)|Lost to Follow-up|0|||
13495297|NCT03129100|27071120|FG014|Lead-In Period (Period 1)|Lost to Follow-up|0|||
13495298|NCT03129100|27071121|FG015|Lead-In Period (Period 1)|Lost to Follow-up|0|||
13495299|NCT03129100|27071122|FG016|Lead-In Period (Period 1)|Lost to Follow-up|0|||
13495300|NCT03129100|27071123|FG017|Lead-In Period (Period 1)|Lost to Follow-up|0|||
13495301|NCT03129100|27071124|FG018|Lead-In Period (Period 1)|Lost to Follow-up|0|||
13495302|NCT03129100|27071125|FG019|Lead-In Period (Period 1)|Lost to Follow-up|0|||
13495303|NCT03129100|27071126|FG020|Lead-In Period (Period 1)|Lost to Follow-up|0|||
13495304|NCT03129100|27071127|FG021|Lead-In Period (Period 1)|Lost to Follow-up|0|||
13495305|NCT03129100|27071128|FG022|Lead-In Period (Period 1)|Lost to Follow-up|0|||
13394508|NCT00657046|26787225|FG002|Overall Study|Withdrawal by Subject|0|||
13394509|NCT00657046|26787223|FG000|Overall Study|Death|0|||
13394510|NCT00657046|26787224|FG001|Overall Study|Death|0|||
13394511|NCT00657046|26787225|FG002|Overall Study|Death|1|||
13394512|NCT00657046|26787223|FG000|Overall Study|Surgery|0|||
13394513|NCT00657046|26787224|FG001|Overall Study|Surgery|0|||
13394514|NCT00657046|26787225|FG002|Overall Study|Surgery|1|||
13394515|NCT00657020|26787256|FG000|PERIOD 1|Adverse Event|0|||
13394516|NCT00657020|26787257|FG001|PERIOD 1|Adverse Event|1|||
13394517|NCT00656851|26787286|FG000|Overall Study|Withdrawal by Subject|0|||
13394518|NCT00656851|26787287|FG001|Overall Study|Withdrawal by Subject|4|||
13394519|NCT00656799|26787311|FG000|Overall Study|Death|2|||
13394520|NCT00656669|26787322|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4|||
13394521|NCT00656669|26787322|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2|||
13394522|NCT00656669|26787322|FG000|AC (Cycles 6-9)|Adverse Event|1|||
13394523|NCT00656669|26787322|FG000|AC (Cycles 6-9)|Did not start segment 3|1|||
13394524|NCT00656617|26787330|FG000|Overall Study|Adverse Event|1|||
13394525|NCT00656617|26787330|FG000|Overall Study|Death|2|||
13394526|NCT00656617|26787330|FG000|Overall Study|Insurance Issues|2|||
13495306|NCT03129100|27071129|FG023|Lead-In Period (Period 1)|Lost to Follow-up|0|||
13495307|NCT03129100|27071130|FG024|Lead-In Period (Period 1)|Lost to Follow-up|0|||
13495308|NCT03129100|27071131|FG025|Lead-In Period (Period 1)|Lost to Follow-up|0|||
13495309|NCT03129100|27071106|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
13495310|NCT03129100|27071107|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
13495311|NCT03129100|27071108|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
13495312|NCT03129100|27071109|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
13495313|NCT03129100|27071110|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
13495314|NCT03129100|27071111|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
13495315|NCT03129100|27071112|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
13495316|NCT03129100|27071113|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
13495317|NCT03129100|27071114|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
13495318|NCT03129100|27071115|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
13495319|NCT03129100|27071116|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
13495320|NCT03129100|27071117|FG011|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
13495321|NCT03129100|27071118|FG012|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
13495322|NCT03129100|27071119|FG013|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
13495323|NCT03129100|27071120|FG014|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
13495324|NCT03129100|27071121|FG015|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
13495325|NCT03129100|27071122|FG016|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
13495326|NCT03129100|27071123|FG017|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
13495327|NCT03129100|27071124|FG018|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
13495328|NCT03129100|27071125|FG019|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
13495329|NCT03129100|27071126|FG020|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
13495330|NCT03129100|27071127|FG021|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
13495331|NCT03129100|27071128|FG022|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
13495332|NCT03129100|27071129|FG023|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
13495333|NCT03129100|27071130|FG024|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
13495334|NCT03129100|27071131|FG025|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
13495335|NCT03129100|27071106|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3|||
13495336|NCT03129100|27071107|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2|||
13495337|NCT03129100|27071108|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0|||
13495338|NCT03129100|27071109|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0|||
13495339|NCT03129100|27071110|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0|||
13495340|NCT03129100|27071111|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0|||
13495341|NCT03129100|27071112|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0|||
13495342|NCT03129100|27071113|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0|||
13495343|NCT03129100|27071114|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0|||
13495344|NCT03129100|27071115|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0|||
13495345|NCT03129100|27071116|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0|||
13495346|NCT03129100|27071117|FG011|Lead-In Period (Period 1)|Lack of Efficacy|0|||
13495347|NCT03129100|27071118|FG012|Lead-In Period (Period 1)|Lack of Efficacy|0|||
13495348|NCT03129100|27071119|FG013|Lead-In Period (Period 1)|Lack of Efficacy|0|||
13495349|NCT03129100|27071120|FG014|Lead-In Period (Period 1)|Lack of Efficacy|0|||
13495350|NCT03129100|27071121|FG015|Lead-In Period (Period 1)|Lack of Efficacy|0|||
13495351|NCT03129100|27071122|FG016|Lead-In Period (Period 1)|Lack of Efficacy|0|||
13495352|NCT03129100|27071123|FG017|Lead-In Period (Period 1)|Lack of Efficacy|0|||
13495353|NCT03129100|27071124|FG018|Lead-In Period (Period 1)|Lack of Efficacy|0|||
13495354|NCT03129100|27071125|FG019|Lead-In Period (Period 1)|Lack of Efficacy|0|||
13495355|NCT03129100|27071126|FG020|Lead-In Period (Period 1)|Lack of Efficacy|0|||
13495356|NCT03129100|27071127|FG021|Lead-In Period (Period 1)|Lack of Efficacy|0|||
13495357|NCT03129100|27071128|FG022|Lead-In Period (Period 1)|Lack of Efficacy|0|||
13208365|NCT01939158|26241442|FG003|Overall Study|No longer meets eligibility criteria|0|||
13495358|NCT03129100|27071129|FG023|Lead-In Period (Period 1)|Lack of Efficacy|0|||
13495359|NCT03129100|27071130|FG024|Lead-In Period (Period 1)|Lack of Efficacy|0|||
13495360|NCT03129100|27071131|FG025|Lead-In Period (Period 1)|Lack of Efficacy|0|||
13495361|NCT03129100|27071106|FG000|Lead-In Period (Period 1)|Surgery Programmed|0|||
13495362|NCT03129100|27071107|FG001|Lead-In Period (Period 1)|Surgery Programmed|1|||
13495363|NCT03129100|27071108|FG002|Lead-In Period (Period 1)|Surgery Programmed|0|||
13495364|NCT03129100|27071109|FG003|Lead-In Period (Period 1)|Surgery Programmed|0|||
13495365|NCT03129100|27071110|FG004|Lead-In Period (Period 1)|Surgery Programmed|0|||
13495366|NCT03129100|27071111|FG005|Lead-In Period (Period 1)|Surgery Programmed|0|||
13495367|NCT03129100|27071112|FG006|Lead-In Period (Period 1)|Surgery Programmed|0|||
13495368|NCT03129100|27071113|FG007|Lead-In Period (Period 1)|Surgery Programmed|0|||
13495369|NCT03129100|27071114|FG008|Lead-In Period (Period 1)|Surgery Programmed|0|||
13495370|NCT03129100|27071115|FG009|Lead-In Period (Period 1)|Surgery Programmed|0|||
13495371|NCT03129100|27071116|FG010|Lead-In Period (Period 1)|Surgery Programmed|0|||
13495372|NCT03129100|27071117|FG011|Lead-In Period (Period 1)|Surgery Programmed|0|||
13495373|NCT03129100|27071118|FG012|Lead-In Period (Period 1)|Surgery Programmed|0|||
13495374|NCT03129100|27071119|FG013|Lead-In Period (Period 1)|Surgery Programmed|0|||
13495375|NCT03129100|27071120|FG014|Lead-In Period (Period 1)|Surgery Programmed|0|||
13495376|NCT03129100|27071121|FG015|Lead-In Period (Period 1)|Surgery Programmed|0|||
13495377|NCT03129100|27071122|FG016|Lead-In Period (Period 1)|Surgery Programmed|0|||
13495378|NCT03129100|27071123|FG017|Lead-In Period (Period 1)|Surgery Programmed|0|||
13495379|NCT03129100|27071124|FG018|Lead-In Period (Period 1)|Surgery Programmed|0|||
13495380|NCT03129100|27071125|FG019|Lead-In Period (Period 1)|Surgery Programmed|0|||
13495381|NCT03129100|27071126|FG020|Lead-In Period (Period 1)|Surgery Programmed|0|||
13495382|NCT03129100|27071127|FG021|Lead-In Period (Period 1)|Surgery Programmed|0|||
13495383|NCT03129100|27071128|FG022|Lead-In Period (Period 1)|Surgery Programmed|0|||
13495384|NCT03129100|27071129|FG023|Lead-In Period (Period 1)|Surgery Programmed|0|||
13495385|NCT03129100|27071130|FG024|Lead-In Period (Period 1)|Surgery Programmed|0|||
13495386|NCT03129100|27071131|FG025|Lead-In Period (Period 1)|Surgery Programmed|0|||
13495387|NCT03129100|27071106|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0|||
13495388|NCT03129100|27071107|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0|||
13495389|NCT03129100|27071108|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2|||
13495390|NCT03129100|27071109|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1|||
13495391|NCT03129100|27071110|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0|||
13495392|NCT03129100|27071111|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2|||
13495393|NCT03129100|27071112|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0|||
13495394|NCT03129100|27071113|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0|||
13495395|NCT03129100|27071114|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0|||
13495396|NCT03129100|27071115|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0|||
13495397|NCT03129100|27071116|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0|||
13495398|NCT03129100|27071117|FG011|Period2 Extension Period (Group A and B)|Adverse Event|0|||
13495399|NCT03129100|27071118|FG012|Period2 Extension Period (Group A and B)|Adverse Event|0|||
13495400|NCT03129100|27071119|FG013|Period2 Extension Period (Group A and B)|Adverse Event|0|||
13495401|NCT03129100|27071120|FG014|Period2 Extension Period (Group A and B)|Adverse Event|0|||
13495402|NCT03129100|27071121|FG015|Period2 Extension Period (Group A and B)|Adverse Event|0|||
13495403|NCT03129100|27071122|FG016|Period2 Extension Period (Group A and B)|Adverse Event|0|||
13495404|NCT03129100|27071123|FG017|Period2 Extension Period (Group A and B)|Adverse Event|0|||
13495405|NCT03129100|27071124|FG018|Period2 Extension Period (Group A and B)|Adverse Event|0|||
13495406|NCT03129100|27071125|FG019|Period2 Extension Period (Group A and B)|Adverse Event|0|||
13495407|NCT03129100|27071126|FG020|Period2 Extension Period (Group A and B)|Adverse Event|0|||
13495408|NCT03129100|27071127|FG021|Period2 Extension Period (Group A and B)|Adverse Event|0|||
13495409|NCT03129100|27071128|FG022|Period2 Extension Period (Group A and B)|Adverse Event|0|||
13495410|NCT03129100|27071129|FG023|Period2 Extension Period (Group A and B)|Adverse Event|0|||
13208366|NCT01939158|26241439|FG000|Overall Study|Other|1|||
13495411|NCT03129100|27071130|FG024|Period2 Extension Period (Group A and B)|Adverse Event|0|||
13495412|NCT03129100|27071131|FG025|Period2 Extension Period (Group A and B)|Adverse Event|0|||
13495413|NCT03129100|27071106|FG000|Period2 Extension Period (Group A and B)|Death|0|||
13495414|NCT03129100|27071107|FG001|Period2 Extension Period (Group A and B)|Death|0|||
13495415|NCT03129100|27071108|FG002|Period2 Extension Period (Group A and B)|Death|1|||
13495416|NCT03129100|27071109|FG003|Period2 Extension Period (Group A and B)|Death|0|||
13495417|NCT03129100|27071110|FG004|Period2 Extension Period (Group A and B)|Death|0|||
13495418|NCT03129100|27071111|FG005|Period2 Extension Period (Group A and B)|Death|0|||
13495419|NCT03129100|27071112|FG006|Period2 Extension Period (Group A and B)|Death|0|||
13495420|NCT03129100|27071113|FG007|Period2 Extension Period (Group A and B)|Death|0|||
13495421|NCT03129100|27071114|FG008|Period2 Extension Period (Group A and B)|Death|0|||
13495422|NCT03129100|27071115|FG009|Period2 Extension Period (Group A and B)|Death|0|||
13495423|NCT03129100|27071116|FG010|Period2 Extension Period (Group A and B)|Death|0|||
13495424|NCT03129100|27071117|FG011|Period2 Extension Period (Group A and B)|Death|0|||
13495425|NCT03129100|27071118|FG012|Period2 Extension Period (Group A and B)|Death|0|||
13495426|NCT03129100|27071119|FG013|Period2 Extension Period (Group A and B)|Death|0|||
13495427|NCT03129100|27071120|FG014|Period2 Extension Period (Group A and B)|Death|0|||
13495428|NCT03129100|27071121|FG015|Period2 Extension Period (Group A and B)|Death|0|||
13495429|NCT03129100|27071122|FG016|Period2 Extension Period (Group A and B)|Death|0|||
13495430|NCT03129100|27071123|FG017|Period2 Extension Period (Group A and B)|Death|0|||
13495431|NCT03129100|27071124|FG018|Period2 Extension Period (Group A and B)|Death|0|||
13495432|NCT03129100|27071125|FG019|Period2 Extension Period (Group A and B)|Death|0|||
13495433|NCT03129100|27071126|FG020|Period2 Extension Period (Group A and B)|Death|0|||
13495434|NCT03129100|27071127|FG021|Period2 Extension Period (Group A and B)|Death|0|||
13495435|NCT03129100|27071128|FG022|Period2 Extension Period (Group A and B)|Death|0|||
13495436|NCT03129100|27071129|FG023|Period2 Extension Period (Group A and B)|Death|0|||
13495437|NCT03129100|27071130|FG024|Period2 Extension Period (Group A and B)|Death|0|||
13495438|NCT03129100|27071131|FG025|Period2 Extension Period (Group A and B)|Death|0|||
13495439|NCT03129100|27071106|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
13495440|NCT03129100|27071107|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
13495441|NCT03129100|27071108|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13|||
13495442|NCT03129100|27071109|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5|||
13495443|NCT03129100|27071110|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
13495444|NCT03129100|27071111|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
13495445|NCT03129100|27071112|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2|||
13495446|NCT03129100|27071113|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
13495447|NCT03129100|27071114|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
13495448|NCT03129100|27071115|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
13495449|NCT03129100|27071116|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
13495450|NCT03129100|27071117|FG011|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
13495451|NCT03129100|27071118|FG012|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
13495452|NCT03129100|27071119|FG013|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
13495453|NCT03129100|27071120|FG014|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
13495454|NCT03129100|27071121|FG015|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
13495455|NCT03129100|27071122|FG016|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
13495456|NCT03129100|27071123|FG017|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
13495457|NCT03129100|27071124|FG018|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
13495458|NCT03129100|27071125|FG019|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
13495459|NCT03129100|27071126|FG020|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
13495460|NCT03129100|27071127|FG021|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
13495461|NCT03129100|27071128|FG022|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
13495462|NCT03129100|27071129|FG023|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
13495463|NCT03129100|27071130|FG024|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
13495464|NCT03129100|27071131|FG025|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
13495465|NCT03129100|27071106|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0|||
13495466|NCT03129100|27071107|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0|||
13495467|NCT03129100|27071108|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1|||
13495468|NCT03129100|27071109|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0|||
13495469|NCT03129100|27071110|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0|||
13495470|NCT03129100|27071111|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0|||
13495471|NCT03129100|27071112|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0|||
13495472|NCT03129100|27071113|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0|||
13495473|NCT03129100|27071114|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0|||
13495474|NCT03129100|27071115|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0|||
13495475|NCT03129100|27071116|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0|||
13495476|NCT03129100|27071117|FG011|Period2 Extension Period (Group A and B)|Physician Decision|0|||
13495477|NCT03129100|27071118|FG012|Period2 Extension Period (Group A and B)|Physician Decision|0|||
13495478|NCT03129100|27071119|FG013|Period2 Extension Period (Group A and B)|Physician Decision|0|||
13495479|NCT03129100|27071120|FG014|Period2 Extension Period (Group A and B)|Physician Decision|0|||
13495480|NCT03129100|27071121|FG015|Period2 Extension Period (Group A and B)|Physician Decision|0|||
13495481|NCT03129100|27071122|FG016|Period2 Extension Period (Group A and B)|Physician Decision|0|||
13495482|NCT03129100|27071123|FG017|Period2 Extension Period (Group A and B)|Physician Decision|0|||
13495483|NCT03129100|27071124|FG018|Period2 Extension Period (Group A and B)|Physician Decision|0|||
13495484|NCT03129100|27071125|FG019|Period2 Extension Period (Group A and B)|Physician Decision|0|||
13495485|NCT03129100|27071126|FG020|Period2 Extension Period (Group A and B)|Physician Decision|0|||
13495486|NCT03129100|27071127|FG021|Period2 Extension Period (Group A and B)|Physician Decision|0|||
13495487|NCT03129100|27071128|FG022|Period2 Extension Period (Group A and B)|Physician Decision|0|||
13495488|NCT03129100|27071129|FG023|Period2 Extension Period (Group A and B)|Physician Decision|0|||
13495489|NCT03129100|27071130|FG024|Period2 Extension Period (Group A and B)|Physician Decision|0|||
13495490|NCT03129100|27071131|FG025|Period2 Extension Period (Group A and B)|Physician Decision|0|||
13495491|NCT03129100|27071106|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
13495492|NCT03129100|27071107|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
13495493|NCT03129100|27071108|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2|||
13495494|NCT03129100|27071109|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
13495495|NCT03129100|27071110|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
13495496|NCT03129100|27071111|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
13495497|NCT03129100|27071112|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
13495498|NCT03129100|27071113|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
13495499|NCT03129100|27071114|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
13495500|NCT03129100|27071115|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
13495501|NCT03129100|27071116|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
13495502|NCT03129100|27071117|FG011|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
13495503|NCT03129100|27071118|FG012|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
13495504|NCT03129100|27071119|FG013|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
13495505|NCT03129100|27071120|FG014|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
13495506|NCT03129100|27071121|FG015|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
13495507|NCT03129100|27071122|FG016|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
13495508|NCT03129100|27071123|FG017|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
13495509|NCT03129100|27071124|FG018|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
13495510|NCT03129100|27071125|FG019|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
13495511|NCT03129100|27071126|FG020|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
13495512|NCT03129100|27071127|FG021|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
13495513|NCT03129100|27071128|FG022|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
13495514|NCT03129100|27071129|FG023|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
13495515|NCT03129100|27071130|FG024|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
13495516|NCT03129100|27071131|FG025|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
13495517|NCT03129100|27071106|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
13495518|NCT03129100|27071107|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
13495519|NCT03129100|27071108|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2|||
13495520|NCT03129100|27071109|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
13495521|NCT03129100|27071110|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
13495522|NCT03129100|27071111|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
13495523|NCT03129100|27071112|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
13495524|NCT03129100|27071113|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
13495525|NCT03129100|27071114|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
13495526|NCT03129100|27071115|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
13495527|NCT03129100|27071116|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
13495528|NCT03129100|27071117|FG011|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
13495529|NCT03129100|27071118|FG012|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
13495530|NCT03129100|27071119|FG013|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
13495531|NCT03129100|27071120|FG014|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
13495532|NCT03129100|27071121|FG015|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
13495533|NCT03129100|27071122|FG016|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
13495534|NCT03129100|27071123|FG017|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
13495535|NCT03129100|27071124|FG018|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
13495536|NCT03129100|27071125|FG019|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
13495537|NCT03129100|27071126|FG020|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
13495538|NCT03129100|27071127|FG021|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
13495539|NCT03129100|27071128|FG022|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
13495540|NCT03129100|27071129|FG023|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
13495541|NCT03129100|27071130|FG024|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
13495542|NCT03129100|27071131|FG025|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
13495543|NCT03129100|27071106|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
13495544|NCT03129100|27071107|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
13495545|NCT03129100|27071108|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
13495546|NCT03129100|27071109|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
13495547|NCT03129100|27071110|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5|||
13495548|NCT03129100|27071111|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6|||
13495549|NCT03129100|27071112|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19|||
13495550|NCT03129100|27071113|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
13495551|NCT03129100|27071114|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
13495552|NCT03129100|27071115|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
13495553|NCT03129100|27071116|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
13495554|NCT03129100|27071117|FG011|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
13495555|NCT03129100|27071118|FG012|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
13495556|NCT03129100|27071119|FG013|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
13495557|NCT03129100|27071120|FG014|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
13495558|NCT03129100|27071121|FG015|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
13495559|NCT03129100|27071122|FG016|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
13495560|NCT03129100|27071123|FG017|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
13495561|NCT03129100|27071124|FG018|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
13495562|NCT03129100|27071125|FG019|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
13495563|NCT03129100|27071126|FG020|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
13495564|NCT03129100|27071127|FG021|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
13495565|NCT03129100|27071128|FG022|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
13495566|NCT03129100|27071129|FG023|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
13495567|NCT03129100|27071130|FG024|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
13495568|NCT03129100|27071131|FG025|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
13495569|NCT03129100|27071106|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
13495570|NCT03129100|27071107|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
13495571|NCT03129100|27071108|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
13495572|NCT03129100|27071109|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
13495573|NCT03129100|27071110|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
13495574|NCT03129100|27071111|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
13495575|NCT03129100|27071112|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
13495576|NCT03129100|27071113|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
13495577|NCT03129100|27071114|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
13495578|NCT03129100|27071115|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1|||
13495579|NCT03129100|27071116|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
13495580|NCT03129100|27071117|FG011|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
13495581|NCT03129100|27071118|FG012|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
13495582|NCT03129100|27071119|FG013|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
13495583|NCT03129100|27071120|FG014|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
13495584|NCT03129100|27071121|FG015|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
13495585|NCT03129100|27071122|FG016|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
13495586|NCT03129100|27071123|FG017|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
13495587|NCT03129100|27071124|FG018|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
13495588|NCT03129100|27071125|FG019|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
13495589|NCT03129100|27071126|FG020|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
13495590|NCT03129100|27071127|FG021|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
13495591|NCT03129100|27071128|FG022|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
13495592|NCT03129100|27071129|FG023|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
13495593|NCT03129100|27071130|FG024|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
13495594|NCT03129100|27071131|FG025|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
13495595|NCT03129100|27071106|FG000|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
13495596|NCT03129100|27071107|FG001|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
13495597|NCT03129100|27071108|FG002|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
13495598|NCT03129100|27071109|FG003|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
13495599|NCT03129100|27071110|FG004|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
13495600|NCT03129100|27071111|FG005|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
13495601|NCT03129100|27071112|FG006|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
13495602|NCT03129100|27071113|FG007|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
13495603|NCT03129100|27071114|FG008|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
13495604|NCT03129100|27071115|FG009|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
13495605|NCT03129100|27071116|FG010|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
13495606|NCT03129100|27071117|FG011|Period3-Long-Term Extension Period A & B|Adverse Event|6|||
13495607|NCT03129100|27071118|FG012|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
13495608|NCT03129100|27071119|FG013|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
13495609|NCT03129100|27071120|FG014|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
13495610|NCT03129100|27071121|FG015|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
13495611|NCT03129100|27071122|FG016|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
13495612|NCT03129100|27071123|FG017|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
13495613|NCT03129100|27071124|FG018|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
13495614|NCT03129100|27071125|FG019|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
13495615|NCT03129100|27071126|FG020|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
13495616|NCT03129100|27071127|FG021|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
13495617|NCT03129100|27071128|FG022|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
13495618|NCT03129100|27071129|FG023|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
13495619|NCT03129100|27071130|FG024|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
13495620|NCT03129100|27071131|FG025|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
13495621|NCT03129100|27071106|FG000|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
13495622|NCT03129100|27071107|FG001|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
13495623|NCT03129100|27071108|FG002|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
13495624|NCT03129100|27071109|FG003|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
13495625|NCT03129100|27071110|FG004|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
13495626|NCT03129100|27071111|FG005|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
13495627|NCT03129100|27071112|FG006|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
13495628|NCT03129100|27071113|FG007|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
13495629|NCT03129100|27071114|FG008|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
13495630|NCT03129100|27071115|FG009|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
13495631|NCT03129100|27071116|FG010|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
13495632|NCT03129100|27071117|FG011|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|12|||
13495633|NCT03129100|27071118|FG012|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|7|||
13495634|NCT03129100|27071119|FG013|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|4|||
13495635|NCT03129100|27071120|FG014|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|2|||
13495636|NCT03129100|27071121|FG015|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
13495637|NCT03129100|27071122|FG016|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
13495638|NCT03129100|27071123|FG017|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
13495639|NCT03129100|27071124|FG018|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
13495640|NCT03129100|27071125|FG019|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
13495641|NCT03129100|27071126|FG020|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
13495642|NCT03129100|27071127|FG021|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
13495643|NCT03129100|27071128|FG022|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
13495644|NCT03129100|27071129|FG023|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
13495645|NCT03129100|27071130|FG024|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
13495646|NCT03129100|27071131|FG025|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
13495647|NCT03129100|27071106|FG000|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
13495648|NCT03129100|27071107|FG001|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
13495649|NCT03129100|27071108|FG002|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
13495650|NCT03129100|27071109|FG003|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
13495651|NCT03129100|27071110|FG004|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
13495652|NCT03129100|27071111|FG005|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
13495653|NCT03129100|27071112|FG006|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
13495654|NCT03129100|27071113|FG007|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
13495655|NCT03129100|27071114|FG008|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
13495656|NCT03129100|27071115|FG009|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
13495657|NCT03129100|27071116|FG010|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
13495658|NCT03129100|27071117|FG011|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
13495659|NCT03129100|27071118|FG012|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
13495660|NCT03129100|27071119|FG013|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
13495661|NCT03129100|27071120|FG014|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
13495662|NCT03129100|27071121|FG015|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
13495663|NCT03129100|27071122|FG016|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
13495664|NCT03129100|27071123|FG017|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
13495665|NCT03129100|27071124|FG018|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
13495666|NCT03129100|27071125|FG019|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
13495667|NCT03129100|27071126|FG020|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
13495668|NCT03129100|27071127|FG021|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
13495669|NCT03129100|27071128|FG022|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
13495670|NCT03129100|27071129|FG023|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
13495671|NCT03129100|27071130|FG024|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
13495672|NCT03129100|27071131|FG025|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
13495673|NCT03129100|27071106|FG000|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
13495674|NCT03129100|27071107|FG001|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
13495675|NCT03129100|27071108|FG002|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
13495676|NCT03129100|27071109|FG003|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
13495677|NCT03129100|27071110|FG004|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
13495678|NCT03129100|27071111|FG005|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
13495679|NCT03129100|27071112|FG006|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
13495680|NCT03129100|27071113|FG007|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
13495681|NCT03129100|27071114|FG008|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
13495682|NCT03129100|27071115|FG009|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
13495683|NCT03129100|27071116|FG010|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
13495684|NCT03129100|27071117|FG011|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
13495685|NCT03129100|27071118|FG012|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
13495686|NCT03129100|27071119|FG013|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
13495687|NCT03129100|27071120|FG014|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
13495688|NCT03129100|27071121|FG015|Period3-Long-Term Extension Period A & B|Lack of Efficacy|1|||
13495689|NCT03129100|27071122|FG016|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
13495690|NCT03129100|27071123|FG017|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
13495691|NCT03129100|27071124|FG018|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
13495692|NCT03129100|27071125|FG019|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
13495693|NCT03129100|27071126|FG020|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
13495694|NCT03129100|27071127|FG021|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
13495695|NCT03129100|27071128|FG022|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
13495696|NCT03129100|27071129|FG023|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
13495697|NCT03129100|27071130|FG024|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
13495698|NCT03129100|27071131|FG025|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
13495699|NCT03129100|27071106|FG000|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
13495700|NCT03129100|27071107|FG001|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
13495701|NCT03129100|27071108|FG002|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
13495702|NCT03129100|27071109|FG003|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
13495703|NCT03129100|27071110|FG004|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
13495704|NCT03129100|27071111|FG005|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
13495705|NCT03129100|27071112|FG006|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
13495706|NCT03129100|27071113|FG007|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
13495707|NCT03129100|27071114|FG008|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
13495708|NCT03129100|27071115|FG009|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
13495709|NCT03129100|27071116|FG010|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
13495710|NCT03129100|27071117|FG011|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
13495711|NCT03129100|27071118|FG012|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|24|||
13495712|NCT03129100|27071119|FG013|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
13495713|NCT03129100|27071120|FG014|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|2|||
13495714|NCT03129100|27071121|FG015|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|8|||
13495715|NCT03129100|27071122|FG016|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
13495716|NCT03129100|27071123|FG017|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
13495717|NCT03129100|27071124|FG018|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
13495718|NCT03129100|27071125|FG019|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
13495719|NCT03129100|27071126|FG020|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
13495720|NCT03129100|27071127|FG021|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
13495721|NCT03129100|27071128|FG022|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
13495722|NCT03129100|27071129|FG023|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
13495723|NCT03129100|27071130|FG024|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
13495724|NCT03129100|27071131|FG025|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
13495725|NCT03129100|27071106|FG000|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
13495726|NCT03129100|27071107|FG001|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
13495727|NCT03129100|27071108|FG002|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
13495728|NCT03129100|27071109|FG003|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
13495729|NCT03129100|27071110|FG004|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
13495730|NCT03129100|27071111|FG005|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
13495731|NCT03129100|27071112|FG006|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
13495732|NCT03129100|27071113|FG007|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
13495733|NCT03129100|27071114|FG008|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
13495734|NCT03129100|27071115|FG009|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
13495735|NCT03129100|27071116|FG010|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
13495736|NCT03129100|27071117|FG011|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
13495737|NCT03129100|27071118|FG012|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
13495738|NCT03129100|27071119|FG013|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
13495739|NCT03129100|27071120|FG014|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
13495740|NCT03129100|27071121|FG015|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
13495741|NCT03129100|27071122|FG016|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
13495742|NCT03129100|27071123|FG017|Period 3 (Flare)|Escalated to IXE80Q2W|2|||
13495743|NCT03129100|27071124|FG018|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
13495744|NCT03129100|27071125|FG019|Period 3 (Flare)|Escalated to IXE80Q2W|3|||
13495745|NCT03129100|27071126|FG020|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
13495746|NCT03129100|27071127|FG021|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
13495747|NCT03129100|27071128|FG022|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
13495748|NCT03129100|27071129|FG023|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
13495749|NCT03129100|27071130|FG024|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
13495750|NCT03129100|27071131|FG025|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
13495751|NCT03129100|27071106|FG000|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
13495752|NCT03129100|27071107|FG001|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
13495753|NCT03129100|27071108|FG002|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
13495754|NCT03129100|27071109|FG003|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
13495755|NCT03129100|27071110|FG004|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
13495756|NCT03129100|27071111|FG005|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
13495757|NCT03129100|27071112|FG006|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
13495758|NCT03129100|27071113|FG007|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
13495759|NCT03129100|27071114|FG008|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
13495760|NCT03129100|27071115|FG009|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
13495761|NCT03129100|27071116|FG010|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
13495762|NCT03129100|27071117|FG011|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
13495763|NCT03129100|27071118|FG012|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
13495764|NCT03129100|27071119|FG013|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
13495765|NCT03129100|27071120|FG014|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
13495766|NCT03129100|27071121|FG015|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
13495767|NCT03129100|27071122|FG016|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
13495768|NCT03129100|27071123|FG017|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
13495769|NCT03129100|27071124|FG018|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
13495770|NCT03129100|27071125|FG019|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
13495771|NCT03129100|27071126|FG020|Period 3 (Dose Escalation)|Withdrawal by Subject|2|||
13495772|NCT03129100|27071127|FG021|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
13495773|NCT03129100|27071128|FG022|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
13495774|NCT03129100|27071129|FG023|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
13495775|NCT03129100|27071130|FG024|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
13495776|NCT03129100|27071131|FG025|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
13495777|NCT03129100|27071106|FG000|Period 3 (Dose Escalation)|Physician Decision|0|||
13495778|NCT03129100|27071107|FG001|Period 3 (Dose Escalation)|Physician Decision|0|||
13495779|NCT03129100|27071108|FG002|Period 3 (Dose Escalation)|Physician Decision|0|||
13495780|NCT03129100|27071109|FG003|Period 3 (Dose Escalation)|Physician Decision|0|||
13495781|NCT03129100|27071110|FG004|Period 3 (Dose Escalation)|Physician Decision|0|||
13495782|NCT03129100|27071111|FG005|Period 3 (Dose Escalation)|Physician Decision|0|||
13495783|NCT03129100|27071112|FG006|Period 3 (Dose Escalation)|Physician Decision|0|||
13495784|NCT03129100|27071113|FG007|Period 3 (Dose Escalation)|Physician Decision|0|||
13495785|NCT03129100|27071114|FG008|Period 3 (Dose Escalation)|Physician Decision|0|||
13495786|NCT03129100|27071115|FG009|Period 3 (Dose Escalation)|Physician Decision|0|||
13495787|NCT03129100|27071116|FG010|Period 3 (Dose Escalation)|Physician Decision|0|||
13495788|NCT03129100|27071117|FG011|Period 3 (Dose Escalation)|Physician Decision|0|||
13495789|NCT03129100|27071118|FG012|Period 3 (Dose Escalation)|Physician Decision|0|||
13495790|NCT03129100|27071119|FG013|Period 3 (Dose Escalation)|Physician Decision|0|||
13495791|NCT03129100|27071120|FG014|Period 3 (Dose Escalation)|Physician Decision|0|||
13495792|NCT03129100|27071121|FG015|Period 3 (Dose Escalation)|Physician Decision|0|||
13495793|NCT03129100|27071122|FG016|Period 3 (Dose Escalation)|Physician Decision|0|||
13495794|NCT03129100|27071123|FG017|Period 3 (Dose Escalation)|Physician Decision|0|||
13495795|NCT03129100|27071124|FG018|Period 3 (Dose Escalation)|Physician Decision|0|||
13495796|NCT03129100|27071125|FG019|Period 3 (Dose Escalation)|Physician Decision|0|||
13495797|NCT03129100|27071126|FG020|Period 3 (Dose Escalation)|Physician Decision|1|||
13495798|NCT03129100|27071127|FG021|Period 3 (Dose Escalation)|Physician Decision|0|||
13495799|NCT03129100|27071128|FG022|Period 3 (Dose Escalation)|Physician Decision|0|||
13495800|NCT03129100|27071129|FG023|Period 3 (Dose Escalation)|Physician Decision|0|||
13495801|NCT03129100|27071130|FG024|Period 3 (Dose Escalation)|Physician Decision|0|||
13495802|NCT03129100|27071131|FG025|Period 3 (Dose Escalation)|Physician Decision|0|||
13495803|NCT03129100|27071106|FG000|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
13495804|NCT03129100|27071107|FG001|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
13495805|NCT03129100|27071108|FG002|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
13495806|NCT03129100|27071109|FG003|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
13495807|NCT03129100|27071110|FG004|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
13495808|NCT03129100|27071111|FG005|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
13495809|NCT03129100|27071112|FG006|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
13495810|NCT03129100|27071113|FG007|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
13495811|NCT03129100|27071114|FG008|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
13495812|NCT03129100|27071115|FG009|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
13495813|NCT03129100|27071116|FG010|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
13495814|NCT03129100|27071117|FG011|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
13495815|NCT03129100|27071118|FG012|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
13495816|NCT03129100|27071119|FG013|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
13495817|NCT03129100|27071120|FG014|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
13495818|NCT03129100|27071121|FG015|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
13495819|NCT03129100|27071122|FG016|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
13495820|NCT03129100|27071123|FG017|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
13495821|NCT03129100|27071124|FG018|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
13495822|NCT03129100|27071125|FG019|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
13495823|NCT03129100|27071126|FG020|Period 3 (Dose Escalation)|Lack of Efficacy|1|||
13495824|NCT03129100|27071127|FG021|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
13495825|NCT03129100|27071128|FG022|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
13495826|NCT03129100|27071129|FG023|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
13495827|NCT03129100|27071130|FG024|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
13495828|NCT03129100|27071131|FG025|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
13495829|NCT03129100|27071106|FG000|Period 4 (Post Treatment Follow-up)|Death|0|||
13495830|NCT03129100|27071107|FG001|Period 4 (Post Treatment Follow-up)|Death|0|||
13495831|NCT03129100|27071108|FG002|Period 4 (Post Treatment Follow-up)|Death|0|||
13495832|NCT03129100|27071109|FG003|Period 4 (Post Treatment Follow-up)|Death|0|||
13495833|NCT03129100|27071110|FG004|Period 4 (Post Treatment Follow-up)|Death|0|||
13495834|NCT03129100|27071111|FG005|Period 4 (Post Treatment Follow-up)|Death|0|||
13495835|NCT03129100|27071112|FG006|Period 4 (Post Treatment Follow-up)|Death|0|||
13495836|NCT03129100|27071113|FG007|Period 4 (Post Treatment Follow-up)|Death|0|||
13495837|NCT03129100|27071114|FG008|Period 4 (Post Treatment Follow-up)|Death|0|||
13495838|NCT03129100|27071115|FG009|Period 4 (Post Treatment Follow-up)|Death|0|||
13495839|NCT03129100|27071116|FG010|Period 4 (Post Treatment Follow-up)|Death|0|||
13495840|NCT03129100|27071117|FG011|Period 4 (Post Treatment Follow-up)|Death|0|||
13495841|NCT03129100|27071118|FG012|Period 4 (Post Treatment Follow-up)|Death|0|||
13495842|NCT03129100|27071119|FG013|Period 4 (Post Treatment Follow-up)|Death|0|||
13495843|NCT03129100|27071120|FG014|Period 4 (Post Treatment Follow-up)|Death|0|||
13495844|NCT03129100|27071121|FG015|Period 4 (Post Treatment Follow-up)|Death|0|||
13495845|NCT03129100|27071122|FG016|Period 4 (Post Treatment Follow-up)|Death|0|||
13495846|NCT03129100|27071123|FG017|Period 4 (Post Treatment Follow-up)|Death|0|||
13495847|NCT03129100|27071124|FG018|Period 4 (Post Treatment Follow-up)|Death|0|||
13495848|NCT03129100|27071125|FG019|Period 4 (Post Treatment Follow-up)|Death|0|||
13495849|NCT03129100|27071126|FG020|Period 4 (Post Treatment Follow-up)|Death|0|||
13495850|NCT03129100|27071127|FG021|Period 4 (Post Treatment Follow-up)|Death|0|||
13495851|NCT03129100|27071128|FG022|Period 4 (Post Treatment Follow-up)|Death|0|||
13495852|NCT03129100|27071129|FG023|Period 4 (Post Treatment Follow-up)|Death|0|||
13495853|NCT03129100|27071130|FG024|Period 4 (Post Treatment Follow-up)|Death|1|||
13495854|NCT03129100|27071131|FG025|Period 4 (Post Treatment Follow-up)|Death|0|||
13495855|NCT03129100|27071106|FG000|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
13495856|NCT03129100|27071107|FG001|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
13495857|NCT03129100|27071108|FG002|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
13495858|NCT03129100|27071109|FG003|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
13495859|NCT03129100|27071110|FG004|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
13495860|NCT03129100|27071111|FG005|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
13495861|NCT03129100|27071112|FG006|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
13495862|NCT03129100|27071113|FG007|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
13495863|NCT03129100|27071114|FG008|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
13495864|NCT03129100|27071115|FG009|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
13495865|NCT03129100|27071116|FG010|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
13495866|NCT03129100|27071117|FG011|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
13495867|NCT03129100|27071118|FG012|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
13495868|NCT03129100|27071119|FG013|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
13495869|NCT03129100|27071120|FG014|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
13495870|NCT03129100|27071121|FG015|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
13495871|NCT03129100|27071122|FG016|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
13495872|NCT03129100|27071123|FG017|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
13495873|NCT03129100|27071124|FG018|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
13495874|NCT03129100|27071125|FG019|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
13495875|NCT03129100|27071126|FG020|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
13495876|NCT03129100|27071127|FG021|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
13495877|NCT03129100|27071128|FG022|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
13495878|NCT03129100|27071129|FG023|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
13495879|NCT03129100|27071130|FG024|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
13495880|NCT03129100|27071131|FG025|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
13495881|NCT03129100|27071106|FG000|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
13495882|NCT03129100|27071107|FG001|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
13495883|NCT03129100|27071108|FG002|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
13495884|NCT03129100|27071109|FG003|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
13495885|NCT03129100|27071110|FG004|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
13495886|NCT03129100|27071111|FG005|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
13495887|NCT03129100|27071112|FG006|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
13495888|NCT03129100|27071113|FG007|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
13495889|NCT03129100|27071114|FG008|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
13495890|NCT03129100|27071115|FG009|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
13495891|NCT03129100|27071116|FG010|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
13495892|NCT03129100|27071117|FG011|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
13495893|NCT03129100|27071118|FG012|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
13495894|NCT03129100|27071119|FG013|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
13495895|NCT03129100|27071120|FG014|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
13495896|NCT03129100|27071121|FG015|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
13495897|NCT03129100|27071122|FG016|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
13495898|NCT03129100|27071123|FG017|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
13495899|NCT03129100|27071124|FG018|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
13495900|NCT03129100|27071125|FG019|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
13495901|NCT03129100|27071126|FG020|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
13495902|NCT03129100|27071127|FG021|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
13495903|NCT03129100|27071128|FG022|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
13495904|NCT03129100|27071129|FG023|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|3|||
13495905|NCT03129100|27071130|FG024|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|20|||
13495906|NCT03129100|27071131|FG025|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|37|||
13495907|NCT03129100|27071106|FG000|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
13495908|NCT03129100|27071107|FG001|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
13495909|NCT03129100|27071108|FG002|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
13495910|NCT03129100|27071109|FG003|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
13495911|NCT03129100|27071110|FG004|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
13495912|NCT03129100|27071111|FG005|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
13495913|NCT03129100|27071112|FG006|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
13495914|NCT03129100|27071113|FG007|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
13495915|NCT03129100|27071114|FG008|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
13495916|NCT03129100|27071115|FG009|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
13495917|NCT03129100|27071116|FG010|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
13495918|NCT03129100|27071117|FG011|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
13495919|NCT03129100|27071118|FG012|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
13495920|NCT03129100|27071119|FG013|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
13495921|NCT03129100|27071120|FG014|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
13495922|NCT03129100|27071121|FG015|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
13495923|NCT03129100|27071122|FG016|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
13495924|NCT03129100|27071123|FG017|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
13495925|NCT03129100|27071124|FG018|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
13495926|NCT03129100|27071125|FG019|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
13495927|NCT03129100|27071126|FG020|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
13495928|NCT03129100|27071127|FG021|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
13495929|NCT03129100|27071128|FG022|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
13495930|NCT03129100|27071129|FG023|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
13495931|NCT03129100|27071130|FG024|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|2|||
13495932|NCT03129100|27071131|FG025|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
13495933|NCT03129100|27071106|FG000|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
13495934|NCT03129100|27071107|FG001|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
13495935|NCT03129100|27071108|FG002|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
13495936|NCT03129100|27071109|FG003|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
13495937|NCT03129100|27071110|FG004|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
13495938|NCT03129100|27071111|FG005|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
13495939|NCT03129100|27071112|FG006|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
13495940|NCT03129100|27071113|FG007|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
13495941|NCT03129100|27071114|FG008|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
13495942|NCT03129100|27071115|FG009|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
13495943|NCT03129100|27071116|FG010|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
13495944|NCT03129100|27071117|FG011|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
13495945|NCT03129100|27071118|FG012|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
13495946|NCT03129100|27071119|FG013|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
13495947|NCT03129100|27071120|FG014|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
13495948|NCT03129100|27071121|FG015|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
13495949|NCT03129100|27071122|FG016|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
13495950|NCT03129100|27071123|FG017|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
13495951|NCT03129100|27071124|FG018|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
13495952|NCT03129100|27071125|FG019|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
13495953|NCT03129100|27071126|FG020|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
13495954|NCT03129100|27071127|FG021|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
13495955|NCT03129100|27071128|FG022|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
13495956|NCT03129100|27071129|FG023|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
13495957|NCT03129100|27071130|FG024|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
13495958|NCT03129100|27071131|FG025|Period 4 (Post Treatment Follow-up)|Missed follow-up|1|||
13495959|NCT03129100|27071106|FG000|Period 4 (Post Treatment Follow-up)|Other|0|||
13495960|NCT03129100|27071107|FG001|Period 4 (Post Treatment Follow-up)|Other|0|||
13495961|NCT03129100|27071108|FG002|Period 4 (Post Treatment Follow-up)|Other|0|||
13495962|NCT03129100|27071109|FG003|Period 4 (Post Treatment Follow-up)|Other|0|||
13495963|NCT03129100|27071110|FG004|Period 4 (Post Treatment Follow-up)|Other|0|||
13495964|NCT03129100|27071111|FG005|Period 4 (Post Treatment Follow-up)|Other|0|||
13495965|NCT03129100|27071112|FG006|Period 4 (Post Treatment Follow-up)|Other|0|||
13495966|NCT03129100|27071113|FG007|Period 4 (Post Treatment Follow-up)|Other|0|||
13495967|NCT03129100|27071114|FG008|Period 4 (Post Treatment Follow-up)|Other|0|||
13495968|NCT03129100|27071115|FG009|Period 4 (Post Treatment Follow-up)|Other|0|||
13495969|NCT03129100|27071116|FG010|Period 4 (Post Treatment Follow-up)|Other|0|||
13495970|NCT03129100|27071117|FG011|Period 4 (Post Treatment Follow-up)|Other|0|||
13495971|NCT03129100|27071118|FG012|Period 4 (Post Treatment Follow-up)|Other|0|||
13495972|NCT03129100|27071119|FG013|Period 4 (Post Treatment Follow-up)|Other|0|||
13495973|NCT03129100|27071120|FG014|Period 4 (Post Treatment Follow-up)|Other|0|||
13495974|NCT03129100|27071121|FG015|Period 4 (Post Treatment Follow-up)|Other|0|||
13495975|NCT03129100|27071122|FG016|Period 4 (Post Treatment Follow-up)|Other|0|||
13495976|NCT03129100|27071123|FG017|Period 4 (Post Treatment Follow-up)|Other|0|||
13495977|NCT03129100|27071124|FG018|Period 4 (Post Treatment Follow-up)|Other|0|||
13495978|NCT03129100|27071125|FG019|Period 4 (Post Treatment Follow-up)|Other|0|||
13495979|NCT03129100|27071126|FG020|Period 4 (Post Treatment Follow-up)|Other|0|||
13495980|NCT03129100|27071127|FG021|Period 4 (Post Treatment Follow-up)|Other|0|||
13495981|NCT03129100|27071128|FG022|Period 4 (Post Treatment Follow-up)|Other|0|||
13495982|NCT03129100|27071129|FG023|Period 4 (Post Treatment Follow-up)|Other|0|||
13495983|NCT03129100|27071130|FG024|Period 4 (Post Treatment Follow-up)|Other|0|||
13495984|NCT03129100|27071131|FG025|Period 4 (Post Treatment Follow-up)|Other|2|||
13495985|NCT02831257|27071145|FG000|Overall Study|Lack of Efficacy|3|||
13495986|NCT02831257|27071145|FG000|Overall Study|Adverse Event|2|||
13495987|NCT02831257|27071145|FG000|Overall Study|Physician Decision|1|||
13495988|NCT02831257|27071145|FG000|Overall Study|Withdrawal by Subject|6|||
13495989|NCT02374814|27071190|FG000|Overall Study|Lost to Follow-up|1|||
13495990|NCT02374814|27071191|FG001|Overall Study|Lost to Follow-up|1|||
13495991|NCT02374814|27071192|FG002|Overall Study|Lost to Follow-up|0|||
13495992|NCT02374814|27071193|FG003|Overall Study|Lost to Follow-up|1|||
13495993|NCT02374814|27071194|FG004|Overall Study|Lost to Follow-up|0|||
13495994|NCT02374814|27071195|FG005|Overall Study|Lost to Follow-up|0|||
13495995|NCT02374814|27071190|FG000|Overall Study|Withdrawal by Subject|0|||
13495996|NCT02374814|27071191|FG001|Overall Study|Withdrawal by Subject|0|||
13495997|NCT02374814|27071192|FG002|Overall Study|Withdrawal by Subject|1|||
13495998|NCT02374814|27071193|FG003|Overall Study|Withdrawal by Subject|1|||
13495999|NCT02374814|27071194|FG004|Overall Study|Withdrawal by Subject|0|||
13496000|NCT02374814|27071195|FG005|Overall Study|Withdrawal by Subject|0|||
13496001|NCT02142738|27071215|FG000|Overall Study|Adverse Event|13|||
13496002|NCT02142738|27071216|FG001|Overall Study|Adverse Event|9|||
13496003|NCT02142738|27071215|FG000|Overall Study|Death|92|||
13496004|NCT02142738|27071216|FG001|Overall Study|Death|112|||
13496005|NCT02142738|27071215|FG000|Overall Study|Lost to Follow-up|0|||
13496006|NCT02142738|27071216|FG001|Overall Study|Lost to Follow-up|3|||
13496007|NCT02142738|27071215|FG000|Overall Study|Withdrawal by Subject|6|||
13496008|NCT02142738|27071216|FG001|Overall Study|Withdrawal by Subject|7|||
13496009|NCT02142738|27071215|FG000|Overall Study|Follow up ended by sponsor|43|||
13496010|NCT02142738|27071216|FG001|Overall Study|Follow up ended by sponsor|20|||
13496011|NCT01667133|27071386|FG000|Phase 1: Dose-escalation|Adverse Event|0|||
13496012|NCT01667133|27071387|FG001|Phase 1: Dose-escalation|Adverse Event|0|||
13496013|NCT01667133|27071388|FG002|Phase 1: Dose-escalation|Adverse Event|1|||
13496014|NCT01667133|27071389|FG003|Phase 1: Dose-escalation|Adverse Event|0|||
13496015|NCT01667133|27071390|FG004|Phase 1: Dose-escalation|Adverse Event|0|||
13496016|NCT01667133|27071391|FG005|Phase 1: Dose-escalation|Adverse Event|0|||
13496017|NCT01667133|27071392|FG006|Phase 1: Dose-escalation|Adverse Event|0|||
13496018|NCT01667133|27071393|FG007|Phase 1: Dose-escalation|Adverse Event|0|||
13496019|NCT01667133|27071394|FG008|Phase 1: Dose-escalation|Adverse Event|0|||
13496020|NCT01667133|27071395|FG009|Phase 1: Dose-escalation|Adverse Event|0|||
13496021|NCT01667133|27071396|FG010|Phase 1: Dose-escalation|Adverse Event|0|||
13496022|NCT01667133|27071397|FG011|Phase 1: Dose-escalation|Adverse Event|0|||
13496023|NCT01667133|27071386|FG000|Phase 1: Dose-escalation|Lack of Efficacy|0|||
13496024|NCT01667133|27071387|FG001|Phase 1: Dose-escalation|Lack of Efficacy|0|||
13496025|NCT01667133|27071388|FG002|Phase 1: Dose-escalation|Lack of Efficacy|1|||
13496026|NCT01667133|27071389|FG003|Phase 1: Dose-escalation|Lack of Efficacy|0|||
13496027|NCT01667133|27071390|FG004|Phase 1: Dose-escalation|Lack of Efficacy|0|||
13496028|NCT01667133|27071391|FG005|Phase 1: Dose-escalation|Lack of Efficacy|0|||
13496029|NCT01667133|27071392|FG006|Phase 1: Dose-escalation|Lack of Efficacy|0|||
13496030|NCT01667133|27071393|FG007|Phase 1: Dose-escalation|Lack of Efficacy|0|||
13496031|NCT01667133|27071394|FG008|Phase 1: Dose-escalation|Lack of Efficacy|0|||
13496032|NCT01667133|27071395|FG009|Phase 1: Dose-escalation|Lack of Efficacy|0|||
13496033|NCT01667133|27071396|FG010|Phase 1: Dose-escalation|Lack of Efficacy|0|||
13496034|NCT01667133|27071397|FG011|Phase 1: Dose-escalation|Lack of Efficacy|0|||
13496035|NCT01667133|27071386|FG000|Phase 1: Dose-escalation|Progressive Disease|0|||
13496036|NCT01667133|27071387|FG001|Phase 1: Dose-escalation|Progressive Disease|1|||
13496037|NCT01667133|27071388|FG002|Phase 1: Dose-escalation|Progressive Disease|2|||
13496038|NCT01667133|27071389|FG003|Phase 1: Dose-escalation|Progressive Disease|0|||
13496039|NCT01667133|27071390|FG004|Phase 1: Dose-escalation|Progressive Disease|1|||
13496040|NCT01667133|27071391|FG005|Phase 1: Dose-escalation|Progressive Disease|1|||
13496041|NCT01667133|27071392|FG006|Phase 1: Dose-escalation|Progressive Disease|1|||
13496042|NCT01667133|27071393|FG007|Phase 1: Dose-escalation|Progressive Disease|0|||
13496043|NCT01667133|27071394|FG008|Phase 1: Dose-escalation|Progressive Disease|0|||
13496044|NCT01667133|27071395|FG009|Phase 1: Dose-escalation|Progressive Disease|0|||
13496045|NCT01667133|27071396|FG010|Phase 1: Dose-escalation|Progressive Disease|0|||
13496046|NCT01667133|27071397|FG011|Phase 1: Dose-escalation|Progressive Disease|0|||
13496047|NCT01667133|27071386|FG000|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
13496048|NCT01667133|27071387|FG001|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
13496049|NCT01667133|27071388|FG002|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
13496050|NCT01667133|27071389|FG003|Phase 1: Dose-escalation|Withdrawal by Subject|1|||
13496051|NCT01667133|27071390|FG004|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
13496052|NCT01667133|27071391|FG005|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
13496053|NCT01667133|27071392|FG006|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
13496054|NCT01667133|27071393|FG007|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
13496055|NCT01667133|27071394|FG008|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
13496056|NCT01667133|27071395|FG009|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
13496057|NCT01667133|27071396|FG010|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
13496058|NCT01667133|27071397|FG011|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
13496059|NCT01667133|27071386|FG000|Phase 2: Dose-expansion|Adverse Event|0|||
13496060|NCT01667133|27071387|FG001|Phase 2: Dose-expansion|Adverse Event|0|||
13496061|NCT01667133|27071388|FG002|Phase 2: Dose-expansion|Adverse Event|0|||
13496062|NCT01667133|27071389|FG003|Phase 2: Dose-expansion|Adverse Event|0|||
13496063|NCT01667133|27071390|FG004|Phase 2: Dose-expansion|Adverse Event|0|||
13496064|NCT01667133|27071391|FG005|Phase 2: Dose-expansion|Adverse Event|0|||
13496065|NCT01667133|27071392|FG006|Phase 2: Dose-expansion|Adverse Event|0|||
13496066|NCT01667133|27071393|FG007|Phase 2: Dose-expansion|Adverse Event|2|||
13496067|NCT01667133|27071394|FG008|Phase 2: Dose-expansion|Adverse Event|1|||
13496068|NCT01667133|27071395|FG009|Phase 2: Dose-expansion|Adverse Event|1|||
13496069|NCT01667133|27071396|FG010|Phase 2: Dose-expansion|Adverse Event|0|||
13496070|NCT01667133|27071397|FG011|Phase 2: Dose-expansion|Adverse Event|0|||
13496071|NCT01667133|27071386|FG000|Phase 2: Dose-expansion|Lack of Efficacy|0|||
13496072|NCT01667133|27071387|FG001|Phase 2: Dose-expansion|Lack of Efficacy|0|||
13496073|NCT01667133|27071388|FG002|Phase 2: Dose-expansion|Lack of Efficacy|0|||
13496074|NCT01667133|27071389|FG003|Phase 2: Dose-expansion|Lack of Efficacy|0|||
13496075|NCT01667133|27071390|FG004|Phase 2: Dose-expansion|Lack of Efficacy|0|||
13496076|NCT01667133|27071391|FG005|Phase 2: Dose-expansion|Lack of Efficacy|0|||
13496077|NCT01667133|27071392|FG006|Phase 2: Dose-expansion|Lack of Efficacy|0|||
13496078|NCT01667133|27071393|FG007|Phase 2: Dose-expansion|Lack of Efficacy|0|||
13496079|NCT01667133|27071394|FG008|Phase 2: Dose-expansion|Lack of Efficacy|0|||
13496080|NCT01667133|27071395|FG009|Phase 2: Dose-expansion|Lack of Efficacy|2|||
13496081|NCT01667133|27071396|FG010|Phase 2: Dose-expansion|Lack of Efficacy|0|||
13496082|NCT01667133|27071397|FG011|Phase 2: Dose-expansion|Lack of Efficacy|0|||
13496083|NCT01667133|27071386|FG000|Phase 2: Dose-expansion|Progressive Disease|0|||
13496084|NCT01667133|27071387|FG001|Phase 2: Dose-expansion|Progressive Disease|0|||
13496085|NCT01667133|27071388|FG002|Phase 2: Dose-expansion|Progressive Disease|0|||
13496086|NCT01667133|27071389|FG003|Phase 2: Dose-expansion|Progressive Disease|0|||
13496087|NCT01667133|27071390|FG004|Phase 2: Dose-expansion|Progressive Disease|0|||
13496088|NCT01667133|27071391|FG005|Phase 2: Dose-expansion|Progressive Disease|0|||
13496089|NCT01667133|27071392|FG006|Phase 2: Dose-expansion|Progressive Disease|0|||
13496090|NCT01667133|27071393|FG007|Phase 2: Dose-expansion|Progressive Disease|0|||
13496091|NCT01667133|27071394|FG008|Phase 2: Dose-expansion|Progressive Disease|0|||
13496092|NCT01667133|27071395|FG009|Phase 2: Dose-expansion|Progressive Disease|0|||
13496093|NCT01667133|27071396|FG010|Phase 2: Dose-expansion|Progressive Disease|3|||
13496094|NCT01667133|27071397|FG011|Phase 2: Dose-expansion|Progressive Disease|5|||
13496095|NCT01667133|27071386|FG000|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
13496096|NCT01667133|27071387|FG001|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
13496097|NCT01667133|27071388|FG002|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
13496098|NCT01667133|27071389|FG003|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
13496099|NCT01667133|27071390|FG004|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
13496100|NCT01667133|27071391|FG005|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
13496101|NCT01667133|27071392|FG006|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
13496102|NCT01667133|27071393|FG007|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
13496103|NCT01667133|27071394|FG008|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
13496104|NCT01667133|27071395|FG009|Phase 2: Dose-expansion|Withdrawal by Subject|2|||
13496105|NCT01667133|27071396|FG010|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
13496106|NCT01667133|27071397|FG011|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
13496107|NCT01667133|27071386|FG000|Phase 2: Dose-expansion|Death|0|||
13496108|NCT01667133|27071387|FG001|Phase 2: Dose-expansion|Death|0|||
13496109|NCT01667133|27071388|FG002|Phase 2: Dose-expansion|Death|0|||
13496110|NCT01667133|27071389|FG003|Phase 2: Dose-expansion|Death|0|||
13496111|NCT01667133|27071390|FG004|Phase 2: Dose-expansion|Death|0|||
13496112|NCT01667133|27071391|FG005|Phase 2: Dose-expansion|Death|0|||
13496113|NCT01667133|27071392|FG006|Phase 2: Dose-expansion|Death|0|||
13496114|NCT01667133|27071393|FG007|Phase 2: Dose-expansion|Death|0|||
13496115|NCT01667133|27071394|FG008|Phase 2: Dose-expansion|Death|0|||
13496116|NCT01667133|27071395|FG009|Phase 2: Dose-expansion|Death|1|||
13496117|NCT01667133|27071396|FG010|Phase 2: Dose-expansion|Death|0|||
13496118|NCT01667133|27071397|FG011|Phase 2: Dose-expansion|Death|0|||
13496119|NCT01667133|27071386|FG000|Phase 2: Dose-expansion|Other|0|||
13496120|NCT01667133|27071387|FG001|Phase 2: Dose-expansion|Other|0|||
13496121|NCT01667133|27071388|FG002|Phase 2: Dose-expansion|Other|0|||
13496122|NCT01667133|27071389|FG003|Phase 2: Dose-expansion|Other|0|||
13496123|NCT01667133|27071390|FG004|Phase 2: Dose-expansion|Other|0|||
13496124|NCT01667133|27071391|FG005|Phase 2: Dose-expansion|Other|0|||
13496125|NCT01667133|27071392|FG006|Phase 2: Dose-expansion|Other|0|||
13496126|NCT01667133|27071393|FG007|Phase 2: Dose-expansion|Other|0|||
13496127|NCT01667133|27071394|FG008|Phase 2: Dose-expansion|Other|0|||
13496128|NCT01667133|27071395|FG009|Phase 2: Dose-expansion|Other|0|||
13496129|NCT01667133|27071396|FG010|Phase 2: Dose-expansion|Other|0|||
13496130|NCT01667133|27071397|FG011|Phase 2: Dose-expansion|Other|1|||
13496131|NCT01427725|27071427|FG000|Overall Study|Lost to Follow-up|17|||
13496132|NCT01427725|27071427|FG000|Overall Study|Protocol Violation|1|||
13496133|NCT01427725|27071427|FG000|Overall Study|Drug not administered|1|||
13496134|NCT01427725|27071427|FG000|Overall Study|Failure to visit|7|||
13496135|NCT01427725|27071427|FG000|Overall Study|Adverse Event|46|||
13496136|NCT01427725|27071427|FG000|Overall Study|Failure to visit after administration|40|||
13496137|NCT01427725|27071427|FG000|Overall Study|Patient's rejection|27|||
13496138|NCT01427725|27071427|FG000|Overall Study|Transfer to a different hospital|17|||
13496139|NCT01427725|27071427|FG000|Overall Study|Lack of Efficacy|8|||
13496140|NCT01427725|27071427|FG000|Overall Study|Death|7|||
13496141|NCT01427725|27071427|FG000|Overall Study|Symptom improvement|6|||
13496142|NCT01427725|27071427|FG000|Overall Study|AE and Patient's rejection|5|||
13496143|NCT01427725|27071427|FG000|Overall Study|Physician Decision|5|||
13496144|NCT01427725|27071427|FG000|Overall Study|Exacerbation of underlying disease|5|||
13496145|NCT01427725|27071427|FG000|Overall Study|Oral feeding difficulty|5|||
13496146|NCT01427725|27071427|FG000|Overall Study|Lack of Efficacy and Patient's rejection|1|||
13496147|NCT01427725|27071427|FG000|Overall Study|Forgetting prescription|1|||
13496148|NCT01427725|27071427|FG000|Overall Study|Other|2|||
13133757|NCT02765165|25988891|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0|||
13133758|NCT02765165|25988892|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0|||
13133759|NCT02765165|25988893|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0|||
13133760|NCT02765165|25988894|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0|||
13133761|NCT02765165|25988895|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2|||
13133762|NCT02765165|25988896|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2|||
13133763|NCT02765165|25988897|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1|||
13133764|NCT02765100|25988910|FG000|Overall Study|subject found ineligible after baseline|1|||
13133765|NCT02765100|25988911|FG001|Overall Study|subject found ineligible after baseline|1|||
13133766|NCT02765100|25988910|FG000|Overall Study|Lost to Follow-up|0|||
13133767|NCT02765100|25988911|FG001|Overall Study|Lost to Follow-up|1|||
13133768|NCT02765035|25988941|FG000|First Intervention (90 Days)|Adverse Event|1|||
13133769|NCT02765035|25988942|FG001|First Intervention (90 Days)|Adverse Event|1|||
13133770|NCT02765035|25988941|FG000|Second Intervention (30 Days)|Protocol Violation|2|||
13133771|NCT02765035|25988942|FG001|Second Intervention (30 Days)|Protocol Violation|2|||
13133772|NCT02764775|25988948|FG000|Overall Study|Death|1|||
13133773|NCT02764775|25988948|FG000|Overall Study|Lost to Follow-up|2|||
13133774|NCT02764775|25988948|FG000|Overall Study|Withdrawal by Subject|3|||
13133775|NCT02764762|25988954|FG000|Overall Study|Adverse Event|5|||
13133776|NCT02764762|25988954|FG000|Overall Study|Voluntary Withdrawal|3|||
13133777|NCT02764762|25988954|FG000|Overall Study|Significant Deviation|1|||
13133778|NCT02764697|25988961|FG000|Overall Study|Lack of Efficacy|3|||
13133779|NCT02764333|25988967|FG000|Overall Study|Ineligible|1|||
13133780|NCT02764320|25988980|FG000|Overall Study|Withdrawal by Subject|35|||
13133781|NCT02764320|25988981|FG001|Overall Study|Withdrawal by Subject|38|||
13133782|NCT02764320|25988980|FG000|Overall Study|Protocol Violation|11|||
13496149|NCT04608344|27071469|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0|||
13496150|NCT04608344|27071470|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1|||
13496151|NCT04608344|27071469|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1|||
13496152|NCT04608344|27071470|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0|||
13496215|NCT03364673|27071861|FG000|Overall Study|Withdrawal by Subject|2|||
13496216|NCT03364673|27071861|FG000|Overall Study|Injury unrelated to study|3|||
13496217|NCT03343704|27071908|FG000|Overall Study|Refused to complete follow up|0|||
13496218|NCT03343704|27071909|FG001|Overall Study|Refused to complete follow up|1|||
13496219|NCT03343704|27071908|FG000|Overall Study|Death|0|||
13496220|NCT03343704|27071909|FG001|Overall Study|Death|1|||
13496221|NCT03343704|27071908|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1|||
13496222|NCT03343704|27071909|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0|||
13496223|NCT03265145|27071930|FG000|Overall Study|Protocol Violation|2|||
13496224|NCT03265145|27071931|FG001|Overall Study|Protocol Violation|0|||
13496225|NCT03265145|27071930|FG000|Overall Study|Adverse Event|1|||
13496226|NCT03265145|27071931|FG001|Overall Study|Adverse Event|0|||
13496227|NCT03265145|27071930|FG000|Overall Study|Withdrawal by Subject|23|||
13496228|NCT03265145|27071931|FG001|Overall Study|Withdrawal by Subject|19|||
13496229|NCT03265145|27071930|FG000|Overall Study|Death|12|||
13496230|NCT03265145|27071931|FG001|Overall Study|Death|12|||
13496231|NCT03265145|27071930|FG000|Overall Study|Lost to Follow-up|13|||
13496232|NCT03265145|27071931|FG001|Overall Study|Lost to Follow-up|9|||
13496233|NCT03265145|27071930|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0|||
13496234|NCT03265145|27071931|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1|||
13496235|NCT03265145|27071930|FG000|Overall Study|Switched back to previous medication|1|||
13496236|NCT03265145|27071931|FG001|Overall Study|Switched back to previous medication|0|||
13496237|NCT03265145|27071930|FG000|Overall Study|Did not want to take medication|1|||
13496238|NCT03265145|27071931|FG001|Overall Study|Did not want to take medication|0|||
13496239|NCT03265145|27071930|FG000|Overall Study|Subject could not afford medication|0|||
13496240|NCT03265145|27071931|FG001|Overall Study|Subject could not afford medication|1|||
13496241|NCT03265145|27071930|FG000|Overall Study|Site closed|2|||
13496242|NCT03265145|27071931|FG001|Overall Study|Site closed|3|||
13496243|NCT03265145|27071930|FG000|Overall Study|Incorrectly randomized|16|||
13496244|NCT03265145|27071931|FG001|Overall Study|Incorrectly randomized|6|||
13496245|NCT03265145|27071930|FG000|Overall Study|Entered into Electronic Data Capture in error|0|||
13496246|NCT03265145|27071931|FG001|Overall Study|Entered into Electronic Data Capture in error|1|||
13496247|NCT03265145|27071930|FG000|Overall Study|Physician Decision|0|||
13496248|NCT03265145|27071931|FG001|Overall Study|Physician Decision|3|||
13496249|NCT03265145|27071930|FG000|Overall Study|Subject transferred to another facility|0|||
13496250|NCT03265145|27071931|FG001|Overall Study|Subject transferred to another facility|1|||
13496251|NCT02921789|27072375|FG000|Overall Study|Adverse Event|0|||
13496252|NCT02921789|27072376|FG001|Overall Study|Adverse Event|1|||
13496253|NCT02921789|27072375|FG000|Overall Study|Lost to Follow-up|1|||
13496254|NCT02921789|27072376|FG001|Overall Study|Lost to Follow-up|0|||
13496255|NCT02921789|27072375|FG000|Overall Study|Protocol Deviation|2|||
13496256|NCT02921789|27072376|FG001|Overall Study|Protocol Deviation|0|||
13496257|NCT02921789|27072375|FG000|Overall Study|Withdrawal by Subject|2|||
13496258|NCT02921789|27072376|FG001|Overall Study|Withdrawal by Subject|1|||
13496259|NCT02921789|27072375|FG000|Overall Study|Miscellaneous|3|||
13496260|NCT02921789|27072376|FG001|Overall Study|Miscellaneous|2|||
13496261|NCT02898077|27072405|FG000|Overall Study|Enrolled/randomized, but never treated|1|||
13496262|NCT02898077|27072406|FG001|Overall Study|Enrolled/randomized, but never treated|1|||
13496263|NCT02898077|27072405|FG000|Overall Study|Lost to Follow-up|4|||
13496264|NCT02898077|27072406|FG001|Overall Study|Lost to Follow-up|3|||
13496265|NCT02898077|27072405|FG000|Overall Study|Physician Decision|0|||
13496266|NCT02898077|27072406|FG001|Overall Study|Physician Decision|2|||
13496267|NCT02898077|27072405|FG000|Overall Study|Sponsor Decision|32|||
13496268|NCT02898077|27072406|FG001|Overall Study|Sponsor Decision|13|||
13496269|NCT02898077|27072405|FG000|Overall Study|Withdrawal by Subject|6|||
13496270|NCT02898077|27072406|FG001|Overall Study|Withdrawal by Subject|3|||
13496271|NCT02898077|27072405|FG000|Overall Study|Discontinued from treatment but refused follow-up|2|||
13496272|NCT02898077|27072406|FG001|Overall Study|Discontinued from treatment but refused follow-up|1|||
13496273|NCT02898077|27072405|FG000|Overall Study|Ended extension period|3|||
13496274|NCT02898077|27072406|FG001|Overall Study|Ended extension period|0|||
13496275|NCT02471339|27072462|FG000|Overall Study|Did not provide follow-up data|2|||
13496276|NCT02471339|27072463|FG001|Overall Study|Did not provide follow-up data|0|||
13496277|NCT02470585|27072496|FG000|Overall Study|Death|82|||
13496278|NCT02470585|27072497|FG001|Overall Study|Death|87|||
13496279|NCT02470585|27072498|FG002|Overall Study|Death|86|||
13496280|NCT02470585|27072496|FG000|Overall Study|Withdrawal by Subject|19|||
13496281|NCT02470585|27072497|FG001|Overall Study|Withdrawal by Subject|21|||
13496282|NCT02470585|27072498|FG002|Overall Study|Withdrawal by Subject|29|||
13496283|NCT02470585|27072496|FG000|Overall Study|Lost to Follow-up|2|||
13496284|NCT02470585|27072497|FG001|Overall Study|Lost to Follow-up|5|||
13496153|NCT04350372|27071483|FG000|Overall Study|Death|1|||
13496154|NCT04234984|27071567|FG000|Follow-up at 6 Weeks|Lost to Follow-up|2|||
13496155|NCT04234984|27071567|FG000|Follow-up at the Second Time Point|Death|1|||
13496156|NCT04234984|27071567|FG000|Follow-up at the Second Time Point|Mentally unable to fill in the questionnaire|1|||
13496157|NCT04227197|27071587|FG000|Randomization|Protocol Violation|1|||
13496158|NCT04227197|27071588|FG001|Randomization|Protocol Violation|0|||
13496159|NCT04227197|27071587|FG000|Randomization|Discontinued participation because uncomfortable sharing information|1|||
13496160|NCT04227197|27071588|FG001|Randomization|Discontinued participation because uncomfortable sharing information|0|||
13496161|NCT04227197|27071587|FG000|Primary Care Provider (PCP) Visit|Did not complete PCP visit|2|||
13496162|NCT04227197|27071588|FG001|Primary Care Provider (PCP) Visit|Did not complete PCP visit|0|||
13496163|NCT04227197|27071587|FG000|2-week Follow-up Survey for Caregivers|Not responsive|7|||
13496164|NCT04227197|27071588|FG001|2-week Follow-up Survey for Caregivers|Not responsive|5|||
13496165|NCT04227197|27071587|FG000|2-week Follow-up Survey for Caregivers|Lost to Follow-up|5|||
13496166|NCT04227197|27071588|FG001|2-week Follow-up Survey for Caregivers|Lost to Follow-up|0|||
13496167|NCT04227197|27071587|FG000|2-week Follow-up Survey for PCP's|Not responsive|20|||
13496168|NCT04227197|27071588|FG001|2-week Follow-up Survey for PCP's|Not responsive|25|||
13496169|NCT04227197|27071587|FG000|7-month Follow-up Survey for Caregivers|Lost to Follow-up|11|||
13496170|NCT04227197|27071588|FG001|7-month Follow-up Survey for Caregivers|Lost to Follow-up|3|||
13496171|NCT04105725|27071605|FG000|Primary Intervention|Lost to Follow-up|0|||
13496172|NCT04105725|27071606|FG001|Primary Intervention|Lost to Follow-up|2|||
13496173|NCT04105725|27071605|FG000|Primary Intervention|Withdrawal by Subject|0|||
13496174|NCT04105725|27071606|FG001|Primary Intervention|Withdrawal by Subject|1|||
13496175|NCT04066023|27071654|FG000|Overall Study|Adverse Event|0|||
13496176|NCT04066023|27071655|FG001|Overall Study|Adverse Event|0|||
13496177|NCT04066023|27071656|FG002|Overall Study|Adverse Event|1|||
13496178|NCT04066023|27071654|FG000|Overall Study|Sponsor decision|3|||
13496179|NCT04066023|27071655|FG001|Overall Study|Sponsor decision|6|||
13496180|NCT04066023|27071656|FG002|Overall Study|Sponsor decision|2|||
13496181|NCT04066023|27071654|FG000|Overall Study|Physician Decision|0|||
13496182|NCT04066023|27071655|FG001|Overall Study|Physician Decision|0|||
13496183|NCT04066023|27071656|FG002|Overall Study|Physician Decision|1|||
13496184|NCT04066023|27071654|FG000|Overall Study|Lost to Follow-up|0|||
13496185|NCT04066023|27071655|FG001|Overall Study|Lost to Follow-up|1|||
13496186|NCT04066023|27071656|FG002|Overall Study|Lost to Follow-up|1|||
13496187|NCT04066023|27071654|FG000|Overall Study|Noncompliance|0|||
13496188|NCT04066023|27071655|FG001|Overall Study|Noncompliance|1|||
13496189|NCT04066023|27071656|FG002|Overall Study|Noncompliance|1|||
13496190|NCT03882957|27071723|FG000|Overall Study|Did not complete all three arms|1|||
13496191|NCT03387852|27071828|FG000|Overall Study|Adverse event (AE)|3|||
13496192|NCT03387852|27071829|FG001|Overall Study|Adverse event (AE)|0|||
13496193|NCT03387852|27071830|FG002|Overall Study|Adverse event (AE)|2|||
13496194|NCT03387852|27071831|FG003|Overall Study|Adverse event (AE)|0|||
13496195|NCT03387852|27071828|FG000|Overall Study|Loss of asthma control (LOAC)|28|||
13496196|NCT03387852|27071829|FG001|Overall Study|Loss of asthma control (LOAC)|16|||
13496197|NCT03387852|27071830|FG002|Overall Study|Loss of asthma control (LOAC)|20|||
13496198|NCT03387852|27071831|FG003|Overall Study|Loss of asthma control (LOAC)|14|||
13496199|NCT03387852|27071828|FG000|Overall Study|Withdrawal by participant|1|||
13496200|NCT03387852|27071829|FG001|Overall Study|Withdrawal by participant|1|||
13496201|NCT03387852|27071830|FG002|Overall Study|Withdrawal by participant|3|||
13496202|NCT03387852|27071831|FG003|Overall Study|Withdrawal by participant|2|||
13496203|NCT03387852|27071828|FG000|Overall Study|Other- Unspecified|1|||
13496204|NCT03387852|27071829|FG001|Overall Study|Other- Unspecified|1|||
13496205|NCT03387852|27071830|FG002|Overall Study|Other- Unspecified|2|||
13496206|NCT03387852|27071831|FG003|Overall Study|Other- Unspecified|1|||
13496207|NCT03387852|27071828|FG000|Overall Study|Poor compliance to protocol|0|||
13496208|NCT03387852|27071829|FG001|Overall Study|Poor compliance to protocol|0|||
13496209|NCT03387852|27071830|FG002|Overall Study|Poor compliance to protocol|0|||
13496210|NCT03387852|27071831|FG003|Overall Study|Poor compliance to protocol|1|||
13496211|NCT03387852|27071828|FG000|Overall Study|Randomized and not treated|0|||
13496212|NCT03387852|27071829|FG001|Overall Study|Randomized and not treated|0|||
13496213|NCT03387852|27071830|FG002|Overall Study|Randomized and not treated|0|||
13496214|NCT03387852|27071831|FG003|Overall Study|Randomized and not treated|1|||
13496285|NCT02470585|27072498|FG002|Overall Study|Lost to Follow-up|4|||
13496286|NCT02470585|27072496|FG000|Overall Study|Other|4|||
13496287|NCT02470585|27072497|FG001|Overall Study|Other|4|||
13496288|NCT02470585|27072498|FG002|Overall Study|Other|6|||
13496289|NCT02163694|27072555|FG000|Overall Study|Adverse event- related to progression|3|||
13496290|NCT02163694|27072556|FG001|Overall Study|Adverse event- related to progression|8|||
13496291|NCT02163694|27072555|FG000|Overall Study|Adverse event- not related to progression|7|||
13496292|NCT02163694|27072556|FG001|Overall Study|Adverse event- not related to progression|17|||
13496293|NCT02163694|27072555|FG000|Overall Study|Withdrew consent|8|||
13496294|NCT02163694|27072556|FG001|Overall Study|Withdrew consent|21|||
13496295|NCT02163694|27072555|FG000|Overall Study|Lost to Follow-up|1|||
13496296|NCT02163694|27072556|FG001|Overall Study|Lost to Follow-up|2|||
13496297|NCT02163694|27072555|FG000|Overall Study|Progressive disease per protocol|122|||
13496298|NCT02163694|27072556|FG001|Overall Study|Progressive disease per protocol|197|||
13496299|NCT02163694|27072555|FG000|Overall Study|Other, not specified|13|||
13496300|NCT02163694|27072556|FG001|Overall Study|Other, not specified|22|||
13496301|NCT01966471|27072589|FG000|Overall Study|Death|44|||
13496302|NCT01966471|27072590|FG001|Overall Study|Death|56|||
13496303|NCT01966471|27072589|FG000|Overall Study|Lost to Follow-up|46|||
13496304|NCT01966471|27072590|FG001|Overall Study|Lost to Follow-up|39|||
13496305|NCT01966471|27072589|FG000|Overall Study|Various reasons|4|||
13496306|NCT01966471|27072590|FG001|Overall Study|Various reasons|4|||
13496307|NCT01966471|27072589|FG000|Overall Study|Physician Decision|7|||
13496308|NCT01966471|27072590|FG001|Overall Study|Physician Decision|5|||
13496309|NCT01966471|27072589|FG000|Overall Study|Study Terminated By Sponsor|758|||
13496310|NCT01966471|27072590|FG001|Overall Study|Study Terminated By Sponsor|773|||
13496311|NCT01966471|27072589|FG000|Overall Study|Withdrawal by Subject|59|||
13496312|NCT01966471|27072590|FG001|Overall Study|Withdrawal by Subject|51|||
13496313|NCT01307423|27072827|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
13496314|NCT01307423|27072828|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
13496315|NCT01307423|27072829|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6|||
13496316|NCT01307423|27072830|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
13496317|NCT01307423|27072831|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
13496318|NCT01307423|27072832|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
13496319|NCT01307423|27072833|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
13496320|NCT01307423|27072834|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
13496321|NCT01307423|27072835|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
13496322|NCT01307423|27072827|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1|||
13496323|NCT01307423|27072828|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
13496324|NCT01307423|27072829|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
13496325|NCT01307423|27072830|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
13496326|NCT01307423|27072831|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
13496327|NCT01307423|27072832|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
13496328|NCT01307423|27072833|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
13496329|NCT01307423|27072834|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
13496330|NCT01307423|27072835|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
13496331|NCT01307423|27072827|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8|||
13496332|NCT01307423|27072828|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
13496333|NCT01307423|27072829|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10|||
13496334|NCT01307423|27072830|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
13496335|NCT01307423|27072831|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
13496336|NCT01307423|27072832|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
13496337|NCT01307423|27072833|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
13496338|NCT01307423|27072834|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
13496339|NCT01307423|27072835|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
13496340|NCT01307423|27072827|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
13496341|NCT01307423|27072828|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
13496342|NCT01307423|27072829|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
13496343|NCT01307423|27072830|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
13496344|NCT01307423|27072831|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
13496345|NCT01307423|27072832|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
13496346|NCT01307423|27072833|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
13496347|NCT01307423|27072834|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
13496348|NCT01307423|27072835|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
13496349|NCT01307423|27072827|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5|||
13496350|NCT01307423|27072828|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
13496351|NCT01307423|27072829|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
13496352|NCT01307423|27072830|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
13496353|NCT01307423|27072831|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
13496354|NCT01307423|27072832|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
13496355|NCT01307423|27072833|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
13496356|NCT01307423|27072834|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
13496357|NCT01307423|27072835|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
13496358|NCT01307423|27072827|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
13133783|NCT02764320|25988981|FG001|Overall Study|Protocol Violation|6|||
13496359|NCT01307423|27072828|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
13496360|NCT01307423|27072829|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
13496361|NCT01307423|27072830|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
13496362|NCT01307423|27072831|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
13496363|NCT01307423|27072832|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
13496364|NCT01307423|27072833|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
13496365|NCT01307423|27072834|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
13496366|NCT01307423|27072835|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
13496367|NCT01307423|27072827|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
13496368|NCT01307423|27072828|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
13496369|NCT01307423|27072829|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
13496370|NCT01307423|27072830|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
13496371|NCT01307423|27072831|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
13496372|NCT01307423|27072832|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
13496373|NCT01307423|27072833|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
13496374|NCT01307423|27072834|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
13496375|NCT01307423|27072835|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
13496376|NCT01307423|27072827|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
13496377|NCT01307423|27072828|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
13496378|NCT01307423|27072829|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
13496379|NCT01307423|27072830|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
13496380|NCT01307423|27072831|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
13496381|NCT01307423|27072832|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
13496382|NCT01307423|27072833|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
13496383|NCT01307423|27072834|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
13496384|NCT01307423|27072835|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
13496385|NCT01307423|27072827|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
13496386|NCT01307423|27072828|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3|||
13496387|NCT01307423|27072829|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
13496388|NCT01307423|27072830|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
13496389|NCT01307423|27072831|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
13496390|NCT01307423|27072832|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
13496391|NCT01307423|27072833|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
13496392|NCT01307423|27072834|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
13496393|NCT01307423|27072835|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
13496394|NCT01307423|27072827|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
13496395|NCT01307423|27072828|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
13496396|NCT01307423|27072829|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
13496397|NCT01307423|27072830|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3|||
13496398|NCT01307423|27072831|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1|||
13496399|NCT01307423|27072832|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
13496400|NCT01307423|27072833|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
13496401|NCT01307423|27072834|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
13496402|NCT01307423|27072835|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
13496403|NCT01307423|27072827|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
13496404|NCT01307423|27072828|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
13496405|NCT01307423|27072829|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
13496406|NCT01307423|27072830|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
13496407|NCT01307423|27072831|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
13496408|NCT01307423|27072832|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1|||
13496409|NCT01307423|27072833|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
13496410|NCT01307423|27072834|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
13496411|NCT01307423|27072835|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
13496412|NCT01307423|27072827|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
13496413|NCT01307423|27072828|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11|||
13496414|NCT01307423|27072829|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2|||
13496415|NCT01307423|27072830|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
13496416|NCT01307423|27072831|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
13496417|NCT01307423|27072832|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
13496418|NCT01307423|27072833|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
13496419|NCT01307423|27072834|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
13496420|NCT01307423|27072835|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
13496421|NCT01307423|27072827|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
13496422|NCT01307423|27072828|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
13496423|NCT01307423|27072829|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
13496424|NCT01307423|27072830|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2|||
13496425|NCT01307423|27072831|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
13496426|NCT01307423|27072832|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
13496427|NCT01307423|27072833|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
13496428|NCT01307423|27072834|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
13496429|NCT01307423|27072835|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
13496430|NCT01307423|27072827|FG000|Active Treatment Phase (Week 25-52)|Other|0|||
13496431|NCT01307423|27072828|FG001|Active Treatment Phase (Week 25-52)|Other|0|||
13496432|NCT01307423|27072829|FG002|Active Treatment Phase (Week 25-52)|Other|0|||
13496433|NCT01307423|27072830|FG003|Active Treatment Phase (Week 25-52)|Other|1|||
13496434|NCT01307423|27072831|FG004|Active Treatment Phase (Week 25-52)|Other|0|||
13496435|NCT01307423|27072832|FG005|Active Treatment Phase (Week 25-52)|Other|0|||
13496436|NCT01307423|27072833|FG006|Active Treatment Phase (Week 25-52)|Other|0|||
13496437|NCT01307423|27072834|FG007|Active Treatment Phase (Week 25-52)|Other|0|||
13496438|NCT01307423|27072835|FG008|Active Treatment Phase (Week 25-52)|Other|0|||
13496439|NCT01307423|27072827|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
13496440|NCT01307423|27072828|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
13496441|NCT01307423|27072829|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
13496442|NCT01307423|27072830|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
13496443|NCT01307423|27072831|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
13496444|NCT01307423|27072832|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1|||
13496445|NCT01307423|27072833|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
13496446|NCT01307423|27072834|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
13496447|NCT01307423|27072835|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
13496448|NCT01307423|27072827|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
13496449|NCT01307423|27072828|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2|||
13496450|NCT01307423|27072829|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7|||
13496451|NCT01307423|27072830|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
13496452|NCT01307423|27072831|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
13496453|NCT01307423|27072832|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
13496454|NCT01307423|27072833|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
13496455|NCT01307423|27072834|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1|||
13496456|NCT01307423|27072835|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1|||
13496457|NCT01307423|27072827|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
13496458|NCT01307423|27072828|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
13496459|NCT01307423|27072829|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5|||
13496460|NCT01307423|27072830|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
13496461|NCT01307423|27072831|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
13496462|NCT01307423|27072832|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
13496463|NCT01307423|27072833|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
13496464|NCT01307423|27072834|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
13496465|NCT01307423|27072835|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3|||
13496466|NCT01307423|27072827|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
13496467|NCT01307423|27072828|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
13496468|NCT01307423|27072829|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1|||
13496469|NCT01307423|27072830|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
13496470|NCT01307423|27072831|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
13496471|NCT01307423|27072832|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
13496472|NCT01307423|27072833|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
13496473|NCT01307423|27072834|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
13496474|NCT01307423|27072835|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
13496475|NCT01307423|27072827|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
13496476|NCT01307423|27072828|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13|||
13496477|NCT01307423|27072829|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12|||
13496478|NCT01307423|27072830|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
13496479|NCT01307423|27072831|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
13496480|NCT01307423|27072832|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
13496481|NCT01307423|27072833|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
13496482|NCT01307423|27072834|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
13496483|NCT01307423|27072835|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2|||
13496484|NCT01307423|27072827|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
13496485|NCT01307423|27072828|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
13496486|NCT01307423|27072829|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
13496487|NCT01307423|27072830|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
13496488|NCT01307423|27072831|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
13496489|NCT01307423|27072832|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
13496490|NCT01307423|27072833|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
13496491|NCT01307423|27072834|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
13496492|NCT01307423|27072835|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
13496493|NCT01307423|27072827|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
13133784|NCT02764320|25988980|FG000|Overall Study|Adverse Event|2|||
13496494|NCT01307423|27072828|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1|||
13496495|NCT01307423|27072829|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
13496496|NCT01307423|27072830|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
13496497|NCT01307423|27072831|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
13496498|NCT01307423|27072832|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
13496499|NCT01307423|27072833|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
13496500|NCT01307423|27072834|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3|||
13496501|NCT01307423|27072835|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4|||
13496502|NCT01307423|27072827|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
13496503|NCT01307423|27072828|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
13496504|NCT01307423|27072829|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
13496505|NCT01307423|27072830|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
13496506|NCT01307423|27072831|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
13496507|NCT01307423|27072832|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
13496508|NCT01307423|27072833|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
13496509|NCT01307423|27072834|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1|||
13496510|NCT01307423|27072835|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
13496511|NCT01307423|27072827|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
13496512|NCT01307423|27072828|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
13496513|NCT01307423|27072829|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
13496514|NCT01307423|27072830|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
13496515|NCT01307423|27072831|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
13496516|NCT01307423|27072832|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
13496517|NCT01307423|27072833|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
13496518|NCT01307423|27072834|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
13496519|NCT01307423|27072835|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
13496520|NCT01307423|27072827|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
13496521|NCT01307423|27072828|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
13496522|NCT01307423|27072829|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8|||
13496523|NCT01307423|27072830|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
13496524|NCT01307423|27072831|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
13496525|NCT01307423|27072832|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
13496526|NCT01307423|27072833|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
13496527|NCT01307423|27072834|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
13496528|NCT01307423|27072835|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
13496529|NCT01307423|27072827|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
13496530|NCT01307423|27072828|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2|||
13496531|NCT01307423|27072829|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3|||
13496532|NCT01307423|27072830|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
13496533|NCT01307423|27072831|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
13496534|NCT01307423|27072832|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
13496535|NCT01307423|27072833|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
13496536|NCT01307423|27072834|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
13496537|NCT01307423|27072835|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
13496538|NCT01307423|27072827|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
13496539|NCT01307423|27072828|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
13496540|NCT01307423|27072829|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
13496541|NCT01307423|27072830|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
13496542|NCT01307423|27072831|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
13496543|NCT01307423|27072832|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
13496544|NCT01307423|27072833|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
13496545|NCT01307423|27072834|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
13496546|NCT01307423|27072835|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
13496547|NCT01307423|27072827|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
13496548|NCT01307423|27072828|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2|||
13496549|NCT01307423|27072829|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0|||
13496550|NCT01307423|27072830|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
13496551|NCT01307423|27072831|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
13496552|NCT01307423|27072832|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
13496553|NCT01307423|27072833|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
13496554|NCT01307423|27072834|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
13496555|NCT01307423|27072835|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0|||
13496556|NCT01307423|27072827|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
13133785|NCT02764320|25988981|FG001|Overall Study|Adverse Event|0|||
13496557|NCT01307423|27072828|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
13496558|NCT01307423|27072829|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
13496559|NCT01307423|27072830|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
13496560|NCT01307423|27072831|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
13496561|NCT01307423|27072832|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
13496562|NCT01307423|27072833|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
13496563|NCT01307423|27072834|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
13496564|NCT01307423|27072835|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
13496565|NCT01307423|27072827|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
13496566|NCT01307423|27072828|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5|||
13496567|NCT01307423|27072829|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
13496568|NCT01307423|27072830|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
13496569|NCT01307423|27072831|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
13496570|NCT01307423|27072832|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
13496571|NCT01307423|27072833|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
13496572|NCT01307423|27072834|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1|||
13496573|NCT01307423|27072835|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
13496574|NCT01307423|27072827|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
13496575|NCT01307423|27072828|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
13496576|NCT01307423|27072829|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
13496577|NCT01307423|27072830|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
13496578|NCT01307423|27072831|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
13496579|NCT01307423|27072832|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
13496580|NCT01307423|27072833|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
13496581|NCT01307423|27072834|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
13496582|NCT01307423|27072835|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
13496583|NCT01307423|27072827|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
13496584|NCT01307423|27072828|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
13496585|NCT01307423|27072829|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
13496586|NCT01307423|27072830|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
13496587|NCT01307423|27072831|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
13496588|NCT01307423|27072832|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
13496589|NCT01307423|27072833|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
13496590|NCT01307423|27072834|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
13496591|NCT01307423|27072835|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
13496592|NCT01307423|27072827|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
13496593|NCT01307423|27072828|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1|||
13496594|NCT01307423|27072829|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1|||
13496595|NCT01307423|27072830|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
13496596|NCT01307423|27072831|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
13496597|NCT01307423|27072832|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
13496598|NCT01307423|27072833|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
13496599|NCT01307423|27072834|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
13496600|NCT01307423|27072835|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
13496601|NCT01307423|27072827|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
13496602|NCT01307423|27072828|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2|||
13496603|NCT01307423|27072829|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1|||
13496604|NCT01307423|27072830|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
13496605|NCT01307423|27072831|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
13496606|NCT01307423|27072832|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
13496607|NCT01307423|27072833|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
13496608|NCT01307423|27072834|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
13496609|NCT01307423|27072835|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
13496610|NCT01307423|27072827|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
13496611|NCT01307423|27072828|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6|||
13496612|NCT01307423|27072829|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
13496613|NCT01307423|27072830|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
13496614|NCT01307423|27072831|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
13496615|NCT01307423|27072832|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
13496616|NCT01307423|27072833|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
13496617|NCT01307423|27072834|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
13496618|NCT01307423|27072835|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
13496619|NCT01307423|27072827|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
13496620|NCT01307423|27072828|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1|||
13496621|NCT01307423|27072829|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
13496622|NCT01307423|27072830|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
13496623|NCT01307423|27072831|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
13496624|NCT01307423|27072832|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
13496625|NCT01307423|27072833|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
13496626|NCT01307423|27072834|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
13496627|NCT01307423|27072835|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
13496628|NCT01307423|27072827|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
13496629|NCT01307423|27072828|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
13496630|NCT01307423|27072829|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2|||
13496631|NCT01307423|27072830|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
13496632|NCT01307423|27072831|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
13496633|NCT01307423|27072832|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
13496634|NCT01307423|27072833|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
13496635|NCT01307423|27072834|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
13496636|NCT01307423|27072835|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
13496637|NCT00655876|27072963|FG000|Overall Study|Protocol Violation|9|||
13496638|NCT00655876|27072964|FG001|Overall Study|Protocol Violation|7|||
13496639|NCT00265941|27073037|FG000|Overall Study|Protocol Violation|22|||
13496640|NCT00265941|27073038|FG001|Overall Study|Protocol Violation|25|||
13496641|NCT00265941|27073037|FG000|Overall Study|Lost to Follow-up|1|||
13496642|NCT00265941|27073038|FG001|Overall Study|Lost to Follow-up|1|||
13496643|NCT00114140|27073052|FG000|Overall Study|Protocol Violation|7|||
13496644|NCT00047008|27073065|FG000|Overall Study|Withdrawn consent|2|||
13496645|NCT00047008|27073066|FG001|Overall Study|Withdrawn consent|3|||
13496646|NCT00047008|27073065|FG000|Overall Study|Ineligible|9|||
13496647|NCT00047008|27073066|FG001|Overall Study|Ineligible|8|||
13496648|NCT03935880|27073119|FG000|Overall Study|Lost to Follow-up|0|||
13496649|NCT03935880|27073120|FG001|Overall Study|Lost to Follow-up|1|||
13496650|NCT03852719|27073150|FG000|Overall Study|Still on study|50|||
13496651|NCT03852719|27073151|FG001|Overall Study|Still on study|48|||
13496652|NCT03852719|27073152|FG002|Overall Study|Still on study|47|||
13496653|NCT03852719|27073150|FG000|Overall Study|Withdrawal of consent|0|||
13496654|NCT03852719|27073151|FG001|Overall Study|Withdrawal of consent|1|||
13496655|NCT03852719|27073152|FG002|Overall Study|Withdrawal of consent|2|||
13496656|NCT03852719|27073150|FG000|Overall Study|Physician Decision|0|||
13496657|NCT03852719|27073151|FG001|Overall Study|Physician Decision|0|||
13496658|NCT03852719|27073152|FG002|Overall Study|Physician Decision|1|||
13496659|NCT03852719|27073150|FG000|Overall Study|Pregnancy|1|||
13496660|NCT03852719|27073151|FG001|Overall Study|Pregnancy|0|||
13496661|NCT03852719|27073152|FG002|Overall Study|Pregnancy|0|||
13496662|NCT03521934|27073179|FG000|Overall Study|Death|65|||
13496663|NCT03521934|27073180|FG001|Overall Study|Death|73|||
13496664|NCT03521934|27073179|FG000|Overall Study|Withdrawal by Subject|18|||
13496665|NCT03521934|27073180|FG001|Overall Study|Withdrawal by Subject|23|||
13496666|NCT03521934|27073179|FG000|Overall Study|Site Terminated by Sponsor|39|||
13496667|NCT03521934|27073180|FG001|Overall Study|Site Terminated by Sponsor|35|||
13496668|NCT03521934|27073179|FG000|Overall Study|Study Terminated by Sponsor|483|||
13496669|NCT03521934|27073180|FG001|Overall Study|Study Terminated by Sponsor|477|||
13496670|NCT03521934|27073179|FG000|Overall Study|Reason not Specified|3|||
13496671|NCT03521934|27073180|FG001|Overall Study|Reason not Specified|6|||
13496672|NCT03318861|27073242|FG000|Overall Study|Death|1|||
13496673|NCT03318861|27073243|FG001|Overall Study|Death|2|||
13496674|NCT03318861|27073244|FG002|Overall Study|Death|2|||
13496675|NCT03318861|27073245|FG003|Overall Study|Death|1|||
13496676|NCT03318861|27073246|FG004|Overall Study|Death|1|||
13496677|NCT03318861|27073242|FG000|Overall Study|Still on Study|2|||
13496678|NCT03318861|27073243|FG001|Overall Study|Still on Study|1|||
13496679|NCT03318861|27073244|FG002|Overall Study|Still on Study|1|||
13496680|NCT03318861|27073245|FG003|Overall Study|Still on Study|2|||
13496681|NCT03318861|27073246|FG004|Overall Study|Still on Study|1|||
13496682|NCT03318861|27073242|FG000|Overall Study|Enrolled But Did Not Initiate KITE-585|0|||
13496683|NCT03318861|27073243|FG001|Overall Study|Enrolled But Did Not Initiate KITE-585|1|||
13496684|NCT03318861|27073244|FG002|Overall Study|Enrolled But Did Not Initiate KITE-585|0|||
13496685|NCT03318861|27073245|FG003|Overall Study|Enrolled But Did Not Initiate KITE-585|1|||
13496686|NCT03318861|27073246|FG004|Overall Study|Enrolled But Did Not Initiate KITE-585|1|||
13496687|NCT03315143|27073273|FG000|Overall Study|Death|240|||
13496688|NCT03315143|27073274|FG001|Overall Study|Death|246|||
13496689|NCT03315143|27073273|FG000|Overall Study|Withdrawal by Subject|57|||
13496690|NCT03315143|27073274|FG001|Overall Study|Withdrawal by Subject|68|||
13496691|NCT03315143|27073273|FG000|Overall Study|Site Terminated by Sponsor|256|||
13496692|NCT03315143|27073274|FG001|Overall Study|Site Terminated by Sponsor|282|||
13496693|NCT03315143|27073273|FG000|Overall Study|Study Terminated by Sponsor|4723|||
13496694|NCT03315143|27073274|FG001|Overall Study|Study Terminated by Sponsor|4664|||
13496695|NCT03315143|27073273|FG000|Overall Study|Reason not Specified|16|||
13496696|NCT03315143|27073274|FG001|Overall Study|Reason not Specified|32|||
13496697|NCT03148795|27073291|FG000|Overall Study|Death|6|||
13496698|NCT03148795|27073291|FG000|Overall Study|Adverse Event|5|||
13496699|NCT03148795|27073291|FG000|Overall Study|Other|15|||
13496700|NCT03148795|27073291|FG000|Overall Study|No Longer Clinically Benefitting|2|||
13496701|NCT03148795|27073291|FG000|Overall Study|Global Deterioration Of Health Status|6|||
13496702|NCT03148795|27073291|FG000|Overall Study|Withdrawal by Subject|2|||
13496703|NCT03148795|27073291|FG000|Overall Study|Progressive Disease|62|||
13496704|NCT03148795|27073291|FG000|Overall Study|Ongoing|30|||
13496705|NCT03025542|27073358|FG000|Overall Study|Adverse Event|0|||
13496706|NCT03025542|27073359|FG001|Overall Study|Adverse Event|2|||
13496707|NCT03025542|27073358|FG000|Overall Study|Lost to Follow-up|1|||
13496708|NCT03025542|27073359|FG001|Overall Study|Lost to Follow-up|0|||
13496709|NCT03025542|27073358|FG000|Overall Study|Withdrawal by Subject|1|||
13496710|NCT03025542|27073359|FG001|Overall Study|Withdrawal by Subject|0|||
13496711|NCT02849626|27073672|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11|||
13496712|NCT02849626|27073673|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3|||
13496713|NCT02849626|27073674|FG002|Core Phase (up to 23 Weeks)|Adverse Event|0|||
13496714|NCT02849626|27073675|FG003|Core Phase (up to 23 Weeks)|Adverse Event|0|||
13496715|NCT02849626|27073672|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7|||
13496716|NCT02849626|27073673|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2|||
13496717|NCT02849626|27073674|FG002|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
13496718|NCT02849626|27073675|FG003|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
13496719|NCT02849626|27073672|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6|||
13496720|NCT02849626|27073673|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2|||
13496721|NCT02849626|27073674|FG002|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
13496722|NCT02849626|27073675|FG003|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
13496723|NCT02849626|27073672|FG000|Core Phase (up to 23 Weeks)|Non-specified|3|||
13496724|NCT02849626|27073673|FG001|Core Phase (up to 23 Weeks)|Non-specified|0|||
13496725|NCT02849626|27073674|FG002|Core Phase (up to 23 Weeks)|Non-specified|0|||
13496726|NCT02849626|27073675|FG003|Core Phase (up to 23 Weeks)|Non-specified|0|||
13496727|NCT02849626|27073672|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3|||
13496728|NCT02849626|27073673|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2|||
13496729|NCT02849626|27073674|FG002|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
13496730|NCT02849626|27073675|FG003|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
13496731|NCT02849626|27073672|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4|||
13496732|NCT02849626|27073673|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
13496733|NCT02849626|27073674|FG002|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
13496734|NCT02849626|27073675|FG003|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
13496735|NCT02849626|27073672|FG000|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|3|||
13496736|NCT02849626|27073673|FG001|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|1|||
13496737|NCT02849626|27073674|FG002|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
13496738|NCT02849626|27073675|FG003|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
13496739|NCT02849626|27073672|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1|||
13496740|NCT02849626|27073673|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
13496741|NCT02849626|27073674|FG002|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
13496742|NCT02849626|27073675|FG003|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
13496743|NCT02849626|27073672|FG000|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
13496744|NCT02849626|27073673|FG001|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
13496745|NCT02849626|27073674|FG002|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|3|||
13496746|NCT02849626|27073675|FG003|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
13496747|NCT02849626|27073672|FG000|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
13496748|NCT02849626|27073673|FG001|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
13496749|NCT02849626|27073674|FG002|Extension Phase B (up to 89 Weeks)|Participant choice|1|||
13496750|NCT02849626|27073675|FG003|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
13496751|NCT02849626|27073672|FG000|Extension Phase B (up to 89 Weeks)|Other|0|||
13496752|NCT02849626|27073673|FG001|Extension Phase B (up to 89 Weeks)|Other|0|||
13496753|NCT02849626|27073674|FG002|Extension Phase B (up to 89 Weeks)|Other|1|||
13496754|NCT02849626|27073675|FG003|Extension Phase B (up to 89 Weeks)|Other|0|||
13496755|NCT02659540|27073738|FG000|Overall Study|Adverse Event|3|||
13496756|NCT02659540|27073739|FG001|Overall Study|Adverse Event|2|||
13496757|NCT02659540|27073738|FG000|Overall Study|Death|1|||
13496758|NCT02659540|27073739|FG001|Overall Study|Death|0|||
13496759|NCT02659540|27073738|FG000|Overall Study|Progressive disease|2|||
13496760|NCT02659540|27073739|FG001|Overall Study|Progressive disease|6|||
13496761|NCT01220999|27073839|FG000|Overall Study|Progressive disease|0|||
13496762|NCT01220999|27073840|FG001|Overall Study|Progressive disease|0|||
13496763|NCT01220999|27073841|FG002|Overall Study|Progressive disease|1|||
13496764|NCT01220999|27073842|FG003|Overall Study|Progressive disease|0|||
13496765|NCT01220999|27073843|FG004|Overall Study|Progressive disease|0|||
13496766|NCT01097746|27073850|FG000|Overall Study|Adverse Event|4|||
13496767|NCT01097746|27073850|FG000|Overall Study|taken off study before any treatment given|1|||
13496768|NCT00142415|27073897|FG000|Overall Study|Physician Decision|0|||
13496769|NCT00142415|27073898|FG001|Overall Study|Physician Decision|0|||
13496770|NCT00142415|27073899|FG002|Overall Study|Physician Decision|0|||
13496771|NCT00142415|27073900|FG003|Overall Study|Physician Decision|0|||
13496772|NCT00142415|27073901|FG004|Overall Study|Physician Decision|1|||
13496773|NCT00142415|27073902|FG005|Overall Study|Physician Decision|2|||
13496774|NCT04392583|27073925|FG000|Overall Study|Participant declined follow-up and subsequently withdrawn|1|||
13496847|NCT03219333|27074178|FG000|Overall Study|Death|94|||
13496848|NCT03219333|27074179|FG001|Overall Study|Death|44|||
13496849|NCT03219333|27074178|FG000|Overall Study|Includes 4 participants who were enrolled and never received study treatment.|2|||
13496850|NCT03219333|27074179|FG001|Overall Study|Includes 4 participants who were enrolled and never received study treatment.|2|||
13496851|NCT02881957|27074210|FG000|Overall Study|Comfort care|0|||
13496852|NCT02881957|27074211|FG001|Overall Study|Comfort care|1|||
13496853|NCT02881957|27074210|FG000|Overall Study|Concurrent trial enrollment|0|||
13496854|NCT02881957|27074211|FG001|Overall Study|Concurrent trial enrollment|1|||
13496855|NCT02881957|27074210|FG000|Overall Study|Discharged within 48 hours|0|||
13496856|NCT02881957|27074211|FG001|Overall Study|Discharged within 48 hours|1|||
13496857|NCT02881957|27074210|FG000|Overall Study|Withdrawal by Subject|2|||
13496858|NCT02881957|27074211|FG001|Overall Study|Withdrawal by Subject|1|||
13496859|NCT02881957|27074210|FG000|Overall Study|Protocol Violation|1|||
13496860|NCT02881957|27074211|FG001|Overall Study|Protocol Violation|0|||
13496861|NCT02761694|27074377|FG000|Overall Study|Lack of Efficacy|0|||
13496862|NCT02761694|27074378|FG001|Overall Study|Lack of Efficacy|0|||
13496863|NCT02761694|27074379|FG002|Overall Study|Lack of Efficacy|0|||
13496864|NCT02761694|27074380|FG003|Overall Study|Lack of Efficacy|0|||
13496865|NCT02761694|27074381|FG004|Overall Study|Lack of Efficacy|0|||
13496866|NCT02761694|27074382|FG005|Overall Study|Lack of Efficacy|0|||
13496867|NCT02761694|27074383|FG006|Overall Study|Lack of Efficacy|6|||
13496868|NCT02761694|27074384|FG007|Overall Study|Lack of Efficacy|0|||
13496869|NCT02761694|27074385|FG008|Overall Study|Lack of Efficacy|0|||
13496870|NCT02761694|27074386|FG009|Overall Study|Lack of Efficacy|1|||
13496871|NCT02761694|27074387|FG010|Overall Study|Lack of Efficacy|1|||
13496872|NCT02761694|27074388|FG011|Overall Study|Lack of Efficacy|4|||
13496873|NCT02761694|27074377|FG000|Overall Study|Death|0|||
13496874|NCT02761694|27074378|FG001|Overall Study|Death|0|||
13496875|NCT02761694|27074379|FG002|Overall Study|Death|0|||
13496876|NCT02761694|27074380|FG003|Overall Study|Death|0|||
13496877|NCT02761694|27074381|FG004|Overall Study|Death|0|||
13496878|NCT02761694|27074382|FG005|Overall Study|Death|0|||
13496879|NCT02761694|27074383|FG006|Overall Study|Death|2|||
13496880|NCT02761694|27074384|FG007|Overall Study|Death|0|||
13496881|NCT02761694|27074385|FG008|Overall Study|Death|2|||
13496882|NCT02761694|27074386|FG009|Overall Study|Death|2|||
13496883|NCT02761694|27074387|FG010|Overall Study|Death|1|||
13496884|NCT02761694|27074388|FG011|Overall Study|Death|0|||
13496885|NCT02761694|27074377|FG000|Overall Study|Physician Decision|0|||
13496886|NCT02761694|27074378|FG001|Overall Study|Physician Decision|0|||
13496887|NCT02761694|27074379|FG002|Overall Study|Physician Decision|0|||
13496888|NCT02761694|27074380|FG003|Overall Study|Physician Decision|0|||
13496889|NCT02761694|27074381|FG004|Overall Study|Physician Decision|0|||
13496890|NCT02761694|27074382|FG005|Overall Study|Physician Decision|0|||
13496891|NCT02761694|27074383|FG006|Overall Study|Physician Decision|1|||
13496892|NCT02761694|27074384|FG007|Overall Study|Physician Decision|0|||
13496893|NCT02761694|27074385|FG008|Overall Study|Physician Decision|0|||
13496894|NCT02761694|27074386|FG009|Overall Study|Physician Decision|0|||
13496895|NCT02761694|27074387|FG010|Overall Study|Physician Decision|0|||
13496896|NCT02761694|27074388|FG011|Overall Study|Physician Decision|0|||
13496897|NCT02761694|27074377|FG000|Overall Study|Withdrawal by Subject|0|||
13496898|NCT02761694|27074378|FG001|Overall Study|Withdrawal by Subject|0|||
13496899|NCT02761694|27074379|FG002|Overall Study|Withdrawal by Subject|0|||
13496900|NCT02761694|27074380|FG003|Overall Study|Withdrawal by Subject|1|||
13496901|NCT02761694|27074381|FG004|Overall Study|Withdrawal by Subject|0|||
13496902|NCT02761694|27074382|FG005|Overall Study|Withdrawal by Subject|0|||
13496903|NCT02761694|27074383|FG006|Overall Study|Withdrawal by Subject|4|||
13496904|NCT02761694|27074384|FG007|Overall Study|Withdrawal by Subject|0|||
13496905|NCT02761694|27074385|FG008|Overall Study|Withdrawal by Subject|2|||
13496906|NCT02761694|27074386|FG009|Overall Study|Withdrawal by Subject|1|||
13496907|NCT02761694|27074387|FG010|Overall Study|Withdrawal by Subject|0|||
13496908|NCT02761694|27074388|FG011|Overall Study|Withdrawal by Subject|0|||
13496909|NCT02761694|27074377|FG000|Overall Study|Lost to Follow-up|0|||
13496910|NCT02761694|27074378|FG001|Overall Study|Lost to Follow-up|0|||
13496911|NCT02761694|27074379|FG002|Overall Study|Lost to Follow-up|0|||
13496912|NCT02761694|27074380|FG003|Overall Study|Lost to Follow-up|0|||
13496913|NCT02761694|27074381|FG004|Overall Study|Lost to Follow-up|0|||
13496914|NCT02761694|27074382|FG005|Overall Study|Lost to Follow-up|0|||
13496915|NCT02761694|27074383|FG006|Overall Study|Lost to Follow-up|1|||
13496916|NCT02761694|27074384|FG007|Overall Study|Lost to Follow-up|0|||
13496917|NCT02761694|27074385|FG008|Overall Study|Lost to Follow-up|0|||
13496918|NCT02761694|27074386|FG009|Overall Study|Lost to Follow-up|0|||
13496919|NCT02761694|27074387|FG010|Overall Study|Lost to Follow-up|0|||
13496920|NCT02761694|27074388|FG011|Overall Study|Lost to Follow-up|1|||
13496921|NCT02761694|27074377|FG000|Overall Study|Adverse Event|0|||
13496922|NCT02761694|27074378|FG001|Overall Study|Adverse Event|0|||
13496923|NCT02761694|27074379|FG002|Overall Study|Adverse Event|0|||
13496924|NCT02761694|27074380|FG003|Overall Study|Adverse Event|0|||
13496775|NCT04326439|27073958|FG000|Overall Study|Withdrawal by Subject|1|||
13496776|NCT04326439|27073959|FG001|Overall Study|Withdrawal by Subject|0|||
13496777|NCT04326439|27073958|FG000|Overall Study|Proceeded to HSCT after Induction 2|0|||
13496778|NCT04326439|27073959|FG001|Overall Study|Proceeded to HSCT after Induction 2|2|||
13496779|NCT04326439|27073958|FG000|Overall Study|Relapse after Induction 2|0|||
13496780|NCT04326439|27073959|FG001|Overall Study|Relapse after Induction 2|1|||
13496781|NCT04326439|27073958|FG000|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|1|||
13496782|NCT04326439|27073959|FG001|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|0|||
13496783|NCT04003142|27074060|FG000|Double-blind Period (12 Weeks)|Adverse Event|1|||
13496784|NCT04003142|27074061|FG001|Double-blind Period (12 Weeks)|Adverse Event|1|||
13496785|NCT04003142|27074062|FG002|Double-blind Period (12 Weeks)|Adverse Event|2|||
13496786|NCT04003142|27074063|FG003|Double-blind Period (12 Weeks)|Adverse Event|0|||
13496787|NCT04003142|27074064|FG004|Double-blind Period (12 Weeks)|Adverse Event|0|||
13496788|NCT04003142|27074060|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
13496789|NCT04003142|27074061|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
13496790|NCT04003142|27074062|FG002|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
13496791|NCT04003142|27074063|FG003|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
13496792|NCT04003142|27074064|FG004|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
13496793|NCT04003142|27074060|FG000|Double-blind Period (12 Weeks)|Protocol Deviation|1|||
13496794|NCT04003142|27074061|FG001|Double-blind Period (12 Weeks)|Protocol Deviation|5|||
13496795|NCT04003142|27074062|FG002|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
13496796|NCT04003142|27074063|FG003|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
13496797|NCT04003142|27074064|FG004|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
13496798|NCT04003142|27074060|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|11|||
13496799|NCT04003142|27074061|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
13496800|NCT04003142|27074062|FG002|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
13496801|NCT04003142|27074063|FG003|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
13496802|NCT04003142|27074064|FG004|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
13496803|NCT04003142|27074060|FG000|Double-blind Period (12 Weeks)|Miscellaneous|2|||
13496804|NCT04003142|27074061|FG001|Double-blind Period (12 Weeks)|Miscellaneous|1|||
13496805|NCT04003142|27074062|FG002|Double-blind Period (12 Weeks)|Miscellaneous|2|||
13496806|NCT04003142|27074063|FG003|Double-blind Period (12 Weeks)|Miscellaneous|0|||
13496807|NCT04003142|27074064|FG004|Double-blind Period (12 Weeks)|Miscellaneous|0|||
13496808|NCT04003142|27074060|FG000|Extension Period (40 Weeks)|Adverse Event|0|||
13496809|NCT04003142|27074061|FG001|Extension Period (40 Weeks)|Adverse Event|4|||
13496810|NCT04003142|27074062|FG002|Extension Period (40 Weeks)|Adverse Event|4|||
13496811|NCT04003142|27074063|FG003|Extension Period (40 Weeks)|Adverse Event|2|||
13496812|NCT04003142|27074064|FG004|Extension Period (40 Weeks)|Adverse Event|3|||
13496813|NCT04003142|27074060|FG000|Extension Period (40 Weeks)|Death|0|||
13496814|NCT04003142|27074061|FG001|Extension Period (40 Weeks)|Death|0|||
13496815|NCT04003142|27074062|FG002|Extension Period (40 Weeks)|Death|0|||
13496816|NCT04003142|27074063|FG003|Extension Period (40 Weeks)|Death|0|||
13496817|NCT04003142|27074064|FG004|Extension Period (40 Weeks)|Death|1|||
13496818|NCT04003142|27074060|FG000|Extension Period (40 Weeks)|Lost to Follow-up|0|||
13496819|NCT04003142|27074061|FG001|Extension Period (40 Weeks)|Lost to Follow-up|2|||
13496820|NCT04003142|27074062|FG002|Extension Period (40 Weeks)|Lost to Follow-up|1|||
13496821|NCT04003142|27074063|FG003|Extension Period (40 Weeks)|Lost to Follow-up|2|||
13496822|NCT04003142|27074064|FG004|Extension Period (40 Weeks)|Lost to Follow-up|1|||
13496823|NCT04003142|27074060|FG000|Extension Period (40 Weeks)|Protocol Deviation|0|||
13496824|NCT04003142|27074061|FG001|Extension Period (40 Weeks)|Protocol Deviation|0|||
13496825|NCT04003142|27074062|FG002|Extension Period (40 Weeks)|Protocol Deviation|2|||
13496826|NCT04003142|27074063|FG003|Extension Period (40 Weeks)|Protocol Deviation|0|||
13496827|NCT04003142|27074064|FG004|Extension Period (40 Weeks)|Protocol Deviation|0|||
13496828|NCT04003142|27074060|FG000|Extension Period (40 Weeks)|Withdrawal by Subject|0|||
13496829|NCT04003142|27074061|FG001|Extension Period (40 Weeks)|Withdrawal by Subject|17|||
13496830|NCT04003142|27074062|FG002|Extension Period (40 Weeks)|Withdrawal by Subject|14|||
13496831|NCT04003142|27074063|FG003|Extension Period (40 Weeks)|Withdrawal by Subject|9|||
13496832|NCT04003142|27074064|FG004|Extension Period (40 Weeks)|Withdrawal by Subject|5|||
13496833|NCT04003142|27074060|FG000|Extension Period (40 Weeks)|Miscellaneous|0|||
13496834|NCT04003142|27074061|FG001|Extension Period (40 Weeks)|Miscellaneous|4|||
13496835|NCT04003142|27074062|FG002|Extension Period (40 Weeks)|Miscellaneous|1|||
13496836|NCT04003142|27074063|FG003|Extension Period (40 Weeks)|Miscellaneous|0|||
13496837|NCT04003142|27074064|FG004|Extension Period (40 Weeks)|Miscellaneous|2|||
13496838|NCT03402841|27074111|FG000|Overall Study|Withdrawal by Subject|3|||
13496839|NCT03402841|27074111|FG000|Overall Study|Lost to Follow-up|2|||
13496840|NCT03402841|27074111|FG000|Overall Study|Death|146|||
13496841|NCT03383666|27074123|FG000|Overall Study|Withdrawal by Subject|2|||
13496842|NCT03383666|27074123|FG000|Overall Study|Lost to Follow-up|2|||
13496843|NCT03219333|27074178|FG000|Overall Study|Withdrawal by Subject|8|||
13496844|NCT03219333|27074179|FG001|Overall Study|Withdrawal by Subject|3|||
13496845|NCT03219333|27074178|FG000|Overall Study|Lost to Follow-up|1|||
13496846|NCT03219333|27074179|FG001|Overall Study|Lost to Follow-up|0|||
13496925|NCT02761694|27074381|FG004|Overall Study|Adverse Event|0|||
13496926|NCT02761694|27074382|FG005|Overall Study|Adverse Event|0|||
13496927|NCT02761694|27074383|FG006|Overall Study|Adverse Event|1|||
13496928|NCT02761694|27074384|FG007|Overall Study|Adverse Event|0|||
13496929|NCT02761694|27074385|FG008|Overall Study|Adverse Event|1|||
13496930|NCT02761694|27074386|FG009|Overall Study|Adverse Event|0|||
13496931|NCT02761694|27074387|FG010|Overall Study|Adverse Event|0|||
13496932|NCT02761694|27074388|FG011|Overall Study|Adverse Event|1|||
13496933|NCT02761694|27074377|FG000|Overall Study|Other|4|||
13496934|NCT02761694|27074378|FG001|Overall Study|Other|4|||
13496935|NCT02761694|27074379|FG002|Overall Study|Other|1|||
13496936|NCT02761694|27074380|FG003|Overall Study|Other|2|||
13496937|NCT02761694|27074381|FG004|Overall Study|Other|3|||
13496938|NCT02761694|27074382|FG005|Overall Study|Other|3|||
13496939|NCT02761694|27074383|FG006|Overall Study|Other|18|||
13496940|NCT02761694|27074384|FG007|Overall Study|Other|8|||
13496941|NCT02761694|27074385|FG008|Overall Study|Other|0|||
13496942|NCT02761694|27074386|FG009|Overall Study|Other|1|||
13496943|NCT02761694|27074387|FG010|Overall Study|Other|1|||
13496944|NCT02761694|27074388|FG011|Overall Study|Other|0|||
13496945|NCT02574455|27074427|FG000|Overall Study|Death|197|||
13496946|NCT02574455|27074428|FG001|Overall Study|Death|210|||
13496947|NCT02574455|27074427|FG000|Overall Study|Withdrawal of Consent|11|||
13496948|NCT02574455|27074428|FG001|Overall Study|Withdrawal of Consent|28|||
13496949|NCT02574455|27074427|FG000|Overall Study|Lost to Follow-up|4|||
13496950|NCT02574455|27074428|FG001|Overall Study|Lost to Follow-up|4|||
13496951|NCT02574455|27074427|FG000|Overall Study|Sponsor's Decision|55|||
13496952|NCT02574455|27074428|FG001|Overall Study|Sponsor's Decision|20|||
13496953|NCT02493660|27074459|FG000|Overall Study|Physician Decision|0|||
13496954|NCT02493660|27074460|FG001|Overall Study|Physician Decision|1|||
13496955|NCT02493660|27074459|FG000|Overall Study|Adverse Event|4|||
13496956|NCT02493660|27074460|FG001|Overall Study|Adverse Event|2|||
13496957|NCT02493660|27074459|FG000|Overall Study|Withdrawal by Subject|2|||
13496958|NCT02493660|27074460|FG001|Overall Study|Withdrawal by Subject|3|||
13496959|NCT02493660|27074459|FG000|Overall Study|Subject unable to return for follow-up visits|2|||
13496960|NCT02493660|27074460|FG001|Overall Study|Subject unable to return for follow-up visits|0|||
13496961|NCT02493660|27074459|FG000|Overall Study|Protocol Violation|0|||
13496962|NCT02493660|27074460|FG001|Overall Study|Protocol Violation|1|||
13496963|NCT02493660|27074459|FG000|Overall Study|Death|0|||
13496964|NCT02493660|27074460|FG001|Overall Study|Death|1|||
13496965|NCT02493660|27074459|FG000|Overall Study|Lost to Follow-up|2|||
13496966|NCT02493660|27074460|FG001|Overall Study|Lost to Follow-up|4|||
13496967|NCT02232087|27074501|FG000|Overall Study|Withdrawal by Subject|2|||
13496968|NCT02232087|27074502|FG001|Overall Study|Withdrawal by Subject|0|||
13496969|NCT02232087|27074503|FG002|Overall Study|Withdrawal by Subject|0|||
13496970|NCT02232087|27074504|FG003|Overall Study|Withdrawal by Subject|0|||
13496971|NCT02232087|27074505|FG004|Overall Study|Withdrawal by Subject|0|||
13496972|NCT02232087|27074506|FG005|Overall Study|Withdrawal by Subject|1|||
13496973|NCT02232087|27074501|FG000|Overall Study|poor inhalation technique|0|||
13496974|NCT02232087|27074502|FG001|Overall Study|poor inhalation technique|1|||
13496975|NCT02232087|27074503|FG002|Overall Study|poor inhalation technique|0|||
13496976|NCT02232087|27074504|FG003|Overall Study|poor inhalation technique|0|||
13496977|NCT02232087|27074505|FG004|Overall Study|poor inhalation technique|0|||
13496978|NCT02232087|27074506|FG005|Overall Study|poor inhalation technique|2|||
13496979|NCT02232087|27074501|FG000|Overall Study|protocol stop criteria|0|||
13496980|NCT02232087|27074502|FG001|Overall Study|protocol stop criteria|1|||
13496981|NCT02232087|27074503|FG002|Overall Study|protocol stop criteria|0|||
13496982|NCT02232087|27074504|FG003|Overall Study|protocol stop criteria|1|||
13496983|NCT02232087|27074505|FG004|Overall Study|protocol stop criteria|0|||
13496984|NCT02232087|27074506|FG005|Overall Study|protocol stop criteria|0|||
13496985|NCT02232087|27074501|FG000|Overall Study|Adverse Event|0|||
13496986|NCT02232087|27074502|FG001|Overall Study|Adverse Event|0|||
13496987|NCT02232087|27074503|FG002|Overall Study|Adverse Event|0|||
13496988|NCT02232087|27074504|FG003|Overall Study|Adverse Event|0|||
13496989|NCT02232087|27074505|FG004|Overall Study|Adverse Event|1|||
13496990|NCT02232087|27074506|FG005|Overall Study|Adverse Event|0|||
13496991|NCT01952847|27074561|FG000|Overall Study|Ineligible|1|||
13496992|NCT01952847|27074562|FG001|Overall Study|Ineligible|0|||
13496993|NCT01952847|27074563|FG002|Overall Study|Ineligible|0|||
13496994|NCT01952847|27074564|FG003|Overall Study|Ineligible|0|||
13496995|NCT01952847|27074561|FG000|Overall Study|Lack of Insurance Coverage|0|||
13496996|NCT01952847|27074562|FG001|Overall Study|Lack of Insurance Coverage|1|||
13496997|NCT01952847|27074563|FG002|Overall Study|Lack of Insurance Coverage|0|||
13496998|NCT01952847|27074564|FG003|Overall Study|Lack of Insurance Coverage|0|||
13496999|NCT01952847|27074561|FG000|Overall Study|Withdrawal by Subject|1|||
13497000|NCT01952847|27074562|FG001|Overall Study|Withdrawal by Subject|1|||
13497001|NCT01952847|27074563|FG002|Overall Study|Withdrawal by Subject|0|||
13497002|NCT01952847|27074564|FG003|Overall Study|Withdrawal by Subject|1|||
13497003|NCT01889238|27074583|FG000|Overall Study|Treatment ongoing|9|||
13497004|NCT01672892|27074616|FG000|Overall Study|Protocol Violation|7|||
13497005|NCT01672892|27074617|FG001|Overall Study|Protocol Violation|3|||
13497006|NCT01560585|27074624|FG000|Overall Study|Physician Decision|3|||
13497007|NCT00979212|27074649|FG000|Overall Study|Protocol Violation|1|||
13497008|NCT00979212|27074650|FG001|Overall Study|Protocol Violation|8|||
13497009|NCT00979212|27074649|FG000|Overall Study|No protocol therapy received|1|||
13497010|NCT00979212|27074650|FG001|Overall Study|No protocol therapy received|0|||
13497011|NCT00777491|27074677|FG000|Overall Study|Protocol Violation|0|||
13497012|NCT00777491|27074678|FG001|Overall Study|Protocol Violation|2|||
13497013|NCT00777491|27074677|FG000|Overall Study|Did not receive any protocol treatment|2|||
13497014|NCT00777491|27074678|FG001|Overall Study|Did not receive any protocol treatment|0|||
13497015|NCT00759655|27074691|FG000|Overall Study|Termination of the study by sponsor|1|||
13497016|NCT00145795|27074722|FG000|Overall Study|Adverse Event|1|||
13497017|NCT00145795|27074723|FG001|Overall Study|Adverse Event|0|||
13497018|NCT00005044|27074748|FG000|Overall Study|Protocol Violation|37|||
13497019|NCT00005044|27074749|FG001|Overall Study|Protocol Violation|46|||
13497020|NCT00005044|27074748|FG000|Overall Study|Withdrawal by Subject|1|||
13497021|NCT00005044|27074749|FG001|Overall Study|Withdrawal by Subject|5|||
13497022|NCT00005044|27074748|FG000|Overall Study|No protocol treatment|0|||
13497023|NCT00005044|27074749|FG001|Overall Study|No protocol treatment|1|||
13497024|NCT00002874|27074778|FG000|Overall Study|Withdrawal by Subject|1|||
13497025|NCT00002874|27074779|FG001|Overall Study|Withdrawal by Subject|1|||
13497026|NCT00002874|27074778|FG000|Overall Study|Protocol Violation|44|||
13497027|NCT00002874|27074779|FG001|Overall Study|Protocol Violation|34|||
13497028|NCT03428100|27074964|FG000|Overall Study|Adverse Event|1|||
13497029|NCT03428100|27074965|FG001|Overall Study|Adverse Event|0|||
13497030|NCT03428100|27074966|FG002|Overall Study|Adverse Event|3|||
13497031|NCT03428100|27074967|FG003|Overall Study|Adverse Event|1|||
13497032|NCT03428100|27074964|FG000|Overall Study|Lack of Efficacy|16|||
13497033|NCT03428100|27074965|FG001|Overall Study|Lack of Efficacy|10|||
13497034|NCT03428100|27074966|FG002|Overall Study|Lack of Efficacy|7|||
13497035|NCT03428100|27074967|FG003|Overall Study|Lack of Efficacy|6|||
13497036|NCT03428100|27074964|FG000|Overall Study|Protocol Deviation|0|||
13497037|NCT03428100|27074965|FG001|Overall Study|Protocol Deviation|2|||
13497038|NCT03428100|27074966|FG002|Overall Study|Protocol Deviation|2|||
13497039|NCT03428100|27074967|FG003|Overall Study|Protocol Deviation|0|||
13497040|NCT03428100|27074964|FG000|Overall Study|Withdrawal by Subject|4|||
13497041|NCT03428100|27074965|FG001|Overall Study|Withdrawal by Subject|0|||
13497042|NCT03428100|27074966|FG002|Overall Study|Withdrawal by Subject|0|||
13497043|NCT03428100|27074967|FG003|Overall Study|Withdrawal by Subject|0|||
13497044|NCT03428100|27074964|FG000|Overall Study|Physician Decision|0|||
13497045|NCT03428100|27074965|FG001|Overall Study|Physician Decision|1|||
13497046|NCT03428100|27074966|FG002|Overall Study|Physician Decision|0|||
13497047|NCT03428100|27074967|FG003|Overall Study|Physician Decision|0|||
13497048|NCT03341936|27074977|FG000|Overall Study|Ineligible|1|||
13497049|NCT03341936|27074977|FG000|Overall Study|Disease Progression|2|||
13497050|NCT03341936|27074977|FG000|Overall Study|Withdrew Consent|4|||
13497051|NCT03341936|27074977|FG000|Overall Study|Non-Compliance|1|||
13497052|NCT03341936|27074977|FG000|Overall Study|Physician Decision|1|||
13497053|NCT03341936|27074977|FG000|Overall Study|Withdrawal by Subject|1|||
13497054|NCT03341936|27074977|FG000|Overall Study|Other|1|||
13497055|NCT03144687|27075042|FG000|Overall Study|Death|0|||
13497056|NCT03144687|27075043|FG001|Overall Study|Death|2|||
13497057|NCT03144687|27075042|FG000|Overall Study|Lost to Follow-up|0|||
13497058|NCT03144687|27075043|FG001|Overall Study|Lost to Follow-up|1|||
13497059|NCT03144687|27075042|FG000|Overall Study|Physician Decision|0|||
13497060|NCT03144687|27075043|FG001|Overall Study|Physician Decision|1|||
13497061|NCT03144687|27075042|FG000|Overall Study|Withdrawal by Subject|1|||
13497062|NCT03144687|27075043|FG001|Overall Study|Withdrawal by Subject|3|||
13497063|NCT03144687|27075042|FG000|Overall Study|Not Reported|2|||
13497064|NCT03144687|27075043|FG001|Overall Study|Not Reported|0|||
13497065|NCT02880371|27075220|FG000|Phase 1b|Lost to Follow-up|1|||
13497066|NCT02880371|27075221|FG001|Phase 1b|Lost to Follow-up|0|||
13497067|NCT02880371|27075222|FG002|Phase 1b|Lost to Follow-up|0|||
13497068|NCT02880371|27075223|FG003|Phase 1b|Lost to Follow-up|0|||
13497069|NCT02880371|27075224|FG004|Phase 1b|Lost to Follow-up|0|||
13497070|NCT02880371|27075225|FG005|Phase 1b|Lost to Follow-up|0|||
13497071|NCT02880371|27075226|FG006|Phase 1b|Lost to Follow-up|0|||
13497072|NCT02880371|27075227|FG007|Phase 1b|Lost to Follow-up|0|||
13497073|NCT02880371|27075220|FG000|Phase 1b|Participants terminated by Sponsor|1|||
13497074|NCT02880371|27075221|FG001|Phase 1b|Participants terminated by Sponsor|0|||
13497075|NCT02880371|27075222|FG002|Phase 1b|Participants terminated by Sponsor|0|||
13497076|NCT02880371|27075223|FG003|Phase 1b|Participants terminated by Sponsor|0|||
13497077|NCT02880371|27075224|FG004|Phase 1b|Participants terminated by Sponsor|0|||
13497078|NCT02880371|27075225|FG005|Phase 1b|Participants terminated by Sponsor|0|||
13497079|NCT02880371|27075226|FG006|Phase 1b|Participants terminated by Sponsor|0|||
13497080|NCT02880371|27075227|FG007|Phase 1b|Participants terminated by Sponsor|0|||
13497081|NCT02880371|27075220|FG000|Phase 1b|Withdrawal by Subject|0|||
13497082|NCT02880371|27075221|FG001|Phase 1b|Withdrawal by Subject|0|||
13497083|NCT02880371|27075222|FG002|Phase 1b|Withdrawal by Subject|1|||
13497084|NCT02880371|27075223|FG003|Phase 1b|Withdrawal by Subject|0|||
13497085|NCT02880371|27075224|FG004|Phase 1b|Withdrawal by Subject|0|||
13497086|NCT02880371|27075225|FG005|Phase 1b|Withdrawal by Subject|0|||
13497087|NCT02880371|27075226|FG006|Phase 1b|Withdrawal by Subject|0|||
13497088|NCT02880371|27075227|FG007|Phase 1b|Withdrawal by Subject|0|||
13497089|NCT02880371|27075220|FG000|Phase 1b|Death|4|||
13497090|NCT02880371|27075221|FG001|Phase 1b|Death|6|||
13497091|NCT02880371|27075222|FG002|Phase 1b|Death|5|||
13497092|NCT02880371|27075223|FG003|Phase 1b|Death|1|||
13497093|NCT02880371|27075224|FG004|Phase 1b|Death|0|||
13497094|NCT02880371|27075225|FG005|Phase 1b|Death|0|||
13497095|NCT02880371|27075226|FG006|Phase 1b|Death|0|||
13497096|NCT02880371|27075227|FG007|Phase 1b|Death|0|||
13497097|NCT02880371|27075220|FG000|Phase 1b|Enrolled but not Treated|0|||
13497098|NCT02880371|27075221|FG001|Phase 1b|Enrolled but not Treated|1|||
13497099|NCT02880371|27075222|FG002|Phase 1b|Enrolled but not Treated|0|||
13497100|NCT02880371|27075223|FG003|Phase 1b|Enrolled but not Treated|0|||
13497101|NCT02880371|27075224|FG004|Phase 1b|Enrolled but not Treated|0|||
13497102|NCT02880371|27075225|FG005|Phase 1b|Enrolled but not Treated|0|||
13497103|NCT02880371|27075226|FG006|Phase 1b|Enrolled but not Treated|0|||
13497104|NCT02880371|27075227|FG007|Phase 1b|Enrolled but not Treated|0|||
13497105|NCT02880371|27075220|FG000|Phase 2|Enrolled but not Treated|0|||
13497106|NCT02880371|27075221|FG001|Phase 2|Enrolled but not Treated|0|||
13497107|NCT02880371|27075222|FG002|Phase 2|Enrolled but not Treated|0|||
13497108|NCT02880371|27075223|FG003|Phase 2|Enrolled but not Treated|0|||
13497109|NCT02880371|27075224|FG004|Phase 2|Enrolled but not Treated|0|||
13497110|NCT02880371|27075225|FG005|Phase 2|Enrolled but not Treated|1|||
13497111|NCT02880371|27075226|FG006|Phase 2|Enrolled but not Treated|1|||
13497112|NCT02880371|27075227|FG007|Phase 2|Enrolled but not Treated|0|||
13497113|NCT02880371|27075220|FG000|Phase 2|Other|0|||
13497114|NCT02880371|27075221|FG001|Phase 2|Other|0|||
13497115|NCT02880371|27075222|FG002|Phase 2|Other|0|||
13497116|NCT02880371|27075223|FG003|Phase 2|Other|0|||
13497117|NCT02880371|27075224|FG004|Phase 2|Other|0|||
13497118|NCT02880371|27075225|FG005|Phase 2|Other|1|||
13497119|NCT02880371|27075226|FG006|Phase 2|Other|2|||
13497120|NCT02880371|27075227|FG007|Phase 2|Other|1|||
13497121|NCT02880371|27075220|FG000|Phase 2|Participants terminated by Sponsor|0|||
13497122|NCT02880371|27075221|FG001|Phase 2|Participants terminated by Sponsor|0|||
13497123|NCT02880371|27075222|FG002|Phase 2|Participants terminated by Sponsor|0|||
13497124|NCT02880371|27075223|FG003|Phase 2|Participants terminated by Sponsor|0|||
13497125|NCT02880371|27075224|FG004|Phase 2|Participants terminated by Sponsor|1|||
13497126|NCT02880371|27075225|FG005|Phase 2|Participants terminated by Sponsor|6|||
13497127|NCT02880371|27075226|FG006|Phase 2|Participants terminated by Sponsor|1|||
13497128|NCT02880371|27075227|FG007|Phase 2|Participants terminated by Sponsor|5|||
13497129|NCT02880371|27075220|FG000|Phase 2|Death|0|||
13497130|NCT02880371|27075221|FG001|Phase 2|Death|0|||
13497131|NCT02880371|27075222|FG002|Phase 2|Death|0|||
13497132|NCT02880371|27075223|FG003|Phase 2|Death|0|||
13497133|NCT02880371|27075224|FG004|Phase 2|Death|1|||
13497134|NCT02880371|27075225|FG005|Phase 2|Death|10|||
13497135|NCT02880371|27075226|FG006|Phase 2|Death|20|||
13497136|NCT02880371|27075227|FG007|Phase 2|Death|5|||
13497137|NCT02880371|27075220|FG000|Phase 2|Lost to Follow-up|0|||
13497138|NCT02880371|27075221|FG001|Phase 2|Lost to Follow-up|0|||
13497139|NCT02880371|27075222|FG002|Phase 2|Lost to Follow-up|0|||
13497140|NCT02880371|27075223|FG003|Phase 2|Lost to Follow-up|0|||
13497141|NCT02880371|27075224|FG004|Phase 2|Lost to Follow-up|0|||
13497142|NCT02880371|27075225|FG005|Phase 2|Lost to Follow-up|0|||
13497143|NCT02880371|27075226|FG006|Phase 2|Lost to Follow-up|3|||
13497144|NCT02880371|27075227|FG007|Phase 2|Lost to Follow-up|0|||
13497145|NCT02880371|27075220|FG000|Phase 2|Withdrawal by Subject|0|||
13497146|NCT02880371|27075221|FG001|Phase 2|Withdrawal by Subject|0|||
13497147|NCT02880371|27075222|FG002|Phase 2|Withdrawal by Subject|0|||
13497148|NCT02880371|27075223|FG003|Phase 2|Withdrawal by Subject|0|||
13497149|NCT02880371|27075224|FG004|Phase 2|Withdrawal by Subject|0|||
13497150|NCT02880371|27075225|FG005|Phase 2|Withdrawal by Subject|1|||
13497151|NCT02880371|27075226|FG006|Phase 2|Withdrawal by Subject|1|||
13497152|NCT02880371|27075227|FG007|Phase 2|Withdrawal by Subject|0|||
13133786|NCT02764320|25988980|FG000|Overall Study|Health Issues unable to continue|2|||
13133787|NCT02764320|25988981|FG001|Overall Study|Health Issues unable to continue|0|||
13133788|NCT02764320|25988980|FG000|Overall Study|Did not meet inclusion criteria|1|||
13133789|NCT02764320|25988981|FG001|Overall Study|Did not meet inclusion criteria|0|||
13133790|NCT02764320|25988980|FG000|Overall Study|Subject moved|0|||
13133791|NCT02764320|25988981|FG001|Overall Study|Subject moved|2|||
13133792|NCT02764320|25988980|FG000|Overall Study|Overused medication unavailable|0|||
13133793|NCT02764320|25988981|FG001|Overall Study|Overused medication unavailable|1|||
13133794|NCT02764320|25988980|FG000|Overall Study|Seeking care outside site|0|||
13133795|NCT02764320|25988981|FG001|Overall Study|Seeking care outside site|1|||
13133796|NCT02764320|25988980|FG000|Overall Study|Technology barriers|0|||
13133797|NCT02764320|25988981|FG001|Overall Study|Technology barriers|1|||
13133798|NCT02764229|25988987|FG000|Overall Study|Withdrawal by Subject|15|||
13133799|NCT02764229|25988987|FG000|Overall Study|Adverse Event|9|||
13133800|NCT02764229|25988987|FG000|Overall Study|Physician Decision|5|||
13133801|NCT02764229|25988987|FG000|Overall Study|Lost to Follow-up|3|||
13133802|NCT02764229|25988987|FG000|Overall Study|Lack of Efficacy|1|||
13133803|NCT02764229|25988987|FG000|Overall Study|Study Stopped by Sponsor|69|||
13133804|NCT02764190|25989038|FG000|Overall Study|Lost to Follow-up|17|||
13133805|NCT02764190|25989039|FG001|Overall Study|Lost to Follow-up|13|||
13133806|NCT02764151|25989174|FG000|Overall Study|Subject refused further follow-up|0|||
13133807|NCT02764151|25989175|FG001|Overall Study|Subject refused further follow-up|0|||
13133808|NCT02764151|25989176|FG002|Overall Study|Subject refused further follow-up|0|||
13133809|NCT02764151|25989177|FG003|Overall Study|Subject refused further follow-up|1|||
13133810|NCT02764151|25989174|FG000|Overall Study|Other|0|||
13133811|NCT02764151|25989175|FG001|Overall Study|Other|0|||
13133812|NCT02764151|25989176|FG002|Overall Study|Other|0|||
13133813|NCT02764151|25989177|FG003|Overall Study|Other|2|||
13133814|NCT02763644|25989202|FG000|Overall Study|Patient/guardian decision|1|||
13133815|NCT02763644|25989203|FG001|Overall Study|Patient/guardian decision|0|||
13133816|NCT02763644|25989202|FG000|Overall Study|Death|1|||
13133817|NCT02763644|25989203|FG001|Overall Study|Death|1|||
13133818|NCT02763644|25989202|FG000|Overall Study|Adverse Event|1|||
13133819|NCT02763644|25989203|FG001|Overall Study|Adverse Event|1|||
13133820|NCT02763566|25989244|FG000|Overall Study|Lost to Follow-up|1|||
13133821|NCT02763566|25989245|FG001|Overall Study|Lost to Follow-up|4|||
13133822|NCT02763566|25989246|FG002|Overall Study|Lost to Follow-up|0|||
13133823|NCT02763566|25989247|FG003|Overall Study|Lost to Follow-up|1|||
13133824|NCT02763566|25989244|FG000|Overall Study|On study treatment at study conclusion|114|||
13133825|NCT02763566|25989245|FG001|Overall Study|On study treatment at study conclusion|34|||
13133826|NCT02763566|25989246|FG002|Overall Study|On study treatment at study conclusion|54|||
13133827|NCT02763566|25989247|FG003|Overall Study|On study treatment at study conclusion|13|||
13133828|NCT02763566|25989244|FG000|Overall Study|Withdrawal by Subject|3|||
13133829|NCT02763566|25989245|FG001|Overall Study|Withdrawal by Subject|1|||
13133830|NCT02763566|25989246|FG002|Overall Study|Withdrawal by Subject|0|||
13133831|NCT02763566|25989247|FG003|Overall Study|Withdrawal by Subject|0|||
13133832|NCT02763254|25989254|FG000|Overall Study|Adverse Event|1|||
13133833|NCT02763215|25989277|FG000|Overall Study|Participants withdrew from study|3|||
13133834|NCT02763215|25989277|FG000|Overall Study|Missed visit|1|||
13497153|NCT02880371|27075220|FG000|Phase 2|End of Study page not completed by error|0|||
13497154|NCT02880371|27075221|FG001|Phase 2|End of Study page not completed by error|0|||
13497155|NCT02880371|27075222|FG002|Phase 2|End of Study page not completed by error|0|||
13497156|NCT02880371|27075223|FG003|Phase 2|End of Study page not completed by error|0|||
13497157|NCT02880371|27075224|FG004|Phase 2|End of Study page not completed by error|0|||
13497158|NCT02880371|27075225|FG005|Phase 2|End of Study page not completed by error|1|||
13497159|NCT02880371|27075226|FG006|Phase 2|End of Study page not completed by error|0|||
13497160|NCT02880371|27075227|FG007|Phase 2|End of Study page not completed by error|0|||
13497161|NCT02434354|27075233|FG000|Overall Study|screen fail|3|||
13497162|NCT02419417|27075532|FG000|Overall Study|Disease progression|5|||
13497163|NCT02419417|27075533|FG001|Overall Study|Disease progression|4|||
13497164|NCT02419417|27075534|FG002|Overall Study|Disease progression|13|||
13497165|NCT02419417|27075535|FG003|Overall Study|Disease progression|10|||
13497166|NCT02419417|27075536|FG004|Overall Study|Disease progression|10|||
13497167|NCT02419417|27075537|FG005|Overall Study|Disease progression|3|||
13497168|NCT02419417|27075538|FG006|Overall Study|Disease progression|4|||
13497169|NCT02419417|27075539|FG007|Overall Study|Disease progression|5|||
13497170|NCT02419417|27075540|FG008|Overall Study|Disease progression|13|||
13497171|NCT02419417|27075541|FG009|Overall Study|Disease progression|9|||
13497172|NCT02419417|27075542|FG010|Overall Study|Disease progression|0|||
13497173|NCT02419417|27075532|FG000|Overall Study|Study drug toxicity|0|||
13497174|NCT02419417|27075533|FG001|Overall Study|Study drug toxicity|0|||
13497175|NCT02419417|27075534|FG002|Overall Study|Study drug toxicity|0|||
13497176|NCT02419417|27075535|FG003|Overall Study|Study drug toxicity|0|||
13497177|NCT02419417|27075536|FG004|Overall Study|Study drug toxicity|1|||
13497178|NCT02419417|27075537|FG005|Overall Study|Study drug toxicity|0|||
13497179|NCT02419417|27075538|FG006|Overall Study|Study drug toxicity|0|||
13497180|NCT02419417|27075539|FG007|Overall Study|Study drug toxicity|0|||
13497181|NCT02419417|27075540|FG008|Overall Study|Study drug toxicity|0|||
13497182|NCT02419417|27075541|FG009|Overall Study|Study drug toxicity|0|||
13497183|NCT02419417|27075542|FG010|Overall Study|Study drug toxicity|0|||
13497184|NCT02419417|27075532|FG000|Overall Study|Adverse event unrelated to study drug|0|||
13497185|NCT02419417|27075533|FG001|Overall Study|Adverse event unrelated to study drug|0|||
13497186|NCT02419417|27075534|FG002|Overall Study|Adverse event unrelated to study drug|0|||
13497187|NCT02419417|27075535|FG003|Overall Study|Adverse event unrelated to study drug|0|||
13497188|NCT02419417|27075536|FG004|Overall Study|Adverse event unrelated to study drug|2|||
13497189|NCT02419417|27075537|FG005|Overall Study|Adverse event unrelated to study drug|1|||
13497190|NCT02419417|27075538|FG006|Overall Study|Adverse event unrelated to study drug|0|||
13497191|NCT02419417|27075539|FG007|Overall Study|Adverse event unrelated to study drug|1|||
13497192|NCT02419417|27075540|FG008|Overall Study|Adverse event unrelated to study drug|0|||
13497193|NCT02419417|27075541|FG009|Overall Study|Adverse event unrelated to study drug|0|||
13497194|NCT02419417|27075542|FG010|Overall Study|Adverse event unrelated to study drug|0|||
13497195|NCT02419417|27075532|FG000|Overall Study|Participant request to discontinue|0|||
13497196|NCT02419417|27075533|FG001|Overall Study|Participant request to discontinue|0|||
13497197|NCT02419417|27075534|FG002|Overall Study|Participant request to discontinue|0|||
13497198|NCT02419417|27075535|FG003|Overall Study|Participant request to discontinue|0|||
13497199|NCT02419417|27075536|FG004|Overall Study|Participant request to discontinue|0|||
13497200|NCT02419417|27075537|FG005|Overall Study|Participant request to discontinue|0|||
13497201|NCT02419417|27075538|FG006|Overall Study|Participant request to discontinue|0|||
13497202|NCT02419417|27075539|FG007|Overall Study|Participant request to discontinue|0|||
13497203|NCT02419417|27075540|FG008|Overall Study|Participant request to discontinue|0|||
13497204|NCT02419417|27075541|FG009|Overall Study|Participant request to discontinue|1|||
13497205|NCT02419417|27075542|FG010|Overall Study|Participant request to discontinue|0|||
13497206|NCT02419417|27075532|FG000|Overall Study|Withdrawal by Subject|0|||
13497207|NCT02419417|27075533|FG001|Overall Study|Withdrawal by Subject|0|||
13497208|NCT02419417|27075534|FG002|Overall Study|Withdrawal by Subject|0|||
13497209|NCT02419417|27075535|FG003|Overall Study|Withdrawal by Subject|0|||
13497210|NCT02419417|27075536|FG004|Overall Study|Withdrawal by Subject|0|||
13497211|NCT02419417|27075537|FG005|Overall Study|Withdrawal by Subject|0|||
13497212|NCT02419417|27075538|FG006|Overall Study|Withdrawal by Subject|0|||
13497213|NCT02419417|27075539|FG007|Overall Study|Withdrawal by Subject|0|||
13497214|NCT02419417|27075540|FG008|Overall Study|Withdrawal by Subject|0|||
13497215|NCT02419417|27075541|FG009|Overall Study|Withdrawal by Subject|0|||
13497216|NCT02419417|27075542|FG010|Overall Study|Withdrawal by Subject|1|||
13497217|NCT02051608|27075609|FG000|Part 1: Double Blind Treatment|Death|3|||
13497218|NCT02051608|27075610|FG001|Part 1: Double Blind Treatment|Death|3|||
13497219|NCT02051608|27075611|FG002|Part 1: Double Blind Treatment|Death|0|||
13497220|NCT02051608|27075612|FG003|Part 1: Double Blind Treatment|Death|0|||
13497221|NCT02051608|27075609|FG000|Part 1: Double Blind Treatment|Adverse Event|2|||
13497222|NCT02051608|27075610|FG001|Part 1: Double Blind Treatment|Adverse Event|8|||
13497223|NCT02051608|27075611|FG002|Part 1: Double Blind Treatment|Adverse Event|0|||
13497224|NCT02051608|27075612|FG003|Part 1: Double Blind Treatment|Adverse Event|0|||
13497225|NCT02051608|27075609|FG000|Part 1: Double Blind Treatment|Withdrawal by Subject|42|||
13497226|NCT02051608|27075610|FG001|Part 1: Double Blind Treatment|Withdrawal by Subject|29|||
13497227|NCT02051608|27075611|FG002|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
13497228|NCT02051608|27075612|FG003|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
13497229|NCT02051608|27075609|FG000|Part 1: Double Blind Treatment|Physician Decision|2|||
13497230|NCT02051608|27075610|FG001|Part 1: Double Blind Treatment|Physician Decision|4|||
13497231|NCT02051608|27075611|FG002|Part 1: Double Blind Treatment|Physician Decision|0|||
13497232|NCT02051608|27075612|FG003|Part 1: Double Blind Treatment|Physician Decision|0|||
13497233|NCT02051608|27075609|FG000|Part 1: Double Blind Treatment|Lost to Follow-up|1|||
13497234|NCT02051608|27075610|FG001|Part 1: Double Blind Treatment|Lost to Follow-up|2|||
13497235|NCT02051608|27075611|FG002|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
13497236|NCT02051608|27075612|FG003|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
13497237|NCT02051608|27075609|FG000|Part 1: Double Blind Treatment|Protocol Violation|0|||
13497238|NCT02051608|27075610|FG001|Part 1: Double Blind Treatment|Protocol Violation|1|||
13497239|NCT02051608|27075611|FG002|Part 1: Double Blind Treatment|Protocol Violation|0|||
13497240|NCT02051608|27075612|FG003|Part 1: Double Blind Treatment|Protocol Violation|0|||
13497241|NCT02051608|27075609|FG000|Part 1: Double Blind Treatment|Non-Compliance|2|||
13497242|NCT02051608|27075610|FG001|Part 1: Double Blind Treatment|Non-Compliance|4|||
13497243|NCT02051608|27075611|FG002|Part 1: Double Blind Treatment|Non-Compliance|0|||
13497244|NCT02051608|27075612|FG003|Part 1: Double Blind Treatment|Non-Compliance|0|||
13497245|NCT02051608|27075609|FG000|Part 1: Double Blind Treatment|Other|6|||
13497246|NCT02051608|27075610|FG001|Part 1: Double Blind Treatment|Other|3|||
13497247|NCT02051608|27075611|FG002|Part 1: Double Blind Treatment|Other|0|||
13497248|NCT02051608|27075612|FG003|Part 1: Double Blind Treatment|Other|0|||
13497249|NCT02051608|27075609|FG000|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|3|||
13497250|NCT02051608|27075610|FG001|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|2|||
13497251|NCT02051608|27075611|FG002|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
13497252|NCT02051608|27075612|FG003|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
13497253|NCT02051608|27075609|FG000|Part 2: Open-label Extension|Adverse Event|0|||
13497254|NCT02051608|27075610|FG001|Part 2: Open-label Extension|Adverse Event|0|||
13497255|NCT02051608|27075611|FG002|Part 2: Open-label Extension|Adverse Event|6|||
13497256|NCT02051608|27075612|FG003|Part 2: Open-label Extension|Adverse Event|8|||
13497257|NCT02051608|27075609|FG000|Part 2: Open-label Extension|Death|0|||
13497258|NCT02051608|27075610|FG001|Part 2: Open-label Extension|Death|0|||
13497259|NCT02051608|27075611|FG002|Part 2: Open-label Extension|Death|7|||
13497260|NCT02051608|27075612|FG003|Part 2: Open-label Extension|Death|4|||
13497261|NCT02051608|27075609|FG000|Part 2: Open-label Extension|Lost to Follow-up|0|||
13497262|NCT02051608|27075610|FG001|Part 2: Open-label Extension|Lost to Follow-up|0|||
13497263|NCT02051608|27075611|FG002|Part 2: Open-label Extension|Lost to Follow-up|0|||
13497264|NCT02051608|27075612|FG003|Part 2: Open-label Extension|Lost to Follow-up|1|||
13497265|NCT02051608|27075609|FG000|Part 2: Open-label Extension|Non-Compliance|0|||
13497266|NCT02051608|27075610|FG001|Part 2: Open-label Extension|Non-Compliance|0|||
13497267|NCT02051608|27075611|FG002|Part 2: Open-label Extension|Non-Compliance|1|||
13497268|NCT02051608|27075612|FG003|Part 2: Open-label Extension|Non-Compliance|1|||
13497269|NCT02051608|27075609|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
13497270|NCT02051608|27075610|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
13497271|NCT02051608|27075611|FG002|Part 2: Open-label Extension|Withdrawal by Subject|39|||
13497272|NCT02051608|27075612|FG003|Part 2: Open-label Extension|Withdrawal by Subject|32|||
13497273|NCT02051608|27075609|FG000|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
13497274|NCT02051608|27075610|FG001|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
13497275|NCT02051608|27075611|FG002|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
13497276|NCT02051608|27075612|FG003|Part 2: Open-label Extension|Study Terminated By Sponsor|1|||
13497277|NCT02051608|27075609|FG000|Part 2: Open-label Extension|Physician Decision|0|||
13497278|NCT02051608|27075610|FG001|Part 2: Open-label Extension|Physician Decision|0|||
13497279|NCT02051608|27075611|FG002|Part 2: Open-label Extension|Physician Decision|8|||
13497280|NCT02051608|27075612|FG003|Part 2: Open-label Extension|Physician Decision|5|||
13497281|NCT02051608|27075609|FG000|Part 2: Open-label Extension|Other|0|||
13497282|NCT02051608|27075610|FG001|Part 2: Open-label Extension|Other|0|||
13497283|NCT02051608|27075611|FG002|Part 2: Open-label Extension|Other|9|||
13497284|NCT02051608|27075612|FG003|Part 2: Open-label Extension|Other|9|||
13497285|NCT00726596|27075633|FG000|Overall Study|Adverse Event|2|||
13497286|NCT00726596|27075634|FG001|Overall Study|Adverse Event|1|||
13497287|NCT00726596|27075633|FG000|Overall Study|Withdrawal by Subject|3|||
13497288|NCT00726596|27075634|FG001|Overall Study|Withdrawal by Subject|3|||
13497289|NCT00489827|27075663|FG000|Overall Study|Intraoperative exclusion criteria|1|||
13497290|NCT00489827|27075664|FG001|Overall Study|Intraoperative exclusion criteria|1|||
13497291|NCT00489827|27075663|FG000|Overall Study|Intraoperative exclusion criteria|1|||
13497292|NCT00489827|27075664|FG001|Overall Study|Intraoperative exclusion criteria|1|||
13497293|NCT04311463|27075883|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
13497294|NCT04311463|27075884|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0|||
13497295|NCT04311463|27075883|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
13497296|NCT04311463|27075884|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
13497297|NCT04311463|27075883|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2|||
13497298|NCT04311463|27075884|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
13497299|NCT03930186|27075931|FG000|Weeks 0 to 16|Adverse Event|6|||
13497300|NCT03930186|27075931|FG000|Weeks 0 to 16|Withdrawal by Subject|6|||
13497301|NCT03930186|27075931|FG000|Weeks 16 to 32|Adverse Event|1|||
13497302|NCT03930186|27075931|FG000|Weeks 16 to 32|Withdrawal by Subject|3|||
13497303|NCT03740100|27075937|FG000|Overall Study|Adverse Event|1|||
13497304|NCT03740100|27075937|FG000|Overall Study|Death|1|||
13497305|NCT04808609|27076008|FG000|Overall Study|Lost to Follow-up|0|||
13497306|NCT04808609|27076009|FG001|Overall Study|Lost to Follow-up|2|||
13497307|NCT04808609|27076008|FG000|Overall Study|Administrative Withdrawal|0|||
13497308|NCT04808609|27076009|FG001|Overall Study|Administrative Withdrawal|1|||
13497309|NCT04577781|27076025|FG000|Overall Study|Adverse Event|2|||
13497310|NCT04577781|27076026|FG001|Overall Study|Adverse Event|2|||
13497311|NCT04577781|27076025|FG000|Overall Study|Physician Decision|1|||
13497312|NCT04577781|27076026|FG001|Overall Study|Physician Decision|0|||
13497313|NCT04524598|27076077|FG000|Phase I - Feasibility|Lost to Follow-up|2|||
13497314|NCT04524598|27076078|FG001|Phase I - Feasibility|Lost to Follow-up|4|||
13497315|NCT04524598|27076079|FG002|Phase I - Feasibility|Lost to Follow-up|0|||
13497316|NCT04524598|27076080|FG003|Phase I - Feasibility|Lost to Follow-up|0|||
13497317|NCT04524598|27076081|FG004|Phase I - Feasibility|Lost to Follow-up|0|||
13497318|NCT04524598|27076077|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2|||
13497319|NCT04524598|27076078|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1|||
13497320|NCT04524598|27076079|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
13497321|NCT04524598|27076080|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
13497322|NCT04524598|27076081|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
13497323|NCT04524598|27076077|FG000|Phase II - Outcomes|Lost to Follow-up|0|||
13497324|NCT04524598|27076078|FG001|Phase II - Outcomes|Lost to Follow-up|0|||
13497325|NCT04524598|27076079|FG002|Phase II - Outcomes|Lost to Follow-up|16|||
13497326|NCT04524598|27076080|FG003|Phase II - Outcomes|Lost to Follow-up|8|||
13497327|NCT04524598|27076081|FG004|Phase II - Outcomes|Lost to Follow-up|0|||
13497328|NCT04524598|27076077|FG000|Phase II - Outcomes|Withdrawal by Subject|0|||
13497329|NCT04524598|27076078|FG001|Phase II - Outcomes|Withdrawal by Subject|0|||
13497330|NCT04524598|27076079|FG002|Phase II - Outcomes|Withdrawal by Subject|2|||
13497331|NCT04524598|27076080|FG003|Phase II - Outcomes|Withdrawal by Subject|0|||
13497332|NCT04524598|27076081|FG004|Phase II - Outcomes|Withdrawal by Subject|0|||
13497333|NCT04524598|27076077|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
13497334|NCT04524598|27076078|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
13497335|NCT04524598|27076079|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8|||
13497336|NCT04524598|27076080|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5|||
13497337|NCT04524598|27076081|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
13497338|NCT04524598|27076077|FG000|Phase II - Control Extension|Lost to Follow-up|0|||
13497339|NCT04524598|27076078|FG001|Phase II - Control Extension|Lost to Follow-up|0|||
13497340|NCT04524598|27076079|FG002|Phase II - Control Extension|Lost to Follow-up|0|||
13497341|NCT04524598|27076080|FG003|Phase II - Control Extension|Lost to Follow-up|0|||
13497342|NCT04524598|27076081|FG004|Phase II - Control Extension|Lost to Follow-up|6|||
13497343|NCT04524598|27076077|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
13497344|NCT04524598|27076078|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
13497345|NCT04524598|27076079|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
13497346|NCT04524598|27076080|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
13497347|NCT04524598|27076081|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6|||
13497348|NCT04432298|27076116|FG000|Overall Study|Other than specified|1|||
13497349|NCT04432298|27076117|FG001|Overall Study|Other than specified|0|||
13497350|NCT04432298|27076116|FG000|Overall Study|Lost to Follow-up|0|||
13497351|NCT04432298|27076117|FG001|Overall Study|Lost to Follow-up|1|||
13497352|NCT04432298|27076116|FG000|Overall Study|Death|3|||
13497353|NCT04432298|27076117|FG001|Overall Study|Death|2|||
13497354|NCT04432298|27076116|FG000|Overall Study|Withdrawal by Subject|2|||
13497355|NCT04432298|27076117|FG001|Overall Study|Withdrawal by Subject|0|||
13497356|NCT04428034|27076124|FG000|Enrollment to Intervention Completion|Protocol Violation|9|||
13497357|NCT04428034|27076124|FG000|Enrollment to Intervention Completion|Suspected Fraudulent Case|1|||
13497358|NCT03853694|27076187|FG000|Overall Study|Protocol Violation|3|||
13497359|NCT03853694|27076188|FG001|Overall Study|Protocol Violation|5|||
13497360|NCT03853694|27076189|FG002|Overall Study|Protocol Violation|3|||
13497361|NCT03853694|27076187|FG000|Overall Study|Delivered early|0|||
13497362|NCT03853694|27076188|FG001|Overall Study|Delivered early|1|||
13497363|NCT03853694|27076189|FG002|Overall Study|Delivered early|0|||
13497364|NCT03853694|27076187|FG000|Overall Study|not suitable to proceed|0|||
13497365|NCT03853694|27076188|FG001|Overall Study|not suitable to proceed|1|||
13497366|NCT03853694|27076189|FG002|Overall Study|not suitable to proceed|0|||
13497367|NCT03853694|27076187|FG000|Overall Study|difficult surgery|0|||
13497368|NCT03853694|27076188|FG001|Overall Study|difficult surgery|0|||
13497369|NCT03853694|27076189|FG002|Overall Study|difficult surgery|1|||
13497370|NCT03853694|27076187|FG000|Overall Study|Lost to Follow-up|0|||
13497371|NCT03853694|27076188|FG001|Overall Study|Lost to Follow-up|1|||
13497372|NCT03853694|27076189|FG002|Overall Study|Lost to Follow-up|0|||
13497373|NCT03853694|27076187|FG000|Overall Study|Withdrawal by Subject|0|||
13497374|NCT03853694|27076188|FG001|Overall Study|Withdrawal by Subject|1|||
13497375|NCT03853694|27076189|FG002|Overall Study|Withdrawal by Subject|0|||
13497376|NCT03785340|27076208|FG000|Overall Study|Lost to Follow-up|2|||
13497377|NCT03785340|27076209|FG001|Overall Study|Lost to Follow-up|0|||
13497378|NCT03785340|27076208|FG000|Overall Study|Adverse Event|1|||
13497379|NCT03785340|27076209|FG001|Overall Study|Adverse Event|0|||
13497380|NCT02865850|27076439|FG000|Overall Study|Death|15|||
13497381|NCT02865850|27076440|FG001|Overall Study|Death|19|||
13497382|NCT02865850|27076439|FG000|Overall Study|Withdrawal by Subject|3|||
13497383|NCT02865850|27076440|FG001|Overall Study|Withdrawal by Subject|2|||
13497384|NCT02865850|27076439|FG000|Overall Study|Lost to Follow-up|3|||
13497385|NCT02865850|27076440|FG001|Overall Study|Lost to Follow-up|2|||
13497386|NCT02746471|27076447|FG000|Overall Study|Death|43|||
13497387|NCT02746471|27076447|FG000|Overall Study|Exited before 36 months|1119|||
13497388|NCT02591953|27076459|FG000|Overall Study|Lost to Follow-up|6|||
13497389|NCT02591953|27076460|FG001|Overall Study|Lost to Follow-up|6|||
13497390|NCT02509494|27076592|FG000|Overall Study|Lost to Follow-up|8|||
13497391|NCT02509494|27076593|FG001|Overall Study|Lost to Follow-up|47|||
13497392|NCT02509494|27076594|FG002|Overall Study|Lost to Follow-up|19|||
13497393|NCT02509494|27076595|FG003|Overall Study|Lost to Follow-up|6|||
13497394|NCT02509494|27076596|FG004|Overall Study|Lost to Follow-up|3|||
13497395|NCT02509494|27076597|FG005|Overall Study|Lost to Follow-up|3|||
13497396|NCT02509494|27076598|FG006|Overall Study|Lost to Follow-up|1|||
13497397|NCT02509494|27076599|FG007|Overall Study|Lost to Follow-up|3|||
13497398|NCT02509494|27076600|FG008|Overall Study|Lost to Follow-up|1|||
13497399|NCT02509494|27076592|FG000|Overall Study|Physician Decision|2|||
13497400|NCT02509494|27076593|FG001|Overall Study|Physician Decision|1|||
13497401|NCT02509494|27076594|FG002|Overall Study|Physician Decision|0|||
13497402|NCT02509494|27076595|FG003|Overall Study|Physician Decision|0|||
13497403|NCT02509494|27076596|FG004|Overall Study|Physician Decision|0|||
13497404|NCT02509494|27076597|FG005|Overall Study|Physician Decision|0|||
13497405|NCT02509494|27076598|FG006|Overall Study|Physician Decision|0|||
13497406|NCT02509494|27076599|FG007|Overall Study|Physician Decision|0|||
13497407|NCT02509494|27076600|FG008|Overall Study|Physician Decision|0|||
13497408|NCT02509494|27076592|FG000|Overall Study|Withdrawal by Subject|4|||
13497409|NCT02509494|27076593|FG001|Overall Study|Withdrawal by Subject|17|||
13497410|NCT02509494|27076594|FG002|Overall Study|Withdrawal by Subject|7|||
13497411|NCT02509494|27076595|FG003|Overall Study|Withdrawal by Subject|5|||
13497412|NCT02509494|27076596|FG004|Overall Study|Withdrawal by Subject|0|||
13497413|NCT02509494|27076597|FG005|Overall Study|Withdrawal by Subject|6|||
13497414|NCT02509494|27076598|FG006|Overall Study|Withdrawal by Subject|1|||
13497415|NCT02509494|27076599|FG007|Overall Study|Withdrawal by Subject|2|||
13497416|NCT02509494|27076600|FG008|Overall Study|Withdrawal by Subject|1|||
13497417|NCT02509494|27076592|FG000|Overall Study|Death|0|||
13497418|NCT02509494|27076593|FG001|Overall Study|Death|1|||
13497419|NCT02509494|27076594|FG002|Overall Study|Death|0|||
13497420|NCT02509494|27076595|FG003|Overall Study|Death|0|||
13497421|NCT02509494|27076596|FG004|Overall Study|Death|1|||
13497422|NCT02509494|27076597|FG005|Overall Study|Death|0|||
13497423|NCT02509494|27076598|FG006|Overall Study|Death|0|||
13497424|NCT02509494|27076599|FG007|Overall Study|Death|1|||
13497425|NCT02509494|27076600|FG008|Overall Study|Death|0|||
13497426|NCT02509494|27076592|FG000|Overall Study|Other|0|||
13497427|NCT02509494|27076593|FG001|Overall Study|Other|4|||
13497428|NCT02509494|27076594|FG002|Overall Study|Other|5|||
13497429|NCT02509494|27076595|FG003|Overall Study|Other|0|||
13497430|NCT02509494|27076596|FG004|Overall Study|Other|0|||
13497431|NCT02509494|27076597|FG005|Overall Study|Other|0|||
13497432|NCT02509494|27076598|FG006|Overall Study|Other|0|||
13497433|NCT02509494|27076599|FG007|Overall Study|Other|0|||
13497434|NCT02509494|27076600|FG008|Overall Study|Other|0|||
13497435|NCT02509494|27076592|FG000|Overall Study|Non-Compliance With Study Drug|1|||
13497436|NCT02509494|27076593|FG001|Overall Study|Non-Compliance With Study Drug|11|||
13497437|NCT02509494|27076594|FG002|Overall Study|Non-Compliance With Study Drug|7|||
13497438|NCT02509494|27076595|FG003|Overall Study|Non-Compliance With Study Drug|0|||
13497439|NCT02509494|27076596|FG004|Overall Study|Non-Compliance With Study Drug|1|||
13497440|NCT02509494|27076597|FG005|Overall Study|Non-Compliance With Study Drug|2|||
13497441|NCT02509494|27076598|FG006|Overall Study|Non-Compliance With Study Drug|1|||
13497442|NCT02509494|27076599|FG007|Overall Study|Non-Compliance With Study Drug|1|||
13497443|NCT02509494|27076600|FG008|Overall Study|Non-Compliance With Study Drug|0|||
13497444|NCT02600923|27076646|FG000|Overall Study|Death|10|||
13497445|NCT02600923|27076646|FG000|Overall Study|Adverse Event|3|||
13497446|NCT02600923|27076646|FG000|Overall Study|Global deterioration of health status|2|||
13497447|NCT02600923|27076646|FG000|Overall Study|Insufficient clinical response|6|||
13497448|NCT02600923|27076646|FG000|Overall Study|Lost to Follow-up|1|||
13497449|NCT02600923|27076646|FG000|Overall Study|Withdrawal by Subject|5|||
13497450|NCT02600923|27076646|FG000|Overall Study|Objective progression or relapse|50|||
13497451|NCT02600923|27076646|FG000|Overall Study|Study terminated by Sponsor|53|||
13497452|NCT02600923|27076646|FG000|Overall Study|Not treated|1|||
13497453|NCT02371889|27076667|FG000|Overall Study|Adverse medication effect|11|||
13497454|NCT02371889|27076668|FG001|Overall Study|Adverse medication effect|2|||
13497455|NCT02371889|27076667|FG000|Overall Study|Lost to Follow-up|6|||
13497456|NCT02371889|27076668|FG001|Overall Study|Lost to Follow-up|5|||
13497457|NCT02371889|27076667|FG000|Overall Study|Personal time constraints|2|||
13497458|NCT02371889|27076668|FG001|Overall Study|Personal time constraints|4|||
13497459|NCT02371889|27076667|FG000|Overall Study|Lack of Efficacy|0|||
13497460|NCT02371889|27076668|FG001|Overall Study|Lack of Efficacy|2|||
13497461|NCT02371889|27076667|FG000|Overall Study|Relapse|0|||
13497462|NCT02371889|27076668|FG001|Overall Study|Relapse|1|||
13497463|NCT02100722|27076721|FG000|Overall Study|Withdrawal pre-procedure|4|||
13497464|NCT02100722|27076722|FG001|Overall Study|Withdrawal pre-procedure|9|||
13497465|NCT02100722|27076721|FG000|Overall Study|Withdrawal post-procedure|0|||
13497466|NCT02100722|27076722|FG001|Overall Study|Withdrawal post-procedure|3|||
13497467|NCT02100722|27076721|FG000|Overall Study|Lost to Follow-up|2|||
13497468|NCT02100722|27076722|FG001|Overall Study|Lost to Follow-up|2|||
13497469|NCT02100722|27076721|FG000|Overall Study|Continuing on study|751|||
13497470|NCT02100722|27076722|FG001|Overall Study|Continuing on study|729|||
13497471|NCT02046096|27076748|FG000|Overall Study|Death|28|||
13497472|NCT02046096|27076749|FG001|Overall Study|Death|45|||
13497473|NCT02046096|27076748|FG000|Overall Study|Lost to Follow-up|9|||
13497474|NCT02046096|27076749|FG001|Overall Study|Lost to Follow-up|20|||
13497475|NCT02046096|27076748|FG000|Overall Study|Withdrawal by Subject|5|||
13497476|NCT02046096|27076749|FG001|Overall Study|Withdrawal by Subject|17|||
13497477|NCT02046096|27076748|FG000|Overall Study|Other endpoint|2|||
13497478|NCT02046096|27076749|FG001|Overall Study|Other endpoint|19|||
13497479|NCT01945775|27076785|FG000|Overall Study|Death|214|||
13497480|NCT01945775|27076786|FG001|Overall Study|Death|98|||
13497481|NCT01945775|27076785|FG000|Overall Study|Lost to Follow-up|12|||
13497482|NCT01945775|27076786|FG001|Overall Study|Lost to Follow-up|7|||
13497483|NCT01945775|27076785|FG000|Overall Study|Withdrawal by Subject|11|||
13497484|NCT01945775|27076786|FG001|Overall Study|Withdrawal by Subject|21|||
13497485|NCT01945775|27076785|FG000|Overall Study|Other|50|||
13497486|NCT01945775|27076786|FG001|Overall Study|Other|18|||
13497487|NCT01781637|27076801|FG000|Overall Study|Adverse Event|1|||
13497488|NCT01781637|27076802|FG001|Overall Study|Adverse Event|0|||
13497489|NCT01781637|27076801|FG000|Overall Study|Lack of Efficacy|2|||
13497490|NCT01781637|27076802|FG001|Overall Study|Lack of Efficacy|6|||
13497491|NCT01781637|27076801|FG000|Overall Study|Withdrawal by Subject|1|||
13497492|NCT01781637|27076802|FG001|Overall Study|Withdrawal by Subject|0|||
13497493|NCT00407602|27076815|FG000|Overall Study|Death - unrelated to device|1|||
13497494|NCT00407602|27076815|FG000|Overall Study|Device explanted|5|||
13497495|NCT00407602|27076815|FG000|Overall Study|Withdrawal by Subject|1|||
13497496|NCT04567186|27076846|FG000|Period 1|COVID-19 related|1|||
13497497|NCT04567186|27076847|FG001|Period 1|COVID-19 related|0|||
13497498|NCT04567186|27076846|FG000|Period 1|Protocol Violation|0|||
13497499|NCT04567186|27076847|FG001|Period 1|Protocol Violation|1|||
13497500|NCT04567186|27076846|FG000|Period 1|Adverse Event|0|||
13497501|NCT04567186|27076847|FG001|Period 1|Adverse Event|2|||
13497502|NCT04567186|27076846|FG000|Period 2|COVID-19 Related|0|||
13497503|NCT04567186|27076847|FG001|Period 2|COVID-19 Related|1|||
13497504|NCT04567186|27076846|FG000|Period 2|Protocol Violation|0|||
13497505|NCT04567186|27076847|FG001|Period 2|Protocol Violation|1|||
13497506|NCT04567186|27076846|FG000|Period 2|Lost to Follow-up|0|||
13497507|NCT04567186|27076847|FG001|Period 2|Lost to Follow-up|1|||
13497508|NCT04567186|27076846|FG000|Period 3|Subject no longer meets eligibilty criteria|1|||
13497509|NCT04567186|27076847|FG001|Period 3|Subject no longer meets eligibilty criteria|0|||
13497510|NCT04065074|27076937|FG000|Overall Study|Adverse Event|1|||
13497511|NCT04065074|27076937|FG000|Overall Study|Protocol Non-Compliance after injection|1|||
13497512|NCT03980730|27076960|FG000|Overall Study|Study Terminated by Sponsor|0|||
13497513|NCT03980730|27076961|FG001|Overall Study|Study Terminated by Sponsor|3|||
13497514|NCT03980730|27076960|FG000|Overall Study|Adverse Event|2|||
13497515|NCT03980730|27076961|FG001|Overall Study|Adverse Event|0|||
13497516|NCT03980730|27076960|FG000|Overall Study|Sponsor Request|0|||
13497517|NCT03980730|27076961|FG001|Overall Study|Sponsor Request|1|||
13497518|NCT03793010|27076978|FG000|Overall Study|Withdrawal by Subject|5|||
13497519|NCT03793010|27076979|FG001|Overall Study|Withdrawal by Subject|7|||
13497520|NCT03793010|27076978|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19|||
13497521|NCT03793010|27076979|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18|||
13497522|NCT03793010|27076978|FG000|Overall Study|Lost to Follow-up|1|||
13497523|NCT03793010|27076979|FG001|Overall Study|Lost to Follow-up|2|||
13497524|NCT03793010|27076978|FG000|Overall Study|Patient couldn't sit still for injection|1|||
13497525|NCT03793010|27076979|FG001|Overall Study|Patient couldn't sit still for injection|0|||
13497526|NCT03793010|27076978|FG000|Overall Study|Withdrew to pursue other treatment|1|||
13497527|NCT03793010|27076979|FG001|Overall Study|Withdrew to pursue other treatment|0|||
13497528|NCT03793010|27076978|FG000|Overall Study|Did not meet eligibility criteria|1|||
13497529|NCT03793010|27076979|FG001|Overall Study|Did not meet eligibility criteria|0|||
13497530|NCT03644017|27077005|FG000|Overall Study|Access Abandonment|5|||
13497531|NCT03644017|27077005|FG000|Overall Study|Kidney Transplant|2|||
13497532|NCT03529942|27077019|FG000|Overall Study|Withdrawal by Subject|13|||
13497533|NCT03529942|27077019|FG000|Overall Study|Physician Decision|1|||
13497534|NCT03529942|27077019|FG000|Overall Study|Lost to Follow-up|7|||
13497535|NCT03529942|27077019|FG000|Overall Study|Needle inserted but no drug administered|1|||
13497536|NCT03529942|27077019|FG000|Overall Study|Personal reasons|1|||
13497537|NCT03349775|27077034|FG000|Overall Study|Side Effects|1|||
13497538|NCT03349775|27077035|FG001|Overall Study|Side Effects|2|||
13497539|NCT03349775|27077034|FG000|Overall Study|Withdrawal by Subject|1|||
13497540|NCT03349775|27077035|FG001|Overall Study|Withdrawal by Subject|1|||
13497541|NCT03349775|27077034|FG000|Overall Study|No primary outcome measurements|0|||
13497542|NCT03349775|27077035|FG001|Overall Study|No primary outcome measurements|1|||
13497543|NCT03207815|27077062|FG000|Overall Study|Protocol Violation|3|||
13497544|NCT03207815|27077063|FG001|Overall Study|Protocol Violation|1|||
13497545|NCT03207815|27077062|FG000|Overall Study|Adverse Event|1|||
13497546|NCT03207815|27077063|FG001|Overall Study|Adverse Event|2|||
13497547|NCT03207815|27077062|FG000|Overall Study|Lost to Follow-up|1|||
13497548|NCT03207815|27077063|FG001|Overall Study|Lost to Follow-up|2|||
13497549|NCT03207815|27077062|FG000|Overall Study|Investigator's Discretion|1|||
13497550|NCT03207815|27077063|FG001|Overall Study|Investigator's Discretion|1|||
13497551|NCT03207815|27077062|FG000|Overall Study|Lack of Efficacy|0|||
13497552|NCT03207815|27077063|FG001|Overall Study|Lack of Efficacy|1|||
13497553|NCT03207815|27077062|FG000|Overall Study|Pregnancy/Partner Pregnancy|1|||
13497554|NCT03207815|27077063|FG001|Overall Study|Pregnancy/Partner Pregnancy|0|||
13497555|NCT03207815|27077062|FG000|Overall Study|Withdrew Consent|1|||
13497556|NCT03207815|27077063|FG001|Overall Study|Withdrew Consent|0|||
13497557|NCT02968563|27077104|FG000|Overall Study|Adverse Event|0|||
13497558|NCT02968563|27077105|FG001|Overall Study|Adverse Event|6|||
13497559|NCT02968563|27077104|FG000|Overall Study|Death|1|||
13497560|NCT02968563|27077105|FG001|Overall Study|Death|1|||
13497561|NCT02968563|27077104|FG000|Overall Study|Lost to Follow-up|0|||
13497562|NCT02968563|27077105|FG001|Overall Study|Lost to Follow-up|1|||
13497563|NCT02787044|27077126|FG000|Overall Study|Lost to Follow-up|15|||
13497564|NCT02787044|27077127|FG001|Overall Study|Lost to Follow-up|19|||
13497565|NCT02698163|27077148|FG000|Overall Study|Lost to Follow-up|0|||
13497566|NCT02698163|27077149|FG001|Overall Study|Lost to Follow-up|1|||
13497567|NCT01816165|27077248|FG000|Overall Study|Adverse Event|1|||
13497568|NCT01816165|27077249|FG001|Overall Study|Adverse Event|0|||
13497569|NCT01816165|27077250|FG002|Overall Study|Adverse Event|0|||
13497570|NCT01816165|27077251|FG003|Overall Study|Adverse Event|0|||
13497571|NCT01813929|27077320|FG000|Overall Study|Withdrawal by Subject|0|||
13497572|NCT01813929|27077321|FG001|Overall Study|Withdrawal by Subject|1|||
13497573|NCT00882050|27077361|FG000|Overall Study|Physician Decision|1|||
13497574|NCT00882050|27077362|FG001|Overall Study|Physician Decision|0|||
13497575|NCT00882050|27077363|FG002|Overall Study|Physician Decision|0|||
13497576|NCT00070564|27077432|FG000|Overall Study|Progression|2|||
13497577|NCT00070564|27077433|FG001|Overall Study|Progression|4|||
13497578|NCT00070564|27077434|FG002|Overall Study|Progression|7|||
13497579|NCT00070564|27077435|FG003|Overall Study|Progression|7|||
13497580|NCT00070564|27077436|FG004|Overall Study|Progression|1|||
13497581|NCT00070564|27077437|FG005|Overall Study|Progression|0|||
13497582|NCT00070564|27077432|FG000|Overall Study|Delinquent|1|||
13497583|NCT00070564|27077433|FG001|Overall Study|Delinquent|4|||
13497584|NCT00070564|27077434|FG002|Overall Study|Delinquent|2|||
13497585|NCT00070564|27077435|FG003|Overall Study|Delinquent|0|||
13497586|NCT00070564|27077436|FG004|Overall Study|Delinquent|0|||
13497587|NCT00070564|27077437|FG005|Overall Study|Delinquent|0|||
13497588|NCT00070564|27077432|FG000|Overall Study|Adverse Event|150|||
13497589|NCT00070564|27077433|FG001|Overall Study|Adverse Event|142|||
13497590|NCT00070564|27077434|FG002|Overall Study|Adverse Event|120|||
13497591|NCT00070564|27077435|FG003|Overall Study|Adverse Event|108|||
13497592|NCT00070564|27077436|FG004|Overall Study|Adverse Event|63|||
13497593|NCT00070564|27077437|FG005|Overall Study|Adverse Event|36|||
13497594|NCT00070564|27077432|FG000|Overall Study|Death|4|||
13497595|NCT00070564|27077433|FG001|Overall Study|Death|1|||
13497596|NCT00070564|27077434|FG002|Overall Study|Death|5|||
13497597|NCT00070564|27077435|FG003|Overall Study|Death|3|||
13497598|NCT00070564|27077436|FG004|Overall Study|Death|0|||
13497599|NCT00070564|27077437|FG005|Overall Study|Death|1|||
13497600|NCT00070564|27077432|FG000|Overall Study|Other, not protocol specified|17|||
13497601|NCT00070564|27077433|FG001|Overall Study|Other, not protocol specified|15|||
13497602|NCT00070564|27077434|FG002|Overall Study|Other, not protocol specified|14|||
13497603|NCT00070564|27077435|FG003|Overall Study|Other, not protocol specified|19|||
13497604|NCT00070564|27077436|FG004|Overall Study|Other, not protocol specified|6|||
13497605|NCT00070564|27077437|FG005|Overall Study|Other, not protocol specified|7|||
13497606|NCT00070564|27077432|FG000|Overall Study|Withdrawal by Subject|26|||
13497607|NCT00070564|27077433|FG001|Overall Study|Withdrawal by Subject|37|||
13497608|NCT00070564|27077434|FG002|Overall Study|Withdrawal by Subject|23|||
13497609|NCT00070564|27077435|FG003|Overall Study|Withdrawal by Subject|30|||
13497610|NCT00070564|27077436|FG004|Overall Study|Withdrawal by Subject|8|||
13497611|NCT00070564|27077437|FG005|Overall Study|Withdrawal by Subject|8|||
13497612|NCT00070564|27077432|FG000|Overall Study|Not reported|0|||
13497613|NCT00070564|27077433|FG001|Overall Study|Not reported|0|||
13497614|NCT00070564|27077434|FG002|Overall Study|Not reported|0|||
13497615|NCT00070564|27077435|FG003|Overall Study|Not reported|0|||
13497616|NCT00070564|27077436|FG004|Overall Study|Not reported|1|||
13497617|NCT00070564|27077437|FG005|Overall Study|Not reported|0|||
13497618|NCT04425720|27077471|FG000|Overall Study|Withdrawal by Subject|0|||
13497619|NCT04425720|27077472|FG001|Overall Study|Withdrawal by Subject|20|||
13497620|NCT04409509|27077529|FG000|Overall Study|Failure to meet randomization requirement|1|||
13497621|NCT04409509|27077530|FG001|Overall Study|Failure to meet randomization requirement|0|||
13497622|NCT04409509|27077529|FG000|Overall Study|Adverse Event|0|||
13497623|NCT04409509|27077530|FG001|Overall Study|Adverse Event|1|||
13497624|NCT04409509|27077529|FG000|Overall Study|Death|11|||
13497625|NCT04409509|27077530|FG001|Overall Study|Death|10|||
13497626|NCT04409509|27077529|FG000|Overall Study|Non-compliance with study drug|0|||
13497627|NCT04409509|27077530|FG001|Overall Study|Non-compliance with study drug|1|||
13497628|NCT04409509|27077529|FG000|Overall Study|Lost to Follow-up|0|||
13497629|NCT04409509|27077530|FG001|Overall Study|Lost to Follow-up|3|||
13497630|NCT04409509|27077529|FG000|Overall Study|Withdrawal by Subject|0|||
13497631|NCT04409509|27077530|FG001|Overall Study|Withdrawal by Subject|3|||
13497632|NCT04409509|27077529|FG000|Overall Study|Randomized by mistake|0|||
13497633|NCT04409509|27077530|FG001|Overall Study|Randomized by mistake|1|||
13497634|NCT04409509|27077529|FG000|Overall Study|Other|1|||
13497635|NCT04409509|27077530|FG001|Overall Study|Other|1|||
13497636|NCT04380519|27077560|FG000|Overall Study|Withdrawal by Subject|4|||
13497637|NCT04380519|27077561|FG001|Overall Study|Withdrawal by Subject|0|||
13497638|NCT04380519|27077562|FG002|Overall Study|Withdrawal by Subject|1|||
13497639|NCT04380519|27077560|FG000|Overall Study|Death|14|||
13497640|NCT04380519|27077561|FG001|Overall Study|Death|9|||
13497641|NCT04380519|27077562|FG002|Overall Study|Death|6|||
13497642|NCT04380519|27077560|FG000|Overall Study|Adverse Event|0|||
13497643|NCT04380519|27077561|FG001|Overall Study|Adverse Event|1|||
13497644|NCT04380519|27077562|FG002|Overall Study|Adverse Event|0|||
13497645|NCT04380519|27077560|FG000|Overall Study|relatives' decision|0|||
13497646|NCT04380519|27077561|FG001|Overall Study|relatives' decision|1|||
13497647|NCT04380519|27077562|FG002|Overall Study|relatives' decision|0|||
13497648|NCT04362813|27077585|FG000|Overall Study|Death|12|||
13497649|NCT04362813|27077586|FG001|Overall Study|Death|16|||
13497650|NCT04362813|27077585|FG000|Overall Study|Withdrawal by Subject|3|||
13497651|NCT04362813|27077586|FG001|Overall Study|Withdrawal by Subject|1|||
13497652|NCT04362813|27077585|FG000|Overall Study|Protocol Violation|0|||
13497653|NCT04362813|27077586|FG001|Overall Study|Protocol Violation|3|||
13497654|NCT04362813|27077585|FG000|Overall Study|Lost to Follow-up|1|||
13497655|NCT04362813|27077586|FG001|Overall Study|Lost to Follow-up|1|||
13497656|NCT04362813|27077585|FG000|Overall Study|Enrolled but did not receive treatment|2|||
13497657|NCT04362813|27077586|FG001|Overall Study|Enrolled but did not receive treatment|4|||
13497658|NCT03922321|27077720|FG000|Overall Study|Participant Moved|1|||
13497659|NCT03922321|27077720|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1|||
13497660|NCT03911713|27077759|FG000|Overall Study|Lost to Follow-up|0|||
13497661|NCT03911713|27077760|FG001|Overall Study|Lost to Follow-up|2|||
13497662|NCT03911713|27077761|FG002|Overall Study|Lost to Follow-up|0|||
13497663|NCT03911713|27077762|FG003|Overall Study|Lost to Follow-up|0|||
13497664|NCT03911713|27077763|FG004|Overall Study|Lost to Follow-up|0|||
13497665|NCT03911713|27077759|FG000|Overall Study|Other|0|||
13497666|NCT03911713|27077760|FG001|Overall Study|Other|0|||
13497667|NCT03911713|27077761|FG002|Overall Study|Other|0|||
13497668|NCT03911713|27077762|FG003|Overall Study|Other|1|||
13497669|NCT03911713|27077763|FG004|Overall Study|Other|0|||
13497670|NCT03911713|27077759|FG000|Overall Study|Randomized, Never Dosed|1|||
13497671|NCT03911713|27077760|FG001|Overall Study|Randomized, Never Dosed|0|||
13497672|NCT03911713|27077761|FG002|Overall Study|Randomized, Never Dosed|0|||
13497673|NCT03911713|27077762|FG003|Overall Study|Randomized, Never Dosed|1|||
13497674|NCT03911713|27077763|FG004|Overall Study|Randomized, Never Dosed|0|||
13497675|NCT03852459|27077802|FG000|Overall Study|Adverse Event|2|||
13497676|NCT03852459|27077803|FG001|Overall Study|Adverse Event|2|||
13497677|NCT03852459|27077802|FG000|Overall Study|Withdrawal by Subject|1|||
13497678|NCT03852459|27077803|FG001|Overall Study|Withdrawal by Subject|1|||
13497679|NCT03740919|27077876|FG000|Lead-in Period|Lost to Follow-up|1|||
13497680|NCT03740919|27077877|FG001|Lead-in Period|Lost to Follow-up|0|||
13497681|NCT03740919|27077878|FG002|Lead-in Period|Lost to Follow-up|0|||
13497682|NCT03740919|27077879|FG003|Lead-in Period|Lost to Follow-up|0|||
13497683|NCT03740919|27077876|FG000|Lead-in Period|Physician Decision|2|||
13497684|NCT03740919|27077877|FG001|Lead-in Period|Physician Decision|0|||
13497685|NCT03740919|27077878|FG002|Lead-in Period|Physician Decision|0|||
13497686|NCT03740919|27077879|FG003|Lead-in Period|Physician Decision|0|||
13497687|NCT03740919|27077876|FG000|Lead-in Period|Protocol Violation|1|||
13497688|NCT03740919|27077877|FG001|Lead-in Period|Protocol Violation|0|||
13497689|NCT03740919|27077878|FG002|Lead-in Period|Protocol Violation|0|||
13497690|NCT03740919|27077879|FG003|Lead-in Period|Protocol Violation|0|||
13497691|NCT03740919|27077876|FG000|Lead-in Period|Withdrawal by Subject|10|||
13497692|NCT03740919|27077877|FG001|Lead-in Period|Withdrawal by Subject|0|||
13497693|NCT03740919|27077878|FG002|Lead-in Period|Withdrawal by Subject|0|||
13497694|NCT03740919|27077879|FG003|Lead-in Period|Withdrawal by Subject|0|||
13497695|NCT03740919|27077876|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18|||
13497696|NCT03740919|27077877|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
13497697|NCT03740919|27077878|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
13497698|NCT03740919|27077879|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
13497699|NCT03740919|27077876|FG000|Lead-in Period|Study Task Too Burdensome|1|||
13497700|NCT03740919|27077877|FG001|Lead-in Period|Study Task Too Burdensome|0|||
13497701|NCT03740919|27077878|FG002|Lead-in Period|Study Task Too Burdensome|0|||
13497702|NCT03740919|27077879|FG003|Lead-in Period|Study Task Too Burdensome|0|||
13497703|NCT03740919|27077876|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1|||
13497704|NCT03740919|27077877|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
13497705|NCT03740919|27077878|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
13497706|NCT03740919|27077879|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
13497707|NCT03740919|27077876|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1|||
13497708|NCT03740919|27077877|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
13497709|NCT03740919|27077878|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
13497710|NCT03740919|27077879|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
13497711|NCT03740919|27077876|FG000|Treatment Period|Adverse Event|0|||
13497712|NCT03740919|27077877|FG001|Treatment Period|Adverse Event|0|||
13497713|NCT03740919|27077878|FG002|Treatment Period|Adverse Event|2|||
13497714|NCT03740919|27077879|FG003|Treatment Period|Adverse Event|0|||
13497715|NCT03740919|27077876|FG000|Treatment Period|Protocol Violation|0|||
13497716|NCT03740919|27077877|FG001|Treatment Period|Protocol Violation|1|||
13497717|NCT03740919|27077878|FG002|Treatment Period|Protocol Violation|0|||
13497718|NCT03740919|27077879|FG003|Treatment Period|Protocol Violation|0|||
13497719|NCT03740919|27077876|FG000|Treatment Period|Withdrawal by Subject|0|||
13497720|NCT03740919|27077877|FG001|Treatment Period|Withdrawal by Subject|7|||
13497721|NCT03740919|27077878|FG002|Treatment Period|Withdrawal by Subject|6|||
13497722|NCT03740919|27077879|FG003|Treatment Period|Withdrawal by Subject|2|||
13497723|NCT03740919|27077876|FG000|Treatment Period|Terminated by Sponsor|0|||
13497724|NCT03740919|27077877|FG001|Treatment Period|Terminated by Sponsor|1|||
13497725|NCT03740919|27077878|FG002|Treatment Period|Terminated by Sponsor|0|||
13497726|NCT03740919|27077879|FG003|Treatment Period|Terminated by Sponsor|0|||
13497727|NCT03740919|27077876|FG000|Treatment Period|Issue with Insulin Pump|0|||
13497728|NCT03740919|27077877|FG001|Treatment Period|Issue with Insulin Pump|1|||
13497729|NCT03740919|27077878|FG002|Treatment Period|Issue with Insulin Pump|0|||
13497730|NCT03740919|27077879|FG003|Treatment Period|Issue with Insulin Pump|0|||
13497731|NCT03740919|27077876|FG000|Treatment Period|Due to COVID-19 Pandemic|0|||
13497732|NCT03740919|27077877|FG001|Treatment Period|Due to COVID-19 Pandemic|0|||
13497733|NCT03740919|27077878|FG002|Treatment Period|Due to COVID-19 Pandemic|3|||
13497734|NCT03740919|27077879|FG003|Treatment Period|Due to COVID-19 Pandemic|1|||
13497735|NCT03740919|27077876|FG000|Treatment Period|Failure of Inclusion Criteria|0|||
13497736|NCT03740919|27077877|FG001|Treatment Period|Failure of Inclusion Criteria|0|||
13497737|NCT03740919|27077878|FG002|Treatment Period|Failure of Inclusion Criteria|1|||
13497738|NCT03740919|27077879|FG003|Treatment Period|Failure of Inclusion Criteria|0|||
13497739|NCT03740919|27077876|FG000|Treatment Period|Not Completing Diary|0|||
13497740|NCT03740919|27077877|FG001|Treatment Period|Not Completing Diary|0|||
13497741|NCT03740919|27077878|FG002|Treatment Period|Not Completing Diary|1|||
13497742|NCT03740919|27077879|FG003|Treatment Period|Not Completing Diary|0|||
13497743|NCT03740919|27077876|FG000|Treatment Period|Insulin Painful to Participant|0|||
13497744|NCT03740919|27077877|FG001|Treatment Period|Insulin Painful to Participant|0|||
13497745|NCT03740919|27077878|FG002|Treatment Period|Insulin Painful to Participant|1|||
13497746|NCT03740919|27077879|FG003|Treatment Period|Insulin Painful to Participant|0|||
13497747|NCT03647488|27077949|FG000|Overall Study|Progressive disease|10|||
13497748|NCT03647488|27077950|FG001|Overall Study|Progressive disease|0|||
13497749|NCT03647488|27077951|FG002|Overall Study|Progressive disease|0|||
13497750|NCT03647488|27077949|FG000|Overall Study|Adverse Event|5|||
13497751|NCT03647488|27077950|FG001|Overall Study|Adverse Event|0|||
13497752|NCT03647488|27077951|FG002|Overall Study|Adverse Event|0|||
13497753|NCT03647488|27077949|FG000|Overall Study|Clinical progression|2|||
13497754|NCT03647488|27077950|FG001|Overall Study|Clinical progression|0|||
13497755|NCT03647488|27077951|FG002|Overall Study|Clinical progression|0|||
13497756|NCT03647488|27077949|FG000|Overall Study|Participant refused to take investigational product|1|||
13497757|NCT03647488|27077950|FG001|Overall Study|Participant refused to take investigational product|0|||
13497758|NCT03647488|27077951|FG002|Overall Study|Participant refused to take investigational product|0|||
13497759|NCT03614923|27077975|FG000|Overall Study|Withdrawal by Subject|2|||
13497760|NCT03614923|27077976|FG001|Overall Study|Withdrawal by Subject|1|||
13497761|NCT03614923|27077977|FG002|Overall Study|Withdrawal by Subject|1|||
13497762|NCT03614923|27077975|FG000|Overall Study|Adverse Event|0|||
13497763|NCT03614923|27077976|FG001|Overall Study|Adverse Event|2|||
13497764|NCT03614923|27077977|FG002|Overall Study|Adverse Event|1|||
13497765|NCT03614923|27077975|FG000|Overall Study|Lost to Follow-up|1|||
13497766|NCT03614923|27077976|FG001|Overall Study|Lost to Follow-up|0|||
13497767|NCT03614923|27077977|FG002|Overall Study|Lost to Follow-up|1|||
13497768|NCT03614923|27077975|FG000|Overall Study|Lack of Efficacy|2|||
13497769|NCT03614923|27077976|FG001|Overall Study|Lack of Efficacy|0|||
13497770|NCT03614923|27077977|FG002|Overall Study|Lack of Efficacy|1|||
13497771|NCT03614923|27077975|FG000|Overall Study|Non-compliance|0|||
13497772|NCT03614923|27077976|FG001|Overall Study|Non-compliance|1|||
13497773|NCT03614923|27077977|FG002|Overall Study|Non-compliance|0|||
13497774|NCT03614923|27077975|FG000|Overall Study|Other|0|||
13497775|NCT03614923|27077976|FG001|Overall Study|Other|1|||
13497776|NCT03614923|27077977|FG002|Overall Study|Other|1|||
13497777|NCT03502187|27078019|FG000|Overall Study|Withdrawal by Subject|4|||
13497778|NCT03502187|27078020|FG001|Overall Study|Withdrawal by Subject|3|||
13497779|NCT03502187|27078021|FG002|Overall Study|Withdrawal by Subject|3|||
13497780|NCT03502187|27078019|FG000|Overall Study|Lost to Follow-up|5|||
13497781|NCT03502187|27078020|FG001|Overall Study|Lost to Follow-up|4|||
13497782|NCT03502187|27078021|FG002|Overall Study|Lost to Follow-up|5|||
13497783|NCT03447262|27078043|FG000|Overall Study|Adverse Event|7|||
13497784|NCT03447262|27078043|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
13497785|NCT03447262|27078043|FG000|Overall Study|Commercial Drug is Available for Participant|9|||
13497786|NCT03447262|27078043|FG000|Overall Study|Death|2|||
13497787|NCT03447262|27078043|FG000|Overall Study|Study Termination by Sponsor|455|||
13497788|NCT03447262|27078043|FG000|Overall Study|Other|4|||
13497789|NCT03432819|27078074|FG000|Overall Study|Lost to Follow-up|2|||
13497790|NCT03432819|27078075|FG001|Overall Study|Lost to Follow-up|2|||
13497791|NCT03432819|27078074|FG000|Overall Study|Withdrawal by Subject|5|||
13497792|NCT03432819|27078075|FG001|Overall Study|Withdrawal by Subject|3|||
13497793|NCT03323749|27078100|FG000|Double-blind Period|Lost to Follow-up|4|||
13497794|NCT03323749|27078101|FG001|Double-blind Period|Lost to Follow-up|5|||
13497795|NCT03323749|27078100|FG000|Double-blind Period|Adverse Event|3|||
13497796|NCT03323749|27078101|FG001|Double-blind Period|Adverse Event|1|||
13497797|NCT03323749|27078100|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83|||
13497798|NCT03323749|27078101|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88|||
13497799|NCT03323749|27078100|FG000|Open-Label Period|Adverse Event|3|||
13497800|NCT03323749|27078101|FG001|Open-Label Period|Adverse Event|10|||
13497801|NCT03323749|27078100|FG000|Open-Label Period|Withdrawal by Subject|7|||
13497802|NCT03323749|27078101|FG001|Open-Label Period|Withdrawal by Subject|5|||
13497803|NCT03322566|27078129|FG000|Overall Study|Death|34|||
13497804|NCT03322566|27078130|FG001|Overall Study|Death|35|||
13497805|NCT03322566|27078131|FG002|Overall Study|Death|23|||
13497806|NCT03322566|27078129|FG000|Overall Study|Physician Decision|6|||
13497807|NCT03322566|27078130|FG001|Overall Study|Physician Decision|7|||
13497808|NCT03322566|27078131|FG002|Overall Study|Physician Decision|2|||
13497809|NCT03322566|27078129|FG000|Overall Study|Withdrawal by Subject|4|||
13497810|NCT03322566|27078130|FG001|Overall Study|Withdrawal by Subject|3|||
13497811|NCT03322566|27078131|FG002|Overall Study|Withdrawal by Subject|6|||
13497812|NCT03322566|27078129|FG000|Overall Study|Lost to Follow-up|0|||
13497813|NCT03322566|27078130|FG001|Overall Study|Lost to Follow-up|0|||
13497814|NCT03322566|27078131|FG002|Overall Study|Lost to Follow-up|1|||
13497815|NCT03322566|27078129|FG000|Overall Study|Study terminated by sponsor|1|||
13497816|NCT03322566|27078130|FG001|Overall Study|Study terminated by sponsor|0|||
13497817|NCT03322566|27078131|FG002|Overall Study|Study terminated by sponsor|1|||
13497818|NCT03322540|27078155|FG000|Overall Study|Death|21|||
13497819|NCT03322540|27078156|FG001|Overall Study|Death|28|||
13497820|NCT03322540|27078155|FG000|Overall Study|Lost to Follow-up|0|||
13497821|NCT03322540|27078156|FG001|Overall Study|Lost to Follow-up|1|||
13497822|NCT03322540|27078155|FG000|Overall Study|Physician Decision|7|||
13497823|NCT03322540|27078156|FG001|Overall Study|Physician Decision|6|||
13497824|NCT03322540|27078155|FG000|Overall Study|Withdrawal by Subject|3|||
13497825|NCT03322540|27078156|FG001|Overall Study|Withdrawal by Subject|1|||
13497826|NCT03322540|27078155|FG000|Overall Study|Study terminated by sponsor|0|||
13497827|NCT03322540|27078156|FG001|Overall Study|Study terminated by sponsor|1|||
13497828|NCT03189719|27078243|FG000|Overall Study|Death|260|||
13497829|NCT03189719|27078244|FG001|Overall Study|Death|308|||
13497830|NCT03189719|27078243|FG000|Overall Study|Withdrawal by Subject|5|||
13497831|NCT03189719|27078244|FG001|Overall Study|Withdrawal by Subject|3|||
13497832|NCT03189719|27078243|FG000|Overall Study|Ongoing in Study|108|||
13497833|NCT03189719|27078244|FG001|Overall Study|Ongoing in Study|65|||
13497834|NCT03155997|27078260|FG000|Overall Study|Withdrawal by Subject|119|||
13497835|NCT03155997|27078261|FG001|Overall Study|Withdrawal by Subject|134|||
13497836|NCT03155997|27078260|FG000|Overall Study|Lost to Follow-up|12|||
13497837|NCT03155997|27078261|FG001|Overall Study|Lost to Follow-up|13|||
13497838|NCT03155997|27078260|FG000|Overall Study|Missing disposition data|0|||
13497839|NCT03155997|27078261|FG001|Overall Study|Missing disposition data|1|||
13497840|NCT03155997|27078260|FG000|Overall Study|On study treatment|2027|||
13497841|NCT03155997|27078261|FG001|Overall Study|On study treatment|2074|||
13497842|NCT03072043|27078283|FG000|Overall Study|Death|0|||
13497843|NCT03072043|27078284|FG001|Overall Study|Death|0|||
13497844|NCT03072043|27078285|FG002|Overall Study|Death|3|||
13497845|NCT03072043|27078283|FG000|Overall Study|Adverse Event|0|||
13497846|NCT03072043|27078284|FG001|Overall Study|Adverse Event|0|||
13497847|NCT03072043|27078285|FG002|Overall Study|Adverse Event|2|||
13497848|NCT03072043|27078283|FG000|Overall Study|Withdrawal by Subject|0|||
13381445|NCT00753415|26748245|FG001|Part A|Withdrawal by Subject|0|||
13497849|NCT03072043|27078284|FG001|Overall Study|Withdrawal by Subject|0|||
13497850|NCT03072043|27078285|FG002|Overall Study|Withdrawal by Subject|4|||
13497851|NCT02905032|27078340|FG000|Overall Study|Withdrawal by Subject|2|||
13497852|NCT02905032|27078341|FG001|Overall Study|Withdrawal by Subject|0|||
13497853|NCT02905032|27078342|FG002|Overall Study|Withdrawal by Subject|0|||
13497854|NCT02905032|27078340|FG000|Overall Study|Protocol Violation|6|||
13497855|NCT02905032|27078341|FG001|Overall Study|Protocol Violation|12|||
13497856|NCT02905032|27078342|FG002|Overall Study|Protocol Violation|0|||
13497857|NCT02837029|27078367|FG000|Screening|Failed to meet screening requirements.|7|||
13497858|NCT02837029|27078368|FG001|Screening|Failed to meet screening requirements.|3|||
13497859|NCT02837029|27078369|FG002|Screening|Failed to meet screening requirements.|0|||
13497860|NCT02837029|27078367|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2|||
13497861|NCT02837029|27078368|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
13497862|NCT02837029|27078369|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
13497863|NCT02837029|27078367|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
13497864|NCT02837029|27078368|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2|||
13497865|NCT02837029|27078369|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
13497866|NCT02837029|27078367|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
13497867|NCT02837029|27078368|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1|||
13497868|NCT02837029|27078369|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
13497869|NCT02837029|27078367|FG000|Cycle 2 and Beyond|Adverse Event|1|||
13497870|NCT02837029|27078368|FG001|Cycle 2 and Beyond|Adverse Event|0|||
13497871|NCT02837029|27078369|FG002|Cycle 2 and Beyond|Adverse Event|0|||
13497872|NCT02837029|27078367|FG000|2 Year Follow-up|Death|6|||
13497873|NCT02837029|27078368|FG001|2 Year Follow-up|Death|7|||
13497874|NCT02837029|27078369|FG002|2 Year Follow-up|Death|0|||
13497875|NCT02737475|27079198|FG000|Overall Study|Other reasons|0|||
13497876|NCT02737475|27079199|FG001|Overall Study|Other reasons|0|||
13497877|NCT02737475|27079200|FG002|Overall Study|Other reasons|0|||
13497878|NCT02737475|27079201|FG003|Overall Study|Other reasons|0|||
13497879|NCT02737475|27079202|FG004|Overall Study|Other reasons|1|||
13497880|NCT02737475|27079203|FG005|Overall Study|Other reasons|1|||
13497881|NCT02737475|27079204|FG006|Overall Study|Other reasons|0|||
13497882|NCT02737475|27079205|FG007|Overall Study|Other reasons|0|||
13497883|NCT02737475|27079206|FG008|Overall Study|Other reasons|1|||
13497884|NCT02737475|27079207|FG009|Overall Study|Other reasons|0|||
13497885|NCT02737475|27079208|FG010|Overall Study|Other reasons|1|||
13497886|NCT02737475|27079209|FG011|Overall Study|Other reasons|0|||
13497887|NCT02737475|27079210|FG012|Overall Study|Other reasons|0|||
13497888|NCT02737475|27079211|FG013|Overall Study|Other reasons|0|||
13497889|NCT02737475|27079212|FG014|Overall Study|Other reasons|0|||
13497890|NCT02737475|27079213|FG015|Overall Study|Other reasons|0|||
13497891|NCT02737475|27079214|FG016|Overall Study|Other reasons|0|||
13497892|NCT02737475|27079215|FG017|Overall Study|Other reasons|0|||
13497893|NCT02737475|27079216|FG018|Overall Study|Other reasons|0|||
13497894|NCT02737475|27079217|FG019|Overall Study|Other reasons|0|||
13497895|NCT02737475|27079218|FG020|Overall Study|Other reasons|0|||
13497896|NCT02737475|27079219|FG021|Overall Study|Other reasons|1|||
13497897|NCT02737475|27079220|FG022|Overall Study|Other reasons|0|||
13497898|NCT02737475|27079221|FG023|Overall Study|Other reasons|1|||
13497899|NCT02737475|27079222|FG024|Overall Study|Other reasons|1|||
13497900|NCT02737475|27079223|FG025|Overall Study|Other reasons|1|||
13497901|NCT02737475|27079224|FG026|Overall Study|Other reasons|0|||
13497902|NCT02737475|27079198|FG000|Overall Study|Death|1|||
13497903|NCT02737475|27079199|FG001|Overall Study|Death|0|||
13497904|NCT02737475|27079200|FG002|Overall Study|Death|0|||
13497905|NCT02737475|27079201|FG003|Overall Study|Death|1|||
13497906|NCT02737475|27079202|FG004|Overall Study|Death|0|||
13497907|NCT02737475|27079203|FG005|Overall Study|Death|0|||
13497908|NCT02737475|27079204|FG006|Overall Study|Death|0|||
13497909|NCT02737475|27079205|FG007|Overall Study|Death|2|||
13497910|NCT02737475|27079206|FG008|Overall Study|Death|0|||
13497911|NCT02737475|27079207|FG009|Overall Study|Death|0|||
13497912|NCT02737475|27079208|FG010|Overall Study|Death|0|||
13497913|NCT02737475|27079209|FG011|Overall Study|Death|4|||
13497914|NCT02737475|27079210|FG012|Overall Study|Death|2|||
13497915|NCT02737475|27079211|FG013|Overall Study|Death|2|||
13497916|NCT02737475|27079212|FG014|Overall Study|Death|0|||
13497917|NCT02737475|27079213|FG015|Overall Study|Death|2|||
13497918|NCT02737475|27079214|FG016|Overall Study|Death|2|||
13497919|NCT02737475|27079215|FG017|Overall Study|Death|2|||
13497920|NCT02737475|27079216|FG018|Overall Study|Death|1|||
13497921|NCT02737475|27079217|FG019|Overall Study|Death|0|||
13497922|NCT02737475|27079218|FG020|Overall Study|Death|0|||
13497923|NCT02737475|27079219|FG021|Overall Study|Death|0|||
13497924|NCT02737475|27079220|FG022|Overall Study|Death|0|||
13497925|NCT02737475|27079221|FG023|Overall Study|Death|0|||
13497926|NCT02737475|27079222|FG024|Overall Study|Death|0|||
13497927|NCT02737475|27079223|FG025|Overall Study|Death|0|||
13497928|NCT02737475|27079224|FG026|Overall Study|Death|0|||
13497929|NCT02737475|27079198|FG000|Overall Study|Participant withdrew consent|0|||
13497930|NCT02737475|27079199|FG001|Overall Study|Participant withdrew consent|0|||
13497931|NCT02737475|27079200|FG002|Overall Study|Participant withdrew consent|0|||
13497932|NCT02737475|27079201|FG003|Overall Study|Participant withdrew consent|0|||
13497933|NCT02737475|27079202|FG004|Overall Study|Participant withdrew consent|0|||
13497934|NCT02737475|27079203|FG005|Overall Study|Participant withdrew consent|2|||
13497935|NCT02737475|27079204|FG006|Overall Study|Participant withdrew consent|0|||
13497936|NCT02737475|27079205|FG007|Overall Study|Participant withdrew consent|0|||
13497937|NCT02737475|27079206|FG008|Overall Study|Participant withdrew consent|0|||
13497938|NCT02737475|27079207|FG009|Overall Study|Participant withdrew consent|0|||
13497939|NCT02737475|27079208|FG010|Overall Study|Participant withdrew consent|0|||
13497940|NCT02737475|27079209|FG011|Overall Study|Participant withdrew consent|0|||
13497941|NCT02737475|27079210|FG012|Overall Study|Participant withdrew consent|0|||
13497942|NCT02737475|27079211|FG013|Overall Study|Participant withdrew consent|0|||
13497943|NCT02737475|27079212|FG014|Overall Study|Participant withdrew consent|1|||
13497944|NCT02737475|27079213|FG015|Overall Study|Participant withdrew consent|0|||
13497945|NCT02737475|27079214|FG016|Overall Study|Participant withdrew consent|0|||
13497946|NCT02737475|27079215|FG017|Overall Study|Participant withdrew consent|2|||
13497947|NCT02737475|27079216|FG018|Overall Study|Participant withdrew consent|1|||
13497948|NCT02737475|27079217|FG019|Overall Study|Participant withdrew consent|0|||
13497949|NCT02737475|27079218|FG020|Overall Study|Participant withdrew consent|2|||
13497950|NCT02737475|27079219|FG021|Overall Study|Participant withdrew consent|0|||
13497951|NCT02737475|27079220|FG022|Overall Study|Participant withdrew consent|0|||
13497952|NCT02737475|27079221|FG023|Overall Study|Participant withdrew consent|0|||
13497953|NCT02737475|27079222|FG024|Overall Study|Participant withdrew consent|0|||
13497954|NCT02737475|27079223|FG025|Overall Study|Participant withdrew consent|0|||
13497955|NCT02737475|27079224|FG026|Overall Study|Participant withdrew consent|0|||
13497956|NCT02737475|27079198|FG000|Overall Study|Lost to Follow-up|0|||
13497957|NCT02737475|27079199|FG001|Overall Study|Lost to Follow-up|0|||
13497958|NCT02737475|27079200|FG002|Overall Study|Lost to Follow-up|0|||
13497959|NCT02737475|27079201|FG003|Overall Study|Lost to Follow-up|0|||
13497960|NCT02737475|27079202|FG004|Overall Study|Lost to Follow-up|0|||
13497961|NCT02737475|27079203|FG005|Overall Study|Lost to Follow-up|0|||
13497962|NCT02737475|27079204|FG006|Overall Study|Lost to Follow-up|0|||
13497963|NCT02737475|27079205|FG007|Overall Study|Lost to Follow-up|0|||
13497964|NCT02737475|27079206|FG008|Overall Study|Lost to Follow-up|0|||
13497965|NCT02737475|27079207|FG009|Overall Study|Lost to Follow-up|0|||
13497966|NCT02737475|27079208|FG010|Overall Study|Lost to Follow-up|0|||
13497967|NCT02737475|27079209|FG011|Overall Study|Lost to Follow-up|0|||
13497968|NCT02737475|27079210|FG012|Overall Study|Lost to Follow-up|0|||
13497969|NCT02737475|27079211|FG013|Overall Study|Lost to Follow-up|0|||
13497970|NCT02737475|27079212|FG014|Overall Study|Lost to Follow-up|0|||
13497971|NCT02737475|27079213|FG015|Overall Study|Lost to Follow-up|1|||
13497972|NCT02737475|27079214|FG016|Overall Study|Lost to Follow-up|0|||
13497973|NCT02737475|27079215|FG017|Overall Study|Lost to Follow-up|0|||
13497974|NCT02737475|27079216|FG018|Overall Study|Lost to Follow-up|0|||
13497975|NCT02737475|27079217|FG019|Overall Study|Lost to Follow-up|0|||
13497976|NCT02737475|27079218|FG020|Overall Study|Lost to Follow-up|0|||
13497977|NCT02737475|27079219|FG021|Overall Study|Lost to Follow-up|0|||
13497978|NCT02737475|27079220|FG022|Overall Study|Lost to Follow-up|0|||
13497979|NCT02737475|27079221|FG023|Overall Study|Lost to Follow-up|0|||
13497980|NCT02737475|27079222|FG024|Overall Study|Lost to Follow-up|0|||
13497981|NCT02737475|27079223|FG025|Overall Study|Lost to Follow-up|0|||
13497982|NCT02737475|27079224|FG026|Overall Study|Lost to Follow-up|0|||
13497983|NCT02737475|27079198|FG000|Overall Study|Disease Progression|0|||
13497984|NCT02737475|27079199|FG001|Overall Study|Disease Progression|0|||
13497985|NCT02737475|27079200|FG002|Overall Study|Disease Progression|0|||
13497986|NCT02737475|27079201|FG003|Overall Study|Disease Progression|0|||
13497987|NCT02737475|27079202|FG004|Overall Study|Disease Progression|0|||
13497988|NCT02737475|27079203|FG005|Overall Study|Disease Progression|0|||
13497989|NCT02737475|27079204|FG006|Overall Study|Disease Progression|0|||
13497990|NCT02737475|27079205|FG007|Overall Study|Disease Progression|0|||
13497991|NCT02737475|27079206|FG008|Overall Study|Disease Progression|0|||
13497992|NCT02737475|27079207|FG009|Overall Study|Disease Progression|0|||
13497993|NCT02737475|27079208|FG010|Overall Study|Disease Progression|0|||
13497994|NCT02737475|27079209|FG011|Overall Study|Disease Progression|0|||
13497995|NCT02737475|27079210|FG012|Overall Study|Disease Progression|0|||
13497996|NCT02737475|27079211|FG013|Overall Study|Disease Progression|0|||
13497997|NCT02737475|27079212|FG014|Overall Study|Disease Progression|0|||
13497998|NCT02737475|27079213|FG015|Overall Study|Disease Progression|0|||
13497999|NCT02737475|27079214|FG016|Overall Study|Disease Progression|0|||
13498000|NCT02737475|27079215|FG017|Overall Study|Disease Progression|0|||
13498001|NCT02737475|27079216|FG018|Overall Study|Disease Progression|0|||
13498002|NCT02737475|27079217|FG019|Overall Study|Disease Progression|0|||
13498003|NCT02737475|27079218|FG020|Overall Study|Disease Progression|0|||
13498004|NCT02737475|27079219|FG021|Overall Study|Disease Progression|0|||
13498005|NCT02737475|27079220|FG022|Overall Study|Disease Progression|0|||
13498006|NCT02737475|27079221|FG023|Overall Study|Disease Progression|0|||
13498007|NCT02737475|27079222|FG024|Overall Study|Disease Progression|0|||
13498008|NCT02737475|27079223|FG025|Overall Study|Disease Progression|0|||
13498009|NCT02737475|27079224|FG026|Overall Study|Disease Progression|1|||
13498010|NCT02642965|27079240|FG000|Overall Study|Lack of Efficacy|4|||
13498011|NCT02642965|27079240|FG000|Overall Study|Physician Decision|9|||
13498012|NCT02604433|27079307|FG000|Overall Study|Withdrawal by Subject|37|||
13498013|NCT02604433|27079308|FG001|Overall Study|Withdrawal by Subject|16|||
13498014|NCT02604433|27079307|FG000|Overall Study|Adverse Event|4|||
13498015|NCT02604433|27079308|FG001|Overall Study|Adverse Event|0|||
13498016|NCT02604433|27079307|FG000|Overall Study|Other reasons|3|||
13498017|NCT02604433|27079308|FG001|Overall Study|Other reasons|5|||
13498018|NCT02604433|27079307|FG000|Overall Study|Death|4|||
13498019|NCT02604433|27079308|FG001|Overall Study|Death|1|||
13498020|NCT02604433|27079307|FG000|Overall Study|Transition to Rollover Protocol|169|||
13498021|NCT02604433|27079308|FG001|Overall Study|Transition to Rollover Protocol|82|||
13498022|NCT02604433|27079307|FG000|Overall Study|Physician Decision|1|||
13498023|NCT02604433|27079308|FG001|Overall Study|Physician Decision|1|||
13498024|NCT02604433|27079307|FG000|Overall Study|Lack of Efficacy|0|||
13498025|NCT02604433|27079308|FG001|Overall Study|Lack of Efficacy|1|||
13498026|NCT02410343|27079377|FG000|Core Period (24 Weeks)|Adverse Event|1|||
13498027|NCT02410343|27079378|FG001|Core Period (24 Weeks)|Adverse Event|0|||
13498028|NCT02410343|27079377|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4|||
13498029|NCT02410343|27079378|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7|||
13498030|NCT02410343|27079377|FG000|Extension Period (12 Months)|Adverse Event|1|||
13498031|NCT02410343|27079378|FG001|Extension Period (12 Months)|Adverse Event|0|||
13498032|NCT02410343|27079377|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0|||
13498033|NCT02410343|27079378|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1|||
13498034|NCT02045303|27079463|FG000|Overall Study|Protocol Violation|2|||
13498035|NCT02045303|27079464|FG001|Overall Study|Protocol Violation|1|||
13498036|NCT02045303|27079465|FG002|Overall Study|Protocol Violation|0|||
13498037|NCT02045303|27079463|FG000|Overall Study|Withdrawal by Subject|0|||
13498038|NCT02045303|27079464|FG001|Overall Study|Withdrawal by Subject|2|||
13498039|NCT02045303|27079465|FG002|Overall Study|Withdrawal by Subject|0|||
13498040|NCT02025556|27079492|FG000|Overall Study|Adverse Event|0|||
13498041|NCT02025556|27079493|FG001|Overall Study|Adverse Event|4|||
13498042|NCT02025556|27079494|FG002|Overall Study|Adverse Event|2|||
13498043|NCT02025556|27079492|FG000|Overall Study|Lack of Efficacy|2|||
13498044|NCT02025556|27079493|FG001|Overall Study|Lack of Efficacy|1|||
13498045|NCT02025556|27079494|FG002|Overall Study|Lack of Efficacy|0|||
13498046|NCT02025556|27079492|FG000|Overall Study|Protocol Violation|2|||
13498047|NCT02025556|27079493|FG001|Overall Study|Protocol Violation|1|||
13498048|NCT02025556|27079494|FG002|Overall Study|Protocol Violation|0|||
13498049|NCT02025556|27079492|FG000|Overall Study|Withdrawal by Subject|0|||
13498050|NCT02025556|27079493|FG001|Overall Study|Withdrawal by Subject|3|||
13498051|NCT02025556|27079494|FG002|Overall Study|Withdrawal by Subject|6|||
13498052|NCT02025556|27079492|FG000|Overall Study|Lost to Follow-up|2|||
13498053|NCT02025556|27079493|FG001|Overall Study|Lost to Follow-up|4|||
13498054|NCT02025556|27079494|FG002|Overall Study|Lost to Follow-up|0|||
13498055|NCT02025556|27079492|FG000|Overall Study|Reason not reported|0|||
13498056|NCT02025556|27079493|FG001|Overall Study|Reason not reported|0|||
13498057|NCT02025556|27079494|FG002|Overall Study|Reason not reported|1|||
13498058|NCT01986933|27079557|FG000|Placebo-controlled (Part A)|Adverse Event|1|||
13498059|NCT01986933|27079558|FG001|Placebo-controlled (Part A)|Adverse Event|5|||
13498060|NCT01986933|27079559|FG002|Placebo-controlled (Part A)|Adverse Event|2|||
13498061|NCT01986933|27079560|FG003|Placebo-controlled (Part A)|Adverse Event|2|||
13498062|NCT01986933|27079561|FG004|Placebo-controlled (Part A)|Adverse Event|4|||
13498063|NCT01986933|27079557|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3|||
13498064|NCT01986933|27079558|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1|||
13498065|NCT01986933|27079559|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1|||
13498066|NCT01986933|27079560|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2|||
13498067|NCT01986933|27079561|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1|||
13498068|NCT01986933|27079557|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5|||
13498069|NCT01986933|27079558|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
13498070|NCT01986933|27079559|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6|||
13498071|NCT01986933|27079560|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
13498072|NCT01986933|27079561|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7|||
13498073|NCT01986933|27079557|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0|||
13498074|NCT01986933|27079558|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1|||
13498075|NCT01986933|27079559|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0|||
13498076|NCT01986933|27079560|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1|||
13498077|NCT01986933|27079561|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0|||
13498078|NCT01986933|27079557|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
13498079|NCT01986933|27079558|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
13498080|NCT01986933|27079559|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
13498081|NCT01986933|27079560|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
13498082|NCT01986933|27079561|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2|||
13498083|NCT01986933|27079557|FG000|Active-to-active (Part B)|Adverse Event|0|||
13498084|NCT01986933|27079558|FG001|Active-to-active (Part B)|Adverse Event|2|||
13498085|NCT01986933|27079559|FG002|Active-to-active (Part B)|Adverse Event|0|||
13498086|NCT01986933|27079560|FG003|Active-to-active (Part B)|Adverse Event|1|||
13498087|NCT01986933|27079561|FG004|Active-to-active (Part B)|Adverse Event|3|||
13498088|NCT01986933|27079557|FG000|Active-to-active (Part B)|Lack of Efficacy|0|||
13498089|NCT01986933|27079558|FG001|Active-to-active (Part B)|Lack of Efficacy|3|||
13498090|NCT01986933|27079559|FG002|Active-to-active (Part B)|Lack of Efficacy|2|||
13498091|NCT01986933|27079560|FG003|Active-to-active (Part B)|Lack of Efficacy|0|||
13498092|NCT01986933|27079561|FG004|Active-to-active (Part B)|Lack of Efficacy|4|||
13498093|NCT01986933|27079557|FG000|Active-to-active (Part B)|Pregnancy|0|||
13498094|NCT01986933|27079558|FG001|Active-to-active (Part B)|Pregnancy|0|||
13498095|NCT01986933|27079559|FG002|Active-to-active (Part B)|Pregnancy|0|||
13498096|NCT01986933|27079560|FG003|Active-to-active (Part B)|Pregnancy|0|||
13498097|NCT01986933|27079561|FG004|Active-to-active (Part B)|Pregnancy|1|||
13498098|NCT01986933|27079557|FG000|Active-to-active (Part B)|Physician Decision|0|||
13498099|NCT01986933|27079558|FG001|Active-to-active (Part B)|Physician Decision|0|||
13498100|NCT01986933|27079559|FG002|Active-to-active (Part B)|Physician Decision|1|||
13498101|NCT01986933|27079560|FG003|Active-to-active (Part B)|Physician Decision|1|||
13498102|NCT01986933|27079561|FG004|Active-to-active (Part B)|Physician Decision|0|||
13498103|NCT01986933|27079557|FG000|Active-to-active (Part B)|Withdrawal by Subject|0|||
13498104|NCT01986933|27079558|FG001|Active-to-active (Part B)|Withdrawal by Subject|4|||
13498105|NCT01986933|27079559|FG002|Active-to-active (Part B)|Withdrawal by Subject|7|||
13498106|NCT01986933|27079560|FG003|Active-to-active (Part B)|Withdrawal by Subject|6|||
13498107|NCT01986933|27079561|FG004|Active-to-active (Part B)|Withdrawal by Subject|6|||
13498108|NCT01986933|27079557|FG000|Active-to-active (Part B)|Lost to Follow-up|0|||
13498109|NCT01986933|27079558|FG001|Active-to-active (Part B)|Lost to Follow-up|0|||
13498110|NCT01986933|27079559|FG002|Active-to-active (Part B)|Lost to Follow-up|0|||
13498111|NCT01986933|27079560|FG003|Active-to-active (Part B)|Lost to Follow-up|0|||
13498112|NCT01986933|27079561|FG004|Active-to-active (Part B)|Lost to Follow-up|1|||
13498113|NCT01986933|27079557|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0|||
13498114|NCT01986933|27079558|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1|||
13498115|NCT01986933|27079559|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0|||
13498116|NCT01986933|27079560|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1|||
13498117|NCT01986933|27079561|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1|||
13498118|NCT01986933|27079557|FG000|Placebo-to-active (Part B)|Adverse Event|0|||
13498119|NCT01986933|27079558|FG001|Placebo-to-active (Part B)|Adverse Event|1|||
13498120|NCT01986933|27079559|FG002|Placebo-to-active (Part B)|Adverse Event|0|||
13498121|NCT01986933|27079560|FG003|Placebo-to-active (Part B)|Adverse Event|1|||
13498122|NCT01986933|27079561|FG004|Placebo-to-active (Part B)|Adverse Event|0|||
13498123|NCT01986933|27079557|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0|||
13498124|NCT01986933|27079558|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0|||
13498125|NCT01986933|27079559|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0|||
13498126|NCT01986933|27079560|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1|||
13498127|NCT01986933|27079561|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0|||
13498128|NCT01986933|27079557|FG000|Placebo-to-active (Part B)|Protocol Violation|0|||
13498129|NCT01986933|27079558|FG001|Placebo-to-active (Part B)|Protocol Violation|0|||
13498130|NCT01986933|27079559|FG002|Placebo-to-active (Part B)|Protocol Violation|1|||
13498131|NCT01986933|27079560|FG003|Placebo-to-active (Part B)|Protocol Violation|0|||
13498132|NCT01986933|27079561|FG004|Placebo-to-active (Part B)|Protocol Violation|0|||
13498133|NCT01986933|27079557|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
13498134|NCT01986933|27079558|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
13498135|NCT01986933|27079559|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4|||
13498136|NCT01986933|27079560|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
13498137|NCT01986933|27079561|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
13498138|NCT01986933|27079557|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0|||
13498139|NCT01986933|27079558|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1|||
13498140|NCT01986933|27079559|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0|||
13498141|NCT01986933|27079560|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0|||
13498142|NCT01986933|27079561|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0|||
13498143|NCT00710970|27079739|FG000|Overall Study|Never took drug|3|||
13498144|NCT00685919|27079790|FG000|Overall Study|Withdrawal by Subject|0|||
13498145|NCT00685919|27079791|FG001|Overall Study|Withdrawal by Subject|0|||
13498146|NCT00685919|27079792|FG002|Overall Study|Withdrawal by Subject|1|||
13498147|NCT00685919|27079793|FG003|Overall Study|Withdrawal by Subject|0|||
13498148|NCT00685919|27079790|FG000|Overall Study|Physician Decision|1|||
13498149|NCT00685919|27079791|FG001|Overall Study|Physician Decision|0|||
13498150|NCT00685919|27079792|FG002|Overall Study|Physician Decision|0|||
13498151|NCT00685919|27079793|FG003|Overall Study|Physician Decision|0|||
13498152|NCT00344487|27079802|FG000|Overall Study|immunologic failure|1|||
13498153|NCT00281658|27079843|FG000|Randomized Phase|Adverse Event|0|||
13498154|NCT00281658|27079844|FG001|Randomized Phase|Adverse Event|2|||
13498155|NCT00281658|27079845|FG002|Randomized Phase|Adverse Event|0|||
13498156|NCT00281658|27079846|FG003|Randomized Phase|Adverse Event|0|||
13498157|NCT00281658|27079843|FG000|Randomized Phase|Lost to Follow-up|34|||
13498158|NCT00281658|27079844|FG001|Randomized Phase|Lost to Follow-up|27|||
13498159|NCT00281658|27079845|FG002|Randomized Phase|Lost to Follow-up|0|||
13498160|NCT00281658|27079846|FG003|Randomized Phase|Lost to Follow-up|0|||
13498161|NCT00281658|27079843|FG000|Randomized Phase|Withdrawal by Subject|8|||
13498162|NCT00281658|27079844|FG001|Randomized Phase|Withdrawal by Subject|7|||
13498163|NCT00281658|27079845|FG002|Randomized Phase|Withdrawal by Subject|0|||
13498164|NCT00281658|27079846|FG003|Randomized Phase|Withdrawal by Subject|0|||
13498165|NCT00281658|27079843|FG000|Randomized Phase|Study closed/terminated|1|||
13498166|NCT00281658|27079844|FG001|Randomized Phase|Study closed/terminated|1|||
13498167|NCT00281658|27079845|FG002|Randomized Phase|Study closed/terminated|0|||
13498168|NCT00281658|27079846|FG003|Randomized Phase|Study closed/terminated|0|||
13498169|NCT00281658|27079843|FG000|Randomized Phase|Disease progression|36|||
13498170|NCT00281658|27079844|FG001|Randomized Phase|Disease progression|27|||
13498171|NCT00281658|27079845|FG002|Randomized Phase|Disease progression|0|||
13498172|NCT00281658|27079846|FG003|Randomized Phase|Disease progression|0|||
13498173|NCT00281658|27079843|FG000|Randomized Phase|Physician Decision|1|||
13498174|NCT00281658|27079844|FG001|Randomized Phase|Physician Decision|1|||
13498175|NCT00281658|27079845|FG002|Randomized Phase|Physician Decision|0|||
13498176|NCT00281658|27079846|FG003|Randomized Phase|Physician Decision|0|||
13498177|NCT00281658|27079843|FG000|Randomized Phase|Other reasons as defined per protocol|4|||
13498178|NCT00281658|27079844|FG001|Randomized Phase|Other reasons as defined per protocol|3|||
13498179|NCT00281658|27079845|FG002|Randomized Phase|Other reasons as defined per protocol|0|||
13498180|NCT00281658|27079846|FG003|Randomized Phase|Other reasons as defined per protocol|0|||
13498181|NCT00281658|27079843|FG000|Randomized Phase|Reason for withdrawal unspecified|4|||
13498182|NCT00281658|27079844|FG001|Randomized Phase|Reason for withdrawal unspecified|5|||
13498183|NCT00281658|27079845|FG002|Randomized Phase|Reason for withdrawal unspecified|0|||
13498184|NCT00281658|27079846|FG003|Randomized Phase|Reason for withdrawal unspecified|0|||
13498185|NCT00281658|27079843|FG000|Randomized Phase|Treatment ongoing|1|||
13498186|NCT00281658|27079844|FG001|Randomized Phase|Treatment ongoing|0|||
13498187|NCT00281658|27079845|FG002|Randomized Phase|Treatment ongoing|0|||
13498188|NCT00281658|27079846|FG003|Randomized Phase|Treatment ongoing|0|||
13498189|NCT00281658|27079843|FG000|Open Label Phase|Adverse Event|0|||
13498190|NCT00281658|27079844|FG001|Open Label Phase|Adverse Event|0|||
13498191|NCT00281658|27079845|FG002|Open Label Phase|Adverse Event|1|||
13498192|NCT00281658|27079846|FG003|Open Label Phase|Adverse Event|0|||
13498193|NCT00281658|27079843|FG000|Open Label Phase|Lost to Follow-up|0|||
13498194|NCT00281658|27079844|FG001|Open Label Phase|Lost to Follow-up|0|||
13498195|NCT00281658|27079845|FG002|Open Label Phase|Lost to Follow-up|16|||
13133835|NCT02763215|25989277|FG000|Overall Study|Visit outside visit-window|1|||
13133836|NCT02763215|25989277|FG000|Overall Study|Death|1|||
13133837|NCT02763215|25989277|FG000|Overall Study|Lost to Follow-up|1|||
13133838|NCT02763046|25989314|FG000|Overall Study|Adverse Event|5|||
13133839|NCT02763046|25989315|FG001|Overall Study|Adverse Event|4|||
13133840|NCT02763046|25989316|FG002|Overall Study|Adverse Event|0|||
13133841|NCT02763046|25989314|FG000|Overall Study|Lack of Efficacy|1|||
13133842|NCT02763046|25989315|FG001|Overall Study|Lack of Efficacy|1|||
13133843|NCT02763046|25989316|FG002|Overall Study|Lack of Efficacy|3|||
13133844|NCT02763046|25989314|FG000|Overall Study|Physician Decision|1|||
13133845|NCT02763046|25989315|FG001|Overall Study|Physician Decision|0|||
13133846|NCT02763046|25989316|FG002|Overall Study|Physician Decision|1|||
13133847|NCT02763046|25989314|FG000|Overall Study|Subject/guardian decision|2|||
13133848|NCT02763046|25989315|FG001|Overall Study|Subject/guardian decision|0|||
13133849|NCT02763046|25989316|FG002|Overall Study|Subject/guardian decision|4|||
13133850|NCT02762994|25989391|FG000|Overall Study|Withdrawal by Subject|0|||
13133851|NCT02762994|25989392|FG001|Overall Study|Withdrawal by Subject|1|||
13133852|NCT02762994|25989393|FG002|Overall Study|Withdrawal by Subject|2|||
13133853|NCT02762994|25989394|FG003|Overall Study|Withdrawal by Subject|0|||
13133854|NCT02762994|25989391|FG000|Overall Study|Protocol Violation|1|||
13133855|NCT02762994|25989392|FG001|Overall Study|Protocol Violation|0|||
13133856|NCT02762994|25989393|FG002|Overall Study|Protocol Violation|0|||
13133857|NCT02762994|25989394|FG003|Overall Study|Protocol Violation|2|||
13133858|NCT02762708|25989425|FG000|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
13133859|NCT02762708|25989426|FG001|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|2|||
13133860|NCT02762708|25989427|FG002|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
13133861|NCT02762708|25989428|FG003|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
13133862|NCT02762578|25989535|FG000|Overall Study|Adverse Event|1|||
13133863|NCT02762578|25989536|FG001|Overall Study|Adverse Event|6|||
13133864|NCT02762578|25989535|FG000|Overall Study|Protocol Violation|4|||
13133865|NCT02762578|25989536|FG001|Overall Study|Protocol Violation|2|||
13133866|NCT02762578|25989535|FG000|Overall Study|Withdrawal by Subject|4|||
13133867|NCT02762578|25989536|FG001|Overall Study|Withdrawal by Subject|2|||
13133868|NCT02762578|25989535|FG000|Overall Study|Unclassified|6|||
13133869|NCT02762578|25989536|FG001|Overall Study|Unclassified|0|||
13133870|NCT02762565|25989544|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11|||
13133871|NCT02762500|25989569|FG000|Overall Study|Lack of Efficacy|1|||
13133872|NCT02762500|25989570|FG001|Overall Study|Lack of Efficacy|0|||
13133873|NCT02762500|25989569|FG000|Overall Study|Withdrawal by Subject|1|||
13133874|NCT02762500|25989570|FG001|Overall Study|Withdrawal by Subject|1|||
13133875|NCT02762500|25989569|FG000|Overall Study|Adverse Event|0|||
13133876|NCT02762500|25989570|FG001|Overall Study|Adverse Event|2|||
13133877|NCT02762370|25989595|FG000|Overall Study|Protocol Violation|1|||
13133878|NCT02762370|25989596|FG001|Overall Study|Protocol Violation|0|||
13133879|NCT02762084|25989644|FG000|Overall Study|Withdrawal by Subject|1|||
13133880|NCT02762084|25989645|FG001|Overall Study|Withdrawal by Subject|0|||
13133881|NCT02762084|25989646|FG002|Overall Study|Withdrawal by Subject|0|||
13133882|NCT02762084|25989644|FG000|Overall Study|Adverse Event|0|||
13133883|NCT02762084|25989645|FG001|Overall Study|Adverse Event|0|||
13133884|NCT02762084|25989646|FG002|Overall Study|Adverse Event|1|||
13133885|NCT02761993|25989670|FG000|Overall Study|Adverse Event|0|||
13133886|NCT02761993|25989671|FG001|Overall Study|Adverse Event|2|||
13133887|NCT02761993|25989672|FG002|Overall Study|Adverse Event|0|||
13133888|NCT02761993|25989670|FG000|Overall Study|Lost to Follow-up|1|||
13133889|NCT02761993|25989671|FG001|Overall Study|Lost to Follow-up|3|||
13133890|NCT02761993|25989672|FG002|Overall Study|Lost to Follow-up|2|||
13133891|NCT02761993|25989670|FG000|Overall Study|Withdrawal by Subject|1|||
13133892|NCT02761993|25989671|FG001|Overall Study|Withdrawal by Subject|1|||
13133893|NCT02761993|25989672|FG002|Overall Study|Withdrawal by Subject|2|||
13498196|NCT00281658|27079846|FG003|Open Label Phase|Lost to Follow-up|2|||
13498197|NCT00281658|27079843|FG000|Open Label Phase|Withdrawal by Subject|0|||
13498198|NCT00281658|27079844|FG001|Open Label Phase|Withdrawal by Subject|0|||
13498199|NCT00281658|27079845|FG002|Open Label Phase|Withdrawal by Subject|3|||
13498200|NCT00281658|27079846|FG003|Open Label Phase|Withdrawal by Subject|2|||
13498201|NCT00281658|27079843|FG000|Open Label Phase|Disease progression|0|||
13498202|NCT00281658|27079844|FG001|Open Label Phase|Disease progression|0|||
13498203|NCT00281658|27079845|FG002|Open Label Phase|Disease progression|18|||
13498204|NCT00281658|27079846|FG003|Open Label Phase|Disease progression|0|||
13498205|NCT00281658|27079843|FG000|Open Label Phase|Physician Decision|0|||
13498206|NCT00281658|27079844|FG001|Open Label Phase|Physician Decision|0|||
13498207|NCT00281658|27079845|FG002|Open Label Phase|Physician Decision|1|||
13498208|NCT00281658|27079846|FG003|Open Label Phase|Physician Decision|0|||
13498209|NCT00281658|27079843|FG000|Open Label Phase|Relocation of patient|0|||
13498210|NCT00281658|27079844|FG001|Open Label Phase|Relocation of patient|0|||
13498211|NCT00281658|27079845|FG002|Open Label Phase|Relocation of patient|1|||
13498212|NCT00281658|27079846|FG003|Open Label Phase|Relocation of patient|0|||
13498213|NCT00281658|27079843|FG000|Open Label Phase|Reason for withdrawal unspecified|0|||
13498214|NCT00281658|27079844|FG001|Open Label Phase|Reason for withdrawal unspecified|0|||
13498215|NCT00281658|27079845|FG002|Open Label Phase|Reason for withdrawal unspecified|5|||
13498216|NCT00281658|27079846|FG003|Open Label Phase|Reason for withdrawal unspecified|0|||
13498217|NCT04034355|27079951|FG000|Overall Study|Study terminated by Sponsor|10|||
13498218|NCT04034355|27079952|FG001|Overall Study|Study terminated by Sponsor|17|||
13498219|NCT04034355|27079951|FG000|Overall Study|Withdrawal by Subject|12|||
13498220|NCT04034355|27079952|FG001|Overall Study|Withdrawal by Subject|11|||
13498221|NCT04034355|27079951|FG000|Overall Study|Site terminated by Sponsor|4|||
13498222|NCT04034355|27079952|FG001|Overall Study|Site terminated by Sponsor|5|||
13498223|NCT04034355|27079951|FG000|Overall Study|Adverse Event|2|||
13498224|NCT04034355|27079952|FG001|Overall Study|Adverse Event|0|||
13498225|NCT04034355|27079951|FG000|Overall Study|Death|1|||
13498226|NCT04034355|27079952|FG001|Overall Study|Death|1|||
13498227|NCT04034355|27079951|FG000|Overall Study|Not reported|2|||
13498228|NCT04034355|27079952|FG001|Overall Study|Not reported|0|||
13498229|NCT04034355|27079951|FG000|Overall Study|Lost to Follow-up|1|||
13498230|NCT04034355|27079952|FG001|Overall Study|Lost to Follow-up|0|||
13498231|NCT04034355|27079951|FG000|Overall Study|Physician Decision|1|||
13498232|NCT04034355|27079952|FG001|Overall Study|Physician Decision|0|||
13498233|NCT04034355|27079951|FG000|Overall Study|Protocol Violation|0|||
13498234|NCT04034355|27079952|FG001|Overall Study|Protocol Violation|1|||
13498235|NCT04034355|27079951|FG000|Overall Study|Progressive disease|1|||
13498236|NCT04034355|27079952|FG001|Overall Study|Progressive disease|0|||
13498237|NCT03721276|27079997|FG000|Overall Study|Lost to Follow-up|5|||
13498238|NCT03721276|27079998|FG001|Overall Study|Lost to Follow-up|3|||
13498239|NCT03721276|27079997|FG000|Overall Study|Adverse Event|0|||
13498240|NCT03721276|27079998|FG001|Overall Study|Adverse Event|1|||
13498241|NCT03637491|27080095|FG000|Overall Study|Death|9|||
13498242|NCT03637491|27080096|FG001|Overall Study|Death|9|||
13498243|NCT03637491|27080097|FG002|Overall Study|Death|5|||
13498244|NCT03637491|27080098|FG003|Overall Study|Death|3|||
13498245|NCT03637491|27080095|FG000|Overall Study|Lost to Follow-up|0|||
13498246|NCT03637491|27080096|FG001|Overall Study|Lost to Follow-up|1|||
13498247|NCT03637491|27080097|FG002|Overall Study|Lost to Follow-up|0|||
13498248|NCT03637491|27080098|FG003|Overall Study|Lost to Follow-up|1|||
13498249|NCT03637491|27080095|FG000|Overall Study|Study Terminated By Sponsor|0|||
13498250|NCT03637491|27080096|FG001|Overall Study|Study Terminated By Sponsor|2|||
13498251|NCT03637491|27080097|FG002|Overall Study|Study Terminated By Sponsor|1|||
13498252|NCT03637491|27080098|FG003|Overall Study|Study Terminated By Sponsor|0|||
13498253|NCT03637491|27080095|FG000|Overall Study|Withdrawal by Subject|1|||
13498254|NCT03637491|27080096|FG001|Overall Study|Withdrawal by Subject|0|||
13498255|NCT03637491|27080097|FG002|Overall Study|Withdrawal by Subject|1|||
13498256|NCT03637491|27080098|FG003|Overall Study|Withdrawal by Subject|2|||
13498257|NCT03334539|27080577|FG000|Overall Study|Adverse Event|3|||
13498258|NCT03334539|27080578|FG001|Overall Study|Adverse Event|5|||
13498259|NCT03334539|27080579|FG002|Overall Study|Adverse Event|0|||
13498260|NCT03334539|27080577|FG000|Overall Study|Withdrawal by Subject|0|||
13498261|NCT03334539|27080578|FG001|Overall Study|Withdrawal by Subject|1|||
13498262|NCT03334539|27080579|FG002|Overall Study|Withdrawal by Subject|1|||
13498263|NCT03334539|27080577|FG000|Overall Study|Administrative Reasons|1|||
13498264|NCT03334539|27080578|FG001|Overall Study|Administrative Reasons|0|||
13498265|NCT03334539|27080579|FG002|Overall Study|Administrative Reasons|0|||
13498266|NCT03334539|27080577|FG000|Overall Study|Hypertension Not Controlled|0|||
13498267|NCT03334539|27080578|FG001|Overall Study|Hypertension Not Controlled|1|||
13498268|NCT03334539|27080579|FG002|Overall Study|Hypertension Not Controlled|0|||
13498269|NCT03269344|27080620|FG000|Overall Study|Protocol Violation|4|||
13498270|NCT03269344|27080621|FG001|Overall Study|Protocol Violation|3|||
13498271|NCT03076775|27080683|FG000|Overall Study|Lost to Follow-up|1|||
13498272|NCT03076775|27080684|FG001|Overall Study|Lost to Follow-up|0|||
13498273|NCT02660827|27080783|FG000|From Study to End of Continued Access|Withdrawal by Subject|21|||
13498274|NCT02660827|27080783|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2|||
13498275|NCT02660827|27080783|FG000|From Study to End of Continued Access|Adverse Event|3|||
13498276|NCT02660827|27080783|FG000|From Study to End of Continued Access|didn't participate continued access period|5|||
13498277|NCT02660827|27080783|FG000|Period 1: Study Period|Withdrawal by Subject|1|||
13498278|NCT02660827|27080783|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20|||
13498279|NCT02660827|27080783|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2|||
13498280|NCT02660827|27080783|FG000|Period 2: Continued Access Period|Adverse Event|3|||
13498281|NCT02054104|27080824|FG000|Overall Study|Did not want to continue due to college classes|1|||
13498282|NCT02054104|27080825|FG001|Overall Study|Did not want to continue due to college classes|0|||
13498283|NCT02054104|27080824|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1|||
13498284|NCT02054104|27080825|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0|||
13498285|NCT02054104|27080824|FG000|Overall Study|No evidence of immunologic response|2|||
13498286|NCT02054104|27080825|FG001|Overall Study|No evidence of immunologic response|2|||
13498287|NCT02054104|27080824|FG000|Overall Study|Disease Progression On Study|4|||
13498288|NCT02054104|27080825|FG001|Overall Study|Disease Progression On Study|5|||
13498289|NCT02054104|27080824|FG000|Overall Study|Diagnosis of lymphoma|0|||
13498290|NCT02054104|27080825|FG001|Overall Study|Diagnosis of lymphoma|1|||
13498291|NCT02054104|27080824|FG000|Overall Study|Inconclusive response|0|||
13498292|NCT02054104|27080825|FG001|Overall Study|Inconclusive response|1|||
13498293|NCT01757665|27080981|FG000|Overall Study|Still on Study - Visit Completed|240|||
13498294|NCT01757665|27080982|FG001|Overall Study|Still on Study - Visit Completed|30|||
13498295|NCT01757665|27080981|FG000|Overall Study|Still on Study - Visit Pending|398|||
13498296|NCT01757665|27080982|FG001|Overall Study|Still on Study - Visit Pending|40|||
13498297|NCT01757665|27080981|FG000|Overall Study|Still on Study - Missed Visit|14|||
13498298|NCT01757665|27080982|FG001|Overall Study|Still on Study - Missed Visit|1|||
13498299|NCT01757665|27080981|FG000|Overall Study|Death|25|||
13498300|NCT01757665|27080982|FG001|Overall Study|Death|8|||
13498301|NCT01757665|27080981|FG000|Overall Study|Explant|1|||
13498302|NCT01757665|27080982|FG001|Overall Study|Explant|2|||
13498303|NCT01757665|27080981|FG000|Overall Study|Withdrawal by Subject|10|||
13498304|NCT01757665|27080982|FG001|Overall Study|Withdrawal by Subject|0|||
13498305|NCT01757665|27080981|FG000|Overall Study|Lost to Follow-up|1|||
13498306|NCT01757665|27080982|FG001|Overall Study|Lost to Follow-up|1|||
13498307|NCT01757665|27080981|FG000|Overall Study|Not Implanted with Device|5|||
13498308|NCT01757665|27080982|FG001|Overall Study|Not Implanted with Device|1|||
13498309|NCT00603954|27081085|FG000|Overall Study|Protocol Violation|1|||
13498310|NCT00603954|27081086|FG001|Overall Study|Protocol Violation|2|||
13498311|NCT04532294|27081135|FG000|Overall Study|Withdrawal by Subject|0|||
13498312|NCT04532294|27081136|FG001|Overall Study|Withdrawal by Subject|0|||
13498313|NCT04532294|27081137|FG002|Overall Study|Withdrawal by Subject|1|||
13498314|NCT04532294|27081135|FG000|Overall Study|Participants Not Dosed|0|||
13498315|NCT04532294|27081136|FG001|Overall Study|Participants Not Dosed|0|||
13498316|NCT04532294|27081137|FG002|Overall Study|Participants Not Dosed|2|||
13498317|NCT04250077|27081176|FG000|Overall Study|Withdrawal by Subject|0|||
13498318|NCT04250077|27081177|FG001|Overall Study|Withdrawal by Subject|1|||
13498319|NCT04250077|27081178|FG002|Overall Study|Withdrawal by Subject|0|||
13498320|NCT04250077|27081176|FG000|Overall Study|Lost to Follow-up|2|||
13498321|NCT04250077|27081177|FG001|Overall Study|Lost to Follow-up|3|||
13498322|NCT04250077|27081178|FG002|Overall Study|Lost to Follow-up|0|||
13498323|NCT03505710|27081345|FG000|Overall Study|Progressive Disease|22|||
13498324|NCT03505710|27081346|FG001|Overall Study|Progressive Disease|9|||
13498325|NCT03505710|27081347|FG002|Overall Study|Progressive Disease|34|||
13498326|NCT03505710|27081345|FG000|Overall Study|Clinical Progression|6|||
13498327|NCT03505710|27081346|FG001|Overall Study|Clinical Progression|6|||
13498328|NCT03505710|27081347|FG002|Overall Study|Clinical Progression|3|||
13498329|NCT03505710|27081345|FG000|Overall Study|Adverse Event|12|||
13498330|NCT03505710|27081346|FG001|Overall Study|Adverse Event|5|||
13498331|NCT03505710|27081347|FG002|Overall Study|Adverse Event|27|||
13498332|NCT03505710|27081345|FG000|Overall Study|Withdrawal by Subject|1|||
13498333|NCT03505710|27081346|FG001|Overall Study|Withdrawal by Subject|3|||
13498334|NCT03505710|27081347|FG002|Overall Study|Withdrawal by Subject|3|||
13498335|NCT03505710|27081345|FG000|Overall Study|Physician Decision|1|||
13498336|NCT03505710|27081346|FG001|Overall Study|Physician Decision|0|||
13498337|NCT03505710|27081347|FG002|Overall Study|Physician Decision|2|||
13498338|NCT03505710|27081345|FG000|Overall Study|Death|4|||
13498339|NCT03505710|27081346|FG001|Overall Study|Death|3|||
13498340|NCT03505710|27081347|FG002|Overall Study|Death|6|||
13498341|NCT03505710|27081345|FG000|Overall Study|Other Reasons|1|||
13498342|NCT03505710|27081346|FG001|Overall Study|Other Reasons|1|||
13498343|NCT03505710|27081347|FG002|Overall Study|Other Reasons|1|||
13498344|NCT03296553|27081360|FG000|Overall Study|Withdrawal by Subject|1|||
13498345|NCT03296553|27081361|FG001|Overall Study|Withdrawal by Subject|1|||
13498346|NCT03296553|27081360|FG000|Overall Study|Death|1|||
13498347|NCT03296553|27081361|FG001|Overall Study|Death|0|||
13498348|NCT03000569|27081500|FG000|Overall Study|Withdrawal by Subject|1|||
13498349|NCT03000569|27081501|FG001|Overall Study|Withdrawal by Subject|0|||
13498350|NCT03000530|27081709|FG000|Overall Study|Adverse Event|0|||
13498351|NCT03000530|27081710|FG001|Overall Study|Adverse Event|0|||
13498352|NCT03000530|27081711|FG002|Overall Study|Adverse Event|2|||
13498353|NCT03000530|27081709|FG000|Overall Study|Lost to Follow-up|0|||
13498354|NCT03000530|27081710|FG001|Overall Study|Lost to Follow-up|3|||
13498355|NCT03000530|27081711|FG002|Overall Study|Lost to Follow-up|1|||
13498356|NCT03000530|27081709|FG000|Overall Study|Withdrawal by Subject|0|||
13498357|NCT03000530|27081710|FG001|Overall Study|Withdrawal by Subject|2|||
13498358|NCT03000530|27081711|FG002|Overall Study|Withdrawal by Subject|1|||
13498359|NCT02978781|27081791|FG000|Part A|Adverse Event|1|||
13498360|NCT02978781|27081792|FG001|Part A|Adverse Event|1|||
13498361|NCT02978781|27081793|FG002|Part A|Adverse Event|0|||
13498362|NCT02978781|27081794|FG003|Part A|Adverse Event|0|||
13498363|NCT02978781|27081795|FG004|Part A|Adverse Event|0|||
13498364|NCT02978781|27081791|FG000|Part A|Withdrawal by Subject|0|||
13498365|NCT02978781|27081792|FG001|Part A|Withdrawal by Subject|1|||
13498366|NCT02978781|27081793|FG002|Part A|Withdrawal by Subject|0|||
13498367|NCT02978781|27081794|FG003|Part A|Withdrawal by Subject|0|||
13498368|NCT02978781|27081795|FG004|Part A|Withdrawal by Subject|0|||
13498369|NCT02978781|27081791|FG000|Part B|Withdrawal by Subject|0|||
13498370|NCT02978781|27081792|FG001|Part B|Withdrawal by Subject|0|||
13498371|NCT02978781|27081793|FG002|Part B|Withdrawal by Subject|0|||
13498372|NCT02978781|27081794|FG003|Part B|Withdrawal by Subject|1|||
13498373|NCT02978781|27081795|FG004|Part B|Withdrawal by Subject|0|||
13498374|NCT02978781|27081791|FG000|Part C|Adverse Event|0|||
13498375|NCT02978781|27081792|FG001|Part C|Adverse Event|0|||
13498376|NCT02978781|27081793|FG002|Part C|Adverse Event|0|||
13498377|NCT02978781|27081794|FG003|Part C|Adverse Event|0|||
13498378|NCT02978781|27081795|FG004|Part C|Adverse Event|2|||
13498379|NCT02978781|27081791|FG000|Part C|Withdrawal by Subject|0|||
13498380|NCT02978781|27081792|FG001|Part C|Withdrawal by Subject|0|||
13498381|NCT02978781|27081793|FG002|Part C|Withdrawal by Subject|0|||
13498382|NCT02978781|27081794|FG003|Part C|Withdrawal by Subject|0|||
13498383|NCT02978781|27081795|FG004|Part C|Withdrawal by Subject|1|||
13498384|NCT02978781|27081791|FG000|Part C|Tremor not improved due to Topamax discontinuation|0|||
13498385|NCT02978781|27081792|FG001|Part C|Tremor not improved due to Topamax discontinuation|0|||
13498386|NCT02978781|27081793|FG002|Part C|Tremor not improved due to Topamax discontinuation|0|||
13498387|NCT02978781|27081794|FG003|Part C|Tremor not improved due to Topamax discontinuation|0|||
13498388|NCT02978781|27081795|FG004|Part C|Tremor not improved due to Topamax discontinuation|1|||
13498389|NCT02964507|27081908|FG000|Overall Study|Protocol specified Withdrawal criteria met|0|||
13498390|NCT02964507|27081909|FG001|Overall Study|Protocol specified Withdrawal criteria met|1|||
13498391|NCT02964507|27081910|FG002|Overall Study|Protocol specified Withdrawal criteria met|0|||
13498392|NCT02964507|27081911|FG003|Overall Study|Protocol specified Withdrawal criteria met|0|||
13498393|NCT02964507|27081912|FG004|Overall Study|Protocol specified Withdrawal criteria met|1|||
13498394|NCT02964507|27081913|FG005|Overall Study|Protocol specified Withdrawal criteria met|0|||
13498395|NCT02964507|27081914|FG006|Overall Study|Protocol specified Withdrawal criteria met|0|||
13498396|NCT02964507|27081915|FG007|Overall Study|Protocol specified Withdrawal criteria met|0|||
13498397|NCT02964507|27081908|FG000|Overall Study|Ongoing at the time of analysis|1|||
13498398|NCT02964507|27081909|FG001|Overall Study|Ongoing at the time of analysis|0|||
13498399|NCT02964507|27081910|FG002|Overall Study|Ongoing at the time of analysis|2|||
13498400|NCT02964507|27081911|FG003|Overall Study|Ongoing at the time of analysis|0|||
13498401|NCT02964507|27081912|FG004|Overall Study|Ongoing at the time of analysis|0|||
13498402|NCT02964507|27081913|FG005|Overall Study|Ongoing at the time of analysis|0|||
13498403|NCT02964507|27081914|FG006|Overall Study|Ongoing at the time of analysis|0|||
13498404|NCT02964507|27081915|FG007|Overall Study|Ongoing at the time of analysis|0|||
13498405|NCT02964507|27081908|FG000|Overall Study|Study terminated by Sponsor|9|||
13498406|NCT02964507|27081909|FG001|Overall Study|Study terminated by Sponsor|1|||
13498407|NCT02964507|27081910|FG002|Overall Study|Study terminated by Sponsor|9|||
13498408|NCT02964507|27081911|FG003|Overall Study|Study terminated by Sponsor|3|||
13498409|NCT02964507|27081912|FG004|Overall Study|Study terminated by Sponsor|3|||
13498410|NCT02964507|27081913|FG005|Overall Study|Study terminated by Sponsor|2|||
13498411|NCT02964507|27081914|FG006|Overall Study|Study terminated by Sponsor|0|||
13498412|NCT02964507|27081915|FG007|Overall Study|Study terminated by Sponsor|0|||
13498413|NCT02964507|27081908|FG000|Overall Study|Other|3|||
13498414|NCT02964507|27081909|FG001|Overall Study|Other|0|||
13498415|NCT02964507|27081910|FG002|Overall Study|Other|0|||
13498416|NCT02964507|27081911|FG003|Overall Study|Other|0|||
13498417|NCT02964507|27081912|FG004|Overall Study|Other|1|||
13498418|NCT02964507|27081913|FG005|Overall Study|Other|0|||
13498419|NCT02964507|27081914|FG006|Overall Study|Other|0|||
13498420|NCT02964507|27081915|FG007|Overall Study|Other|0|||
13498421|NCT02964507|27081908|FG000|Overall Study|Death|11|||
13498422|NCT02964507|27081909|FG001|Overall Study|Death|9|||
13498423|NCT02964507|27081910|FG002|Overall Study|Death|12|||
13498424|NCT02964507|27081911|FG003|Overall Study|Death|2|||
13498425|NCT02964507|27081912|FG004|Overall Study|Death|10|||
13498426|NCT02964507|27081913|FG005|Overall Study|Death|5|||
13498427|NCT02964507|27081914|FG006|Overall Study|Death|0|||
13498428|NCT02964507|27081915|FG007|Overall Study|Death|0|||
13498429|NCT02964507|27081908|FG000|Overall Study|Withdrawal by Subject|1|||
13498430|NCT02964507|27081909|FG001|Overall Study|Withdrawal by Subject|0|||
13498431|NCT02964507|27081910|FG002|Overall Study|Withdrawal by Subject|1|||
13498432|NCT02964507|27081911|FG003|Overall Study|Withdrawal by Subject|1|||
13498433|NCT02964507|27081912|FG004|Overall Study|Withdrawal by Subject|0|||
13498434|NCT02964507|27081913|FG005|Overall Study|Withdrawal by Subject|1|||
13498435|NCT02964507|27081914|FG006|Overall Study|Withdrawal by Subject|0|||
13498436|NCT02964507|27081915|FG007|Overall Study|Withdrawal by Subject|0|||
13498437|NCT02964507|27081908|FG000|Overall Study|Physician Decision|1|||
13498438|NCT02964507|27081909|FG001|Overall Study|Physician Decision|0|||
13498439|NCT02964507|27081910|FG002|Overall Study|Physician Decision|1|||
13498440|NCT02964507|27081911|FG003|Overall Study|Physician Decision|0|||
13498441|NCT02964507|27081912|FG004|Overall Study|Physician Decision|1|||
13498442|NCT02964507|27081913|FG005|Overall Study|Physician Decision|0|||
13498443|NCT02964507|27081914|FG006|Overall Study|Physician Decision|0|||
13498444|NCT02964507|27081915|FG007|Overall Study|Physician Decision|0|||
13498445|NCT02942277|27081976|FG000|Year 1|Withdrawal by Subject|0|||
13498446|NCT02942277|27081977|FG001|Year 1|Withdrawal by Subject|0|||
13498447|NCT02942277|27081978|FG002|Year 1|Withdrawal by Subject|0|||
13498448|NCT02942277|27081979|FG003|Year 1|Withdrawal by Subject|0|||
13498449|NCT02942277|27081980|FG004|Year 1|Withdrawal by Subject|1|||
13498450|NCT02942277|27081981|FG005|Year 1|Withdrawal by Subject|3|||
13498451|NCT02942277|27081982|FG006|Year 1|Withdrawal by Subject|0|||
13498452|NCT02942277|27081983|FG007|Year 1|Withdrawal by Subject|1|||
13498453|NCT02942277|27081984|FG008|Year 1|Withdrawal by Subject|0|||
13498454|NCT02942277|27081985|FG009|Year 1|Withdrawal by Subject|0|||
13498455|NCT02942277|27081986|FG010|Year 1|Withdrawal by Subject|3|||
13498456|NCT02942277|27081976|FG000|Year 1|Travel|0|||
13498457|NCT02942277|27081977|FG001|Year 1|Travel|1|||
13498458|NCT02942277|27081978|FG002|Year 1|Travel|0|||
13498459|NCT02942277|27081979|FG003|Year 1|Travel|0|||
13498460|NCT02942277|27081980|FG004|Year 1|Travel|4|||
13498461|NCT02942277|27081981|FG005|Year 1|Travel|5|||
13498462|NCT02942277|27081982|FG006|Year 1|Travel|0|||
13498463|NCT02942277|27081983|FG007|Year 1|Travel|0|||
13498464|NCT02942277|27081984|FG008|Year 1|Travel|0|||
13498465|NCT02942277|27081985|FG009|Year 1|Travel|0|||
13498466|NCT02942277|27081986|FG010|Year 1|Travel|8|||
13498467|NCT02942277|27081976|FG000|Year 1|Joined Army|0|||
13498468|NCT02942277|27081977|FG001|Year 1|Joined Army|1|||
13498469|NCT02942277|27081978|FG002|Year 1|Joined Army|0|||
13498470|NCT02942277|27081979|FG003|Year 1|Joined Army|0|||
13498471|NCT02942277|27081980|FG004|Year 1|Joined Army|0|||
13498472|NCT02942277|27081981|FG005|Year 1|Joined Army|0|||
13498473|NCT02942277|27081982|FG006|Year 1|Joined Army|0|||
13498474|NCT02942277|27081983|FG007|Year 1|Joined Army|0|||
13498475|NCT02942277|27081984|FG008|Year 1|Joined Army|0|||
13498476|NCT02942277|27081985|FG009|Year 1|Joined Army|0|||
13498477|NCT02942277|27081986|FG010|Year 1|Joined Army|0|||
13498478|NCT02942277|27081976|FG000|Year 1|Subject met withdrawal criteria|0|||
13208367|NCT01939158|26241440|FG001|Overall Study|Other|3|||
13208368|NCT01939158|26241441|FG002|Overall Study|Other|4|||
13208369|NCT01939158|26241442|FG003|Overall Study|Other|3|||
13208370|NCT01939028|26241455|FG000|Overall Study|Withdrawal by Subject|5|||
13208371|NCT01939028|26241455|FG000|Overall Study|Physician Decision|7|||
13208372|NCT01939002|26241528|FG000|Overall Study|Adverse Event|13|||
13498479|NCT02942277|27081977|FG001|Year 1|Subject met withdrawal criteria|0|||
13498480|NCT02942277|27081978|FG002|Year 1|Subject met withdrawal criteria|0|||
13498481|NCT02942277|27081979|FG003|Year 1|Subject met withdrawal criteria|1|||
13498482|NCT02942277|27081980|FG004|Year 1|Subject met withdrawal criteria|0|||
13498483|NCT02942277|27081981|FG005|Year 1|Subject met withdrawal criteria|0|||
13498484|NCT02942277|27081982|FG006|Year 1|Subject met withdrawal criteria|0|||
13498485|NCT02942277|27081983|FG007|Year 1|Subject met withdrawal criteria|0|||
13498486|NCT02942277|27081984|FG008|Year 1|Subject met withdrawal criteria|0|||
13498487|NCT02942277|27081985|FG009|Year 1|Subject met withdrawal criteria|0|||
13498488|NCT02942277|27081986|FG010|Year 1|Subject met withdrawal criteria|0|||
13498489|NCT02942277|27081976|FG000|Year 1|Lost to Follow-up|0|||
13498490|NCT02942277|27081977|FG001|Year 1|Lost to Follow-up|0|||
13498491|NCT02942277|27081978|FG002|Year 1|Lost to Follow-up|0|||
13498492|NCT02942277|27081979|FG003|Year 1|Lost to Follow-up|0|||
13498493|NCT02942277|27081980|FG004|Year 1|Lost to Follow-up|1|||
13498494|NCT02942277|27081981|FG005|Year 1|Lost to Follow-up|0|||
13498495|NCT02942277|27081982|FG006|Year 1|Lost to Follow-up|0|||
13498496|NCT02942277|27081983|FG007|Year 1|Lost to Follow-up|0|||
13498497|NCT02942277|27081984|FG008|Year 1|Lost to Follow-up|0|||
13498498|NCT02942277|27081985|FG009|Year 1|Lost to Follow-up|0|||
13498499|NCT02942277|27081986|FG010|Year 1|Lost to Follow-up|2|||
13498500|NCT02942277|27081976|FG000|Year 1|Protocol Violation|0|||
13498501|NCT02942277|27081977|FG001|Year 1|Protocol Violation|0|||
13498502|NCT02942277|27081978|FG002|Year 1|Protocol Violation|0|||
13498503|NCT02942277|27081979|FG003|Year 1|Protocol Violation|0|||
13498504|NCT02942277|27081980|FG004|Year 1|Protocol Violation|1|||
13498505|NCT02942277|27081981|FG005|Year 1|Protocol Violation|1|||
13498506|NCT02942277|27081982|FG006|Year 1|Protocol Violation|0|||
13498507|NCT02942277|27081983|FG007|Year 1|Protocol Violation|0|||
13498508|NCT02942277|27081984|FG008|Year 1|Protocol Violation|0|||
13498509|NCT02942277|27081985|FG009|Year 1|Protocol Violation|0|||
13498510|NCT02942277|27081986|FG010|Year 1|Protocol Violation|2|||
13498511|NCT02942277|27081976|FG000|Year 1|Pregnancy|0|||
13498512|NCT02942277|27081977|FG001|Year 1|Pregnancy|0|||
13498513|NCT02942277|27081978|FG002|Year 1|Pregnancy|0|||
13498514|NCT02942277|27081979|FG003|Year 1|Pregnancy|0|||
13498515|NCT02942277|27081980|FG004|Year 1|Pregnancy|0|||
13498516|NCT02942277|27081981|FG005|Year 1|Pregnancy|1|||
13498517|NCT02942277|27081982|FG006|Year 1|Pregnancy|0|||
13498518|NCT02942277|27081983|FG007|Year 1|Pregnancy|0|||
13498519|NCT02942277|27081984|FG008|Year 1|Pregnancy|0|||
13498520|NCT02942277|27081985|FG009|Year 1|Pregnancy|0|||
13498521|NCT02942277|27081986|FG010|Year 1|Pregnancy|0|||
13498522|NCT02942277|27081976|FG000|Year 2|Lost to Follow-up|0|||
13498523|NCT02942277|27081977|FG001|Year 2|Lost to Follow-up|0|||
13498524|NCT02942277|27081978|FG002|Year 2|Lost to Follow-up|0|||
13498525|NCT02942277|27081979|FG003|Year 2|Lost to Follow-up|0|||
13498526|NCT02942277|27081980|FG004|Year 2|Lost to Follow-up|2|||
13498527|NCT02942277|27081981|FG005|Year 2|Lost to Follow-up|1|||
13498528|NCT02942277|27081982|FG006|Year 2|Lost to Follow-up|0|||
13498529|NCT02942277|27081983|FG007|Year 2|Lost to Follow-up|0|||
13498530|NCT02942277|27081984|FG008|Year 2|Lost to Follow-up|0|||
13498531|NCT02942277|27081985|FG009|Year 2|Lost to Follow-up|0|||
13498532|NCT02942277|27081986|FG010|Year 2|Lost to Follow-up|0|||
13498533|NCT02942277|27081976|FG000|Year 2|Did not rescreen|0|||
13498534|NCT02942277|27081977|FG001|Year 2|Did not rescreen|0|||
13498535|NCT02942277|27081978|FG002|Year 2|Did not rescreen|1|||
13498536|NCT02942277|27081979|FG003|Year 2|Did not rescreen|1|||
13498537|NCT02942277|27081980|FG004|Year 2|Did not rescreen|9|||
13208373|NCT01939002|26241529|FG001|Overall Study|Adverse Event|13|||
13498538|NCT02942277|27081981|FG005|Year 2|Did not rescreen|6|||
13208374|NCT01939002|26241528|FG000|Overall Study|Withdrawal by Subject|5|||
13498539|NCT02942277|27081982|FG006|Year 2|Did not rescreen|0|||
13498540|NCT02942277|27081983|FG007|Year 2|Did not rescreen|1|||
13498541|NCT02942277|27081984|FG008|Year 2|Did not rescreen|0|||
13498542|NCT02942277|27081985|FG009|Year 2|Did not rescreen|0|||
13498543|NCT02942277|27081986|FG010|Year 2|Did not rescreen|21|||
13498544|NCT02942277|27081976|FG000|Year 2|Met withdrawal criteria|0|||
13498545|NCT02942277|27081977|FG001|Year 2|Met withdrawal criteria|0|||
13498546|NCT02942277|27081978|FG002|Year 2|Met withdrawal criteria|0|||
13498547|NCT02942277|27081979|FG003|Year 2|Met withdrawal criteria|0|||
13498548|NCT02942277|27081980|FG004|Year 2|Met withdrawal criteria|1|||
13498549|NCT02942277|27081981|FG005|Year 2|Met withdrawal criteria|2|||
13498550|NCT02942277|27081982|FG006|Year 2|Met withdrawal criteria|0|||
13498551|NCT02942277|27081983|FG007|Year 2|Met withdrawal criteria|0|||
13498552|NCT02942277|27081984|FG008|Year 2|Met withdrawal criteria|0|||
13498553|NCT02942277|27081985|FG009|Year 2|Met withdrawal criteria|0|||
13498554|NCT02942277|27081986|FG010|Year 2|Met withdrawal criteria|1|||
13498555|NCT02942277|27081976|FG000|Year 2|Travel|0|||
13498556|NCT02942277|27081977|FG001|Year 2|Travel|1|||
13498557|NCT02942277|27081978|FG002|Year 2|Travel|0|||
13498558|NCT02942277|27081979|FG003|Year 2|Travel|0|||
13498559|NCT02942277|27081980|FG004|Year 2|Travel|0|||
13498560|NCT02942277|27081981|FG005|Year 2|Travel|1|||
13498561|NCT02942277|27081982|FG006|Year 2|Travel|0|||
13498562|NCT02942277|27081983|FG007|Year 2|Travel|0|||
13498563|NCT02942277|27081984|FG008|Year 2|Travel|0|||
13498564|NCT02942277|27081985|FG009|Year 2|Travel|1|||
13498565|NCT02942277|27081986|FG010|Year 2|Travel|3|||
13498566|NCT02942277|27081976|FG000|Year 2|Non-compliant|0|||
13498567|NCT02942277|27081977|FG001|Year 2|Non-compliant|0|||
13498568|NCT02942277|27081978|FG002|Year 2|Non-compliant|0|||
13498569|NCT02942277|27081979|FG003|Year 2|Non-compliant|0|||
13498570|NCT02942277|27081980|FG004|Year 2|Non-compliant|1|||
13498571|NCT02942277|27081981|FG005|Year 2|Non-compliant|1|||
13498572|NCT02942277|27081982|FG006|Year 2|Non-compliant|0|||
13498573|NCT02942277|27081983|FG007|Year 2|Non-compliant|0|||
13498574|NCT02942277|27081984|FG008|Year 2|Non-compliant|0|||
13498575|NCT02942277|27081985|FG009|Year 2|Non-compliant|0|||
13498576|NCT02942277|27081986|FG010|Year 2|Non-compliant|0|||
13498577|NCT02942277|27081976|FG000|Year 2|Withdrawal by Subject|0|||
13498578|NCT02942277|27081977|FG001|Year 2|Withdrawal by Subject|0|||
13498579|NCT02942277|27081978|FG002|Year 2|Withdrawal by Subject|0|||
13498580|NCT02942277|27081979|FG003|Year 2|Withdrawal by Subject|0|||
13498581|NCT02942277|27081980|FG004|Year 2|Withdrawal by Subject|0|||
13498582|NCT02942277|27081981|FG005|Year 2|Withdrawal by Subject|0|||
13498583|NCT02942277|27081982|FG006|Year 2|Withdrawal by Subject|1|||
13498584|NCT02942277|27081983|FG007|Year 2|Withdrawal by Subject|0|||
13498585|NCT02942277|27081984|FG008|Year 2|Withdrawal by Subject|0|||
13498586|NCT02942277|27081985|FG009|Year 2|Withdrawal by Subject|0|||
13498587|NCT02942277|27081986|FG010|Year 2|Withdrawal by Subject|0|||
13498588|NCT02942017|27082021|FG000|Overall Study|Adverse Event|0|||
13498589|NCT02942017|27082022|FG001|Overall Study|Adverse Event|1|||
13498590|NCT02942017|27082021|FG000|Overall Study|Withdrawal by Subject|0|||
13498591|NCT02942017|27082022|FG001|Overall Study|Withdrawal by Subject|1|||
13498592|NCT02942017|27082021|FG000|Overall Study|Lost to Follow-up|1|||
13498593|NCT02942017|27082022|FG001|Overall Study|Lost to Follow-up|1|||
13498594|NCT02942017|27082021|FG000|Overall Study|Randomized but not dosed|1|||
13498595|NCT02942017|27082022|FG001|Overall Study|Randomized but not dosed|3|||
13498596|NCT02942004|27082073|FG000|Overall Study|Withdrawal by Subject|0|||
13498597|NCT02942004|27082074|FG001|Overall Study|Withdrawal by Subject|2|||
13498598|NCT02942004|27082075|FG002|Overall Study|Withdrawal by Subject|3|||
13498599|NCT02942004|27082073|FG000|Overall Study|Lost to Follow-up|1|||
13498600|NCT02942004|27082074|FG001|Overall Study|Lost to Follow-up|1|||
13498601|NCT02942004|27082075|FG002|Overall Study|Lost to Follow-up|2|||
13498602|NCT02942004|27082073|FG000|Overall Study|Randomized but not dosed|3|||
13498603|NCT02942004|27082074|FG001|Overall Study|Randomized but not dosed|9|||
13498604|NCT02942004|27082075|FG002|Overall Study|Randomized but not dosed|4|||
13498605|NCT02861014|27082109|FG000|Primary Analysis|Adverse Event|7|||
13498606|NCT02861014|27082109|FG000|Primary Analysis|Death|1|||
13498607|NCT02861014|27082109|FG000|Primary Analysis|Lack of Efficacy|3|||
13498608|NCT02861014|27082109|FG000|Primary Analysis|Physician Decision|2|||
13498609|NCT02861014|27082109|FG000|Primary Analysis|Pregnancy|4|||
13498610|NCT02861014|27082109|FG000|Primary Analysis|Protocol Violation|2|||
13498611|NCT02861014|27082109|FG000|Primary Analysis|Study Terminated By Sponsor|3|||
13498612|NCT02861014|27082109|FG000|Primary Analysis|Withdrawal by Subject|14|||
13498613|NCT02861014|27082109|FG000|Primary Analysis|Commercial ocrelizumab|3|||
13498614|NCT02861014|27082109|FG000|Safety Follow-up|Adverse Event|1|||
13498615|NCT02861014|27082109|FG000|Safety Follow-up|Pregnancy|1|||
13498616|NCT02861014|27082109|FG000|Safety Follow-up|Withdrawal by Subject|9|||
13498617|NCT02861014|27082109|FG000|Safety Follow-up|Study terminated by sponsor|1|||
13498618|NCT02861014|27082109|FG000|Safety Follow-up|Physician Decision|1|||
13498619|NCT02861014|27082109|FG000|Safety Follow-up|Roll-over to a long term extension study|1|||
13498620|NCT02861014|27082109|FG000|Safety Follow-up|Commercial ocrelizumab|36|||
13498621|NCT02726880|27082133|FG000|Overall Study|Withdrawal by Subject|2|||
13498622|NCT02726880|27082134|FG001|Overall Study|Withdrawal by Subject|0|||
13498623|NCT02726880|27082133|FG000|Overall Study|Lost to Follow-up|1|||
13498624|NCT02726880|27082134|FG001|Overall Study|Lost to Follow-up|3|||
13208375|NCT01939002|26241529|FG001|Overall Study|Withdrawal by Subject|3|||
13498625|NCT02583048|27082233|FG000|Overall Study|Withdrawal by Subject|0|||
13498626|NCT02583048|27082234|FG001|Overall Study|Withdrawal by Subject|1|||
13498627|NCT02583048|27082235|FG002|Overall Study|Withdrawal by Subject|0|||
13498628|NCT02583048|27082233|FG000|Overall Study|Failed to meet eligibility criterion|0|||
13498629|NCT02583048|27082234|FG001|Overall Study|Failed to meet eligibility criterion|0|||
13498630|NCT02583048|27082235|FG002|Overall Study|Failed to meet eligibility criterion|1|||
13498631|NCT02539160|27082258|FG000|Phase 1 Pre-crossover|Adverse Event|3|||
13498632|NCT02539160|27082259|FG001|Phase 1 Pre-crossover|Adverse Event|3|||
13498633|NCT02539160|27082260|FG002|Phase 1 Pre-crossover|Adverse Event|2|||
13498634|NCT02539160|27082261|FG003|Phase 1 Pre-crossover|Adverse Event|1|||
13498635|NCT02539160|27082258|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2|||
13498636|NCT02539160|27082259|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
13498637|NCT02539160|27082260|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
13498638|NCT02539160|27082261|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0|||
13498639|NCT02539160|27082258|FG000|Phase 1 Pre-crossover|Protocol Violation|0|||
13498640|NCT02539160|27082259|FG001|Phase 1 Pre-crossover|Protocol Violation|0|||
13498641|NCT02539160|27082260|FG002|Phase 1 Pre-crossover|Protocol Violation|0|||
13498642|NCT02539160|27082261|FG003|Phase 1 Pre-crossover|Protocol Violation|2|||
13498643|NCT02507973|27082269|FG000|Overall Study|Adverse Event|1|||
13381446|NCT00753415|26748246|FG002|Part A|Withdrawal by Subject|1|||
13381447|NCT00753415|26748247|FG003|Part A|Withdrawal by Subject|0|||
13381448|NCT00753415|26748248|FG004|Part A|Withdrawal by Subject|0|||
13381449|NCT00753415|26748249|FG005|Part A|Withdrawal by Subject|0|||
13381450|NCT00753415|26748250|FG006|Part A|Withdrawal by Subject|0|||
13381451|NCT00753415|26748251|FG007|Part A|Withdrawal by Subject|0|||
13381452|NCT00753415|26748252|FG008|Part A|Withdrawal by Subject|0|||
13381453|NCT00753415|26748253|FG009|Part A|Withdrawal by Subject|0|||
13381454|NCT00753415|26748244|FG000|Part B|Lost to Follow-up|0|||
13381455|NCT00753415|26748245|FG001|Part B|Lost to Follow-up|0|||
13498644|NCT02477618|27082298|FG000|Overall Study|Completed Visits but Discontinued Drug|2|||
13498645|NCT02477618|27082299|FG001|Overall Study|Completed Visits but Discontinued Drug|1|||
13498646|NCT02477618|27082298|FG000|Overall Study|Died in Double-Blind Treatment Period|11|||
13498647|NCT02477618|27082299|FG001|Overall Study|Died in Double-Blind Treatment Period|11|||
13498648|NCT02477618|27082298|FG000|Overall Study|Adverse Event|1|||
13498649|NCT02477618|27082299|FG001|Overall Study|Adverse Event|1|||
13498650|NCT02477618|27082298|FG000|Overall Study|Transferred Away from Study Site|1|||
13498651|NCT02477618|27082299|FG001|Overall Study|Transferred Away from Study Site|0|||
13498652|NCT02477618|27082298|FG000|Overall Study|Left Study Site for Rehabilitation|0|||
13498653|NCT02477618|27082299|FG001|Overall Study|Left Study Site for Rehabilitation|1|||
13498654|NCT02003924|27082512|FG000|Double-blind Phase|Lost to Follow-up|2|||
13498655|NCT02003924|27082513|FG001|Double-blind Phase|Lost to Follow-up|1|||
13498656|NCT02003924|27082514|FG002|Double-blind Phase|Lost to Follow-up|0|||
13498657|NCT02003924|27082512|FG000|Double-blind Phase|Protocol Violation|1|||
13498658|NCT02003924|27082513|FG001|Double-blind Phase|Protocol Violation|2|||
13498659|NCT02003924|27082514|FG002|Double-blind Phase|Protocol Violation|0|||
13498660|NCT02003924|27082512|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71|||
13498661|NCT02003924|27082513|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47|||
13498662|NCT02003924|27082514|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0|||
13498663|NCT02003924|27082512|FG000|Double-blind Phase|Disease Progression|229|||
13498664|NCT02003924|27082513|FG001|Double-blind Phase|Disease Progression|247|||
13498665|NCT02003924|27082514|FG002|Double-blind Phase|Disease Progression|0|||
13498666|NCT02003924|27082512|FG000|Double-blind Phase|Adverse Event|120|||
13498667|NCT02003924|27082513|FG001|Double-blind Phase|Adverse Event|31|||
13498668|NCT02003924|27082514|FG002|Double-blind Phase|Adverse Event|0|||
13498669|NCT02003924|27082512|FG000|Double-blind Phase|Randomized But not Treated|3|||
13498670|NCT02003924|27082513|FG001|Double-blind Phase|Randomized But not Treated|3|||
13498671|NCT02003924|27082514|FG002|Double-blind Phase|Randomized But not Treated|0|||
13498672|NCT02003924|27082512|FG000|Double-blind Phase|Other|29|||
13498673|NCT02003924|27082513|FG001|Double-blind Phase|Other|50|||
13498674|NCT02003924|27082514|FG002|Double-blind Phase|Other|0|||
13498675|NCT02003924|27082512|FG000|Open-label Phase|Lost to Follow-up|0|||
13498676|NCT02003924|27082513|FG001|Open-label Phase|Lost to Follow-up|0|||
13498677|NCT02003924|27082514|FG002|Open-label Phase|Lost to Follow-up|1|||
13498678|NCT02003924|27082512|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9|||
13498679|NCT02003924|27082513|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0|||
13498680|NCT02003924|27082514|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1|||
13498681|NCT02003924|27082512|FG000|Open-label Phase|Disease Progression|59|||
13498682|NCT02003924|27082513|FG001|Open-label Phase|Disease Progression|0|||
13498683|NCT02003924|27082514|FG002|Open-label Phase|Disease Progression|5|||
13498684|NCT02003924|27082512|FG000|Open-label Phase|Adverse Event|25|||
13498685|NCT02003924|27082513|FG001|Open-label Phase|Adverse Event|0|||
13498686|NCT02003924|27082514|FG002|Open-label Phase|Adverse Event|10|||
13498687|NCT02003924|27082512|FG000|Open-label Phase|Other|7|||
13498688|NCT02003924|27082513|FG001|Open-label Phase|Other|0|||
13498689|NCT02003924|27082514|FG002|Open-label Phase|Other|0|||
13498690|NCT02003924|27082512|FG000|Long-term Follow-up Phase|Death|288|||
13498691|NCT02003924|27082513|FG001|Long-term Follow-up Phase|Death|174|||
13498692|NCT02003924|27082514|FG002|Long-term Follow-up Phase|Death|4|||
13498693|NCT02003924|27082512|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
13498694|NCT02003924|27082513|FG001|Long-term Follow-up Phase|Lost to Follow-up|6|||
13498695|NCT02003924|27082514|FG002|Long-term Follow-up Phase|Lost to Follow-up|1|||
13498696|NCT02003924|27082512|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66|||
13498697|NCT02003924|27082513|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55|||
13498698|NCT02003924|27082514|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1|||
13498699|NCT02003924|27082512|FG000|Long-term Follow-up Phase|Other|5|||
13498700|NCT02003924|27082513|FG001|Long-term Follow-up Phase|Other|2|||
13498701|NCT02003924|27082514|FG002|Long-term Follow-up Phase|Other|1|||
13498702|NCT01971970|27082540|FG000|Baseline Until Week 6|Stopped anti-TNF use|1|||
13498703|NCT01971970|27082541|FG001|Baseline Until Week 6|Stopped anti-TNF use|0|||
13498704|NCT01971970|27082540|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0|||
13498705|NCT01971970|27082541|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1|||
13498706|NCT01971970|27082540|FG000|Week 14 Until Week 22|Lost to Follow-up|0|||
13498707|NCT01971970|27082541|FG001|Week 14 Until Week 22|Lost to Follow-up|1|||
13498708|NCT01971970|27082540|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7|||
13498709|NCT01971970|27082541|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3|||
13498710|NCT01971970|27082540|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1|||
13498711|NCT01971970|27082541|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0|||
13498712|NCT01971970|27082540|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0|||
13498713|NCT01971970|27082541|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1|||
13498714|NCT01971970|27082540|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1|||
13498715|NCT01971970|27082541|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3|||
13498716|NCT01969409|27082568|FG000|Overall Study|Death|2|||
13498717|NCT01969409|27082569|FG001|Overall Study|Death|2|||
13498718|NCT01969409|27082568|FG000|Overall Study|Transplant|1|||
13498719|NCT01969409|27082569|FG001|Overall Study|Transplant|1|||
13498720|NCT01969409|27082568|FG000|Overall Study|Withdrawal by Subject|0|||
13498721|NCT01969409|27082569|FG001|Overall Study|Withdrawal by Subject|1|||
13498722|NCT01307787|27082596|FG000|Overall Study|Withdrawal by Subject|2|||
13498723|NCT01307787|27082597|FG001|Overall Study|Withdrawal by Subject|0|||
13498724|NCT01250912|27082606|FG000|Overall Study|Lost to Follow-up|1|||
13498725|NCT00659646|27082669|FG000|Overall Study|Protocol Violation|12|||
13498726|NCT00659646|27082670|FG001|Overall Study|Protocol Violation|8|||
13498727|NCT00659646|27082669|FG000|Overall Study|Adverse Event|1|||
13498728|NCT00659646|27082670|FG001|Overall Study|Adverse Event|0|||
13498729|NCT00659646|27082669|FG000|Overall Study|Lost to Follow-up|1|||
13498730|NCT00659646|27082670|FG001|Overall Study|Lost to Follow-up|0|||
13498731|NCT00659646|27082669|FG000|Overall Study|protocol noncompliance after randomized|1|||
13498732|NCT00659646|27082670|FG001|Overall Study|protocol noncompliance after randomized|0|||
13498733|NCT00369317|27082686|FG000|Overall Study|Adverse Event|3|||
13498734|NCT00369317|27082686|FG000|Overall Study|Death|1|||
13498735|NCT00369317|27082686|FG000|Overall Study|Lack of Efficacy|5|||
13498736|NCT00369317|27082686|FG000|Overall Study|Physician Decision|2|||
13498737|NCT00369317|27082686|FG000|Overall Study|Withdrawal by Subject|8|||
13498738|NCT00369317|27082686|FG000|Overall Study|Ineligible|1|||
13498739|NCT00261807|27082694|FG000|Overall Study|Lost to Follow-up|2|||
13498740|NCT00261807|27082694|FG000|Overall Study|Adverse Event|2|||
13498741|NCT00261807|27082694|FG000|Overall Study|Death|1|||
13498742|NCT00261807|27082694|FG000|Overall Study|Protocol Violation|2|||
13498743|NCT04620798|27082761|FG000|Overall Study|Lost to Follow-up|126|||
13498744|NCT04620798|27082762|FG001|Overall Study|Lost to Follow-up|138|||
13498745|NCT04256629|27082921|FG000|Overall Study|Adverse Event|0|||
13498746|NCT04256629|27082922|FG001|Overall Study|Adverse Event|0|||
13498747|NCT04256629|27082923|FG002|Overall Study|Adverse Event|0|||
13498748|NCT04256629|27082924|FG003|Overall Study|Adverse Event|0|||
13498749|NCT04256629|27082925|FG004|Overall Study|Adverse Event|0|||
13498750|NCT04256629|27082926|FG005|Overall Study|Adverse Event|1|||
13498751|NCT04256629|27082921|FG000|Overall Study|Protocol Violation|0|||
13498752|NCT04256629|27082922|FG001|Overall Study|Protocol Violation|1|||
13498753|NCT04256629|27082923|FG002|Overall Study|Protocol Violation|0|||
13498754|NCT04256629|27082924|FG003|Overall Study|Protocol Violation|0|||
13498755|NCT04256629|27082925|FG004|Overall Study|Protocol Violation|0|||
13498756|NCT04256629|27082926|FG005|Overall Study|Protocol Violation|0|||
13498757|NCT03284853|27082945|FG000|Overall Study|Adverse Event|40|||
13498758|NCT03284853|27082946|FG001|Overall Study|Adverse Event|4|||
13498759|NCT03284853|27082945|FG000|Overall Study|Withdrawal by Subject|5|||
13498760|NCT03284853|27082946|FG001|Overall Study|Withdrawal by Subject|1|||
13498761|NCT03284853|27082945|FG000|Overall Study|Lost to Follow-up|1|||
13498762|NCT03284853|27082946|FG001|Overall Study|Lost to Follow-up|0|||
13498763|NCT03284853|27082945|FG000|Overall Study|Lack of Efficacy|1|||
13498764|NCT03284853|27082946|FG001|Overall Study|Lack of Efficacy|0|||
13498765|NCT03284853|27082945|FG000|Overall Study|Disallowed Concurrent Medication|1|||
13498766|NCT03284853|27082946|FG001|Overall Study|Disallowed Concurrent Medication|1|||
13498767|NCT03284853|27082945|FG000|Overall Study|Protocol Violation|3|||
13498768|NCT03284853|27082946|FG001|Overall Study|Protocol Violation|3|||
13498769|NCT03284853|27082945|FG000|Overall Study|Death|0|||
13498770|NCT03284853|27082946|FG001|Overall Study|Death|1|||
13498771|NCT03284853|27082945|FG000|Overall Study|Other - Reason not reported in CSR|4|||
13498772|NCT03284853|27082946|FG001|Overall Study|Other - Reason not reported in CSR|3|||
13498773|NCT02774889|27083032|FG000|Overall Study|Lost to Follow-up|2|||
13498774|NCT02774889|27083033|FG001|Overall Study|Lost to Follow-up|1|||
13498775|NCT02297438|27083103|FG000|Overall Study|Death|79|||
13498776|NCT02297438|27083104|FG001|Overall Study|Death|86|||
13498777|NCT02297438|27083103|FG000|Overall Study|Lost to Follow-up|9|||
13498778|NCT02297438|27083104|FG001|Overall Study|Lost to Follow-up|7|||
13498779|NCT02297438|27083103|FG000|Overall Study|Withdrawal by Subject|7|||
13498780|NCT02297438|27083104|FG001|Overall Study|Withdrawal by Subject|0|||
13498781|NCT02297438|27083103|FG000|Overall Study|Other|9|||
13498782|NCT02297438|27083104|FG001|Overall Study|Other|5|||
13498783|NCT02297438|27083103|FG000|Overall Study|Ongoing|65|||
13498784|NCT02297438|27083104|FG001|Overall Study|Ongoing|73|||
13498785|NCT02297412|27083121|FG000|Overall Study|Canceled|1|||
13498786|NCT02297412|27083122|FG001|Overall Study|Canceled|1|||
13498787|NCT02250326|27083195|FG000|Treatment Period|Death|1|||
13498788|NCT02250326|27083196|FG001|Treatment Period|Death|12|||
13498789|NCT02250326|27083197|FG002|Treatment Period|Death|2|||
13498790|NCT02250326|27083195|FG000|Treatment Period|Adverse Event|8|||
13498791|NCT02250326|27083196|FG001|Treatment Period|Adverse Event|4|||
13498792|NCT02250326|27083197|FG002|Treatment Period|Adverse Event|8|||
13498793|NCT02250326|27083195|FG000|Treatment Period|Progressive Disease|42|||
13498794|NCT02250326|27083196|FG001|Treatment Period|Progressive Disease|36|||
13498795|NCT02250326|27083197|FG002|Treatment Period|Progressive Disease|45|||
13498796|NCT02250326|27083195|FG000|Treatment Period|Symptomatic Deterioration|9|||
13498797|NCT02250326|27083196|FG001|Treatment Period|Symptomatic Deterioration|4|||
13498798|NCT02250326|27083197|FG002|Treatment Period|Symptomatic Deterioration|10|||
13498799|NCT02250326|27083195|FG000|Treatment Period|Withdrawal by Subject|11|||
13498800|NCT02250326|27083196|FG001|Treatment Period|Withdrawal by Subject|5|||
13498801|NCT02250326|27083197|FG002|Treatment Period|Withdrawal by Subject|4|||
13498802|NCT02250326|27083195|FG000|Treatment Period|Miscellaneous|8|||
13498803|NCT02250326|27083196|FG001|Treatment Period|Miscellaneous|2|||
13498804|NCT02250326|27083197|FG002|Treatment Period|Miscellaneous|7|||
13498805|NCT02250326|27083195|FG000|Treatment Period|Randomized or assigned; not treated|2|||
13498806|NCT02250326|27083196|FG001|Treatment Period|Randomized or assigned; not treated|1|||
13498807|NCT02250326|27083197|FG002|Treatment Period|Randomized or assigned; not treated|1|||
13498808|NCT02250326|27083195|FG000|Follow-Up Period|Death|46|||
13498809|NCT02250326|27083196|FG001|Follow-Up Period|Death|26|||
13498810|NCT02250326|27083197|FG002|Follow-Up Period|Death|32|||
13498811|NCT02250326|27083195|FG000|Follow-Up Period|Unknown or Missing|2|||
13498812|NCT02250326|27083196|FG001|Follow-Up Period|Unknown or Missing|3|||
13498813|NCT02250326|27083197|FG002|Follow-Up Period|Unknown or Missing|3|||
13498814|NCT02250326|27083195|FG000|Follow-Up Period|Lost to Follow-up|1|||
13498815|NCT02250326|27083196|FG001|Follow-Up Period|Lost to Follow-up|1|||
13498816|NCT02250326|27083197|FG002|Follow-Up Period|Lost to Follow-up|3|||
13498817|NCT01503515|27083238|FG000|Overall Study|Adverse Event|4|||
13498818|NCT01503515|27083239|FG001|Overall Study|Adverse Event|5|||
13498819|NCT01503515|27083238|FG000|Overall Study|Death|0|||
13498820|NCT01503515|27083239|FG001|Overall Study|Death|1|||
13498821|NCT01503515|27083238|FG000|Overall Study|Physician Decision|14|||
13498822|NCT01503515|27083239|FG001|Overall Study|Physician Decision|23|||
13498823|NCT01503515|27083238|FG000|Overall Study|Withdrawal by Subject|0|||
13498824|NCT01503515|27083239|FG001|Overall Study|Withdrawal by Subject|1|||
13498825|NCT01503515|27083238|FG000|Overall Study|Institutional dx of proven/probable IFI|2|||
13498826|NCT01503515|27083239|FG001|Overall Study|Institutional dx of proven/probable IFI|4|||
13498827|NCT01503515|27083238|FG000|Overall Study|Ineligible|1|||
13498828|NCT01503515|27083239|FG001|Overall Study|Ineligible|1|||
13498829|NCT00245960|27083290|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6|||
13498830|NCT00245960|27083291|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7|||
13498831|NCT00245960|27083290|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0|||
13498832|NCT00245960|27083291|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1|||
13498833|NCT00245960|27083290|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2|||
13498834|NCT00245960|27083291|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0|||
13498835|NCT00245960|27083290|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2|||
13498836|NCT00245960|27083291|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1|||
13498837|NCT00245960|27083290|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3|||
13498838|NCT00245960|27083291|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0|||
13498839|NCT00245960|27083290|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
13498840|NCT00245960|27083291|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
13498841|NCT00245960|27083290|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8|||
13498842|NCT00245960|27083291|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4|||
13498843|NCT00245960|27083290|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
13498844|NCT00245960|27083291|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
13498845|NCT00245960|27083290|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2|||
13498846|NCT00245960|27083291|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5|||
13498847|NCT00245960|27083290|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1|||
13498848|NCT00245960|27083291|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3|||
13498849|NCT00245960|27083290|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1|||
13498850|NCT00245960|27083291|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3|||
13498851|NCT00245960|27083290|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0|||
13498852|NCT00245960|27083291|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1|||
13498853|NCT04015336|27083440|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1|||
13498854|NCT03913091|27083569|FG000|Overall Study|Lost to Follow-up|18|||
13498855|NCT03913091|27083570|FG001|Overall Study|Lost to Follow-up|11|||
13498856|NCT03913091|27083569|FG000|Overall Study|Required additional meds/surgery|1|||
13498857|NCT03913091|27083570|FG001|Overall Study|Required additional meds/surgery|2|||
13498858|NCT03913091|27083569|FG000|Overall Study|Chronic pain/history of substance abuse|1|||
13498859|NCT03913091|27083570|FG001|Overall Study|Chronic pain/history of substance abuse|1|||
13498860|NCT03738332|27083579|FG000|Overall Study|Withdrawal by Subject|1|||
13498861|NCT03416179|27083602|FG000|Overall Study|Death|67|||
13498862|NCT03416179|27083603|FG001|Overall Study|Death|60|||
13498863|NCT03416179|27083604|FG002|Overall Study|Death|96|||
13498864|NCT03416179|27083605|FG003|Overall Study|Death|88|||
13498865|NCT03416179|27083602|FG000|Overall Study|Withdrawal by Subject|13|||
13498866|NCT03416179|27083603|FG001|Overall Study|Withdrawal by Subject|19|||
13498867|NCT03416179|27083604|FG002|Overall Study|Withdrawal by Subject|5|||
13498868|NCT03416179|27083605|FG003|Overall Study|Withdrawal by Subject|6|||
13498869|NCT03416179|27083602|FG000|Overall Study|Ongoing|121|||
13498870|NCT03416179|27083603|FG001|Overall Study|Ongoing|123|||
13498871|NCT03416179|27083604|FG002|Overall Study|Ongoing|62|||
13498872|NCT03416179|27083605|FG003|Overall Study|Ongoing|66|||
13498873|NCT03416179|27083602|FG000|Overall Study|Lost to Follow-up|0|||
13498874|NCT03416179|27083603|FG001|Overall Study|Lost to Follow-up|0|||
13498875|NCT03416179|27083604|FG002|Overall Study|Lost to Follow-up|0|||
13498876|NCT03416179|27083605|FG003|Overall Study|Lost to Follow-up|2|||
13498877|NCT03416179|27083602|FG000|Overall Study|Other|0|||
13498878|NCT03416179|27083603|FG001|Overall Study|Other|1|||
13498879|NCT03416179|27083604|FG002|Overall Study|Other|0|||
13498880|NCT03416179|27083605|FG003|Overall Study|Other|0|||
13498881|NCT03353922|27083629|FG000|Overall Study|Withdrawal by Subject|1|||
13498882|NCT03353922|27083630|FG001|Overall Study|Withdrawal by Subject|0|||
13498883|NCT03353922|27083631|FG002|Overall Study|Withdrawal by Subject|1|||
13498884|NCT03353922|27083632|FG003|Overall Study|Withdrawal by Subject|1|||
13498885|NCT03353922|27083633|FG004|Overall Study|Withdrawal by Subject|0|||
13498886|NCT03353922|27083634|FG005|Overall Study|Withdrawal by Subject|0|||
13498887|NCT03353922|27083629|FG000|Overall Study|Adverse Event|0|||
13498888|NCT03353922|27083630|FG001|Overall Study|Adverse Event|1|||
13498889|NCT03353922|27083631|FG002|Overall Study|Adverse Event|0|||
13498890|NCT03353922|27083632|FG003|Overall Study|Adverse Event|0|||
13498891|NCT03353922|27083633|FG004|Overall Study|Adverse Event|0|||
13498892|NCT03353922|27083634|FG005|Overall Study|Adverse Event|0|||
13498893|NCT03173456|27083723|FG000|Baseline|Medication dispensing system malfunction'|0|||
13498894|NCT03173456|27083724|FG001|Baseline|Medication dispensing system malfunction'|1|||
13498895|NCT03173456|27083725|FG002|Baseline|Medication dispensing system malfunction'|0|||
13498896|NCT03173456|27083726|FG003|Baseline|Medication dispensing system malfunction'|0|||
13498897|NCT03173456|27083727|FG004|Baseline|Medication dispensing system malfunction'|2|||
13498898|NCT03173456|27083723|FG000|2 Hour Follow-up|Withdrawal by Subject|0|||
13498899|NCT03173456|27083724|FG001|2 Hour Follow-up|Withdrawal by Subject|1|||
13498900|NCT03173456|27083725|FG002|2 Hour Follow-up|Withdrawal by Subject|1|||
13498901|NCT03173456|27083726|FG003|2 Hour Follow-up|Withdrawal by Subject|1|||
13498902|NCT03173456|27083727|FG004|2 Hour Follow-up|Withdrawal by Subject|2|||
13498903|NCT02820753|27083748|FG000|2 Month|Withdrawal by Subject|3|||
13498904|NCT02820753|27083749|FG001|2 Month|Withdrawal by Subject|3|||
13498905|NCT02820753|27083748|FG000|2 Month|Lost to Follow-up|24|||
13498906|NCT02820753|27083749|FG001|2 Month|Lost to Follow-up|26|||
13498907|NCT02820753|27083748|FG000|2 Month|Stopped per NIH Hold|51|||
13498908|NCT02820753|27083749|FG001|2 Month|Stopped per NIH Hold|13|||
13498909|NCT02820753|27083748|FG000|6 Month|Withdrawal by Subject|2|||
13498910|NCT02820753|27083749|FG001|6 Month|Withdrawal by Subject|2|||
13498911|NCT02820753|27083748|FG000|6 Month|Lost to Follow-up|20|||
13498912|NCT02820753|27083749|FG001|6 Month|Lost to Follow-up|27|||
13498913|NCT02820753|27083748|FG000|6 Month|Stopped per NIH Hold|81|||
13498914|NCT02820753|27083749|FG001|6 Month|Stopped per NIH Hold|81|||
13498915|NCT02820753|27083748|FG000|6 Month|Death|0|||
13498916|NCT02820753|27083749|FG001|6 Month|Death|1|||
13498917|NCT02574286|27083784|FG000|Overall Study|Adverse Event|3|||
13498918|NCT02574286|27083784|FG000|Overall Study|Withdrawal by Subject|2|||
13498919|NCT02471144|27083881|FG000|Induction Period (Up to Week 12)|Adverse Event|0|||
13498920|NCT02471144|27083882|FG001|Induction Period (Up to Week 12)|Adverse Event|1|||
13498921|NCT02471144|27083883|FG002|Induction Period (Up to Week 12)|Adverse Event|1|||
13498922|NCT02471144|27083884|FG003|Induction Period (Up to Week 12)|Adverse Event|0|||
13498923|NCT02471144|27083885|FG004|Induction Period (Up to Week 12)|Adverse Event|0|||
13498924|NCT02471144|27083886|FG005|Induction Period (Up to Week 12)|Adverse Event|0|||
13498925|NCT02471144|27083887|FG006|Induction Period (Up to Week 12)|Adverse Event|0|||
13498926|NCT02471144|27083888|FG007|Induction Period (Up to Week 12)|Adverse Event|0|||
13498927|NCT02471144|27083889|FG008|Induction Period (Up to Week 12)|Adverse Event|0|||
13498928|NCT02471144|27083890|FG009|Induction Period (Up to Week 12)|Adverse Event|0|||
13498929|NCT02471144|27083891|FG010|Induction Period (Up to Week 12)|Adverse Event|0|||
13498930|NCT02471144|27083881|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
13498931|NCT02471144|27083882|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
13498932|NCT02471144|27083883|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
13498933|NCT02471144|27083884|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1|||
13498934|NCT02471144|27083885|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
13498935|NCT02471144|27083886|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
13498936|NCT02471144|27083887|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
13498937|NCT02471144|27083888|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
13498938|NCT02471144|27083889|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
13498939|NCT02471144|27083890|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
13498940|NCT02471144|27083891|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
13498941|NCT02471144|27083881|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0|||
13498942|NCT02471144|27083882|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0|||
13498943|NCT02471144|27083883|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1|||
13498944|NCT02471144|27083884|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0|||
13498945|NCT02471144|27083885|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0|||
13498946|NCT02471144|27083886|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0|||
13498947|NCT02471144|27083887|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0|||
13498948|NCT02471144|27083888|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0|||
13498949|NCT02471144|27083889|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0|||
13498950|NCT02471144|27083890|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0|||
13498951|NCT02471144|27083891|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0|||
13498952|NCT02471144|27083881|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
13498953|NCT02471144|27083882|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
13498954|NCT02471144|27083883|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
13498955|NCT02471144|27083884|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
13498956|NCT02471144|27083885|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
13498957|NCT02471144|27083886|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
13498958|NCT02471144|27083887|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
13498959|NCT02471144|27083888|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
13498960|NCT02471144|27083889|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
13498961|NCT02471144|27083890|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
13498962|NCT02471144|27083891|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
13498963|NCT02471144|27083881|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
13498964|NCT02471144|27083882|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
13498965|NCT02471144|27083883|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
13498966|NCT02471144|27083884|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
13498967|NCT02471144|27083885|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
13498968|NCT02471144|27083886|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
13498969|NCT02471144|27083887|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
13498970|NCT02471144|27083888|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
13498971|NCT02471144|27083889|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
13498972|NCT02471144|27083890|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
13498973|NCT02471144|27083891|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
13498974|NCT02471144|27083881|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
13498975|NCT02471144|27083882|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
13498976|NCT02471144|27083883|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
13498977|NCT02471144|27083884|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
13498978|NCT02471144|27083885|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
13498979|NCT02471144|27083886|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1|||
13498980|NCT02471144|27083887|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
13498981|NCT02471144|27083888|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
13498982|NCT02471144|27083889|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3|||
13498983|NCT02471144|27083890|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
13498984|NCT02471144|27083891|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
13498985|NCT02471144|27083881|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
13498986|NCT02471144|27083882|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
13498987|NCT02471144|27083883|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
13498988|NCT02471144|27083884|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
13498989|NCT02471144|27083885|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
13498990|NCT02471144|27083886|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
13498991|NCT02471144|27083887|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
13498992|NCT02471144|27083888|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
13498993|NCT02471144|27083889|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1|||
13498994|NCT02471144|27083890|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
13498995|NCT02471144|27083891|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
13498996|NCT02471144|27083881|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
13498997|NCT02471144|27083882|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
13498998|NCT02471144|27083883|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
13498999|NCT02471144|27083884|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
13499000|NCT02471144|27083885|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
13499001|NCT02471144|27083886|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
13499002|NCT02471144|27083887|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
13499003|NCT02471144|27083888|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2|||
13499004|NCT02471144|27083889|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1|||
13499005|NCT02471144|27083890|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
13499006|NCT02471144|27083891|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
13499007|NCT02471144|27083881|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
13499008|NCT02471144|27083882|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
13499009|NCT02471144|27083883|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
13499010|NCT02471144|27083884|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
13499011|NCT02471144|27083885|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
13499012|NCT02471144|27083886|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
13499013|NCT02471144|27083887|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
13499014|NCT02471144|27083888|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
13499015|NCT02471144|27083889|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
13499016|NCT02471144|27083890|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|5|||
13499017|NCT02471144|27083891|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|2|||
13499018|NCT02471144|27083881|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
13499019|NCT02471144|27083882|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
13499020|NCT02471144|27083883|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
13499021|NCT02471144|27083884|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
13499022|NCT02471144|27083885|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
13499023|NCT02471144|27083886|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
13499024|NCT02471144|27083887|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
13499025|NCT02471144|27083888|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
13499026|NCT02471144|27083889|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
13499027|NCT02471144|27083890|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2|||
13499028|NCT02471144|27083891|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
13499029|NCT02471144|27083881|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
13499030|NCT02471144|27083882|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
13499031|NCT02471144|27083883|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
13499032|NCT02471144|27083884|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
13499033|NCT02471144|27083885|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
13499034|NCT02471144|27083886|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
13499035|NCT02471144|27083887|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
13499036|NCT02471144|27083888|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
13499037|NCT02471144|27083889|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
13499038|NCT02471144|27083890|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
13499039|NCT02471144|27083891|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2|||
13499040|NCT02366728|27083938|FG000|Overall Study|Death|0|||
13499041|NCT02366728|27083939|FG001|Overall Study|Death|0|||
13499042|NCT02366728|27083940|FG002|Overall Study|Death|1|||
13499043|NCT02366728|27083938|FG000|Overall Study|Adverse Event|1|||
13499044|NCT02366728|27083939|FG001|Overall Study|Adverse Event|0|||
13499045|NCT02366728|27083940|FG002|Overall Study|Adverse Event|0|||
13499046|NCT02366728|27083938|FG000|Overall Study|Screen Failure|2|||
13499047|NCT02366728|27083939|FG001|Overall Study|Screen Failure|1|||
13499048|NCT02366728|27083940|FG002|Overall Study|Screen Failure|0|||
13499049|NCT02366728|27083938|FG000|Overall Study|Only yielded 2 vaccines|1|||
13499050|NCT02366728|27083939|FG001|Overall Study|Only yielded 2 vaccines|0|||
13133894|NCT02761980|25989715|FG000|Overall Study|Adverse Event|4|||
13133895|NCT02761980|25989716|FG001|Overall Study|Adverse Event|6|||
13133896|NCT02761980|25989717|FG002|Overall Study|Adverse Event|5|||
13133897|NCT02761980|25989718|FG003|Overall Study|Adverse Event|6|||
13133898|NCT02761980|25989715|FG000|Overall Study|Withdrawal by Subject|0|||
13133899|NCT02761980|25989716|FG001|Overall Study|Withdrawal by Subject|1|||
13133900|NCT02761980|25989717|FG002|Overall Study|Withdrawal by Subject|0|||
13133901|NCT02761980|25989718|FG003|Overall Study|Withdrawal by Subject|0|||
13133902|NCT02761980|25989715|FG000|Overall Study|Other|0|||
13133903|NCT02761980|25989716|FG001|Overall Study|Other|0|||
13133904|NCT02761980|25989717|FG002|Overall Study|Other|1|||
13133905|NCT02761980|25989718|FG003|Overall Study|Other|0|||
13133906|NCT02761915|25989790|FG000|Overall Study|Death|3|||
13133907|NCT02761915|25989791|FG001|Overall Study|Death|1|||
13133908|NCT02761915|25989792|FG002|Overall Study|Death|1|||
13133909|NCT02761915|25989793|FG003|Overall Study|Death|1|||
13499051|NCT02366728|27083940|FG002|Overall Study|Only yielded 2 vaccines|0|||
13499052|NCT02236572|27083948|FG000|Overall Study|Withdrawal by Subject|1|||
13499053|NCT02236572|27083948|FG000|Overall Study|Protocol Violation|1|||
13499054|NCT02236572|27083948|FG000|Overall Study|Lost to Follow-up|1|||
13499055|NCT02083354|27083990|FG000|Overall Study|Withdrawal by Subject|9|||
13499056|NCT02083354|27083990|FG000|Overall Study|Lost to Follow-up|1|||
13499057|NCT02083354|27083990|FG000|Overall Study|Adverse Event|3|||
13499058|NCT02083354|27083990|FG000|Overall Study|Disease progression|46|||
13499059|NCT02083354|27083990|FG000|Overall Study|Study closed/terminated|5|||
13499060|NCT01411332|27084159|FG000|Overall Study|Lost to Follow-up|1|||
13499061|NCT01411332|27084160|FG001|Overall Study|Lost to Follow-up|0|||
13499062|NCT01411332|27084159|FG000|Overall Study|Protocol Violation|1|||
13499063|NCT01411332|27084160|FG001|Overall Study|Protocol Violation|1|||
13499064|NCT01411332|27084159|FG000|Overall Study|Withdrawal by Subject|0|||
13499065|NCT01411332|27084160|FG001|Overall Study|Withdrawal by Subject|1|||
13499066|NCT01399918|27084168|FG000|Overall Study|Not eligible and not enrolled in the study|2|||
13499067|NCT01078454|27084193|FG000|Overall Study|Adverse Event|1|||
13499068|NCT01078454|27084194|FG001|Overall Study|Adverse Event|1|||
13499069|NCT01078454|27084193|FG000|Overall Study|Death|0|||
13499070|NCT01078454|27084194|FG001|Overall Study|Death|1|||
13499071|NCT00687596|27084237|FG000|Overall Study|Adverse Event (AE)|10|||
13499072|NCT00687596|27084238|FG001|Overall Study|Adverse Event (AE)|3|||
13499073|NCT00687596|27084237|FG000|Overall Study|Radiological Disease Progression|6|||
13499074|NCT00687596|27084238|FG001|Overall Study|Radiological Disease Progression|2|||
13499075|NCT00687596|27084237|FG000|Overall Study|Clinical Disease Progression|1|||
13499076|NCT00687596|27084238|FG001|Overall Study|Clinical Disease Progression|3|||
13499077|NCT00687596|27084237|FG000|Overall Study|Investigator Discretion|3|||
13499078|NCT00687596|27084238|FG001|Overall Study|Investigator Discretion|1|||
13499079|NCT00687596|27084237|FG000|Overall Study|Sponsor Terminated Study|6|||
13499080|NCT00687596|27084238|FG001|Overall Study|Sponsor Terminated Study|17|||
13499081|NCT00112840|27084264|FG000|Overall Study|Physician Decision|1|||
13499082|NCT00112840|27084265|FG001|Overall Study|Physician Decision|0|||
13499083|NCT00112840|27084266|FG002|Overall Study|Physician Decision|0|||
13499084|NCT00112840|27084264|FG000|Overall Study|Withdrawal by Subject|1|||
13499085|NCT00112840|27084265|FG001|Overall Study|Withdrawal by Subject|0|||
13499086|NCT00112840|27084266|FG002|Overall Study|Withdrawal by Subject|1|||
13499087|NCT00112840|27084264|FG000|Overall Study|Protocol Violation|0|||
13499088|NCT00112840|27084265|FG001|Overall Study|Protocol Violation|0|||
13499089|NCT00112840|27084266|FG002|Overall Study|Protocol Violation|5|||
13208376|NCT01939002|26241528|FG000|Overall Study|Other|1|||
13499090|NCT04671342|27084305|FG000|Consented and Screened (Visit 1)|Screen Failure|3|||
13499091|NCT04671342|27084305|FG000|Consented and Screened (Visit 1)|Lost to Follow-up|4|||
13499092|NCT04671342|27084305|FG000|Consented and Screened (Visit 1)|Withdrawal by Subject|1|||
13499093|NCT04671342|27084305|FG000|Consented and Screened (Visit 1)|Withdrawn by sponsor due to recruitment consideration (CSA patients)|39|||
13499094|NCT04671342|27084305|FG000|Completed Visit 2 With Evaluable Data|Unusable device data|58|||
13499095|NCT04671342|27084305|FG000|Completed Visit 2 With Evaluable Data|Unusable PSG data|1|||
13499096|NCT04580394|27084317|FG000|First Intervention|Incorrectly Randomized|1|||
13499097|NCT04580394|27084317|FG000|First Intervention|Physician Decision|1|||
13499098|NCT04580394|27084317|FG000|First Intervention|Lost to Follow-up|1|||
13499099|NCT04580394|27084317|FG000|Washout (One Week)|Withdrawal by Subject|1|||
13499100|NCT04580394|27084317|FG000|Washout (One Week)|Adverse Event|1|||
13499101|NCT04580394|27084317|FG000|Washout (One Week)|Withdrawal by Subject|2|||
13499102|NCT04580394|27084317|FG000|Third Intervention|Adverse Event|1|||
13499103|NCT04580394|27084317|FG000|Third Intervention|Withdrawal by Subject|1|||
13499104|NCT04580394|27084317|FG000|Washout (One Week)|Withdrawal by Subject|2|||
13499105|NCT04373460|27084354|FG000|Overall Study|Did not receive tranfusion|18|||
13499106|NCT04373460|27084355|FG001|Overall Study|Did not receive tranfusion|26|||
13499107|NCT04365257|27084378|FG000|Overall Study|Physician Decision|1|||
13499108|NCT04365257|27084379|FG001|Overall Study|Physician Decision|0|||
13499109|NCT04365257|27084378|FG000|Overall Study|Patient Noncompliance|1|||
13499110|NCT04365257|27084379|FG001|Overall Study|Patient Noncompliance|0|||
13499111|NCT04365257|27084378|FG000|Overall Study|Withdrawal by Subject|0|||
13499112|NCT04365257|27084379|FG001|Overall Study|Withdrawal by Subject|1|||
13499113|NCT04239872|27084454|FG000|Overall Study|Lost to Follow-up|0|||
13499114|NCT04239872|27084455|FG001|Overall Study|Lost to Follow-up|1|||
13499115|NCT04093024|27084550|FG000|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
13499116|NCT04093024|27084551|FG001|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
13499117|NCT04093024|27084550|FG000|Double-blind Period|Discontinued treatment due to adverse event|0|||
13499118|NCT04093024|27084551|FG001|Double-blind Period|Discontinued treatment due to adverse event|2|||
13499119|NCT04093024|27084550|FG000|Double-blind Period|Discontinued treatment due to other reason|0|||
13499120|NCT04093024|27084551|FG001|Double-blind Period|Discontinued treatment due to other reason|1|||
13499121|NCT04093024|27084550|FG000|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|0|||
13499122|NCT04093024|27084551|FG001|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|1|||
13499123|NCT04062448|27084561|FG000|Overall Study|Lost to Follow-up|1|||
13499124|NCT04062448|27084561|FG000|Overall Study|Withdrawal by Subject|1|||
13499125|NCT04062448|27084561|FG000|Overall Study|Ongoing|14|||
13499126|NCT04030195|27084586|FG000|Overall Study|Withdrawal by Subject|2|||
13499127|NCT04030195|27084587|FG001|Overall Study|Withdrawal by Subject|0|||
13499128|NCT04030195|27084588|FG002|Overall Study|Withdrawal by Subject|0|||
13499129|NCT03833817|27084637|FG000|Overall Study|Withdrawal by Subject|3|||
13499130|NCT03833817|27084638|FG001|Overall Study|Withdrawal by Subject|3|||
13499131|NCT03833817|27084637|FG000|Overall Study|Lost to Follow-up|3|||
13499132|NCT03833817|27084638|FG001|Overall Study|Lost to Follow-up|3|||
13499133|NCT03536143|27084679|FG000|Overall Study|Early termination, Sponsor decision|1|||
13499134|NCT03462719|27084719|FG000|Overall Study|Withdrawal by Subject|2|||
13499135|NCT03462719|27084720|FG001|Overall Study|Withdrawal by Subject|3|||
13499136|NCT03462719|27084719|FG000|Overall Study|Ongoing|93|||
13499137|NCT03462719|27084720|FG001|Overall Study|Ongoing|91|||
13499138|NCT03201965|27084755|FG000|Overall Study|Death|5|||
13499139|NCT03201965|27084756|FG001|Overall Study|Death|27|||
13499140|NCT03201965|27084757|FG002|Overall Study|Death|27|||
13499141|NCT03201965|27084755|FG000|Overall Study|Lost to Follow-up|0|||
13499142|NCT03201965|27084756|FG001|Overall Study|Lost to Follow-up|1|||
13499143|NCT03201965|27084757|FG002|Overall Study|Lost to Follow-up|0|||
13499144|NCT03201965|27084755|FG000|Overall Study|Withdrawal by Subject|3|||
13499145|NCT03201965|27084756|FG001|Overall Study|Withdrawal by Subject|13|||
13499146|NCT03201965|27084757|FG002|Overall Study|Withdrawal by Subject|4|||
13499147|NCT03201965|27084755|FG000|Overall Study|Ongoing|20|||
13499148|NCT03201965|27084756|FG001|Overall Study|Ongoing|152|||
13499149|NCT03201965|27084757|FG002|Overall Study|Ongoing|164|||
13499150|NCT02988661|27084816|FG000|Overall Study|Death|2|||
13499151|NCT02988661|27084817|FG001|Overall Study|Death|18|||
13499152|NCT02988661|27084816|FG000|Overall Study|Lost to Follow-up|0|||
13499153|NCT02988661|27084817|FG001|Overall Study|Lost to Follow-up|33|||
13499154|NCT02988661|27084816|FG000|Overall Study|Withdrawal by Subject|0|||
13499155|NCT02988661|27084817|FG001|Overall Study|Withdrawal by Subject|6|||
13499156|NCT02988661|27084816|FG000|Overall Study|Unable to complete the 18-month survey|1|||
13499157|NCT02988661|27084817|FG001|Overall Study|Unable to complete the 18-month survey|27|||
13499158|NCT02933489|27084835|FG000|Overall Study|Ineligible|3|||
13499159|NCT02933489|27084836|FG001|Overall Study|Ineligible|3|||
13499160|NCT02933489|27084835|FG000|Overall Study|Withdrawal by Subject|27|||
13499161|NCT02933489|27084836|FG001|Overall Study|Withdrawal by Subject|18|||
13499162|NCT02933489|27084835|FG000|Overall Study|Unable to complete exams (other)|14|||
13499163|NCT02933489|27084836|FG001|Overall Study|Unable to complete exams (other)|7|||
13499164|NCT02928224|27084951|FG000|Overall Study|Randomized, Not Treated|0|||
13499165|NCT02928224|27084952|FG001|Overall Study|Randomized, Not Treated|2|||
13499166|NCT02928224|27084953|FG002|Overall Study|Randomized, Not Treated|4|||
13499167|NCT02928224|27084954|FG003|Overall Study|Randomized, Not Treated|28|||
13499168|NCT02928224|27084951|FG000|Overall Study|Treatment Ongoing|6|||
13499169|NCT02928224|27084952|FG001|Overall Study|Treatment Ongoing|78|||
13499170|NCT02928224|27084953|FG002|Overall Study|Treatment Ongoing|78|||
13499171|NCT02928224|27084954|FG003|Overall Study|Treatment Ongoing|37|||
13499172|NCT02928224|27084951|FG000|Overall Study|Progressive Disease|23|||
13499173|NCT02928224|27084952|FG001|Overall Study|Progressive Disease|104|||
13499174|NCT02928224|27084953|FG002|Overall Study|Progressive Disease|101|||
13499175|NCT02928224|27084954|FG003|Overall Study|Progressive Disease|103|||
13499176|NCT02928224|27084951|FG000|Overall Study|Adverse Event|2|||
13394527|NCT00656617|26787330|FG000|Overall Study|Move to different clinical trial|2|||
13394528|NCT00656513|26787359|FG000|Overall Study|Protocol Violation|1|||
13499177|NCT02928224|27084952|FG001|Overall Study|Adverse Event|11|||
13499178|NCT02928224|27084953|FG002|Overall Study|Adverse Event|11|||
13499179|NCT02928224|27084954|FG003|Overall Study|Adverse Event|10|||
13499180|NCT02928224|27084951|FG000|Overall Study|Changes in Patient's Condition|3|||
13499181|NCT02928224|27084952|FG001|Overall Study|Changes in Patient's Condition|9|||
13499182|NCT02928224|27084953|FG002|Overall Study|Changes in Patient's Condition|9|||
13499183|NCT02928224|27084954|FG003|Overall Study|Changes in Patient's Condition|13|||
13499184|NCT02928224|27084951|FG000|Overall Study|Death|1|||
13499185|NCT02928224|27084952|FG001|Overall Study|Death|7|||
13499186|NCT02928224|27084953|FG002|Overall Study|Death|5|||
13499187|NCT02928224|27084954|FG003|Overall Study|Death|11|||
13499188|NCT02928224|27084951|FG000|Overall Study|Withdrawal by Subject|1|||
13499189|NCT02928224|27084952|FG001|Overall Study|Withdrawal by Subject|4|||
13499190|NCT02928224|27084953|FG002|Overall Study|Withdrawal by Subject|3|||
13499191|NCT02928224|27084954|FG003|Overall Study|Withdrawal by Subject|9|||
13499192|NCT02928224|27084951|FG000|Overall Study|Dose Interruptions>28|1|||
13499193|NCT02928224|27084952|FG001|Overall Study|Dose Interruptions>28|2|||
13499194|NCT02928224|27084953|FG002|Overall Study|Dose Interruptions>28|2|||
13499195|NCT02928224|27084954|FG003|Overall Study|Dose Interruptions>28|4|||
13499196|NCT02928224|27084951|FG000|Overall Study|Patient Decision to Discontinue Drug|0|||
13499197|NCT02928224|27084952|FG001|Overall Study|Patient Decision to Discontinue Drug|2|||
13499198|NCT02928224|27084953|FG002|Overall Study|Patient Decision to Discontinue Drug|2|||
13499199|NCT02928224|27084954|FG003|Overall Study|Patient Decision to Discontinue Drug|4|||
13499200|NCT02928224|27084951|FG000|Overall Study|Physician Decision|0|||
13499201|NCT02928224|27084952|FG001|Overall Study|Physician Decision|2|||
13499202|NCT02928224|27084953|FG002|Overall Study|Physician Decision|4|||
13499203|NCT02928224|27084954|FG003|Overall Study|Physician Decision|2|||
13499204|NCT02928224|27084951|FG000|Overall Study|not listed|0|||
13499205|NCT02928224|27084952|FG001|Overall Study|not listed|3|||
13499206|NCT02928224|27084953|FG002|Overall Study|not listed|1|||
13499207|NCT02928224|27084954|FG003|Overall Study|not listed|0|||
13499208|NCT02890355|27084977|FG000|Overall Study|Adverse Event|5|||
13499209|NCT02890355|27084978|FG001|Overall Study|Adverse Event|5|||
13499210|NCT02890355|27084977|FG000|Overall Study|Refusal unrelated to adverse event|5|||
13499211|NCT02890355|27084978|FG001|Overall Study|Refusal unrelated to adverse event|10|||
13499212|NCT02890355|27084977|FG000|Overall Study|Progression/relapse|46|||
13499213|NCT02890355|27084978|FG001|Overall Study|Progression/relapse|39|||
13499214|NCT02890355|27084977|FG000|Overall Study|Not protocol specified|3|||
13499215|NCT02890355|27084978|FG001|Overall Study|Not protocol specified|4|||
13499216|NCT02820623|27084996|FG000|Overall Study|Withdrawal by Subject|1|||
13499217|NCT02820623|27084997|FG001|Overall Study|Withdrawal by Subject|3|||
13499218|NCT02820623|27084998|FG002|Overall Study|Withdrawal by Subject|3|||
13499219|NCT02820623|27084996|FG000|Overall Study|Participation interrupted due to COVID-19|3|||
13499220|NCT02820623|27084997|FG001|Overall Study|Participation interrupted due to COVID-19|3|||
13499221|NCT02820623|27084998|FG002|Overall Study|Participation interrupted due to COVID-19|2|||
13499222|NCT02820623|27084996|FG000|Overall Study|Therapist unable to enroll clients|1|||
13499223|NCT02820623|27084997|FG001|Overall Study|Therapist unable to enroll clients|1|||
13499224|NCT02820623|27084998|FG002|Overall Study|Therapist unable to enroll clients|3|||
13499225|NCT02820623|27084996|FG000|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
13499226|NCT02820623|27084997|FG001|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
13499227|NCT02820623|27084998|FG002|Overall Study|Clients declined, piloting condition, or only telehealth|3|||
13499228|NCT02780804|27085038|FG000|Overall Study|Death|1|||
13499229|NCT02780804|27085039|FG001|Overall Study|Death|0|||
13499230|NCT02780804|27085040|FG002|Overall Study|Death|0|||
13499231|NCT02780804|27085038|FG000|Overall Study|Lack of Efficacy|5|||
13499232|NCT02780804|27085039|FG001|Overall Study|Lack of Efficacy|8|||
13499233|NCT02780804|27085040|FG002|Overall Study|Lack of Efficacy|4|||
13499234|NCT02780804|27085038|FG000|Overall Study|Physician Decision|0|||
13499235|NCT02780804|27085039|FG001|Overall Study|Physician Decision|0|||
13394529|NCT00656513|26787360|FG001|Overall Study|Protocol Violation|0|||
13499236|NCT02780804|27085040|FG002|Overall Study|Physician Decision|2|||
13499237|NCT02780804|27085038|FG000|Overall Study|Withdrawal by Subject|0|||
13499238|NCT02780804|27085039|FG001|Overall Study|Withdrawal by Subject|1|||
13499239|NCT02780804|27085040|FG002|Overall Study|Withdrawal by Subject|0|||
13499240|NCT02642042|27085055|FG000|Overall Study|Adverse Event|22|||
13499241|NCT02642042|27085055|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
13499242|NCT02642042|27085055|FG000|Overall Study|Progression/Relapse|28|||
13499243|NCT02642042|27085055|FG000|Overall Study|Death|1|||
13499244|NCT02642042|27085055|FG000|Overall Study|Not Protocol Specified|2|||
13499245|NCT02583269|27085102|FG000|Overall Study|Patient hospitalized prior to start|1|||
13499246|NCT02583269|27085103|FG001|Overall Study|Patient hospitalized prior to start|0|||
13499247|NCT02583269|27085104|FG002|Overall Study|Patient hospitalized prior to start|0|||
13499248|NCT02583269|27085105|FG003|Overall Study|Patient hospitalized prior to start|0|||
13499249|NCT02583269|27085106|FG004|Overall Study|Patient hospitalized prior to start|0|||
13499250|NCT02306161|27085158|FG000|Overall Study|Death|1|||
13499251|NCT02306161|27085159|FG001|Overall Study|Death|3|||
13499252|NCT02306161|27085158|FG000|Overall Study|Lack of Efficacy|20|||
13499253|NCT02306161|27085159|FG001|Overall Study|Lack of Efficacy|43|||
13499254|NCT02306161|27085158|FG000|Overall Study|Physician Decision|30|||
13499255|NCT02306161|27085159|FG001|Overall Study|Physician Decision|18|||
13499256|NCT02306161|27085158|FG000|Overall Study|Withdrawal by Subject|4|||
13499257|NCT02306161|27085159|FG001|Overall Study|Withdrawal by Subject|0|||
13499258|NCT02306161|27085158|FG000|Overall Study|Ineligible|9|||
13499259|NCT02306161|27085159|FG001|Overall Study|Ineligible|5|||
13499260|NCT02278120|27085180|FG000|Overall Study|Progressive disease|122|||
13499261|NCT02278120|27085181|FG001|Overall Study|Progressive disease|174|||
13499262|NCT02278120|27085180|FG000|Overall Study|Patient/guardian decision|14|||
13499263|NCT02278120|27085181|FG001|Overall Study|Patient/guardian decision|8|||
13499264|NCT02278120|27085180|FG000|Overall Study|Adverse Event|12|||
13499265|NCT02278120|27085181|FG001|Overall Study|Adverse Event|10|||
13499266|NCT02278120|27085180|FG000|Overall Study|Physician Decision|8|||
13499267|NCT02278120|27085181|FG001|Overall Study|Physician Decision|19|||
13499268|NCT02278120|27085180|FG000|Overall Study|Death|3|||
13499269|NCT02278120|27085181|FG001|Overall Study|Death|3|||
13499270|NCT02278120|27085180|FG000|Overall Study|Lost to Follow-up|2|||
13499271|NCT02278120|27085181|FG001|Overall Study|Lost to Follow-up|0|||
13499272|NCT02278120|27085180|FG000|Overall Study|Protocol Violation|0|||
13499273|NCT02278120|27085181|FG001|Overall Study|Protocol Violation|2|||
13499274|NCT02272790|27085334|FG000|Overall Study|Physician Decision|0|||
13499275|NCT02272790|27085335|FG001|Overall Study|Physician Decision|1|||
13499276|NCT02272790|27085336|FG002|Overall Study|Physician Decision|0|||
13499277|NCT02272790|27085337|FG003|Overall Study|Physician Decision|0|||
13499278|NCT02272790|27085338|FG004|Overall Study|Physician Decision|0|||
13499279|NCT02272790|27085339|FG005|Overall Study|Physician Decision|0|||
13499280|NCT02257528|27085348|FG000|Overall Study|Never received study treatment|1|||
13499281|NCT02180867|27085399|FG000|Overall Study|Adverse Event|3|||
13499282|NCT02180867|27085400|FG001|Overall Study|Adverse Event|4|||
13499283|NCT02180867|27085401|FG002|Overall Study|Adverse Event|1|||
13499284|NCT02180867|27085402|FG003|Overall Study|Adverse Event|5|||
13499285|NCT02180867|27085403|FG004|Overall Study|Adverse Event|0|||
13499286|NCT02180867|27085404|FG005|Overall Study|Adverse Event|0|||
13499287|NCT02180867|27085405|FG006|Overall Study|Adverse Event|0|||
13499288|NCT02180867|27085399|FG000|Overall Study|Death|0|||
13499289|NCT02180867|27085400|FG001|Overall Study|Death|0|||
13499290|NCT02180867|27085401|FG002|Overall Study|Death|0|||
13499291|NCT02180867|27085402|FG003|Overall Study|Death|0|||
13499292|NCT02180867|27085403|FG004|Overall Study|Death|1|||
13499293|NCT02180867|27085404|FG005|Overall Study|Death|0|||
13499294|NCT02180867|27085405|FG006|Overall Study|Death|0|||
13499295|NCT02180867|27085399|FG000|Overall Study|Lack of Efficacy|0|||
13499296|NCT02180867|27085400|FG001|Overall Study|Lack of Efficacy|2|||
13499297|NCT02180867|27085401|FG002|Overall Study|Lack of Efficacy|0|||
13499298|NCT02180867|27085402|FG003|Overall Study|Lack of Efficacy|1|||
13499299|NCT02180867|27085403|FG004|Overall Study|Lack of Efficacy|6|||
13499300|NCT02180867|27085404|FG005|Overall Study|Lack of Efficacy|0|||
13499301|NCT02180867|27085405|FG006|Overall Study|Lack of Efficacy|1|||
13499302|NCT02180867|27085399|FG000|Overall Study|Physician Decision|1|||
13499303|NCT02180867|27085400|FG001|Overall Study|Physician Decision|3|||
13499304|NCT02180867|27085401|FG002|Overall Study|Physician Decision|1|||
13499305|NCT02180867|27085402|FG003|Overall Study|Physician Decision|10|||
13499306|NCT02180867|27085403|FG004|Overall Study|Physician Decision|9|||
13499307|NCT02180867|27085404|FG005|Overall Study|Physician Decision|3|||
13499308|NCT02180867|27085405|FG006|Overall Study|Physician Decision|4|||
13499309|NCT02180867|27085399|FG000|Overall Study|Withdrawal by Subject|0|||
13499310|NCT02180867|27085400|FG001|Overall Study|Withdrawal by Subject|0|||
13499311|NCT02180867|27085401|FG002|Overall Study|Withdrawal by Subject|0|||
13499312|NCT02180867|27085402|FG003|Overall Study|Withdrawal by Subject|1|||
13499313|NCT02180867|27085403|FG004|Overall Study|Withdrawal by Subject|1|||
13499314|NCT02180867|27085404|FG005|Overall Study|Withdrawal by Subject|0|||
13499315|NCT02180867|27085405|FG006|Overall Study|Withdrawal by Subject|0|||
13499316|NCT02180867|27085399|FG000|Overall Study|Ineligible|1|||
13499317|NCT02180867|27085400|FG001|Overall Study|Ineligible|2|||
13499318|NCT02180867|27085401|FG002|Overall Study|Ineligible|0|||
13499319|NCT02180867|27085402|FG003|Overall Study|Ineligible|3|||
13499320|NCT02180867|27085403|FG004|Overall Study|Ineligible|5|||
13499321|NCT02180867|27085404|FG005|Overall Study|Ineligible|0|||
13499322|NCT02180867|27085405|FG006|Overall Study|Ineligible|0|||
13499323|NCT02180867|27085399|FG000|Overall Study|Repeat Eligibility Studies|0|||
13499324|NCT02180867|27085400|FG001|Overall Study|Repeat Eligibility Studies|0|||
13499325|NCT02180867|27085401|FG002|Overall Study|Repeat Eligibility Studies|0|||
13499326|NCT02180867|27085402|FG003|Overall Study|Repeat Eligibility Studies|0|||
13499327|NCT02180867|27085403|FG004|Overall Study|Repeat Eligibility Studies|1|||
13499328|NCT02180867|27085404|FG005|Overall Study|Repeat Eligibility Studies|0|||
13499329|NCT02180867|27085405|FG006|Overall Study|Repeat Eligibility Studies|0|||
13499330|NCT02180867|27085399|FG000|Overall Study|Refusal of further protocol therapy|1|||
13499331|NCT02180867|27085400|FG001|Overall Study|Refusal of further protocol therapy|0|||
13499332|NCT02180867|27085401|FG002|Overall Study|Refusal of further protocol therapy|2|||
13499333|NCT02180867|27085402|FG003|Overall Study|Refusal of further protocol therapy|6|||
13499334|NCT02180867|27085403|FG004|Overall Study|Refusal of further protocol therapy|4|||
13499335|NCT02180867|27085404|FG005|Overall Study|Refusal of further protocol therapy|0|||
13499336|NCT02180867|27085405|FG006|Overall Study|Refusal of further protocol therapy|0|||
13499337|NCT02154490|27085415|FG000|Overall Study|No tissue submitted|23|||
13499338|NCT02154490|27085415|FG000|Overall Study|No biomarker results|167|||
13499339|NCT02154490|27085415|FG000|Overall Study|Not assigned to a sub-study|270|||
13499340|NCT02154490|27085415|FG000|Overall Study|Did not register to a sub-study|749|||
13499341|NCT02125461|27085451|FG000|Overall Study|Withdrawal by Subject|30|||
13499342|NCT02125461|27085452|FG001|Overall Study|Withdrawal by Subject|16|||
13499343|NCT02125461|27085451|FG000|Overall Study|Lost to Follow-up|8|||
13499344|NCT02125461|27085452|FG001|Overall Study|Lost to Follow-up|3|||
13499345|NCT02125461|27085451|FG000|Overall Study|Death|260|||
13499346|NCT02125461|27085452|FG001|Overall Study|Death|149|||
13499347|NCT02125461|27085451|FG000|Overall Study|Missing Termination Reason|0|||
13499348|NCT02125461|27085452|FG001|Overall Study|Missing Termination Reason|1|||
13499349|NCT01951885|27085507|FG000|Overall Study|ineligible due to a change in conditioning regimen|0|||
13499350|NCT01951885|27085508|FG001|Overall Study|ineligible due to a change in conditioning regimen|1|||
13499351|NCT01951885|27085507|FG000|Overall Study|Adverse Event|1|||
13499352|NCT01951885|27085508|FG001|Overall Study|Adverse Event|0|||
13499353|NCT01951885|27085507|FG000|Overall Study|Withdrawal by Subject|0|||
13499354|NCT01951885|27085508|FG001|Overall Study|Withdrawal by Subject|1|||
13499355|NCT01951885|27085507|FG000|Overall Study|ineligible due to a change in donor|0|||
13499356|NCT01951885|27085508|FG001|Overall Study|ineligible due to a change in donor|1|||
13499357|NCT01951885|27085507|FG000|Overall Study|ineligible after experiencing cardiac issues|0|||
13499358|NCT01951885|27085508|FG001|Overall Study|ineligible after experiencing cardiac issues|1|||
13499359|NCT01886872|27085551|FG000|Overall Study|Ineligible|7|||
13499360|NCT01886872|27085552|FG001|Overall Study|Ineligible|4|||
13499361|NCT01886872|27085553|FG002|Overall Study|Ineligible|12|||
13499362|NCT01776840|27085619|FG000|Overall Study|Lost to Follow-up|4|||
13499363|NCT01776840|27085620|FG001|Overall Study|Lost to Follow-up|4|||
13499364|NCT01776840|27085619|FG000|Overall Study|Withdrawal by Subject|42|||
13499365|NCT01776840|27085620|FG001|Overall Study|Withdrawal by Subject|22|||
13499366|NCT01776840|27085619|FG000|Overall Study|Ongoing|112|||
13499367|NCT01776840|27085620|FG001|Overall Study|Ongoing|129|||
13499368|NCT01522976|27085653|FG000|Overall Study|Ineligible|4|||
13499369|NCT01522976|27085654|FG001|Overall Study|Ineligible|0|||
13499370|NCT01522976|27085655|FG002|Overall Study|Ineligible|1|||
13499371|NCT01522976|27085653|FG000|Overall Study|Death|7|||
13499372|NCT01522976|27085654|FG001|Overall Study|Death|6|||
13499373|NCT01522976|27085655|FG002|Overall Study|Death|2|||
13499374|NCT01522976|27085653|FG000|Overall Study|Still on treatment|9|||
13499375|NCT01522976|27085654|FG001|Overall Study|Still on treatment|9|||
13499376|NCT01522976|27085655|FG002|Overall Study|Still on treatment|6|||
13499377|NCT01522976|27085653|FG000|Overall Study|Disease progression|28|||
13499378|NCT01522976|27085654|FG001|Overall Study|Disease progression|30|||
13499379|NCT01522976|27085655|FG002|Overall Study|Disease progression|25|||
13499380|NCT01522976|27085653|FG000|Overall Study|Adverse Event|17|||
13499381|NCT01522976|27085654|FG001|Overall Study|Adverse Event|7|||
13499382|NCT01522976|27085655|FG002|Overall Study|Adverse Event|18|||
13499383|NCT01522976|27085653|FG000|Overall Study|Refusal unrelated to adverse event|10|||
13499384|NCT01522976|27085654|FG001|Overall Study|Refusal unrelated to adverse event|13|||
13499385|NCT01522976|27085655|FG002|Overall Study|Refusal unrelated to adverse event|14|||
13499386|NCT01522976|27085653|FG000|Overall Study|Not protocol specified|22|||
13499387|NCT01522976|27085654|FG001|Overall Study|Not protocol specified|27|||
13499388|NCT01522976|27085655|FG002|Overall Study|Not protocol specified|27|||
13499389|NCT01465334|27085688|FG000|Overall Study|Disease Progression|1|||
13499390|NCT01465334|27085689|FG001|Overall Study|Disease Progression|0|||
13499391|NCT01465334|27085688|FG000|Overall Study|Adverse Event|1|||
13499392|NCT01465334|27085689|FG001|Overall Study|Adverse Event|0|||
13499393|NCT01465334|27085688|FG000|Overall Study|Richter's transformation|0|||
13499394|NCT01465334|27085689|FG001|Overall Study|Richter's transformation|3|||
13499395|NCT01465334|27085688|FG000|Overall Study|Refractory Disease|0|||
13499396|NCT01465334|27085689|FG001|Overall Study|Refractory Disease|3|||
13499397|NCT01358877|27085758|FG000|Overall Study|Death|80|||
13499398|NCT01358877|27085759|FG001|Overall Study|Death|89|||
13499399|NCT01358877|27085758|FG000|Overall Study|Ongoing follow-up for post-recurrence|87|||
13499400|NCT01358877|27085759|FG001|Overall Study|Ongoing follow-up for post-recurrence|108|||
13499401|NCT01358877|27085758|FG000|Overall Study|Ongoing follow-up for IDFS event|2084|||
13499402|NCT01358877|27085759|FG001|Overall Study|Ongoing follow-up for IDFS event|2073|||
13499403|NCT01358877|27085758|FG000|Overall Study|Ongoing follow-up for overall survival|7|||
13499404|NCT01358877|27085759|FG001|Overall Study|Ongoing follow-up for overall survival|5|||
13499405|NCT01358877|27085758|FG000|Overall Study|Other|142|||
13499406|NCT01358877|27085759|FG001|Overall Study|Other|129|||
13499407|NCT01286272|27085776|FG000|Overall Study|Ineligible after beginning treatment|1|||
13499408|NCT01286272|27085777|FG001|Overall Study|Ineligible after beginning treatment|3|||
13499409|NCT01275677|27085802|FG000|Overall Study|Not at risk for recurrence.|1|||
13499410|NCT01275677|27085803|FG001|Overall Study|Not at risk for recurrence.|1|||
13499411|NCT01275677|27085802|FG000|Overall Study|No follow-up|26|||
13499412|NCT01275677|27085803|FG001|Overall Study|No follow-up|37|||
13499413|NCT01275677|27085802|FG000|Overall Study|No clinical follow up.|1|||
13499414|NCT01275677|27085803|FG001|Overall Study|No clinical follow up.|4|||
13499415|NCT00972478|27085869|FG000|Overall Study|Adverse Event|3|||
13499416|NCT00972478|27085870|FG001|Overall Study|Adverse Event|16|||
13499417|NCT00972478|27085869|FG000|Overall Study|Withdrawal by Subject|1|||
13499418|NCT00972478|27085870|FG001|Overall Study|Withdrawal by Subject|8|||
13499419|NCT00972478|27085869|FG000|Overall Study|Progression/Relapse|0|||
13499420|NCT00972478|27085870|FG001|Overall Study|Progression/Relapse|2|||
13499421|NCT00972478|27085869|FG000|Overall Study|Death|0|||
13499422|NCT00972478|27085870|FG001|Overall Study|Death|2|||
13499423|NCT00972478|27085869|FG000|Overall Study|Not protocol specified|1|||
13499424|NCT00972478|27085870|FG001|Overall Study|Not protocol specified|1|||
13499425|NCT00972478|27085869|FG000|Overall Study|Ineligible|1|||
13499426|NCT00972478|27085870|FG001|Overall Study|Ineligible|7|||
13499427|NCT00972478|27085869|FG000|Overall Study|Not start protocol treatment|1|||
13499428|NCT00972478|27085870|FG001|Overall Study|Not start protocol treatment|2|||
13499429|NCT00937937|27085879|FG000|Overall Study|Adverse Event|6|||
13499430|NCT00937937|27085879|FG000|Overall Study|Withdrawal by Subject|2|||
13499431|NCT00937937|27085879|FG000|Overall Study|Progression/relapse|61|||
13499432|NCT00937937|27085879|FG000|Overall Study|Death|1|||
13499433|NCT00937937|27085879|FG000|Overall Study|Other|2|||
13499434|NCT00769379|27085904|FG000|Overall Study|No follow up data mapped to Other.|3|||
13499435|NCT00769379|27085905|FG001|Overall Study|No follow up data mapped to Other.|13|||
13499436|NCT00658814|27085926|FG000|Remission Induction Chemotherapy|Adverse Event|1|||
13499437|NCT00658814|27085927|FG001|Remission Induction Chemotherapy|Adverse Event|3|||
13499438|NCT00658814|27085926|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3|||
13499439|NCT00658814|27085927|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4|||
13499440|NCT00658814|27085926|FG000|Remission Induction Chemotherapy|Progression/Relapse|0|||
13499441|NCT00658814|27085927|FG001|Remission Induction Chemotherapy|Progression/Relapse|1|||
13499442|NCT00658814|27085926|FG000|Remission Induction Chemotherapy|Death|1|||
13499443|NCT00658814|27085927|FG001|Remission Induction Chemotherapy|Death|4|||
13499444|NCT00658814|27085926|FG000|Remission Induction Chemotherapy|Not protocol specified|2|||
13499445|NCT00658814|27085927|FG001|Remission Induction Chemotherapy|Not protocol specified|4|||
13499446|NCT00658814|27085926|FG000|Remission Induction Chemotherapy|Not eligible|1|||
13499447|NCT00658814|27085927|FG001|Remission Induction Chemotherapy|Not eligible|2|||
13499448|NCT00658814|27085926|FG000|Consolidation Therapy|Not protocol specified|0|||
13499449|NCT00658814|27085927|FG001|Consolidation Therapy|Not protocol specified|1|||
13499450|NCT00658814|27085926|FG000|Consolidation Therapy|Not eligible|2|||
13499451|NCT00658814|27085927|FG001|Consolidation Therapy|Not eligible|2|||
13499452|NCT00658814|27085926|FG000|Maintenance Therapy|Adverse Event|1|||
13499453|NCT00658814|27085927|FG001|Maintenance Therapy|Adverse Event|1|||
13499454|NCT00658814|27085926|FG000|Maintenance Therapy|Not protocol specified|1|||
13499455|NCT00658814|27085927|FG001|Maintenance Therapy|Not protocol specified|0|||
13499456|NCT00658814|27085926|FG000|Maintenance Therapy|Not eligible|1|||
13499457|NCT00658814|27085927|FG001|Maintenance Therapy|Not eligible|0|||
13499458|NCT00644228|27085944|FG000|Randomization & Eligibility|Ineligible|31|||
13499459|NCT00644228|27085945|FG001|Randomization & Eligibility|Ineligible|21|||
13499460|NCT00644228|27085944|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1|||
13499461|NCT00644228|27085945|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0|||
13499462|NCT00644228|27085944|FG000|Randomization & Eligibility|Invalid Consent|0|||
13499463|NCT00644228|27085945|FG001|Randomization & Eligibility|Invalid Consent|1|||
13499464|NCT00644228|27085944|FG000|Induction Therapy|Adverse Event|22|||
13499465|NCT00644228|27085945|FG001|Induction Therapy|Adverse Event|55|||
13499466|NCT00644228|27085944|FG000|Induction Therapy|Withdrawal by Subject|10|||
13499467|NCT00644228|27085945|FG001|Induction Therapy|Withdrawal by Subject|3|||
13499468|NCT00644228|27085944|FG000|Induction Therapy|Progression/Relapse|24|||
13499469|NCT00644228|27085945|FG001|Induction Therapy|Progression/Relapse|12|||
13499470|NCT00644228|27085944|FG000|Induction Therapy|Death|3|||
13499471|NCT00644228|27085945|FG001|Induction Therapy|Death|7|||
13499472|NCT00644228|27085944|FG000|Induction Therapy|Not Protocol-Specified|24|||
13499473|NCT00644228|27085945|FG001|Induction Therapy|Not Protocol-Specified|28|||
13499474|NCT00644228|27085944|FG000|Maintenance|Adverse Event|27|||
13499475|NCT00644228|27085945|FG001|Maintenance|Adverse Event|31|||
13499476|NCT00644228|27085944|FG000|Maintenance|Withdrawal by Subject|6|||
13499477|NCT00644228|27085945|FG001|Maintenance|Withdrawal by Subject|4|||
13499478|NCT00644228|27085944|FG000|Maintenance|Progression/Relapse|67|||
13499479|NCT00644228|27085945|FG001|Maintenance|Progression/Relapse|42|||
13499480|NCT00644228|27085944|FG000|Maintenance|Death|3|||
13499481|NCT00644228|27085945|FG001|Maintenance|Death|3|||
13499482|NCT00644228|27085944|FG000|Maintenance|Not Protocol-Specified|14|||
13499483|NCT00644228|27085945|FG001|Maintenance|Not Protocol-Specified|15|||
13499484|NCT00644228|27085944|FG000|Maintenance|On Treatment|26|||
13499485|NCT00644228|27085945|FG001|Maintenance|On Treatment|40|||
13499486|NCT00601900|27085984|FG000|Overall Study|Withdrawal by Subject|0|||
13499487|NCT00601900|27085985|FG001|Overall Study|Withdrawal by Subject|3|||
13499488|NCT00588770|27086002|FG000|Overall Study|Disease progression|85|||
13499489|NCT00588770|27086003|FG001|Overall Study|Disease progression|68|||
13499490|NCT00588770|27086002|FG000|Overall Study|Adverse Event|29|||
13499491|NCT00588770|27086003|FG001|Overall Study|Adverse Event|58|||
13499492|NCT00588770|27086002|FG000|Overall Study|Death|13|||
13499493|NCT00588770|27086003|FG001|Overall Study|Death|22|||
13499494|NCT00588770|27086002|FG000|Overall Study|Withdrawal by Subject|15|||
13499495|NCT00588770|27086003|FG001|Overall Study|Withdrawal by Subject|25|||
13499496|NCT00588770|27086002|FG000|Overall Study|Alternative therapy|2|||
13499497|NCT00588770|27086003|FG001|Overall Study|Alternative therapy|4|||
13499498|NCT00588770|27086002|FG000|Overall Study|Other complicating disease|3|||
13499499|NCT00588770|27086003|FG001|Overall Study|Other complicating disease|2|||
13499500|NCT00588770|27086002|FG000|Overall Study|Not start protocol therapy|0|||
13499501|NCT00588770|27086003|FG001|Overall Study|Not start protocol therapy|9|||
13499502|NCT00588770|27086002|FG000|Overall Study|Lack of Efficacy|8|||
13499503|NCT00588770|27086003|FG001|Overall Study|Lack of Efficacy|10|||
13499504|NCT00588770|27086002|FG000|Overall Study|Physician discretion|2|||
13499505|NCT00588770|27086003|FG001|Overall Study|Physician discretion|0|||
13499506|NCT00588770|27086002|FG000|Overall Study|Patient non-compliance|2|||
13499507|NCT00588770|27086003|FG001|Overall Study|Patient non-compliance|2|||
13499508|NCT00433511|27086027|FG000|Step 1|Adverse Event|50|||
13499509|NCT00433511|27086028|FG001|Step 1|Adverse Event|157|||
13499510|NCT00433511|27086029|FG002|Step 1|Adverse Event|153|||
13499511|NCT00433511|27086027|FG000|Step 1|Withdrawal by Subject|45|||
13499512|NCT00433511|27086028|FG001|Step 1|Withdrawal by Subject|143|||
13499513|NCT00433511|27086029|FG002|Step 1|Withdrawal by Subject|154|||
13499514|NCT00433511|27086027|FG000|Step 1|Death|3|||
13499515|NCT00433511|27086028|FG001|Step 1|Death|1|||
13499516|NCT00433511|27086029|FG002|Step 1|Death|1|||
13499517|NCT00433511|27086027|FG000|Step 1|Physician Decision|1|||
13499518|NCT00433511|27086028|FG001|Step 1|Physician Decision|4|||
13499519|NCT00433511|27086029|FG002|Step 1|Physician Decision|3|||
13499520|NCT00433511|27086027|FG000|Step 1|Never started protocol therapy|28|||
13499521|NCT00433511|27086028|FG001|Step 1|Never started protocol therapy|64|||
13499522|NCT00433511|27086029|FG002|Step 1|Never started protocol therapy|66|||
13499523|NCT00433511|27086027|FG000|Step 1|Alternative therapy|2|||
13499524|NCT00433511|27086028|FG001|Step 1|Alternative therapy|1|||
13499525|NCT00433511|27086029|FG002|Step 1|Alternative therapy|3|||
13499526|NCT00433511|27086027|FG000|Step 1|Disease progression, relapse|5|||
13499527|NCT00433511|27086028|FG001|Step 1|Disease progression, relapse|3|||
13499528|NCT00433511|27086029|FG002|Step 1|Disease progression, relapse|3|||
13499529|NCT00433511|27086027|FG000|Step 1|Other complicating disease|2|||
13499530|NCT00433511|27086028|FG001|Step 1|Other complicating disease|6|||
13499531|NCT00433511|27086029|FG002|Step 1|Other complicating disease|3|||
13499532|NCT00433511|27086027|FG000|Step 1|Non-breast cancer surgery/wound issues|0|||
13499533|NCT00433511|27086028|FG001|Step 1|Non-breast cancer surgery/wound issues|4|||
13499534|NCT00433511|27086029|FG002|Step 1|Non-breast cancer surgery/wound issues|1|||
13499535|NCT00433511|27086027|FG000|Step 1|Suspected recurrence|0|||
13499536|NCT00433511|27086028|FG001|Step 1|Suspected recurrence|1|||
13499537|NCT00433511|27086029|FG002|Step 1|Suspected recurrence|0|||
13499538|NCT00433511|27086027|FG000|Step 1|Insurance/drug distribution issues|0|||
13499539|NCT00433511|27086028|FG001|Step 1|Insurance/drug distribution issues|1|||
13499540|NCT00433511|27086029|FG002|Step 1|Insurance/drug distribution issues|2|||
13499541|NCT00433511|27086027|FG000|Step 1|Patient moved|0|||
13499542|NCT00433511|27086028|FG001|Step 1|Patient moved|0|||
13499543|NCT00433511|27086029|FG002|Step 1|Patient moved|1|||
13499544|NCT00433511|27086027|FG000|Step 2 (Arm D)|Adverse Event|0|||
13499545|NCT00433511|27086028|FG001|Step 2 (Arm D)|Adverse Event|0|||
13499546|NCT00433511|27086029|FG002|Step 2 (Arm D)|Adverse Event|135|||
13499547|NCT00433511|27086027|FG000|Step 2 (Arm D)|Withdrawal by Subject|0|||
13499548|NCT00433511|27086028|FG001|Step 2 (Arm D)|Withdrawal by Subject|0|||
13499549|NCT00433511|27086029|FG002|Step 2 (Arm D)|Withdrawal by Subject|181|||
13499550|NCT00433511|27086027|FG000|Step 2 (Arm D)|Never started protocol therapy|0|||
13499551|NCT00433511|27086028|FG001|Step 2 (Arm D)|Never started protocol therapy|0|||
13499552|NCT00433511|27086029|FG002|Step 2 (Arm D)|Never started protocol therapy|148|||
13499553|NCT00433511|27086027|FG000|Step 2 (Arm D)|Physician Decision|0|||
13499554|NCT00433511|27086028|FG001|Step 2 (Arm D)|Physician Decision|0|||
13499555|NCT00433511|27086029|FG002|Step 2 (Arm D)|Physician Decision|9|||
13499556|NCT00433511|27086027|FG000|Step 2 (Arm D)|Disease progression, relapse|0|||
13499557|NCT00433511|27086028|FG001|Step 2 (Arm D)|Disease progression, relapse|0|||
13499558|NCT00433511|27086029|FG002|Step 2 (Arm D)|Disease progression, relapse|7|||
13499559|NCT00433511|27086027|FG000|Step 2 (Arm D)|Other complicating disease|0|||
13499560|NCT00433511|27086028|FG001|Step 2 (Arm D)|Other complicating disease|0|||
13499561|NCT00433511|27086029|FG002|Step 2 (Arm D)|Other complicating disease|3|||
13499562|NCT00433511|27086027|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
13499563|NCT00433511|27086028|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
13499564|NCT00433511|27086029|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2|||
13499565|NCT00433511|27086027|FG000|Step 2 (Arm D)|Suspected recurrence|0|||
13499566|NCT00433511|27086028|FG001|Step 2 (Arm D)|Suspected recurrence|0|||
13499567|NCT00433511|27086029|FG002|Step 2 (Arm D)|Suspected recurrence|1|||
13499568|NCT00433511|27086027|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
13499569|NCT00433511|27086028|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
13499570|NCT00433511|27086029|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4|||
13499571|NCT00433511|27086027|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
13499572|NCT00433511|27086028|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
13499573|NCT00433511|27086029|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1|||
13499574|NCT00354835|27086066|FG000|Overall Study|Death|1|||
13499575|NCT00354835|27086067|FG001|Overall Study|Death|1|||
13499576|NCT00354835|27086066|FG000|Overall Study|Physician Decision|8|||
13499577|NCT00354835|27086067|FG001|Overall Study|Physician Decision|13|||
13499578|NCT00354835|27086066|FG000|Overall Study|Withdrawal by Subject|2|||
13499579|NCT00354835|27086067|FG001|Overall Study|Withdrawal by Subject|1|||
13499580|NCT00354835|27086066|FG000|Overall Study|Ineligible|17|||
13499581|NCT00354835|27086067|FG001|Overall Study|Ineligible|16|||
13499582|NCT00354835|27086066|FG000|Overall Study|Disease progression or relapse|15|||
13499583|NCT00354835|27086067|FG001|Overall Study|Disease progression or relapse|22|||
13499584|NCT00354835|27086066|FG000|Overall Study|Adverse Event|6|||
13499585|NCT00354835|27086067|FG001|Overall Study|Adverse Event|0|||
13499586|NCT00354835|27086066|FG000|Overall Study|Refusal of further therapy|3|||
13499587|NCT00354835|27086067|FG001|Overall Study|Refusal of further therapy|8|||
13499588|NCT00324805|27086086|FG000|Overall Study|Adverse Event|62|||
13499589|NCT00324805|27086087|FG001|Overall Study|Adverse Event|203|||
13499590|NCT00324805|27086086|FG000|Overall Study|Progression|7|||
13499591|NCT00324805|27086087|FG001|Overall Study|Progression|35|||
13499592|NCT00324805|27086086|FG000|Overall Study|Withdrawal by Subject|51|||
13499593|NCT00324805|27086087|FG001|Overall Study|Withdrawal by Subject|174|||
13499594|NCT00324805|27086086|FG000|Overall Study|Death|6|||
13499595|NCT00324805|27086087|FG001|Overall Study|Death|9|||
13499596|NCT00324805|27086086|FG000|Overall Study|Alternative therapy|4|||
13499597|NCT00324805|27086087|FG001|Overall Study|Alternative therapy|8|||
13499598|NCT00324805|27086086|FG000|Overall Study|Other complicating disease|1|||
13499599|NCT00324805|27086087|FG001|Overall Study|Other complicating disease|9|||
13499600|NCT00324805|27086086|FG000|Overall Study|Other reasons|7|||
13499601|NCT00324805|27086087|FG001|Overall Study|Other reasons|26|||
13499602|NCT00324805|27086086|FG000|Overall Study|Other|0|||
13499603|NCT00324805|27086087|FG001|Overall Study|Other|2|||
13499604|NCT00324805|27086086|FG000|Overall Study|Did not start therapy|12|||
13499605|NCT00324805|27086087|FG001|Overall Study|Did not start therapy|17|||
13499606|NCT00070499|27086172|FG000|Overall Study|Adverse Event|6|||
13499607|NCT00070499|27086173|FG001|Overall Study|Adverse Event|6|||
13499608|NCT00070499|27086174|FG002|Overall Study|Adverse Event|19|||
13499609|NCT00070499|27086175|FG003|Overall Study|Adverse Event|15|||
13499610|NCT00070499|27086172|FG000|Overall Study|Refusal unrelated to adverse effects|7|||
13499611|NCT00070499|27086173|FG001|Overall Study|Refusal unrelated to adverse effects|5|||
13499612|NCT00070499|27086174|FG002|Overall Study|Refusal unrelated to adverse effects|5|||
13499613|NCT00070499|27086175|FG003|Overall Study|Refusal unrelated to adverse effects|8|||
13499614|NCT00070499|27086172|FG000|Overall Study|Progression/relapse|4|||
13499615|NCT00070499|27086173|FG001|Overall Study|Progression/relapse|2|||
13499616|NCT00070499|27086174|FG002|Overall Study|Progression/relapse|1|||
13499617|NCT00070499|27086175|FG003|Overall Study|Progression/relapse|4|||
13499618|NCT00070499|27086172|FG000|Overall Study|Death|1|||
13381456|NCT00753415|26748246|FG002|Part B|Lost to Follow-up|0|||
13499619|NCT00070499|27086173|FG001|Overall Study|Death|1|||
13499620|NCT00070499|27086174|FG002|Overall Study|Death|1|||
13499621|NCT00070499|27086175|FG003|Overall Study|Death|2|||
13499622|NCT00070499|27086172|FG000|Overall Study|Other - not protocol specified|7|||
13499623|NCT00070499|27086173|FG001|Overall Study|Other - not protocol specified|3|||
13499624|NCT00070499|27086174|FG002|Overall Study|Other - not protocol specified|12|||
13499625|NCT00070499|27086175|FG003|Overall Study|Other - not protocol specified|20|||
13499626|NCT00070499|27086172|FG000|Overall Study|Still on protocol treatment|10|||
13499627|NCT00070499|27086173|FG001|Overall Study|Still on protocol treatment|4|||
13499628|NCT00070499|27086174|FG002|Overall Study|Still on protocol treatment|79|||
13499629|NCT00070499|27086175|FG003|Overall Study|Still on protocol treatment|57|||
13499630|NCT00070499|27086172|FG000|Overall Study|Did not start treatment|1|||
13499631|NCT00070499|27086173|FG001|Overall Study|Did not start treatment|0|||
13499632|NCT00070499|27086174|FG002|Overall Study|Did not start treatment|0|||
13499633|NCT00070499|27086175|FG003|Overall Study|Did not start treatment|2|||
13499634|NCT00070499|27086172|FG000|Overall Study|Not eligible|2|||
13499635|NCT00070499|27086173|FG001|Overall Study|Not eligible|5|||
13499636|NCT00070499|27086174|FG002|Overall Study|Not eligible|3|||
13499637|NCT00070499|27086175|FG003|Overall Study|Not eligible|2|||
13499638|NCT00005780|27086192|FG000|Vaccine Administration Following EPOCH-R|Participant progressed before receiving the last vaccine.|1|||
13208377|NCT01939002|26241529|FG001|Overall Study|Other|2|||
13208378|NCT01938846|26241731|FG000|Overall Study|Progressive disease|26|||
13208379|NCT01938846|26241732|FG001|Overall Study|Progressive disease|18|||
13208380|NCT01938846|26241733|FG002|Overall Study|Progressive disease|16|||
13208381|NCT01938846|26241731|FG000|Overall Study|Adverse Event|8|||
13208382|NCT01938846|26241732|FG001|Overall Study|Adverse Event|4|||
13208383|NCT01938846|26241733|FG002|Overall Study|Adverse Event|3|||
13208384|NCT01938846|26241731|FG000|Overall Study|Withdrawal by Subject|2|||
13208385|NCT01938846|26241732|FG001|Overall Study|Withdrawal by Subject|2|||
13208386|NCT01938846|26241733|FG002|Overall Study|Withdrawal by Subject|1|||
13208387|NCT01938846|26241731|FG000|Overall Study|Other than listed|5|||
13208388|NCT01938846|26241732|FG001|Overall Study|Other than listed|1|||
13208389|NCT01938846|26241733|FG002|Overall Study|Other than listed|4|||
13208390|NCT01938716|26241743|FG000|Overall Study|Physician Decision|2|||
13208391|NCT01938716|26241743|FG000|Overall Study|Withdrawal by Subject|2|||
13208392|NCT01938625|26241770|FG000|Overall Study|Withdrawal by Subject|0|||
13208393|NCT01938625|26241771|FG001|Overall Study|Withdrawal by Subject|1|||
13208394|NCT01938625|26241770|FG000|Overall Study|Adverse Event|0|||
13208395|NCT01938625|26241771|FG001|Overall Study|Adverse Event|1|||
13208396|NCT01938573|26241780|FG000|Overall Study|Lack of Efficacy|1|||
13208397|NCT01938573|26241781|FG001|Overall Study|Lack of Efficacy|0|||
13208398|NCT01938573|26241780|FG000|Overall Study|Operation at other hospital|1|||
13208399|NCT01938573|26241781|FG001|Overall Study|Operation at other hospital|0|||
13208400|NCT01938430|26242149|FG000|Overall Study|Randomized but Not Treated|0|||
13208401|NCT01938430|26242150|FG001|Overall Study|Randomized but Not Treated|0|||
13208402|NCT01938430|26242151|FG002|Overall Study|Randomized but Not Treated|0|||
13208403|NCT01938430|26242152|FG003|Overall Study|Randomized but Not Treated|0|||
13208404|NCT01938430|26242153|FG004|Overall Study|Randomized but Not Treated|0|||
13208405|NCT01938430|26242154|FG005|Overall Study|Randomized but Not Treated|0|||
13208406|NCT01938430|26242155|FG006|Overall Study|Randomized but Not Treated|0|||
13208407|NCT01938430|26242156|FG007|Overall Study|Randomized but Not Treated|0|||
13208408|NCT01938430|26242157|FG008|Overall Study|Randomized but Not Treated|0|||
13208409|NCT01938430|26242158|FG009|Overall Study|Randomized but Not Treated|0|||
13208410|NCT01938430|26242159|FG010|Overall Study|Randomized but Not Treated|1|||
13208411|NCT01938430|26242160|FG011|Overall Study|Randomized but Not Treated|0|||
13381457|NCT00753415|26748247|FG003|Part B|Lost to Follow-up|0|||
13133910|NCT02761915|25989794|FG004|Overall Study|Death|0|||
13381458|NCT00753415|26748248|FG004|Part B|Lost to Follow-up|0|||
13208412|NCT01938430|26242161|FG012|Overall Study|Randomized but Not Treated|0|||
13381459|NCT00753415|26748249|FG005|Part B|Lost to Follow-up|0|||
13381460|NCT00753415|26748250|FG006|Part B|Lost to Follow-up|0|||
13381461|NCT00753415|26748251|FG007|Part B|Lost to Follow-up|1|||
13381462|NCT00753415|26748252|FG008|Part B|Lost to Follow-up|1|||
13381463|NCT00753415|26748253|FG009|Part B|Lost to Follow-up|0|||
13381464|NCT00753415|26748244|FG000|Part B|Disease progression|0|||
13381465|NCT00753415|26748245|FG001|Part B|Disease progression|0|||
13381466|NCT00753415|26748246|FG002|Part B|Disease progression|0|||
13381467|NCT00753415|26748247|FG003|Part B|Disease progression|0|||
13381468|NCT00753415|26748248|FG004|Part B|Disease progression|0|||
13381469|NCT00753415|26748249|FG005|Part B|Disease progression|0|||
13381470|NCT00753415|26748250|FG006|Part B|Disease progression|0|||
13381471|NCT00753415|26748251|FG007|Part B|Disease progression|0|||
13381472|NCT00753415|26748252|FG008|Part B|Disease progression|2|||
13381473|NCT00753415|26748253|FG009|Part B|Disease progression|1|||
13381474|NCT00753272|26748322|FG000|Overall Study|Adverse Event|878|||
13381475|NCT00753272|26748323|FG001|Overall Study|Adverse Event|869|||
13381476|NCT00753272|26748322|FG000|Overall Study|Protocol Violation|28|||
13381477|NCT00753272|26748323|FG001|Overall Study|Protocol Violation|46|||
13394530|NCT00656513|26787361|FG002|Overall Study|Protocol Violation|2|||
13381478|NCT00753272|26748322|FG000|Overall Study|Withdrawal by Subject|2481|||
13381479|NCT00753272|26748323|FG001|Overall Study|Withdrawal by Subject|2407|||
13381480|NCT00753272|26748322|FG000|Overall Study|Lost to Follow-up|491|||
13381481|NCT00753272|26748323|FG001|Overall Study|Lost to Follow-up|497|||
13381482|NCT00753272|26748322|FG000|Overall Study|Other|1104|||
13381483|NCT00753272|26748323|FG001|Overall Study|Other|1088|||
13381484|NCT00753012|26748340|FG000|Overall Study|Ineligible, abnormal cardiac histo|1|||
13381485|NCT00753012|26748341|FG001|Overall Study|Ineligible, abnormal cardiac histo|0|||
13381486|NCT00753012|26748340|FG000|Overall Study|Adverse Event|2|||
13381487|NCT00753012|26748341|FG001|Overall Study|Adverse Event|0|||
13381488|NCT00753012|26748340|FG000|Overall Study|Withdrawal by Subject|0|||
13381489|NCT00753012|26748341|FG001|Overall Study|Withdrawal by Subject|1|||
13381490|NCT00753012|26748340|FG000|Overall Study|Lost to Follow-up|4|||
13381491|NCT00753012|26748341|FG001|Overall Study|Lost to Follow-up|0|||
13381492|NCT00753012|26748340|FG000|Overall Study|Confounded endpoint data|1|||
13381493|NCT00753012|26748341|FG001|Overall Study|Confounded endpoint data|0|||
13381494|NCT00752986|26748368|FG000|Overall Study|Withdrawal by Subject|2|||
13381495|NCT00752986|26748369|FG001|Overall Study|Withdrawal by Subject|1|||
13381496|NCT00752986|26748370|FG002|Overall Study|Withdrawal by Subject|2|||
13381497|NCT00752986|26748368|FG000|Overall Study|Protocol Violation|3|||
13381498|NCT00752986|26748369|FG001|Overall Study|Protocol Violation|0|||
13381499|NCT00752986|26748370|FG002|Overall Study|Protocol Violation|0|||
13381500|NCT00752895|26748385|FG000|Overall Study|Withdrawal by Subject|8|||
13381501|NCT00752895|26748386|FG001|Overall Study|Withdrawal by Subject|3|||
13381502|NCT00752856|26748405|FG000|Overall Study|randomized but did not do viral kinetics|0|||
13381503|NCT00752856|26748406|FG001|Overall Study|randomized but did not do viral kinetics|1|||
13381504|NCT00752791|26748418|FG000|Overall Study|Adverse Event|7|||
13381505|NCT00752791|26748418|FG000|Overall Study|Withdrawal by Subject|1|||
13381506|NCT00752791|26748418|FG000|Overall Study|Physician Decision|1|||
13381507|NCT00752791|26748418|FG000|Overall Study|Death|1|||
13381508|NCT00752791|26748418|FG000|Overall Study|Renal transplant|3|||
13381509|NCT00752791|26748418|FG000|Overall Study|Switched to hemodialysis|2|||
13381510|NCT00752791|26748418|FG000|Overall Study|Protocol deviation|1|||
13381511|NCT00752726|26748450|FG000|Overall Study|Lost to Follow-up|2|||
13381512|NCT00752726|26748451|FG001|Overall Study|Lost to Follow-up|1|||
13381513|NCT00752726|26748450|FG000|Overall Study|Adverse Event|3|||
13381514|NCT00752726|26748451|FG001|Overall Study|Adverse Event|0|||
13381515|NCT00752726|26748450|FG000|Overall Study|Withdrawal by Subject|5|||
13381516|NCT00752726|26748451|FG001|Overall Study|Withdrawal by Subject|10|||
13381517|NCT00752726|26748450|FG000|Overall Study|Other Reason|1|||
13381518|NCT00752726|26748451|FG001|Overall Study|Other Reason|2|||
13381519|NCT00752622|26748464|FG000|Induction Phase|Adverse Event|3|||
13381520|NCT00752622|26748464|FG000|Induction Phase|Other|3|||
13381521|NCT00752622|26748464|FG000|Induction Phase|Non-responder|14|||
13381522|NCT00752622|26748464|FG000|Induction Phase|Withdrawal by Subject|1|||
13381523|NCT00752622|26748464|FG000|Induction Phase|Premature study termination|14|||
13381524|NCT00752622|26748464|FG000|Observational Phase|Premature Study Termination|36|||
13381525|NCT00752622|26748464|FG000|Observational Phase|Non-responder|2|||
13381526|NCT00752622|26748464|FG000|Observational Phase|Withdrawal by Subject|2|||
13381527|NCT00752622|26748464|FG000|Observational Phase|Adverse Event|1|||
13381528|NCT00752622|26748464|FG000|Observational Phase|Other|2|||
13381529|NCT00752622|26748464|FG000|Interventional Phase|Non-responder|2|||
13381530|NCT00752622|26748464|FG000|Interventional Phase|Physician Decision|1|||
13381531|NCT00752622|26748464|FG000|Interventional Phase|Premature Study Termination|5|||
13381532|NCT00752609|26748490|FG000|Overall Study|Adverse Event|2|||
13381533|NCT00752609|26748491|FG001|Overall Study|Adverse Event|2|||
13381534|NCT00752609|26748490|FG000|Overall Study|Withdrawal by Subject|3|||
13381535|NCT00752609|26748491|FG001|Overall Study|Withdrawal by Subject|0|||
13381536|NCT00752609|26748490|FG000|Overall Study|Physician Decision|1|||
13381537|NCT00752609|26748491|FG001|Overall Study|Physician Decision|0|||
13381538|NCT00752609|26748490|FG000|Overall Study|Death|1|||
13381539|NCT00752609|26748491|FG001|Overall Study|Death|0|||
13381540|NCT00752609|26748490|FG000|Overall Study|Met exclusion criteria|1|||
13381541|NCT00752609|26748491|FG001|Overall Study|Met exclusion criteria|0|||
13381542|NCT00752609|26748490|FG000|Overall Study|Received Aranesp in error|1|||
13381543|NCT00752609|26748491|FG001|Overall Study|Received Aranesp in error|0|||
13381544|NCT00752557|26748526|FG000|Overall Study|Withdrawal by Subject|4|||
13381545|NCT00752557|26748527|FG001|Overall Study|Withdrawal by Subject|3|||
13381546|NCT00752557|26748528|FG002|Overall Study|Withdrawal by Subject|3|||
13381547|NCT00752557|26748526|FG000|Overall Study|Unspecified resaons|0|||
13381548|NCT00752557|26748527|FG001|Overall Study|Unspecified resaons|2|||
13381549|NCT00752557|26748528|FG002|Overall Study|Unspecified resaons|2|||
13381550|NCT00752557|26748526|FG000|Overall Study|Lost to Follow-up|1|||
13381551|NCT00752557|26748527|FG001|Overall Study|Lost to Follow-up|0|||
13381552|NCT00752557|26748528|FG002|Overall Study|Lost to Follow-up|1|||
13381553|NCT00752232|26748622|FG000|Overall Study|Protocol Violation|0|||
13381554|NCT00752232|26748623|FG001|Overall Study|Protocol Violation|0|||
13381555|NCT00752232|26748624|FG002|Overall Study|Protocol Violation|0|||
13381556|NCT00752232|26748625|FG003|Overall Study|Protocol Violation|0|||
13381557|NCT00752232|26748626|FG004|Overall Study|Protocol Violation|0|||
13381558|NCT00752232|26748627|FG005|Overall Study|Protocol Violation|1|||
13381559|NCT00752232|26748628|FG006|Overall Study|Protocol Violation|0|||
13381560|NCT00752232|26748622|FG000|Overall Study|Caregiver request|2|||
13381561|NCT00752232|26748623|FG001|Overall Study|Caregiver request|0|||
13381562|NCT00752232|26748624|FG002|Overall Study|Caregiver request|0|||
13381563|NCT00752232|26748625|FG003|Overall Study|Caregiver request|0|||
13381564|NCT00752232|26748626|FG004|Overall Study|Caregiver request|1|||
13381565|NCT00752232|26748627|FG005|Overall Study|Caregiver request|0|||
13381566|NCT00752232|26748628|FG006|Overall Study|Caregiver request|0|||
13381567|NCT00752232|26748622|FG000|Overall Study|Investigator request|0|||
13381568|NCT00752232|26748623|FG001|Overall Study|Investigator request|0|||
13381569|NCT00752232|26748624|FG002|Overall Study|Investigator request|0|||
13381570|NCT00752232|26748625|FG003|Overall Study|Investigator request|0|||
13381571|NCT00752232|26748626|FG004|Overall Study|Investigator request|1|||
13381572|NCT00752232|26748627|FG005|Overall Study|Investigator request|0|||
13381573|NCT00752232|26748628|FG006|Overall Study|Investigator request|0|||
13381574|NCT00752232|26748622|FG000|Overall Study|Subject request|0|||
13381575|NCT00752232|26748623|FG001|Overall Study|Subject request|0|||
13381576|NCT00752232|26748624|FG002|Overall Study|Subject request|1|||
13394531|NCT00656513|26787359|FG000|Overall Study|Withdrawal by Subject|0|||
13394532|NCT00656513|26787360|FG001|Overall Study|Withdrawal by Subject|11|||
13394533|NCT00656513|26787361|FG002|Overall Study|Withdrawal by Subject|4|||
13394534|NCT00656513|26787359|FG000|Overall Study|Death|0|||
13394535|NCT00656513|26787360|FG001|Overall Study|Death|0|||
13394536|NCT00656513|26787361|FG002|Overall Study|Death|1|||
13394537|NCT00656513|26787359|FG000|Overall Study|Missing data|0|||
13394538|NCT00656513|26787360|FG001|Overall Study|Missing data|11|||
13394539|NCT00656513|26787361|FG002|Overall Study|Missing data|9|||
13394540|NCT00656513|26787359|FG000|Overall Study|Incomplete treatment|3|||
13394541|NCT00656513|26787360|FG001|Overall Study|Incomplete treatment|0|||
13394542|NCT00656513|26787361|FG002|Overall Study|Incomplete treatment|0|||
13394543|NCT00656513|26787359|FG000|Overall Study|Treatment completed outside of timeframe|0|||
13381577|NCT00752232|26748625|FG003|Overall Study|Subject request|0|||
13381578|NCT00752232|26748626|FG004|Overall Study|Subject request|0|||
13381579|NCT00752232|26748627|FG005|Overall Study|Subject request|0|||
13381580|NCT00752232|26748628|FG006|Overall Study|Subject request|0|||
13381581|NCT00752232|26748622|FG000|Overall Study|Group home admission|0|||
13381582|NCT00752232|26748623|FG001|Overall Study|Group home admission|0|||
13381583|NCT00752232|26748624|FG002|Overall Study|Group home admission|0|||
13381584|NCT00752232|26748625|FG003|Overall Study|Group home admission|1|||
13381585|NCT00752232|26748626|FG004|Overall Study|Group home admission|0|||
13381586|NCT00752232|26748627|FG005|Overall Study|Group home admission|0|||
13381587|NCT00752232|26748628|FG006|Overall Study|Group home admission|0|||
13381588|NCT00752232|26748622|FG000|Overall Study|Caregiver could not attend the subject|0|||
13381589|NCT00752232|26748623|FG001|Overall Study|Caregiver could not attend the subject|0|||
13381590|NCT00752232|26748624|FG002|Overall Study|Caregiver could not attend the subject|0|||
13381591|NCT00752232|26748625|FG003|Overall Study|Caregiver could not attend the subject|0|||
13381592|NCT00752232|26748626|FG004|Overall Study|Caregiver could not attend the subject|1|||
13381593|NCT00752232|26748627|FG005|Overall Study|Caregiver could not attend the subject|0|||
13381594|NCT00752232|26748628|FG006|Overall Study|Caregiver could not attend the subject|0|||
13381595|NCT00752219|26748659|FG000|Overall Study|Clinical failure|0|||
13381596|NCT00752219|26748660|FG001|Overall Study|Clinical failure|1|||
13381597|NCT00752219|26748659|FG000|Overall Study|Adverse Event|5|||
13381598|NCT00752219|26748660|FG001|Overall Study|Adverse Event|3|||
13381599|NCT00752219|26748659|FG000|Overall Study|Protocol deviation|1|||
13381600|NCT00752219|26748660|FG001|Overall Study|Protocol deviation|0|||
13381601|NCT00752219|26748659|FG000|Overall Study|Lost to Follow-up|1|||
13381602|NCT00752219|26748660|FG001|Overall Study|Lost to Follow-up|2|||
13381603|NCT00752219|26748659|FG000|Overall Study|Randomized but not treated|1|||
13381604|NCT00752219|26748660|FG001|Overall Study|Randomized but not treated|0|||
13381605|NCT00752219|26748659|FG000|Overall Study|Other|3|||
13381606|NCT00752219|26748660|FG001|Overall Study|Other|0|||
13381607|NCT00752206|26748685|FG000|Overall Study|Disease progression|8|||
13381608|NCT00752206|26748686|FG001|Overall Study|Disease progression|11|||
13381609|NCT00752206|26748685|FG000|Overall Study|Pregnancy|1|||
13381610|NCT00752206|26748686|FG001|Overall Study|Pregnancy|0|||
13381611|NCT00752128|26748693|FG000|Overall Study|Withdrawal by Subject|4|||
13381612|NCT00752089|26748709|FG000|Overall Study|Adverse Event|1|||
13381613|NCT00752089|26748709|FG000|Overall Study|Protocol Deviation|2|||
13381614|NCT00752089|26748709|FG000|Overall Study|Could not attend visit 9|1|||
13381615|NCT00752089|26748709|FG000|Overall Study|Not capable of wearing partial denture|1|||
13381616|NCT00752089|26748709|FG000|Overall Study|Cannot continue the study|1|||
13381617|NCT00751998|26748715|FG000|Overall Study|Lost to Follow-up|7|||
13381618|NCT00751998|26748715|FG000|Overall Study|Death|11|||
13381619|NCT00751998|26748715|FG000|Overall Study|Withdrawal by Subject|2|||
13381620|NCT00751933|26748725|FG000|Overall Study|Withdrawal by Subject|0|||
13133911|NCT02761915|25989795|FG005|Overall Study|Death|1|||
13133912|NCT02761915|25989790|FG000|Overall Study|Withdrawal by Subject|1|||
13133913|NCT02761915|25989791|FG001|Overall Study|Withdrawal by Subject|0|||
13133914|NCT02761915|25989792|FG002|Overall Study|Withdrawal by Subject|0|||
13133915|NCT02761915|25989793|FG003|Overall Study|Withdrawal by Subject|0|||
13133916|NCT02761915|25989794|FG004|Overall Study|Withdrawal by Subject|1|||
13133917|NCT02761915|25989795|FG005|Overall Study|Withdrawal by Subject|2|||
13133918|NCT02761915|25989790|FG000|Overall Study|Disease Progression|0|||
13133919|NCT02761915|25989791|FG001|Overall Study|Disease Progression|0|||
13133920|NCT02761915|25989792|FG002|Overall Study|Disease Progression|0|||
13133921|NCT02761915|25989793|FG003|Overall Study|Disease Progression|2|||
13133922|NCT02761915|25989794|FG004|Overall Study|Disease Progression|2|||
13133923|NCT02761915|25989795|FG005|Overall Study|Disease Progression|2|||
13133924|NCT02761733|25989838|FG000|Overall Study|Death|3|||
13133925|NCT02761733|25989839|FG001|Overall Study|Death|5|||
13133926|NCT02761733|25989840|FG002|Overall Study|Death|1|||
13133927|NCT02761733|25989841|FG003|Overall Study|Death|1|||
13133928|NCT02761733|25989838|FG000|Overall Study|Lost to Follow-up|6|||
13133929|NCT02761733|25989839|FG001|Overall Study|Lost to Follow-up|7|||
13133930|NCT02761733|25989840|FG002|Overall Study|Lost to Follow-up|0|||
13133931|NCT02761733|25989841|FG003|Overall Study|Lost to Follow-up|3|||
13133932|NCT02761733|25989838|FG000|Overall Study|Physician Decision|4|||
13133933|NCT02761733|25989839|FG001|Overall Study|Physician Decision|0|||
13381621|NCT00751933|26748726|FG001|Overall Study|Withdrawal by Subject|1|||
13381622|NCT00751933|26748727|FG002|Overall Study|Withdrawal by Subject|0|||
13394544|NCT00656513|26787360|FG001|Overall Study|Treatment completed outside of timeframe|3|||
13394545|NCT00656513|26787361|FG002|Overall Study|Treatment completed outside of timeframe|1|||
13394546|NCT00656513|26787359|FG000|Overall Study|Missing baseline form|0|||
13394547|NCT00656513|26787360|FG001|Overall Study|Missing baseline form|5|||
13394548|NCT00656513|26787361|FG002|Overall Study|Missing baseline form|5|||
13394549|NCT00656474|26787370|FG000|Overall Study|Other Reason|1|||
13394550|NCT00656370|26787386|FG000|Overall Study|Screen Failures|7|||
13394551|NCT00656370|26787386|FG000|Overall Study|Alternates|3|||
13394552|NCT00656292|26787409|FG000|Overall Study|Withdrawal by Subject|2|||
13394553|NCT00656292|26787410|FG001|Overall Study|Withdrawal by Subject|3|||
13394554|NCT00656292|26787409|FG000|Overall Study|Screen failure|1|||
13394555|NCT00656292|26787410|FG001|Overall Study|Screen failure|2|||
13394556|NCT00656175|26787423|FG000|Overall Study|Adverse Event|1|||
13394557|NCT00656175|26787424|FG001|Overall Study|Adverse Event|0|||
13394558|NCT00656175|26787423|FG000|Overall Study|Transportation issues|0|||
13394559|NCT00656175|26787424|FG001|Overall Study|Transportation issues|1|||
13394560|NCT00656136|26787441|FG000|Overall Study|Progressive disease|177|||
13394561|NCT00656136|26787442|FG001|Overall Study|Progressive disease|322|||
13394562|NCT00656136|26787441|FG000|Overall Study|Other Adverse Event|5|||
13394563|NCT00656136|26787442|FG001|Overall Study|Other Adverse Event|51|||
13394564|NCT00656136|26787441|FG000|Overall Study|Protocol Violation|2|||
13394565|NCT00656136|26787442|FG001|Overall Study|Protocol Violation|3|||
13394566|NCT00656136|26787441|FG000|Overall Study|Patient refused to take study medication|7|||
13394567|NCT00656136|26787442|FG001|Overall Study|Patient refused to take study medication|10|||
13394568|NCT00656136|26787441|FG000|Overall Study|Unknown and others|4|||
13394569|NCT00656136|26787442|FG001|Overall Study|Unknown and others|4|||
13394570|NCT00656084|26787451|FG000|Overall Study|Adverse Event|4|||
13394571|NCT00656084|26787451|FG000|Overall Study|Withdrawal by Subject|1|||
13394572|NCT00656084|26787451|FG000|Overall Study|Patient Request|1|||
13394573|NCT00656084|26787451|FG000|Overall Study|Investigator Request|1|||
13394574|NCT00656058|26787462|FG000|Overall Study|Withdrawal by Subject|2|||
13394575|NCT00656058|26787462|FG000|Overall Study|Withdrawal by Subject|4|||
13394576|NCT00656019|26787485|FG000|Overall Study|Not Eligible|10|||
13394577|NCT00656019|26787486|FG001|Overall Study|Not Eligible|0|||
13394578|NCT00656019|26787487|FG002|Overall Study|Not Eligible|0|||
13394579|NCT00656019|26787488|FG003|Overall Study|Not Eligible|0|||
13394580|NCT00656019|26787485|FG000|Overall Study|Withdrawal by Subject|2|||
13394581|NCT00656019|26787486|FG001|Overall Study|Withdrawal by Subject|0|||
13394582|NCT00656019|26787487|FG002|Overall Study|Withdrawal by Subject|0|||
13394583|NCT00656019|26787488|FG003|Overall Study|Withdrawal by Subject|0|||
13381623|NCT00751933|26748728|FG003|Overall Study|Withdrawal by Subject|0|||
13381624|NCT00751933|26748725|FG000|Overall Study|Physician Decision|0|||
13208413|NCT01938430|26242162|FG013|Overall Study|Randomized but Not Treated|1|||
13208414|NCT01938430|26242149|FG000|Overall Study|Adverse Event|0|||
13208415|NCT01938430|26242150|FG001|Overall Study|Adverse Event|0|||
13208416|NCT01938430|26242151|FG002|Overall Study|Adverse Event|0|||
13208417|NCT01938430|26242152|FG003|Overall Study|Adverse Event|0|||
13208418|NCT01938430|26242153|FG004|Overall Study|Adverse Event|0|||
13208419|NCT01938430|26242154|FG005|Overall Study|Adverse Event|0|||
13208420|NCT01938430|26242155|FG006|Overall Study|Adverse Event|1|||
13208421|NCT01938430|26242156|FG007|Overall Study|Adverse Event|0|||
13208422|NCT01938430|26242157|FG008|Overall Study|Adverse Event|0|||
13208423|NCT01938430|26242158|FG009|Overall Study|Adverse Event|0|||
13208424|NCT01938430|26242159|FG010|Overall Study|Adverse Event|0|||
13208425|NCT01938430|26242160|FG011|Overall Study|Adverse Event|0|||
13208426|NCT01938430|26242161|FG012|Overall Study|Adverse Event|0|||
13381625|NCT00751933|26748726|FG001|Overall Study|Physician Decision|0|||
13381626|NCT00751933|26748727|FG002|Overall Study|Physician Decision|1|||
13133934|NCT02761733|25989840|FG002|Overall Study|Physician Decision|0|||
13381627|NCT00751933|26748728|FG003|Overall Study|Physician Decision|1|||
13381628|NCT00751881|26748785|FG000|Core Treatment Period|Not treated|1|||
13381629|NCT00751881|26748786|FG001|Core Treatment Period|Not treated|1|||
13208427|NCT01938430|26242162|FG013|Overall Study|Adverse Event|0|||
13208428|NCT01938430|26242149|FG000|Overall Study|Death|1|||
13394584|NCT00656019|26787485|FG000|Overall Study|Lost to Follow-up|2|||
13394585|NCT00656019|26787486|FG001|Overall Study|Lost to Follow-up|1|||
13394586|NCT00656019|26787487|FG002|Overall Study|Lost to Follow-up|0|||
13394587|NCT00656019|26787488|FG003|Overall Study|Lost to Follow-up|0|||
13394588|NCT00655980|26787509|FG000|Overall Study|surgery canceled; or subject or anesthes|26|||
13394589|NCT00655980|26787510|FG001|Overall Study|surgery canceled; or subject or anesthes|31|||
13394590|NCT00655980|26787511|FG002|Overall Study|surgery canceled; or subject or anesthes|5|||
13394591|NCT00655928|26787524|FG000|Overall Study|Withdrawal by Subject|2|||
13394592|NCT00655928|26787525|FG001|Overall Study|Withdrawal by Subject|1|||
13394593|NCT00655928|26787524|FG000|Overall Study|Physician Decision|1|||
13394594|NCT00655928|26787525|FG001|Overall Study|Physician Decision|1|||
13394595|NCT00655889|26787532|FG000|Overall Study|Inadequate cell growth|1|||
13394596|NCT00655889|26787532|FG000|Overall Study|Protocol Violation|1|||
13394597|NCT00655863|26787601|FG000|Overall Study|Lost to Follow-up|0|||
13394598|NCT00655863|26787602|FG001|Overall Study|Lost to Follow-up|0|||
13394599|NCT00655863|26787603|FG002|Overall Study|Lost to Follow-up|1|||
13394600|NCT00655850|26787612|FG000|Overall Study|Death|2|||
13394601|NCT00655850|26787612|FG000|Overall Study|Withdrawal by Subject|1|||
13394602|NCT00655824|26787648|FG000|Overall Study|Adverse Event|3|||
13394603|NCT00655824|26787648|FG000|Overall Study|Early Termination of Study by Sponsor|74|||
13133935|NCT02761733|25989841|FG003|Overall Study|Physician Decision|0|||
13133936|NCT02761733|25989838|FG000|Overall Study|Withdrawal by Subject|2|||
13133937|NCT02761733|25989839|FG001|Overall Study|Withdrawal by Subject|0|||
13135654|NCT02738138|25995884|FG001|Overall Study|Adverse Event|1|||
13381630|NCT00751881|26748787|FG002|Core Treatment Period|Not treated|2|||
13381631|NCT00751881|26748785|FG000|Core Treatment Period|Adverse Event|26|||
13394604|NCT00655824|26787648|FG000|Overall Study|Protocol Violation|1|||
13296495|NCT01370356|26496636|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12|||
13381632|NCT00751881|26748786|FG001|Core Treatment Period|Adverse Event|54|||
13381633|NCT00751881|26748787|FG002|Core Treatment Period|Adverse Event|58|||
13381634|NCT00751881|26748785|FG000|Core Treatment Period|Lack of Efficacy|37|||
13381635|NCT00751881|26748786|FG001|Core Treatment Period|Lack of Efficacy|30|||
13381636|NCT00751881|26748787|FG002|Core Treatment Period|Lack of Efficacy|20|||
13381637|NCT00751881|26748785|FG000|Core Treatment Period|Poor compliance to protocol|15|||
13381638|NCT00751881|26748786|FG001|Core Treatment Period|Poor compliance to protocol|3|||
13381639|NCT00751881|26748787|FG002|Core Treatment Period|Poor compliance to protocol|4|||
13381640|NCT00751881|26748785|FG000|Core Treatment Period|Lost to Follow-up|6|||
13381641|NCT00751881|26748786|FG001|Core Treatment Period|Lost to Follow-up|4|||
13381642|NCT00751881|26748787|FG002|Core Treatment Period|Lost to Follow-up|3|||
13381643|NCT00751881|26748785|FG000|Core Treatment Period|Other: protocol deviation|3|||
13381644|NCT00751881|26748786|FG001|Core Treatment Period|Other: protocol deviation|3|||
13381645|NCT00751881|26748787|FG002|Core Treatment Period|Other: protocol deviation|7|||
13381646|NCT00751881|26748785|FG000|Core Treatment Period|Other: wish to parent|5|||
13394605|NCT00655824|26787648|FG000|Overall Study|Withdrawal by Subject|4|||
13394606|NCT00655824|26787648|FG000|Overall Study|Deterioration of Trial Disease|2|||
13394607|NCT00655746|26787667|FG000|Overall Study|Withdrawal by Subject|1|||
13394608|NCT00655733|26787702|FG000|Overall Study|Lost to Follow-up|2|||
13394609|NCT00655733|26787703|FG001|Overall Study|Lost to Follow-up|2|||
13394610|NCT00655733|26787702|FG000|Overall Study|Adverse Event|2|||
13394611|NCT00655733|26787703|FG001|Overall Study|Adverse Event|2|||
13394612|NCT00655733|26787702|FG000|Overall Study|Withdrawal by Subject|3|||
13394613|NCT00655733|26787703|FG001|Overall Study|Withdrawal by Subject|3|||
13394614|NCT00655733|26787702|FG000|Overall Study|Physician Decision|0|||
13394615|NCT00655733|26787703|FG001|Overall Study|Physician Decision|1|||
13394616|NCT00655668|26787713|FG000|Overall Study|Adverse Event|6|||
13394617|NCT00655668|26787713|FG000|Overall Study|Death|5|||
13394618|NCT00655668|26787713|FG000|Overall Study|Disease Progression|27|||
13394619|NCT00655668|26787713|FG000|Overall Study|Study Terminated|9|||
13394620|NCT00655668|26787713|FG000|Overall Study|Other|1|||
13394621|NCT00655668|26787713|FG000|Overall Study|New Lymphoma Treatment Started|4|||
13394622|NCT00655668|26787713|FG000|Overall Study|Withdrawal by Subject|2|||
13394623|NCT00655629|26787756|FG000|Overall Study|Adverse Event|4|||
13394624|NCT00655629|26787757|FG001|Overall Study|Adverse Event|1|||
13394625|NCT00655629|26787756|FG000|Overall Study|Lack of Efficacy|2|||
13394626|NCT00655629|26787757|FG001|Overall Study|Lack of Efficacy|12|||
13394627|NCT00655629|26787756|FG000|Overall Study|Lost to Follow-up|4|||
13135655|NCT02738138|25995883|FG000|Overall Study|Lost to Follow-up|2|||
13394628|NCT00655629|26787757|FG001|Overall Study|Lost to Follow-up|3|||
13135656|NCT02738138|25995884|FG001|Overall Study|Lost to Follow-up|0|||
13208429|NCT01938430|26242150|FG001|Overall Study|Death|2|||
13381647|NCT00751881|26748786|FG001|Core Treatment Period|Other: wish to parent|7|||
13381648|NCT00751881|26748787|FG002|Core Treatment Period|Other: wish to parent|4|||
13381649|NCT00751881|26748785|FG000|Core Treatment Period|Other: personal/family constraints|6|||
13381650|NCT00751881|26748786|FG001|Core Treatment Period|Other: personal/family constraints|7|||
13381651|NCT00751881|26748787|FG002|Core Treatment Period|Other: personal/family constraints|10|||
13381652|NCT00751881|26748785|FG000|Core Treatment Period|Other: MS treatment change|6|||
13208430|NCT01938430|26242151|FG002|Overall Study|Death|2|||
13208431|NCT01938430|26242152|FG003|Overall Study|Death|1|||
13208432|NCT01938430|26242153|FG004|Overall Study|Death|0|||
13208433|NCT01938430|26242154|FG005|Overall Study|Death|0|||
13208434|NCT01938430|26242155|FG006|Overall Study|Death|1|||
13208435|NCT01938430|26242156|FG007|Overall Study|Death|1|||
13208436|NCT01938430|26242157|FG008|Overall Study|Death|2|||
13208437|NCT01938430|26242158|FG009|Overall Study|Death|3|||
13208438|NCT01938430|26242159|FG010|Overall Study|Death|0|||
13208439|NCT01938430|26242160|FG011|Overall Study|Death|0|||
13208440|NCT01938430|26242161|FG012|Overall Study|Death|0|||
13208441|NCT01938430|26242162|FG013|Overall Study|Death|0|||
13208442|NCT01938430|26242149|FG000|Overall Study|Investigator's Discretion|0|||
13208443|NCT01938430|26242150|FG001|Overall Study|Investigator's Discretion|0|||
13208444|NCT01938430|26242151|FG002|Overall Study|Investigator's Discretion|1|||
13208445|NCT01938430|26242152|FG003|Overall Study|Investigator's Discretion|0|||
13208446|NCT01938430|26242153|FG004|Overall Study|Investigator's Discretion|0|||
13208447|NCT01938430|26242154|FG005|Overall Study|Investigator's Discretion|0|||
13394629|NCT00655629|26787756|FG000|Overall Study|Protocol Violation|5|||
13381653|NCT00751881|26748786|FG001|Core Treatment Period|Other: MS treatment change|4|||
13381654|NCT00751881|26748787|FG002|Core Treatment Period|Other: MS treatment change|4|||
13381655|NCT00751881|26748785|FG000|Core Treatment Period|Other: tolerability complaints|2|||
13381656|NCT00751881|26748786|FG001|Core Treatment Period|Other: tolerability complaints|0|||
13381657|NCT00751881|26748787|FG002|Core Treatment Period|Other: tolerability complaints|0|||
13381658|NCT00751881|26748785|FG000|Core Treatment Period|Other:participant's decision/unspecified|19|||
13381659|NCT00751881|26748786|FG001|Core Treatment Period|Other:participant's decision/unspecified|22|||
13381660|NCT00751881|26748787|FG002|Core Treatment Period|Other:participant's decision/unspecified|16|||
13381661|NCT00751881|26748785|FG000|Extension Study Period|Adverse Event|18|||
13381662|NCT00751881|26748786|FG001|Extension Study Period|Adverse Event|20|||
13381663|NCT00751881|26748787|FG002|Extension Study Period|Adverse Event|21|||
13381664|NCT00751881|26748785|FG000|Extension Study Period|Lack of Efficacy|14|||
13381665|NCT00751881|26748786|FG001|Extension Study Period|Lack of Efficacy|10|||
13381666|NCT00751881|26748787|FG002|Extension Study Period|Lack of Efficacy|20|||
13381667|NCT00751881|26748785|FG000|Extension Study Period|Lost to Follow-up|4|||
13381668|NCT00751881|26748786|FG001|Extension Study Period|Lost to Follow-up|9|||
13381669|NCT00751881|26748787|FG002|Extension Study Period|Lost to Follow-up|6|||
13381670|NCT00751881|26748785|FG000|Extension Study Period|Poor Compliance to Protocol|3|||
13208448|NCT01938430|26242155|FG006|Overall Study|Investigator's Discretion|0|||
13381671|NCT00751881|26748786|FG001|Extension Study Period|Poor Compliance to Protocol|2|||
13381672|NCT00751881|26748787|FG002|Extension Study Period|Poor Compliance to Protocol|1|||
13208449|NCT01938430|26242156|FG007|Overall Study|Investigator's Discretion|0|||
13394630|NCT00655629|26787757|FG001|Overall Study|Protocol Violation|3|||
13394631|NCT00655629|26787756|FG000|Overall Study|consent withdrawn|6|||
13394632|NCT00655629|26787757|FG001|Overall Study|consent withdrawn|4|||
13381673|NCT00751881|26748785|FG000|Extension Study Period|Other than specified above|26|||
13381674|NCT00751881|26748786|FG001|Extension Study Period|Other than specified above|30|||
13381675|NCT00751881|26748787|FG002|Extension Study Period|Other than specified above|18|||
13381676|NCT00751790|26748793|FG000|Overall Study|Lost to Follow-up|1|||
13381677|NCT00751790|26748793|FG000|Overall Study|Death|3|||
13381678|NCT00751790|26748793|FG000|Overall Study|Withdrawal by Subject|1|||
13381679|NCT00751621|26748812|FG000|Overall Study|Adverse Event|1|||
13381680|NCT00751621|26748812|FG000|Overall Study|Withdrawal by Subject|1|||
13381681|NCT00751621|26748812|FG000|Overall Study|Subject moved to another country|1|||
13381682|NCT00751621|26748812|FG000|Overall Study|Poor adherence to asthma treatment|1|||
13381683|NCT00751400|26748827|FG000|Overall Study|Lost to Follow-up|10|||
13381684|NCT00751348|26748856|FG000|Overall Study|Withdrawal by Subject|5|||
13381685|NCT00751348|26748857|FG001|Overall Study|Withdrawal by Subject|2|||
13381686|NCT00751348|26748856|FG000|Overall Study|Migration from study area|1|||
13381687|NCT00751348|26748857|FG001|Overall Study|Migration from study area|0|||
13381688|NCT00751296|26748864|FG000|Overall Study|Adverse Event|2|||
13381689|NCT00751140|26748874|FG000|Overall Study|benign angioma excluded from analysis|1|||
13381690|NCT00751114|26748904|FG000|Overall Study|Adverse Event|2|||
13381691|NCT00751114|26748905|FG001|Overall Study|Adverse Event|4|||
13381692|NCT00751114|26748904|FG000|Overall Study|Protocol Violation|8|||
13381693|NCT00751114|26748905|FG001|Overall Study|Protocol Violation|9|||
13381694|NCT00751114|26748904|FG000|Overall Study|Withdrawal by Subject|9|||
13381695|NCT00751114|26748905|FG001|Overall Study|Withdrawal by Subject|4|||
13381696|NCT00751114|26748904|FG000|Overall Study|Lost to Follow-up|4|||
13381697|NCT00751114|26748905|FG001|Overall Study|Lost to Follow-up|7|||
13381698|NCT00751114|26748904|FG000|Overall Study|Lack of Efficacy|0|||
13381699|NCT00751114|26748905|FG001|Overall Study|Lack of Efficacy|7|||
13381700|NCT00751114|26748904|FG000|Overall Study|Not Treated|13|||
13381701|NCT00751114|26748905|FG001|Overall Study|Not Treated|1|||
13381702|NCT00751114|26748904|FG000|Overall Study|Out of country for 2 months|1|||
13381703|NCT00751114|26748905|FG001|Overall Study|Out of country for 2 months|0|||
13381704|NCT00751114|26748904|FG000|Overall Study|Move to another city|1|||
13381705|NCT00751114|26748905|FG001|Overall Study|Move to another city|0|||
13381706|NCT00751101|26748930|FG000|Overall Study|Withdrawal by Subject|1|||
13381707|NCT00751101|26748931|FG001|Overall Study|Withdrawal by Subject|0|||
13381708|NCT00751101|26748930|FG000|Overall Study|No HFS / Never Started Patch/|0|||
13381709|NCT00751101|26748931|FG001|Overall Study|No HFS / Never Started Patch/|4|||
13381710|NCT00751101|26748930|FG000|Overall Study|Never began capecitabine|1|||
13381711|NCT00751101|26748931|FG001|Overall Study|Never began capecitabine|0|||
13381712|NCT00751101|26748930|FG000|Overall Study|Physician Decision|0|||
13381713|NCT00751101|26748931|FG001|Overall Study|Physician Decision|1|||
13381714|NCT00751036|26748950|FG000|Overall Study|Disease Progression|28|||
13381715|NCT00751036|26748951|FG001|Overall Study|Disease Progression|29|||
13381716|NCT00751036|26748950|FG000|Overall Study|Adverse Event|6|||
13381717|NCT00751036|26748951|FG001|Overall Study|Adverse Event|4|||
13381718|NCT00751036|26748950|FG000|Overall Study|Administrative Problems|3|||
13133938|NCT02761733|25989840|FG002|Overall Study|Withdrawal by Subject|0|||
13133939|NCT02761733|25989841|FG003|Overall Study|Withdrawal by Subject|0|||
13133940|NCT02761733|25989838|FG000|Overall Study|Discharged from Study Site|10|||
13133941|NCT02761733|25989839|FG001|Overall Study|Discharged from Study Site|9|||
13133942|NCT02761733|25989840|FG002|Overall Study|Discharged from Study Site|25|||
13133943|NCT02761733|25989841|FG003|Overall Study|Discharged from Study Site|11|||
13133944|NCT02761733|25989838|FG000|Overall Study|Cognitive Impairment|5|||
13133945|NCT02761733|25989839|FG001|Overall Study|Cognitive Impairment|0|||
13133946|NCT02761733|25989840|FG002|Overall Study|Cognitive Impairment|1|||
13394633|NCT00655564|26787764|FG000|Overall Study|Adverse Event|1|||
13394634|NCT00655564|26787764|FG000|Overall Study|Lost to Follow-up|1|||
13208450|NCT01938430|26242157|FG008|Overall Study|Investigator's Discretion|0|||
13208451|NCT01938430|26242158|FG009|Overall Study|Investigator's Discretion|0|||
13208452|NCT01938430|26242159|FG010|Overall Study|Investigator's Discretion|0|||
13208453|NCT01938430|26242160|FG011|Overall Study|Investigator's Discretion|0|||
13208454|NCT01938430|26242161|FG012|Overall Study|Investigator's Discretion|0|||
13208455|NCT01938430|26242162|FG013|Overall Study|Investigator's Discretion|0|||
13208456|NCT01938430|26242149|FG000|Overall Study|Lack of Efficacy|3|||
13208457|NCT01938430|26242150|FG001|Overall Study|Lack of Efficacy|1|||
13208458|NCT01938430|26242151|FG002|Overall Study|Lack of Efficacy|1|||
13208459|NCT01938430|26242152|FG003|Overall Study|Lack of Efficacy|1|||
13208460|NCT01938430|26242153|FG004|Overall Study|Lack of Efficacy|0|||
13208461|NCT01938430|26242154|FG005|Overall Study|Lack of Efficacy|0|||
13208462|NCT01938430|26242155|FG006|Overall Study|Lack of Efficacy|0|||
13208463|NCT01938430|26242156|FG007|Overall Study|Lack of Efficacy|0|||
13208464|NCT01938430|26242157|FG008|Overall Study|Lack of Efficacy|1|||
13208465|NCT01938430|26242158|FG009|Overall Study|Lack of Efficacy|0|||
13208466|NCT01938430|26242159|FG010|Overall Study|Lack of Efficacy|2|||
13208467|NCT01938430|26242160|FG011|Overall Study|Lack of Efficacy|1|||
13381719|NCT00751036|26748951|FG001|Overall Study|Administrative Problems|4|||
13381720|NCT00751036|26748950|FG000|Overall Study|Withdrawal by Subject|5|||
13381721|NCT00751036|26748951|FG001|Overall Study|Withdrawal by Subject|2|||
13381722|NCT00751036|26748950|FG000|Overall Study|Death|3|||
13381723|NCT00751036|26748951|FG001|Overall Study|Death|3|||
13381724|NCT00751036|26748950|FG000|Overall Study|Lost to Follow-up|0|||
13381725|NCT00751036|26748951|FG001|Overall Study|Lost to Follow-up|1|||
13381726|NCT00751036|26748950|FG000|Overall Study|Protocol Violation|1|||
13381727|NCT00751036|26748951|FG001|Overall Study|Protocol Violation|0|||
13381728|NCT00751036|26748950|FG000|Overall Study|Missing end of Treatment Page|2|||
13208468|NCT01938430|26242161|FG012|Overall Study|Lack of Efficacy|0|||
13208469|NCT01938430|26242162|FG013|Overall Study|Lack of Efficacy|0|||
13208470|NCT01938430|26242149|FG000|Overall Study|Lost to Follow-up|0|||
13208471|NCT01938430|26242150|FG001|Overall Study|Lost to Follow-up|0|||
13208472|NCT01938430|26242151|FG002|Overall Study|Lost to Follow-up|1|||
13208473|NCT01938430|26242152|FG003|Overall Study|Lost to Follow-up|0|||
13208474|NCT01938430|26242153|FG004|Overall Study|Lost to Follow-up|0|||
13208475|NCT01938430|26242154|FG005|Overall Study|Lost to Follow-up|1|||
13208476|NCT01938430|26242155|FG006|Overall Study|Lost to Follow-up|0|||
13381729|NCT00751036|26748951|FG001|Overall Study|Missing end of Treatment Page|3|||
13381730|NCT00751023|26748978|FG000|Overall Study|Lost to Follow-up|11|||
13381731|NCT00751023|26748979|FG001|Overall Study|Lost to Follow-up|7|||
13381732|NCT00750919|26748989|FG000|Overall Study|Adverse Event|9|||
13381733|NCT00750919|26748989|FG000|Overall Study|Withdrawal by Subject|1|||
13381734|NCT00750919|26748989|FG000|Overall Study|Lack of Efficacy|8|||
13394635|NCT00655564|26787764|FG000|Overall Study|Desired Alternate Therapy|1|||
13394636|NCT00655551|26787788|FG000|All Periods Combined|Adverse Event|0|||
13394637|NCT00655551|26787789|FG001|All Periods Combined|Adverse Event|3|||
13394638|NCT00655551|26787790|FG002|All Periods Combined|Adverse Event|4|||
13394639|NCT00655551|26787788|FG000|Period 2 (up to 7 Days)|Adverse Event|0|||
13394640|NCT00655551|26787789|FG001|Period 2 (up to 7 Days)|Adverse Event|1|||
13394641|NCT00655551|26787790|FG002|Period 2 (up to 7 Days)|Adverse Event|0|||
13394642|NCT00655551|26787788|FG000|Period 3 (up to 7 Days)|Adverse Event|0|||
13394643|NCT00655551|26787789|FG001|Period 3 (up to 7 Days)|Adverse Event|0|||
13394644|NCT00655551|26787790|FG002|Period 3 (up to 7 Days)|Adverse Event|4|||
13394645|NCT00655551|26787788|FG000|Period 4 (up to 7 Days)|Adverse Event|0|||
13394646|NCT00655551|26787789|FG001|Period 4 (up to 7 Days)|Adverse Event|2|||
13394647|NCT00655551|26787790|FG002|Period 4 (up to 7 Days)|Adverse Event|0|||
13394648|NCT00655499|26787799|FG000|Overall Study|not eligible|4|||
13394649|NCT00655486|26787806|FG000|Overall Study|Adverse Event|10|||
13394650|NCT00655486|26787806|FG000|Overall Study|Lack of Efficacy|8|||
13394651|NCT00655486|26787806|FG000|Overall Study|Withdrawal by Subject|4|||
13394652|NCT00655486|26787806|FG000|Overall Study|Protocol Violation|1|||
13394653|NCT00655486|26787806|FG000|Overall Study|Unsatisfactory compliance|2|||
13394654|NCT00655486|26787806|FG000|Overall Study|Other: Pregnancy|1|||
13394655|NCT00655486|26787806|FG000|Overall Study|Other: Could not tolerate BID dosing|1|||
13394656|NCT00655486|26787806|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1|||
13394657|NCT00655356|26787825|FG000|Overall Study|Withdrawal by Subject|3|||
13394658|NCT00655356|26787826|FG001|Overall Study|Withdrawal by Subject|4|||
13394659|NCT00655356|26787825|FG000|Overall Study|Sponsor Request|10|||
13394660|NCT00655356|26787826|FG001|Overall Study|Sponsor Request|4|||
13394661|NCT00655356|26787825|FG000|Overall Study|Adverse Event|1|||
13394662|NCT00655356|26787826|FG001|Overall Study|Adverse Event|1|||
13394663|NCT00655356|26787825|FG000|Overall Study|Protocol Violation|2|||
13394664|NCT00655356|26787826|FG001|Overall Study|Protocol Violation|1|||
13394665|NCT00655356|26787825|FG000|Overall Study|Other Reason|1|||
13394666|NCT00655356|26787826|FG001|Overall Study|Other Reason|0|||
13394667|NCT00654940|26787845|FG000|Period 1|Adverse Event|0|||
13394668|NCT00654940|26787846|FG001|Period 1|Adverse Event|1|||
13381735|NCT00750919|26748989|FG000|Overall Study|Could not cooperate, unrelated to trial|4|||
13381736|NCT00750919|26748989|FG000|Overall Study|Other|36|||
13381737|NCT00750893|26749003|FG000|Overall Study|Adverse Event|5|||
13381738|NCT00750893|26749003|FG000|Overall Study|Withdrawal by Subject|10|||
13381739|NCT00750893|26749003|FG000|Overall Study|Lost to Follow-up|510|||
13381740|NCT00750893|26749003|FG000|Overall Study|Other|17|||
13381741|NCT00750880|26749028|FG000|Overall Study|Adverse Event|76|||
13381742|NCT00750880|26749028|FG000|Overall Study|Death|4|||
13381743|NCT00750880|26749028|FG000|Overall Study|Lack of Efficacy|46|||
13381744|NCT00750880|26749028|FG000|Overall Study|Lost to Follow-up|10|||
13381745|NCT00750880|26749028|FG000|Overall Study|Protocol Violation|15|||
13381746|NCT00750880|26749028|FG000|Overall Study|Withdrawal by Subject|33|||
13381747|NCT00750880|26749028|FG000|Overall Study|Physician Decision|20|||
13381748|NCT00750880|26749028|FG000|Overall Study|Administrative|11|||
13381749|NCT00750867|26749035|FG000|Overall Study|Adverse Event|2|||
13381750|NCT00750737|26749050|FG000|Overall Study|Withdrawal by Subject|3|||
13381751|NCT00750737|26749051|FG001|Overall Study|Withdrawal by Subject|3|||
13381752|NCT00750438|26749072|FG000|Overall Study|Protocol Violation|4|||
13381753|NCT00750438|26749073|FG001|Overall Study|Protocol Violation|1|||
13381754|NCT00750438|26749072|FG000|Overall Study|Physician Decision|2|||
13381755|NCT00750438|26749073|FG001|Overall Study|Physician Decision|2|||
13381756|NCT00750438|26749072|FG000|Overall Study|Withdrawal by Subject|1|||
13381757|NCT00750438|26749073|FG001|Overall Study|Withdrawal by Subject|1|||
13381758|NCT00750308|26749100|FG000|First Treatment|Adverse Event|0|||
13381759|NCT00750308|26749101|FG001|First Treatment|Adverse Event|1|||
13381760|NCT00750308|26749102|FG002|First Treatment|Adverse Event|0|||
13381761|NCT00750308|26749103|FG003|First Treatment|Adverse Event|0|||
13381762|NCT00750308|26749104|FG004|First Treatment|Adverse Event|0|||
13381763|NCT00750308|26749105|FG005|First Treatment|Adverse Event|0|||
13381764|NCT00750308|26749106|FG006|First Treatment|Adverse Event|0|||
13381765|NCT00750308|26749107|FG007|First Treatment|Adverse Event|0|||
13381766|NCT00750308|26749108|FG008|First Treatment|Adverse Event|0|||
13381767|NCT00750308|26749109|FG009|First Treatment|Adverse Event|0|||
13381768|NCT00750308|26749110|FG010|First Treatment|Adverse Event|1|||
13381769|NCT00750308|26749111|FG011|First Treatment|Adverse Event|1|||
13381770|NCT00750308|26749100|FG000|First Treatment|Withdrawal by Subject|0|||
13381771|NCT00750308|26749101|FG001|First Treatment|Withdrawal by Subject|0|||
13381772|NCT00750308|26749102|FG002|First Treatment|Withdrawal by Subject|0|||
13381773|NCT00750308|26749103|FG003|First Treatment|Withdrawal by Subject|1|||
13381774|NCT00750308|26749104|FG004|First Treatment|Withdrawal by Subject|0|||
13381775|NCT00750308|26749105|FG005|First Treatment|Withdrawal by Subject|0|||
13381776|NCT00750308|26749106|FG006|First Treatment|Withdrawal by Subject|0|||
13381777|NCT00750308|26749107|FG007|First Treatment|Withdrawal by Subject|1|||
13381778|NCT00750308|26749108|FG008|First Treatment|Withdrawal by Subject|0|||
13381779|NCT00750308|26749109|FG009|First Treatment|Withdrawal by Subject|0|||
13381780|NCT00750308|26749110|FG010|First Treatment|Withdrawal by Subject|0|||
13381781|NCT00750308|26749111|FG011|First Treatment|Withdrawal by Subject|0|||
13381782|NCT00750308|26749100|FG000|Second Treatment|Adverse Event|0|||
13381783|NCT00750308|26749101|FG001|Second Treatment|Adverse Event|0|||
13381784|NCT00750308|26749102|FG002|Second Treatment|Adverse Event|0|||
13381785|NCT00750308|26749103|FG003|Second Treatment|Adverse Event|0|||
13381786|NCT00750308|26749104|FG004|Second Treatment|Adverse Event|0|||
13381787|NCT00750308|26749105|FG005|Second Treatment|Adverse Event|1|||
13381788|NCT00750308|26749106|FG006|Second Treatment|Adverse Event|0|||
13381789|NCT00750308|26749107|FG007|Second Treatment|Adverse Event|0|||
13381790|NCT00750308|26749108|FG008|Second Treatment|Adverse Event|1|||
13381791|NCT00750308|26749109|FG009|Second Treatment|Adverse Event|0|||
13381792|NCT00750308|26749110|FG010|Second Treatment|Adverse Event|0|||
13381793|NCT00750308|26749111|FG011|Second Treatment|Adverse Event|0|||
13381794|NCT00750308|26749100|FG000|Second Treatment|Withdrawal by Subject|0|||
13381795|NCT00750308|26749101|FG001|Second Treatment|Withdrawal by Subject|0|||
13381796|NCT00750308|26749102|FG002|Second Treatment|Withdrawal by Subject|0|||
13381797|NCT00750308|26749103|FG003|Second Treatment|Withdrawal by Subject|0|||
13381798|NCT00750308|26749104|FG004|Second Treatment|Withdrawal by Subject|1|||
13381799|NCT00750308|26749105|FG005|Second Treatment|Withdrawal by Subject|0|||
13394669|NCT00654940|26787845|FG000|Period 1|Intolerable Pain Level|1|||
13208477|NCT01938430|26242156|FG007|Overall Study|Lost to Follow-up|0|||
13208478|NCT01938430|26242157|FG008|Overall Study|Lost to Follow-up|0|||
13208479|NCT01938430|26242158|FG009|Overall Study|Lost to Follow-up|0|||
13208480|NCT01938430|26242159|FG010|Overall Study|Lost to Follow-up|0|||
13208481|NCT01938430|26242160|FG011|Overall Study|Lost to Follow-up|0|||
13208482|NCT01938430|26242161|FG012|Overall Study|Lost to Follow-up|0|||
13208483|NCT01938430|26242162|FG013|Overall Study|Lost to Follow-up|0|||
13208484|NCT01938430|26242149|FG000|Overall Study|Withdrew Consent|0|||
13381800|NCT00750308|26749106|FG006|Second Treatment|Withdrawal by Subject|0|||
13381801|NCT00750308|26749107|FG007|Second Treatment|Withdrawal by Subject|0|||
13381802|NCT00750308|26749108|FG008|Second Treatment|Withdrawal by Subject|0|||
13381803|NCT00750308|26749109|FG009|Second Treatment|Withdrawal by Subject|0|||
13381804|NCT00750308|26749110|FG010|Second Treatment|Withdrawal by Subject|0|||
13381805|NCT00750308|26749111|FG011|Second Treatment|Withdrawal by Subject|0|||
13381806|NCT00750308|26749100|FG000|Third Treatment|Withdrawal by Subject|0|||
13381807|NCT00750308|26749101|FG001|Third Treatment|Withdrawal by Subject|1|||
13381808|NCT00750308|26749102|FG002|Third Treatment|Withdrawal by Subject|0|||
13381809|NCT00750308|26749103|FG003|Third Treatment|Withdrawal by Subject|0|||
13381810|NCT00750308|26749104|FG004|Third Treatment|Withdrawal by Subject|0|||
13381811|NCT00750308|26749105|FG005|Third Treatment|Withdrawal by Subject|0|||
13381812|NCT00750308|26749106|FG006|Third Treatment|Withdrawal by Subject|0|||
13381813|NCT00750308|26749107|FG007|Third Treatment|Withdrawal by Subject|0|||
13381814|NCT00750308|26749108|FG008|Third Treatment|Withdrawal by Subject|0|||
13381815|NCT00750308|26749109|FG009|Third Treatment|Withdrawal by Subject|0|||
13381816|NCT00750308|26749110|FG010|Third Treatment|Withdrawal by Subject|0|||
13381817|NCT00750308|26749111|FG011|Third Treatment|Withdrawal by Subject|0|||
13394670|NCT00654940|26787846|FG001|Period 1|Intolerable Pain Level|0|||
13394671|NCT00654901|26787877|FG000|Overall Study|Lost to Follow-up|1|||
13394672|NCT00654901|26787878|FG001|Overall Study|Lost to Follow-up|0|||
13394673|NCT00654901|26787879|FG002|Overall Study|Lost to Follow-up|1|||
13394674|NCT00654901|26787880|FG003|Overall Study|Lost to Follow-up|0|||
13394675|NCT00654901|26787877|FG000|Overall Study|Withdrawal by Subject|3|||
13208485|NCT01938430|26242150|FG001|Overall Study|Withdrew Consent|0|||
13208486|NCT01938430|26242151|FG002|Overall Study|Withdrew Consent|0|||
13381818|NCT00750204|26749124|FG000|Overall Study|study halted prematurely|1|||
13381819|NCT00750204|26749125|FG001|Overall Study|study halted prematurely|1|||
13381820|NCT00750152|26749140|FG000|Overall Study|Adverse Event|2|||
13381821|NCT00750152|26749141|FG001|Overall Study|Adverse Event|1|||
13381822|NCT00750152|26749140|FG000|Overall Study|Lost to Follow-up|8|||
13381823|NCT00750152|26749141|FG001|Overall Study|Lost to Follow-up|13|||
13381824|NCT00750152|26749140|FG000|Overall Study|Withdrawal by Subject|3|||
13381825|NCT00750152|26749141|FG001|Overall Study|Withdrawal by Subject|3|||
13381826|NCT00750152|26749140|FG000|Overall Study|Physician Decision|1|||
13381827|NCT00750152|26749141|FG001|Overall Study|Physician Decision|1|||
13381828|NCT00750152|26749140|FG000|Overall Study|Non-compliance|0|||
13381829|NCT00750152|26749141|FG001|Overall Study|Non-compliance|1|||
13381830|NCT00750152|26749140|FG000|Overall Study|Termination by sponsor|1|||
13381831|NCT00750152|26749141|FG001|Overall Study|Termination by sponsor|0|||
13381832|NCT00750152|26749140|FG000|Overall Study|Other|7|||
13381833|NCT00750152|26749141|FG001|Overall Study|Other|8|||
13381834|NCT00750139|26749168|FG000|Overall Study|Adverse Event|1|||
13381835|NCT00750139|26749169|FG001|Overall Study|Adverse Event|2|||
13381836|NCT00750139|26749170|FG002|Overall Study|Adverse Event|0|||
13381837|NCT00750139|26749171|FG003|Overall Study|Adverse Event|1|||
13381838|NCT00750139|26749168|FG000|Overall Study|Lost to Follow-up|17|||
13381839|NCT00750139|26749169|FG001|Overall Study|Lost to Follow-up|12|||
13381840|NCT00750139|26749170|FG002|Overall Study|Lost to Follow-up|15|||
13381841|NCT00750139|26749171|FG003|Overall Study|Lost to Follow-up|6|||
13381842|NCT00750139|26749168|FG000|Overall Study|Withdrawal by Subject|3|||
13381843|NCT00750139|26749169|FG001|Overall Study|Withdrawal by Subject|2|||
13381844|NCT00750139|26749170|FG002|Overall Study|Withdrawal by Subject|6|||
13381845|NCT00750139|26749171|FG003|Overall Study|Withdrawal by Subject|2|||
13381846|NCT00750139|26749168|FG000|Overall Study|Physician Decision|1|||
13381847|NCT00750139|26749169|FG001|Overall Study|Physician Decision|1|||
13394676|NCT00654901|26787878|FG001|Overall Study|Withdrawal by Subject|0|||
13381848|NCT00750139|26749170|FG002|Overall Study|Physician Decision|0|||
13381849|NCT00750139|26749171|FG003|Overall Study|Physician Decision|0|||
13381850|NCT00750139|26749168|FG000|Overall Study|Non-compliance|1|||
13208487|NCT01938430|26242152|FG003|Overall Study|Withdrew Consent|0|||
13208488|NCT01938430|26242153|FG004|Overall Study|Withdrew Consent|0|||
13296496|NCT01370356|26496637|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9|||
13394677|NCT00654901|26787879|FG002|Overall Study|Withdrawal by Subject|1|||
13394678|NCT00654901|26787880|FG003|Overall Study|Withdrawal by Subject|0|||
13394679|NCT00654875|26787905|FG000|Overall Study|Adverse Event|5|||
13394680|NCT00654875|26787906|FG001|Overall Study|Adverse Event|5|||
13394681|NCT00654875|26787905|FG000|Overall Study|Withdrawal by Subject|4|||
13394682|NCT00654875|26787906|FG001|Overall Study|Withdrawal by Subject|4|||
13394683|NCT00654875|26787905|FG000|Overall Study|Protocol Violation|3|||
13394684|NCT00654875|26787906|FG001|Overall Study|Protocol Violation|3|||
13394685|NCT00654875|26787905|FG000|Overall Study|Lack of Efficacy|2|||
13394686|NCT00654875|26787906|FG001|Overall Study|Lack of Efficacy|2|||
13394687|NCT00654875|26787905|FG000|Overall Study|Lost to Follow-up|1|||
13394688|NCT00654875|26787906|FG001|Overall Study|Lost to Follow-up|3|||
13394689|NCT00654875|26787905|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
13394690|NCT00654875|26787906|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
13394691|NCT00654875|26787905|FG000|Overall Study|Administrative Problems|1|||
13394692|NCT00654875|26787906|FG001|Overall Study|Administrative Problems|0|||
13394693|NCT00654745|26787946|FG000|Overall Study|Adverse Event|12|||
13394694|NCT00654745|26787946|FG000|Overall Study|Lost to Follow-up|7|||
13394695|NCT00654745|26787946|FG000|Overall Study|Protocol Violation|11|||
13394696|NCT00654745|26787946|FG000|Overall Study|Withdrawal by Subject|10|||
13394697|NCT00654745|26787946|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3|||
13208489|NCT01938430|26242154|FG005|Overall Study|Withdrew Consent|0|||
13208490|NCT01938430|26242155|FG006|Overall Study|Withdrew Consent|0|||
13208491|NCT01938430|26242156|FG007|Overall Study|Withdrew Consent|0|||
13208492|NCT01938430|26242157|FG008|Overall Study|Withdrew Consent|1|||
13394698|NCT00654732|26787959|FG000|Overall Study|Adverse Event|4|||
13394699|NCT00654732|26787960|FG001|Overall Study|Adverse Event|6|||
13394700|NCT00654641|26787973|FG000|Overall Study|Lost to Follow-up|2|||
13394701|NCT00654641|26787974|FG001|Overall Study|Lost to Follow-up|3|||
13394702|NCT00654498|26788009|FG000|Overall Study|Not Treated|1|||
13394703|NCT00654498|26788010|FG001|Overall Study|Not Treated|0|||
13394704|NCT00654498|26788009|FG000|Overall Study|Adverse Event|6|||
13394705|NCT00654498|26788010|FG001|Overall Study|Adverse Event|1|||
13394706|NCT00654498|26788009|FG000|Overall Study|Protocol Violation|1|||
13394707|NCT00654498|26788010|FG001|Overall Study|Protocol Violation|1|||
13394708|NCT00654498|26788009|FG000|Overall Study|Lost to Follow-up|1|||
13394709|NCT00654498|26788010|FG001|Overall Study|Lost to Follow-up|5|||
13394710|NCT00654498|26788009|FG000|Overall Study|Withdrawal by Subject|1|||
13394711|NCT00654498|26788010|FG001|Overall Study|Withdrawal by Subject|0|||
13394712|NCT00654498|26788009|FG000|Overall Study|Other reason not defined above|4|||
13394713|NCT00654498|26788010|FG001|Overall Study|Other reason not defined above|5|||
13394714|NCT00654420|26788045|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
13394715|NCT00654420|26788046|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
13394716|NCT00654420|26788047|FG002|Phase I (Dose Escalation)|Adverse Event|0|||
13394717|NCT00654420|26788048|FG003|Phase I (Dose Escalation)|Adverse Event|0|||
13394718|NCT00654420|26788045|FG000|Phase I (Dose Escalation)|Progressive Disease|4|||
13394719|NCT00654420|26788046|FG001|Phase I (Dose Escalation)|Progressive Disease|15|||
13394720|NCT00654420|26788047|FG002|Phase I (Dose Escalation)|Progressive Disease|0|||
13394721|NCT00654420|26788048|FG003|Phase I (Dose Escalation)|Progressive Disease|0|||
13394722|NCT00654420|26788045|FG000|Phase II|Adverse Event|0|||
13394723|NCT00654420|26788046|FG001|Phase II|Adverse Event|0|||
13394724|NCT00654420|26788047|FG002|Phase II|Adverse Event|3|||
13394725|NCT00654420|26788048|FG003|Phase II|Adverse Event|3|||
13394726|NCT00654420|26788045|FG000|Phase II|Lost to Follow-up|0|||
13394727|NCT00654420|26788046|FG001|Phase II|Lost to Follow-up|0|||
13394728|NCT00654420|26788047|FG002|Phase II|Lost to Follow-up|0|||
13394729|NCT00654420|26788048|FG003|Phase II|Lost to Follow-up|1|||
13394730|NCT00654420|26788045|FG000|Phase II|Physician Decision|0|||
13394731|NCT00654420|26788046|FG001|Phase II|Physician Decision|0|||
13394732|NCT00654420|26788047|FG002|Phase II|Physician Decision|0|||
13394733|NCT00654420|26788048|FG003|Phase II|Physician Decision|4|||
13394734|NCT00654420|26788045|FG000|Phase II|Progressive Disease|0|||
13394735|NCT00654420|26788046|FG001|Phase II|Progressive Disease|0|||
13394736|NCT00654420|26788047|FG002|Phase II|Progressive Disease|29|||
13394737|NCT00654420|26788048|FG003|Phase II|Progressive Disease|29|||
13394738|NCT00654420|26788045|FG000|Phase II|Withdrawal by Subject|0|||
13394739|NCT00654420|26788046|FG001|Phase II|Withdrawal by Subject|0|||
13394740|NCT00654420|26788047|FG002|Phase II|Withdrawal by Subject|4|||
13394741|NCT00654420|26788048|FG003|Phase II|Withdrawal by Subject|1|||
13394742|NCT00654420|26788045|FG000|Phase II|Missing Disposition Record|0|||
13394743|NCT00654420|26788046|FG001|Phase II|Missing Disposition Record|0|||
13394744|NCT00654420|26788047|FG002|Phase II|Missing Disposition Record|1|||
13394745|NCT00654420|26788048|FG003|Phase II|Missing Disposition Record|0|||
13394746|NCT00654381|26788097|FG000|1st Stage|Adverse Event|3|||
13394747|NCT00654381|26788098|FG001|1st Stage|Adverse Event|3|||
13394748|NCT00654381|26788099|FG002|1st Stage|Adverse Event|3|||
13394749|NCT00654381|26788100|FG003|1st Stage|Adverse Event|3|||
13394750|NCT00654381|26788101|FG004|1st Stage|Adverse Event|2|||
13394751|NCT00654381|26788102|FG005|1st Stage|Adverse Event|1|||
13394752|NCT00654381|26788097|FG000|1st Stage|Withdrawal by Subject|0|||
13394753|NCT00654381|26788098|FG001|1st Stage|Withdrawal by Subject|0|||
13394754|NCT00654381|26788099|FG002|1st Stage|Withdrawal by Subject|0|||
13381851|NCT00750139|26749169|FG001|Overall Study|Non-compliance|0|||
13381852|NCT00750139|26749170|FG002|Overall Study|Non-compliance|1|||
13381853|NCT00750139|26749171|FG003|Overall Study|Non-compliance|3|||
13381854|NCT00750139|26749168|FG000|Overall Study|Termination by sponsor|4|||
13381855|NCT00750139|26749169|FG001|Overall Study|Termination by sponsor|0|||
13381856|NCT00750139|26749170|FG002|Overall Study|Termination by sponsor|0|||
13381857|NCT00750139|26749171|FG003|Overall Study|Termination by sponsor|1|||
13381858|NCT00750139|26749168|FG000|Overall Study|Non-specific|62|||
13381859|NCT00750139|26749169|FG001|Overall Study|Non-specific|42|||
13381860|NCT00750139|26749170|FG002|Overall Study|Non-specific|79|||
13381861|NCT00750139|26749171|FG003|Overall Study|Non-specific|33|||
13381862|NCT00750061|26749186|FG000|Overall Study|Adverse Event|2|||
13381863|NCT00750061|26749187|FG001|Overall Study|Adverse Event|0|||
13381864|NCT00750061|26749186|FG000|Overall Study|Withdrawal by Subject|0|||
13381865|NCT00750061|26749187|FG001|Overall Study|Withdrawal by Subject|1|||
13381866|NCT00750061|26749186|FG000|Overall Study|Physician Decision|0|||
13381867|NCT00750061|26749187|FG001|Overall Study|Physician Decision|1|||
13381868|NCT00749996|26749202|FG000|Overall Study|Lost to Follow-up|7|||
13381869|NCT00749996|26749203|FG001|Overall Study|Lost to Follow-up|4|||
13381870|NCT00749996|26749202|FG000|Overall Study|Withdrawal by Subject|5|||
13381871|NCT00749996|26749203|FG001|Overall Study|Withdrawal by Subject|4|||
13381872|NCT00749996|26749202|FG000|Overall Study|Protocol Violation|2|||
13381873|NCT00749996|26749203|FG001|Overall Study|Protocol Violation|3|||
13381874|NCT00749996|26749202|FG000|Overall Study|Physician Decision|2|||
13381875|NCT00749996|26749203|FG001|Overall Study|Physician Decision|0|||
13381876|NCT00749996|26749202|FG000|Overall Study|Pregnancy|0|||
13381877|NCT00749996|26749203|FG001|Overall Study|Pregnancy|2|||
13381878|NCT00749996|26749202|FG000|Overall Study|Adverse Event|1|||
13381879|NCT00749996|26749203|FG001|Overall Study|Adverse Event|0|||
13381880|NCT00749996|26749202|FG000|Overall Study|Death|1|||
13381881|NCT00749996|26749203|FG001|Overall Study|Death|0|||
13381882|NCT00749944|26749276|FG000|Overall Study|Lost to Follow-up|2|||
13381883|NCT00749944|26749277|FG001|Overall Study|Lost to Follow-up|1|||
13381884|NCT00749944|26749276|FG000|Overall Study|Other|1|||
13208493|NCT01938430|26242158|FG009|Overall Study|Withdrew Consent|0|||
13394755|NCT00654381|26788100|FG003|1st Stage|Withdrawal by Subject|1|||
13394756|NCT00654381|26788101|FG004|1st Stage|Withdrawal by Subject|0|||
13394757|NCT00654381|26788102|FG005|1st Stage|Withdrawal by Subject|1|||
13394758|NCT00654381|26788097|FG000|1st Stage|Investigator's decision|0|||
13208494|NCT01938430|26242159|FG010|Overall Study|Withdrew Consent|0|||
13208495|NCT01938430|26242160|FG011|Overall Study|Withdrew Consent|0|||
13381885|NCT00749944|26749277|FG001|Overall Study|Other|0|||
13381886|NCT00749944|26749276|FG000|Overall Study|Withdrawal by Subject|2|||
13381887|NCT00749944|26749277|FG001|Overall Study|Withdrawal by Subject|0|||
13381888|NCT00749892|26749283|FG000|Overall Study|Withdrawal by Subject|3|||
13381889|NCT00749775|26749301|FG000|Overall Study|Protocol Violation|24|||
13381890|NCT00749775|26749301|FG000|Overall Study|Lost to Follow-up|36|||
13381891|NCT00749775|26749301|FG000|Overall Study|No visit after first day of treatment|44|||
13381892|NCT00749775|26749301|FG000|Overall Study|No drug administration|3|||
13381893|NCT00749684|26749308|FG000|Overall Study|Death|1|||
13381894|NCT00749684|26749308|FG000|Overall Study|Adverse Event|27|||
13381895|NCT00749684|26749308|FG000|Overall Study|Participant's Wish|10|||
13381896|NCT00749684|26749308|FG000|Overall Study|Not Documented|1|||
13381897|NCT00749684|26749308|FG000|Overall Study|Progressive Desease|31|||
13381898|NCT00749684|26749308|FG000|Overall Study|Therapy according to protocol + AE|2|||
13381899|NCT00749684|26749308|FG000|Overall Study|AE+discontinuation on participants wish|1|||
13381900|NCT00749684|26749308|FG000|Overall Study|Missing|9|||
13381901|NCT00749580|26749323|FG000|Overall Study|Lost to Follow-up|4|||
13381902|NCT00749580|26749324|FG001|Overall Study|Lost to Follow-up|8|||
13381903|NCT00749580|26749323|FG000|Overall Study|Adverse Event|0|||
13381904|NCT00749580|26749324|FG001|Overall Study|Adverse Event|1|||
13381905|NCT00749463|26749360|FG000|Overall Study|Adverse Event|0|||
13381906|NCT00749463|26749361|FG001|Overall Study|Adverse Event|4|||
13208496|NCT01938430|26242161|FG012|Overall Study|Withdrew Consent|0|||
13208497|NCT01938430|26242162|FG013|Overall Study|Withdrew Consent|0|||
13208498|NCT01938391|26242174|FG000|6 Month Follow up|Withdrawal by Subject|1|||
13208499|NCT01938391|26242174|FG000|12 Month Follow up|Physician Decision|1|||
13208500|NCT01938391|26242174|FG000|12 Month Follow up|Withdrawal by Subject|1|||
13208501|NCT01937884|26242201|FG000|Overall Study|Withdrawal by Subject|1|||
13208502|NCT01937884|26242202|FG001|Overall Study|Withdrawal by Subject|0|||
13208503|NCT01937871|26242283|FG000|Overall Study|Adverse Event|6|||
13208504|NCT01937871|26242284|FG001|Overall Study|Adverse Event|6|||
13208505|NCT01937871|26242285|FG002|Overall Study|Adverse Event|2|||
13208506|NCT01937871|26242283|FG000|Overall Study|Lost to Follow-up|8|||
13208507|NCT01937871|26242284|FG001|Overall Study|Lost to Follow-up|2|||
13208508|NCT01937871|26242285|FG002|Overall Study|Lost to Follow-up|4|||
13208509|NCT01937871|26242283|FG000|Overall Study|Withdrawal by Subject|9|||
13208510|NCT01937871|26242284|FG001|Overall Study|Withdrawal by Subject|6|||
13208511|NCT01937871|26242285|FG002|Overall Study|Withdrawal by Subject|4|||
13208512|NCT01937871|26242283|FG000|Overall Study|Physician Decision|0|||
13208513|NCT01937871|26242284|FG001|Overall Study|Physician Decision|1|||
13208514|NCT01937871|26242285|FG002|Overall Study|Physician Decision|0|||
13208515|NCT01937871|26242283|FG000|Overall Study|Entry Criteria Not Met|1|||
13208516|NCT01937871|26242284|FG001|Overall Study|Entry Criteria Not Met|2|||
13208517|NCT01937871|26242285|FG002|Overall Study|Entry Criteria Not Met|1|||
13208518|NCT01937715|26242423|FG000|Overall Study|Death|0|||
13208519|NCT01937715|26242424|FG001|Overall Study|Death|0|||
13208520|NCT01937715|26242425|FG002|Overall Study|Death|0|||
13208521|NCT01937715|26242426|FG003|Overall Study|Death|1|||
13208522|NCT01937715|26242427|FG004|Overall Study|Death|0|||
13381907|NCT00749463|26749362|FG002|Overall Study|Adverse Event|1|||
13381908|NCT00749463|26749360|FG000|Overall Study|Withdrawal by Subject|1|||
13381909|NCT00749463|26749361|FG001|Overall Study|Withdrawal by Subject|0|||
13381910|NCT00749463|26749362|FG002|Overall Study|Withdrawal by Subject|0|||
13381911|NCT00749411|26749377|FG000|Overall Study|Adverse Event|0|||
13381912|NCT00749411|26749378|FG001|Overall Study|Adverse Event|2|||
13381913|NCT00749411|26749377|FG000|Overall Study|Lack of Efficacy|0|||
13381914|NCT00749411|26749378|FG001|Overall Study|Lack of Efficacy|1|||
13381915|NCT00749411|26749377|FG000|Overall Study|Protocol Violation|1|||
13381916|NCT00749411|26749378|FG001|Overall Study|Protocol Violation|1|||
13381917|NCT00749411|26749377|FG000|Overall Study|Protocol-defined stopping criteria|0|||
13381918|NCT00749411|26749378|FG001|Overall Study|Protocol-defined stopping criteria|1|||
13381919|NCT00749398|26749394|FG000|Overall Study|Lack of Efficacy|7|||
13381920|NCT00749398|26749394|FG000|Overall Study|Adverse Event|4|||
13381921|NCT00749398|26749394|FG000|Overall Study|Serious adverse event|11|||
13381922|NCT00749398|26749394|FG000|Overall Study|Withdrawal by Subject|17|||
13381923|NCT00749398|26749394|FG000|Overall Study|Lost to Follow-up|11|||
13381924|NCT00749398|26749394|FG000|Overall Study|Reason not specified|2|||
13381925|NCT00749398|26749394|FG000|Overall Study|Unknown reason|1|||
13394759|NCT00654381|26788098|FG001|1st Stage|Investigator's decision|0|||
13394760|NCT00654381|26788099|FG002|1st Stage|Investigator's decision|0|||
13381926|NCT00749203|26749415|FG000|no Infusion at Week 1|Lost to Follow-up|0|||
13381927|NCT00749203|26749416|FG001|no Infusion at Week 1|Lost to Follow-up|1|||
13381928|NCT00749203|26749415|FG000|no Infusion at Week 1|Withdrawal by Subject|0|||
13381929|NCT00749203|26749416|FG001|no Infusion at Week 1|Withdrawal by Subject|1|||
13381930|NCT00749203|26749415|FG000|no Infusion at Week 1|delayed-onset sedation|0|||
13381931|NCT00749203|26749416|FG001|no Infusion at Week 1|delayed-onset sedation|1|||
13381932|NCT00749203|26749415|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0|||
13381933|NCT00749203|26749416|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1|||
13381934|NCT00749203|26749415|FG000|Second Infusion at 2 Weeks|Protocol Violation|0|||
13381935|NCT00749203|26749416|FG001|Second Infusion at 2 Weeks|Protocol Violation|1|||
13381936|NCT00749203|26749415|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0|||
13381937|NCT00749203|26749416|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1|||
13381938|NCT00749190|26749515|FG000|Overall Study|Adverse Event|0|||
13381939|NCT00749190|26749516|FG001|Overall Study|Adverse Event|2|||
13381940|NCT00749190|26749517|FG002|Overall Study|Adverse Event|0|||
13381941|NCT00749190|26749518|FG003|Overall Study|Adverse Event|4|||
13381942|NCT00749190|26749519|FG004|Overall Study|Adverse Event|0|||
13381943|NCT00749190|26749520|FG005|Overall Study|Adverse Event|3|||
13381944|NCT00749190|26749521|FG006|Overall Study|Adverse Event|0|||
13381945|NCT00749190|26749515|FG000|Overall Study|Lack of Efficacy|3|||
13381946|NCT00749190|26749516|FG001|Overall Study|Lack of Efficacy|1|||
13381947|NCT00749190|26749517|FG002|Overall Study|Lack of Efficacy|1|||
13381948|NCT00749190|26749518|FG003|Overall Study|Lack of Efficacy|0|||
13381949|NCT00749190|26749519|FG004|Overall Study|Lack of Efficacy|0|||
13381950|NCT00749190|26749520|FG005|Overall Study|Lack of Efficacy|1|||
13381951|NCT00749190|26749521|FG006|Overall Study|Lack of Efficacy|0|||
13381952|NCT00749190|26749515|FG000|Overall Study|Withdrawal by Subject|2|||
13381953|NCT00749190|26749516|FG001|Overall Study|Withdrawal by Subject|1|||
13381954|NCT00749190|26749517|FG002|Overall Study|Withdrawal by Subject|0|||
13381955|NCT00749190|26749518|FG003|Overall Study|Withdrawal by Subject|0|||
13381956|NCT00749190|26749519|FG004|Overall Study|Withdrawal by Subject|0|||
13381957|NCT00749190|26749520|FG005|Overall Study|Withdrawal by Subject|1|||
13381958|NCT00749190|26749521|FG006|Overall Study|Withdrawal by Subject|0|||
13381959|NCT00749190|26749515|FG000|Overall Study|Protocol Violation|0|||
13381960|NCT00749190|26749516|FG001|Overall Study|Protocol Violation|1|||
13381961|NCT00749190|26749517|FG002|Overall Study|Protocol Violation|0|||
13381962|NCT00749190|26749518|FG003|Overall Study|Protocol Violation|0|||
13381963|NCT00749190|26749519|FG004|Overall Study|Protocol Violation|0|||
13381964|NCT00749190|26749520|FG005|Overall Study|Protocol Violation|0|||
13381965|NCT00749190|26749521|FG006|Overall Study|Protocol Violation|1|||
13381966|NCT00749190|26749515|FG000|Overall Study|Other reason not defined above|0|||
13381967|NCT00749190|26749516|FG001|Overall Study|Other reason not defined above|0|||
13381968|NCT00749190|26749517|FG002|Overall Study|Other reason not defined above|0|||
13381969|NCT00749190|26749518|FG003|Overall Study|Other reason not defined above|1|||
13381970|NCT00749190|26749519|FG004|Overall Study|Other reason not defined above|0|||
13381971|NCT00749190|26749520|FG005|Overall Study|Other reason not defined above|0|||
13394761|NCT00654381|26788100|FG003|1st Stage|Investigator's decision|1|||
13381972|NCT00749190|26749521|FG006|Overall Study|Other reason not defined above|0|||
13381973|NCT00748969|26749536|FG000|Overall Study|Withdrawal by Subject|1|||
13381974|NCT00748969|26749537|FG001|Overall Study|Withdrawal by Subject|0|||
13381975|NCT00748969|26749536|FG000|Overall Study|Withdrawal by Subject|0|||
13381976|NCT00748969|26749537|FG001|Overall Study|Withdrawal by Subject|1|||
13381977|NCT00748709|26749551|FG000|Overall Study|Progressive disease|15|||
13381978|NCT00748709|26749551|FG000|Overall Study|Drug reducing Toxity|2|||
13381979|NCT00748709|26749551|FG000|Overall Study|Other Adverse Event|1|||
13394762|NCT00654381|26788101|FG004|1st Stage|Investigator's decision|0|||
13208523|NCT01937715|26242423|FG000|Overall Study|Withdrawal by Subject|0|||
13208524|NCT01937715|26242424|FG001|Overall Study|Withdrawal by Subject|1|||
13208525|NCT01937715|26242425|FG002|Overall Study|Withdrawal by Subject|0|||
13208526|NCT01937715|26242426|FG003|Overall Study|Withdrawal by Subject|0|||
13208527|NCT01937715|26242427|FG004|Overall Study|Withdrawal by Subject|2|||
13208528|NCT01937715|26242423|FG000|Overall Study|Other|0|||
13208529|NCT01937715|26242424|FG001|Overall Study|Other|0|||
13208530|NCT01937715|26242425|FG002|Overall Study|Other|0|||
13208531|NCT01937715|26242426|FG003|Overall Study|Other|3|||
13208532|NCT01937715|26242427|FG004|Overall Study|Other|0|||
13208533|NCT01937559|26242461|FG000|Overall Study|Physician Decision|3|||
13208534|NCT01937559|26242462|FG001|Overall Study|Physician Decision|3|||
13208535|NCT01937559|26242463|FG002|Overall Study|Physician Decision|0|||
13208536|NCT01937559|26242461|FG000|Overall Study|Withdrawal by Subject|6|||
13208537|NCT01937559|26242462|FG001|Overall Study|Withdrawal by Subject|4|||
13208538|NCT01937559|26242463|FG002|Overall Study|Withdrawal by Subject|0|||
13208539|NCT01937559|26242461|FG000|Overall Study|screen fail|2|||
13208540|NCT01937559|26242462|FG001|Overall Study|screen fail|4|||
13208541|NCT01937559|26242463|FG002|Overall Study|screen fail|0|||
13208542|NCT01937390|26242473|FG000|Overall Study|Death|2|||
13208543|NCT01937390|26242473|FG000|Overall Study|Lost to Follow-up|7|||
13208544|NCT01937390|26242473|FG000|Overall Study|Withdrawal by Subject|5|||
13208545|NCT01937390|26242473|FG000|Overall Study|Fail to return|21|||
13208546|NCT01937364|26242490|FG000|Overall Study|Adverse Event|2|||
13208547|NCT01937364|26242491|FG001|Overall Study|Adverse Event|1|||
13208548|NCT01937351|26242529|FG000|Overall Study|Withdrawal by Subject|4|||
13208549|NCT01937351|26242530|FG001|Overall Study|Withdrawal by Subject|2|||
13208550|NCT01937351|26242529|FG000|Overall Study|Death|1|||
13208551|NCT01937351|26242530|FG001|Overall Study|Death|0|||
13208552|NCT01937351|26242529|FG000|Overall Study|Not treated w device, per protocol fail|4|||
13394763|NCT00654381|26788102|FG005|1st Stage|Investigator's decision|0|||
13394764|NCT00654381|26788097|FG000|2nd Stage|Adverse Event|2|||
13208553|NCT01937351|26242530|FG001|Overall Study|Not treated w device, per protocol fail|0|||
13208554|NCT01937312|26242550|FG000|Overall Study|Adverse Event|10|||
13208555|NCT01937312|26242551|FG001|Overall Study|Adverse Event|1|||
13208556|NCT01937312|26242550|FG000|Overall Study|Lack of Efficacy|0|||
13208557|NCT01937312|26242551|FG001|Overall Study|Lack of Efficacy|1|||
13208558|NCT01937312|26242550|FG000|Overall Study|Withdrawal of subject prior to treatment|1|||
13208559|NCT01937312|26242551|FG001|Overall Study|Withdrawal of subject prior to treatment|1|||
13208560|NCT01937299|26242569|FG000|Overall Study|Adverse Event|13|||
13208561|NCT01937299|26242570|FG001|Overall Study|Adverse Event|0|||
13208562|NCT01937299|26242569|FG000|Overall Study|Lack of Efficacy|0|||
13208563|NCT01937299|26242570|FG001|Overall Study|Lack of Efficacy|4|||
13208564|NCT01937299|26242569|FG000|Overall Study|Withdrawal by Subject|1|||
13296497|NCT01370356|26496636|FG000|Overall Study|AE Not Related to Study Drug|1|||
13296498|NCT01370356|26496637|FG001|Overall Study|AE Not Related to Study Drug|4|||
13296499|NCT01370317|26496655|FG000|Overall Study|Participant withdrew consent|1|||
13296500|NCT01370317|26496656|FG001|Overall Study|Participant withdrew consent|0|||
13296501|NCT01370317|26496655|FG000|Overall Study|Protocol deviation|0|||
13296502|NCT01370317|26496656|FG001|Overall Study|Protocol deviation|1|||
13296503|NCT01370265|26496676|FG000|First Intervention|Adverse Event|1|||
13296504|NCT01370265|26496677|FG001|First Intervention|Adverse Event|1|||
13296505|NCT01370213|26496705|FG000|Overall Study|Early Death|1|||
13296506|NCT01370213|26496706|FG001|Overall Study|Early Death|0|||
13296507|NCT01370213|26496707|FG002|Overall Study|Early Death|0|||
13296508|NCT01370213|26496705|FG000|Overall Study|Not evaluable|0|||
13296509|NCT01370213|26496706|FG001|Overall Study|Not evaluable|2|||
13296510|NCT01370213|26496707|FG002|Overall Study|Not evaluable|0|||
13296511|NCT01370083|26496724|FG000|Overall Study|Lost to Follow-up|2|||
13296512|NCT01370083|26496725|FG001|Overall Study|Lost to Follow-up|0|||
13296513|NCT01370083|26496724|FG000|Overall Study|Adverse Event|0|||
13208565|NCT01937299|26242570|FG001|Overall Study|Withdrawal by Subject|0|||
13208566|NCT01937130|26242610|FG000|Overall Study|Withdrawal by Subject|0|||
13208567|NCT01937130|26242611|FG001|Overall Study|Withdrawal by Subject|0|||
13208568|NCT01937130|26242612|FG002|Overall Study|Withdrawal by Subject|0|||
13208569|NCT01937130|26242613|FG003|Overall Study|Withdrawal by Subject|1|||
13208570|NCT01937130|26242610|FG000|Overall Study|Adverse Event|0|||
13208571|NCT01937130|26242611|FG001|Overall Study|Adverse Event|1|||
13208572|NCT01937130|26242612|FG002|Overall Study|Adverse Event|0|||
13208573|NCT01937130|26242613|FG003|Overall Study|Adverse Event|1|||
13208574|NCT01937130|26242610|FG000|Overall Study|Death|1|||
13208575|NCT01937130|26242611|FG001|Overall Study|Death|1|||
13208576|NCT01937130|26242612|FG002|Overall Study|Death|1|||
13208577|NCT01937130|26242613|FG003|Overall Study|Death|0|||
13208578|NCT01937130|26242610|FG000|Overall Study|Lost to Follow-up|2|||
13208579|NCT01937130|26242611|FG001|Overall Study|Lost to Follow-up|0|||
13208580|NCT01937130|26242612|FG002|Overall Study|Lost to Follow-up|2|||
13208581|NCT01937130|26242613|FG003|Overall Study|Lost to Follow-up|0|||
13208582|NCT01937130|26242610|FG000|Overall Study|Physician Decision|0|||
13208583|NCT01937130|26242611|FG001|Overall Study|Physician Decision|1|||
13208584|NCT01937130|26242612|FG002|Overall Study|Physician Decision|0|||
13208585|NCT01937130|26242613|FG003|Overall Study|Physician Decision|0|||
13208586|NCT01937130|26242610|FG000|Overall Study|Patients unable to swallow|0|||
13208587|NCT01937130|26242611|FG001|Overall Study|Patients unable to swallow|1|||
13208588|NCT01937130|26242612|FG002|Overall Study|Patients unable to swallow|0|||
13208589|NCT01937130|26242613|FG003|Overall Study|Patients unable to swallow|0|||
13208590|NCT01937130|26242610|FG000|Overall Study|Patient lost to FU due to death|2|||
13208591|NCT01937130|26242611|FG001|Overall Study|Patient lost to FU due to death|0|||
13208592|NCT01937130|26242612|FG002|Overall Study|Patient lost to FU due to death|0|||
13208593|NCT01937130|26242613|FG003|Overall Study|Patient lost to FU due to death|0|||
13208594|NCT01936974|26242626|FG000|Overall Study|Physician Decision|2|||
13394765|NCT00654381|26788098|FG001|2nd Stage|Adverse Event|0|||
13208595|NCT01936974|26242627|FG001|Overall Study|Physician Decision|5|||
13208596|NCT01936948|26242650|FG000|Overall Study|no 30-day follow-up data|0|||
13208597|NCT01936948|26242651|FG001|Overall Study|no 30-day follow-up data|3|||
13208598|NCT01936948|26242652|FG002|Overall Study|no 30-day follow-up data|3|||
13208599|NCT01936948|26242653|FG003|Overall Study|no 30-day follow-up data|3|||
13208600|NCT01936870|26242669|FG000|Overall Study|No Visit After Treatment|176|||
13208601|NCT01936870|26242669|FG000|Overall Study|Protocol Violation|12|||
13208602|NCT01936870|26242669|FG000|Overall Study|No Drug Administration|1|||
13208603|NCT01936649|26242676|FG000|Overall Study|Withdrawal by Subject|4|||
13208604|NCT01936649|26242676|FG000|Overall Study|Physician Decision|2|||
13208605|NCT01936649|26242676|FG000|Overall Study|Protocol Violation|2|||
13208606|NCT01936649|26242676|FG000|Overall Study|Other than specified above|5|||
13208607|NCT01936623|26242695|FG000|Overall Study|Lost to Follow-up|0|||
13208608|NCT01936623|26242696|FG001|Overall Study|Lost to Follow-up|5|||
13208609|NCT01936181|26242716|FG000|Randomised, Double-blind|Adverse Event|27|||
13208610|NCT01936181|26242717|FG001|Randomised, Double-blind|Adverse Event|21|||
13208611|NCT01936181|26242718|FG002|Randomised, Double-blind|Adverse Event|0|||
13208612|NCT01936181|26242719|FG003|Randomised, Double-blind|Adverse Event|0|||
13208613|NCT01936181|26242716|FG000|Randomised, Double-blind|Protocol Violation|1|||
13208614|NCT01936181|26242717|FG001|Randomised, Double-blind|Protocol Violation|5|||
13208615|NCT01936181|26242718|FG002|Randomised, Double-blind|Protocol Violation|0|||
13208616|NCT01936181|26242719|FG003|Randomised, Double-blind|Protocol Violation|0|||
13208617|NCT01936181|26242716|FG000|Randomised, Double-blind|Lack of Efficacy|5|||
13208618|NCT01936181|26242717|FG001|Randomised, Double-blind|Lack of Efficacy|6|||
13208619|NCT01936181|26242718|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
13208620|NCT01936181|26242719|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
13208621|NCT01936181|26242716|FG000|Randomised, Double-blind|Lost to Follow-up|0|||
13208622|NCT01936181|26242717|FG001|Randomised, Double-blind|Lost to Follow-up|1|||
13208623|NCT01936181|26242718|FG002|Randomised, Double-blind|Lost to Follow-up|0|||
13208624|NCT01936181|26242719|FG003|Randomised, Double-blind|Lost to Follow-up|0|||
13208625|NCT01936181|26242716|FG000|Randomised, Double-blind|Pregnancy|0|||
13208626|NCT01936181|26242717|FG001|Randomised, Double-blind|Pregnancy|1|||
13208627|NCT01936181|26242718|FG002|Randomised, Double-blind|Pregnancy|0|||
13208628|NCT01936181|26242719|FG003|Randomised, Double-blind|Pregnancy|0|||
13208629|NCT01936181|26242716|FG000|Randomised, Double-blind|Physician Decision|4|||
13208630|NCT01936181|26242717|FG001|Randomised, Double-blind|Physician Decision|4|||
13208631|NCT01936181|26242718|FG002|Randomised, Double-blind|Physician Decision|0|||
13208632|NCT01936181|26242719|FG003|Randomised, Double-blind|Physician Decision|0|||
13208633|NCT01936181|26242716|FG000|Randomised, Double-blind|Withdrawal by Subject|23|||
13208634|NCT01936181|26242717|FG001|Randomised, Double-blind|Withdrawal by Subject|26|||
13208635|NCT01936181|26242718|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
13208636|NCT01936181|26242719|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
13208637|NCT01936181|26242716|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
13208638|NCT01936181|26242717|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
13208639|NCT01936181|26242718|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
13208640|NCT01936181|26242719|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
13208641|NCT01936181|26242716|FG000|Transition-extension|Adverse Event|3|||
13208642|NCT01936181|26242717|FG001|Transition-extension|Adverse Event|0|||
13208643|NCT01936181|26242718|FG002|Transition-extension|Adverse Event|3|||
13208644|NCT01936181|26242719|FG003|Transition-extension|Adverse Event|1|||
13208645|NCT01936181|26242716|FG000|Transition-extension|Lost to Follow-up|3|||
13208646|NCT01936181|26242717|FG001|Transition-extension|Lost to Follow-up|0|||
13208647|NCT01936181|26242718|FG002|Transition-extension|Lost to Follow-up|1|||
13208648|NCT01936181|26242719|FG003|Transition-extension|Lost to Follow-up|2|||
13208649|NCT01936181|26242716|FG000|Transition-extension|Physician Decision|2|||
13208650|NCT01936181|26242717|FG001|Transition-extension|Physician Decision|0|||
13208651|NCT01936181|26242718|FG002|Transition-extension|Physician Decision|0|||
13208652|NCT01936181|26242719|FG003|Transition-extension|Physician Decision|1|||
13208653|NCT01936181|26242716|FG000|Transition-extension|Withdrawal by Subject|7|||
13208654|NCT01936181|26242717|FG001|Transition-extension|Withdrawal by Subject|0|||
13208655|NCT01936181|26242718|FG002|Transition-extension|Withdrawal by Subject|2|||
13208656|NCT01936181|26242719|FG003|Transition-extension|Withdrawal by Subject|1|||
13208657|NCT01935947|26242752|FG000|Overall Study|Adverse Event|0|||
13208658|NCT01935947|26242753|FG001|Overall Study|Adverse Event|2|||
13208659|NCT01935947|26242754|FG002|Overall Study|Adverse Event|0|||
13208660|NCT01935947|26242752|FG000|Overall Study|Diease Progression|2|||
13208661|NCT01935947|26242753|FG001|Overall Study|Diease Progression|2|||
13208662|NCT01935947|26242754|FG002|Overall Study|Diease Progression|2|||
13208663|NCT01935947|26242752|FG000|Overall Study|Death|1|||
13208664|NCT01935947|26242753|FG001|Overall Study|Death|0|||
13208665|NCT01935947|26242754|FG002|Overall Study|Death|0|||
13208666|NCT01935700|26242769|FG000|Overall Study|Withdrawal by Subject|1|||
13208667|NCT01935700|26242770|FG001|Overall Study|Withdrawal by Subject|0|||
13208668|NCT01935700|26242769|FG000|Overall Study|Physician Decision|4|||
13208669|NCT01935700|26242770|FG001|Overall Study|Physician Decision|0|||
13208670|NCT01935336|26242807|FG000|Overall Study|Adverse Event|1|||
13208671|NCT01935336|26242808|FG001|Overall Study|Adverse Event|0|||
13208672|NCT01935336|26242809|FG002|Overall Study|Adverse Event|0|||
13208673|NCT01935336|26242810|FG003|Overall Study|Adverse Event|0|||
13208674|NCT01935336|26242807|FG000|Overall Study|Progressive disease|5|||
13208675|NCT01935336|26242808|FG001|Overall Study|Progressive disease|3|||
13208676|NCT01935336|26242809|FG002|Overall Study|Progressive disease|47|||
13208677|NCT01935336|26242810|FG003|Overall Study|Progressive disease|66|||
13208678|NCT01935128|26242835|FG000|Overall Study|Death|1|||
13208679|NCT01935128|26242835|FG000|Overall Study|Adverse Event|6|||
13208680|NCT01934972|26242870|FG000|Overall Study|Withdrawal by Subject|9|||
13208681|NCT01934972|26242871|FG001|Overall Study|Withdrawal by Subject|6|||
13208682|NCT01934894|26242893|FG000|Overall Study|Adverse Event|1|||
13208683|NCT01934894|26242894|FG001|Overall Study|Adverse Event|2|||
13208684|NCT01934894|26242893|FG000|Overall Study|Death|2|||
13208685|NCT01934894|26242894|FG001|Overall Study|Death|0|||
13208686|NCT01934894|26242893|FG000|Overall Study|Withdrawal by Subject|0|||
13208687|NCT01934894|26242894|FG001|Overall Study|Withdrawal by Subject|1|||
13208688|NCT01934894|26242893|FG000|Overall Study|Progressive Disease|3|||
13208689|NCT01934894|26242894|FG001|Overall Study|Progressive Disease|2|||
13208690|NCT01934790|26242924|FG000|Treatment|Adverse Event|3|||
13208691|NCT01934790|26242924|FG000|Treatment|Clinical progression|6|||
13208692|NCT01934790|26242924|FG000|Treatment|Radiological progression|4|||
13208693|NCT01934790|26242924|FG000|Treatment|Withdrawal by Subject|2|||
13208694|NCT01934790|26242924|FG000|Treatment|Study drug never administered|1|||
13208695|NCT01934790|26242924|FG000|Active Follow up|Death|20|||
13208696|NCT01934790|26242924|FG000|Active Follow up|Physician Decision|2|||
13208697|NCT01934790|26242924|FG000|Active Follow up|Progressive disease|1|||
13208698|NCT01934790|26242924|FG000|Active Follow up|Other reason|1|||
13208699|NCT01934556|26242966|FG000|Overall Study|Withdrawal by Subject|0|||
13208700|NCT01934556|26242967|FG001|Overall Study|Withdrawal by Subject|1|||
13208701|NCT01934556|26242968|FG002|Overall Study|Withdrawal by Subject|1|||
13208702|NCT01934556|26242966|FG000|Overall Study|Lost to Follow-up|4|||
13208703|NCT01934556|26242967|FG001|Overall Study|Lost to Follow-up|10|||
13208704|NCT01934556|26242968|FG002|Overall Study|Lost to Follow-up|7|||
13208705|NCT01934556|26242966|FG000|Overall Study|Death|1|||
13208706|NCT01934556|26242967|FG001|Overall Study|Death|5|||
13208707|NCT01934556|26242968|FG002|Overall Study|Death|2|||
13208708|NCT01934504|26243003|FG000|Overall Study|Protocol Deviation|0|||
13208709|NCT01934504|26243004|FG001|Overall Study|Protocol Deviation|0|||
13208710|NCT01934504|26243005|FG002|Overall Study|Protocol Deviation|0|||
13208711|NCT01934504|26243006|FG003|Overall Study|Protocol Deviation|2|||
13208712|NCT01934504|26243003|FG000|Overall Study|Study Terminated by Sponsor|1|||
13208713|NCT01934504|26243004|FG001|Overall Study|Study Terminated by Sponsor|0|||
13208714|NCT01934504|26243005|FG002|Overall Study|Study Terminated by Sponsor|5|||
13208715|NCT01934504|26243006|FG003|Overall Study|Study Terminated by Sponsor|5|||
13208716|NCT01934335|26243023|FG000|Overall Study|Withdrawal by Subject|1|||
13208717|NCT01934335|26243024|FG001|Overall Study|Withdrawal by Subject|1|||
13208718|NCT01934218|26243038|FG000|Double-blind Phase|Adverse Event|8|||
13208719|NCT01934218|26243039|FG001|Double-blind Phase|Adverse Event|8|||
13208720|NCT01934218|26243038|FG000|Double-blind Phase|Lack of Efficacy|6|||
13208721|NCT01934218|26243039|FG001|Double-blind Phase|Lack of Efficacy|7|||
13208722|NCT01934218|26243038|FG000|Double-blind Phase|Lost to Follow-up|7|||
13208723|NCT01934218|26243039|FG001|Double-blind Phase|Lost to Follow-up|14|||
13208724|NCT01934218|26243038|FG000|Double-blind Phase|Physician Decision|1|||
13208725|NCT01934218|26243039|FG001|Double-blind Phase|Physician Decision|2|||
13208726|NCT01934218|26243038|FG000|Double-blind Phase|Protocol Violation|4|||
13208727|NCT01934218|26243039|FG001|Double-blind Phase|Protocol Violation|0|||
13208728|NCT01934218|26243038|FG000|Double-blind Phase|Withdrawal by Subject|16|||
13208729|NCT01934218|26243039|FG001|Double-blind Phase|Withdrawal by Subject|13|||
13208730|NCT01934218|26243038|FG000|Double-blind Phase|Noncompliance with Study Protocol|5|||
13208731|NCT01934218|26243039|FG001|Double-blind Phase|Noncompliance with Study Protocol|8|||
13208732|NCT01934218|26243038|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1|||
13208733|NCT01934218|26243039|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2|||
13208734|NCT01934218|26243038|FG000|Open-Label Phase|Adverse Event|2|||
13208735|NCT01934218|26243039|FG001|Open-Label Phase|Adverse Event|4|||
13208736|NCT01934218|26243038|FG000|Open-Label Phase|Lack of Efficacy|1|||
13208737|NCT01934218|26243039|FG001|Open-Label Phase|Lack of Efficacy|4|||
13208738|NCT01934218|26243038|FG000|Open-Label Phase|Lost to Follow-up|4|||
13208739|NCT01934218|26243039|FG001|Open-Label Phase|Lost to Follow-up|2|||
13208740|NCT01934218|26243038|FG000|Open-Label Phase|Physician Decision|1|||
13208741|NCT01934218|26243039|FG001|Open-Label Phase|Physician Decision|0|||
13208742|NCT01934218|26243038|FG000|Open-Label Phase|Protocol Violation|1|||
13208743|NCT01934218|26243039|FG001|Open-Label Phase|Protocol Violation|0|||
13208744|NCT01934218|26243038|FG000|Open-Label Phase|Withdrawal by Subject|13|||
13208745|NCT01934218|26243039|FG001|Open-Label Phase|Withdrawal by Subject|11|||
13208746|NCT01934218|26243038|FG000|Open-Label Phase|Noncompliance with Study Protocol|4|||
13296514|NCT01370083|26496725|FG001|Overall Study|Adverse Event|1|||
13208747|NCT01934218|26243039|FG001|Open-Label Phase|Noncompliance with Study Protocol|2|||
13208748|NCT01934218|26243038|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0|||
13208749|NCT01934218|26243039|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1|||
13208750|NCT01934192|26243186|FG000|Overall Study|Protocol Violation|0|||
13208751|NCT01934192|26243187|FG001|Overall Study|Protocol Violation|0|||
13208752|NCT01934192|26243188|FG002|Overall Study|Protocol Violation|0|||
13208753|NCT01934192|26243189|FG003|Overall Study|Protocol Violation|1|||
13208754|NCT01934192|26243186|FG000|Overall Study|Other: reached stopping criteria|6|||
13208755|NCT01934192|26243187|FG001|Overall Study|Other: reached stopping criteria|5|||
13208756|NCT01934192|26243188|FG002|Overall Study|Other: reached stopping criteria|1|||
13208757|NCT01934192|26243189|FG003|Overall Study|Other: reached stopping criteria|0|||
13208758|NCT01934192|26243186|FG000|Overall Study|Physician Decision|3|||
13208759|NCT01934192|26243187|FG001|Overall Study|Physician Decision|2|||
13208760|NCT01934192|26243188|FG002|Overall Study|Physician Decision|0|||
13208761|NCT01934192|26243189|FG003|Overall Study|Physician Decision|0|||
13208762|NCT01934140|26243244|FG000|Persistence Phase (Year 6-10)|Other|24|||
13208763|NCT01934140|26243245|FG001|Persistence Phase (Year 6-10)|Other|6|||
13208764|NCT01934140|26243244|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5|||
13208765|NCT01934140|26243245|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2|||
13208766|NCT01934140|26243244|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31|||
13208767|NCT01934140|26243245|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10|||
13208768|NCT01934140|26243244|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2|||
13208769|NCT01934140|26243245|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0|||
13208770|NCT01934140|26243244|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21|||
13208771|NCT01934140|26243245|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7|||
13208772|NCT01934140|26243244|FG000|Booster Phase (6 Months)|Lost to Follow-up|1|||
13208773|NCT01934140|26243245|FG001|Booster Phase (6 Months)|Lost to Follow-up|0|||
13208774|NCT01934140|26243244|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2|||
13208775|NCT01934140|26243245|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1|||
13208776|NCT01934140|26243244|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2|||
13208777|NCT01934140|26243245|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2|||
13208778|NCT01934010|26243272|FG000|Overall Study|Adverse Event|1|||
13208779|NCT01934010|26243273|FG001|Overall Study|Adverse Event|1|||
13208780|NCT01934010|26243274|FG002|Overall Study|Adverse Event|0|||
13208781|NCT01934010|26243272|FG000|Overall Study|Withdrawal by Subject|15|||
13208782|NCT01934010|26243273|FG001|Overall Study|Withdrawal by Subject|6|||
13208783|NCT01934010|26243274|FG002|Overall Study|Withdrawal by Subject|2|||
13208784|NCT01934010|26243272|FG000|Overall Study|Lost to Follow-up|7|||
13208785|NCT01934010|26243273|FG001|Overall Study|Lost to Follow-up|4|||
13208786|NCT01934010|26243274|FG002|Overall Study|Lost to Follow-up|0|||
13208787|NCT01933919|26243315|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0|||
13208788|NCT01933919|26243316|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1|||
13208789|NCT01933919|26243315|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0|||
13208790|NCT01933919|26243316|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1|||
13208791|NCT01933919|26243315|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0|||
13208792|NCT01933919|26243316|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2|||
13208793|NCT01933919|26243315|FG000|Open-label Long-term Phase|Adverse Event|2|||
13208794|NCT01933919|26243316|FG001|Open-label Long-term Phase|Adverse Event|0|||
13208795|NCT01933919|26243315|FG000|Open-label Long-term Phase|Withdrawal by Subject|3|||
13208796|NCT01933919|26243316|FG001|Open-label Long-term Phase|Withdrawal by Subject|4|||
13208797|NCT01933919|26243315|FG000|Open-label Long-term Phase|Lost to Follow-up|1|||
13208798|NCT01933919|26243316|FG001|Open-label Long-term Phase|Lost to Follow-up|0|||
13208799|NCT01933919|26243315|FG000|Open-label Long-term Phase|Other|1|||
13208800|NCT01933919|26243316|FG001|Open-label Long-term Phase|Other|2|||
13208801|NCT01933880|26243388|FG000|Overall Study|Withdrawal by Subject|5|||
13208802|NCT01933880|26243389|FG001|Overall Study|Withdrawal by Subject|0|||
13208803|NCT01933880|26243388|FG000|Overall Study|Lack of Efficacy|1|||
13208804|NCT01933880|26243389|FG001|Overall Study|Lack of Efficacy|0|||
13208805|NCT01933880|26243388|FG000|Overall Study|Concomitant medication Interference|0|||
13208806|NCT01933880|26243389|FG001|Overall Study|Concomitant medication Interference|1|||
13208807|NCT01933880|26243388|FG000|Overall Study|Followup exceeded 4 days to visit window|19|||
13208808|NCT01933880|26243389|FG001|Overall Study|Followup exceeded 4 days to visit window|0|||
13208809|NCT01933880|26243388|FG000|Overall Study|Other|4|||
13208810|NCT01933880|26243389|FG001|Overall Study|Other|0|||
13208811|NCT01933880|26243388|FG000|Overall Study|Protocol Violation|1|||
13208812|NCT01933880|26243389|FG001|Overall Study|Protocol Violation|0|||
13208813|NCT01933789|26243716|FG000|Overall Study|Death|0|||
13208814|NCT01933789|26243717|FG001|Overall Study|Death|0|||
13208815|NCT01933789|26243718|FG002|Overall Study|Death|0|||
13208816|NCT01933789|26243719|FG003|Overall Study|Death|0|||
13208817|NCT01933789|26243720|FG004|Overall Study|Death|21|||
13208818|NCT01933789|26243721|FG005|Overall Study|Death|32|||
13208819|NCT01933789|26243722|FG006|Overall Study|Death|0|||
13208820|NCT01933789|26243723|FG007|Overall Study|Death|0|||
13208821|NCT01933789|26243724|FG008|Overall Study|Death|0|||
13208822|NCT01933789|26243716|FG000|Overall Study|Lost to Follow-up|0|||
13208823|NCT01933789|26243717|FG001|Overall Study|Lost to Follow-up|0|||
13208824|NCT01933789|26243718|FG002|Overall Study|Lost to Follow-up|0|||
13208825|NCT01933789|26243719|FG003|Overall Study|Lost to Follow-up|1|||
13208826|NCT01933789|26243720|FG004|Overall Study|Lost to Follow-up|8|||
13208827|NCT01933789|26243721|FG005|Overall Study|Lost to Follow-up|9|||
13208828|NCT01933789|26243722|FG006|Overall Study|Lost to Follow-up|1|||
13208829|NCT01933789|26243723|FG007|Overall Study|Lost to Follow-up|4|||
13208830|NCT01933789|26243724|FG008|Overall Study|Lost to Follow-up|0|||
13208831|NCT01933789|26243716|FG000|Overall Study|Withdrawal by Subject|2|||
13208832|NCT01933789|26243717|FG001|Overall Study|Withdrawal by Subject|1|||
13208833|NCT01933789|26243718|FG002|Overall Study|Withdrawal by Subject|0|||
13208834|NCT01933789|26243719|FG003|Overall Study|Withdrawal by Subject|0|||
13208835|NCT01933789|26243720|FG004|Overall Study|Withdrawal by Subject|17|||
13208836|NCT01933789|26243721|FG005|Overall Study|Withdrawal by Subject|16|||
13208837|NCT01933789|26243722|FG006|Overall Study|Withdrawal by Subject|1|||
13208838|NCT01933789|26243723|FG007|Overall Study|Withdrawal by Subject|4|||
13208839|NCT01933789|26243724|FG008|Overall Study|Withdrawal by Subject|0|||
13208840|NCT01933789|26243716|FG000|Overall Study|Became Ineligible|4|||
13208841|NCT01933789|26243717|FG001|Overall Study|Became Ineligible|0|||
13208842|NCT01933789|26243718|FG002|Overall Study|Became Ineligible|0|||
13208843|NCT01933789|26243719|FG003|Overall Study|Became Ineligible|0|||
13208844|NCT01933789|26243720|FG004|Overall Study|Became Ineligible|13|||
13208845|NCT01933789|26243721|FG005|Overall Study|Became Ineligible|10|||
13208846|NCT01933789|26243722|FG006|Overall Study|Became Ineligible|13|||
13208847|NCT01933789|26243723|FG007|Overall Study|Became Ineligible|6|||
13208848|NCT01933789|26243724|FG008|Overall Study|Became Ineligible|0|||
13208849|NCT01933672|26243778|FG000|Metformin Run-in Period|Adverse Event|1|||
13208850|NCT01933672|26243779|FG001|Metformin Run-in Period|Adverse Event|0|||
13208851|NCT01933672|26243780|FG002|Metformin Run-in Period|Adverse Event|0|||
13208852|NCT01933672|26243781|FG003|Metformin Run-in Period|Adverse Event|0|||
13208853|NCT01933672|26243782|FG004|Metformin Run-in Period|Adverse Event|0|||
13208854|NCT01933672|26243783|FG005|Metformin Run-in Period|Adverse Event|0|||
13208855|NCT01933672|26243784|FG006|Metformin Run-in Period|Adverse Event|0|||
13208856|NCT01933672|26243778|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4|||
13208857|NCT01933672|26243779|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0|||
13208858|NCT01933672|26243780|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0|||
13208859|NCT01933672|26243781|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0|||
13208860|NCT01933672|26243782|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0|||
13208861|NCT01933672|26243783|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0|||
13208862|NCT01933672|26243784|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0|||
13208863|NCT01933672|26243778|FG000|Metformin Run-in Period|Other|5|||
13208864|NCT01933672|26243779|FG001|Metformin Run-in Period|Other|0|||
13208865|NCT01933672|26243780|FG002|Metformin Run-in Period|Other|0|||
13208866|NCT01933672|26243781|FG003|Metformin Run-in Period|Other|0|||
13208867|NCT01933672|26243782|FG004|Metformin Run-in Period|Other|0|||
13208868|NCT01933672|26243783|FG005|Metformin Run-in Period|Other|0|||
13208869|NCT01933672|26243784|FG006|Metformin Run-in Period|Other|0|||
13208870|NCT01933672|26243778|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
13208871|NCT01933672|26243779|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
13208872|NCT01933672|26243780|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
13208873|NCT01933672|26243781|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
13208874|NCT01933672|26243782|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1|||
13208875|NCT01933672|26243783|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
13208876|NCT01933672|26243784|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
13208877|NCT01933672|26243778|FG000|First Intervention Period (12-16 Days)|Other|0|||
13208878|NCT01933672|26243779|FG001|First Intervention Period (12-16 Days)|Other|0|||
13208879|NCT01933672|26243780|FG002|First Intervention Period (12-16 Days)|Other|1|||
13208880|NCT01933672|26243781|FG003|First Intervention Period (12-16 Days)|Other|0|||
13208881|NCT01933672|26243782|FG004|First Intervention Period (12-16 Days)|Other|0|||
13208882|NCT01933672|26243783|FG005|First Intervention Period (12-16 Days)|Other|1|||
13208883|NCT01933672|26243784|FG006|First Intervention Period (12-16 Days)|Other|0|||
13208884|NCT01933672|26243778|FG000|Second Intervention Period (12-16 Days)|Other|0|||
13208885|NCT01933672|26243779|FG001|Second Intervention Period (12-16 Days)|Other|1|||
13208886|NCT01933672|26243780|FG002|Second Intervention Period (12-16 Days)|Other|1|||
13208887|NCT01933672|26243781|FG003|Second Intervention Period (12-16 Days)|Other|0|||
13208888|NCT01933672|26243782|FG004|Second Intervention Period (12-16 Days)|Other|0|||
13208889|NCT01933672|26243783|FG005|Second Intervention Period (12-16 Days)|Other|0|||
13208890|NCT01933672|26243784|FG006|Second Intervention Period (12-16 Days)|Other|0|||
13208891|NCT01933672|26243778|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
13208892|NCT01933672|26243779|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
13208893|NCT01933672|26243780|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
13208894|NCT01933672|26243781|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1|||
13208895|NCT01933672|26243782|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
13208896|NCT01933672|26243783|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
13208897|NCT01933672|26243784|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
13208898|NCT01933672|26243778|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
13208899|NCT01933672|26243779|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1|||
13208900|NCT01933672|26243780|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
13208901|NCT01933672|26243781|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
13208902|NCT01933672|26243782|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
13208903|NCT01933672|26243783|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
13208904|NCT01933672|26243784|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
13208905|NCT01933594|26243893|FG000|Overall Study|Lost to Follow-up|1|||
13208906|NCT01933594|26243894|FG001|Overall Study|Lost to Follow-up|0|||
13208907|NCT01933594|26243895|FG002|Overall Study|Lost to Follow-up|0|||
13208908|NCT01933594|26243896|FG003|Overall Study|Lost to Follow-up|0|||
13208909|NCT01933594|26243897|FG004|Overall Study|Lost to Follow-up|1|||
13208910|NCT01933594|26243898|FG005|Overall Study|Lost to Follow-up|0|||
13208911|NCT01933594|26243893|FG000|Overall Study|Ineligible for subsequent study step|0|||
13208912|NCT01933594|26243894|FG001|Overall Study|Ineligible for subsequent study step|0|||
13208913|NCT01933594|26243895|FG002|Overall Study|Ineligible for subsequent study step|0|||
13208914|NCT01933594|26243896|FG003|Overall Study|Ineligible for subsequent study step|0|||
13208915|NCT01933594|26243897|FG004|Overall Study|Ineligible for subsequent study step|1|||
13208916|NCT01933594|26243898|FG005|Overall Study|Ineligible for subsequent study step|0|||
13208917|NCT01933334|26243915|FG000|Overall Study|Adverse Event|5|||
13208918|NCT01933334|26243916|FG001|Overall Study|Adverse Event|1|||
13208919|NCT01933334|26243915|FG000|Overall Study|Withdrawal by Subject|0|||
13208920|NCT01933334|26243916|FG001|Overall Study|Withdrawal by Subject|1|||
13208921|NCT01933217|26243935|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1|||
13208922|NCT01933217|26243936|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3|||
13208923|NCT01933217|26243935|FG000|Randomization (4 Weeks)|Lost to Follow-up|1|||
13208924|NCT01933217|26243936|FG001|Randomization (4 Weeks)|Lost to Follow-up|1|||
13208925|NCT01933113|26243942|FG000|Overall Study|Fractured nonfunctioning lead.|1|||
13208926|NCT01933048|26243962|FG000|Overall Study|Lost to Follow-up|15|||
13208927|NCT01933048|26243963|FG001|Overall Study|Lost to Follow-up|18|||
13208928|NCT01933048|26243962|FG000|Overall Study|personal reasons|1|||
13208929|NCT01933048|26243963|FG001|Overall Study|personal reasons|1|||
13208930|NCT01933048|26243962|FG000|Overall Study|Protocol Violation|7|||
13208931|NCT01933048|26243963|FG001|Overall Study|Protocol Violation|8|||
13208932|NCT01933048|26243962|FG000|Overall Study|Physician Decision|1|||
13208933|NCT01933048|26243963|FG001|Overall Study|Physician Decision|0|||
13208934|NCT01933048|26243962|FG000|Overall Study|unknown reasons|1|||
13208935|NCT01933048|26243963|FG001|Overall Study|unknown reasons|1|||
13208936|NCT01932996|26243980|FG000|Overall Study|Protocol Violation|2|||
13208937|NCT01932996|26243981|FG001|Overall Study|Protocol Violation|0|||
13208938|NCT01932970|26243991|FG000|Overall Study|Withdrawal by Subject|5|||
13208939|NCT01932970|26243991|FG000|Overall Study|Death|1|||
13208940|NCT01932970|26243991|FG000|Overall Study|Lost to Follow-up|2|||
13208941|NCT01932970|26243991|FG000|Overall Study|Protocol Specified Criteria|10|||
13208942|NCT01932788|26244004|FG000|Overall Study|Protocol Violation|18|||
13208943|NCT01932788|26244005|FG001|Overall Study|Protocol Violation|0|||
13208944|NCT01932788|26244004|FG000|Overall Study|Lost to Follow-up|18|||
13208945|NCT01932788|26244005|FG001|Overall Study|Lost to Follow-up|46|||
13208946|NCT01932788|26244004|FG000|Overall Study|Lack of Efficacy|2|||
13208947|NCT01932788|26244005|FG001|Overall Study|Lack of Efficacy|0|||
13208948|NCT01932788|26244004|FG000|Overall Study|Withdrawal by Subject|0|||
13208949|NCT01932788|26244005|FG001|Overall Study|Withdrawal by Subject|5|||
13208950|NCT01932762|26244052|FG000|Overall Study|Withdrawal by Subject|1|||
13208951|NCT01932762|26244053|FG001|Overall Study|Withdrawal by Subject|2|||
13208952|NCT01932762|26244054|FG002|Overall Study|Withdrawal by Subject|0|||
13208953|NCT01932762|26244055|FG003|Overall Study|Withdrawal by Subject|0|||
13208954|NCT01932762|26244052|FG000|Overall Study|Lost to Follow-up|4|||
13208955|NCT01932762|26244053|FG001|Overall Study|Lost to Follow-up|0|||
13208956|NCT01932762|26244054|FG002|Overall Study|Lost to Follow-up|0|||
13208957|NCT01932762|26244055|FG003|Overall Study|Lost to Follow-up|1|||
13208958|NCT01932762|26244052|FG000|Overall Study|Physician Decision|1|||
13208959|NCT01932762|26244053|FG001|Overall Study|Physician Decision|0|||
13208960|NCT01932762|26244054|FG002|Overall Study|Physician Decision|0|||
13208961|NCT01932762|26244055|FG003|Overall Study|Physician Decision|0|||
13208962|NCT01932697|26244074|FG000|Overall Study|Received a different amount of tx|1|||
13208963|NCT01932697|26244075|FG001|Overall Study|Received a different amount of tx|0|||
13208964|NCT01932697|26244074|FG000|Overall Study|Ineligible|1|||
13208965|NCT01932697|26244075|FG001|Overall Study|Ineligible|0|||
13208966|NCT01932437|26244136|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
13394766|NCT00654381|26788099|FG002|2nd Stage|Adverse Event|2|||
13208967|NCT01932437|26244137|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
13208968|NCT01932437|26244138|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
13208969|NCT01932437|26244139|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
13208970|NCT01932437|26244140|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
13208971|NCT01932437|26244141|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1|||
13208972|NCT01932294|26244149|FG000|Overall Study|Death|43|||
13208973|NCT01932294|26244149|FG000|Overall Study|Lost to Follow-up|8|||
13208974|NCT01932294|26244149|FG000|Overall Study|VAD Implantation|20|||
13208975|NCT01932294|26244149|FG000|Overall Study|Heart Transplantation|16|||
13208976|NCT01932294|26244149|FG000|Overall Study|Transferred to other hospitals|12|||
13208977|NCT01931995|26244164|FG000|First Intervention (1 Day)|Withdrawal by Subject|2|||
13208978|NCT01931995|26244165|FG001|First Intervention (1 Day)|Withdrawal by Subject|2|||
13208979|NCT01931995|26244164|FG000|First Intervention (1 Day)|Physician Decision|1|||
13208980|NCT01931995|26244165|FG001|First Intervention (1 Day)|Physician Decision|1|||
13208981|NCT01931995|26244164|FG000|First Intervention (1 Day)|Lost to Follow-up|1|||
13208982|NCT01931995|26244165|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
13208983|NCT01931956|26244534|FG000|Overall Study|Death|42|||
13208984|NCT01931956|26244535|FG001|Overall Study|Death|7|||
13208985|NCT01931956|26244536|FG002|Overall Study|Death|379|||
13208986|NCT01931956|26244537|FG003|Overall Study|Death|96|||
13208987|NCT01931956|26244534|FG000|Overall Study|Withdrawal by Subject|5|||
13208988|NCT01931956|26244535|FG001|Overall Study|Withdrawal by Subject|0|||
13208989|NCT01931956|26244536|FG002|Overall Study|Withdrawal by Subject|70|||
13208990|NCT01931956|26244537|FG003|Overall Study|Withdrawal by Subject|30|||
13208991|NCT01931956|26244534|FG000|Overall Study|Lost to Follow-up|2|||
13208992|NCT01931956|26244535|FG001|Overall Study|Lost to Follow-up|0|||
13208993|NCT01931956|26244536|FG002|Overall Study|Lost to Follow-up|11|||
13208994|NCT01931956|26244537|FG003|Overall Study|Lost to Follow-up|7|||
13208995|NCT01931956|26244534|FG000|Overall Study|Expected|2|||
13208996|NCT01931956|26244535|FG001|Overall Study|Expected|0|||
13208997|NCT01931956|26244536|FG002|Overall Study|Expected|6|||
13208998|NCT01931956|26244537|FG003|Overall Study|Expected|0|||
13208999|NCT01931956|26244534|FG000|Overall Study|Not due|0|||
13209000|NCT01931956|26244535|FG001|Overall Study|Not due|0|||
13209001|NCT01931956|26244536|FG002|Overall Study|Not due|21|||
13209002|NCT01931956|26244537|FG003|Overall Study|Not due|0|||
13209003|NCT01931865|26244545|FG000|Overall Study|Lost to Follow-up|2|||
13209004|NCT01931865|26244545|FG000|Overall Study|Withdrawal by Subject|2|||
13209005|NCT01931839|26244635|FG000|Overall Study|Death|0|||
13209006|NCT01931839|26244636|FG001|Overall Study|Death|1|||
13209007|NCT01931839|26244637|FG002|Overall Study|Death|2|||
13209008|NCT01931839|26244638|FG003|Overall Study|Death|0|||
13209009|NCT01931839|26244639|FG004|Overall Study|Death|0|||
13209010|NCT01931839|26244640|FG005|Overall Study|Death|0|||
13209011|NCT01931839|26244641|FG006|Overall Study|Death|0|||
13209012|NCT01931839|26244635|FG000|Overall Study|Physician Decision|1|||
13209013|NCT01931839|26244636|FG001|Overall Study|Physician Decision|0|||
13209014|NCT01931839|26244637|FG002|Overall Study|Physician Decision|1|||
13209015|NCT01931839|26244638|FG003|Overall Study|Physician Decision|0|||
13209016|NCT01931839|26244639|FG004|Overall Study|Physician Decision|0|||
13209017|NCT01931839|26244640|FG005|Overall Study|Physician Decision|0|||
13209018|NCT01931839|26244641|FG006|Overall Study|Physician Decision|1|||
13209019|NCT01931839|26244635|FG000|Overall Study|Withdrawal of consent|0|||
13209020|NCT01931839|26244636|FG001|Overall Study|Withdrawal of consent|0|||
13209021|NCT01931839|26244637|FG002|Overall Study|Withdrawal of consent|0|||
13209022|NCT01931839|26244638|FG003|Overall Study|Withdrawal of consent|0|||
13209023|NCT01931839|26244639|FG004|Overall Study|Withdrawal of consent|1|||
13209024|NCT01931839|26244640|FG005|Overall Study|Withdrawal of consent|0|||
13209025|NCT01931839|26244641|FG006|Overall Study|Withdrawal of consent|0|||
13209026|NCT01931839|26244635|FG000|Overall Study|Adverse Event|9|||
13209027|NCT01931839|26244636|FG001|Overall Study|Adverse Event|4|||
13209028|NCT01931839|26244637|FG002|Overall Study|Adverse Event|1|||
13209029|NCT01931839|26244638|FG003|Overall Study|Adverse Event|3|||
13209030|NCT01931839|26244639|FG004|Overall Study|Adverse Event|0|||
13209031|NCT01931839|26244640|FG005|Overall Study|Adverse Event|0|||
13209032|NCT01931839|26244641|FG006|Overall Study|Adverse Event|1|||
13209033|NCT01931839|26244635|FG000|Overall Study|Withdrawal of consent (not due to AE)|11|||
13209034|NCT01931839|26244636|FG001|Overall Study|Withdrawal of consent (not due to AE)|8|||
13209035|NCT01931839|26244637|FG002|Overall Study|Withdrawal of consent (not due to AE)|13|||
13209036|NCT01931839|26244638|FG003|Overall Study|Withdrawal of consent (not due to AE)|3|||
13209037|NCT01931839|26244639|FG004|Overall Study|Withdrawal of consent (not due to AE)|0|||
13209038|NCT01931839|26244640|FG005|Overall Study|Withdrawal of consent (not due to AE)|2|||
13209039|NCT01931839|26244641|FG006|Overall Study|Withdrawal of consent (not due to AE)|2|||
13209040|NCT01931839|26244635|FG000|Overall Study|Other non-compliance|15|||
13209041|NCT01931839|26244636|FG001|Overall Study|Other non-compliance|9|||
13209042|NCT01931839|26244637|FG002|Overall Study|Other non-compliance|12|||
13209043|NCT01931839|26244638|FG003|Overall Study|Other non-compliance|3|||
13209044|NCT01931839|26244639|FG004|Overall Study|Other non-compliance|0|||
13209045|NCT01931839|26244640|FG005|Overall Study|Other non-compliance|3|||
13209046|NCT01931839|26244641|FG006|Overall Study|Other non-compliance|0|||
13209047|NCT01931839|26244635|FG000|Overall Study|Lost to Follow-up|1|||
13209048|NCT01931839|26244636|FG001|Overall Study|Lost to Follow-up|2|||
13209049|NCT01931839|26244637|FG002|Overall Study|Lost to Follow-up|4|||
13209050|NCT01931839|26244638|FG003|Overall Study|Lost to Follow-up|5|||
13209051|NCT01931839|26244639|FG004|Overall Study|Lost to Follow-up|0|||
13209052|NCT01931839|26244640|FG005|Overall Study|Lost to Follow-up|0|||
13209053|NCT01931839|26244641|FG006|Overall Study|Lost to Follow-up|0|||
13209054|NCT01931839|26244635|FG000|Overall Study|Other|4|||
13209055|NCT01931839|26244636|FG001|Overall Study|Other|2|||
13209056|NCT01931839|26244637|FG002|Overall Study|Other|6|||
13209057|NCT01931839|26244638|FG003|Overall Study|Other|0|||
13209058|NCT01931839|26244639|FG004|Overall Study|Other|0|||
13209059|NCT01931839|26244640|FG005|Overall Study|Other|0|||
13209060|NCT01931839|26244641|FG006|Overall Study|Other|0|||
13209061|NCT01931735|26244688|FG000|Randomized Phase|Lost to Follow-up|2|||
13209062|NCT01931735|26244689|FG001|Randomized Phase|Lost to Follow-up|2|||
13209063|NCT01931735|26244690|FG002|Randomized Phase|Lost to Follow-up|5|||
13209064|NCT01931735|26244691|FG003|Randomized Phase|Lost to Follow-up|0|||
13209065|NCT01931735|26244688|FG000|Observational Non-Randomized Phase|Adverse Event|0|||
13209066|NCT01931735|26244689|FG001|Observational Non-Randomized Phase|Adverse Event|0|||
13209067|NCT01931735|26244690|FG002|Observational Non-Randomized Phase|Adverse Event|0|||
13209068|NCT01931735|26244691|FG003|Observational Non-Randomized Phase|Adverse Event|1|||
13209069|NCT01931735|26244688|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
13209070|NCT01931735|26244689|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
13209071|NCT01931735|26244690|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
13209072|NCT01931735|26244691|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1|||
13209073|NCT01931670|26244799|FG000|Treatment Period|Exclusionary Medication Received|1|||
13209074|NCT01931670|26244800|FG001|Treatment Period|Exclusionary Medication Received|1|||
13209075|NCT01931670|26244801|FG002|Treatment Period|Exclusionary Medication Received|1|||
13209076|NCT01931670|26244799|FG000|Treatment Period|Surgery/Invasive Intervention|4|||
13209077|NCT01931670|26244800|FG001|Treatment Period|Surgery/Invasive Intervention|2|||
13209078|NCT01931670|26244801|FG002|Treatment Period|Surgery/Invasive Intervention|0|||
13209079|NCT01931670|26244799|FG000|Treatment Period|Subject Noncompliant|4|||
13209080|NCT01931670|26244800|FG001|Treatment Period|Subject Noncompliant|9|||
13209081|NCT01931670|26244801|FG002|Treatment Period|Subject Noncompliant|5|||
13209082|NCT01931670|26244799|FG000|Treatment Period|Adverse Event|19|||
13209083|NCT01931670|26244800|FG001|Treatment Period|Adverse Event|8|||
13209084|NCT01931670|26244801|FG002|Treatment Period|Adverse Event|21|||
13209085|NCT01931670|26244799|FG000|Treatment Period|Lack of Efficacy|11|||
13209086|NCT01931670|26244800|FG001|Treatment Period|Lack of Efficacy|2|||
13209087|NCT01931670|26244801|FG002|Treatment Period|Lack of Efficacy|2|||
13209088|NCT01931670|26244799|FG000|Treatment Period|Pregnancy|7|||
13209089|NCT01931670|26244800|FG001|Treatment Period|Pregnancy|2|||
13209090|NCT01931670|26244801|FG002|Treatment Period|Pregnancy|0|||
13209091|NCT01931670|26244799|FG000|Treatment Period|Other|8|||
13209092|NCT01931670|26244800|FG001|Treatment Period|Other|7|||
13209093|NCT01931670|26244801|FG002|Treatment Period|Other|2|||
13209094|NCT01931670|26244799|FG000|Treatment Period|Consent Withdrawn by Subject|17|||
13209095|NCT01931670|26244800|FG001|Treatment Period|Consent Withdrawn by Subject|12|||
13209096|NCT01931670|26244801|FG002|Treatment Period|Consent Withdrawn by Subject|7|||
13209097|NCT01931670|26244799|FG000|Treatment Period|Lost to Follow-up|19|||
13209098|NCT01931670|26244800|FG001|Treatment Period|Lost to Follow-up|5|||
13209099|NCT01931670|26244801|FG002|Treatment Period|Lost to Follow-up|7|||
13209100|NCT01931670|26244799|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3|||
13209101|NCT01931670|26244800|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
13209102|NCT01931670|26244801|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
13209103|NCT01931670|26244799|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0|||
13209104|NCT01931670|26244800|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2|||
13209105|NCT01931670|26244801|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1|||
13209106|NCT01931670|26244799|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
13209107|NCT01931670|26244800|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
13209108|NCT01931670|26244801|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2|||
13209109|NCT01931670|26244799|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6|||
13209110|NCT01931670|26244800|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
13209111|NCT01931670|26244801|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
13209112|NCT01931670|26244799|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6|||
13209113|NCT01931670|26244800|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3|||
13209114|NCT01931670|26244801|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13|||
13209115|NCT01931670|26244799|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
13209116|NCT01931670|26244800|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
13209117|NCT01931670|26244801|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2|||
13209118|NCT01931566|26244824|FG000|Overall Study|Randomized But Not Treated|6|||
13209119|NCT01931566|26244825|FG001|Overall Study|Randomized But Not Treated|9|||
13209120|NCT01931566|26244826|FG002|Overall Study|Randomized But Not Treated|14|||
13209121|NCT01931566|26244824|FG000|Overall Study|Adverse Event|37|||
13209122|NCT01931566|26244825|FG001|Overall Study|Adverse Event|167|||
13209123|NCT01931566|26244826|FG002|Overall Study|Adverse Event|132|||
13209124|NCT01931566|26244824|FG000|Overall Study|Major Protocol Deviation|5|||
13209125|NCT01931566|26244825|FG001|Overall Study|Major Protocol Deviation|14|||
13209126|NCT01931566|26244826|FG002|Overall Study|Major Protocol Deviation|21|||
13209127|NCT01931566|26244824|FG000|Overall Study|Lost to Follow-up|3|||
13209128|NCT01931566|26244825|FG001|Overall Study|Lost to Follow-up|26|||
13209129|NCT01931566|26244826|FG002|Overall Study|Lost to Follow-up|23|||
13209130|NCT01931566|26244824|FG000|Overall Study|Voluntary Withdrawal|78|||
13209131|NCT01931566|26244825|FG001|Overall Study|Voluntary Withdrawal|245|||
13209132|NCT01931566|26244826|FG002|Overall Study|Voluntary Withdrawal|225|||
13209133|NCT01931566|26244824|FG000|Overall Study|Study Termination|289|||
13209134|NCT01931566|26244825|FG001|Overall Study|Study Termination|968|||
13209135|NCT01931566|26244826|FG002|Overall Study|Study Termination|1037|||
13209136|NCT01931566|26244824|FG000|Overall Study|Reason Not Specified|11|||
13209137|NCT01931566|26244825|FG001|Overall Study|Reason Not Specified|47|||
13209138|NCT01931566|26244826|FG002|Overall Study|Reason Not Specified|53|||
13209139|NCT01931566|26244824|FG000|Overall Study|Missing|0|||
13209140|NCT01931566|26244825|FG001|Overall Study|Missing|0|||
13209141|NCT01931566|26244826|FG002|Overall Study|Missing|1|||
13209142|NCT01931475|26244860|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20|||
13209143|NCT01931475|26244861|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10|||
13209144|NCT01931475|26244860|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1|||
13209145|NCT01931475|26244861|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0|||
13209146|NCT01931475|26244860|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16|||
13209147|NCT01931475|26244861|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12|||
13209148|NCT01931475|26244860|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2|||
13209149|NCT01931475|26244861|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3|||
13209150|NCT01931475|26244860|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0|||
13209151|NCT01931475|26244861|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1|||
13209152|NCT01931475|26244860|FG000|Period 2: Extension Treatment Phase|Adverse Event|0|||
13209153|NCT01931475|26244861|FG001|Period 2: Extension Treatment Phase|Adverse Event|8|||
13209154|NCT01931475|26244860|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1|||
13209155|NCT01931475|26244861|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0|||
13209156|NCT01931475|26244860|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0|||
13209157|NCT01931475|26244861|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9|||
13209158|NCT01931475|26244860|FG000|Period 2: Extension Treatment Phase|Physician Decision|1|||
13209159|NCT01931475|26244861|FG001|Period 2: Extension Treatment Phase|Physician Decision|1|||
13209160|NCT01931475|26244860|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1|||
13209161|NCT01931475|26244861|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0|||
13209162|NCT01931475|26244860|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
13209163|NCT01931475|26244861|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
13209164|NCT01931462|26244874|FG000|Overall Study|Withdrawal by Subject|1|||
13209165|NCT01931397|26244885|FG000|Overall Study|Physician Decision|2|||
13209166|NCT01931397|26244885|FG000|Overall Study|Withdrawal by Subject|8|||
13209167|NCT01931397|26244885|FG000|Overall Study|moved out of state|1|||
13209168|NCT01931202|26244939|FG000|Overall Study|Withdrawal by Subject|0|||
13209169|NCT01931202|26244940|FG001|Overall Study|Withdrawal by Subject|0|||
13209170|NCT01931202|26244941|FG002|Overall Study|Withdrawal by Subject|2|||
13209171|NCT01931202|26244939|FG000|Overall Study|Lost to Follow-up|0|||
13209172|NCT01931202|26244940|FG001|Overall Study|Lost to Follow-up|5|||
13209173|NCT01931202|26244941|FG002|Overall Study|Lost to Follow-up|2|||
13209174|NCT01931150|26244954|FG000|Overall Study|Withdrawal by Subject|1|||
13209175|NCT01931150|26244955|FG001|Overall Study|Withdrawal by Subject|2|||
13209176|NCT01931059|26244974|FG000|Day 1|Pregnancy|0|||
13209177|NCT01931059|26244975|FG001|Day 1|Pregnancy|1|||
13209178|NCT01931059|26244974|FG000|Day3|Lost to Follow-up|1|||
13209179|NCT01931059|26244975|FG001|Day3|Lost to Follow-up|0|||
13209180|NCT01930890|26245002|FG000|Overall Study|Study Termination|14|||
13209181|NCT01930890|26245003|FG001|Overall Study|Study Termination|28|||
13209182|NCT01930890|26245004|FG002|Overall Study|Study Termination|13|||
13209183|NCT01930890|26245005|FG003|Overall Study|Study Termination|25|||
13209184|NCT01930890|26245002|FG000|Overall Study|Death|0|||
13209185|NCT01930890|26245003|FG001|Overall Study|Death|0|||
13209186|NCT01930890|26245004|FG002|Overall Study|Death|0|||
13209187|NCT01930890|26245005|FG003|Overall Study|Death|1|||
13209188|NCT01930890|26245002|FG000|Overall Study|Investigator Decision|0|||
13209189|NCT01930890|26245003|FG001|Overall Study|Investigator Decision|1|||
13209190|NCT01930890|26245004|FG002|Overall Study|Investigator Decision|0|||
13209191|NCT01930890|26245005|FG003|Overall Study|Investigator Decision|0|||
13209192|NCT01930890|26245002|FG000|Overall Study|Consent Withdrawn|0|||
13209193|NCT01930890|26245003|FG001|Overall Study|Consent Withdrawn|3|||
13209194|NCT01930890|26245004|FG002|Overall Study|Consent Withdrawn|0|||
13209195|NCT01930890|26245005|FG003|Overall Study|Consent Withdrawn|1|||
13209196|NCT01930890|26245002|FG000|Overall Study|Adverse Event|0|||
13209197|NCT01930890|26245003|FG001|Overall Study|Adverse Event|1|||
13209198|NCT01930890|26245004|FG002|Overall Study|Adverse Event|0|||
13209199|NCT01930890|26245005|FG003|Overall Study|Adverse Event|0|||
13209200|NCT01930799|26245012|FG000|Overall Study|Withdrawal by Subject|3|||
13209201|NCT01930799|26245012|FG000|Overall Study|Lost to Follow-up|5|||
13209202|NCT01930214|26245039|FG000|Overall Study|Death|4|||
13209203|NCT01930214|26245040|FG001|Overall Study|Death|4|||
13209204|NCT01930214|26245041|FG002|Overall Study|Death|11|||
13209205|NCT01930214|26245039|FG000|Overall Study|Lost to Follow-up|12|||
13209206|NCT01930214|26245040|FG001|Overall Study|Lost to Follow-up|13|||
13209207|NCT01930214|26245041|FG002|Overall Study|Lost to Follow-up|12|||
13209208|NCT01930214|26245039|FG000|Overall Study|Voluntary withdrawal of infomed consent|2|||
13209209|NCT01930214|26245040|FG001|Overall Study|Voluntary withdrawal of infomed consent|4|||
13209210|NCT01930214|26245041|FG002|Overall Study|Voluntary withdrawal of infomed consent|2|||
13209211|NCT01930214|26245039|FG000|Overall Study|Physician Decision|2|||
13209212|NCT01930214|26245040|FG001|Overall Study|Physician Decision|0|||
13209213|NCT01930214|26245041|FG002|Overall Study|Physician Decision|0|||
13209214|NCT01930188|26245075|FG000|Overall Study|unclassified|4|||
13209215|NCT01930188|26245076|FG001|Overall Study|unclassified|5|||
13209216|NCT01930188|26245077|FG002|Overall Study|unclassified|3|||
13209217|NCT01930188|26245075|FG000|Overall Study|Missing follow-up information|2|||
13209218|NCT01930188|26245076|FG001|Overall Study|Missing follow-up information|2|||
13209219|NCT01930188|26245077|FG002|Overall Study|Missing follow-up information|3|||
13209220|NCT01930188|26245075|FG000|Overall Study|Lost to Follow-up|5|||
13209221|NCT01930188|26245076|FG001|Overall Study|Lost to Follow-up|2|||
13209222|NCT01930188|26245077|FG002|Overall Study|Lost to Follow-up|2|||
13209223|NCT01930188|26245075|FG000|Overall Study|Death|2|||
13209224|NCT01930188|26245076|FG001|Overall Study|Death|1|||
13209225|NCT01930188|26245077|FG002|Overall Study|Death|3|||
13209226|NCT01930188|26245075|FG000|Overall Study|Withdrawal by Subject|9|||
13209227|NCT01930188|26245076|FG001|Overall Study|Withdrawal by Subject|11|||
13209228|NCT01930188|26245077|FG002|Overall Study|Withdrawal by Subject|8|||
13209229|NCT01930175|26245117|FG000|Core Study|Lost to Follow-up|0|||
13209230|NCT01930175|26245118|FG001|Core Study|Lost to Follow-up|1|||
13209231|NCT01930175|26245119|FG002|Core Study|Lost to Follow-up|0|||
13209232|NCT01930175|26245117|FG000|Core Study|Adverse Event|0|||
13209233|NCT01930175|26245118|FG001|Core Study|Adverse Event|0|||
13209234|NCT01930175|26245119|FG002|Core Study|Adverse Event|1|||
13209235|NCT01930162|26245130|FG000|Overall Study|Abnormal test procedure result(s)|4|||
13209236|NCT01930162|26245130|FG000|Overall Study|Death|1|||
13209237|NCT01930123|26245147|FG000|Overall Study|Adverse Event|1|||
13209238|NCT01930123|26245148|FG001|Overall Study|Adverse Event|0|||
13209239|NCT01930123|26245147|FG000|Overall Study|Physician Decision|21|||
13209240|NCT01930123|26245148|FG001|Overall Study|Physician Decision|8|||
13209241|NCT01930123|26245147|FG000|Overall Study|Withdrawal by Subject|1|||
13209242|NCT01930123|26245148|FG001|Overall Study|Withdrawal by Subject|0|||
13209243|NCT01930045|26245180|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0|||
13209244|NCT01930045|26245181|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0|||
13209245|NCT01930045|26245182|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0|||
13209246|NCT01930045|26245183|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0|||
13209247|NCT01930045|26245184|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0|||
13209248|NCT01930045|26245185|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1|||
13209249|NCT01930045|26245180|FG000|Pause (up to 37 Days)|Protocol Violation|0|||
13209250|NCT01930045|26245181|FG001|Pause (up to 37 Days)|Protocol Violation|0|||
13209251|NCT01930045|26245182|FG002|Pause (up to 37 Days)|Protocol Violation|0|||
13209252|NCT01930045|26245183|FG003|Pause (up to 37 Days)|Protocol Violation|0|||
13209253|NCT01930045|26245184|FG004|Pause (up to 37 Days)|Protocol Violation|0|||
13394767|NCT00654381|26788100|FG003|2nd Stage|Adverse Event|3|||
13209254|NCT01930045|26245185|FG005|Pause (up to 37 Days)|Protocol Violation|1|||
13209255|NCT01929993|26245198|FG000|Overall Study|Protocol Violation|4|||
13209256|NCT01929993|26245199|FG001|Overall Study|Protocol Violation|6|||
13209257|NCT01929993|26245198|FG000|Overall Study|Absent CIN, invasion present or artifact|26|||
13209258|NCT01929993|26245199|FG001|Overall Study|Absent CIN, invasion present or artifact|22|||
13209259|NCT01929980|26245205|FG000|Overall Study|Physician Decision|1|||
13209260|NCT01929876|26245220|FG000|Period 2|Non-Compliance|1|||
13209261|NCT01929863|26245266|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1|||
13209262|NCT01929863|26245267|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0|||
13209263|NCT01929863|26245266|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0|||
13209264|NCT01929863|26245267|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1|||
13209265|NCT01929863|26245266|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0|||
13209266|NCT01929863|26245267|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1|||
13209267|NCT01929707|26245306|FG000|Intervention Period 1|Lost to Follow-up|0|||
13209268|NCT01929707|26245307|FG001|Intervention Period 1|Lost to Follow-up|0|||
13209269|NCT01929707|26245308|FG002|Intervention Period 1|Lost to Follow-up|0|||
13209270|NCT01929707|26245309|FG003|Intervention Period 1|Lost to Follow-up|1|||
13209271|NCT01929707|26245310|FG004|Intervention Period 1|Lost to Follow-up|0|||
13209272|NCT01929707|26245311|FG005|Intervention Period 1|Lost to Follow-up|0|||
13209273|NCT01929707|26245312|FG006|Intervention Period 1|Lost to Follow-up|0|||
13209274|NCT01929707|26245313|FG007|Intervention Period 1|Lost to Follow-up|0|||
13209275|NCT01929707|26245306|FG000|Intervention Period 1|Withdrawal by Subject|0|||
13209276|NCT01929707|26245307|FG001|Intervention Period 1|Withdrawal by Subject|0|||
13209277|NCT01929707|26245308|FG002|Intervention Period 1|Withdrawal by Subject|0|||
13209278|NCT01929707|26245309|FG003|Intervention Period 1|Withdrawal by Subject|2|||
13209279|NCT01929707|26245310|FG004|Intervention Period 1|Withdrawal by Subject|0|||
13209280|NCT01929707|26245311|FG005|Intervention Period 1|Withdrawal by Subject|0|||
13209281|NCT01929707|26245312|FG006|Intervention Period 1|Withdrawal by Subject|0|||
13209282|NCT01929707|26245313|FG007|Intervention Period 1|Withdrawal by Subject|0|||
13209283|NCT01929707|26245306|FG000|Intervention Period 2|Withdrawal by Subject|0|||
13209284|NCT01929707|26245307|FG001|Intervention Period 2|Withdrawal by Subject|0|||
13209285|NCT01929707|26245308|FG002|Intervention Period 2|Withdrawal by Subject|0|||
13209286|NCT01929707|26245309|FG003|Intervention Period 2|Withdrawal by Subject|0|||
13209287|NCT01929707|26245310|FG004|Intervention Period 2|Withdrawal by Subject|0|||
13209288|NCT01929707|26245311|FG005|Intervention Period 2|Withdrawal by Subject|2|||
13209289|NCT01929707|26245312|FG006|Intervention Period 2|Withdrawal by Subject|0|||
13209290|NCT01929707|26245313|FG007|Intervention Period 2|Withdrawal by Subject|0|||
13209291|NCT01929681|26245334|FG000|Overall Study|Withdrawal by Subject|1|||
13209292|NCT01929681|26245335|FG001|Overall Study|Withdrawal by Subject|0|||
13209293|NCT01929681|26245334|FG000|Overall Study|Physician Decision|1|||
13209294|NCT01929681|26245335|FG001|Overall Study|Physician Decision|1|||
13209295|NCT01929408|26245342|FG000|Overall Study|received HCT as initial treatment|8|||
13209296|NCT01929395|26245362|FG000|Overall Study|Did not complete - non-related toxicity|1|||
13209297|NCT01929395|26245363|FG001|Overall Study|Did not complete - non-related toxicity|0|||
13209298|NCT01929395|26245364|FG002|Overall Study|Did not complete - non-related toxicity|0|||
13209299|NCT01929395|26245362|FG000|Overall Study|Withdrawal by Subject|0|||
13209300|NCT01929395|26245363|FG001|Overall Study|Withdrawal by Subject|1|||
13209301|NCT01929395|26245364|FG002|Overall Study|Withdrawal by Subject|0|||
13209302|NCT01929395|26245362|FG000|Overall Study|Screen Fail|0|||
13209303|NCT01929395|26245363|FG001|Overall Study|Screen Fail|0|||
13209304|NCT01929395|26245364|FG002|Overall Study|Screen Fail|1|||
13209305|NCT01929343|26245400|FG000|Overall Study|Physician Decision|0|||
13209306|NCT01929343|26245401|FG001|Overall Study|Physician Decision|2|||
13209307|NCT01929343|26245402|FG002|Overall Study|Physician Decision|0|||
13209308|NCT01929343|26245400|FG000|Overall Study|Withdrawal by Subject|1|||
13209309|NCT01929343|26245401|FG001|Overall Study|Withdrawal by Subject|0|||
13209310|NCT01929343|26245402|FG002|Overall Study|Withdrawal by Subject|0|||
13209311|NCT01929317|26245476|FG000|Dose Increase Effect Verification Phase|Adverse Event|5|||
13209312|NCT01929317|26245477|FG001|Dose Increase Effect Verification Phase|Adverse Event|1|||
13209313|NCT01929317|26245476|FG000|Dose Increase Effect Verification Phase|Physician Decision|1|||
13209314|NCT01929317|26245477|FG001|Dose Increase Effect Verification Phase|Physician Decision|0|||
13209315|NCT01929317|26245476|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3|||
13209316|NCT01929317|26245477|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0|||
13209317|NCT01929317|26245476|FG000|Long-term Phase|Adverse Event|5|||
13209318|NCT01929317|26245477|FG001|Long-term Phase|Adverse Event|1|||
13209319|NCT01929317|26245476|FG000|Long-term Phase|Physician Decision|3|||
13209320|NCT01929317|26245477|FG001|Long-term Phase|Physician Decision|0|||
13209321|NCT01929317|26245476|FG000|Long-term Phase|Withdrawal by Subject|4|||
13209322|NCT01929317|26245477|FG001|Long-term Phase|Withdrawal by Subject|0|||
13209323|NCT01929317|26245476|FG000|Long-term Phase|Protocol Violation|1|||
13209324|NCT01929317|26245477|FG001|Long-term Phase|Protocol Violation|0|||
13209325|NCT01929317|26245476|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1|||
13209326|NCT01929317|26245477|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0|||
13209327|NCT01929317|26245476|FG000|Long-term Phase|Study Closed/Terminated|5|||
13209328|NCT01929317|26245477|FG001|Long-term Phase|Study Closed/Terminated|3|||
13209329|NCT01929226|26245508|FG000|Overall Study|Lost to Follow-up|4|||
13209330|NCT01929226|26245509|FG001|Overall Study|Lost to Follow-up|0|||
13209331|NCT01929226|26245508|FG000|Overall Study|Withdrawal by Subject|1|||
13209332|NCT01929226|26245509|FG001|Overall Study|Withdrawal by Subject|1|||
13209333|NCT01929135|26245530|FG000|Overall Study|Lost to Follow-up|1|||
13209334|NCT01929135|26245531|FG001|Overall Study|Lost to Follow-up|1|||
13209335|NCT01929109|26245566|FG000|Period 1 (All Groups)|Deviation from protocol|0|||
13209336|NCT01929109|26245567|FG001|Period 1 (All Groups)|Deviation from protocol|0|||
13209337|NCT01929109|26245568|FG002|Period 1 (All Groups)|Deviation from protocol|1|||
13209338|NCT01929109|26245569|FG003|Period 1 (All Groups)|Deviation from protocol|0|||
13209339|NCT01929109|26245570|FG004|Period 1 (All Groups)|Deviation from protocol|0|||
13209340|NCT01929083|26245597|FG000|Intervention 1|Lost to Follow-up|2|||
13209341|NCT01929083|26245598|FG001|Intervention 1|Lost to Follow-up|0|||
13209342|NCT01929083|26245597|FG000|Intervention 1|Nonadherent to study medications|1|||
13209343|NCT01929083|26245598|FG001|Intervention 1|Nonadherent to study medications|0|||
13209344|NCT01929083|26245597|FG000|Intervention 2|Adverse Event|0|||
13209345|NCT01929083|26245598|FG001|Intervention 2|Adverse Event|1|||
13209346|NCT01929044|26245623|FG000|Overall Study|Adverse Event|1|||
13209347|NCT01929044|26245624|FG001|Overall Study|Adverse Event|0|||
13209348|NCT01929044|26245623|FG000|Overall Study|Protocol Violation|9|||
13209349|NCT01929044|26245624|FG001|Overall Study|Protocol Violation|14|||
13209350|NCT01929044|26245623|FG000|Overall Study|Not Treated|1|||
13209351|NCT01929044|26245624|FG001|Overall Study|Not Treated|3|||
13209352|NCT01929031|26245661|FG000|Overall Study|Adverse Event|3|||
13209353|NCT01929031|26245662|FG001|Overall Study|Adverse Event|1|||
13209354|NCT01929031|26245663|FG002|Overall Study|Adverse Event|1|||
13209355|NCT01929031|26245664|FG003|Overall Study|Adverse Event|0|||
13209356|NCT01929031|26245665|FG004|Overall Study|Adverse Event|0|||
13209357|NCT01929031|26245666|FG005|Overall Study|Adverse Event|0|||
13209358|NCT01929031|26245661|FG000|Overall Study|Protocol Violation|1|||
13209359|NCT01929031|26245662|FG001|Overall Study|Protocol Violation|0|||
13209360|NCT01929031|26245663|FG002|Overall Study|Protocol Violation|0|||
13209361|NCT01929031|26245664|FG003|Overall Study|Protocol Violation|0|||
13209362|NCT01929031|26245665|FG004|Overall Study|Protocol Violation|0|||
13209363|NCT01929031|26245666|FG005|Overall Study|Protocol Violation|1|||
13209364|NCT01929031|26245661|FG000|Overall Study|Reason other than specified above|0|||
13209365|NCT01929031|26245662|FG001|Overall Study|Reason other than specified above|1|||
13209366|NCT01929031|26245663|FG002|Overall Study|Reason other than specified above|0|||
13209367|NCT01929031|26245664|FG003|Overall Study|Reason other than specified above|0|||
13209368|NCT01929031|26245665|FG004|Overall Study|Reason other than specified above|1|||
13209369|NCT01929031|26245666|FG005|Overall Study|Reason other than specified above|0|||
13209370|NCT01929018|26245695|FG000|Overall Study|Lost to Follow-up|1|||
13209371|NCT01929018|26245696|FG001|Overall Study|Lost to Follow-up|0|||
13209372|NCT01929018|26245695|FG000|Overall Study|Hospitalization|0|||
13209373|NCT01929018|26245696|FG001|Overall Study|Hospitalization|1|||
13209374|NCT01928940|26245744|FG000|Overall Study|Adverse Event|0|||
13209375|NCT01928940|26245745|FG001|Overall Study|Adverse Event|1|||
13209376|NCT01928927|26245888|FG000|Overall Study|Lost to Follow-up|1|||
13209377|NCT01928927|26245889|FG001|Overall Study|Lost to Follow-up|0|||
13209378|NCT01928927|26245888|FG000|Overall Study|Withdrawal by Subject|1|||
13209379|NCT01928927|26245889|FG001|Overall Study|Withdrawal by Subject|1|||
13209380|NCT01928862|26245942|FG000|Overall Study|Lost to Follow-up|1|||
13209381|NCT01928862|26245943|FG001|Overall Study|Lost to Follow-up|0|||
13209382|NCT01928862|26245944|FG002|Overall Study|Lost to Follow-up|0|||
13209383|NCT01928862|26245945|FG003|Overall Study|Lost to Follow-up|0|||
13209384|NCT01928862|26245946|FG004|Overall Study|Lost to Follow-up|1|||
13209385|NCT01928771|26246033|FG000|Overall Study|Adverse Event|6|||
13209386|NCT01928771|26246034|FG001|Overall Study|Adverse Event|5|||
13209387|NCT01928771|26246035|FG002|Overall Study|Adverse Event|1|||
13209388|NCT01928771|26246033|FG000|Overall Study|Death|2|||
13209389|NCT01928771|26246034|FG001|Overall Study|Death|2|||
13209390|NCT01928771|26246035|FG002|Overall Study|Death|2|||
13209391|NCT01928771|26246033|FG000|Overall Study|Lost to Follow-up|5|||
13209392|NCT01928771|26246034|FG001|Overall Study|Lost to Follow-up|6|||
13209393|NCT01928771|26246035|FG002|Overall Study|Lost to Follow-up|3|||
13209394|NCT01928771|26246033|FG000|Overall Study|Withdrawal by Subject|20|||
13209395|NCT01928771|26246034|FG001|Overall Study|Withdrawal by Subject|15|||
13209396|NCT01928771|26246035|FG002|Overall Study|Withdrawal by Subject|17|||
13209397|NCT01928771|26246033|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
13209398|NCT01928771|26246034|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
13209399|NCT01928771|26246035|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
13209400|NCT01928771|26246033|FG000|Overall Study|Other Reasons|9|||
13209401|NCT01928771|26246034|FG001|Overall Study|Other Reasons|9|||
13209402|NCT01928771|26246035|FG002|Overall Study|Other Reasons|14|||
13209403|NCT01928771|26246033|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
13209404|NCT01928771|26246034|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
13209405|NCT01928771|26246035|FG002|Overall Study|Severe Non-Compliance to Protocol|2|||
13209406|NCT01928758|26246058|FG000|Overall Study|Lost to Follow-up|14|||
13209407|NCT01928758|26246059|FG001|Overall Study|Lost to Follow-up|9|||
13209408|NCT01928758|26246058|FG000|Overall Study|Withdrawal by Subject|5|||
13209409|NCT01928758|26246059|FG001|Overall Study|Withdrawal by Subject|2|||
13209410|NCT01928758|26246058|FG000|Overall Study|Adverse Event|3|||
13209411|NCT01928758|26246059|FG001|Overall Study|Adverse Event|5|||
13209412|NCT01928758|26246058|FG000|Overall Study|Protocol Violation|3|||
13209413|NCT01928758|26246059|FG001|Overall Study|Protocol Violation|4|||
13209414|NCT01928719|26246083|FG000|Overall Study|Lost to Follow-up|26|||
13209415|NCT01928719|26246084|FG001|Overall Study|Lost to Follow-up|11|||
13209416|NCT01928719|26246083|FG000|Overall Study|Withdrawal by Subject|22|||
13394768|NCT00654381|26788101|FG004|2nd Stage|Adverse Event|7|||
13209417|NCT01928719|26246084|FG001|Overall Study|Withdrawal by Subject|7|||
13209418|NCT01928719|26246083|FG000|Overall Study|Protocol Violation|3|||
13209419|NCT01928719|26246084|FG001|Overall Study|Protocol Violation|1|||
13209420|NCT01928719|26246083|FG000|Overall Study|Adverse Event|1|||
13209421|NCT01928719|26246084|FG001|Overall Study|Adverse Event|0|||
13209422|NCT01928615|26246101|FG000|Overall Study|Study Terminated by Sponsor|2|||
13209423|NCT01928485|26246156|FG000|Overall Study|Physician Decision|0|||
13209424|NCT01928485|26246157|FG001|Overall Study|Physician Decision|1|||
13209425|NCT01928472|26246237|FG000|Overall Study|Death|0|||
13209426|NCT01928472|26246238|FG001|Overall Study|Death|0|||
13209427|NCT01928472|26246239|FG002|Overall Study|Death|1|||
13209428|NCT01928472|26246240|FG003|Overall Study|Death|0|||
13209429|NCT01928472|26246237|FG000|Overall Study|Withdrawal by Subject|4|||
13209430|NCT01928472|26246238|FG001|Overall Study|Withdrawal by Subject|4|||
13209431|NCT01928472|26246239|FG002|Overall Study|Withdrawal by Subject|1|||
13209432|NCT01928472|26246240|FG003|Overall Study|Withdrawal by Subject|2|||
13209433|NCT01928472|26246237|FG000|Overall Study|Lost to Follow-up|2|||
13209434|NCT01928472|26246238|FG001|Overall Study|Lost to Follow-up|3|||
13209435|NCT01928472|26246239|FG002|Overall Study|Lost to Follow-up|4|||
13209436|NCT01928472|26246240|FG003|Overall Study|Lost to Follow-up|0|||
13209437|NCT01928472|26246237|FG000|Overall Study|Administrative Reason|2|||
13209438|NCT01928472|26246238|FG001|Overall Study|Administrative Reason|1|||
13209439|NCT01928472|26246239|FG002|Overall Study|Administrative Reason|0|||
13209440|NCT01928472|26246240|FG003|Overall Study|Administrative Reason|0|||
13209441|NCT01928472|26246237|FG000|Overall Study|Unclassified|0|||
13209442|NCT01928472|26246238|FG001|Overall Study|Unclassified|0|||
13209443|NCT01928472|26246239|FG002|Overall Study|Unclassified|1|||
13209444|NCT01928472|26246240|FG003|Overall Study|Unclassified|0|||
13209445|NCT01928433|26246273|FG000|Overall Study|Adverse Event|5|||
13209446|NCT01928433|26246274|FG001|Overall Study|Adverse Event|2|||
13209447|NCT01928433|26246275|FG002|Overall Study|Adverse Event|5|||
13209448|NCT01928433|26246273|FG000|Overall Study|Protocol Violation|0|||
13209449|NCT01928433|26246274|FG001|Overall Study|Protocol Violation|0|||
13209450|NCT01928433|26246275|FG002|Overall Study|Protocol Violation|2|||
13209451|NCT01928433|26246273|FG000|Overall Study|Lack of Efficacy|5|||
13209452|NCT01928433|26246274|FG001|Overall Study|Lack of Efficacy|4|||
13209453|NCT01928433|26246275|FG002|Overall Study|Lack of Efficacy|4|||
13209454|NCT01928433|26246273|FG000|Overall Study|Withdrawal by Subject|0|||
13209455|NCT01928433|26246274|FG001|Overall Study|Withdrawal by Subject|4|||
13209456|NCT01928433|26246275|FG002|Overall Study|Withdrawal by Subject|0|||
13209457|NCT01928433|26246273|FG000|Overall Study|Negative screening urine culture|7|||
13209458|NCT01928433|26246274|FG001|Overall Study|Negative screening urine culture|6|||
13209459|NCT01928433|26246275|FG002|Overall Study|Negative screening urine culture|10|||
13209460|NCT01928433|26246273|FG000|Overall Study|Lost to Follow-up|0|||
13209461|NCT01928433|26246274|FG001|Overall Study|Lost to Follow-up|2|||
13209462|NCT01928433|26246275|FG002|Overall Study|Lost to Follow-up|3|||
13209463|NCT01928433|26246273|FG000|Overall Study|Other reasons|3|||
13209464|NCT01928433|26246274|FG001|Overall Study|Other reasons|3|||
13209465|NCT01928433|26246275|FG002|Overall Study|Other reasons|4|||
13209466|NCT01928394|26246393|FG000|Treatment Period|Disease progression|17|||
13209467|NCT01928394|26246394|FG001|Treatment Period|Disease progression|2|||
13209468|NCT01928394|26246395|FG002|Treatment Period|Disease progression|12|||
13209469|NCT01928394|26246396|FG003|Treatment Period|Disease progression|48|||
13209470|NCT01928394|26246397|FG004|Treatment Period|Disease progression|3|||
13209471|NCT01928394|26246398|FG005|Treatment Period|Disease progression|25|||
13209472|NCT01928394|26246399|FG006|Treatment Period|Disease progression|38|||
13296515|NCT01370018|26496731|FG000|Overall Study|Did not meet criteria for analysis|1|||
13296516|NCT01370005|26496794|FG000|Overall Study|Not treated|1|||
13296517|NCT01370005|26496795|FG001|Overall Study|Not treated|0|||
13296518|NCT01370005|26496796|FG002|Overall Study|Not treated|0|||
13296519|NCT01370005|26496794|FG000|Overall Study|Adverse Event|5|||
13296520|NCT01370005|26496795|FG001|Overall Study|Adverse Event|5|||
13296521|NCT01370005|26496796|FG002|Overall Study|Adverse Event|6|||
13381980|NCT00748709|26749551|FG000|Overall Study|Withdrawal by Subject|1|||
13381981|NCT00748709|26749551|FG000|Overall Study|Other Reasons|1|||
13209473|NCT01928394|26246400|FG007|Treatment Period|Disease progression|16|||
13209474|NCT01928394|26246401|FG008|Treatment Period|Disease progression|3|||
13209475|NCT01928394|26246402|FG009|Treatment Period|Disease progression|11|||
13209476|NCT01928394|26246403|FG010|Treatment Period|Disease progression|22|||
13209477|NCT01928394|26246404|FG011|Treatment Period|Disease progression|73|||
13209478|NCT01928394|26246405|FG012|Treatment Period|Disease progression|38|||
13209479|NCT01928394|26246406|FG013|Treatment Period|Disease progression|118|||
13209480|NCT01928394|26246407|FG014|Treatment Period|Disease progression|59|||
13209481|NCT01928394|26246408|FG015|Treatment Period|Disease progression|1|||
13209482|NCT01928394|26246409|FG016|Treatment Period|Disease progression|43|||
13209483|NCT01928394|26246410|FG017|Treatment Period|Disease progression|56|||
13296522|NCT01370005|26496794|FG000|Overall Study|Lack of Efficacy|1|||
13296523|NCT01370005|26496795|FG001|Overall Study|Lack of Efficacy|0|||
13381982|NCT00748566|26749581|FG000|Overall Study|Adverse Event|49|||
13209484|NCT01928394|26246411|FG018|Treatment Period|Disease progression|50|||
13209485|NCT01928394|26246412|FG019|Treatment Period|Disease progression|71|||
13209486|NCT01928394|26246413|FG020|Treatment Period|Disease progression|30|||
13209487|NCT01928394|26246414|FG021|Treatment Period|Disease progression|31|||
13209488|NCT01928394|26246415|FG022|Treatment Period|Disease progression|31|||
13209489|NCT01928394|26246393|FG000|Treatment Period|Study drug toxicity|1|||
13209490|NCT01928394|26246394|FG001|Treatment Period|Study drug toxicity|1|||
13209491|NCT01928394|26246395|FG002|Treatment Period|Study drug toxicity|3|||
13209492|NCT01928394|26246396|FG003|Treatment Period|Study drug toxicity|3|||
13209493|NCT01928394|26246397|FG004|Treatment Period|Study drug toxicity|0|||
13209494|NCT01928394|26246398|FG005|Treatment Period|Study drug toxicity|9|||
13209495|NCT01928394|26246399|FG006|Treatment Period|Study drug toxicity|7|||
13209496|NCT01928394|26246400|FG007|Treatment Period|Study drug toxicity|1|||
13209497|NCT01928394|26246401|FG008|Treatment Period|Study drug toxicity|0|||
13209498|NCT01928394|26246402|FG009|Treatment Period|Study drug toxicity|5|||
13209499|NCT01928394|26246403|FG010|Treatment Period|Study drug toxicity|2|||
13209500|NCT01928394|26246404|FG011|Treatment Period|Study drug toxicity|3|||
13209501|NCT01928394|26246405|FG012|Treatment Period|Study drug toxicity|7|||
13209502|NCT01928394|26246406|FG013|Treatment Period|Study drug toxicity|5|||
13209503|NCT01928394|26246407|FG014|Treatment Period|Study drug toxicity|12|||
13209504|NCT01928394|26246408|FG015|Treatment Period|Study drug toxicity|0|||
13209505|NCT01928394|26246409|FG016|Treatment Period|Study drug toxicity|3|||
13209506|NCT01928394|26246410|FG017|Treatment Period|Study drug toxicity|3|||
13209507|NCT01928394|26246411|FG018|Treatment Period|Study drug toxicity|12|||
13209508|NCT01928394|26246412|FG019|Treatment Period|Study drug toxicity|15|||
13209509|NCT01928394|26246413|FG020|Treatment Period|Study drug toxicity|4|||
13209510|NCT01928394|26246414|FG021|Treatment Period|Study drug toxicity|7|||
13209511|NCT01928394|26246415|FG022|Treatment Period|Study drug toxicity|4|||
13209512|NCT01928394|26246393|FG000|Treatment Period|AE unrelated to study drug|0|||
13209513|NCT01928394|26246394|FG001|Treatment Period|AE unrelated to study drug|0|||
13209514|NCT01928394|26246395|FG002|Treatment Period|AE unrelated to study drug|2|||
13209515|NCT01928394|26246396|FG003|Treatment Period|AE unrelated to study drug|3|||
13209516|NCT01928394|26246397|FG004|Treatment Period|AE unrelated to study drug|0|||
13209517|NCT01928394|26246398|FG005|Treatment Period|AE unrelated to study drug|5|||
13209518|NCT01928394|26246399|FG006|Treatment Period|AE unrelated to study drug|1|||
13209519|NCT01928394|26246400|FG007|Treatment Period|AE unrelated to study drug|0|||
13209520|NCT01928394|26246401|FG008|Treatment Period|AE unrelated to study drug|0|||
13209521|NCT01928394|26246402|FG009|Treatment Period|AE unrelated to study drug|2|||
13209522|NCT01928394|26246403|FG010|Treatment Period|AE unrelated to study drug|0|||
13209523|NCT01928394|26246404|FG011|Treatment Period|AE unrelated to study drug|12|||
13209524|NCT01928394|26246405|FG012|Treatment Period|AE unrelated to study drug|6|||
13209525|NCT01928394|26246406|FG013|Treatment Period|AE unrelated to study drug|13|||
13209526|NCT01928394|26246407|FG014|Treatment Period|AE unrelated to study drug|6|||
13209527|NCT01928394|26246408|FG015|Treatment Period|AE unrelated to study drug|1|||
13209528|NCT01928394|26246409|FG016|Treatment Period|AE unrelated to study drug|1|||
13209529|NCT01928394|26246410|FG017|Treatment Period|AE unrelated to study drug|6|||
13209530|NCT01928394|26246411|FG018|Treatment Period|AE unrelated to study drug|3|||
13209531|NCT01928394|26246412|FG019|Treatment Period|AE unrelated to study drug|5|||
13209532|NCT01928394|26246413|FG020|Treatment Period|AE unrelated to study drug|1|||
13209533|NCT01928394|26246414|FG021|Treatment Period|AE unrelated to study drug|1|||
13209534|NCT01928394|26246415|FG022|Treatment Period|AE unrelated to study drug|0|||
13209535|NCT01928394|26246393|FG000|Treatment Period|Participant request to stop therapy|0|||
13209536|NCT01928394|26246394|FG001|Treatment Period|Participant request to stop therapy|0|||
13209537|NCT01928394|26246395|FG002|Treatment Period|Participant request to stop therapy|0|||
13209538|NCT01928394|26246396|FG003|Treatment Period|Participant request to stop therapy|0|||
13209539|NCT01928394|26246397|FG004|Treatment Period|Participant request to stop therapy|0|||
13209540|NCT01928394|26246398|FG005|Treatment Period|Participant request to stop therapy|3|||
13209541|NCT01928394|26246399|FG006|Treatment Period|Participant request to stop therapy|3|||
13209542|NCT01928394|26246400|FG007|Treatment Period|Participant request to stop therapy|0|||
13209543|NCT01928394|26246401|FG008|Treatment Period|Participant request to stop therapy|0|||
13209544|NCT01928394|26246402|FG009|Treatment Period|Participant request to stop therapy|0|||
13209545|NCT01928394|26246403|FG010|Treatment Period|Participant request to stop therapy|3|||
13209546|NCT01928394|26246404|FG011|Treatment Period|Participant request to stop therapy|2|||
13209547|NCT01928394|26246405|FG012|Treatment Period|Participant request to stop therapy|1|||
13209548|NCT01928394|26246406|FG013|Treatment Period|Participant request to stop therapy|2|||
13209549|NCT01928394|26246407|FG014|Treatment Period|Participant request to stop therapy|4|||
13209550|NCT01928394|26246408|FG015|Treatment Period|Participant request to stop therapy|0|||
13209551|NCT01928394|26246409|FG016|Treatment Period|Participant request to stop therapy|1|||
13209552|NCT01928394|26246410|FG017|Treatment Period|Participant request to stop therapy|3|||
13209553|NCT01928394|26246411|FG018|Treatment Period|Participant request to stop therapy|1|||
13296524|NCT01370005|26496796|FG002|Overall Study|Lack of Efficacy|0|||
13209554|NCT01928394|26246412|FG019|Treatment Period|Participant request to stop therapy|1|||
13209555|NCT01928394|26246413|FG020|Treatment Period|Participant request to stop therapy|3|||
13209556|NCT01928394|26246414|FG021|Treatment Period|Participant request to stop therapy|1|||
13209557|NCT01928394|26246415|FG022|Treatment Period|Participant request to stop therapy|3|||
13209558|NCT01928394|26246393|FG000|Treatment Period|Participant withdrew consent|0|||
13209559|NCT01928394|26246394|FG001|Treatment Period|Participant withdrew consent|0|||
13209560|NCT01928394|26246395|FG002|Treatment Period|Participant withdrew consent|1|||
13209561|NCT01928394|26246396|FG003|Treatment Period|Participant withdrew consent|1|||
13209562|NCT01928394|26246397|FG004|Treatment Period|Participant withdrew consent|0|||
13209563|NCT01928394|26246398|FG005|Treatment Period|Participant withdrew consent|1|||
13209564|NCT01928394|26246399|FG006|Treatment Period|Participant withdrew consent|0|||
13209565|NCT01928394|26246400|FG007|Treatment Period|Participant withdrew consent|1|||
13209566|NCT01928394|26246401|FG008|Treatment Period|Participant withdrew consent|0|||
13209567|NCT01928394|26246402|FG009|Treatment Period|Participant withdrew consent|0|||
13209568|NCT01928394|26246403|FG010|Treatment Period|Participant withdrew consent|1|||
13209569|NCT01928394|26246404|FG011|Treatment Period|Participant withdrew consent|1|||
13209570|NCT01928394|26246405|FG012|Treatment Period|Participant withdrew consent|1|||
13209571|NCT01928394|26246406|FG013|Treatment Period|Participant withdrew consent|0|||
13209572|NCT01928394|26246407|FG014|Treatment Period|Participant withdrew consent|2|||
13209573|NCT01928394|26246408|FG015|Treatment Period|Participant withdrew consent|0|||
13209574|NCT01928394|26246409|FG016|Treatment Period|Participant withdrew consent|2|||
13209575|NCT01928394|26246410|FG017|Treatment Period|Participant withdrew consent|1|||
13209576|NCT01928394|26246411|FG018|Treatment Period|Participant withdrew consent|1|||
13209577|NCT01928394|26246412|FG019|Treatment Period|Participant withdrew consent|1|||
13209578|NCT01928394|26246413|FG020|Treatment Period|Participant withdrew consent|0|||
13209579|NCT01928394|26246414|FG021|Treatment Period|Participant withdrew consent|2|||
13209580|NCT01928394|26246415|FG022|Treatment Period|Participant withdrew consent|0|||
13209581|NCT01928394|26246393|FG000|Treatment Period|Poor/non-compliance|0|||
13209582|NCT01928394|26246394|FG001|Treatment Period|Poor/non-compliance|0|||
13209583|NCT01928394|26246395|FG002|Treatment Period|Poor/non-compliance|0|||
13209584|NCT01928394|26246396|FG003|Treatment Period|Poor/non-compliance|1|||
13209585|NCT01928394|26246397|FG004|Treatment Period|Poor/non-compliance|0|||
13209586|NCT01928394|26246398|FG005|Treatment Period|Poor/non-compliance|0|||
13209587|NCT01928394|26246399|FG006|Treatment Period|Poor/non-compliance|0|||
13209588|NCT01928394|26246400|FG007|Treatment Period|Poor/non-compliance|0|||
13209589|NCT01928394|26246401|FG008|Treatment Period|Poor/non-compliance|0|||
13209590|NCT01928394|26246402|FG009|Treatment Period|Poor/non-compliance|0|||
13209591|NCT01928394|26246403|FG010|Treatment Period|Poor/non-compliance|0|||
13209592|NCT01928394|26246404|FG011|Treatment Period|Poor/non-compliance|0|||
13209593|NCT01928394|26246405|FG012|Treatment Period|Poor/non-compliance|1|||
13209594|NCT01928394|26246406|FG013|Treatment Period|Poor/non-compliance|0|||
13209595|NCT01928394|26246407|FG014|Treatment Period|Poor/non-compliance|1|||
13209596|NCT01928394|26246408|FG015|Treatment Period|Poor/non-compliance|0|||
13209597|NCT01928394|26246409|FG016|Treatment Period|Poor/non-compliance|0|||
13209598|NCT01928394|26246410|FG017|Treatment Period|Poor/non-compliance|1|||
13209599|NCT01928394|26246411|FG018|Treatment Period|Poor/non-compliance|0|||
13209600|NCT01928394|26246412|FG019|Treatment Period|Poor/non-compliance|1|||
13209601|NCT01928394|26246413|FG020|Treatment Period|Poor/non-compliance|0|||
13209602|NCT01928394|26246414|FG021|Treatment Period|Poor/non-compliance|0|||
13209603|NCT01928394|26246415|FG022|Treatment Period|Poor/non-compliance|0|||
13209604|NCT01928394|26246393|FG000|Treatment Period|other reason|0|||
13209605|NCT01928394|26246394|FG001|Treatment Period|other reason|0|||
13209606|NCT01928394|26246395|FG002|Treatment Period|other reason|0|||
13209607|NCT01928394|26246396|FG003|Treatment Period|other reason|0|||
13209608|NCT01928394|26246397|FG004|Treatment Period|other reason|0|||
13209609|NCT01928394|26246398|FG005|Treatment Period|other reason|0|||
13209610|NCT01928394|26246399|FG006|Treatment Period|other reason|0|||
13209611|NCT01928394|26246400|FG007|Treatment Period|other reason|0|||
13209612|NCT01928394|26246401|FG008|Treatment Period|other reason|0|||
13209613|NCT01928394|26246402|FG009|Treatment Period|other reason|0|||
13209614|NCT01928394|26246403|FG010|Treatment Period|other reason|1|||
13209615|NCT01928394|26246404|FG011|Treatment Period|other reason|1|||
13209616|NCT01928394|26246405|FG012|Treatment Period|other reason|1|||
13209617|NCT01928394|26246406|FG013|Treatment Period|other reason|0|||
13209618|NCT01928394|26246407|FG014|Treatment Period|other reason|1|||
13209619|NCT01928394|26246408|FG015|Treatment Period|other reason|0|||
13209620|NCT01928394|26246409|FG016|Treatment Period|other reason|0|||
13209621|NCT01928394|26246410|FG017|Treatment Period|other reason|0|||
13209622|NCT01928394|26246411|FG018|Treatment Period|other reason|2|||
13209623|NCT01928394|26246412|FG019|Treatment Period|other reason|2|||
13209624|NCT01928394|26246413|FG020|Treatment Period|other reason|0|||
13209625|NCT01928394|26246414|FG021|Treatment Period|other reason|0|||
13209626|NCT01928394|26246415|FG022|Treatment Period|other reason|0|||
13209627|NCT01928394|26246393|FG000|Treatment Period|Maximum clinical benefit|0|||
13209628|NCT01928394|26246394|FG001|Treatment Period|Maximum clinical benefit|0|||
13209629|NCT01928394|26246395|FG002|Treatment Period|Maximum clinical benefit|0|||
13209630|NCT01928394|26246396|FG003|Treatment Period|Maximum clinical benefit|0|||
13209631|NCT01928394|26246397|FG004|Treatment Period|Maximum clinical benefit|0|||
13209632|NCT01928394|26246398|FG005|Treatment Period|Maximum clinical benefit|0|||
13209633|NCT01928394|26246399|FG006|Treatment Period|Maximum clinical benefit|0|||
13209634|NCT01928394|26246400|FG007|Treatment Period|Maximum clinical benefit|0|||
13209635|NCT01928394|26246401|FG008|Treatment Period|Maximum clinical benefit|0|||
13209636|NCT01928394|26246402|FG009|Treatment Period|Maximum clinical benefit|0|||
13209637|NCT01928394|26246403|FG010|Treatment Period|Maximum clinical benefit|1|||
13209638|NCT01928394|26246404|FG011|Treatment Period|Maximum clinical benefit|1|||
13209639|NCT01928394|26246405|FG012|Treatment Period|Maximum clinical benefit|0|||
13209640|NCT01928394|26246406|FG013|Treatment Period|Maximum clinical benefit|0|||
13209641|NCT01928394|26246407|FG014|Treatment Period|Maximum clinical benefit|1|||
13209642|NCT01928394|26246408|FG015|Treatment Period|Maximum clinical benefit|0|||
13209643|NCT01928394|26246409|FG016|Treatment Period|Maximum clinical benefit|0|||
13209644|NCT01928394|26246410|FG017|Treatment Period|Maximum clinical benefit|1|||
13209645|NCT01928394|26246411|FG018|Treatment Period|Maximum clinical benefit|1|||
13209646|NCT01928394|26246412|FG019|Treatment Period|Maximum clinical benefit|0|||
13209647|NCT01928394|26246413|FG020|Treatment Period|Maximum clinical benefit|2|||
13209648|NCT01928394|26246414|FG021|Treatment Period|Maximum clinical benefit|0|||
13209649|NCT01928394|26246415|FG022|Treatment Period|Maximum clinical benefit|0|||
13209650|NCT01928394|26246393|FG000|Treatment Period|Lost to Follow-up|0|||
13209651|NCT01928394|26246394|FG001|Treatment Period|Lost to Follow-up|0|||
13209652|NCT01928394|26246395|FG002|Treatment Period|Lost to Follow-up|0|||
13209653|NCT01928394|26246396|FG003|Treatment Period|Lost to Follow-up|0|||
13209654|NCT01928394|26246397|FG004|Treatment Period|Lost to Follow-up|0|||
13209655|NCT01928394|26246398|FG005|Treatment Period|Lost to Follow-up|0|||
13209656|NCT01928394|26246399|FG006|Treatment Period|Lost to Follow-up|0|||
13209657|NCT01928394|26246400|FG007|Treatment Period|Lost to Follow-up|0|||
13209658|NCT01928394|26246401|FG008|Treatment Period|Lost to Follow-up|0|||
13209659|NCT01928394|26246402|FG009|Treatment Period|Lost to Follow-up|0|||
13209660|NCT01928394|26246403|FG010|Treatment Period|Lost to Follow-up|0|||
13209661|NCT01928394|26246404|FG011|Treatment Period|Lost to Follow-up|0|||
13209662|NCT01928394|26246405|FG012|Treatment Period|Lost to Follow-up|0|||
13209663|NCT01928394|26246406|FG013|Treatment Period|Lost to Follow-up|0|||
13209664|NCT01928394|26246407|FG014|Treatment Period|Lost to Follow-up|0|||
13209665|NCT01928394|26246408|FG015|Treatment Period|Lost to Follow-up|0|||
13209666|NCT01928394|26246409|FG016|Treatment Period|Lost to Follow-up|0|||
13209667|NCT01928394|26246410|FG017|Treatment Period|Lost to Follow-up|0|||
13209668|NCT01928394|26246411|FG018|Treatment Period|Lost to Follow-up|0|||
13209669|NCT01928394|26246412|FG019|Treatment Period|Lost to Follow-up|0|||
13209670|NCT01928394|26246413|FG020|Treatment Period|Lost to Follow-up|0|||
13209671|NCT01928394|26246414|FG021|Treatment Period|Lost to Follow-up|0|||
13209672|NCT01928394|26246415|FG022|Treatment Period|Lost to Follow-up|1|||
13209673|NCT01928394|26246393|FG000|Treatment Period|Death|0|||
13209674|NCT01928394|26246394|FG001|Treatment Period|Death|0|||
13209675|NCT01928394|26246395|FG002|Treatment Period|Death|0|||
13209676|NCT01928394|26246396|FG003|Treatment Period|Death|0|||
13209677|NCT01928394|26246397|FG004|Treatment Period|Death|0|||
13209678|NCT01928394|26246398|FG005|Treatment Period|Death|0|||
13209679|NCT01928394|26246399|FG006|Treatment Period|Death|0|||
13209680|NCT01928394|26246400|FG007|Treatment Period|Death|0|||
13209681|NCT01928394|26246401|FG008|Treatment Period|Death|0|||
13209682|NCT01928394|26246402|FG009|Treatment Period|Death|0|||
13209683|NCT01928394|26246403|FG010|Treatment Period|Death|0|||
13209684|NCT01928394|26246404|FG011|Treatment Period|Death|0|||
13209685|NCT01928394|26246405|FG012|Treatment Period|Death|0|||
13209686|NCT01928394|26246406|FG013|Treatment Period|Death|1|||
13209687|NCT01928394|26246407|FG014|Treatment Period|Death|2|||
13209688|NCT01928394|26246408|FG015|Treatment Period|Death|0|||
13209689|NCT01928394|26246409|FG016|Treatment Period|Death|0|||
13209690|NCT01928394|26246410|FG017|Treatment Period|Death|0|||
13209691|NCT01928394|26246411|FG018|Treatment Period|Death|0|||
13209692|NCT01928394|26246412|FG019|Treatment Period|Death|0|||
13209693|NCT01928394|26246413|FG020|Treatment Period|Death|0|||
13209694|NCT01928394|26246414|FG021|Treatment Period|Death|0|||
13209695|NCT01928394|26246415|FG022|Treatment Period|Death|0|||
13209696|NCT01928394|26246393|FG000|Follow-up Period|Participant withdrew consent|3|||
13209697|NCT01928394|26246394|FG001|Follow-up Period|Participant withdrew consent|0|||
13209698|NCT01928394|26246395|FG002|Follow-up Period|Participant withdrew consent|1|||
13209699|NCT01928394|26246396|FG003|Follow-up Period|Participant withdrew consent|4|||
13209700|NCT01928394|26246397|FG004|Follow-up Period|Participant withdrew consent|0|||
13209701|NCT01928394|26246398|FG005|Follow-up Period|Participant withdrew consent|2|||
13209702|NCT01928394|26246399|FG006|Follow-up Period|Participant withdrew consent|5|||
13209703|NCT01928394|26246400|FG007|Follow-up Period|Participant withdrew consent|1|||
13209704|NCT01928394|26246401|FG008|Follow-up Period|Participant withdrew consent|0|||
13209705|NCT01928394|26246402|FG009|Follow-up Period|Participant withdrew consent|0|||
13209706|NCT01928394|26246403|FG010|Follow-up Period|Participant withdrew consent|5|||
13209707|NCT01928394|26246404|FG011|Follow-up Period|Participant withdrew consent|8|||
13209708|NCT01928394|26246405|FG012|Follow-up Period|Participant withdrew consent|2|||
13209709|NCT01928394|26246406|FG013|Follow-up Period|Participant withdrew consent|12|||
13209710|NCT01928394|26246407|FG014|Follow-up Period|Participant withdrew consent|7|||
13209711|NCT01928394|26246408|FG015|Follow-up Period|Participant withdrew consent|0|||
13209712|NCT01928394|26246409|FG016|Follow-up Period|Participant withdrew consent|5|||
13209713|NCT01928394|26246410|FG017|Follow-up Period|Participant withdrew consent|3|||
13209714|NCT01928394|26246411|FG018|Follow-up Period|Participant withdrew consent|2|||
13209715|NCT01928394|26246412|FG019|Follow-up Period|Participant withdrew consent|7|||
13209716|NCT01928394|26246413|FG020|Follow-up Period|Participant withdrew consent|4|||
13209717|NCT01928394|26246414|FG021|Follow-up Period|Participant withdrew consent|6|||
13209718|NCT01928394|26246415|FG022|Follow-up Period|Participant withdrew consent|2|||
13209719|NCT01928394|26246393|FG000|Follow-up Period|Death|0|||
13209720|NCT01928394|26246394|FG001|Follow-up Period|Death|0|||
13209721|NCT01928394|26246395|FG002|Follow-up Period|Death|2|||
13209722|NCT01928394|26246396|FG003|Follow-up Period|Death|6|||
13209723|NCT01928394|26246397|FG004|Follow-up Period|Death|0|||
13209724|NCT01928394|26246398|FG005|Follow-up Period|Death|6|||
13209725|NCT01928394|26246399|FG006|Follow-up Period|Death|6|||
13209726|NCT01928394|26246400|FG007|Follow-up Period|Death|2|||
13209727|NCT01928394|26246401|FG008|Follow-up Period|Death|1|||
13209728|NCT01928394|26246402|FG009|Follow-up Period|Death|2|||
13209729|NCT01928394|26246403|FG010|Follow-up Period|Death|4|||
13209730|NCT01928394|26246404|FG011|Follow-up Period|Death|12|||
13209731|NCT01928394|26246405|FG012|Follow-up Period|Death|11|||
13209732|NCT01928394|26246406|FG013|Follow-up Period|Death|25|||
13209733|NCT01928394|26246407|FG014|Follow-up Period|Death|18|||
13209734|NCT01928394|26246408|FG015|Follow-up Period|Death|0|||
13209735|NCT01928394|26246409|FG016|Follow-up Period|Death|6|||
13209736|NCT01928394|26246410|FG017|Follow-up Period|Death|5|||
13209737|NCT01928394|26246411|FG018|Follow-up Period|Death|13|||
13209738|NCT01928394|26246412|FG019|Follow-up Period|Death|13|||
13209739|NCT01928394|26246413|FG020|Follow-up Period|Death|5|||
13209740|NCT01928394|26246414|FG021|Follow-up Period|Death|3|||
13209741|NCT01928394|26246415|FG022|Follow-up Period|Death|2|||
13209742|NCT01928394|26246393|FG000|Follow-up Period|other reason|0|||
13209743|NCT01928394|26246394|FG001|Follow-up Period|other reason|0|||
13209744|NCT01928394|26246395|FG002|Follow-up Period|other reason|0|||
13209745|NCT01928394|26246396|FG003|Follow-up Period|other reason|0|||
13209746|NCT01928394|26246397|FG004|Follow-up Period|other reason|0|||
13209747|NCT01928394|26246398|FG005|Follow-up Period|other reason|0|||
13209748|NCT01928394|26246399|FG006|Follow-up Period|other reason|1|||
13209749|NCT01928394|26246400|FG007|Follow-up Period|other reason|3|||
13209750|NCT01928394|26246401|FG008|Follow-up Period|other reason|0|||
13209751|NCT01928394|26246402|FG009|Follow-up Period|other reason|0|||
13209752|NCT01928394|26246403|FG010|Follow-up Period|other reason|2|||
13209753|NCT01928394|26246404|FG011|Follow-up Period|other reason|1|||
13209754|NCT01928394|26246405|FG012|Follow-up Period|other reason|0|||
13209755|NCT01928394|26246406|FG013|Follow-up Period|other reason|1|||
13209756|NCT01928394|26246407|FG014|Follow-up Period|other reason|4|||
13296525|NCT01370005|26496794|FG000|Overall Study|Non compliant with protocol|0|||
13296526|NCT01370005|26496795|FG001|Overall Study|Non compliant with protocol|1|||
13296527|NCT01370005|26496796|FG002|Overall Study|Non compliant with protocol|2|||
13296528|NCT01370005|26496794|FG000|Overall Study|Lost to Follow-up|1|||
13296529|NCT01370005|26496795|FG001|Overall Study|Lost to Follow-up|1|||
13296530|NCT01370005|26496796|FG002|Overall Study|Lost to Follow-up|1|||
13296531|NCT01370005|26496794|FG000|Overall Study|Patient refusal to continue,not due toAE|5|||
13296532|NCT01370005|26496795|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
13296533|NCT01370005|26496796|FG002|Overall Study|Patient refusal to continue,not due toAE|0|||
13296534|NCT01370005|26496794|FG000|Overall Study|Other reason not defined above|3|||
13296535|NCT01370005|26496795|FG001|Overall Study|Other reason not defined above|0|||
13296536|NCT01370005|26496796|FG002|Overall Study|Other reason not defined above|2|||
13296537|NCT01369849|26496828|FG000|Overall Study|Ineligible prior to treatment|0|||
13296538|NCT01369849|26496829|FG001|Overall Study|Ineligible prior to treatment|0|||
13296539|NCT01369849|26496830|FG002|Overall Study|Ineligible prior to treatment|1|||
13296540|NCT01369849|26496828|FG000|Overall Study|Ineligible after receiving treatment|0|||
13296541|NCT01369849|26496829|FG001|Overall Study|Ineligible after receiving treatment|1|||
13296542|NCT01369849|26496830|FG002|Overall Study|Ineligible after receiving treatment|0|||
13296543|NCT01369784|26496857|FG000|Overall Study|Protocol Violation|12|||
13296544|NCT01369680|26496891|FG000|Overall Study|Lost to Follow-up|0|||
13296545|NCT01369680|26496892|FG001|Overall Study|Lost to Follow-up|0|||
13394769|NCT00654381|26788102|FG005|2nd Stage|Adverse Event|2|||
13209757|NCT01928394|26246408|FG015|Follow-up Period|other reason|0|||
13209758|NCT01928394|26246409|FG016|Follow-up Period|other reason|2|||
13209759|NCT01928394|26246410|FG017|Follow-up Period|other reason|0|||
13296546|NCT01369680|26496893|FG002|Overall Study|Lost to Follow-up|1|||
13296547|NCT01369680|26496894|FG003|Overall Study|Lost to Follow-up|2|||
13296548|NCT01369641|26496900|FG000|Overall Study|Withdrawal by Subject|1|||
13209760|NCT01928394|26246411|FG018|Follow-up Period|other reason|1|||
13209761|NCT01928394|26246412|FG019|Follow-up Period|other reason|1|||
13209762|NCT01928394|26246413|FG020|Follow-up Period|other reason|0|||
13209763|NCT01928394|26246414|FG021|Follow-up Period|other reason|0|||
13209764|NCT01928394|26246415|FG022|Follow-up Period|other reason|1|||
13209765|NCT01928394|26246393|FG000|Follow-up Period|Lost to Follow-up|0|||
13209766|NCT01928394|26246394|FG001|Follow-up Period|Lost to Follow-up|0|||
13209767|NCT01928394|26246395|FG002|Follow-up Period|Lost to Follow-up|0|||
13209768|NCT01928394|26246396|FG003|Follow-up Period|Lost to Follow-up|0|||
13209769|NCT01928394|26246397|FG004|Follow-up Period|Lost to Follow-up|0|||
13209770|NCT01928394|26246398|FG005|Follow-up Period|Lost to Follow-up|0|||
13209771|NCT01928394|26246399|FG006|Follow-up Period|Lost to Follow-up|0|||
13209772|NCT01928394|26246400|FG007|Follow-up Period|Lost to Follow-up|0|||
13209773|NCT01928394|26246401|FG008|Follow-up Period|Lost to Follow-up|0|||
13209774|NCT01928394|26246402|FG009|Follow-up Period|Lost to Follow-up|0|||
13209775|NCT01928394|26246403|FG010|Follow-up Period|Lost to Follow-up|0|||
13209776|NCT01928394|26246404|FG011|Follow-up Period|Lost to Follow-up|1|||
13209777|NCT01928394|26246405|FG012|Follow-up Period|Lost to Follow-up|1|||
13209778|NCT01928394|26246406|FG013|Follow-up Period|Lost to Follow-up|0|||
13209779|NCT01928394|26246407|FG014|Follow-up Period|Lost to Follow-up|1|||
13209780|NCT01928394|26246408|FG015|Follow-up Period|Lost to Follow-up|0|||
13209781|NCT01928394|26246409|FG016|Follow-up Period|Lost to Follow-up|1|||
13209782|NCT01928394|26246410|FG017|Follow-up Period|Lost to Follow-up|0|||
13209783|NCT01928394|26246411|FG018|Follow-up Period|Lost to Follow-up|0|||
13209784|NCT01928394|26246412|FG019|Follow-up Period|Lost to Follow-up|0|||
13209785|NCT01928394|26246413|FG020|Follow-up Period|Lost to Follow-up|0|||
13209786|NCT01928394|26246414|FG021|Follow-up Period|Lost to Follow-up|0|||
13209787|NCT01928394|26246415|FG022|Follow-up Period|Lost to Follow-up|1|||
13209788|NCT01928381|26246436|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60|||
13209789|NCT01928381|26246437|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
13209790|NCT01928381|26246438|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
13209791|NCT01928381|26246439|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
13209792|NCT01928381|26246440|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
13209793|NCT01928381|26246441|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
13209794|NCT01928381|26246442|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
13209795|NCT01928381|26246436|FG000|Part 1 - Pain Training|Pain training criteria not met|29|||
13209796|NCT01928381|26246437|FG001|Part 1 - Pain Training|Pain training criteria not met|0|||
13209797|NCT01928381|26246438|FG002|Part 1 - Pain Training|Pain training criteria not met|0|||
13209798|NCT01928381|26246439|FG003|Part 1 - Pain Training|Pain training criteria not met|0|||
13209799|NCT01928381|26246440|FG004|Part 1 - Pain Training|Pain training criteria not met|0|||
13209800|NCT01928381|26246441|FG005|Part 1 - Pain Training|Pain training criteria not met|0|||
13209801|NCT01928381|26246442|FG006|Part 1 - Pain Training|Pain training criteria not met|0|||
13209802|NCT01928381|26246436|FG000|Part 1 - Pain Training|Withdrawal by Subject|1|||
13209803|NCT01928381|26246437|FG001|Part 1 - Pain Training|Withdrawal by Subject|0|||
13209804|NCT01928381|26246438|FG002|Part 1 - Pain Training|Withdrawal by Subject|0|||
13209805|NCT01928381|26246439|FG003|Part 1 - Pain Training|Withdrawal by Subject|0|||
13209806|NCT01928381|26246440|FG004|Part 1 - Pain Training|Withdrawal by Subject|0|||
13209807|NCT01928381|26246441|FG005|Part 1 - Pain Training|Withdrawal by Subject|0|||
13209808|NCT01928381|26246442|FG006|Part 1 - Pain Training|Withdrawal by Subject|0|||
13209809|NCT01928381|26246436|FG000|Part 1 - Pain Training|Lost to Follow-up|4|||
13209810|NCT01928381|26246437|FG001|Part 1 - Pain Training|Lost to Follow-up|0|||
13209811|NCT01928381|26246438|FG002|Part 1 - Pain Training|Lost to Follow-up|0|||
13209812|NCT01928381|26246439|FG003|Part 1 - Pain Training|Lost to Follow-up|0|||
13209813|NCT01928381|26246440|FG004|Part 1 - Pain Training|Lost to Follow-up|0|||
13209814|NCT01928381|26246441|FG005|Part 1 - Pain Training|Lost to Follow-up|0|||
13209815|NCT01928381|26246442|FG006|Part 1 - Pain Training|Lost to Follow-up|0|||
13209816|NCT01928381|26246436|FG000|Part 1 - Pain Training|Protocol Violation|1|||
13209817|NCT01928381|26246437|FG001|Part 1 - Pain Training|Protocol Violation|0|||
13209818|NCT01928381|26246438|FG002|Part 1 - Pain Training|Protocol Violation|0|||
13209819|NCT01928381|26246439|FG003|Part 1 - Pain Training|Protocol Violation|0|||
13209820|NCT01928381|26246440|FG004|Part 1 - Pain Training|Protocol Violation|0|||
13209821|NCT01928381|26246441|FG005|Part 1 - Pain Training|Protocol Violation|0|||
13209822|NCT01928381|26246442|FG006|Part 1 - Pain Training|Protocol Violation|0|||
13209823|NCT01928381|26246436|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1|||
13209824|NCT01928381|26246437|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
13209825|NCT01928381|26246438|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
13209826|NCT01928381|26246439|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
13209827|NCT01928381|26246440|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
13209828|NCT01928381|26246441|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
13209829|NCT01928381|26246442|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
13209830|NCT01928381|26246436|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2|||
13209831|NCT01928381|26246437|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
13209832|NCT01928381|26246438|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
13209833|NCT01928381|26246439|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
13209834|NCT01928381|26246440|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
13209835|NCT01928381|26246441|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
13209836|NCT01928381|26246442|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
13209837|NCT01928381|26246436|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1|||
13209838|NCT01928381|26246437|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
13209839|NCT01928381|26246438|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
13209840|NCT01928381|26246439|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
13209841|NCT01928381|26246440|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
13209842|NCT01928381|26246441|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
13209843|NCT01928381|26246442|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
13209844|NCT01928381|26246436|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10|||
13209845|NCT01928381|26246437|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
13209846|NCT01928381|26246438|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
13209847|NCT01928381|26246439|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
13209848|NCT01928381|26246440|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
13209849|NCT01928381|26246441|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
13209850|NCT01928381|26246442|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
13209851|NCT01928381|26246436|FG000|Part 2 - First Intervention|Withdrawal by Subject|0|||
13209852|NCT01928381|26246437|FG001|Part 2 - First Intervention|Withdrawal by Subject|0|||
13209853|NCT01928381|26246438|FG002|Part 2 - First Intervention|Withdrawal by Subject|1|||
13209854|NCT01928381|26246439|FG003|Part 2 - First Intervention|Withdrawal by Subject|0|||
13209855|NCT01928381|26246440|FG004|Part 2 - First Intervention|Withdrawal by Subject|0|||
13209856|NCT01928381|26246441|FG005|Part 2 - First Intervention|Withdrawal by Subject|0|||
13209857|NCT01928381|26246442|FG006|Part 2 - First Intervention|Withdrawal by Subject|0|||
13209858|NCT01928381|26246436|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
13209859|NCT01928381|26246437|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
13209860|NCT01928381|26246438|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1|||
13209861|NCT01928381|26246439|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
13209862|NCT01928381|26246440|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
13209863|NCT01928381|26246441|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
13209864|NCT01928381|26246442|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
13209865|NCT01928381|26246436|FG000|Part 2 - First Intervention|Eligibility criterion not met|0|||
13209866|NCT01928381|26246437|FG001|Part 2 - First Intervention|Eligibility criterion not met|0|||
13209867|NCT01928381|26246438|FG002|Part 2 - First Intervention|Eligibility criterion not met|0|||
13209868|NCT01928381|26246439|FG003|Part 2 - First Intervention|Eligibility criterion not met|0|||
13209869|NCT01928381|26246440|FG004|Part 2 - First Intervention|Eligibility criterion not met|0|||
13209870|NCT01928381|26246441|FG005|Part 2 - First Intervention|Eligibility criterion not met|1|||
13209871|NCT01928381|26246442|FG006|Part 2 - First Intervention|Eligibility criterion not met|1|||
13209872|NCT01928381|26246436|FG000|Part 2 - First Intervention|Lost to Follow-up|0|||
13209873|NCT01928381|26246437|FG001|Part 2 - First Intervention|Lost to Follow-up|0|||
13209874|NCT01928381|26246438|FG002|Part 2 - First Intervention|Lost to Follow-up|0|||
13209875|NCT01928381|26246439|FG003|Part 2 - First Intervention|Lost to Follow-up|1|||
13209876|NCT01928381|26246440|FG004|Part 2 - First Intervention|Lost to Follow-up|0|||
13209877|NCT01928381|26246441|FG005|Part 2 - First Intervention|Lost to Follow-up|0|||
13209878|NCT01928381|26246442|FG006|Part 2 - First Intervention|Lost to Follow-up|0|||
13209879|NCT01928381|26246436|FG000|Washout First Intervention|Protocol Violation|0|||
13209880|NCT01928381|26246437|FG001|Washout First Intervention|Protocol Violation|0|||
13209881|NCT01928381|26246438|FG002|Washout First Intervention|Protocol Violation|0|||
13209882|NCT01928381|26246439|FG003|Washout First Intervention|Protocol Violation|0|||
13209883|NCT01928381|26246440|FG004|Washout First Intervention|Protocol Violation|1|||
13209884|NCT01928381|26246441|FG005|Washout First Intervention|Protocol Violation|0|||
13209885|NCT01928381|26246442|FG006|Washout First Intervention|Protocol Violation|0|||
13209886|NCT01928381|26246436|FG000|Part 2 - Second Intervention|Lost to Follow-up|0|||
13209887|NCT01928381|26246437|FG001|Part 2 - Second Intervention|Lost to Follow-up|1|||
13209888|NCT01928381|26246438|FG002|Part 2 - Second Intervention|Lost to Follow-up|0|||
13209889|NCT01928381|26246439|FG003|Part 2 - Second Intervention|Lost to Follow-up|1|||
13209890|NCT01928381|26246440|FG004|Part 2 - Second Intervention|Lost to Follow-up|0|||
13209891|NCT01928381|26246441|FG005|Part 2 - Second Intervention|Lost to Follow-up|0|||
13209892|NCT01928381|26246442|FG006|Part 2 - Second Intervention|Lost to Follow-up|0|||
13209893|NCT01928381|26246436|FG000|Part 2 - Post Third Intervention|Protocol Violation|0|||
13209894|NCT01928381|26246437|FG001|Part 2 - Post Third Intervention|Protocol Violation|0|||
13209895|NCT01928381|26246438|FG002|Part 2 - Post Third Intervention|Protocol Violation|1|||
13209896|NCT01928381|26246439|FG003|Part 2 - Post Third Intervention|Protocol Violation|0|||
13209897|NCT01928381|26246440|FG004|Part 2 - Post Third Intervention|Protocol Violation|0|||
13209898|NCT01928381|26246441|FG005|Part 2 - Post Third Intervention|Protocol Violation|0|||
13209899|NCT01928381|26246442|FG006|Part 2 - Post Third Intervention|Protocol Violation|0|||
13209900|NCT01928329|26246461|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1|||
13209901|NCT01928329|26246462|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3|||
13209902|NCT01928329|26246461|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0|||
13209903|NCT01928329|26246462|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1|||
13209904|NCT01928329|26246461|FG000|Overall Study|Adverse Event|5|||
13209905|NCT01928329|26246462|FG001|Overall Study|Adverse Event|3|||
13209906|NCT01928329|26246461|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4|||
13209907|NCT01928329|26246462|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1|||
13209908|NCT01928329|26246461|FG000|Overall Study|Withdrawal by Subject|1|||
13209909|NCT01928329|26246462|FG001|Overall Study|Withdrawal by Subject|5|||
13209910|NCT01928329|26246461|FG000|Overall Study|Physician Decision|1|||
13209911|NCT01928329|26246462|FG001|Overall Study|Physician Decision|1|||
13209912|NCT01928225|26246477|FG000|Overall Study|Pregnancy|1|||
13209913|NCT01928225|26246478|FG001|Overall Study|Pregnancy|0|||
13209914|NCT01928225|26246477|FG000|Overall Study|basaloid cervical cancer|1|||
13209915|NCT01928225|26246478|FG001|Overall Study|basaloid cervical cancer|0|||
13209916|NCT01928225|26246477|FG000|Overall Study|Lost to Follow-up|1|||
13209917|NCT01928225|26246478|FG001|Overall Study|Lost to Follow-up|3|||
13209918|NCT01928082|26246498|FG000|Overall Study|Study terminated.|1|||
13209919|NCT01927861|26246643|FG000|Extension Phase (104 Weeks)|Adverse Event|0|||
13209920|NCT01927861|26246644|FG001|Extension Phase (104 Weeks)|Adverse Event|2|||
13209921|NCT01927861|26246643|FG000|Extension Phase (104 Weeks)|Unclassified|0|||
13209922|NCT01927861|26246644|FG001|Extension Phase (104 Weeks)|Unclassified|1|||
13209923|NCT01927757|26246664|FG000|Overall Study|Withdrawal by Subject|14|||
13209924|NCT01927757|26246664|FG000|Overall Study|Lost to Follow-up|2|||
13209925|NCT01927757|26246664|FG000|Overall Study|Decision by Sponsor|2|||
13209926|NCT01927757|26246664|FG000|Overall Study|Other|1|||
13209927|NCT01927757|26246664|FG000|Overall Study|Ethical Reasons|4|||
13209928|NCT01927627|26246671|FG000|Overall Study|Adverse Event|3|||
13209929|NCT01927627|26246671|FG000|Overall Study|Lack of Efficacy|1|||
13209930|NCT01927627|26246671|FG000|Overall Study|Financial Concerns|1|||
13209931|NCT01927562|26246677|FG000|Overall Study|Lost to Follow-up|30|||
13209932|NCT01927562|26246677|FG000|Overall Study|Withdrawal by Subject|3|||
13209933|NCT01927562|26246677|FG000|Overall Study|Physician Decision|5|||
13296549|NCT01369615|26496913|FG000|Overall Study|Withdrawal by Subject|0|||
13296550|NCT01369615|26496914|FG001|Overall Study|Withdrawal by Subject|1|||
13296551|NCT01369615|26496913|FG000|Overall Study|Lost to Follow-up|0|||
13296552|NCT01369615|26496914|FG001|Overall Study|Lost to Follow-up|1|||
13296553|NCT01369511|26496941|FG000|Overall Study|Adverse Event|1|||
13296554|NCT01369511|26496942|FG001|Overall Study|Adverse Event|1|||
13296555|NCT01369511|26496943|FG002|Overall Study|Adverse Event|5|||
13296556|NCT01369511|26496944|FG003|Overall Study|Adverse Event|0|||
13296557|NCT01369511|26496941|FG000|Overall Study|Entry criteria not met|2|||
13296558|NCT01369511|26496942|FG001|Overall Study|Entry criteria not met|0|||
13296559|NCT01369511|26496943|FG002|Overall Study|Entry criteria not met|0|||
13296560|NCT01369511|26496944|FG003|Overall Study|Entry criteria not met|1|||
13296561|NCT01369511|26496941|FG000|Overall Study|Lost to Follow-up|0|||
13296562|NCT01369511|26496942|FG001|Overall Study|Lost to Follow-up|1|||
13296563|NCT01369511|26496943|FG002|Overall Study|Lost to Follow-up|1|||
13296564|NCT01369511|26496944|FG003|Overall Study|Lost to Follow-up|2|||
13296565|NCT01369511|26496941|FG000|Overall Study|Protocol Violation|0|||
13296566|NCT01369511|26496942|FG001|Overall Study|Protocol Violation|1|||
13296567|NCT01369511|26496943|FG002|Overall Study|Protocol Violation|0|||
13296568|NCT01369511|26496944|FG003|Overall Study|Protocol Violation|2|||
13296569|NCT01369511|26496941|FG000|Overall Study|Physician Decision|3|||
13296570|NCT01369511|26496942|FG001|Overall Study|Physician Decision|4|||
13296571|NCT01369511|26496943|FG002|Overall Study|Physician Decision|0|||
13296572|NCT01369511|26496944|FG003|Overall Study|Physician Decision|0|||
13296573|NCT01369511|26496941|FG000|Overall Study|Sponsor decision|2|||
13296574|NCT01369511|26496942|FG001|Overall Study|Sponsor decision|0|||
13296575|NCT01369511|26496943|FG002|Overall Study|Sponsor decision|1|||
13296576|NCT01369511|26496944|FG003|Overall Study|Sponsor decision|0|||
13296577|NCT01369511|26496941|FG000|Overall Study|Withdrawal by Subject|5|||
13296578|NCT01369511|26496942|FG001|Overall Study|Withdrawal by Subject|6|||
13296579|NCT01369511|26496943|FG002|Overall Study|Withdrawal by Subject|4|||
13296580|NCT01369511|26496944|FG003|Overall Study|Withdrawal by Subject|6|||
13296581|NCT01369498|26496987|FG000|Overall Study|Lack of Efficacy|9|||
13296582|NCT01369498|26496988|FG001|Overall Study|Lack of Efficacy|9|||
13296583|NCT01369498|26496989|FG002|Overall Study|Lack of Efficacy|1|||
13296584|NCT01369498|26496990|FG003|Overall Study|Lack of Efficacy|3|||
13296585|NCT01369498|26496987|FG000|Overall Study|Adverse Event|1|||
13296586|NCT01369498|26496988|FG001|Overall Study|Adverse Event|2|||
13296587|NCT01369498|26496989|FG002|Overall Study|Adverse Event|0|||
13296588|NCT01369498|26496990|FG003|Overall Study|Adverse Event|1|||
13296589|NCT01369498|26496987|FG000|Overall Study|Withdrawal of Consent|0|||
13296590|NCT01369498|26496988|FG001|Overall Study|Withdrawal of Consent|1|||
13209934|NCT01927497|26246690|FG000|Overall Study|Death|0|||
13209935|NCT01927497|26246691|FG001|Overall Study|Death|1|||
13209936|NCT01927497|26246690|FG000|Overall Study|Protocol Violation|2|||
13209937|NCT01927497|26246691|FG001|Overall Study|Protocol Violation|0|||
13209938|NCT01927419|26246712|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
13209939|NCT01927419|26246713|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
13209940|NCT01927419|26246712|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1|||
13209941|NCT01927419|26246713|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0|||
13209942|NCT01927419|26246712|FG000|Treatment Period|Disease progression|17|||
13209943|NCT01927419|26246713|FG001|Treatment Period|Disease progression|20|||
13209944|NCT01927419|26246712|FG000|Treatment Period|Study drug toxicity|48|||
13209945|NCT01927419|26246713|FG001|Treatment Period|Study drug toxicity|10|||
13209946|NCT01927419|26246712|FG000|Treatment Period|Death|0|||
13209947|NCT01927419|26246713|FG001|Treatment Period|Death|1|||
13209948|NCT01927419|26246712|FG000|Treatment Period|Adverse event unrelated to study drug|6|||
13209949|NCT01927419|26246713|FG001|Treatment Period|Adverse event unrelated to study drug|3|||
13209950|NCT01927419|26246712|FG000|Treatment Period|Participant request to discontinue|12|||
13209951|NCT01927419|26246713|FG001|Treatment Period|Participant request to discontinue|4|||
13209952|NCT01927419|26246712|FG000|Treatment Period|Withdrawal by Subject|1|||
13209953|NCT01927419|26246713|FG001|Treatment Period|Withdrawal by Subject|1|||
13209954|NCT01927419|26246712|FG000|Treatment Period|Maximum Clinical Benefit|6|||
13209955|NCT01927419|26246713|FG001|Treatment Period|Maximum Clinical Benefit|2|||
13209956|NCT01927419|26246712|FG000|Treatment Period|Other reasons|3|||
13209957|NCT01927419|26246713|FG001|Treatment Period|Other reasons|4|||
13209958|NCT01927419|26246712|FG000|Treatment Period|Not Reported|1|||
13209959|NCT01927419|26246713|FG001|Treatment Period|Not Reported|1|||
13209960|NCT01927367|26246734|FG000|Overall Study|Withdrawal by Subject|7|||
13209961|NCT01927367|26246735|FG001|Overall Study|Withdrawal by Subject|4|||
13209962|NCT01927367|26246734|FG000|Overall Study|No baseline data|0|||
13209963|NCT01927367|26246735|FG001|Overall Study|No baseline data|1|||
13209964|NCT01927341|26246804|FG000|Phase 1b|Lost to Follow-up|1|||
13209965|NCT01927341|26246805|FG001|Phase 1b|Lost to Follow-up|0|||
13209966|NCT01927341|26246806|FG002|Phase 1b|Lost to Follow-up|0|||
13209967|NCT01927341|26246807|FG003|Phase 1b|Lost to Follow-up|0|||
13209968|NCT01927341|26246808|FG004|Phase 1b|Lost to Follow-up|0|||
13209969|NCT01927341|26246804|FG000|Phase 1b|Death|2|||
13209970|NCT01927341|26246805|FG001|Phase 1b|Death|0|||
13209971|NCT01927341|26246806|FG002|Phase 1b|Death|0|||
13209972|NCT01927341|26246807|FG003|Phase 1b|Death|0|||
13209973|NCT01927341|26246808|FG004|Phase 1b|Death|0|||
13209974|NCT01927341|26246804|FG000|Phase 1b|Follow-up completed|7|||
13209975|NCT01927341|26246805|FG001|Phase 1b|Follow-up completed|0|||
13209976|NCT01927341|26246806|FG002|Phase 1b|Follow-up completed|0|||
13209977|NCT01927341|26246807|FG003|Phase 1b|Follow-up completed|0|||
13209978|NCT01927341|26246808|FG004|Phase 1b|Follow-up completed|0|||
13209979|NCT01927341|26246804|FG000|Phase 2|Lost to Follow-up|0|||
13209980|NCT01927341|26246805|FG001|Phase 2|Lost to Follow-up|1|||
13209981|NCT01927341|26246806|FG002|Phase 2|Lost to Follow-up|0|||
13209982|NCT01927341|26246807|FG003|Phase 2|Lost to Follow-up|0|||
13209983|NCT01927341|26246808|FG004|Phase 2|Lost to Follow-up|0|||
13209984|NCT01927341|26246804|FG000|Phase 2|Participant withdrew consent|0|||
13209985|NCT01927341|26246805|FG001|Phase 2|Participant withdrew consent|2|||
13209986|NCT01927341|26246806|FG002|Phase 2|Participant withdrew consent|1|||
13209987|NCT01927341|26246807|FG003|Phase 2|Participant withdrew consent|2|||
13209988|NCT01927341|26246808|FG004|Phase 2|Participant withdrew consent|3|||
13209989|NCT01927341|26246804|FG000|Phase 2|Death|0|||
13209990|NCT01927341|26246805|FG001|Phase 2|Death|4|||
13209991|NCT01927341|26246806|FG002|Phase 2|Death|0|||
13209992|NCT01927341|26246807|FG003|Phase 2|Death|3|||
13209993|NCT01927341|26246808|FG004|Phase 2|Death|2|||
13209994|NCT01927341|26246804|FG000|Phase 2|New cancer therapy|0|||
13209995|NCT01927341|26246805|FG001|Phase 2|New cancer therapy|1|||
13209996|NCT01927341|26246806|FG002|Phase 2|New cancer therapy|0|||
13209997|NCT01927341|26246807|FG003|Phase 2|New cancer therapy|4|||
13209998|NCT01927341|26246808|FG004|Phase 2|New cancer therapy|1|||
13209999|NCT01927341|26246804|FG000|Phase 2|Disease progression|0|||
13210000|NCT01927341|26246805|FG001|Phase 2|Disease progression|1|||
13210001|NCT01927341|26246806|FG002|Phase 2|Disease progression|1|||
13210002|NCT01927341|26246807|FG003|Phase 2|Disease progression|1|||
13210003|NCT01927341|26246808|FG004|Phase 2|Disease progression|0|||
13210004|NCT01927341|26246804|FG000|Phase 2|Follow-up completed|0|||
13210005|NCT01927341|26246805|FG001|Phase 2|Follow-up completed|6|||
13210006|NCT01927341|26246806|FG002|Phase 2|Follow-up completed|3|||
13210007|NCT01927341|26246807|FG003|Phase 2|Follow-up completed|5|||
13210008|NCT01927341|26246808|FG004|Phase 2|Follow-up completed|2|||
13210009|NCT01927068|26246824|FG000|Overall Study|Death|37|||
13210010|NCT01927068|26246825|FG001|Overall Study|Death|3|||
13210011|NCT01927068|26246824|FG000|Overall Study|Withdrawal by Subject|50|||
13210012|NCT01927068|26246825|FG001|Overall Study|Withdrawal by Subject|3|||
13210013|NCT01927068|26246824|FG000|Overall Study|Lost to Follow-up|10|||
13210014|NCT01927068|26246825|FG001|Overall Study|Lost to Follow-up|2|||
13210015|NCT01927068|26246824|FG000|Overall Study|Physician Decision|9|||
13210016|NCT01927068|26246825|FG001|Overall Study|Physician Decision|0|||
13210017|NCT01927068|26246824|FG000|Overall Study|Missed last follow-up visit|2|||
13210018|NCT01927068|26246825|FG001|Overall Study|Missed last follow-up visit|0|||
13210019|NCT01927055|26246842|FG000|Open-label|Adverse Event|6|||
13210020|NCT01927055|26246843|FG001|Open-label|Adverse Event|0|||
13210021|NCT01927055|26246844|FG002|Open-label|Adverse Event|0|||
13210022|NCT01927055|26246842|FG000|Open-label|Withdrawal by Subject|1|||
13210023|NCT01927055|26246843|FG001|Open-label|Withdrawal by Subject|0|||
13210024|NCT01927055|26246844|FG002|Open-label|Withdrawal by Subject|0|||
13210025|NCT01927055|26246842|FG000|Open-label|Study Stopped|4|||
13210026|NCT01927055|26246843|FG001|Open-label|Study Stopped|0|||
13210027|NCT01927055|26246844|FG002|Open-label|Study Stopped|0|||
13210028|NCT01927055|26246842|FG000|Open-label|Supine Hypertension|4|||
13210029|NCT01927055|26246843|FG001|Open-label|Supine Hypertension|0|||
13210030|NCT01927055|26246844|FG002|Open-label|Supine Hypertension|0|||
13210031|NCT01927055|26246842|FG000|Open-label|Difficulty attending study visits|1|||
13210032|NCT01927055|26246843|FG001|Open-label|Difficulty attending study visits|0|||
13210033|NCT01927055|26246844|FG002|Open-label|Difficulty attending study visits|0|||
13210034|NCT01927055|26246842|FG000|Double-Blind|Adverse Event|0|||
13210035|NCT01927055|26246843|FG001|Double-Blind|Adverse Event|1|||
13210036|NCT01927055|26246844|FG002|Double-Blind|Adverse Event|1|||
13210037|NCT01927055|26246842|FG000|Double-Blind|Protocol Violation|0|||
13210038|NCT01927055|26246843|FG001|Double-Blind|Protocol Violation|0|||
13210039|NCT01927055|26246844|FG002|Double-Blind|Protocol Violation|1|||
13210040|NCT01927055|26246842|FG000|Double-Blind|Withdrawal by Subject|0|||
13210041|NCT01927055|26246843|FG001|Double-Blind|Withdrawal by Subject|2|||
13210042|NCT01927055|26246844|FG002|Double-Blind|Withdrawal by Subject|3|||
13210043|NCT01927055|26246842|FG000|Double-Blind|Study Stopped|0|||
13210044|NCT01927055|26246843|FG001|Double-Blind|Study Stopped|7|||
13210045|NCT01927055|26246844|FG002|Double-Blind|Study Stopped|7|||
13210046|NCT01927055|26246842|FG000|Double-Blind|Supine Hypertension|0|||
13210047|NCT01927055|26246843|FG001|Double-Blind|Supine Hypertension|0|||
13210048|NCT01927055|26246844|FG002|Double-Blind|Supine Hypertension|1|||
13210049|NCT01927055|26246842|FG000|Double-Blind|Extended Vacation|0|||
13210050|NCT01927055|26246843|FG001|Double-Blind|Extended Vacation|1|||
13210051|NCT01927055|26246844|FG002|Double-Blind|Extended Vacation|0|||
13210052|NCT01926886|26246860|FG000|Overall Study|Administrative/other|1|||
13210053|NCT01926886|26246861|FG001|Overall Study|Administrative/other|0|||
13210054|NCT01926886|26246860|FG000|Overall Study|Adverse event/intercurrent illness|4|||
13210055|NCT01926886|26246861|FG001|Overall Study|Adverse event/intercurrent illness|0|||
13210056|NCT01926886|26246860|FG000|Overall Study|Disease progression/recurrence|4|||
13210057|NCT01926886|26246861|FG001|Overall Study|Disease progression/recurrence|0|||
13210058|NCT01926886|26246860|FG000|Overall Study|Withdrawal by Subject|15|||
13210059|NCT01926886|26246861|FG001|Overall Study|Withdrawal by Subject|0|||
13210060|NCT01926886|26246860|FG000|Overall Study|Failure to return|3|||
13210061|NCT01926886|26246861|FG001|Overall Study|Failure to return|0|||
13210062|NCT01926886|26246860|FG000|Overall Study|Recurrence of disease|1|||
13210063|NCT01926886|26246861|FG001|Overall Study|Recurrence of disease|0|||
13210064|NCT01926886|26246860|FG000|Overall Study|Progression of disease|2|||
13210065|NCT01926886|26246861|FG001|Overall Study|Progression of disease|0|||
13210066|NCT01926886|26246860|FG000|Overall Study|Death|1|||
13210067|NCT01926886|26246861|FG001|Overall Study|Death|0|||
13210068|NCT01926886|26246860|FG000|Overall Study|Did not cooperate|1|||
13210069|NCT01926886|26246861|FG001|Overall Study|Did not cooperate|0|||
13210070|NCT01926782|26247029|FG000|Overall Study|Participant moved|2|||
13210071|NCT01926782|26247030|FG001|Overall Study|Participant moved|0|||
13210072|NCT01926782|26247031|FG002|Overall Study|Participant moved|1|||
13210073|NCT01926782|26247032|FG003|Overall Study|Participant moved|1|||
13210074|NCT01926782|26247033|FG004|Overall Study|Participant moved|0|||
13210075|NCT01926782|26247034|FG005|Overall Study|Participant moved|3|||
13210076|NCT01926782|26247029|FG000|Overall Study|Physician Decision|0|||
13210077|NCT01926782|26247030|FG001|Overall Study|Physician Decision|2|||
13210078|NCT01926782|26247031|FG002|Overall Study|Physician Decision|1|||
13210079|NCT01926782|26247032|FG003|Overall Study|Physician Decision|1|||
13210080|NCT01926782|26247033|FG004|Overall Study|Physician Decision|0|||
13210081|NCT01926782|26247034|FG005|Overall Study|Physician Decision|0|||
13210082|NCT01926782|26247029|FG000|Overall Study|Other than specified|2|||
13210083|NCT01926782|26247030|FG001|Overall Study|Other than specified|3|||
13210084|NCT01926782|26247031|FG002|Overall Study|Other than specified|5|||
13210085|NCT01926782|26247032|FG003|Overall Study|Other than specified|12|||
13210086|NCT01926782|26247033|FG004|Overall Study|Other than specified|4|||
13210087|NCT01926782|26247034|FG005|Overall Study|Other than specified|11|||
13210088|NCT01926782|26247029|FG000|Overall Study|Adverse Event|13|||
13210089|NCT01926782|26247030|FG001|Overall Study|Adverse Event|4|||
13210090|NCT01926782|26247031|FG002|Overall Study|Adverse Event|17|||
13210091|NCT01926782|26247032|FG003|Overall Study|Adverse Event|4|||
13210092|NCT01926782|26247033|FG004|Overall Study|Adverse Event|3|||
13210093|NCT01926782|26247034|FG005|Overall Study|Adverse Event|14|||
13210094|NCT01926782|26247029|FG000|Overall Study|Poor compliance to protocol|5|||
13210095|NCT01926782|26247030|FG001|Overall Study|Poor compliance to protocol|3|||
13210096|NCT01926782|26247031|FG002|Overall Study|Poor compliance to protocol|8|||
13210097|NCT01926782|26247032|FG003|Overall Study|Poor compliance to protocol|0|||
13210098|NCT01926782|26247033|FG004|Overall Study|Poor compliance to protocol|1|||
13210099|NCT01926782|26247034|FG005|Overall Study|Poor compliance to protocol|6|||
13210100|NCT01926782|26247029|FG000|Overall Study|Randomized and not treated|0|||
13210101|NCT01926782|26247030|FG001|Overall Study|Randomized and not treated|0|||
13210102|NCT01926782|26247031|FG002|Overall Study|Randomized and not treated|0|||
13210103|NCT01926782|26247032|FG003|Overall Study|Randomized and not treated|1|||
13210104|NCT01926782|26247033|FG004|Overall Study|Randomized and not treated|0|||
13210105|NCT01926782|26247034|FG005|Overall Study|Randomized and not treated|0|||
13210106|NCT01926782|26247029|FG000|Overall Study|Withdrawal by Subject|6|||
13210107|NCT01926782|26247030|FG001|Overall Study|Withdrawal by Subject|1|||
13210108|NCT01926782|26247031|FG002|Overall Study|Withdrawal by Subject|8|||
13210109|NCT01926782|26247032|FG003|Overall Study|Withdrawal by Subject|1|||
13210110|NCT01926782|26247033|FG004|Overall Study|Withdrawal by Subject|0|||
13210111|NCT01926782|26247034|FG005|Overall Study|Withdrawal by Subject|5|||
13210112|NCT01926782|26247029|FG000|Overall Study|Related to study drug administration|0|||
13210113|NCT01926782|26247030|FG001|Overall Study|Related to study drug administration|0|||
13210114|NCT01926782|26247031|FG002|Overall Study|Related to study drug administration|0|||
13210115|NCT01926782|26247032|FG003|Overall Study|Related to study drug administration|0|||
13210116|NCT01926782|26247033|FG004|Overall Study|Related to study drug administration|0|||
13210117|NCT01926782|26247034|FG005|Overall Study|Related to study drug administration|2|||
13210118|NCT01926626|26247046|FG000|Overall Study|Withdrawal by Subject|15|||
13210119|NCT01926626|26247046|FG000|Overall Study|Lost to Follow-up|7|||
13210120|NCT01926509|26247076|FG000|Overall Study|vital sign met discontinuation criteria|1|||
13210121|NCT01926509|26247077|FG001|Overall Study|vital sign met discontinuation criteria|0|||
13210122|NCT01926509|26247078|FG002|Overall Study|vital sign met discontinuation criteria|0|||
13210123|NCT01926509|26247079|FG003|Overall Study|vital sign met discontinuation criteria|0|||
13210124|NCT01926444|26247134|FG000|Overall Study|Colonoscopy not performed|0|||
13210125|NCT01926444|26247135|FG001|Overall Study|Colonoscopy not performed|0|||
13210126|NCT01926444|26247136|FG002|Overall Study|Colonoscopy not performed|4|||
13210127|NCT01926444|26247137|FG003|Overall Study|Colonoscopy not performed|2|||
13210128|NCT01926119|26247149|FG000|Overall Study|Withdrawal by Subject|1|||
13210129|NCT01926028|26247193|FG000|Overall Study|Lost to Follow-up|7|||
13210130|NCT01926028|26247194|FG001|Overall Study|Lost to Follow-up|6|||
13210131|NCT01926028|26247195|FG002|Overall Study|Lost to Follow-up|0|||
13210132|NCT01926028|26247193|FG000|Overall Study|Physician Decision|1|||
13210133|NCT01926028|26247194|FG001|Overall Study|Physician Decision|5|||
13210134|NCT01926028|26247195|FG002|Overall Study|Physician Decision|0|||
13210135|NCT01926028|26247193|FG000|Overall Study|Withdrawal by Subject|9|||
13210136|NCT01926028|26247194|FG001|Overall Study|Withdrawal by Subject|9|||
13210137|NCT01926028|26247195|FG002|Overall Study|Withdrawal by Subject|2|||
13210138|NCT01926028|26247193|FG000|Overall Study|Non compliance or other reasons|4|||
13210139|NCT01926028|26247194|FG001|Overall Study|Non compliance or other reasons|2|||
13210140|NCT01926028|26247195|FG002|Overall Study|Non compliance or other reasons|0|||
13210141|NCT01926015|26247232|FG000|Overall Study|Withdrawal by parent/guardian|0|||
13210142|NCT01926015|26247233|FG001|Overall Study|Withdrawal by parent/guardian|1|||
13210143|NCT01926015|26247232|FG000|Overall Study|Randomized not treated|2|||
13210144|NCT01926015|26247233|FG001|Overall Study|Randomized not treated|0|||
13210145|NCT01925989|26247259|FG000|Period 1|Sponsor Decision|1|||
13210146|NCT01925989|26247260|FG001|Period 1|Sponsor Decision|1|||
13210147|NCT01925989|26247261|FG002|Period 1|Sponsor Decision|0|||
13210148|NCT01925989|26247259|FG000|Period 1|Withdrawal by Subject|0|||
13210149|NCT01925989|26247260|FG001|Period 1|Withdrawal by Subject|1|||
13210150|NCT01925989|26247261|FG002|Period 1|Withdrawal by Subject|0|||
13210151|NCT01925950|26247274|FG000|Part 2|Withdrawal by Subject|1|||
13210152|NCT01925950|26247275|FG001|Part 2|Withdrawal by Subject|0|||
13210153|NCT01925768|26247330|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
13210154|NCT01925768|26247331|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
13210155|NCT01925768|26247330|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
13210156|NCT01925768|26247331|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2|||
13210157|NCT01925768|26247330|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
13210158|NCT01925768|26247331|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
13210159|NCT01925768|26247330|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
13210160|NCT01925768|26247331|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
13210161|NCT01925768|26247330|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
13210162|NCT01925768|26247331|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
13210163|NCT01925768|26247330|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0|||
13210164|NCT01925768|26247331|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1|||
13210165|NCT01925768|26247330|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
13210166|NCT01925768|26247331|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
13210167|NCT01925768|26247330|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7|||
13210168|NCT01925768|26247331|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9|||
13210169|NCT01925768|26247330|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2|||
13210170|NCT01925768|26247331|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1|||
13210171|NCT01925768|26247330|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0|||
13210172|NCT01925768|26247331|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1|||
13210173|NCT01925768|26247330|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5|||
13210174|NCT01925768|26247331|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1|||
13210175|NCT01925703|26247339|FG000|Overall Study|Physician Decision|1|||
13210176|NCT01925703|26247339|FG000|Overall Study|Lost to Follow-up|2|||
13210177|NCT01925703|26247339|FG000|Overall Study|Discharge prior to full iron repletion|1|||
13210178|NCT01925612|26247392|FG000|Overall Study|Progressive Disease|1|||
13210179|NCT01925612|26247393|FG001|Overall Study|Progressive Disease|1|||
13210180|NCT01925612|26247394|FG002|Overall Study|Progressive Disease|1|||
13210181|NCT01925612|26247395|FG003|Overall Study|Progressive Disease|0|||
13210182|NCT01925612|26247396|FG004|Overall Study|Progressive Disease|0|||
13210183|NCT01925612|26247392|FG000|Overall Study|Adverse Event|3|||
13210184|NCT01925612|26247393|FG001|Overall Study|Adverse Event|3|||
13210185|NCT01925612|26247394|FG002|Overall Study|Adverse Event|0|||
13210186|NCT01925612|26247395|FG003|Overall Study|Adverse Event|1|||
13210187|NCT01925612|26247396|FG004|Overall Study|Adverse Event|2|||
13210188|NCT01925417|26247406|FG000|Overall Study|Withdrawal by Subject|2|||
13210189|NCT01925417|26247406|FG000|Overall Study|Death|1|||
13210190|NCT01925339|26247421|FG000|Overall Study|Adverse Event|2|||
13210191|NCT01925339|26247422|FG001|Overall Study|Adverse Event|0|||
13210192|NCT01925274|26247509|FG000|Overall Study|Death|1|||
13210193|NCT01925274|26247510|FG001|Overall Study|Death|0|||
13210194|NCT01925274|26247511|FG002|Overall Study|Death|0|||
13210195|NCT01925274|26247509|FG000|Overall Study|Lost to Follow-up|0|||
13210196|NCT01925274|26247510|FG001|Overall Study|Lost to Follow-up|1|||
13210197|NCT01925274|26247511|FG002|Overall Study|Lost to Follow-up|0|||
13210198|NCT01925274|26247509|FG000|Overall Study|Withdrawal by Subject|1|||
13210199|NCT01925274|26247510|FG001|Overall Study|Withdrawal by Subject|2|||
13210200|NCT01925274|26247511|FG002|Overall Study|Withdrawal by Subject|0|||
13210201|NCT01925274|26247509|FG000|Overall Study|Study terminated by sponsor|4|||
13210202|NCT01925274|26247510|FG001|Overall Study|Study terminated by sponsor|0|||
13210203|NCT01925274|26247511|FG002|Overall Study|Study terminated by sponsor|0|||
13210204|NCT01925274|26247509|FG000|Overall Study|Protocol amendment|1|||
13210205|NCT01925274|26247510|FG001|Overall Study|Protocol amendment|3|||
13210206|NCT01925274|26247511|FG002|Overall Study|Protocol amendment|6|||
13210207|NCT01925209|26247554|FG000|Treatment Epoch|Physician Decision|1|||
13210208|NCT01925209|26247555|FG001|Treatment Epoch|Physician Decision|0|||
13210209|NCT01925209|26247556|FG002|Treatment Epoch|Physician Decision|0|||
13210210|NCT01925209|26247557|FG003|Treatment Epoch|Physician Decision|0|||
13210211|NCT01925209|26247554|FG000|Treatment Epoch|Non-compliance with study treatment|0|||
13210212|NCT01925209|26247555|FG001|Treatment Epoch|Non-compliance with study treatment|0|||
13210213|NCT01925209|26247556|FG002|Treatment Epoch|Non-compliance with study treatment|0|||
13210214|NCT01925209|26247557|FG003|Treatment Epoch|Non-compliance with study treatment|1|||
13210215|NCT01925209|26247554|FG000|Treatment Epoch|Death|1|||
13210216|NCT01925209|26247555|FG001|Treatment Epoch|Death|0|||
13210217|NCT01925209|26247556|FG002|Treatment Epoch|Death|0|||
13210218|NCT01925209|26247557|FG003|Treatment Epoch|Death|0|||
13210219|NCT01925209|26247554|FG000|Treatment Epoch|Protocol deviation|0|||
13210220|NCT01925209|26247555|FG001|Treatment Epoch|Protocol deviation|0|||
13210221|NCT01925209|26247556|FG002|Treatment Epoch|Protocol deviation|1|||
13210222|NCT01925209|26247557|FG003|Treatment Epoch|Protocol deviation|1|||
13210223|NCT01925209|26247554|FG000|Treatment Epoch|Withdrawal by Subject|4|||
13210224|NCT01925209|26247555|FG001|Treatment Epoch|Withdrawal by Subject|3|||
13210225|NCT01925209|26247556|FG002|Treatment Epoch|Withdrawal by Subject|3|||
13210226|NCT01925209|26247557|FG003|Treatment Epoch|Withdrawal by Subject|2|||
13210227|NCT01925209|26247554|FG000|Treatment Epoch|Adverse Event|3|||
13210228|NCT01925209|26247555|FG001|Treatment Epoch|Adverse Event|5|||
13210229|NCT01925209|26247556|FG002|Treatment Epoch|Adverse Event|3|||
13210230|NCT01925209|26247557|FG003|Treatment Epoch|Adverse Event|1|||
13210231|NCT01925209|26247554|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0|||
13210232|NCT01925209|26247555|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
13210233|NCT01925209|26247556|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
13210234|NCT01925209|26247557|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2|||
13210235|NCT01925209|26247554|FG000|Maintenance Treatment Epoch|Adverse Event|0|||
13210236|NCT01925209|26247555|FG001|Maintenance Treatment Epoch|Adverse Event|0|||
13210237|NCT01925209|26247556|FG002|Maintenance Treatment Epoch|Adverse Event|1|||
13210238|NCT01925209|26247557|FG003|Maintenance Treatment Epoch|Adverse Event|0|||
13210239|NCT01925209|26247554|FG000|Follow-up|Adverse Event|1|||
13210240|NCT01925209|26247555|FG001|Follow-up|Adverse Event|4|||
13210241|NCT01925209|26247556|FG002|Follow-up|Adverse Event|0|||
13210242|NCT01925209|26247557|FG003|Follow-up|Adverse Event|1|||
13210243|NCT01925209|26247554|FG000|Follow-up|Physician Decision|0|||
13210244|NCT01925209|26247555|FG001|Follow-up|Physician Decision|0|||
13210245|NCT01925209|26247556|FG002|Follow-up|Physician Decision|1|||
13210246|NCT01925209|26247557|FG003|Follow-up|Physician Decision|0|||
13210247|NCT01925209|26247554|FG000|Follow-up|Non-compliance with study treatment|0|||
13210248|NCT01925209|26247555|FG001|Follow-up|Non-compliance with study treatment|0|||
13210249|NCT01925209|26247556|FG002|Follow-up|Non-compliance with study treatment|0|||
13210250|NCT01925209|26247557|FG003|Follow-up|Non-compliance with study treatment|1|||
13210251|NCT01925209|26247554|FG000|Follow-up|Withdrawal by Subject|0|||
13210252|NCT01925209|26247555|FG001|Follow-up|Withdrawal by Subject|2|||
13210253|NCT01925209|26247556|FG002|Follow-up|Withdrawal by Subject|0|||
13210254|NCT01925209|26247557|FG003|Follow-up|Withdrawal by Subject|2|||
13210255|NCT01925183|26247572|FG000|Overall Study|Adverse Event|1|||
13210256|NCT01925183|26247573|FG001|Overall Study|Adverse Event|0|||
13210257|NCT01925170|26247593|FG000|Overall Study|Unverified cancer status|53|||
13210258|NCT01925014|26247634|FG000|Overall Study|Inappropriate enrollment|4|||
13210259|NCT01925014|26247635|FG001|Overall Study|Inappropriate enrollment|6|||
13210260|NCT01925014|26247634|FG000|Overall Study|Withdrawal by Subject|5|||
13210261|NCT01925014|26247635|FG001|Overall Study|Withdrawal by Subject|13|||
13210262|NCT01924845|26247645|FG000|Overall Study|Adverse Event|3|||
13210263|NCT01924845|26247645|FG000|Overall Study|Withdrawal by Subject|2|||
13210264|NCT01924845|26247645|FG000|Overall Study|Protocol Violation|1|||
13210265|NCT01924806|26247664|FG000|Overall Study|Physician Decision|2|||
13210266|NCT01924806|26247665|FG001|Overall Study|Physician Decision|1|||
13210267|NCT01924767|26247781|FG000|Overall Study|Adverse Event|1|||
13210268|NCT01924767|26247782|FG001|Overall Study|Adverse Event|0|||
13210269|NCT01924767|26247783|FG002|Overall Study|Adverse Event|1|||
13210270|NCT01924767|26247784|FG003|Overall Study|Adverse Event|0|||
13210271|NCT01924767|26247785|FG004|Overall Study|Adverse Event|0|||
13210272|NCT01924754|26247829|FG000|Overall Study|Lost to Follow-up|1|||
13210273|NCT01924754|26247830|FG001|Overall Study|Lost to Follow-up|2|||
13210274|NCT01924754|26247831|FG002|Overall Study|Lost to Follow-up|1|||
13210275|NCT01924754|26247829|FG000|Overall Study|Pregnancy|0|||
13210276|NCT01924754|26247830|FG001|Overall Study|Pregnancy|1|||
13210277|NCT01924754|26247831|FG002|Overall Study|Pregnancy|2|||
13210278|NCT01924689|26247908|FG000|Overall Study|Death|0|||
13210279|NCT01924689|26247909|FG001|Overall Study|Death|1|||
13210280|NCT01924689|26247910|FG002|Overall Study|Death|0|||
13210281|NCT01924689|26247911|FG003|Overall Study|Death|1|||
13210282|NCT01924689|26247912|FG004|Overall Study|Death|0|||
13210283|NCT01924689|26247913|FG005|Overall Study|Death|0|||
13210284|NCT01924689|26247908|FG000|Overall Study|Disease progression|0|||
13210285|NCT01924689|26247909|FG001|Overall Study|Disease progression|0|||
13210286|NCT01924689|26247910|FG002|Overall Study|Disease progression|2|||
13210287|NCT01924689|26247911|FG003|Overall Study|Disease progression|0|||
13210288|NCT01924689|26247912|FG004|Overall Study|Disease progression|3|||
13210289|NCT01924689|26247913|FG005|Overall Study|Disease progression|2|||
13210290|NCT01924689|26247908|FG000|Overall Study|New therapy or study|3|||
13210291|NCT01924689|26247909|FG001|Overall Study|New therapy or study|2|||
13210292|NCT01924689|26247910|FG002|Overall Study|New therapy or study|1|||
13210293|NCT01924689|26247911|FG003|Overall Study|New therapy or study|4|||
13210294|NCT01924689|26247912|FG004|Overall Study|New therapy or study|2|||
13210295|NCT01924689|26247913|FG005|Overall Study|New therapy or study|0|||
13210296|NCT01924689|26247908|FG000|Overall Study|Withdrawal of consent|0|||
13210297|NCT01924689|26247909|FG001|Overall Study|Withdrawal of consent|0|||
13210298|NCT01924689|26247910|FG002|Overall Study|Withdrawal of consent|1|||
13210299|NCT01924689|26247911|FG003|Overall Study|Withdrawal of consent|1|||
13210300|NCT01924689|26247912|FG004|Overall Study|Withdrawal of consent|0|||
13210301|NCT01924689|26247913|FG005|Overall Study|Withdrawal of consent|0|||
13210302|NCT01924689|26247908|FG000|Overall Study|Other|0|||
13210303|NCT01924689|26247909|FG001|Overall Study|Other|0|||
13210304|NCT01924689|26247910|FG002|Overall Study|Other|0|||
13210305|NCT01924689|26247911|FG003|Overall Study|Other|0|||
13210306|NCT01924689|26247912|FG004|Overall Study|Other|1|||
13210307|NCT01924689|26247913|FG005|Overall Study|Other|0|||
13210308|NCT01924429|26247950|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3|||
13210309|NCT01924429|26247951|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
13210310|NCT01924364|26247968|FG000|Overall Study|Physician Decision|3|||
13210311|NCT01924299|26247995|FG000|Period 2|Withdrawal by Subject|1|||
13210312|NCT01924299|26247996|FG001|Period 2|Withdrawal by Subject|0|||
13210313|NCT01924299|26247995|FG000|Period 2|Adverse Event|0|||
13210314|NCT01924299|26247996|FG001|Period 2|Adverse Event|1|||
13210315|NCT01924182|26248015|FG000|Overall Study|Withdrawal by Subject|1|||
13210316|NCT01924182|26248016|FG001|Overall Study|Withdrawal by Subject|0|||
13210317|NCT01923896|26248035|FG000|Overall Study|Adverse Event|1|||
13210318|NCT01923896|26248036|FG001|Overall Study|Adverse Event|0|||
13210319|NCT01923740|26248305|FG000|Overall Study|Lost to Follow-up|4|||
13210320|NCT01923740|26248306|FG001|Overall Study|Lost to Follow-up|9|||
13210321|NCT01923740|26248305|FG000|Overall Study|Withdrawal by Subject|2|||
13210322|NCT01923740|26248306|FG001|Overall Study|Withdrawal by Subject|0|||
13210323|NCT01923467|26248312|FG000|Overall Study|Lost to Follow-up|62|||
13210324|NCT01923467|26248312|FG000|Overall Study|Subject non-interest|479|||
13210325|NCT01923428|26248335|FG000|Overall Study|Adverse Event|8|||
13210326|NCT01923428|26248336|FG001|Overall Study|Adverse Event|6|||
13210327|NCT01923428|26248337|FG002|Overall Study|Adverse Event|3|||
13210328|NCT01923428|26248338|FG003|Overall Study|Adverse Event|3|||
13210329|NCT01923428|26248335|FG000|Overall Study|Withdrawal by Subject|5|||
13210330|NCT01923428|26248336|FG001|Overall Study|Withdrawal by Subject|3|||
13210331|NCT01923428|26248337|FG002|Overall Study|Withdrawal by Subject|0|||
13210332|NCT01923428|26248338|FG003|Overall Study|Withdrawal by Subject|4|||
13210333|NCT01923428|26248335|FG000|Overall Study|Lost to Follow-up|2|||
13210334|NCT01923428|26248336|FG001|Overall Study|Lost to Follow-up|1|||
13210335|NCT01923428|26248337|FG002|Overall Study|Lost to Follow-up|5|||
13210336|NCT01923428|26248338|FG003|Overall Study|Lost to Follow-up|0|||
13210337|NCT01923428|26248335|FG000|Overall Study|Protocol Violation|3|||
13210338|NCT01923428|26248336|FG001|Overall Study|Protocol Violation|0|||
13210339|NCT01923428|26248337|FG002|Overall Study|Protocol Violation|2|||
13210340|NCT01923428|26248338|FG003|Overall Study|Protocol Violation|1|||
13210341|NCT01923428|26248335|FG000|Overall Study|Non Compliance to treatment|1|||
13210342|NCT01923428|26248336|FG001|Overall Study|Non Compliance to treatment|2|||
13210343|NCT01923428|26248337|FG002|Overall Study|Non Compliance to treatment|0|||
13210344|NCT01923428|26248338|FG003|Overall Study|Non Compliance to treatment|1|||
13210345|NCT01923428|26248335|FG000|Overall Study|Lack of Efficacy|0|||
13210346|NCT01923428|26248336|FG001|Overall Study|Lack of Efficacy|0|||
13210347|NCT01923428|26248337|FG002|Overall Study|Lack of Efficacy|1|||
13210348|NCT01923428|26248338|FG003|Overall Study|Lack of Efficacy|1|||
13210349|NCT01923389|26248367|FG000|Overall Study|Protocol Violation|1|||
13210350|NCT01923389|26248368|FG001|Overall Study|Protocol Violation|0|||
13210351|NCT01923363|26248377|FG000|Overall Study|Protocol Violation|1|||
13210352|NCT01923311|26248427|FG000|Overall Study|Pregnancy|1|||
13210353|NCT01923311|26248428|FG001|Overall Study|Pregnancy|0|||
13210354|NCT01923311|26248427|FG000|Overall Study|Investigator's Discretion|1|||
13210355|NCT01923311|26248428|FG001|Overall Study|Investigator's Discretion|0|||
13210356|NCT01923311|26248427|FG000|Overall Study|Non-Compliance with Study Drug|2|||
13210357|NCT01923311|26248428|FG001|Overall Study|Non-Compliance with Study Drug|1|||
13210358|NCT01923311|26248427|FG000|Overall Study|Withdrew Consent|1|||
13210359|NCT01923311|26248428|FG001|Overall Study|Withdrew Consent|0|||
13210360|NCT01923311|26248427|FG000|Overall Study|Study Terminated by Sponsor|12|||
13210361|NCT01923311|26248428|FG001|Overall Study|Study Terminated by Sponsor|0|||
13210362|NCT01923285|26248447|FG000|Overall Study|Withdrawal by Subject|7|||
13210363|NCT01923285|26248448|FG001|Overall Study|Withdrawal by Subject|6|||
13210364|NCT01923181|26248551|FG000|Overall Study|Protocol Violation|2|||
13210365|NCT01923181|26248552|FG001|Overall Study|Protocol Violation|2|||
13210366|NCT01923181|26248553|FG002|Overall Study|Protocol Violation|0|||
13210367|NCT01923181|26248554|FG003|Overall Study|Protocol Violation|2|||
13210368|NCT01923181|26248555|FG004|Overall Study|Protocol Violation|2|||
13210369|NCT01923181|26248556|FG005|Overall Study|Protocol Violation|1|||
13210370|NCT01923181|26248557|FG006|Overall Study|Protocol Violation|1|||
13210371|NCT01923181|26248558|FG007|Overall Study|Protocol Violation|2|||
13210372|NCT01923181|26248559|FG008|Overall Study|Protocol Violation|1|||
13210373|NCT01923181|26248551|FG000|Overall Study|Withdrawal by Subject|0|||
13210374|NCT01923181|26248552|FG001|Overall Study|Withdrawal by Subject|1|||
13210375|NCT01923181|26248553|FG002|Overall Study|Withdrawal by Subject|0|||
13210376|NCT01923181|26248554|FG003|Overall Study|Withdrawal by Subject|1|||
13210377|NCT01923181|26248555|FG004|Overall Study|Withdrawal by Subject|4|||
13210378|NCT01923181|26248556|FG005|Overall Study|Withdrawal by Subject|2|||
13210379|NCT01923181|26248557|FG006|Overall Study|Withdrawal by Subject|4|||
13210380|NCT01923181|26248558|FG007|Overall Study|Withdrawal by Subject|3|||
13210381|NCT01923181|26248559|FG008|Overall Study|Withdrawal by Subject|1|||
13210382|NCT01923181|26248551|FG000|Overall Study|Other|1|||
13210383|NCT01923181|26248552|FG001|Overall Study|Other|0|||
13210384|NCT01923181|26248553|FG002|Overall Study|Other|0|||
13210385|NCT01923181|26248554|FG003|Overall Study|Other|1|||
13210386|NCT01923181|26248555|FG004|Overall Study|Other|0|||
13210387|NCT01923181|26248556|FG005|Overall Study|Other|0|||
13210388|NCT01923181|26248557|FG006|Overall Study|Other|0|||
13210389|NCT01923181|26248558|FG007|Overall Study|Other|0|||
13210390|NCT01923181|26248559|FG008|Overall Study|Other|0|||
13210391|NCT01923181|26248551|FG000|Overall Study|Lost to Follow-up|0|||
13210392|NCT01923181|26248552|FG001|Overall Study|Lost to Follow-up|3|||
13210393|NCT01923181|26248553|FG002|Overall Study|Lost to Follow-up|2|||
13210394|NCT01923181|26248554|FG003|Overall Study|Lost to Follow-up|1|||
13210395|NCT01923181|26248555|FG004|Overall Study|Lost to Follow-up|2|||
13210396|NCT01923181|26248556|FG005|Overall Study|Lost to Follow-up|1|||
13210397|NCT01923181|26248557|FG006|Overall Study|Lost to Follow-up|3|||
13210398|NCT01923181|26248558|FG007|Overall Study|Lost to Follow-up|3|||
13210399|NCT01923181|26248559|FG008|Overall Study|Lost to Follow-up|1|||
13210400|NCT01922934|26248576|FG000|Eligible Patients|Death|0|||
13210401|NCT01922934|26248577|FG001|Eligible Patients|Death|7|||
13210402|NCT01922934|26248576|FG000|Eligible Patients|Physician Decision|17|||
13210403|NCT01922934|26248577|FG001|Eligible Patients|Physician Decision|0|||
13210404|NCT01922934|26248576|FG000|Eligible Patients|Did not meet inclusion criteria|36|||
13210405|NCT01922934|26248577|FG001|Eligible Patients|Did not meet inclusion criteria|81|||
13210406|NCT01922934|26248576|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169|||
13210407|NCT01922934|26248577|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0|||
13210408|NCT01922934|26248576|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66|||
13210409|NCT01922934|26248577|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0|||
13210410|NCT01922934|26248576|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21|||
13210411|NCT01922934|26248577|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284|||
13210412|NCT01922895|26248594|FG000|Overall Study|Death|0|||
13210413|NCT01922895|26248595|FG001|Overall Study|Death|1|||
13210414|NCT01922895|26248594|FG000|Overall Study|Withdrawal by Subject|1|||
13210415|NCT01922895|26248595|FG001|Overall Study|Withdrawal by Subject|2|||
13210416|NCT01922895|26248594|FG000|Overall Study|Lost to Follow-up|5|||
13210417|NCT01922895|26248595|FG001|Overall Study|Lost to Follow-up|11|||
13210418|NCT01922739|26248626|FG000|Titration/Adjustment Period|Adverse Event|3|||
13210419|NCT01922739|26248626|FG000|Titration/Adjustment Period|Withdrawal by Subject|5|||
13210420|NCT01922739|26248626|FG000|Titration/Adjustment Period|Lost to Follow-up|1|||
13210421|NCT01922739|26248626|FG000|Titration/Adjustment Period|Lack of Efficacy|3|||
13210422|NCT01922739|26248626|FG000|Open-label Treatment Period|Adverse Event|6|||
13210423|NCT01922739|26248626|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
13210424|NCT01922739|26248626|FG000|Open-label Treatment Period|Noncompliance to study medication|3|||
13210425|NCT01922739|26248626|FG000|Open-label Treatment Period|Protocol Violation|5|||
13210426|NCT01922739|26248626|FG000|Open-label Treatment Period|Pregnancy|1|||
13210427|NCT01922739|26248626|FG000|Open-label Treatment Period|Noncompliance to study procedures|1|||
13210428|NCT01922739|26248626|FG000|Open-label Treatment Period|Lost to Follow-up|2|||
13210429|NCT01922739|26248626|FG000|Open-label Treatment Period|Physician Decision|1|||
13210430|NCT01922739|26248626|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1|||
13210431|NCT01922349|26248744|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
13210432|NCT01922349|26248745|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
13210433|NCT01922349|26248746|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
13210434|NCT01922349|26248747|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1|||
13210435|NCT01922271|26248772|FG000|WASHOUT Period|Withdrawal by Subject|1|||
13210436|NCT01922271|26248773|FG001|WASHOUT Period|Withdrawal by Subject|0|||
13210437|NCT01922258|26248788|FG000|Overall Study|Lost to Follow-up|1|||
13210438|NCT01922258|26248789|FG001|Overall Study|Lost to Follow-up|1|||
13210439|NCT01922258|26248788|FG000|Overall Study|Adverse Event|9|||
13210440|NCT01922258|26248789|FG001|Overall Study|Adverse Event|2|||
13210441|NCT01922258|26248788|FG000|Overall Study|Met Withdrawal Criteria|0|||
13210442|NCT01922258|26248789|FG001|Overall Study|Met Withdrawal Criteria|4|||
13210443|NCT01922258|26248788|FG000|Overall Study|Withdrawn by the Investigator|1|||
13210444|NCT01922258|26248789|FG001|Overall Study|Withdrawn by the Investigator|4|||
13210445|NCT01922258|26248788|FG000|Overall Study|Withdrawal by participant|5|||
13210446|NCT01922258|26248789|FG001|Overall Study|Withdrawal by participant|5|||
13210447|NCT01922102|26248833|FG000|Overall Study|Withdrawal by Subject|7|||
13210448|NCT01922102|26248834|FG001|Overall Study|Withdrawal by Subject|3|||
13210449|NCT01922102|26248835|FG002|Overall Study|Withdrawal by Subject|7|||
13210450|NCT01922102|26248833|FG000|Overall Study|Physician Decision|0|||
13210451|NCT01922102|26248834|FG001|Overall Study|Physician Decision|2|||
13210452|NCT01922102|26248835|FG002|Overall Study|Physician Decision|1|||
13210453|NCT01922102|26248833|FG000|Overall Study|Adverse Event|1|||
13210454|NCT01922102|26248834|FG001|Overall Study|Adverse Event|2|||
13210455|NCT01922102|26248835|FG002|Overall Study|Adverse Event|0|||
13210456|NCT01922102|26248833|FG000|Overall Study|Lost to Follow-up|1|||
13210457|NCT01922102|26248834|FG001|Overall Study|Lost to Follow-up|0|||
13210458|NCT01922102|26248835|FG002|Overall Study|Lost to Follow-up|0|||
13210459|NCT01922102|26248833|FG000|Overall Study|Administrative problems|0|||
13210460|NCT01922102|26248834|FG001|Overall Study|Administrative problems|2|||
13210461|NCT01922102|26248835|FG002|Overall Study|Administrative problems|0|||
13210462|NCT01922089|26248852|FG000|Overall Study|Adverse Event|18|||
13210463|NCT01922089|26248853|FG001|Overall Study|Adverse Event|13|||
13210464|NCT01922089|26248852|FG000|Overall Study|Protocol Deviation|10|||
13210465|NCT01922089|26248853|FG001|Overall Study|Protocol Deviation|7|||
13210466|NCT01922089|26248852|FG000|Overall Study|Withdrawal by Subject|3|||
13210467|NCT01922089|26248853|FG001|Overall Study|Withdrawal by Subject|4|||
13210468|NCT01922089|26248852|FG000|Overall Study|administrative problems|4|||
13210469|NCT01922089|26248853|FG001|Overall Study|administrative problems|1|||
13210470|NCT01922089|26248852|FG000|Overall Study|Physician Decision|2|||
13210471|NCT01922089|26248853|FG001|Overall Study|Physician Decision|3|||
13210472|NCT01922089|26248852|FG000|Overall Study|Death|2|||
13210473|NCT01922089|26248853|FG001|Overall Study|Death|1|||
13210474|NCT01922089|26248852|FG000|Overall Study|Lost to Follow-up|0|||
13210475|NCT01922089|26248853|FG001|Overall Study|Lost to Follow-up|1|||
13210476|NCT01922037|26248952|FG000|Overall Study|Withdrawal by Subject|2|||
13210477|NCT01922037|26248953|FG001|Overall Study|Withdrawal by Subject|44|||
13210478|NCT01922037|26248952|FG000|Overall Study|Adverse Event|1|||
13210479|NCT01922037|26248953|FG001|Overall Study|Adverse Event|7|||
13210480|NCT01922037|26248952|FG000|Overall Study|Death|0|||
13210481|NCT01922037|26248953|FG001|Overall Study|Death|5|||
13210482|NCT01922037|26248952|FG000|Overall Study|Pregnancy|0|||
13210483|NCT01922037|26248953|FG001|Overall Study|Pregnancy|2|||
13210484|NCT01922037|26248952|FG000|Overall Study|Participant non-compliance|4|||
13210485|NCT01922037|26248953|FG001|Overall Study|Participant non-compliance|46|||
13210486|NCT01922037|26248952|FG000|Overall Study|Investigator/Sponsor decision|1|||
13210487|NCT01922037|26248953|FG001|Overall Study|Investigator/Sponsor decision|4|||
13210488|NCT01922037|26248952|FG000|Overall Study|Other unspecified|2|||
13210489|NCT01922037|26248953|FG001|Overall Study|Other unspecified|66|||
13210490|NCT01922011|26249000|FG000|Overall Study|Protocol Violation|0|||
13210491|NCT01922011|26249001|FG001|Overall Study|Protocol Violation|1|||
13210492|NCT01922011|26249000|FG000|Overall Study|Physician Decision|0|||
13210493|NCT01922011|26249001|FG001|Overall Study|Physician Decision|1|||
13210494|NCT01922011|26249000|FG000|Overall Study|Parent/Guardian Decision|3|||
13210495|NCT01922011|26249001|FG001|Overall Study|Parent/Guardian Decision|0|||
13210496|NCT01922011|26249000|FG000|Overall Study|Lost to Follow-up|0|||
13210497|NCT01922011|26249001|FG001|Overall Study|Lost to Follow-up|1|||
13210498|NCT01922011|26249000|FG000|Overall Study|Missed Test-of-Cure Visit|0|||
13210499|NCT01922011|26249001|FG001|Overall Study|Missed Test-of-Cure Visit|2|||
13210500|NCT01922011|26249000|FG000|Overall Study|Not Treated|1|||
13210501|NCT01922011|26249001|FG001|Overall Study|Not Treated|0|||
13381983|NCT00748566|26749581|FG000|Overall Study|Death|1|||
13210502|NCT01922011|26249000|FG000|Overall Study|Lack of willing home health agency|1|||
13210503|NCT01922011|26249001|FG001|Overall Study|Lack of willing home health agency|0|||
13210504|NCT01922011|26249000|FG000|Overall Study|Randomized in error|1|||
13210505|NCT01922011|26249001|FG001|Overall Study|Randomized in error|0|||
13210506|NCT01921829|26249054|FG000|Overall Study|Withdrawal by Subject|0|||
13210507|NCT01921829|26249055|FG001|Overall Study|Withdrawal by Subject|1|||
13210508|NCT01921517|26249068|FG000|Overall Study|Lost to Follow-up|5|||
13210509|NCT01921517|26249069|FG001|Overall Study|Lost to Follow-up|0|||
13210510|NCT01921517|26249068|FG000|Overall Study|Newly diagnosed health concern|2|||
13210511|NCT01921517|26249069|FG001|Overall Study|Newly diagnosed health concern|0|||
13210512|NCT01921517|26249068|FG000|Overall Study|Physician Decision|0|||
13210513|NCT01921517|26249069|FG001|Overall Study|Physician Decision|2|||
13210514|NCT01921517|26249068|FG000|Overall Study|Withdrawal by Subject|7|||
13210515|NCT01921517|26249069|FG001|Overall Study|Withdrawal by Subject|3|||
13210516|NCT01921517|26249068|FG000|Overall Study|Subject missed final imaging|1|||
13210517|NCT01921517|26249069|FG001|Overall Study|Subject missed final imaging|4|||
13210518|NCT01921387|26249078|FG000|Overall Study|Adverse Event|1|||
13210519|NCT01921348|26249095|FG000|Overall Study|Withdrawal by Subject|1|||
13210520|NCT01921348|26249096|FG001|Overall Study|Withdrawal by Subject|0|||
13210521|NCT01921348|26249095|FG000|Overall Study|Lost to Follow-up|0|||
13210522|NCT01921348|26249096|FG001|Overall Study|Lost to Follow-up|2|||
13210523|NCT01921270|26249114|FG000|Overall Study|Withdrawal by Subject|1|||
13210524|NCT01921257|26249121|FG000|Overall Study|Adverse Event|1|||
13210525|NCT01921257|26249121|FG000|Overall Study|Protocol Violation|1|||
13210526|NCT01921257|26249121|FG000|Overall Study|Withdrawal by Subject|1|||
13210527|NCT01921205|26249156|FG000|Overall Study|Adverse Event|12|||
13210528|NCT01921205|26249157|FG001|Overall Study|Adverse Event|7|||
13210529|NCT01921205|26249156|FG000|Overall Study|Lack of Efficacy|1|||
13210530|NCT01921205|26249157|FG001|Overall Study|Lack of Efficacy|0|||
13210531|NCT01921205|26249156|FG000|Overall Study|Protocol Violation|1|||
13210532|NCT01921205|26249157|FG001|Overall Study|Protocol Violation|3|||
13210533|NCT01921205|26249156|FG000|Overall Study|Lost to Follow-up|1|||
13210534|NCT01921205|26249157|FG001|Overall Study|Lost to Follow-up|1|||
13210535|NCT01921205|26249156|FG000|Overall Study|Withdrawal by Subject|6|||
13210536|NCT01921205|26249157|FG001|Overall Study|Withdrawal by Subject|5|||
13210537|NCT01921205|26249156|FG000|Overall Study|Use Of Prohibited Medication|0|||
13210538|NCT01921205|26249157|FG001|Overall Study|Use Of Prohibited Medication|1|||
13210539|NCT01921205|26249156|FG000|Overall Study|The Excessive Use Of Rescue Medication|0|||
13210540|NCT01921205|26249157|FG001|Overall Study|The Excessive Use Of Rescue Medication|1|||
13210541|NCT01921205|26249156|FG000|Overall Study|Non Compliance Of The Parent|0|||
13210542|NCT01921205|26249157|FG001|Overall Study|Non Compliance Of The Parent|1|||
13210543|NCT01921205|26249156|FG000|Overall Study|Non Compliance Of Child|0|||
13210544|NCT01921205|26249157|FG001|Overall Study|Non Compliance Of Child|1|||
13210545|NCT01921179|26249177|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
13210546|NCT01921179|26249178|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
13210547|NCT01921179|26249177|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2|||
13210548|NCT01921179|26249178|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0|||
13210549|NCT01921101|26249193|FG000|Overall Study|Death|16|||
13210550|NCT01921101|26249194|FG001|Overall Study|Death|6|||
13210551|NCT01920958|26249212|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5|||
13210552|NCT01920932|26249262|FG000|Overall Study|Death|1|||
13210553|NCT01920932|26249262|FG000|Overall Study|Withdrawal of consent|1|||
13210554|NCT01920893|26249295|FG000|Overall Study|Adverse Event|5|||
13210555|NCT01920893|26249296|FG001|Overall Study|Adverse Event|2|||
13210556|NCT01920893|26249295|FG000|Overall Study|Lack of Efficacy|2|||
13210557|NCT01920893|26249296|FG001|Overall Study|Lack of Efficacy|0|||
13210558|NCT01920854|26249442|FG000|Overall Study|Withdrawal by Subject|1|||
13210559|NCT01920854|26249443|FG001|Overall Study|Withdrawal by Subject|0|||
13210560|NCT01920854|26249444|FG002|Overall Study|Withdrawal by Subject|0|||
13210561|NCT01920854|26249445|FG003|Overall Study|Withdrawal by Subject|0|||
13210562|NCT01920854|26249446|FG004|Overall Study|Withdrawal by Subject|1|||
13210563|NCT01920854|26249447|FG005|Overall Study|Withdrawal by Subject|0|||
13210564|NCT01920854|26249448|FG006|Overall Study|Withdrawal by Subject|1|||
13210565|NCT01920711|26249470|FG000|Overall Study|Death|347|||
13210566|NCT01920711|26249471|FG001|Overall Study|Death|356|||
13210567|NCT01920711|26249470|FG000|Overall Study|Lost to Follow-up|13|||
13210568|NCT01920711|26249471|FG001|Overall Study|Lost to Follow-up|14|||
13210569|NCT01920711|26249470|FG000|Overall Study|Withdrawal by Subject|4|||
13210570|NCT01920711|26249471|FG001|Overall Study|Withdrawal by Subject|3|||
13210571|NCT01920594|26249526|FG000|Overall Study|Adverse Event|4|||
13210572|NCT01920594|26249527|FG001|Overall Study|Adverse Event|2|||
13210573|NCT01920594|26249526|FG000|Overall Study|Lost to Follow-up|1|||
13210574|NCT01920594|26249527|FG001|Overall Study|Lost to Follow-up|0|||
13210575|NCT01920594|26249526|FG000|Overall Study|Recovery|2|||
13210576|NCT01920594|26249527|FG001|Overall Study|Recovery|0|||
13210577|NCT01920594|26249526|FG000|Overall Study|Investigator discretion|0|||
13210578|NCT01920594|26249527|FG001|Overall Study|Investigator discretion|1|||
13210579|NCT01920568|26249555|FG000|Overall Study|Adverse Event|27|||
13210580|NCT01920568|26249556|FG001|Overall Study|Adverse Event|8|||
13210581|NCT01920568|26249555|FG000|Overall Study|Protocol Violation|5|||
13210582|NCT01920568|26249556|FG001|Overall Study|Protocol Violation|3|||
13210583|NCT01920568|26249555|FG000|Overall Study|Lost to Follow-up|2|||
13210584|NCT01920568|26249556|FG001|Overall Study|Lost to Follow-up|2|||
13210585|NCT01920568|26249555|FG000|Overall Study|Physician Decision|13|||
13210586|NCT01920568|26249556|FG001|Overall Study|Physician Decision|4|||
13210587|NCT01920568|26249555|FG000|Overall Study|Withdrawal by Subject|79|||
13210588|NCT01920568|26249556|FG001|Overall Study|Withdrawal by Subject|55|||
13210589|NCT01920568|26249555|FG000|Overall Study|Death due to disease progression|25|||
13210590|NCT01920568|26249556|FG001|Overall Study|Death due to disease progression|12|||
13210591|NCT01920555|26249629|FG000|Overall Study|Physician Decision|1|||
13210592|NCT01920555|26249630|FG001|Overall Study|Physician Decision|2|||
13210593|NCT01920555|26249631|FG002|Overall Study|Physician Decision|1|||
13210594|NCT01920555|26249632|FG003|Overall Study|Physician Decision|2|||
13210595|NCT01920555|26249633|FG004|Overall Study|Physician Decision|0|||
13210596|NCT01920555|26249629|FG000|Overall Study|Lack of Efficacy|2|||
13210597|NCT01920555|26249630|FG001|Overall Study|Lack of Efficacy|0|||
13210598|NCT01920555|26249631|FG002|Overall Study|Lack of Efficacy|0|||
13210599|NCT01920555|26249632|FG003|Overall Study|Lack of Efficacy|0|||
13210600|NCT01920555|26249633|FG004|Overall Study|Lack of Efficacy|0|||
13210601|NCT01920555|26249629|FG000|Overall Study|Travel Difficulties|1|||
13210602|NCT01920555|26249630|FG001|Overall Study|Travel Difficulties|1|||
13210603|NCT01920555|26249631|FG002|Overall Study|Travel Difficulties|0|||
13210604|NCT01920555|26249632|FG003|Overall Study|Travel Difficulties|0|||
13210605|NCT01920555|26249633|FG004|Overall Study|Travel Difficulties|1|||
13210606|NCT01920555|26249629|FG000|Overall Study|Lost to Follow-up|0|||
13210607|NCT01920555|26249630|FG001|Overall Study|Lost to Follow-up|1|||
13210608|NCT01920555|26249631|FG002|Overall Study|Lost to Follow-up|0|||
13210609|NCT01920555|26249632|FG003|Overall Study|Lost to Follow-up|1|||
13210610|NCT01920555|26249633|FG004|Overall Study|Lost to Follow-up|0|||
13210611|NCT01920477|26249671|FG000|Overall Study|Adverse Event|0|||
13210612|NCT01920477|26249672|FG001|Overall Study|Adverse Event|1|||
13210613|NCT01920477|26249671|FG000|Overall Study|Lack of Efficacy|1|||
13210614|NCT01920477|26249672|FG001|Overall Study|Lack of Efficacy|0|||
13210615|NCT01920477|26249671|FG000|Overall Study|Study closed/terminated|14|||
13210616|NCT01920477|26249672|FG001|Overall Study|Study closed/terminated|15|||
13210617|NCT01920477|26249671|FG000|Overall Study|Withdrawal by Subject|0|||
13210618|NCT01920477|26249672|FG001|Overall Study|Withdrawal by Subject|1|||
13210619|NCT01920178|26249689|FG000|Overall Study|Lost to Follow-up|2|||
13210620|NCT01920178|26249690|FG001|Overall Study|Lost to Follow-up|1|||
13210621|NCT01920152|26249733|FG000|Overall Study|Withdrawal by Subject|1|||
13210622|NCT01920152|26249734|FG001|Overall Study|Withdrawal by Subject|2|||
13210623|NCT01920061|26250296|FG000|Overall Study|Death|1|||
13210624|NCT01920061|26250297|FG001|Overall Study|Death|1|||
13210625|NCT01920061|26250298|FG002|Overall Study|Death|0|||
13210626|NCT01920061|26250299|FG003|Overall Study|Death|1|||
13210627|NCT01920061|26250300|FG004|Overall Study|Death|1|||
13210628|NCT01920061|26250301|FG005|Overall Study|Death|0|||
13210629|NCT01920061|26250302|FG006|Overall Study|Death|0|||
13210630|NCT01920061|26250303|FG007|Overall Study|Death|1|||
13210631|NCT01920061|26250304|FG008|Overall Study|Death|0|||
13210632|NCT01920061|26250305|FG009|Overall Study|Death|1|||
13210633|NCT01920061|26250306|FG010|Overall Study|Death|0|||
13210634|NCT01920061|26250307|FG011|Overall Study|Death|1|||
13210635|NCT01920061|26250308|FG012|Overall Study|Death|0|||
13210636|NCT01920061|26250309|FG013|Overall Study|Death|2|||
13210637|NCT01920061|26250310|FG014|Overall Study|Death|0|||
13210638|NCT01920061|26250311|FG015|Overall Study|Death|0|||
13210639|NCT01920061|26250312|FG016|Overall Study|Death|0|||
13210640|NCT01920061|26250313|FG017|Overall Study|Death|0|||
13210641|NCT01920061|26250314|FG018|Overall Study|Death|1|||
13210642|NCT01920061|26250315|FG019|Overall Study|Death|0|||
13210643|NCT01920061|26250296|FG000|Overall Study|Lost to Follow-up|0|||
13210644|NCT01920061|26250297|FG001|Overall Study|Lost to Follow-up|2|||
13210645|NCT01920061|26250298|FG002|Overall Study|Lost to Follow-up|0|||
13210646|NCT01920061|26250299|FG003|Overall Study|Lost to Follow-up|0|||
13210647|NCT01920061|26250300|FG004|Overall Study|Lost to Follow-up|0|||
13210648|NCT01920061|26250301|FG005|Overall Study|Lost to Follow-up|0|||
13210649|NCT01920061|26250302|FG006|Overall Study|Lost to Follow-up|1|||
13210650|NCT01920061|26250303|FG007|Overall Study|Lost to Follow-up|0|||
13210651|NCT01920061|26250304|FG008|Overall Study|Lost to Follow-up|0|||
13210652|NCT01920061|26250305|FG009|Overall Study|Lost to Follow-up|0|||
13210653|NCT01920061|26250306|FG010|Overall Study|Lost to Follow-up|3|||
13210654|NCT01920061|26250307|FG011|Overall Study|Lost to Follow-up|0|||
13210655|NCT01920061|26250308|FG012|Overall Study|Lost to Follow-up|0|||
13210656|NCT01920061|26250309|FG013|Overall Study|Lost to Follow-up|0|||
13210657|NCT01920061|26250310|FG014|Overall Study|Lost to Follow-up|0|||
13210658|NCT01920061|26250311|FG015|Overall Study|Lost to Follow-up|0|||
13210659|NCT01920061|26250312|FG016|Overall Study|Lost to Follow-up|0|||
13210660|NCT01920061|26250313|FG017|Overall Study|Lost to Follow-up|1|||
13210661|NCT01920061|26250314|FG018|Overall Study|Lost to Follow-up|4|||
13210662|NCT01920061|26250315|FG019|Overall Study|Lost to Follow-up|3|||
13210663|NCT01920061|26250296|FG000|Overall Study|Other|1|||
13210664|NCT01920061|26250297|FG001|Overall Study|Other|1|||
13210665|NCT01920061|26250298|FG002|Overall Study|Other|2|||
13210666|NCT01920061|26250299|FG003|Overall Study|Other|1|||
13210667|NCT01920061|26250300|FG004|Overall Study|Other|0|||
13210668|NCT01920061|26250301|FG005|Overall Study|Other|1|||
13210669|NCT01920061|26250302|FG006|Overall Study|Other|0|||
13210670|NCT01920061|26250303|FG007|Overall Study|Other|0|||
13210671|NCT01920061|26250304|FG008|Overall Study|Other|0|||
13210672|NCT01920061|26250305|FG009|Overall Study|Other|1|||
13210673|NCT01920061|26250306|FG010|Overall Study|Other|1|||
13210674|NCT01920061|26250307|FG011|Overall Study|Other|2|||
13210675|NCT01920061|26250308|FG012|Overall Study|Other|1|||
13210676|NCT01920061|26250309|FG013|Overall Study|Other|4|||
13210677|NCT01920061|26250310|FG014|Overall Study|Other|0|||
13210678|NCT01920061|26250311|FG015|Overall Study|Other|1|||
13210679|NCT01920061|26250312|FG016|Overall Study|Other|1|||
13210680|NCT01920061|26250313|FG017|Overall Study|Other|0|||
13210681|NCT01920061|26250314|FG018|Overall Study|Other|1|||
13210682|NCT01920061|26250315|FG019|Overall Study|Other|1|||
13210683|NCT01920061|26250296|FG000|Overall Study|Participant refused further follow-up|0|||
13210684|NCT01920061|26250297|FG001|Overall Study|Participant refused further follow-up|0|||
13210685|NCT01920061|26250298|FG002|Overall Study|Participant refused further follow-up|0|||
13210686|NCT01920061|26250299|FG003|Overall Study|Participant refused further follow-up|0|||
13210687|NCT01920061|26250300|FG004|Overall Study|Participant refused further follow-up|1|||
13210688|NCT01920061|26250301|FG005|Overall Study|Participant refused further follow-up|1|||
13210689|NCT01920061|26250302|FG006|Overall Study|Participant refused further follow-up|0|||
13210690|NCT01920061|26250303|FG007|Overall Study|Participant refused further follow-up|0|||
13210691|NCT01920061|26250304|FG008|Overall Study|Participant refused further follow-up|1|||
13210692|NCT01920061|26250305|FG009|Overall Study|Participant refused further follow-up|0|||
13210693|NCT01920061|26250306|FG010|Overall Study|Participant refused further follow-up|1|||
13210694|NCT01920061|26250307|FG011|Overall Study|Participant refused further follow-up|0|||
13210695|NCT01920061|26250308|FG012|Overall Study|Participant refused further follow-up|1|||
13210696|NCT01920061|26250309|FG013|Overall Study|Participant refused further follow-up|0|||
13210697|NCT01920061|26250310|FG014|Overall Study|Participant refused further follow-up|1|||
13210698|NCT01920061|26250311|FG015|Overall Study|Participant refused further follow-up|2|||
13210699|NCT01920061|26250312|FG016|Overall Study|Participant refused further follow-up|1|||
13210700|NCT01920061|26250313|FG017|Overall Study|Participant refused further follow-up|1|||
13210701|NCT01920061|26250314|FG018|Overall Study|Participant refused further follow-up|0|||
13210702|NCT01920061|26250315|FG019|Overall Study|Participant refused further follow-up|0|||
13210703|NCT01919970|26250330|FG000|Overall Study|Withdrawal by Subject|3|||
13210704|NCT01919970|26250331|FG001|Overall Study|Withdrawal by Subject|0|||
13210705|NCT01919814|26250344|FG000|Overall Study|Adverse Event|1|||
13210706|NCT01919814|26250345|FG001|Overall Study|Adverse Event|0|||
13210707|NCT01919814|26250344|FG000|Overall Study|Protocol Violation|1|||
13210708|NCT01919814|26250345|FG001|Overall Study|Protocol Violation|0|||
13210709|NCT01919814|26250344|FG000|Overall Study|Withdrawal by Subject|1|||
13210710|NCT01919814|26250345|FG001|Overall Study|Withdrawal by Subject|0|||
13210711|NCT01919801|26250375|FG000|Overall Study|Withdrawal by Subject|1|||
13210712|NCT01919801|26250376|FG001|Overall Study|Withdrawal by Subject|0|||
13210713|NCT01919801|26250375|FG000|Overall Study|Physician Decision|0|||
13210714|NCT01919801|26250376|FG001|Overall Study|Physician Decision|1|||
13210715|NCT01919801|26250375|FG000|Overall Study|Lost to Follow-up|0|||
13210716|NCT01919801|26250376|FG001|Overall Study|Lost to Follow-up|1|||
13210717|NCT01919801|26250375|FG000|Overall Study|Other|0|||
13210718|NCT01919801|26250376|FG001|Overall Study|Other|1|||
13210719|NCT01919723|26250395|FG000|Overall Study|Blood Samples Hemolyzed|2|||
13210720|NCT01919723|26250396|FG001|Overall Study|Blood Samples Hemolyzed|2|||
13210721|NCT01919489|26250437|FG000|Overall Study|Rejected the need of injections|4|||
13210722|NCT01919489|26250438|FG001|Overall Study|Rejected the need of injections|7|||
13210723|NCT01919489|26250437|FG000|Overall Study|Adverse Event|10|||
13210724|NCT01919489|26250438|FG001|Overall Study|Adverse Event|0|||
13210725|NCT01919489|26250437|FG000|Overall Study|Hospital readmission|2|||
13210726|NCT01919489|26250438|FG001|Overall Study|Hospital readmission|9|||
13210727|NCT01919489|26250437|FG000|Overall Study|Death|2|||
13210728|NCT01919489|26250438|FG001|Overall Study|Death|1|||
13210729|NCT01919489|26250437|FG000|Overall Study|Lost to Follow-up|38|||
13210730|NCT01919489|26250438|FG001|Overall Study|Lost to Follow-up|27|||
13210731|NCT01919411|26250461|FG000|Overall Study|Lost to Follow-up|2|||
13210732|NCT01919411|26250462|FG001|Overall Study|Lost to Follow-up|4|||
13210733|NCT01919411|26250461|FG000|Overall Study|Physician Decision|1|||
13210734|NCT01919411|26250462|FG001|Overall Study|Physician Decision|0|||
13210735|NCT01919411|26250461|FG000|Overall Study|Protocol Violation|2|||
13210736|NCT01919411|26250462|FG001|Overall Study|Protocol Violation|1|||
13210737|NCT01919398|26250492|FG000|Overall Study|Progressive Disease|0|||
13210738|NCT01919398|26250493|FG001|Overall Study|Progressive Disease|0|||
13210739|NCT01919398|26250494|FG002|Overall Study|Progressive Disease|4|||
13210740|NCT01919307|26250503|FG000|Overall Study|Withdrawal by Subject|9|||
13210741|NCT01919229|26250542|FG000|Overall Study|Subject/guardian decision|0|||
13210742|NCT01919229|26250543|FG001|Overall Study|Subject/guardian decision|0|||
13210743|NCT01919229|26250544|FG002|Overall Study|Subject/guardian decision|1|||
13210744|NCT01919190|26250567|FG000|Overall Study|Intra-op findings, etc.|3|||
13210745|NCT01919190|26250568|FG001|Overall Study|Intra-op findings, etc.|0|||
13210746|NCT01919164|26250636|FG000|Overall Study|Adverse Event|6|||
13210747|NCT01919164|26250637|FG001|Overall Study|Adverse Event|4|||
13210748|NCT01919164|26250638|FG002|Overall Study|Adverse Event|9|||
13210749|NCT01919164|26250639|FG003|Overall Study|Adverse Event|3|||
13210750|NCT01919164|26250640|FG004|Overall Study|Adverse Event|2|||
13210751|NCT01919164|26250636|FG000|Overall Study|Lost to Follow-up|2|||
13210752|NCT01919164|26250637|FG001|Overall Study|Lost to Follow-up|2|||
13210753|NCT01919164|26250638|FG002|Overall Study|Lost to Follow-up|2|||
13210754|NCT01919164|26250639|FG003|Overall Study|Lost to Follow-up|0|||
13210755|NCT01919164|26250640|FG004|Overall Study|Lost to Follow-up|4|||
13210756|NCT01919164|26250636|FG000|Overall Study|Death|1|||
13210757|NCT01919164|26250637|FG001|Overall Study|Death|0|||
13210758|NCT01919164|26250638|FG002|Overall Study|Death|0|||
13210759|NCT01919164|26250639|FG003|Overall Study|Death|0|||
13210760|NCT01919164|26250640|FG004|Overall Study|Death|0|||
13210761|NCT01919164|26250636|FG000|Overall Study|Protocol Violation|6|||
13210762|NCT01919164|26250637|FG001|Overall Study|Protocol Violation|0|||
13210763|NCT01919164|26250638|FG002|Overall Study|Protocol Violation|3|||
13210764|NCT01919164|26250639|FG003|Overall Study|Protocol Violation|2|||
13210765|NCT01919164|26250640|FG004|Overall Study|Protocol Violation|2|||
13210766|NCT01919164|26250636|FG000|Overall Study|Disease progression|2|||
13210767|NCT01919164|26250637|FG001|Overall Study|Disease progression|2|||
13210768|NCT01919164|26250638|FG002|Overall Study|Disease progression|1|||
13210769|NCT01919164|26250639|FG003|Overall Study|Disease progression|2|||
13210770|NCT01919164|26250640|FG004|Overall Study|Disease progression|1|||
13210771|NCT01919164|26250636|FG000|Overall Study|Withdrew consent|13|||
13210772|NCT01919164|26250637|FG001|Overall Study|Withdrew consent|13|||
13210773|NCT01919164|26250638|FG002|Overall Study|Withdrew consent|14|||
13210774|NCT01919164|26250639|FG003|Overall Study|Withdrew consent|14|||
13210775|NCT01919164|26250640|FG004|Overall Study|Withdrew consent|9|||
13210776|NCT01919164|26250636|FG000|Overall Study|Other Un-specified|13|||
13210777|NCT01919164|26250637|FG001|Overall Study|Other Un-specified|9|||
13210778|NCT01919164|26250638|FG002|Overall Study|Other Un-specified|8|||
13210779|NCT01919164|26250639|FG003|Overall Study|Other Un-specified|7|||
13210780|NCT01919164|26250640|FG004|Overall Study|Other Un-specified|15|||
13210781|NCT01919112|26250688|FG000|Secondary Analysis-day 30|Death|1|||
13210782|NCT01919112|26250689|FG001|Secondary Analysis-day 30|Death|1|||
13210783|NCT01919112|26250690|FG002|Secondary Analysis-day 30|Death|1|||
13210784|NCT01919112|26250688|FG000|Secondary Analysis-day 30|Lost to Follow-up|1|||
13210785|NCT01919112|26250689|FG001|Secondary Analysis-day 30|Lost to Follow-up|0|||
13210786|NCT01919112|26250690|FG002|Secondary Analysis-day 30|Lost to Follow-up|0|||
13210787|NCT01918774|26250707|FG000|Overall Study|Lost prior to first CBTw session|4|||
13210788|NCT01918774|26250707|FG000|Overall Study|Lost to Follow-up|1|||
13210789|NCT01918371|26250788|FG000|Overall Study|Missing Data|1|||
13210790|NCT01918371|26250789|FG001|Overall Study|Missing Data|1|||
13210791|NCT01918332|26250812|FG000|Overall Study|Adverse Event|0|||
13210792|NCT01918332|26250813|FG001|Overall Study|Adverse Event|0|||
13210793|NCT01918332|26250814|FG002|Overall Study|Adverse Event|0|||
13210794|NCT01918332|26250815|FG003|Overall Study|Adverse Event|1|||
13210795|NCT01918332|26250812|FG000|Overall Study|Withdrawal by Subject|2|||
13210796|NCT01918332|26250813|FG001|Overall Study|Withdrawal by Subject|3|||
13210797|NCT01918332|26250814|FG002|Overall Study|Withdrawal by Subject|2|||
13210798|NCT01918332|26250815|FG003|Overall Study|Withdrawal by Subject|3|||
13210799|NCT01918332|26250812|FG000|Overall Study|Protocol Violation|6|||
13210800|NCT01918332|26250813|FG001|Overall Study|Protocol Violation|2|||
13210801|NCT01918332|26250814|FG002|Overall Study|Protocol Violation|6|||
13210802|NCT01918332|26250815|FG003|Overall Study|Protocol Violation|3|||
13210803|NCT01918332|26250812|FG000|Overall Study|lipid result by central lab did not meet|0|||
13210804|NCT01918332|26250813|FG001|Overall Study|lipid result by central lab did not meet|0|||
13210805|NCT01918332|26250814|FG002|Overall Study|lipid result by central lab did not meet|1|||
13210806|NCT01918332|26250815|FG003|Overall Study|lipid result by central lab did not meet|0|||
13210807|NCT01918306|26250844|FG000|Overall Study|progresive disease|4|||
13210808|NCT01918306|26250845|FG001|Overall Study|progresive disease|0|||
13210809|NCT01918306|26250846|FG002|Overall Study|progresive disease|1|||
13210810|NCT01918306|26250847|FG003|Overall Study|progresive disease|1|||
13210811|NCT01918306|26250844|FG000|Overall Study|Withdrawal by Subject|0|||
13210812|NCT01918306|26250845|FG001|Overall Study|Withdrawal by Subject|0|||
13210813|NCT01918306|26250846|FG002|Overall Study|Withdrawal by Subject|0|||
13210814|NCT01918306|26250847|FG003|Overall Study|Withdrawal by Subject|2|||
13210815|NCT01918306|26250844|FG000|Overall Study|neutropenia|1|||
13210816|NCT01918306|26250845|FG001|Overall Study|neutropenia|0|||
13210817|NCT01918306|26250846|FG002|Overall Study|neutropenia|0|||
13210818|NCT01918306|26250847|FG003|Overall Study|neutropenia|0|||
13210819|NCT01918306|26250844|FG000|Overall Study|Lack of Efficacy|1|||
13210820|NCT01918306|26250845|FG001|Overall Study|Lack of Efficacy|0|||
13210821|NCT01918306|26250846|FG002|Overall Study|Lack of Efficacy|0|||
13210822|NCT01918306|26250847|FG003|Overall Study|Lack of Efficacy|0|||
13210823|NCT01918306|26250844|FG000|Overall Study|progress disease, crossover|0|||
13210824|NCT01918306|26250845|FG001|Overall Study|progress disease, crossover|0|||
13210825|NCT01918306|26250846|FG002|Overall Study|progress disease, crossover|1|||
13210826|NCT01918306|26250847|FG003|Overall Study|progress disease, crossover|0|||
13210827|NCT01918085|26250862|FG000|Test Period 1: Strata Strip|Adverse Event|0|||
13210828|NCT01918085|26250863|FG001|Test Period 1: Strata Strip|Adverse Event|1|||
13210829|NCT01918033|26250911|FG000|Overall Study|Adverse Event|1|||
13210830|NCT01918033|26250912|FG001|Overall Study|Adverse Event|0|||
13210831|NCT01918033|26250913|FG002|Overall Study|Adverse Event|2|||
13210832|NCT01918033|26250911|FG000|Overall Study|Lost to Follow-up|0|||
13210833|NCT01918033|26250912|FG001|Overall Study|Lost to Follow-up|1|||
13210834|NCT01918033|26250913|FG002|Overall Study|Lost to Follow-up|0|||
13210835|NCT01918033|26250911|FG000|Overall Study|Protocol Violation|2|||
13210836|NCT01918033|26250912|FG001|Overall Study|Protocol Violation|0|||
13210837|NCT01918033|26250913|FG002|Overall Study|Protocol Violation|1|||
13210838|NCT01918033|26250911|FG000|Overall Study|Withdrawal by Subject|2|||
13210839|NCT01918033|26250912|FG001|Overall Study|Withdrawal by Subject|1|||
13210840|NCT01918033|26250913|FG002|Overall Study|Withdrawal by Subject|0|||
13210841|NCT01917968|26250948|FG000|Overall Study|Death|3|||
13210842|NCT01917968|26250949|FG001|Overall Study|Death|2|||
13210843|NCT01917968|26250948|FG000|Overall Study|Lost to Follow-up|21|||
13210844|NCT01917968|26250949|FG001|Overall Study|Lost to Follow-up|39|||
13210845|NCT01917968|26250948|FG000|Overall Study|Physician Decision|1|||
13210846|NCT01917968|26250949|FG001|Overall Study|Physician Decision|2|||
13210847|NCT01917968|26250948|FG000|Overall Study|Withdrawal by Subject|20|||
13210848|NCT01917968|26250949|FG001|Overall Study|Withdrawal by Subject|35|||
13210849|NCT01917968|26250948|FG000|Overall Study|Subject Relocation|5|||
13210850|NCT01917968|26250949|FG001|Overall Study|Subject Relocation|1|||
13210851|NCT01917968|26250948|FG000|Overall Study|36M Missed Visit|3|||
13210852|NCT01917968|26250949|FG001|Overall Study|36M Missed Visit|2|||
13210853|NCT01917968|26250948|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1|||
13210854|NCT01917968|26250949|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0|||
13210855|NCT01917968|26250948|FG000|Overall Study|Change in Family Circumstances|0|||
13210856|NCT01917968|26250949|FG001|Overall Study|Change in Family Circumstances|1|||
13210857|NCT01917968|26250948|FG000|Overall Study|No Data Available|0|||
13210858|NCT01917968|26250949|FG001|Overall Study|No Data Available|2|||
13210859|NCT01917747|26250968|FG000|Overall Study|Withdrawal by Subject|1|||
13210860|NCT01917747|26250969|FG001|Overall Study|Withdrawal by Subject|2|||
13210861|NCT01917747|26250968|FG000|Overall Study|Lost to Follow-up|18|||
13210862|NCT01917747|26250969|FG001|Overall Study|Lost to Follow-up|9|||
13210863|NCT01917656|26251000|FG000|Overall Study|Adverse Event|11|||
13210864|NCT01917656|26251001|FG001|Overall Study|Adverse Event|0|||
13210865|NCT01917656|26251000|FG000|Overall Study|Withdrawal criteria|8|||
13210866|NCT01917656|26251001|FG001|Overall Study|Withdrawal criteria|14|||
13210867|NCT01917656|26251000|FG000|Overall Study|Unclassified|0|||
13210868|NCT01917656|26251001|FG001|Overall Study|Unclassified|3|||
13210869|NCT01917656|26251000|FG000|Overall Study|Withdrawal by Subject|4|||
13210870|NCT01917656|26251001|FG001|Overall Study|Withdrawal by Subject|3|||
13210871|NCT01917656|26251000|FG000|Overall Study|Lost to Follow-up|3|||
13210872|NCT01917656|26251001|FG001|Overall Study|Lost to Follow-up|4|||
13210873|NCT01917526|26251016|FG000|Overall Study|Protocol Violation|1|||
13210874|NCT01917526|26251017|FG001|Overall Study|Protocol Violation|1|||
13210875|NCT01917344|26251023|FG000|Overall Study|Withdrawal by Subject|1|||
13210876|NCT01917084|26251031|FG000|Overall Study|Withdrawal by Subject|1|||
13296591|NCT01369498|26496989|FG002|Overall Study|Withdrawal of Consent|1|||
13296592|NCT01369498|26496990|FG003|Overall Study|Withdrawal of Consent|1|||
13296593|NCT01369498|26496987|FG000|Overall Study|Death|0|||
13296594|NCT01369498|26496988|FG001|Overall Study|Death|0|||
13296595|NCT01369498|26496989|FG002|Overall Study|Death|1|||
13296596|NCT01369498|26496990|FG003|Overall Study|Death|0|||
13296597|NCT01369498|26496987|FG000|Overall Study|Investigator's Discretion|1|||
13296598|NCT01369498|26496988|FG001|Overall Study|Investigator's Discretion|0|||
13296599|NCT01369498|26496989|FG002|Overall Study|Investigator's Discretion|1|||
13296600|NCT01369498|26496990|FG003|Overall Study|Investigator's Discretion|3|||
13296601|NCT01369498|26496987|FG000|Overall Study|Unknown Reason|1|||
13296602|NCT01369498|26496988|FG001|Overall Study|Unknown Reason|0|||
13296603|NCT01369498|26496989|FG002|Overall Study|Unknown Reason|11|||
13296604|NCT01369498|26496990|FG003|Overall Study|Unknown Reason|6|||
13296605|NCT01369498|26496987|FG000|Overall Study|Disease Progression|0|||
13296606|NCT01369498|26496988|FG001|Overall Study|Disease Progression|0|||
13210877|NCT01917006|26251085|FG000|Randomized-treatment Period|Lost to Follow-up|1|||
13210878|NCT01917006|26251086|FG001|Randomized-treatment Period|Lost to Follow-up|0|||
13210879|NCT01917006|26251087|FG002|Randomized-treatment Period|Lost to Follow-up|0|||
13210880|NCT01917006|26251088|FG003|Randomized-treatment Period|Lost to Follow-up|1|||
13210881|NCT01917006|26251089|FG004|Randomized-treatment Period|Lost to Follow-up|0|||
13210882|NCT01917006|26251090|FG005|Randomized-treatment Period|Lost to Follow-up|0|||
13210883|NCT01917006|26251091|FG006|Randomized-treatment Period|Lost to Follow-up|0|||
13210884|NCT01917006|26251092|FG007|Randomized-treatment Period|Lost to Follow-up|0|||
13210885|NCT01917006|26251085|FG000|Randomized-treatment Period|Personal Reasons|0|||
13210886|NCT01917006|26251086|FG001|Randomized-treatment Period|Personal Reasons|0|||
13210887|NCT01917006|26251087|FG002|Randomized-treatment Period|Personal Reasons|0|||
13210888|NCT01917006|26251088|FG003|Randomized-treatment Period|Personal Reasons|0|||
13210889|NCT01917006|26251089|FG004|Randomized-treatment Period|Personal Reasons|0|||
13210890|NCT01917006|26251090|FG005|Randomized-treatment Period|Personal Reasons|1|||
13210891|NCT01917006|26251091|FG006|Randomized-treatment Period|Personal Reasons|0|||
13210892|NCT01917006|26251092|FG007|Randomized-treatment Period|Personal Reasons|0|||
13210893|NCT01917006|26251085|FG000|Randomized-treatment Period|Protocol Violation|1|||
13210894|NCT01917006|26251086|FG001|Randomized-treatment Period|Protocol Violation|0|||
13210895|NCT01917006|26251087|FG002|Randomized-treatment Period|Protocol Violation|0|||
13210896|NCT01917006|26251088|FG003|Randomized-treatment Period|Protocol Violation|0|||
13210897|NCT01917006|26251089|FG004|Randomized-treatment Period|Protocol Violation|0|||
13210898|NCT01917006|26251090|FG005|Randomized-treatment Period|Protocol Violation|0|||
13210899|NCT01917006|26251091|FG006|Randomized-treatment Period|Protocol Violation|0|||
13210900|NCT01917006|26251092|FG007|Randomized-treatment Period|Protocol Violation|0|||
13210901|NCT01917006|26251085|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
13210902|NCT01917006|26251086|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
13210903|NCT01917006|26251087|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
13296607|NCT01369498|26496989|FG002|Overall Study|Disease Progression|0|||
13296608|NCT01369498|26496990|FG003|Overall Study|Disease Progression|1|||
13296609|NCT01369485|26497037|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7|||
13296610|NCT01369485|26497038|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5|||
13296611|NCT01369485|26497037|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12|||
13296612|NCT01369485|26497038|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8|||
13296613|NCT01369485|26497037|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2|||
13296614|NCT01369485|26497038|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4|||
13210904|NCT01917006|26251088|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
13210905|NCT01917006|26251089|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
13210906|NCT01917006|26251090|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
13210907|NCT01917006|26251091|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1|||
13210908|NCT01917006|26251092|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
13210909|NCT01917006|26251085|FG000|Open-label Period|Adverse Event|0|||
13210910|NCT01917006|26251086|FG001|Open-label Period|Adverse Event|0|||
13210911|NCT01917006|26251087|FG002|Open-label Period|Adverse Event|0|||
13210912|NCT01917006|26251088|FG003|Open-label Period|Adverse Event|0|||
13210913|NCT01917006|26251089|FG004|Open-label Period|Adverse Event|0|||
13210914|NCT01917006|26251090|FG005|Open-label Period|Adverse Event|0|||
13210915|NCT01917006|26251091|FG006|Open-label Period|Adverse Event|0|||
13210916|NCT01917006|26251092|FG007|Open-label Period|Adverse Event|1|||
13210917|NCT01917006|26251085|FG000|Open-label Period|Lost to Follow-up|0|||
13210918|NCT01917006|26251086|FG001|Open-label Period|Lost to Follow-up|0|||
13210919|NCT01917006|26251087|FG002|Open-label Period|Lost to Follow-up|0|||
13210920|NCT01917006|26251088|FG003|Open-label Period|Lost to Follow-up|0|||
13210921|NCT01917006|26251089|FG004|Open-label Period|Lost to Follow-up|0|||
13210922|NCT01917006|26251090|FG005|Open-label Period|Lost to Follow-up|0|||
13210923|NCT01917006|26251091|FG006|Open-label Period|Lost to Follow-up|0|||
13210924|NCT01917006|26251092|FG007|Open-label Period|Lost to Follow-up|1|||
13210925|NCT01916980|26251115|FG000|Overall Study|Adverse Event|4|||
13210926|NCT01916980|26251116|FG001|Overall Study|Adverse Event|2|||
13210927|NCT01916980|26251115|FG000|Overall Study|Lack of Efficacy|2|||
13210928|NCT01916980|26251116|FG001|Overall Study|Lack of Efficacy|2|||
13210929|NCT01916980|26251115|FG000|Overall Study|Withdrawal by Subject|1|||
13210930|NCT01916980|26251116|FG001|Overall Study|Withdrawal by Subject|0|||
13210931|NCT01916967|26251167|FG000|Overall Study|Adverse Event|0|||
13210932|NCT01916967|26251168|FG001|Overall Study|Adverse Event|0|||
13210933|NCT01916967|26251169|FG002|Overall Study|Adverse Event|2|||
13210934|NCT01916967|26251167|FG000|Overall Study|Lack of Efficacy|0|||
13210935|NCT01916967|26251168|FG001|Overall Study|Lack of Efficacy|0|||
13210936|NCT01916967|26251169|FG002|Overall Study|Lack of Efficacy|6|||
13210937|NCT01916967|26251167|FG000|Overall Study|Physician Decision|0|||
13210938|NCT01916967|26251168|FG001|Overall Study|Physician Decision|0|||
13210939|NCT01916967|26251169|FG002|Overall Study|Physician Decision|1|||
13210940|NCT01916967|26251167|FG000|Overall Study|Protocol Violation|0|||
13210941|NCT01916967|26251168|FG001|Overall Study|Protocol Violation|1|||
13210942|NCT01916967|26251169|FG002|Overall Study|Protocol Violation|0|||
13210943|NCT01916824|26251182|FG000|Overall Study|Lost to Follow-up|3|||
13210944|NCT01916824|26251183|FG001|Overall Study|Lost to Follow-up|6|||
13210945|NCT01916824|26251182|FG000|Overall Study|Physician Decision|2|||
13210946|NCT01916824|26251183|FG001|Overall Study|Physician Decision|0|||
13210947|NCT01916824|26251182|FG000|Overall Study|Withdrawal by Subject|2|||
13210948|NCT01916824|26251183|FG001|Overall Study|Withdrawal by Subject|3|||
13210949|NCT01916304|26251193|FG000|Overall Study|Screening failure|17|||
13210950|NCT01916226|26251240|FG000|Overall Study|Adverse Event|1|||
13210951|NCT01916226|26251241|FG001|Overall Study|Adverse Event|0|||
13210952|NCT01916226|26251242|FG002|Overall Study|Adverse Event|1|||
13210953|NCT01916226|26251243|FG003|Overall Study|Adverse Event|1|||
13210954|NCT01916226|26251240|FG000|Overall Study|Lack of Efficacy|0|||
13210955|NCT01916226|26251241|FG001|Overall Study|Lack of Efficacy|0|||
13210956|NCT01916226|26251242|FG002|Overall Study|Lack of Efficacy|2|||
13210957|NCT01916226|26251243|FG003|Overall Study|Lack of Efficacy|1|||
13210958|NCT01916226|26251240|FG000|Overall Study|Protocol Violation|0|||
13210959|NCT01916226|26251241|FG001|Overall Study|Protocol Violation|1|||
13210960|NCT01916226|26251242|FG002|Overall Study|Protocol Violation|0|||
13210961|NCT01916226|26251243|FG003|Overall Study|Protocol Violation|1|||
13210962|NCT01916226|26251240|FG000|Overall Study|Physician Decision|0|||
13210963|NCT01916226|26251241|FG001|Overall Study|Physician Decision|0|||
13210964|NCT01916226|26251242|FG002|Overall Study|Physician Decision|0|||
13210965|NCT01916226|26251243|FG003|Overall Study|Physician Decision|1|||
13210966|NCT01916109|26251249|FG000|Overall Study|Withdrawal by Subject|1|||
13210967|NCT01915940|26251273|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39|||
13210968|NCT01915940|26251274|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
13210969|NCT01915940|26251275|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
13210970|NCT01915940|26251273|FG000|Treatment Period|Decision of Participant|0|||
13210971|NCT01915940|26251274|FG001|Treatment Period|Decision of Participant|1|||
13210972|NCT01915940|26251275|FG002|Treatment Period|Decision of Participant|3|||
13210973|NCT01915940|26251273|FG000|Treatment Period|Adverse Event|0|||
13210974|NCT01915940|26251274|FG001|Treatment Period|Adverse Event|9|||
13210975|NCT01915940|26251275|FG002|Treatment Period|Adverse Event|1|||
13210976|NCT01915940|26251273|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
13210977|NCT01915940|26251274|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
13210978|NCT01915940|26251275|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
13210979|NCT01915914|26251308|FG000|Acute Phase|Withdrawal by Subject|4|||
13210980|NCT01915914|26251309|FG001|Acute Phase|Withdrawal by Subject|0|||
13210981|NCT01915914|26251310|FG002|Acute Phase|Withdrawal by Subject|0|||
13210982|NCT01915914|26251311|FG003|Acute Phase|Withdrawal by Subject|0|||
13210983|NCT01915914|26251308|FG000|Acute Phase|Lost to Follow-up|4|||
13210984|NCT01915914|26251309|FG001|Acute Phase|Lost to Follow-up|0|||
13210985|NCT01915914|26251310|FG002|Acute Phase|Lost to Follow-up|0|||
13210986|NCT01915914|26251311|FG003|Acute Phase|Lost to Follow-up|0|||
13210987|NCT01915914|26251308|FG000|Acute Phase|Physician Decision|1|||
13210988|NCT01915914|26251309|FG001|Acute Phase|Physician Decision|0|||
13210989|NCT01915914|26251310|FG002|Acute Phase|Physician Decision|0|||
13210990|NCT01915914|26251311|FG003|Acute Phase|Physician Decision|0|||
13210991|NCT01915914|26251308|FG000|Acute Phase|Accepted Other Topic Therapies|1|||
13210992|NCT01915914|26251309|FG001|Acute Phase|Accepted Other Topic Therapies|0|||
13210993|NCT01915914|26251310|FG002|Acute Phase|Accepted Other Topic Therapies|0|||
13210994|NCT01915914|26251311|FG003|Acute Phase|Accepted Other Topic Therapies|0|||
13210995|NCT01915914|26251308|FG000|Acute Phase|"Not Achieved treatment success"|1|||
13210996|NCT01915914|26251309|FG001|Acute Phase|"Not Achieved treatment success"|0|||
13210997|NCT01915914|26251310|FG002|Acute Phase|"Not Achieved treatment success"|0|||
13210998|NCT01915914|26251311|FG003|Acute Phase|"Not Achieved treatment success"|0|||
13210999|NCT01915914|26251308|FG000|Acute Phase|Missing|1|||
13211000|NCT01915914|26251309|FG001|Acute Phase|Missing|0|||
13211001|NCT01915914|26251310|FG002|Acute Phase|Missing|0|||
13211002|NCT01915914|26251311|FG003|Acute Phase|Missing|0|||
13211003|NCT01915914|26251308|FG000|Maintenance Phase|Withdrawal by Subject|0|||
13211004|NCT01915914|26251309|FG001|Maintenance Phase|Withdrawal by Subject|1|||
13211005|NCT01915914|26251310|FG002|Maintenance Phase|Withdrawal by Subject|1|||
13211006|NCT01915914|26251311|FG003|Maintenance Phase|Withdrawal by Subject|0|||
13211007|NCT01915914|26251308|FG000|Maintenance Phase|Lost to Follow-up|0|||
13211008|NCT01915914|26251309|FG001|Maintenance Phase|Lost to Follow-up|4|||
13211009|NCT01915914|26251310|FG002|Maintenance Phase|Lost to Follow-up|1|||
13211010|NCT01915914|26251311|FG003|Maintenance Phase|Lost to Follow-up|0|||
13211011|NCT01915914|26251308|FG000|Maintenance Phase|Missing|0|||
13211012|NCT01915914|26251309|FG001|Maintenance Phase|Missing|1|||
13211013|NCT01915914|26251310|FG002|Maintenance Phase|Missing|0|||
13211014|NCT01915914|26251311|FG003|Maintenance Phase|Missing|0|||
13211015|NCT01915914|26251308|FG000|Follow-up Phase|Withdrawal by Subject|0|||
13211016|NCT01915914|26251309|FG001|Follow-up Phase|Withdrawal by Subject|0|||
13211017|NCT01915914|26251310|FG002|Follow-up Phase|Withdrawal by Subject|0|||
13211018|NCT01915914|26251311|FG003|Follow-up Phase|Withdrawal by Subject|1|||
13211019|NCT01915914|26251308|FG000|Follow-up Phase|Physician Decision|0|||
13211020|NCT01915914|26251309|FG001|Follow-up Phase|Physician Decision|0|||
13211021|NCT01915914|26251310|FG002|Follow-up Phase|Physician Decision|0|||
13211022|NCT01915914|26251311|FG003|Follow-up Phase|Physician Decision|1|||
13211023|NCT01915849|26251334|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1|||
13211024|NCT01915849|26251335|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0|||
13211025|NCT01915849|26251336|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0|||
13211026|NCT01915849|26251337|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0|||
13211027|NCT01915849|26251334|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
13211028|NCT01915849|26251335|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
13211029|NCT01915849|26251336|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
13211030|NCT01915849|26251337|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
13211031|NCT01915771|26251361|FG000|Day 1|Withdrawal by Subject|1|||
13211032|NCT01915771|26251361|FG000|Day 15|Withdrawal by Subject|1|||
13211033|NCT01915732|26251392|FG000|Overall Study|Withdrawal by Subject|18|||
13211034|NCT01915732|26251393|FG001|Overall Study|Withdrawal by Subject|18|||
13211035|NCT01915732|26251392|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
13211036|NCT01915732|26251393|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
13211037|NCT01915732|26251392|FG000|Overall Study|Adverse Event|12|||
13211038|NCT01915732|26251393|FG001|Overall Study|Adverse Event|4|||
13211039|NCT01915732|26251392|FG000|Overall Study|Protocol Violation|5|||
13211040|NCT01915732|26251393|FG001|Overall Study|Protocol Violation|5|||
13211041|NCT01915732|26251392|FG000|Overall Study|Lack of Efficacy|6|||
13211042|NCT01915732|26251393|FG001|Overall Study|Lack of Efficacy|11|||
13211043|NCT01915732|26251392|FG000|Overall Study|Lost to Follow-up|22|||
13211044|NCT01915732|26251393|FG001|Overall Study|Lost to Follow-up|26|||
13211045|NCT01915732|26251392|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1|||
13211046|NCT01915732|26251393|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0|||
13211047|NCT01915732|26251392|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1|||
13211048|NCT01915732|26251393|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0|||
13211049|NCT01915732|26251392|FG000|Overall Study|Drug Release Error|1|||
13211050|NCT01915732|26251393|FG001|Overall Study|Drug Release Error|0|||
13211051|NCT01915732|26251392|FG000|Overall Study|Recovered|1|||
13211052|NCT01915732|26251393|FG001|Overall Study|Recovered|0|||
13211053|NCT01915732|26251392|FG000|Overall Study|Pregnancy|1|||
13211054|NCT01915732|26251393|FG001|Overall Study|Pregnancy|0|||
13211055|NCT01915732|26251392|FG000|Overall Study|Poor Perceived Efficacy|1|||
13211056|NCT01915732|26251393|FG001|Overall Study|Poor Perceived Efficacy|0|||
13211057|NCT01915732|26251392|FG000|Overall Study|Par. Unable to Come to the Hospital|0|||
13211058|NCT01915732|26251393|FG001|Overall Study|Par. Unable to Come to the Hospital|1|||
13211059|NCT01915732|26251392|FG000|Overall Study|Got Well|0|||
13211060|NCT01915732|26251393|FG001|Overall Study|Got Well|1|||
13211061|NCT01915732|26251392|FG000|Overall Study|Par. not Willing to Continue Treatment|0|||
13211062|NCT01915732|26251393|FG001|Overall Study|Par. not Willing to Continue Treatment|1|||
13211063|NCT01915732|26251392|FG000|Overall Study|Par. Refused to Hospital Visits|0|||
13211064|NCT01915732|26251393|FG001|Overall Study|Par. Refused to Hospital Visits|1|||
13211065|NCT01915732|26251392|FG000|Overall Study|Job Transfer|0|||
13211066|NCT01915732|26251393|FG001|Overall Study|Job Transfer|1|||
13211067|NCT01915732|26251392|FG000|Overall Study|Improper Facial Procedure|0|||
13211068|NCT01915732|26251393|FG001|Overall Study|Improper Facial Procedure|1|||
13211069|NCT01915732|26251392|FG000|Overall Study|Poor Conscious Effect|0|||
13211070|NCT01915732|26251393|FG001|Overall Study|Poor Conscious Effect|1|||
13211071|NCT01915498|26251973|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
13211072|NCT01915498|26251974|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
13211073|NCT01915498|26251975|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
13211074|NCT01915498|26251976|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
13211075|NCT01915498|26251977|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
13211076|NCT01915498|26251978|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
13211077|NCT01915498|26251979|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
13211078|NCT01915498|26251980|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
13211079|NCT01915498|26251981|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
13211080|NCT01915498|26251982|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
13211081|NCT01915498|26251983|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
13211082|NCT01915498|26251984|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
13211083|NCT01915498|26251985|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
13211084|NCT01915498|26251986|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
13211085|NCT01915498|26251987|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
13211086|NCT01915498|26251988|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
13211087|NCT01915498|26251989|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
13211088|NCT01915498|26251990|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
13211089|NCT01915498|26251991|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
13211090|NCT01915498|26251973|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
13211091|NCT01915498|26251974|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
13211092|NCT01915498|26251975|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
13211093|NCT01915498|26251976|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
13211094|NCT01915498|26251977|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
13211095|NCT01915498|26251978|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
13211096|NCT01915498|26251979|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
13211097|NCT01915498|26251980|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
13211098|NCT01915498|26251981|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
13211099|NCT01915498|26251982|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
13211100|NCT01915498|26251983|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
13211101|NCT01915498|26251984|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
13211102|NCT01915498|26251985|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
13211103|NCT01915498|26251986|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
13211104|NCT01915498|26251987|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
13211105|NCT01915498|26251988|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
13211106|NCT01915498|26251989|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
13211107|NCT01915498|26251990|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16|||
13211108|NCT01915498|26251991|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
13211109|NCT01915498|26251973|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1|||
13211110|NCT01915498|26251974|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
13211111|NCT01915498|26251975|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
13211112|NCT01915498|26251976|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
13211113|NCT01915498|26251977|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
13211114|NCT01915498|26251978|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
13211115|NCT01915498|26251979|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
13211116|NCT01915498|26251980|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15|||
13211117|NCT01915498|26251981|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
13211118|NCT01915498|26251982|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7|||
13211119|NCT01915498|26251983|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
13211120|NCT01915498|26251984|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
13211121|NCT01915498|26251985|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
13211122|NCT01915498|26251986|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24|||
13211123|NCT01915498|26251987|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14|||
13211124|NCT01915498|26251988|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9|||
13211125|NCT01915498|26251989|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8|||
13211126|NCT01915498|26251990|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41|||
13211127|NCT01915498|26251991|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0|||
13211128|NCT01915498|26251973|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
13211129|NCT01915498|26251974|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
13211130|NCT01915498|26251975|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
13211131|NCT01915498|26251976|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
13211132|NCT01915498|26251977|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
13211133|NCT01915498|26251978|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
13211134|NCT01915498|26251979|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
13211135|NCT01915498|26251980|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
13211136|NCT01915498|26251981|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
13211137|NCT01915498|26251982|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
13211138|NCT01915498|26251983|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1|||
13211139|NCT01915498|26251984|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
13211140|NCT01915498|26251985|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
13211141|NCT01915498|26251986|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
13211142|NCT01915498|26251987|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
13211143|NCT01915498|26251988|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
13211144|NCT01915498|26251989|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
13211145|NCT01915498|26251990|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
13211146|NCT01915498|26251991|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
13211147|NCT01915498|26251973|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
13211148|NCT01915498|26251974|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
13211149|NCT01915498|26251975|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
13211150|NCT01915498|26251976|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
13211151|NCT01915498|26251977|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
13211152|NCT01915498|26251978|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
13211153|NCT01915498|26251979|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
13211154|NCT01915498|26251980|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
13211155|NCT01915498|26251981|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
13211156|NCT01915498|26251982|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
13211157|NCT01915498|26251983|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
13211158|NCT01915498|26251984|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
13211159|NCT01915498|26251985|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
13211160|NCT01915498|26251986|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
13211161|NCT01915498|26251987|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
13211162|NCT01915498|26251988|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
13211163|NCT01915498|26251989|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3|||
13211164|NCT01915498|26251990|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16|||
13211165|NCT01915498|26251991|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
13211166|NCT01915498|26251973|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
13211167|NCT01915498|26251974|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
13211168|NCT01915498|26251975|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
13211169|NCT01915498|26251976|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
13211170|NCT01915498|26251977|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
13211171|NCT01915498|26251978|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
13211172|NCT01915498|26251979|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
13211173|NCT01915498|26251980|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
13211174|NCT01915498|26251981|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
13211175|NCT01915498|26251982|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
13211176|NCT01915498|26251983|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
13211177|NCT01915498|26251984|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
13211178|NCT01915498|26251985|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
13211179|NCT01915498|26251986|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
13211180|NCT01915498|26251987|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
13211181|NCT01915498|26251988|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
13211182|NCT01915498|26251989|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
13211183|NCT01915498|26251990|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
13211184|NCT01915498|26251991|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
13211185|NCT01915498|26251973|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
13211186|NCT01915498|26251974|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
13211187|NCT01915498|26251975|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2|||
13211188|NCT01915498|26251976|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
13211189|NCT01915498|26251977|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
13211190|NCT01915498|26251978|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
13211191|NCT01915498|26251979|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
13211192|NCT01915498|26251980|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
13211193|NCT01915498|26251981|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
13211194|NCT01915498|26251982|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
13211195|NCT01915498|26251983|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
13211196|NCT01915498|26251984|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
13211197|NCT01915498|26251985|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
13211198|NCT01915498|26251986|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
13211199|NCT01915498|26251987|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
13211200|NCT01915498|26251988|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
13211201|NCT01915498|26251989|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4|||
13211202|NCT01915498|26251990|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8|||
13211203|NCT01915498|26251991|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
13211204|NCT01915498|26251973|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
13211205|NCT01915498|26251974|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
13211206|NCT01915498|26251975|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
13211207|NCT01915498|26251976|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
13211208|NCT01915498|26251977|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
13211209|NCT01915498|26251978|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
13211210|NCT01915498|26251979|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
13211211|NCT01915498|26251980|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
13211212|NCT01915498|26251981|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
13211213|NCT01915498|26251982|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
13211214|NCT01915498|26251983|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
13211215|NCT01915498|26251984|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
13211216|NCT01915498|26251985|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
13211217|NCT01915498|26251986|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6|||
13211218|NCT01915498|26251987|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5|||
13211219|NCT01915498|26251988|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
13211220|NCT01915498|26251989|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
13211221|NCT01915498|26251990|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9|||
13211222|NCT01915498|26251991|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
13211223|NCT01915498|26251973|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
13211224|NCT01915498|26251974|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
13211225|NCT01915498|26251975|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
13211226|NCT01915498|26251976|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
13211227|NCT01915498|26251977|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
13211228|NCT01915498|26251978|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
13211229|NCT01915498|26251979|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
13211230|NCT01915498|26251980|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
13211231|NCT01915498|26251981|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
13211232|NCT01915498|26251982|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
13211233|NCT01915498|26251983|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
13211234|NCT01915498|26251984|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
13211235|NCT01915498|26251985|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
13211236|NCT01915498|26251986|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
13211237|NCT01915498|26251987|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
13211238|NCT01915498|26251988|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
13211239|NCT01915498|26251989|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
13211240|NCT01915498|26251990|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
13211241|NCT01915498|26251991|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
13211242|NCT01915498|26251973|FG000|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1|||
13211243|NCT01915498|26251974|FG001|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
13211244|NCT01915498|26251975|FG002|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
13211245|NCT01915498|26251976|FG003|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
13211246|NCT01915498|26251977|FG004|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
13211247|NCT01915498|26251978|FG005|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1|||
13211248|NCT01915498|26251979|FG006|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
13211249|NCT01915498|26251980|FG007|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
13211250|NCT01915498|26251981|FG008|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
13211251|NCT01915498|26251982|FG009|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
13211252|NCT01915498|26251983|FG010|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
13211253|NCT01915498|26251984|FG011|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
13211254|NCT01915498|26251985|FG012|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
13211255|NCT01915498|26251986|FG013|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
13211256|NCT01915498|26251987|FG014|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1|||
13211257|NCT01915498|26251988|FG015|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
13211258|NCT01915498|26251989|FG016|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
13211259|NCT01915498|26251990|FG017|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|2|||
13211260|NCT01915498|26251991|FG018|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
13211261|NCT01915498|26251973|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
13211262|NCT01915498|26251974|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
13211263|NCT01915498|26251975|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
13211264|NCT01915498|26251976|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
13211265|NCT01915498|26251977|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
13211266|NCT01915498|26251978|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
13211267|NCT01915498|26251979|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
13211268|NCT01915498|26251980|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
13211269|NCT01915498|26251981|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
13211270|NCT01915498|26251982|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
13211271|NCT01915498|26251983|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
13211272|NCT01915498|26251984|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
13211273|NCT01915498|26251985|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
13211274|NCT01915498|26251986|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
13211275|NCT01915498|26251987|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
13211276|NCT01915498|26251988|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
13211277|NCT01915498|26251989|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
13211278|NCT01915498|26251990|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
13211279|NCT01915498|26251991|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
13211280|NCT01915498|26251973|FG000|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
13211281|NCT01915498|26251974|FG001|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
13211282|NCT01915498|26251975|FG002|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
13211283|NCT01915498|26251976|FG003|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
13211284|NCT01915498|26251977|FG004|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
13211285|NCT01915498|26251978|FG005|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
13211286|NCT01915498|26251979|FG006|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
13211287|NCT01915498|26251980|FG007|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
13211288|NCT01915498|26251981|FG008|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
13211289|NCT01915498|26251982|FG009|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
13211290|NCT01915498|26251983|FG010|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
13211291|NCT01915498|26251984|FG011|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
13211292|NCT01915498|26251985|FG012|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
13211293|NCT01915498|26251986|FG013|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
13211294|NCT01915498|26251987|FG014|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
13211295|NCT01915498|26251988|FG015|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
13211296|NCT01915498|26251989|FG016|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
13211297|NCT01915498|26251990|FG017|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
13211298|NCT01915498|26251991|FG018|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|2|||
13211299|NCT01915303|26252018|FG000|Core Phase|Adverse Event|7|||
13211300|NCT01915303|26252018|FG000|Core Phase|Unsatisfactory therapeutic effect|3|||
13211301|NCT01915303|26252018|FG000|Core Phase|Death|2|||
13211302|NCT01915303|26252018|FG000|Core Phase|Protocol Violation|2|||
13211303|NCT01915303|26252018|FG000|Core Phase|Abnormal lab value|1|||
13211304|NCT01915303|26252018|FG000|Core Phase|Withdrawal by Subject|1|||
13211305|NCT01915303|26252018|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
13211306|NCT01915303|26252018|FG000|Extension Phase|Withdrawal by Subject|4|||
13211307|NCT01915303|26252018|FG000|Extension Phase|Adverse Event|3|||
13211308|NCT01915303|26252018|FG000|Extension Phase|Death|1|||
13211309|NCT01915303|26252018|FG000|Extension Phase|Protocol Violation|1|||
13211310|NCT01915095|26252059|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
13211311|NCT01915095|26252060|FG001|Overall Study|Some subjects were unable to commit to the training study.|0|||
13211312|NCT01915095|26252061|FG002|Overall Study|Some subjects were unable to commit to the training study.|0|||
13211313|NCT01915095|26252062|FG003|Overall Study|Some subjects were unable to commit to the training study.|4|||
13211314|NCT01915095|26252063|FG004|Overall Study|Some subjects were unable to commit to the training study.|6|||
13211315|NCT01914926|26252076|FG000|Overall Study|Adverse Event|1|||
13211316|NCT01914926|26252077|FG001|Overall Study|Adverse Event|0|||
13211317|NCT01914926|26252076|FG000|Overall Study|uncooperative, agitated and removed|0|||
13211318|NCT01914926|26252077|FG001|Overall Study|uncooperative, agitated and removed|1|||
13211319|NCT01914757|26252161|FG000|Overall Study|Severe non-compliance to protocol|3|||
13211320|NCT01914757|26252162|FG001|Overall Study|Severe non-compliance to protocol|1|||
13211321|NCT01914757|26252163|FG002|Overall Study|Severe non-compliance to protocol|2|||
13211322|NCT01914757|26252161|FG000|Overall Study|Lost to Follow-up|5|||
13211323|NCT01914757|26252162|FG001|Overall Study|Lost to Follow-up|8|||
13211324|NCT01914757|26252163|FG002|Overall Study|Lost to Follow-up|6|||
13211325|NCT01914757|26252161|FG000|Overall Study|Withdrawal by Subject|15|||
13211326|NCT01914757|26252162|FG001|Overall Study|Withdrawal by Subject|27|||
13211327|NCT01914757|26252163|FG002|Overall Study|Withdrawal by Subject|19|||
13211328|NCT01914757|26252161|FG000|Overall Study|Death|2|||
13211329|NCT01914757|26252162|FG001|Overall Study|Death|2|||
13211330|NCT01914757|26252163|FG002|Overall Study|Death|1|||
13211331|NCT01914757|26252161|FG000|Overall Study|Adverse Event|4|||
13211332|NCT01914757|26252162|FG001|Overall Study|Adverse Event|3|||
13211333|NCT01914757|26252163|FG002|Overall Study|Adverse Event|4|||
13211334|NCT01914757|26252161|FG000|Overall Study|Study specific withdrawal criteria|0|||
13211335|NCT01914757|26252162|FG001|Overall Study|Study specific withdrawal criteria|1|||
13211336|NCT01914757|26252163|FG002|Overall Study|Study specific withdrawal criteria|0|||
13211337|NCT01914757|26252161|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
13211338|NCT01914757|26252162|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
13211339|NCT01914757|26252163|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
13211340|NCT01914757|26252161|FG000|Overall Study|Other reasons|5|||
13211341|NCT01914757|26252162|FG001|Overall Study|Other reasons|9|||
13211342|NCT01914757|26252163|FG002|Overall Study|Other reasons|4|||
13211343|NCT01914679|26252169|FG000|Overall Study|Lack of Efficacy|1|||
13211344|NCT01914679|26252169|FG000|Overall Study|Sponsor terminated study|4|||
13211345|NCT01914666|26252212|FG000|Treatment Period|Lack of Efficacy|0|||
13211346|NCT01914666|26252213|FG001|Treatment Period|Lack of Efficacy|0|||
13211347|NCT01914666|26252214|FG002|Treatment Period|Lack of Efficacy|2|||
13211348|NCT01914666|26252212|FG000|Treatment Period|Adverse Event|10|||
13211349|NCT01914666|26252213|FG001|Treatment Period|Adverse Event|4|||
13211350|NCT01914666|26252214|FG002|Treatment Period|Adverse Event|2|||
13381984|NCT00748566|26749581|FG000|Overall Study|Lack of Efficacy|12|||
13211351|NCT01914666|26252212|FG000|Treatment Period|Withdrawal by Subject|3|||
13211352|NCT01914666|26252213|FG001|Treatment Period|Withdrawal by Subject|2|||
13211353|NCT01914666|26252214|FG002|Treatment Period|Withdrawal by Subject|2|||
13211354|NCT01914666|26252212|FG000|Treatment Period|Physician Decision|0|||
13211355|NCT01914666|26252213|FG001|Treatment Period|Physician Decision|0|||
13211356|NCT01914666|26252214|FG002|Treatment Period|Physician Decision|2|||
13211357|NCT01914393|26252256|FG000|Overall Study|Protocol Violation|11|||
13211358|NCT01914393|26252257|FG001|Overall Study|Protocol Violation|3|||
13211359|NCT01914393|26252258|FG002|Overall Study|Protocol Violation|19|||
13211360|NCT01914393|26252256|FG000|Overall Study|Lack of Efficacy|11|||
13211361|NCT01914393|26252257|FG001|Overall Study|Lack of Efficacy|16|||
13211362|NCT01914393|26252258|FG002|Overall Study|Lack of Efficacy|5|||
13211363|NCT01914393|26252256|FG000|Overall Study|no reason given|14|||
13211364|NCT01914393|26252257|FG001|Overall Study|no reason given|8|||
13211365|NCT01914393|26252258|FG002|Overall Study|no reason given|16|||
13211366|NCT01914393|26252256|FG000|Overall Study|Adverse Event|29|||
13211367|NCT01914393|26252257|FG001|Overall Study|Adverse Event|18|||
13211368|NCT01914393|26252258|FG002|Overall Study|Adverse Event|31|||
13211369|NCT01914393|26252256|FG000|Overall Study|Withdrawal by Subject|38|||
13211370|NCT01914393|26252257|FG001|Overall Study|Withdrawal by Subject|20|||
13211371|NCT01914393|26252258|FG002|Overall Study|Withdrawal by Subject|47|||
13211372|NCT01914393|26252256|FG000|Overall Study|Lost to Follow-up|12|||
13211373|NCT01914393|26252257|FG001|Overall Study|Lost to Follow-up|6|||
13211374|NCT01914393|26252258|FG002|Overall Study|Lost to Follow-up|19|||
13211375|NCT01914393|26252256|FG000|Overall Study|subject never dosed|0|||
13211376|NCT01914393|26252257|FG001|Overall Study|subject never dosed|0|||
13211377|NCT01914393|26252258|FG002|Overall Study|subject never dosed|1|||
13211378|NCT01913639|26252267|FG000|Overall Study|Not Eligible|3|||
13211379|NCT01913483|26252284|FG000|Overall Study|Withdrawal by Subject|1|||
13211380|NCT01913483|26252285|FG001|Overall Study|Withdrawal by Subject|2|||
13211381|NCT01913483|26252284|FG000|Overall Study|Lost to Follow-up|6|||
13211382|NCT01913483|26252285|FG001|Overall Study|Lost to Follow-up|3|||
13211383|NCT01913483|26252284|FG000|Overall Study|Death|14|||
13211384|NCT01913483|26252285|FG001|Overall Study|Death|17|||
13211385|NCT01913470|26252310|FG000|Overall Study|Lost to Follow-up|0|||
13211386|NCT01913470|26252311|FG001|Overall Study|Lost to Follow-up|1|||
13211387|NCT01913470|26252310|FG000|Overall Study|Physician Decision|0|||
13211388|NCT01913470|26252311|FG001|Overall Study|Physician Decision|1|||
13211389|NCT01913470|26252310|FG000|Overall Study|Withdrawal by Subject|0|||
13211390|NCT01913470|26252311|FG001|Overall Study|Withdrawal by Subject|1|||
13211391|NCT01913405|26252367|FG000|Overall Study|Withdrawal by Subject|1|||
13211392|NCT01913405|26252367|FG000|Overall Study|Adverse Event|1|||
13211393|NCT01913353|26252442|FG000|Overall Study|Adverse Event|2|||
13211394|NCT01913353|26252443|FG001|Overall Study|Adverse Event|0|||
13211395|NCT01913353|26252442|FG000|Overall Study|Physician Decision|0|||
13211396|NCT01913353|26252443|FG001|Overall Study|Physician Decision|2|||
13211397|NCT01913353|26252442|FG000|Overall Study|Withdrawal by Subject|20|||
13211398|NCT01913353|26252443|FG001|Overall Study|Withdrawal by Subject|6|||
13211399|NCT01913353|26252442|FG000|Overall Study|multiple reasons|10|||
13211400|NCT01913353|26252443|FG001|Overall Study|multiple reasons|7|||
13211401|NCT01913340|26252472|FG000|Overall Study|Death|2|||
13211402|NCT01913340|26252473|FG001|Overall Study|Death|5|||
13211403|NCT01913340|26252472|FG000|Overall Study|Lost to Follow-up|1|||
13211404|NCT01913340|26252473|FG001|Overall Study|Lost to Follow-up|1|||
13211405|NCT01913327|26252492|FG000|Overall Study|Withdrawal by Subject|0|||
13211406|NCT01913327|26252493|FG001|Overall Study|Withdrawal by Subject|1|||
13211407|NCT01913041|26252499|FG000|Overall Study|Protocol Violation|35|||
13211408|NCT01913041|26252499|FG000|Overall Study|Withdrawal by Subject|3|||
13211409|NCT01913041|26252499|FG000|Overall Study|Physician Decision|1|||
13211410|NCT01912963|26252528|FG000|Overall Study|Disease Progression (RECIST1.1)|6|||
13211411|NCT01912963|26252529|FG001|Overall Study|Disease Progression (RECIST1.1)|9|||
13211412|NCT01912963|26252530|FG002|Overall Study|Disease Progression (RECIST1.1)|5|||
13394770|NCT00654381|26788097|FG000|2nd Stage|Withdrawal by Subject|0|||
13211413|NCT01912963|26252528|FG000|Overall Study|Disease Progression (not RECIST1.1)|0|||
13211414|NCT01912963|26252529|FG001|Overall Study|Disease Progression (not RECIST1.1)|7|||
13211415|NCT01912963|26252530|FG002|Overall Study|Disease Progression (not RECIST1.1)|1|||
13211416|NCT01912963|26252528|FG000|Overall Study|Adverse Event|0|||
13211417|NCT01912963|26252529|FG001|Overall Study|Adverse Event|1|||
13211418|NCT01912963|26252530|FG002|Overall Study|Adverse Event|1|||
13211419|NCT01912963|26252528|FG000|Overall Study|Withdrawal by Subject|0|||
13211420|NCT01912963|26252529|FG001|Overall Study|Withdrawal by Subject|1|||
13211421|NCT01912963|26252530|FG002|Overall Study|Withdrawal by Subject|0|||
13211422|NCT01912963|26252528|FG000|Overall Study|Sought treatment locally|0|||
13211423|NCT01912963|26252529|FG001|Overall Study|Sought treatment locally|1|||
13211424|NCT01912963|26252530|FG002|Overall Study|Sought treatment locally|0|||
13211425|NCT01912872|26252585|FG000|Overall Study|Lost to Follow-up|2|||
13211426|NCT01912872|26252586|FG001|Overall Study|Lost to Follow-up|3|||
13211427|NCT01912872|26252587|FG002|Overall Study|Lost to Follow-up|5|||
13394771|NCT00654381|26788098|FG001|2nd Stage|Withdrawal by Subject|0|||
13211428|NCT01912872|26252588|FG003|Overall Study|Lost to Follow-up|5|||
13211429|NCT01912872|26252585|FG000|Overall Study|Other unspecified|3|||
13211430|NCT01912872|26252586|FG001|Overall Study|Other unspecified|1|||
13211431|NCT01912872|26252587|FG002|Overall Study|Other unspecified|3|||
13211432|NCT01912872|26252588|FG003|Overall Study|Other unspecified|0|||
13211433|NCT01912872|26252585|FG000|Overall Study|Informed consent withdrawn|0|||
13211434|NCT01912872|26252586|FG001|Overall Study|Informed consent withdrawn|0|||
13211435|NCT01912872|26252587|FG002|Overall Study|Informed consent withdrawn|1|||
13211436|NCT01912872|26252588|FG003|Overall Study|Informed consent withdrawn|1|||
13211437|NCT01912872|26252585|FG000|Overall Study|Non-compliance with lab inc/exclusion|0|||
13211438|NCT01912872|26252586|FG001|Overall Study|Non-compliance with lab inc/exclusion|0|||
13211439|NCT01912872|26252587|FG002|Overall Study|Non-compliance with lab inc/exclusion|0|||
13211440|NCT01912872|26252588|FG003|Overall Study|Non-compliance with lab inc/exclusion|1|||
13211441|NCT01912872|26252585|FG000|Overall Study|Protocol Violation|0|||
13211442|NCT01912872|26252586|FG001|Overall Study|Protocol Violation|0|||
13211443|NCT01912872|26252587|FG002|Overall Study|Protocol Violation|1|||
13211444|NCT01912872|26252588|FG003|Overall Study|Protocol Violation|0|||
13211445|NCT01912872|26252585|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
13211446|NCT01912872|26252586|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
13211447|NCT01912872|26252587|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
13211448|NCT01912872|26252588|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
13211449|NCT01912872|26252585|FG000|Overall Study|Withdrawal of study medication|0|||
13211450|NCT01912872|26252586|FG001|Overall Study|Withdrawal of study medication|0|||
13211451|NCT01912872|26252587|FG002|Overall Study|Withdrawal of study medication|0|||
13211452|NCT01912872|26252588|FG003|Overall Study|Withdrawal of study medication|2|||
13211453|NCT01912872|26252585|FG000|Overall Study|Missing|0|||
13211454|NCT01912872|26252586|FG001|Overall Study|Missing|0|||
13211455|NCT01912872|26252587|FG002|Overall Study|Missing|0|||
13211456|NCT01912872|26252588|FG003|Overall Study|Missing|1|||
13211457|NCT01912807|26252607|FG000|Overall Study|Did not meet elegibility criteria|6|||
13211458|NCT01912807|26252608|FG001|Overall Study|Did not meet elegibility criteria|4|||
13211459|NCT01912807|26252607|FG000|Overall Study|Lost to Follow-up|36|||
13211460|NCT01912807|26252608|FG001|Overall Study|Lost to Follow-up|37|||
13211461|NCT01912781|26252644|FG000|Overall Study|Withdrawal by Subject|2|||
13211462|NCT01912781|26252645|FG001|Overall Study|Withdrawal by Subject|0|||
13211463|NCT01912768|26252681|FG000|Overall Study|Adverse Event|2|||
13211464|NCT01912768|26252682|FG001|Overall Study|Adverse Event|0|||
13211465|NCT01912768|26252681|FG000|Overall Study|Lost to Follow-up|2|||
13211466|NCT01912768|26252682|FG001|Overall Study|Lost to Follow-up|1|||
13211467|NCT01912768|26252681|FG000|Overall Study|Withdrawal by Subject|5|||
13211468|NCT01912768|26252682|FG001|Overall Study|Withdrawal by Subject|3|||
13211469|NCT01912768|26252681|FG000|Overall Study|Randomized in error|1|||
13211470|NCT01912768|26252682|FG001|Overall Study|Randomized in error|0|||
13211471|NCT01912729|26252699|FG000|Overall Study|Withdrawal by Subject|0|||
13211472|NCT01912729|26252700|FG001|Overall Study|Withdrawal by Subject|1|||
13211473|NCT01912612|26252750|FG000|Overall Study|Adverse Event|4|||
13211474|NCT01912612|26252751|FG001|Overall Study|Adverse Event|0|||
13211475|NCT01912612|26252752|FG002|Overall Study|Adverse Event|0|||
13211476|NCT01912612|26252750|FG000|Overall Study|Withdrew consent|1|||
13211477|NCT01912612|26252751|FG001|Overall Study|Withdrew consent|0|||
13211478|NCT01912612|26252752|FG002|Overall Study|Withdrew consent|0|||
13211479|NCT01912612|26252750|FG000|Overall Study|Study design change|0|||
13211480|NCT01912612|26252751|FG001|Overall Study|Study design change|0|||
13211481|NCT01912612|26252752|FG002|Overall Study|Study design change|3|||
13211482|NCT01912599|26252773|FG000|Overall Study|Withdrawal by Subject|0|||
13211483|NCT01912599|26252774|FG001|Overall Study|Withdrawal by Subject|1|||
13211484|NCT01912456|26252815|FG000|Period 1|Physician Decision|0|||
13211485|NCT01912456|26252816|FG001|Period 1|Physician Decision|0|||
13211486|NCT01912456|26252817|FG002|Period 1|Physician Decision|1|||
13211487|NCT01912456|26252818|FG003|Period 1|Physician Decision|0|||
13211488|NCT01912456|26252815|FG000|Period 1|non-compliance|1|||
13211489|NCT01912456|26252816|FG001|Period 1|non-compliance|0|||
13211490|NCT01912456|26252817|FG002|Period 1|non-compliance|0|||
13211491|NCT01912456|26252818|FG003|Period 1|non-compliance|1|||
13211492|NCT01912456|26252815|FG000|Period 1|Adverse Event|1|||
13211493|NCT01912456|26252816|FG001|Period 1|Adverse Event|0|||
13211494|NCT01912456|26252817|FG002|Period 1|Adverse Event|0|||
13211495|NCT01912456|26252818|FG003|Period 1|Adverse Event|1|||
13211496|NCT01912456|26252815|FG000|Period 1|Withdrawal by Subject|0|||
13211497|NCT01912456|26252816|FG001|Period 1|Withdrawal by Subject|1|||
13211498|NCT01912456|26252817|FG002|Period 1|Withdrawal by Subject|1|||
13211499|NCT01912456|26252818|FG003|Period 1|Withdrawal by Subject|1|||
13211500|NCT01912456|26252815|FG000|Period 2|Lack of Efficacy|0|||
13211501|NCT01912456|26252816|FG001|Period 2|Lack of Efficacy|2|||
13211502|NCT01912456|26252817|FG002|Period 2|Lack of Efficacy|0|||
13211503|NCT01912456|26252818|FG003|Period 2|Lack of Efficacy|0|||
13211504|NCT01912456|26252815|FG000|Period 2|Adverse Event|0|||
13211505|NCT01912456|26252816|FG001|Period 2|Adverse Event|0|||
13211506|NCT01912456|26252817|FG002|Period 2|Adverse Event|0|||
13211507|NCT01912456|26252818|FG003|Period 2|Adverse Event|1|||
13211508|NCT01912404|26252831|FG000|Overall Study|Due to personal reasons|1|||
13211509|NCT01912404|26252832|FG001|Overall Study|Due to personal reasons|0|||
13211510|NCT01912339|26252854|FG000|Blinded (0 to 3 Months)|Declined to participate|1|||
13211511|NCT01912339|26252855|FG001|Blinded (0 to 3 Months)|Declined to participate|0|||
13211512|NCT01912339|26252856|FG002|Blinded (0 to 3 Months)|Declined to participate|0|||
13211513|NCT01912339|26252854|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1|||
13211514|NCT01912339|26252855|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
13211515|NCT01912339|26252856|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
13211516|NCT01912339|26252854|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1|||
13211517|NCT01912339|26252855|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
13211518|NCT01912339|26252856|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
13211519|NCT01912339|26252854|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5|||
13211520|NCT01912339|26252855|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
13211521|NCT01912339|26252856|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
13211522|NCT01912339|26252854|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5|||
13211523|NCT01912339|26252855|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
13211524|NCT01912339|26252856|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
13211525|NCT01912339|26252854|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1|||
13211526|NCT01912339|26252855|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0|||
13211527|NCT01912339|26252856|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3|||
13211528|NCT01912339|26252854|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1|||
13211529|NCT01912339|26252855|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
13211530|NCT01912339|26252856|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
13211531|NCT01912339|26252854|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1|||
13211532|NCT01912339|26252855|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
13211533|NCT01912339|26252856|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
13211534|NCT01912339|26252854|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
13211535|NCT01912339|26252855|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
13211536|NCT01912339|26252856|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1|||
13211537|NCT01912339|26252854|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
13211538|NCT01912339|26252855|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
13211539|NCT01912339|26252856|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1|||
13211540|NCT01912339|26252854|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
13211541|NCT01912339|26252855|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
13211542|NCT01912339|26252856|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1|||
13211543|NCT01912339|26252854|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
13211544|NCT01912339|26252855|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
13211545|NCT01912339|26252856|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1|||
13211546|NCT01912339|26252854|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120|||
13211547|NCT01912339|26252855|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0|||
13211548|NCT01912339|26252856|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46|||
13211549|NCT01912287|26252874|FG000|Overall Study|Ineligible|1|||
13211550|NCT01912287|26252875|FG001|Overall Study|Ineligible|0|||
13211551|NCT01912287|26252876|FG002|Overall Study|Ineligible|1|||
13211552|NCT01912287|26252874|FG000|Overall Study|No-show|0|||
13211553|NCT01912287|26252875|FG001|Overall Study|No-show|0|||
13211554|NCT01912287|26252876|FG002|Overall Study|No-show|1|||
13211555|NCT01912287|26252874|FG000|Overall Study|Dissatisfaction with assigned treatment|4|||
13211556|NCT01912287|26252875|FG001|Overall Study|Dissatisfaction with assigned treatment|2|||
13211557|NCT01912287|26252876|FG002|Overall Study|Dissatisfaction with assigned treatment|1|||
13211558|NCT01912287|26252874|FG000|Overall Study|Felt treatment no longer needed|0|||
13211559|NCT01912287|26252875|FG001|Overall Study|Felt treatment no longer needed|1|||
13211560|NCT01912287|26252876|FG002|Overall Study|Felt treatment no longer needed|0|||
13211561|NCT01912287|26252874|FG000|Overall Study|Life circumstances|4|||
13211562|NCT01912287|26252875|FG001|Overall Study|Life circumstances|2|||
13211563|NCT01912287|26252876|FG002|Overall Study|Life circumstances|0|||
13211564|NCT01912287|26252874|FG000|Overall Study|Lost Interest|1|||
13211565|NCT01912287|26252875|FG001|Overall Study|Lost Interest|0|||
13211566|NCT01912287|26252876|FG002|Overall Study|Lost Interest|0|||
13211567|NCT01912287|26252874|FG000|Overall Study|Uknown reason - subject drop out|5|||
13211568|NCT01912287|26252875|FG001|Overall Study|Uknown reason - subject drop out|7|||
13211569|NCT01912287|26252876|FG002|Overall Study|Uknown reason - subject drop out|3|||
13211570|NCT01912287|26252874|FG000|Overall Study|Missed Assesment|1|||
13211571|NCT01912287|26252875|FG001|Overall Study|Missed Assesment|1|||
13211572|NCT01912287|26252876|FG002|Overall Study|Missed Assesment|1|||
13211573|NCT01912287|26252874|FG000|Overall Study|Scheduling/change in availability|17|||
13211574|NCT01912287|26252875|FG001|Overall Study|Scheduling/change in availability|10|||
13211575|NCT01912287|26252876|FG002|Overall Study|Scheduling/change in availability|8|||
13381985|NCT00748566|26749581|FG000|Overall Study|Lost to Follow-up|1|||
13211576|NCT01912222|26252909|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1|||
13211577|NCT01912222|26252910|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
13211578|NCT01912222|26252911|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
13211579|NCT01912222|26252909|FG000|Part B: Treatment Period|Progressive disease|10|||
13211580|NCT01912222|26252910|FG001|Part B: Treatment Period|Progressive disease|12|||
13211581|NCT01912222|26252911|FG002|Part B: Treatment Period|Progressive disease|15|||
13211582|NCT01912222|26252909|FG000|Part B: Treatment Period|Adverse Event|1|||
13211583|NCT01912222|26252910|FG001|Part B: Treatment Period|Adverse Event|2|||
13211584|NCT01912222|26252911|FG002|Part B: Treatment Period|Adverse Event|3|||
13211585|NCT01912222|26252909|FG000|Part B: Treatment Period|Withdrawal by Subject|2|||
13211586|NCT01912222|26252910|FG001|Part B: Treatment Period|Withdrawal by Subject|1|||
13211587|NCT01912222|26252911|FG002|Part B: Treatment Period|Withdrawal by Subject|2|||
13211588|NCT01911845|26252927|FG000|Overall Study|Adverse Event|2|||
13211589|NCT01911845|26252927|FG000|Overall Study|Lost to Follow-up|1|||
13211590|NCT01911845|26252927|FG000|Overall Study|Other (not specified)|3|||
13211591|NCT01911819|26252948|FG000|Overall Study|Adverse Event|0|||
13211592|NCT01911819|26252949|FG001|Overall Study|Adverse Event|1|||
13211593|NCT01911819|26252950|FG002|Overall Study|Adverse Event|0|||
13211594|NCT01911819|26252948|FG000|Overall Study|Withdrawal by Subject|1|||
13211595|NCT01911819|26252949|FG001|Overall Study|Withdrawal by Subject|1|||
13211596|NCT01911819|26252950|FG002|Overall Study|Withdrawal by Subject|0|||
13211597|NCT01911793|26252979|FG000|Overall Study|Physician Decision|1|||
13211598|NCT01911793|26252980|FG001|Overall Study|Physician Decision|5|||
13211599|NCT01911780|26253005|FG000|Double-blind Period (8 Weeks)|Adverse Event|1|||
13211600|NCT01911780|26253006|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
13211601|NCT01911780|26253005|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
13211602|NCT01911780|26253006|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
13211603|NCT01911780|26253005|FG000|Double-blind Period (8 Weeks)|Personal reason|1|||
13211604|NCT01911780|26253006|FG001|Double-blind Period (8 Weeks)|Personal reason|0|||
13211605|NCT01911780|26253005|FG000|Extension Period (52 Weeks)|Adverse Event|3|||
13211606|NCT01911780|26253006|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
13211607|NCT01911780|26253005|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0|||
13211608|NCT01911780|26253006|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2|||
13211609|NCT01911780|26253005|FG000|Extension Period (52 Weeks)|Personal reason|1|||
13211610|NCT01911780|26253006|FG001|Extension Period (52 Weeks)|Personal reason|1|||
13211611|NCT01911546|26253015|FG000|Overall Study|Lost to Follow-up|1|||
13211612|NCT01911546|26253015|FG000|Overall Study|Everolimus was discontinued|5|||
13211613|NCT01911442|26253051|FG000|Overall Study|Adverse Event|2|||
13211614|NCT01911442|26253052|FG001|Overall Study|Adverse Event|2|||
13211615|NCT01911442|26253053|FG002|Overall Study|Adverse Event|4|||
13211616|NCT01911442|26253051|FG000|Overall Study|Lack of Efficacy|1|||
13211617|NCT01911442|26253052|FG001|Overall Study|Lack of Efficacy|1|||
13211618|NCT01911442|26253053|FG002|Overall Study|Lack of Efficacy|1|||
13211619|NCT01911442|26253051|FG000|Overall Study|Lost to Follow-up|2|||
13211620|NCT01911442|26253052|FG001|Overall Study|Lost to Follow-up|0|||
13211621|NCT01911442|26253053|FG002|Overall Study|Lost to Follow-up|1|||
13211622|NCT01911442|26253051|FG000|Overall Study|Withdrawal by Subject|1|||
13211623|NCT01911442|26253052|FG001|Overall Study|Withdrawal by Subject|0|||
13211624|NCT01911442|26253053|FG002|Overall Study|Withdrawal by Subject|6|||
13211625|NCT01911442|26253051|FG000|Overall Study|Mother's Work Schedule|0|||
13211626|NCT01911442|26253052|FG001|Overall Study|Mother's Work Schedule|1|||
13211627|NCT01911442|26253053|FG002|Overall Study|Mother's Work Schedule|0|||
13211628|NCT01911429|26253095|FG000|Overall Study|Adverse Event|5|||
13211629|NCT01911429|26253096|FG001|Overall Study|Adverse Event|3|||
13211630|NCT01911429|26253097|FG002|Overall Study|Adverse Event|9|||
13211631|NCT01911429|26253095|FG000|Overall Study|Lack of Efficacy|1|||
13211632|NCT01911429|26253096|FG001|Overall Study|Lack of Efficacy|2|||
13211633|NCT01911429|26253097|FG002|Overall Study|Lack of Efficacy|4|||
13211634|NCT01911429|26253095|FG000|Overall Study|Lost to Follow-up|0|||
13211635|NCT01911429|26253096|FG001|Overall Study|Lost to Follow-up|0|||
13211636|NCT01911429|26253097|FG002|Overall Study|Lost to Follow-up|1|||
13211637|NCT01911429|26253095|FG000|Overall Study|Protocol Violation|0|||
13211638|NCT01911429|26253096|FG001|Overall Study|Protocol Violation|0|||
13211639|NCT01911429|26253097|FG002|Overall Study|Protocol Violation|1|||
13211640|NCT01911429|26253095|FG000|Overall Study|Withdrawal by Subject|5|||
13211641|NCT01911429|26253096|FG001|Overall Study|Withdrawal by Subject|5|||
13211642|NCT01911429|26253097|FG002|Overall Study|Withdrawal by Subject|4|||
13211643|NCT01911429|26253095|FG000|Overall Study|Accidental randomization|0|||
13211644|NCT01911429|26253096|FG001|Overall Study|Accidental randomization|0|||
13211645|NCT01911429|26253097|FG002|Overall Study|Accidental randomization|1|||
13211646|NCT01911429|26253095|FG000|Overall Study|subject left study|1|||
13211647|NCT01911429|26253096|FG001|Overall Study|subject left study|0|||
13211648|NCT01911429|26253097|FG002|Overall Study|subject left study|0|||
13211649|NCT01911273|26253134|FG000|Overall Study|Progression of Disease|1|||
13211650|NCT01911273|26253135|FG001|Overall Study|Progression of Disease|0|||
13211651|NCT01911273|26253134|FG000|Overall Study|Withdrawal by Subject|0|||
13211652|NCT01911273|26253135|FG001|Overall Study|Withdrawal by Subject|2|||
13211653|NCT01911260|26253158|FG000|Supplementation Period|transference or evasion of school|7|||
13211654|NCT01911260|26253159|FG001|Supplementation Period|transference or evasion of school|9|||
13211655|NCT01911260|26253160|FG002|Supplementation Period|transference or evasion of school|7|||
13211656|NCT01911260|26253161|FG003|Supplementation Period|transference or evasion of school|6|||
13211657|NCT01911260|26253158|FG000|Supplementation Period|Adverse Event|2|||
13211658|NCT01911260|26253159|FG001|Supplementation Period|Adverse Event|0|||
13211659|NCT01911260|26253160|FG002|Supplementation Period|Adverse Event|1|||
13211660|NCT01911260|26253161|FG003|Supplementation Period|Adverse Event|0|||
13211661|NCT01911260|26253158|FG000|Supplementation Period|refused to receive supplement|1|||
13211662|NCT01911260|26253159|FG001|Supplementation Period|refused to receive supplement|0|||
13211663|NCT01911260|26253160|FG002|Supplementation Period|refused to receive supplement|1|||
13211664|NCT01911260|26253161|FG003|Supplementation Period|refused to receive supplement|0|||
13211665|NCT01911260|26253158|FG000|Supplementation Period|less than 12 weeks supplementation|0|||
13211666|NCT01911260|26253159|FG001|Supplementation Period|less than 12 weeks supplementation|3|||
13211667|NCT01911260|26253160|FG002|Supplementation Period|less than 12 weeks supplementation|1|||
13211668|NCT01911260|26253161|FG003|Supplementation Period|less than 12 weeks supplementation|2|||
13211669|NCT01911260|26253158|FG000|Follow-up Period|transference or evasion of school|13|||
13211670|NCT01911260|26253159|FG001|Follow-up Period|transference or evasion of school|20|||
13211671|NCT01911260|26253160|FG002|Follow-up Period|transference or evasion of school|15|||
13211672|NCT01911260|26253161|FG003|Follow-up Period|transference or evasion of school|12|||
13211673|NCT01910519|26253192|FG000|Overall Study|Withdrawal by Subject|2|||
13211674|NCT01910519|26253193|FG001|Overall Study|Withdrawal by Subject|0|||
13211675|NCT01910519|26253192|FG000|Overall Study|Adverse Event|2|||
13211676|NCT01910519|26253193|FG001|Overall Study|Adverse Event|0|||
13211677|NCT01910441|26253206|FG000|Overall Study|Sponsor decision|0|||
13211678|NCT01910441|26253207|FG001|Overall Study|Sponsor decision|2|||
13211679|NCT01910441|26253206|FG000|Overall Study|Lost to Follow-up|6|||
13211680|NCT01910441|26253207|FG001|Overall Study|Lost to Follow-up|5|||
13211681|NCT01910441|26253206|FG000|Overall Study|Withdrawal by Subject|0|||
13211682|NCT01910441|26253207|FG001|Overall Study|Withdrawal by Subject|1|||
13211683|NCT01910441|26253206|FG000|Overall Study|Non-compliance|0|||
13211684|NCT01910441|26253207|FG001|Overall Study|Non-compliance|1|||
13211685|NCT01910441|26253206|FG000|Overall Study|Adverse Event|1|||
13211686|NCT01910441|26253207|FG001|Overall Study|Adverse Event|0|||
13211687|NCT01910441|26253206|FG000|Overall Study|Physician Decision|0|||
13211688|NCT01910441|26253207|FG001|Overall Study|Physician Decision|1|||
13211689|NCT01910402|26253282|FG000|Randomized Phase|Adverse Event|10|||
13211690|NCT01910402|26253283|FG001|Randomized Phase|Adverse Event|18|||
13211691|NCT01910402|26253282|FG000|Randomized Phase|Physician Decision|1|||
13211692|NCT01910402|26253283|FG001|Randomized Phase|Physician Decision|0|||
13211693|NCT01910402|26253282|FG000|Randomized Phase|Lack of Efficacy|5|||
13211694|NCT01910402|26253283|FG001|Randomized Phase|Lack of Efficacy|4|||
13211695|NCT01910402|26253282|FG000|Randomized Phase|Lost to Follow-up|11|||
13211696|NCT01910402|26253283|FG001|Randomized Phase|Lost to Follow-up|13|||
13211697|NCT01910402|26253282|FG000|Randomized Phase|Protocol Violation|10|||
13211698|NCT01910402|26253283|FG001|Randomized Phase|Protocol Violation|13|||
13211699|NCT01910402|26253282|FG000|Randomized Phase|Withdrawal by Subject|5|||
13211700|NCT01910402|26253283|FG001|Randomized Phase|Withdrawal by Subject|7|||
13211701|NCT01910402|26253282|FG000|Continuation Phase|Ongoing|84|||
13211702|NCT01910402|26253283|FG001|Continuation Phase|Ongoing|0|||
13211703|NCT01910402|26253282|FG000|Continuation Phase|Adverse Event|1|||
13211704|NCT01910402|26253283|FG001|Continuation Phase|Adverse Event|0|||
13211705|NCT01910402|26253282|FG000|Continuation Phase|Protocol Violation|3|||
13211706|NCT01910402|26253283|FG001|Continuation Phase|Protocol Violation|0|||
13211707|NCT01910402|26253282|FG000|Continuation Phase|Withdrawal by Subject|2|||
13211708|NCT01910402|26253283|FG001|Continuation Phase|Withdrawal by Subject|0|||
13211709|NCT01910389|26253320|FG000|Overall Study|Withdrawal by Subject|2|||
13211710|NCT01910389|26253321|FG001|Overall Study|Withdrawal by Subject|0|||
13211711|NCT01910389|26253320|FG000|Overall Study|Study Closed|13|||
13211712|NCT01910389|26253321|FG001|Overall Study|Study Closed|8|||
13211713|NCT01910298|26253346|FG000|Overall Study|Adverse Event|1|||
13211714|NCT01910298|26253347|FG001|Overall Study|Adverse Event|0|||
13211715|NCT01910298|26253346|FG000|Overall Study|Withdrawal by Subject|2|||
13211716|NCT01910298|26253347|FG001|Overall Study|Withdrawal by Subject|7|||
13211717|NCT01910298|26253346|FG000|Overall Study|Protocol Deviation|0|||
13211718|NCT01910298|26253347|FG001|Overall Study|Protocol Deviation|5|||
13211719|NCT01910298|26253346|FG000|Overall Study|Lost to Follow-up|1|||
13211720|NCT01910298|26253347|FG001|Overall Study|Lost to Follow-up|1|||
13211721|NCT01910298|26253346|FG000|Overall Study|Study Terminated by Sponsor|1|||
13211722|NCT01910298|26253347|FG001|Overall Study|Study Terminated by Sponsor|17|||
13211723|NCT01910298|26253346|FG000|Overall Study|Other Miscellaneous Reasons|0|||
13211724|NCT01910298|26253347|FG001|Overall Study|Other Miscellaneous Reasons|2|||
13211725|NCT01910181|26253374|FG000|Overall Study|Death|37|||
13211726|NCT01910181|26253374|FG000|Overall Study|Lost to Follow-up|3|||
13211727|NCT01910181|26253374|FG000|Overall Study|Study Terminated by Sponsor|6|||
13211728|NCT01910129|26253404|FG000|Randomized Phase 2|Withdrawal by Subject|2|||
13211729|NCT01910129|26253405|FG001|Randomized Phase 2|Withdrawal by Subject|1|||
13211730|NCT01910129|26253406|FG002|Randomized Phase 2|Withdrawal by Subject|0|||
13211731|NCT01910129|26253404|FG000|Randomized Phase 3|Withdrawal by Subject|0|||
13211732|NCT01910129|26253405|FG001|Randomized Phase 3|Withdrawal by Subject|1|||
13211733|NCT01910129|26253406|FG002|Randomized Phase 3|Withdrawal by Subject|0|||
13211734|NCT01910116|26253489|FG000|Overall Study|Adverse Event|0|||
13211735|NCT01910116|26253490|FG001|Overall Study|Adverse Event|3|||
13211736|NCT01910116|26253489|FG000|Overall Study|Lack of Efficacy|3|||
13211737|NCT01910116|26253490|FG001|Overall Study|Lack of Efficacy|4|||
13211738|NCT01910116|26253489|FG000|Overall Study|Lost to Follow-up|1|||
13211739|NCT01910116|26253490|FG001|Overall Study|Lost to Follow-up|0|||
13211740|NCT01910116|26253489|FG000|Overall Study|Protocol Violation|1|||
13211741|NCT01910116|26253490|FG001|Overall Study|Protocol Violation|2|||
13211742|NCT01910116|26253489|FG000|Overall Study|Withdrawal by Subject|8|||
13211743|NCT01910116|26253490|FG001|Overall Study|Withdrawal by Subject|3|||
13211744|NCT01910116|26253489|FG000|Overall Study|uncertain allocation|1|||
13211745|NCT01910116|26253490|FG001|Overall Study|uncertain allocation|3|||
13211746|NCT01910116|26253489|FG000|Overall Study|incomplete data|0|||
13211747|NCT01910116|26253490|FG001|Overall Study|incomplete data|1|||
13211748|NCT01909973|26253505|FG000|Overall Study|Lost to Follow-up|1|||
13211749|NCT01909973|26253506|FG001|Overall Study|Lost to Follow-up|0|||
13211750|NCT01909934|26253522|FG000|Overall Study|Ongoing|23|||
13211751|NCT01909934|26253522|FG000|Overall Study|Withdrawal by Subject|3|||
13211752|NCT01909934|26253522|FG000|Overall Study|Lost to Follow-up|1|||
13211753|NCT01909934|26253522|FG000|Overall Study|Withdrawal of Informed Consent|1|||
13211754|NCT01909934|26253522|FG000|Overall Study|Death|22|||
13211755|NCT01909804|26253605|FG000|Overall Study|Randomized but Never Treated|0|||
13211756|NCT01909804|26253606|FG001|Overall Study|Randomized but Never Treated|0|||
13211757|NCT01909804|26253607|FG002|Overall Study|Randomized but Never Treated|0|||
13211758|NCT01909804|26253608|FG003|Overall Study|Randomized but Never Treated|0|||
13211759|NCT01909804|26253609|FG004|Overall Study|Randomized but Never Treated|0|||
13211760|NCT01909804|26253610|FG005|Overall Study|Randomized but Never Treated|0|||
13211761|NCT01909804|26253611|FG006|Overall Study|Randomized but Never Treated|1|||
13211762|NCT01909804|26253612|FG007|Overall Study|Randomized but Never Treated|0|||
13211763|NCT01909804|26253613|FG008|Overall Study|Randomized but Never Treated|0|||
13211764|NCT01909804|26253614|FG009|Overall Study|Randomized but Never Treated|0|||
13211765|NCT01909804|26253615|FG010|Overall Study|Randomized but Never Treated|0|||
13211766|NCT01909804|26253616|FG011|Overall Study|Randomized but Never Treated|1|||
13211767|NCT01909804|26253605|FG000|Overall Study|Death|0|||
13211768|NCT01909804|26253606|FG001|Overall Study|Death|0|||
13211769|NCT01909804|26253607|FG002|Overall Study|Death|0|||
13211770|NCT01909804|26253608|FG003|Overall Study|Death|0|||
13211771|NCT01909804|26253609|FG004|Overall Study|Death|0|||
13211772|NCT01909804|26253610|FG005|Overall Study|Death|0|||
13211773|NCT01909804|26253611|FG006|Overall Study|Death|0|||
13211774|NCT01909804|26253612|FG007|Overall Study|Death|0|||
13211775|NCT01909804|26253613|FG008|Overall Study|Death|0|||
13211776|NCT01909804|26253614|FG009|Overall Study|Death|0|||
13211777|NCT01909804|26253615|FG010|Overall Study|Death|1|||
13211778|NCT01909804|26253616|FG011|Overall Study|Death|0|||
13211779|NCT01909804|26253605|FG000|Overall Study|Lack of Efficacy|4|||
13211780|NCT01909804|26253606|FG001|Overall Study|Lack of Efficacy|1|||
13211781|NCT01909804|26253607|FG002|Overall Study|Lack of Efficacy|0|||
13211782|NCT01909804|26253608|FG003|Overall Study|Lack of Efficacy|0|||
13211783|NCT01909804|26253609|FG004|Overall Study|Lack of Efficacy|7|||
13211784|NCT01909804|26253610|FG005|Overall Study|Lack of Efficacy|3|||
13211785|NCT01909804|26253611|FG006|Overall Study|Lack of Efficacy|1|||
13211786|NCT01909804|26253612|FG007|Overall Study|Lack of Efficacy|1|||
13211787|NCT01909804|26253613|FG008|Overall Study|Lack of Efficacy|0|||
13211788|NCT01909804|26253614|FG009|Overall Study|Lack of Efficacy|1|||
13211789|NCT01909804|26253615|FG010|Overall Study|Lack of Efficacy|0|||
13211790|NCT01909804|26253616|FG011|Overall Study|Lack of Efficacy|1|||
13211791|NCT01909804|26253605|FG000|Overall Study|Withdrew Consent|0|||
13211792|NCT01909804|26253606|FG001|Overall Study|Withdrew Consent|0|||
13211793|NCT01909804|26253607|FG002|Overall Study|Withdrew Consent|0|||
13211794|NCT01909804|26253608|FG003|Overall Study|Withdrew Consent|0|||
13211795|NCT01909804|26253609|FG004|Overall Study|Withdrew Consent|1|||
13211796|NCT01909804|26253610|FG005|Overall Study|Withdrew Consent|1|||
13211797|NCT01909804|26253611|FG006|Overall Study|Withdrew Consent|0|||
13211798|NCT01909804|26253612|FG007|Overall Study|Withdrew Consent|0|||
13211799|NCT01909804|26253613|FG008|Overall Study|Withdrew Consent|0|||
13211800|NCT01909804|26253614|FG009|Overall Study|Withdrew Consent|0|||
13211801|NCT01909804|26253615|FG010|Overall Study|Withdrew Consent|0|||
13211802|NCT01909804|26253616|FG011|Overall Study|Withdrew Consent|0|||
13211803|NCT01909804|26253605|FG000|Overall Study|Protocol Violation|0|||
13211804|NCT01909804|26253606|FG001|Overall Study|Protocol Violation|0|||
13211805|NCT01909804|26253607|FG002|Overall Study|Protocol Violation|0|||
13211806|NCT01909804|26253608|FG003|Overall Study|Protocol Violation|0|||
13211807|NCT01909804|26253609|FG004|Overall Study|Protocol Violation|0|||
13211808|NCT01909804|26253610|FG005|Overall Study|Protocol Violation|0|||
13211809|NCT01909804|26253611|FG006|Overall Study|Protocol Violation|0|||
13211810|NCT01909804|26253612|FG007|Overall Study|Protocol Violation|0|||
13211811|NCT01909804|26253613|FG008|Overall Study|Protocol Violation|0|||
13211812|NCT01909804|26253614|FG009|Overall Study|Protocol Violation|0|||
13211813|NCT01909804|26253615|FG010|Overall Study|Protocol Violation|0|||
13211814|NCT01909804|26253616|FG011|Overall Study|Protocol Violation|1|||
13211815|NCT01909791|26253684|FG000|Overall Study|Death|9|||
13211816|NCT01909791|26253685|FG001|Overall Study|Death|8|||
13211817|NCT01909791|26253686|FG002|Overall Study|Death|4|||
13211818|NCT01909791|26253684|FG000|Overall Study|Withdrawal by Subject|5|||
13211819|NCT01909791|26253685|FG001|Overall Study|Withdrawal by Subject|9|||
13211820|NCT01909791|26253686|FG002|Overall Study|Withdrawal by Subject|13|||
13211821|NCT01909791|26253684|FG000|Overall Study|Lost to Follow-up|5|||
13211822|NCT01909791|26253685|FG001|Overall Study|Lost to Follow-up|11|||
13211823|NCT01909791|26253686|FG002|Overall Study|Lost to Follow-up|10|||
13211824|NCT01909791|26253684|FG000|Overall Study|Missed Visit|2|||
13211825|NCT01909791|26253685|FG001|Overall Study|Missed Visit|0|||
13211826|NCT01909791|26253686|FG002|Overall Study|Missed Visit|1|||
13211827|NCT01909778|26253712|FG000|Overall Study|failed screening|1|||
13211828|NCT01909674|26253725|FG000|Overall Study|Withdrawal by Subject|5|||
13211829|NCT01909674|26253726|FG001|Overall Study|Withdrawal by Subject|2|||
13211830|NCT01909479|26253755|FG000|From Baseline to Week 26|Adverse Event|3|||
13211831|NCT01909479|26253756|FG001|From Baseline to Week 26|Adverse Event|2|||
13211832|NCT01909479|26253755|FG000|From Baseline to Week 26|Withdrawal by Subject|3|||
13211833|NCT01909479|26253756|FG001|From Baseline to Week 26|Withdrawal by Subject|6|||
13211834|NCT01909479|26253755|FG000|From Baseline to Week 26|Site and study closed by PI|0|||
13211835|NCT01909479|26253756|FG001|From Baseline to Week 26|Site and study closed by PI|1|||
13211836|NCT01909479|26253755|FG000|26 - 52 Weeks|Adverse Event|0|||
13211837|NCT01909479|26253756|FG001|26 - 52 Weeks|Adverse Event|1|||
13211838|NCT01909479|26253755|FG000|26 - 52 Weeks|Withdrawal by Subject|2|||
13211839|NCT01909479|26253756|FG001|26 - 52 Weeks|Withdrawal by Subject|1|||
13211840|NCT01909479|26253755|FG000|26 - 52 Weeks|Lost to Follow-up|1|||
13211841|NCT01909479|26253756|FG001|26 - 52 Weeks|Lost to Follow-up|0|||
13211842|NCT01909479|26253755|FG000|52 Weeks to End of Study|Withdrawal by Subject|18|||
13211843|NCT01909479|26253756|FG001|52 Weeks to End of Study|Withdrawal by Subject|8|||
13211844|NCT01909479|26253755|FG000|52 Weeks to End of Study|Adverse Event|2|||
13211845|NCT01909479|26253756|FG001|52 Weeks to End of Study|Adverse Event|1|||
13211846|NCT01909479|26253755|FG000|52 Weeks to End of Study|Death|0|||
13211847|NCT01909479|26253756|FG001|52 Weeks to End of Study|Death|1|||
13211848|NCT01909479|26253755|FG000|52 Weeks to End of Study|Lost to Follow-up|1|||
13211849|NCT01909479|26253756|FG001|52 Weeks to End of Study|Lost to Follow-up|0|||
13211850|NCT01909479|26253755|FG000|52 Weeks to End of Study|Protocol Violation|1|||
13211851|NCT01909479|26253756|FG001|52 Weeks to End of Study|Protocol Violation|0|||
13211852|NCT01909479|26253755|FG000|52 Weeks to End of Study|Progressive disease|1|||
13211853|NCT01909479|26253756|FG001|52 Weeks to End of Study|Progressive disease|1|||
13211854|NCT01909479|26253755|FG000|52 Weeks to End of Study|Personal reasons|2|||
13211855|NCT01909479|26253756|FG001|52 Weeks to End of Study|Personal reasons|1|||
13211856|NCT01909479|26253755|FG000|52 Weeks to End of Study|Sponsor's decision|1|||
13211857|NCT01909479|26253756|FG001|52 Weeks to End of Study|Sponsor's decision|1|||
13211858|NCT01909479|26253755|FG000|52 Weeks to End of Study|Study termination by sponsor|0|||
13211859|NCT01909479|26253756|FG001|52 Weeks to End of Study|Study termination by sponsor|1|||
13211860|NCT01909479|26253755|FG000|52 Weeks to End of Study|Lack of contact|1|||
13211861|NCT01909479|26253756|FG001|52 Weeks to End of Study|Lack of contact|0|||
13211862|NCT01909479|26253755|FG000|52 Weeks to End of Study|Occurrence of malignancy|1|||
13211863|NCT01909479|26253756|FG001|52 Weeks to End of Study|Occurrence of malignancy|0|||
13211864|NCT01909479|26253755|FG000|52 Weeks to End of Study|Diabetes not controlled|0|||
13211865|NCT01909479|26253756|FG001|52 Weeks to End of Study|Diabetes not controlled|1|||
13211866|NCT01909466|26253779|FG000|Overall Study|Lost to Follow-up|5|||
13211867|NCT01909466|26253780|FG001|Overall Study|Lost to Follow-up|7|||
13211868|NCT01909466|26253779|FG000|Overall Study|Adverse Event|3|||
13211869|NCT01909466|26253780|FG001|Overall Study|Adverse Event|4|||
13211870|NCT01909466|26253779|FG000|Overall Study|Met Withdrawal Criteria|0|||
13211871|NCT01909466|26253780|FG001|Overall Study|Met Withdrawal Criteria|3|||
13211872|NCT01909466|26253779|FG000|Overall Study|Physician Decision|2|||
13211873|NCT01909466|26253780|FG001|Overall Study|Physician Decision|0|||
13211874|NCT01909466|26253779|FG000|Overall Study|Withdrawal by Subject|11|||
13211875|NCT01909466|26253780|FG001|Overall Study|Withdrawal by Subject|9|||
13211876|NCT01909466|26253779|FG000|Overall Study|Lack of Efficacy|1|||
13211877|NCT01909466|26253780|FG001|Overall Study|Lack of Efficacy|0|||
13211878|NCT01909336|26253804|FG000|Overall Study|Lost to Follow-up|4|||
13211879|NCT01909336|26253805|FG001|Overall Study|Lost to Follow-up|2|||
13211880|NCT01909336|26253806|FG002|Overall Study|Lost to Follow-up|2|||
13211881|NCT01909336|26253804|FG000|Overall Study|Physician Decision|0|||
13211882|NCT01909336|26253805|FG001|Overall Study|Physician Decision|1|||
13211883|NCT01909336|26253806|FG002|Overall Study|Physician Decision|1|||
13211884|NCT01908907|26253833|FG000|Overall Study|Physician Decision|1|||
13211885|NCT01908907|26253834|FG001|Overall Study|Physician Decision|0|||
13211886|NCT01908907|26253833|FG000|Overall Study|Protocol Violation|1|||
13211887|NCT01908907|26253834|FG001|Overall Study|Protocol Violation|0|||
13211888|NCT01908829|26253957|FG000|Overall Study|Adverse Event|13|||
13211889|NCT01908829|26253958|FG001|Overall Study|Adverse Event|11|||
13211890|NCT01908829|26253959|FG002|Overall Study|Adverse Event|13|||
13211891|NCT01908829|26253957|FG000|Overall Study|Lost to Follow-up|4|||
13211892|NCT01908829|26253958|FG001|Overall Study|Lost to Follow-up|2|||
13211893|NCT01908829|26253959|FG002|Overall Study|Lost to Follow-up|1|||
13211894|NCT01908829|26253957|FG000|Overall Study|Randomized no double-blind drug received|1|||
13211895|NCT01908829|26253958|FG001|Overall Study|Randomized no double-blind drug received|0|||
13211896|NCT01908829|26253959|FG002|Overall Study|Randomized no double-blind drug received|1|||
13211897|NCT01908829|26253957|FG000|Overall Study|Discontinued (no EoT page)|2|||
13211898|NCT01908829|26253958|FG001|Overall Study|Discontinued (no EoT page)|0|||
13211899|NCT01908829|26253959|FG002|Overall Study|Discontinued (no EoT page)|0|||
13211900|NCT01908829|26253957|FG000|Overall Study|Miscellaneous|0|||
13211901|NCT01908829|26253958|FG001|Overall Study|Miscellaneous|2|||
13211902|NCT01908829|26253959|FG002|Overall Study|Miscellaneous|0|||
13211903|NCT01908829|26253957|FG000|Overall Study|Protocol Violation|2|||
13211904|NCT01908829|26253958|FG001|Overall Study|Protocol Violation|2|||
13211905|NCT01908829|26253959|FG002|Overall Study|Protocol Violation|0|||
13211906|NCT01908829|26253957|FG000|Overall Study|Lack of Efficacy|1|||
13211907|NCT01908829|26253958|FG001|Overall Study|Lack of Efficacy|3|||
13211908|NCT01908829|26253959|FG002|Overall Study|Lack of Efficacy|2|||
13211909|NCT01908829|26253957|FG000|Overall Study|Withdrawal by Subject|26|||
13211910|NCT01908829|26253958|FG001|Overall Study|Withdrawal by Subject|29|||
13211911|NCT01908829|26253959|FG002|Overall Study|Withdrawal by Subject|22|||
13211912|NCT01908816|26253995|FG000|Overall Study|Subject's no longer requires study drug|0|||
13211913|NCT01908816|26253996|FG001|Overall Study|Subject's no longer requires study drug|0|||
13211914|NCT01908816|26253997|FG002|Overall Study|Subject's no longer requires study drug|0|||
13211915|NCT01908816|26253998|FG003|Overall Study|Subject's no longer requires study drug|1|||
13211916|NCT01908816|26253995|FG000|Overall Study|Protocol deviation|1|||
13211917|NCT01908816|26253996|FG001|Overall Study|Protocol deviation|2|||
13211918|NCT01908816|26253997|FG002|Overall Study|Protocol deviation|1|||
13211919|NCT01908816|26253998|FG003|Overall Study|Protocol deviation|1|||
13211920|NCT01908816|26253995|FG000|Overall Study|Withdrawal by Subject|0|||
13211921|NCT01908816|26253996|FG001|Overall Study|Withdrawal by Subject|4|||
13211922|NCT01908816|26253997|FG002|Overall Study|Withdrawal by Subject|2|||
13211923|NCT01908816|26253998|FG003|Overall Study|Withdrawal by Subject|2|||
13211924|NCT01908816|26253995|FG000|Overall Study|Lost to Follow-up|3|||
13211925|NCT01908816|26253996|FG001|Overall Study|Lost to Follow-up|5|||
13211926|NCT01908816|26253997|FG002|Overall Study|Lost to Follow-up|4|||
13211927|NCT01908816|26253998|FG003|Overall Study|Lost to Follow-up|2|||
13211928|NCT01908816|26253995|FG000|Overall Study|Death|1|||
13211929|NCT01908816|26253996|FG001|Overall Study|Death|0|||
13211930|NCT01908816|26253997|FG002|Overall Study|Death|7|||
13211931|NCT01908816|26253998|FG003|Overall Study|Death|1|||
13211932|NCT01908816|26253995|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
13211933|NCT01908816|26253996|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
13211934|NCT01908816|26253997|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
13211935|NCT01908816|26253998|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
13211936|NCT01908816|26253995|FG000|Overall Study|Early termination|87|||
13211937|NCT01908816|26253996|FG001|Overall Study|Early termination|60|||
13211938|NCT01908816|26253997|FG002|Overall Study|Early termination|43|||
13211939|NCT01908816|26253998|FG003|Overall Study|Early termination|28|||
13211940|NCT01908803|26254016|FG000|Overall Study|Adverse Event|1|||
13211941|NCT01908803|26254017|FG001|Overall Study|Adverse Event|0|||
13211942|NCT01908803|26254016|FG000|Overall Study|Physician Decision|0|||
13211943|NCT01908803|26254017|FG001|Overall Study|Physician Decision|1|||
13211944|NCT01908803|26254016|FG000|Overall Study|Withdrawal by Subject|1|||
13211945|NCT01908803|26254017|FG001|Overall Study|Withdrawal by Subject|0|||
13211946|NCT01908803|26254016|FG000|Overall Study|Randomization Error|1|||
13211947|NCT01908803|26254017|FG001|Overall Study|Randomization Error|0|||
13211948|NCT01908803|26254016|FG000|Overall Study|Adverse Event (pre-treatment)|1|||
13211949|NCT01908803|26254017|FG001|Overall Study|Adverse Event (pre-treatment)|0|||
13211950|NCT01908699|26254040|FG000|Overall Study|Adverse Event|8|||
13211951|NCT01908699|26254041|FG001|Overall Study|Adverse Event|12|||
13211952|NCT01908699|26254040|FG000|Overall Study|Lack of Efficacy|2|||
13211953|NCT01908699|26254041|FG001|Overall Study|Lack of Efficacy|2|||
13211954|NCT01908699|26254040|FG000|Overall Study|Lost to Follow-up|2|||
13211955|NCT01908699|26254041|FG001|Overall Study|Lost to Follow-up|4|||
13211956|NCT01908699|26254040|FG000|Overall Study|Physician Decision|8|||
13211957|NCT01908699|26254041|FG001|Overall Study|Physician Decision|8|||
13211958|NCT01908699|26254040|FG000|Overall Study|Withdrawal by Subject|15|||
13211959|NCT01908699|26254041|FG001|Overall Study|Withdrawal by Subject|10|||
13211960|NCT01908699|26254040|FG000|Overall Study|Pregnancy|0|||
13211961|NCT01908699|26254041|FG001|Overall Study|Pregnancy|1|||
13211962|NCT01908699|26254040|FG000|Overall Study|Randomized in Error|1|||
13211963|NCT01908699|26254041|FG001|Overall Study|Randomized in Error|0|||
13211964|NCT01908699|26254040|FG000|Overall Study|Death|9|||
13211965|NCT01908699|26254041|FG001|Overall Study|Death|12|||
13211966|NCT01908699|26254040|FG000|Overall Study|Progressive Disease|30|||
13211967|NCT01908699|26254041|FG001|Overall Study|Progressive Disease|29|||
13211968|NCT01908634|26254051|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1|||
13211969|NCT01908634|26254051|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5|||
13211970|NCT01908582|26254064|FG000|Period 2|Physician Decision|1|||
13211971|NCT01908582|26254064|FG000|Period 2|Withdrawal by Subject|1|||
13211972|NCT01908426|26254081|FG000|Overall Study|Adverse Event|98|||
13211973|NCT01908426|26254082|FG001|Overall Study|Adverse Event|11|||
13211974|NCT01908426|26254081|FG000|Overall Study|Clinical Deterioration|72|||
13211975|NCT01908426|26254082|FG001|Overall Study|Clinical Deterioration|38|||
13211976|NCT01908426|26254081|FG000|Overall Study|Lack of Efficacy|3|||
13211977|NCT01908426|26254082|FG001|Overall Study|Lack of Efficacy|0|||
13211978|NCT01908426|26254081|FG000|Overall Study|Lost to Follow-up|0|||
13211979|NCT01908426|26254082|FG001|Overall Study|Lost to Follow-up|1|||
13211980|NCT01908426|26254081|FG000|Overall Study|Physician Decision|3|||
13211981|NCT01908426|26254082|FG001|Overall Study|Physician Decision|3|||
13211982|NCT01908426|26254081|FG000|Overall Study|Withdrawal by Subject|11|||
13211983|NCT01908426|26254082|FG001|Overall Study|Withdrawal by Subject|6|||
13211984|NCT01908426|26254081|FG000|Overall Study|Progressive Disease|206|||
13211985|NCT01908426|26254082|FG001|Overall Study|Progressive Disease|152|||
13211986|NCT01908426|26254081|FG000|Overall Study|Protocol Violation|1|||
13211987|NCT01908426|26254082|FG001|Overall Study|Protocol Violation|0|||
13211988|NCT01908426|26254081|FG000|Overall Study|No Study Treatment Given|3|||
13211989|NCT01908426|26254082|FG001|Overall Study|No Study Treatment Given|0|||
13211990|NCT01908205|26254115|FG000|Overall Study|Lost to Follow-up|2|||
13211991|NCT01908205|26254116|FG001|Overall Study|Lost to Follow-up|0|||
13211992|NCT01908205|26254115|FG000|Overall Study|Withdrawal by Subject|3|||
13211993|NCT01908205|26254116|FG001|Overall Study|Withdrawal by Subject|1|||
13211994|NCT01908140|26254131|FG000|Overall Study|Other or Progressive Disease|5|||
13211995|NCT01908140|26254132|FG001|Overall Study|Other or Progressive Disease|12|||
13211996|NCT01908140|26254131|FG000|Overall Study|Lack of Efficacy|7|||
13211997|NCT01908140|26254132|FG001|Overall Study|Lack of Efficacy|5|||
13211998|NCT01908140|26254131|FG000|Overall Study|Withdrawal by Subject|23|||
13211999|NCT01908140|26254132|FG001|Overall Study|Withdrawal by Subject|24|||
13212000|NCT01908140|26254131|FG000|Overall Study|Lost to Follow-up|1|||
13212001|NCT01908140|26254132|FG001|Overall Study|Lost to Follow-up|6|||
13212002|NCT01908140|26254131|FG000|Overall Study|Protocol Violation|8|||
13212003|NCT01908140|26254132|FG001|Overall Study|Protocol Violation|9|||
13212004|NCT01908140|26254131|FG000|Overall Study|Adverse Event|22|||
13212005|NCT01908140|26254132|FG001|Overall Study|Adverse Event|23|||
13212006|NCT01908101|26254138|FG000|Overall Study|Physician Decision|1|||
13212007|NCT01908101|26254138|FG000|Overall Study|Withdrawal by Subject|1|||
13212008|NCT01908101|26254138|FG000|Overall Study|Incorrect Diagnosis|2|||
13212009|NCT01908101|26254138|FG000|Overall Study|Incorrect Starting Dose|1|||
13212010|NCT01908101|26254138|FG000|Overall Study|Did not complete the first cycle|4|||
13212011|NCT01907906|26254223|FG000|Overall Study|Withdrawal by Subject|1|||
13212012|NCT01907906|26254224|FG001|Overall Study|Withdrawal by Subject|0|||
13212013|NCT01907906|26254223|FG000|Overall Study|Physician Decision|3|||
13212014|NCT01907906|26254224|FG001|Overall Study|Physician Decision|1|||
13212015|NCT01907854|26254249|FG000|Overall Study|Protocol Violation|1|||
13212016|NCT01907854|26254250|FG001|Overall Study|Protocol Violation|1|||
13212017|NCT01907854|26254249|FG000|Overall Study|Withdrawal by Subject|9|||
13212018|NCT01907854|26254250|FG001|Overall Study|Withdrawal by Subject|7|||
13212019|NCT01907854|26254249|FG000|Overall Study|Lost to Follow-up|2|||
13212020|NCT01907854|26254250|FG001|Overall Study|Lost to Follow-up|2|||
13212021|NCT01907854|26254249|FG000|Overall Study|Unclassified|4|||
13212022|NCT01907854|26254250|FG001|Overall Study|Unclassified|3|||
13212023|NCT01907828|26254283|FG000|Overall Study|Exclusion criteria not met|0|||
13212024|NCT01907828|26254284|FG001|Overall Study|Exclusion criteria not met|1|||
13212025|NCT01907828|26254283|FG000|Overall Study|Withdrawal by Subject|3|||
13212026|NCT01907828|26254284|FG001|Overall Study|Withdrawal by Subject|4|||
13212027|NCT01907828|26254283|FG000|Overall Study|Lost to Follow-up|3|||
13212028|NCT01907828|26254284|FG001|Overall Study|Lost to Follow-up|0|||
13212029|NCT01907828|26254283|FG000|Overall Study|Participant refused 24-month follow-up|1|||
13212030|NCT01907828|26254284|FG001|Overall Study|Participant refused 24-month follow-up|0|||
13212031|NCT01907828|26254283|FG000|Overall Study|Participant met exclusion criteria|0|||
13212032|NCT01907828|26254284|FG001|Overall Study|Participant met exclusion criteria|1|||
13212033|NCT01907815|26254305|FG000|Overall Study|Withdrawal by Subject|1|||
13212034|NCT01907815|26254306|FG001|Overall Study|Withdrawal by Subject|0|||
13212035|NCT01907737|26254318|FG000|Overall Study|Withdrawal by Subject|1|||
13381986|NCT00748566|26749581|FG000|Overall Study|Protocol Violation|13|||
13212036|NCT01907516|26254332|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5|||
13212037|NCT01907516|26254333|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9|||
13212038|NCT01907516|26254332|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
13212039|NCT01907516|26254333|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3|||
13212040|NCT01907516|26254332|FG000|First Intervention (3 Weeks)|Delivered before second arm|3|||
13212041|NCT01907516|26254333|FG001|First Intervention (3 Weeks)|Delivered before second arm|4|||
13212042|NCT01907516|26254332|FG000|First Intervention (3 Weeks)|Developed DKA during study|1|||
13212043|NCT01907516|26254333|FG001|First Intervention (3 Weeks)|Developed DKA during study|0|||
13212044|NCT01907217|26254352|FG000|Overall Study|Withdrawal by Subject|0|||
13212045|NCT01907217|26254353|FG001|Overall Study|Withdrawal by Subject|2|||
13212046|NCT01907100|26254380|FG000|Overall Study|PD based on modified RECIST criteria|31|||
13212047|NCT01907100|26254381|FG001|Overall Study|PD based on modified RECIST criteria|32|||
13212048|NCT01907100|26254382|FG002|Overall Study|PD based on modified RECIST criteria|95|||
13212049|NCT01907100|26254383|FG003|Overall Study|PD based on modified RECIST criteria|92|||
13212050|NCT01907100|26254380|FG000|Overall Study|Withdrawal by Subject|2|||
13212051|NCT01907100|26254381|FG001|Overall Study|Withdrawal by Subject|5|||
13212052|NCT01907100|26254382|FG002|Overall Study|Withdrawal by Subject|10|||
13212053|NCT01907100|26254383|FG003|Overall Study|Withdrawal by Subject|13|||
13212054|NCT01907100|26254380|FG000|Overall Study|Protocol Violation|0|||
13212055|NCT01907100|26254381|FG001|Overall Study|Protocol Violation|0|||
13212056|NCT01907100|26254382|FG002|Overall Study|Protocol Violation|1|||
13212057|NCT01907100|26254383|FG003|Overall Study|Protocol Violation|1|||
13212058|NCT01907100|26254380|FG000|Overall Study|Lost to Follow-up|0|||
13212059|NCT01907100|26254381|FG001|Overall Study|Lost to Follow-up|0|||
13212060|NCT01907100|26254382|FG002|Overall Study|Lost to Follow-up|0|||
13212061|NCT01907100|26254383|FG003|Overall Study|Lost to Follow-up|1|||
13212062|NCT01907100|26254380|FG000|Overall Study|Not treated|2|||
13212063|NCT01907100|26254381|FG001|Overall Study|Not treated|0|||
13212064|NCT01907100|26254382|FG002|Overall Study|Not treated|1|||
13212065|NCT01907100|26254383|FG003|Overall Study|Not treated|2|||
13212066|NCT01907100|26254380|FG000|Overall Study|Other than reasons specified|1|||
13212067|NCT01907100|26254381|FG001|Overall Study|Other than reasons specified|0|||
13212068|NCT01907100|26254382|FG002|Overall Study|Other than reasons specified|10|||
13212069|NCT01907100|26254383|FG003|Overall Study|Other than reasons specified|6|||
13212070|NCT01907100|26254380|FG000|Overall Study|Adverse event (AE)|6|||
13212071|NCT01907100|26254381|FG001|Overall Study|Adverse event (AE)|3|||
13212072|NCT01907100|26254382|FG002|Overall Study|Adverse event (AE)|22|||
13212073|NCT01907100|26254383|FG003|Overall Study|Adverse event (AE)|23|||
13212074|NCT01907100|26254380|FG000|Overall Study|Worsening/AE underlying cancer disease|0|||
13212075|NCT01907100|26254381|FG001|Overall Study|Worsening/AE underlying cancer disease|0|||
13212076|NCT01907100|26254382|FG002|Overall Study|Worsening/AE underlying cancer disease|8|||
13212077|NCT01907100|26254383|FG003|Overall Study|Worsening/AE underlying cancer disease|8|||
13212078|NCT01907087|26254394|FG000|Overall Study|Withdrawal by Subject|1|||
13212079|NCT01906489|26254455|FG000|Overall Study|Adverse Event|10|||
13212080|NCT01906489|26254456|FG001|Overall Study|Adverse Event|3|||
13212081|NCT01906489|26254455|FG000|Overall Study|Worsening of CKD|6|||
13212082|NCT01906489|26254456|FG001|Overall Study|Worsening of CKD|4|||
13212083|NCT01906489|26254455|FG000|Overall Study|Withdrawal by Subject|5|||
13212084|NCT01906489|26254456|FG001|Overall Study|Withdrawal by Subject|0|||
13212085|NCT01906489|26254455|FG000|Overall Study|Worsening of Anemia|1|||
13212086|NCT01906489|26254456|FG001|Overall Study|Worsening of Anemia|0|||
13212087|NCT01906489|26254455|FG000|Overall Study|Protocol Violation|0|||
13212088|NCT01906489|26254456|FG001|Overall Study|Protocol Violation|1|||
13212089|NCT01906489|26254455|FG000|Overall Study|Non- Compliance|1|||
13212090|NCT01906489|26254456|FG001|Overall Study|Non- Compliance|0|||
13212091|NCT01906489|26254455|FG000|Overall Study|Sponsor Decision|1|||
13212092|NCT01906489|26254456|FG001|Overall Study|Sponsor Decision|0|||
13212093|NCT01906489|26254455|FG000|Overall Study|Lost to Follow-up|1|||
13212094|NCT01906489|26254456|FG001|Overall Study|Lost to Follow-up|1|||
13212095|NCT01906489|26254455|FG000|Overall Study|Other|1|||
13212096|NCT01906489|26254456|FG001|Overall Study|Other|0|||
13212097|NCT01906476|26254471|FG000|Overall Study|Lost to Follow-up|17|||
13212098|NCT01906476|26254472|FG001|Overall Study|Lost to Follow-up|16|||
13212099|NCT01906372|26254479|FG000|Overall Study|Withdrawal by Subject|2|||
13212100|NCT01906346|26254487|FG000|Overall Study|AEs|1|||
13212101|NCT01906008|26254502|FG000|Overall Study|Lost to Follow-up|2|||
13212102|NCT01906008|26254503|FG001|Overall Study|Lost to Follow-up|0|||
13212103|NCT01906008|26254502|FG000|Overall Study|Oxaliplatin toxicity|2|||
13212104|NCT01906008|26254503|FG001|Overall Study|Oxaliplatin toxicity|0|||
13212105|NCT01906008|26254502|FG000|Overall Study|Protocol Violation|0|||
13212106|NCT01906008|26254503|FG001|Overall Study|Protocol Violation|1|||
13212107|NCT01906008|26254502|FG000|Overall Study|Withdrawal by Subject|1|||
13212108|NCT01906008|26254503|FG001|Overall Study|Withdrawal by Subject|5|||
13212109|NCT01906008|26254502|FG000|Overall Study|Did not start study med|3|||
13212110|NCT01906008|26254503|FG001|Overall Study|Did not start study med|4|||
13212111|NCT01906008|26254502|FG000|Overall Study|Oxaliplatin stops|10|||
13212112|NCT01906008|26254503|FG001|Overall Study|Oxaliplatin stops|8|||
13212113|NCT01906008|26254502|FG000|Overall Study|Hospice|1|||
13212114|NCT01906008|26254503|FG001|Overall Study|Hospice|0|||
13212115|NCT01906008|26254502|FG000|Overall Study|Physician Decision|3|||
13212116|NCT01906008|26254503|FG001|Overall Study|Physician Decision|3|||
13212117|NCT01906008|26254502|FG000|Overall Study|Lack of compliance of study med|5|||
13212118|NCT01906008|26254503|FG001|Overall Study|Lack of compliance of study med|3|||
13212119|NCT01906008|26254502|FG000|Overall Study|Adverse Event|0|||
13212120|NCT01906008|26254503|FG001|Overall Study|Adverse Event|3|||
13212121|NCT01905943|26254622|FG000|Overall Study|Withdrawal of consent|90|||
13212122|NCT01905943|26254622|FG000|Overall Study|Lost to Follow-up|16|||
13212123|NCT01905943|26254622|FG000|Overall Study|Investigator discretion|7|||
13212124|NCT01905943|26254622|FG000|Overall Study|Death|186|||
13212125|NCT01905943|26254622|FG000|Overall Study|Adverse Event|3|||
13212126|NCT01905943|26254622|FG000|Overall Study|Other|12|||
13212127|NCT01905683|26254637|FG000|Overall Study|Protocol Violation|1|||
13212128|NCT01905683|26254637|FG000|Overall Study|Re-injection criteria not met; others|13|||
13212129|NCT01905683|26254637|FG000|Overall Study|Physician Decision|1|||
13212130|NCT01905683|26254637|FG000|Overall Study|Lack of Efficacy|8|||
13212131|NCT01905683|26254637|FG000|Overall Study|Withdrawal by Subject|20|||
13212132|NCT01905683|26254637|FG000|Overall Study|Adverse Event|4|||
13212133|NCT01905683|26254637|FG000|Overall Study|Lost to Follow-up|4|||
13212134|NCT01905657|26254673|FG000|Overall Study|Adverse Event|23|||
13212135|NCT01905657|26254674|FG001|Overall Study|Adverse Event|17|||
13212136|NCT01905657|26254675|FG002|Overall Study|Adverse Event|18|||
13212137|NCT01905657|26254673|FG000|Overall Study|Clinical Progression|103|||
13212138|NCT01905657|26254674|FG001|Overall Study|Clinical Progression|78|||
13212139|NCT01905657|26254675|FG002|Overall Study|Clinical Progression|59|||
13212140|NCT01905657|26254673|FG000|Overall Study|Death|40|||
13212141|NCT01905657|26254674|FG001|Overall Study|Death|43|||
13212142|NCT01905657|26254675|FG002|Overall Study|Death|47|||
13212143|NCT01905657|26254673|FG000|Overall Study|Excluded Medication|13|||
13212144|NCT01905657|26254674|FG001|Overall Study|Excluded Medication|16|||
13212145|NCT01905657|26254675|FG002|Overall Study|Excluded Medication|9|||
13212146|NCT01905657|26254673|FG000|Overall Study|Lost to Follow-up|1|||
13212147|NCT01905657|26254674|FG001|Overall Study|Lost to Follow-up|2|||
13212148|NCT01905657|26254675|FG002|Overall Study|Lost to Follow-up|1|||
13212149|NCT01905657|26254673|FG000|Overall Study|Physician Decision|5|||
13212150|NCT01905657|26254674|FG001|Overall Study|Physician Decision|8|||
13212151|NCT01905657|26254675|FG002|Overall Study|Physician Decision|12|||
13212152|NCT01905657|26254673|FG000|Overall Study|Protocol Violation|2|||
13212153|NCT01905657|26254674|FG001|Overall Study|Protocol Violation|1|||
13212154|NCT01905657|26254675|FG002|Overall Study|Protocol Violation|1|||
13212155|NCT01905657|26254673|FG000|Overall Study|Screen Failure|0|||
13212156|NCT01905657|26254674|FG001|Overall Study|Screen Failure|1|||
13212157|NCT01905657|26254675|FG002|Overall Study|Screen Failure|0|||
13212158|NCT01905657|26254673|FG000|Overall Study|Withdrawal by Subject|15|||
13212159|NCT01905657|26254674|FG001|Overall Study|Withdrawal by Subject|21|||
13212160|NCT01905657|26254675|FG002|Overall Study|Withdrawal by Subject|53|||
13212161|NCT01905657|26254673|FG000|Overall Study|Sponsor Decision|1|||
13212162|NCT01905657|26254674|FG001|Overall Study|Sponsor Decision|0|||
13212163|NCT01905657|26254675|FG002|Overall Study|Sponsor Decision|0|||
13212164|NCT01905592|26254716|FG000|Overall Study|Disease Progression|51|||
13212165|NCT01905592|26254717|FG001|Overall Study|Disease Progression|110|||
13212166|NCT01905592|26254716|FG000|Overall Study|Toxicity|1|||
13212167|NCT01905592|26254717|FG001|Overall Study|Toxicity|16|||
13212168|NCT01905592|26254716|FG000|Overall Study|Physician Decision|0|||
13212169|NCT01905592|26254717|FG001|Overall Study|Physician Decision|2|||
13212170|NCT01905592|26254716|FG000|Overall Study|Start of New anti-cancer Treatment|1|||
13212171|NCT01905592|26254717|FG001|Overall Study|Start of New anti-cancer Treatment|0|||
13212172|NCT01905592|26254716|FG000|Overall Study|Protocol Violation|0|||
13212173|NCT01905592|26254717|FG001|Overall Study|Protocol Violation|1|||
13212174|NCT01905592|26254716|FG000|Overall Study|Sponsor's decision|1|||
13212175|NCT01905592|26254717|FG001|Overall Study|Sponsor's decision|1|||
13212176|NCT01905592|26254716|FG000|Overall Study|Not treated|7|||
13212177|NCT01905592|26254717|FG001|Overall Study|Not treated|3|||
13212178|NCT01905592|26254716|FG000|Overall Study|Withdrawal by Subject|10|||
13212179|NCT01905592|26254717|FG001|Overall Study|Withdrawal by Subject|2|||
13212180|NCT01905553|26254734|FG000|Period 2|Adverse Event|1|||
13212181|NCT01905553|26254735|FG001|Period 2|Adverse Event|0|||
13212182|NCT01905540|26254766|FG000|Period 3|Other|1|||
13212183|NCT01905540|26254767|FG001|Period 3|Other|0|||
13212184|NCT01905540|26254768|FG002|Period 3|Other|1|||
13212185|NCT01905540|26254769|FG003|Period 3|Other|1|||
13212186|NCT01905267|26254784|FG000|Overall Study|Physician Decision|2|||
13212187|NCT01905267|26254785|FG001|Overall Study|Physician Decision|2|||
13212188|NCT01904903|26254796|FG000|Overall Study|Withdrawal by Subject|1|||
13296615|NCT01369485|26497037|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2|||
13296616|NCT01369485|26497038|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0|||
13296617|NCT01369485|26497037|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11|||
13212189|NCT01904773|26254821|FG000|Screen|Screen failure|3|||
13212190|NCT01904773|26254822|FG001|Screen|Screen failure|0|||
13212191|NCT01904773|26254823|FG002|Screen|Screen failure|0|||
13212192|NCT01904773|26254824|FG003|Screen|Screen failure|0|||
13212193|NCT01904773|26254825|FG004|Screen|Screen failure|0|||
13212194|NCT01904773|26254826|FG005|Screen|Screen failure|0|||
13212195|NCT01904773|26254827|FG006|Screen|Screen failure|0|||
13296618|NCT01369485|26497038|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9|||
13296619|NCT01369485|26497037|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2|||
13296620|NCT01369485|26497038|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3|||
13296621|NCT01369485|26497037|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3|||
13296622|NCT01369485|26497038|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4|||
13296623|NCT01369485|26497037|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17|||
13296624|NCT01369485|26497038|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20|||
13296625|NCT01369485|26497037|FG000|Open Label Phase (Week 12 to Month 12)|Death|0|||
13296626|NCT01369485|26497038|FG001|Open Label Phase (Week 12 to Month 12)|Death|1|||
13296627|NCT01369485|26497037|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0|||
13296628|NCT01369485|26497038|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3|||
13296629|NCT01369433|26497051|FG000|Overall Study|Adverse Event|31|||
13296630|NCT01369433|26497052|FG001|Overall Study|Adverse Event|1|||
13296631|NCT01369433|26497051|FG000|Overall Study|Required significant surgical procedure|1|||
13296632|NCT01369433|26497052|FG001|Overall Study|Required significant surgical procedure|0|||
13296633|NCT01369433|26497051|FG000|Overall Study|Non-compliance|1|||
13296634|NCT01369433|26497052|FG001|Overall Study|Non-compliance|0|||
13296635|NCT01369433|26497051|FG000|Overall Study|Withdrawal by Subject|5|||
13296636|NCT01369433|26497052|FG001|Overall Study|Withdrawal by Subject|2|||
13296637|NCT01369433|26497051|FG000|Overall Study|Study terminated by Sponsor|67|||
13296638|NCT01369433|26497052|FG001|Overall Study|Study terminated by Sponsor|0|||
13296639|NCT01369433|26497051|FG000|Overall Study|Lost to Follow-up|1|||
13296640|NCT01369433|26497052|FG001|Overall Study|Lost to Follow-up|0|||
13296641|NCT01369433|26497051|FG000|Overall Study|Death|5|||
13296642|NCT01369433|26497052|FG001|Overall Study|Death|0|||
13296643|NCT01369433|26497051|FG000|Overall Study|Investigator discretion|6|||
13296644|NCT01369433|26497052|FG001|Overall Study|Investigator discretion|1|||
13296645|NCT01369433|26497051|FG000|Overall Study|Progressive Disease|92|||
13296646|NCT01369433|26497052|FG001|Overall Study|Progressive Disease|12|||
13296647|NCT01369355|26497103|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9|||
13296648|NCT01369355|26497104|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12|||
13296649|NCT01369355|26497105|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6|||
13296650|NCT01369355|26497106|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7|||
13296651|NCT01369355|26497107|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14|||
13296652|NCT01369355|26497108|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25|||
13296653|NCT01369355|26497109|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
13296654|NCT01369355|26497110|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
13296655|NCT01369355|26497111|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
13296656|NCT01369355|26497103|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
13296657|NCT01369355|26497104|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14|||
13296658|NCT01369355|26497105|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
13296659|NCT01369355|26497106|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
13296660|NCT01369355|26497107|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126|||
13296661|NCT01369355|26497108|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217|||
13296662|NCT01369355|26497109|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
13296663|NCT01369355|26497110|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
13296664|NCT01369355|26497111|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
13296665|NCT01369355|26497103|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
13296666|NCT01369355|26497104|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
13296667|NCT01369355|26497105|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
13296668|NCT01369355|26497106|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
13296669|NCT01369355|26497107|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
13296670|NCT01369355|26497108|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2|||
13296671|NCT01369355|26497109|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
13296672|NCT01369355|26497110|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
13296673|NCT01369355|26497111|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
13296674|NCT01369355|26497103|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
13296675|NCT01369355|26497104|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
13296676|NCT01369355|26497105|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
13296677|NCT01369355|26497106|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2|||
13296678|NCT01369355|26497107|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5|||
13296679|NCT01369355|26497108|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6|||
13296680|NCT01369355|26497109|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
13212196|NCT01904773|26254828|FG007|Screen|Screen failure|0|||
13212197|NCT01904773|26254829|FG008|Screen|Screen failure|0|||
13394772|NCT00654381|26788099|FG002|2nd Stage|Withdrawal by Subject|0|||
13212198|NCT01904773|26254821|FG000|Screen|Withdrawal by Subject|1|||
13212199|NCT01904773|26254822|FG001|Screen|Withdrawal by Subject|0|||
13212200|NCT01904773|26254823|FG002|Screen|Withdrawal by Subject|0|||
13212201|NCT01904773|26254824|FG003|Screen|Withdrawal by Subject|0|||
13212202|NCT01904773|26254825|FG004|Screen|Withdrawal by Subject|0|||
13212203|NCT01904773|26254826|FG005|Screen|Withdrawal by Subject|0|||
13212204|NCT01904773|26254827|FG006|Screen|Withdrawal by Subject|0|||
13212205|NCT01904773|26254828|FG007|Screen|Withdrawal by Subject|0|||
13212206|NCT01904773|26254829|FG008|Screen|Withdrawal by Subject|0|||
13212207|NCT01904773|26254821|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1|||
13212208|NCT01904773|26254822|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
13212209|NCT01904773|26254823|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
13212210|NCT01904773|26254824|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
13212211|NCT01904773|26254825|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
13212212|NCT01904773|26254826|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
13212213|NCT01904773|26254827|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
13212214|NCT01904773|26254828|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
13212215|NCT01904773|26254829|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
13212216|NCT01904773|26254821|FG000|First Intervention|Adverse Event|0|||
13212217|NCT01904773|26254822|FG001|First Intervention|Adverse Event|0|||
13212218|NCT01904773|26254823|FG002|First Intervention|Adverse Event|0|||
13212219|NCT01904773|26254824|FG003|First Intervention|Adverse Event|0|||
13212220|NCT01904773|26254825|FG004|First Intervention|Adverse Event|0|||
13212221|NCT01904773|26254826|FG005|First Intervention|Adverse Event|0|||
13212222|NCT01904773|26254827|FG006|First Intervention|Adverse Event|1|||
13212223|NCT01904773|26254828|FG007|First Intervention|Adverse Event|0|||
13212224|NCT01904773|26254829|FG008|First Intervention|Adverse Event|0|||
13212225|NCT01904773|26254821|FG000|Placebo Washout First Intervention|Condition worsened|0|||
13212226|NCT01904773|26254822|FG001|Placebo Washout First Intervention|Condition worsened|1|||
13212227|NCT01904773|26254823|FG002|Placebo Washout First Intervention|Condition worsened|0|||
13212228|NCT01904773|26254824|FG003|Placebo Washout First Intervention|Condition worsened|0|||
13212229|NCT01904773|26254825|FG004|Placebo Washout First Intervention|Condition worsened|0|||
13212230|NCT01904773|26254826|FG005|Placebo Washout First Intervention|Condition worsened|0|||
13212231|NCT01904773|26254827|FG006|Placebo Washout First Intervention|Condition worsened|0|||
13212232|NCT01904773|26254828|FG007|Placebo Washout First Intervention|Condition worsened|0|||
13212233|NCT01904773|26254829|FG008|Placebo Washout First Intervention|Condition worsened|0|||
13212234|NCT01904773|26254821|FG000|Fifth Intervention|Adverse Event|0|||
13212235|NCT01904773|26254822|FG001|Fifth Intervention|Adverse Event|0|||
13212236|NCT01904773|26254823|FG002|Fifth Intervention|Adverse Event|0|||
13212237|NCT01904773|26254824|FG003|Fifth Intervention|Adverse Event|0|||
13212238|NCT01904773|26254825|FG004|Fifth Intervention|Adverse Event|0|||
13212239|NCT01904773|26254826|FG005|Fifth Intervention|Adverse Event|0|||
13212240|NCT01904773|26254827|FG006|Fifth Intervention|Adverse Event|0|||
13212241|NCT01904773|26254828|FG007|Fifth Intervention|Adverse Event|1|||
13212242|NCT01904773|26254829|FG008|Fifth Intervention|Adverse Event|0|||
13212243|NCT01904773|26254821|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
13212244|NCT01904773|26254822|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1|||
13212245|NCT01904773|26254823|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
13212246|NCT01904773|26254824|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
13212247|NCT01904773|26254825|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
13212248|NCT01904773|26254826|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
13212249|NCT01904773|26254827|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
13212250|NCT01904773|26254828|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
13212251|NCT01904773|26254829|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
13212252|NCT01904760|26254844|FG000|Overall Study|Protocol Violation|1|||
13212253|NCT01904760|26254845|FG001|Overall Study|Protocol Violation|0|||
13212254|NCT01904721|26254894|FG000|Overall Study|Other Reasons|0|||
13212255|NCT01904721|26254895|FG001|Overall Study|Other Reasons|0|||
13212256|NCT01904721|26254896|FG002|Overall Study|Other Reasons|1|||
13212257|NCT01904721|26254897|FG003|Overall Study|Other Reasons|1|||
13212258|NCT01904721|26254898|FG004|Overall Study|Other Reasons|2|||
13212259|NCT01904721|26254899|FG005|Overall Study|Other Reasons|2|||
13212260|NCT01904721|26254900|FG006|Overall Study|Other Reasons|2|||
13212261|NCT01904721|26254894|FG000|Overall Study|Personal Reasons|0|||
13212262|NCT01904721|26254895|FG001|Overall Study|Personal Reasons|0|||
13212263|NCT01904721|26254896|FG002|Overall Study|Personal Reasons|0|||
13212264|NCT01904721|26254897|FG003|Overall Study|Personal Reasons|0|||
13212265|NCT01904721|26254898|FG004|Overall Study|Personal Reasons|2|||
13212266|NCT01904721|26254899|FG005|Overall Study|Personal Reasons|3|||
13212267|NCT01904721|26254900|FG006|Overall Study|Personal Reasons|3|||
13212268|NCT01904721|26254894|FG000|Overall Study|Lost to Follow-up|0|||
13212269|NCT01904721|26254895|FG001|Overall Study|Lost to Follow-up|0|||
13212270|NCT01904721|26254896|FG002|Overall Study|Lost to Follow-up|0|||
13212271|NCT01904721|26254897|FG003|Overall Study|Lost to Follow-up|0|||
13212272|NCT01904721|26254898|FG004|Overall Study|Lost to Follow-up|1|||
13212273|NCT01904721|26254899|FG005|Overall Study|Lost to Follow-up|3|||
13212274|NCT01904721|26254900|FG006|Overall Study|Lost to Follow-up|1|||
13212275|NCT01904721|26254894|FG000|Overall Study|Lack of Efficacy|0|||
13212276|NCT01904721|26254895|FG001|Overall Study|Lack of Efficacy|0|||
13212277|NCT01904721|26254896|FG002|Overall Study|Lack of Efficacy|0|||
13212278|NCT01904721|26254897|FG003|Overall Study|Lack of Efficacy|0|||
13212279|NCT01904721|26254898|FG004|Overall Study|Lack of Efficacy|0|||
13212280|NCT01904721|26254899|FG005|Overall Study|Lack of Efficacy|0|||
13212281|NCT01904721|26254900|FG006|Overall Study|Lack of Efficacy|1|||
13212282|NCT01904721|26254894|FG000|Overall Study|Adverse Event|0|||
13212283|NCT01904721|26254895|FG001|Overall Study|Adverse Event|0|||
13212284|NCT01904721|26254896|FG002|Overall Study|Adverse Event|0|||
13212285|NCT01904721|26254897|FG003|Overall Study|Adverse Event|0|||
13212286|NCT01904721|26254898|FG004|Overall Study|Adverse Event|3|||
13212287|NCT01904721|26254899|FG005|Overall Study|Adverse Event|1|||
13212288|NCT01904721|26254900|FG006|Overall Study|Adverse Event|0|||
13212289|NCT01904604|26254939|FG000|Overall Study|Withdrew before receiving dosing|0|||
13212290|NCT01904604|26254940|FG001|Overall Study|Withdrew before receiving dosing|1|||
13212291|NCT01904604|26254941|FG002|Overall Study|Withdrew before receiving dosing|0|||
13212292|NCT01904604|26254939|FG000|Overall Study|Non-compliance|1|||
13212293|NCT01904604|26254940|FG001|Overall Study|Non-compliance|0|||
13212294|NCT01904604|26254941|FG002|Overall Study|Non-compliance|0|||
13212295|NCT01904604|26254939|FG000|Overall Study|Anxiety about OFC/Refused OFC|2|||
13212296|NCT01904604|26254940|FG001|Overall Study|Anxiety about OFC/Refused OFC|0|||
13212297|NCT01904604|26254941|FG002|Overall Study|Anxiety about OFC/Refused OFC|0|||
13212298|NCT01904604|26254939|FG000|Overall Study|Patch site reactions|1|||
13212299|NCT01904604|26254940|FG001|Overall Study|Patch site reactions|1|||
13212300|NCT01904604|26254941|FG002|Overall Study|Patch site reactions|0|||
13212301|NCT01904604|26254939|FG000|Overall Study|Increased syncope|0|||
13212302|NCT01904604|26254940|FG001|Overall Study|Increased syncope|1|||
13212303|NCT01904604|26254941|FG002|Overall Study|Increased syncope|0|||
13212304|NCT01904604|26254939|FG000|Overall Study|Unrelated illness|0|||
13212305|NCT01904604|26254940|FG001|Overall Study|Unrelated illness|1|||
13212306|NCT01904604|26254941|FG002|Overall Study|Unrelated illness|0|||
13212307|NCT01904604|26254939|FG000|Overall Study|Passed Week 52 OFC|1|||
13212308|NCT01904604|26254940|FG001|Overall Study|Passed Week 52 OFC|0|||
13212309|NCT01904604|26254941|FG002|Overall Study|Passed Week 52 OFC|0|||
13212310|NCT01904604|26254939|FG000|Overall Study|Withdrawal by Subject|1|||
13212311|NCT01904604|26254940|FG001|Overall Study|Withdrawal by Subject|2|||
13212312|NCT01904604|26254941|FG002|Overall Study|Withdrawal by Subject|0|||
13212313|NCT01904604|26254939|FG000|Overall Study|Participant Relocated|1|||
13212314|NCT01904604|26254940|FG001|Overall Study|Participant Relocated|1|||
13212315|NCT01904604|26254941|FG002|Overall Study|Participant Relocated|1|||
13212316|NCT01904604|26254939|FG000|Overall Study|Lost to Follow-up|0|||
13212317|NCT01904604|26254940|FG001|Overall Study|Lost to Follow-up|0|||
13212318|NCT01904604|26254941|FG002|Overall Study|Lost to Follow-up|1|||
13212319|NCT01904383|26254948|FG000|Overall Study|CRF not collected|117|||
13212320|NCT01904383|26254948|FG000|Overall Study|Reason not listed|147|||
13212321|NCT01904383|26254948|FG000|Overall Study|Lost to Follow-up|674|||
13212322|NCT01904383|26254948|FG000|Overall Study|Lack of Efficacy|370|||
13212323|NCT01904383|26254948|FG000|Overall Study|Improvement|141|||
13212324|NCT01904383|26254948|FG000|Overall Study|Adverse Event|271|||
13212325|NCT01904383|26254948|FG000|Overall Study|No patient visit after entry|54|||
13212326|NCT01904149|26254989|FG000|Overall Study|Adverse Event|3|||
13212327|NCT01904149|26254990|FG001|Overall Study|Adverse Event|4|||
13212328|NCT01904149|26254991|FG002|Overall Study|Adverse Event|0|||
13212329|NCT01904149|26254992|FG003|Overall Study|Adverse Event|1|||
13212330|NCT01904149|26254993|FG004|Overall Study|Adverse Event|1|||
13212331|NCT01904149|26254994|FG005|Overall Study|Adverse Event|2|||
13212332|NCT01904149|26254989|FG000|Overall Study|Lack of Efficacy|0|||
13212333|NCT01904149|26254990|FG001|Overall Study|Lack of Efficacy|3|||
13212334|NCT01904149|26254991|FG002|Overall Study|Lack of Efficacy|1|||
13212335|NCT01904149|26254992|FG003|Overall Study|Lack of Efficacy|3|||
13212336|NCT01904149|26254993|FG004|Overall Study|Lack of Efficacy|3|||
13212337|NCT01904149|26254994|FG005|Overall Study|Lack of Efficacy|1|||
13212338|NCT01904149|26254989|FG000|Overall Study|Withdrawal by Subject|1|||
13212339|NCT01904149|26254990|FG001|Overall Study|Withdrawal by Subject|3|||
13212340|NCT01904149|26254991|FG002|Overall Study|Withdrawal by Subject|1|||
13212341|NCT01904149|26254992|FG003|Overall Study|Withdrawal by Subject|0|||
13212342|NCT01904149|26254993|FG004|Overall Study|Withdrawal by Subject|1|||
13212343|NCT01904149|26254994|FG005|Overall Study|Withdrawal by Subject|0|||
13212344|NCT01904149|26254989|FG000|Overall Study|Protocol Violation|0|||
13212345|NCT01904149|26254990|FG001|Overall Study|Protocol Violation|1|||
13212346|NCT01904149|26254991|FG002|Overall Study|Protocol Violation|0|||
13212347|NCT01904149|26254992|FG003|Overall Study|Protocol Violation|0|||
13212348|NCT01904149|26254993|FG004|Overall Study|Protocol Violation|0|||
13212349|NCT01904149|26254994|FG005|Overall Study|Protocol Violation|0|||
13212350|NCT01904149|26254989|FG000|Overall Study|non compliance with study drug|1|||
13212351|NCT01904149|26254990|FG001|Overall Study|non compliance with study drug|0|||
13212352|NCT01904149|26254991|FG002|Overall Study|non compliance with study drug|0|||
13212353|NCT01904149|26254992|FG003|Overall Study|non compliance with study drug|0|||
13212354|NCT01904149|26254993|FG004|Overall Study|non compliance with study drug|0|||
13212355|NCT01904149|26254994|FG005|Overall Study|non compliance with study drug|0|||
13212356|NCT01904058|26255045|FG000|Overall Study|Adverse Event|2|||
13212357|NCT01904058|26255046|FG001|Overall Study|Adverse Event|0|||
13212358|NCT01904058|26255047|FG002|Overall Study|Adverse Event|0|||
13212359|NCT01904058|26255048|FG003|Overall Study|Adverse Event|0|||
13212360|NCT01904058|26255045|FG000|Overall Study|Withdrawal by Subject|1|||
13212361|NCT01904058|26255046|FG001|Overall Study|Withdrawal by Subject|0|||
13212362|NCT01904058|26255047|FG002|Overall Study|Withdrawal by Subject|1|||
13212363|NCT01904058|26255048|FG003|Overall Study|Withdrawal by Subject|0|||
13212364|NCT01904058|26255045|FG000|Overall Study|Pregnancy|0|||
13212365|NCT01904058|26255046|FG001|Overall Study|Pregnancy|0|||
13212366|NCT01904058|26255047|FG002|Overall Study|Pregnancy|0|||
13212367|NCT01904058|26255048|FG003|Overall Study|Pregnancy|1|||
13212368|NCT01904032|26255067|FG000|Overall Study|Adverse Event|3|||
13212369|NCT01904032|26255068|FG001|Overall Study|Adverse Event|1|||
13212370|NCT01904032|26255067|FG000|Overall Study|Lost to Follow-up|4|||
13212371|NCT01904032|26255068|FG001|Overall Study|Lost to Follow-up|2|||
13212372|NCT01904019|26255085|FG000|1 Year Follow-up|Withdrawal by Subject|4|||
13212373|NCT01904019|26255085|FG000|1 Year Follow-up|Impossibility to contact patient|5|||
13212374|NCT01904019|26255085|FG000|3 Year Follow-up|Withdrawal by Subject|1|||
13212375|NCT01904019|26255085|FG000|3 Year Follow-up|Impossibility to contact patient|14|||
13212376|NCT01904019|26255085|FG000|5 Year Follow-up|Withdrawal by Subject|2|||
13212377|NCT01904019|26255085|FG000|5 Year Follow-up|Impossibility to contact patient|4|||
13212378|NCT01903993|26255107|FG000|Overall Study|Death|118|||
13212379|NCT01903993|26255108|FG001|Overall Study|Death|121|||
13212380|NCT01903993|26255107|FG000|Overall Study|Withdrawal by Subject|15|||
13212381|NCT01903993|26255108|FG001|Overall Study|Withdrawal by Subject|4|||
13212382|NCT01903993|26255107|FG000|Overall Study|Lost to Follow-up|2|||
13212383|NCT01903993|26255108|FG001|Overall Study|Lost to Follow-up|3|||
13212384|NCT01903993|26255107|FG000|Overall Study|Study Terminated by Sponsor|8|||
13212385|NCT01903993|26255108|FG001|Overall Study|Study Terminated by Sponsor|14|||
13212386|NCT01903993|26255107|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0|||
13212387|NCT01903993|26255108|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2|||
13212388|NCT01903876|26255123|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184|||
13212389|NCT01903876|26255124|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108|||
13212390|NCT01903876|26255123|FG000|Six-Month Follow-up Period|Lost to Follow-up|91|||
13212391|NCT01903876|26255124|FG001|Six-Month Follow-up Period|Lost to Follow-up|145|||
13212392|NCT01903863|26255151|FG000|Overall Study|Physician Decision|2|||
13212393|NCT01903863|26255152|FG001|Overall Study|Physician Decision|0|||
13212394|NCT01903837|26255207|FG000|Part A|Withdrawal by Subject|4|||
13212395|NCT01903837|26255208|FG001|Part A|Withdrawal by Subject|9|||
13212396|NCT01903837|26255209|FG002|Part A|Withdrawal by Subject|8|||
13212397|NCT01903837|26255210|FG003|Part A|Withdrawal by Subject|5|||
13212398|NCT01903837|26255207|FG000|Part A|Adverse Event|3|||
13212399|NCT01903837|26255208|FG001|Part A|Adverse Event|6|||
13212400|NCT01903837|26255209|FG002|Part A|Adverse Event|9|||
13212401|NCT01903837|26255210|FG003|Part A|Adverse Event|6|||
13212402|NCT01903837|26255207|FG000|Part A|Lost to Follow-up|9|||
13212403|NCT01903837|26255208|FG001|Part A|Lost to Follow-up|7|||
13212404|NCT01903837|26255209|FG002|Part A|Lost to Follow-up|7|||
13212405|NCT01903837|26255210|FG003|Part A|Lost to Follow-up|2|||
13212406|NCT01903837|26255207|FG000|Part A|Non-compliance with study drug|1|||
13212407|NCT01903837|26255208|FG001|Part A|Non-compliance with study drug|4|||
13212408|NCT01903837|26255209|FG002|Part A|Non-compliance with study drug|4|||
13212409|NCT01903837|26255210|FG003|Part A|Non-compliance with study drug|0|||
13212410|NCT01903837|26255207|FG000|Part A|Physician Decision|1|||
13212411|NCT01903837|26255208|FG001|Part A|Physician Decision|1|||
13212412|NCT01903837|26255209|FG002|Part A|Physician Decision|0|||
13212413|NCT01903837|26255210|FG003|Part A|Physician Decision|0|||
13212414|NCT01903837|26255207|FG000|Part A|Protocol Violation|1|||
13212415|NCT01903837|26255208|FG001|Part A|Protocol Violation|1|||
13212416|NCT01903837|26255209|FG002|Part A|Protocol Violation|0|||
13212417|NCT01903837|26255210|FG003|Part A|Protocol Violation|0|||
13212418|NCT01903837|26255207|FG000|Part B|Lost to Follow-up|0|||
13212419|NCT01903837|26255208|FG001|Part B|Lost to Follow-up|3|||
13212420|NCT01903837|26255209|FG002|Part B|Lost to Follow-up|3|||
13212421|NCT01903837|26255210|FG003|Part B|Lost to Follow-up|4|||
13212422|NCT01903837|26255207|FG000|Part B|Withdrawal by Subject|1|||
13212423|NCT01903837|26255208|FG001|Part B|Withdrawal by Subject|2|||
13212424|NCT01903837|26255209|FG002|Part B|Withdrawal by Subject|0|||
13212425|NCT01903837|26255210|FG003|Part B|Withdrawal by Subject|3|||
13212426|NCT01903837|26255207|FG000|Part B|Adverse Event|3|||
13212427|NCT01903837|26255208|FG001|Part B|Adverse Event|0|||
13212428|NCT01903837|26255209|FG002|Part B|Adverse Event|2|||
13212429|NCT01903837|26255210|FG003|Part B|Adverse Event|0|||
13212430|NCT01903837|26255207|FG000|Part B|Non-compliance with study drug|2|||
13212431|NCT01903837|26255208|FG001|Part B|Non-compliance with study drug|0|||
13212432|NCT01903837|26255209|FG002|Part B|Non-compliance with study drug|0|||
13212433|NCT01903837|26255210|FG003|Part B|Non-compliance with study drug|1|||
13212434|NCT01903837|26255207|FG000|Part B|Incarceration|2|||
13212435|NCT01903837|26255208|FG001|Part B|Incarceration|0|||
13212436|NCT01903837|26255209|FG002|Part B|Incarceration|0|||
13212437|NCT01903837|26255210|FG003|Part B|Incarceration|1|||
13212438|NCT01903837|26255207|FG000|Part B|Physician Decision|1|||
13212439|NCT01903837|26255208|FG001|Part B|Physician Decision|0|||
13212440|NCT01903837|26255209|FG002|Part B|Physician Decision|0|||
13212441|NCT01903837|26255210|FG003|Part B|Physician Decision|2|||
13212442|NCT01903837|26255207|FG000|Part B|Lack of Efficacy|0|||
13212443|NCT01903837|26255208|FG001|Part B|Lack of Efficacy|1|||
13212444|NCT01903837|26255209|FG002|Part B|Lack of Efficacy|0|||
13212445|NCT01903837|26255210|FG003|Part B|Lack of Efficacy|0|||
13212446|NCT01903811|26255230|FG000|Overall Study|No measurable disease|1|||
13212447|NCT01903811|26255231|FG001|Overall Study|No measurable disease|1|||
13212448|NCT01903811|26255230|FG000|Overall Study|Incomplete/discontinued prior therapy|1|||
13212449|NCT01903811|26255231|FG001|Overall Study|Incomplete/discontinued prior therapy|1|||
13212450|NCT01903811|26255230|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6|||
13212451|NCT01903811|26255231|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11|||
13212452|NCT01903811|26255230|FG000|Overall Study|Withdrawal by Subject|0|||
13212453|NCT01903811|26255231|FG001|Overall Study|Withdrawal by Subject|1|||
13212454|NCT01903720|26255248|FG000|Overall Study|Inclusion / exclusion criteria not met|6|||
13212455|NCT01903720|26255248|FG000|Overall Study|Adverse Event|1|||
13212456|NCT01903720|26255248|FG000|Overall Study|Rescinding of informed consent|2|||
13212457|NCT01903720|26255248|FG000|Overall Study|Lost to Follow-up|2|||
13212458|NCT01903720|26255248|FG000|Overall Study|Treatment with alternative drug|1|||
13212459|NCT01903525|26255267|FG000|Overall Study|Lost to Follow-up|5|||
13212460|NCT01903525|26255268|FG001|Overall Study|Lost to Follow-up|9|||
13212461|NCT01903525|26255267|FG000|Overall Study|Adverse Event|0|||
13212462|NCT01903525|26255268|FG001|Overall Study|Adverse Event|1|||
13212463|NCT01903460|26255298|FG000|Overall Study|Adverse Event|0|||
13212464|NCT01903460|26255299|FG001|Overall Study|Adverse Event|0|||
13212465|NCT01903460|26255300|FG002|Overall Study|Adverse Event|0|||
13212466|NCT01903460|26255301|FG003|Overall Study|Adverse Event|1|||
13212467|NCT01903434|26255312|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1|||
13212468|NCT01903434|26255313|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0|||
13212469|NCT01903434|26255312|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0|||
13212470|NCT01903434|26255313|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2|||
13212471|NCT01903356|26255323|FG000|Overall Study|Lost to Follow-up|7|||
13212472|NCT01903356|26255323|FG000|Overall Study|Violated inclusion/exclusion criteria|5|||
13212473|NCT01903356|26255323|FG000|Overall Study|Violated the dosage and administration|3|||
13212474|NCT01903252|26255411|FG000|Double-Blind Induction|Adverse Event|20|||
13212475|NCT01903252|26255412|FG001|Double-Blind Induction|Adverse Event|18|||
13212476|NCT01903252|26255413|FG002|Double-Blind Induction|Adverse Event|0|||
13212477|NCT01903252|26255414|FG003|Double-Blind Induction|Adverse Event|0|||
13212478|NCT01903252|26255415|FG004|Double-Blind Induction|Adverse Event|0|||
13212479|NCT01903252|26255416|FG005|Double-Blind Induction|Adverse Event|0|||
13212480|NCT01903252|26255411|FG000|Double-Blind Induction|Withdrawal by Subject|10|||
13212481|NCT01903252|26255412|FG001|Double-Blind Induction|Withdrawal by Subject|13|||
13212482|NCT01903252|26255413|FG002|Double-Blind Induction|Withdrawal by Subject|0|||
13212483|NCT01903252|26255414|FG003|Double-Blind Induction|Withdrawal by Subject|0|||
13212484|NCT01903252|26255415|FG004|Double-Blind Induction|Withdrawal by Subject|0|||
13212485|NCT01903252|26255416|FG005|Double-Blind Induction|Withdrawal by Subject|0|||
13212486|NCT01903252|26255411|FG000|Double-Blind Induction|Physician Decision|2|||
13212487|NCT01903252|26255412|FG001|Double-Blind Induction|Physician Decision|3|||
13212488|NCT01903252|26255413|FG002|Double-Blind Induction|Physician Decision|0|||
13212489|NCT01903252|26255414|FG003|Double-Blind Induction|Physician Decision|0|||
13212490|NCT01903252|26255415|FG004|Double-Blind Induction|Physician Decision|0|||
13212491|NCT01903252|26255416|FG005|Double-Blind Induction|Physician Decision|0|||
13212492|NCT01903252|26255411|FG000|Double-Blind Induction|non-compliance,|7|||
13212493|NCT01903252|26255412|FG001|Double-Blind Induction|non-compliance,|7|||
13212494|NCT01903252|26255413|FG002|Double-Blind Induction|non-compliance,|0|||
13212495|NCT01903252|26255414|FG003|Double-Blind Induction|non-compliance,|0|||
13212496|NCT01903252|26255415|FG004|Double-Blind Induction|non-compliance,|0|||
13212497|NCT01903252|26255416|FG005|Double-Blind Induction|non-compliance,|0|||
13212498|NCT01903252|26255411|FG000|Extended Induction, Open-Label|Adverse Event|0|||
13212499|NCT01903252|26255412|FG001|Extended Induction, Open-Label|Adverse Event|0|||
13212500|NCT01903252|26255413|FG002|Extended Induction, Open-Label|Adverse Event|17|||
13212501|NCT01903252|26255414|FG003|Extended Induction, Open-Label|Adverse Event|0|||
13212502|NCT01903252|26255415|FG004|Extended Induction, Open-Label|Adverse Event|0|||
13212503|NCT01903252|26255416|FG005|Extended Induction, Open-Label|Adverse Event|0|||
13212504|NCT01903252|26255411|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0|||
13212505|NCT01903252|26255412|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0|||
13212506|NCT01903252|26255413|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5|||
13212507|NCT01903252|26255414|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0|||
13212508|NCT01903252|26255415|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0|||
13212509|NCT01903252|26255416|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0|||
13212510|NCT01903252|26255411|FG000|Extended Induction, Open-Label|Physician Decision|0|||
13212511|NCT01903252|26255412|FG001|Extended Induction, Open-Label|Physician Decision|0|||
13212512|NCT01903252|26255413|FG002|Extended Induction, Open-Label|Physician Decision|1|||
13212513|NCT01903252|26255414|FG003|Extended Induction, Open-Label|Physician Decision|0|||
13212514|NCT01903252|26255415|FG004|Extended Induction, Open-Label|Physician Decision|0|||
13212515|NCT01903252|26255416|FG005|Extended Induction, Open-Label|Physician Decision|0|||
13212516|NCT01903252|26255411|FG000|Maintenance, Open-Label|Adverse Event|0|||
13212517|NCT01903252|26255412|FG001|Maintenance, Open-Label|Adverse Event|0|||
13212518|NCT01903252|26255413|FG002|Maintenance, Open-Label|Adverse Event|0|||
13212519|NCT01903252|26255414|FG003|Maintenance, Open-Label|Adverse Event|3|||
13212520|NCT01903252|26255415|FG004|Maintenance, Open-Label|Adverse Event|9|||
13212521|NCT01903252|26255416|FG005|Maintenance, Open-Label|Adverse Event|14|||
13212522|NCT01903252|26255411|FG000|Maintenance, Open-Label|Withdrawal by Subject|0|||
13212523|NCT01903252|26255412|FG001|Maintenance, Open-Label|Withdrawal by Subject|0|||
13212524|NCT01903252|26255413|FG002|Maintenance, Open-Label|Withdrawal by Subject|0|||
13212525|NCT01903252|26255414|FG003|Maintenance, Open-Label|Withdrawal by Subject|1|||
13212526|NCT01903252|26255415|FG004|Maintenance, Open-Label|Withdrawal by Subject|6|||
13212527|NCT01903252|26255416|FG005|Maintenance, Open-Label|Withdrawal by Subject|2|||
13212528|NCT01903252|26255411|FG000|Maintenance, Open-Label|Other|0|||
13212529|NCT01903252|26255412|FG001|Maintenance, Open-Label|Other|0|||
13212530|NCT01903252|26255413|FG002|Maintenance, Open-Label|Other|0|||
13212531|NCT01903252|26255414|FG003|Maintenance, Open-Label|Other|2|||
13212532|NCT01903252|26255415|FG004|Maintenance, Open-Label|Other|6|||
13212533|NCT01903252|26255416|FG005|Maintenance, Open-Label|Other|2|||
13212534|NCT01903031|26255466|FG000|Overall Study|Not Able to Attend Clinic|1|||
13212535|NCT01903031|26255467|FG001|Overall Study|Not Able to Attend Clinic|1|||
13212536|NCT01903031|26255468|FG002|Overall Study|Not Able to Attend Clinic|0|||
13212537|NCT01903031|26255466|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1|||
13212538|NCT01903031|26255467|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
13212539|NCT01903031|26255468|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
13212540|NCT01903031|26255466|FG000|Overall Study|Adverse Event|0|||
13212541|NCT01903031|26255467|FG001|Overall Study|Adverse Event|1|||
13212542|NCT01903031|26255468|FG002|Overall Study|Adverse Event|0|||
13212543|NCT01903031|26255466|FG000|Overall Study|Withdrawal by Subject|0|||
13212544|NCT01903031|26255467|FG001|Overall Study|Withdrawal by Subject|1|||
13212545|NCT01903031|26255468|FG002|Overall Study|Withdrawal by Subject|1|||
13212546|NCT01903031|26255466|FG000|Overall Study|Protocol Violation|0|||
13212547|NCT01903031|26255467|FG001|Overall Study|Protocol Violation|0|||
13212548|NCT01903031|26255468|FG002|Overall Study|Protocol Violation|2|||
13212549|NCT01903031|26255466|FG000|Overall Study|Lost to Follow-up|0|||
13212550|NCT01903031|26255467|FG001|Overall Study|Lost to Follow-up|0|||
13212551|NCT01903031|26255468|FG002|Overall Study|Lost to Follow-up|1|||
13212552|NCT01903031|26255466|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
13212553|NCT01903031|26255467|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
13212554|NCT01903031|26255468|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1|||
13212555|NCT01902966|26255474|FG000|Overall Study|Death|1|||
13212556|NCT01902966|26255474|FG000|Overall Study|Physician Decision|1|||
13212557|NCT01902966|26255474|FG000|Overall Study|Withdrawal by Subject|1|||
13212558|NCT01902888|26255481|FG000|Overall Study|Study Terminated|3|||
13212559|NCT01902628|26255490|FG000|Overall Study|Withdrawal of participant's consent|7|||
13212560|NCT01902628|26255490|FG000|Overall Study|Adverse Event|41|||
13212561|NCT01902628|26255490|FG000|Overall Study|Lost to Follow-up|35|||
13212562|NCT01902303|26255505|FG000|Overall Study|Adverse Event|0|||
13212563|NCT01902303|26255506|FG001|Overall Study|Adverse Event|1|||
13212564|NCT01902303|26255505|FG000|Overall Study|Lost to Follow-up|0|||
13212565|NCT01902303|26255506|FG001|Overall Study|Lost to Follow-up|1|||
13212566|NCT01902303|26255505|FG000|Overall Study|Protocol Violation|2|||
13212567|NCT01902303|26255506|FG001|Overall Study|Protocol Violation|2|||
13212568|NCT01902303|26255505|FG000|Overall Study|subject lost investigational product|0|||
13212569|NCT01902303|26255506|FG001|Overall Study|subject lost investigational product|1|||
13212570|NCT01902303|26255505|FG000|Overall Study|Did not develop a cold sore|21|||
13212571|NCT01902303|26255506|FG001|Overall Study|Did not develop a cold sore|19|||
13212572|NCT01902290|26255546|FG000|Overall Study|Withdrawal by Subject|19|||
13212573|NCT01902290|26255547|FG001|Overall Study|Withdrawal by Subject|27|||
13212574|NCT01902290|26255546|FG000|Overall Study|Lost to Follow-up|2|||
13212575|NCT01902290|26255547|FG001|Overall Study|Lost to Follow-up|2|||
13212576|NCT01902290|26255546|FG000|Overall Study|Death|1|||
13212577|NCT01902290|26255547|FG001|Overall Study|Death|0|||
13212578|NCT01902290|26255546|FG000|Overall Study|Sponsor Decision|26|||
13212579|NCT01902290|26255547|FG001|Overall Study|Sponsor Decision|24|||
13212580|NCT01902134|26255588|FG000|Overall Study|Adverse Event|3|||
13212581|NCT01902134|26255589|FG001|Overall Study|Adverse Event|1|||
13212582|NCT01902134|26255590|FG002|Overall Study|Adverse Event|2|||
13212583|NCT01902134|26255591|FG003|Overall Study|Adverse Event|1|||
13212584|NCT01902134|26255592|FG004|Overall Study|Adverse Event|1|||
13212585|NCT01902134|26255593|FG005|Overall Study|Adverse Event|3|||
13212586|NCT01902134|26255588|FG000|Overall Study|Lack of Efficacy|0|||
13212587|NCT01902134|26255589|FG001|Overall Study|Lack of Efficacy|0|||
13212588|NCT01902134|26255590|FG002|Overall Study|Lack of Efficacy|2|||
13212589|NCT01902134|26255591|FG003|Overall Study|Lack of Efficacy|0|||
13212590|NCT01902134|26255592|FG004|Overall Study|Lack of Efficacy|0|||
13212591|NCT01902134|26255593|FG005|Overall Study|Lack of Efficacy|1|||
13212592|NCT01902134|26255588|FG000|Overall Study|Physician Decision|0|||
13212593|NCT01902134|26255589|FG001|Overall Study|Physician Decision|1|||
13212594|NCT01902134|26255590|FG002|Overall Study|Physician Decision|0|||
13212595|NCT01902134|26255591|FG003|Overall Study|Physician Decision|0|||
13212596|NCT01902134|26255592|FG004|Overall Study|Physician Decision|0|||
13212597|NCT01902134|26255593|FG005|Overall Study|Physician Decision|0|||
13212598|NCT01902134|26255588|FG000|Overall Study|Protocol Violation|0|||
13212599|NCT01902134|26255589|FG001|Overall Study|Protocol Violation|0|||
13212600|NCT01902134|26255590|FG002|Overall Study|Protocol Violation|0|||
13212601|NCT01902134|26255591|FG003|Overall Study|Protocol Violation|0|||
13212602|NCT01902134|26255592|FG004|Overall Study|Protocol Violation|0|||
13212603|NCT01902134|26255593|FG005|Overall Study|Protocol Violation|1|||
13212604|NCT01902134|26255588|FG000|Overall Study|Withdrawal by Subject|4|||
13212605|NCT01902134|26255589|FG001|Overall Study|Withdrawal by Subject|8|||
13212606|NCT01902134|26255590|FG002|Overall Study|Withdrawal by Subject|9|||
13212607|NCT01902134|26255591|FG003|Overall Study|Withdrawal by Subject|1|||
13212608|NCT01902134|26255592|FG004|Overall Study|Withdrawal by Subject|5|||
13212609|NCT01902134|26255593|FG005|Overall Study|Withdrawal by Subject|4|||
13212610|NCT01902134|26255588|FG000|Overall Study|no compliance|1|||
13212611|NCT01902134|26255589|FG001|Overall Study|no compliance|0|||
13212612|NCT01902134|26255590|FG002|Overall Study|no compliance|0|||
13212613|NCT01902134|26255591|FG003|Overall Study|no compliance|0|||
13212614|NCT01902134|26255592|FG004|Overall Study|no compliance|0|||
13212615|NCT01902134|26255593|FG005|Overall Study|no compliance|0|||
13212616|NCT01902134|26255588|FG000|Overall Study|Other|0|||
13212617|NCT01902134|26255589|FG001|Overall Study|Other|1|||
13212618|NCT01902134|26255590|FG002|Overall Study|Other|2|||
13212619|NCT01902134|26255591|FG003|Overall Study|Other|0|||
13212620|NCT01902134|26255592|FG004|Overall Study|Other|1|||
13212621|NCT01902134|26255593|FG005|Overall Study|Other|0|||
13212622|NCT01901874|26255608|FG000|Screening Committee Retrospective Review|Protocol Violation|47|||
13212623|NCT01901874|26255608|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1|||
13212624|NCT01901874|26255608|FG000|1-Year (365-Day) MAE Evaluation|Death|7|||
13212625|NCT01901874|26255608|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5|||
13212626|NCT01901874|26255608|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2|||
13212627|NCT01901874|26255608|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6|||
13212628|NCT01901848|26255623|FG000|Randomized and Treated|Lost to Follow-up|3|||
13212629|NCT01901848|26255624|FG001|Randomized and Treated|Lost to Follow-up|6|||
13212630|NCT01901848|26255623|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10|||
13212631|NCT01901848|26255624|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0|||
13212632|NCT01901653|26255706|FG000|Overall Study|Death|2|||
13212633|NCT01901653|26255707|FG001|Overall Study|Death|1|||
13212634|NCT01901653|26255708|FG002|Overall Study|Death|8|||
13212635|NCT01901653|26255709|FG003|Overall Study|Death|3|||
13212636|NCT01901653|26255710|FG004|Overall Study|Death|2|||
13212637|NCT01901653|26255711|FG005|Overall Study|Death|2|||
13212638|NCT01901653|26255712|FG006|Overall Study|Death|6|||
13212639|NCT01901653|26255713|FG007|Overall Study|Death|9|||
13212640|NCT01901653|26255714|FG008|Overall Study|Death|1|||
13212641|NCT01901653|26255715|FG009|Overall Study|Death|16|||
13212642|NCT01901653|26255716|FG010|Overall Study|Death|2|||
13212643|NCT01901653|26255717|FG011|Overall Study|Death|15|||
13212644|NCT01901653|26255718|FG012|Overall Study|Death|4|||
13212645|NCT01901653|26255706|FG000|Overall Study|Lost to Follow-up|1|||
13212646|NCT01901653|26255707|FG001|Overall Study|Lost to Follow-up|0|||
13212647|NCT01901653|26255708|FG002|Overall Study|Lost to Follow-up|2|||
13212648|NCT01901653|26255709|FG003|Overall Study|Lost to Follow-up|0|||
13212649|NCT01901653|26255710|FG004|Overall Study|Lost to Follow-up|0|||
13212650|NCT01901653|26255711|FG005|Overall Study|Lost to Follow-up|1|||
13212651|NCT01901653|26255712|FG006|Overall Study|Lost to Follow-up|0|||
13212652|NCT01901653|26255713|FG007|Overall Study|Lost to Follow-up|1|||
13212653|NCT01901653|26255714|FG008|Overall Study|Lost to Follow-up|0|||
13212654|NCT01901653|26255715|FG009|Overall Study|Lost to Follow-up|0|||
13212655|NCT01901653|26255716|FG010|Overall Study|Lost to Follow-up|0|||
13212656|NCT01901653|26255717|FG011|Overall Study|Lost to Follow-up|0|||
13212657|NCT01901653|26255718|FG012|Overall Study|Lost to Follow-up|0|||
13212658|NCT01901653|26255706|FG000|Overall Study|Withdrawal by Subject|0|||
13212659|NCT01901653|26255707|FG001|Overall Study|Withdrawal by Subject|0|||
13212660|NCT01901653|26255708|FG002|Overall Study|Withdrawal by Subject|0|||
13212661|NCT01901653|26255709|FG003|Overall Study|Withdrawal by Subject|0|||
13212662|NCT01901653|26255710|FG004|Overall Study|Withdrawal by Subject|0|||
13212663|NCT01901653|26255711|FG005|Overall Study|Withdrawal by Subject|0|||
13212664|NCT01901653|26255712|FG006|Overall Study|Withdrawal by Subject|1|||
13212665|NCT01901653|26255713|FG007|Overall Study|Withdrawal by Subject|0|||
13212666|NCT01901653|26255714|FG008|Overall Study|Withdrawal by Subject|0|||
13212667|NCT01901653|26255715|FG009|Overall Study|Withdrawal by Subject|0|||
13212668|NCT01901653|26255716|FG010|Overall Study|Withdrawal by Subject|0|||
13212669|NCT01901653|26255717|FG011|Overall Study|Withdrawal by Subject|0|||
13212670|NCT01901653|26255718|FG012|Overall Study|Withdrawal by Subject|0|||
13212671|NCT01901653|26255706|FG000|Overall Study|Alive at Study Termination by Sponsor|0|||
13212672|NCT01901653|26255707|FG001|Overall Study|Alive at Study Termination by Sponsor|0|||
13212673|NCT01901653|26255708|FG002|Overall Study|Alive at Study Termination by Sponsor|1|||
13212674|NCT01901653|26255709|FG003|Overall Study|Alive at Study Termination by Sponsor|0|||
13212675|NCT01901653|26255710|FG004|Overall Study|Alive at Study Termination by Sponsor|0|||
13212676|NCT01901653|26255711|FG005|Overall Study|Alive at Study Termination by Sponsor|0|||
13212677|NCT01901653|26255712|FG006|Overall Study|Alive at Study Termination by Sponsor|0|||
13212678|NCT01901653|26255713|FG007|Overall Study|Alive at Study Termination by Sponsor|0|||
13212679|NCT01901653|26255714|FG008|Overall Study|Alive at Study Termination by Sponsor|0|||
13212680|NCT01901653|26255715|FG009|Overall Study|Alive at Study Termination by Sponsor|2|||
13212681|NCT01901653|26255716|FG010|Overall Study|Alive at Study Termination by Sponsor|0|||
13212682|NCT01901653|26255717|FG011|Overall Study|Alive at Study Termination by Sponsor|1|||
13212683|NCT01901653|26255718|FG012|Overall Study|Alive at Study Termination by Sponsor|1|||
13212684|NCT01901614|26255731|FG000|Overall Study|Adverse Event|0|||
13212685|NCT01901614|26255732|FG001|Overall Study|Adverse Event|1|||
13212686|NCT01901614|26255731|FG000|Overall Study|Lost to Follow-up|1|||
13212687|NCT01901614|26255732|FG001|Overall Study|Lost to Follow-up|0|||
13212688|NCT01901614|26255731|FG000|Overall Study|Screen Fail|1|||
13212689|NCT01901614|26255732|FG001|Overall Study|Screen Fail|0|||
13212690|NCT01901419|26255803|FG000|Overall Study|Protocol Violation|2|||
13212691|NCT01901419|26255804|FG001|Overall Study|Protocol Violation|6|||
13212692|NCT01901419|26255803|FG000|Overall Study|unavailable researchers|6|||
13212693|NCT01901419|26255804|FG001|Overall Study|unavailable researchers|3|||
13212694|NCT01901393|26255827|FG000|Overall Study|Adverse Event|1|||
13212695|NCT01901393|26255828|FG001|Overall Study|Adverse Event|0|||
13212696|NCT01901341|26255847|FG000|Overall Study|Adverse Event|4|||
13212697|NCT01901341|26255848|FG001|Overall Study|Adverse Event|2|||
13212698|NCT01901341|26255847|FG000|Overall Study|Lack of Efficacy|0|||
13212699|NCT01901341|26255848|FG001|Overall Study|Lack of Efficacy|2|||
13212700|NCT01901341|26255847|FG000|Overall Study|Lost to Follow-up|0|||
13212701|NCT01901341|26255848|FG001|Overall Study|Lost to Follow-up|1|||
13212702|NCT01901341|26255847|FG000|Overall Study|Protocol Violation|2|||
13212703|NCT01901341|26255848|FG001|Overall Study|Protocol Violation|0|||
13212704|NCT01901341|26255847|FG000|Overall Study|Study Terminated by Sponsor|13|||
13212705|NCT01901341|26255848|FG001|Overall Study|Study Terminated by Sponsor|15|||
13212706|NCT01901341|26255847|FG000|Overall Study|Withdrawal by Subject|1|||
13212707|NCT01901341|26255848|FG001|Overall Study|Withdrawal by Subject|1|||
13212708|NCT01901328|26255867|FG000|Overall Study|Lost to Follow-up|1|||
13212709|NCT01901328|26255868|FG001|Overall Study|Lost to Follow-up|0|||
13212710|NCT01901328|26255867|FG000|Overall Study|Physician Decision|0|||
13212711|NCT01901328|26255868|FG001|Overall Study|Physician Decision|1|||
13212712|NCT01901328|26255867|FG000|Overall Study|Protocol Violation|1|||
13212713|NCT01901328|26255868|FG001|Overall Study|Protocol Violation|1|||
13212714|NCT01901328|26255867|FG000|Overall Study|Study Terminated by Sponsor|19|||
13212715|NCT01901328|26255868|FG001|Overall Study|Study Terminated by Sponsor|16|||
13212716|NCT01901328|26255867|FG000|Overall Study|Withdrawal by Subject|1|||
13212717|NCT01901328|26255868|FG001|Overall Study|Withdrawal by Subject|2|||
13212718|NCT01901328|26255867|FG000|Overall Study|Lack of Efficacy|0|||
13212719|NCT01901328|26255868|FG001|Overall Study|Lack of Efficacy|1|||
13212720|NCT01901302|26255887|FG000|Overall Study|Adverse Event|2|||
13212721|NCT01901302|26255888|FG001|Overall Study|Adverse Event|1|||
13212722|NCT01901302|26255887|FG000|Overall Study|Lack of Efficacy|0|||
13212723|NCT01901302|26255888|FG001|Overall Study|Lack of Efficacy|2|||
13212724|NCT01901302|26255887|FG000|Overall Study|Study Terminated by Sponsor|23|||
13212725|NCT01901302|26255888|FG001|Overall Study|Study Terminated by Sponsor|20|||
13212726|NCT01901302|26255887|FG000|Overall Study|Withdrawal by Subject|2|||
13212727|NCT01901302|26255888|FG001|Overall Study|Withdrawal by Subject|0|||
13212728|NCT01901289|26255894|FG000|Overall Study|Death|32|||
13212729|NCT01901289|26255894|FG000|Overall Study|Lost to Follow-up|16|||
13212730|NCT01901289|26255894|FG000|Overall Study|Withdrawal by Subject|35|||
13212731|NCT01901289|26255894|FG000|Overall Study|Other type of endpoint met|2|||
13212732|NCT01901224|26255905|FG000|Overall Study|study was not funded and terminated|2|||
13212733|NCT01901185|26255914|FG000|Overall Study|Withdrawal by Subject|2|||
13212734|NCT01901146|26255937|FG000|Neoadjuvant Phase|Death|1|||
13212735|NCT01901146|26255938|FG001|Neoadjuvant Phase|Death|2|||
13212736|NCT01901146|26255939|FG002|Neoadjuvant Phase|Death|0|||
13212737|NCT01901146|26255940|FG003|Neoadjuvant Phase|Death|0|||
13212738|NCT01901146|26255941|FG004|Neoadjuvant Phase|Death|0|||
13212739|NCT01901146|26255937|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2|||
13212740|NCT01901146|26255938|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3|||
13212741|NCT01901146|26255939|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
13212742|NCT01901146|26255940|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
13212743|NCT01901146|26255941|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
13212744|NCT01901146|26255937|FG000|Neoadjuvant Phase|Lost to Follow-up|0|||
13212745|NCT01901146|26255938|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
13212746|NCT01901146|26255939|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
13212747|NCT01901146|26255940|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
13212748|NCT01901146|26255941|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
13212749|NCT01901146|26255937|FG000|Neoadjuvant Phase|Physician Decision|1|||
13212750|NCT01901146|26255938|FG001|Neoadjuvant Phase|Physician Decision|2|||
13212751|NCT01901146|26255939|FG002|Neoadjuvant Phase|Physician Decision|0|||
13212752|NCT01901146|26255940|FG003|Neoadjuvant Phase|Physician Decision|0|||
13212753|NCT01901146|26255941|FG004|Neoadjuvant Phase|Physician Decision|0|||
13212754|NCT01901146|26255937|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
13212755|NCT01901146|26255938|FG001|Neoadjuvant Phase|Withdrawal by Subject|5|||
13212756|NCT01901146|26255939|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
13212757|NCT01901146|26255940|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
13212758|NCT01901146|26255941|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
13212759|NCT01901146|26255937|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
13212760|NCT01901146|26255938|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1|||
13212761|NCT01901146|26255939|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
13212762|NCT01901146|26255940|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
13212763|NCT01901146|26255941|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
13212764|NCT01901146|26255937|FG000|Adjuvant Phase|Other|0|||
13212765|NCT01901146|26255938|FG001|Adjuvant Phase|Other|0|||
13212766|NCT01901146|26255939|FG002|Adjuvant Phase|Other|1|||
13212767|NCT01901146|26255940|FG003|Adjuvant Phase|Other|0|||
13212768|NCT01901146|26255941|FG004|Adjuvant Phase|Other|0|||
13212769|NCT01901146|26255937|FG000|Adjuvant Phase|Death|0|||
13212770|NCT01901146|26255938|FG001|Adjuvant Phase|Death|0|||
13212771|NCT01901146|26255939|FG002|Adjuvant Phase|Death|0|||
13212772|NCT01901146|26255940|FG003|Adjuvant Phase|Death|0|||
13212773|NCT01901146|26255941|FG004|Adjuvant Phase|Death|3|||
13212774|NCT01901146|26255937|FG000|Adjuvant Phase|Disease Progression or Recurrence|0|||
13212775|NCT01901146|26255938|FG001|Adjuvant Phase|Disease Progression or Recurrence|0|||
13212776|NCT01901146|26255939|FG002|Adjuvant Phase|Disease Progression or Recurrence|12|||
13212777|NCT01901146|26255940|FG003|Adjuvant Phase|Disease Progression or Recurrence|4|||
13212778|NCT01901146|26255941|FG004|Adjuvant Phase|Disease Progression or Recurrence|3|||
13212779|NCT01901146|26255937|FG000|Adjuvant Phase|Physician Decision|0|||
13212780|NCT01901146|26255938|FG001|Adjuvant Phase|Physician Decision|0|||
13212781|NCT01901146|26255939|FG002|Adjuvant Phase|Physician Decision|9|||
13212782|NCT01901146|26255940|FG003|Adjuvant Phase|Physician Decision|2|||
13212783|NCT01901146|26255941|FG004|Adjuvant Phase|Physician Decision|4|||
13212784|NCT01901146|26255937|FG000|Adjuvant Phase|Withdrawal by Subject|0|||
13212785|NCT01901146|26255938|FG001|Adjuvant Phase|Withdrawal by Subject|0|||
13212786|NCT01901146|26255939|FG002|Adjuvant Phase|Withdrawal by Subject|4|||
13212787|NCT01901146|26255940|FG003|Adjuvant Phase|Withdrawal by Subject|1|||
13212788|NCT01901146|26255941|FG004|Adjuvant Phase|Withdrawal by Subject|4|||
13212789|NCT01901055|26255975|FG000|Randomization But Not Titrated|Did not come to titration study|1|||
13212790|NCT01901055|26255976|FG001|Randomization But Not Titrated|Did not come to titration study|1|||
13212791|NCT01901055|26255975|FG000|Randomization But Not Titrated|Physician Decision|0|||
13212792|NCT01901055|26255976|FG001|Randomization But Not Titrated|Physician Decision|1|||
13212793|NCT01901055|26255975|FG000|Started Protocol to Week 6|Physician Decision|2|||
13212794|NCT01901055|26255976|FG001|Started Protocol to Week 6|Physician Decision|1|||
13212795|NCT01901055|26255975|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0|||
13212796|NCT01901055|26255976|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2|||
13212797|NCT01901055|26255975|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1|||
13212798|NCT01901055|26255976|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0|||
13212799|NCT01901055|26255975|FG000|Started Protocol to Week 6|Withdrawal by Subject|0|||
13212800|NCT01901055|26255976|FG001|Started Protocol to Week 6|Withdrawal by Subject|1|||
13212801|NCT01901055|26255975|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1|||
13212802|NCT01901055|26255976|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0|||
13212803|NCT01901055|26255975|FG000|Week 12 Assessment|Withdrawal by Subject|0|||
13212804|NCT01901055|26255976|FG001|Week 12 Assessment|Withdrawal by Subject|4|||
13212805|NCT01901055|26255975|FG000|Week 24|Withdrawal by Subject|13|||
13212806|NCT01901055|26255976|FG001|Week 24|Withdrawal by Subject|19|||
13212807|NCT01901055|26255975|FG000|Week 24|Physician Decision|1|||
13212808|NCT01901055|26255976|FG001|Week 24|Physician Decision|0|||
13212809|NCT01901055|26255975|FG000|Week 36|Withdrawal by Subject|0|||
13212810|NCT01901055|26255976|FG001|Week 36|Withdrawal by Subject|5|||
13212811|NCT01900899|26256007|FG000|Overall Study|Withdrawal by Subject|7|||
13212812|NCT01900899|26256008|FG001|Overall Study|Withdrawal by Subject|1|||
13212813|NCT01900899|26256007|FG000|Overall Study|Migrated from study area|2|||
13212814|NCT01900899|26256008|FG001|Overall Study|Migrated from study area|0|||
13212815|NCT01900730|26256021|FG000|Overall Study|Withdrawal by Subject|1|||
13212816|NCT01900730|26256022|FG001|Overall Study|Withdrawal by Subject|0|||
13212817|NCT01900730|26256021|FG000|Overall Study|Screen Failure|1|||
13212818|NCT01900730|26256022|FG001|Overall Study|Screen Failure|0|||
13212819|NCT01900691|26256029|FG000|Overall Study|Death|7|||
13212820|NCT01900691|26256029|FG000|Overall Study|Lost to Follow-up|4|||
13212821|NCT01900691|26256029|FG000|Overall Study|Study Device Not Placed|3|||
13212822|NCT01900691|26256029|FG000|Overall Study|Non study stent placed|2|||
13212823|NCT01900691|26256029|FG000|Overall Study|Six month Follow up completed, stent not removed|2|||
13212824|NCT01900691|26256029|FG000|Overall Study|Complete stent migration through digestive tract|1|||
13212825|NCT01900665|26256077|FG000|Placebo Controlled Period|Death|9|||
13212826|NCT01900665|26256078|FG001|Placebo Controlled Period|Death|16|||
13212827|NCT01900665|26256077|FG000|Placebo Controlled Period|Adverse Event|48|||
13212828|NCT01900665|26256078|FG001|Placebo Controlled Period|Adverse Event|39|||
13212829|NCT01900665|26256077|FG000|Placebo Controlled Period|Protocol Violation|1|||
13212830|NCT01900665|26256078|FG001|Placebo Controlled Period|Protocol Violation|7|||
13212831|NCT01900665|26256077|FG000|Placebo Controlled Period|Withdrawal by Subject|33|||
13212832|NCT01900665|26256078|FG001|Placebo Controlled Period|Withdrawal by Subject|45|||
13212833|NCT01900665|26256077|FG000|Placebo Controlled Period|Physician Decision|11|||
13212834|NCT01900665|26256078|FG001|Placebo Controlled Period|Physician Decision|7|||
13212835|NCT01900665|26256077|FG000|Placebo Controlled Period|Lost to Follow-up|3|||
13212836|NCT01900665|26256078|FG001|Placebo Controlled Period|Lost to Follow-up|0|||
13212837|NCT01900665|26256077|FG000|Placebo Controlled Period|Caregiver Decision|33|||
13212838|NCT01900665|26256078|FG001|Placebo Controlled Period|Caregiver Decision|41|||
13212839|NCT01900665|26256077|FG000|Placebo Controlled Period|Entry Criteria Not Met|5|||
13212840|NCT01900665|26256078|FG001|Placebo Controlled Period|Entry Criteria Not Met|9|||
13212841|NCT01900665|26256077|FG000|Open Label Period|Adverse Event|16|||
13212842|NCT01900665|26256078|FG001|Open Label Period|Adverse Event|20|||
13212843|NCT01900665|26256077|FG000|Open Label Period|Death|5|||
13212844|NCT01900665|26256078|FG001|Open Label Period|Death|6|||
13212845|NCT01900665|26256077|FG000|Open Label Period|Lost to Follow-up|1|||
13212846|NCT01900665|26256078|FG001|Open Label Period|Lost to Follow-up|1|||
13212847|NCT01900665|26256077|FG000|Open Label Period|Parent/Caregiver Decision|33|||
13212848|NCT01900665|26256078|FG001|Open Label Period|Parent/Caregiver Decision|34|||
13212849|NCT01900665|26256077|FG000|Open Label Period|Physician Decision|4|||
13212850|NCT01900665|26256078|FG001|Open Label Period|Physician Decision|4|||
13212851|NCT01900665|26256077|FG000|Open Label Period|Protocol Violation|0|||
13212852|NCT01900665|26256078|FG001|Open Label Period|Protocol Violation|1|||
13212853|NCT01900665|26256077|FG000|Open Label Period|Sponsor Decision|802|||
13212854|NCT01900665|26256078|FG001|Open Label Period|Sponsor Decision|765|||
13212855|NCT01900665|26256077|FG000|Open Label Period|Withdrawal by Subject|20|||
13212856|NCT01900665|26256078|FG001|Open Label Period|Withdrawal by Subject|28|||
13212857|NCT01900652|26256119|FG000|Overall Study|Progressive Disease|1|||
13212858|NCT01900652|26256120|FG001|Overall Study|Progressive Disease|0|||
13212859|NCT01900652|26256119|FG000|Overall Study|Consent withdrawn by subject|1|||
13212860|NCT01900652|26256120|FG001|Overall Study|Consent withdrawn by subject|1|||
13212861|NCT01900652|26256119|FG000|Overall Study|Death|3|||
13212862|NCT01900652|26256120|FG001|Overall Study|Death|0|||
13212863|NCT01900652|26256119|FG000|Overall Study|Adverse Event|2|||
13212864|NCT01900652|26256120|FG001|Overall Study|Adverse Event|1|||
13212865|NCT01900652|26256119|FG000|Overall Study|Physician Decision|1|||
13212866|NCT01900652|26256120|FG001|Overall Study|Physician Decision|1|||
13212867|NCT01900626|26256143|FG000|Overall Study|study was closed due to low enrollment|1|||
13212868|NCT01900626|26256144|FG001|Overall Study|study was closed due to low enrollment|1|||
13212869|NCT01900444|26256157|FG000|Overall Study|Protocol Violation|2|||
13212870|NCT01900444|26256157|FG000|Overall Study|Lost to Follow-up|1|||
13212871|NCT01900431|26256189|FG000|Principal Treatment Period (Part A)|Adverse Event|1|||
13212872|NCT01900431|26256190|FG001|Principal Treatment Period (Part A)|Adverse Event|3|||
13212873|NCT01900431|26256191|FG002|Principal Treatment Period (Part A)|Adverse Event|0|||
13212874|NCT01900431|26256189|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
13212875|NCT01900431|26256190|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
13212876|NCT01900431|26256191|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0|||
13212877|NCT01900431|26256189|FG000|Principal Treatment Period (Part A)|Other than specified above|0|||
13212878|NCT01900431|26256190|FG001|Principal Treatment Period (Part A)|Other than specified above|1|||
13212879|NCT01900431|26256191|FG002|Principal Treatment Period (Part A)|Other than specified above|0|||
13212880|NCT01900431|26256189|FG000|Extended Treatment Period (Part B)|Adverse Event|0|||
13212881|NCT01900431|26256190|FG001|Extended Treatment Period (Part B)|Adverse Event|2|||
13212882|NCT01900431|26256191|FG002|Extended Treatment Period (Part B)|Adverse Event|0|||
13212883|NCT01900431|26256189|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1|||
13212884|NCT01900431|26256190|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7|||
13212885|NCT01900431|26256191|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0|||
13212886|NCT01900431|26256189|FG000|Extended Treatment Period (Part B)|Other than specified above|0|||
13212887|NCT01900431|26256190|FG001|Extended Treatment Period (Part B)|Other than specified above|1|||
13212888|NCT01900431|26256191|FG002|Extended Treatment Period (Part B)|Other than specified above|0|||
13212889|NCT01900431|26256189|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0|||
13212890|NCT01900431|26256190|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0|||
13212891|NCT01900431|26256191|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2|||
13212892|NCT01900431|26256189|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
13212893|NCT01900431|26256190|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
13212894|NCT01900431|26256191|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3|||
13212895|NCT01900431|26256189|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
13212896|NCT01900431|26256190|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
13212897|NCT01900431|26256191|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3|||
13212898|NCT01900314|26256206|FG000|Overall Study|Lost to Follow-up|1|||
13212899|NCT01900314|26256207|FG001|Overall Study|Lost to Follow-up|0|||
13212900|NCT01900314|26256206|FG000|Overall Study|Protocol Violation|0|||
13212901|NCT01900314|26256207|FG001|Overall Study|Protocol Violation|1|||
13212902|NCT01900314|26256206|FG000|Overall Study|Withdrawal by Subject|3|||
13212903|NCT01900314|26256207|FG001|Overall Study|Withdrawal by Subject|3|||
13212904|NCT01900054|26256214|FG000|Overall Study|Physician Decision|1|||
13212905|NCT01900054|26256214|FG000|Overall Study|Withdrawal by Subject|1|||
13212906|NCT01899768|26256288|FG000|Part A|Adverse Event|2|||
13212907|NCT01899768|26256288|FG000|Part A|Withdrawal by Subject|1|||
13212908|NCT01899768|26256288|FG000|Part B|Adverse Event|1|||
13212909|NCT01899768|26256288|FG000|Part B|Withdrawal by Subject|1|||
13212910|NCT01899742|26256303|FG000|Overall Study|Adverse Event|5|||
13212911|NCT01899742|26256304|FG001|Overall Study|Adverse Event|4|||
13212912|NCT01899742|26256303|FG000|Overall Study|Lack of Efficacy|1|||
13212913|NCT01899742|26256304|FG001|Overall Study|Lack of Efficacy|5|||
13212914|NCT01899742|26256303|FG000|Overall Study|Protocol Violation|2|||
13212915|NCT01899742|26256304|FG001|Overall Study|Protocol Violation|2|||
13212916|NCT01899742|26256303|FG000|Overall Study|Withdrawal by Subject|9|||
13212917|NCT01899742|26256304|FG001|Overall Study|Withdrawal by Subject|5|||
13212918|NCT01899729|26256332|FG000|Overall Study|Adverse Event|1|||
13212919|NCT01899729|26256333|FG001|Overall Study|Adverse Event|0|||
13212920|NCT01899729|26256334|FG002|Overall Study|Adverse Event|0|||
13212921|NCT01899729|26256335|FG003|Overall Study|Adverse Event|0|||
13212922|NCT01899729|26256336|FG004|Overall Study|Adverse Event|1|||
13212923|NCT01899729|26256332|FG000|Overall Study|Withdrawal by Subject|1|||
13212924|NCT01899729|26256333|FG001|Overall Study|Withdrawal by Subject|2|||
13212925|NCT01899729|26256334|FG002|Overall Study|Withdrawal by Subject|0|||
13212926|NCT01899729|26256335|FG003|Overall Study|Withdrawal by Subject|0|||
13212927|NCT01899729|26256336|FG004|Overall Study|Withdrawal by Subject|0|||
13212928|NCT01899729|26256332|FG000|Overall Study|Lack of Efficacy|0|||
13212929|NCT01899729|26256333|FG001|Overall Study|Lack of Efficacy|0|||
13212930|NCT01899729|26256334|FG002|Overall Study|Lack of Efficacy|2|||
13212931|NCT01899729|26256335|FG003|Overall Study|Lack of Efficacy|0|||
13212932|NCT01899729|26256336|FG004|Overall Study|Lack of Efficacy|1|||
13212933|NCT01899053|26256631|FG000|Overall Study|Progressive Disease|4|||
13212934|NCT01899053|26256632|FG001|Overall Study|Progressive Disease|0|||
13212935|NCT01899053|26256633|FG002|Overall Study|Progressive Disease|3|||
13212936|NCT01899053|26256634|FG003|Overall Study|Progressive Disease|0|||
13212937|NCT01899053|26256635|FG004|Overall Study|Progressive Disease|3|||
13212938|NCT01899053|26256636|FG005|Overall Study|Progressive Disease|1|||
13212939|NCT01899053|26256637|FG006|Overall Study|Progressive Disease|1|||
13212940|NCT01899053|26256638|FG007|Overall Study|Progressive Disease|1|||
13212941|NCT01899053|26256639|FG008|Overall Study|Progressive Disease|4|||
13212942|NCT01899053|26256640|FG009|Overall Study|Progressive Disease|3|||
13212943|NCT01899053|26256641|FG010|Overall Study|Progressive Disease|12|||
13212944|NCT01899053|26256642|FG011|Overall Study|Progressive Disease|5|||
13212945|NCT01899053|26256643|FG012|Overall Study|Progressive Disease|8|||
13212946|NCT01899053|26256644|FG013|Overall Study|Progressive Disease|17|||
13212947|NCT01899053|26256631|FG000|Overall Study|Adverse Event|1|||
13212948|NCT01899053|26256632|FG001|Overall Study|Adverse Event|1|||
13212949|NCT01899053|26256633|FG002|Overall Study|Adverse Event|1|||
13212950|NCT01899053|26256634|FG003|Overall Study|Adverse Event|3|||
13212951|NCT01899053|26256635|FG004|Overall Study|Adverse Event|1|||
13212952|NCT01899053|26256636|FG005|Overall Study|Adverse Event|1|||
13212953|NCT01899053|26256637|FG006|Overall Study|Adverse Event|1|||
13212954|NCT01899053|26256638|FG007|Overall Study|Adverse Event|0|||
13212955|NCT01899053|26256639|FG008|Overall Study|Adverse Event|2|||
13212956|NCT01899053|26256640|FG009|Overall Study|Adverse Event|0|||
13212957|NCT01899053|26256641|FG010|Overall Study|Adverse Event|3|||
13212958|NCT01899053|26256642|FG011|Overall Study|Adverse Event|1|||
13212959|NCT01899053|26256643|FG012|Overall Study|Adverse Event|2|||
13212960|NCT01899053|26256644|FG013|Overall Study|Adverse Event|2|||
13212961|NCT01899053|26256631|FG000|Overall Study|Reason Not Specified|0|||
13212962|NCT01899053|26256632|FG001|Overall Study|Reason Not Specified|0|||
13212963|NCT01899053|26256633|FG002|Overall Study|Reason Not Specified|0|||
13212964|NCT01899053|26256634|FG003|Overall Study|Reason Not Specified|0|||
13212965|NCT01899053|26256635|FG004|Overall Study|Reason Not Specified|0|||
13212966|NCT01899053|26256636|FG005|Overall Study|Reason Not Specified|0|||
13212967|NCT01899053|26256637|FG006|Overall Study|Reason Not Specified|1|||
13212968|NCT01899053|26256638|FG007|Overall Study|Reason Not Specified|0|||
13212969|NCT01899053|26256639|FG008|Overall Study|Reason Not Specified|0|||
13212970|NCT01899053|26256640|FG009|Overall Study|Reason Not Specified|0|||
13212971|NCT01899053|26256641|FG010|Overall Study|Reason Not Specified|0|||
13212972|NCT01899053|26256642|FG011|Overall Study|Reason Not Specified|0|||
13212973|NCT01899053|26256643|FG012|Overall Study|Reason Not Specified|1|||
13212974|NCT01899053|26256644|FG013|Overall Study|Reason Not Specified|0|||
13212975|NCT01899053|26256631|FG000|Overall Study|Withdrawal by Subject|1|||
13212976|NCT01899053|26256632|FG001|Overall Study|Withdrawal by Subject|1|||
13212977|NCT01899053|26256633|FG002|Overall Study|Withdrawal by Subject|2|||
13212978|NCT01899053|26256634|FG003|Overall Study|Withdrawal by Subject|0|||
13212979|NCT01899053|26256635|FG004|Overall Study|Withdrawal by Subject|2|||
13212980|NCT01899053|26256636|FG005|Overall Study|Withdrawal by Subject|0|||
13212981|NCT01899053|26256637|FG006|Overall Study|Withdrawal by Subject|0|||
13212982|NCT01899053|26256638|FG007|Overall Study|Withdrawal by Subject|1|||
13212983|NCT01899053|26256639|FG008|Overall Study|Withdrawal by Subject|0|||
13212984|NCT01899053|26256640|FG009|Overall Study|Withdrawal by Subject|0|||
13212985|NCT01899053|26256641|FG010|Overall Study|Withdrawal by Subject|0|||
13212986|NCT01899053|26256642|FG011|Overall Study|Withdrawal by Subject|0|||
13212987|NCT01899053|26256643|FG012|Overall Study|Withdrawal by Subject|1|||
13212988|NCT01899053|26256644|FG013|Overall Study|Withdrawal by Subject|1|||
13212989|NCT01899053|26256631|FG000|Overall Study|Protocol Violation|0|||
13212990|NCT01899053|26256632|FG001|Overall Study|Protocol Violation|0|||
13212991|NCT01899053|26256633|FG002|Overall Study|Protocol Violation|1|||
13212992|NCT01899053|26256634|FG003|Overall Study|Protocol Violation|0|||
13212993|NCT01899053|26256635|FG004|Overall Study|Protocol Violation|0|||
13212994|NCT01899053|26256636|FG005|Overall Study|Protocol Violation|0|||
13212995|NCT01899053|26256637|FG006|Overall Study|Protocol Violation|0|||
13212996|NCT01899053|26256638|FG007|Overall Study|Protocol Violation|0|||
13212997|NCT01899053|26256639|FG008|Overall Study|Protocol Violation|0|||
13212998|NCT01899053|26256640|FG009|Overall Study|Protocol Violation|0|||
13212999|NCT01899053|26256641|FG010|Overall Study|Protocol Violation|0|||
13213000|NCT01899053|26256642|FG011|Overall Study|Protocol Violation|0|||
13213001|NCT01899053|26256643|FG012|Overall Study|Protocol Violation|0|||
13213002|NCT01899053|26256644|FG013|Overall Study|Protocol Violation|0|||
13213003|NCT01899053|26256631|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
13213004|NCT01899053|26256632|FG001|Overall Study|Unsatisfactory Therapeutic Response|1|||
13213005|NCT01899053|26256633|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
13213006|NCT01899053|26256634|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
13213007|NCT01899053|26256635|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
13213008|NCT01899053|26256636|FG005|Overall Study|Unsatisfactory Therapeutic Response|0|||
13213009|NCT01899053|26256637|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
13213010|NCT01899053|26256638|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
13213011|NCT01899053|26256639|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
13213012|NCT01899053|26256640|FG009|Overall Study|Unsatisfactory Therapeutic Response|0|||
13213013|NCT01899053|26256641|FG010|Overall Study|Unsatisfactory Therapeutic Response|1|||
13213014|NCT01899053|26256642|FG011|Overall Study|Unsatisfactory Therapeutic Response|0|||
13213015|NCT01899053|26256643|FG012|Overall Study|Unsatisfactory Therapeutic Response|0|||
13213016|NCT01899053|26256644|FG013|Overall Study|Unsatisfactory Therapeutic Response|0|||
13213017|NCT01899053|26256631|FG000|Overall Study|Symptomatic Deterioration|0|||
13213018|NCT01899053|26256632|FG001|Overall Study|Symptomatic Deterioration|0|||
13213019|NCT01899053|26256633|FG002|Overall Study|Symptomatic Deterioration|0|||
13213020|NCT01899053|26256634|FG003|Overall Study|Symptomatic Deterioration|0|||
13213021|NCT01899053|26256635|FG004|Overall Study|Symptomatic Deterioration|0|||
13213022|NCT01899053|26256636|FG005|Overall Study|Symptomatic Deterioration|1|||
13213023|NCT01899053|26256637|FG006|Overall Study|Symptomatic Deterioration|0|||
13213024|NCT01899053|26256638|FG007|Overall Study|Symptomatic Deterioration|1|||
13213025|NCT01899053|26256639|FG008|Overall Study|Symptomatic Deterioration|0|||
13213026|NCT01899053|26256640|FG009|Overall Study|Symptomatic Deterioration|0|||
13213027|NCT01899053|26256641|FG010|Overall Study|Symptomatic Deterioration|0|||
13213028|NCT01899053|26256642|FG011|Overall Study|Symptomatic Deterioration|1|||
13213029|NCT01899053|26256643|FG012|Overall Study|Symptomatic Deterioration|2|||
13213030|NCT01899053|26256644|FG013|Overall Study|Symptomatic Deterioration|0|||
13213031|NCT01898923|26256665|FG000|Overall Study|Lack of Efficacy|5|||
13213032|NCT01898923|26256666|FG001|Overall Study|Lack of Efficacy|6|||
13213033|NCT01898923|26256665|FG000|Overall Study|Adverse Event|3|||
13213034|NCT01898923|26256666|FG001|Overall Study|Adverse Event|1|||
13213035|NCT01898923|26256665|FG000|Overall Study|Lost to Follow-up|0|||
13213036|NCT01898923|26256666|FG001|Overall Study|Lost to Follow-up|1|||
13213037|NCT01898923|26256665|FG000|Overall Study|Withdrawal by Subject|4|||
13213038|NCT01898923|26256666|FG001|Overall Study|Withdrawal by Subject|7|||
13213039|NCT01898923|26256665|FG000|Overall Study|Physician Decision|3|||
13213040|NCT01898923|26256666|FG001|Overall Study|Physician Decision|4|||
13213041|NCT01898923|26256665|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1|||
13213042|NCT01898923|26256666|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2|||
13213043|NCT01898884|26256836|FG000|Multiple Dose Period|Adverse Event|0|||
13213044|NCT01898884|26256837|FG001|Multiple Dose Period|Adverse Event|0|||
13213045|NCT01898884|26256838|FG002|Multiple Dose Period|Adverse Event|0|||
13213046|NCT01898884|26256839|FG003|Multiple Dose Period|Adverse Event|0|||
13213047|NCT01898884|26256840|FG004|Multiple Dose Period|Adverse Event|0|||
13213048|NCT01898884|26256841|FG005|Multiple Dose Period|Adverse Event|0|||
13213049|NCT01898884|26256842|FG006|Multiple Dose Period|Adverse Event|1|||
13213050|NCT01898884|26256843|FG007|Multiple Dose Period|Adverse Event|0|||
13213051|NCT01898884|26256844|FG008|Multiple Dose Period|Adverse Event|0|||
13213052|NCT01898884|26256836|FG000|Multiple Dose Period|Randomized Not Treated|0|||
13213053|NCT01898884|26256837|FG001|Multiple Dose Period|Randomized Not Treated|0|||
13213054|NCT01898884|26256838|FG002|Multiple Dose Period|Randomized Not Treated|0|||
13213055|NCT01898884|26256839|FG003|Multiple Dose Period|Randomized Not Treated|0|||
13213056|NCT01898884|26256840|FG004|Multiple Dose Period|Randomized Not Treated|0|||
13213057|NCT01898884|26256841|FG005|Multiple Dose Period|Randomized Not Treated|0|||
13213058|NCT01898884|26256842|FG006|Multiple Dose Period|Randomized Not Treated|0|||
13213059|NCT01898884|26256843|FG007|Multiple Dose Period|Randomized Not Treated|0|||
13213060|NCT01898884|26256844|FG008|Multiple Dose Period|Randomized Not Treated|1|||
13213061|NCT01898806|26256851|FG000|Overall Study|Withdrawal by Subject|2|||
13213062|NCT01898806|26256851|FG000|Overall Study|Physician Decision|1|||
13213063|NCT01898598|26256874|FG000|Overall Study|Adverse Event|1|||
13213064|NCT01898598|26256875|FG001|Overall Study|Adverse Event|0|||
13213065|NCT01898598|26256874|FG000|Overall Study|Withdrawal by Subject|3|||
13213066|NCT01898598|26256875|FG001|Overall Study|Withdrawal by Subject|0|||
13213067|NCT01898598|26256874|FG000|Overall Study|Lost to Follow-up|0|||
13213068|NCT01898598|26256875|FG001|Overall Study|Lost to Follow-up|1|||
13213069|NCT01898598|26256874|FG000|Overall Study|Other|0|||
13213070|NCT01898598|26256875|FG001|Overall Study|Other|1|||
13213071|NCT01898442|26256908|FG000|Overall Study|Hemolysis/technical problems|1|||
13213072|NCT01898442|26256909|FG001|Overall Study|Hemolysis/technical problems|2|||
13213073|NCT01898442|26256910|FG002|Overall Study|Hemolysis/technical problems|2|||
13213074|NCT01898442|26256908|FG000|Overall Study|Patient vomited pills|0|||
13213075|NCT01898442|26256909|FG001|Overall Study|Patient vomited pills|0|||
13213076|NCT01898442|26256910|FG002|Overall Study|Patient vomited pills|1|||
13213077|NCT01898299|26256923|FG000|Post Treatment (One Month)|Lost to Follow-up|3|||
13213078|NCT01898299|26256924|FG001|Post Treatment (One Month)|Lost to Follow-up|4|||
13213079|NCT01898286|26256933|FG000|Overall Study|Withdrawal by Subject|1|||
13213080|NCT01898286|26256933|FG000|Overall Study|Protocol Violation|1|||
13213081|NCT01898286|26256933|FG000|Overall Study|Lost to Follow-up|1|||
13213082|NCT01898208|26256987|FG000|Overall Study|Positive blood culture|17|||
13213083|NCT01898208|26256988|FG001|Overall Study|Positive blood culture|23|||
13213084|NCT01898208|26256989|FG002|Overall Study|Positive blood culture|15|||
13213085|NCT01898208|26256987|FG000|Overall Study|Death/comfort care within 24 hours|10|||
13213086|NCT01898208|26256988|FG001|Overall Study|Death/comfort care within 24 hours|9|||
13213087|NCT01898208|26256989|FG002|Overall Study|Death/comfort care within 24 hours|8|||
13213088|NCT01898208|26256987|FG000|Overall Study|Negative Gram Stain|6|||
13213089|NCT01898208|26256988|FG001|Overall Study|Negative Gram Stain|9|||
13213090|NCT01898208|26256989|FG002|Overall Study|Negative Gram Stain|6|||
13213091|NCT01898208|26256987|FG000|Overall Study|Non-Blood Specimens in Bottles|3|||
13213092|NCT01898208|26256988|FG001|Overall Study|Non-Blood Specimens in Bottles|5|||
13213093|NCT01898208|26256989|FG002|Overall Study|Non-Blood Specimens in Bottles|4|||
13213094|NCT01898208|26256987|FG000|Overall Study|System/Technical Error|1|||
13213095|NCT01898208|26256988|FG001|Overall Study|System/Technical Error|2|||
13213096|NCT01898208|26256989|FG002|Overall Study|System/Technical Error|3|||
13213097|NCT01898208|26256987|FG000|Overall Study|Lost to Follow-up|3|||
13213098|NCT01898208|26256988|FG001|Overall Study|Lost to Follow-up|1|||
13213099|NCT01898208|26256989|FG002|Overall Study|Lost to Follow-up|1|||
13213100|NCT01898195|26257010|FG000|Smoking Abstinence|Did not have good measurements|35|||
13213101|NCT01898195|26257011|FG001|Smoking Abstinence|Did not have good measurements|38|||
13213102|NCT01898195|26257012|FG002|Smoking Abstinence|Did not have good measurements|36|||
13213103|NCT01898130|26257027|FG000|Treatment|Withdrawal by Subject|2|||
13213104|NCT01898130|26257027|FG000|Treatment|Progressive Disease|4|||
13213105|NCT01898130|26257027|FG000|Follow up Until PD or Death|Lost to Follow-up|1|||
13213106|NCT01898091|26257040|FG000|Overall Study|Lost to Follow-up|1|||
13213107|NCT01898091|26257041|FG001|Overall Study|Lost to Follow-up|1|||
13213108|NCT01898091|26257040|FG000|Overall Study|Withdrawal by Subject|1|||
13213109|NCT01898091|26257041|FG001|Overall Study|Withdrawal by Subject|5|||
13213110|NCT01898078|26257064|FG000|Overall Study|Progressive Disease|1|||
13213111|NCT01898078|26257065|FG001|Overall Study|Progressive Disease|5|||
13213112|NCT01898078|26257064|FG000|Overall Study|Adverse Event|2|||
13213113|NCT01898078|26257065|FG001|Overall Study|Adverse Event|1|||
13213114|NCT01898078|26257064|FG000|Overall Study|Withdrawal by Subject|1|||
13213115|NCT01898078|26257065|FG001|Overall Study|Withdrawal by Subject|1|||
13213116|NCT01898078|26257064|FG000|Overall Study|Symptomatic Deterioration|2|||
13213117|NCT01898078|26257065|FG001|Overall Study|Symptomatic Deterioration|0|||
13213118|NCT01898078|26257064|FG000|Overall Study|Reason not Specified|0|||
13213119|NCT01898078|26257065|FG001|Overall Study|Reason not Specified|1|||
13213120|NCT01897896|26257152|FG000|Overall Study|Death|1|||
13213121|NCT01897896|26257153|FG001|Overall Study|Death|0|||
13213122|NCT01897896|26257152|FG000|Overall Study|Adverse Event|11|||
13213123|NCT01897896|26257153|FG001|Overall Study|Adverse Event|1|||
13213124|NCT01897896|26257152|FG000|Overall Study|Lost to Follow-up|1|||
13213125|NCT01897896|26257153|FG001|Overall Study|Lost to Follow-up|0|||
13213126|NCT01897896|26257152|FG000|Overall Study|Non-compliance with study drug dosing|1|||
13213127|NCT01897896|26257153|FG001|Overall Study|Non-compliance with study drug dosing|1|||
13213128|NCT01897896|26257152|FG000|Overall Study|Withdrawal by Subject|7|||
13213129|NCT01897896|26257153|FG001|Overall Study|Withdrawal by Subject|1|||
13213130|NCT01897896|26257152|FG000|Overall Study|Require drug that interfere with study|1|||
13213131|NCT01897896|26257153|FG001|Overall Study|Require drug that interfere with study|4|||
13213132|NCT01897896|26257152|FG000|Overall Study|Protocol Violation|1|||
13213133|NCT01897896|26257153|FG001|Overall Study|Protocol Violation|1|||
13213134|NCT01897896|26257152|FG000|Overall Study|Withdrawal per Investigator's judgement|1|||
13213135|NCT01897896|26257153|FG001|Overall Study|Withdrawal per Investigator's judgement|1|||
13213136|NCT01897896|26257152|FG000|Overall Study|Caregiver can no longer participate|0|||
13213137|NCT01897896|26257153|FG001|Overall Study|Caregiver can no longer participate|2|||
13213138|NCT01897896|26257152|FG000|Overall Study|Other than specified|2|||
13213139|NCT01897896|26257153|FG001|Overall Study|Other than specified|1|||
13213140|NCT01897727|26257166|FG000|Overall Study|Exclusion: central sleep apnea|0|||
13213141|NCT01897727|26257167|FG001|Overall Study|Exclusion: central sleep apnea|1|||
13213142|NCT01897714|26257230|FG000|Phase I (Dose Escalation)|Disease progression|3|||
13213143|NCT01897714|26257231|FG001|Phase I (Dose Escalation)|Disease progression|5|||
13213144|NCT01897714|26257232|FG002|Phase I (Dose Escalation)|Disease progression|1|||
13213145|NCT01897714|26257233|FG003|Phase I (Dose Escalation)|Disease progression|3|||
13213146|NCT01897714|26257234|FG004|Phase I (Dose Escalation)|Disease progression|0|||
13213147|NCT01897714|26257235|FG005|Phase I (Dose Escalation)|Disease progression|0|||
13213148|NCT01897714|26257230|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
13213149|NCT01897714|26257231|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
13213150|NCT01897714|26257232|FG002|Phase I (Dose Escalation)|Adverse Event|4|||
13213151|NCT01897714|26257233|FG003|Phase I (Dose Escalation)|Adverse Event|3|||
13213152|NCT01897714|26257234|FG004|Phase I (Dose Escalation)|Adverse Event|0|||
13213153|NCT01897714|26257235|FG005|Phase I (Dose Escalation)|Adverse Event|0|||
13213154|NCT01897714|26257230|FG000|Phase I (Dose Escalation)|Other|0|||
13213155|NCT01897714|26257231|FG001|Phase I (Dose Escalation)|Other|1|||
13213156|NCT01897714|26257232|FG002|Phase I (Dose Escalation)|Other|0|||
13213157|NCT01897714|26257233|FG003|Phase I (Dose Escalation)|Other|0|||
13213158|NCT01897714|26257234|FG004|Phase I (Dose Escalation)|Other|0|||
13213159|NCT01897714|26257235|FG005|Phase I (Dose Escalation)|Other|0|||
13213160|NCT01897714|26257230|FG000|Phase II (MTD)|Withdrawal by Subject|0|||
13213161|NCT01897714|26257231|FG001|Phase II (MTD)|Withdrawal by Subject|0|||
13213162|NCT01897714|26257232|FG002|Phase II (MTD)|Withdrawal by Subject|0|||
13213163|NCT01897714|26257233|FG003|Phase II (MTD)|Withdrawal by Subject|0|||
13213164|NCT01897714|26257234|FG004|Phase II (MTD)|Withdrawal by Subject|0|||
13213165|NCT01897714|26257235|FG005|Phase II (MTD)|Withdrawal by Subject|1|||
13213166|NCT01897714|26257230|FG000|Phase II (MTD)|Lost to Follow-up|0|||
13213167|NCT01897714|26257231|FG001|Phase II (MTD)|Lost to Follow-up|0|||
13213168|NCT01897714|26257232|FG002|Phase II (MTD)|Lost to Follow-up|0|||
13213169|NCT01897714|26257233|FG003|Phase II (MTD)|Lost to Follow-up|0|||
13213170|NCT01897714|26257234|FG004|Phase II (MTD)|Lost to Follow-up|1|||
13213171|NCT01897714|26257235|FG005|Phase II (MTD)|Lost to Follow-up|0|||
13213172|NCT01897714|26257230|FG000|Phase II (MTD)|Death|0|||
13213173|NCT01897714|26257231|FG001|Phase II (MTD)|Death|0|||
13213174|NCT01897714|26257232|FG002|Phase II (MTD)|Death|0|||
13213175|NCT01897714|26257233|FG003|Phase II (MTD)|Death|0|||
13213176|NCT01897714|26257234|FG004|Phase II (MTD)|Death|25|||
13213177|NCT01897714|26257235|FG005|Phase II (MTD)|Death|10|||
13213178|NCT01897714|26257230|FG000|Phase II (MTD)|Study terminated with patient alive|0|||
13213179|NCT01897714|26257231|FG001|Phase II (MTD)|Study terminated with patient alive|0|||
13213180|NCT01897714|26257232|FG002|Phase II (MTD)|Study terminated with patient alive|0|||
13213181|NCT01897714|26257233|FG003|Phase II (MTD)|Study terminated with patient alive|0|||
13394773|NCT00654381|26788100|FG003|2nd Stage|Withdrawal by Subject|0|||
13213182|NCT01897714|26257234|FG004|Phase II (MTD)|Study terminated with patient alive|1|||
13213183|NCT01897714|26257235|FG005|Phase II (MTD)|Study terminated with patient alive|0|||
13213184|NCT01897714|26257230|FG000|Phase II (MTD)|Other|0|||
13213185|NCT01897714|26257231|FG001|Phase II (MTD)|Other|0|||
13213186|NCT01897714|26257232|FG002|Phase II (MTD)|Other|0|||
13213187|NCT01897714|26257233|FG003|Phase II (MTD)|Other|0|||
13213188|NCT01897714|26257234|FG004|Phase II (MTD)|Other|3|||
13213189|NCT01897714|26257235|FG005|Phase II (MTD)|Other|0|||
13213190|NCT01897532|26257250|FG000|Discontinuation From Treatment|Not Treated|7|||
13213191|NCT01897532|26257251|FG001|Discontinuation From Treatment|Not Treated|5|||
13213192|NCT01897532|26257250|FG000|Discontinuation From Treatment|Other reason than specified|196|||
13213193|NCT01897532|26257251|FG001|Discontinuation From Treatment|Other reason than specified|176|||
13213194|NCT01897532|26257250|FG000|Discontinuation From Treatment|Withdrawal by Subject|333|||
13213195|NCT01897532|26257251|FG001|Discontinuation From Treatment|Withdrawal by Subject|281|||
13213196|NCT01897532|26257250|FG000|Discontinuation From Treatment|Non compliance|24|||
13213197|NCT01897532|26257251|FG001|Discontinuation From Treatment|Non compliance|15|||
13213198|NCT01897532|26257250|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402|||
13213199|NCT01897532|26257251|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362|||
13213200|NCT01897532|26257250|FG000|Discontinuation From Trial|Not Treated|7|||
13213201|NCT01897532|26257251|FG001|Discontinuation From Trial|Not Treated|5|||
13213202|NCT01897532|26257250|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55|||
13213203|NCT01897532|26257251|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36|||
13213204|NCT01897493|26257266|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1|||
13213205|NCT01897233|26257290|FG000|Part B (24 Weeks)|Adverse Event|1|||
13213206|NCT01897233|26257290|FG000|Part B (24 Weeks)|Withdrawal by Subject|2|||
13213207|NCT01897233|26257290|FG000|Part B (24 Weeks)|Physician Decision|1|||
13213208|NCT01896986|26257303|FG000|Overall Study|samples lost|14|||
13213209|NCT01896986|26257304|FG001|Overall Study|samples lost|23|||
13213210|NCT01896934|26257312|FG000|Overall Study|Adverse Event|1|||
13213211|NCT01896934|26257312|FG000|Overall Study|Withdrawal by Subject|1|||
13213212|NCT01896895|26257338|FG000|Double-blind MP|Physician Decision|0|||
13213213|NCT01896895|26257339|FG001|Double-blind MP|Physician Decision|0|||
13213214|NCT01896895|26257340|FG002|Double-blind MP|Physician Decision|1|||
13213215|NCT01896895|26257341|FG003|Double-blind MP|Physician Decision|0|||
13213216|NCT01896895|26257338|FG000|Double-blind MP|Withdrawal by Subject|0|||
13213217|NCT01896895|26257339|FG001|Double-blind MP|Withdrawal by Subject|2|||
13213218|NCT01896895|26257340|FG002|Double-blind MP|Withdrawal by Subject|1|||
13213219|NCT01896895|26257341|FG003|Double-blind MP|Withdrawal by Subject|0|||
13213220|NCT01896895|26257338|FG000|Double-blind MP|Lost to Follow-up|1|||
13213221|NCT01896895|26257339|FG001|Double-blind MP|Lost to Follow-up|0|||
13213222|NCT01896895|26257340|FG002|Double-blind MP|Lost to Follow-up|1|||
13213223|NCT01896895|26257341|FG003|Double-blind MP|Lost to Follow-up|0|||
13213224|NCT01896869|26257367|FG000|Overall Study|Withdrawal by Subject|0|||
13213225|NCT01896869|26257368|FG001|Overall Study|Withdrawal by Subject|6|||
13213226|NCT01896869|26257367|FG000|Overall Study|Lost to Follow-up|1|||
13213227|NCT01896869|26257368|FG001|Overall Study|Lost to Follow-up|0|||
13213228|NCT01896856|26257406|FG000|Overall Study|Transportation issues / Non-compliance|0|||
13213229|NCT01896856|26257407|FG001|Overall Study|Transportation issues / Non-compliance|0|||
13213230|NCT01896856|26257408|FG002|Overall Study|Transportation issues / Non-compliance|1|||
13213231|NCT01896856|26257409|FG003|Overall Study|Transportation issues / Non-compliance|0|||
13213232|NCT01896856|26257410|FG004|Overall Study|Transportation issues / Non-compliance|0|||
13213233|NCT01896856|26257411|FG005|Overall Study|Transportation issues / Non-compliance|0|||
13213234|NCT01896726|26257426|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1|||
13213235|NCT01896726|26257426|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1|||
13213236|NCT01896700|26257453|FG000|Overall Study|Adverse Event|4|||
13213237|NCT01896700|26257454|FG001|Overall Study|Adverse Event|5|||
13213238|NCT01896700|26257453|FG000|Overall Study|Withdrawal by Subject|0|||
13213239|NCT01896700|26257454|FG001|Overall Study|Withdrawal by Subject|1|||
13213240|NCT01896557|26257473|FG000|Clopidogrel Alone|Adverse Event|1|||
13213241|NCT01896557|26257474|FG001|Clopidogrel Alone|Adverse Event|0|||
13213242|NCT01896557|26257473|FG000|Clopidogrel + GI Protector|low adherence|1|||
13213243|NCT01896557|26257474|FG001|Clopidogrel + GI Protector|low adherence|1|||
13213244|NCT01896557|26257473|FG000|Clopidogrel + GI Protector|Reading error|1|||
13213245|NCT01896557|26257474|FG001|Clopidogrel + GI Protector|Reading error|3|||
13213246|NCT01896531|26257496|FG000|Overall Study|Death|57|||
13213247|NCT01896531|26257497|FG001|Overall Study|Death|59|||
13213248|NCT01896531|26257496|FG000|Overall Study|Lost to Follow-up|3|||
13213249|NCT01896531|26257497|FG001|Overall Study|Lost to Follow-up|0|||
13213250|NCT01896531|26257496|FG000|Overall Study|Non-compliance|0|||
13213251|NCT01896531|26257497|FG001|Overall Study|Non-compliance|1|||
13213252|NCT01896531|26257496|FG000|Overall Study|Study Ended by Sponsor|7|||
13213253|NCT01896531|26257497|FG001|Overall Study|Study Ended by Sponsor|20|||
13213254|NCT01896531|26257496|FG000|Overall Study|Withdrawal by Subject|3|||
13213255|NCT01896531|26257497|FG001|Overall Study|Withdrawal by Subject|2|||
13213256|NCT01896531|26257496|FG000|Overall Study|Death Prior to Treatment|1|||
13213257|NCT01896531|26257497|FG001|Overall Study|Death Prior to Treatment|0|||
13213258|NCT01896297|26257504|FG000|Overall Study|Died in post treatment phase|1|||
13213259|NCT01896271|26257518|FG000|Overall Study|Physician Decision|10|||
13213260|NCT01896232|26257545|FG000|Overall Study|Death|6|||
13213261|NCT01896232|26257546|FG001|Overall Study|Death|10|||
13213262|NCT01896232|26257545|FG000|Overall Study|Withdrawal by Subject|32|||
13213263|NCT01896232|26257546|FG001|Overall Study|Withdrawal by Subject|31|||
13213264|NCT01896232|26257545|FG000|Overall Study|Sponsor Decision|2|||
13213265|NCT01896232|26257546|FG001|Overall Study|Sponsor Decision|0|||
13213266|NCT01896232|26257545|FG000|Overall Study|Lost to Follow-up|9|||
13213267|NCT01896232|26257546|FG001|Overall Study|Lost to Follow-up|12|||
13213268|NCT01896193|26257581|FG000|Overall Study|Lack of Efficacy|20|||
13213269|NCT01896193|26257582|FG001|Overall Study|Lack of Efficacy|11|||
13213270|NCT01896193|26257581|FG000|Overall Study|Protocol Violation|0|||
13213271|NCT01896193|26257582|FG001|Overall Study|Protocol Violation|1|||
13213272|NCT01896193|26257581|FG000|Overall Study|Withdrew Consent|1|||
13213273|NCT01896193|26257582|FG001|Overall Study|Withdrew Consent|0|||
13213274|NCT01896128|26257603|FG000|Overall Study|Withdrawal by Subject|3|||
13213275|NCT01896128|26257604|FG001|Overall Study|Withdrawal by Subject|3|||
13213276|NCT01896102|26257632|FG000|Overall Study|Death|1|||
13213277|NCT01896102|26257632|FG000|Overall Study|Participant to receive allogenic transplant|2|||
13213278|NCT01896050|26257649|FG000|Overall Study|Adverse Event|37|||
13213279|NCT01896050|26257650|FG001|Overall Study|Adverse Event|2|||
13213280|NCT01896050|26257649|FG000|Overall Study|Death|1|||
13213281|NCT01896050|26257650|FG001|Overall Study|Death|0|||
13213282|NCT01895777|26257682|FG000|Overall Study|Adverse Event|1|||
13213283|NCT01895777|26257683|FG001|Overall Study|Adverse Event|2|||
13213284|NCT01895777|26257682|FG000|Overall Study|Lost to Follow-up|2|||
13213285|NCT01895777|26257683|FG001|Overall Study|Lost to Follow-up|0|||
13213286|NCT01895777|26257682|FG000|Overall Study|Not treated|1|||
13213287|NCT01895777|26257683|FG001|Overall Study|Not treated|0|||
13213288|NCT01895777|26257682|FG000|Overall Study|Other reasons|3|||
13213289|NCT01895777|26257683|FG001|Overall Study|Other reasons|2|||
13213290|NCT01895777|26257682|FG000|Overall Study|Non-compliance with the CTP|2|||
13213291|NCT01895777|26257683|FG001|Overall Study|Non-compliance with the CTP|1|||
13213292|NCT01895608|26257726|FG000|Overall Study|change in health status|0|||
13213293|NCT01895608|26257727|FG001|Overall Study|change in health status|1|||
13213294|NCT01895608|26257728|FG002|Overall Study|change in health status|1|||
13213295|NCT01895608|26257729|FG003|Overall Study|change in health status|0|||
13213296|NCT01895608|26257726|FG000|Overall Study|Withdrawal by Subject|0|||
13213297|NCT01895608|26257727|FG001|Overall Study|Withdrawal by Subject|0|||
13213298|NCT01895608|26257728|FG002|Overall Study|Withdrawal by Subject|2|||
13213299|NCT01895608|26257729|FG003|Overall Study|Withdrawal by Subject|0|||
13213300|NCT01895543|26257745|FG000|Overall Study|Withdrawal by Subject|43|||
13213301|NCT01895543|26257745|FG000|Overall Study|Lost to Follow-up|25|||
13213302|NCT01895543|26257745|FG000|Overall Study|Adverse Event|28|||
13213303|NCT01895543|26257745|FG000|Overall Study|Subject's substantial non-compliance|6|||
13213304|NCT01895543|26257745|FG000|Overall Study|Protocol Violation|1|||
13213305|NCT01895543|26257745|FG000|Overall Study|Physician Decision|2|||
13213306|NCT01895543|26257745|FG000|Overall Study|Other (Not fulfilling above criteria)|24|||
13213307|NCT01895452|26257762|FG000|Overall Study|Adverse Event|1|||
13213308|NCT01895452|26257763|FG001|Overall Study|Adverse Event|4|||
13213309|NCT01895452|26257762|FG000|Overall Study|Lost to Follow-up|1|||
13213310|NCT01895452|26257763|FG001|Overall Study|Lost to Follow-up|5|||
13213311|NCT01895452|26257762|FG000|Overall Study|Pregnancy|0|||
13213312|NCT01895452|26257763|FG001|Overall Study|Pregnancy|1|||
13213313|NCT01895452|26257762|FG000|Overall Study|Withdrawal by Subject|2|||
13213314|NCT01895452|26257763|FG001|Overall Study|Withdrawal by Subject|14|||
13213315|NCT01895452|26257762|FG000|Overall Study|Underlying disease|0|||
13213316|NCT01895452|26257763|FG001|Overall Study|Underlying disease|3|||
13213317|NCT01895452|26257762|FG000|Overall Study|Noncompliance with study drug|0|||
13213318|NCT01895452|26257763|FG001|Overall Study|Noncompliance with study drug|1|||
13213319|NCT01895361|26257802|FG000|Overall Study|Adverse Event|1|||
13213320|NCT01895361|26257803|FG001|Overall Study|Adverse Event|1|||
13213321|NCT01895361|26257804|FG002|Overall Study|Adverse Event|3|||
13213322|NCT01895361|26257802|FG000|Overall Study|Death|2|||
13213323|NCT01895361|26257803|FG001|Overall Study|Death|1|||
13213324|NCT01895361|26257804|FG002|Overall Study|Death|2|||
13213325|NCT01895361|26257802|FG000|Overall Study|Lost to Follow-up|4|||
13296681|NCT01369355|26497110|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
13296682|NCT01369355|26497111|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
13296683|NCT01369355|26497103|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
13296684|NCT01369355|26497104|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2|||
13213326|NCT01895361|26257803|FG001|Overall Study|Lost to Follow-up|4|||
13213327|NCT01895361|26257804|FG002|Overall Study|Lost to Follow-up|6|||
13213328|NCT01895361|26257802|FG000|Overall Study|Non-compliance with study|1|||
13213329|NCT01895361|26257803|FG001|Overall Study|Non-compliance with study|3|||
13213330|NCT01895361|26257804|FG002|Overall Study|Non-compliance with study|1|||
13213331|NCT01895361|26257802|FG000|Overall Study|Physician Decision|2|||
13213332|NCT01895361|26257803|FG001|Overall Study|Physician Decision|2|||
13213333|NCT01895361|26257804|FG002|Overall Study|Physician Decision|2|||
13213334|NCT01895361|26257802|FG000|Overall Study|Withdrawal by Subject|7|||
13213335|NCT01895361|26257803|FG001|Overall Study|Withdrawal by Subject|6|||
13213336|NCT01895361|26257804|FG002|Overall Study|Withdrawal by Subject|6|||
13213337|NCT01895361|26257802|FG000|Overall Study|Lack of Efficacy|0|||
13213338|NCT01895361|26257803|FG001|Overall Study|Lack of Efficacy|1|||
13213339|NCT01895361|26257804|FG002|Overall Study|Lack of Efficacy|0|||
13213340|NCT01895361|26257802|FG000|Overall Study|Reasons different from categories above|7|||
13213341|NCT01895361|26257803|FG001|Overall Study|Reasons different from categories above|3|||
13213342|NCT01895361|26257804|FG002|Overall Study|Reasons different from categories above|4|||
13213343|NCT01895335|26257823|FG000|Overall Study|Adverse Event|106|||
13213344|NCT01895335|26257823|FG000|Overall Study|Lack of Efficacy|53|||
13213345|NCT01895335|26257823|FG000|Overall Study|Poor Compliance to Protocol|11|||
13213346|NCT01895335|26257823|FG000|Overall Study|Included But Not treated|1|||
13213347|NCT01895335|26257823|FG000|Overall Study|Other than Specified Above|44|||
13213348|NCT01895322|26257832|FG000|Overall Study|Adverse Event|1|||
13213349|NCT01895322|26257832|FG000|Overall Study|Withdrawal by Subject|2|||
13213350|NCT01895322|26257832|FG000|Overall Study|Protocol Violation|10|||
13213351|NCT01895309|26257851|FG000|Overall Study|Adverse Event|13|||
13213352|NCT01895309|26257852|FG001|Overall Study|Adverse Event|17|||
13213353|NCT01895309|26257851|FG000|Overall Study|Protocol Violation|1|||
13213354|NCT01895309|26257852|FG001|Overall Study|Protocol Violation|0|||
13213355|NCT01895309|26257851|FG000|Overall Study|Lack of Efficacy|1|||
13213356|NCT01895309|26257852|FG001|Overall Study|Lack of Efficacy|3|||
13213357|NCT01895309|26257851|FG000|Overall Study|Lost to Follow-up|1|||
13213358|NCT01895309|26257852|FG001|Overall Study|Lost to Follow-up|3|||
13213359|NCT01895309|26257851|FG000|Overall Study|Physician Decision|15|||
13213360|NCT01895309|26257852|FG001|Overall Study|Physician Decision|10|||
13213361|NCT01895309|26257851|FG000|Overall Study|Withdrawal by Subject|9|||
13213362|NCT01895309|26257852|FG001|Overall Study|Withdrawal by Subject|18|||
13213363|NCT01895270|26257865|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0|||
13213364|NCT01895270|26257866|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2|||
13213365|NCT01895270|26257865|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3|||
13213366|NCT01895270|26257866|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2|||
13213367|NCT01895270|26257865|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3|||
13213368|NCT01895270|26257866|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1|||
13213369|NCT01895270|26257865|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0|||
13213370|NCT01895270|26257866|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1|||
13213371|NCT01895270|26257865|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3|||
13213372|NCT01895270|26257866|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5|||
13213373|NCT01895270|26257865|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0|||
13213374|NCT01895270|26257866|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1|||
13213375|NCT01895270|26257865|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0|||
13213376|NCT01895270|26257866|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1|||
13213377|NCT01895101|26257890|FG000|Overall Study|OPCAB procedure|1|||
13213378|NCT01895101|26257891|FG001|Overall Study|OPCAB procedure|1|||
13213379|NCT01895101|26257892|FG002|Overall Study|OPCAB procedure|3|||
13213380|NCT01895101|26257890|FG000|Overall Study|Withdrawal by Subject|0|||
13213381|NCT01895101|26257891|FG001|Overall Study|Withdrawal by Subject|1|||
13213382|NCT01895101|26257892|FG002|Overall Study|Withdrawal by Subject|2|||
13213383|NCT01895101|26257890|FG000|Overall Study|another study, enrolled in other study|0|||
13213384|NCT01895101|26257891|FG001|Overall Study|another study, enrolled in other study|1|||
13213385|NCT01895101|26257892|FG002|Overall Study|another study, enrolled in other study|0|||
13213386|NCT01895101|26257890|FG000|Overall Study|Death|0|||
13213387|NCT01895101|26257891|FG001|Overall Study|Death|1|||
13213388|NCT01895101|26257892|FG002|Overall Study|Death|0|||
13213389|NCT01895101|26257890|FG000|Overall Study|coagulation disorder|0|||
13213390|NCT01895101|26257891|FG001|Overall Study|coagulation disorder|1|||
13213391|NCT01895101|26257892|FG002|Overall Study|coagulation disorder|0|||
13213392|NCT01894984|26257915|FG000|Overall Study|Other|314|||
13213393|NCT01894984|26257916|FG001|Overall Study|Other|175|||
13296685|NCT01369355|26497105|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7|||
13296686|NCT01369355|26497106|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
13296687|NCT01369355|26497107|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8|||
13296688|NCT01369355|26497108|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22|||
13296689|NCT01369355|26497109|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
13296690|NCT01369355|26497110|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
13296691|NCT01369355|26497111|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
13296692|NCT01369355|26497103|FG000|Week 0 - Week 44 (Maintenance)|Other|0|||
13296693|NCT01369355|26497104|FG001|Week 0 - Week 44 (Maintenance)|Other|0|||
13213394|NCT01894919|26258086|FG000|Overall Study|Withdrawal by Subject|1|||
13213395|NCT01894919|26258087|FG001|Overall Study|Withdrawal by Subject|0|||
13213396|NCT01894919|26258088|FG002|Overall Study|Withdrawal by Subject|0|||
13213397|NCT01894919|26258089|FG003|Overall Study|Withdrawal by Subject|0|||
13213398|NCT01894919|26258090|FG004|Overall Study|Withdrawal by Subject|1|||
13213399|NCT01894919|26258091|FG005|Overall Study|Withdrawal by Subject|0|||
13213400|NCT01894919|26258092|FG006|Overall Study|Withdrawal by Subject|0|||
13213401|NCT01894919|26258093|FG007|Overall Study|Withdrawal by Subject|0|||
13213402|NCT01894919|26258094|FG008|Overall Study|Withdrawal by Subject|0|||
13213403|NCT01894919|26258095|FG009|Overall Study|Withdrawal by Subject|1|||
13213404|NCT01894919|26258096|FG010|Overall Study|Withdrawal by Subject|1|||
13213405|NCT01894919|26258097|FG011|Overall Study|Withdrawal by Subject|0|||
13213406|NCT01894919|26258098|FG012|Overall Study|Withdrawal by Subject|0|||
13213407|NCT01894919|26258086|FG000|Overall Study|Adverse Event|0|||
13213408|NCT01894919|26258087|FG001|Overall Study|Adverse Event|0|||
13213409|NCT01894919|26258088|FG002|Overall Study|Adverse Event|0|||
13213410|NCT01894919|26258089|FG003|Overall Study|Adverse Event|0|||
13213411|NCT01894919|26258090|FG004|Overall Study|Adverse Event|0|||
13213412|NCT01894919|26258091|FG005|Overall Study|Adverse Event|0|||
13213413|NCT01894919|26258092|FG006|Overall Study|Adverse Event|0|||
13213414|NCT01894919|26258093|FG007|Overall Study|Adverse Event|0|||
13213415|NCT01894919|26258094|FG008|Overall Study|Adverse Event|0|||
13213416|NCT01894919|26258095|FG009|Overall Study|Adverse Event|0|||
13213417|NCT01894919|26258096|FG010|Overall Study|Adverse Event|1|||
13213418|NCT01894919|26258097|FG011|Overall Study|Adverse Event|0|||
13213419|NCT01894919|26258098|FG012|Overall Study|Adverse Event|0|||
13213420|NCT01894919|26258086|FG000|Overall Study|Other-Unspecified|1|||
13213421|NCT01894919|26258087|FG001|Overall Study|Other-Unspecified|0|||
13213422|NCT01894919|26258088|FG002|Overall Study|Other-Unspecified|0|||
13213423|NCT01894919|26258089|FG003|Overall Study|Other-Unspecified|0|||
13213424|NCT01894919|26258090|FG004|Overall Study|Other-Unspecified|0|||
13213425|NCT01894919|26258091|FG005|Overall Study|Other-Unspecified|0|||
13213426|NCT01894919|26258092|FG006|Overall Study|Other-Unspecified|0|||
13213427|NCT01894919|26258093|FG007|Overall Study|Other-Unspecified|0|||
13213428|NCT01894919|26258094|FG008|Overall Study|Other-Unspecified|0|||
13213429|NCT01894919|26258095|FG009|Overall Study|Other-Unspecified|0|||
13213430|NCT01894919|26258096|FG010|Overall Study|Other-Unspecified|0|||
13213431|NCT01894919|26258097|FG011|Overall Study|Other-Unspecified|0|||
13213432|NCT01894919|26258098|FG012|Overall Study|Other-Unspecified|0|||
13213433|NCT01894919|26258086|FG000|Overall Study|Lost to Follow-up|0|||
13213434|NCT01894919|26258087|FG001|Overall Study|Lost to Follow-up|0|||
13213435|NCT01894919|26258088|FG002|Overall Study|Lost to Follow-up|0|||
13213436|NCT01894919|26258089|FG003|Overall Study|Lost to Follow-up|0|||
13213437|NCT01894919|26258090|FG004|Overall Study|Lost to Follow-up|2|||
13213438|NCT01894919|26258091|FG005|Overall Study|Lost to Follow-up|0|||
13213439|NCT01894919|26258092|FG006|Overall Study|Lost to Follow-up|0|||
13213440|NCT01894919|26258093|FG007|Overall Study|Lost to Follow-up|0|||
13213441|NCT01894919|26258094|FG008|Overall Study|Lost to Follow-up|0|||
13213442|NCT01894919|26258095|FG009|Overall Study|Lost to Follow-up|0|||
13213443|NCT01894919|26258096|FG010|Overall Study|Lost to Follow-up|0|||
13213444|NCT01894919|26258097|FG011|Overall Study|Lost to Follow-up|0|||
13213445|NCT01894919|26258098|FG012|Overall Study|Lost to Follow-up|0|||
13213446|NCT01894841|26258121|FG000|Overall Study|Withdrawal by Subject|9|||
13213447|NCT01894841|26258122|FG001|Overall Study|Withdrawal by Subject|4|||
13213448|NCT01894841|26258121|FG000|Overall Study|Withdrawn by investigator|2|||
13213449|NCT01894841|26258122|FG001|Overall Study|Withdrawn by investigator|2|||
13213450|NCT01894841|26258121|FG000|Overall Study|Lost to Follow-up|7|||
13213451|NCT01894841|26258122|FG001|Overall Study|Lost to Follow-up|3|||
13213452|NCT01894776|26258130|FG000|Overall Study|Withdrawal by Subject|1|||
13213453|NCT01894620|26258145|FG000|Overall Study|Withdrawal by Subject|0|||
13213454|NCT01894620|26258146|FG001|Overall Study|Withdrawal by Subject|1|||
13213455|NCT01894607|26258153|FG000|Overall Study|Ineligible|1|||
13213456|NCT01894581|26258166|FG000|Overall Study|Withdrawal by Subject|2|||
13213457|NCT01894581|26258167|FG001|Overall Study|Withdrawal by Subject|3|||
13213458|NCT01894581|26258166|FG000|Overall Study|Screen Failure|3|||
13213459|NCT01894581|26258167|FG001|Overall Study|Screen Failure|4|||
13213460|NCT01894568|26258214|FG000|Overall Study|Adverse Event|2|||
13213461|NCT01894568|26258215|FG001|Overall Study|Adverse Event|3|||
13213462|NCT01894568|26258214|FG000|Overall Study|Protocol required discontinuation|2|||
13213463|NCT01894568|26258215|FG001|Overall Study|Protocol required discontinuation|1|||
13213464|NCT01894568|26258214|FG000|Overall Study|Withdrawal by Subject|5|||
13213465|NCT01894568|26258215|FG001|Overall Study|Withdrawal by Subject|5|||
13213466|NCT01894568|26258214|FG000|Overall Study|Physician Decision|1|||
13213467|NCT01894568|26258215|FG001|Overall Study|Physician Decision|0|||
13213468|NCT01894568|26258214|FG000|Overall Study|Lost to Follow-up|0|||
13213469|NCT01894568|26258215|FG001|Overall Study|Lost to Follow-up|1|||
13213470|NCT01894516|26258277|FG000|Period 1 (Baseline up to Week 12)|Other|0|||
13213471|NCT01894516|26258278|FG001|Period 1 (Baseline up to Week 12)|Other|1|||
13213472|NCT01894516|26258279|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
13213473|NCT01894516|26258280|FG003|Period 1 (Baseline up to Week 12)|Other|0|||
13213474|NCT01894516|26258277|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2|||
13213475|NCT01894516|26258278|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
13213476|NCT01894516|26258279|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
13213477|NCT01894516|26258280|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
13213478|NCT01894516|26258277|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
13213479|NCT01894516|26258278|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
13213480|NCT01894516|26258279|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
13213481|NCT01894516|26258280|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
13213482|NCT01894516|26258277|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
13213483|NCT01894516|26258278|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
13213484|NCT01894516|26258279|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1|||
13213485|NCT01894516|26258280|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
13213486|NCT01894516|26258277|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
13213487|NCT01894516|26258278|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
13213488|NCT01894516|26258279|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
13213489|NCT01894516|26258280|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
13213490|NCT01894516|26258277|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
13213491|NCT01894516|26258278|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
13213492|NCT01894516|26258279|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1|||
13213493|NCT01894516|26258280|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
13213494|NCT01894516|26258277|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
13213495|NCT01894516|26258278|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
13213496|NCT01894516|26258279|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
13213497|NCT01894516|26258280|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
13213498|NCT01894516|26258277|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
13213499|NCT01894516|26258278|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
13213500|NCT01894516|26258279|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
13213501|NCT01894516|26258280|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
13213502|NCT01894477|26258295|FG000|Overall Study|Protocol Violation|0|||
13213503|NCT01894477|26258296|FG001|Overall Study|Protocol Violation|1|||
13213504|NCT01894477|26258295|FG000|Overall Study|protocol changed due SC changed to cord|0|||
13213505|NCT01894477|26258296|FG001|Overall Study|protocol changed due SC changed to cord|1|||
13213506|NCT01894256|26258350|FG000|Part A|Adverse Event|0|||
13213507|NCT01894256|26258351|FG001|Part A|Adverse Event|1|||
13213508|NCT01894256|26258352|FG002|Part A|Adverse Event|0|||
13213509|NCT01894256|26258350|FG000|Part B|Death|0|||
13213510|NCT01894256|26258351|FG001|Part B|Death|1|||
13213511|NCT01894256|26258352|FG002|Part B|Death|1|||
13213512|NCT01894256|26258350|FG000|Part B|Withdrawal by Subject|0|||
13213513|NCT01894256|26258351|FG001|Part B|Withdrawal by Subject|1|||
13213514|NCT01894256|26258352|FG002|Part B|Withdrawal by Subject|0|||
13213515|NCT01894256|26258350|FG000|Part B|Lack of Efficacy|15|||
13213516|NCT01894256|26258351|FG001|Part B|Lack of Efficacy|12|||
13213517|NCT01894256|26258352|FG002|Part B|Lack of Efficacy|13|||
13213518|NCT01894243|26258399|FG000|Overall Study|Adverse Event|0|||
13213519|NCT01894243|26258400|FG001|Overall Study|Adverse Event|1|||
13213520|NCT01894243|26258401|FG002|Overall Study|Adverse Event|2|||
13213521|NCT01894243|26258399|FG000|Overall Study|Death|0|||
13213522|NCT01894243|26258400|FG001|Overall Study|Death|0|||
13213523|NCT01894243|26258401|FG002|Overall Study|Death|3|||
13213524|NCT01894243|26258399|FG000|Overall Study|Lack of Efficacy|3|||
13213525|NCT01894243|26258400|FG001|Overall Study|Lack of Efficacy|3|||
13213526|NCT01894243|26258401|FG002|Overall Study|Lack of Efficacy|1|||
13213527|NCT01894243|26258399|FG000|Overall Study|Condition under investigation worsened|8|||
13213528|NCT01894243|26258400|FG001|Overall Study|Condition under investigation worsened|6|||
13213529|NCT01894243|26258401|FG002|Overall Study|Condition under investigation worsened|2|||
13213530|NCT01894243|26258399|FG000|Overall Study|Subject decision|1|||
13213531|NCT01894243|26258400|FG001|Overall Study|Subject decision|0|||
13213532|NCT01894243|26258401|FG002|Overall Study|Subject decision|0|||
13213533|NCT01894243|26258399|FG000|Overall Study|Other|1|||
13213534|NCT01894243|26258400|FG001|Overall Study|Other|0|||
13213535|NCT01894243|26258401|FG002|Overall Study|Other|0|||
13213536|NCT01894230|26258432|FG000|Overall Study|Lost to Follow-up|2|||
13213537|NCT01894230|26258433|FG001|Overall Study|Lost to Follow-up|2|||
13213538|NCT01894230|26258432|FG000|Overall Study|Withdrawal by Subject|4|||
13213539|NCT01894230|26258433|FG001|Overall Study|Withdrawal by Subject|4|||
13213540|NCT01894230|26258432|FG000|Overall Study|Non-adherent|0|||
13213541|NCT01894230|26258433|FG001|Overall Study|Non-adherent|1|||
13213542|NCT01894230|26258432|FG000|Overall Study|Death|1|||
13213543|NCT01894230|26258433|FG001|Overall Study|Death|0|||
13381987|NCT00748566|26749581|FG000|Overall Study|Withdrawal by Subject|22|||
13394774|NCT00654381|26788101|FG004|2nd Stage|Withdrawal by Subject|1|||
13213544|NCT01894152|26258476|FG000|Overall Study|No DMR and no Stent thrombosis|151|||
13213545|NCT01894100|26258491|FG000|Overall Study|Lost to Follow-up|0|||
13213546|NCT01894100|26258492|FG001|Overall Study|Lost to Follow-up|1|||
13213547|NCT01894100|26258491|FG000|Overall Study|Withdrawal by Subject|3|||
13213548|NCT01894100|26258492|FG001|Overall Study|Withdrawal by Subject|0|||
13213549|NCT01894022|26258551|FG000|Overall Study|Death|1|||
13213550|NCT01894022|26258552|FG001|Overall Study|Death|0|||
13213551|NCT01894022|26258551|FG000|Overall Study|Adverse Event, non-fatal|1|||
13213552|NCT01894022|26258552|FG001|Overall Study|Adverse Event, non-fatal|0|||
13213553|NCT01894022|26258551|FG000|Overall Study|Study Closed/terminated|7|||
13213554|NCT01894022|26258552|FG001|Overall Study|Study Closed/terminated|10|||
13213555|NCT01893905|26258565|FG000|Overall Study|Withdrawal by Subject|1|||
13213556|NCT01893905|26258566|FG001|Overall Study|Withdrawal by Subject|0|||
13213557|NCT01893905|26258565|FG000|Overall Study|Adverse Event|9|||
13213558|NCT01893905|26258566|FG001|Overall Study|Adverse Event|3|||
13213559|NCT01893905|26258565|FG000|Overall Study|Lack of Efficacy|5|||
13213560|NCT01893905|26258566|FG001|Overall Study|Lack of Efficacy|7|||
13213561|NCT01893905|26258565|FG000|Overall Study|Lost to Follow-up|1|||
13213562|NCT01893905|26258566|FG001|Overall Study|Lost to Follow-up|0|||
13213563|NCT01893905|26258565|FG000|Overall Study|Protocol Violation|6|||
13213564|NCT01893905|26258566|FG001|Overall Study|Protocol Violation|1|||
13213565|NCT01893905|26258565|FG000|Overall Study|Lack of adherence to treatment|2|||
13213566|NCT01893905|26258566|FG001|Overall Study|Lack of adherence to treatment|0|||
13213567|NCT01893905|26258565|FG000|Overall Study|Other reason|1|||
13213568|NCT01893905|26258566|FG001|Overall Study|Other reason|3|||
13213569|NCT01893827|26258579|FG000|Overall Study|Lost to Follow-up|19|||
13213570|NCT01893827|26258580|FG001|Overall Study|Lost to Follow-up|26|||
13213571|NCT01893411|26258652|FG000|Overall Study|Protocol Violation|1|||
13213572|NCT01893411|26258653|FG001|Overall Study|Protocol Violation|0|||
13213573|NCT01893411|26258654|FG002|Overall Study|Protocol Violation|0|||
13213574|NCT01893411|26258652|FG000|Overall Study|Physician Decision|1|||
13213575|NCT01893411|26258653|FG001|Overall Study|Physician Decision|1|||
13213576|NCT01893411|26258654|FG002|Overall Study|Physician Decision|2|||
13213577|NCT01893411|26258652|FG000|Overall Study|Lack of Efficacy|2|||
13213578|NCT01893411|26258653|FG001|Overall Study|Lack of Efficacy|1|||
13213579|NCT01893411|26258654|FG002|Overall Study|Lack of Efficacy|0|||
13213580|NCT01893411|26258652|FG000|Overall Study|Other|3|||
13213581|NCT01893411|26258653|FG001|Overall Study|Other|1|||
13213582|NCT01893411|26258654|FG002|Overall Study|Other|3|||
13213583|NCT01893411|26258652|FG000|Overall Study|Adverse Event|1|||
13213584|NCT01893411|26258653|FG001|Overall Study|Adverse Event|0|||
13213585|NCT01893411|26258654|FG002|Overall Study|Adverse Event|0|||
13213586|NCT01893411|26258652|FG000|Overall Study|Withdrawal by Subject|7|||
13213587|NCT01893411|26258653|FG001|Overall Study|Withdrawal by Subject|4|||
13213588|NCT01893411|26258654|FG002|Overall Study|Withdrawal by Subject|3|||
13213589|NCT01893411|26258652|FG000|Overall Study|Lost to Follow-up|2|||
13213590|NCT01893411|26258653|FG001|Overall Study|Lost to Follow-up|0|||
13213591|NCT01893411|26258654|FG002|Overall Study|Lost to Follow-up|1|||
13213592|NCT01893346|26258681|FG000|Overall Study|Lost to Follow-up|0|||
13213593|NCT01893346|26258682|FG001|Overall Study|Lost to Follow-up|1|||
13213594|NCT01893346|26258683|FG002|Overall Study|Lost to Follow-up|0|||
13213595|NCT01893346|26258684|FG003|Overall Study|Lost to Follow-up|0|||
13213596|NCT01893346|26258681|FG000|Overall Study|Protocol Violation|1|||
13213597|NCT01893346|26258682|FG001|Overall Study|Protocol Violation|0|||
13213598|NCT01893346|26258683|FG002|Overall Study|Protocol Violation|0|||
13213599|NCT01893346|26258684|FG003|Overall Study|Protocol Violation|0|||
13213600|NCT01893346|26258681|FG000|Overall Study|Withdrawal by Subject|2|||
13213601|NCT01893346|26258682|FG001|Overall Study|Withdrawal by Subject|0|||
13213602|NCT01893346|26258683|FG002|Overall Study|Withdrawal by Subject|0|||
13213603|NCT01893346|26258684|FG003|Overall Study|Withdrawal by Subject|0|||
13213604|NCT01893281|26258693|FG000|Overall Study|Adverse Event|1|||
13213605|NCT01893281|26258693|FG000|Overall Study|Protocol Violation|1|||
13213606|NCT01893281|26258693|FG000|Overall Study|Withdrawal by Subject|1|||
13213607|NCT01893203|26258702|FG000|Overall Study|Withdrawal by Subject|1|||
13213608|NCT01892657|26258720|FG000|Overall Study|Withdrawal by Subject|6|||
13213609|NCT01892657|26258720|FG000|Overall Study|Protocol Violation|12|||
13213610|NCT01892540|26258747|FG000|Overall Study|Did not complete PET/MRI|0|||
13213611|NCT01892540|26258748|FG001|Overall Study|Did not complete PET/MRI|0|||
13213612|NCT01892540|26258749|FG002|Overall Study|Did not complete PET/MRI|2|||
13213613|NCT01892540|26258747|FG000|Overall Study|Did not fit in scanner|0|||
13213614|NCT01892540|26258748|FG001|Overall Study|Did not fit in scanner|0|||
13213615|NCT01892540|26258749|FG002|Overall Study|Did not fit in scanner|1|||
13213616|NCT01892501|26258759|FG000|Overall Study|Protocol Violation|2|||
13213617|NCT01892501|26258759|FG000|Overall Study|Puncture not carried out|9|||
13213618|NCT01892501|26258759|FG000|Overall Study|Radiological monitoring not carried out|5|||
13213619|NCT01892501|26258759|FG000|Overall Study|Non-contributory histological result|12|||
13213620|NCT01892436|26258810|FG000|Overall Study|Withdrawal by Subject|8|||
13213621|NCT01892436|26258811|FG001|Overall Study|Withdrawal by Subject|15|||
13213622|NCT01892436|26258812|FG002|Overall Study|Withdrawal by Subject|4|||
13213623|NCT01892436|26258813|FG003|Overall Study|Withdrawal by Subject|4|||
13213624|NCT01892436|26258810|FG000|Overall Study|Death|1|||
13213625|NCT01892436|26258811|FG001|Overall Study|Death|1|||
13213626|NCT01892436|26258812|FG002|Overall Study|Death|0|||
13213627|NCT01892436|26258813|FG003|Overall Study|Death|0|||
13213628|NCT01892436|26258810|FG000|Overall Study|Physician Decision|2|||
13213629|NCT01892436|26258811|FG001|Overall Study|Physician Decision|1|||
13213630|NCT01892436|26258812|FG002|Overall Study|Physician Decision|0|||
13213631|NCT01892436|26258813|FG003|Overall Study|Physician Decision|1|||
13213632|NCT01892436|26258810|FG000|Overall Study|Pregnancy|0|||
13213633|NCT01892436|26258811|FG001|Overall Study|Pregnancy|2|||
13213634|NCT01892436|26258812|FG002|Overall Study|Pregnancy|1|||
13213635|NCT01892436|26258813|FG003|Overall Study|Pregnancy|0|||
13213636|NCT01892436|26258810|FG000|Overall Study|Technical problems|2|||
13213637|NCT01892436|26258811|FG001|Overall Study|Technical problems|1|||
13213638|NCT01892436|26258812|FG002|Overall Study|Technical problems|1|||
13213639|NCT01892436|26258813|FG003|Overall Study|Technical problems|1|||
13213640|NCT01892436|26258810|FG000|Overall Study|Lack of Efficacy|1|||
13213641|NCT01892436|26258811|FG001|Overall Study|Lack of Efficacy|2|||
13213642|NCT01892436|26258812|FG002|Overall Study|Lack of Efficacy|2|||
13213643|NCT01892436|26258813|FG003|Overall Study|Lack of Efficacy|2|||
13213644|NCT01892436|26258810|FG000|Overall Study|Lost to Follow-up|1|||
13213645|NCT01892436|26258811|FG001|Overall Study|Lost to Follow-up|1|||
13213646|NCT01892436|26258812|FG002|Overall Study|Lost to Follow-up|1|||
13213647|NCT01892436|26258813|FG003|Overall Study|Lost to Follow-up|3|||
13213648|NCT01892436|26258810|FG000|Overall Study|non-compliance with treatment|1|||
13213649|NCT01892436|26258811|FG001|Overall Study|non-compliance with treatment|0|||
13213650|NCT01892436|26258812|FG002|Overall Study|non-compliance with treatment|0|||
13213651|NCT01892436|26258813|FG003|Overall Study|non-compliance with treatment|0|||
13213652|NCT01892436|26258810|FG000|Overall Study|Adverse Event|7|||
13213653|NCT01892436|26258811|FG001|Overall Study|Adverse Event|6|||
13213654|NCT01892436|26258812|FG002|Overall Study|Adverse Event|2|||
13213655|NCT01892436|26258813|FG003|Overall Study|Adverse Event|3|||
13213656|NCT01892345|26258838|FG000|Overall Study|Adverse Event|0|||
13213657|NCT01892345|26258839|FG001|Overall Study|Adverse Event|2|||
13213658|NCT01892345|26258838|FG000|Overall Study|Death|1|||
13213659|NCT01892345|26258839|FG001|Overall Study|Death|0|||
13213660|NCT01892345|26258838|FG000|Overall Study|Lost to Follow-up|3|||
13213661|NCT01892345|26258839|FG001|Overall Study|Lost to Follow-up|0|||
13213662|NCT01892345|26258838|FG000|Overall Study|Withdrawal by Subject|12|||
13213663|NCT01892345|26258839|FG001|Overall Study|Withdrawal by Subject|1|||
13213664|NCT01892293|26258847|FG000|Overall Study|Apheresed but not treated|4|||
13213665|NCT01892189|26258915|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
13213666|NCT01892189|26258916|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
13213667|NCT01892189|26258917|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
13213668|NCT01892189|26258918|FG003|Washout Period 1 (7 Days)|Adverse Event|0|||
13213669|NCT01892189|26258919|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
13213670|NCT01892189|26258920|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
13213671|NCT01892189|26258921|FG006|Washout Period 1 (7 Days)|Adverse Event|0|||
13213672|NCT01892189|26258922|FG007|Washout Period 1 (7 Days)|Adverse Event|0|||
13213673|NCT01892189|26258923|FG008|Washout Period 1 (7 Days)|Adverse Event|1|||
13213674|NCT01892189|26258915|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
13213675|NCT01892189|26258916|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
13213676|NCT01892189|26258917|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2|||
13213677|NCT01892189|26258918|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
13213678|NCT01892189|26258919|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
13213679|NCT01892189|26258920|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
13213680|NCT01892189|26258921|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
13213681|NCT01892189|26258922|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
13213682|NCT01892189|26258923|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
13213683|NCT01892189|26258915|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
13213684|NCT01892189|26258916|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
13213685|NCT01892189|26258917|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
13213686|NCT01892189|26258918|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
13213687|NCT01892189|26258919|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
13213688|NCT01892189|26258920|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1|||
13213689|NCT01892189|26258921|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
13213690|NCT01892189|26258922|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
13213691|NCT01892189|26258923|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
13213692|NCT01892163|26258942|FG000|Overall Study|Death|1|||
13213693|NCT01892163|26258943|FG001|Overall Study|Death|1|||
13213694|NCT01892163|26258942|FG000|Overall Study|Lost to Follow-up|1|||
13213695|NCT01892163|26258943|FG001|Overall Study|Lost to Follow-up|0|||
13213696|NCT01892020|26258964|FG000|Period 1|Adverse Event|1|||
13213697|NCT01892020|26258965|FG001|Period 1|Adverse Event|1|||
13213698|NCT01892020|26258964|FG000|Period 1|Protocol Violation|2|||
13213699|NCT01892020|26258965|FG001|Period 1|Protocol Violation|4|||
13213700|NCT01892020|26258964|FG000|Period 1|Unclassified|0|||
13213701|NCT01892020|26258965|FG001|Period 1|Unclassified|1|||
13213702|NCT01892020|26258964|FG000|Period 2|Protocol Violation|1|||
13213703|NCT01892020|26258965|FG001|Period 2|Protocol Violation|0|||
13213704|NCT01891890|26259016|FG000|Overall Study|Lost to Follow-up|0|||
13213705|NCT01891890|26259017|FG001|Overall Study|Lost to Follow-up|0|||
13213706|NCT01891890|26259018|FG002|Overall Study|Lost to Follow-up|1|||
13213707|NCT01891890|26259016|FG000|Overall Study|Study ended before endpoint reached|7|||
13213708|NCT01891890|26259017|FG001|Overall Study|Study ended before endpoint reached|3|||
13213709|NCT01891890|26259018|FG002|Overall Study|Study ended before endpoint reached|6|||
13213710|NCT01891864|26259049|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
13213711|NCT01891864|26259050|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
13213712|NCT01891864|26259051|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
13213713|NCT01891864|26259052|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
13213714|NCT01891864|26259053|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
13213715|NCT01891864|26259054|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
13213716|NCT01891864|26259049|FG000|Treatment Period 1|Physician Decision|0|||
13213717|NCT01891864|26259050|FG001|Treatment Period 1|Physician Decision|1|||
13213718|NCT01891864|26259051|FG002|Treatment Period 1|Physician Decision|0|||
13213719|NCT01891864|26259052|FG003|Treatment Period 1|Physician Decision|0|||
13213720|NCT01891864|26259053|FG004|Treatment Period 1|Physician Decision|0|||
13213721|NCT01891864|26259054|FG005|Treatment Period 1|Physician Decision|0|||
13213722|NCT01891864|26259049|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
13213723|NCT01891864|26259050|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1|||
13213724|NCT01891864|26259051|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
13213725|NCT01891864|26259052|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
13213726|NCT01891864|26259053|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
13213727|NCT01891864|26259054|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
13213728|NCT01891864|26259049|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
13213729|NCT01891864|26259050|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
13213730|NCT01891864|26259051|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
13213731|NCT01891864|26259052|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
13213732|NCT01891864|26259053|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
13213733|NCT01891864|26259054|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
13213734|NCT01891864|26259049|FG000|Treatment Period 1|Withdrawal by Subject|2|||
13213735|NCT01891864|26259050|FG001|Treatment Period 1|Withdrawal by Subject|5|||
13213736|NCT01891864|26259051|FG002|Treatment Period 1|Withdrawal by Subject|0|||
13213737|NCT01891864|26259052|FG003|Treatment Period 1|Withdrawal by Subject|0|||
13213738|NCT01891864|26259053|FG004|Treatment Period 1|Withdrawal by Subject|0|||
13213739|NCT01891864|26259054|FG005|Treatment Period 1|Withdrawal by Subject|0|||
13213740|NCT01891864|26259049|FG000|Treatment Period 1|Lost to Follow-up|1|||
13213741|NCT01891864|26259050|FG001|Treatment Period 1|Lost to Follow-up|0|||
13213742|NCT01891864|26259051|FG002|Treatment Period 1|Lost to Follow-up|0|||
13213743|NCT01891864|26259052|FG003|Treatment Period 1|Lost to Follow-up|0|||
13213744|NCT01891864|26259053|FG004|Treatment Period 1|Lost to Follow-up|0|||
13213745|NCT01891864|26259054|FG005|Treatment Period 1|Lost to Follow-up|0|||
13213746|NCT01891864|26259049|FG000|Treatment Period 2|Protocol Violation|0|||
13213747|NCT01891864|26259050|FG001|Treatment Period 2|Protocol Violation|0|||
13213748|NCT01891864|26259051|FG002|Treatment Period 2|Protocol Violation|0|||
13213749|NCT01891864|26259052|FG003|Treatment Period 2|Protocol Violation|1|||
13213750|NCT01891864|26259053|FG004|Treatment Period 2|Protocol Violation|0|||
13213751|NCT01891864|26259054|FG005|Treatment Period 2|Protocol Violation|0|||
13213752|NCT01891864|26259049|FG000|Treatment Period 2|Physician Decision|0|||
13213753|NCT01891864|26259050|FG001|Treatment Period 2|Physician Decision|0|||
13213754|NCT01891864|26259051|FG002|Treatment Period 2|Physician Decision|1|||
13213755|NCT01891864|26259052|FG003|Treatment Period 2|Physician Decision|0|||
13213756|NCT01891864|26259053|FG004|Treatment Period 2|Physician Decision|0|||
13213757|NCT01891864|26259054|FG005|Treatment Period 2|Physician Decision|0|||
13213758|NCT01891864|26259049|FG000|Treatment Period 2|Site Termination|0|||
13213759|NCT01891864|26259050|FG001|Treatment Period 2|Site Termination|0|||
13213760|NCT01891864|26259051|FG002|Treatment Period 2|Site Termination|1|||
13213761|NCT01891864|26259052|FG003|Treatment Period 2|Site Termination|2|||
13213762|NCT01891864|26259053|FG004|Treatment Period 2|Site Termination|0|||
13213763|NCT01891864|26259054|FG005|Treatment Period 2|Site Termination|0|||
13213764|NCT01891864|26259049|FG000|Treatment Period 2|Lack of Efficacy|0|||
13213765|NCT01891864|26259050|FG001|Treatment Period 2|Lack of Efficacy|0|||
13213766|NCT01891864|26259051|FG002|Treatment Period 2|Lack of Efficacy|1|||
13213767|NCT01891864|26259052|FG003|Treatment Period 2|Lack of Efficacy|0|||
13213768|NCT01891864|26259053|FG004|Treatment Period 2|Lack of Efficacy|1|||
13213769|NCT01891864|26259054|FG005|Treatment Period 2|Lack of Efficacy|0|||
13213770|NCT01891864|26259049|FG000|Treatment Period 2|Adverse Event|0|||
13213771|NCT01891864|26259050|FG001|Treatment Period 2|Adverse Event|0|||
13213772|NCT01891864|26259051|FG002|Treatment Period 2|Adverse Event|1|||
13213773|NCT01891864|26259052|FG003|Treatment Period 2|Adverse Event|2|||
13213774|NCT01891864|26259053|FG004|Treatment Period 2|Adverse Event|0|||
13213775|NCT01891864|26259054|FG005|Treatment Period 2|Adverse Event|4|||
13213776|NCT01891864|26259049|FG000|Treatment Period 2|Termination of Site|0|||
13213777|NCT01891864|26259050|FG001|Treatment Period 2|Termination of Site|0|||
13213778|NCT01891864|26259051|FG002|Treatment Period 2|Termination of Site|0|||
13213779|NCT01891864|26259052|FG003|Treatment Period 2|Termination of Site|0|||
13213780|NCT01891864|26259053|FG004|Treatment Period 2|Termination of Site|2|||
13213781|NCT01891864|26259054|FG005|Treatment Period 2|Termination of Site|0|||
13213782|NCT01891864|26259049|FG000|Treatment Period 2|Withdrawal by Subject|0|||
13213783|NCT01891864|26259050|FG001|Treatment Period 2|Withdrawal by Subject|0|||
13213784|NCT01891864|26259051|FG002|Treatment Period 2|Withdrawal by Subject|3|||
13213785|NCT01891864|26259052|FG003|Treatment Period 2|Withdrawal by Subject|4|||
13213786|NCT01891864|26259053|FG004|Treatment Period 2|Withdrawal by Subject|1|||
13213787|NCT01891864|26259054|FG005|Treatment Period 2|Withdrawal by Subject|1|||
13213788|NCT01891864|26259049|FG000|Extension Period|Lack of Efficacy|0|||
13213789|NCT01891864|26259050|FG001|Extension Period|Lack of Efficacy|0|||
13213790|NCT01891864|26259051|FG002|Extension Period|Lack of Efficacy|0|||
13213791|NCT01891864|26259052|FG003|Extension Period|Lack of Efficacy|1|||
13213792|NCT01891864|26259053|FG004|Extension Period|Lack of Efficacy|1|||
13213793|NCT01891864|26259054|FG005|Extension Period|Lack of Efficacy|0|||
13213794|NCT01891864|26259049|FG000|Extension Period|Pregnancy|0|||
13213795|NCT01891864|26259050|FG001|Extension Period|Pregnancy|0|||
13213796|NCT01891864|26259051|FG002|Extension Period|Pregnancy|1|||
13213797|NCT01891864|26259052|FG003|Extension Period|Pregnancy|0|||
13213798|NCT01891864|26259053|FG004|Extension Period|Pregnancy|0|||
13213799|NCT01891864|26259054|FG005|Extension Period|Pregnancy|0|||
13213800|NCT01891864|26259049|FG000|Extension Period|Adverse Event|0|||
13213801|NCT01891864|26259050|FG001|Extension Period|Adverse Event|0|||
13213802|NCT01891864|26259051|FG002|Extension Period|Adverse Event|4|||
13213803|NCT01891864|26259052|FG003|Extension Period|Adverse Event|2|||
13213804|NCT01891864|26259053|FG004|Extension Period|Adverse Event|2|||
13213805|NCT01891864|26259054|FG005|Extension Period|Adverse Event|0|||
13213806|NCT01891864|26259049|FG000|Extension Period|Withdrawal by Subject|0|||
13213807|NCT01891864|26259050|FG001|Extension Period|Withdrawal by Subject|0|||
13213808|NCT01891864|26259051|FG002|Extension Period|Withdrawal by Subject|1|||
13213809|NCT01891864|26259052|FG003|Extension Period|Withdrawal by Subject|2|||
13213810|NCT01891864|26259053|FG004|Extension Period|Withdrawal by Subject|4|||
13213811|NCT01891864|26259054|FG005|Extension Period|Withdrawal by Subject|0|||
13213812|NCT01891864|26259049|FG000|Extension Period|Lost to Follow-up|0|||
13213813|NCT01891864|26259050|FG001|Extension Period|Lost to Follow-up|0|||
13213814|NCT01891864|26259051|FG002|Extension Period|Lost to Follow-up|2|||
13213815|NCT01891864|26259052|FG003|Extension Period|Lost to Follow-up|0|||
13213816|NCT01891864|26259053|FG004|Extension Period|Lost to Follow-up|0|||
13213817|NCT01891864|26259054|FG005|Extension Period|Lost to Follow-up|0|||
13213818|NCT01891721|26259078|FG000|Overall Study|Lost to Follow-up|10|||
13213819|NCT01891721|26259079|FG001|Overall Study|Lost to Follow-up|5|||
13213820|NCT01891721|26259080|FG002|Overall Study|Lost to Follow-up|1|||
13213821|NCT01891669|26259262|FG000|Overall Study|Death|0|||
13213822|NCT01891669|26259263|FG001|Overall Study|Death|0|||
13213823|NCT01891669|26259264|FG002|Overall Study|Death|0|||
13213824|NCT01891669|26259265|FG003|Overall Study|Death|0|||
13213825|NCT01891669|26259266|FG004|Overall Study|Death|0|||
13213826|NCT01891669|26259267|FG005|Overall Study|Death|0|||
13213827|NCT01891669|26259268|FG006|Overall Study|Death|0|||
13213828|NCT01891669|26259269|FG007|Overall Study|Death|1|||
13213829|NCT01891669|26259270|FG008|Overall Study|Death|0|||
13213830|NCT01891669|26259271|FG009|Overall Study|Death|1|||
13213831|NCT01891669|26259262|FG000|Overall Study|Withdrawal by Subject|1|||
13213832|NCT01891669|26259263|FG001|Overall Study|Withdrawal by Subject|1|||
13213833|NCT01891669|26259264|FG002|Overall Study|Withdrawal by Subject|0|||
13213834|NCT01891669|26259265|FG003|Overall Study|Withdrawal by Subject|0|||
13213835|NCT01891669|26259266|FG004|Overall Study|Withdrawal by Subject|0|||
13213836|NCT01891669|26259267|FG005|Overall Study|Withdrawal by Subject|0|||
13213837|NCT01891669|26259268|FG006|Overall Study|Withdrawal by Subject|1|||
13213838|NCT01891669|26259269|FG007|Overall Study|Withdrawal by Subject|2|||
13213839|NCT01891669|26259270|FG008|Overall Study|Withdrawal by Subject|1|||
13213840|NCT01891669|26259271|FG009|Overall Study|Withdrawal by Subject|1|||
13213841|NCT01891669|26259262|FG000|Overall Study|Other|1|||
13213842|NCT01891669|26259263|FG001|Overall Study|Other|0|||
13213843|NCT01891669|26259264|FG002|Overall Study|Other|0|||
13213844|NCT01891669|26259265|FG003|Overall Study|Other|0|||
13213845|NCT01891669|26259266|FG004|Overall Study|Other|0|||
13213846|NCT01891669|26259267|FG005|Overall Study|Other|0|||
13213847|NCT01891669|26259268|FG006|Overall Study|Other|0|||
13213848|NCT01891669|26259269|FG007|Overall Study|Other|1|||
13213849|NCT01891669|26259270|FG008|Overall Study|Other|0|||
13213850|NCT01891669|26259271|FG009|Overall Study|Other|0|||
13213851|NCT01891396|26259340|FG000|Overall Study|Withdrawal by Subject|4|||
13213852|NCT01891396|26259341|FG001|Overall Study|Withdrawal by Subject|4|||
13213853|NCT01891396|26259342|FG002|Overall Study|Withdrawal by Subject|3|||
13213854|NCT01891396|26259340|FG000|Overall Study|Lost to Follow-up|0|||
13213855|NCT01891396|26259341|FG001|Overall Study|Lost to Follow-up|1|||
13213856|NCT01891396|26259342|FG002|Overall Study|Lost to Follow-up|0|||
13213857|NCT01891357|26259351|FG000|Overall Study|Protocol Violation|3|||
13213858|NCT01890967|26259437|FG000|Overall Study|Adverse Event|3|||
13213859|NCT01890967|26259438|FG001|Overall Study|Adverse Event|3|||
13213860|NCT01890967|26259439|FG002|Overall Study|Adverse Event|3|||
13213861|NCT01890967|26259440|FG003|Overall Study|Adverse Event|2|||
13213862|NCT01890967|26259441|FG004|Overall Study|Adverse Event|1|||
13213863|NCT01890967|26259442|FG005|Overall Study|Adverse Event|7|||
13213864|NCT01890967|26259437|FG000|Overall Study|Death|1|||
13213865|NCT01890967|26259438|FG001|Overall Study|Death|0|||
13213866|NCT01890967|26259439|FG002|Overall Study|Death|0|||
13213867|NCT01890967|26259440|FG003|Overall Study|Death|0|||
13213868|NCT01890967|26259441|FG004|Overall Study|Death|0|||
13213869|NCT01890967|26259442|FG005|Overall Study|Death|0|||
13213870|NCT01890967|26259437|FG000|Overall Study|Lost to Follow-up|1|||
13213871|NCT01890967|26259438|FG001|Overall Study|Lost to Follow-up|1|||
13213872|NCT01890967|26259439|FG002|Overall Study|Lost to Follow-up|1|||
13213873|NCT01890967|26259440|FG003|Overall Study|Lost to Follow-up|1|||
13213874|NCT01890967|26259441|FG004|Overall Study|Lost to Follow-up|0|||
13213875|NCT01890967|26259442|FG005|Overall Study|Lost to Follow-up|1|||
13213876|NCT01890967|26259437|FG000|Overall Study|Protocol Violation|0|||
13213877|NCT01890967|26259438|FG001|Overall Study|Protocol Violation|3|||
13213878|NCT01890967|26259439|FG002|Overall Study|Protocol Violation|3|||
13213879|NCT01890967|26259440|FG003|Overall Study|Protocol Violation|2|||
13213880|NCT01890967|26259441|FG004|Overall Study|Protocol Violation|4|||
13213881|NCT01890967|26259442|FG005|Overall Study|Protocol Violation|1|||
13213882|NCT01890967|26259437|FG000|Overall Study|Sponsor Decision|2|||
13213883|NCT01890967|26259438|FG001|Overall Study|Sponsor Decision|0|||
13213884|NCT01890967|26259439|FG002|Overall Study|Sponsor Decision|1|||
13213885|NCT01890967|26259440|FG003|Overall Study|Sponsor Decision|3|||
13213886|NCT01890967|26259441|FG004|Overall Study|Sponsor Decision|2|||
13213887|NCT01890967|26259442|FG005|Overall Study|Sponsor Decision|3|||
13213888|NCT01890967|26259437|FG000|Overall Study|Withdrawal by Subject|3|||
13213889|NCT01890967|26259438|FG001|Overall Study|Withdrawal by Subject|4|||
13213890|NCT01890967|26259439|FG002|Overall Study|Withdrawal by Subject|2|||
13213891|NCT01890967|26259440|FG003|Overall Study|Withdrawal by Subject|3|||
13213892|NCT01890967|26259441|FG004|Overall Study|Withdrawal by Subject|3|||
13213893|NCT01890967|26259442|FG005|Overall Study|Withdrawal by Subject|1|||
13213894|NCT01890915|26259459|FG000|Overall Study|Adverse Event|1|||
13213895|NCT01890915|26259460|FG001|Overall Study|Adverse Event|0|||
13213896|NCT01890915|26259459|FG000|Overall Study|Protocol Violation|2|||
13213897|NCT01890915|26259460|FG001|Overall Study|Protocol Violation|0|||
13213898|NCT01890915|26259459|FG000|Overall Study|Equipment Malfunction|0|||
13213899|NCT01890915|26259460|FG001|Overall Study|Equipment Malfunction|1|||
13213900|NCT01890785|26259496|FG000|Third Intervention|Withdrawal by Subject|0|||
13213901|NCT01890785|26259497|FG001|Third Intervention|Withdrawal by Subject|1|||
13213902|NCT01890785|26259498|FG002|Third Intervention|Withdrawal by Subject|0|||
13213903|NCT01890785|26259499|FG003|Third Intervention|Withdrawal by Subject|0|||
13213904|NCT01890785|26259500|FG004|Third Intervention|Withdrawal by Subject|0|||
13213905|NCT01890785|26259501|FG005|Third Intervention|Withdrawal by Subject|0|||
13213906|NCT01890759|26259540|FG000|Overall Study|Protocol Violation|0|||
13213907|NCT01890759|26259541|FG001|Overall Study|Protocol Violation|2|||
13213908|NCT01890759|26259540|FG000|Overall Study|Lost to Follow-up|0|||
13213909|NCT01890759|26259541|FG001|Overall Study|Lost to Follow-up|2|||
13213910|NCT01890759|26259540|FG000|Overall Study|Withdrawal by Subject|2|||
13213911|NCT01890759|26259541|FG001|Overall Study|Withdrawal by Subject|8|||
13213912|NCT01890746|26259632|FG000|Overall Study|Death|39|||
13213913|NCT01890746|26259633|FG001|Overall Study|Death|30|||
13213914|NCT01890746|26259632|FG000|Overall Study|Adverse Event|1|||
13213915|NCT01890746|26259633|FG001|Overall Study|Adverse Event|0|||
13213916|NCT01890746|26259632|FG000|Overall Study|Lost to Follow-up|4|||
13213917|NCT01890746|26259633|FG001|Overall Study|Lost to Follow-up|1|||
13213918|NCT01890746|26259632|FG000|Overall Study|Physician Decision|3|||
13213919|NCT01890746|26259633|FG001|Overall Study|Physician Decision|2|||
13213920|NCT01890746|26259632|FG000|Overall Study|Withdrawal by Subject|5|||
13213921|NCT01890746|26259633|FG001|Overall Study|Withdrawal by Subject|8|||
13213922|NCT01890707|26259646|FG000|Overall Study|Lost to Follow-up|1|||
13213923|NCT01890707|26259647|FG001|Overall Study|Lost to Follow-up|1|||
13213924|NCT01890512|26259653|FG000|Overall Study|Physician Decision|1|||
13213925|NCT01890512|26259653|FG000|Overall Study|Withdrawal by Subject|1|||
13213926|NCT01890512|26259653|FG000|Overall Study|Protocol Violation|1|||
13213927|NCT01890473|26259686|FG000|Overall Study|Lost to Follow-up|1|||
13213928|NCT01890473|26259687|FG001|Overall Study|Lost to Follow-up|0|||
13213929|NCT01890473|26259686|FG000|Overall Study|Poor/non-compliance|1|||
13213930|NCT01890473|26259687|FG001|Overall Study|Poor/non-compliance|0|||
13213931|NCT01890434|26259719|FG000|Overall Study|Adverse Event|8|||
13213932|NCT01890434|26259719|FG000|Overall Study|PCI at external hospital|1|||
13213933|NCT01890434|26259719|FG000|Overall Study|Assessment discrepancy|1|||
13213934|NCT01890434|26259719|FG000|Overall Study|CRC didn't contact participant for FU|1|||
13213935|NCT01890434|26259719|FG000|Overall Study|Could not get whole set of images|1|||
13213936|NCT01890434|26259719|FG000|Overall Study|Decline to return for GSPECT|1|||
13213937|NCT01890434|26259719|FG000|Overall Study|GSPECT at rest was not done|1|||
13213938|NCT01890434|26259719|FG000|Overall Study|Participant didn't complete MRI|1|||
13213939|NCT01890434|26259719|FG000|Overall Study|Uncontactable by phone|1|||
13213940|NCT01890434|26259719|FG000|Overall Study|Moved out of position|1|||
13213941|NCT01890434|26259719|FG000|Overall Study|Unable to contact|1|||
13213942|NCT01890434|26259719|FG000|Overall Study|Withdrawal by PI for ICA not performed|2|||
13213943|NCT01890421|26259744|FG000|Overall Study|Adverse Event|1|||
13213944|NCT01890421|26259744|FG000|Overall Study|Other reason|10|||
13213945|NCT01890265|26259785|FG000|Overall Study|Other (Unspecified reason)|0|||
13213946|NCT01890265|26259786|FG001|Overall Study|Other (Unspecified reason)|1|||
13213947|NCT01890265|26259787|FG002|Overall Study|Other (Unspecified reason)|0|||
13213948|NCT01890265|26259788|FG003|Overall Study|Other (Unspecified reason)|0|||
13213949|NCT01890265|26259789|FG004|Overall Study|Other (Unspecified reason)|0|||
13213950|NCT01890265|26259790|FG005|Overall Study|Other (Unspecified reason)|0|||
13213951|NCT01890265|26259785|FG000|Overall Study|Progressive disease|6|||
13213952|NCT01890265|26259786|FG001|Overall Study|Progressive disease|6|||
13213953|NCT01890265|26259787|FG002|Overall Study|Progressive disease|0|||
13213954|NCT01890265|26259788|FG003|Overall Study|Progressive disease|0|||
13213955|NCT01890265|26259789|FG004|Overall Study|Progressive disease|0|||
13213956|NCT01890265|26259790|FG005|Overall Study|Progressive disease|0|||
13213957|NCT01890265|26259785|FG000|Overall Study|Adverse Event|2|||
13213958|NCT01890265|26259786|FG001|Overall Study|Adverse Event|1|||
13213959|NCT01890265|26259787|FG002|Overall Study|Adverse Event|0|||
13213960|NCT01890265|26259788|FG003|Overall Study|Adverse Event|0|||
13213961|NCT01890265|26259789|FG004|Overall Study|Adverse Event|0|||
13213962|NCT01890265|26259790|FG005|Overall Study|Adverse Event|0|||
13213963|NCT01890265|26259785|FG000|Overall Study|Death|2|||
13213964|NCT01890265|26259786|FG001|Overall Study|Death|3|||
13213965|NCT01890265|26259787|FG002|Overall Study|Death|1|||
13213966|NCT01890265|26259788|FG003|Overall Study|Death|0|||
13213967|NCT01890265|26259789|FG004|Overall Study|Death|0|||
13213968|NCT01890265|26259790|FG005|Overall Study|Death|0|||
13213969|NCT01890265|26259785|FG000|Overall Study|Withdrawal by Subject|0|||
13213970|NCT01890265|26259786|FG001|Overall Study|Withdrawal by Subject|2|||
13213971|NCT01890265|26259787|FG002|Overall Study|Withdrawal by Subject|3|||
13213972|NCT01890265|26259788|FG003|Overall Study|Withdrawal by Subject|0|||
13213973|NCT01890265|26259789|FG004|Overall Study|Withdrawal by Subject|2|||
13213974|NCT01890265|26259790|FG005|Overall Study|Withdrawal by Subject|0|||
13213975|NCT01890148|26259808|FG000|Overall Study|Adverse Event|1|||
13213976|NCT01890122|26259883|FG000|Overall Study|Adverse Event|1|||
13213977|NCT01890122|26259884|FG001|Overall Study|Adverse Event|1|||
13213978|NCT01890122|26259885|FG002|Overall Study|Adverse Event|1|||
13213979|NCT01890122|26259886|FG003|Overall Study|Adverse Event|2|||
13213980|NCT01890122|26259883|FG000|Overall Study|Major Protocol Deviation|3|||
13213981|NCT01890122|26259884|FG001|Overall Study|Major Protocol Deviation|1|||
13213982|NCT01890122|26259885|FG002|Overall Study|Major Protocol Deviation|0|||
13213983|NCT01890122|26259886|FG003|Overall Study|Major Protocol Deviation|1|||
13213984|NCT01890122|26259883|FG000|Overall Study|Lost to Follow-up|0|||
13213985|NCT01890122|26259884|FG001|Overall Study|Lost to Follow-up|1|||
13213986|NCT01890122|26259885|FG002|Overall Study|Lost to Follow-up|2|||
13213987|NCT01890122|26259886|FG003|Overall Study|Lost to Follow-up|2|||
13213988|NCT01890122|26259883|FG000|Overall Study|Voluntary Withdrawal|8|||
13213989|NCT01890122|26259884|FG001|Overall Study|Voluntary Withdrawal|8|||
13213990|NCT01890122|26259885|FG002|Overall Study|Voluntary Withdrawal|2|||
13213991|NCT01890122|26259886|FG003|Overall Study|Voluntary Withdrawal|11|||
13213992|NCT01890122|26259883|FG000|Overall Study|Lack of Efficacy|14|||
13213993|NCT01890122|26259884|FG001|Overall Study|Lack of Efficacy|24|||
13213994|NCT01890122|26259885|FG002|Overall Study|Lack of Efficacy|7|||
13213995|NCT01890122|26259886|FG003|Overall Study|Lack of Efficacy|41|||
13213996|NCT01890122|26259883|FG000|Overall Study|Reason not Specified|0|||
13213997|NCT01890122|26259884|FG001|Overall Study|Reason not Specified|1|||
13296694|NCT01369355|26497105|FG002|Week 0 - Week 44 (Maintenance)|Other|1|||
13296695|NCT01369355|26497106|FG003|Week 0 - Week 44 (Maintenance)|Other|0|||
13296696|NCT01369355|26497107|FG004|Week 0 - Week 44 (Maintenance)|Other|1|||
13213998|NCT01890122|26259885|FG002|Overall Study|Reason not Specified|1|||
13213999|NCT01890122|26259886|FG003|Overall Study|Reason not Specified|2|||
13214000|NCT01890122|26259883|FG000|Overall Study|Randomized but not Treated|1|||
13214001|NCT01890122|26259884|FG001|Overall Study|Randomized but not Treated|1|||
13214002|NCT01890122|26259885|FG002|Overall Study|Randomized but not Treated|0|||
13214003|NCT01890122|26259886|FG003|Overall Study|Randomized but not Treated|0|||
13214004|NCT01890109|26259912|FG000|Overall Study|Withdrawal by Subject|0|||
13214005|NCT01890109|26259913|FG001|Overall Study|Withdrawal by Subject|3|||
13214006|NCT01890109|26259912|FG000|Overall Study|Lost to Follow-up|1|||
13214007|NCT01890109|26259913|FG001|Overall Study|Lost to Follow-up|2|||
13214008|NCT01889862|26259960|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4|||
13214009|NCT01889862|26259961|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
13214010|NCT01889862|26259962|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
13214011|NCT01889862|26259963|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
13214012|NCT01889862|26259964|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
13214013|NCT01889862|26259960|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2|||
13214014|NCT01889862|26259961|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
13214015|NCT01889862|26259962|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
13214016|NCT01889862|26259963|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
13214017|NCT01889862|26259964|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
13214018|NCT01889862|26259960|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4|||
13214019|NCT01889862|26259961|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
13214020|NCT01889862|26259962|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
13214021|NCT01889862|26259963|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
13214022|NCT01889862|26259964|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
13214023|NCT01889862|26259960|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2|||
13214024|NCT01889862|26259961|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
13214025|NCT01889862|26259962|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
13214026|NCT01889862|26259963|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
13214027|NCT01889862|26259964|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
13214028|NCT01889862|26259960|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
13214029|NCT01889862|26259961|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
13214030|NCT01889862|26259962|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1|||
13214031|NCT01889862|26259963|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
13214032|NCT01889862|26259964|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
13214033|NCT01889862|26259960|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
13214034|NCT01889862|26259961|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
13214035|NCT01889862|26259962|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
13214036|NCT01889862|26259963|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
13214037|NCT01889862|26259964|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5|||
13214038|NCT01889862|26259960|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
13214039|NCT01889862|26259961|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
13214040|NCT01889862|26259962|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
13214041|NCT01889862|26259963|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
13214042|NCT01889862|26259964|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14|||
13214043|NCT01889862|26259960|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
13214044|NCT01889862|26259961|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
13214045|NCT01889862|26259962|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
13214046|NCT01889862|26259963|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
13214047|NCT01889862|26259964|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4|||
13214048|NCT01889862|26259960|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
13214049|NCT01889862|26259961|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
13214050|NCT01889862|26259962|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
13214051|NCT01889862|26259963|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
13214052|NCT01889862|26259964|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5|||
13214053|NCT01889862|26259960|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
13214054|NCT01889862|26259961|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
13214055|NCT01889862|26259962|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
13214056|NCT01889862|26259963|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
13214057|NCT01889862|26259964|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2|||
13214058|NCT01889602|26259999|FG000|First Intervention|Adverse Event|1|||
13214059|NCT01889602|26260000|FG001|First Intervention|Adverse Event|1|||
13214060|NCT01889602|26260001|FG002|First Intervention|Adverse Event|1|||
13214061|NCT01889602|26259999|FG000|First Intervention|Protocol Violation|0|||
13214062|NCT01889602|26260000|FG001|First Intervention|Protocol Violation|1|||
13214063|NCT01889602|26260001|FG002|First Intervention|Protocol Violation|1|||
13214064|NCT01889602|26259999|FG000|First Intervention|Study ending|0|||
13214065|NCT01889602|26260000|FG001|First Intervention|Study ending|1|||
13214066|NCT01889602|26260001|FG002|First Intervention|Study ending|0|||
13214067|NCT01889602|26259999|FG000|Second Intervention|Adverse Event|0|||
13214068|NCT01889602|26260000|FG001|Second Intervention|Adverse Event|0|||
13381988|NCT00748566|26749581|FG000|Overall Study|Study terminated by sponsor|5|||
13214069|NCT01889602|26260001|FG002|Second Intervention|Adverse Event|1|||
13214070|NCT01889602|26259999|FG000|Second Intervention|Study ending|1|||
13214071|NCT01889602|26260000|FG001|Second Intervention|Study ending|0|||
13214072|NCT01889602|26260001|FG002|Second Intervention|Study ending|0|||
13214073|NCT01889602|26259999|FG000|Second Intervention|Withdrawal by Subject|0|||
13214074|NCT01889602|26260000|FG001|Second Intervention|Withdrawal by Subject|0|||
13214075|NCT01889602|26260001|FG002|Second Intervention|Withdrawal by Subject|1|||
13214076|NCT01889602|26259999|FG000|Third Intervention|Protocol Violation|1|||
13214077|NCT01889602|26260000|FG001|Third Intervention|Protocol Violation|0|||
13214078|NCT01889602|26260001|FG002|Third Intervention|Protocol Violation|0|||
13214079|NCT01889602|26259999|FG000|Third Intervention|Withdrawal by Subject|2|||
13214080|NCT01889602|26260000|FG001|Third Intervention|Withdrawal by Subject|2|||
13214081|NCT01889602|26260001|FG002|Third Intervention|Withdrawal by Subject|0|||
13214082|NCT01889251|26260014|FG000|Overall Study|Adverse Event|1|||
13214083|NCT01889251|26260015|FG001|Overall Study|Adverse Event|0|||
13214084|NCT01889069|26260066|FG000|Overall Study|Death|18|||
13214085|NCT01889069|26260066|FG000|Overall Study|Progression of Disease|14|||
13214086|NCT01889069|26260066|FG000|Overall Study|Lost to Follow-up|6|||
13214087|NCT01889069|26260066|FG000|Overall Study|Other|4|||
13214088|NCT01889069|26260066|FG000|Overall Study|Consent Withdrawal|3|||
13214089|NCT01888965|26260074|FG000|Overall Study|Adverse Event|5|||
13214090|NCT01888965|26260074|FG000|Overall Study|Lack of Efficacy|4|||
13214091|NCT01888900|26260101|FG000|Overall Study|failed treatment|0|||
13214092|NCT01888900|26260102|FG001|Overall Study|failed treatment|2|||
13214093|NCT01888874|26260210|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
13214094|NCT01888874|26260211|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
13214095|NCT01888874|26260212|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
13214096|NCT01888874|26260213|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4|||
13214097|NCT01888874|26260214|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
13214098|NCT01888874|26260215|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
13214099|NCT01888874|26260216|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
13214100|NCT01888874|26260210|FG000|Period 1 (Baseline up to Week 12)|Other|1|||
13214101|NCT01888874|26260211|FG001|Period 1 (Baseline up to Week 12)|Other|0|||
13214102|NCT01888874|26260212|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
13214103|NCT01888874|26260213|FG003|Period 1 (Baseline up to Week 12)|Other|1|||
13214104|NCT01888874|26260214|FG004|Period 1 (Baseline up to Week 12)|Other|3|||
13214105|NCT01888874|26260215|FG005|Period 1 (Baseline up to Week 12)|Other|3|||
13214106|NCT01888874|26260216|FG006|Period 1 (Baseline up to Week 12)|Other|0|||
13214107|NCT01888874|26260210|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
13214108|NCT01888874|26260211|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
13214109|NCT01888874|26260212|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
13214110|NCT01888874|26260213|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
13214111|NCT01888874|26260214|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
13214112|NCT01888874|26260215|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
13214113|NCT01888874|26260216|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1|||
13214114|NCT01888874|26260210|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
13214115|NCT01888874|26260211|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
13214116|NCT01888874|26260212|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3|||
13214117|NCT01888874|26260213|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
13214118|NCT01888874|26260214|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
13214119|NCT01888874|26260215|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
13214120|NCT01888874|26260216|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
13214121|NCT01888874|26260210|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
13214122|NCT01888874|26260211|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
13214123|NCT01888874|26260212|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
13214124|NCT01888874|26260213|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
13214125|NCT01888874|26260214|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1|||
13214126|NCT01888874|26260215|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
13214127|NCT01888874|26260216|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
13214128|NCT01888874|26260210|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
13214129|NCT01888874|26260211|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1|||
13214130|NCT01888874|26260212|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
13214131|NCT01888874|26260213|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
13214132|NCT01888874|26260214|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
13214133|NCT01888874|26260215|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
13214134|NCT01888874|26260216|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
13214135|NCT01888874|26260210|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
13214136|NCT01888874|26260211|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
13214137|NCT01888874|26260212|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
13214138|NCT01888874|26260213|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
13214139|NCT01888874|26260214|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
13214140|NCT01888874|26260215|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
13214141|NCT01888874|26260216|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
13214142|NCT01888874|26260210|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
13214143|NCT01888874|26260211|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
13214144|NCT01888874|26260212|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
13296697|NCT01369355|26497108|FG005|Week 0 - Week 44 (Maintenance)|Other|0|||
13214145|NCT01888874|26260213|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
13214146|NCT01888874|26260214|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
13214147|NCT01888874|26260215|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
13214148|NCT01888874|26260216|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
13214149|NCT01888874|26260210|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
13214150|NCT01888874|26260211|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
13214151|NCT01888874|26260212|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
13214152|NCT01888874|26260213|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
13214153|NCT01888874|26260214|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1|||
13214154|NCT01888874|26260215|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
13214155|NCT01888874|26260216|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
13214156|NCT01888874|26260210|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
13214157|NCT01888874|26260211|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
13214158|NCT01888874|26260212|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2|||
13214159|NCT01888874|26260213|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
13214160|NCT01888874|26260214|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
13214161|NCT01888874|26260215|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1|||
13214162|NCT01888874|26260216|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
13214163|NCT01888874|26260210|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
13214164|NCT01888874|26260211|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
13214165|NCT01888874|26260212|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1|||
13214166|NCT01888874|26260213|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
13214167|NCT01888874|26260214|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
13214168|NCT01888874|26260215|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
13214169|NCT01888874|26260216|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
13214170|NCT01888874|26260210|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
13214171|NCT01888874|26260211|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
13214172|NCT01888874|26260212|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
13214173|NCT01888874|26260213|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
13214174|NCT01888874|26260214|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
13214175|NCT01888874|26260215|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
13214176|NCT01888874|26260216|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
13214177|NCT01888874|26260210|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
13214178|NCT01888874|26260211|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
13214179|NCT01888874|26260212|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
13214180|NCT01888874|26260213|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
13214181|NCT01888874|26260214|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
13214182|NCT01888874|26260215|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
13214183|NCT01888874|26260216|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
13214184|NCT01888640|26260280|FG000|Overall Study|Lost to Follow-up|1|||
13214185|NCT01888640|26260281|FG001|Overall Study|Lost to Follow-up|2|||
13214186|NCT01888640|26260282|FG002|Overall Study|Lost to Follow-up|0|||
13214187|NCT01888640|26260280|FG000|Overall Study|Withdrawal by Subject|15|||
13214188|NCT01888640|26260281|FG001|Overall Study|Withdrawal by Subject|11|||
13214189|NCT01888640|26260282|FG002|Overall Study|Withdrawal by Subject|4|||
13214190|NCT01888640|26260280|FG000|Overall Study|Minimum dose not met|10|||
13214191|NCT01888640|26260281|FG001|Overall Study|Minimum dose not met|16|||
13214192|NCT01888640|26260282|FG002|Overall Study|Minimum dose not met|0|||
13214193|NCT01888640|26260280|FG000|Overall Study|Given wrong unit (placebo)|1|||
13214194|NCT01888640|26260281|FG001|Overall Study|Given wrong unit (placebo)|0|||
13214195|NCT01888640|26260282|FG002|Overall Study|Given wrong unit (placebo)|0|||
13214196|NCT01888640|26260280|FG000|Overall Study|Excluded for prior TENS|0|||
13214197|NCT01888640|26260281|FG001|Overall Study|Excluded for prior TENS|1|||
13214198|NCT01888640|26260282|FG002|Overall Study|Excluded for prior TENS|0|||
13214199|NCT01888640|26260280|FG000|Overall Study|Researcher Termination of Participant|0|||
13214200|NCT01888640|26260281|FG001|Overall Study|Researcher Termination of Participant|1|||
13214201|NCT01888640|26260282|FG002|Overall Study|Researcher Termination of Participant|1|||
13214202|NCT01888497|26260305|FG000|Washout Period 1|Withdrawal by Subject|0|||
13214203|NCT01888497|26260306|FG001|Washout Period 1|Withdrawal by Subject|0|||
13214204|NCT01888497|26260307|FG002|Washout Period 1|Withdrawal by Subject|1|||
13214205|NCT01888497|26260308|FG003|Washout Period 1|Withdrawal by Subject|1|||
13214206|NCT01888497|26260305|FG000|Washout Period 2|Adverse Event|0|||
13214207|NCT01888497|26260306|FG001|Washout Period 2|Adverse Event|0|||
13214208|NCT01888497|26260307|FG002|Washout Period 2|Adverse Event|0|||
13214209|NCT01888497|26260308|FG003|Washout Period 2|Adverse Event|1|||
13214210|NCT01888497|26260305|FG000|Washout Period 2|Withdrawal by Subject|0|||
13214211|NCT01888497|26260306|FG001|Washout Period 2|Withdrawal by Subject|0|||
13214212|NCT01888497|26260307|FG002|Washout Period 2|Withdrawal by Subject|0|||
13214213|NCT01888497|26260308|FG003|Washout Period 2|Withdrawal by Subject|1|||
13381989|NCT00748566|26749581|FG000|Overall Study|Other|9|||
13214214|NCT01888432|26260353|FG000|12-month Analysis (FAS)|Lost to Follow-up|0|||
13214215|NCT01888432|26260354|FG001|12-month Analysis (FAS)|Lost to Follow-up|2|||
13214216|NCT01888432|26260353|FG000|12-month Analysis (FAS)|Physician Decision|1|||
13214217|NCT01888432|26260354|FG001|12-month Analysis (FAS)|Physician Decision|1|||
13214218|NCT01888432|26260353|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6|||
13214219|NCT01888432|26260354|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3|||
13214220|NCT01888432|26260353|FG000|12-month Analysis (FAS)|Death|4|||
13214221|NCT01888432|26260354|FG001|12-month Analysis (FAS)|Death|3|||
13214222|NCT01888432|26260353|FG000|24-month Analysis (FAS)|Graft loss|0|||
13214223|NCT01888432|26260354|FG001|24-month Analysis (FAS)|Graft loss|1|||
13214224|NCT01888432|26260353|FG000|24-month Analysis (FAS)|Lost to Follow-up|0|||
13214225|NCT01888432|26260354|FG001|24-month Analysis (FAS)|Lost to Follow-up|2|||
13214226|NCT01888432|26260353|FG000|24-month Analysis (FAS)|Physician Decision|2|||
13214227|NCT01888432|26260354|FG001|24-month Analysis (FAS)|Physician Decision|4|||
13214228|NCT01888432|26260353|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7|||
13214229|NCT01888432|26260354|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6|||
13214230|NCT01888432|26260353|FG000|24-month Analysis (FAS)|Death|8|||
13214231|NCT01888432|26260354|FG001|24-month Analysis (FAS)|Death|4|||
13214232|NCT01888432|26260353|FG000|36-month Analysis (Extension)|Death|1|||
13214233|NCT01888432|26260354|FG001|36-month Analysis (Extension)|Death|0|||
13214234|NCT01888367|26260381|FG000|Overall Study|Physician Decision|3|||
13214235|NCT01888367|26260382|FG001|Overall Study|Physician Decision|4|||
13214236|NCT01888367|26260383|FG002|Overall Study|Physician Decision|2|||
13214237|NCT01888367|26260381|FG000|Overall Study|Death|2|||
13214238|NCT01888367|26260382|FG001|Overall Study|Death|0|||
13214239|NCT01888367|26260383|FG002|Overall Study|Death|1|||
13214240|NCT01888367|26260381|FG000|Overall Study|Withdrawal by Subject|1|||
13214241|NCT01888367|26260382|FG001|Overall Study|Withdrawal by Subject|0|||
13214242|NCT01888367|26260383|FG002|Overall Study|Withdrawal by Subject|1|||
13214243|NCT01888367|26260381|FG000|Overall Study|Lost to Follow-up|1|||
13214244|NCT01888367|26260382|FG001|Overall Study|Lost to Follow-up|1|||
13214245|NCT01888367|26260383|FG002|Overall Study|Lost to Follow-up|0|||
13214246|NCT01888367|26260381|FG000|Overall Study|Protocol Violation|0|||
13214247|NCT01888367|26260382|FG001|Overall Study|Protocol Violation|0|||
13214248|NCT01888367|26260383|FG002|Overall Study|Protocol Violation|1|||
13214249|NCT01888367|26260381|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1|||
13214250|NCT01888367|26260382|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
13214251|NCT01888367|26260383|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
13214252|NCT01888003|26260410|FG000|Overall Study|Study Terminated|5|||
13214253|NCT01888003|26260411|FG001|Overall Study|Study Terminated|6|||
13214254|NCT01888003|26260412|FG002|Overall Study|Study Terminated|40|||
13214255|NCT01887912|26260445|FG000|Overall Study|Serious adverse event|400|||
13214256|NCT01887912|26260446|FG001|Overall Study|Serious adverse event|198|||
13214257|NCT01887912|26260445|FG000|Overall Study|Other Adverse Event|34|||
13214258|NCT01887912|26260446|FG001|Overall Study|Other Adverse Event|15|||
13214259|NCT01887912|26260445|FG000|Overall Study|Protocol Violation|67|||
13214260|NCT01887912|26260446|FG001|Overall Study|Protocol Violation|37|||
13214261|NCT01887912|26260445|FG000|Overall Study|Lost to Follow-up|163|||
13214262|NCT01887912|26260446|FG001|Overall Study|Lost to Follow-up|74|||
13214263|NCT01887912|26260445|FG000|Overall Study|Withdrawal by Subject|606|||
13214264|NCT01887912|26260446|FG001|Overall Study|Withdrawal by Subject|349|||
13214265|NCT01887912|26260445|FG000|Overall Study|Other|122|||
13214266|NCT01887912|26260446|FG001|Overall Study|Other|58|||
13214267|NCT01887717|26260473|FG000|Overall Study|Withdrawal by Subject|1|||
13214268|NCT01887717|26260474|FG001|Overall Study|Withdrawal by Subject|7|||
13214269|NCT01887717|26260473|FG000|Overall Study|Physician Decision|0|||
13214270|NCT01887717|26260474|FG001|Overall Study|Physician Decision|2|||
13214271|NCT01887717|26260473|FG000|Overall Study|Administrative reasons|5|||
13214272|NCT01887717|26260474|FG001|Overall Study|Administrative reasons|2|||
13214273|NCT01887678|26260523|FG000|Overall Study|Adverse Event|4|||
13214274|NCT01887678|26260524|FG001|Overall Study|Adverse Event|6|||
13214275|NCT01887678|26260523|FG000|Overall Study|Exceeded rescue medication dosage|4|||
13214276|NCT01887678|26260524|FG001|Overall Study|Exceeded rescue medication dosage|5|||
13214277|NCT01887678|26260523|FG000|Overall Study|Withdrawal of consent|3|||
13214278|NCT01887678|26260524|FG001|Overall Study|Withdrawal of consent|4|||
13214279|NCT01887678|26260523|FG000|Overall Study|Lost to Follow-up|4|||
13214280|NCT01887678|26260524|FG001|Overall Study|Lost to Follow-up|2|||
13214281|NCT01887678|26260523|FG000|Overall Study|Deterioration of clinical condition|0|||
13214282|NCT01887678|26260524|FG001|Overall Study|Deterioration of clinical condition|4|||
13214283|NCT01887678|26260523|FG000|Overall Study|Lack of Efficacy|1|||
13296698|NCT01369355|26497109|FG006|Week 0 - Week 44 (Maintenance)|Other|0|||
13214284|NCT01887678|26260524|FG001|Overall Study|Lack of Efficacy|2|||
13214285|NCT01887678|26260523|FG000|Overall Study|Non-compliance|0|||
13296699|NCT01369355|26497110|FG007|Week 0 - Week 44 (Maintenance)|Other|0|||
13214286|NCT01887678|26260524|FG001|Overall Study|Non-compliance|3|||
13214287|NCT01887678|26260523|FG000|Overall Study|Specified|1|||
13214288|NCT01887678|26260524|FG001|Overall Study|Specified|2|||
13214289|NCT01887600|26260641|FG000|Overall Study|Death|39|||
13214290|NCT01887600|26260642|FG001|Overall Study|Death|16|||
13214291|NCT01887600|26260641|FG000|Overall Study|Lack of Efficacy|3|||
13214292|NCT01887600|26260642|FG001|Overall Study|Lack of Efficacy|26|||
13214293|NCT01887600|26260641|FG000|Overall Study|Lost to Follow-up|5|||
13214294|NCT01887600|26260642|FG001|Overall Study|Lost to Follow-up|1|||
13214295|NCT01887600|26260641|FG000|Overall Study|Physician Decision|7|||
13214296|NCT01887600|26260642|FG001|Overall Study|Physician Decision|8|||
13214297|NCT01887600|26260641|FG000|Overall Study|Protocol Deviation|3|||
13214298|NCT01887600|26260642|FG001|Overall Study|Protocol Deviation|0|||
13214299|NCT01887600|26260641|FG000|Overall Study|Withdrawal by Subject|58|||
13214300|NCT01887600|26260642|FG001|Overall Study|Withdrawal by Subject|52|||
13214301|NCT01887600|26260641|FG000|Overall Study|Adverse Event|21|||
13214302|NCT01887600|26260642|FG001|Overall Study|Adverse Event|9|||
13214303|NCT01887600|26260641|FG000|Overall Study|Non-compliance with study drug|3|||
13214304|NCT01887600|26260642|FG001|Overall Study|Non-compliance with study drug|0|||
13214305|NCT01887600|26260641|FG000|Overall Study|Miscellaneous|6|||
13214306|NCT01887600|26260642|FG001|Overall Study|Miscellaneous|2|||
13214307|NCT01887600|26260641|FG000|Overall Study|Progressive Disease|1|||
13214308|NCT01887600|26260642|FG001|Overall Study|Progressive Disease|0|||
13214309|NCT01887418|26260669|FG000|Overall Study|Travelling difficulties|0|||
13214310|NCT01887418|26260670|FG001|Overall Study|Travelling difficulties|0|||
13214311|NCT01887418|26260671|FG002|Overall Study|Travelling difficulties|1|||
13214312|NCT01887353|26260684|FG000|Overall Study|Study stopped early|4|||
13214313|NCT01887353|26260685|FG001|Overall Study|Study stopped early|3|||
13214314|NCT01887288|26260692|FG000|Overall Study|The study was terminated and the PI has|16|||
13214315|NCT01887210|26260711|FG000|Overall Study|Withdrawal by Subject|1|||
13214316|NCT01887210|26260712|FG001|Overall Study|Withdrawal by Subject|3|||
13214317|NCT01887210|26260711|FG000|Overall Study|Lost to Follow-up|0|||
13214318|NCT01887210|26260712|FG001|Overall Study|Lost to Follow-up|1|||
13214319|NCT01886833|26260722|FG000|Overall Study|IgA not available from both periods|204|||
13214320|NCT01886781|26260735|FG000|Overall Study|Protocol Violation|5|||
13214321|NCT01886781|26260736|FG001|Overall Study|Protocol Violation|0|||
13214322|NCT01886781|26260735|FG000|Overall Study|Adverse Event|1|||
13214323|NCT01886781|26260736|FG001|Overall Study|Adverse Event|0|||
13214324|NCT01886781|26260735|FG000|Overall Study|Lost to Follow-up|5|||
13214325|NCT01886781|26260736|FG001|Overall Study|Lost to Follow-up|0|||
13214326|NCT01886781|26260735|FG000|Overall Study|Withdrawal by Subject|2|||
13214327|NCT01886781|26260736|FG001|Overall Study|Withdrawal by Subject|1|||
13214328|NCT01886781|26260735|FG000|Overall Study|Worsening of symptoms|1|||
13214329|NCT01886781|26260736|FG001|Overall Study|Worsening of symptoms|1|||
13214330|NCT01886716|26260763|FG000|Week 1|Lost to Follow-up|0|||
13214331|NCT01886716|26260764|FG001|Week 1|Lost to Follow-up|0|||
13214332|NCT01886716|26260765|FG002|Week 1|Lost to Follow-up|2|||
13214333|NCT01886716|26260766|FG003|Week 1|Lost to Follow-up|2|||
13214334|NCT01886716|26260763|FG000|Week 2|Lost to Follow-up|3|||
13214335|NCT01886716|26260764|FG001|Week 2|Lost to Follow-up|2|||
13214336|NCT01886716|26260765|FG002|Week 2|Lost to Follow-up|1|||
13214337|NCT01886716|26260766|FG003|Week 2|Lost to Follow-up|3|||
13214338|NCT01886716|26260763|FG000|Week 3|Lost to Follow-up|1|||
13214339|NCT01886716|26260764|FG001|Week 3|Lost to Follow-up|1|||
13214340|NCT01886716|26260765|FG002|Week 3|Lost to Follow-up|0|||
13214341|NCT01886716|26260766|FG003|Week 3|Lost to Follow-up|1|||
13214342|NCT01886690|26260787|FG000|Overall Study|Protocol Violation|0|||
13214343|NCT01886690|26260788|FG001|Overall Study|Protocol Violation|1|||
13214344|NCT01886690|26260787|FG000|Overall Study|Personal Reasons|0|||
13214345|NCT01886690|26260788|FG001|Overall Study|Personal Reasons|1|||
13214346|NCT01886378|26260811|FG000|Overall Study|Adverse Event|1|||
13214347|NCT01886378|26260811|FG000|Overall Study|Withdrawal by Subject|4|||
13214348|NCT01886313|26260824|FG000|Overall Study|Adverse Event|1|||
13214349|NCT01886313|26260825|FG001|Overall Study|Adverse Event|1|||
13214350|NCT01886300|26260838|FG000|Overall Study|Trial terminated by sponsor|16|||
13214351|NCT01886287|26260845|FG000|Overall Study|Radiographic disease progression|1|||
13214352|NCT01886287|26260845|FG000|Overall Study|Clinical progression due to disease|1|||
13214353|NCT01886105|26260852|FG000|Overall Study|Lack of Efficacy|3|||
13214354|NCT01885936|26260869|FG000|Overall Study|Withdrawal by Subject|1|||
13214355|NCT01885936|26260870|FG001|Overall Study|Withdrawal by Subject|0|||
13214356|NCT01885559|26260897|FG000|Overall Study|Lost to Follow-up|15|||
13214357|NCT01885559|26260898|FG001|Overall Study|Lost to Follow-up|16|||
13214358|NCT01885559|26260897|FG000|Overall Study|Less than full participation|9|||
13214359|NCT01885559|26260898|FG001|Overall Study|Less than full participation|19|||
13214360|NCT01885559|26260897|FG000|Overall Study|Protocol Violation|0|||
13214361|NCT01885559|26260898|FG001|Overall Study|Protocol Violation|1|||
13214362|NCT01885208|26260921|FG000|Overall Study|Unclassified|32|||
13214363|NCT01885208|26260922|FG001|Overall Study|Unclassified|38|||
13214364|NCT01885195|26260942|FG000|Overall Study|Adverse Event|29|||
13214365|NCT01885195|26260942|FG000|Overall Study|Death|1|||
13214366|NCT01885195|26260942|FG000|Overall Study|Disease Progression|67|||
13214367|NCT01885195|26260942|FG000|Overall Study|Protocol Deviation|2|||
13214368|NCT01885195|26260942|FG000|Overall Study|Physician Decision|3|||
13214369|NCT01885195|26260942|FG000|Overall Study|Patient/guardian decision|8|||
13214370|NCT01885182|26260971|FG000|Overall Study|Adverse Event|11|||
13214371|NCT01885182|26260972|FG001|Overall Study|Adverse Event|13|||
13214372|NCT01885182|26260971|FG000|Overall Study|Withdrawal by Subject|13|||
13214373|NCT01885182|26260972|FG001|Overall Study|Withdrawal by Subject|6|||
13214374|NCT01885182|26260971|FG000|Overall Study|Lost to Follow-up|2|||
13214375|NCT01885182|26260972|FG001|Overall Study|Lost to Follow-up|2|||
13214376|NCT01885182|26260971|FG000|Overall Study|Lack of Efficacy|8|||
13214377|NCT01885182|26260972|FG001|Overall Study|Lack of Efficacy|1|||
13214378|NCT01885104|26260987|FG000|Overall Study|Withdrawal of Consent|1|||
13214379|NCT01885104|26260988|FG001|Overall Study|Withdrawal of Consent|0|||
13214380|NCT01885104|26260987|FG000|Overall Study|Lost to Follow-up|0|||
13214381|NCT01885104|26260988|FG001|Overall Study|Lost to Follow-up|1|||
13214382|NCT01885104|26260987|FG000|Overall Study|Physician Decision|1|||
13214383|NCT01885104|26260988|FG001|Overall Study|Physician Decision|0|||
13214384|NCT01885078|26261539|FG000|Treatment Period|Adverse Event|52|||
13214385|NCT01885078|26261540|FG001|Treatment Period|Adverse Event|136|||
13214386|NCT01885078|26261541|FG002|Treatment Period|Adverse Event|30|||
13214387|NCT01885078|26261542|FG003|Treatment Period|Adverse Event|73|||
13214388|NCT01885078|26261543|FG004|Treatment Period|Adverse Event|17|||
13214389|NCT01885078|26261544|FG005|Treatment Period|Adverse Event|72|||
13214390|NCT01885078|26261545|FG006|Treatment Period|Adverse Event|24|||
13214391|NCT01885078|26261546|FG007|Treatment Period|Adverse Event|5|||
13214392|NCT01885078|26261547|FG008|Treatment Period|Adverse Event|0|||
13214393|NCT01885078|26261548|FG009|Treatment Period|Adverse Event|0|||
13214394|NCT01885078|26261539|FG000|Treatment Period|Death|13|||
13214395|NCT01885078|26261540|FG001|Treatment Period|Death|33|||
13214396|NCT01885078|26261541|FG002|Treatment Period|Death|5|||
13214397|NCT01885078|26261542|FG003|Treatment Period|Death|9|||
13214398|NCT01885078|26261543|FG004|Treatment Period|Death|2|||
13214399|NCT01885078|26261544|FG005|Treatment Period|Death|10|||
13214400|NCT01885078|26261545|FG006|Treatment Period|Death|3|||
13214401|NCT01885078|26261546|FG007|Treatment Period|Death|2|||
13214402|NCT01885078|26261547|FG008|Treatment Period|Death|0|||
13214403|NCT01885078|26261548|FG009|Treatment Period|Death|0|||
13214404|NCT01885078|26261539|FG000|Treatment Period|Lack of Efficacy|12|||
13214405|NCT01885078|26261540|FG001|Treatment Period|Lack of Efficacy|33|||
13214406|NCT01885078|26261541|FG002|Treatment Period|Lack of Efficacy|10|||
13214407|NCT01885078|26261542|FG003|Treatment Period|Lack of Efficacy|23|||
13214408|NCT01885078|26261543|FG004|Treatment Period|Lack of Efficacy|24|||
13214409|NCT01885078|26261544|FG005|Treatment Period|Lack of Efficacy|58|||
13214410|NCT01885078|26261545|FG006|Treatment Period|Lack of Efficacy|9|||
13214411|NCT01885078|26261546|FG007|Treatment Period|Lack of Efficacy|5|||
13214412|NCT01885078|26261547|FG008|Treatment Period|Lack of Efficacy|0|||
13214413|NCT01885078|26261548|FG009|Treatment Period|Lack of Efficacy|0|||
13214414|NCT01885078|26261539|FG000|Treatment Period|Lost to Follow-up|16|||
13214415|NCT01885078|26261540|FG001|Treatment Period|Lost to Follow-up|19|||
13214416|NCT01885078|26261541|FG002|Treatment Period|Lost to Follow-up|7|||
13214417|NCT01885078|26261542|FG003|Treatment Period|Lost to Follow-up|9|||
13214418|NCT01885078|26261543|FG004|Treatment Period|Lost to Follow-up|2|||
13214419|NCT01885078|26261544|FG005|Treatment Period|Lost to Follow-up|8|||
13214420|NCT01885078|26261545|FG006|Treatment Period|Lost to Follow-up|2|||
13214421|NCT01885078|26261546|FG007|Treatment Period|Lost to Follow-up|0|||
13214422|NCT01885078|26261547|FG008|Treatment Period|Lost to Follow-up|0|||
13214423|NCT01885078|26261548|FG009|Treatment Period|Lost to Follow-up|0|||
13214424|NCT01885078|26261539|FG000|Treatment Period|Physician Decision|19|||
13214425|NCT01885078|26261540|FG001|Treatment Period|Physician Decision|21|||
13214426|NCT01885078|26261541|FG002|Treatment Period|Physician Decision|5|||
13214427|NCT01885078|26261542|FG003|Treatment Period|Physician Decision|12|||
13214428|NCT01885078|26261543|FG004|Treatment Period|Physician Decision|9|||
13214429|NCT01885078|26261544|FG005|Treatment Period|Physician Decision|24|||
13214430|NCT01885078|26261545|FG006|Treatment Period|Physician Decision|4|||
13214431|NCT01885078|26261546|FG007|Treatment Period|Physician Decision|3|||
13214432|NCT01885078|26261547|FG008|Treatment Period|Physician Decision|0|||
13214433|NCT01885078|26261548|FG009|Treatment Period|Physician Decision|0|||
13214434|NCT01885078|26261539|FG000|Treatment Period|Protocol Violation|3|||
13214435|NCT01885078|26261540|FG001|Treatment Period|Protocol Violation|5|||
13214436|NCT01885078|26261541|FG002|Treatment Period|Protocol Violation|0|||
13214437|NCT01885078|26261542|FG003|Treatment Period|Protocol Violation|3|||
13214438|NCT01885078|26261543|FG004|Treatment Period|Protocol Violation|1|||
13214439|NCT01885078|26261544|FG005|Treatment Period|Protocol Violation|6|||
13214440|NCT01885078|26261545|FG006|Treatment Period|Protocol Violation|0|||
13214441|NCT01885078|26261546|FG007|Treatment Period|Protocol Violation|0|||
13214442|NCT01885078|26261547|FG008|Treatment Period|Protocol Violation|0|||
13214443|NCT01885078|26261548|FG009|Treatment Period|Protocol Violation|0|||
13214444|NCT01885078|26261539|FG000|Treatment Period|Sponsor Decision|245|||
13214445|NCT01885078|26261540|FG001|Treatment Period|Sponsor Decision|648|||
13214446|NCT01885078|26261541|FG002|Treatment Period|Sponsor Decision|49|||
13214447|NCT01885078|26261542|FG003|Treatment Period|Sponsor Decision|90|||
13214448|NCT01885078|26261543|FG004|Treatment Period|Sponsor Decision|20|||
13214449|NCT01885078|26261544|FG005|Treatment Period|Sponsor Decision|38|||
13214450|NCT01885078|26261545|FG006|Treatment Period|Sponsor Decision|162|||
13214451|NCT01885078|26261546|FG007|Treatment Period|Sponsor Decision|3|||
13214452|NCT01885078|26261547|FG008|Treatment Period|Sponsor Decision|0|||
13214453|NCT01885078|26261548|FG009|Treatment Period|Sponsor Decision|0|||
13214454|NCT01885078|26261539|FG000|Treatment Period|Withdrawal by Subject|72|||
13214455|NCT01885078|26261540|FG001|Treatment Period|Withdrawal by Subject|132|||
13214456|NCT01885078|26261541|FG002|Treatment Period|Withdrawal by Subject|25|||
13214457|NCT01885078|26261542|FG003|Treatment Period|Withdrawal by Subject|63|||
13214458|NCT01885078|26261543|FG004|Treatment Period|Withdrawal by Subject|15|||
13214459|NCT01885078|26261544|FG005|Treatment Period|Withdrawal by Subject|34|||
13214460|NCT01885078|26261545|FG006|Treatment Period|Withdrawal by Subject|17|||
13214461|NCT01885078|26261546|FG007|Treatment Period|Withdrawal by Subject|10|||
13214462|NCT01885078|26261547|FG008|Treatment Period|Withdrawal by Subject|0|||
13214463|NCT01885078|26261548|FG009|Treatment Period|Withdrawal by Subject|0|||
13214464|NCT01885078|26261539|FG000|Treatment Period|Other|0|||
13214465|NCT01885078|26261540|FG001|Treatment Period|Other|0|||
13214466|NCT01885078|26261541|FG002|Treatment Period|Other|0|||
13214467|NCT01885078|26261542|FG003|Treatment Period|Other|1|||
13214468|NCT01885078|26261543|FG004|Treatment Period|Other|0|||
13214469|NCT01885078|26261544|FG005|Treatment Period|Other|0|||
13214470|NCT01885078|26261545|FG006|Treatment Period|Other|0|||
13214471|NCT01885078|26261546|FG007|Treatment Period|Other|0|||
13214472|NCT01885078|26261547|FG008|Treatment Period|Other|0|||
13214473|NCT01885078|26261548|FG009|Treatment Period|Other|0|||
13214474|NCT01885078|26261539|FG000|Step-down Period|Sponsor Decision|0|||
13214475|NCT01885078|26261540|FG001|Step-down Period|Sponsor Decision|0|||
13214476|NCT01885078|26261541|FG002|Step-down Period|Sponsor Decision|0|||
13214477|NCT01885078|26261542|FG003|Step-down Period|Sponsor Decision|0|||
13214478|NCT01885078|26261543|FG004|Step-down Period|Sponsor Decision|0|||
13214479|NCT01885078|26261544|FG005|Step-down Period|Sponsor Decision|0|||
13214480|NCT01885078|26261545|FG006|Step-down Period|Sponsor Decision|0|||
13214481|NCT01885078|26261546|FG007|Step-down Period|Sponsor Decision|0|||
13214482|NCT01885078|26261547|FG008|Step-down Period|Sponsor Decision|1|||
13214483|NCT01885078|26261548|FG009|Step-down Period|Sponsor Decision|1|||
13214484|NCT01885078|26261539|FG000|Step-down Period|Adverse Event|0|||
13214485|NCT01885078|26261540|FG001|Step-down Period|Adverse Event|0|||
13214486|NCT01885078|26261541|FG002|Step-down Period|Adverse Event|0|||
13214487|NCT01885078|26261542|FG003|Step-down Period|Adverse Event|0|||
13214488|NCT01885078|26261543|FG004|Step-down Period|Adverse Event|0|||
13214489|NCT01885078|26261544|FG005|Step-down Period|Adverse Event|0|||
13214490|NCT01885078|26261545|FG006|Step-down Period|Adverse Event|0|||
13214491|NCT01885078|26261546|FG007|Step-down Period|Adverse Event|0|||
13214492|NCT01885078|26261547|FG008|Step-down Period|Adverse Event|29|||
13214493|NCT01885078|26261548|FG009|Step-down Period|Adverse Event|38|||
13214494|NCT01885078|26261539|FG000|Step-down Period|Withdrawal by Subject|0|||
13214495|NCT01885078|26261540|FG001|Step-down Period|Withdrawal by Subject|0|||
13214496|NCT01885078|26261541|FG002|Step-down Period|Withdrawal by Subject|0|||
13214497|NCT01885078|26261542|FG003|Step-down Period|Withdrawal by Subject|0|||
13214498|NCT01885078|26261543|FG004|Step-down Period|Withdrawal by Subject|0|||
13214499|NCT01885078|26261544|FG005|Step-down Period|Withdrawal by Subject|0|||
13214500|NCT01885078|26261545|FG006|Step-down Period|Withdrawal by Subject|0|||
13214501|NCT01885078|26261546|FG007|Step-down Period|Withdrawal by Subject|0|||
13214502|NCT01885078|26261547|FG008|Step-down Period|Withdrawal by Subject|25|||
13214503|NCT01885078|26261548|FG009|Step-down Period|Withdrawal by Subject|15|||
13214504|NCT01885078|26261539|FG000|Step-down Period|Physician Decision|0|||
13214505|NCT01885078|26261540|FG001|Step-down Period|Physician Decision|0|||
13214506|NCT01885078|26261541|FG002|Step-down Period|Physician Decision|0|||
13214507|NCT01885078|26261542|FG003|Step-down Period|Physician Decision|0|||
13214508|NCT01885078|26261543|FG004|Step-down Period|Physician Decision|0|||
13214509|NCT01885078|26261544|FG005|Step-down Period|Physician Decision|0|||
13214510|NCT01885078|26261545|FG006|Step-down Period|Physician Decision|0|||
13214511|NCT01885078|26261546|FG007|Step-down Period|Physician Decision|0|||
13214512|NCT01885078|26261547|FG008|Step-down Period|Physician Decision|7|||
13214513|NCT01885078|26261548|FG009|Step-down Period|Physician Decision|2|||
13214514|NCT01885078|26261539|FG000|Step-down Period|Death|0|||
13214515|NCT01885078|26261540|FG001|Step-down Period|Death|0|||
13214516|NCT01885078|26261541|FG002|Step-down Period|Death|0|||
13214517|NCT01885078|26261542|FG003|Step-down Period|Death|0|||
13296700|NCT01369355|26497111|FG008|Week 0 - Week 44 (Maintenance)|Other|0|||
13214518|NCT01885078|26261543|FG004|Step-down Period|Death|0|||
13214519|NCT01885078|26261544|FG005|Step-down Period|Death|0|||
13214520|NCT01885078|26261545|FG006|Step-down Period|Death|0|||
13214521|NCT01885078|26261546|FG007|Step-down Period|Death|0|||
13214522|NCT01885078|26261547|FG008|Step-down Period|Death|4|||
13214523|NCT01885078|26261548|FG009|Step-down Period|Death|3|||
13214524|NCT01885078|26261539|FG000|Step-down Period|Lost to Follow-up|0|||
13214525|NCT01885078|26261540|FG001|Step-down Period|Lost to Follow-up|0|||
13214526|NCT01885078|26261541|FG002|Step-down Period|Lost to Follow-up|0|||
13214527|NCT01885078|26261542|FG003|Step-down Period|Lost to Follow-up|0|||
13214528|NCT01885078|26261543|FG004|Step-down Period|Lost to Follow-up|0|||
13214529|NCT01885078|26261544|FG005|Step-down Period|Lost to Follow-up|0|||
13214530|NCT01885078|26261545|FG006|Step-down Period|Lost to Follow-up|0|||
13214531|NCT01885078|26261546|FG007|Step-down Period|Lost to Follow-up|0|||
13214532|NCT01885078|26261547|FG008|Step-down Period|Lost to Follow-up|1|||
13214533|NCT01885078|26261548|FG009|Step-down Period|Lost to Follow-up|1|||
13214534|NCT01885078|26261539|FG000|Step-down Period|Lack of Efficacy|0|||
13214535|NCT01885078|26261540|FG001|Step-down Period|Lack of Efficacy|0|||
13214536|NCT01885078|26261541|FG002|Step-down Period|Lack of Efficacy|0|||
13214537|NCT01885078|26261542|FG003|Step-down Period|Lack of Efficacy|0|||
13214538|NCT01885078|26261543|FG004|Step-down Period|Lack of Efficacy|0|||
13214539|NCT01885078|26261544|FG005|Step-down Period|Lack of Efficacy|0|||
13214540|NCT01885078|26261545|FG006|Step-down Period|Lack of Efficacy|0|||
13214541|NCT01885078|26261546|FG007|Step-down Period|Lack of Efficacy|0|||
13214542|NCT01885078|26261547|FG008|Step-down Period|Lack of Efficacy|1|||
13214543|NCT01885078|26261548|FG009|Step-down Period|Lack of Efficacy|0|||
13214544|NCT01885078|26261539|FG000|Step-down Period|Protocol Violation|0|||
13214545|NCT01885078|26261540|FG001|Step-down Period|Protocol Violation|0|||
13214546|NCT01885078|26261541|FG002|Step-down Period|Protocol Violation|0|||
13214547|NCT01885078|26261542|FG003|Step-down Period|Protocol Violation|0|||
13214548|NCT01885078|26261543|FG004|Step-down Period|Protocol Violation|0|||
13214549|NCT01885078|26261544|FG005|Step-down Period|Protocol Violation|0|||
13214550|NCT01885078|26261545|FG006|Step-down Period|Protocol Violation|0|||
13214551|NCT01885078|26261546|FG007|Step-down Period|Protocol Violation|0|||
13214552|NCT01885078|26261547|FG008|Step-down Period|Protocol Violation|1|||
13214553|NCT01885078|26261548|FG009|Step-down Period|Protocol Violation|1|||
13214554|NCT01885000|26261577|FG000|Overall Study|Adverse Event|1|||
13214555|NCT01885000|26261578|FG001|Overall Study|Adverse Event|0|||
13214556|NCT01885000|26261577|FG000|Overall Study|Withdrawal by Subject|1|||
13214557|NCT01885000|26261578|FG001|Overall Study|Withdrawal by Subject|1|||
13214558|NCT01885000|26261577|FG000|Overall Study|Protocol Violation|0|||
13214559|NCT01885000|26261578|FG001|Overall Study|Protocol Violation|1|||
13214560|NCT01884688|26261584|FG000|Overall Study|Screen Failure|2|||
13214561|NCT01884675|26261631|FG000|Overall Study|Study closed/terminated|3|||
13214562|NCT01884675|26261632|FG001|Overall Study|Study closed/terminated|2|||
13214563|NCT01884597|26261671|FG000|Overall Study|Adverse Event|0|||
13214564|NCT01884597|26261672|FG001|Overall Study|Adverse Event|0|||
13214565|NCT01884597|26261673|FG002|Overall Study|Adverse Event|1|||
13214566|NCT01884597|26261671|FG000|Overall Study|Lack of Efficacy|1|||
13214567|NCT01884597|26261672|FG001|Overall Study|Lack of Efficacy|0|||
13214568|NCT01884597|26261673|FG002|Overall Study|Lack of Efficacy|0|||
13214569|NCT01884597|26261671|FG000|Overall Study|Death|0|||
13214570|NCT01884597|26261672|FG001|Overall Study|Death|1|||
13214571|NCT01884597|26261673|FG002|Overall Study|Death|0|||
13214572|NCT01884571|26261686|FG000|Overall Study|Adverse Event|1|||
13214573|NCT01884571|26261686|FG000|Overall Study|Death|2|||
13214574|NCT01884571|26261686|FG000|Overall Study|Withdrawal by Subject|2|||
13214575|NCT01884571|26261686|FG000|Overall Study|Disease progression|3|||
13214576|NCT01884545|26261805|FG000|Overall Study|Lost to Follow-up|6|||
13214577|NCT01884545|26261806|FG001|Overall Study|Lost to Follow-up|4|||
13214578|NCT01884545|26261807|FG002|Overall Study|Lost to Follow-up|9|||
13214579|NCT01884545|26261808|FG003|Overall Study|Lost to Follow-up|4|||
13214580|NCT01884545|26261805|FG000|Overall Study|Patient withdrawn|7|||
13214581|NCT01884545|26261806|FG001|Overall Study|Patient withdrawn|12|||
13214582|NCT01884545|26261807|FG002|Overall Study|Patient withdrawn|5|||
13214583|NCT01884545|26261808|FG003|Overall Study|Patient withdrawn|5|||
13214584|NCT01884545|26261805|FG000|Overall Study|Non-adherence|0|||
13214585|NCT01884545|26261806|FG001|Overall Study|Non-adherence|2|||
13381990|NCT00748553|26749595|FG000|Overall Study|Adverse Event|0|||
13214586|NCT01884545|26261807|FG002|Overall Study|Non-adherence|0|||
13214587|NCT01884545|26261808|FG003|Overall Study|Non-adherence|0|||
13214588|NCT01884350|26261837|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17|||
13214589|NCT01884350|26261838|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20|||
13214590|NCT01884350|26261839|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0|||
13214591|NCT01884350|26261837|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6|||
13214592|NCT01884350|26261838|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4|||
13214593|NCT01884350|26261839|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0|||
13214594|NCT01884350|26261837|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
13214595|NCT01884350|26261838|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1|||
13214596|NCT01884350|26261839|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
13214597|NCT01884350|26261837|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7|||
13214598|NCT01884350|26261838|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6|||
13214599|NCT01884350|26261839|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0|||
13214600|NCT01884350|26261837|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15|||
13214601|NCT01884350|26261838|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11|||
13214602|NCT01884350|26261839|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0|||
13214603|NCT01884350|26261837|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
13214604|NCT01884350|26261838|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2|||
13214605|NCT01884350|26261839|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
13214606|NCT01884350|26261837|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2|||
13214607|NCT01884350|26261838|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5|||
13214608|NCT01884350|26261839|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0|||
13214609|NCT01884350|26261837|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2|||
13214610|NCT01884350|26261838|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
13214611|NCT01884350|26261839|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
13214612|NCT01884350|26261837|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
13214613|NCT01884350|26261838|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
13214614|NCT01884350|26261839|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0|||
13214615|NCT01884350|26261837|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
13214616|NCT01884350|26261838|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
13214617|NCT01884350|26261839|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0|||
13214618|NCT01884350|26261837|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
13214619|NCT01884350|26261838|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
13214620|NCT01884350|26261839|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0|||
13214621|NCT01884350|26261837|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21|||
13214622|NCT01884350|26261838|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0|||
13214623|NCT01884350|26261839|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2|||
13214624|NCT01884350|26261837|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7|||
13214625|NCT01884350|26261838|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
13394775|NCT00654381|26788102|FG005|2nd Stage|Withdrawal by Subject|1|||
13214626|NCT01884350|26261839|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
13214627|NCT01884350|26261837|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
13214628|NCT01884350|26261838|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0|||
13214629|NCT01884350|26261839|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
13214630|NCT01884350|26261837|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17|||
13214631|NCT01884350|26261838|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6|||
13214632|NCT01884350|26261839|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3|||
13214633|NCT01884350|26261837|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17|||
13214634|NCT01884350|26261838|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3|||
13214635|NCT01884350|26261839|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0|||
13214636|NCT01884350|26261837|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3|||
13214637|NCT01884350|26261838|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0|||
13214638|NCT01884350|26261839|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2|||
13214639|NCT01884350|26261837|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4|||
13214640|NCT01884350|26261838|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
13214641|NCT01884350|26261839|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
13214642|NCT01884350|26261837|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3|||
13214643|NCT01884350|26261838|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
13214644|NCT01884350|26261839|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
13214645|NCT01884350|26261837|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4|||
13214646|NCT01884350|26261838|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1|||
13214647|NCT01884350|26261839|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0|||
13214648|NCT01884350|26261837|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1|||
13214649|NCT01884350|26261838|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
13214650|NCT01884350|26261839|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
13214651|NCT01884350|26261837|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2|||
13214652|NCT01884350|26261838|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
13214653|NCT01884350|26261839|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
13214654|NCT01884337|26261854|FG000|Treatment|Adverse Event|2|||
13214655|NCT01884337|26261855|FG001|Treatment|Adverse Event|2|||
13214656|NCT01884337|26261854|FG000|Treatment|Subj. request to discont. treatment|2|||
13214657|NCT01884337|26261855|FG001|Treatment|Subj. request to discont. treatment|0|||
13214658|NCT01884337|26261854|FG000|Follow-up Period|Lost to Follow-up|1|||
13214659|NCT01884337|26261855|FG001|Follow-up Period|Lost to Follow-up|1|||
13214660|NCT01884311|26261865|FG000|Overall Study|Withdrawal by Subject|3|||
13214661|NCT01884311|26261865|FG000|Overall Study|withdrew consent due to AEs|1|||
13214662|NCT01884311|26261865|FG000|Overall Study|Precautionary measure|1|||
13214663|NCT01884077|26261882|FG000|Overall Study|screen fail|0|||
13394776|NCT00654381|26788097|FG000|2nd Stage|Investigator's decision|0|||
13214664|NCT01884077|26261883|FG001|Overall Study|screen fail|2|||
13214665|NCT01884077|26261882|FG000|Overall Study|canceled surgery|2|||
13214666|NCT01884077|26261883|FG001|Overall Study|canceled surgery|0|||
13214667|NCT01884077|26261882|FG000|Overall Study|Lost to Follow-up|0|||
13214668|NCT01884077|26261883|FG001|Overall Study|Lost to Follow-up|4|||
13214669|NCT01884077|26261882|FG000|Overall Study|study closed|6|||
13214670|NCT01884077|26261883|FG001|Overall Study|study closed|4|||
13214671|NCT01884025|26261918|FG000|Overall Study|Lost to Follow-up|3|||
13214672|NCT01884025|26261919|FG001|Overall Study|Lost to Follow-up|4|||
13214673|NCT01883895|26261926|FG000|Overall Study|Lost to Follow-up|2|||
13214674|NCT01883635|26261945|FG000|Overall Study|Withdrawal by Subject|4|||
13214675|NCT01883635|26261946|FG001|Overall Study|Withdrawal by Subject|0|||
13214676|NCT01883492|26261983|FG000|Overall Study|Lost to Follow-up|3|||
13214677|NCT01883492|26261984|FG001|Overall Study|Lost to Follow-up|4|||
13214678|NCT01883492|26261983|FG000|Overall Study|Surgery on contra-lateral hip|0|||
13214679|NCT01883492|26261984|FG001|Overall Study|Surgery on contra-lateral hip|1|||
13214680|NCT01883492|26261983|FG000|Overall Study|Poor X-ray quality|7|||
13214681|NCT01883492|26261984|FG001|Overall Study|Poor X-ray quality|4|||
13214682|NCT01883492|26261983|FG000|Overall Study|Withdrawal by Subject|1|||
13214683|NCT01883492|26261984|FG001|Overall Study|Withdrawal by Subject|0|||
13214684|NCT01883492|26261983|FG000|Overall Study|inappropriate implant used|1|||
13214685|NCT01883492|26261984|FG001|Overall Study|inappropriate implant used|1|||
13214686|NCT01883492|26261983|FG000|Overall Study|bone anatomy did not meet study criteria|1|||
13214687|NCT01883492|26261984|FG001|Overall Study|bone anatomy did not meet study criteria|1|||
13296701|NCT01369355|26497103|FG000|Long-term Extension (Week 44-272)|Adverse Event|0|||
13296702|NCT01369355|26497104|FG001|Long-term Extension (Week 44-272)|Adverse Event|0|||
13296703|NCT01369355|26497105|FG002|Long-term Extension (Week 44-272)|Adverse Event|0|||
13296704|NCT01369355|26497106|FG003|Long-term Extension (Week 44-272)|Adverse Event|0|||
13296705|NCT01369355|26497107|FG004|Long-term Extension (Week 44-272)|Adverse Event|0|||
13296706|NCT01369355|26497108|FG005|Long-term Extension (Week 44-272)|Adverse Event|0|||
13296707|NCT01369355|26497109|FG006|Long-term Extension (Week 44-272)|Adverse Event|15|||
13296708|NCT01369355|26497110|FG007|Long-term Extension (Week 44-272)|Adverse Event|29|||
13296709|NCT01369355|26497111|FG008|Long-term Extension (Week 44-272)|Adverse Event|53|||
13296710|NCT01369355|26497103|FG000|Long-term Extension (Week 44-272)|Death|0|||
13296711|NCT01369355|26497104|FG001|Long-term Extension (Week 44-272)|Death|0|||
13296712|NCT01369355|26497105|FG002|Long-term Extension (Week 44-272)|Death|0|||
13296713|NCT01369355|26497106|FG003|Long-term Extension (Week 44-272)|Death|0|||
13296714|NCT01369355|26497107|FG004|Long-term Extension (Week 44-272)|Death|0|||
13296715|NCT01369355|26497108|FG005|Long-term Extension (Week 44-272)|Death|0|||
13296716|NCT01369355|26497109|FG006|Long-term Extension (Week 44-272)|Death|0|||
13296717|NCT01369355|26497110|FG007|Long-term Extension (Week 44-272)|Death|1|||
13296718|NCT01369355|26497111|FG008|Long-term Extension (Week 44-272)|Death|3|||
13296719|NCT01369355|26497103|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
13296720|NCT01369355|26497104|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
13296721|NCT01369355|26497105|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
13296722|NCT01369355|26497106|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
13296723|NCT01369355|26497107|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
13296724|NCT01369355|26497108|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
13296725|NCT01369355|26497109|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12|||
13296726|NCT01369355|26497110|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26|||
13296727|NCT01369355|26497111|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29|||
13296728|NCT01369355|26497103|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0|||
13296729|NCT01369355|26497104|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0|||
13296730|NCT01369355|26497105|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0|||
13296731|NCT01369355|26497106|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0|||
13296732|NCT01369355|26497107|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0|||
13296733|NCT01369355|26497108|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0|||
13296734|NCT01369355|26497109|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0|||
13296735|NCT01369355|26497110|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1|||
13296736|NCT01369355|26497111|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2|||
13296737|NCT01369355|26497103|FG000|Long-term Extension (Week 44-272)|Physician Decision|0|||
13296738|NCT01369355|26497104|FG001|Long-term Extension (Week 44-272)|Physician Decision|0|||
13296739|NCT01369355|26497105|FG002|Long-term Extension (Week 44-272)|Physician Decision|0|||
13296740|NCT01369355|26497106|FG003|Long-term Extension (Week 44-272)|Physician Decision|0|||
13296741|NCT01369355|26497107|FG004|Long-term Extension (Week 44-272)|Physician Decision|0|||
13296742|NCT01369355|26497108|FG005|Long-term Extension (Week 44-272)|Physician Decision|0|||
13296743|NCT01369355|26497109|FG006|Long-term Extension (Week 44-272)|Physician Decision|1|||
13296744|NCT01369355|26497110|FG007|Long-term Extension (Week 44-272)|Physician Decision|5|||
13296745|NCT01369355|26497111|FG008|Long-term Extension (Week 44-272)|Physician Decision|11|||
13296746|NCT01369355|26497103|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
13296747|NCT01369355|26497104|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
13214688|NCT01883453|26261997|FG000|Overall Study|No episode of common cold|25|||
13214689|NCT01883453|26261998|FG001|Overall Study|No episode of common cold|23|||
13214690|NCT01883362|26262029|FG000|Treatment|Adverse Event|1|||
13214691|NCT01883362|26262030|FG001|Treatment|Adverse Event|8|||
13214692|NCT01883362|26262029|FG000|Treatment|Withdrawal by Subject|6|||
13214693|NCT01883362|26262030|FG001|Treatment|Withdrawal by Subject|2|||
13214694|NCT01883362|26262029|FG000|Treatment|Administrative problems|4|||
13214695|NCT01883362|26262030|FG001|Treatment|Administrative problems|1|||
13214696|NCT01883362|26262029|FG000|Treatment|Relapse|4|||
13214697|NCT01883362|26262030|FG001|Treatment|Relapse|2|||
13214698|NCT01883362|26262029|FG000|Treatment|Randomized, not treated|1|||
13214699|NCT01883362|26262030|FG001|Treatment|Randomized, not treated|1|||
13214700|NCT01883362|26262029|FG000|Post Treatment Follow-up|Protocol Violation|0|||
13214701|NCT01883362|26262030|FG001|Post Treatment Follow-up|Protocol Violation|1|||
13214702|NCT01883362|26262029|FG000|Post Treatment Follow-up|Withdrawal by Subject|4|||
13214703|NCT01883362|26262030|FG001|Post Treatment Follow-up|Withdrawal by Subject|3|||
13214704|NCT01883362|26262029|FG000|Post Treatment Follow-up|Lost to Follow-up|1|||
13214705|NCT01883362|26262030|FG001|Post Treatment Follow-up|Lost to Follow-up|4|||
13214706|NCT01883362|26262029|FG000|Post Treatment Follow-up|Administrative problems|2|||
13214707|NCT01883362|26262030|FG001|Post Treatment Follow-up|Administrative problems|0|||
13214708|NCT01883362|26262029|FG000|Post Treatment Follow-up|Death|8|||
13214709|NCT01883362|26262030|FG001|Post Treatment Follow-up|Death|4|||
13214710|NCT01883362|26262029|FG000|Post Treatment Follow-up|Relapse|1|||
13214711|NCT01883362|26262030|FG001|Post Treatment Follow-up|Relapse|2|||
13214712|NCT01882985|26262039|FG000|Overall Study|Lost to Follow-up|1|||
13214713|NCT01882985|26262039|FG000|Overall Study|Withdrawal by Subject|1|||
13214714|NCT01882907|26262062|FG000|Overall Study|Adverse Event|3|||
13214715|NCT01882907|26262063|FG001|Overall Study|Adverse Event|1|||
13214716|NCT01882907|26262062|FG000|Overall Study|Lack of Efficacy|0|||
13214717|NCT01882907|26262063|FG001|Overall Study|Lack of Efficacy|3|||
13214718|NCT01882907|26262062|FG000|Overall Study|Lost to Follow-up|1|||
13214719|NCT01882907|26262063|FG001|Overall Study|Lost to Follow-up|4|||
13214720|NCT01882907|26262062|FG000|Overall Study|Protocol Violation|10|||
13214721|NCT01882907|26262063|FG001|Overall Study|Protocol Violation|14|||
13214722|NCT01882907|26262062|FG000|Overall Study|Withdrawal by Subject|0|||
13214723|NCT01882907|26262063|FG001|Overall Study|Withdrawal by Subject|6|||
13214724|NCT01882829|26262079|FG000|Overall Study|Adverse Event|4|||
13214725|NCT01882829|26262079|FG000|Overall Study|Protocol Violation|1|||
13214726|NCT01882829|26262079|FG000|Overall Study|Withdrawal by Subject|1|||
13214727|NCT01882803|26262092|FG000|Overall Study|Disease Progression|53|||
13214728|NCT01882803|26262092|FG000|Overall Study|Adverse Event|22|||
13214729|NCT01882803|26262092|FG000|Overall Study|Death|7|||
13214730|NCT01882803|26262092|FG000|Overall Study|Physician Decision|7|||
13214731|NCT01882803|26262092|FG000|Overall Study|Protocol Violation|1|||
13214732|NCT01882803|26262092|FG000|Overall Study|Withdrawal by Subject|4|||
13214733|NCT01882647|26262115|FG000|Overall Study|Lost to Follow-up|2|||
13214734|NCT01882647|26262116|FG001|Overall Study|Lost to Follow-up|2|||
13214735|NCT01882647|26262115|FG000|Overall Study|Withdrawal by Subject|0|||
13214736|NCT01882647|26262116|FG001|Overall Study|Withdrawal by Subject|4|||
13214737|NCT01882465|26262132|FG000|Period 1|Lens Discomfort|0|||
13214738|NCT01882465|26262133|FG001|Period 1|Lens Discomfort|0|||
13214739|NCT01882465|26262134|FG002|Period 1|Lens Discomfort|0|||
13214740|NCT01882465|26262135|FG003|Period 1|Lens Discomfort|1|||
13214741|NCT01882465|26262136|FG004|Period 1|Lens Discomfort|0|||
13214742|NCT01882465|26262137|FG005|Period 1|Lens Discomfort|0|||
13214743|NCT01882465|26262138|FG006|Period 1|Lens Discomfort|0|||
13214744|NCT01882465|26262132|FG000|Period 1|Withdrawal by Subject|0|||
13214745|NCT01882465|26262133|FG001|Period 1|Withdrawal by Subject|0|||
13214746|NCT01882465|26262134|FG002|Period 1|Withdrawal by Subject|0|||
13214747|NCT01882465|26262135|FG003|Period 1|Withdrawal by Subject|0|||
13214748|NCT01882465|26262136|FG004|Period 1|Withdrawal by Subject|0|||
13214749|NCT01882465|26262137|FG005|Period 1|Withdrawal by Subject|0|||
13214750|NCT01882465|26262138|FG006|Period 1|Withdrawal by Subject|1|||
13214751|NCT01882465|26262132|FG000|Period 2|Protocol Violation|0|||
13214752|NCT01882465|26262133|FG001|Period 2|Protocol Violation|0|||
13214753|NCT01882465|26262134|FG002|Period 2|Protocol Violation|0|||
13214754|NCT01882465|26262135|FG003|Period 2|Protocol Violation|0|||
13214755|NCT01882465|26262136|FG004|Period 2|Protocol Violation|1|||
13214756|NCT01882465|26262137|FG005|Period 2|Protocol Violation|0|||
13214757|NCT01882465|26262138|FG006|Period 2|Protocol Violation|0|||
13214758|NCT01882439|26262331|FG000|Overall Study|Adverse event related to study drug|3|||
13214759|NCT01882439|26262332|FG001|Overall Study|Adverse event related to study drug|8|||
13214760|NCT01882439|26262333|FG002|Overall Study|Adverse event related to study drug|1|||
13214761|NCT01882439|26262334|FG003|Overall Study|Adverse event related to study drug|2|||
13214762|NCT01882439|26262331|FG000|Overall Study|Pregnancy|0|||
13214763|NCT01882439|26262332|FG001|Overall Study|Pregnancy|1|||
13214764|NCT01882439|26262333|FG002|Overall Study|Pregnancy|0|||
13214765|NCT01882439|26262334|FG003|Overall Study|Pregnancy|0|||
13214766|NCT01882439|26262331|FG000|Overall Study|Protocol Violation|2|||
13214767|NCT01882439|26262332|FG001|Overall Study|Protocol Violation|2|||
13214768|NCT01882439|26262333|FG002|Overall Study|Protocol Violation|0|||
13214769|NCT01882439|26262334|FG003|Overall Study|Protocol Violation|1|||
13214770|NCT01882439|26262331|FG000|Overall Study|No longer willing to participate|1|||
13214771|NCT01882439|26262332|FG001|Overall Study|No longer willing to participate|4|||
13214772|NCT01882439|26262333|FG002|Overall Study|No longer willing to participate|2|||
13214773|NCT01882439|26262334|FG003|Overall Study|No longer willing to participate|3|||
13214774|NCT01882439|26262331|FG000|Overall Study|Medication error with no associated AE|0|||
13214775|NCT01882439|26262332|FG001|Overall Study|Medication error with no associated AE|0|||
13214776|NCT01882439|26262333|FG002|Overall Study|Medication error with no associated AE|2|||
13214777|NCT01882439|26262334|FG003|Overall Study|Medication error with no associated AE|0|||
13214778|NCT01882439|26262331|FG000|Overall Study|Insufficient clinical response|1|||
13214779|NCT01882439|26262332|FG001|Overall Study|Insufficient clinical response|4|||
13214780|NCT01882439|26262333|FG002|Overall Study|Insufficient clinical response|4|||
13214781|NCT01882439|26262334|FG003|Overall Study|Insufficient clinical response|2|||
13214782|NCT01882439|26262331|FG000|Overall Study|Adverse event unrelated to study drug|2|||
13214783|NCT01882439|26262332|FG001|Overall Study|Adverse event unrelated to study drug|2|||
13214784|NCT01882439|26262333|FG002|Overall Study|Adverse event unrelated to study drug|1|||
13214785|NCT01882439|26262334|FG003|Overall Study|Adverse event unrelated to study drug|1|||
13214786|NCT01882257|26262351|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0|||
13214787|NCT01882257|26262352|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2|||
13214788|NCT01882257|26262353|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1|||
13214789|NCT01882257|26262351|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0|||
13214790|NCT01882257|26262352|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11|||
13214791|NCT01882257|26262353|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4|||
13214792|NCT01882088|26262368|FG000|Overall Study|Intolerance of esophageal manometry|1|||
13214793|NCT01882088|26262368|FG000|Overall Study|no possibility to place the catheter|1|||
13214794|NCT01882088|26262368|FG000|Overall Study|Protocol Violation|1|||
13214795|NCT01882088|26262368|FG000|Overall Study|inadequate pH-impedance tracings|2|||
13214796|NCT01881789|26262428|FG000|Overall Study|Withdrawal by Subject|0|||
13214797|NCT01881789|26262429|FG001|Overall Study|Withdrawal by Subject|2|||
13214798|NCT01881789|26262430|FG002|Overall Study|Withdrawal by Subject|1|||
13214799|NCT01881789|26262431|FG003|Overall Study|Withdrawal by Subject|0|||
13214800|NCT01881789|26262432|FG004|Overall Study|Withdrawal by Subject|1|||
13214801|NCT01881789|26262433|FG005|Overall Study|Withdrawal by Subject|1|||
13214802|NCT01881789|26262428|FG000|Overall Study|Study Terminated by Sponsor|0|||
13214803|NCT01881789|26262429|FG001|Overall Study|Study Terminated by Sponsor|0|||
13214804|NCT01881789|26262430|FG002|Overall Study|Study Terminated by Sponsor|0|||
13214805|NCT01881789|26262431|FG003|Overall Study|Study Terminated by Sponsor|0|||
13214806|NCT01881789|26262432|FG004|Overall Study|Study Terminated by Sponsor|0|||
13214807|NCT01881789|26262433|FG005|Overall Study|Study Terminated by Sponsor|1|||
13214808|NCT01881789|26262428|FG000|Overall Study|Other|3|||
13214809|NCT01881789|26262429|FG001|Overall Study|Other|5|||
13214810|NCT01881789|26262430|FG002|Overall Study|Other|2|||
13214811|NCT01881789|26262431|FG003|Overall Study|Other|3|||
13214812|NCT01881789|26262432|FG004|Overall Study|Other|1|||
13214813|NCT01881789|26262433|FG005|Overall Study|Other|1|||
13214814|NCT01881776|26262469|FG000|Overall Study|Lost to Follow-up|1|||
13214815|NCT01881776|26262470|FG001|Overall Study|Lost to Follow-up|2|||
13214816|NCT01881776|26262471|FG002|Overall Study|Lost to Follow-up|1|||
13214817|NCT01881776|26262469|FG000|Overall Study|Protocol Violation|0|||
13214818|NCT01881776|26262470|FG001|Overall Study|Protocol Violation|2|||
13214819|NCT01881776|26262471|FG002|Overall Study|Protocol Violation|1|||
13214820|NCT01881750|26262496|FG000|Overall Study|Changes in concomitant therapies|2|||
13214821|NCT01881750|26262497|FG001|Overall Study|Changes in concomitant therapies|3|||
13214822|NCT01881750|26262496|FG000|Overall Study|Lost to Follow-up|0|||
13214823|NCT01881750|26262497|FG001|Overall Study|Lost to Follow-up|1|||
13214824|NCT01881737|26262508|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
13214825|NCT01881737|26262508|FG000|Overall Study|Withdrawal by Subject|1|||
13214826|NCT01881737|26262508|FG000|Overall Study|Worsening of baseline behavior|1|||
13214827|NCT01881620|26262519|FG000|Overall Study|Protocol Violation|4|||
13214828|NCT01881425|26262542|FG000|Overall Study|Death|5|||
13214829|NCT01881425|26262543|FG001|Overall Study|Death|1|||
13214830|NCT01881425|26262542|FG000|Overall Study|Withdrawal by Subject|8|||
13214831|NCT01881425|26262543|FG001|Overall Study|Withdrawal by Subject|3|||
13214832|NCT01881425|26262542|FG000|Overall Study|Physician Decision|2|||
13214833|NCT01881425|26262543|FG001|Overall Study|Physician Decision|1|||
13214834|NCT01881425|26262542|FG000|Overall Study|Adverse Event|3|||
13214835|NCT01881425|26262543|FG001|Overall Study|Adverse Event|0|||
13214836|NCT01881425|26262542|FG000|Overall Study|General Anesthesia panic attack|0|||
13214837|NCT01881425|26262543|FG001|Overall Study|General Anesthesia panic attack|1|||
13214838|NCT01881425|26262542|FG000|Overall Study|Subject randomized after study treatment cut off|0|||
13214839|NCT01881425|26262543|FG001|Overall Study|Subject randomized after study treatment cut off|1|||
13214840|NCT01881425|26262542|FG000|Overall Study|Lost to Follow-up|7|||
13214841|NCT01881425|26262543|FG001|Overall Study|Lost to Follow-up|2|||
13214842|NCT01881230|26262579|FG000|Overall Study|Death|2|||
13214843|NCT01881230|26262580|FG001|Overall Study|Death|0|||
13214844|NCT01881230|26262581|FG002|Overall Study|Death|1|||
13214845|NCT01881230|26262579|FG000|Overall Study|Adverse Event|9|||
13214846|NCT01881230|26262580|FG001|Overall Study|Adverse Event|13|||
13214847|NCT01881230|26262581|FG002|Overall Study|Adverse Event|12|||
13214848|NCT01881230|26262579|FG000|Overall Study|Progressive Disease|31|||
13214849|NCT01881230|26262580|FG001|Overall Study|Progressive Disease|35|||
13214850|NCT01881230|26262581|FG002|Overall Study|Progressive Disease|36|||
13214851|NCT01881230|26262579|FG000|Overall Study|Symptomatic Deterioration|3|||
13214852|NCT01881230|26262580|FG001|Overall Study|Symptomatic Deterioration|3|||
13214853|NCT01881230|26262581|FG002|Overall Study|Symptomatic Deterioration|1|||
13214854|NCT01881230|26262579|FG000|Overall Study|Withdrawal by Subject|6|||
13214855|NCT01881230|26262580|FG001|Overall Study|Withdrawal by Subject|4|||
13214856|NCT01881230|26262581|FG002|Overall Study|Withdrawal by Subject|6|||
13214857|NCT01881230|26262579|FG000|Overall Study|Physician Decision|4|||
13214858|NCT01881230|26262580|FG001|Overall Study|Physician Decision|3|||
13214859|NCT01881230|26262581|FG002|Overall Study|Physician Decision|6|||
13214860|NCT01881230|26262579|FG000|Overall Study|Non-Compliance with Study Drug|1|||
13214861|NCT01881230|26262580|FG001|Overall Study|Non-Compliance with Study Drug|2|||
13214862|NCT01881230|26262581|FG002|Overall Study|Non-Compliance with Study Drug|0|||
13214863|NCT01881230|26262579|FG000|Overall Study|Given Commercially Available Drug|0|||
13214864|NCT01881230|26262580|FG001|Overall Study|Given Commercially Available Drug|0|||
13214865|NCT01881230|26262581|FG002|Overall Study|Given Commercially Available Drug|2|||
13214866|NCT01881230|26262579|FG000|Overall Study|Protocol Violation|1|||
13214867|NCT01881230|26262580|FG001|Overall Study|Protocol Violation|1|||
13214868|NCT01881230|26262581|FG002|Overall Study|Protocol Violation|0|||
13214869|NCT01881230|26262579|FG000|Overall Study|Miscellaneous|3|||
13214870|NCT01881230|26262580|FG001|Overall Study|Miscellaneous|3|||
13214871|NCT01881230|26262581|FG002|Overall Study|Miscellaneous|0|||
13214872|NCT01881230|26262579|FG000|Overall Study|Untreated: Other|0|||
13214873|NCT01881230|26262580|FG001|Overall Study|Untreated: Other|0|||
13214874|NCT01881230|26262581|FG002|Overall Study|Untreated: Other|1|||
13214875|NCT01881230|26262579|FG000|Overall Study|Untreated: Death|0|||
13214876|NCT01881230|26262580|FG001|Overall Study|Untreated: Death|0|||
13214877|NCT01881230|26262581|FG002|Overall Study|Untreated: Death|1|||
13214878|NCT01881230|26262579|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1|||
13214879|NCT01881230|26262580|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0|||
13214880|NCT01881230|26262581|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0|||
13214881|NCT01881126|26262594|FG000|Overall Study|Non-compliance|1|||
13214882|NCT01881126|26262595|FG001|Overall Study|Non-compliance|1|||
13214883|NCT01881126|26262594|FG000|Overall Study|Adverse Event|0|||
13214884|NCT01881126|26262595|FG001|Overall Study|Adverse Event|1|||
13214885|NCT01881009|26262611|FG000|Summer Camp Session (6 Days)|Unable to wear device|0|||
13214886|NCT01881009|26262612|FG001|Summer Camp Session (6 Days)|Unable to wear device|1|||
13214887|NCT01880957|26262635|FG000|Overall Study|Diagnosis: Unipolar Depression|12|||
13214888|NCT01880957|26262636|FG001|Overall Study|Diagnosis: Unipolar Depression|0|||
13214889|NCT01880957|26262635|FG000|Overall Study|Lost to Follow-up|11|||
13214890|NCT01880957|26262636|FG001|Overall Study|Lost to Follow-up|0|||
13214891|NCT01880957|26262635|FG000|Overall Study|Poor Tolerance to Lithium/Declined Treatment|5|||
13214892|NCT01880957|26262636|FG001|Overall Study|Poor Tolerance to Lithium/Declined Treatment|0|||
13214893|NCT01880736|26262691|FG000|Overall Study|Adverse Event|0|||
13214894|NCT01880736|26262692|FG001|Overall Study|Adverse Event|0|||
13214895|NCT01880736|26262693|FG002|Overall Study|Adverse Event|0|||
13214896|NCT01880736|26262694|FG003|Overall Study|Adverse Event|1|||
13214897|NCT01880736|26262691|FG000|Overall Study|Withdrawal Criteria|1|||
13214898|NCT01880736|26262692|FG001|Overall Study|Withdrawal Criteria|2|||
13214899|NCT01880736|26262693|FG002|Overall Study|Withdrawal Criteria|1|||
13214900|NCT01880736|26262694|FG003|Overall Study|Withdrawal Criteria|5|||
13214901|NCT01880593|26262719|FG000|Overall Study|Adverse Event|1|||
13214902|NCT01880593|26262720|FG001|Overall Study|Adverse Event|0|||
13214903|NCT01880593|26262719|FG000|Overall Study|Lack of Efficacy|1|||
13214904|NCT01880593|26262720|FG001|Overall Study|Lack of Efficacy|5|||
13214905|NCT01880593|26262719|FG000|Overall Study|Withdrawal by Subject|6|||
13214906|NCT01880593|26262720|FG001|Overall Study|Withdrawal by Subject|1|||
13214907|NCT01880554|26262730|FG000|Overall Study|Protocol Violation|14|||
13214908|NCT01880554|26262730|FG000|Overall Study|Simon's design requirements|2|||
13214909|NCT01880528|26262751|FG000|Overall Study|Other|1|||
13214910|NCT01880528|26262752|FG001|Overall Study|Other|1|||
13214911|NCT01880515|26262767|FG000|Overall Study|Lost to Follow-up|3|||
13214912|NCT01880515|26262768|FG001|Overall Study|Lost to Follow-up|2|||
13214913|NCT01880515|26262767|FG000|Overall Study|Disease Progression|5|||
13214914|NCT01880515|26262768|FG001|Overall Study|Disease Progression|7|||
13214915|NCT01880437|26262802|FG000|Overall Study|Death|12|||
13214916|NCT01880437|26262803|FG001|Overall Study|Death|4|||
13214917|NCT01880437|26262804|FG002|Overall Study|Death|17|||
13214918|NCT01880437|26262802|FG000|Overall Study|Study terminated by Sponsor|3|||
13214919|NCT01880437|26262803|FG001|Overall Study|Study terminated by Sponsor|0|||
13214920|NCT01880437|26262804|FG002|Overall Study|Study terminated by Sponsor|2|||
13214921|NCT01880424|26262833|FG000|Overall Study|Adverse Event|7|||
13214922|NCT01880424|26262834|FG001|Overall Study|Adverse Event|6|||
13214923|NCT01880424|26262833|FG000|Overall Study|Lack of Efficacy|1|||
13214924|NCT01880424|26262834|FG001|Overall Study|Lack of Efficacy|4|||
13214925|NCT01880424|26262833|FG000|Overall Study|Lost to Follow-up|3|||
13214926|NCT01880424|26262834|FG001|Overall Study|Lost to Follow-up|2|||
13214927|NCT01880424|26262833|FG000|Overall Study|Protocol Violation|11|||
13214928|NCT01880424|26262834|FG001|Overall Study|Protocol Violation|13|||
13214929|NCT01880424|26262833|FG000|Overall Study|Withdrawal by Subject|10|||
13214930|NCT01880424|26262834|FG001|Overall Study|Withdrawal by Subject|30|||
13214931|NCT01880424|26262833|FG000|Overall Study|Other|1|||
13214932|NCT01880424|26262834|FG001|Overall Study|Other|0|||
13214933|NCT01880086|26262859|FG000|Overall Study|Lost to Follow-up|1|||
13214934|NCT01880086|26262860|FG001|Overall Study|Lost to Follow-up|1|||
13214935|NCT01879852|26262879|FG000|Overall Study|Withdrawal by Subject|2|||
13214936|NCT01879852|26262880|FG001|Overall Study|Withdrawal by Subject|0|||
13214937|NCT01879722|26263059|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
13214938|NCT01879722|26263060|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
13214939|NCT01879722|26263061|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
13214940|NCT01879722|26263062|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
13214941|NCT01879722|26263063|FG004|Overall Study|Pretreatment Event/Adverse Event|1|||
13214942|NCT01879722|26263064|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
13214943|NCT01879722|26263065|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
13214944|NCT01879722|26263066|FG007|Overall Study|Pretreatment Event/Adverse Event|1|||
13214945|NCT01879722|26263067|FG008|Overall Study|Pretreatment Event/Adverse Event|1|||
13214946|NCT01879722|26263068|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
13214947|NCT01879722|26263059|FG000|Overall Study|Voluntary Withdrawal|0|||
13214948|NCT01879722|26263060|FG001|Overall Study|Voluntary Withdrawal|0|||
13214949|NCT01879722|26263061|FG002|Overall Study|Voluntary Withdrawal|0|||
13214950|NCT01879722|26263062|FG003|Overall Study|Voluntary Withdrawal|0|||
13214951|NCT01879722|26263063|FG004|Overall Study|Voluntary Withdrawal|0|||
13214952|NCT01879722|26263064|FG005|Overall Study|Voluntary Withdrawal|0|||
13214953|NCT01879722|26263065|FG006|Overall Study|Voluntary Withdrawal|0|||
13214954|NCT01879722|26263066|FG007|Overall Study|Voluntary Withdrawal|0|||
13214955|NCT01879722|26263067|FG008|Overall Study|Voluntary Withdrawal|1|||
13214956|NCT01879722|26263068|FG009|Overall Study|Voluntary Withdrawal|0|||
13214957|NCT01879683|26263077|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1|||
13214958|NCT01879618|26263084|FG000|Overall Study|Does not meet entrance criteria|1|||
13214959|NCT01879618|26263084|FG000|Overall Study|Withdrawal by Subject|1|||
13214960|NCT01879618|26263084|FG000|Overall Study|Surgery;changed schedule; not available|8|||
13214961|NCT01879618|26263084|FG000|Overall Study|Protocol Violation|6|||
13214962|NCT01879618|26263084|FG000|Overall Study|Adverse Event|5|||
13214963|NCT01879579|26263119|FG000|Overall Study|Phone incompatible with texting platform|3|||
13214964|NCT01879579|26263120|FG001|Overall Study|Phone incompatible with texting platform|0|||
13214965|NCT01879579|26263119|FG000|Overall Study|Did not enroll in texting platform|1|||
13214966|NCT01879579|26263120|FG001|Overall Study|Did not enroll in texting platform|0|||
13214967|NCT01879579|26263119|FG000|Overall Study|Did not initiate insulin treatment|1|||
13214968|NCT01879579|26263120|FG001|Overall Study|Did not initiate insulin treatment|0|||
13214969|NCT01879579|26263119|FG000|Overall Study|Phenotypic type 1 diabetes|0|||
13214970|NCT01879579|26263120|FG001|Overall Study|Phenotypic type 1 diabetes|1|||
13214971|NCT01879579|26263119|FG000|Overall Study|Discontinued insulin - possible allergy|0|||
13214972|NCT01879579|26263120|FG001|Overall Study|Discontinued insulin - possible allergy|1|||
13214973|NCT01879553|26263148|FG000|Overall Study|Withdrawal by Subject|1|||
13214974|NCT01879553|26263149|FG001|Overall Study|Withdrawal by Subject|0|||
13214975|NCT01879410|26263164|FG000|Overall Study|Adverse Event|9|||
13214976|NCT01879410|26263165|FG001|Overall Study|Adverse Event|14|||
13214977|NCT01879410|26263164|FG000|Overall Study|Lack of Efficacy|4|||
13214978|NCT01879410|26263165|FG001|Overall Study|Lack of Efficacy|6|||
13214979|NCT01879410|26263164|FG000|Overall Study|Protocol Violation|1|||
13214980|NCT01879410|26263165|FG001|Overall Study|Protocol Violation|7|||
13214981|NCT01879410|26263164|FG000|Overall Study|Lost to Follow-up|2|||
13214982|NCT01879410|26263165|FG001|Overall Study|Lost to Follow-up|1|||
13214983|NCT01879410|26263164|FG000|Overall Study|Withdrawal by Subject|7|||
13214984|NCT01879410|26263165|FG001|Overall Study|Withdrawal by Subject|8|||
13214985|NCT01879410|26263164|FG000|Overall Study|Randomised in Error|1|||
13214986|NCT01879410|26263165|FG001|Overall Study|Randomised in Error|2|||
13214987|NCT01878890|26263191|FG000|Overall Study|Protocol Violation|0|||
13214988|NCT01878890|26263192|FG001|Overall Study|Protocol Violation|1|||
13214989|NCT01878890|26263193|FG002|Overall Study|Protocol Violation|0|||
13214990|NCT01878890|26263194|FG003|Overall Study|Protocol Violation|0|||
13214991|NCT01878383|26263208|FG000|Overall Study|Lost to Follow-up|0|||
13214992|NCT01878383|26263209|FG001|Overall Study|Lost to Follow-up|1499|||
13214993|NCT01878292|26263230|FG000|Randomized|Protocol Violation|1|||
13214994|NCT01878292|26263231|FG001|Randomized|Protocol Violation|0|||
13214995|NCT01878292|26263232|FG002|Randomized|Protocol Violation|0|||
13214996|NCT01878292|26263230|FG000|Randomized|Lost to Follow-up|1|||
13214997|NCT01878292|26263231|FG001|Randomized|Lost to Follow-up|0|||
13214998|NCT01878292|26263232|FG002|Randomized|Lost to Follow-up|0|||
13214999|NCT01878292|26263230|FG000|Randomized|Adverse Event|1|||
13215000|NCT01878292|26263231|FG001|Randomized|Adverse Event|0|||
13215001|NCT01878292|26263232|FG002|Randomized|Adverse Event|0|||
13215002|NCT01878292|26263230|FG000|Double-blind Treatment Period|Other Reasons|2|||
13215003|NCT01878292|26263231|FG001|Double-blind Treatment Period|Other Reasons|0|||
13215004|NCT01878292|26263232|FG002|Double-blind Treatment Period|Other Reasons|0|||
13215005|NCT01878292|26263230|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
13215006|NCT01878292|26263231|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
13215007|NCT01878292|26263232|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
13215008|NCT01878292|26263230|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
13215009|NCT01878292|26263231|FG001|Double-blind Treatment Period|Withdrawal by Subject|7|||
13215010|NCT01878292|26263232|FG002|Double-blind Treatment Period|Withdrawal by Subject|8|||
13215011|NCT01878292|26263230|FG000|Double-blind Treatment Period|Protocol Violation|3|||
13215012|NCT01878292|26263231|FG001|Double-blind Treatment Period|Protocol Violation|4|||
13215013|NCT01878292|26263232|FG002|Double-blind Treatment Period|Protocol Violation|2|||
13215014|NCT01878292|26263230|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
13215015|NCT01878292|26263231|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
13215016|NCT01878292|26263232|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
13215017|NCT01878292|26263230|FG000|Double-blind Treatment Period|Adverse Event|4|||
13215018|NCT01878292|26263231|FG001|Double-blind Treatment Period|Adverse Event|9|||
13215019|NCT01878292|26263232|FG002|Double-blind Treatment Period|Adverse Event|8|||
13215020|NCT01878292|26263230|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5|||
13215021|NCT01878292|26263231|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8|||
13215022|NCT01878292|26263232|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4|||
13215023|NCT01878253|26263243|FG000|Overall Study|Death|1|||
13215024|NCT01878253|26263243|FG000|Overall Study|SIdus System Removal|3|||
13215025|NCT01878253|26263243|FG000|Overall Study|Withdrawal by Subject|1|||
13215026|NCT01878253|26263243|FG000|Overall Study|Lost to Follow-up|2|||
13215027|NCT01878253|26263243|FG000|Overall Study|Completed Study w/o Follow-up Data|2|||
13215028|NCT01878214|26263264|FG000|Overall Study|Withdrawal by Subject|18|||
13215029|NCT01878214|26263265|FG001|Overall Study|Withdrawal by Subject|7|||
13215030|NCT01878214|26263264|FG000|Overall Study|Death|0|||
13215031|NCT01878214|26263265|FG001|Overall Study|Death|1|||
13215032|NCT01878214|26263264|FG000|Overall Study|Lost to Follow-up|35|||
13215033|NCT01878214|26263265|FG001|Overall Study|Lost to Follow-up|36|||
13215034|NCT01878175|26263284|FG000|Overall Study|Developed contraindicated health problem|2|||
13215035|NCT01878149|26263297|FG000|Overall Study|Did Not Meet Eligibility Criteria|2|||
13215036|NCT01878149|26263298|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
13215037|NCT01878097|26263313|FG000|Baseline|Surveys not fully completed|2497|||
13215038|NCT01878097|26263314|FG001|Baseline|Surveys not fully completed|1800|||
13215039|NCT01878097|26263313|FG000|Implementation Year 1|Surveys not fully completed|3202|||
13296748|NCT01369355|26497105|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
13296749|NCT01369355|26497106|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
13296750|NCT01369355|26497107|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
13296751|NCT01369355|26497108|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
13296752|NCT01369355|26497109|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1|||
13296753|NCT01369355|26497110|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5|||
13296754|NCT01369355|26497111|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9|||
13296755|NCT01369355|26497103|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
13296756|NCT01369355|26497104|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
13296757|NCT01369355|26497105|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
13296758|NCT01369355|26497106|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
13296759|NCT01369355|26497107|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
13296760|NCT01369355|26497108|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
13296761|NCT01369355|26497109|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12|||
13296762|NCT01369355|26497110|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30|||
13296763|NCT01369355|26497111|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47|||
13296764|NCT01369355|26497103|FG000|Long-term Extension (Week 44-272)|Other|0|||
13296765|NCT01369355|26497104|FG001|Long-term Extension (Week 44-272)|Other|0|||
13296766|NCT01369355|26497105|FG002|Long-term Extension (Week 44-272)|Other|0|||
13296767|NCT01369355|26497106|FG003|Long-term Extension (Week 44-272)|Other|0|||
13296768|NCT01369355|26497107|FG004|Long-term Extension (Week 44-272)|Other|0|||
13296769|NCT01369355|26497108|FG005|Long-term Extension (Week 44-272)|Other|0|||
13296770|NCT01369355|26497109|FG006|Long-term Extension (Week 44-272)|Other|110|||
13296771|NCT01369355|26497110|FG007|Long-term Extension (Week 44-272)|Other|9|||
13296772|NCT01369355|26497111|FG008|Long-term Extension (Week 44-272)|Other|17|||
13296773|NCT01369342|26497141|FG000|Overall Study|Withdrawal by Subject|7|||
13296774|NCT01369342|26497142|FG001|Overall Study|Withdrawal by Subject|7|||
13215040|NCT01878097|26263314|FG001|Implementation Year 1|Surveys not fully completed|2549|||
13215041|NCT01878097|26263313|FG000|Implementation Year 2|Surveys not fully completed|3281|||
13215042|NCT01878097|26263314|FG001|Implementation Year 2|Surveys not fully completed|2841|||
13215043|NCT01878097|26263313|FG000|Implementation Year 3|Surveys not fully completed|3494|||
13215044|NCT01878097|26263314|FG001|Implementation Year 3|Surveys not fully completed|2980|||
13215045|NCT01878097|26263313|FG000|Implementation Year 4|Surveys not fully completed|3604|||
13215046|NCT01878097|26263314|FG001|Implementation Year 4|Surveys not fully completed|3007|||
13215047|NCT01878084|26263321|FG000|Overall Study|Physician Decision|2|||
13215048|NCT01877915|26263350|FG000|Overall Study|Lost to Follow-up|10|||
13215049|NCT01877915|26263351|FG001|Overall Study|Lost to Follow-up|9|||
13215050|NCT01877915|26263350|FG000|Overall Study|Withdrawal by Subject|42|||
13215051|NCT01877915|26263351|FG001|Overall Study|Withdrawal by Subject|55|||
13215052|NCT01877915|26263350|FG000|Overall Study|Other|2|||
13215053|NCT01877915|26263351|FG001|Overall Study|Other|4|||
13215054|NCT01877720|26263378|FG000|Overall Study|Adverse Event|1|||
13215055|NCT01877720|26263379|FG001|Overall Study|Adverse Event|0|||
13215056|NCT01877668|26263624|FG000|Overall Study|Death|0|||
13215057|NCT01877668|26263625|FG001|Overall Study|Death|0|||
13215058|NCT01877668|26263626|FG002|Overall Study|Death|0|||
13215059|NCT01877668|26263627|FG003|Overall Study|Death|1|||
13215060|NCT01877668|26263628|FG004|Overall Study|Death|0|||
13215061|NCT01877668|26263624|FG000|Overall Study|No longer met study criteria|1|||
13215062|NCT01877668|26263625|FG001|Overall Study|No longer met study criteria|0|||
13215063|NCT01877668|26263626|FG002|Overall Study|No longer met study criteria|1|||
13215064|NCT01877668|26263627|FG003|Overall Study|No longer met study criteria|0|||
13215065|NCT01877668|26263628|FG004|Overall Study|No longer met study criteria|0|||
13215066|NCT01877668|26263624|FG000|Overall Study|Insufficient clinical response|0|||
13215067|NCT01877668|26263625|FG001|Overall Study|Insufficient clinical response|1|||
13215068|NCT01877668|26263626|FG002|Overall Study|Insufficient clinical response|2|||
13215069|NCT01877668|26263627|FG003|Overall Study|Insufficient clinical response|2|||
13215070|NCT01877668|26263628|FG004|Overall Study|Insufficient clinical response|0|||
13215071|NCT01877668|26263624|FG000|Overall Study|Lost to Follow-up|0|||
13215072|NCT01877668|26263625|FG001|Overall Study|Lost to Follow-up|2|||
13215073|NCT01877668|26263626|FG002|Overall Study|Lost to Follow-up|1|||
13215074|NCT01877668|26263627|FG003|Overall Study|Lost to Follow-up|0|||
13215075|NCT01877668|26263628|FG004|Overall Study|Lost to Follow-up|0|||
13215076|NCT01877668|26263624|FG000|Overall Study|Withdrawal by Subject|2|||
13215077|NCT01877668|26263625|FG001|Overall Study|Withdrawal by Subject|0|||
13215078|NCT01877668|26263626|FG002|Overall Study|Withdrawal by Subject|3|||
13215079|NCT01877668|26263627|FG003|Overall Study|Withdrawal by Subject|2|||
13215080|NCT01877668|26263628|FG004|Overall Study|Withdrawal by Subject|2|||
13215081|NCT01877668|26263624|FG000|Overall Study|Other|1|||
13215082|NCT01877668|26263625|FG001|Overall Study|Other|1|||
13215083|NCT01877668|26263626|FG002|Overall Study|Other|1|||
13215084|NCT01877668|26263627|FG003|Overall Study|Other|1|||
13215085|NCT01877668|26263628|FG004|Overall Study|Other|3|||
13215086|NCT01877668|26263624|FG000|Overall Study|Protocol Violation|1|||
13215087|NCT01877668|26263625|FG001|Overall Study|Protocol Violation|1|||
13215088|NCT01877668|26263626|FG002|Overall Study|Protocol Violation|0|||
13215089|NCT01877668|26263627|FG003|Overall Study|Protocol Violation|0|||
13215090|NCT01877668|26263628|FG004|Overall Study|Protocol Violation|3|||
13215091|NCT01877668|26263624|FG000|Overall Study|Adverse event related to study drug|2|||
13215092|NCT01877668|26263625|FG001|Overall Study|Adverse event related to study drug|2|||
13215093|NCT01877668|26263626|FG002|Overall Study|Adverse event related to study drug|2|||
13215094|NCT01877668|26263627|FG003|Overall Study|Adverse event related to study drug|2|||
13215095|NCT01877668|26263628|FG004|Overall Study|Adverse event related to study drug|1|||
13215096|NCT01877668|26263624|FG000|Overall Study|Adverse event unrelated to study drug|4|||
13215097|NCT01877668|26263625|FG001|Overall Study|Adverse event unrelated to study drug|1|||
13215098|NCT01877668|26263626|FG002|Overall Study|Adverse event unrelated to study drug|2|||
13215099|NCT01877668|26263627|FG003|Overall Study|Adverse event unrelated to study drug|0|||
13215100|NCT01877668|26263628|FG004|Overall Study|Adverse event unrelated to study drug|1|||
13215101|NCT01877551|26263647|FG000|Overall Study|Physician Decision|0|||
13215102|NCT01877551|26263648|FG001|Overall Study|Physician Decision|1|||
13215103|NCT01877421|26263839|FG000|Phase 2|Lost to Follow-up|0|||
13215104|NCT01877421|26263840|FG001|Phase 2|Lost to Follow-up|0|||
13215105|NCT01877421|26263841|FG002|Phase 2|Lost to Follow-up|0|||
13215106|NCT01877421|26263842|FG003|Phase 2|Lost to Follow-up|0|||
13215107|NCT01877421|26263843|FG004|Phase 2|Lost to Follow-up|0|||
13215108|NCT01877421|26263844|FG005|Phase 2|Lost to Follow-up|0|||
13215109|NCT01877421|26263845|FG006|Phase 2|Lost to Follow-up|1|||
13215110|NCT01877421|26263846|FG007|Phase 2|Lost to Follow-up|0|||
13215111|NCT01877421|26263847|FG008|Phase 2|Lost to Follow-up|0|||
13215112|NCT01877421|26263848|FG009|Phase 2|Lost to Follow-up|0|||
13215113|NCT01877421|26263849|FG010|Phase 2|Lost to Follow-up|0|||
13215114|NCT01877421|26263850|FG011|Phase 2|Lost to Follow-up|0|||
13215115|NCT01877421|26263851|FG012|Phase 2|Lost to Follow-up|0|||
13215116|NCT01877421|26263852|FG013|Phase 2|Lost to Follow-up|0|||
13215117|NCT01877421|26263853|FG014|Phase 2|Lost to Follow-up|0|||
13215118|NCT01877421|26263854|FG015|Phase 2|Lost to Follow-up|0|||
13215119|NCT01877421|26263855|FG016|Phase 2|Lost to Follow-up|0|||
13215120|NCT01877421|26263856|FG017|Phase 2|Lost to Follow-up|0|||
13215121|NCT01877421|26263839|FG000|Phase 2|Withdrawal by Subject|0|||
13215122|NCT01877421|26263840|FG001|Phase 2|Withdrawal by Subject|0|||
13215123|NCT01877421|26263841|FG002|Phase 2|Withdrawal by Subject|0|||
13215124|NCT01877421|26263842|FG003|Phase 2|Withdrawal by Subject|0|||
13215125|NCT01877421|26263843|FG004|Phase 2|Withdrawal by Subject|0|||
13215126|NCT01877421|26263844|FG005|Phase 2|Withdrawal by Subject|0|||
13215127|NCT01877421|26263845|FG006|Phase 2|Withdrawal by Subject|0|||
13215128|NCT01877421|26263846|FG007|Phase 2|Withdrawal by Subject|0|||
13215129|NCT01877421|26263847|FG008|Phase 2|Withdrawal by Subject|1|||
13215130|NCT01877421|26263848|FG009|Phase 2|Withdrawal by Subject|0|||
13215131|NCT01877421|26263849|FG010|Phase 2|Withdrawal by Subject|1|||
13215132|NCT01877421|26263850|FG011|Phase 2|Withdrawal by Subject|0|||
13215133|NCT01877421|26263851|FG012|Phase 2|Withdrawal by Subject|1|||
13215134|NCT01877421|26263852|FG013|Phase 2|Withdrawal by Subject|0|||
13215135|NCT01877421|26263853|FG014|Phase 2|Withdrawal by Subject|0|||
13215136|NCT01877421|26263854|FG015|Phase 2|Withdrawal by Subject|1|||
13215137|NCT01877421|26263855|FG016|Phase 2|Withdrawal by Subject|0|||
13215138|NCT01877421|26263856|FG017|Phase 2|Withdrawal by Subject|0|||
13215139|NCT01877421|26263839|FG000|Phase 2|Protocol Violation|0|||
13215140|NCT01877421|26263840|FG001|Phase 2|Protocol Violation|0|||
13215141|NCT01877421|26263841|FG002|Phase 2|Protocol Violation|0|||
13215142|NCT01877421|26263842|FG003|Phase 2|Protocol Violation|0|||
13215143|NCT01877421|26263843|FG004|Phase 2|Protocol Violation|0|||
13215144|NCT01877421|26263844|FG005|Phase 2|Protocol Violation|0|||
13215145|NCT01877421|26263845|FG006|Phase 2|Protocol Violation|0|||
13215146|NCT01877421|26263846|FG007|Phase 2|Protocol Violation|0|||
13215147|NCT01877421|26263847|FG008|Phase 2|Protocol Violation|0|||
13215148|NCT01877421|26263848|FG009|Phase 2|Protocol Violation|0|||
13215149|NCT01877421|26263849|FG010|Phase 2|Protocol Violation|1|||
13215150|NCT01877421|26263850|FG011|Phase 2|Protocol Violation|0|||
13215151|NCT01877421|26263851|FG012|Phase 2|Protocol Violation|0|||
13215152|NCT01877421|26263852|FG013|Phase 2|Protocol Violation|0|||
13215153|NCT01877421|26263853|FG014|Phase 2|Protocol Violation|0|||
13215154|NCT01877421|26263854|FG015|Phase 2|Protocol Violation|0|||
13215155|NCT01877421|26263855|FG016|Phase 2|Protocol Violation|0|||
13215156|NCT01877421|26263856|FG017|Phase 2|Protocol Violation|0|||
13215157|NCT01877408|26263880|FG000|Overall Study|Lost to Follow-up|0|||
13215158|NCT01877408|26263881|FG001|Overall Study|Lost to Follow-up|2|||
13215159|NCT01877278|26263896|FG000|Overall Study|Lost to Follow-up|3|||
13215160|NCT01877278|26263897|FG001|Overall Study|Lost to Follow-up|3|||
13215161|NCT01877265|26263921|FG000|Treatment Period 1|Sponsor Decision|0|||
13215162|NCT01877265|26263922|FG001|Treatment Period 1|Sponsor Decision|0|||
13215163|NCT01877265|26263923|FG002|Treatment Period 1|Sponsor Decision|1|||
13215164|NCT01877265|26263924|FG003|Treatment Period 1|Sponsor Decision|0|||
13215165|NCT01877265|26263925|FG004|Treatment Period 1|Sponsor Decision|0|||
13215166|NCT01877265|26263926|FG005|Treatment Period 1|Sponsor Decision|0|||
13215167|NCT01877265|26263921|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
13215168|NCT01877265|26263922|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
13215169|NCT01877265|26263923|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
13215170|NCT01877265|26263924|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
13215171|NCT01877265|26263925|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
13215172|NCT01877265|26263926|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1|||
13215173|NCT01877265|26263921|FG000|Treatment Period 3|Lost to Follow-up|1|||
13215174|NCT01877265|26263922|FG001|Treatment Period 3|Lost to Follow-up|0|||
13215175|NCT01877265|26263923|FG002|Treatment Period 3|Lost to Follow-up|0|||
13215176|NCT01877265|26263924|FG003|Treatment Period 3|Lost to Follow-up|0|||
13215177|NCT01877265|26263925|FG004|Treatment Period 3|Lost to Follow-up|0|||
13215178|NCT01877265|26263926|FG005|Treatment Period 3|Lost to Follow-up|0|||
13215179|NCT01877239|26263934|FG000|Overall Study|Adverse Event|4|||
13215180|NCT01877239|26263934|FG000|Overall Study|Disease Remission|1|||
13215181|NCT01877239|26263934|FG000|Overall Study|Withdrawal by Subject|4|||
13215182|NCT01877239|26263934|FG000|Overall Study|Other|2|||
13215183|NCT01877239|26263934|FG000|Overall Study|Lack of Efficacy|4|||
13215184|NCT01877239|26263934|FG000|Overall Study|Data not available|35|||
13215185|NCT01877187|26263965|FG000|Overall Study|Death|2|||
13215186|NCT01877187|26263965|FG000|Overall Study|Withdrawal by Subject|4|||
13215187|NCT01877187|26263965|FG000|Overall Study|Lost to Follow-up|3|||
13215188|NCT01877187|26263965|FG000|Overall Study|Declining clinical status|11|||
13215189|NCT01877187|26263965|FG000|Overall Study|Liver transplant|2|||
13215190|NCT01877083|26263974|FG000|Treatment Phase|Disease Progression|10|||
13215191|NCT01877083|26263974|FG000|Treatment Phase|Clinical Progression|1|||
13215192|NCT01877083|26263974|FG000|Treatment Phase|Adverse Event|6|||
13215193|NCT01877083|26263974|FG000|Treatment Phase|Withdrawal by Subject|2|||
13215194|NCT01877083|26263974|FG000|Treatment Phase|Lost to Follow-up|1|||
13215195|NCT01877083|26263974|FG000|Extension Phase|Disease Progression|3|||
13215196|NCT01877083|26263974|FG000|Extension Phase|Adverse Event|2|||
13215197|NCT01876979|26263987|FG000|Overall Study|Physician Decision|2|||
13215198|NCT01876979|26263988|FG001|Overall Study|Physician Decision|3|||
13215199|NCT01876901|26264015|FG000|Overall Study|Protocol Violation|10|||
13215200|NCT01876901|26264016|FG001|Overall Study|Protocol Violation|2|||
13215201|NCT01876901|26264015|FG000|Overall Study|No or other surgical intervention|7|||
13215202|NCT01876901|26264016|FG001|Overall Study|No or other surgical intervention|5|||
13215203|NCT01876823|26264031|FG000|Overall Study|Withdrawal by Subject|5|||
13215204|NCT01876823|26264031|FG000|Overall Study|Physician Decision|2|||
13215205|NCT01876823|26264031|FG000|Overall Study|Patients moved|2|||
13215206|NCT01876810|26264044|FG000|Overall Study|Physician Decision|0|||
13215207|NCT01876810|26264045|FG001|Overall Study|Physician Decision|1|||
13215208|NCT01876784|26264058|FG000|Overall Study|Withdrawal by Subject|17|||
13215209|NCT01876784|26264059|FG001|Overall Study|Withdrawal by Subject|2|||
13215210|NCT01876784|26264058|FG000|Overall Study|Adverse Event|15|||
13215211|NCT01876784|26264059|FG001|Overall Study|Adverse Event|2|||
13215212|NCT01876784|26264058|FG000|Overall Study|Protocol Violation|1|||
13215213|NCT01876784|26264059|FG001|Overall Study|Protocol Violation|0|||
13215214|NCT01876784|26264058|FG000|Overall Study|Disease progression|37|||
13215215|NCT01876784|26264059|FG001|Overall Study|Disease progression|67|||
13215216|NCT01876784|26264058|FG000|Overall Study|Lost to Follow-up|0|||
13215217|NCT01876784|26264059|FG001|Overall Study|Lost to Follow-up|1|||
13215218|NCT01876784|26264058|FG000|Overall Study|Death|1|||
13215219|NCT01876784|26264059|FG001|Overall Study|Death|0|||
13215220|NCT01876784|26264058|FG000|Overall Study|Randomized but not treated|2|||
13215221|NCT01876784|26264059|FG001|Overall Study|Randomized but not treated|1|||
13215222|NCT01876784|26264058|FG000|Overall Study|Other than specified above|5|||
13215223|NCT01876784|26264059|FG001|Overall Study|Other than specified above|6|||
13215224|NCT01876784|26264058|FG000|Overall Study|Ongoing|41|||
13215225|NCT01876784|26264059|FG001|Overall Study|Ongoing|40|||
13215226|NCT01876732|26264066|FG000|Overall Study|MMA was not over 800mg/dL|75|||
13215227|NCT01876706|26264085|FG000|Overall Study|BPH Intervention|9|||
13215228|NCT01876706|26264085|FG000|Overall Study|Lost to Follow-up|7|||
13215229|NCT01876706|26264085|FG000|Overall Study|Withdrawals|6|||
13215230|NCT01876706|26264085|FG000|Overall Study|Death|3|||
13215231|NCT01876511|26264130|FG000|Overall Study|Disease Progression-clinical/radiologic|11|||
13215232|NCT01876511|26264131|FG001|Overall Study|Disease Progression-clinical/radiologic|24|||
13215233|NCT01876511|26264132|FG002|Overall Study|Disease Progression-clinical/radiologic|16|||
13215234|NCT01876511|26264130|FG000|Overall Study|Death (unrelated)|3|||
13215235|NCT01876511|26264131|FG001|Overall Study|Death (unrelated)|0|||
13215236|NCT01876511|26264132|FG002|Overall Study|Death (unrelated)|2|||
13215237|NCT01876511|26264130|FG000|Overall Study|Drug-related Toxicity|5|||
13215238|NCT01876511|26264131|FG001|Overall Study|Drug-related Toxicity|1|||
13215239|NCT01876511|26264132|FG002|Overall Study|Drug-related Toxicity|6|||
13215240|NCT01876511|26264130|FG000|Overall Study|Patient Decision|3|||
13215241|NCT01876511|26264131|FG001|Overall Study|Patient Decision|0|||
13215242|NCT01876511|26264132|FG002|Overall Study|Patient Decision|6|||
13215243|NCT01876511|26264130|FG000|Overall Study|Physician Decision|1|||
13215244|NCT01876511|26264131|FG001|Overall Study|Physician Decision|0|||
13215245|NCT01876511|26264132|FG002|Overall Study|Physician Decision|1|||
13215246|NCT01876446|26264155|FG000|Overall Study|Death|0|||
13215247|NCT01876446|26264156|FG001|Overall Study|Death|1|||
13215248|NCT01876446|26264155|FG000|Overall Study|Withdrawal by Subject|1|||
13215249|NCT01876446|26264156|FG001|Overall Study|Withdrawal by Subject|2|||
13215250|NCT01876446|26264155|FG000|Overall Study|Physician Decision|1|||
13215251|NCT01876446|26264156|FG001|Overall Study|Physician Decision|3|||
13215252|NCT01876420|26264170|FG000|Overall Study|Missed 30 day visit|1|||
13215253|NCT01876381|26264177|FG000|Overall Study|Lack of Efficacy|5|||
13215254|NCT01876381|26264177|FG000|Overall Study|Physician Decision|1|||
13215255|NCT01876381|26264177|FG000|Overall Study|Withdrawal by Subject|1|||
13215256|NCT01876368|26264210|FG000|Overall Study|Adverse Event|2|||
13215257|NCT01876368|26264211|FG001|Overall Study|Adverse Event|5|||
13215258|NCT01876368|26264210|FG000|Overall Study|Lack of Efficacy|1|||
13215259|NCT01876368|26264211|FG001|Overall Study|Lack of Efficacy|0|||
13215260|NCT01876368|26264210|FG000|Overall Study|Lost to Follow-up|0|||
13215261|NCT01876368|26264211|FG001|Overall Study|Lost to Follow-up|1|||
13215262|NCT01876368|26264210|FG000|Overall Study|Non-compliance with study treatment|0|||
13215263|NCT01876368|26264211|FG001|Overall Study|Non-compliance with study treatment|1|||
13215264|NCT01876368|26264210|FG000|Overall Study|Physician Decision|0|||
13215265|NCT01876368|26264211|FG001|Overall Study|Physician Decision|2|||
13215266|NCT01876368|26264210|FG000|Overall Study|Protocol deviation|3|||
13215267|NCT01876368|26264211|FG001|Overall Study|Protocol deviation|3|||
13215268|NCT01876368|26264210|FG000|Overall Study|Subject/guardian decision|3|||
13215269|NCT01876368|26264211|FG001|Overall Study|Subject/guardian decision|1|||
13215270|NCT01876251|26264278|FG000|Overall Study|Clinical progression|1|||
13215271|NCT01876251|26264279|FG001|Overall Study|Clinical progression|0|||
13215272|NCT01876251|26264280|FG002|Overall Study|Clinical progression|0|||
13215273|NCT01876251|26264278|FG000|Overall Study|Death|2|||
13215274|NCT01876251|26264279|FG001|Overall Study|Death|0|||
13215275|NCT01876251|26264280|FG002|Overall Study|Death|1|||
13215276|NCT01876251|26264278|FG000|Overall Study|Participant started new treatment|1|||
13215277|NCT01876251|26264279|FG001|Overall Study|Participant started new treatment|0|||
13215278|NCT01876251|26264280|FG002|Overall Study|Participant started new treatment|1|||
13215279|NCT01876251|26264278|FG000|Overall Study|Participant refused further follow-up|0|||
13215280|NCT01876251|26264279|FG001|Overall Study|Participant refused further follow-up|0|||
13215281|NCT01876251|26264280|FG002|Overall Study|Participant refused further follow-up|1|||
13215282|NCT01876251|26264278|FG000|Overall Study|Study terminated|1|||
13215283|NCT01876251|26264279|FG001|Overall Study|Study terminated|0|||
13215284|NCT01876251|26264280|FG002|Overall Study|Study terminated|0|||
13215285|NCT01876251|26264278|FG000|Overall Study|Objective progression or relapse|10|||
13215286|NCT01876251|26264279|FG001|Overall Study|Objective progression or relapse|3|||
13215287|NCT01876251|26264280|FG002|Overall Study|Objective progression or relapse|8|||
13215288|NCT01876082|26264299|FG000|Overall Study|Withdrawal by Subject|0|||
13215289|NCT01876082|26264300|FG001|Overall Study|Withdrawal by Subject|2|||
13215290|NCT01876082|26264299|FG000|Overall Study|Protocol Violation|1|||
13215291|NCT01876082|26264300|FG001|Overall Study|Protocol Violation|0|||
13215292|NCT01876082|26264299|FG000|Overall Study|Adverse Event|1|||
13215293|NCT01876082|26264300|FG001|Overall Study|Adverse Event|1|||
13215294|NCT01876082|26264299|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0|||
13215295|NCT01876082|26264300|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1|||
13215296|NCT01876043|26264312|FG000|Overall Study|Death|1|||
13215297|NCT01876043|26264312|FG000|Overall Study|Withdrawal by Subject|1|||
13215298|NCT01875991|26264340|FG000|Overall Study|Withdrawal by Subject|6|||
13215299|NCT01875991|26264341|FG001|Overall Study|Withdrawal by Subject|6|||
13215300|NCT01875991|26264340|FG000|Overall Study|Sponsor Decision|1|||
13215301|NCT01875991|26264341|FG001|Overall Study|Sponsor Decision|0|||
13215302|NCT01875874|26264348|FG000|Overall Study|Death|3|||
13215303|NCT01875848|26264363|FG000|Overall Study|Withdrawal by Subject|2|||
13215304|NCT01875848|26264364|FG001|Overall Study|Withdrawal by Subject|0|||
13215305|NCT01875731|26264379|FG000|Overall Study|Fail to obtain lab sample|1|||
13215306|NCT01875731|26264380|FG001|Overall Study|Fail to obtain lab sample|0|||
13215307|NCT01875471|26264393|FG000|Overall Study|Adverse Event|0|||
13215308|NCT01875471|26264394|FG001|Overall Study|Adverse Event|1|||
13215309|NCT01875471|26264393|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
13215310|NCT01875471|26264394|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
13215311|NCT01875445|26264409|FG000|Overall Study|Lost to Follow-up|5|||
13215312|NCT01875445|26264410|FG001|Overall Study|Lost to Follow-up|0|||
13215313|NCT01875445|26264409|FG000|Overall Study|Withdrawal by Subject|2|||
13215314|NCT01875445|26264410|FG001|Overall Study|Withdrawal by Subject|0|||
13215315|NCT01875367|26264432|FG000|Overall Study|Not complete at least 2 questionaries|4|||
13215316|NCT01875367|26264433|FG001|Overall Study|Not complete at least 2 questionaries|2|||
13215317|NCT01875367|26264432|FG000|Overall Study|Not receive study treatment|1|||
13215318|NCT01875367|26264433|FG001|Overall Study|Not receive study treatment|0|||
13215319|NCT01875250|26264453|FG000|Overall Study|Adverse Event|2|||
13215320|NCT01875250|26264454|FG001|Overall Study|Adverse Event|0|||
13215321|NCT01875237|26264485|FG000|Overall Study|GVDH before DLI|1|||
13215322|NCT01875237|26264486|FG001|Overall Study|GVDH before DLI|0|||
13215323|NCT01875237|26264485|FG000|Overall Study|DLI cells could not be produced|1|||
13215324|NCT01875237|26264486|FG001|Overall Study|DLI cells could not be produced|0|||
13215325|NCT01874665|26264519|FG000|Overall Study|Adverse Event|6|||
13215326|NCT01874665|26264520|FG001|Overall Study|Adverse Event|2|||
13215327|NCT01874665|26264519|FG000|Overall Study|Withdrawal by Subject|4|||
13215328|NCT01874665|26264520|FG001|Overall Study|Withdrawal by Subject|1|||
13215329|NCT01874665|26264519|FG000|Overall Study|Physician Decision|3|||
13215330|NCT01874665|26264520|FG001|Overall Study|Physician Decision|0|||
13215331|NCT01874665|26264519|FG000|Overall Study|Clinical Progressive Disease|4|||
13215332|NCT01874665|26264520|FG001|Overall Study|Clinical Progressive Disease|3|||
13215333|NCT01874665|26264519|FG000|Overall Study|Study Terminated by Sponsor|0|||
13215334|NCT01874665|26264520|FG001|Overall Study|Study Terminated by Sponsor|2|||
13215335|NCT01874665|26264519|FG000|Overall Study|Documented Progressive Disease|11|||
13215336|NCT01874665|26264520|FG001|Overall Study|Documented Progressive Disease|7|||
13215337|NCT01874665|26264519|FG000|Overall Study|Other|2|||
13215338|NCT01874665|26264520|FG001|Overall Study|Other|0|||
13215339|NCT01874535|26264533|FG000|Overall Study|Lost to Follow-up|10|||
13215340|NCT01874535|26264534|FG001|Overall Study|Lost to Follow-up|9|||
13215341|NCT01874535|26264533|FG000|Overall Study|incomplete symptom resolution|45|||
13215342|NCT01874535|26264534|FG001|Overall Study|incomplete symptom resolution|35|||
13215343|NCT01874431|26264609|FG000|Overall Study|Physician Decision|0|||
13215344|NCT01874431|26264610|FG001|Overall Study|Physician Decision|0|||
13215345|NCT01874431|26264611|FG002|Overall Study|Physician Decision|1|||
13215346|NCT01874431|26264612|FG003|Overall Study|Physician Decision|0|||
13215347|NCT01874431|26264613|FG004|Overall Study|Physician Decision|0|||
13215348|NCT01874431|26264614|FG005|Overall Study|Physician Decision|0|||
13215349|NCT01874431|26264615|FG006|Overall Study|Physician Decision|0|||
13215350|NCT01874431|26264616|FG007|Overall Study|Physician Decision|0|||
13215351|NCT01874431|26264609|FG000|Overall Study|Adverse Event|5|||
13215352|NCT01874431|26264610|FG001|Overall Study|Adverse Event|4|||
13215353|NCT01874431|26264611|FG002|Overall Study|Adverse Event|6|||
13215354|NCT01874431|26264612|FG003|Overall Study|Adverse Event|5|||
13215355|NCT01874431|26264613|FG004|Overall Study|Adverse Event|2|||
13215356|NCT01874431|26264614|FG005|Overall Study|Adverse Event|8|||
13215357|NCT01874431|26264615|FG006|Overall Study|Adverse Event|2|||
13215358|NCT01874431|26264616|FG007|Overall Study|Adverse Event|3|||
13215359|NCT01874431|26264609|FG000|Overall Study|Protocol Violation|1|||
13215360|NCT01874431|26264610|FG001|Overall Study|Protocol Violation|1|||
13215361|NCT01874431|26264611|FG002|Overall Study|Protocol Violation|1|||
13215362|NCT01874431|26264612|FG003|Overall Study|Protocol Violation|0|||
13215363|NCT01874431|26264613|FG004|Overall Study|Protocol Violation|3|||
13215364|NCT01874431|26264614|FG005|Overall Study|Protocol Violation|2|||
13215365|NCT01874431|26264615|FG006|Overall Study|Protocol Violation|1|||
13215366|NCT01874431|26264616|FG007|Overall Study|Protocol Violation|1|||
13215367|NCT01874431|26264609|FG000|Overall Study|Non-compliance|0|||
13215368|NCT01874431|26264610|FG001|Overall Study|Non-compliance|0|||
13215369|NCT01874431|26264611|FG002|Overall Study|Non-compliance|0|||
13215370|NCT01874431|26264612|FG003|Overall Study|Non-compliance|0|||
13215371|NCT01874431|26264613|FG004|Overall Study|Non-compliance|1|||
13215372|NCT01874431|26264614|FG005|Overall Study|Non-compliance|0|||
13215373|NCT01874431|26264615|FG006|Overall Study|Non-compliance|1|||
13215374|NCT01874431|26264616|FG007|Overall Study|Non-compliance|0|||
13215375|NCT01874431|26264609|FG000|Overall Study|Logistical difficulties|0|||
13215376|NCT01874431|26264610|FG001|Overall Study|Logistical difficulties|0|||
13215377|NCT01874431|26264611|FG002|Overall Study|Logistical difficulties|0|||
13215378|NCT01874431|26264612|FG003|Overall Study|Logistical difficulties|0|||
13215379|NCT01874431|26264613|FG004|Overall Study|Logistical difficulties|0|||
13215380|NCT01874431|26264614|FG005|Overall Study|Logistical difficulties|0|||
13215381|NCT01874431|26264615|FG006|Overall Study|Logistical difficulties|1|||
13215382|NCT01874431|26264616|FG007|Overall Study|Logistical difficulties|0|||
13215383|NCT01874431|26264609|FG000|Overall Study|Withdrawal by Subject|0|||
13215384|NCT01874431|26264610|FG001|Overall Study|Withdrawal by Subject|0|||
13215385|NCT01874431|26264611|FG002|Overall Study|Withdrawal by Subject|1|||
13215386|NCT01874431|26264612|FG003|Overall Study|Withdrawal by Subject|2|||
13215387|NCT01874431|26264613|FG004|Overall Study|Withdrawal by Subject|1|||
13215388|NCT01874431|26264614|FG005|Overall Study|Withdrawal by Subject|1|||
13215389|NCT01874431|26264615|FG006|Overall Study|Withdrawal by Subject|3|||
13215390|NCT01874431|26264616|FG007|Overall Study|Withdrawal by Subject|0|||
13215391|NCT01874431|26264609|FG000|Overall Study|Sponsor decision|0|||
13215392|NCT01874431|26264610|FG001|Overall Study|Sponsor decision|0|||
13215393|NCT01874431|26264611|FG002|Overall Study|Sponsor decision|0|||
13215394|NCT01874431|26264612|FG003|Overall Study|Sponsor decision|0|||
13215395|NCT01874431|26264613|FG004|Overall Study|Sponsor decision|1|||
13215396|NCT01874431|26264614|FG005|Overall Study|Sponsor decision|0|||
13215397|NCT01874431|26264615|FG006|Overall Study|Sponsor decision|0|||
13215398|NCT01874431|26264616|FG007|Overall Study|Sponsor decision|0|||
13215399|NCT01874431|26264609|FG000|Overall Study|Lost to Follow-up|0|||
13381991|NCT00748553|26749596|FG001|Overall Study|Adverse Event|1|||
13381992|NCT00748553|26749595|FG000|Overall Study|disease progression|2|||
13381993|NCT00748553|26749596|FG001|Overall Study|disease progression|0|||
13381994|NCT00748553|26749595|FG000|Overall Study|noncompliance|1|||
13381995|NCT00748553|26749596|FG001|Overall Study|noncompliance|0|||
13215400|NCT01874431|26264610|FG001|Overall Study|Lost to Follow-up|0|||
13215401|NCT01874431|26264611|FG002|Overall Study|Lost to Follow-up|1|||
13215402|NCT01874431|26264612|FG003|Overall Study|Lost to Follow-up|0|||
13215403|NCT01874431|26264613|FG004|Overall Study|Lost to Follow-up|0|||
13215404|NCT01874431|26264614|FG005|Overall Study|Lost to Follow-up|0|||
13215405|NCT01874431|26264615|FG006|Overall Study|Lost to Follow-up|0|||
13215406|NCT01874431|26264616|FG007|Overall Study|Lost to Follow-up|0|||
13215407|NCT01874340|26264655|FG000|Overall Study|Study terminated by Sponsor|6|||
13215408|NCT01874340|26264656|FG001|Overall Study|Study terminated by Sponsor|8|||
13215409|NCT01874340|26264657|FG002|Overall Study|Study terminated by Sponsor|8|||
13215410|NCT01874340|26264658|FG003|Overall Study|Study terminated by Sponsor|4|||
13215411|NCT01874340|26264655|FG000|Overall Study|Withdrawal by Subject|0|||
13215412|NCT01874340|26264656|FG001|Overall Study|Withdrawal by Subject|0|||
13215413|NCT01874340|26264657|FG002|Overall Study|Withdrawal by Subject|0|||
13215414|NCT01874340|26264658|FG003|Overall Study|Withdrawal by Subject|1|||
13215415|NCT01874288|26264707|FG000|Overall Study|Withdrawal by Subject|1|||
13296775|NCT01369342|26497143|FG002|Overall Study|Withdrawal by Subject|2|||
13296776|NCT01369342|26497141|FG000|Overall Study|Lost to Follow-up|5|||
13215416|NCT01874288|26264708|FG001|Overall Study|Withdrawal by Subject|0|||
13215417|NCT01874288|26264709|FG002|Overall Study|Withdrawal by Subject|2|||
13215418|NCT01874288|26264710|FG003|Overall Study|Withdrawal by Subject|1|||
13296777|NCT01369342|26497142|FG001|Overall Study|Lost to Follow-up|2|||
13296778|NCT01369342|26497143|FG002|Overall Study|Lost to Follow-up|1|||
13296779|NCT01369342|26497141|FG000|Overall Study|Not Treated|1|||
13296780|NCT01369342|26497142|FG001|Overall Study|Not Treated|0|||
13215419|NCT01874288|26264711|FG004|Overall Study|Withdrawal by Subject|1|||
13215420|NCT01874288|26264707|FG000|Overall Study|Physician Decision|0|||
13215421|NCT01874288|26264708|FG001|Overall Study|Physician Decision|0|||
13215422|NCT01874288|26264709|FG002|Overall Study|Physician Decision|0|||
13215423|NCT01874288|26264710|FG003|Overall Study|Physician Decision|1|||
13215424|NCT01874288|26264711|FG004|Overall Study|Physician Decision|0|||
13215425|NCT01874288|26264707|FG000|Overall Study|Progressive disease|2|||
13215426|NCT01874288|26264708|FG001|Overall Study|Progressive disease|0|||
13215427|NCT01874288|26264709|FG002|Overall Study|Progressive disease|3|||
13215428|NCT01874288|26264710|FG003|Overall Study|Progressive disease|5|||
13215429|NCT01874288|26264711|FG004|Overall Study|Progressive disease|1|||
13215430|NCT01874275|26264730|FG000|Overall Study|Lost to Follow-up|1|||
13215431|NCT01874275|26264731|FG001|Overall Study|Lost to Follow-up|0|||
13215432|NCT01874145|26264774|FG000|Core Period|Non-compliance|1|||
13215433|NCT01874145|26264775|FG001|Core Period|Non-compliance|0|||
13215434|NCT01874145|26264774|FG000|Core Period|Protocol Violation|1|||
13215435|NCT01874145|26264775|FG001|Core Period|Protocol Violation|1|||
13215436|NCT01874145|26264774|FG000|Core Period|Physician Decision|1|||
13215437|NCT01874145|26264775|FG001|Core Period|Physician Decision|1|||
13215438|NCT01874145|26264774|FG000|Core Period|Adverse Event|0|||
13215439|NCT01874145|26264775|FG001|Core Period|Adverse Event|1|||
13215440|NCT01874145|26264774|FG000|Core Period|Withdrawal by Subject|0|||
13215441|NCT01874145|26264775|FG001|Core Period|Withdrawal by Subject|4|||
13215442|NCT01874145|26264774|FG000|Extension Period|Adverse Event|3|||
13215443|NCT01874145|26264775|FG001|Extension Period|Adverse Event|2|||
13215444|NCT01874145|26264774|FG000|Extension Period|Withdrawal by Subject|2|||
13215445|NCT01874145|26264775|FG001|Extension Period|Withdrawal by Subject|1|||
13215446|NCT01874145|26264774|FG000|Extension Period|Lost to Follow-up|1|||
13215447|NCT01874145|26264775|FG001|Extension Period|Lost to Follow-up|1|||
13215448|NCT01874054|26264786|FG000|Overall Study|Withdrawal by Subject|3|||
13215449|NCT01874054|26264786|FG000|Overall Study|Study Termination by Sponsor|42|||
13215450|NCT01874054|26264786|FG000|Overall Study|Lost to Follow-up|5|||
13381996|NCT00748540|26749605|FG000|Overall Study|Physician Decision|1|||
13394777|NCT00654381|26788098|FG001|2nd Stage|Investigator's decision|0|||
13215451|NCT01874054|26264786|FG000|Overall Study|Death|5|||
13215452|NCT01873950|26264827|FG000|Period 5|Withdrawal by Subject|0|||
13215453|NCT01873950|26264828|FG001|Period 5|Withdrawal by Subject|0|||
13215454|NCT01873950|26264829|FG002|Period 5|Withdrawal by Subject|0|||
13215455|NCT01873950|26264830|FG003|Period 5|Withdrawal by Subject|1|||
13215456|NCT01873950|26264831|FG004|Period 5|Withdrawal by Subject|0|||
13215457|NCT01873859|26264846|FG000|Overall Study|Withdrawal by Subject|0|||
13215458|NCT01873859|26264847|FG001|Overall Study|Withdrawal by Subject|4|||
13215459|NCT01873742|26264860|FG000|Overall Study|Lost to Follow-up|68|||
13215460|NCT01873742|26264861|FG001|Overall Study|Lost to Follow-up|76|||
13215461|NCT01873729|26264868|FG000|Overall Study|Withdrawal by Subject|1|||
13215462|NCT01873586|26264883|FG000|Overall Study|Lost to Follow-up|3|||
13215463|NCT01873495|26264893|FG000|Overall Study|Withdrawal by Subject|1|||
13215464|NCT01873495|26264893|FG000|Overall Study|Physician Decision|3|||
13215465|NCT01873495|26264893|FG000|Overall Study|Adverse Event|1|||
13215466|NCT01873495|26264893|FG000|Overall Study|Removed for Transplantation|1|||
13215467|NCT01873495|26264893|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1|||
13215468|NCT01873417|26264906|FG000|Overall Study|Did Not Receive Any Study Drug|4|||
13215469|NCT01873417|26264906|FG000|Overall Study|Adverse Event|24|||
13215470|NCT01873417|26264906|FG000|Overall Study|Lost to Follow-up|2|||
13215471|NCT01873417|26264906|FG000|Overall Study|Withdrawal by Subject|2|||
13215472|NCT01873417|26264906|FG000|Overall Study|Physician Decision|3|||
13215473|NCT01872910|26264965|FG000|Overall Study|Lost to Follow-up|2|||
13215474|NCT01872910|26264966|FG001|Overall Study|Lost to Follow-up|0|||
13215475|NCT01872910|26264967|FG002|Overall Study|Lost to Follow-up|2|||
13215476|NCT01872910|26264968|FG003|Overall Study|Lost to Follow-up|0|||
13215477|NCT01872910|26264969|FG004|Overall Study|Lost to Follow-up|0|||
13215478|NCT01872910|26264970|FG005|Overall Study|Lost to Follow-up|0|||
13215479|NCT01872715|26264987|FG000|Overall Study|Adverse Event|1|||
13215480|NCT01872715|26264987|FG000|Overall Study|Protocol Violation|1|||
13215481|NCT01872715|26264987|FG000|Overall Study|Withdrawal by Subject|2|||
13215482|NCT01872689|26265074|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
13215483|NCT01872689|26265075|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1|||
13215484|NCT01872689|26265076|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
13215485|NCT01872689|26265077|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
13215486|NCT01872689|26265074|FG000|Double-Blind/Placebo-Controlled Period|Other|1|||
13215487|NCT01872689|26265075|FG001|Double-Blind/Placebo-Controlled Period|Other|1|||
13215488|NCT01872689|26265076|FG002|Double-Blind/Placebo-Controlled Period|Other|6|||
13215489|NCT01872689|26265077|FG003|Double-Blind/Placebo-Controlled Period|Other|3|||
13215490|NCT01872689|26265074|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9|||
13215491|NCT01872689|26265075|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8|||
13215492|NCT01872689|26265076|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14|||
13215493|NCT01872689|26265077|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16|||
13215494|NCT01872689|26265074|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
13215495|NCT01872689|26265075|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
13215496|NCT01872689|26265076|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
13215497|NCT01872689|26265077|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
13215498|NCT01872689|26265074|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0|||
13215499|NCT01872689|26265075|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
13215500|NCT01872689|26265076|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
13215501|NCT01872689|26265077|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1|||
13215502|NCT01872689|26265074|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
13215503|NCT01872689|26265075|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
13215504|NCT01872689|26265076|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
13215505|NCT01872689|26265077|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
13215506|NCT01872689|26265074|FG000|Double-Blind/Placebo-Controlled Period|Death|3|||
13215507|NCT01872689|26265075|FG001|Double-Blind/Placebo-Controlled Period|Death|4|||
13215508|NCT01872689|26265076|FG002|Double-Blind/Placebo-Controlled Period|Death|14|||
13215509|NCT01872689|26265077|FG003|Double-Blind/Placebo-Controlled Period|Death|9|||
13215510|NCT01872689|26265074|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6|||
13215511|NCT01872689|26265075|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3|||
13215512|NCT01872689|26265076|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10|||
13215513|NCT01872689|26265077|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7|||
13215514|NCT01872689|26265074|FG000|Open-Label Period (Only For Monotherapy)|Other|2|||
13215515|NCT01872689|26265075|FG001|Open-Label Period (Only For Monotherapy)|Other|3|||
13215516|NCT01872689|26265076|FG002|Open-Label Period (Only For Monotherapy)|Other|0|||
13215517|NCT01872689|26265077|FG003|Open-Label Period (Only For Monotherapy)|Other|0|||
13215518|NCT01872689|26265074|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11|||
13215519|NCT01872689|26265075|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12|||
13215520|NCT01872689|26265076|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
13215521|NCT01872689|26265077|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
13215522|NCT01872689|26265074|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
13215523|NCT01872689|26265075|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1|||
13215524|NCT01872689|26265076|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
13215525|NCT01872689|26265077|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
13215526|NCT01872689|26265074|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1|||
13215527|NCT01872689|26265075|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3|||
13215528|NCT01872689|26265076|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
13215529|NCT01872689|26265077|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
13215530|NCT01872689|26265074|FG000|Open-Label Period (Only For Monotherapy)|Death|5|||
13215531|NCT01872689|26265075|FG001|Open-Label Period (Only For Monotherapy)|Death|3|||
13215532|NCT01872689|26265076|FG002|Open-Label Period (Only For Monotherapy)|Death|0|||
13215533|NCT01872689|26265077|FG003|Open-Label Period (Only For Monotherapy)|Death|0|||
13215534|NCT01872689|26265074|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2|||
13215535|NCT01872689|26265075|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1|||
13215536|NCT01872689|26265076|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
13215537|NCT01872689|26265077|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
13215538|NCT01872611|26265102|FG000|Overall Study|Adverse Event|3|||
13215539|NCT01872611|26265103|FG001|Overall Study|Adverse Event|1|||
13215540|NCT01872611|26265102|FG000|Overall Study|Adverse Event, prior to treatment|0|||
13215541|NCT01872611|26265103|FG001|Overall Study|Adverse Event, prior to treatment|1|||
13215542|NCT01872611|26265102|FG000|Overall Study|Death|0|||
13215543|NCT01872611|26265103|FG001|Overall Study|Death|1|||
13215544|NCT01872611|26265102|FG000|Overall Study|Death, prior to treatment|0|||
13215545|NCT01872611|26265103|FG001|Overall Study|Death, prior to treatment|1|||
13215546|NCT01872611|26265102|FG000|Overall Study|Lost to Follow-up|8|||
13215547|NCT01872611|26265103|FG001|Overall Study|Lost to Follow-up|1|||
13215548|NCT01872611|26265102|FG000|Overall Study|Physician Decision|1|||
13215549|NCT01872611|26265103|FG001|Overall Study|Physician Decision|0|||
13215550|NCT01872611|26265102|FG000|Overall Study|Withdrawal by Subject|6|||
13215551|NCT01872611|26265103|FG001|Overall Study|Withdrawal by Subject|1|||
13215552|NCT01872611|26265102|FG000|Overall Study|Reason not provided|6|||
13215553|NCT01872611|26265103|FG001|Overall Study|Reason not provided|6|||
13215554|NCT01872078|26265126|FG000|Overall Study|Adverse Event|0|||
13215555|NCT01872078|26265127|FG001|Overall Study|Adverse Event|0|||
13215556|NCT01872078|26265128|FG002|Overall Study|Adverse Event|1|||
13215557|NCT01872078|26265129|FG003|Overall Study|Adverse Event|0|||
13215558|NCT01872078|26265126|FG000|Overall Study|Dose administration non-compliance|0|||
13215559|NCT01872078|26265127|FG001|Overall Study|Dose administration non-compliance|0|||
13215560|NCT01872078|26265128|FG002|Overall Study|Dose administration non-compliance|0|||
13215561|NCT01872078|26265129|FG003|Overall Study|Dose administration non-compliance|1|||
13215562|NCT01872078|26265126|FG000|Overall Study|Protocol Violation|0|||
13215563|NCT01872078|26265127|FG001|Overall Study|Protocol Violation|0|||
13215564|NCT01872078|26265128|FG002|Overall Study|Protocol Violation|1|||
13215565|NCT01872078|26265129|FG003|Overall Study|Protocol Violation|0|||
13215566|NCT01872078|26265126|FG000|Overall Study|Withdrawal by Subject|0|||
13215567|NCT01872078|26265127|FG001|Overall Study|Withdrawal by Subject|0|||
13215568|NCT01872078|26265128|FG002|Overall Study|Withdrawal by Subject|1|||
13215569|NCT01872078|26265129|FG003|Overall Study|Withdrawal by Subject|0|||
13215570|NCT01872078|26265126|FG000|Overall Study|Patient met exclusion criterion 16.|0|||
13215571|NCT01872078|26265127|FG001|Overall Study|Patient met exclusion criterion 16.|0|||
13215572|NCT01872078|26265128|FG002|Overall Study|Patient met exclusion criterion 16.|0|||
13215573|NCT01872078|26265129|FG003|Overall Study|Patient met exclusion criterion 16.|1|||
13296781|NCT01369342|26497143|FG002|Overall Study|Not Treated|0|||
13296782|NCT01369329|26497173|FG000|Overall Study|Withdrawal by Subject|8|||
13296783|NCT01369329|26497174|FG001|Overall Study|Withdrawal by Subject|6|||
13296784|NCT01369329|26497175|FG002|Overall Study|Withdrawal by Subject|10|||
13296785|NCT01369329|26497173|FG000|Overall Study|Lost to Follow-up|2|||
13296786|NCT01369329|26497174|FG001|Overall Study|Lost to Follow-up|2|||
13296787|NCT01369329|26497175|FG002|Overall Study|Lost to Follow-up|2|||
13296788|NCT01369329|26497173|FG000|Overall Study|Other|2|||
13296789|NCT01369329|26497174|FG001|Overall Study|Other|3|||
13296790|NCT01369329|26497175|FG002|Overall Study|Other|2|||
13296791|NCT01369225|26497286|FG000|Overall Study|Withdrawal by Subject|1|||
13296792|NCT01369225|26497287|FG001|Overall Study|Withdrawal by Subject|0|||
13296793|NCT01369225|26497288|FG002|Overall Study|Withdrawal by Subject|2|||
13296794|NCT01369225|26497289|FG003|Overall Study|Withdrawal by Subject|1|||
13296795|NCT01369225|26497290|FG004|Overall Study|Withdrawal by Subject|0|||
13296796|NCT01369225|26497291|FG005|Overall Study|Withdrawal by Subject|0|||
13296797|NCT01369225|26497286|FG000|Overall Study|Does Not Meet Entrance Criteria|0|||
13296798|NCT01369225|26497287|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
13296799|NCT01369225|26497288|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
13296800|NCT01369225|26497289|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
13296801|NCT01369225|26497290|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
13296802|NCT01369225|26497291|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
13296803|NCT01369225|26497286|FG000|Overall Study|Other|1|||
13296804|NCT01369225|26497287|FG001|Overall Study|Other|0|||
13296805|NCT01369225|26497288|FG002|Overall Study|Other|0|||
13296806|NCT01369225|26497289|FG003|Overall Study|Other|0|||
13296807|NCT01369225|26497290|FG004|Overall Study|Other|1|||
13296808|NCT01369225|26497291|FG005|Overall Study|Other|0|||
13296809|NCT01369225|26497286|FG000|Overall Study|Adverse Event|0|||
13296810|NCT01369225|26497287|FG001|Overall Study|Adverse Event|0|||
13296811|NCT01369225|26497288|FG002|Overall Study|Adverse Event|0|||
13296812|NCT01369225|26497289|FG003|Overall Study|Adverse Event|1|||
13296813|NCT01369225|26497290|FG004|Overall Study|Adverse Event|1|||
13296814|NCT01369225|26497291|FG005|Overall Study|Adverse Event|0|||
13296815|NCT01369199|26497316|FG000|Overall Study|Withdrawal by Subject|1|||
13296816|NCT01369199|26497316|FG000|Overall Study|Lost to Follow-up|2|||
13296817|NCT01369069|26497339|FG000|Overall Study|Lost to Follow-up|8|||
13296818|NCT01369069|26497340|FG001|Overall Study|Lost to Follow-up|9|||
13296819|NCT01369069|26497339|FG000|Overall Study|Withdrawal by Subject|9|||
13296820|NCT01369069|26497340|FG001|Overall Study|Withdrawal by Subject|7|||
13296821|NCT01368965|26497351|FG000|Overall Study|Lost to Follow-up|12|||
13296822|NCT01368900|26497363|FG000|Overall Study|Lost to Follow-up|7|||
13296823|NCT01368835|26497372|FG000|Overall Study|Inclusion criteria/photography quality|22|||
13296824|NCT01368835|26497372|FG000|Overall Study|Lost to Follow-up|11|||
13296825|NCT01368614|26497430|FG000|Screening Period|Screen Failure|58|||
13296826|NCT01368614|26497431|FG001|Screening Period|Screen Failure|0|||
13296827|NCT01368614|26497432|FG002|Screening Period|Screen Failure|0|||
13296828|NCT01368614|26497433|FG003|Screening Period|Screen Failure|0|||
13296829|NCT01368614|26497430|FG000|Study Period|Withdrawal by Subject|0|||
13296830|NCT01368614|26497431|FG001|Study Period|Withdrawal by Subject|1|||
13296831|NCT01368614|26497432|FG002|Study Period|Withdrawal by Subject|1|||
13296832|NCT01368614|26497433|FG003|Study Period|Withdrawal by Subject|3|||
13296833|NCT01368614|26497430|FG000|Study Period|Lost to Follow-up|0|||
13296834|NCT01368614|26497431|FG001|Study Period|Lost to Follow-up|0|||
13296835|NCT01368614|26497432|FG002|Study Period|Lost to Follow-up|1|||
13296836|NCT01368614|26497433|FG003|Study Period|Lost to Follow-up|0|||
13296837|NCT01368562|26497439|FG000|Overall Study|Adverse Event|1|||
13296838|NCT01368562|26497439|FG000|Overall Study|Disease progression|1|||
13296839|NCT01368562|26497439|FG000|Overall Study|Lost to Follow-up|1|||
13296840|NCT01368562|26497439|FG000|Overall Study|Death|6|||
13296841|NCT01368562|26497439|FG000|Overall Study|Unresponsive to treatment|5|||
13296842|NCT01368562|26497439|FG000|Overall Study|Other|3|||
13296843|NCT01368562|26497439|FG000|Overall Study|Other than specified|2|||
13296844|NCT01368536|26497470|FG000|Overall Study|Adverse Event|5|||
13296845|NCT01368536|26497471|FG001|Overall Study|Adverse Event|6|||
13296846|NCT01368536|26497472|FG002|Overall Study|Adverse Event|8|||
13296847|NCT01368536|26497470|FG000|Overall Study|Abnormal laboratory value(s)|0|||
13215574|NCT01871870|26265136|FG000|Overall Study|Hardware issues|7|||
13215575|NCT01871870|26265136|FG000|Overall Study|hyperglycemia|2|||
13215576|NCT01871805|26265225|FG000|Phase I|Death|7|||
13215577|NCT01871805|26265226|FG001|Phase I|Death|4|||
13215578|NCT01871805|26265227|FG002|Phase I|Death|6|||
13215579|NCT01871805|26265228|FG003|Phase I|Death|2|||
13215580|NCT01871805|26265229|FG004|Phase I|Death|9|||
13215581|NCT01871805|26265230|FG005|Phase I|Death|0|||
13215582|NCT01871805|26265225|FG000|Phase I|Alive in Survival Follow-up|0|||
13215583|NCT01871805|26265226|FG001|Phase I|Alive in Survival Follow-up|2|||
13215584|NCT01871805|26265227|FG002|Phase I|Alive in Survival Follow-up|4|||
13215585|NCT01871805|26265228|FG003|Phase I|Alive in Survival Follow-up|5|||
13215586|NCT01871805|26265229|FG004|Phase I|Alive in Survival Follow-up|4|||
13215587|NCT01871805|26265230|FG005|Phase I|Alive in Survival Follow-up|0|||
13215588|NCT01871805|26265225|FG000|Phase I|Lost to Follow-up|0|||
13215589|NCT01871805|26265226|FG001|Phase I|Lost to Follow-up|1|||
13215590|NCT01871805|26265227|FG002|Phase I|Lost to Follow-up|3|||
13215591|NCT01871805|26265228|FG003|Phase I|Lost to Follow-up|0|||
13215592|NCT01871805|26265229|FG004|Phase I|Lost to Follow-up|0|||
13215593|NCT01871805|26265230|FG005|Phase I|Lost to Follow-up|0|||
13215594|NCT01871805|26265225|FG000|Phase II|Death|0|||
13215595|NCT01871805|26265226|FG001|Phase II|Death|0|||
13215596|NCT01871805|26265227|FG002|Phase II|Death|0|||
13215597|NCT01871805|26265228|FG003|Phase II|Death|0|||
13215598|NCT01871805|26265229|FG004|Phase II|Death|0|||
13215599|NCT01871805|26265230|FG005|Phase II|Death|45|||
13215600|NCT01871805|26265225|FG000|Phase II|Alive in Survival Follow-up|0|||
13215601|NCT01871805|26265226|FG001|Phase II|Alive in Survival Follow-up|0|||
13215602|NCT01871805|26265227|FG002|Phase II|Alive in Survival Follow-up|0|||
13215603|NCT01871805|26265228|FG003|Phase II|Alive in Survival Follow-up|0|||
13215604|NCT01871805|26265229|FG004|Phase II|Alive in Survival Follow-up|0|||
13215605|NCT01871805|26265230|FG005|Phase II|Alive in Survival Follow-up|29|||
13215606|NCT01871805|26265225|FG000|Phase II|Lost to Follow-up|0|||
13215607|NCT01871805|26265226|FG001|Phase II|Lost to Follow-up|0|||
13215608|NCT01871805|26265227|FG002|Phase II|Lost to Follow-up|0|||
13215609|NCT01871805|26265228|FG003|Phase II|Lost to Follow-up|0|||
13215610|NCT01871805|26265229|FG004|Phase II|Lost to Follow-up|0|||
13215611|NCT01871805|26265230|FG005|Phase II|Lost to Follow-up|13|||
13215612|NCT01871558|26265255|FG000|Overall Study|Other reason|0|||
13215613|NCT01871558|26265256|FG001|Overall Study|Other reason|1|||
13215614|NCT01871558|26265255|FG000|Overall Study|antidiabetic drug prematurely stopped|1|||
13215615|NCT01871558|26265256|FG001|Overall Study|antidiabetic drug prematurely stopped|1|||
13215616|NCT01871558|26265255|FG000|Overall Study|Withdrawal by Subject|2|||
13215617|NCT01871558|26265256|FG001|Overall Study|Withdrawal by Subject|0|||
13215618|NCT01871545|26265302|FG000|Overall Study|Death|2|||
13215619|NCT01871545|26265303|FG001|Overall Study|Death|0|||
13215620|NCT01871545|26265302|FG000|Overall Study|Lack of Efficacy|11|||
13215621|NCT01871545|26265303|FG001|Overall Study|Lack of Efficacy|2|||
13215622|NCT01871545|26265302|FG000|Overall Study|Physician Decision|4|||
13215623|NCT01871545|26265303|FG001|Overall Study|Physician Decision|0|||
13215624|NCT01871545|26265302|FG000|Overall Study|Withdrawal by Subject|0|||
13215625|NCT01871545|26265303|FG001|Overall Study|Withdrawal by Subject|1|||
13215626|NCT01871532|26265344|FG000|Overall Study|Withdrawal by Subject|1|||
13215627|NCT01871532|26265345|FG001|Overall Study|Withdrawal by Subject|2|||
13215628|NCT01871519|26265368|FG000|Overall Study|Death|26|||
13215629|NCT01871519|26265368|FG000|Overall Study|Lost to Follow-up|15|||
13215630|NCT01871519|26265368|FG000|Overall Study|Withdrawal by Subject|49|||
13215631|NCT01871402|26265391|FG000|Overall Study|Lost to Follow-up|1|||
13215632|NCT01871402|26265392|FG001|Overall Study|Lost to Follow-up|0|||
13215633|NCT01871402|26265391|FG000|Overall Study|Withdrawal by Subject|0|||
13215634|NCT01871402|26265392|FG001|Overall Study|Withdrawal by Subject|2|||
13215635|NCT01871402|26265391|FG000|Overall Study|Non-compliance|0|||
13215636|NCT01871402|26265392|FG001|Overall Study|Non-compliance|1|||
13215637|NCT01871285|26265427|FG000|First Intervention (1 Day)|Adverse Event|1|||
13215638|NCT01871285|26265428|FG001|First Intervention (1 Day)|Adverse Event|0|||
13215639|NCT01871285|26265429|FG002|First Intervention (1 Day)|Adverse Event|0|||
13215640|NCT01871285|26265430|FG003|First Intervention (1 Day)|Adverse Event|0|||
13215641|NCT01871285|26265427|FG000|First Intervention (1 Day)|Lost to Follow-up|0|||
13215642|NCT01871285|26265428|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
13215643|NCT01871285|26265429|FG002|First Intervention (1 Day)|Lost to Follow-up|1|||
13215644|NCT01871285|26265430|FG003|First Intervention (1 Day)|Lost to Follow-up|0|||
13215645|NCT01871142|26265446|FG000|Overall Study|Adverse Event|1|||
13215646|NCT01871090|26265463|FG000|Overall Study|Interrogation not done in Emergency Room|1|||
13215647|NCT01871090|26265464|FG001|Overall Study|Interrogation not done in Emergency Room|22|||
13215648|NCT01871090|26265463|FG000|Overall Study|Interrogation not completed correctly|1|||
13215649|NCT01871090|26265464|FG001|Overall Study|Interrogation not completed correctly|0|||
13215650|NCT01871090|26265463|FG000|Overall Study|Subject Non-Compliance|0|||
13215651|NCT01871090|26265464|FG001|Overall Study|Subject Non-Compliance|1|||
13215652|NCT01870999|26265530|FG000|Overall Study|Adverse Event|0|||
13215653|NCT01870999|26265531|FG001|Overall Study|Adverse Event|4|||
13215654|NCT01870999|26265532|FG002|Overall Study|Adverse Event|1|||
13215655|NCT01870999|26265530|FG000|Overall Study|Subject met withdrawal criteria|3|||
13215656|NCT01870999|26265531|FG001|Overall Study|Subject met withdrawal criteria|2|||
13215657|NCT01870999|26265532|FG002|Overall Study|Subject met withdrawal criteria|0|||
13215658|NCT01870999|26265530|FG000|Overall Study|Subject withdrawn by Investigator|1|||
13215659|NCT01870999|26265531|FG001|Overall Study|Subject withdrawn by Investigator|0|||
13215660|NCT01870999|26265532|FG002|Overall Study|Subject withdrawn by Investigator|0|||
13215661|NCT01870999|26265530|FG000|Overall Study|Withdrawal by Subject|0|||
13215662|NCT01870999|26265531|FG001|Overall Study|Withdrawal by Subject|2|||
13215663|NCT01870999|26265532|FG002|Overall Study|Withdrawal by Subject|5|||
13215664|NCT01870999|26265530|FG000|Overall Study|Protocol Violation|0|||
13215665|NCT01870999|26265531|FG001|Overall Study|Protocol Violation|0|||
13215666|NCT01870999|26265532|FG002|Overall Study|Protocol Violation|1|||
13215667|NCT01870973|26265545|FG000|Overall Study|Lost to Follow-up|10|||
13215668|NCT01870973|26265546|FG001|Overall Study|Lost to Follow-up|3|||
13215669|NCT01870921|26265554|FG000|Overall Study|Subject decision|80|||
13215670|NCT01870921|26265554|FG000|Overall Study|Severe non-compliance to protocol|7|||
13215671|NCT01870921|26265554|FG000|Overall Study|Subject Lost to Follow up|2|||
13215672|NCT01870921|26265554|FG000|Overall Study|Other|1|||
13215673|NCT01870869|26265593|FG000|Overall Study|Implanted with nonstudy device|1|||
13215674|NCT01870869|26265594|FG001|Overall Study|Implanted with nonstudy device|3|||
13215675|NCT01870869|26265595|FG002|Overall Study|Implanted with nonstudy device|14|||
13215676|NCT01870869|26265596|FG003|Overall Study|Implanted with nonstudy device|4|||
13215677|NCT01870869|26265593|FG000|Overall Study|Death|0|||
13215678|NCT01870869|26265594|FG001|Overall Study|Death|0|||
13215679|NCT01870869|26265595|FG002|Overall Study|Death|7|||
13215680|NCT01870869|26265596|FG003|Overall Study|Death|1|||
13215681|NCT01870869|26265593|FG000|Overall Study|Subject choice|6|||
13215682|NCT01870869|26265594|FG001|Overall Study|Subject choice|2|||
13215683|NCT01870869|26265595|FG002|Overall Study|Subject choice|22|||
13215684|NCT01870869|26265596|FG003|Overall Study|Subject choice|8|||
13215685|NCT01870869|26265593|FG000|Overall Study|Lost to Follow-up|10|||
13215686|NCT01870869|26265594|FG001|Overall Study|Lost to Follow-up|2|||
13215687|NCT01870869|26265595|FG002|Overall Study|Lost to Follow-up|25|||
13215688|NCT01870869|26265596|FG003|Overall Study|Lost to Follow-up|3|||
13215689|NCT01870869|26265593|FG000|Overall Study|Reason not Specified|1|||
13215690|NCT01870869|26265594|FG001|Overall Study|Reason not Specified|2|||
13215691|NCT01870869|26265595|FG002|Overall Study|Reason not Specified|20|||
13215692|NCT01870869|26265596|FG003|Overall Study|Reason not Specified|4|||
13215693|NCT01870869|26265593|FG000|Overall Study|Not evaluable|10|||
13215694|NCT01870869|26265594|FG001|Overall Study|Not evaluable|5|||
13215695|NCT01870869|26265595|FG002|Overall Study|Not evaluable|42|||
13215696|NCT01870869|26265596|FG003|Overall Study|Not evaluable|10|||
13215697|NCT01870843|26265611|FG000|Overall Study|Adverse Event|10|||
13215698|NCT01870843|26265611|FG000|Overall Study|Lost to Follow-up|24|||
13215699|NCT01870843|26265611|FG000|Overall Study|Death|1|||
13215700|NCT01870843|26265611|FG000|Overall Study|Withdrawal by Subject|18|||
13215701|NCT01870778|26265642|FG000|Overall Study|Withdrawal by Subject|8|||
13215702|NCT01870778|26265643|FG001|Overall Study|Withdrawal by Subject|7|||
13215703|NCT01870778|26265642|FG000|Overall Study|Lost to Follow-up|0|||
13215704|NCT01870778|26265643|FG001|Overall Study|Lost to Follow-up|2|||
13215705|NCT01870739|26265682|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0|||
13215706|NCT01870739|26265683|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1|||
13215707|NCT01870739|26265682|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0|||
13215708|NCT01870739|26265683|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1|||
13215709|NCT01870739|26265682|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3|||
13215710|NCT01870739|26265683|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2|||
13215711|NCT01870739|26265682|FG000|Add-on Period (40 Weeks)|Adverse Event|0|||
13215712|NCT01870739|26265683|FG001|Add-on Period (40 Weeks)|Adverse Event|1|||
13215713|NCT01870739|26265682|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1|||
13215714|NCT01870739|26265683|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0|||
13215715|NCT01870739|26265682|FG000|Add-on Period (40 Weeks)|Protocol deviation|1|||
13215716|NCT01870739|26265683|FG001|Add-on Period (40 Weeks)|Protocol deviation|1|||
13215717|NCT01870739|26265682|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1|||
13215718|NCT01870739|26265683|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0|||
13215719|NCT01870726|26265788|FG000|Overall Study|Withdrawal of informed consent|0|||
13215720|NCT01870726|26265789|FG001|Overall Study|Withdrawal of informed consent|0|||
13215721|NCT01870726|26265790|FG002|Overall Study|Withdrawal of informed consent|0|||
13215722|NCT01870726|26265791|FG003|Overall Study|Withdrawal of informed consent|1|||
13215723|NCT01870726|26265792|FG004|Overall Study|Withdrawal of informed consent|0|||
13215724|NCT01870726|26265793|FG005|Overall Study|Withdrawal of informed consent|0|||
13215725|NCT01870726|26265794|FG006|Overall Study|Withdrawal of informed consent|0|||
13215726|NCT01870726|26265788|FG000|Overall Study|Withdrawal by Subject|0|||
13215727|NCT01870726|26265789|FG001|Overall Study|Withdrawal by Subject|1|||
13215728|NCT01870726|26265790|FG002|Overall Study|Withdrawal by Subject|0|||
13215729|NCT01870726|26265791|FG003|Overall Study|Withdrawal by Subject|0|||
13215730|NCT01870726|26265792|FG004|Overall Study|Withdrawal by Subject|0|||
13215731|NCT01870726|26265793|FG005|Overall Study|Withdrawal by Subject|0|||
13215732|NCT01870726|26265794|FG006|Overall Study|Withdrawal by Subject|0|||
13215733|NCT01870726|26265788|FG000|Overall Study|Adverse Event|0|||
13215734|NCT01870726|26265789|FG001|Overall Study|Adverse Event|0|||
13215735|NCT01870726|26265790|FG002|Overall Study|Adverse Event|0|||
13215736|NCT01870726|26265791|FG003|Overall Study|Adverse Event|0|||
13215737|NCT01870726|26265792|FG004|Overall Study|Adverse Event|1|||
13215738|NCT01870726|26265793|FG005|Overall Study|Adverse Event|1|||
13215739|NCT01870726|26265794|FG006|Overall Study|Adverse Event|0|||
13215740|NCT01870726|26265788|FG000|Overall Study|Progressive disease|5|||
13215741|NCT01870726|26265789|FG001|Overall Study|Progressive disease|5|||
13215742|NCT01870726|26265790|FG002|Overall Study|Progressive disease|4|||
13215743|NCT01870726|26265791|FG003|Overall Study|Progressive disease|5|||
13215744|NCT01870726|26265792|FG004|Overall Study|Progressive disease|6|||
13215745|NCT01870726|26265793|FG005|Overall Study|Progressive disease|4|||
13215746|NCT01870726|26265794|FG006|Overall Study|Progressive disease|10|||
13215747|NCT01870583|26265812|FG000|Overall Study|Protocol Violation|0|||
13215748|NCT01870583|26265813|FG001|Overall Study|Protocol Violation|5|||
13215749|NCT01870583|26265814|FG002|Overall Study|Protocol Violation|3|||
13215750|NCT01870583|26265812|FG000|Overall Study|Lost to Follow-up|11|||
13215751|NCT01870583|26265813|FG001|Overall Study|Lost to Follow-up|13|||
13215752|NCT01870583|26265814|FG002|Overall Study|Lost to Follow-up|5|||
13215753|NCT01870401|26265879|FG000|Overall Study|Death|48|||
13215754|NCT01870401|26265880|FG001|Overall Study|Death|24|||
13215755|NCT01870401|26265879|FG000|Overall Study|Withdrawal by Subject|39|||
13215756|NCT01870401|26265880|FG001|Overall Study|Withdrawal by Subject|26|||
13215757|NCT01870401|26265879|FG000|Overall Study|Lost to Follow-up|19|||
13215758|NCT01870401|26265880|FG001|Overall Study|Lost to Follow-up|14|||
13215759|NCT01870401|26265879|FG000|Overall Study|Other|9|||
13215760|NCT01870401|26265880|FG001|Overall Study|Other|7|||
13215761|NCT01870401|26265879|FG000|Overall Study|On-going in the Study|35|||
13215762|NCT01870401|26265880|FG001|Overall Study|On-going in the Study|25|||
13215763|NCT01870297|26265942|FG000|Overall Study|Adverse Event|0|||
13215764|NCT01870297|26265943|FG001|Overall Study|Adverse Event|0|||
13215765|NCT01870297|26265944|FG002|Overall Study|Adverse Event|0|||
13215766|NCT01870297|26265945|FG003|Overall Study|Adverse Event|0|||
13215767|NCT01870297|26265946|FG004|Overall Study|Adverse Event|2|||
13215768|NCT01870297|26265947|FG005|Overall Study|Adverse Event|0|||
13215769|NCT01870297|26265948|FG006|Overall Study|Adverse Event|0|||
13215770|NCT01870297|26265942|FG000|Overall Study|Lost to Follow-up|0|||
13215771|NCT01870297|26265943|FG001|Overall Study|Lost to Follow-up|1|||
13215772|NCT01870297|26265944|FG002|Overall Study|Lost to Follow-up|1|||
13215773|NCT01870297|26265945|FG003|Overall Study|Lost to Follow-up|0|||
13215774|NCT01870297|26265946|FG004|Overall Study|Lost to Follow-up|0|||
13215775|NCT01870297|26265947|FG005|Overall Study|Lost to Follow-up|0|||
13215776|NCT01870297|26265948|FG006|Overall Study|Lost to Follow-up|0|||
13215777|NCT01870297|26265942|FG000|Overall Study|Withdrawal by Subject|0|||
13215778|NCT01870297|26265943|FG001|Overall Study|Withdrawal by Subject|0|||
13215779|NCT01870297|26265944|FG002|Overall Study|Withdrawal by Subject|0|||
13215780|NCT01870297|26265945|FG003|Overall Study|Withdrawal by Subject|0|||
13215781|NCT01870297|26265946|FG004|Overall Study|Withdrawal by Subject|1|||
13215782|NCT01870297|26265947|FG005|Overall Study|Withdrawal by Subject|1|||
13215783|NCT01870297|26265948|FG006|Overall Study|Withdrawal by Subject|1|||
13215784|NCT01870297|26265942|FG000|Overall Study|Sponsor Decision|0|||
13215785|NCT01870297|26265943|FG001|Overall Study|Sponsor Decision|6|||
13215786|NCT01870297|26265944|FG002|Overall Study|Sponsor Decision|0|||
13215787|NCT01870297|26265945|FG003|Overall Study|Sponsor Decision|0|||
13215788|NCT01870297|26265946|FG004|Overall Study|Sponsor Decision|0|||
13215789|NCT01870297|26265947|FG005|Overall Study|Sponsor Decision|0|||
13215790|NCT01870297|26265948|FG006|Overall Study|Sponsor Decision|1|||
13215791|NCT01870076|26265975|FG000|Overall Study|Withdrawal by Subject|1|||
13215792|NCT01870076|26265976|FG001|Overall Study|Withdrawal by Subject|0|||
13215793|NCT01870076|26265977|FG002|Overall Study|Withdrawal by Subject|1|||
13215794|NCT01870076|26265978|FG003|Overall Study|Withdrawal by Subject|0|||
13215795|NCT01869959|26266060|FG000|Randomization Period|Physician Decision|0|||
13215796|NCT01869959|26266061|FG001|Randomization Period|Physician Decision|0|||
13215797|NCT01869959|26266062|FG002|Randomization Period|Physician Decision|0|||
13215798|NCT01869959|26266063|FG003|Randomization Period|Physician Decision|0|||
13215799|NCT01869959|26266064|FG004|Randomization Period|Physician Decision|1|||
13215800|NCT01869959|26266060|FG000|Treatment Period|Adverse Event|1|||
13215801|NCT01869959|26266061|FG001|Treatment Period|Adverse Event|0|||
13215802|NCT01869959|26266062|FG002|Treatment Period|Adverse Event|3|||
13215803|NCT01869959|26266063|FG003|Treatment Period|Adverse Event|1|||
13215804|NCT01869959|26266064|FG004|Treatment Period|Adverse Event|0|||
13215805|NCT01869959|26266060|FG000|Treatment Period|Sponsor decision|0|||
13215806|NCT01869959|26266061|FG001|Treatment Period|Sponsor decision|1|||
13215807|NCT01869959|26266062|FG002|Treatment Period|Sponsor decision|0|||
13215808|NCT01869959|26266063|FG003|Treatment Period|Sponsor decision|1|||
13215809|NCT01869959|26266064|FG004|Treatment Period|Sponsor decision|0|||
13215810|NCT01869959|26266060|FG000|Treatment Period|Withdrawal by Subject|0|||
13215811|NCT01869959|26266061|FG001|Treatment Period|Withdrawal by Subject|1|||
13215812|NCT01869959|26266062|FG002|Treatment Period|Withdrawal by Subject|0|||
13215813|NCT01869959|26266063|FG003|Treatment Period|Withdrawal by Subject|0|||
13215814|NCT01869959|26266064|FG004|Treatment Period|Withdrawal by Subject|0|||
13215815|NCT01869777|26266077|FG000|Overall Study|Excluded from the analysis, ineligible|1|||
13215816|NCT01869764|26266100|FG000|Overall Study|Withdrawal by Subject|0|||
13215817|NCT01869764|26266101|FG001|Overall Study|Withdrawal by Subject|2|||
13215818|NCT01869725|26266109|FG000|Overall Study|ineligible after registration|1|||
13215819|NCT01869725|26266109|FG000|Overall Study|Death|1|||
13215820|NCT01869725|26266109|FG000|Overall Study|Lost to Follow-up|2|||
13215821|NCT01869699|26266134|FG000|Overall Study|Withdrawal by Subject|1|||
13215822|NCT01869699|26266135|FG001|Overall Study|Withdrawal by Subject|0|||
13215823|NCT01869348|26266148|FG000|Overall Study|Withdrawal by Subject|1|||
13215824|NCT01869348|26266149|FG001|Overall Study|Withdrawal by Subject|1|||
13215825|NCT01869192|26266164|FG000|Preoperative Chemotherapy to Surgery|patient choice|2|||
13215826|NCT01869192|26266165|FG001|Preoperative Chemotherapy to Surgery|patient choice|1|||
13215827|NCT01869192|26266164|FG000|Postoperative Chemotherapy|Physician Decision|0|||
13215828|NCT01869192|26266165|FG001|Postoperative Chemotherapy|Physician Decision|2|||
13215829|NCT01868997|26266188|FG000|Overall Study|Adverse Event|2|||
13215830|NCT01868997|26266189|FG001|Overall Study|Adverse Event|5|||
13215831|NCT01868997|26266188|FG000|Overall Study|Lack of Efficacy|2|||
13215832|NCT01868997|26266189|FG001|Overall Study|Lack of Efficacy|0|||
13215833|NCT01868997|26266188|FG000|Overall Study|Other|3|||
13215834|NCT01868997|26266189|FG001|Overall Study|Other|1|||
13215835|NCT01868893|26266198|FG000|Overall Study|Adverse Event|2|||
13215836|NCT01868893|26266198|FG000|Overall Study|Commercial availability of study drug|17|||
13215837|NCT01868893|26266198|FG000|Overall Study|Neutropenia|1|||
13215838|NCT01868646|26266231|FG000|Overall Study|Do not meet inclusion criteria|3|||
13215839|NCT01868646|26266232|FG001|Overall Study|Do not meet inclusion criteria|5|||
13215840|NCT01868594|26266257|FG000|Overall Study|Do not meet inclusion criteria|4|||
13215841|NCT01868594|26266258|FG001|Overall Study|Do not meet inclusion criteria|3|||
13215842|NCT01868542|26266283|FG000|Overall Study|Protocol Violation|0|||
13215843|NCT01868542|26266284|FG001|Overall Study|Protocol Violation|1|||
13215844|NCT01868542|26266283|FG000|Overall Study|Unclassified|0|||
13215845|NCT01868542|26266284|FG001|Overall Study|Unclassified|1|||
13215846|NCT01868503|26266294|FG000|Overall Study|Withdrawal by Subject|1|||
13215847|NCT01868503|26266294|FG000|Overall Study|Protocol Violation|1|||
13215848|NCT01868477|26266325|FG000|Overall Study|Adverse Event|2|||
13215849|NCT01868477|26266326|FG001|Overall Study|Adverse Event|4|||
13215850|NCT01868477|26266325|FG000|Overall Study|Disease progression|1|||
13215851|NCT01868477|26266326|FG001|Overall Study|Disease progression|1|||
13215852|NCT01868477|26266325|FG000|Overall Study|Withdrawal by Subject|1|||
13215853|NCT01868477|26266326|FG001|Overall Study|Withdrawal by Subject|0|||
13215854|NCT01868243|26266341|FG000|Overall Study|Death|0|||
13215855|NCT01868243|26266342|FG001|Overall Study|Death|1|||
13215856|NCT01868165|26266348|FG000|Overall Study|Withdrawal by Subject|36|||
13215857|NCT01868165|26266348|FG000|Overall Study|Physician Decision|2|||
13215858|NCT01868165|26266348|FG000|Overall Study|Lost to Follow-up|3|||
13215859|NCT01868165|26266348|FG000|Overall Study|Death|4|||
13215860|NCT01868074|26266365|FG000|Overall Study|Lost to Follow-up|3|||
13215861|NCT01868074|26266366|FG001|Overall Study|Lost to Follow-up|2|||
13215862|NCT01868074|26266365|FG000|Overall Study|Withdrawal by Subject|4|||
13215863|NCT01868074|26266366|FG001|Overall Study|Withdrawal by Subject|2|||
13215864|NCT01868035|26266384|FG000|Overall Study|Lost to Follow-up|3|||
13215865|NCT01868035|26266384|FG000|Overall Study|Withdrawal by Subject|1|||
13215866|NCT01868035|26266384|FG000|Overall Study|Progressive Disease|2|||
13215867|NCT01868035|26266384|FG000|Overall Study|Non-compliance|1|||
13215868|NCT01868022|26266618|FG000|Overall Study|Withdrawal by Subject|0|||
13215869|NCT01868022|26266619|FG001|Overall Study|Withdrawal by Subject|0|||
13215870|NCT01868022|26266620|FG002|Overall Study|Withdrawal by Subject|1|||
13215871|NCT01868022|26266621|FG003|Overall Study|Withdrawal by Subject|1|||
13215872|NCT01868022|26266622|FG004|Overall Study|Withdrawal by Subject|0|||
13215873|NCT01868022|26266623|FG005|Overall Study|Withdrawal by Subject|0|||
13215874|NCT01868022|26266624|FG006|Overall Study|Withdrawal by Subject|0|||
13215875|NCT01868022|26266625|FG007|Overall Study|Withdrawal by Subject|1|||
13215876|NCT01868022|26266626|FG008|Overall Study|Withdrawal by Subject|0|||
13215877|NCT01868022|26266618|FG000|Overall Study|Adverse Event|0|||
13215878|NCT01868022|26266619|FG001|Overall Study|Adverse Event|0|||
13215879|NCT01868022|26266620|FG002|Overall Study|Adverse Event|0|||
13215880|NCT01868022|26266621|FG003|Overall Study|Adverse Event|0|||
13215881|NCT01868022|26266622|FG004|Overall Study|Adverse Event|2|||
13215882|NCT01868022|26266623|FG005|Overall Study|Adverse Event|0|||
13215883|NCT01868022|26266624|FG006|Overall Study|Adverse Event|0|||
13215884|NCT01868022|26266625|FG007|Overall Study|Adverse Event|2|||
13215885|NCT01868022|26266626|FG008|Overall Study|Adverse Event|2|||
13215886|NCT01868022|26266618|FG000|Overall Study|Physician Decision|0|||
13215887|NCT01868022|26266619|FG001|Overall Study|Physician Decision|0|||
13215888|NCT01868022|26266620|FG002|Overall Study|Physician Decision|0|||
13215889|NCT01868022|26266621|FG003|Overall Study|Physician Decision|0|||
13215890|NCT01868022|26266622|FG004|Overall Study|Physician Decision|0|||
13215891|NCT01868022|26266623|FG005|Overall Study|Physician Decision|1|||
13215892|NCT01868022|26266624|FG006|Overall Study|Physician Decision|0|||
13215893|NCT01868022|26266625|FG007|Overall Study|Physician Decision|2|||
13215894|NCT01868022|26266626|FG008|Overall Study|Physician Decision|0|||
13215895|NCT01868022|26266618|FG000|Overall Study|Study closed/terminated|0|||
13215896|NCT01868022|26266619|FG001|Overall Study|Study closed/terminated|0|||
13215897|NCT01868022|26266620|FG002|Overall Study|Study closed/terminated|0|||
13215898|NCT01868022|26266621|FG003|Overall Study|Study closed/terminated|0|||
13215899|NCT01868022|26266622|FG004|Overall Study|Study closed/terminated|0|||
13215900|NCT01868022|26266623|FG005|Overall Study|Study closed/terminated|0|||
13215901|NCT01868022|26266624|FG006|Overall Study|Study closed/terminated|0|||
13215902|NCT01868022|26266625|FG007|Overall Study|Study closed/terminated|1|||
13215903|NCT01868022|26266626|FG008|Overall Study|Study closed/terminated|0|||
13215904|NCT01868022|26266618|FG000|Overall Study|Ongoing|0|||
13215905|NCT01868022|26266619|FG001|Overall Study|Ongoing|0|||
13215906|NCT01868022|26266620|FG002|Overall Study|Ongoing|0|||
13215907|NCT01868022|26266621|FG003|Overall Study|Ongoing|0|||
13215908|NCT01868022|26266622|FG004|Overall Study|Ongoing|0|||
13215909|NCT01868022|26266623|FG005|Overall Study|Ongoing|0|||
13215910|NCT01868022|26266624|FG006|Overall Study|Ongoing|0|||
13215911|NCT01868022|26266625|FG007|Overall Study|Ongoing|3|||
13215912|NCT01868022|26266626|FG008|Overall Study|Ongoing|0|||
13215913|NCT01868009|26266639|FG000|Period 1 (5-9 Days)|Adverse Event|0|||
13215914|NCT01868009|26266640|FG001|Period 1 (5-9 Days)|Adverse Event|2|||
13215915|NCT01868009|26266639|FG000|Period 2 (5-9 Days)|Adverse Event|1|||
13215916|NCT01868009|26266640|FG001|Period 2 (5-9 Days)|Adverse Event|0|||
13215917|NCT01868009|26266639|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1|||
13215918|NCT01868009|26266640|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0|||
13215919|NCT01867710|26266719|FG000|Overall Study|Death|25|||
13215920|NCT01867710|26266720|FG001|Overall Study|Death|15|||
13215921|NCT01867710|26266721|FG002|Overall Study|Death|27|||
13215922|NCT01867710|26266722|FG003|Overall Study|Death|20|||
13215923|NCT01867710|26266719|FG000|Overall Study|Lost to Follow-up|3|||
13215924|NCT01867710|26266720|FG001|Overall Study|Lost to Follow-up|4|||
13215925|NCT01867710|26266721|FG002|Overall Study|Lost to Follow-up|3|||
13215926|NCT01867710|26266722|FG003|Overall Study|Lost to Follow-up|2|||
13215927|NCT01867710|26266719|FG000|Overall Study|Withdrawal of consent|2|||
13215928|NCT01867710|26266720|FG001|Overall Study|Withdrawal of consent|5|||
13215929|NCT01867710|26266721|FG002|Overall Study|Withdrawal of consent|1|||
13215930|NCT01867710|26266722|FG003|Overall Study|Withdrawal of consent|2|||
13215931|NCT01867710|26266719|FG000|Overall Study|Study Terminated by Sponsor|9|||
13215932|NCT01867710|26266720|FG001|Overall Study|Study Terminated by Sponsor|13|||
13215933|NCT01867710|26266721|FG002|Overall Study|Study Terminated by Sponsor|8|||
13215934|NCT01867710|26266722|FG003|Overall Study|Study Terminated by Sponsor|16|||
13296848|NCT01368536|26497471|FG001|Overall Study|Abnormal laboratory value(s)|1|||
13296849|NCT01368536|26497472|FG002|Overall Study|Abnormal laboratory value(s)|2|||
13296850|NCT01368536|26497470|FG000|Overall Study|Abnormal test procedure result(s)|0|||
13296851|NCT01368536|26497471|FG001|Overall Study|Abnormal test procedure result(s)|0|||
13296852|NCT01368536|26497472|FG002|Overall Study|Abnormal test procedure result(s)|1|||
13296853|NCT01368536|26497470|FG000|Overall Study|Unsatisfactory therapeutic effect|7|||
13296854|NCT01368536|26497471|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
13296855|NCT01368536|26497472|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
13296856|NCT01368536|26497470|FG000|Overall Study|No longer required study medication|0|||
13296857|NCT01368536|26497471|FG001|Overall Study|No longer required study medication|0|||
13296858|NCT01368536|26497472|FG002|Overall Study|No longer required study medication|1|||
13296859|NCT01368536|26497470|FG000|Overall Study|Withdrawal by Subject|2|||
13296860|NCT01368536|26497471|FG001|Overall Study|Withdrawal by Subject|5|||
13296861|NCT01368536|26497472|FG002|Overall Study|Withdrawal by Subject|4|||
13296862|NCT01368536|26497470|FG000|Overall Study|Lost to Follow-up|3|||
13296863|NCT01368536|26497471|FG001|Overall Study|Lost to Follow-up|3|||
13296864|NCT01368536|26497472|FG002|Overall Study|Lost to Follow-up|5|||
13296865|NCT01368536|26497470|FG000|Overall Study|Administrative problems|34|||
13296866|NCT01368536|26497471|FG001|Overall Study|Administrative problems|39|||
13296867|NCT01368536|26497472|FG002|Overall Study|Administrative problems|35|||
13296868|NCT01368536|26497470|FG000|Overall Study|Protocol deviation|0|||
13296869|NCT01368536|26497471|FG001|Overall Study|Protocol deviation|3|||
13296870|NCT01368536|26497472|FG002|Overall Study|Protocol deviation|1|||
13296871|NCT01368497|26497501|FG000|Overall Study|Lost to Follow-up|2|||
13296872|NCT01368432|26497540|FG000|Overall Study|Lost to Follow-up|0|||
13296873|NCT01368432|26497541|FG001|Overall Study|Lost to Follow-up|1|||
13296874|NCT01368406|26497554|FG000|Overall Study|Lost to Follow-up|8|||
13296875|NCT01368406|26497555|FG001|Overall Study|Lost to Follow-up|4|||
13296876|NCT01368406|26497554|FG000|Overall Study|Withdrawal by Subject|8|||
13296877|NCT01368406|26497555|FG001|Overall Study|Withdrawal by Subject|4|||
13215935|NCT01867710|26266719|FG000|Overall Study|Biochemical progression|0|||
13215936|NCT01867710|26266720|FG001|Overall Study|Biochemical progression|1|||
13215937|NCT01867710|26266721|FG002|Overall Study|Biochemical progression|0|||
13215938|NCT01867710|26266722|FG003|Overall Study|Biochemical progression|0|||
13215939|NCT01867710|26266719|FG000|Overall Study|Clinical progression|0|||
13215940|NCT01867710|26266720|FG001|Overall Study|Clinical progression|0|||
13215941|NCT01867710|26266721|FG002|Overall Study|Clinical progression|1|||
13215942|NCT01867710|26266722|FG003|Overall Study|Clinical progression|0|||
13215943|NCT01867710|26266719|FG000|Overall Study|Disease progression|1|||
13215944|NCT01867710|26266720|FG001|Overall Study|Disease progression|0|||
13215945|NCT01867710|26266721|FG002|Overall Study|Disease progression|0|||
13215946|NCT01867710|26266722|FG003|Overall Study|Disease progression|0|||
13215947|NCT01867710|26266719|FG000|Overall Study|Patient decision|0|||
13215948|NCT01867710|26266720|FG001|Overall Study|Patient decision|0|||
13215949|NCT01867710|26266721|FG002|Overall Study|Patient decision|0|||
13215950|NCT01867710|26266722|FG003|Overall Study|Patient decision|1|||
13215951|NCT01867710|26266719|FG000|Overall Study|Patient to follow subsequent treatment|0|||
13215952|NCT01867710|26266720|FG001|Overall Study|Patient to follow subsequent treatment|1|||
13215953|NCT01867710|26266721|FG002|Overall Study|Patient to follow subsequent treatment|0|||
13215954|NCT01867710|26266722|FG003|Overall Study|Patient to follow subsequent treatment|0|||
13215955|NCT01867710|26266719|FG000|Overall Study|Progressive disease|1|||
13215956|NCT01867710|26266720|FG001|Overall Study|Progressive disease|0|||
13215957|NCT01867710|26266721|FG002|Overall Study|Progressive disease|0|||
13215958|NCT01867710|26266722|FG003|Overall Study|Progressive disease|0|||
13215959|NCT01867710|26266719|FG000|Overall Study|Protocol Violation|0|||
13215960|NCT01867710|26266720|FG001|Overall Study|Protocol Violation|0|||
13215961|NCT01867710|26266721|FG002|Overall Study|Protocol Violation|0|||
13215962|NCT01867710|26266722|FG003|Overall Study|Protocol Violation|1|||
13215963|NCT01867710|26266719|FG000|Overall Study|PSA-progression|0|||
13215964|NCT01867710|26266720|FG001|Overall Study|PSA-progression|1|||
13215965|NCT01867710|26266721|FG002|Overall Study|PSA-progression|0|||
13215966|NCT01867710|26266722|FG003|Overall Study|PSA-progression|0|||
13215967|NCT01867710|26266719|FG000|Overall Study|Study medication no longer effective|0|||
13215968|NCT01867710|26266720|FG001|Overall Study|Study medication no longer effective|1|||
13215969|NCT01867710|26266721|FG002|Overall Study|Study medication no longer effective|0|||
13215970|NCT01867710|26266722|FG003|Overall Study|Study medication no longer effective|0|||
13215971|NCT01867671|26266742|FG000|Overall Study|Adverse Event|5|||
13215972|NCT01867671|26266743|FG001|Overall Study|Adverse Event|3|||
13215973|NCT01867671|26266742|FG000|Overall Study|Anaphylaxis|0|||
13215974|NCT01867671|26266743|FG001|Overall Study|Anaphylaxis|1|||
13215975|NCT01867671|26266742|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2|||
13215976|NCT01867671|26266743|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0|||
13215977|NCT01867671|26266742|FG000|Overall Study|Lost to Follow-up|0|||
13215978|NCT01867671|26266743|FG001|Overall Study|Lost to Follow-up|1|||
13215979|NCT01867671|26266742|FG000|Overall Study|Non-compliance with Study Drug|1|||
13215980|NCT01867671|26266743|FG001|Overall Study|Non-compliance with Study Drug|2|||
13215981|NCT01867671|26266742|FG000|Overall Study|Withdrawal by Subject|21|||
13215982|NCT01867671|26266743|FG001|Overall Study|Withdrawal by Subject|21|||
13215983|NCT01867658|26266756|FG000|Overall Study|Withdrawal by Subject|6|||
13215984|NCT01867658|26266756|FG000|Overall Study|Death|2|||
13215985|NCT01867658|26266756|FG000|Overall Study|Subject could not be contacted|1|||
13215986|NCT01867606|26266779|FG000|Overall Study|Withdrawal by Subject|10|||
13215987|NCT01867606|26266780|FG001|Overall Study|Withdrawal by Subject|14|||
13215988|NCT01867606|26266779|FG000|Overall Study|Protocol Violation|0|||
13215989|NCT01867606|26266780|FG001|Overall Study|Protocol Violation|1|||
13215990|NCT01867580|26266797|FG000|Overall Study|Withdrawal by Subject|2|||
13215991|NCT01867580|26266798|FG001|Overall Study|Withdrawal by Subject|3|||
13215992|NCT01867580|26266797|FG000|Overall Study|Physician Decision|17|||
13215993|NCT01867580|26266798|FG001|Overall Study|Physician Decision|12|||
13215994|NCT01867580|26266797|FG000|Overall Study|Lost to Follow-up|3|||
13215995|NCT01867580|26266798|FG001|Overall Study|Lost to Follow-up|5|||
13215996|NCT01867580|26266797|FG000|Overall Study|Sponsor terminated study|1|||
13215997|NCT01867580|26266798|FG001|Overall Study|Sponsor terminated study|0|||
13215998|NCT01867580|26266797|FG000|Overall Study|Missed follow-up assessment|2|||
13215999|NCT01867580|26266798|FG001|Overall Study|Missed follow-up assessment|1|||
13216000|NCT01867580|26266797|FG000|Overall Study|Interruption to therapy|3|||
13216001|NCT01867580|26266798|FG001|Overall Study|Interruption to therapy|0|||
13216002|NCT01867580|26266797|FG000|Overall Study|Osteomyelitis|0|||
13216003|NCT01867580|26266798|FG001|Overall Study|Osteomyelitis|1|||
13216004|NCT01867580|26266797|FG000|Overall Study|Continuation of therapy|0|||
13216005|NCT01867580|26266798|FG001|Overall Study|Continuation of therapy|1|||
13216006|NCT01867580|26266797|FG000|Overall Study|Wound recurrence|0|||
13381997|NCT00748241|26749615|FG000|Overall Study|Implant failure|1|||
13216007|NCT01867580|26266798|FG001|Overall Study|Wound recurrence|1|||
13216008|NCT01867424|26266817|FG000|Overall Study|Patient noncompliance|2|||
13216009|NCT01867424|26266818|FG001|Overall Study|Patient noncompliance|1|||
13216010|NCT01867307|26266831|FG000|Overall Study|Protocol Violation|2|||
13216011|NCT01867307|26266832|FG001|Overall Study|Protocol Violation|0|||
13216012|NCT01867307|26266831|FG000|Overall Study|Other Adverse Event|1|||
13216013|NCT01867307|26266832|FG001|Overall Study|Other Adverse Event|3|||
13216014|NCT01867294|26266885|FG000|Overall Study|Withdrawal by Subject|1|||
13216015|NCT01867294|26266886|FG001|Overall Study|Withdrawal by Subject|1|||
13216016|NCT01867294|26266887|FG002|Overall Study|Withdrawal by Subject|0|||
13216017|NCT01867294|26266888|FG003|Overall Study|Withdrawal by Subject|0|||
13216018|NCT01867216|26266965|FG000|Overall Study|Withdrawal by Subject|2|||
13216019|NCT01867216|26266966|FG001|Overall Study|Withdrawal by Subject|0|||
13216020|NCT01867216|26266967|FG002|Overall Study|Withdrawal by Subject|0|||
13216021|NCT01867216|26266968|FG003|Overall Study|Withdrawal by Subject|0|||
13216022|NCT01867216|26266969|FG004|Overall Study|Withdrawal by Subject|1|||
13216023|NCT01867216|26266970|FG005|Overall Study|Withdrawal by Subject|0|||
13216024|NCT01867216|26266971|FG006|Overall Study|Withdrawal by Subject|1|||
13216025|NCT01867216|26266965|FG000|Overall Study|Physician Decision|1|||
13216026|NCT01867216|26266966|FG001|Overall Study|Physician Decision|0|||
13216027|NCT01867216|26266967|FG002|Overall Study|Physician Decision|0|||
13216028|NCT01867216|26266968|FG003|Overall Study|Physician Decision|0|||
13216029|NCT01867216|26266969|FG004|Overall Study|Physician Decision|0|||
13216030|NCT01867216|26266970|FG005|Overall Study|Physician Decision|0|||
13216031|NCT01867216|26266971|FG006|Overall Study|Physician Decision|0|||
13216032|NCT01867216|26266965|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1|||
13216033|NCT01867216|26266966|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0|||
13216034|NCT01867216|26266967|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0|||
13216035|NCT01867216|26266968|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0|||
13216036|NCT01867216|26266969|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0|||
13216037|NCT01867216|26266970|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0|||
13216038|NCT01867216|26266971|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0|||
13216039|NCT01867086|26266980|FG000|Overall Study|Disease Progression|1|||
13216040|NCT01867047|26267005|FG000|Overall Study|Lost to Follow-up|3|||
13216041|NCT01867047|26267006|FG001|Overall Study|Lost to Follow-up|3|||
13216042|NCT01867047|26267005|FG000|Overall Study|Withdrawal by Subject|2|||
13216043|NCT01867047|26267006|FG001|Overall Study|Withdrawal by Subject|0|||
13216044|NCT01867047|26267005|FG000|Overall Study|Physician Decision|2|||
13216045|NCT01867047|26267006|FG001|Overall Study|Physician Decision|0|||
13216046|NCT01867047|26267005|FG000|Overall Study|surgery not indicated in protocol|1|||
13216047|NCT01867047|26267006|FG001|Overall Study|surgery not indicated in protocol|2|||
13216048|NCT01867021|26267032|FG000|Overall Study|Adverse Event|0|||
13216049|NCT01867021|26267033|FG001|Overall Study|Adverse Event|1|||
13216050|NCT01867021|26267032|FG000|Overall Study|Not Eligible|0|||
13216051|NCT01867021|26267033|FG001|Overall Study|Not Eligible|1|||
13216052|NCT01867021|26267032|FG000|Overall Study|Death|1|||
13216053|NCT01867021|26267033|FG001|Overall Study|Death|0|||
13216054|NCT01867021|26267032|FG000|Overall Study|Lost to Follow-up|0|||
13216055|NCT01867021|26267033|FG001|Overall Study|Lost to Follow-up|2|||
13216056|NCT01867021|26267032|FG000|Overall Study|Withdrawal by Subject|1|||
13216057|NCT01867021|26267033|FG001|Overall Study|Withdrawal by Subject|6|||
13216058|NCT01867008|26267039|FG000|Overall Study|Withdrawal by Subject|1|||
13216059|NCT01866917|26267054|FG000|Overall Study|Pharmacist stopped dispensing treatment|4|||
13216060|NCT01866917|26267055|FG001|Overall Study|Pharmacist stopped dispensing treatment|6|||
13216061|NCT01866826|26267072|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1|||
13216062|NCT01866826|26267073|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0|||
13216063|NCT01866826|26267072|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0|||
13216064|NCT01866826|26267073|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2|||
13216065|NCT01866826|26267072|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0|||
13216066|NCT01866826|26267073|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1|||
13216067|NCT01866709|26267088|FG000|Overall Study|Adverse Event|1|||
13216068|NCT01866709|26267089|FG001|Overall Study|Adverse Event|0|||
13216069|NCT01866657|26267242|FG000|Overall Study|Surgery canceled|2|||
13216070|NCT01866657|26267243|FG001|Overall Study|Surgery canceled|0|||
13216071|NCT01866423|26267255|FG000|Overall Study|Lack of Efficacy|3|||
13216072|NCT01866423|26267255|FG000|Overall Study|Sponsor Decision|1|||
13216073|NCT01866319|26267279|FG000|Overall Study|Adverse Event|12|||
13216074|NCT01866319|26267280|FG001|Overall Study|Adverse Event|5|||
13216075|NCT01866319|26267281|FG002|Overall Study|Adverse Event|9|||
13216076|NCT01866319|26267279|FG000|Overall Study|Clinical progression|3|||
13216077|NCT01866319|26267280|FG001|Overall Study|Clinical progression|2|||
13216078|NCT01866319|26267281|FG002|Overall Study|Clinical progression|2|||
13216079|NCT01866319|26267279|FG000|Overall Study|Death|153|||
13216080|NCT01866319|26267280|FG001|Overall Study|Death|154|||
13216081|NCT01866319|26267281|FG002|Overall Study|Death|147|||
13216082|NCT01866319|26267279|FG000|Overall Study|Lost to Follow-up|6|||
13216083|NCT01866319|26267280|FG001|Overall Study|Lost to Follow-up|3|||
13216084|NCT01866319|26267281|FG002|Overall Study|Lost to Follow-up|8|||
13216085|NCT01866319|26267279|FG000|Overall Study|Physician Decision|1|||
13216086|NCT01866319|26267280|FG001|Overall Study|Physician Decision|0|||
13216087|NCT01866319|26267281|FG002|Overall Study|Physician Decision|1|||
13216088|NCT01866319|26267279|FG000|Overall Study|Protocol Violation|0|||
13216089|NCT01866319|26267280|FG001|Overall Study|Protocol Violation|0|||
13216090|NCT01866319|26267281|FG002|Overall Study|Protocol Violation|1|||
13216091|NCT01866319|26267279|FG000|Overall Study|Withdrawal by Subject|32|||
13216092|NCT01866319|26267280|FG001|Overall Study|Withdrawal by Subject|14|||
13216093|NCT01866319|26267281|FG002|Overall Study|Withdrawal by Subject|12|||
13216094|NCT01866293|26267291|FG000|Overall Study|Adverse Event|2|||
13216095|NCT01866098|26267330|FG000|Overall Study|Lost to Follow-up|11|||
13216096|NCT01866098|26267331|FG001|Overall Study|Lost to Follow-up|18|||
13216097|NCT01866098|26267332|FG002|Overall Study|Lost to Follow-up|13|||
13216098|NCT01866098|26267330|FG000|Overall Study|Physician Decision|0|||
13216099|NCT01866098|26267331|FG001|Overall Study|Physician Decision|1|||
13216100|NCT01866098|26267332|FG002|Overall Study|Physician Decision|2|||
13216101|NCT01866098|26267330|FG000|Overall Study|Adverse Event|1|||
13216102|NCT01866098|26267331|FG001|Overall Study|Adverse Event|5|||
13216103|NCT01866098|26267332|FG002|Overall Study|Adverse Event|4|||
13216104|NCT01866098|26267330|FG000|Overall Study|Protocol Violation|1|||
13216105|NCT01866098|26267331|FG001|Overall Study|Protocol Violation|0|||
13216106|NCT01866098|26267332|FG002|Overall Study|Protocol Violation|0|||
13216107|NCT01866098|26267330|FG000|Overall Study|Withdrawal by Subject|1|||
13216108|NCT01866098|26267331|FG001|Overall Study|Withdrawal by Subject|2|||
13216109|NCT01866098|26267332|FG002|Overall Study|Withdrawal by Subject|0|||
13216110|NCT01866098|26267330|FG000|Overall Study|Unrelated Hospitalization|2|||
13216111|NCT01866098|26267331|FG001|Overall Study|Unrelated Hospitalization|0|||
13216112|NCT01866098|26267332|FG002|Overall Study|Unrelated Hospitalization|1|||
13216113|NCT01866098|26267330|FG000|Overall Study|Non-compliance|1|||
13216114|NCT01866098|26267331|FG001|Overall Study|Non-compliance|0|||
13216115|NCT01866098|26267332|FG002|Overall Study|Non-compliance|1|||
13216116|NCT01866098|26267330|FG000|Overall Study|Pregnancy|2|||
13216117|NCT01866098|26267331|FG001|Overall Study|Pregnancy|0|||
13216118|NCT01866098|26267332|FG002|Overall Study|Pregnancy|0|||
13216119|NCT01866098|26267330|FG000|Overall Study|Death|0|||
13216120|NCT01866098|26267331|FG001|Overall Study|Death|1|||
13216121|NCT01866098|26267332|FG002|Overall Study|Death|0|||
13216122|NCT01865812|26267416|FG000|Primary Treatment Phase|Adverse Event|2|||
13216123|NCT01865812|26267417|FG001|Primary Treatment Phase|Adverse Event|0|||
13216124|NCT01865812|26267416|FG000|Long-term Safety Extension Phase|Withdrawal by Subject|0|||
13216125|NCT01865812|26267417|FG001|Long-term Safety Extension Phase|Withdrawal by Subject|1|||
13216126|NCT01865812|26267416|FG000|Long-term Safety Extension Phase|Pruritus|0|||
13216127|NCT01865812|26267417|FG001|Long-term Safety Extension Phase|Pruritus|3|||
13216128|NCT01865812|26267416|FG000|Long-term Safety Extension Phase|Physician Decision|0|||
13216129|NCT01865812|26267417|FG001|Long-term Safety Extension Phase|Physician Decision|1|||
13216130|NCT01865812|26267416|FG000|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|0|||
13216131|NCT01865812|26267417|FG001|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|1|||
13216132|NCT01865747|26267434|FG000|Overall Study (ITT)|Adverse Event|32|||
13216133|NCT01865747|26267435|FG001|Overall Study (ITT)|Adverse Event|31|||
13216134|NCT01865747|26267434|FG000|Overall Study (ITT)|Clinical Deterioration|29|||
13216135|NCT01865747|26267435|FG001|Overall Study (ITT)|Clinical Deterioration|50|||
13216136|NCT01865747|26267434|FG000|Overall Study (ITT)|Lack of Efficacy|3|||
13216137|NCT01865747|26267435|FG001|Overall Study (ITT)|Lack of Efficacy|0|||
13216138|NCT01865747|26267434|FG000|Overall Study (ITT)|Protocol Violation|1|||
13216139|NCT01865747|26267435|FG001|Overall Study (ITT)|Protocol Violation|1|||
13216140|NCT01865747|26267434|FG000|Overall Study (ITT)|Physician Decision|5|||
13216141|NCT01865747|26267435|FG001|Overall Study (ITT)|Physician Decision|2|||
13216142|NCT01865747|26267434|FG000|Overall Study (ITT)|Withdrawal by Subject|6|||
13216143|NCT01865747|26267435|FG001|Overall Study (ITT)|Withdrawal by Subject|11|||
13216144|NCT01865747|26267434|FG000|Overall Study (ITT)|Sponsor Decision|0|||
13216145|NCT01865747|26267435|FG001|Overall Study (ITT)|Sponsor Decision|1|||
13216146|NCT01865747|26267434|FG000|Overall Study (ITT)|Progressive Disease|122|||
13216147|NCT01865747|26267435|FG001|Overall Study (ITT)|Progressive Disease|158|||
13216148|NCT01865747|26267434|FG000|Overall Study (ITT)|Reason Not Provided|0|||
13216149|NCT01865747|26267435|FG001|Overall Study (ITT)|Reason Not Provided|1|||
13216150|NCT01865747|26267434|FG000|Primary Intent to Treat (PITT)|Adverse Event|21|||
13216151|NCT01865747|26267435|FG001|Primary Intent to Treat (PITT)|Adverse Event|20|||
13216152|NCT01865747|26267434|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18|||
13216153|NCT01865747|26267435|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29|||
13216154|NCT01865747|26267434|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2|||
13216155|NCT01865747|26267435|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0|||
13216156|NCT01865747|26267434|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1|||
13216157|NCT01865747|26267435|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1|||
13216158|NCT01865747|26267434|FG000|Primary Intent to Treat (PITT)|Physician Decision|4|||
13216159|NCT01865747|26267435|FG001|Primary Intent to Treat (PITT)|Physician Decision|2|||
13216160|NCT01865747|26267434|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3|||
13216161|NCT01865747|26267435|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7|||
13216162|NCT01865747|26267434|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82|||
13216163|NCT01865747|26267435|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92|||
13216164|NCT01865747|26267434|FG000|Primary Intent to Treat (PITT)|Other|0|||
13216165|NCT01865747|26267435|FG001|Primary Intent to Treat (PITT)|Other|1|||
13216166|NCT01865552|26267486|FG000|Period 1|Adverse Event|1|||
13216167|NCT01865552|26267487|FG001|Period 1|Adverse Event|0|||
13216168|NCT01865552|26267488|FG002|Period 1|Adverse Event|0|||
13216169|NCT01865552|26267489|FG003|Period 1|Adverse Event|1|||
13216170|NCT01865552|26267490|FG004|Period 1|Adverse Event|1|||
13216171|NCT01865552|26267491|FG005|Period 1|Adverse Event|1|||
13216172|NCT01865552|26267486|FG000|Period 1|Pathological lab|0|||
13216173|NCT01865552|26267487|FG001|Period 1|Pathological lab|0|||
13216174|NCT01865552|26267488|FG002|Period 1|Pathological lab|0|||
13216175|NCT01865552|26267489|FG003|Period 1|Pathological lab|0|||
13216176|NCT01865552|26267490|FG004|Period 1|Pathological lab|1|||
13216177|NCT01865552|26267491|FG005|Period 1|Pathological lab|0|||
13216178|NCT01865552|26267486|FG000|Period 1|Other|0|||
13216179|NCT01865552|26267487|FG001|Period 1|Other|0|||
13216180|NCT01865552|26267488|FG002|Period 1|Other|0|||
13216181|NCT01865552|26267489|FG003|Period 1|Other|0|||
13216182|NCT01865552|26267490|FG004|Period 1|Other|1|||
13216183|NCT01865552|26267491|FG005|Period 1|Other|0|||
13216184|NCT01865487|26267551|FG000|Overall Study|Lost to Follow-up|0|||
13216185|NCT01865487|26267552|FG001|Overall Study|Lost to Follow-up|0|||
13216186|NCT01865487|26267553|FG002|Overall Study|Lost to Follow-up|0|||
13216187|NCT01865487|26267554|FG003|Overall Study|Lost to Follow-up|1|||
13216188|NCT01865487|26267555|FG004|Overall Study|Lost to Follow-up|0|||
13216189|NCT01865487|26267556|FG005|Overall Study|Lost to Follow-up|0|||
13216190|NCT01865487|26267557|FG006|Overall Study|Lost to Follow-up|1|||
13216191|NCT01865487|26267558|FG007|Overall Study|Lost to Follow-up|0|||
13216192|NCT01865487|26267559|FG008|Overall Study|Lost to Follow-up|0|||
13216193|NCT01865487|26267560|FG009|Overall Study|Lost to Follow-up|0|||
13216194|NCT01865487|26267551|FG000|Overall Study|Withdrawal by Subject|0|||
13216195|NCT01865487|26267552|FG001|Overall Study|Withdrawal by Subject|0|||
13216196|NCT01865487|26267553|FG002|Overall Study|Withdrawal by Subject|0|||
13216197|NCT01865487|26267554|FG003|Overall Study|Withdrawal by Subject|0|||
13216198|NCT01865487|26267555|FG004|Overall Study|Withdrawal by Subject|1|||
13216199|NCT01865487|26267556|FG005|Overall Study|Withdrawal by Subject|0|||
13216200|NCT01865487|26267557|FG006|Overall Study|Withdrawal by Subject|0|||
13216201|NCT01865487|26267558|FG007|Overall Study|Withdrawal by Subject|0|||
13216202|NCT01865487|26267559|FG008|Overall Study|Withdrawal by Subject|0|||
13216203|NCT01865487|26267560|FG009|Overall Study|Withdrawal by Subject|0|||
13216204|NCT01865448|26267675|FG000|Overall Study|Adverse Event|1|||
13216205|NCT01865448|26267676|FG001|Overall Study|Adverse Event|1|||
13216206|NCT01865448|26267675|FG000|Overall Study|Pregnancy|0|||
13216207|NCT01865448|26267676|FG001|Overall Study|Pregnancy|1|||
13216208|NCT01865448|26267675|FG000|Overall Study|dropout unrelated to study|1|||
13216209|NCT01865448|26267676|FG001|Overall Study|dropout unrelated to study|1|||
13216210|NCT01865084|26267712|FG000|Double Blind Period (DB)|Adverse Event|2|||
13216211|NCT01865084|26267713|FG001|Double Blind Period (DB)|Adverse Event|2|||
13216212|NCT01865084|26267714|FG002|Double Blind Period (DB)|Adverse Event|1|||
13216213|NCT01865084|26267712|FG000|Double Blind Period (DB)|Protocol Violation|0|||
13216214|NCT01865084|26267713|FG001|Double Blind Period (DB)|Protocol Violation|0|||
13216215|NCT01865084|26267714|FG002|Double Blind Period (DB)|Protocol Violation|1|||
13216216|NCT01865084|26267712|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
13216217|NCT01865084|26267713|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
13216218|NCT01865084|26267714|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4|||
13216219|NCT01865084|26267712|FG000|Double Blind Period (DB)|Withdrawal by Subject|1|||
13216220|NCT01865084|26267713|FG001|Double Blind Period (DB)|Withdrawal by Subject|0|||
13216221|NCT01865084|26267714|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
13216222|NCT01865084|26267712|FG000|Open Label Extension (OLE) Period|Adverse Event|0|||
13216223|NCT01865084|26267713|FG001|Open Label Extension (OLE) Period|Adverse Event|0|||
13216224|NCT01865084|26267714|FG002|Open Label Extension (OLE) Period|Adverse Event|1|||
13216225|NCT01865084|26267712|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
13216226|NCT01865084|26267713|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
13216227|NCT01865084|26267714|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2|||
13216228|NCT01865084|26267712|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
13216229|NCT01865084|26267713|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1|||
13216230|NCT01865084|26267714|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
13216231|NCT01865084|26267712|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0|||
13216232|NCT01865084|26267713|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8|||
13216233|NCT01865084|26267714|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2|||
13216234|NCT01865084|26267712|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
13216235|NCT01865084|26267713|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
13216236|NCT01865084|26267714|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
13216237|NCT01864603|26267758|FG000|Stage 2|DSMB design modification|86056|||
13216238|NCT01864603|26267759|FG001|Stage 2|DSMB design modification|92558|||
13216239|NCT01864564|26267792|FG000|Overall Study|Lost to Follow-up|17|||
13216240|NCT01864564|26267793|FG001|Overall Study|Lost to Follow-up|23|||
13216241|NCT01864564|26267792|FG000|Overall Study|Withdrawal by Subject|20|||
13216242|NCT01864564|26267793|FG001|Overall Study|Withdrawal by Subject|11|||
13216243|NCT01864564|26267792|FG000|Overall Study|Protocol Violation|0|||
13216244|NCT01864564|26267793|FG001|Overall Study|Protocol Violation|27|||
13216245|NCT01864564|26267792|FG000|Overall Study|not reported|0|||
13216246|NCT01864564|26267793|FG001|Overall Study|not reported|34|||
13216247|NCT01864525|26267808|FG000|Overall Study|Adverse Event|1|||
13216248|NCT01864525|26267809|FG001|Overall Study|Adverse Event|0|||
13216249|NCT01864291|26267817|FG000|Overall Study|need for revision surgery|2|||
13216250|NCT01864200|26267830|FG000|Overall Study|Lost to Follow-up|1|||
13216251|NCT01864200|26267831|FG001|Overall Study|Lost to Follow-up|3|||
13216252|NCT01864200|26267830|FG000|Overall Study|Protocol Violation|1|||
13216253|NCT01864200|26267831|FG001|Overall Study|Protocol Violation|0|||
13216254|NCT01864174|26267852|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15|||
13216255|NCT01864174|26267853|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14|||
13216256|NCT01864174|26267852|FG000|Double Blind - Compliant Randomized|Adverse Event|6|||
13216257|NCT01864174|26267853|FG001|Double Blind - Compliant Randomized|Adverse Event|1|||
13216258|NCT01864174|26267852|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2|||
13216259|NCT01864174|26267853|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0|||
13216260|NCT01864174|26267852|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4|||
13216261|NCT01864174|26267853|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5|||
13216262|NCT01864174|26267852|FG000|Double Blind - Compliant Randomized|Death|1|||
13216263|NCT01864174|26267853|FG001|Double Blind - Compliant Randomized|Death|0|||
13216264|NCT01864174|26267852|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3|||
13216265|NCT01864174|26267853|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10|||
13216266|NCT01864174|26267852|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1|||
13216267|NCT01864174|26267853|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0|||
13216268|NCT01864174|26267852|FG000|Double Blind - Compliant Randomized|Other|6|||
13216269|NCT01864174|26267853|FG001|Double Blind - Compliant Randomized|Other|10|||
13216270|NCT01864174|26267852|FG000|Off Treatment Follow-Up|Other|2|||
13216271|NCT01864174|26267853|FG001|Off Treatment Follow-Up|Other|0|||
13216272|NCT01864174|26267852|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1|||
13216273|NCT01864174|26267853|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0|||
13216274|NCT01864148|26267896|FG000|Overall Study|Other|2|||
13216275|NCT01864148|26267897|FG001|Overall Study|Other|1|||
13216276|NCT01864148|26267898|FG002|Overall Study|Other|1|||
13216277|NCT01864148|26267899|FG003|Overall Study|Other|3|||
13216278|NCT01864148|26267900|FG004|Overall Study|Other|1|||
13216279|NCT01864148|26267896|FG000|Overall Study|Death|0|||
13216280|NCT01864148|26267897|FG001|Overall Study|Death|0|||
13216281|NCT01864148|26267898|FG002|Overall Study|Death|0|||
13216282|NCT01864148|26267899|FG003|Overall Study|Death|1|||
13216283|NCT01864148|26267900|FG004|Overall Study|Death|0|||
13216284|NCT01864148|26267896|FG000|Overall Study|Investigator Decision|5|||
13216285|NCT01864148|26267897|FG001|Overall Study|Investigator Decision|0|||
13216286|NCT01864148|26267898|FG002|Overall Study|Investigator Decision|0|||
13216287|NCT01864148|26267899|FG003|Overall Study|Investigator Decision|4|||
13216288|NCT01864148|26267900|FG004|Overall Study|Investigator Decision|6|||
13216289|NCT01864148|26267896|FG000|Overall Study|Withdrawal by Subject|9|||
13216290|NCT01864148|26267897|FG001|Overall Study|Withdrawal by Subject|2|||
13216291|NCT01864148|26267898|FG002|Overall Study|Withdrawal by Subject|6|||
13216292|NCT01864148|26267899|FG003|Overall Study|Withdrawal by Subject|8|||
13216293|NCT01864148|26267900|FG004|Overall Study|Withdrawal by Subject|8|||
13216294|NCT01864148|26267896|FG000|Overall Study|Lost to Follow-up|0|||
13216295|NCT01864148|26267897|FG001|Overall Study|Lost to Follow-up|0|||
13216296|NCT01864148|26267898|FG002|Overall Study|Lost to Follow-up|0|||
13216297|NCT01864148|26267899|FG003|Overall Study|Lost to Follow-up|2|||
13216298|NCT01864148|26267900|FG004|Overall Study|Lost to Follow-up|1|||
13216299|NCT01864148|26267896|FG000|Overall Study|Adverse Event|4|||
13216300|NCT01864148|26267897|FG001|Overall Study|Adverse Event|2|||
13216301|NCT01864148|26267898|FG002|Overall Study|Adverse Event|4|||
13216302|NCT01864148|26267899|FG003|Overall Study|Adverse Event|7|||
13216303|NCT01864148|26267900|FG004|Overall Study|Adverse Event|7|||
13394778|NCT00654381|26788099|FG002|2nd Stage|Investigator's decision|1|||
13216304|NCT01864148|26267896|FG000|Overall Study|Not Dosed|0|||
13216305|NCT01864148|26267897|FG001|Overall Study|Not Dosed|0|||
13216306|NCT01864148|26267898|FG002|Overall Study|Not Dosed|0|||
13216307|NCT01864148|26267899|FG003|Overall Study|Not Dosed|1|||
13216308|NCT01864148|26267900|FG004|Overall Study|Not Dosed|0|||
13216309|NCT01864018|26267921|FG000|Overall Study|Ineligible|3|||
13216310|NCT01864018|26267922|FG001|Overall Study|Ineligible|1|||
13216311|NCT01864005|26267943|FG000|Overall Study|Protocol Violation|0|||
13216312|NCT01864005|26267944|FG001|Overall Study|Protocol Violation|1|||
13216313|NCT01864005|26267943|FG000|Overall Study|Withdrawal by Subject|0|||
13216314|NCT01864005|26267944|FG001|Overall Study|Withdrawal by Subject|1|||
13216315|NCT01864005|26267943|FG000|Overall Study|Incorrect enrolment|1|||
13216316|NCT01864005|26267944|FG001|Overall Study|Incorrect enrolment|0|||
13216317|NCT01864005|26267943|FG000|Overall Study|Disease need|1|||
13216318|NCT01864005|26267944|FG001|Overall Study|Disease need|1|||
13216319|NCT01864005|26267943|FG000|Overall Study|Need GP IIb/IIIa|1|||
13216320|NCT01864005|26267944|FG001|Overall Study|Need GP IIb/IIIa|3|||
13216321|NCT01863953|26267968|FG000|Overall Study|Adverse Event|0|||
13216322|NCT01863953|26267969|FG001|Overall Study|Adverse Event|0|||
13216323|NCT01863953|26267970|FG002|Overall Study|Adverse Event|1|||
13216324|NCT01863849|26267999|FG000|Overall Study|Lost to Follow-up|1|||
13216325|NCT01863849|26268000|FG001|Overall Study|Lost to Follow-up|0|||
13216326|NCT01863771|26268017|FG000|Induction Phase|Adverse Event|9|||
13216327|NCT01863771|26268018|FG001|Induction Phase|Adverse Event|0|||
13216328|NCT01863771|26268019|FG002|Induction Phase|Adverse Event|0|||
13216329|NCT01863771|26268020|FG003|Induction Phase|Adverse Event|0|||
13216330|NCT01863771|26268017|FG000|Induction Phase|Lack of Efficacy|10|||
13216331|NCT01863771|26268018|FG001|Induction Phase|Lack of Efficacy|0|||
13216332|NCT01863771|26268019|FG002|Induction Phase|Lack of Efficacy|0|||
13216333|NCT01863771|26268020|FG003|Induction Phase|Lack of Efficacy|0|||
13216334|NCT01863771|26268017|FG000|Induction Phase|Withdrawal by Subject|2|||
13216335|NCT01863771|26268018|FG001|Induction Phase|Withdrawal by Subject|0|||
13216336|NCT01863771|26268019|FG002|Induction Phase|Withdrawal by Subject|0|||
13216337|NCT01863771|26268020|FG003|Induction Phase|Withdrawal by Subject|0|||
13216338|NCT01863771|26268017|FG000|Maintenance Phase|Adverse Event|0|||
13216339|NCT01863771|26268018|FG001|Maintenance Phase|Adverse Event|0|||
13216340|NCT01863771|26268019|FG002|Maintenance Phase|Adverse Event|1|||
13216341|NCT01863771|26268020|FG003|Maintenance Phase|Adverse Event|1|||
13216342|NCT01863771|26268017|FG000|Maintenance Phase|Lack of Efficacy|0|||
13216343|NCT01863771|26268018|FG001|Maintenance Phase|Lack of Efficacy|3|||
13216344|NCT01863771|26268019|FG002|Maintenance Phase|Lack of Efficacy|7|||
13216345|NCT01863771|26268020|FG003|Maintenance Phase|Lack of Efficacy|38|||
13216346|NCT01863771|26268017|FG000|Maintenance Phase|Physician Decision|0|||
13216347|NCT01863771|26268018|FG001|Maintenance Phase|Physician Decision|0|||
13216348|NCT01863771|26268019|FG002|Maintenance Phase|Physician Decision|2|||
13216349|NCT01863771|26268020|FG003|Maintenance Phase|Physician Decision|1|||
13216350|NCT01863771|26268017|FG000|Maintenance Phase|Pregnancy|0|||
13216351|NCT01863771|26268018|FG001|Maintenance Phase|Pregnancy|1|||
13216352|NCT01863771|26268019|FG002|Maintenance Phase|Pregnancy|0|||
13216353|NCT01863771|26268020|FG003|Maintenance Phase|Pregnancy|0|||
13216354|NCT01863771|26268017|FG000|Maintenance Phase|Withdrawal by Subject|0|||
13216355|NCT01863771|26268018|FG001|Maintenance Phase|Withdrawal by Subject|1|||
13216356|NCT01863771|26268019|FG002|Maintenance Phase|Withdrawal by Subject|2|||
13216357|NCT01863771|26268020|FG003|Maintenance Phase|Withdrawal by Subject|3|||
13216358|NCT01863758|26268030|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1|||
13216359|NCT01863758|26268030|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1|||
13216360|NCT01863732|26268056|FG000|Overall Study|Adverse Event|2|||
13216361|NCT01863732|26268057|FG001|Overall Study|Adverse Event|0|||
13216362|NCT01863732|26268058|FG002|Overall Study|Adverse Event|3|||
13216363|NCT01863732|26268059|FG003|Overall Study|Adverse Event|3|||
13216364|NCT01863732|26268056|FG000|Overall Study|Lack of Efficacy|1|||
13216365|NCT01863732|26268057|FG001|Overall Study|Lack of Efficacy|0|||
13216366|NCT01863732|26268058|FG002|Overall Study|Lack of Efficacy|2|||
13216367|NCT01863732|26268059|FG003|Overall Study|Lack of Efficacy|1|||
13216368|NCT01863732|26268056|FG000|Overall Study|Lost to Follow-up|2|||
13216369|NCT01863732|26268057|FG001|Overall Study|Lost to Follow-up|2|||
13216370|NCT01863732|26268058|FG002|Overall Study|Lost to Follow-up|1|||
13216371|NCT01863732|26268059|FG003|Overall Study|Lost to Follow-up|1|||
13216372|NCT01863732|26268056|FG000|Overall Study|Physician Decision|1|||
13216373|NCT01863732|26268057|FG001|Overall Study|Physician Decision|0|||
13216374|NCT01863732|26268058|FG002|Overall Study|Physician Decision|1|||
13216375|NCT01863732|26268059|FG003|Overall Study|Physician Decision|0|||
13216376|NCT01863732|26268056|FG000|Overall Study|Pregnancy|0|||
13216377|NCT01863732|26268057|FG001|Overall Study|Pregnancy|0|||
13216378|NCT01863732|26268058|FG002|Overall Study|Pregnancy|0|||
13216379|NCT01863732|26268059|FG003|Overall Study|Pregnancy|1|||
13216380|NCT01863732|26268056|FG000|Overall Study|Technical problems|0|||
13216381|NCT01863732|26268057|FG001|Overall Study|Technical problems|1|||
13216382|NCT01863732|26268058|FG002|Overall Study|Technical problems|1|||
13216383|NCT01863732|26268059|FG003|Overall Study|Technical problems|0|||
13216384|NCT01863732|26268056|FG000|Overall Study|Subject/guardian decision|6|||
13216385|NCT01863732|26268057|FG001|Overall Study|Subject/guardian decision|9|||
13216386|NCT01863732|26268058|FG002|Overall Study|Subject/guardian decision|3|||
13216387|NCT01863732|26268059|FG003|Overall Study|Subject/guardian decision|1|||
13216388|NCT01863732|26268056|FG000|Overall Study|Death|1|||
13216389|NCT01863732|26268057|FG001|Overall Study|Death|0|||
13216390|NCT01863732|26268058|FG002|Overall Study|Death|0|||
13216391|NCT01863732|26268059|FG003|Overall Study|Death|1|||
13216392|NCT01863680|26268067|FG000|Overall Study|Adverse Event|17|||
13216393|NCT01863680|26268067|FG000|Overall Study|Risk of OHSS|17|||
13216394|NCT01863680|26268067|FG000|Overall Study|Spontaneous pregnancy|2|||
13216395|NCT01863680|26268067|FG000|Overall Study|Withdrawal by Subject|1|||
13216396|NCT01863680|26268067|FG000|Overall Study|Did not undergo IVF/ET|14|||
13216397|NCT01863680|26268067|FG000|Overall Study|Other|6|||
13216398|NCT01863667|26268094|FG000|Overall Study|Adverse Event|1|||
13216399|NCT01863667|26268095|FG001|Overall Study|Adverse Event|0|||
13216400|NCT01863667|26268094|FG000|Overall Study|Study terminated by Sponsor|30|||
13216401|NCT01863667|26268095|FG001|Overall Study|Study terminated by Sponsor|30|||
13216402|NCT01863667|26268094|FG000|Overall Study|Withdrawal by Subject|2|||
13216403|NCT01863667|26268095|FG001|Overall Study|Withdrawal by Subject|2|||
13216404|NCT01863433|26268105|FG000|Overall Study|Protocol Violation|1|||
13216405|NCT01863368|26268125|FG000|Phase I, Day 0 to Day 35|Adverse Event|2|||
13216406|NCT01863368|26268126|FG001|Phase I, Day 0 to Day 35|Adverse Event|4|||
13216407|NCT01863368|26268125|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1|||
13216408|NCT01863368|26268126|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0|||
13216409|NCT01863368|26268125|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0|||
13216410|NCT01863368|26268126|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1|||
13216411|NCT01863368|26268125|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0|||
13216412|NCT01863368|26268126|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2|||
13216413|NCT01863368|26268125|FG000|Phase II, Day 35 to Day 90|Adverse Event|1|||
13216414|NCT01863368|26268126|FG001|Phase II, Day 35 to Day 90|Adverse Event|0|||
13216415|NCT01863368|26268125|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1|||
13216416|NCT01863368|26268126|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0|||
13216417|NCT01862991|26268147|FG000|Overall Study|Lost to Follow-up|2|||
13216418|NCT01862991|26268148|FG001|Overall Study|Lost to Follow-up|1|||
13216419|NCT01862991|26268149|FG002|Overall Study|Lost to Follow-up|1|||
13216420|NCT01862991|26268147|FG000|Overall Study|Protocol Violation|1|||
13216421|NCT01862991|26268148|FG001|Overall Study|Protocol Violation|0|||
13216422|NCT01862991|26268149|FG002|Overall Study|Protocol Violation|0|||
13216423|NCT01862874|26268172|FG000|Overall Study|Randomized not treated|1|||
13216424|NCT01862874|26268173|FG001|Overall Study|Randomized not treated|0|||
13216425|NCT01862874|26268172|FG000|Overall Study|Adverse Event|0|||
13216426|NCT01862874|26268173|FG001|Overall Study|Adverse Event|3|||
13216427|NCT01862874|26268172|FG000|Overall Study|Lost to Follow-up|26|||
13216428|NCT01862874|26268173|FG001|Overall Study|Lost to Follow-up|29|||
13216429|NCT01862874|26268172|FG000|Overall Study|Physician Decision|5|||
13216430|NCT01862874|26268173|FG001|Overall Study|Physician Decision|3|||
13216431|NCT01862874|26268172|FG000|Overall Study|Withdrawn by parent/guardian|1|||
13216432|NCT01862874|26268173|FG001|Overall Study|Withdrawn by parent/guardian|1|||
13216433|NCT01862874|26268172|FG000|Overall Study|Withdrawal by Subject|46|||
13216434|NCT01862874|26268173|FG001|Overall Study|Withdrawal by Subject|40|||
13216435|NCT01862874|26268172|FG000|Overall Study|Death|0|||
13216436|NCT01862874|26268173|FG001|Overall Study|Death|1|||
13216437|NCT01862796|26268194|FG000|Overall Study|Prohibited medications|0|||
13216438|NCT01862796|26268195|FG001|Overall Study|Prohibited medications|0|||
13216439|NCT01862796|26268196|FG002|Overall Study|Prohibited medications|1|||
13216440|NCT01862640|26268221|FG000|Overall Study|Adverse Event|4|||
13216441|NCT01862640|26268222|FG001|Overall Study|Adverse Event|10|||
13216442|NCT01862640|26268223|FG002|Overall Study|Adverse Event|6|||
13216443|NCT01862640|26268224|FG003|Overall Study|Adverse Event|8|||
13216444|NCT01862640|26268221|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
13216445|NCT01862640|26268222|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
13216446|NCT01862640|26268223|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
13216447|NCT01862640|26268224|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
13216448|NCT01862640|26268221|FG000|Overall Study|Participant Withdrawn by Investigator|0|||
13216449|NCT01862640|26268222|FG001|Overall Study|Participant Withdrawn by Investigator|1|||
13216450|NCT01862640|26268223|FG002|Overall Study|Participant Withdrawn by Investigator|1|||
13216451|NCT01862640|26268224|FG003|Overall Study|Participant Withdrawn by Investigator|1|||
13216452|NCT01862640|26268221|FG000|Overall Study|Withdrawal by Subject|2|||
13216453|NCT01862640|26268222|FG001|Overall Study|Withdrawal by Subject|4|||
13216454|NCT01862640|26268223|FG002|Overall Study|Withdrawal by Subject|8|||
13216455|NCT01862640|26268224|FG003|Overall Study|Withdrawal by Subject|5|||
13216456|NCT01862640|26268221|FG000|Overall Study|Protocol Deviation|0|||
13216457|NCT01862640|26268222|FG001|Overall Study|Protocol Deviation|0|||
13216458|NCT01862640|26268223|FG002|Overall Study|Protocol Deviation|1|||
13216459|NCT01862640|26268224|FG003|Overall Study|Protocol Deviation|0|||
13216460|NCT01862484|26268237|FG000|Overall Study|Lack of Efficacy|1|||
13216461|NCT01862484|26268238|FG001|Overall Study|Lack of Efficacy|1|||
13216462|NCT01862484|26268237|FG000|Overall Study|Lost to Follow-up|1|||
13216463|NCT01862484|26268238|FG001|Overall Study|Lost to Follow-up|2|||
13216464|NCT01862484|26268237|FG000|Overall Study|Protocol Violation|0|||
13216465|NCT01862484|26268238|FG001|Overall Study|Protocol Violation|2|||
13216466|NCT01862484|26268237|FG000|Overall Study|Withdrawal by Subject|0|||
13216467|NCT01862484|26268238|FG001|Overall Study|Withdrawal by Subject|3|||
13216468|NCT01862328|26268312|FG000|Overall Study|Progressive Disease|3|||
13216469|NCT01862328|26268313|FG001|Overall Study|Progressive Disease|11|||
13216470|NCT01862328|26268314|FG002|Overall Study|Progressive Disease|5|||
13216471|NCT01862328|26268315|FG003|Overall Study|Progressive Disease|6|||
13216472|NCT01862328|26268316|FG004|Overall Study|Progressive Disease|7|||
13216473|NCT01862328|26268317|FG005|Overall Study|Progressive Disease|4|||
13216474|NCT01862328|26268318|FG006|Overall Study|Progressive Disease|3|||
13216475|NCT01862328|26268312|FG000|Overall Study|Adverse Event|0|||
13216476|NCT01862328|26268313|FG001|Overall Study|Adverse Event|4|||
13216477|NCT01862328|26268314|FG002|Overall Study|Adverse Event|0|||
13216478|NCT01862328|26268315|FG003|Overall Study|Adverse Event|1|||
13216479|NCT01862328|26268316|FG004|Overall Study|Adverse Event|0|||
13216480|NCT01862328|26268317|FG005|Overall Study|Adverse Event|2|||
13216481|NCT01862328|26268318|FG006|Overall Study|Adverse Event|4|||
13216482|NCT01862328|26268312|FG000|Overall Study|Other|0|||
13216483|NCT01862328|26268313|FG001|Overall Study|Other|2|||
13216484|NCT01862328|26268314|FG002|Overall Study|Other|1|||
13216485|NCT01862328|26268315|FG003|Overall Study|Other|0|||
13216486|NCT01862328|26268316|FG004|Overall Study|Other|4|||
13216487|NCT01862328|26268317|FG005|Overall Study|Other|0|||
13216488|NCT01862328|26268318|FG006|Overall Study|Other|1|||
13216489|NCT01862328|26268312|FG000|Overall Study|Withdrawal by Subject|1|||
13216490|NCT01862328|26268313|FG001|Overall Study|Withdrawal by Subject|1|||
13216491|NCT01862328|26268314|FG002|Overall Study|Withdrawal by Subject|0|||
13216492|NCT01862328|26268315|FG003|Overall Study|Withdrawal by Subject|0|||
13216493|NCT01862328|26268316|FG004|Overall Study|Withdrawal by Subject|1|||
13216494|NCT01862328|26268317|FG005|Overall Study|Withdrawal by Subject|1|||
13216495|NCT01862328|26268318|FG006|Overall Study|Withdrawal by Subject|1|||
13216496|NCT01862328|26268312|FG000|Overall Study|Symptomatic Deterioration|0|||
13216497|NCT01862328|26268313|FG001|Overall Study|Symptomatic Deterioration|0|||
13216498|NCT01862328|26268314|FG002|Overall Study|Symptomatic Deterioration|0|||
13216499|NCT01862328|26268315|FG003|Overall Study|Symptomatic Deterioration|0|||
13216500|NCT01862328|26268316|FG004|Overall Study|Symptomatic Deterioration|0|||
13216501|NCT01862328|26268317|FG005|Overall Study|Symptomatic Deterioration|0|||
13216502|NCT01862328|26268318|FG006|Overall Study|Symptomatic Deterioration|1|||
13216503|NCT01862250|26268327|FG000|Overall Study|Adverse Event|4|||
13216504|NCT01862029|26268334|FG000|Overall Study|Physician Decision|1|||
13216505|NCT01861717|26268345|FG000|Overall Study|Lost to Follow-up|1|||
13216506|NCT01861717|26268345|FG000|Overall Study|Withdrawal by Subject|1|||
13216507|NCT01861522|26268358|FG000|Overall Study|Adverse Event|1|||
13216508|NCT01861522|26268359|FG001|Overall Study|Adverse Event|0|||
13216509|NCT01861522|26268358|FG000|Overall Study|Withdrawal by Subject|2|||
13216510|NCT01861522|26268359|FG001|Overall Study|Withdrawal by Subject|0|||
13216511|NCT01860989|26268365|FG000|Overall Study|Unsatisfactory therapeutic|5|||
13216512|NCT01860976|26268407|FG000|Blinded Treatment|Adverse Event|1|||
13216513|NCT01860976|26268408|FG001|Blinded Treatment|Adverse Event|3|||
13216514|NCT01860976|26268407|FG000|Blinded Treatment|Lack of Efficacy|5|||
13216515|NCT01860976|26268408|FG001|Blinded Treatment|Lack of Efficacy|12|||
13216516|NCT01860976|26268407|FG000|Blinded Treatment|Subject request to discontinue treatment|2|||
13216517|NCT01860976|26268408|FG001|Blinded Treatment|Subject request to discontinue treatment|3|||
13216518|NCT01860976|26268407|FG000|Blinded Treatment|Withdrawal by Subject|3|||
13216519|NCT01860976|26268408|FG001|Blinded Treatment|Withdrawal by Subject|5|||
13216520|NCT01860976|26268407|FG000|Blinded Treatment|Subject no longer met criteria|1|||
13216521|NCT01860976|26268408|FG001|Blinded Treatment|Subject no longer met criteria|0|||
13216522|NCT01860976|26268407|FG000|Blinded Treatment|Entered Open-Label in error|0|||
13216523|NCT01860976|26268408|FG001|Blinded Treatment|Entered Open-Label in error|1|||
13216524|NCT01860976|26268407|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76|||
13216525|NCT01860976|26268408|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89|||
13216526|NCT01860976|26268407|FG000|Open-Label|Adverse Event|2|||
13216527|NCT01860976|26268408|FG001|Open-Label|Adverse Event|4|||
13216528|NCT01860976|26268407|FG000|Open-Label|Lack of Efficacy|16|||
13216529|NCT01860976|26268408|FG001|Open-Label|Lack of Efficacy|8|||
13216530|NCT01860976|26268407|FG000|Open-Label|Lost to Follow-up|1|||
13216531|NCT01860976|26268408|FG001|Open-Label|Lost to Follow-up|2|||
13216532|NCT01860976|26268407|FG000|Open-Label|Subject request discontinue treatment|4|||
13216533|NCT01860976|26268408|FG001|Open-Label|Subject request discontinue treatment|3|||
13216534|NCT01860976|26268407|FG000|Open-Label|Withdrawal by Subject|4|||
13216535|NCT01860976|26268408|FG001|Open-Label|Withdrawal by Subject|1|||
13216536|NCT01860976|26268407|FG000|Open-Label|Other Reasons|1|||
13216537|NCT01860976|26268408|FG001|Open-Label|Other Reasons|1|||
13216538|NCT01860976|26268407|FG000|Long Term Extension|Adverse Event|4|||
13216539|NCT01860976|26268408|FG001|Long Term Extension|Adverse Event|0|||
13216540|NCT01860976|26268407|FG000|Long Term Extension|Lack of Efficacy|2|||
13216541|NCT01860976|26268408|FG001|Long Term Extension|Lack of Efficacy|0|||
13216542|NCT01860976|26268407|FG000|Long Term Extension|Subject request to discontinue treatment|10|||
13216543|NCT01860976|26268408|FG001|Long Term Extension|Subject request to discontinue treatment|0|||
13216544|NCT01860976|26268407|FG000|Long Term Extension|Lost to Follow-up|2|||
13216545|NCT01860976|26268408|FG001|Long Term Extension|Lost to Follow-up|0|||
13216546|NCT01860976|26268407|FG000|Long Term Extension|subject withdrew consent|7|||
13216547|NCT01860976|26268408|FG001|Long Term Extension|subject withdrew consent|0|||
13216548|NCT01860846|26268421|FG000|Overall Study|Lost to Follow-up|33|||
13296878|NCT01368406|26497554|FG000|Overall Study|relapse of the disease|3|||
13296879|NCT01368406|26497555|FG001|Overall Study|relapse of the disease|2|||
13296880|NCT01368406|26497554|FG000|Overall Study|started working|2|||
13296881|NCT01368406|26497555|FG001|Overall Study|started working|3|||
13296882|NCT01368276|26497572|FG000|Overall Study|Death|1|||
13296883|NCT01368276|26497573|FG001|Overall Study|Death|10|||
13296884|NCT01368211|26497588|FG000|Second Platelets Transfusion|No need for additional transfusion|1|||
13296885|NCT01368211|26497589|FG001|Second Platelets Transfusion|No need for additional transfusion|2|||
13296886|NCT01368081|26497683|FG000|Overall Study|Adverse Event|4|||
13296887|NCT01368081|26497684|FG001|Overall Study|Adverse Event|4|||
13296888|NCT01368081|26497685|FG002|Overall Study|Adverse Event|3|||
13296889|NCT01368081|26497686|FG003|Overall Study|Adverse Event|2|||
13296890|NCT01368081|26497687|FG004|Overall Study|Adverse Event|2|||
13296891|NCT01368081|26497688|FG005|Overall Study|Adverse Event|5|||
13296892|NCT01368081|26497689|FG006|Overall Study|Adverse Event|6|||
13296893|NCT01368081|26497690|FG007|Overall Study|Adverse Event|2|||
13296894|NCT01368081|26497691|FG008|Overall Study|Adverse Event|3|||
13296895|NCT01368081|26497692|FG009|Overall Study|Adverse Event|5|||
13296896|NCT01368081|26497693|FG010|Overall Study|Adverse Event|6|||
13296897|NCT01368081|26497694|FG011|Overall Study|Adverse Event|1|||
13296898|NCT01368081|26497695|FG012|Overall Study|Adverse Event|3|||
13296899|NCT01368081|26497683|FG000|Overall Study|Lack of Efficacy|0|||
13296900|NCT01368081|26497684|FG001|Overall Study|Lack of Efficacy|1|||
13296901|NCT01368081|26497685|FG002|Overall Study|Lack of Efficacy|0|||
13296902|NCT01368081|26497686|FG003|Overall Study|Lack of Efficacy|1|||
13296903|NCT01368081|26497687|FG004|Overall Study|Lack of Efficacy|0|||
13296904|NCT01368081|26497688|FG005|Overall Study|Lack of Efficacy|0|||
13296905|NCT01368081|26497689|FG006|Overall Study|Lack of Efficacy|0|||
13296906|NCT01368081|26497690|FG007|Overall Study|Lack of Efficacy|2|||
13296907|NCT01368081|26497691|FG008|Overall Study|Lack of Efficacy|0|||
13296908|NCT01368081|26497692|FG009|Overall Study|Lack of Efficacy|0|||
13296909|NCT01368081|26497693|FG010|Overall Study|Lack of Efficacy|0|||
13296910|NCT01368081|26497694|FG011|Overall Study|Lack of Efficacy|0|||
13296911|NCT01368081|26497695|FG012|Overall Study|Lack of Efficacy|0|||
13296912|NCT01368081|26497683|FG000|Overall Study|Protocol Violation|0|||
13296913|NCT01368081|26497684|FG001|Overall Study|Protocol Violation|0|||
13296914|NCT01368081|26497685|FG002|Overall Study|Protocol Violation|0|||
13296915|NCT01368081|26497686|FG003|Overall Study|Protocol Violation|0|||
13296916|NCT01368081|26497687|FG004|Overall Study|Protocol Violation|0|||
13296917|NCT01368081|26497688|FG005|Overall Study|Protocol Violation|1|||
13296918|NCT01368081|26497689|FG006|Overall Study|Protocol Violation|0|||
13296919|NCT01368081|26497690|FG007|Overall Study|Protocol Violation|1|||
13296920|NCT01368081|26497691|FG008|Overall Study|Protocol Violation|0|||
13296921|NCT01368081|26497692|FG009|Overall Study|Protocol Violation|0|||
13296922|NCT01368081|26497693|FG010|Overall Study|Protocol Violation|0|||
13296923|NCT01368081|26497694|FG011|Overall Study|Protocol Violation|0|||
13296924|NCT01368081|26497695|FG012|Overall Study|Protocol Violation|0|||
13296925|NCT01368081|26497683|FG000|Overall Study|Lost to Follow-up|0|||
13296926|NCT01368081|26497684|FG001|Overall Study|Lost to Follow-up|0|||
13296927|NCT01368081|26497685|FG002|Overall Study|Lost to Follow-up|0|||
13296928|NCT01368081|26497686|FG003|Overall Study|Lost to Follow-up|0|||
13296929|NCT01368081|26497687|FG004|Overall Study|Lost to Follow-up|0|||
13296930|NCT01368081|26497688|FG005|Overall Study|Lost to Follow-up|0|||
13296931|NCT01368081|26497689|FG006|Overall Study|Lost to Follow-up|0|||
13296932|NCT01368081|26497690|FG007|Overall Study|Lost to Follow-up|0|||
13296933|NCT01368081|26497691|FG008|Overall Study|Lost to Follow-up|0|||
13296934|NCT01368081|26497692|FG009|Overall Study|Lost to Follow-up|0|||
13296935|NCT01368081|26497693|FG010|Overall Study|Lost to Follow-up|0|||
13296936|NCT01368081|26497694|FG011|Overall Study|Lost to Follow-up|0|||
13296937|NCT01368081|26497695|FG012|Overall Study|Lost to Follow-up|1|||
13296938|NCT01368081|26497683|FG000|Overall Study|Withdrawal by Subject|4|||
13296939|NCT01368081|26497684|FG001|Overall Study|Withdrawal by Subject|4|||
13296940|NCT01368081|26497685|FG002|Overall Study|Withdrawal by Subject|1|||
13296941|NCT01368081|26497686|FG003|Overall Study|Withdrawal by Subject|1|||
13296942|NCT01368081|26497687|FG004|Overall Study|Withdrawal by Subject|0|||
13296943|NCT01368081|26497688|FG005|Overall Study|Withdrawal by Subject|3|||
13296944|NCT01368081|26497689|FG006|Overall Study|Withdrawal by Subject|4|||
13296945|NCT01368081|26497690|FG007|Overall Study|Withdrawal by Subject|2|||
13296946|NCT01368081|26497691|FG008|Overall Study|Withdrawal by Subject|5|||
13296947|NCT01368081|26497692|FG009|Overall Study|Withdrawal by Subject|4|||
13296948|NCT01368081|26497693|FG010|Overall Study|Withdrawal by Subject|3|||
13296949|NCT01368081|26497694|FG011|Overall Study|Withdrawal by Subject|2|||
13296950|NCT01368081|26497695|FG012|Overall Study|Withdrawal by Subject|0|||
13296951|NCT01368081|26497683|FG000|Overall Study|Other reason not defined above|2|||
13296952|NCT01368081|26497684|FG001|Overall Study|Other reason not defined above|0|||
13296953|NCT01368081|26497685|FG002|Overall Study|Other reason not defined above|0|||
13296954|NCT01368081|26497686|FG003|Overall Study|Other reason not defined above|1|||
13216549|NCT01860703|26268458|FG000|Overall Study|Adverse Event|1|||
13216550|NCT01860703|26268459|FG001|Overall Study|Adverse Event|4|||
13216551|NCT01860703|26268460|FG002|Overall Study|Adverse Event|0|||
13216552|NCT01860703|26268461|FG003|Overall Study|Adverse Event|2|||
13216553|NCT01860703|26268458|FG000|Overall Study|Withdrawal by Subject|0|||
13216554|NCT01860703|26268459|FG001|Overall Study|Withdrawal by Subject|1|||
13216555|NCT01860703|26268460|FG002|Overall Study|Withdrawal by Subject|0|||
13216556|NCT01860703|26268461|FG003|Overall Study|Withdrawal by Subject|0|||
13216557|NCT01860703|26268458|FG000|Overall Study|Personal reason|1|||
13216558|NCT01860703|26268459|FG001|Overall Study|Personal reason|0|||
13216559|NCT01860703|26268460|FG002|Overall Study|Personal reason|1|||
13216560|NCT01860703|26268461|FG003|Overall Study|Personal reason|0|||
13216561|NCT01860677|26268473|FG000|Second Intervention (1 Day)|Lost to Follow-up|7|||
13216562|NCT01860677|26268474|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
13216563|NCT01860534|26268493|FG000|ROP #1|Needed treatment for ROP|0|||
13216564|NCT01860534|26268494|FG001|ROP #1|Needed treatment for ROP|1|||
13216565|NCT01860534|26268493|FG000|ROP #2|discharged prior to ROP #2|1|||
13216566|NCT01860534|26268494|FG001|ROP #2|discharged prior to ROP #2|0|||
13216567|NCT01860079|26268507|FG000|Overall Study|Physician Decision|14|||
13216568|NCT01860079|26268508|FG001|Overall Study|Physician Decision|22|||
13216569|NCT01860040|26268520|FG000|Overall Study|Withdrawal by Subject|1|||
13216570|NCT01860040|26268521|FG001|Overall Study|Withdrawal by Subject|0|||
13216571|NCT01859988|26268632|FG000|Overall Study|Withdrawal by Subject|6|||
13216572|NCT01859988|26268633|FG001|Overall Study|Withdrawal by Subject|3|||
13216573|NCT01859988|26268634|FG002|Overall Study|Withdrawal by Subject|4|||
13216574|NCT01859988|26268635|FG003|Overall Study|Withdrawal by Subject|3|||
13216575|NCT01859988|26268636|FG004|Overall Study|Withdrawal by Subject|2|||
13216576|NCT01859988|26268637|FG005|Overall Study|Withdrawal by Subject|2|||
13216577|NCT01859988|26268632|FG000|Overall Study|Lack of Efficacy|1|||
13216578|NCT01859988|26268633|FG001|Overall Study|Lack of Efficacy|1|||
13216579|NCT01859988|26268634|FG002|Overall Study|Lack of Efficacy|5|||
13216580|NCT01859988|26268635|FG003|Overall Study|Lack of Efficacy|0|||
13216581|NCT01859988|26268636|FG004|Overall Study|Lack of Efficacy|7|||
13216582|NCT01859988|26268637|FG005|Overall Study|Lack of Efficacy|9|||
13216583|NCT01859988|26268632|FG000|Overall Study|Physician Decision|1|||
13216584|NCT01859988|26268633|FG001|Overall Study|Physician Decision|3|||
13216585|NCT01859988|26268634|FG002|Overall Study|Physician Decision|1|||
13216586|NCT01859988|26268635|FG003|Overall Study|Physician Decision|3|||
13216587|NCT01859988|26268636|FG004|Overall Study|Physician Decision|4|||
13216588|NCT01859988|26268637|FG005|Overall Study|Physician Decision|1|||
13216589|NCT01859988|26268632|FG000|Overall Study|Adverse Event|2|||
13216590|NCT01859988|26268633|FG001|Overall Study|Adverse Event|1|||
13216591|NCT01859988|26268634|FG002|Overall Study|Adverse Event|3|||
13216592|NCT01859988|26268635|FG003|Overall Study|Adverse Event|1|||
13216593|NCT01859988|26268636|FG004|Overall Study|Adverse Event|2|||
13216594|NCT01859988|26268637|FG005|Overall Study|Adverse Event|2|||
13216595|NCT01859988|26268632|FG000|Overall Study|Lost to Follow-up|1|||
13216596|NCT01859988|26268633|FG001|Overall Study|Lost to Follow-up|2|||
13216597|NCT01859988|26268634|FG002|Overall Study|Lost to Follow-up|3|||
13216598|NCT01859988|26268635|FG003|Overall Study|Lost to Follow-up|0|||
13216599|NCT01859988|26268636|FG004|Overall Study|Lost to Follow-up|3|||
13216600|NCT01859988|26268637|FG005|Overall Study|Lost to Follow-up|2|||
13216601|NCT01859988|26268632|FG000|Overall Study|Protocol Violation|0|||
13216602|NCT01859988|26268633|FG001|Overall Study|Protocol Violation|0|||
13216603|NCT01859988|26268634|FG002|Overall Study|Protocol Violation|1|||
13216604|NCT01859988|26268635|FG003|Overall Study|Protocol Violation|0|||
13216605|NCT01859988|26268636|FG004|Overall Study|Protocol Violation|0|||
13216606|NCT01859988|26268637|FG005|Overall Study|Protocol Violation|0|||
13216607|NCT01859988|26268632|FG000|Overall Study|Other than specified above|0|||
13216608|NCT01859988|26268633|FG001|Overall Study|Other than specified above|2|||
13216609|NCT01859988|26268634|FG002|Overall Study|Other than specified above|11|||
13216610|NCT01859988|26268635|FG003|Overall Study|Other than specified above|3|||
13216611|NCT01859988|26268636|FG004|Overall Study|Other than specified above|5|||
13216612|NCT01859988|26268637|FG005|Overall Study|Other than specified above|3|||
13216613|NCT01859949|26268660|FG000|Overall Study|Family Matters|0|||
13216614|NCT01859949|26268661|FG001|Overall Study|Family Matters|1|||
13216615|NCT01859949|26268660|FG000|Overall Study|Physician Decision|2|||
13216616|NCT01859949|26268661|FG001|Overall Study|Physician Decision|4|||
13216617|NCT01859949|26268660|FG000|Overall Study|Withdrawal by Subject|11|||
13216618|NCT01859949|26268661|FG001|Overall Study|Withdrawal by Subject|10|||
13216619|NCT01859949|26268660|FG000|Overall Study|Protocol Violation|1|||
13216620|NCT01859949|26268661|FG001|Overall Study|Protocol Violation|1|||
13216621|NCT01859949|26268660|FG000|Overall Study|Adverse Event|0|||
13216622|NCT01859949|26268661|FG001|Overall Study|Adverse Event|1|||
13216623|NCT01859923|26268726|FG000|Overall Study|Adverse Event|0|||
13216624|NCT01859923|26268727|FG001|Overall Study|Adverse Event|0|||
13216625|NCT01859923|26268728|FG002|Overall Study|Adverse Event|1|||
13216626|NCT01859923|26268729|FG003|Overall Study|Adverse Event|1|||
13216627|NCT01859793|26268746|FG000|First Intervention (8 Weeks)|Protocol Violation|2|||
13216628|NCT01859793|26268747|FG001|First Intervention (8 Weeks)|Protocol Violation|0|||
13216629|NCT01859793|26268746|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
13216630|NCT01859793|26268747|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
13216631|NCT01859793|26268746|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
13216632|NCT01859793|26268747|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
13216633|NCT01859793|26268746|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1|||
13216634|NCT01859793|26268747|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
13216635|NCT01859741|26268798|FG000|Overall Study|Death|3|||
13216636|NCT01859741|26268799|FG001|Overall Study|Death|2|||
13216637|NCT01859741|26268800|FG002|Overall Study|Death|4|||
13216638|NCT01859741|26268801|FG003|Overall Study|Death|3|||
13216639|NCT01859741|26268802|FG004|Overall Study|Death|5|||
13216640|NCT01859741|26268803|FG005|Overall Study|Death|4|||
13216641|NCT01859741|26268804|FG006|Overall Study|Death|51|||
13216642|NCT01859741|26268805|FG007|Overall Study|Death|51|||
13216643|NCT01859741|26268798|FG000|Overall Study|Lost to Follow-up|0|||
13216644|NCT01859741|26268799|FG001|Overall Study|Lost to Follow-up|0|||
13216645|NCT01859741|26268800|FG002|Overall Study|Lost to Follow-up|0|||
13216646|NCT01859741|26268801|FG003|Overall Study|Lost to Follow-up|0|||
13216647|NCT01859741|26268802|FG004|Overall Study|Lost to Follow-up|0|||
13216648|NCT01859741|26268803|FG005|Overall Study|Lost to Follow-up|1|||
13216649|NCT01859741|26268804|FG006|Overall Study|Lost to Follow-up|0|||
13216650|NCT01859741|26268805|FG007|Overall Study|Lost to Follow-up|4|||
13216651|NCT01859741|26268798|FG000|Overall Study|Withdrawal by Subject|0|||
13216652|NCT01859741|26268799|FG001|Overall Study|Withdrawal by Subject|1|||
13216653|NCT01859741|26268800|FG002|Overall Study|Withdrawal by Subject|2|||
13216654|NCT01859741|26268801|FG003|Overall Study|Withdrawal by Subject|0|||
13216655|NCT01859741|26268802|FG004|Overall Study|Withdrawal by Subject|0|||
13216656|NCT01859741|26268803|FG005|Overall Study|Withdrawal by Subject|1|||
13216657|NCT01859741|26268804|FG006|Overall Study|Withdrawal by Subject|1|||
13216658|NCT01859741|26268805|FG007|Overall Study|Withdrawal by Subject|1|||
13216659|NCT01859741|26268798|FG000|Overall Study|Study Terminated by Sponsor|0|||
13216660|NCT01859741|26268799|FG001|Overall Study|Study Terminated by Sponsor|0|||
13216661|NCT01859741|26268800|FG002|Overall Study|Study Terminated by Sponsor|0|||
13216662|NCT01859741|26268801|FG003|Overall Study|Study Terminated by Sponsor|0|||
13216663|NCT01859741|26268802|FG004|Overall Study|Study Terminated by Sponsor|1|||
13216664|NCT01859741|26268803|FG005|Overall Study|Study Terminated by Sponsor|0|||
13216665|NCT01859741|26268804|FG006|Overall Study|Study Terminated by Sponsor|16|||
13216666|NCT01859741|26268805|FG007|Overall Study|Study Terminated by Sponsor|14|||
13216667|NCT01859741|26268798|FG000|Overall Study|Other|0|||
13216668|NCT01859741|26268799|FG001|Overall Study|Other|0|||
13216669|NCT01859741|26268800|FG002|Overall Study|Other|0|||
13216670|NCT01859741|26268801|FG003|Overall Study|Other|0|||
13216671|NCT01859741|26268802|FG004|Overall Study|Other|0|||
13216672|NCT01859741|26268803|FG005|Overall Study|Other|0|||
13216673|NCT01859741|26268804|FG006|Overall Study|Other|2|||
13216674|NCT01859741|26268805|FG007|Overall Study|Other|0|||
13216675|NCT01859715|26268826|FG000|Overall Study|No 2nd VAS|16|||
13216676|NCT01859715|26268827|FG001|Overall Study|No 2nd VAS|8|||
13216677|NCT01859715|26268828|FG002|Overall Study|No 2nd VAS|23|||
13216678|NCT01859702|26268834|FG000|Overall Study|Protocol deviation|3|||
13216679|NCT01859702|26268834|FG000|Overall Study|Adverse Event|2|||
13216680|NCT01859598|26268844|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742|||
13216681|NCT01859507|26268851|FG000|Overall Study|left the country|4|||
13216682|NCT01859494|26268862|FG000|Overall Study|Adverse Event|1|||
13216683|NCT01859403|26268877|FG000|Primary Endpoint Measure|Lost to Follow-up|0|||
13216684|NCT01859403|26268878|FG001|Primary Endpoint Measure|Lost to Follow-up|2|||
13216685|NCT01859403|26268877|FG000|Primary Endpoint Measure|Withdrawal by Subject|1|||
13216686|NCT01859403|26268878|FG001|Primary Endpoint Measure|Withdrawal by Subject|1|||
13216687|NCT01859403|26268877|FG000|Primary Endpoint Measure|Physician Decision|0|||
13216688|NCT01859403|26268878|FG001|Primary Endpoint Measure|Physician Decision|1|||
13216689|NCT01859403|26268877|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6|||
13216690|NCT01859403|26268878|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8|||
13216691|NCT01859390|26268907|FG000|Overall Study|Insufficient Sputum Collected|1|||
13216692|NCT01859390|26268908|FG001|Overall Study|Insufficient Sputum Collected|3|||
13216693|NCT01859390|26268907|FG000|Overall Study|Sample Missing Collection Date|0|||
13216694|NCT01859390|26268908|FG001|Overall Study|Sample Missing Collection Date|1|||
13216695|NCT01859390|26268907|FG000|Overall Study|Tube Cracked|0|||
13216696|NCT01859390|26268908|FG001|Overall Study|Tube Cracked|2|||
13216697|NCT01859390|26268907|FG000|Overall Study|Shipment Error|0|||
13216698|NCT01859390|26268908|FG001|Overall Study|Shipment Error|1|||
13394779|NCT00654381|26788100|FG003|2nd Stage|Investigator's decision|1|||
13216699|NCT01859143|26268929|FG000|Overall Study|Lost to Follow-up|2|||
13216700|NCT01859143|26268930|FG001|Overall Study|Lost to Follow-up|0|||
13216701|NCT01858766|26269059|FG000|Overall Study|Randomized but Never Treated|0|||
13216702|NCT01858766|26269060|FG001|Overall Study|Randomized but Never Treated|0|||
13216703|NCT01858766|26269061|FG002|Overall Study|Randomized but Never Treated|0|||
13216704|NCT01858766|26269062|FG003|Overall Study|Randomized but Never Treated|0|||
13216705|NCT01858766|26269063|FG004|Overall Study|Randomized but Never Treated|0|||
13216706|NCT01858766|26269064|FG005|Overall Study|Randomized but Never Treated|1|||
13216707|NCT01858766|26269065|FG006|Overall Study|Randomized but Never Treated|0|||
13216708|NCT01858766|26269066|FG007|Overall Study|Randomized but Never Treated|0|||
13296955|NCT01368081|26497687|FG004|Overall Study|Other reason not defined above|0|||
13296956|NCT01368081|26497688|FG005|Overall Study|Other reason not defined above|1|||
13296957|NCT01368081|26497689|FG006|Overall Study|Other reason not defined above|2|||
13296958|NCT01368081|26497690|FG007|Overall Study|Other reason not defined above|0|||
13296959|NCT01368081|26497691|FG008|Overall Study|Other reason not defined above|0|||
13296960|NCT01368081|26497692|FG009|Overall Study|Other reason not defined above|1|||
13296961|NCT01368081|26497693|FG010|Overall Study|Other reason not defined above|0|||
13296962|NCT01368081|26497694|FG011|Overall Study|Other reason not defined above|0|||
13296963|NCT01368081|26497695|FG012|Overall Study|Other reason not defined above|3|||
13296964|NCT01368042|26497717|FG000|Overall Study|Death|14|||
13296965|NCT01368042|26497717|FG000|Overall Study|Protocol Violation|11|||
13296966|NCT01368042|26497717|FG000|Overall Study|Lost to Follow-up|4|||
13296967|NCT01368042|26497717|FG000|Overall Study|Transplanted|1|||
13296968|NCT01367886|26497726|FG000|Overall Study|Lost to Follow-up|4|||
13296969|NCT01367886|26497726|FG000|Overall Study|Lack of Efficacy|2|||
13296970|NCT01367886|26497726|FG000|Overall Study|Death|1|||
13296971|NCT01367847|26497747|FG000|Overall Study|Withdrawal by Subject|2|||
13296972|NCT01367847|26497748|FG001|Overall Study|Withdrawal by Subject|2|||
13296973|NCT01367834|26497777|FG000|Overall Study|Withdrawal by Subject|2|||
13296974|NCT01367834|26497778|FG001|Overall Study|Withdrawal by Subject|2|||
13296975|NCT01367834|26497777|FG000|Overall Study|Study was ended.|0|||
13296976|NCT01367834|26497778|FG001|Overall Study|Study was ended.|1|||
13296977|NCT01367704|26497795|FG000|Overall Study|Lost to Follow-up|47|||
13296978|NCT01367704|26497796|FG001|Overall Study|Lost to Follow-up|161|||
13296979|NCT01367665|26497831|FG000|Overall Study|Death|102|||
13296980|NCT01367665|26497832|FG001|Overall Study|Death|19|||
13296981|NCT01367665|26497831|FG000|Overall Study|Lost to Follow-up|222|||
13296982|NCT01367665|26497832|FG001|Overall Study|Lost to Follow-up|22|||
13296983|NCT01367665|26497831|FG000|Overall Study|Not Done|118|||
13296984|NCT01367665|26497832|FG001|Overall Study|Not Done|14|||
13296985|NCT01367457|26497862|FG000|Overall Study|Death|2|||
13296986|NCT01367457|26497863|FG001|Overall Study|Death|0|||
13296987|NCT01367457|26497864|FG002|Overall Study|Death|0|||
13296988|NCT01367457|26497862|FG000|Overall Study|Investigator's decision|2|||
13296989|NCT01367457|26497863|FG001|Overall Study|Investigator's decision|0|||
13296990|NCT01367457|26497864|FG002|Overall Study|Investigator's decision|0|||
13296991|NCT01367457|26497862|FG000|Overall Study|Clinical decline (CD)|2|||
13296992|NCT01367457|26497863|FG001|Overall Study|Clinical decline (CD)|0|||
13296993|NCT01367457|26497864|FG002|Overall Study|Clinical decline (CD)|0|||
13296994|NCT01367457|26497862|FG000|Overall Study|Progression and death|8|||
13296995|NCT01367457|26497863|FG001|Overall Study|Progression and death|0|||
13296996|NCT01367457|26497864|FG002|Overall Study|Progression and death|0|||
13296997|NCT01367457|26497862|FG000|Overall Study|Toxicity|16|||
13296998|NCT01367457|26497863|FG001|Overall Study|Toxicity|0|||
13296999|NCT01367457|26497864|FG002|Overall Study|Toxicity|0|||
13297000|NCT01367457|26497862|FG000|Overall Study|Progression|137|||
13297001|NCT01367457|26497863|FG001|Overall Study|Progression|0|||
13297002|NCT01367457|26497864|FG002|Overall Study|Progression|0|||
13297003|NCT01367457|26497862|FG000|Overall Study|Patient asks for rest + slow progression|1|||
13297004|NCT01367457|26497863|FG001|Overall Study|Patient asks for rest + slow progression|0|||
13297005|NCT01367457|26497864|FG002|Overall Study|Patient asks for rest + slow progression|0|||
13297006|NCT01367457|26497862|FG000|Overall Study|Investigator's opinion, stable disease|1|||
13297007|NCT01367457|26497863|FG001|Overall Study|Investigator's opinion, stable disease|0|||
13297008|NCT01367457|26497864|FG002|Overall Study|Investigator's opinion, stable disease|0|||
13297009|NCT01367457|26497862|FG000|Overall Study|Bleeding from cavernous haemangioma|1|||
13297010|NCT01367457|26497863|FG001|Overall Study|Bleeding from cavernous haemangioma|0|||
13297011|NCT01367457|26497864|FG002|Overall Study|Bleeding from cavernous haemangioma|0|||
13297012|NCT01367457|26497862|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1|||
13297013|NCT01367457|26497863|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
13297014|NCT01367457|26497864|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
13297015|NCT01367457|26497862|FG000|Overall Study|low grade toxicities + stable disease|1|||
13297016|NCT01367457|26497863|FG001|Overall Study|low grade toxicities + stable disease|0|||
13297017|NCT01367457|26497864|FG002|Overall Study|low grade toxicities + stable disease|0|||
13297018|NCT01367457|26497862|FG000|Overall Study|Choledocolithiasis and pancreatitis|1|||
13297019|NCT01367457|26497863|FG001|Overall Study|Choledocolithiasis and pancreatitis|0|||
13297020|NCT01367457|26497864|FG002|Overall Study|Choledocolithiasis and pancreatitis|0|||
13297021|NCT01367457|26497862|FG000|Overall Study|Withdrawal by Subject|1|||
13216709|NCT01858766|26269067|FG008|Overall Study|Randomized but Never Treated|0|||
13216710|NCT01858766|26269068|FG009|Overall Study|Randomized but Never Treated|0|||
13216711|NCT01858766|26269069|FG010|Overall Study|Randomized but Never Treated|0|||
13216712|NCT01858766|26269070|FG011|Overall Study|Randomized but Never Treated|0|||
13216713|NCT01858766|26269071|FG012|Overall Study|Randomized but Never Treated|0|||
13216714|NCT01858766|26269072|FG013|Overall Study|Randomized but Never Treated|0|||
13216715|NCT01858766|26269073|FG014|Overall Study|Randomized but Never Treated|0|||
13216716|NCT01858766|26269074|FG015|Overall Study|Randomized but Never Treated|0|||
13216717|NCT01858766|26269075|FG016|Overall Study|Randomized but Never Treated|0|||
13216718|NCT01858766|26269076|FG017|Overall Study|Randomized but Never Treated|1|||
13216719|NCT01858766|26269077|FG018|Overall Study|Randomized but Never Treated|0|||
13216720|NCT01858766|26269059|FG000|Overall Study|Death|0|||
13216721|NCT01858766|26269060|FG001|Overall Study|Death|0|||
13216722|NCT01858766|26269061|FG002|Overall Study|Death|1|||
13216723|NCT01858766|26269062|FG003|Overall Study|Death|0|||
13216724|NCT01858766|26269063|FG004|Overall Study|Death|0|||
13216725|NCT01858766|26269064|FG005|Overall Study|Death|0|||
13216726|NCT01858766|26269065|FG006|Overall Study|Death|0|||
13216727|NCT01858766|26269066|FG007|Overall Study|Death|0|||
13216728|NCT01858766|26269067|FG008|Overall Study|Death|0|||
13216729|NCT01858766|26269068|FG009|Overall Study|Death|0|||
13216730|NCT01858766|26269069|FG010|Overall Study|Death|0|||
13216731|NCT01858766|26269070|FG011|Overall Study|Death|0|||
13216732|NCT01858766|26269071|FG012|Overall Study|Death|0|||
13216733|NCT01858766|26269072|FG013|Overall Study|Death|0|||
13216734|NCT01858766|26269073|FG014|Overall Study|Death|0|||
13216735|NCT01858766|26269074|FG015|Overall Study|Death|0|||
13216736|NCT01858766|26269075|FG016|Overall Study|Death|0|||
13216737|NCT01858766|26269076|FG017|Overall Study|Death|0|||
13216738|NCT01858766|26269077|FG018|Overall Study|Death|0|||
13216739|NCT01858766|26269059|FG000|Overall Study|Lack of Efficacy|1|||
13216740|NCT01858766|26269060|FG001|Overall Study|Lack of Efficacy|0|||
13216741|NCT01858766|26269061|FG002|Overall Study|Lack of Efficacy|0|||
13216742|NCT01858766|26269062|FG003|Overall Study|Lack of Efficacy|0|||
13216743|NCT01858766|26269063|FG004|Overall Study|Lack of Efficacy|1|||
13216744|NCT01858766|26269064|FG005|Overall Study|Lack of Efficacy|2|||
13216745|NCT01858766|26269065|FG006|Overall Study|Lack of Efficacy|0|||
13216746|NCT01858766|26269066|FG007|Overall Study|Lack of Efficacy|0|||
13216747|NCT01858766|26269067|FG008|Overall Study|Lack of Efficacy|0|||
13216748|NCT01858766|26269068|FG009|Overall Study|Lack of Efficacy|0|||
13216749|NCT01858766|26269069|FG010|Overall Study|Lack of Efficacy|0|||
13216750|NCT01858766|26269070|FG011|Overall Study|Lack of Efficacy|3|||
13216751|NCT01858766|26269071|FG012|Overall Study|Lack of Efficacy|5|||
13216752|NCT01858766|26269072|FG013|Overall Study|Lack of Efficacy|3|||
13216753|NCT01858766|26269073|FG014|Overall Study|Lack of Efficacy|5|||
13216754|NCT01858766|26269074|FG015|Overall Study|Lack of Efficacy|5|||
13216755|NCT01858766|26269075|FG016|Overall Study|Lack of Efficacy|2|||
13216756|NCT01858766|26269076|FG017|Overall Study|Lack of Efficacy|3|||
13216757|NCT01858766|26269077|FG018|Overall Study|Lack of Efficacy|3|||
13216758|NCT01858766|26269059|FG000|Overall Study|Lost to Follow-up|0|||
13216759|NCT01858766|26269060|FG001|Overall Study|Lost to Follow-up|0|||
13216760|NCT01858766|26269061|FG002|Overall Study|Lost to Follow-up|0|||
13216761|NCT01858766|26269062|FG003|Overall Study|Lost to Follow-up|0|||
13216762|NCT01858766|26269063|FG004|Overall Study|Lost to Follow-up|0|||
13216763|NCT01858766|26269064|FG005|Overall Study|Lost to Follow-up|1|||
13216764|NCT01858766|26269065|FG006|Overall Study|Lost to Follow-up|0|||
13216765|NCT01858766|26269066|FG007|Overall Study|Lost to Follow-up|2|||
13216766|NCT01858766|26269067|FG008|Overall Study|Lost to Follow-up|0|||
13216767|NCT01858766|26269068|FG009|Overall Study|Lost to Follow-up|0|||
13216768|NCT01858766|26269069|FG010|Overall Study|Lost to Follow-up|0|||
13216769|NCT01858766|26269070|FG011|Overall Study|Lost to Follow-up|1|||
13216770|NCT01858766|26269071|FG012|Overall Study|Lost to Follow-up|0|||
13216771|NCT01858766|26269072|FG013|Overall Study|Lost to Follow-up|0|||
13216772|NCT01858766|26269073|FG014|Overall Study|Lost to Follow-up|3|||
13216773|NCT01858766|26269074|FG015|Overall Study|Lost to Follow-up|1|||
13216774|NCT01858766|26269075|FG016|Overall Study|Lost to Follow-up|1|||
13216775|NCT01858766|26269076|FG017|Overall Study|Lost to Follow-up|0|||
13216776|NCT01858766|26269077|FG018|Overall Study|Lost to Follow-up|1|||
13216777|NCT01858766|26269059|FG000|Overall Study|Withdrew Consent|0|||
13216778|NCT01858766|26269060|FG001|Overall Study|Withdrew Consent|0|||
13216779|NCT01858766|26269061|FG002|Overall Study|Withdrew Consent|0|||
13216780|NCT01858766|26269062|FG003|Overall Study|Withdrew Consent|0|||
13216781|NCT01858766|26269063|FG004|Overall Study|Withdrew Consent|0|||
13216782|NCT01858766|26269064|FG005|Overall Study|Withdrew Consent|0|||
13216783|NCT01858766|26269065|FG006|Overall Study|Withdrew Consent|0|||
13216784|NCT01858766|26269066|FG007|Overall Study|Withdrew Consent|0|||
13216785|NCT01858766|26269067|FG008|Overall Study|Withdrew Consent|0|||
13216786|NCT01858766|26269068|FG009|Overall Study|Withdrew Consent|0|||
13216787|NCT01858766|26269069|FG010|Overall Study|Withdrew Consent|0|||
13216788|NCT01858766|26269070|FG011|Overall Study|Withdrew Consent|1|||
13216789|NCT01858766|26269071|FG012|Overall Study|Withdrew Consent|0|||
13216790|NCT01858766|26269072|FG013|Overall Study|Withdrew Consent|0|||
13216791|NCT01858766|26269073|FG014|Overall Study|Withdrew Consent|0|||
13216792|NCT01858766|26269074|FG015|Overall Study|Withdrew Consent|0|||
13216793|NCT01858766|26269075|FG016|Overall Study|Withdrew Consent|0|||
13216794|NCT01858766|26269076|FG017|Overall Study|Withdrew Consent|0|||
13216795|NCT01858766|26269077|FG018|Overall Study|Withdrew Consent|0|||
13216796|NCT01858701|26269086|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
13216797|NCT01858701|26269087|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
13216798|NCT01858701|26269086|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1|||
13216799|NCT01858701|26269087|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0|||
13216800|NCT01858701|26269086|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1|||
13216801|NCT01858701|26269087|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2|||
13216802|NCT01858701|26269086|FG000|Period 2, Second 30 Days of Wear|Comfort|0|||
13216803|NCT01858701|26269087|FG001|Period 2, Second 30 Days of Wear|Comfort|1|||
13216804|NCT01858688|26269101|FG000|Overall Study|Withdrawal by Subject|8|||
13216805|NCT01858688|26269101|FG000|Overall Study|Participant began another therapy|3|||
13216806|NCT01858688|26269101|FG000|Overall Study|Physician Decision|2|||
13216807|NCT01858688|26269101|FG000|Overall Study|Progressive Disease|2|||
13216808|NCT01858688|26269101|FG000|Overall Study|Reason not reproted|5|||
13216809|NCT01858636|26269108|FG000|Overall Study|No Device Deployment Attempted|24|||
13216810|NCT01858636|26269108|FG000|Overall Study|Physician Decision|1|||
13216811|NCT01858636|26269108|FG000|Overall Study|Death|1|||
13216812|NCT01858636|26269108|FG000|Overall Study|Lost to Follow-up|1|||
13216813|NCT01858636|26269108|FG000|Overall Study|Withdrawal by Subject|1|||
13216814|NCT01858558|26269124|FG000|Overall Study|Death|1|||
13216815|NCT01858558|26269125|FG001|Overall Study|Death|1|||
13216816|NCT01858558|26269124|FG000|Overall Study|Lost to Follow-up|1|||
13216817|NCT01858558|26269125|FG001|Overall Study|Lost to Follow-up|0|||
13216818|NCT01858558|26269124|FG000|Overall Study|Disease progression|3|||
13216819|NCT01858558|26269125|FG001|Overall Study|Disease progression|1|||
13216820|NCT01858558|26269124|FG000|Overall Study|Product contamination|2|||
13216821|NCT01858558|26269125|FG001|Overall Study|Product contamination|0|||
13216822|NCT01858558|26269124|FG000|Overall Study|Failed expansion of cell product|2|||
13216823|NCT01858558|26269125|FG001|Overall Study|Failed expansion of cell product|0|||
13216824|NCT01858532|26269153|FG000|Overall Study|Adverse Event|58|||
13216825|NCT01858532|26269154|FG001|Overall Study|Adverse Event|50|||
13216826|NCT01858532|26269155|FG002|Overall Study|Adverse Event|23|||
13216827|NCT01858532|26269156|FG003|Overall Study|Adverse Event|28|||
13216828|NCT01858532|26269153|FG000|Overall Study|Withdrew consent|71|||
13216829|NCT01858532|26269154|FG001|Overall Study|Withdrew consent|93|||
13216830|NCT01858532|26269155|FG002|Overall Study|Withdrew consent|46|||
13216831|NCT01858532|26269156|FG003|Overall Study|Withdrew consent|27|||
13216832|NCT01858532|26269153|FG000|Overall Study|Lost to Follow-up|17|||
13216833|NCT01858532|26269154|FG001|Overall Study|Lost to Follow-up|26|||
13216834|NCT01858532|26269155|FG002|Overall Study|Lost to Follow-up|11|||
13216835|NCT01858532|26269156|FG003|Overall Study|Lost to Follow-up|14|||
13216836|NCT01858532|26269153|FG000|Overall Study|Deterioration of medical status|3|||
13216837|NCT01858532|26269154|FG001|Overall Study|Deterioration of medical status|4|||
13216838|NCT01858532|26269155|FG002|Overall Study|Deterioration of medical status|3|||
13216839|NCT01858532|26269156|FG003|Overall Study|Deterioration of medical status|7|||
13216840|NCT01858532|26269153|FG000|Overall Study|Investigator request|3|||
13216841|NCT01858532|26269154|FG001|Overall Study|Investigator request|4|||
13216842|NCT01858532|26269155|FG002|Overall Study|Investigator request|2|||
13216843|NCT01858532|26269156|FG003|Overall Study|Investigator request|6|||
13216844|NCT01858532|26269153|FG000|Overall Study|Other, not specified|29|||
13216845|NCT01858532|26269154|FG001|Overall Study|Other, not specified|15|||
13216846|NCT01858532|26269155|FG002|Overall Study|Other, not specified|13|||
13216847|NCT01858532|26269156|FG003|Overall Study|Other, not specified|11|||
13216848|NCT01858389|26269178|FG000|Overall Study|Death|1|||
13216849|NCT01858389|26269179|FG001|Overall Study|Death|3|||
13216850|NCT01858389|26269178|FG000|Overall Study|Study terminated by sponsor|0|||
13216851|NCT01858389|26269179|FG001|Overall Study|Study terminated by sponsor|2|||
13216852|NCT01858389|26269178|FG000|Overall Study|Withdrawal by Subject|0|||
13216853|NCT01858389|26269179|FG001|Overall Study|Withdrawal by Subject|1|||
13216854|NCT01858389|26269178|FG000|Overall Study|Progressive disease|10|||
13216855|NCT01858389|26269179|FG001|Overall Study|Progressive disease|11|||
13216856|NCT01858389|26269178|FG000|Overall Study|Other|2|||
13216857|NCT01858389|26269179|FG001|Overall Study|Other|4|||
13216858|NCT01858389|26269178|FG000|Overall Study|Adverse Event|3|||
13216859|NCT01858389|26269179|FG001|Overall Study|Adverse Event|1|||
13216860|NCT01858389|26269178|FG000|Overall Study|Did not receive treatment|0|||
13216861|NCT01858389|26269179|FG001|Overall Study|Did not receive treatment|3|||
13216862|NCT01858376|26269188|FG000|Overall Study|Dropped d/t lab work not fitting criter|4|||
13216863|NCT01858363|26269203|FG000|Overall Study|Death|35|||
13216864|NCT01858363|26269204|FG001|Overall Study|Death|9|||
13216865|NCT01858363|26269203|FG000|Overall Study|Withdrawal by Subject|28|||
13216866|NCT01858363|26269204|FG001|Overall Study|Withdrawal by Subject|14|||
13216867|NCT01858363|26269203|FG000|Overall Study|Lost to Follow-up|13|||
13216868|NCT01858363|26269204|FG001|Overall Study|Lost to Follow-up|3|||
13216869|NCT01858194|26269251|FG000|Overall Study|Total Artificial Heart Implant|0|||
13216870|NCT01858194|26269252|FG001|Overall Study|Total Artificial Heart Implant|1|||
13216871|NCT01858194|26269251|FG000|Overall Study|Lost to Follow-up|0|||
13297022|NCT01367457|26497863|FG001|Overall Study|Withdrawal by Subject|0|||
13297023|NCT01367457|26497864|FG002|Overall Study|Withdrawal by Subject|0|||
13297024|NCT01367457|26497862|FG000|Overall Study|CD, associated leukaemia|1|||
13297025|NCT01367457|26497863|FG001|Overall Study|CD, associated leukaemia|0|||
13297026|NCT01367457|26497864|FG002|Overall Study|CD, associated leukaemia|0|||
13297027|NCT01367457|26497862|FG000|Overall Study|Uncontrolled pain|1|||
13297028|NCT01367457|26497863|FG001|Overall Study|Uncontrolled pain|0|||
13297029|NCT01367457|26497864|FG002|Overall Study|Uncontrolled pain|0|||
13297030|NCT01367457|26497862|FG000|Overall Study|Overall status worsens to grade 4|1|||
13297031|NCT01367457|26497863|FG001|Overall Study|Overall status worsens to grade 4|0|||
13297032|NCT01367457|26497864|FG002|Overall Study|Overall status worsens to grade 4|0|||
13297033|NCT01367457|26497862|FG000|Overall Study|Stabilisation + frequent infections|1|||
13297034|NCT01367457|26497863|FG001|Overall Study|Stabilisation + frequent infections|0|||
13297035|NCT01367457|26497864|FG002|Overall Study|Stabilisation + frequent infections|0|||
13297036|NCT01367457|26497862|FG000|Overall Study|No clinical benefit|1|||
13297037|NCT01367457|26497863|FG001|Overall Study|No clinical benefit|0|||
13297038|NCT01367457|26497864|FG002|Overall Study|No clinical benefit|0|||
13297039|NCT01367457|26497862|FG000|Overall Study|Intestinal obstruction with necrosis|1|||
13297040|NCT01367457|26497863|FG001|Overall Study|Intestinal obstruction with necrosis|0|||
13297041|NCT01367457|26497864|FG002|Overall Study|Intestinal obstruction with necrosis|0|||
13297042|NCT01367457|26497862|FG000|Overall Study|Overall decline|1|||
13297043|NCT01367457|26497863|FG001|Overall Study|Overall decline|0|||
13297044|NCT01367457|26497864|FG002|Overall Study|Overall decline|0|||
13297045|NCT01367457|26497862|FG000|Overall Study|Rejection of treatment|1|||
13297046|NCT01367457|26497863|FG001|Overall Study|Rejection of treatment|0|||
13297047|NCT01367457|26497864|FG002|Overall Study|Rejection of treatment|0|||
13297048|NCT01367457|26497862|FG000|Overall Study|Lost to Follow-up|1|||
13297049|NCT01367457|26497863|FG001|Overall Study|Lost to Follow-up|0|||
13297050|NCT01367457|26497864|FG002|Overall Study|Lost to Follow-up|0|||
13297051|NCT01367457|26497862|FG000|Overall Study|Death from septic shock|1|||
13297052|NCT01367457|26497863|FG001|Overall Study|Death from septic shock|0|||
13297053|NCT01367457|26497864|FG002|Overall Study|Death from septic shock|0|||
13216872|NCT01858194|26269252|FG001|Overall Study|Lost to Follow-up|1|||
13216873|NCT01857973|26269265|FG000|Overall Study|Subject did not meet required BG range|3|||
13216874|NCT01857973|26269265|FG000|Overall Study|drop out after 3 failed attempts|1|||
13216875|NCT01857973|26269265|FG000|Overall Study|Physician Decision|1|||
13216876|NCT01857869|26269376|FG000|Primary/Challenge Phase|Lost to Follow-up|2|||
13216877|NCT01857869|26269377|FG001|Primary/Challenge Phase|Lost to Follow-up|0|||
13216878|NCT01857869|26269378|FG002|Primary/Challenge Phase|Lost to Follow-up|0|||
13216879|NCT01857869|26269379|FG003|Primary/Challenge Phase|Lost to Follow-up|0|||
13216880|NCT01857869|26269380|FG004|Primary/Challenge Phase|Lost to Follow-up|0|||
13216881|NCT01857869|26269381|FG005|Primary/Challenge Phase|Lost to Follow-up|0|||
13216882|NCT01857869|26269382|FG006|Primary/Challenge Phase|Lost to Follow-up|0|||
13216883|NCT01857869|26269383|FG007|Primary/Challenge Phase|Lost to Follow-up|0|||
13216884|NCT01857869|26269384|FG008|Primary/Challenge Phase|Lost to Follow-up|0|||
13216885|NCT01857869|26269385|FG009|Primary/Challenge Phase|Lost to Follow-up|0|||
13216886|NCT01857869|26269376|FG000|Primary/Challenge Phase|Pregnancy|1|||
13216887|NCT01857869|26269377|FG001|Primary/Challenge Phase|Pregnancy|0|||
13216888|NCT01857869|26269378|FG002|Primary/Challenge Phase|Pregnancy|0|||
13216889|NCT01857869|26269379|FG003|Primary/Challenge Phase|Pregnancy|0|||
13216890|NCT01857869|26269380|FG004|Primary/Challenge Phase|Pregnancy|0|||
13216891|NCT01857869|26269381|FG005|Primary/Challenge Phase|Pregnancy|0|||
13216892|NCT01857869|26269382|FG006|Primary/Challenge Phase|Pregnancy|0|||
13216893|NCT01857869|26269383|FG007|Primary/Challenge Phase|Pregnancy|0|||
13216894|NCT01857869|26269384|FG008|Primary/Challenge Phase|Pregnancy|0|||
13216895|NCT01857869|26269385|FG009|Primary/Challenge Phase|Pregnancy|0|||
13216896|NCT01857869|26269376|FG000|Primary/Challenge Phase|Protocol Violation|1|||
13216897|NCT01857869|26269377|FG001|Primary/Challenge Phase|Protocol Violation|0|||
13216898|NCT01857869|26269378|FG002|Primary/Challenge Phase|Protocol Violation|0|||
13216899|NCT01857869|26269379|FG003|Primary/Challenge Phase|Protocol Violation|0|||
13216900|NCT01857869|26269380|FG004|Primary/Challenge Phase|Protocol Violation|0|||
13216901|NCT01857869|26269381|FG005|Primary/Challenge Phase|Protocol Violation|0|||
13216902|NCT01857869|26269382|FG006|Primary/Challenge Phase|Protocol Violation|0|||
13216903|NCT01857869|26269383|FG007|Primary/Challenge Phase|Protocol Violation|0|||
13216904|NCT01857869|26269384|FG008|Primary/Challenge Phase|Protocol Violation|0|||
13216905|NCT01857869|26269385|FG009|Primary/Challenge Phase|Protocol Violation|0|||
13216906|NCT01857869|26269376|FG000|Primary/Challenge Phase|Other|1|||
13216907|NCT01857869|26269377|FG001|Primary/Challenge Phase|Other|1|||
13216908|NCT01857869|26269378|FG002|Primary/Challenge Phase|Other|0|||
13216909|NCT01857869|26269379|FG003|Primary/Challenge Phase|Other|0|||
13216910|NCT01857869|26269380|FG004|Primary/Challenge Phase|Other|0|||
13216911|NCT01857869|26269381|FG005|Primary/Challenge Phase|Other|0|||
13216912|NCT01857869|26269382|FG006|Primary/Challenge Phase|Other|0|||
13216913|NCT01857869|26269383|FG007|Primary/Challenge Phase|Other|0|||
13216914|NCT01857869|26269384|FG008|Primary/Challenge Phase|Other|0|||
13216915|NCT01857869|26269385|FG009|Primary/Challenge Phase|Other|0|||
13216916|NCT01857869|26269376|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
13216917|NCT01857869|26269377|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
13216918|NCT01857869|26269378|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
13216919|NCT01857869|26269379|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1|||
13216920|NCT01857869|26269380|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
13216921|NCT01857869|26269381|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
13216922|NCT01857869|26269382|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
13216923|NCT01857869|26269383|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
13216924|NCT01857869|26269384|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
13216925|NCT01857869|26269385|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
13216926|NCT01857869|26269376|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
13216927|NCT01857869|26269377|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
13216928|NCT01857869|26269378|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
13216929|NCT01857869|26269379|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1|||
13216930|NCT01857869|26269380|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
13216931|NCT01857869|26269381|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
13216932|NCT01857869|26269382|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
13216933|NCT01857869|26269383|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
13216934|NCT01857869|26269384|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
13216935|NCT01857869|26269385|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
13216936|NCT01857622|26269403|FG000|Overall Study|Adverse Event|5|||
13216937|NCT01857622|26269404|FG001|Overall Study|Adverse Event|0|||
13216938|NCT01857622|26269405|FG002|Overall Study|Adverse Event|2|||
13216939|NCT01857622|26269403|FG000|Overall Study|Physician Decision|1|||
13216940|NCT01857622|26269404|FG001|Overall Study|Physician Decision|0|||
13216941|NCT01857622|26269405|FG002|Overall Study|Physician Decision|0|||
13216942|NCT01857622|26269403|FG000|Overall Study|Protocol Violation|4|||
13216943|NCT01857622|26269404|FG001|Overall Study|Protocol Violation|1|||
13216944|NCT01857622|26269405|FG002|Overall Study|Protocol Violation|0|||
13216945|NCT01857622|26269403|FG000|Overall Study|Withdrawal by Subject|1|||
13216946|NCT01857622|26269404|FG001|Overall Study|Withdrawal by Subject|0|||
13216947|NCT01857622|26269405|FG002|Overall Study|Withdrawal by Subject|0|||
13216948|NCT01857583|26269428|FG000|Overall Study|Adverse Event|0|||
13216949|NCT01857583|26269429|FG001|Overall Study|Adverse Event|0|||
13216950|NCT01857583|26269430|FG002|Overall Study|Adverse Event|1|||
13216951|NCT01857583|26269431|FG003|Overall Study|Adverse Event|1|||
13216952|NCT01857583|26269428|FG000|Overall Study|Death|0|||
13216953|NCT01857583|26269429|FG001|Overall Study|Death|1|||
13216954|NCT01857583|26269430|FG002|Overall Study|Death|1|||
13216955|NCT01857583|26269431|FG003|Overall Study|Death|0|||
13216956|NCT01857583|26269428|FG000|Overall Study|Physician Decision|0|||
13216957|NCT01857583|26269429|FG001|Overall Study|Physician Decision|0|||
13216958|NCT01857583|26269430|FG002|Overall Study|Physician Decision|0|||
13216959|NCT01857583|26269431|FG003|Overall Study|Physician Decision|1|||
13216960|NCT01857583|26269428|FG000|Overall Study|Withdrawal by Subject|1|||
13216961|NCT01857583|26269429|FG001|Overall Study|Withdrawal by Subject|0|||
13216962|NCT01857583|26269430|FG002|Overall Study|Withdrawal by Subject|1|||
13216963|NCT01857583|26269431|FG003|Overall Study|Withdrawal by Subject|2|||
13216964|NCT01857531|26269442|FG000|Overall Study|Withdrawal by Subject|4|||
13216965|NCT01857323|26269453|FG000|Overall Study|Adverse Event|1|||
13216966|NCT01857323|26269453|FG000|Overall Study|Withdrawal by Subject|3|||
13216967|NCT01857323|26269453|FG000|Overall Study|Non-compliance|1|||
13216968|NCT01857323|26269453|FG000|Overall Study|Protocol Violation|6|||
13216969|NCT01857323|26269453|FG000|Overall Study|Lost to Follow-up|1|||
13216970|NCT01857323|26269453|FG000|Overall Study|Other|4|||
13216971|NCT01857323|26269453|FG000|Overall Study|Did not complete 180 doses|48|||
13216972|NCT01857310|26269538|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315|||
13216973|NCT01857310|26269539|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282|||
13216974|NCT01857271|26269545|FG000|Overall Study|Lost to Follow-up|1|||
13216975|NCT01857206|26269570|FG000|Overall Study|ADMINISTRATIVE REASON|0|||
13216976|NCT01857206|26269571|FG001|Overall Study|ADMINISTRATIVE REASON|1|||
13216977|NCT01857206|26269570|FG000|Overall Study|Lost to Follow-up|9|||
13216978|NCT01857206|26269571|FG001|Overall Study|Lost to Follow-up|6|||
13216979|NCT01857206|26269570|FG000|Overall Study|Unclassified|3|||
13216980|NCT01857206|26269571|FG001|Overall Study|Unclassified|3|||
13216981|NCT01857206|26269570|FG000|Overall Study|Withdrawal by Subject|1|||
13216982|NCT01857206|26269571|FG001|Overall Study|Withdrawal by Subject|0|||
13216983|NCT01857102|26269582|FG000|Period 1|No longer meets Eligibility Criteria|0|||
13216984|NCT01857102|26269583|FG001|Period 1|No longer meets Eligibility Criteria|2|||
13216985|NCT01857102|26269582|FG000|Period 1|Lost to Follow-up|0|||
13216986|NCT01857102|26269583|FG001|Period 1|Lost to Follow-up|3|||
13216987|NCT01857102|26269582|FG000|Period 1|Unsatisfactory Lens Fit|1|||
13216988|NCT01857102|26269583|FG001|Period 1|Unsatisfactory Lens Fit|0|||
13216989|NCT01857102|26269582|FG000|Period 1|Unsatisfactory Visual Response|1|||
13216990|NCT01857102|26269583|FG001|Period 1|Unsatisfactory Visual Response|0|||
13216991|NCT01857102|26269582|FG000|Period 1|Physician Decision|1|||
13216992|NCT01857102|26269583|FG001|Period 1|Physician Decision|0|||
13216993|NCT01857102|26269582|FG000|Period 2|Lens Discomfort|1|||
13216994|NCT01857102|26269583|FG001|Period 2|Lens Discomfort|0|||
13216995|NCT01857102|26269582|FG000|Period 2|Unsatisfactory Lens Fit|1|||
13216996|NCT01857102|26269583|FG001|Period 2|Unsatisfactory Lens Fit|0|||
13216997|NCT01857063|26269616|FG000|Period 1 (7 Days)|Adverse Event|0|||
13216998|NCT01857063|26269617|FG001|Period 1 (7 Days)|Adverse Event|1|||
13216999|NCT01857063|26269616|FG000|Period 1 (7 Days)|Physician Decision|1|||
13217000|NCT01857063|26269617|FG001|Period 1 (7 Days)|Physician Decision|0|||
13217001|NCT01857063|26269616|FG000|Period 1 (7 Days)|Withdrawal by Subject|1|||
13217002|NCT01857063|26269617|FG001|Period 1 (7 Days)|Withdrawal by Subject|3|||
13217003|NCT01857063|26269616|FG000|Period 2 (7 Days)|Adverse Event|2|||
13217004|NCT01857063|26269617|FG001|Period 2 (7 Days)|Adverse Event|1|||
13217005|NCT01857063|26269616|FG000|Period 2 (7 Days)|Physician Decision|1|||
13217006|NCT01857063|26269617|FG001|Period 2 (7 Days)|Physician Decision|1|||
13217007|NCT01857063|26269616|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
13217008|NCT01857063|26269617|FG001|Period 2 (7 Days)|Withdrawal by Subject|0|||
13217009|NCT01856907|26269665|FG000|Overall Study|Pregnancy|0|||
13217010|NCT01856907|26269666|FG001|Overall Study|Pregnancy|1|||
13217011|NCT01856907|26269667|FG002|Overall Study|Pregnancy|0|||
13217012|NCT01856907|26269665|FG000|Overall Study|Pregnancy|0|||
13217013|NCT01856907|26269666|FG001|Overall Study|Pregnancy|1|||
13217014|NCT01856907|26269667|FG002|Overall Study|Pregnancy|0|||
13217015|NCT01856907|26269665|FG000|Overall Study|Withdrawal by Subject|0|||
13217016|NCT01856907|26269666|FG001|Overall Study|Withdrawal by Subject|1|||
13217017|NCT01856907|26269667|FG002|Overall Study|Withdrawal by Subject|0|||
13217018|NCT01856790|26269693|FG000|Closed Loop Control|Withdrawal by Subject|2|||
13217019|NCT01856790|26269693|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2|||
13217020|NCT01856686|26269740|FG000|Overall Study|Lost to Follow-up|5|||
13217021|NCT01856686|26269741|FG001|Overall Study|Lost to Follow-up|11|||
13217022|NCT01856673|26269762|FG000|Overall Study|Withdrawal by Subject|44|||
13217023|NCT01856673|26269763|FG001|Overall Study|Withdrawal by Subject|50|||
13217024|NCT01856673|26269764|FG002|Overall Study|Withdrawal by Subject|33|||
13217025|NCT01856673|26269762|FG000|Overall Study|Lost to Follow-up|31|||
13217026|NCT01856673|26269763|FG001|Overall Study|Lost to Follow-up|34|||
13217027|NCT01856673|26269764|FG002|Overall Study|Lost to Follow-up|0|||
13217028|NCT01856673|26269762|FG000|Overall Study|Unknown reasons|9|||
13217029|NCT01856673|26269763|FG001|Overall Study|Unknown reasons|0|||
13217030|NCT01856673|26269764|FG002|Overall Study|Unknown reasons|0|||
13217031|NCT01856673|26269762|FG000|Overall Study|Psychologist decision|1|||
13217032|NCT01856673|26269763|FG001|Overall Study|Psychologist decision|0|||
13217033|NCT01856673|26269764|FG002|Overall Study|Psychologist decision|0|||
13217034|NCT01856673|26269762|FG000|Overall Study|Paperwork errors|8|||
13217035|NCT01856673|26269763|FG001|Overall Study|Paperwork errors|0|||
13217036|NCT01856673|26269764|FG002|Overall Study|Paperwork errors|0|||
13217037|NCT01856673|26269762|FG000|Overall Study|Death|1|||
13217038|NCT01856673|26269763|FG001|Overall Study|Death|1|||
13217039|NCT01856673|26269764|FG002|Overall Study|Death|0|||
13217040|NCT01856673|26269762|FG000|Overall Study|Protocol Violation|1|||
13217041|NCT01856673|26269763|FG001|Overall Study|Protocol Violation|0|||
13217042|NCT01856673|26269764|FG002|Overall Study|Protocol Violation|1|||
13217043|NCT01856595|26270025|FG000|Overall Study|Withdrawal by Subject|0|||
13217044|NCT01856595|26270026|FG001|Overall Study|Withdrawal by Subject|1|||
13217045|NCT01856595|26270027|FG002|Overall Study|Withdrawal by Subject|0|||
13217046|NCT01856595|26270028|FG003|Overall Study|Withdrawal by Subject|0|||
13217047|NCT01856595|26270029|FG004|Overall Study|Withdrawal by Subject|0|||
13217048|NCT01856595|26270030|FG005|Overall Study|Withdrawal by Subject|0|||
13217049|NCT01856595|26270031|FG006|Overall Study|Withdrawal by Subject|1|||
13217050|NCT01856595|26270032|FG007|Overall Study|Withdrawal by Subject|0|||
13217051|NCT01856595|26270033|FG008|Overall Study|Withdrawal by Subject|0|||
13217052|NCT01856582|26270039|FG000|Overall Study|Died prior to Boost infusion|1|||
13217053|NCT01856569|26270050|FG000|Overall Study|Other|1|||
13217054|NCT01856569|26270050|FG000|Overall Study|Changed Site/Structure|1|||
13217055|NCT01856569|26270050|FG000|Overall Study|Lost to Follow-up|3|||
13217056|NCT01856569|26270050|FG000|Overall Study|Did not met inclusion criteria|8|||
13217057|NCT01856543|26270067|FG000|Overall Study|Treatment discontinued|6|||
13217058|NCT01856543|26270068|FG001|Overall Study|Treatment discontinued|3|||
13217059|NCT01856543|26270067|FG000|Overall Study|Withdrawn before start|7|||
13217060|NCT01856543|26270068|FG001|Overall Study|Withdrawn before start|3|||
13217061|NCT01856322|26270085|FG000|Overall Study|off study due to lack of accrual|0|||
13217062|NCT01856322|26270086|FG001|Overall Study|off study due to lack of accrual|0|||
13381998|NCT00748241|26749615|FG000|Overall Study|Lost to Follow-up|5|||
13217063|NCT01856322|26270087|FG002|Overall Study|off study due to lack of accrual|3|||
13217064|NCT01856309|26270198|FG000|Overall Study|Death|4|||
13217065|NCT01856309|26270199|FG001|Overall Study|Death|6|||
13217066|NCT01856309|26270200|FG002|Overall Study|Death|11|||
13217067|NCT01856309|26270201|FG003|Overall Study|Death|6|||
13217068|NCT01856309|26270198|FG000|Overall Study|Lost to Follow-up|6|||
13217069|NCT01856309|26270199|FG001|Overall Study|Lost to Follow-up|2|||
13217070|NCT01856309|26270200|FG002|Overall Study|Lost to Follow-up|4|||
13217071|NCT01856309|26270201|FG003|Overall Study|Lost to Follow-up|8|||
13217072|NCT01856309|26270198|FG000|Overall Study|Withdrawal by Subject|11|||
13217073|NCT01856309|26270199|FG001|Overall Study|Withdrawal by Subject|13|||
13217074|NCT01856309|26270200|FG002|Overall Study|Withdrawal by Subject|28|||
13217075|NCT01856309|26270201|FG003|Overall Study|Withdrawal by Subject|26|||
13217076|NCT01856309|26270198|FG000|Overall Study|Other|227|||
13217077|NCT01856309|26270199|FG001|Overall Study|Other|225|||
13217078|NCT01856309|26270200|FG002|Overall Study|Other|447|||
13217079|NCT01856309|26270201|FG003|Overall Study|Other|469|||
13217080|NCT01856309|26270198|FG000|Overall Study|Lack of Efficacy|14|||
13217081|NCT01856309|26270199|FG001|Overall Study|Lack of Efficacy|9|||
13217082|NCT01856309|26270200|FG002|Overall Study|Lack of Efficacy|40|||
13217083|NCT01856309|26270201|FG003|Overall Study|Lack of Efficacy|25|||
13217084|NCT01856309|26270198|FG000|Overall Study|Adverse Event|31|||
13217085|NCT01856309|26270199|FG001|Overall Study|Adverse Event|31|||
13217086|NCT01856309|26270200|FG002|Overall Study|Adverse Event|55|||
13217087|NCT01856309|26270201|FG003|Overall Study|Adverse Event|65|||
13217088|NCT01856309|26270198|FG000|Overall Study|Pregnancy|0|||
13217089|NCT01856309|26270199|FG001|Overall Study|Pregnancy|0|||
13217090|NCT01856309|26270200|FG002|Overall Study|Pregnancy|0|||
13217091|NCT01856309|26270201|FG003|Overall Study|Pregnancy|1|||
13217092|NCT01856309|26270198|FG000|Overall Study|Physician Decision|6|||
13217093|NCT01856309|26270199|FG001|Overall Study|Physician Decision|1|||
13217094|NCT01856309|26270200|FG002|Overall Study|Physician Decision|6|||
13217095|NCT01856309|26270201|FG003|Overall Study|Physician Decision|8|||
13217096|NCT01856309|26270198|FG000|Overall Study|Noncompliance With Study Drug|0|||
13217097|NCT01856309|26270199|FG001|Overall Study|Noncompliance With Study Drug|1|||
13217098|NCT01856309|26270200|FG002|Overall Study|Noncompliance With Study Drug|4|||
13217099|NCT01856309|26270201|FG003|Overall Study|Noncompliance With Study Drug|1|||
13217100|NCT01856257|26270311|FG000|Overall Study|Death|2|||
13217101|NCT01856257|26270312|FG001|Overall Study|Death|0|||
13217102|NCT01856257|26270313|FG002|Overall Study|Death|0|||
13217103|NCT01856257|26270314|FG003|Overall Study|Death|0|||
13217104|NCT01856257|26270311|FG000|Overall Study|Physician Decision|0|||
13217105|NCT01856257|26270312|FG001|Overall Study|Physician Decision|0|||
13217106|NCT01856257|26270313|FG002|Overall Study|Physician Decision|0|||
13217107|NCT01856257|26270314|FG003|Overall Study|Physician Decision|1|||
13217108|NCT01856257|26270311|FG000|Overall Study|Withdrawal by Subject|1|||
13217109|NCT01856257|26270312|FG001|Overall Study|Withdrawal by Subject|1|||
13217110|NCT01856257|26270313|FG002|Overall Study|Withdrawal by Subject|0|||
13217111|NCT01856257|26270314|FG003|Overall Study|Withdrawal by Subject|0|||
13217112|NCT01856257|26270311|FG000|Overall Study|Donor complication|0|||
13217113|NCT01856257|26270312|FG001|Overall Study|Donor complication|0|||
13217114|NCT01856257|26270313|FG002|Overall Study|Donor complication|0|||
13217115|NCT01856257|26270314|FG003|Overall Study|Donor complication|1|||
13217116|NCT01856114|26270331|FG000|Overall Study|Withdrawal by Subject|1|||
13217117|NCT01856114|26270332|FG001|Overall Study|Withdrawal by Subject|0|||
13217118|NCT01856114|26270331|FG000|Overall Study|Adverse Event|1|||
13217119|NCT01856114|26270332|FG001|Overall Study|Adverse Event|0|||
13217120|NCT01855958|26270357|FG000|Overall Study|Withdrawal by Subject|1|||
13217121|NCT01855958|26270358|FG001|Overall Study|Withdrawal by Subject|0|||
13217122|NCT01855945|26270529|FG000|Overall Study|Adverse Event|0|||
13217123|NCT01855945|26270530|FG001|Overall Study|Adverse Event|0|||
13217124|NCT01855945|26270531|FG002|Overall Study|Adverse Event|0|||
13217125|NCT01855945|26270532|FG003|Overall Study|Adverse Event|0|||
13217126|NCT01855945|26270533|FG004|Overall Study|Adverse Event|0|||
13217127|NCT01855945|26270534|FG005|Overall Study|Adverse Event|0|||
13217128|NCT01855945|26270535|FG006|Overall Study|Adverse Event|1|||
13217129|NCT01855945|26270536|FG007|Overall Study|Adverse Event|0|||
13217130|NCT01855945|26270537|FG008|Overall Study|Adverse Event|0|||
13217131|NCT01855945|26270538|FG009|Overall Study|Adverse Event|0|||
13217132|NCT01855945|26270539|FG010|Overall Study|Adverse Event|0|||
13217133|NCT01855945|26270540|FG011|Overall Study|Adverse Event|0|||
13217134|NCT01855945|26270529|FG000|Overall Study|Death|0|||
13217135|NCT01855945|26270530|FG001|Overall Study|Death|0|||
13217136|NCT01855945|26270531|FG002|Overall Study|Death|0|||
13217137|NCT01855945|26270532|FG003|Overall Study|Death|0|||
13217138|NCT01855945|26270533|FG004|Overall Study|Death|0|||
13217139|NCT01855945|26270534|FG005|Overall Study|Death|0|||
13217140|NCT01855945|26270535|FG006|Overall Study|Death|2|||
13217141|NCT01855945|26270536|FG007|Overall Study|Death|0|||
13217142|NCT01855945|26270537|FG008|Overall Study|Death|0|||
13217143|NCT01855945|26270538|FG009|Overall Study|Death|0|||
13217144|NCT01855945|26270539|FG010|Overall Study|Death|0|||
13217145|NCT01855945|26270540|FG011|Overall Study|Death|0|||
13217146|NCT01855945|26270529|FG000|Overall Study|Lost to Follow-up|11|||
13217147|NCT01855945|26270530|FG001|Overall Study|Lost to Follow-up|10|||
13217148|NCT01855945|26270531|FG002|Overall Study|Lost to Follow-up|7|||
13217149|NCT01855945|26270532|FG003|Overall Study|Lost to Follow-up|3|||
13217150|NCT01855945|26270533|FG004|Overall Study|Lost to Follow-up|0|||
13217151|NCT01855945|26270534|FG005|Overall Study|Lost to Follow-up|3|||
13217152|NCT01855945|26270535|FG006|Overall Study|Lost to Follow-up|4|||
13217153|NCT01855945|26270536|FG007|Overall Study|Lost to Follow-up|7|||
13217154|NCT01855945|26270537|FG008|Overall Study|Lost to Follow-up|2|||
13217155|NCT01855945|26270538|FG009|Overall Study|Lost to Follow-up|0|||
13217156|NCT01855945|26270539|FG010|Overall Study|Lost to Follow-up|0|||
13217157|NCT01855945|26270540|FG011|Overall Study|Lost to Follow-up|2|||
13217158|NCT01855945|26270529|FG000|Overall Study|Other - Unclassified|1|||
13217159|NCT01855945|26270530|FG001|Overall Study|Other - Unclassified|1|||
13217160|NCT01855945|26270531|FG002|Overall Study|Other - Unclassified|1|||
13217161|NCT01855945|26270532|FG003|Overall Study|Other - Unclassified|0|||
13217162|NCT01855945|26270533|FG004|Overall Study|Other - Unclassified|0|||
13217163|NCT01855945|26270534|FG005|Overall Study|Other - Unclassified|0|||
13217164|NCT01855945|26270535|FG006|Overall Study|Other - Unclassified|2|||
13217165|NCT01855945|26270536|FG007|Overall Study|Other - Unclassified|1|||
13217166|NCT01855945|26270537|FG008|Overall Study|Other - Unclassified|0|||
13217167|NCT01855945|26270538|FG009|Overall Study|Other - Unclassified|0|||
13217168|NCT01855945|26270539|FG010|Overall Study|Other - Unclassified|1|||
13217169|NCT01855945|26270540|FG011|Overall Study|Other - Unclassified|0|||
13217170|NCT01855945|26270529|FG000|Overall Study|Withdrawal by Subject|4|||
13217171|NCT01855945|26270530|FG001|Overall Study|Withdrawal by Subject|0|||
13217172|NCT01855945|26270531|FG002|Overall Study|Withdrawal by Subject|4|||
13217173|NCT01855945|26270532|FG003|Overall Study|Withdrawal by Subject|1|||
13217174|NCT01855945|26270533|FG004|Overall Study|Withdrawal by Subject|1|||
13217175|NCT01855945|26270534|FG005|Overall Study|Withdrawal by Subject|0|||
13217176|NCT01855945|26270535|FG006|Overall Study|Withdrawal by Subject|1|||
13217177|NCT01855945|26270536|FG007|Overall Study|Withdrawal by Subject|0|||
13217178|NCT01855945|26270537|FG008|Overall Study|Withdrawal by Subject|0|||
13217179|NCT01855945|26270538|FG009|Overall Study|Withdrawal by Subject|2|||
13217180|NCT01855945|26270539|FG010|Overall Study|Withdrawal by Subject|4|||
13217181|NCT01855945|26270540|FG011|Overall Study|Withdrawal by Subject|1|||
13217182|NCT01855919|26270579|FG000|Overall Study|Adverse Event|16|||
13217183|NCT01855919|26270580|FG001|Overall Study|Adverse Event|8|||
13217184|NCT01855919|26270579|FG000|Overall Study|Lack of Efficacy|1|||
13217185|NCT01855919|26270580|FG001|Overall Study|Lack of Efficacy|3|||
13217186|NCT01855919|26270579|FG000|Overall Study|Withdrawal by Subject|4|||
13217187|NCT01855919|26270580|FG001|Overall Study|Withdrawal by Subject|10|||
13217188|NCT01855919|26270579|FG000|Overall Study|Entry Criteria Not Met|1|||
13217189|NCT01855919|26270580|FG001|Overall Study|Entry Criteria Not Met|1|||
13217190|NCT01855919|26270579|FG000|Overall Study|Protocol Violation|1|||
13217191|NCT01855919|26270580|FG001|Overall Study|Protocol Violation|4|||
13217192|NCT01855828|26270592|FG000|Overall Study|Adverse Event|1|||
13217193|NCT01855828|26270592|FG000|Overall Study|Withdrawal by Subject|1|||
13217194|NCT01855789|26270619|FG000|1) Baseline up to Week 24|Adverse Event|37|||
13217195|NCT01855789|26270620|FG001|1) Baseline up to Week 24|Adverse Event|0|||
13217196|NCT01855789|26270621|FG002|1) Baseline up to Week 24|Adverse Event|0|||
13217197|NCT01855789|26270622|FG003|1) Baseline up to Week 24|Adverse Event|0|||
13217198|NCT01855789|26270619|FG000|1) Baseline up to Week 24|Death|2|||
13217199|NCT01855789|26270620|FG001|1) Baseline up to Week 24|Death|0|||
13217200|NCT01855789|26270621|FG002|1) Baseline up to Week 24|Death|0|||
13217201|NCT01855789|26270622|FG003|1) Baseline up to Week 24|Death|0|||
13217202|NCT01855789|26270619|FG000|1) Baseline up to Week 24|Lack of Efficacy|16|||
13217203|NCT01855789|26270620|FG001|1) Baseline up to Week 24|Lack of Efficacy|0|||
13217204|NCT01855789|26270621|FG002|1) Baseline up to Week 24|Lack of Efficacy|0|||
13217205|NCT01855789|26270622|FG003|1) Baseline up to Week 24|Lack of Efficacy|0|||
13217206|NCT01855789|26270619|FG000|1) Baseline up to Week 24|Lost to Follow-up|11|||
13217207|NCT01855789|26270620|FG001|1) Baseline up to Week 24|Lost to Follow-up|0|||
13217208|NCT01855789|26270621|FG002|1) Baseline up to Week 24|Lost to Follow-up|0|||
13217209|NCT01855789|26270622|FG003|1) Baseline up to Week 24|Lost to Follow-up|0|||
13217210|NCT01855789|26270619|FG000|1) Baseline up to Week 24|Protocol Violation|4|||
13217211|NCT01855789|26270620|FG001|1) Baseline up to Week 24|Protocol Violation|0|||
13217212|NCT01855789|26270621|FG002|1) Baseline up to Week 24|Protocol Violation|0|||
13217213|NCT01855789|26270622|FG003|1) Baseline up to Week 24|Protocol Violation|0|||
13217214|NCT01855789|26270619|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31|||
13217215|NCT01855789|26270620|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0|||
13217216|NCT01855789|26270621|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0|||
13217217|NCT01855789|26270622|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0|||
13217218|NCT01855789|26270619|FG000|1) Baseline up to Week 24|Physician Decision|4|||
13217219|NCT01855789|26270620|FG001|1) Baseline up to Week 24|Physician Decision|0|||
13217220|NCT01855789|26270621|FG002|1) Baseline up to Week 24|Physician Decision|0|||
13217221|NCT01855789|26270622|FG003|1) Baseline up to Week 24|Physician Decision|0|||
13217222|NCT01855789|26270619|FG000|1) Baseline up to Week 24|Pregnancy|1|||
13217223|NCT01855789|26270620|FG001|1) Baseline up to Week 24|Pregnancy|0|||
13217224|NCT01855789|26270621|FG002|1) Baseline up to Week 24|Pregnancy|0|||
13217225|NCT01855789|26270622|FG003|1) Baseline up to Week 24|Pregnancy|0|||
13217226|NCT01855789|26270619|FG000|1) Baseline up to Week 24|Participant Non-compliance|3|||
13217227|NCT01855789|26270620|FG001|1) Baseline up to Week 24|Participant Non-compliance|0|||
13217228|NCT01855789|26270621|FG002|1) Baseline up to Week 24|Participant Non-compliance|0|||
13217229|NCT01855789|26270622|FG003|1) Baseline up to Week 24|Participant Non-compliance|0|||
13217230|NCT01855789|26270619|FG000|1) Baseline up to Week 24|Sponsor Decision|3|||
13217231|NCT01855789|26270620|FG001|1) Baseline up to Week 24|Sponsor Decision|0|||
13217232|NCT01855789|26270621|FG002|1) Baseline up to Week 24|Sponsor Decision|0|||
13217233|NCT01855789|26270622|FG003|1) Baseline up to Week 24|Sponsor Decision|0|||
13217234|NCT01855789|26270619|FG000|1) Baseline up to Week 24|Other|4|||
13217235|NCT01855789|26270620|FG001|1) Baseline up to Week 24|Other|0|||
13217236|NCT01855789|26270621|FG002|1) Baseline up to Week 24|Other|0|||
13217237|NCT01855789|26270622|FG003|1) Baseline up to Week 24|Other|0|||
13217238|NCT01855789|26270619|FG000|2) Week 24 up to End of Study|Adverse Event|0|||
13217239|NCT01855789|26270620|FG001|2) Week 24 up to End of Study|Adverse Event|4|||
13217240|NCT01855789|26270621|FG002|2) Week 24 up to End of Study|Adverse Event|5|||
13217241|NCT01855789|26270622|FG003|2) Week 24 up to End of Study|Adverse Event|21|||
13217242|NCT01855789|26270619|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
13217243|NCT01855789|26270620|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
13217244|NCT01855789|26270621|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
13217245|NCT01855789|26270622|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1|||
13217246|NCT01855789|26270619|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0|||
13217247|NCT01855789|26270620|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2|||
13217248|NCT01855789|26270621|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5|||
13217249|NCT01855789|26270622|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16|||
13217250|NCT01855789|26270619|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0|||
13217251|NCT01855789|26270620|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1|||
13217252|NCT01855789|26270621|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1|||
13217253|NCT01855789|26270622|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4|||
13217254|NCT01855789|26270619|FG000|2) Week 24 up to End of Study|Protocol Violation|0|||
13217255|NCT01855789|26270620|FG001|2) Week 24 up to End of Study|Protocol Violation|0|||
13217256|NCT01855789|26270621|FG002|2) Week 24 up to End of Study|Protocol Violation|0|||
13217257|NCT01855789|26270622|FG003|2) Week 24 up to End of Study|Protocol Violation|1|||
13217258|NCT01855789|26270619|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0|||
13217259|NCT01855789|26270620|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7|||
13217260|NCT01855789|26270621|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5|||
13217261|NCT01855789|26270622|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8|||
13217262|NCT01855789|26270619|FG000|2) Week 24 up to End of Study|Physician Decision|0|||
13217263|NCT01855789|26270620|FG001|2) Week 24 up to End of Study|Physician Decision|0|||
13217264|NCT01855789|26270621|FG002|2) Week 24 up to End of Study|Physician Decision|2|||
13217265|NCT01855789|26270622|FG003|2) Week 24 up to End of Study|Physician Decision|4|||
13217266|NCT01855789|26270619|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0|||
13217267|NCT01855789|26270620|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1|||
13217268|NCT01855789|26270621|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0|||
13217269|NCT01855789|26270622|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1|||
13217270|NCT01855789|26270619|FG000|2) Week 24 up to End of Study|Sponsor Decision|0|||
13217271|NCT01855789|26270620|FG001|2) Week 24 up to End of Study|Sponsor Decision|0|||
13217272|NCT01855789|26270621|FG002|2) Week 24 up to End of Study|Sponsor Decision|0|||
13217273|NCT01855789|26270622|FG003|2) Week 24 up to End of Study|Sponsor Decision|1|||
13217274|NCT01855789|26270619|FG000|2) Week 24 up to End of Study|Other|0|||
13217275|NCT01855789|26270620|FG001|2) Week 24 up to End of Study|Other|0|||
13217276|NCT01855789|26270621|FG002|2) Week 24 up to End of Study|Other|0|||
13217277|NCT01855789|26270622|FG003|2) Week 24 up to End of Study|Other|1|||
13217278|NCT01855750|26270645|FG000|Overall Study|Death|78|||
13217279|NCT01855750|26270646|FG001|Overall Study|Death|78|||
13217280|NCT01855750|26270645|FG000|Overall Study|Lost to Follow-up|9|||
13217281|NCT01855750|26270646|FG001|Overall Study|Lost to Follow-up|23|||
13217282|NCT01855750|26270645|FG000|Overall Study|Withdrawal by Subject|35|||
13217283|NCT01855750|26270646|FG001|Overall Study|Withdrawal by Subject|28|||
13217284|NCT01855750|26270645|FG000|Overall Study|Sponsor ends the study|297|||
13217285|NCT01855750|26270646|FG001|Overall Study|Sponsor ends the study|290|||
13217286|NCT01855425|26270652|FG000|Overall Study|Physician Decision|20|||
13217287|NCT01855412|26270682|FG000|Overall Study|Death|77|||
13217288|NCT01855412|26270683|FG001|Overall Study|Death|123|||
13217289|NCT01855412|26270684|FG002|Overall Study|Death|30|||
13217290|NCT01855412|26270682|FG000|Overall Study|Lost to Follow-up|28|||
13217291|NCT01855412|26270683|FG001|Overall Study|Lost to Follow-up|46|||
13297054|NCT01367457|26497862|FG000|Overall Study|CD, Suspected disease progression (DP)|1|||
13217292|NCT01855412|26270684|FG002|Overall Study|Lost to Follow-up|15|||
13217293|NCT01855412|26270682|FG000|Overall Study|Withdrawal by Subject|77|||
13217294|NCT01855412|26270683|FG001|Overall Study|Withdrawal by Subject|123|||
13217295|NCT01855412|26270684|FG002|Overall Study|Withdrawal by Subject|24|||
13217296|NCT01855412|26270682|FG000|Overall Study|Physician Decision|25|||
13217297|NCT01855412|26270683|FG001|Overall Study|Physician Decision|31|||
13217298|NCT01855412|26270684|FG002|Overall Study|Physician Decision|3|||
13217299|NCT01855412|26270682|FG000|Overall Study|Site Closure|4|||
13217300|NCT01855412|26270683|FG001|Overall Study|Site Closure|18|||
13217301|NCT01855412|26270684|FG002|Overall Study|Site Closure|1|||
13217302|NCT01855412|26270682|FG000|Overall Study|Reason not Specified|1|||
13217303|NCT01855412|26270683|FG001|Overall Study|Reason not Specified|2|||
13217304|NCT01855412|26270684|FG002|Overall Study|Reason not Specified|3|||
13217305|NCT01855399|26270697|FG000|6 Month|Lost to Follow-up|12|||
13217306|NCT01855399|26270698|FG001|6 Month|Lost to Follow-up|9|||
13217307|NCT01855399|26270697|FG000|6 Month|Withdrawal by Subject|8|||
13217308|NCT01855399|26270698|FG001|6 Month|Withdrawal by Subject|6|||
13217309|NCT01855399|26270697|FG000|12 Month|Lost to Follow-up|7|||
13217310|NCT01855399|26270698|FG001|12 Month|Lost to Follow-up|11|||
13217311|NCT01855243|26270728|FG000|Overall Study|develpoed diabetic ketoacidosis|1|||
13217312|NCT01855243|26270729|FG001|Overall Study|develpoed diabetic ketoacidosis|0|||
13217313|NCT01855243|26270730|FG002|Overall Study|develpoed diabetic ketoacidosis|0|||
13217314|NCT01855126|26270749|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4|||
13217315|NCT01855126|26270750|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6|||
13217316|NCT01855126|26270749|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
13217317|NCT01855126|26270750|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
13217318|NCT01855074|26270761|FG000|Overall Study|Adverse Event|1|||
13217319|NCT01855074|26270761|FG000|Overall Study|Lost to Follow-up|4|||
13217320|NCT01855074|26270761|FG000|Overall Study|Withdrawal by Subject|8|||
13217321|NCT01855074|26270761|FG000|Overall Study|Started but not treated|1|||
13217322|NCT01855048|26270819|FG000|Overall Study|Withdrawal by Subject|0|||
13217323|NCT01855048|26270820|FG001|Overall Study|Withdrawal by Subject|1|||
13217324|NCT01855048|26270821|FG002|Overall Study|Withdrawal by Subject|0|||
13217325|NCT01855048|26270822|FG003|Overall Study|Withdrawal by Subject|0|||
13217326|NCT01855048|26270823|FG004|Overall Study|Withdrawal by Subject|1|||
13217327|NCT01855048|26270824|FG005|Overall Study|Withdrawal by Subject|0|||
13217328|NCT01854944|26270884|FG000|Overall Study|Withdrawal by Subject|0|||
13217329|NCT01854944|26270885|FG001|Overall Study|Withdrawal by Subject|0|||
13217330|NCT01854944|26270886|FG002|Overall Study|Withdrawal by Subject|1|||
13217331|NCT01854918|26270908|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20|||
13217332|NCT01854918|26270909|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49|||
13217333|NCT01854918|26270908|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2|||
13217334|NCT01854918|26270909|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1|||
13217335|NCT01854918|26270908|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3|||
13217336|NCT01854918|26270909|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8|||
13217337|NCT01854918|26270908|FG000|SOC-controlled Period (Year 1)|Death|5|||
13217338|NCT01854918|26270909|FG001|SOC-controlled Period (Year 1)|Death|5|||
13217339|NCT01854918|26270908|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78|||
13217340|NCT01854918|26270909|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117|||
13217341|NCT01854918|26270908|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8|||
13217342|NCT01854918|26270909|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11|||
13217343|NCT01854918|26270908|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27|||
13217344|NCT01854918|26270909|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51|||
13217345|NCT01854918|26270908|FG000|All-IP Period (Years 2 and 3)|Death|5|||
13217346|NCT01854918|26270909|FG001|All-IP Period (Years 2 and 3)|Death|16|||
13217347|NCT01854879|26270915|FG000|Overall Study|Could not complete testing within the scheduled time.|1|||
13217348|NCT01854879|26270915|FG000|Overall Study|screen fail|3|||
13217349|NCT01854879|26270915|FG000|Overall Study|incomplete data set|1|||
13217350|NCT01854827|26270929|FG000|Overall Study|Death|1|||
13217351|NCT01854710|26270952|FG000|Overall Study|Withdrawal by Subject|2|||
13217352|NCT01854710|26270953|FG001|Overall Study|Withdrawal by Subject|1|||
13217353|NCT01854710|26270954|FG002|Overall Study|Withdrawal by Subject|0|||
13217354|NCT01854710|26270955|FG003|Overall Study|Withdrawal by Subject|0|||
13217355|NCT01854710|26270956|FG004|Overall Study|Withdrawal by Subject|0|||
13217356|NCT01854710|26270957|FG005|Overall Study|Withdrawal by Subject|0|||
13217357|NCT01854710|26270952|FG000|Overall Study|CRI procedural error|2|||
13217358|NCT01854710|26270953|FG001|Overall Study|CRI procedural error|2|||
13217359|NCT01854710|26270954|FG002|Overall Study|CRI procedural error|2|||
13217360|NCT01854710|26270955|FG003|Overall Study|CRI procedural error|2|||
13217361|NCT01854710|26270956|FG004|Overall Study|CRI procedural error|2|||
13217362|NCT01854710|26270957|FG005|Overall Study|CRI procedural error|2|||
13217363|NCT01854697|26271013|FG000|Overall Study|Adverse Event|1|||
13217364|NCT01854697|26271014|FG001|Overall Study|Adverse Event|0|||
13217365|NCT01854697|26271015|FG002|Overall Study|Adverse Event|0|||
13217366|NCT01854697|26271016|FG003|Overall Study|Adverse Event|0|||
13217367|NCT01854697|26271017|FG004|Overall Study|Adverse Event|1|||
13217368|NCT01854697|26271013|FG000|Overall Study|Lost to Follow-up|4|||
13217369|NCT01854697|26271014|FG001|Overall Study|Lost to Follow-up|1|||
13217370|NCT01854697|26271015|FG002|Overall Study|Lost to Follow-up|1|||
13217371|NCT01854697|26271016|FG003|Overall Study|Lost to Follow-up|2|||
13217372|NCT01854697|26271017|FG004|Overall Study|Lost to Follow-up|0|||
13217373|NCT01854697|26271013|FG000|Overall Study|To enter another AbbVie study|1|||
13217374|NCT01854697|26271014|FG001|Overall Study|To enter another AbbVie study|0|||
13217375|NCT01854697|26271015|FG002|Overall Study|To enter another AbbVie study|0|||
13217376|NCT01854697|26271016|FG003|Overall Study|To enter another AbbVie study|0|||
13217377|NCT01854697|26271017|FG004|Overall Study|To enter another AbbVie study|1|||
13217378|NCT01854697|26271013|FG000|Overall Study|Withdrew Consent|0|||
13217379|NCT01854697|26271014|FG001|Overall Study|Withdrew Consent|1|||
13217380|NCT01854697|26271015|FG002|Overall Study|Withdrew Consent|0|||
13217381|NCT01854697|26271016|FG003|Overall Study|Withdrew Consent|1|||
13217382|NCT01854697|26271017|FG004|Overall Study|Withdrew Consent|0|||
13217383|NCT01854697|26271013|FG000|Overall Study|Other|0|||
13217384|NCT01854697|26271014|FG001|Overall Study|Other|1|||
13217385|NCT01854697|26271015|FG002|Overall Study|Other|1|||
13217386|NCT01854697|26271016|FG003|Overall Study|Other|0|||
13217387|NCT01854697|26271017|FG004|Overall Study|Other|0|||
13217388|NCT01854658|26271060|FG000|Overall Study|Protocol Violation|6|||
13217389|NCT01854658|26271061|FG001|Overall Study|Protocol Violation|2|||
13217390|NCT01854658|26271062|FG002|Overall Study|Protocol Violation|2|||
13217391|NCT01854658|26271063|FG003|Overall Study|Protocol Violation|1|||
13217392|NCT01854658|26271060|FG000|Overall Study|Physician Decision|7|||
13217393|NCT01854658|26271061|FG001|Overall Study|Physician Decision|5|||
13217394|NCT01854658|26271062|FG002|Overall Study|Physician Decision|2|||
13217395|NCT01854658|26271063|FG003|Overall Study|Physician Decision|4|||
13217396|NCT01854658|26271060|FG000|Overall Study|Lost to Follow-up|8|||
13217397|NCT01854658|26271061|FG001|Overall Study|Lost to Follow-up|9|||
13217398|NCT01854658|26271062|FG002|Overall Study|Lost to Follow-up|8|||
13217399|NCT01854658|26271063|FG003|Overall Study|Lost to Follow-up|4|||
13217400|NCT01854658|26271060|FG000|Overall Study|Withdrawal by Subject|28|||
13217401|NCT01854658|26271061|FG001|Overall Study|Withdrawal by Subject|21|||
13217402|NCT01854658|26271062|FG002|Overall Study|Withdrawal by Subject|29|||
13217403|NCT01854658|26271063|FG003|Overall Study|Withdrawal by Subject|15|||
13217404|NCT01854658|26271060|FG000|Overall Study|Protocol-specified criteria|15|||
13217405|NCT01854658|26271061|FG001|Overall Study|Protocol-specified criteria|15|||
13217406|NCT01854658|26271062|FG002|Overall Study|Protocol-specified criteria|10|||
13217407|NCT01854658|26271063|FG003|Overall Study|Protocol-specified criteria|7|||
13217408|NCT01854658|26271060|FG000|Overall Study|Lack of Efficacy|3|||
13217409|NCT01854658|26271061|FG001|Overall Study|Lack of Efficacy|8|||
13217410|NCT01854658|26271062|FG002|Overall Study|Lack of Efficacy|4|||
13217411|NCT01854658|26271063|FG003|Overall Study|Lack of Efficacy|7|||
13217412|NCT01854658|26271060|FG000|Overall Study|Adverse Event|21|||
13217413|NCT01854658|26271061|FG001|Overall Study|Adverse Event|14|||
13217414|NCT01854658|26271062|FG002|Overall Study|Adverse Event|23|||
13217415|NCT01854658|26271063|FG003|Overall Study|Adverse Event|19|||
13217416|NCT01854658|26271060|FG000|Overall Study|Administrative reasons|5|||
13217417|NCT01854658|26271061|FG001|Overall Study|Administrative reasons|1|||
13217418|NCT01854658|26271062|FG002|Overall Study|Administrative reasons|2|||
13217419|NCT01854658|26271063|FG003|Overall Study|Administrative reasons|2|||
13217420|NCT01854645|26271116|FG000|Overall Study|Protocol-Specified Criteria|13|||
13217421|NCT01854645|26271117|FG001|Overall Study|Protocol-Specified Criteria|10|||
13217422|NCT01854645|26271118|FG002|Overall Study|Protocol-Specified Criteria|8|||
13217423|NCT01854645|26271119|FG003|Overall Study|Protocol-Specified Criteria|5|||
13381999|NCT00748241|26749615|FG000|Overall Study|Death|2|||
13382000|NCT00748215|26749628|FG000|Overall Study|Withdrawal by Subject|7|||
13217424|NCT01854645|26271120|FG004|Overall Study|Protocol-Specified Criteria|7|||
13217425|NCT01854645|26271116|FG000|Overall Study|Administrative Reasons / Missing|0|||
13217426|NCT01854645|26271117|FG001|Overall Study|Administrative Reasons / Missing|0|||
13217427|NCT01854645|26271118|FG002|Overall Study|Administrative Reasons / Missing|0|||
13217428|NCT01854645|26271119|FG003|Overall Study|Administrative Reasons / Missing|1|||
13217429|NCT01854645|26271120|FG004|Overall Study|Administrative Reasons / Missing|1|||
13217430|NCT01854645|26271116|FG000|Overall Study|Protocol Violation|3|||
13217431|NCT01854645|26271117|FG001|Overall Study|Protocol Violation|0|||
13217432|NCT01854645|26271118|FG002|Overall Study|Protocol Violation|5|||
13217433|NCT01854645|26271119|FG003|Overall Study|Protocol Violation|4|||
13217434|NCT01854645|26271120|FG004|Overall Study|Protocol Violation|1|||
13217435|NCT01854645|26271116|FG000|Overall Study|Lost to Follow-up|10|||
13217436|NCT01854645|26271117|FG001|Overall Study|Lost to Follow-up|7|||
13217437|NCT01854645|26271118|FG002|Overall Study|Lost to Follow-up|8|||
13217438|NCT01854645|26271119|FG003|Overall Study|Lost to Follow-up|5|||
13217439|NCT01854645|26271120|FG004|Overall Study|Lost to Follow-up|0|||
13297055|NCT01367457|26497863|FG001|Overall Study|CD, Suspected disease progression (DP)|0|||
13297056|NCT01367457|26497864|FG002|Overall Study|CD, Suspected disease progression (DP)|0|||
13217440|NCT01854645|26271116|FG000|Overall Study|Physician Decision|1|||
13217441|NCT01854645|26271117|FG001|Overall Study|Physician Decision|5|||
13217442|NCT01854645|26271118|FG002|Overall Study|Physician Decision|3|||
13217443|NCT01854645|26271119|FG003|Overall Study|Physician Decision|3|||
13217444|NCT01854645|26271120|FG004|Overall Study|Physician Decision|7|||
13217445|NCT01854645|26271116|FG000|Overall Study|Withdrawal by Subject|31|||
13217446|NCT01854645|26271117|FG001|Overall Study|Withdrawal by Subject|41|||
13217447|NCT01854645|26271118|FG002|Overall Study|Withdrawal by Subject|30|||
13217448|NCT01854645|26271119|FG003|Overall Study|Withdrawal by Subject|21|||
13217449|NCT01854645|26271120|FG004|Overall Study|Withdrawal by Subject|24|||
13217450|NCT01854645|26271116|FG000|Overall Study|Lack of Efficacy|7|||
13217451|NCT01854645|26271117|FG001|Overall Study|Lack of Efficacy|12|||
13217452|NCT01854645|26271118|FG002|Overall Study|Lack of Efficacy|9|||
13217453|NCT01854645|26271119|FG003|Overall Study|Lack of Efficacy|3|||
13217454|NCT01854645|26271120|FG004|Overall Study|Lack of Efficacy|9|||
13217455|NCT01854645|26271116|FG000|Overall Study|Adverse Event|33|||
13217456|NCT01854645|26271117|FG001|Overall Study|Adverse Event|31|||
13217457|NCT01854645|26271118|FG002|Overall Study|Adverse Event|19|||
13217458|NCT01854645|26271119|FG003|Overall Study|Adverse Event|20|||
13217459|NCT01854645|26271120|FG004|Overall Study|Adverse Event|11|||
13217460|NCT01854528|26271143|FG000|Overall Study|Adverse Event|0|||
13217461|NCT01854528|26271144|FG001|Overall Study|Adverse Event|4|||
13217462|NCT01854528|26271143|FG000|Overall Study|Withdrawal by Subject|0|||
13217463|NCT01854528|26271144|FG001|Overall Study|Withdrawal by Subject|2|||
13217464|NCT01854528|26271143|FG000|Overall Study|Virologic Failure|0|||
13217465|NCT01854528|26271144|FG001|Overall Study|Virologic Failure|9|||
13217466|NCT01854047|26271282|FG000|Overall Study|Lack of Efficacy|1|||
13217467|NCT01854047|26271283|FG001|Overall Study|Lack of Efficacy|0|||
13217468|NCT01854047|26271284|FG002|Overall Study|Lack of Efficacy|0|||
13217469|NCT01854047|26271285|FG003|Overall Study|Lack of Efficacy|0|||
13217470|NCT01854047|26271286|FG004|Overall Study|Lack of Efficacy|0|||
13217471|NCT01854047|26271282|FG000|Overall Study|Poor compliance to protocol|3|||
13217472|NCT01854047|26271283|FG001|Overall Study|Poor compliance to protocol|0|||
13217473|NCT01854047|26271284|FG002|Overall Study|Poor compliance to protocol|2|||
13217474|NCT01854047|26271285|FG003|Overall Study|Poor compliance to protocol|0|||
13217475|NCT01854047|26271286|FG004|Overall Study|Poor compliance to protocol|0|||
13217476|NCT01854047|26271282|FG000|Overall Study|Adverse Event|5|||
13217477|NCT01854047|26271283|FG001|Overall Study|Adverse Event|4|||
13217478|NCT01854047|26271284|FG002|Overall Study|Adverse Event|6|||
13217479|NCT01854047|26271285|FG003|Overall Study|Adverse Event|10|||
13217480|NCT01854047|26271286|FG004|Overall Study|Adverse Event|7|||
13217481|NCT01854047|26271282|FG000|Overall Study|Randomized but not treated|0|||
13217482|NCT01854047|26271283|FG001|Overall Study|Randomized but not treated|1|||
13217483|NCT01854047|26271284|FG002|Overall Study|Randomized but not treated|2|||
13217484|NCT01854047|26271285|FG003|Overall Study|Randomized but not treated|0|||
13217485|NCT01854047|26271286|FG004|Overall Study|Randomized but not treated|4|||
13217486|NCT01854047|26271282|FG000|Overall Study|Other than specified above|3|||
13217487|NCT01854047|26271283|FG001|Overall Study|Other than specified above|3|||
13217488|NCT01854047|26271284|FG002|Overall Study|Other than specified above|3|||
13217489|NCT01854047|26271285|FG003|Overall Study|Other than specified above|5|||
13217490|NCT01854047|26271286|FG004|Overall Study|Other than specified above|8|||
13217491|NCT01853982|26271299|FG000|Overall Study|Withdrawal by Subject|1|||
13217492|NCT01853982|26271300|FG001|Overall Study|Withdrawal by Subject|0|||
13217493|NCT01853982|26271299|FG000|Overall Study|Death|1|||
13217494|NCT01853982|26271300|FG001|Overall Study|Death|0|||
13217495|NCT01853982|26271299|FG000|Overall Study|Lost to Follow-up|0|||
13217496|NCT01853982|26271300|FG001|Overall Study|Lost to Follow-up|1|||
13217497|NCT01853878|26271331|FG000|Overall Study|Recurrence|2|||
13217498|NCT01853878|26271332|FG001|Overall Study|Recurrence|0|||
13217499|NCT01853878|26271331|FG000|Overall Study|Adverse Event|2|||
13217500|NCT01853878|26271332|FG001|Overall Study|Adverse Event|0|||
13217501|NCT01853878|26271331|FG000|Overall Study|Withdrawal by Subject|3|||
13217502|NCT01853878|26271332|FG001|Overall Study|Withdrawal by Subject|1|||
13217503|NCT01853878|26271331|FG000|Overall Study|Migrated/moved from the study area|1|||
13217504|NCT01853878|26271332|FG001|Overall Study|Migrated/moved from the study area|0|||
13217505|NCT01853878|26271331|FG000|Overall Study|Other|55|||
13217506|NCT01853878|26271332|FG001|Overall Study|Other|43|||
13217507|NCT01853839|26271354|FG000|Overall Study|Violated inclusion criteria|2|||
13217508|NCT01853839|26271354|FG000|Overall Study|Not meet ITT population definition|58|||
13217509|NCT01853839|26271354|FG000|Overall Study|End of treatment visit too early|33|||
13217510|NCT01853839|26271354|FG000|Overall Study|Lost to follow-up or no valid BP measure|336|||
13217511|NCT01853696|26271369|FG000|Overall Study|Withdrawal by Subject|1|||
13217512|NCT01853696|26271370|FG001|Overall Study|Withdrawal by Subject|1|||
13217513|NCT01853696|26271369|FG000|Overall Study|Lost to Follow-up|5|||
13217514|NCT01853696|26271370|FG001|Overall Study|Lost to Follow-up|4|||
13217515|NCT01853644|26271384|FG000|Registration and Treatment Start|Did not start treatment|1|||
13217516|NCT01853644|26271384|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2|||
13217517|NCT01853644|26271384|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1|||
13217518|NCT01853644|26271384|FG000|Reached First Response/Complete 2 Cycles|Other|1|||
13217519|NCT01853644|26271384|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2|||
13217520|NCT01853644|26271384|FG000|Continued Treatment After First Response|Adverse Event|2|||
13217521|NCT01853644|26271384|FG000|Continued Treatment After First Response|Progressive Diseaes|10|||
13217522|NCT01853618|26271427|FG000|Overall Study|Bile duct stent blockage/progressive dis|1|||
13217523|NCT01853618|26271428|FG001|Overall Study|Bile duct stent blockage/progressive dis|0|||
13217524|NCT01853618|26271429|FG002|Overall Study|Bile duct stent blockage/progressive dis|0|||
13217525|NCT01853618|26271430|FG003|Overall Study|Bile duct stent blockage/progressive dis|0|||
13217526|NCT01853618|26271431|FG004|Overall Study|Bile duct stent blockage/progressive dis|0|||
13217527|NCT01853618|26271427|FG000|Overall Study|Progressive disease|1|||
13217528|NCT01853618|26271428|FG001|Overall Study|Progressive disease|1|||
13217529|NCT01853618|26271429|FG002|Overall Study|Progressive disease|1|||
13217530|NCT01853618|26271430|FG003|Overall Study|Progressive disease|1|||
13217531|NCT01853618|26271431|FG004|Overall Study|Progressive disease|2|||
13217532|NCT01853618|26271427|FG000|Overall Study|Physician Decision|0|||
13217533|NCT01853618|26271428|FG001|Overall Study|Physician Decision|1|||
13217534|NCT01853618|26271429|FG002|Overall Study|Physician Decision|1|||
13217535|NCT01853618|26271430|FG003|Overall Study|Physician Decision|0|||
13217536|NCT01853618|26271431|FG004|Overall Study|Physician Decision|0|||
13217537|NCT01853618|26271427|FG000|Overall Study|Refused further treatment|0|||
13217538|NCT01853618|26271428|FG001|Overall Study|Refused further treatment|0|||
13217539|NCT01853618|26271429|FG002|Overall Study|Refused further treatment|0|||
13217540|NCT01853618|26271430|FG003|Overall Study|Refused further treatment|0|||
13217541|NCT01853618|26271431|FG004|Overall Study|Refused further treatment|1|||
13217542|NCT01853475|26271458|FG000|Overall Study|Withdrawal by Subject|0|||
13217543|NCT01853475|26271459|FG001|Overall Study|Withdrawal by Subject|1|||
13217544|NCT01853475|26271460|FG002|Overall Study|Withdrawal by Subject|0|||
13217545|NCT01853462|26271533|FG000|Overall Study|Withdrawal by Subject|1|||
13217546|NCT01853462|26271534|FG001|Overall Study|Withdrawal by Subject|1|||
13217547|NCT01853397|26271573|FG000|Overall Study|Withdrawal by Subject|0|||
13217548|NCT01853397|26271574|FG001|Overall Study|Withdrawal by Subject|0|||
13217549|NCT01853397|26271575|FG002|Overall Study|Withdrawal by Subject|0|||
13217550|NCT01853397|26271576|FG003|Overall Study|Withdrawal by Subject|1|||
13217551|NCT01853397|26271573|FG000|Overall Study|Subject Noncompliance|0|||
13217552|NCT01853397|26271574|FG001|Overall Study|Subject Noncompliance|0|||
13217553|NCT01853397|26271575|FG002|Overall Study|Subject Noncompliance|0|||
13217554|NCT01853397|26271576|FG003|Overall Study|Subject Noncompliance|1|||
13217555|NCT01853384|26271601|FG000|Randomized|Adverse Event|5|||
13217556|NCT01853384|26271602|FG001|Randomized|Adverse Event|3|||
13217557|NCT01853384|26271601|FG000|Randomized|Death|1|||
13217558|NCT01853384|26271602|FG001|Randomized|Death|2|||
13217559|NCT01853384|26271601|FG000|Randomized|Lost to Follow-up|1|||
13217560|NCT01853384|26271602|FG001|Randomized|Lost to Follow-up|1|||
13217561|NCT01853384|26271601|FG000|Randomized|Withdrawal by Subject|5|||
13217562|NCT01853384|26271602|FG001|Randomized|Withdrawal by Subject|3|||
13217563|NCT01853384|26271601|FG000|Randomized|Sponsor Decision|47|||
13217564|NCT01853384|26271602|FG001|Randomized|Sponsor Decision|34|||
13217565|NCT01853384|26271601|FG000|Randomized|Other|3|||
13217566|NCT01853384|26271602|FG001|Randomized|Other|3|||
13217567|NCT01853384|26271601|FG000|Completed Follow up Visit 1|Early Termination|13|||
13217568|NCT01853384|26271602|FG001|Completed Follow up Visit 1|Early Termination|9|||
13217569|NCT01853384|26271601|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1|||
13217570|NCT01853384|26271602|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0|||
13217571|NCT01853384|26271601|FG000|Completed Follow up Visit 2|Adverse Event|1|||
13217572|NCT01853384|26271602|FG001|Completed Follow up Visit 2|Adverse Event|0|||
13217573|NCT01853384|26271601|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1|||
13217574|NCT01853384|26271602|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2|||
13217575|NCT01853384|26271601|FG000|Completed Follow up Visit 2|Death|1|||
13217576|NCT01853384|26271602|FG001|Completed Follow up Visit 2|Death|0|||
13217577|NCT01853384|26271601|FG000|Completed Follow up Visit 2|Lost to Follow-up|0|||
13217578|NCT01853384|26271602|FG001|Completed Follow up Visit 2|Lost to Follow-up|1|||
13217579|NCT01853280|26271615|FG000|Overall Study|Lack of Efficacy|2|||
13217580|NCT01853280|26271616|FG001|Overall Study|Lack of Efficacy|2|||
13217581|NCT01853280|26271615|FG000|Overall Study|Lost to Follow-up|0|||
13217582|NCT01853280|26271616|FG001|Overall Study|Lost to Follow-up|1|||
13217583|NCT01853280|26271615|FG000|Overall Study|Physician Decision|0|||
13217584|NCT01853280|26271616|FG001|Overall Study|Physician Decision|1|||
13217585|NCT01853280|26271615|FG000|Overall Study|Withdrawal by Subject|0|||
13217586|NCT01853280|26271616|FG001|Overall Study|Withdrawal by Subject|1|||
13217587|NCT01853280|26271615|FG000|Overall Study|Ineligible|0|||
13217588|NCT01853280|26271616|FG001|Overall Study|Ineligible|1|||
13217589|NCT01853254|26271622|FG000|Overall Study|Abnormal Laboratory Test|1|||
13217590|NCT01853254|26271622|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
13217591|NCT01853254|26271622|FG000|Overall Study|Death|1|||
13217592|NCT01853254|26271622|FG000|Overall Study|Failure to Return|43|||
13217593|NCT01853254|26271622|FG000|Overall Study|Insufficient Therapeutic Response|22|||
13217594|NCT01853254|26271622|FG000|Overall Study|Refusal of Treatment|1|||
13217595|NCT01853254|26271622|FG000|Overall Study|Other Protocol Violation|1|||
13217596|NCT01853254|26271622|FG000|Overall Study|Withdrawal of Consent|16|||
13217597|NCT01853254|26271622|FG000|Overall Study|Administrative/Other|16|||
13217598|NCT01853228|26271642|FG000|Phase 1|Lack of Efficacy|8|||
13217599|NCT01853228|26271643|FG001|Phase 1|Lack of Efficacy|0|||
13217600|NCT01853228|26271642|FG000|Phase 1|Other|1|||
13217601|NCT01853228|26271643|FG001|Phase 1|Other|0|||
13217602|NCT01853228|26271642|FG000|Phase 2|Physician Decision|0|||
13217603|NCT01853228|26271643|FG001|Phase 2|Physician Decision|1|||
13217604|NCT01853228|26271642|FG000|Phase 2|Proceed To Transplant|0|||
13217605|NCT01853228|26271643|FG001|Phase 2|Proceed To Transplant|3|||
13217606|NCT01853228|26271642|FG000|Phase 2|Lack of Efficacy|0|||
13217607|NCT01853228|26271643|FG001|Phase 2|Lack of Efficacy|4|||
13217608|NCT01853176|26271656|FG000|Overall Study|Study terminated|4|||
13217609|NCT01853176|26271657|FG001|Overall Study|Study terminated|0|||
13217610|NCT01853137|26271672|FG000|Overall Study|Lost to Follow-up|4|||
13217611|NCT01853137|26271673|FG001|Overall Study|Lost to Follow-up|1|||
13217612|NCT01853072|26271698|FG000|Overall Study|Adverse event prior to treatment|0|||
13217613|NCT01853072|26271699|FG001|Overall Study|Adverse event prior to treatment|1|||
13217614|NCT01853072|26271698|FG000|Overall Study|Adverse Event|0|||
13217615|NCT01853072|26271699|FG001|Overall Study|Adverse Event|3|||
13217616|NCT01853072|26271698|FG000|Overall Study|Death|1|||
13217617|NCT01853072|26271699|FG001|Overall Study|Death|4|||
13217618|NCT01853072|26271698|FG000|Overall Study|Lost to Follow-up|0|||
13217619|NCT01853072|26271699|FG001|Overall Study|Lost to Follow-up|3|||
13217620|NCT01853072|26271698|FG000|Overall Study|Non-compliance with study drug|0|||
13217621|NCT01853072|26271699|FG001|Overall Study|Non-compliance with study drug|1|||
13217622|NCT01853072|26271698|FG000|Overall Study|Physician Decision|1|||
13217623|NCT01853072|26271699|FG001|Overall Study|Physician Decision|1|||
13217624|NCT01853072|26271698|FG000|Overall Study|Withdrawal by Subject|1|||
13217625|NCT01853072|26271699|FG001|Overall Study|Withdrawal by Subject|2|||
13217626|NCT01853072|26271698|FG000|Overall Study|Reason not specified|9|||
13217627|NCT01853072|26271699|FG001|Overall Study|Reason not specified|6|||
13217628|NCT01853046|26271758|FG000|Overall Study|Withdrawal by Subject|1|||
13217629|NCT01853046|26271759|FG001|Overall Study|Withdrawal by Subject|1|||
13217630|NCT01853046|26271758|FG000|Overall Study|Adverse Event|4|||
13217631|NCT01853046|26271759|FG001|Overall Study|Adverse Event|2|||
13217632|NCT01853046|26271758|FG000|Overall Study|Disease progression|13|||
13217633|NCT01853046|26271759|FG001|Overall Study|Disease progression|3|||
13217634|NCT01852942|26271858|FG000|Overall Study|Physician Decision|1|||
13217635|NCT01852942|26271859|FG001|Overall Study|Physician Decision|0|||
13217636|NCT01852942|26271858|FG000|Overall Study|Death|1|||
13217637|NCT01852942|26271859|FG001|Overall Study|Death|1|||
13217638|NCT01852942|26271858|FG000|Overall Study|Withdrawal by Subject|2|||
13217639|NCT01852942|26271859|FG001|Overall Study|Withdrawal by Subject|3|||
13217640|NCT01852942|26271858|FG000|Overall Study|Lost to Follow-up|1|||
13217641|NCT01852942|26271859|FG001|Overall Study|Lost to Follow-up|2|||
13217642|NCT01852825|26271892|FG000|Overall Study|Withdrawal by Subject|2|||
13217643|NCT01852825|26271893|FG001|Overall Study|Withdrawal by Subject|0|||
13217644|NCT01852825|26271894|FG002|Overall Study|Withdrawal by Subject|0|||
13217645|NCT01852812|26271924|FG000|Overall Study|Adverse Event|0|||
13217646|NCT01852812|26271925|FG001|Overall Study|Adverse Event|0|||
13217647|NCT01852812|26271926|FG002|Overall Study|Adverse Event|1|||
13217648|NCT01852812|26271924|FG000|Overall Study|Non-compliance With Study Drug|0|||
13217649|NCT01852812|26271925|FG001|Overall Study|Non-compliance With Study Drug|1|||
13217650|NCT01852812|26271926|FG002|Overall Study|Non-compliance With Study Drug|0|||
13217651|NCT01852591|26271935|FG000|Overall Study|Withdrawal by Subject|2|||
13217652|NCT01852591|26271935|FG000|Overall Study|Not Evaluable at Time of Analysis|1|||
13217653|NCT01852292|26271966|FG000|Overall Study|Untreated - did not receive study drug|3|||
13217654|NCT01852292|26271967|FG001|Overall Study|Untreated - did not receive study drug|1|||
13217655|NCT01852292|26271966|FG000|Overall Study|Death|9|||
13297057|NCT01367457|26497862|FG000|Overall Study|Patient's Wish|1|||
13297058|NCT01367457|26497863|FG001|Overall Study|Patient's Wish|0|||
13297059|NCT01367457|26497864|FG002|Overall Study|Patient's Wish|0|||
13297060|NCT01367457|26497862|FG000|Overall Study|Palliative. Overall decline|1|||
13297061|NCT01367457|26497863|FG001|Overall Study|Palliative. Overall decline|0|||
13297062|NCT01367457|26497864|FG002|Overall Study|Palliative. Overall decline|0|||
13297063|NCT01367457|26497862|FG000|Overall Study|Suspected DP/suspected active infection|1|||
13297064|NCT01367457|26497863|FG001|Overall Study|Suspected DP/suspected active infection|0|||
13297065|NCT01367457|26497864|FG002|Overall Study|Suspected DP/suspected active infection|0|||
13297066|NCT01367275|26497870|FG000|Overall Study|Ineligible|1|||
13297067|NCT01367275|26497870|FG000|Overall Study|Disease Progression|2|||
13297068|NCT01367249|26497885|FG000|Overall Study|Withdrawal by Subject|6|||
13297069|NCT01367249|26497886|FG001|Overall Study|Withdrawal by Subject|6|||
13297070|NCT01367249|26497885|FG000|Overall Study|Other|3|||
13297071|NCT01367249|26497886|FG001|Overall Study|Other|10|||
13297072|NCT01367236|26497901|FG000|Overall Study|Withdrawal by Subject|3|||
13297073|NCT01367236|26497902|FG001|Overall Study|Withdrawal by Subject|1|||
13217656|NCT01852292|26271967|FG001|Overall Study|Death|8|||
13217657|NCT01852292|26271966|FG000|Overall Study|Patient/guardian decision|8|||
13217658|NCT01852292|26271967|FG001|Overall Study|Patient/guardian decision|4|||
13217659|NCT01852292|26271966|FG000|Overall Study|Adverse Event|8|||
13217660|NCT01852292|26271967|FG001|Overall Study|Adverse Event|11|||
13217661|NCT01852292|26271966|FG000|Overall Study|Physician Decision|6|||
13217662|NCT01852292|26271967|FG001|Overall Study|Physician Decision|2|||
13217663|NCT01852292|26271966|FG000|Overall Study|Protocol Violation|2|||
13217664|NCT01852292|26271967|FG001|Overall Study|Protocol Violation|0|||
13217665|NCT01852292|26271966|FG000|Overall Study|Non-compliance with study treatment|1|||
13217666|NCT01852292|26271967|FG001|Overall Study|Non-compliance with study treatment|0|||
13217667|NCT01852292|26271966|FG000|Overall Study|Study terminated by Sponsor|0|||
13217668|NCT01852292|26271967|FG001|Overall Study|Study terminated by Sponsor|1|||
13217669|NCT01852292|26271966|FG000|Overall Study|Progressive disease|42|||
13217670|NCT01852292|26271967|FG001|Overall Study|Progressive disease|52|||
13217671|NCT01852214|26271982|FG000|Period 1|Adverse Event|1|||
13217672|NCT01852214|26271983|FG001|Period 1|Adverse Event|2|||
13217673|NCT01852214|26271982|FG000|Period 1|Withdrawal by Subject|0|||
13217674|NCT01852214|26271983|FG001|Period 1|Withdrawal by Subject|1|||
13217675|NCT01852214|26271982|FG000|Washout Period|Withdrawal by Subject|0|||
13217676|NCT01852214|26271983|FG001|Washout Period|Withdrawal by Subject|1|||
13217677|NCT01852162|26272004|FG000|Overall Study|Adverse Event|1|||
13217678|NCT01852162|26272005|FG001|Overall Study|Adverse Event|0|||
13217679|NCT01852162|26272004|FG000|Overall Study|Withdrawal by Subject|3|||
13217680|NCT01852162|26272005|FG001|Overall Study|Withdrawal by Subject|1|||
13217681|NCT01852110|26272044|FG000|Overall Study|Adverse Event|12|||
13217682|NCT01852110|26272045|FG001|Overall Study|Adverse Event|5|||
13217683|NCT01852110|26272046|FG002|Overall Study|Adverse Event|0|||
13217684|NCT01852110|26272047|FG003|Overall Study|Adverse Event|0|||
13217685|NCT01852110|26272048|FG004|Overall Study|Adverse Event|0|||
13217686|NCT01852110|26272049|FG005|Overall Study|Adverse Event|0|||
13217687|NCT01852110|26272044|FG000|Overall Study|Lost to Follow-up|1|||
13217688|NCT01852110|26272045|FG001|Overall Study|Lost to Follow-up|3|||
13217689|NCT01852110|26272046|FG002|Overall Study|Lost to Follow-up|0|||
13217690|NCT01852110|26272047|FG003|Overall Study|Lost to Follow-up|0|||
13217691|NCT01852110|26272048|FG004|Overall Study|Lost to Follow-up|0|||
13217692|NCT01852110|26272049|FG005|Overall Study|Lost to Follow-up|0|||
13217693|NCT01852110|26272044|FG000|Overall Study|Non-compliance with Study Drug|2|||
13217694|NCT01852110|26272045|FG001|Overall Study|Non-compliance with Study Drug|1|||
13217695|NCT01852110|26272046|FG002|Overall Study|Non-compliance with Study Drug|0|||
13217696|NCT01852110|26272047|FG003|Overall Study|Non-compliance with Study Drug|0|||
13217697|NCT01852110|26272048|FG004|Overall Study|Non-compliance with Study Drug|0|||
13217698|NCT01852110|26272049|FG005|Overall Study|Non-compliance with Study Drug|0|||
13217699|NCT01852110|26272044|FG000|Overall Study|Physician Decision|1|||
13217700|NCT01852110|26272045|FG001|Overall Study|Physician Decision|0|||
13217701|NCT01852110|26272046|FG002|Overall Study|Physician Decision|0|||
13217702|NCT01852110|26272047|FG003|Overall Study|Physician Decision|0|||
13217703|NCT01852110|26272048|FG004|Overall Study|Physician Decision|0|||
13217704|NCT01852110|26272049|FG005|Overall Study|Physician Decision|0|||
13217705|NCT01852110|26272044|FG000|Overall Study|Protocol Violation|0|||
13217706|NCT01852110|26272045|FG001|Overall Study|Protocol Violation|1|||
13217707|NCT01852110|26272046|FG002|Overall Study|Protocol Violation|0|||
13217708|NCT01852110|26272047|FG003|Overall Study|Protocol Violation|0|||
13217709|NCT01852110|26272048|FG004|Overall Study|Protocol Violation|0|||
13217710|NCT01852110|26272049|FG005|Overall Study|Protocol Violation|0|||
13217711|NCT01852110|26272044|FG000|Overall Study|Study Terminated by Sponsor|30|||
13217712|NCT01852110|26272045|FG001|Overall Study|Study Terminated by Sponsor|32|||
13217713|NCT01852110|26272046|FG002|Overall Study|Study Terminated by Sponsor|0|||
13217714|NCT01852110|26272047|FG003|Overall Study|Study Terminated by Sponsor|0|||
13217715|NCT01852110|26272048|FG004|Overall Study|Study Terminated by Sponsor|0|||
13217716|NCT01852110|26272049|FG005|Overall Study|Study Terminated by Sponsor|0|||
13217717|NCT01852110|26272044|FG000|Overall Study|Withdrawal by Subject|4|||
13217718|NCT01852110|26272045|FG001|Overall Study|Withdrawal by Subject|4|||
13217719|NCT01852110|26272046|FG002|Overall Study|Withdrawal by Subject|0|||
13217720|NCT01852110|26272047|FG003|Overall Study|Withdrawal by Subject|0|||
13217721|NCT01852110|26272048|FG004|Overall Study|Withdrawal by Subject|0|||
13217722|NCT01852110|26272049|FG005|Overall Study|Withdrawal by Subject|0|||
13297074|NCT01367158|26498078|FG000|Overall Study|Withdrew consent|0|||
13297075|NCT01367158|26498079|FG001|Overall Study|Withdrew consent|2|||
13297076|NCT01367158|26498080|FG002|Overall Study|Withdrew consent|1|||
13297077|NCT01367158|26498081|FG003|Overall Study|Withdrew consent|0|||
13297078|NCT01367158|26498082|FG004|Overall Study|Withdrew consent|2|||
13297079|NCT01367158|26498083|FG005|Overall Study|Withdrew consent|0|||
13297080|NCT01367158|26498084|FG006|Overall Study|Withdrew consent|0|||
13297081|NCT01367158|26498085|FG007|Overall Study|Withdrew consent|1|||
13297082|NCT01367158|26498086|FG008|Overall Study|Withdrew consent|0|||
13297083|NCT01367158|26498087|FG009|Overall Study|Withdrew consent|0|||
13297084|NCT01367158|26498088|FG010|Overall Study|Withdrew consent|0|||
13297085|NCT01367158|26498078|FG000|Overall Study|Lost to Follow-up|0|||
13217723|NCT01852058|26272145|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1|||
13217724|NCT01852058|26272146|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
13217725|NCT01852058|26272147|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
13217726|NCT01852058|26272148|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
13217727|NCT01852058|26272149|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
13217728|NCT01852058|26272150|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
13217729|NCT01852058|26272151|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
13217730|NCT01852058|26272152|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
13217731|NCT01852058|26272153|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
13217732|NCT01852058|26272154|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
13217733|NCT01852058|26272155|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
13217734|NCT01852058|26272156|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
13217735|NCT01852058|26272145|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
13217736|NCT01852058|26272146|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
13217737|NCT01852058|26272147|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
13217738|NCT01852058|26272148|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
13217739|NCT01852058|26272149|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1|||
13217740|NCT01852058|26272150|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
13217741|NCT01852058|26272151|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
13217742|NCT01852058|26272152|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
13217743|NCT01852058|26272153|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
13217744|NCT01852058|26272154|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
13217745|NCT01852058|26272155|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
13217746|NCT01852058|26272156|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
13217747|NCT01852058|26272145|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
13217748|NCT01852058|26272146|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
13217749|NCT01852058|26272147|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
13217750|NCT01852058|26272148|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
13217751|NCT01852058|26272149|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
13217752|NCT01852058|26272150|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
13217753|NCT01852058|26272151|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
13217754|NCT01852058|26272152|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
13217755|NCT01852058|26272153|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
13217756|NCT01852058|26272154|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
13217757|NCT01852058|26272155|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
13217758|NCT01852058|26272156|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
13217759|NCT01852058|26272145|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
13217760|NCT01852058|26272146|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
13217761|NCT01852058|26272147|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
13217762|NCT01852058|26272148|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
13217763|NCT01852058|26272149|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1|||
13217764|NCT01852058|26272150|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
13217765|NCT01852058|26272151|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
13217766|NCT01852058|26272152|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
13217767|NCT01852058|26272153|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
13217768|NCT01852058|26272154|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
13217769|NCT01852058|26272155|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
13217770|NCT01852058|26272156|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
13217771|NCT01852058|26272145|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
13217772|NCT01852058|26272146|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
13217773|NCT01852058|26272147|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
13217774|NCT01852058|26272148|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
13217775|NCT01852058|26272149|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3|||
13217776|NCT01852058|26272150|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1|||
13217777|NCT01852058|26272151|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
13217778|NCT01852058|26272152|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
13217779|NCT01852058|26272153|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
13217780|NCT01852058|26272154|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
13217781|NCT01852058|26272155|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
13217782|NCT01852058|26272156|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
13217783|NCT01852058|26272145|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
13217784|NCT01852058|26272146|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
13217785|NCT01852058|26272147|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
13217786|NCT01852058|26272148|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1|||
13217787|NCT01852058|26272149|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
13217788|NCT01852058|26272150|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
13217789|NCT01852058|26272151|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
13217790|NCT01852058|26272152|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
13217791|NCT01852058|26272153|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
13297086|NCT01367158|26498079|FG001|Overall Study|Lost to Follow-up|0|||
13297087|NCT01367158|26498080|FG002|Overall Study|Lost to Follow-up|0|||
13297088|NCT01367158|26498081|FG003|Overall Study|Lost to Follow-up|1|||
13297089|NCT01367158|26498082|FG004|Overall Study|Lost to Follow-up|0|||
13297090|NCT01367158|26498083|FG005|Overall Study|Lost to Follow-up|2|||
13297091|NCT01367158|26498084|FG006|Overall Study|Lost to Follow-up|0|||
13297092|NCT01367158|26498085|FG007|Overall Study|Lost to Follow-up|1|||
13297093|NCT01367158|26498086|FG008|Overall Study|Lost to Follow-up|0|||
13297094|NCT01367158|26498087|FG009|Overall Study|Lost to Follow-up|0|||
13297095|NCT01367158|26498088|FG010|Overall Study|Lost to Follow-up|1|||
13297096|NCT01367158|26498078|FG000|Overall Study|Protocol Violation|0|||
13297097|NCT01367158|26498079|FG001|Overall Study|Protocol Violation|1|||
13297098|NCT01367158|26498080|FG002|Overall Study|Protocol Violation|0|||
13297099|NCT01367158|26498081|FG003|Overall Study|Protocol Violation|0|||
13297100|NCT01367158|26498082|FG004|Overall Study|Protocol Violation|0|||
13297101|NCT01367158|26498083|FG005|Overall Study|Protocol Violation|0|||
13297102|NCT01367158|26498084|FG006|Overall Study|Protocol Violation|0|||
13297103|NCT01367158|26498085|FG007|Overall Study|Protocol Violation|0|||
13297104|NCT01367158|26498086|FG008|Overall Study|Protocol Violation|0|||
13297105|NCT01367158|26498087|FG009|Overall Study|Protocol Violation|0|||
13297106|NCT01367158|26498088|FG010|Overall Study|Protocol Violation|0|||
13297107|NCT01367119|26498105|FG000|Overall Study|Adverse Event|1|||
13297108|NCT01367119|26498106|FG001|Overall Study|Adverse Event|0|||
13297109|NCT01367119|26498105|FG000|Overall Study|Withdrawal by Subject|1|||
13297110|NCT01367119|26498106|FG001|Overall Study|Withdrawal by Subject|1|||
13297111|NCT01366846|26498139|FG000|Overall Study|Withdrawal by Subject|2|||
13297112|NCT01366846|26498140|FG001|Overall Study|Withdrawal by Subject|0|||
13297113|NCT01366846|26498141|FG002|Overall Study|Withdrawal by Subject|0|||
13297114|NCT01366846|26498142|FG003|Overall Study|Withdrawal by Subject|0|||
13297115|NCT01366846|26498139|FG000|Overall Study|Communication Difficulties|1|||
13297116|NCT01366846|26498140|FG001|Overall Study|Communication Difficulties|4|||
13297117|NCT01366846|26498141|FG002|Overall Study|Communication Difficulties|0|||
13297118|NCT01366846|26498142|FG003|Overall Study|Communication Difficulties|1|||
13297119|NCT01366846|26498139|FG000|Overall Study|Scheduling Conflicts|0|||
13297120|NCT01366846|26498140|FG001|Overall Study|Scheduling Conflicts|0|||
13297121|NCT01366846|26498141|FG002|Overall Study|Scheduling Conflicts|1|||
13297122|NCT01366846|26498142|FG003|Overall Study|Scheduling Conflicts|0|||
13297123|NCT01366638|26498186|FG000|Overall Study|Withdrawal by Subject|0|||
13297124|NCT01366638|26498187|FG001|Overall Study|Withdrawal by Subject|0|||
13297125|NCT01366638|26498188|FG002|Overall Study|Withdrawal by Subject|6|||
13297126|NCT01366638|26498186|FG000|Overall Study|Other|1|||
13297127|NCT01366638|26498187|FG001|Overall Study|Other|0|||
13297128|NCT01366638|26498188|FG002|Overall Study|Other|0|||
13297129|NCT01366534|26498244|FG000|Overall Study|Lost to Follow-up|1|||
13297130|NCT01366534|26498245|FG001|Overall Study|Lost to Follow-up|0|||
13297131|NCT01366534|26498246|FG002|Overall Study|Lost to Follow-up|0|||
13297132|NCT01366534|26498244|FG000|Overall Study|Migrated|1|||
13297133|NCT01366534|26498245|FG001|Overall Study|Migrated|1|||
13297134|NCT01366534|26498246|FG002|Overall Study|Migrated|0|||
13297135|NCT01366534|26498244|FG000|Overall Study|Declined challenged|0|||
13297136|NCT01366534|26498245|FG001|Overall Study|Declined challenged|1|||
13297137|NCT01366534|26498246|FG002|Overall Study|Declined challenged|0|||
13297138|NCT01366521|26498334|FG000|Overall Study|Adverse Event|1|||
13297139|NCT01366521|26498335|FG001|Overall Study|Adverse Event|0|||
13297140|NCT01366521|26498336|FG002|Overall Study|Adverse Event|0|||
13297141|NCT01366521|26498337|FG003|Overall Study|Adverse Event|0|||
13297142|NCT01366521|26498334|FG000|Overall Study|Protocol Violation|0|||
13297143|NCT01366521|26498335|FG001|Overall Study|Protocol Violation|0|||
13297144|NCT01366521|26498336|FG002|Overall Study|Protocol Violation|1|||
13297145|NCT01366521|26498337|FG003|Overall Study|Protocol Violation|0|||
13297146|NCT01366521|26498334|FG000|Overall Study|Physician Decision|0|||
13297147|NCT01366521|26498335|FG001|Overall Study|Physician Decision|0|||
13297148|NCT01366521|26498336|FG002|Overall Study|Physician Decision|1|||
13297149|NCT01366521|26498337|FG003|Overall Study|Physician Decision|0|||
13297150|NCT01366521|26498334|FG000|Overall Study|Withdrawal by Subject|0|||
13297151|NCT01366521|26498335|FG001|Overall Study|Withdrawal by Subject|1|||
13297152|NCT01366521|26498336|FG002|Overall Study|Withdrawal by Subject|0|||
13297153|NCT01366521|26498337|FG003|Overall Study|Withdrawal by Subject|0|||
13297154|NCT01366443|26498344|FG000|Overall Study|Lost to Follow-up|2|||
13297155|NCT01366443|26498344|FG000|Overall Study|Under 18 yo|1|||
13297156|NCT01366209|26498357|FG000|Overall Study|Adverse Event|6|||
13297157|NCT01366209|26498358|FG001|Overall Study|Adverse Event|7|||
13217792|NCT01852058|26272154|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
13217793|NCT01852058|26272155|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
13217794|NCT01852058|26272156|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
13217795|NCT01852058|26272145|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
13217796|NCT01852058|26272146|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
13217797|NCT01852058|26272147|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
13217798|NCT01852058|26272148|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
13217799|NCT01852058|26272149|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1|||
13217800|NCT01852058|26272150|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7|||
13217801|NCT01852058|26272151|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
13217802|NCT01852058|26272152|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
13217803|NCT01852058|26272153|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
13217804|NCT01852058|26272154|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
13217805|NCT01852058|26272155|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
13217806|NCT01852058|26272156|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
13217807|NCT01852058|26272145|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
13217808|NCT01852058|26272146|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
13217809|NCT01852058|26272147|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
13217810|NCT01852058|26272148|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
13217811|NCT01852058|26272149|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
13217812|NCT01852058|26272150|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
13217813|NCT01852058|26272151|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
13217814|NCT01852058|26272152|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1|||
13217815|NCT01852058|26272153|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
13217816|NCT01852058|26272154|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
13217817|NCT01852058|26272155|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
13217818|NCT01852058|26272156|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
13217819|NCT01852058|26272145|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
13217820|NCT01852058|26272146|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
13217821|NCT01852058|26272147|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
13217822|NCT01852058|26272148|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
13217823|NCT01852058|26272149|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
13217824|NCT01852058|26272150|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
13217825|NCT01852058|26272151|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
13217826|NCT01852058|26272152|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
13217827|NCT01852058|26272153|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1|||
13217828|NCT01852058|26272154|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
13217829|NCT01852058|26272155|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
13217830|NCT01852058|26272156|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
13217831|NCT01852045|26272204|FG000|Overall Study|Adverse Event|1|||
13217832|NCT01852045|26272205|FG001|Overall Study|Adverse Event|0|||
13217833|NCT01852045|26272206|FG002|Overall Study|Adverse Event|0|||
13217834|NCT01852045|26272204|FG000|Overall Study|Lack of Efficacy|3|||
13217835|NCT01852045|26272205|FG001|Overall Study|Lack of Efficacy|0|||
13217836|NCT01852045|26272206|FG002|Overall Study|Lack of Efficacy|0|||
13217837|NCT01852045|26272204|FG000|Overall Study|Lost to Follow-up|0|||
13217838|NCT01852045|26272205|FG001|Overall Study|Lost to Follow-up|1|||
13217839|NCT01852045|26272206|FG002|Overall Study|Lost to Follow-up|1|||
13217840|NCT01852045|26272204|FG000|Overall Study|Withdrawal by Subject|1|||
13217841|NCT01852045|26272205|FG001|Overall Study|Withdrawal by Subject|0|||
13217842|NCT01852045|26272206|FG002|Overall Study|Withdrawal by Subject|1|||
13217843|NCT01852045|26272204|FG000|Overall Study|Other Miscellaneous Reasons|1|||
13217844|NCT01852045|26272205|FG001|Overall Study|Other Miscellaneous Reasons|3|||
13217845|NCT01852045|26272206|FG002|Overall Study|Other Miscellaneous Reasons|2|||
13217846|NCT01851863|26272240|FG000|Overall Study|Did not receive study medication|2|||
13217847|NCT01851863|26272241|FG001|Overall Study|Did not receive study medication|5|||
13217848|NCT01851863|26272242|FG002|Overall Study|Did not receive study medication|3|||
13217849|NCT01851863|26272243|FG003|Overall Study|Did not receive study medication|0|||
13217850|NCT01851863|26272240|FG000|Overall Study|Lost to Follow-up|3|||
13217851|NCT01851863|26272241|FG001|Overall Study|Lost to Follow-up|4|||
13217852|NCT01851863|26272242|FG002|Overall Study|Lost to Follow-up|2|||
13217853|NCT01851863|26272243|FG003|Overall Study|Lost to Follow-up|3|||
13217854|NCT01851720|26272256|FG000|Overall Study|Lost to Follow-up|0|||
13217855|NCT01851720|26272257|FG001|Overall Study|Lost to Follow-up|1|||
13217856|NCT01851590|26272287|FG000|Overall Study|Withdrawal by Subject|0|||
13217857|NCT01851590|26272288|FG001|Overall Study|Withdrawal by Subject|0|||
13217858|NCT01851590|26272289|FG002|Overall Study|Withdrawal by Subject|1|||
13217859|NCT01851590|26272287|FG000|Overall Study|Adverse Event|0|||
13217860|NCT01851590|26272288|FG001|Overall Study|Adverse Event|0|||
13217861|NCT01851590|26272289|FG002|Overall Study|Adverse Event|2|||
13217862|NCT01851590|26272287|FG000|Overall Study|Lack of Efficacy|0|||
13217863|NCT01851590|26272288|FG001|Overall Study|Lack of Efficacy|1|||
13217864|NCT01851590|26272289|FG002|Overall Study|Lack of Efficacy|0|||
13217865|NCT01851330|26272334|FG000|Overall Study|Lack of Efficacy|10|||
13217866|NCT01851330|26272335|FG001|Overall Study|Lack of Efficacy|9|||
13217867|NCT01851330|26272336|FG002|Overall Study|Lack of Efficacy|2|||
13217868|NCT01851330|26272334|FG000|Overall Study|Lost to Follow-up|1|||
13217869|NCT01851330|26272335|FG001|Overall Study|Lost to Follow-up|6|||
13217870|NCT01851330|26272336|FG002|Overall Study|Lost to Follow-up|9|||
13217871|NCT01851330|26272334|FG000|Overall Study|Withdrew Consent|2|||
13217872|NCT01851330|26272335|FG001|Overall Study|Withdrew Consent|1|||
13217873|NCT01851330|26272336|FG002|Overall Study|Withdrew Consent|0|||
13217874|NCT01851330|26272334|FG000|Overall Study|Investigator's Discretion|0|||
13217875|NCT01851330|26272335|FG001|Overall Study|Investigator's Discretion|0|||
13217876|NCT01851330|26272336|FG002|Overall Study|Investigator's Discretion|1|||
13217877|NCT01850823|26272356|FG000|Overall Study|Early Visit Window|0|||
13217878|NCT01850823|26272357|FG001|Overall Study|Early Visit Window|1|||
13217879|NCT01850823|26272358|FG002|Overall Study|Early Visit Window|4|||
13217880|NCT01850823|26272356|FG000|Overall Study|Enrolled in Error|0|||
13217881|NCT01850823|26272357|FG001|Overall Study|Enrolled in Error|1|||
13217882|NCT01850823|26272358|FG002|Overall Study|Enrolled in Error|2|||
13217883|NCT01850823|26272356|FG000|Overall Study|Lack of Efficacy|1|||
13217884|NCT01850823|26272357|FG001|Overall Study|Lack of Efficacy|0|||
13217885|NCT01850823|26272358|FG002|Overall Study|Lack of Efficacy|0|||
13217886|NCT01850823|26272356|FG000|Overall Study|Lost to Follow-up|0|||
13217887|NCT01850823|26272357|FG001|Overall Study|Lost to Follow-up|0|||
13217888|NCT01850823|26272358|FG002|Overall Study|Lost to Follow-up|1|||
13217889|NCT01850823|26272356|FG000|Overall Study|Restricted Medication|0|||
13217890|NCT01850823|26272357|FG001|Overall Study|Restricted Medication|0|||
13217891|NCT01850823|26272358|FG002|Overall Study|Restricted Medication|2|||
13217892|NCT01850823|26272356|FG000|Overall Study|Significant worstening of SAR|0|||
13217893|NCT01850823|26272357|FG001|Overall Study|Significant worstening of SAR|1|||
13217894|NCT01850823|26272358|FG002|Overall Study|Significant worstening of SAR|0|||
13217895|NCT01850823|26272356|FG000|Overall Study|Withdrawal by Subject|2|||
13217896|NCT01850823|26272357|FG001|Overall Study|Withdrawal by Subject|0|||
13217897|NCT01850823|26272358|FG002|Overall Study|Withdrawal by Subject|1|||
13217898|NCT01850641|26272372|FG000|Overall Study|Physician Decision|1|||
13217899|NCT01850641|26272372|FG000|Overall Study|Decrease in serum phosphorus|1|||
13217900|NCT01850641|26272372|FG000|Overall Study|Decrease in serum calcium|2|||
13217901|NCT01850641|26272372|FG000|Overall Study|Increase in serum ferritin|1|||
13217902|NCT01850615|26272395|FG000|Overall Study|Protocol Violation|4|||
13217903|NCT01850615|26272396|FG001|Overall Study|Protocol Violation|1|||
13217904|NCT01850615|26272395|FG000|Overall Study|Adverse Event|2|||
13217905|NCT01850615|26272396|FG001|Overall Study|Adverse Event|1|||
13217906|NCT01850615|26272395|FG000|Overall Study|Withdrawal by Subject|3|||
13217907|NCT01850615|26272396|FG001|Overall Study|Withdrawal by Subject|1|||
13217908|NCT01850615|26272395|FG000|Overall Study|Lost to Follow-up|0|||
13217909|NCT01850615|26272396|FG001|Overall Study|Lost to Follow-up|1|||
13217910|NCT01850615|26272395|FG000|Overall Study|Unclassified|0|||
13217911|NCT01850615|26272396|FG001|Overall Study|Unclassified|1|||
13217912|NCT01850602|26272415|FG000|Overall Study|Adverse Event|7|||
13217913|NCT01850602|26272416|FG001|Overall Study|Adverse Event|10|||
13217914|NCT01850602|26272415|FG000|Overall Study|Physician Decision|2|||
13217915|NCT01850602|26272416|FG001|Overall Study|Physician Decision|1|||
13217916|NCT01850602|26272415|FG000|Overall Study|Withdrawal by Subject|2|||
13217917|NCT01850602|26272416|FG001|Overall Study|Withdrawal by Subject|4|||
13217918|NCT01850602|26272415|FG000|Overall Study|Decrease in serum calcium|2|||
13217919|NCT01850602|26272416|FG001|Overall Study|Decrease in serum calcium|3|||
13217920|NCT01850602|26272415|FG000|Overall Study|Increase in serum ferritin|1|||
13217921|NCT01850602|26272416|FG001|Overall Study|Increase in serum ferritin|0|||
13217922|NCT01850589|26272429|FG000|Overall Study|Withdrawal by Subject|8|||
13217923|NCT01850589|26272430|FG001|Overall Study|Withdrawal by Subject|0|||
13217924|NCT01850563|26272457|FG000|Overall Study|Not eligible|3|||
13217925|NCT01850563|26272458|FG001|Overall Study|Not eligible|0|||
13217926|NCT01850524|26272473|FG000|Overall Study|Ongoing on Treatment|57|||
13217927|NCT01850524|26272474|FG001|Overall Study|Ongoing on Treatment|54|||
13217928|NCT01850524|26272473|FG000|Overall Study|Adverse Event|96|||
13217929|NCT01850524|26272474|FG001|Overall Study|Adverse Event|122|||
13217930|NCT01850524|26272473|FG000|Overall Study|Lost to Follow-up|2|||
13217931|NCT01850524|26272474|FG001|Overall Study|Lost to Follow-up|0|||
13217932|NCT01850524|26272473|FG000|Overall Study|Progressive Disease|166|||
13217933|NCT01850524|26272474|FG001|Overall Study|Progressive Disease|123|||
13217934|NCT01850524|26272473|FG000|Overall Study|Protocol Violation|1|||
13217935|NCT01850524|26272474|FG001|Overall Study|Protocol Violation|2|||
13217936|NCT01850524|26272473|FG000|Overall Study|Withdrawal by Subject|8|||
13217937|NCT01850524|26272474|FG001|Overall Study|Withdrawal by Subject|19|||
13217938|NCT01850524|26272473|FG000|Overall Study|Participant Wished to Discontinue Treatment|15|||
13217939|NCT01850524|26272474|FG001|Overall Study|Participant Wished to Discontinue Treatment|22|||
13217940|NCT01850524|26272473|FG000|Overall Study|Investigator Decision|4|||
13217941|NCT01850524|26272474|FG001|Overall Study|Investigator Decision|4|||
13217942|NCT01850524|26272473|FG000|Overall Study|Participants Removed From Study|0|||
13217943|NCT01850524|26272474|FG001|Overall Study|Participants Removed From Study|1|||
13217944|NCT01850524|26272473|FG000|Overall Study|Medical Monitor Decision|0|||
13217945|NCT01850524|26272474|FG001|Overall Study|Medical Monitor Decision|1|||
13217946|NCT01850524|26272473|FG000|Overall Study|Participants Decision|2|||
13297158|NCT01366209|26498357|FG000|Overall Study|Withdrawal by Subject|4|||
13297159|NCT01366209|26498358|FG001|Overall Study|Withdrawal by Subject|4|||
13297160|NCT01366209|26498357|FG000|Overall Study|Death|12|||
13297161|NCT01366209|26498358|FG001|Overall Study|Death|19|||
13297162|NCT01366209|26498357|FG000|Overall Study|Lung transplantation|6|||
13297163|NCT01366209|26498358|FG001|Overall Study|Lung transplantation|1|||
13297164|NCT01366209|26498357|FG000|Overall Study|Lost to Follow-up|2|||
13297165|NCT01366209|26498358|FG001|Overall Study|Lost to Follow-up|1|||
13297166|NCT01366209|26498357|FG000|Overall Study|Physician Decision|1|||
13297167|NCT01366209|26498358|FG001|Overall Study|Physician Decision|0|||
13297168|NCT01366209|26498357|FG000|Overall Study|Sponsors decision|0|||
13297169|NCT01366209|26498358|FG001|Overall Study|Sponsors decision|1|||
13297170|NCT01366209|26498357|FG000|Overall Study|Withdrew consent|4|||
13297171|NCT01366209|26498358|FG001|Overall Study|Withdrew consent|3|||
13297172|NCT01366092|26498369|FG000|Overall Study|Progressive cGVHD|2|||
13297173|NCT01366092|26498369|FG000|Overall Study|Physician Decision|1|||
13297174|NCT01366092|26498369|FG000|Overall Study|Withdrawal by Subject|1|||
13297175|NCT01365910|26498378|FG000|Overall Study|Withdrawal by Subject|7|||
13297176|NCT01365910|26498378|FG000|Overall Study|disease progression|18|||
13297177|NCT01365910|26498378|FG000|Overall Study|Adverse Event|3|||
13297178|NCT01365910|26498378|FG000|Overall Study|other complicating disease|1|||
13297179|NCT01365910|26498378|FG000|Overall Study|pt did not get tx, nausea/vomiting|1|||
13297180|NCT01365546|26498388|FG000|Overall Study|Withdrawal by Subject|1|||
13297181|NCT01365546|26498388|FG000|Overall Study|Screen failure|9|||
13297182|NCT01365546|26498388|FG000|Overall Study|Study termination|1|||
13297183|NCT01365507|26498409|FG000|Overall Study|Withdrawal Criteria|8|||
13297184|NCT01365507|26498410|FG001|Overall Study|Withdrawal Criteria|5|||
13297185|NCT01365507|26498409|FG000|Overall Study|Unclassified|1|||
13297186|NCT01365507|26498410|FG001|Overall Study|Unclassified|4|||
13297187|NCT01365494|26498429|FG000|Overall Study|Adverse Event|1|||
13297188|NCT01365494|26498430|FG001|Overall Study|Adverse Event|0|||
13297189|NCT01365494|26498429|FG000|Overall Study|Withdrawal by Subject|0|||
13297190|NCT01365494|26498430|FG001|Overall Study|Withdrawal by Subject|1|||
13297191|NCT01365494|26498429|FG000|Overall Study|Lost to Follow-up|1|||
13297192|NCT01365494|26498430|FG001|Overall Study|Lost to Follow-up|2|||
13297193|NCT01365481|26498461|FG000|Overall Study|Adverse Event|6|||
13297194|NCT01365481|26498462|FG001|Overall Study|Adverse Event|9|||
13297195|NCT01365481|26498463|FG002|Overall Study|Adverse Event|0|||
13297196|NCT01365481|26498464|FG003|Overall Study|Adverse Event|2|||
13297197|NCT01365481|26498461|FG000|Overall Study|Withdrawal by Subject|0|||
13297198|NCT01365481|26498462|FG001|Overall Study|Withdrawal by Subject|2|||
13297199|NCT01365481|26498463|FG002|Overall Study|Withdrawal by Subject|1|||
13297200|NCT01365481|26498464|FG003|Overall Study|Withdrawal by Subject|1|||
13297201|NCT01365481|26498461|FG000|Overall Study|Lost to Follow-up|1|||
13297202|NCT01365481|26498462|FG001|Overall Study|Lost to Follow-up|1|||
13297203|NCT01365481|26498463|FG002|Overall Study|Lost to Follow-up|2|||
13297204|NCT01365481|26498464|FG003|Overall Study|Lost to Follow-up|3|||
13297205|NCT01365481|26498461|FG000|Overall Study|Abnormal laboratory value(s)|0|||
13297206|NCT01365481|26498462|FG001|Overall Study|Abnormal laboratory value(s)|1|||
13297207|NCT01365481|26498463|FG002|Overall Study|Abnormal laboratory value(s)|0|||
13297208|NCT01365481|26498464|FG003|Overall Study|Abnormal laboratory value(s)|0|||
13297209|NCT01365481|26498461|FG000|Overall Study|Administrative problems|0|||
13297210|NCT01365481|26498462|FG001|Overall Study|Administrative problems|1|||
13297211|NCT01365481|26498463|FG002|Overall Study|Administrative problems|0|||
13297212|NCT01365481|26498464|FG003|Overall Study|Administrative problems|0|||
13297213|NCT01365481|26498461|FG000|Overall Study|Protocol deviation|0|||
13297214|NCT01365481|26498462|FG001|Overall Study|Protocol deviation|1|||
13297215|NCT01365481|26498463|FG002|Overall Study|Protocol deviation|0|||
13297216|NCT01365481|26498464|FG003|Overall Study|Protocol deviation|1|||
13297217|NCT01365481|26498461|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
13297218|NCT01365481|26498462|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
13297219|NCT01365481|26498463|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
13297220|NCT01365481|26498464|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
13297221|NCT01365468|26498483|FG000|Overall Study|Physician Decision|1|||
13297222|NCT01365468|26498484|FG001|Overall Study|Physician Decision|0|||
13297223|NCT01365468|26498483|FG000|Overall Study|Disease progression|1|||
13297224|NCT01365468|26498484|FG001|Overall Study|Disease progression|0|||
13297225|NCT01365468|26498483|FG000|Overall Study|Lost to Follow-up|2|||
13217947|NCT01850524|26272474|FG001|Overall Study|Participants Decision|2|||
13217948|NCT01850524|26272473|FG000|Overall Study|Progressive Disease Per Local Lab|1|||
13217949|NCT01850524|26272474|FG001|Overall Study|Progressive Disease Per Local Lab|0|||
13217950|NCT01850524|26272473|FG000|Overall Study|Lack of Improvement|0|||
13217951|NCT01850524|26272474|FG001|Overall Study|Lack of Improvement|1|||
13217952|NCT01850524|26272473|FG000|Overall Study|Minimal Response|1|||
13217953|NCT01850524|26272474|FG001|Overall Study|Minimal Response|0|||
13217954|NCT01850524|26272473|FG000|Overall Study|Comorbidities|1|||
13217955|NCT01850524|26272474|FG001|Overall Study|Comorbidities|0|||
13217956|NCT01850446|26272513|FG000|Overall Study|Lack of Efficacy|1|||
13217957|NCT01850446|26272514|FG001|Overall Study|Lack of Efficacy|0|||
13217958|NCT01850446|26272513|FG000|Overall Study|Withdrawal by Subject|4|||
13217959|NCT01850446|26272514|FG001|Overall Study|Withdrawal by Subject|0|||
13217960|NCT01850446|26272513|FG000|Overall Study|Protocol Violation|0|||
13217961|NCT01850446|26272514|FG001|Overall Study|Protocol Violation|2|||
13217962|NCT01850030|26272533|FG000|Overall Study|Adverse Event|64|||
13217963|NCT01850030|26272534|FG001|Overall Study|Adverse Event|82|||
13217964|NCT01850030|26272533|FG000|Overall Study|Lack of Efficacy|3|||
13297226|NCT01365468|26498484|FG001|Overall Study|Lost to Follow-up|0|||
13297227|NCT01365455|26498584|FG000|Induction Period|Adverse Event|5|||
13297228|NCT01365455|26498585|FG001|Induction Period|Adverse Event|3|||
13297229|NCT01365455|26498586|FG002|Induction Period|Adverse Event|4|||
13297230|NCT01365455|26498587|FG003|Induction Period|Adverse Event|0|||
13297231|NCT01365455|26498588|FG004|Induction Period|Adverse Event|0|||
13297232|NCT01365455|26498584|FG000|Induction Period|Lack of Efficacy|1|||
13297233|NCT01365455|26498585|FG001|Induction Period|Lack of Efficacy|1|||
13297234|NCT01365455|26498586|FG002|Induction Period|Lack of Efficacy|0|||
13297235|NCT01365455|26498587|FG003|Induction Period|Lack of Efficacy|0|||
13297236|NCT01365455|26498588|FG004|Induction Period|Lack of Efficacy|0|||
13297237|NCT01365455|26498584|FG000|Induction Period|Pregnancy|0|||
13297238|NCT01365455|26498585|FG001|Induction Period|Pregnancy|1|||
13297239|NCT01365455|26498586|FG002|Induction Period|Pregnancy|0|||
13297240|NCT01365455|26498587|FG003|Induction Period|Pregnancy|0|||
13297241|NCT01365455|26498588|FG004|Induction Period|Pregnancy|0|||
13297242|NCT01365455|26498584|FG000|Induction Period|Protocol deviation|0|||
13297243|NCT01365455|26498585|FG001|Induction Period|Protocol deviation|1|||
13297244|NCT01365455|26498586|FG002|Induction Period|Protocol deviation|1|||
13297245|NCT01365455|26498587|FG003|Induction Period|Protocol deviation|0|||
13297246|NCT01365455|26498588|FG004|Induction Period|Protocol deviation|0|||
13297247|NCT01365455|26498584|FG000|Induction Period|Subject/guardian decision|9|||
13297248|NCT01365455|26498585|FG001|Induction Period|Subject/guardian decision|1|||
13297249|NCT01365455|26498586|FG002|Induction Period|Subject/guardian decision|8|||
13297250|NCT01365455|26498587|FG003|Induction Period|Subject/guardian decision|0|||
13297251|NCT01365455|26498588|FG004|Induction Period|Subject/guardian decision|0|||
13297252|NCT01365455|26498584|FG000|Induction Period|Lost to Follow-up|0|||
13297253|NCT01365455|26498585|FG001|Induction Period|Lost to Follow-up|0|||
13297254|NCT01365455|26498586|FG002|Induction Period|Lost to Follow-up|3|||
13297255|NCT01365455|26498587|FG003|Induction Period|Lost to Follow-up|0|||
13297256|NCT01365455|26498588|FG004|Induction Period|Lost to Follow-up|0|||
13297257|NCT01365455|26498584|FG000|Maintenance Period|Adverse Event|12|||
13297258|NCT01365455|26498585|FG001|Maintenance Period|Adverse Event|5|||
13297259|NCT01365455|26498586|FG002|Maintenance Period|Adverse Event|1|||
13297260|NCT01365455|26498587|FG003|Maintenance Period|Adverse Event|2|||
13297261|NCT01365455|26498588|FG004|Maintenance Period|Adverse Event|4|||
13297262|NCT01365455|26498584|FG000|Maintenance Period|Lack of Efficacy|10|||
13297263|NCT01365455|26498585|FG001|Maintenance Period|Lack of Efficacy|2|||
13297264|NCT01365455|26498586|FG002|Maintenance Period|Lack of Efficacy|0|||
13297265|NCT01365455|26498587|FG003|Maintenance Period|Lack of Efficacy|2|||
13297266|NCT01365455|26498588|FG004|Maintenance Period|Lack of Efficacy|2|||
13297267|NCT01365455|26498584|FG000|Maintenance Period|Lost to Follow-up|2|||
13297268|NCT01365455|26498585|FG001|Maintenance Period|Lost to Follow-up|4|||
13297269|NCT01365455|26498586|FG002|Maintenance Period|Lost to Follow-up|0|||
13297270|NCT01365455|26498587|FG003|Maintenance Period|Lost to Follow-up|0|||
13297271|NCT01365455|26498588|FG004|Maintenance Period|Lost to Follow-up|3|||
13297272|NCT01365455|26498584|FG000|Maintenance Period|Non-compliance with study treatment|0|||
13297273|NCT01365455|26498585|FG001|Maintenance Period|Non-compliance with study treatment|0|||
13297274|NCT01365455|26498586|FG002|Maintenance Period|Non-compliance with study treatment|0|||
13297275|NCT01365455|26498587|FG003|Maintenance Period|Non-compliance with study treatment|1|||
13297276|NCT01365455|26498588|FG004|Maintenance Period|Non-compliance with study treatment|0|||
13297277|NCT01365455|26498584|FG000|Maintenance Period|Physician Decision|0|||
13297278|NCT01365455|26498585|FG001|Maintenance Period|Physician Decision|1|||
13297279|NCT01365455|26498586|FG002|Maintenance Period|Physician Decision|0|||
13217965|NCT01850030|26272534|FG001|Overall Study|Lack of Efficacy|1|||
13217966|NCT01850030|26272533|FG000|Overall Study|Lost to Follow-up|5|||
13297280|NCT01365455|26498587|FG003|Maintenance Period|Physician Decision|0|||
13297281|NCT01365455|26498588|FG004|Maintenance Period|Physician Decision|1|||
13297282|NCT01365455|26498584|FG000|Maintenance Period|Pregnancy|0|||
13217967|NCT01850030|26272534|FG001|Overall Study|Lost to Follow-up|5|||
13217968|NCT01850030|26272533|FG000|Overall Study|Withdrawal by Subject|3|||
13217969|NCT01850030|26272534|FG001|Overall Study|Withdrawal by Subject|4|||
13217970|NCT01850030|26272533|FG000|Overall Study|Protocol Violation|24|||
13217971|NCT01850030|26272534|FG001|Overall Study|Protocol Violation|28|||
13217972|NCT01850030|26272533|FG000|Overall Study|pregnancy not confirmed at visit 4|248|||
13217973|NCT01850030|26272534|FG001|Overall Study|pregnancy not confirmed at visit 4|249|||
13217974|NCT01850004|26272548|FG000|Overall Study|Poor/Non-compliance|1|||
13217975|NCT01850004|26272548|FG000|Overall Study|Participant Withdrew Consent|9|||
13217976|NCT01850004|26272548|FG000|Overall Study|Participant Request to Discontinue Treatment|2|||
13217977|NCT01850004|26272548|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
13217978|NCT01850004|26272548|FG000|Overall Study|Adverse Event Related to Study Drug|4|||
13217979|NCT01850004|26272548|FG000|Overall Study|Other Reasons|2|||
13217980|NCT01850004|26272548|FG000|Overall Study|Participant No Longer Meets Study Criteria|1|||
13217981|NCT01850004|26272548|FG000|Overall Study|Maximum Clinical Benefit|4|||
13217982|NCT01849874|26272573|FG000|Overall Study|Death|34|||
13217983|NCT01849874|26272574|FG001|Overall Study|Death|16|||
13217984|NCT01849874|26272573|FG000|Overall Study|Withdrawal by Subject|4|||
13217985|NCT01849874|26272574|FG001|Overall Study|Withdrawal by Subject|8|||
13217986|NCT01849874|26272573|FG000|Overall Study|Lost to Follow-up|0|||
13217987|NCT01849874|26272574|FG001|Overall Study|Lost to Follow-up|1|||
13217988|NCT01849874|26272573|FG000|Overall Study|Randomized but Never Treated|1|||
13217989|NCT01849874|26272574|FG001|Overall Study|Randomized but Never Treated|8|||
13217990|NCT01849874|26272573|FG000|Overall Study|Ongoing|162|||
13217991|NCT01849874|26272574|FG001|Overall Study|Ongoing|69|||
13217992|NCT01849848|26272590|FG000|Overall Study|Physician Decision|1|||
13217993|NCT01849848|26272590|FG000|Overall Study|Progression of the primary disease|3|||
13217994|NCT01849783|26272605|FG000|Overall Study|Adverse Event|5|||
13217995|NCT01849783|26272605|FG000|Overall Study|Death|2|||
13217996|NCT01849783|26272605|FG000|Overall Study|Physician Decision|1|||
13217997|NCT01849783|26272605|FG000|Overall Study|Withdrawal by Subject|1|||
13217998|NCT01849783|26272605|FG000|Overall Study|Unable to comply|2|||
13217999|NCT01849783|26272605|FG000|Overall Study|Disease progression|11|||
13218000|NCT01849588|26272614|FG000|Overall Study|Lack of Efficacy|3|||
13218001|NCT01849562|26272635|FG000|Overall Study|Lost to Follow-up|1|||
13218002|NCT01849562|26272636|FG001|Overall Study|Lost to Follow-up|0|||
13218003|NCT01849562|26272637|FG002|Overall Study|Lost to Follow-up|0|||
13218004|NCT01849562|26272635|FG000|Overall Study|Non-compliance with Study Drug|1|||
13218005|NCT01849562|26272636|FG001|Overall Study|Non-compliance with Study Drug|0|||
13218006|NCT01849562|26272637|FG002|Overall Study|Non-compliance with Study Drug|0|||
13218007|NCT01849497|26272652|FG000|Overall Study|Withdrawal by Subject|1|||
13218008|NCT01849497|26272653|FG001|Overall Study|Withdrawal by Subject|2|||
13218009|NCT01849497|26272652|FG000|Overall Study|Sponsor Decision|0|||
13218010|NCT01849497|26272653|FG001|Overall Study|Sponsor Decision|1|||
13218011|NCT01849497|26272652|FG000|Overall Study|Lost to Follow-up|0|||
13218012|NCT01849497|26272653|FG001|Overall Study|Lost to Follow-up|1|||
13218013|NCT01849458|26272665|FG000|Overall Study|Lost to Follow-up|4|||
13218014|NCT01849289|26272688|FG000|Overall Study|Adverse Event|3|||
13218015|NCT01849289|26272689|FG001|Overall Study|Adverse Event|3|||
13218016|NCT01849289|26272688|FG000|Overall Study|Protocol Violation|3|||
13218017|NCT01849289|26272689|FG001|Overall Study|Protocol Violation|3|||
13218018|NCT01849289|26272688|FG000|Overall Study|Withdrawal criteria|1|||
13218019|NCT01849289|26272689|FG001|Overall Study|Withdrawal criteria|0|||
13218020|NCT01849289|26272688|FG000|Overall Study|Unclassified|25|||
13218021|NCT01849289|26272689|FG001|Overall Study|Unclassified|18|||
13218022|NCT01849276|26272703|FG000|Followed for Survival for 5 Years|Death|1|||
13218023|NCT01849276|26272703|FG000|Followed for Survival for 5 Years|Early termination of the study|1|||
13218024|NCT01849055|26272754|FG000|Overall Study|Withdrawal by Subject|0|||
13218025|NCT01849055|26272755|FG001|Overall Study|Withdrawal by Subject|0|||
13218026|NCT01849055|26272756|FG002|Overall Study|Withdrawal by Subject|1|||
13218027|NCT01849055|26272757|FG003|Overall Study|Withdrawal by Subject|0|||
13218028|NCT01849055|26272758|FG004|Overall Study|Withdrawal by Subject|0|||
13218029|NCT01849055|26272759|FG005|Overall Study|Withdrawal by Subject|0|||
13297283|NCT01365455|26498585|FG001|Maintenance Period|Pregnancy|4|||
13297284|NCT01365455|26498586|FG002|Maintenance Period|Pregnancy|0|||
13297285|NCT01365455|26498587|FG003|Maintenance Period|Pregnancy|0|||
13394780|NCT00654381|26788101|FG004|2nd Stage|Investigator's decision|0|||
13218030|NCT01848990|26272828|FG000|Overall Study|Adverse Event|6|||
13218031|NCT01848990|26272829|FG001|Overall Study|Adverse Event|2|||
13218032|NCT01848990|26272830|FG002|Overall Study|Adverse Event|0|||
13218033|NCT01848990|26272828|FG000|Overall Study|Lost to Follow-up|6|||
13218034|NCT01848990|26272829|FG001|Overall Study|Lost to Follow-up|2|||
13218035|NCT01848990|26272830|FG002|Overall Study|Lost to Follow-up|2|||
13218036|NCT01848990|26272828|FG000|Overall Study|Protocol Violation|1|||
13218037|NCT01848990|26272829|FG001|Overall Study|Protocol Violation|1|||
13218038|NCT01848990|26272830|FG002|Overall Study|Protocol Violation|0|||
13218039|NCT01848990|26272828|FG000|Overall Study|Withdrawal by Subject|29|||
13297286|NCT01365455|26498588|FG004|Maintenance Period|Pregnancy|2|||
13218040|NCT01848990|26272829|FG001|Overall Study|Withdrawal by Subject|10|||
13218041|NCT01848990|26272830|FG002|Overall Study|Withdrawal by Subject|11|||
13218042|NCT01848990|26272828|FG000|Overall Study|Physician Decision|1|||
13218043|NCT01848990|26272829|FG001|Overall Study|Physician Decision|1|||
13218044|NCT01848990|26272830|FG002|Overall Study|Physician Decision|0|||
13218045|NCT01848990|26272828|FG000|Overall Study|Non Compliance|1|||
13218046|NCT01848990|26272829|FG001|Overall Study|Non Compliance|0|||
13218047|NCT01848990|26272830|FG002|Overall Study|Non Compliance|0|||
13218048|NCT01848990|26272828|FG000|Overall Study|Death|1|||
13218049|NCT01848990|26272829|FG001|Overall Study|Death|0|||
13218050|NCT01848990|26272830|FG002|Overall Study|Death|1|||
13218051|NCT01848990|26272828|FG000|Overall Study|Other|1|||
13218052|NCT01848990|26272829|FG001|Overall Study|Other|4|||
13218053|NCT01848990|26272830|FG002|Overall Study|Other|2|||
13218054|NCT01848938|26272853|FG000|Overall Study|Lost to Follow-up|1|||
13218055|NCT01848938|26272854|FG001|Overall Study|Lost to Follow-up|1|||
13218056|NCT01848834|26272905|FG000|Overall Study|Adverse Event|3|||
13218057|NCT01848834|26272906|FG001|Overall Study|Adverse Event|11|||
13218058|NCT01848834|26272907|FG002|Overall Study|Adverse Event|3|||
13218059|NCT01848834|26272908|FG003|Overall Study|Adverse Event|5|||
13218060|NCT01848834|26272909|FG004|Overall Study|Adverse Event|9|||
13218061|NCT01848834|26272905|FG000|Overall Study|Death|2|||
13218062|NCT01848834|26272906|FG001|Overall Study|Death|11|||
13218063|NCT01848834|26272907|FG002|Overall Study|Death|1|||
13218064|NCT01848834|26272908|FG003|Overall Study|Death|8|||
13218065|NCT01848834|26272909|FG004|Overall Study|Death|27|||
13218066|NCT01848834|26272905|FG000|Overall Study|Excluded Medication|5|||
13218067|NCT01848834|26272906|FG001|Overall Study|Excluded Medication|4|||
13218068|NCT01848834|26272907|FG002|Overall Study|Excluded Medication|3|||
13218069|NCT01848834|26272908|FG003|Overall Study|Excluded Medication|6|||
13218070|NCT01848834|26272909|FG004|Overall Study|Excluded Medication|6|||
13218071|NCT01848834|26272905|FG000|Overall Study|Lost to Follow-up|5|||
13218072|NCT01848834|26272906|FG001|Overall Study|Lost to Follow-up|5|||
13218073|NCT01848834|26272907|FG002|Overall Study|Lost to Follow-up|3|||
13218074|NCT01848834|26272908|FG003|Overall Study|Lost to Follow-up|0|||
13218075|NCT01848834|26272909|FG004|Overall Study|Lost to Follow-up|3|||
13218076|NCT01848834|26272905|FG000|Overall Study|Physician Decision|1|||
13218077|NCT01848834|26272906|FG001|Overall Study|Physician Decision|3|||
13218078|NCT01848834|26272907|FG002|Overall Study|Physician Decision|4|||
13218079|NCT01848834|26272908|FG003|Overall Study|Physician Decision|0|||
13218080|NCT01848834|26272909|FG004|Overall Study|Physician Decision|11|||
13218081|NCT01848834|26272905|FG000|Overall Study|Protocol Violation|0|||
13218082|NCT01848834|26272906|FG001|Overall Study|Protocol Violation|0|||
13218083|NCT01848834|26272907|FG002|Overall Study|Protocol Violation|0|||
13218084|NCT01848834|26272908|FG003|Overall Study|Protocol Violation|0|||
13218085|NCT01848834|26272909|FG004|Overall Study|Protocol Violation|1|||
13218086|NCT01848834|26272905|FG000|Overall Study|Sponsor Decision|1|||
13218087|NCT01848834|26272906|FG001|Overall Study|Sponsor Decision|1|||
13218088|NCT01848834|26272907|FG002|Overall Study|Sponsor Decision|0|||
13218089|NCT01848834|26272908|FG003|Overall Study|Sponsor Decision|1|||
13218090|NCT01848834|26272909|FG004|Overall Study|Sponsor Decision|1|||
13218091|NCT01848834|26272905|FG000|Overall Study|Withdrawal by Subject|2|||
13218092|NCT01848834|26272906|FG001|Overall Study|Withdrawal by Subject|13|||
13218093|NCT01848834|26272907|FG002|Overall Study|Withdrawal by Subject|10|||
13218094|NCT01848834|26272908|FG003|Overall Study|Withdrawal by Subject|6|||
13218095|NCT01848834|26272909|FG004|Overall Study|Withdrawal by Subject|36|||
13218096|NCT01848756|26272921|FG000|Overall Study|Adverse Event|1|||
13218097|NCT01848756|26272921|FG000|Overall Study|Withdrawal by Subject|1|||
13218098|NCT01848756|26272921|FG000|Overall Study|Enrolled in Error|1|||
13218099|NCT01848483|26272942|FG000|Overall Study|Death|2|||
13218100|NCT01848483|26272943|FG001|Overall Study|Death|1|||
13218101|NCT01848483|26272942|FG000|Overall Study|Lost to Follow-up|6|||
13218102|NCT01848483|26272943|FG001|Overall Study|Lost to Follow-up|8|||
13218103|NCT01848483|26272942|FG000|Overall Study|Withdrawal by Subject|1|||
13218104|NCT01848483|26272943|FG001|Overall Study|Withdrawal by Subject|0|||
13218105|NCT01848483|26272942|FG000|Overall Study|Incarceration|2|||
13218106|NCT01848483|26272943|FG001|Overall Study|Incarceration|2|||
13218107|NCT01848457|26272980|FG000|Overall Study|Death|1|||
13218108|NCT01848457|26272981|FG001|Overall Study|Death|0|||
13218109|NCT01848457|26272982|FG002|Overall Study|Death|0|||
13218110|NCT01848457|26272983|FG003|Overall Study|Death|0|||
13218111|NCT01848353|26273052|FG000|Phase 1|Withdrawal by Subject|3|||
13218112|NCT01848353|26273053|FG001|Phase 1|Withdrawal by Subject|1|||
13218113|NCT01848353|26273054|FG002|Phase 1|Withdrawal by Subject|0|||
13218114|NCT01848353|26273055|FG003|Phase 1|Withdrawal by Subject|0|||
13218115|NCT01848353|26273052|FG000|Phase 2|Withdrawal by Subject|3|||
13218116|NCT01848353|26273053|FG001|Phase 2|Withdrawal by Subject|2|||
13218117|NCT01848353|26273054|FG002|Phase 2|Withdrawal by Subject|0|||
13218118|NCT01848353|26273055|FG003|Phase 2|Withdrawal by Subject|0|||
13218119|NCT01848353|26273052|FG000|Phase 3|Withdrawal by Subject|1|||
13218120|NCT01848353|26273053|FG001|Phase 3|Withdrawal by Subject|1|||
13218121|NCT01848353|26273054|FG002|Phase 3|Withdrawal by Subject|0|||
13218122|NCT01848353|26273055|FG003|Phase 3|Withdrawal by Subject|0|||
13218123|NCT01848288|26273066|FG000|Overall Study|Death|1|||
13218124|NCT01848288|26273066|FG000|Overall Study|Protocol Violation|1|||
13218125|NCT01848288|26273066|FG000|Overall Study|Withdrawal by Subject|1|||
13218126|NCT01848210|26273085|FG000|Overall Study|Informed Consent Form Withdrawal|28|||
13382001|NCT00748215|26749629|FG001|Overall Study|Withdrawal by Subject|7|||
13382002|NCT00748215|26749628|FG000|Overall Study|Treatment change|2|||
13382003|NCT00748215|26749629|FG001|Overall Study|Treatment change|1|||
13218127|NCT01848210|26273086|FG001|Overall Study|Informed Consent Form Withdrawal|24|||
13218128|NCT01848210|26273085|FG000|Overall Study|Lost to Follow-up|24|||
13218129|NCT01848210|26273086|FG001|Overall Study|Lost to Follow-up|12|||
13218130|NCT01848210|26273085|FG000|Overall Study|Protocol Violation|3|||
13218131|NCT01848210|26273086|FG001|Overall Study|Protocol Violation|5|||
13218132|NCT01848210|26273085|FG000|Overall Study|Use of Forbidden Drugs|9|||
13218133|NCT01848210|26273086|FG001|Overall Study|Use of Forbidden Drugs|10|||
13218134|NCT01848210|26273085|FG000|Overall Study|Impedition Condition|5|||
13218135|NCT01848210|26273086|FG001|Overall Study|Impedition Condition|9|||
13218136|NCT01848210|26273085|FG000|Overall Study|Adverse Event|7|||
13218137|NCT01848210|26273086|FG001|Overall Study|Adverse Event|9|||
13218138|NCT01848210|26273085|FG000|Overall Study|Discontinuation Criterion|5|||
13218139|NCT01848210|26273086|FG001|Overall Study|Discontinuation Criterion|7|||
13218140|NCT01848210|26273085|FG000|Overall Study|Hypesensitivity|1|||
13218141|NCT01848210|26273086|FG001|Overall Study|Hypesensitivity|0|||
13218142|NCT01848210|26273085|FG000|Overall Study|Hepatic Function Alteration|4|||
13218143|NCT01848210|26273086|FG001|Overall Study|Hepatic Function Alteration|0|||
13218144|NCT01848210|26273085|FG000|Overall Study|Chronic Venous Insufficiency Course|1|||
13218145|NCT01848210|26273086|FG001|Overall Study|Chronic Venous Insufficiency Course|2|||
13218146|NCT01848210|26273085|FG000|Overall Study|Administrative|1|||
13218147|NCT01848210|26273086|FG001|Overall Study|Administrative|0|||
13218148|NCT01848145|26273097|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1|||
13218149|NCT01848145|26273097|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1|||
13218150|NCT01848145|26273097|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1|||
13218151|NCT01848145|26273097|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1|||
13218152|NCT01848145|26273097|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6|||
13218153|NCT01848145|26273097|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3|||
13218154|NCT01848145|26273097|FG000|Subsequent Infusions: Weeks 3-8|Death|1|||
13218155|NCT01847885|26273137|FG000|Initial Enrollment (Consented)|Protocol Violation|1|||
13218156|NCT01847885|26273138|FG001|Initial Enrollment (Consented)|Protocol Violation|0|||
13218157|NCT01847885|26273139|FG002|Initial Enrollment (Consented)|Protocol Violation|0|||
13218158|NCT01847885|26273137|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2|||
13218159|NCT01847885|26273138|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
13218160|NCT01847885|26273139|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
13218161|NCT01847885|26273137|FG000|Initial Enrollment (Consented)|Screen failure|39|||
13218162|NCT01847885|26273138|FG001|Initial Enrollment (Consented)|Screen failure|0|||
13218163|NCT01847885|26273139|FG002|Initial Enrollment (Consented)|Screen failure|0|||
13297287|NCT01365455|26498584|FG000|Maintenance Period|Protocol deviation|1|||
13297288|NCT01365455|26498585|FG001|Maintenance Period|Protocol deviation|1|||
13297289|NCT01365455|26498586|FG002|Maintenance Period|Protocol deviation|0|||
13297290|NCT01365455|26498587|FG003|Maintenance Period|Protocol deviation|0|||
13297291|NCT01365455|26498588|FG004|Maintenance Period|Protocol deviation|0|||
13297292|NCT01365455|26498584|FG000|Maintenance Period|Subject/guardian decision|4|||
13297293|NCT01365455|26498585|FG001|Maintenance Period|Subject/guardian decision|6|||
13297294|NCT01365455|26498586|FG002|Maintenance Period|Subject/guardian decision|2|||
13297295|NCT01365455|26498587|FG003|Maintenance Period|Subject/guardian decision|4|||
13297296|NCT01365455|26498588|FG004|Maintenance Period|Subject/guardian decision|1|||
13297297|NCT01365273|26498605|FG000|Overall Study|Lost to Follow-up|1|||
13297298|NCT01365273|26498606|FG001|Overall Study|Lost to Follow-up|0|||
13297299|NCT01365273|26498605|FG000|Overall Study|Protocol Violation|0|||
13297300|NCT01365273|26498606|FG001|Overall Study|Protocol Violation|1|||
13297301|NCT01365273|26498605|FG000|Overall Study|Physician Decision|1|||
13297302|NCT01365273|26498606|FG001|Overall Study|Physician Decision|0|||
13297303|NCT01365130|26498613|FG000|Overall Study|Progression/worsening of Dx prior to txt|2|||
13297304|NCT01365091|26498652|FG000|Period 1|Adverse Event|1|||
13297305|NCT01365091|26498653|FG001|Period 1|Adverse Event|0|||
13297306|NCT01365091|26498654|FG002|Period 1|Adverse Event|2|||
13297307|NCT01365091|26498655|FG003|Period 1|Adverse Event|3|||
13297308|NCT01365091|26498652|FG000|Period 1|Positive test result for drugs of abuse|1|||
13297309|NCT01365091|26498653|FG001|Period 1|Positive test result for drugs of abuse|0|||
13297310|NCT01365091|26498654|FG002|Period 1|Positive test result for drugs of abuse|0|||
13297311|NCT01365091|26498655|FG003|Period 1|Positive test result for drugs of abuse|0|||
13297312|NCT01365091|26498652|FG000|Period 1|No longer met study criteria|0|||
13297313|NCT01365091|26498653|FG001|Period 1|No longer met study criteria|1|||
13297314|NCT01365091|26498654|FG002|Period 1|No longer met study criteria|0|||
13297315|NCT01365091|26498655|FG003|Period 1|No longer met study criteria|0|||
13218164|NCT01847885|26273137|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6|||
13218165|NCT01847885|26273138|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
13218166|NCT01847885|26273139|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
13218167|NCT01847885|26273137|FG000|Randomization|Protocol Violation|0|||
13218168|NCT01847885|26273138|FG001|Randomization|Protocol Violation|1|||
13218169|NCT01847885|26273139|FG002|Randomization|Protocol Violation|0|||
13218170|NCT01847885|26273137|FG000|Randomization|Withdrawal by Subject|0|||
13218171|NCT01847885|26273138|FG001|Randomization|Withdrawal by Subject|0|||
13218172|NCT01847885|26273139|FG002|Randomization|Withdrawal by Subject|2|||
13218173|NCT01847885|26273137|FG000|Randomization|Screen Failure|0|||
13218174|NCT01847885|26273138|FG001|Randomization|Screen Failure|3|||
13218175|NCT01847885|26273139|FG002|Randomization|Screen Failure|0|||
13218176|NCT01847755|26273145|FG000|Overall Study|Adverse Event|2|||
13218177|NCT01847755|26273145|FG000|Overall Study|Withdrawal by Subject|2|||
13218178|NCT01847755|26273145|FG000|Overall Study|Physician Decision|1|||
13218179|NCT01847443|26273180|FG000|Study Period 1|Withdrawal by Subject|0|||
13218180|NCT01847443|26273181|FG001|Study Period 1|Withdrawal by Subject|1|||
13218181|NCT01847443|26273182|FG002|Study Period 1|Withdrawal by Subject|0|||
13218182|NCT01847443|26273183|FG003|Study Period 1|Withdrawal by Subject|0|||
13218183|NCT01847443|26273180|FG000|Washout Period Before Study Period 2|Adverse Event|1|||
13218184|NCT01847443|26273181|FG001|Washout Period Before Study Period 2|Adverse Event|1|||
13218185|NCT01847443|26273182|FG002|Washout Period Before Study Period 2|Adverse Event|0|||
13218186|NCT01847443|26273183|FG003|Washout Period Before Study Period 2|Adverse Event|0|||
13218187|NCT01847443|26273180|FG000|Washout Period Before Study Period 2|Other reason|1|||
13218188|NCT01847443|26273181|FG001|Washout Period Before Study Period 2|Other reason|0|||
13218189|NCT01847443|26273182|FG002|Washout Period Before Study Period 2|Other reason|0|||
13218190|NCT01847443|26273183|FG003|Washout Period Before Study Period 2|Other reason|0|||
13218191|NCT01847443|26273180|FG000|Washout Period Before Study Period 3|Other reason|1|||
13218192|NCT01847443|26273181|FG001|Washout Period Before Study Period 3|Other reason|0|||
13218193|NCT01847443|26273182|FG002|Washout Period Before Study Period 3|Other reason|0|||
13218194|NCT01847443|26273183|FG003|Washout Period Before Study Period 3|Other reason|0|||
13218195|NCT01847443|26273180|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1|||
13218196|NCT01847443|26273181|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
13218197|NCT01847443|26273182|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
13218198|NCT01847443|26273183|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
13218199|NCT01847443|26273180|FG000|Washout Period Before Study Period 4|Positive alcohol test|1|||
13218200|NCT01847443|26273181|FG001|Washout Period Before Study Period 4|Positive alcohol test|0|||
13218201|NCT01847443|26273182|FG002|Washout Period Before Study Period 4|Positive alcohol test|0|||
13218202|NCT01847443|26273183|FG003|Washout Period Before Study Period 4|Positive alcohol test|0|||
13218203|NCT01847313|26273202|FG000|Overall Study|Death|0|||
13218204|NCT01847313|26273203|FG001|Overall Study|Death|1|||
13218205|NCT01847313|26273202|FG000|Overall Study|Withdrawal by Subject|0|||
13218206|NCT01847313|26273203|FG001|Overall Study|Withdrawal by Subject|1|||
13218207|NCT01847209|26273210|FG000|Overall Study|Withdrawal by Subject|1|||
13218208|NCT01847209|26273210|FG000|Overall Study|No lung nodule found on intraop CT scan|1|||
13218209|NCT01847092|26273225|FG000|Overall Study|Adverse Event|12|||
13218210|NCT01847092|26273226|FG001|Overall Study|Adverse Event|3|||
13218211|NCT01847092|26273225|FG000|Overall Study|Withdrawal by Subject|5|||
13218212|NCT01847092|26273226|FG001|Overall Study|Withdrawal by Subject|5|||
13218213|NCT01847092|26273225|FG000|Overall Study|Protocol Specified|8|||
13218214|NCT01847092|26273226|FG001|Overall Study|Protocol Specified|0|||
13218215|NCT01847092|26273225|FG000|Overall Study|Physician Decision|1|||
13218216|NCT01847092|26273226|FG001|Overall Study|Physician Decision|1|||
13218217|NCT01847092|26273225|FG000|Overall Study|Protocol Violation|0|||
13218218|NCT01847092|26273226|FG001|Overall Study|Protocol Violation|2|||
13218219|NCT01846741|26273284|FG000|Baseline Visit|Subject did not meet entry criteria|2|||
13218220|NCT01846624|26273294|FG000|Overall Study|Died during induction, no midostaurin|1|||
13218221|NCT01846611|26273311|FG000|Overall Study|Lost to Follow-up|4|||
13218222|NCT01846611|26273312|FG001|Overall Study|Lost to Follow-up|6|||
13218223|NCT01846611|26273311|FG000|Overall Study|Withdrawal by Subject|15|||
13218224|NCT01846611|26273312|FG001|Overall Study|Withdrawal by Subject|19|||
13218225|NCT01846611|26273311|FG000|Overall Study|Other|19|||
13218226|NCT01846611|26273312|FG001|Overall Study|Other|18|||
13218227|NCT01846507|26273331|FG000|Overall Study|Lost to Follow-up|4|||
13218228|NCT01846507|26273331|FG000|Overall Study|Protocol Violation|1|||
13218229|NCT01846507|26273331|FG000|Overall Study|Missing data|2|||
13218230|NCT01846442|26273382|FG000|Overall Study|Adverse Event|2|||
13218231|NCT01846442|26273383|FG001|Overall Study|Adverse Event|4|||
13218232|NCT01846442|26273384|FG002|Overall Study|Adverse Event|2|||
13218233|NCT01846442|26273385|FG003|Overall Study|Adverse Event|1|||
13218234|NCT01846442|26273382|FG000|Overall Study|Lost to Follow-up|0|||
13218235|NCT01846442|26273383|FG001|Overall Study|Lost to Follow-up|0|||
13218236|NCT01846442|26273384|FG002|Overall Study|Lost to Follow-up|1|||
13218237|NCT01846442|26273385|FG003|Overall Study|Lost to Follow-up|0|||
13218238|NCT01846442|26273382|FG000|Overall Study|Withdrawal by Subject|3|||
13218239|NCT01846442|26273383|FG001|Overall Study|Withdrawal by Subject|2|||
13218240|NCT01846442|26273384|FG002|Overall Study|Withdrawal by Subject|0|||
13218241|NCT01846442|26273385|FG003|Overall Study|Withdrawal by Subject|1|||
13218242|NCT01846442|26273382|FG000|Overall Study|Left the city/Lost medication|1|||
13218243|NCT01846442|26273383|FG001|Overall Study|Left the city/Lost medication|0|||
13218244|NCT01846442|26273384|FG002|Overall Study|Left the city/Lost medication|1|||
13218245|NCT01846442|26273385|FG003|Overall Study|Left the city/Lost medication|1|||
13297316|NCT01365091|26498652|FG000|Period 1|Withdrawal by Subject|0|||
13297317|NCT01365091|26498653|FG001|Period 1|Withdrawal by Subject|1|||
13297318|NCT01365091|26498654|FG002|Period 1|Withdrawal by Subject|0|||
13297319|NCT01365091|26498655|FG003|Period 1|Withdrawal by Subject|0|||
13297320|NCT01365091|26498652|FG000|Period 1|Personal reasons|0|||
13297321|NCT01365091|26498653|FG001|Period 1|Personal reasons|0|||
13297322|NCT01365091|26498654|FG002|Period 1|Personal reasons|1|||
13297323|NCT01365091|26498655|FG003|Period 1|Personal reasons|0|||
13297324|NCT01365091|26498652|FG000|Period 2|Withdrawal by Subject|1|||
13297325|NCT01365091|26498653|FG001|Period 2|Withdrawal by Subject|0|||
13297326|NCT01365091|26498654|FG002|Period 2|Withdrawal by Subject|0|||
13297327|NCT01365091|26498655|FG003|Period 2|Withdrawal by Subject|0|||
13297328|NCT01365091|26498652|FG000|Period 2|Adverse Event|0|||
13297329|NCT01365091|26498653|FG001|Period 2|Adverse Event|0|||
13297330|NCT01365091|26498654|FG002|Period 2|Adverse Event|1|||
13297331|NCT01365091|26498655|FG003|Period 2|Adverse Event|0|||
13297332|NCT01365052|26498676|FG000|Overall Study|Adverse Event|4|||
13297333|NCT01365052|26498677|FG001|Overall Study|Adverse Event|4|||
13297334|NCT01365039|26498692|FG000|Overall Study|Study related symptoms and complaints|1|||
13297335|NCT01365039|26498693|FG001|Overall Study|Study related symptoms and complaints|0|||
13297336|NCT01364922|26498714|FG000|Open-label (OL) Period|Adverse Event|7|||
13297337|NCT01364922|26498715|FG001|Open-label (OL) Period|Adverse Event|0|||
13297338|NCT01364922|26498716|FG002|Open-label (OL) Period|Adverse Event|0|||
13297339|NCT01364922|26498714|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6|||
13297340|NCT01364922|26498715|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
13297341|NCT01364922|26498716|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
13297342|NCT01364922|26498714|FG000|Open-label (OL) Period|Withdrawal by Subject|4|||
13297343|NCT01364922|26498715|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
13297344|NCT01364922|26498716|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
13297345|NCT01364922|26498714|FG000|Open-label (OL) Period|Lack of Efficacy|3|||
13297346|NCT01364922|26498715|FG001|Open-label (OL) Period|Lack of Efficacy|0|||
13297347|NCT01364922|26498716|FG002|Open-label (OL) Period|Lack of Efficacy|0|||
13297348|NCT01364922|26498714|FG000|Open-label (OL) Period|Lost to Follow-up|1|||
13297349|NCT01364922|26498715|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
13297350|NCT01364922|26498716|FG002|Open-label (OL) Period|Lost to Follow-up|0|||
13297351|NCT01364922|26498714|FG000|Open-label (OL) Period|Other, Unspecified|1|||
13297352|NCT01364922|26498715|FG001|Open-label (OL) Period|Other, Unspecified|0|||
13297353|NCT01364922|26498716|FG002|Open-label (OL) Period|Other, Unspecified|0|||
13297354|NCT01364922|26498714|FG000|Double-Blind (DB) Period|Lack of Efficacy|0|||
13297355|NCT01364922|26498715|FG001|Double-Blind (DB) Period|Lack of Efficacy|3|||
13297356|NCT01364922|26498716|FG002|Double-Blind (DB) Period|Lack of Efficacy|4|||
13297357|NCT01364922|26498714|FG000|Double-Blind (DB) Period|Subject Noncompliant|0|||
13297358|NCT01364922|26498715|FG001|Double-Blind (DB) Period|Subject Noncompliant|1|||
13297359|NCT01364922|26498716|FG002|Double-Blind (DB) Period|Subject Noncompliant|0|||
13297360|NCT01364922|26498714|FG000|Double-Blind (DB) Period|Adverse Event|0|||
13297361|NCT01364922|26498715|FG001|Double-Blind (DB) Period|Adverse Event|0|||
13297362|NCT01364922|26498716|FG002|Double-Blind (DB) Period|Adverse Event|1|||
13297363|NCT01364922|26498714|FG000|Double-Blind (DB) Period|Other, Unspecified|0|||
13297364|NCT01364922|26498715|FG001|Double-Blind (DB) Period|Other, Unspecified|1|||
13297365|NCT01364922|26498716|FG002|Double-Blind (DB) Period|Other, Unspecified|0|||
13297366|NCT01364870|26498737|FG000|Overall Study|Withdrawal by Subject|13|||
13297367|NCT01364870|26498738|FG001|Overall Study|Withdrawal by Subject|24|||
13297368|NCT01364870|26498739|FG002|Overall Study|Withdrawal by Subject|10|||
13297369|NCT01364870|26498737|FG000|Overall Study|Adverse Event|8|||
13297370|NCT01364870|26498738|FG001|Overall Study|Adverse Event|6|||
13297371|NCT01364870|26498739|FG002|Overall Study|Adverse Event|4|||
13297372|NCT01364870|26498737|FG000|Overall Study|Protocol Violation|1|||
13297373|NCT01364870|26498738|FG001|Overall Study|Protocol Violation|0|||
13297374|NCT01364870|26498739|FG002|Overall Study|Protocol Violation|0|||
13297375|NCT01364727|26498747|FG000|Overall Study|Not Eligible|2|||
13297376|NCT01364649|26498764|FG000|Overall Study|Pretreatment Event or Adverse Event|20|||
13297377|NCT01364649|26498765|FG001|Overall Study|Pretreatment Event or Adverse Event|14|||
13297378|NCT01364649|26498764|FG000|Overall Study|Lack of Efficacy|6|||
13297379|NCT01364649|26498765|FG001|Overall Study|Lack of Efficacy|0|||
13297380|NCT01364649|26498764|FG000|Overall Study|Non-compliance with Investigational Drug|1|||
13297381|NCT01364649|26498765|FG001|Overall Study|Non-compliance with Investigational Drug|0|||
13297382|NCT01364649|26498764|FG000|Overall Study|Protocol Deviations|4|||
13218246|NCT01846416|26273438|FG000|Treatment Phase|Death|2|||
13218247|NCT01846416|26273439|FG001|Treatment Phase|Death|9|||
13218248|NCT01846416|26273440|FG002|Treatment Phase|Death|1|||
13218249|NCT01846416|26273438|FG000|Treatment Phase|Withdrawal by Subject|2|||
13218250|NCT01846416|26273439|FG001|Treatment Phase|Withdrawal by Subject|4|||
13218251|NCT01846416|26273440|FG002|Treatment Phase|Withdrawal by Subject|2|||
13218252|NCT01846416|26273438|FG000|Treatment Phase|Other|1|||
13218253|NCT01846416|26273439|FG001|Treatment Phase|Other|5|||
13218254|NCT01846416|26273440|FG002|Treatment Phase|Other|1|||
13218255|NCT01846416|26273438|FG000|Treatment Phase|Physician Decision|1|||
13218256|NCT01846416|26273439|FG001|Treatment Phase|Physician Decision|2|||
13218257|NCT01846416|26273440|FG002|Treatment Phase|Physician Decision|0|||
13218258|NCT01846416|26273438|FG000|Treatment Phase|Adverse Event|3|||
13218259|NCT01846416|26273439|FG001|Treatment Phase|Adverse Event|4|||
13218260|NCT01846416|26273440|FG002|Treatment Phase|Adverse Event|0|||
13218261|NCT01846416|26273438|FG000|Treatment Phase|Non-compliance|0|||
13218262|NCT01846416|26273439|FG001|Treatment Phase|Non-compliance|2|||
13218263|NCT01846416|26273440|FG002|Treatment Phase|Non-compliance|0|||
13218264|NCT01846416|26273438|FG000|Treatment Phase|Study Terminated by Sponsor|1|||
13218265|NCT01846416|26273439|FG001|Treatment Phase|Study Terminated by Sponsor|4|||
13218266|NCT01846416|26273440|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
13218267|NCT01846416|26273438|FG000|Treatment Phase|Progressive Disease|21|||
13218268|NCT01846416|26273439|FG001|Treatment Phase|Progressive Disease|63|||
13218269|NCT01846416|26273440|FG002|Treatment Phase|Progressive Disease|9|||
13218270|NCT01846416|26273438|FG000|Survival Follow-up|Death|21|||
13218271|NCT01846416|26273439|FG001|Survival Follow-up|Death|62|||
13218272|NCT01846416|26273440|FG002|Survival Follow-up|Death|9|||
13218273|NCT01846416|26273438|FG000|Survival Follow-up|Lost to Follow-up|0|||
13218274|NCT01846416|26273439|FG001|Survival Follow-up|Lost to Follow-up|2|||
13218275|NCT01846416|26273440|FG002|Survival Follow-up|Lost to Follow-up|2|||
13218276|NCT01846416|26273438|FG000|Survival Follow-up|Withdrawal by Subject|2|||
13218277|NCT01846416|26273439|FG001|Survival Follow-up|Withdrawal by Subject|7|||
13218278|NCT01846416|26273440|FG002|Survival Follow-up|Withdrawal by Subject|0|||
13218279|NCT01846416|26273438|FG000|Survival Follow-up|Study Terminated by Sponsor|2|||
13218280|NCT01846416|26273439|FG001|Survival Follow-up|Study Terminated by Sponsor|8|||
13218281|NCT01846416|26273440|FG002|Survival Follow-up|Study Terminated by Sponsor|0|||
13218282|NCT01846416|26273438|FG000|Survival Follow-up|Other|3|||
13218283|NCT01846416|26273439|FG001|Survival Follow-up|Other|1|||
13218284|NCT01846416|26273440|FG002|Survival Follow-up|Other|1|||
13218285|NCT01846299|26273483|FG000|Overall Study|Physician Decision|4|||
13218286|NCT01846299|26273484|FG001|Overall Study|Physician Decision|2|||
13218287|NCT01846299|26273483|FG000|Overall Study|Protocol deviation|1|||
13218288|NCT01846299|26273484|FG001|Overall Study|Protocol deviation|0|||
13218289|NCT01846299|26273483|FG000|Overall Study|Death|1|||
13218290|NCT01846299|26273484|FG001|Overall Study|Death|2|||
13218291|NCT01846299|26273483|FG000|Overall Study|Lost to Follow-up|3|||
13218292|NCT01846299|26273484|FG001|Overall Study|Lost to Follow-up|0|||
13218293|NCT01846299|26273483|FG000|Overall Study|Withdrawal by Subject|1|||
13218294|NCT01846299|26273484|FG001|Overall Study|Withdrawal by Subject|6|||
13218295|NCT01846299|26273483|FG000|Overall Study|Adverse Event|2|||
13218296|NCT01846299|26273484|FG001|Overall Study|Adverse Event|0|||
13218297|NCT01846221|26273505|FG000|Overall Study|Catheter Failure|2|||
13218298|NCT01846221|26273506|FG001|Overall Study|Catheter Failure|0|||
13218299|NCT01846221|26273505|FG000|Overall Study|Age Exclusion|1|||
13218300|NCT01846221|26273506|FG001|Overall Study|Age Exclusion|0|||
13218301|NCT01846208|26273536|FG000|Overall Study|Withdrew prior to treatment|1|||
13218302|NCT01846208|26273537|FG001|Overall Study|Withdrew prior to treatment|1|||
13218303|NCT01846208|26273538|FG002|Overall Study|Withdrew prior to treatment|1|||
13218304|NCT01846208|26273536|FG000|Overall Study|Dosing Symptoms|1|||
13218305|NCT01846208|26273537|FG001|Overall Study|Dosing Symptoms|2|||
13218306|NCT01846208|26273538|FG002|Overall Study|Dosing Symptoms|6|||
13218307|NCT01846208|26273536|FG000|Overall Study|Withdrawal by Subject|5|||
13218308|NCT01846208|26273537|FG001|Overall Study|Withdrawal by Subject|0|||
13218309|NCT01846208|26273538|FG002|Overall Study|Withdrawal by Subject|0|||
13218310|NCT01846208|26273536|FG000|Overall Study|Non-compliance|1|||
13218311|NCT01846208|26273537|FG001|Overall Study|Non-compliance|1|||
13218312|NCT01846208|26273538|FG002|Overall Study|Non-compliance|0|||
13218313|NCT01846208|26273536|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1|||
13218314|NCT01846208|26273537|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
13218315|NCT01846208|26273538|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
13218316|NCT01846208|26273536|FG000|Overall Study|Refused SU OFC|0|||
13218317|NCT01846208|26273537|FG001|Overall Study|Refused SU OFC|0|||
13218318|NCT01846208|26273538|FG002|Overall Study|Refused SU OFC|1|||
13218319|NCT01846104|26273546|FG000|Overall Study|Withdrawal by Subject|1|||
13218320|NCT01846039|26273558|FG000|Overall Study|Protocol Violation|1|||
13218321|NCT01846039|26273558|FG000|Overall Study|Subject Withdrew Consent|1|||
13218322|NCT01845974|26273571|FG000|Overall Study|screen failure|1|||
13218323|NCT01845974|26273572|FG001|Overall Study|screen failure|0|||
13218324|NCT01845831|26273609|FG000|Inpatient Phase|Withdrawal by Subject|1|||
13218325|NCT01845831|26273610|FG001|Inpatient Phase|Withdrawal by Subject|1|||
13218326|NCT01845831|26273611|FG002|Inpatient Phase|Withdrawal by Subject|0|||
13218327|NCT01845831|26273612|FG003|Inpatient Phase|Withdrawal by Subject|0|||
13218328|NCT01845831|26273613|FG004|Inpatient Phase|Withdrawal by Subject|0|||
13218329|NCT01845818|26273659|FG000|Overall Study|Withdrawal by Subject|0|||
13218330|NCT01845818|26273660|FG001|Overall Study|Withdrawal by Subject|1|||
13218331|NCT01845818|26273659|FG000|Overall Study|Lost to Follow-up|7|||
13218332|NCT01845818|26273660|FG001|Overall Study|Lost to Follow-up|5|||
13218333|NCT01845818|26273659|FG000|Overall Study|Administrative Reasons|3|||
13218334|NCT01845818|26273660|FG001|Overall Study|Administrative Reasons|1|||
13218335|NCT01845818|26273659|FG000|Overall Study|Serious Adverse Event|1|||
13218336|NCT01845818|26273660|FG001|Overall Study|Serious Adverse Event|1|||
13218337|NCT01845818|26273659|FG000|Overall Study|Other|25|||
13218338|NCT01845818|26273660|FG001|Overall Study|Other|8|||
13218339|NCT01845818|26273659|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5|||
13218340|NCT01845818|26273660|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0|||
13218341|NCT01845818|26273659|FG000|Overall Study|No Follow-Up Data Available|4|||
13218342|NCT01845818|26273660|FG001|Overall Study|No Follow-Up Data Available|1|||
13218343|NCT01845805|26273677|FG000|Overall Study|Withdrawal by Subject|1|||
13218344|NCT01845805|26273678|FG001|Overall Study|Withdrawal by Subject|2|||
13218345|NCT01845805|26273677|FG000|Overall Study|Disease Progression|13|||
13218346|NCT01845805|26273678|FG001|Overall Study|Disease Progression|14|||
13218347|NCT01845805|26273677|FG000|Overall Study|Drug-related Toxicity|4|||
13218348|NCT01845805|26273678|FG001|Overall Study|Drug-related Toxicity|0|||
13218349|NCT01845077|26273735|FG000|Washout Period|Lost to Follow-up|0|||
13218350|NCT01845077|26273736|FG001|Washout Period|Lost to Follow-up|1|||
13218351|NCT01845077|26273737|FG002|Washout Period|Lost to Follow-up|0|||
13218352|NCT01845077|26273738|FG003|Washout Period|Lost to Follow-up|1|||
13218353|NCT01845077|26273739|FG004|Washout Period|Lost to Follow-up|0|||
13218354|NCT01845077|26273740|FG005|Washout Period|Lost to Follow-up|1|||
13218355|NCT01845077|26273735|FG000|Washout Period|Adverse Event|1|||
13218356|NCT01845077|26273736|FG001|Washout Period|Adverse Event|0|||
13218357|NCT01845077|26273737|FG002|Washout Period|Adverse Event|0|||
13218358|NCT01845077|26273738|FG003|Washout Period|Adverse Event|0|||
13218359|NCT01845077|26273739|FG004|Washout Period|Adverse Event|0|||
13218360|NCT01845077|26273740|FG005|Washout Period|Adverse Event|0|||
13218361|NCT01845077|26273735|FG000|Washout Period|elevated lab values (not clinic. sign.)|0|||
13218362|NCT01845077|26273736|FG001|Washout Period|elevated lab values (not clinic. sign.)|0|||
13297383|NCT01364649|26498765|FG001|Overall Study|Protocol Deviations|8|||
13297384|NCT01364649|26498764|FG000|Overall Study|Withdrawal of Consent|9|||
13297385|NCT01364649|26498765|FG001|Overall Study|Withdrawal of Consent|7|||
13297386|NCT01364649|26498764|FG000|Overall Study|Lost to Follow-up|12|||
13297387|NCT01364649|26498765|FG001|Overall Study|Lost to Follow-up|13|||
13297388|NCT01364649|26498764|FG000|Overall Study|Other|4|||
13297389|NCT01364649|26498765|FG001|Overall Study|Other|1|||
13297390|NCT01364597|26498801|FG000|Overall Study|Adverse Event|4|||
13297391|NCT01364597|26498802|FG001|Overall Study|Adverse Event|5|||
13297392|NCT01364597|26498803|FG002|Overall Study|Adverse Event|16|||
13297393|NCT01364597|26498804|FG003|Overall Study|Adverse Event|7|||
13297394|NCT01364597|26498801|FG000|Overall Study|Lack of Efficacy|4|||
13297395|NCT01364597|26498802|FG001|Overall Study|Lack of Efficacy|4|||
13297396|NCT01364597|26498803|FG002|Overall Study|Lack of Efficacy|23|||
13297397|NCT01364597|26498804|FG003|Overall Study|Lack of Efficacy|8|||
13297398|NCT01364597|26498801|FG000|Overall Study|Protocol Violation|0|||
13297399|NCT01364597|26498802|FG001|Overall Study|Protocol Violation|0|||
13297400|NCT01364597|26498803|FG002|Overall Study|Protocol Violation|2|||
13297401|NCT01364597|26498804|FG003|Overall Study|Protocol Violation|0|||
13297402|NCT01364597|26498801|FG000|Overall Study|Lost to Follow-up|0|||
13297403|NCT01364597|26498802|FG001|Overall Study|Lost to Follow-up|0|||
13297404|NCT01364597|26498803|FG002|Overall Study|Lost to Follow-up|5|||
13297405|NCT01364597|26498804|FG003|Overall Study|Lost to Follow-up|3|||
13297406|NCT01364597|26498801|FG000|Overall Study|Withdrawal by Subject|4|||
13297407|NCT01364597|26498802|FG001|Overall Study|Withdrawal by Subject|1|||
13297408|NCT01364597|26498803|FG002|Overall Study|Withdrawal by Subject|18|||
13297409|NCT01364597|26498804|FG003|Overall Study|Withdrawal by Subject|6|||
13297410|NCT01364597|26498801|FG000|Overall Study|Non compliance|1|||
13297411|NCT01364597|26498802|FG001|Overall Study|Non compliance|0|||
13297412|NCT01364597|26498803|FG002|Overall Study|Non compliance|1|||
13297413|NCT01364597|26498804|FG003|Overall Study|Non compliance|0|||
13297414|NCT01364597|26498801|FG000|Overall Study|Lack of compliance|1|||
13297415|NCT01364597|26498802|FG001|Overall Study|Lack of compliance|0|||
13297416|NCT01364597|26498803|FG002|Overall Study|Lack of compliance|0|||
13297417|NCT01364597|26498804|FG003|Overall Study|Lack of compliance|0|||
13297418|NCT01364597|26498801|FG000|Overall Study|End of treatment epilepsy|1|||
13297419|NCT01364597|26498802|FG001|Overall Study|End of treatment epilepsy|0|||
13297420|NCT01364597|26498803|FG002|Overall Study|End of treatment epilepsy|0|||
13297421|NCT01364597|26498804|FG003|Overall Study|End of treatment epilepsy|0|||
13297422|NCT01364597|26498801|FG000|Overall Study|No Seizures|1|||
13297423|NCT01364597|26498802|FG001|Overall Study|No Seizures|0|||
13218363|NCT01845077|26273737|FG002|Washout Period|elevated lab values (not clinic. sign.)|1|||
13218364|NCT01845077|26273738|FG003|Washout Period|elevated lab values (not clinic. sign.)|0|||
13218365|NCT01845077|26273739|FG004|Washout Period|elevated lab values (not clinic. sign.)|0|||
13218366|NCT01845077|26273740|FG005|Washout Period|elevated lab values (not clinic. sign.)|0|||
13218367|NCT01845077|26273735|FG000|Washout Period|Protocol Violation|0|||
13218368|NCT01845077|26273736|FG001|Washout Period|Protocol Violation|0|||
13218369|NCT01845077|26273737|FG002|Washout Period|Protocol Violation|0|||
13218370|NCT01845077|26273738|FG003|Washout Period|Protocol Violation|1|||
13218371|NCT01845077|26273739|FG004|Washout Period|Protocol Violation|1|||
13218372|NCT01845077|26273740|FG005|Washout Period|Protocol Violation|0|||
13218373|NCT01845025|26273769|FG000|Overall Study|Adverse Event|6|||
13218374|NCT01845025|26273770|FG001|Overall Study|Adverse Event|3|||
13218375|NCT01845025|26273769|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
13218376|NCT01845025|26273770|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
13218377|NCT01845025|26273769|FG000|Overall Study|Withdrawal by Subject|48|||
13218378|NCT01845025|26273770|FG001|Overall Study|Withdrawal by Subject|44|||
13218379|NCT01845025|26273769|FG000|Overall Study|Lost to Follow-up|13|||
13218380|NCT01845025|26273770|FG001|Overall Study|Lost to Follow-up|13|||
13218381|NCT01845025|26273769|FG000|Overall Study|Administrative problems|8|||
13218382|NCT01845025|26273770|FG001|Overall Study|Administrative problems|8|||
13218383|NCT01845025|26273769|FG000|Overall Study|Death|2|||
13218384|NCT01845025|26273770|FG001|Overall Study|Death|0|||
13218385|NCT01845025|26273769|FG000|Overall Study|Protocol deviation|3|||
13218386|NCT01845025|26273770|FG001|Overall Study|Protocol deviation|6|||
13218387|NCT01845025|26273769|FG000|Overall Study|Missing|1|||
13218388|NCT01845025|26273770|FG001|Overall Study|Missing|1|||
13218389|NCT01844986|26273799|FG000|Overall Study|Severe non-compliance to protocol|1|||
13218390|NCT01844986|26273800|FG001|Overall Study|Severe non-compliance to protocol|0|||
13218391|NCT01844986|26273799|FG000|Overall Study|Withdrawal by Subject|21|||
13218392|NCT01844986|26273800|FG001|Overall Study|Withdrawal by Subject|14|||
13218393|NCT01844986|26273799|FG000|Overall Study|Death|55|||
13218394|NCT01844986|26273800|FG001|Overall Study|Death|26|||
13218395|NCT01844895|26273818|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1|||
13218396|NCT01844895|26273818|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1|||
13218397|NCT01844895|26273818|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1|||
13218398|NCT01844895|26273818|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1|||
13218399|NCT01844895|26273818|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1|||
13218400|NCT01844895|26273818|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3|||
13218401|NCT01844895|26273818|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1|||
13218402|NCT01844830|26273853|FG000|Overall Study|Withdrawal by Subject|1|||
13218403|NCT01844830|26273854|FG001|Overall Study|Withdrawal by Subject|0|||
13218404|NCT01844817|26273871|FG000|Enrolled and Randomized|Withdrawal by Subject|2|||
13218405|NCT01844817|26273872|FG001|Enrolled and Randomized|Withdrawal by Subject|3|||
13218406|NCT01844817|26273871|FG000|Treatment|Progressive Disease|27|||
13218407|NCT01844817|26273872|FG001|Treatment|Progressive Disease|36|||
13218408|NCT01844817|26273871|FG000|Treatment|Adverse Event|17|||
13218409|NCT01844817|26273872|FG001|Treatment|Adverse Event|9|||
13218410|NCT01844817|26273871|FG000|Treatment|Withdrawal by Subject|10|||
13218411|NCT01844817|26273872|FG001|Treatment|Withdrawal by Subject|6|||
13218412|NCT01844817|26273871|FG000|Treatment|Death|10|||
13218413|NCT01844817|26273872|FG001|Treatment|Death|8|||
13218414|NCT01844817|26273871|FG000|Treatment|Lost to Follow-up|0|||
13218415|NCT01844817|26273872|FG001|Treatment|Lost to Follow-up|1|||
13218416|NCT01844817|26273871|FG000|Treatment|Other|0|||
13218417|NCT01844817|26273872|FG001|Treatment|Other|3|||
13218418|NCT01844778|26273906|FG000|Overall Study|Protocol deviation|0|||
13218419|NCT01844778|26273907|FG001|Overall Study|Protocol deviation|1|||
13218420|NCT01844778|26273908|FG002|Overall Study|Protocol deviation|2|||
13218421|NCT01844778|26273906|FG000|Overall Study|Withdrawal by Subject|2|||
13218422|NCT01844778|26273907|FG001|Overall Study|Withdrawal by Subject|0|||
13218423|NCT01844778|26273908|FG002|Overall Study|Withdrawal by Subject|0|||
13218424|NCT01844778|26273906|FG000|Overall Study|Adverse Event|0|||
13218425|NCT01844778|26273907|FG001|Overall Study|Adverse Event|2|||
13218426|NCT01844778|26273908|FG002|Overall Study|Adverse Event|2|||
13218427|NCT01844765|26273960|FG000|Overall Study|Adverse Event|6|||
13218428|NCT01844765|26273961|FG001|Overall Study|Adverse Event|8|||
13218429|NCT01844765|26273960|FG000|Overall Study|Withdrawal by Subject|2|||
13218430|NCT01844765|26273961|FG001|Overall Study|Withdrawal by Subject|3|||
13218431|NCT01844765|26273960|FG000|Overall Study|Disease progression|1|||
13218432|NCT01844765|26273961|FG001|Overall Study|Disease progression|0|||
13218433|NCT01844765|26273960|FG000|Overall Study|Administrative problems|3|||
13218434|NCT01844765|26273961|FG001|Overall Study|Administrative problems|4|||
13218435|NCT01844765|26273960|FG000|Overall Study|Protocol deviation|2|||
13218436|NCT01844765|26273961|FG001|Overall Study|Protocol deviation|0|||
13218437|NCT01844765|26273960|FG000|Overall Study|Untreated|1|||
13218438|NCT01844765|26273961|FG001|Overall Study|Untreated|0|||
13218439|NCT01844700|26273980|FG000|Overall Study|Lack of Efficacy|1|||
13218440|NCT01844700|26273981|FG001|Overall Study|Lack of Efficacy|0|||
13218441|NCT01844700|26273980|FG000|Overall Study|refused medication switch|1|||
13218442|NCT01844700|26273981|FG001|Overall Study|refused medication switch|0|||
13218443|NCT01844700|26273980|FG000|Overall Study|Withdrawal by Subject|1|||
13218444|NCT01844700|26273981|FG001|Overall Study|Withdrawal by Subject|0|||
13218445|NCT01844700|26273980|FG000|Overall Study|stopped taking meds|0|||
13218446|NCT01844700|26273981|FG001|Overall Study|stopped taking meds|1|||
13218447|NCT01844687|26274042|FG000|Visit 1|Protocol Violation|3|||
13218448|NCT01844687|26274042|FG000|Visit 1|Lost to Follow-up|5|||
13218449|NCT01844687|26274042|FG000|Visit 2|Withdrawal by Subject|1|||
13218450|NCT01844687|26274042|FG000|Visit 2|Protocol Violation|1|||
13218451|NCT01844687|26274042|FG000|Visit 3|Lost to Follow-up|1|||
13218452|NCT01844687|26274042|FG000|Visit 3|Withdrawal by Subject|3|||
13218453|NCT01844687|26274042|FG000|Visit 3|child care problems|1|||
13218454|NCT01844687|26274042|FG000|Visit 4|Pregnancy|1|||
13218455|NCT01844687|26274042|FG000|Visit 4|Lost to Follow-up|1|||
13218456|NCT01844687|26274042|FG000|Visit 4|Withdrawal by Subject|2|||
13218457|NCT01844583|26274077|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8|||
13218458|NCT01844583|26274078|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10|||
13218459|NCT01844531|26274121|FG000|Overall Study|Withdrawal by Subject|0|||
13218460|NCT01844531|26274122|FG001|Overall Study|Withdrawal by Subject|1|||
13218461|NCT01844531|26274123|FG002|Overall Study|Withdrawal by Subject|0|||
13218462|NCT01844531|26274124|FG003|Overall Study|Withdrawal by Subject|0|||
13218463|NCT01844518|26274146|FG000|Overall Study|Adverse Event|7|||
13218464|NCT01844518|26274147|FG001|Overall Study|Adverse Event|1|||
13218465|NCT01844518|26274146|FG000|Overall Study|Lack of Efficacy|17|||
13218466|NCT01844518|26274147|FG001|Overall Study|Lack of Efficacy|5|||
13218467|NCT01844518|26274146|FG000|Overall Study|Participant's request to discontinue|4|||
13218468|NCT01844518|26274147|FG001|Overall Study|Participant's request to discontinue|1|||
13218469|NCT01844518|26274146|FG000|Overall Study|Poor/Non-compliance|1|||
13218470|NCT01844518|26274147|FG001|Overall Study|Poor/Non-compliance|0|||
13218471|NCT01844518|26274146|FG000|Overall Study|No Longer Met Study Criteria|2|||
13218472|NCT01844518|26274147|FG001|Overall Study|No Longer Met Study Criteria|0|||
13218473|NCT01844518|26274146|FG000|Overall Study|Withdrawal by Subject|9|||
13218474|NCT01844518|26274147|FG001|Overall Study|Withdrawal by Subject|0|||
13218475|NCT01844518|26274146|FG000|Overall Study|Pregnancy|1|||
13218476|NCT01844518|26274147|FG001|Overall Study|Pregnancy|0|||
13297424|NCT01364597|26498803|FG002|Overall Study|No Seizures|0|||
13297425|NCT01364597|26498804|FG003|Overall Study|No Seizures|0|||
13297426|NCT01364597|26498801|FG000|Overall Study|Lack of reliability from the subject's caregiver|1|||
13297427|NCT01364597|26498802|FG001|Overall Study|Lack of reliability from the subject's caregiver|0|||
13297428|NCT01364597|26498803|FG002|Overall Study|Lack of reliability from the subject's caregiver|0|||
13297429|NCT01364597|26498804|FG003|Overall Study|Lack of reliability from the subject's caregiver|0|||
13297430|NCT01364597|26498801|FG000|Overall Study|Cure|1|||
13297431|NCT01364597|26498802|FG001|Overall Study|Cure|0|||
13297432|NCT01364597|26498803|FG002|Overall Study|Cure|0|||
13297433|NCT01364597|26498804|FG003|Overall Study|Cure|0|||
13297434|NCT01364597|26498801|FG000|Overall Study|Patient was moving|0|||
13297435|NCT01364597|26498802|FG001|Overall Study|Patient was moving|1|||
13297436|NCT01364597|26498803|FG002|Overall Study|Patient was moving|0|||
13297437|NCT01364597|26498804|FG003|Overall Study|Patient was moving|0|||
13297438|NCT01364597|26498801|FG000|Overall Study|Seizures resolved|0|||
13297439|NCT01364597|26498802|FG001|Overall Study|Seizures resolved|0|||
13297440|NCT01364597|26498803|FG002|Overall Study|Seizures resolved|1|||
13297441|NCT01364597|26498804|FG003|Overall Study|Seizures resolved|0|||
13297442|NCT01364597|26498801|FG000|Overall Study|Patient became seizure-free after surgery|0|||
13297443|NCT01364597|26498802|FG001|Overall Study|Patient became seizure-free after surgery|0|||
13297444|NCT01364597|26498803|FG002|Overall Study|Patient became seizure-free after surgery|1|||
13297445|NCT01364597|26498804|FG003|Overall Study|Patient became seizure-free after surgery|0|||
13297446|NCT01364597|26498801|FG000|Overall Study|5 year without seizures. Treatment is finish|0|||
13297447|NCT01364597|26498802|FG001|Overall Study|5 year without seizures. Treatment is finish|0|||
13297448|NCT01364597|26498803|FG002|Overall Study|5 year without seizures. Treatment is finish|1|||
13297449|NCT01364597|26498804|FG003|Overall Study|5 year without seizures. Treatment is finish|0|||
13297450|NCT01364597|26498801|FG000|Overall Study|Patient cured from Epilepsy|0|||
13297451|NCT01364597|26498802|FG001|Overall Study|Patient cured from Epilepsy|0|||
13297452|NCT01364597|26498803|FG002|Overall Study|Patient cured from Epilepsy|1|||
13297453|NCT01364597|26498804|FG003|Overall Study|Patient cured from Epilepsy|0|||
13297454|NCT01364597|26498801|FG000|Overall Study|Investigator decision|0|||
13297455|NCT01364597|26498802|FG001|Overall Study|Investigator decision|0|||
13297456|NCT01364597|26498803|FG002|Overall Study|Investigator decision|1|||
13297457|NCT01364597|26498804|FG003|Overall Study|Investigator decision|0|||
13297458|NCT01364597|26498801|FG000|Overall Study|Sponsor recommended discontinuation|0|||
13297459|NCT01364597|26498802|FG001|Overall Study|Sponsor recommended discontinuation|0|||
13218477|NCT01844505|26274207|FG000|Overall Study|Disease progression|170|||
13218478|NCT01844505|26274208|FG001|Overall Study|Disease progression|88|||
13218479|NCT01844505|26274209|FG002|Overall Study|Disease progression|224|||
13218480|NCT01844505|26274207|FG000|Overall Study|Study drug toxicity|40|||
13218481|NCT01844505|26274208|FG001|Overall Study|Study drug toxicity|131|||
13218482|NCT01844505|26274209|FG002|Overall Study|Study drug toxicity|50|||
13218483|NCT01844505|26274207|FG000|Overall Study|Death|1|||
13218484|NCT01844505|26274208|FG001|Overall Study|Death|3|||
13218485|NCT01844505|26274209|FG002|Overall Study|Death|1|||
13218486|NCT01844505|26274207|FG000|Overall Study|Adverse event unrelated to study drug|7|||
13218487|NCT01844505|26274208|FG001|Overall Study|Adverse event unrelated to study drug|15|||
13218488|NCT01844505|26274209|FG002|Overall Study|Adverse event unrelated to study drug|6|||
13218489|NCT01844505|26274207|FG000|Overall Study|Subject request discontinue treatment|17|||
13218490|NCT01844505|26274208|FG001|Overall Study|Subject request discontinue treatment|14|||
13218491|NCT01844505|26274209|FG002|Overall Study|Subject request discontinue treatment|8|||
13218492|NCT01844505|26274207|FG000|Overall Study|Withdrawal by Subject|0|||
13218493|NCT01844505|26274208|FG001|Overall Study|Withdrawal by Subject|3|||
13218494|NCT01844505|26274209|FG002|Overall Study|Withdrawal by Subject|0|||
13218495|NCT01844505|26274207|FG000|Overall Study|Lost to Follow-up|1|||
13218496|NCT01844505|26274208|FG001|Overall Study|Lost to Follow-up|0|||
13218497|NCT01844505|26274209|FG002|Overall Study|Lost to Follow-up|0|||
13218498|NCT01844505|26274207|FG000|Overall Study|Maximum clinical benefit|8|||
13218499|NCT01844505|26274208|FG001|Overall Study|Maximum clinical benefit|11|||
13218500|NCT01844505|26274209|FG002|Overall Study|Maximum clinical benefit|2|||
13218501|NCT01844505|26274207|FG000|Overall Study|Poor/non-compliance|1|||
13218502|NCT01844505|26274208|FG001|Overall Study|Poor/non-compliance|1|||
13218503|NCT01844505|26274209|FG002|Overall Study|Poor/non-compliance|1|||
13218504|NCT01844505|26274207|FG000|Overall Study|Subject no longer meets criteria|0|||
13218505|NCT01844505|26274208|FG001|Overall Study|Subject no longer meets criteria|1|||
13218506|NCT01844505|26274209|FG002|Overall Study|Subject no longer meets criteria|0|||
13218507|NCT01844505|26274207|FG000|Overall Study|Other Reasons|4|||
13218508|NCT01844505|26274208|FG001|Overall Study|Other Reasons|2|||
13218509|NCT01844505|26274209|FG002|Overall Study|Other Reasons|2|||
13218510|NCT01844505|26274207|FG000|Overall Study|Not Reported|0|||
13218511|NCT01844505|26274208|FG001|Overall Study|Not Reported|0|||
13218512|NCT01844505|26274209|FG002|Overall Study|Not Reported|1|||
13218513|NCT01844375|26274226|FG000|Overall Study|Protocol Violation|1|||
13297460|NCT01364597|26498803|FG002|Overall Study|Sponsor recommended discontinuation|0|||
13297461|NCT01364597|26498804|FG003|Overall Study|Sponsor recommended discontinuation|1|||
13297462|NCT01364597|26498801|FG000|Overall Study|Parents went abroad with the patient|0|||
13297463|NCT01364597|26498802|FG001|Overall Study|Parents went abroad with the patient|0|||
13297464|NCT01364597|26498803|FG002|Overall Study|Parents went abroad with the patient|1|||
13297465|NCT01364597|26498804|FG003|Overall Study|Parents went abroad with the patient|0|||
13297466|NCT01364597|26498801|FG000|Overall Study|BRV discontinued as no seizures during 2 years|0|||
13297467|NCT01364597|26498802|FG001|Overall Study|BRV discontinued as no seizures during 2 years|0|||
13297468|NCT01364597|26498803|FG002|Overall Study|BRV discontinued as no seizures during 2 years|1|||
13297469|NCT01364597|26498804|FG003|Overall Study|BRV discontinued as no seizures during 2 years|0|||
13297470|NCT01364597|26498801|FG000|Overall Study|BRV administration dropout|0|||
13297471|NCT01364597|26498802|FG001|Overall Study|BRV administration dropout|0|||
13297472|NCT01364597|26498803|FG002|Overall Study|BRV administration dropout|1|||
13297473|NCT01364597|26498804|FG003|Overall Study|BRV administration dropout|0|||
13297474|NCT01364597|26498801|FG000|Overall Study|Dropout|0|||
13297475|NCT01364597|26498802|FG001|Overall Study|Dropout|0|||
13297476|NCT01364597|26498803|FG002|Overall Study|Dropout|3|||
13297477|NCT01364597|26498804|FG003|Overall Study|Dropout|1|||
13297478|NCT01364597|26498801|FG000|Overall Study|Unreliable subject|0|||
13297479|NCT01364597|26498802|FG001|Overall Study|Unreliable subject|0|||
13297480|NCT01364597|26498803|FG002|Overall Study|Unreliable subject|0|||
13297481|NCT01364597|26498804|FG003|Overall Study|Unreliable subject|1|||
13297482|NCT01364597|26498801|FG000|Overall Study|Other|0|||
13297483|NCT01364597|26498802|FG001|Overall Study|Other|0|||
13297484|NCT01364597|26498803|FG002|Overall Study|Other|0|||
13297485|NCT01364597|26498804|FG003|Overall Study|Other|1|||
13297486|NCT01364467|26498821|FG000|Overall Study|Lost to Follow-up|1|||
13297487|NCT01364467|26498822|FG001|Overall Study|Lost to Follow-up|2|||
13297488|NCT01364428|26498843|FG000|Overall Study|Adverse Event|1|||
13297489|NCT01364428|26498844|FG001|Overall Study|Adverse Event|2|||
13297490|NCT01364428|26498843|FG000|Overall Study|Protocol Violation|2|||
13297491|NCT01364428|26498844|FG001|Overall Study|Protocol Violation|0|||
13297492|NCT01364428|26498843|FG000|Overall Study|Withdrawal Criteria|14|||
13297493|NCT01364428|26498844|FG001|Overall Study|Withdrawal Criteria|10|||
13297494|NCT01364428|26498843|FG000|Overall Study|Other|3|||
13297495|NCT01364428|26498844|FG001|Overall Study|Other|3|||
13297496|NCT01364389|26498904|FG000|Overall Study|Withdrawal by Subject|0|||
13297497|NCT01364389|26498905|FG001|Overall Study|Withdrawal by Subject|1|||
13297498|NCT01364389|26498906|FG002|Overall Study|Withdrawal by Subject|0|||
13297499|NCT01364389|26498904|FG000|Overall Study|Protocol deviation|0|||
13297500|NCT01364389|26498905|FG001|Overall Study|Protocol deviation|0|||
13297501|NCT01364389|26498906|FG002|Overall Study|Protocol deviation|1|||
13297502|NCT01364389|26498904|FG000|Overall Study|Administrative problems|1|||
13297503|NCT01364389|26498905|FG001|Overall Study|Administrative problems|0|||
13218514|NCT01844375|26274227|FG001|Overall Study|Protocol Violation|1|||
13218515|NCT01844284|26274442|FG000|Overall Study|Lost to Follow-up|12|||
13218516|NCT01844284|26274443|FG001|Overall Study|Lost to Follow-up|7|||
13218517|NCT01844115|26274458|FG000|Overall Study|Adverse Event|4|||
13218518|NCT01844115|26274459|FG001|Overall Study|Adverse Event|22|||
13218519|NCT01844115|26274458|FG000|Overall Study|Lack of Efficacy|1|||
13218520|NCT01844115|26274459|FG001|Overall Study|Lack of Efficacy|4|||
13218521|NCT01844115|26274458|FG000|Overall Study|Protocol Violation|12|||
13218522|NCT01844115|26274459|FG001|Overall Study|Protocol Violation|10|||
13218523|NCT01844115|26274458|FG000|Overall Study|Withdrawal by Subject|11|||
13218524|NCT01844115|26274459|FG001|Overall Study|Withdrawal by Subject|11|||
13218525|NCT01844115|26274458|FG000|Overall Study|Lost to Follow-up|11|||
13218526|NCT01844115|26274459|FG001|Overall Study|Lost to Follow-up|10|||
13218527|NCT01844115|26274458|FG000|Overall Study|Pregnancy|0|||
13218528|NCT01844115|26274459|FG001|Overall Study|Pregnancy|1|||
13218529|NCT01844076|26274489|FG000|Overall Study|Adverse Event|1|||
13218530|NCT01844076|26274490|FG001|Overall Study|Adverse Event|0|||
13218531|NCT01844076|26274491|FG002|Overall Study|Adverse Event|0|||
13218532|NCT01844076|26274492|FG003|Overall Study|Adverse Event|0|||
13218533|NCT01844076|26274489|FG000|Overall Study|Withdrawal by Subject|1|||
13218534|NCT01844076|26274490|FG001|Overall Study|Withdrawal by Subject|0|||
13218535|NCT01844076|26274491|FG002|Overall Study|Withdrawal by Subject|0|||
13218536|NCT01844076|26274492|FG003|Overall Study|Withdrawal by Subject|0|||
13218537|NCT01843972|26274591|FG000|Overall Study|Withdrawal by Subject|0|||
13218538|NCT01843972|26274592|FG001|Overall Study|Withdrawal by Subject|0|||
13218539|NCT01843972|26274593|FG002|Overall Study|Withdrawal by Subject|0|||
13218540|NCT01843972|26274594|FG003|Overall Study|Withdrawal by Subject|0|||
13218541|NCT01843972|26274595|FG004|Overall Study|Withdrawal by Subject|1|||
13218542|NCT01843972|26274596|FG005|Overall Study|Withdrawal by Subject|0|||
13218543|NCT01843972|26274597|FG006|Overall Study|Withdrawal by Subject|0|||
13218544|NCT01843972|26274598|FG007|Overall Study|Withdrawal by Subject|0|||
13297504|NCT01364389|26498906|FG002|Overall Study|Administrative problems|0|||
13297505|NCT01364389|26498904|FG000|Overall Study|Adverse Event|1|||
13297506|NCT01364389|26498905|FG001|Overall Study|Adverse Event|0|||
13297507|NCT01364389|26498906|FG002|Overall Study|Adverse Event|0|||
13297508|NCT01364298|26498935|FG000|Overall Study|Adverse Event|3|||
13297509|NCT01364298|26498936|FG001|Overall Study|Adverse Event|4|||
13297510|NCT01364298|26498935|FG000|Overall Study|Lack of adherence to treatment|1|||
13297511|NCT01364298|26498936|FG001|Overall Study|Lack of adherence to treatment|3|||
13297512|NCT01364298|26498935|FG000|Overall Study|Lack of Efficacy|1|||
13297513|NCT01364298|26498936|FG001|Overall Study|Lack of Efficacy|0|||
13297514|NCT01364298|26498935|FG000|Overall Study|Lost to Follow-up|5|||
13297515|NCT01364298|26498936|FG001|Overall Study|Lost to Follow-up|10|||
13297516|NCT01364298|26498935|FG000|Overall Study|Withdrawal by Subject|3|||
13297517|NCT01364298|26498936|FG001|Overall Study|Withdrawal by Subject|3|||
13297518|NCT01364298|26498935|FG000|Overall Study|Other|1|||
13297519|NCT01364298|26498936|FG001|Overall Study|Other|3|||
13297520|NCT01364233|26498942|FG000|Overall Study|Lost to Follow-up|1|||
13297521|NCT01363986|26498952|FG000|Overall Study|Disease progression|1|||
13297522|NCT01363908|26498989|FG000|Chronic Dosing (CD) Phase|Adverse Event|1|||
13297523|NCT01363908|26498990|FG001|Chronic Dosing (CD) Phase|Adverse Event|1|||
13297524|NCT01363908|26498989|FG000|Chronic Dosing (CD) Phase|Patient decision|0|||
13297525|NCT01363908|26498990|FG001|Chronic Dosing (CD) Phase|Patient decision|1|||
13297526|NCT01363908|26498989|FG000|Chronic Dosing (CD) Phase|Physician Decision|0|||
13297527|NCT01363908|26498990|FG001|Chronic Dosing (CD) Phase|Physician Decision|1|||
13297528|NCT01363908|26498989|FG000|Chronic Dosing (CD) Phase|Early study termination|9|||
13297529|NCT01363908|26498990|FG001|Chronic Dosing (CD) Phase|Early study termination|3|||
13297530|NCT01363765|26499009|FG000|Overall Study|non-diagnostic|2621|||
13297531|NCT01363765|26499010|FG001|Overall Study|non-diagnostic|1124|||
13297532|NCT01363765|26499009|FG000|Overall Study|duplicate records|736|||
13297533|NCT01363765|26499010|FG001|Overall Study|duplicate records|3177|||
13297534|NCT01363765|26499009|FG000|Overall Study|non-resident|156|||
13297535|NCT01363765|26499010|FG001|Overall Study|non-resident|76|||
13297536|NCT01363765|26499009|FG000|Overall Study|age not recorded (used for cross-linkage|117|||
13297537|NCT01363765|26499010|FG001|Overall Study|age not recorded (used for cross-linkage|354|||
13297538|NCT01363765|26499009|FG000|Overall Study|smear during intervention|2170|||
13297539|NCT01363765|26499010|FG001|Overall Study|smear during intervention|0|||
13297540|NCT01363713|26499018|FG000|Overall Study|Adverse Event|1|||
13297541|NCT01363713|26499018|FG000|Overall Study|Protocol Violation|3|||
13297542|NCT01363713|26499018|FG000|Overall Study|Withdrawal by Subject|2|||
13297543|NCT01363700|26499047|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
13297544|NCT01363700|26499048|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1|||
13297545|NCT01363700|26499049|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
13297546|NCT01363700|26499050|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
13297547|NCT01363700|26499051|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
13218545|NCT01843972|26274599|FG008|Overall Study|Withdrawal by Subject|0|||
13218546|NCT01843972|26274600|FG009|Overall Study|Withdrawal by Subject|0|||
13218547|NCT01843933|26274613|FG000|Overall Study|Data lost|6|||
13218548|NCT01843933|26274614|FG001|Overall Study|Data lost|4|||
13218549|NCT01843842|26274641|FG000|Overall Study|Do not meet inclusion criteria|1|||
13218550|NCT01843842|26274642|FG001|Overall Study|Do not meet inclusion criteria|1|||
13218551|NCT01843803|26274661|FG000|Overall Study|not a Veteran, did not see provider|1|||
13218552|NCT01843803|26274662|FG001|Overall Study|not a Veteran, did not see provider|3|||
13218553|NCT01843777|26274677|FG000|Overall Study|Withdrawal by Subject|1|||
13218554|NCT01843777|26274678|FG001|Overall Study|Withdrawal by Subject|0|||
13218555|NCT01843673|26274692|FG000|Overall Study|Lack of Efficacy|2|||
13218556|NCT01843673|26274692|FG000|Overall Study|Withdrawal by Subject|4|||
13218557|NCT01843660|26274712|FG000|Overall Study|Other|30|||
13218558|NCT01843348|26274762|FG000|Overall Study|Withdrawal by Subject|4|||
13218559|NCT01843348|26274763|FG001|Overall Study|Withdrawal by Subject|16|||
13218560|NCT01843348|26274764|FG002|Overall Study|Withdrawal by Subject|18|||
13218561|NCT01843348|26274762|FG000|Overall Study|Lost to Follow-up|5|||
13218562|NCT01843348|26274763|FG001|Overall Study|Lost to Follow-up|4|||
13218563|NCT01843348|26274764|FG002|Overall Study|Lost to Follow-up|2|||
13218564|NCT01843348|26274762|FG000|Overall Study|Death|5|||
13218565|NCT01843348|26274763|FG001|Overall Study|Death|3|||
13218566|NCT01843348|26274764|FG002|Overall Study|Death|4|||
13218567|NCT01843348|26274762|FG000|Overall Study|Graft loss/retransplantation|5|||
13218568|NCT01843348|26274763|FG001|Overall Study|Graft loss/retransplantation|8|||
13218569|NCT01843348|26274764|FG002|Overall Study|Graft loss/retransplantation|11|||
13218570|NCT01843348|26274762|FG000|Overall Study|Various reasons|4|||
13218571|NCT01843348|26274763|FG001|Overall Study|Various reasons|9|||
13218572|NCT01843348|26274764|FG002|Overall Study|Various reasons|6|||
13218573|NCT01843205|26274825|FG000|First Treatment (11 Days)|Withdrawal by Subject|1|||
13218574|NCT01843205|26274826|FG001|First Treatment (11 Days)|Withdrawal by Subject|0|||
13218575|NCT01843192|26274865|FG000|Overall Study|Intra-operative exclusions per protocol|2|||
13218576|NCT01843192|26274866|FG001|Overall Study|Intra-operative exclusions per protocol|6|||
13218577|NCT01843192|26274867|FG002|Overall Study|Intra-operative exclusions per protocol|2|||
13218578|NCT01843062|26274886|FG000|Overall Study|Protocol Violation|1|||
13218579|NCT01843062|26274887|FG001|Overall Study|Protocol Violation|0|||
13218580|NCT01843062|26274886|FG000|Overall Study|New treatment following progression|2|||
13218581|NCT01843062|26274887|FG001|Overall Study|New treatment following progression|0|||
13218582|NCT01843062|26274886|FG000|Overall Study|Pregnancy|1|||
13218583|NCT01843062|26274887|FG001|Overall Study|Pregnancy|0|||
13218584|NCT01843062|26274886|FG000|Overall Study|Adverse Event|2|||
13218585|NCT01843062|26274887|FG001|Overall Study|Adverse Event|0|||
13218586|NCT01843062|26274886|FG000|Overall Study|Incorrect randomisation|1|||
13218587|NCT01843062|26274887|FG001|Overall Study|Incorrect randomisation|0|||
13218588|NCT01843062|26274886|FG000|Overall Study|Withdrawal by Subject|12|||
13218589|NCT01843062|26274887|FG001|Overall Study|Withdrawal by Subject|3|||
13218590|NCT01843062|26274886|FG000|Overall Study|Death|1|||
13218591|NCT01843062|26274887|FG001|Overall Study|Death|2|||
13218592|NCT01843062|26274886|FG000|Overall Study|Lost to Follow-up|2|||
13218593|NCT01843062|26274887|FG001|Overall Study|Lost to Follow-up|4|||
13218594|NCT01843023|26274906|FG000|Overall Study|Death|1|||
13218595|NCT01843023|26274907|FG001|Overall Study|Death|0|||
13218596|NCT01843023|26274906|FG000|Overall Study|Lost to Follow-up|24|||
13218597|NCT01843023|26274907|FG001|Overall Study|Lost to Follow-up|29|||
13218598|NCT01843023|26274906|FG000|Overall Study|Withdrawal by Subject|8|||
13218599|NCT01843023|26274907|FG001|Overall Study|Withdrawal by Subject|6|||
13218600|NCT01842958|26274932|FG000|Overall Study|Lost to Follow-up|1|||
13218601|NCT01842958|26274933|FG001|Overall Study|Lost to Follow-up|1|||
13218602|NCT01842633|26274990|FG000|Overall Study|Screen Failure|1|||
13218603|NCT01842633|26274991|FG001|Overall Study|Screen Failure|0|||
13218604|NCT01842633|26274992|FG002|Overall Study|Screen Failure|0|||
13218605|NCT01842633|26274990|FG000|Overall Study|Adverse Event|1|||
13218606|NCT01842633|26274991|FG001|Overall Study|Adverse Event|1|||
13218607|NCT01842633|26274992|FG002|Overall Study|Adverse Event|0|||
13218608|NCT01842633|26274990|FG000|Overall Study|Withdrawal by Subject|0|||
13218609|NCT01842633|26274991|FG001|Overall Study|Withdrawal by Subject|1|||
13218610|NCT01842633|26274992|FG002|Overall Study|Withdrawal by Subject|0|||
13218611|NCT01842633|26274990|FG000|Overall Study|Technical issues|1|||
13218612|NCT01842633|26274991|FG001|Overall Study|Technical issues|0|||
13218613|NCT01842633|26274992|FG002|Overall Study|Technical issues|0|||
13218614|NCT01842620|26275011|FG000|Period 1|Withdrawal by Subject|1|||
13218615|NCT01842620|26275012|FG001|Period 1|Withdrawal by Subject|0|||
13218616|NCT01842607|26275033|FG000|Overall Study|Adverse Event|11|||
13218617|NCT01842607|26275033|FG000|Overall Study|Lack of Efficacy|19|||
13218618|NCT01842607|26275033|FG000|Overall Study|Protocol Violation|8|||
13218619|NCT01842607|26275033|FG000|Overall Study|Protocol defined stopping criteria|2|||
13218620|NCT01842607|26275033|FG000|Overall Study|Lost to Follow-up|3|||
13218621|NCT01842607|26275033|FG000|Overall Study|Physician Decision|9|||
13218622|NCT01842607|26275033|FG000|Overall Study|Withdrawal by Subject|14|||
13218623|NCT01842581|26275056|FG000|Overall Study|Adverse Event|6|||
13218624|NCT01842581|26275057|FG001|Overall Study|Adverse Event|4|||
13218625|NCT01842581|26275056|FG000|Overall Study|HE breakthrough|26|||
13218626|NCT01842581|26275057|FG001|Overall Study|HE breakthrough|13|||
13218627|NCT01842581|26275056|FG000|Overall Study|Liver transplant|2|||
13218628|NCT01842581|26275057|FG001|Overall Study|Liver transplant|0|||
13218629|NCT01842581|26275056|FG000|Overall Study|Lost to Follow-up|2|||
13218630|NCT01842581|26275057|FG001|Overall Study|Lost to Follow-up|5|||
13218631|NCT01842581|26275056|FG000|Overall Study|Withdrawal by Subject|5|||
13218632|NCT01842581|26275057|FG001|Overall Study|Withdrawal by Subject|7|||
13218633|NCT01842581|26275056|FG000|Overall Study|Other than specified|3|||
13218634|NCT01842581|26275057|FG001|Overall Study|Other than specified|1|||
13218635|NCT01842438|26275076|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6|||
13218636|NCT01842438|26275077|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8|||
13218637|NCT01842438|26275076|FG000|T2: 6month Follow-up|Withdrawal by Subject|4|||
13218638|NCT01842438|26275077|FG001|T2: 6month Follow-up|Withdrawal by Subject|3|||
13218639|NCT01842438|26275076|FG000|T2: 6month Follow-up|Death|0|||
13218640|NCT01842438|26275077|FG001|T2: 6month Follow-up|Death|1|||
13218641|NCT01842334|26275090|FG000|Overall Study|Withdrawal by Subject|3|||
13218642|NCT01842334|26275091|FG001|Overall Study|Withdrawal by Subject|3|||
13218643|NCT01842334|26275090|FG000|Overall Study|Moved away mid-study|0|||
13218644|NCT01842334|26275091|FG001|Overall Study|Moved away mid-study|1|||
13218645|NCT01842308|26275126|FG000|Overall Study|Withdrawal by Subject|0|||
13218646|NCT01842308|26275127|FG001|Overall Study|Withdrawal by Subject|0|||
13218647|NCT01842308|26275128|FG002|Overall Study|Withdrawal by Subject|0|||
13218648|NCT01842308|26275129|FG003|Overall Study|Withdrawal by Subject|0|||
13218649|NCT01842308|26275130|FG004|Overall Study|Withdrawal by Subject|1|||
13218650|NCT01841970|26275148|FG000|Overall Study|Withdrawal by Subject|1|||
13218651|NCT01841970|26275148|FG000|Overall Study|Physician Decision|2|||
13218652|NCT01841970|26275148|FG000|Overall Study|Lost to Follow-up|8|||
13218653|NCT01841762|26275158|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51|||
13218654|NCT01841762|26275158|FG000|Treatment Period|Adverse Event|16|||
13218655|NCT01841762|26275158|FG000|Treatment Period|Death|1|||
13218656|NCT01841762|26275158|FG000|Treatment Period|Withdrawal by Subject|7|||
13218657|NCT01841762|26275158|FG000|Treatment Period|Lost to Follow-up|1|||
13218658|NCT01841762|26275158|FG000|Treatment Period|Physician Decision|2|||
13218659|NCT01841762|26275158|FG000|Treatment Period|Other, including non-compliance|5|||
13218660|NCT01841762|26275158|FG000|Post-Treatment Safety Follow-Up Period|Death|1|||
13218661|NCT01841762|26275158|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7|||
13218662|NCT01841762|26275158|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6|||
13218663|NCT01841762|26275158|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1|||
13218664|NCT01841697|26275181|FG000|Overall Study|Death|0|||
13218665|NCT01841697|26275182|FG001|Overall Study|Death|1|||
13218666|NCT01841697|26275181|FG000|Overall Study|Lost to Follow-up|4|||
13218667|NCT01841697|26275182|FG001|Overall Study|Lost to Follow-up|1|||
13218668|NCT01841697|26275181|FG000|Overall Study|Withdrawal by Subject|16|||
13218669|NCT01841697|26275182|FG001|Overall Study|Withdrawal by Subject|16|||
13218670|NCT01841593|26275205|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0|||
13218671|NCT01841593|26275206|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1|||
13218672|NCT01841593|26275205|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1|||
13218673|NCT01841593|26275206|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0|||
13218674|NCT01841567|26275213|FG000|Overall Study|Adverse Event|3|||
13297548|NCT01363661|26499074|FG000|Overall Study|Adverse Event|9|||
13297549|NCT01363661|26499075|FG001|Overall Study|Adverse Event|2|||
13297550|NCT01363661|26499074|FG000|Overall Study|Withdrawal by Subject|1|||
13297551|NCT01363661|26499075|FG001|Overall Study|Withdrawal by Subject|1|||
13297552|NCT01363661|26499074|FG000|Overall Study|Protocol Violation|1|||
13297553|NCT01363661|26499075|FG001|Overall Study|Protocol Violation|0|||
13297554|NCT01363661|26499074|FG000|Overall Study|Lost to Follow-up|3|||
13297555|NCT01363661|26499075|FG001|Overall Study|Lost to Follow-up|1|||
13297556|NCT01363440|26499114|FG000|Overall Study|Adverse Event|5|||
13297557|NCT01363440|26499115|FG001|Overall Study|Adverse Event|4|||
13297558|NCT01363440|26499116|FG002|Overall Study|Adverse Event|4|||
13297559|NCT01363440|26499114|FG000|Overall Study|Death|3|||
13297560|NCT01363440|26499115|FG001|Overall Study|Death|7|||
13297561|NCT01363440|26499116|FG002|Overall Study|Death|5|||
13297562|NCT01363440|26499114|FG000|Overall Study|Withdrawal by Subject|9|||
13297563|NCT01363440|26499115|FG001|Overall Study|Withdrawal by Subject|11|||
13297564|NCT01363440|26499116|FG002|Overall Study|Withdrawal by Subject|11|||
13297565|NCT01363440|26499114|FG000|Overall Study|Lost to Follow-up|2|||
13297566|NCT01363440|26499115|FG001|Overall Study|Lost to Follow-up|4|||
13297567|NCT01363440|26499116|FG002|Overall Study|Lost to Follow-up|5|||
13297568|NCT01363440|26499114|FG000|Overall Study|Other|4|||
13297569|NCT01363440|26499115|FG001|Overall Study|Other|5|||
13297570|NCT01363440|26499116|FG002|Overall Study|Other|2|||
13297571|NCT01363349|26499129|FG000|Overall Study|Adverse Event|6|||
13297572|NCT01363349|26499130|FG001|Overall Study|Adverse Event|7|||
13297573|NCT01363349|26499129|FG000|Overall Study|Lack of Efficacy|3|||
13297574|NCT01363349|26499130|FG001|Overall Study|Lack of Efficacy|10|||
13218675|NCT01841554|26275226|FG000|Overall Study|Death|7|||
13218676|NCT01841554|26275226|FG000|Overall Study|No Implantation|1|||
13218677|NCT01841554|26275226|FG000|Overall Study|Discontinued Follow Up|5|||
13218678|NCT01841554|26275226|FG000|Overall Study|Study exit due to secondary intervention|6|||
13297575|NCT01363349|26499129|FG000|Overall Study|Non compliance/Protocol deviations|2|||
13297576|NCT01363349|26499130|FG001|Overall Study|Non compliance/Protocol deviations|2|||
13297577|NCT01363349|26499129|FG000|Overall Study|Withdrawal by Subject|14|||
13297578|NCT01363349|26499130|FG001|Overall Study|Withdrawal by Subject|6|||
13297579|NCT01363349|26499129|FG000|Overall Study|Lost to Follow-up|5|||
13297580|NCT01363349|26499130|FG001|Overall Study|Lost to Follow-up|6|||
13297581|NCT01363349|26499129|FG000|Overall Study|Not reported|36|||
13297582|NCT01363349|26499130|FG001|Overall Study|Not reported|37|||
13297583|NCT01363349|26499129|FG000|Overall Study|missing|1|||
13297584|NCT01363349|26499130|FG001|Overall Study|missing|2|||
13297585|NCT01363297|26499236|FG000|Overall Study|Other|0|||
13297586|NCT01363297|26499237|FG001|Overall Study|Other|0|||
13297587|NCT01363297|26499238|FG002|Overall Study|Other|0|||
13297588|NCT01363297|26499239|FG003|Overall Study|Other|0|||
13297589|NCT01363297|26499240|FG004|Overall Study|Other|1|||
13297590|NCT01363297|26499236|FG000|Overall Study|Death|3|||
13297591|NCT01363297|26499237|FG001|Overall Study|Death|6|||
13297592|NCT01363297|26499238|FG002|Overall Study|Death|6|||
13297593|NCT01363297|26499239|FG003|Overall Study|Death|10|||
13297594|NCT01363297|26499240|FG004|Overall Study|Death|30|||
13297595|NCT01363076|26499265|FG000|Overall Study|Withdrawal by Subject|0|||
13297596|NCT01363076|26499266|FG001|Overall Study|Withdrawal by Subject|1|||
13297597|NCT01363011|26499313|FG000|Main Study|Adverse Event|2|||
13297598|NCT01363011|26499314|FG001|Main Study|Adverse Event|3|||
13297599|NCT01363011|26499313|FG000|Main Study|Investigator's Discretion|1|||
13297600|NCT01363011|26499314|FG001|Main Study|Investigator's Discretion|1|||
13297601|NCT01363011|26499313|FG000|Main Study|Withdrew Consent|1|||
13297602|NCT01363011|26499314|FG001|Main Study|Withdrew Consent|4|||
13297603|NCT01363011|26499313|FG000|Main Study|Protocol Violation|0|||
13297604|NCT01363011|26499314|FG001|Main Study|Protocol Violation|1|||
13297605|NCT01363011|26499313|FG000|Extension Phase|Adverse Event|1|||
13297606|NCT01363011|26499314|FG001|Extension Phase|Adverse Event|1|||
13297607|NCT01363011|26499313|FG000|Extension Phase|Lack of Efficacy|0|||
13297608|NCT01363011|26499314|FG001|Extension Phase|Lack of Efficacy|1|||
13297609|NCT01363011|26499313|FG000|Extension Phase|Investigator's Discretion|2|||
13297610|NCT01363011|26499314|FG001|Extension Phase|Investigator's Discretion|2|||
13297611|NCT01363011|26499313|FG000|Extension Phase|Withdrew Consent|0|||
13297612|NCT01363011|26499314|FG001|Extension Phase|Withdrew Consent|1|||
13297613|NCT01363011|26499313|FG000|Extension Phase|Lost to Follow-up|0|||
13297614|NCT01363011|26499314|FG001|Extension Phase|Lost to Follow-up|2|||
13297615|NCT01363011|26499313|FG000|Extension Phase|Rolled Over to Another Gilead Study|2|||
13297616|NCT01363011|26499314|FG001|Extension Phase|Rolled Over to Another Gilead Study|1|||
13297617|NCT01362790|26499381|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1|||
13297618|NCT01362790|26499382|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
13297619|NCT01362790|26499383|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
13297620|NCT01362790|26499384|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
13297621|NCT01362790|26499385|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
13297622|NCT01362790|26499386|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
13297623|NCT01362790|26499387|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
13297624|NCT01362790|26499381|FG000|Pilot Phase & Phase 2|Adverse Event|0|||
13297625|NCT01362790|26499382|FG001|Pilot Phase & Phase 2|Adverse Event|1|||
13297626|NCT01362790|26499383|FG002|Pilot Phase & Phase 2|Adverse Event|0|||
13297627|NCT01362790|26499384|FG003|Pilot Phase & Phase 2|Adverse Event|1|||
13297628|NCT01362790|26499385|FG004|Pilot Phase & Phase 2|Adverse Event|0|||
13297629|NCT01362790|26499386|FG005|Pilot Phase & Phase 2|Adverse Event|2|||
13297630|NCT01362790|26499387|FG006|Pilot Phase & Phase 2|Adverse Event|0|||
13297631|NCT01362790|26499381|FG000|Pilot Phase & Phase 2|Physician Decision|0|||
13297632|NCT01362790|26499382|FG001|Pilot Phase & Phase 2|Physician Decision|0|||
13297633|NCT01362790|26499383|FG002|Pilot Phase & Phase 2|Physician Decision|0|||
13218679|NCT01841359|26275253|FG000|Overall Study|Underwent reversal of Roux-en-Y gastric bypass (RYGB)|2|||
13218680|NCT01841359|26275253|FG000|Overall Study|Concommitant medical issues|2|||
13218681|NCT01841359|26275253|FG000|Overall Study|Adverse Event|3|||
13218682|NCT01841359|26275253|FG000|Overall Study|Did not receive study drug at visit 4 prior to mixed meal testing|1|||
13218683|NCT01841073|26275270|FG000|Overall Study|Adverse Event|1|||
13218684|NCT01841073|26275271|FG001|Overall Study|Adverse Event|1|||
13218685|NCT01841073|26275270|FG000|Overall Study|Physician Decision|1|||
13218686|NCT01841073|26275271|FG001|Overall Study|Physician Decision|0|||
13218687|NCT01841073|26275270|FG000|Overall Study|Lost to Follow-up|0|||
13218688|NCT01841073|26275271|FG001|Overall Study|Lost to Follow-up|2|||
13218689|NCT01841060|26275280|FG000|Overall Study|Protocol Violation|10|||
13218690|NCT01840943|26275321|FG000|Overall Study|Withdrawal by Subject|5|||
13297634|NCT01362790|26499384|FG003|Pilot Phase & Phase 2|Physician Decision|1|||
13218691|NCT01840943|26275322|FG001|Overall Study|Withdrawal by Subject|6|||
13218692|NCT01840943|26275321|FG000|Overall Study|Physician Decision|4|||
13218693|NCT01840943|26275322|FG001|Overall Study|Physician Decision|2|||
13218694|NCT01840943|26275321|FG000|Overall Study|Lost to Follow-up|4|||
13218695|NCT01840943|26275322|FG001|Overall Study|Lost to Follow-up|4|||
13218696|NCT01840605|26275341|FG000|Overall Study|Adverse Event|0|||
13218697|NCT01840605|26275342|FG001|Overall Study|Adverse Event|1|||
13218698|NCT01840605|26275341|FG000|Overall Study|Physician Decision|2|||
13218699|NCT01840605|26275342|FG001|Overall Study|Physician Decision|1|||
13218700|NCT01840579|26275570|FG000|Overall Study|Status not recorded|0|||
13218701|NCT01840579|26275571|FG001|Overall Study|Status not recorded|0|||
13218702|NCT01840579|26275572|FG002|Overall Study|Status not recorded|2|||
13218703|NCT01840579|26275573|FG003|Overall Study|Status not recorded|3|||
13218704|NCT01840579|26275574|FG004|Overall Study|Status not recorded|4|||
13218705|NCT01840579|26275575|FG005|Overall Study|Status not recorded|3|||
13218706|NCT01840579|26275576|FG006|Overall Study|Status not recorded|0|||
13218707|NCT01840579|26275577|FG007|Overall Study|Status not recorded|3|||
13218708|NCT01840579|26275578|FG008|Overall Study|Status not recorded|3|||
13218709|NCT01840579|26275579|FG009|Overall Study|Status not recorded|3|||
13218710|NCT01840579|26275570|FG000|Overall Study|Progressive disease|3|||
13218711|NCT01840579|26275571|FG001|Overall Study|Progressive disease|5|||
13218712|NCT01840579|26275572|FG002|Overall Study|Progressive disease|0|||
13218713|NCT01840579|26275573|FG003|Overall Study|Progressive disease|0|||
13218714|NCT01840579|26275574|FG004|Overall Study|Progressive disease|0|||
13218715|NCT01840579|26275575|FG005|Overall Study|Progressive disease|0|||
13218716|NCT01840579|26275576|FG006|Overall Study|Progressive disease|0|||
13218717|NCT01840579|26275577|FG007|Overall Study|Progressive disease|0|||
13218718|NCT01840579|26275578|FG008|Overall Study|Progressive disease|0|||
13218719|NCT01840579|26275579|FG009|Overall Study|Progressive disease|0|||
13218720|NCT01840579|26275570|FG000|Overall Study|Ongoing in study|0|||
13218721|NCT01840579|26275571|FG001|Overall Study|Ongoing in study|1|||
13218722|NCT01840579|26275572|FG002|Overall Study|Ongoing in study|0|||
13218723|NCT01840579|26275573|FG003|Overall Study|Ongoing in study|0|||
13218724|NCT01840579|26275574|FG004|Overall Study|Ongoing in study|0|||
13218725|NCT01840579|26275575|FG005|Overall Study|Ongoing in study|0|||
13218726|NCT01840579|26275576|FG006|Overall Study|Ongoing in study|0|||
13218727|NCT01840579|26275577|FG007|Overall Study|Ongoing in study|0|||
13218728|NCT01840579|26275578|FG008|Overall Study|Ongoing in study|0|||
13218729|NCT01840579|26275579|FG009|Overall Study|Ongoing in study|0|||
13218730|NCT01840579|26275570|FG000|Overall Study|Death|0|||
13218731|NCT01840579|26275571|FG001|Overall Study|Death|0|||
13218732|NCT01840579|26275572|FG002|Overall Study|Death|0|||
13218733|NCT01840579|26275573|FG003|Overall Study|Death|0|||
13218734|NCT01840579|26275574|FG004|Overall Study|Death|0|||
13218735|NCT01840579|26275575|FG005|Overall Study|Death|1|||
13218736|NCT01840579|26275576|FG006|Overall Study|Death|0|||
13218737|NCT01840579|26275577|FG007|Overall Study|Death|0|||
13218738|NCT01840579|26275578|FG008|Overall Study|Death|0|||
13218739|NCT01840579|26275579|FG009|Overall Study|Death|0|||
13218740|NCT01840579|26275570|FG000|Overall Study|Adverse Event|0|||
13218741|NCT01840579|26275571|FG001|Overall Study|Adverse Event|1|||
13218742|NCT01840579|26275572|FG002|Overall Study|Adverse Event|0|||
13218743|NCT01840579|26275573|FG003|Overall Study|Adverse Event|0|||
13218744|NCT01840579|26275574|FG004|Overall Study|Adverse Event|0|||
13218745|NCT01840579|26275575|FG005|Overall Study|Adverse Event|0|||
13218746|NCT01840579|26275576|FG006|Overall Study|Adverse Event|0|||
13218747|NCT01840579|26275577|FG007|Overall Study|Adverse Event|0|||
13218748|NCT01840579|26275578|FG008|Overall Study|Adverse Event|0|||
13218749|NCT01840579|26275579|FG009|Overall Study|Adverse Event|0|||
13218750|NCT01840579|26275570|FG000|Overall Study|Follow-up ended by Sponsor|0|||
13218751|NCT01840579|26275571|FG001|Overall Study|Follow-up ended by Sponsor|0|||
13218752|NCT01840579|26275572|FG002|Overall Study|Follow-up ended by Sponsor|0|||
13218753|NCT01840579|26275573|FG003|Overall Study|Follow-up ended by Sponsor|0|||
13218754|NCT01840579|26275574|FG004|Overall Study|Follow-up ended by Sponsor|0|||
13218755|NCT01840579|26275575|FG005|Overall Study|Follow-up ended by Sponsor|0|||
13218756|NCT01840579|26275576|FG006|Overall Study|Follow-up ended by Sponsor|2|||
13218757|NCT01840579|26275577|FG007|Overall Study|Follow-up ended by Sponsor|0|||
13218758|NCT01840579|26275578|FG008|Overall Study|Follow-up ended by Sponsor|0|||
13218759|NCT01840579|26275579|FG009|Overall Study|Follow-up ended by Sponsor|0|||
13218760|NCT01840410|26275622|FG000|Overall Study|Physician Decision|1|||
13218761|NCT01840410|26275623|FG001|Overall Study|Physician Decision|2|||
13218762|NCT01840410|26275622|FG000|Overall Study|Pregnancy|1|||
13218763|NCT01840410|26275623|FG001|Overall Study|Pregnancy|0|||
13218764|NCT01840410|26275622|FG000|Overall Study|Protocol deviation|1|||
13218765|NCT01840410|26275623|FG001|Overall Study|Protocol deviation|0|||
13218766|NCT01840410|26275622|FG000|Overall Study|Lost to Follow-up|1|||
13218767|NCT01840410|26275623|FG001|Overall Study|Lost to Follow-up|0|||
13218768|NCT01840410|26275622|FG000|Overall Study|Withdrawal by Subject|2|||
13218769|NCT01840410|26275623|FG001|Overall Study|Withdrawal by Subject|1|||
13218770|NCT01840410|26275622|FG000|Overall Study|Adverse Event|1|||
13218771|NCT01840410|26275623|FG001|Overall Study|Adverse Event|1|||
13218772|NCT01840228|26275656|FG000|Overall Study|Lost to Follow-up|1|||
13218773|NCT01840228|26275657|FG001|Overall Study|Lost to Follow-up|1|||
13218774|NCT01840163|26275684|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19|||
13218775|NCT01840163|26275685|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16|||
13218776|NCT01840163|26275684|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48|||
13218777|NCT01840163|26275685|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40|||
13218778|NCT01840163|26275684|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43|||
13218779|NCT01840163|26275685|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35|||
13218780|NCT01839916|26275696|FG000|Overall Study|Death|9|||
13218781|NCT01839916|26275696|FG000|Overall Study|Physician Decision|17|||
13218782|NCT01839916|26275696|FG000|Overall Study|Relapse|12|||
13218783|NCT01839916|26275696|FG000|Overall Study|GVHD|2|||
13297635|NCT01362790|26499385|FG004|Pilot Phase & Phase 2|Physician Decision|0|||
13297636|NCT01362790|26499386|FG005|Pilot Phase & Phase 2|Physician Decision|0|||
13297637|NCT01362790|26499387|FG006|Pilot Phase & Phase 2|Physician Decision|0|||
13297638|NCT01362790|26499381|FG000|Pilot Phase & Phase 2|Developed antibodies|7|||
13297639|NCT01362790|26499382|FG001|Pilot Phase & Phase 2|Developed antibodies|2|||
13297640|NCT01362790|26499383|FG002|Pilot Phase & Phase 2|Developed antibodies|3|||
13297641|NCT01362790|26499384|FG003|Pilot Phase & Phase 2|Developed antibodies|8|||
13297642|NCT01362790|26499385|FG004|Pilot Phase & Phase 2|Developed antibodies|0|||
13297643|NCT01362790|26499386|FG005|Pilot Phase & Phase 2|Developed antibodies|0|||
13297644|NCT01362790|26499387|FG006|Pilot Phase & Phase 2|Developed antibodies|0|||
13297645|NCT01362790|26499381|FG000|Pilot Phase & Phase 2|Refused further treatment|0|||
13297646|NCT01362790|26499382|FG001|Pilot Phase & Phase 2|Refused further treatment|1|||
13297647|NCT01362790|26499383|FG002|Pilot Phase & Phase 2|Refused further treatment|0|||
13297648|NCT01362790|26499384|FG003|Pilot Phase & Phase 2|Refused further treatment|0|||
13297649|NCT01362790|26499385|FG004|Pilot Phase & Phase 2|Refused further treatment|0|||
13297650|NCT01362790|26499386|FG005|Pilot Phase & Phase 2|Refused further treatment|0|||
13297651|NCT01362790|26499387|FG006|Pilot Phase & Phase 2|Refused further treatment|0|||
13297652|NCT01362790|26499381|FG000|Pilot Phase & Phase 2|Progressive disease|1|||
13297653|NCT01362790|26499382|FG001|Pilot Phase & Phase 2|Progressive disease|2|||
13297654|NCT01362790|26499383|FG002|Pilot Phase & Phase 2|Progressive disease|2|||
13297655|NCT01362790|26499384|FG003|Pilot Phase & Phase 2|Progressive disease|3|||
13297656|NCT01362790|26499385|FG004|Pilot Phase & Phase 2|Progressive disease|0|||
13297657|NCT01362790|26499386|FG005|Pilot Phase & Phase 2|Progressive disease|2|||
13297658|NCT01362790|26499387|FG006|Pilot Phase & Phase 2|Progressive disease|0|||
13297659|NCT01362790|26499381|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1|||
13297660|NCT01362790|26499382|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
13297661|NCT01362790|26499383|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
13297662|NCT01362790|26499384|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
13297663|NCT01362790|26499385|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
13297664|NCT01362790|26499386|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
13297665|NCT01362790|26499387|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
13297666|NCT01362790|26499381|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
13297667|NCT01362790|26499382|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2|||
13297668|NCT01362790|26499383|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
13297669|NCT01362790|26499384|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
13297670|NCT01362790|26499385|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
13297671|NCT01362790|26499386|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
13297672|NCT01362790|26499387|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
13297673|NCT01362790|26499381|FG000|Pilot Phase & Phase 2|Death on study|0|||
13297674|NCT01362790|26499382|FG001|Pilot Phase & Phase 2|Death on study|0|||
13297675|NCT01362790|26499383|FG002|Pilot Phase & Phase 2|Death on study|0|||
13297676|NCT01362790|26499384|FG003|Pilot Phase & Phase 2|Death on study|1|||
13297677|NCT01362790|26499385|FG004|Pilot Phase & Phase 2|Death on study|0|||
13297678|NCT01362790|26499386|FG005|Pilot Phase & Phase 2|Death on study|0|||
13297679|NCT01362790|26499387|FG006|Pilot Phase & Phase 2|Death on study|0|||
13297680|NCT01362790|26499381|FG000|Dose De-escalation of Regimen A|Adverse Event|0|||
13297681|NCT01362790|26499382|FG001|Dose De-escalation of Regimen A|Adverse Event|0|||
13297682|NCT01362790|26499383|FG002|Dose De-escalation of Regimen A|Adverse Event|0|||
13297683|NCT01362790|26499384|FG003|Dose De-escalation of Regimen A|Adverse Event|0|||
13297684|NCT01362790|26499385|FG004|Dose De-escalation of Regimen A|Adverse Event|1|||
13297685|NCT01362790|26499386|FG005|Dose De-escalation of Regimen A|Adverse Event|0|||
13297686|NCT01362790|26499387|FG006|Dose De-escalation of Regimen A|Adverse Event|0|||
13297687|NCT01362790|26499381|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
13297688|NCT01362790|26499382|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
13297689|NCT01362790|26499383|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
13297690|NCT01362790|26499384|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
13297691|NCT01362790|26499385|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3|||
13297692|NCT01362790|26499386|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
13218784|NCT01839916|26275696|FG000|Overall Study|Graft Failure|1|||
13218785|NCT01839656|26275725|FG000|Overall Study|Withdrawal by Subject|1|||
13218786|NCT01839656|26275726|FG001|Overall Study|Withdrawal by Subject|1|||
13218787|NCT01839656|26275725|FG000|Overall Study|Adverse event, serious fatal|1|||
13218788|NCT01839656|26275726|FG001|Overall Study|Adverse event, serious fatal|4|||
13218789|NCT01839656|26275725|FG000|Overall Study|Early study closure|0|||
13218790|NCT01839656|26275726|FG001|Overall Study|Early study closure|11|||
13218791|NCT01839656|26275725|FG000|Overall Study|Adverse Event|1|||
13218792|NCT01839656|26275726|FG001|Overall Study|Adverse Event|0|||
13218793|NCT01839487|26275758|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1|||
13218794|NCT01839487|26275759|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
13218795|NCT01839487|26275760|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
13218796|NCT01839487|26275761|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
13218797|NCT01839487|26275762|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
13218798|NCT01839487|26275763|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
13218799|NCT01839487|26275758|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14|||
13218800|NCT01839487|26275759|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6|||
13218801|NCT01839487|26275760|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
13218802|NCT01839487|26275761|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
13218803|NCT01839487|26275762|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
13218804|NCT01839487|26275763|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
13218805|NCT01839487|26275758|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
13218806|NCT01839487|26275759|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1|||
13218807|NCT01839487|26275760|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
13218808|NCT01839487|26275761|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
13218809|NCT01839487|26275762|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
13218810|NCT01839487|26275763|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
13218811|NCT01839487|26275758|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1|||
13218812|NCT01839487|26275759|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
13218813|NCT01839487|26275760|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
13218814|NCT01839487|26275761|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
13218815|NCT01839487|26275762|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
13218816|NCT01839487|26275763|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
13218817|NCT01839487|26275758|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
13218818|NCT01839487|26275759|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
13218819|NCT01839487|26275760|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12|||
13218820|NCT01839487|26275761|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9|||
13218821|NCT01839487|26275762|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4|||
13218822|NCT01839487|26275763|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8|||
13218823|NCT01839487|26275758|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
13218824|NCT01839487|26275759|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
13218825|NCT01839487|26275760|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46|||
13218826|NCT01839487|26275761|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49|||
13218827|NCT01839487|26275762|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71|||
13218828|NCT01839487|26275763|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32|||
13218829|NCT01839487|26275758|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
13218830|NCT01839487|26275759|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
13218831|NCT01839487|26275760|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2|||
13218832|NCT01839487|26275761|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
13218833|NCT01839487|26275762|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1|||
13297693|NCT01362790|26499387|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
13297694|NCT01362790|26499381|FG000|Dose De-escalation of Regimen A|Progressive disease|0|||
13297695|NCT01362790|26499382|FG001|Dose De-escalation of Regimen A|Progressive disease|0|||
13297696|NCT01362790|26499383|FG002|Dose De-escalation of Regimen A|Progressive disease|0|||
13297697|NCT01362790|26499384|FG003|Dose De-escalation of Regimen A|Progressive disease|0|||
13297698|NCT01362790|26499385|FG004|Dose De-escalation of Regimen A|Progressive disease|2|||
13297699|NCT01362790|26499386|FG005|Dose De-escalation of Regimen A|Progressive disease|0|||
13297700|NCT01362790|26499387|FG006|Dose De-escalation of Regimen A|Progressive disease|0|||
13382004|NCT00748215|26749628|FG000|Overall Study|Change in patient condition|0|||
13382005|NCT00748215|26749629|FG001|Overall Study|Change in patient condition|3|||
13382006|NCT00748215|26749628|FG000|Overall Study|Non-compliant|0|||
13382007|NCT00748215|26749629|FG001|Overall Study|Non-compliant|2|||
13382008|NCT00748215|26749628|FG000|Overall Study|Adverse Event|0|||
13382009|NCT00748215|26749629|FG001|Overall Study|Adverse Event|5|||
13382010|NCT00748189|26749691|FG000|Overall Study|Death|99|||
13382011|NCT00748189|26749692|FG001|Overall Study|Death|84|||
13382012|NCT00748189|26749691|FG000|Overall Study|Withdrawal by Subject|23|||
13382013|NCT00748189|26749692|FG001|Overall Study|Withdrawal by Subject|29|||
13218834|NCT01839487|26275763|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
13218835|NCT01839487|26275758|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
13218836|NCT01839487|26275759|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
13218837|NCT01839487|26275760|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
13218838|NCT01839487|26275761|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1|||
13218839|NCT01839487|26275762|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10|||
13218840|NCT01839487|26275763|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3|||
13218841|NCT01839487|26275758|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
13218842|NCT01839487|26275759|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
13218843|NCT01839487|26275760|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
13218844|NCT01839487|26275761|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3|||
13218845|NCT01839487|26275762|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2|||
13218846|NCT01839487|26275763|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
13218847|NCT01839279|26275792|FG000|Overall Study|Adverse Event|4|||
13218848|NCT01839279|26275793|FG001|Overall Study|Adverse Event|1|||
13218849|NCT01839279|26275794|FG002|Overall Study|Adverse Event|1|||
13218850|NCT01839279|26275792|FG000|Overall Study|Withdrawal by Subject|4|||
13218851|NCT01839279|26275793|FG001|Overall Study|Withdrawal by Subject|1|||
13218852|NCT01839279|26275794|FG002|Overall Study|Withdrawal by Subject|1|||
13218853|NCT01839279|26275792|FG000|Overall Study|Classified as 'Other'|5|||
13218854|NCT01839279|26275793|FG001|Overall Study|Classified as 'Other'|0|||
13218855|NCT01839279|26275794|FG002|Overall Study|Classified as 'Other'|0|||
13218856|NCT01839188|26275836|FG000|Overall Study|Withdrawal by Subject|1|||
13218857|NCT01838941|26275843|FG000|Overall Study|Adverse Event|1|||
13218858|NCT01838941|26275843|FG000|Overall Study|Withdrawal by Subject|1|||
13218859|NCT01838876|26275858|FG000|Overall Study|Adverse Event|49|||
13218860|NCT01838876|26275858|FG000|Overall Study|Insufficient Therapeutic Response|10|||
13218861|NCT01838876|26275858|FG000|Overall Study|Protocol Violation|34|||
13218862|NCT01838876|26275858|FG000|Overall Study|Withdrawal of Consent|33|||
13218863|NCT01838876|26275858|FG000|Overall Study|Lost to Follow-up|21|||
13218864|NCT01838876|26275858|FG000|Overall Study|Study or Site Terminated by Sponsor|1|||
13218865|NCT01838876|26275858|FG000|Overall Study|Reason not Specified|7|||
13218866|NCT01838876|26275858|FG000|Overall Study|Did not meet eligibility criteria|78|||
13218867|NCT01838694|26275874|FG000|Overall Study|Adverse Event|0|||
13218868|NCT01838694|26275875|FG001|Overall Study|Adverse Event|1|||
13218869|NCT01838681|26275920|FG000|Period A|Adverse Event|39|||
13218870|NCT01838681|26275921|FG001|Period A|Adverse Event|0|||
13218871|NCT01838681|26275922|FG002|Period A|Adverse Event|0|||
13218872|NCT01838681|26275923|FG003|Period A|Adverse Event|0|||
13218873|NCT01838681|26275920|FG000|Period A|Lack of Efficacy|21|||
13218874|NCT01838681|26275921|FG001|Period A|Lack of Efficacy|0|||
13218875|NCT01838681|26275922|FG002|Period A|Lack of Efficacy|0|||
13218876|NCT01838681|26275923|FG003|Period A|Lack of Efficacy|0|||
13218877|NCT01838681|26275920|FG000|Period A|Early response|148|||
13218878|NCT01838681|26275921|FG001|Period A|Early response|0|||
13218879|NCT01838681|26275922|FG002|Period A|Early response|0|||
13218880|NCT01838681|26275923|FG003|Period A|Early response|0|||
13218881|NCT01838681|26275920|FG000|Period A|Withdrawal by Subject|70|||
13218882|NCT01838681|26275921|FG001|Period A|Withdrawal by Subject|0|||
13218883|NCT01838681|26275922|FG002|Period A|Withdrawal by Subject|0|||
13218884|NCT01838681|26275923|FG003|Period A|Withdrawal by Subject|0|||
13218885|NCT01838681|26275920|FG000|Period A|Protocol Violation|16|||
13218886|NCT01838681|26275921|FG001|Period A|Protocol Violation|0|||
13218887|NCT01838681|26275922|FG002|Period A|Protocol Violation|0|||
13218888|NCT01838681|26275923|FG003|Period A|Protocol Violation|0|||
13218889|NCT01838681|26275920|FG000|Period A|Non-compliance with IMP|6|||
13218890|NCT01838681|26275921|FG001|Period A|Non-compliance with IMP|0|||
13218891|NCT01838681|26275922|FG002|Period A|Non-compliance with IMP|0|||
13218892|NCT01838681|26275923|FG003|Period A|Non-compliance with IMP|0|||
13218893|NCT01838681|26275920|FG000|Period A|Lost to Follow-up|4|||
13218894|NCT01838681|26275921|FG001|Period A|Lost to Follow-up|0|||
13218895|NCT01838681|26275922|FG002|Period A|Lost to Follow-up|0|||
13218896|NCT01838681|26275923|FG003|Period A|Lost to Follow-up|0|||
13218897|NCT01838681|26275920|FG000|Period A|Withdrawal before treatment|4|||
13218898|NCT01838681|26275921|FG001|Period A|Withdrawal before treatment|0|||
13218899|NCT01838681|26275922|FG002|Period A|Withdrawal before treatment|0|||
13218900|NCT01838681|26275923|FG003|Period A|Withdrawal before treatment|0|||
13218901|NCT01838681|26275920|FG000|Period A|Administrative or other reasons|17|||
13218902|NCT01838681|26275921|FG001|Period A|Administrative or other reasons|0|||
13218903|NCT01838681|26275922|FG002|Period A|Administrative or other reasons|0|||
13218904|NCT01838681|26275923|FG003|Period A|Administrative or other reasons|0|||
13218905|NCT01838681|26275920|FG000|Period B/A+|Adverse Event|0|||
13218906|NCT01838681|26275921|FG001|Period B/A+|Adverse Event|13|||
13218907|NCT01838681|26275922|FG002|Period B/A+|Adverse Event|27|||
13218908|NCT01838681|26275923|FG003|Period B/A+|Adverse Event|16|||
13218909|NCT01838681|26275920|FG000|Period B/A+|Lack of Efficacy|0|||
13218910|NCT01838681|26275921|FG001|Period B/A+|Lack of Efficacy|9|||
13218911|NCT01838681|26275922|FG002|Period B/A+|Lack of Efficacy|11|||
13218912|NCT01838681|26275923|FG003|Period B/A+|Lack of Efficacy|6|||
13218913|NCT01838681|26275920|FG000|Period B/A+|Withdrawal by Subject|0|||
13218914|NCT01838681|26275921|FG001|Period B/A+|Withdrawal by Subject|28|||
13218915|NCT01838681|26275922|FG002|Period B/A+|Withdrawal by Subject|35|||
13218916|NCT01838681|26275923|FG003|Period B/A+|Withdrawal by Subject|47|||
13218917|NCT01838681|26275920|FG000|Period B/A+|Protocol Violation|0|||
13218918|NCT01838681|26275921|FG001|Period B/A+|Protocol Violation|1|||
13218919|NCT01838681|26275922|FG002|Period B/A+|Protocol Violation|4|||
13218920|NCT01838681|26275923|FG003|Period B/A+|Protocol Violation|6|||
13218921|NCT01838681|26275920|FG000|Period B/A+|Non-compliance with IMP|0|||
13218922|NCT01838681|26275921|FG001|Period B/A+|Non-compliance with IMP|2|||
13218923|NCT01838681|26275922|FG002|Period B/A+|Non-compliance with IMP|3|||
13218924|NCT01838681|26275923|FG003|Period B/A+|Non-compliance with IMP|3|||
13218925|NCT01838681|26275920|FG000|Period B/A+|Lost to Follow-up|0|||
13218926|NCT01838681|26275921|FG001|Period B/A+|Lost to Follow-up|2|||
13218927|NCT01838681|26275922|FG002|Period B/A+|Lost to Follow-up|5|||
13218928|NCT01838681|26275923|FG003|Period B/A+|Lost to Follow-up|11|||
13218929|NCT01838681|26275920|FG000|Period B/A+|Withdrawal before treatment|0|||
13218930|NCT01838681|26275921|FG001|Period B/A+|Withdrawal before treatment|1|||
13218931|NCT01838681|26275922|FG002|Period B/A+|Withdrawal before treatment|0|||
13218932|NCT01838681|26275923|FG003|Period B/A+|Withdrawal before treatment|0|||
13218933|NCT01838681|26275920|FG000|Period B/A+|Administrative or other reasons|0|||
13218934|NCT01838681|26275921|FG001|Period B/A+|Administrative or other reasons|6|||
13218935|NCT01838681|26275922|FG002|Period B/A+|Administrative or other reasons|10|||
13218936|NCT01838681|26275923|FG003|Period B/A+|Administrative or other reasons|28|||
13218937|NCT01838642|26275936|FG000|Overall Study|Died on study|1|||
13218938|NCT01838616|26276010|FG000|Titration Period|Adverse Event|18|||
13218939|NCT01838616|26276011|FG001|Titration Period|Adverse Event|48|||
13218940|NCT01838616|26276010|FG000|Titration Period|Lack of Efficacy|5|||
13218941|NCT01838616|26276011|FG001|Titration Period|Lack of Efficacy|12|||
13218942|NCT01838616|26276010|FG000|Titration Period|Withdrawal by Subject|5|||
13218943|NCT01838616|26276011|FG001|Titration Period|Withdrawal by Subject|5|||
13218944|NCT01838616|26276010|FG000|Titration Period|Technical problems|1|||
13218945|NCT01838616|26276011|FG001|Titration Period|Technical problems|0|||
13218946|NCT01838616|26276010|FG000|Titration Period|Other|1|||
13218947|NCT01838616|26276011|FG001|Titration Period|Other|0|||
13218948|NCT01838616|26276010|FG000|Titration Period|Protocol Violation|0|||
13218949|NCT01838616|26276011|FG001|Titration Period|Protocol Violation|1|||
13218950|NCT01838616|26276010|FG000|Continuation Period|Lack of Efficacy|3|||
13218951|NCT01838616|26276011|FG001|Continuation Period|Lack of Efficacy|5|||
13218952|NCT01838616|26276010|FG000|Continuation Period|Adverse Event|8|||
13218953|NCT01838616|26276011|FG001|Continuation Period|Adverse Event|4|||
13218954|NCT01838616|26276010|FG000|Continuation Period|Protocol Violation|2|||
13218955|NCT01838616|26276011|FG001|Continuation Period|Protocol Violation|0|||
13218956|NCT01838616|26276010|FG000|Continuation Period|Lost to Follow-up|1|||
13218957|NCT01838616|26276011|FG001|Continuation Period|Lost to Follow-up|0|||
13218958|NCT01838616|26276010|FG000|Continuation Period|Withdrawal by Subject|0|||
13218959|NCT01838616|26276011|FG001|Continuation Period|Withdrawal by Subject|4|||
13218960|NCT01838616|26276010|FG000|Continuation Period|Technical problems|0|||
13218961|NCT01838616|26276011|FG001|Continuation Period|Technical problems|1|||
13218962|NCT01838616|26276010|FG000|Pick-up Arm|Lack of Efficacy|4|||
13218963|NCT01838616|26276011|FG001|Pick-up Arm|Lack of Efficacy|0|||
13218964|NCT01838616|26276010|FG000|Pick-up Arm|Adverse Event|9|||
13218965|NCT01838616|26276011|FG001|Pick-up Arm|Adverse Event|0|||
13218966|NCT01838616|26276010|FG000|Pick-up Arm|Withdrawal by Subject|1|||
13218967|NCT01838616|26276011|FG001|Pick-up Arm|Withdrawal by Subject|0|||
13218968|NCT01838616|26276010|FG000|Pick-up Arm|Technical problems|1|||
13218969|NCT01838616|26276011|FG001|Pick-up Arm|Technical problems|0|||
13218970|NCT01838590|26276044|FG000|Overall Study|Lack of Efficacy|12|||
13218971|NCT01838590|26276045|FG001|Overall Study|Lack of Efficacy|4|||
13218972|NCT01838590|26276044|FG000|Overall Study|Lost to Follow-up|0|||
13218973|NCT01838590|26276045|FG001|Overall Study|Lost to Follow-up|1|||
13218974|NCT01838551|26276051|FG000|Overall Study|Adverse Event|16|||
13218975|NCT01838551|26276051|FG000|Overall Study|Death|1|||
13218976|NCT01838551|26276051|FG000|Overall Study|Lack of Efficacy|10|||
13218977|NCT01838551|26276051|FG000|Overall Study|Physician Decision|4|||
13218978|NCT01838551|26276051|FG000|Overall Study|Withdrawal by Subject|10|||
13218979|NCT01838551|26276051|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7|||
13218980|NCT01838499|26276068|FG000|Overall Study|Protocol Violation|0|||
13218981|NCT01838499|26276069|FG001|Overall Study|Protocol Violation|1|||
13218982|NCT01838499|26276068|FG000|Overall Study|Lost to Follow-up|2|||
13218983|NCT01838499|26276069|FG001|Overall Study|Lost to Follow-up|4|||
13218984|NCT01838499|26276068|FG000|Overall Study|Lack of Efficacy|1|||
13218985|NCT01838499|26276069|FG001|Overall Study|Lack of Efficacy|2|||
13218986|NCT01838499|26276068|FG000|Overall Study|Adverse Event|2|||
13218987|NCT01838499|26276069|FG001|Overall Study|Adverse Event|1|||
13218988|NCT01838499|26276068|FG000|Overall Study|Withdrawal by Subject|19|||
13218989|NCT01838499|26276069|FG001|Overall Study|Withdrawal by Subject|9|||
13218990|NCT01838447|26276094|FG000|Overall Study|Change in surgical plan|1|||
13218991|NCT01838447|26276095|FG001|Overall Study|Change in surgical plan|2|||
13218992|NCT01838447|26276094|FG000|Overall Study|Withdrawal by Subject|1|||
13218993|NCT01838447|26276095|FG001|Overall Study|Withdrawal by Subject|1|||
13218994|NCT01838213|26276108|FG000|Overall Study|Ineligible|166|||
13218995|NCT01838213|26276109|FG001|Overall Study|Ineligible|191|||
13218996|NCT01838044|26276147|FG000|Overall Study|Adverse Event|4|||
13218997|NCT01838044|26276148|FG001|Overall Study|Adverse Event|6|||
13218998|NCT01838044|26276147|FG000|Overall Study|Protocol Violation|3|||
13218999|NCT01838044|26276148|FG001|Overall Study|Protocol Violation|3|||
13219000|NCT01838044|26276147|FG000|Overall Study|Withdrawal by Subject|0|||
13219001|NCT01838044|26276148|FG001|Overall Study|Withdrawal by Subject|2|||
13219002|NCT01838044|26276147|FG000|Overall Study|Insufficient clinical response|1|||
13219003|NCT01838044|26276148|FG001|Overall Study|Insufficient clinical response|2|||
13219004|NCT01838044|26276147|FG000|Overall Study|Medication error without associated AE|0|||
13219005|NCT01838044|26276148|FG001|Overall Study|Medication error without associated AE|1|||
13219006|NCT01838044|26276147|FG000|Overall Study|Lost to Follow-up|0|||
13219007|NCT01838044|26276148|FG001|Overall Study|Lost to Follow-up|2|||
13219008|NCT01837966|26276161|FG000|Overall Study|Withdrawal by Subject|2|||
13219009|NCT01837966|26276162|FG001|Overall Study|Withdrawal by Subject|1|||
13219010|NCT01837823|26276192|FG000|Overall Study|Lost to Follow-up|6|||
13219011|NCT01837797|26276239|FG000|Period 1|Adverse Event|9|||
13219012|NCT01837797|26276240|FG001|Period 1|Adverse Event|0|||
13219013|NCT01837797|26276241|FG002|Period 1|Adverse Event|0|||
13219014|NCT01837797|26276242|FG003|Period 1|Adverse Event|0|||
13219015|NCT01837797|26276243|FG004|Period 1|Adverse Event|0|||
13219016|NCT01837797|26276239|FG000|Period 1|Withdrawal by Subject|6|||
13219017|NCT01837797|26276240|FG001|Period 1|Withdrawal by Subject|0|||
13219018|NCT01837797|26276241|FG002|Period 1|Withdrawal by Subject|0|||
13219019|NCT01837797|26276242|FG003|Period 1|Withdrawal by Subject|0|||
13219020|NCT01837797|26276243|FG004|Period 1|Withdrawal by Subject|0|||
13219021|NCT01837797|26276239|FG000|Period 1|Administrative reasons|76|||
13219022|NCT01837797|26276240|FG001|Period 1|Administrative reasons|0|||
13219023|NCT01837797|26276241|FG002|Period 1|Administrative reasons|0|||
13219024|NCT01837797|26276242|FG003|Period 1|Administrative reasons|0|||
13219025|NCT01837797|26276243|FG004|Period 1|Administrative reasons|0|||
13219026|NCT01837797|26276239|FG000|Period 1|Withdrawal of consent before treatment|1|||
13219027|NCT01837797|26276240|FG001|Period 1|Withdrawal of consent before treatment|0|||
13219028|NCT01837797|26276241|FG002|Period 1|Withdrawal of consent before treatment|0|||
13219029|NCT01837797|26276242|FG003|Period 1|Withdrawal of consent before treatment|0|||
13219030|NCT01837797|26276243|FG004|Period 1|Withdrawal of consent before treatment|0|||
13219031|NCT01837797|26276239|FG000|Period 1|Other|10|||
13219032|NCT01837797|26276240|FG001|Period 1|Other|0|||
13219033|NCT01837797|26276241|FG002|Period 1|Other|0|||
13219034|NCT01837797|26276242|FG003|Period 1|Other|0|||
13219035|NCT01837797|26276243|FG004|Period 1|Other|0|||
13219036|NCT01837797|26276239|FG000|Period 2|Administrative or other reasons|0|||
13219037|NCT01837797|26276240|FG001|Period 2|Administrative or other reasons|5|||
13219038|NCT01837797|26276241|FG002|Period 2|Administrative or other reasons|2|||
13219039|NCT01837797|26276242|FG003|Period 2|Administrative or other reasons|4|||
13219040|NCT01837797|26276243|FG004|Period 2|Administrative or other reasons|0|||
13219041|NCT01837797|26276239|FG000|Period 2|Adverse Event|0|||
13219042|NCT01837797|26276240|FG001|Period 2|Adverse Event|0|||
13219043|NCT01837797|26276241|FG002|Period 2|Adverse Event|0|||
13219044|NCT01837797|26276242|FG003|Period 2|Adverse Event|1|||
13219045|NCT01837797|26276243|FG004|Period 2|Adverse Event|0|||
13219046|NCT01837797|26276239|FG000|Period 3|Adverse Event|0|||
13219047|NCT01837797|26276240|FG001|Period 3|Adverse Event|0|||
13219048|NCT01837797|26276241|FG002|Period 3|Adverse Event|0|||
13219049|NCT01837797|26276242|FG003|Period 3|Adverse Event|0|||
13219050|NCT01837797|26276243|FG004|Period 3|Adverse Event|1|||
13219051|NCT01837797|26276239|FG000|Period 3|Administrative reasons|0|||
13219052|NCT01837797|26276240|FG001|Period 3|Administrative reasons|0|||
13219053|NCT01837797|26276241|FG002|Period 3|Administrative reasons|0|||
13219054|NCT01837797|26276242|FG003|Period 3|Administrative reasons|0|||
13219055|NCT01837797|26276243|FG004|Period 3|Administrative reasons|20|||
13219056|NCT01837797|26276239|FG000|Period 3|Other|0|||
13219057|NCT01837797|26276240|FG001|Period 3|Other|0|||
13219058|NCT01837797|26276241|FG002|Period 3|Other|0|||
13219059|NCT01837797|26276242|FG003|Period 3|Other|0|||
13219060|NCT01837797|26276243|FG004|Period 3|Other|2|||
13219061|NCT01837719|26276312|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1|||
13219062|NCT01837719|26276312|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1|||
13219063|NCT01837680|26276355|FG000|Overall Study|Lost to Follow-up|2|||
13219064|NCT01837680|26276356|FG001|Overall Study|Lost to Follow-up|2|||
13219065|NCT01837680|26276355|FG000|Overall Study|lack of insurance|0|||
13219066|NCT01837680|26276356|FG001|Overall Study|lack of insurance|2|||
13219067|NCT01837680|26276355|FG000|Overall Study|allergic reaction|6|||
13219068|NCT01837680|26276356|FG001|Overall Study|allergic reaction|0|||
13219069|NCT01837680|26276355|FG000|Overall Study|switched to oral hypoglycemic or diet|2|||
13219070|NCT01837680|26276356|FG001|Overall Study|switched to oral hypoglycemic or diet|4|||
13219071|NCT01836549|26276396|FG000|Overall Study|Did not receive study drug|0|||
13219072|NCT01836549|26276397|FG001|Overall Study|Did not receive study drug|0|||
13219073|NCT01836549|26276398|FG002|Overall Study|Did not receive study drug|1|||
13219074|NCT01836549|26276399|FG003|Overall Study|Did not receive study drug|0|||
13219075|NCT01836549|26276400|FG004|Overall Study|Did not receive study drug|0|||
13219076|NCT01836549|26276401|FG005|Overall Study|Did not receive study drug|0|||
13219077|NCT01836549|26276402|FG006|Overall Study|Did not receive study drug|0|||
13219078|NCT01836549|26276396|FG000|Overall Study|Patient declared ineligible|0|||
13219079|NCT01836549|26276397|FG001|Overall Study|Patient declared ineligible|0|||
13219080|NCT01836549|26276398|FG002|Overall Study|Patient declared ineligible|0|||
13219081|NCT01836549|26276399|FG003|Overall Study|Patient declared ineligible|1|||
13219082|NCT01836549|26276400|FG004|Overall Study|Patient declared ineligible|0|||
13219083|NCT01836549|26276401|FG005|Overall Study|Patient declared ineligible|0|||
13219084|NCT01836549|26276402|FG006|Overall Study|Patient declared ineligible|0|||
13219085|NCT01836549|26276396|FG000|Overall Study|Patient inevaluable to start therapy|0|||
13219086|NCT01836549|26276397|FG001|Overall Study|Patient inevaluable to start therapy|0|||
13219087|NCT01836549|26276398|FG002|Overall Study|Patient inevaluable to start therapy|0|||
13219088|NCT01836549|26276399|FG003|Overall Study|Patient inevaluable to start therapy|0|||
13219089|NCT01836549|26276400|FG004|Overall Study|Patient inevaluable to start therapy|0|||
13219090|NCT01836549|26276401|FG005|Overall Study|Patient inevaluable to start therapy|0|||
13219091|NCT01836549|26276402|FG006|Overall Study|Patient inevaluable to start therapy|1|||
13219092|NCT01836523|26276437|FG000|Overall Study|Adverse Event|15|||
13219093|NCT01836523|26276438|FG001|Overall Study|Adverse Event|41|||
13219094|NCT01836523|26276439|FG002|Overall Study|Adverse Event|49|||
13219095|NCT01836523|26276440|FG003|Overall Study|Adverse Event|14|||
13219096|NCT01836523|26276437|FG000|Overall Study|Protocol Violation|6|||
13219097|NCT01836523|26276438|FG001|Overall Study|Protocol Violation|3|||
13219098|NCT01836523|26276439|FG002|Overall Study|Protocol Violation|2|||
13219099|NCT01836523|26276440|FG003|Overall Study|Protocol Violation|4|||
13219100|NCT01836523|26276437|FG000|Overall Study|Met Withdrawal Criteria|13|||
13219101|NCT01836523|26276438|FG001|Overall Study|Met Withdrawal Criteria|13|||
13219102|NCT01836523|26276439|FG002|Overall Study|Met Withdrawal Criteria|21|||
13219103|NCT01836523|26276440|FG003|Overall Study|Met Withdrawal Criteria|27|||
13219104|NCT01836523|26276437|FG000|Overall Study|Unclassified|17|||
13219105|NCT01836523|26276438|FG001|Overall Study|Unclassified|28|||
13219106|NCT01836523|26276439|FG002|Overall Study|Unclassified|19|||
13219107|NCT01836523|26276440|FG003|Overall Study|Unclassified|29|||
13219108|NCT01836471|26276481|FG000|Overall Study|Pregnancy|1|||
13219109|NCT01836471|26276482|FG001|Overall Study|Pregnancy|0|||
13219110|NCT01836471|26276483|FG002|Overall Study|Pregnancy|0|||
13219111|NCT01836471|26276484|FG003|Overall Study|Pregnancy|0|||
13219112|NCT01836471|26276485|FG004|Overall Study|Pregnancy|0|||
13219113|NCT01836471|26276481|FG000|Overall Study|Withdrawal by Subject|3|||
13219114|NCT01836471|26276482|FG001|Overall Study|Withdrawal by Subject|4|||
13219115|NCT01836471|26276483|FG002|Overall Study|Withdrawal by Subject|1|||
13219116|NCT01836471|26276484|FG003|Overall Study|Withdrawal by Subject|0|||
13219117|NCT01836471|26276485|FG004|Overall Study|Withdrawal by Subject|2|||
13219118|NCT01836471|26276481|FG000|Overall Study|Physician Decision|0|||
13219119|NCT01836471|26276482|FG001|Overall Study|Physician Decision|1|||
13219120|NCT01836471|26276483|FG002|Overall Study|Physician Decision|0|||
13219121|NCT01836471|26276484|FG003|Overall Study|Physician Decision|0|||
13219122|NCT01836471|26276485|FG004|Overall Study|Physician Decision|0|||
13219123|NCT01836471|26276481|FG000|Overall Study|Lost to Follow-up|0|||
13219124|NCT01836471|26276482|FG001|Overall Study|Lost to Follow-up|0|||
13219125|NCT01836471|26276483|FG002|Overall Study|Lost to Follow-up|0|||
13219126|NCT01836471|26276484|FG003|Overall Study|Lost to Follow-up|1|||
13219127|NCT01836471|26276485|FG004|Overall Study|Lost to Follow-up|1|||
13219128|NCT01836471|26276481|FG000|Overall Study|Adverse Event|6|||
13219129|NCT01836471|26276482|FG001|Overall Study|Adverse Event|3|||
13219130|NCT01836471|26276483|FG002|Overall Study|Adverse Event|1|||
13219131|NCT01836471|26276484|FG003|Overall Study|Adverse Event|1|||
13219132|NCT01836471|26276485|FG004|Overall Study|Adverse Event|2|||
13219133|NCT01836471|26276481|FG000|Overall Study|Non compliance with tx|1|||
13219134|NCT01836471|26276482|FG001|Overall Study|Non compliance with tx|1|||
13219135|NCT01836471|26276483|FG002|Overall Study|Non compliance with tx|0|||
13219136|NCT01836471|26276484|FG003|Overall Study|Non compliance with tx|0|||
13219137|NCT01836471|26276485|FG004|Overall Study|Non compliance with tx|0|||
13219138|NCT01836458|26276520|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
13219139|NCT01836458|26276521|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
13219140|NCT01836458|26276522|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
13219141|NCT01836458|26276523|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
13219142|NCT01836276|26276536|FG000|Overall Study|Lost to Follow-up|28|||
13219143|NCT01836276|26276537|FG001|Overall Study|Lost to Follow-up|51|||
13219144|NCT01836198|26276567|FG000|Part A, Period 2|Protocol Violation|0|||
13219145|NCT01836198|26276568|FG001|Part A, Period 2|Protocol Violation|1|||
13219146|NCT01836198|26276569|FG002|Part A, Period 2|Protocol Violation|0|||
13219147|NCT01835899|26276597|FG000|Overall Study|Adverse Event|0|||
13219148|NCT01835899|26276598|FG001|Overall Study|Adverse Event|0|||
13219149|NCT01835899|26276599|FG002|Overall Study|Adverse Event|1|||
13219150|NCT01835899|26276597|FG000|Overall Study|Other than stated above|0|||
13219151|NCT01835899|26276598|FG001|Overall Study|Other than stated above|1|||
13219152|NCT01835899|26276599|FG002|Overall Study|Other than stated above|0|||
13219153|NCT01835587|26276671|FG000|Overall Study|Disease Recurrence or Relapse|0|||
13219154|NCT01835587|26276672|FG001|Overall Study|Disease Recurrence or Relapse|3|||
13219155|NCT01835587|26276673|FG002|Overall Study|Disease Recurrence or Relapse|0|||
13219156|NCT01835587|26276674|FG003|Overall Study|Disease Recurrence or Relapse|3|||
13219157|NCT01835587|26276671|FG000|Overall Study|Withdrawal by Subject|2|||
13219158|NCT01835587|26276672|FG001|Overall Study|Withdrawal by Subject|0|||
13219159|NCT01835587|26276673|FG002|Overall Study|Withdrawal by Subject|0|||
13219160|NCT01835587|26276674|FG003|Overall Study|Withdrawal by Subject|3|||
13219161|NCT01835587|26276671|FG000|Overall Study|Adverse Event|0|||
13219162|NCT01835587|26276672|FG001|Overall Study|Adverse Event|0|||
13219163|NCT01835587|26276673|FG002|Overall Study|Adverse Event|2|||
13219164|NCT01835587|26276674|FG003|Overall Study|Adverse Event|2|||
13219165|NCT01835587|26276671|FG000|Overall Study|Death|0|||
13219166|NCT01835587|26276672|FG001|Overall Study|Death|0|||
13219167|NCT01835587|26276673|FG002|Overall Study|Death|0|||
13219168|NCT01835587|26276674|FG003|Overall Study|Death|1|||
13219169|NCT01835587|26276671|FG000|Overall Study|Miscellaneous|0|||
13219170|NCT01835587|26276672|FG001|Overall Study|Miscellaneous|1|||
13219171|NCT01835587|26276673|FG002|Overall Study|Miscellaneous|0|||
13219172|NCT01835587|26276674|FG003|Overall Study|Miscellaneous|0|||
13219173|NCT01835548|26276702|FG000|Dose Optimization Period|Adverse Event|0|||
13219174|NCT01835548|26276703|FG001|Dose Optimization Period|Adverse Event|0|||
13219175|NCT01835548|26276704|FG002|Dose Optimization Period|Adverse Event|1|||
13219176|NCT01835548|26276702|FG000|Dose Optimization Period|Withdrawal by Subject|0|||
13219177|NCT01835548|26276703|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
13219178|NCT01835548|26276704|FG002|Dose Optimization Period|Withdrawal by Subject|1|||
13219179|NCT01835548|26276702|FG000|Double-Blind Treatment Period|Adverse Event|0|||
13219180|NCT01835548|26276703|FG001|Double-Blind Treatment Period|Adverse Event|1|||
13219181|NCT01835548|26276704|FG002|Double-Blind Treatment Period|Adverse Event|0|||
13219182|NCT01835548|26276702|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
13219183|NCT01835548|26276703|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
13219184|NCT01835548|26276704|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
13219185|NCT01835470|26276716|FG000|Long Term Treatment Period|Subject Request to Discontinue|1|||
13219186|NCT01835470|26276716|FG000|Long Term Treatment Period|Lack of Efficacy|3|||
13219187|NCT01835431|26276741|FG000|Overall Study|Adverse Event|1|||
13219188|NCT01835431|26276742|FG001|Overall Study|Adverse Event|0|||
13219189|NCT01835431|26276741|FG000|Overall Study|other|0|||
13219190|NCT01835431|26276742|FG001|Overall Study|other|2|||
13219191|NCT01835431|26276741|FG000|Overall Study|Withdrawal by Subject|6|||
13219192|NCT01835431|26276742|FG001|Overall Study|Withdrawal by Subject|10|||
13219193|NCT01835431|26276741|FG000|Overall Study|Protocol Violation|1|||
13219194|NCT01835431|26276742|FG001|Overall Study|Protocol Violation|0|||
13219195|NCT01835223|26276767|FG000|Overall Study|Adverse Event|1|||
13219196|NCT01835223|26276768|FG001|Overall Study|Adverse Event|0|||
13219197|NCT01835223|26276767|FG000|Overall Study|Withdrawal by Subject|2|||
13219198|NCT01835223|26276768|FG001|Overall Study|Withdrawal by Subject|0|||
13219199|NCT01835223|26276767|FG000|Overall Study|Disease progression|2|||
13219200|NCT01835223|26276768|FG001|Overall Study|Disease progression|1|||
13219201|NCT01835223|26276767|FG000|Overall Study|Became Inelligible|4|||
13219202|NCT01835223|26276768|FG001|Overall Study|Became Inelligible|0|||
13219203|NCT01835158|26276785|FG000|Overall Study|Withdrawal by Subject|1|||
13219204|NCT01835158|26276786|FG001|Overall Study|Withdrawal by Subject|6|||
13219205|NCT01835145|26276808|FG000|Overall Study|Ineligible prior to treatment|1|||
13219206|NCT01835145|26276809|FG001|Overall Study|Ineligible prior to treatment|0|||
13219207|NCT01835132|26276851|FG000|Initial Phase|Insufficient Therapeutic Response|2|||
13219208|NCT01835015|26276940|FG000|Overall Study|Adverse Event|0|||
13219209|NCT01835015|26276941|FG001|Overall Study|Adverse Event|0|||
13219210|NCT01835015|26276942|FG002|Overall Study|Adverse Event|1|||
13219211|NCT01835015|26276943|FG003|Overall Study|Adverse Event|0|||
13219212|NCT01835015|26276944|FG004|Overall Study|Adverse Event|0|||
13219213|NCT01834729|26276971|FG000|Overall Study|Did not return bowel diaries|0|||
13219214|NCT01834729|26276972|FG001|Overall Study|Did not return bowel diaries|0|||
13219215|NCT01834729|26276973|FG002|Overall Study|Did not return bowel diaries|3|||
13219216|NCT01834729|26276974|FG003|Overall Study|Did not return bowel diaries|0|||
13219217|NCT01834729|26276971|FG000|Overall Study|Withdrawal by Subject|1|||
13219218|NCT01834729|26276972|FG001|Overall Study|Withdrawal by Subject|1|||
13219219|NCT01834729|26276973|FG002|Overall Study|Withdrawal by Subject|0|||
13219220|NCT01834729|26276974|FG003|Overall Study|Withdrawal by Subject|0|||
13219221|NCT01834729|26276971|FG000|Overall Study|Adverse Event|0|||
13219222|NCT01834729|26276972|FG001|Overall Study|Adverse Event|0|||
13219223|NCT01834729|26276973|FG002|Overall Study|Adverse Event|0|||
13219224|NCT01834729|26276974|FG003|Overall Study|Adverse Event|2|||
13219225|NCT01834586|26276981|FG000|Overall Study|Adverse Event|1|||
13219226|NCT01834274|26276998|FG000|Overall Study|Study Termination|41|||
13219227|NCT01834274|26276999|FG001|Overall Study|Study Termination|38|||
13219228|NCT01834274|26276998|FG000|Overall Study|Withdrawal by Subject|1|||
13219229|NCT01834274|26276999|FG001|Overall Study|Withdrawal by Subject|1|||
13219230|NCT01834274|26276998|FG000|Overall Study|Lost to Follow-up|3|||
13219231|NCT01834274|26276999|FG001|Overall Study|Lost to Follow-up|1|||
13219232|NCT01834274|26276998|FG000|Overall Study|Other|2|||
13219233|NCT01834274|26276999|FG001|Overall Study|Other|1|||
13219234|NCT01834222|26277010|FG000|Overall Study|Not meet inclusion/exclusion criteria|1|||
13219235|NCT01833897|26277020|FG000|Overall Study|Lack of Efficacy|1|||
13219236|NCT01833832|26277030|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1|||
13219237|NCT01833533|26277051|FG000|Overall Study|Adverse Event|0|||
13219238|NCT01833533|26277052|FG001|Overall Study|Adverse Event|1|||
13219239|NCT01833533|26277051|FG000|Overall Study|Lost to Follow-up|4|||
13219240|NCT01833533|26277052|FG001|Overall Study|Lost to Follow-up|9|||
13219241|NCT01833533|26277051|FG000|Overall Study|To Enter an Extension Study|0|||
13219242|NCT01833533|26277052|FG001|Overall Study|To Enter an Extension Study|4|||
13219243|NCT01833533|26277051|FG000|Overall Study|Other|2|||
13219244|NCT01833533|26277052|FG001|Overall Study|Other|7|||
13219245|NCT01833520|26277073|FG000|Overall Study|Lack of Efficacy|3|||
13219246|NCT01833520|26277074|FG001|Overall Study|Lack of Efficacy|3|||
13219247|NCT01833520|26277075|FG002|Overall Study|Lack of Efficacy|8|||
13219248|NCT01833520|26277076|FG003|Overall Study|Lack of Efficacy|3|||
13219249|NCT01833494|26277085|FG000|Overall Study|Adverse Event|24|||
13219250|NCT01833494|26277085|FG000|Overall Study|Physician Decision|6|||
13219251|NCT01833494|26277085|FG000|Overall Study|Withdrawal by Subject|6|||
13219252|NCT01833494|26277085|FG000|Overall Study|Decrease in serum phosphorus|4|||
13219253|NCT01833494|26277085|FG000|Overall Study|Decrease in serum calcium|4|||
13219254|NCT01833494|26277085|FG000|Overall Study|Increase in serum ferritin|1|||
13219255|NCT01833455|26277110|FG000|Overall Study|Withdrawal by Subject|1|||
13219256|NCT01833455|26277111|FG001|Overall Study|Withdrawal by Subject|0|||
13219257|NCT01833169|26277124|FG000|Overall Study|Disease Progression|99|||
13219258|NCT01833169|26277124|FG000|Overall Study|Adverse Event|33|||
13219259|NCT01833169|26277124|FG000|Overall Study|Withdrawal by Subject|9|||
13219260|NCT01833169|26277124|FG000|Overall Study|Death|3|||
13219261|NCT01833169|26277124|FG000|Overall Study|Physician Decision|2|||
13219262|NCT01833143|26277133|FG000|Overall Study|Not Treated|1|||
13219263|NCT01833065|26277176|FG000|Overall Study|Adverse Event|6|||
13219264|NCT01833065|26277177|FG001|Overall Study|Adverse Event|1|||
13219265|NCT01833065|26277178|FG002|Overall Study|Adverse Event|0|||
13219266|NCT01833065|26277179|FG003|Overall Study|Adverse Event|2|||
13219267|NCT01833065|26277180|FG004|Overall Study|Adverse Event|3|||
13219268|NCT01833065|26277176|FG000|Overall Study|Protocol Violation|1|||
13219269|NCT01833065|26277177|FG001|Overall Study|Protocol Violation|0|||
13219270|NCT01833065|26277178|FG002|Overall Study|Protocol Violation|0|||
13219271|NCT01833065|26277179|FG003|Overall Study|Protocol Violation|0|||
13219272|NCT01833065|26277180|FG004|Overall Study|Protocol Violation|2|||
13219273|NCT01833065|26277176|FG000|Overall Study|Lost to Follow-up|1|||
13219274|NCT01833065|26277177|FG001|Overall Study|Lost to Follow-up|0|||
13219275|NCT01833065|26277178|FG002|Overall Study|Lost to Follow-up|0|||
13219276|NCT01833065|26277179|FG003|Overall Study|Lost to Follow-up|0|||
13219277|NCT01833065|26277180|FG004|Overall Study|Lost to Follow-up|3|||
13219278|NCT01833065|26277176|FG000|Overall Study|Withdrawal by Subject|6|||
13219279|NCT01833065|26277177|FG001|Overall Study|Withdrawal by Subject|2|||
13219280|NCT01833065|26277178|FG002|Overall Study|Withdrawal by Subject|4|||
13219281|NCT01833065|26277179|FG003|Overall Study|Withdrawal by Subject|3|||
13219282|NCT01833065|26277180|FG004|Overall Study|Withdrawal by Subject|11|||
13219283|NCT01833065|26277176|FG000|Overall Study|Subject's substantial non-compliance|0|||
13219284|NCT01833065|26277177|FG001|Overall Study|Subject's substantial non-compliance|1|||
13219285|NCT01833065|26277178|FG002|Overall Study|Subject's substantial non-compliance|0|||
13219286|NCT01833065|26277179|FG003|Overall Study|Subject's substantial non-compliance|0|||
13219287|NCT01833065|26277180|FG004|Overall Study|Subject's substantial non-compliance|0|||
13219288|NCT01833065|26277176|FG000|Overall Study|Trial terminated by sponsor|8|||
13219289|NCT01833065|26277177|FG001|Overall Study|Trial terminated by sponsor|8|||
13219290|NCT01833065|26277178|FG002|Overall Study|Trial terminated by sponsor|7|||
13394781|NCT00654381|26788102|FG005|2nd Stage|Investigator's decision|0|||
13394782|NCT00654381|26788097|FG000|Extension Stage|Adverse Event|1|||
13219291|NCT01833065|26277179|FG003|Overall Study|Trial terminated by sponsor|3|||
13219292|NCT01833065|26277180|FG004|Overall Study|Trial terminated by sponsor|13|||
13219293|NCT01833065|26277176|FG000|Overall Study|Others|2|||
13219294|NCT01833065|26277177|FG001|Overall Study|Others|1|||
13219295|NCT01833065|26277178|FG002|Overall Study|Others|1|||
13219296|NCT01833065|26277179|FG003|Overall Study|Others|1|||
13219297|NCT01833065|26277180|FG004|Overall Study|Others|4|||
13219298|NCT01832818|26277191|FG000|Overall Study|Lost to Follow-up|6|||
13219299|NCT01832766|26277204|FG000|Washout|Lost to Follow-up|0|||
13219300|NCT01832766|26277205|FG001|Washout|Lost to Follow-up|1|||
13219301|NCT01832727|26277333|FG000|Overall Study|Adverse Event|4|||
13219302|NCT01832727|26277334|FG001|Overall Study|Adverse Event|6|||
13219303|NCT01832727|26277335|FG002|Overall Study|Adverse Event|1|||
13219304|NCT01832727|26277336|FG003|Overall Study|Adverse Event|0|||
13219305|NCT01832727|26277337|FG004|Overall Study|Adverse Event|1|||
13219306|NCT01832727|26277338|FG005|Overall Study|Adverse Event|1|||
13219307|NCT01832727|26277339|FG006|Overall Study|Adverse Event|2|||
13219308|NCT01832727|26277340|FG007|Overall Study|Adverse Event|1|||
13219309|NCT01832727|26277341|FG008|Overall Study|Adverse Event|9|||
13219310|NCT01832727|26277333|FG000|Overall Study|Disease progression|3|||
13219311|NCT01832727|26277334|FG001|Overall Study|Disease progression|0|||
13219312|NCT01832727|26277335|FG002|Overall Study|Disease progression|2|||
13219313|NCT01832727|26277336|FG003|Overall Study|Disease progression|1|||
13219314|NCT01832727|26277337|FG004|Overall Study|Disease progression|3|||
13219315|NCT01832727|26277338|FG005|Overall Study|Disease progression|3|||
13219316|NCT01832727|26277339|FG006|Overall Study|Disease progression|6|||
13219317|NCT01832727|26277340|FG007|Overall Study|Disease progression|2|||
13219318|NCT01832727|26277341|FG008|Overall Study|Disease progression|7|||
13219319|NCT01832727|26277333|FG000|Overall Study|Lost to Follow-up|0|||
13219320|NCT01832727|26277334|FG001|Overall Study|Lost to Follow-up|0|||
13219321|NCT01832727|26277335|FG002|Overall Study|Lost to Follow-up|0|||
13219322|NCT01832727|26277336|FG003|Overall Study|Lost to Follow-up|1|||
13219323|NCT01832727|26277337|FG004|Overall Study|Lost to Follow-up|0|||
13219324|NCT01832727|26277338|FG005|Overall Study|Lost to Follow-up|0|||
13219325|NCT01832727|26277339|FG006|Overall Study|Lost to Follow-up|0|||
13219326|NCT01832727|26277340|FG007|Overall Study|Lost to Follow-up|0|||
13219327|NCT01832727|26277341|FG008|Overall Study|Lost to Follow-up|0|||
13219328|NCT01832727|26277333|FG000|Overall Study|Physician Decision|1|||
13219329|NCT01832727|26277334|FG001|Overall Study|Physician Decision|0|||
13219330|NCT01832727|26277335|FG002|Overall Study|Physician Decision|0|||
13219331|NCT01832727|26277336|FG003|Overall Study|Physician Decision|1|||
13219332|NCT01832727|26277337|FG004|Overall Study|Physician Decision|0|||
13219333|NCT01832727|26277338|FG005|Overall Study|Physician Decision|1|||
13219334|NCT01832727|26277339|FG006|Overall Study|Physician Decision|0|||
13219335|NCT01832727|26277340|FG007|Overall Study|Physician Decision|0|||
13219336|NCT01832727|26277341|FG008|Overall Study|Physician Decision|0|||
13219337|NCT01832727|26277333|FG000|Overall Study|Withdrawal by Subject|1|||
13219338|NCT01832727|26277334|FG001|Overall Study|Withdrawal by Subject|1|||
13219339|NCT01832727|26277335|FG002|Overall Study|Withdrawal by Subject|0|||
13219340|NCT01832727|26277336|FG003|Overall Study|Withdrawal by Subject|1|||
13219341|NCT01832727|26277337|FG004|Overall Study|Withdrawal by Subject|0|||
13219342|NCT01832727|26277338|FG005|Overall Study|Withdrawal by Subject|1|||
13219343|NCT01832727|26277339|FG006|Overall Study|Withdrawal by Subject|0|||
13219344|NCT01832727|26277340|FG007|Overall Study|Withdrawal by Subject|2|||
13219345|NCT01832727|26277341|FG008|Overall Study|Withdrawal by Subject|1|||
13219346|NCT01832727|26277333|FG000|Overall Study|Study terminated by sponsor|0|||
13219347|NCT01832727|26277334|FG001|Overall Study|Study terminated by sponsor|0|||
13219348|NCT01832727|26277335|FG002|Overall Study|Study terminated by sponsor|0|||
13219349|NCT01832727|26277336|FG003|Overall Study|Study terminated by sponsor|0|||
13219350|NCT01832727|26277337|FG004|Overall Study|Study terminated by sponsor|0|||
13219351|NCT01832727|26277338|FG005|Overall Study|Study terminated by sponsor|0|||
13219352|NCT01832727|26277339|FG006|Overall Study|Study terminated by sponsor|0|||
13219353|NCT01832727|26277340|FG007|Overall Study|Study terminated by sponsor|1|||
13219354|NCT01832727|26277341|FG008|Overall Study|Study terminated by sponsor|1|||
13219355|NCT01832532|26277354|FG000|Overall Study|Withdrawal by Subject|5|||
13219356|NCT01832532|26277355|FG001|Overall Study|Withdrawal by Subject|2|||
13219357|NCT01832493|26277364|FG000|Overall Study|Physician Decision|2|||
13219358|NCT01832493|26277364|FG000|Overall Study|Protocol Violation|4|||
13219359|NCT01832493|26277364|FG000|Overall Study|Unable to place LV lead|2|||
13219360|NCT01832480|26277377|FG000|Overall Study|Lost to Follow-up|33|||
13219361|NCT01832480|26277378|FG001|Overall Study|Lost to Follow-up|30|||
13219362|NCT01832480|26277377|FG000|Overall Study|Withdrawal by Subject|0|||
13219363|NCT01832480|26277378|FG001|Overall Study|Withdrawal by Subject|2|||
13219364|NCT01832480|26277377|FG000|Overall Study|post randomization ineligible|8|||
13219365|NCT01832480|26277378|FG001|Overall Study|post randomization ineligible|10|||
13219366|NCT01832155|26277406|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1|||
13219367|NCT01832155|26277407|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0|||
13219368|NCT01832155|26277406|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1|||
13219369|NCT01832155|26277407|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0|||
13219370|NCT01832038|26277416|FG000|Overall Study|Death|5|||
13219371|NCT01832038|26277416|FG000|Overall Study|Adverse Event|50|||
13219372|NCT01832038|26277416|FG000|Overall Study|Lack of Efficacy|81|||
13219373|NCT01832038|26277416|FG000|Overall Study|Protocol Violation|7|||
13219374|NCT01832038|26277416|FG000|Overall Study|Lost to Follow-up|10|||
13219375|NCT01832038|26277416|FG000|Overall Study|Withdrawal by Subject|49|||
13219376|NCT01832038|26277416|FG000|Overall Study|Visit non-compliance|2|||
13219377|NCT01832038|26277416|FG000|Overall Study|Subject refused to return visit|2|||
13219378|NCT01832038|26277416|FG000|Overall Study|Not convenient to come back to site|2|||
13219379|NCT01832038|26277416|FG000|Overall Study|Participant was asked to quit|5|||
13219380|NCT01832038|26277416|FG000|Overall Study|Back home|1|||
13219381|NCT01832038|26277416|FG000|Overall Study|Pregnancy|1|||
13219382|NCT01832038|26277416|FG000|Overall Study|Low compliance|3|||
13219383|NCT01832038|26277416|FG000|Overall Study|Prohibit procedure|2|||
13219384|NCT01832038|26277416|FG000|Overall Study|Not possible to visit the hospital|1|||
13219385|NCT01832038|26277416|FG000|Overall Study|Changes of implementation system|3|||
13219386|NCT01832038|26277416|FG000|Overall Study|Plan to pregnancy|7|||
13219387|NCT01832038|26277416|FG000|Overall Study|Bad mood and has suicidal thought|1|||
13219388|NCT01832038|26277416|FG000|Overall Study|Prohibited concomitant medication|1|||
13219389|NCT01832038|26277416|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1|||
13219390|NCT01832038|26277416|FG000|Overall Study|Subject considered the efficacy was poor|1|||
13219391|NCT01831856|26277429|FG000|Overall Study|Adverse Event|5|||
13219392|NCT01831856|26277430|FG001|Overall Study|Adverse Event|8|||
13219393|NCT01831856|26277429|FG000|Overall Study|Lack of Efficacy|13|||
13219394|NCT01831856|26277430|FG001|Overall Study|Lack of Efficacy|11|||
13219395|NCT01831856|26277429|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16|||
13219396|NCT01831856|26277430|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18|||
13219397|NCT01831817|26277481|FG000|Overall Study|Lost to Follow-up|1|||
13219398|NCT01831817|26277482|FG001|Overall Study|Lost to Follow-up|0|||
13219399|NCT01831817|26277483|FG002|Overall Study|Lost to Follow-up|0|||
13219400|NCT01831817|26277484|FG003|Overall Study|Lost to Follow-up|0|||
13219401|NCT01831817|26277481|FG000|Overall Study|Withdrawl of Consent|3|||
13219402|NCT01831817|26277482|FG001|Overall Study|Withdrawl of Consent|0|||
13219403|NCT01831817|26277483|FG002|Overall Study|Withdrawl of Consent|0|||
13219404|NCT01831817|26277484|FG003|Overall Study|Withdrawl of Consent|0|||
13219405|NCT01831804|26277607|FG000|Overall Study|Adverse Event|0|||
13219406|NCT01831804|26277608|FG001|Overall Study|Adverse Event|0|||
13219407|NCT01831804|26277609|FG002|Overall Study|Adverse Event|0|||
13219408|NCT01831804|26277610|FG003|Overall Study|Adverse Event|0|||
13219409|NCT01831804|26277611|FG004|Overall Study|Adverse Event|0|||
13219410|NCT01831804|26277612|FG005|Overall Study|Adverse Event|0|||
13219411|NCT01831804|26277613|FG006|Overall Study|Adverse Event|1|||
13219412|NCT01831804|26277614|FG007|Overall Study|Adverse Event|0|||
13219413|NCT01831804|26277615|FG008|Overall Study|Adverse Event|1|||
13219414|NCT01831804|26277607|FG000|Overall Study|Protocol Violation|0|||
13219415|NCT01831804|26277608|FG001|Overall Study|Protocol Violation|0|||
13219416|NCT01831804|26277609|FG002|Overall Study|Protocol Violation|2|||
13219417|NCT01831804|26277610|FG003|Overall Study|Protocol Violation|0|||
13219418|NCT01831804|26277611|FG004|Overall Study|Protocol Violation|0|||
13219419|NCT01831804|26277612|FG005|Overall Study|Protocol Violation|0|||
13219420|NCT01831804|26277613|FG006|Overall Study|Protocol Violation|0|||
13219421|NCT01831804|26277614|FG007|Overall Study|Protocol Violation|0|||
13219422|NCT01831804|26277615|FG008|Overall Study|Protocol Violation|0|||
13219423|NCT01831804|26277607|FG000|Overall Study|Protocol defined stopping criteria|1|||
13219424|NCT01831804|26277608|FG001|Overall Study|Protocol defined stopping criteria|1|||
13219425|NCT01831804|26277609|FG002|Overall Study|Protocol defined stopping criteria|3|||
13219426|NCT01831804|26277610|FG003|Overall Study|Protocol defined stopping criteria|0|||
13219427|NCT01831804|26277611|FG004|Overall Study|Protocol defined stopping criteria|1|||
13219428|NCT01831804|26277612|FG005|Overall Study|Protocol defined stopping criteria|0|||
13219429|NCT01831804|26277613|FG006|Overall Study|Protocol defined stopping criteria|0|||
13219430|NCT01831804|26277614|FG007|Overall Study|Protocol defined stopping criteria|0|||
13219431|NCT01831804|26277615|FG008|Overall Study|Protocol defined stopping criteria|0|||
13219432|NCT01831804|26277607|FG000|Overall Study|Lost to Follow-up|0|||
13219433|NCT01831804|26277608|FG001|Overall Study|Lost to Follow-up|0|||
13219434|NCT01831804|26277609|FG002|Overall Study|Lost to Follow-up|1|||
13219435|NCT01831804|26277610|FG003|Overall Study|Lost to Follow-up|0|||
13219436|NCT01831804|26277611|FG004|Overall Study|Lost to Follow-up|0|||
13219437|NCT01831804|26277612|FG005|Overall Study|Lost to Follow-up|0|||
13219438|NCT01831804|26277613|FG006|Overall Study|Lost to Follow-up|0|||
13219439|NCT01831804|26277614|FG007|Overall Study|Lost to Follow-up|0|||
13219440|NCT01831804|26277615|FG008|Overall Study|Lost to Follow-up|1|||
13219441|NCT01831804|26277607|FG000|Overall Study|Investigator discretion|0|||
13219442|NCT01831804|26277608|FG001|Overall Study|Investigator discretion|0|||
13219443|NCT01831804|26277609|FG002|Overall Study|Investigator discretion|0|||
13219444|NCT01831804|26277610|FG003|Overall Study|Investigator discretion|0|||
13219445|NCT01831804|26277611|FG004|Overall Study|Investigator discretion|1|||
13219446|NCT01831804|26277612|FG005|Overall Study|Investigator discretion|0|||
13219447|NCT01831804|26277613|FG006|Overall Study|Investigator discretion|0|||
13219448|NCT01831804|26277614|FG007|Overall Study|Investigator discretion|1|||
13219449|NCT01831804|26277615|FG008|Overall Study|Investigator discretion|0|||
13219450|NCT01831804|26277607|FG000|Overall Study|Withdrew Consent|0|||
13219451|NCT01831804|26277608|FG001|Overall Study|Withdrew Consent|1|||
13219452|NCT01831804|26277609|FG002|Overall Study|Withdrew Consent|0|||
13219453|NCT01831804|26277610|FG003|Overall Study|Withdrew Consent|0|||
13219454|NCT01831804|26277611|FG004|Overall Study|Withdrew Consent|0|||
13219455|NCT01831804|26277612|FG005|Overall Study|Withdrew Consent|0|||
13219456|NCT01831804|26277613|FG006|Overall Study|Withdrew Consent|0|||
13297701|NCT01362608|26499430|FG000|Overall Study|Protocol Violation|0|||
13297702|NCT01362608|26499431|FG001|Overall Study|Protocol Violation|1|||
13297703|NCT01362608|26499430|FG000|Overall Study|Lost to Follow-up|3|||
13297704|NCT01362608|26499431|FG001|Overall Study|Lost to Follow-up|1|||
13297705|NCT01362608|26499430|FG000|Overall Study|Withdrawal by Subject|1|||
13297706|NCT01362608|26499431|FG001|Overall Study|Withdrawal by Subject|2|||
13297707|NCT01362608|26499430|FG000|Overall Study|Lack of Efficacy|0|||
13297708|NCT01362608|26499431|FG001|Overall Study|Lack of Efficacy|2|||
13297709|NCT01362608|26499430|FG000|Overall Study|Adverse Event|0|||
13297710|NCT01362608|26499431|FG001|Overall Study|Adverse Event|2|||
13297711|NCT01362530|26499451|FG000|Base Study (Cycle 1)|Adverse Event|2|||
13297712|NCT01362530|26499452|FG001|Base Study (Cycle 1)|Adverse Event|0|||
13297713|NCT01362530|26499451|FG000|Base Study (Cycle 1)|Physician Decision|0|||
13297714|NCT01362530|26499452|FG001|Base Study (Cycle 1)|Physician Decision|1|||
13297715|NCT01362530|26499451|FG000|Base Study (Cycle 1)|Protocol Violation|2|||
13297716|NCT01362530|26499452|FG001|Base Study (Cycle 1)|Protocol Violation|0|||
13297717|NCT01362530|26499451|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1|||
13297718|NCT01362530|26499452|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2|||
13297719|NCT01362530|26499451|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2|||
13297720|NCT01362530|26499452|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0|||
13297721|NCT01362530|26499451|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51|||
13297722|NCT01362530|26499452|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0|||
13297723|NCT01362530|26499451|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25|||
13297724|NCT01362530|26499452|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0|||
13297725|NCT01362530|26499451|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4|||
13297726|NCT01362530|26499452|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0|||
13297727|NCT01362530|26499451|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1|||
13297728|NCT01362530|26499452|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0|||
13297729|NCT01362530|26499451|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1|||
13297730|NCT01362530|26499452|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0|||
13297731|NCT01362530|26499451|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19|||
13297732|NCT01362530|26499452|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0|||
13297733|NCT01362530|26499451|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4|||
13297734|NCT01362530|26499452|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0|||
13297735|NCT01362530|26499451|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18|||
13297736|NCT01362530|26499452|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0|||
13297737|NCT01362517|26499462|FG000|Overall Study|Protocol Violation|1|||
13297738|NCT01362517|26499462|FG000|Overall Study|Lost to Follow-up|1|||
13297739|NCT01362491|26499520|FG000|Overall Study|Ineligible|1|||
13297740|NCT01362491|26499521|FG001|Overall Study|Ineligible|0|||
13297741|NCT01362491|26499522|FG002|Overall Study|Ineligible|0|||
13297742|NCT01362439|26499539|FG000|Overall Study|Adverse Event|1|||
13297743|NCT01362439|26499539|FG000|Overall Study|Lack of Efficacy|3|||
13297744|NCT01362439|26499539|FG000|Overall Study|Lost to Follow-up|2|||
13297745|NCT01362439|26499539|FG000|Overall Study|Study medication non-compliant|1|||
13297746|NCT01362439|26499539|FG000|Overall Study|Participant who withdrew consent|8|||
13297747|NCT01362348|26499558|FG000|Overall Study|Protocol-defined stopping criteria|9|||
13297748|NCT01362348|26499558|FG000|Overall Study|Study closed/terminated|5|||
13297749|NCT01362322|26499595|FG000|Overall Study|Withdrawal by Subject|3|||
13297750|NCT01362322|26499596|FG001|Overall Study|Withdrawal by Subject|1|||
13297751|NCT01362322|26499595|FG000|Overall Study|Lost to Follow-up|2|||
13297752|NCT01362322|26499596|FG001|Overall Study|Lost to Follow-up|6|||
13297753|NCT01362296|26499651|FG000|Randomized Phase (RP)|PD including Death due to PD|56|||
13297754|NCT01362296|26499652|FG001|Randomized Phase (RP)|PD including Death due to PD|28|||
13297755|NCT01362296|26499653|FG002|Randomized Phase (RP)|PD including Death due to PD|0|||
13297756|NCT01362296|26499654|FG003|Randomized Phase (RP)|PD including Death due to PD|0|||
13297757|NCT01362296|26499651|FG000|Randomized Phase (RP)|Physician Decision|1|||
13297758|NCT01362296|26499652|FG001|Randomized Phase (RP)|Physician Decision|9|||
13297759|NCT01362296|26499653|FG002|Randomized Phase (RP)|Physician Decision|0|||
13297760|NCT01362296|26499654|FG003|Randomized Phase (RP)|Physician Decision|0|||
13297761|NCT01362296|26499651|FG000|Randomized Phase (RP)|Withdrawal by Subject|2|||
13297762|NCT01362296|26499652|FG001|Randomized Phase (RP)|Withdrawal by Subject|1|||
13297763|NCT01362296|26499653|FG002|Randomized Phase (RP)|Withdrawal by Subject|0|||
13297764|NCT01362296|26499654|FG003|Randomized Phase (RP)|Withdrawal by Subject|0|||
13219457|NCT01831804|26277614|FG007|Overall Study|Withdrew Consent|2|||
13219458|NCT01831804|26277615|FG008|Overall Study|Withdrew Consent|0|||
13219459|NCT01831791|26277643|FG000|Overall Study|Withdrawal by Subject|10|||
13219460|NCT01831765|26277679|FG000|Overall Study|Lack of Efficacy|1|||
13219461|NCT01831765|26277680|FG001|Overall Study|Lack of Efficacy|0|||
13219462|NCT01831765|26277681|FG002|Overall Study|Lack of Efficacy|0|||
13219463|NCT01831765|26277679|FG000|Overall Study|Other, sponsor withdrew subject|0|||
13219464|NCT01831765|26277680|FG001|Overall Study|Other, sponsor withdrew subject|1|||
13219465|NCT01831765|26277681|FG002|Overall Study|Other, sponsor withdrew subject|0|||
13219466|NCT01831765|26277679|FG000|Overall Study|Pregnancy|1|||
13219467|NCT01831765|26277680|FG001|Overall Study|Pregnancy|1|||
13219468|NCT01831765|26277681|FG002|Overall Study|Pregnancy|2|||
13219469|NCT01831765|26277679|FG000|Overall Study|Death|0|||
13219470|NCT01831765|26277680|FG001|Overall Study|Death|1|||
13219471|NCT01831765|26277681|FG002|Overall Study|Death|1|||
13219472|NCT01831765|26277679|FG000|Overall Study|Other, site closed|1|||
13219473|NCT01831765|26277680|FG001|Overall Study|Other, site closed|1|||
13219474|NCT01831765|26277681|FG002|Overall Study|Other, site closed|0|||
13219475|NCT01831765|26277679|FG000|Overall Study|Adverse Event|5|||
13219476|NCT01831765|26277680|FG001|Overall Study|Adverse Event|3|||
13219477|NCT01831765|26277681|FG002|Overall Study|Adverse Event|3|||
13219478|NCT01831765|26277679|FG000|Overall Study|Withdrawal by Subject|22|||
13219479|NCT01831765|26277680|FG001|Overall Study|Withdrawal by Subject|7|||
13219480|NCT01831765|26277681|FG002|Overall Study|Withdrawal by Subject|17|||
13219481|NCT01831765|26277679|FG000|Overall Study|Withdrawal criteria|12|||
13219482|NCT01831765|26277680|FG001|Overall Study|Withdrawal criteria|10|||
13219483|NCT01831765|26277681|FG002|Overall Study|Withdrawal criteria|16|||
13219484|NCT01831765|26277679|FG000|Overall Study|Lost to Follow-up|2|||
13219485|NCT01831765|26277680|FG001|Overall Study|Lost to Follow-up|3|||
13219486|NCT01831765|26277681|FG002|Overall Study|Lost to Follow-up|3|||
13219487|NCT01831726|26277690|FG000|Overall Study|Adverse Event|16|||
13219488|NCT01831726|26277690|FG000|Overall Study|Death|7|||
13219489|NCT01831726|26277690|FG000|Overall Study|Disease Progression|49|||
13219490|NCT01831726|26277690|FG000|Overall Study|Physician Decision|1|||
13219491|NCT01831726|26277690|FG000|Overall Study|Subject/guardian decision|7|||
13219492|NCT01831596|26277696|FG000|Overall Study|Other|8|||
13219493|NCT01831544|26277715|FG000|Overall Study|Death|1|||
13219494|NCT01831544|26277715|FG000|Overall Study|Still on original MVAD device|2|||
13219495|NCT01831466|26277874|FG000|Overall Study|Protocol Violation|1|||
13219496|NCT01831466|26277875|FG001|Overall Study|Protocol Violation|1|||
13219497|NCT01831466|26277876|FG002|Overall Study|Protocol Violation|2|||
13219498|NCT01831466|26277877|FG003|Overall Study|Protocol Violation|0|||
13219499|NCT01831466|26277878|FG004|Overall Study|Protocol Violation|0|||
13219500|NCT01831466|26277879|FG005|Overall Study|Protocol Violation|1|||
13219501|NCT01831466|26277880|FG006|Overall Study|Protocol Violation|0|||
13219502|NCT01831466|26277881|FG007|Overall Study|Protocol Violation|0|||
13219503|NCT01831466|26277882|FG008|Overall Study|Protocol Violation|0|||
13219504|NCT01831466|26277883|FG009|Overall Study|Protocol Violation|0|||
13219505|NCT01831466|26277884|FG010|Overall Study|Protocol Violation|0|||
13219506|NCT01831466|26277885|FG011|Overall Study|Protocol Violation|0|||
13219507|NCT01831466|26277874|FG000|Overall Study|Other|2|||
13219508|NCT01831466|26277875|FG001|Overall Study|Other|3|||
13219509|NCT01831466|26277876|FG002|Overall Study|Other|2|||
13219510|NCT01831466|26277877|FG003|Overall Study|Other|2|||
13219511|NCT01831466|26277878|FG004|Overall Study|Other|2|||
13219512|NCT01831466|26277879|FG005|Overall Study|Other|1|||
13219513|NCT01831466|26277880|FG006|Overall Study|Other|0|||
13219514|NCT01831466|26277881|FG007|Overall Study|Other|0|||
13219515|NCT01831466|26277882|FG008|Overall Study|Other|0|||
13219516|NCT01831466|26277883|FG009|Overall Study|Other|0|||
13219517|NCT01831466|26277884|FG010|Overall Study|Other|0|||
13219518|NCT01831466|26277885|FG011|Overall Study|Other|0|||
13219519|NCT01831466|26277874|FG000|Overall Study|Non-compliance with study treatment|2|||
13219520|NCT01831466|26277875|FG001|Overall Study|Non-compliance with study treatment|1|||
13219521|NCT01831466|26277876|FG002|Overall Study|Non-compliance with study treatment|1|||
13219522|NCT01831466|26277877|FG003|Overall Study|Non-compliance with study treatment|0|||
13219523|NCT01831466|26277878|FG004|Overall Study|Non-compliance with study treatment|0|||
13219524|NCT01831466|26277879|FG005|Overall Study|Non-compliance with study treatment|1|||
13219525|NCT01831466|26277880|FG006|Overall Study|Non-compliance with study treatment|0|||
13219526|NCT01831466|26277881|FG007|Overall Study|Non-compliance with study treatment|0|||
13219527|NCT01831466|26277882|FG008|Overall Study|Non-compliance with study treatment|0|||
13219528|NCT01831466|26277883|FG009|Overall Study|Non-compliance with study treatment|0|||
13219529|NCT01831466|26277884|FG010|Overall Study|Non-compliance with study treatment|0|||
13219530|NCT01831466|26277885|FG011|Overall Study|Non-compliance with study treatment|0|||
13219531|NCT01831466|26277874|FG000|Overall Study|Death|0|||
13219532|NCT01831466|26277875|FG001|Overall Study|Death|1|||
13219533|NCT01831466|26277876|FG002|Overall Study|Death|0|||
13219534|NCT01831466|26277877|FG003|Overall Study|Death|0|||
13219535|NCT01831466|26277878|FG004|Overall Study|Death|0|||
13219536|NCT01831466|26277879|FG005|Overall Study|Death|0|||
13219537|NCT01831466|26277880|FG006|Overall Study|Death|0|||
13219538|NCT01831466|26277881|FG007|Overall Study|Death|0|||
13219539|NCT01831466|26277882|FG008|Overall Study|Death|0|||
13219540|NCT01831466|26277883|FG009|Overall Study|Death|0|||
13219541|NCT01831466|26277884|FG010|Overall Study|Death|0|||
13219542|NCT01831466|26277885|FG011|Overall Study|Death|0|||
13219543|NCT01831466|26277874|FG000|Overall Study|Withdrawal by Subject|6|||
13219544|NCT01831466|26277875|FG001|Overall Study|Withdrawal by Subject|3|||
13219545|NCT01831466|26277876|FG002|Overall Study|Withdrawal by Subject|3|||
13219546|NCT01831466|26277877|FG003|Overall Study|Withdrawal by Subject|3|||
13219547|NCT01831466|26277878|FG004|Overall Study|Withdrawal by Subject|3|||
13219548|NCT01831466|26277879|FG005|Overall Study|Withdrawal by Subject|5|||
13219549|NCT01831466|26277880|FG006|Overall Study|Withdrawal by Subject|0|||
13219550|NCT01831466|26277881|FG007|Overall Study|Withdrawal by Subject|0|||
13219551|NCT01831466|26277882|FG008|Overall Study|Withdrawal by Subject|0|||
13219552|NCT01831466|26277883|FG009|Overall Study|Withdrawal by Subject|1|||
13219553|NCT01831466|26277884|FG010|Overall Study|Withdrawal by Subject|0|||
13219554|NCT01831466|26277885|FG011|Overall Study|Withdrawal by Subject|1|||
13219555|NCT01831466|26277874|FG000|Overall Study|Lost to Follow-up|0|||
13219556|NCT01831466|26277875|FG001|Overall Study|Lost to Follow-up|1|||
13219557|NCT01831466|26277876|FG002|Overall Study|Lost to Follow-up|4|||
13219558|NCT01831466|26277877|FG003|Overall Study|Lost to Follow-up|2|||
13219559|NCT01831466|26277878|FG004|Overall Study|Lost to Follow-up|0|||
13219560|NCT01831466|26277879|FG005|Overall Study|Lost to Follow-up|3|||
13219561|NCT01831466|26277880|FG006|Overall Study|Lost to Follow-up|0|||
13219562|NCT01831466|26277881|FG007|Overall Study|Lost to Follow-up|0|||
13219563|NCT01831466|26277882|FG008|Overall Study|Lost to Follow-up|0|||
13219564|NCT01831466|26277883|FG009|Overall Study|Lost to Follow-up|1|||
13219565|NCT01831466|26277884|FG010|Overall Study|Lost to Follow-up|0|||
13219566|NCT01831466|26277885|FG011|Overall Study|Lost to Follow-up|1|||
13219567|NCT01831466|26277874|FG000|Overall Study|Lack of Efficacy|5|||
13219568|NCT01831466|26277875|FG001|Overall Study|Lack of Efficacy|8|||
13219569|NCT01831466|26277876|FG002|Overall Study|Lack of Efficacy|7|||
13219570|NCT01831466|26277877|FG003|Overall Study|Lack of Efficacy|6|||
13219571|NCT01831466|26277878|FG004|Overall Study|Lack of Efficacy|9|||
13219572|NCT01831466|26277879|FG005|Overall Study|Lack of Efficacy|8|||
13219573|NCT01831466|26277880|FG006|Overall Study|Lack of Efficacy|1|||
13219574|NCT01831466|26277881|FG007|Overall Study|Lack of Efficacy|1|||
13219575|NCT01831466|26277882|FG008|Overall Study|Lack of Efficacy|2|||
13219576|NCT01831466|26277883|FG009|Overall Study|Lack of Efficacy|2|||
13219577|NCT01831466|26277884|FG010|Overall Study|Lack of Efficacy|2|||
13219578|NCT01831466|26277885|FG011|Overall Study|Lack of Efficacy|0|||
13219579|NCT01831466|26277874|FG000|Overall Study|Adverse Event|0|||
13219580|NCT01831466|26277875|FG001|Overall Study|Adverse Event|0|||
13219581|NCT01831466|26277876|FG002|Overall Study|Adverse Event|4|||
13219582|NCT01831466|26277877|FG003|Overall Study|Adverse Event|6|||
13219583|NCT01831466|26277878|FG004|Overall Study|Adverse Event|3|||
13219584|NCT01831466|26277879|FG005|Overall Study|Adverse Event|7|||
13219585|NCT01831466|26277880|FG006|Overall Study|Adverse Event|0|||
13219586|NCT01831466|26277881|FG007|Overall Study|Adverse Event|1|||
13219587|NCT01831466|26277882|FG008|Overall Study|Adverse Event|1|||
13219588|NCT01831466|26277883|FG009|Overall Study|Adverse Event|1|||
13219589|NCT01831466|26277884|FG010|Overall Study|Adverse Event|0|||
13219590|NCT01831466|26277885|FG011|Overall Study|Adverse Event|2|||
13219591|NCT01831427|26277976|FG000|Overall Study|Adverse Event|0|||
13219592|NCT01831427|26277977|FG001|Overall Study|Adverse Event|1|||
13219593|NCT01831427|26277978|FG002|Overall Study|Adverse Event|0|||
13219594|NCT01831427|26277979|FG003|Overall Study|Adverse Event|0|||
13219595|NCT01831427|26277980|FG004|Overall Study|Adverse Event|0|||
13219596|NCT01831427|26277981|FG005|Overall Study|Adverse Event|1|||
13219597|NCT01831427|26277982|FG006|Overall Study|Adverse Event|0|||
13219598|NCT01831427|26277983|FG007|Overall Study|Adverse Event|1|||
13219599|NCT01831427|26277984|FG008|Overall Study|Adverse Event|0|||
13219600|NCT01831427|26277985|FG009|Overall Study|Adverse Event|0|||
13219601|NCT01831427|26277986|FG010|Overall Study|Adverse Event|2|||
13219602|NCT01831427|26277976|FG000|Overall Study|Investigator's Discretion|0|||
13219603|NCT01831427|26277977|FG001|Overall Study|Investigator's Discretion|0|||
13219604|NCT01831427|26277978|FG002|Overall Study|Investigator's Discretion|0|||
13219605|NCT01831427|26277979|FG003|Overall Study|Investigator's Discretion|1|||
13219606|NCT01831427|26277980|FG004|Overall Study|Investigator's Discretion|0|||
13219607|NCT01831427|26277981|FG005|Overall Study|Investigator's Discretion|0|||
13219608|NCT01831427|26277982|FG006|Overall Study|Investigator's Discretion|0|||
13219609|NCT01831427|26277983|FG007|Overall Study|Investigator's Discretion|0|||
13219610|NCT01831427|26277984|FG008|Overall Study|Investigator's Discretion|0|||
13219611|NCT01831427|26277985|FG009|Overall Study|Investigator's Discretion|0|||
13219612|NCT01831427|26277986|FG010|Overall Study|Investigator's Discretion|0|||
13219613|NCT01831427|26277976|FG000|Overall Study|Withdrew Consent|0|||
13219614|NCT01831427|26277977|FG001|Overall Study|Withdrew Consent|0|||
13219615|NCT01831427|26277978|FG002|Overall Study|Withdrew Consent|0|||
13219616|NCT01831427|26277979|FG003|Overall Study|Withdrew Consent|0|||
13219617|NCT01831427|26277980|FG004|Overall Study|Withdrew Consent|0|||
13219618|NCT01831427|26277981|FG005|Overall Study|Withdrew Consent|0|||
13219619|NCT01831427|26277982|FG006|Overall Study|Withdrew Consent|2|||
13219620|NCT01831427|26277983|FG007|Overall Study|Withdrew Consent|0|||
13219621|NCT01831427|26277984|FG008|Overall Study|Withdrew Consent|0|||
13219622|NCT01831427|26277985|FG009|Overall Study|Withdrew Consent|1|||
13219623|NCT01831427|26277986|FG010|Overall Study|Withdrew Consent|1|||
13382014|NCT00748189|26749691|FG000|Overall Study|Physician Decision|16|||
13219624|NCT01831258|26278015|FG000|Overall Study|Withdrawal by Subject|2|||
13219625|NCT01831258|26278016|FG001|Overall Study|Withdrawal by Subject|1|||
13219626|NCT01831258|26278015|FG000|Overall Study|Lost to Follow-up|3|||
13219627|NCT01831258|26278016|FG001|Overall Study|Lost to Follow-up|2|||
13219628|NCT01831089|26278075|FG000|Cohort I: Dose Level 1|Progressive disease|3|||
13219629|NCT01831089|26278076|FG001|Cohort I: Dose Level 1|Progressive disease|0|||
13219630|NCT01831089|26278077|FG002|Cohort I: Dose Level 1|Progressive disease|0|||
13219631|NCT01831089|26278078|FG003|Cohort I: Dose Level 1|Progressive disease|0|||
13219632|NCT01831089|26278079|FG004|Cohort I: Dose Level 1|Progressive disease|0|||
13219633|NCT01831089|26278080|FG005|Cohort I: Dose Level 1|Progressive disease|0|||
13219634|NCT01831089|26278075|FG000|Cohort II: Dose Level 2|Progressive disease|0|||
13219635|NCT01831089|26278076|FG001|Cohort II: Dose Level 2|Progressive disease|2|||
13219636|NCT01831089|26278077|FG002|Cohort II: Dose Level 2|Progressive disease|0|||
13219637|NCT01831089|26278078|FG003|Cohort II: Dose Level 2|Progressive disease|0|||
13219638|NCT01831089|26278079|FG004|Cohort II: Dose Level 2|Progressive disease|0|||
13219639|NCT01831089|26278080|FG005|Cohort II: Dose Level 2|Progressive disease|0|||
13219640|NCT01831089|26278075|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0|||
13219641|NCT01831089|26278076|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1|||
13219642|NCT01831089|26278077|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0|||
13219643|NCT01831089|26278078|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0|||
13219644|NCT01831089|26278079|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0|||
13219645|NCT01831089|26278080|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0|||
13219646|NCT01831089|26278075|FG000|Cohort III: Dose Level 3|Progressive disease|0|||
13219647|NCT01831089|26278076|FG001|Cohort III: Dose Level 3|Progressive disease|0|||
13219648|NCT01831089|26278077|FG002|Cohort III: Dose Level 3|Progressive disease|3|||
13219649|NCT01831089|26278078|FG003|Cohort III: Dose Level 3|Progressive disease|0|||
13219650|NCT01831089|26278079|FG004|Cohort III: Dose Level 3|Progressive disease|0|||
13219651|NCT01831089|26278080|FG005|Cohort III: Dose Level 3|Progressive disease|0|||
13219652|NCT01831089|26278075|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
13219653|NCT01831089|26278076|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
13219654|NCT01831089|26278077|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1|||
13219655|NCT01831089|26278078|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
13219656|NCT01831089|26278079|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
13219657|NCT01831089|26278080|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
13219658|NCT01831089|26278075|FG000|Cohort III: Dose Level 3|Adverse Event|0|||
13219659|NCT01831089|26278076|FG001|Cohort III: Dose Level 3|Adverse Event|0|||
13219660|NCT01831089|26278077|FG002|Cohort III: Dose Level 3|Adverse Event|1|||
13219661|NCT01831089|26278078|FG003|Cohort III: Dose Level 3|Adverse Event|0|||
13219662|NCT01831089|26278079|FG004|Cohort III: Dose Level 3|Adverse Event|0|||
13219663|NCT01831089|26278080|FG005|Cohort III: Dose Level 3|Adverse Event|0|||
13219664|NCT01831089|26278075|FG000|Cohort III: Dose Level 3|Global end of study|0|||
13219665|NCT01831089|26278076|FG001|Cohort III: Dose Level 3|Global end of study|0|||
13219666|NCT01831089|26278077|FG002|Cohort III: Dose Level 3|Global end of study|1|||
13219667|NCT01831089|26278078|FG003|Cohort III: Dose Level 3|Global end of study|0|||
13219668|NCT01831089|26278079|FG004|Cohort III: Dose Level 3|Global end of study|0|||
13219669|NCT01831089|26278080|FG005|Cohort III: Dose Level 3|Global end of study|0|||
13219670|NCT01831089|26278075|FG000|Cohort IV: Dose Level 4|Progressive disease|0|||
13219671|NCT01831089|26278076|FG001|Cohort IV: Dose Level 4|Progressive disease|0|||
13219672|NCT01831089|26278077|FG002|Cohort IV: Dose Level 4|Progressive disease|0|||
13219673|NCT01831089|26278078|FG003|Cohort IV: Dose Level 4|Progressive disease|6|||
13219674|NCT01831089|26278079|FG004|Cohort IV: Dose Level 4|Progressive disease|0|||
13219675|NCT01831089|26278080|FG005|Cohort IV: Dose Level 4|Progressive disease|0|||
13219676|NCT01831089|26278075|FG000|Cohort V: Dose Level 5|Progressive disease|0|||
13219677|NCT01831089|26278076|FG001|Cohort V: Dose Level 5|Progressive disease|0|||
13219678|NCT01831089|26278077|FG002|Cohort V: Dose Level 5|Progressive disease|0|||
13219679|NCT01831089|26278078|FG003|Cohort V: Dose Level 5|Progressive disease|0|||
13219680|NCT01831089|26278079|FG004|Cohort V: Dose Level 5|Progressive disease|30|||
13219681|NCT01831089|26278080|FG005|Cohort V: Dose Level 5|Progressive disease|0|||
13219682|NCT01831089|26278075|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
13219683|NCT01831089|26278076|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
13219684|NCT01831089|26278077|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
13219685|NCT01831089|26278078|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
13219686|NCT01831089|26278079|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3|||
13219687|NCT01831089|26278080|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
13219688|NCT01831089|26278075|FG000|Cohort V: Dose Level 5|Death|0|||
13219689|NCT01831089|26278076|FG001|Cohort V: Dose Level 5|Death|0|||
13219690|NCT01831089|26278077|FG002|Cohort V: Dose Level 5|Death|0|||
13219691|NCT01831089|26278078|FG003|Cohort V: Dose Level 5|Death|0|||
13219692|NCT01831089|26278079|FG004|Cohort V: Dose Level 5|Death|1|||
13219693|NCT01831089|26278080|FG005|Cohort V: Dose Level 5|Death|0|||
13219694|NCT01831089|26278075|FG000|Cohort V: Dose Level 5|Global end of study|0|||
13219695|NCT01831089|26278076|FG001|Cohort V: Dose Level 5|Global end of study|0|||
13219696|NCT01831089|26278077|FG002|Cohort V: Dose Level 5|Global end of study|0|||
13219697|NCT01831089|26278078|FG003|Cohort V: Dose Level 5|Global end of study|0|||
13219698|NCT01831089|26278079|FG004|Cohort V: Dose Level 5|Global end of study|2|||
13219699|NCT01831089|26278080|FG005|Cohort V: Dose Level 5|Global end of study|0|||
13219700|NCT01831089|26278075|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0|||
13219701|NCT01831089|26278076|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0|||
13219702|NCT01831089|26278077|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0|||
13219703|NCT01831089|26278078|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0|||
13219704|NCT01831089|26278079|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1|||
13219705|NCT01831089|26278080|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0|||
13219706|NCT01831089|26278075|FG000|Cohort B: Arm B|Progressive disease|0|||
13219707|NCT01831089|26278076|FG001|Cohort B: Arm B|Progressive disease|0|||
13219708|NCT01831089|26278077|FG002|Cohort B: Arm B|Progressive disease|0|||
13219709|NCT01831089|26278078|FG003|Cohort B: Arm B|Progressive disease|0|||
13219710|NCT01831089|26278079|FG004|Cohort B: Arm B|Progressive disease|0|||
13219711|NCT01831089|26278080|FG005|Cohort B: Arm B|Progressive disease|8|||
13219712|NCT01831089|26278075|FG000|Cohort B: Arm B|Physician Decision|0|||
13219713|NCT01831089|26278076|FG001|Cohort B: Arm B|Physician Decision|0|||
13219714|NCT01831089|26278077|FG002|Cohort B: Arm B|Physician Decision|0|||
13219715|NCT01831089|26278078|FG003|Cohort B: Arm B|Physician Decision|0|||
13219716|NCT01831089|26278079|FG004|Cohort B: Arm B|Physician Decision|0|||
13219717|NCT01831089|26278080|FG005|Cohort B: Arm B|Physician Decision|2|||
13219718|NCT01831089|26278075|FG000|Cohort B: Arm B|Never treated|0|||
13219719|NCT01831089|26278076|FG001|Cohort B: Arm B|Never treated|0|||
13219720|NCT01831089|26278077|FG002|Cohort B: Arm B|Never treated|0|||
13219721|NCT01831089|26278078|FG003|Cohort B: Arm B|Never treated|0|||
13219722|NCT01831089|26278079|FG004|Cohort B: Arm B|Never treated|0|||
13219723|NCT01831089|26278080|FG005|Cohort B: Arm B|Never treated|2|||
13219724|NCT01831089|26278075|FG000|Cohort B: Arm B|Adverse Event|0|||
13219725|NCT01831089|26278076|FG001|Cohort B: Arm B|Adverse Event|0|||
13219726|NCT01831089|26278077|FG002|Cohort B: Arm B|Adverse Event|0|||
13219727|NCT01831089|26278078|FG003|Cohort B: Arm B|Adverse Event|0|||
13219728|NCT01831089|26278079|FG004|Cohort B: Arm B|Adverse Event|0|||
13219729|NCT01831089|26278080|FG005|Cohort B: Arm B|Adverse Event|1|||
13219730|NCT01831089|26278075|FG000|Cohort B: Arm B|Global end of study|0|||
13219731|NCT01831089|26278076|FG001|Cohort B: Arm B|Global end of study|0|||
13219732|NCT01831089|26278077|FG002|Cohort B: Arm B|Global end of study|0|||
13219733|NCT01831089|26278078|FG003|Cohort B: Arm B|Global end of study|0|||
13219734|NCT01831089|26278079|FG004|Cohort B: Arm B|Global end of study|0|||
13219735|NCT01831089|26278080|FG005|Cohort B: Arm B|Global end of study|1|||
13219736|NCT01830972|26278111|FG000|Part II|Withdrawal by Subject|2|||
13219737|NCT01830972|26278112|FG001|Part II|Withdrawal by Subject|2|||
13219738|NCT01830972|26278111|FG000|Part III|Withdrawal by Subject|1|||
13219739|NCT01830972|26278112|FG001|Part III|Withdrawal by Subject|0|||
13219740|NCT01830972|26278111|FG000|Part III|Noncompliance|1|||
13219741|NCT01830972|26278112|FG001|Part III|Noncompliance|0|||
13219742|NCT01830972|26278111|FG000|Part IV|Withdrawal by Subject|2|||
13219743|NCT01830972|26278112|FG001|Part IV|Withdrawal by Subject|1|||
13219744|NCT01830972|26278111|FG000|Part IV|Non-Compliance|1|||
13219745|NCT01830972|26278112|FG001|Part IV|Non-Compliance|0|||
13219746|NCT01830920|26278165|FG000|Overall Study|Adverse Event|1|||
13219747|NCT01830920|26278166|FG001|Overall Study|Adverse Event|0|||
13219748|NCT01830920|26278167|FG002|Overall Study|Adverse Event|1|||
13219749|NCT01830920|26278168|FG003|Overall Study|Adverse Event|0|||
13219750|NCT01830920|26278169|FG004|Overall Study|Adverse Event|0|||
13219751|NCT01830920|26278165|FG000|Overall Study|Withdrawal by Subject|2|||
13219752|NCT01830920|26278166|FG001|Overall Study|Withdrawal by Subject|2|||
13219753|NCT01830920|26278167|FG002|Overall Study|Withdrawal by Subject|1|||
13219754|NCT01830920|26278168|FG003|Overall Study|Withdrawal by Subject|7|||
13219755|NCT01830920|26278169|FG004|Overall Study|Withdrawal by Subject|1|||
13219756|NCT01830920|26278165|FG000|Overall Study|Death|3|||
13219757|NCT01830920|26278166|FG001|Overall Study|Death|3|||
13219758|NCT01830920|26278167|FG002|Overall Study|Death|5|||
13219759|NCT01830920|26278168|FG003|Overall Study|Death|4|||
13219760|NCT01830920|26278169|FG004|Overall Study|Death|4|||
13219761|NCT01830920|26278165|FG000|Overall Study|Other|15|||
13297765|NCT01362296|26499651|FG000|Randomized Phase (RP)|Adverse Event|20|||
13297766|NCT01362296|26499652|FG001|Randomized Phase (RP)|Adverse Event|4|||
13297767|NCT01362296|26499653|FG002|Randomized Phase (RP)|Adverse Event|0|||
13297768|NCT01362296|26499654|FG003|Randomized Phase (RP)|Adverse Event|0|||
13297769|NCT01362296|26499651|FG000|Randomized Phase (RP)|Study Closed/Terminated|8|||
13297770|NCT01362296|26499652|FG001|Randomized Phase (RP)|Study Closed/Terminated|1|||
13297771|NCT01362296|26499653|FG002|Randomized Phase (RP)|Study Closed/Terminated|0|||
13297772|NCT01362296|26499654|FG003|Randomized Phase (RP)|Study Closed/Terminated|0|||
13219762|NCT01830920|26278166|FG001|Overall Study|Other|1|||
13219763|NCT01830920|26278167|FG002|Overall Study|Other|1|||
13219764|NCT01830920|26278168|FG003|Overall Study|Other|5|||
13219765|NCT01830920|26278169|FG004|Overall Study|Other|3|||
13219766|NCT01830881|26278220|FG000|Overall Study|Changed decision to have an abortion|0|||
13219767|NCT01830881|26278221|FG001|Overall Study|Changed decision to have an abortion|1|||
13219768|NCT01830855|26278338|FG000|Overall Study|Other|7|||
13219769|NCT01830855|26278339|FG001|Overall Study|Other|1|||
13219770|NCT01830855|26278340|FG002|Overall Study|Other|4|||
13219771|NCT01830855|26278341|FG003|Overall Study|Other|4|||
13219772|NCT01830855|26278338|FG000|Overall Study|Medication error without associated AE|1|||
13219773|NCT01830855|26278339|FG001|Overall Study|Medication error without associated AE|0|||
13219774|NCT01830855|26278340|FG002|Overall Study|Medication error without associated AE|0|||
13219775|NCT01830855|26278341|FG003|Overall Study|Medication error without associated AE|1|||
13219776|NCT01830855|26278338|FG000|Overall Study|Pregnancy|3|||
13219777|NCT01830855|26278339|FG001|Overall Study|Pregnancy|1|||
13219778|NCT01830855|26278340|FG002|Overall Study|Pregnancy|2|||
13219779|NCT01830855|26278341|FG003|Overall Study|Pregnancy|1|||
13219780|NCT01830855|26278338|FG000|Overall Study|No longer meets eligibility criteria|11|||
13219781|NCT01830855|26278339|FG001|Overall Study|No longer meets eligibility criteria|2|||
13219782|NCT01830855|26278340|FG002|Overall Study|No longer meets eligibility criteria|3|||
13219783|NCT01830855|26278341|FG003|Overall Study|No longer meets eligibility criteria|5|||
13219784|NCT01830855|26278338|FG000|Overall Study|Adverse Event|11|||
13219785|NCT01830855|26278339|FG001|Overall Study|Adverse Event|5|||
13219786|NCT01830855|26278340|FG002|Overall Study|Adverse Event|6|||
13219787|NCT01830855|26278341|FG003|Overall Study|Adverse Event|3|||
13219788|NCT01830855|26278338|FG000|Overall Study|Protocol deviation|10|||
13219789|NCT01830855|26278339|FG001|Overall Study|Protocol deviation|5|||
13219790|NCT01830855|26278340|FG002|Overall Study|Protocol deviation|6|||
13219791|NCT01830855|26278341|FG003|Overall Study|Protocol deviation|6|||
13219792|NCT01830855|26278338|FG000|Overall Study|Withdrawal by Subject|33|||
13219793|NCT01830855|26278339|FG001|Overall Study|Withdrawal by Subject|14|||
13219794|NCT01830855|26278340|FG002|Overall Study|Withdrawal by Subject|10|||
13297773|NCT01362296|26499651|FG000|Crossover Phase|PD including Death due to PD|0|||
13297774|NCT01362296|26499652|FG001|Crossover Phase|PD including Death due to PD|0|||
13297775|NCT01362296|26499653|FG002|Crossover Phase|PD including Death due to PD|16|||
13297776|NCT01362296|26499654|FG003|Crossover Phase|PD including Death due to PD|1|||
13297777|NCT01362296|26499651|FG000|Crossover Phase|Withdrawal by Subject|0|||
13297778|NCT01362296|26499652|FG001|Crossover Phase|Withdrawal by Subject|0|||
13297779|NCT01362296|26499653|FG002|Crossover Phase|Withdrawal by Subject|2|||
13297780|NCT01362296|26499654|FG003|Crossover Phase|Withdrawal by Subject|1|||
13297781|NCT01362296|26499651|FG000|Crossover Phase|Adverse Event|0|||
13297782|NCT01362296|26499652|FG001|Crossover Phase|Adverse Event|0|||
13297783|NCT01362296|26499653|FG002|Crossover Phase|Adverse Event|4|||
13297784|NCT01362296|26499654|FG003|Crossover Phase|Adverse Event|0|||
13297785|NCT01362296|26499651|FG000|Crossover Phase|Study Closed/Terminated|0|||
13297786|NCT01362296|26499652|FG001|Crossover Phase|Study Closed/Terminated|0|||
13297787|NCT01362296|26499653|FG002|Crossover Phase|Study Closed/Terminated|1|||
13297788|NCT01362296|26499654|FG003|Crossover Phase|Study Closed/Terminated|0|||
13297789|NCT01362270|26499671|FG000|Overall Study|Withdrawal by Subject|1|||
13297790|NCT01362270|26499672|FG001|Overall Study|Withdrawal by Subject|0|||
13297791|NCT01362270|26499671|FG000|Overall Study|Met exclusion criteria after 1st session|0|||
13297792|NCT01362270|26499672|FG001|Overall Study|Met exclusion criteria after 1st session|1|||
13297793|NCT01362270|26499671|FG000|Overall Study|Met excl. criteria before 1st session|1|||
13297794|NCT01362270|26499672|FG001|Overall Study|Met excl. criteria before 1st session|1|||
13297795|NCT01362244|26499750|FG000|Overall Study|Adverse Event|3|||
13297796|NCT01362244|26499751|FG001|Overall Study|Adverse Event|5|||
13297797|NCT01362244|26499750|FG000|Overall Study|Lack of Efficacy|5|||
13297798|NCT01362244|26499751|FG001|Overall Study|Lack of Efficacy|11|||
13297799|NCT01362244|26499750|FG000|Overall Study|Lost to Follow-up|0|||
13297800|NCT01362244|26499751|FG001|Overall Study|Lost to Follow-up|2|||
13297801|NCT01362244|26499750|FG000|Overall Study|Protocol Violation|5|||
13297802|NCT01362244|26499751|FG001|Overall Study|Protocol Violation|1|||
13297803|NCT01362244|26499750|FG000|Overall Study|Withdrawal by Subject|2|||
13297804|NCT01362244|26499751|FG001|Overall Study|Withdrawal by Subject|1|||
13297805|NCT01362244|26499750|FG000|Overall Study|Did not Meet Continuation Criteria|17|||
13297806|NCT01362244|26499751|FG001|Overall Study|Did not Meet Continuation Criteria|11|||
13297807|NCT01362244|26499750|FG000|Overall Study|Protocol Defined Stopping Criteria|0|||
13297808|NCT01362244|26499751|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
13297809|NCT01362140|26499780|FG000|Overall Study|Noncompliance|1|||
13297810|NCT01362140|26499781|FG001|Overall Study|Noncompliance|0|||
13297811|NCT01362140|26499780|FG000|Overall Study|Adverse Event|2|||
13219795|NCT01830855|26278341|FG003|Overall Study|Withdrawal by Subject|12|||
13219796|NCT01830855|26278338|FG000|Overall Study|No longer willing to participate|32|||
13219797|NCT01830855|26278339|FG001|Overall Study|No longer willing to participate|13|||
13219798|NCT01830855|26278340|FG002|Overall Study|No longer willing to participate|12|||
13219799|NCT01830855|26278341|FG003|Overall Study|No longer willing to participate|17|||
13297812|NCT01362140|26499781|FG001|Overall Study|Adverse Event|2|||
13297813|NCT01362140|26499780|FG000|Overall Study|Withdrawal by Subject|3|||
13297814|NCT01362140|26499781|FG001|Overall Study|Withdrawal by Subject|3|||
13297815|NCT01362140|26499780|FG000|Overall Study|Administrative Decision|0|||
13297816|NCT01362140|26499781|FG001|Overall Study|Administrative Decision|1|||
13297817|NCT01362140|26499780|FG000|Overall Study|Death|2|||
13297818|NCT01362140|26499781|FG001|Overall Study|Death|1|||
13297819|NCT01362140|26499780|FG000|Overall Study|Other|1|||
13297820|NCT01362140|26499781|FG001|Overall Study|Other|1|||
13297821|NCT01362140|26499780|FG000|Overall Study|Protocol-specified Criteria|1|||
13297822|NCT01362140|26499781|FG001|Overall Study|Protocol-specified Criteria|2|||
13297823|NCT01362140|26499780|FG000|Overall Study|Discontinued Without Receiving Treatment|0|||
13297824|NCT01362140|26499781|FG001|Overall Study|Discontinued Without Receiving Treatment|1|||
13297825|NCT01362062|26499805|FG000|Overall Study|Adverse Event|1|||
13297826|NCT01362062|26499806|FG001|Overall Study|Adverse Event|0|||
13297827|NCT01362062|26499805|FG000|Overall Study|Lost to Follow-up|11|||
13297828|NCT01362062|26499806|FG001|Overall Study|Lost to Follow-up|0|||
13297829|NCT01362062|26499805|FG000|Overall Study|Withdrawal by Subject|2|||
13297830|NCT01362062|26499806|FG001|Overall Study|Withdrawal by Subject|0|||
13297831|NCT01362062|26499805|FG000|Overall Study|Non-compliant participant|2|||
13297832|NCT01362062|26499806|FG001|Overall Study|Non-compliant participant|0|||
13297833|NCT01362062|26499805|FG000|Overall Study|Detected with Spondylo-arthritis|1|||
13297834|NCT01362062|26499806|FG001|Overall Study|Detected with Spondylo-arthritis|0|||
13297835|NCT01362062|26499805|FG000|Overall Study|Had significant improvement|9|||
13297836|NCT01362062|26499806|FG001|Overall Study|Had significant improvement|0|||
13297837|NCT01362049|26499857|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
13297838|NCT01362049|26499858|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
13297839|NCT01362049|26499859|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2|||
13297840|NCT01362049|26499860|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1|||
13297841|NCT01362049|26499857|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5|||
13297842|NCT01362049|26499858|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
13297843|NCT01362049|26499859|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2|||
13297844|NCT01362049|26499860|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
13297845|NCT01361919|26499884|FG000|Overall Study|technical issues|10|||
13297846|NCT01361919|26499885|FG001|Overall Study|technical issues|12|||
13297847|NCT01361919|26499886|FG002|Overall Study|technical issues|10|||
13297848|NCT01361607|26499919|FG000|Overall Study|Adverse Event|38|||
13297849|NCT01361607|26499920|FG001|Overall Study|Adverse Event|29|||
13297850|NCT01361607|26499919|FG000|Overall Study|Withdrawal by Subject|19|||
13297851|NCT01361607|26499920|FG001|Overall Study|Withdrawal by Subject|8|||
13297852|NCT01361607|26499919|FG000|Overall Study|Withdrawal by Investigator|5|||
13297853|NCT01361607|26499920|FG001|Overall Study|Withdrawal by Investigator|3|||
13297854|NCT01361607|26499919|FG000|Overall Study|Lost to Follow-up|1|||
13297855|NCT01361607|26499920|FG001|Overall Study|Lost to Follow-up|0|||
13297856|NCT01361607|26499919|FG000|Overall Study|Met Withdrawal Criteria|1|||
13297857|NCT01361607|26499920|FG001|Overall Study|Met Withdrawal Criteria|1|||
13297858|NCT01361594|26499935|FG000|Overall Study|Withdrawal by Subject|1|||
13297859|NCT01361594|26499936|FG001|Overall Study|Withdrawal by Subject|2|||
13297860|NCT01361568|26499985|FG000|Overall Study|Adverse Event|0|||
13297861|NCT01361568|26499986|FG001|Overall Study|Adverse Event|0|||
13297862|NCT01361568|26499987|FG002|Overall Study|Adverse Event|0|||
13297863|NCT01361568|26499988|FG003|Overall Study|Adverse Event|0|||
13297864|NCT01361568|26499989|FG004|Overall Study|Adverse Event|1|||
13297865|NCT01361568|26499990|FG005|Overall Study|Adverse Event|0|||
13297866|NCT01361568|26499985|FG000|Overall Study|Physician Decision|0|||
13297867|NCT01361568|26499986|FG001|Overall Study|Physician Decision|0|||
13297868|NCT01361568|26499987|FG002|Overall Study|Physician Decision|0|||
13297869|NCT01361568|26499988|FG003|Overall Study|Physician Decision|0|||
13297870|NCT01361568|26499989|FG004|Overall Study|Physician Decision|0|||
13297871|NCT01361568|26499990|FG005|Overall Study|Physician Decision|1|||
13297872|NCT01361568|26499985|FG000|Overall Study|Withdrawal by Subject|2|||
13297873|NCT01361568|26499986|FG001|Overall Study|Withdrawal by Subject|1|||
13297874|NCT01361568|26499987|FG002|Overall Study|Withdrawal by Subject|0|||
13297875|NCT01361568|26499988|FG003|Overall Study|Withdrawal by Subject|0|||
13297876|NCT01361568|26499989|FG004|Overall Study|Withdrawal by Subject|0|||
13297877|NCT01361568|26499990|FG005|Overall Study|Withdrawal by Subject|1|||
13297878|NCT01361464|26499999|FG000|Overall Study|Death|1|||
13297879|NCT01361464|26499999|FG000|Overall Study|Withdrawal by Subject|2|||
13297880|NCT01361308|26500046|FG000|Overall Study|Withdrawal by Subject|9|||
13297881|NCT01361308|26500047|FG001|Overall Study|Withdrawal by Subject|13|||
13297882|NCT01361308|26500046|FG000|Overall Study|Physician Decision|3|||
13297883|NCT01361308|26500047|FG001|Overall Study|Physician Decision|3|||
13297884|NCT01361308|26500046|FG000|Overall Study|Lack of Efficacy|2|||
13297885|NCT01361308|26500047|FG001|Overall Study|Lack of Efficacy|0|||
13297886|NCT01361308|26500046|FG000|Overall Study|Protocol Violation|1|||
13297887|NCT01361308|26500047|FG001|Overall Study|Protocol Violation|0|||
13297888|NCT01361308|26500046|FG000|Overall Study|Lost to Follow-up|5|||
13297889|NCT01361308|26500047|FG001|Overall Study|Lost to Follow-up|4|||
13297890|NCT01361308|26500046|FG000|Overall Study|Adverse Event|8|||
13297891|NCT01361308|26500047|FG001|Overall Study|Adverse Event|4|||
13297892|NCT01361308|26500046|FG000|Overall Study|Eligibility Criteria Not Met|2|||
13297893|NCT01361308|26500047|FG001|Overall Study|Eligibility Criteria Not Met|3|||
13297894|NCT01361308|26500046|FG000|Overall Study|Failed C-SSRS|5|||
13297895|NCT01361308|26500047|FG001|Overall Study|Failed C-SSRS|2|||
13297896|NCT01361308|26500046|FG000|Overall Study|Other|0|||
13297897|NCT01361308|26500047|FG001|Overall Study|Other|1|||
13297898|NCT01361178|26500060|FG000|Overall Study|Death|13|||
13382015|NCT00748189|26749692|FG001|Overall Study|Physician Decision|5|||
13382016|NCT00748189|26749691|FG000|Overall Study|Lost to Follow-up|8|||
13382017|NCT00748189|26749692|FG001|Overall Study|Lost to Follow-up|15|||
13382018|NCT00748189|26749691|FG000|Overall Study|Study terminated by Sponsor|70|||
13382019|NCT00748189|26749692|FG001|Overall Study|Study terminated by Sponsor|79|||
13382020|NCT00748098|26749755|FG000|First Treatment Intervention Period|Adverse Event|1|||
13382021|NCT00748098|26749756|FG001|First Treatment Intervention Period|Adverse Event|1|||
13382022|NCT00748098|26749755|FG000|First Treatment Intervention Period|Protocol Violation|1|||
13382023|NCT00748098|26749756|FG001|First Treatment Intervention Period|Protocol Violation|0|||
13382024|NCT00748098|26749755|FG000|First Treatment Intervention Period|Lost to Follow-up|1|||
13382025|NCT00748098|26749756|FG001|First Treatment Intervention Period|Lost to Follow-up|0|||
13382026|NCT00748098|26749755|FG000|First Treatment Intervention Period|Withdrawal by Subject|2|||
13382027|NCT00748098|26749756|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
13382028|NCT00748098|26749755|FG000|First Taper Period|Protocol Violation|1|||
13382029|NCT00748098|26749756|FG001|First Taper Period|Protocol Violation|0|||
13382030|NCT00748098|26749755|FG000|First Taper Period|Withdrawal by Subject|2|||
13382031|NCT00748098|26749756|FG001|First Taper Period|Withdrawal by Subject|0|||
13382032|NCT00748098|26749755|FG000|First Taper Period|Protocol Stopping Criteria Met|0|||
13382033|NCT00748098|26749756|FG001|First Taper Period|Protocol Stopping Criteria Met|1|||
13382034|NCT00748098|26749755|FG000|1-Week Washout Period|Adverse Event|0|||
13382035|NCT00748098|26749756|FG001|1-Week Washout Period|Adverse Event|1|||
13382036|NCT00748098|26749755|FG000|1-Week Washout Period|Withdrawal by Subject|2|||
13382037|NCT00748098|26749756|FG001|1-Week Washout Period|Withdrawal by Subject|0|||
13382038|NCT00748098|26749755|FG000|Second Treatment Intervention Period|Adverse Event|4|||
13382039|NCT00748098|26749756|FG001|Second Treatment Intervention Period|Adverse Event|1|||
13382040|NCT00748098|26749755|FG000|Second Treatment Intervention Period|Lost to Follow-up|1|||
13382041|NCT00748098|26749756|FG001|Second Treatment Intervention Period|Lost to Follow-up|1|||
13382042|NCT00748098|26749755|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1|||
13382043|NCT00748098|26749756|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1|||
13382044|NCT00748033|26749784|FG000|Overall Study|Adverse Event|0|||
13382045|NCT00748033|26749785|FG001|Overall Study|Adverse Event|1|||
13382046|NCT00747812|26749800|FG000|Overall Study|Research Site Staff Relocation|5|||
13382047|NCT00747812|26749801|FG001|Overall Study|Research Site Staff Relocation|3|||
13382048|NCT00747643|26749820|FG000|Overall Study|Withdrawal by Subject|36|||
13382049|NCT00747643|26749821|FG001|Overall Study|Withdrawal by Subject|27|||
13382050|NCT00747617|26749836|FG000|Overall Study|Lost to Follow-up|3|||
13382051|NCT00747617|26749837|FG001|Overall Study|Lost to Follow-up|1|||
13382052|NCT00747565|26749852|FG000|Overall Study|Withdrawal by Subject|10|||
13382053|NCT00747565|26749853|FG001|Overall Study|Withdrawal by Subject|6|||
13382054|NCT00747565|26749852|FG000|Overall Study|Lost to Follow-up|4|||
13382055|NCT00747565|26749853|FG001|Overall Study|Lost to Follow-up|1|||
13382056|NCT00747474|26749892|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
13382057|NCT00747474|26749893|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
13382058|NCT00747474|26749894|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
13382059|NCT00747474|26749895|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
13382060|NCT00747474|26749896|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
13382061|NCT00747474|26749897|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
13382062|NCT00747474|26749898|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
13382063|NCT00747474|26749899|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1|||
13382064|NCT00747474|26749900|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
13382065|NCT00747474|26749901|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
13382066|NCT00747474|26749902|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
13382067|NCT00747474|26749903|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
13382068|NCT00747461|26749910|FG000|Overall Study|study terminated by sponsor|5|||
13382069|NCT00747435|26749920|FG000|Overall Study|Lost to Follow-up|2|||
13382070|NCT00747435|26749920|FG000|Overall Study|Withdrawal by Subject|3|||
13382071|NCT00747435|26749920|FG000|Overall Study|Still undergoing follow up|1|||
13382072|NCT00747344|26749941|FG000|Controlled Period|Adverse Event|3|||
13382073|NCT00747344|26749942|FG001|Controlled Period|Adverse Event|0|||
13382074|NCT00747344|26749943|FG002|Controlled Period|Adverse Event|0|||
13382075|NCT00747344|26749944|FG003|Controlled Period|Adverse Event|0|||
13382076|NCT00747344|26749941|FG000|Controlled Period|Lack of Efficacy|2|||
13382077|NCT00747344|26749942|FG001|Controlled Period|Lack of Efficacy|1|||
13297899|NCT01361178|26500061|FG001|Overall Study|Death|0|||
13297900|NCT01361126|26500083|FG000|Overall Study|Sponsor decision|0|||
13297901|NCT01361126|26500084|FG001|Overall Study|Sponsor decision|2|||
13297902|NCT01361009|26500093|FG000|Overall Study|Protocol Violation|116|||
13297903|NCT01360996|26500122|FG000|Overall Study|Withdrawal by Subject|4|||
13297904|NCT01360996|26500123|FG001|Overall Study|Withdrawal by Subject|3|||
13297905|NCT01360996|26500124|FG002|Overall Study|Withdrawal by Subject|2|||
13297906|NCT01360996|26500122|FG000|Overall Study|Noncompliant|2|||
13297907|NCT01360996|26500123|FG001|Overall Study|Noncompliant|0|||
13297908|NCT01360996|26500124|FG002|Overall Study|Noncompliant|0|||
13297909|NCT01360866|26500163|FG000|Overall Study|Lost to Follow-up|11|||
13297910|NCT01360866|26500164|FG001|Overall Study|Lost to Follow-up|28|||
13297911|NCT01360866|26500165|FG002|Overall Study|Lost to Follow-up|41|||
13297912|NCT01360866|26500166|FG003|Overall Study|Lost to Follow-up|0|||
13297913|NCT01360866|26500163|FG000|Overall Study|Adverse Event|56|||
13297914|NCT01360866|26500164|FG001|Overall Study|Adverse Event|61|||
13297915|NCT01360866|26500165|FG002|Overall Study|Adverse Event|134|||
13297916|NCT01360866|26500166|FG003|Overall Study|Adverse Event|6|||
13297917|NCT01360866|26500163|FG000|Overall Study|Paticipant met withdrawal criteria|11|||
13297918|NCT01360866|26500164|FG001|Overall Study|Paticipant met withdrawal criteria|28|||
13297919|NCT01360866|26500165|FG002|Overall Study|Paticipant met withdrawal criteria|54|||
13297920|NCT01360866|26500166|FG003|Overall Study|Paticipant met withdrawal criteria|0|||
13297921|NCT01360866|26500163|FG000|Overall Study|Withdrawn by Investigator|9|||
13297922|NCT01360866|26500164|FG001|Overall Study|Withdrawn by Investigator|8|||
13297923|NCT01360866|26500165|FG002|Overall Study|Withdrawn by Investigator|31|||
13297924|NCT01360866|26500166|FG003|Overall Study|Withdrawn by Investigator|2|||
13297925|NCT01360866|26500163|FG000|Overall Study|Withdrawal by participant|79|||
13297926|NCT01360866|26500164|FG001|Overall Study|Withdrawal by participant|89|||
13297927|NCT01360866|26500165|FG002|Overall Study|Withdrawal by participant|168|||
13297928|NCT01360866|26500166|FG003|Overall Study|Withdrawal by participant|8|||
13297929|NCT01360866|26500163|FG000|Overall Study|Protocol Deviation|25|||
13297930|NCT01360866|26500164|FG001|Overall Study|Protocol Deviation|33|||
13297931|NCT01360866|26500165|FG002|Overall Study|Protocol Deviation|61|||
13297932|NCT01360866|26500166|FG003|Overall Study|Protocol Deviation|2|||
13297933|NCT01360866|26500163|FG000|Overall Study|Lack of Efficacy|30|||
13297934|NCT01360866|26500164|FG001|Overall Study|Lack of Efficacy|40|||
13297935|NCT01360866|26500165|FG002|Overall Study|Lack of Efficacy|30|||
13297936|NCT01360866|26500166|FG003|Overall Study|Lack of Efficacy|4|||
13297937|NCT01360840|26500226|FG000|Overall Study|Ongoing at data cut-off|10|||
13297938|NCT01360840|26500227|FG001|Overall Study|Ongoing at data cut-off|10|||
13297939|NCT01360840|26500228|FG002|Overall Study|Ongoing at data cut-off|9|||
13297940|NCT01360762|26500238|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7|||
13297941|NCT01360762|26500238|FG000|Main Study Period (12-month Treatment)|Death|5|||
13297942|NCT01360762|26500238|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1|||
13297943|NCT01360762|26500238|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15|||
13297944|NCT01360762|26500238|FG000|Main Study Period (12-month Treatment)|Discontinuation|1|||
13297945|NCT01360762|26500238|FG000|Whole Study Period|Lost to Follow-up|10|||
13297946|NCT01360762|26500238|FG000|Whole Study Period|Death|7|||
13297947|NCT01360762|26500238|FG000|Whole Study Period|Patient relapsed|18|||
13297948|NCT01360762|26500238|FG000|Whole Study Period|Discontinuation of study drug for safety|1|||
13297949|NCT01360645|26500299|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16|||
13297950|NCT01360645|26500300|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
13297951|NCT01360645|26500301|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
13297952|NCT01360645|26500302|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
13297953|NCT01360645|26500299|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19|||
13297954|NCT01360645|26500300|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
13297955|NCT01360645|26500301|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
13297956|NCT01360645|26500302|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
13297957|NCT01360645|26500299|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16|||
13297958|NCT01360645|26500300|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
13297959|NCT01360645|26500301|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
13297960|NCT01360645|26500302|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
13297961|NCT01360645|26500299|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34|||
13297962|NCT01360645|26500300|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
13297963|NCT01360645|26500301|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
13297964|NCT01360645|26500302|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
13297965|NCT01360645|26500299|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24|||
13297966|NCT01360645|26500300|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
13297967|NCT01360645|26500301|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
13297968|NCT01360645|26500302|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
13297969|NCT01360645|26500299|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5|||
13297970|NCT01360645|26500300|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
13297971|NCT01360645|26500301|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
13297972|NCT01360645|26500302|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
13297973|NCT01360645|26500299|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
13297974|NCT01360645|26500300|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
13297975|NCT01360645|26500301|FG002|Phase B (6 Weeks)|Lost to Follow-up|0|||
13297976|NCT01360645|26500302|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
13297977|NCT01360645|26500299|FG000|Phase B (6 Weeks)|Adverse Event|0|||
13297978|NCT01360645|26500300|FG001|Phase B (6 Weeks)|Adverse Event|6|||
13297979|NCT01360645|26500301|FG002|Phase B (6 Weeks)|Adverse Event|0|||
13297980|NCT01360645|26500302|FG003|Phase B (6 Weeks)|Adverse Event|0|||
13297981|NCT01360645|26500299|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
13297982|NCT01360645|26500300|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3|||
13297983|NCT01360645|26500301|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
13297984|NCT01360645|26500302|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
13297985|NCT01360645|26500299|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
13297986|NCT01360645|26500300|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3|||
13297987|NCT01360645|26500301|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8|||
13297988|NCT01360645|26500302|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0|||
13297989|NCT01360645|26500299|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
13297990|NCT01360645|26500300|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
13297991|NCT01360645|26500301|FG002|Phase B (6 Weeks)|Protocol Deviation|3|||
13297992|NCT01360645|26500302|FG003|Phase B (6 Weeks)|Protocol Deviation|0|||
13297993|NCT01360645|26500299|FG000|Phase A+|Lost to Follow-up|0|||
13297994|NCT01360645|26500300|FG001|Phase A+|Lost to Follow-up|0|||
13297995|NCT01360645|26500301|FG002|Phase A+|Lost to Follow-up|0|||
13297996|NCT01360645|26500302|FG003|Phase A+|Lost to Follow-up|7|||
13297997|NCT01360645|26500299|FG000|Phase A+|Adverse Event|0|||
13297998|NCT01360645|26500300|FG001|Phase A+|Adverse Event|0|||
13297999|NCT01360645|26500301|FG002|Phase A+|Adverse Event|0|||
13298000|NCT01360645|26500302|FG003|Phase A+|Adverse Event|2|||
13298001|NCT01360645|26500299|FG000|Phase A+|Met Withdrawal Criteria|0|||
13298002|NCT01360645|26500300|FG001|Phase A+|Met Withdrawal Criteria|0|||
13298003|NCT01360645|26500301|FG002|Phase A+|Met Withdrawal Criteria|0|||
13298004|NCT01360645|26500302|FG003|Phase A+|Met Withdrawal Criteria|4|||
13298005|NCT01360645|26500299|FG000|Phase A+|Physician Decision|0|||
13298006|NCT01360645|26500300|FG001|Phase A+|Physician Decision|0|||
13298007|NCT01360645|26500301|FG002|Phase A+|Physician Decision|0|||
13298008|NCT01360645|26500302|FG003|Phase A+|Physician Decision|2|||
13298009|NCT01360645|26500299|FG000|Phase A+|Withdrawal by Subject|0|||
13298010|NCT01360645|26500300|FG001|Phase A+|Withdrawal by Subject|0|||
13298011|NCT01360645|26500301|FG002|Phase A+|Withdrawal by Subject|0|||
13298012|NCT01360645|26500302|FG003|Phase A+|Withdrawal by Subject|5|||
13298013|NCT01360645|26500299|FG000|Phase A+|Protocol Deviation|0|||
13298014|NCT01360645|26500300|FG001|Phase A+|Protocol Deviation|0|||
13298015|NCT01360645|26500301|FG002|Phase A+|Protocol Deviation|0|||
13298016|NCT01360645|26500302|FG003|Phase A+|Protocol Deviation|4|||
13298017|NCT01360632|26500391|FG000|Phase A (8 Weeks)|Lost to Follow-up|27|||
13298018|NCT01360632|26500392|FG001|Phase A (8 Weeks)|Lost to Follow-up|0|||
13298019|NCT01360632|26500393|FG002|Phase A (8 Weeks)|Lost to Follow-up|0|||
13298020|NCT01360632|26500394|FG003|Phase A (8 Weeks)|Lost to Follow-up|0|||
13298021|NCT01360632|26500395|FG004|Phase A (8 Weeks)|Lost to Follow-up|0|||
13298022|NCT01360632|26500391|FG000|Phase A (8 Weeks)|Adverse Event|60|||
13298023|NCT01360632|26500392|FG001|Phase A (8 Weeks)|Adverse Event|0|||
13298024|NCT01360632|26500393|FG002|Phase A (8 Weeks)|Adverse Event|0|||
13298025|NCT01360632|26500394|FG003|Phase A (8 Weeks)|Adverse Event|0|||
13298026|NCT01360632|26500395|FG004|Phase A (8 Weeks)|Adverse Event|0|||
13298027|NCT01360632|26500391|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45|||
13298028|NCT01360632|26500392|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
13298029|NCT01360632|26500393|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
13298030|NCT01360632|26500394|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
13298031|NCT01360632|26500395|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
13298032|NCT01360632|26500391|FG000|Phase A (8 Weeks)|Physician Decision|10|||
13298033|NCT01360632|26500392|FG001|Phase A (8 Weeks)|Physician Decision|0|||
13298034|NCT01360632|26500393|FG002|Phase A (8 Weeks)|Physician Decision|0|||
13298035|NCT01360632|26500394|FG003|Phase A (8 Weeks)|Physician Decision|0|||
13298036|NCT01360632|26500395|FG004|Phase A (8 Weeks)|Physician Decision|0|||
13298037|NCT01360632|26500391|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74|||
13298038|NCT01360632|26500392|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0|||
13298039|NCT01360632|26500393|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0|||
13298040|NCT01360632|26500394|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0|||
13298041|NCT01360632|26500395|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0|||
13298042|NCT01360632|26500391|FG000|Phase A (8 Weeks)|Protocol Deviation|39|||
13298043|NCT01360632|26500392|FG001|Phase A (8 Weeks)|Protocol Deviation|0|||
13298044|NCT01360632|26500393|FG002|Phase A (8 Weeks)|Protocol Deviation|0|||
13298045|NCT01360632|26500394|FG003|Phase A (8 Weeks)|Protocol Deviation|0|||
13298046|NCT01360632|26500395|FG004|Phase A (8 Weeks)|Protocol Deviation|0|||
13298047|NCT01360632|26500391|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
13298048|NCT01360632|26500392|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
13298049|NCT01360632|26500393|FG002|Phase B (6 Weeks)|Lost to Follow-up|1|||
13298050|NCT01360632|26500394|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
13298051|NCT01360632|26500395|FG004|Phase B (6 Weeks)|Lost to Follow-up|0|||
13298052|NCT01360632|26500391|FG000|Phase B (6 Weeks)|Adverse Event|0|||
13298053|NCT01360632|26500392|FG001|Phase B (6 Weeks)|Adverse Event|3|||
13298054|NCT01360632|26500393|FG002|Phase B (6 Weeks)|Adverse Event|9|||
13298055|NCT01360632|26500394|FG003|Phase B (6 Weeks)|Adverse Event|3|||
13298056|NCT01360632|26500395|FG004|Phase B (6 Weeks)|Adverse Event|0|||
13298057|NCT01360632|26500391|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
13298058|NCT01360632|26500392|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
13298059|NCT01360632|26500393|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
13298060|NCT01360632|26500394|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1|||
13298061|NCT01360632|26500395|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
13298062|NCT01360632|26500391|FG000|Phase B (6 Weeks)|Physician Decision|0|||
13298063|NCT01360632|26500392|FG001|Phase B (6 Weeks)|Physician Decision|0|||
13298064|NCT01360632|26500393|FG002|Phase B (6 Weeks)|Physician Decision|0|||
13298065|NCT01360632|26500394|FG003|Phase B (6 Weeks)|Physician Decision|1|||
13298066|NCT01360632|26500395|FG004|Phase B (6 Weeks)|Physician Decision|0|||
13298067|NCT01360632|26500391|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
13298068|NCT01360632|26500392|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4|||
13298069|NCT01360632|26500393|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4|||
13298070|NCT01360632|26500394|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7|||
13298071|NCT01360632|26500395|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0|||
13298072|NCT01360632|26500391|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
13298073|NCT01360632|26500392|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
13298074|NCT01360632|26500393|FG002|Phase B (6 Weeks)|Protocol Deviation|4|||
13298075|NCT01360632|26500394|FG003|Phase B (6 Weeks)|Protocol Deviation|1|||
13298076|NCT01360632|26500395|FG004|Phase B (6 Weeks)|Protocol Deviation|0|||
13298077|NCT01360632|26500391|FG000|Phase B (6 Weeks)|Lack of Efficacy|0|||
13298078|NCT01360632|26500392|FG001|Phase B (6 Weeks)|Lack of Efficacy|1|||
13298079|NCT01360632|26500393|FG002|Phase B (6 Weeks)|Lack of Efficacy|0|||
13298080|NCT01360632|26500394|FG003|Phase B (6 Weeks)|Lack of Efficacy|0|||
13298081|NCT01360632|26500395|FG004|Phase B (6 Weeks)|Lack of Efficacy|0|||
13298082|NCT01360632|26500391|FG000|Phase A+|Lost to Follow-up|0|||
13298083|NCT01360632|26500392|FG001|Phase A+|Lost to Follow-up|0|||
13298084|NCT01360632|26500393|FG002|Phase A+|Lost to Follow-up|0|||
13298085|NCT01360632|26500394|FG003|Phase A+|Lost to Follow-up|0|||
13298086|NCT01360632|26500395|FG004|Phase A+|Lost to Follow-up|2|||
13298087|NCT01360632|26500391|FG000|Phase A+|Adverse Event|0|||
13298088|NCT01360632|26500392|FG001|Phase A+|Adverse Event|0|||
13298089|NCT01360632|26500393|FG002|Phase A+|Adverse Event|0|||
13298090|NCT01360632|26500394|FG003|Phase A+|Adverse Event|0|||
13298091|NCT01360632|26500395|FG004|Phase A+|Adverse Event|2|||
13298092|NCT01360632|26500391|FG000|Phase A+|Met Withdrawal Criteria|0|||
13298093|NCT01360632|26500392|FG001|Phase A+|Met Withdrawal Criteria|0|||
13298094|NCT01360632|26500393|FG002|Phase A+|Met Withdrawal Criteria|0|||
13298095|NCT01360632|26500394|FG003|Phase A+|Met Withdrawal Criteria|0|||
13298096|NCT01360632|26500395|FG004|Phase A+|Met Withdrawal Criteria|7|||
13298097|NCT01360632|26500391|FG000|Phase A+|Physician Decision|0|||
13298098|NCT01360632|26500392|FG001|Phase A+|Physician Decision|0|||
13298099|NCT01360632|26500393|FG002|Phase A+|Physician Decision|0|||
13298100|NCT01360632|26500394|FG003|Phase A+|Physician Decision|0|||
13298101|NCT01360632|26500395|FG004|Phase A+|Physician Decision|3|||
13298102|NCT01360632|26500391|FG000|Phase A+|Withdrawal by Subject|0|||
13298103|NCT01360632|26500392|FG001|Phase A+|Withdrawal by Subject|0|||
13298104|NCT01360632|26500393|FG002|Phase A+|Withdrawal by Subject|0|||
13298105|NCT01360632|26500394|FG003|Phase A+|Withdrawal by Subject|0|||
13298106|NCT01360632|26500395|FG004|Phase A+|Withdrawal by Subject|8|||
13298107|NCT01360632|26500391|FG000|Phase A+|Protocol Deviation|0|||
13298108|NCT01360632|26500392|FG001|Phase A+|Protocol Deviation|0|||
13298109|NCT01360632|26500393|FG002|Phase A+|Protocol Deviation|0|||
13298110|NCT01360632|26500394|FG003|Phase A+|Protocol Deviation|0|||
13298111|NCT01360632|26500395|FG004|Phase A+|Protocol Deviation|3|||
13298112|NCT01360554|26500438|FG000|Overall Study|Death|359|||
13298113|NCT01360554|26500439|FG001|Overall Study|Death|371|||
13298114|NCT01360554|26500438|FG000|Overall Study|Lost to Follow-up|4|||
13298115|NCT01360554|26500439|FG001|Overall Study|Lost to Follow-up|4|||
13298116|NCT01360554|26500438|FG000|Overall Study|Withdrawal by Subject|23|||
13298117|NCT01360554|26500439|FG001|Overall Study|Withdrawal by Subject|24|||
13298118|NCT01360554|26500438|FG000|Overall Study|Study terminated by sponsor|49|||
13298119|NCT01360554|26500439|FG001|Overall Study|Study terminated by sponsor|37|||
13298120|NCT01360554|26500438|FG000|Overall Study|Other, not specified|1|||
13298121|NCT01360554|26500439|FG001|Overall Study|Other, not specified|0|||
13298122|NCT01360554|26500438|FG000|Overall Study|Randomized but not treated.|3|||
13298123|NCT01360554|26500439|FG001|Overall Study|Randomized but not treated.|3|||
13298124|NCT01360398|26500463|FG000|Overall Study|Withdrawal by Subject|14|||
13298125|NCT01360398|26500463|FG000|Overall Study|Other|7|||
13298126|NCT01360398|26500463|FG000|Overall Study|Migrated/moved from study area|1|||
13298127|NCT01360021|26500496|FG000|Overall Study|Eligibility criteria + other|2|||
13298128|NCT01360021|26500497|FG001|Overall Study|Eligibility criteria + other|1|||
13298129|NCT01360021|26500498|FG002|Overall Study|Eligibility criteria + other|1|||
13298130|NCT01360021|26500496|FG000|Overall Study|Protocol Violation|0|||
13298131|NCT01360021|26500497|FG001|Overall Study|Protocol Violation|0|||
13298132|NCT01360021|26500498|FG002|Overall Study|Protocol Violation|1|||
13298133|NCT01360021|26500496|FG000|Overall Study|Withdrawal by Subject|4|||
13298134|NCT01360021|26500497|FG001|Overall Study|Withdrawal by Subject|0|||
13298135|NCT01360021|26500498|FG002|Overall Study|Withdrawal by Subject|2|||
13298136|NCT01360021|26500496|FG000|Overall Study|Adverse Event|2|||
13298137|NCT01360021|26500497|FG001|Overall Study|Adverse Event|3|||
13298138|NCT01360021|26500498|FG002|Overall Study|Adverse Event|3|||
13298139|NCT01359956|26500533|FG000|Overall Study|Death|61|||
13298140|NCT01359956|26500534|FG001|Overall Study|Death|64|||
13298141|NCT01359956|26500535|FG002|Overall Study|Death|67|||
13298142|NCT01359956|26500536|FG003|Overall Study|Death|58|||
13298143|NCT01359943|26500592|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1|||
13298144|NCT01359943|26500593|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
13298145|NCT01359943|26500594|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
13298146|NCT01359943|26500592|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1|||
13298147|NCT01359943|26500593|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2|||
13298148|NCT01359943|26500594|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0|||
13298149|NCT01359943|26500592|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
13298150|NCT01359943|26500593|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2|||
13298151|NCT01359943|26500594|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
13298152|NCT01359943|26500592|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1|||
13298153|NCT01359943|26500593|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
13298154|NCT01359943|26500594|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
13298155|NCT01359943|26500592|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1|||
13298156|NCT01359943|26500593|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3|||
13298157|NCT01359943|26500594|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4|||
13298158|NCT01359943|26500592|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
13298159|NCT01359943|26500593|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1|||
13298160|NCT01359943|26500594|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
13298161|NCT01359943|26500592|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
13298162|NCT01359943|26500593|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
13298163|NCT01359943|26500594|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
13298164|NCT01359943|26500592|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
13298165|NCT01359943|26500593|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1|||
13298166|NCT01359943|26500594|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
13298167|NCT01359943|26500592|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3|||
13298168|NCT01359943|26500593|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5|||
13298169|NCT01359943|26500594|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1|||
13298170|NCT01359943|26500592|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1|||
13298171|NCT01359943|26500593|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5|||
13298172|NCT01359943|26500594|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4|||
13298173|NCT01359943|26500592|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1|||
13298174|NCT01359943|26500593|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
13298175|NCT01359943|26500594|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
13298176|NCT01359943|26500592|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
13298177|NCT01359943|26500593|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1|||
13298178|NCT01359943|26500594|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
13298179|NCT01359943|26500592|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
13298180|NCT01359943|26500593|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
13298181|NCT01359943|26500594|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
13298182|NCT01359943|26500592|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
13298183|NCT01359943|26500593|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1|||
13298184|NCT01359943|26500594|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
13298185|NCT01359943|26500592|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3|||
13298186|NCT01359943|26500593|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5|||
13298187|NCT01359943|26500594|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1|||
13298188|NCT01359904|26500613|FG000|Overall Study|Withdrawal by Subject|1|||
13298189|NCT01359904|26500614|FG001|Overall Study|Withdrawal by Subject|0|||
13298190|NCT01359644|26500687|FG000|Treatment Period|Lack of Efficacy|0|||
13298191|NCT01359644|26500688|FG001|Treatment Period|Lack of Efficacy|1|||
13298192|NCT01359644|26500689|FG002|Treatment Period|Lack of Efficacy|0|||
13298193|NCT01359644|26500690|FG003|Treatment Period|Lack of Efficacy|0|||
13298194|NCT01359644|26500691|FG004|Treatment Period|Lack of Efficacy|0|||
13298195|NCT01359644|26500692|FG005|Treatment Period|Lack of Efficacy|0|||
13298196|NCT01359644|26500693|FG006|Treatment Period|Lack of Efficacy|0|||
13298197|NCT01359644|26500694|FG007|Treatment Period|Lack of Efficacy|0|||
13298198|NCT01359644|26500695|FG008|Treatment Period|Lack of Efficacy|0|||
13298199|NCT01359644|26500696|FG009|Treatment Period|Lack of Efficacy|0|||
13298200|NCT01359644|26500687|FG000|Treatment Period|Adverse Event|0|||
13298201|NCT01359644|26500688|FG001|Treatment Period|Adverse Event|0|||
13298202|NCT01359644|26500689|FG002|Treatment Period|Adverse Event|1|||
13298203|NCT01359644|26500690|FG003|Treatment Period|Adverse Event|0|||
13298204|NCT01359644|26500691|FG004|Treatment Period|Adverse Event|0|||
13298205|NCT01359644|26500692|FG005|Treatment Period|Adverse Event|1|||
13298206|NCT01359644|26500693|FG006|Treatment Period|Adverse Event|0|||
13298207|NCT01359644|26500694|FG007|Treatment Period|Adverse Event|0|||
13298208|NCT01359644|26500695|FG008|Treatment Period|Adverse Event|0|||
13298209|NCT01359644|26500696|FG009|Treatment Period|Adverse Event|0|||
13298210|NCT01359644|26500687|FG000|Treatment Period|Lost to Follow-up|0|||
13298211|NCT01359644|26500688|FG001|Treatment Period|Lost to Follow-up|0|||
13298212|NCT01359644|26500689|FG002|Treatment Period|Lost to Follow-up|0|||
13298213|NCT01359644|26500690|FG003|Treatment Period|Lost to Follow-up|0|||
13298214|NCT01359644|26500691|FG004|Treatment Period|Lost to Follow-up|0|||
13298215|NCT01359644|26500692|FG005|Treatment Period|Lost to Follow-up|1|||
13298216|NCT01359644|26500693|FG006|Treatment Period|Lost to Follow-up|0|||
13298217|NCT01359644|26500694|FG007|Treatment Period|Lost to Follow-up|0|||
13298218|NCT01359644|26500695|FG008|Treatment Period|Lost to Follow-up|0|||
13298219|NCT01359644|26500696|FG009|Treatment Period|Lost to Follow-up|0|||
13298220|NCT01359644|26500687|FG000|Follow-up Period|Withdrawal by Subject|0|||
13298221|NCT01359644|26500688|FG001|Follow-up Period|Withdrawal by Subject|0|||
13298222|NCT01359644|26500689|FG002|Follow-up Period|Withdrawal by Subject|0|||
13298223|NCT01359644|26500690|FG003|Follow-up Period|Withdrawal by Subject|0|||
13298224|NCT01359644|26500691|FG004|Follow-up Period|Withdrawal by Subject|0|||
13298225|NCT01359644|26500692|FG005|Follow-up Period|Withdrawal by Subject|1|||
13298226|NCT01359644|26500693|FG006|Follow-up Period|Withdrawal by Subject|0|||
13298227|NCT01359644|26500694|FG007|Follow-up Period|Withdrawal by Subject|0|||
13298228|NCT01359644|26500695|FG008|Follow-up Period|Withdrawal by Subject|0|||
13298229|NCT01359644|26500696|FG009|Follow-up Period|Withdrawal by Subject|0|||
13298230|NCT01359644|26500687|FG000|Follow-up Period|Lost to Follow-up|0|||
13298231|NCT01359644|26500688|FG001|Follow-up Period|Lost to Follow-up|0|||
13298232|NCT01359644|26500689|FG002|Follow-up Period|Lost to Follow-up|0|||
13298233|NCT01359644|26500690|FG003|Follow-up Period|Lost to Follow-up|0|||
13298234|NCT01359644|26500691|FG004|Follow-up Period|Lost to Follow-up|0|||
13298235|NCT01359644|26500692|FG005|Follow-up Period|Lost to Follow-up|0|||
13298236|NCT01359644|26500693|FG006|Follow-up Period|Lost to Follow-up|1|||
13298237|NCT01359644|26500694|FG007|Follow-up Period|Lost to Follow-up|2|||
13298238|NCT01359644|26500695|FG008|Follow-up Period|Lost to Follow-up|0|||
13298239|NCT01359644|26500696|FG009|Follow-up Period|Lost to Follow-up|0|||
13298240|NCT01359592|26500717|FG000|Initial Registration|Adverse Event|1|||
13298241|NCT01359592|26500718|FG001|Initial Registration|Adverse Event|0|||
13298242|NCT01359592|26500719|FG002|Initial Registration|Adverse Event|0|||
13298243|NCT01359592|26500720|FG003|Initial Registration|Adverse Event|0|||
13298244|NCT01359592|26500717|FG000|Initial Registration|Death|1|||
13298245|NCT01359592|26500718|FG001|Initial Registration|Death|0|||
13298246|NCT01359592|26500719|FG002|Initial Registration|Death|0|||
13298247|NCT01359592|26500720|FG003|Initial Registration|Death|0|||
13298248|NCT01359592|26500717|FG000|Initial Registration|Other reason not protocol specified|1|||
13298249|NCT01359592|26500718|FG001|Initial Registration|Other reason not protocol specified|0|||
13298250|NCT01359592|26500719|FG002|Initial Registration|Other reason not protocol specified|0|||
13298251|NCT01359592|26500720|FG003|Initial Registration|Other reason not protocol specified|0|||
13298252|NCT01359592|26500717|FG000|Initial Registration|Ineligible|26|||
13298253|NCT01359592|26500718|FG001|Initial Registration|Ineligible|0|||
13298254|NCT01359592|26500719|FG002|Initial Registration|Ineligible|0|||
13298255|NCT01359592|26500720|FG003|Initial Registration|Ineligible|0|||
13298256|NCT01359592|26500717|FG000|PET-Directed Therapy|Adverse Event|0|||
13298257|NCT01359592|26500718|FG001|PET-Directed Therapy|Adverse Event|0|||
13298258|NCT01359592|26500719|FG002|PET-Directed Therapy|Adverse Event|1|||
13298259|NCT01359592|26500720|FG003|PET-Directed Therapy|Adverse Event|0|||
13298260|NCT01359592|26500717|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
13298261|NCT01359592|26500718|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
13298262|NCT01359592|26500719|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1|||
13298263|NCT01359592|26500720|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
13298264|NCT01359592|26500717|FG000|PET-Directed Therapy|Ineligible|0|||
13298265|NCT01359592|26500718|FG001|PET-Directed Therapy|Ineligible|0|||
13298266|NCT01359592|26500719|FG002|PET-Directed Therapy|Ineligible|24|||
13298267|NCT01359592|26500720|FG003|PET-Directed Therapy|Ineligible|0|||
13298268|NCT01359449|26500749|FG000|Overall Study|Lost to Follow-up|1|||
13298269|NCT01359449|26500750|FG001|Overall Study|Lost to Follow-up|0|||
13298270|NCT01359449|26500749|FG000|Overall Study|Protocol Violation|0|||
13298271|NCT01359449|26500750|FG001|Overall Study|Protocol Violation|2|||
13298272|NCT01359449|26500749|FG000|Overall Study|Withdrawal by Subject|3|||
13298273|NCT01359449|26500750|FG001|Overall Study|Withdrawal by Subject|2|||
13298274|NCT01359254|26500765|FG000|Overall Study|Death|1|||
13298275|NCT01359254|26500766|FG001|Overall Study|Death|0|||
13298276|NCT01359150|26500795|FG000|Overall Study|Lack of Efficacy|1|||
13298277|NCT01359150|26500796|FG001|Overall Study|Lack of Efficacy|1|||
13298278|NCT01359150|26500795|FG000|Overall Study|Withdrawal by Subject|1|||
13298279|NCT01359150|26500796|FG001|Overall Study|Withdrawal by Subject|1|||
13298280|NCT01359150|26500795|FG000|Overall Study|Adverse Event|4|||
13298281|NCT01359150|26500796|FG001|Overall Study|Adverse Event|3|||
13298282|NCT01359150|26500795|FG000|Overall Study|Other|1|||
13298283|NCT01359150|26500796|FG001|Overall Study|Other|0|||
13298284|NCT01359046|26500811|FG000|Overall Study|Did not receive allocated intervention|6|||
13298285|NCT01359046|26500812|FG001|Overall Study|Did not receive allocated intervention|6|||
13298286|NCT01359046|26500811|FG000|Overall Study|Physician Decision|1|||
13298287|NCT01359046|26500812|FG001|Overall Study|Physician Decision|11|||
13298288|NCT01358981|26500895|FG000|Period 1|Withdrawal by Subject|0|||
13298289|NCT01358981|26500896|FG001|Period 1|Withdrawal by Subject|0|||
13298290|NCT01358981|26500897|FG002|Period 1|Withdrawal by Subject|0|||
13298291|NCT01358981|26500898|FG003|Period 1|Withdrawal by Subject|1|||
13298292|NCT01358981|26500899|FG004|Period 1|Withdrawal by Subject|0|||
13298293|NCT01358981|26500900|FG005|Period 1|Withdrawal by Subject|0|||
13298294|NCT01358981|26500901|FG006|Period 1|Withdrawal by Subject|0|||
13298295|NCT01358968|26500920|FG000|Period 2|Adverse Event|0|||
13298296|NCT01358968|26500921|FG001|Period 2|Adverse Event|1|||
13298297|NCT01358968|26500922|FG002|Period 2|Adverse Event|0|||
13298298|NCT01358968|26500923|FG003|Period 2|Adverse Event|0|||
13298299|NCT01358968|26500920|FG000|Continued Access Phase|Progression of Disease|0|||
13298300|NCT01358968|26500921|FG001|Continued Access Phase|Progression of Disease|0|||
13298301|NCT01358968|26500922|FG002|Continued Access Phase|Progression of Disease|8|||
13298302|NCT01358968|26500923|FG003|Continued Access Phase|Progression of Disease|4|||
13298303|NCT01358968|26500920|FG000|Continued Access Phase|Protocol Violation|0|||
13298304|NCT01358968|26500921|FG001|Continued Access Phase|Protocol Violation|0|||
13298305|NCT01358968|26500922|FG002|Continued Access Phase|Protocol Violation|0|||
13298306|NCT01358968|26500923|FG003|Continued Access Phase|Protocol Violation|2|||
13298307|NCT01358968|26500920|FG000|Continued Access Phase|Withdrawal by Subject|0|||
13298308|NCT01358968|26500921|FG001|Continued Access Phase|Withdrawal by Subject|0|||
13298309|NCT01358968|26500922|FG002|Continued Access Phase|Withdrawal by Subject|3|||
13298310|NCT01358968|26500923|FG003|Continued Access Phase|Withdrawal by Subject|0|||
13298311|NCT01358968|26500920|FG000|Continued Access Phase|Death|0|||
13298312|NCT01358968|26500921|FG001|Continued Access Phase|Death|0|||
13298313|NCT01358968|26500922|FG002|Continued Access Phase|Death|1|||
13298314|NCT01358968|26500923|FG003|Continued Access Phase|Death|1|||
13298315|NCT01358864|26501037|FG000|Overall Study|Adverse Event|0|||
13298316|NCT01358864|26501038|FG001|Overall Study|Adverse Event|6|||
13298317|NCT01358864|26501039|FG002|Overall Study|Adverse Event|9|||
13298318|NCT01358864|26501040|FG003|Overall Study|Adverse Event|0|||
13298319|NCT01358864|26501041|FG004|Overall Study|Adverse Event|4|||
13298320|NCT01358864|26501042|FG005|Overall Study|Adverse Event|8|||
13298321|NCT01358864|26501043|FG006|Overall Study|Adverse Event|12|||
13298322|NCT01358864|26501044|FG007|Overall Study|Adverse Event|7|||
13298323|NCT01358864|26501037|FG000|Overall Study|Lack of Efficacy|26|||
13298324|NCT01358864|26501038|FG001|Overall Study|Lack of Efficacy|3|||
13298325|NCT01358864|26501039|FG002|Overall Study|Lack of Efficacy|4|||
13298326|NCT01358864|26501040|FG003|Overall Study|Lack of Efficacy|19|||
13298327|NCT01358864|26501041|FG004|Overall Study|Lack of Efficacy|7|||
13298328|NCT01358864|26501042|FG005|Overall Study|Lack of Efficacy|4|||
13298329|NCT01358864|26501043|FG006|Overall Study|Lack of Efficacy|49|||
13298330|NCT01358864|26501044|FG007|Overall Study|Lack of Efficacy|44|||
13298331|NCT01358864|26501037|FG000|Overall Study|Lost to Follow-up|0|||
13298332|NCT01358864|26501038|FG001|Overall Study|Lost to Follow-up|0|||
13298333|NCT01358864|26501039|FG002|Overall Study|Lost to Follow-up|1|||
13298334|NCT01358864|26501040|FG003|Overall Study|Lost to Follow-up|0|||
13298335|NCT01358864|26501041|FG004|Overall Study|Lost to Follow-up|0|||
13298336|NCT01358864|26501042|FG005|Overall Study|Lost to Follow-up|0|||
13298337|NCT01358864|26501043|FG006|Overall Study|Lost to Follow-up|0|||
13298338|NCT01358864|26501044|FG007|Overall Study|Lost to Follow-up|1|||
13298339|NCT01358864|26501037|FG000|Overall Study|Withdrawal by Subject|3|||
13298340|NCT01358864|26501038|FG001|Overall Study|Withdrawal by Subject|4|||
13298341|NCT01358864|26501039|FG002|Overall Study|Withdrawal by Subject|2|||
13298342|NCT01358864|26501040|FG003|Overall Study|Withdrawal by Subject|0|||
13298343|NCT01358864|26501041|FG004|Overall Study|Withdrawal by Subject|0|||
13298344|NCT01358864|26501042|FG005|Overall Study|Withdrawal by Subject|1|||
13298345|NCT01358864|26501043|FG006|Overall Study|Withdrawal by Subject|1|||
13298346|NCT01358864|26501044|FG007|Overall Study|Withdrawal by Subject|3|||
13298347|NCT01358864|26501037|FG000|Overall Study|Other reason not defined above|2|||
13298348|NCT01358864|26501038|FG001|Overall Study|Other reason not defined above|0|||
13298349|NCT01358864|26501039|FG002|Overall Study|Other reason not defined above|0|||
13298350|NCT01358864|26501040|FG003|Overall Study|Other reason not defined above|0|||
13298351|NCT01358864|26501041|FG004|Overall Study|Other reason not defined above|0|||
13298352|NCT01358864|26501042|FG005|Overall Study|Other reason not defined above|0|||
13298353|NCT01358864|26501043|FG006|Overall Study|Other reason not defined above|2|||
13298354|NCT01358864|26501044|FG007|Overall Study|Other reason not defined above|0|||
13298355|NCT01358864|26501037|FG000|Overall Study|Not treated|0|||
13298356|NCT01358864|26501038|FG001|Overall Study|Not treated|0|||
13298357|NCT01358864|26501039|FG002|Overall Study|Not treated|0|||
13298358|NCT01358864|26501040|FG003|Overall Study|Not treated|0|||
13298359|NCT01358864|26501041|FG004|Overall Study|Not treated|0|||
13298360|NCT01358864|26501042|FG005|Overall Study|Not treated|0|||
13298361|NCT01358864|26501043|FG006|Overall Study|Not treated|1|||
13298362|NCT01358864|26501044|FG007|Overall Study|Not treated|0|||
13298363|NCT01358825|26501072|FG000|Overall Study|Blood sample not drawn|0|||
13298364|NCT01358825|26501073|FG001|Overall Study|Blood sample not drawn|1|||
13298365|NCT01358760|26501115|FG000|Overall Study|Adverse Event|3|||
13298366|NCT01358760|26501116|FG001|Overall Study|Adverse Event|4|||
13298367|NCT01358760|26501117|FG002|Overall Study|Adverse Event|3|||
13298368|NCT01358760|26501115|FG000|Overall Study|Lost to Follow-up|1|||
13298369|NCT01358760|26501116|FG001|Overall Study|Lost to Follow-up|1|||
13298370|NCT01358760|26501117|FG002|Overall Study|Lost to Follow-up|3|||
13298371|NCT01358760|26501115|FG000|Overall Study|Withdrawal by Subject|5|||
13298372|NCT01358760|26501116|FG001|Overall Study|Withdrawal by Subject|3|||
13298373|NCT01358760|26501117|FG002|Overall Study|Withdrawal by Subject|2|||
13298374|NCT01358760|26501115|FG000|Overall Study|Physician Decision|1|||
13298375|NCT01358760|26501116|FG001|Overall Study|Physician Decision|0|||
13298376|NCT01358760|26501117|FG002|Overall Study|Physician Decision|1|||
13298377|NCT01358760|26501115|FG000|Overall Study|Entry criteria not met/Non-compliance|12|||
13298378|NCT01358760|26501116|FG001|Overall Study|Entry criteria not met/Non-compliance|12|||
13298379|NCT01358760|26501117|FG002|Overall Study|Entry criteria not met/Non-compliance|16|||
13298380|NCT01358734|26501171|FG000|Overall Study|Adverse Event|4|||
13298381|NCT01358734|26501172|FG001|Overall Study|Adverse Event|7|||
13298382|NCT01358734|26501173|FG002|Overall Study|Adverse Event|3|||
13298383|NCT01358734|26501171|FG000|Overall Study|Lack of Efficacy|0|||
13298384|NCT01358734|26501172|FG001|Overall Study|Lack of Efficacy|1|||
13298385|NCT01358734|26501173|FG002|Overall Study|Lack of Efficacy|3|||
13298386|NCT01358734|26501171|FG000|Overall Study|Withdrawal by Subject|1|||
13298387|NCT01358734|26501172|FG001|Overall Study|Withdrawal by Subject|6|||
13298388|NCT01358734|26501173|FG002|Overall Study|Withdrawal by Subject|3|||
13298389|NCT01358734|26501171|FG000|Overall Study|Death|3|||
13298390|NCT01358734|26501172|FG001|Overall Study|Death|7|||
13298391|NCT01358734|26501173|FG002|Overall Study|Death|2|||
13298392|NCT01358734|26501171|FG000|Overall Study|Progressive Disease|5|||
13298393|NCT01358734|26501172|FG001|Overall Study|Progressive Disease|13|||
13298394|NCT01358734|26501173|FG002|Overall Study|Progressive Disease|16|||
13298395|NCT01358734|26501171|FG000|Overall Study|Non-compliance with study drug|0|||
13298396|NCT01358734|26501172|FG001|Overall Study|Non-compliance with study drug|0|||
13298397|NCT01358734|26501173|FG002|Overall Study|Non-compliance with study drug|1|||
13298398|NCT01358734|26501171|FG000|Overall Study|Other|2|||
13298399|NCT01358734|26501172|FG001|Overall Study|Other|5|||
13298400|NCT01358734|26501173|FG002|Overall Study|Other|4|||
13298401|NCT01358734|26501171|FG000|Overall Study|Protocol Violation|0|||
13298402|NCT01358734|26501172|FG001|Overall Study|Protocol Violation|0|||
13298403|NCT01358734|26501173|FG002|Overall Study|Protocol Violation|2|||
13298404|NCT01358721|26501236|FG000|Overall Study|Withdrawal by Subject|0|||
13298405|NCT01358721|26501237|FG001|Overall Study|Withdrawal by Subject|0|||
13298406|NCT01358721|26501238|FG002|Overall Study|Withdrawal by Subject|0|||
13298407|NCT01358721|26501239|FG003|Overall Study|Withdrawal by Subject|1|||
13298408|NCT01358721|26501236|FG000|Overall Study|Death|0|||
13298409|NCT01358721|26501237|FG001|Overall Study|Death|2|||
13298410|NCT01358721|26501238|FG002|Overall Study|Death|0|||
13298411|NCT01358721|26501239|FG003|Overall Study|Death|0|||
13298412|NCT01358721|26501236|FG000|Overall Study|Study Drug Toxicity|1|||
13298413|NCT01358721|26501237|FG001|Overall Study|Study Drug Toxicity|3|||
13298414|NCT01358721|26501238|FG002|Overall Study|Study Drug Toxicity|4|||
13298415|NCT01358721|26501239|FG003|Overall Study|Study Drug Toxicity|5|||
13298416|NCT01358721|26501236|FG000|Overall Study|SUBJ request to discontinue study TRT|0|||
13298417|NCT01358721|26501237|FG001|Overall Study|SUBJ request to discontinue study TRT|0|||
13298418|NCT01358721|26501238|FG002|Overall Study|SUBJ request to discontinue study TRT|0|||
13298419|NCT01358721|26501239|FG003|Overall Study|SUBJ request to discontinue study TRT|1|||
13298420|NCT01358721|26501236|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
13298421|NCT01358721|26501237|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
13298422|NCT01358721|26501238|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
13298423|NCT01358721|26501239|FG003|Overall Study|Subject No Longer Meets Study Criteria|1|||
13298424|NCT01358721|26501236|FG000|Overall Study|Adverse Event related to study drug|1|||
13298425|NCT01358721|26501237|FG001|Overall Study|Adverse Event related to study drug|0|||
13298426|NCT01358721|26501238|FG002|Overall Study|Adverse Event related to study drug|0|||
13298427|NCT01358721|26501239|FG003|Overall Study|Adverse Event related to study drug|1|||
13298428|NCT01358721|26501236|FG000|Overall Study|Disease Progression|19|||
13298429|NCT01358721|26501237|FG001|Overall Study|Disease Progression|15|||
13298430|NCT01358721|26501238|FG002|Overall Study|Disease Progression|17|||
13298431|NCT01358721|26501239|FG003|Overall Study|Disease Progression|15|||
13298432|NCT01358721|26501236|FG000|Overall Study|Out of State/Unmet Criteria|0|||
13298433|NCT01358721|26501237|FG001|Overall Study|Out of State/Unmet Criteria|0|||
13298434|NCT01358721|26501238|FG002|Overall Study|Out of State/Unmet Criteria|1|||
13298435|NCT01358721|26501239|FG003|Overall Study|Out of State/Unmet Criteria|0|||
13298436|NCT01358708|26501265|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2|||
13298437|NCT01358708|26501266|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
13298438|NCT01358708|26501265|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
13298439|NCT01358708|26501266|FG001|Double-Blind Treatment Phase|Protocol Violation|0|||
13298440|NCT01358578|26501331|FG000|Induction Period|Adverse Event|2|||
13298441|NCT01358578|26501332|FG001|Induction Period|Adverse Event|4|||
13298442|NCT01358578|26501333|FG002|Induction Period|Adverse Event|2|||
13298443|NCT01358578|26501334|FG003|Induction Period|Adverse Event|6|||
13298444|NCT01358578|26501335|FG004|Induction Period|Adverse Event|0|||
13298445|NCT01358578|26501336|FG005|Induction Period|Adverse Event|0|||
13298446|NCT01358578|26501331|FG000|Induction Period|Lack of Efficacy|0|||
13298447|NCT01358578|26501332|FG001|Induction Period|Lack of Efficacy|0|||
13298448|NCT01358578|26501333|FG002|Induction Period|Lack of Efficacy|9|||
13298449|NCT01358578|26501334|FG003|Induction Period|Lack of Efficacy|1|||
13298450|NCT01358578|26501335|FG004|Induction Period|Lack of Efficacy|0|||
13298451|NCT01358578|26501336|FG005|Induction Period|Lack of Efficacy|0|||
13298452|NCT01358578|26501331|FG000|Induction Period|Lost to Follow-up|0|||
13298453|NCT01358578|26501332|FG001|Induction Period|Lost to Follow-up|0|||
13298454|NCT01358578|26501333|FG002|Induction Period|Lost to Follow-up|1|||
13298455|NCT01358578|26501334|FG003|Induction Period|Lost to Follow-up|4|||
13298456|NCT01358578|26501335|FG004|Induction Period|Lost to Follow-up|0|||
13298457|NCT01358578|26501336|FG005|Induction Period|Lost to Follow-up|0|||
13298458|NCT01358578|26501331|FG000|Induction Period|Physician Decision|2|||
13298459|NCT01358578|26501332|FG001|Induction Period|Physician Decision|1|||
13298460|NCT01358578|26501333|FG002|Induction Period|Physician Decision|2|||
13298461|NCT01358578|26501334|FG003|Induction Period|Physician Decision|0|||
13298462|NCT01358578|26501335|FG004|Induction Period|Physician Decision|0|||
13298463|NCT01358578|26501336|FG005|Induction Period|Physician Decision|0|||
13298464|NCT01358578|26501331|FG000|Induction Period|Protocol Deviation|3|||
13298465|NCT01358578|26501332|FG001|Induction Period|Protocol Deviation|5|||
13298466|NCT01358578|26501333|FG002|Induction Period|Protocol Deviation|0|||
13298467|NCT01358578|26501334|FG003|Induction Period|Protocol Deviation|3|||
13298468|NCT01358578|26501335|FG004|Induction Period|Protocol Deviation|0|||
13298469|NCT01358578|26501336|FG005|Induction Period|Protocol Deviation|0|||
13298470|NCT01358578|26501331|FG000|Induction Period|technical problems|0|||
13298471|NCT01358578|26501332|FG001|Induction Period|technical problems|0|||
13298472|NCT01358578|26501333|FG002|Induction Period|technical problems|1|||
13298473|NCT01358578|26501334|FG003|Induction Period|technical problems|1|||
13298474|NCT01358578|26501335|FG004|Induction Period|technical problems|0|||
13298475|NCT01358578|26501336|FG005|Induction Period|technical problems|0|||
13298476|NCT01358578|26501331|FG000|Induction Period|Withdrawal by Subject|5|||
13298477|NCT01358578|26501332|FG001|Induction Period|Withdrawal by Subject|5|||
13298478|NCT01358578|26501333|FG002|Induction Period|Withdrawal by Subject|10|||
13298479|NCT01358578|26501334|FG003|Induction Period|Withdrawal by Subject|6|||
13298480|NCT01358578|26501335|FG004|Induction Period|Withdrawal by Subject|0|||
13298481|NCT01358578|26501336|FG005|Induction Period|Withdrawal by Subject|0|||
13298482|NCT01358578|26501331|FG000|Maintenance Period|Adverse Event|2|||
13298483|NCT01358578|26501332|FG001|Maintenance Period|Adverse Event|7|||
13298484|NCT01358578|26501333|FG002|Maintenance Period|Adverse Event|0|||
13298485|NCT01358578|26501334|FG003|Maintenance Period|Adverse Event|6|||
13298486|NCT01358578|26501335|FG004|Maintenance Period|Adverse Event|4|||
13298487|NCT01358578|26501336|FG005|Maintenance Period|Adverse Event|3|||
13298488|NCT01358578|26501331|FG000|Maintenance Period|Lack of Efficacy|10|||
13298489|NCT01358578|26501332|FG001|Maintenance Period|Lack of Efficacy|2|||
13298490|NCT01358578|26501333|FG002|Maintenance Period|Lack of Efficacy|0|||
13298491|NCT01358578|26501334|FG003|Maintenance Period|Lack of Efficacy|11|||
13298492|NCT01358578|26501335|FG004|Maintenance Period|Lack of Efficacy|3|||
13298493|NCT01358578|26501336|FG005|Maintenance Period|Lack of Efficacy|0|||
13298494|NCT01358578|26501331|FG000|Maintenance Period|Lost to Follow-up|4|||
13298495|NCT01358578|26501332|FG001|Maintenance Period|Lost to Follow-up|0|||
13298496|NCT01358578|26501333|FG002|Maintenance Period|Lost to Follow-up|0|||
13298497|NCT01358578|26501334|FG003|Maintenance Period|Lost to Follow-up|5|||
13298498|NCT01358578|26501335|FG004|Maintenance Period|Lost to Follow-up|1|||
13298499|NCT01358578|26501336|FG005|Maintenance Period|Lost to Follow-up|1|||
13298500|NCT01358578|26501331|FG000|Maintenance Period|Non-compliance with study treatment|3|||
13298501|NCT01358578|26501332|FG001|Maintenance Period|Non-compliance with study treatment|1|||
13298502|NCT01358578|26501333|FG002|Maintenance Period|Non-compliance with study treatment|0|||
13298503|NCT01358578|26501334|FG003|Maintenance Period|Non-compliance with study treatment|2|||
13298504|NCT01358578|26501335|FG004|Maintenance Period|Non-compliance with study treatment|1|||
13298505|NCT01358578|26501336|FG005|Maintenance Period|Non-compliance with study treatment|2|||
13298506|NCT01358578|26501331|FG000|Maintenance Period|Physician Decision|0|||
13298507|NCT01358578|26501332|FG001|Maintenance Period|Physician Decision|1|||
13298508|NCT01358578|26501333|FG002|Maintenance Period|Physician Decision|0|||
13298509|NCT01358578|26501334|FG003|Maintenance Period|Physician Decision|1|||
13298510|NCT01358578|26501335|FG004|Maintenance Period|Physician Decision|0|||
13298511|NCT01358578|26501336|FG005|Maintenance Period|Physician Decision|0|||
13298512|NCT01358578|26501331|FG000|Maintenance Period|Pregnancy|1|||
13298513|NCT01358578|26501332|FG001|Maintenance Period|Pregnancy|0|||
13298514|NCT01358578|26501333|FG002|Maintenance Period|Pregnancy|0|||
13298515|NCT01358578|26501334|FG003|Maintenance Period|Pregnancy|0|||
13298516|NCT01358578|26501335|FG004|Maintenance Period|Pregnancy|0|||
13298517|NCT01358578|26501336|FG005|Maintenance Period|Pregnancy|0|||
13298518|NCT01358578|26501331|FG000|Maintenance Period|Protocol deviation|7|||
13298519|NCT01358578|26501332|FG001|Maintenance Period|Protocol deviation|4|||
13298520|NCT01358578|26501333|FG002|Maintenance Period|Protocol deviation|0|||
13298521|NCT01358578|26501334|FG003|Maintenance Period|Protocol deviation|2|||
13298522|NCT01358578|26501335|FG004|Maintenance Period|Protocol deviation|2|||
13298523|NCT01358578|26501336|FG005|Maintenance Period|Protocol deviation|2|||
13298524|NCT01358578|26501331|FG000|Maintenance Period|Withdrawal by Subject|12|||
13298525|NCT01358578|26501332|FG001|Maintenance Period|Withdrawal by Subject|7|||
13298526|NCT01358578|26501333|FG002|Maintenance Period|Withdrawal by Subject|2|||
13298527|NCT01358578|26501334|FG003|Maintenance Period|Withdrawal by Subject|15|||
13298528|NCT01358578|26501335|FG004|Maintenance Period|Withdrawal by Subject|6|||
13298529|NCT01358578|26501336|FG005|Maintenance Period|Withdrawal by Subject|3|||
13298530|NCT01358578|26501331|FG000|Follow-up Period|Adverse Event|1|||
13298531|NCT01358578|26501332|FG001|Follow-up Period|Adverse Event|1|||
13298532|NCT01358578|26501333|FG002|Follow-up Period|Adverse Event|0|||
13298533|NCT01358578|26501334|FG003|Follow-up Period|Adverse Event|0|||
13298534|NCT01358578|26501335|FG004|Follow-up Period|Adverse Event|0|||
13298535|NCT01358578|26501336|FG005|Follow-up Period|Adverse Event|0|||
13298536|NCT01358578|26501331|FG000|Follow-up Period|Lack of Efficacy|3|||
13298537|NCT01358578|26501332|FG001|Follow-up Period|Lack of Efficacy|0|||
13298538|NCT01358578|26501333|FG002|Follow-up Period|Lack of Efficacy|4|||
13298539|NCT01358578|26501334|FG003|Follow-up Period|Lack of Efficacy|1|||
13298540|NCT01358578|26501335|FG004|Follow-up Period|Lack of Efficacy|0|||
13298541|NCT01358578|26501336|FG005|Follow-up Period|Lack of Efficacy|0|||
13298542|NCT01358578|26501331|FG000|Follow-up Period|Lost to Follow-up|0|||
13298543|NCT01358578|26501332|FG001|Follow-up Period|Lost to Follow-up|1|||
13298544|NCT01358578|26501333|FG002|Follow-up Period|Lost to Follow-up|0|||
13298545|NCT01358578|26501334|FG003|Follow-up Period|Lost to Follow-up|4|||
13298546|NCT01358578|26501335|FG004|Follow-up Period|Lost to Follow-up|0|||
13298547|NCT01358578|26501336|FG005|Follow-up Period|Lost to Follow-up|0|||
13298548|NCT01358578|26501331|FG000|Follow-up Period|non- compliance with study treatment|1|||
13298549|NCT01358578|26501332|FG001|Follow-up Period|non- compliance with study treatment|0|||
13298550|NCT01358578|26501333|FG002|Follow-up Period|non- compliance with study treatment|0|||
13298551|NCT01358578|26501334|FG003|Follow-up Period|non- compliance with study treatment|0|||
13298552|NCT01358578|26501335|FG004|Follow-up Period|non- compliance with study treatment|0|||
13298553|NCT01358578|26501336|FG005|Follow-up Period|non- compliance with study treatment|0|||
13298554|NCT01358578|26501331|FG000|Follow-up Period|Pregnancy|1|||
13298555|NCT01358578|26501332|FG001|Follow-up Period|Pregnancy|0|||
13298556|NCT01358578|26501333|FG002|Follow-up Period|Pregnancy|0|||
13298557|NCT01358578|26501334|FG003|Follow-up Period|Pregnancy|0|||
13298558|NCT01358578|26501335|FG004|Follow-up Period|Pregnancy|0|||
13298559|NCT01358578|26501336|FG005|Follow-up Period|Pregnancy|0|||
13298560|NCT01358578|26501331|FG000|Follow-up Period|Withdrawal by Subject|3|||
13298561|NCT01358578|26501332|FG001|Follow-up Period|Withdrawal by Subject|3|||
13298562|NCT01358578|26501333|FG002|Follow-up Period|Withdrawal by Subject|1|||
13298563|NCT01358578|26501334|FG003|Follow-up Period|Withdrawal by Subject|12|||
13298564|NCT01358578|26501335|FG004|Follow-up Period|Withdrawal by Subject|0|||
13298565|NCT01358578|26501336|FG005|Follow-up Period|Withdrawal by Subject|0|||
13298566|NCT01358578|26501331|FG000|Follow-up Period|Physician Decision|1|||
13298567|NCT01358578|26501332|FG001|Follow-up Period|Physician Decision|1|||
13298568|NCT01358578|26501333|FG002|Follow-up Period|Physician Decision|0|||
13298569|NCT01358578|26501334|FG003|Follow-up Period|Physician Decision|2|||
13298570|NCT01358578|26501335|FG004|Follow-up Period|Physician Decision|0|||
13298571|NCT01358578|26501336|FG005|Follow-up Period|Physician Decision|0|||
13298572|NCT01358526|26501359|FG000|Open-label Titration Period|Adverse Event|95|||
13298573|NCT01358526|26501360|FG001|Open-label Titration Period|Adverse Event|0|||
13298574|NCT01358526|26501361|FG002|Open-label Titration Period|Adverse Event|0|||
13382078|NCT00747344|26749943|FG002|Controlled Period|Lack of Efficacy|0|||
13298575|NCT01358526|26501359|FG000|Open-label Titration Period|Withdrawal by Subject|65|||
13298576|NCT01358526|26501360|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
13394783|NCT00654381|26788098|FG001|Extension Stage|Adverse Event|2|||
13298577|NCT01358526|26501361|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
13298578|NCT01358526|26501359|FG000|Open-label Titration Period|Lost to Follow-up|25|||
13298579|NCT01358526|26501360|FG001|Open-label Titration Period|Lost to Follow-up|0|||
13298580|NCT01358526|26501361|FG002|Open-label Titration Period|Lost to Follow-up|0|||
13298581|NCT01358526|26501359|FG000|Open-label Titration Period|Lack of Efficacy|107|||
13298582|NCT01358526|26501360|FG001|Open-label Titration Period|Lack of Efficacy|0|||
13298583|NCT01358526|26501361|FG002|Open-label Titration Period|Lack of Efficacy|0|||
13298584|NCT01358526|26501359|FG000|Open-label Titration Period|Confirmed or suspected diversion|16|||
13298585|NCT01358526|26501360|FG001|Open-label Titration Period|Confirmed or suspected diversion|0|||
13298586|NCT01358526|26501361|FG002|Open-label Titration Period|Confirmed or suspected diversion|0|||
13298587|NCT01358526|26501359|FG000|Open-label Titration Period|Administrative|8|||
13298588|NCT01358526|26501360|FG001|Open-label Titration Period|Administrative|0|||
13298589|NCT01358526|26501361|FG002|Open-label Titration Period|Administrative|0|||
13298590|NCT01358526|26501359|FG000|Open-label Titration Period|Did not qualify|178|||
13298591|NCT01358526|26501360|FG001|Open-label Titration Period|Did not qualify|0|||
13298592|NCT01358526|26501361|FG002|Open-label Titration Period|Did not qualify|0|||
13298593|NCT01358526|26501359|FG000|Double-blind Phase|Adverse Event|0|||
13298594|NCT01358526|26501360|FG001|Double-blind Phase|Adverse Event|24|||
13298595|NCT01358526|26501361|FG002|Double-blind Phase|Adverse Event|23|||
13298596|NCT01358526|26501359|FG000|Double-blind Phase|Withdrawal by Subject|0|||
13298597|NCT01358526|26501360|FG001|Double-blind Phase|Withdrawal by Subject|10|||
13298598|NCT01358526|26501361|FG002|Double-blind Phase|Withdrawal by Subject|8|||
13298599|NCT01358526|26501359|FG000|Double-blind Phase|Lost to Follow-up|0|||
13298600|NCT01358526|26501360|FG001|Double-blind Phase|Lost to Follow-up|4|||
13298601|NCT01358526|26501361|FG002|Double-blind Phase|Lost to Follow-up|1|||
13298602|NCT01358526|26501359|FG000|Double-blind Phase|Lack of Efficacy|0|||
13298603|NCT01358526|26501360|FG001|Double-blind Phase|Lack of Efficacy|31|||
13298604|NCT01358526|26501361|FG002|Double-blind Phase|Lack of Efficacy|73|||
13298605|NCT01358526|26501359|FG000|Double-blind Phase|Confirmed or suspected diversion|0|||
13298606|NCT01358526|26501360|FG001|Double-blind Phase|Confirmed or suspected diversion|5|||
13298607|NCT01358526|26501361|FG002|Double-blind Phase|Confirmed or suspected diversion|6|||
13298608|NCT01358526|26501359|FG000|Double-blind Phase|Administrative|0|||
13298609|NCT01358526|26501360|FG001|Double-blind Phase|Administrative|6|||
13298610|NCT01358526|26501361|FG002|Double-blind Phase|Administrative|10|||
13298611|NCT01358357|26501402|FG000|Open Label Phase|Adverse Event|0|||
13298612|NCT01358357|26501403|FG001|Open Label Phase|Adverse Event|0|||
13298613|NCT01358357|26501404|FG002|Open Label Phase|Adverse Event|59|||
13298614|NCT01358357|26501402|FG000|Open Label Phase|Lack of Efficacy|0|||
13298615|NCT01358357|26501403|FG001|Open Label Phase|Lack of Efficacy|0|||
13298616|NCT01358357|26501404|FG002|Open Label Phase|Lack of Efficacy|107|||
13298617|NCT01358357|26501402|FG000|Open Label Phase|Lost to Follow-up|0|||
13298618|NCT01358357|26501403|FG001|Open Label Phase|Lost to Follow-up|0|||
13298619|NCT01358357|26501404|FG002|Open Label Phase|Lost to Follow-up|76|||
13298620|NCT01358357|26501402|FG000|Open Label Phase|Protocol Violation|0|||
13298621|NCT01358357|26501403|FG001|Open Label Phase|Protocol Violation|0|||
13298622|NCT01358357|26501404|FG002|Open Label Phase|Protocol Violation|45|||
13298623|NCT01358357|26501402|FG000|Open Label Phase|Withdrawal by Subject|0|||
13298624|NCT01358357|26501403|FG001|Open Label Phase|Withdrawal by Subject|0|||
13298625|NCT01358357|26501404|FG002|Open Label Phase|Withdrawal by Subject|112|||
13298626|NCT01358357|26501402|FG000|Open Label Phase|Did not meet criteria for DB phase|0|||
13298627|NCT01358357|26501403|FG001|Open Label Phase|Did not meet criteria for DB phase|0|||
13298628|NCT01358357|26501404|FG002|Open Label Phase|Did not meet criteria for DB phase|16|||
13298629|NCT01358357|26501402|FG000|Open Label Phase|Terminated at study completion|0|||
13298630|NCT01358357|26501403|FG001|Open Label Phase|Terminated at study completion|0|||
13298631|NCT01358357|26501404|FG002|Open Label Phase|Terminated at study completion|5|||
13298632|NCT01358357|26501402|FG000|Open Label Phase|Mood episode|0|||
13298633|NCT01358357|26501403|FG001|Open Label Phase|Mood episode|0|||
13298634|NCT01358357|26501404|FG002|Open Label Phase|Mood episode|42|||
13298635|NCT01358357|26501402|FG000|Double-Blind Phase|Adverse Event|8|||
13298636|NCT01358357|26501403|FG001|Double-Blind Phase|Adverse Event|5|||
13298637|NCT01358357|26501404|FG002|Double-Blind Phase|Adverse Event|0|||
13298638|NCT01358357|26501402|FG000|Double-Blind Phase|Lost to Follow-up|5|||
13298639|NCT01358357|26501403|FG001|Double-Blind Phase|Lost to Follow-up|7|||
13298640|NCT01358357|26501404|FG002|Double-Blind Phase|Lost to Follow-up|0|||
13298641|NCT01358357|26501402|FG000|Double-Blind Phase|Protocol Violation|1|||
13298642|NCT01358357|26501403|FG001|Double-Blind Phase|Protocol Violation|11|||
13298643|NCT01358357|26501404|FG002|Double-Blind Phase|Protocol Violation|0|||
13298644|NCT01358357|26501402|FG000|Double-Blind Phase|Protocol Violation|16|||
13298645|NCT01358357|26501403|FG001|Double-Blind Phase|Protocol Violation|12|||
13298646|NCT01358357|26501404|FG002|Double-Blind Phase|Protocol Violation|0|||
13298647|NCT01358357|26501402|FG000|Double-Blind Phase|Terminated at study completion|2|||
13298648|NCT01358357|26501403|FG001|Double-Blind Phase|Terminated at study completion|0|||
13298649|NCT01358357|26501404|FG002|Double-Blind Phase|Terminated at study completion|0|||
13394784|NCT00654381|26788099|FG002|Extension Stage|Adverse Event|9|||
13298650|NCT01358357|26501402|FG000|Double-Blind Phase|Recurrence of mood event|48|||
13298651|NCT01358357|26501403|FG001|Double-Blind Phase|Recurrence of mood event|64|||
13298652|NCT01358357|26501404|FG002|Double-Blind Phase|Recurrence of mood event|0|||
13298653|NCT01358357|26501402|FG000|Double-Blind Phase|Administrative|0|||
13298654|NCT01358357|26501403|FG001|Double-Blind Phase|Administrative|1|||
13298655|NCT01358357|26501404|FG002|Double-Blind Phase|Administrative|0|||
13298656|NCT01358331|26501443|FG000|Overall Study|Lost to Follow-up|0|||
13298657|NCT01358331|26501444|FG001|Overall Study|Lost to Follow-up|0|||
13298658|NCT01358331|26501445|FG002|Overall Study|Lost to Follow-up|0|||
13298659|NCT01358331|26501446|FG003|Overall Study|Lost to Follow-up|1|||
13298660|NCT01358331|26501447|FG004|Overall Study|Lost to Follow-up|0|||
13298661|NCT01358331|26501448|FG005|Overall Study|Lost to Follow-up|0|||
13298662|NCT01358331|26501443|FG000|Overall Study|Withdrawal by Subject|0|||
13298663|NCT01358331|26501444|FG001|Overall Study|Withdrawal by Subject|0|||
13298664|NCT01358331|26501445|FG002|Overall Study|Withdrawal by Subject|0|||
13298665|NCT01358331|26501446|FG003|Overall Study|Withdrawal by Subject|1|||
13298666|NCT01358331|26501447|FG004|Overall Study|Withdrawal by Subject|1|||
13298667|NCT01358331|26501448|FG005|Overall Study|Withdrawal by Subject|1|||
13298668|NCT01358331|26501443|FG000|Overall Study|Adverse Events|1|||
13298669|NCT01358331|26501444|FG001|Overall Study|Adverse Events|1|||
13298670|NCT01358331|26501445|FG002|Overall Study|Adverse Events|1|||
13298671|NCT01358331|26501446|FG003|Overall Study|Adverse Events|0|||
13298672|NCT01358331|26501447|FG004|Overall Study|Adverse Events|1|||
13298673|NCT01358331|26501448|FG005|Overall Study|Adverse Events|5|||
13298674|NCT01358331|26501443|FG000|Overall Study|Symptomatic Deterioration|0|||
13298675|NCT01358331|26501444|FG001|Overall Study|Symptomatic Deterioration|0|||
13298676|NCT01358331|26501445|FG002|Overall Study|Symptomatic Deterioration|0|||
13298677|NCT01358331|26501446|FG003|Overall Study|Symptomatic Deterioration|0|||
13298678|NCT01358331|26501447|FG004|Overall Study|Symptomatic Deterioration|1|||
13298679|NCT01358331|26501448|FG005|Overall Study|Symptomatic Deterioration|0|||
13298680|NCT01358331|26501443|FG000|Overall Study|Participants did not wish to continue|0|||
13298681|NCT01358331|26501444|FG001|Overall Study|Participants did not wish to continue|0|||
13298682|NCT01358331|26501445|FG002|Overall Study|Participants did not wish to continue|0|||
13298683|NCT01358331|26501446|FG003|Overall Study|Participants did not wish to continue|0|||
13298684|NCT01358331|26501447|FG004|Overall Study|Participants did not wish to continue|1|||
13298685|NCT01358331|26501448|FG005|Overall Study|Participants did not wish to continue|0|||
13298686|NCT01358331|26501443|FG000|Overall Study|Progress of disease under investigation|1|||
13298687|NCT01358331|26501444|FG001|Overall Study|Progress of disease under investigation|2|||
13298688|NCT01358331|26501445|FG002|Overall Study|Progress of disease under investigation|3|||
13298689|NCT01358331|26501446|FG003|Overall Study|Progress of disease under investigation|1|||
13298690|NCT01358331|26501447|FG004|Overall Study|Progress of disease under investigation|3|||
13298691|NCT01358331|26501448|FG005|Overall Study|Progress of disease under investigation|0|||
13298692|NCT01358175|26501491|FG000|Overall Study|Death|1|||
13298693|NCT01358175|26501492|FG001|Overall Study|Death|0|||
13298694|NCT01358175|26501493|FG002|Overall Study|Death|1|||
13298695|NCT01358175|26501491|FG000|Overall Study|Withdrawal by Subject|9|||
13298696|NCT01358175|26501492|FG001|Overall Study|Withdrawal by Subject|5|||
13298697|NCT01358175|26501493|FG002|Overall Study|Withdrawal by Subject|10|||
13298698|NCT01358175|26501491|FG000|Overall Study|Technical issues|0|||
13298699|NCT01358175|26501492|FG001|Overall Study|Technical issues|1|||
13298700|NCT01358175|26501493|FG002|Overall Study|Technical issues|0|||
13298701|NCT01358175|26501491|FG000|Overall Study|Pregnancy|0|||
13298702|NCT01358175|26501492|FG001|Overall Study|Pregnancy|1|||
13298703|NCT01358175|26501493|FG002|Overall Study|Pregnancy|0|||
13298704|NCT01358175|26501491|FG000|Overall Study|Physician Decision|1|||
13298705|NCT01358175|26501492|FG001|Overall Study|Physician Decision|0|||
13298706|NCT01358175|26501493|FG002|Overall Study|Physician Decision|0|||
13298707|NCT01358175|26501491|FG000|Overall Study|Non Compliance with Study Treatment|0|||
13298708|NCT01358175|26501492|FG001|Overall Study|Non Compliance with Study Treatment|1|||
13298709|NCT01358175|26501493|FG002|Overall Study|Non Compliance with Study Treatment|1|||
13298710|NCT01358175|26501491|FG000|Overall Study|Lost to Follow-up|1|||
13298711|NCT01358175|26501492|FG001|Overall Study|Lost to Follow-up|1|||
13298712|NCT01358175|26501493|FG002|Overall Study|Lost to Follow-up|3|||
13298713|NCT01358175|26501491|FG000|Overall Study|Lack of Efficacy|3|||
13298714|NCT01358175|26501492|FG001|Overall Study|Lack of Efficacy|8|||
13298715|NCT01358175|26501493|FG002|Overall Study|Lack of Efficacy|6|||
13298716|NCT01358175|26501491|FG000|Overall Study|Adverse Event|6|||
13298717|NCT01358175|26501492|FG001|Overall Study|Adverse Event|11|||
13298718|NCT01358175|26501493|FG002|Overall Study|Adverse Event|11|||
13298719|NCT01357980|26501548|FG000|Overall Study|Lack of Efficacy|0|||
13298720|NCT01357980|26501549|FG001|Overall Study|Lack of Efficacy|1|||
13298721|NCT01357980|26501550|FG002|Overall Study|Lack of Efficacy|0|||
13298722|NCT01357980|26501551|FG003|Overall Study|Lack of Efficacy|0|||
13298723|NCT01357980|26501548|FG000|Overall Study|Consent withdrawn|0|||
13298724|NCT01357980|26501549|FG001|Overall Study|Consent withdrawn|0|||
13298725|NCT01357980|26501550|FG002|Overall Study|Consent withdrawn|1|||
13298726|NCT01357980|26501551|FG003|Overall Study|Consent withdrawn|0|||
13298727|NCT01357915|26501574|FG000|Overall Study|Lost to Follow-up|3|||
13298728|NCT01357915|26501575|FG001|Overall Study|Lost to Follow-up|0|||
13298729|NCT01357889|26501622|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2|||
13298730|NCT01357889|26501623|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1|||
13298731|NCT01357889|26501622|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
13298732|NCT01357889|26501623|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
13298733|NCT01357889|26501622|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1|||
13298734|NCT01357889|26501623|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0|||
13298735|NCT01357889|26501622|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
13298736|NCT01357889|26501623|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
13298737|NCT01357889|26501622|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0|||
13298738|NCT01357889|26501623|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2|||
13298739|NCT01357889|26501622|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0|||
13298740|NCT01357889|26501623|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2|||
13298741|NCT01357889|26501622|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5|||
13298742|NCT01357889|26501623|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2|||
13298743|NCT01357889|26501622|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2|||
13298744|NCT01357889|26501623|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1|||
13298745|NCT01357889|26501622|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
13298746|NCT01357889|26501623|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
13298747|NCT01357889|26501622|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1|||
13298748|NCT01357889|26501623|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0|||
13298749|NCT01357889|26501622|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0|||
13298750|NCT01357889|26501623|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4|||
13298751|NCT01357889|26501622|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1|||
13298752|NCT01357889|26501623|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0|||
13298753|NCT01357889|26501622|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1|||
13298754|NCT01357889|26501623|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0|||
13298755|NCT01357850|26501708|FG000|Overall Study|Lost to Follow-up|1|||
13298756|NCT01357850|26501709|FG001|Overall Study|Lost to Follow-up|0|||
13298757|NCT01357850|26501710|FG002|Overall Study|Lost to Follow-up|0|||
13298758|NCT01357850|26501711|FG003|Overall Study|Lost to Follow-up|0|||
13298759|NCT01357655|26501733|FG000|Overall Study|Administrative Reason by Sponsor|45|||
13298760|NCT01357655|26501734|FG001|Overall Study|Administrative Reason by Sponsor|0|||
13298761|NCT01357655|26501733|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
13298762|NCT01357655|26501734|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
13298763|NCT01357655|26501733|FG000|Overall Study|Disease Progression|1|||
13298764|NCT01357655|26501734|FG001|Overall Study|Disease Progression|0|||
13298765|NCT01357655|26501733|FG000|Overall Study|Lost to Follow-up|2|||
13298766|NCT01357655|26501734|FG001|Overall Study|Lost to Follow-up|0|||
13298767|NCT01357655|26501733|FG000|Overall Study|Maximum Clinical Benefit|2|||
13298768|NCT01357655|26501734|FG001|Overall Study|Maximum Clinical Benefit|0|||
13298769|NCT01357655|26501733|FG000|Overall Study|Reason Unspecified|1|||
13298770|NCT01357655|26501734|FG001|Overall Study|Reason Unspecified|0|||
13298771|NCT01357655|26501733|FG000|Overall Study|Study Drug Toxicity|11|||
13298772|NCT01357655|26501734|FG001|Overall Study|Study Drug Toxicity|0|||
13298773|NCT01357655|26501733|FG000|Overall Study|Subject Withdrew Consent|1|||
13298774|NCT01357655|26501734|FG001|Overall Study|Subject Withdrew Consent|0|||
13298775|NCT01357616|26501753|FG000|Overall Study|Adverse Event|1|||
13298776|NCT01357616|26501754|FG001|Overall Study|Adverse Event|1|||
13298777|NCT01357616|26501753|FG000|Overall Study|Lost to Follow-up|4|||
13298778|NCT01357616|26501754|FG001|Overall Study|Lost to Follow-up|3|||
13298779|NCT01357616|26501753|FG000|Overall Study|Protocol Violation|0|||
13298780|NCT01357616|26501754|FG001|Overall Study|Protocol Violation|2|||
13298781|NCT01357616|26501753|FG000|Overall Study|Inadequate Control of IOP|1|||
13298782|NCT01357616|26501754|FG001|Overall Study|Inadequate Control of IOP|2|||
13298783|NCT01357616|26501753|FG000|Overall Study|Decision Unrelated to Adverse Event|3|||
13298784|NCT01357616|26501754|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
13298785|NCT01357616|26501753|FG000|Overall Study|Withdrawal by Subject|1|||
13298786|NCT01357616|26501754|FG001|Overall Study|Withdrawal by Subject|0|||
13298787|NCT01357577|26501775|FG000|Overall Study|Lost to Follow-up|20|||
13298788|NCT01357577|26501776|FG001|Overall Study|Lost to Follow-up|16|||
13298789|NCT01357577|26501775|FG000|Overall Study|Withdrawal by Subject|16|||
13298790|NCT01357577|26501776|FG001|Overall Study|Withdrawal by Subject|8|||
13298791|NCT01357577|26501775|FG000|Overall Study|look at data in database?|1|||
13298792|NCT01357577|26501776|FG001|Overall Study|look at data in database?|2|||
13298793|NCT01357551|26501795|FG000|Overall Study|Withdrawal by Subject|6|||
13298794|NCT01357551|26501796|FG001|Overall Study|Withdrawal by Subject|4|||
13298795|NCT01357551|26501795|FG000|Overall Study|Death|0|||
13298796|NCT01357551|26501796|FG001|Overall Study|Death|1|||
13298797|NCT01357551|26501795|FG000|Overall Study|Lost to Follow-up|16|||
13298798|NCT01357551|26501796|FG001|Overall Study|Lost to Follow-up|6|||
13298799|NCT01357239|26501864|FG000|Stratum: All Patients|Adverse Event|0|||
13298800|NCT01357239|26501865|FG001|Stratum: All Patients|Adverse Event|0|||
13298801|NCT01357239|26501866|FG002|Stratum: All Patients|Adverse Event|1|||
13298802|NCT01357239|26501867|FG003|Stratum: All Patients|Adverse Event|1|||
13298803|NCT01357239|26501864|FG000|Stratum: All Patients|Subject withdrew consent|0|||
13298804|NCT01357239|26501865|FG001|Stratum: All Patients|Subject withdrew consent|0|||
13298805|NCT01357239|26501866|FG002|Stratum: All Patients|Subject withdrew consent|1|||
13298806|NCT01357239|26501867|FG003|Stratum: All Patients|Subject withdrew consent|1|||
13298807|NCT01357239|26501864|FG000|Stratum I: Fully-Methylated|Adverse Event|0|||
13298808|NCT01357239|26501865|FG001|Stratum I: Fully-Methylated|Adverse Event|0|||
13298809|NCT01357239|26501866|FG002|Stratum I: Fully-Methylated|Adverse Event|1|||
13298810|NCT01357239|26501867|FG003|Stratum I: Fully-Methylated|Adverse Event|0|||
13298811|NCT01357239|26501864|FG000|Stratum II: Partially-Methylated|Adverse Event|0|||
13298812|NCT01357239|26501865|FG001|Stratum II: Partially-Methylated|Adverse Event|0|||
13298813|NCT01357239|26501866|FG002|Stratum II: Partially-Methylated|Adverse Event|0|||
13298814|NCT01357239|26501867|FG003|Stratum II: Partially-Methylated|Adverse Event|1|||
13298815|NCT01357239|26501864|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
13298816|NCT01357239|26501865|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
13298817|NCT01357239|26501866|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
13298818|NCT01357239|26501867|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
13298819|NCT01357161|26501906|FG000|Part 1 (Open Label Run-in)|Death|5|||
13298820|NCT01357161|26501907|FG001|Part 1 (Open Label Run-in)|Death|0|||
13298821|NCT01357161|26501908|FG002|Part 1 (Open Label Run-in)|Death|0|||
13298822|NCT01357161|26501906|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3|||
13298823|NCT01357161|26501907|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
13298824|NCT01357161|26501908|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
13298825|NCT01357161|26501906|FG000|Part 1 (Open Label Run-in)|Physician Decision|1|||
13298826|NCT01357161|26501907|FG001|Part 1 (Open Label Run-in)|Physician Decision|0|||
13298827|NCT01357161|26501908|FG002|Part 1 (Open Label Run-in)|Physician Decision|0|||
13298828|NCT01357161|26501906|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5|||
13298829|NCT01357161|26501907|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
13298830|NCT01357161|26501908|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
13298831|NCT01357161|26501906|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1|||
13298832|NCT01357161|26501907|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
13298833|NCT01357161|26501908|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
13298834|NCT01357161|26501906|FG000|Part 2 (Double-Blind Comparison)|Death|0|||
13298835|NCT01357161|26501907|FG001|Part 2 (Double-Blind Comparison)|Death|22|||
13298836|NCT01357161|26501908|FG002|Part 2 (Double-Blind Comparison)|Death|19|||
13298837|NCT01357161|26501906|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0|||
13298838|NCT01357161|26501907|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1|||
13298839|NCT01357161|26501908|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6|||
13298840|NCT01357161|26501906|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0|||
13298841|NCT01357161|26501907|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1|||
13298842|NCT01357161|26501908|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4|||
13298843|NCT01357161|26501906|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0|||
13298844|NCT01357161|26501907|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1|||
13298845|NCT01357161|26501908|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3|||
13298846|NCT01357161|26501906|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0|||
13298847|NCT01357161|26501907|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29|||
13298848|NCT01357161|26501908|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26|||
13298849|NCT01357161|26501906|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0|||
13298850|NCT01357161|26501907|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5|||
13298851|NCT01357161|26501908|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4|||
13298852|NCT01356966|26501925|FG000|Overall Study|Withdrawal by Subject|1|||
13298853|NCT01356966|26501926|FG001|Overall Study|Withdrawal by Subject|2|||
13298854|NCT01356966|26501925|FG000|Overall Study|Physician Decision|1|||
13298855|NCT01356966|26501926|FG001|Overall Study|Physician Decision|0|||
13298856|NCT01356940|26501941|FG000|First Intervention (28 Days)|Adverse Event|1|||
13298857|NCT01356940|26501942|FG001|First Intervention (28 Days)|Adverse Event|0|||
13298858|NCT01356940|26501941|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1|||
13298859|NCT01356940|26501942|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0|||
13298860|NCT01356602|26502011|FG000|Overall Study|Protocol Deviation|0|||
13298861|NCT01356602|26502012|FG001|Overall Study|Protocol Deviation|1|||
13298862|NCT01356602|26502013|FG002|Overall Study|Protocol Deviation|1|||
13298863|NCT01356602|26502011|FG000|Overall Study|Administrative Problems|1|||
13298864|NCT01356602|26502012|FG001|Overall Study|Administrative Problems|4|||
13298865|NCT01356602|26502013|FG002|Overall Study|Administrative Problems|5|||
13298866|NCT01356602|26502011|FG000|Overall Study|Lost to Follow-up|4|||
13298867|NCT01356602|26502012|FG001|Overall Study|Lost to Follow-up|5|||
13298868|NCT01356602|26502013|FG002|Overall Study|Lost to Follow-up|6|||
13298869|NCT01356602|26502011|FG000|Overall Study|Withdrawal by Subject|4|||
13298870|NCT01356602|26502012|FG001|Overall Study|Withdrawal by Subject|3|||
13298871|NCT01356602|26502013|FG002|Overall Study|Withdrawal by Subject|7|||
13298872|NCT01356602|26502011|FG000|Overall Study|Lack of Efficacy|0|||
13298873|NCT01356602|26502012|FG001|Overall Study|Lack of Efficacy|1|||
13298874|NCT01356602|26502013|FG002|Overall Study|Lack of Efficacy|4|||
13298875|NCT01356602|26502011|FG000|Overall Study|Adverse Event|0|||
13298876|NCT01356602|26502012|FG001|Overall Study|Adverse Event|1|||
13298877|NCT01356602|26502013|FG002|Overall Study|Adverse Event|1|||
13298878|NCT01356589|26502021|FG000|Overall Study|Enrolled, but not treated|3|||
13298879|NCT01356589|26502021|FG000|Overall Study|Dose data not recorded|2|||
13298880|NCT01356407|26502044|FG000|Overall Study|Lost to Follow-up|2|||
13298881|NCT01356407|26502045|FG001|Overall Study|Lost to Follow-up|0|||
13298882|NCT01356407|26502044|FG000|Overall Study|Patient Withdrew Consent|2|||
13298883|NCT01356407|26502045|FG001|Overall Study|Patient Withdrew Consent|1|||
13298884|NCT01356407|26502044|FG000|Overall Study|Could not afford IMP administration|0|||
13298885|NCT01356407|26502045|FG001|Overall Study|Could not afford IMP administration|1|||
13298886|NCT01356407|26502044|FG000|Overall Study|Not complete Endoscopy|2|||
13298887|NCT01356407|26502045|FG001|Overall Study|Not complete Endoscopy|2|||
13298888|NCT01355679|26502054|FG000|Overall Study|benign tumor types found at biopsy|2|||
13298889|NCT01355627|26502069|FG000|Overall Study|Request By the Patient to Discontinue|5|||
13298890|NCT01355627|26502070|FG001|Overall Study|Request By the Patient to Discontinue|7|||
13298891|NCT01355627|26502069|FG000|Overall Study|Lost to Follow-up|8|||
13298892|NCT01355627|26502070|FG001|Overall Study|Lost to Follow-up|7|||
13298893|NCT01355627|26502069|FG000|Overall Study|Fatal Adverse Event|19|||
13298894|NCT01355627|26502070|FG001|Overall Study|Fatal Adverse Event|23|||
13298895|NCT01355627|26502069|FG000|Overall Study|Other|1|||
13298896|NCT01355627|26502070|FG001|Overall Study|Other|1|||
13298897|NCT01355575|26502082|FG000|Overall Study|Withdrawal by Subject|2|||
13298898|NCT01355523|26502131|FG000|Overall Study|Withdrawal by Subject|1|||
13298899|NCT01355523|26502132|FG001|Overall Study|Withdrawal by Subject|4|||
13298900|NCT01355523|26502131|FG000|Overall Study|Lost to Follow-up|0|||
13298901|NCT01355523|26502132|FG001|Overall Study|Lost to Follow-up|2|||
13298902|NCT01355523|26502131|FG000|Overall Study|Protocol Violation|0|||
13298903|NCT01355523|26502132|FG001|Overall Study|Protocol Violation|2|||
13298904|NCT01355523|26502131|FG000|Overall Study|Adverse Event|0|||
13298905|NCT01355523|26502132|FG001|Overall Study|Adverse Event|2|||
13298906|NCT01355497|26502147|FG000|Overall Study|Death|19|||
13298907|NCT01355497|26502148|FG001|Overall Study|Death|18|||
13298908|NCT01355497|26502147|FG000|Overall Study|Lost to Follow-up|3|||
13298909|NCT01355497|26502148|FG001|Overall Study|Lost to Follow-up|0|||
13298910|NCT01355497|26502147|FG000|Overall Study|Protocol Violation|0|||
13298911|NCT01355497|26502148|FG001|Overall Study|Protocol Violation|1|||
13298912|NCT01355497|26502147|FG000|Overall Study|other-not provided|9|||
13298913|NCT01355497|26502148|FG001|Overall Study|other-not provided|4|||
13298914|NCT01355497|26502147|FG000|Overall Study|Withdrawal by Subject|12|||
13298915|NCT01355497|26502148|FG001|Overall Study|Withdrawal by Subject|20|||
13298916|NCT01355497|26502147|FG000|Overall Study|noncompliance|1|||
13298917|NCT01355497|26502148|FG001|Overall Study|noncompliance|2|||
13298918|NCT01355497|26502147|FG000|Overall Study|progressive disease|11|||
13298919|NCT01355497|26502148|FG001|Overall Study|progressive disease|8|||
13298920|NCT01355497|26502147|FG000|Overall Study|Adverse Event|11|||
13298921|NCT01355497|26502148|FG001|Overall Study|Adverse Event|10|||
13298922|NCT01355302|26502163|FG000|Phase 1b|Death|4|||
13298923|NCT01355302|26502164|FG001|Phase 1b|Death|0|||
13298924|NCT01355302|26502165|FG002|Phase 1b|Death|0|||
13298925|NCT01355302|26502163|FG000|Phase 1b|Study terminated by sponsor|2|||
13298926|NCT01355302|26502164|FG001|Phase 1b|Study terminated by sponsor|0|||
13298927|NCT01355302|26502165|FG002|Phase 1b|Study terminated by sponsor|0|||
13298928|NCT01355289|26502202|FG000|Core Study|Adverse Event, Non-Fatal|1|||
13298929|NCT01355289|26502203|FG001|Core Study|Adverse Event, Non-Fatal|0|||
13298930|NCT01355289|26502204|FG002|Core Study|Adverse Event, Non-Fatal|0|||
13298931|NCT01355289|26502205|FG003|Core Study|Adverse Event, Non-Fatal|0|||
13298932|NCT01355289|26502206|FG004|Core Study|Adverse Event, Non-Fatal|0|||
13298933|NCT01355289|26502202|FG000|Core Study|Inadequate Therapeutic Effect|0|||
13298934|NCT01355289|26502203|FG001|Core Study|Inadequate Therapeutic Effect|0|||
13298935|NCT01355289|26502204|FG002|Core Study|Inadequate Therapeutic Effect|0|||
13298936|NCT01355289|26502205|FG003|Core Study|Inadequate Therapeutic Effect|1|||
13298937|NCT01355289|26502206|FG004|Core Study|Inadequate Therapeutic Effect|0|||
13298938|NCT01355289|26502202|FG000|Core Study|Other|0|||
13298939|NCT01355289|26502203|FG001|Core Study|Other|0|||
13298940|NCT01355289|26502204|FG002|Core Study|Other|0|||
13298941|NCT01355289|26502205|FG003|Core Study|Other|1|||
13298942|NCT01355289|26502206|FG004|Core Study|Other|0|||
13298943|NCT01355289|26502202|FG000|Open Label Extension|Adverse Event, Non-Fatal|0|||
13298944|NCT01355289|26502203|FG001|Open Label Extension|Adverse Event, Non-Fatal|0|||
13298945|NCT01355289|26502204|FG002|Open Label Extension|Adverse Event, Non-Fatal|0|||
13298946|NCT01355289|26502205|FG003|Open Label Extension|Adverse Event, Non-Fatal|0|||
13298947|NCT01355289|26502206|FG004|Open Label Extension|Adverse Event, Non-Fatal|1|||
13298948|NCT01355289|26502202|FG000|Open Label Extension|Lost to Follow-up|0|||
13298949|NCT01355289|26502203|FG001|Open Label Extension|Lost to Follow-up|0|||
13298950|NCT01355289|26502204|FG002|Open Label Extension|Lost to Follow-up|0|||
13298951|NCT01355289|26502205|FG003|Open Label Extension|Lost to Follow-up|0|||
13298952|NCT01355289|26502206|FG004|Open Label Extension|Lost to Follow-up|1|||
13298953|NCT01355289|26502202|FG000|Open Label Extension|Inadequate Therapeutic Effect|0|||
13298954|NCT01355289|26502203|FG001|Open Label Extension|Inadequate Therapeutic Effect|0|||
13298955|NCT01355289|26502204|FG002|Open Label Extension|Inadequate Therapeutic Effect|0|||
13298956|NCT01355289|26502205|FG003|Open Label Extension|Inadequate Therapeutic Effect|0|||
13298957|NCT01355289|26502206|FG004|Open Label Extension|Inadequate Therapeutic Effect|29|||
13298958|NCT01355289|26502202|FG000|Open Label Extension|Other|0|||
13298959|NCT01355289|26502203|FG001|Open Label Extension|Other|0|||
13298960|NCT01355289|26502204|FG002|Open Label Extension|Other|0|||
13298961|NCT01355289|26502205|FG003|Open Label Extension|Other|0|||
13298962|NCT01355289|26502206|FG004|Open Label Extension|Other|3|||
13298963|NCT01355159|26502267|FG000|Overall Study|Withdrew consent|39|||
13298964|NCT01355159|26502268|FG001|Overall Study|Withdrew consent|47|||
13298965|NCT01355159|26502267|FG000|Overall Study|No primary outcome data|17|||
13298966|NCT01355159|26502268|FG001|Overall Study|No primary outcome data|11|||
13298967|NCT01355159|26502267|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22|||
13298968|NCT01355159|26502268|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15|||
13298969|NCT01355159|26502267|FG000|Overall Study|Early intrauterine fetal death|6|||
13298970|NCT01355159|26502268|FG001|Overall Study|Early intrauterine fetal death|6|||
13298971|NCT01355081|26502301|FG000|Overall Study|Pretreatment Event or Adverse Event|3|||
13298972|NCT01355081|26502302|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
13298973|NCT01355081|26502303|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
13298974|NCT01355081|26502301|FG000|Overall Study|Major Protocol Deviation|0|||
13298975|NCT01355081|26502302|FG001|Overall Study|Major Protocol Deviation|1|||
13298976|NCT01355081|26502303|FG002|Overall Study|Major Protocol Deviation|0|||
13298977|NCT01355081|26502301|FG000|Overall Study|Lost to Follow-up|0|||
13298978|NCT01355081|26502302|FG001|Overall Study|Lost to Follow-up|0|||
13298979|NCT01355081|26502303|FG002|Overall Study|Lost to Follow-up|1|||
13298980|NCT01355081|26502301|FG000|Overall Study|Withdrawal of Consent|2|||
13298981|NCT01355081|26502302|FG001|Overall Study|Withdrawal of Consent|3|||
13298982|NCT01355081|26502303|FG002|Overall Study|Withdrawal of Consent|3|||
13298983|NCT01355081|26502301|FG000|Overall Study|Lack of Efficacy|2|||
13298984|NCT01355081|26502302|FG001|Overall Study|Lack of Efficacy|1|||
13298985|NCT01355081|26502303|FG002|Overall Study|Lack of Efficacy|1|||
13298986|NCT01355081|26502301|FG000|Overall Study|Non Compliance with Study Medication|0|||
13298987|NCT01355081|26502302|FG001|Overall Study|Non Compliance with Study Medication|1|||
13298988|NCT01355081|26502303|FG002|Overall Study|Non Compliance with Study Medication|0|||
13298989|NCT01355068|26502322|FG000|First Intervention Period|Adverse Event|0|||
13298990|NCT01355068|26502323|FG001|First Intervention Period|Adverse Event|1|||
13298991|NCT01355068|26502322|FG000|First Intervention Period|Withdrawal by Subject|0|||
13298992|NCT01355068|26502323|FG001|First Intervention Period|Withdrawal by Subject|1|||
13298993|NCT01354964|26502346|FG000|Overall Study|Lost to Follow-up|2|||
13298994|NCT01354964|26502347|FG001|Overall Study|Lost to Follow-up|0|||
13298995|NCT01354964|26502346|FG000|Overall Study|IV access issues|1|||
13298996|NCT01354964|26502347|FG001|Overall Study|IV access issues|1|||
13298997|NCT01354964|26502346|FG000|Overall Study|Physician Decision|1|||
13298998|NCT01354964|26502347|FG001|Overall Study|Physician Decision|0|||
13298999|NCT01354938|26502355|FG000|Overall Study|Lost to Follow-up|1|||
13299000|NCT01354899|26502362|FG000|Overall Study|discharge from the hospital|2|||
13299001|NCT01354899|26502362|FG000|Overall Study|Protocol Violation|1|||
13299002|NCT01354496|26502400|FG000|Period 1|Adverse Event|0|||
13299003|NCT01354496|26502401|FG001|Period 1|Adverse Event|0|||
13299004|NCT01354496|26502402|FG002|Period 1|Adverse Event|1|||
13299005|NCT01354496|26502403|FG003|Period 1|Adverse Event|0|||
13299006|NCT01354496|26502404|FG004|Period 1|Adverse Event|0|||
13299007|NCT01354496|26502405|FG005|Period 1|Adverse Event|0|||
13299008|NCT01354496|26502400|FG000|Period 1|Physician Decision|0|||
13299009|NCT01354496|26502401|FG001|Period 1|Physician Decision|0|||
13299010|NCT01354496|26502402|FG002|Period 1|Physician Decision|1|||
13299011|NCT01354496|26502403|FG003|Period 1|Physician Decision|0|||
13299012|NCT01354496|26502404|FG004|Period 1|Physician Decision|0|||
13299013|NCT01354496|26502405|FG005|Period 1|Physician Decision|0|||
13299014|NCT01354496|26502400|FG000|Period 2|Adverse Event|0|||
13299015|NCT01354496|26502401|FG001|Period 2|Adverse Event|0|||
13299016|NCT01354496|26502402|FG002|Period 2|Adverse Event|0|||
13299017|NCT01354496|26502403|FG003|Period 2|Adverse Event|1|||
13299018|NCT01354496|26502404|FG004|Period 2|Adverse Event|0|||
13299019|NCT01354496|26502405|FG005|Period 2|Adverse Event|0|||
13299020|NCT01354496|26502400|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0|||
13299021|NCT01354496|26502401|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1|||
13299022|NCT01354496|26502402|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0|||
13299023|NCT01354496|26502403|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1|||
13299024|NCT01354496|26502404|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0|||
13299025|NCT01354496|26502405|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0|||
13299026|NCT01354431|26502432|FG000|Pre-Treatment Period|Not reported|1|||
13299027|NCT01354431|26502433|FG001|Pre-Treatment Period|Not reported|0|||
13299028|NCT01354431|26502434|FG002|Pre-Treatment Period|Not reported|0|||
13299029|NCT01354431|26502432|FG000|Treatment Period|Disease Progression|50|||
13299030|NCT01354431|26502433|FG001|Treatment Period|Disease Progression|40|||
13299031|NCT01354431|26502434|FG002|Treatment Period|Disease Progression|44|||
13299032|NCT01354431|26502432|FG000|Treatment Period|Study Drug Toxicity|5|||
13299033|NCT01354431|26502433|FG001|Treatment Period|Study Drug Toxicity|8|||
13299034|NCT01354431|26502434|FG002|Treatment Period|Study Drug Toxicity|4|||
13299035|NCT01354431|26502432|FG000|Treatment Period|Death|0|||
13299036|NCT01354431|26502433|FG001|Treatment Period|Death|1|||
13299037|NCT01354431|26502434|FG002|Treatment Period|Death|0|||
13299038|NCT01354431|26502432|FG000|Treatment Period|AE unrelated to study drug|1|||
13299039|NCT01354431|26502433|FG001|Treatment Period|AE unrelated to study drug|2|||
13299040|NCT01354431|26502434|FG002|Treatment Period|AE unrelated to study drug|5|||
13299041|NCT01354431|26502432|FG000|Treatment Period|Participant request to discontinue|2|||
13299042|NCT01354431|26502433|FG001|Treatment Period|Participant request to discontinue|2|||
13299043|NCT01354431|26502434|FG002|Treatment Period|Participant request to discontinue|1|||
13299044|NCT01354431|26502432|FG000|Treatment Period|Participant withdrew consent|0|||
13299045|NCT01354431|26502433|FG001|Treatment Period|Participant withdrew consent|1|||
13299046|NCT01354431|26502434|FG002|Treatment Period|Participant withdrew consent|0|||
13299047|NCT01354431|26502432|FG000|Treatment Period|Participant no longer meeting study criteria|1|||
13299048|NCT01354431|26502433|FG001|Treatment Period|Participant no longer meeting study criteria|0|||
13299049|NCT01354431|26502434|FG002|Treatment Period|Participant no longer meeting study criteria|0|||
13299050|NCT01354353|26502517|FG000|Overall Study|Adverse Event|1|||
13299051|NCT01354353|26502518|FG001|Overall Study|Adverse Event|0|||
13299052|NCT01354353|26502519|FG002|Overall Study|Adverse Event|0|||
13299053|NCT01354353|26502520|FG003|Overall Study|Adverse Event|4|||
13299054|NCT01354353|26502521|FG004|Overall Study|Adverse Event|0|||
13299055|NCT01354353|26502522|FG005|Overall Study|Adverse Event|5|||
13299056|NCT01354353|26502517|FG000|Overall Study|Entry Criteria Not Met|0|||
13299057|NCT01354353|26502518|FG001|Overall Study|Entry Criteria Not Met|0|||
13299058|NCT01354353|26502519|FG002|Overall Study|Entry Criteria Not Met|0|||
13299059|NCT01354353|26502520|FG003|Overall Study|Entry Criteria Not Met|1|||
13299060|NCT01354353|26502521|FG004|Overall Study|Entry Criteria Not Met|1|||
13299061|NCT01354353|26502522|FG005|Overall Study|Entry Criteria Not Met|0|||
13299062|NCT01354353|26502517|FG000|Overall Study|Physician Decision|0|||
13299063|NCT01354353|26502518|FG001|Overall Study|Physician Decision|1|||
13299064|NCT01354353|26502519|FG002|Overall Study|Physician Decision|1|||
13299065|NCT01354353|26502520|FG003|Overall Study|Physician Decision|0|||
13299066|NCT01354353|26502521|FG004|Overall Study|Physician Decision|0|||
13299067|NCT01354353|26502522|FG005|Overall Study|Physician Decision|0|||
13299068|NCT01354353|26502517|FG000|Overall Study|Withdrawal by Subject|2|||
13299069|NCT01354353|26502518|FG001|Overall Study|Withdrawal by Subject|0|||
13299070|NCT01354353|26502519|FG002|Overall Study|Withdrawal by Subject|1|||
13299071|NCT01354353|26502520|FG003|Overall Study|Withdrawal by Subject|0|||
13299072|NCT01354353|26502521|FG004|Overall Study|Withdrawal by Subject|0|||
13299073|NCT01354353|26502522|FG005|Overall Study|Withdrawal by Subject|1|||
13299074|NCT01354314|26502669|FG000|Overall Study|Lost to Follow-up|1|||
13299075|NCT01354314|26502670|FG001|Overall Study|Lost to Follow-up|0|||
13299076|NCT01354314|26502671|FG002|Overall Study|Lost to Follow-up|1|||
13299077|NCT01354314|26502672|FG003|Overall Study|Lost to Follow-up|1|||
13299078|NCT01354314|26502669|FG000|Overall Study|Withdrawal by Subject|0|||
13299079|NCT01354314|26502670|FG001|Overall Study|Withdrawal by Subject|0|||
13299080|NCT01354314|26502671|FG002|Overall Study|Withdrawal by Subject|1|||
13299081|NCT01354314|26502672|FG003|Overall Study|Withdrawal by Subject|0|||
13382079|NCT00747344|26749944|FG003|Controlled Period|Lack of Efficacy|0|||
13382080|NCT00747344|26749941|FG000|Controlled Period|Other|0|||
13382081|NCT00747344|26749942|FG001|Controlled Period|Other|3|||
13382082|NCT00747344|26749943|FG002|Controlled Period|Other|0|||
13382083|NCT00747344|26749944|FG003|Controlled Period|Other|0|||
13382084|NCT00747344|26749941|FG000|After Controlled Period|Adverse Event|0|||
13382085|NCT00747344|26749942|FG001|After Controlled Period|Adverse Event|0|||
13382086|NCT00747344|26749943|FG002|After Controlled Period|Adverse Event|0|||
13382087|NCT00747344|26749944|FG003|After Controlled Period|Adverse Event|1|||
13382088|NCT00747227|26749963|FG000|Overall Study|Death|3|||
13382089|NCT00747227|26749964|FG001|Overall Study|Death|1|||
13382090|NCT00747227|26749963|FG000|Overall Study|Withdrawal by Subject|1|||
13382091|NCT00747227|26749964|FG001|Overall Study|Withdrawal by Subject|0|||
13382092|NCT00747227|26749963|FG000|Overall Study|Lost to Follow-up|1|||
13382093|NCT00747227|26749964|FG001|Overall Study|Lost to Follow-up|2|||
13382094|NCT00747227|26749963|FG000|Overall Study|Illness|1|||
13382095|NCT00747227|26749964|FG001|Overall Study|Illness|1|||
13382096|NCT00747149|26749983|FG000|Overall Study|Adverse Event|0|||
13382097|NCT00747149|26749984|FG001|Overall Study|Adverse Event|15|||
13382098|NCT00747149|26749983|FG000|Overall Study|Lost to Follow-up|0|||
13382099|NCT00747149|26749984|FG001|Overall Study|Lost to Follow-up|10|||
13382100|NCT00747149|26749983|FG000|Overall Study|Withdrawal by Subject|0|||
13299082|NCT01354314|26502669|FG000|Overall Study|Adverse Event|0|||
13299083|NCT01354314|26502670|FG001|Overall Study|Adverse Event|0|||
13299084|NCT01354314|26502671|FG002|Overall Study|Adverse Event|0|||
13299085|NCT01354314|26502672|FG003|Overall Study|Adverse Event|1|||
13299086|NCT01354314|26502669|FG000|Overall Study|Protocol Violation|1|||
13299087|NCT01354314|26502670|FG001|Overall Study|Protocol Violation|1|||
13299088|NCT01354314|26502671|FG002|Overall Study|Protocol Violation|0|||
13299089|NCT01354314|26502672|FG003|Overall Study|Protocol Violation|0|||
13299090|NCT01354314|26502669|FG000|Overall Study|Less than 90% Adherence|4|||
13299091|NCT01354314|26502670|FG001|Overall Study|Less than 90% Adherence|2|||
13299092|NCT01354314|26502671|FG002|Overall Study|Less than 90% Adherence|6|||
13299093|NCT01354314|26502672|FG003|Overall Study|Less than 90% Adherence|4|||
13299094|NCT01354223|26502693|FG000|Overall Study|Withdrawal by Subject|3|||
13299095|NCT01354223|26502694|FG001|Overall Study|Withdrawal by Subject|1|||
13299096|NCT01354132|26502739|FG000|Randomization|Physician Decision|1|||
13299097|NCT01354132|26502740|FG001|Randomization|Physician Decision|0|||
13299098|NCT01354132|26502739|FG000|Randomization|Withdrawal by Subject|0|||
13299099|NCT01354132|26502740|FG001|Randomization|Withdrawal by Subject|1|||
13299100|NCT01354132|26502739|FG000|Double Blind (Visits 1-7)|Adverse Event|1|||
13299101|NCT01354132|26502740|FG001|Double Blind (Visits 1-7)|Adverse Event|0|||
13299102|NCT01354132|26502739|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8|||
13299103|NCT01354132|26502740|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11|||
13299104|NCT01354132|26502739|FG000|1 Month Post Study Medication|Withdrawal by Subject|1|||
13299105|NCT01354132|26502740|FG001|1 Month Post Study Medication|Withdrawal by Subject|3|||
13299106|NCT01354106|26502748|FG000|Overall Study|Withdrawal by Subject|2|||
13299107|NCT01354028|26502763|FG000|Overall Study|Physician Decision|0|||
13299108|NCT01354028|26502764|FG001|Overall Study|Physician Decision|2|||
13299109|NCT01354028|26502763|FG000|Overall Study|Discharged before study start|2|||
13299110|NCT01354028|26502764|FG001|Overall Study|Discharged before study start|2|||
13299111|NCT01354028|26502763|FG000|Overall Study|No quiet alert state|0|||
13299112|NCT01354028|26502764|FG001|Overall Study|No quiet alert state|1|||
13299113|NCT01353963|26502776|FG000|Overall Study|Adverse Event|2|||
13299114|NCT01353911|26502875|FG000|Overall Study|Lost to Follow-up|2|||
13299115|NCT01353911|26502876|FG001|Overall Study|Lost to Follow-up|6|||
13299116|NCT01353911|26502877|FG002|Overall Study|Lost to Follow-up|4|||
13299117|NCT01353911|26502878|FG003|Overall Study|Lost to Follow-up|0|||
13299118|NCT01353911|26502879|FG004|Overall Study|Lost to Follow-up|4|||
13299119|NCT01353911|26502880|FG005|Overall Study|Lost to Follow-up|4|||
13299120|NCT01353911|26502881|FG006|Overall Study|Lost to Follow-up|3|||
13299121|NCT01353911|26502882|FG007|Overall Study|Lost to Follow-up|6|||
13299122|NCT01353911|26502875|FG000|Overall Study|Withdrawal by Subject|2|||
13299123|NCT01353911|26502876|FG001|Overall Study|Withdrawal by Subject|3|||
13299124|NCT01353911|26502877|FG002|Overall Study|Withdrawal by Subject|4|||
13299125|NCT01353911|26502878|FG003|Overall Study|Withdrawal by Subject|2|||
13299126|NCT01353911|26502879|FG004|Overall Study|Withdrawal by Subject|2|||
13299127|NCT01353911|26502880|FG005|Overall Study|Withdrawal by Subject|3|||
13299128|NCT01353911|26502881|FG006|Overall Study|Withdrawal by Subject|3|||
13299129|NCT01353911|26502882|FG007|Overall Study|Withdrawal by Subject|9|||
13299130|NCT01353911|26502875|FG000|Overall Study|Status Not Recorded|4|||
13299131|NCT01353911|26502876|FG001|Overall Study|Status Not Recorded|0|||
13299132|NCT01353911|26502877|FG002|Overall Study|Status Not Recorded|1|||
13299133|NCT01353911|26502878|FG003|Overall Study|Status Not Recorded|0|||
13299134|NCT01353911|26502879|FG004|Overall Study|Status Not Recorded|0|||
13299135|NCT01353911|26502880|FG005|Overall Study|Status Not Recorded|0|||
13299136|NCT01353911|26502881|FG006|Overall Study|Status Not Recorded|0|||
13299137|NCT01353911|26502882|FG007|Overall Study|Status Not Recorded|0|||
13299138|NCT01353898|26502927|FG000|Overall Study|Study site terminated|0|||
13299139|NCT01353898|26502928|FG001|Overall Study|Study site terminated|0|||
13299140|NCT01353898|26502929|FG002|Overall Study|Study site terminated|0|||
13299141|NCT01353898|26502930|FG003|Overall Study|Study site terminated|0|||
13299142|NCT01353898|26502931|FG004|Overall Study|Study site terminated|0|||
13299143|NCT01353898|26502932|FG005|Overall Study|Study site terminated|1|||
13299144|NCT01353859|26502947|FG000|Overall Study|Adverse Event|3|||
13299145|NCT01353859|26502947|FG000|Overall Study|Lack of Efficacy|1|||
13299146|NCT01353703|26503000|FG000|Overall Study|Migrated/moved from study area|1|||
13299147|NCT01353703|26503001|FG001|Overall Study|Migrated/moved from study area|0|||
13299148|NCT01353664|26503007|FG000|Overall Study|Other|3|||
13299149|NCT01353664|26503007|FG000|Overall Study|Disease Progression|16|||
13299150|NCT01353586|26503028|FG000|Overall Study|Procedure terminated prior to ablation|3|||
13299151|NCT01353586|26503029|FG001|Overall Study|Procedure terminated prior to ablation|0|||
13299152|NCT01353586|26503028|FG000|Overall Study|Never had insertion of study catheter|4|||
13299153|NCT01353586|26503029|FG001|Overall Study|Never had insertion of study catheter|1|||
13299154|NCT01353586|26503028|FG000|Overall Study|Neurological exam not done|0|||
13299155|NCT01353586|26503029|FG001|Overall Study|Neurological exam not done|1|||
13299156|NCT01353508|26503120|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
13299157|NCT01353508|26503121|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
13299158|NCT01353508|26503122|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
13299159|NCT01353508|26503123|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1|||
13299160|NCT01353508|26503120|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1|||
13299161|NCT01353508|26503121|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
13299162|NCT01353508|26503122|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
13299163|NCT01353508|26503123|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
13299164|NCT01353313|26503214|FG000|Overall Study|Lost to Follow-up|22|||
13299165|NCT01353313|26503215|FG001|Overall Study|Lost to Follow-up|23|||
13299166|NCT01353313|26503214|FG000|Overall Study|Incomplete Follow-up or No Study Data|12|||
13299167|NCT01353313|26503215|FG001|Overall Study|Incomplete Follow-up or No Study Data|15|||
13299168|NCT01353274|26503225|FG000|Overall Study|No case report form (CRF) collected|28|||
13299169|NCT01353222|26503238|FG000|Overall Study|Death|30|||
13299170|NCT01353222|26503239|FG001|Overall Study|Death|30|||
13299171|NCT01353222|26503238|FG000|Overall Study|Withdrawal by Subject|8|||
13299172|NCT01353222|26503239|FG001|Overall Study|Withdrawal by Subject|5|||
13299173|NCT01353222|26503238|FG000|Overall Study|Study Terminated|31|||
13299174|NCT01353222|26503239|FG001|Overall Study|Study Terminated|37|||
13299175|NCT01353222|26503238|FG000|Overall Study|Site closed research department|1|||
13299176|NCT01353222|26503239|FG001|Overall Study|Site closed research department|0|||
13382101|NCT00747149|26749984|FG001|Overall Study|Withdrawal by Subject|6|||
13382102|NCT00747149|26749983|FG000|Overall Study|Did not receive treatment|0|||
13382103|NCT00747149|26749984|FG001|Overall Study|Did not receive treatment|1|||
13382104|NCT00747149|26749983|FG000|Overall Study|Incorrect enrollment|0|||
13382105|NCT00747149|26749984|FG001|Overall Study|Incorrect enrollment|6|||
13382106|NCT00747149|26749983|FG000|Overall Study|Severe non-compliance to protocol|0|||
13382107|NCT00747149|26749984|FG001|Overall Study|Severe non-compliance to protocol|1|||
13382108|NCT00747149|26749983|FG000|Overall Study|Not reported|1|||
13382109|NCT00747149|26749984|FG001|Overall Study|Not reported|4|||
13382110|NCT00747006|26750060|FG000|Overall Study|Adverse Event|1|||
13382111|NCT00747006|26750061|FG001|Overall Study|Adverse Event|0|||
13382112|NCT00747006|26750062|FG002|Overall Study|Adverse Event|0|||
13382113|NCT00747006|26750060|FG000|Overall Study|Lost to Follow-up|0|||
13382114|NCT00747006|26750061|FG001|Overall Study|Lost to Follow-up|1|||
13382115|NCT00747006|26750062|FG002|Overall Study|Lost to Follow-up|0|||
13382116|NCT00747006|26750060|FG000|Overall Study|Physician Decision|2|||
13382117|NCT00747006|26750061|FG001|Overall Study|Physician Decision|0|||
13382118|NCT00747006|26750062|FG002|Overall Study|Physician Decision|1|||
13382119|NCT00746941|26750101|FG000|Overall Study|Death|2|||
13382120|NCT00746941|26750102|FG001|Overall Study|Death|0|||
13382121|NCT00746941|26750103|FG002|Overall Study|Death|0|||
13382122|NCT00746941|26750104|FG003|Overall Study|Death|6|||
13382123|NCT00746941|26750101|FG000|Overall Study|Physician Decision|0|||
13382124|NCT00746941|26750102|FG001|Overall Study|Physician Decision|0|||
13382125|NCT00746941|26750103|FG002|Overall Study|Physician Decision|2|||
13382126|NCT00746941|26750104|FG003|Overall Study|Physician Decision|0|||
13382127|NCT00746941|26750101|FG000|Overall Study|Withdrawal by Subject|3|||
13382128|NCT00746941|26750102|FG001|Overall Study|Withdrawal by Subject|0|||
13382129|NCT00746941|26750103|FG002|Overall Study|Withdrawal by Subject|0|||
13382130|NCT00746941|26750104|FG003|Overall Study|Withdrawal by Subject|2|||
13382131|NCT00746941|26750101|FG000|Overall Study|Other, reason not provided|2|||
13382132|NCT00746941|26750102|FG001|Overall Study|Other, reason not provided|4|||
13382133|NCT00746941|26750103|FG002|Overall Study|Other, reason not provided|0|||
13382134|NCT00746941|26750104|FG003|Overall Study|Other, reason not provided|4|||
13382135|NCT00746941|26750101|FG000|Overall Study|Adverse Event|0|||
13382136|NCT00746941|26750102|FG001|Overall Study|Adverse Event|0|||
13382137|NCT00746941|26750103|FG002|Overall Study|Adverse Event|0|||
13382138|NCT00746941|26750104|FG003|Overall Study|Adverse Event|1|||
13382139|NCT00746798|26750139|FG000|Overall Study|Protocol Violation|0|||
13382140|NCT00746798|26750140|FG001|Overall Study|Protocol Violation|1|||
13382141|NCT00746798|26750141|FG002|Overall Study|Protocol Violation|0|||
13382142|NCT00746798|26750142|FG003|Overall Study|Protocol Violation|0|||
13382143|NCT00746798|26750139|FG000|Overall Study|Withdrawal by Subject|0|||
13382144|NCT00746798|26750140|FG001|Overall Study|Withdrawal by Subject|1|||
13382145|NCT00746798|26750141|FG002|Overall Study|Withdrawal by Subject|1|||
13382146|NCT00746798|26750142|FG003|Overall Study|Withdrawal by Subject|0|||
13382147|NCT00746798|26750139|FG000|Overall Study|Death|0|||
13382148|NCT00746798|26750140|FG001|Overall Study|Death|0|||
13382149|NCT00746798|26750141|FG002|Overall Study|Death|2|||
13382150|NCT00746798|26750142|FG003|Overall Study|Death|0|||
13382151|NCT00746798|26750139|FG000|Overall Study|Participant unable to return for visit|1|||
13382152|NCT00746798|26750140|FG001|Overall Study|Participant unable to return for visit|0|||
13382153|NCT00746798|26750141|FG002|Overall Study|Participant unable to return for visit|0|||
13382154|NCT00746798|26750142|FG003|Overall Study|Participant unable to return for visit|0|||
13382155|NCT00746785|26750160|FG000|Overall Study|Lost to Follow-up|29|||
13382156|NCT00746785|26750161|FG001|Overall Study|Lost to Follow-up|25|||
13382157|NCT00746785|26750162|FG002|Overall Study|Lost to Follow-up|27|||
13299177|NCT01352845|26503333|FG000|Overall Study|Lost to Follow-up|313|||
13299178|NCT01352845|26503334|FG001|Overall Study|Lost to Follow-up|92|||
13299179|NCT01352845|26503333|FG000|Overall Study|No Longer Willing to Participate|205|||
13299180|NCT01352845|26503334|FG001|Overall Study|No Longer Willing to Participate|58|||
13299181|NCT01352845|26503333|FG000|Overall Study|Withdrawal by Subject|48|||
13299182|NCT01352845|26503334|FG001|Overall Study|Withdrawal by Subject|16|||
13299183|NCT01352845|26503333|FG000|Overall Study|No Longer Meets Eligibility Criteria|24|||
13299184|NCT01352845|26503334|FG001|Overall Study|No Longer Meets Eligibility Criteria|11|||
13299185|NCT01352845|26503333|FG000|Overall Study|Pregnancy|27|||
13299186|NCT01352845|26503334|FG001|Overall Study|Pregnancy|7|||
13299187|NCT01352845|26503333|FG000|Overall Study|Adverse Event|22|||
13299188|NCT01352845|26503334|FG001|Overall Study|Adverse Event|6|||
13299189|NCT01352845|26503333|FG000|Overall Study|Other|17|||
13299190|NCT01352845|26503334|FG001|Overall Study|Other|7|||
13299191|NCT01352845|26503333|FG000|Overall Study|Protocol Violation|12|||
13299192|NCT01352845|26503334|FG001|Overall Study|Protocol Violation|6|||
13299193|NCT01352845|26503333|FG000|Overall Study|Death|3|||
13299194|NCT01352845|26503334|FG001|Overall Study|Death|0|||
13299195|NCT01352793|26503365|FG000|Overall Study|Lost to Follow-up|289|||
13299196|NCT01352793|26503366|FG001|Overall Study|Lost to Follow-up|125|||
13299197|NCT01352793|26503365|FG000|Overall Study|Withdrawal by Subject|120|||
13299198|NCT01352793|26503366|FG001|Overall Study|Withdrawal by Subject|55|||
13299199|NCT01352793|26503365|FG000|Overall Study|Protocol Violation|44|||
13299200|NCT01352793|26503366|FG001|Overall Study|Protocol Violation|23|||
13299201|NCT01352793|26503365|FG000|Overall Study|Adverse Event|44|||
13299202|NCT01352793|26503366|FG001|Overall Study|Adverse Event|10|||
13299203|NCT01352793|26503365|FG000|Overall Study|Physician Decision|1|||
13299204|NCT01352793|26503366|FG001|Overall Study|Physician Decision|0|||
13299205|NCT01352793|26503365|FG000|Overall Study|Pregnancy|26|||
13299206|NCT01352793|26503366|FG001|Overall Study|Pregnancy|8|||
13299207|NCT01352793|26503365|FG000|Overall Study|Other|25|||
13299208|NCT01352793|26503366|FG001|Overall Study|Other|7|||
13299209|NCT01352793|26503365|FG000|Overall Study|Medication error|2|||
13299210|NCT01352793|26503366|FG001|Overall Study|Medication error|2|||
13299211|NCT01352793|26503365|FG000|Overall Study|Death|1|||
13299212|NCT01352793|26503366|FG001|Overall Study|Death|0|||
13299213|NCT01352793|26503365|FG000|Overall Study|Randomized but not vaccinated|8|||
13299214|NCT01352793|26503366|FG001|Overall Study|Randomized but not vaccinated|0|||
13299215|NCT01352793|26503365|FG000|Overall Study|No longer meets eligibility criteria|25|||
13299216|NCT01352793|26503366|FG001|Overall Study|No longer meets eligibility criteria|15|||
13299217|NCT01352741|26503461|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4|||
13299218|NCT01352741|26503462|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0|||
13299219|NCT01352741|26503461|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19|||
13299220|NCT01352741|26503462|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0|||
13299221|NCT01352741|26503461|FG000|Open-label Tapentadol Titration Period|Adverse Event|34|||
13299222|NCT01352741|26503462|FG001|Open-label Tapentadol Titration Period|Adverse Event|0|||
13299223|NCT01352741|26503461|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7|||
13299224|NCT01352741|26503462|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0|||
13299225|NCT01352741|26503461|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5|||
13299226|NCT01352741|26503462|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0|||
13299227|NCT01352741|26503461|FG000|Open-label Tapentadol Titration Period|Other|4|||
13299228|NCT01352741|26503462|FG001|Open-label Tapentadol Titration Period|Other|0|||
13299229|NCT01352741|26503461|FG000|Double-blind Comparative Period|Protocol Violation|2|||
13299230|NCT01352741|26503462|FG001|Double-blind Comparative Period|Protocol Violation|0|||
13299231|NCT01352741|26503461|FG000|Double-blind Comparative Period|Lack of Efficacy|0|||
13299232|NCT01352741|26503462|FG001|Double-blind Comparative Period|Lack of Efficacy|3|||
13299233|NCT01352741|26503461|FG000|Double-blind Comparative Period|Adverse Event|16|||
13299234|NCT01352741|26503462|FG001|Double-blind Comparative Period|Adverse Event|17|||
13299235|NCT01352741|26503461|FG000|Double-blind Comparative Period|Lost to Follow-up|1|||
13299236|NCT01352741|26503462|FG001|Double-blind Comparative Period|Lost to Follow-up|0|||
13299237|NCT01352741|26503461|FG000|Double-blind Comparative Period|Death|0|||
13299238|NCT01352741|26503462|FG001|Double-blind Comparative Period|Death|1|||
13299239|NCT01352741|26503461|FG000|Double-blind Comparative Period|Withdrawal of consent|8|||
13299240|NCT01352741|26503462|FG001|Double-blind Comparative Period|Withdrawal of consent|3|||
13299241|NCT01352741|26503461|FG000|Double-blind Comparative Period|Other|1|||
13299242|NCT01352741|26503462|FG001|Double-blind Comparative Period|Other|2|||
13299243|NCT01352741|26503461|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4|||
13299244|NCT01352741|26503462|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0|||
13299245|NCT01352741|26503461|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1|||
13299246|NCT01352741|26503462|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0|||
13299247|NCT01352741|26503461|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2|||
13299248|NCT01352741|26503462|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0|||
13299249|NCT01352741|26503461|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1|||
13299250|NCT01352741|26503462|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0|||
13299251|NCT01352715|26503491|FG000|Overall Study|Death|3|||
13299252|NCT01352715|26503492|FG001|Overall Study|Death|3|||
13299253|NCT01352715|26503491|FG000|Overall Study|Lost to Follow-up|5|||
13299254|NCT01352715|26503492|FG001|Overall Study|Lost to Follow-up|7|||
13299255|NCT01352715|26503491|FG000|Overall Study|Withdrawal by Subject|4|||
13299256|NCT01352715|26503492|FG001|Overall Study|Withdrawal by Subject|8|||
13299257|NCT01352715|26503491|FG000|Overall Study|site closure|16|||
13299258|NCT01352715|26503492|FG001|Overall Study|site closure|15|||
13299259|NCT01352715|26503491|FG000|Overall Study|no final visit in closeout period|15|||
13299260|NCT01352715|26503492|FG001|Overall Study|no final visit in closeout period|12|||
13299261|NCT01352715|26503491|FG000|Overall Study|major ineligibility|2|||
13299262|NCT01352715|26503492|FG001|Overall Study|major ineligibility|1|||
13299263|NCT01352585|26503521|FG000|Overall Study|Adverse Event|2|||
13299264|NCT01352585|26503522|FG001|Overall Study|Adverse Event|1|||
13299265|NCT01352585|26503521|FG000|Overall Study|Lost to Follow-up|1|||
13299266|NCT01352585|26503522|FG001|Overall Study|Lost to Follow-up|0|||
13299267|NCT01352585|26503521|FG000|Overall Study|Other|5|||
13299268|NCT01352585|26503522|FG001|Overall Study|Other|2|||
13299269|NCT01352507|26503560|FG000|Treatment Period 1|Adverse Event|3|||
13299270|NCT01352507|26503561|FG001|Treatment Period 1|Adverse Event|0|||
13299271|NCT01352507|26503560|FG000|Treatment Period 1|Lost to Follow-up|3|||
13299272|NCT01352507|26503561|FG001|Treatment Period 1|Lost to Follow-up|4|||
13299273|NCT01352507|26503560|FG000|Treatment Period 1|Withdrawal by Subject|7|||
13299274|NCT01352507|26503561|FG001|Treatment Period 1|Withdrawal by Subject|5|||
13299275|NCT01352507|26503560|FG000|Treatment Period 1|Physician Decision|1|||
13299276|NCT01352507|26503561|FG001|Treatment Period 1|Physician Decision|0|||
13299277|NCT01352507|26503560|FG000|Washout Period|Withdrawal by Subject|0|||
13299278|NCT01352507|26503561|FG001|Washout Period|Withdrawal by Subject|1|||
13299279|NCT01352507|26503560|FG000|Treatment Period 2|Entry Criteria Not Met|1|||
13299280|NCT01352507|26503561|FG001|Treatment Period 2|Entry Criteria Not Met|0|||
13299281|NCT01352507|26503560|FG000|Treatment Period 2|Withdrawal by Subject|4|||
13299282|NCT01352507|26503561|FG001|Treatment Period 2|Withdrawal by Subject|3|||
13299283|NCT01352507|26503560|FG000|Treatment Period 2|Lack of Efficacy|1|||
13299284|NCT01352507|26503561|FG001|Treatment Period 2|Lack of Efficacy|0|||
13299285|NCT01352416|26503584|FG000|Overall Study|Physician Decision|1|||
13299286|NCT01352416|26503585|FG001|Overall Study|Physician Decision|2|||
13299287|NCT01352416|26503586|FG002|Overall Study|Physician Decision|2|||
13299288|NCT01352416|26503587|FG003|Overall Study|Physician Decision|1|||
13299289|NCT01352221|26503654|FG000|Double-blind Phase|Adverse Event|6|||
13299290|NCT01352221|26503655|FG001|Double-blind Phase|Adverse Event|4|||
13299291|NCT01352221|26503656|FG002|Double-blind Phase|Adverse Event|0|||
13299292|NCT01352221|26503657|FG003|Double-blind Phase|Adverse Event|0|||
13299293|NCT01352221|26503654|FG000|Double-blind Phase|Withdrawal by Subject|3|||
13299294|NCT01352221|26503655|FG001|Double-blind Phase|Withdrawal by Subject|5|||
13299295|NCT01352221|26503656|FG002|Double-blind Phase|Withdrawal by Subject|0|||
13299296|NCT01352221|26503657|FG003|Double-blind Phase|Withdrawal by Subject|0|||
13299297|NCT01352221|26503654|FG000|Double-blind Phase|Lost to Follow-up|0|||
13299298|NCT01352221|26503655|FG001|Double-blind Phase|Lost to Follow-up|1|||
13299299|NCT01352221|26503656|FG002|Double-blind Phase|Lost to Follow-up|0|||
13299300|NCT01352221|26503657|FG003|Double-blind Phase|Lost to Follow-up|0|||
13299301|NCT01352221|26503654|FG000|Double-blind Phase|Protocol Violation|0|||
13299302|NCT01352221|26503655|FG001|Double-blind Phase|Protocol Violation|1|||
13299303|NCT01352221|26503656|FG002|Double-blind Phase|Protocol Violation|0|||
13299304|NCT01352221|26503657|FG003|Double-blind Phase|Protocol Violation|0|||
13299305|NCT01352221|26503654|FG000|Open-label Phase|Physician Decision|0|||
13299306|NCT01352221|26503655|FG001|Open-label Phase|Physician Decision|0|||
13299307|NCT01352221|26503656|FG002|Open-label Phase|Physician Decision|2|||
13299308|NCT01352221|26503657|FG003|Open-label Phase|Physician Decision|1|||
13299309|NCT01352221|26503654|FG000|Open-label Phase|Pregnancy|0|||
13299310|NCT01352221|26503655|FG001|Open-label Phase|Pregnancy|0|||
13299311|NCT01352221|26503656|FG002|Open-label Phase|Pregnancy|1|||
13299312|NCT01352221|26503657|FG003|Open-label Phase|Pregnancy|0|||
13299313|NCT01352221|26503654|FG000|Open-label Phase|Adverse Event|0|||
13299314|NCT01352221|26503655|FG001|Open-label Phase|Adverse Event|0|||
13299315|NCT01352221|26503656|FG002|Open-label Phase|Adverse Event|8|||
13299316|NCT01352221|26503657|FG003|Open-label Phase|Adverse Event|4|||
13299317|NCT01352221|26503654|FG000|Open-label Phase|Withdrawal by Subject|0|||
13299318|NCT01352221|26503655|FG001|Open-label Phase|Withdrawal by Subject|0|||
13299319|NCT01352221|26503656|FG002|Open-label Phase|Withdrawal by Subject|1|||
13299320|NCT01352221|26503657|FG003|Open-label Phase|Withdrawal by Subject|6|||
13299321|NCT01352221|26503654|FG000|Open-label Phase|Worsening of IBD|0|||
13299322|NCT01352221|26503655|FG001|Open-label Phase|Worsening of IBD|0|||
13299323|NCT01352221|26503656|FG002|Open-label Phase|Worsening of IBD|1|||
13299324|NCT01352221|26503657|FG003|Open-label Phase|Worsening of IBD|0|||
13299325|NCT01352117|26503716|FG000|Overall Study|Death|15|||
13299326|NCT01352117|26503717|FG001|Overall Study|Death|16|||
13299327|NCT01352117|26503716|FG000|Overall Study|Withdrawal by Subject|1|||
13299328|NCT01352117|26503717|FG001|Overall Study|Withdrawal by Subject|0|||
13299329|NCT01352117|26503716|FG000|Overall Study|Lost to Follow-up|2|||
13299330|NCT01352117|26503717|FG001|Overall Study|Lost to Follow-up|7|||
13299331|NCT01352117|26503716|FG000|Overall Study|Non-adherent to study requirements|1|||
13299332|NCT01352117|26503717|FG001|Overall Study|Non-adherent to study requirements|1|||
13299333|NCT01352117|26503716|FG000|Overall Study|Did not initiate study treatment|1|||
13299334|NCT01352117|26503717|FG001|Overall Study|Did not initiate study treatment|0|||
13299335|NCT01352117|26503716|FG000|Overall Study|Ineligible (no KS diagnosis)|1|||
13299336|NCT01352117|26503717|FG001|Overall Study|Ineligible (no KS diagnosis)|0|||
13299337|NCT01351623|26503723|FG000|Overall Study|Protocol Violation|2|||
13299338|NCT01351623|26503723|FG000|Overall Study|Adverse Event|4|||
13299339|NCT01351623|26503723|FG000|Overall Study|Withdrawal by Subject|1|||
13299340|NCT01351623|26503723|FG000|Overall Study|Death|2|||
13299341|NCT01351415|26503750|FG000|Overall Study|Withdrawal by Subject|15|||
13299342|NCT01351415|26503751|FG001|Overall Study|Withdrawal by Subject|17|||
13299343|NCT01351415|26503750|FG000|Overall Study|Trial termination by the Sponsor|28|||
13299344|NCT01351415|26503751|FG001|Overall Study|Trial termination by the Sponsor|19|||
13299345|NCT01351415|26503750|FG000|Overall Study|Lost to Follow-up|5|||
13299346|NCT01351415|26503751|FG001|Overall Study|Lost to Follow-up|7|||
13299347|NCT01351415|26503750|FG000|Overall Study|Death|190|||
13299348|NCT01351415|26503751|FG001|Overall Study|Death|187|||
13299349|NCT01351415|26503750|FG000|Overall Study|Physician Decision|2|||
13299350|NCT01351415|26503751|FG001|Overall Study|Physician Decision|3|||
13299351|NCT01351415|26503750|FG000|Overall Study|Reason unknown|0|||
13299352|NCT01351415|26503751|FG001|Overall Study|Reason unknown|2|||
13299353|NCT01351415|26503750|FG000|Overall Study|Never Started|5|||
13299354|NCT01351415|26503751|FG001|Overall Study|Never Started|5|||
13299355|NCT01351350|26503880|FG000|Overall Study|Disease Progression|5|||
13299356|NCT01351350|26503881|FG001|Overall Study|Disease Progression|13|||
13299357|NCT01351350|26503882|FG002|Overall Study|Disease Progression|6|||
13299358|NCT01351350|26503883|FG003|Overall Study|Disease Progression|8|||
13299359|NCT01351350|26503884|FG004|Overall Study|Disease Progression|5|||
13299360|NCT01351350|26503880|FG000|Overall Study|Adverse Event|1|||
13299361|NCT01351350|26503881|FG001|Overall Study|Adverse Event|10|||
13299362|NCT01351350|26503882|FG002|Overall Study|Adverse Event|1|||
13299363|NCT01351350|26503883|FG003|Overall Study|Adverse Event|2|||
13299364|NCT01351350|26503884|FG004|Overall Study|Adverse Event|0|||
13299365|NCT01351350|26503880|FG000|Overall Study|Participant Decision|2|||
13299366|NCT01351350|26503881|FG001|Overall Study|Participant Decision|6|||
13299367|NCT01351350|26503882|FG002|Overall Study|Participant Decision|3|||
13299368|NCT01351350|26503883|FG003|Overall Study|Participant Decision|3|||
13299369|NCT01351350|26503884|FG004|Overall Study|Participant Decision|2|||
13299370|NCT01351350|26503880|FG000|Overall Study|Enrolled but not Treated|0|||
13299371|NCT01351350|26503881|FG001|Overall Study|Enrolled but not Treated|0|||
13299372|NCT01351350|26503882|FG002|Overall Study|Enrolled but not Treated|1|||
13299373|NCT01351350|26503883|FG003|Overall Study|Enrolled but not Treated|0|||
13299374|NCT01351350|26503884|FG004|Overall Study|Enrolled but not Treated|0|||
13299375|NCT01351025|26503921|FG000|Week 0 - 20|Lost to Follow-up|2|||
13299376|NCT01351025|26503922|FG001|Week 0 - 20|Lost to Follow-up|1|||
13299377|NCT01351025|26503921|FG000|Week 0 - 20|Withdrawal by Subject|1|||
13299378|NCT01351025|26503922|FG001|Week 0 - 20|Withdrawal by Subject|0|||
13299379|NCT01351025|26503921|FG000|Week 24 - 44|Lost to Follow-up|0|||
13299380|NCT01351025|26503922|FG001|Week 24 - 44|Lost to Follow-up|2|||
13299381|NCT01351025|26503921|FG000|Week 24 - 44|Site closed|0|||
13299382|NCT01351025|26503922|FG001|Week 24 - 44|Site closed|1|||
13299383|NCT01351025|26503921|FG000|Week 24 - 44|unable to get to clinic|1|||
13299384|NCT01351025|26503922|FG001|Week 24 - 44|unable to get to clinic|1|||
13299385|NCT01350999|26503967|FG000|Overall Study|Adverse Event|4|||
13299386|NCT01350999|26503968|FG001|Overall Study|Adverse Event|9|||
13299387|NCT01350999|26503969|FG002|Overall Study|Adverse Event|10|||
13299388|NCT01350999|26503967|FG000|Overall Study|Voluntary withdrawal|3|||
13299389|NCT01350999|26503968|FG001|Overall Study|Voluntary withdrawal|4|||
13299390|NCT01350999|26503969|FG002|Overall Study|Voluntary withdrawal|6|||
13299391|NCT01350999|26503967|FG000|Overall Study|Difficulty Making it to Study Visit|1|||
13299392|NCT01350999|26503968|FG001|Overall Study|Difficulty Making it to Study Visit|1|||
13299393|NCT01350999|26503969|FG002|Overall Study|Difficulty Making it to Study Visit|5|||
13299394|NCT01350973|26504014|FG000|Overall Study|Adverse Event|4|||
13299395|NCT01350973|26504015|FG001|Overall Study|Adverse Event|7|||
13299396|NCT01350973|26504016|FG002|Overall Study|Adverse Event|7|||
13299397|NCT01350973|26504014|FG000|Overall Study|Voluntary Withdrawal|2|||
13299398|NCT01350973|26504015|FG001|Overall Study|Voluntary Withdrawal|1|||
13299399|NCT01350973|26504016|FG002|Overall Study|Voluntary Withdrawal|1|||
13299400|NCT01350804|26504118|FG000|Core Study|Withdrawal by Subject|11|||
13299401|NCT01350804|26504119|FG001|Core Study|Withdrawal by Subject|17|||
13299402|NCT01350804|26504120|FG002|Core Study|Withdrawal by Subject|16|||
13299403|NCT01350804|26504121|FG003|Core Study|Withdrawal by Subject|7|||
13299404|NCT01350804|26504118|FG000|Core Study|Study terminated by Sponsor|0|||
13299405|NCT01350804|26504119|FG001|Core Study|Study terminated by Sponsor|0|||
13299406|NCT01350804|26504120|FG002|Core Study|Study terminated by Sponsor|0|||
13299407|NCT01350804|26504121|FG003|Core Study|Study terminated by Sponsor|2|||
13299408|NCT01350804|26504118|FG000|Core Study|Protocol deviation|1|||
13299409|NCT01350804|26504119|FG001|Core Study|Protocol deviation|0|||
13299410|NCT01350804|26504120|FG002|Core Study|Protocol deviation|1|||
13299411|NCT01350804|26504121|FG003|Core Study|Protocol deviation|0|||
13299412|NCT01350804|26504118|FG000|Core Study|Physician Decision|1|||
13299413|NCT01350804|26504119|FG001|Core Study|Physician Decision|0|||
13299414|NCT01350804|26504120|FG002|Core Study|Physician Decision|1|||
13299415|NCT01350804|26504121|FG003|Core Study|Physician Decision|3|||
13299416|NCT01350804|26504118|FG000|Core Study|Lost to Follow-up|3|||
13299417|NCT01350804|26504119|FG001|Core Study|Lost to Follow-up|0|||
13299418|NCT01350804|26504120|FG002|Core Study|Lost to Follow-up|2|||
13299419|NCT01350804|26504121|FG003|Core Study|Lost to Follow-up|1|||
13299420|NCT01350804|26504118|FG000|Core Study|Lack of Efficacy|16|||
13299421|NCT01350804|26504119|FG001|Core Study|Lack of Efficacy|19|||
13299422|NCT01350804|26504120|FG002|Core Study|Lack of Efficacy|18|||
13299423|NCT01350804|26504121|FG003|Core Study|Lack of Efficacy|5|||
13299424|NCT01350804|26504118|FG000|Core Study|Death|1|||
13299425|NCT01350804|26504119|FG001|Core Study|Death|1|||
13299426|NCT01350804|26504120|FG002|Core Study|Death|1|||
13299427|NCT01350804|26504121|FG003|Core Study|Death|0|||
13299428|NCT01350804|26504118|FG000|Core Study|Adverse Event|8|||
13299429|NCT01350804|26504119|FG001|Core Study|Adverse Event|10|||
13299430|NCT01350804|26504120|FG002|Core Study|Adverse Event|8|||
13299431|NCT01350804|26504121|FG003|Core Study|Adverse Event|8|||
13299432|NCT01350804|26504118|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5|||
13299433|NCT01350804|26504119|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6|||
13299434|NCT01350804|26504120|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4|||
13299435|NCT01350804|26504121|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3|||
13299436|NCT01350804|26504118|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
13299437|NCT01350804|26504119|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
13299438|NCT01350804|26504120|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64|||
13299439|NCT01350804|26504121|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16|||
13299440|NCT01350804|26504118|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1|||
13299441|NCT01350804|26504119|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0|||
13299442|NCT01350804|26504120|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2|||
13299443|NCT01350804|26504121|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0|||
13299444|NCT01350804|26504118|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
13299445|NCT01350804|26504119|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1|||
13299446|NCT01350804|26504120|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
13299447|NCT01350804|26504121|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
13299448|NCT01350804|26504118|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
13299449|NCT01350804|26504119|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
13299450|NCT01350804|26504120|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0|||
13299451|NCT01350804|26504121|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1|||
13299452|NCT01350804|26504118|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3|||
13299453|NCT01350804|26504119|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1|||
13299454|NCT01350804|26504120|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2|||
13299455|NCT01350804|26504121|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3|||
13299456|NCT01350544|26504134|FG000|Overall Study|Administrative Withdrawal|0|||
13299457|NCT01350544|26504135|FG001|Overall Study|Administrative Withdrawal|1|||
13299458|NCT01350544|26504134|FG000|Overall Study|Death|1|||
13299459|NCT01350544|26504135|FG001|Overall Study|Death|2|||
13299460|NCT01350544|26504134|FG000|Overall Study|Moved out of LA County|2|||
13299461|NCT01350544|26504135|FG001|Overall Study|Moved out of LA County|2|||
13299462|NCT01350544|26504134|FG000|Overall Study|Medical Issues|1|||
13299463|NCT01350544|26504135|FG001|Overall Study|Medical Issues|1|||
13299464|NCT01350544|26504134|FG000|Overall Study|Withdrawal by Subject|0|||
13299465|NCT01350544|26504135|FG001|Overall Study|Withdrawal by Subject|1|||
13299466|NCT01350544|26504134|FG000|Overall Study|Incarceration|1|||
13299467|NCT01350544|26504135|FG001|Overall Study|Incarceration|0|||
13299468|NCT01350544|26504134|FG000|Overall Study|Lost to Follow-up|18|||
13299469|NCT01350544|26504135|FG001|Overall Study|Lost to Follow-up|15|||
13299470|NCT01350505|26504141|FG000|Overall Study|Lost to Follow-up|4|||
13299471|NCT01350492|26504164|FG000|Intervention|Lost to Follow-up|2|||
13299472|NCT01350492|26504165|FG001|Intervention|Lost to Follow-up|5|||
13299473|NCT01350492|26504164|FG000|Intervention|Withdrawal by Subject|3|||
13299474|NCT01350492|26504165|FG001|Intervention|Withdrawal by Subject|1|||
13299475|NCT01350492|26504164|FG000|Post Intervention Follow-Up|Lost to Follow-up|6|||
13299476|NCT01350492|26504165|FG001|Post Intervention Follow-Up|Lost to Follow-up|1|||
13299477|NCT01350492|26504164|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0|||
13299478|NCT01350492|26504165|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1|||
13299479|NCT01350414|26504184|FG000|Overall Study|Lost to Follow-up|13|||
13299480|NCT01350414|26504184|FG000|Overall Study|Withdrawal by Subject|4|||
13299481|NCT01350414|26504184|FG000|Overall Study|Physician Decision|2|||
13299482|NCT01350336|26504249|FG000|Overall Study|Lost to Follow-up|31|||
13299483|NCT01350336|26504249|FG000|Overall Study|Withdrawal by Subject|14|||
13299484|NCT01350336|26504249|FG000|Overall Study|Physician Decision|8|||
13299485|NCT01350336|26504249|FG000|Overall Study|Death|4|||
13299486|NCT01350271|26504273|FG000|Overall Study|Lost to Follow-up|21|||
13299487|NCT01350271|26504274|FG001|Overall Study|Lost to Follow-up|17|||
13299488|NCT01350271|26504275|FG002|Overall Study|Lost to Follow-up|26|||
13299489|NCT01350141|26504319|FG000|Overall Study|Lost to Follow-up|1|||
13299490|NCT01350141|26504320|FG001|Overall Study|Lost to Follow-up|0|||
13299491|NCT01350141|26504321|FG002|Overall Study|Lost to Follow-up|1|||
13299492|NCT01350141|26504319|FG000|Overall Study|Withdrawal by Subject|1|||
13299493|NCT01350141|26504320|FG001|Overall Study|Withdrawal by Subject|0|||
13299494|NCT01350141|26504321|FG002|Overall Study|Withdrawal by Subject|0|||
13299495|NCT01350141|26504319|FG000|Overall Study|Randomized but not treated|1|||
13299496|NCT01350141|26504320|FG001|Overall Study|Randomized but not treated|0|||
13299497|NCT01350141|26504321|FG002|Overall Study|Randomized but not treated|0|||
13299498|NCT01350128|26504385|FG000|Overall Study|Withdrawal by Subject|3|||
13299499|NCT01350128|26504385|FG000|Overall Study|Protocol discontinuation criteria|8|||
13299500|NCT01350128|26504385|FG000|Overall Study|Physician Decision|1|||
13299501|NCT01350128|26504385|FG000|Overall Study|Lost to Follow-up|2|||
13299502|NCT01350115|26504404|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0|||
13299503|NCT01350115|26504405|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1|||
13299504|NCT01350115|26504404|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0|||
13299505|NCT01350115|26504405|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1|||
13299506|NCT01350115|26504404|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1|||
13299507|NCT01350115|26504405|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0|||
13299508|NCT01350102|26504436|FG000|Overall Study|Adverse Event|0|||
13299509|NCT01350102|26504437|FG001|Overall Study|Adverse Event|0|||
13299510|NCT01350102|26504438|FG002|Overall Study|Adverse Event|1|||
13299511|NCT01350102|26504439|FG003|Overall Study|Adverse Event|0|||
13299512|NCT01349907|26504482|FG000|Overall Study|Adverse Event|37|||
13299513|NCT01349907|26504483|FG001|Overall Study|Adverse Event|11|||
13299514|NCT01349907|26504482|FG000|Overall Study|Treatment failure|13|||
13299515|NCT01349907|26504483|FG001|Overall Study|Treatment failure|4|||
13299516|NCT01349907|26504482|FG000|Overall Study|Lost to Follow-up|25|||
13299517|NCT01349907|26504483|FG001|Overall Study|Lost to Follow-up|6|||
13299518|NCT01349907|26504482|FG000|Overall Study|Withdrawal by Subject|30|||
13299519|NCT01349907|26504483|FG001|Overall Study|Withdrawal by Subject|8|||
13299520|NCT01349907|26504482|FG000|Overall Study|Protocol Violation|33|||
13299521|NCT01349907|26504483|FG001|Overall Study|Protocol Violation|13|||
13299522|NCT01349907|26504482|FG000|Overall Study|Administrative|1|||
13299523|NCT01349907|26504483|FG001|Overall Study|Administrative|1|||
13299524|NCT01349829|26504508|FG000|Overall Study|Lost to Follow-up|4|||
13299525|NCT01349829|26504509|FG001|Overall Study|Lost to Follow-up|8|||
13299526|NCT01349829|26504508|FG000|Overall Study|Consent withdrawal|3|||
13299527|NCT01349829|26504509|FG001|Overall Study|Consent withdrawal|8|||
13299528|NCT01349829|26504508|FG000|Overall Study|Migrated/moved|2|||
13299529|NCT01349829|26504509|FG001|Overall Study|Migrated/moved|7|||
13299530|NCT01349816|26504573|FG000|Overall Study|Withdrawal by Subject|4|||
13299531|NCT01349816|26504573|FG000|Overall Study|Physician Decision|1|||
13299532|NCT01349816|26504573|FG000|Overall Study|Adverse Event|14|||
13299533|NCT01349816|26504573|FG000|Overall Study|Lost to Follow-up|2|||
13299534|NCT01349816|26504573|FG000|Overall Study|Protocol Violation|1|||
13299535|NCT01349816|26504573|FG000|Overall Study|Protocol-specified criteria|8|||
13299536|NCT01349803|26504656|FG000|Overall Study|Adverse Event|0|||
13299537|NCT01349803|26504657|FG001|Overall Study|Adverse Event|0|||
13299538|NCT01349803|26504658|FG002|Overall Study|Adverse Event|0|||
13299539|NCT01349803|26504659|FG003|Overall Study|Adverse Event|2|||
13299540|NCT01349803|26504656|FG000|Overall Study|Withdrawal by Subject|1|||
13299541|NCT01349803|26504657|FG001|Overall Study|Withdrawal by Subject|0|||
13299542|NCT01349803|26504658|FG002|Overall Study|Withdrawal by Subject|0|||
13299543|NCT01349803|26504659|FG003|Overall Study|Withdrawal by Subject|0|||
13299544|NCT01349803|26504656|FG000|Overall Study|Protocol-specified criteria|0|||
13299545|NCT01349803|26504657|FG001|Overall Study|Protocol-specified criteria|1|||
13299546|NCT01349803|26504658|FG002|Overall Study|Protocol-specified criteria|3|||
13299547|NCT01349803|26504659|FG003|Overall Study|Protocol-specified criteria|0|||
13299548|NCT01349790|26504680|FG000|Overall Study|Investigator Judgement|3|||
13299549|NCT01349790|26504680|FG000|Overall Study|Death|2|||
13299550|NCT01349790|26504680|FG000|Overall Study|Withdrawal by Patient|2|||
13299551|NCT01349790|26504680|FG000|Overall Study|Adverse Event|1|||
13299552|NCT01349790|26504680|FG000|Overall Study|Lost to Follow-up|1|||
13299553|NCT01349673|26504689|FG000|Overall Study|Progression Of Disease Past 40 cm|1|||
13299554|NCT01349673|26504689|FG000|Overall Study|No Longer Qualified For Study|1|||
13299555|NCT01349673|26504689|FG000|Overall Study|Site Closure|10|||
13299556|NCT01349673|26504689|FG000|Overall Study|Withdrawal by Subject|21|||
13299557|NCT01349673|26504689|FG000|Overall Study|Lost to Follow-up|6|||
13299558|NCT01349673|26504689|FG000|Overall Study|Adverse Event|17|||
13299559|NCT01349673|26504689|FG000|Overall Study|Study Terminated By Sponsor|50|||
13299560|NCT01349673|26504689|FG000|Overall Study|Lack of Efficacy|8|||
13299561|NCT01349660|26504715|FG000|Overall Study|Still Receiving Study Treatment|0|||
13299562|NCT01349660|26504716|FG001|Overall Study|Still Receiving Study Treatment|0|||
13299563|NCT01349660|26504717|FG002|Overall Study|Still Receiving Study Treatment|1|||
13299564|NCT01349660|26504715|FG000|Overall Study|Disease Progression|2|||
13299565|NCT01349660|26504716|FG001|Overall Study|Disease Progression|4|||
13299566|NCT01349660|26504717|FG002|Overall Study|Disease Progression|50|||
13299567|NCT01349660|26504715|FG000|Overall Study|Adverse Event|1|||
13299568|NCT01349660|26504716|FG001|Overall Study|Adverse Event|1|||
13299569|NCT01349660|26504717|FG002|Overall Study|Adverse Event|12|||
13299570|NCT01349660|26504715|FG000|Overall Study|Withdrawal by Subject|2|||
13299571|NCT01349660|26504716|FG001|Overall Study|Withdrawal by Subject|0|||
13299572|NCT01349660|26504717|FG002|Overall Study|Withdrawal by Subject|9|||
13299573|NCT01349660|26504715|FG000|Overall Study|Death|1|||
13299574|NCT01349660|26504716|FG001|Overall Study|Death|1|||
13299575|NCT01349660|26504717|FG002|Overall Study|Death|0|||
13299576|NCT01349660|26504715|FG000|Overall Study|Non-Permitted Interventions|0|||
13299577|NCT01349660|26504716|FG001|Overall Study|Non-Permitted Interventions|0|||
13299578|NCT01349660|26504717|FG002|Overall Study|Non-Permitted Interventions|2|||
13299579|NCT01349660|26504715|FG000|Overall Study|Study Compliance|0|||
13299580|NCT01349660|26504716|FG001|Overall Study|Study Compliance|0|||
13299581|NCT01349660|26504717|FG002|Overall Study|Study Compliance|1|||
13299582|NCT01349660|26504715|FG000|Overall Study|Declining Performance Status|0|||
13299583|NCT01349660|26504716|FG001|Overall Study|Declining Performance Status|0|||
13299584|NCT01349660|26504717|FG002|Overall Study|Declining Performance Status|1|||
13299585|NCT01349595|26504730|FG000|Overall Study|Lack of funding|2|||
13299586|NCT01349595|26504731|FG001|Overall Study|Lack of funding|2|||
13299587|NCT01349569|26504743|FG000|Overall Study|Lack of Efficacy|4|||
13299588|NCT01349465|26504762|FG000|Overall Study|Adverse Event|1|||
13299589|NCT01349465|26504763|FG001|Overall Study|Adverse Event|0|||
13299590|NCT01349465|26504762|FG000|Overall Study|Death|3|||
13299591|NCT01349465|26504763|FG001|Overall Study|Death|0|||
13299592|NCT01349465|26504762|FG000|Overall Study|Lost to Follow-up|10|||
13299593|NCT01349465|26504763|FG001|Overall Study|Lost to Follow-up|1|||
13299594|NCT01349465|26504762|FG000|Overall Study|Withdrawal by Subject|4|||
13299595|NCT01349465|26504763|FG001|Overall Study|Withdrawal by Subject|2|||
13299596|NCT01349465|26504762|FG000|Overall Study|Subject Ineligible To Continue The Trial|0|||
13299597|NCT01349465|26504763|FG001|Overall Study|Subject Ineligible To Continue The Trial|19|||
13299598|NCT01349192|26504782|FG000|Overall Study|Protocol Violation|0|||
13299599|NCT01349192|26504783|FG001|Overall Study|Protocol Violation|1|||
13299600|NCT01349192|26504782|FG000|Overall Study|Withdrawal by Subject|0|||
13299601|NCT01349192|26504783|FG001|Overall Study|Withdrawal by Subject|2|||
13299602|NCT01349192|26504782|FG000|Overall Study|Lost to Follow-up|1|||
13299603|NCT01349192|26504783|FG001|Overall Study|Lost to Follow-up|3|||
13299604|NCT01349192|26504782|FG000|Overall Study|Failure to adhere to Protocol|2|||
13299605|NCT01349192|26504783|FG001|Overall Study|Failure to adhere to Protocol|0|||
13299606|NCT01349049|26504863|FG000|Overall Study|Disease progression|3|||
13299607|NCT01349049|26504864|FG001|Overall Study|Disease progression|5|||
13299608|NCT01349049|26504865|FG002|Overall Study|Disease progression|3|||
13299609|NCT01349049|26504866|FG003|Overall Study|Disease progression|2|||
13299610|NCT01349049|26504867|FG004|Overall Study|Disease progression|2|||
13299611|NCT01349049|26504868|FG005|Overall Study|Disease progression|2|||
13299612|NCT01349049|26504869|FG006|Overall Study|Disease progression|3|||
13299613|NCT01349049|26504870|FG007|Overall Study|Disease progression|2|||
13299614|NCT01349049|26504871|FG008|Overall Study|Disease progression|33|||
13299615|NCT01349049|26504863|FG000|Overall Study|Adverse Event|0|||
13299616|NCT01349049|26504864|FG001|Overall Study|Adverse Event|1|||
13299617|NCT01349049|26504865|FG002|Overall Study|Adverse Event|0|||
13299618|NCT01349049|26504866|FG003|Overall Study|Adverse Event|0|||
13299619|NCT01349049|26504867|FG004|Overall Study|Adverse Event|0|||
13299620|NCT01349049|26504868|FG005|Overall Study|Adverse Event|3|||
13299621|NCT01349049|26504869|FG006|Overall Study|Adverse Event|1|||
13299622|NCT01349049|26504870|FG007|Overall Study|Adverse Event|0|||
13299623|NCT01349049|26504871|FG008|Overall Study|Adverse Event|4|||
13299624|NCT01349049|26504863|FG000|Overall Study|Physician Decision|0|||
13299625|NCT01349049|26504864|FG001|Overall Study|Physician Decision|1|||
13299626|NCT01349049|26504865|FG002|Overall Study|Physician Decision|0|||
13299627|NCT01349049|26504866|FG003|Overall Study|Physician Decision|0|||
13299628|NCT01349049|26504867|FG004|Overall Study|Physician Decision|0|||
13299629|NCT01349049|26504868|FG005|Overall Study|Physician Decision|0|||
13299630|NCT01349049|26504869|FG006|Overall Study|Physician Decision|0|||
13299631|NCT01349049|26504870|FG007|Overall Study|Physician Decision|0|||
13299632|NCT01349049|26504871|FG008|Overall Study|Physician Decision|2|||
13299633|NCT01349049|26504863|FG000|Overall Study|Protocol Violation|0|||
13299634|NCT01349049|26504864|FG001|Overall Study|Protocol Violation|0|||
13299635|NCT01349049|26504865|FG002|Overall Study|Protocol Violation|0|||
13299636|NCT01349049|26504866|FG003|Overall Study|Protocol Violation|0|||
13299637|NCT01349049|26504867|FG004|Overall Study|Protocol Violation|0|||
13299638|NCT01349049|26504868|FG005|Overall Study|Protocol Violation|0|||
13299639|NCT01349049|26504869|FG006|Overall Study|Protocol Violation|0|||
13299640|NCT01349049|26504870|FG007|Overall Study|Protocol Violation|0|||
13299641|NCT01349049|26504871|FG008|Overall Study|Protocol Violation|1|||
13299642|NCT01349049|26504863|FG000|Overall Study|Hematopoietic stem cell transplant|0|||
13299643|NCT01349049|26504864|FG001|Overall Study|Hematopoietic stem cell transplant|0|||
13299644|NCT01349049|26504865|FG002|Overall Study|Hematopoietic stem cell transplant|0|||
13299645|NCT01349049|26504866|FG003|Overall Study|Hematopoietic stem cell transplant|0|||
13299646|NCT01349049|26504867|FG004|Overall Study|Hematopoietic stem cell transplant|1|||
13299647|NCT01349049|26504868|FG005|Overall Study|Hematopoietic stem cell transplant|0|||
13299648|NCT01349049|26504869|FG006|Overall Study|Hematopoietic stem cell transplant|1|||
13299649|NCT01349049|26504870|FG007|Overall Study|Hematopoietic stem cell transplant|1|||
13299650|NCT01349049|26504871|FG008|Overall Study|Hematopoietic stem cell transplant|0|||
13299651|NCT01349049|26504863|FG000|Overall Study|Other|0|||
13299652|NCT01349049|26504864|FG001|Overall Study|Other|0|||
13299653|NCT01349049|26504865|FG002|Overall Study|Other|0|||
13299654|NCT01349049|26504866|FG003|Overall Study|Other|0|||
13299655|NCT01349049|26504867|FG004|Overall Study|Other|0|||
13299656|NCT01349049|26504868|FG005|Overall Study|Other|1|||
13299657|NCT01349049|26504869|FG006|Overall Study|Other|0|||
13299658|NCT01349049|26504870|FG007|Overall Study|Other|0|||
13299659|NCT01349049|26504871|FG008|Overall Study|Other|4|||
13299660|NCT01349049|26504863|FG000|Overall Study|Death|0|||
13299661|NCT01349049|26504864|FG001|Overall Study|Death|0|||
13299662|NCT01349049|26504865|FG002|Overall Study|Death|0|||
13299663|NCT01349049|26504866|FG003|Overall Study|Death|0|||
13299664|NCT01349049|26504867|FG004|Overall Study|Death|0|||
13299665|NCT01349049|26504868|FG005|Overall Study|Death|0|||
13299666|NCT01349049|26504869|FG006|Overall Study|Death|0|||
13299667|NCT01349049|26504870|FG007|Overall Study|Death|1|||
13299668|NCT01349049|26504871|FG008|Overall Study|Death|5|||
13299669|NCT01349049|26504863|FG000|Overall Study|Non-compliance|0|||
13299670|NCT01349049|26504864|FG001|Overall Study|Non-compliance|0|||
13299671|NCT01349049|26504865|FG002|Overall Study|Non-compliance|0|||
13299672|NCT01349049|26504866|FG003|Overall Study|Non-compliance|1|||
13299673|NCT01349049|26504867|FG004|Overall Study|Non-compliance|0|||
13299674|NCT01349049|26504868|FG005|Overall Study|Non-compliance|0|||
13299675|NCT01349049|26504869|FG006|Overall Study|Non-compliance|0|||
13299676|NCT01349049|26504870|FG007|Overall Study|Non-compliance|0|||
13299677|NCT01349049|26504871|FG008|Overall Study|Non-compliance|0|||
13299678|NCT01349049|26504863|FG000|Overall Study|Withdrawal by Subject|0|||
13299679|NCT01349049|26504864|FG001|Overall Study|Withdrawal by Subject|0|||
13299680|NCT01349049|26504865|FG002|Overall Study|Withdrawal by Subject|0|||
13299681|NCT01349049|26504866|FG003|Overall Study|Withdrawal by Subject|0|||
13299682|NCT01349049|26504867|FG004|Overall Study|Withdrawal by Subject|0|||
13299683|NCT01349049|26504868|FG005|Overall Study|Withdrawal by Subject|0|||
13299684|NCT01349049|26504869|FG006|Overall Study|Withdrawal by Subject|0|||
13299685|NCT01349049|26504870|FG007|Overall Study|Withdrawal by Subject|0|||
13299686|NCT01349049|26504871|FG008|Overall Study|Withdrawal by Subject|6|||
13299687|NCT01349036|26504894|FG000|Overall Study|Disease progression|13|||
13299688|NCT01349036|26504895|FG001|Overall Study|Disease progression|22|||
13299689|NCT01349036|26504894|FG000|Overall Study|Other|1|||
13299690|NCT01349036|26504895|FG001|Overall Study|Other|0|||
13299691|NCT01349036|26504894|FG000|Overall Study|Withdrawal by Subject|0|||
13299692|NCT01349036|26504895|FG001|Overall Study|Withdrawal by Subject|2|||
13299693|NCT01348854|26504910|FG000|Overall Study|Lost to Follow-up|2|||
13299694|NCT01348854|26504911|FG001|Overall Study|Lost to Follow-up|1|||
13299695|NCT01348854|26504910|FG000|Overall Study|Withdrawal by Subject|1|||
13299696|NCT01348854|26504911|FG001|Overall Study|Withdrawal by Subject|0|||
13299697|NCT01348828|26504930|FG000|Overall Study|Death|20|||
13299698|NCT01348828|26504930|FG000|Overall Study|Withdrawals/Lost to Follow-up|10|||
13299699|NCT01348828|26504930|FG000|Overall Study|Conversion|2|||
13299700|NCT01348828|26504930|FG000|Overall Study|missed visit|1|||
13299701|NCT01348789|26504943|FG000|Overall Study|Protocol Violation|2|||
13299702|NCT01348789|26504943|FG000|Overall Study|Withdrawal by Subject|2|||
13299703|NCT01348776|26504958|FG000|Overall Study|Lost to Follow-up|3|||
13299704|NCT01348763|26504965|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1|||
13299705|NCT01348763|26504965|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1|||
13299706|NCT01348698|26504974|FG000|Overall Study|Does not meet lesion size criteria|1|||
13299707|NCT01348698|26504974|FG000|Overall Study|Death|3|||
13299708|NCT01348698|26504974|FG000|Overall Study|PI decision to close study|68|||
13299709|NCT01348542|26504997|FG000|Overall Study|Withdrawal by Subject|3|||
13299710|NCT01348542|26504998|FG001|Overall Study|Withdrawal by Subject|0|||
13299711|NCT01348490|26505056|FG000|Overall Study|Death|1|||
13299712|NCT01348490|26505056|FG000|Overall Study|Adverse Event|3|||
13299713|NCT01348490|26505056|FG000|Overall Study|Consent withdrawn|7|||
13299714|NCT01348490|26505056|FG000|Overall Study|Disease progression|3|||
13299715|NCT01348490|26505056|FG000|Overall Study|Lost to Follow-up|1|||
13299716|NCT01348490|26505056|FG000|Overall Study|Termination of clinical trial by sponsor|1|||
13299717|NCT01348490|26505056|FG000|Overall Study|Other Unspecified|8|||
13299718|NCT01348425|26505068|FG000|Overall Study|Imaging was not taken.|1|||
13299719|NCT01348425|26505069|FG001|Overall Study|Imaging was not taken.|1|||
13299720|NCT01348347|26505103|FG000|Overall Study|Withdrawal by Subject|1|||
13299721|NCT01348347|26505104|FG001|Overall Study|Withdrawal by Subject|1|||
13299722|NCT01348347|26505105|FG002|Overall Study|Withdrawal by Subject|1|||
13299723|NCT01348347|26505103|FG000|Overall Study|Progressive disease|2|||
13299724|NCT01348347|26505104|FG001|Overall Study|Progressive disease|5|||
13299725|NCT01348347|26505105|FG002|Overall Study|Progressive disease|5|||
13299726|NCT01348165|26505256|FG000|Overall Study|Adverse Event|0|||
13299727|NCT01348165|26505257|FG001|Overall Study|Adverse Event|0|||
13299728|NCT01348165|26505258|FG002|Overall Study|Adverse Event|0|||
13299729|NCT01348165|26505259|FG003|Overall Study|Adverse Event|0|||
13299730|NCT01348165|26505260|FG004|Overall Study|Adverse Event|0|||
13299731|NCT01348165|26505261|FG005|Overall Study|Adverse Event|0|||
13299732|NCT01348165|26505262|FG006|Overall Study|Adverse Event|1|||
13299733|NCT01348139|26505343|FG000|Period 1|Adverse Event|1|||
13299734|NCT01348139|26505344|FG001|Period 1|Adverse Event|0|||
13299735|NCT01348139|26505345|FG002|Period 1|Adverse Event|0|||
13299736|NCT01348139|26505346|FG003|Period 1|Adverse Event|0|||
13299737|NCT01348139|26505347|FG004|Period 1|Adverse Event|0|||
13299738|NCT01348139|26505348|FG005|Period 1|Adverse Event|0|||
13299739|NCT01348100|26505415|FG000|Overall Study|Subject Withdrew Consent|0|||
13299740|NCT01348100|26505416|FG001|Overall Study|Subject Withdrew Consent|0|||
13299741|NCT01348100|26505417|FG002|Overall Study|Subject Withdrew Consent|2|||
13299742|NCT01348100|26505418|FG003|Overall Study|Subject Withdrew Consent|0|||
13299743|NCT01348100|26505419|FG004|Overall Study|Subject Withdrew Consent|1|||
13299744|NCT01348100|26505420|FG005|Overall Study|Subject Withdrew Consent|0|||
13299745|NCT01348100|26505421|FG006|Overall Study|Subject Withdrew Consent|1|||
13299746|NCT01348100|26505415|FG000|Overall Study|Protocol Deviation|0|||
13299747|NCT01348100|26505416|FG001|Overall Study|Protocol Deviation|0|||
13299748|NCT01348100|26505417|FG002|Overall Study|Protocol Deviation|0|||
13299749|NCT01348100|26505418|FG003|Overall Study|Protocol Deviation|1|||
13299750|NCT01348100|26505419|FG004|Overall Study|Protocol Deviation|0|||
13299751|NCT01348100|26505420|FG005|Overall Study|Protocol Deviation|0|||
13299752|NCT01348100|26505421|FG006|Overall Study|Protocol Deviation|0|||
13299753|NCT01348100|26505415|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
13299754|NCT01348100|26505416|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
13299755|NCT01348100|26505417|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
13299756|NCT01348100|26505418|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
13299757|NCT01348100|26505419|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0|||
13299758|NCT01348100|26505420|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1|||
13299759|NCT01348100|26505421|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0|||
13299760|NCT01348100|26505415|FG000|Overall Study|Lost to Follow-up|0|||
13299761|NCT01348100|26505416|FG001|Overall Study|Lost to Follow-up|0|||
13299762|NCT01348100|26505417|FG002|Overall Study|Lost to Follow-up|0|||
13299763|NCT01348100|26505418|FG003|Overall Study|Lost to Follow-up|0|||
13299764|NCT01348100|26505419|FG004|Overall Study|Lost to Follow-up|0|||
13299765|NCT01348100|26505420|FG005|Overall Study|Lost to Follow-up|0|||
13299766|NCT01348100|26505421|FG006|Overall Study|Lost to Follow-up|1|||
13299767|NCT01348100|26505415|FG000|Overall Study|Administrative Problems|0|||
13299768|NCT01348100|26505416|FG001|Overall Study|Administrative Problems|0|||
13299769|NCT01348100|26505417|FG002|Overall Study|Administrative Problems|0|||
13299770|NCT01348100|26505418|FG003|Overall Study|Administrative Problems|0|||
13299771|NCT01348100|26505419|FG004|Overall Study|Administrative Problems|0|||
13299772|NCT01348100|26505420|FG005|Overall Study|Administrative Problems|1|||
13299773|NCT01348100|26505421|FG006|Overall Study|Administrative Problems|1|||
13299774|NCT01348087|26505437|FG000|Overall Study|Unsatisfactory therapeutic effect|35|||
13299775|NCT01348087|26505437|FG000|Overall Study|Administrative problems|79|||
13299776|NCT01348087|26505437|FG000|Overall Study|protocol deviation|1|||
13299777|NCT01348087|26505437|FG000|Overall Study|Lost to Follow-up|1|||
13299778|NCT01348087|26505437|FG000|Overall Study|Subject withdrew consent|7|||
13299779|NCT01348087|26505437|FG000|Overall Study|Adverse Event|25|||
13299780|NCT01347931|26505449|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1|||
13299781|NCT01347879|26505488|FG000|Overall Study|Adverse Event|0|||
13299782|NCT01347879|26505489|FG001|Overall Study|Adverse Event|12|||
13299783|NCT01347879|26505488|FG000|Overall Study|Lost to Follow-up|2|||
13299784|NCT01347879|26505489|FG001|Overall Study|Lost to Follow-up|0|||
13299785|NCT01347879|26505488|FG000|Overall Study|Withdrawal by Subject|3|||
13299786|NCT01347879|26505489|FG001|Overall Study|Withdrawal by Subject|2|||
13299787|NCT01347879|26505488|FG000|Overall Study|Other|2|||
13299788|NCT01347879|26505489|FG001|Overall Study|Other|3|||
13299789|NCT01347866|26505915|FG000|Overall Study|Death|0|||
13299790|NCT01347866|26505916|FG001|Overall Study|Death|0|||
13299791|NCT01347866|26505917|FG002|Overall Study|Death|0|||
13299792|NCT01347866|26505918|FG003|Overall Study|Death|1|||
13299793|NCT01347866|26505919|FG004|Overall Study|Death|2|||
13299794|NCT01347866|26505920|FG005|Overall Study|Death|2|||
13299795|NCT01347866|26505921|FG006|Overall Study|Death|1|||
13299796|NCT01347866|26505922|FG007|Overall Study|Death|0|||
13299797|NCT01347866|26505923|FG008|Overall Study|Death|4|||
13299798|NCT01347866|26505924|FG009|Overall Study|Death|1|||
13299799|NCT01347866|26505925|FG010|Overall Study|Death|3|||
13299800|NCT01347866|26505926|FG011|Overall Study|Death|1|||
13299801|NCT01347866|26505927|FG012|Overall Study|Death|2|||
13299802|NCT01347866|26505928|FG013|Overall Study|Death|0|||
13299803|NCT01347866|26505929|FG014|Overall Study|Death|0|||
13299804|NCT01347866|26505930|FG015|Overall Study|Death|1|||
13299805|NCT01347866|26505931|FG016|Overall Study|Death|0|||
13299806|NCT01347866|26505915|FG000|Overall Study|Lost to Follow-up|0|||
13299807|NCT01347866|26505916|FG001|Overall Study|Lost to Follow-up|0|||
13299808|NCT01347866|26505917|FG002|Overall Study|Lost to Follow-up|0|||
13299809|NCT01347866|26505918|FG003|Overall Study|Lost to Follow-up|0|||
13299810|NCT01347866|26505919|FG004|Overall Study|Lost to Follow-up|0|||
13299811|NCT01347866|26505920|FG005|Overall Study|Lost to Follow-up|0|||
13299812|NCT01347866|26505921|FG006|Overall Study|Lost to Follow-up|0|||
13299813|NCT01347866|26505922|FG007|Overall Study|Lost to Follow-up|1|||
13299814|NCT01347866|26505923|FG008|Overall Study|Lost to Follow-up|1|||
13299815|NCT01347866|26505924|FG009|Overall Study|Lost to Follow-up|0|||
13299816|NCT01347866|26505925|FG010|Overall Study|Lost to Follow-up|0|||
13299817|NCT01347866|26505926|FG011|Overall Study|Lost to Follow-up|0|||
13299818|NCT01347866|26505927|FG012|Overall Study|Lost to Follow-up|0|||
13299819|NCT01347866|26505928|FG013|Overall Study|Lost to Follow-up|0|||
13299820|NCT01347866|26505929|FG014|Overall Study|Lost to Follow-up|0|||
13299821|NCT01347866|26505930|FG015|Overall Study|Lost to Follow-up|0|||
13299822|NCT01347866|26505931|FG016|Overall Study|Lost to Follow-up|0|||
13299823|NCT01347866|26505915|FG000|Overall Study|Other|3|||
13299824|NCT01347866|26505916|FG001|Overall Study|Other|1|||
13299825|NCT01347866|26505917|FG002|Overall Study|Other|1|||
13299826|NCT01347866|26505918|FG003|Overall Study|Other|4|||
13299827|NCT01347866|26505919|FG004|Overall Study|Other|5|||
13299828|NCT01347866|26505920|FG005|Overall Study|Other|0|||
13299829|NCT01347866|26505921|FG006|Overall Study|Other|5|||
13299830|NCT01347866|26505922|FG007|Overall Study|Other|3|||
13299831|NCT01347866|26505923|FG008|Overall Study|Other|22|||
13299832|NCT01347866|26505924|FG009|Overall Study|Other|5|||
13299833|NCT01347866|26505925|FG010|Overall Study|Other|0|||
13299834|NCT01347866|26505926|FG011|Overall Study|Other|3|||
13299835|NCT01347866|26505927|FG012|Overall Study|Other|4|||
13299836|NCT01347866|26505928|FG013|Overall Study|Other|4|||
13299837|NCT01347866|26505929|FG014|Overall Study|Other|2|||
13299838|NCT01347866|26505930|FG015|Overall Study|Other|3|||
13299839|NCT01347866|26505931|FG016|Overall Study|Other|0|||
13299840|NCT01347866|26505915|FG000|Overall Study|Subject refused further follow-up|2|||
13299841|NCT01347866|26505916|FG001|Overall Study|Subject refused further follow-up|0|||
13299842|NCT01347866|26505917|FG002|Overall Study|Subject refused further follow-up|0|||
13299843|NCT01347866|26505918|FG003|Overall Study|Subject refused further follow-up|2|||
13299844|NCT01347866|26505919|FG004|Overall Study|Subject refused further follow-up|0|||
13299845|NCT01347866|26505920|FG005|Overall Study|Subject refused further follow-up|1|||
13299846|NCT01347866|26505921|FG006|Overall Study|Subject refused further follow-up|0|||
13299847|NCT01347866|26505922|FG007|Overall Study|Subject refused further follow-up|0|||
13299848|NCT01347866|26505923|FG008|Overall Study|Subject refused further follow-up|4|||
13299849|NCT01347866|26505924|FG009|Overall Study|Subject refused further follow-up|1|||
13299850|NCT01347866|26505925|FG010|Overall Study|Subject refused further follow-up|0|||
13299851|NCT01347866|26505926|FG011|Overall Study|Subject refused further follow-up|0|||
13299852|NCT01347866|26505927|FG012|Overall Study|Subject refused further follow-up|1|||
13299853|NCT01347866|26505928|FG013|Overall Study|Subject refused further follow-up|3|||
13299854|NCT01347866|26505929|FG014|Overall Study|Subject refused further follow-up|1|||
13299855|NCT01347866|26505930|FG015|Overall Study|Subject refused further follow-up|0|||
13299856|NCT01347866|26505931|FG016|Overall Study|Subject refused further follow-up|2|||
13299857|NCT01347840|26505946|FG000|Overall Study|Withdrawal by Subject|1|||
13299858|NCT01347762|26505985|FG000|Overall Study|Lost to Follow-up|0|||
13299859|NCT01347762|26505986|FG001|Overall Study|Lost to Follow-up|1|||
13299860|NCT01347762|26505987|FG002|Overall Study|Lost to Follow-up|6|||
13299861|NCT01347762|26505988|FG003|Overall Study|Lost to Follow-up|5|||
13299862|NCT01347762|26505985|FG000|Overall Study|Withdrawal by Subject|4|||
13299863|NCT01347762|26505986|FG001|Overall Study|Withdrawal by Subject|1|||
13299864|NCT01347762|26505987|FG002|Overall Study|Withdrawal by Subject|3|||
13299865|NCT01347762|26505988|FG003|Overall Study|Withdrawal by Subject|3|||
13299866|NCT01347710|26506005|FG000|Overall Study|Withdrawal by Subject|2|||
13299867|NCT01347710|26506005|FG000|Overall Study|Adverse Event|4|||
13299868|NCT01347710|26506005|FG000|Overall Study|Angio or SPECT not completed|18|||
13299869|NCT01347710|26506005|FG000|Overall Study|issue with vitals prior to dosing|1|||
13299870|NCT01347710|26506005|FG000|Overall Study|Lost to Follow-up|1|||
13299871|NCT01347710|26506005|FG000|Overall Study|Physician Decision|2|||
13299872|NCT01347710|26506005|FG000|Overall Study|Other|3|||
13299873|NCT01347580|26506040|FG000|Overall Study|Withdrawal by Subject|13|||
13299874|NCT01347580|26506041|FG001|Overall Study|Withdrawal by Subject|23|||
13299875|NCT01347580|26506040|FG000|Overall Study|Death|30|||
13299876|NCT01347580|26506041|FG001|Overall Study|Death|19|||
13299877|NCT01347580|26506040|FG000|Overall Study|Protocol Violation|10|||
13299878|NCT01347580|26506041|FG001|Overall Study|Protocol Violation|7|||
13299879|NCT01347580|26506040|FG000|Overall Study|Lost to Follow-up|3|||
13299880|NCT01347580|26506041|FG001|Overall Study|Lost to Follow-up|1|||
13299881|NCT01347580|26506040|FG000|Overall Study|Had other reason|9|||
13299882|NCT01347580|26506041|FG001|Overall Study|Had other reason|6|||
13299883|NCT01347554|26506060|FG000|Overall Study|Lack of Efficacy|7|||
13299884|NCT01347554|26506061|FG001|Overall Study|Lack of Efficacy|11|||
13299885|NCT01347307|26506078|FG000|Overall Study|Death|0|||
13299886|NCT01347307|26506079|FG001|Overall Study|Death|4|||
13299887|NCT01347307|26506078|FG000|Overall Study|Physician Decision|0|||
13299888|NCT01347307|26506079|FG001|Overall Study|Physician Decision|1|||
13299889|NCT01347112|26506096|FG000|Overall Study|Withdrawal by Subject|1|||
13299890|NCT01347112|26506097|FG001|Overall Study|Withdrawal by Subject|7|||
13299891|NCT01347112|26506096|FG000|Overall Study|Lost to Follow-up|3|||
13299892|NCT01347112|26506097|FG001|Overall Study|Lost to Follow-up|5|||
13299893|NCT01347086|26506227|FG000|Overall Study|failed screening visit|0|||
13299894|NCT01347086|26506228|FG001|Overall Study|failed screening visit|0|||
13299895|NCT01347086|26506229|FG002|Overall Study|failed screening visit|1|||
13299896|NCT01347086|26506230|FG003|Overall Study|failed screening visit|0|||
13299897|NCT01347086|26506231|FG004|Overall Study|failed screening visit|0|||
13299898|NCT01347086|26506232|FG005|Overall Study|failed screening visit|0|||
13299899|NCT01347086|26506233|FG006|Overall Study|failed screening visit|1|||
13299900|NCT01347086|26506234|FG007|Overall Study|failed screening visit|1|||
13299901|NCT01347086|26506235|FG008|Overall Study|failed screening visit|0|||
13299902|NCT01347086|26506236|FG009|Overall Study|failed screening visit|1|||
13299903|NCT01347073|26506250|FG000|Overall Study|Adverse Event|1|||
13299904|NCT01347073|26506250|FG000|Overall Study|Liver Transplant|1|||
13299905|NCT01346969|26506293|FG000|Overall Study|Withdrawal by Subject|0|||
13299906|NCT01346969|26506294|FG001|Overall Study|Withdrawal by Subject|0|||
13299907|NCT01346969|26506295|FG002|Overall Study|Withdrawal by Subject|1|||
13299908|NCT01346969|26506296|FG003|Overall Study|Withdrawal by Subject|0|||
13299909|NCT01346969|26506293|FG000|Overall Study|Lost to Follow-up|1|||
13299910|NCT01346969|26506294|FG001|Overall Study|Lost to Follow-up|0|||
13299911|NCT01346969|26506295|FG002|Overall Study|Lost to Follow-up|2|||
13299912|NCT01346969|26506296|FG003|Overall Study|Lost to Follow-up|0|||
13299913|NCT01346969|26506293|FG000|Overall Study|Physician Decision|0|||
13299914|NCT01346969|26506294|FG001|Overall Study|Physician Decision|0|||
13299915|NCT01346969|26506295|FG002|Overall Study|Physician Decision|0|||
13299916|NCT01346969|26506296|FG003|Overall Study|Physician Decision|1|||
13299917|NCT01346969|26506293|FG000|Overall Study|Randomized but not treated|1|||
13299918|NCT01346969|26506294|FG001|Overall Study|Randomized but not treated|0|||
13299919|NCT01346969|26506295|FG002|Overall Study|Randomized but not treated|0|||
13299920|NCT01346969|26506296|FG003|Overall Study|Randomized but not treated|0|||
13299921|NCT01346774|26506309|FG000|Overall Study|Did not take a single dose|6|||
13299922|NCT01346774|26506310|FG001|Overall Study|Did not take a single dose|4|||
13299923|NCT01346774|26506309|FG000|Overall Study|Lost to Follow-up|3|||
13299924|NCT01346774|26506310|FG001|Overall Study|Lost to Follow-up|4|||
13299925|NCT01346774|26506309|FG000|Overall Study|Withdrawal by Subject|1|||
13299926|NCT01346774|26506310|FG001|Overall Study|Withdrawal by Subject|4|||
13299927|NCT01346774|26506309|FG000|Overall Study|Protocol Violation|2|||
13299928|NCT01346774|26506310|FG001|Overall Study|Protocol Violation|3|||
13299929|NCT01346774|26506309|FG000|Overall Study|Adverse Event|1|||
13299930|NCT01346774|26506310|FG001|Overall Study|Adverse Event|2|||
13299931|NCT01346709|26506318|FG000|Overall Study|Protocol Violation|35|||
13299932|NCT01346709|26506318|FG000|Overall Study|Lost to Follow-up|31|||
13299933|NCT01346709|26506318|FG000|Overall Study|Missing data in candidate risk factor|285|||
13299934|NCT01346696|26506331|FG000|Overall Study|Death|1|||
13299935|NCT01346592|26506431|FG000|Overall Study|Lost to Follow-up|62|||
13299936|NCT01346592|26506432|FG001|Overall Study|Lost to Follow-up|29|||
13299937|NCT01346592|26506433|FG002|Overall Study|Lost to Follow-up|29|||
13299938|NCT01346592|26506431|FG000|Overall Study|Protocol Violation|2|||
13299939|NCT01346592|26506432|FG001|Overall Study|Protocol Violation|1|||
13299940|NCT01346592|26506433|FG002|Overall Study|Protocol Violation|0|||
13299941|NCT01346592|26506431|FG000|Overall Study|Death|1|||
13299942|NCT01346592|26506432|FG001|Overall Study|Death|3|||
13299943|NCT01346592|26506433|FG002|Overall Study|Death|4|||
13299944|NCT01346592|26506431|FG000|Overall Study|Adverse Event|0|||
13299945|NCT01346592|26506432|FG001|Overall Study|Adverse Event|1|||
13299946|NCT01346592|26506433|FG002|Overall Study|Adverse Event|0|||
13299947|NCT01346592|26506431|FG000|Overall Study|Withdrawal by Subject|77|||
13299948|NCT01346592|26506432|FG001|Overall Study|Withdrawal by Subject|51|||
13299949|NCT01346592|26506433|FG002|Overall Study|Withdrawal by Subject|38|||
13299950|NCT01346592|26506431|FG000|Overall Study|Inappropriate enrollment|3|||
13299951|NCT01346592|26506432|FG001|Overall Study|Inappropriate enrollment|1|||
13299952|NCT01346592|26506433|FG002|Overall Study|Inappropriate enrollment|1|||
13299953|NCT01346592|26506431|FG000|Overall Study|Administrative reason|1|||
13299954|NCT01346592|26506432|FG001|Overall Study|Administrative reason|0|||
13299955|NCT01346592|26506433|FG002|Overall Study|Administrative reason|0|||
13299956|NCT01346592|26506431|FG000|Overall Study|Unable to Classify|7|||
13299957|NCT01346592|26506432|FG001|Overall Study|Unable to Classify|3|||
13299958|NCT01346592|26506433|FG002|Overall Study|Unable to Classify|6|||
13299959|NCT01346540|26506449|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3|||
13299960|NCT01346540|26506450|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8|||
13299961|NCT01346540|26506449|FG000|Overall Study|Adverse Event|0|||
13299962|NCT01346540|26506450|FG001|Overall Study|Adverse Event|4|||
13299963|NCT01346514|26506475|FG000|Overall Study|Lost to Follow-up|19|||
13299964|NCT01346514|26506476|FG001|Overall Study|Lost to Follow-up|30|||
13299965|NCT01346514|26506475|FG000|Overall Study|Withdrawal by Subject|7|||
13299966|NCT01346514|26506476|FG001|Overall Study|Withdrawal by Subject|3|||
13299967|NCT01346514|26506475|FG000|Overall Study|Death|3|||
13299968|NCT01346514|26506476|FG001|Overall Study|Death|4|||
13299969|NCT01346501|26506496|FG000|Overall Study|Initiated Other Biological Agents|3|||
13299970|NCT01346501|26506497|FG001|Overall Study|Initiated Other Biological Agents|1|||
13299971|NCT01346501|26506496|FG000|Overall Study|Other|8|||
13299972|NCT01346501|26506497|FG001|Overall Study|Other|12|||
13299973|NCT01346475|26506516|FG000|First Intervention|Lost to Follow-up|4|||
13299974|NCT01346475|26506517|FG001|First Intervention|Lost to Follow-up|3|||
13299975|NCT01346410|26506524|FG000|Overall Study|Death|1|||
13299976|NCT01346371|26506537|FG000|Overall Study|Lost to Follow-up|2|||
13299977|NCT01346371|26506538|FG001|Overall Study|Lost to Follow-up|0|||
13299978|NCT01346293|26506571|FG000|Overall Study|Protocol Violation|30|||
13299979|NCT01346293|26506572|FG001|Overall Study|Protocol Violation|9|||
13299980|NCT01346293|26506571|FG000|Overall Study|Lost to Follow-up|21|||
13299981|NCT01346293|26506572|FG001|Overall Study|Lost to Follow-up|8|||
13299982|NCT01346293|26506571|FG000|Overall Study|Withdrawal by Subject|15|||
13299983|NCT01346293|26506572|FG001|Overall Study|Withdrawal by Subject|4|||
13299984|NCT01346293|26506571|FG000|Overall Study|Other|1|||
13299985|NCT01346293|26506572|FG001|Overall Study|Other|0|||
13299986|NCT01346189|26506599|FG000|Overall Study|Withdrawal by Subject|7|||
13299987|NCT01346189|26506600|FG001|Overall Study|Withdrawal by Subject|5|||
13299988|NCT01346189|26506601|FG002|Overall Study|Withdrawal by Subject|3|||
13299989|NCT01346189|26506602|FG003|Overall Study|Withdrawal by Subject|5|||
13299990|NCT01346189|26506599|FG000|Overall Study|Physician Decision|4|||
13299991|NCT01346189|26506600|FG001|Overall Study|Physician Decision|0|||
13299992|NCT01346189|26506601|FG002|Overall Study|Physician Decision|0|||
13299993|NCT01346189|26506602|FG003|Overall Study|Physician Decision|0|||
13299994|NCT01346189|26506599|FG000|Overall Study|Moved|3|||
13299995|NCT01346189|26506600|FG001|Overall Study|Moved|0|||
13299996|NCT01346189|26506601|FG002|Overall Study|Moved|4|||
13299997|NCT01346189|26506602|FG003|Overall Study|Moved|0|||
13299998|NCT01346189|26506599|FG000|Overall Study|Other|2|||
13299999|NCT01346189|26506600|FG001|Overall Study|Other|4|||
13300000|NCT01346189|26506601|FG002|Overall Study|Other|7|||
13300001|NCT01346189|26506602|FG003|Overall Study|Other|3|||
13300002|NCT01346189|26506599|FG000|Overall Study|Death|0|||
13300003|NCT01346189|26506600|FG001|Overall Study|Death|3|||
13300004|NCT01346189|26506601|FG002|Overall Study|Death|0|||
13300005|NCT01346189|26506602|FG003|Overall Study|Death|0|||
13300006|NCT01346189|26506599|FG000|Overall Study|Non-health system primary care physician|0|||
13300007|NCT01346189|26506600|FG001|Overall Study|Non-health system primary care physician|5|||
13300008|NCT01346189|26506601|FG002|Overall Study|Non-health system primary care physician|0|||
13300009|NCT01346189|26506602|FG003|Overall Study|Non-health system primary care physician|0|||
13300010|NCT01346189|26506599|FG000|Overall Study|Travel|0|||
13300011|NCT01346189|26506600|FG001|Overall Study|Travel|0|||
13300012|NCT01346189|26506601|FG002|Overall Study|Travel|0|||
13300013|NCT01346189|26506602|FG003|Overall Study|Travel|3|||
13300014|NCT01346176|26506623|FG000|Recruited|Protocol Violation|1|||
13300015|NCT01346176|26506624|FG001|Recruited|Protocol Violation|0|||
13300016|NCT01346176|26506625|FG002|Recruited|Protocol Violation|0|||
13300017|NCT01346176|26506623|FG000|Completed Advance Directive|Death|3|||
13300018|NCT01346176|26506624|FG001|Completed Advance Directive|Death|2|||
13300019|NCT01346176|26506625|FG002|Completed Advance Directive|Death|2|||
13300020|NCT01346176|26506623|FG000|Completed Advance Directive|Became Ineligible|3|||
13300021|NCT01346176|26506624|FG001|Completed Advance Directive|Became Ineligible|0|||
13300022|NCT01346176|26506625|FG002|Completed Advance Directive|Became Ineligible|1|||
13300023|NCT01346176|26506623|FG000|Completed Advance Directive|Other reason did not complete AD|7|||
13300024|NCT01346176|26506624|FG001|Completed Advance Directive|Other reason did not complete AD|12|||
13300025|NCT01346176|26506625|FG002|Completed Advance Directive|Other reason did not complete AD|7|||
13300026|NCT01346176|26506623|FG000|Completed Satisfaction Survey|Death|3|||
13300027|NCT01346176|26506624|FG001|Completed Satisfaction Survey|Death|0|||
13300028|NCT01346176|26506625|FG002|Completed Satisfaction Survey|Death|2|||
13300029|NCT01346176|26506623|FG000|Completed Satisfaction Survey|Lost to Follow-up|3|||
13300030|NCT01346176|26506624|FG001|Completed Satisfaction Survey|Lost to Follow-up|4|||
13300031|NCT01346176|26506625|FG002|Completed Satisfaction Survey|Lost to Follow-up|4|||
13300032|NCT01346059|26506642|FG000|Overall Study|Withdrawal by Subject|1|||
13300033|NCT01346059|26506643|FG001|Overall Study|Withdrawal by Subject|0|||
13300034|NCT01345929|26506658|FG000|Overall Study|Withdrawal by Subject|9|||
13300035|NCT01345929|26506659|FG001|Overall Study|Withdrawal by Subject|8|||
13300036|NCT01345929|26506658|FG000|Overall Study|Lost to Follow-up|9|||
13300037|NCT01345929|26506659|FG001|Overall Study|Lost to Follow-up|9|||
13300038|NCT01345929|26506658|FG000|Overall Study|Adverse Event|0|||
13300039|NCT01345929|26506659|FG001|Overall Study|Adverse Event|1|||
13300040|NCT01345929|26506658|FG000|Overall Study|Didn't meet eligibility criteria|2|||
13300041|NCT01345929|26506659|FG001|Overall Study|Didn't meet eligibility criteria|0|||
13300042|NCT01345929|26506658|FG000|Overall Study|40,000 CFU/ML|1|||
13300043|NCT01345929|26506659|FG001|Overall Study|40,000 CFU/ML|0|||
13300044|NCT01345929|26506658|FG000|Overall Study|Patient withdrawal|0|||
13300045|NCT01345929|26506659|FG001|Overall Study|Patient withdrawal|1|||
13300046|NCT01345786|26506718|FG000|Overall Study|Adverse Event|0|||
13300047|NCT01345786|26506719|FG001|Overall Study|Adverse Event|1|||
13300048|NCT01345786|26506720|FG002|Overall Study|Adverse Event|3|||
13300049|NCT01345786|26506721|FG003|Overall Study|Adverse Event|1|||
13300050|NCT01345786|26506718|FG000|Overall Study|Subject withdrew consent|2|||
13300051|NCT01345786|26506719|FG001|Overall Study|Subject withdrew consent|2|||
13300052|NCT01345786|26506720|FG002|Overall Study|Subject withdrew consent|1|||
13300053|NCT01345786|26506721|FG003|Overall Study|Subject withdrew consent|0|||
13300054|NCT01345786|26506718|FG000|Overall Study|Noncompliance with protocol|1|||
13300055|NCT01345786|26506719|FG001|Overall Study|Noncompliance with protocol|0|||
13300056|NCT01345786|26506720|FG002|Overall Study|Noncompliance with protocol|1|||
13300057|NCT01345786|26506721|FG003|Overall Study|Noncompliance with protocol|0|||
13300058|NCT01345786|26506718|FG000|Overall Study|Administrative|3|||
13300059|NCT01345786|26506719|FG001|Overall Study|Administrative|5|||
13300060|NCT01345786|26506720|FG002|Overall Study|Administrative|0|||
13300061|NCT01345786|26506721|FG003|Overall Study|Administrative|0|||
13300062|NCT01345786|26506718|FG000|Overall Study|Lost to Follow-up|0|||
13300063|NCT01345786|26506719|FG001|Overall Study|Lost to Follow-up|0|||
13300064|NCT01345786|26506720|FG002|Overall Study|Lost to Follow-up|0|||
13300065|NCT01345786|26506721|FG003|Overall Study|Lost to Follow-up|2|||
13300066|NCT01345682|26506760|FG000|Overall Study|Progressive disease per RECIST|226|||
13300067|NCT01345682|26506761|FG001|Overall Study|Progressive disease per RECIST|93|||
13300068|NCT01345682|26506760|FG000|Overall Study|Worsening of underlying cancer disease|23|||
13300069|NCT01345682|26506761|FG001|Overall Study|Worsening of underlying cancer disease|12|||
13300070|NCT01345682|26506760|FG000|Overall Study|Adverse Event|51|||
13300071|NCT01345682|26506761|FG001|Overall Study|Adverse Event|41|||
13300072|NCT01345682|26506760|FG000|Overall Study|Non-compliance with protocol|0|||
13300073|NCT01345682|26506761|FG001|Overall Study|Non-compliance with protocol|1|||
13300074|NCT01345682|26506760|FG000|Overall Study|Lost to Follow-up|0|||
13300075|NCT01345682|26506761|FG001|Overall Study|Lost to Follow-up|1|||
13300076|NCT01345682|26506760|FG000|Overall Study|Refused to continue trial medication|16|||
13300077|NCT01345682|26506761|FG001|Overall Study|Refused to continue trial medication|9|||
13300078|NCT01345682|26506760|FG000|Overall Study|Not treated|2|||
13300079|NCT01345682|26506761|FG001|Overall Study|Not treated|1|||
13300080|NCT01345682|26506760|FG000|Overall Study|Reason other than those specified above|4|||
13300081|NCT01345682|26506761|FG001|Overall Study|Reason other than those specified above|3|||
13300082|NCT01345669|26506784|FG000|Overall Study|Primary tumour recurrence|53|||
13300083|NCT01345669|26506785|FG001|Overall Study|Primary tumour recurrence|32|||
13300084|NCT01345669|26506784|FG000|Overall Study|Second primary tumour|4|||
13300085|NCT01345669|26506785|FG001|Overall Study|Second primary tumour|3|||
13300086|NCT01345669|26506784|FG000|Overall Study|Adverse Event|63|||
13300087|NCT01345669|26506785|FG001|Overall Study|Adverse Event|9|||
13300088|NCT01345669|26506784|FG000|Overall Study|Protocol Violation|3|||
13300089|NCT01345669|26506785|FG001|Overall Study|Protocol Violation|1|||
13300090|NCT01345669|26506784|FG000|Overall Study|Lost to Follow-up|1|||
13300091|NCT01345669|26506785|FG001|Overall Study|Lost to Follow-up|1|||
13300092|NCT01345669|26506784|FG000|Overall Study|Withdrawal by Subject|52|||
13300093|NCT01345669|26506785|FG001|Overall Study|Withdrawal by Subject|13|||
13300094|NCT01345669|26506784|FG000|Overall Study|Other Reasons|111|||
13300095|NCT01345669|26506785|FG001|Overall Study|Other Reasons|60|||
13300096|NCT01345630|26506848|FG000|Overall Study|Adverse Event|22|||
13300097|NCT01345630|26506849|FG001|Overall Study|Adverse Event|23|||
13300098|NCT01345630|26506848|FG000|Overall Study|Lost to Follow-up|17|||
13300099|NCT01345630|26506849|FG001|Overall Study|Lost to Follow-up|16|||
13300100|NCT01345630|26506848|FG000|Overall Study|Protocol Violation|4|||
13300101|NCT01345630|26506849|FG001|Overall Study|Protocol Violation|1|||
13300102|NCT01345630|26506848|FG000|Overall Study|Medication error without associated AE|0|||
13300103|NCT01345630|26506849|FG001|Overall Study|Medication error without associated AE|1|||
13300104|NCT01345630|26506848|FG000|Overall Study|Study terminated by sponsor|254|||
13300105|NCT01345630|26506849|FG001|Overall Study|Study terminated by sponsor|285|||
13300106|NCT01345630|26506848|FG000|Overall Study|Other reasons|6|||
13300107|NCT01345630|26506849|FG001|Overall Study|Other reasons|8|||
13300108|NCT01345630|26506848|FG000|Overall Study|Withdrawn due to pregnancy|1|||
13300109|NCT01345630|26506849|FG001|Overall Study|Withdrawn due to pregnancy|2|||
13300110|NCT01345630|26506848|FG000|Overall Study|No longer willing to participate|9|||
13300111|NCT01345630|26506849|FG001|Overall Study|No longer willing to participate|12|||
13300112|NCT01345630|26506848|FG000|Overall Study|Insufficient clinical response|48|||
13300113|NCT01345630|26506849|FG001|Overall Study|Insufficient clinical response|11|||
13300114|NCT01345591|26506860|FG000|Overall Study|Lost to Follow-up|1|||
13300115|NCT01345318|26506867|FG000|Overall Study|Adverse Event|16|||
13300116|NCT01345318|26506867|FG000|Overall Study|Lack of Efficacy|17|||
13300117|NCT01345318|26506867|FG000|Overall Study|Lost to Follow-up|2|||
13300118|NCT01345318|26506867|FG000|Overall Study|Protocol Violation|1|||
13300119|NCT01345318|26506867|FG000|Overall Study|Withdrawal by Subject|41|||
13300120|NCT01345318|26506867|FG000|Overall Study|Other|3|||
13300121|NCT01345292|26506906|FG000|Overall Study|Withdrawal by Subject|2|||
13300122|NCT01345292|26506907|FG001|Overall Study|Withdrawal by Subject|0|||
13300123|NCT01345292|26506908|FG002|Overall Study|Withdrawal by Subject|1|||
13300124|NCT01345253|26506931|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22|||
13300125|NCT01345253|26506932|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27|||
13300126|NCT01345253|26506931|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11|||
13300127|NCT01345253|26506932|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7|||
13300128|NCT01345253|26506931|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1|||
13300129|NCT01345253|26506932|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5|||
13300130|NCT01345253|26506931|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6|||
13300131|NCT01345253|26506932|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1|||
13300132|NCT01345253|26506931|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3|||
13300133|NCT01345253|26506932|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8|||
13300134|NCT01345253|26506931|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4|||
13300135|NCT01345253|26506932|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12|||
13300136|NCT01345253|26506931|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9|||
13300137|NCT01345253|26506932|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19|||
13300138|NCT01345253|26506931|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7|||
13300139|NCT01345253|26506932|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18|||
13300140|NCT01345253|26506931|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0|||
13300141|NCT01345253|26506932|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1|||
13300142|NCT01345253|26506931|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3|||
13300143|NCT01345253|26506932|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7|||
13300144|NCT01345253|26506931|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2|||
13300145|NCT01345253|26506932|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5|||
13300146|NCT01345253|26506931|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4|||
13300147|NCT01345253|26506932|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6|||
13300148|NCT01345253|26506931|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11|||
13300149|NCT01345253|26506932|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24|||
13300150|NCT01345253|26506931|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37|||
13300151|NCT01345253|26506932|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82|||
13300152|NCT01345253|26506931|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
13300153|NCT01345253|26506932|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
13300154|NCT01345188|26506944|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2|||
13300155|NCT01345188|26506944|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1|||
13300156|NCT01345162|26506957|FG000|Overall Study|Protocol Violation|2|||
13300157|NCT01345162|26506958|FG001|Overall Study|Protocol Violation|4|||
13300158|NCT01345123|26506988|FG000|Overall Study|participants no longer with health plan|79|||
13300159|NCT01345123|26506989|FG001|Overall Study|participants no longer with health plan|85|||
13300160|NCT01345123|26506990|FG002|Overall Study|participants no longer with health plan|88|||
13300161|NCT01345058|26507011|FG000|Overall Study|Withdrawal by Subject|1|||
13300162|NCT01345058|26507012|FG001|Overall Study|Withdrawal by Subject|0|||
13300163|NCT01345058|26507011|FG000|Overall Study|Participant Reported Increase in Events|1|||
13300164|NCT01345058|26507012|FG001|Overall Study|Participant Reported Increase in Events|0|||
13300165|NCT01345058|26507011|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1|||
13300166|NCT01345058|26507012|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0|||
13300167|NCT01345058|26507011|FG000|Overall Study|Participant Stopped Taking Study Drug|1|||
13300168|NCT01345058|26507012|FG001|Overall Study|Participant Stopped Taking Study Drug|0|||
13300169|NCT01345058|26507011|FG000|Overall Study|Participant No-Show at Multiple Visits|1|||
13300170|NCT01345058|26507012|FG001|Overall Study|Participant No-Show at Multiple Visits|0|||
13300171|NCT01344876|26507032|FG000|Overall Study|Adverse Event|0|||
13300172|NCT01344876|26507033|FG001|Overall Study|Adverse Event|0|||
13300173|NCT01344876|26507034|FG002|Overall Study|Adverse Event|0|||
13300174|NCT01344876|26507035|FG003|Overall Study|Adverse Event|0|||
13300175|NCT01344876|26507036|FG004|Overall Study|Adverse Event|1|||
13300176|NCT01344876|26507032|FG000|Overall Study|Withdrawal by Subject|0|||
13300177|NCT01344876|26507033|FG001|Overall Study|Withdrawal by Subject|0|||
13300178|NCT01344876|26507034|FG002|Overall Study|Withdrawal by Subject|1|||
13300179|NCT01344876|26507035|FG003|Overall Study|Withdrawal by Subject|0|||
13300180|NCT01344876|26507036|FG004|Overall Study|Withdrawal by Subject|0|||
13300181|NCT01344876|26507032|FG000|Overall Study|Definite progression of primary disease|1|||
13300182|NCT01344876|26507033|FG001|Overall Study|Definite progression of primary disease|0|||
13300183|NCT01344876|26507034|FG002|Overall Study|Definite progression of primary disease|0|||
13300184|NCT01344876|26507035|FG003|Overall Study|Definite progression of primary disease|3|||
13300185|NCT01344876|26507036|FG004|Overall Study|Definite progression of primary disease|0|||
13300186|NCT01344824|26507044|FG000|Overall Study|Adverse Event|15|||
13300187|NCT01344824|26507044|FG000|Overall Study|Withdrawal by Subject|6|||
13300188|NCT01344824|26507044|FG000|Overall Study|Other complicating disease|1|||
13300189|NCT01344824|26507044|FG000|Overall Study|Progression|15|||
13300190|NCT01344759|26507081|FG000|Overall Study|Patients failed to reach sedation level|0|||
13300191|NCT01344759|26507082|FG001|Overall Study|Patients failed to reach sedation level|2|||
13300192|NCT01344629|26507107|FG000|Crossover Period 2|Withdrawal by Subject|0|||
13300193|NCT01344629|26507108|FG001|Crossover Period 2|Withdrawal by Subject|1|||
13300194|NCT01344538|26507121|FG000|Overall Study|Adverse Event|1|||
13300195|NCT01344538|26507122|FG001|Overall Study|Adverse Event|1|||
13300196|NCT01344538|26507121|FG000|Overall Study|Lost to Follow-up|1|||
13300197|NCT01344538|26507122|FG001|Overall Study|Lost to Follow-up|0|||
13300198|NCT01344460|26507169|FG000|Overall Study|Withdrawal by Subject|1|||
13300199|NCT01344460|26507169|FG000|Overall Study|Lost to Follow-up|2|||
13300200|NCT01344447|26507213|FG000|Overall Study|Adverse Event|1|||
13300201|NCT01344447|26507213|FG000|Overall Study|Protocol Violation|1|||
13300202|NCT01344447|26507213|FG000|Overall Study|Withdrawal by Subject|1|||
13300203|NCT01344447|26507213|FG000|Overall Study|The contrast was not seen|1|||
13300204|NCT01344447|26507213|FG000|Overall Study|Physician Decision|1|||
13300205|NCT01344447|26507213|FG000|Overall Study|MRA unsuccessful|1|||
13300206|NCT01344447|26507213|FG000|Overall Study|Bolus tracking failed|1|||
13300207|NCT01344447|26507213|FG000|Overall Study|Error of power injector|1|||
13382158|NCT00746733|26750225|FG000|Second Intervention|Adverse Event|1|||
13382159|NCT00746733|26750226|FG001|Second Intervention|Adverse Event|0|||
13382160|NCT00746733|26750225|FG000|Third Intervention|Withdrawal by Subject|1|||
13382161|NCT00746733|26750226|FG001|Third Intervention|Withdrawal by Subject|1|||
13382162|NCT00746590|26750232|FG000|Overall Study|Death|1|||
13382163|NCT00746564|26750247|FG000|Overall Study|Required Pacemaker/ICD Implant|2|||
13382164|NCT00746551|26750262|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2|||
13382165|NCT00746551|26750263|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4|||
13382166|NCT00746551|26750262|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9|||
13382167|NCT00746551|26750263|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7|||
13382168|NCT00746551|26750262|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6|||
13382169|NCT00746551|26750263|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8|||
13382170|NCT00746356|26750274|FG000|Overall Study|Withdrawal by Subject|2|||
13382171|NCT00746356|26750275|FG001|Overall Study|Withdrawal by Subject|3|||
13382172|NCT00746356|26750274|FG000|Overall Study|Death|7|||
13382173|NCT00746356|26750275|FG001|Overall Study|Death|3|||
13382174|NCT00746356|26750274|FG000|Overall Study|Lost to Follow-up|1|||
13382175|NCT00746356|26750275|FG001|Overall Study|Lost to Follow-up|0|||
13382176|NCT00746356|26750274|FG000|Overall Study|Removal of Device|0|||
13382177|NCT00746356|26750275|FG001|Overall Study|Removal of Device|1|||
13382178|NCT00746356|26750274|FG000|Overall Study|Patient relocated|1|||
13382179|NCT00746356|26750275|FG001|Overall Study|Patient relocated|0|||
13382180|NCT00746330|26750316|FG000|Period 1|Abnormal test procedure result|0|||
13382181|NCT00746330|26750317|FG001|Period 1|Abnormal test procedure result|0|||
13382182|NCT00746330|26750318|FG002|Period 1|Abnormal test procedure result|1|||
13382183|NCT00746330|26750319|FG003|Period 1|Abnormal test procedure result|0|||
13382184|NCT00746252|26750332|FG000|Overall Study|weight gain >7.5 %|1|||
13382185|NCT00746252|26750333|FG001|Overall Study|weight gain >7.5 %|2|||
13382186|NCT00746096|26750348|FG000|Overall Study|Adverse Event|1|||
13382187|NCT00746096|26750349|FG001|Overall Study|Adverse Event|0|||
13382188|NCT00746096|26750348|FG000|Overall Study|Withdrawal by Subject|5|||
13382189|NCT00746096|26750349|FG001|Overall Study|Withdrawal by Subject|1|||
13382190|NCT00746096|26750348|FG000|Overall Study|Lost to Follow-up|2|||
13382191|NCT00746096|26750349|FG001|Overall Study|Lost to Follow-up|1|||
13382192|NCT00746096|26750348|FG000|Overall Study|Protocol Violation|1|||
13382193|NCT00746096|26750349|FG001|Overall Study|Protocol Violation|0|||
13382194|NCT00746096|26750348|FG000|Overall Study|No study drug treatment|1|||
13382195|NCT00746096|26750349|FG001|Overall Study|No study drug treatment|1|||
13382196|NCT00745901|26750400|FG000|Overall Study|Adverse Event|3|||
13382197|NCT00745901|26750401|FG001|Overall Study|Adverse Event|4|||
13382198|NCT00745901|26750400|FG000|Overall Study|Protocol Violation|0|||
13382199|NCT00745901|26750401|FG001|Overall Study|Protocol Violation|1|||
13382200|NCT00745901|26750400|FG000|Overall Study|Withdrawal by Subject|1|||
13382201|NCT00745901|26750401|FG001|Overall Study|Withdrawal by Subject|0|||
13382202|NCT00745901|26750400|FG000|Overall Study|Lost to Follow-up|7|||
13382203|NCT00745901|26750401|FG001|Overall Study|Lost to Follow-up|4|||
13382204|NCT00745901|26750400|FG000|Overall Study|Pregnancy|2|||
13300208|NCT01344369|26507236|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
13300209|NCT01344369|26507237|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
13300210|NCT01344369|26507236|FG000|Washout of 28 Days|Physician Decision|0|||
13300211|NCT01344369|26507237|FG001|Washout of 28 Days|Physician Decision|1|||
13300212|NCT01344369|26507236|FG000|Second Intervention|Emesis within 2 x Tmax|0|||
13300213|NCT01344369|26507237|FG001|Second Intervention|Emesis within 2 x Tmax|1|||
13300214|NCT01344356|26507256|FG000|Overall Study|Physician Decision|0|||
13300215|NCT01344356|26507257|FG001|Overall Study|Physician Decision|3|||
13300216|NCT01344356|26507256|FG000|Overall Study|Lost to Follow-up|0|||
13300217|NCT01344356|26507257|FG001|Overall Study|Lost to Follow-up|6|||
13300218|NCT01344226|26507266|FG000|Overall Study|Protocol Violation|2|||
13300219|NCT01344226|26507266|FG000|Overall Study|Withdrawal by Subject|3|||
13300220|NCT01344226|26507266|FG000|Overall Study|Lack of Efficacy|3|||
13300221|NCT01344161|26507285|FG000|Overall Study|Lost to Follow-up|4|||
13300222|NCT01344161|26507286|FG001|Overall Study|Lost to Follow-up|1|||
13300223|NCT01344161|26507285|FG000|Overall Study|Pregnancy|0|||
13300224|NCT01344161|26507286|FG001|Overall Study|Pregnancy|1|||
13300225|NCT01344161|26507285|FG000|Overall Study|Protocol Violation|1|||
13300226|NCT01344161|26507286|FG001|Overall Study|Protocol Violation|1|||
13300227|NCT01344057|26507295|FG000|Overall Study|Premature Withdrawal|1|||
13300228|NCT01343901|26507318|FG000|Overall Study|Death|85|||
13300229|NCT01343901|26507318|FG000|Overall Study|Physician Decision|4|||
13300230|NCT01343901|26507318|FG000|Overall Study|Lost to Follow-up|12|||
13300231|NCT01343901|26507318|FG000|Overall Study|Management by another medical team|11|||
13300232|NCT01343901|26507318|FG000|Overall Study|Participant decision|1|||
13300233|NCT01343888|26507366|FG000|Overall Study|Adverse Event|12|||
13300234|NCT01343888|26507367|FG001|Overall Study|Adverse Event|22|||
13300235|NCT01343888|26507368|FG002|Overall Study|Adverse Event|5|||
13300236|NCT01343888|26507366|FG000|Overall Study|Lack of Efficacy|9|||
13300237|NCT01343888|26507367|FG001|Overall Study|Lack of Efficacy|9|||
13300238|NCT01343888|26507368|FG002|Overall Study|Lack of Efficacy|13|||
13300239|NCT01343888|26507366|FG000|Overall Study|Lost to Follow-up|0|||
13300240|NCT01343888|26507367|FG001|Overall Study|Lost to Follow-up|2|||
13300241|NCT01343888|26507368|FG002|Overall Study|Lost to Follow-up|1|||
13300242|NCT01343888|26507366|FG000|Overall Study|Protocol Violation|0|||
13300243|NCT01343888|26507367|FG001|Overall Study|Protocol Violation|2|||
13300244|NCT01343888|26507368|FG002|Overall Study|Protocol Violation|0|||
13300245|NCT01343888|26507366|FG000|Overall Study|Withdrawal by Subject|4|||
13300246|NCT01343888|26507367|FG001|Overall Study|Withdrawal by Subject|4|||
13300247|NCT01343888|26507368|FG002|Overall Study|Withdrawal by Subject|2|||
13300248|NCT01343888|26507366|FG000|Overall Study|other than stated above|0|||
13300249|NCT01343888|26507367|FG001|Overall Study|other than stated above|0|||
13300250|NCT01343888|26507368|FG002|Overall Study|other than stated above|1|||
13300251|NCT01343823|26507395|FG000|Overall Study|Study Terminated|1|||
13300252|NCT01343823|26507396|FG001|Overall Study|Study Terminated|0|||
13300253|NCT01343823|26507397|FG002|Overall Study|Study Terminated|0|||
13300254|NCT01343823|26507398|FG003|Overall Study|Study Terminated|1|||
13300255|NCT01343823|26507395|FG000|Overall Study|Withdrawal by Subject|1|||
13300256|NCT01343823|26507396|FG001|Overall Study|Withdrawal by Subject|0|||
13300257|NCT01343823|26507397|FG002|Overall Study|Withdrawal by Subject|0|||
13300258|NCT01343823|26507398|FG003|Overall Study|Withdrawal by Subject|0|||
13300259|NCT01343693|26507405|FG000|Overall Study|Lost to Follow-up|9|||
13300260|NCT01343407|26507438|FG000|Second Treatment Period (Part 2)|Adverse Event|0|||
13300261|NCT01343407|26507439|FG001|Second Treatment Period (Part 2)|Adverse Event|0|||
13300262|NCT01343407|26507440|FG002|Second Treatment Period (Part 2)|Adverse Event|1|||
13300263|NCT01343407|26507441|FG003|Second Treatment Period (Part 2)|Adverse Event|0|||
13300264|NCT01343407|26507442|FG004|Second Treatment Period (Part 2)|Adverse Event|0|||
13300265|NCT01343407|26507443|FG005|Second Treatment Period (Part 2)|Adverse Event|0|||
13382205|NCT00745901|26750401|FG001|Overall Study|Pregnancy|4|||
13382206|NCT00745901|26750400|FG000|Overall Study|Lack of compliance|2|||
13382207|NCT00745901|26750401|FG001|Overall Study|Lack of compliance|2|||
13382208|NCT00745901|26750400|FG000|Overall Study|Patient's next menses did not start with|1|||
13382209|NCT00745901|26750401|FG001|Overall Study|Patient's next menses did not start with|0|||
13382210|NCT00745901|26750400|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0|||
13382211|NCT00745901|26750401|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2|||
13382212|NCT00745901|26750400|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1|||
13382213|NCT00745901|26750401|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1|||
13382214|NCT00745901|26750400|FG000|Overall Study|Patient didn't take any study medication|7|||
13382215|NCT00745901|26750401|FG001|Overall Study|Patient didn't take any study medication|3|||
13382216|NCT00745875|26750416|FG000|Overall Study|Continuing study treatment|4|||
13382217|NCT00745875|26750417|FG001|Overall Study|Continuing study treatment|4|||
13382218|NCT00745849|26750426|FG000|First Intervention|Withdrawal by Subject|0|||
13382219|NCT00745849|26750427|FG001|First Intervention|Withdrawal by Subject|1|||
13382220|NCT00745849|26750426|FG000|First Intervention|Lost to Follow-up|1|||
13382221|NCT00745849|26750427|FG001|First Intervention|Lost to Follow-up|1|||
13382222|NCT00745849|26750426|FG000|Second Intervention|Lost to Follow-up|2|||
13300266|NCT01343407|26507438|FG000|Second Washout (Part 2)|Withdrawal by Subject|0|||
13300267|NCT01343407|26507439|FG001|Second Washout (Part 2)|Withdrawal by Subject|0|||
13300268|NCT01343407|26507440|FG002|Second Washout (Part 2)|Withdrawal by Subject|1|||
13300269|NCT01343407|26507441|FG003|Second Washout (Part 2)|Withdrawal by Subject|0|||
13300270|NCT01343407|26507442|FG004|Second Washout (Part 2)|Withdrawal by Subject|0|||
13300271|NCT01343407|26507443|FG005|Second Washout (Part 2)|Withdrawal by Subject|0|||
13300272|NCT01343368|26507484|FG000|Overall Study|Death|1|||
13300273|NCT01343368|26507485|FG001|Overall Study|Death|0|||
13300274|NCT01343368|26507484|FG000|Overall Study|Lost to Follow-up|1|||
13300275|NCT01343368|26507485|FG001|Overall Study|Lost to Follow-up|0|||
13300276|NCT01343277|26507508|FG000|Overall Study|Other|3|||
13300277|NCT01343277|26507509|FG001|Overall Study|Other|3|||
13300278|NCT01343277|26507508|FG000|Overall Study|Withdrawal by Subject|18|||
13300279|NCT01343277|26507509|FG001|Overall Study|Withdrawal by Subject|13|||
13300280|NCT01343277|26507508|FG000|Overall Study|Physician Decision|1|||
13300281|NCT01343277|26507509|FG001|Overall Study|Physician Decision|2|||
13300282|NCT01343277|26507508|FG000|Overall Study|Death|10|||
13300283|NCT01343277|26507509|FG001|Overall Study|Death|1|||
13300284|NCT01343277|26507508|FG000|Overall Study|Adverse Event|67|||
13300285|NCT01343277|26507509|FG001|Overall Study|Adverse Event|13|||
13300286|NCT01343277|26507508|FG000|Overall Study|Disease progression|270|||
13300287|NCT01343277|26507509|FG001|Overall Study|Disease progression|138|||
13300288|NCT01343277|26507508|FG000|Overall Study|Randomized not treated|6|||
13300289|NCT01343277|26507509|FG001|Overall Study|Randomized not treated|21|||
13300290|NCT01343277|26507508|FG000|Overall Study|Treatment ongoing|8|||
13300291|NCT01343277|26507509|FG001|Overall Study|Treatment ongoing|2|||
13300292|NCT01343277|26507508|FG000|Overall Study|Subsequent anticancer therapy|1|||
13300293|NCT01343277|26507509|FG001|Overall Study|Subsequent anticancer therapy|0|||
13300294|NCT01343082|26507517|FG000|The run-in Period|Not meeting criteria|3|||
13300295|NCT01343082|26507518|FG001|The run-in Period|Not meeting criteria|4|||
13300296|NCT01343082|26507519|FG002|The run-in Period|Not meeting criteria|5|||
13300297|NCT01343082|26507517|FG000|Treatment Period , Switched to DE-111|Adverse Event|1|||
13300298|NCT01343082|26507518|FG001|Treatment Period , Switched to DE-111|Adverse Event|4|||
13300299|NCT01343082|26507519|FG002|Treatment Period , Switched to DE-111|Adverse Event|3|||
13300300|NCT01343082|26507517|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0|||
13300301|NCT01343082|26507518|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1|||
13300302|NCT01343082|26507519|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2|||
13300303|NCT01343082|26507517|FG000|Treatment Period , Switched to DE-111|Physician Decision|0|||
13300304|NCT01343082|26507518|FG001|Treatment Period , Switched to DE-111|Physician Decision|2|||
13300305|NCT01343082|26507519|FG002|Treatment Period , Switched to DE-111|Physician Decision|2|||
13300306|NCT01343082|26507517|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4|||
13300307|NCT01343082|26507518|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2|||
13300308|NCT01343082|26507519|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5|||
13300309|NCT01343056|26507570|FG000|Overall Study|Lost to Follow-up|7|||
13300310|NCT01343056|26507571|FG001|Overall Study|Lost to Follow-up|5|||
13300311|NCT01343056|26507572|FG002|Overall Study|Lost to Follow-up|3|||
13300312|NCT01343056|26507573|FG003|Overall Study|Lost to Follow-up|9|||
13300313|NCT01343043|26507648|FG000|Overall Study|Disease progression before treatment|1|||
13300314|NCT01343043|26507649|FG001|Overall Study|Disease progression before treatment|0|||
13300315|NCT01343043|26507650|FG002|Overall Study|Disease progression before treatment|0|||
13300316|NCT01343043|26507651|FG003|Overall Study|Disease progression before treatment|0|||
13300317|NCT01343043|26507648|FG000|Overall Study|Withdrawal by Subject|1|||
13300318|NCT01343043|26507649|FG001|Overall Study|Withdrawal by Subject|0|||
13300319|NCT01343043|26507650|FG002|Overall Study|Withdrawal by Subject|0|||
13300320|NCT01343043|26507651|FG003|Overall Study|Withdrawal by Subject|0|||
13300321|NCT01343043|26507648|FG000|Overall Study|Death|1|||
13300322|NCT01343043|26507649|FG001|Overall Study|Death|1|||
13300323|NCT01343043|26507650|FG002|Overall Study|Death|0|||
13300324|NCT01343043|26507651|FG003|Overall Study|Death|1|||
13300325|NCT01342965|26507672|FG000|Overall Study|Death|58|||
13300326|NCT01342965|26507673|FG001|Overall Study|Death|57|||
13394785|NCT00654381|26788100|FG003|Extension Stage|Adverse Event|7|||
13300327|NCT01342965|26507672|FG000|Overall Study|Lost to Follow-up|5|||
13300328|NCT01342965|26507673|FG001|Overall Study|Lost to Follow-up|3|||
13300329|NCT01342965|26507672|FG000|Overall Study|Other Reasons- Unspecified|44|||
13300330|NCT01342965|26507673|FG001|Overall Study|Other Reasons- Unspecified|38|||
13300331|NCT01342965|26507672|FG000|Overall Study|Withdrawal by Subject|2|||
13300332|NCT01342965|26507673|FG001|Overall Study|Withdrawal by Subject|9|||
13300333|NCT01342926|26507764|FG000|Overall Study|Adverse Event|5|||
13300334|NCT01342926|26507765|FG001|Overall Study|Adverse Event|8|||
13300335|NCT01342926|26507766|FG002|Overall Study|Adverse Event|10|||
13300336|NCT01342926|26507767|FG003|Overall Study|Adverse Event|7|||
13300337|NCT01342926|26507764|FG000|Overall Study|Lost to Follow-up|0|||
13300338|NCT01342926|26507765|FG001|Overall Study|Lost to Follow-up|1|||
13300339|NCT01342926|26507766|FG002|Overall Study|Lost to Follow-up|1|||
13300340|NCT01342926|26507767|FG003|Overall Study|Lost to Follow-up|0|||
13300341|NCT01342926|26507764|FG000|Overall Study|Investigator Discretion|2|||
13300342|NCT01342926|26507765|FG001|Overall Study|Investigator Discretion|2|||
13300343|NCT01342926|26507766|FG002|Overall Study|Investigator Discretion|0|||
13300344|NCT01342926|26507767|FG003|Overall Study|Investigator Discretion|0|||
13300345|NCT01342926|26507764|FG000|Overall Study|Withdrawal by Subject|2|||
13300346|NCT01342926|26507765|FG001|Overall Study|Withdrawal by Subject|4|||
13300347|NCT01342926|26507766|FG002|Overall Study|Withdrawal by Subject|3|||
13300348|NCT01342926|26507767|FG003|Overall Study|Withdrawal by Subject|5|||
13300349|NCT01342913|26507785|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66|||
13300350|NCT01342913|26507786|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
13300351|NCT01342913|26507787|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
13300352|NCT01342913|26507785|FG000|2-week Run-in Period|Physician Decision|6|||
13300353|NCT01342913|26507786|FG001|2-week Run-in Period|Physician Decision|0|||
13300354|NCT01342913|26507787|FG002|2-week Run-in Period|Physician Decision|0|||
13300355|NCT01342913|26507785|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
13300356|NCT01342913|26507786|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
13300357|NCT01342913|26507787|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
13300358|NCT01342913|26507785|FG000|2-week Run-in Period|Adverse Event|2|||
13300359|NCT01342913|26507786|FG001|2-week Run-in Period|Adverse Event|0|||
13300360|NCT01342913|26507787|FG002|2-week Run-in Period|Adverse Event|0|||
13300361|NCT01342913|26507785|FG000|2-week Run-in Period|Protocol Violation|5|||
13300362|NCT01342913|26507786|FG001|2-week Run-in Period|Protocol Violation|0|||
13300363|NCT01342913|26507787|FG002|2-week Run-in Period|Protocol Violation|0|||
13300364|NCT01342913|26507785|FG000|2-week Run-in Period|Continuation Criteria Not Met|88|||
13300365|NCT01342913|26507786|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
13300366|NCT01342913|26507787|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
13300367|NCT01342913|26507785|FG000|Double-Blind Treatment Period|Adverse Event|0|||
13300368|NCT01342913|26507786|FG001|Double-Blind Treatment Period|Adverse Event|3|||
13300369|NCT01342913|26507787|FG002|Double-Blind Treatment Period|Adverse Event|6|||
13300370|NCT01342913|26507785|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
13300371|NCT01342913|26507786|FG001|Double-Blind Treatment Period|Lack of Efficacy|2|||
13300372|NCT01342913|26507787|FG002|Double-Blind Treatment Period|Lack of Efficacy|3|||
13300373|NCT01342913|26507785|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
13300374|NCT01342913|26507786|FG001|Double-Blind Treatment Period|Protocol Violation|6|||
13300375|NCT01342913|26507787|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
13300376|NCT01342913|26507785|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
13300377|NCT01342913|26507786|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
13300378|NCT01342913|26507787|FG002|Double-Blind Treatment Period|Lost to Follow-up|3|||
13300379|NCT01342913|26507785|FG000|Double-Blind Treatment Period|Physician Decision|0|||
13300380|NCT01342913|26507786|FG001|Double-Blind Treatment Period|Physician Decision|2|||
13300381|NCT01342913|26507787|FG002|Double-Blind Treatment Period|Physician Decision|0|||
13300382|NCT01342913|26507785|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
13300383|NCT01342913|26507786|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
13300384|NCT01342913|26507787|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2|||
13300385|NCT01342887|26507796|FG000|Overall Study|Death|2|||
13300386|NCT01342796|26507817|FG000|Overall Study|Withdrawal by Subject|2|||
13300387|NCT01342796|26507818|FG001|Overall Study|Withdrawal by Subject|0|||
13300388|NCT01342796|26507817|FG000|Overall Study|Lost to Follow-up|0|||
13300389|NCT01342796|26507818|FG001|Overall Study|Lost to Follow-up|3|||
13300390|NCT01342796|26507817|FG000|Overall Study|Inappropriate enrollment|1|||
13300391|NCT01342796|26507818|FG001|Overall Study|Inappropriate enrollment|0|||
13300392|NCT01342640|26507826|FG000|Overall Study|Adverse Event|3|||
13300393|NCT01342640|26507826|FG000|Overall Study|Protocol Violation|16|||
13300394|NCT01342640|26507826|FG000|Overall Study|Lost to Follow-up|21|||
13300395|NCT01342640|26507826|FG000|Overall Study|Other|1|||
13300396|NCT01342510|26507853|FG000|Overall Study|Protocol Violation|12|||
13300397|NCT01342510|26507854|FG001|Overall Study|Protocol Violation|6|||
13300398|NCT01342510|26507855|FG002|Overall Study|Protocol Violation|13|||
13300399|NCT01342510|26507856|FG003|Overall Study|Protocol Violation|11|||
13300400|NCT01342484|26507880|FG000|Overall Study|Other Reasons|1|||
13300401|NCT01342484|26507881|FG001|Overall Study|Other Reasons|0|||
13300402|NCT01342484|26507882|FG002|Overall Study|Other Reasons|0|||
13300403|NCT01342484|26507880|FG000|Overall Study|Protocol Violation|0|||
13300404|NCT01342484|26507881|FG001|Overall Study|Protocol Violation|0|||
13300405|NCT01342484|26507882|FG002|Overall Study|Protocol Violation|1|||
13300406|NCT01342484|26507880|FG000|Overall Study|Withdrawal by Subject|1|||
13300407|NCT01342484|26507881|FG001|Overall Study|Withdrawal by Subject|0|||
13300408|NCT01342484|26507882|FG002|Overall Study|Withdrawal by Subject|0|||
13300409|NCT01342445|26507903|FG000|Overall Study|Experienced side effects|0|||
13300410|NCT01342445|26507904|FG001|Overall Study|Experienced side effects|2|||
13300411|NCT01342367|26507919|FG000|Overall Study|Death|1|||
13300412|NCT01342367|26507920|FG001|Overall Study|Death|0|||
13300413|NCT01342367|26507919|FG000|Overall Study|Withdrawal by Subject|1|||
13300414|NCT01342367|26507920|FG001|Overall Study|Withdrawal by Subject|2|||
13300415|NCT01342341|26507933|FG000|Overall Study|Lost to Follow-up|4|||
13300416|NCT01342341|26507934|FG001|Overall Study|Lost to Follow-up|4|||
13300417|NCT01342211|26508016|FG000|Overall Study|Lost to Follow-up|0|||
13300418|NCT01342211|26508017|FG001|Overall Study|Lost to Follow-up|0|||
13300419|NCT01342211|26508018|FG002|Overall Study|Lost to Follow-up|0|||
13300420|NCT01342211|26508019|FG003|Overall Study|Lost to Follow-up|1|||
13300421|NCT01342211|26508020|FG004|Overall Study|Lost to Follow-up|0|||
13300422|NCT01342211|26508016|FG000|Overall Study|Adverse Event|0|||
13300423|NCT01342211|26508017|FG001|Overall Study|Adverse Event|0|||
13300424|NCT01342211|26508018|FG002|Overall Study|Adverse Event|0|||
13300425|NCT01342211|26508019|FG003|Overall Study|Adverse Event|0|||
13300426|NCT01342211|26508020|FG004|Overall Study|Adverse Event|1|||
13300427|NCT01342211|26508016|FG000|Overall Study|Withdrawal by Subject|0|||
13300428|NCT01342211|26508017|FG001|Overall Study|Withdrawal by Subject|0|||
13300429|NCT01342211|26508018|FG002|Overall Study|Withdrawal by Subject|0|||
13300430|NCT01342211|26508019|FG003|Overall Study|Withdrawal by Subject|1|||
13300431|NCT01342211|26508020|FG004|Overall Study|Withdrawal by Subject|0|||
13300432|NCT01342211|26508016|FG000|Overall Study|Randomized, but not Treated|0|||
13300433|NCT01342211|26508017|FG001|Overall Study|Randomized, but not Treated|2|||
13300434|NCT01342211|26508018|FG002|Overall Study|Randomized, but not Treated|0|||
13300435|NCT01342211|26508019|FG003|Overall Study|Randomized, but not Treated|0|||
13300436|NCT01342211|26508020|FG004|Overall Study|Randomized, but not Treated|1|||
13300437|NCT01342094|26508033|FG000|Overall Study|Adverse Event|5|||
13300438|NCT01342094|26508034|FG001|Overall Study|Adverse Event|0|||
13300439|NCT01342094|26508033|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
13300440|NCT01342094|26508034|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
13300441|NCT01342094|26508033|FG000|Overall Study|Withdrawal by Subject|0|||
13300442|NCT01342094|26508034|FG001|Overall Study|Withdrawal by Subject|2|||
13300443|NCT01342081|26508052|FG000|Overall Study|Did not receive allocated intervention|0|||
13300444|NCT01342081|26508053|FG001|Overall Study|Did not receive allocated intervention|0|||
13300445|NCT01342081|26508054|FG002|Overall Study|Did not receive allocated intervention|1|||
13300446|NCT01342081|26508052|FG000|Overall Study|Adverse Event|1|||
13300447|NCT01342081|26508053|FG001|Overall Study|Adverse Event|0|||
13300448|NCT01342081|26508054|FG002|Overall Study|Adverse Event|0|||
13300449|NCT01342081|26508052|FG000|Overall Study|Physician Decision|0|||
13300450|NCT01342081|26508053|FG001|Overall Study|Physician Decision|1|||
13300451|NCT01342081|26508054|FG002|Overall Study|Physician Decision|0|||
13300452|NCT01342081|26508052|FG000|Overall Study|Withdrawal by Subject|1|||
13300453|NCT01342081|26508053|FG001|Overall Study|Withdrawal by Subject|1|||
13300454|NCT01342081|26508054|FG002|Overall Study|Withdrawal by Subject|0|||
13300455|NCT01341990|26508069|FG000|Overall Study|Adverse Event|0|||
13300456|NCT01341990|26508070|FG001|Overall Study|Adverse Event|1|||
13300457|NCT01341990|26508069|FG000|Overall Study|Torn Study Lens|1|||
13300458|NCT01341990|26508070|FG001|Overall Study|Torn Study Lens|0|||
13300459|NCT01341990|26508069|FG000|Overall Study|Withdrawal by Subject|2|||
13300460|NCT01341990|26508070|FG001|Overall Study|Withdrawal by Subject|0|||
13300461|NCT01341782|26508093|FG000|Overall Study|Adverse Event|1|||
13300462|NCT01341782|26508094|FG001|Overall Study|Adverse Event|1|||
13300463|NCT01341782|26508093|FG000|Overall Study|Withdrawal by Subject|6|||
13300464|NCT01341782|26508094|FG001|Overall Study|Withdrawal by Subject|5|||
13300465|NCT01341782|26508093|FG000|Overall Study|Missed 3 consecutive doses|0|||
13300466|NCT01341782|26508094|FG001|Overall Study|Missed 3 consecutive doses|4|||
13300467|NCT01341782|26508093|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0|||
13300468|NCT01341782|26508094|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1|||
13300469|NCT01341782|26508093|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
13300470|NCT01341782|26508094|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
13300471|NCT01341782|26508093|FG000|Overall Study|Other|5|||
13300472|NCT01341782|26508094|FG001|Overall Study|Other|0|||
13300473|NCT01341652|26508115|FG000|Overall Study|Incorrect Random Assignment|0|||
13300474|NCT01341652|26508116|FG001|Overall Study|Incorrect Random Assignment|1|||
13300475|NCT01341652|26508115|FG000|Overall Study|ineligible; presence metastatic disease|0|||
13300476|NCT01341652|26508116|FG001|Overall Study|ineligible; presence metastatic disease|1|||
13300477|NCT01341639|26508144|FG000|Infant Series|Protocol Violation|1|||
13300478|NCT01341639|26508145|FG001|Infant Series|Protocol Violation|0|||
13300479|NCT01341639|26508144|FG000|Infant Series|Not Vaccinated|0|||
13300480|NCT01341639|26508145|FG001|Infant Series|Not Vaccinated|1|||
13300481|NCT01341639|26508144|FG000|Infant Series|Adverse Event|0|||
13300482|NCT01341639|26508145|FG001|Infant Series|Adverse Event|5|||
13300483|NCT01341639|26508144|FG000|Infant Series|Withdrawal by Subject|11|||
13300484|NCT01341639|26508145|FG001|Infant Series|Withdrawal by Subject|8|||
13300485|NCT01341639|26508144|FG000|Infant Series|Lost to Follow-up|0|||
13300486|NCT01341639|26508145|FG001|Infant Series|Lost to Follow-up|2|||
13300487|NCT01341639|26508144|FG000|Infant Series|Site 0048 Participants|17|||
13300488|NCT01341639|26508145|FG001|Infant Series|Site 0048 Participants|16|||
13300489|NCT01341639|26508144|FG000|Interim Period|Withdrawal by Subject|6|||
13300490|NCT01341639|26508145|FG001|Interim Period|Withdrawal by Subject|7|||
13300491|NCT01341639|26508144|FG000|Interim Period|Lost to Follow-up|2|||
13300492|NCT01341639|26508145|FG001|Interim Period|Lost to Follow-up|0|||
13300493|NCT01341639|26508144|FG000|Interim Period|Physician Decision|0|||
13300494|NCT01341639|26508145|FG001|Interim Period|Physician Decision|1|||
13300495|NCT01341639|26508144|FG000|Interim Period|Protocol Violation|0|||
13300496|NCT01341639|26508145|FG001|Interim Period|Protocol Violation|1|||
13300497|NCT01341639|26508144|FG000|Post-Treatment|Withdrawal by Subject|0|||
13300498|NCT01341639|26508145|FG001|Post-Treatment|Withdrawal by Subject|1|||
13300499|NCT01341639|26508144|FG000|Post-Treatment|Adverse Event|0|||
13300500|NCT01341639|26508145|FG001|Post-Treatment|Adverse Event|2|||
13300501|NCT01341587|26508158|FG000|Overall Study|Lost to Follow-up|2|||
13300502|NCT01341587|26508159|FG001|Overall Study|Lost to Follow-up|0|||
13300503|NCT01341587|26508158|FG000|Overall Study|stopped using the meters|2|||
13300504|NCT01341587|26508159|FG001|Overall Study|stopped using the meters|10|||
13300505|NCT01341470|26508210|FG000|Overall Study|Sponsor decision|0|||
13300506|NCT01341470|26508211|FG001|Overall Study|Sponsor decision|0|||
13300507|NCT01341470|26508212|FG002|Overall Study|Sponsor decision|1|||
13300508|NCT01341470|26508213|FG003|Overall Study|Sponsor decision|1|||
13300509|NCT01341470|26508214|FG004|Overall Study|Sponsor decision|0|||
13300510|NCT01341470|26508215|FG005|Overall Study|Sponsor decision|1|||
13300511|NCT01341457|26508238|FG000|Overall Study|Adverse Event|2|||
13300512|NCT01341457|26508239|FG001|Overall Study|Adverse Event|0|||
13300513|NCT01340976|26508292|FG000|Overall Study|Physician Decision|2|||
13300514|NCT01340976|26508293|FG001|Overall Study|Physician Decision|0|||
13300515|NCT01340976|26508294|FG002|Overall Study|Physician Decision|1|||
13300516|NCT01340976|26508295|FG003|Overall Study|Physician Decision|1|||
13300517|NCT01340976|26508296|FG004|Overall Study|Physician Decision|1|||
13300518|NCT01340976|26508297|FG005|Overall Study|Physician Decision|0|||
13300519|NCT01340976|26508292|FG000|Overall Study|Death|0|||
13300520|NCT01340976|26508293|FG001|Overall Study|Death|1|||
13300521|NCT01340976|26508294|FG002|Overall Study|Death|0|||
13300522|NCT01340976|26508295|FG003|Overall Study|Death|0|||
13300523|NCT01340976|26508296|FG004|Overall Study|Death|0|||
13300524|NCT01340976|26508297|FG005|Overall Study|Death|0|||
13300525|NCT01340976|26508292|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1|||
13300526|NCT01340976|26508293|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
13300527|NCT01340976|26508294|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
13300528|NCT01340976|26508295|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
13300529|NCT01340976|26508296|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
13300530|NCT01340976|26508297|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
13300531|NCT01340976|26508292|FG000|Overall Study|Withdrawal by Subject|0|||
13300532|NCT01340976|26508293|FG001|Overall Study|Withdrawal by Subject|0|||
13300533|NCT01340976|26508294|FG002|Overall Study|Withdrawal by Subject|0|||
13300534|NCT01340976|26508295|FG003|Overall Study|Withdrawal by Subject|1|||
13300535|NCT01340976|26508296|FG004|Overall Study|Withdrawal by Subject|1|||
13300536|NCT01340976|26508297|FG005|Overall Study|Withdrawal by Subject|0|||
13300537|NCT01340976|26508292|FG000|Overall Study|Other anemia treatment|1|||
13300538|NCT01340976|26508293|FG001|Overall Study|Other anemia treatment|0|||
13300539|NCT01340976|26508294|FG002|Overall Study|Other anemia treatment|2|||
13300540|NCT01340976|26508295|FG003|Overall Study|Other anemia treatment|1|||
13300541|NCT01340976|26508296|FG004|Overall Study|Other anemia treatment|0|||
13300542|NCT01340976|26508297|FG005|Overall Study|Other anemia treatment|1|||
13300543|NCT01340976|26508292|FG000|Overall Study|Adverse Event|0|||
13300544|NCT01340976|26508293|FG001|Overall Study|Adverse Event|1|||
13300545|NCT01340976|26508294|FG002|Overall Study|Adverse Event|0|||
13300546|NCT01340976|26508295|FG003|Overall Study|Adverse Event|0|||
13300547|NCT01340976|26508296|FG004|Overall Study|Adverse Event|0|||
13300548|NCT01340976|26508297|FG005|Overall Study|Adverse Event|0|||
13300549|NCT01340937|26508467|FG000|Period 1: Infant Series|Other protocol criterion not met|0|||
13300550|NCT01340937|26508468|FG001|Period 1: Infant Series|Other protocol criterion not met|1|||
13300551|NCT01340937|26508469|FG002|Period 1: Infant Series|Other protocol criterion not met|1|||
13300552|NCT01340937|26508470|FG003|Period 1: Infant Series|Other protocol criterion not met|0|||
13382223|NCT00745849|26750427|FG001|Second Intervention|Lost to Follow-up|1|||
13382224|NCT00745823|26750458|FG000|Overall Study|Adverse Event|5|||
13382225|NCT00745823|26750459|FG001|Overall Study|Adverse Event|3|||
13382226|NCT00745823|26750458|FG000|Overall Study|Lack of Efficacy|20|||
13382227|NCT00745823|26750459|FG001|Overall Study|Lack of Efficacy|6|||
13382228|NCT00745823|26750458|FG000|Overall Study|Lost to Follow-up|10|||
13382229|NCT00745823|26750459|FG001|Overall Study|Lost to Follow-up|11|||
13382230|NCT00745823|26750458|FG000|Overall Study|Physician Decision|10|||
13382231|NCT00745823|26750459|FG001|Overall Study|Physician Decision|5|||
13382232|NCT00745823|26750458|FG000|Overall Study|Pregnancy|0|||
13382233|NCT00745823|26750459|FG001|Overall Study|Pregnancy|4|||
13382234|NCT00745823|26750458|FG000|Overall Study|Withdrawal by Subject|14|||
13382235|NCT00745823|26750459|FG001|Overall Study|Withdrawal by Subject|8|||
13382236|NCT00745823|26750458|FG000|Overall Study|Study Terminated by Sponsor|326|||
13382237|NCT00745823|26750459|FG001|Overall Study|Study Terminated by Sponsor|349|||
13300553|NCT01340937|26508467|FG000|Period 1: Infant Series|Adverse Event|0|||
13300554|NCT01340937|26508468|FG001|Period 1: Infant Series|Adverse Event|1|||
13300555|NCT01340937|26508469|FG002|Period 1: Infant Series|Adverse Event|4|||
13300556|NCT01340937|26508470|FG003|Period 1: Infant Series|Adverse Event|0|||
13300557|NCT01340937|26508467|FG000|Period 1: Infant Series|Death|2|||
13300558|NCT01340937|26508468|FG001|Period 1: Infant Series|Death|0|||
13300559|NCT01340937|26508469|FG002|Period 1: Infant Series|Death|2|||
13300560|NCT01340937|26508470|FG003|Period 1: Infant Series|Death|0|||
13300561|NCT01340937|26508467|FG000|Period 1: Infant Series|Lost to Follow-up|20|||
13300562|NCT01340937|26508468|FG001|Period 1: Infant Series|Lost to Follow-up|14|||
13300563|NCT01340937|26508469|FG002|Period 1: Infant Series|Lost to Follow-up|12|||
13300564|NCT01340937|26508470|FG003|Period 1: Infant Series|Lost to Follow-up|13|||
13300565|NCT01340937|26508467|FG000|Period 1: Infant Series|Physician Decision|2|||
13300566|NCT01340937|26508468|FG001|Period 1: Infant Series|Physician Decision|3|||
13300567|NCT01340937|26508469|FG002|Period 1: Infant Series|Physician Decision|1|||
13300568|NCT01340937|26508470|FG003|Period 1: Infant Series|Physician Decision|0|||
13300569|NCT01340937|26508467|FG000|Period 1: Infant Series|Protocol Violation|1|||
13300570|NCT01340937|26508468|FG001|Period 1: Infant Series|Protocol Violation|4|||
13300571|NCT01340937|26508469|FG002|Period 1: Infant Series|Protocol Violation|4|||
13300572|NCT01340937|26508470|FG003|Period 1: Infant Series|Protocol Violation|3|||
13300573|NCT01340937|26508467|FG000|Period 1: Infant Series|Withdrawal by Subject|33|||
13300574|NCT01340937|26508468|FG001|Period 1: Infant Series|Withdrawal by Subject|32|||
13300575|NCT01340937|26508469|FG002|Period 1: Infant Series|Withdrawal by Subject|30|||
13300576|NCT01340937|26508470|FG003|Period 1: Infant Series|Withdrawal by Subject|15|||
13300577|NCT01340937|26508467|FG000|Period 1: Infant Series|Randomized but not vaccinated|0|||
13300578|NCT01340937|26508468|FG001|Period 1: Infant Series|Randomized but not vaccinated|5|||
13300579|NCT01340937|26508469|FG002|Period 1: Infant Series|Randomized but not vaccinated|2|||
13300580|NCT01340937|26508470|FG003|Period 1: Infant Series|Randomized but not vaccinated|1|||
13300581|NCT01340937|26508467|FG000|Period 2: Interim Period|Withdrawal by Subject|28|||
13300582|NCT01340937|26508468|FG001|Period 2: Interim Period|Withdrawal by Subject|23|||
13300583|NCT01340937|26508469|FG002|Period 2: Interim Period|Withdrawal by Subject|17|||
13300584|NCT01340937|26508470|FG003|Period 2: Interim Period|Withdrawal by Subject|12|||
13300585|NCT01340937|26508467|FG000|Period 2: Interim Period|Adverse Event|1|||
13300586|NCT01340937|26508468|FG001|Period 2: Interim Period|Adverse Event|0|||
13300587|NCT01340937|26508469|FG002|Period 2: Interim Period|Adverse Event|1|||
13300588|NCT01340937|26508470|FG003|Period 2: Interim Period|Adverse Event|0|||
13300589|NCT01340937|26508467|FG000|Period 2: Interim Period|Lost to Follow-up|29|||
13300590|NCT01340937|26508468|FG001|Period 2: Interim Period|Lost to Follow-up|48|||
13300591|NCT01340937|26508469|FG002|Period 2: Interim Period|Lost to Follow-up|53|||
13300592|NCT01340937|26508470|FG003|Period 2: Interim Period|Lost to Follow-up|23|||
13300593|NCT01340937|26508467|FG000|Period 2: Interim Period|Physician Decision|0|||
13300594|NCT01340937|26508468|FG001|Period 2: Interim Period|Physician Decision|1|||
13300595|NCT01340937|26508469|FG002|Period 2: Interim Period|Physician Decision|1|||
13300596|NCT01340937|26508470|FG003|Period 2: Interim Period|Physician Decision|0|||
13300597|NCT01340937|26508467|FG000|Period 2: Interim Period|Protocol Violation|5|||
13300598|NCT01340937|26508468|FG001|Period 2: Interim Period|Protocol Violation|3|||
13300599|NCT01340937|26508469|FG002|Period 2: Interim Period|Protocol Violation|6|||
13300600|NCT01340937|26508470|FG003|Period 2: Interim Period|Protocol Violation|3|||
13300601|NCT01340937|26508467|FG000|Period 2: Interim Period|Technical problems|4|||
13300602|NCT01340937|26508468|FG001|Period 2: Interim Period|Technical problems|4|||
13300603|NCT01340937|26508469|FG002|Period 2: Interim Period|Technical problems|6|||
13300604|NCT01340937|26508470|FG003|Period 2: Interim Period|Technical problems|3|||
13300605|NCT01340937|26508467|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
13300606|NCT01340937|26508468|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
13300607|NCT01340937|26508469|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
13300608|NCT01340937|26508470|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
13300609|NCT01340937|26508467|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6|||
13300610|NCT01340937|26508468|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14|||
13300611|NCT01340937|26508469|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7|||
13300612|NCT01340937|26508470|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8|||
13300613|NCT01340937|26508467|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0|||
13300614|NCT01340937|26508468|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0|||
13300615|NCT01340937|26508469|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0|||
13300616|NCT01340937|26508470|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1|||
13300617|NCT01340937|26508467|FG000|Period 3: Toddler Vaccinations|Technical problem|1|||
13300618|NCT01340937|26508468|FG001|Period 3: Toddler Vaccinations|Technical problem|1|||
13300619|NCT01340937|26508469|FG002|Period 3: Toddler Vaccinations|Technical problem|1|||
13300620|NCT01340937|26508470|FG003|Period 3: Toddler Vaccinations|Technical problem|0|||
13300621|NCT01340898|26508580|FG000|Primary Phase|Serious Adverse Events|0|||
13300622|NCT01340898|26508581|FG001|Primary Phase|Serious Adverse Events|0|||
13300623|NCT01340898|26508582|FG002|Primary Phase|Serious Adverse Events|1|||
13300624|NCT01340898|26508580|FG000|Primary Phase|Withdrawal by Subject|8|||
13300625|NCT01340898|26508581|FG001|Primary Phase|Withdrawal by Subject|7|||
13300626|NCT01340898|26508582|FG002|Primary Phase|Withdrawal by Subject|5|||
13300627|NCT01340898|26508580|FG000|Primary Phase|Migrated/moved from study area|4|||
13300628|NCT01340898|26508581|FG001|Primary Phase|Migrated/moved from study area|1|||
13300629|NCT01340898|26508582|FG002|Primary Phase|Migrated/moved from study area|0|||
13300630|NCT01340898|26508580|FG000|Primary Phase|Lost to Follow-up|4|||
13300631|NCT01340898|26508581|FG001|Primary Phase|Lost to Follow-up|1|||
13300632|NCT01340898|26508582|FG002|Primary Phase|Lost to Follow-up|0|||
13300633|NCT01340898|26508580|FG000|Booster Phase|Withdrawal by Subject|3|||
13300634|NCT01340898|26508581|FG001|Booster Phase|Withdrawal by Subject|0|||
13300635|NCT01340898|26508582|FG002|Booster Phase|Withdrawal by Subject|4|||
13300636|NCT01340898|26508580|FG000|Booster Phase|Migrated/moved from study area|3|||
13300637|NCT01340898|26508581|FG001|Booster Phase|Migrated/moved from study area|0|||
13300638|NCT01340898|26508582|FG002|Booster Phase|Migrated/moved from study area|0|||
13300639|NCT01340898|26508580|FG000|Booster Phase|Lost to Follow-up|4|||
13300640|NCT01340898|26508581|FG001|Booster Phase|Lost to Follow-up|2|||
13300641|NCT01340898|26508582|FG002|Booster Phase|Lost to Follow-up|3|||
13300642|NCT01340872|26508649|FG000|Double-blind Phase|Adverse Event|6|||
13300643|NCT01340872|26508650|FG001|Double-blind Phase|Adverse Event|4|||
13300644|NCT01340872|26508651|FG002|Double-blind Phase|Adverse Event|0|||
13300645|NCT01340872|26508652|FG003|Double-blind Phase|Adverse Event|0|||
13300646|NCT01340872|26508649|FG000|Double-blind Phase|Withdrawal by Subject|3|||
13300647|NCT01340872|26508650|FG001|Double-blind Phase|Withdrawal by Subject|5|||
13300648|NCT01340872|26508651|FG002|Double-blind Phase|Withdrawal by Subject|0|||
13300649|NCT01340872|26508652|FG003|Double-blind Phase|Withdrawal by Subject|0|||
13300650|NCT01340872|26508649|FG000|Double-blind Phase|Lost to Follow-up|0|||
13300651|NCT01340872|26508650|FG001|Double-blind Phase|Lost to Follow-up|1|||
13300652|NCT01340872|26508651|FG002|Double-blind Phase|Lost to Follow-up|0|||
13300653|NCT01340872|26508652|FG003|Double-blind Phase|Lost to Follow-up|0|||
13300654|NCT01340872|26508649|FG000|Double-blind Phase|Protocol Violation|0|||
13300655|NCT01340872|26508650|FG001|Double-blind Phase|Protocol Violation|1|||
13300656|NCT01340872|26508651|FG002|Double-blind Phase|Protocol Violation|0|||
13300657|NCT01340872|26508652|FG003|Double-blind Phase|Protocol Violation|0|||
13300658|NCT01340872|26508649|FG000|Open-label Phase|Physician Decision|0|||
13300659|NCT01340872|26508650|FG001|Open-label Phase|Physician Decision|0|||
13300660|NCT01340872|26508651|FG002|Open-label Phase|Physician Decision|2|||
13300661|NCT01340872|26508652|FG003|Open-label Phase|Physician Decision|1|||
13300662|NCT01340872|26508649|FG000|Open-label Phase|Pregnancy|0|||
13300663|NCT01340872|26508650|FG001|Open-label Phase|Pregnancy|0|||
13300664|NCT01340872|26508651|FG002|Open-label Phase|Pregnancy|1|||
13300665|NCT01340872|26508652|FG003|Open-label Phase|Pregnancy|0|||
13300666|NCT01340872|26508649|FG000|Open-label Phase|Adverse Event|0|||
13300667|NCT01340872|26508650|FG001|Open-label Phase|Adverse Event|0|||
13300668|NCT01340872|26508651|FG002|Open-label Phase|Adverse Event|8|||
13300669|NCT01340872|26508652|FG003|Open-label Phase|Adverse Event|4|||
13300670|NCT01340872|26508649|FG000|Open-label Phase|Withdrawal by Subject|0|||
13300671|NCT01340872|26508650|FG001|Open-label Phase|Withdrawal by Subject|0|||
13300672|NCT01340872|26508651|FG002|Open-label Phase|Withdrawal by Subject|1|||
13300673|NCT01340872|26508652|FG003|Open-label Phase|Withdrawal by Subject|6|||
13300674|NCT01340872|26508649|FG000|Open-label Phase|Worsening of IBD|0|||
13300675|NCT01340872|26508650|FG001|Open-label Phase|Worsening of IBD|0|||
13300676|NCT01340872|26508651|FG002|Open-label Phase|Worsening of IBD|1|||
13300677|NCT01340872|26508652|FG003|Open-label Phase|Worsening of IBD|0|||
13300678|NCT01340794|26508673|FG000|Overall Study|Withdrawal by Subject|0|||
13300679|NCT01340794|26508674|FG001|Overall Study|Withdrawal by Subject|1|||
13300680|NCT01340768|26508689|FG000|Overall Study|Lost to Follow-up|10|||
13300681|NCT01340768|26508690|FG001|Overall Study|Lost to Follow-up|4|||
13300682|NCT01340768|26508689|FG000|Overall Study|Withdrawal by Subject|5|||
13300683|NCT01340768|26508690|FG001|Overall Study|Withdrawal by Subject|1|||
13300684|NCT01340768|26508689|FG000|Overall Study|Other|2|||
13300685|NCT01340768|26508690|FG001|Overall Study|Other|0|||
13300686|NCT01340664|26508717|FG000|Overall Study|Adverse Event|0|||
13300687|NCT01340664|26508718|FG001|Overall Study|Adverse Event|1|||
13300688|NCT01340664|26508719|FG002|Overall Study|Adverse Event|7|||
13300689|NCT01340664|26508717|FG000|Overall Study|Lost to Follow-up|2|||
13300690|NCT01340664|26508718|FG001|Overall Study|Lost to Follow-up|0|||
13300691|NCT01340664|26508719|FG002|Overall Study|Lost to Follow-up|2|||
13300692|NCT01340664|26508717|FG000|Overall Study|Withdrawal by Subject|2|||
13300693|NCT01340664|26508718|FG001|Overall Study|Withdrawal by Subject|4|||
13300694|NCT01340664|26508719|FG002|Overall Study|Withdrawal by Subject|0|||
13300695|NCT01340664|26508717|FG000|Overall Study|Glycemic withdrawal criteria|2|||
13300696|NCT01340664|26508718|FG001|Overall Study|Glycemic withdrawal criteria|0|||
13300697|NCT01340664|26508719|FG002|Overall Study|Glycemic withdrawal criteria|0|||
13394786|NCT00654381|26788101|FG004|Extension Stage|Adverse Event|1|||
13300698|NCT01340664|26508717|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0|||
13300699|NCT01340664|26508718|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1|||
13300700|NCT01340664|26508719|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2|||
13300701|NCT01340664|26508717|FG000|Overall Study|Other|1|||
13300702|NCT01340664|26508718|FG001|Overall Study|Other|2|||
13300703|NCT01340664|26508719|FG002|Overall Study|Other|2|||
13300704|NCT01340651|26508735|FG000|Overall Study|Adverse Event|3|||
13300705|NCT01340651|26508735|FG000|Overall Study|Consent Withdrawn|2|||
13300706|NCT01340651|26508735|FG000|Overall Study|Commercial Supply per Sponsor|12|||
13300707|NCT01340625|26508758|FG000|First Intervention|Adverse Event|1|||
13300708|NCT01340625|26508759|FG001|First Intervention|Adverse Event|0|||
13300709|NCT01340625|26508758|FG000|Washout Period of 28 Days|Withdrawal by Subject|1|||
13300710|NCT01340625|26508759|FG001|Washout Period of 28 Days|Withdrawal by Subject|0|||
13300711|NCT01340495|26508768|FG000|Overall Study|Withdrawal by Subject|1|||
13300712|NCT01340482|26508789|FG000|Overall Study|Adverse Event|2|||
13300713|NCT01340482|26508790|FG001|Overall Study|Adverse Event|0|||
13300714|NCT01340482|26508791|FG002|Overall Study|Adverse Event|0|||
13300715|NCT01340300|26508834|FG000|Overall Study|Lost to Follow-up|3|||
13300716|NCT01340300|26508835|FG001|Overall Study|Lost to Follow-up|0|||
13300717|NCT01340300|26508836|FG002|Overall Study|Lost to Follow-up|5|||
13300718|NCT01340300|26508837|FG003|Overall Study|Lost to Follow-up|10|||
13300719|NCT01340300|26508834|FG000|Overall Study|Withdrawal by Subject|5|||
13300720|NCT01340300|26508835|FG001|Overall Study|Withdrawal by Subject|6|||
13300721|NCT01340300|26508836|FG002|Overall Study|Withdrawal by Subject|6|||
13300722|NCT01340300|26508837|FG003|Overall Study|Withdrawal by Subject|3|||
13300723|NCT01340300|26508834|FG000|Overall Study|Adverse Event|1|||
13300724|NCT01340300|26508835|FG001|Overall Study|Adverse Event|0|||
13300725|NCT01340300|26508836|FG002|Overall Study|Adverse Event|4|||
13300726|NCT01340300|26508837|FG003|Overall Study|Adverse Event|0|||
13300727|NCT01340300|26508834|FG000|Overall Study|Physician Decision|0|||
13300728|NCT01340300|26508835|FG001|Overall Study|Physician Decision|1|||
13300729|NCT01340300|26508836|FG002|Overall Study|Physician Decision|0|||
13300730|NCT01340300|26508837|FG003|Overall Study|Physician Decision|0|||
13300731|NCT01340300|26508834|FG000|Overall Study|Unrelated sickness|0|||
13300732|NCT01340300|26508835|FG001|Overall Study|Unrelated sickness|2|||
13300733|NCT01340300|26508836|FG002|Overall Study|Unrelated sickness|0|||
13300734|NCT01340300|26508837|FG003|Overall Study|Unrelated sickness|1|||
13300735|NCT01340209|26508882|FG000|Overall Study|Adverse Event|1|||
13300736|NCT01340209|26508883|FG001|Overall Study|Adverse Event|1|||
13300737|NCT01340209|26508884|FG002|Overall Study|Adverse Event|2|||
13300738|NCT01340209|26508882|FG000|Overall Study|Protocol Violation|1|||
13300739|NCT01340209|26508883|FG001|Overall Study|Protocol Violation|2|||
13300740|NCT01340209|26508884|FG002|Overall Study|Protocol Violation|1|||
13300741|NCT01340209|26508882|FG000|Overall Study|Withdrawal by Subject|0|||
13300742|NCT01340209|26508883|FG001|Overall Study|Withdrawal by Subject|0|||
13300743|NCT01340209|26508884|FG002|Overall Study|Withdrawal by Subject|1|||
13300744|NCT01340209|26508882|FG000|Overall Study|Other reason not defined above|3|||
13300745|NCT01340209|26508883|FG001|Overall Study|Other reason not defined above|5|||
13300746|NCT01340209|26508884|FG002|Overall Study|Other reason not defined above|4|||
13300747|NCT01340196|26508915|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2|||
13300748|NCT01340066|26508930|FG000|Placebo Run in Period|Screen Failures|27|||
13300749|NCT01340066|26508931|FG001|Placebo Run in Period|Screen Failures|0|||
13300750|NCT01340066|26508932|FG002|Placebo Run in Period|Screen Failures|0|||
13300751|NCT01340066|26508930|FG000|5 Week Double Blind Randomization Period|Adverse Event|0|||
13300752|NCT01340066|26508931|FG001|5 Week Double Blind Randomization Period|Adverse Event|2|||
13300753|NCT01340066|26508932|FG002|5 Week Double Blind Randomization Period|Adverse Event|2|||
13300754|NCT01340066|26508930|FG000|5 Week Double Blind Randomization Period|Physician Decision|0|||
13300755|NCT01340066|26508931|FG001|5 Week Double Blind Randomization Period|Physician Decision|1|||
13300756|NCT01340066|26508932|FG002|5 Week Double Blind Randomization Period|Physician Decision|0|||
13300757|NCT01340066|26508930|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0|||
13300758|NCT01340066|26508931|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2|||
13300759|NCT01340066|26508932|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1|||
13300760|NCT01340027|26509343|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
13300761|NCT01340027|26509344|FG001|Overall Study|Randomized but Never Received Study Drug|0|||
13300762|NCT01340027|26509345|FG002|Overall Study|Randomized but Never Received Study Drug|1|||
13300763|NCT01340027|26509346|FG003|Overall Study|Randomized but Never Received Study Drug|0|||
13300764|NCT01340027|26509347|FG004|Overall Study|Randomized but Never Received Study Drug|0|||
13300765|NCT01340027|26509348|FG005|Overall Study|Randomized but Never Received Study Drug|0|||
13300766|NCT01340027|26509349|FG006|Overall Study|Randomized but Never Received Study Drug|0|||
13300767|NCT01340027|26509350|FG007|Overall Study|Randomized but Never Received Study Drug|0|||
13300768|NCT01340027|26509351|FG008|Overall Study|Randomized but Never Received Study Drug|0|||
13300769|NCT01340027|26509352|FG009|Overall Study|Randomized but Never Received Study Drug|0|||
13300770|NCT01340027|26509353|FG010|Overall Study|Randomized but Never Received Study Drug|0|||
13300771|NCT01340027|26509354|FG011|Overall Study|Randomized but Never Received Study Drug|0|||
13300772|NCT01340027|26509343|FG000|Overall Study|Adverse Event|0|||
13300773|NCT01340027|26509344|FG001|Overall Study|Adverse Event|1|||
13300774|NCT01340027|26509345|FG002|Overall Study|Adverse Event|2|||
13300775|NCT01340027|26509346|FG003|Overall Study|Adverse Event|0|||
13300776|NCT01340027|26509347|FG004|Overall Study|Adverse Event|1|||
13300777|NCT01340027|26509348|FG005|Overall Study|Adverse Event|2|||
13300778|NCT01340027|26509349|FG006|Overall Study|Adverse Event|2|||
13300779|NCT01340027|26509350|FG007|Overall Study|Adverse Event|1|||
13300780|NCT01340027|26509351|FG008|Overall Study|Adverse Event|4|||
13300781|NCT01340027|26509352|FG009|Overall Study|Adverse Event|1|||
13300782|NCT01340027|26509353|FG010|Overall Study|Adverse Event|1|||
13300783|NCT01340027|26509354|FG011|Overall Study|Adverse Event|3|||
13300784|NCT01340027|26509343|FG000|Overall Study|Lack of Efficacy|0|||
13300785|NCT01340027|26509344|FG001|Overall Study|Lack of Efficacy|0|||
13300786|NCT01340027|26509345|FG002|Overall Study|Lack of Efficacy|0|||
13300787|NCT01340027|26509346|FG003|Overall Study|Lack of Efficacy|0|||
13300788|NCT01340027|26509347|FG004|Overall Study|Lack of Efficacy|0|||
13300789|NCT01340027|26509348|FG005|Overall Study|Lack of Efficacy|0|||
13382238|NCT00745615|26750520|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3|||
13382239|NCT00745615|26750521|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1|||
13300790|NCT01340027|26509349|FG006|Overall Study|Lack of Efficacy|1|||
13300791|NCT01340027|26509350|FG007|Overall Study|Lack of Efficacy|1|||
13300792|NCT01340027|26509351|FG008|Overall Study|Lack of Efficacy|1|||
13300793|NCT01340027|26509352|FG009|Overall Study|Lack of Efficacy|0|||
13300794|NCT01340027|26509353|FG010|Overall Study|Lack of Efficacy|0|||
13300795|NCT01340027|26509354|FG011|Overall Study|Lack of Efficacy|0|||
13300796|NCT01340027|26509343|FG000|Overall Study|Lost to Follow-up|0|||
13300797|NCT01340027|26509344|FG001|Overall Study|Lost to Follow-up|1|||
13300798|NCT01340027|26509345|FG002|Overall Study|Lost to Follow-up|0|||
13300799|NCT01340027|26509346|FG003|Overall Study|Lost to Follow-up|0|||
13300800|NCT01340027|26509347|FG004|Overall Study|Lost to Follow-up|0|||
13300801|NCT01340027|26509348|FG005|Overall Study|Lost to Follow-up|0|||
13300802|NCT01340027|26509349|FG006|Overall Study|Lost to Follow-up|1|||
13300803|NCT01340027|26509350|FG007|Overall Study|Lost to Follow-up|0|||
13300804|NCT01340027|26509351|FG008|Overall Study|Lost to Follow-up|0|||
13300805|NCT01340027|26509352|FG009|Overall Study|Lost to Follow-up|1|||
13300806|NCT01340027|26509353|FG010|Overall Study|Lost to Follow-up|0|||
13300807|NCT01340027|26509354|FG011|Overall Study|Lost to Follow-up|0|||
13300808|NCT01340027|26509343|FG000|Overall Study|Protocol Violation|1|||
13300809|NCT01340027|26509344|FG001|Overall Study|Protocol Violation|2|||
13300810|NCT01340027|26509345|FG002|Overall Study|Protocol Violation|0|||
13300811|NCT01340027|26509346|FG003|Overall Study|Protocol Violation|0|||
13300812|NCT01340027|26509347|FG004|Overall Study|Protocol Violation|6|||
13300813|NCT01340027|26509348|FG005|Overall Study|Protocol Violation|0|||
13300814|NCT01340027|26509349|FG006|Overall Study|Protocol Violation|0|||
13300815|NCT01340027|26509350|FG007|Overall Study|Protocol Violation|1|||
13300816|NCT01340027|26509351|FG008|Overall Study|Protocol Violation|2|||
13300817|NCT01340027|26509352|FG009|Overall Study|Protocol Violation|2|||
13300818|NCT01340027|26509353|FG010|Overall Study|Protocol Violation|0|||
13300819|NCT01340027|26509354|FG011|Overall Study|Protocol Violation|0|||
13300820|NCT01340027|26509343|FG000|Overall Study|Withdrawal by Subject|4|||
13300821|NCT01340027|26509344|FG001|Overall Study|Withdrawal by Subject|3|||
13300822|NCT01340027|26509345|FG002|Overall Study|Withdrawal by Subject|1|||
13300823|NCT01340027|26509346|FG003|Overall Study|Withdrawal by Subject|3|||
13300824|NCT01340027|26509347|FG004|Overall Study|Withdrawal by Subject|3|||
13300825|NCT01340027|26509348|FG005|Overall Study|Withdrawal by Subject|2|||
13300826|NCT01340027|26509349|FG006|Overall Study|Withdrawal by Subject|3|||
13300827|NCT01340027|26509350|FG007|Overall Study|Withdrawal by Subject|4|||
13300828|NCT01340027|26509351|FG008|Overall Study|Withdrawal by Subject|1|||
13300829|NCT01340027|26509352|FG009|Overall Study|Withdrawal by Subject|2|||
13300830|NCT01340027|26509353|FG010|Overall Study|Withdrawal by Subject|0|||
13300831|NCT01340027|26509354|FG011|Overall Study|Withdrawal by Subject|1|||
13300832|NCT01340027|26509343|FG000|Overall Study|Miscellaneous|0|||
13300833|NCT01340027|26509344|FG001|Overall Study|Miscellaneous|0|||
13300834|NCT01340027|26509345|FG002|Overall Study|Miscellaneous|0|||
13300835|NCT01340027|26509346|FG003|Overall Study|Miscellaneous|1|||
13300836|NCT01340027|26509347|FG004|Overall Study|Miscellaneous|0|||
13300837|NCT01340027|26509348|FG005|Overall Study|Miscellaneous|0|||
13300838|NCT01340027|26509349|FG006|Overall Study|Miscellaneous|0|||
13300839|NCT01340027|26509350|FG007|Overall Study|Miscellaneous|0|||
13300840|NCT01340027|26509351|FG008|Overall Study|Miscellaneous|0|||
13300841|NCT01340027|26509352|FG009|Overall Study|Miscellaneous|0|||
13300842|NCT01340027|26509353|FG010|Overall Study|Miscellaneous|1|||
13300843|NCT01340027|26509354|FG011|Overall Study|Miscellaneous|0|||
13300844|NCT01340014|26509369|FG000|Period 1, First 7 Days|Adverse Event|1|||
13300845|NCT01340014|26509370|FG001|Period 1, First 7 Days|Adverse Event|0|||
13300846|NCT01340014|26509369|FG000|Period 1, First 7 Days|Personal Reasons|1|||
13300847|NCT01340014|26509370|FG001|Period 1, First 7 Days|Personal Reasons|0|||
13300848|NCT01340014|26509369|FG000|Period 2, Second 7 Days|Adverse Event|0|||
13300849|NCT01340014|26509370|FG001|Period 2, Second 7 Days|Adverse Event|1|||
13300850|NCT01339923|26509461|FG000|Overall Study|Adverse Event|1|||
13300851|NCT01339923|26509462|FG001|Overall Study|Adverse Event|1|||
13300852|NCT01339923|26509463|FG002|Overall Study|Adverse Event|1|||
13300853|NCT01339923|26509464|FG003|Overall Study|Adverse Event|0|||
13300854|NCT01339923|26509465|FG004|Overall Study|Adverse Event|0|||
13300855|NCT01339923|26509466|FG005|Overall Study|Adverse Event|0|||
13300856|NCT01339923|26509467|FG006|Overall Study|Adverse Event|1|||
13300857|NCT01339923|26509461|FG000|Overall Study|Inappropriate Enrollment|1|||
13300858|NCT01339923|26509462|FG001|Overall Study|Inappropriate Enrollment|0|||
13300859|NCT01339923|26509463|FG002|Overall Study|Inappropriate Enrollment|0|||
13300860|NCT01339923|26509464|FG003|Overall Study|Inappropriate Enrollment|0|||
13300861|NCT01339923|26509465|FG004|Overall Study|Inappropriate Enrollment|0|||
13300862|NCT01339923|26509466|FG005|Overall Study|Inappropriate Enrollment|1|||
13300863|NCT01339923|26509467|FG006|Overall Study|Inappropriate Enrollment|0|||
13300864|NCT01339923|26509461|FG000|Overall Study|Lost to Follow-up|4|||
13300865|NCT01339923|26509462|FG001|Overall Study|Lost to Follow-up|4|||
13300866|NCT01339923|26509463|FG002|Overall Study|Lost to Follow-up|0|||
13300867|NCT01339923|26509464|FG003|Overall Study|Lost to Follow-up|3|||
13300868|NCT01339923|26509465|FG004|Overall Study|Lost to Follow-up|1|||
13300869|NCT01339923|26509466|FG005|Overall Study|Lost to Follow-up|1|||
13300870|NCT01339923|26509467|FG006|Overall Study|Lost to Follow-up|5|||
13300871|NCT01339923|26509461|FG000|Overall Study|Protocol Violation|0|||
13300872|NCT01339923|26509462|FG001|Overall Study|Protocol Violation|0|||
13300873|NCT01339923|26509463|FG002|Overall Study|Protocol Violation|0|||
13300874|NCT01339923|26509464|FG003|Overall Study|Protocol Violation|0|||
13300875|NCT01339923|26509465|FG004|Overall Study|Protocol Violation|0|||
13300876|NCT01339923|26509466|FG005|Overall Study|Protocol Violation|3|||
13300877|NCT01339923|26509467|FG006|Overall Study|Protocol Violation|1|||
13300878|NCT01339923|26509461|FG000|Overall Study|Unable to Classify|1|||
13300879|NCT01339923|26509462|FG001|Overall Study|Unable to Classify|0|||
13300880|NCT01339923|26509463|FG002|Overall Study|Unable to Classify|1|||
13300881|NCT01339923|26509464|FG003|Overall Study|Unable to Classify|0|||
13300882|NCT01339923|26509465|FG004|Overall Study|Unable to Classify|0|||
13300883|NCT01339923|26509466|FG005|Overall Study|Unable to Classify|1|||
13300884|NCT01339923|26509467|FG006|Overall Study|Unable to Classify|5|||
13300885|NCT01339923|26509461|FG000|Overall Study|Withdrawal by Subject|7|||
13300886|NCT01339923|26509462|FG001|Overall Study|Withdrawal by Subject|11|||
13300887|NCT01339923|26509463|FG002|Overall Study|Withdrawal by Subject|6|||
13300888|NCT01339923|26509464|FG003|Overall Study|Withdrawal by Subject|1|||
13300889|NCT01339923|26509465|FG004|Overall Study|Withdrawal by Subject|4|||
13300890|NCT01339923|26509466|FG005|Overall Study|Withdrawal by Subject|3|||
13300891|NCT01339923|26509467|FG006|Overall Study|Withdrawal by Subject|2|||
13300892|NCT01339897|26509506|FG000|Overall Study|Adverse Event|1|||
13300893|NCT01339897|26509507|FG001|Overall Study|Adverse Event|0|||
13300894|NCT01339897|26509508|FG002|Overall Study|Adverse Event|0|||
13300895|NCT01339897|26509509|FG003|Overall Study|Adverse Event|1|||
13300896|NCT01339832|26509522|FG000|Overall Study|Lost to Follow-up|3|||
13300897|NCT01339832|26509522|FG000|Overall Study|Death|11|||
13300898|NCT01339559|26509533|FG000|Overall Study|Adverse Event|92|||
13300899|NCT01339559|26509533|FG000|Overall Study|Death|5|||
13300900|NCT01339559|26509533|FG000|Overall Study|Lack of Efficacy|164|||
13300901|NCT01339559|26509533|FG000|Overall Study|Lost to Follow-up|22|||
13300902|NCT01339559|26509533|FG000|Overall Study|Subject choice|89|||
13300903|NCT01339559|26509533|FG000|Overall Study|Protocol Violation|15|||
13300904|NCT01339559|26509533|FG000|Overall Study|Study closure at site|1|||
13300905|NCT01339559|26509533|FG000|Overall Study|Incarcerated|2|||
13300906|NCT01339559|26509533|FG000|Overall Study|Epilepsy surgery|1|||
13300907|NCT01339559|26509533|FG000|Overall Study|Pregnancy planned|2|||
13300908|NCT01339559|26509533|FG000|Overall Study|Left the country|1|||
13300909|NCT01339559|26509533|FG000|Overall Study|Investigator decision|2|||
13300910|NCT01339559|26509533|FG000|Overall Study|Patient didn't wish to continue|1|||
13300911|NCT01339559|26509533|FG000|Overall Study|PI decision|1|||
13300912|NCT01339429|26509540|FG000|Overall Study|Withdrawal by Subject|1|||
13300913|NCT01339429|26509540|FG000|Overall Study|Physician Decision|3|||
13300914|NCT01339390|26509553|FG000|Overall Study|Death|32|||
13300915|NCT01339390|26509554|FG001|Overall Study|Death|29|||
13300916|NCT01339390|26509553|FG000|Overall Study|Lost to Follow-up|125|||
13300917|NCT01339390|26509554|FG001|Overall Study|Lost to Follow-up|127|||
13300918|NCT01339273|26509593|FG000|Overall Study|Lost to Follow-up|8|||
13300919|NCT01339273|26509594|FG001|Overall Study|Lost to Follow-up|8|||
13300920|NCT01339052|26509621|FG000|Overall Study|Disease progression|13|||
13300921|NCT01339052|26509622|FG001|Overall Study|Disease progression|46|||
13300922|NCT01339052|26509621|FG000|Overall Study|Adverse Event|1|||
13300923|NCT01339052|26509622|FG001|Overall Study|Adverse Event|1|||
13300924|NCT01339052|26509621|FG000|Overall Study|Withdrawal by Subject|0|||
13300925|NCT01339052|26509622|FG001|Overall Study|Withdrawal by Subject|3|||
13300926|NCT01339052|26509621|FG000|Overall Study|Physician Decision|1|||
13300927|NCT01339052|26509622|FG001|Overall Study|Physician Decision|0|||
13300928|NCT01339000|26509643|FG000|Overall Study|study closed due to lack of drug supply|1|||
13394787|NCT00654381|26788102|FG005|Extension Stage|Adverse Event|1|||
13300929|NCT01339000|26509644|FG001|Overall Study|study closed due to lack of drug supply|0|||
13300930|NCT01338987|26509675|FG000|Overall Study|enrolled on new protocol|0|||
13300931|NCT01338987|26509676|FG001|Overall Study|enrolled on new protocol|0|||
13300932|NCT01338987|26509677|FG002|Overall Study|enrolled on new protocol|1|||
13300933|NCT01338987|26509678|FG003|Overall Study|enrolled on new protocol|0|||
13300934|NCT01338987|26509679|FG004|Overall Study|enrolled on new protocol|0|||
13300935|NCT01338987|26509675|FG000|Overall Study|Disease progression on study|2|||
13300936|NCT01338987|26509676|FG001|Overall Study|Disease progression on study|1|||
13300937|NCT01338987|26509677|FG002|Overall Study|Disease progression on study|1|||
13300938|NCT01338987|26509678|FG003|Overall Study|Disease progression on study|0|||
13300939|NCT01338987|26509679|FG004|Overall Study|Disease progression on study|0|||
13300940|NCT01338870|26509748|FG000|Overall Study|Lost to Follow-up|0|||
13300941|NCT01338870|26509749|FG001|Overall Study|Lost to Follow-up|0|||
13300942|NCT01338870|26509750|FG002|Overall Study|Lost to Follow-up|1|||
13300943|NCT01338870|26509751|FG003|Overall Study|Lost to Follow-up|0|||
13300944|NCT01338870|26509752|FG004|Overall Study|Lost to Follow-up|1|||
13300945|NCT01338870|26509753|FG005|Overall Study|Lost to Follow-up|0|||
13300946|NCT01338870|26509748|FG000|Overall Study|Withdrawal by Subject|2|||
13300947|NCT01338870|26509749|FG001|Overall Study|Withdrawal by Subject|3|||
13300948|NCT01338870|26509750|FG002|Overall Study|Withdrawal by Subject|4|||
13300949|NCT01338870|26509751|FG003|Overall Study|Withdrawal by Subject|0|||
13300950|NCT01338870|26509752|FG004|Overall Study|Withdrawal by Subject|0|||
13300951|NCT01338870|26509753|FG005|Overall Study|Withdrawal by Subject|2|||
13300952|NCT01338870|26509748|FG000|Overall Study|Other|3|||
13300953|NCT01338870|26509749|FG001|Overall Study|Other|3|||
13300954|NCT01338870|26509750|FG002|Overall Study|Other|3|||
13300955|NCT01338870|26509751|FG003|Overall Study|Other|2|||
13300956|NCT01338870|26509752|FG004|Overall Study|Other|0|||
13300957|NCT01338870|26509753|FG005|Overall Study|Other|2|||
13300958|NCT01338870|26509748|FG000|Overall Study|Protocol Violation|0|||
13300959|NCT01338870|26509749|FG001|Overall Study|Protocol Violation|2|||
13300960|NCT01338870|26509750|FG002|Overall Study|Protocol Violation|2|||
13300961|NCT01338870|26509751|FG003|Overall Study|Protocol Violation|2|||
13300962|NCT01338870|26509752|FG004|Overall Study|Protocol Violation|1|||
13300963|NCT01338870|26509753|FG005|Overall Study|Protocol Violation|1|||
13300964|NCT01338870|26509748|FG000|Overall Study|Adverse Event|4|||
13300965|NCT01338870|26509749|FG001|Overall Study|Adverse Event|4|||
13300966|NCT01338870|26509750|FG002|Overall Study|Adverse Event|1|||
13300967|NCT01338870|26509751|FG003|Overall Study|Adverse Event|5|||
13300968|NCT01338870|26509752|FG004|Overall Study|Adverse Event|4|||
13300969|NCT01338870|26509753|FG005|Overall Study|Adverse Event|1|||
13300970|NCT01338818|26509761|FG000|Overall Study|Adverse Event|8|||
13300971|NCT01338818|26509761|FG000|Overall Study|Lack of Efficacy|5|||
13300972|NCT01338818|26509761|FG000|Overall Study|no longer require study drug|1|||
13300973|NCT01338818|26509761|FG000|Overall Study|Withdrawal by Subject|11|||
13300974|NCT01338818|26509761|FG000|Overall Study|Lost to Follow-up|4|||
13300975|NCT01338818|26509761|FG000|Overall Study|Administrative problems|3|||
13300976|NCT01338818|26509761|FG000|Overall Study|Protocol Deviation|4|||
13300977|NCT01338792|26509769|FG000|Overall Study|Adverse Event|2|||
13300978|NCT01338792|26509769|FG000|Overall Study|Death|1|||
13300979|NCT01338792|26509769|FG000|Overall Study|Withdrawal by Subject|1|||
13300980|NCT01338610|26509786|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1|||
13300981|NCT01338610|26509787|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1|||
13300982|NCT01338610|26509788|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0|||
13300983|NCT01338610|26509786|FG000|Overall Study|Protocol Violation|1|||
13300984|NCT01338610|26509787|FG001|Overall Study|Protocol Violation|0|||
13300985|NCT01338610|26509788|FG002|Overall Study|Protocol Violation|1|||
13300986|NCT01338610|26509786|FG000|Overall Study|Adverse Event|3|||
13300987|NCT01338610|26509787|FG001|Overall Study|Adverse Event|0|||
13300988|NCT01338610|26509788|FG002|Overall Study|Adverse Event|0|||
13300989|NCT01338493|26509795|FG000|Enrolled|Withdrawal by Subject|1|||
13300990|NCT01338493|26509795|FG000|Enrolled|Patient not implanted|4|||
13300991|NCT01338493|26509795|FG000|Discharge|Death|1|||
13300992|NCT01338493|26509795|FG000|Discharge|Missed visit|1|||
13300993|NCT01338493|26509795|FG000|6 Months Follow up|Lost to Follow-up|11|||
13300994|NCT01338493|26509795|FG000|6 Months Follow up|Missed visit|8|||
13300995|NCT01338493|26509795|FG000|12 Months Follow up|Lost to Follow-up|9|||
13300996|NCT01338415|26509833|FG000|Core + Extension|Adverse Event|8|||
13300997|NCT01338415|26509834|FG001|Core + Extension|Adverse Event|6|||
13300998|NCT01338415|26509835|FG002|Core + Extension|Adverse Event|0|||
13300999|NCT01338415|26509833|FG000|Core + Extension|Withdrawal by Subject|1|||
13301000|NCT01338415|26509834|FG001|Core + Extension|Withdrawal by Subject|1|||
13301001|NCT01338415|26509835|FG002|Core + Extension|Withdrawal by Subject|0|||
13301002|NCT01338415|26509833|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0|||
13301003|NCT01338415|26509834|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2|||
13301004|NCT01338415|26509835|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0|||
13301005|NCT01338415|26509833|FG000|Core + Extension|Other (administrative reason)|1|||
13301006|NCT01338415|26509834|FG001|Core + Extension|Other (administrative reason)|0|||
13301007|NCT01338415|26509835|FG002|Core + Extension|Other (administrative reason)|0|||
13301008|NCT01338415|26509833|FG000|Exceptional Use Treatment Period|Administrative decision|0|||
13301009|NCT01338415|26509834|FG001|Exceptional Use Treatment Period|Administrative decision|0|||
13301010|NCT01338415|26509835|FG002|Exceptional Use Treatment Period|Administrative decision|1|||
13301011|NCT01338415|26509833|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
13301012|NCT01338415|26509834|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
13301013|NCT01338415|26509835|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3|||
13301014|NCT01338415|26509833|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
13301015|NCT01338415|26509834|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
13301016|NCT01338415|26509835|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1|||
13301017|NCT01338415|26509833|FG000|Exceptional Use Treatment Period|Death|0|||
13301018|NCT01338415|26509834|FG001|Exceptional Use Treatment Period|Death|0|||
13301019|NCT01338415|26509835|FG002|Exceptional Use Treatment Period|Death|1|||
13301020|NCT01338298|26509850|FG000|Overall Study|Withdrawal by Subject|1|||
13301021|NCT01338298|26509851|FG001|Overall Study|Withdrawal by Subject|1|||
13301022|NCT01338298|26509850|FG000|Overall Study|Abdominal Pain and scheduled surgery|0|||
13301023|NCT01338298|26509851|FG001|Overall Study|Abdominal Pain and scheduled surgery|1|||
13301024|NCT01338298|26509850|FG000|Overall Study|Administrative error|0|||
13301025|NCT01338298|26509851|FG001|Overall Study|Administrative error|1|||
13301026|NCT01338298|26509850|FG000|Overall Study|Positive symptom worsening|1|||
13301027|NCT01338298|26509851|FG001|Overall Study|Positive symptom worsening|0|||
13301028|NCT01338298|26509850|FG000|Overall Study|Depressive symptoms and nausea|1|||
13301029|NCT01338298|26509851|FG001|Overall Study|Depressive symptoms and nausea|0|||
13301030|NCT01338298|26509850|FG000|Overall Study|Non-adherence|1|||
13301031|NCT01338298|26509851|FG001|Overall Study|Non-adherence|0|||
13301032|NCT01338025|26509870|FG000|Overall Study|Unexpected closure of study|10|||
13301033|NCT01338025|26509871|FG001|Overall Study|Unexpected closure of study|9|||
13301034|NCT01338025|26509870|FG000|Overall Study|Withdrawal by Subject|0|||
13301035|NCT01338025|26509871|FG001|Overall Study|Withdrawal by Subject|2|||
13301036|NCT01338025|26509870|FG000|Overall Study|Found ineligible after starting|1|||
13301037|NCT01338025|26509871|FG001|Overall Study|Found ineligible after starting|0|||
13301038|NCT01338012|26509877|FG000|Overall Study|Death|4|||
13301039|NCT01338012|26509877|FG000|Overall Study|Study terminated|4|||
13301040|NCT01337986|26509918|FG000|Overall Study|Adverse Event|2|||
13301041|NCT01337986|26509919|FG001|Overall Study|Adverse Event|2|||
13301042|NCT01337986|26509918|FG000|Overall Study|Lost to Follow-up|1|||
13301043|NCT01337986|26509919|FG001|Overall Study|Lost to Follow-up|0|||
13301044|NCT01337986|26509918|FG000|Overall Study|Protocol Violation|0|||
13301045|NCT01337986|26509919|FG001|Overall Study|Protocol Violation|3|||
13301046|NCT01337973|26509940|FG000|Overall Study|Lost to Follow-up|2|||
13301047|NCT01337973|26509941|FG001|Overall Study|Lost to Follow-up|4|||
13301048|NCT01337973|26509942|FG002|Overall Study|Lost to Follow-up|3|||
13301049|NCT01337973|26509940|FG000|Overall Study|Death|1|||
13301050|NCT01337973|26509941|FG001|Overall Study|Death|2|||
13301051|NCT01337973|26509942|FG002|Overall Study|Death|1|||
13301052|NCT01337973|26509940|FG000|Overall Study|Withdrawal by Subject|10|||
13301053|NCT01337973|26509941|FG001|Overall Study|Withdrawal by Subject|8|||
13301054|NCT01337973|26509942|FG002|Overall Study|Withdrawal by Subject|4|||
13301055|NCT01337973|26509940|FG000|Overall Study|missing data on primary outcome|3|||
13301056|NCT01337973|26509941|FG001|Overall Study|missing data on primary outcome|1|||
13301057|NCT01337973|26509942|FG002|Overall Study|missing data on primary outcome|3|||
13301058|NCT01337960|26509972|FG000|Overall Study|Lost to Follow-up|1|||
13301059|NCT01337960|26509973|FG001|Overall Study|Lost to Follow-up|0|||
13301060|NCT01337960|26509974|FG002|Overall Study|Lost to Follow-up|0|||
13301061|NCT01337960|26509972|FG000|Overall Study|Withdrawal by Subject|1|||
13301062|NCT01337960|26509973|FG001|Overall Study|Withdrawal by Subject|0|||
13301063|NCT01337960|26509974|FG002|Overall Study|Withdrawal by Subject|0|||
13301064|NCT01337674|26509999|FG000|Treatment Period 1|Adverse Event|0|||
13301065|NCT01337674|26510000|FG001|Treatment Period 1|Adverse Event|1|||
13301066|NCT01337674|26510001|FG002|Treatment Period 1|Adverse Event|0|||
13301067|NCT01337674|26510002|FG003|Treatment Period 1|Adverse Event|0|||
13301068|NCT01337674|26509999|FG000|Treatment Period 1|Discontinued due to blood draws|0|||
13301069|NCT01337674|26510000|FG001|Treatment Period 1|Discontinued due to blood draws|0|||
13301070|NCT01337674|26510001|FG002|Treatment Period 1|Discontinued due to blood draws|0|||
13301071|NCT01337674|26510002|FG003|Treatment Period 1|Discontinued due to blood draws|1|||
13301072|NCT01337674|26509999|FG000|Treatment Period 2|Withdrawal by Subject|0|||
13301073|NCT01337674|26510000|FG001|Treatment Period 2|Withdrawal by Subject|0|||
13301074|NCT01337674|26510001|FG002|Treatment Period 2|Withdrawal by Subject|1|||
13301075|NCT01337674|26510002|FG003|Treatment Period 2|Withdrawal by Subject|0|||
13301076|NCT01337635|26510017|FG000|Overall Study|Lost to Follow-up|0|||
13301077|NCT01337635|26510018|FG001|Overall Study|Lost to Follow-up|1|||
13301078|NCT01337596|26510080|FG000|Overall Study|Withdrawal by Subject|0|||
13301079|NCT01337596|26510081|FG001|Overall Study|Withdrawal by Subject|0|||
13301080|NCT01337596|26510082|FG002|Overall Study|Withdrawal by Subject|0|||
13301081|NCT01337596|26510083|FG003|Overall Study|Withdrawal by Subject|0|||
13301082|NCT01337596|26510084|FG004|Overall Study|Withdrawal by Subject|2|||
13301083|NCT01337596|26510085|FG005|Overall Study|Withdrawal by Subject|0|||
13301084|NCT01337596|26510086|FG006|Overall Study|Withdrawal by Subject|0|||
13301085|NCT01337596|26510087|FG007|Overall Study|Withdrawal by Subject|0|||
13301086|NCT01337596|26510088|FG008|Overall Study|Withdrawal by Subject|0|||
13301087|NCT01337297|26510101|FG000|Overall Study|They entered to single anodal tDCS|4|||
13301088|NCT01337297|26510102|FG001|Overall Study|They entered to single anodal tDCS|3|||
13301089|NCT01337297|26510101|FG000|Overall Study|Lost to Follow-up|1|||
13301090|NCT01337297|26510102|FG001|Overall Study|Lost to Follow-up|3|||
13301091|NCT01337167|26510175|FG000|Infant Series|Adverse Event|1|||
13301092|NCT01337167|26510176|FG001|Infant Series|Adverse Event|1|||
13301093|NCT01337167|26510175|FG000|Infant Series|Death|1|||
13301094|NCT01337167|26510176|FG001|Infant Series|Death|1|||
13301095|NCT01337167|26510175|FG000|Infant Series|Lost to Follow-up|13|||
13301096|NCT01337167|26510176|FG001|Infant Series|Lost to Follow-up|7|||
13301097|NCT01337167|26510175|FG000|Infant Series|Non-compliance with study drug|2|||
13301098|NCT01337167|26510176|FG001|Infant Series|Non-compliance with study drug|1|||
13301099|NCT01337167|26510175|FG000|Infant Series|Physician Decision|3|||
13301100|NCT01337167|26510176|FG001|Infant Series|Physician Decision|1|||
13301101|NCT01337167|26510175|FG000|Infant Series|Protocol Violation|22|||
13301102|NCT01337167|26510176|FG001|Infant Series|Protocol Violation|9|||
13301103|NCT01337167|26510175|FG000|Infant Series|Withdrawal by Subject|15|||
13301104|NCT01337167|26510176|FG001|Infant Series|Withdrawal by Subject|4|||
13301105|NCT01337167|26510175|FG000|Infant Series|Randomized but not vaccinated|5|||
13301106|NCT01337167|26510176|FG001|Infant Series|Randomized but not vaccinated|3|||
13301107|NCT01337167|26510175|FG000|Interim Period|Lost to Follow-up|51|||
13301108|NCT01337167|26510176|FG001|Interim Period|Lost to Follow-up|23|||
13301109|NCT01337167|26510175|FG000|Interim Period|Non-compliance with study drug|1|||
13301110|NCT01337167|26510176|FG001|Interim Period|Non-compliance with study drug|0|||
13301111|NCT01337167|26510175|FG000|Interim Period|Physician Decision|6|||
13301112|NCT01337167|26510176|FG001|Interim Period|Physician Decision|3|||
13301113|NCT01337167|26510175|FG000|Interim Period|Protocol Violation|5|||
13301114|NCT01337167|26510176|FG001|Interim Period|Protocol Violation|3|||
13301115|NCT01337167|26510175|FG000|Interim Period|Withdrawal by Subject|18|||
13301116|NCT01337167|26510176|FG001|Interim Period|Withdrawal by Subject|10|||
13301117|NCT01337167|26510175|FG000|Interim Period|Other protocol criterion not met|0|||
13301118|NCT01337167|26510176|FG001|Interim Period|Other protocol criterion not met|1|||
13301119|NCT01337167|26510175|FG000|Toddler Vaccinations|Lost to Follow-up|11|||
13301120|NCT01337167|26510176|FG001|Toddler Vaccinations|Lost to Follow-up|12|||
13301121|NCT01337167|26510175|FG000|Toddler Vaccinations|Protocol Violation|0|||
13301122|NCT01337167|26510176|FG001|Toddler Vaccinations|Protocol Violation|1|||
13301123|NCT01337167|26510175|FG000|Toddler Vaccinations|Withdrawal by Subject|3|||
13301124|NCT01337167|26510176|FG001|Toddler Vaccinations|Withdrawal by Subject|0|||
13301125|NCT01337115|26510195|FG000|Overall Study|Protocol Violation|2|||
13301126|NCT01337115|26510196|FG001|Overall Study|Protocol Violation|0|||
13301127|NCT01337089|26510206|FG000|Overall Study|Adverse Event|237|||
13301128|NCT01337089|26510206|FG000|Overall Study|Withdrawal by Subject|129|||
13301129|NCT01337089|26510206|FG000|Overall Study|Withdrawal by Investigator|33|||
13301130|NCT01337089|26510206|FG000|Overall Study|Met Withdrawal Criteria|3|||
13301131|NCT01337089|26510206|FG000|Overall Study|Lost to Follow-up|2|||
13301132|NCT01337050|26510274|FG000|Overall Study|Death|0|||
13301133|NCT01337050|26510275|FG001|Overall Study|Death|0|||
13301134|NCT01337050|26510276|FG002|Overall Study|Death|4|||
13301135|NCT01337050|26510274|FG000|Overall Study|Other|4|||
13301136|NCT01337050|26510275|FG001|Overall Study|Other|6|||
13301137|NCT01337050|26510276|FG002|Overall Study|Other|8|||
13301138|NCT01337050|26510274|FG000|Overall Study|Participants refused further follow-up|0|||
13301139|NCT01337050|26510275|FG001|Overall Study|Participants refused further follow-up|7|||
13301140|NCT01337050|26510276|FG002|Overall Study|Participants refused further follow-up|7|||
13382240|NCT00745615|26750522|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
13382241|NCT00745615|26750523|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4|||
13382242|NCT00745615|26750524|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
13382243|NCT00745615|26750525|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
13382244|NCT00745615|26750520|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
13382245|NCT00745615|26750521|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1|||
13382246|NCT00745615|26750522|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
13382247|NCT00745615|26750523|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
13382248|NCT00745615|26750524|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
13382249|NCT00745615|26750525|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
13382250|NCT00745615|26750520|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2|||
13382251|NCT00745615|26750521|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3|||
13382252|NCT00745615|26750522|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
13382253|NCT00745615|26750523|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
13382254|NCT00745615|26750524|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
13301141|NCT01336972|26510321|FG000|Overall Study|Adverse Event|1|||
13301142|NCT01336972|26510322|FG001|Overall Study|Adverse Event|1|||
13301143|NCT01336972|26510323|FG002|Overall Study|Adverse Event|0|||
13301144|NCT01336894|26510348|FG000|Follow-up|Study terminated prematurely|2|||
13301145|NCT01336894|26510349|FG001|Follow-up|Study terminated prematurely|7|||
13301146|NCT01336764|26510362|FG000|Overall Study|Withdrawal by Subject|5|||
13301147|NCT01336764|26510363|FG001|Overall Study|Withdrawal by Subject|5|||
13301148|NCT01336738|26510421|FG000|Overall Study|Adverse Event|0|||
13301149|NCT01336738|26510422|FG001|Overall Study|Adverse Event|3|||
13301150|NCT01336738|26510423|FG002|Overall Study|Adverse Event|2|||
13301151|NCT01336738|26510424|FG003|Overall Study|Adverse Event|1|||
13301152|NCT01336738|26510425|FG004|Overall Study|Adverse Event|3|||
13301153|NCT01336738|26510421|FG000|Overall Study|Lost to Follow-up|2|||
13301154|NCT01336738|26510422|FG001|Overall Study|Lost to Follow-up|1|||
13301155|NCT01336738|26510423|FG002|Overall Study|Lost to Follow-up|2|||
13301156|NCT01336738|26510424|FG003|Overall Study|Lost to Follow-up|2|||
13301157|NCT01336738|26510425|FG004|Overall Study|Lost to Follow-up|2|||
13301158|NCT01336738|26510421|FG000|Overall Study|Did not meet entrance criteria|0|||
13301159|NCT01336738|26510422|FG001|Overall Study|Did not meet entrance criteria|1|||
13301160|NCT01336738|26510423|FG002|Overall Study|Did not meet entrance criteria|0|||
13301161|NCT01336738|26510424|FG003|Overall Study|Did not meet entrance criteria|0|||
13301162|NCT01336738|26510425|FG004|Overall Study|Did not meet entrance criteria|0|||
13301163|NCT01336738|26510421|FG000|Overall Study|Protocol Violation|0|||
13301164|NCT01336738|26510422|FG001|Overall Study|Protocol Violation|1|||
13301165|NCT01336738|26510423|FG002|Overall Study|Protocol Violation|0|||
13301166|NCT01336738|26510424|FG003|Overall Study|Protocol Violation|0|||
13301167|NCT01336738|26510425|FG004|Overall Study|Protocol Violation|0|||
13301168|NCT01336738|26510421|FG000|Overall Study|Withdrawal by Subject|2|||
13301169|NCT01336738|26510422|FG001|Overall Study|Withdrawal by Subject|0|||
13301170|NCT01336738|26510423|FG002|Overall Study|Withdrawal by Subject|2|||
13301171|NCT01336738|26510424|FG003|Overall Study|Withdrawal by Subject|1|||
13301172|NCT01336738|26510425|FG004|Overall Study|Withdrawal by Subject|1|||
13301173|NCT01336738|26510421|FG000|Overall Study|Other|3|||
13301174|NCT01336738|26510422|FG001|Overall Study|Other|3|||
13301175|NCT01336738|26510423|FG002|Overall Study|Other|2|||
13301176|NCT01336738|26510424|FG003|Overall Study|Other|3|||
13301177|NCT01336738|26510425|FG004|Overall Study|Other|4|||
13301178|NCT01336712|26510437|FG000|Overall Study|Death|2|||
13301179|NCT01336712|26510437|FG000|Overall Study|Lack of Efficacy|1|||
13301180|NCT01336647|26510458|FG000|Overall Study|Lost to Follow-up|4|||
13301181|NCT01336647|26510459|FG001|Overall Study|Lost to Follow-up|1|||
13301182|NCT01336647|26510460|FG002|Overall Study|Lost to Follow-up|3|||
13301183|NCT01336608|26510485|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102|||
13301184|NCT01336608|26510486|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
13301185|NCT01336608|26510487|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
13301186|NCT01336608|26510488|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
13301187|NCT01336608|26510485|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9|||
13301188|NCT01336608|26510486|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
13301189|NCT01336608|26510487|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
13301190|NCT01336608|26510488|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
13301191|NCT01336608|26510485|FG000|2-week, Single-blind Run-In Period|Adverse Event|1|||
13301192|NCT01336608|26510486|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
13301193|NCT01336608|26510487|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
13301194|NCT01336608|26510488|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
13301195|NCT01336608|26510485|FG000|2-week, Single-blind Run-In Period|Physician Decision|1|||
13301196|NCT01336608|26510486|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
13301197|NCT01336608|26510487|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
13301198|NCT01336608|26510488|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
13301199|NCT01336608|26510485|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2|||
13301200|NCT01336608|26510486|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
13301201|NCT01336608|26510487|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
13301202|NCT01336608|26510488|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
13301203|NCT01336608|26510485|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
13301204|NCT01336608|26510486|FG001|24-week, Double-blind Treatment Period|Adverse Event|8|||
13301205|NCT01336608|26510487|FG002|24-week, Double-blind Treatment Period|Adverse Event|6|||
13301206|NCT01336608|26510488|FG003|24-week, Double-blind Treatment Period|Adverse Event|7|||
13301207|NCT01336608|26510485|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
13301208|NCT01336608|26510486|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
13301209|NCT01336608|26510487|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
13301210|NCT01336608|26510488|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
13301211|NCT01336608|26510485|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
13301212|NCT01336608|26510486|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
13301213|NCT01336608|26510487|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
13301214|NCT01336608|26510488|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6|||
13301215|NCT01336608|26510485|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
13301216|NCT01336608|26510486|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4|||
13301217|NCT01336608|26510487|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3|||
13301218|NCT01336608|26510488|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3|||
13301219|NCT01336608|26510485|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
13301220|NCT01336608|26510486|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
13301221|NCT01336608|26510487|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3|||
13301222|NCT01336608|26510488|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6|||
13301223|NCT01336608|26510485|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
13301224|NCT01336608|26510486|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
13301225|NCT01336608|26510487|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
13301226|NCT01336608|26510488|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
13301227|NCT01336608|26510485|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
13301228|NCT01336608|26510486|FG001|24-week, Double-blind Treatment Period|Physician Decision|3|||
13301229|NCT01336608|26510487|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
13301230|NCT01336608|26510488|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
13301231|NCT01336608|26510485|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
13301232|NCT01336608|26510486|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
13301233|NCT01336608|26510487|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
13301234|NCT01336608|26510488|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1|||
13301235|NCT01336569|26510494|FG000|Overall Study|Lost to Follow-up|4|||
13301236|NCT01336205|26510511|FG000|Overall Study|Other|22|||
13301237|NCT01336205|26510512|FG001|Overall Study|Other|9|||
13301238|NCT01336205|26510511|FG000|Overall Study|Lost to Follow-up|40|||
13301239|NCT01336205|26510512|FG001|Overall Study|Lost to Follow-up|20|||
13301240|NCT01336205|26510511|FG000|Overall Study|Study-Specific Withdrawal Criteria|16|||
13301241|NCT01336205|26510512|FG001|Overall Study|Study-Specific Withdrawal Criteria|7|||
13301242|NCT01336205|26510511|FG000|Overall Study|Lack of Efficacy|4|||
13301243|NCT01336205|26510512|FG001|Overall Study|Lack of Efficacy|0|||
13301244|NCT01336205|26510511|FG000|Overall Study|Severe noncompliance with protocol|9|||
13301245|NCT01336205|26510512|FG001|Overall Study|Severe noncompliance with protocol|2|||
13301246|NCT01336205|26510511|FG000|Overall Study|Adverse Event|56|||
13301247|NCT01336205|26510512|FG001|Overall Study|Adverse Event|6|||
13301248|NCT01336205|26510511|FG000|Overall Study|Death|1|||
13301249|NCT01336205|26510512|FG001|Overall Study|Death|1|||
13301250|NCT01336205|26510511|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9|||
13301251|NCT01336205|26510512|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
13301252|NCT01336205|26510511|FG000|Overall Study|Withdrawal by Subject|72|||
13301253|NCT01336205|26510512|FG001|Overall Study|Withdrawal by Subject|38|||
13301254|NCT01336205|26510511|FG000|Overall Study|Did not receive treatment|4|||
13301255|NCT01336205|26510512|FG001|Overall Study|Did not receive treatment|0|||
13301256|NCT01336023|26510541|FG000|Week 0 to Week 26|Adverse Event|8|||
13301257|NCT01336023|26510542|FG001|Week 0 to Week 26|Adverse Event|10|||
13301258|NCT01336023|26510543|FG002|Week 0 to Week 26|Adverse Event|24|||
13301259|NCT01336023|26510541|FG000|Week 0 to Week 26|Lack of Efficacy|0|||
13301260|NCT01336023|26510542|FG001|Week 0 to Week 26|Lack of Efficacy|1|||
13301261|NCT01336023|26510543|FG002|Week 0 to Week 26|Lack of Efficacy|0|||
13301262|NCT01336023|26510541|FG000|Week 0 to Week 26|Protocol Violation|1|||
13301263|NCT01336023|26510542|FG001|Week 0 to Week 26|Protocol Violation|2|||
13301264|NCT01336023|26510543|FG002|Week 0 to Week 26|Protocol Violation|0|||
13301265|NCT01336023|26510541|FG000|Week 0 to Week 26|Withdrawal Criteria|34|||
13301266|NCT01336023|26510542|FG001|Week 0 to Week 26|Withdrawal Criteria|69|||
13301267|NCT01336023|26510543|FG002|Week 0 to Week 26|Withdrawal Criteria|40|||
13301268|NCT01336023|26510541|FG000|Week 0 to Week 26|Unclassified|5|||
13301269|NCT01336023|26510542|FG001|Week 0 to Week 26|Unclassified|16|||
13301270|NCT01336023|26510543|FG002|Week 0 to Week 26|Unclassified|9|||
13301271|NCT01336023|26510541|FG000|Week 27 to 52|Adverse Event|1|||
13301272|NCT01336023|26510542|FG001|Week 27 to 52|Adverse Event|5|||
13301273|NCT01336023|26510543|FG002|Week 27 to 52|Adverse Event|2|||
13301274|NCT01336023|26510541|FG000|Week 27 to 52|Protocol Violation|0|||
13301275|NCT01336023|26510542|FG001|Week 27 to 52|Protocol Violation|2|||
13301276|NCT01336023|26510543|FG002|Week 27 to 52|Protocol Violation|1|||
13301277|NCT01336023|26510541|FG000|Week 27 to 52|Withdrawal Criteria|14|||
13301278|NCT01336023|26510542|FG001|Week 27 to 52|Withdrawal Criteria|19|||
13301279|NCT01336023|26510543|FG002|Week 27 to 52|Withdrawal Criteria|16|||
13301280|NCT01336023|26510541|FG000|Week 27 to 52|Unclassified|13|||
13301281|NCT01336023|26510542|FG001|Week 27 to 52|Unclassified|18|||
13301282|NCT01336023|26510543|FG002|Week 27 to 52|Unclassified|9|||
13301283|NCT01335997|26510560|FG000|Period I and II|Adverse Event|63|||
13301284|NCT01335997|26510561|FG001|Period I and II|Adverse Event|43|||
13301285|NCT01335997|26510560|FG000|Period I and II|Noncompliance with Study Drug|1|||
13301286|NCT01335997|26510561|FG001|Period I and II|Noncompliance with Study Drug|1|||
13301287|NCT01335997|26510560|FG000|Period I and II|Lost to Follow-up|3|||
13301288|NCT01335997|26510561|FG001|Period I and II|Lost to Follow-up|5|||
13301289|NCT01335997|26510560|FG000|Period I and II|Withdrawal by Subject|9|||
13301290|NCT01335997|26510561|FG001|Period I and II|Withdrawal by Subject|4|||
13301291|NCT01335997|26510560|FG000|Period I and II|Study Terminated by Sponsor|406|||
13301292|NCT01335997|26510561|FG001|Period I and II|Study Terminated by Sponsor|415|||
13301293|NCT01335997|26510560|FG000|Period I and II|Protocol Violation|9|||
13301294|NCT01335997|26510561|FG001|Period I and II|Protocol Violation|10|||
13301295|NCT01335997|26510560|FG000|Period I and II|Physician Decision|2|||
13301296|NCT01335997|26510561|FG001|Period I and II|Physician Decision|1|||
13301297|NCT01335997|26510560|FG000|Period III|Adverse Event|0|||
13301298|NCT01335997|26510561|FG001|Period III|Adverse Event|2|||
13301299|NCT01335997|26510560|FG000|Period III|Study Terminated by Sponsor|77|||
13301300|NCT01335997|26510561|FG001|Period III|Study Terminated by Sponsor|76|||
13301301|NCT01335997|26510560|FG000|Period III|Protocol Violation|0|||
13301302|NCT01335997|26510561|FG001|Period III|Protocol Violation|1|||
13301303|NCT01335997|26510560|FG000|Period III|Lost to Follow-up|1|||
13301304|NCT01335997|26510561|FG001|Period III|Lost to Follow-up|0|||
13301305|NCT01335971|26510606|FG000|Overall Study|Withdrawal by Subject|1|||
13301306|NCT01335971|26510607|FG001|Overall Study|Withdrawal by Subject|0|||
13301307|NCT01335971|26510608|FG002|Overall Study|Withdrawal by Subject|0|||
13301308|NCT01335971|26510606|FG000|Overall Study|Did not complete bronchoscopy|1|||
13301309|NCT01335971|26510607|FG001|Overall Study|Did not complete bronchoscopy|1|||
13301310|NCT01335971|26510608|FG002|Overall Study|Did not complete bronchoscopy|1|||
13301311|NCT01335698|26510685|FG000|Treatment Stage 1|Lack of Efficacy|3|||
13301312|NCT01335698|26510686|FG001|Treatment Stage 1|Lack of Efficacy|1|||
13301313|NCT01335698|26510687|FG002|Treatment Stage 1|Lack of Efficacy|3|||
13301314|NCT01335698|26510688|FG003|Treatment Stage 1|Lack of Efficacy|3|||
13301315|NCT01335698|26510689|FG004|Treatment Stage 1|Lack of Efficacy|1|||
13301316|NCT01335698|26510685|FG000|Treatment Stage 1|Adverse Event|1|||
13301317|NCT01335698|26510686|FG001|Treatment Stage 1|Adverse Event|2|||
13301318|NCT01335698|26510687|FG002|Treatment Stage 1|Adverse Event|2|||
13301319|NCT01335698|26510688|FG003|Treatment Stage 1|Adverse Event|1|||
13301320|NCT01335698|26510689|FG004|Treatment Stage 1|Adverse Event|1|||
13301321|NCT01335698|26510685|FG000|Treatment Stage 1|Withdrawal by Subject|1|||
13301322|NCT01335698|26510686|FG001|Treatment Stage 1|Withdrawal by Subject|2|||
13301323|NCT01335698|26510687|FG002|Treatment Stage 1|Withdrawal by Subject|0|||
13301324|NCT01335698|26510688|FG003|Treatment Stage 1|Withdrawal by Subject|1|||
13301325|NCT01335698|26510689|FG004|Treatment Stage 1|Withdrawal by Subject|0|||
13301326|NCT01335698|26510685|FG000|Treatment Stage 1|Lost to Follow-up|1|||
13301327|NCT01335698|26510686|FG001|Treatment Stage 1|Lost to Follow-up|1|||
13301328|NCT01335698|26510687|FG002|Treatment Stage 1|Lost to Follow-up|0|||
13301329|NCT01335698|26510688|FG003|Treatment Stage 1|Lost to Follow-up|0|||
13301330|NCT01335698|26510689|FG004|Treatment Stage 1|Lost to Follow-up|0|||
13301331|NCT01335698|26510685|FG000|Treatment Stage 1|Poor compliance/noncompliance|0|||
13301332|NCT01335698|26510686|FG001|Treatment Stage 1|Poor compliance/noncompliance|1|||
13301333|NCT01335698|26510687|FG002|Treatment Stage 1|Poor compliance/noncompliance|0|||
13301334|NCT01335698|26510688|FG003|Treatment Stage 1|Poor compliance/noncompliance|2|||
13301335|NCT01335698|26510689|FG004|Treatment Stage 1|Poor compliance/noncompliance|0|||
13301336|NCT01335698|26510685|FG000|Treatment Stage 1|No longer meets study criteria|1|||
13301337|NCT01335698|26510686|FG001|Treatment Stage 1|No longer meets study criteria|1|||
13301338|NCT01335698|26510687|FG002|Treatment Stage 1|No longer meets study criteria|0|||
13301339|NCT01335698|26510688|FG003|Treatment Stage 1|No longer meets study criteria|1|||
13301340|NCT01335698|26510689|FG004|Treatment Stage 1|No longer meets study criteria|0|||
13301341|NCT01335698|26510685|FG000|Treatment Stage 1|Other|1|||
13301342|NCT01335698|26510686|FG001|Treatment Stage 1|Other|0|||
13301343|NCT01335698|26510687|FG002|Treatment Stage 1|Other|0|||
13301344|NCT01335698|26510688|FG003|Treatment Stage 1|Other|1|||
13301345|NCT01335698|26510689|FG004|Treatment Stage 1|Other|0|||
13301346|NCT01335698|26510685|FG000|Treatment Stage 2|Lack of Efficacy|2|||
13301347|NCT01335698|26510686|FG001|Treatment Stage 2|Lack of Efficacy|1|||
13301348|NCT01335698|26510687|FG002|Treatment Stage 2|Lack of Efficacy|3|||
13301349|NCT01335698|26510688|FG003|Treatment Stage 2|Lack of Efficacy|1|||
13301350|NCT01335698|26510689|FG004|Treatment Stage 2|Lack of Efficacy|0|||
13301351|NCT01335698|26510685|FG000|Treatment Stage 2|Adverse Event|2|||
13301352|NCT01335698|26510686|FG001|Treatment Stage 2|Adverse Event|0|||
13301353|NCT01335698|26510687|FG002|Treatment Stage 2|Adverse Event|0|||
13301354|NCT01335698|26510688|FG003|Treatment Stage 2|Adverse Event|3|||
13301355|NCT01335698|26510689|FG004|Treatment Stage 2|Adverse Event|0|||
13301356|NCT01335698|26510685|FG000|Treatment Stage 2|Withdrawal by Subject|3|||
13301357|NCT01335698|26510686|FG001|Treatment Stage 2|Withdrawal by Subject|1|||
13301358|NCT01335698|26510687|FG002|Treatment Stage 2|Withdrawal by Subject|1|||
13301359|NCT01335698|26510688|FG003|Treatment Stage 2|Withdrawal by Subject|0|||
13301360|NCT01335698|26510689|FG004|Treatment Stage 2|Withdrawal by Subject|0|||
13301361|NCT01335698|26510685|FG000|Treatment Stage 2|Poor compliance/noncompliance|1|||
13301362|NCT01335698|26510686|FG001|Treatment Stage 2|Poor compliance/noncompliance|0|||
13301363|NCT01335698|26510687|FG002|Treatment Stage 2|Poor compliance/noncompliance|1|||
13301364|NCT01335698|26510688|FG003|Treatment Stage 2|Poor compliance/noncompliance|3|||
13301365|NCT01335698|26510689|FG004|Treatment Stage 2|Poor compliance/noncompliance|1|||
13301366|NCT01335698|26510685|FG000|Treatment Stage 2|Lost to Follow-up|1|||
13301367|NCT01335698|26510686|FG001|Treatment Stage 2|Lost to Follow-up|0|||
13301368|NCT01335698|26510687|FG002|Treatment Stage 2|Lost to Follow-up|0|||
13301369|NCT01335698|26510688|FG003|Treatment Stage 2|Lost to Follow-up|0|||
13301370|NCT01335698|26510689|FG004|Treatment Stage 2|Lost to Follow-up|0|||
13301371|NCT01335698|26510685|FG000|Treatment Stage 2|Capsules received at state hospital|1|||
13301372|NCT01335698|26510686|FG001|Treatment Stage 2|Capsules received at state hospital|0|||
13301373|NCT01335698|26510687|FG002|Treatment Stage 2|Capsules received at state hospital|0|||
13301374|NCT01335698|26510688|FG003|Treatment Stage 2|Capsules received at state hospital|0|||
13301375|NCT01335698|26510689|FG004|Treatment Stage 2|Capsules received at state hospital|0|||
13301376|NCT01335698|26510685|FG000|Treatment Stage 2|Subject no longer meets study criteria|0|||
13301377|NCT01335698|26510686|FG001|Treatment Stage 2|Subject no longer meets study criteria|0|||
13301378|NCT01335698|26510687|FG002|Treatment Stage 2|Subject no longer meets study criteria|0|||
13301379|NCT01335698|26510688|FG003|Treatment Stage 2|Subject no longer meets study criteria|1|||
13301380|NCT01335698|26510689|FG004|Treatment Stage 2|Subject no longer meets study criteria|0|||
13301381|NCT01335698|26510685|FG000|Treatment Stage 2|Switched to another formulation|1|||
13301382|NCT01335698|26510686|FG001|Treatment Stage 2|Switched to another formulation|1|||
13301383|NCT01335698|26510687|FG002|Treatment Stage 2|Switched to another formulation|0|||
13301384|NCT01335698|26510688|FG003|Treatment Stage 2|Switched to another formulation|0|||
13301385|NCT01335698|26510689|FG004|Treatment Stage 2|Switched to another formulation|0|||
13301386|NCT01335477|26510758|FG000|Overall Study|Adverse Event|30|||
13301387|NCT01335477|26510759|FG001|Overall Study|Adverse Event|42|||
13301388|NCT01335477|26510758|FG000|Overall Study|Non compliant with protocol|0|||
13301389|NCT01335477|26510759|FG001|Overall Study|Non compliant with protocol|2|||
13301390|NCT01335477|26510758|FG000|Overall Study|Lost to Follow-up|1|||
13301391|NCT01335477|26510759|FG001|Overall Study|Lost to Follow-up|2|||
13301392|NCT01335477|26510758|FG000|Overall Study|Consent withdrawn, not due to AE|7|||
13301393|NCT01335477|26510759|FG001|Overall Study|Consent withdrawn, not due to AE|9|||
13301394|NCT01335477|26510758|FG000|Overall Study|Not treated|1|||
13301395|NCT01335477|26510759|FG001|Overall Study|Not treated|2|||
13301396|NCT01335477|26510758|FG000|Overall Study|Reason other than those stated above|2|||
13301397|NCT01335477|26510759|FG001|Overall Study|Reason other than those stated above|2|||
13301398|NCT01335464|26510828|FG000|Overall Study|Adverse Event|15|||
13301399|NCT01335464|26510829|FG001|Overall Study|Adverse Event|25|||
13301400|NCT01335464|26510828|FG000|Overall Study|Non compliant with protocol|2|||
13301401|NCT01335464|26510829|FG001|Overall Study|Non compliant with protocol|0|||
13301402|NCT01335464|26510828|FG000|Overall Study|Consent withdrawn, not due to AE|12|||
13301403|NCT01335464|26510829|FG001|Overall Study|Consent withdrawn, not due to AE|23|||
13301404|NCT01335464|26510828|FG000|Overall Study|Not treated|2|||
13301405|NCT01335464|26510829|FG001|Overall Study|Not treated|0|||
13301406|NCT01335464|26510828|FG000|Overall Study|Reason other than those stated above|1|||
13301407|NCT01335464|26510829|FG001|Overall Study|Reason other than those stated above|1|||
13301408|NCT01335399|26510850|FG000|Pre-treatment Period|No longer meeting study criteria|0|||
13301409|NCT01335399|26510851|FG001|Pre-treatment Period|No longer meeting study criteria|1|||
13301410|NCT01335399|26510850|FG000|Pre-treatment Period|Participant request to discontinue|0|||
13301411|NCT01335399|26510851|FG001|Pre-treatment Period|Participant request to discontinue|1|||
13301412|NCT01335399|26510850|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0|||
13301413|NCT01335399|26510851|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1|||
13301414|NCT01335399|26510850|FG000|Pre-treatment Period|Consent withdrawal|3|||
13301415|NCT01335399|26510851|FG001|Pre-treatment Period|Consent withdrawal|0|||
13301416|NCT01335399|26510850|FG000|Treatment Period|Disease progression|117|||
13301417|NCT01335399|26510851|FG001|Treatment Period|Disease progression|145|||
13301418|NCT01335399|26510850|FG000|Treatment Period|Adverse event unrelated to study drug|110|||
13301419|NCT01335399|26510851|FG001|Treatment Period|Adverse event unrelated to study drug|73|||
13301420|NCT01335399|26510850|FG000|Treatment Period|Study drug toxicity|52|||
13301421|NCT01335399|26510851|FG001|Treatment Period|Study drug toxicity|64|||
13301422|NCT01335399|26510850|FG000|Treatment Period|Participant request to discontinue|30|||
13301423|NCT01335399|26510851|FG001|Treatment Period|Participant request to discontinue|22|||
13301424|NCT01335399|26510850|FG000|Treatment Period|Other reasons|30|||
13301425|NCT01335399|26510851|FG001|Treatment Period|Other reasons|30|||
13301426|NCT01335399|26510850|FG000|Treatment Period|Consent withdrawal|10|||
13301427|NCT01335399|26510851|FG001|Treatment Period|Consent withdrawal|7|||
13301428|NCT01335399|26510850|FG000|Treatment Period|Death|7|||
13301429|NCT01335399|26510851|FG001|Treatment Period|Death|6|||
13301430|NCT01335399|26510850|FG000|Treatment Period|Poor/Non-compliance|3|||
13301431|NCT01335399|26510851|FG001|Treatment Period|Poor/Non-compliance|4|||
13301432|NCT01335399|26510850|FG000|Treatment Period|Lost to Follow-up|2|||
13301433|NCT01335399|26510851|FG001|Treatment Period|Lost to Follow-up|2|||
13301434|NCT01335399|26510850|FG000|Treatment Period|Maximum clinical benefit|1|||
13301435|NCT01335399|26510851|FG001|Treatment Period|Maximum clinical benefit|1|||
13301436|NCT01335399|26510850|FG000|Treatment Period|No longer meet study criteria|1|||
13301437|NCT01335399|26510851|FG001|Treatment Period|No longer meet study criteria|1|||
13301438|NCT01335399|26510850|FG000|Treatment Period|Administrative reasons by Sponsor|8|||
13301439|NCT01335399|26510851|FG001|Treatment Period|Administrative reasons by Sponsor|16|||
13301440|NCT01335009|26510872|FG000|Overall Study|Too ill to travel to study sites|1|||
13301441|NCT01335009|26510873|FG001|Overall Study|Too ill to travel to study sites|0|||
13301442|NCT01335009|26510872|FG000|Overall Study|Death|28|||
13301443|NCT01335009|26510873|FG001|Overall Study|Death|32|||
13301444|NCT01335009|26510872|FG000|Overall Study|Withdrawal by Subject|1|||
13301445|NCT01335009|26510873|FG001|Overall Study|Withdrawal by Subject|1|||
13301446|NCT01335009|26510872|FG000|Overall Study|Lost to Follow-up|1|||
13301447|NCT01335009|26510873|FG001|Overall Study|Lost to Follow-up|0|||
13382255|NCT00745615|26750525|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
13382256|NCT00745615|26750520|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
13382257|NCT00745615|26750521|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1|||
13382258|NCT00745615|26750522|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
13382259|NCT00745615|26750523|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
13382260|NCT00745615|26750524|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
13382261|NCT00745615|26750525|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
13382262|NCT00745615|26750520|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
13382263|NCT00745615|26750521|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1|||
13382264|NCT00745615|26750522|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
13382265|NCT00745615|26750523|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
13382266|NCT00745615|26750524|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
13382267|NCT00745615|26750525|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
13382268|NCT00745615|26750520|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
13382269|NCT00745615|26750521|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
13382270|NCT00745615|26750522|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
13382271|NCT00745615|26750523|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
13382272|NCT00745615|26750524|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
13382273|NCT00745615|26750525|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
13382274|NCT00745615|26750520|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
13382275|NCT00745615|26750521|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
13382276|NCT00745615|26750522|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
13382277|NCT00745615|26750523|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
13382278|NCT00745615|26750524|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
13382279|NCT00745615|26750525|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
13382280|NCT00745615|26750520|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
13382281|NCT00745615|26750521|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
13382282|NCT00745615|26750522|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
13382283|NCT00745615|26750523|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
13382284|NCT00745615|26750524|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9|||
13382285|NCT00745615|26750525|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11|||
13382286|NCT00745615|26750520|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
13382287|NCT00745615|26750521|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
13382288|NCT00745615|26750522|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
13382289|NCT00745615|26750523|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
13382290|NCT00745615|26750524|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2|||
13382291|NCT00745615|26750525|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8|||
13382292|NCT00745615|26750520|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
13382293|NCT00745615|26750521|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
13382294|NCT00745615|26750522|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
13382295|NCT00745615|26750523|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
13382296|NCT00745615|26750524|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2|||
13382297|NCT00745615|26750525|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5|||
13382298|NCT00745615|26750520|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
13382299|NCT00745615|26750521|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
13382300|NCT00745615|26750522|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
13382301|NCT00745615|26750523|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
13382302|NCT00745615|26750524|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1|||
13382303|NCT00745615|26750525|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3|||
13382304|NCT00745615|26750520|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
13382305|NCT00745615|26750521|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
13301448|NCT01334918|26510906|FG000|Overall Study|Did not receive study drug|6|||
13301449|NCT01334918|26510907|FG001|Overall Study|Did not receive study drug|0|||
13301450|NCT01334918|26510906|FG000|Overall Study|Adverse Event|2|||
13301451|NCT01334918|26510907|FG001|Overall Study|Adverse Event|0|||
13301452|NCT01334918|26510906|FG000|Overall Study|Withdrawal by Subject|0|||
13301453|NCT01334918|26510907|FG001|Overall Study|Withdrawal by Subject|1|||
13301454|NCT01334866|26510917|FG000|Overall Study|Withdrawal by Subject|10|||
13301455|NCT01334866|26510917|FG000|Overall Study|Lost to Follow-up|3|||
13301456|NCT01334866|26510917|FG000|Overall Study|Physician Decision|3|||
13301457|NCT01334866|26510917|FG000|Overall Study|medically necessary prior to procedure|2|||
13301458|NCT01334866|26510917|FG000|Overall Study|medically necessary post-procedure|1|||
13301459|NCT01334710|26510924|FG000|Overall Study|Trial was terminated|3|||
13301460|NCT01334554|26510939|FG000|Overall Study|Adverse Event|4|||
13301461|NCT01334554|26510940|FG001|Overall Study|Adverse Event|2|||
13301462|NCT01334515|26510955|FG000|Overall Study|Adverse Event|1|||
13301463|NCT01334515|26510956|FG001|Overall Study|Adverse Event|6|||
13301464|NCT01334515|26510955|FG000|Overall Study|Death|1|||
13301465|NCT01334515|26510956|FG001|Overall Study|Death|0|||
13301466|NCT01334515|26510955|FG000|Overall Study|Lack of Efficacy|8|||
13301467|NCT01334515|26510956|FG001|Overall Study|Lack of Efficacy|21|||
13301468|NCT01334515|26510955|FG000|Overall Study|Physician Decision|1|||
13301469|NCT01334515|26510956|FG001|Overall Study|Physician Decision|1|||
13301470|NCT01334515|26510955|FG000|Overall Study|Withdrawal by Subject|1|||
13301471|NCT01334515|26510956|FG001|Overall Study|Withdrawal by Subject|1|||
13301472|NCT01334125|26510975|FG000|Overall Study|Lost to Follow-up|3|||
13301473|NCT01334125|26510976|FG001|Overall Study|Lost to Follow-up|3|||
13301474|NCT01333956|26511023|FG000|Overall Study|Lost to Follow-up|1|||
13301475|NCT01333956|26511024|FG001|Overall Study|Lost to Follow-up|2|||
13301476|NCT01333956|26511025|FG002|Overall Study|Lost to Follow-up|0|||
13301477|NCT01333956|26511026|FG003|Overall Study|Lost to Follow-up|1|||
13301478|NCT01333956|26511023|FG000|Overall Study|Unable to complete study procedure|1|||
13301479|NCT01333956|26511024|FG001|Overall Study|Unable to complete study procedure|0|||
13301480|NCT01333956|26511025|FG002|Overall Study|Unable to complete study procedure|0|||
13301481|NCT01333956|26511026|FG003|Overall Study|Unable to complete study procedure|1|||
13301482|NCT01333956|26511023|FG000|Overall Study|Withdrawal by Subject|0|||
13301483|NCT01333956|26511024|FG001|Overall Study|Withdrawal by Subject|2|||
13301484|NCT01333956|26511025|FG002|Overall Study|Withdrawal by Subject|1|||
13301485|NCT01333956|26511026|FG003|Overall Study|Withdrawal by Subject|0|||
13301486|NCT01333943|26511049|FG000|Overall Study|Known neuropathy|1|||
13301487|NCT01333943|26511050|FG001|Overall Study|Known neuropathy|0|||
13301488|NCT01333865|26511057|FG000|Overall Study|Adverse Event|2|||
13301489|NCT01333722|26511076|FG000|Overall Study|Lack of Efficacy|0|||
13301490|NCT01333722|26511077|FG001|Overall Study|Lack of Efficacy|2|||
13301491|NCT01333722|26511076|FG000|Overall Study|Withdrawal by Subject|0|||
13301492|NCT01333722|26511077|FG001|Overall Study|Withdrawal by Subject|1|||
13301493|NCT01333501|26511130|FG000|Overall Study|Adverse Event|3|||
13301494|NCT01333501|26511131|FG001|Overall Study|Adverse Event|1|||
13301495|NCT01333501|26511130|FG000|Overall Study|Abnormal laboratory value|2|||
13301496|NCT01333501|26511131|FG001|Overall Study|Abnormal laboratory value|1|||
13301497|NCT01333501|26511130|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
13301498|NCT01333501|26511131|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
13301499|NCT01333501|26511130|FG000|Overall Study|Withdrawn consent|3|||
13301500|NCT01333501|26511131|FG001|Overall Study|Withdrawn consent|12|||
13301501|NCT01333475|26511146|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1|||
13301502|NCT01333475|26511147|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0|||
13301503|NCT01333475|26511146|FG000|Overall Study|Toxicity|1|||
13301504|NCT01333475|26511147|FG001|Overall Study|Toxicity|3|||
13301505|NCT01333397|26511235|FG000|Overall Study|Lost to Follow-up|1|||
13301506|NCT01333397|26511236|FG001|Overall Study|Lost to Follow-up|0|||
13301507|NCT01333397|26511237|FG002|Overall Study|Lost to Follow-up|0|||
13301508|NCT01333397|26511238|FG003|Overall Study|Lost to Follow-up|1|||
13301509|NCT01333397|26511239|FG004|Overall Study|Lost to Follow-up|0|||
13301510|NCT01333189|26511274|FG000|Overall Study|Time constraints|1|||
13301511|NCT01333189|26511275|FG001|Overall Study|Time constraints|0|||
13301512|NCT01333189|26511274|FG000|Overall Study|Adverse Event|1|||
13301513|NCT01333189|26511275|FG001|Overall Study|Adverse Event|0|||
13301514|NCT01333189|26511274|FG000|Overall Study|Transportation difficulties|0|||
13301515|NCT01333189|26511275|FG001|Overall Study|Transportation difficulties|1|||
13301516|NCT01333189|26511274|FG000|Overall Study|Moved from region|0|||
13301517|NCT01333189|26511275|FG001|Overall Study|Moved from region|1|||
13301518|NCT01333111|26511309|FG000|Overall Study|patient undergoing major surgery|0|||
13301519|NCT01333111|26511310|FG001|Overall Study|patient undergoing major surgery|2|||
13301520|NCT01333111|26511311|FG002|Overall Study|patient undergoing major surgery|0|||
13301521|NCT01333111|26511309|FG000|Overall Study|personal reasons|0|||
13301522|NCT01333111|26511310|FG001|Overall Study|personal reasons|0|||
13301523|NCT01333111|26511311|FG002|Overall Study|personal reasons|1|||
13301524|NCT01333111|26511309|FG000|Overall Study|unclassified|1|||
13301525|NCT01333111|26511310|FG001|Overall Study|unclassified|0|||
13301526|NCT01333111|26511311|FG002|Overall Study|unclassified|0|||
13301527|NCT01333111|26511309|FG000|Overall Study|withdrawal criteria|0|||
13301528|NCT01333111|26511310|FG001|Overall Study|withdrawal criteria|1|||
13301529|NCT01333111|26511311|FG002|Overall Study|withdrawal criteria|0|||
13301530|NCT01333111|26511309|FG000|Overall Study|Non-compliance|1|||
13301531|NCT01333111|26511310|FG001|Overall Study|Non-compliance|0|||
13301532|NCT01333111|26511311|FG002|Overall Study|Non-compliance|0|||
13301533|NCT01333111|26511309|FG000|Overall Study|Ineffective therapy|0|||
13301534|NCT01333111|26511310|FG001|Overall Study|Ineffective therapy|0|||
13301535|NCT01333111|26511311|FG002|Overall Study|Ineffective therapy|1|||
13301536|NCT01333072|26511324|FG000|Overall Study|Lost to Follow-up|3|||
13301537|NCT01333072|26511325|FG001|Overall Study|Lost to Follow-up|0|||
13301538|NCT01333072|26511324|FG000|Overall Study|Adverse Event|2|||
13301539|NCT01333072|26511325|FG001|Overall Study|Adverse Event|4|||
13301540|NCT01333072|26511324|FG000|Overall Study|Physician Decision|1|||
13301541|NCT01333072|26511325|FG001|Overall Study|Physician Decision|0|||
13301542|NCT01333059|26511342|FG000|Overall Study|Physician Decision|3|||
13301543|NCT01333059|26511343|FG001|Overall Study|Physician Decision|3|||
13301544|NCT01333059|26511342|FG000|Overall Study|Protocol Violation|3|||
13301545|NCT01333059|26511343|FG001|Overall Study|Protocol Violation|0|||
13301546|NCT01333033|26511372|FG000|Overall Study|Ineligible|0|||
13301547|NCT01333033|26511373|FG001|Overall Study|Ineligible|0|||
13301548|NCT01333033|26511374|FG002|Overall Study|Ineligible|0|||
13301549|NCT01333033|26511375|FG003|Overall Study|Ineligible|0|||
13301550|NCT01333033|26511376|FG004|Overall Study|Ineligible|6|||
13301551|NCT01333033|26511377|FG005|Overall Study|Ineligible|8|||
13301552|NCT01333033|26511372|FG000|Overall Study|Withdrawal by Subject|0|||
13301553|NCT01333033|26511373|FG001|Overall Study|Withdrawal by Subject|0|||
13301554|NCT01333033|26511374|FG002|Overall Study|Withdrawal by Subject|0|||
13301555|NCT01333033|26511375|FG003|Overall Study|Withdrawal by Subject|0|||
13301556|NCT01333033|26511376|FG004|Overall Study|Withdrawal by Subject|4|||
13301557|NCT01333033|26511377|FG005|Overall Study|Withdrawal by Subject|2|||
13301558|NCT01333033|26511372|FG000|Overall Study|PET inevaluable|0|||
13301559|NCT01333033|26511373|FG001|Overall Study|PET inevaluable|0|||
13301560|NCT01333033|26511374|FG002|Overall Study|PET inevaluable|0|||
13301561|NCT01333033|26511375|FG003|Overall Study|PET inevaluable|0|||
13301562|NCT01333033|26511376|FG004|Overall Study|PET inevaluable|2|||
13301563|NCT01333033|26511377|FG005|Overall Study|PET inevaluable|4|||
13301564|NCT01333033|26511372|FG000|Overall Study|Adverse Event|0|||
13301565|NCT01333033|26511373|FG001|Overall Study|Adverse Event|0|||
13301566|NCT01333033|26511374|FG002|Overall Study|Adverse Event|0|||
13301567|NCT01333033|26511375|FG003|Overall Study|Adverse Event|0|||
13301568|NCT01333033|26511376|FG004|Overall Study|Adverse Event|2|||
13301569|NCT01333033|26511377|FG005|Overall Study|Adverse Event|1|||
13301570|NCT01333033|26511372|FG000|Overall Study|Progression|0|||
13301571|NCT01333033|26511373|FG001|Overall Study|Progression|0|||
13301572|NCT01333033|26511374|FG002|Overall Study|Progression|0|||
13301573|NCT01333033|26511375|FG003|Overall Study|Progression|0|||
13301574|NCT01333033|26511376|FG004|Overall Study|Progression|0|||
13301575|NCT01333033|26511377|FG005|Overall Study|Progression|1|||
13301576|NCT01333033|26511372|FG000|Overall Study|MD Decision|0|||
13301577|NCT01333033|26511373|FG001|Overall Study|MD Decision|0|||
13301578|NCT01333033|26511374|FG002|Overall Study|MD Decision|0|||
13301579|NCT01333033|26511375|FG003|Overall Study|MD Decision|0|||
13301580|NCT01333033|26511376|FG004|Overall Study|MD Decision|0|||
13301581|NCT01333033|26511377|FG005|Overall Study|MD Decision|2|||
13301582|NCT01332994|26511435|FG000|Overall Study|Adverse Event|34|||
13301583|NCT01332994|26511435|FG000|Overall Study|Death|1|||
13301584|NCT01332994|26511435|FG000|Overall Study|Lack of Efficacy|1|||
13301585|NCT01332994|26511435|FG000|Overall Study|Lost to Follow-up|4|||
13301586|NCT01332994|26511435|FG000|Overall Study|Protocol Violation|6|||
13301587|NCT01332994|26511435|FG000|Overall Study|Withdrawal by Subject|15|||
13301588|NCT01332994|26511435|FG000|Overall Study|Administrative Problem|2|||
13301589|NCT01332994|26511435|FG000|Overall Study|Other|8|||
13301590|NCT01332968|26511514|FG000|Induction Period|Adverse Event|23|||
13301591|NCT01332968|26511515|FG001|Induction Period|Adverse Event|26|||
13301592|NCT01332968|26511516|FG002|Induction Period|Adverse Event|0|||
13301593|NCT01332968|26511517|FG003|Induction Period|Adverse Event|0|||
13301594|NCT01332968|26511518|FG004|Induction Period|Adverse Event|0|||
13301595|NCT01332968|26511519|FG005|Induction Period|Adverse Event|0|||
13301596|NCT01332968|26511520|FG006|Induction Period|Adverse Event|0|||
13301597|NCT01332968|26511521|FG007|Induction Period|Adverse Event|0|||
13301598|NCT01332968|26511514|FG000|Induction Period|Death|1|||
13301599|NCT01332968|26511515|FG001|Induction Period|Death|4|||
13301600|NCT01332968|26511516|FG002|Induction Period|Death|0|||
13301601|NCT01332968|26511517|FG003|Induction Period|Death|0|||
13301602|NCT01332968|26511518|FG004|Induction Period|Death|0|||
13301603|NCT01332968|26511519|FG005|Induction Period|Death|0|||
13301604|NCT01332968|26511520|FG006|Induction Period|Death|0|||
13301605|NCT01332968|26511521|FG007|Induction Period|Death|0|||
13301606|NCT01332968|26511514|FG000|Induction Period|Non-compliance|1|||
13301607|NCT01332968|26511515|FG001|Induction Period|Non-compliance|0|||
13301608|NCT01332968|26511516|FG002|Induction Period|Non-compliance|0|||
13301609|NCT01332968|26511517|FG003|Induction Period|Non-compliance|0|||
13301610|NCT01332968|26511518|FG004|Induction Period|Non-compliance|0|||
13301611|NCT01332968|26511519|FG005|Induction Period|Non-compliance|0|||
13301612|NCT01332968|26511520|FG006|Induction Period|Non-compliance|0|||
13301613|NCT01332968|26511521|FG007|Induction Period|Non-compliance|0|||
13301614|NCT01332968|26511514|FG000|Induction Period|Other|2|||
13301615|NCT01332968|26511515|FG001|Induction Period|Other|2|||
13301616|NCT01332968|26511516|FG002|Induction Period|Other|0|||
13301617|NCT01332968|26511517|FG003|Induction Period|Other|0|||
13301618|NCT01332968|26511518|FG004|Induction Period|Other|0|||
13301619|NCT01332968|26511519|FG005|Induction Period|Other|0|||
13301620|NCT01332968|26511520|FG006|Induction Period|Other|0|||
13301621|NCT01332968|26511521|FG007|Induction Period|Other|0|||
13301622|NCT01332968|26511514|FG000|Induction Period|Physician Decision|6|||
13301623|NCT01332968|26511515|FG001|Induction Period|Physician Decision|1|||
13301624|NCT01332968|26511516|FG002|Induction Period|Physician Decision|0|||
13301625|NCT01332968|26511517|FG003|Induction Period|Physician Decision|0|||
13301626|NCT01332968|26511518|FG004|Induction Period|Physician Decision|0|||
13301627|NCT01332968|26511519|FG005|Induction Period|Physician Decision|0|||
13301628|NCT01332968|26511520|FG006|Induction Period|Physician Decision|0|||
13301629|NCT01332968|26511521|FG007|Induction Period|Physician Decision|0|||
13301630|NCT01332968|26511514|FG000|Induction Period|Progressive Disease|15|||
13301631|NCT01332968|26511515|FG001|Induction Period|Progressive Disease|7|||
13301632|NCT01332968|26511516|FG002|Induction Period|Progressive Disease|0|||
13301633|NCT01332968|26511517|FG003|Induction Period|Progressive Disease|0|||
13301634|NCT01332968|26511518|FG004|Induction Period|Progressive Disease|0|||
13301635|NCT01332968|26511519|FG005|Induction Period|Progressive Disease|0|||
13301636|NCT01332968|26511520|FG006|Induction Period|Progressive Disease|0|||
13301637|NCT01332968|26511521|FG007|Induction Period|Progressive Disease|0|||
13301638|NCT01332968|26511514|FG000|Induction Period|Protocol Violation|3|||
13301639|NCT01332968|26511515|FG001|Induction Period|Protocol Violation|4|||
13301640|NCT01332968|26511516|FG002|Induction Period|Protocol Violation|0|||
13301641|NCT01332968|26511517|FG003|Induction Period|Protocol Violation|0|||
13301642|NCT01332968|26511518|FG004|Induction Period|Protocol Violation|0|||
13301643|NCT01332968|26511519|FG005|Induction Period|Protocol Violation|0|||
13301644|NCT01332968|26511520|FG006|Induction Period|Protocol Violation|0|||
13301645|NCT01332968|26511521|FG007|Induction Period|Protocol Violation|0|||
13301646|NCT01332968|26511514|FG000|Induction Period|Withdrawal by Subject|3|||
13301647|NCT01332968|26511515|FG001|Induction Period|Withdrawal by Subject|5|||
13301648|NCT01332968|26511516|FG002|Induction Period|Withdrawal by Subject|0|||
13301649|NCT01332968|26511517|FG003|Induction Period|Withdrawal by Subject|0|||
13301650|NCT01332968|26511518|FG004|Induction Period|Withdrawal by Subject|0|||
13301651|NCT01332968|26511519|FG005|Induction Period|Withdrawal by Subject|0|||
13301652|NCT01332968|26511520|FG006|Induction Period|Withdrawal by Subject|0|||
13301653|NCT01332968|26511521|FG007|Induction Period|Withdrawal by Subject|0|||
13301654|NCT01332968|26511514|FG000|Induction Period|Randomised but not treated|4|||
13301655|NCT01332968|26511515|FG001|Induction Period|Randomised but not treated|7|||
13301656|NCT01332968|26511516|FG002|Induction Period|Randomised but not treated|0|||
13301657|NCT01332968|26511517|FG003|Induction Period|Randomised but not treated|0|||
13301658|NCT01332968|26511518|FG004|Induction Period|Randomised but not treated|0|||
13301659|NCT01332968|26511519|FG005|Induction Period|Randomised but not treated|0|||
13301660|NCT01332968|26511520|FG006|Induction Period|Randomised but not treated|0|||
13301661|NCT01332968|26511521|FG007|Induction Period|Randomised but not treated|0|||
13301662|NCT01332968|26511514|FG000|Maintenance/Observation Period|Adverse Event|0|||
13301663|NCT01332968|26511515|FG001|Maintenance/Observation Period|Adverse Event|0|||
13301664|NCT01332968|26511516|FG002|Maintenance/Observation Period|Adverse Event|53|||
13301665|NCT01332968|26511517|FG003|Maintenance/Observation Period|Adverse Event|66|||
13301666|NCT01332968|26511518|FG004|Maintenance/Observation Period|Adverse Event|0|||
13301667|NCT01332968|26511519|FG005|Maintenance/Observation Period|Adverse Event|0|||
13301668|NCT01332968|26511520|FG006|Maintenance/Observation Period|Adverse Event|0|||
13301669|NCT01332968|26511521|FG007|Maintenance/Observation Period|Adverse Event|0|||
13301670|NCT01332968|26511514|FG000|Maintenance/Observation Period|Death|0|||
13301671|NCT01332968|26511515|FG001|Maintenance/Observation Period|Death|0|||
13301672|NCT01332968|26511516|FG002|Maintenance/Observation Period|Death|5|||
13301673|NCT01332968|26511517|FG003|Maintenance/Observation Period|Death|6|||
13301674|NCT01332968|26511518|FG004|Maintenance/Observation Period|Death|0|||
13301675|NCT01332968|26511519|FG005|Maintenance/Observation Period|Death|0|||
13301676|NCT01332968|26511520|FG006|Maintenance/Observation Period|Death|0|||
13301677|NCT01332968|26511521|FG007|Maintenance/Observation Period|Death|0|||
13301678|NCT01332968|26511514|FG000|Maintenance/Observation Period|Lost to Follow-up|0|||
13301679|NCT01332968|26511515|FG001|Maintenance/Observation Period|Lost to Follow-up|0|||
13301680|NCT01332968|26511516|FG002|Maintenance/Observation Period|Lost to Follow-up|1|||
13301681|NCT01332968|26511517|FG003|Maintenance/Observation Period|Lost to Follow-up|2|||
13301682|NCT01332968|26511518|FG004|Maintenance/Observation Period|Lost to Follow-up|0|||
13301683|NCT01332968|26511519|FG005|Maintenance/Observation Period|Lost to Follow-up|0|||
13301684|NCT01332968|26511520|FG006|Maintenance/Observation Period|Lost to Follow-up|0|||
13301685|NCT01332968|26511521|FG007|Maintenance/Observation Period|Lost to Follow-up|0|||
13301686|NCT01332968|26511514|FG000|Maintenance/Observation Period|Non-compliance|0|||
13301687|NCT01332968|26511515|FG001|Maintenance/Observation Period|Non-compliance|0|||
13301688|NCT01332968|26511516|FG002|Maintenance/Observation Period|Non-compliance|4|||
13301689|NCT01332968|26511517|FG003|Maintenance/Observation Period|Non-compliance|3|||
13301690|NCT01332968|26511518|FG004|Maintenance/Observation Period|Non-compliance|0|||
13301691|NCT01332968|26511519|FG005|Maintenance/Observation Period|Non-compliance|0|||
13301692|NCT01332968|26511520|FG006|Maintenance/Observation Period|Non-compliance|0|||
13301693|NCT01332968|26511521|FG007|Maintenance/Observation Period|Non-compliance|0|||
13301694|NCT01332968|26511514|FG000|Maintenance/Observation Period|Other|0|||
13301695|NCT01332968|26511515|FG001|Maintenance/Observation Period|Other|0|||
13301696|NCT01332968|26511516|FG002|Maintenance/Observation Period|Other|4|||
13301697|NCT01332968|26511517|FG003|Maintenance/Observation Period|Other|7|||
13301698|NCT01332968|26511518|FG004|Maintenance/Observation Period|Other|0|||
13301699|NCT01332968|26511519|FG005|Maintenance/Observation Period|Other|0|||
13301700|NCT01332968|26511520|FG006|Maintenance/Observation Period|Other|0|||
13301701|NCT01332968|26511521|FG007|Maintenance/Observation Period|Other|0|||
13301702|NCT01332968|26511514|FG000|Maintenance/Observation Period|Physician Decision|0|||
13301703|NCT01332968|26511515|FG001|Maintenance/Observation Period|Physician Decision|0|||
13301704|NCT01332968|26511516|FG002|Maintenance/Observation Period|Physician Decision|14|||
13301705|NCT01332968|26511517|FG003|Maintenance/Observation Period|Physician Decision|19|||
13301706|NCT01332968|26511518|FG004|Maintenance/Observation Period|Physician Decision|0|||
13301707|NCT01332968|26511519|FG005|Maintenance/Observation Period|Physician Decision|1|||
13301708|NCT01332968|26511520|FG006|Maintenance/Observation Period|Physician Decision|0|||
13301709|NCT01332968|26511521|FG007|Maintenance/Observation Period|Physician Decision|0|||
13301710|NCT01332968|26511514|FG000|Maintenance/Observation Period|Progressive Disease|0|||
13301711|NCT01332968|26511515|FG001|Maintenance/Observation Period|Progressive Disease|0|||
13301712|NCT01332968|26511516|FG002|Maintenance/Observation Period|Progressive Disease|72|||
13301713|NCT01332968|26511517|FG003|Maintenance/Observation Period|Progressive Disease|40|||
13301714|NCT01332968|26511518|FG004|Maintenance/Observation Period|Progressive Disease|0|||
13301715|NCT01332968|26511519|FG005|Maintenance/Observation Period|Progressive Disease|0|||
13301716|NCT01332968|26511520|FG006|Maintenance/Observation Period|Progressive Disease|0|||
13301717|NCT01332968|26511521|FG007|Maintenance/Observation Period|Progressive Disease|0|||
13301718|NCT01332968|26511514|FG000|Maintenance/Observation Period|Protocol Violation|0|||
13301719|NCT01332968|26511515|FG001|Maintenance/Observation Period|Protocol Violation|0|||
13301720|NCT01332968|26511516|FG002|Maintenance/Observation Period|Protocol Violation|1|||
13301721|NCT01332968|26511517|FG003|Maintenance/Observation Period|Protocol Violation|1|||
13301722|NCT01332968|26511518|FG004|Maintenance/Observation Period|Protocol Violation|0|||
13301723|NCT01332968|26511519|FG005|Maintenance/Observation Period|Protocol Violation|0|||
13301724|NCT01332968|26511520|FG006|Maintenance/Observation Period|Protocol Violation|0|||
13301725|NCT01332968|26511521|FG007|Maintenance/Observation Period|Protocol Violation|0|||
13301726|NCT01332968|26511514|FG000|Maintenance/Observation Period|Withdrawal by Subject|0|||
13301727|NCT01332968|26511515|FG001|Maintenance/Observation Period|Withdrawal by Subject|0|||
13301728|NCT01332968|26511516|FG002|Maintenance/Observation Period|Withdrawal by Subject|7|||
13301729|NCT01332968|26511517|FG003|Maintenance/Observation Period|Withdrawal by Subject|5|||
13301730|NCT01332968|26511518|FG004|Maintenance/Observation Period|Withdrawal by Subject|0|||
13301731|NCT01332968|26511519|FG005|Maintenance/Observation Period|Withdrawal by Subject|0|||
13301732|NCT01332968|26511520|FG006|Maintenance/Observation Period|Withdrawal by Subject|0|||
13301733|NCT01332968|26511521|FG007|Maintenance/Observation Period|Withdrawal by Subject|0|||
13301734|NCT01332968|26511514|FG000|Follow-Up Period|Adverse Event|0|||
13301735|NCT01332968|26511515|FG001|Follow-Up Period|Adverse Event|0|||
13301736|NCT01332968|26511516|FG002|Follow-Up Period|Adverse Event|0|||
13301737|NCT01332968|26511517|FG003|Follow-Up Period|Adverse Event|0|||
13301738|NCT01332968|26511518|FG004|Follow-Up Period|Adverse Event|0|||
13301739|NCT01332968|26511519|FG005|Follow-Up Period|Adverse Event|0|||
13301740|NCT01332968|26511520|FG006|Follow-Up Period|Adverse Event|0|||
13301741|NCT01332968|26511521|FG007|Follow-Up Period|Adverse Event|4|||
13301742|NCT01332968|26511514|FG000|Follow-Up Period|Death|0|||
13301743|NCT01332968|26511515|FG001|Follow-Up Period|Death|0|||
13301744|NCT01332968|26511516|FG002|Follow-Up Period|Death|0|||
13301745|NCT01332968|26511517|FG003|Follow-Up Period|Death|0|||
13301746|NCT01332968|26511518|FG004|Follow-Up Period|Death|0|||
13301747|NCT01332968|26511519|FG005|Follow-Up Period|Death|0|||
13301748|NCT01332968|26511520|FG006|Follow-Up Period|Death|27|||
13301749|NCT01332968|26511521|FG007|Follow-Up Period|Death|30|||
13301750|NCT01332968|26511514|FG000|Follow-Up Period|Lost to Follow-up|0|||
13301751|NCT01332968|26511515|FG001|Follow-Up Period|Lost to Follow-up|0|||
13301752|NCT01332968|26511516|FG002|Follow-Up Period|Lost to Follow-up|0|||
13301753|NCT01332968|26511517|FG003|Follow-Up Period|Lost to Follow-up|0|||
13301754|NCT01332968|26511518|FG004|Follow-Up Period|Lost to Follow-up|0|||
13301755|NCT01332968|26511519|FG005|Follow-Up Period|Lost to Follow-up|0|||
13301756|NCT01332968|26511520|FG006|Follow-Up Period|Lost to Follow-up|11|||
13301757|NCT01332968|26511521|FG007|Follow-Up Period|Lost to Follow-up|15|||
13301758|NCT01332968|26511514|FG000|Follow-Up Period|Non-compliance|0|||
13301759|NCT01332968|26511515|FG001|Follow-Up Period|Non-compliance|0|||
13301760|NCT01332968|26511516|FG002|Follow-Up Period|Non-compliance|0|||
13301761|NCT01332968|26511517|FG003|Follow-Up Period|Non-compliance|0|||
13301762|NCT01332968|26511518|FG004|Follow-Up Period|Non-compliance|0|||
13301763|NCT01332968|26511519|FG005|Follow-Up Period|Non-compliance|0|||
13301764|NCT01332968|26511520|FG006|Follow-Up Period|Non-compliance|4|||
13301765|NCT01332968|26511521|FG007|Follow-Up Period|Non-compliance|9|||
13301766|NCT01332968|26511514|FG000|Follow-Up Period|Other|0|||
13301767|NCT01332968|26511515|FG001|Follow-Up Period|Other|0|||
13301768|NCT01332968|26511516|FG002|Follow-Up Period|Other|0|||
13301769|NCT01332968|26511517|FG003|Follow-Up Period|Other|0|||
13301770|NCT01332968|26511518|FG004|Follow-Up Period|Other|0|||
13301771|NCT01332968|26511519|FG005|Follow-Up Period|Other|0|||
13301772|NCT01332968|26511520|FG006|Follow-Up Period|Other|18|||
13301773|NCT01332968|26511521|FG007|Follow-Up Period|Other|21|||
13301774|NCT01332968|26511514|FG000|Follow-Up Period|Physician Decision|0|||
13301775|NCT01332968|26511515|FG001|Follow-Up Period|Physician Decision|0|||
13301776|NCT01332968|26511516|FG002|Follow-Up Period|Physician Decision|0|||
13301777|NCT01332968|26511517|FG003|Follow-Up Period|Physician Decision|0|||
13301778|NCT01332968|26511518|FG004|Follow-Up Period|Physician Decision|0|||
13301779|NCT01332968|26511519|FG005|Follow-Up Period|Physician Decision|0|||
13301780|NCT01332968|26511520|FG006|Follow-Up Period|Physician Decision|12|||
13301781|NCT01332968|26511521|FG007|Follow-Up Period|Physician Decision|15|||
13301782|NCT01332968|26511514|FG000|Follow-Up Period|Progressive Disease|0|||
13301783|NCT01332968|26511515|FG001|Follow-Up Period|Progressive Disease|0|||
13301784|NCT01332968|26511516|FG002|Follow-Up Period|Progressive Disease|0|||
13301785|NCT01332968|26511517|FG003|Follow-Up Period|Progressive Disease|0|||
13301786|NCT01332968|26511518|FG004|Follow-Up Period|Progressive Disease|0|||
13301787|NCT01332968|26511519|FG005|Follow-Up Period|Progressive Disease|0|||
13301788|NCT01332968|26511520|FG006|Follow-Up Period|Progressive Disease|126|||
13301789|NCT01332968|26511521|FG007|Follow-Up Period|Progressive Disease|106|||
13301790|NCT01332968|26511514|FG000|Follow-Up Period|Protocol Violation|0|||
13301791|NCT01332968|26511515|FG001|Follow-Up Period|Protocol Violation|0|||
13301792|NCT01332968|26511516|FG002|Follow-Up Period|Protocol Violation|0|||
13301793|NCT01332968|26511517|FG003|Follow-Up Period|Protocol Violation|0|||
13301794|NCT01332968|26511518|FG004|Follow-Up Period|Protocol Violation|0|||
13301795|NCT01332968|26511519|FG005|Follow-Up Period|Protocol Violation|0|||
13301796|NCT01332968|26511520|FG006|Follow-Up Period|Protocol Violation|1|||
13301797|NCT01332968|26511521|FG007|Follow-Up Period|Protocol Violation|0|||
13301798|NCT01332968|26511514|FG000|Follow-Up Period|Withdrawal by Subject|0|||
13301799|NCT01332968|26511515|FG001|Follow-Up Period|Withdrawal by Subject|0|||
13301800|NCT01332968|26511516|FG002|Follow-Up Period|Withdrawal by Subject|0|||
13301801|NCT01332968|26511517|FG003|Follow-Up Period|Withdrawal by Subject|0|||
13301802|NCT01332968|26511518|FG004|Follow-Up Period|Withdrawal by Subject|0|||
13301803|NCT01332968|26511519|FG005|Follow-Up Period|Withdrawal by Subject|0|||
13301804|NCT01332968|26511520|FG006|Follow-Up Period|Withdrawal by Subject|29|||
13301805|NCT01332968|26511521|FG007|Follow-Up Period|Withdrawal by Subject|32|||
13301806|NCT01332968|26511514|FG000|Follow-Up Period|No reason provided|0|||
13301807|NCT01332968|26511515|FG001|Follow-Up Period|No reason provided|0|||
13301808|NCT01332968|26511516|FG002|Follow-Up Period|No reason provided|0|||
13301809|NCT01332968|26511517|FG003|Follow-Up Period|No reason provided|0|||
13301810|NCT01332968|26511518|FG004|Follow-Up Period|No reason provided|0|||
13301811|NCT01332968|26511519|FG005|Follow-Up Period|No reason provided|0|||
13301812|NCT01332968|26511520|FG006|Follow-Up Period|No reason provided|2|||
13301813|NCT01332968|26511521|FG007|Follow-Up Period|No reason provided|3|||
13301814|NCT01332851|26511560|FG000|Overall Study|Withdrawal by Subject|4|||
13301815|NCT01332851|26511561|FG001|Overall Study|Withdrawal by Subject|2|||
13301816|NCT01332851|26511560|FG000|Overall Study|Lost to Follow-up|7|||
13301817|NCT01332851|26511561|FG001|Overall Study|Lost to Follow-up|11|||
13301818|NCT01332799|26511578|FG000|Overall Study|Insufficient funding|10|||
13301819|NCT01332799|26511579|FG001|Overall Study|Insufficient funding|10|||
13301820|NCT01332630|26511585|FG000|Overall Study|Withdrawal by Subject|3|||
13301821|NCT01332331|26511640|FG000|Overall Study|Lost to Follow-up|0|||
13301822|NCT01332331|26511641|FG001|Overall Study|Lost to Follow-up|1|||
13301823|NCT01332331|26511640|FG000|Overall Study|Adverse Event|1|||
13301824|NCT01332331|26511641|FG001|Overall Study|Adverse Event|1|||
13301825|NCT01332331|26511640|FG000|Overall Study|Physician Decision|1|||
13301826|NCT01332331|26511641|FG001|Overall Study|Physician Decision|0|||
13301827|NCT01332318|26511760|FG000|Overall Study|Adverse Event|0|||
13301828|NCT01332318|26511761|FG001|Overall Study|Adverse Event|3|||
13301829|NCT01332318|26511762|FG002|Overall Study|Adverse Event|0|||
13301830|NCT01332318|26511763|FG003|Overall Study|Adverse Event|0|||
13301831|NCT01332318|26511760|FG000|Overall Study|Withdrawal by Subject|1|||
13301832|NCT01332318|26511761|FG001|Overall Study|Withdrawal by Subject|1|||
13301833|NCT01332318|26511762|FG002|Overall Study|Withdrawal by Subject|0|||
13301834|NCT01332318|26511763|FG003|Overall Study|Withdrawal by Subject|1|||
13301835|NCT01332318|26511760|FG000|Overall Study|Protocol Violation|1|||
13301836|NCT01332318|26511761|FG001|Overall Study|Protocol Violation|0|||
13301837|NCT01332318|26511762|FG002|Overall Study|Protocol Violation|1|||
13301838|NCT01332318|26511763|FG003|Overall Study|Protocol Violation|1|||
13301839|NCT01332305|26511801|FG000|Overall Study|Adverse Event|1|||
13301840|NCT01332305|26511802|FG001|Overall Study|Adverse Event|4|||
13301841|NCT01332305|26511803|FG002|Overall Study|Adverse Event|6|||
13301842|NCT01332305|26511804|FG003|Overall Study|Adverse Event|3|||
13301843|NCT01332305|26511805|FG004|Overall Study|Adverse Event|5|||
13301844|NCT01332305|26511801|FG000|Overall Study|Withdrawal by Subject|6|||
13301845|NCT01332305|26511802|FG001|Overall Study|Withdrawal by Subject|5|||
13301846|NCT01332305|26511803|FG002|Overall Study|Withdrawal by Subject|4|||
13301847|NCT01332305|26511804|FG003|Overall Study|Withdrawal by Subject|1|||
13301848|NCT01332305|26511805|FG004|Overall Study|Withdrawal by Subject|0|||
13301849|NCT01332305|26511801|FG000|Overall Study|Lost to Follow-up|0|||
13301850|NCT01332305|26511802|FG001|Overall Study|Lost to Follow-up|2|||
13301851|NCT01332305|26511803|FG002|Overall Study|Lost to Follow-up|3|||
13301852|NCT01332305|26511804|FG003|Overall Study|Lost to Follow-up|2|||
13301853|NCT01332305|26511805|FG004|Overall Study|Lost to Follow-up|3|||
13301854|NCT01332305|26511801|FG000|Overall Study|Protocol Violation|1|||
13301855|NCT01332305|26511802|FG001|Overall Study|Protocol Violation|2|||
13301856|NCT01332305|26511803|FG002|Overall Study|Protocol Violation|1|||
13301857|NCT01332305|26511804|FG003|Overall Study|Protocol Violation|0|||
13301858|NCT01332305|26511805|FG004|Overall Study|Protocol Violation|3|||
13301859|NCT01332305|26511801|FG000|Overall Study|Withdrawal by Sponsor|1|||
13301860|NCT01332305|26511802|FG001|Overall Study|Withdrawal by Sponsor|0|||
13301861|NCT01332305|26511803|FG002|Overall Study|Withdrawal by Sponsor|0|||
13301862|NCT01332305|26511804|FG003|Overall Study|Withdrawal by Sponsor|1|||
13301863|NCT01332305|26511805|FG004|Overall Study|Withdrawal by Sponsor|1|||
13301864|NCT01332305|26511801|FG000|Overall Study|Treatment Failure|1|||
13301865|NCT01332305|26511802|FG001|Overall Study|Treatment Failure|1|||
13301866|NCT01332305|26511803|FG002|Overall Study|Treatment Failure|0|||
13301867|NCT01332305|26511804|FG003|Overall Study|Treatment Failure|0|||
13301868|NCT01332305|26511805|FG004|Overall Study|Treatment Failure|0|||
13301869|NCT01332305|26511801|FG000|Overall Study|Physician Decision|0|||
13301870|NCT01332305|26511802|FG001|Overall Study|Physician Decision|0|||
13301871|NCT01332305|26511803|FG002|Overall Study|Physician Decision|0|||
13301872|NCT01332305|26511804|FG003|Overall Study|Physician Decision|1|||
13301873|NCT01332305|26511805|FG004|Overall Study|Physician Decision|0|||
13301874|NCT01332292|26511868|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
13301875|NCT01332292|26511869|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
13301876|NCT01332292|26511868|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
13301877|NCT01332292|26511869|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1|||
13301878|NCT01332292|26511868|FG000|Treatment Period 2 (14 Days)|Physician Decision|1|||
13301879|NCT01332292|26511869|FG001|Treatment Period 2 (14 Days)|Physician Decision|1|||
13301880|NCT01332227|26511894|FG000|Overall Study|Adverse Event|4|||
13301881|NCT01332227|26511895|FG001|Overall Study|Adverse Event|1|||
13301882|NCT01332227|26511894|FG000|Overall Study|Withdrawal by Subject|5|||
13301883|NCT01332227|26511895|FG001|Overall Study|Withdrawal by Subject|1|||
13301884|NCT01332227|26511894|FG000|Overall Study|Lost to Follow-up|2|||
13301885|NCT01332227|26511895|FG001|Overall Study|Lost to Follow-up|0|||
13301886|NCT01332227|26511894|FG000|Overall Study|Lack of Efficacy|3|||
13301887|NCT01332227|26511895|FG001|Overall Study|Lack of Efficacy|1|||
13301888|NCT01332227|26511894|FG000|Overall Study|Poor compliance/noncompliance|1|||
13301889|NCT01332227|26511895|FG001|Overall Study|Poor compliance/noncompliance|1|||
13301890|NCT01332227|26511894|FG000|Overall Study|Patient moved from area|1|||
13301891|NCT01332227|26511895|FG001|Overall Study|Patient moved from area|0|||
13301892|NCT01332227|26511894|FG000|Overall Study|Patient began prohibited medication|0|||
13301893|NCT01332227|26511895|FG001|Overall Study|Patient began prohibited medication|1|||
13301894|NCT01332149|26511956|FG000|Overall Study|Adverse Event|11|||
13301895|NCT01332149|26511957|FG001|Overall Study|Adverse Event|9|||
13301896|NCT01332149|26511956|FG000|Overall Study|Other unspecified|5|||
13301897|NCT01332149|26511957|FG001|Overall Study|Other unspecified|7|||
13301898|NCT01332149|26511956|FG000|Overall Study|Protocol Violation|1|||
13301899|NCT01332149|26511957|FG001|Overall Study|Protocol Violation|3|||
13301900|NCT01332149|26511956|FG000|Overall Study|Withdrawal by Subject|4|||
13301901|NCT01332149|26511957|FG001|Overall Study|Withdrawal by Subject|5|||
13301902|NCT01332149|26511956|FG000|Overall Study|Lost to Follow-up|1|||
13301903|NCT01332149|26511957|FG001|Overall Study|Lost to Follow-up|1|||
13301904|NCT01332149|26511956|FG000|Overall Study|Insufficient clinical response|4|||
13301905|NCT01332149|26511957|FG001|Overall Study|Insufficient clinical response|7|||
13301906|NCT01332149|26511956|FG000|Overall Study|Did not meet entrance criteria|3|||
13301907|NCT01332149|26511957|FG001|Overall Study|Did not meet entrance criteria|4|||
13301908|NCT01332149|26511956|FG000|Overall Study|Randomized but not treated|1|||
13301909|NCT01332149|26511957|FG001|Overall Study|Randomized but not treated|2|||
13301910|NCT01332019|26512046|FG000|Overall Study|Was Not Dosed|1|||
13301911|NCT01332019|26512047|FG001|Overall Study|Was Not Dosed|0|||
13301912|NCT01332019|26512046|FG000|Overall Study|Other|16|||
13301913|NCT01332019|26512047|FG001|Overall Study|Other|18|||
13301914|NCT01332019|26512046|FG000|Overall Study|Death|2|||
13301915|NCT01332019|26512047|FG001|Overall Study|Death|1|||
13301916|NCT01332019|26512046|FG000|Overall Study|Physician Decision|4|||
13301917|NCT01332019|26512047|FG001|Overall Study|Physician Decision|3|||
13301918|NCT01332019|26512046|FG000|Overall Study|Withdrawal by Subject|73|||
13301919|NCT01332019|26512047|FG001|Overall Study|Withdrawal by Subject|71|||
13301920|NCT01332019|26512046|FG000|Overall Study|Lost to Follow-up|4|||
13301921|NCT01332019|26512047|FG001|Overall Study|Lost to Follow-up|7|||
13301922|NCT01332019|26512046|FG000|Overall Study|Adverse Event|13|||
13301923|NCT01332019|26512047|FG001|Overall Study|Adverse Event|22|||
13301924|NCT01331837|26512094|FG000|Overall Study|Death|30|||
13301925|NCT01331837|26512095|FG001|Overall Study|Death|34|||
13301926|NCT01331837|26512094|FG000|Overall Study|Lost to Follow-up|3|||
13301927|NCT01331837|26512095|FG001|Overall Study|Lost to Follow-up|1|||
13301928|NCT01331837|26512094|FG000|Overall Study|Info not recorded|10|||
13301929|NCT01331837|26512095|FG001|Overall Study|Info not recorded|16|||
13301930|NCT01331837|26512094|FG000|Overall Study|Withdrawal by Subject|13|||
13301931|NCT01331837|26512095|FG001|Overall Study|Withdrawal by Subject|16|||
13301932|NCT01331824|26512104|FG000|Overall Study|Adverse Event|2|||
13301933|NCT01331824|26512104|FG000|Overall Study|Death|1|||
13301934|NCT01331824|26512104|FG000|Overall Study|Disease Progression|9|||
13301935|NCT01331824|26512104|FG000|Overall Study|Withdrawal by Subject|1|||
13301936|NCT01331681|26512140|FG000|Overall Study|Adverse Event|10|||
13301937|NCT01331681|26512141|FG001|Overall Study|Adverse Event|13|||
13301938|NCT01331681|26512142|FG002|Overall Study|Adverse Event|10|||
13301939|NCT01331681|26512140|FG000|Overall Study|Death|6|||
13301940|NCT01331681|26512141|FG001|Overall Study|Death|6|||
13301941|NCT01331681|26512142|FG002|Overall Study|Death|2|||
13301942|NCT01331681|26512140|FG000|Overall Study|Lack of Efficacy|0|||
13301943|NCT01331681|26512141|FG001|Overall Study|Lack of Efficacy|1|||
13301944|NCT01331681|26512142|FG002|Overall Study|Lack of Efficacy|0|||
13301945|NCT01331681|26512140|FG000|Overall Study|Withdrawal by Subject|12|||
13301946|NCT01331681|26512141|FG001|Overall Study|Withdrawal by Subject|8|||
13301947|NCT01331681|26512142|FG002|Overall Study|Withdrawal by Subject|15|||
13301948|NCT01331681|26512140|FG000|Overall Study|Protocol Violation|1|||
13301949|NCT01331681|26512141|FG001|Overall Study|Protocol Violation|1|||
13301950|NCT01331681|26512142|FG002|Overall Study|Protocol Violation|0|||
13301951|NCT01331681|26512140|FG000|Overall Study|Lost to Follow-up|2|||
13301952|NCT01331681|26512141|FG001|Overall Study|Lost to Follow-up|4|||
13301953|NCT01331681|26512142|FG002|Overall Study|Lost to Follow-up|1|||
13301954|NCT01331681|26512140|FG000|Overall Study|Physician Decision|2|||
13301955|NCT01331681|26512141|FG001|Overall Study|Physician Decision|0|||
13301956|NCT01331681|26512142|FG002|Overall Study|Physician Decision|4|||
13301957|NCT01331681|26512140|FG000|Overall Study|Therapeutic procedure required|1|||
13301958|NCT01331681|26512141|FG001|Overall Study|Therapeutic procedure required|0|||
13301959|NCT01331681|26512142|FG002|Overall Study|Therapeutic procedure required|0|||
13301960|NCT01331681|26512140|FG000|Overall Study|Sponsor decision|1|||
13301961|NCT01331681|26512141|FG001|Overall Study|Sponsor decision|1|||
13301962|NCT01331681|26512142|FG002|Overall Study|Sponsor decision|0|||
13301963|NCT01331681|26512140|FG000|Overall Study|Switching to other therapy|0|||
13301964|NCT01331681|26512141|FG001|Overall Study|Switching to other therapy|0|||
13301965|NCT01331681|26512142|FG002|Overall Study|Switching to other therapy|1|||
13301966|NCT01331681|26512140|FG000|Overall Study|Not Received Study Treatment|0|||
13301967|NCT01331681|26512141|FG001|Overall Study|Not Received Study Treatment|0|||
13301968|NCT01331681|26512142|FG002|Overall Study|Not Received Study Treatment|2|||
13301969|NCT01331291|26512160|FG000|Overall Study|Lack of Efficacy|2|||
13301970|NCT01331291|26512161|FG001|Overall Study|Lack of Efficacy|8|||
13301971|NCT01331291|26512160|FG000|Overall Study|Death|0|||
13301972|NCT01331291|26512161|FG001|Overall Study|Death|1|||
13301973|NCT01331239|26512239|FG000|Part II: Core Study|Adverse Event|0|||
13301974|NCT01331239|26512240|FG001|Part II: Core Study|Adverse Event|3|||
13301975|NCT01331239|26512241|FG002|Part II: Core Study|Adverse Event|0|||
13301976|NCT01331239|26512239|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0|||
13301977|NCT01331239|26512240|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2|||
13301978|NCT01331239|26512241|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1|||
13301979|NCT01331239|26512239|FG000|Part II: Core Study|Withdrawal by Subject|0|||
13301980|NCT01331239|26512240|FG001|Part II: Core Study|Withdrawal by Subject|2|||
13301981|NCT01331239|26512241|FG002|Part II: Core Study|Withdrawal by Subject|0|||
13301982|NCT01331239|26512239|FG000|Part II: Core Study|Administrative problems|0|||
13301983|NCT01331239|26512240|FG001|Part II: Core Study|Administrative problems|1|||
13301984|NCT01331239|26512241|FG002|Part II: Core Study|Administrative problems|0|||
13301985|NCT01331161|26512256|FG000|Overall Study|Physician Decision|1|||
13301986|NCT01331161|26512257|FG001|Overall Study|Physician Decision|0|||
13301987|NCT01331161|26512256|FG000|Overall Study|Lost to Follow-up|0|||
13301988|NCT01331161|26512257|FG001|Overall Study|Lost to Follow-up|1|||
13301989|NCT01331161|26512256|FG000|Overall Study|Pregnancy|0|||
13301990|NCT01331161|26512257|FG001|Overall Study|Pregnancy|1|||
13301991|NCT01331109|26512269|FG000|Overall Study|Adverse Event|6|||
13301992|NCT01331109|26512269|FG000|Overall Study|Lack of Efficacy|2|||
13301993|NCT01331109|26512269|FG000|Overall Study|Protocol Violation|3|||
13301994|NCT01331109|26512269|FG000|Overall Study|Withdrawal by Subject|7|||
13301995|NCT01331109|26512269|FG000|Overall Study|Lost to Follow-up|1|||
13301996|NCT01331109|26512269|FG000|Overall Study|Study Terminated by Sponsor|38|||
13301997|NCT01331005|26512286|FG000|Overall Study|Lost to Follow-up|2|||
13301998|NCT01331005|26512287|FG001|Overall Study|Lost to Follow-up|1|||
13301999|NCT01331005|26512286|FG000|Overall Study|Withdrawal by Subject|2|||
13302000|NCT01331005|26512287|FG001|Overall Study|Withdrawal by Subject|3|||
13302001|NCT01330914|26512295|FG000|Overall Study|Withdrawal by Subject|4|||
13302002|NCT01330914|26512295|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3|||
13302003|NCT01330628|26512310|FG000|Overall Study|Death|2|||
13302004|NCT01330628|26512311|FG001|Overall Study|Death|3|||
13302005|NCT01330628|26512310|FG000|Overall Study|Lost to Follow-up|5|||
13302006|NCT01330628|26512311|FG001|Overall Study|Lost to Follow-up|6|||
13302007|NCT01330628|26512310|FG000|Overall Study|Adverse Event|44|||
13302008|NCT01330628|26512311|FG001|Overall Study|Adverse Event|25|||
13302009|NCT01330628|26512310|FG000|Overall Study|Withdrawn|18|||
13302010|NCT01330628|26512311|FG001|Overall Study|Withdrawn|6|||
13302011|NCT01330628|26512310|FG000|Overall Study|Didn't receive study treatment|1|||
13302012|NCT01330628|26512311|FG001|Overall Study|Didn't receive study treatment|0|||
13302013|NCT01330459|26512332|FG000|Overall Study|Physician Decision|0|||
13302014|NCT01330459|26512333|FG001|Overall Study|Physician Decision|2|||
13302015|NCT01330433|26512360|FG000|Overall Study|Death|1|||
13302016|NCT01330433|26512361|FG001|Overall Study|Death|3|||
13302017|NCT01330433|26512360|FG000|Overall Study|Lost to Follow-up|1|||
13302018|NCT01330433|26512361|FG001|Overall Study|Lost to Follow-up|0|||
13302019|NCT01330381|26512413|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
13302020|NCT01330381|26512414|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4|||
13302021|NCT01330381|26512415|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
13302022|NCT01330381|26512413|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2|||
13302023|NCT01330381|26512414|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1|||
13302024|NCT01330381|26512415|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0|||
13302025|NCT01330381|26512413|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
13302026|NCT01330381|26512414|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
13302027|NCT01330381|26512415|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0|||
13302028|NCT01330381|26512413|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1|||
13302029|NCT01330381|26512414|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
13302030|NCT01330381|26512415|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
13302031|NCT01330381|26512413|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1|||
13302032|NCT01330381|26512414|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
13302033|NCT01330381|26512415|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
13302034|NCT01330381|26512413|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
13302035|NCT01330381|26512414|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
13302036|NCT01330381|26512415|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
13302037|NCT01330381|26512413|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7|||
13302038|NCT01330381|26512414|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0|||
13302039|NCT01330381|26512415|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16|||
13302040|NCT01330381|26512413|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2|||
13302041|NCT01330381|26512414|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
13302042|NCT01330381|26512415|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
13302043|NCT01330381|26512413|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
13302044|NCT01330381|26512414|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0|||
13302045|NCT01330381|26512415|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
13302046|NCT01330381|26512413|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
13302047|NCT01330381|26512414|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
13302048|NCT01330381|26512415|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1|||
13302049|NCT01330316|26512458|FG000|Overall Study|Adverse Event|2|||
13302050|NCT01330316|26512459|FG001|Overall Study|Adverse Event|2|||
13302051|NCT01330316|26512458|FG000|Overall Study|Lack of Efficacy|0|||
13302052|NCT01330316|26512459|FG001|Overall Study|Lack of Efficacy|10|||
13302053|NCT01330316|26512458|FG000|Overall Study|Lost to Follow-up|0|||
13302054|NCT01330316|26512459|FG001|Overall Study|Lost to Follow-up|1|||
13302055|NCT01330316|26512458|FG000|Overall Study|Withdrawal by Subject|0|||
13302056|NCT01330316|26512459|FG001|Overall Study|Withdrawal by Subject|1|||
13302057|NCT01330316|26512458|FG000|Overall Study|other than above|0|||
13302058|NCT01330316|26512459|FG001|Overall Study|other than above|1|||
13302059|NCT01330303|26512472|FG000|Period 1|Adverse Event|1|||
13302060|NCT01330303|26512473|FG001|Period 1|Adverse Event|0|||
13302061|NCT01330303|26512472|FG000|Period 1|Protocol Violation|0|||
13302062|NCT01330303|26512473|FG001|Period 1|Protocol Violation|1|||
13302063|NCT01330303|26512472|FG000|Period 1|Withdrawal by Subject|0|||
13302064|NCT01330303|26512473|FG001|Period 1|Withdrawal by Subject|1|||
13302065|NCT01330108|26512480|FG000|Overall Study|Withdrawal by Subject|4|||
13302066|NCT01330030|26512493|FG000|Overall Study|Lost to Follow-up|16|||
13302067|NCT01330030|26512494|FG001|Overall Study|Lost to Follow-up|17|||
13302068|NCT01330017|26512556|FG000|Overall Study|Adverse Event|0|||
13302069|NCT01330017|26512557|FG001|Overall Study|Adverse Event|1|||
13302070|NCT01330017|26512558|FG002|Overall Study|Adverse Event|1|||
13302071|NCT01330017|26512559|FG003|Overall Study|Adverse Event|4|||
13302072|NCT01330017|26512560|FG004|Overall Study|Adverse Event|0|||
13302073|NCT01330017|26512556|FG000|Overall Study|Withdrawal by Subject|0|||
13302074|NCT01330017|26512557|FG001|Overall Study|Withdrawal by Subject|0|||
13302075|NCT01330017|26512558|FG002|Overall Study|Withdrawal by Subject|1|||
13302076|NCT01330017|26512559|FG003|Overall Study|Withdrawal by Subject|0|||
13302077|NCT01330017|26512560|FG004|Overall Study|Withdrawal by Subject|1|||
13302078|NCT01330017|26512556|FG000|Overall Study|Lost to Follow-up|0|||
13302079|NCT01330017|26512557|FG001|Overall Study|Lost to Follow-up|0|||
13302080|NCT01330017|26512558|FG002|Overall Study|Lost to Follow-up|1|||
13302081|NCT01330017|26512559|FG003|Overall Study|Lost to Follow-up|0|||
13302082|NCT01330017|26512560|FG004|Overall Study|Lost to Follow-up|0|||
13302083|NCT01330017|26512556|FG000|Overall Study|Protocol Violation|0|||
13302084|NCT01330017|26512557|FG001|Overall Study|Protocol Violation|0|||
13302085|NCT01330017|26512558|FG002|Overall Study|Protocol Violation|0|||
13302086|NCT01330017|26512559|FG003|Overall Study|Protocol Violation|1|||
13302087|NCT01330017|26512560|FG004|Overall Study|Protocol Violation|0|||
13302088|NCT01330017|26512556|FG000|Overall Study|Unknown Reason|5|||
13302089|NCT01330017|26512557|FG001|Overall Study|Unknown Reason|3|||
13302090|NCT01330017|26512558|FG002|Overall Study|Unknown Reason|5|||
13302091|NCT01330017|26512559|FG003|Overall Study|Unknown Reason|7|||
13302092|NCT01330017|26512560|FG004|Overall Study|Unknown Reason|2|||
13302093|NCT01329978|26512642|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1|||
13302094|NCT01329978|26512643|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2|||
13302095|NCT01329978|26512644|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
13302096|NCT01329978|26512645|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
13302097|NCT01329978|26512646|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
13302098|NCT01329978|26512642|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
13382306|NCT00745615|26750522|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
13382307|NCT00745615|26750523|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
13382308|NCT00745615|26750524|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
13382309|NCT00745615|26750525|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1|||
13382310|NCT00745615|26750520|FG000|Open-Label (up to Approx 10.5 Years)|Death|0|||
13382311|NCT00745615|26750521|FG001|Open-Label (up to Approx 10.5 Years)|Death|0|||
13382312|NCT00745615|26750522|FG002|Open-Label (up to Approx 10.5 Years)|Death|0|||
13382313|NCT00745615|26750523|FG003|Open-Label (up to Approx 10.5 Years)|Death|0|||
13382314|NCT00745615|26750524|FG004|Open-Label (up to Approx 10.5 Years)|Death|0|||
13382315|NCT00745615|26750525|FG005|Open-Label (up to Approx 10.5 Years)|Death|1|||
13382316|NCT00745615|26750520|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
13382317|NCT00745615|26750521|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
13382318|NCT00745615|26750522|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
13382319|NCT00745615|26750523|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
13382320|NCT00745615|26750524|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8|||
13382321|NCT00745615|26750525|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10|||
13382322|NCT00745498|26750549|FG000|Overall Study|Lost to Follow-up|1|||
13382323|NCT00745498|26750550|FG001|Overall Study|Lost to Follow-up|1|||
13382324|NCT00745498|26750551|FG002|Overall Study|Lost to Follow-up|3|||
13382325|NCT00745498|26750549|FG000|Overall Study|Injection of intravitreal silicone oil o|3|||
13382326|NCT00745498|26750550|FG001|Overall Study|Injection of intravitreal silicone oil o|4|||
13382327|NCT00745498|26750551|FG002|Overall Study|Injection of intravitreal silicone oil o|4|||
13382328|NCT00745498|26750549|FG000|Overall Study|Non-PDR related VH|0|||
13382329|NCT00745498|26750550|FG001|Overall Study|Non-PDR related VH|1|||
13382330|NCT00745498|26750551|FG002|Overall Study|Non-PDR related VH|1|||
13382331|NCT00745498|26750549|FG000|Overall Study|Edophthalmitis after preoperative IVB|1|||
13382332|NCT00745498|26750550|FG001|Overall Study|Edophthalmitis after preoperative IVB|0|||
13382333|NCT00745498|26750551|FG002|Overall Study|Edophthalmitis after preoperative IVB|0|||
13382334|NCT00745368|26750564|FG000|Overall Study|Unable to provide sample|3|||
13382335|NCT00745251|26750579|FG000|Overall Study|Adverse Event|1|||
13382336|NCT00745251|26750580|FG001|Overall Study|Adverse Event|2|||
13382337|NCT00745251|26750579|FG000|Overall Study|Withdrawal by Subject|1|||
13382338|NCT00745251|26750580|FG001|Overall Study|Withdrawal by Subject|1|||
13382339|NCT00745121|26750593|FG000|Overall Study|Death|3|||
13302099|NCT01329978|26512643|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8|||
13302100|NCT01329978|26512644|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
13302101|NCT01329978|26512645|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
13302102|NCT01329978|26512646|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
13302103|NCT01329978|26512642|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
13302104|NCT01329978|26512643|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
13302105|NCT01329978|26512644|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3|||
13302106|NCT01329978|26512645|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
13302107|NCT01329978|26512646|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
13302108|NCT01329978|26512642|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
13302109|NCT01329978|26512643|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1|||
13302110|NCT01329978|26512644|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
13302111|NCT01329978|26512645|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
13302112|NCT01329978|26512646|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
13302113|NCT01329978|26512642|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
13302114|NCT01329978|26512643|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1|||
13302115|NCT01329978|26512644|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
13302116|NCT01329978|26512645|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
13302117|NCT01329978|26512646|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
13302118|NCT01329978|26512642|FG000|Rerandomization Treatment Period|Lost to Follow-up|0|||
13302119|NCT01329978|26512643|FG001|Rerandomization Treatment Period|Lost to Follow-up|0|||
13302120|NCT01329978|26512644|FG002|Rerandomization Treatment Period|Lost to Follow-up|0|||
13302121|NCT01329978|26512645|FG003|Rerandomization Treatment Period|Lost to Follow-up|5|||
13302122|NCT01329978|26512646|FG004|Rerandomization Treatment Period|Lost to Follow-up|3|||
13302123|NCT01329978|26512642|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0|||
13302124|NCT01329978|26512643|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0|||
13302125|NCT01329978|26512644|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0|||
13302126|NCT01329978|26512645|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0|||
13302127|NCT01329978|26512646|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1|||
13302128|NCT01329939|26512697|FG000|Overall Study|Lost to Follow-up|3|||
13302129|NCT01329939|26512698|FG001|Overall Study|Lost to Follow-up|0|||
13302130|NCT01329939|26512699|FG002|Overall Study|Lost to Follow-up|1|||
13302131|NCT01329939|26512700|FG003|Overall Study|Lost to Follow-up|2|||
13302132|NCT01329939|26512697|FG000|Overall Study|Withdrawal by Subject|0|||
13302133|NCT01329939|26512698|FG001|Overall Study|Withdrawal by Subject|1|||
13302134|NCT01329939|26512699|FG002|Overall Study|Withdrawal by Subject|0|||
13302135|NCT01329939|26512700|FG003|Overall Study|Withdrawal by Subject|0|||
13302136|NCT01329939|26512697|FG000|Overall Study|Adverse Event|0|||
13302137|NCT01329939|26512698|FG001|Overall Study|Adverse Event|0|||
13302138|NCT01329939|26512699|FG002|Overall Study|Adverse Event|0|||
13302139|NCT01329939|26512700|FG003|Overall Study|Adverse Event|3|||
13302140|NCT01329900|26512706|FG000|Overall Study|Elevated creatinine/renal function|1|||
13302141|NCT01329562|26512762|FG000|Overall Study|Protocol Violation|5|||
13302142|NCT01329562|26512763|FG001|Overall Study|Protocol Violation|3|||
13302143|NCT01329562|26512762|FG000|Overall Study|Lost to Follow-up|1|||
13302144|NCT01329562|26512763|FG001|Overall Study|Lost to Follow-up|1|||
13302145|NCT01329562|26512762|FG000|Overall Study|Subject withdrew due to personal issues.|3|||
13302146|NCT01329562|26512763|FG001|Overall Study|Subject withdrew due to personal issues.|2|||
13302147|NCT01329562|26512762|FG000|Overall Study|Physician Decision|0|||
13302148|NCT01329562|26512763|FG001|Overall Study|Physician Decision|1|||
13302149|NCT01329549|26512776|FG000|Overall Study|Withdrawal by Subject|1|||
13302150|NCT01329549|26512776|FG000|Overall Study|Adverse Event|1|||
13302151|NCT01329419|26512784|FG000|Overall Study|Protocol Violation|235|||
13302152|NCT01329341|26512790|FG000|Overall Study|Withdrawal by Subject|44|||
13302153|NCT01329328|26512811|FG000|Overall Study|Withdrawal by Subject|2|||
13302154|NCT01329328|26512812|FG001|Overall Study|Withdrawal by Subject|4|||
13302155|NCT01329328|26512813|FG002|Overall Study|Withdrawal by Subject|3|||
13302156|NCT01329263|26512832|FG000|Overall Study|Lost to Follow-up|4|||
13302157|NCT01329263|26512833|FG001|Overall Study|Lost to Follow-up|21|||
13302158|NCT01329263|26512832|FG000|Overall Study|Withdrawal by Subject|1|||
13302159|NCT01329263|26512833|FG001|Overall Study|Withdrawal by Subject|2|||
13302160|NCT01329029|26512910|FG000|Overall Study|Withdrawal by Subject|117|||
13302161|NCT01329029|26512911|FG001|Overall Study|Withdrawal by Subject|87|||
13302162|NCT01329029|26512910|FG000|Overall Study|Adverse Event|82|||
13302163|NCT01329029|26512911|FG001|Overall Study|Adverse Event|29|||
13302164|NCT01329029|26512910|FG000|Overall Study|Death|16|||
13302165|NCT01329029|26512911|FG001|Overall Study|Death|19|||
13302166|NCT01329029|26512910|FG000|Overall Study|Other|14|||
13302167|NCT01329029|26512911|FG001|Overall Study|Other|20|||
13302168|NCT01329029|26512910|FG000|Overall Study|COPD Exacerbation|11|||
13302169|NCT01329029|26512911|FG001|Overall Study|COPD Exacerbation|18|||
13302170|NCT01329029|26512910|FG000|Overall Study|Physician Decision|16|||
13302171|NCT01329029|26512911|FG001|Overall Study|Physician Decision|13|||
13302172|NCT01329029|26512910|FG000|Overall Study|Lost to Follow-up|8|||
13302173|NCT01329029|26512911|FG001|Overall Study|Lost to Follow-up|5|||
13302174|NCT01329029|26512910|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5|||
13302175|NCT01329029|26512911|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1|||
13302176|NCT01328951|26512942|FG000|Overall Study|Disease Progression|17|||
13302177|NCT01328951|26512943|FG001|Overall Study|Disease Progression|14|||
13302178|NCT01328951|26512942|FG000|Overall Study|Adverse Event|2|||
13302179|NCT01328951|26512943|FG001|Overall Study|Adverse Event|0|||
13302180|NCT01328951|26512942|FG000|Overall Study|Death|243|||
13302181|NCT01328951|26512943|FG001|Overall Study|Death|258|||
13302182|NCT01328951|26512942|FG000|Overall Study|Lost to Follow-up|6|||
13302183|NCT01328951|26512943|FG001|Overall Study|Lost to Follow-up|7|||
13302184|NCT01328951|26512942|FG000|Overall Study|Withdrawal by Subject|6|||
13302185|NCT01328951|26512943|FG001|Overall Study|Withdrawal by Subject|6|||
13302186|NCT01328951|26512942|FG000|Overall Study|Study Closed by the Sponsor|36|||
13302187|NCT01328951|26512943|FG001|Overall Study|Study Closed by the Sponsor|31|||
13302188|NCT01328951|26512942|FG000|Overall Study|Other|11|||
13302189|NCT01328951|26512943|FG001|Overall Study|Other|6|||
13302190|NCT01328756|26512962|FG000|Overall Study|Protocol Violation|4|||
13302191|NCT01328756|26512962|FG000|Overall Study|Adverse Event|39|||
13302192|NCT01328756|26512962|FG000|Overall Study|Lack of Efficacy|5|||
13302193|NCT01328756|26512962|FG000|Overall Study|Withdrawal by Subject|41|||
13302194|NCT01328756|26512962|FG000|Overall Study|Lost to Follow-up|5|||
13302195|NCT01328756|26512962|FG000|Overall Study|Other|29|||
13302196|NCT01328717|26512969|FG000|Overall Study|Adverse Event|1|||
13302197|NCT01328574|26512983|FG000|Overall Study|Refused further treatment|1|||
13302198|NCT01328548|26513008|FG000|Overall Study|Death|3|||
13302199|NCT01328548|26513009|FG001|Overall Study|Death|0|||
13302200|NCT01328548|26513008|FG000|Overall Study|Protocol Violation|1|||
13302201|NCT01328548|26513009|FG001|Overall Study|Protocol Violation|0|||
13302202|NCT01328535|26513020|FG000|Overall Study|Ineligible|1|||
13302203|NCT01328496|26513045|FG000|Overall Study|Significant Change in Health Status|1|||
13302204|NCT01328496|26513046|FG001|Overall Study|Significant Change in Health Status|0|||
13302205|NCT01328444|26513097|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
13302206|NCT01328444|26513098|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
13302207|NCT01328444|26513099|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
13302208|NCT01328444|26513100|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
13302209|NCT01328444|26513101|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5|||
13302210|NCT01328444|26513102|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
13302211|NCT01328444|26513097|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
13302212|NCT01328444|26513098|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
13302213|NCT01328444|26513099|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
13302214|NCT01328444|26513100|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
13302215|NCT01328444|26513101|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
13302216|NCT01328444|26513102|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
13302217|NCT01328444|26513097|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
13302218|NCT01328444|26513098|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
13302219|NCT01328444|26513099|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
13302220|NCT01328444|26513100|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
13302221|NCT01328444|26513101|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
13302222|NCT01328444|26513102|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
13302223|NCT01328444|26513097|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
13302224|NCT01328444|26513098|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1|||
13302225|NCT01328444|26513099|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
13302226|NCT01328444|26513100|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
13302227|NCT01328444|26513101|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2|||
13302228|NCT01328444|26513102|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
13302229|NCT01328444|26513097|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2|||
13302230|NCT01328444|26513098|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
13302231|NCT01328444|26513099|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
13302232|NCT01328444|26513100|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
13302233|NCT01328444|26513101|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
13302234|NCT01328444|26513102|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
13302235|NCT01328444|26513097|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
13302236|NCT01328444|26513098|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
13302237|NCT01328444|26513099|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
13302238|NCT01328444|26513100|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
13302239|NCT01328444|26513101|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
13302240|NCT01328444|26513102|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
13302241|NCT01328444|26513097|FG000|Washout Period (14 Days)|Adverse Event|1|||
13302242|NCT01328444|26513098|FG001|Washout Period (14 Days)|Adverse Event|1|||
13302243|NCT01328444|26513099|FG002|Washout Period (14 Days)|Adverse Event|0|||
13302244|NCT01328444|26513100|FG003|Washout Period (14 Days)|Adverse Event|1|||
13302245|NCT01328444|26513101|FG004|Washout Period (14 Days)|Adverse Event|1|||
13302246|NCT01328444|26513102|FG005|Washout Period (14 Days)|Adverse Event|2|||
13302247|NCT01328444|26513097|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
13302248|NCT01328444|26513098|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
13302249|NCT01328444|26513099|FG002|Washout Period (14 Days)|Lack of Efficacy|0|||
13302250|NCT01328444|26513100|FG003|Washout Period (14 Days)|Lack of Efficacy|0|||
13302251|NCT01328444|26513101|FG004|Washout Period (14 Days)|Lack of Efficacy|0|||
13302252|NCT01328444|26513102|FG005|Washout Period (14 Days)|Lack of Efficacy|1|||
13302253|NCT01328444|26513097|FG000|Washout Period (14 Days)|Withdrawal by Subject|0|||
13302254|NCT01328444|26513098|FG001|Washout Period (14 Days)|Withdrawal by Subject|0|||
13302255|NCT01328444|26513099|FG002|Washout Period (14 Days)|Withdrawal by Subject|0|||
13302256|NCT01328444|26513100|FG003|Washout Period (14 Days)|Withdrawal by Subject|0|||
13302257|NCT01328444|26513101|FG004|Washout Period (14 Days)|Withdrawal by Subject|0|||
13302258|NCT01328444|26513102|FG005|Washout Period (14 Days)|Withdrawal by Subject|1|||
13302259|NCT01328444|26513097|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5|||
13302260|NCT01328444|26513098|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
13302261|NCT01328444|26513099|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
13302262|NCT01328444|26513100|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
13302263|NCT01328444|26513101|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
13302264|NCT01328444|26513102|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
13302265|NCT01328444|26513097|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5|||
13302266|NCT01328444|26513098|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
13302267|NCT01328444|26513099|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
13302268|NCT01328444|26513100|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
13302269|NCT01328444|26513101|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
13302270|NCT01328444|26513102|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4|||
13302271|NCT01328444|26513097|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
13302272|NCT01328444|26513098|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
13302273|NCT01328444|26513099|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
13302274|NCT01328444|26513100|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
13302275|NCT01328444|26513101|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
13302276|NCT01328444|26513102|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
13302277|NCT01328444|26513097|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
13302278|NCT01328444|26513098|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
13302279|NCT01328444|26513099|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
13302280|NCT01328444|26513100|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
13302281|NCT01328444|26513101|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
13382340|NCT00745121|26750594|FG001|Overall Study|Death|0|||
13382341|NCT00745121|26750593|FG000|Overall Study|Adverse Event|1|||
13382342|NCT00745121|26750594|FG001|Overall Study|Adverse Event|0|||
13382343|NCT00745121|26750593|FG000|Overall Study|Lost to Follow-up|1|||
13382344|NCT00745121|26750594|FG001|Overall Study|Lost to Follow-up|0|||
13382345|NCT00745121|26750593|FG000|Overall Study|Withdrawal by Subject|4|||
13382346|NCT00745121|26750594|FG001|Overall Study|Withdrawal by Subject|2|||
13382347|NCT00745095|26750633|FG000|Overall Study|Declined to participate|1|||
13382348|NCT00745095|26750634|FG001|Overall Study|Declined to participate|0|||
13382349|NCT00745095|26750635|FG002|Overall Study|Declined to participate|0|||
13219800|NCT01830855|26278338|FG000|Overall Study|Lost to Follow-up|47|||
13219801|NCT01830855|26278339|FG001|Overall Study|Lost to Follow-up|20|||
13219802|NCT01830855|26278340|FG002|Overall Study|Lost to Follow-up|23|||
13219803|NCT01830855|26278341|FG003|Overall Study|Lost to Follow-up|33|||
13219804|NCT01830816|26278374|FG000|Overall Study|Progressive Disease|12|||
13219805|NCT01830816|26278375|FG001|Overall Study|Progressive Disease|7|||
13219806|NCT01830816|26278376|FG002|Overall Study|Progressive Disease|7|||
13219807|NCT01830816|26278374|FG000|Overall Study|Adverse Event|3|||
13219808|NCT01830816|26278375|FG001|Overall Study|Adverse Event|4|||
13219809|NCT01830816|26278376|FG002|Overall Study|Adverse Event|0|||
13219810|NCT01830816|26278374|FG000|Overall Study|Study Terminated by Sponsor|1|||
13219811|NCT01830816|26278375|FG001|Overall Study|Study Terminated by Sponsor|1|||
13219812|NCT01830816|26278376|FG002|Overall Study|Study Terminated by Sponsor|0|||
13219813|NCT01830816|26278374|FG000|Overall Study|Withdrawal by Subject|1|||
13219814|NCT01830816|26278375|FG001|Overall Study|Withdrawal by Subject|1|||
13219815|NCT01830816|26278376|FG002|Overall Study|Withdrawal by Subject|0|||
13219816|NCT01830816|26278374|FG000|Overall Study|Lost to Follow-up|0|||
13219817|NCT01830816|26278375|FG001|Overall Study|Lost to Follow-up|1|||
13219818|NCT01830816|26278376|FG002|Overall Study|Lost to Follow-up|0|||
13219819|NCT01830816|26278374|FG000|Overall Study|Symptomatic Deterioration|1|||
13219820|NCT01830816|26278375|FG001|Overall Study|Symptomatic Deterioration|0|||
13219821|NCT01830816|26278376|FG002|Overall Study|Symptomatic Deterioration|0|||
13219822|NCT01830816|26278374|FG000|Overall Study|Reason not Specified|2|||
13219823|NCT01830816|26278375|FG001|Overall Study|Reason not Specified|0|||
13219824|NCT01830816|26278376|FG002|Overall Study|Reason not Specified|0|||
13219825|NCT01830595|26278393|FG000|First Period|Withdrawal by Subject|1|||
13302282|NCT01328444|26513102|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
13302283|NCT01328444|26513097|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
13302284|NCT01328444|26513098|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
13302285|NCT01328444|26513099|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
13302286|NCT01328444|26513100|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
13302287|NCT01328444|26513101|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
13302288|NCT01328444|26513102|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
13302289|NCT01328444|26513097|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
13302290|NCT01328444|26513098|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
13302291|NCT01328444|26513099|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
13302292|NCT01328444|26513100|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
13302293|NCT01328444|26513101|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
13302294|NCT01328444|26513102|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
13302295|NCT01328431|26513117|FG000|Baseline|Protocol Violation|0|||
13302296|NCT01328431|26513118|FG001|Baseline|Protocol Violation|2|||
13302297|NCT01328431|26513117|FG000|1 Month (1M)|Lost to Follow-up|55|||
13302298|NCT01328431|26513118|FG001|1 Month (1M)|Lost to Follow-up|58|||
13302299|NCT01328431|26513117|FG000|3 Month (3M)|Death|2|||
13302300|NCT01328431|26513118|FG001|3 Month (3M)|Death|2|||
13302301|NCT01328431|26513117|FG000|3 Month (3M)|Lost to Follow-up|75|||
13302302|NCT01328431|26513118|FG001|3 Month (3M)|Lost to Follow-up|70|||
13302303|NCT01328431|26513117|FG000|12 Month (12M)|Death|2|||
13302304|NCT01328431|26513118|FG001|12 Month (12M)|Death|6|||
13302305|NCT01328431|26513117|FG000|12 Month (12M)|Lost to Follow-up|82|||
13302306|NCT01328431|26513118|FG001|12 Month (12M)|Lost to Follow-up|91|||
13302307|NCT01328366|26513138|FG000|Overall Study|Death|1|||
13302308|NCT01328366|26513138|FG000|Overall Study|Withdrawal by Subject|2|||
13302309|NCT01328366|26513138|FG000|Overall Study|Lost to Follow-up|7|||
13302310|NCT01328249|26513153|FG000|Overall Study|Adverse Event|3|||
13302311|NCT01328249|26513154|FG001|Overall Study|Adverse Event|0|||
13302312|NCT01328249|26513153|FG000|Overall Study|Disease progression|1|||
13302313|NCT01328249|26513154|FG001|Overall Study|Disease progression|0|||
13302314|NCT01328249|26513153|FG000|Overall Study|Withdrawal by Subject|1|||
13302315|NCT01328249|26513154|FG001|Overall Study|Withdrawal by Subject|1|||
13302316|NCT01328249|26513153|FG000|Overall Study|Moved before end of treatment visit|1|||
13302317|NCT01328249|26513154|FG001|Overall Study|Moved before end of treatment visit|0|||
13302318|NCT01328249|26513153|FG000|Overall Study|Subject choice|1|||
13302319|NCT01328249|26513154|FG001|Overall Study|Subject choice|1|||
13302320|NCT01328249|26513153|FG000|Overall Study|Protocol Violation|0|||
13302321|NCT01328249|26513154|FG001|Overall Study|Protocol Violation|1|||
13302322|NCT01328093|26513198|FG000|Double-Blind Phase|Adverse Event|78|||
13302323|NCT01328093|26513199|FG001|Double-Blind Phase|Adverse Event|15|||
13302324|NCT01328093|26513198|FG000|Double-Blind Phase|Withdrawal by Subject|42|||
13302325|NCT01328093|26513199|FG001|Double-Blind Phase|Withdrawal by Subject|14|||
13302326|NCT01328093|26513198|FG000|Double-Blind Phase|Lost to Follow-up|39|||
13302327|NCT01328093|26513199|FG001|Double-Blind Phase|Lost to Follow-up|14|||
13302328|NCT01328093|26513198|FG000|Double-Blind Phase|Protocol Violation|30|||
13302329|NCT01328093|26513199|FG001|Double-Blind Phase|Protocol Violation|10|||
13302330|NCT01328093|26513198|FG000|Double-Blind Phase|Lack of Efficacy|55|||
13302331|NCT01328093|26513199|FG001|Double-Blind Phase|Lack of Efficacy|13|||
13302332|NCT01328093|26513198|FG000|Double-Blind Phase|Sponsor Decision|17|||
13302333|NCT01328093|26513199|FG001|Double-Blind Phase|Sponsor Decision|3|||
13302334|NCT01328093|26513198|FG000|Double-Blind Phase|Entry Criteria Not Met|7|||
13302335|NCT01328093|26513199|FG001|Double-Blind Phase|Entry Criteria Not Met|5|||
13302336|NCT01328093|26513198|FG000|Double-Blind Phase|Scheduling conflict|8|||
13302337|NCT01328093|26513199|FG001|Double-Blind Phase|Scheduling conflict|3|||
13302338|NCT01328093|26513198|FG000|Double-Blind Phase|Subject is moving or has moved|8|||
13302339|NCT01328093|26513199|FG001|Double-Blind Phase|Subject is moving or has moved|1|||
13302340|NCT01328093|26513198|FG000|Double-Blind Phase|Death|1|||
13302341|NCT01328093|26513199|FG001|Double-Blind Phase|Death|0|||
13302342|NCT01328093|26513198|FG000|Open-Label Phase|Sponsor Decision|98|||
13302343|NCT01328093|26513199|FG001|Open-Label Phase|Sponsor Decision|34|||
13302344|NCT01328093|26513198|FG000|Open-Label Phase|Protocol Violation|8|||
13302345|NCT01328093|26513199|FG001|Open-Label Phase|Protocol Violation|3|||
13302346|NCT01328093|26513198|FG000|Open-Label Phase|Lost to Follow-up|10|||
13302347|NCT01328093|26513199|FG001|Open-Label Phase|Lost to Follow-up|1|||
13302348|NCT01328093|26513198|FG000|Open-Label Phase|Adverse Event|10|||
13302349|NCT01328093|26513199|FG001|Open-Label Phase|Adverse Event|4|||
13302350|NCT01328093|26513198|FG000|Open-Label Phase|Lack of Efficacy|5|||
13302351|NCT01328093|26513199|FG001|Open-Label Phase|Lack of Efficacy|6|||
13302352|NCT01328093|26513198|FG000|Open-Label Phase|Withdrawal by Subject|4|||
13302353|NCT01328093|26513199|FG001|Open-Label Phase|Withdrawal by Subject|1|||
13302354|NCT01328093|26513198|FG000|Open-Label Phase|Scheduling conflict|2|||
13302355|NCT01328093|26513199|FG001|Open-Label Phase|Scheduling conflict|1|||
13302356|NCT01328093|26513198|FG000|Open-Label Phase|Subject is moving or has moved|2|||
13302357|NCT01328093|26513199|FG001|Open-Label Phase|Subject is moving or has moved|0|||
13302358|NCT01328093|26513198|FG000|Open-Label Phase|Entry Criteria Not Met|1|||
13302359|NCT01328093|26513199|FG001|Open-Label Phase|Entry Criteria Not Met|0|||
13302360|NCT01328080|26513205|FG000|Overall Study|Lost to Follow-up|5|||
13302361|NCT01328054|26513233|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0|||
13302362|NCT01328054|26513234|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2|||
13302363|NCT01328054|26513233|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0|||
13302364|NCT01328054|26513234|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1|||
13302365|NCT01328054|26513233|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0|||
13302366|NCT01328054|26513234|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2|||
13302367|NCT01328041|26513258|FG000|Overall Study|Adverse Event|7|||
13302368|NCT01328041|26513258|FG000|Overall Study|Lack of Efficacy|27|||
13302369|NCT01328041|26513258|FG000|Overall Study|Protocol Violation|7|||
13302370|NCT01328041|26513258|FG000|Overall Study|Lost to Follow-up|7|||
13302371|NCT01328041|26513258|FG000|Overall Study|Physician Decision|2|||
13302372|NCT01328041|26513258|FG000|Overall Study|Withdrawal by Subject|7|||
13302373|NCT01328002|26513270|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66|||
13302374|NCT01328002|26513271|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0|||
13302375|NCT01328002|26513270|FG000|Open-Label Period|Adverse Event|8|||
13302376|NCT01328002|26513271|FG001|Open-Label Period|Adverse Event|0|||
13302377|NCT01328002|26513270|FG000|Open-Label Period|Lack of Efficacy|3|||
13302378|NCT01328002|26513271|FG001|Open-Label Period|Lack of Efficacy|0|||
13302379|NCT01328002|26513270|FG000|Open-Label Period|Protocol Violation|2|||
13302380|NCT01328002|26513271|FG001|Open-Label Period|Protocol Violation|0|||
13302381|NCT01328002|26513270|FG000|Open-Label Period|Withdrawal by Subject|9|||
13302382|NCT01328002|26513271|FG001|Open-Label Period|Withdrawal by Subject|0|||
13302383|NCT01328002|26513270|FG000|Open-Label Period|Lost to Follow-up|6|||
13302384|NCT01328002|26513271|FG001|Open-Label Period|Lost to Follow-up|0|||
13302385|NCT01328002|26513270|FG000|Open-Label Period|Other Reason|2|||
13302386|NCT01328002|26513271|FG001|Open-Label Period|Other Reason|0|||
13302387|NCT01328002|26513270|FG000|Double-Blind Period|Adverse Event|1|||
13302388|NCT01328002|26513271|FG001|Double-Blind Period|Adverse Event|0|||
13302389|NCT01328002|26513270|FG000|Double-Blind Period|Lack of Efficacy|1|||
13302390|NCT01328002|26513271|FG001|Double-Blind Period|Lack of Efficacy|0|||
13302391|NCT01327885|26513290|FG000|Overall Study|Disease progression-according to RECIST|173|||
13302392|NCT01327885|26513291|FG001|Overall Study|Disease progression-according to RECIST|165|||
13302393|NCT01327885|26513290|FG000|Overall Study|Clinical progression|24|||
13302394|NCT01327885|26513291|FG001|Overall Study|Clinical progression|27|||
13302395|NCT01327885|26513290|FG000|Overall Study|Adverse Event|14|||
13302396|NCT01327885|26513291|FG001|Overall Study|Adverse Event|10|||
13302397|NCT01327885|26513290|FG000|Overall Study|Subject choice|5|||
13302398|NCT01327885|26513291|FG001|Overall Study|Subject choice|10|||
13302399|NCT01327885|26513290|FG000|Overall Study|Other|8|||
13302400|NCT01327885|26513291|FG001|Overall Study|Other|6|||
13302401|NCT01327885|26513290|FG000|Overall Study|Withdrawal of consent from study|3|||
13302402|NCT01327885|26513291|FG001|Overall Study|Withdrawal of consent from study|4|||
13302403|NCT01327885|26513290|FG000|Overall Study|Not treated|1|||
13302404|NCT01327885|26513291|FG001|Overall Study|Not treated|1|||
13302405|NCT01327885|26513290|FG000|Overall Study|Administrative decision|0|||
13302406|NCT01327885|26513291|FG001|Overall Study|Administrative decision|1|||
13302407|NCT01327846|26513379|FG000|Core Phase|Subject decision (vital status: missing)|1|||
13302408|NCT01327846|26513380|FG001|Core Phase|Subject decision (vital status: missing)|2|||
13302409|NCT01327846|26513381|FG002|Core Phase|Subject decision (vital status: missing)|2|||
13302410|NCT01327846|26513382|FG003|Core Phase|Subject decision (vital status: missing)|1|||
13302411|NCT01327846|26513379|FG000|Core Phase|Subject decision (vital stat: unkn)|0|||
13302412|NCT01327846|26513380|FG001|Core Phase|Subject decision (vital stat: unkn)|0|||
13302413|NCT01327846|26513381|FG002|Core Phase|Subject decision (vital stat: unkn)|3|||
13302414|NCT01327846|26513382|FG003|Core Phase|Subject decision (vital stat: unkn)|3|||
13302415|NCT01327846|26513379|FG000|Core Phase|Subject decision (vital stat: dead)|1|||
13302416|NCT01327846|26513380|FG001|Core Phase|Subject decision (vital stat: dead)|3|||
13302417|NCT01327846|26513381|FG002|Core Phase|Subject decision (vital stat: dead)|4|||
13302418|NCT01327846|26513382|FG003|Core Phase|Subject decision (vital stat: dead)|4|||
13302419|NCT01327846|26513379|FG000|Core Phase|Subject decision (vital stat: alive)|23|||
13302420|NCT01327846|26513380|FG001|Core Phase|Subject decision (vital stat: alive)|24|||
13302421|NCT01327846|26513381|FG002|Core Phase|Subject decision (vital stat: alive)|13|||
13302422|NCT01327846|26513382|FG003|Core Phase|Subject decision (vital stat: alive)|20|||
13302423|NCT01327846|26513379|FG000|Core Phase|Lost to Follow-up|3|||
13302424|NCT01327846|26513380|FG001|Core Phase|Lost to Follow-up|3|||
13302425|NCT01327846|26513381|FG002|Core Phase|Lost to Follow-up|4|||
13302426|NCT01327846|26513382|FG003|Core Phase|Lost to Follow-up|5|||
13302427|NCT01327846|26513379|FG000|Extension Phase|Study terminated by sponsor|1073|||
13302428|NCT01327846|26513380|FG001|Extension Phase|Study terminated by sponsor|1124|||
13302429|NCT01327846|26513381|FG002|Extension Phase|Study terminated by sponsor|1067|||
13302430|NCT01327846|26513382|FG003|Extension Phase|Study terminated by sponsor|1660|||
13302431|NCT01327846|26513379|FG000|Extension Phase|Withdrawal by Subject|20|||
13302432|NCT01327846|26513380|FG001|Extension Phase|Withdrawal by Subject|13|||
13302433|NCT01327846|26513381|FG002|Extension Phase|Withdrawal by Subject|19|||
13302434|NCT01327846|26513382|FG003|Extension Phase|Withdrawal by Subject|37|||
13302435|NCT01327846|26513379|FG000|Extension Phase|Lost to Follow-up|4|||
13302436|NCT01327846|26513380|FG001|Extension Phase|Lost to Follow-up|3|||
13302437|NCT01327846|26513381|FG002|Extension Phase|Lost to Follow-up|4|||
13302438|NCT01327846|26513382|FG003|Extension Phase|Lost to Follow-up|7|||
13302439|NCT01327846|26513379|FG000|Extension Phase|Technical Problems|2|||
13302440|NCT01327846|26513380|FG001|Extension Phase|Technical Problems|4|||
13302441|NCT01327846|26513381|FG002|Extension Phase|Technical Problems|2|||
13302442|NCT01327846|26513382|FG003|Extension Phase|Technical Problems|2|||
13302443|NCT01327703|26513417|FG000|Second Treatment Period|Adverse Event|1|||
13302444|NCT01327703|26513418|FG001|Second Treatment Period|Adverse Event|1|||
13302445|NCT01327703|26513417|FG000|Second Treatment Period|Protocol Violation|0|||
13302446|NCT01327703|26513418|FG001|Second Treatment Period|Protocol Violation|1|||
13302447|NCT01327651|26513565|FG000|Self-administered Dosing Period|Lost to Follow-up|3|||
13302448|NCT01327651|26513566|FG001|Self-administered Dosing Period|Lost to Follow-up|2|||
13302449|NCT01327651|26513567|FG002|Self-administered Dosing Period|Lost to Follow-up|4|||
13302450|NCT01327651|26513568|FG003|Self-administered Dosing Period|Lost to Follow-up|2|||
13302451|NCT01327651|26513569|FG004|Self-administered Dosing Period|Lost to Follow-up|3|||
13302452|NCT01327651|26513570|FG005|Self-administered Dosing Period|Lost to Follow-up|0|||
13302453|NCT01327651|26513571|FG006|Self-administered Dosing Period|Lost to Follow-up|8|||
13302454|NCT01327651|26513572|FG007|Self-administered Dosing Period|Lost to Follow-up|9|||
13302455|NCT01327651|26513573|FG008|Self-administered Dosing Period|Lost to Follow-up|10|||
13302456|NCT01327651|26513565|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1|||
13302457|NCT01327651|26513566|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
13302458|NCT01327651|26513567|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
13302459|NCT01327651|26513568|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
13302460|NCT01327651|26513569|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
13302461|NCT01327651|26513570|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
13302462|NCT01327651|26513571|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
13302463|NCT01327651|26513572|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
13302464|NCT01327651|26513573|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
13302465|NCT01327651|26513565|FG000|Self-administered Dosing Period|Withdrawal by Subject|0|||
13302466|NCT01327651|26513566|FG001|Self-administered Dosing Period|Withdrawal by Subject|1|||
13302467|NCT01327651|26513567|FG002|Self-administered Dosing Period|Withdrawal by Subject|0|||
13302468|NCT01327651|26513568|FG003|Self-administered Dosing Period|Withdrawal by Subject|1|||
13302469|NCT01327651|26513569|FG004|Self-administered Dosing Period|Withdrawal by Subject|0|||
13302470|NCT01327651|26513570|FG005|Self-administered Dosing Period|Withdrawal by Subject|0|||
13302471|NCT01327651|26513571|FG006|Self-administered Dosing Period|Withdrawal by Subject|2|||
13302472|NCT01327651|26513572|FG007|Self-administered Dosing Period|Withdrawal by Subject|1|||
13302473|NCT01327651|26513573|FG008|Self-administered Dosing Period|Withdrawal by Subject|1|||
13302474|NCT01327651|26513565|FG000|Post Study Follow-up|Lost to Follow-up|0|||
13302475|NCT01327651|26513566|FG001|Post Study Follow-up|Lost to Follow-up|1|||
13302476|NCT01327651|26513567|FG002|Post Study Follow-up|Lost to Follow-up|1|||
13302477|NCT01327651|26513568|FG003|Post Study Follow-up|Lost to Follow-up|0|||
13302478|NCT01327651|26513569|FG004|Post Study Follow-up|Lost to Follow-up|0|||
13302479|NCT01327651|26513570|FG005|Post Study Follow-up|Lost to Follow-up|0|||
13302480|NCT01327651|26513571|FG006|Post Study Follow-up|Lost to Follow-up|4|||
13302481|NCT01327651|26513572|FG007|Post Study Follow-up|Lost to Follow-up|1|||
13302482|NCT01327651|26513573|FG008|Post Study Follow-up|Lost to Follow-up|2|||
13302483|NCT01327612|26513653|FG000|Overall Study|Withdrawal by Subject|0|||
13302484|NCT01327612|26513654|FG001|Overall Study|Withdrawal by Subject|0|||
13302485|NCT01327612|26513655|FG002|Overall Study|Withdrawal by Subject|0|||
13302486|NCT01327612|26513656|FG003|Overall Study|Withdrawal by Subject|0|||
13302487|NCT01327612|26513657|FG004|Overall Study|Withdrawal by Subject|0|||
13302488|NCT01327612|26513658|FG005|Overall Study|Withdrawal by Subject|1|||
13302489|NCT01327612|26513659|FG006|Overall Study|Withdrawal by Subject|0|||
13302490|NCT01327612|26513653|FG000|Overall Study|Disease Progression|1|||
13302491|NCT01327612|26513654|FG001|Overall Study|Disease Progression|1|||
13302492|NCT01327612|26513655|FG002|Overall Study|Disease Progression|1|||
13302493|NCT01327612|26513656|FG003|Overall Study|Disease Progression|0|||
13302494|NCT01327612|26513657|FG004|Overall Study|Disease Progression|1|||
13302495|NCT01327612|26513658|FG005|Overall Study|Disease Progression|2|||
13302496|NCT01327612|26513659|FG006|Overall Study|Disease Progression|2|||
13302497|NCT01327612|26513653|FG000|Overall Study|Administrative Decision|0|||
13302498|NCT01327612|26513654|FG001|Overall Study|Administrative Decision|0|||
13302499|NCT01327612|26513655|FG002|Overall Study|Administrative Decision|0|||
13302500|NCT01327612|26513656|FG003|Overall Study|Administrative Decision|1|||
13302501|NCT01327612|26513657|FG004|Overall Study|Administrative Decision|0|||
13302502|NCT01327612|26513658|FG005|Overall Study|Administrative Decision|0|||
13302503|NCT01327612|26513659|FG006|Overall Study|Administrative Decision|0|||
13302504|NCT01327612|26513653|FG000|Overall Study|Death|0|||
13302505|NCT01327612|26513654|FG001|Overall Study|Death|0|||
13302506|NCT01327612|26513655|FG002|Overall Study|Death|0|||
13302507|NCT01327612|26513656|FG003|Overall Study|Death|0|||
13302508|NCT01327612|26513657|FG004|Overall Study|Death|1|||
13302509|NCT01327612|26513658|FG005|Overall Study|Death|0|||
13302510|NCT01327612|26513659|FG006|Overall Study|Death|0|||
13302511|NCT01327599|26513669|FG000|Overall Study|Adverse Event|1|||
13302512|NCT01327599|26513669|FG000|Overall Study|Could Not Attend Visit|1|||
13302513|NCT01327599|26513669|FG000|Overall Study|Withdrawal of Consent|1|||
13302514|NCT01327573|26513685|FG000|Overall Study|Physician Decision|3|||
13302515|NCT01327573|26513686|FG001|Overall Study|Physician Decision|1|||
13302516|NCT01327547|26513744|FG000|Overall Study|Adverse Event|4|||
13302517|NCT01327547|26513745|FG001|Overall Study|Adverse Event|1|||
13302518|NCT01327547|26513744|FG000|Overall Study|Death|1|||
13302519|NCT01327547|26513745|FG001|Overall Study|Death|2|||
13302520|NCT01327547|26513744|FG000|Overall Study|Lost to Follow-up|6|||
13302521|NCT01327547|26513745|FG001|Overall Study|Lost to Follow-up|6|||
13302522|NCT01327547|26513744|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
13302523|NCT01327547|26513745|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
13302524|NCT01327547|26513744|FG000|Overall Study|Withdrawal by Subject|3|||
13302525|NCT01327547|26513745|FG001|Overall Study|Withdrawal by Subject|7|||
13302526|NCT01327547|26513744|FG000|Overall Study|Does Not Meet Entrance Criteria|2|||
13302527|NCT01327547|26513745|FG001|Overall Study|Does Not Meet Entrance Criteria|2|||
13302528|NCT01327547|26513744|FG000|Overall Study|Protocol Violation|1|||
13302529|NCT01327547|26513745|FG001|Overall Study|Protocol Violation|0|||
13302530|NCT01327547|26513744|FG000|Overall Study|Non-compliance due to alcohol intake|0|||
13302531|NCT01327547|26513745|FG001|Overall Study|Non-compliance due to alcohol intake|1|||
13302532|NCT01327547|26513744|FG000|Overall Study|Required prohibited medication|2|||
13302533|NCT01327547|26513745|FG001|Overall Study|Required prohibited medication|0|||
13302534|NCT01327547|26513744|FG000|Overall Study|Non-compliance with study procedures|1|||
13302535|NCT01327547|26513745|FG001|Overall Study|Non-compliance with study procedures|0|||
13302536|NCT01327547|26513744|FG000|Overall Study|By investigator in subject's interest|0|||
13302537|NCT01327547|26513745|FG001|Overall Study|By investigator in subject's interest|1|||
13302538|NCT01327495|26513856|FG000|Overall Study|Adverse Event|2|||
13302539|NCT01327495|26513857|FG001|Overall Study|Adverse Event|1|||
13302540|NCT01327495|26513858|FG002|Overall Study|Adverse Event|1|||
13302541|NCT01327495|26513859|FG003|Overall Study|Adverse Event|0|||
13302542|NCT01327495|26513860|FG004|Overall Study|Adverse Event|0|||
13302543|NCT01327495|26513861|FG005|Overall Study|Adverse Event|2|||
13302544|NCT01327495|26513856|FG000|Overall Study|Withdrawal by Subject|0|||
13302545|NCT01327495|26513857|FG001|Overall Study|Withdrawal by Subject|1|||
13302546|NCT01327495|26513858|FG002|Overall Study|Withdrawal by Subject|1|||
13302547|NCT01327495|26513859|FG003|Overall Study|Withdrawal by Subject|0|||
13302548|NCT01327495|26513860|FG004|Overall Study|Withdrawal by Subject|1|||
13302549|NCT01327495|26513861|FG005|Overall Study|Withdrawal by Subject|0|||
13302550|NCT01327495|26513856|FG000|Overall Study|Physician Decision|0|||
13302551|NCT01327495|26513857|FG001|Overall Study|Physician Decision|0|||
13302552|NCT01327495|26513858|FG002|Overall Study|Physician Decision|0|||
13302553|NCT01327495|26513859|FG003|Overall Study|Physician Decision|0|||
13302554|NCT01327495|26513860|FG004|Overall Study|Physician Decision|2|||
13302555|NCT01327495|26513861|FG005|Overall Study|Physician Decision|0|||
13302556|NCT01327482|26513868|FG000|Overall Study|Adverse Event|1|||
13302557|NCT01327339|26513876|FG000|Overall Study|Protocol Violation|8|||
13302558|NCT01327300|26513895|FG000|Washout (3 Weeks)|Withdrawal by Subject|1|||
13302559|NCT01327300|26513896|FG001|Washout (3 Weeks)|Withdrawal by Subject|0|||
13302560|NCT01327053|26513977|FG000|Overall Study|Adverse Event|23|||
13302561|NCT01327053|26513978|FG001|Overall Study|Adverse Event|57|||
13302562|NCT01327053|26513977|FG000|Overall Study|Patient/guardian decision|11|||
13302563|NCT01327053|26513978|FG001|Overall Study|Patient/guardian decision|35|||
13302564|NCT01327053|26513977|FG000|Overall Study|Physician Decision|10|||
13302565|NCT01327053|26513978|FG001|Overall Study|Physician Decision|14|||
13302566|NCT01327053|26513977|FG000|Overall Study|Death|1|||
13302567|NCT01327053|26513978|FG001|Overall Study|Death|5|||
13302568|NCT01327053|26513977|FG000|Overall Study|Lost to Follow-up|2|||
13302569|NCT01327053|26513978|FG001|Overall Study|Lost to Follow-up|4|||
13302570|NCT01327053|26513977|FG000|Overall Study|Non-compliance with study treatment|0|||
13302571|NCT01327053|26513978|FG001|Overall Study|Non-compliance with study treatment|5|||
13302572|NCT01327053|26513977|FG000|Overall Study|Study terminated by Sponsor|1|||
13302573|NCT01327053|26513978|FG001|Overall Study|Study terminated by Sponsor|3|||
13302574|NCT01327053|26513977|FG000|Overall Study|Progressive disease|31|||
13302575|NCT01327053|26513978|FG001|Overall Study|Progressive disease|26|||
13302576|NCT01327053|26513977|FG000|Overall Study|Protocol Violation|0|||
13302577|NCT01327053|26513978|FG001|Overall Study|Protocol Violation|1|||
13302578|NCT01327053|26513977|FG000|Overall Study|Untreated|0|||
13302579|NCT01327053|26513978|FG001|Overall Study|Untreated|1|||
13302580|NCT01326962|26513996|FG000|Overall Study|Adverse Event|1|||
13302581|NCT01326962|26513996|FG000|Overall Study|Withdrawal by Subject|1|||
13302582|NCT01326962|26513996|FG000|Overall Study|Lost to Follow-up|3|||
13302583|NCT01326962|26513996|FG000|Overall Study|Other|2|||
13302584|NCT01326910|26514015|FG000|Overall Study|Withdrawal by Subject|3|||
13302585|NCT01326910|26514016|FG001|Overall Study|Withdrawal by Subject|2|||
13302586|NCT01326910|26514015|FG000|Overall Study|Protocol Violation|1|||
13302587|NCT01326910|26514016|FG001|Overall Study|Protocol Violation|1|||
13302588|NCT01326845|26514045|FG000|Overall Study|Administrative Problems|5|||
13302589|NCT01326845|26514046|FG001|Overall Study|Administrative Problems|2|||
13302590|NCT01326845|26514045|FG000|Overall Study|Adverse Event|1|||
13302591|NCT01326845|26514046|FG001|Overall Study|Adverse Event|0|||
13302592|NCT01326845|26514045|FG000|Overall Study|Misisng|1|||
13302593|NCT01326845|26514046|FG001|Overall Study|Misisng|3|||
13302594|NCT01326728|26514070|FG000|Overall Study|Death|13|||
13302595|NCT01326728|26514071|FG001|Overall Study|Death|0|||
13302596|NCT01326728|26514070|FG000|Overall Study|Early closure of study|34|||
13302597|NCT01326728|26514071|FG001|Overall Study|Early closure of study|9|||
13302598|NCT01326702|26514147|FG000|Overall Study|Other|1|||
13302599|NCT01326702|26514148|FG001|Overall Study|Other|0|||
13302600|NCT01326702|26514149|FG002|Overall Study|Other|0|||
13302601|NCT01326702|26514150|FG003|Overall Study|Other|0|||
13302602|NCT01326702|26514151|FG004|Overall Study|Other|0|||
13302603|NCT01326702|26514152|FG005|Overall Study|Other|1|||
13302604|NCT01326702|26514153|FG006|Overall Study|Other|0|||
13302605|NCT01326702|26514147|FG000|Overall Study|progressive disease|1|||
13302606|NCT01326702|26514148|FG001|Overall Study|progressive disease|1|||
13302607|NCT01326702|26514149|FG002|Overall Study|progressive disease|3|||
13302608|NCT01326702|26514150|FG003|Overall Study|progressive disease|1|||
13302609|NCT01326702|26514151|FG004|Overall Study|progressive disease|3|||
13302610|NCT01326702|26514152|FG005|Overall Study|progressive disease|2|||
13302611|NCT01326702|26514153|FG006|Overall Study|progressive disease|3|||
13302612|NCT01326702|26514147|FG000|Overall Study|Death|0|||
13302613|NCT01326702|26514148|FG001|Overall Study|Death|1|||
13302614|NCT01326702|26514149|FG002|Overall Study|Death|0|||
13302615|NCT01326702|26514150|FG003|Overall Study|Death|0|||
13302616|NCT01326702|26514151|FG004|Overall Study|Death|0|||
13302617|NCT01326702|26514152|FG005|Overall Study|Death|0|||
13302618|NCT01326702|26514153|FG006|Overall Study|Death|0|||
13302619|NCT01326702|26514147|FG000|Overall Study|Adverse Event|0|||
13302620|NCT01326702|26514148|FG001|Overall Study|Adverse Event|0|||
13302621|NCT01326702|26514149|FG002|Overall Study|Adverse Event|1|||
13302622|NCT01326702|26514150|FG003|Overall Study|Adverse Event|1|||
13302623|NCT01326702|26514151|FG004|Overall Study|Adverse Event|0|||
13302624|NCT01326702|26514152|FG005|Overall Study|Adverse Event|3|||
13302625|NCT01326702|26514153|FG006|Overall Study|Adverse Event|1|||
13302626|NCT01326702|26514147|FG000|Overall Study|Withdrawal by Subject|0|||
13302627|NCT01326702|26514148|FG001|Overall Study|Withdrawal by Subject|0|||
13302628|NCT01326702|26514149|FG002|Overall Study|Withdrawal by Subject|1|||
13302629|NCT01326702|26514150|FG003|Overall Study|Withdrawal by Subject|0|||
13302630|NCT01326702|26514151|FG004|Overall Study|Withdrawal by Subject|1|||
13302631|NCT01326702|26514152|FG005|Overall Study|Withdrawal by Subject|1|||
13302632|NCT01326702|26514153|FG006|Overall Study|Withdrawal by Subject|3|||
13302633|NCT01326702|26514147|FG000|Overall Study|Not Treated|0|||
13302634|NCT01326702|26514148|FG001|Overall Study|Not Treated|0|||
13302635|NCT01326702|26514149|FG002|Overall Study|Not Treated|0|||
13302636|NCT01326702|26514150|FG003|Overall Study|Not Treated|1|||
13302637|NCT01326702|26514151|FG004|Overall Study|Not Treated|0|||
13302638|NCT01326702|26514152|FG005|Overall Study|Not Treated|1|||
13302639|NCT01326702|26514153|FG006|Overall Study|Not Treated|0|||
13302640|NCT01326546|26514166|FG000|Overall Study|Lost to Follow-up|8|||
13302641|NCT01326546|26514167|FG001|Overall Study|Lost to Follow-up|7|||
13302642|NCT01326546|26514166|FG000|Overall Study|Protocol Violation|3|||
13302643|NCT01326546|26514167|FG001|Overall Study|Protocol Violation|4|||
13302644|NCT01326546|26514166|FG000|Overall Study|Pregnancy|0|||
13302645|NCT01326546|26514167|FG001|Overall Study|Pregnancy|1|||
13302646|NCT01326546|26514166|FG000|Overall Study|Adverse Event|1|||
13302647|NCT01326546|26514167|FG001|Overall Study|Adverse Event|0|||
13302648|NCT01326546|26514166|FG000|Overall Study|Withdrawal by Subject|5|||
13302649|NCT01326546|26514167|FG001|Overall Study|Withdrawal by Subject|1|||
13302650|NCT01326533|26514182|FG000|Overall Study|Lost to Follow-up|2|||
13302651|NCT01326533|26514183|FG001|Overall Study|Lost to Follow-up|0|||
13302652|NCT01326533|26514182|FG000|Overall Study|Withdrawal by Subject|1|||
13302653|NCT01326533|26514183|FG001|Overall Study|Withdrawal by Subject|0|||
13302654|NCT01326533|26514182|FG000|Overall Study|Adverse Event|1|||
13302655|NCT01326533|26514183|FG001|Overall Study|Adverse Event|0|||
13302656|NCT01326481|26514192|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1|||
13302657|NCT01326104|26514205|FG000|Overall Study|progressed prior to vaccine|0|||
13302658|NCT01326104|26514206|FG001|Overall Study|progressed prior to vaccine|2|||
13302659|NCT01326104|26514205|FG000|Overall Study|unable to make vaccine|0|||
13302660|NCT01326104|26514206|FG001|Overall Study|unable to make vaccine|2|||
13302661|NCT01326026|26514227|FG000|Overall Study|Adverse Event|4|||
13302662|NCT01326026|26514228|FG001|Overall Study|Adverse Event|3|||
13302663|NCT01326026|26514227|FG000|Overall Study|Withdrawal Criteria|5|||
13302664|NCT01326026|26514228|FG001|Overall Study|Withdrawal Criteria|7|||
13302665|NCT01326026|26514227|FG000|Overall Study|Other|3|||
13302666|NCT01326026|26514228|FG001|Overall Study|Other|3|||
13302667|NCT01325701|26514245|FG000|Overall Study|Adverse Event|12|||
13302668|NCT01325701|26514246|FG001|Overall Study|Adverse Event|0|||
13302669|NCT01325701|26514245|FG000|Overall Study|Protocol Violation|1|||
13302670|NCT01325701|26514246|FG001|Overall Study|Protocol Violation|0|||
13302671|NCT01325701|26514245|FG000|Overall Study|Physician Decision|2|||
13302672|NCT01325701|26514246|FG001|Overall Study|Physician Decision|2|||
13302673|NCT01325701|26514245|FG000|Overall Study|Withdrawal by Subject|2|||
13302674|NCT01325701|26514246|FG001|Overall Study|Withdrawal by Subject|1|||
13302675|NCT01325701|26514245|FG000|Overall Study|Rollerover Extension Study|4|||
13302676|NCT01325701|26514246|FG001|Overall Study|Rollerover Extension Study|0|||
13302677|NCT01325623|26514290|FG000|Overall Study|Withdrawal by Subject|3|||
13302678|NCT01325584|26514300|FG000|Overall Study|Death|1|||
13382350|NCT00745095|26750636|FG003|Overall Study|Declined to participate|0|||
13382351|NCT00745095|26750637|FG004|Overall Study|Declined to participate|92|||
13382352|NCT00745095|26750638|FG005|Overall Study|Declined to participate|95|||
13382353|NCT00745095|26750633|FG000|Overall Study|Ineligible due to GFR criteria|0|||
13382354|NCT00745095|26750634|FG001|Overall Study|Ineligible due to GFR criteria|2|||
13382355|NCT00745095|26750635|FG002|Overall Study|Ineligible due to GFR criteria|3|||
13382356|NCT00745095|26750636|FG003|Overall Study|Ineligible due to GFR criteria|3|||
13382357|NCT00745095|26750637|FG004|Overall Study|Ineligible due to GFR criteria|30|||
13382358|NCT00745095|26750638|FG005|Overall Study|Ineligible due to GFR criteria|28|||
13382359|NCT00744991|26750655|FG000|Overall Study|Progressive Disease|11|||
13382360|NCT00744991|26750655|FG000|Overall Study|Withdrawal by Subject|8|||
13382361|NCT00744991|26750655|FG000|Overall Study|Physician Decision|3|||
13382362|NCT00744991|26750655|FG000|Overall Study|Adverse Event|2|||
13382363|NCT00744991|26750655|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
13382364|NCT00744978|26750710|FG000|Period 1|Lost to Follow-up|1|||
13382365|NCT00744978|26750711|FG001|Period 1|Lost to Follow-up|0|||
13382366|NCT00744978|26750710|FG000|Period 1|Withdrawal by Subject|0|||
13382367|NCT00744978|26750711|FG001|Period 1|Withdrawal by Subject|2|||
13382368|NCT00744978|26750710|FG000|Period 1|Other|0|||
13382369|NCT00744978|26750711|FG001|Period 1|Other|2|||
13382370|NCT00744978|26750710|FG000|Period 1|Adverse Event|4|||
13382371|NCT00744978|26750711|FG001|Period 1|Adverse Event|0|||
13382372|NCT00744978|26750710|FG000|Period 1|Randomized but not Treated|1|||
13382373|NCT00744978|26750711|FG001|Period 1|Randomized but not Treated|1|||
13382374|NCT00744978|26750710|FG000|Period 2|Adverse Event|0|||
13382375|NCT00744978|26750711|FG001|Period 2|Adverse Event|1|||
13382376|NCT00744939|26750757|FG000|Overall Study|Withdrawal by Subject|9|||
13382377|NCT00744939|26750757|FG000|Overall Study|Protocol Violation|13|||
13382378|NCT00744939|26750757|FG000|Overall Study|Death|24|||
13382379|NCT00744939|26750757|FG000|Overall Study|distance|4|||
13382380|NCT00744939|26750757|FG000|Overall Study|Lost to Follow-up|12|||
13382381|NCT00744939|26750757|FG000|Overall Study|Medical history exclusionary|1|||
13382382|NCT00744939|26750757|FG000|Overall Study|Did not receive Magnevist|7|||
13382383|NCT00744939|26750757|FG000|Overall Study|Failed inclusion/exclusion criteria|19|||
13382384|NCT00744939|26750757|FG000|Overall Study|coma|1|||
13382385|NCT00744939|26750757|FG000|Overall Study|incorrect race|1|||
13382386|NCT00744874|26750775|FG000|Overall Study|Lost to Follow-up|1|||
13382387|NCT00744874|26750775|FG000|Overall Study|Withdrawal by Subject|1|||
13382388|NCT00744874|26750775|FG000|Overall Study|Study Device not available at procedure|1|||
13382389|NCT00744874|26750775|FG000|Overall Study|Unable to accomodate schedule|1|||
13382390|NCT00744861|26750796|FG000|Feasibility Stage 1|Withdrawal by Subject|1|||
13382391|NCT00744861|26750797|FG001|Feasibility Stage 1|Withdrawal by Subject|1|||
13382392|NCT00744861|26750798|FG002|Feasibility Stage 1|Withdrawal by Subject|0|||
13382393|NCT00744861|26750799|FG003|Feasibility Stage 1|Withdrawal by Subject|0|||
13382394|NCT00744861|26750796|FG000|Feasibility Stage 1|Pregnancy|0|||
13382395|NCT00744861|26750797|FG001|Feasibility Stage 1|Pregnancy|1|||
13382396|NCT00744861|26750798|FG002|Feasibility Stage 1|Pregnancy|0|||
13382397|NCT00744861|26750799|FG003|Feasibility Stage 1|Pregnancy|0|||
13382398|NCT00744861|26750796|FG000|Pivotal Stage 2|Adverse Event|0|||
13382399|NCT00744861|26750797|FG001|Pivotal Stage 2|Adverse Event|0|||
13382400|NCT00744861|26750798|FG002|Pivotal Stage 2|Adverse Event|6|||
13382401|NCT00744861|26750799|FG003|Pivotal Stage 2|Adverse Event|11|||
13382402|NCT00744861|26750796|FG000|Pivotal Stage 2|Death|0|||
13382403|NCT00744861|26750797|FG001|Pivotal Stage 2|Death|0|||
13382404|NCT00744861|26750798|FG002|Pivotal Stage 2|Death|0|||
13382405|NCT00744861|26750799|FG003|Pivotal Stage 2|Death|1|||
13382406|NCT00744861|26750796|FG000|Pivotal Stage 2|Lost to Follow-up|0|||
13382407|NCT00744861|26750797|FG001|Pivotal Stage 2|Lost to Follow-up|0|||
13382408|NCT00744861|26750798|FG002|Pivotal Stage 2|Lost to Follow-up|13|||
13302679|NCT01325532|26514317|FG000|Overall Study|Withdrawal by Subject|2|||
13302680|NCT01325532|26514318|FG001|Overall Study|Withdrawal by Subject|0|||
13302681|NCT01325493|26514337|FG000|Overall Study|Protocol Violation|0|||
13302682|NCT01325493|26514338|FG001|Overall Study|Protocol Violation|1|||
13302683|NCT01325493|26514337|FG000|Overall Study|loss of neuromonitoring signals|0|||
13302684|NCT01325493|26514338|FG001|Overall Study|loss of neuromonitoring signals|2|||
13302685|NCT01325493|26514337|FG000|Overall Study|Allergy|1|||
13302686|NCT01325493|26514338|FG001|Overall Study|Allergy|0|||
13302687|NCT01325428|26514355|FG000|Part A|Progressive disease according to RECIST|9|||
13302688|NCT01325428|26514355|FG000|Part A|Clinical signs, symptoms of progression|2|||
13302689|NCT01325428|26514355|FG000|Part A|Other adverse event|1|||
13302690|NCT01325428|26514355|FG000|Part A|Refused continue taking trial medication|2|||
13302691|NCT01325428|26514355|FG000|Part A|Other reason not defined above|2|||
13302692|NCT01325428|26514355|FG000|Part B|Refused continue taking trial medication|2|||
13302693|NCT01325428|26514355|FG000|Part B|Other reason not defined above|1|||
13302694|NCT01325350|26514408|FG000|Overall Study|Adverse Event|3|||
13302695|NCT01325350|26514409|FG001|Overall Study|Adverse Event|3|||
13302696|NCT01325350|26514410|FG002|Overall Study|Adverse Event|3|||
13302697|NCT01325350|26514411|FG003|Overall Study|Adverse Event|1|||
13302698|NCT01325350|26514412|FG004|Overall Study|Adverse Event|2|||
13302699|NCT01325350|26514408|FG000|Overall Study|Pregnancy|0|||
13302700|NCT01325350|26514409|FG001|Overall Study|Pregnancy|0|||
13302701|NCT01325350|26514410|FG002|Overall Study|Pregnancy|1|||
13302702|NCT01325350|26514411|FG003|Overall Study|Pregnancy|0|||
13302703|NCT01325350|26514412|FG004|Overall Study|Pregnancy|1|||
13302704|NCT01325350|26514408|FG000|Overall Study|Lost to Follow-up|1|||
13302705|NCT01325350|26514409|FG001|Overall Study|Lost to Follow-up|0|||
13302706|NCT01325350|26514410|FG002|Overall Study|Lost to Follow-up|5|||
13302707|NCT01325350|26514411|FG003|Overall Study|Lost to Follow-up|1|||
13302708|NCT01325350|26514412|FG004|Overall Study|Lost to Follow-up|5|||
13302709|NCT01325350|26514408|FG000|Overall Study|Personal Reasons|2|||
13302710|NCT01325350|26514409|FG001|Overall Study|Personal Reasons|1|||
13302711|NCT01325350|26514410|FG002|Overall Study|Personal Reasons|6|||
13302712|NCT01325350|26514411|FG003|Overall Study|Personal Reasons|5|||
13302713|NCT01325350|26514412|FG004|Overall Study|Personal Reasons|3|||
13302714|NCT01325350|26514408|FG000|Overall Study|Protocol Violation|0|||
13302715|NCT01325350|26514409|FG001|Overall Study|Protocol Violation|0|||
13302716|NCT01325350|26514410|FG002|Overall Study|Protocol Violation|0|||
13302717|NCT01325350|26514411|FG003|Overall Study|Protocol Violation|1|||
13302718|NCT01325350|26514412|FG004|Overall Study|Protocol Violation|0|||
13302719|NCT01325350|26514408|FG000|Overall Study|Withdrawal by Subject|0|||
13302720|NCT01325350|26514409|FG001|Overall Study|Withdrawal by Subject|0|||
13302721|NCT01325350|26514410|FG002|Overall Study|Withdrawal by Subject|1|||
13302722|NCT01325350|26514411|FG003|Overall Study|Withdrawal by Subject|1|||
13302723|NCT01325350|26514412|FG004|Overall Study|Withdrawal by Subject|0|||
13302724|NCT01325350|26514408|FG000|Overall Study|Did Not Receive Treatment|0|||
13302725|NCT01325350|26514409|FG001|Overall Study|Did Not Receive Treatment|1|||
13302726|NCT01325350|26514410|FG002|Overall Study|Did Not Receive Treatment|1|||
13302727|NCT01325350|26514411|FG003|Overall Study|Did Not Receive Treatment|0|||
13302728|NCT01325350|26514412|FG004|Overall Study|Did Not Receive Treatment|1|||
13302729|NCT01325337|26514465|FG000|Overall Study|Adverse Event|0|||
13302730|NCT01325337|26514466|FG001|Overall Study|Adverse Event|2|||
13302731|NCT01325337|26514467|FG002|Overall Study|Adverse Event|2|||
13302732|NCT01325337|26514468|FG003|Overall Study|Adverse Event|1|||
13302733|NCT01325337|26514469|FG004|Overall Study|Adverse Event|2|||
13302734|NCT01325337|26514465|FG000|Overall Study|Lost to Follow-up|2|||
13302735|NCT01325337|26514466|FG001|Overall Study|Lost to Follow-up|2|||
13302736|NCT01325337|26514467|FG002|Overall Study|Lost to Follow-up|2|||
13302737|NCT01325337|26514468|FG003|Overall Study|Lost to Follow-up|1|||
13302738|NCT01325337|26514469|FG004|Overall Study|Lost to Follow-up|2|||
13302739|NCT01325337|26514465|FG000|Overall Study|Personal Reasons|2|||
13302740|NCT01325337|26514466|FG001|Overall Study|Personal Reasons|5|||
13302741|NCT01325337|26514467|FG002|Overall Study|Personal Reasons|4|||
13302742|NCT01325337|26514468|FG003|Overall Study|Personal Reasons|8|||
13302743|NCT01325337|26514469|FG004|Overall Study|Personal Reasons|3|||
13302744|NCT01325337|26514465|FG000|Overall Study|Withdrawal by Subject|1|||
13302745|NCT01325337|26514466|FG001|Overall Study|Withdrawal by Subject|0|||
13302746|NCT01325337|26514467|FG002|Overall Study|Withdrawal by Subject|1|||
13302747|NCT01325337|26514468|FG003|Overall Study|Withdrawal by Subject|0|||
13302748|NCT01325337|26514469|FG004|Overall Study|Withdrawal by Subject|1|||
13302749|NCT01325207|26514511|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
13302750|NCT01325207|26514512|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
13302751|NCT01325207|26514513|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
13302752|NCT01325207|26514514|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
13302753|NCT01325207|26514515|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2|||
13302754|NCT01325207|26514516|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
13382409|NCT00744861|26750799|FG003|Pivotal Stage 2|Lost to Follow-up|14|||
13382410|NCT00744861|26750796|FG000|Pivotal Stage 2|Physician Decision|0|||
13302755|NCT01325207|26514511|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
13302756|NCT01325207|26514512|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
13302757|NCT01325207|26514513|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
13302758|NCT01325207|26514514|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
13302759|NCT01325207|26514515|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2|||
13302760|NCT01325207|26514516|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5|||
13302761|NCT01325207|26514511|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
13302762|NCT01325207|26514512|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
13302763|NCT01325207|26514513|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
13302764|NCT01325207|26514514|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
13302765|NCT01325207|26514515|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0|||
13302766|NCT01325207|26514516|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4|||
13302767|NCT01325207|26514511|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
13302768|NCT01325207|26514512|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1|||
13302769|NCT01325207|26514513|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
13302770|NCT01325207|26514514|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
13302771|NCT01325207|26514515|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
13302772|NCT01325207|26514516|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
13302773|NCT01325207|26514511|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
13302774|NCT01325207|26514512|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
13302775|NCT01325207|26514513|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
13302776|NCT01325207|26514514|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
13302777|NCT01325207|26514515|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
13302778|NCT01325207|26514516|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1|||
13302779|NCT01325207|26514511|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
13302780|NCT01325207|26514512|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
13302781|NCT01325207|26514513|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
13302782|NCT01325207|26514514|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
13302783|NCT01325207|26514515|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
13302784|NCT01325207|26514516|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1|||
13302785|NCT01325207|26514511|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
13302786|NCT01325207|26514512|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
13302787|NCT01325207|26514513|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
13302788|NCT01325207|26514514|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
13302789|NCT01325207|26514515|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1|||
13302790|NCT01325207|26514516|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
13302791|NCT01324999|26514529|FG000|Overall Study|Adverse Event|3|||
13302792|NCT01324999|26514529|FG000|Overall Study|Withdrawal by Subject|2|||
13302793|NCT01324947|26514542|FG000|Overall Study|Adverse Event|7|||
13302794|NCT01324947|26514542|FG000|Overall Study|Death|10|||
13302795|NCT01324947|26514542|FG000|Overall Study|Other|3|||
13302796|NCT01324947|26514542|FG000|Overall Study|Progressive Disease|50|||
13302797|NCT01324947|26514542|FG000|Overall Study|Withdrawal by Subject|3|||
13302798|NCT01324947|26514542|FG000|Overall Study|1 discontinued before starting drug|1|||
13302799|NCT01324830|26514712|FG000|Overall Study|Progressive Disease|3|||
13302800|NCT01324830|26514713|FG001|Overall Study|Progressive Disease|2|||
13302801|NCT01324830|26514714|FG002|Overall Study|Progressive Disease|3|||
13302802|NCT01324830|26514715|FG003|Overall Study|Progressive Disease|3|||
13302803|NCT01324830|26514716|FG004|Overall Study|Progressive Disease|6|||
13302804|NCT01324830|26514717|FG005|Overall Study|Progressive Disease|6|||
13302805|NCT01324830|26514718|FG006|Overall Study|Progressive Disease|3|||
13302806|NCT01324830|26514719|FG007|Overall Study|Progressive Disease|3|||
13302807|NCT01324830|26514720|FG008|Overall Study|Progressive Disease|3|||
13302808|NCT01324830|26514721|FG009|Overall Study|Progressive Disease|6|||
13302809|NCT01324830|26514722|FG010|Overall Study|Progressive Disease|2|||
13302810|NCT01324830|26514723|FG011|Overall Study|Progressive Disease|1|||
13302811|NCT01324830|26514724|FG012|Overall Study|Progressive Disease|1|||
13302812|NCT01324830|26514725|FG013|Overall Study|Progressive Disease|1|||
13302813|NCT01324830|26514726|FG014|Overall Study|Progressive Disease|1|||
13302814|NCT01324830|26514727|FG015|Overall Study|Progressive Disease|3|||
13302815|NCT01324830|26514728|FG016|Overall Study|Progressive Disease|2|||
13302816|NCT01324830|26514729|FG017|Overall Study|Progressive Disease|3|||
13302817|NCT01324830|26514730|FG018|Overall Study|Progressive Disease|4|||
13302818|NCT01324830|26514712|FG000|Overall Study|Dose limiting toxicity|0|||
13302819|NCT01324830|26514713|FG001|Overall Study|Dose limiting toxicity|0|||
13302820|NCT01324830|26514714|FG002|Overall Study|Dose limiting toxicity|0|||
13302821|NCT01324830|26514715|FG003|Overall Study|Dose limiting toxicity|0|||
13302822|NCT01324830|26514716|FG004|Overall Study|Dose limiting toxicity|1|||
13302823|NCT01324830|26514717|FG005|Overall Study|Dose limiting toxicity|0|||
13302824|NCT01324830|26514718|FG006|Overall Study|Dose limiting toxicity|0|||
13302825|NCT01324830|26514719|FG007|Overall Study|Dose limiting toxicity|0|||
13302826|NCT01324830|26514720|FG008|Overall Study|Dose limiting toxicity|0|||
13302827|NCT01324830|26514721|FG009|Overall Study|Dose limiting toxicity|0|||
13302828|NCT01324830|26514722|FG010|Overall Study|Dose limiting toxicity|0|||
13302829|NCT01324830|26514723|FG011|Overall Study|Dose limiting toxicity|0|||
13302830|NCT01324830|26514724|FG012|Overall Study|Dose limiting toxicity|0|||
13302831|NCT01324830|26514725|FG013|Overall Study|Dose limiting toxicity|0|||
13302832|NCT01324830|26514726|FG014|Overall Study|Dose limiting toxicity|0|||
13302833|NCT01324830|26514727|FG015|Overall Study|Dose limiting toxicity|0|||
13302834|NCT01324830|26514728|FG016|Overall Study|Dose limiting toxicity|1|||
13302835|NCT01324830|26514729|FG017|Overall Study|Dose limiting toxicity|1|||
13302836|NCT01324830|26514730|FG018|Overall Study|Dose limiting toxicity|1|||
13302837|NCT01324830|26514712|FG000|Overall Study|Reason not mentioned above|0|||
13302838|NCT01324830|26514713|FG001|Overall Study|Reason not mentioned above|0|||
13302839|NCT01324830|26514714|FG002|Overall Study|Reason not mentioned above|0|||
13302840|NCT01324830|26514715|FG003|Overall Study|Reason not mentioned above|0|||
13302841|NCT01324830|26514716|FG004|Overall Study|Reason not mentioned above|0|||
13302842|NCT01324830|26514717|FG005|Overall Study|Reason not mentioned above|0|||
13302843|NCT01324830|26514718|FG006|Overall Study|Reason not mentioned above|0|||
13302844|NCT01324830|26514719|FG007|Overall Study|Reason not mentioned above|0|||
13302845|NCT01324830|26514720|FG008|Overall Study|Reason not mentioned above|0|||
13302846|NCT01324830|26514721|FG009|Overall Study|Reason not mentioned above|0|||
13302847|NCT01324830|26514722|FG010|Overall Study|Reason not mentioned above|0|||
13302848|NCT01324830|26514723|FG011|Overall Study|Reason not mentioned above|0|||
13302849|NCT01324830|26514724|FG012|Overall Study|Reason not mentioned above|0|||
13302850|NCT01324830|26514725|FG013|Overall Study|Reason not mentioned above|0|||
13302851|NCT01324830|26514726|FG014|Overall Study|Reason not mentioned above|0|||
13302852|NCT01324830|26514727|FG015|Overall Study|Reason not mentioned above|0|||
13302853|NCT01324830|26514728|FG016|Overall Study|Reason not mentioned above|0|||
13302854|NCT01324830|26514729|FG017|Overall Study|Reason not mentioned above|1|||
13302855|NCT01324830|26514730|FG018|Overall Study|Reason not mentioned above|0|||
13302856|NCT01324830|26514712|FG000|Overall Study|Adverse Event, serious fatal|0|||
13302857|NCT01324830|26514713|FG001|Overall Study|Adverse Event, serious fatal|1|||
13302858|NCT01324830|26514714|FG002|Overall Study|Adverse Event, serious fatal|0|||
13302859|NCT01324830|26514715|FG003|Overall Study|Adverse Event, serious fatal|0|||
13302860|NCT01324830|26514716|FG004|Overall Study|Adverse Event, serious fatal|0|||
13302861|NCT01324830|26514717|FG005|Overall Study|Adverse Event, serious fatal|0|||
13302862|NCT01324830|26514718|FG006|Overall Study|Adverse Event, serious fatal|0|||
13302863|NCT01324830|26514719|FG007|Overall Study|Adverse Event, serious fatal|0|||
13302864|NCT01324830|26514720|FG008|Overall Study|Adverse Event, serious fatal|0|||
13302865|NCT01324830|26514721|FG009|Overall Study|Adverse Event, serious fatal|0|||
13302866|NCT01324830|26514722|FG010|Overall Study|Adverse Event, serious fatal|0|||
13302867|NCT01324830|26514723|FG011|Overall Study|Adverse Event, serious fatal|0|||
13302868|NCT01324830|26514724|FG012|Overall Study|Adverse Event, serious fatal|0|||
13302869|NCT01324830|26514725|FG013|Overall Study|Adverse Event, serious fatal|0|||
13302870|NCT01324830|26514726|FG014|Overall Study|Adverse Event, serious fatal|0|||
13302871|NCT01324830|26514727|FG015|Overall Study|Adverse Event, serious fatal|0|||
13302872|NCT01324830|26514728|FG016|Overall Study|Adverse Event, serious fatal|0|||
13302873|NCT01324830|26514729|FG017|Overall Study|Adverse Event, serious fatal|0|||
13302874|NCT01324830|26514730|FG018|Overall Study|Adverse Event, serious fatal|0|||
13302875|NCT01324830|26514712|FG000|Overall Study|Adverse Event, non-fatal|0|||
13302876|NCT01324830|26514713|FG001|Overall Study|Adverse Event, non-fatal|0|||
13302877|NCT01324830|26514714|FG002|Overall Study|Adverse Event, non-fatal|0|||
13302878|NCT01324830|26514715|FG003|Overall Study|Adverse Event, non-fatal|0|||
13302879|NCT01324830|26514716|FG004|Overall Study|Adverse Event, non-fatal|0|||
13302880|NCT01324830|26514717|FG005|Overall Study|Adverse Event, non-fatal|0|||
13302881|NCT01324830|26514718|FG006|Overall Study|Adverse Event, non-fatal|0|||
13302882|NCT01324830|26514719|FG007|Overall Study|Adverse Event, non-fatal|0|||
13302883|NCT01324830|26514720|FG008|Overall Study|Adverse Event, non-fatal|2|||
13302884|NCT01324830|26514721|FG009|Overall Study|Adverse Event, non-fatal|0|||
13302885|NCT01324830|26514722|FG010|Overall Study|Adverse Event, non-fatal|1|||
13302886|NCT01324830|26514723|FG011|Overall Study|Adverse Event, non-fatal|0|||
13302887|NCT01324830|26514724|FG012|Overall Study|Adverse Event, non-fatal|0|||
13302888|NCT01324830|26514725|FG013|Overall Study|Adverse Event, non-fatal|0|||
13302889|NCT01324830|26514726|FG014|Overall Study|Adverse Event, non-fatal|0|||
13302890|NCT01324830|26514727|FG015|Overall Study|Adverse Event, non-fatal|0|||
13302891|NCT01324830|26514728|FG016|Overall Study|Adverse Event, non-fatal|0|||
13302892|NCT01324830|26514729|FG017|Overall Study|Adverse Event, non-fatal|1|||
13302893|NCT01324830|26514730|FG018|Overall Study|Adverse Event, non-fatal|0|||
13302894|NCT01324830|26514712|FG000|Overall Study|Withdrawal by Subject|0|||
13302895|NCT01324830|26514713|FG001|Overall Study|Withdrawal by Subject|0|||
13302896|NCT01324830|26514714|FG002|Overall Study|Withdrawal by Subject|0|||
13382411|NCT00744861|26750797|FG001|Pivotal Stage 2|Physician Decision|0|||
13382412|NCT00744861|26750798|FG002|Pivotal Stage 2|Physician Decision|3|||
13302897|NCT01324830|26514715|FG003|Overall Study|Withdrawal by Subject|0|||
13302898|NCT01324830|26514716|FG004|Overall Study|Withdrawal by Subject|0|||
13302899|NCT01324830|26514717|FG005|Overall Study|Withdrawal by Subject|1|||
13302900|NCT01324830|26514718|FG006|Overall Study|Withdrawal by Subject|0|||
13302901|NCT01324830|26514719|FG007|Overall Study|Withdrawal by Subject|0|||
13302902|NCT01324830|26514720|FG008|Overall Study|Withdrawal by Subject|0|||
13302903|NCT01324830|26514721|FG009|Overall Study|Withdrawal by Subject|0|||
13302904|NCT01324830|26514722|FG010|Overall Study|Withdrawal by Subject|1|||
13302905|NCT01324830|26514723|FG011|Overall Study|Withdrawal by Subject|0|||
13302906|NCT01324830|26514724|FG012|Overall Study|Withdrawal by Subject|0|||
13302907|NCT01324830|26514725|FG013|Overall Study|Withdrawal by Subject|0|||
13302908|NCT01324830|26514726|FG014|Overall Study|Withdrawal by Subject|0|||
13302909|NCT01324830|26514727|FG015|Overall Study|Withdrawal by Subject|0|||
13302910|NCT01324830|26514728|FG016|Overall Study|Withdrawal by Subject|0|||
13302911|NCT01324830|26514729|FG017|Overall Study|Withdrawal by Subject|0|||
13302912|NCT01324830|26514730|FG018|Overall Study|Withdrawal by Subject|1|||
13302913|NCT01324622|26514765|FG000|Overall Study|Lost to Follow-up|7|||
13302914|NCT01324622|26514766|FG001|Overall Study|Lost to Follow-up|7|||
13302915|NCT01324622|26514765|FG000|Overall Study|Death|1|||
13302916|NCT01324622|26514766|FG001|Overall Study|Death|0|||
13302917|NCT01324622|26514765|FG000|Overall Study|Lack of Efficacy|1|||
13302918|NCT01324622|26514766|FG001|Overall Study|Lack of Efficacy|0|||
13302919|NCT01324570|26514785|FG000|Overall Study|Adverse Event|4|||
13302920|NCT01324570|26514786|FG001|Overall Study|Adverse Event|7|||
13302921|NCT01324570|26514785|FG000|Overall Study|Withdrawal by Subject|0|||
13302922|NCT01324570|26514786|FG001|Overall Study|Withdrawal by Subject|3|||
13302923|NCT01324570|26514785|FG000|Overall Study|Lack of Efficacy|0|||
13302924|NCT01324570|26514786|FG001|Overall Study|Lack of Efficacy|1|||
13302925|NCT01324570|26514785|FG000|Overall Study|Confirmed or suspected diversion|0|||
13302926|NCT01324570|26514786|FG001|Overall Study|Confirmed or suspected diversion|1|||
13302927|NCT01324570|26514785|FG000|Overall Study|Administrative|0|||
13302928|NCT01324570|26514786|FG001|Overall Study|Administrative|2|||
13302929|NCT01324440|26514805|FG000|Overall Study|Subject moved|0|||
13302930|NCT01324440|26514806|FG001|Overall Study|Subject moved|1|||
13302931|NCT01324401|26514821|FG000|Overall Study|Withdrawn before any treatment|0|||
13302932|NCT01324401|26514822|FG001|Overall Study|Withdrawn before any treatment|3|||
13302933|NCT01324401|26514821|FG000|Overall Study|Adverse Event|1|||
13302934|NCT01324401|26514822|FG001|Overall Study|Adverse Event|3|||
13302935|NCT01324388|26514852|FG000|Part 1 of Study|Adverse Event|2|||
13302936|NCT01324388|26514853|FG001|Part 1 of Study|Adverse Event|0|||
13302937|NCT01324388|26514854|FG002|Part 1 of Study|Adverse Event|0|||
13302938|NCT01324388|26514855|FG003|Part 1 of Study|Adverse Event|0|||
13302939|NCT01324388|26514852|FG000|Part 1 of Study|Protocol Violation|1|||
13302940|NCT01324388|26514853|FG001|Part 1 of Study|Protocol Violation|2|||
13302941|NCT01324388|26514854|FG002|Part 1 of Study|Protocol Violation|0|||
13302942|NCT01324388|26514855|FG003|Part 1 of Study|Protocol Violation|0|||
13302943|NCT01324388|26514852|FG000|Part 1 of Study|Physician Decision|1|||
13302944|NCT01324388|26514853|FG001|Part 1 of Study|Physician Decision|0|||
13302945|NCT01324388|26514854|FG002|Part 1 of Study|Physician Decision|0|||
13302946|NCT01324388|26514855|FG003|Part 1 of Study|Physician Decision|0|||
13302947|NCT01324388|26514852|FG000|Part 2 of Study: First Intervention|Protocol Violation|0|||
13302948|NCT01324388|26514853|FG001|Part 2 of Study: First Intervention|Protocol Violation|0|||
13302949|NCT01324388|26514854|FG002|Part 2 of Study: First Intervention|Protocol Violation|0|||
13302950|NCT01324388|26514855|FG003|Part 2 of Study: First Intervention|Protocol Violation|1|||
13302951|NCT01324388|26514852|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
13302952|NCT01324388|26514853|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
13302953|NCT01324388|26514854|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1|||
13302954|NCT01324388|26514855|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
13302955|NCT01324349|26514872|FG000|Overall Study|Death|1|||
13302956|NCT01324349|26514873|FG001|Overall Study|Death|1|||
13302957|NCT01324349|26514872|FG000|Overall Study|Withdrawal by Subject|0|||
13302958|NCT01324349|26514873|FG001|Overall Study|Withdrawal by Subject|1|||
13302959|NCT01324323|26514895|FG000|Overall Study|Withdrawal by Subject|1|||
13302960|NCT01324310|26514917|FG000|Overall Study|Adverse Event|1|||
13302961|NCT01324310|26514917|FG000|Overall Study|Disease Progression|1|||
13302962|NCT01324271|26514926|FG000|Overall Study|Lost to Follow-up|3|||
13302963|NCT01324271|26514927|FG001|Overall Study|Lost to Follow-up|0|||
13302964|NCT01324271|26514926|FG000|Overall Study|Physician Decision|1|||
13302965|NCT01324271|26514927|FG001|Overall Study|Physician Decision|0|||
13302966|NCT01324232|26515002|FG000|Overall Study|Protocol Violation|0|||
13302967|NCT01324232|26515003|FG001|Overall Study|Protocol Violation|0|||
13302968|NCT01324232|26515004|FG002|Overall Study|Protocol Violation|0|||
13302969|NCT01324232|26515005|FG003|Overall Study|Protocol Violation|2|||
13302970|NCT01324232|26515002|FG000|Overall Study|Missing|0|||
13302971|NCT01324232|26515003|FG001|Overall Study|Missing|0|||
13302972|NCT01324232|26515004|FG002|Overall Study|Missing|1|||
13302973|NCT01324232|26515005|FG003|Overall Study|Missing|0|||
13302974|NCT01324232|26515002|FG000|Overall Study|Participant's Personal Reason/Decision|0|||
13302975|NCT01324232|26515003|FG001|Overall Study|Participant's Personal Reason/Decision|1|||
13302976|NCT01324232|26515004|FG002|Overall Study|Participant's Personal Reason/Decision|0|||
13302977|NCT01324232|26515005|FG003|Overall Study|Participant's Personal Reason/Decision|0|||
13302978|NCT01324232|26515002|FG000|Overall Study|Lack of Efficacy|2|||
13302979|NCT01324232|26515003|FG001|Overall Study|Lack of Efficacy|1|||
13302980|NCT01324232|26515004|FG002|Overall Study|Lack of Efficacy|2|||
13302981|NCT01324232|26515005|FG003|Overall Study|Lack of Efficacy|2|||
13302982|NCT01324232|26515002|FG000|Overall Study|Participant Refused Medication|0|||
13302983|NCT01324232|26515003|FG001|Overall Study|Participant Refused Medication|1|||
13302984|NCT01324232|26515004|FG002|Overall Study|Participant Refused Medication|0|||
13302985|NCT01324232|26515005|FG003|Overall Study|Participant Refused Medication|0|||
13302986|NCT01324232|26515002|FG000|Overall Study|Intercurrent illness|0|||
13302987|NCT01324232|26515003|FG001|Overall Study|Intercurrent illness|0|||
13302988|NCT01324232|26515004|FG002|Overall Study|Intercurrent illness|0|||
13302989|NCT01324232|26515005|FG003|Overall Study|Intercurrent illness|1|||
13302990|NCT01324232|26515002|FG000|Overall Study|Adverse Event|2|||
13302991|NCT01324232|26515003|FG001|Overall Study|Adverse Event|5|||
13302992|NCT01324232|26515004|FG002|Overall Study|Adverse Event|6|||
13302993|NCT01324232|26515005|FG003|Overall Study|Adverse Event|6|||
13302994|NCT01324232|26515002|FG000|Overall Study|Withdrawal by Subject|0|||
13302995|NCT01324232|26515003|FG001|Overall Study|Withdrawal by Subject|3|||
13302996|NCT01324232|26515004|FG002|Overall Study|Withdrawal by Subject|4|||
13302997|NCT01324232|26515005|FG003|Overall Study|Withdrawal by Subject|0|||
13302998|NCT01324232|26515002|FG000|Overall Study|Lost to Follow-up|1|||
13302999|NCT01324232|26515003|FG001|Overall Study|Lost to Follow-up|0|||
13303000|NCT01324232|26515004|FG002|Overall Study|Lost to Follow-up|0|||
13303001|NCT01324232|26515005|FG003|Overall Study|Lost to Follow-up|0|||
13303002|NCT01324141|26515039|FG000|Overall Study|Declined to participate before treatment started|1|||
13303003|NCT01324141|26515039|FG000|Overall Study|Disease progression on study|1|||
13303004|NCT01324102|26515053|FG000|Overall Study|illness|1|||
13303005|NCT01324102|26515054|FG001|Overall Study|illness|6|||
13303006|NCT01324024|26515070|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
13303007|NCT01324024|26515071|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
13303008|NCT01323972|26515116|FG000|Overall Study|Withdrawal by Subject|1|||
13303009|NCT01323972|26515117|FG001|Overall Study|Withdrawal by Subject|0|||
13303010|NCT01323972|26515118|FG002|Overall Study|Withdrawal by Subject|1|||
13303011|NCT01323972|26515119|FG003|Overall Study|Withdrawal by Subject|0|||
13303012|NCT01323972|26515116|FG000|Overall Study|Migrated/moved from study area|1|||
13303013|NCT01323972|26515117|FG001|Overall Study|Migrated/moved from study area|2|||
13303014|NCT01323972|26515118|FG002|Overall Study|Migrated/moved from study area|0|||
13303015|NCT01323972|26515119|FG003|Overall Study|Migrated/moved from study area|0|||
13303016|NCT01323972|26515116|FG000|Overall Study|Lost to Follow-up|0|||
13303017|NCT01323972|26515117|FG001|Overall Study|Lost to Follow-up|1|||
13303018|NCT01323972|26515118|FG002|Overall Study|Lost to Follow-up|1|||
13303019|NCT01323972|26515119|FG003|Overall Study|Lost to Follow-up|1|||
13303020|NCT01323946|26515250|FG000|Overall Study|Lost to Follow-up|0|||
13303021|NCT01323946|26515251|FG001|Overall Study|Lost to Follow-up|1|||
13303022|NCT01323946|26515252|FG002|Overall Study|Lost to Follow-up|0|||
13303023|NCT01323946|26515250|FG000|Overall Study|Parents refused the last blood draw|1|||
13303024|NCT01323946|26515251|FG001|Overall Study|Parents refused the last blood draw|0|||
13303025|NCT01323946|26515252|FG002|Overall Study|Parents refused the last blood draw|0|||
13303026|NCT01323946|26515250|FG000|Overall Study|Withdrawal by Subject|2|||
13303027|NCT01323946|26515251|FG001|Overall Study|Withdrawal by Subject|2|||
13303028|NCT01323946|26515252|FG002|Overall Study|Withdrawal by Subject|0|||
13303029|NCT01323920|26515261|FG000|Overall Study|Death|5|||
13303030|NCT01323920|26515261|FG000|Overall Study|Withdrawal by Subject|1|||
13303031|NCT01323790|26515309|FG000|Overall Study|Other|3|||
13303032|NCT01323790|26515310|FG001|Overall Study|Other|2|||
13303033|NCT01323790|26515311|FG002|Overall Study|Other|1|||
13303034|NCT01323790|26515309|FG000|Overall Study|Lost to Follow-up|11|||
13303035|NCT01323790|26515310|FG001|Overall Study|Lost to Follow-up|9|||
13303036|NCT01323790|26515311|FG002|Overall Study|Lost to Follow-up|9|||
13303037|NCT01323790|26515309|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
13303038|NCT01323790|26515310|FG001|Overall Study|Study-Specific Withdrawal Criteria|3|||
13303039|NCT01323790|26515311|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
13303040|NCT01323790|26515309|FG000|Overall Study|Lack of Efficacy|3|||
13303041|NCT01323790|26515310|FG001|Overall Study|Lack of Efficacy|0|||
13303042|NCT01323790|26515311|FG002|Overall Study|Lack of Efficacy|3|||
13303043|NCT01323790|26515309|FG000|Overall Study|Adverse Event|11|||
13303044|NCT01323790|26515310|FG001|Overall Study|Adverse Event|24|||
13303045|NCT01323790|26515311|FG002|Overall Study|Adverse Event|12|||
13303046|NCT01323790|26515309|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
13303047|NCT01323790|26515310|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
13303048|NCT01323790|26515311|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
13303049|NCT01323790|26515309|FG000|Overall Study|Withdrawal by Subject|23|||
13303050|NCT01323790|26515310|FG001|Overall Study|Withdrawal by Subject|20|||
13303051|NCT01323790|26515311|FG002|Overall Study|Withdrawal by Subject|13|||
13303052|NCT01323790|26515309|FG000|Overall Study|Did Not Receive Treatment|2|||
13303053|NCT01323790|26515310|FG001|Overall Study|Did Not Receive Treatment|0|||
13303054|NCT01323790|26515311|FG002|Overall Study|Did Not Receive Treatment|1|||
13303055|NCT01323790|26515309|FG000|Overall Study|Severe non-compliance with protocol|2|||
13303056|NCT01323790|26515310|FG001|Overall Study|Severe non-compliance with protocol|2|||
13303057|NCT01323790|26515311|FG002|Overall Study|Severe non-compliance with protocol|2|||
13303058|NCT01323673|26515338|FG000|Overall Study|Adverse Event|0|||
13303059|NCT01323673|26515339|FG001|Overall Study|Adverse Event|1|||
13303060|NCT01323673|26515338|FG000|Overall Study|Lost to Follow-up|0|||
13303061|NCT01323673|26515339|FG001|Overall Study|Lost to Follow-up|1|||
13303062|NCT01323673|26515338|FG000|Overall Study|Protocol Violation|1|||
13303063|NCT01323673|26515339|FG001|Overall Study|Protocol Violation|0|||
13303064|NCT01323673|26515338|FG000|Overall Study|Withdrawal by Subject|2|||
13303065|NCT01323673|26515339|FG001|Overall Study|Withdrawal by Subject|3|||
13303066|NCT01323660|26515390|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6|||
13303067|NCT01323660|26515391|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
13303068|NCT01323660|26515392|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
13303069|NCT01323660|26515393|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
13303070|NCT01323660|26515394|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
13303071|NCT01323660|26515395|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4|||
13303072|NCT01323660|26515390|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
13303073|NCT01323660|26515391|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
13303074|NCT01323660|26515392|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
13303075|NCT01323660|26515393|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
13303076|NCT01323660|26515394|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
13303077|NCT01323660|26515395|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3|||
13303078|NCT01323660|26515390|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
13303079|NCT01323660|26515391|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
13303080|NCT01323660|26515392|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
13303081|NCT01323660|26515393|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
13303082|NCT01323660|26515394|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
13303083|NCT01323660|26515395|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
13303084|NCT01323660|26515390|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
13303085|NCT01323660|26515391|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
13303086|NCT01323660|26515392|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
13303087|NCT01323660|26515393|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
13303088|NCT01323660|26515394|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1|||
13303089|NCT01323660|26515395|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
13303090|NCT01323660|26515390|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
13303091|NCT01323660|26515391|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
13303092|NCT01323660|26515392|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
13303093|NCT01323660|26515393|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
13303094|NCT01323660|26515394|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
13303095|NCT01323660|26515395|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
13303096|NCT01323660|26515390|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5|||
13303097|NCT01323660|26515391|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
13303098|NCT01323660|26515392|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
13303099|NCT01323660|26515393|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
13303100|NCT01323660|26515394|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3|||
13303101|NCT01323660|26515395|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
13303102|NCT01323660|26515390|FG000|Washout Period (14 Days)|Adverse Event|0|||
13303103|NCT01323660|26515391|FG001|Washout Period (14 Days)|Adverse Event|0|||
13303104|NCT01323660|26515392|FG002|Washout Period (14 Days)|Adverse Event|0|||
13303105|NCT01323660|26515393|FG003|Washout Period (14 Days)|Adverse Event|0|||
13303106|NCT01323660|26515394|FG004|Washout Period (14 Days)|Adverse Event|1|||
13303107|NCT01323660|26515395|FG005|Washout Period (14 Days)|Adverse Event|0|||
13303108|NCT01323660|26515390|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
13303109|NCT01323660|26515391|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
13303110|NCT01323660|26515392|FG002|Washout Period (14 Days)|Lack of Efficacy|1|||
13303111|NCT01323660|26515393|FG003|Washout Period (14 Days)|Lack of Efficacy|3|||
13303112|NCT01323660|26515394|FG004|Washout Period (14 Days)|Lack of Efficacy|2|||
13303113|NCT01323660|26515395|FG005|Washout Period (14 Days)|Lack of Efficacy|2|||
13303114|NCT01323660|26515390|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
13303115|NCT01323660|26515391|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
13303116|NCT01323660|26515392|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
13303117|NCT01323660|26515393|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
13303118|NCT01323660|26515394|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
13303119|NCT01323660|26515395|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2|||
13303120|NCT01323660|26515390|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9|||
13303121|NCT01323660|26515391|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
13303122|NCT01323660|26515392|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
13303123|NCT01323660|26515393|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
13303124|NCT01323660|26515394|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
13303125|NCT01323660|26515395|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
13303126|NCT01323660|26515390|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
13303127|NCT01323660|26515391|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
13303128|NCT01323660|26515392|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
13303129|NCT01323660|26515393|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
13303130|NCT01323660|26515394|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
13303131|NCT01323660|26515395|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1|||
13303132|NCT01323660|26515390|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
13303133|NCT01323660|26515391|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
13303134|NCT01323660|26515392|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
13303135|NCT01323660|26515393|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
13303136|NCT01323660|26515394|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
13303137|NCT01323660|26515395|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
13303138|NCT01323660|26515390|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
13303139|NCT01323660|26515391|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
13303140|NCT01323660|26515392|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
13303141|NCT01323660|26515393|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
13303142|NCT01323660|26515394|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
13303143|NCT01323660|26515395|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
13303144|NCT01323647|26515417|FG000|Overall Study|Migrated/moved from study area|2|||
13303145|NCT01323647|26515418|FG001|Overall Study|Migrated/moved from study area|0|||
13303146|NCT01323647|26515417|FG000|Overall Study|Withdrawal by Subject|5|||
13303147|NCT01323647|26515418|FG001|Overall Study|Withdrawal by Subject|0|||
13303148|NCT01323647|26515417|FG000|Overall Study|Lost to Follow-up|2|||
13303149|NCT01323647|26515418|FG001|Overall Study|Lost to Follow-up|0|||
13303150|NCT01323634|26515434|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125|||
13303151|NCT01323634|26515435|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
13303152|NCT01323634|26515436|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
13303153|NCT01323634|26515434|FG000|2-week Run-in Period|Continuation Criteria not Met|73|||
13303154|NCT01323634|26515435|FG001|2-week Run-in Period|Continuation Criteria not Met|0|||
13303155|NCT01323634|26515436|FG002|2-week Run-in Period|Continuation Criteria not Met|0|||
13303156|NCT01323634|26515434|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
13303157|NCT01323634|26515435|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
13303158|NCT01323634|26515436|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
13303159|NCT01323634|26515434|FG000|2-week Run-in Period|Physician Decision|5|||
13303160|NCT01323634|26515435|FG001|2-week Run-in Period|Physician Decision|0|||
13303161|NCT01323634|26515436|FG002|2-week Run-in Period|Physician Decision|0|||
13382413|NCT00744861|26750799|FG003|Pivotal Stage 2|Physician Decision|1|||
13382414|NCT00744861|26750796|FG000|Pivotal Stage 2|Protocol Violation|0|||
13382415|NCT00744861|26750797|FG001|Pivotal Stage 2|Protocol Violation|0|||
13382416|NCT00744861|26750798|FG002|Pivotal Stage 2|Protocol Violation|0|||
13382417|NCT00744861|26750799|FG003|Pivotal Stage 2|Protocol Violation|1|||
13382418|NCT00744861|26750796|FG000|Pivotal Stage 2|Withdrawal by Subject|0|||
13382419|NCT00744861|26750797|FG001|Pivotal Stage 2|Withdrawal by Subject|0|||
13382420|NCT00744861|26750798|FG002|Pivotal Stage 2|Withdrawal by Subject|20|||
13382421|NCT00744861|26750799|FG003|Pivotal Stage 2|Withdrawal by Subject|14|||
13382422|NCT00744861|26750796|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0|||
13382423|NCT00744861|26750797|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0|||
13382424|NCT00744861|26750798|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60|||
13382425|NCT00744861|26750799|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63|||
13382426|NCT00744796|26750807|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12|||
13382427|NCT00744757|26750822|FG000|Overall Study|Objective disease progression|7|||
13382428|NCT00744757|26750822|FG000|Overall Study|Physician Decision|5|||
13382429|NCT00744757|26750822|FG000|Overall Study|Withdrawal by Subject|1|||
13382430|NCT00744757|26750822|FG000|Overall Study|Death|6|||
13382431|NCT00744757|26750822|FG000|Overall Study|Adverse Event|2|||
13382432|NCT00744653|26750830|FG000|Overall Study|antineoplastic treatment|11|||
13382433|NCT00744653|26750830|FG000|Overall Study|Death|1|||
13382434|NCT00744653|26750830|FG000|Overall Study|Lost to Follow-up|1|||
13382435|NCT00744653|26750830|FG000|Overall Study|Physician Decision|3|||
13382436|NCT00744627|26750891|FG000|Overall Study|Adverse Event|6|||
13382437|NCT00744627|26750892|FG001|Overall Study|Adverse Event|9|||
13382438|NCT00744627|26750891|FG000|Overall Study|Lack of Efficacy|7|||
13382439|NCT00744627|26750892|FG001|Overall Study|Lack of Efficacy|3|||
13382440|NCT00744627|26750891|FG000|Overall Study|Noncompliance|0|||
13382441|NCT00744627|26750892|FG001|Overall Study|Noncompliance|1|||
13382442|NCT00744627|26750891|FG000|Overall Study|Protocol Deviations|0|||
13303162|NCT01323634|26515434|FG000|2-week Run-in Period|Protocol Violation|1|||
13303163|NCT01323634|26515435|FG001|2-week Run-in Period|Protocol Violation|0|||
13303164|NCT01323634|26515436|FG002|2-week Run-in Period|Protocol Violation|0|||
13303165|NCT01323634|26515434|FG000|2-week Run-in Period|Adverse Event|1|||
13303166|NCT01323634|26515435|FG001|2-week Run-in Period|Adverse Event|0|||
13303167|NCT01323634|26515436|FG002|2-week Run-in Period|Adverse Event|0|||
13303168|NCT01323634|26515434|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0|||
13303169|NCT01323634|26515435|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8|||
13303170|NCT01323634|26515436|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4|||
13303171|NCT01323634|26515434|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
13303172|NCT01323634|26515435|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
13303173|NCT01323634|26515436|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
13303174|NCT01323634|26515434|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
13303175|NCT01323634|26515435|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6|||
13303176|NCT01323634|26515436|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7|||
13303177|NCT01323634|26515434|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
13303178|NCT01323634|26515435|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
13303179|NCT01323634|26515436|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
13303180|NCT01323634|26515434|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0|||
13303181|NCT01323634|26515435|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2|||
13303182|NCT01323634|26515436|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3|||
13303183|NCT01323634|26515434|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
13303184|NCT01323634|26515435|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7|||
13303185|NCT01323634|26515436|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4|||
13303186|NCT01323634|26515434|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0|||
13303187|NCT01323634|26515435|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
13303188|NCT01323634|26515436|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
13303189|NCT01323621|26515452|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121|||
13303190|NCT01323621|26515453|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
13303191|NCT01323621|26515454|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
13303192|NCT01323621|26515452|FG000|2-week, Single-blind Run In Period|Physician Decision|7|||
13303193|NCT01323621|26515453|FG001|2-week, Single-blind Run In Period|Physician Decision|0|||
13303194|NCT01323621|26515454|FG002|2-week, Single-blind Run In Period|Physician Decision|0|||
13303195|NCT01323621|26515452|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12|||
13303196|NCT01323621|26515453|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
13303197|NCT01323621|26515454|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
13303198|NCT01323621|26515452|FG000|2-week, Single-blind Run In Period|Protocol Violation|1|||
13303199|NCT01323621|26515453|FG001|2-week, Single-blind Run In Period|Protocol Violation|0|||
13303200|NCT01323621|26515454|FG002|2-week, Single-blind Run In Period|Protocol Violation|0|||
13303201|NCT01323621|26515452|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1|||
13303202|NCT01323621|26515453|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
13303203|NCT01323621|26515454|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
13303204|NCT01323621|26515452|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86|||
13303205|NCT01323621|26515453|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
13303206|NCT01323621|26515454|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
13303207|NCT01323621|26515452|FG000|12-week, Double-blind Treatment Period|Adverse Event|0|||
13303208|NCT01323621|26515453|FG001|12-week, Double-blind Treatment Period|Adverse Event|1|||
13303209|NCT01323621|26515454|FG002|12-week, Double-blind Treatment Period|Adverse Event|5|||
13303210|NCT01323621|26515452|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0|||
13303211|NCT01323621|26515453|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2|||
13303212|NCT01323621|26515454|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6|||
13303213|NCT01323621|26515452|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0|||
13303214|NCT01323621|26515453|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4|||
13303215|NCT01323621|26515454|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4|||
13303216|NCT01323621|26515452|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
13303217|NCT01323621|26515453|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1|||
13303218|NCT01323621|26515454|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
13303219|NCT01323621|26515452|FG000|12-week, Double-blind Treatment Period|Physician Decision|0|||
13303220|NCT01323621|26515453|FG001|12-week, Double-blind Treatment Period|Physician Decision|2|||
13303221|NCT01323621|26515454|FG002|12-week, Double-blind Treatment Period|Physician Decision|1|||
13303222|NCT01323621|26515452|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
13303223|NCT01323621|26515453|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5|||
13303224|NCT01323621|26515454|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
13303225|NCT01323582|26515477|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
13303226|NCT01323582|26515478|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
13303227|NCT01323582|26515477|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0|||
13303228|NCT01323582|26515478|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1|||
13303229|NCT01323582|26515477|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0|||
13303230|NCT01323582|26515478|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1|||
13303231|NCT01323530|26515530|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
13303232|NCT01323530|26515531|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
13303233|NCT01323530|26515532|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
13303234|NCT01323530|26515533|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
13303235|NCT01323530|26515534|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
13303236|NCT01323530|26515535|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
13303237|NCT01323530|26515536|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
13303238|NCT01323530|26515530|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
13303239|NCT01323530|26515531|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
13303240|NCT01323530|26515532|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
13303241|NCT01323530|26515533|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
13303242|NCT01323530|26515534|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2|||
13303243|NCT01323530|26515535|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
13303244|NCT01323530|26515536|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
13303245|NCT01323530|26515530|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
13303246|NCT01323530|26515531|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
13303247|NCT01323530|26515532|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
13303248|NCT01323530|26515533|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
13303249|NCT01323530|26515534|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
13303250|NCT01323530|26515535|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
13303251|NCT01323530|26515536|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
13303252|NCT01323530|26515530|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
13303253|NCT01323530|26515531|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
13303254|NCT01323530|26515532|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
13303255|NCT01323530|26515533|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
13303256|NCT01323530|26515534|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
13303257|NCT01323530|26515535|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
13303258|NCT01323530|26515536|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2|||
13303259|NCT01323530|26515530|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
13303260|NCT01323530|26515531|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
13303261|NCT01323530|26515532|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
13303262|NCT01323530|26515533|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
13303263|NCT01323530|26515534|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
13303264|NCT01323530|26515535|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
13303265|NCT01323530|26515536|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3|||
13303266|NCT01323530|26515530|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
13303267|NCT01323530|26515531|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
13303268|NCT01323530|26515532|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
13303269|NCT01323530|26515533|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
13303270|NCT01323530|26515534|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
13303271|NCT01323530|26515535|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
13303272|NCT01323530|26515536|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8|||
13303273|NCT01323530|26515530|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
13303274|NCT01323530|26515531|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
13303275|NCT01323530|26515532|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
13303276|NCT01323530|26515533|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
13303277|NCT01323530|26515534|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
13303278|NCT01323530|26515535|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
13303279|NCT01323530|26515536|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3|||
13303280|NCT01323530|26515530|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
13303281|NCT01323530|26515531|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
13303282|NCT01323530|26515532|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
13303283|NCT01323530|26515533|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
13303284|NCT01323530|26515534|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
13303285|NCT01323530|26515535|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
13303286|NCT01323530|26515536|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1|||
13303287|NCT01323478|26515551|FG000|Overall Study|Adverse Event|7|||
13303288|NCT01323478|26515551|FG000|Overall Study|Lack of Efficacy|4|||
13303289|NCT01323478|26515551|FG000|Overall Study|Non-compliance With Study Product|3|||
13303290|NCT01323478|26515551|FG000|Overall Study|Protocol Violation|1|||
13303291|NCT01323478|26515551|FG000|Overall Study|Withdrawal of Consent|1|||
13303292|NCT01323478|26515551|FG000|Overall Study|Administrative or Other Reasons|8|||
13303293|NCT01323387|26515564|FG000|Overall Study|Withdrawal by Subject|41|||
13303294|NCT01323387|26515564|FG000|Overall Study|Radiographic Data Unavailable|1|||
13303295|NCT01323387|26515564|FG000|Overall Study|Revision|14|||
13303296|NCT01323387|26515564|FG000|Overall Study|Protocol Violation|12|||
13303297|NCT01323387|26515564|FG000|Overall Study|Randomized but Never Treated|16|||
13303298|NCT01323192|26515587|FG000|Overall Study|Adverse Event|6|||
13303299|NCT01323192|26515588|FG001|Overall Study|Adverse Event|1|||
13303300|NCT01323192|26515587|FG000|Overall Study|Withdrawal by Subject|3|||
13303301|NCT01323192|26515588|FG001|Overall Study|Withdrawal by Subject|1|||
13303302|NCT01323192|26515587|FG000|Overall Study|Noncompliance with study medication|0|||
13303303|NCT01323192|26515588|FG001|Overall Study|Noncompliance with study medication|3|||
13303304|NCT01323192|26515587|FG000|Overall Study|Nonmedical reasons|0|||
13303305|NCT01323192|26515588|FG001|Overall Study|Nonmedical reasons|1|||
13303306|NCT01322490|26515609|FG000|Treatment Period|Adverse Event|12|||
13303307|NCT01322490|26515610|FG001|Treatment Period|Adverse Event|18|||
13303308|NCT01322490|26515611|FG002|Treatment Period|Adverse Event|15|||
13303309|NCT01322490|26515609|FG000|Treatment Period|Death|5|||
13303310|NCT01322490|26515610|FG001|Treatment Period|Death|7|||
13303311|NCT01322490|26515611|FG002|Treatment Period|Death|3|||
13303312|NCT01322490|26515609|FG000|Treatment Period|Lack of Efficacy|89|||
13303313|NCT01322490|26515610|FG001|Treatment Period|Lack of Efficacy|100|||
13303314|NCT01322490|26515611|FG002|Treatment Period|Lack of Efficacy|112|||
13303315|NCT01322490|26515609|FG000|Treatment Period|Physician Decision|0|||
13303316|NCT01322490|26515610|FG001|Treatment Period|Physician Decision|2|||
13303317|NCT01322490|26515611|FG002|Treatment Period|Physician Decision|1|||
13303318|NCT01322490|26515609|FG000|Treatment Period|Protocol Violation|7|||
13303319|NCT01322490|26515610|FG001|Treatment Period|Protocol Violation|5|||
13303320|NCT01322490|26515611|FG002|Treatment Period|Protocol Violation|4|||
13303321|NCT01322490|26515609|FG000|Treatment Period|Withdrawal by Subject|14|||
13303322|NCT01322490|26515610|FG001|Treatment Period|Withdrawal by Subject|16|||
13303323|NCT01322490|26515611|FG002|Treatment Period|Withdrawal by Subject|11|||
13303324|NCT01322490|26515609|FG000|Treatment Period|Non-compliance with study drug|0|||
13303325|NCT01322490|26515610|FG001|Treatment Period|Non-compliance with study drug|0|||
13303326|NCT01322490|26515611|FG002|Treatment Period|Non-compliance with study drug|1|||
13303327|NCT01322490|26515609|FG000|Treatment Period|Other per report|2|||
13303328|NCT01322490|26515610|FG001|Treatment Period|Other per report|2|||
13303329|NCT01322490|26515611|FG002|Treatment Period|Other per report|1|||
13303330|NCT01322490|26515609|FG000|Treatment Period|Randomized but Not Treated|3|||
13303331|NCT01322490|26515610|FG001|Treatment Period|Randomized but Not Treated|3|||
13303332|NCT01322490|26515611|FG002|Treatment Period|Randomized but Not Treated|5|||
13303333|NCT01322490|26515609|FG000|Long Term Follow-up Period|Death|235|||
13303334|NCT01322490|26515610|FG001|Long Term Follow-up Period|Death|239|||
13303335|NCT01322490|26515611|FG002|Long Term Follow-up Period|Death|236|||
13303336|NCT01322490|26515609|FG000|Long Term Follow-up Period|Lost to Follow-up|2|||
13303337|NCT01322490|26515610|FG001|Long Term Follow-up Period|Lost to Follow-up|2|||
13303338|NCT01322490|26515611|FG002|Long Term Follow-up Period|Lost to Follow-up|3|||
13303339|NCT01322490|26515609|FG000|Long Term Follow-up Period|Withdrawal by Subject|9|||
13303340|NCT01322490|26515610|FG001|Long Term Follow-up Period|Withdrawal by Subject|6|||
13303341|NCT01322490|26515611|FG002|Long Term Follow-up Period|Withdrawal by Subject|6|||
13303342|NCT01322490|26515609|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160|||
13303343|NCT01322490|26515610|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158|||
13303344|NCT01322490|26515611|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165|||
13303345|NCT01322490|26515609|FG000|Long Term Follow-up Period|Other per report|3|||
13382443|NCT00744627|26750892|FG001|Overall Study|Protocol Deviations|2|||
13303346|NCT01322490|26515610|FG001|Long Term Follow-up Period|Other per report|2|||
13303347|NCT01322490|26515611|FG002|Long Term Follow-up Period|Other per report|2|||
13303348|NCT01322490|26515609|FG000|Long Term Follow-up Period|Unknown/Missing|0|||
13303349|NCT01322490|26515610|FG001|Long Term Follow-up Period|Unknown/Missing|1|||
13303350|NCT01322490|26515611|FG002|Long Term Follow-up Period|Unknown/Missing|1|||
13303351|NCT01322386|26515626|FG000|Overall Study|Protocol Violation|0|||
13303352|NCT01322386|26515627|FG001|Overall Study|Protocol Violation|1|||
13303353|NCT01322386|26515626|FG000|Overall Study|Physician Decision|0|||
13303354|NCT01322386|26515627|FG001|Overall Study|Physician Decision|1|||
13303355|NCT01322347|26515669|FG000|Overall Study|Adverse Event|7|||
13303356|NCT01322347|26515670|FG001|Overall Study|Adverse Event|2|||
13303357|NCT01322347|26515669|FG000|Overall Study|Death|5|||
13303358|NCT01322347|26515670|FG001|Overall Study|Death|3|||
13303359|NCT01322347|26515669|FG000|Overall Study|Physician Decision|2|||
13303360|NCT01322347|26515670|FG001|Overall Study|Physician Decision|1|||
13303361|NCT01322347|26515669|FG000|Overall Study|Protocol Violation|5|||
13303362|NCT01322347|26515670|FG001|Overall Study|Protocol Violation|2|||
13303363|NCT01322347|26515669|FG000|Overall Study|Withdrawal by Subject|1|||
13303364|NCT01322347|26515670|FG001|Overall Study|Withdrawal by Subject|4|||
13303365|NCT01322347|26515669|FG000|Overall Study|non-protocol change to ESA or IV iron|14|||
13303366|NCT01322347|26515670|FG001|Overall Study|non-protocol change to ESA or IV iron|6|||
13303367|NCT01322347|26515669|FG000|Overall Study|blood transfusion|5|||
13303368|NCT01322347|26515670|FG001|Overall Study|blood transfusion|5|||
13303369|NCT01322347|26515669|FG000|Overall Study|sponsor decision|1|||
13303370|NCT01322347|26515670|FG001|Overall Study|sponsor decision|3|||
13303371|NCT01322347|26515669|FG000|Overall Study|ineligible|6|||
13303372|NCT01322347|26515670|FG001|Overall Study|ineligible|3|||
13303373|NCT01322347|26515669|FG000|Overall Study|kidney transplant|3|||
13303374|NCT01322347|26515670|FG001|Overall Study|kidney transplant|1|||
13303375|NCT01322347|26515669|FG000|Overall Study|study drug withheld > 12 wks|0|||
13303376|NCT01322347|26515670|FG001|Overall Study|study drug withheld > 12 wks|1|||
13303377|NCT01322347|26515669|FG000|Overall Study|moved/changed dialysis|2|||
13303378|NCT01322347|26515670|FG001|Overall Study|moved/changed dialysis|4|||
13303379|NCT01322009|26515685|FG000|Overall Study|Death|0|||
13303380|NCT01322009|26515686|FG001|Overall Study|Death|1|||
13303381|NCT01322009|26515685|FG000|Overall Study|Adverse Event|0|||
13303382|NCT01322009|26515686|FG001|Overall Study|Adverse Event|1|||
13303383|NCT01322009|26515685|FG000|Overall Study|ng tube discontinued|0|||
13303384|NCT01322009|26515686|FG001|Overall Study|ng tube discontinued|1|||
13303385|NCT01321879|26515692|FG000|Overall Study|Lack of Efficacy|5|||
13303386|NCT01321879|26515692|FG000|Overall Study|Adverse Event|5|||
13303387|NCT01321879|26515692|FG000|Overall Study|Death|3|||
13303388|NCT01321879|26515692|FG000|Overall Study|Withdrawal by Subject|1|||
13303389|NCT01321749|26515705|FG000|Overall Study|Lost to Follow-up|4|||
13303390|NCT01321749|26515706|FG001|Overall Study|Lost to Follow-up|11|||
13303391|NCT01321749|26515705|FG000|Overall Study|Protocol Violation|4|||
13303392|NCT01321749|26515706|FG001|Overall Study|Protocol Violation|7|||
13303393|NCT01321749|26515705|FG000|Overall Study|Withdrawal by Subject|5|||
13303394|NCT01321749|26515706|FG001|Overall Study|Withdrawal by Subject|4|||
13303395|NCT01321723|26515735|FG000|Overall Study|Adverse Event|3|||
13303396|NCT01321723|26515736|FG001|Overall Study|Adverse Event|5|||
13303397|NCT01321723|26515737|FG002|Overall Study|Adverse Event|2|||
13303398|NCT01321723|26515735|FG000|Overall Study|Withdrawal by Subject|2|||
13303399|NCT01321723|26515736|FG001|Overall Study|Withdrawal by Subject|0|||
13303400|NCT01321723|26515737|FG002|Overall Study|Withdrawal by Subject|2|||
13303401|NCT01321710|26515762|FG000|Overall Study|Lost to Follow-up|4|||
13303402|NCT01321710|26515763|FG001|Overall Study|Lost to Follow-up|5|||
13303403|NCT01321710|26515764|FG002|Overall Study|Lost to Follow-up|0|||
13303404|NCT01321697|26515770|FG000|Overall Study|Study Terminated|7|||
13303405|NCT01321606|26515797|FG000|Overall Study|Lost to Follow-up|0|||
13303406|NCT01321606|26515798|FG001|Overall Study|Lost to Follow-up|0|||
13303407|NCT01321606|26515799|FG002|Overall Study|Lost to Follow-up|0|||
13303408|NCT01321606|26515800|FG003|Overall Study|Lost to Follow-up|1|||
13303409|NCT01321008|26515806|FG000|Overall Study|Early Study Termination|1|||
13303410|NCT01320943|26515832|FG000|Overall Study|Lost to Follow-up|1|||
13303411|NCT01320943|26515833|FG001|Overall Study|Lost to Follow-up|0|||
13303412|NCT01320943|26515832|FG000|Overall Study|Physician Decision|0|||
13303413|NCT01320943|26515833|FG001|Overall Study|Physician Decision|1|||
13303414|NCT01320943|26515832|FG000|Overall Study|Randomized but not Treated|0|||
13303415|NCT01320943|26515833|FG001|Overall Study|Randomized but not Treated|1|||
13303416|NCT01320735|26515852|FG000|Overall Study|Adverse Event|3|||
13303417|NCT01320735|26515852|FG000|Overall Study|Withdrawal by Subject|3|||
13303418|NCT01320735|26515852|FG000|Overall Study|Lost to Follow-up|13|||
13303419|NCT01320735|26515852|FG000|Overall Study|Administrative Reason|6|||
13303420|NCT01320735|26515852|FG000|Overall Study|Progression/Hormone-Refractory Pca|55|||
13303421|NCT01320735|26515852|FG000|Overall Study|Protocol Violation|1|||
13303422|NCT01320735|26515852|FG000|Overall Study|Other|1|||
13303423|NCT01320735|26515852|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7|||
13303424|NCT01320735|26515852|FG000|Overall Study|Investigator Unable to be Contacted|17|||
13303425|NCT01320722|26515905|FG000|Overall Study|Did not Receive Intervention|3|||
13303426|NCT01320722|26515906|FG001|Overall Study|Did not Receive Intervention|2|||
13303427|NCT01320722|26515907|FG002|Overall Study|Did not Receive Intervention|1|||
13303428|NCT01320722|26515908|FG003|Overall Study|Did not Receive Intervention|1|||
13303429|NCT01320722|26515909|FG004|Overall Study|Did not Receive Intervention|2|||
13303430|NCT01320722|26515905|FG000|Overall Study|Lost to Follow-up|0|||
13303431|NCT01320722|26515906|FG001|Overall Study|Lost to Follow-up|1|||
13303432|NCT01320722|26515907|FG002|Overall Study|Lost to Follow-up|0|||
13303433|NCT01320722|26515908|FG003|Overall Study|Lost to Follow-up|1|||
13303434|NCT01320722|26515909|FG004|Overall Study|Lost to Follow-up|3|||
13303435|NCT01320722|26515905|FG000|Overall Study|Not Available for the 8 Week Visit|0|||
13303436|NCT01320722|26515906|FG001|Overall Study|Not Available for the 8 Week Visit|3|||
13303437|NCT01320722|26515907|FG002|Overall Study|Not Available for the 8 Week Visit|0|||
13303438|NCT01320722|26515908|FG003|Overall Study|Not Available for the 8 Week Visit|0|||
13303439|NCT01320722|26515909|FG004|Overall Study|Not Available for the 8 Week Visit|0|||
13303440|NCT01320722|26515905|FG000|Overall Study|Participant Developed a Rash|0|||
13303441|NCT01320722|26515906|FG001|Overall Study|Participant Developed a Rash|0|||
13303442|NCT01320722|26515907|FG002|Overall Study|Participant Developed a Rash|2|||
13303443|NCT01320722|26515908|FG003|Overall Study|Participant Developed a Rash|1|||
13303444|NCT01320722|26515909|FG004|Overall Study|Participant Developed a Rash|1|||
13303445|NCT01320722|26515905|FG000|Overall Study|Non-compliant with Medication|0|||
13303446|NCT01320722|26515906|FG001|Overall Study|Non-compliant with Medication|0|||
13303447|NCT01320722|26515907|FG002|Overall Study|Non-compliant with Medication|1|||
13303448|NCT01320722|26515908|FG003|Overall Study|Non-compliant with Medication|0|||
13303449|NCT01320722|26515909|FG004|Overall Study|Non-compliant with Medication|0|||
13303450|NCT01320722|26515905|FG000|Overall Study|Adverse Event|0|||
13303451|NCT01320722|26515906|FG001|Overall Study|Adverse Event|0|||
13303452|NCT01320722|26515907|FG002|Overall Study|Adverse Event|3|||
13303453|NCT01320722|26515908|FG003|Overall Study|Adverse Event|6|||
13303454|NCT01320722|26515909|FG004|Overall Study|Adverse Event|0|||
13303455|NCT01320722|26515905|FG000|Overall Study|Not Compliant with Study Procedures|0|||
13303456|NCT01320722|26515906|FG001|Overall Study|Not Compliant with Study Procedures|0|||
13303457|NCT01320722|26515907|FG002|Overall Study|Not Compliant with Study Procedures|0|||
13303458|NCT01320722|26515908|FG003|Overall Study|Not Compliant with Study Procedures|4|||
13303459|NCT01320722|26515909|FG004|Overall Study|Not Compliant with Study Procedures|0|||
13303460|NCT01320722|26515905|FG000|Overall Study|Pregnancy|0|||
13303461|NCT01320722|26515906|FG001|Overall Study|Pregnancy|0|||
13303462|NCT01320722|26515907|FG002|Overall Study|Pregnancy|0|||
13303463|NCT01320722|26515908|FG003|Overall Study|Pregnancy|1|||
13303464|NCT01320722|26515909|FG004|Overall Study|Pregnancy|0|||
13303465|NCT01320722|26515905|FG000|Overall Study|Started an Exclusionary Medication|0|||
13303466|NCT01320722|26515906|FG001|Overall Study|Started an Exclusionary Medication|0|||
13303467|NCT01320722|26515907|FG002|Overall Study|Started an Exclusionary Medication|0|||
13303468|NCT01320722|26515908|FG003|Overall Study|Started an Exclusionary Medication|0|||
13303469|NCT01320722|26515909|FG004|Overall Study|Started an Exclusionary Medication|1|||
13303470|NCT01320722|26515905|FG000|Overall Study|Withdrew due to Health Condition|0|||
13303471|NCT01320722|26515906|FG001|Overall Study|Withdrew due to Health Condition|0|||
13303472|NCT01320722|26515907|FG002|Overall Study|Withdrew due to Health Condition|0|||
13303473|NCT01320722|26515908|FG003|Overall Study|Withdrew due to Health Condition|0|||
13303474|NCT01320722|26515909|FG004|Overall Study|Withdrew due to Health Condition|1|||
13303475|NCT01320683|26515916|FG000|Overall Study|Positive antibody response|1|||
13303476|NCT01320293|26515924|FG000|Overall Study|Lack of Efficacy|1|||
13303477|NCT01320293|26515924|FG000|Overall Study|Adverse Event|1|||
13303478|NCT01320202|26515966|FG000|Overall Study|Adverse Event|5|||
13303479|NCT01320202|26515967|FG001|Overall Study|Adverse Event|5|||
13303480|NCT01320202|26515966|FG000|Overall Study|Death|5|||
13303481|NCT01320202|26515967|FG001|Overall Study|Death|3|||
13303482|NCT01320202|26515966|FG000|Overall Study|Lost to Follow-up|1|||
13303483|NCT01320202|26515967|FG001|Overall Study|Lost to Follow-up|0|||
13303484|NCT01320202|26515966|FG000|Overall Study|Physician Decision|3|||
13303485|NCT01320202|26515967|FG001|Overall Study|Physician Decision|1|||
13303486|NCT01320202|26515966|FG000|Overall Study|Protocol Violation|2|||
13303487|NCT01320202|26515967|FG001|Overall Study|Protocol Violation|1|||
13303488|NCT01320202|26515966|FG000|Overall Study|Withdrawal by Subject|10|||
13303489|NCT01320202|26515967|FG001|Overall Study|Withdrawal by Subject|3|||
13303490|NCT01320202|26515966|FG000|Overall Study|non-protocol change to ESA or IV iron|17|||
13303491|NCT01320202|26515967|FG001|Overall Study|non-protocol change to ESA or IV iron|20|||
13303492|NCT01320202|26515966|FG000|Overall Study|kidney transplant|1|||
13303493|NCT01320202|26515967|FG001|Overall Study|kidney transplant|2|||
13303494|NCT01320202|26515966|FG000|Overall Study|blood transfusion|1|||
13303495|NCT01320202|26515967|FG001|Overall Study|blood transfusion|7|||
13303496|NCT01320202|26515966|FG000|Overall Study|moved/changed dialysis|5|||
13303497|NCT01320202|26515967|FG001|Overall Study|moved/changed dialysis|2|||
13303498|NCT01320202|26515966|FG000|Overall Study|sponsor request|2|||
13303499|NCT01320202|26515967|FG001|Overall Study|sponsor request|0|||
13303500|NCT01320202|26515966|FG000|Overall Study|ineligible|3|||
13303501|NCT01320202|26515967|FG001|Overall Study|ineligible|0|||
13303502|NCT01320202|26515966|FG000|Overall Study|regained renal function|1|||
13303503|NCT01320202|26515967|FG001|Overall Study|regained renal function|0|||
13303504|NCT01320150|26515977|FG000|Overall Study|Protocol Violation|15|||
13303505|NCT01320150|26515977|FG000|Overall Study|Withdrawal by Subject|5|||
13303506|NCT01320150|26515977|FG000|Overall Study|Death|2|||
13303507|NCT01320150|26515977|FG000|Overall Study|Lost to Follow-up|44|||
13303508|NCT01320033|26516013|FG000|Overall Study|Lack of Efficacy|0|||
13303509|NCT01320033|26516014|FG001|Overall Study|Lack of Efficacy|0|||
13303510|NCT01320033|26516015|FG002|Overall Study|Lack of Efficacy|1|||
13303511|NCT01320033|26516013|FG000|Overall Study|Adverse Event|9|||
13303512|NCT01320033|26516014|FG001|Overall Study|Adverse Event|7|||
13303513|NCT01320033|26516015|FG002|Overall Study|Adverse Event|8|||
13303514|NCT01320033|26516013|FG000|Overall Study|Withdrawal by Subject|22|||
13303515|NCT01320033|26516014|FG001|Overall Study|Withdrawal by Subject|23|||
13303516|NCT01320033|26516015|FG002|Overall Study|Withdrawal by Subject|23|||
13303517|NCT01320033|26516013|FG000|Overall Study|Protocol Violation|3|||
13303518|NCT01320033|26516014|FG001|Overall Study|Protocol Violation|5|||
13303519|NCT01320033|26516015|FG002|Overall Study|Protocol Violation|3|||
13303520|NCT01320033|26516013|FG000|Overall Study|Lost to Follow-up|22|||
13303521|NCT01320033|26516014|FG001|Overall Study|Lost to Follow-up|26|||
13303522|NCT01320033|26516015|FG002|Overall Study|Lost to Follow-up|17|||
13303523|NCT01320033|26516013|FG000|Overall Study|Other|2|||
13303524|NCT01320033|26516014|FG001|Overall Study|Other|3|||
13303525|NCT01320033|26516015|FG002|Overall Study|Other|1|||
13303526|NCT01319383|26516035|FG000|Overall Study|No ex vivo or in vivo response|4|||
13303527|NCT01319383|26516036|FG001|Overall Study|No ex vivo or in vivo response|0|||
13303528|NCT01319383|26516035|FG000|Overall Study|Physician Decision|3|||
13303529|NCT01319383|26516036|FG001|Overall Study|Physician Decision|0|||
13303530|NCT01319383|26516035|FG000|Overall Study|Lack of Efficacy|5|||
13303531|NCT01319383|26516036|FG001|Overall Study|Lack of Efficacy|9|||
13303532|NCT01319383|26516035|FG000|Overall Study|No in vivo response to interval doses|0|||
13303533|NCT01319383|26516036|FG001|Overall Study|No in vivo response to interval doses|1|||
13303534|NCT01318902|26516126|FG000|Overall Study|Symptomatic Deterioration|0|||
13303535|NCT01318902|26516127|FG001|Overall Study|Symptomatic Deterioration|1|||
13303536|NCT01318902|26516128|FG002|Overall Study|Symptomatic Deterioration|1|||
13303537|NCT01318902|26516129|FG003|Overall Study|Symptomatic Deterioration|2|||
13303538|NCT01318902|26516126|FG000|Overall Study|Withdrawal by Patient|0|||
13303539|NCT01318902|26516127|FG001|Overall Study|Withdrawal by Patient|1|||
13303540|NCT01318902|26516128|FG002|Overall Study|Withdrawal by Patient|0|||
13303541|NCT01318902|26516129|FG003|Overall Study|Withdrawal by Patient|3|||
13303542|NCT01318902|26516126|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
13303543|NCT01318902|26516127|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
13303544|NCT01318902|26516128|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
13303545|NCT01318902|26516129|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
13303546|NCT01318902|26516126|FG000|Overall Study|Adverse Event|0|||
13303547|NCT01318902|26516127|FG001|Overall Study|Adverse Event|1|||
13303548|NCT01318902|26516128|FG002|Overall Study|Adverse Event|0|||
13303549|NCT01318902|26516129|FG003|Overall Study|Adverse Event|0|||
13303550|NCT01318902|26516126|FG000|Overall Study|Terminated by Sponsor|0|||
13303551|NCT01318902|26516127|FG001|Overall Study|Terminated by Sponsor|0|||
13303552|NCT01318902|26516128|FG002|Overall Study|Terminated by Sponsor|1|||
13303553|NCT01318902|26516129|FG003|Overall Study|Terminated by Sponsor|0|||
13303554|NCT01318811|26516144|FG000|Overall Study|Physician Decision|1|||
13303555|NCT01318811|26516145|FG001|Overall Study|Physician Decision|1|||
13303556|NCT01318811|26516144|FG000|Overall Study|CRRT stopped for head CT|0|||
13303557|NCT01318811|26516145|FG001|Overall Study|CRRT stopped for head CT|1|||
13303558|NCT01318811|26516144|FG000|Overall Study|Death|0|||
13303559|NCT01318811|26516145|FG001|Overall Study|Death|1|||
13303560|NCT01318811|26516144|FG000|Overall Study|CRRT stopped for head MRI|0|||
13303561|NCT01318811|26516145|FG001|Overall Study|CRRT stopped for head MRI|1|||
13303562|NCT01317615|26516156|FG000|Overall Study|Disease progression|25|||
13303563|NCT01317615|26516156|FG000|Overall Study|New cancer therapy|5|||
13303564|NCT01317615|26516156|FG000|Overall Study|Death|6|||
13303565|NCT01317615|26516156|FG000|Overall Study|Withdrawal by Subject|5|||
13303566|NCT01317615|26516156|FG000|Overall Study|Abnormal laboratory value(s)|1|||
13303567|NCT01317615|26516156|FG000|Overall Study|Adverse Event|7|||
13303568|NCT01316614|26516173|FG000|Overall Study|No solid lesion and FNA not indicated|25|||
13303569|NCT01316614|26516173|FG000|Overall Study|Cytology slides not available for review|4|||
13303570|NCT01316614|26516173|FG000|Overall Study|Cystic lesion|5|||
13303571|NCT01316614|26516173|FG000|Overall Study|Inadequate number of passes|2|||
13303572|NCT01316614|26516173|FG000|Overall Study|Medically unstable|1|||
13303573|NCT01316575|26516192|FG000|Overall Study|Withdrawal by Subject|2|||
13303574|NCT01316575|26516193|FG001|Overall Study|Withdrawal by Subject|0|||
13303575|NCT01316575|26516192|FG000|Overall Study|Required alternate treatment|0|||
13303576|NCT01316575|26516193|FG001|Overall Study|Required alternate treatment|1|||
13303577|NCT01315847|26516212|FG000|Part I, Period 1|Reached maximum number of arterial lines|3|||
13303578|NCT01315847|26516213|FG001|Part I, Period 1|Reached maximum number of arterial lines|0|||
13303579|NCT01315847|26516212|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0|||
13303580|NCT01315847|26516213|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1|||
13303581|NCT01315678|26516238|FG000|Overall Study|Withdrawal by Subject|7|||
13303582|NCT01315678|26516239|FG001|Overall Study|Withdrawal by Subject|3|||
13303583|NCT01315678|26516238|FG000|Overall Study|Adverse Event|3|||
13303584|NCT01315678|26516239|FG001|Overall Study|Adverse Event|1|||
13303585|NCT01315678|26516238|FG000|Overall Study|Lost to Follow-up|1|||
13303586|NCT01315678|26516239|FG001|Overall Study|Lost to Follow-up|0|||
13303587|NCT01315678|26516238|FG000|Overall Study|similar reason to those listed above|3|||
13382444|NCT00744627|26750891|FG000|Overall Study|Voluntary Withdrawal|9|||
13303588|NCT01315678|26516239|FG001|Overall Study|similar reason to those listed above|2|||
13303589|NCT01315249|26516272|FG000|Overall Study|Adverse Event|22|||
13303590|NCT01315249|26516273|FG001|Overall Study|Adverse Event|26|||
13303591|NCT01315249|26516272|FG000|Overall Study|Withdrawal by Subject|11|||
13303592|NCT01315249|26516273|FG001|Overall Study|Withdrawal by Subject|10|||
13303593|NCT01315249|26516272|FG000|Overall Study|Protocol Violation|8|||
13303594|NCT01315249|26516273|FG001|Overall Study|Protocol Violation|5|||
13303595|NCT01315249|26516272|FG000|Overall Study|Abnormal test results|1|||
13303596|NCT01315249|26516273|FG001|Overall Study|Abnormal test results|2|||
13303597|NCT01315249|26516272|FG000|Overall Study|Administrative problems|1|||
13303598|NCT01315249|26516273|FG001|Overall Study|Administrative problems|0|||
13303599|NCT01315249|26516272|FG000|Overall Study|inability to use device|1|||
13303600|NCT01315249|26516273|FG001|Overall Study|inability to use device|0|||
13303601|NCT01315249|26516272|FG000|Overall Study|Lack of Efficacy|0|||
13303602|NCT01315249|26516273|FG001|Overall Study|Lack of Efficacy|1|||
13303603|NCT01315249|26516272|FG000|Overall Study|Lost to Follow-up|0|||
13303604|NCT01315249|26516273|FG001|Overall Study|Lost to Follow-up|2|||
13303605|NCT01315249|26516272|FG000|Overall Study|Death|0|||
13303606|NCT01315249|26516273|FG001|Overall Study|Death|1|||
13303607|NCT01315132|26516280|FG000|Overall Study|not treated due to disease progression|1|||
13303608|NCT01314911|26516327|FG000|Overall Study|Lost to Follow-up|3|||
13303609|NCT01314911|26516328|FG001|Overall Study|Lost to Follow-up|2|||
13303610|NCT01314911|26516327|FG000|Overall Study|Withdrawal by Subject|1|||
13303611|NCT01314911|26516328|FG001|Overall Study|Withdrawal by Subject|3|||
13303612|NCT01314911|26516327|FG000|Overall Study|Received Non-randomized Study Drug|0|||
13303613|NCT01314911|26516328|FG001|Overall Study|Received Non-randomized Study Drug|1|||
13303614|NCT01314911|26516327|FG000|Overall Study|Never Started Treatment|1|||
13303615|NCT01314911|26516328|FG001|Overall Study|Never Started Treatment|0|||
13303616|NCT01314261|26516392|FG000|Overall Study|Adverse Event|1|||
13303617|NCT01314261|26516393|FG001|Overall Study|Adverse Event|0|||
13303618|NCT01314261|26516394|FG002|Overall Study|Adverse Event|0|||
13303619|NCT01314261|26516395|FG003|Overall Study|Adverse Event|0|||
13303620|NCT01314261|26516392|FG000|Overall Study|Withdrawal by Subject|0|||
13303621|NCT01314261|26516393|FG001|Overall Study|Withdrawal by Subject|3|||
13303622|NCT01314261|26516394|FG002|Overall Study|Withdrawal by Subject|1|||
13303623|NCT01314261|26516395|FG003|Overall Study|Withdrawal by Subject|0|||
13303624|NCT01314261|26516392|FG000|Overall Study|Lost to Follow-up|1|||
13303625|NCT01314261|26516393|FG001|Overall Study|Lost to Follow-up|0|||
13303626|NCT01314261|26516394|FG002|Overall Study|Lost to Follow-up|2|||
13303627|NCT01314261|26516395|FG003|Overall Study|Lost to Follow-up|2|||
13303628|NCT01314261|26516392|FG000|Overall Study|Virologic Failure|0|||
13303629|NCT01314261|26516393|FG001|Overall Study|Virologic Failure|1|||
13303630|NCT01314261|26516394|FG002|Overall Study|Virologic Failure|0|||
13303631|NCT01314261|26516395|FG003|Overall Study|Virologic Failure|1|||
13303632|NCT01313858|26516426|FG000|Overall Study|Premature Treatment Termination|251|||
13303633|NCT01313858|26516427|FG001|Overall Study|Premature Treatment Termination|219|||
13303634|NCT01313858|26516428|FG002|Overall Study|Premature Treatment Termination|191|||
13303635|NCT01313858|26516426|FG000|Overall Study|Lost to Follow-up|35|||
13303636|NCT01313858|26516427|FG001|Overall Study|Lost to Follow-up|51|||
13303637|NCT01313858|26516428|FG002|Overall Study|Lost to Follow-up|47|||
13303638|NCT01313780|26516443|FG000|Overall Study|Lack of Efficacy|4|||
13303639|NCT01313780|26516444|FG001|Overall Study|Lack of Efficacy|2|||
13303640|NCT01313780|26516443|FG000|Overall Study|Adverse Event|6|||
13303641|NCT01313780|26516444|FG001|Overall Study|Adverse Event|11|||
13303642|NCT01313780|26516443|FG000|Overall Study|Withdrawal by Subject|2|||
13303643|NCT01313780|26516444|FG001|Overall Study|Withdrawal by Subject|8|||
13303644|NCT01313780|26516443|FG000|Overall Study|Protocol Violation|10|||
13303645|NCT01313780|26516444|FG001|Overall Study|Protocol Violation|4|||
13303646|NCT01313780|26516443|FG000|Overall Study|missing data|3|||
13303647|NCT01313780|26516444|FG001|Overall Study|missing data|3|||
13303648|NCT01313767|26516493|FG000|Overall Study|Adverse Event|1|||
13303649|NCT01313767|26516494|FG001|Overall Study|Adverse Event|0|||
13303650|NCT01313767|26516493|FG000|Overall Study|Lost to Follow-up|1|||
13303651|NCT01313767|26516494|FG001|Overall Study|Lost to Follow-up|0|||
13303652|NCT01313767|26516493|FG000|Overall Study|Withdrawal by Subject|2|||
13303653|NCT01313767|26516494|FG001|Overall Study|Withdrawal by Subject|1|||
13303654|NCT01313767|26516493|FG000|Overall Study|Protocol Violation|3|||
13303655|NCT01313767|26516494|FG001|Overall Study|Protocol Violation|1|||
13303656|NCT01313728|26516511|FG000|Informed Consent to Baseline|Withdrawal by Subject|1|||
13303657|NCT01313676|26516542|FG000|Overall Study|Adverse Event|395|||
13303658|NCT01313676|26516543|FG001|Overall Study|Adverse Event|365|||
13303659|NCT01313676|26516544|FG002|Overall Study|Adverse Event|372|||
13303660|NCT01313676|26516545|FG003|Overall Study|Adverse Event|333|||
13303661|NCT01313676|26516542|FG000|Overall Study|Lack of Efficacy|98|||
13303662|NCT01313676|26516543|FG001|Overall Study|Lack of Efficacy|90|||
13303663|NCT01313676|26516544|FG002|Overall Study|Lack of Efficacy|65|||
13303664|NCT01313676|26516545|FG003|Overall Study|Lack of Efficacy|46|||
13303665|NCT01313676|26516542|FG000|Overall Study|Protocol Violation|37|||
13303666|NCT01313676|26516543|FG001|Overall Study|Protocol Violation|44|||
13303667|NCT01313676|26516544|FG002|Overall Study|Protocol Violation|46|||
13303668|NCT01313676|26516545|FG003|Overall Study|Protocol Violation|44|||
13303669|NCT01313676|26516542|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3|||
13303670|NCT01313676|26516543|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4|||
13303671|NCT01313676|26516544|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2|||
13303672|NCT01313676|26516545|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11|||
13303673|NCT01313676|26516542|FG000|Overall Study|Study Closed/terminated|7|||
13303674|NCT01313676|26516543|FG001|Overall Study|Study Closed/terminated|6|||
13303675|NCT01313676|26516544|FG002|Overall Study|Study Closed/terminated|9|||
13303676|NCT01313676|26516545|FG003|Overall Study|Study Closed/terminated|9|||
13303677|NCT01313676|26516542|FG000|Overall Study|Lost to Follow-up|0|||
13303678|NCT01313676|26516543|FG001|Overall Study|Lost to Follow-up|0|||
13303679|NCT01313676|26516544|FG002|Overall Study|Lost to Follow-up|1|||
13303680|NCT01313676|26516545|FG003|Overall Study|Lost to Follow-up|0|||
13303681|NCT01313676|26516542|FG000|Overall Study|Physician Decision|53|||
13303682|NCT01313676|26516543|FG001|Overall Study|Physician Decision|64|||
13303683|NCT01313676|26516544|FG002|Overall Study|Physician Decision|62|||
13303684|NCT01313676|26516545|FG003|Overall Study|Physician Decision|48|||
13303685|NCT01313676|26516542|FG000|Overall Study|Decision by Participant or Proxy|643|||
13303686|NCT01313676|26516543|FG001|Overall Study|Decision by Participant or Proxy|527|||
13303687|NCT01313676|26516544|FG002|Overall Study|Decision by Participant or Proxy|515|||
13303688|NCT01313676|26516545|FG003|Overall Study|Decision by Participant or Proxy|492|||
13303689|NCT01313676|26516542|FG000|Overall Study|Sponsor Terminated Study Treatment|1|||
13303690|NCT01313676|26516543|FG001|Overall Study|Sponsor Terminated Study Treatment|1|||
13303691|NCT01313676|26516544|FG002|Overall Study|Sponsor Terminated Study Treatment|0|||
13303692|NCT01313676|26516545|FG003|Overall Study|Sponsor Terminated Study Treatment|1|||
13303693|NCT01313676|26516542|FG000|Overall Study|Investigator Site Closed|12|||
13303694|NCT01313676|26516543|FG001|Overall Study|Investigator Site Closed|11|||
13303695|NCT01313676|26516544|FG002|Overall Study|Investigator Site Closed|15|||
13303696|NCT01313676|26516545|FG003|Overall Study|Investigator Site Closed|10|||
13303697|NCT01313676|26516542|FG000|Overall Study|Missing|1|||
13303698|NCT01313676|26516543|FG001|Overall Study|Missing|1|||
13303699|NCT01313676|26516544|FG002|Overall Study|Missing|1|||
13303700|NCT01313676|26516545|FG003|Overall Study|Missing|0|||
13303701|NCT01313663|26516586|FG000|Overall Study|Study Closed/Terminated|2|||
13303702|NCT01313663|26516587|FG001|Overall Study|Study Closed/Terminated|4|||
13303703|NCT01313663|26516586|FG000|Overall Study|Lost to Follow-up|0|||
13303704|NCT01313663|26516587|FG001|Overall Study|Lost to Follow-up|1|||
13303705|NCT01313663|26516586|FG000|Overall Study|Physician Decision|0|||
13303706|NCT01313663|26516587|FG001|Overall Study|Physician Decision|2|||
13303707|NCT01313663|26516586|FG000|Overall Study|Withdrawal by Subject|2|||
13303708|NCT01313663|26516587|FG001|Overall Study|Withdrawal by Subject|1|||
13303709|NCT01313650|26516622|FG000|Overall Study|Adverse Event|9|||
13303710|NCT01313650|26516623|FG001|Overall Study|Adverse Event|34|||
13303711|NCT01313650|26516624|FG002|Overall Study|Adverse Event|24|||
13303712|NCT01313650|26516625|FG003|Overall Study|Adverse Event|23|||
13303713|NCT01313650|26516622|FG000|Overall Study|Lack of Efficacy|37|||
13303714|NCT01313650|26516623|FG001|Overall Study|Lack of Efficacy|20|||
13303715|NCT01313650|26516624|FG002|Overall Study|Lack of Efficacy|32|||
13303716|NCT01313650|26516625|FG003|Overall Study|Lack of Efficacy|20|||
13303717|NCT01313650|26516622|FG000|Overall Study|Lost to Follow-up|1|||
13303718|NCT01313650|26516623|FG001|Overall Study|Lost to Follow-up|0|||
13303719|NCT01313650|26516624|FG002|Overall Study|Lost to Follow-up|3|||
13303720|NCT01313650|26516625|FG003|Overall Study|Lost to Follow-up|2|||
13303721|NCT01313650|26516622|FG000|Overall Study|Withdrawal by Subject|16|||
13303722|NCT01313650|26516623|FG001|Overall Study|Withdrawal by Subject|20|||
13303723|NCT01313650|26516624|FG002|Overall Study|Withdrawal by Subject|15|||
13303724|NCT01313650|26516625|FG003|Overall Study|Withdrawal by Subject|15|||
13303725|NCT01313650|26516622|FG000|Overall Study|Protocol Violation|4|||
13303726|NCT01313650|26516623|FG001|Overall Study|Protocol Violation|7|||
13303727|NCT01313650|26516624|FG002|Overall Study|Protocol Violation|5|||
13303728|NCT01313650|26516625|FG003|Overall Study|Protocol Violation|6|||
13303729|NCT01313650|26516622|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9|||
13303730|NCT01313650|26516623|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13|||
13303731|NCT01313650|26516624|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24|||
13303732|NCT01313650|26516625|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15|||
13303733|NCT01313637|26516660|FG000|Overall Study|Adverse Event|17|||
13303734|NCT01313637|26516661|FG001|Overall Study|Adverse Event|24|||
13303735|NCT01313637|26516662|FG002|Overall Study|Adverse Event|25|||
13303736|NCT01313637|26516663|FG003|Overall Study|Adverse Event|18|||
13303737|NCT01313637|26516660|FG000|Overall Study|Lack of Efficacy|44|||
13303738|NCT01313637|26516661|FG001|Overall Study|Lack of Efficacy|38|||
13303739|NCT01313637|26516662|FG002|Overall Study|Lack of Efficacy|37|||
13303740|NCT01313637|26516663|FG003|Overall Study|Lack of Efficacy|24|||
13303741|NCT01313637|26516660|FG000|Overall Study|Protocol Violation|4|||
13303742|NCT01313637|26516661|FG001|Overall Study|Protocol Violation|3|||
13303743|NCT01313637|26516662|FG002|Overall Study|Protocol Violation|11|||
13303744|NCT01313637|26516663|FG003|Overall Study|Protocol Violation|5|||
13303745|NCT01313637|26516660|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16|||
13303746|NCT01313637|26516661|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15|||
13303747|NCT01313637|26516662|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14|||
13303748|NCT01313637|26516663|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13|||
13303749|NCT01313637|26516660|FG000|Overall Study|Lost to Follow-up|0|||
13303750|NCT01313637|26516661|FG001|Overall Study|Lost to Follow-up|2|||
13303751|NCT01313637|26516662|FG002|Overall Study|Lost to Follow-up|1|||
13303752|NCT01313637|26516663|FG003|Overall Study|Lost to Follow-up|3|||
13303753|NCT01313637|26516660|FG000|Overall Study|Withdrawal by Subject|11|||
13303754|NCT01313637|26516661|FG001|Overall Study|Withdrawal by Subject|13|||
13303755|NCT01313637|26516662|FG002|Overall Study|Withdrawal by Subject|18|||
13303756|NCT01313637|26516663|FG003|Overall Study|Withdrawal by Subject|15|||
13303757|NCT01313624|26516682|FG000|Double-Blind Phase|Adverse Event|27|||
13303758|NCT01313624|26516683|FG001|Double-Blind Phase|Adverse Event|4|||
13303759|NCT01313624|26516682|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
13303760|NCT01313624|26516683|FG001|Double-Blind Phase|Withdrawal by Subject|4|||
13303761|NCT01313624|26516682|FG000|Double-Blind Phase|Lost to Follow-up|0|||
13303762|NCT01313624|26516683|FG001|Double-Blind Phase|Lost to Follow-up|2|||
13303763|NCT01313624|26516682|FG000|Double-Blind Phase|Physician Decision|1|||
13303764|NCT01313624|26516683|FG001|Double-Blind Phase|Physician Decision|0|||
13303765|NCT01313624|26516682|FG000|Double-Blind Phase|Lack of Efficacy|1|||
13303766|NCT01313624|26516683|FG001|Double-Blind Phase|Lack of Efficacy|0|||
13303767|NCT01313624|26516682|FG000|Open-Label Phase|Adverse Event|1|||
13303768|NCT01313624|26516683|FG001|Open-Label Phase|Adverse Event|10|||
13303769|NCT01313624|26516682|FG000|Open-Label Phase|Withdrawal by Subject|2|||
13303770|NCT01313624|26516683|FG001|Open-Label Phase|Withdrawal by Subject|2|||
13303771|NCT01313624|26516682|FG000|Open-Label Phase|Lost to Follow-up|1|||
13303772|NCT01313624|26516683|FG001|Open-Label Phase|Lost to Follow-up|1|||
13303773|NCT01313559|26516702|FG000|Overall Study|Withdrawal by Subject|1|||
13303774|NCT01313559|26516703|FG001|Overall Study|Withdrawal by Subject|2|||
13303775|NCT01313559|26516702|FG000|Overall Study|Disease progression|1|||
13303776|NCT01313559|26516703|FG001|Overall Study|Disease progression|0|||
13303777|NCT01313559|26516702|FG000|Overall Study|Rising PSA|2|||
13303778|NCT01313559|26516703|FG001|Overall Study|Rising PSA|0|||
13303779|NCT01313312|26516749|FG000|Overall Study|Adverse Event|5|||
13303780|NCT01313312|26516749|FG000|Overall Study|Withdrawal by Subject|18|||
13303781|NCT01313312|26516749|FG000|Overall Study|Lack of Efficacy|3|||
13303782|NCT01313312|26516749|FG000|Overall Study|Investigator Decision|1|||
13303783|NCT01313312|26516749|FG000|Overall Study|Observational Phase|1|||
13303784|NCT01313312|26516749|FG000|Overall Study|Subject Withdrawn Early in Error|4|||
13303785|NCT01313312|26516749|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4|||
13303786|NCT01313299|26516773|FG000|Overall Study|Adverse Event|3|||
13303787|NCT01313299|26516774|FG001|Overall Study|Adverse Event|1|||
13303788|NCT01313299|26516775|FG002|Overall Study|Adverse Event|1|||
13303789|NCT01313299|26516773|FG000|Overall Study|Lost to Follow-up|1|||
13303790|NCT01313299|26516774|FG001|Overall Study|Lost to Follow-up|0|||
13303791|NCT01313299|26516775|FG002|Overall Study|Lost to Follow-up|0|||
13303792|NCT01313299|26516773|FG000|Overall Study|Protocol Violation|2|||
13303793|NCT01313299|26516774|FG001|Overall Study|Protocol Violation|0|||
13303794|NCT01313299|26516775|FG002|Overall Study|Protocol Violation|0|||
13303795|NCT01313299|26516773|FG000|Overall Study|Withdrawal by Subject|1|||
13303796|NCT01313299|26516774|FG001|Overall Study|Withdrawal by Subject|0|||
13303797|NCT01313299|26516775|FG002|Overall Study|Withdrawal by Subject|2|||
13303798|NCT01313299|26516773|FG000|Overall Study|Family reason and moved out of state|0|||
13303799|NCT01313299|26516774|FG001|Overall Study|Family reason and moved out of state|2|||
13303800|NCT01313299|26516775|FG002|Overall Study|Family reason and moved out of state|0|||
13303801|NCT01313299|26516773|FG000|Overall Study|Lack of subject compliance|0|||
13303802|NCT01313299|26516774|FG001|Overall Study|Lack of subject compliance|0|||
13303803|NCT01313299|26516775|FG002|Overall Study|Lack of subject compliance|1|||
13303804|NCT01313286|26516786|FG000|Period 1|Withdrawal by Subject|2|||
13303805|NCT01313286|26516787|FG001|Period 1|Withdrawal by Subject|0|||
13303806|NCT01313273|26516806|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1|||
13303807|NCT01313273|26516807|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0|||
13303808|NCT01313273|26516806|FG000|Overall Study|Withdrawal by Subject|1|||
13303809|NCT01313273|26516807|FG001|Overall Study|Withdrawal by Subject|0|||
13303810|NCT01313273|26516806|FG000|Overall Study|Screening Chromogranin A-in normal range|0|||
13303811|NCT01313273|26516807|FG001|Overall Study|Screening Chromogranin A-in normal range|1|||
13303812|NCT01313221|26516867|FG000|Overall Study|Protocol Violation|0|||
13303813|NCT01313221|26516868|FG001|Overall Study|Protocol Violation|1|||
13303814|NCT01313221|26516869|FG002|Overall Study|Protocol Violation|1|||
13303815|NCT01313221|26516867|FG000|Overall Study|Non-compliance|3|||
13303816|NCT01313221|26516868|FG001|Overall Study|Non-compliance|0|||
13303817|NCT01313221|26516869|FG002|Overall Study|Non-compliance|2|||
13303818|NCT01313221|26516867|FG000|Overall Study|Withdrawal by Subject|2|||
13303819|NCT01313221|26516868|FG001|Overall Study|Withdrawal by Subject|3|||
13303820|NCT01313221|26516869|FG002|Overall Study|Withdrawal by Subject|5|||
13303821|NCT01313221|26516867|FG000|Overall Study|Requirement for alternative therapy|0|||
13303822|NCT01313221|26516868|FG001|Overall Study|Requirement for alternative therapy|1|||
13303823|NCT01313221|26516869|FG002|Overall Study|Requirement for alternative therapy|1|||
13303824|NCT01313221|26516867|FG000|Overall Study|Lost to Follow-up|6|||
13303825|NCT01313221|26516868|FG001|Overall Study|Lost to Follow-up|3|||
13303826|NCT01313221|26516869|FG002|Overall Study|Lost to Follow-up|1|||
13303827|NCT01313221|26516867|FG000|Overall Study|Other|1|||
13303828|NCT01313221|26516868|FG001|Overall Study|Other|0|||
13303829|NCT01313221|26516869|FG002|Overall Study|Other|0|||
13303830|NCT01313221|26516867|FG000|Overall Study|Adverse Event|0|||
13303831|NCT01313221|26516868|FG001|Overall Study|Adverse Event|0|||
13303832|NCT01313221|26516869|FG002|Overall Study|Adverse Event|7|||
13303833|NCT01313221|26516867|FG000|Overall Study|Disease progression|0|||
13303834|NCT01313221|26516868|FG001|Overall Study|Disease progression|0|||
13303835|NCT01313221|26516869|FG002|Overall Study|Disease progression|2|||
13303836|NCT01313221|26516867|FG000|Overall Study|Physician Decision|0|||
13303837|NCT01313221|26516868|FG001|Overall Study|Physician Decision|0|||
13303838|NCT01313221|26516869|FG002|Overall Study|Physician Decision|2|||
13303839|NCT01313221|26516867|FG000|Overall Study|Pregnancy|0|||
13303840|NCT01313221|26516868|FG001|Overall Study|Pregnancy|0|||
13303841|NCT01313221|26516869|FG002|Overall Study|Pregnancy|2|||
13303842|NCT01313208|26516964|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3|||
13303843|NCT01313208|26516965|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2|||
13303844|NCT01313208|26516964|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1|||
13303845|NCT01313208|26516965|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2|||
13303846|NCT01313208|26516964|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0|||
13303847|NCT01313208|26516965|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1|||
13303848|NCT01313208|26516964|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1|||
13303849|NCT01313208|26516965|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0|||
13303850|NCT01313208|26516964|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1|||
13303851|NCT01313208|26516965|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0|||
13303852|NCT01313208|26516964|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3|||
13303853|NCT01313208|26516965|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1|||
13303854|NCT01313208|26516964|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0|||
13303855|NCT01313208|26516965|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2|||
13303856|NCT01313208|26516964|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1|||
13303857|NCT01313208|26516965|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0|||
13303858|NCT01313208|26516964|FG000|Open-label Phase (Weeks 13 - 24)|Other|2|||
13303859|NCT01313208|26516965|FG001|Open-label Phase (Weeks 13 - 24)|Other|0|||
13303860|NCT01313182|26516984|FG000|Overall Study|Protocol Violation|66|||
13303861|NCT01313182|26516985|FG001|Overall Study|Protocol Violation|92|||
13303862|NCT01313117|26516994|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
13303863|NCT01313117|26516994|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
13303864|NCT01313078|26517001|FG000|Overall Study|Death|1|||
13303865|NCT01313078|26517001|FG000|Overall Study|Discontinued study drug|1|||
13303866|NCT01313078|26517001|FG000|Overall Study|Withdrawal by Subject|1|||
13303867|NCT01313039|26517007|FG000|Overall Study|Physician Decision|1|||
13303868|NCT01313039|26517007|FG000|Overall Study|Adverse Event|1|||
13303869|NCT01312961|26517040|FG000|Overall Study|Adverse Event|3|||
13303870|NCT01312961|26517041|FG001|Overall Study|Adverse Event|3|||
13303871|NCT01312961|26517040|FG000|Overall Study|Lack of Efficacy|11|||
13303872|NCT01312961|26517041|FG001|Overall Study|Lack of Efficacy|1|||
13303873|NCT01312961|26517040|FG000|Overall Study|Poor compliance to protocol|1|||
13303874|NCT01312961|26517041|FG001|Overall Study|Poor compliance to protocol|0|||
13303875|NCT01312961|26517040|FG000|Overall Study|Other than specified above|2|||
13303876|NCT01312961|26517041|FG001|Overall Study|Other than specified above|3|||
13303877|NCT01312909|26517098|FG000|Overall Study|Randomized but not treated|1|||
13303878|NCT01312909|26517099|FG001|Overall Study|Randomized but not treated|3|||
13303879|NCT01312909|26517100|FG002|Overall Study|Randomized but not treated|1|||
13303880|NCT01312909|26517098|FG000|Overall Study|Adverse Event|1|||
13303881|NCT01312909|26517099|FG001|Overall Study|Adverse Event|0|||
13303882|NCT01312909|26517100|FG002|Overall Study|Adverse Event|3|||
13303883|NCT01312909|26517098|FG000|Overall Study|Protocol Violation|2|||
13303884|NCT01312909|26517099|FG001|Overall Study|Protocol Violation|0|||
13303885|NCT01312909|26517100|FG002|Overall Study|Protocol Violation|2|||
13303886|NCT01312909|26517098|FG000|Overall Study|Other|9|||
13303887|NCT01312909|26517099|FG001|Overall Study|Other|6|||
13303888|NCT01312909|26517100|FG002|Overall Study|Other|11|||
13303889|NCT01312909|26517098|FG000|Overall Study|Withdrawal by Subject|8|||
13303890|NCT01312909|26517099|FG001|Overall Study|Withdrawal by Subject|10|||
13303891|NCT01312909|26517100|FG002|Overall Study|Withdrawal by Subject|7|||
13303892|NCT01312909|26517098|FG000|Overall Study|Lost to Follow-up|21|||
13303893|NCT01312909|26517099|FG001|Overall Study|Lost to Follow-up|17|||
13303894|NCT01312909|26517100|FG002|Overall Study|Lost to Follow-up|20|||
13303895|NCT01312909|26517098|FG000|Overall Study|Insufficient clinical response|0|||
13303896|NCT01312909|26517099|FG001|Overall Study|Insufficient clinical response|0|||
13303897|NCT01312909|26517100|FG002|Overall Study|Insufficient clinical response|1|||
13303898|NCT01312909|26517098|FG000|Overall Study|Entrance criteria not met|0|||
13303899|NCT01312909|26517099|FG001|Overall Study|Entrance criteria not met|0|||
13303900|NCT01312909|26517100|FG002|Overall Study|Entrance criteria not met|2|||
13303901|NCT01312779|26517132|FG000|Overall Study|Withdrawal by Subject|2|||
13303902|NCT01312779|26517132|FG000|Overall Study|Death|3|||
13303903|NCT01312779|26517132|FG000|Overall Study|Not Implanted with Device|27|||
13303904|NCT01312467|26517141|FG000|Overall Study|Adverse Event|4|||
13303905|NCT01312467|26517141|FG000|Overall Study|Lost to Follow-up|1|||
13303906|NCT01312467|26517141|FG000|Overall Study|Withdrawal by Subject|2|||
13303907|NCT01312467|26517141|FG000|Overall Study|Deported to country of origin|1|||
13303908|NCT01312467|26517141|FG000|Overall Study|Another medical condition|1|||
13303909|NCT01312467|26517141|FG000|Overall Study|Ineligible|4|||
13303910|NCT01312428|26517156|FG000|Overall Study|Study Termination|3|||
13303911|NCT01312428|26517157|FG001|Overall Study|Study Termination|4|||
13303912|NCT01312129|26517170|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0|||
13303913|NCT01312129|26517171|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1|||
13303914|NCT01311661|26517315|FG000|Overall Study|Adverse Event|2|||
13303915|NCT01311661|26517315|FG000|Overall Study|Protocol Violation|3|||
13303916|NCT01311661|26517315|FG000|Overall Study|Withdrawal by Subject|2|||
13303917|NCT01311648|26517371|FG000|Main Study|Protocol Violation|0|||
13303918|NCT01311648|26517372|FG001|Main Study|Protocol Violation|1|||
13303919|NCT01311648|26517371|FG000|Main Study|Adverse Event|0|||
13303920|NCT01311648|26517372|FG001|Main Study|Adverse Event|1|||
13303921|NCT01311648|26517371|FG000|Main Study|Inhibitor management|0|||
13303922|NCT01311648|26517372|FG001|Main Study|Inhibitor management|17|||
13303923|NCT01311648|26517371|FG000|Main Study|Withdrawal by Subject|0|||
13303924|NCT01311648|26517372|FG001|Main Study|Withdrawal by Subject|2|||
13303925|NCT01311648|26517371|FG000|Extension Study|Physician Decision|0|||
13303926|NCT01311648|26517372|FG001|Extension Study|Physician Decision|1|||
13303927|NCT01311648|26517371|FG000|Extension Study|ITI therapy with marketed product|0|||
13303928|NCT01311648|26517372|FG001|Extension Study|ITI therapy with marketed product|1|||
13303929|NCT01311648|26517371|FG000|Extension Study|Incorrect visit planning|0|||
13303930|NCT01311648|26517372|FG001|Extension Study|Incorrect visit planning|1|||
13303931|NCT01311648|26517371|FG000|Extension Study|Family's decision|0|||
13303932|NCT01311648|26517372|FG001|Extension Study|Family's decision|1|||
13303933|NCT01311648|26517371|FG000|Extension Study|Failure of ITI therapy|0|||
13303934|NCT01311648|26517372|FG001|Extension Study|Failure of ITI therapy|3|||
13303935|NCT01311648|26517371|FG000|Extension Study|Long travel|0|||
13303936|NCT01311648|26517372|FG001|Extension Study|Long travel|1|||
13303937|NCT01311648|26517371|FG000|Extension Study|Diagnosed with von Willebrand disease|1|||
13303938|NCT01311648|26517372|FG001|Extension Study|Diagnosed with von Willebrand disease|0|||
13303939|NCT01311648|26517371|FG000|Extension Study|Withdrawal by Subject|0|||
13303940|NCT01311648|26517372|FG001|Extension Study|Withdrawal by Subject|1|||
13303941|NCT01311648|26517371|FG000|Extension Study|Inhibitor management|0|||
13303942|NCT01311648|26517372|FG001|Extension Study|Inhibitor management|2|||
13303943|NCT01311557|26517395|FG000|Overall Study|Serious adverse event|0|||
13303944|NCT01311557|26517396|FG001|Overall Study|Serious adverse event|1|||
13303945|NCT01311557|26517395|FG000|Overall Study|Protocol Violation|4|||
13303946|NCT01311557|26517396|FG001|Overall Study|Protocol Violation|2|||
13303947|NCT01311557|26517395|FG000|Overall Study|Lost to Follow-up|0|||
13303948|NCT01311557|26517396|FG001|Overall Study|Lost to Follow-up|1|||
13303949|NCT01311557|26517395|FG000|Overall Study|Withdrawal by Subject|1|||
13303950|NCT01311557|26517396|FG001|Overall Study|Withdrawal by Subject|2|||
13303951|NCT01311505|26517427|FG000|First Intervention Period|Protocol Violation|0|||
13303952|NCT01311505|26517428|FG001|First Intervention Period|Protocol Violation|1|||
13303953|NCT01311024|26517441|FG000|Overall Study|Protocol Violation|35|||
13303954|NCT01311024|26517442|FG001|Overall Study|Protocol Violation|22|||
13303955|NCT01310868|26517450|FG000|Overall Study|Do not have histologically confirmed GBM|13|||
13303956|NCT01310803|26517465|FG000|Overall Study|Subject terminated by Sponsor|1|||
13303957|NCT01310803|26517466|FG001|Overall Study|Subject terminated by Sponsor|0|||
13382445|NCT00744627|26750892|FG001|Overall Study|Voluntary Withdrawal|6|||
13382446|NCT00744627|26750891|FG000|Overall Study|Lost to Follow-up|2|||
13382447|NCT00744627|26750892|FG001|Overall Study|Lost to Follow-up|1|||
13382448|NCT00744627|26750891|FG000|Overall Study|Other|1|||
13382449|NCT00744627|26750892|FG001|Overall Study|Other|0|||
13382450|NCT00744523|26750917|FG000|30 Days After the Procedure|Insufficient follow-up|0|||
13382451|NCT00744523|26750918|FG001|30 Days After the Procedure|Insufficient follow-up|5|||
13382452|NCT00744497|26750959|FG000|Overall Study|Withdrawal by Subject|21|||
13382453|NCT00744497|26750960|FG001|Overall Study|Withdrawal by Subject|18|||
13382454|NCT00744497|26750959|FG000|Overall Study|Death|11|||
13382455|NCT00744497|26750960|FG001|Overall Study|Death|9|||
13382456|NCT00744497|26750959|FG000|Overall Study|Lost to Follow-up|4|||
13382457|NCT00744497|26750960|FG001|Overall Study|Lost to Follow-up|2|||
13382458|NCT00744497|26750959|FG000|Overall Study|Poor compliance/noncompliance|9|||
13303958|NCT01310777|26517484|FG000|Overall Study|Adverse Event|23|||
13303959|NCT01310777|26517485|FG001|Overall Study|Adverse Event|1|||
13303960|NCT01310777|26517486|FG002|Overall Study|Adverse Event|15|||
13303961|NCT01310777|26517484|FG000|Overall Study|Lost to Follow-up|0|||
13303962|NCT01310777|26517485|FG001|Overall Study|Lost to Follow-up|4|||
13303963|NCT01310777|26517486|FG002|Overall Study|Lost to Follow-up|1|||
13303964|NCT01310777|26517484|FG000|Overall Study|Patient's Decision Unrelated to AE|1|||
13303965|NCT01310777|26517485|FG001|Overall Study|Patient's Decision Unrelated to AE|1|||
13303966|NCT01310777|26517486|FG002|Overall Study|Patient's Decision Unrelated to AE|2|||
13303967|NCT01310777|26517484|FG000|Overall Study|Inadequate Control of IOP|5|||
13303968|NCT01310777|26517485|FG001|Overall Study|Inadequate Control of IOP|7|||
13303969|NCT01310777|26517486|FG002|Overall Study|Inadequate Control of IOP|10|||
13303970|NCT01310777|26517484|FG000|Overall Study|Other|4|||
13303971|NCT01310777|26517485|FG001|Overall Study|Other|1|||
13303972|NCT01310777|26517486|FG002|Overall Study|Other|2|||
13303973|NCT01310699|26517503|FG000|Overall Study|Patients did not complete tandem.|4|||
13303974|NCT01310699|26517504|FG001|Overall Study|Patients did not complete tandem.|6|||
13303975|NCT01310413|26517677|FG000|Day 0 to Day 385|Withdrawal by Subject|5|||
13303976|NCT01310413|26517678|FG001|Day 0 to Day 385|Withdrawal by Subject|2|||
13303977|NCT01310413|26517679|FG002|Day 0 to Day 385|Withdrawal by Subject|0|||
13303978|NCT01310413|26517680|FG003|Day 0 to Day 385|Withdrawal by Subject|2|||
13303979|NCT01310413|26517681|FG004|Day 0 to Day 385|Withdrawal by Subject|1|||
13303980|NCT01310413|26517682|FG005|Day 0 to Day 385|Withdrawal by Subject|1|||
13303981|NCT01310413|26517683|FG006|Day 0 to Day 385|Withdrawal by Subject|0|||
13303982|NCT01310413|26517677|FG000|Day 0 to Day 385|Lost to Follow-up|18|||
13303983|NCT01310413|26517678|FG001|Day 0 to Day 385|Lost to Follow-up|3|||
13303984|NCT01310413|26517679|FG002|Day 0 to Day 385|Lost to Follow-up|3|||
13303985|NCT01310413|26517680|FG003|Day 0 to Day 385|Lost to Follow-up|5|||
13303986|NCT01310413|26517681|FG004|Day 0 to Day 385|Lost to Follow-up|1|||
13303987|NCT01310413|26517682|FG005|Day 0 to Day 385|Lost to Follow-up|2|||
13303988|NCT01310413|26517683|FG006|Day 0 to Day 385|Lost to Follow-up|0|||
13303989|NCT01310413|26517677|FG000|Day 0 to Day 385|Migrated/moved from study area|3|||
13303990|NCT01310413|26517678|FG001|Day 0 to Day 385|Migrated/moved from study area|3|||
13303991|NCT01310413|26517679|FG002|Day 0 to Day 385|Migrated/moved from study area|1|||
13303992|NCT01310413|26517680|FG003|Day 0 to Day 385|Migrated/moved from study area|1|||
13303993|NCT01310413|26517681|FG004|Day 0 to Day 385|Migrated/moved from study area|1|||
13303994|NCT01310413|26517682|FG005|Day 0 to Day 385|Migrated/moved from study area|0|||
13303995|NCT01310413|26517683|FG006|Day 0 to Day 385|Migrated/moved from study area|0|||
13303996|NCT01310413|26517677|FG000|Day 0 to Day 385|Other|1|||
13303997|NCT01310413|26517678|FG001|Day 0 to Day 385|Other|0|||
13303998|NCT01310413|26517679|FG002|Day 0 to Day 385|Other|3|||
13303999|NCT01310413|26517680|FG003|Day 0 to Day 385|Other|0|||
13304000|NCT01310413|26517681|FG004|Day 0 to Day 385|Other|0|||
13304001|NCT01310413|26517682|FG005|Day 0 to Day 385|Other|0|||
13304002|NCT01310413|26517683|FG006|Day 0 to Day 385|Other|0|||
13304003|NCT01310413|26517677|FG000|From Day U0 to Day U385|Withdrawal by Subject|0|||
13304004|NCT01310413|26517678|FG001|From Day U0 to Day U385|Withdrawal by Subject|0|||
13304005|NCT01310413|26517679|FG002|From Day U0 to Day U385|Withdrawal by Subject|0|||
13304006|NCT01310413|26517680|FG003|From Day U0 to Day U385|Withdrawal by Subject|0|||
13304007|NCT01310413|26517681|FG004|From Day U0 to Day U385|Withdrawal by Subject|0|||
13304008|NCT01310413|26517682|FG005|From Day U0 to Day U385|Withdrawal by Subject|0|||
13304009|NCT01310413|26517683|FG006|From Day U0 to Day U385|Withdrawal by Subject|1|||
13304010|NCT01310413|26517677|FG000|From Day U0 to Day U385|Lost to Follow-up|0|||
13304011|NCT01310413|26517678|FG001|From Day U0 to Day U385|Lost to Follow-up|0|||
13304012|NCT01310413|26517679|FG002|From Day U0 to Day U385|Lost to Follow-up|0|||
13304013|NCT01310413|26517680|FG003|From Day U0 to Day U385|Lost to Follow-up|0|||
13304014|NCT01310413|26517681|FG004|From Day U0 to Day U385|Lost to Follow-up|0|||
13304015|NCT01310413|26517682|FG005|From Day U0 to Day U385|Lost to Follow-up|0|||
13304016|NCT01310413|26517683|FG006|From Day U0 to Day U385|Lost to Follow-up|2|||
13304017|NCT01310127|26517702|FG000|Overall Study|Protocol Violation|1|||
13304018|NCT01310127|26517703|FG001|Overall Study|Protocol Violation|1|||
13304019|NCT01310127|26517702|FG000|Overall Study|advanced psc cataract outlier|1|||
13304020|NCT01310127|26517703|FG001|Overall Study|advanced psc cataract outlier|0|||
13304021|NCT01310075|26517716|FG000|Overall Study|Lost to Follow-up|1|||
13304022|NCT01310075|26517717|FG001|Overall Study|Lost to Follow-up|0|||
13304023|NCT01310075|26517716|FG000|Overall Study|Physician Decision|10|||
13304024|NCT01310075|26517717|FG001|Overall Study|Physician Decision|7|||
13304025|NCT01310075|26517716|FG000|Overall Study|Protocol Violation|2|||
13304026|NCT01310075|26517717|FG001|Overall Study|Protocol Violation|2|||
13304027|NCT01310075|26517716|FG000|Overall Study|Withdrawal by Subject|1|||
13304028|NCT01310075|26517717|FG001|Overall Study|Withdrawal by Subject|1|||
13304029|NCT01310036|26517730|FG000|Overall Study|Administrative/other|10|||
13304030|NCT01310036|26517730|FG000|Overall Study|Withdrew Consent|11|||
13304031|NCT01310036|26517730|FG000|Overall Study|Refused Treatment/Did not Cooperate|4|||
13304032|NCT01310036|26517730|FG000|Overall Study|Progression of Disease|164|||
13304033|NCT01310036|26517730|FG000|Overall Study|Death|1|||
13304034|NCT01310036|26517730|FG000|Overall Study|Adverse event or intercurrent illness|12|||
13304035|NCT01309997|26517759|FG000|Overall Study|Adverse Event|1|||
13304036|NCT01309997|26517760|FG001|Overall Study|Adverse Event|0|||
13304037|NCT01309997|26517759|FG000|Overall Study|Death|1|||
13304038|NCT01309997|26517760|FG001|Overall Study|Death|3|||
13304039|NCT01309997|26517759|FG000|Overall Study|Lack of Efficacy|2|||
13304040|NCT01309997|26517760|FG001|Overall Study|Lack of Efficacy|2|||
13304041|NCT01309997|26517759|FG000|Overall Study|Withdrawal by Subject|1|||
13304042|NCT01309997|26517760|FG001|Overall Study|Withdrawal by Subject|1|||
13304043|NCT01309919|26517779|FG000|Overall Study|Did not receive a postpartum IUD|17|||
13304044|NCT01309919|26517780|FG001|Overall Study|Did not receive a postpartum IUD|48|||
13304045|NCT01309893|26517793|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1|||
13304046|NCT01309893|26517794|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0|||
13304047|NCT01309893|26517793|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0|||
13304048|NCT01309893|26517794|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1|||
13304049|NCT01309841|26517842|FG000|Overall Study|Other|0|||
13304050|NCT01309841|26517843|FG001|Overall Study|Other|1|||
13304051|NCT01309841|26517844|FG002|Overall Study|Other|1|||
13304052|NCT01309841|26517842|FG000|Overall Study|Lost to Follow-up|7|||
13304053|NCT01309841|26517843|FG001|Overall Study|Lost to Follow-up|6|||
13304054|NCT01309841|26517844|FG002|Overall Study|Lost to Follow-up|4|||
13304055|NCT01309841|26517842|FG000|Overall Study|Study-Specific Withdrawal Criteria|3|||
13304056|NCT01309841|26517843|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
13304057|NCT01309841|26517844|FG002|Overall Study|Study-Specific Withdrawal Criteria|2|||
13304058|NCT01309841|26517842|FG000|Overall Study|Lack of Efficacy|0|||
13304059|NCT01309841|26517843|FG001|Overall Study|Lack of Efficacy|0|||
13304060|NCT01309841|26517844|FG002|Overall Study|Lack of Efficacy|2|||
13304061|NCT01309841|26517842|FG000|Overall Study|Adverse Event|9|||
13304062|NCT01309841|26517843|FG001|Overall Study|Adverse Event|22|||
13304063|NCT01309841|26517844|FG002|Overall Study|Adverse Event|11|||
13304064|NCT01309841|26517842|FG000|Overall Study|Death|1|||
13304065|NCT01309841|26517843|FG001|Overall Study|Death|0|||
13304066|NCT01309841|26517844|FG002|Overall Study|Death|0|||
13304067|NCT01309841|26517842|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
13304068|NCT01309841|26517843|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
13304069|NCT01309841|26517844|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
13304070|NCT01309841|26517842|FG000|Overall Study|Withdrawal by Subject|17|||
13304071|NCT01309841|26517843|FG001|Overall Study|Withdrawal by Subject|6|||
13304072|NCT01309841|26517844|FG002|Overall Study|Withdrawal by Subject|13|||
13304073|NCT01309841|26517842|FG000|Overall Study|Did Not Receive Treatment|2|||
13304074|NCT01309841|26517843|FG001|Overall Study|Did Not Receive Treatment|0|||
13304075|NCT01309841|26517844|FG002|Overall Study|Did Not Receive Treatment|1|||
13304076|NCT01309841|26517842|FG000|Overall Study|Severe non-compliance with protocol|0|||
13304077|NCT01309841|26517843|FG001|Overall Study|Severe non-compliance with protocol|5|||
13304078|NCT01309841|26517844|FG002|Overall Study|Severe non-compliance with protocol|2|||
13304079|NCT01309828|26517863|FG000|Overall Study|Adverse Event|10|||
13304080|NCT01309828|26517864|FG001|Overall Study|Adverse Event|11|||
13304081|NCT01309828|26517863|FG000|Overall Study|Voluntary Withdrawal|5|||
13304082|NCT01309828|26517864|FG001|Overall Study|Voluntary Withdrawal|4|||
13304083|NCT01309828|26517863|FG000|Overall Study|Major Protocol Deviation|0|||
13304084|NCT01309828|26517864|FG001|Overall Study|Major Protocol Deviation|1|||
13304085|NCT01309828|26517863|FG000|Overall Study|Other|1|||
13304086|NCT01309828|26517864|FG001|Overall Study|Other|0|||
13304087|NCT01309737|26518071|FG000|Week 0 to 16|Death|1|||
13304088|NCT01309737|26518072|FG001|Week 0 to 16|Death|0|||
13304089|NCT01309737|26518073|FG002|Week 0 to 16|Death|1|||
13304090|NCT01309737|26518074|FG003|Week 0 to 16|Death|0|||
13304091|NCT01309737|26518075|FG004|Week 0 to 16|Death|0|||
13304092|NCT01309737|26518071|FG000|Week 0 to 16|Adverse Event|11|||
13304093|NCT01309737|26518072|FG001|Week 0 to 16|Adverse Event|10|||
13304094|NCT01309737|26518073|FG002|Week 0 to 16|Adverse Event|5|||
13304095|NCT01309737|26518074|FG003|Week 0 to 16|Adverse Event|0|||
13304096|NCT01309737|26518075|FG004|Week 0 to 16|Adverse Event|0|||
13304097|NCT01309737|26518071|FG000|Week 0 to 16|Lack of Efficacy|15|||
13304098|NCT01309737|26518072|FG001|Week 0 to 16|Lack of Efficacy|2|||
13304099|NCT01309737|26518073|FG002|Week 0 to 16|Lack of Efficacy|24|||
13304100|NCT01309737|26518074|FG003|Week 0 to 16|Lack of Efficacy|0|||
13304101|NCT01309737|26518075|FG004|Week 0 to 16|Lack of Efficacy|0|||
13304102|NCT01309737|26518071|FG000|Week 0 to 16|Lost to Follow-up|7|||
13304103|NCT01309737|26518072|FG001|Week 0 to 16|Lost to Follow-up|8|||
13304104|NCT01309737|26518073|FG002|Week 0 to 16|Lost to Follow-up|3|||
13304105|NCT01309737|26518074|FG003|Week 0 to 16|Lost to Follow-up|0|||
13304106|NCT01309737|26518075|FG004|Week 0 to 16|Lost to Follow-up|0|||
13304107|NCT01309737|26518071|FG000|Week 0 to 16|Withdrawal by Subject|7|||
13304108|NCT01309737|26518072|FG001|Week 0 to 16|Withdrawal by Subject|6|||
13304109|NCT01309737|26518073|FG002|Week 0 to 16|Withdrawal by Subject|7|||
13304110|NCT01309737|26518074|FG003|Week 0 to 16|Withdrawal by Subject|0|||
13304111|NCT01309737|26518075|FG004|Week 0 to 16|Withdrawal by Subject|0|||
13304112|NCT01309737|26518071|FG000|Week 0 to 16|Other|10|||
13304113|NCT01309737|26518072|FG001|Week 0 to 16|Other|14|||
13304114|NCT01309737|26518073|FG002|Week 0 to 16|Other|4|||
13304115|NCT01309737|26518074|FG003|Week 0 to 16|Other|0|||
13304116|NCT01309737|26518075|FG004|Week 0 to 16|Other|0|||
13304117|NCT01309737|26518071|FG000|Week 0 to 16|Randomized, but not treated|1|||
13304118|NCT01309737|26518072|FG001|Week 0 to 16|Randomized, but not treated|0|||
13304119|NCT01309737|26518073|FG002|Week 0 to 16|Randomized, but not treated|0|||
13304120|NCT01309737|26518074|FG003|Week 0 to 16|Randomized, but not treated|0|||
13304121|NCT01309737|26518075|FG004|Week 0 to 16|Randomized, but not treated|0|||
13304122|NCT01309737|26518071|FG000|Week 16 to 52|Death|0|||
13304123|NCT01309737|26518072|FG001|Week 16 to 52|Death|0|||
13304124|NCT01309737|26518073|FG002|Week 16 to 52|Death|0|||
13304125|NCT01309737|26518074|FG003|Week 16 to 52|Death|0|||
13304126|NCT01309737|26518075|FG004|Week 16 to 52|Death|1|||
13304127|NCT01309737|26518071|FG000|Week 16 to 52|Adverse Event|7|||
13304128|NCT01309737|26518072|FG001|Week 16 to 52|Adverse Event|7|||
13304129|NCT01309737|26518073|FG002|Week 16 to 52|Adverse Event|0|||
13304130|NCT01309737|26518074|FG003|Week 16 to 52|Adverse Event|6|||
13304131|NCT01309737|26518075|FG004|Week 16 to 52|Adverse Event|5|||
13304132|NCT01309737|26518071|FG000|Week 16 to 52|Lack of Efficacy|107|||
13304133|NCT01309737|26518072|FG001|Week 16 to 52|Lack of Efficacy|76|||
13304134|NCT01309737|26518073|FG002|Week 16 to 52|Lack of Efficacy|0|||
13304135|NCT01309737|26518074|FG003|Week 16 to 52|Lack of Efficacy|25|||
13304136|NCT01309737|26518075|FG004|Week 16 to 52|Lack of Efficacy|21|||
13304137|NCT01309737|26518071|FG000|Week 16 to 52|Lost to Follow-up|4|||
13304138|NCT01309737|26518072|FG001|Week 16 to 52|Lost to Follow-up|2|||
13304139|NCT01309737|26518073|FG002|Week 16 to 52|Lost to Follow-up|0|||
13304140|NCT01309737|26518074|FG003|Week 16 to 52|Lost to Follow-up|1|||
13382459|NCT00744497|26750960|FG001|Overall Study|Poor compliance/noncompliance|5|||
13382460|NCT00744497|26750959|FG000|Overall Study|No longer meets study criteria|7|||
13382461|NCT00744497|26750960|FG001|Overall Study|No longer meets study criteria|3|||
13382462|NCT00744497|26750959|FG000|Overall Study|Administrative Reason By Sponsor|25|||
13382463|NCT00744497|26750960|FG001|Overall Study|Administrative Reason By Sponsor|8|||
13382464|NCT00744497|26750959|FG000|Overall Study|Disease progression|312|||
13382465|NCT00744497|26750960|FG001|Overall Study|Disease progression|219|||
13382466|NCT00744497|26750959|FG000|Overall Study|Study drug toxicity|68|||
13382467|NCT00744497|26750960|FG001|Overall Study|Study drug toxicity|141|||
13382468|NCT00744497|26750959|FG000|Overall Study|Adverse event unrelated to study drug|78|||
13382469|NCT00744497|26750960|FG001|Overall Study|Adverse event unrelated to study drug|122|||
13382470|NCT00744497|26750959|FG000|Overall Study|Patient requested to stop study drug|65|||
13382471|NCT00744497|26750960|FG001|Overall Study|Patient requested to stop study drug|80|||
13382472|NCT00744497|26750959|FG000|Overall Study|Maximum clinical benefit|141|||
13382473|NCT00744497|26750960|FG001|Overall Study|Maximum clinical benefit|142|||
13382474|NCT00744497|26750959|FG000|Overall Study|Not defined|19|||
13382475|NCT00744497|26750960|FG001|Overall Study|Not defined|13|||
13382476|NCT00744471|26751099|FG000|Overall Study|Randomized but not treated|1|||
13382477|NCT00744471|26751100|FG001|Overall Study|Randomized but not treated|1|||
13382478|NCT00744471|26751101|FG002|Overall Study|Randomized but not treated|4|||
13382479|NCT00744471|26751102|FG003|Overall Study|Randomized but not treated|0|||
13382480|NCT00744471|26751099|FG000|Overall Study|Death|0|||
13382481|NCT00744471|26751100|FG001|Overall Study|Death|0|||
13382482|NCT00744471|26751101|FG002|Overall Study|Death|0|||
13382483|NCT00744471|26751102|FG003|Overall Study|Death|1|||
13382484|NCT00744471|26751099|FG000|Overall Study|Adverse Event|6|||
13382485|NCT00744471|26751100|FG001|Overall Study|Adverse Event|7|||
13382486|NCT00744471|26751101|FG002|Overall Study|Adverse Event|5|||
13382487|NCT00744471|26751102|FG003|Overall Study|Adverse Event|9|||
13382488|NCT00744471|26751099|FG000|Overall Study|Withdrawal by Subject|9|||
13382489|NCT00744471|26751100|FG001|Overall Study|Withdrawal by Subject|9|||
13382490|NCT00744471|26751101|FG002|Overall Study|Withdrawal by Subject|15|||
13382491|NCT00744471|26751102|FG003|Overall Study|Withdrawal by Subject|12|||
13382492|NCT00744471|26751099|FG000|Overall Study|Protocol Violation|1|||
13382493|NCT00744471|26751100|FG001|Overall Study|Protocol Violation|4|||
13382494|NCT00744471|26751101|FG002|Overall Study|Protocol Violation|1|||
13382495|NCT00744471|26751102|FG003|Overall Study|Protocol Violation|2|||
13382496|NCT00744471|26751099|FG000|Overall Study|Entered extension study|41|||
13382497|NCT00744471|26751100|FG001|Overall Study|Entered extension study|84|||
13382498|NCT00744471|26751101|FG002|Overall Study|Entered extension study|100|||
13382499|NCT00744471|26751102|FG003|Overall Study|Entered extension study|91|||
13382500|NCT00744471|26751099|FG000|Overall Study|Other|2|||
13382501|NCT00744471|26751100|FG001|Overall Study|Other|3|||
13382502|NCT00744471|26751101|FG002|Overall Study|Other|6|||
13382503|NCT00744471|26751102|FG003|Overall Study|Other|2|||
13382504|NCT00744471|26751099|FG000|Overall Study|Lack of Efficacy|83|||
13382505|NCT00744471|26751100|FG001|Overall Study|Lack of Efficacy|37|||
13382506|NCT00744471|26751101|FG002|Overall Study|Lack of Efficacy|19|||
13382507|NCT00744471|26751102|FG003|Overall Study|Lack of Efficacy|31|||
13304141|NCT01309737|26518075|FG004|Week 16 to 52|Lost to Follow-up|4|||
13304142|NCT01309737|26518071|FG000|Week 16 to 52|Withdrawal by Subject|5|||
13304143|NCT01309737|26518072|FG001|Week 16 to 52|Withdrawal by Subject|6|||
13304144|NCT01309737|26518073|FG002|Week 16 to 52|Withdrawal by Subject|0|||
13304145|NCT01309737|26518074|FG003|Week 16 to 52|Withdrawal by Subject|0|||
13304146|NCT01309737|26518075|FG004|Week 16 to 52|Withdrawal by Subject|2|||
13304147|NCT01309737|26518071|FG000|Week 16 to 52|Other|10|||
13304148|NCT01309737|26518072|FG001|Week 16 to 52|Other|12|||
13304149|NCT01309737|26518073|FG002|Week 16 to 52|Other|0|||
13304150|NCT01309737|26518074|FG003|Week 16 to 52|Other|2|||
13304151|NCT01309737|26518075|FG004|Week 16 to 52|Other|0|||
13304152|NCT01309659|26518122|FG000|Overall Study|Protocol Violation|0|||
13304153|NCT01309659|26518123|FG001|Overall Study|Protocol Violation|1|||
13304154|NCT01309386|26518148|FG000|Overall Study|Other|2|||
13304155|NCT01309386|26518149|FG001|Overall Study|Other|0|||
13304156|NCT01309386|26518148|FG000|Overall Study|Withdrawal by Subject|2|||
13304157|NCT01309386|26518149|FG001|Overall Study|Withdrawal by Subject|0|||
13304158|NCT01309386|26518148|FG000|Overall Study|Progressive disease|9|||
13304159|NCT01309386|26518149|FG001|Overall Study|Progressive disease|11|||
13304160|NCT01309386|26518148|FG000|Overall Study|Physician Decision|1|||
13304161|NCT01309386|26518149|FG001|Overall Study|Physician Decision|1|||
13304162|NCT01309386|26518148|FG000|Overall Study|Lack of Efficacy|3|||
13304163|NCT01309386|26518149|FG001|Overall Study|Lack of Efficacy|1|||
13304164|NCT01309386|26518148|FG000|Overall Study|Adverse Event|5|||
13304165|NCT01309386|26518149|FG001|Overall Study|Adverse Event|8|||
13304166|NCT01309308|26518164|FG000|Overall Study|Lost to Follow-up|6|||
13304167|NCT01309308|26518165|FG001|Overall Study|Lost to Follow-up|4|||
13304168|NCT01309282|26518184|FG000|Overall Study|Lost to Follow-up|1|||
13304169|NCT01309269|26518192|FG000|Overall Study|Adverse Event|56|||
13304170|NCT01309269|26518192|FG000|Overall Study|Withdrawal by Subject|25|||
13304171|NCT01309269|26518192|FG000|Overall Study|Lack of Acceptance|15|||
13304172|NCT01309269|26518192|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119|||
13304173|NCT01309269|26518192|FG000|Overall Study|Kidney Transplant|25|||
13304174|NCT01309269|26518192|FG000|Overall Study|Administrative Problems|141|||
13304175|NCT01309269|26518192|FG000|Overall Study|Other|256|||
13304176|NCT01309269|26518192|FG000|Overall Study|Other|1|||
13304177|NCT01309269|26518192|FG000|Overall Study|Study Completion Data Not Recorded|95|||
13304178|NCT01309269|26518192|FG000|Overall Study|Enrolled but not Treated|107|||
13304179|NCT01309243|26518223|FG000|Randomized Phase Through Week 96|Randomized but not treated|6|||
13304180|NCT01309243|26518224|FG001|Randomized Phase Through Week 96|Randomized but not treated|7|||
13304181|NCT01309243|26518223|FG000|Randomized Phase Through Week 96|Adverse Event|12|||
13304182|NCT01309243|26518224|FG001|Randomized Phase Through Week 96|Adverse Event|43|||
13304183|NCT01309243|26518223|FG000|Randomized Phase Through Week 96|Death|0|||
13304184|NCT01309243|26518224|FG001|Randomized Phase Through Week 96|Death|1|||
13304185|NCT01309243|26518223|FG000|Randomized Phase Through Week 96|Pregnancy|2|||
13304186|NCT01309243|26518224|FG001|Randomized Phase Through Week 96|Pregnancy|0|||
13304187|NCT01309243|26518223|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16|||
13304188|NCT01309243|26518224|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4|||
13304189|NCT01309243|26518223|FG000|Randomized Phase Through Week 96|Investigators Discretion|3|||
13304190|NCT01309243|26518224|FG001|Randomized Phase Through Week 96|Investigators Discretion|6|||
13304191|NCT01309243|26518223|FG000|Randomized Phase Through Week 96|Withdrew Consent|12|||
13304192|NCT01309243|26518224|FG001|Randomized Phase Through Week 96|Withdrew Consent|18|||
13304193|NCT01309243|26518223|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23|||
13304194|NCT01309243|26518224|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22|||
13304195|NCT01309243|26518223|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9|||
13304196|NCT01309243|26518224|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7|||
13304197|NCT01309243|26518223|FG000|Randomized Phase Through Week 96|Protocol Violation|1|||
13304198|NCT01309243|26518224|FG001|Randomized Phase Through Week 96|Protocol Violation|1|||
13304199|NCT01309243|26518223|FG000|Extension Phase|Lost to Follow-up|6|||
13304200|NCT01309243|26518224|FG001|Extension Phase|Lost to Follow-up|0|||
13304201|NCT01309204|26518237|FG000|Overall Study|Adverse Event|48|||
13304202|NCT01309204|26518238|FG001|Overall Study|Adverse Event|58|||
13304203|NCT01309204|26518237|FG000|Overall Study|Lost to Follow-up|2|||
13304204|NCT01309204|26518238|FG001|Overall Study|Lost to Follow-up|2|||
13304205|NCT01309204|26518237|FG000|Overall Study|Subject's decision unrelated to an AE|9|||
13304206|NCT01309204|26518238|FG001|Overall Study|Subject's decision unrelated to an AE|10|||
13304207|NCT01309204|26518237|FG000|Overall Study|Inadequate control of IOP|4|||
13304208|NCT01309204|26518238|FG001|Overall Study|Inadequate control of IOP|4|||
13304209|NCT01309204|26518237|FG000|Overall Study|Other|4|||
13304210|NCT01309204|26518238|FG001|Overall Study|Other|1|||
13304211|NCT01309165|26518257|FG000|Overall Study|Lost to Follow-up|4|||
13304212|NCT01309165|26518258|FG001|Overall Study|Lost to Follow-up|3|||
13304213|NCT01309165|26518257|FG000|Overall Study|Return to work|1|||
13304214|NCT01309165|26518258|FG001|Overall Study|Return to work|2|||
13304215|NCT01309165|26518257|FG000|Overall Study|Left country|0|||
13304216|NCT01309165|26518258|FG001|Overall Study|Left country|1|||
13304217|NCT01309165|26518257|FG000|Overall Study|No transportation|0|||
13304218|NCT01309165|26518258|FG001|Overall Study|No transportation|1|||
13304219|NCT01309165|26518257|FG000|Overall Study|Admitted to hospital for second stroke|1|||
13304220|NCT01309165|26518258|FG001|Overall Study|Admitted to hospital for second stroke|0|||
13304221|NCT01309100|26518271|FG000|Overall Study|Protocol Violation|1|||
13304222|NCT01309100|26518271|FG000|Overall Study|Positive Slit lamp finding|1|||
13304223|NCT01308853|26518278|FG000|Overall Study|Adverse Event|1|||
13304224|NCT01308853|26518278|FG000|Overall Study|Lost to Follow-up|2|||
13304225|NCT01308853|26518278|FG000|Overall Study|Insertion of permanent implants|1|||
13304226|NCT01308788|26518317|FG000|2-year Treatment|medication change by treating physician|4|||
13304227|NCT01308788|26518318|FG001|2-year Treatment|medication change by treating physician|11|||
13304228|NCT01308762|26518339|FG000|Overall Study|Protocol Violation|0|||
13304229|NCT01308762|26518340|FG001|Overall Study|Protocol Violation|1|||
13304230|NCT01308762|26518341|FG002|Overall Study|Protocol Violation|0|||
13304231|NCT01308749|26518376|FG000|Period 1: Double Blind Treatment|Adverse Event|1|||
13304232|NCT01308749|26518377|FG001|Period 1: Double Blind Treatment|Adverse Event|0|||
13304233|NCT01308749|26518376|FG000|Period 2: Open Label Treatment|Adverse Event|0|||
13304234|NCT01308749|26518377|FG001|Period 2: Open Label Treatment|Adverse Event|1|||
13304235|NCT01308749|26518376|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0|||
13304236|NCT01308749|26518377|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1|||
13304237|NCT01308736|26518390|FG000|Overall Study|Did not attend a single session|6|||
13304238|NCT01308736|26518391|FG001|Overall Study|Did not attend a single session|5|||
13304239|NCT01308580|26518438|FG000|Overall Study|Lost to Follow-up|12|||
13304240|NCT01308580|26518439|FG001|Overall Study|Lost to Follow-up|7|||
13304241|NCT01308567|26518487|FG000|Overall Study|Lost to Follow-up|2|||
13304242|NCT01308567|26518488|FG001|Overall Study|Lost to Follow-up|4|||
13304243|NCT01308567|26518489|FG002|Overall Study|Lost to Follow-up|4|||
13304244|NCT01308476|26518516|FG000|Overall Study|Lost to Follow-up|2|||
13304245|NCT01308476|26518517|FG001|Overall Study|Lost to Follow-up|2|||
13304246|NCT01308476|26518516|FG000|Overall Study|Other|1|||
13304247|NCT01308476|26518517|FG001|Overall Study|Other|0|||
13304248|NCT01308463|26518526|FG000|Overall Study|Study Discontinued|23|||
13304249|NCT01308463|26518526|FG000|Overall Study|Death|4|||
13304250|NCT01308463|26518526|FG000|Overall Study|Revision|2|||
13304251|NCT01308424|26518541|FG000|Baseline Eligibility|Screen Failures|71|||
13304252|NCT01308424|26518542|FG001|Baseline Eligibility|Screen Failures|0|||
13304253|NCT01308424|26518543|FG002|Baseline Eligibility|Screen Failures|0|||
13304254|NCT01308424|26518541|FG000|Randomization|Adverse Event|0|||
13304255|NCT01308424|26518542|FG001|Randomization|Adverse Event|1|||
13304256|NCT01308424|26518543|FG002|Randomization|Adverse Event|1|||
13304257|NCT01308424|26518541|FG000|Randomization|Lost to Follow-up|0|||
13304258|NCT01308424|26518542|FG001|Randomization|Lost to Follow-up|1|||
13304259|NCT01308424|26518543|FG002|Randomization|Lost to Follow-up|0|||
13304260|NCT01308424|26518541|FG000|Randomization|Physician Decision|0|||
13304261|NCT01308424|26518542|FG001|Randomization|Physician Decision|1|||
13304262|NCT01308424|26518543|FG002|Randomization|Physician Decision|1|||
13304263|NCT01308008|26518560|FG000|4 Weeks|Illness, disinterest, time|9|||
13304264|NCT01308008|26518561|FG001|4 Weeks|Illness, disinterest, time|2|||
13304265|NCT01307891|26518578|FG000|Overall Study|Progressive Disease|3|||
13304266|NCT01307891|26518579|FG001|Overall Study|Progressive Disease|1|||
13304267|NCT01307800|26518690|FG000|Overall Study|Adverse Event|9|||
13304268|NCT01307800|26518691|FG001|Overall Study|Adverse Event|8|||
13304269|NCT01307800|26518692|FG002|Overall Study|Adverse Event|10|||
13304270|NCT01307800|26518693|FG003|Overall Study|Adverse Event|14|||
13304271|NCT01307800|26518690|FG000|Overall Study|Entry Criteria Not Met|0|||
13304272|NCT01307800|26518691|FG001|Overall Study|Entry Criteria Not Met|0|||
13304273|NCT01307800|26518692|FG002|Overall Study|Entry Criteria Not Met|0|||
13304274|NCT01307800|26518693|FG003|Overall Study|Entry Criteria Not Met|2|||
13304275|NCT01307800|26518690|FG000|Overall Study|Lost to Follow-up|5|||
13304276|NCT01307800|26518691|FG001|Overall Study|Lost to Follow-up|6|||
13304277|NCT01307800|26518692|FG002|Overall Study|Lost to Follow-up|2|||
13304278|NCT01307800|26518693|FG003|Overall Study|Lost to Follow-up|8|||
13304279|NCT01307800|26518690|FG000|Overall Study|Perceived Lack of Efficacy|24|||
13304280|NCT01307800|26518691|FG001|Overall Study|Perceived Lack of Efficacy|23|||
13304281|NCT01307800|26518692|FG002|Overall Study|Perceived Lack of Efficacy|20|||
13304282|NCT01307800|26518693|FG003|Overall Study|Perceived Lack of Efficacy|33|||
13304283|NCT01307800|26518690|FG000|Overall Study|Protocol Violation|0|||
13304284|NCT01307800|26518691|FG001|Overall Study|Protocol Violation|3|||
13304285|NCT01307800|26518692|FG002|Overall Study|Protocol Violation|4|||
13304286|NCT01307800|26518693|FG003|Overall Study|Protocol Violation|5|||
13304287|NCT01307800|26518690|FG000|Overall Study|Schedule Conflict Prevented Continuation|0|||
13304288|NCT01307800|26518691|FG001|Overall Study|Schedule Conflict Prevented Continuation|3|||
13304289|NCT01307800|26518692|FG002|Overall Study|Schedule Conflict Prevented Continuation|1|||
13304290|NCT01307800|26518693|FG003|Overall Study|Schedule Conflict Prevented Continuation|2|||
13304291|NCT01307800|26518690|FG000|Overall Study|Sponsor Decision|6|||
13304292|NCT01307800|26518691|FG001|Overall Study|Sponsor Decision|9|||
13304293|NCT01307800|26518692|FG002|Overall Study|Sponsor Decision|12|||
13382508|NCT00744471|26751099|FG000|Overall Study|Lost to Follow-up|0|||
13304294|NCT01307800|26518693|FG003|Overall Study|Sponsor Decision|28|||
13304295|NCT01307800|26518690|FG000|Overall Study|Withdrawal by Subject|10|||
13304296|NCT01307800|26518691|FG001|Overall Study|Withdrawal by Subject|11|||
13304297|NCT01307800|26518692|FG002|Overall Study|Withdrawal by Subject|8|||
13304298|NCT01307800|26518693|FG003|Overall Study|Withdrawal by Subject|15|||
13304299|NCT01307800|26518690|FG000|Overall Study|Participant Moved|0|||
13304300|NCT01307800|26518691|FG001|Overall Study|Participant Moved|2|||
13304301|NCT01307800|26518692|FG002|Overall Study|Participant Moved|1|||
13304302|NCT01307800|26518693|FG003|Overall Study|Participant Moved|3|||
13304303|NCT01307579|26518712|FG000|Overall Study|Death|3|||
13304304|NCT01307579|26518713|FG001|Overall Study|Death|6|||
13304305|NCT01307579|26518712|FG000|Overall Study|Physician Decision|26|||
13304306|NCT01307579|26518713|FG001|Overall Study|Physician Decision|29|||
13304307|NCT01307579|26518712|FG000|Overall Study|Withdrawal by Subject|7|||
13304308|NCT01307579|26518713|FG001|Overall Study|Withdrawal by Subject|3|||
13304309|NCT01307579|26518712|FG000|Overall Study|Institutional diagnosis of IFD|21|||
13304310|NCT01307579|26518713|FG001|Overall Study|Institutional diagnosis of IFD|36|||
13304311|NCT01307579|26518712|FG000|Overall Study|Begin conditioning for HSCT|42|||
13304312|NCT01307579|26518713|FG001|Overall Study|Begin conditioning for HSCT|44|||
13304313|NCT01307579|26518712|FG000|Overall Study|Refractory or relapsed AML|38|||
13304314|NCT01307579|26518713|FG001|Overall Study|Refractory or relapsed AML|23|||
13304315|NCT01307579|26518712|FG000|Overall Study|Ineligible|3|||
13304316|NCT01307579|26518713|FG001|Overall Study|Ineligible|4|||
13304317|NCT01307501|26518728|FG000|Overall Study|Treatment Failure|1|||
13304318|NCT01307501|26518728|FG000|Overall Study|Death|20|||
13304319|NCT01307501|26518728|FG000|Overall Study|Lost to Follow-up|1|||
13304320|NCT01307501|26518728|FG000|Overall Study|Starting Hospice|1|||
13304321|NCT01307449|26518771|FG000|Overall Study|Adverse Event|1|||
13304322|NCT01307449|26518772|FG001|Overall Study|Adverse Event|0|||
13304323|NCT01307449|26518773|FG002|Overall Study|Adverse Event|0|||
13304324|NCT01307449|26518774|FG003|Overall Study|Adverse Event|0|||
13304325|NCT01307319|26518795|FG000|Overall Study|Adverse Event|2|||
13304326|NCT01307319|26518796|FG001|Overall Study|Adverse Event|2|||
13304327|NCT01307319|26518797|FG002|Overall Study|Adverse Event|1|||
13304328|NCT01307319|26518795|FG000|Overall Study|Lost to Follow-up|1|||
13304329|NCT01307319|26518796|FG001|Overall Study|Lost to Follow-up|0|||
13304330|NCT01307319|26518797|FG002|Overall Study|Lost to Follow-up|1|||
13304331|NCT01307319|26518795|FG000|Overall Study|Protocol Violation|1|||
13304332|NCT01307319|26518796|FG001|Overall Study|Protocol Violation|1|||
13304333|NCT01307319|26518797|FG002|Overall Study|Protocol Violation|0|||
13304334|NCT01307319|26518795|FG000|Overall Study|Withdrawal by Subject|0|||
13304335|NCT01307319|26518796|FG001|Overall Study|Withdrawal by Subject|1|||
13304336|NCT01307319|26518797|FG002|Overall Study|Withdrawal by Subject|2|||
13304337|NCT01307319|26518795|FG000|Overall Study|Other|0|||
13304338|NCT01307319|26518796|FG001|Overall Study|Other|4|||
13304339|NCT01307319|26518797|FG002|Overall Study|Other|3|||
13304340|NCT01307267|26519455|FG000|Overall Study|Death|4|||
13304341|NCT01307267|26519456|FG001|Overall Study|Death|3|||
13304342|NCT01307267|26519457|FG002|Overall Study|Death|5|||
13304343|NCT01307267|26519458|FG003|Overall Study|Death|3|||
13304344|NCT01307267|26519459|FG004|Overall Study|Death|1|||
13304345|NCT01307267|26519460|FG005|Overall Study|Death|26|||
13304346|NCT01307267|26519461|FG006|Overall Study|Death|2|||
13304347|NCT01307267|26519462|FG007|Overall Study|Death|2|||
13304348|NCT01307267|26519463|FG008|Overall Study|Death|21|||
13304349|NCT01307267|26519464|FG009|Overall Study|Death|2|||
13304350|NCT01307267|26519465|FG010|Overall Study|Death|3|||
13304351|NCT01307267|26519466|FG011|Overall Study|Death|9|||
13304352|NCT01307267|26519467|FG012|Overall Study|Death|0|||
13304353|NCT01307267|26519468|FG013|Overall Study|Death|0|||
13304354|NCT01307267|26519469|FG014|Overall Study|Death|0|||
13304355|NCT01307267|26519470|FG015|Overall Study|Death|0|||
13304356|NCT01307267|26519471|FG016|Overall Study|Death|1|||
13304357|NCT01307267|26519472|FG017|Overall Study|Death|1|||
13304358|NCT01307267|26519473|FG018|Overall Study|Death|2|||
13382509|NCT00744471|26751100|FG001|Overall Study|Lost to Follow-up|0|||
13382510|NCT00744471|26751101|FG002|Overall Study|Lost to Follow-up|2|||
13304359|NCT01307267|26519474|FG019|Overall Study|Death|8|||
13304360|NCT01307267|26519475|FG020|Overall Study|Death|1|||
13304361|NCT01307267|26519476|FG021|Overall Study|Death|2|||
13304362|NCT01307267|26519477|FG022|Overall Study|Death|2|||
13304363|NCT01307267|26519455|FG000|Overall Study|Lost to Follow-up|0|||
13304364|NCT01307267|26519456|FG001|Overall Study|Lost to Follow-up|0|||
13304365|NCT01307267|26519457|FG002|Overall Study|Lost to Follow-up|0|||
13304366|NCT01307267|26519458|FG003|Overall Study|Lost to Follow-up|0|||
13304367|NCT01307267|26519459|FG004|Overall Study|Lost to Follow-up|0|||
13304368|NCT01307267|26519460|FG005|Overall Study|Lost to Follow-up|7|||
13304369|NCT01307267|26519461|FG006|Overall Study|Lost to Follow-up|0|||
13304370|NCT01307267|26519462|FG007|Overall Study|Lost to Follow-up|0|||
13304371|NCT01307267|26519463|FG008|Overall Study|Lost to Follow-up|1|||
13304372|NCT01307267|26519464|FG009|Overall Study|Lost to Follow-up|2|||
13304373|NCT01307267|26519465|FG010|Overall Study|Lost to Follow-up|1|||
13304374|NCT01307267|26519466|FG011|Overall Study|Lost to Follow-up|0|||
13304375|NCT01307267|26519467|FG012|Overall Study|Lost to Follow-up|0|||
13304376|NCT01307267|26519468|FG013|Overall Study|Lost to Follow-up|0|||
13304377|NCT01307267|26519469|FG014|Overall Study|Lost to Follow-up|0|||
13304378|NCT01307267|26519470|FG015|Overall Study|Lost to Follow-up|0|||
13304379|NCT01307267|26519471|FG016|Overall Study|Lost to Follow-up|0|||
13304380|NCT01307267|26519472|FG017|Overall Study|Lost to Follow-up|0|||
13304381|NCT01307267|26519473|FG018|Overall Study|Lost to Follow-up|0|||
13304382|NCT01307267|26519474|FG019|Overall Study|Lost to Follow-up|2|||
13304383|NCT01307267|26519475|FG020|Overall Study|Lost to Follow-up|0|||
13304384|NCT01307267|26519476|FG021|Overall Study|Lost to Follow-up|0|||
13304385|NCT01307267|26519477|FG022|Overall Study|Lost to Follow-up|0|||
13304386|NCT01307267|26519455|FG000|Overall Study|Withdrawal by Subject|0|||
13304387|NCT01307267|26519456|FG001|Overall Study|Withdrawal by Subject|0|||
13304388|NCT01307267|26519457|FG002|Overall Study|Withdrawal by Subject|0|||
13304389|NCT01307267|26519458|FG003|Overall Study|Withdrawal by Subject|0|||
13304390|NCT01307267|26519459|FG004|Overall Study|Withdrawal by Subject|0|||
13304391|NCT01307267|26519460|FG005|Overall Study|Withdrawal by Subject|1|||
13304392|NCT01307267|26519461|FG006|Overall Study|Withdrawal by Subject|0|||
13304393|NCT01307267|26519462|FG007|Overall Study|Withdrawal by Subject|1|||
13304394|NCT01307267|26519463|FG008|Overall Study|Withdrawal by Subject|5|||
13304395|NCT01307267|26519464|FG009|Overall Study|Withdrawal by Subject|1|||
13304396|NCT01307267|26519465|FG010|Overall Study|Withdrawal by Subject|1|||
13304397|NCT01307267|26519466|FG011|Overall Study|Withdrawal by Subject|1|||
13304398|NCT01307267|26519467|FG012|Overall Study|Withdrawal by Subject|0|||
13304399|NCT01307267|26519468|FG013|Overall Study|Withdrawal by Subject|0|||
13304400|NCT01307267|26519469|FG014|Overall Study|Withdrawal by Subject|0|||
13304401|NCT01307267|26519470|FG015|Overall Study|Withdrawal by Subject|0|||
13304402|NCT01307267|26519471|FG016|Overall Study|Withdrawal by Subject|0|||
13304403|NCT01307267|26519472|FG017|Overall Study|Withdrawal by Subject|0|||
13304404|NCT01307267|26519473|FG018|Overall Study|Withdrawal by Subject|0|||
13304405|NCT01307267|26519474|FG019|Overall Study|Withdrawal by Subject|3|||
13304406|NCT01307267|26519475|FG020|Overall Study|Withdrawal by Subject|0|||
13304407|NCT01307267|26519476|FG021|Overall Study|Withdrawal by Subject|0|||
13304408|NCT01307267|26519477|FG022|Overall Study|Withdrawal by Subject|0|||
13304409|NCT01307267|26519455|FG000|Overall Study|Other|0|||
13304410|NCT01307267|26519456|FG001|Overall Study|Other|0|||
13304411|NCT01307267|26519457|FG002|Overall Study|Other|0|||
13304412|NCT01307267|26519458|FG003|Overall Study|Other|0|||
13304413|NCT01307267|26519459|FG004|Overall Study|Other|0|||
13304414|NCT01307267|26519460|FG005|Overall Study|Other|7|||
13304415|NCT01307267|26519461|FG006|Overall Study|Other|0|||
13304416|NCT01307267|26519462|FG007|Overall Study|Other|1|||
13304417|NCT01307267|26519463|FG008|Overall Study|Other|3|||
13304418|NCT01307267|26519464|FG009|Overall Study|Other|0|||
13304419|NCT01307267|26519465|FG010|Overall Study|Other|1|||
13382511|NCT00744471|26751102|FG003|Overall Study|Lost to Follow-up|0|||
13382512|NCT00744328|26751123|FG000|Overall Study|Lost to Follow-up|2|||
13382513|NCT00744328|26751124|FG001|Overall Study|Lost to Follow-up|5|||
13382514|NCT00744328|26751125|FG002|Overall Study|Lost to Follow-up|3|||
13382515|NCT00744328|26751123|FG000|Overall Study|Withdrawal by Subject|5|||
13382516|NCT00744328|26751124|FG001|Overall Study|Withdrawal by Subject|3|||
13382517|NCT00744328|26751125|FG002|Overall Study|Withdrawal by Subject|4|||
13382518|NCT00744328|26751123|FG000|Overall Study|Found ineligible after randomization|0|||
13382519|NCT00744328|26751124|FG001|Overall Study|Found ineligible after randomization|0|||
13382520|NCT00744328|26751125|FG002|Overall Study|Found ineligible after randomization|1|||
13382521|NCT00744263|26751152|FG000|Overall Study|Death|3006|||
13382522|NCT00744263|26751153|FG001|Overall Study|Death|3005|||
13382523|NCT00744263|26751152|FG000|Overall Study|Lost to Follow-up|2038|||
13382524|NCT00744263|26751153|FG001|Overall Study|Lost to Follow-up|2135|||
13382525|NCT00744263|26751152|FG000|Overall Study|Withdrawal by Subject|166|||
13382526|NCT00744263|26751153|FG001|Overall Study|Withdrawal by Subject|150|||
13382527|NCT00744263|26751152|FG000|Overall Study|Physician Decision|20|||
13382528|NCT00744263|26751153|FG001|Overall Study|Physician Decision|23|||
13382529|NCT00744263|26751152|FG000|Overall Study|Protocol Violation|3|||
13382530|NCT00744263|26751153|FG001|Overall Study|Protocol Violation|5|||
13382531|NCT00744263|26751152|FG000|Overall Study|Adverse Event|1|||
13382532|NCT00744263|26751153|FG001|Overall Study|Adverse Event|0|||
13382533|NCT00744263|26751152|FG000|Overall Study|Other|2|||
13382534|NCT00744263|26751153|FG001|Overall Study|Other|2|||
13382535|NCT00744237|26751174|FG000|Overall Study|Lack of Efficacy|1|||
13382536|NCT00744237|26751175|FG001|Overall Study|Lack of Efficacy|1|||
13382537|NCT00744237|26751176|FG002|Overall Study|Lack of Efficacy|0|||
13382538|NCT00744237|26751174|FG000|Overall Study|Withdrawal by Subject|9|||
13382539|NCT00744237|26751175|FG001|Overall Study|Withdrawal by Subject|5|||
13382540|NCT00744237|26751176|FG002|Overall Study|Withdrawal by Subject|3|||
13382541|NCT00744237|26751174|FG000|Overall Study|Lost to Follow-up|1|||
13304420|NCT01307267|26519466|FG011|Overall Study|Other|1|||
13304421|NCT01307267|26519467|FG012|Overall Study|Other|1|||
13304422|NCT01307267|26519468|FG013|Overall Study|Other|0|||
13304423|NCT01307267|26519469|FG014|Overall Study|Other|2|||
13304424|NCT01307267|26519470|FG015|Overall Study|Other|1|||
13304425|NCT01307267|26519471|FG016|Overall Study|Other|0|||
13304426|NCT01307267|26519472|FG017|Overall Study|Other|0|||
13304427|NCT01307267|26519473|FG018|Overall Study|Other|0|||
13304428|NCT01307267|26519474|FG019|Overall Study|Other|19|||
13304429|NCT01307267|26519475|FG020|Overall Study|Other|2|||
13304430|NCT01307267|26519476|FG021|Overall Study|Other|3|||
13304431|NCT01307267|26519477|FG022|Overall Study|Other|2|||
13304432|NCT01307111|26519494|FG000|IUD Insertion|Lost to Follow-up|2|||
13304433|NCT01307111|26519495|FG001|IUD Insertion|Lost to Follow-up|0|||
13304434|NCT01307111|26519494|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2|||
13304435|NCT01307111|26519495|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2|||
13304436|NCT01307020|26519568|FG000|Overall Study|Lost to Follow-up|0|||
13304437|NCT01307020|26519569|FG001|Overall Study|Lost to Follow-up|0|||
13304438|NCT01307020|26519570|FG002|Overall Study|Lost to Follow-up|1|||
13304439|NCT01307020|26519571|FG003|Overall Study|Lost to Follow-up|1|||
13304440|NCT01307020|26519572|FG004|Overall Study|Lost to Follow-up|0|||
13304441|NCT01307020|26519573|FG005|Overall Study|Lost to Follow-up|0|||
13304442|NCT01307020|26519574|FG006|Overall Study|Lost to Follow-up|1|||
13304443|NCT01307020|26519575|FG007|Overall Study|Lost to Follow-up|0|||
13304444|NCT01307020|26519576|FG008|Overall Study|Lost to Follow-up|0|||
13304445|NCT01307020|26519577|FG009|Overall Study|Lost to Follow-up|0|||
13304446|NCT01307020|26519568|FG000|Overall Study|Electronic data capture failure|0|||
13304447|NCT01307020|26519569|FG001|Overall Study|Electronic data capture failure|1|||
13304448|NCT01307020|26519570|FG002|Overall Study|Electronic data capture failure|0|||
13304449|NCT01307020|26519571|FG003|Overall Study|Electronic data capture failure|0|||
13304450|NCT01307020|26519572|FG004|Overall Study|Electronic data capture failure|0|||
13304451|NCT01307020|26519573|FG005|Overall Study|Electronic data capture failure|0|||
13304452|NCT01307020|26519574|FG006|Overall Study|Electronic data capture failure|0|||
13304453|NCT01307020|26519575|FG007|Overall Study|Electronic data capture failure|0|||
13304454|NCT01307020|26519576|FG008|Overall Study|Electronic data capture failure|0|||
13304455|NCT01307020|26519577|FG009|Overall Study|Electronic data capture failure|0|||
13304456|NCT01306968|26519612|FG000|Overall Study|Lost to Follow-up|1|||
13304457|NCT01306968|26519613|FG001|Overall Study|Lost to Follow-up|1|||
13304458|NCT01306968|26519614|FG002|Overall Study|Lost to Follow-up|0|||
13304459|NCT01306968|26519615|FG003|Overall Study|Lost to Follow-up|0|||
13304460|NCT01306968|26519612|FG000|Overall Study|Physician Decision|0|||
13304461|NCT01306968|26519613|FG001|Overall Study|Physician Decision|1|||
13304462|NCT01306968|26519614|FG002|Overall Study|Physician Decision|0|||
13304463|NCT01306968|26519615|FG003|Overall Study|Physician Decision|0|||
13304464|NCT01306968|26519612|FG000|Overall Study|Relocated and left active duty|0|||
13304465|NCT01306968|26519613|FG001|Overall Study|Relocated and left active duty|1|||
13304466|NCT01306968|26519614|FG002|Overall Study|Relocated and left active duty|1|||
13304467|NCT01306968|26519615|FG003|Overall Study|Relocated and left active duty|1|||
13304468|NCT01306968|26519612|FG000|Overall Study|Withdrew - time commitment|0|||
13304469|NCT01306968|26519613|FG001|Overall Study|Withdrew - time commitment|0|||
13304470|NCT01306968|26519614|FG002|Overall Study|Withdrew - time commitment|0|||
13304471|NCT01306968|26519615|FG003|Overall Study|Withdrew - time commitment|2|||
13304472|NCT01306968|26519612|FG000|Overall Study|Withdrew over privacy concerns|0|||
13304473|NCT01306968|26519613|FG001|Overall Study|Withdrew over privacy concerns|0|||
13304474|NCT01306968|26519614|FG002|Overall Study|Withdrew over privacy concerns|0|||
13304475|NCT01306968|26519615|FG003|Overall Study|Withdrew over privacy concerns|1|||
13304476|NCT01306942|26519658|FG000|Phase I|Adverse Event|2|||
13304477|NCT01306942|26519659|FG001|Phase I|Adverse Event|2|||
13304478|NCT01306942|26519660|FG002|Phase I|Adverse Event|0|||
13304479|NCT01306942|26519661|FG003|Phase I|Adverse Event|0|||
13304480|NCT01306942|26519658|FG000|Phase I|Physician Decision|3|||
13304481|NCT01306942|26519659|FG001|Phase I|Physician Decision|1|||
13304482|NCT01306942|26519660|FG002|Phase I|Physician Decision|0|||
13304483|NCT01306942|26519661|FG003|Phase I|Physician Decision|0|||
13304484|NCT01306942|26519658|FG000|Phase II|Adverse Event|0|||
13304485|NCT01306942|26519659|FG001|Phase II|Adverse Event|0|||
13304486|NCT01306942|26519660|FG002|Phase II|Adverse Event|0|||
13304487|NCT01306942|26519661|FG003|Phase II|Adverse Event|6|||
13304488|NCT01306942|26519658|FG000|Phase II|Physician Decision|2|||
13304489|NCT01306942|26519659|FG001|Phase II|Physician Decision|0|||
13304490|NCT01306942|26519660|FG002|Phase II|Physician Decision|0|||
13304491|NCT01306942|26519661|FG003|Phase II|Physician Decision|5|||
13304492|NCT01306942|26519658|FG000|Phase II|Withdrawal by Subject|0|||
13304493|NCT01306942|26519659|FG001|Phase II|Withdrawal by Subject|0|||
13304494|NCT01306942|26519660|FG002|Phase II|Withdrawal by Subject|0|||
13304495|NCT01306942|26519661|FG003|Phase II|Withdrawal by Subject|2|||
13304496|NCT01306942|26519658|FG000|Phase II|Death|0|||
13304497|NCT01306942|26519659|FG001|Phase II|Death|0|||
13304498|NCT01306942|26519660|FG002|Phase II|Death|0|||
13304499|NCT01306942|26519661|FG003|Phase II|Death|1|||
13304500|NCT01306942|26519658|FG000|Phase II|Not finished treatment|0|||
13304501|NCT01306942|26519659|FG001|Phase II|Not finished treatment|0|||
13304502|NCT01306942|26519660|FG002|Phase II|Not finished treatment|0|||
13304503|NCT01306942|26519661|FG003|Phase II|Not finished treatment|1|||
13304504|NCT01306942|26519658|FG000|Phase II|Protocol Violation|0|||
13304505|NCT01306942|26519659|FG001|Phase II|Protocol Violation|0|||
13304506|NCT01306942|26519660|FG002|Phase II|Protocol Violation|0|||
13304507|NCT01306942|26519661|FG003|Phase II|Protocol Violation|1|||
13304508|NCT01306929|26519668|FG000|Overall Study|Withdrawal by Subject|23|||
13304509|NCT01306929|26519668|FG000|Overall Study|Adverse Event|21|||
13304510|NCT01306929|26519668|FG000|Overall Study|Physician Decision|13|||
13304511|NCT01306929|26519668|FG000|Overall Study|Death|8|||
13304512|NCT01306929|26519668|FG000|Overall Study|Withdrawal by parent/guardian|5|||
13304513|NCT01306929|26519668|FG000|Overall Study|Protocol Violation|3|||
13304514|NCT01306929|26519668|FG000|Overall Study|Non-compliance with study drug|2|||
13304515|NCT01306929|26519668|FG000|Overall Study|Lost to Follow-up|2|||
13304516|NCT01306929|26519668|FG000|Overall Study|Various|17|||
13304517|NCT01306890|26519675|FG000|Overall Study|Adverse Event|2|||
13304518|NCT01306890|26519675|FG000|Overall Study|Death|1223|||
13304519|NCT01306890|26519675|FG000|Overall Study|Lost to Follow-up|58|||
13304520|NCT01306890|26519675|FG000|Overall Study|Withdrawal by Subject|88|||
13304521|NCT01306890|26519675|FG000|Overall Study|Unspecified reasons|104|||
13304522|NCT01306890|26519675|FG000|Overall Study|Study Termination|3|||
13304523|NCT01306890|26519675|FG000|Overall Study|No discontinuation documentation|41|||
13304524|NCT01306877|26519700|FG000|Overall Study|Lost to Follow-up|3|||
13304525|NCT01306877|26519701|FG001|Overall Study|Lost to Follow-up|3|||
13304526|NCT01306877|26519700|FG000|Overall Study|Physician Decision|0|||
13304527|NCT01306877|26519701|FG001|Overall Study|Physician Decision|1|||
13304528|NCT01306656|26519720|FG000|Overall Study|Lost to Follow-up|1|||
13304529|NCT01306656|26519721|FG001|Overall Study|Lost to Follow-up|0|||
13304530|NCT01306643|26519732|FG000|Overall Study|Adverse Event|5|||
13304531|NCT01306643|26519732|FG000|Overall Study|Disease Progression|7|||
13304532|NCT01306643|26519732|FG000|Overall Study|Other: Change in Eligibility Status|1|||
13304533|NCT01306617|26519783|FG000|Overall Study|Adverse Event|1|||
13304534|NCT01306617|26519784|FG001|Overall Study|Adverse Event|0|||
13304535|NCT01306617|26519785|FG002|Overall Study|Adverse Event|0|||
13304536|NCT01306617|26519783|FG000|Overall Study|Virologic Failure|0|||
13304537|NCT01306617|26519784|FG001|Overall Study|Virologic Failure|0|||
13304538|NCT01306617|26519785|FG002|Overall Study|Virologic Failure|5|||
13304539|NCT01306617|26519783|FG000|Overall Study|Non-compliance|0|||
13304540|NCT01306617|26519784|FG001|Overall Study|Non-compliance|1|||
13304541|NCT01306617|26519785|FG002|Overall Study|Non-compliance|0|||
13304542|NCT01306331|26519800|FG000|Overall Study|Adverse Event|28|||
13304543|NCT01306331|26519801|FG001|Overall Study|Adverse Event|25|||
13304544|NCT01306331|26519800|FG000|Overall Study|Lost to Follow-up|321|||
13304545|NCT01306331|26519801|FG001|Overall Study|Lost to Follow-up|323|||
13304546|NCT01306331|26519800|FG000|Overall Study|Physician Decision|26|||
13304547|NCT01306331|26519801|FG001|Overall Study|Physician Decision|22|||
13304548|NCT01306331|26519800|FG000|Overall Study|Pregnancy|136|||
13304549|NCT01306331|26519801|FG001|Overall Study|Pregnancy|151|||
13304550|NCT01306331|26519800|FG000|Overall Study|Protocol Violation|154|||
13304551|NCT01306331|26519801|FG001|Overall Study|Protocol Violation|124|||
13304552|NCT01306331|26519800|FG000|Overall Study|Withdrawal by Subject|163|||
13304553|NCT01306331|26519801|FG001|Overall Study|Withdrawal by Subject|152|||
13304554|NCT01306331|26519800|FG000|Overall Study|Not sexually active|29|||
13304555|NCT01306331|26519801|FG001|Overall Study|Not sexually active|28|||
13304556|NCT01306331|26519800|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10|||
13304557|NCT01306331|26519801|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20|||
13304558|NCT01306331|26519800|FG000|Overall Study|Other|34|||
13304559|NCT01306331|26519801|FG001|Overall Study|Other|32|||
13304560|NCT01306305|26519822|FG000|Overall Study|Lost to Follow-up|1|||
13304561|NCT01306305|26519823|FG001|Overall Study|Lost to Follow-up|0|||
13304562|NCT01306305|26519822|FG000|Overall Study|Withdrew consent|1|||
13304563|NCT01306305|26519823|FG001|Overall Study|Withdrew consent|0|||
13304564|NCT01306253|26519844|FG000|Overall Study|Lost to Follow-up|1|||
13304565|NCT01306253|26519845|FG001|Overall Study|Lost to Follow-up|1|||
13304566|NCT01306214|26519872|FG000|Overall Study|Death|0|||
13304567|NCT01306214|26519873|FG001|Overall Study|Death|0|||
13304568|NCT01306214|26519874|FG002|Overall Study|Death|1|||
13304569|NCT01306214|26519872|FG000|Overall Study|Lost to Follow-up|3|||
13304570|NCT01306214|26519873|FG001|Overall Study|Lost to Follow-up|5|||
13304571|NCT01306214|26519874|FG002|Overall Study|Lost to Follow-up|4|||
13304572|NCT01306214|26519872|FG000|Overall Study|Withdrawal by Subject|24|||
13304573|NCT01306214|26519873|FG001|Overall Study|Withdrawal by Subject|22|||
13304574|NCT01306214|26519874|FG002|Overall Study|Withdrawal by Subject|16|||
13304575|NCT01306214|26519872|FG000|Overall Study|Not treated|1|||
13304576|NCT01306214|26519873|FG001|Overall Study|Not treated|1|||
13304577|NCT01306214|26519874|FG002|Overall Study|Not treated|1|||
13304578|NCT01306201|26519884|FG000|Overall Study|Arrhythmia|4|||
13304579|NCT01306201|26519884|FG000|Overall Study|Files could not be processed|3|||
13304580|NCT01306201|26519884|FG000|Overall Study|Files unreadable|3|||
13304581|NCT01306162|26519925|FG000|Period 1|Adverse Event|0|||
13304582|NCT01306162|26519926|FG001|Period 1|Adverse Event|0|||
13304583|NCT01306162|26519927|FG002|Period 1|Adverse Event|0|||
13304584|NCT01306162|26519928|FG003|Period 1|Adverse Event|1|||
13304585|NCT01306162|26519925|FG000|Washout 1|Non-compliance to protocol|0|||
13304586|NCT01306162|26519926|FG001|Washout 1|Non-compliance to protocol|1|||
13304587|NCT01306162|26519927|FG002|Washout 1|Non-compliance to protocol|0|||
13304588|NCT01306162|26519928|FG003|Washout 1|Non-compliance to protocol|0|||
13304589|NCT01306058|26519951|FG000|Overall Study|Death|1|||
13304590|NCT01306058|26519951|FG000|Overall Study|Enrolled but did not get treatment|1|||
13304591|NCT01306032|26520022|FG000|First Intervention|Adverse Event|1|||
13304592|NCT01306032|26520023|FG001|First Intervention|Adverse Event|0|||
13304593|NCT01306032|26520024|FG002|First Intervention|Adverse Event|1|||
13304594|NCT01306032|26520025|FG003|First Intervention|Adverse Event|0|||
13304595|NCT01306032|26520026|FG004|First Intervention|Adverse Event|0|||
13304596|NCT01306032|26520027|FG005|First Intervention|Adverse Event|1|||
13304597|NCT01306032|26520022|FG000|First Intervention|Withdrawal by Subject|0|||
13304598|NCT01306032|26520023|FG001|First Intervention|Withdrawal by Subject|2|||
13304599|NCT01306032|26520024|FG002|First Intervention|Withdrawal by Subject|0|||
13304600|NCT01306032|26520025|FG003|First Intervention|Withdrawal by Subject|1|||
13304601|NCT01306032|26520026|FG004|First Intervention|Withdrawal by Subject|0|||
13304602|NCT01306032|26520027|FG005|First Intervention|Withdrawal by Subject|0|||
13304603|NCT01306032|26520022|FG000|First Intervention|Death|0|||
13304604|NCT01306032|26520023|FG001|First Intervention|Death|0|||
13304605|NCT01306032|26520024|FG002|First Intervention|Death|1|||
13304606|NCT01306032|26520025|FG003|First Intervention|Death|0|||
13304607|NCT01306032|26520026|FG004|First Intervention|Death|0|||
13304608|NCT01306032|26520027|FG005|First Intervention|Death|0|||
13304609|NCT01306032|26520022|FG000|First Intervention|Ineligible|0|||
13304610|NCT01306032|26520023|FG001|First Intervention|Ineligible|0|||
13304611|NCT01306032|26520024|FG002|First Intervention|Ineligible|0|||
13304612|NCT01306032|26520025|FG003|First Intervention|Ineligible|0|||
13304613|NCT01306032|26520026|FG004|First Intervention|Ineligible|0|||
13304614|NCT01306032|26520027|FG005|First Intervention|Ineligible|1|||
13304615|NCT01306032|26520022|FG000|First Intervention|Progressive disease|0|||
13382542|NCT00744237|26751175|FG001|Overall Study|Lost to Follow-up|1|||
13382543|NCT00744237|26751176|FG002|Overall Study|Lost to Follow-up|1|||
13382544|NCT00744237|26751174|FG000|Overall Study|Protocol Violation|3|||
13382545|NCT00744237|26751175|FG001|Overall Study|Protocol Violation|4|||
13382546|NCT00744237|26751176|FG002|Overall Study|Protocol Violation|3|||
13382547|NCT00744237|26751174|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
13382548|NCT00744237|26751175|FG001|Overall Study|Inclusion/Exclusion criteria not met|0|||
13382549|NCT00744237|26751176|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
13382550|NCT00744237|26751174|FG000|Overall Study|Dosing Error|1|||
13382551|NCT00744237|26751175|FG001|Overall Study|Dosing Error|0|||
13382552|NCT00744237|26751176|FG002|Overall Study|Dosing Error|1|||
13382553|NCT00744237|26751174|FG000|Overall Study|Study Drug Error|1|||
13382554|NCT00744237|26751175|FG001|Overall Study|Study Drug Error|0|||
13382555|NCT00744237|26751176|FG002|Overall Study|Study Drug Error|0|||
13382556|NCT00744237|26751174|FG000|Overall Study|Prohibited Concomitant Medication|0|||
13382557|NCT00744237|26751175|FG001|Overall Study|Prohibited Concomitant Medication|0|||
13382558|NCT00744237|26751176|FG002|Overall Study|Prohibited Concomitant Medication|1|||
13382559|NCT00744237|26751174|FG000|Overall Study|Poor Compliance|0|||
13382560|NCT00744237|26751175|FG001|Overall Study|Poor Compliance|2|||
13382561|NCT00744237|26751176|FG002|Overall Study|Poor Compliance|0|||
13382562|NCT00744237|26751174|FG000|Overall Study|Administrative. Site Closed|1|||
13382563|NCT00744237|26751175|FG001|Overall Study|Administrative. Site Closed|1|||
13382564|NCT00744237|26751176|FG002|Overall Study|Administrative. Site Closed|1|||
13382565|NCT00744237|26751174|FG000|Overall Study|Adverse Event|9|||
13382566|NCT00744237|26751175|FG001|Overall Study|Adverse Event|13|||
13382567|NCT00744237|26751176|FG002|Overall Study|Adverse Event|5|||
13382568|NCT00744055|26751191|FG000|Overall Study|Withdrawal by Subject|6|||
13394788|NCT00654381|26788097|FG000|Extension Stage|Protocol Violation|0|||
13394789|NCT00654381|26788098|FG001|Extension Stage|Protocol Violation|0|||
13394790|NCT00654381|26788099|FG002|Extension Stage|Protocol Violation|0|||
13394791|NCT00654381|26788100|FG003|Extension Stage|Protocol Violation|1|||
13394792|NCT00654381|26788101|FG004|Extension Stage|Protocol Violation|0|||
13394793|NCT00654381|26788102|FG005|Extension Stage|Protocol Violation|0|||
13394794|NCT00654381|26788097|FG000|Extension Stage|Lack of Efficacy|0|||
13394795|NCT00654381|26788098|FG001|Extension Stage|Lack of Efficacy|0|||
13394796|NCT00654381|26788099|FG002|Extension Stage|Lack of Efficacy|1|||
13394797|NCT00654381|26788100|FG003|Extension Stage|Lack of Efficacy|0|||
13394798|NCT00654381|26788101|FG004|Extension Stage|Lack of Efficacy|0|||
13394799|NCT00654381|26788102|FG005|Extension Stage|Lack of Efficacy|0|||
13394800|NCT00654381|26788097|FG000|Extension Stage|Withdrawal by Subject|0|||
13394801|NCT00654381|26788098|FG001|Extension Stage|Withdrawal by Subject|0|||
13394802|NCT00654381|26788099|FG002|Extension Stage|Withdrawal by Subject|1|||
13304616|NCT01306032|26520023|FG001|First Intervention|Progressive disease|0|||
13304617|NCT01306032|26520024|FG002|First Intervention|Progressive disease|0|||
13304618|NCT01306032|26520025|FG003|First Intervention|Progressive disease|0|||
13304619|NCT01306032|26520026|FG004|First Intervention|Progressive disease|2|||
13304620|NCT01306032|26520027|FG005|First Intervention|Progressive disease|0|||
13304621|NCT01306032|26520022|FG000|Disease Progression/Crossover|Withdrawal by Subject|0|||
13304622|NCT01306032|26520023|FG001|Disease Progression/Crossover|Withdrawal by Subject|0|||
13304623|NCT01306032|26520024|FG002|Disease Progression/Crossover|Withdrawal by Subject|0|||
13304624|NCT01306032|26520025|FG003|Disease Progression/Crossover|Withdrawal by Subject|1|||
13304625|NCT01306032|26520026|FG004|Disease Progression/Crossover|Withdrawal by Subject|0|||
13304626|NCT01306032|26520027|FG005|Disease Progression/Crossover|Withdrawal by Subject|0|||
13304627|NCT01306032|26520022|FG000|Disease Progression/Crossover|other/symptomatic progression|0|||
13304628|NCT01306032|26520023|FG001|Disease Progression/Crossover|other/symptomatic progression|2|||
13304629|NCT01306032|26520024|FG002|Disease Progression/Crossover|other/symptomatic progression|0|||
13304630|NCT01306032|26520025|FG003|Disease Progression/Crossover|other/symptomatic progression|2|||
13304631|NCT01306032|26520026|FG004|Disease Progression/Crossover|other/symptomatic progression|0|||
13304632|NCT01306032|26520027|FG005|Disease Progression/Crossover|other/symptomatic progression|0|||
13304633|NCT01305941|26520041|FG000|Overall Study|Adverse Event|6|||
13304634|NCT01305941|26520041|FG000|Overall Study|Clinical decline|2|||
13304635|NCT01305941|26520041|FG000|Overall Study|Withdrawal by Subject|1|||
13304636|NCT01305941|26520041|FG000|Overall Study|Death|1|||
13304637|NCT01305577|26520080|FG000|Overall Study|Adverse Event|2|||
13304638|NCT01305577|26520081|FG001|Overall Study|Adverse Event|2|||
13304639|NCT01305577|26520082|FG002|Overall Study|Adverse Event|1|||
13304640|NCT01305577|26520080|FG000|Overall Study|Withdrawal by Subject|7|||
13304641|NCT01305577|26520081|FG001|Overall Study|Withdrawal by Subject|5|||
13304642|NCT01305577|26520082|FG002|Overall Study|Withdrawal by Subject|6|||
13304643|NCT01305577|26520080|FG000|Overall Study|Lost to Follow-up|4|||
13304644|NCT01305577|26520081|FG001|Overall Study|Lost to Follow-up|3|||
13304645|NCT01305577|26520082|FG002|Overall Study|Lost to Follow-up|2|||
13304646|NCT01305577|26520080|FG000|Overall Study|Protocol Deviation|0|||
13304647|NCT01305577|26520081|FG001|Overall Study|Protocol Deviation|1|||
13304648|NCT01305577|26520082|FG002|Overall Study|Protocol Deviation|1|||
13304649|NCT01305564|26520099|FG000|Overall Study|Death|21|||
13304650|NCT01305564|26520099|FG000|Overall Study|Lost to Follow-up|12|||
13304651|NCT01305564|26520099|FG000|Overall Study|Withdrawal by Subject|1|||
13304652|NCT01305564|26520099|FG000|Overall Study|Physician Decision|3|||
13304653|NCT01305408|26520156|FG000|Overall Study|Adverse Event|10|||
13304654|NCT01305408|26520157|FG001|Overall Study|Adverse Event|7|||
13304655|NCT01305408|26520156|FG000|Overall Study|Lack of Efficacy|3|||
13304656|NCT01305408|26520157|FG001|Overall Study|Lack of Efficacy|4|||
13304657|NCT01305408|26520156|FG000|Overall Study|Withdrawal by Subject|9|||
13304658|NCT01305408|26520157|FG001|Overall Study|Withdrawal by Subject|9|||
13304659|NCT01305408|26520156|FG000|Overall Study|Protocol Violation|4|||
13304660|NCT01305408|26520157|FG001|Overall Study|Protocol Violation|6|||
13304661|NCT01305408|26520156|FG000|Overall Study|Lost to Follow-up|5|||
13304662|NCT01305408|26520157|FG001|Overall Study|Lost to Follow-up|3|||
13304663|NCT01305408|26520156|FG000|Overall Study|Noncompliance with study medication|0|||
13304664|NCT01305408|26520157|FG001|Overall Study|Noncompliance with study medication|1|||
13304665|NCT01305408|26520156|FG000|Overall Study|Noncompliance with study procedures|0|||
13304666|NCT01305408|26520157|FG001|Overall Study|Noncompliance with study procedures|1|||
13304667|NCT01305408|26520156|FG000|Overall Study|Other|1|||
13304668|NCT01305408|26520157|FG001|Overall Study|Other|0|||
13304669|NCT01305239|26520167|FG000|Overall Study|Adverse Event|22|||
13304670|NCT01305239|26520167|FG000|Overall Study|Exemestane taken prior to inclusion only|1|||
13304671|NCT01305200|26520205|FG000|Overall Study|Physician Decision|4|||
13304672|NCT01305200|26520206|FG001|Overall Study|Physician Decision|6|||
13304673|NCT01305200|26520207|FG002|Overall Study|Physician Decision|1|||
13304674|NCT01305200|26520205|FG000|Overall Study|Withdrawal by Subject|24|||
13304675|NCT01305200|26520206|FG001|Overall Study|Withdrawal by Subject|21|||
13304676|NCT01305200|26520207|FG002|Overall Study|Withdrawal by Subject|1|||
13304677|NCT01305200|26520205|FG000|Overall Study|Ineligible|1|||
13304678|NCT01305200|26520206|FG001|Overall Study|Ineligible|2|||
13304679|NCT01305200|26520207|FG002|Overall Study|Ineligible|1|||
13304680|NCT01305200|26520205|FG000|Overall Study|Death|0|||
13304681|NCT01305200|26520206|FG001|Overall Study|Death|2|||
13304682|NCT01305200|26520207|FG002|Overall Study|Death|0|||
13304683|NCT01305044|26520238|FG000|Overall Study|Withdrawal by Subject|3|||
13304684|NCT01305044|26520239|FG001|Overall Study|Withdrawal by Subject|6|||
13304685|NCT01304940|26520252|FG000|Overall Study|not meet symptom severity requirement|3|||
13304686|NCT01304940|26520253|FG001|Overall Study|not meet symptom severity requirement|0|||
13304687|NCT01304706|26520259|FG000|Overall Study|Adverse Event|2|||
13304688|NCT01304706|26520259|FG000|Overall Study|Lack of Efficacy|1|||
13304689|NCT01304706|26520259|FG000|Overall Study|Death|3|||
13304690|NCT01304706|26520259|FG000|Overall Study|Withdrawal by Subject|3|||
13304691|NCT01304706|26520259|FG000|Overall Study|Lost to Follow-up|7|||
13304692|NCT01304706|26520259|FG000|Overall Study|Discontinued due to failed drug admin.|1|||
13304693|NCT01304693|26520292|FG000|Overall Study|Adverse Event|0|||
13304694|NCT01304693|26520293|FG001|Overall Study|Adverse Event|0|||
13304695|NCT01304693|26520294|FG002|Overall Study|Adverse Event|0|||
13304696|NCT01304693|26520295|FG003|Overall Study|Adverse Event|0|||
13304697|NCT01304693|26520296|FG004|Overall Study|Adverse Event|1|||
13304698|NCT01304693|26520292|FG000|Overall Study|Decision Unrelated to an Adverse Event|0|||
13304699|NCT01304693|26520293|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
13304700|NCT01304693|26520294|FG002|Overall Study|Decision Unrelated to an Adverse Event|1|||
13304701|NCT01304693|26520295|FG003|Overall Study|Decision Unrelated to an Adverse Event|1|||
13304702|NCT01304693|26520296|FG004|Overall Study|Decision Unrelated to an Adverse Event|0|||
13304703|NCT01304498|26520323|FG000|Overall Study|Adverse Event|1|||
13304704|NCT01304498|26520324|FG001|Overall Study|Adverse Event|1|||
13304705|NCT01304498|26520323|FG000|Overall Study|Withdrawal by Subject|2|||
13304706|NCT01304498|26520324|FG001|Overall Study|Withdrawal by Subject|3|||
13304707|NCT01304498|26520323|FG000|Overall Study|Protocol Violation|1|||
13304708|NCT01304498|26520324|FG001|Overall Study|Protocol Violation|0|||
13304709|NCT01304498|26520323|FG000|Overall Study|Lost to Follow-up|2|||
13304710|NCT01304498|26520324|FG001|Overall Study|Lost to Follow-up|1|||
13304711|NCT01304329|26520348|FG000|Third Intervention (3 Days)|Adverse Event|0|||
13304712|NCT01304329|26520349|FG001|Third Intervention (3 Days)|Adverse Event|1|||
13304713|NCT01304329|26520350|FG002|Third Intervention (3 Days)|Adverse Event|0|||
13304714|NCT01304329|26520351|FG003|Third Intervention (3 Days)|Adverse Event|0|||
13304715|NCT01304329|26520352|FG004|Third Intervention (3 Days)|Adverse Event|0|||
13304716|NCT01304329|26520353|FG005|Third Intervention (3 Days)|Adverse Event|0|||
13304717|NCT01304147|26520364|FG000|Second Intervention (7days)|Withdrawal by Subject|1|||
13304718|NCT01304147|26520365|FG001|Second Intervention (7days)|Withdrawal by Subject|1|||
13304719|NCT01303965|26520384|FG000|Overall Study|Adverse Event|1|||
13304720|NCT01303965|26520385|FG001|Overall Study|Adverse Event|1|||
13304721|NCT01303965|26520384|FG000|Overall Study|Death|0|||
13304722|NCT01303965|26520385|FG001|Overall Study|Death|3|||
13304723|NCT01303965|26520384|FG000|Overall Study|Withdrawal by Subject|1|||
13304724|NCT01303965|26520385|FG001|Overall Study|Withdrawal by Subject|0|||
13304725|NCT01303965|26520384|FG000|Overall Study|Disease Progression|1|||
13304726|NCT01303965|26520385|FG001|Overall Study|Disease Progression|6|||
13304727|NCT01303861|26520419|FG000|Overall Study|Lost to Follow-up|34|||
13304728|NCT01303861|26520420|FG001|Overall Study|Lost to Follow-up|14|||
13304729|NCT01303861|26520421|FG002|Overall Study|Lost to Follow-up|27|||
13304730|NCT01303861|26520422|FG003|Overall Study|Lost to Follow-up|31|||
13304731|NCT01303861|26520419|FG000|Overall Study|Lack of Efficacy|3|||
13304732|NCT01303861|26520420|FG001|Overall Study|Lack of Efficacy|2|||
13304733|NCT01303861|26520421|FG002|Overall Study|Lack of Efficacy|1|||
13304734|NCT01303861|26520422|FG003|Overall Study|Lack of Efficacy|0|||
13304735|NCT01303861|26520419|FG000|Overall Study|Withdrawal by Subject|16|||
13304736|NCT01303861|26520420|FG001|Overall Study|Withdrawal by Subject|8|||
13304737|NCT01303861|26520421|FG002|Overall Study|Withdrawal by Subject|8|||
13304738|NCT01303861|26520422|FG003|Overall Study|Withdrawal by Subject|23|||
13304739|NCT01303861|26520419|FG000|Overall Study|Adverse Event|4|||
13304740|NCT01303861|26520420|FG001|Overall Study|Adverse Event|1|||
13304741|NCT01303861|26520421|FG002|Overall Study|Adverse Event|0|||
13304742|NCT01303861|26520422|FG003|Overall Study|Adverse Event|5|||
13304743|NCT01303861|26520419|FG000|Overall Study|Pregnancy|1|||
13304744|NCT01303861|26520420|FG001|Overall Study|Pregnancy|0|||
13304745|NCT01303861|26520421|FG002|Overall Study|Pregnancy|0|||
13304746|NCT01303861|26520422|FG003|Overall Study|Pregnancy|0|||
13304747|NCT01303627|26520435|FG000|Overall Study|the failure while performing URS|0|||
13304748|NCT01303627|26520436|FG001|Overall Study|the failure while performing URS|1|||
13304749|NCT01303510|26520457|FG000|Overall Study|Lost to Follow-up|1|||
13304750|NCT01303510|26520458|FG001|Overall Study|Lost to Follow-up|0|||
13304751|NCT01303445|26520491|FG000|First Intervention (7 Days)|Withdrawal by Subject|1|||
13304752|NCT01303445|26520492|FG001|First Intervention (7 Days)|Withdrawal by Subject|0|||
13304753|NCT01303445|26520491|FG000|Second Intervention (7 Days)|Adverse Event|0|||
13304754|NCT01303445|26520492|FG001|Second Intervention (7 Days)|Adverse Event|2|||
13304755|NCT01303445|26520491|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
13304756|NCT01303445|26520492|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
13304757|NCT01303445|26520491|FG000|Washout (14 Days)|Protocol Violation|1|||
13304758|NCT01303445|26520492|FG001|Washout (14 Days)|Protocol Violation|0|||
13304759|NCT01303445|26520491|FG000|Washout (14 Days)|Lost to Follow-up|0|||
13304760|NCT01303445|26520492|FG001|Washout (14 Days)|Lost to Follow-up|2|||
13304761|NCT01303445|26520491|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1|||
13304762|NCT01303445|26520492|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0|||
13304763|NCT01303445|26520491|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0|||
13304764|NCT01303445|26520492|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1|||
13304765|NCT01303419|26520502|FG000|Overall Study|Discontinuation of study|60|||
13304766|NCT01303419|26520502|FG000|Overall Study|Did not complete both imaging methods|5|||
13304767|NCT01303419|26520502|FG000|Overall Study|Did not meet all I/E after screening|31|||
13304768|NCT01303380|26520530|FG000|Overall Study|Lack of compliance to study procedures|1|||
13304769|NCT01303172|26520549|FG000|Overall Study|Physician Decision|9|||
13304770|NCT01303172|26520550|FG001|Overall Study|Physician Decision|6|||
13304771|NCT01303172|26520549|FG000|Overall Study|Adverse Event|5|||
13304772|NCT01303172|26520550|FG001|Overall Study|Adverse Event|2|||
13304773|NCT01303172|26520549|FG000|Overall Study|Withdrawal by Subject|4|||
13304774|NCT01303172|26520550|FG001|Overall Study|Withdrawal by Subject|2|||
13304775|NCT01303172|26520549|FG000|Overall Study|Death|20|||
13304776|NCT01303172|26520550|FG001|Overall Study|Death|7|||
13304777|NCT01303172|26520549|FG000|Overall Study|Lack of Efficacy|25|||
13304778|NCT01303172|26520550|FG001|Overall Study|Lack of Efficacy|17|||
13304779|NCT01303159|26520557|FG000|Overall Study|Death|16|||
13304780|NCT01303159|26520557|FG000|Overall Study|Study Termination|7|||
13304781|NCT01302964|26520572|FG000|Overall Study|Adverse Event|1|||
13304782|NCT01302964|26520573|FG001|Overall Study|Adverse Event|0|||
13304783|NCT01302938|26520623|FG000|Overall Study|Withdrawal by Subject|1|||
13304784|NCT01302938|26520624|FG001|Overall Study|Withdrawal by Subject|0|||
13304785|NCT01302938|26520623|FG000|Overall Study|Adverse Event|1|||
13304786|NCT01302938|26520624|FG001|Overall Study|Adverse Event|0|||
13304787|NCT01302899|26520681|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1|||
13304788|NCT01302899|26520682|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0|||
13304789|NCT01302899|26520681|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0|||
13304790|NCT01302899|26520682|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1|||
13304791|NCT01302834|26520731|FG000|Overall Study|Protocol Violation|17|||
13304792|NCT01302834|26520732|FG001|Overall Study|Protocol Violation|23|||
13304793|NCT01302834|26520731|FG000|Overall Study|HIV positive|1|||
13304794|NCT01302834|26520732|FG001|Overall Study|HIV positive|3|||
13304795|NCT01302691|26520757|FG000|Overall Study|Adverse Event|2|||
13304796|NCT01302691|26520758|FG001|Overall Study|Adverse Event|0|||
13304797|NCT01302691|26520757|FG000|Overall Study|Death|0|||
13304798|NCT01302691|26520758|FG001|Overall Study|Death|1|||
13304799|NCT01302691|26520757|FG000|Overall Study|Lost to Follow-up|1|||
13304800|NCT01302691|26520758|FG001|Overall Study|Lost to Follow-up|0|||
13304801|NCT01302691|26520757|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6|||
13304802|NCT01302691|26520758|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4|||
13304803|NCT01302691|26520757|FG000|Overall Study|Physician Decision|0|||
13304804|NCT01302691|26520758|FG001|Overall Study|Physician Decision|1|||
13304805|NCT01302691|26520757|FG000|Overall Study|Protocol Violation|1|||
13304806|NCT01302691|26520758|FG001|Overall Study|Protocol Violation|0|||
13304807|NCT01302548|26520775|FG000|Overall Study|Lost to Follow-up|2|||
13304808|NCT01302548|26520776|FG001|Overall Study|Lost to Follow-up|1|||
13304809|NCT01302418|26520782|FG000|Overall Study|Protocol Violation|9|||
13304810|NCT01302418|26520782|FG000|Overall Study|Non-evaluable|9|||
13304811|NCT01302392|26520809|FG000|Overall Study|Lost to Follow-up|1|||
13304812|NCT01302392|26520810|FG001|Overall Study|Lost to Follow-up|0|||
13304813|NCT01302392|26520809|FG000|Overall Study|Withdrawal by Subject|6|||
13304814|NCT01302392|26520810|FG001|Overall Study|Withdrawal by Subject|1|||
13304815|NCT01302366|26520818|FG000|Overall Study|patient choice or noncompliance|5|||
13304816|NCT01302119|26520837|FG000|Overall Study|Withdrawal by Subject|30|||
13304817|NCT01302119|26520838|FG001|Overall Study|Withdrawal by Subject|20|||
13304818|NCT01302119|26520837|FG000|Overall Study|Lost to Follow-up|10|||
13304819|NCT01302119|26520838|FG001|Overall Study|Lost to Follow-up|4|||
13304820|NCT01302119|26520837|FG000|Overall Study|Adverse Event|2|||
13304821|NCT01302119|26520838|FG001|Overall Study|Adverse Event|1|||
13304822|NCT01302119|26520837|FG000|Overall Study|Non-compliance|4|||
13304823|NCT01302119|26520838|FG001|Overall Study|Non-compliance|2|||
13304824|NCT01302119|26520837|FG000|Overall Study|Non-specific|4|||
13304825|NCT01302119|26520838|FG001|Overall Study|Non-specific|1|||
13304826|NCT01302080|26521065|FG000|Overall Study|Withdrew Consent|92|||
13382569|NCT00744055|26751192|FG001|Overall Study|Withdrawal by Subject|9|||
13382570|NCT00744055|26751191|FG000|Overall Study|Lack of Efficacy|0|||
13382571|NCT00744055|26751192|FG001|Overall Study|Lack of Efficacy|1|||
13382572|NCT00744055|26751191|FG000|Overall Study|Physician Decision|0|||
13382573|NCT00744055|26751192|FG001|Overall Study|Physician Decision|2|||
13382574|NCT00744055|26751191|FG000|Overall Study|Protocol Violation|1|||
13382575|NCT00744055|26751192|FG001|Overall Study|Protocol Violation|1|||
13382576|NCT00744055|26751191|FG000|Overall Study|Lost to Follow-up|0|||
13382577|NCT00744055|26751192|FG001|Overall Study|Lost to Follow-up|1|||
13382578|NCT00744042|26751207|FG000|Overall Study|Withdrawal by Subject|1|||
13382579|NCT00743652|26751298|FG000|Overall Study|Parent/Legal Guardian Request|3|||
13382580|NCT00743652|26751299|FG001|Overall Study|Parent/Legal Guardian Request|2|||
13382581|NCT00743652|26751300|FG002|Overall Study|Parent/Legal Guardian Request|2|||
13382582|NCT00743652|26751301|FG003|Overall Study|Parent/Legal Guardian Request|2|||
13382583|NCT00743652|26751302|FG004|Overall Study|Parent/Legal Guardian Request|0|||
13382584|NCT00743652|26751298|FG000|Overall Study|Adverse Event|3|||
13304827|NCT01302080|26521066|FG001|Overall Study|Withdrew Consent|39|||
13304828|NCT01302080|26521065|FG000|Overall Study|Patient/Family Moved|28|||
13304829|NCT01302080|26521066|FG001|Overall Study|Patient/Family Moved|3|||
13304830|NCT01302080|26521065|FG000|Overall Study|Lost to Follow-up|192|||
13304831|NCT01302080|26521066|FG001|Overall Study|Lost to Follow-up|93|||
13304832|NCT01302080|26521065|FG000|Overall Study|Death|1|||
13304833|NCT01302080|26521066|FG001|Overall Study|Death|0|||
13304834|NCT01302080|26521065|FG000|Overall Study|Other|52|||
13304835|NCT01302080|26521066|FG001|Overall Study|Other|8|||
13304836|NCT01302080|26521065|FG000|Overall Study|Reason Missing For Discontinuation|1|||
13304837|NCT01302080|26521066|FG001|Overall Study|Reason Missing For Discontinuation|0|||
13304838|NCT01302067|26521147|FG000|Overall Study|Death|0|||
13304839|NCT01302067|26521148|FG001|Overall Study|Death|0|||
13304840|NCT01302067|26521149|FG002|Overall Study|Death|1|||
13304841|NCT01302067|26521147|FG000|Overall Study|Physician Decision|9|||
13304842|NCT01302067|26521148|FG001|Overall Study|Physician Decision|5|||
13304843|NCT01302067|26521149|FG002|Overall Study|Physician Decision|14|||
13304844|NCT01302067|26521147|FG000|Overall Study|Lack of Efficacy|8|||
13304845|NCT01302067|26521148|FG001|Overall Study|Lack of Efficacy|4|||
13304846|NCT01302067|26521149|FG002|Overall Study|Lack of Efficacy|2|||
13304847|NCT01302067|26521147|FG000|Overall Study|Lost to Follow-up|9|||
13304848|NCT01302067|26521148|FG001|Overall Study|Lost to Follow-up|4|||
13304849|NCT01302067|26521149|FG002|Overall Study|Lost to Follow-up|15|||
13304850|NCT01302067|26521147|FG000|Overall Study|Withdrawal by Subject|13|||
13304851|NCT01302067|26521148|FG001|Overall Study|Withdrawal by Subject|6|||
13304852|NCT01302067|26521149|FG002|Overall Study|Withdrawal by Subject|10|||
13304853|NCT01302067|26521147|FG000|Overall Study|Other|1|||
13304854|NCT01302067|26521148|FG001|Overall Study|Other|1|||
13304855|NCT01302067|26521149|FG002|Overall Study|Other|3|||
13304856|NCT01302067|26521147|FG000|Overall Study|Protocol Violation|11|||
13304857|NCT01302067|26521148|FG001|Overall Study|Protocol Violation|0|||
13304858|NCT01302067|26521149|FG002|Overall Study|Protocol Violation|8|||
13304859|NCT01302067|26521147|FG000|Overall Study|Adverse Event|27|||
13304860|NCT01302067|26521148|FG001|Overall Study|Adverse Event|14|||
13304861|NCT01302067|26521149|FG002|Overall Study|Adverse Event|45|||
13304862|NCT01302054|26521180|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4|||
13304863|NCT01302054|26521181|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
13304864|NCT01302054|26521182|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
13304865|NCT01302054|26521180|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17|||
13304866|NCT01302054|26521181|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
13304867|NCT01302054|26521182|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
13304868|NCT01302054|26521180|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16|||
13304869|NCT01302054|26521181|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
13304870|NCT01302054|26521182|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
13304871|NCT01302054|26521180|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8|||
13304872|NCT01302054|26521181|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
13304873|NCT01302054|26521182|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
13304874|NCT01302054|26521180|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13|||
13304875|NCT01302054|26521181|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
13304876|NCT01302054|26521182|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
13304877|NCT01302054|26521180|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314|||
13304878|NCT01302054|26521181|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
13304879|NCT01302054|26521182|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
13304880|NCT01302054|26521180|FG000|Tolterodine Open-Label Run-In Phase|Other|7|||
13304881|NCT01302054|26521181|FG001|Tolterodine Open-Label Run-In Phase|Other|0|||
13304882|NCT01302054|26521182|FG002|Tolterodine Open-Label Run-In Phase|Other|0|||
13304883|NCT01302054|26521180|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2|||
13304884|NCT01302054|26521181|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
13304885|NCT01302054|26521182|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
13304886|NCT01302054|26521180|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0|||
13304887|NCT01302054|26521181|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2|||
13304888|NCT01302054|26521182|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4|||
13304889|NCT01302054|26521180|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
13304890|NCT01302054|26521181|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
13304891|NCT01302054|26521182|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
13304892|NCT01302054|26521180|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
13304893|NCT01302054|26521181|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6|||
13304894|NCT01302054|26521182|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14|||
13304895|NCT01302054|26521180|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
13304896|NCT01302054|26521181|FG001|Double-Blind Treatment Phase|Protocol Violation|3|||
13304897|NCT01302054|26521182|FG002|Double-Blind Treatment Phase|Protocol Violation|6|||
13304898|NCT01302054|26521180|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
13304899|NCT01302054|26521181|FG001|Double-Blind Treatment Phase|Adverse Event|10|||
13304900|NCT01302054|26521182|FG002|Double-Blind Treatment Phase|Adverse Event|10|||
13304901|NCT01302054|26521180|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
13304902|NCT01302054|26521181|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
13304903|NCT01302054|26521182|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2|||
13304904|NCT01302054|26521180|FG000|Double-Blind Treatment Phase|Other|0|||
13304905|NCT01302054|26521181|FG001|Double-Blind Treatment Phase|Other|4|||
13304906|NCT01302054|26521182|FG002|Double-Blind Treatment Phase|Other|9|||
13304907|NCT01302041|26521213|FG000|Overall Study|Death|5|||
13304908|NCT01302041|26521213|FG000|Overall Study|Withdrawal by Subject|4|||
13304909|NCT01302041|26521213|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29|||
13304910|NCT01302041|26521213|FG000|Overall Study|Other-Miscellaneous Reason|2|||
13304911|NCT01301950|26521234|FG000|Overall Study|Surgery was cancelled by patient|0|||
13304912|NCT01301950|26521235|FG001|Overall Study|Surgery was cancelled by patient|1|||
13382585|NCT00743652|26751299|FG001|Overall Study|Adverse Event|0|||
13382586|NCT00743652|26751300|FG002|Overall Study|Adverse Event|0|||
13382587|NCT00743652|26751301|FG003|Overall Study|Adverse Event|0|||
13382588|NCT00743652|26751302|FG004|Overall Study|Adverse Event|0|||
13382589|NCT00743652|26751298|FG000|Overall Study|Death|2|||
13382590|NCT00743652|26751299|FG001|Overall Study|Death|0|||
13382591|NCT00743652|26751300|FG002|Overall Study|Death|0|||
13382592|NCT00743652|26751301|FG003|Overall Study|Death|0|||
13382593|NCT00743652|26751302|FG004|Overall Study|Death|0|||
13382594|NCT00743652|26751298|FG000|Overall Study|Investigator Request|0|||
13382595|NCT00743652|26751299|FG001|Overall Study|Investigator Request|0|||
13382596|NCT00743652|26751300|FG002|Overall Study|Investigator Request|0|||
13382597|NCT00743652|26751301|FG003|Overall Study|Investigator Request|2|||
13382598|NCT00743652|26751302|FG004|Overall Study|Investigator Request|0|||
13382599|NCT00743652|26751298|FG000|Overall Study|Other|1|||
13382600|NCT00743652|26751299|FG001|Overall Study|Other|1|||
13382601|NCT00743652|26751300|FG002|Overall Study|Other|0|||
13382602|NCT00743652|26751301|FG003|Overall Study|Other|0|||
13382603|NCT00743652|26751302|FG004|Overall Study|Other|0|||
13382604|NCT00743652|26751298|FG000|Overall Study|Lost to Follow-up|1|||
13382605|NCT00743652|26751299|FG001|Overall Study|Lost to Follow-up|0|||
13382606|NCT00743652|26751300|FG002|Overall Study|Lost to Follow-up|0|||
13382607|NCT00743652|26751301|FG003|Overall Study|Lost to Follow-up|0|||
13382608|NCT00743652|26751302|FG004|Overall Study|Lost to Follow-up|0|||
13382609|NCT00743509|26751309|FG000|Overall Study|Withdrawal by Subject|2|||
13382610|NCT00743483|26751315|FG000|Baseline Period|Physician Decision|1|||
13382611|NCT00743483|26751315|FG000|Treatment Period|Adverse Event|1|||
13382612|NCT00743444|26751327|FG000|First Intervention|Catheter placement problems|0|||
13382613|NCT00743444|26751328|FG001|First Intervention|Catheter placement problems|1|||
13382614|NCT00743444|26751327|FG000|Washout Period|Adverse Event|0|||
13382615|NCT00743444|26751328|FG001|Washout Period|Adverse Event|1|||
13382616|NCT00743431|26751334|FG000|Overall Study|Toxicity|6|||
13382617|NCT00743431|26751334|FG000|Overall Study|Tumor progression|56|||
13382618|NCT00743431|26751334|FG000|Overall Study|Withdrawal by Subject|13|||
13382619|NCT00743431|26751334|FG000|Overall Study|Death|9|||
13382620|NCT00743431|26751334|FG000|Overall Study|Reason for discontinuation not specified|29|||
13382621|NCT00743431|26751334|FG000|Overall Study|No documentation available|13|||
13382622|NCT00743366|26751343|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
13382623|NCT00743366|26751344|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
13382624|NCT00743340|26751350|FG000|Overall Study|Study medication non-compliance|1|||
13382625|NCT00743340|26751350|FG000|Overall Study|Lost to Follow-up|1|||
13382626|NCT00743340|26751350|FG000|Overall Study|Withdrawal from the Study|5|||
13382627|NCT00743340|26751350|FG000|Overall Study|Protocol Violation|1|||
13382628|NCT00743340|26751350|FG000|Overall Study|Virologic failure|8|||
13382629|NCT00743340|26751350|FG000|Overall Study|Pregnancy|1|||
13382630|NCT00743340|26751350|FG000|Overall Study|Rolled over to other Gilead Study|23|||
13382631|NCT00743340|26751350|FG000|Overall Study|Participant Relocated|1|||
13382632|NCT00743288|26751370|FG000|Overall Study|Adverse Event|1|||
13382633|NCT00743288|26751371|FG001|Overall Study|Adverse Event|1|||
13382634|NCT00743288|26751372|FG002|Overall Study|Adverse Event|2|||
13382635|NCT00743288|26751373|FG003|Overall Study|Adverse Event|2|||
13382636|NCT00743288|26751374|FG004|Overall Study|Adverse Event|1|||
13382637|NCT00743288|26751375|FG005|Overall Study|Adverse Event|1|||
13382638|NCT00743288|26751376|FG006|Overall Study|Adverse Event|2|||
13382639|NCT00743288|26751370|FG000|Overall Study|Withdrawal by Subject|0|||
13382640|NCT00743288|26751371|FG001|Overall Study|Withdrawal by Subject|0|||
13382641|NCT00743288|26751372|FG002|Overall Study|Withdrawal by Subject|1|||
13382642|NCT00743288|26751373|FG003|Overall Study|Withdrawal by Subject|0|||
13382643|NCT00743288|26751374|FG004|Overall Study|Withdrawal by Subject|0|||
13382644|NCT00743288|26751375|FG005|Overall Study|Withdrawal by Subject|1|||
13382645|NCT00743288|26751376|FG006|Overall Study|Withdrawal by Subject|1|||
13382646|NCT00743288|26751370|FG000|Overall Study|Progressive disease (PD)|2|||
13382647|NCT00743288|26751371|FG001|Overall Study|Progressive disease (PD)|0|||
13382648|NCT00743288|26751372|FG002|Overall Study|Progressive disease (PD)|1|||
13382649|NCT00743288|26751373|FG003|Overall Study|Progressive disease (PD)|4|||
13382650|NCT00743288|26751374|FG004|Overall Study|Progressive disease (PD)|5|||
13382651|NCT00743288|26751375|FG005|Overall Study|Progressive disease (PD)|3|||
13382652|NCT00743288|26751376|FG006|Overall Study|Progressive disease (PD)|6|||
13382653|NCT00743288|26751370|FG000|Overall Study|Worsening of condition (Not PD)|0|||
13304913|NCT01301833|26521274|FG000|Overall Study|Adverse Event|7|||
13304914|NCT01301833|26521275|FG001|Overall Study|Adverse Event|5|||
13304915|NCT01301833|26521276|FG002|Overall Study|Adverse Event|5|||
13304916|NCT01301833|26521277|FG003|Overall Study|Adverse Event|5|||
13304917|NCT01301833|26521274|FG000|Overall Study|Lack of Efficacy|1|||
13304918|NCT01301833|26521275|FG001|Overall Study|Lack of Efficacy|1|||
13304919|NCT01301833|26521276|FG002|Overall Study|Lack of Efficacy|0|||
13304920|NCT01301833|26521277|FG003|Overall Study|Lack of Efficacy|0|||
13304921|NCT01301833|26521274|FG000|Overall Study|Physician Decision|3|||
13304922|NCT01301833|26521275|FG001|Overall Study|Physician Decision|1|||
13304923|NCT01301833|26521276|FG002|Overall Study|Physician Decision|1|||
13304924|NCT01301833|26521277|FG003|Overall Study|Physician Decision|0|||
13304925|NCT01301833|26521274|FG000|Overall Study|Withdrawal by Subject|3|||
13304926|NCT01301833|26521275|FG001|Overall Study|Withdrawal by Subject|1|||
13304927|NCT01301833|26521276|FG002|Overall Study|Withdrawal by Subject|1|||
13304928|NCT01301833|26521277|FG003|Overall Study|Withdrawal by Subject|2|||
13304929|NCT01301833|26521274|FG000|Overall Study|Personal matter|1|||
13304930|NCT01301833|26521275|FG001|Overall Study|Personal matter|0|||
13304931|NCT01301833|26521276|FG002|Overall Study|Personal matter|0|||
13304932|NCT01301833|26521277|FG003|Overall Study|Personal matter|0|||
13304933|NCT01301729|26521290|FG000|Overall Study|Withdrawal by Subject|2|||
13304934|NCT01301729|26521290|FG000|Overall Study|Participant did not Return for Treatment|1|||
13304935|NCT01301729|26521290|FG000|Overall Study|Violated Selection Criteria|1|||
13304936|NCT01301625|26521362|FG000|Overall Study|Death|5|||
13304937|NCT01301625|26521362|FG000|Overall Study|Not Due|21|||
13304938|NCT01301625|26521362|FG000|Overall Study|Expected|8|||
13304939|NCT01301625|26521362|FG000|Overall Study|Lost to Follow-up|1|||
13304940|NCT01301508|26521387|FG000|Overall Study|Withdrawal by Subject|1|||
13304941|NCT01301508|26521388|FG001|Overall Study|Withdrawal by Subject|2|||
13304942|NCT01301508|26521387|FG000|Overall Study|Lost to Follow-up|0|||
13304943|NCT01301508|26521388|FG001|Overall Study|Lost to Follow-up|1|||
13304944|NCT01301456|26521651|FG000|Stage 1|Withdrawal by Subject|0|||
13304945|NCT01301456|26521652|FG001|Stage 1|Withdrawal by Subject|0|||
13304946|NCT01301456|26521653|FG002|Stage 1|Withdrawal by Subject|1|||
13304947|NCT01301456|26521654|FG003|Stage 1|Withdrawal by Subject|0|||
13304948|NCT01301456|26521655|FG004|Stage 1|Withdrawal by Subject|1|||
13304949|NCT01301456|26521656|FG005|Stage 1|Withdrawal by Subject|0|||
13304950|NCT01301456|26521657|FG006|Stage 1|Withdrawal by Subject|0|||
13304951|NCT01301456|26521658|FG007|Stage 1|Withdrawal by Subject|0|||
13304952|NCT01301456|26521659|FG008|Stage 1|Withdrawal by Subject|0|||
13304953|NCT01301456|26521660|FG009|Stage 1|Withdrawal by Subject|0|||
13304954|NCT01301456|26521661|FG010|Stage 1|Withdrawal by Subject|0|||
13304955|NCT01301456|26521662|FG011|Stage 1|Withdrawal by Subject|0|||
13304956|NCT01301456|26521651|FG000|Stage 1|Randomized but not treated|0|||
13304957|NCT01301456|26521652|FG001|Stage 1|Randomized but not treated|0|||
13304958|NCT01301456|26521653|FG002|Stage 1|Randomized but not treated|0|||
13304959|NCT01301456|26521654|FG003|Stage 1|Randomized but not treated|0|||
13304960|NCT01301456|26521655|FG004|Stage 1|Randomized but not treated|0|||
13304961|NCT01301456|26521656|FG005|Stage 1|Randomized but not treated|0|||
13304962|NCT01301456|26521657|FG006|Stage 1|Randomized but not treated|1|||
13304963|NCT01301456|26521658|FG007|Stage 1|Randomized but not treated|0|||
13304964|NCT01301456|26521659|FG008|Stage 1|Randomized but not treated|0|||
13304965|NCT01301456|26521660|FG009|Stage 1|Randomized but not treated|0|||
13304966|NCT01301456|26521661|FG010|Stage 1|Randomized but not treated|0|||
13304967|NCT01301456|26521662|FG011|Stage 1|Randomized but not treated|0|||
13304968|NCT01301456|26521651|FG000|Stage 2|Adverse Event|0|||
13304969|NCT01301456|26521652|FG001|Stage 2|Adverse Event|0|||
13304970|NCT01301456|26521653|FG002|Stage 2|Adverse Event|0|||
13304971|NCT01301456|26521654|FG003|Stage 2|Adverse Event|0|||
13304972|NCT01301456|26521655|FG004|Stage 2|Adverse Event|0|||
13304973|NCT01301456|26521656|FG005|Stage 2|Adverse Event|0|||
13304974|NCT01301456|26521657|FG006|Stage 2|Adverse Event|0|||
13304975|NCT01301456|26521658|FG007|Stage 2|Adverse Event|0|||
13304976|NCT01301456|26521659|FG008|Stage 2|Adverse Event|0|||
13304977|NCT01301456|26521660|FG009|Stage 2|Adverse Event|0|||
13304978|NCT01301456|26521661|FG010|Stage 2|Adverse Event|1|||
13304979|NCT01301456|26521662|FG011|Stage 2|Adverse Event|0|||
13304980|NCT01301391|26521674|FG000|Overall Study|Death|13|||
13304981|NCT01301391|26521674|FG000|Overall Study|Lost to Follow-up|3|||
13304982|NCT01301391|26521674|FG000|Overall Study|Physician Decision|2|||
13304983|NCT01301391|26521674|FG000|Overall Study|Sponsor's decision|8|||
13382654|NCT00743288|26751371|FG001|Overall Study|Worsening of condition (Not PD)|2|||
13382655|NCT00743288|26751372|FG002|Overall Study|Worsening of condition (Not PD)|1|||
13382656|NCT00743288|26751373|FG003|Overall Study|Worsening of condition (Not PD)|1|||
13382657|NCT00743288|26751374|FG004|Overall Study|Worsening of condition (Not PD)|0|||
13382658|NCT00743288|26751375|FG005|Overall Study|Worsening of condition (Not PD)|0|||
13382659|NCT00743288|26751376|FG006|Overall Study|Worsening of condition (Not PD)|0|||
13382660|NCT00743275|26751395|FG000|Overall Study|Protocol Violation|0|||
13382661|NCT00743275|26751396|FG001|Overall Study|Protocol Violation|1|||
13382662|NCT00743249|26751411|FG000|Overall Study|Adverse Event|0|||
13304984|NCT01301274|26521693|FG000|Overall Study|Physician Decision|2|||
13304985|NCT01301274|26521694|FG001|Overall Study|Physician Decision|1|||
13304986|NCT01301092|26521719|FG000|Overall Study|Lost to Follow-up|0|||
13304987|NCT01301092|26521720|FG001|Overall Study|Lost to Follow-up|0|||
13304988|NCT01301092|26521721|FG002|Overall Study|Lost to Follow-up|1|||
13304989|NCT01301079|26521804|FG000|Overall Study|Lost to Follow-up|2|||
13304990|NCT01301079|26521805|FG001|Overall Study|Lost to Follow-up|2|||
13304991|NCT01301066|26521818|FG000|Overall Study|Lost to Follow-up|5|||
13304992|NCT01301066|26521819|FG001|Overall Study|Lost to Follow-up|11|||
13304993|NCT01301066|26521818|FG000|Overall Study|Protocol Violation|8|||
13219826|NCT01830595|26278394|FG001|First Period|Withdrawal by Subject|3|||
13219827|NCT01830595|26278393|FG000|Washout|Withdrawal by Subject|2|||
13219828|NCT01830595|26278394|FG001|Washout|Withdrawal by Subject|2|||
13219829|NCT01830543|26278436|FG000|Overall Study|Subject Decision|19|||
13219830|NCT01830543|26278437|FG001|Overall Study|Subject Decision|21|||
13219831|NCT01830543|26278438|FG002|Overall Study|Subject Decision|57|||
13219832|NCT01830543|26278436|FG000|Overall Study|Adverse Event|91|||
13219833|NCT01830543|26278437|FG001|Overall Study|Adverse Event|77|||
13219834|NCT01830543|26278438|FG002|Overall Study|Adverse Event|76|||
13219835|NCT01830543|26278436|FG000|Overall Study|Death|20|||
13304994|NCT01301066|26521819|FG001|Overall Study|Protocol Violation|7|||
13304995|NCT01301066|26521818|FG000|Overall Study|Withdrawal by Subject|4|||
13304996|NCT01301066|26521819|FG001|Overall Study|Withdrawal by Subject|9|||
13304997|NCT01301066|26521818|FG000|Overall Study|Adverse Event|6|||
13304998|NCT01301066|26521819|FG001|Overall Study|Adverse Event|6|||
13382663|NCT00743249|26751412|FG001|Overall Study|Adverse Event|4|||
13382664|NCT00743249|26751411|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0|||
13382665|NCT00743249|26751412|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1|||
13382666|NCT00743249|26751411|FG000|Overall Study|Unsuccessful insertion of stent|2|||
13382667|NCT00743249|26751412|FG001|Overall Study|Unsuccessful insertion of stent|1|||
13382668|NCT00743197|26751425|FG000|Overall Study|Study terminated due to departure of PI.|1|||
13382669|NCT00743197|26751426|FG001|Overall Study|Study terminated due to departure of PI.|2|||
13382670|NCT00743145|26751442|FG000|Overall Study|Withdrawal by Subject|1|||
13382671|NCT00743145|26751442|FG000|Overall Study|Adverse Event|2|||
13382672|NCT00743145|26751442|FG000|Overall Study|Pregnancy|1|||
13382673|NCT00743119|26751456|FG000|Overall Study|unreliable|3|||
13382674|NCT00743119|26751456|FG000|Overall Study|Withdrawal by Subject|1|||
13382675|NCT00743106|26751471|FG000|Overall Study|Met intraoperative exclusion criterion|8|||
13382676|NCT00743106|26751472|FG001|Overall Study|Met intraoperative exclusion criterion|5|||
13382677|NCT00742924|26751495|FG000|Overall Study|Adverse Event|0|||
13382678|NCT00742924|26751496|FG001|Overall Study|Adverse Event|0|||
13382679|NCT00742924|26751497|FG002|Overall Study|Adverse Event|1|||
13382680|NCT00742924|26751498|FG003|Overall Study|Adverse Event|1|||
13382681|NCT00742924|26751495|FG000|Overall Study|Lack of Efficacy|5|||
13382682|NCT00742924|26751496|FG001|Overall Study|Lack of Efficacy|1|||
13382683|NCT00742924|26751497|FG002|Overall Study|Lack of Efficacy|2|||
13382684|NCT00742924|26751498|FG003|Overall Study|Lack of Efficacy|4|||
13382685|NCT00742924|26751495|FG000|Overall Study|Physician Decision|0|||
13382686|NCT00742924|26751496|FG001|Overall Study|Physician Decision|0|||
13382687|NCT00742924|26751497|FG002|Overall Study|Physician Decision|0|||
13382688|NCT00742924|26751498|FG003|Overall Study|Physician Decision|1|||
13382689|NCT00742924|26751495|FG000|Overall Study|Withdrawal by Subject|0|||
13382690|NCT00742924|26751496|FG001|Overall Study|Withdrawal by Subject|1|||
13382691|NCT00742924|26751497|FG002|Overall Study|Withdrawal by Subject|1|||
13382692|NCT00742924|26751498|FG003|Overall Study|Withdrawal by Subject|0|||
13382693|NCT00742885|26751551|FG000|Overall Study|Lost to Follow-up|1|||
13382694|NCT00742885|26751552|FG001|Overall Study|Lost to Follow-up|0|||
13382695|NCT00742859|26751579|FG000|Overall Study|Adverse Event|5|||
13382696|NCT00742859|26751580|FG001|Overall Study|Adverse Event|6|||
13382697|NCT00742859|26751581|FG002|Overall Study|Adverse Event|3|||
13382698|NCT00742859|26751582|FG003|Overall Study|Adverse Event|1|||
13382699|NCT00742859|26751579|FG000|Overall Study|Death|1|||
13382700|NCT00742859|26751580|FG001|Overall Study|Death|0|||
13382701|NCT00742859|26751581|FG002|Overall Study|Death|0|||
13382702|NCT00742859|26751582|FG003|Overall Study|Death|1|||
13382703|NCT00742859|26751579|FG000|Overall Study|Physician Decision|1|||
13382704|NCT00742859|26751580|FG001|Overall Study|Physician Decision|2|||
13382705|NCT00742859|26751581|FG002|Overall Study|Physician Decision|0|||
13382706|NCT00742859|26751582|FG003|Overall Study|Physician Decision|0|||
13382707|NCT00742859|26751579|FG000|Overall Study|Withdrawal by Subject|4|||
13382708|NCT00742859|26751580|FG001|Overall Study|Withdrawal by Subject|2|||
13219836|NCT01830543|26278437|FG001|Overall Study|Death|22|||
13304999|NCT01301066|26521818|FG000|Overall Study|Sponsor Decision|2|||
13305000|NCT01301066|26521819|FG001|Overall Study|Sponsor Decision|1|||
13305001|NCT01301066|26521818|FG000|Overall Study|Physician Decision|0|||
13382709|NCT00742859|26751581|FG002|Overall Study|Withdrawal by Subject|4|||
13382710|NCT00742859|26751582|FG003|Overall Study|Withdrawal by Subject|1|||
13382711|NCT00742859|26751579|FG000|Overall Study|Endpoint|0|||
13382712|NCT00742859|26751580|FG001|Overall Study|Endpoint|1|||
13305002|NCT01301066|26521819|FG001|Overall Study|Physician Decision|1|||
13305003|NCT01301066|26521818|FG000|Overall Study|Other|2|||
13305004|NCT01301066|26521819|FG001|Overall Study|Other|0|||
13305005|NCT01301027|26521838|FG000|Overall Study|Physician Decision|2|||
13305006|NCT01301027|26521839|FG001|Overall Study|Physician Decision|0|||
13305007|NCT01301027|26521838|FG000|Overall Study|Withdrawal by Subject|2|||
13305008|NCT01301027|26521839|FG001|Overall Study|Withdrawal by Subject|3|||
13305009|NCT01301027|26521838|FG000|Overall Study|Adverse Event|0|||
13305010|NCT01301027|26521839|FG001|Overall Study|Adverse Event|2|||
13305011|NCT01301027|26521838|FG000|Overall Study|Fracture|1|||
13305012|NCT01301027|26521839|FG001|Overall Study|Fracture|3|||
13305013|NCT01301027|26521838|FG000|Overall Study|Transplant|0|||
13305014|NCT01301027|26521839|FG001|Overall Study|Transplant|2|||
13305015|NCT01301027|26521838|FG000|Overall Study|Volume Overload|3|||
13305016|NCT01301027|26521839|FG001|Overall Study|Volume Overload|0|||
13305017|NCT01301001|26521852|FG000|First Intervention|Lost to Follow-up|4|||
13305018|NCT01301001|26521853|FG001|First Intervention|Lost to Follow-up|4|||
13305019|NCT01301001|26521852|FG000|First Intervention|Withdrawal by Subject|1|||
13305020|NCT01301001|26521853|FG001|First Intervention|Withdrawal by Subject|4|||
13305021|NCT01301001|26521852|FG000|First Intervention|Adverse Event|5|||
13305022|NCT01301001|26521853|FG001|First Intervention|Adverse Event|0|||
13305023|NCT01301001|26521852|FG000|First Intervention|Protocol Violation|0|||
13305024|NCT01301001|26521853|FG001|First Intervention|Protocol Violation|1|||
13305025|NCT01301001|26521852|FG000|Second Intervention|Adverse Event|2|||
13305026|NCT01301001|26521853|FG001|Second Intervention|Adverse Event|0|||
13305027|NCT01301001|26521852|FG000|Second Intervention|Withdrawal by Subject|2|||
13305028|NCT01301001|26521853|FG001|Second Intervention|Withdrawal by Subject|0|||
13305029|NCT01300923|26521867|FG000|Overall Study|Physician Decision|0|||
13305030|NCT01300923|26521868|FG001|Overall Study|Physician Decision|2|||
13305031|NCT01300819|26521903|FG000|Overall Study|Adverse Event|9|||
13305032|NCT01300819|26521904|FG001|Overall Study|Adverse Event|27|||
13305033|NCT01300819|26521903|FG000|Overall Study|Lack of Efficacy|2|||
13305034|NCT01300819|26521904|FG001|Overall Study|Lack of Efficacy|1|||
13305035|NCT01300819|26521903|FG000|Overall Study|Withdrawal by Subject|10|||
13305036|NCT01300819|26521904|FG001|Overall Study|Withdrawal by Subject|12|||
13305037|NCT01300819|26521903|FG000|Overall Study|Patient was 1 month late for Visit 10|0|||
13305038|NCT01300819|26521904|FG001|Overall Study|Patient was 1 month late for Visit 10|1|||
13305039|NCT01300819|26521903|FG000|Overall Study|Refusal to down titrate study drug|0|||
13305040|NCT01300819|26521904|FG001|Overall Study|Refusal to down titrate study drug|1|||
13305041|NCT01300819|26521903|FG000|Overall Study|Administrative reason|0|||
13305042|NCT01300819|26521904|FG001|Overall Study|Administrative reason|1|||
13305043|NCT01300819|26521903|FG000|Overall Study|Safety follow up not done by mistake|0|||
13305044|NCT01300819|26521904|FG001|Overall Study|Safety follow up not done by mistake|1|||
13305045|NCT01300819|26521903|FG000|Overall Study|Follow up call was not done|1|||
13305046|NCT01300819|26521904|FG001|Overall Study|Follow up call was not done|0|||
13305047|NCT01300767|26521934|FG000|Overall Study|Discomfort|2|||
13305048|NCT01300767|26521934|FG000|Overall Study|Biomicroscopy|1|||
13305049|NCT01300767|26521934|FG000|Overall Study|Unacceptable fit|1|||
13305050|NCT01300741|26521964|FG000|Overall Study|Lens deposits|1|||
13305051|NCT01300741|26521964|FG000|Overall Study|Lost to Follow-up|1|||
13305052|NCT01300741|26521964|FG000|Overall Study|Discomfort|1|||
13305053|NCT01300650|26521972|FG000|Overall Study|Adverse Event|1|||
13305054|NCT01300572|26521987|FG000|Overall Study|HAMA + post dosimetry|1|||
13305055|NCT01300546|26522022|FG000|Overall Study|Withdrawal by Subject|1|||
13305056|NCT01300546|26522023|FG001|Overall Study|Withdrawal by Subject|0|||
13305057|NCT01300546|26522022|FG000|Overall Study|Lost to Follow-up|0|||
13305058|NCT01300546|26522023|FG001|Overall Study|Lost to Follow-up|2|||
13305059|NCT01300546|26522022|FG000|Overall Study|Lack of Efficacy|0|||
13305060|NCT01300546|26522023|FG001|Overall Study|Lack of Efficacy|3|||
13305061|NCT01300546|26522022|FG000|Overall Study|Adverse Event|0|||
13305062|NCT01300546|26522023|FG001|Overall Study|Adverse Event|1|||
13305063|NCT01300455|26522048|FG000|Washout|Withdrawal by Subject|1|||
13305064|NCT01300455|26522049|FG001|Washout|Withdrawal by Subject|0|||
13305065|NCT01300351|26522070|FG000|Overall Study|Did not receive treatment|2|||
13305066|NCT01300351|26522071|FG001|Overall Study|Did not receive treatment|0|||
13305067|NCT01300351|26522070|FG000|Overall Study|Ongoing treatment at data cut-off|27|||
13305068|NCT01300351|26522071|FG001|Overall Study|Ongoing treatment at data cut-off|23|||
13305069|NCT01300351|26522070|FG000|Overall Study|Lost to Follow-up|0|||
13382713|NCT00742859|26751581|FG002|Overall Study|Endpoint|1|||
13305070|NCT01300351|26522071|FG001|Overall Study|Lost to Follow-up|1|||
13305071|NCT01300351|26522070|FG000|Overall Study|Adverse Event|0|||
13305072|NCT01300351|26522071|FG001|Overall Study|Adverse Event|4|||
13305073|NCT01300351|26522070|FG000|Overall Study|Withdrawal by Subject|7|||
13305074|NCT01300351|26522071|FG001|Overall Study|Withdrawal by Subject|10|||
13305075|NCT01300338|26522086|FG000|Overall Study|Lost to Follow-up|5|||
13305076|NCT01300338|26522087|FG001|Overall Study|Lost to Follow-up|0|||
13305077|NCT01300286|26522097|FG000|Overall Study|did not get dosed|1|||
13305078|NCT01300260|26522134|FG000|Period 1 of Study: First Intervention|Adverse Event|0|||
13305079|NCT01300260|26522135|FG001|Period 1 of Study: First Intervention|Adverse Event|1|||
13305080|NCT01300260|26522134|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1|||
13305081|NCT01300260|26522135|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0|||
13305082|NCT01300260|26522134|FG000|Period 2 of Study: Second Intervention|Adverse Event|0|||
13305083|NCT01300260|26522135|FG001|Period 2 of Study: Second Intervention|Adverse Event|1|||
13305084|NCT01300247|26522172|FG000|Overall Study|Death|1|||
13305085|NCT01300247|26522173|FG001|Overall Study|Death|1|||
13305086|NCT01300247|26522172|FG000|Overall Study|Lost to Follow-up|2|||
13305087|NCT01300247|26522173|FG001|Overall Study|Lost to Follow-up|0|||
13305088|NCT01300247|26522172|FG000|Overall Study|Withdrawal by Subject|1|||
13305089|NCT01300247|26522173|FG001|Overall Study|Withdrawal by Subject|0|||
13305090|NCT01300247|26522172|FG000|Overall Study|Non-Compliance|0|||
13305091|NCT01300247|26522173|FG001|Overall Study|Non-Compliance|1|||
13305092|NCT01300234|26522214|FG000|Overall Study|Adverse Event|1|||
13305093|NCT01300234|26522215|FG001|Overall Study|Adverse Event|1|||
13305094|NCT01300234|26522214|FG000|Overall Study|Protocol Violation|2|||
13305095|NCT01300234|26522215|FG001|Overall Study|Protocol Violation|3|||
13305096|NCT01300234|26522214|FG000|Overall Study|Withdrawal by Subject|5|||
13305097|NCT01300234|26522215|FG001|Overall Study|Withdrawal by Subject|9|||
13305098|NCT01300234|26522214|FG000|Overall Study|Lost to Follow-up|14|||
13305099|NCT01300234|26522215|FG001|Overall Study|Lost to Follow-up|12|||
13305100|NCT01300234|26522214|FG000|Overall Study|Pregnancy|2|||
13305101|NCT01300234|26522215|FG001|Overall Study|Pregnancy|1|||
13305102|NCT01300234|26522214|FG000|Overall Study|Participant reached stopping critera|2|||
13305103|NCT01300234|26522215|FG001|Overall Study|Participant reached stopping critera|0|||
13305104|NCT01300234|26522214|FG000|Overall Study|Participant stopped medication|1|||
13305105|NCT01300234|26522215|FG001|Overall Study|Participant stopped medication|1|||
13305106|NCT01300234|26522214|FG000|Overall Study|Participant refused return to hospital|1|||
13305107|NCT01300234|26522215|FG001|Overall Study|Participant refused return to hospital|0|||
13305108|NCT01300052|26522240|FG000|Overall Study|Adverse Event|3|||
13305109|NCT01300052|26522241|FG001|Overall Study|Adverse Event|0|||
13305110|NCT01300052|26522240|FG000|Overall Study|Withdrawal by Subject|2|||
13305111|NCT01300052|26522241|FG001|Overall Study|Withdrawal by Subject|2|||
13305112|NCT01300052|26522240|FG000|Overall Study|Protocol Violation|1|||
13305113|NCT01300052|26522241|FG001|Overall Study|Protocol Violation|1|||
13305114|NCT01299961|26522249|FG000|Overall Study|Adverse Event|3|||
13305115|NCT01299961|26522249|FG000|Overall Study|Lack of Efficacy|2|||
13305116|NCT01299961|26522249|FG000|Overall Study|Lost to Follow-up|1|||
13305117|NCT01299909|26522272|FG000|Overall Study|Lost to Follow-up|22|||
13305118|NCT01299909|26522273|FG001|Overall Study|Lost to Follow-up|18|||
13305119|NCT01299909|26522274|FG002|Overall Study|Lost to Follow-up|17|||
13305120|NCT01299896|26522287|FG000|Overall Study|Withdrawal by Subject|1|||
13305121|NCT01299896|26522288|FG001|Overall Study|Withdrawal by Subject|7|||
13305122|NCT01299896|26522287|FG000|Overall Study|Lost to Follow-up|0|||
13305123|NCT01299896|26522288|FG001|Overall Study|Lost to Follow-up|11|||
13305124|NCT01299805|26522323|FG000|Overall Study|Adverse Event|2|||
13305125|NCT01299805|26522324|FG001|Overall Study|Adverse Event|0|||
13305126|NCT01299766|26522339|FG000|Overall Study|Death|5|||
13305127|NCT01299766|26522340|FG001|Overall Study|Death|4|||
13305128|NCT01299766|26522339|FG000|Overall Study|Withdrawal by Subject|29|||
13305129|NCT01299766|26522340|FG001|Overall Study|Withdrawal by Subject|19|||
13305130|NCT01299727|26522394|FG000|Overall Study|Withdrawal by Subject|1|||
13305131|NCT01299727|26522395|FG001|Overall Study|Withdrawal by Subject|0|||
13305132|NCT01299727|26522396|FG002|Overall Study|Withdrawal by Subject|0|||
13305133|NCT01299727|26522394|FG000|Overall Study|Adverse Event|0|||
13305134|NCT01299727|26522395|FG001|Overall Study|Adverse Event|0|||
13305135|NCT01299727|26522396|FG002|Overall Study|Adverse Event|1|||
13305136|NCT01299727|26522394|FG000|Overall Study|Completed the Treatment Period|3|||
13305137|NCT01299727|26522395|FG001|Overall Study|Completed the Treatment Period|4|||
13305138|NCT01299727|26522396|FG002|Overall Study|Completed the Treatment Period|3|||
13305139|NCT01299584|26522405|FG000|Overall Study|Protocol Violation|9|||
13305140|NCT01299571|26522413|FG000|Overall Study|Protocol Violation|107|||
13305141|NCT01299389|26522442|FG000|Double-blind|Adverse Event|45|||
13305142|NCT01299389|26522443|FG001|Double-blind|Adverse Event|27|||
13305143|NCT01299389|26522444|FG002|Double-blind|Adverse Event|0|||
13305144|NCT01299389|26522445|FG003|Double-blind|Adverse Event|0|||
13305145|NCT01299389|26522442|FG000|Double-blind|Lack of Efficacy|45|||
13305146|NCT01299389|26522443|FG001|Double-blind|Lack of Efficacy|21|||
13305147|NCT01299389|26522444|FG002|Double-blind|Lack of Efficacy|0|||
13305148|NCT01299389|26522445|FG003|Double-blind|Lack of Efficacy|0|||
13305149|NCT01299389|26522442|FG000|Double-blind|Lost to Follow-up|2|||
13305150|NCT01299389|26522443|FG001|Double-blind|Lost to Follow-up|1|||
13305151|NCT01299389|26522444|FG002|Double-blind|Lost to Follow-up|0|||
13305152|NCT01299389|26522445|FG003|Double-blind|Lost to Follow-up|0|||
13305153|NCT01299389|26522442|FG000|Double-blind|Withdrawal by Subject|16|||
13305154|NCT01299389|26522443|FG001|Double-blind|Withdrawal by Subject|13|||
13305155|NCT01299389|26522444|FG002|Double-blind|Withdrawal by Subject|0|||
13305156|NCT01299389|26522445|FG003|Double-blind|Withdrawal by Subject|0|||
13305157|NCT01299389|26522442|FG000|Double-blind|Other|1|||
13305158|NCT01299389|26522443|FG001|Double-blind|Other|1|||
13305159|NCT01299389|26522444|FG002|Double-blind|Other|0|||
13305160|NCT01299389|26522445|FG003|Double-blind|Other|0|||
13305161|NCT01299389|26522442|FG000|Double-blind|"fail to meet study population criteria"|0|||
13305162|NCT01299389|26522443|FG001|Double-blind|"fail to meet study population criteria"|1|||
13305163|NCT01299389|26522444|FG002|Double-blind|"fail to meet study population criteria"|0|||
13305164|NCT01299389|26522445|FG003|Double-blind|"fail to meet study population criteria"|0|||
13305165|NCT01299389|26522442|FG000|Post-observational|Other|0|||
13305166|NCT01299389|26522443|FG001|Post-observational|Other|0|||
13305167|NCT01299389|26522444|FG002|Post-observational|Other|12|||
13305168|NCT01299389|26522445|FG003|Post-observational|Other|6|||
13305169|NCT01299376|26522482|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1|||
13305170|NCT01299376|26522483|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2|||
13305171|NCT01299376|26522482|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0|||
13305172|NCT01299376|26522483|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1|||
13305173|NCT01299376|26522482|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0|||
13305174|NCT01299376|26522483|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1|||
13305175|NCT01299376|26522482|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4|||
13305176|NCT01299376|26522483|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7|||
13305177|NCT01299376|26522482|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1|||
13305178|NCT01299376|26522483|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0|||
13305179|NCT01299376|26522482|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
13305180|NCT01299376|26522483|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
13305181|NCT01299376|26522482|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2|||
13305182|NCT01299376|26522483|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1|||
13305183|NCT01299376|26522482|FG000|Extension (Weeks 9 to 52)|Adverse Event|2|||
13305184|NCT01299376|26522483|FG001|Extension (Weeks 9 to 52)|Adverse Event|3|||
13305185|NCT01299376|26522482|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1|||
13305186|NCT01299376|26522483|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2|||
13305187|NCT01299376|26522482|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4|||
13305188|NCT01299376|26522483|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9|||
13305189|NCT01299376|26522482|FG000|Extension (Weeks 9 to 52)|Physician Decision|1|||
13305190|NCT01299376|26522483|FG001|Extension (Weeks 9 to 52)|Physician Decision|0|||
13305191|NCT01299272|26522540|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140|||
13305192|NCT01299272|26522541|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
13305193|NCT01299272|26522542|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
13305194|NCT01299272|26522543|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
13305195|NCT01299272|26522540|FG000|Acute Open-label (OL) Period|Adverse Event|140|||
13305196|NCT01299272|26522541|FG001|Acute Open-label (OL) Period|Adverse Event|0|||
13305197|NCT01299272|26522542|FG002|Acute Open-label (OL) Period|Adverse Event|0|||
13305198|NCT01299272|26522543|FG003|Acute Open-label (OL) Period|Adverse Event|0|||
13305199|NCT01299272|26522540|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56|||
13305200|NCT01299272|26522541|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
13305201|NCT01299272|26522542|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
13305202|NCT01299272|26522543|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
13305203|NCT01299272|26522540|FG000|Acute Open-label (OL) Period|Protocol Violation|36|||
13305204|NCT01299272|26522541|FG001|Acute Open-label (OL) Period|Protocol Violation|0|||
13305205|NCT01299272|26522542|FG002|Acute Open-label (OL) Period|Protocol Violation|0|||
13305206|NCT01299272|26522543|FG003|Acute Open-label (OL) Period|Protocol Violation|0|||
13305207|NCT01299272|26522540|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14|||
13305208|NCT01299272|26522541|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0|||
13305209|NCT01299272|26522542|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0|||
13305210|NCT01299272|26522543|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0|||
13305211|NCT01299272|26522540|FG000|Acute Open-label (OL) Period|Sponsor Decision|13|||
13305212|NCT01299272|26522541|FG001|Acute Open-label (OL) Period|Sponsor Decision|0|||
13305213|NCT01299272|26522542|FG002|Acute Open-label (OL) Period|Sponsor Decision|0|||
13305214|NCT01299272|26522543|FG003|Acute Open-label (OL) Period|Sponsor Decision|0|||
13305215|NCT01299272|26522540|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10|||
13305216|NCT01299272|26522541|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0|||
13305217|NCT01299272|26522542|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0|||
13305218|NCT01299272|26522543|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0|||
13305219|NCT01299272|26522540|FG000|Acute Open-label (OL) Period|Physician Decision|5|||
13305220|NCT01299272|26522541|FG001|Acute Open-label (OL) Period|Physician Decision|0|||
13305221|NCT01299272|26522542|FG002|Acute Open-label (OL) Period|Physician Decision|0|||
13305222|NCT01299272|26522543|FG003|Acute Open-label (OL) Period|Physician Decision|0|||
13305223|NCT01299272|26522540|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
13305224|NCT01299272|26522541|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80|||
13305225|NCT01299272|26522542|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
13305226|NCT01299272|26522543|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
13305227|NCT01299272|26522540|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0|||
13305228|NCT01299272|26522541|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44|||
13305229|NCT01299272|26522542|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0|||
13305230|NCT01299272|26522543|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0|||
13305231|NCT01299272|26522540|FG000|Stabilization Open-label (OL) Period|Adverse Event|0|||
13305232|NCT01299272|26522541|FG001|Stabilization Open-label (OL) Period|Adverse Event|42|||
13305233|NCT01299272|26522542|FG002|Stabilization Open-label (OL) Period|Adverse Event|0|||
13305234|NCT01299272|26522543|FG003|Stabilization Open-label (OL) Period|Adverse Event|0|||
13305235|NCT01299272|26522540|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
13305236|NCT01299272|26522541|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42|||
13305237|NCT01299272|26522542|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
13305238|NCT01299272|26522543|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
13305239|NCT01299272|26522540|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
13305240|NCT01299272|26522541|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12|||
13382714|NCT00742859|26751582|FG003|Overall Study|Endpoint|2|||
13382715|NCT00742859|26751579|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0|||
13382716|NCT00742859|26751580|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1|||
13382717|NCT00742859|26751581|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1|||
13382718|NCT00742859|26751582|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0|||
13382719|NCT00742859|26751579|FG000|Overall Study|Sponsor req visit schedule noncompliance|0|||
13382720|NCT00742859|26751580|FG001|Overall Study|Sponsor req visit schedule noncompliance|0|||
13382721|NCT00742859|26751581|FG002|Overall Study|Sponsor req visit schedule noncompliance|0|||
13382722|NCT00742859|26751582|FG003|Overall Study|Sponsor req visit schedule noncompliance|1|||
13382723|NCT00742859|26751579|FG000|Overall Study|Sponsor request patient out of town|0|||
13382724|NCT00742859|26751580|FG001|Overall Study|Sponsor request patient out of town|0|||
13382725|NCT00742859|26751581|FG002|Overall Study|Sponsor request patient out of town|1|||
13382726|NCT00742859|26751582|FG003|Overall Study|Sponsor request patient out of town|1|||
13382727|NCT00742859|26751579|FG000|Overall Study|Site error|0|||
13382728|NCT00742859|26751580|FG001|Overall Study|Site error|0|||
13382729|NCT00742859|26751581|FG002|Overall Study|Site error|1|||
13382730|NCT00742859|26751582|FG003|Overall Study|Site error|1|||
13382731|NCT00742781|26751593|FG000|Overall Study|Withdrawal by Subject|3|||
13382732|NCT00742625|26751604|FG000|Remission Induction|Progression|6|||
13382733|NCT00742625|26751604|FG000|Remission Induction|Failed induction|8|||
13382734|NCT00742625|26751604|FG000|Remission Induction|Adverse Event|3|||
13382735|NCT00742625|26751604|FG000|Remission Induction|Death|10|||
13382736|NCT00742625|26751604|FG000|Remission Induction|Refusal|5|||
13382737|NCT00742625|26751604|FG000|Remission Induction|Non protocol treatment|17|||
13382738|NCT00742625|26751604|FG000|Remission Induction|Other, not specified|5|||
13382739|NCT00742625|26751604|FG000|Consolidation|Progression|5|||
13382740|NCT00742625|26751604|FG000|Consolidation|Adverse Event|1|||
13382741|NCT00742625|26751604|FG000|Consolidation|Death|1|||
13382742|NCT00742625|26751604|FG000|Consolidation|Refused|1|||
13382743|NCT00742625|26751604|FG000|Consolidation|Non protocol therapy|13|||
13382744|NCT00742560|26751692|FG000|Overall Study|Adverse Event|0|||
13382745|NCT00742560|26751693|FG001|Overall Study|Adverse Event|0|||
13382746|NCT00742560|26751694|FG002|Overall Study|Adverse Event|1|||
13382747|NCT00742560|26751695|FG003|Overall Study|Adverse Event|1|||
13382748|NCT00742560|26751696|FG004|Overall Study|Adverse Event|1|||
13382749|NCT00742560|26751692|FG000|Overall Study|Death|0|||
13382750|NCT00742560|26751693|FG001|Overall Study|Death|2|||
13382751|NCT00742560|26751694|FG002|Overall Study|Death|0|||
13382752|NCT00742560|26751695|FG003|Overall Study|Death|2|||
13382753|NCT00742560|26751696|FG004|Overall Study|Death|3|||
13382754|NCT00742560|26751692|FG000|Overall Study|Subject's Decision|1|||
13382755|NCT00742560|26751693|FG001|Overall Study|Subject's Decision|0|||
13382756|NCT00742560|26751694|FG002|Overall Study|Subject's Decision|2|||
13382757|NCT00742560|26751695|FG003|Overall Study|Subject's Decision|3|||
13382758|NCT00742560|26751696|FG004|Overall Study|Subject's Decision|3|||
13382759|NCT00742560|26751692|FG000|Overall Study|Investigator's Decision|0|||
13382760|NCT00742560|26751693|FG001|Overall Study|Investigator's Decision|0|||
13382761|NCT00742560|26751694|FG002|Overall Study|Investigator's Decision|4|||
13382762|NCT00742560|26751695|FG003|Overall Study|Investigator's Decision|1|||
13382763|NCT00742560|26751696|FG004|Overall Study|Investigator's Decision|0|||
13382764|NCT00742560|26751692|FG000|Overall Study|Disease Progression|1|||
13382765|NCT00742560|26751693|FG001|Overall Study|Disease Progression|0|||
13382766|NCT00742560|26751694|FG002|Overall Study|Disease Progression|5|||
13382767|NCT00742560|26751695|FG003|Overall Study|Disease Progression|17|||
13382768|NCT00742560|26751696|FG004|Overall Study|Disease Progression|16|||
13382769|NCT00742560|26751692|FG000|Overall Study|New Multiple Myeloma Therapy|1|||
13382770|NCT00742560|26751693|FG001|Overall Study|New Multiple Myeloma Therapy|0|||
13382771|NCT00742560|26751694|FG002|Overall Study|New Multiple Myeloma Therapy|2|||
13305241|NCT01299272|26522542|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
13305242|NCT01299272|26522543|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
13305243|NCT01299272|26522540|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
13305244|NCT01299272|26522541|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11|||
13305245|NCT01299272|26522542|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
13305246|NCT01299272|26522543|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
13305247|NCT01299272|26522540|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
13305248|NCT01299272|26522541|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9|||
13305249|NCT01299272|26522542|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
13305250|NCT01299272|26522543|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
13305251|NCT01299272|26522540|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
13305252|NCT01299272|26522541|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6|||
13305253|NCT01299272|26522542|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
13305254|NCT01299272|26522543|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
13305255|NCT01299272|26522540|FG000|Stabilization Open-label (OL) Period|Physician Decision|0|||
13305256|NCT01299272|26522541|FG001|Stabilization Open-label (OL) Period|Physician Decision|3|||
13305257|NCT01299272|26522542|FG002|Stabilization Open-label (OL) Period|Physician Decision|0|||
13305258|NCT01299272|26522543|FG003|Stabilization Open-label (OL) Period|Physician Decision|0|||
13305259|NCT01299272|26522540|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
13305260|NCT01299272|26522541|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
13305261|NCT01299272|26522542|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22|||
13305262|NCT01299272|26522543|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15|||
13305263|NCT01299272|26522540|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
13305264|NCT01299272|26522541|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
13305265|NCT01299272|26522542|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20|||
13305266|NCT01299272|26522543|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10|||
13305267|NCT01299272|26522540|FG000|Double-blind (DB) Randomized Period|Adverse Event|0|||
13305268|NCT01299272|26522541|FG001|Double-blind (DB) Randomized Period|Adverse Event|0|||
13305269|NCT01299272|26522542|FG002|Double-blind (DB) Randomized Period|Adverse Event|8|||
13305270|NCT01299272|26522543|FG003|Double-blind (DB) Randomized Period|Adverse Event|9|||
13305271|NCT01299272|26522540|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0|||
13305272|NCT01299272|26522541|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0|||
13305273|NCT01299272|26522542|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8|||
13305274|NCT01299272|26522543|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7|||
13305275|NCT01299272|26522540|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
13305276|NCT01299272|26522541|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
13305277|NCT01299272|26522542|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
13305278|NCT01299272|26522543|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
13305279|NCT01299272|26522540|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
13305280|NCT01299272|26522541|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
13305281|NCT01299272|26522542|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4|||
13305282|NCT01299272|26522543|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10|||
13305283|NCT01299272|26522540|FG000|Double-blind (DB) Randomized Period|Physician Decision|0|||
13305284|NCT01299272|26522541|FG001|Double-blind (DB) Randomized Period|Physician Decision|0|||
13305285|NCT01299272|26522542|FG002|Double-blind (DB) Randomized Period|Physician Decision|2|||
13305286|NCT01299272|26522543|FG003|Double-blind (DB) Randomized Period|Physician Decision|1|||
13305287|NCT01299272|26522540|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
13305288|NCT01299272|26522541|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
13305289|NCT01299272|26522542|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
13305290|NCT01299272|26522543|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
13305291|NCT01299116|26522567|FG000|Overall Study|Lost to Follow-up|65|||
13305292|NCT01299116|26522568|FG001|Overall Study|Lost to Follow-up|9|||
13305293|NCT01299116|26522569|FG002|Overall Study|Lost to Follow-up|11|||
13305294|NCT01299038|26522582|FG000|Overall Study|Withdrawal by Subject|1|||
13305295|NCT01299038|26522583|FG001|Overall Study|Withdrawal by Subject|0|||
13305296|NCT01299025|26522602|FG000|Overall Study|Withdrawal by Subject|2|||
13305297|NCT01299025|26522603|FG001|Overall Study|Withdrawal by Subject|1|||
13305298|NCT01299025|26522602|FG000|Overall Study|Lost to Follow-up|1|||
13305299|NCT01299025|26522603|FG001|Overall Study|Lost to Follow-up|0|||
13305300|NCT01298999|26522620|FG000|Overall Study|Physician Decision|0|||
13305301|NCT01298999|26522621|FG001|Overall Study|Physician Decision|1|||
13305302|NCT01298999|26522620|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3|||
13305303|NCT01298999|26522621|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0|||
13305304|NCT01298778|26522648|FG000|Overall Study|Lost to Follow-up|2|||
13305305|NCT01298778|26522649|FG001|Overall Study|Lost to Follow-up|3|||
13305306|NCT01298778|26522648|FG000|Overall Study|Incorrect use of VAS|1|||
13305307|NCT01298778|26522649|FG001|Overall Study|Incorrect use of VAS|0|||
13305308|NCT01298778|26522648|FG000|Overall Study|Withdrawal by Subject|0|||
13305309|NCT01298778|26522649|FG001|Overall Study|Withdrawal by Subject|1|||
13305310|NCT01298778|26522648|FG000|Overall Study|Protocol Violation|0|||
13305311|NCT01298778|26522649|FG001|Overall Study|Protocol Violation|1|||
13305312|NCT01298778|26522648|FG000|Overall Study|not meet inclusion/exclusion criteria|0|||
13305313|NCT01298778|26522649|FG001|Overall Study|not meet inclusion/exclusion criteria|1|||
13305314|NCT01298765|26522659|FG000|Titration Period|Adverse Event|26|||
13305315|NCT01298765|26522659|FG000|Titration Period|Death|1|||
13305316|NCT01298765|26522659|FG000|Titration Period|Lack of Efficacy|21|||
13305317|NCT01298765|26522659|FG000|Titration Period|Lost to Follow-up|9|||
13305318|NCT01298765|26522659|FG000|Titration Period|Physician Decision|1|||
13305319|NCT01298765|26522659|FG000|Titration Period|Withdrawal by Subject|10|||
13305320|NCT01298765|26522659|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8|||
13305321|NCT01298765|26522659|FG000|Long-Term Treatment Period|Adverse Event|19|||
13305322|NCT01298765|26522659|FG000|Long-Term Treatment Period|Lack of Efficacy|6|||
13305323|NCT01298765|26522659|FG000|Long-Term Treatment Period|Lost to Follow-up|8|||
13305324|NCT01298765|26522659|FG000|Long-Term Treatment Period|Withdrawal by Subject|19|||
13305325|NCT01298765|26522659|FG000|Long-Term Treatment Period|Physician Decision|1|||
13305326|NCT01298765|26522659|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46|||
13305327|NCT01298700|26522674|FG000|Overall Study|Adverse Event|50|||
13305328|NCT01298700|26522675|FG001|Overall Study|Adverse Event|51|||
13305329|NCT01298700|26522674|FG000|Overall Study|Lack of Efficacy|9|||
13305330|NCT01298700|26522675|FG001|Overall Study|Lack of Efficacy|14|||
13305331|NCT01298700|26522674|FG000|Overall Study|Lost to Follow-up|5|||
13305332|NCT01298700|26522675|FG001|Overall Study|Lost to Follow-up|2|||
13305333|NCT01298700|26522674|FG000|Overall Study|Withdrawal by Subject|12|||
13305334|NCT01298700|26522675|FG001|Overall Study|Withdrawal by Subject|9|||
13305335|NCT01298700|26522674|FG000|Overall Study|Protocol Violation|6|||
13305336|NCT01298700|26522675|FG001|Overall Study|Protocol Violation|4|||
13305337|NCT01298700|26522674|FG000|Overall Study|Other Miscellaneous Reasons|16|||
13305338|NCT01298700|26522675|FG001|Overall Study|Other Miscellaneous Reasons|15|||
13305339|NCT01298700|26522674|FG000|Overall Study|Did not Receive Study Drug|3|||
13305340|NCT01298700|26522675|FG001|Overall Study|Did not Receive Study Drug|5|||
13305341|NCT01298661|26522763|FG000|Overall Study|Withdrawal by Subject|2|||
13305342|NCT01298661|26522764|FG001|Overall Study|Withdrawal by Subject|0|||
13305343|NCT01298661|26522765|FG002|Overall Study|Withdrawal by Subject|2|||
13305344|NCT01298648|26522776|FG000|Overall Study|Withdrawal by Subject|2|||
13305345|NCT01298648|26522776|FG000|Overall Study|Lost to Follow-up|21|||
13305346|NCT01298596|26522791|FG000|Overall Study|Withdrawal by Subject|1|||
13305347|NCT01298596|26522792|FG001|Overall Study|Withdrawal by Subject|1|||
13305348|NCT01298596|26522791|FG000|Overall Study|Death|5|||
13305349|NCT01298596|26522792|FG001|Overall Study|Death|3|||
13305350|NCT01298596|26522791|FG000|Overall Study|Lost to Follow-up|6|||
13305351|NCT01298596|26522792|FG001|Overall Study|Lost to Follow-up|14|||
13305352|NCT01298596|26522791|FG000|Overall Study|Referred for further management|16|||
13305353|NCT01298596|26522792|FG001|Overall Study|Referred for further management|15|||
13305354|NCT01298570|26522815|FG000|Overall Study|Disease progression, relapse during acti|64|||
13305355|NCT01298570|26522816|FG001|Overall Study|Disease progression, relapse during acti|40|||
13305356|NCT01298570|26522815|FG000|Overall Study|Adverse Event|20|||
13305357|NCT01298570|26522816|FG001|Overall Study|Adverse Event|2|||
13305358|NCT01298570|26522815|FG000|Overall Study|Withdrawal by Subject|21|||
13305359|NCT01298570|26522816|FG001|Overall Study|Withdrawal by Subject|6|||
13305360|NCT01298570|26522815|FG000|Overall Study|Treatment delay > 4 weeks|4|||
13305361|NCT01298570|26522816|FG001|Overall Study|Treatment delay > 4 weeks|5|||
13382772|NCT00742560|26751695|FG003|Overall Study|New Multiple Myeloma Therapy|3|||
13382773|NCT00742560|26751696|FG004|Overall Study|New Multiple Myeloma Therapy|4|||
13382774|NCT00742560|26751692|FG000|Overall Study|Other|0|||
13382775|NCT00742560|26751693|FG001|Overall Study|Other|1|||
13382776|NCT00742560|26751694|FG002|Overall Study|Other|8|||
13382777|NCT00742560|26751695|FG003|Overall Study|Other|9|||
13382778|NCT00742560|26751696|FG004|Overall Study|Other|9|||
13382779|NCT00742560|26751692|FG000|Overall Study|MIssing|0|||
13382780|NCT00742560|26751693|FG001|Overall Study|MIssing|0|||
13382781|NCT00742560|26751694|FG002|Overall Study|MIssing|0|||
13382782|NCT00742560|26751695|FG003|Overall Study|MIssing|0|||
13382783|NCT00742560|26751696|FG004|Overall Study|MIssing|1|||
13382784|NCT00742508|26751765|FG000|8-Week Primary Evaluation Period|Adverse Event|2|||
13382785|NCT00742508|26751766|FG001|8-Week Primary Evaluation Period|Adverse Event|4|||
13382786|NCT00742508|26751765|FG000|8-Week Primary Evaluation Period|Protocol Violation|1|||
13382787|NCT00742508|26751766|FG001|8-Week Primary Evaluation Period|Protocol Violation|0|||
13382788|NCT00742508|26751765|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8|||
13382789|NCT00742508|26751766|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5|||
13382790|NCT00742508|26751765|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0|||
13382791|NCT00742508|26751766|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2|||
13305362|NCT01298570|26522815|FG000|Overall Study|Physician Decision|4|||
13305363|NCT01298570|26522816|FG001|Overall Study|Physician Decision|2|||
13305364|NCT01298570|26522815|FG000|Overall Study|Other complicating disease|2|||
13305365|NCT01298570|26522816|FG001|Overall Study|Other complicating disease|1|||
13305366|NCT01298570|26522815|FG000|Overall Study|Surgery|2|||
13382792|NCT00742508|26751765|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0|||
13382793|NCT00742508|26751766|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1|||
13382794|NCT00742417|26751795|FG000|Randomized|Withdrawal by legal representative|0|||
13382795|NCT00742417|26751796|FG001|Randomized|Withdrawal by legal representative|1|||
13382796|NCT00742417|26751795|FG000|Randomized|Withdrawal by Subject|1|||
13382797|NCT00742417|26751796|FG001|Randomized|Withdrawal by Subject|0|||
13382798|NCT00742417|26751795|FG000|Randomized|Physician Decision|1|||
13382799|NCT00742417|26751796|FG001|Randomized|Physician Decision|0|||
13382800|NCT00742417|26751795|FG000|Intensive Period|Withdrawal by Subject|1|||
13382801|NCT00742417|26751796|FG001|Intensive Period|Withdrawal by Subject|1|||
13382802|NCT00742417|26751795|FG000|Intensive Period|Adverse Event|2|||
13382803|NCT00742417|26751796|FG001|Intensive Period|Adverse Event|0|||
13382804|NCT00742391|26751811|FG000|Overall Study|Adverse Event|2|||
13382805|NCT00742391|26751812|FG001|Overall Study|Adverse Event|1|||
13382806|NCT00742391|26751811|FG000|Overall Study|Lost to Follow-up|1|||
13382807|NCT00742391|26751812|FG001|Overall Study|Lost to Follow-up|0|||
13382808|NCT00742391|26751811|FG000|Overall Study|Protocol Violation|1|||
13382809|NCT00742391|26751812|FG001|Overall Study|Protocol Violation|0|||
13382810|NCT00742326|26751827|FG000|Overall Study|Physician Decision|0|||
13382811|NCT00742326|26751828|FG001|Overall Study|Physician Decision|1|||
13382812|NCT00742274|26751841|FG000|Overall Study|Death|1|||
13382813|NCT00742274|26751842|FG001|Overall Study|Death|0|||
13382814|NCT00742274|26751841|FG000|Overall Study|Withdrawal by Subject|1|||
13382815|NCT00742274|26751842|FG001|Overall Study|Withdrawal by Subject|2|||
13382816|NCT00742274|26751841|FG000|Overall Study|Removed for medical reasons|1|||
13382817|NCT00742274|26751842|FG001|Overall Study|Removed for medical reasons|1|||
13382818|NCT00742235|26751857|FG000|Overall Study|Lost to Follow-up|0|||
13382819|NCT00742235|26751858|FG001|Overall Study|Lost to Follow-up|31|||
13394803|NCT00654381|26788100|FG003|Extension Stage|Withdrawal by Subject|1|||
13394804|NCT00654381|26788101|FG004|Extension Stage|Withdrawal by Subject|1|||
13394805|NCT00654381|26788102|FG005|Extension Stage|Withdrawal by Subject|1|||
13394806|NCT00654381|26788097|FG000|Extension Stage|Closure of the trial site|0|||
13394807|NCT00654381|26788098|FG001|Extension Stage|Closure of the trial site|0|||
13394808|NCT00654381|26788099|FG002|Extension Stage|Closure of the trial site|0|||
13394809|NCT00654381|26788100|FG003|Extension Stage|Closure of the trial site|0|||
13394810|NCT00654381|26788101|FG004|Extension Stage|Closure of the trial site|1|||
13394811|NCT00654381|26788102|FG005|Extension Stage|Closure of the trial site|1|||
13394812|NCT00654368|26788143|FG000|Overall Study|Ineligibility determined|6|||
13394813|NCT00654368|26788144|FG001|Overall Study|Ineligibility determined|0|||
13394814|NCT00654368|26788145|FG002|Overall Study|Ineligibility determined|0|||
13394815|NCT00654368|26788143|FG000|Overall Study|Protocol deviation|3|||
13394816|NCT00654368|26788144|FG001|Overall Study|Protocol deviation|2|||
13394817|NCT00654368|26788145|FG002|Overall Study|Protocol deviation|1|||
13394818|NCT00654368|26788143|FG000|Overall Study|Non-compliance|2|||
13394819|NCT00654368|26788144|FG001|Overall Study|Non-compliance|1|||
13394820|NCT00654368|26788145|FG002|Overall Study|Non-compliance|2|||
13394821|NCT00654368|26788143|FG000|Overall Study|Withdrawal by Subject|5|||
13394822|NCT00654368|26788144|FG001|Overall Study|Withdrawal by Subject|2|||
13394823|NCT00654368|26788145|FG002|Overall Study|Withdrawal by Subject|2|||
13394824|NCT00654368|26788143|FG000|Overall Study|Disease progression|21|||
13394825|NCT00654368|26788144|FG001|Overall Study|Disease progression|31|||
13394826|NCT00654368|26788145|FG002|Overall Study|Disease progression|13|||
13394827|NCT00654368|26788143|FG000|Overall Study|Requirement for alternative therapy|1|||
13394828|NCT00654368|26788144|FG001|Overall Study|Requirement for alternative therapy|1|||
13394829|NCT00654368|26788145|FG002|Overall Study|Requirement for alternative therapy|1|||
13394830|NCT00654368|26788143|FG000|Overall Study|Physician Decision|0|||
13394831|NCT00654368|26788144|FG001|Overall Study|Physician Decision|0|||
13394832|NCT00654368|26788145|FG002|Overall Study|Physician Decision|2|||
13394833|NCT00654368|26788143|FG000|Overall Study|Death|1|||
13394834|NCT00654368|26788144|FG001|Overall Study|Death|0|||
13305367|NCT01298570|26522816|FG001|Overall Study|Surgery|1|||
13305368|NCT01298570|26522815|FG000|Overall Study|Symptomatic progression/deterioration|3|||
13305369|NCT01298570|26522816|FG001|Overall Study|Symptomatic progression/deterioration|2|||
13305370|NCT01298570|26522815|FG000|Overall Study|Death|0|||
13394835|NCT00654368|26788145|FG002|Overall Study|Death|0|||
13394836|NCT00654368|26788143|FG000|Overall Study|Pregnancy|0|||
13394837|NCT00654368|26788144|FG001|Overall Study|Pregnancy|0|||
13394838|NCT00654368|26788145|FG002|Overall Study|Pregnancy|2|||
13394839|NCT00654368|26788143|FG000|Overall Study|Other|0|||
13394840|NCT00654368|26788144|FG001|Overall Study|Other|2|||
13394841|NCT00654368|26788145|FG002|Overall Study|Other|3|||
13394842|NCT00654368|26788143|FG000|Overall Study|Adverse Event|14|||
13394843|NCT00654368|26788144|FG001|Overall Study|Adverse Event|9|||
13305371|NCT01298570|26522816|FG001|Overall Study|Death|1|||
13305372|NCT01298570|26522815|FG000|Overall Study|Ineligibility|0|||
13305373|NCT01298570|26522816|FG001|Overall Study|Ineligibility|1|||
13305374|NCT01298531|26522949|FG000|Overall Study|Lack of Efficacy|0|||
13305375|NCT01298531|26522950|FG001|Overall Study|Lack of Efficacy|1|||
13305376|NCT01298531|26522949|FG000|Overall Study|Lost to Follow-up|2|||
13305377|NCT01298531|26522950|FG001|Overall Study|Lost to Follow-up|0|||
13305378|NCT01298531|26522949|FG000|Overall Study|Protocol Violation|1|||
13305379|NCT01298531|26522950|FG001|Overall Study|Protocol Violation|1|||
13305380|NCT01298531|26522949|FG000|Overall Study|Adverse Event|4|||
13305381|NCT01298531|26522950|FG001|Overall Study|Adverse Event|3|||
13305382|NCT01298531|26522949|FG000|Overall Study|Does not meet entrance criteria|0|||
13305383|NCT01298531|26522950|FG001|Overall Study|Does not meet entrance criteria|1|||
13305384|NCT01298531|26522949|FG000|Overall Study|Other|2|||
13394844|NCT00654368|26788145|FG002|Overall Study|Adverse Event|6|||
13394845|NCT00654355|26788162|FG000|Overall Study|Lost to Follow-up|2|||
13394846|NCT00654355|26788163|FG001|Overall Study|Lost to Follow-up|2|||
13394847|NCT00654238|26788170|FG000|Overall Study|Screen Failures|4|||
13394848|NCT00654186|26788178|FG000|Overall Study|Withdrawal by Subject|5|||
13394849|NCT00654095|26788184|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
13394850|NCT00654095|26788184|FG000|Overall Study|Elevated triglyceride level (2)|1|||
13394851|NCT00654095|26788184|FG000|Overall Study|Elevated alanine aminotransferase (3)|1|||
13394852|NCT00654095|26788184|FG000|Overall Study|Adverse Event|11|||
13394853|NCT00654095|26788184|FG000|Overall Study|Withdrawal by Subject|5|||
13394854|NCT00654095|26788184|FG000|Overall Study|Elevated alanine aminotransferase (4)|7|||
13305385|NCT01298531|26522950|FG001|Overall Study|Other|1|||
13305386|NCT01298518|26523012|FG000|Overall Study|Withdrawal by Subject|0|||
13305387|NCT01298518|26523013|FG001|Overall Study|Withdrawal by Subject|0|||
13305388|NCT01298518|26523014|FG002|Overall Study|Withdrawal by Subject|1|||
13305389|NCT01298492|26523022|FG000|Overall Study|Death|2|||
13305390|NCT01298492|26523022|FG000|Overall Study|Insufficient Clinical Response|22|||
13305391|NCT01298492|26523022|FG000|Overall Study|Lost to Follow-up|12|||
13305392|NCT01298492|26523022|FG000|Overall Study|Withdrawal by Subject|47|||
13305393|NCT01298492|26523022|FG000|Overall Study|Other (Unspecified)|7|||
13305394|NCT01298492|26523022|FG000|Overall Study|Withdrawn Due to Pregnancy|1|||
13305395|NCT01298492|26523022|FG000|Overall Study|Protocol Violation|2|||
13305396|NCT01298492|26523022|FG000|Overall Study|Adverse Event(Related to Study Drug)|8|||
13305397|NCT01298492|26523022|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18|||
13305398|NCT01298362|26523047|FG000|Overall Study|Did not provide 12month BMD measurements|38|||
13305399|NCT01298362|26523048|FG001|Overall Study|Did not provide 12month BMD measurements|43|||
13305400|NCT01298323|26523061|FG000|Overall Study|Adverse Event|2|||
13305401|NCT01298323|26523062|FG001|Overall Study|Adverse Event|4|||
13305402|NCT01298323|26523061|FG000|Overall Study|Death|11|||
13305403|NCT01298323|26523062|FG001|Overall Study|Death|16|||
13305404|NCT01298323|26523061|FG000|Overall Study|Lost to Follow-up|1|||
13305405|NCT01298323|26523062|FG001|Overall Study|Lost to Follow-up|0|||
13305406|NCT01298323|26523061|FG000|Overall Study|Withdrawal by Subject|6|||
13305407|NCT01298323|26523062|FG001|Overall Study|Withdrawal by Subject|3|||
13305408|NCT01298323|26523061|FG000|Overall Study|Protocol Violation|1|||
13305409|NCT01298323|26523062|FG001|Overall Study|Protocol Violation|0|||
13305410|NCT01298323|26523061|FG000|Overall Study|Other|10|||
13305411|NCT01298323|26523062|FG001|Overall Study|Other|9|||
13305412|NCT01298323|26523061|FG000|Overall Study|Ongoing|55|||
13305413|NCT01298323|26523062|FG001|Overall Study|Ongoing|55|||
13305414|NCT01298323|26523061|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
13305415|NCT01298323|26523062|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
13305416|NCT01298193|26523077|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2|||
13305417|NCT01298193|26523077|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16|||
13305418|NCT01298193|26523077|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9|||
13305419|NCT01298193|26523077|FG000|Efficacy Phase (Second Cycle)|Death|1|||
13305420|NCT01298141|26523089|FG000|Overall Study|Adverse Event|3|||
13305421|NCT01298141|26523089|FG000|Overall Study|Refusal of Required Study Procedures|1|||
13305422|NCT01298141|26523089|FG000|Overall Study|Withdrawal by Subject|6|||
13305423|NCT01298141|26523089|FG000|Overall Study|Termination of Study by the Investigator|5|||
13305424|NCT01298141|26523089|FG000|Overall Study|Other|5|||
13305425|NCT01298141|26523089|FG000|Overall Study|Lost to Follow-up|1|||
13305426|NCT01298141|26523089|FG000|Overall Study|Death|6|||
13305427|NCT01298141|26523089|FG000|Overall Study|Not treated|4|||
13305428|NCT01297959|26523142|FG000|Overall Study|Adverse Event|0|||
13305429|NCT01297959|26523143|FG001|Overall Study|Adverse Event|1|||
13305430|NCT01297959|26523142|FG000|Overall Study|Protocol Violation|2|||
13305431|NCT01297959|26523143|FG001|Overall Study|Protocol Violation|1|||
13305432|NCT01297959|26523142|FG000|Overall Study|Withdrawal by Subject|5|||
13305433|NCT01297959|26523143|FG001|Overall Study|Withdrawal by Subject|4|||
13305434|NCT01297959|26523142|FG000|Overall Study|Physician Decision|0|||
13305435|NCT01297959|26523143|FG001|Overall Study|Physician Decision|1|||
13305436|NCT01297959|26523142|FG000|Overall Study|Unrelated medical illness / complication|0|||
13305437|NCT01297959|26523143|FG001|Overall Study|Unrelated medical illness / complication|2|||
13305438|NCT01297959|26523142|FG000|Overall Study|Other|13|||
13305439|NCT01297959|26523143|FG001|Overall Study|Other|7|||
13305440|NCT01297920|26523161|FG000|Overall Study|Adverse Event|42|||
13305441|NCT01297920|26523162|FG001|Overall Study|Adverse Event|10|||
13305442|NCT01297920|26523163|FG002|Overall Study|Adverse Event|38|||
13305443|NCT01297920|26523161|FG000|Overall Study|Patient Decision Unrelated to AE|6|||
13305444|NCT01297920|26523162|FG001|Overall Study|Patient Decision Unrelated to AE|5|||
13305445|NCT01297920|26523163|FG002|Overall Study|Patient Decision Unrelated to AE|2|||
13305446|NCT01297920|26523161|FG000|Overall Study|Noncompliance|1|||
13305447|NCT01297920|26523162|FG001|Overall Study|Noncompliance|0|||
13305448|NCT01297920|26523163|FG002|Overall Study|Noncompliance|0|||
13305449|NCT01297920|26523161|FG000|Overall Study|Protocol Violation|1|||
13305450|NCT01297920|26523162|FG001|Overall Study|Protocol Violation|3|||
13305451|NCT01297920|26523163|FG002|Overall Study|Protocol Violation|0|||
13305452|NCT01297920|26523161|FG000|Overall Study|Inadequate Control of IOP|7|||
13305453|NCT01297920|26523162|FG001|Overall Study|Inadequate Control of IOP|9|||
13305454|NCT01297920|26523163|FG002|Overall Study|Inadequate Control of IOP|17|||
13305455|NCT01297920|26523161|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1|||
13305456|NCT01297920|26523162|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
13305457|NCT01297920|26523163|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
13305458|NCT01297517|26523181|FG000|Overall Study|Adverse Event|21|||
13305459|NCT01297517|26523182|FG001|Overall Study|Adverse Event|7|||
13305460|NCT01297517|26523183|FG002|Overall Study|Adverse Event|16|||
13305461|NCT01297517|26523181|FG000|Overall Study|Lost to Follow-up|1|||
13305462|NCT01297517|26523182|FG001|Overall Study|Lost to Follow-up|0|||
13305463|NCT01297517|26523183|FG002|Overall Study|Lost to Follow-up|1|||
13305464|NCT01297517|26523181|FG000|Overall Study|Patient Decision Unrelated to AE|2|||
13305465|NCT01297517|26523182|FG001|Overall Study|Patient Decision Unrelated to AE|3|||
13305466|NCT01297517|26523183|FG002|Overall Study|Patient Decision Unrelated to AE|7|||
13305467|NCT01297517|26523181|FG000|Overall Study|Noncompliance|1|||
13305468|NCT01297517|26523182|FG001|Overall Study|Noncompliance|0|||
13305469|NCT01297517|26523183|FG002|Overall Study|Noncompliance|0|||
13305470|NCT01297517|26523181|FG000|Overall Study|Protocol Violation|1|||
13305471|NCT01297517|26523182|FG001|Overall Study|Protocol Violation|1|||
13305472|NCT01297517|26523183|FG002|Overall Study|Protocol Violation|1|||
13305473|NCT01297517|26523181|FG000|Overall Study|Inadequate Control of IOP|1|||
13305474|NCT01297517|26523182|FG001|Overall Study|Inadequate Control of IOP|1|||
13305475|NCT01297517|26523183|FG002|Overall Study|Inadequate Control of IOP|2|||
13305476|NCT01297504|26523197|FG000|Overall Study|Invalid Consent|1|||
13305477|NCT01297504|26523197|FG000|Overall Study|Received Palivizumab in Previous Season|1|||
13305478|NCT01297504|26523197|FG000|Overall Study|No Study Visits|4|||
13305479|NCT01297504|26523197|FG000|Overall Study|Death|3|||
13305480|NCT01297504|26523197|FG000|Overall Study|Lost to Follow-up|43|||
13305481|NCT01297504|26523197|FG000|Overall Study|Withdrawal by Subject|9|||
13305482|NCT01297504|26523197|FG000|Overall Study|Site Closure|3|||
13305483|NCT01297504|26523197|FG000|Overall Study|Protocol Violation|3|||
13305484|NCT01297491|26523220|FG000|Overall Study|Adverse Event|11|||
13305485|NCT01297491|26523221|FG001|Overall Study|Adverse Event|6|||
13305486|NCT01297491|26523220|FG000|Overall Study|Physician Decision|3|||
13305487|NCT01297491|26523221|FG001|Overall Study|Physician Decision|2|||
13305488|NCT01297491|26523220|FG000|Overall Study|Progressive disease|11|||
13305489|NCT01297491|26523221|FG001|Overall Study|Progressive disease|20|||
13305490|NCT01297491|26523220|FG000|Overall Study|Patient/Guardian decision|3|||
13305491|NCT01297491|26523221|FG001|Overall Study|Patient/Guardian decision|4|||
13305492|NCT01297491|26523220|FG000|Overall Study|Death|2|||
13305493|NCT01297491|26523221|FG001|Overall Study|Death|1|||
13305494|NCT01297465|26523260|FG000|Overall Study|Lack of Ovarian Response|1|||
13305495|NCT01297465|26523261|FG001|Overall Study|Lack of Ovarian Response|1|||
13305496|NCT01297465|26523260|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
13305497|NCT01297465|26523261|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
13305498|NCT01297465|26523260|FG000|Overall Study|No Oocytes Retrieved|1|||
13305499|NCT01297465|26523261|FG001|Overall Study|No Oocytes Retrieved|1|||
13305500|NCT01297465|26523260|FG000|Overall Study|Poor oocyte quality|0|||
13305501|NCT01297465|26523261|FG001|Overall Study|Poor oocyte quality|1|||
13305502|NCT01297465|26523260|FG000|Overall Study|No Fertilization|6|||
13305503|NCT01297465|26523261|FG001|Overall Study|No Fertilization|4|||
13305504|NCT01297465|26523260|FG000|Overall Study|All Embryos Discarded|0|||
13305505|NCT01297465|26523261|FG001|Overall Study|All Embryos Discarded|1|||
13305506|NCT01297465|26523260|FG000|Overall Study|Intention to Freeze all Embryos|0|||
13305507|NCT01297465|26523261|FG001|Overall Study|Intention to Freeze all Embryos|1|||
13305508|NCT01297322|26523287|FG000|Overall Study|Lost to Follow-up|1|||
13305509|NCT01297322|26523288|FG001|Overall Study|Lost to Follow-up|0|||
13305510|NCT01297322|26523287|FG000|Overall Study|Withdrawal by Subject|0|||
13305511|NCT01297322|26523288|FG001|Overall Study|Withdrawal by Subject|1|||
13305512|NCT01297322|26523287|FG000|Overall Study|Protocol Violation|0|||
13305513|NCT01297322|26523288|FG001|Overall Study|Protocol Violation|3|||
13305514|NCT01297309|26523307|FG000|Overall Study|Eligibility failure|2|||
13305515|NCT01297309|26523307|FG000|Overall Study|Screen failure|2|||
13305516|NCT01297309|26523307|FG000|Overall Study|Withdrawal by Subject|5|||
13305517|NCT01297309|26523307|FG000|Overall Study|Adverse Event|1|||
13305518|NCT01297309|26523307|FG000|Overall Study|Investigator Decision|2|||
13305519|NCT01297309|26523307|FG000|Overall Study|Death|1|||
13305520|NCT01297309|26523307|FG000|Overall Study|Participant not entering extensionperiod|1|||
13305521|NCT01297270|26523355|FG000|Overall Study|Adverse Event|19|||
13305522|NCT01297270|26523356|FG001|Overall Study|Adverse Event|32|||
13305523|NCT01297270|26523357|FG002|Overall Study|Adverse Event|5|||
13305524|NCT01297270|26523355|FG000|Overall Study|Lack of Efficacy|15|||
13305525|NCT01297270|26523356|FG001|Overall Study|Lack of Efficacy|17|||
13305526|NCT01297270|26523357|FG002|Overall Study|Lack of Efficacy|15|||
13305527|NCT01297270|26523355|FG000|Overall Study|Lost to Follow-up|1|||
13305528|NCT01297270|26523356|FG001|Overall Study|Lost to Follow-up|2|||
13305529|NCT01297270|26523357|FG002|Overall Study|Lost to Follow-up|1|||
13305530|NCT01297270|26523355|FG000|Overall Study|Protocol Violation|0|||
13305531|NCT01297270|26523356|FG001|Overall Study|Protocol Violation|2|||
13305532|NCT01297270|26523357|FG002|Overall Study|Protocol Violation|0|||
13305533|NCT01297270|26523355|FG000|Overall Study|Withdrawal by Subject|7|||
13305534|NCT01297270|26523356|FG001|Overall Study|Withdrawal by Subject|15|||
13305535|NCT01297270|26523357|FG002|Overall Study|Withdrawal by Subject|7|||
13305536|NCT01297270|26523355|FG000|Overall Study|Other reason not defined above|3|||
13305537|NCT01297270|26523356|FG001|Overall Study|Other reason not defined above|3|||
13305538|NCT01297270|26523357|FG002|Overall Study|Other reason not defined above|1|||
13305539|NCT01297270|26523355|FG000|Overall Study|Not treated|0|||
13305540|NCT01297270|26523356|FG001|Overall Study|Not treated|1|||
13305541|NCT01297270|26523357|FG002|Overall Study|Not treated|0|||
13305542|NCT01297244|26523378|FG000|Overall Study|Progressive disease|22|||
13305543|NCT01297244|26523379|FG001|Overall Study|Progressive disease|3|||
13305544|NCT01297244|26523378|FG000|Overall Study|Adverse Event|9|||
13305545|NCT01297244|26523379|FG001|Overall Study|Adverse Event|1|||
13305546|NCT01297244|26523378|FG000|Overall Study|Death|1|||
13305547|NCT01297244|26523379|FG001|Overall Study|Death|1|||
13305548|NCT01297244|26523378|FG000|Overall Study|Clinical progression|1|||
13305549|NCT01297244|26523379|FG001|Overall Study|Clinical progression|1|||
13305550|NCT01297244|26523378|FG000|Overall Study|Withdrawal by Subject|2|||
13305551|NCT01297244|26523379|FG001|Overall Study|Withdrawal by Subject|0|||
13305552|NCT01297062|26523421|FG000|Overall Study|Adverse Event|2|||
13305553|NCT01297062|26523422|FG001|Overall Study|Adverse Event|0|||
13305554|NCT01297062|26523423|FG002|Overall Study|Adverse Event|1|||
13305555|NCT01297062|26523424|FG003|Overall Study|Adverse Event|0|||
13305556|NCT01297062|26523425|FG004|Overall Study|Adverse Event|0|||
13305557|NCT01297062|26523426|FG005|Overall Study|Adverse Event|0|||
13305558|NCT01297062|26523427|FG006|Overall Study|Adverse Event|0|||
13305559|NCT01297062|26523421|FG000|Overall Study|Physician Decision|1|||
13305560|NCT01297062|26523422|FG001|Overall Study|Physician Decision|0|||
13305561|NCT01297062|26523423|FG002|Overall Study|Physician Decision|1|||
13305562|NCT01297062|26523424|FG003|Overall Study|Physician Decision|0|||
13305563|NCT01297062|26523425|FG004|Overall Study|Physician Decision|0|||
13305564|NCT01297062|26523426|FG005|Overall Study|Physician Decision|0|||
13305565|NCT01297062|26523427|FG006|Overall Study|Physician Decision|6|||
13305566|NCT01297062|26523421|FG000|Overall Study|Protocol Violation|0|||
13305567|NCT01297062|26523422|FG001|Overall Study|Protocol Violation|0|||
13305568|NCT01297062|26523423|FG002|Overall Study|Protocol Violation|0|||
13305569|NCT01297062|26523424|FG003|Overall Study|Protocol Violation|0|||
13305570|NCT01297062|26523425|FG004|Overall Study|Protocol Violation|1|||
13305571|NCT01297062|26523426|FG005|Overall Study|Protocol Violation|0|||
13305572|NCT01297062|26523427|FG006|Overall Study|Protocol Violation|0|||
13305573|NCT01297062|26523421|FG000|Overall Study|Subject Decision|1|||
13305574|NCT01297062|26523422|FG001|Overall Study|Subject Decision|1|||
13305575|NCT01297062|26523423|FG002|Overall Study|Subject Decision|0|||
13305576|NCT01297062|26523424|FG003|Overall Study|Subject Decision|1|||
13305577|NCT01297062|26523425|FG004|Overall Study|Subject Decision|1|||
13305578|NCT01297062|26523426|FG005|Overall Study|Subject Decision|1|||
13305579|NCT01297062|26523427|FG006|Overall Study|Subject Decision|2|||
13305580|NCT01296932|26523539|FG000|Overall Study|Dose limiting toxicity|0|||
13305581|NCT01296932|26523540|FG001|Overall Study|Dose limiting toxicity|0|||
13305582|NCT01296932|26523541|FG002|Overall Study|Dose limiting toxicity|0|||
13305583|NCT01296932|26523542|FG003|Overall Study|Dose limiting toxicity|0|||
13305584|NCT01296932|26523543|FG004|Overall Study|Dose limiting toxicity|0|||
13305585|NCT01296932|26523544|FG005|Overall Study|Dose limiting toxicity|0|||
13305586|NCT01296932|26523545|FG006|Overall Study|Dose limiting toxicity|1|||
13305587|NCT01296932|26523546|FG007|Overall Study|Dose limiting toxicity|0|||
13305588|NCT01296932|26523547|FG008|Overall Study|Dose limiting toxicity|1|||
13305589|NCT01296932|26523539|FG000|Overall Study|Progressive disease|2|||
13305590|NCT01296932|26523540|FG001|Overall Study|Progressive disease|0|||
13305591|NCT01296932|26523541|FG002|Overall Study|Progressive disease|1|||
13305592|NCT01296932|26523542|FG003|Overall Study|Progressive disease|1|||
13305593|NCT01296932|26523543|FG004|Overall Study|Progressive disease|2|||
13305594|NCT01296932|26523544|FG005|Overall Study|Progressive disease|3|||
13305595|NCT01296932|26523545|FG006|Overall Study|Progressive disease|1|||
13305596|NCT01296932|26523546|FG007|Overall Study|Progressive disease|0|||
13305597|NCT01296932|26523547|FG008|Overall Study|Progressive disease|0|||
13305598|NCT01296932|26523539|FG000|Overall Study|Withdrawal by Subject|0|||
13305599|NCT01296932|26523540|FG001|Overall Study|Withdrawal by Subject|0|||
13305600|NCT01296932|26523541|FG002|Overall Study|Withdrawal by Subject|1|||
13305601|NCT01296932|26523542|FG003|Overall Study|Withdrawal by Subject|1|||
13382820|NCT00742209|26751975|FG000|Overall Study|Adverse Event|11|||
13382821|NCT00742209|26751976|FG001|Overall Study|Adverse Event|4|||
13382822|NCT00742209|26751977|FG002|Overall Study|Adverse Event|17|||
13382823|NCT00742209|26751978|FG003|Overall Study|Adverse Event|16|||
13382824|NCT00742209|26751979|FG004|Overall Study|Adverse Event|13|||
13382825|NCT00742209|26751975|FG000|Overall Study|Participant Withdrew Consent|8|||
13382826|NCT00742209|26751976|FG001|Overall Study|Participant Withdrew Consent|4|||
13382827|NCT00742209|26751977|FG002|Overall Study|Participant Withdrew Consent|14|||
13382828|NCT00742209|26751978|FG003|Overall Study|Participant Withdrew Consent|7|||
13382829|NCT00742209|26751979|FG004|Overall Study|Participant Withdrew Consent|4|||
13382830|NCT00742209|26751975|FG000|Overall Study|Protocol Violation|6|||
13382831|NCT00742209|26751976|FG001|Overall Study|Protocol Violation|5|||
13382832|NCT00742209|26751977|FG002|Overall Study|Protocol Violation|4|||
13382833|NCT00742209|26751978|FG003|Overall Study|Protocol Violation|5|||
13382834|NCT00742209|26751979|FG004|Overall Study|Protocol Violation|3|||
13382835|NCT00742209|26751975|FG000|Overall Study|Lost to Follow-up|3|||
13382836|NCT00742209|26751976|FG001|Overall Study|Lost to Follow-up|4|||
13382837|NCT00742209|26751977|FG002|Overall Study|Lost to Follow-up|5|||
13382838|NCT00742209|26751978|FG003|Overall Study|Lost to Follow-up|5|||
13382839|NCT00742209|26751979|FG004|Overall Study|Lost to Follow-up|3|||
13382840|NCT00742209|26751975|FG000|Overall Study|Lack of Efficacy|6|||
13382841|NCT00742209|26751976|FG001|Overall Study|Lack of Efficacy|1|||
13382842|NCT00742209|26751977|FG002|Overall Study|Lack of Efficacy|1|||
13382843|NCT00742209|26751978|FG003|Overall Study|Lack of Efficacy|3|||
13382844|NCT00742209|26751979|FG004|Overall Study|Lack of Efficacy|1|||
13382845|NCT00742209|26751975|FG000|Overall Study|Investigator Discretion|0|||
13382846|NCT00742209|26751976|FG001|Overall Study|Investigator Discretion|0|||
13382847|NCT00742209|26751977|FG002|Overall Study|Investigator Discretion|5|||
13382848|NCT00742209|26751978|FG003|Overall Study|Investigator Discretion|1|||
13382849|NCT00742209|26751979|FG004|Overall Study|Investigator Discretion|1|||
13382850|NCT00742183|26751992|FG000|Overall Study|Adverse Event|2|||
13382851|NCT00742183|26751993|FG001|Overall Study|Adverse Event|2|||
13382852|NCT00742183|26751992|FG000|Overall Study|Death|1|||
13382853|NCT00742183|26751993|FG001|Overall Study|Death|0|||
13382854|NCT00742183|26751992|FG000|Overall Study|Physician Decision|0|||
13382855|NCT00742183|26751993|FG001|Overall Study|Physician Decision|2|||
13382856|NCT00742183|26751992|FG000|Overall Study|Lost to Follow-up|4|||
13382857|NCT00742183|26751993|FG001|Overall Study|Lost to Follow-up|4|||
13382858|NCT00742183|26751992|FG000|Overall Study|Required skin-graft|1|||
13382859|NCT00742183|26751993|FG001|Overall Study|Required skin-graft|1|||
13382860|NCT00742183|26751992|FG000|Overall Study|Withdrawal by Subject|1|||
13382861|NCT00742183|26751993|FG001|Overall Study|Withdrawal by Subject|0|||
13382862|NCT00742183|26751992|FG000|Overall Study|Lack of Efficacy|0|||
13382863|NCT00742183|26751993|FG001|Overall Study|Lack of Efficacy|3|||
13382864|NCT00742079|26752014|FG000|Overall Study|Lost to Follow-up|0|||
13382865|NCT00742079|26752015|FG001|Overall Study|Lost to Follow-up|1|||
13382866|NCT00742027|26752031|FG000|Overall Study|Disease Progression|76|||
13382867|NCT00742027|26752031|FG000|Overall Study|New Cancer Therapy|19|||
13382868|NCT00742027|26752031|FG000|Overall Study|Withdrawal by Subject|18|||
13382869|NCT00742027|26752031|FG000|Overall Study|Death|7|||
13382870|NCT00742027|26752031|FG000|Overall Study|Lost to Follow-up|4|||
13382871|NCT00742027|26752031|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2|||
13382872|NCT00742027|26752031|FG000|Overall Study|Missing|2|||
13382873|NCT00742027|26752031|FG000|Overall Study|Administrative Problems|1|||
13382874|NCT00742001|26752055|FG000|Overall Study|Withdrawn; health exclusion (flu)|0|||
13382875|NCT00742001|26752056|FG001|Overall Study|Withdrawn; health exclusion (flu)|0|||
13382876|NCT00742001|26752057|FG002|Overall Study|Withdrawn; health exclusion (flu)|1|||
13382877|NCT00741936|26752090|FG000|Overall Study|Lost to Follow-up|1|||
13382878|NCT00741936|26752091|FG001|Overall Study|Lost to Follow-up|1|||
13382879|NCT00741936|26752090|FG000|Overall Study|Adverse Event|3|||
13382880|NCT00741936|26752091|FG001|Overall Study|Adverse Event|4|||
13382881|NCT00741936|26752090|FG000|Overall Study|Pregnancy|0|||
13382882|NCT00741936|26752091|FG001|Overall Study|Pregnancy|1|||
13382883|NCT00741936|26752090|FG000|Overall Study|Protocol Violation|2|||
13382884|NCT00741936|26752091|FG001|Overall Study|Protocol Violation|0|||
13382885|NCT00741936|26752090|FG000|Overall Study|Lack of Efficacy|0|||
13305602|NCT01296932|26523543|FG004|Overall Study|Withdrawal by Subject|0|||
13305603|NCT01296932|26523544|FG005|Overall Study|Withdrawal by Subject|0|||
13305604|NCT01296932|26523545|FG006|Overall Study|Withdrawal by Subject|3|||
13305605|NCT01296932|26523546|FG007|Overall Study|Withdrawal by Subject|0|||
13219837|NCT01830543|26278438|FG002|Overall Study|Death|22|||
13219838|NCT01830543|26278436|FG000|Overall Study|Protocol Violation|3|||
13219839|NCT01830543|26278437|FG001|Overall Study|Protocol Violation|7|||
13219840|NCT01830543|26278438|FG002|Overall Study|Protocol Violation|7|||
13219841|NCT01830543|26278436|FG000|Overall Study|Physician Decision|11|||
13219842|NCT01830543|26278437|FG001|Overall Study|Physician Decision|5|||
13219843|NCT01830543|26278438|FG002|Overall Study|Physician Decision|12|||
13219844|NCT01830543|26278436|FG000|Overall Study|Withdrawal by consent|3|||
13219845|NCT01830543|26278437|FG001|Overall Study|Withdrawal by consent|3|||
13219846|NCT01830543|26278438|FG002|Overall Study|Withdrawal by consent|3|||
13305606|NCT01296932|26523547|FG008|Overall Study|Withdrawal by Subject|0|||
13305607|NCT01296932|26523539|FG000|Overall Study|Adverse Event|1|||
13305608|NCT01296932|26523540|FG001|Overall Study|Adverse Event|1|||
13305609|NCT01296932|26523541|FG002|Overall Study|Adverse Event|1|||
13305610|NCT01296932|26523542|FG003|Overall Study|Adverse Event|2|||
13305611|NCT01296932|26523543|FG004|Overall Study|Adverse Event|1|||
13305612|NCT01296932|26523544|FG005|Overall Study|Adverse Event|0|||
13305613|NCT01296932|26523545|FG006|Overall Study|Adverse Event|0|||
13305614|NCT01296932|26523546|FG007|Overall Study|Adverse Event|0|||
13305615|NCT01296932|26523547|FG008|Overall Study|Adverse Event|1|||
13305616|NCT01296932|26523539|FG000|Overall Study|Investigator decision|0|||
13305617|NCT01296932|26523540|FG001|Overall Study|Investigator decision|1|||
13305618|NCT01296932|26523541|FG002|Overall Study|Investigator decision|0|||
13305619|NCT01296932|26523542|FG003|Overall Study|Investigator decision|1|||
13305620|NCT01296932|26523543|FG004|Overall Study|Investigator decision|0|||
13305621|NCT01296932|26523544|FG005|Overall Study|Investigator decision|0|||
13305622|NCT01296932|26523545|FG006|Overall Study|Investigator decision|1|||
13305623|NCT01296932|26523546|FG007|Overall Study|Investigator decision|0|||
13305624|NCT01296932|26523547|FG008|Overall Study|Investigator decision|1|||
13305625|NCT01296932|26523539|FG000|Overall Study|No clinical benefit anymore|0|||
13305626|NCT01296932|26523540|FG001|Overall Study|No clinical benefit anymore|1|||
13305627|NCT01296932|26523541|FG002|Overall Study|No clinical benefit anymore|0|||
13305628|NCT01296932|26523542|FG003|Overall Study|No clinical benefit anymore|0|||
13305629|NCT01296932|26523543|FG004|Overall Study|No clinical benefit anymore|0|||
13305630|NCT01296932|26523544|FG005|Overall Study|No clinical benefit anymore|0|||
13305631|NCT01296932|26523545|FG006|Overall Study|No clinical benefit anymore|0|||
13305632|NCT01296932|26523546|FG007|Overall Study|No clinical benefit anymore|0|||
13305633|NCT01296932|26523547|FG008|Overall Study|No clinical benefit anymore|0|||
13305634|NCT01296932|26523539|FG000|Overall Study|Physician Decision|0|||
13305635|NCT01296932|26523540|FG001|Overall Study|Physician Decision|0|||
13305636|NCT01296932|26523541|FG002|Overall Study|Physician Decision|1|||
13305637|NCT01296932|26523542|FG003|Overall Study|Physician Decision|0|||
13305638|NCT01296932|26523543|FG004|Overall Study|Physician Decision|0|||
13305639|NCT01296932|26523544|FG005|Overall Study|Physician Decision|0|||
13305640|NCT01296932|26523545|FG006|Overall Study|Physician Decision|0|||
13305641|NCT01296932|26523546|FG007|Overall Study|Physician Decision|0|||
13305642|NCT01296932|26523547|FG008|Overall Study|Physician Decision|0|||
13305643|NCT01296932|26523539|FG000|Overall Study|IV problems, administration not possible|0|||
13305644|NCT01296932|26523540|FG001|Overall Study|IV problems, administration not possible|0|||
13305645|NCT01296932|26523541|FG002|Overall Study|IV problems, administration not possible|1|||
13305646|NCT01296932|26523542|FG003|Overall Study|IV problems, administration not possible|0|||
13305647|NCT01296932|26523543|FG004|Overall Study|IV problems, administration not possible|0|||
13305648|NCT01296932|26523544|FG005|Overall Study|IV problems, administration not possible|0|||
13305649|NCT01296932|26523545|FG006|Overall Study|IV problems, administration not possible|0|||
13305650|NCT01296932|26523546|FG007|Overall Study|IV problems, administration not possible|0|||
13305651|NCT01296932|26523547|FG008|Overall Study|IV problems, administration not possible|0|||
13305652|NCT01296932|26523539|FG000|Overall Study|per protocol|0|||
13305653|NCT01296932|26523540|FG001|Overall Study|per protocol|0|||
13305654|NCT01296932|26523541|FG002|Overall Study|per protocol|1|||
13305655|NCT01296932|26523542|FG003|Overall Study|per protocol|1|||
13305656|NCT01296932|26523543|FG004|Overall Study|per protocol|0|||
13305657|NCT01296932|26523544|FG005|Overall Study|per protocol|0|||
13305658|NCT01296932|26523545|FG006|Overall Study|per protocol|0|||
13305659|NCT01296932|26523546|FG007|Overall Study|per protocol|0|||
13305660|NCT01296932|26523547|FG008|Overall Study|per protocol|0|||
13305661|NCT01296932|26523539|FG000|Overall Study|Low benefit and too many side effects|0|||
13305662|NCT01296932|26523540|FG001|Overall Study|Low benefit and too many side effects|0|||
13305663|NCT01296932|26523541|FG002|Overall Study|Low benefit and too many side effects|0|||
13305664|NCT01296932|26523542|FG003|Overall Study|Low benefit and too many side effects|0|||
13305665|NCT01296932|26523543|FG004|Overall Study|Low benefit and too many side effects|0|||
13305666|NCT01296932|26523544|FG005|Overall Study|Low benefit and too many side effects|0|||
13305667|NCT01296932|26523545|FG006|Overall Study|Low benefit and too many side effects|0|||
13305668|NCT01296932|26523546|FG007|Overall Study|Low benefit and too many side effects|1|||
13219847|NCT01830543|26278436|FG000|Overall Study|Other|12|||
13305669|NCT01296932|26523547|FG008|Overall Study|Low benefit and too many side effects|0|||
13305670|NCT01296932|26523539|FG000|Overall Study|No adequate treatment response|0|||
13305671|NCT01296932|26523540|FG001|Overall Study|No adequate treatment response|0|||
13305672|NCT01296932|26523541|FG002|Overall Study|No adequate treatment response|0|||
13305673|NCT01296932|26523542|FG003|Overall Study|No adequate treatment response|0|||
13305674|NCT01296932|26523543|FG004|Overall Study|No adequate treatment response|0|||
13305675|NCT01296932|26523544|FG005|Overall Study|No adequate treatment response|0|||
13305676|NCT01296932|26523545|FG006|Overall Study|No adequate treatment response|0|||
13305677|NCT01296932|26523546|FG007|Overall Study|No adequate treatment response|1|||
13305678|NCT01296932|26523547|FG008|Overall Study|No adequate treatment response|0|||
13305679|NCT01296932|26523539|FG000|Overall Study|Dosage already reduced, AE still present|0|||
13305680|NCT01296932|26523540|FG001|Overall Study|Dosage already reduced, AE still present|0|||
13305681|NCT01296932|26523541|FG002|Overall Study|Dosage already reduced, AE still present|0|||
13305682|NCT01296932|26523542|FG003|Overall Study|Dosage already reduced, AE still present|0|||
13305683|NCT01296932|26523543|FG004|Overall Study|Dosage already reduced, AE still present|0|||
13305684|NCT01296932|26523544|FG005|Overall Study|Dosage already reduced, AE still present|0|||
13305685|NCT01296932|26523545|FG006|Overall Study|Dosage already reduced, AE still present|0|||
13305686|NCT01296932|26523546|FG007|Overall Study|Dosage already reduced, AE still present|0|||
13305687|NCT01296932|26523547|FG008|Overall Study|Dosage already reduced, AE still present|1|||
13305688|NCT01296711|26523814|FG000|Overall Study|Adverse Event|3|||
13305689|NCT01296711|26523815|FG001|Overall Study|Adverse Event|1|||
13305690|NCT01296711|26523816|FG002|Overall Study|Adverse Event|4|||
13305691|NCT01296711|26523817|FG003|Overall Study|Adverse Event|3|||
13305692|NCT01296711|26523818|FG004|Overall Study|Adverse Event|1|||
13305693|NCT01296711|26523819|FG005|Overall Study|Adverse Event|6|||
13305694|NCT01296711|26523820|FG006|Overall Study|Adverse Event|11|||
13305695|NCT01296711|26523821|FG007|Overall Study|Adverse Event|3|||
13305696|NCT01296711|26523814|FG000|Overall Study|Lack of Efficacy|1|||
13305697|NCT01296711|26523815|FG001|Overall Study|Lack of Efficacy|4|||
13305698|NCT01296711|26523816|FG002|Overall Study|Lack of Efficacy|1|||
13305699|NCT01296711|26523817|FG003|Overall Study|Lack of Efficacy|1|||
13305700|NCT01296711|26523818|FG004|Overall Study|Lack of Efficacy|1|||
13305701|NCT01296711|26523819|FG005|Overall Study|Lack of Efficacy|0|||
13305702|NCT01296711|26523820|FG006|Overall Study|Lack of Efficacy|2|||
13305703|NCT01296711|26523821|FG007|Overall Study|Lack of Efficacy|3|||
13305704|NCT01296711|26523814|FG000|Overall Study|Lost to Follow-up|0|||
13305705|NCT01296711|26523815|FG001|Overall Study|Lost to Follow-up|0|||
13305706|NCT01296711|26523816|FG002|Overall Study|Lost to Follow-up|1|||
13305707|NCT01296711|26523817|FG003|Overall Study|Lost to Follow-up|1|||
13305708|NCT01296711|26523818|FG004|Overall Study|Lost to Follow-up|2|||
13305709|NCT01296711|26523819|FG005|Overall Study|Lost to Follow-up|0|||
13305710|NCT01296711|26523820|FG006|Overall Study|Lost to Follow-up|4|||
13305711|NCT01296711|26523821|FG007|Overall Study|Lost to Follow-up|2|||
13305712|NCT01296711|26523814|FG000|Overall Study|Protocol Violation|0|||
13305713|NCT01296711|26523815|FG001|Overall Study|Protocol Violation|0|||
13305714|NCT01296711|26523816|FG002|Overall Study|Protocol Violation|0|||
13305715|NCT01296711|26523817|FG003|Overall Study|Protocol Violation|1|||
13305716|NCT01296711|26523818|FG004|Overall Study|Protocol Violation|1|||
13305717|NCT01296711|26523819|FG005|Overall Study|Protocol Violation|0|||
13305718|NCT01296711|26523820|FG006|Overall Study|Protocol Violation|0|||
13305719|NCT01296711|26523821|FG007|Overall Study|Protocol Violation|0|||
13305720|NCT01296711|26523814|FG000|Overall Study|Withdrawal by Subject|4|||
13305721|NCT01296711|26523815|FG001|Overall Study|Withdrawal by Subject|2|||
13305722|NCT01296711|26523816|FG002|Overall Study|Withdrawal by Subject|2|||
13305723|NCT01296711|26523817|FG003|Overall Study|Withdrawal by Subject|1|||
13305724|NCT01296711|26523818|FG004|Overall Study|Withdrawal by Subject|1|||
13305725|NCT01296711|26523819|FG005|Overall Study|Withdrawal by Subject|1|||
13305726|NCT01296711|26523820|FG006|Overall Study|Withdrawal by Subject|2|||
13305727|NCT01296711|26523821|FG007|Overall Study|Withdrawal by Subject|1|||
13305728|NCT01296711|26523814|FG000|Overall Study|Study termination|8|||
13305729|NCT01296711|26523815|FG001|Overall Study|Study termination|1|||
13305730|NCT01296711|26523816|FG002|Overall Study|Study termination|5|||
13305731|NCT01296711|26523817|FG003|Overall Study|Study termination|4|||
13305732|NCT01296711|26523818|FG004|Overall Study|Study termination|4|||
13305733|NCT01296711|26523819|FG005|Overall Study|Study termination|4|||
13305734|NCT01296711|26523820|FG006|Overall Study|Study termination|8|||
13305735|NCT01296711|26523821|FG007|Overall Study|Study termination|10|||
13305736|NCT01296711|26523814|FG000|Overall Study|Continued elevated liver enzymes|0|||
13305737|NCT01296711|26523815|FG001|Overall Study|Continued elevated liver enzymes|0|||
13305738|NCT01296711|26523816|FG002|Overall Study|Continued elevated liver enzymes|0|||
13305739|NCT01296711|26523817|FG003|Overall Study|Continued elevated liver enzymes|1|||
13305740|NCT01296711|26523818|FG004|Overall Study|Continued elevated liver enzymes|0|||
13305741|NCT01296711|26523819|FG005|Overall Study|Continued elevated liver enzymes|0|||
13305742|NCT01296711|26523820|FG006|Overall Study|Continued elevated liver enzymes|0|||
13305743|NCT01296711|26523821|FG007|Overall Study|Continued elevated liver enzymes|0|||
13305744|NCT01296711|26523814|FG000|Overall Study|Methotrexate discontinued|0|||
13305745|NCT01296711|26523815|FG001|Overall Study|Methotrexate discontinued|0|||
13305746|NCT01296711|26523816|FG002|Overall Study|Methotrexate discontinued|0|||
13305747|NCT01296711|26523817|FG003|Overall Study|Methotrexate discontinued|1|||
13305748|NCT01296711|26523818|FG004|Overall Study|Methotrexate discontinued|0|||
13305749|NCT01296711|26523819|FG005|Overall Study|Methotrexate discontinued|0|||
13305750|NCT01296711|26523820|FG006|Overall Study|Methotrexate discontinued|0|||
13305751|NCT01296711|26523821|FG007|Overall Study|Methotrexate discontinued|0|||
13305752|NCT01296711|26523814|FG000|Overall Study|Investigator discretion|0|||
13305753|NCT01296711|26523815|FG001|Overall Study|Investigator discretion|0|||
13305754|NCT01296711|26523816|FG002|Overall Study|Investigator discretion|0|||
13305755|NCT01296711|26523817|FG003|Overall Study|Investigator discretion|0|||
13305756|NCT01296711|26523818|FG004|Overall Study|Investigator discretion|0|||
13305757|NCT01296711|26523819|FG005|Overall Study|Investigator discretion|0|||
13305758|NCT01296711|26523820|FG006|Overall Study|Investigator discretion|1|||
13305759|NCT01296711|26523821|FG007|Overall Study|Investigator discretion|0|||
13305760|NCT01296711|26523814|FG000|Overall Study|Other|0|||
13305761|NCT01296711|26523815|FG001|Overall Study|Other|0|||
13305762|NCT01296711|26523816|FG002|Overall Study|Other|0|||
13305763|NCT01296711|26523817|FG003|Overall Study|Other|0|||
13305764|NCT01296711|26523818|FG004|Overall Study|Other|0|||
13305765|NCT01296711|26523819|FG005|Overall Study|Other|0|||
13305766|NCT01296711|26523820|FG006|Overall Study|Other|1|||
13305767|NCT01296711|26523821|FG007|Overall Study|Other|0|||
13305768|NCT01296711|26523814|FG000|Overall Study|Required restricted steroid injections|0|||
13305769|NCT01296711|26523815|FG001|Overall Study|Required restricted steroid injections|0|||
13305770|NCT01296711|26523816|FG002|Overall Study|Required restricted steroid injections|0|||
13305771|NCT01296711|26523817|FG003|Overall Study|Required restricted steroid injections|0|||
13305772|NCT01296711|26523818|FG004|Overall Study|Required restricted steroid injections|0|||
13305773|NCT01296711|26523819|FG005|Overall Study|Required restricted steroid injections|0|||
13305774|NCT01296711|26523820|FG006|Overall Study|Required restricted steroid injections|1|||
13305775|NCT01296711|26523821|FG007|Overall Study|Required restricted steroid injections|0|||
13305776|NCT01296711|26523814|FG000|Overall Study|Ongoing missed appointments|0|||
13305777|NCT01296711|26523815|FG001|Overall Study|Ongoing missed appointments|0|||
13305778|NCT01296711|26523816|FG002|Overall Study|Ongoing missed appointments|0|||
13305779|NCT01296711|26523817|FG003|Overall Study|Ongoing missed appointments|0|||
13305780|NCT01296711|26523818|FG004|Overall Study|Ongoing missed appointments|0|||
13305781|NCT01296711|26523819|FG005|Overall Study|Ongoing missed appointments|0|||
13305782|NCT01296711|26523820|FG006|Overall Study|Ongoing missed appointments|1|||
13305783|NCT01296711|26523821|FG007|Overall Study|Ongoing missed appointments|0|||
13305784|NCT01296711|26523814|FG000|Overall Study|Failure to comply with visits|0|||
13305785|NCT01296711|26523815|FG001|Overall Study|Failure to comply with visits|0|||
13305786|NCT01296711|26523816|FG002|Overall Study|Failure to comply with visits|0|||
13305787|NCT01296711|26523817|FG003|Overall Study|Failure to comply with visits|0|||
13305788|NCT01296711|26523818|FG004|Overall Study|Failure to comply with visits|0|||
13305789|NCT01296711|26523819|FG005|Overall Study|Failure to comply with visits|0|||
13305790|NCT01296711|26523820|FG006|Overall Study|Failure to comply with visits|0|||
13305791|NCT01296711|26523821|FG007|Overall Study|Failure to comply with visits|1|||
13305792|NCT01296711|26523814|FG000|Overall Study|Patient decision due to transport|0|||
13305793|NCT01296711|26523815|FG001|Overall Study|Patient decision due to transport|0|||
13305794|NCT01296711|26523816|FG002|Overall Study|Patient decision due to transport|0|||
13305795|NCT01296711|26523817|FG003|Overall Study|Patient decision due to transport|0|||
13305796|NCT01296711|26523818|FG004|Overall Study|Patient decision due to transport|0|||
13305797|NCT01296711|26523819|FG005|Overall Study|Patient decision due to transport|0|||
13305798|NCT01296711|26523820|FG006|Overall Study|Patient decision due to transport|0|||
13305799|NCT01296711|26523821|FG007|Overall Study|Patient decision due to transport|1|||
13305800|NCT01296698|26523880|FG000|Overall Study|Adverse Event|1|||
13305801|NCT01296698|26523881|FG001|Overall Study|Adverse Event|0|||
13305802|NCT01296698|26523880|FG000|Overall Study|Death|1|||
13305803|NCT01296698|26523881|FG001|Overall Study|Death|0|||
13305804|NCT01296698|26523880|FG000|Overall Study|Lost to Follow-up|19|||
13305805|NCT01296698|26523881|FG001|Overall Study|Lost to Follow-up|1|||
13305806|NCT01296698|26523880|FG000|Overall Study|Withdrawal by Subject|12|||
13305807|NCT01296698|26523881|FG001|Overall Study|Withdrawal by Subject|0|||
13305808|NCT01296698|26523880|FG000|Overall Study|Difficulty Contacting Subject|2|||
13305809|NCT01296698|26523881|FG001|Overall Study|Difficulty Contacting Subject|0|||
13305810|NCT01296698|26523880|FG000|Overall Study|Study Terminated by Sponsor|209|||
13305811|NCT01296698|26523881|FG001|Overall Study|Study Terminated by Sponsor|12|||
13305812|NCT01296672|26523898|FG000|Overall Study|Lost to Follow-up|73|||
13305813|NCT01296672|26523899|FG001|Overall Study|Lost to Follow-up|18|||
13305814|NCT01296568|26523915|FG000|Continued Access Phase|Lost to Follow-up|1|||
13305815|NCT01296568|26523915|FG000|Continued Access Phase|Withdrawal by Subject|1|||
13305816|NCT01296568|26523915|FG000|Continued Access Phase|Disease Progression|1|||
13305817|NCT01296412|26523934|FG000|Overall Study|Adverse Event|8|||
13305818|NCT01296412|26523935|FG001|Overall Study|Adverse Event|29|||
13305819|NCT01296412|26523934|FG000|Overall Study|Lack of Efficacy|1|||
13305820|NCT01296412|26523935|FG001|Overall Study|Lack of Efficacy|0|||
13305821|NCT01296412|26523934|FG000|Overall Study|Lost to Follow-up|10|||
13305822|NCT01296412|26523935|FG001|Overall Study|Lost to Follow-up|7|||
13305823|NCT01296412|26523934|FG000|Overall Study|Non-compliance with study drug|1|||
13305824|NCT01296412|26523935|FG001|Overall Study|Non-compliance with study drug|2|||
13305825|NCT01296412|26523934|FG000|Overall Study|Other reason not specified|20|||
13382886|NCT00741936|26752091|FG001|Overall Study|Lack of Efficacy|2|||
13382887|NCT00741936|26752090|FG000|Overall Study|Low compliance|3|||
13382888|NCT00741936|26752091|FG001|Overall Study|Low compliance|0|||
13382889|NCT00741819|26752104|FG000|Overall Study|Adverse Event|3|||
13382890|NCT00741819|26752104|FG000|Overall Study|Withdrawal by Subject|3|||
13382891|NCT00741819|26752104|FG000|Overall Study|Death|1|||
13382892|NCT00741819|26752104|FG000|Overall Study|Disease progression|1|||
13382893|NCT00741611|26752131|FG000|Overall Study|Death|0|||
13382894|NCT00741611|26752132|FG001|Overall Study|Death|0|||
13382895|NCT00741611|26752133|FG002|Overall Study|Death|1|||
13382896|NCT00741611|26752131|FG000|Overall Study|Withdrawal by Subject|0|||
13382897|NCT00741611|26752132|FG001|Overall Study|Withdrawal by Subject|2|||
13382898|NCT00741611|26752133|FG002|Overall Study|Withdrawal by Subject|2|||
13382899|NCT00741598|26752154|FG000|Overall Study|Lost to Follow-up|3|||
13382900|NCT00741598|26752155|FG001|Overall Study|Lost to Follow-up|4|||
13382901|NCT00741598|26752154|FG000|Overall Study|Lack of Efficacy|1|||
13382902|NCT00741598|26752155|FG001|Overall Study|Lack of Efficacy|2|||
13382903|NCT00741598|26752154|FG000|Overall Study|Physician Decision|1|||
13382904|NCT00741598|26752155|FG001|Overall Study|Physician Decision|1|||
13382905|NCT00741598|26752154|FG000|Overall Study|Pregnancy|1|||
13382906|NCT00741598|26752155|FG001|Overall Study|Pregnancy|0|||
13382907|NCT00741598|26752154|FG000|Overall Study|Withdrawal by Subject|3|||
13382908|NCT00741598|26752155|FG001|Overall Study|Withdrawal by Subject|2|||
13382909|NCT00741338|26752170|FG000|Overall Study|Adverse Event|0|||
13382910|NCT00741338|26752171|FG001|Overall Study|Adverse Event|1|||
13382911|NCT00741286|26752186|FG000|Overall Study|Lost to Follow-up|15|||
13382912|NCT00741286|26752187|FG001|Overall Study|Lost to Follow-up|10|||
13382913|NCT00741286|26752186|FG000|Overall Study|Adverse Event|1|||
13382914|NCT00741286|26752187|FG001|Overall Study|Adverse Event|6|||
13382915|NCT00741286|26752186|FG000|Overall Study|Protocol Violation|3|||
13382916|NCT00741286|26752187|FG001|Overall Study|Protocol Violation|2|||
13382917|NCT00741286|26752186|FG000|Overall Study|Primary Outcome|1|||
13382918|NCT00741286|26752187|FG001|Overall Study|Primary Outcome|1|||
13382919|NCT00741260|26752236|FG000|Overall Study|Disease Progression|3|||
13382920|NCT00741260|26752237|FG001|Overall Study|Disease Progression|5|||
13382921|NCT00741260|26752238|FG002|Overall Study|Disease Progression|3|||
13382922|NCT00741260|26752239|FG003|Overall Study|Disease Progression|3|||
13382923|NCT00741260|26752240|FG004|Overall Study|Disease Progression|5|||
13382924|NCT00741260|26752241|FG005|Overall Study|Disease Progression|37|||
13382925|NCT00741260|26752242|FG006|Overall Study|Disease Progression|4|||
13382926|NCT00741260|26752236|FG000|Overall Study|Death|0|||
13382927|NCT00741260|26752237|FG001|Overall Study|Death|1|||
13382928|NCT00741260|26752238|FG002|Overall Study|Death|0|||
13382929|NCT00741260|26752239|FG003|Overall Study|Death|1|||
13382930|NCT00741260|26752240|FG004|Overall Study|Death|2|||
13382931|NCT00741260|26752241|FG005|Overall Study|Death|2|||
13382932|NCT00741260|26752242|FG006|Overall Study|Death|1|||
13382933|NCT00741260|26752236|FG000|Overall Study|Withdrawal by Subject|0|||
13382934|NCT00741260|26752237|FG001|Overall Study|Withdrawal by Subject|0|||
13382935|NCT00741260|26752238|FG002|Overall Study|Withdrawal by Subject|0|||
13382936|NCT00741260|26752239|FG003|Overall Study|Withdrawal by Subject|0|||
13382937|NCT00741260|26752240|FG004|Overall Study|Withdrawal by Subject|1|||
13382938|NCT00741260|26752241|FG005|Overall Study|Withdrawal by Subject|3|||
13382939|NCT00741260|26752242|FG006|Overall Study|Withdrawal by Subject|1|||
13382940|NCT00741260|26752236|FG000|Overall Study|Physician Decision|1|||
13382941|NCT00741260|26752237|FG001|Overall Study|Physician Decision|1|||
13382942|NCT00741260|26752238|FG002|Overall Study|Physician Decision|0|||
13382943|NCT00741260|26752239|FG003|Overall Study|Physician Decision|0|||
13305826|NCT01296412|26523935|FG001|Overall Study|Other reason not specified|15|||
13305827|NCT01296412|26523934|FG000|Overall Study|Physician Decision|1|||
13305828|NCT01296412|26523935|FG001|Overall Study|Physician Decision|3|||
13305829|NCT01296412|26523934|FG000|Overall Study|Pregnancy|0|||
13305830|NCT01296412|26523935|FG001|Overall Study|Pregnancy|1|||
13305831|NCT01296412|26523934|FG000|Overall Study|Withdrawal by Subject|10|||
13382944|NCT00741260|26752240|FG004|Overall Study|Physician Decision|0|||
13382945|NCT00741260|26752241|FG005|Overall Study|Physician Decision|0|||
13382946|NCT00741260|26752242|FG006|Overall Study|Physician Decision|0|||
13382947|NCT00741260|26752236|FG000|Overall Study|Other|2|||
13382948|NCT00741260|26752237|FG001|Overall Study|Other|1|||
13382949|NCT00741260|26752238|FG002|Overall Study|Other|1|||
13382950|NCT00741260|26752239|FG003|Overall Study|Other|2|||
13382951|NCT00741260|26752240|FG004|Overall Study|Other|1|||
13382952|NCT00741260|26752241|FG005|Overall Study|Other|3|||
13382953|NCT00741260|26752242|FG006|Overall Study|Other|1|||
13382954|NCT00741091|26752252|FG000|Overall Study|Death|13|||
13382955|NCT00741091|26752252|FG000|Overall Study|Lost to Follow-up|16|||
13305832|NCT01296412|26523935|FG001|Overall Study|Withdrawal by Subject|13|||
13305833|NCT01296347|26523958|FG000|Allocation|Withdrawal by Subject|1|||
13305834|NCT01296347|26523959|FG001|Allocation|Withdrawal by Subject|2|||
13305835|NCT01296347|26523958|FG000|Allocation|Lack of Efficacy|1|||
13305836|NCT01296347|26523959|FG001|Allocation|Lack of Efficacy|2|||
13305837|NCT01296347|26523958|FG000|Allocation|not received infusion|1|||
13305838|NCT01296347|26523959|FG001|Allocation|not received infusion|0|||
13305839|NCT01296347|26523958|FG000|6 Week Follow up|Death|0|||
13305840|NCT01296347|26523959|FG001|6 Week Follow up|Death|1|||
13305841|NCT01296347|26523958|FG000|3 Month Follow up|Death|1|||
13305842|NCT01296347|26523959|FG001|3 Month Follow up|Death|0|||
13305843|NCT01296347|26523958|FG000|3 Month Follow up|Lost to Follow-up|0|||
13305844|NCT01296347|26523959|FG001|3 Month Follow up|Lost to Follow-up|1|||
13305845|NCT01296347|26523958|FG000|6 Month Follow up|Death|2|||
13305846|NCT01296347|26523959|FG001|6 Month Follow up|Death|1|||
13305847|NCT01296347|26523958|FG000|6 Month Follow up|Lost to Follow-up|0|||
13305848|NCT01296347|26523959|FG001|6 Month Follow up|Lost to Follow-up|1|||
13305849|NCT01296347|26523958|FG000|12 Month Follow up|Lost to Follow-up|3|||
13305850|NCT01296347|26523959|FG001|12 Month Follow up|Lost to Follow-up|1|||
13305851|NCT01296347|26523958|FG000|12 Month Follow up|Death|1|||
13305852|NCT01296347|26523959|FG001|12 Month Follow up|Death|1|||
13305853|NCT01296347|26523958|FG000|12 Month Follow up|Withdrawal by Subject|0|||
13305854|NCT01296347|26523959|FG001|12 Month Follow up|Withdrawal by Subject|1|||
13305855|NCT01296152|26523988|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
13305856|NCT01296035|26523995|FG000|Overall Study|Withdrawal by Subject|1|||
13305857|NCT01295905|26524014|FG000|Overall Study|Did not meet inclusion criteria|1|||
13305858|NCT01295905|26524015|FG001|Overall Study|Did not meet inclusion criteria|0|||
13305859|NCT01295905|26524014|FG000|Overall Study|Met exclusion criteria|1|||
13305860|NCT01295905|26524015|FG001|Overall Study|Met exclusion criteria|0|||
13305861|NCT01295827|26524426|FG000|Overall Study|Adverse Event|1|||
13305862|NCT01295827|26524427|FG001|Overall Study|Adverse Event|2|||
13305863|NCT01295827|26524428|FG002|Overall Study|Adverse Event|2|||
13305864|NCT01295827|26524429|FG003|Overall Study|Adverse Event|1|||
13305865|NCT01295827|26524430|FG004|Overall Study|Adverse Event|1|||
13305866|NCT01295827|26524431|FG005|Overall Study|Adverse Event|4|||
13305867|NCT01295827|26524432|FG006|Overall Study|Adverse Event|15|||
13305868|NCT01295827|26524433|FG007|Overall Study|Adverse Event|49|||
13305869|NCT01295827|26524434|FG008|Overall Study|Adverse Event|22|||
13305870|NCT01295827|26524435|FG009|Overall Study|Adverse Event|7|||
13305871|NCT01295827|26524436|FG010|Overall Study|Adverse Event|50|||
13305872|NCT01295827|26524437|FG011|Overall Study|Adverse Event|21|||
13305873|NCT01295827|26524438|FG012|Overall Study|Adverse Event|0|||
13305874|NCT01295827|26524439|FG013|Overall Study|Adverse Event|0|||
13305875|NCT01295827|26524440|FG014|Overall Study|Adverse Event|0|||
13305876|NCT01295827|26524426|FG000|Overall Study|Lost to Follow-up|0|||
13305877|NCT01295827|26524427|FG001|Overall Study|Lost to Follow-up|0|||
13305878|NCT01295827|26524428|FG002|Overall Study|Lost to Follow-up|3|||
13305879|NCT01295827|26524429|FG003|Overall Study|Lost to Follow-up|0|||
13305880|NCT01295827|26524430|FG004|Overall Study|Lost to Follow-up|1|||
13305881|NCT01295827|26524431|FG005|Overall Study|Lost to Follow-up|0|||
13305882|NCT01295827|26524432|FG006|Overall Study|Lost to Follow-up|4|||
13305883|NCT01295827|26524433|FG007|Overall Study|Lost to Follow-up|8|||
13305884|NCT01295827|26524434|FG008|Overall Study|Lost to Follow-up|7|||
13305885|NCT01295827|26524435|FG009|Overall Study|Lost to Follow-up|4|||
13305886|NCT01295827|26524436|FG010|Overall Study|Lost to Follow-up|7|||
13305887|NCT01295827|26524437|FG011|Overall Study|Lost to Follow-up|3|||
13305888|NCT01295827|26524438|FG012|Overall Study|Lost to Follow-up|0|||
13305889|NCT01295827|26524439|FG013|Overall Study|Lost to Follow-up|0|||
13305890|NCT01295827|26524440|FG014|Overall Study|Lost to Follow-up|0|||
13305891|NCT01295827|26524426|FG000|Overall Study|Not Reported|0|||
13305892|NCT01295827|26524427|FG001|Overall Study|Not Reported|0|||
13305893|NCT01295827|26524428|FG002|Overall Study|Not Reported|0|||
13305894|NCT01295827|26524429|FG003|Overall Study|Not Reported|1|||
13305895|NCT01295827|26524430|FG004|Overall Study|Not Reported|0|||
13305896|NCT01295827|26524431|FG005|Overall Study|Not Reported|0|||
13305897|NCT01295827|26524432|FG006|Overall Study|Not Reported|24|||
13305898|NCT01295827|26524433|FG007|Overall Study|Not Reported|58|||
13305899|NCT01295827|26524434|FG008|Overall Study|Not Reported|41|||
13305900|NCT01295827|26524435|FG009|Overall Study|Not Reported|2|||
13305901|NCT01295827|26524436|FG010|Overall Study|Not Reported|23|||
13305902|NCT01295827|26524437|FG011|Overall Study|Not Reported|13|||
13305903|NCT01295827|26524438|FG012|Overall Study|Not Reported|0|||
13305904|NCT01295827|26524439|FG013|Overall Study|Not Reported|0|||
13305905|NCT01295827|26524440|FG014|Overall Study|Not Reported|0|||
13305906|NCT01295827|26524426|FG000|Overall Study|Progressive Disease|2|||
13305907|NCT01295827|26524427|FG001|Overall Study|Progressive Disease|1|||
13305908|NCT01295827|26524428|FG002|Overall Study|Progressive Disease|5|||
13305909|NCT01295827|26524429|FG003|Overall Study|Progressive Disease|2|||
13305910|NCT01295827|26524430|FG004|Overall Study|Progressive Disease|0|||
13305911|NCT01295827|26524431|FG005|Overall Study|Progressive Disease|1|||
13305912|NCT01295827|26524432|FG006|Overall Study|Progressive Disease|87|||
13305913|NCT01295827|26524433|FG007|Overall Study|Progressive Disease|144|||
13305914|NCT01295827|26524434|FG008|Overall Study|Progressive Disease|85|||
13305915|NCT01295827|26524435|FG009|Overall Study|Progressive Disease|40|||
13305916|NCT01295827|26524436|FG010|Overall Study|Progressive Disease|175|||
13305917|NCT01295827|26524437|FG011|Overall Study|Progressive Disease|136|||
13305918|NCT01295827|26524438|FG012|Overall Study|Progressive Disease|0|||
13305919|NCT01295827|26524439|FG013|Overall Study|Progressive Disease|0|||
13305920|NCT01295827|26524440|FG014|Overall Study|Progressive Disease|0|||
13305921|NCT01295827|26524426|FG000|Overall Study|Screen Failure|0|||
13305922|NCT01295827|26524427|FG001|Overall Study|Screen Failure|0|||
13305923|NCT01295827|26524428|FG002|Overall Study|Screen Failure|0|||
13305924|NCT01295827|26524429|FG003|Overall Study|Screen Failure|0|||
13305925|NCT01295827|26524430|FG004|Overall Study|Screen Failure|0|||
13305926|NCT01295827|26524431|FG005|Overall Study|Screen Failure|0|||
13305927|NCT01295827|26524432|FG006|Overall Study|Screen Failure|2|||
13305928|NCT01295827|26524433|FG007|Overall Study|Screen Failure|2|||
13305929|NCT01295827|26524434|FG008|Overall Study|Screen Failure|2|||
13305930|NCT01295827|26524435|FG009|Overall Study|Screen Failure|0|||
13305931|NCT01295827|26524436|FG010|Overall Study|Screen Failure|1|||
13305932|NCT01295827|26524437|FG011|Overall Study|Screen Failure|0|||
13305933|NCT01295827|26524438|FG012|Overall Study|Screen Failure|0|||
13305934|NCT01295827|26524439|FG013|Overall Study|Screen Failure|0|||
13305935|NCT01295827|26524440|FG014|Overall Study|Screen Failure|0|||
13305936|NCT01295827|26524426|FG000|Overall Study|Withdrawal by Subject|1|||
13305937|NCT01295827|26524427|FG001|Overall Study|Withdrawal by Subject|0|||
13305938|NCT01295827|26524428|FG002|Overall Study|Withdrawal by Subject|2|||
13305939|NCT01295827|26524429|FG003|Overall Study|Withdrawal by Subject|0|||
13305940|NCT01295827|26524430|FG004|Overall Study|Withdrawal by Subject|0|||
13305941|NCT01295827|26524431|FG005|Overall Study|Withdrawal by Subject|1|||
13305942|NCT01295827|26524432|FG006|Overall Study|Withdrawal by Subject|13|||
13305943|NCT01295827|26524433|FG007|Overall Study|Withdrawal by Subject|35|||
13305944|NCT01295827|26524434|FG008|Overall Study|Withdrawal by Subject|11|||
13305945|NCT01295827|26524435|FG009|Overall Study|Withdrawal by Subject|2|||
13305946|NCT01295827|26524436|FG010|Overall Study|Withdrawal by Subject|18|||
13305947|NCT01295827|26524437|FG011|Overall Study|Withdrawal by Subject|13|||
13305948|NCT01295827|26524438|FG012|Overall Study|Withdrawal by Subject|0|||
13305949|NCT01295827|26524439|FG013|Overall Study|Withdrawal by Subject|0|||
13305950|NCT01295827|26524440|FG014|Overall Study|Withdrawal by Subject|0|||
13305951|NCT01295827|26524426|FG000|Overall Study|Other|0|||
13305952|NCT01295827|26524427|FG001|Overall Study|Other|0|||
13305953|NCT01295827|26524428|FG002|Overall Study|Other|0|||
13305954|NCT01295827|26524429|FG003|Overall Study|Other|0|||
13305955|NCT01295827|26524430|FG004|Overall Study|Other|0|||
13305956|NCT01295827|26524431|FG005|Overall Study|Other|0|||
13305957|NCT01295827|26524432|FG006|Overall Study|Other|1|||
13305958|NCT01295827|26524433|FG007|Overall Study|Other|1|||
13305959|NCT01295827|26524434|FG008|Overall Study|Other|1|||
13305960|NCT01295827|26524435|FG009|Overall Study|Other|0|||
13305961|NCT01295827|26524436|FG010|Overall Study|Other|2|||
13305962|NCT01295827|26524437|FG011|Overall Study|Other|0|||
13305963|NCT01295827|26524438|FG012|Overall Study|Other|0|||
13305964|NCT01295827|26524439|FG013|Overall Study|Other|0|||
13305965|NCT01295827|26524440|FG014|Overall Study|Other|0|||
13305966|NCT01295814|26524461|FG000|Overall Study|Lack of Efficacy|0|||
13305967|NCT01295814|26524462|FG001|Overall Study|Lack of Efficacy|2|||
13305968|NCT01295814|26524461|FG000|Overall Study|Withdrawal by Subject|2|||
13305969|NCT01295814|26524462|FG001|Overall Study|Withdrawal by Subject|0|||
13305970|NCT01295671|26524510|FG000|Overall Study|Lost to Follow-up|4|||
13305971|NCT01295671|26524511|FG001|Overall Study|Lost to Follow-up|6|||
13305972|NCT01295671|26524512|FG002|Overall Study|Lost to Follow-up|3|||
13305973|NCT01295671|26524510|FG000|Overall Study|Withdrawal by Subject|3|||
13305974|NCT01295671|26524511|FG001|Overall Study|Withdrawal by Subject|1|||
13305975|NCT01295671|26524512|FG002|Overall Study|Withdrawal by Subject|0|||
13305976|NCT01295580|26524539|FG000|Overall Study|Protocol Violation|4|||
13305977|NCT01295580|26524540|FG001|Overall Study|Protocol Violation|2|||
13305978|NCT01295580|26524539|FG000|Overall Study|Withdrawal by Subject|1|||
13305979|NCT01295580|26524540|FG001|Overall Study|Withdrawal by Subject|4|||
13305980|NCT01295580|26524539|FG000|Overall Study|Adverse Event|2|||
13305981|NCT01295580|26524540|FG001|Overall Study|Adverse Event|1|||
13305982|NCT01295580|26524539|FG000|Overall Study|Lost to Follow-up|1|||
13305983|NCT01295580|26524540|FG001|Overall Study|Lost to Follow-up|0|||
13305984|NCT01295580|26524539|FG000|Overall Study|Lack of Efficacy|1|||
13305985|NCT01295580|26524540|FG001|Overall Study|Lack of Efficacy|0|||
13305986|NCT01295580|26524539|FG000|Overall Study|Other: inconvenience|1|||
13305987|NCT01295580|26524540|FG001|Overall Study|Other: inconvenience|0|||
13305988|NCT01295580|26524539|FG000|Overall Study|Other: family objection|0|||
13305989|NCT01295580|26524540|FG001|Overall Study|Other: family objection|1|||
13305990|NCT01295320|26524557|FG000|Overall Study|Adverse Event|2|||
13305991|NCT01295320|26524557|FG000|Overall Study|Lost to Follow-up|4|||
13305992|NCT01295320|26524557|FG000|Overall Study|Withdrawal by Subject|2|||
13305993|NCT01295320|26524557|FG000|Overall Study|Subject was bedridden|1|||
13305994|NCT01295320|26524557|FG000|Overall Study|Unable to travel|1|||
13305995|NCT01295281|26524570|FG000|First Intervention (7 Days)|Death|0|||
13305996|NCT01295281|26524571|FG001|First Intervention (7 Days)|Death|1|||
13305997|NCT01295034|26524586|FG000|Overall Study|Lost to Follow-up|5|||
13305998|NCT01295034|26524587|FG001|Overall Study|Lost to Follow-up|5|||
13305999|NCT01294917|26524595|FG000|Overall Study|Relocation|5|||
13306000|NCT01294917|26524595|FG000|Overall Study|Inconvenience|1|||
13306001|NCT01294800|26524634|FG000|Overall Study|Adverse Event|7|||
13306002|NCT01294800|26524635|FG001|Overall Study|Adverse Event|6|||
13306003|NCT01294800|26524636|FG002|Overall Study|Adverse Event|12|||
13306004|NCT01294800|26524637|FG003|Overall Study|Adverse Event|5|||
13306005|NCT01294800|26524634|FG000|Overall Study|Subject Withdrew Consent|2|||
13306006|NCT01294800|26524635|FG001|Overall Study|Subject Withdrew Consent|2|||
13306007|NCT01294800|26524636|FG002|Overall Study|Subject Withdrew Consent|2|||
13306008|NCT01294800|26524637|FG003|Overall Study|Subject Withdrew Consent|11|||
13306009|NCT01294800|26524634|FG000|Overall Study|Lost to Follow-up|0|||
13306010|NCT01294800|26524635|FG001|Overall Study|Lost to Follow-up|0|||
13306011|NCT01294800|26524636|FG002|Overall Study|Lost to Follow-up|1|||
13306012|NCT01294800|26524637|FG003|Overall Study|Lost to Follow-up|0|||
13306013|NCT01294800|26524634|FG000|Overall Study|Non-compliance With Protocol|0|||
13306014|NCT01294800|26524635|FG001|Overall Study|Non-compliance With Protocol|1|||
13306015|NCT01294800|26524636|FG002|Overall Study|Non-compliance With Protocol|1|||
13306016|NCT01294800|26524637|FG003|Overall Study|Non-compliance With Protocol|0|||
13306017|NCT01294800|26524634|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
13306018|NCT01294800|26524635|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
13306019|NCT01294800|26524636|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
13306020|NCT01294800|26524637|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
13306021|NCT01294787|26524686|FG000|Period 1|Adverse Event|0|||
13306022|NCT01294787|26524687|FG001|Period 1|Adverse Event|0|||
13306023|NCT01294787|26524688|FG002|Period 1|Adverse Event|0|||
13306024|NCT01294787|26524689|FG003|Period 1|Adverse Event|0|||
13306025|NCT01294787|26524690|FG004|Period 1|Adverse Event|1|||
13306026|NCT01294787|26524691|FG005|Period 1|Adverse Event|0|||
13306027|NCT01294787|26524686|FG000|Period 1|Withdrawal by Subject|0|||
13306028|NCT01294787|26524687|FG001|Period 1|Withdrawal by Subject|0|||
13306029|NCT01294787|26524688|FG002|Period 1|Withdrawal by Subject|0|||
13306030|NCT01294787|26524689|FG003|Period 1|Withdrawal by Subject|1|||
13306031|NCT01294787|26524690|FG004|Period 1|Withdrawal by Subject|1|||
13306032|NCT01294787|26524691|FG005|Period 1|Withdrawal by Subject|1|||
13306033|NCT01294787|26524686|FG000|Period 1|Administrative problem|0|||
13306034|NCT01294787|26524687|FG001|Period 1|Administrative problem|0|||
13306035|NCT01294787|26524688|FG002|Period 1|Administrative problem|1|||
13306036|NCT01294787|26524689|FG003|Period 1|Administrative problem|0|||
13306037|NCT01294787|26524690|FG004|Period 1|Administrative problem|0|||
13306038|NCT01294787|26524691|FG005|Period 1|Administrative problem|1|||
13306039|NCT01294787|26524686|FG000|Period 2|Adverse Event|0|||
13306040|NCT01294787|26524687|FG001|Period 2|Adverse Event|3|||
13306041|NCT01294787|26524688|FG002|Period 2|Adverse Event|0|||
13306042|NCT01294787|26524689|FG003|Period 2|Adverse Event|1|||
13306043|NCT01294787|26524690|FG004|Period 2|Adverse Event|0|||
13306044|NCT01294787|26524691|FG005|Period 2|Adverse Event|0|||
13306045|NCT01294787|26524686|FG000|Period 2|No longer needs study drug|0|||
13306046|NCT01294787|26524687|FG001|Period 2|No longer needs study drug|0|||
13306047|NCT01294787|26524688|FG002|Period 2|No longer needs study drug|0|||
13306048|NCT01294787|26524689|FG003|Period 2|No longer needs study drug|1|||
13306049|NCT01294787|26524690|FG004|Period 2|No longer needs study drug|0|||
13306050|NCT01294787|26524691|FG005|Period 2|No longer needs study drug|0|||
13306051|NCT01294787|26524686|FG000|Period 3|Adverse Event|0|||
13306052|NCT01294787|26524687|FG001|Period 3|Adverse Event|0|||
13306053|NCT01294787|26524688|FG002|Period 3|Adverse Event|0|||
13306054|NCT01294787|26524689|FG003|Period 3|Adverse Event|0|||
13306055|NCT01294787|26524690|FG004|Period 3|Adverse Event|1|||
13306056|NCT01294787|26524691|FG005|Period 3|Adverse Event|0|||
13306057|NCT01294696|26524709|FG000|Overall Study|Screening failures|7|||
13306058|NCT01294696|26524709|FG000|Overall Study|Protocol Violation|8|||
13306059|NCT01294696|26524709|FG000|Overall Study|Missing BPI Response|7|||
13306060|NCT01294696|26524709|FG000|Overall Study|Site closure|52|||
13306061|NCT01294683|26524766|FG000|Precrossover (Periods I/II)|Adverse Event|49|||
13306062|NCT01294683|26524767|FG001|Precrossover (Periods I/II)|Adverse Event|52|||
13306063|NCT01294683|26524766|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3|||
13306064|NCT01294683|26524767|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6|||
13306065|NCT01294683|26524766|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
13306066|NCT01294683|26524767|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
13306067|NCT01294683|26524766|FG000|Precrossover (Periods I/II)|Physician Decision|1|||
13306068|NCT01294683|26524767|FG001|Precrossover (Periods I/II)|Physician Decision|0|||
13306069|NCT01294683|26524766|FG000|Precrossover (Periods I/II)|Protocol Violation|5|||
13306070|NCT01294683|26524767|FG001|Precrossover (Periods I/II)|Protocol Violation|5|||
13306071|NCT01294683|26524766|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187|||
13306072|NCT01294683|26524767|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192|||
13306073|NCT01294683|26524766|FG000|Precrossover (Periods I/II)|Technical Problems|0|||
13306074|NCT01294683|26524767|FG001|Precrossover (Periods I/II)|Technical Problems|1|||
13306075|NCT01294683|26524766|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11|||
13306076|NCT01294683|26524767|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9|||
13306077|NCT01294683|26524766|FG000|Post Crossover (Period III)|Adverse Event|6|||
13306078|NCT01294683|26524767|FG001|Post Crossover (Period III)|Adverse Event|6|||
13306079|NCT01294683|26524766|FG000|Post Crossover (Period III)|Lost to Follow-up|1|||
13306080|NCT01294683|26524767|FG001|Post Crossover (Period III)|Lost to Follow-up|3|||
13306081|NCT01294683|26524766|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23|||
13306082|NCT01294683|26524767|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21|||
13306083|NCT01294683|26524766|FG000|Post Crossover (Period III)|Withdrawal by Subject|3|||
13306084|NCT01294683|26524767|FG001|Post Crossover (Period III)|Withdrawal by Subject|2|||
13306085|NCT01294670|26524815|FG000|Overall Study|Not treated|1|||
13306086|NCT01294670|26524816|FG001|Overall Study|Not treated|0|||
13306087|NCT01294670|26524817|FG002|Overall Study|Not treated|0|||
13306088|NCT01294670|26524818|FG003|Overall Study|Not treated|0|||
13306089|NCT01294670|26524819|FG004|Overall Study|Not treated|0|||
13306090|NCT01294644|26524858|FG000|Overall Study|Adverse Event|2|||
13306091|NCT01294644|26524859|FG001|Overall Study|Adverse Event|0|||
13306092|NCT01294644|26524860|FG002|Overall Study|Adverse Event|1|||
13306093|NCT01294644|26524858|FG000|Overall Study|Withdrawal by Subject|3|||
13306094|NCT01294644|26524859|FG001|Overall Study|Withdrawal by Subject|7|||
13306095|NCT01294644|26524860|FG002|Overall Study|Withdrawal by Subject|4|||
13306096|NCT01294644|26524858|FG000|Overall Study|Lost to Follow-up|3|||
13306097|NCT01294644|26524859|FG001|Overall Study|Lost to Follow-up|2|||
13306098|NCT01294644|26524860|FG002|Overall Study|Lost to Follow-up|5|||
13306099|NCT01294644|26524858|FG000|Overall Study|Miscellaneous Reason|2|||
13306100|NCT01294644|26524859|FG001|Overall Study|Miscellaneous Reason|1|||
13306101|NCT01294644|26524860|FG002|Overall Study|Miscellaneous Reason|4|||
13306102|NCT01294592|26524895|FG000|Overall Study|Adverse Event|28|||
13306103|NCT01294592|26524896|FG001|Overall Study|Adverse Event|13|||
13306104|NCT01294592|26524895|FG000|Overall Study|Lack of Efficacy|7|||
13306105|NCT01294592|26524896|FG001|Overall Study|Lack of Efficacy|5|||
13306106|NCT01294592|26524895|FG000|Overall Study|Protocol Violation|1|||
13306107|NCT01294592|26524896|FG001|Overall Study|Protocol Violation|7|||
13306108|NCT01294592|26524895|FG000|Overall Study|Lost to Follow-up|7|||
13306109|NCT01294592|26524896|FG001|Overall Study|Lost to Follow-up|9|||
13306110|NCT01294592|26524895|FG000|Overall Study|Physician Decision|6|||
13306111|NCT01294592|26524896|FG001|Overall Study|Physician Decision|11|||
13306112|NCT01294592|26524895|FG000|Overall Study|Withdrawal by Subject|28|||
13306113|NCT01294592|26524896|FG001|Overall Study|Withdrawal by Subject|28|||
13306114|NCT01294579|26524908|FG000|Overall Study|Disease progression|12|||
13306115|NCT01294579|26524908|FG000|Overall Study|Adverse Event|11|||
13306116|NCT01294579|26524908|FG000|Overall Study|Study closed/terminated|3|||
13306117|NCT01294579|26524908|FG000|Overall Study|Lost to Follow-up|1|||
13306118|NCT01294579|26524908|FG000|Overall Study|Physician Decision|3|||
13306119|NCT01294579|26524908|FG000|Overall Study|Withdrawal by Subject|5|||
13306120|NCT01294553|26524916|FG000|Overall Study|Duplicated Participants|1|||
13306121|NCT01294553|26524916|FG000|Overall Study|Protocol Violation|268|||
13306122|NCT01294514|26524926|FG000|Overall Study|Excluded due to Arrhythmia|1|||
13306123|NCT01294462|26524945|FG000|Overall Study|Lost to Follow-up|1|||
13306124|NCT01294462|26524946|FG001|Overall Study|Lost to Follow-up|0|||
13306125|NCT01294462|26524945|FG000|Overall Study|Withdrawal by Subject|65|||
13306126|NCT01294462|26524946|FG001|Overall Study|Withdrawal by Subject|63|||
13306127|NCT01294449|26524959|FG000|Overall Study|Death|11|||
13306128|NCT01294449|26524960|FG001|Overall Study|Death|12|||
13306129|NCT01294449|26524959|FG000|Overall Study|Withdrawal by Subject|1|||
13306130|NCT01294449|26524960|FG001|Overall Study|Withdrawal by Subject|3|||
13306131|NCT01294436|26524999|FG000|Overall Study|Adverse Event|10|||
13306132|NCT01294436|26525000|FG001|Overall Study|Adverse Event|17|||
13306133|NCT01294436|26524999|FG000|Overall Study|Withdrawal by Subject|11|||
13306134|NCT01294436|26525000|FG001|Overall Study|Withdrawal by Subject|28|||
13306135|NCT01294436|26524999|FG000|Overall Study|subject no longer meets study criteria|5|||
13306136|NCT01294436|26525000|FG001|Overall Study|subject no longer meets study criteria|20|||
13306137|NCT01294436|26524999|FG000|Overall Study|poor/non-compliance|2|||
13306138|NCT01294436|26525000|FG001|Overall Study|poor/non-compliance|5|||
13306139|NCT01294423|26525024|FG000|Overall Study|Adverse Event|1|||
13306140|NCT01294423|26525025|FG001|Overall Study|Adverse Event|2|||
13306141|NCT01294423|26525026|FG002|Overall Study|Adverse Event|3|||
13306142|NCT01294423|26525024|FG000|Overall Study|Withdrawal by Subject|1|||
13306143|NCT01294423|26525025|FG001|Overall Study|Withdrawal by Subject|2|||
13306144|NCT01294423|26525026|FG002|Overall Study|Withdrawal by Subject|2|||
13306145|NCT01294423|26525024|FG000|Overall Study|subject no longer meets study criteria|2|||
13306146|NCT01294423|26525025|FG001|Overall Study|subject no longer meets study criteria|5|||
13306147|NCT01294423|26525026|FG002|Overall Study|subject no longer meets study criteria|2|||
13306148|NCT01294423|26525024|FG000|Overall Study|poor/non-compliance|1|||
13306149|NCT01294423|26525025|FG001|Overall Study|poor/non-compliance|0|||
13306150|NCT01294423|26525026|FG002|Overall Study|poor/non-compliance|1|||
13306151|NCT01294397|26525038|FG000|Overall Study|Withdrawal by Subject|1|||
13306152|NCT01294397|26525038|FG000|Overall Study|Administrative Decision|1|||
13306153|NCT01294371|26525048|FG000|Overall Study|Adverse Event|1|||
13306154|NCT01294371|26525048|FG000|Overall Study|Withdrawal by Subject|12|||
13306155|NCT01294371|26525048|FG000|Overall Study|Lost to Follow-up|6|||
13306156|NCT01294371|26525048|FG000|Overall Study|Administrative Reason|1|||
13306157|NCT01294371|26525048|FG000|Overall Study|Other|14|||
13306158|NCT01294358|26525108|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
13306159|NCT01294358|26525109|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2|||
13306160|NCT01294358|26525110|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
13306161|NCT01294358|26525111|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
13306162|NCT01294358|26525112|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
13306163|NCT01294358|26525108|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
13306164|NCT01294358|26525109|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
13306165|NCT01294358|26525110|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2|||
13306166|NCT01294358|26525111|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
13306167|NCT01294358|26525112|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
13306168|NCT01294358|26525108|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
13306169|NCT01294358|26525109|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
13306170|NCT01294358|26525110|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
13306171|NCT01294358|26525111|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1|||
13306172|NCT01294358|26525112|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
13306173|NCT01294358|26525108|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
13306174|NCT01294358|26525109|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
13306175|NCT01294358|26525110|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
13306176|NCT01294358|26525111|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
13306177|NCT01294358|26525112|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1|||
13306178|NCT01294150|26525129|FG000|Overall Study|Physician Decision|2|||
13306179|NCT01294150|26525130|FG001|Overall Study|Physician Decision|2|||
13382956|NCT00741091|26752252|FG000|Overall Study|Withdrawal by Subject|6|||
13382957|NCT00741091|26752252|FG000|Overall Study|Missed Visit|22|||
13382958|NCT00741039|26752265|FG000|Overall Study|Patient non-compliance|2|||
13382959|NCT00741039|26752266|FG001|Overall Study|Patient non-compliance|0|||
13382960|NCT00741013|26752287|FG000|Overall Study|Adverse Event|1|||
13382961|NCT00741013|26752288|FG001|Overall Study|Adverse Event|0|||
13382962|NCT00741013|26752289|FG002|Overall Study|Adverse Event|0|||
13382963|NCT00741013|26752287|FG000|Overall Study|Withdrawal by Subject|0|||
13382964|NCT00741013|26752288|FG001|Overall Study|Withdrawal by Subject|0|||
13382965|NCT00741013|26752289|FG002|Overall Study|Withdrawal by Subject|1|||
13382966|NCT00741013|26752287|FG000|Overall Study|Discovered failed screen after enrolled|0|||
13382967|NCT00741013|26752288|FG001|Overall Study|Discovered failed screen after enrolled|2|||
13382968|NCT00741013|26752289|FG002|Overall Study|Discovered failed screen after enrolled|0|||
13382969|NCT00740870|26752310|FG000|Overall Study|Not Catheterized|4|||
13382970|NCT00740870|26752310|FG000|Overall Study|Further testing contraindicated implant|17|||
13382971|NCT00740857|26752349|FG000|Overall Study|Withdrawal by Subject|1|||
13382972|NCT00740857|26752350|FG001|Overall Study|Withdrawal by Subject|0|||
13382973|NCT00740857|26752351|FG002|Overall Study|Withdrawal by Subject|0|||
13382974|NCT00740792|26752382|FG000|Overall Study|Adverse Event|3|||
13382975|NCT00740792|26752383|FG001|Overall Study|Adverse Event|1|||
13382976|NCT00740792|26752384|FG002|Overall Study|Adverse Event|1|||
13382977|NCT00740792|26752385|FG003|Overall Study|Adverse Event|3|||
13382978|NCT00740792|26752382|FG000|Overall Study|Lack of Efficacy|1|||
13382979|NCT00740792|26752383|FG001|Overall Study|Lack of Efficacy|1|||
13382980|NCT00740792|26752384|FG002|Overall Study|Lack of Efficacy|0|||
13382981|NCT00740792|26752385|FG003|Overall Study|Lack of Efficacy|3|||
13382982|NCT00740792|26752382|FG000|Overall Study|Lost to Follow-up|2|||
13382983|NCT00740792|26752383|FG001|Overall Study|Lost to Follow-up|1|||
13382984|NCT00740792|26752384|FG002|Overall Study|Lost to Follow-up|0|||
13382985|NCT00740792|26752385|FG003|Overall Study|Lost to Follow-up|0|||
13382986|NCT00740792|26752382|FG000|Overall Study|Protocol Violation|0|||
13382987|NCT00740792|26752383|FG001|Overall Study|Protocol Violation|1|||
13382988|NCT00740792|26752384|FG002|Overall Study|Protocol Violation|0|||
13382989|NCT00740792|26752385|FG003|Overall Study|Protocol Violation|2|||
13382990|NCT00740792|26752382|FG000|Overall Study|Withdrawal by Subject|1|||
13382991|NCT00740792|26752383|FG001|Overall Study|Withdrawal by Subject|1|||
13382992|NCT00740792|26752384|FG002|Overall Study|Withdrawal by Subject|0|||
13306180|NCT01294046|26525145|FG000|Overall Study|Infection and surgical explant|1|||
13306181|NCT01294046|26525145|FG000|Overall Study|Eligibility criteria expanded|1|||
13306182|NCT01294046|26525145|FG000|Overall Study|Stimulation response inadqequate|1|||
13382993|NCT00740792|26752385|FG003|Overall Study|Withdrawal by Subject|0|||
13382994|NCT00740792|26752382|FG000|Overall Study|administrative|3|||
13382995|NCT00740792|26752383|FG001|Overall Study|administrative|3|||
13382996|NCT00740792|26752384|FG002|Overall Study|administrative|8|||
13382997|NCT00740792|26752385|FG003|Overall Study|administrative|2|||
13382998|NCT00740779|26752403|FG000|Overall Study|Adverse Event|4|||
13382999|NCT00740779|26752404|FG001|Overall Study|Adverse Event|6|||
13383000|NCT00740779|26752405|FG002|Overall Study|Adverse Event|3|||
13383001|NCT00740779|26752403|FG000|Overall Study|Protocol Violation|1|||
13383002|NCT00740779|26752404|FG001|Overall Study|Protocol Violation|1|||
13383003|NCT00740779|26752405|FG002|Overall Study|Protocol Violation|1|||
13383004|NCT00740779|26752403|FG000|Overall Study|Lack of Efficacy|0|||
13383005|NCT00740779|26752404|FG001|Overall Study|Lack of Efficacy|0|||
13383006|NCT00740779|26752405|FG002|Overall Study|Lack of Efficacy|2|||
13383007|NCT00740779|26752403|FG000|Overall Study|Withdrawal by Subject|2|||
13383008|NCT00740779|26752404|FG001|Overall Study|Withdrawal by Subject|4|||
13383009|NCT00740779|26752405|FG002|Overall Study|Withdrawal by Subject|2|||
13383010|NCT00740779|26752403|FG000|Overall Study|Lost to Follow-up|2|||
13383011|NCT00740779|26752404|FG001|Overall Study|Lost to Follow-up|3|||
13383012|NCT00740779|26752405|FG002|Overall Study|Lost to Follow-up|5|||
13383013|NCT00740714|26752489|FG000|Overall Study|Withdrawal by Subject|17|||
13383014|NCT00740714|26752490|FG001|Overall Study|Withdrawal by Subject|19|||
13383015|NCT00740714|26752491|FG002|Overall Study|Withdrawal by Subject|29|||
13383016|NCT00740636|26752504|FG000|Overall Study|Adverse Event|0|||
13383017|NCT00740636|26752505|FG001|Overall Study|Adverse Event|2|||
13383018|NCT00740636|26752504|FG000|Overall Study|Patient Ineligible|0|||
13383019|NCT00740636|26752505|FG001|Overall Study|Patient Ineligible|1|||
13383020|NCT00740636|26752504|FG000|Overall Study|Patient Not Treated|0|||
13383021|NCT00740636|26752505|FG001|Overall Study|Patient Not Treated|1|||
13383022|NCT00740636|26752504|FG000|Overall Study|Progressive Disease|1|||
13383023|NCT00740636|26752505|FG001|Overall Study|Progressive Disease|0|||
13383024|NCT00740636|26752504|FG000|Overall Study|Death|1|||
13383025|NCT00740636|26752505|FG001|Overall Study|Death|0|||
13383026|NCT00740597|26752511|FG000|Overall Study|insurance would not cover treatment|1|||
13383027|NCT00740584|26752518|FG000|Overall Study|Withdrawal by Subject|1|||
13383028|NCT00740220|26752524|FG000|Overall Study|screen failures (non-COPD patients)|9|||
13383029|NCT00740116|26752545|FG000|Overall Study|Withdrawal by Subject|1|||
13383030|NCT00740116|26752546|FG001|Overall Study|Withdrawal by Subject|1|||
13383031|NCT00740116|26752545|FG000|Overall Study|Protocol Violation|1|||
13383032|NCT00740116|26752546|FG001|Overall Study|Protocol Violation|4|||
13383033|NCT00740051|26752573|FG000|Overall Study|Lack of Efficacy|2|||
13383034|NCT00740051|26752574|FG001|Overall Study|Lack of Efficacy|5|||
13383035|NCT00740051|26752573|FG000|Overall Study|Adverse Event|1|||
13383036|NCT00740051|26752574|FG001|Overall Study|Adverse Event|4|||
13383037|NCT00740051|26752573|FG000|Overall Study|Protocol Violation|2|||
13383038|NCT00740051|26752574|FG001|Overall Study|Protocol Violation|6|||
13383039|NCT00740051|26752573|FG000|Overall Study|Lost to Follow-up|3|||
13383040|NCT00740051|26752574|FG001|Overall Study|Lost to Follow-up|8|||
13383041|NCT00740051|26752573|FG000|Overall Study|Withdrawal by Subject|6|||
13306183|NCT01293968|26525158|FG000|Overall Study|non-cooperation|3|||
13306184|NCT01293968|26525159|FG001|Overall Study|non-cooperation|3|||
13306185|NCT01293695|26525180|FG000|Overall Study|Withdrawal by Subject|7|||
13306186|NCT01293695|26525181|FG001|Overall Study|Withdrawal by Subject|1|||
13306187|NCT01293695|26525180|FG000|Overall Study|Lost to Follow-up|8|||
13306188|NCT01293695|26525181|FG001|Overall Study|Lost to Follow-up|6|||
13383042|NCT00740051|26752574|FG001|Overall Study|Withdrawal by Subject|8|||
13383043|NCT00740051|26752573|FG000|Overall Study|Other reason (not specified)|4|||
13383044|NCT00740051|26752574|FG001|Overall Study|Other reason (not specified)|1|||
13383045|NCT00739973|26752688|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35|||
13383046|NCT00739973|26752689|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
13383047|NCT00739973|26752690|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
13383048|NCT00739973|26752691|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
13383049|NCT00739973|26752692|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
13383050|NCT00739973|26752693|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
13383051|NCT00739973|26752694|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
13383052|NCT00739973|26752695|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
13383053|NCT00739973|26752696|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
13383054|NCT00739973|26752688|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38|||
13383055|NCT00739973|26752689|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
13383056|NCT00739973|26752690|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
13383057|NCT00739973|26752691|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
13383058|NCT00739973|26752692|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
13383059|NCT00739973|26752693|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
13383060|NCT00739973|26752694|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
13383061|NCT00739973|26752695|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
13383062|NCT00739973|26752696|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
13383063|NCT00739973|26752688|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810|||
13383064|NCT00739973|26752689|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
13383065|NCT00739973|26752690|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
13383066|NCT00739973|26752691|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
13383067|NCT00739973|26752692|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
13383068|NCT00739973|26752693|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
13383069|NCT00739973|26752694|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
13383070|NCT00739973|26752695|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
13383071|NCT00739973|26752696|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
13383072|NCT00739973|26752688|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86|||
13383073|NCT00739973|26752689|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
13383074|NCT00739973|26752690|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
13383075|NCT00739973|26752691|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
13383076|NCT00739973|26752692|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
13383077|NCT00739973|26752693|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
13383078|NCT00739973|26752694|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
13383079|NCT00739973|26752695|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
13383080|NCT00739973|26752696|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
13383081|NCT00739973|26752688|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17|||
13383082|NCT00739973|26752689|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
13383083|NCT00739973|26752690|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
13383084|NCT00739973|26752691|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
13383085|NCT00739973|26752692|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
13383086|NCT00739973|26752693|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
13383087|NCT00739973|26752694|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
13383088|NCT00739973|26752695|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
13383089|NCT00739973|26752696|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
13383090|NCT00739973|26752688|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12|||
13383091|NCT00739973|26752689|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
13383092|NCT00739973|26752690|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
13383093|NCT00739973|26752691|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
13383094|NCT00739973|26752692|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
13383095|NCT00739973|26752693|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
13383096|NCT00739973|26752694|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
13383097|NCT00739973|26752695|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
13383098|NCT00739973|26752696|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
13383099|NCT00739973|26752688|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11|||
13383100|NCT00739973|26752689|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
13383101|NCT00739973|26752690|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
13383102|NCT00739973|26752691|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
13383103|NCT00739973|26752692|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
13383104|NCT00739973|26752693|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
13383105|NCT00739973|26752694|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
13383106|NCT00739973|26752695|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
13383107|NCT00739973|26752696|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
13383108|NCT00739973|26752688|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
13383109|NCT00739973|26752689|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
13383110|NCT00739973|26752690|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
13383111|NCT00739973|26752691|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2|||
13383112|NCT00739973|26752692|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7|||
13383113|NCT00739973|26752693|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
13383114|NCT00739973|26752694|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
13383115|NCT00739973|26752695|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
13383116|NCT00739973|26752696|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
13383117|NCT00739973|26752688|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
13383118|NCT00739973|26752689|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
13383119|NCT00739973|26752690|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
13383120|NCT00739973|26752691|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
13383121|NCT00739973|26752692|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
13383122|NCT00739973|26752693|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
13383123|NCT00739973|26752694|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
13383124|NCT00739973|26752695|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
13383125|NCT00739973|26752696|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
13383126|NCT00739973|26752688|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
13383127|NCT00739973|26752689|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
13383128|NCT00739973|26752690|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
13383129|NCT00739973|26752691|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
13383130|NCT00739973|26752692|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
13383131|NCT00739973|26752693|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
13383132|NCT00739973|26752694|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
13383133|NCT00739973|26752695|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
13383134|NCT00739973|26752696|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
13383135|NCT00739973|26752688|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17|||
13383136|NCT00739973|26752689|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
13383137|NCT00739973|26752690|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
13383138|NCT00739973|26752691|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4|||
13383139|NCT00739973|26752692|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
13383140|NCT00739973|26752693|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
13383141|NCT00739973|26752694|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
13383142|NCT00739973|26752695|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
13383143|NCT00739973|26752696|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
13383144|NCT00739973|26752688|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
13383145|NCT00739973|26752689|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
13383146|NCT00739973|26752690|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1|||
13383147|NCT00739973|26752691|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
13383148|NCT00739973|26752692|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
13383149|NCT00739973|26752693|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
13383150|NCT00739973|26752694|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
13383151|NCT00739973|26752695|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
13383152|NCT00739973|26752696|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
13383153|NCT00739973|26752688|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
13383154|NCT00739973|26752689|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
13383155|NCT00739973|26752690|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
13383156|NCT00739973|26752691|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
13383157|NCT00739973|26752692|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
13306189|NCT01293539|26525187|FG000|Overall Study|Physician Decision|1|||
13306190|NCT01293240|26525204|FG000|Overall Study|Noncompliance|2|||
13306191|NCT01293123|26525225|FG000|Overall Study|Lost to Follow-up|0|||
13306192|NCT01293123|26525226|FG001|Overall Study|Lost to Follow-up|1|||
13306193|NCT01293084|26525236|FG000|Overall Study|Physician Decision|3|||
13306194|NCT01293084|26525236|FG000|Overall Study|Withdrawal by Subject|2|||
13306195|NCT01293032|26525256|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
13306196|NCT01293032|26525257|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
13306197|NCT01293032|26525258|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5|||
13306198|NCT01293032|26525259|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
13306199|NCT01293032|26525256|FG000|Treatment|Adverse Event|0|||
13306200|NCT01293032|26525257|FG001|Treatment|Adverse Event|0|||
13306201|NCT01293032|26525258|FG002|Treatment|Adverse Event|1|||
13306202|NCT01293032|26525259|FG003|Treatment|Adverse Event|1|||
13306203|NCT01293032|26525256|FG000|Treatment|Withdrawal by Subject|2|||
13306204|NCT01293032|26525257|FG001|Treatment|Withdrawal by Subject|4|||
13306205|NCT01293032|26525258|FG002|Treatment|Withdrawal by Subject|0|||
13306206|NCT01293032|26525259|FG003|Treatment|Withdrawal by Subject|0|||
13306207|NCT01293032|26525256|FG000|Treatment|Disease Progression, relapse|0|||
13306208|NCT01293032|26525257|FG001|Treatment|Disease Progression, relapse|1|||
13306209|NCT01293032|26525258|FG002|Treatment|Disease Progression, relapse|0|||
13306210|NCT01293032|26525259|FG003|Treatment|Disease Progression, relapse|0|||
13306211|NCT01293006|26525293|FG000|Period 2|Lost to Follow-up|1|||
13306212|NCT01293006|26525294|FG001|Period 2|Lost to Follow-up|0|||
13306213|NCT01293006|26525295|FG002|Period 2|Lost to Follow-up|0|||
13306214|NCT01293006|26525296|FG003|Period 2|Lost to Follow-up|0|||
13383158|NCT00739973|26752693|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
13383159|NCT00739973|26752694|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
13383160|NCT00739973|26752695|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
13383161|NCT00739973|26752696|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
13383162|NCT00739973|26752688|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
13383163|NCT00739973|26752689|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
13383164|NCT00739973|26752690|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4|||
13383165|NCT00739973|26752691|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
13383166|NCT00739973|26752692|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
13383167|NCT00739973|26752693|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
13383168|NCT00739973|26752694|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
13383169|NCT00739973|26752695|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3|||
13383170|NCT00739973|26752696|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
13383171|NCT00739973|26752688|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
13383172|NCT00739973|26752689|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
13383173|NCT00739973|26752690|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
13383174|NCT00739973|26752691|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
13383175|NCT00739973|26752692|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
13383176|NCT00739973|26752693|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
13383177|NCT00739973|26752694|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1|||
13383178|NCT00739973|26752695|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
13383179|NCT00739973|26752696|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
13383180|NCT00739973|26752688|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5|||
13383181|NCT00739973|26752689|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
13383182|NCT00739973|26752690|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
13383183|NCT00739973|26752691|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
13383184|NCT00739973|26752692|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
13383185|NCT00739973|26752693|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
13383186|NCT00739973|26752694|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
13383187|NCT00739973|26752695|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
13383188|NCT00739973|26752696|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
13383189|NCT00739973|26752688|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
13383190|NCT00739973|26752689|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1|||
13383191|NCT00739973|26752690|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
13383192|NCT00739973|26752691|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
13383193|NCT00739973|26752692|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
13383194|NCT00739973|26752693|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
13383195|NCT00739973|26752694|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2|||
13383196|NCT00739973|26752695|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
13383197|NCT00739973|26752696|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
13383198|NCT00739934|26752718|FG000|Voriconazole IV|Adverse Event|6|||
13383199|NCT00739934|26752718|FG000|Voriconazole Oral|Other|3|||
13383200|NCT00739908|26752743|FG000|Overall Study|Adverse Event|5|||
13383201|NCT00739908|26752744|FG001|Overall Study|Adverse Event|6|||
13383202|NCT00739908|26752743|FG000|Overall Study|Withdrawal by Subject|4|||
13383203|NCT00739908|26752744|FG001|Overall Study|Withdrawal by Subject|2|||
13383204|NCT00739908|26752743|FG000|Overall Study|Lost to Follow-up|14|||
13383205|NCT00739908|26752744|FG001|Overall Study|Lost to Follow-up|9|||
13383206|NCT00739908|26752743|FG000|Overall Study|Non-Compliance With Study Procedures|2|||
13383207|NCT00739908|26752744|FG001|Overall Study|Non-Compliance With Study Procedures|3|||
13394855|NCT00654095|26788184|FG000|Overall Study|Adverse reaction did not improve (5)|4|||
13394856|NCT00654095|26788184|FG000|Overall Study|Did not meet inclusion criteria|1|||
13394857|NCT00654004|26788205|FG000|Overall Study|Lost to Follow-up|1|||
13394858|NCT00654004|26788206|FG001|Overall Study|Lost to Follow-up|0|||
13394859|NCT00653991|26788223|FG000|3 Month Follow-up|Participant would not respond|150|||
13394860|NCT00653991|26788224|FG001|3 Month Follow-up|Participant would not respond|157|||
13394861|NCT00653991|26788223|FG000|6 Month Follow-up|Participant would not respond|133|||
13394862|NCT00653991|26788224|FG001|6 Month Follow-up|Participant would not respond|141|||
13394863|NCT00653939|26788247|FG000|Overall Study|Adverse Event|1|||
13394864|NCT00653939|26788248|FG001|Overall Study|Adverse Event|3|||
13394865|NCT00653939|26788247|FG000|Overall Study|Withdrawal by Subject|3|||
13394866|NCT00653939|26788248|FG001|Overall Study|Withdrawal by Subject|3|||
13394867|NCT00653939|26788247|FG000|Overall Study|Physician Decision|4|||
13394868|NCT00653939|26788248|FG001|Overall Study|Physician Decision|0|||
13394869|NCT00653939|26788247|FG000|Overall Study|Disease Progression|2|||
13383208|NCT00739908|26752743|FG000|Overall Study|Non-Compliance With Study Medication|0|||
13383209|NCT00739908|26752744|FG001|Overall Study|Non-Compliance With Study Medication|3|||
13383210|NCT00739908|26752743|FG000|Overall Study|Lack of Efficacy|0|||
13383211|NCT00739908|26752744|FG001|Overall Study|Lack of Efficacy|1|||
13383212|NCT00739908|26752743|FG000|Overall Study|Relocation|0|||
13383213|NCT00739908|26752744|FG001|Overall Study|Relocation|1|||
13383214|NCT00739882|26752769|FG000|Double-blind Period|Adverse Event|1|||
13383215|NCT00739882|26752770|FG001|Double-blind Period|Adverse Event|2|||
13383216|NCT00739882|26752769|FG000|Double-blind Period|Protocol Violation|1|||
13383217|NCT00739882|26752770|FG001|Double-blind Period|Protocol Violation|0|||
13383218|NCT00739882|26752769|FG000|Double-blind Period|Lack of Efficacy|1|||
13383219|NCT00739882|26752770|FG001|Double-blind Period|Lack of Efficacy|1|||
13383220|NCT00739882|26752769|FG000|Double-blind Period|Other|16|||
13383221|NCT00739882|26752770|FG001|Double-blind Period|Other|8|||
13383222|NCT00739882|26752769|FG000|Open-label Period|Adverse Event|1|||
13383223|NCT00739882|26752770|FG001|Open-label Period|Adverse Event|0|||
13383224|NCT00739882|26752769|FG000|Open-label Period|Other|9|||
13383225|NCT00739882|26752770|FG001|Open-label Period|Other|5|||
13383226|NCT00739661|26752787|FG000|Overall Study|Adverse Event|2|||
13383227|NCT00739661|26752788|FG001|Overall Study|Adverse Event|0|||
13383228|NCT00739661|26752787|FG000|Overall Study|Physician decision to withdraw patient|1|||
13383229|NCT00739661|26752788|FG001|Overall Study|Physician decision to withdraw patient|0|||
13383230|NCT00739661|26752787|FG000|Overall Study|Patient decision to withdraw|9|||
13383231|NCT00739661|26752788|FG001|Overall Study|Patient decision to withdraw|4|||
13383232|NCT00739661|26752787|FG000|Overall Study|Disease progression, radiographic|33|||
13383233|NCT00739661|26752788|FG001|Overall Study|Disease progression, radiographic|37|||
13383234|NCT00739661|26752787|FG000|Overall Study|Reason for discontinuation not available|1|||
13383235|NCT00739661|26752788|FG001|Overall Study|Reason for discontinuation not available|1|||
13383236|NCT00739648|26752807|FG000|Overall Study|Adverse Event|3|||
13383237|NCT00739648|26752808|FG001|Overall Study|Adverse Event|15|||
13383238|NCT00739648|26752807|FG000|Overall Study|Withdrawal by Subject|13|||
13383239|NCT00739648|26752808|FG001|Overall Study|Withdrawal by Subject|25|||
13383240|NCT00739648|26752807|FG000|Overall Study|Lost to Follow-up|4|||
13383241|NCT00739648|26752808|FG001|Overall Study|Lost to Follow-up|7|||
13383242|NCT00739648|26752807|FG000|Overall Study|Death|2|||
13383243|NCT00739648|26752808|FG001|Overall Study|Death|0|||
13383244|NCT00739648|26752807|FG000|Overall Study|Do not know|4|||
13383245|NCT00739648|26752808|FG001|Overall Study|Do not know|6|||
13383246|NCT00739596|26752829|FG000|Overall Study|Adverse Event|12|||
13383247|NCT00739596|26752830|FG001|Overall Study|Adverse Event|6|||
13383248|NCT00739596|26752829|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
13383249|NCT00739596|26752830|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
13383250|NCT00739596|26752829|FG000|Overall Study|Patient Withdrew Consent|8|||
13383251|NCT00739596|26752830|FG001|Overall Study|Patient Withdrew Consent|8|||
13383252|NCT00739596|26752829|FG000|Overall Study|Lost to Follow-up|0|||
13383253|NCT00739596|26752830|FG001|Overall Study|Lost to Follow-up|2|||
13383254|NCT00739596|26752829|FG000|Overall Study|Protocol Deviation|1|||
13383255|NCT00739596|26752830|FG001|Overall Study|Protocol Deviation|1|||
13383256|NCT00739310|26752837|FG000|Overall Study|Poor adherance to prescribed therapy|4|||
13383257|NCT00739310|26752837|FG000|Overall Study|Withdrawal by Subject|1|||
13383258|NCT00739310|26752837|FG000|Overall Study|Lost to Follow-up|2|||
13383259|NCT00739297|26752873|FG000|First Washout Period of 4-7 Days|Adverse Event|0|||
13383260|NCT00739297|26752874|FG001|First Washout Period of 4-7 Days|Adverse Event|0|||
13383261|NCT00739297|26752875|FG002|First Washout Period of 4-7 Days|Adverse Event|0|||
13383262|NCT00739297|26752876|FG003|First Washout Period of 4-7 Days|Adverse Event|2|||
13383263|NCT00739297|26752877|FG004|First Washout Period of 4-7 Days|Adverse Event|0|||
13383264|NCT00739297|26752878|FG005|First Washout Period of 4-7 Days|Adverse Event|0|||
13383265|NCT00739297|26752879|FG006|First Washout Period of 4-7 Days|Adverse Event|2|||
13383266|NCT00739297|26752873|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
13383267|NCT00739297|26752874|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
13383268|NCT00739297|26752875|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
13383269|NCT00739297|26752876|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
13383270|NCT00739297|26752877|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
13383271|NCT00739297|26752878|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
13383272|NCT00739297|26752879|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
13383273|NCT00739102|26752897|FG000|Overall Study|Death|5|||
13383274|NCT00739102|26752897|FG000|Overall Study|Withdrawal by Subject|10|||
13383275|NCT00739063|26752903|FG000|Overall Study|Screen failures|8|||
13383276|NCT00738920|26752927|FG000|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
13383277|NCT00738920|26752928|FG001|Baseline to 2-Week Follow-Up|Lost to Follow-up|9|||
13394870|NCT00653939|26788248|FG001|Overall Study|Disease Progression|3|||
13383278|NCT00738920|26752929|FG002|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
13383279|NCT00738920|26752927|FG000|Baseline to 2-Week Follow-Up|Withdrawal by Subject|8|||
13394871|NCT00653939|26788247|FG000|Overall Study|Other|2|||
13383280|NCT00738920|26752928|FG001|Baseline to 2-Week Follow-Up|Withdrawal by Subject|14|||
13383281|NCT00738920|26752929|FG002|Baseline to 2-Week Follow-Up|Withdrawal by Subject|7|||
13383282|NCT00738920|26752927|FG000|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|3|||
13383283|NCT00738920|26752928|FG001|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|5|||
13383284|NCT00738920|26752929|FG002|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|6|||
13383285|NCT00738920|26752927|FG000|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|5|||
13383286|NCT00738920|26752928|FG001|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|7|||
13383287|NCT00738920|26752929|FG002|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|6|||
13383288|NCT00738920|26752927|FG000|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|3|||
13383289|NCT00738920|26752928|FG001|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|0|||
13383290|NCT00738920|26752929|FG002|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|2|||
13383291|NCT00738920|26752927|FG000|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
13383292|NCT00738920|26752928|FG001|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|0|||
13383293|NCT00738920|26752929|FG002|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
13383294|NCT00738920|26752927|FG000|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|2|||
13383295|NCT00738920|26752928|FG001|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|4|||
13383296|NCT00738920|26752929|FG002|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|7|||
13383297|NCT00738920|26752927|FG000|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|2|||
13383298|NCT00738920|26752928|FG001|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|3|||
13383299|NCT00738920|26752929|FG002|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|5|||
13383300|NCT00738920|26752927|FG000|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
13383301|NCT00738920|26752928|FG001|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|0|||
13383302|NCT00738920|26752929|FG002|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
13383303|NCT00738920|26752927|FG000|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
13383304|NCT00738920|26752928|FG001|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|1|||
13383305|NCT00738920|26752929|FG002|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
13383306|NCT00738894|26752947|FG000|Overall Study|Lost to Follow-up|23|||
13383307|NCT00738894|26752948|FG001|Overall Study|Lost to Follow-up|13|||
13383308|NCT00738894|26752947|FG000|Overall Study|Withdrawal by Subject|10|||
13383309|NCT00738894|26752948|FG001|Overall Study|Withdrawal by Subject|15|||
13383310|NCT00738894|26752947|FG000|Overall Study|Physician Decision|4|||
13383311|NCT00738894|26752948|FG001|Overall Study|Physician Decision|5|||
13383312|NCT00738894|26752947|FG000|Overall Study|Death|2|||
13383313|NCT00738894|26752948|FG001|Overall Study|Death|0|||
13383314|NCT00738881|26752967|FG000|Overall Study|Withdrawal by Subject|0|||
13383315|NCT00738881|26752968|FG001|Overall Study|Withdrawal by Subject|2|||
13383316|NCT00738699|26752991|FG000|Overall Study|Withdrawal by Subject|5|||
13383317|NCT00738699|26752992|FG001|Overall Study|Withdrawal by Subject|0|||
13383318|NCT00738699|26752991|FG000|Overall Study|Lost to Follow-up|1|||
13383319|NCT00738699|26752992|FG001|Overall Study|Lost to Follow-up|0|||
13383320|NCT00738699|26752991|FG000|Overall Study|Death|144|||
13383321|NCT00738699|26752992|FG001|Overall Study|Death|68|||
13383322|NCT00738699|26752991|FG000|Overall Study|Discontinuation of study by Sponsor|123|||
13383323|NCT00738699|26752992|FG001|Overall Study|Discontinuation of study by Sponsor|72|||
13383324|NCT00738699|26752991|FG000|Overall Study|Other|2|||
13383325|NCT00738699|26752992|FG001|Overall Study|Other|0|||
13383326|NCT00738673|26753027|FG000|Overall Study|Adverse Event|1|||
13383327|NCT00738673|26753028|FG001|Overall Study|Adverse Event|0|||
13383328|NCT00738673|26753027|FG000|Overall Study|Lack of Efficacy|19|||
13383329|NCT00738673|26753028|FG001|Overall Study|Lack of Efficacy|8|||
13383330|NCT00738673|26753027|FG000|Overall Study|Protocol Violation|1|||
13383331|NCT00738673|26753028|FG001|Overall Study|Protocol Violation|2|||
13383332|NCT00738673|26753027|FG000|Overall Study|Withdrawal by Subject|3|||
13383333|NCT00738673|26753028|FG001|Overall Study|Withdrawal by Subject|1|||
13383334|NCT00738582|26753043|FG000|Combination Therapy|Completed Combination Therapy|1|||
13383335|NCT00738582|26753044|FG001|Combination Therapy|Completed Combination Therapy|0|||
13383336|NCT00738582|26753043|FG000|Combination Therapy|Physician Decision|1|||
13383337|NCT00738582|26753044|FG001|Combination Therapy|Physician Decision|0|||
13383338|NCT00738582|26753043|FG000|Combination Therapy|Toxicity to Chemotherapy|1|||
13383339|NCT00738582|26753044|FG001|Combination Therapy|Toxicity to Chemotherapy|0|||
13383340|NCT00738582|26753043|FG000|Combination Therapy|Other|5|||
13383341|NCT00738582|26753044|FG001|Combination Therapy|Other|0|||
13383342|NCT00738582|26753043|FG000|Combination Therapy|Adverse Event|16|||
13383343|NCT00738582|26753044|FG001|Combination Therapy|Adverse Event|0|||
13383344|NCT00738582|26753043|FG000|Combination Therapy|Progressive Disease|9|||
13383345|NCT00738582|26753044|FG001|Combination Therapy|Progressive Disease|0|||
13383346|NCT00738582|26753043|FG000|Maintenance Therapy|Other|0|||
13383347|NCT00738582|26753044|FG001|Maintenance Therapy|Other|2|||
13383348|NCT00738582|26753043|FG000|Maintenance Therapy|Adverse Event|0|||
13383349|NCT00738582|26753044|FG001|Maintenance Therapy|Adverse Event|6|||
13383350|NCT00738582|26753043|FG000|Maintenance Therapy|Progressive Disease|0|||
13383351|NCT00738582|26753044|FG001|Maintenance Therapy|Progressive Disease|47|||
13383352|NCT00738582|26753043|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
13383353|NCT00738582|26753044|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
13383354|NCT00738530|26753075|FG000|Overall Study|Death|220|||
13383355|NCT00738530|26753076|FG001|Overall Study|Death|224|||
13383356|NCT00738530|26753075|FG000|Overall Study|Lost to Follow-up|8|||
13383357|NCT00738530|26753076|FG001|Overall Study|Lost to Follow-up|6|||
13383358|NCT00738530|26753075|FG000|Overall Study|Withdrawal by Subject|6|||
13383359|NCT00738530|26753076|FG001|Overall Study|Withdrawal by Subject|8|||
13383360|NCT00738400|26753101|FG000|Overall Study|Adverse Event|3|||
13383361|NCT00738400|26753102|FG001|Overall Study|Adverse Event|1|||
13383362|NCT00738400|26753101|FG000|Overall Study|Withdrawal by Subject|0|||
13383363|NCT00738400|26753102|FG001|Overall Study|Withdrawal by Subject|1|||
13383364|NCT00738400|26753101|FG000|Overall Study|Lack of Efficacy|0|||
13383365|NCT00738400|26753102|FG001|Overall Study|Lack of Efficacy|1|||
13383366|NCT00738400|26753101|FG000|Overall Study|Lost to Follow-up|0|||
13383367|NCT00738400|26753102|FG001|Overall Study|Lost to Follow-up|3|||
13383368|NCT00738400|26753101|FG000|Overall Study|Protocol Violation|1|||
13383369|NCT00738400|26753102|FG001|Overall Study|Protocol Violation|0|||
13383370|NCT00738400|26753101|FG000|Overall Study|Non-compliant with study medication|0|||
13383371|NCT00738400|26753102|FG001|Overall Study|Non-compliant with study medication|1|||
13383372|NCT00738374|26753145|FG000|Induction Treatment Phase|Adverse Event|14|||
13383373|NCT00738374|26753146|FG001|Induction Treatment Phase|Adverse Event|0|||
13383374|NCT00738374|26753147|FG002|Induction Treatment Phase|Adverse Event|0|||
13383375|NCT00738374|26753148|FG003|Induction Treatment Phase|Adverse Event|0|||
13383376|NCT00738374|26753145|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4|||
13383377|NCT00738374|26753146|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0|||
13383378|NCT00738374|26753147|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0|||
13383379|NCT00738374|26753148|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0|||
13383380|NCT00738374|26753145|FG000|Induction Treatment Phase|Physician Decision|2|||
13383381|NCT00738374|26753146|FG001|Induction Treatment Phase|Physician Decision|0|||
13383382|NCT00738374|26753147|FG002|Induction Treatment Phase|Physician Decision|0|||
13383383|NCT00738374|26753148|FG003|Induction Treatment Phase|Physician Decision|0|||
13383384|NCT00738374|26753145|FG000|Induction Treatment Phase|Protocol Violation|2|||
13383385|NCT00738374|26753146|FG001|Induction Treatment Phase|Protocol Violation|0|||
13383386|NCT00738374|26753147|FG002|Induction Treatment Phase|Protocol Violation|0|||
13383387|NCT00738374|26753148|FG003|Induction Treatment Phase|Protocol Violation|0|||
13383388|NCT00738374|26753145|FG000|Induction Treatment Phase|Non-compliance|1|||
13383389|NCT00738374|26753146|FG001|Induction Treatment Phase|Non-compliance|0|||
13383390|NCT00738374|26753147|FG002|Induction Treatment Phase|Non-compliance|0|||
13383391|NCT00738374|26753148|FG003|Induction Treatment Phase|Non-compliance|0|||
13383392|NCT00738374|26753145|FG000|Induction Treatment Phase|Withdrawal by Subject|1|||
13383393|NCT00738374|26753146|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
13383394|NCT00738374|26753147|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
13383395|NCT00738374|26753148|FG003|Induction Treatment Phase|Withdrawal by Subject|0|||
13383396|NCT00738374|26753145|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0|||
13383397|NCT00738374|26753146|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1|||
13383398|NCT00738374|26753147|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2|||
13383399|NCT00738374|26753148|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0|||
13383400|NCT00738374|26753145|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0|||
13383401|NCT00738374|26753146|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4|||
13383402|NCT00738374|26753147|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5|||
13383403|NCT00738374|26753148|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11|||
13383404|NCT00738374|26753145|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
13383405|NCT00738374|26753146|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
13383406|NCT00738374|26753147|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
13383407|NCT00738374|26753148|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1|||
13383408|NCT00738374|26753145|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
13383409|NCT00738374|26753146|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1|||
13383410|NCT00738374|26753147|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
13383411|NCT00738374|26753148|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
13383412|NCT00738374|26753145|FG000|Maintenance Treatment/Observation Phase|Other|0|||
13383413|NCT00738374|26753146|FG001|Maintenance Treatment/Observation Phase|Other|1|||
13383414|NCT00738374|26753147|FG002|Maintenance Treatment/Observation Phase|Other|0|||
13383415|NCT00738374|26753148|FG003|Maintenance Treatment/Observation Phase|Other|0|||
13383416|NCT00738283|26753154|FG000|Overall Study|Death|1|||
13383417|NCT00738283|26753154|FG000|Overall Study|Transfer to another facility|2|||
13383418|NCT00738283|26753154|FG000|Overall Study|Discharge home prior to end of study|1|||
13383419|NCT00738101|26753168|FG000|Overall Study|Physician Decision|5|||
13383420|NCT00738101|26753168|FG000|Overall Study|Death|1|||
13383421|NCT00738101|26753168|FG000|Overall Study|Repeat enrollment|1|||
13383422|NCT00738062|26753203|FG000|Open Label Treatment|Lack of Efficacy|5|||
13383423|NCT00738062|26753204|FG001|Open Label Treatment|Lack of Efficacy|0|||
13383424|NCT00738062|26753205|FG002|Open Label Treatment|Lack of Efficacy|0|||
13383425|NCT00738062|26753203|FG000|Open Label Treatment|Adverse Event|11|||
13383426|NCT00738062|26753204|FG001|Open Label Treatment|Adverse Event|0|||
13383427|NCT00738062|26753205|FG002|Open Label Treatment|Adverse Event|0|||
13383428|NCT00738062|26753203|FG000|Open Label Treatment|Protocol Violation|2|||
13383429|NCT00738062|26753204|FG001|Open Label Treatment|Protocol Violation|0|||
13383430|NCT00738062|26753205|FG002|Open Label Treatment|Protocol Violation|0|||
13383431|NCT00738062|26753203|FG000|Open Label Treatment|Withdrawal by Subject|9|||
13383432|NCT00738062|26753204|FG001|Open Label Treatment|Withdrawal by Subject|0|||
13383433|NCT00738062|26753205|FG002|Open Label Treatment|Withdrawal by Subject|0|||
13383434|NCT00738062|26753203|FG000|Open Label Treatment|Investigator Decision|1|||
13383435|NCT00738062|26753204|FG001|Open Label Treatment|Investigator Decision|0|||
13383436|NCT00738062|26753205|FG002|Open Label Treatment|Investigator Decision|0|||
13383437|NCT00738062|26753203|FG000|Open-Label Extension|Adverse Event|5|||
13383438|NCT00738062|26753204|FG001|Open-Label Extension|Adverse Event|0|||
13383439|NCT00738062|26753205|FG002|Open-Label Extension|Adverse Event|0|||
13383440|NCT00738062|26753203|FG000|Open-Label Extension|Physician Decision|1|||
13383441|NCT00738062|26753204|FG001|Open-Label Extension|Physician Decision|0|||
13383442|NCT00738062|26753205|FG002|Open-Label Extension|Physician Decision|0|||
13383443|NCT00738062|26753203|FG000|Open-Label Extension|Lack of Efficacy|2|||
13383444|NCT00738062|26753204|FG001|Open-Label Extension|Lack of Efficacy|0|||
13383445|NCT00738062|26753205|FG002|Open-Label Extension|Lack of Efficacy|0|||
13383446|NCT00738062|26753203|FG000|Open-Label Extension|Withdrawal by Subject|6|||
13383447|NCT00738062|26753204|FG001|Open-Label Extension|Withdrawal by Subject|0|||
13383448|NCT00738062|26753205|FG002|Open-Label Extension|Withdrawal by Subject|0|||
13383449|NCT00738062|26753203|FG000|Open-Label Extension|Protocol Violation|1|||
13383450|NCT00738062|26753204|FG001|Open-Label Extension|Protocol Violation|0|||
13383451|NCT00738062|26753205|FG002|Open-Label Extension|Protocol Violation|0|||
13383452|NCT00738062|26753203|FG000|Open-Label Extension|Study Terminated|2|||
13383453|NCT00738062|26753204|FG001|Open-Label Extension|Study Terminated|0|||
13383454|NCT00738062|26753205|FG002|Open-Label Extension|Study Terminated|0|||
13383455|NCT00737711|26753238|FG000|Overall Study|Adverse Event|2|||
13383456|NCT00737711|26753238|FG000|Overall Study|Death|8|||
13383457|NCT00737711|26753238|FG000|Overall Study|Failure to return|4|||
13383458|NCT00737711|26753238|FG000|Overall Study|Protocol Violation|1|||
13383459|NCT00737711|26753238|FG000|Overall Study|Withdrawal by Subject|5|||
13383460|NCT00737711|26753238|FG000|Overall Study|Blood transfusion|6|||
13383461|NCT00737711|26753238|FG000|Overall Study|Other|5|||
13383462|NCT00737698|26753256|FG000|Overall Study|Withdrawal by Subject|6|||
13383463|NCT00737698|26753257|FG001|Overall Study|Withdrawal by Subject|5|||
13383464|NCT00737698|26753258|FG002|Overall Study|Withdrawal by Subject|3|||
13383465|NCT00737698|26753256|FG000|Overall Study|Death|0|||
13383466|NCT00737698|26753257|FG001|Overall Study|Death|0|||
13383467|NCT00737698|26753258|FG002|Overall Study|Death|1|||
13383468|NCT00737672|26753301|FG000|Overall Study|Graft Abandonment|48|||
13383469|NCT00737672|26753302|FG001|Overall Study|Graft Abandonment|56|||
13383470|NCT00737672|26753301|FG000|Overall Study|Death|23|||
13383471|NCT00737672|26753302|FG001|Overall Study|Death|22|||
13383472|NCT00737672|26753301|FG000|Overall Study|Withdrawal by Subject|1|||
13383473|NCT00737672|26753302|FG001|Overall Study|Withdrawal by Subject|2|||
13383474|NCT00737672|26753301|FG000|Overall Study|Lost to Follow-up|1|||
13383475|NCT00737672|26753302|FG001|Overall Study|Lost to Follow-up|0|||
13383476|NCT00737672|26753301|FG000|Overall Study|Miscellaneous|7|||
13383477|NCT00737672|26753302|FG001|Overall Study|Miscellaneous|1|||
13383478|NCT00737672|26753301|FG000|Overall Study|Physician Decision|0|||
13383479|NCT00737672|26753302|FG001|Overall Study|Physician Decision|2|||
13383480|NCT00737633|26753317|FG000|Overall Study|Study terminated by sponsor|44|||
13383481|NCT00737633|26753318|FG001|Overall Study|Study terminated by sponsor|55|||
13383482|NCT00737633|26753317|FG000|Overall Study|Lost to Follow-up|0|||
13383483|NCT00737633|26753318|FG001|Overall Study|Lost to Follow-up|1|||
13383484|NCT00737633|26753317|FG000|Overall Study|protocol non-compliance|0|||
13383485|NCT00737633|26753318|FG001|Overall Study|protocol non-compliance|1|||
13383486|NCT00737568|26753355|FG000|Treatment Period Through Week 240|Investigator's Discretion|6|||
13383487|NCT00737568|26753356|FG001|Treatment Period Through Week 240|Investigator's Discretion|5|||
13383488|NCT00737568|26753355|FG000|Treatment Period Through Week 240|Withdrew Consent|5|||
13383489|NCT00737568|26753356|FG001|Treatment Period Through Week 240|Withdrew Consent|6|||
13383490|NCT00737568|26753355|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3|||
13383491|NCT00737568|26753356|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4|||
13383492|NCT00737568|26753355|FG000|Treatment Period Through Week 240|Lost to Follow-up|3|||
13383493|NCT00737568|26753356|FG001|Treatment Period Through Week 240|Lost to Follow-up|3|||
13383494|NCT00737568|26753355|FG000|Treatment Period Through Week 240|Protocol Violation|2|||
13383495|NCT00737568|26753356|FG001|Treatment Period Through Week 240|Protocol Violation|3|||
13383496|NCT00737568|26753355|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1|||
13383497|NCT00737568|26753356|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0|||
13383498|NCT00737568|26753355|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25|||
13383499|NCT00737568|26753356|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17|||
13383500|NCT00737568|26753355|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0|||
13383501|NCT00737568|26753356|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1|||
13383502|NCT00737568|26753355|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1|||
13383503|NCT00737568|26753356|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0|||
13383504|NCT00737529|26753372|FG000|Overall Study|Disease Progression|95|||
13383505|NCT00737529|26753372|FG000|Overall Study|Adverse Event|24|||
13383506|NCT00737529|26753372|FG000|Overall Study|Withdrawal by Subject|5|||
13383507|NCT00737529|26753372|FG000|Overall Study|Death|4|||
13383508|NCT00737529|26753372|FG000|Overall Study|Protocol Violation|1|||
13383509|NCT00737529|26753372|FG000|Overall Study|Other|4|||
13383510|NCT00737477|26753390|FG000|Overall Study|Adverse Event|9|||
13383511|NCT00737477|26753390|FG000|Overall Study|Death|9|||
13383512|NCT00737477|26753390|FG000|Overall Study|Treatment Refusal|1|||
13383513|NCT00737477|26753390|FG000|Overall Study|Withdrawal by Subject|1|||
13383514|NCT00737477|26753390|FG000|Overall Study|Renal Transplantation|10|||
13383515|NCT00737477|26753390|FG000|Overall Study|Other|4|||
13383516|NCT00737464|26753413|FG000|Overall Study|Adverse Event|1|||
13383517|NCT00737464|26753413|FG000|Overall Study|Death|6|||
13383518|NCT00737464|26753413|FG000|Overall Study|Other - Failure to Return|1|||
13383519|NCT00737464|26753413|FG000|Overall Study|Refused Treatment / Withdrew Consent|6|||
13383520|NCT00737464|26753413|FG000|Overall Study|Other reasons|4|||
13383521|NCT00737438|26753419|FG000|Overall Study|Withdrawal by Subject|2|||
13383522|NCT00737438|26753419|FG000|Overall Study|Patient ineligible|1|||
13383523|NCT00737282|26753431|FG000|Overall Study|Study prematurely terminated|175|||
13383524|NCT00737100|26753485|FG000|Overall Study|Adverse Event|6|||
13383525|NCT00737100|26753486|FG001|Overall Study|Adverse Event|5|||
13383526|NCT00737100|26753487|FG002|Overall Study|Adverse Event|3|||
13383527|NCT00737100|26753485|FG000|Overall Study|Lost to Follow-up|0|||
13383528|NCT00737100|26753486|FG001|Overall Study|Lost to Follow-up|1|||
13383529|NCT00737100|26753487|FG002|Overall Study|Lost to Follow-up|0|||
13383530|NCT00737100|26753485|FG000|Overall Study|Withdrawal by Subject|0|||
13383531|NCT00737100|26753486|FG001|Overall Study|Withdrawal by Subject|0|||
13383532|NCT00737100|26753487|FG002|Overall Study|Withdrawal by Subject|3|||
13383533|NCT00737100|26753485|FG000|Overall Study|Reason discontinued not explained above|1|||
13383534|NCT00737100|26753486|FG001|Overall Study|Reason discontinued not explained above|1|||
13383535|NCT00737100|26753487|FG002|Overall Study|Reason discontinued not explained above|1|||
13383536|NCT00737061|26753503|FG000|Waiting Period|Lost to Follow-up|6|||
13383537|NCT00737061|26753503|FG000|Waiting Period|Withdrawal by Subject|1|||
13383538|NCT00737061|26753503|FG000|Waiting Period|Bilateral placement failure|34|||
13383539|NCT00737061|26753503|FG000|Waiting Period|Deemed patent following HSG|26|||
13383540|NCT00737061|26753503|FG000|Waiting Period|Alternative contraception failure|3|||
13383541|NCT00737061|26753503|FG000|Waiting Period|Elected surgical tubal ligation|5|||
13383542|NCT00737061|26753503|FG000|1 Year Wearing Period|Lost to Follow-up|11|||
13383543|NCT00737061|26753503|FG000|1 Year Wearing Period|Withdrawal by Subject|2|||
13383544|NCT00737061|26753503|FG000|1 Year Wearing Period|Discontinued reilance|3|||
13383545|NCT00737061|26753503|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1|||
13383546|NCT00737048|26753554|FG000|Overall Study|Physician Decision|0|||
13383547|NCT00737048|26753555|FG001|Overall Study|Physician Decision|0|||
13383548|NCT00737048|26753556|FG002|Overall Study|Physician Decision|1|||
13383549|NCT00737048|26753554|FG000|Overall Study|Adverse Event|0|||
13383550|NCT00737048|26753555|FG001|Overall Study|Adverse Event|1|||
13383551|NCT00737048|26753556|FG002|Overall Study|Adverse Event|0|||
13383552|NCT00737048|26753554|FG000|Overall Study|Worsening of the symptoms|3|||
13383553|NCT00737048|26753555|FG001|Overall Study|Worsening of the symptoms|5|||
13383554|NCT00737048|26753556|FG002|Overall Study|Worsening of the symptoms|3|||
13383555|NCT00736996|26753580|FG000|Overall Study|Lost to Follow-up|1|||
13383556|NCT00736996|26753581|FG001|Overall Study|Lost to Follow-up|9|||
13383557|NCT00736996|26753582|FG002|Overall Study|Lost to Follow-up|2|||
13383558|NCT00736957|26753594|FG000|Overall Study|Adverse Event|43|||
13383559|NCT00736957|26753594|FG000|Overall Study|Withdrawal by Subject|49|||
13383560|NCT00736957|26753594|FG000|Overall Study|violation of eligibility criteria|2|||
13383561|NCT00736957|26753594|FG000|Overall Study|did not attend hospital appointments|1|||
13383562|NCT00736957|26753594|FG000|Overall Study|not eligible for Treatment Period I|22|||
13383563|NCT00736957|26753594|FG000|Overall Study|Physician Decision|5|||
13383564|NCT00736944|26753626|FG000|Induction|Death|1|||
13383565|NCT00736944|26753626|FG000|Definitive Treatment|Physician Decision|1|||
13383566|NCT00736879|26753693|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
13383567|NCT00736879|26753694|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
13383568|NCT00736879|26753695|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
13383569|NCT00736879|26753696|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
13383570|NCT00736879|26753693|FG000|Double Blind Treatment Period|Adverse Event|0|||
13383571|NCT00736879|26753694|FG001|Double Blind Treatment Period|Adverse Event|1|||
13383572|NCT00736879|26753695|FG002|Double Blind Treatment Period|Adverse Event|1|||
13383573|NCT00736879|26753696|FG003|Double Blind Treatment Period|Adverse Event|0|||
13383574|NCT00736879|26753693|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
13383575|NCT00736879|26753694|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
13383576|NCT00736879|26753695|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
13383577|NCT00736879|26753696|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
13383578|NCT00736879|26753693|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
13383579|NCT00736879|26753694|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
13383580|NCT00736879|26753695|FG002|Double Blind Treatment Period|Lost to Follow-up|2|||
13383581|NCT00736879|26753696|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
13383582|NCT00736879|26753693|FG000|Double Blind Treatment Period|Poor non-compliance|0|||
13383583|NCT00736879|26753694|FG001|Double Blind Treatment Period|Poor non-compliance|0|||
13383584|NCT00736879|26753695|FG002|Double Blind Treatment Period|Poor non-compliance|1|||
13383585|NCT00736879|26753696|FG003|Double Blind Treatment Period|Poor non-compliance|1|||
13383586|NCT00736879|26753693|FG000|Double Blind Treatment Period|No longer met criteria|0|||
13383587|NCT00736879|26753694|FG001|Double Blind Treatment Period|No longer met criteria|1|||
13383588|NCT00736879|26753695|FG002|Double Blind Treatment Period|No longer met criteria|0|||
13383589|NCT00736879|26753696|FG003|Double Blind Treatment Period|No longer met criteria|0|||
13383590|NCT00736879|26753693|FG000|Double Blind Treatment Period|non-specified|0|||
13383591|NCT00736879|26753694|FG001|Double Blind Treatment Period|non-specified|1|||
13383592|NCT00736879|26753695|FG002|Double Blind Treatment Period|non-specified|0|||
13383593|NCT00736879|26753696|FG003|Double Blind Treatment Period|non-specified|0|||
13383594|NCT00736879|26753693|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
13383595|NCT00736879|26753694|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1|||
13383596|NCT00736879|26753695|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
13383597|NCT00736879|26753696|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
13383598|NCT00736879|26753693|FG000|Follow up Period - No Drug Treatment|non-specified|1|||
13383599|NCT00736879|26753694|FG001|Follow up Period - No Drug Treatment|non-specified|2|||
13383600|NCT00736879|26753695|FG002|Follow up Period - No Drug Treatment|non-specified|0|||
13383601|NCT00736879|26753696|FG003|Follow up Period - No Drug Treatment|non-specified|0|||
13383602|NCT00736853|26753740|FG000|Open-Label Period|Physician Decision|2|||
13383603|NCT00736853|26753741|FG001|Open-Label Period|Physician Decision|0|||
13383604|NCT00736853|26753742|FG002|Open-Label Period|Physician Decision|0|||
13383605|NCT00736853|26753740|FG000|Open-Label Period|Adverse Event|31|||
13383606|NCT00736853|26753741|FG001|Open-Label Period|Adverse Event|0|||
13383607|NCT00736853|26753742|FG002|Open-Label Period|Adverse Event|0|||
13383608|NCT00736853|26753740|FG000|Open-Label Period|Withdrawal by Subject|16|||
13383609|NCT00736853|26753741|FG001|Open-Label Period|Withdrawal by Subject|0|||
13383610|NCT00736853|26753742|FG002|Open-Label Period|Withdrawal by Subject|0|||
13383611|NCT00736853|26753740|FG000|Open-Label Period|Started but not treated|42|||
13383612|NCT00736853|26753741|FG001|Open-Label Period|Started but not treated|0|||
13383613|NCT00736853|26753742|FG002|Open-Label Period|Started but not treated|0|||
13383614|NCT00736853|26753740|FG000|Open-Label Period|Failed to meet the transfer criteria|40|||
13383615|NCT00736853|26753741|FG001|Open-Label Period|Failed to meet the transfer criteria|0|||
13383616|NCT00736853|26753742|FG002|Open-Label Period|Failed to meet the transfer criteria|0|||
13383617|NCT00736853|26753740|FG000|Open-Label Period|Unable to attend hospital appointments|1|||
13383618|NCT00736853|26753741|FG001|Open-Label Period|Unable to attend hospital appointments|0|||
13383619|NCT00736853|26753742|FG002|Open-Label Period|Unable to attend hospital appointments|0|||
13383620|NCT00736853|26753740|FG000|Double-Blind Period|Lack of Efficacy|0|||
13383621|NCT00736853|26753741|FG001|Double-Blind Period|Lack of Efficacy|19|||
13383622|NCT00736853|26753742|FG002|Double-Blind Period|Lack of Efficacy|42|||
13383623|NCT00736853|26753740|FG000|Double-Blind Period|Adverse Event|0|||
13383624|NCT00736853|26753741|FG001|Double-Blind Period|Adverse Event|3|||
13383625|NCT00736853|26753742|FG002|Double-Blind Period|Adverse Event|2|||
13383626|NCT00736853|26753740|FG000|Double-Blind Period|Withdrawal by Subject|0|||
13383627|NCT00736853|26753741|FG001|Double-Blind Period|Withdrawal by Subject|1|||
13383628|NCT00736853|26753742|FG002|Double-Blind Period|Withdrawal by Subject|4|||
13383629|NCT00736853|26753740|FG000|Double-Blind Period|Ineligible to participate the study|0|||
13383630|NCT00736853|26753741|FG001|Double-Blind Period|Ineligible to participate the study|1|||
13383631|NCT00736853|26753742|FG002|Double-Blind Period|Ineligible to participate the study|0|||
13383632|NCT00736723|26753755|FG000|Overall Study|Withdrawal by Subject|4|||
13383633|NCT00736723|26753756|FG001|Overall Study|Withdrawal by Subject|3|||
13383634|NCT00736645|26753783|FG000|Overall Study|Adverse Event|0|||
13383635|NCT00736645|26753784|FG001|Overall Study|Adverse Event|2|||
13383636|NCT00736645|26753785|FG002|Overall Study|Adverse Event|0|||
13383637|NCT00736645|26753786|FG003|Overall Study|Adverse Event|0|||
13383638|NCT00736502|26753794|FG000|Overall Study|Adverse Event|22|||
13383639|NCT00736502|26753794|FG000|Overall Study|Lack of Efficacy|16|||
13383640|NCT00736502|26753794|FG000|Overall Study|Lost to Follow-up|27|||
13383641|NCT00736489|26753953|FG000|Period 1|Lost to Follow-up|1|||
13383642|NCT00736489|26753954|FG001|Period 1|Lost to Follow-up|0|||
13383643|NCT00736489|26753955|FG002|Period 1|Lost to Follow-up|0|||
13383644|NCT00736489|26753956|FG003|Period 1|Lost to Follow-up|0|||
13383645|NCT00736489|26753957|FG004|Period 1|Lost to Follow-up|0|||
13383646|NCT00736489|26753958|FG005|Period 1|Lost to Follow-up|0|||
13383647|NCT00736489|26753953|FG000|Period 1|Withdrawal by Subject|0|||
13383648|NCT00736489|26753954|FG001|Period 1|Withdrawal by Subject|0|||
13383649|NCT00736489|26753955|FG002|Period 1|Withdrawal by Subject|0|||
13383650|NCT00736489|26753956|FG003|Period 1|Withdrawal by Subject|0|||
13383651|NCT00736489|26753957|FG004|Period 1|Withdrawal by Subject|0|||
13383652|NCT00736489|26753958|FG005|Period 1|Withdrawal by Subject|1|||
13383653|NCT00736476|26753985|FG000|Overall Study|Adverse Event|1|||
13383654|NCT00736476|26753986|FG001|Overall Study|Adverse Event|0|||
13383655|NCT00736450|26753994|FG000|Overall Study|Not ABC gene eligible|19|||
13383656|NCT00736450|26753994|FG000|Overall Study|Withdrawal by Subject|5|||
13383657|NCT00736450|26753994|FG000|Overall Study|Physician Decision|1|||
13383658|NCT00736385|26754013|FG000|Overall Study|Withdrawal by Subject|2|||
13383659|NCT00736385|26754014|FG001|Overall Study|Withdrawal by Subject|2|||
13383660|NCT00736385|26754013|FG000|Overall Study|Adverse Event|0|||
13383661|NCT00736385|26754014|FG001|Overall Study|Adverse Event|1|||
13383662|NCT00736333|26754025|FG000|Overall Study|Did Not Receive Drug or Not Documented|7|||
13383663|NCT00736333|26754025|FG000|Overall Study|Data Missing|2|||
13383664|NCT00736333|26754025|FG000|Overall Study|Tumor Progression|75|||
13383665|NCT00736333|26754025|FG000|Overall Study|Toxicity|6|||
13383666|NCT00736333|26754025|FG000|Overall Study|Withdrawal by Subject|10|||
13383667|NCT00736333|26754025|FG000|Overall Study|Death|7|||
13383668|NCT00736333|26754025|FG000|Overall Study|Other|4|||
13383669|NCT00736255|26754050|FG000|Overall Study|Adverse Event|1|||
13383670|NCT00736255|26754051|FG001|Overall Study|Adverse Event|0|||
13383671|NCT00736255|26754050|FG000|Overall Study|Physician Decision|1|||
13383672|NCT00736255|26754051|FG001|Overall Study|Physician Decision|0|||
13383673|NCT00736255|26754050|FG000|Overall Study|Non-compliance|1|||
13383674|NCT00736255|26754051|FG001|Overall Study|Non-compliance|1|||
13383675|NCT00736190|26754066|FG000|Overall Study|Pregnancy|1|||
13383676|NCT00736190|26754066|FG000|Overall Study|Withdrawal by Subject|1|||
13383677|NCT00736190|26754066|FG000|Overall Study|Adverse Event|1|||
13383678|NCT00736099|26754169|FG000|Overall Study|Adverse Event|61|||
13383679|NCT00736099|26754170|FG001|Overall Study|Adverse Event|18|||
13383680|NCT00736099|26754169|FG000|Overall Study|Protocol Violation|10|||
13383681|NCT00736099|26754170|FG001|Overall Study|Protocol Violation|4|||
13383682|NCT00736099|26754169|FG000|Overall Study|Lost to Follow-up|12|||
13383683|NCT00736099|26754170|FG001|Overall Study|Lost to Follow-up|5|||
13383684|NCT00736099|26754169|FG000|Overall Study|Withdrawal by Subject|42|||
13383685|NCT00736099|26754170|FG001|Overall Study|Withdrawal by Subject|13|||
13383686|NCT00736099|26754169|FG000|Overall Study|Lack of Efficacy|15|||
13383687|NCT00736099|26754170|FG001|Overall Study|Lack of Efficacy|8|||
13383688|NCT00736099|26754169|FG000|Overall Study|Other reason|43|||
13383689|NCT00736099|26754170|FG001|Overall Study|Other reason|10|||
13383690|NCT00736034|26754176|FG000|Overall Study|Adverse Event|2|||
13383691|NCT00735943|26754195|FG000|Overall Study|Lost to Follow-up|1|||
13383692|NCT00735943|26754195|FG000|Overall Study|Adverse Event|1|||
13383693|NCT00735904|26754204|FG000|Overall Study|Adverse Event|3|||
13383694|NCT00735904|26754204|FG000|Overall Study|Death|20|||
13383695|NCT00735904|26754204|FG000|Overall Study|Protocol Violation|1|||
13383696|NCT00735904|26754204|FG000|Overall Study|Withdrawal by Subject|1|||
13383697|NCT00735904|26754204|FG000|Overall Study|Study Terminated by Sponsor|5|||
13383698|NCT00735904|26754204|FG000|Overall Study|Other|8|||
13383699|NCT00735878|26754225|FG000|Phase I- Dose Determination|Withdrawal by Subject|0|||
13383700|NCT00735878|26754226|FG001|Phase I- Dose Determination|Withdrawal by Subject|0|||
13383701|NCT00735878|26754227|FG002|Phase I- Dose Determination|Withdrawal by Subject|1|||
13383702|NCT00735709|26754350|FG000|Overall Study|Adverse Event|2|||
13383703|NCT00735709|26754351|FG001|Overall Study|Adverse Event|3|||
13383704|NCT00735709|26754352|FG002|Overall Study|Adverse Event|1|||
13383705|NCT00735709|26754353|FG003|Overall Study|Adverse Event|5|||
13383706|NCT00735709|26754350|FG000|Overall Study|Lack of Efficacy|8|||
13383707|NCT00735709|26754351|FG001|Overall Study|Lack of Efficacy|4|||
13383708|NCT00735709|26754352|FG002|Overall Study|Lack of Efficacy|2|||
13383709|NCT00735709|26754353|FG003|Overall Study|Lack of Efficacy|3|||
13383710|NCT00735709|26754350|FG000|Overall Study|Noncompliance|0|||
13383711|NCT00735709|26754351|FG001|Overall Study|Noncompliance|0|||
13383712|NCT00735709|26754352|FG002|Overall Study|Noncompliance|1|||
13383713|NCT00735709|26754353|FG003|Overall Study|Noncompliance|0|||
13383714|NCT00735709|26754350|FG000|Overall Study|Protocol deviations|1|||
13383715|NCT00735709|26754351|FG001|Overall Study|Protocol deviations|2|||
13383716|NCT00735709|26754352|FG002|Overall Study|Protocol deviations|1|||
13383717|NCT00735709|26754353|FG003|Overall Study|Protocol deviations|1|||
13383718|NCT00735709|26754350|FG000|Overall Study|Voluntary Withdrawal|1|||
13383719|NCT00735709|26754351|FG001|Overall Study|Voluntary Withdrawal|3|||
13383720|NCT00735709|26754352|FG002|Overall Study|Voluntary Withdrawal|5|||
13383721|NCT00735709|26754353|FG003|Overall Study|Voluntary Withdrawal|7|||
13383722|NCT00735709|26754350|FG000|Overall Study|Lost to Follow-up|0|||
13383723|NCT00735709|26754351|FG001|Overall Study|Lost to Follow-up|1|||
13383724|NCT00735709|26754352|FG002|Overall Study|Lost to Follow-up|1|||
13383725|NCT00735709|26754353|FG003|Overall Study|Lost to Follow-up|1|||
13383726|NCT00735709|26754350|FG000|Overall Study|Excluded medication|1|||
13383727|NCT00735709|26754351|FG001|Overall Study|Excluded medication|0|||
13383728|NCT00735709|26754352|FG002|Overall Study|Excluded medication|0|||
13383729|NCT00735709|26754353|FG003|Overall Study|Excluded medication|1|||
13383730|NCT00735696|26754367|FG000|Overall Study|Withdrawal by Subject|1|||
13383731|NCT00735696|26754367|FG000|Overall Study|Enrolled but never Treated|1|||
13383732|NCT00735644|26754420|FG000|Overall Study|Did not receive study vaccine|0|||
13383733|NCT00735644|26754421|FG001|Overall Study|Did not receive study vaccine|1|||
13383734|NCT00735644|26754422|FG002|Overall Study|Did not receive study vaccine|0|||
13383735|NCT00735644|26754423|FG003|Overall Study|Did not receive study vaccine|0|||
13383736|NCT00735644|26754424|FG004|Overall Study|Did not receive study vaccine|0|||
13383737|NCT00735644|26754420|FG000|Overall Study|Withdrawal by Subject|0|||
13383738|NCT00735644|26754421|FG001|Overall Study|Withdrawal by Subject|1|||
13383739|NCT00735644|26754422|FG002|Overall Study|Withdrawal by Subject|1|||
13383740|NCT00735644|26754423|FG003|Overall Study|Withdrawal by Subject|1|||
13383741|NCT00735644|26754424|FG004|Overall Study|Withdrawal by Subject|0|||
13383742|NCT00735553|26754440|FG000|Overall Study|Study prematurely terminated|77|||
13383743|NCT00735475|26754465|FG000|Overall Study|Adverse Event|0|||
13383744|NCT00735475|26754466|FG001|Overall Study|Adverse Event|1|||
13383745|NCT00735475|26754465|FG000|Overall Study|Death|1|||
13383746|NCT00735475|26754466|FG001|Overall Study|Death|1|||
13383747|NCT00735475|26754465|FG000|Overall Study|Lost to Follow-up|3|||
13383748|NCT00735475|26754466|FG001|Overall Study|Lost to Follow-up|3|||
13383749|NCT00735475|26754465|FG000|Overall Study|Physician Decision|0|||
13383750|NCT00735475|26754466|FG001|Overall Study|Physician Decision|1|||
13383751|NCT00735475|26754465|FG000|Overall Study|Withdrawal by Subject|4|||
13383752|NCT00735475|26754466|FG001|Overall Study|Withdrawal by Subject|5|||
13383753|NCT00735397|26754478|FG000|Overall Study|Adverse Event|194|||
13383754|NCT00735397|26754478|FG000|Overall Study|Lost to Follow-up|33|||
13383755|NCT00735397|26754478|FG000|Overall Study|Participant choice|252|||
13383756|NCT00735397|26754478|FG000|Overall Study|Inadequate therapeutic effect|202|||
13383757|NCT00735397|26754478|FG000|Overall Study|Administrative/Other|502|||
13383758|NCT00735371|26754509|FG000|Overall Study|Adverse Event|3|||
13383759|NCT00735371|26754510|FG001|Overall Study|Adverse Event|3|||
13383760|NCT00735371|26754511|FG002|Overall Study|Adverse Event|4|||
13383761|NCT00735371|26754512|FG003|Overall Study|Adverse Event|1|||
13383762|NCT00735371|26754509|FG000|Overall Study|Protocol Violation|2|||
13383763|NCT00735371|26754510|FG001|Overall Study|Protocol Violation|2|||
13383764|NCT00735371|26754511|FG002|Overall Study|Protocol Violation|0|||
13383765|NCT00735371|26754512|FG003|Overall Study|Protocol Violation|3|||
13383766|NCT00735371|26754509|FG000|Overall Study|Withdrawal by Subject|0|||
13383767|NCT00735371|26754510|FG001|Overall Study|Withdrawal by Subject|2|||
13383768|NCT00735371|26754511|FG002|Overall Study|Withdrawal by Subject|2|||
13383769|NCT00735371|26754512|FG003|Overall Study|Withdrawal by Subject|0|||
13383770|NCT00735371|26754509|FG000|Overall Study|Lost to Follow-up|1|||
13383771|NCT00735371|26754510|FG001|Overall Study|Lost to Follow-up|1|||
13383772|NCT00735371|26754511|FG002|Overall Study|Lost to Follow-up|3|||
13383773|NCT00735371|26754512|FG003|Overall Study|Lost to Follow-up|1|||
13383774|NCT00735371|26754509|FG000|Overall Study|Lack of Efficacy|4|||
13383775|NCT00735371|26754510|FG001|Overall Study|Lack of Efficacy|2|||
13383776|NCT00735371|26754511|FG002|Overall Study|Lack of Efficacy|0|||
13383777|NCT00735371|26754512|FG003|Overall Study|Lack of Efficacy|4|||
13383778|NCT00735371|26754509|FG000|Overall Study|Sponsor Decision|3|||
13383779|NCT00735371|26754510|FG001|Overall Study|Sponsor Decision|1|||
13383780|NCT00735371|26754511|FG002|Overall Study|Sponsor Decision|0|||
13383781|NCT00735371|26754512|FG003|Overall Study|Sponsor Decision|1|||
13383782|NCT00735371|26754509|FG000|Overall Study|Protocol Violation|0|||
13383783|NCT00735371|26754510|FG001|Overall Study|Protocol Violation|1|||
13383784|NCT00735371|26754511|FG002|Overall Study|Protocol Violation|2|||
13383785|NCT00735371|26754512|FG003|Overall Study|Protocol Violation|0|||
13383786|NCT00735371|26754509|FG000|Overall Study|Prior Vyvanse Exposure|1|||
13383787|NCT00735371|26754510|FG001|Overall Study|Prior Vyvanse Exposure|1|||
13383788|NCT00735371|26754511|FG002|Overall Study|Prior Vyvanse Exposure|0|||
13383789|NCT00735371|26754512|FG003|Overall Study|Prior Vyvanse Exposure|0|||
13383790|NCT00735371|26754509|FG000|Overall Study|Exclusion criteria|1|||
13383791|NCT00735371|26754510|FG001|Overall Study|Exclusion criteria|0|||
13383792|NCT00735371|26754511|FG002|Overall Study|Exclusion criteria|0|||
13383793|NCT00735371|26754512|FG003|Overall Study|Exclusion criteria|0|||
13383794|NCT00735254|26754535|FG000|Overall Study|Protocol Violation|1|||
13383795|NCT00735254|26754536|FG001|Overall Study|Protocol Violation|1|||
13383796|NCT00735254|26754537|FG002|Overall Study|Protocol Violation|1|||
13383797|NCT00735254|26754538|FG003|Overall Study|Protocol Violation|0|||
13383798|NCT00735072|26754559|FG000|Overall Study|interrupted study med during ARV change|1|||
13383799|NCT00735072|26754560|FG001|Overall Study|interrupted study med during ARV change|0|||
13383800|NCT00735072|26754559|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0|||
13383801|NCT00735072|26754560|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1|||
13383802|NCT00735007|26754587|FG000|Overall Study|Adverse Event|4|||
13383803|NCT00735007|26754587|FG000|Overall Study|Protocol Violation|1|||
13383804|NCT00734994|26754594|FG000|Overall Study|Withdrawal by Subject|1|||
13383805|NCT00734929|26754629|FG000|Overall Study|Lost to Follow-up|1|||
13383806|NCT00734929|26754630|FG001|Overall Study|Lost to Follow-up|2|||
13383807|NCT00734929|26754629|FG000|Overall Study|No intervention/ screen fail|5|||
13383808|NCT00734929|26754630|FG001|Overall Study|No intervention/ screen fail|3|||
13383809|NCT00734851|26754642|FG000|Overall Study|Withdrawal by Subject|2|||
13383810|NCT00734851|26754642|FG000|Overall Study|Lost to Follow-up|1|||
13383811|NCT00734851|26754642|FG000|Overall Study|Physician Decision|18|||
13383812|NCT00734747|26754651|FG000|SRS Procedure|No staples placed|3|||
13383813|NCT00734747|26754651|FG000|6 Month Follow-up|Did not meet inclusion criteria|3|||
13383814|NCT00734656|26754678|FG000|Lab Session 1|Withdrawal by Subject|2|||
13383815|NCT00734656|26754679|FG001|Lab Session 1|Withdrawal by Subject|0|||
13383816|NCT00734656|26754680|FG002|Lab Session 1|Withdrawal by Subject|0|||
13383817|NCT00734656|26754681|FG003|Lab Session 1|Withdrawal by Subject|0|||
13383818|NCT00734656|26754678|FG000|Washout 1|Withdrawal by Subject|1|||
13383819|NCT00734656|26754679|FG001|Washout 1|Withdrawal by Subject|5|||
13383820|NCT00734656|26754680|FG002|Washout 1|Withdrawal by Subject|2|||
13383821|NCT00734656|26754681|FG003|Washout 1|Withdrawal by Subject|3|||
13383822|NCT00734656|26754678|FG000|Lab Session 2|Withdrawal by Subject|1|||
13383823|NCT00734656|26754679|FG001|Lab Session 2|Withdrawal by Subject|0|||
13383824|NCT00734656|26754680|FG002|Lab Session 2|Withdrawal by Subject|0|||
13383825|NCT00734656|26754681|FG003|Lab Session 2|Withdrawal by Subject|1|||
13383826|NCT00734656|26754678|FG000|Washout 2|Withdrawal by Subject|1|||
13383827|NCT00734656|26754679|FG001|Washout 2|Withdrawal by Subject|1|||
13383828|NCT00734656|26754680|FG002|Washout 2|Withdrawal by Subject|1|||
13383829|NCT00734656|26754681|FG003|Washout 2|Withdrawal by Subject|0|||
13383830|NCT00734656|26754678|FG000|Washout 3|Withdrawal by Subject|1|||
13383831|NCT00734656|26754679|FG001|Washout 3|Withdrawal by Subject|0|||
13383832|NCT00734656|26754680|FG002|Washout 3|Withdrawal by Subject|0|||
13383833|NCT00734656|26754681|FG003|Washout 3|Withdrawal by Subject|1|||
13383834|NCT00734656|26754678|FG000|Lab Session 4|Withdrawal by Subject|0|||
13383835|NCT00734656|26754679|FG001|Lab Session 4|Withdrawal by Subject|0|||
13383836|NCT00734656|26754680|FG002|Lab Session 4|Withdrawal by Subject|0|||
13383837|NCT00734656|26754681|FG003|Lab Session 4|Withdrawal by Subject|1|||
13383838|NCT00734630|26754696|FG000|Overall Study|Lack of Efficacy|4|||
13394872|NCT00653939|26788248|FG001|Overall Study|Other|6|||
13394873|NCT00653523|26788254|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
13394874|NCT00653523|26788254|FG000|Overall Study|Elevated creatine phosphokinase (2)|1|||
13394875|NCT00653523|26788254|FG000|Overall Study|Adverse Event|7|||
13394876|NCT00653523|26788254|FG000|Overall Study|Withdrawal by Subject|6|||
13394877|NCT00653523|26788254|FG000|Overall Study|Elevated alanine aminotransferase (3)|2|||
13394878|NCT00653523|26788254|FG000|Overall Study|Adverse reaction did not improve (4)|1|||
13394879|NCT00653432|26788285|FG000|Overall Study|Adverse Event|4|||
13394880|NCT00653432|26788286|FG001|Overall Study|Adverse Event|1|||
13394881|NCT00653432|26788285|FG000|Overall Study|Withdrawal by Subject|4|||
13394882|NCT00653432|26788286|FG001|Overall Study|Withdrawal by Subject|5|||
13394883|NCT00653432|26788285|FG000|Overall Study|Lost to Follow-up|7|||
13394884|NCT00653432|26788286|FG001|Overall Study|Lost to Follow-up|6|||
13394885|NCT00653432|26788285|FG000|Overall Study|Use/Need of Con Therapy|2|||
13394886|NCT00653432|26788286|FG001|Overall Study|Use/Need of Con Therapy|1|||
13394887|NCT00653432|26788285|FG000|Overall Study|Other - Reason Not Provided|5|||
13394888|NCT00653432|26788286|FG001|Overall Study|Other - Reason Not Provided|3|||
13394889|NCT00653328|26788295|FG000|Overall Study|Withdrawal by Subject|1|||
13394890|NCT00653328|26788295|FG000|Overall Study|Adverse Event|2|||
13394891|NCT00653328|26788295|FG000|Overall Study|Disease progression|10|||
13394892|NCT00653328|26788295|FG000|Overall Study|Drug manufacturer no longing making drug|2|||
13394893|NCT00653263|26788303|FG000|Overall Study|Withdrawal by Subject|1|||
13394894|NCT00653263|26788303|FG000|Overall Study|Physician Decision|1|||
13394895|NCT00653224|26788494|FG000|Overall Study|Adverse Event|2|||
13394896|NCT00653224|26788495|FG001|Overall Study|Adverse Event|1|||
13394897|NCT00653224|26788494|FG000|Overall Study|Lack of Efficacy|1|||
13394898|NCT00653224|26788495|FG001|Overall Study|Lack of Efficacy|2|||
13394899|NCT00653224|26788494|FG000|Overall Study|Loss of efficacy|1|||
13394900|NCT00653224|26788495|FG001|Overall Study|Loss of efficacy|0|||
13394901|NCT00653224|26788494|FG000|Overall Study|Lost to Follow-up|1|||
13394902|NCT00653224|26788495|FG001|Overall Study|Lost to Follow-up|0|||
13394903|NCT00653224|26788494|FG000|Overall Study|Other|2|||
13394904|NCT00653224|26788495|FG001|Overall Study|Other|4|||
13394905|NCT00653159|26788516|FG000|Overall Study|Adverse Event|4|||
13394906|NCT00653159|26788517|FG001|Overall Study|Adverse Event|1|||
13394907|NCT00653159|26788516|FG000|Overall Study|Lost to Follow-up|1|||
13394908|NCT00653159|26788517|FG001|Overall Study|Lost to Follow-up|2|||
13394909|NCT00653068|26788538|FG000|Overall Study|Death|9|||
13394910|NCT00653068|26788538|FG000|Overall Study|Lack of Efficacy|34|||
13383839|NCT00734630|26754697|FG001|Overall Study|Lack of Efficacy|4|||
13383840|NCT00734630|26754696|FG000|Overall Study|Withdrawal by Subject|7|||
13383841|NCT00734630|26754697|FG001|Overall Study|Withdrawal by Subject|9|||
13383842|NCT00734630|26754696|FG000|Overall Study|Lost to Follow-up|13|||
13383843|NCT00734630|26754697|FG001|Overall Study|Lost to Follow-up|7|||
13383844|NCT00734630|26754696|FG000|Overall Study|Protocol Violation|0|||
13383845|NCT00734630|26754697|FG001|Overall Study|Protocol Violation|3|||
13383846|NCT00734630|26754696|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
13383847|NCT00734630|26754697|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
13383848|NCT00734630|26754696|FG000|Overall Study|Adverse Event|3|||
13383849|NCT00734630|26754697|FG001|Overall Study|Adverse Event|6|||
13383850|NCT00734630|26754696|FG000|Overall Study|Randomized in Error|0|||
13383851|NCT00734630|26754697|FG001|Overall Study|Randomized in Error|1|||
13383852|NCT00734630|26754696|FG000|Overall Study|Tested Positive for Illegal Drug Use|1|||
13383853|NCT00734630|26754697|FG001|Overall Study|Tested Positive for Illegal Drug Use|1|||
13383854|NCT00734630|26754696|FG000|Overall Study|Poor Compliance|1|||
13383855|NCT00734630|26754697|FG001|Overall Study|Poor Compliance|1|||
13383856|NCT00734617|26754710|FG000|Overall Study|Adverse Event|4|||
13383857|NCT00734617|26754711|FG001|Overall Study|Adverse Event|7|||
13383858|NCT00734617|26754710|FG000|Overall Study|Withdrawal by Subject|103|||
13383859|NCT00734617|26754711|FG001|Overall Study|Withdrawal by Subject|95|||
13383860|NCT00734604|26754778|FG000|Overall Study|Adverse Event|0|||
13383861|NCT00734604|26754779|FG001|Overall Study|Adverse Event|2|||
13383862|NCT00734604|26754780|FG002|Overall Study|Adverse Event|0|||
13383863|NCT00734604|26754781|FG003|Overall Study|Adverse Event|2|||
13383864|NCT00734604|26754782|FG004|Overall Study|Adverse Event|1|||
13383865|NCT00734604|26754783|FG005|Overall Study|Adverse Event|1|||
13383866|NCT00734604|26754778|FG000|Overall Study|Serious Adverse Event|1|||
13383867|NCT00734604|26754779|FG001|Overall Study|Serious Adverse Event|0|||
13383868|NCT00734604|26754780|FG002|Overall Study|Serious Adverse Event|1|||
13383869|NCT00734604|26754781|FG003|Overall Study|Serious Adverse Event|2|||
13383870|NCT00734604|26754782|FG004|Overall Study|Serious Adverse Event|0|||
13383871|NCT00734604|26754783|FG005|Overall Study|Serious Adverse Event|1|||
13383872|NCT00734604|26754778|FG000|Overall Study|Lost to Follow-up|1|||
13383873|NCT00734604|26754779|FG001|Overall Study|Lost to Follow-up|2|||
13383874|NCT00734604|26754780|FG002|Overall Study|Lost to Follow-up|2|||
13383875|NCT00734604|26754781|FG003|Overall Study|Lost to Follow-up|4|||
13383876|NCT00734604|26754782|FG004|Overall Study|Lost to Follow-up|2|||
13383877|NCT00734604|26754783|FG005|Overall Study|Lost to Follow-up|3|||
13383878|NCT00734604|26754778|FG000|Overall Study|Physician Decision|0|||
13383879|NCT00734604|26754779|FG001|Overall Study|Physician Decision|1|||
13383880|NCT00734604|26754780|FG002|Overall Study|Physician Decision|1|||
13383881|NCT00734604|26754781|FG003|Overall Study|Physician Decision|0|||
13383882|NCT00734604|26754782|FG004|Overall Study|Physician Decision|0|||
13383883|NCT00734604|26754783|FG005|Overall Study|Physician Decision|0|||
13383884|NCT00734604|26754778|FG000|Overall Study|Protocol Violation|0|||
13383885|NCT00734604|26754779|FG001|Overall Study|Protocol Violation|2|||
13383886|NCT00734604|26754780|FG002|Overall Study|Protocol Violation|0|||
13383887|NCT00734604|26754781|FG003|Overall Study|Protocol Violation|0|||
13383888|NCT00734604|26754782|FG004|Overall Study|Protocol Violation|1|||
13383889|NCT00734604|26754783|FG005|Overall Study|Protocol Violation|0|||
13383890|NCT00734604|26754778|FG000|Overall Study|Sponsor Decision|1|||
13383891|NCT00734604|26754779|FG001|Overall Study|Sponsor Decision|2|||
13383892|NCT00734604|26754780|FG002|Overall Study|Sponsor Decision|1|||
13383893|NCT00734604|26754781|FG003|Overall Study|Sponsor Decision|0|||
13383894|NCT00734604|26754782|FG004|Overall Study|Sponsor Decision|2|||
13383895|NCT00734604|26754783|FG005|Overall Study|Sponsor Decision|0|||
13383896|NCT00734604|26754778|FG000|Overall Study|Withdrawal by Subject|0|||
13383897|NCT00734604|26754779|FG001|Overall Study|Withdrawal by Subject|2|||
13383898|NCT00734604|26754780|FG002|Overall Study|Withdrawal by Subject|0|||
13383899|NCT00734604|26754781|FG003|Overall Study|Withdrawal by Subject|1|||
13383900|NCT00734604|26754782|FG004|Overall Study|Withdrawal by Subject|2|||
13383901|NCT00734604|26754783|FG005|Overall Study|Withdrawal by Subject|1|||
13383902|NCT00734604|26754778|FG000|Overall Study|Lack of Efficacy|0|||
13383903|NCT00734604|26754779|FG001|Overall Study|Lack of Efficacy|1|||
13383904|NCT00734604|26754780|FG002|Overall Study|Lack of Efficacy|1|||
13383905|NCT00734604|26754781|FG003|Overall Study|Lack of Efficacy|0|||
13383906|NCT00734604|26754782|FG004|Overall Study|Lack of Efficacy|0|||
13383907|NCT00734604|26754783|FG005|Overall Study|Lack of Efficacy|0|||
13394911|NCT00653068|26788538|FG000|Overall Study|Physician Decision|4|||
13394912|NCT00653068|26788538|FG000|Overall Study|Withdrawal by Subject|1|||
13394913|NCT00653068|26788538|FG000|Overall Study|Ineligible|2|||
13394914|NCT00652951|26788682|FG000|Booster Phase|Adverse event, non-fatal|0|||
13394915|NCT00652951|26788683|FG001|Booster Phase|Adverse event, non-fatal|1|||
13394916|NCT00652951|26788684|FG002|Booster Phase|Adverse event, non-fatal|0|||
13394917|NCT00652951|26788682|FG000|Booster Phase|Other|1|||
13394918|NCT00652951|26788683|FG001|Booster Phase|Other|0|||
13394919|NCT00652951|26788684|FG002|Booster Phase|Other|0|||
13394920|NCT00652938|26788759|FG000|Overall Study|Adverse Event|1|||
13394921|NCT00652938|26788760|FG001|Overall Study|Adverse Event|0|||
13383908|NCT00734591|26754802|FG000|Screening for Prospective Period|Site did not participate|1604|||
13383909|NCT00734591|26754803|FG001|Screening for Prospective Period|Site did not participate|1488|||
13383910|NCT00734591|26754802|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913|||
13383911|NCT00734591|26754803|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803|||
13383912|NCT00734591|26754802|FG000|Prospective Period|Withdrawal by Subject|11|||
13383913|NCT00734591|26754803|FG001|Prospective Period|Withdrawal by Subject|9|||
13383914|NCT00734591|26754802|FG000|Prospective Period|Lost to Follow-up|37|||
13383915|NCT00734591|26754803|FG001|Prospective Period|Lost to Follow-up|33|||
13383916|NCT00734591|26754802|FG000|Prospective Period|Study Terminated|1|||
13383917|NCT00734591|26754803|FG001|Prospective Period|Study Terminated|0|||
13383918|NCT00734591|26754802|FG000|Prospective Period|Other|2|||
13383919|NCT00734591|26754803|FG001|Prospective Period|Other|2|||
13383920|NCT00734578|26754845|FG000|Overall Study|Adverse Event|4|||
13383921|NCT00734578|26754846|FG001|Overall Study|Adverse Event|6|||
13383922|NCT00734578|26754847|FG002|Overall Study|Adverse Event|1|||
13383923|NCT00734578|26754845|FG000|Overall Study|Protocol Violation|8|||
13383924|NCT00734578|26754846|FG001|Overall Study|Protocol Violation|6|||
13383925|NCT00734578|26754847|FG002|Overall Study|Protocol Violation|3|||
13383926|NCT00734578|26754845|FG000|Overall Study|Withdrawal by Subject|7|||
13383927|NCT00734578|26754846|FG001|Overall Study|Withdrawal by Subject|8|||
13383928|NCT00734578|26754847|FG002|Overall Study|Withdrawal by Subject|11|||
13383929|NCT00734578|26754845|FG000|Overall Study|Lost to Follow-up|9|||
13383930|NCT00734578|26754846|FG001|Overall Study|Lost to Follow-up|3|||
13383931|NCT00734578|26754847|FG002|Overall Study|Lost to Follow-up|5|||
13383932|NCT00734578|26754845|FG000|Overall Study|Lack of Efficacy|3|||
13383933|NCT00734578|26754846|FG001|Overall Study|Lack of Efficacy|2|||
13383934|NCT00734578|26754847|FG002|Overall Study|Lack of Efficacy|5|||
13383935|NCT00734578|26754845|FG000|Overall Study|Randomized in error|1|||
13383936|NCT00734578|26754846|FG001|Overall Study|Randomized in error|0|||
13383937|NCT00734578|26754847|FG002|Overall Study|Randomized in error|0|||
13383938|NCT00734578|26754845|FG000|Overall Study|Exclusion criteria|1|||
13383939|NCT00734578|26754846|FG001|Overall Study|Exclusion criteria|0|||
13383940|NCT00734578|26754847|FG002|Overall Study|Exclusion criteria|0|||
13383941|NCT00734539|26754882|FG000|Main Study|Death|33|||
13383942|NCT00734539|26754883|FG001|Main Study|Death|32|||
13383943|NCT00734539|26754882|FG000|Main Study|Physician Decision|2|||
13383944|NCT00734539|26754883|FG001|Main Study|Physician Decision|0|||
13383945|NCT00734539|26754882|FG000|Main Study|Withdrawal by Subject|1|||
13383946|NCT00734539|26754883|FG001|Main Study|Withdrawal by Subject|3|||
13383947|NCT00734539|26754882|FG000|Main Study|Enrolled in error; ineligible|1|||
13383948|NCT00734539|26754883|FG001|Main Study|Enrolled in error; ineligible|0|||
13383949|NCT00734474|26755078|FG000|Overall Study|Entry Criteria Not Met|0|||
13383950|NCT00734474|26755079|FG001|Overall Study|Entry Criteria Not Met|0|||
13383951|NCT00734474|26755080|FG002|Overall Study|Entry Criteria Not Met|5|||
13383952|NCT00734474|26755081|FG003|Overall Study|Entry Criteria Not Met|0|||
13383953|NCT00734474|26755082|FG004|Overall Study|Entry Criteria Not Met|3|||
13383954|NCT00734474|26755083|FG005|Overall Study|Entry Criteria Not Met|1|||
13383955|NCT00734474|26755084|FG006|Overall Study|Entry Criteria Not Met|0|||
13383956|NCT00734474|26755085|FG007|Overall Study|Entry Criteria Not Met|1|||
13383957|NCT00734474|26755086|FG008|Overall Study|Entry Criteria Not Met|1|||
13383958|NCT00734474|26755078|FG000|Overall Study|Lost to Follow-up|1|||
13383959|NCT00734474|26755079|FG001|Overall Study|Lost to Follow-up|0|||
13383960|NCT00734474|26755080|FG002|Overall Study|Lost to Follow-up|13|||
13383961|NCT00734474|26755081|FG003|Overall Study|Lost to Follow-up|0|||
13383962|NCT00734474|26755082|FG004|Overall Study|Lost to Follow-up|11|||
13383963|NCT00734474|26755083|FG005|Overall Study|Lost to Follow-up|1|||
13383964|NCT00734474|26755084|FG006|Overall Study|Lost to Follow-up|0|||
13383965|NCT00734474|26755085|FG007|Overall Study|Lost to Follow-up|9|||
13383966|NCT00734474|26755086|FG008|Overall Study|Lost to Follow-up|4|||
13383967|NCT00734474|26755078|FG000|Overall Study|Withdrawal by Subject|2|||
13383968|NCT00734474|26755079|FG001|Overall Study|Withdrawal by Subject|1|||
13383969|NCT00734474|26755080|FG002|Overall Study|Withdrawal by Subject|18|||
13383970|NCT00734474|26755081|FG003|Overall Study|Withdrawal by Subject|0|||
13383971|NCT00734474|26755082|FG004|Overall Study|Withdrawal by Subject|24|||
13383972|NCT00734474|26755083|FG005|Overall Study|Withdrawal by Subject|2|||
13383973|NCT00734474|26755084|FG006|Overall Study|Withdrawal by Subject|0|||
13383974|NCT00734474|26755085|FG007|Overall Study|Withdrawal by Subject|36|||
13383975|NCT00734474|26755086|FG008|Overall Study|Withdrawal by Subject|21|||
13383976|NCT00734474|26755078|FG000|Overall Study|Physician Decision|0|||
13383977|NCT00734474|26755079|FG001|Overall Study|Physician Decision|0|||
13383978|NCT00734474|26755080|FG002|Overall Study|Physician Decision|4|||
13383979|NCT00734474|26755081|FG003|Overall Study|Physician Decision|1|||
13383980|NCT00734474|26755082|FG004|Overall Study|Physician Decision|11|||
13383981|NCT00734474|26755083|FG005|Overall Study|Physician Decision|0|||
13383982|NCT00734474|26755084|FG006|Overall Study|Physician Decision|0|||
13383983|NCT00734474|26755085|FG007|Overall Study|Physician Decision|9|||
13383984|NCT00734474|26755086|FG008|Overall Study|Physician Decision|9|||
13383985|NCT00734474|26755078|FG000|Overall Study|Adverse Event|4|||
13383986|NCT00734474|26755079|FG001|Overall Study|Adverse Event|4|||
13383987|NCT00734474|26755080|FG002|Overall Study|Adverse Event|63|||
13383988|NCT00734474|26755081|FG003|Overall Study|Adverse Event|1|||
13383989|NCT00734474|26755082|FG004|Overall Study|Adverse Event|64|||
13383990|NCT00734474|26755083|FG005|Overall Study|Adverse Event|0|||
13383991|NCT00734474|26755084|FG006|Overall Study|Adverse Event|1|||
13383992|NCT00734474|26755085|FG007|Overall Study|Adverse Event|65|||
13383993|NCT00734474|26755086|FG008|Overall Study|Adverse Event|39|||
13383994|NCT00734474|26755078|FG000|Overall Study|Protocol Violation|0|||
13383995|NCT00734474|26755079|FG001|Overall Study|Protocol Violation|0|||
13383996|NCT00734474|26755080|FG002|Overall Study|Protocol Violation|4|||
13383997|NCT00734474|26755081|FG003|Overall Study|Protocol Violation|0|||
13383998|NCT00734474|26755082|FG004|Overall Study|Protocol Violation|3|||
13383999|NCT00734474|26755083|FG005|Overall Study|Protocol Violation|0|||
13384000|NCT00734474|26755084|FG006|Overall Study|Protocol Violation|0|||
13384001|NCT00734474|26755085|FG007|Overall Study|Protocol Violation|3|||
13384002|NCT00734474|26755086|FG008|Overall Study|Protocol Violation|1|||
13384003|NCT00734474|26755078|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8|||
13384004|NCT00734474|26755079|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25|||
13384005|NCT00734474|26755080|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0|||
13384006|NCT00734474|26755081|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8|||
13384007|NCT00734474|26755082|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0|||
13384008|NCT00734474|26755083|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21|||
13384009|NCT00734474|26755084|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23|||
13384010|NCT00734474|26755085|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0|||
13384011|NCT00734474|26755086|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0|||
13384012|NCT00734474|26755078|FG000|Overall Study|Sponsor Decision|0|||
13384013|NCT00734474|26755079|FG001|Overall Study|Sponsor Decision|0|||
13384014|NCT00734474|26755080|FG002|Overall Study|Sponsor Decision|0|||
13384015|NCT00734474|26755081|FG003|Overall Study|Sponsor Decision|0|||
13384016|NCT00734474|26755082|FG004|Overall Study|Sponsor Decision|2|||
13384017|NCT00734474|26755083|FG005|Overall Study|Sponsor Decision|0|||
13384018|NCT00734474|26755084|FG006|Overall Study|Sponsor Decision|0|||
13384019|NCT00734474|26755085|FG007|Overall Study|Sponsor Decision|0|||
13384020|NCT00734474|26755086|FG008|Overall Study|Sponsor Decision|0|||
13384021|NCT00734474|26755078|FG000|Overall Study|Death|0|||
13384022|NCT00734474|26755079|FG001|Overall Study|Death|0|||
13384023|NCT00734474|26755080|FG002|Overall Study|Death|1|||
13384024|NCT00734474|26755081|FG003|Overall Study|Death|0|||
13384025|NCT00734474|26755082|FG004|Overall Study|Death|0|||
13384026|NCT00734474|26755083|FG005|Overall Study|Death|0|||
13384027|NCT00734474|26755084|FG006|Overall Study|Death|0|||
13384028|NCT00734474|26755085|FG007|Overall Study|Death|2|||
13384029|NCT00734474|26755086|FG008|Overall Study|Death|1|||
13384030|NCT00734474|26755078|FG000|Overall Study|Lack of Efficacy|0|||
13384031|NCT00734474|26755079|FG001|Overall Study|Lack of Efficacy|0|||
13384032|NCT00734474|26755080|FG002|Overall Study|Lack of Efficacy|4|||
13384033|NCT00734474|26755081|FG003|Overall Study|Lack of Efficacy|0|||
13384034|NCT00734474|26755082|FG004|Overall Study|Lack of Efficacy|0|||
13384035|NCT00734474|26755083|FG005|Overall Study|Lack of Efficacy|0|||
13384036|NCT00734474|26755084|FG006|Overall Study|Lack of Efficacy|0|||
13384037|NCT00734474|26755085|FG007|Overall Study|Lack of Efficacy|4|||
13384038|NCT00734474|26755086|FG008|Overall Study|Lack of Efficacy|6|||
13384039|NCT00734214|26755099|FG000|Overall Study|Withdrawal by Subject|3|||
13384040|NCT00734214|26755100|FG001|Overall Study|Withdrawal by Subject|4|||
13384041|NCT00734214|26755099|FG000|Overall Study|MD withdrawal|1|||
13384042|NCT00734214|26755100|FG001|Overall Study|MD withdrawal|0|||
13384043|NCT00734162|26755337|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
13384044|NCT00734162|26755338|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1|||
13384045|NCT00734162|26755339|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
13384046|NCT00734162|26755340|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2|||
13384047|NCT00734162|26755337|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
13384048|NCT00734162|26755338|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
13384049|NCT00734162|26755339|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
13384050|NCT00734162|26755340|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2|||
13384051|NCT00734162|26755337|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1|||
13384052|NCT00734162|26755338|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
13384053|NCT00734162|26755339|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
13384054|NCT00734162|26755340|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
13306215|NCT01292928|26525315|FG000|Overall Study|Death|8|||
13306216|NCT01292928|26525315|FG000|Overall Study|Withdrawal by Subject|8|||
13306217|NCT01292928|26525315|FG000|Overall Study|Lost to Follow-up|6|||
13306218|NCT01292928|26525315|FG000|Overall Study|Physician Decision|2|||
13306219|NCT01292876|26525323|FG000|Overall Study|Physician Decision|4|||
13306220|NCT01292837|26525334|FG000|Overall Study|Adverse Event|1|||
13306221|NCT01292837|26525334|FG000|Overall Study|Further treatment determined|1|||
13384055|NCT00734162|26755337|FG000|Open-Label Phase|Withdrew Consent|1|||
13384056|NCT00734162|26755338|FG001|Open-Label Phase|Withdrew Consent|0|||
13384057|NCT00734162|26755339|FG002|Open-Label Phase|Withdrew Consent|1|||
13384058|NCT00734162|26755340|FG003|Open-Label Phase|Withdrew Consent|1|||
13384059|NCT00734162|26755337|FG000|Open-Label Phase|Lost to Follow-up|1|||
13384060|NCT00734162|26755338|FG001|Open-Label Phase|Lost to Follow-up|2|||
13384061|NCT00734162|26755339|FG002|Open-Label Phase|Lost to Follow-up|0|||
13384062|NCT00734162|26755340|FG003|Open-Label Phase|Lost to Follow-up|1|||
13384063|NCT00734162|26755337|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
13384064|NCT00734162|26755338|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
13384065|NCT00734162|26755339|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
13384066|NCT00734162|26755340|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1|||
13384067|NCT00734149|26755349|FG000|Overall Study|Withdrawal by Subject|1|||
13384068|NCT00734097|26755366|FG000|Screening|Protocol Violation|12|||
13384069|NCT00734097|26755366|FG000|Screening|Withdrawal by Subject|5|||
13384070|NCT00734097|26755366|FG000|Screening|Lost to Follow-up|2|||
13384071|NCT00734097|26755366|FG000|Screening|Unconfirmed pregnancy|1|||
13384072|NCT00734097|26755366|FG000|Open Label|Lost to Follow-up|7|||
13384073|NCT00734097|26755366|FG000|Open Label|Withdrawal by Subject|5|||
13384074|NCT00734097|26755366|FG000|Open Label|Protocol Violation|4|||
13384075|NCT00734071|26755427|FG000|Overall Study|Adverse Event|4|||
13384076|NCT00734071|26755428|FG001|Overall Study|Adverse Event|3|||
13384077|NCT00734071|26755427|FG000|Overall Study|Lack of Efficacy|3|||
13384078|NCT00734071|26755428|FG001|Overall Study|Lack of Efficacy|1|||
13384079|NCT00734071|26755427|FG000|Overall Study|Noncompliance|2|||
13384080|NCT00734071|26755428|FG001|Overall Study|Noncompliance|2|||
13384081|NCT00734071|26755427|FG000|Overall Study|Protocol Deviations|3|||
13384082|NCT00734071|26755428|FG001|Overall Study|Protocol Deviations|4|||
13384083|NCT00734071|26755427|FG000|Overall Study|Voluntary Withdrawal|9|||
13384084|NCT00734071|26755428|FG001|Overall Study|Voluntary Withdrawal|7|||
13384085|NCT00734071|26755427|FG000|Overall Study|Lost to Follow-up|16|||
13384086|NCT00734071|26755428|FG001|Overall Study|Lost to Follow-up|8|||
13384087|NCT00734071|26755427|FG000|Overall Study|Other|1|||
13384088|NCT00734071|26755428|FG001|Overall Study|Other|2|||
13384089|NCT00734032|26755459|FG000|Overall Study|Adverse Event|0|||
13384090|NCT00734032|26755460|FG001|Overall Study|Adverse Event|1|||
13384091|NCT00734032|26755461|FG002|Overall Study|Adverse Event|0|||
13384092|NCT00734032|26755462|FG003|Overall Study|Adverse Event|0|||
13384093|NCT00733980|26755511|FG000|Overall Study|Adverse Event|5|||
13384094|NCT00733980|26755512|FG001|Overall Study|Adverse Event|2|||
13384095|NCT00733980|26755511|FG000|Overall Study|Lack of Efficacy|0|||
13384096|NCT00733980|26755512|FG001|Overall Study|Lack of Efficacy|1|||
13384097|NCT00733980|26755511|FG000|Overall Study|Protocol Violation|2|||
13384098|NCT00733980|26755512|FG001|Overall Study|Protocol Violation|1|||
13384099|NCT00733980|26755511|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
13384100|NCT00733980|26755512|FG001|Overall Study|Protocol defined stopping criteria reach|1|||
13384101|NCT00733980|26755511|FG000|Overall Study|Lost to Follow-up|6|||
13384102|NCT00733980|26755512|FG001|Overall Study|Lost to Follow-up|11|||
13384103|NCT00733980|26755511|FG000|Overall Study|Physician Decision|2|||
13384104|NCT00733980|26755512|FG001|Overall Study|Physician Decision|3|||
13384105|NCT00733980|26755511|FG000|Overall Study|Withdrawal by Subject|6|||
13384106|NCT00733980|26755512|FG001|Overall Study|Withdrawal by Subject|2|||
13384107|NCT00733954|26755561|FG000|Overall Study|Lost to Follow-up|5|||
13384108|NCT00733954|26755562|FG001|Overall Study|Lost to Follow-up|2|||
13384109|NCT00733954|26755561|FG000|Overall Study|Protocol Violation|1|||
13384110|NCT00733954|26755562|FG001|Overall Study|Protocol Violation|0|||
13384111|NCT00733954|26755561|FG000|Overall Study|Withdrawal by Subject|2|||
13384112|NCT00733954|26755562|FG001|Overall Study|Withdrawal by Subject|0|||
13384113|NCT00733902|26755693|FG000|Overall Study|Death|0|||
13384114|NCT00733902|26755694|FG001|Overall Study|Death|0|||
13384115|NCT00733902|26755695|FG002|Overall Study|Death|0|||
13384116|NCT00733902|26755696|FG003|Overall Study|Death|1|||
13384117|NCT00733902|26755693|FG000|Overall Study|Adverse Event|3|||
13384118|NCT00733902|26755694|FG001|Overall Study|Adverse Event|4|||
13384119|NCT00733902|26755695|FG002|Overall Study|Adverse Event|7|||
13384120|NCT00733902|26755696|FG003|Overall Study|Adverse Event|11|||
13384121|NCT00733902|26755693|FG000|Overall Study|Lack of Efficacy|56|||
13384122|NCT00733902|26755694|FG001|Overall Study|Lack of Efficacy|21|||
13384123|NCT00733902|26755695|FG002|Overall Study|Lack of Efficacy|34|||
13384124|NCT00733902|26755696|FG003|Overall Study|Lack of Efficacy|23|||
13384125|NCT00733902|26755693|FG000|Overall Study|Protocol Violation|4|||
13384126|NCT00733902|26755694|FG001|Overall Study|Protocol Violation|6|||
13384127|NCT00733902|26755695|FG002|Overall Study|Protocol Violation|3|||
13384128|NCT00733902|26755696|FG003|Overall Study|Protocol Violation|3|||
13384129|NCT00733902|26755693|FG000|Overall Study|Withdrawal by Subject|10|||
13384130|NCT00733902|26755694|FG001|Overall Study|Withdrawal by Subject|5|||
13384131|NCT00733902|26755695|FG002|Overall Study|Withdrawal by Subject|4|||
13384132|NCT00733902|26755696|FG003|Overall Study|Withdrawal by Subject|16|||
13384133|NCT00733902|26755693|FG000|Overall Study|Entered extension study|89|||
13384134|NCT00733902|26755694|FG001|Overall Study|Entered extension study|124|||
13384135|NCT00733902|26755695|FG002|Overall Study|Entered extension study|111|||
13384136|NCT00733902|26755696|FG003|Overall Study|Entered extension study|109|||
13384137|NCT00733902|26755693|FG000|Overall Study|Randomized but not treated|2|||
13384138|NCT00733902|26755694|FG001|Overall Study|Randomized but not treated|2|||
13384139|NCT00733902|26755695|FG002|Overall Study|Randomized but not treated|2|||
13384140|NCT00733902|26755696|FG003|Overall Study|Randomized but not treated|1|||
13384141|NCT00733824|26755731|FG000|Phase I|Withdrawal by Subject|1|||
13384142|NCT00733824|26755732|FG001|Phase I|Withdrawal by Subject|0|||
13384143|NCT00733824|26755733|FG002|Phase I|Withdrawal by Subject|0|||
13384144|NCT00733824|26755734|FG003|Phase I|Withdrawal by Subject|0|||
13384145|NCT00733824|26755735|FG004|Phase I|Withdrawal by Subject|0|||
13384146|NCT00733746|26755745|FG000|Overall Study|Ineligible|5|||
13384147|NCT00733499|26755810|FG000|Pre-operative|Protocol Violation|0|||
13384148|NCT00733499|26755811|FG001|Pre-operative|Protocol Violation|1|||
13384149|NCT00733499|26755810|FG000|3 Months Follow-up|Death|1|||
13384150|NCT00733499|26755811|FG001|3 Months Follow-up|Death|2|||
13384151|NCT00733499|26755810|FG000|6 Months Follow-up|Death|0|||
13384152|NCT00733499|26755811|FG001|6 Months Follow-up|Death|2|||
13384153|NCT00733499|26755810|FG000|6 Months Follow-up|Adverse Event|0|||
13384154|NCT00733499|26755811|FG001|6 Months Follow-up|Adverse Event|1|||
13384155|NCT00733499|26755810|FG000|12 Months Follow-up|Death|2|||
13384156|NCT00733499|26755811|FG001|12 Months Follow-up|Death|1|||
13384157|NCT00733499|26755810|FG000|24 Months Follow-up|Death|0|||
13384158|NCT00733499|26755811|FG001|24 Months Follow-up|Death|1|||
13384159|NCT00733499|26755810|FG000|5 Year Followup|Adverse Event|2|||
13384160|NCT00733499|26755811|FG001|5 Year Followup|Adverse Event|2|||
13384161|NCT00733499|26755810|FG000|5 Year Followup|Non device related AE|0|||
13384162|NCT00733499|26755811|FG001|5 Year Followup|Non device related AE|1|||
13384163|NCT00733499|26755810|FG000|5 Year Followup|Revision of Study Implant|0|||
13384164|NCT00733499|26755811|FG001|5 Year Followup|Revision of Study Implant|1|||
13384165|NCT00733499|26755810|FG000|5 Year Followup|Lost to Follow-up|2|||
13384166|NCT00733499|26755811|FG001|5 Year Followup|Lost to Follow-up|0|||
13384167|NCT00733499|26755810|FG000|5 Year Followup|Death|13|||
13384168|NCT00733499|26755811|FG001|5 Year Followup|Death|19|||
13384169|NCT00733499|26755810|FG000|5 Year Followup|missing, unable to locate|0|||
13384170|NCT00733499|26755811|FG001|5 Year Followup|missing, unable to locate|1|||
13384171|NCT00733499|26755810|FG000|5 Year Followup|Withdrawal by Subject|4|||
13384172|NCT00733499|26755811|FG001|5 Year Followup|Withdrawal by Subject|1|||
13384173|NCT00733499|26755810|FG000|10 Year Followup|Death|9|||
13384174|NCT00733499|26755811|FG001|10 Year Followup|Death|7|||
13384175|NCT00733499|26755810|FG000|10 Year Followup|Adverse Event|3|||
13384176|NCT00733499|26755811|FG001|10 Year Followup|Adverse Event|3|||
13384177|NCT00733499|26755810|FG000|10 Year Followup|Lost to Follow-up|3|||
13384178|NCT00733499|26755811|FG001|10 Year Followup|Lost to Follow-up|2|||
13384179|NCT00733499|26755810|FG000|10 Year Followup|Withdrawal by Subject|5|||
13384180|NCT00733499|26755811|FG001|10 Year Followup|Withdrawal by Subject|5|||
13384181|NCT00733499|26755810|FG000|10 Year Followup|missing, unable to locate|0|||
13384182|NCT00733499|26755811|FG001|10 Year Followup|missing, unable to locate|2|||
13384183|NCT00733421|26755840|FG000|Overall Study|Withdrawal by Subject|1|||
13384184|NCT00733421|26755841|FG001|Overall Study|Withdrawal by Subject|1|||
13384185|NCT00733408|26755853|FG000|Overall Study|Adverse Event|4|||
13384186|NCT00733369|26755976|FG000|Overall Study|Lost to Follow-up|2|||
13384187|NCT00733369|26755977|FG001|Overall Study|Lost to Follow-up|1|||
13384188|NCT00733369|26755976|FG000|Overall Study|Adverse Event|4|||
13384189|NCT00733369|26755977|FG001|Overall Study|Adverse Event|4|||
13384190|NCT00733369|26755976|FG000|Overall Study|Protocol Violation|4|||
13384191|NCT00733369|26755977|FG001|Overall Study|Protocol Violation|4|||
13384192|NCT00733304|26756067|FG000|Overall Study|Adverse Event|3|||
13384193|NCT00733304|26756068|FG001|Overall Study|Adverse Event|0|||
13384194|NCT00733304|26756069|FG002|Overall Study|Adverse Event|0|||
13384195|NCT00733304|26756067|FG000|Overall Study|Lack of Efficacy|0|||
13384196|NCT00733304|26756068|FG001|Overall Study|Lack of Efficacy|0|||
13384197|NCT00733304|26756069|FG002|Overall Study|Lack of Efficacy|2|||
13384198|NCT00733304|26756067|FG000|Overall Study|Lost to Follow-up|0|||
13384199|NCT00733304|26756068|FG001|Overall Study|Lost to Follow-up|1|||
13384200|NCT00733304|26756069|FG002|Overall Study|Lost to Follow-up|0|||
13384201|NCT00733304|26756067|FG000|Overall Study|Physician Decision|3|||
13384202|NCT00733304|26756068|FG001|Overall Study|Physician Decision|1|||
13384203|NCT00733304|26756069|FG002|Overall Study|Physician Decision|3|||
13384204|NCT00733304|26756067|FG000|Overall Study|Withdrawal by Subject|1|||
13384205|NCT00733304|26756068|FG001|Overall Study|Withdrawal by Subject|1|||
13384206|NCT00733304|26756069|FG002|Overall Study|Withdrawal by Subject|0|||
13384207|NCT00733291|26756100|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1|||
13384208|NCT00733291|26756101|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
13384209|NCT00733291|26756102|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
13384210|NCT00733291|26756103|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
13384211|NCT00733226|26756126|FG000|Overall Study|Withdrawal by Subject|1|||
13384212|NCT00733226|26756127|FG001|Overall Study|Withdrawal by Subject|0|||
13384213|NCT00733226|26756126|FG000|Overall Study|Lost to Follow-up|2|||
13384214|NCT00733226|26756127|FG001|Overall Study|Lost to Follow-up|0|||
13384215|NCT00733226|26756126|FG000|Overall Study|moved to another place|2|||
13384216|NCT00733226|26756127|FG001|Overall Study|moved to another place|0|||
13384217|NCT00733005|26756142|FG000|Overall Study|Adverse Event|0|||
13384218|NCT00733005|26756143|FG001|Overall Study|Adverse Event|1|||
13384219|NCT00733005|26756142|FG000|Overall Study|Treatment Failure|0|||
13384220|NCT00733005|26756143|FG001|Overall Study|Treatment Failure|1|||
13384221|NCT00733005|26756142|FG000|Overall Study|Withdrawal by Subject|0|||
13384222|NCT00733005|26756143|FG001|Overall Study|Withdrawal by Subject|1|||
13384223|NCT00733005|26756142|FG000|Overall Study|Protocol Violation|2|||
13384224|NCT00733005|26756143|FG001|Overall Study|Protocol Violation|0|||
13384225|NCT00732992|26756167|FG000|Overall Study|Adverse Event|1|||
13384226|NCT00732992|26756168|FG001|Overall Study|Adverse Event|1|||
13384227|NCT00732992|26756167|FG000|Overall Study|Objective Progression or Relapse|3|||
13384228|NCT00732992|26756168|FG001|Overall Study|Objective Progression or Relapse|5|||
13384229|NCT00732992|26756167|FG000|Overall Study|Global Deterioration of Health Status|1|||
13384230|NCT00732992|26756168|FG001|Overall Study|Global Deterioration of Health Status|0|||
13384231|NCT00732992|26756167|FG000|Overall Study|Withdrawal by Subject|1|||
13384232|NCT00732992|26756168|FG001|Overall Study|Withdrawal by Subject|0|||
13384233|NCT00732940|26756243|FG000|Overall Study|Withdrawal by Subject|1|||
13384234|NCT00732940|26756244|FG001|Overall Study|Withdrawal by Subject|2|||
13384235|NCT00732940|26756243|FG000|Overall Study|Adverse Event|0|||
13384236|NCT00732940|26756244|FG001|Overall Study|Adverse Event|1|||
13384237|NCT00732940|26756243|FG000|Overall Study|Lost to Follow-up|1|||
13384238|NCT00732940|26756244|FG001|Overall Study|Lost to Follow-up|0|||
13384239|NCT00732875|26756252|FG000|Overall Study|Adverse Event|16|||
13384240|NCT00732875|26756252|FG000|Overall Study|Withdrawal by Subject|6|||
13384241|NCT00732875|26756252|FG000|Overall Study|Lack of Efficacy|13|||
13384242|NCT00732758|26756271|FG000|Overall Study|Lost to Follow-up|8|||
13384243|NCT00732758|26756272|FG001|Overall Study|Lost to Follow-up|16|||
13384244|NCT00732641|26756297|FG000|Overall Study|Relapse or Progressive Disease|65|||
13384245|NCT00732641|26756298|FG001|Overall Study|Relapse or Progressive Disease|101|||
13384246|NCT00732641|26756297|FG000|Overall Study|Serious Adverse Events|12|||
13384247|NCT00732641|26756298|FG001|Overall Study|Serious Adverse Events|3|||
13384248|NCT00732641|26756297|FG000|Overall Study|Physician Decision|6|||
13384249|NCT00732641|26756298|FG001|Overall Study|Physician Decision|0|||
13384250|NCT00732641|26756297|FG000|Overall Study|Withdrawal by Subject|4|||
13384251|NCT00732641|26756298|FG001|Overall Study|Withdrawal by Subject|2|||
13384252|NCT00732641|26756297|FG000|Overall Study|Unable to Complete|1|||
13384253|NCT00732641|26756298|FG001|Overall Study|Unable to Complete|1|||
13384254|NCT00732641|26756297|FG000|Overall Study|Other|18|||
13384255|NCT00732641|26756298|FG001|Overall Study|Other|5|||
13384256|NCT00732615|26756317|FG000|Overall Study|Withdrawal by Subject|3|||
13384257|NCT00732615|26756318|FG001|Overall Study|Withdrawal by Subject|1|||
13384258|NCT00732615|26756317|FG000|Overall Study|Lost to Follow-up|0|||
13384259|NCT00732615|26756318|FG001|Overall Study|Lost to Follow-up|1|||
13384260|NCT00732615|26756317|FG000|Overall Study|Adverse Event|0|||
13384261|NCT00732615|26756318|FG001|Overall Study|Adverse Event|2|||
13384262|NCT00732615|26756317|FG000|Overall Study|Physician Decision|3|||
13384263|NCT00732615|26756318|FG001|Overall Study|Physician Decision|0|||
13384264|NCT00732615|26756317|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
13384265|NCT00732615|26756318|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
13384266|NCT00732498|26756327|FG000|Overall Study|Ineligible|1|||
13384267|NCT00732498|26756327|FG000|Overall Study|Adverse Event|2|||
13384268|NCT00732498|26756327|FG000|Overall Study|Physician Decision|3|||
13384269|NCT00732472|26756438|FG000|Overall Study|Adverse Event|0|||
13384270|NCT00732472|26756439|FG001|Overall Study|Adverse Event|1|||
13384271|NCT00732472|26756440|FG002|Overall Study|Adverse Event|1|||
13384272|NCT00732472|26756441|FG003|Overall Study|Adverse Event|1|||
13384273|NCT00732472|26756438|FG000|Overall Study|Protocol Violation|0|||
13384274|NCT00732472|26756439|FG001|Overall Study|Protocol Violation|0|||
13384275|NCT00732472|26756440|FG002|Overall Study|Protocol Violation|0|||
13384276|NCT00732472|26756441|FG003|Overall Study|Protocol Violation|1|||
13384277|NCT00732472|26756438|FG000|Overall Study|Withdrawal by Subject|0|||
13384278|NCT00732472|26756439|FG001|Overall Study|Withdrawal by Subject|2|||
13384279|NCT00732472|26756440|FG002|Overall Study|Withdrawal by Subject|0|||
13384280|NCT00732472|26756441|FG003|Overall Study|Withdrawal by Subject|1|||
13384281|NCT00732381|26756456|FG000|Overall Study|Adverse Event|1|||
13384282|NCT00732381|26756457|FG001|Overall Study|Adverse Event|0|||
13384283|NCT00732381|26756456|FG000|Overall Study|Treatment Failure|1|||
13384284|NCT00732381|26756457|FG001|Overall Study|Treatment Failure|1|||
13384285|NCT00732303|26756465|FG000|Overall Study|Study Terminated|2|||
13384286|NCT00732251|26756473|FG000|Overall Study|Lost to Follow-up|3|||
13384287|NCT00732251|26756473|FG000|Overall Study|Withdrawal by Subject|3|||
13384288|NCT00732251|26756473|FG000|Overall Study|Early Term due to Site Closure|1|||
13384289|NCT00732238|26756488|FG000|Overall Study|Bacteremia|4|||
13384290|NCT00732238|26756489|FG001|Overall Study|Bacteremia|1|||
13384291|NCT00732238|26756488|FG000|Overall Study|Asymptomatic bacteriuria|1|||
13384292|NCT00732238|26756489|FG001|Overall Study|Asymptomatic bacteriuria|0|||
13384293|NCT00732199|26756507|FG000|Overall Study|Withdrawal by Subject|25|||
13384294|NCT00732199|26756508|FG001|Overall Study|Withdrawal by Subject|18|||
13384295|NCT00732199|26756507|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9|||
13384296|NCT00732199|26756508|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8|||
13384297|NCT00732160|26756535|FG000|Overall Study|Adverse Event|1|||
13384298|NCT00732160|26756536|FG001|Overall Study|Adverse Event|0|||
13384299|NCT00732160|26756537|FG002|Overall Study|Adverse Event|1|||
13384300|NCT00732160|26756538|FG003|Overall Study|Adverse Event|1|||
13384301|NCT00732160|26756535|FG000|Overall Study|scheduling|4|||
13384302|NCT00732160|26756536|FG001|Overall Study|scheduling|4|||
13384303|NCT00732160|26756537|FG002|Overall Study|scheduling|2|||
13384304|NCT00732160|26756538|FG003|Overall Study|scheduling|1|||
13384305|NCT00732069|26756556|FG000|Washout After First Study Drug|Adverse Event|1|||
13384306|NCT00732069|26756557|FG001|Washout After First Study Drug|Adverse Event|0|||
13384307|NCT00732069|26756558|FG002|Washout After First Study Drug|Adverse Event|0|||
13384308|NCT00732069|26756559|FG003|Washout After First Study Drug|Adverse Event|0|||
13384309|NCT00732069|26756560|FG004|Washout After First Study Drug|Adverse Event|0|||
13384310|NCT00732069|26756561|FG005|Washout After First Study Drug|Adverse Event|0|||
13384311|NCT00731939|26756611|FG000|Overall Study|Adverse Event|6|||
13384312|NCT00731939|26756611|FG000|Overall Study|Lost to Follow-up|15|||
13384313|NCT00731939|26756611|FG000|Overall Study|Not implanted with study device|9|||
13384314|NCT00731939|26756611|FG000|Overall Study|Withdrawal by Subject|2|||
13384315|NCT00731939|26756611|FG000|Overall Study|Did not meet enrollment criteria|2|||
13384316|NCT00731822|26756630|FG000|Overall Study|Adverse Event|2|||
13384317|NCT00731822|26756631|FG001|Overall Study|Adverse Event|1|||
13384318|NCT00731822|26756630|FG000|Overall Study|Protocol Violation|1|||
13384319|NCT00731822|26756631|FG001|Overall Study|Protocol Violation|0|||
13384320|NCT00731822|26756630|FG000|Overall Study|Lost to Follow-up|1|||
13384321|NCT00731822|26756631|FG001|Overall Study|Lost to Follow-up|0|||
13384322|NCT00731783|26756658|FG000|One Month Follow-Up Visit|Lost to Follow-up|14|||
13384323|NCT00731783|26756659|FG001|One Month Follow-Up Visit|Lost to Follow-up|22|||
13384324|NCT00731783|26756658|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7|||
13384325|NCT00731783|26756659|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16|||
13384326|NCT00731783|26756658|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6|||
13384327|NCT00731783|26756659|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3|||
13384328|NCT00731783|26756658|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6|||
13384329|NCT00731783|26756659|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7|||
13384330|NCT00731731|26756684|FG000|Overall Study|Protocol Violation|0|||
13384331|NCT00731731|26756685|FG001|Overall Study|Protocol Violation|0|||
13384332|NCT00731731|26756686|FG002|Overall Study|Protocol Violation|1|||
13384333|NCT00731731|26756684|FG000|Overall Study|Cancel prior to treatment|0|||
13384334|NCT00731731|26756685|FG001|Overall Study|Cancel prior to treatment|0|||
13384335|NCT00731731|26756686|FG002|Overall Study|Cancel prior to treatment|2|||
13384336|NCT00731692|26756740|FG000|Core Study (36 Months)|Lack of Efficacy|11|||
13384337|NCT00731692|26756741|FG001|Core Study (36 Months)|Lack of Efficacy|23|||
13384338|NCT00731692|26756742|FG002|Core Study (36 Months)|Lack of Efficacy|64|||
13384339|NCT00731692|26756740|FG000|Core Study (36 Months)|Physician Decision|1|||
13384340|NCT00731692|26756741|FG001|Core Study (36 Months)|Physician Decision|0|||
13384341|NCT00731692|26756742|FG002|Core Study (36 Months)|Physician Decision|2|||
13384342|NCT00731692|26756740|FG000|Core Study (36 Months)|Death|2|||
13384343|NCT00731692|26756741|FG001|Core Study (36 Months)|Death|1|||
13384344|NCT00731692|26756742|FG002|Core Study (36 Months)|Death|2|||
13384345|NCT00731692|26756740|FG000|Core Study (36 Months)|Lost to Follow-up|1|||
13384346|NCT00731692|26756741|FG001|Core Study (36 Months)|Lost to Follow-up|3|||
13384347|NCT00731692|26756742|FG002|Core Study (36 Months)|Lost to Follow-up|3|||
13384348|NCT00731692|26756740|FG000|Core Study (36 Months)|Administrative|2|||
13384349|NCT00731692|26756741|FG001|Core Study (36 Months)|Administrative|2|||
13384350|NCT00731692|26756742|FG002|Core Study (36 Months)|Administrative|6|||
13384351|NCT00731692|26756740|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4|||
13384352|NCT00731692|26756741|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3|||
13384353|NCT00731692|26756742|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5|||
13384354|NCT00731692|26756740|FG000|Core Study (36 Months)|Protocol Violation|4|||
13384355|NCT00731692|26756741|FG001|Core Study (36 Months)|Protocol Violation|5|||
13384356|NCT00731692|26756742|FG002|Core Study (36 Months)|Protocol Violation|8|||
13384357|NCT00731692|26756740|FG000|Core Study (36 Months)|Abnormal Lab values|6|||
13384358|NCT00731692|26756741|FG001|Core Study (36 Months)|Abnormal Lab values|19|||
13384359|NCT00731692|26756742|FG002|Core Study (36 Months)|Abnormal Lab values|5|||
13384360|NCT00731692|26756740|FG000|Core Study (36 Months)|Adverse Event|25|||
13384361|NCT00731692|26756741|FG001|Core Study (36 Months)|Adverse Event|28|||
13384362|NCT00731692|26756742|FG002|Core Study (36 Months)|Adverse Event|29|||
13384363|NCT00731692|26756740|FG000|Core Study (36 Months)|Withdrawal by Subject|12|||
13384364|NCT00731692|26756741|FG001|Core Study (36 Months)|Withdrawal by Subject|32|||
13384365|NCT00731692|26756742|FG002|Core Study (36 Months)|Withdrawal by Subject|46|||
13384366|NCT00731692|26756740|FG000|Extension Phase|Admin Problems: Terminated # patients|69|||
13384367|NCT00731692|26756741|FG001|Extension Phase|Admin Problems: Terminated # patients|189|||
13384368|NCT00731692|26756742|FG002|Extension Phase|Admin Problems: Terminated # patients|277|||
13384369|NCT00731692|26756740|FG000|Extension Phase|Abnormal test procedure|0|||
13384370|NCT00731692|26756741|FG001|Extension Phase|Abnormal test procedure|0|||
13384371|NCT00731692|26756742|FG002|Extension Phase|Abnormal test procedure|1|||
13384372|NCT00731692|26756740|FG000|Extension Phase|Abnormal lab values|0|||
13394922|NCT00652938|26788761|FG002|Overall Study|Adverse Event|2|||
13394923|NCT00652938|26788759|FG000|Overall Study|Withdrawal by Subject|0|||
13394924|NCT00652938|26788760|FG001|Overall Study|Withdrawal by Subject|6|||
13394925|NCT00652938|26788761|FG002|Overall Study|Withdrawal by Subject|1|||
13394926|NCT00652938|26788759|FG000|Overall Study|Lost to Follow-up|0|||
13394927|NCT00652938|26788760|FG001|Overall Study|Lost to Follow-up|0|||
13394928|NCT00652938|26788761|FG002|Overall Study|Lost to Follow-up|2|||
13394929|NCT00652938|26788759|FG000|Overall Study|fear of blood sampling|0|||
13394930|NCT00652938|26788760|FG001|Overall Study|fear of blood sampling|1|||
13394931|NCT00652938|26788761|FG002|Overall Study|fear of blood sampling|0|||
13394932|NCT00652899|26788773|FG000|Overall Study|Death|1|||
13394933|NCT00652899|26788773|FG000|Overall Study|Treating physician decision|1|||
13394934|NCT00652834|26788779|FG000|Overall Study|Withdrawal by Subject|3|||
13394935|NCT00652834|26788779|FG000|Overall Study|Lost to Follow-up|2|||
13394936|NCT00652743|26788864|FG000|Months 12-18|Lost to Follow-up|1|||
13394937|NCT00652743|26788865|FG001|Months 12-18|Lost to Follow-up|2|||
13394938|NCT00652743|26788866|FG002|Months 12-18|Lost to Follow-up|7|||
13394939|NCT00652743|26788864|FG000|Months 24-30|Other|5|||
13394940|NCT00652743|26788865|FG001|Months 24-30|Other|1|||
13394941|NCT00652743|26788866|FG002|Months 24-30|Other|11|||
13394942|NCT00652743|26788864|FG000|Months 36-42|Serious Adverse Events|0|||
13394943|NCT00652743|26788865|FG001|Months 36-42|Serious Adverse Events|1|||
13394944|NCT00652743|26788866|FG002|Months 36-42|Serious Adverse Events|1|||
13394945|NCT00652743|26788864|FG000|Months 36-42|Withdrawal by Subject|1|||
13394946|NCT00652743|26788865|FG001|Months 36-42|Withdrawal by Subject|1|||
13394947|NCT00652743|26788866|FG002|Months 36-42|Withdrawal by Subject|0|||
13394948|NCT00652743|26788864|FG000|Months 36-42|Lost to Follow-up|0|||
13394949|NCT00652743|26788865|FG001|Months 36-42|Lost to Follow-up|1|||
13394950|NCT00652743|26788866|FG002|Months 36-42|Lost to Follow-up|0|||
13394951|NCT00652743|26788864|FG000|Months 36-42|Migrated/moved from study area|1|||
13394952|NCT00652743|26788865|FG001|Months 36-42|Migrated/moved from study area|0|||
13394953|NCT00652743|26788866|FG002|Months 36-42|Migrated/moved from study area|0|||
13394954|NCT00652743|26788864|FG000|Months 36-42|Other|4|||
13394955|NCT00652743|26788865|FG001|Months 36-42|Other|2|||
13394956|NCT00652743|26788866|FG002|Months 36-42|Other|8|||
13394957|NCT00652626|26788952|FG000|Initial Treatment Phase|Adverse Event|0|||
13394958|NCT00652626|26788953|FG001|Initial Treatment Phase|Adverse Event|0|||
13394959|NCT00652626|26788954|FG002|Initial Treatment Phase|Adverse Event|0|||
13394960|NCT00652626|26788955|FG003|Initial Treatment Phase|Adverse Event|0|||
13394961|NCT00652626|26788956|FG004|Initial Treatment Phase|Adverse Event|1|||
13394962|NCT00652626|26788957|FG005|Initial Treatment Phase|Adverse Event|0|||
13394963|NCT00652626|26788958|FG006|Initial Treatment Phase|Adverse Event|0|||
13394964|NCT00652626|26788952|FG000|Initial Treatment Phase|Protocol Violation|0|||
13394965|NCT00652626|26788953|FG001|Initial Treatment Phase|Protocol Violation|0|||
13394966|NCT00652626|26788954|FG002|Initial Treatment Phase|Protocol Violation|0|||
13394967|NCT00652626|26788955|FG003|Initial Treatment Phase|Protocol Violation|1|||
13394968|NCT00652626|26788956|FG004|Initial Treatment Phase|Protocol Violation|0|||
13394969|NCT00652626|26788957|FG005|Initial Treatment Phase|Protocol Violation|0|||
13394970|NCT00652626|26788958|FG006|Initial Treatment Phase|Protocol Violation|0|||
13394971|NCT00652626|26788952|FG000|Initial Treatment Phase|Physician Decision|0|||
13394972|NCT00652626|26788953|FG001|Initial Treatment Phase|Physician Decision|0|||
13394973|NCT00652626|26788954|FG002|Initial Treatment Phase|Physician Decision|0|||
13394974|NCT00652626|26788955|FG003|Initial Treatment Phase|Physician Decision|0|||
13394975|NCT00652626|26788956|FG004|Initial Treatment Phase|Physician Decision|1|||
13394976|NCT00652626|26788957|FG005|Initial Treatment Phase|Physician Decision|0|||
13394977|NCT00652626|26788958|FG006|Initial Treatment Phase|Physician Decision|0|||
13394978|NCT00652626|26788952|FG000|Initial Treatment Phase|Sponsor Request|0|||
13394979|NCT00652626|26788953|FG001|Initial Treatment Phase|Sponsor Request|0|||
13394980|NCT00652626|26788954|FG002|Initial Treatment Phase|Sponsor Request|1|||
13394981|NCT00652626|26788955|FG003|Initial Treatment Phase|Sponsor Request|0|||
13394982|NCT00652626|26788956|FG004|Initial Treatment Phase|Sponsor Request|0|||
13394983|NCT00652626|26788957|FG005|Initial Treatment Phase|Sponsor Request|0|||
13394984|NCT00652626|26788958|FG006|Initial Treatment Phase|Sponsor Request|0|||
13394985|NCT00652626|26788952|FG000|Initial Treatment Phase|Lost to Follow-up|0|||
13394986|NCT00652626|26788953|FG001|Initial Treatment Phase|Lost to Follow-up|0|||
13394987|NCT00652626|26788954|FG002|Initial Treatment Phase|Lost to Follow-up|0|||
13394988|NCT00652626|26788955|FG003|Initial Treatment Phase|Lost to Follow-up|0|||
13384373|NCT00731692|26756741|FG001|Extension Phase|Abnormal lab values|0|||
13384374|NCT00731692|26756742|FG002|Extension Phase|Abnormal lab values|1|||
13384375|NCT00731692|26756740|FG000|Extension Phase|Lost to Follow-up|0|||
13384376|NCT00731692|26756741|FG001|Extension Phase|Lost to Follow-up|1|||
13384377|NCT00731692|26756742|FG002|Extension Phase|Lost to Follow-up|4|||
13384378|NCT00731692|26756740|FG000|Extension Phase|Withdrawal by Subject|4|||
13384379|NCT00731692|26756741|FG001|Extension Phase|Withdrawal by Subject|5|||
13384380|NCT00731692|26756742|FG002|Extension Phase|Withdrawal by Subject|3|||
13384381|NCT00731692|26756740|FG000|Extension Phase|Adverse Event|1|||
13384382|NCT00731692|26756741|FG001|Extension Phase|Adverse Event|1|||
13384383|NCT00731692|26756742|FG002|Extension Phase|Adverse Event|15|||
13384384|NCT00731679|26756757|FG000|Overall Study|Adverse Event|7|||
13384385|NCT00731679|26756758|FG001|Overall Study|Adverse Event|8|||
13384386|NCT00731679|26756757|FG000|Overall Study|Withdrawal by Subject|8|||
13384387|NCT00731679|26756758|FG001|Overall Study|Withdrawal by Subject|8|||
13384388|NCT00731679|26756757|FG000|Overall Study|Lost to Follow-up|7|||
13384389|NCT00731679|26756758|FG001|Overall Study|Lost to Follow-up|8|||
13384390|NCT00731679|26756757|FG000|Overall Study|Noncompliance|0|||
13384391|NCT00731679|26756758|FG001|Overall Study|Noncompliance|1|||
13384392|NCT00731679|26756757|FG000|Overall Study|Pregnancy|0|||
13384393|NCT00731679|26756758|FG001|Overall Study|Pregnancy|1|||
13384394|NCT00731666|26756766|FG000|Overall Study|Adverse Event|2|||
13384395|NCT00731666|26756766|FG000|Overall Study|Lost to Follow-up|8|||
13384396|NCT00731666|26756766|FG000|Overall Study|Withdrawal by Subject|2|||
13384397|NCT00731549|26756781|FG000|Overall Study|Lost to Follow-up|19|||
13384398|NCT00731549|26756781|FG000|Overall Study|Met withdrawal criteria|24|||
13384399|NCT00731549|26756781|FG000|Overall Study|Physician Decision|16|||
13384400|NCT00731549|26756781|FG000|Overall Study|Withdrawal by Subject|89|||
13384401|NCT00731549|26756781|FG000|Overall Study|Protocol deviation|1|||
13384402|NCT00731549|26756781|FG000|Overall Study|Adverse Event|31|||
13384403|NCT00731549|26756781|FG000|Overall Study|Lack of efficacy with AE|37|||
13384404|NCT00731549|26756781|FG000|Overall Study|Lack of efficacy without AE|6|||
13384405|NCT00731133|26756788|FG000|Overall Study|Withdrawal by Subject|10|||
13384406|NCT00731120|26756833|FG000|Overall Study|Adverse Event|7|||
13384407|NCT00731120|26756834|FG001|Overall Study|Adverse Event|6|||
13384408|NCT00731120|26756835|FG002|Overall Study|Adverse Event|8|||
13384409|NCT00731120|26756833|FG000|Overall Study|Lack of Efficacy|4|||
13384410|NCT00731120|26756834|FG001|Overall Study|Lack of Efficacy|5|||
13384411|NCT00731120|26756835|FG002|Overall Study|Lack of Efficacy|4|||
13384412|NCT00731120|26756833|FG000|Overall Study|Noncompliance with Study Drug|3|||
13384413|NCT00731120|26756834|FG001|Overall Study|Noncompliance with Study Drug|3|||
13384414|NCT00731120|26756835|FG002|Overall Study|Noncompliance with Study Drug|1|||
13384415|NCT00731120|26756833|FG000|Overall Study|Protocol Deviations|1|||
13384416|NCT00731120|26756834|FG001|Overall Study|Protocol Deviations|6|||
13384417|NCT00731120|26756835|FG002|Overall Study|Protocol Deviations|1|||
13384418|NCT00731120|26756833|FG000|Overall Study|Withdrawal of Consent|13|||
13384419|NCT00731120|26756834|FG001|Overall Study|Withdrawal of Consent|8|||
13384420|NCT00731120|26756835|FG002|Overall Study|Withdrawal of Consent|4|||
13384421|NCT00731120|26756833|FG000|Overall Study|Lost to Follow-up|10|||
13384422|NCT00731120|26756834|FG001|Overall Study|Lost to Follow-up|15|||
13384423|NCT00731120|26756835|FG002|Overall Study|Lost to Follow-up|17|||
13384424|NCT00731120|26756833|FG000|Overall Study|Other|4|||
13384425|NCT00731120|26756834|FG001|Overall Study|Other|0|||
13384426|NCT00731120|26756835|FG002|Overall Study|Other|1|||
13384427|NCT00731042|26756848|FG000|Second Intervention|Did not meet inclusion criteria|0|||
13384428|NCT00731042|26756849|FG001|Second Intervention|Did not meet inclusion criteria|2|||
13384429|NCT00730925|26756858|FG000|Overall Study|Progressive Disease|21|||
13384430|NCT00730925|26756858|FG000|Overall Study|Dose reducing Event|2|||
13384431|NCT00730925|26756858|FG000|Overall Study|Other Averse Event|7|||
13384432|NCT00730925|26756858|FG000|Overall Study|Protocol Violation|1|||
13384433|NCT00730925|26756858|FG000|Overall Study|Withdrawal by Subject|1|||
13384434|NCT00730925|26756858|FG000|Overall Study|Switch to combination therapy|8|||
13384435|NCT00730925|26756858|FG000|Overall Study|Other|1|||
13384436|NCT00730912|26756879|FG000|Overall Study|Discontinued|0|||
13384437|NCT00730912|26756880|FG001|Overall Study|Discontinued|0|||
13384438|NCT00730912|26756881|FG002|Overall Study|Discontinued|1|||
13384439|NCT00730886|26756912|FG000|Overall Study|Lost to Follow-up|1|||
13384440|NCT00730886|26756913|FG001|Overall Study|Lost to Follow-up|0|||
13384441|NCT00730886|26756912|FG000|Overall Study|Physician Decision|1|||
13384442|NCT00730886|26756913|FG001|Overall Study|Physician Decision|0|||
13384443|NCT00730847|26756922|FG000|Overall Study|Adverse Event|1|||
13384444|NCT00730847|26756922|FG000|Overall Study|Protocol Violation|2|||
13384445|NCT00730847|26756922|FG000|Overall Study|Withdrawal by Subject|16|||
13384446|NCT00730847|26756922|FG000|Overall Study|Lost to Follow-up|67|||
13384447|NCT00730847|26756922|FG000|Overall Study|Unknown completion status|21|||
13384448|NCT00730847|26756922|FG000|Overall Study|Other|24|||
13384449|NCT00730756|26756951|FG000|Overall Study|Adverse Event|2|||
13384450|NCT00730756|26756952|FG001|Overall Study|Adverse Event|0|||
13384451|NCT00730756|26756951|FG000|Overall Study|Lack of Efficacy|1|||
13384452|NCT00730756|26756952|FG001|Overall Study|Lack of Efficacy|1|||
13384453|NCT00730756|26756951|FG000|Overall Study|Protocol Deviation|1|||
13384454|NCT00730756|26756952|FG001|Overall Study|Protocol Deviation|2|||
13384455|NCT00730756|26756951|FG000|Overall Study|Lost to Follow-up|0|||
13384456|NCT00730756|26756952|FG001|Overall Study|Lost to Follow-up|1|||
13384457|NCT00730756|26756951|FG000|Overall Study|Withdrew Consent|0|||
13384458|NCT00730756|26756952|FG001|Overall Study|Withdrew Consent|1|||
13384459|NCT00730691|26757055|FG000|Overall Study|Adverse Event|4|||
13384460|NCT00730691|26757056|FG001|Overall Study|Adverse Event|8|||
13384461|NCT00730691|26757057|FG002|Overall Study|Adverse Event|11|||
13384462|NCT00730691|26757058|FG003|Overall Study|Adverse Event|11|||
13384463|NCT00730691|26757059|FG004|Overall Study|Adverse Event|23|||
13384464|NCT00730691|26757055|FG000|Overall Study|Lack of Efficacy|4|||
13384465|NCT00730691|26757056|FG001|Overall Study|Lack of Efficacy|4|||
13384466|NCT00730691|26757057|FG002|Overall Study|Lack of Efficacy|2|||
13384467|NCT00730691|26757058|FG003|Overall Study|Lack of Efficacy|1|||
13384468|NCT00730691|26757059|FG004|Overall Study|Lack of Efficacy|1|||
13384469|NCT00730691|26757055|FG000|Overall Study|Non-compliance with Study Drug|6|||
13384470|NCT00730691|26757056|FG001|Overall Study|Non-compliance with Study Drug|1|||
13384471|NCT00730691|26757057|FG002|Overall Study|Non-compliance with Study Drug|6|||
13384472|NCT00730691|26757058|FG003|Overall Study|Non-compliance with Study Drug|3|||
13384473|NCT00730691|26757059|FG004|Overall Study|Non-compliance with Study Drug|3|||
13384474|NCT00730691|26757055|FG000|Overall Study|Protocol Deviations|3|||
13384475|NCT00730691|26757056|FG001|Overall Study|Protocol Deviations|5|||
13384476|NCT00730691|26757057|FG002|Overall Study|Protocol Deviations|3|||
13384477|NCT00730691|26757058|FG003|Overall Study|Protocol Deviations|7|||
13384478|NCT00730691|26757059|FG004|Overall Study|Protocol Deviations|5|||
13384479|NCT00730691|26757055|FG000|Overall Study|Withdrawal of Consent|7|||
13384480|NCT00730691|26757056|FG001|Overall Study|Withdrawal of Consent|9|||
13384481|NCT00730691|26757057|FG002|Overall Study|Withdrawal of Consent|3|||
13384482|NCT00730691|26757058|FG003|Overall Study|Withdrawal of Consent|6|||
13384483|NCT00730691|26757059|FG004|Overall Study|Withdrawal of Consent|3|||
13384484|NCT00730691|26757055|FG000|Overall Study|Lost to Follow-up|11|||
13384485|NCT00730691|26757056|FG001|Overall Study|Lost to Follow-up|8|||
13384486|NCT00730691|26757057|FG002|Overall Study|Lost to Follow-up|13|||
13384487|NCT00730691|26757058|FG003|Overall Study|Lost to Follow-up|15|||
13384488|NCT00730691|26757059|FG004|Overall Study|Lost to Follow-up|13|||
13384489|NCT00730691|26757055|FG000|Overall Study|Other|1|||
13384490|NCT00730691|26757056|FG001|Overall Study|Other|1|||
13384491|NCT00730691|26757057|FG002|Overall Study|Other|1|||
13384492|NCT00730691|26757058|FG003|Overall Study|Other|2|||
13384493|NCT00730691|26757059|FG004|Overall Study|Other|2|||
13384494|NCT00730405|26757112|FG000|Overall Study-Treatment Phase|Adverse Event|5|||
13384495|NCT00730405|26757113|FG001|Overall Study-Treatment Phase|Adverse Event|10|||
13384496|NCT00730405|26757114|FG002|Overall Study-Treatment Phase|Adverse Event|4|||
13384497|NCT00730405|26757115|FG003|Overall Study-Treatment Phase|Adverse Event|8|||
13384498|NCT00730405|26757116|FG004|Overall Study-Treatment Phase|Adverse Event|4|||
13384499|NCT00730405|26757112|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4|||
13384500|NCT00730405|26757113|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5|||
13384501|NCT00730405|26757114|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6|||
13384502|NCT00730405|26757115|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4|||
13384503|NCT00730405|26757116|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4|||
13384504|NCT00730405|26757112|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
13384505|NCT00730405|26757113|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
13384506|NCT00730405|26757114|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5|||
13384507|NCT00730405|26757115|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
13384508|NCT00730405|26757116|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
13384509|NCT00730405|26757112|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7|||
13384510|NCT00730405|26757113|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1|||
13384511|NCT00730405|26757114|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2|||
13384512|NCT00730405|26757115|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5|||
13384513|NCT00730405|26757116|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8|||
13384514|NCT00730405|26757112|FG000|Overall Study-Treatment Phase|Did not met eligibility|0|||
13384515|NCT00730405|26757113|FG001|Overall Study-Treatment Phase|Did not met eligibility|0|||
13384516|NCT00730405|26757114|FG002|Overall Study-Treatment Phase|Did not met eligibility|1|||
13384517|NCT00730405|26757115|FG003|Overall Study-Treatment Phase|Did not met eligibility|0|||
13384518|NCT00730405|26757116|FG004|Overall Study-Treatment Phase|Did not met eligibility|0|||
13384519|NCT00730405|26757112|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0|||
13384520|NCT00730405|26757113|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0|||
13384521|NCT00730405|26757114|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1|||
13384522|NCT00730405|26757115|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0|||
13384523|NCT00730405|26757116|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0|||
13394989|NCT00652626|26788956|FG004|Initial Treatment Phase|Lost to Follow-up|1|||
13384524|NCT00730405|26757112|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1|||
13384525|NCT00730405|26757113|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
13384526|NCT00730405|26757114|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
13384527|NCT00730405|26757115|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
13384528|NCT00730405|26757116|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
13384529|NCT00730405|26757112|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
13384530|NCT00730405|26757113|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1|||
13384531|NCT00730405|26757114|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
13384532|NCT00730405|26757115|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
13384533|NCT00730405|26757116|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
13384534|NCT00730405|26757112|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0|||
13384535|NCT00730405|26757113|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1|||
13384536|NCT00730405|26757114|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0|||
13384537|NCT00730405|26757115|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0|||
13384538|NCT00730405|26757116|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2|||
13384539|NCT00730405|26757112|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
13384540|NCT00730405|26757113|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
13384541|NCT00730405|26757114|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1|||
13384542|NCT00730405|26757115|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
13384543|NCT00730405|26757116|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
13384544|NCT00730405|26757112|FG000|Overall Study-Treatment Phase|Misrandomized|0|||
13384545|NCT00730405|26757113|FG001|Overall Study-Treatment Phase|Misrandomized|1|||
13384546|NCT00730405|26757114|FG002|Overall Study-Treatment Phase|Misrandomized|0|||
13384547|NCT00730405|26757115|FG003|Overall Study-Treatment Phase|Misrandomized|0|||
13384548|NCT00730405|26757116|FG004|Overall Study-Treatment Phase|Misrandomized|0|||
13384549|NCT00730405|26757112|FG000|Overall Study-Treatment Phase|Study drug interrupted|0|||
13384550|NCT00730405|26757113|FG001|Overall Study-Treatment Phase|Study drug interrupted|1|||
13384551|NCT00730405|26757114|FG002|Overall Study-Treatment Phase|Study drug interrupted|0|||
13384552|NCT00730405|26757115|FG003|Overall Study-Treatment Phase|Study drug interrupted|0|||
13384553|NCT00730405|26757116|FG004|Overall Study-Treatment Phase|Study drug interrupted|0|||
13384554|NCT00730405|26757112|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
13384555|NCT00730405|26757113|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
13384556|NCT00730405|26757114|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
13384557|NCT00730405|26757115|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1|||
13384558|NCT00730405|26757116|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
13384559|NCT00730405|26757112|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
13384560|NCT00730405|26757113|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
13384561|NCT00730405|26757114|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1|||
13384562|NCT00730405|26757115|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
13384563|NCT00730405|26757116|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
13384564|NCT00730405|26757112|FG000|Overall Study-Treatment Phase|Change of location|0|||
13384565|NCT00730405|26757113|FG001|Overall Study-Treatment Phase|Change of location|0|||
13384566|NCT00730405|26757114|FG002|Overall Study-Treatment Phase|Change of location|0|||
13384567|NCT00730405|26757115|FG003|Overall Study-Treatment Phase|Change of location|1|||
13384568|NCT00730405|26757116|FG004|Overall Study-Treatment Phase|Change of location|0|||
13384569|NCT00730405|26757112|FG000|Overall Study-Treatment Phase|Pregnancy|0|||
13384570|NCT00730405|26757113|FG001|Overall Study-Treatment Phase|Pregnancy|1|||
13384571|NCT00730405|26757114|FG002|Overall Study-Treatment Phase|Pregnancy|0|||
13384572|NCT00730405|26757115|FG003|Overall Study-Treatment Phase|Pregnancy|0|||
13384573|NCT00730405|26757116|FG004|Overall Study-Treatment Phase|Pregnancy|0|||
13384574|NCT00730405|26757112|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
13384575|NCT00730405|26757113|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
13384576|NCT00730405|26757114|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
13384577|NCT00730405|26757115|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
13384578|NCT00730405|26757116|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1|||
13384579|NCT00730405|26757112|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1|||
13384580|NCT00730405|26757113|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
13384581|NCT00730405|26757114|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
13384582|NCT00730405|26757115|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
13384583|NCT00730405|26757116|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
13384584|NCT00730405|26757112|FG000|Overall Study-follow-up Phase|Adverse Event|2|||
13384585|NCT00730405|26757113|FG001|Overall Study-follow-up Phase|Adverse Event|6|||
13384586|NCT00730405|26757114|FG002|Overall Study-follow-up Phase|Adverse Event|2|||
13394990|NCT00652626|26788957|FG005|Initial Treatment Phase|Lost to Follow-up|0|||
13384587|NCT00730405|26757115|FG003|Overall Study-follow-up Phase|Adverse Event|3|||
13384588|NCT00730405|26757116|FG004|Overall Study-follow-up Phase|Adverse Event|4|||
13384589|NCT00730405|26757112|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7|||
13384590|NCT00730405|26757113|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6|||
13384591|NCT00730405|26757114|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8|||
13384592|NCT00730405|26757115|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4|||
13384593|NCT00730405|26757116|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6|||
13384594|NCT00730405|26757112|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7|||
13384595|NCT00730405|26757113|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
13384596|NCT00730405|26757114|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
13384597|NCT00730405|26757115|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6|||
13384598|NCT00730405|26757116|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10|||
13384599|NCT00730405|26757112|FG000|Overall Study-follow-up Phase|Death|0|||
13384600|NCT00730405|26757113|FG001|Overall Study-follow-up Phase|Death|1|||
13384601|NCT00730405|26757114|FG002|Overall Study-follow-up Phase|Death|0|||
13384602|NCT00730405|26757115|FG003|Overall Study-follow-up Phase|Death|1|||
13384603|NCT00730405|26757116|FG004|Overall Study-follow-up Phase|Death|0|||
13384604|NCT00730405|26757112|FG000|Overall Study-follow-up Phase|Change of location|1|||
13384605|NCT00730405|26757113|FG001|Overall Study-follow-up Phase|Change of location|1|||
13384606|NCT00730405|26757114|FG002|Overall Study-follow-up Phase|Change of location|0|||
13384607|NCT00730405|26757115|FG003|Overall Study-follow-up Phase|Change of location|1|||
13384608|NCT00730405|26757116|FG004|Overall Study-follow-up Phase|Change of location|0|||
13384609|NCT00730405|26757112|FG000|Overall Study-follow-up Phase|Did not met eligibility|0|||
13384610|NCT00730405|26757113|FG001|Overall Study-follow-up Phase|Did not met eligibility|0|||
13384611|NCT00730405|26757114|FG002|Overall Study-follow-up Phase|Did not met eligibility|1|||
13384612|NCT00730405|26757115|FG003|Overall Study-follow-up Phase|Did not met eligibility|0|||
13384613|NCT00730405|26757116|FG004|Overall Study-follow-up Phase|Did not met eligibility|0|||
13384614|NCT00730405|26757112|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
13384615|NCT00730405|26757113|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
13384616|NCT00730405|26757114|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1|||
13384617|NCT00730405|26757115|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
13384618|NCT00730405|26757116|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
13384619|NCT00730405|26757112|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
13384620|NCT00730405|26757113|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
13384621|NCT00730405|26757114|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1|||
13384622|NCT00730405|26757115|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
13384623|NCT00730405|26757116|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
13384624|NCT00730405|26757112|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
13384625|NCT00730405|26757113|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
13384626|NCT00730405|26757114|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
13384627|NCT00730405|26757115|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
13384628|NCT00730405|26757116|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1|||
13384629|NCT00730405|26757112|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1|||
13384630|NCT00730405|26757113|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
13384631|NCT00730405|26757114|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
13384632|NCT00730405|26757115|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
13384633|NCT00730405|26757116|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
13384634|NCT00730405|26757112|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
13384635|NCT00730405|26757113|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
13384636|NCT00730405|26757114|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
13384637|NCT00730405|26757115|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1|||
13384638|NCT00730405|26757116|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
13384639|NCT00730405|26757112|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
13384640|NCT00730405|26757113|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
13384641|NCT00730405|26757114|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
13384642|NCT00730405|26757115|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
13384643|NCT00730405|26757116|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
13384644|NCT00730405|26757112|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
13384645|NCT00730405|26757113|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
13384646|NCT00730405|26757114|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
13384647|NCT00730405|26757115|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
13384648|NCT00730405|26757116|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
13384649|NCT00730405|26757112|FG000|Overall Study-follow-up Phase|Use of restricted medication|0|||
13384650|NCT00730405|26757113|FG001|Overall Study-follow-up Phase|Use of restricted medication|1|||
13384651|NCT00730405|26757114|FG002|Overall Study-follow-up Phase|Use of restricted medication|0|||
13384652|NCT00730405|26757115|FG003|Overall Study-follow-up Phase|Use of restricted medication|0|||
13384653|NCT00730405|26757116|FG004|Overall Study-follow-up Phase|Use of restricted medication|0|||
13384654|NCT00730405|26757112|FG000|Overall Study-follow-up Phase|Non-compliance|1|||
13384655|NCT00730405|26757113|FG001|Overall Study-follow-up Phase|Non-compliance|0|||
13384656|NCT00730405|26757114|FG002|Overall Study-follow-up Phase|Non-compliance|2|||
13384657|NCT00730405|26757115|FG003|Overall Study-follow-up Phase|Non-compliance|0|||
13384658|NCT00730405|26757116|FG004|Overall Study-follow-up Phase|Non-compliance|0|||
13384659|NCT00730405|26757112|FG000|Overall Study-follow-up Phase|Missing|0|||
13384660|NCT00730405|26757113|FG001|Overall Study-follow-up Phase|Missing|0|||
13384661|NCT00730405|26757114|FG002|Overall Study-follow-up Phase|Missing|2|||
13384662|NCT00730405|26757115|FG003|Overall Study-follow-up Phase|Missing|0|||
13384663|NCT00730405|26757116|FG004|Overall Study-follow-up Phase|Missing|0|||
13384664|NCT00730405|26757112|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
13384665|NCT00730405|26757113|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
13384666|NCT00730405|26757114|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
13384667|NCT00730405|26757115|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
13384668|NCT00730405|26757116|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1|||
13384669|NCT00730405|26757112|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
13384670|NCT00730405|26757113|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
13384671|NCT00730405|26757114|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1|||
13384672|NCT00730405|26757115|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
13384673|NCT00730405|26757116|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
13384674|NCT00730405|26757112|FG000|Overall Study-follow-up Phase|Mis-randomized|0|||
13384675|NCT00730405|26757113|FG001|Overall Study-follow-up Phase|Mis-randomized|1|||
13384676|NCT00730405|26757114|FG002|Overall Study-follow-up Phase|Mis-randomized|0|||
13384677|NCT00730405|26757115|FG003|Overall Study-follow-up Phase|Mis-randomized|0|||
13384678|NCT00730405|26757116|FG004|Overall Study-follow-up Phase|Mis-randomized|0|||
13384679|NCT00730405|26757112|FG000|Overall Study-follow-up Phase|Other Protocol violation|0|||
13384680|NCT00730405|26757113|FG001|Overall Study-follow-up Phase|Other Protocol violation|0|||
13384681|NCT00730405|26757114|FG002|Overall Study-follow-up Phase|Other Protocol violation|1|||
13384682|NCT00730405|26757115|FG003|Overall Study-follow-up Phase|Other Protocol violation|0|||
13384683|NCT00730405|26757116|FG004|Overall Study-follow-up Phase|Other Protocol violation|0|||
13384684|NCT00730405|26757112|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
13384685|NCT00730405|26757113|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
13384686|NCT00730405|26757114|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
13384687|NCT00730405|26757115|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1|||
13384688|NCT00730405|26757116|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
13384689|NCT00730405|26757112|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1|||
13384690|NCT00730405|26757113|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
13384691|NCT00730405|26757114|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
13384692|NCT00730405|26757115|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
13384693|NCT00730405|26757116|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
13384694|NCT00730327|26757144|FG000|Overall Study|Lost to Follow-up|14|||
13384695|NCT00730327|26757145|FG001|Overall Study|Lost to Follow-up|16|||
13384696|NCT00730327|26757144|FG000|Overall Study|Adverse Event|8|||
13384697|NCT00730327|26757145|FG001|Overall Study|Adverse Event|1|||
13384698|NCT00730327|26757144|FG000|Overall Study|Withdrawal by Subject|3|||
13384699|NCT00730327|26757145|FG001|Overall Study|Withdrawal by Subject|13|||
13384700|NCT00730327|26757144|FG000|Overall Study|Subject withdrew (reason not specified)|2|||
13384701|NCT00730327|26757145|FG001|Overall Study|Subject withdrew (reason not specified)|7|||
13384702|NCT00730275|26757184|FG000|Overall Study|Withdrawal by Subject|0|||
13384703|NCT00730275|26757185|FG001|Overall Study|Withdrawal by Subject|0|||
13384704|NCT00730275|26757186|FG002|Overall Study|Withdrawal by Subject|0|||
13384705|NCT00730275|26757187|FG003|Overall Study|Withdrawal by Subject|1|||
13384706|NCT00730236|26757204|FG000|Overall Study|Adverse Event|4|||
13384707|NCT00730236|26757204|FG000|Overall Study|Withdrawal by Subject|1|||
13384708|NCT00730236|26757204|FG000|Overall Study|Non-compliance|1|||
13384709|NCT00730171|26757214|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5|||
13384710|NCT00730171|26757214|FG000|Overall Study|Adverse Event|193|||
13384711|NCT00730171|26757214|FG000|Overall Study|Protocol Violation|48|||
13384712|NCT00730171|26757214|FG000|Overall Study|Withdrawal by Subject|202|||
13384713|NCT00730171|26757214|FG000|Overall Study|Lost to Follow-up|121|||
13384714|NCT00730171|26757214|FG000|Overall Study|Insufficient Therapeutic Response|141|||
13384715|NCT00730171|26757214|FG000|Overall Study|Other|61|||
13384716|NCT00730158|26757259|FG000|Overall Study|Withdrawal by Subject|1|||
13384717|NCT00730158|26757260|FG001|Overall Study|Withdrawal by Subject|1|||
13384718|NCT00730132|26757278|FG000|Overall Study|Protocol Violation|154|||
13384719|NCT00730132|26757278|FG000|Overall Study|Death|1|||
13384720|NCT00730041|26757303|FG000|Overall Study|Lost to Follow-up|0|||
13384721|NCT00730041|26757304|FG001|Overall Study|Lost to Follow-up|2|||
13384722|NCT00730028|26757367|FG000|Overall Study|Adverse Event|23|||
13384723|NCT00730028|26757368|FG001|Overall Study|Adverse Event|26|||
13384724|NCT00730028|26757369|FG002|Overall Study|Adverse Event|16|||
13384725|NCT00730028|26757370|FG003|Overall Study|Adverse Event|20|||
13384726|NCT00730028|26757371|FG004|Overall Study|Adverse Event|43|||
13384727|NCT00730028|26757367|FG000|Overall Study|Lost to Follow-up|13|||
13384728|NCT00730028|26757368|FG001|Overall Study|Lost to Follow-up|26|||
13384729|NCT00730028|26757369|FG002|Overall Study|Lost to Follow-up|22|||
13384730|NCT00730028|26757370|FG003|Overall Study|Lost to Follow-up|26|||
13384731|NCT00730028|26757371|FG004|Overall Study|Lost to Follow-up|25|||
13384732|NCT00730028|26757367|FG000|Overall Study|Protocol Violation|6|||
13384733|NCT00730028|26757368|FG001|Overall Study|Protocol Violation|1|||
13384734|NCT00730028|26757369|FG002|Overall Study|Protocol Violation|1|||
13384735|NCT00730028|26757370|FG003|Overall Study|Protocol Violation|2|||
13384736|NCT00730028|26757371|FG004|Overall Study|Protocol Violation|0|||
13384737|NCT00730028|26757367|FG000|Overall Study|Withdrawal by Subject|9|||
13384738|NCT00730028|26757368|FG001|Overall Study|Withdrawal by Subject|5|||
13384739|NCT00730028|26757369|FG002|Overall Study|Withdrawal by Subject|4|||
13384740|NCT00730028|26757370|FG003|Overall Study|Withdrawal by Subject|5|||
13384741|NCT00730028|26757371|FG004|Overall Study|Withdrawal by Subject|9|||
13384742|NCT00730028|26757367|FG000|Overall Study|Physician Decision|3|||
13384743|NCT00730028|26757368|FG001|Overall Study|Physician Decision|3|||
13384744|NCT00730028|26757369|FG002|Overall Study|Physician Decision|2|||
13384745|NCT00730028|26757370|FG003|Overall Study|Physician Decision|3|||
13384746|NCT00730028|26757371|FG004|Overall Study|Physician Decision|2|||
13384747|NCT00730028|26757367|FG000|Overall Study|Treatment Failure|5|||
13384748|NCT00730028|26757368|FG001|Overall Study|Treatment Failure|5|||
13384749|NCT00730028|26757369|FG002|Overall Study|Treatment Failure|0|||
13384750|NCT00730028|26757370|FG003|Overall Study|Treatment Failure|0|||
13384751|NCT00730028|26757371|FG004|Overall Study|Treatment Failure|1|||
13384752|NCT00730028|26757367|FG000|Overall Study|Randomization Error|1|||
13384753|NCT00730028|26757368|FG001|Overall Study|Randomization Error|0|||
13384754|NCT00730028|26757369|FG002|Overall Study|Randomization Error|0|||
13384755|NCT00730028|26757370|FG003|Overall Study|Randomization Error|0|||
13384756|NCT00730028|26757371|FG004|Overall Study|Randomization Error|2|||
13384757|NCT00730015|26757415|FG000|Overall Study|Adverse Event|11|||
13384758|NCT00730015|26757416|FG001|Overall Study|Adverse Event|10|||
13384759|NCT00730015|26757417|FG002|Overall Study|Adverse Event|8|||
13384760|NCT00730015|26757415|FG000|Overall Study|Protocol Violation|2|||
13384761|NCT00730015|26757416|FG001|Overall Study|Protocol Violation|6|||
13384762|NCT00730015|26757417|FG002|Overall Study|Protocol Violation|4|||
13384763|NCT00730015|26757415|FG000|Overall Study|Withdrawal by Subject|12|||
13384764|NCT00730015|26757416|FG001|Overall Study|Withdrawal by Subject|12|||
13384765|NCT00730015|26757417|FG002|Overall Study|Withdrawal by Subject|8|||
13384766|NCT00730015|26757415|FG000|Overall Study|Lost to Follow-up|4|||
13384767|NCT00730015|26757416|FG001|Overall Study|Lost to Follow-up|10|||
13384768|NCT00730015|26757417|FG002|Overall Study|Lost to Follow-up|3|||
13384769|NCT00730015|26757415|FG000|Overall Study|Lack of Efficacy|1|||
13384770|NCT00730015|26757416|FG001|Overall Study|Lack of Efficacy|2|||
13384771|NCT00730015|26757417|FG002|Overall Study|Lack of Efficacy|8|||
13384772|NCT00730015|26757415|FG000|Overall Study|Other Reason|1|||
13384773|NCT00730015|26757416|FG001|Overall Study|Other Reason|0|||
13384774|NCT00730015|26757417|FG002|Overall Study|Other Reason|1|||
13384775|NCT00729937|26757630|FG000|Overall Study|Lost to Follow-up|49|||
13384776|NCT00729937|26757631|FG001|Overall Study|Lost to Follow-up|58|||
13384777|NCT00729937|26757632|FG002|Overall Study|Lost to Follow-up|18|||
13384778|NCT00729937|26757633|FG003|Overall Study|Lost to Follow-up|33|||
13384779|NCT00729937|26757634|FG004|Overall Study|Lost to Follow-up|18|||
13384780|NCT00729937|26757635|FG005|Overall Study|Lost to Follow-up|23|||
13384781|NCT00729937|26757630|FG000|Overall Study|Physician Decision|7|||
13384782|NCT00729937|26757631|FG001|Overall Study|Physician Decision|16|||
13384783|NCT00729937|26757632|FG002|Overall Study|Physician Decision|2|||
13384784|NCT00729937|26757633|FG003|Overall Study|Physician Decision|0|||
13384785|NCT00729937|26757634|FG004|Overall Study|Physician Decision|5|||
13384786|NCT00729937|26757635|FG005|Overall Study|Physician Decision|8|||
13384787|NCT00729937|26757630|FG000|Overall Study|Death|1|||
13384788|NCT00729937|26757631|FG001|Overall Study|Death|0|||
13384789|NCT00729937|26757632|FG002|Overall Study|Death|1|||
13384790|NCT00729937|26757633|FG003|Overall Study|Death|0|||
13384791|NCT00729937|26757634|FG004|Overall Study|Death|0|||
13394991|NCT00652626|26788958|FG006|Initial Treatment Phase|Lost to Follow-up|0|||
13384792|NCT00729937|26757635|FG005|Overall Study|Death|1|||
13384793|NCT00729937|26757630|FG000|Overall Study|Withdrawal by Subject|3|||
13384794|NCT00729937|26757631|FG001|Overall Study|Withdrawal by Subject|5|||
13384795|NCT00729937|26757632|FG002|Overall Study|Withdrawal by Subject|6|||
13384796|NCT00729937|26757633|FG003|Overall Study|Withdrawal by Subject|0|||
13384797|NCT00729937|26757634|FG004|Overall Study|Withdrawal by Subject|4|||
13384798|NCT00729937|26757635|FG005|Overall Study|Withdrawal by Subject|2|||
13384799|NCT00729937|26757630|FG000|Overall Study|Randomized but not treated|12|||
13384800|NCT00729937|26757631|FG001|Overall Study|Randomized but not treated|6|||
13384801|NCT00729937|26757632|FG002|Overall Study|Randomized but not treated|1|||
13384802|NCT00729937|26757633|FG003|Overall Study|Randomized but not treated|0|||
13384803|NCT00729937|26757634|FG004|Overall Study|Randomized but not treated|1|||
13384804|NCT00729937|26757635|FG005|Overall Study|Randomized but not treated|3|||
13384805|NCT00729937|26757630|FG000|Overall Study|Did not meet eligibility criteria|2|||
13384806|NCT00729937|26757631|FG001|Overall Study|Did not meet eligibility criteria|1|||
13384807|NCT00729937|26757632|FG002|Overall Study|Did not meet eligibility criteria|0|||
13384808|NCT00729937|26757633|FG003|Overall Study|Did not meet eligibility criteria|0|||
13384809|NCT00729937|26757634|FG004|Overall Study|Did not meet eligibility criteria|0|||
13384810|NCT00729937|26757635|FG005|Overall Study|Did not meet eligibility criteria|0|||
13384811|NCT00729937|26757630|FG000|Overall Study|Incarcerated|0|||
13384812|NCT00729937|26757631|FG001|Overall Study|Incarcerated|2|||
13384813|NCT00729937|26757632|FG002|Overall Study|Incarcerated|1|||
13384814|NCT00729937|26757633|FG003|Overall Study|Incarcerated|1|||
13384815|NCT00729937|26757634|FG004|Overall Study|Incarcerated|0|||
13384816|NCT00729937|26757635|FG005|Overall Study|Incarcerated|0|||
13384817|NCT00729859|26757680|FG000|Overall Study|Adverse Event|0|||
13384818|NCT00729859|26757681|FG001|Overall Study|Adverse Event|1|||
13384819|NCT00729859|26757682|FG002|Overall Study|Adverse Event|0|||
13384820|NCT00729859|26757680|FG000|Overall Study|Withdrawal by Subject|0|||
13384821|NCT00729859|26757681|FG001|Overall Study|Withdrawal by Subject|1|||
13384822|NCT00729859|26757682|FG002|Overall Study|Withdrawal by Subject|0|||
13384823|NCT00729833|26757726|FG000|Overall Study|Death|5|||
13384824|NCT00729833|26757727|FG001|Overall Study|Death|1|||
13384825|NCT00729833|26757728|FG002|Overall Study|Death|3|||
13384826|NCT00729833|26757729|FG003|Overall Study|Death|5|||
13384827|NCT00729833|26757726|FG000|Overall Study|Study Terminated by Sponsor|0|||
13384828|NCT00729833|26757727|FG001|Overall Study|Study Terminated by Sponsor|0|||
13384829|NCT00729833|26757728|FG002|Overall Study|Study Terminated by Sponsor|1|||
13384830|NCT00729833|26757729|FG003|Overall Study|Study Terminated by Sponsor|0|||
13384831|NCT00729833|26757726|FG000|Overall Study|Lost to Follow-up|1|||
13384832|NCT00729833|26757727|FG001|Overall Study|Lost to Follow-up|0|||
13384833|NCT00729833|26757728|FG002|Overall Study|Lost to Follow-up|0|||
13384834|NCT00729833|26757729|FG003|Overall Study|Lost to Follow-up|0|||
13384835|NCT00729833|26757726|FG000|Overall Study|Withdrawal by Subject|3|||
13384836|NCT00729833|26757727|FG001|Overall Study|Withdrawal by Subject|1|||
13384837|NCT00729833|26757728|FG002|Overall Study|Withdrawal by Subject|3|||
13384838|NCT00729833|26757729|FG003|Overall Study|Withdrawal by Subject|0|||
13384839|NCT00729833|26757726|FG000|Overall Study|Unspecified Reasons|11|||
13384840|NCT00729833|26757727|FG001|Overall Study|Unspecified Reasons|5|||
13384841|NCT00729833|26757728|FG002|Overall Study|Unspecified Reasons|5|||
13384842|NCT00729833|26757729|FG003|Overall Study|Unspecified Reasons|1|||
13384843|NCT00729690|26757756|FG000|Overall Study|IT Catheter Malfunction|0|||
13384844|NCT00729690|26757757|FG001|Overall Study|IT Catheter Malfunction|2|||
13384845|NCT00729690|26757758|FG002|Overall Study|IT Catheter Malfunction|2|||
13384846|NCT00729651|26757777|FG000|Overall Study|Withdrawal by Subject|5|||
13384847|NCT00729651|26757778|FG001|Overall Study|Withdrawal by Subject|6|||
13384848|NCT00729651|26757777|FG000|Overall Study|Lost to Follow-up|5|||
13384849|NCT00729651|26757778|FG001|Overall Study|Lost to Follow-up|4|||
13384850|NCT00729651|26757777|FG000|Overall Study|Protocol Violation|0|||
13384851|NCT00729651|26757778|FG001|Overall Study|Protocol Violation|1|||
13384852|NCT00729651|26757777|FG000|Overall Study|Adverse Event|7|||
13384853|NCT00729651|26757778|FG001|Overall Study|Adverse Event|3|||
13384854|NCT00729651|26757777|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0|||
13384855|NCT00729651|26757778|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4|||
13384856|NCT00729651|26757777|FG000|Overall Study|Subject's private reason|2|||
13384857|NCT00729651|26757778|FG001|Overall Study|Subject's private reason|0|||
13384858|NCT00729612|26757787|FG000|Overall Study|Non evaluable for response|10|||
13384859|NCT00729586|26757807|FG000|Overall Study|Ineligible|0|||
13384860|NCT00729586|26757808|FG001|Overall Study|Ineligible|1|||
13384861|NCT00729586|26757807|FG000|Overall Study|never treated|1|||
13384862|NCT00729586|26757808|FG001|Overall Study|never treated|0|||
13384863|NCT00729560|26757814|FG000|Overall Study|Withdrawal by Subject|3|||
13384864|NCT00729469|26757857|FG000|Overall Study|Adverse Event|14|||
13384865|NCT00729469|26757858|FG001|Overall Study|Adverse Event|25|||
13384866|NCT00729469|26757857|FG000|Overall Study|Lost to Follow-up|9|||
13384867|NCT00729469|26757858|FG001|Overall Study|Lost to Follow-up|9|||
13384868|NCT00729469|26757857|FG000|Overall Study|Protocol Violation|2|||
13384869|NCT00729469|26757858|FG001|Overall Study|Protocol Violation|1|||
13384870|NCT00729469|26757857|FG000|Overall Study|Withdrawal by Subject|19|||
13384871|NCT00729469|26757858|FG001|Overall Study|Withdrawal by Subject|8|||
13384872|NCT00729469|26757857|FG000|Overall Study|Other-Not mentioned|9|||
13384873|NCT00729469|26757858|FG001|Overall Study|Other-Not mentioned|4|||
13384874|NCT00729378|26758061|FG000|Baseline|Did not complete study measurements|72|||
13384875|NCT00729378|26758062|FG001|Baseline|Did not complete study measurements|33|||
13384876|NCT00729378|26758061|FG000|Baseline|Withdrawal by Subject|66|||
13384877|NCT00729378|26758062|FG001|Baseline|Withdrawal by Subject|59|||
13384878|NCT00729378|26758061|FG000|12-months|Lost to Follow-up|100|||
13384879|NCT00729378|26758062|FG001|12-months|Lost to Follow-up|65|||
13384880|NCT00729378|26758061|FG000|24-months|Lost to Follow-up|72|||
13384881|NCT00729378|26758062|FG001|24-months|Lost to Follow-up|51|||
13384882|NCT00729378|26758061|FG000|36-months|Lost to Follow-up|15|||
13384883|NCT00729378|26758062|FG001|36-months|Lost to Follow-up|6|||
13384884|NCT00729365|26758083|FG000|Overall Study|Physician Decision|33|||
13384885|NCT00729365|26758084|FG001|Overall Study|Physician Decision|6|||
13384886|NCT00729365|26758085|FG002|Overall Study|Physician Decision|7|||
13384887|NCT00729326|26758134|FG000|Overall Study|Lost to Follow-up|2|||
13384888|NCT00729326|26758135|FG001|Overall Study|Lost to Follow-up|0|||
13384889|NCT00729326|26758134|FG000|Overall Study|Physician Decision|0|||
13384890|NCT00729326|26758135|FG001|Overall Study|Physician Decision|1|||
13384891|NCT00729326|26758134|FG000|Overall Study|Protocol Violation|3|||
13384892|NCT00729326|26758135|FG001|Overall Study|Protocol Violation|2|||
13384893|NCT00729326|26758134|FG000|Overall Study|Subject Decision|4|||
13384894|NCT00729326|26758135|FG001|Overall Study|Subject Decision|4|||
13384895|NCT00729326|26758134|FG000|Overall Study|Sponsor Decision|1|||
13384896|NCT00729326|26758135|FG001|Overall Study|Sponsor Decision|2|||
13384897|NCT00729248|26758142|FG000|Overall Study|Physician Decision|2|||
13384898|NCT00729183|26758181|FG000|Overall Study|Adverse Event|11|||
13384899|NCT00729183|26758182|FG001|Overall Study|Adverse Event|5|||
13384900|NCT00729183|26758181|FG000|Overall Study|Lack of Efficacy|0|||
13384901|NCT00729183|26758182|FG001|Overall Study|Lack of Efficacy|1|||
13384902|NCT00729183|26758181|FG000|Overall Study|Lost to Follow-up|3|||
13384903|NCT00729183|26758182|FG001|Overall Study|Lost to Follow-up|1|||
13384904|NCT00729183|26758181|FG000|Overall Study|Physician Decision|1|||
13384905|NCT00729183|26758182|FG001|Overall Study|Physician Decision|1|||
13384906|NCT00729183|26758181|FG000|Overall Study|Protocol Violation|1|||
13384907|NCT00729183|26758182|FG001|Overall Study|Protocol Violation|0|||
13384908|NCT00729183|26758181|FG000|Overall Study|Withdrawal by Subject|9|||
13384909|NCT00729183|26758182|FG001|Overall Study|Withdrawal by Subject|7|||
13384910|NCT00729157|26758192|FG000|Overall Study|Withdrawal by Subject|1|||
13384911|NCT00728988|26758217|FG000|Overall Study|Not Treated|2|||
13384912|NCT00728988|26758218|FG001|Overall Study|Not Treated|2|||
13384913|NCT00728988|26758217|FG000|Overall Study|Death|1|||
13384914|NCT00728988|26758218|FG001|Overall Study|Death|1|||
13384915|NCT00728988|26758217|FG000|Overall Study|Adverse Event|3|||
13384916|NCT00728988|26758218|FG001|Overall Study|Adverse Event|2|||
13384917|NCT00728988|26758217|FG000|Overall Study|Other|85|||
13384918|NCT00728988|26758218|FG001|Overall Study|Other|77|||
13384919|NCT00728988|26758217|FG000|Overall Study|Withdrawal by Subject|2|||
13384920|NCT00728988|26758218|FG001|Overall Study|Withdrawal by Subject|6|||
13384921|NCT00728962|26758224|FG000|Implant Placement Surgery|Adverse Event|8|||
13384922|NCT00728962|26758224|FG000|Implant Placement Surgery|Lost to Follow-up|1|||
13384923|NCT00728962|26758224|FG000|Implant Placement Surgery|Protocol Violation|1|||
13384924|NCT00728962|26758224|FG000|Permanent Prosthesis Placement|Adverse Event|3|||
13384925|NCT00728962|26758224|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3|||
13384926|NCT00728949|26758249|FG000|Overall Study|Adverse Event|8|||
13384927|NCT00728949|26758250|FG001|Overall Study|Adverse Event|0|||
13384928|NCT00728949|26758249|FG000|Overall Study|Withdrawal by Subject|2|||
13384929|NCT00728949|26758250|FG001|Overall Study|Withdrawal by Subject|2|||
13384930|NCT00728949|26758249|FG000|Overall Study|Abnormal Lab Results|0|||
13384931|NCT00728949|26758250|FG001|Overall Study|Abnormal Lab Results|2|||
13384932|NCT00728949|26758249|FG000|Overall Study|On treatment at cutoff date|1|||
13384933|NCT00728949|26758250|FG001|Overall Study|On treatment at cutoff date|0|||
13384934|NCT00728936|26758288|FG000|Overall Study|Withdrawal by Subject|0|||
13384935|NCT00728936|26758289|FG001|Overall Study|Withdrawal by Subject|0|||
13384936|NCT00728936|26758290|FG002|Overall Study|Withdrawal by Subject|0|||
13384937|NCT00728936|26758291|FG003|Overall Study|Withdrawal by Subject|0|||
13384938|NCT00728936|26758292|FG004|Overall Study|Withdrawal by Subject|0|||
13384939|NCT00728936|26758293|FG005|Overall Study|Withdrawal by Subject|1|||
13384940|NCT00728936|26758294|FG006|Overall Study|Withdrawal by Subject|0|||
13384941|NCT00728884|26758300|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13|||
13384942|NCT00728884|26758300|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4|||
13384943|NCT00728754|26758313|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
13384944|NCT00728754|26758314|FG001|Permanent Prosthesis Placement|Adverse Event|1|||
13384945|NCT00728754|26758313|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3|||
13384946|NCT00728754|26758314|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3|||
13384947|NCT00728754|26758313|FG000|One Year Post Placement Follow-up|Adverse Event|1|||
13384948|NCT00728754|26758314|FG001|One Year Post Placement Follow-up|Adverse Event|0|||
13384949|NCT00728689|26758337|FG000|Washout Period (Days 4 - 10)|Death in family|1|||
13384950|NCT00728689|26758338|FG001|Washout Period (Days 4 - 10)|Death in family|0|||
13384951|NCT00728494|26758361|FG000|Overall Study|Adverse Event|7|||
13394992|NCT00652626|26788952|FG000|Extension Phase|Withdrawal by Subject|0|||
13384952|NCT00728494|26758362|FG001|Overall Study|Adverse Event|0|||
13394993|NCT00652626|26788953|FG001|Extension Phase|Withdrawal by Subject|0|||
13384953|NCT00728494|26758361|FG000|Overall Study|Withdrawal by Subject|0|||
13384954|NCT00728494|26758362|FG001|Overall Study|Withdrawal by Subject|2|||
13384955|NCT00728494|26758361|FG000|Overall Study|Lack of Efficacy|2|||
13384956|NCT00728494|26758362|FG001|Overall Study|Lack of Efficacy|4|||
13384957|NCT00728494|26758361|FG000|Overall Study|No data available|0|||
13384958|NCT00728494|26758362|FG001|Overall Study|No data available|1|||
13384959|NCT00728481|26758385|FG000|Overall Study|Withdrawal by Subject|0|||
13384960|NCT00728481|26758386|FG001|Overall Study|Withdrawal by Subject|1|||
13384961|NCT00728481|26758385|FG000|Overall Study|Adverse Event|0|||
13384962|NCT00728481|26758386|FG001|Overall Study|Adverse Event|1|||
13384963|NCT00728481|26758385|FG000|Overall Study|Study medication non-compliance|0|||
13384964|NCT00728481|26758386|FG001|Overall Study|Study medication non-compliance|2|||
13384965|NCT00728481|26758385|FG000|Overall Study|Incorrectly assigned to opposite arm|1|||
13384966|NCT00728481|26758386|FG001|Overall Study|Incorrectly assigned to opposite arm|0|||
13384967|NCT00728468|26758410|FG000|Overall Study|Enrolled but not treated|1|||
13384968|NCT00728468|26758410|FG000|Overall Study|Death|1|||
13384969|NCT00728468|26758410|FG000|Overall Study|Protocol Violation|4|||
13384970|NCT00728468|26758410|FG000|Overall Study|Objective progression or relapse|9|||
13384971|NCT00728468|26758410|FG000|Overall Study|Study terminated by sponsor|1|||
13384972|NCT00728416|26758425|FG000|Overall Study|Adverse Event|1|||
13384973|NCT00728416|26758426|FG001|Overall Study|Adverse Event|1|||
13384974|NCT00728416|26758425|FG000|Overall Study|Treatment Failure|0|||
13384975|NCT00728416|26758426|FG001|Overall Study|Treatment Failure|1|||
13384976|NCT00728416|26758425|FG000|Overall Study|Withdrawal by Subject|1|||
13384977|NCT00728416|26758426|FG001|Overall Study|Withdrawal by Subject|0|||
13384978|NCT00728182|26758461|FG000|Overall Study|Adverse Event|1|||
13384979|NCT00728182|26758462|FG001|Overall Study|Adverse Event|0|||
13384980|NCT00728182|26758461|FG000|Overall Study|Lost to Follow-up|2|||
13384981|NCT00728182|26758462|FG001|Overall Study|Lost to Follow-up|0|||
13384982|NCT00728182|26758461|FG000|Overall Study|Death|0|||
13384983|NCT00728182|26758462|FG001|Overall Study|Death|2|||
13384984|NCT00728182|26758461|FG000|Overall Study|Protocol Noncompliance|0|||
13384985|NCT00728182|26758462|FG001|Overall Study|Protocol Noncompliance|1|||
13384986|NCT00728130|26758469|FG000|Overall Study|Withdrawal by Subject|1|||
13384987|NCT00728130|26758469|FG000|Overall Study|Paperwork not completed in time|1|||
13384988|NCT00728130|26758469|FG000|Overall Study|Physician Decision|1|||
13384989|NCT00727961|26758481|FG000|Overall Study|Lost to Follow-up|1|||
13384990|NCT00727961|26758481|FG000|Overall Study|Adverse Event|4|||
13384991|NCT00727961|26758481|FG000|Overall Study|Patient's refusal|2|||
13384992|NCT00727961|26758481|FG000|Overall Study|Progression|30|||
13384993|NCT00727909|26758490|FG000|Overall Study|Withdrawal by Subject|5|||
13384994|NCT00727909|26758491|FG001|Overall Study|Withdrawal by Subject|11|||
13384995|NCT00727909|26758492|FG002|Overall Study|Withdrawal by Subject|8|||
13384996|NCT00727909|26758493|FG003|Overall Study|Withdrawal by Subject|5|||
13384997|NCT00727909|26758490|FG000|Overall Study|Death|0|||
13384998|NCT00727909|26758491|FG001|Overall Study|Death|0|||
13384999|NCT00727909|26758492|FG002|Overall Study|Death|1|||
13385000|NCT00727909|26758493|FG003|Overall Study|Death|0|||
13385001|NCT00727844|26758507|FG000|Initial Randomization|Physician Decision|2|||
13385002|NCT00727844|26758508|FG001|Initial Randomization|Physician Decision|0|||
13385003|NCT00727844|26758509|FG002|Initial Randomization|Physician Decision|0|||
13385004|NCT00727844|26758510|FG003|Initial Randomization|Physician Decision|0|||
13385005|NCT00727714|26758520|FG000|Overall Study|Lost to Follow-up|2|||
13385006|NCT00727649|26758539|FG000|First Intervention (4-weeks)|Lost to Follow-up|1|||
13385007|NCT00727649|26758540|FG001|First Intervention (4-weeks)|Lost to Follow-up|2|||
13385008|NCT00727649|26758539|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2|||
13385009|NCT00727649|26758540|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1|||
13385010|NCT00727649|26758539|FG000|Wash-out (2-weeks)|Lost to Follow-up|3|||
13385011|NCT00727649|26758540|FG001|Wash-out (2-weeks)|Lost to Follow-up|1|||
13385012|NCT00727649|26758539|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1|||
13385013|NCT00727649|26758540|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2|||
13385014|NCT00727649|26758539|FG000|Second Intervention (4-weeks)|Death|1|||
13385015|NCT00727649|26758540|FG001|Second Intervention (4-weeks)|Death|0|||
13385016|NCT00727649|26758539|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0|||
13385017|NCT00727649|26758540|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1|||
13385018|NCT00727649|26758539|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0|||
13385019|NCT00727649|26758540|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2|||
13385020|NCT00727571|26758578|FG000|Overall Study|Ineligibility determined|1|||
13385021|NCT00727571|26758579|FG001|Overall Study|Ineligibility determined|1|||
13385022|NCT00727571|26758580|FG002|Overall Study|Ineligibility determined|1|||
13385023|NCT00727571|26758581|FG003|Overall Study|Ineligibility determined|0|||
13385024|NCT00727571|26758578|FG000|Overall Study|Death|0|||
13385025|NCT00727571|26758579|FG001|Overall Study|Death|19|||
13385026|NCT00727571|26758580|FG002|Overall Study|Death|5|||
13385027|NCT00727571|26758581|FG003|Overall Study|Death|1|||
13385028|NCT00727571|26758578|FG000|Overall Study|Physician Decision|0|||
13385029|NCT00727571|26758579|FG001|Overall Study|Physician Decision|5|||
13385030|NCT00727571|26758580|FG002|Overall Study|Physician Decision|0|||
13385031|NCT00727571|26758581|FG003|Overall Study|Physician Decision|0|||
13385032|NCT00727571|26758578|FG000|Overall Study|Withdrawal by Subject|0|||
13385033|NCT00727571|26758579|FG001|Overall Study|Withdrawal by Subject|10|||
13385034|NCT00727571|26758580|FG002|Overall Study|Withdrawal by Subject|11|||
13385035|NCT00727571|26758581|FG003|Overall Study|Withdrawal by Subject|0|||
13385036|NCT00727571|26758578|FG000|Overall Study|Subject Non Compliance|0|||
13385037|NCT00727571|26758579|FG001|Overall Study|Subject Non Compliance|6|||
13385038|NCT00727571|26758580|FG002|Overall Study|Subject Non Compliance|0|||
13385039|NCT00727571|26758581|FG003|Overall Study|Subject Non Compliance|4|||
13385040|NCT00727571|26758578|FG000|Overall Study|Dismissed from nursing home|0|||
13385041|NCT00727571|26758579|FG001|Overall Study|Dismissed from nursing home|9|||
13385042|NCT00727571|26758580|FG002|Overall Study|Dismissed from nursing home|5|||
13385043|NCT00727571|26758581|FG003|Overall Study|Dismissed from nursing home|0|||
13385044|NCT00727571|26758578|FG000|Overall Study|Hospitalization|0|||
13385045|NCT00727571|26758579|FG001|Overall Study|Hospitalization|1|||
13385046|NCT00727571|26758580|FG002|Overall Study|Hospitalization|0|||
13385047|NCT00727571|26758581|FG003|Overall Study|Hospitalization|1|||
13385048|NCT00727571|26758578|FG000|Overall Study|AE not leading to hospitalization|0|||
13385049|NCT00727571|26758579|FG001|Overall Study|AE not leading to hospitalization|0|||
13385050|NCT00727571|26758580|FG002|Overall Study|AE not leading to hospitalization|2|||
13385051|NCT00727571|26758581|FG003|Overall Study|AE not leading to hospitalization|0|||
13385052|NCT00727571|26758578|FG000|Overall Study|Other|0|||
13385053|NCT00727571|26758579|FG001|Overall Study|Other|4|||
13385054|NCT00727571|26758580|FG002|Overall Study|Other|6|||
13385055|NCT00727571|26758581|FG003|Overall Study|Other|0|||
13385056|NCT00727558|26758606|FG000|Overall Study|Lens issue|0|||
13385057|NCT00727558|26758607|FG001|Overall Study|Lens issue|1|||
13385058|NCT00727558|26758606|FG000|Overall Study|Adverse Event|0|||
13385059|NCT00727558|26758607|FG001|Overall Study|Adverse Event|1|||
13385060|NCT00727558|26758606|FG000|Overall Study|Subject unable to return for follow-up|1|||
13385061|NCT00727558|26758607|FG001|Overall Study|Subject unable to return for follow-up|1|||
13385062|NCT00727558|26758606|FG000|Overall Study|Lost to Follow-up|1|||
13385063|NCT00727558|26758607|FG001|Overall Study|Lost to Follow-up|0|||
13394994|NCT00652626|26788954|FG002|Extension Phase|Withdrawal by Subject|0|||
13394995|NCT00652626|26788955|FG003|Extension Phase|Withdrawal by Subject|0|||
13394996|NCT00652626|26788956|FG004|Extension Phase|Withdrawal by Subject|0|||
13394997|NCT00652626|26788957|FG005|Extension Phase|Withdrawal by Subject|2|||
13394998|NCT00652626|26788958|FG006|Extension Phase|Withdrawal by Subject|0|||
13394999|NCT00652626|26788952|FG000|Extension Phase|Adverse Event|0|||
13395000|NCT00652626|26788953|FG001|Extension Phase|Adverse Event|0|||
13395001|NCT00652626|26788954|FG002|Extension Phase|Adverse Event|0|||
13395002|NCT00652626|26788955|FG003|Extension Phase|Adverse Event|0|||
13395003|NCT00652626|26788956|FG004|Extension Phase|Adverse Event|0|||
13395004|NCT00652626|26788957|FG005|Extension Phase|Adverse Event|2|||
13395005|NCT00652626|26788958|FG006|Extension Phase|Adverse Event|1|||
13395006|NCT00652626|26788952|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0|||
13395007|NCT00652626|26788953|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0|||
13395008|NCT00652626|26788954|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0|||
13395009|NCT00652626|26788955|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0|||
13395010|NCT00652626|26788956|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0|||
13395011|NCT00652626|26788957|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6|||
13395012|NCT00652626|26788958|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0|||
13395013|NCT00652626|26788952|FG000|Extension Phase|Physician Decision|0|||
13395014|NCT00652626|26788953|FG001|Extension Phase|Physician Decision|0|||
13395015|NCT00652626|26788954|FG002|Extension Phase|Physician Decision|0|||
13395016|NCT00652626|26788955|FG003|Extension Phase|Physician Decision|0|||
13395017|NCT00652626|26788956|FG004|Extension Phase|Physician Decision|0|||
13395018|NCT00652626|26788957|FG005|Extension Phase|Physician Decision|1|||
13395019|NCT00652626|26788958|FG006|Extension Phase|Physician Decision|1|||
13395020|NCT00652626|26788952|FG000|Extension Phase|Death|0|||
13395021|NCT00652626|26788953|FG001|Extension Phase|Death|0|||
13395022|NCT00652626|26788954|FG002|Extension Phase|Death|0|||
13395023|NCT00652626|26788955|FG003|Extension Phase|Death|0|||
13395024|NCT00652626|26788956|FG004|Extension Phase|Death|0|||
13395025|NCT00652626|26788957|FG005|Extension Phase|Death|1|||
13395026|NCT00652626|26788958|FG006|Extension Phase|Death|1|||
13395027|NCT00652366|26789007|FG000|Overall Study|Adverse Event|8|||
13395028|NCT00652366|26789008|FG001|Overall Study|Adverse Event|4|||
13395029|NCT00652366|26789009|FG002|Overall Study|Adverse Event|7|||
13395030|NCT00652366|26789010|FG003|Overall Study|Adverse Event|17|||
13395031|NCT00652366|26789011|FG004|Overall Study|Adverse Event|13|||
13395032|NCT00652366|26789007|FG000|Overall Study|Death|5|||
13395033|NCT00652366|26789008|FG001|Overall Study|Death|4|||
13395034|NCT00652366|26789009|FG002|Overall Study|Death|1|||
13395035|NCT00652366|26789010|FG003|Overall Study|Death|8|||
13395036|NCT00652366|26789011|FG004|Overall Study|Death|5|||
13395037|NCT00652366|26789007|FG000|Overall Study|Lack of Efficacy|84|||
13385064|NCT00727532|26758615|FG000|Overall Study|Adverse Event|1|||
13385065|NCT00727532|26758615|FG000|Overall Study|Withdrawal by Subject|1|||
13385066|NCT00727506|26758727|FG000|Overall Study|Adverse Event|0|||
13385067|NCT00727506|26758728|FG001|Overall Study|Adverse Event|0|||
13385068|NCT00727506|26758729|FG002|Overall Study|Adverse Event|4|||
13385069|NCT00727506|26758730|FG003|Overall Study|Adverse Event|4|||
13385070|NCT00727506|26758731|FG004|Overall Study|Adverse Event|1|||
13385071|NCT00727506|26758732|FG005|Overall Study|Adverse Event|8|||
13385072|NCT00727506|26758727|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
13385073|NCT00727506|26758728|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
13385074|NCT00727506|26758729|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
13385075|NCT00727506|26758730|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
13385076|NCT00727506|26758731|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
13385077|NCT00727506|26758732|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
13385078|NCT00727506|26758727|FG000|Overall Study|Progressive disease|4|||
13385079|NCT00727506|26758728|FG001|Overall Study|Progressive disease|7|||
13385080|NCT00727506|26758729|FG002|Overall Study|Progressive disease|9|||
13385081|NCT00727506|26758730|FG003|Overall Study|Progressive disease|28|||
13385082|NCT00727506|26758731|FG004|Overall Study|Progressive disease|38|||
13385083|NCT00727506|26758732|FG005|Overall Study|Progressive disease|28|||
13385084|NCT00727506|26758727|FG000|Overall Study|Refused to continue medication|0|||
13385085|NCT00727506|26758728|FG001|Overall Study|Refused to continue medication|1|||
13385086|NCT00727506|26758729|FG002|Overall Study|Refused to continue medication|2|||
13385087|NCT00727506|26758730|FG003|Overall Study|Refused to continue medication|3|||
13385088|NCT00727506|26758731|FG004|Overall Study|Refused to continue medication|1|||
13385089|NCT00727506|26758732|FG005|Overall Study|Refused to continue medication|2|||
13385090|NCT00727506|26758727|FG000|Overall Study|Other reason not described above|0|||
13385091|NCT00727506|26758728|FG001|Overall Study|Other reason not described above|0|||
13385092|NCT00727506|26758729|FG002|Overall Study|Other reason not described above|1|||
13385093|NCT00727506|26758730|FG003|Overall Study|Other reason not described above|4|||
13385094|NCT00727506|26758731|FG004|Overall Study|Other reason not described above|1|||
13385095|NCT00727506|26758732|FG005|Overall Study|Other reason not described above|1|||
13385096|NCT00727441|26758762|FG000|Overall Study|Disease Progression|11|||
13385097|NCT00727441|26758763|FG001|Overall Study|Disease Progression|14|||
13385098|NCT00727441|26758764|FG002|Overall Study|Disease Progression|17|||
13385099|NCT00727441|26758762|FG000|Overall Study|Eligibility|7|||
13385100|NCT00727441|26758763|FG001|Overall Study|Eligibility|5|||
13385101|NCT00727441|26758764|FG002|Overall Study|Eligibility|7|||
13385102|NCT00727441|26758762|FG000|Overall Study|Death|0|||
13385103|NCT00727441|26758763|FG001|Overall Study|Death|1|||
13385104|NCT00727441|26758764|FG002|Overall Study|Death|1|||
13385105|NCT00727441|26758762|FG000|Overall Study|Physician Decision|0|||
13385106|NCT00727441|26758763|FG001|Overall Study|Physician Decision|1|||
13385107|NCT00727441|26758764|FG002|Overall Study|Physician Decision|0|||
13385108|NCT00727441|26758762|FG000|Overall Study|Withdrawal by Subject|0|||
13385109|NCT00727441|26758763|FG001|Overall Study|Withdrawal by Subject|1|||
13385110|NCT00727441|26758764|FG002|Overall Study|Withdrawal by Subject|0|||
13385111|NCT00727415|26758775|FG000|Phase I|Dose Limiting Toxicity|2|||
13385112|NCT00727402|26758781|FG000|Overall Study|Physician Decision|116|||
13385113|NCT00727311|26758790|FG000|Overall Study|Did not receive drug|316|||
13385114|NCT00727311|26758790|FG000|Overall Study|Missing end of therapy data|205|||
13385115|NCT00727311|26758790|FG000|Overall Study|Adverse Event|58|||
13385116|NCT00727311|26758790|FG000|Overall Study|Lack of Efficacy|242|||
13385117|NCT00727311|26758790|FG000|Overall Study|Lost to Follow-up|73|||
13385118|NCT00727311|26758790|FG000|Overall Study|Withdrawal by Subject|77|||
13385119|NCT00727311|26758790|FG000|Overall Study|Other|97|||
13385120|NCT00727311|26758790|FG000|Overall Study|Multiple reasons|39|||
13385121|NCT00727272|26758811|FG000|Washout Period A|Adverse Event|0|||
13385122|NCT00727272|26758812|FG001|Washout Period A|Adverse Event|0|||
13385123|NCT00727272|26758813|FG002|Washout Period A|Adverse Event|1|||
13385124|NCT00727272|26758811|FG000|Washout Period B|Withdrawal by Subject|0|||
13385125|NCT00727272|26758812|FG001|Washout Period B|Withdrawal by Subject|0|||
13385126|NCT00727272|26758813|FG002|Washout Period B|Withdrawal by Subject|1|||
13385127|NCT00727259|26758820|FG000|Overall Study|Not all questionnaires completed|1055|||
13385128|NCT00727246|26758847|FG000|Overall Study|could not complete MRI|0|||
13385129|NCT00727246|26758848|FG001|Overall Study|could not complete MRI|1|||
13385130|NCT00727246|26758849|FG002|Overall Study|could not complete MRI|0|||
13385131|NCT00727246|26758850|FG003|Overall Study|could not complete MRI|1|||
13385132|NCT00727246|26758847|FG000|Overall Study|incidental finding|0|||
13385133|NCT00727246|26758848|FG001|Overall Study|incidental finding|0|||
13385134|NCT00727246|26758849|FG002|Overall Study|incidental finding|0|||
13385135|NCT00727246|26758850|FG003|Overall Study|incidental finding|1|||
13385136|NCT00727246|26758847|FG000|Overall Study|withdrawn|0|||
13385137|NCT00727246|26758848|FG001|Overall Study|withdrawn|0|||
13385138|NCT00727246|26758849|FG002|Overall Study|withdrawn|1|||
13385139|NCT00727246|26758850|FG003|Overall Study|withdrawn|0|||
13385140|NCT00727194|26758888|FG000|Screening Period|Low QMG scores|0|||
13385141|NCT00727194|26758889|FG001|Screening Period|Low QMG scores|0|||
13385142|NCT00727194|26758890|FG002|Screening Period|Low QMG scores|6|||
13385143|NCT00727194|26758888|FG000|Screening Period|Lacked AChR antibodies|0|||
13385144|NCT00727194|26758889|FG001|Screening Period|Lacked AChR antibodies|0|||
13385145|NCT00727194|26758890|FG002|Screening Period|Lacked AChR antibodies|5|||
13385146|NCT00727194|26758888|FG000|Screening Period|Not stable on concomitant MG therapy|0|||
13385147|NCT00727194|26758889|FG001|Screening Period|Not stable on concomitant MG therapy|0|||
13385148|NCT00727194|26758890|FG002|Screening Period|Not stable on concomitant MG therapy|2|||
13385149|NCT00727194|26758888|FG000|Screening Period|Severe infections|0|||
13385150|NCT00727194|26758889|FG001|Screening Period|Severe infections|0|||
13385151|NCT00727194|26758890|FG002|Screening Period|Severe infections|2|||
13385152|NCT00727194|26758888|FG000|Screening Period|History of thymoma|0|||
13385153|NCT00727194|26758889|FG001|Screening Period|History of thymoma|0|||
13385154|NCT00727194|26758890|FG002|Screening Period|History of thymoma|1|||
13385155|NCT00727194|26758888|FG000|Treatment Period 2|Lack of Efficacy|0|||
13385156|NCT00727194|26758889|FG001|Treatment Period 2|Lack of Efficacy|1|||
13385157|NCT00727194|26758890|FG002|Treatment Period 2|Lack of Efficacy|0|||
13385158|NCT00727025|26758902|FG000|Overall Study|Physician Decision|23|||
13385159|NCT00726999|26758921|FG000|Overall Study|Physician Decision|0|||
13385160|NCT00726999|26758922|FG001|Overall Study|Physician Decision|1|||
13385161|NCT00726999|26758921|FG000|Overall Study|Withdrawal by Subject|2|||
13385162|NCT00726999|26758922|FG001|Overall Study|Withdrawal by Subject|0|||
13385163|NCT00726999|26758921|FG000|Overall Study|Protocol Violation|1|||
13385164|NCT00726999|26758922|FG001|Overall Study|Protocol Violation|0|||
13385165|NCT00726986|26758931|FG000|Induction Phase|Adverse Event|4|||
13385166|NCT00726986|26758931|FG000|Induction Phase|Withdrawal by Subject|2|||
13385167|NCT00726986|26758931|FG000|Induction Phase|Death|2|||
13385168|NCT00726986|26758931|FG000|Induction Phase|Lack of Efficacy|5|||
13385169|NCT00726986|26758931|FG000|Induction Phase|Secondary Disease|2|||
13385170|NCT00726986|26758931|FG000|Maintenance Phase|Adverse Event|1|||
13385171|NCT00726986|26758931|FG000|Maintenance Phase|Lack of Efficacy|2|||
13385172|NCT00726895|26758947|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
13385173|NCT00726895|26758948|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
13385174|NCT00726882|26758956|FG000|Overall Study|Withdrawal by Subject|5|||
13385175|NCT00726882|26758956|FG000|Overall Study|Lost to Follow-up|7|||
13385176|NCT00726882|26758956|FG000|Overall Study|Other|10|||
13385177|NCT00726752|26758972|FG000|Overall Study|Lack of Efficacy|6|||
13385178|NCT00726661|26758994|FG000|Overall Study|Lost to Follow-up|36|||
13385179|NCT00726661|26758995|FG001|Overall Study|Lost to Follow-up|11|||
13385180|NCT00726661|26758994|FG000|Overall Study|Withdrawal by Subject|17|||
13385181|NCT00726661|26758995|FG001|Overall Study|Withdrawal by Subject|13|||
13385182|NCT00726661|26758994|FG000|Overall Study|Trial terminated by sponsor|214|||
13385183|NCT00726661|26758995|FG001|Overall Study|Trial terminated by sponsor|187|||
13385184|NCT00726661|26758994|FG000|Overall Study|Death|475|||
13385185|NCT00726661|26758995|FG001|Overall Study|Death|159|||
13385186|NCT00726661|26758994|FG000|Overall Study|Physician Decision|25|||
13385187|NCT00726661|26758995|FG001|Overall Study|Physician Decision|13|||
13385188|NCT00726661|26758994|FG000|Overall Study|Other|47|||
13385189|NCT00726661|26758995|FG001|Overall Study|Other|35|||
13385190|NCT00726622|26759020|FG000|Overall Study|Withdrawal by Subject|16|||
13385191|NCT00726622|26759021|FG001|Overall Study|Withdrawal by Subject|2|||
13385192|NCT00726622|26759020|FG000|Overall Study|Physician Decision|0|||
13385193|NCT00726622|26759021|FG001|Overall Study|Physician Decision|1|||
13385194|NCT00726622|26759020|FG000|Overall Study|Metastasis|2|||
13385195|NCT00726622|26759021|FG001|Overall Study|Metastasis|0|||
13385196|NCT00726609|26759027|FG000|Overall Study|Adverse Event|10|||
13385197|NCT00726609|26759027|FG000|Overall Study|Withdrawal by Subject|2|||
13385198|NCT00726609|26759027|FG000|Overall Study|Lack of Efficacy|25|||
13385199|NCT00726609|26759027|FG000|Overall Study|Other|16|||
13385200|NCT00726609|26759027|FG000|Overall Study|Missing|42|||
13385201|NCT00726609|26759027|FG000|Overall Study|Other|3|||
13385202|NCT00726557|26759034|FG000|Overall Study|Screening failure|4|||
13385203|NCT00726557|26759034|FG000|Overall Study|No end of treatment documentation|37|||
13385204|NCT00726557|26759034|FG000|Overall Study|No follow-up documentation available|55|||
13385205|NCT00726557|26759034|FG000|Overall Study|Treatment less than 3 months|17|||
13385206|NCT00726557|26759034|FG000|Overall Study|Inclusion criteria not met|15|||
13385207|NCT00726453|26759051|FG000|Primary Enrollment Group|Death|18|||
13385208|NCT00726453|26759052|FG001|Primary Enrollment Group|Death|0|||
13385209|NCT00726453|26759051|FG000|Primary Enrollment Group|Withdrawal by Subject|13|||
13385210|NCT00726453|26759052|FG001|Primary Enrollment Group|Withdrawal by Subject|0|||
13385211|NCT00726453|26759051|FG000|38 mm Length Group|Death|0|||
13385212|NCT00726453|26759052|FG001|38 mm Length Group|Death|3|||
13385213|NCT00726388|26759073|FG000|Overall Study|Withdrawal by Subject|5|||
13385214|NCT00726388|26759073|FG000|Overall Study|Adverse Event|3|||
13385215|NCT00726388|26759073|FG000|Overall Study|Lost to Follow-up|10|||
13385216|NCT00726388|26759073|FG000|Overall Study|Participants Non-compliant With Study Procedures|5|||
13385217|NCT00726388|26759073|FG000|Overall Study|Other|5|||
13385218|NCT00726388|26759073|FG000|Overall Study|Enrolled, Not Treated|79|||
13385219|NCT00726323|26759104|FG000|Overall Study|Withdrawal by Subject|3|||
13385220|NCT00726323|26759105|FG001|Overall Study|Withdrawal by Subject|1|||
13385221|NCT00726323|26759104|FG000|Overall Study|Physician Decision|1|||
13385222|NCT00726323|26759105|FG001|Overall Study|Physician Decision|0|||
13385223|NCT00726323|26759104|FG000|Overall Study|Progressive disease|23|||
13385224|NCT00726323|26759105|FG001|Overall Study|Progressive disease|16|||
13385225|NCT00726323|26759104|FG000|Overall Study|Clinical progression|0|||
13385226|NCT00726323|26759105|FG001|Overall Study|Clinical progression|3|||
13385227|NCT00726323|26759104|FG000|Overall Study|Adverse Event|9|||
13385228|NCT00726323|26759105|FG001|Overall Study|Adverse Event|9|||
13385229|NCT00726323|26759104|FG000|Overall Study|Death|1|||
13385230|NCT00726323|26759105|FG001|Overall Study|Death|0|||
13385231|NCT00726323|26759104|FG000|Overall Study|Participant wished to discontinue|0|||
13385232|NCT00726323|26759105|FG001|Overall Study|Participant wished to discontinue|1|||
13385233|NCT00726323|26759104|FG000|Overall Study|Metastatic lesions inferred cyst|0|||
13385234|NCT00726323|26759105|FG001|Overall Study|Metastatic lesions inferred cyst|1|||
13385235|NCT00726232|26759172|FG000|Initial Phase (Dose-finding)|Death|0|||
13385236|NCT00726232|26759173|FG001|Initial Phase (Dose-finding)|Death|0|||
13385237|NCT00726232|26759174|FG002|Initial Phase (Dose-finding)|Death|0|||
13385238|NCT00726232|26759175|FG003|Initial Phase (Dose-finding)|Death|0|||
13385239|NCT00726232|26759176|FG004|Initial Phase (Dose-finding)|Death|1|||
13385240|NCT00726232|26759177|FG005|Initial Phase (Dose-finding)|Death|0|||
13385241|NCT00726232|26759178|FG006|Initial Phase (Dose-finding)|Death|0|||
13385242|NCT00726232|26759179|FG007|Initial Phase (Dose-finding)|Death|0|||
13385243|NCT00726232|26759172|FG000|Initial Phase (Dose-finding)|Adverse Event|2|||
13385244|NCT00726232|26759173|FG001|Initial Phase (Dose-finding)|Adverse Event|2|||
13385245|NCT00726232|26759174|FG002|Initial Phase (Dose-finding)|Adverse Event|2|||
13385246|NCT00726232|26759175|FG003|Initial Phase (Dose-finding)|Adverse Event|1|||
13385247|NCT00726232|26759176|FG004|Initial Phase (Dose-finding)|Adverse Event|7|||
13385248|NCT00726232|26759177|FG005|Initial Phase (Dose-finding)|Adverse Event|3|||
13385249|NCT00726232|26759178|FG006|Initial Phase (Dose-finding)|Adverse Event|0|||
13385250|NCT00726232|26759179|FG007|Initial Phase (Dose-finding)|Adverse Event|0|||
13385251|NCT00726232|26759172|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
13385252|NCT00726232|26759173|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
13385253|NCT00726232|26759174|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
13385254|NCT00726232|26759175|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1|||
13385255|NCT00726232|26759176|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
13385256|NCT00726232|26759177|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
13385257|NCT00726232|26759178|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
13385258|NCT00726232|26759179|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
13385259|NCT00726232|26759172|FG000|Initial Phase (Dose-finding)|Disease progression|3|||
13385260|NCT00726232|26759173|FG001|Initial Phase (Dose-finding)|Disease progression|1|||
13385261|NCT00726232|26759174|FG002|Initial Phase (Dose-finding)|Disease progression|0|||
13385262|NCT00726232|26759175|FG003|Initial Phase (Dose-finding)|Disease progression|0|||
13385263|NCT00726232|26759176|FG004|Initial Phase (Dose-finding)|Disease progression|0|||
13385264|NCT00726232|26759177|FG005|Initial Phase (Dose-finding)|Disease progression|0|||
13385265|NCT00726232|26759178|FG006|Initial Phase (Dose-finding)|Disease progression|0|||
13385266|NCT00726232|26759179|FG007|Initial Phase (Dose-finding)|Disease progression|0|||
13385267|NCT00726232|26759172|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
13385268|NCT00726232|26759173|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
13385269|NCT00726232|26759174|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
13385270|NCT00726232|26759175|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
13385271|NCT00726232|26759176|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9|||
13385272|NCT00726232|26759177|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
13385273|NCT00726232|26759178|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
13385274|NCT00726232|26759179|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
13385275|NCT00726232|26759172|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
13385276|NCT00726232|26759173|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
13385277|NCT00726232|26759174|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
13385278|NCT00726232|26759175|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2|||
13385279|NCT00726232|26759176|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4|||
13385280|NCT00726232|26759177|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
13385281|NCT00726232|26759178|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
13385282|NCT00726232|26759179|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
13385283|NCT00726232|26759172|FG000|Initial Phase (Dose-finding)|Unspecified reason|1|||
13385284|NCT00726232|26759173|FG001|Initial Phase (Dose-finding)|Unspecified reason|0|||
13385285|NCT00726232|26759174|FG002|Initial Phase (Dose-finding)|Unspecified reason|0|||
13385286|NCT00726232|26759175|FG003|Initial Phase (Dose-finding)|Unspecified reason|0|||
13385287|NCT00726232|26759176|FG004|Initial Phase (Dose-finding)|Unspecified reason|0|||
13385288|NCT00726232|26759177|FG005|Initial Phase (Dose-finding)|Unspecified reason|0|||
13385289|NCT00726232|26759178|FG006|Initial Phase (Dose-finding)|Unspecified reason|0|||
13385290|NCT00726232|26759179|FG007|Initial Phase (Dose-finding)|Unspecified reason|0|||
13385291|NCT00726232|26759172|FG000|Expansion Phase|Death|0|||
13385292|NCT00726232|26759173|FG001|Expansion Phase|Death|0|||
13385293|NCT00726232|26759174|FG002|Expansion Phase|Death|0|||
13385294|NCT00726232|26759175|FG003|Expansion Phase|Death|0|||
13385295|NCT00726232|26759176|FG004|Expansion Phase|Death|0|||
13385296|NCT00726232|26759177|FG005|Expansion Phase|Death|0|||
13385297|NCT00726232|26759178|FG006|Expansion Phase|Death|0|||
13385298|NCT00726232|26759179|FG007|Expansion Phase|Death|1|||
13385299|NCT00726232|26759172|FG000|Expansion Phase|Adverse Event|0|||
13385300|NCT00726232|26759173|FG001|Expansion Phase|Adverse Event|0|||
13385301|NCT00726232|26759174|FG002|Expansion Phase|Adverse Event|0|||
13385302|NCT00726232|26759175|FG003|Expansion Phase|Adverse Event|0|||
13385303|NCT00726232|26759176|FG004|Expansion Phase|Adverse Event|0|||
13385304|NCT00726232|26759177|FG005|Expansion Phase|Adverse Event|0|||
13385305|NCT00726232|26759178|FG006|Expansion Phase|Adverse Event|6|||
13385306|NCT00726232|26759179|FG007|Expansion Phase|Adverse Event|11|||
13385307|NCT00726232|26759172|FG000|Expansion Phase|Withdrawal by Subject|0|||
13385308|NCT00726232|26759173|FG001|Expansion Phase|Withdrawal by Subject|0|||
13385309|NCT00726232|26759174|FG002|Expansion Phase|Withdrawal by Subject|0|||
13385310|NCT00726232|26759175|FG003|Expansion Phase|Withdrawal by Subject|0|||
13385311|NCT00726232|26759176|FG004|Expansion Phase|Withdrawal by Subject|0|||
13385312|NCT00726232|26759177|FG005|Expansion Phase|Withdrawal by Subject|0|||
13385313|NCT00726232|26759178|FG006|Expansion Phase|Withdrawal by Subject|2|||
13385314|NCT00726232|26759179|FG007|Expansion Phase|Withdrawal by Subject|3|||
13385315|NCT00726232|26759172|FG000|Expansion Phase|Disease progression|0|||
13385316|NCT00726232|26759173|FG001|Expansion Phase|Disease progression|0|||
13385317|NCT00726232|26759174|FG002|Expansion Phase|Disease progression|0|||
13385318|NCT00726232|26759175|FG003|Expansion Phase|Disease progression|0|||
13385319|NCT00726232|26759176|FG004|Expansion Phase|Disease progression|0|||
13385320|NCT00726232|26759177|FG005|Expansion Phase|Disease progression|0|||
13385321|NCT00726232|26759178|FG006|Expansion Phase|Disease progression|4|||
13385322|NCT00726232|26759179|FG007|Expansion Phase|Disease progression|0|||
13385323|NCT00726232|26759172|FG000|Expansion Phase|Termination of the trial by sponsor|0|||
13385324|NCT00726232|26759173|FG001|Expansion Phase|Termination of the trial by sponsor|0|||
13385325|NCT00726232|26759174|FG002|Expansion Phase|Termination of the trial by sponsor|0|||
13385326|NCT00726232|26759175|FG003|Expansion Phase|Termination of the trial by sponsor|0|||
13385327|NCT00726232|26759176|FG004|Expansion Phase|Termination of the trial by sponsor|0|||
13385328|NCT00726232|26759177|FG005|Expansion Phase|Termination of the trial by sponsor|0|||
13385329|NCT00726232|26759178|FG006|Expansion Phase|Termination of the trial by sponsor|10|||
13385330|NCT00726232|26759179|FG007|Expansion Phase|Termination of the trial by sponsor|16|||
13385331|NCT00726232|26759172|FG000|Expansion Phase|Per Investigator: lack of response|0|||
13385332|NCT00726232|26759173|FG001|Expansion Phase|Per Investigator: lack of response|0|||
13385333|NCT00726232|26759174|FG002|Expansion Phase|Per Investigator: lack of response|0|||
13385334|NCT00726232|26759175|FG003|Expansion Phase|Per Investigator: lack of response|0|||
13385335|NCT00726232|26759176|FG004|Expansion Phase|Per Investigator: lack of response|0|||
13385336|NCT00726232|26759177|FG005|Expansion Phase|Per Investigator: lack of response|0|||
13385337|NCT00726232|26759178|FG006|Expansion Phase|Per Investigator: lack of response|1|||
13385338|NCT00726232|26759179|FG007|Expansion Phase|Per Investigator: lack of response|7|||
13385339|NCT00726232|26759172|FG000|Expansion Phase|Unspecified reason|0|||
13385340|NCT00726232|26759173|FG001|Expansion Phase|Unspecified reason|0|||
13385341|NCT00726232|26759174|FG002|Expansion Phase|Unspecified reason|0|||
13385342|NCT00726232|26759175|FG003|Expansion Phase|Unspecified reason|0|||
13385343|NCT00726232|26759176|FG004|Expansion Phase|Unspecified reason|0|||
13385344|NCT00726232|26759177|FG005|Expansion Phase|Unspecified reason|0|||
13385345|NCT00726232|26759178|FG006|Expansion Phase|Unspecified reason|1|||
13385346|NCT00726232|26759179|FG007|Expansion Phase|Unspecified reason|0|||
13385347|NCT00726063|26759192|FG000|Overall Study|Adverse Event|9|||
13385348|NCT00726063|26759193|FG001|Overall Study|Adverse Event|7|||
13385349|NCT00725985|26759373|FG000|ITP- Treatment Disposition|Adverse Event|20|||
13385350|NCT00725985|26759374|FG001|ITP- Treatment Disposition|Adverse Event|10|||
13385351|NCT00725985|26759375|FG002|ITP- Treatment Disposition|Adverse Event|5|||
13385352|NCT00725985|26759376|FG003|ITP- Treatment Disposition|Adverse Event|0|||
13385353|NCT00725985|26759377|FG004|ITP- Treatment Disposition|Adverse Event|0|||
13385354|NCT00725985|26759378|FG005|ITP- Treatment Disposition|Adverse Event|0|||
13385355|NCT00725985|26759379|FG006|ITP- Treatment Disposition|Adverse Event|0|||
13385356|NCT00725985|26759380|FG007|ITP- Treatment Disposition|Adverse Event|0|||
13385357|NCT00725985|26759381|FG008|ITP- Treatment Disposition|Adverse Event|0|||
13385358|NCT00725985|26759382|FG009|ITP- Treatment Disposition|Adverse Event|0|||
13385359|NCT00725985|26759383|FG010|ITP- Treatment Disposition|Adverse Event|0|||
13385360|NCT00725985|26759384|FG011|ITP- Treatment Disposition|Adverse Event|0|||
13385361|NCT00725985|26759373|FG000|ITP- Treatment Disposition|Lost to Follow-up|0|||
13385362|NCT00725985|26759374|FG001|ITP- Treatment Disposition|Lost to Follow-up|0|||
13385363|NCT00725985|26759375|FG002|ITP- Treatment Disposition|Lost to Follow-up|2|||
13385364|NCT00725985|26759376|FG003|ITP- Treatment Disposition|Lost to Follow-up|0|||
13385365|NCT00725985|26759377|FG004|ITP- Treatment Disposition|Lost to Follow-up|0|||
13385366|NCT00725985|26759378|FG005|ITP- Treatment Disposition|Lost to Follow-up|0|||
13395038|NCT00652366|26789008|FG001|Overall Study|Lack of Efficacy|58|||
13395039|NCT00652366|26789009|FG002|Overall Study|Lack of Efficacy|53|||
13395040|NCT00652366|26789010|FG003|Overall Study|Lack of Efficacy|133|||
13395041|NCT00652366|26789011|FG004|Overall Study|Lack of Efficacy|13|||
13395042|NCT00652366|26789007|FG000|Overall Study|Violation of Selection Criteria|0|||
13395043|NCT00652366|26789008|FG001|Overall Study|Violation of Selection Criteria|0|||
13395044|NCT00652366|26789009|FG002|Overall Study|Violation of Selection Criteria|1|||
13395045|NCT00652366|26789010|FG003|Overall Study|Violation of Selection Criteria|0|||
13395046|NCT00652366|26789011|FG004|Overall Study|Violation of Selection Criteria|0|||
13395047|NCT00652366|26789007|FG000|Overall Study|Protocol Violation|1|||
13395048|NCT00652366|26789008|FG001|Overall Study|Protocol Violation|0|||
13395049|NCT00652366|26789009|FG002|Overall Study|Protocol Violation|0|||
13395050|NCT00652366|26789010|FG003|Overall Study|Protocol Violation|0|||
13395051|NCT00652366|26789011|FG004|Overall Study|Protocol Violation|0|||
13395052|NCT00652366|26789007|FG000|Overall Study|Refused treatment|3|||
13395053|NCT00652366|26789008|FG001|Overall Study|Refused treatment|7|||
13395054|NCT00652366|26789009|FG002|Overall Study|Refused treatment|6|||
13395055|NCT00652366|26789010|FG003|Overall Study|Refused treatment|17|||
13395056|NCT00652366|26789011|FG004|Overall Study|Refused treatment|5|||
13395057|NCT00652366|26789007|FG000|Overall Study|Other|5|||
13395058|NCT00652366|26789008|FG001|Overall Study|Other|2|||
13395059|NCT00652366|26789009|FG002|Overall Study|Other|3|||
13395060|NCT00652366|26789010|FG003|Overall Study|Other|4|||
13395061|NCT00652366|26789011|FG004|Overall Study|Other|0|||
13395062|NCT00652340|26789026|FG000|Overall Study|Had not progressed.|4|||
13395063|NCT00652340|26789027|FG001|Overall Study|Had not progressed.|3|||
13395064|NCT00652327|26789040|FG000|Overall Study|Adverse Event|0|||
13395065|NCT00652327|26789041|FG001|Overall Study|Adverse Event|2|||
13395066|NCT00652327|26789040|FG000|Overall Study|Lost to Follow-up|0|||
13395067|NCT00652327|26789041|FG001|Overall Study|Lost to Follow-up|3|||
13395068|NCT00652093|26789140|FG000|Overall Study|Withdrawal by Subject|0|||
13395069|NCT00652093|26789141|FG001|Overall Study|Withdrawal by Subject|0|||
13395070|NCT00652093|26789142|FG002|Overall Study|Withdrawal by Subject|1|||
13395071|NCT00652093|26789143|FG003|Overall Study|Withdrawal by Subject|0|||
13395072|NCT00652093|26789144|FG004|Overall Study|Withdrawal by Subject|1|||
13395073|NCT00652093|26789145|FG005|Overall Study|Withdrawal by Subject|0|||
13395074|NCT00652093|26789140|FG000|Overall Study|Physician Decision|0|||
13395075|NCT00652093|26789141|FG001|Overall Study|Physician Decision|0|||
13395076|NCT00652093|26789142|FG002|Overall Study|Physician Decision|0|||
13395077|NCT00652093|26789143|FG003|Overall Study|Physician Decision|0|||
13395078|NCT00652093|26789144|FG004|Overall Study|Physician Decision|1|||
13395079|NCT00652093|26789145|FG005|Overall Study|Physician Decision|0|||
13395080|NCT00652028|26789200|FG000|Overall Study|Adverse Event|1|||
13395081|NCT00652028|26789201|FG001|Overall Study|Adverse Event|0|||
13395082|NCT00652028|26789202|FG002|Overall Study|Adverse Event|0|||
13395083|NCT00652028|26789203|FG003|Overall Study|Adverse Event|0|||
13395084|NCT00652028|26789200|FG000|Overall Study|No Longer Meets Entry Criteria|0|||
13395085|NCT00652028|26789201|FG001|Overall Study|No Longer Meets Entry Criteria|1|||
13395086|NCT00652028|26789202|FG002|Overall Study|No Longer Meets Entry Criteria|0|||
13395087|NCT00652028|26789203|FG003|Overall Study|No Longer Meets Entry Criteria|0|||
13395088|NCT00652028|26789200|FG000|Overall Study|Physician Decision|0|||
13395089|NCT00652028|26789201|FG001|Overall Study|Physician Decision|0|||
13395090|NCT00652028|26789202|FG002|Overall Study|Physician Decision|1|||
13395091|NCT00652028|26789203|FG003|Overall Study|Physician Decision|0|||
13395092|NCT00651937|26789218|FG000|Overall Study|Withdrawal by Subject|4|||
13395093|NCT00651937|26789219|FG001|Overall Study|Withdrawal by Subject|1|||
13395094|NCT00651924|26789232|FG000|Overall Study|Withdrawal by PI|0|||
13395095|NCT00651924|26789233|FG001|Overall Study|Withdrawal by PI|2|||
13395096|NCT00651924|26789232|FG000|Overall Study|Withdrawal by Subject|0|||
13395097|NCT00651924|26789233|FG001|Overall Study|Withdrawal by Subject|5|||
13395098|NCT00651820|26789242|FG000|Overall Study|Lost to Follow-up|2|||
13395099|NCT00651755|26789261|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1|||
13395100|NCT00651755|26789262|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0|||
13395101|NCT00651755|26789261|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0|||
13395102|NCT00651755|26789262|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1|||
13395103|NCT00651664|26789417|FG000|Overall Study|Occurrence of Adverse Event(s)|0|||
13395104|NCT00651664|26789418|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
13385367|NCT00725985|26759379|FG006|ITP- Treatment Disposition|Lost to Follow-up|0|||
13385368|NCT00725985|26759380|FG007|ITP- Treatment Disposition|Lost to Follow-up|0|||
13385369|NCT00725985|26759381|FG008|ITP- Treatment Disposition|Lost to Follow-up|0|||
13385370|NCT00725985|26759382|FG009|ITP- Treatment Disposition|Lost to Follow-up|0|||
13385371|NCT00725985|26759383|FG010|ITP- Treatment Disposition|Lost to Follow-up|0|||
13385372|NCT00725985|26759384|FG011|ITP- Treatment Disposition|Lost to Follow-up|0|||
13385373|NCT00725985|26759373|FG000|ITP- Treatment Disposition|Randomized but not treated|1|||
13385374|NCT00725985|26759374|FG001|ITP- Treatment Disposition|Randomized but not treated|0|||
13385375|NCT00725985|26759375|FG002|ITP- Treatment Disposition|Randomized but not treated|0|||
13385376|NCT00725985|26759376|FG003|ITP- Treatment Disposition|Randomized but not treated|0|||
13385377|NCT00725985|26759377|FG004|ITP- Treatment Disposition|Randomized but not treated|0|||
13385378|NCT00725985|26759378|FG005|ITP- Treatment Disposition|Randomized but not treated|0|||
13385379|NCT00725985|26759379|FG006|ITP- Treatment Disposition|Randomized but not treated|0|||
13395105|NCT00651664|26789419|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
13395106|NCT00651664|26789420|FG003|Overall Study|Occurrence of Adverse Event(s)|0|||
13395107|NCT00651664|26789421|FG004|Overall Study|Occurrence of Adverse Event(s)|0|||
13395108|NCT00651664|26789422|FG005|Overall Study|Occurrence of Adverse Event(s)|0|||
13395109|NCT00651664|26789423|FG006|Overall Study|Occurrence of Adverse Event(s)|1|||
13395110|NCT00651664|26789424|FG007|Overall Study|Occurrence of Adverse Event(s)|0|||
13395111|NCT00651664|26789425|FG008|Overall Study|Occurrence of Adverse Event(s)|1|||
13395112|NCT00651664|26789426|FG009|Overall Study|Occurrence of Adverse Event(s)|0|||
13395113|NCT00651664|26789417|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
13395114|NCT00651664|26789418|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
13395115|NCT00651664|26789419|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
13395116|NCT00651664|26789420|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
13395117|NCT00651664|26789421|FG004|Overall Study|Unsatisfactory Therapeutic Response|1|||
13395118|NCT00651664|26789422|FG005|Overall Study|Unsatisfactory Therapeutic Response|1|||
13395119|NCT00651664|26789423|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
13395120|NCT00651664|26789424|FG007|Overall Study|Unsatisfactory Therapeutic Response|1|||
13395121|NCT00651664|26789425|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
13395122|NCT00651664|26789426|FG009|Overall Study|Unsatisfactory Therapeutic Response|1|||
13395123|NCT00651664|26789417|FG000|Overall Study|Progressive Disease|3|||
13395124|NCT00651664|26789418|FG001|Overall Study|Progressive Disease|3|||
13395125|NCT00651664|26789419|FG002|Overall Study|Progressive Disease|3|||
13395126|NCT00651664|26789420|FG003|Overall Study|Progressive Disease|12|||
13395127|NCT00651664|26789421|FG004|Overall Study|Progressive Disease|4|||
13395128|NCT00651664|26789422|FG005|Overall Study|Progressive Disease|1|||
13395129|NCT00651664|26789423|FG006|Overall Study|Progressive Disease|3|||
13395130|NCT00651664|26789424|FG007|Overall Study|Progressive Disease|6|||
13395131|NCT00651664|26789425|FG008|Overall Study|Progressive Disease|5|||
13395132|NCT00651664|26789426|FG009|Overall Study|Progressive Disease|5|||
13395133|NCT00651664|26789417|FG000|Overall Study|Patient Declined Further Treatment|0|||
13395134|NCT00651664|26789418|FG001|Overall Study|Patient Declined Further Treatment|0|||
13395135|NCT00651664|26789419|FG002|Overall Study|Patient Declined Further Treatment|0|||
13395136|NCT00651664|26789420|FG003|Overall Study|Patient Declined Further Treatment|1|||
13395137|NCT00651664|26789421|FG004|Overall Study|Patient Declined Further Treatment|1|||
13395138|NCT00651664|26789422|FG005|Overall Study|Patient Declined Further Treatment|1|||
13395139|NCT00651664|26789423|FG006|Overall Study|Patient Declined Further Treatment|0|||
13395140|NCT00651664|26789424|FG007|Overall Study|Patient Declined Further Treatment|0|||
13395141|NCT00651664|26789425|FG008|Overall Study|Patient Declined Further Treatment|0|||
13395142|NCT00651664|26789426|FG009|Overall Study|Patient Declined Further Treatment|1|||
13395143|NCT00651664|26789417|FG000|Overall Study|Symptomatic Deterioration|0|||
13395144|NCT00651664|26789418|FG001|Overall Study|Symptomatic Deterioration|0|||
13395145|NCT00651664|26789419|FG002|Overall Study|Symptomatic Deterioration|0|||
13395146|NCT00651664|26789420|FG003|Overall Study|Symptomatic Deterioration|1|||
13395147|NCT00651664|26789421|FG004|Overall Study|Symptomatic Deterioration|0|||
13395148|NCT00651664|26789422|FG005|Overall Study|Symptomatic Deterioration|0|||
13395149|NCT00651664|26789423|FG006|Overall Study|Symptomatic Deterioration|1|||
13395150|NCT00651664|26789424|FG007|Overall Study|Symptomatic Deterioration|0|||
13395151|NCT00651664|26789425|FG008|Overall Study|Symptomatic Deterioration|1|||
13395152|NCT00651664|26789426|FG009|Overall Study|Symptomatic Deterioration|0|||
13395153|NCT00651664|26789417|FG000|Overall Study|Reason not Specified|0|||
13395154|NCT00651664|26789418|FG001|Overall Study|Reason not Specified|0|||
13395155|NCT00651664|26789419|FG002|Overall Study|Reason not Specified|0|||
13395156|NCT00651664|26789420|FG003|Overall Study|Reason not Specified|0|||
13395157|NCT00651664|26789421|FG004|Overall Study|Reason not Specified|0|||
13395158|NCT00651664|26789422|FG005|Overall Study|Reason not Specified|0|||
13395159|NCT00651664|26789423|FG006|Overall Study|Reason not Specified|1|||
13395160|NCT00651664|26789424|FG007|Overall Study|Reason not Specified|0|||
13395161|NCT00651664|26789425|FG008|Overall Study|Reason not Specified|0|||
13395162|NCT00651664|26789426|FG009|Overall Study|Reason not Specified|0|||
13395163|NCT00651313|26789439|FG000|Overall Study|Adverse Event|0|||
13395164|NCT00651313|26789440|FG001|Overall Study|Adverse Event|1|||
13395165|NCT00651313|26789439|FG000|Overall Study|Withdrawal by Subject|3|||
13395166|NCT00651313|26789440|FG001|Overall Study|Withdrawal by Subject|1|||
13395167|NCT00651313|26789439|FG000|Overall Study|Lost to Follow-up|1|||
13395168|NCT00651313|26789440|FG001|Overall Study|Lost to Follow-up|1|||
13395169|NCT00651313|26789439|FG000|Overall Study|Adminstrative Discontinuation|2|||
13385380|NCT00725985|26759380|FG007|ITP- Treatment Disposition|Randomized but not treated|0|||
13385381|NCT00725985|26759381|FG008|ITP- Treatment Disposition|Randomized but not treated|0|||
13385382|NCT00725985|26759382|FG009|ITP- Treatment Disposition|Randomized but not treated|0|||
13385383|NCT00725985|26759383|FG010|ITP- Treatment Disposition|Randomized but not treated|0|||
13385384|NCT00725985|26759384|FG011|ITP- Treatment Disposition|Randomized but not treated|0|||
13385385|NCT00725985|26759373|FG000|ITP- Treatment Disposition|Converted to CDMS|30|||
13385386|NCT00725985|26759374|FG001|ITP- Treatment Disposition|Converted to CDMS|27|||
13385387|NCT00725985|26759375|FG002|ITP- Treatment Disposition|Converted to CDMS|71|||
13385388|NCT00725985|26759376|FG003|ITP- Treatment Disposition|Converted to CDMS|0|||
13385389|NCT00725985|26759377|FG004|ITP- Treatment Disposition|Converted to CDMS|0|||
13385390|NCT00725985|26759378|FG005|ITP- Treatment Disposition|Converted to CDMS|0|||
13385391|NCT00725985|26759379|FG006|ITP- Treatment Disposition|Converted to CDMS|0|||
13385392|NCT00725985|26759380|FG007|ITP- Treatment Disposition|Converted to CDMS|0|||
13385393|NCT00725985|26759381|FG008|ITP- Treatment Disposition|Converted to CDMS|0|||
13385394|NCT00725985|26759382|FG009|ITP- Treatment Disposition|Converted to CDMS|0|||
13385395|NCT00725985|26759383|FG010|ITP- Treatment Disposition|Converted to CDMS|0|||
13385396|NCT00725985|26759384|FG011|ITP- Treatment Disposition|Converted to CDMS|0|||
13385397|NCT00725985|26759373|FG000|ITP- Treatment Disposition|Other|50|||
13385398|NCT00725985|26759374|FG001|ITP- Treatment Disposition|Other|38|||
13385399|NCT00725985|26759375|FG002|ITP- Treatment Disposition|Other|24|||
13385400|NCT00725985|26759376|FG003|ITP- Treatment Disposition|Other|0|||
13385401|NCT00725985|26759377|FG004|ITP- Treatment Disposition|Other|0|||
13385402|NCT00725985|26759378|FG005|ITP- Treatment Disposition|Other|0|||
13385403|NCT00725985|26759379|FG006|ITP- Treatment Disposition|Other|0|||
13385404|NCT00725985|26759380|FG007|ITP- Treatment Disposition|Other|0|||
13385405|NCT00725985|26759381|FG008|ITP- Treatment Disposition|Other|0|||
13385406|NCT00725985|26759382|FG009|ITP- Treatment Disposition|Other|0|||
13385407|NCT00725985|26759383|FG010|ITP- Treatment Disposition|Other|0|||
13385408|NCT00725985|26759384|FG011|ITP- Treatment Disposition|Other|0|||
13385409|NCT00725985|26759373|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0|||
13385410|NCT00725985|26759374|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0|||
13385411|NCT00725985|26759375|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0|||
13385412|NCT00725985|26759376|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2|||
13385413|NCT00725985|26759377|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2|||
13385414|NCT00725985|26759378|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5|||
13385415|NCT00725985|26759379|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0|||
13385416|NCT00725985|26759380|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0|||
13385417|NCT00725985|26759381|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0|||
13385418|NCT00725985|26759382|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0|||
13385419|NCT00725985|26759383|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0|||
13385420|NCT00725985|26759384|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0|||
13385421|NCT00725985|26759373|FG000|OLMP (Up to 96 Weeks)|Death|0|||
13385422|NCT00725985|26759374|FG001|OLMP (Up to 96 Weeks)|Death|0|||
13385423|NCT00725985|26759375|FG002|OLMP (Up to 96 Weeks)|Death|0|||
13385424|NCT00725985|26759376|FG003|OLMP (Up to 96 Weeks)|Death|0|||
13385425|NCT00725985|26759377|FG004|OLMP (Up to 96 Weeks)|Death|1|||
13385426|NCT00725985|26759378|FG005|OLMP (Up to 96 Weeks)|Death|0|||
13385427|NCT00725985|26759379|FG006|OLMP (Up to 96 Weeks)|Death|0|||
13385428|NCT00725985|26759380|FG007|OLMP (Up to 96 Weeks)|Death|0|||
13385429|NCT00725985|26759381|FG008|OLMP (Up to 96 Weeks)|Death|0|||
13385430|NCT00725985|26759382|FG009|OLMP (Up to 96 Weeks)|Death|0|||
13385431|NCT00725985|26759383|FG010|OLMP (Up to 96 Weeks)|Death|0|||
13385432|NCT00725985|26759384|FG011|OLMP (Up to 96 Weeks)|Death|0|||
13385433|NCT00725985|26759373|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
13385434|NCT00725985|26759374|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
13385435|NCT00725985|26759375|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
13385436|NCT00725985|26759376|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1|||
13385437|NCT00725985|26759377|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
13385438|NCT00725985|26759378|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
13385439|NCT00725985|26759379|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
13385440|NCT00725985|26759380|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
13385441|NCT00725985|26759381|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
13385442|NCT00725985|26759382|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
13385443|NCT00725985|26759383|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
13385444|NCT00725985|26759384|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
13385445|NCT00725985|26759373|FG000|OLMP (Up to 96 Weeks)|Disease progression|0|||
13385446|NCT00725985|26759374|FG001|OLMP (Up to 96 Weeks)|Disease progression|0|||
13385447|NCT00725985|26759375|FG002|OLMP (Up to 96 Weeks)|Disease progression|0|||
13385448|NCT00725985|26759376|FG003|OLMP (Up to 96 Weeks)|Disease progression|0|||
13385449|NCT00725985|26759377|FG004|OLMP (Up to 96 Weeks)|Disease progression|0|||
13385450|NCT00725985|26759378|FG005|OLMP (Up to 96 Weeks)|Disease progression|4|||
13385451|NCT00725985|26759379|FG006|OLMP (Up to 96 Weeks)|Disease progression|0|||
13385452|NCT00725985|26759380|FG007|OLMP (Up to 96 Weeks)|Disease progression|0|||
13385453|NCT00725985|26759381|FG008|OLMP (Up to 96 Weeks)|Disease progression|0|||
13385454|NCT00725985|26759382|FG009|OLMP (Up to 96 Weeks)|Disease progression|0|||
13385455|NCT00725985|26759383|FG010|OLMP (Up to 96 Weeks)|Disease progression|0|||
13385456|NCT00725985|26759384|FG011|OLMP (Up to 96 Weeks)|Disease progression|0|||
13385457|NCT00725985|26759373|FG000|OLMP (Up to 96 Weeks)|Other|0|||
13385458|NCT00725985|26759374|FG001|OLMP (Up to 96 Weeks)|Other|0|||
13385459|NCT00725985|26759375|FG002|OLMP (Up to 96 Weeks)|Other|0|||
13385460|NCT00725985|26759376|FG003|OLMP (Up to 96 Weeks)|Other|15|||
13385461|NCT00725985|26759377|FG004|OLMP (Up to 96 Weeks)|Other|20|||
13385462|NCT00725985|26759378|FG005|OLMP (Up to 96 Weeks)|Other|44|||
13385463|NCT00725985|26759379|FG006|OLMP (Up to 96 Weeks)|Other|0|||
13385464|NCT00725985|26759380|FG007|OLMP (Up to 96 Weeks)|Other|0|||
13385465|NCT00725985|26759381|FG008|OLMP (Up to 96 Weeks)|Other|0|||
13385466|NCT00725985|26759382|FG009|OLMP (Up to 96 Weeks)|Other|0|||
13385467|NCT00725985|26759383|FG010|OLMP (Up to 96 Weeks)|Other|0|||
13385468|NCT00725985|26759384|FG011|OLMP (Up to 96 Weeks)|Other|0|||
13385469|NCT00725985|26759373|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
13385470|NCT00725985|26759374|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
13385471|NCT00725985|26759375|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
13385472|NCT00725985|26759376|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
13385473|NCT00725985|26759377|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
13385474|NCT00725985|26759378|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
13385475|NCT00725985|26759379|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
13385476|NCT00725985|26759380|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1|||
13385477|NCT00725985|26759381|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
13385478|NCT00725985|26759382|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
13385479|NCT00725985|26759383|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
13385480|NCT00725985|26759384|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
13385481|NCT00725985|26759373|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
13385482|NCT00725985|26759374|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
13385483|NCT00725985|26759375|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
13385484|NCT00725985|26759376|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
13385485|NCT00725985|26759377|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
13385486|NCT00725985|26759378|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
13385487|NCT00725985|26759379|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
13385488|NCT00725985|26759380|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
13385489|NCT00725985|26759381|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1|||
13385490|NCT00725985|26759382|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
13385491|NCT00725985|26759383|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
13385492|NCT00725985|26759384|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
13385493|NCT00725985|26759373|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
13385494|NCT00725985|26759374|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
13385495|NCT00725985|26759375|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
13385496|NCT00725985|26759376|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
13385497|NCT00725985|26759377|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
13385498|NCT00725985|26759378|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
13385499|NCT00725985|26759379|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9|||
13385500|NCT00725985|26759380|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8|||
13385501|NCT00725985|26759381|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16|||
13385502|NCT00725985|26759382|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
13385503|NCT00725985|26759383|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
13385504|NCT00725985|26759384|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
13385505|NCT00725985|26759373|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0|||
13385506|NCT00725985|26759374|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0|||
13385507|NCT00725985|26759375|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0|||
13385508|NCT00725985|26759376|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0|||
13385509|NCT00725985|26759377|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0|||
13385510|NCT00725985|26759378|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0|||
13385511|NCT00725985|26759379|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0|||
13385512|NCT00725985|26759380|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0|||
13385513|NCT00725985|26759381|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0|||
13385514|NCT00725985|26759382|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34|||
13385515|NCT00725985|26759383|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36|||
13385516|NCT00725985|26759384|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14|||
13385517|NCT00725920|26759397|FG000|Overall Study|Lack of Efficacy|3|||
13385518|NCT00725920|26759398|FG001|Overall Study|Lack of Efficacy|6|||
13385519|NCT00725842|26759407|FG000|Overall Study|Lost to Follow-up|19|||
13385520|NCT00725842|26759407|FG000|Overall Study|Death|1|||
13385521|NCT00725842|26759407|FG000|Overall Study|Positive HCV-RNA at Visit 2|13|||
13385522|NCT00725842|26759407|FG000|Overall Study|Consent date prior to study start date|5|||
13385523|NCT00725842|26759407|FG000|Overall Study|Inclusion criterion not met|1|||
13385524|NCT00725842|26759407|FG000|Overall Study|No Visit 1 data|1|||
13385525|NCT00725764|26759427|FG000|Overall Study|Withdrawal by Subject|2|||
13385526|NCT00725764|26759427|FG000|Overall Study|Physician Decision|1|||
13385527|NCT00725764|26759427|FG000|Overall Study|Progressive Disease|7|||
13385528|NCT00725764|26759427|FG000|Overall Study|Lost to Follow-up|1|||
13385529|NCT00725764|26759427|FG000|Overall Study|Death|1|||
13385530|NCT00725764|26759427|FG000|Overall Study|Participant non compliant with protocol|1|||
13385531|NCT00725764|26759427|FG000|Overall Study|Decline in performance status|1|||
13385532|NCT00725725|26759478|FG000|Overall Study|Adverse Event|1|||
13385533|NCT00725725|26759479|FG001|Overall Study|Adverse Event|3|||
13385534|NCT00725725|26759480|FG002|Overall Study|Adverse Event|2|||
13385535|NCT00725725|26759478|FG000|Overall Study|Lost to Follow-up|2|||
13385536|NCT00725725|26759479|FG001|Overall Study|Lost to Follow-up|0|||
13385537|NCT00725725|26759480|FG002|Overall Study|Lost to Follow-up|2|||
13385538|NCT00725725|26759478|FG000|Overall Study|Withdrawal by Subject|1|||
13385539|NCT00725725|26759479|FG001|Overall Study|Withdrawal by Subject|0|||
13385540|NCT00725725|26759480|FG002|Overall Study|Withdrawal by Subject|1|||
13385541|NCT00725725|26759478|FG000|Overall Study|Protocol Violation|0|||
13385542|NCT00725725|26759479|FG001|Overall Study|Protocol Violation|1|||
13385543|NCT00725725|26759480|FG002|Overall Study|Protocol Violation|0|||
13385544|NCT00725712|26759523|FG000|Overall Study|Withdrawal by Subject|2|||
13385545|NCT00725712|26759524|FG001|Overall Study|Withdrawal by Subject|1|||
13385546|NCT00725712|26759523|FG000|Overall Study|Protocol Violation|1|||
13385547|NCT00725712|26759524|FG001|Overall Study|Protocol Violation|0|||
13385548|NCT00725712|26759523|FG000|Overall Study|Progressive disease|37|||
13385549|NCT00725712|26759524|FG001|Overall Study|Progressive disease|16|||
13385550|NCT00725712|26759523|FG000|Overall Study|Clinical progression not based on RECIST|0|||
13385551|NCT00725712|26759524|FG001|Overall Study|Clinical progression not based on RECIST|3|||
13385552|NCT00725712|26759523|FG000|Overall Study|Adverse Event|5|||
13385553|NCT00725712|26759524|FG001|Overall Study|Adverse Event|5|||
13385554|NCT00725712|26759523|FG000|Overall Study|Death|2|||
13385555|NCT00725712|26759524|FG001|Overall Study|Death|0|||
13385556|NCT00725712|26759523|FG000|Overall Study|Other: Death|1|||
13385557|NCT00725712|26759524|FG001|Overall Study|Other: Death|0|||
13385558|NCT00725712|26759523|FG000|Overall Study|Hospitalized, unable to continue|0|||
13385559|NCT00725712|26759524|FG001|Overall Study|Hospitalized, unable to continue|1|||
13385560|NCT00725621|26759549|FG000|Overall Study|Adverse Event|25|||
13385561|NCT00725621|26759549|FG000|Overall Study|Lack of Efficacy|46|||
13385562|NCT00725621|26759549|FG000|Overall Study|Withdrawal by Subject|57|||
13385563|NCT00725621|26759549|FG000|Overall Study|Physician Decision|19|||
13385564|NCT00725621|26759549|FG000|Overall Study|Lost to Follow-up|52|||
13385565|NCT00725621|26759549|FG000|Overall Study|Non-compliance|8|||
13385566|NCT00725621|26759549|FG000|Overall Study|Continued treatment by other physician|6|||
13385567|NCT00725621|26759549|FG000|Overall Study|Switched to other study|1|||
13385568|NCT00725621|26759549|FG000|Overall Study|Switched to other drug|1|||
13385569|NCT00725621|26759549|FG000|Overall Study|Prepared for elective surgery|1|||
13385570|NCT00725621|26759549|FG000|Overall Study|Reason not specified|55|||
13385571|NCT00725608|26759557|FG000|Overall Study|Lost to Follow-up|60|||
13385572|NCT00725608|26759557|FG000|Overall Study|Adverse Event|14|||
13385573|NCT00725608|26759557|FG000|Overall Study|Individual reasons|86|||
13385574|NCT00725608|26759557|FG000|Overall Study|Other|7|||
13385575|NCT00725543|26759568|FG000|Overall Study|Adverse Event|10|||
13385576|NCT00725543|26759568|FG000|Overall Study|Lack of Efficacy|3|||
13385577|NCT00725543|26759568|FG000|Overall Study|Withdrawal by Subject|10|||
13385578|NCT00725543|26759568|FG000|Overall Study|Physician Decision|5|||
13385579|NCT00725543|26759568|FG000|Overall Study|Lost to Follow-up|4|||
13385580|NCT00725543|26759568|FG000|Overall Study|Non-compliance|2|||
13385581|NCT00725543|26759568|FG000|Overall Study|Other|119|||
13385582|NCT00725452|26759579|FG000|Overall Study|Adverse Event|3|||
13385583|NCT00725452|26759579|FG000|Overall Study|Lack of Efficacy|2|||
13385584|NCT00725452|26759579|FG000|Overall Study|Reason not specified|1|||
13385585|NCT00725452|26759579|FG000|Overall Study|Physician Decision|1|||
13385586|NCT00725452|26759579|FG000|Overall Study|Withdrawal by Subject|3|||
13385587|NCT00725452|26759579|FG000|Overall Study|Lost to Follow-up|1|||
13385588|NCT00725322|26759594|FG000|Washout (28 Days)|Withdrawal by Subject|2|||
13385589|NCT00725322|26759595|FG001|Washout (28 Days)|Withdrawal by Subject|0|||
13385590|NCT00725322|26759594|FG000|Washout (28 Days)|Protocol Violation|0|||
13385591|NCT00725322|26759595|FG001|Washout (28 Days)|Protocol Violation|1|||
13385592|NCT00725296|26759606|FG000|Overall Study|Adverse Event|11|||
13385593|NCT00725296|26759606|FG000|Overall Study|Lack of Efficacy|7|||
13385594|NCT00725296|26759606|FG000|Overall Study|Withdrawal by Subject|3|||
13385595|NCT00725296|26759606|FG000|Overall Study|Non-Compliance|2|||
13385596|NCT00725296|26759606|FG000|Overall Study|Lost to Follow-up|1|||
13385597|NCT00725296|26759606|FG000|Overall Study|Other|38|||
13385598|NCT00725283|26759618|FG000|Overall Study|Missing Code|3|||
13385599|NCT00725283|26759618|FG000|Overall Study|Death|5|||
13385600|NCT00725283|26759618|FG000|Overall Study|Other|6|||
13385601|NCT00725283|26759618|FG000|Overall Study|Withdrawal by Subject|10|||
13385602|NCT00725205|26759626|FG000|Overall Study|Adverse Event|22|||
13385603|NCT00725205|26759626|FG000|Overall Study|Investigator Discontinued|1|||
13385604|NCT00725205|26759626|FG000|Overall Study|Non-compliance With Protocol|14|||
13385605|NCT00725205|26759626|FG000|Overall Study|Other|8|||
13385606|NCT00725205|26759626|FG000|Overall Study|Protocol Defined Clinical Event|1|||
13385607|NCT00725205|26759626|FG000|Overall Study|Treatment Failure|41|||
13385608|NCT00725101|26759648|FG000|Overall Study|Death|3|||
13385609|NCT00725101|26759648|FG000|Overall Study|Lost to Follow-up|353|||
13385610|NCT00725101|26759648|FG000|Overall Study|Protocol Violation|1|||
13385611|NCT00725101|26759648|FG000|Overall Study|Withdrawal by Subject|127|||
13385612|NCT00725101|26759648|FG000|Overall Study|not specified/no reason given|11|||
13385613|NCT00725075|26759702|FG000|Overall Study|Use of Excluded Medication|0|||
13385614|NCT00725075|26759703|FG001|Overall Study|Use of Excluded Medication|1|||
13385615|NCT00725075|26759704|FG002|Overall Study|Use of Excluded Medication|0|||
13385616|NCT00725075|26759702|FG000|Overall Study|Protocol Violation|0|||
13385617|NCT00725075|26759703|FG001|Overall Study|Protocol Violation|0|||
13385618|NCT00725075|26759704|FG002|Overall Study|Protocol Violation|1|||
13385619|NCT00725075|26759702|FG000|Overall Study|Lost to Follow-up|1|||
13385620|NCT00725075|26759703|FG001|Overall Study|Lost to Follow-up|0|||
13385621|NCT00725075|26759704|FG002|Overall Study|Lost to Follow-up|0|||
13385622|NCT00725075|26759702|FG000|Overall Study|Withdrawal by Subject|4|||
13385623|NCT00725075|26759703|FG001|Overall Study|Withdrawal by Subject|5|||
13385624|NCT00725075|26759704|FG002|Overall Study|Withdrawal by Subject|4|||
13385625|NCT00725075|26759702|FG000|Overall Study|Adverse Event|2|||
13385626|NCT00725075|26759703|FG001|Overall Study|Adverse Event|1|||
13385627|NCT00725075|26759704|FG002|Overall Study|Adverse Event|1|||
13385628|NCT00725075|26759702|FG000|Overall Study|Worsening of Disease|2|||
13385629|NCT00725075|26759703|FG001|Overall Study|Worsening of Disease|1|||
13385630|NCT00725075|26759704|FG002|Overall Study|Worsening of Disease|2|||
13385631|NCT00725075|26759702|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
13385632|NCT00725075|26759703|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
13385633|NCT00725075|26759704|FG002|Overall Study|Inclusion/Exclusion Criteria|1|||
13385634|NCT00725075|26759702|FG000|Overall Study|Other|1|||
13385635|NCT00725075|26759703|FG001|Overall Study|Other|0|||
13385636|NCT00725075|26759704|FG002|Overall Study|Other|0|||
13385637|NCT00725010|26759714|FG000|Overall Study|Toxicity|9|||
13385638|NCT00725010|26759714|FG000|Overall Study|Tumor Progression|7|||
13385639|NCT00725010|26759714|FG000|Overall Study|Withdrawal by Subject|2|||
13385640|NCT00725010|26759714|FG000|Overall Study|Death|1|||
13385641|NCT00725010|26759714|FG000|Overall Study|Lost to Follow-up|1|||
13385642|NCT00725010|26759714|FG000|Overall Study|Hepatopathy probably not Temodal-related|1|||
13385643|NCT00725010|26759714|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1|||
13385644|NCT00725010|26759714|FG000|Overall Study|No further documentation|1|||
13385645|NCT00725010|26759714|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2|||
13385646|NCT00724971|26759731|FG000|Overall Study|Adverse Event|5|||
13385647|NCT00724971|26759731|FG000|Overall Study|Withdrawal by Subject|1|||
13385648|NCT00724958|26759742|FG000|Overall Study|Adverse Event|28|||
13385649|NCT00724958|26759742|FG000|Overall Study|Loss of Response|40|||
13385650|NCT00724958|26759742|FG000|Overall Study|No Response|18|||
13385651|NCT00724958|26759742|FG000|Overall Study|Remission|7|||
13385652|NCT00724958|26759742|FG000|Overall Study|Other Reason|76|||
13385653|NCT00724958|26759742|FG000|Overall Study|No documentation for end of therapy|13|||
13385654|NCT00724945|26759755|FG000|Period 1|non-compliance|1|||
13385655|NCT00724945|26759756|FG001|Period 1|non-compliance|0|||
13385656|NCT00724945|26759755|FG000|Period 1|Adverse Event|1|||
13385657|NCT00724945|26759756|FG001|Period 1|Adverse Event|1|||
13385658|NCT00724945|26759755|FG000|Period 1|Lost to Follow-up|1|||
13385659|NCT00724945|26759756|FG001|Period 1|Lost to Follow-up|0|||
13385660|NCT00724945|26759755|FG000|Period 2|lens comfort issue|3|||
13385661|NCT00724945|26759756|FG001|Period 2|lens comfort issue|0|||
13385662|NCT00724945|26759755|FG000|Period 2|lens physiology issue|1|||
13385663|NCT00724945|26759756|FG001|Period 2|lens physiology issue|0|||
13385664|NCT00724932|26759832|FG000|Overall Study|Lost to Follow-up|1|||
13385665|NCT00724932|26759833|FG001|Overall Study|Lost to Follow-up|0|||
13385666|NCT00724932|26759832|FG000|Overall Study|Not treated|4|||
13385667|NCT00724932|26759833|FG001|Overall Study|Not treated|3|||
13385668|NCT00724893|26759908|FG000|Overall Study|Adverse Event|76|||
13385669|NCT00724893|26759909|FG001|Overall Study|Adverse Event|142|||
13385670|NCT00724893|26759908|FG000|Overall Study|Withdrawal by Subject|0|||
13385671|NCT00724893|26759909|FG001|Overall Study|Withdrawal by Subject|1|||
13385672|NCT00724893|26759908|FG000|Overall Study|Lack of virologic response|94|||
13385673|NCT00724893|26759909|FG001|Overall Study|Lack of virologic response|202|||
13385674|NCT00724893|26759908|FG000|Overall Study|Reason not specified|193|||
13385675|NCT00724893|26759909|FG001|Overall Study|Reason not specified|7|||
13385676|NCT00724893|26759908|FG000|Overall Study|Patient choice|0|||
13385677|NCT00724893|26759909|FG001|Overall Study|Patient choice|26|||
13385678|NCT00724893|26759908|FG000|Overall Study|Geographic reasons|0|||
13385679|NCT00724893|26759909|FG001|Overall Study|Geographic reasons|11|||
13385680|NCT00724893|26759908|FG000|Overall Study|Incarceration|0|||
13385681|NCT00724893|26759909|FG001|Overall Study|Incarceration|9|||
13385682|NCT00724893|26759908|FG000|Overall Study|Substance abuse|0|||
13385683|NCT00724893|26759909|FG001|Overall Study|Substance abuse|3|||
13385684|NCT00724893|26759908|FG000|Overall Study|Financial reasons|0|||
13385685|NCT00724893|26759909|FG001|Overall Study|Financial reasons|2|||
13385686|NCT00724893|26759908|FG000|Overall Study|Assigned shorter treatment|0|||
13385687|NCT00724893|26759909|FG001|Overall Study|Assigned shorter treatment|2|||
13385688|NCT00724893|26759908|FG000|Overall Study|Lost to Follow-up|0|||
13385689|NCT00724893|26759909|FG001|Overall Study|Lost to Follow-up|52|||
13385690|NCT00724893|26759908|FG000|Overall Study|Unknown, missing data|1|||
13385691|NCT00724893|26759909|FG001|Overall Study|Unknown, missing data|1|||
13385692|NCT00724867|26759949|FG000|Overall Study|Adverse Event|25|||
13385693|NCT00724867|26759949|FG000|Overall Study|Lack of Efficacy|14|||
13385694|NCT00724867|26759949|FG000|Overall Study|Lost to Follow-up|12|||
13385695|NCT00724867|26759949|FG000|Overall Study|Non-compliance with study drug|6|||
13385696|NCT00724867|26759949|FG000|Overall Study|Physician Decision|17|||
13385697|NCT00724867|26759949|FG000|Overall Study|Protocol Violation|1|||
13385698|NCT00724867|26759949|FG000|Overall Study|Withdrawal by Subject|31|||
13385699|NCT00724867|26759949|FG000|Overall Study|Sponsor decision to end study|14|||
13385700|NCT00724867|26759949|FG000|Overall Study|Subject incarcerated|1|||
13385701|NCT00724867|26759949|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4|||
13385702|NCT00724867|26759949|FG000|Overall Study|Subject moved out of state|1|||
13385703|NCT00724867|26759949|FG000|Overall Study|Elected to exit due to site closure|2|||
13385704|NCT00724854|26759971|FG000|Overall Study|Lack of Efficacy|187|||
13385705|NCT00724854|26759972|FG001|Overall Study|Lack of Efficacy|13|||
13385706|NCT00724854|26759971|FG000|Overall Study|Lost to Follow-up|87|||
13385707|NCT00724854|26759972|FG001|Overall Study|Lost to Follow-up|10|||
13385708|NCT00724854|26759971|FG000|Overall Study|Adverse Event|62|||
13385709|NCT00724854|26759972|FG001|Overall Study|Adverse Event|4|||
13385710|NCT00724854|26759971|FG000|Overall Study|Other|42|||
13385711|NCT00724854|26759972|FG001|Overall Study|Other|3|||
13385712|NCT00724854|26759971|FG000|Overall Study|Death|11|||
13385713|NCT00724854|26759972|FG001|Overall Study|Death|0|||
13385714|NCT00724854|26759971|FG000|Overall Study|Change of treatment|7|||
13385715|NCT00724854|26759972|FG001|Overall Study|Change of treatment|0|||
13385716|NCT00724854|26759971|FG000|Overall Study|Withdrawal by Subject|5|||
13385717|NCT00724854|26759972|FG001|Overall Study|Withdrawal by Subject|0|||
13385718|NCT00724854|26759971|FG000|Overall Study|Adverse event + lack of efficacy|2|||
13385719|NCT00724854|26759972|FG001|Overall Study|Adverse event + lack of efficacy|1|||
13385720|NCT00724815|26759991|FG000|Overall Study|Randomized, not treated|31|||
13385721|NCT00724815|26759992|FG001|Overall Study|Randomized, not treated|30|||
13385722|NCT00724815|26759991|FG000|Overall Study|Adverse Event|5|||
13385723|NCT00724815|26759992|FG001|Overall Study|Adverse Event|3|||
13385724|NCT00724815|26759991|FG000|Overall Study|Lost to Follow-up|4|||
13385725|NCT00724815|26759992|FG001|Overall Study|Lost to Follow-up|1|||
13385726|NCT00724815|26759991|FG000|Overall Study|Other Various|3|||
13385727|NCT00724815|26759992|FG001|Overall Study|Other Various|5|||
13385728|NCT00724711|26760031|FG000|Overall Study|Adverse Event|7|||
13385729|NCT00724711|26760032|FG001|Overall Study|Adverse Event|3|||
13385730|NCT00724711|26760031|FG000|Overall Study|Pregnancy|0|||
13385731|NCT00724711|26760032|FG001|Overall Study|Pregnancy|1|||
13385732|NCT00724711|26760031|FG000|Overall Study|Lack of Efficacy|0|||
13385733|NCT00724711|26760032|FG001|Overall Study|Lack of Efficacy|1|||
13385734|NCT00724711|26760031|FG000|Overall Study|Physician Decision|0|||
13385735|NCT00724711|26760032|FG001|Overall Study|Physician Decision|3|||
13385736|NCT00724711|26760031|FG000|Overall Study|Withdrawal by Subject|5|||
13385737|NCT00724711|26760032|FG001|Overall Study|Withdrawal by Subject|4|||
13385738|NCT00724711|26760031|FG000|Overall Study|Lost to Follow-up|4|||
13385739|NCT00724711|26760032|FG001|Overall Study|Lost to Follow-up|5|||
13385740|NCT00724711|26760031|FG000|Overall Study|Protocol Violation|1|||
13385741|NCT00724711|26760032|FG001|Overall Study|Protocol Violation|0|||
13385742|NCT00724503|26760047|FG000|Overall Study|Lost to Follow-up|4|||
13385743|NCT00724503|26760048|FG001|Overall Study|Lost to Follow-up|8|||
13385744|NCT00724503|26760047|FG000|Overall Study|Withdrawal by Subject|11|||
13385745|NCT00724503|26760048|FG001|Overall Study|Withdrawal by Subject|23|||
13385746|NCT00724503|26760047|FG000|Overall Study|Death|190|||
13385747|NCT00724503|26760048|FG001|Overall Study|Death|182|||
13385748|NCT00724503|26760047|FG000|Overall Study|Adverse Event|1|||
13385749|NCT00724503|26760048|FG001|Overall Study|Adverse Event|0|||
13385750|NCT00724503|26760047|FG000|Overall Study|Not otherwise specified|4|||
13385751|NCT00724503|26760048|FG001|Overall Study|Not otherwise specified|7|||
13385752|NCT00724451|26760056|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7|||
13385753|NCT00724451|26760056|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3|||
13385754|NCT00724451|26760056|FG000|Overall Study|Not Eligible for Treatment|431|||
13385755|NCT00724451|26760056|FG000|Overall Study|Participant Refused Treatment|89|||
13385756|NCT00724451|26760056|FG000|Overall Study|Never Started Treatment|89|||
13385757|NCT00724451|26760056|FG000|Overall Study|Unknown; No Data Sources Available|9|||
13385758|NCT00724451|26760056|FG000|Overall Study|Physician Decision|116|||
13385759|NCT00724451|26760056|FG000|Overall Study|Withdrawal by Subject|45|||
13385760|NCT00724451|26760056|FG000|Overall Study|Investigator + Participant Decision|13|||
13385761|NCT00724373|26760062|FG000|Overall Study|Adverse Event|41|||
13385762|NCT00724373|26760062|FG000|Overall Study|Lack of Efficacy|82|||
13385763|NCT00724373|26760062|FG000|Overall Study|Lost to Follow-up|7|||
13385764|NCT00724373|26760062|FG000|Overall Study|Non-compliance|2|||
13385765|NCT00724373|26760062|FG000|Overall Study|HCV RNA negative after 4 weeks|9|||
13385766|NCT00724373|26760062|FG000|Overall Study|Participant moved away|1|||
13385767|NCT00724373|26760062|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2|||
13385768|NCT00724373|26760062|FG000|Overall Study|Only to have 24 week regimen|1|||
13385769|NCT00724373|26760062|FG000|Overall Study|Viral Relapse|1|||
13385770|NCT00724373|26760062|FG000|Overall Study|Acute HCV infection|1|||
13385771|NCT00724373|26760062|FG000|Overall Study|Drug Relapse|1|||
13385772|NCT00724373|26760062|FG000|Overall Study|Tolerability|23|||
13385773|NCT00724282|26760068|FG000|Overall Study|Withdrawal by Subject|3|||
13385774|NCT00724282|26760068|FG000|Overall Study|Physician Decision|1|||
13385775|NCT00724243|26760075|FG000|Overall Study|Lack of Efficacy|10|||
13385776|NCT00724243|26760075|FG000|Overall Study|Adverse Event|5|||
13385777|NCT00724152|26760104|FG000|Two-arm Study Period|Withdrawal by Subject|3|||
13385778|NCT00724152|26760105|FG001|Two-arm Study Period|Withdrawal by Subject|2|||
13385779|NCT00724152|26760106|FG002|Two-arm Study Period|Withdrawal by Subject|0|||
13385780|NCT00724152|26760104|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
13385781|NCT00724152|26760105|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2|||
13385782|NCT00724152|26760106|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
13385783|NCT00724126|26760121|FG000|Overall Study|Adverse Event|2|||
13385784|NCT00724126|26760122|FG001|Overall Study|Adverse Event|0|||
13385785|NCT00724126|26760121|FG000|Overall Study|Withdrawal by Subject|8|||
13385786|NCT00724126|26760122|FG001|Overall Study|Withdrawal by Subject|6|||
13385787|NCT00724126|26760121|FG000|Overall Study|Lost to Follow-up|6|||
13385788|NCT00724126|26760122|FG001|Overall Study|Lost to Follow-up|6|||
13385789|NCT00724126|26760121|FG000|Overall Study|Noncompliance|2|||
13385790|NCT00724126|26760122|FG001|Overall Study|Noncompliance|1|||
13385791|NCT00724126|26760121|FG000|Overall Study|Subject randomized although ineligible|1|||
13385792|NCT00724126|26760122|FG001|Overall Study|Subject randomized although ineligible|1|||
13385793|NCT00724126|26760121|FG000|Overall Study|Subject had to leave vicinity of site|0|||
13385794|NCT00724126|26760122|FG001|Overall Study|Subject had to leave vicinity of site|1|||
13385795|NCT00724061|26760131|FG000|Dose Escalation Phase|Adverse Event|2|||
13385796|NCT00724061|26760131|FG000|Dose Escalation Phase|Disease Progression|3|||
13385797|NCT00723957|26760160|FG000|Overall Study|Adverse event unrelated to study drug|1|||
13385798|NCT00723957|26760161|FG001|Overall Study|Adverse event unrelated to study drug|4|||
13385799|NCT00723957|26760160|FG000|Overall Study|Death|3|||
13385800|NCT00723957|26760161|FG001|Overall Study|Death|4|||
13385801|NCT00723957|26760160|FG000|Overall Study|Disease progression|27|||
13385802|NCT00723957|26760161|FG001|Overall Study|Disease progression|25|||
13385803|NCT00723957|26760160|FG000|Overall Study|Maximum clinical benefit|4|||
13385804|NCT00723957|26760161|FG001|Overall Study|Maximum clinical benefit|5|||
13385805|NCT00723957|26760160|FG000|Overall Study|Investigator decision|1|||
13385806|NCT00723957|26760161|FG001|Overall Study|Investigator decision|1|||
13385807|NCT00723957|26760160|FG000|Overall Study|Study drug toxicity|4|||
13385808|NCT00723957|26760161|FG001|Overall Study|Study drug toxicity|6|||
13385809|NCT00723957|26760160|FG000|Overall Study|Withdrawal by Subject|7|||
13385810|NCT00723957|26760161|FG001|Overall Study|Withdrawal by Subject|5|||
13385811|NCT00723957|26760160|FG000|Overall Study|Reason not analyzed|1|||
13385812|NCT00723957|26760161|FG001|Overall Study|Reason not analyzed|0|||
13385813|NCT00723957|26760160|FG000|Overall Study|Never received treatment|3|||
13385814|NCT00723957|26760161|FG001|Overall Study|Never received treatment|3|||
13385815|NCT00723944|26760174|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
13385816|NCT00723944|26760175|FG001|Permanent Prosthesis Placement|Adverse Event|7|||
13385817|NCT00723944|26760174|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2|||
13385818|NCT00723944|26760175|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2|||
13385819|NCT00723944|26760174|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1|||
13385820|NCT00723944|26760175|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4|||
13385821|NCT00723892|26760189|FG000|Overall Study|Participant not tracked|33|||
13385822|NCT00723892|26760190|FG001|Overall Study|Participant not tracked|35|||
13385823|NCT00723892|26760189|FG000|Overall Study|Virological criterion|24|||
13385824|NCT00723892|26760190|FG001|Overall Study|Virological criterion|9|||
13385825|NCT00723892|26760189|FG000|Overall Study|Withdrawal by Subject|6|||
13385826|NCT00723892|26760190|FG001|Overall Study|Withdrawal by Subject|9|||
13385827|NCT00723892|26760189|FG000|Overall Study|End planned|11|||
13385828|NCT00723892|26760190|FG001|Overall Study|End planned|7|||
13385829|NCT00723892|26760189|FG000|Overall Study|Bad tolerance|5|||
13385830|NCT00723892|26760190|FG001|Overall Study|Bad tolerance|5|||
13385831|NCT00723892|26760189|FG000|Overall Study|Multiple reasons|17|||
13385832|NCT00723892|26760190|FG001|Overall Study|Multiple reasons|12|||
13385833|NCT00723892|26760189|FG000|Overall Study|Other|6|||
13385834|NCT00723892|26760190|FG001|Overall Study|Other|3|||
13385835|NCT00723892|26760189|FG000|Overall Study|Study end|1|||
13385836|NCT00723892|26760190|FG001|Overall Study|Study end|3|||
13385837|NCT00723892|26760189|FG000|Overall Study|Weight loss|1|||
13385838|NCT00723892|26760190|FG001|Overall Study|Weight loss|3|||
13385839|NCT00723892|26760189|FG000|Overall Study|Alcohol abuse|0|||
13385840|NCT00723892|26760190|FG001|Overall Study|Alcohol abuse|1|||
13385841|NCT00723892|26760189|FG000|Overall Study|Intercurrent infection|2|||
13385842|NCT00723892|26760190|FG001|Overall Study|Intercurrent infection|0|||
13385843|NCT00723892|26760189|FG000|Overall Study|Drug addiction|1|||
13385844|NCT00723892|26760190|FG001|Overall Study|Drug addiction|0|||
13385845|NCT00723840|26760203|FG000|Overall Study|Lost to Follow-up|2|||
13385846|NCT00723840|26760203|FG000|Overall Study|Failure to return|18|||
13385847|NCT00723840|26760203|FG000|Overall Study|Withdrawal by Subject|55|||
13385848|NCT00723840|26760203|FG000|Overall Study|Serious Adverse Events|3|||
13385849|NCT00723840|26760203|FG000|Overall Study|Other Medical Event|2|||
13385850|NCT00723840|26760203|FG000|Overall Study|Unspecified reason|2|||
13385851|NCT00723801|26760218|FG000|Overall Study|Lost to Follow-up|1|||
13385852|NCT00723801|26760219|FG001|Overall Study|Lost to Follow-up|2|||
13385853|NCT00723801|26760218|FG000|Overall Study|Protocol Violation|2|||
13385854|NCT00723801|26760219|FG001|Overall Study|Protocol Violation|1|||
13385855|NCT00723710|26760225|FG000|Overall Study|Disease progression|48|||
13385856|NCT00723710|26760225|FG000|Overall Study|Adverse Event|88|||
13385857|NCT00723710|26760225|FG000|Overall Study|Withdrawal by Subject|36|||
13385858|NCT00723710|26760225|FG000|Overall Study|Physician Decision|2|||
13385859|NCT00723697|26760235|FG000|Overall Study|Physician questionnaires not received|2|||
13385860|NCT00723697|26760235|FG000|Overall Study|Missing Informed Consent Form|10|||
13385861|NCT00723697|26760235|FG000|Overall Study|Other exclusion criteria applied|6|||
13385862|NCT00723606|26760258|FG000|Overall Study|Adverse Event|2|||
13385863|NCT00723606|26760259|FG001|Overall Study|Adverse Event|5|||
13385864|NCT00723606|26760258|FG000|Overall Study|Other|2|||
13385865|NCT00723606|26760259|FG001|Overall Study|Other|0|||
13385866|NCT00723606|26760258|FG000|Overall Study|Withdrawal by Subject|0|||
13385867|NCT00723606|26760259|FG001|Overall Study|Withdrawal by Subject|2|||
13385868|NCT00723554|26760308|FG000|Overall Study|Adverse Event|12|||
13385869|NCT00723554|26760308|FG000|Overall Study|Investigator's judgement|5|||
13385870|NCT00723554|26760308|FG000|Overall Study|Inhaled medication other than iloprost|4|||
13385871|NCT00723554|26760308|FG000|Overall Study|Withdrawal of consent|3|||
13385872|NCT00723554|26760308|FG000|Overall Study|Other|3|||
13385873|NCT00723554|26760308|FG000|Overall Study|Lost to Follow-up|1|||
13385874|NCT00723554|26760308|FG000|Overall Study|Non-compliance|1|||
13385875|NCT00723528|26760380|FG000|Period 1: Controlled Period (CP)|Adverse Event|0|||
13385876|NCT00723528|26760381|FG001|Period 1: Controlled Period (CP)|Adverse Event|0|||
13385877|NCT00723528|26760382|FG002|Period 1: Controlled Period (CP)|Adverse Event|1|||
13385878|NCT00723528|26760383|FG003|Period 1: Controlled Period (CP)|Adverse Event|0|||
13385879|NCT00723528|26760384|FG004|Period 1: Controlled Period (CP)|Adverse Event|0|||
13385880|NCT00723528|26760385|FG005|Period 1: Controlled Period (CP)|Adverse Event|0|||
13385881|NCT00723528|26760386|FG006|Period 1: Controlled Period (CP)|Adverse Event|0|||
13385882|NCT00723528|26760380|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2|||
13385883|NCT00723528|26760381|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
13385884|NCT00723528|26760382|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
13385885|NCT00723528|26760383|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
13385886|NCT00723528|26760384|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
13385887|NCT00723528|26760385|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
13385888|NCT00723528|26760386|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
13385889|NCT00723528|26760380|FG000|Period 1: Controlled Period (CP)|Physician Decision|0|||
13385890|NCT00723528|26760381|FG001|Period 1: Controlled Period (CP)|Physician Decision|0|||
13385891|NCT00723528|26760382|FG002|Period 1: Controlled Period (CP)|Physician Decision|1|||
13385892|NCT00723528|26760383|FG003|Period 1: Controlled Period (CP)|Physician Decision|0|||
13385893|NCT00723528|26760384|FG004|Period 1: Controlled Period (CP)|Physician Decision|0|||
13385894|NCT00723528|26760385|FG005|Period 1: Controlled Period (CP)|Physician Decision|0|||
13385895|NCT00723528|26760386|FG006|Period 1: Controlled Period (CP)|Physician Decision|0|||
13385896|NCT00723528|26760380|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
13385897|NCT00723528|26760381|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
13385898|NCT00723528|26760382|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1|||
13385899|NCT00723528|26760383|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
13385900|NCT00723528|26760384|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
13385901|NCT00723528|26760385|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
13385902|NCT00723528|26760386|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
13385903|NCT00723528|26760380|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2|||
13385904|NCT00723528|26760381|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
13385905|NCT00723528|26760382|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1|||
13385906|NCT00723528|26760383|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
13385907|NCT00723528|26760384|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
13385908|NCT00723528|26760385|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
13385909|NCT00723528|26760386|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
13385910|NCT00723528|26760380|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0|||
13385911|NCT00723528|26760381|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0|||
13385912|NCT00723528|26760382|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0|||
13385913|NCT00723528|26760383|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1|||
13385914|NCT00723528|26760384|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0|||
13385915|NCT00723528|26760385|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1|||
13385916|NCT00723528|26760386|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1|||
13385917|NCT00723528|26760380|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
13385918|NCT00723528|26760381|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
13385919|NCT00723528|26760382|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
13385920|NCT00723528|26760383|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
13385921|NCT00723528|26760384|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
13385922|NCT00723528|26760385|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1|||
13385923|NCT00723528|26760386|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
13385924|NCT00723528|26760380|FG000|Period 2: After Controlled Period|Other|0|||
13385925|NCT00723528|26760381|FG001|Period 2: After Controlled Period|Other|0|||
13385926|NCT00723528|26760382|FG002|Period 2: After Controlled Period|Other|0|||
13385927|NCT00723528|26760383|FG003|Period 2: After Controlled Period|Other|0|||
13385928|NCT00723528|26760384|FG004|Period 2: After Controlled Period|Other|1|||
13385929|NCT00723528|26760385|FG005|Period 2: After Controlled Period|Other|4|||
13385930|NCT00723528|26760386|FG006|Period 2: After Controlled Period|Other|0|||
13385931|NCT00723528|26760380|FG000|Period 2: After Controlled Period|Adverse Event|0|||
13385932|NCT00723528|26760381|FG001|Period 2: After Controlled Period|Adverse Event|0|||
13385933|NCT00723528|26760382|FG002|Period 2: After Controlled Period|Adverse Event|0|||
13385934|NCT00723528|26760383|FG003|Period 2: After Controlled Period|Adverse Event|0|||
13385935|NCT00723528|26760384|FG004|Period 2: After Controlled Period|Adverse Event|1|||
13385936|NCT00723528|26760385|FG005|Period 2: After Controlled Period|Adverse Event|0|||
13385937|NCT00723528|26760386|FG006|Period 2: After Controlled Period|Adverse Event|1|||
13385938|NCT00723528|26760380|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
13385939|NCT00723528|26760381|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
13385940|NCT00723528|26760382|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
13385941|NCT00723528|26760383|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
13385942|NCT00723528|26760384|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
13385943|NCT00723528|26760385|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
13385944|NCT00723528|26760386|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1|||
13385945|NCT00723528|26760380|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
13385946|NCT00723528|26760381|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
13385947|NCT00723528|26760382|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
13385948|NCT00723528|26760383|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
13385949|NCT00723528|26760384|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
13385950|NCT00723528|26760385|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
13385951|NCT00723528|26760386|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1|||
13385952|NCT00723489|26760425|FG000|Overall Study|Physician Decision|0|||
13385953|NCT00723489|26760426|FG001|Overall Study|Physician Decision|1|||
13385954|NCT00723489|26760427|FG002|Overall Study|Physician Decision|0|||
13385955|NCT00723489|26760428|FG003|Overall Study|Physician Decision|0|||
13385956|NCT00723489|26760425|FG000|Overall Study|Pregnancy|0|||
13385957|NCT00723489|26760426|FG001|Overall Study|Pregnancy|0|||
13385958|NCT00723489|26760427|FG002|Overall Study|Pregnancy|0|||
13385959|NCT00723489|26760428|FG003|Overall Study|Pregnancy|1|||
13385960|NCT00723489|26760425|FG000|Overall Study|Withdrawal by Subject|0|||
13385961|NCT00723489|26760426|FG001|Overall Study|Withdrawal by Subject|0|||
13385962|NCT00723489|26760427|FG002|Overall Study|Withdrawal by Subject|0|||
13385963|NCT00723489|26760428|FG003|Overall Study|Withdrawal by Subject|1|||
13385964|NCT00723489|26760425|FG000|Overall Study|Seropositive at baseline|1|||
13385965|NCT00723489|26760426|FG001|Overall Study|Seropositive at baseline|0|||
13385966|NCT00723489|26760427|FG002|Overall Study|Seropositive at baseline|0|||
13385967|NCT00723489|26760428|FG003|Overall Study|Seropositive at baseline|0|||
13385968|NCT00723489|26760425|FG000|Overall Study|Prohibited Medication|0|||
13385969|NCT00723489|26760426|FG001|Overall Study|Prohibited Medication|0|||
13385970|NCT00723489|26760427|FG002|Overall Study|Prohibited Medication|0|||
13385971|NCT00723489|26760428|FG003|Overall Study|Prohibited Medication|1|||
13385972|NCT00723489|26760425|FG000|Overall Study|Samples Collected Out of Window|0|||
13385973|NCT00723489|26760426|FG001|Overall Study|Samples Collected Out of Window|3|||
13385974|NCT00723489|26760427|FG002|Overall Study|Samples Collected Out of Window|0|||
13385975|NCT00723489|26760428|FG003|Overall Study|Samples Collected Out of Window|0|||
13385976|NCT00723450|26760477|FG000|Open-Label Phase|Adverse Event|26|||
13385977|NCT00723450|26760478|FG001|Open-Label Phase|Adverse Event|0|||
13385978|NCT00723450|26760479|FG002|Open-Label Phase|Adverse Event|0|||
13385979|NCT00723450|26760477|FG000|Open-Label Phase|Lack of Efficacy|18|||
13385980|NCT00723450|26760478|FG001|Open-Label Phase|Lack of Efficacy|0|||
13385981|NCT00723450|26760479|FG002|Open-Label Phase|Lack of Efficacy|0|||
13385982|NCT00723450|26760477|FG000|Open-Label Phase|Protocol Violation|35|||
13385983|NCT00723450|26760478|FG001|Open-Label Phase|Protocol Violation|0|||
13385984|NCT00723450|26760479|FG002|Open-Label Phase|Protocol Violation|0|||
13385985|NCT00723450|26760477|FG000|Open-Label Phase|Lost to Follow-up|7|||
13385986|NCT00723450|26760478|FG001|Open-Label Phase|Lost to Follow-up|0|||
13385987|NCT00723450|26760479|FG002|Open-Label Phase|Lost to Follow-up|0|||
13385988|NCT00723450|26760477|FG000|Open-Label Phase|Physician Decision|2|||
13385989|NCT00723450|26760478|FG001|Open-Label Phase|Physician Decision|0|||
13385990|NCT00723450|26760479|FG002|Open-Label Phase|Physician Decision|0|||
13385991|NCT00723450|26760477|FG000|Open-Label Phase|Withdrawal by Subject|37|||
13385992|NCT00723450|26760478|FG001|Open-Label Phase|Withdrawal by Subject|0|||
13385993|NCT00723450|26760479|FG002|Open-Label Phase|Withdrawal by Subject|0|||
13385994|NCT00723450|26760477|FG000|Randomized Phase|Adverse Event|0|||
13385995|NCT00723450|26760478|FG001|Randomized Phase|Adverse Event|26|||
13385996|NCT00723450|26760479|FG002|Randomized Phase|Adverse Event|17|||
13385997|NCT00723450|26760477|FG000|Randomized Phase|Lack of Efficacy|0|||
13385998|NCT00723450|26760478|FG001|Randomized Phase|Lack of Efficacy|11|||
13385999|NCT00723450|26760479|FG002|Randomized Phase|Lack of Efficacy|11|||
13386000|NCT00723450|26760477|FG000|Randomized Phase|Protocol Violation|0|||
13386001|NCT00723450|26760478|FG001|Randomized Phase|Protocol Violation|9|||
13386002|NCT00723450|26760479|FG002|Randomized Phase|Protocol Violation|13|||
13386003|NCT00723450|26760477|FG000|Randomized Phase|Lost to Follow-up|0|||
13386004|NCT00723450|26760478|FG001|Randomized Phase|Lost to Follow-up|2|||
13386005|NCT00723450|26760479|FG002|Randomized Phase|Lost to Follow-up|3|||
13386006|NCT00723450|26760477|FG000|Randomized Phase|Physician Decision|0|||
13386007|NCT00723450|26760478|FG001|Randomized Phase|Physician Decision|3|||
13386008|NCT00723450|26760479|FG002|Randomized Phase|Physician Decision|1|||
13386009|NCT00723450|26760477|FG000|Randomized Phase|Withdrawal by Subject|0|||
13386010|NCT00723450|26760478|FG001|Randomized Phase|Withdrawal by Subject|14|||
13386011|NCT00723450|26760479|FG002|Randomized Phase|Withdrawal by Subject|22|||
13386012|NCT00723398|26760557|FG000|Overall Study|Withdrawal by Subject|2|||
13386013|NCT00723398|26760558|FG001|Overall Study|Withdrawal by Subject|6|||
13386014|NCT00723398|26760559|FG002|Overall Study|Withdrawal by Subject|4|||
13386015|NCT00723398|26760560|FG003|Overall Study|Withdrawal by Subject|4|||
13386016|NCT00723398|26760561|FG004|Overall Study|Withdrawal by Subject|4|||
13386017|NCT00723398|26760557|FG000|Overall Study|Protocol Violation|2|||
13386018|NCT00723398|26760558|FG001|Overall Study|Protocol Violation|1|||
13386019|NCT00723398|26760559|FG002|Overall Study|Protocol Violation|5|||
13386020|NCT00723398|26760560|FG003|Overall Study|Protocol Violation|0|||
13386021|NCT00723398|26760561|FG004|Overall Study|Protocol Violation|0|||
13386022|NCT00723398|26760557|FG000|Overall Study|Physician Decision|2|||
13386023|NCT00723398|26760558|FG001|Overall Study|Physician Decision|2|||
13386024|NCT00723398|26760559|FG002|Overall Study|Physician Decision|5|||
13386025|NCT00723398|26760560|FG003|Overall Study|Physician Decision|0|||
13386026|NCT00723398|26760561|FG004|Overall Study|Physician Decision|1|||
13386027|NCT00723398|26760557|FG000|Overall Study|Adverse Event|0|||
13386028|NCT00723398|26760558|FG001|Overall Study|Adverse Event|5|||
13386029|NCT00723398|26760559|FG002|Overall Study|Adverse Event|3|||
13386030|NCT00723398|26760560|FG003|Overall Study|Adverse Event|1|||
13386031|NCT00723398|26760561|FG004|Overall Study|Adverse Event|4|||
13386032|NCT00723398|26760557|FG000|Overall Study|Lost to Follow-up|0|||
13386033|NCT00723398|26760558|FG001|Overall Study|Lost to Follow-up|1|||
13386034|NCT00723398|26760559|FG002|Overall Study|Lost to Follow-up|0|||
13386035|NCT00723398|26760560|FG003|Overall Study|Lost to Follow-up|0|||
13386036|NCT00723398|26760561|FG004|Overall Study|Lost to Follow-up|0|||
13386037|NCT00723294|26760568|FG000|Overall Study|Lobular histology|2|||
13386038|NCT00723294|26760568|FG000|Overall Study|>25% intraductal component|1|||
13386039|NCT00723294|26760568|FG000|Overall Study|No MRI tumor enhancement|1|||
13386040|NCT00723294|26760568|FG000|Overall Study|1.0-Tesla MRI|1|||
13386041|NCT00723294|26760568|FG000|Overall Study|No cryoabalation|2|||
13386042|NCT00723294|26760568|FG000|Overall Study|Did not undergo surgery|1|||
13386043|NCT00723294|26760568|FG000|Overall Study|Treated prior to registration|1|||
13386044|NCT00723294|26760568|FG000|Overall Study|Treated by non-credentialed surgeon|1|||
13386045|NCT00723294|26760568|FG000|Overall Study|Benign lesion|1|||
13386046|NCT00723294|26760568|FG000|Overall Study|Withdrawal by Subject|1|||
13386047|NCT00723294|26760568|FG000|Overall Study|No treatment due to probe failure|1|||
13386048|NCT00723255|26760595|FG000|Overall Study|Ineligible: Inadequate pathology|1|||
13386049|NCT00723255|26760595|FG000|Overall Study|Ineligible: Second primary|1|||
13386050|NCT00723255|26760595|FG000|Overall Study|Ineligible: Wrong Primary|2|||
13386051|NCT00723229|26760614|FG000|First Intervention|Lost to Follow-up|7|||
13386052|NCT00723229|26760615|FG001|First Intervention|Lost to Follow-up|3|||
13386053|NCT00723203|26760621|FG000|Overall Study|Withdrawal by Subject|3|||
13386054|NCT00723190|26760638|FG000|Overall Study|Withdrawal by Subject|45|||
13386055|NCT00723190|26760638|FG000|Overall Study|Lost to Follow-up|37|||
13386056|NCT00723190|26760638|FG000|Overall Study|Adverse Event|18|||
13386057|NCT00723190|26760638|FG000|Overall Study|Lack of Efficacy|16|||
13386058|NCT00723190|26760638|FG000|Overall Study|Protocol Violation|15|||
13386059|NCT00723190|26760638|FG000|Overall Study|Other-Premature Discontinuation|9|||
13386060|NCT00723190|26760638|FG000|Overall Study|Other-Not included in safety population|2|||
13386061|NCT00723125|26760657|FG000|Overall Study|Met Dx|1|||
13386062|NCT00723125|26760658|FG001|Overall Study|Met Dx|0|||
13386063|NCT00723125|26760657|FG000|Overall Study|Withdrawal by Subject|15|||
13386064|NCT00723125|26760658|FG001|Overall Study|Withdrawal by Subject|6|||
13386065|NCT00723125|26760657|FG000|Overall Study|Adverse Event|2|||
13386066|NCT00723125|26760658|FG001|Overall Study|Adverse Event|0|||
13386067|NCT00723021|26760716|FG000|Intervention Period 4|Adverse Event|0|||
13386068|NCT00723021|26760717|FG001|Intervention Period 4|Adverse Event|0|||
13386069|NCT00723021|26760718|FG002|Intervention Period 4|Adverse Event|0|||
13386070|NCT00723021|26760719|FG003|Intervention Period 4|Adverse Event|0|||
13386071|NCT00723021|26760720|FG004|Intervention Period 4|Adverse Event|1|||
13386072|NCT00723008|26760749|FG000|Enrollment|Lost to Follow-up|1|||
13386073|NCT00723008|26760750|FG001|Enrollment|Lost to Follow-up|0|||
13386074|NCT00723008|26760749|FG000|4-Week Double Blinded|Lack of Efficacy|0|||
13386075|NCT00723008|26760750|FG001|4-Week Double Blinded|Lack of Efficacy|1|||
13386076|NCT00723008|26760749|FG000|4-Week Double Blinded|Withdrawal by Subject|1|||
13386077|NCT00723008|26760750|FG001|4-Week Double Blinded|Withdrawal by Subject|1|||
13386078|NCT00723008|26760749|FG000|4-Week Double Blinded|Lost to Follow-up|4|||
13386079|NCT00723008|26760750|FG001|4-Week Double Blinded|Lost to Follow-up|3|||
13386080|NCT00723008|26760749|FG000|4-Week Unblinded Treatment|Adverse Event|1|||
13386081|NCT00723008|26760750|FG001|4-Week Unblinded Treatment|Adverse Event|0|||
13386082|NCT00723008|26760749|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0|||
13386083|NCT00723008|26760750|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1|||
13386084|NCT00722800|26760767|FG000|Overall Study|Withdrawal by Subject|1|||
13386085|NCT00722800|26760768|FG001|Overall Study|Withdrawal by Subject|0|||
13386086|NCT00722800|26760767|FG000|Overall Study|Physician Decision|1|||
13386087|NCT00722800|26760768|FG001|Overall Study|Physician Decision|0|||
13386088|NCT00722761|26760783|FG000|Overall Study|Lost to Follow-up|1|||
13386089|NCT00722761|26760784|FG001|Overall Study|Lost to Follow-up|4|||
13386090|NCT00722761|26760783|FG000|Overall Study|Withdrawal by Subject|5|||
13386091|NCT00722761|26760784|FG001|Overall Study|Withdrawal by Subject|2|||
13386092|NCT00722423|26760799|FG000|Overall Study|Protocol Violation|0|||
13386093|NCT00722423|26760800|FG001|Overall Study|Protocol Violation|1|||
13386094|NCT00722371|26760873|FG000|Overall Study|Adverse Event|6|||
13386095|NCT00722371|26760874|FG001|Overall Study|Adverse Event|13|||
13386096|NCT00722371|26760875|FG002|Overall Study|Adverse Event|9|||
13386097|NCT00722371|26760876|FG003|Overall Study|Adverse Event|10|||
13386098|NCT00722371|26760877|FG004|Overall Study|Adverse Event|6|||
13386099|NCT00722371|26760878|FG005|Overall Study|Adverse Event|8|||
13386100|NCT00722371|26760879|FG006|Overall Study|Adverse Event|4|||
13386101|NCT00722371|26760873|FG000|Overall Study|Contraindication|0|||
13386102|NCT00722371|26760874|FG001|Overall Study|Contraindication|0|||
13386103|NCT00722371|26760875|FG002|Overall Study|Contraindication|1|||
13386104|NCT00722371|26760876|FG003|Overall Study|Contraindication|0|||
13386105|NCT00722371|26760877|FG004|Overall Study|Contraindication|0|||
13386106|NCT00722371|26760878|FG005|Overall Study|Contraindication|0|||
13386107|NCT00722371|26760879|FG006|Overall Study|Contraindication|0|||
13386108|NCT00722371|26760873|FG000|Overall Study|Creatinine / Creatinine clearance|2|||
13386109|NCT00722371|26760874|FG001|Overall Study|Creatinine / Creatinine clearance|1|||
13386110|NCT00722371|26760875|FG002|Overall Study|Creatinine / Creatinine clearance|2|||
13386111|NCT00722371|26760876|FG003|Overall Study|Creatinine / Creatinine clearance|3|||
13386112|NCT00722371|26760877|FG004|Overall Study|Creatinine / Creatinine clearance|2|||
13386113|NCT00722371|26760878|FG005|Overall Study|Creatinine / Creatinine clearance|1|||
13386114|NCT00722371|26760879|FG006|Overall Study|Creatinine / Creatinine clearance|1|||
13386115|NCT00722371|26760873|FG000|Overall Study|Excluded medication|0|||
13386116|NCT00722371|26760874|FG001|Overall Study|Excluded medication|1|||
13386117|NCT00722371|26760875|FG002|Overall Study|Excluded medication|1|||
13386118|NCT00722371|26760876|FG003|Overall Study|Excluded medication|0|||
13386119|NCT00722371|26760877|FG004|Overall Study|Excluded medication|0|||
13386120|NCT00722371|26760878|FG005|Overall Study|Excluded medication|0|||
13386121|NCT00722371|26760879|FG006|Overall Study|Excluded medication|1|||
13386122|NCT00722371|26760873|FG000|Overall Study|Hyperglycemia|2|||
13386123|NCT00722371|26760874|FG001|Overall Study|Hyperglycemia|6|||
13386124|NCT00722371|26760875|FG002|Overall Study|Hyperglycemia|4|||
13386125|NCT00722371|26760876|FG003|Overall Study|Hyperglycemia|2|||
13386126|NCT00722371|26760877|FG004|Overall Study|Hyperglycemia|5|||
13386127|NCT00722371|26760878|FG005|Overall Study|Hyperglycemia|1|||
13386128|NCT00722371|26760879|FG006|Overall Study|Hyperglycemia|1|||
13386129|NCT00722371|26760873|FG000|Overall Study|Hypoglycemia|1|||
13386130|NCT00722371|26760874|FG001|Overall Study|Hypoglycemia|0|||
13386131|NCT00722371|26760875|FG002|Overall Study|Hypoglycemia|0|||
13386132|NCT00722371|26760876|FG003|Overall Study|Hypoglycemia|0|||
13386133|NCT00722371|26760877|FG004|Overall Study|Hypoglycemia|0|||
13386134|NCT00722371|26760878|FG005|Overall Study|Hypoglycemia|0|||
13386135|NCT00722371|26760879|FG006|Overall Study|Hypoglycemia|0|||
13386136|NCT00722371|26760873|FG000|Overall Study|Lack of Efficacy|4|||
13386137|NCT00722371|26760874|FG001|Overall Study|Lack of Efficacy|6|||
13386138|NCT00722371|26760875|FG002|Overall Study|Lack of Efficacy|6|||
13386139|NCT00722371|26760876|FG003|Overall Study|Lack of Efficacy|6|||
13386140|NCT00722371|26760877|FG004|Overall Study|Lack of Efficacy|2|||
13386141|NCT00722371|26760878|FG005|Overall Study|Lack of Efficacy|3|||
13386142|NCT00722371|26760879|FG006|Overall Study|Lack of Efficacy|0|||
13386143|NCT00722371|26760873|FG000|Overall Study|Lost to Follow-up|11|||
13386144|NCT00722371|26760874|FG001|Overall Study|Lost to Follow-up|14|||
13386145|NCT00722371|26760875|FG002|Overall Study|Lost to Follow-up|21|||
13386146|NCT00722371|26760876|FG003|Overall Study|Lost to Follow-up|13|||
13386147|NCT00722371|26760877|FG004|Overall Study|Lost to Follow-up|8|||
13386148|NCT00722371|26760878|FG005|Overall Study|Lost to Follow-up|16|||
13386149|NCT00722371|26760879|FG006|Overall Study|Lost to Follow-up|13|||
13386150|NCT00722371|26760873|FG000|Overall Study|Physician Decision|5|||
13386151|NCT00722371|26760874|FG001|Overall Study|Physician Decision|2|||
13386152|NCT00722371|26760875|FG002|Overall Study|Physician Decision|2|||
13386153|NCT00722371|26760876|FG003|Overall Study|Physician Decision|5|||
13386154|NCT00722371|26760877|FG004|Overall Study|Physician Decision|2|||
13386155|NCT00722371|26760878|FG005|Overall Study|Physician Decision|3|||
13386156|NCT00722371|26760879|FG006|Overall Study|Physician Decision|4|||
13386157|NCT00722371|26760873|FG000|Overall Study|Pregnancy|1|||
13386158|NCT00722371|26760874|FG001|Overall Study|Pregnancy|1|||
13386159|NCT00722371|26760875|FG002|Overall Study|Pregnancy|0|||
13386160|NCT00722371|26760876|FG003|Overall Study|Pregnancy|0|||
13386161|NCT00722371|26760877|FG004|Overall Study|Pregnancy|0|||
13386162|NCT00722371|26760878|FG005|Overall Study|Pregnancy|1|||
13386163|NCT00722371|26760879|FG006|Overall Study|Pregnancy|0|||
13386164|NCT00722371|26760873|FG000|Overall Study|Protocol Violation|6|||
13386165|NCT00722371|26760874|FG001|Overall Study|Protocol Violation|1|||
13386166|NCT00722371|26760875|FG002|Overall Study|Protocol Violation|0|||
13386167|NCT00722371|26760876|FG003|Overall Study|Protocol Violation|1|||
13386168|NCT00722371|26760877|FG004|Overall Study|Protocol Violation|4|||
13386169|NCT00722371|26760878|FG005|Overall Study|Protocol Violation|2|||
13386170|NCT00722371|26760879|FG006|Overall Study|Protocol Violation|1|||
13386171|NCT00722371|26760873|FG000|Overall Study|Withdrawal by Subject|18|||
13386172|NCT00722371|26760874|FG001|Overall Study|Withdrawal by Subject|27|||
13386173|NCT00722371|26760875|FG002|Overall Study|Withdrawal by Subject|19|||
13386174|NCT00722371|26760876|FG003|Overall Study|Withdrawal by Subject|23|||
13386175|NCT00722371|26760877|FG004|Overall Study|Withdrawal by Subject|19|||
13386176|NCT00722371|26760878|FG005|Overall Study|Withdrawal by Subject|18|||
13386177|NCT00722371|26760879|FG006|Overall Study|Withdrawal by Subject|26|||
13386178|NCT00722137|26760912|FG000|Overall Study|Overt Disease Progression|5|||
13386179|NCT00722137|26760913|FG001|Overall Study|Overt Disease Progression|4|||
13386180|NCT00722137|26760912|FG000|Overall Study|Adverse Event|17|||
13386181|NCT00722137|26760913|FG001|Overall Study|Adverse Event|21|||
13386182|NCT00722137|26760912|FG000|Overall Study|Death|12|||
13386183|NCT00722137|26760913|FG001|Overall Study|Death|7|||
13386184|NCT00722137|26760912|FG000|Overall Study|Withdrawal by Subject|6|||
13386185|NCT00722137|26760913|FG001|Overall Study|Withdrawal by Subject|9|||
13386186|NCT00722137|26760912|FG000|Overall Study|Other Reason Unknown|3|||
13386187|NCT00722137|26760913|FG001|Overall Study|Other Reason Unknown|4|||
13386188|NCT00722137|26760912|FG000|Overall Study|Randomized But Not Treated|2|||
13386189|NCT00722137|26760913|FG001|Overall Study|Randomized But Not Treated|3|||
13386190|NCT00721968|26760928|FG000|Overall Study|Lost to Follow-up|2|||
13386191|NCT00721968|26760929|FG001|Overall Study|Lost to Follow-up|0|||
13386192|NCT00721955|26760953|FG000|Overall Study|Adverse Event|0|||
13386193|NCT00721955|26760954|FG001|Overall Study|Adverse Event|0|||
13386194|NCT00721955|26760955|FG002|Overall Study|Adverse Event|2|||
13386195|NCT00721799|26760992|FG000|Overall Study|Withdrawal by Subject|7|||
13386196|NCT00721799|26760992|FG000|Overall Study|withdraw by subject after scan 1|1|||
13386197|NCT00721734|26761120|FG000|Overall Study|Progressive Disease|3|||
13386198|NCT00721734|26761121|FG001|Overall Study|Progressive Disease|10|||
13386199|NCT00721734|26761122|FG002|Overall Study|Progressive Disease|4|||
13386200|NCT00721734|26761123|FG003|Overall Study|Progressive Disease|5|||
13386201|NCT00721734|26761124|FG004|Overall Study|Progressive Disease|2|||
13386202|NCT00721734|26761120|FG000|Overall Study|Adverse Event|3|||
13386203|NCT00721734|26761121|FG001|Overall Study|Adverse Event|1|||
13386204|NCT00721734|26761122|FG002|Overall Study|Adverse Event|4|||
13386205|NCT00721734|26761123|FG003|Overall Study|Adverse Event|0|||
13386206|NCT00721734|26761124|FG004|Overall Study|Adverse Event|3|||
13386207|NCT00721734|26761120|FG000|Overall Study|Withdrawal by Subject|2|||
13386208|NCT00721734|26761121|FG001|Overall Study|Withdrawal by Subject|1|||
13386209|NCT00721734|26761122|FG002|Overall Study|Withdrawal by Subject|0|||
13386210|NCT00721734|26761123|FG003|Overall Study|Withdrawal by Subject|0|||
13386211|NCT00721734|26761124|FG004|Overall Study|Withdrawal by Subject|1|||
13386212|NCT00721734|26761120|FG000|Overall Study|Other|0|||
13386213|NCT00721734|26761121|FG001|Overall Study|Other|0|||
13386214|NCT00721734|26761122|FG002|Overall Study|Other|0|||
13386215|NCT00721734|26761123|FG003|Overall Study|Other|1|||
13386216|NCT00721734|26761124|FG004|Overall Study|Other|0|||
13386217|NCT00721630|26761131|FG000|Overall Study|Participant found to be ineligible|1|||
13386218|NCT00721578|26761146|FG000|Overall Study|Death|1|||
13386219|NCT00721578|26761147|FG001|Overall Study|Death|1|||
13386220|NCT00721578|26761146|FG000|Overall Study|Withdrawal by Subject|1|||
13386221|NCT00721578|26761147|FG001|Overall Study|Withdrawal by Subject|1|||
13386222|NCT00721409|26761280|FG000|Overall Study|Global deterioration of health status|2|||
13386223|NCT00721409|26761281|FG001|Overall Study|Global deterioration of health status|6|||
13386224|NCT00721409|26761282|FG002|Overall Study|Global deterioration of health status|3|||
13386225|NCT00721409|26761280|FG000|Overall Study|Death|0|||
13386226|NCT00721409|26761281|FG001|Overall Study|Death|1|||
13386227|NCT00721409|26761282|FG002|Overall Study|Death|0|||
13386228|NCT00721409|26761280|FG000|Overall Study|Randomized not Treated|0|||
13386229|NCT00721409|26761281|FG001|Overall Study|Randomized not Treated|1|||
13386230|NCT00721409|26761282|FG002|Overall Study|Randomized not Treated|4|||
13395170|NCT00651313|26789440|FG001|Overall Study|Adminstrative Discontinuation|3|||
13395171|NCT00651261|26789461|FG000|Overall Study|Adverse Event|32|||
13395172|NCT00651261|26789462|FG001|Overall Study|Adverse Event|22|||
13395173|NCT00651261|26789461|FG000|Overall Study|Death|18|||
13395174|NCT00651261|26789462|FG001|Overall Study|Death|18|||
13395175|NCT00651261|26789461|FG000|Overall Study|Withdrawal by Subject|22|||
13395176|NCT00651261|26789462|FG001|Overall Study|Withdrawal by Subject|40|||
13395177|NCT00651261|26789461|FG000|Overall Study|Induction failure|24|||
13395178|NCT00651261|26789462|FG001|Overall Study|Induction failure|35|||
13395179|NCT00651261|26789461|FG000|Overall Study|Disease progression|58|||
13395180|NCT00651261|26789462|FG001|Overall Study|Disease progression|58|||
13395181|NCT00651261|26789461|FG000|Overall Study|Alternative therapy|109|||
13395182|NCT00651261|26789462|FG001|Overall Study|Alternative therapy|107|||
13395183|NCT00651261|26789461|FG000|Overall Study|Other disease or participant decisions|23|||
13395184|NCT00651261|26789462|FG001|Overall Study|Other disease or participant decisions|23|||
13395185|NCT00651261|26789461|FG000|Overall Study|Never treated|5|||
13395186|NCT00651261|26789462|FG001|Overall Study|Never treated|3|||
13395187|NCT00651183|26789481|FG000|Overall Study|Lack of Efficacy|1|||
13395188|NCT00651183|26789482|FG001|Overall Study|Lack of Efficacy|0|||
13395189|NCT00651183|26789481|FG000|Overall Study|Efficacy insufficient + patients wish|0|||
13395190|NCT00651183|26789482|FG001|Overall Study|Efficacy insufficient + patients wish|1|||
13395191|NCT00651183|26789481|FG000|Overall Study|Tolerability insufficient|5|||
13395192|NCT00651183|26789482|FG001|Overall Study|Tolerability insufficient|2|||
13395193|NCT00651183|26789481|FG000|Overall Study|Tolerability insufficient +Patients wish|0|||
13395194|NCT00651183|26789482|FG001|Overall Study|Tolerability insufficient +Patients wish|1|||
13395195|NCT00651183|26789481|FG000|Overall Study|Withdrawal by Subject|6|||
13395196|NCT00651183|26789482|FG001|Overall Study|Withdrawal by Subject|3|||
13395197|NCT00651183|26789481|FG000|Overall Study|Lost to Follow-up|3|||
13395198|NCT00651183|26789482|FG001|Overall Study|Lost to Follow-up|1|||
13395199|NCT00651183|26789481|FG000|Overall Study|Other reasons|4|||
13395200|NCT00651183|26789482|FG001|Overall Study|Other reasons|2|||
13395201|NCT00651183|26789481|FG000|Overall Study|missing|1|||
13395202|NCT00651183|26789482|FG001|Overall Study|missing|0|||
13395203|NCT00651157|26789490|FG000|Overall Study|Death|1|||
13395204|NCT00651157|26789490|FG000|Overall Study|Protocol Violation|1|||
13395205|NCT00651118|26789521|FG000|Overall Study|Adverse Event|4|||
13395206|NCT00651118|26789522|FG001|Overall Study|Adverse Event|0|||
13395207|NCT00651118|26789523|FG002|Overall Study|Adverse Event|1|||
13395208|NCT00651118|26789524|FG003|Overall Study|Adverse Event|1|||
13395209|NCT00651118|26789521|FG000|Overall Study|Protocol Violation|2|||
13395210|NCT00651118|26789522|FG001|Overall Study|Protocol Violation|2|||
13395211|NCT00651118|26789523|FG002|Overall Study|Protocol Violation|6|||
13395212|NCT00651118|26789524|FG003|Overall Study|Protocol Violation|2|||
13395213|NCT00651118|26789521|FG000|Overall Study|Lost to Follow-up|2|||
13395214|NCT00651118|26789522|FG001|Overall Study|Lost to Follow-up|0|||
13395215|NCT00651118|26789523|FG002|Overall Study|Lost to Follow-up|1|||
13395216|NCT00651118|26789524|FG003|Overall Study|Lost to Follow-up|2|||
13395217|NCT00651118|26789521|FG000|Overall Study|administrative|1|||
13395218|NCT00651118|26789522|FG001|Overall Study|administrative|4|||
13395219|NCT00651118|26789523|FG002|Overall Study|administrative|2|||
13395220|NCT00651118|26789524|FG003|Overall Study|administrative|1|||
13395221|NCT00651118|26789521|FG000|Overall Study|Withdrawal by Subject|0|||
13395222|NCT00651118|26789522|FG001|Overall Study|Withdrawal by Subject|1|||
13395223|NCT00651118|26789523|FG002|Overall Study|Withdrawal by Subject|1|||
13395224|NCT00651118|26789524|FG003|Overall Study|Withdrawal by Subject|1|||
13395225|NCT00650845|26789547|FG000|Overall Study|Withdrawal by Subject|5|||
13386231|NCT00721409|26761280|FG000|Overall Study|Reason not specified|1|||
13395226|NCT00650845|26789548|FG001|Overall Study|Withdrawal by Subject|0|||
13395227|NCT00650845|26789547|FG000|Overall Study|Protocol Violation|0|||
13386232|NCT00721409|26761281|FG001|Overall Study|Reason not specified|0|||
13386233|NCT00721409|26761282|FG002|Overall Study|Reason not specified|2|||
13386234|NCT00721409|26761280|FG000|Overall Study|Adverse Event|0|||
13386235|NCT00721409|26761281|FG001|Overall Study|Adverse Event|13|||
13386236|NCT00721409|26761282|FG002|Overall Study|Adverse Event|2|||
13386237|NCT00721409|26761280|FG000|Overall Study|Lost to Follow-up|0|||
13386238|NCT00721409|26761281|FG001|Overall Study|Lost to Follow-up|0|||
13386239|NCT00721409|26761282|FG002|Overall Study|Lost to Follow-up|1|||
13386240|NCT00721409|26761280|FG000|Overall Study|Withdrawal by Subject|1|||
13386241|NCT00721409|26761281|FG001|Overall Study|Withdrawal by Subject|6|||
13386242|NCT00721409|26761282|FG002|Overall Study|Withdrawal by Subject|5|||
13386243|NCT00721409|26761280|FG000|Overall Study|Objective progression or relapse|8|||
13386244|NCT00721409|26761281|FG001|Overall Study|Objective progression or relapse|55|||
13386245|NCT00721409|26761282|FG002|Overall Study|Objective progression or relapse|62|||
13386246|NCT00721396|26761331|FG000|Overall Study|Adverse Event|4|||
13386247|NCT00721396|26761332|FG001|Overall Study|Adverse Event|7|||
13386248|NCT00721396|26761333|FG002|Overall Study|Adverse Event|2|||
13386249|NCT00721396|26761334|FG003|Overall Study|Adverse Event|0|||
13386250|NCT00721396|26761331|FG000|Overall Study|Withdrawal by Subject|12|||
13386251|NCT00721396|26761332|FG001|Overall Study|Withdrawal by Subject|15|||
13386252|NCT00721396|26761333|FG002|Overall Study|Withdrawal by Subject|3|||
13386253|NCT00721396|26761334|FG003|Overall Study|Withdrawal by Subject|7|||
13386254|NCT00721396|26761331|FG000|Overall Study|Lost to Follow-up|7|||
13386255|NCT00721396|26761332|FG001|Overall Study|Lost to Follow-up|9|||
13386256|NCT00721396|26761333|FG002|Overall Study|Lost to Follow-up|3|||
13386257|NCT00721396|26761334|FG003|Overall Study|Lost to Follow-up|3|||
13386258|NCT00721396|26761331|FG000|Overall Study|Protocol Violation|4|||
13386259|NCT00721396|26761332|FG001|Overall Study|Protocol Violation|3|||
13386260|NCT00721396|26761333|FG002|Overall Study|Protocol Violation|1|||
13386261|NCT00721396|26761334|FG003|Overall Study|Protocol Violation|0|||
13386262|NCT00721396|26761331|FG000|Overall Study|Inappropriate enrollment|0|||
13386263|NCT00721396|26761332|FG001|Overall Study|Inappropriate enrollment|2|||
13386264|NCT00721396|26761333|FG002|Overall Study|Inappropriate enrollment|0|||
13386265|NCT00721396|26761334|FG003|Overall Study|Inappropriate enrollment|0|||
13386266|NCT00721396|26761331|FG000|Overall Study|Administrative reason|3|||
13386267|NCT00721396|26761332|FG001|Overall Study|Administrative reason|0|||
13386268|NCT00721396|26761333|FG002|Overall Study|Administrative reason|1|||
13386269|NCT00721396|26761334|FG003|Overall Study|Administrative reason|0|||
13386270|NCT00721279|26761353|FG000|Overall Study|Lack of Efficacy|6|||
13386271|NCT00721279|26761354|FG001|Overall Study|Lack of Efficacy|3|||
13386272|NCT00721279|26761353|FG000|Overall Study|Tolerability insufficient|5|||
13386273|NCT00721279|26761354|FG001|Overall Study|Tolerability insufficient|2|||
13386274|NCT00721279|26761353|FG000|Overall Study|Withdrawal by Subject|13|||
13386275|NCT00721279|26761354|FG001|Overall Study|Withdrawal by Subject|3|||
13386276|NCT00721279|26761353|FG000|Overall Study|Other|12|||
13386277|NCT00721279|26761354|FG001|Overall Study|Other|16|||
13386278|NCT00721227|26761371|FG000|Overall Study|Lost to Follow-up|3|||
13386279|NCT00721227|26761372|FG001|Overall Study|Lost to Follow-up|0|||
13386280|NCT00721227|26761371|FG000|Overall Study|Noncompliance with scheduled visits.|1|||
13386281|NCT00721227|26761372|FG001|Overall Study|Noncompliance with scheduled visits.|0|||
13386282|NCT00721214|26761385|FG000|Overall Study|Chose another center for transplant|1|||
13386283|NCT00721214|26761385|FG000|Overall Study|Death|3|||
13386284|NCT00721149|26761396|FG000|Overall Study|Physician Decision|1|||
13386285|NCT00721123|26761472|FG000|Overall Study|Adverse Event|96|||
13386286|NCT00721123|26761472|FG000|Overall Study|Death|10|||
13386287|NCT00721123|26761472|FG000|Overall Study|Insufficient Therapeutic Response|21|||
13386288|NCT00721123|26761472|FG000|Overall Study|Protocol Violation|1|||
13386289|NCT00721123|26761472|FG000|Overall Study|Refused Treatment|41|||
13386290|NCT00721123|26761472|FG000|Overall Study|Failure to Return|9|||
13386291|NCT00721123|26761472|FG000|Overall Study|Withdrawal by Subject|5|||
13386292|NCT00721110|26761511|FG000|Overall Study|Ultram use|1|||
13386293|NCT00721110|26761512|FG001|Overall Study|Ultram use|0|||
13386294|NCT00721110|26761513|FG002|Overall Study|Ultram use|0|||
13386295|NCT00721110|26761514|FG003|Overall Study|Ultram use|0|||
13386296|NCT00721110|26761511|FG000|Overall Study|vertical incision|0|||
13386297|NCT00721110|26761512|FG001|Overall Study|vertical incision|0|||
13386298|NCT00721110|26761513|FG002|Overall Study|vertical incision|1|||
13386299|NCT00721110|26761514|FG003|Overall Study|vertical incision|0|||
13386300|NCT00720941|26761561|FG000|Overall Study|Death|334|||
13386301|NCT00720941|26761562|FG001|Overall Study|Death|335|||
13386302|NCT00720941|26761561|FG000|Overall Study|Protocol Violation|0|||
13386303|NCT00720941|26761562|FG001|Overall Study|Protocol Violation|2|||
13386304|NCT00720941|26761561|FG000|Overall Study|Lost to Follow-up|17|||
13386305|NCT00720941|26761562|FG001|Overall Study|Lost to Follow-up|15|||
13386306|NCT00720941|26761561|FG000|Overall Study|Physician Decision|1|||
13386307|NCT00720941|26761562|FG001|Overall Study|Physician Decision|5|||
13386308|NCT00720941|26761561|FG000|Overall Study|Withdrawal by Subject|27|||
13386309|NCT00720941|26761562|FG001|Overall Study|Withdrawal by Subject|35|||
13386310|NCT00720941|26761561|FG000|Overall Study|Ongoing|34|||
13386311|NCT00720941|26761562|FG001|Overall Study|Ongoing|23|||
13395228|NCT00650845|26789548|FG001|Overall Study|Protocol Violation|13|||
13395229|NCT00650806|26789599|FG000|Overall Study|Adverse Event|0|||
13395230|NCT00650806|26789600|FG001|Overall Study|Adverse Event|5|||
13395231|NCT00650806|26789601|FG002|Overall Study|Adverse Event|3|||
13395232|NCT00650806|26789602|FG003|Overall Study|Adverse Event|4|||
13395233|NCT00650806|26789599|FG000|Overall Study|Lost to Follow-up|7|||
13395234|NCT00650806|26789600|FG001|Overall Study|Lost to Follow-up|6|||
13395235|NCT00650806|26789601|FG002|Overall Study|Lost to Follow-up|11|||
13395236|NCT00650806|26789602|FG003|Overall Study|Lost to Follow-up|10|||
13395237|NCT00650806|26789599|FG000|Overall Study|Protocol Violation|0|||
13395238|NCT00650806|26789600|FG001|Overall Study|Protocol Violation|0|||
13395239|NCT00650806|26789601|FG002|Overall Study|Protocol Violation|0|||
13395240|NCT00650806|26789602|FG003|Overall Study|Protocol Violation|1|||
13395241|NCT00650806|26789599|FG000|Overall Study|Pregnancy|0|||
13395242|NCT00650806|26789600|FG001|Overall Study|Pregnancy|0|||
13395243|NCT00650806|26789601|FG002|Overall Study|Pregnancy|0|||
13395244|NCT00650806|26789602|FG003|Overall Study|Pregnancy|1|||
13395245|NCT00650806|26789599|FG000|Overall Study|Withdrawal by Subject|7|||
13395246|NCT00650806|26789600|FG001|Overall Study|Withdrawal by Subject|5|||
13395247|NCT00650806|26789601|FG002|Overall Study|Withdrawal by Subject|8|||
13395248|NCT00650806|26789602|FG003|Overall Study|Withdrawal by Subject|6|||
13395249|NCT00650806|26789599|FG000|Overall Study|Noncompliance with study drug regimen|1|||
13395250|NCT00650806|26789600|FG001|Overall Study|Noncompliance with study drug regimen|1|||
13395251|NCT00650806|26789601|FG002|Overall Study|Noncompliance with study drug regimen|0|||
13395252|NCT00650806|26789602|FG003|Overall Study|Noncompliance with study drug regimen|0|||
13395253|NCT00650806|26789599|FG000|Overall Study|Study terminated by sponsor|2|||
13395254|NCT00650806|26789600|FG001|Overall Study|Study terminated by sponsor|3|||
13395255|NCT00650806|26789601|FG002|Overall Study|Study terminated by sponsor|5|||
13395256|NCT00650806|26789602|FG003|Overall Study|Study terminated by sponsor|4|||
13395257|NCT00650806|26789599|FG000|Overall Study|Other|1|||
13395258|NCT00650806|26789600|FG001|Overall Study|Other|1|||
13395259|NCT00650806|26789601|FG002|Overall Study|Other|2|||
13395260|NCT00650806|26789602|FG003|Overall Study|Other|0|||
13395261|NCT00650767|26790117|FG000|Overall Study|Adverse Event|0|||
13395262|NCT00650767|26790118|FG001|Overall Study|Adverse Event|3|||
13395263|NCT00650767|26790119|FG002|Overall Study|Adverse Event|10|||
13395264|NCT00650767|26790120|FG003|Overall Study|Adverse Event|8|||
13395265|NCT00650767|26790117|FG000|Overall Study|Death|1|||
13395266|NCT00650767|26790118|FG001|Overall Study|Death|0|||
13395267|NCT00650767|26790119|FG002|Overall Study|Death|0|||
13395268|NCT00650767|26790120|FG003|Overall Study|Death|0|||
13395269|NCT00650767|26790117|FG000|Overall Study|Withdrawal by Subject|2|||
13395270|NCT00650767|26790118|FG001|Overall Study|Withdrawal by Subject|4|||
13395271|NCT00650767|26790119|FG002|Overall Study|Withdrawal by Subject|3|||
13395272|NCT00650767|26790120|FG003|Overall Study|Withdrawal by Subject|3|||
13395273|NCT00650767|26790117|FG000|Overall Study|Lost to Follow-up|1|||
13395274|NCT00650767|26790118|FG001|Overall Study|Lost to Follow-up|1|||
13395275|NCT00650767|26790119|FG002|Overall Study|Lost to Follow-up|1|||
13395276|NCT00650767|26790120|FG003|Overall Study|Lost to Follow-up|0|||
13395277|NCT00650767|26790117|FG000|Overall Study|Other|1|||
13395278|NCT00650767|26790118|FG001|Overall Study|Other|1|||
13395279|NCT00650767|26790119|FG002|Overall Study|Other|0|||
13395280|NCT00650767|26790120|FG003|Overall Study|Other|0|||
13395281|NCT00650585|26790147|FG000|Overall Study|Lost to Follow-up|505|||
13395282|NCT00650585|26790148|FG001|Overall Study|Lost to Follow-up|482|||
13395283|NCT00650585|26790147|FG000|Overall Study|No parental consent|935|||
13395284|NCT00650585|26790148|FG001|Overall Study|No parental consent|866|||
13395285|NCT00650585|26790147|FG000|Overall Study|Excluded/ruled ineligible|357|||
13395286|NCT00650585|26790148|FG001|Overall Study|Excluded/ruled ineligible|129|||
13395287|NCT00650104|26790163|FG000|Overall Study|Adverse Event|17|||
13395288|NCT00650104|26790163|FG000|Overall Study|Death|2|||
13395289|NCT00650104|26790163|FG000|Overall Study|Withdrawal by Subject|11|||
13395290|NCT00650104|26790163|FG000|Overall Study|Physician Decision|7|||
13395291|NCT00650104|26790163|FG000|Overall Study|Lost to Follow-up|1|||
13395292|NCT00650104|26790163|FG000|Overall Study|Non-compliance|2|||
13395293|NCT00650104|26790163|FG000|Overall Study|Sponsor Terminated Dosing|1|||
13395294|NCT00650091|26790189|FG000|Amended Study Design|Withdrawal by Subject|12|||
13395295|NCT00650091|26790190|FG001|Amended Study Design|Withdrawal by Subject|11|||
13395296|NCT00650091|26790191|FG002|Amended Study Design|Withdrawal by Subject|0|||
13395297|NCT00650091|26790189|FG000|Amended Study Design|Physician Decision|5|||
13395298|NCT00650091|26790190|FG001|Amended Study Design|Physician Decision|0|||
13395299|NCT00650091|26790191|FG002|Amended Study Design|Physician Decision|0|||
13395300|NCT00650091|26790189|FG000|Amended Study Design|Adverse Event|1|||
13395301|NCT00650091|26790190|FG001|Amended Study Design|Adverse Event|4|||
13395302|NCT00650091|26790191|FG002|Amended Study Design|Adverse Event|0|||
13395303|NCT00650091|26790189|FG000|Amended Study Design|Lung transplantation|4|||
13386312|NCT00720902|26761595|FG000|Overall Study|Withdrawal by Subject|1|||
13386313|NCT00720902|26761596|FG001|Overall Study|Withdrawal by Subject|0|||
13386314|NCT00720902|26761595|FG000|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|3|||
13386315|NCT00720902|26761596|FG001|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|0|||
13386316|NCT00720876|26761604|FG000|Overall Study|found to be ineligible after starting tx|2|||
13386317|NCT00720798|26761625|FG000|Overall Study|Adverse Event|304|||
13386318|NCT00720798|26761625|FG000|Overall Study|Death|39|||
13386319|NCT00720798|26761625|FG000|Overall Study|Insufficient Therapeutic Response|129|||
13386320|NCT00720798|26761625|FG000|Overall Study|Protocol Violation|4|||
13386321|NCT00720798|26761625|FG000|Overall Study|Refused Treatment|151|||
13386322|NCT00720798|26761625|FG000|Overall Study|Failure to Return|46|||
13386323|NCT00720798|26761625|FG000|Overall Study|Reason not Specified|83|||
13386324|NCT00720759|26761648|FG000|Overall Study|Lost to Follow-up|0|||
13386325|NCT00720759|26761649|FG001|Overall Study|Lost to Follow-up|1|||
13386326|NCT00720759|26761650|FG002|Overall Study|Lost to Follow-up|1|||
13386327|NCT00720759|26761651|FG003|Overall Study|Lost to Follow-up|0|||
13386328|NCT00720499|26761716|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2|||
13386329|NCT00720499|26761717|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
13386330|NCT00720499|26761716|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1|||
13386331|NCT00720499|26761717|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2|||
13386332|NCT00720499|26761716|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2|||
13386333|NCT00720499|26761717|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3|||
13386334|NCT00720434|26761752|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
13386335|NCT00720434|26761753|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1|||
13386336|NCT00720434|26761754|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
13386337|NCT00720434|26761755|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
13386338|NCT00720434|26761752|FG000|Open-Label Period (Week 5-72)|Adverse Event|0|||
13386339|NCT00720434|26761753|FG001|Open-Label Period (Week 5-72)|Adverse Event|0|||
13386340|NCT00720434|26761754|FG002|Open-Label Period (Week 5-72)|Adverse Event|0|||
13386341|NCT00720434|26761755|FG003|Open-Label Period (Week 5-72)|Adverse Event|2|||
13386342|NCT00720434|26761752|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1|||
13386343|NCT00720434|26761753|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
13386344|NCT00720434|26761754|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
13386345|NCT00720434|26761755|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
13386346|NCT00720434|26761752|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
13386347|NCT00720434|26761753|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
13386348|NCT00720434|26761754|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
13386349|NCT00720434|26761755|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
13386350|NCT00720434|26761752|FG000|Open-Label Period (Week 5-72)|Other|4|||
13386351|NCT00720434|26761753|FG001|Open-Label Period (Week 5-72)|Other|3|||
13386352|NCT00720434|26761754|FG002|Open-Label Period (Week 5-72)|Other|3|||
13386353|NCT00720434|26761755|FG003|Open-Label Period (Week 5-72)|Other|2|||
13386354|NCT00720382|26761770|FG000|Overall Study|Adverse Event|54|||
13386355|NCT00720382|26761771|FG001|Overall Study|Adverse Event|17|||
13386356|NCT00720382|26761770|FG000|Overall Study|Lack of Efficacy|18|||
13386357|NCT00720382|26761771|FG001|Overall Study|Lack of Efficacy|7|||
13386358|NCT00720382|26761770|FG000|Overall Study|Non-Compliance|15|||
13386359|NCT00720382|26761771|FG001|Overall Study|Non-Compliance|5|||
13386360|NCT00720382|26761770|FG000|Overall Study|Withdrawal by Subject|47|||
13386361|NCT00720382|26761771|FG001|Overall Study|Withdrawal by Subject|11|||
13386362|NCT00720382|26761770|FG000|Overall Study|Lost to Follow-up|28|||
13386363|NCT00720382|26761771|FG001|Overall Study|Lost to Follow-up|14|||
13386364|NCT00720382|26761770|FG000|Overall Study|administrative|14|||
13386365|NCT00720382|26761771|FG001|Overall Study|administrative|5|||
13386366|NCT00720356|26761787|FG000|Registration to Study|Determined to have methylated MGMT|67|||
13386367|NCT00720356|26761787|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1|||
13386368|NCT00720356|26761787|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1|||
13386369|NCT00720356|26761787|FG000|Went on to be Treated Cycle 3|Adverse Event|1|||
13386370|NCT00720356|26761787|FG000|Went on to be Treated Cycle 3|Physician Decision|1|||
13386371|NCT00720356|26761787|FG000|Follow up Until Death|Withdrawal by Subject|1|||
13386372|NCT00720356|26761787|FG000|Follow up Until Death|Alive at last data collection|4|||
13386373|NCT00720343|26761795|FG000|Overall Study|Physician Decision|3|||
13386374|NCT00720343|26761795|FG000|Overall Study|No data|3|||
13386375|NCT00720278|26761825|FG000|Overall Study|Adverse Event|5|||
13386376|NCT00720278|26761826|FG001|Overall Study|Adverse Event|3|||
13386377|NCT00720278|26761827|FG002|Overall Study|Adverse Event|4|||
13395304|NCT00650091|26790190|FG001|Amended Study Design|Lung transplantation|2|||
13395305|NCT00650091|26790191|FG002|Amended Study Design|Lung transplantation|0|||
13395306|NCT00650091|26790189|FG000|Amended Study Design|Other|1|||
13395307|NCT00650091|26790190|FG001|Amended Study Design|Other|3|||
13395308|NCT00650091|26790191|FG002|Amended Study Design|Other|0|||
13475853|NCT02924064|27001310|FG000|Overall Study|Withdrawal by Subject|4|||
13475854|NCT02924064|27001311|FG001|Overall Study|Withdrawal by Subject|5|||
13386378|NCT00720278|26761825|FG000|Overall Study|Withdrawal by Subject|0|||
13386379|NCT00720278|26761826|FG001|Overall Study|Withdrawal by Subject|1|||
13386380|NCT00720278|26761827|FG002|Overall Study|Withdrawal by Subject|0|||
13386381|NCT00720278|26761825|FG000|Overall Study|Lost to Follow-up|0|||
13386382|NCT00720278|26761826|FG001|Overall Study|Lost to Follow-up|0|||
13386383|NCT00720278|26761827|FG002|Overall Study|Lost to Follow-up|1|||
13386384|NCT00720278|26761825|FG000|Overall Study|Non-compliance|1|||
13386385|NCT00720278|26761826|FG001|Overall Study|Non-compliance|0|||
13386386|NCT00720278|26761827|FG002|Overall Study|Non-compliance|0|||
13386387|NCT00720278|26761825|FG000|Overall Study|eligibility criteria violation|1|||
13386388|NCT00720278|26761826|FG001|Overall Study|eligibility criteria violation|0|||
13386389|NCT00720278|26761827|FG002|Overall Study|eligibility criteria violation|1|||
13386390|NCT00720226|26761842|FG000|Overall Study|Withdrawal by Subject|7|||
13386391|NCT00720226|26761843|FG001|Overall Study|Withdrawal by Subject|4|||
13386392|NCT00720213|26761885|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7|||
13386393|NCT00720213|26761886|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0|||
13386394|NCT00720213|26761887|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0|||
13386395|NCT00720122|26761893|FG000|Overall Study|Lost to Follow-up|1|||
13386396|NCT00720122|26761893|FG000|Overall Study|Physician Decision|1|||
13386397|NCT00720122|26761893|FG000|Overall Study|Withdrawal by Subject|7|||
13386398|NCT00720109|26761915|FG000|Induction Period|Did not meet eligibility criteria|3|||
13386399|NCT00720109|26761916|FG001|Induction Period|Did not meet eligibility criteria|0|||
13386400|NCT00720109|26761917|FG002|Induction Period|Did not meet eligibility criteria|0|||
13386401|NCT00720109|26761915|FG000|Induction Period|Bone Marrow Transplant|2|||
13386402|NCT00720109|26761916|FG001|Induction Period|Bone Marrow Transplant|0|||
13386403|NCT00720109|26761917|FG002|Induction Period|Bone Marrow Transplant|0|||
13386404|NCT00720109|26761915|FG000|Induction Period|Physician Decision|1|||
13386405|NCT00720109|26761916|FG001|Induction Period|Physician Decision|0|||
13386406|NCT00720109|26761917|FG002|Induction Period|Physician Decision|0|||
13386407|NCT00720109|26761915|FG000|Risk Stratification Period|Adverse Event|0|||
13386408|NCT00720109|26761916|FG001|Risk Stratification Period|Adverse Event|1|||
13386409|NCT00720109|26761917|FG002|Risk Stratification Period|Adverse Event|0|||
13386410|NCT00720109|26761915|FG000|Risk Stratification Period|Physician Decision|0|||
13386411|NCT00720109|26761916|FG001|Risk Stratification Period|Physician Decision|2|||
13386412|NCT00720109|26761917|FG002|Risk Stratification Period|Physician Decision|1|||
13386413|NCT00720109|26761915|FG000|Risk Stratification Period|Bone marrow transplant|0|||
13386414|NCT00720109|26761916|FG001|Risk Stratification Period|Bone marrow transplant|9|||
13386415|NCT00720109|26761917|FG002|Risk Stratification Period|Bone marrow transplant|7|||
13386416|NCT00720109|26761915|FG000|Risk Stratification Period|Disease progression or relapse|0|||
13386417|NCT00720109|26761916|FG001|Risk Stratification Period|Disease progression or relapse|2|||
13386418|NCT00720109|26761917|FG002|Risk Stratification Period|Disease progression or relapse|0|||
13386419|NCT00720109|26761915|FG000|Risk Stratification Period|Development of second malignant neoplasm|0|||
13386420|NCT00720109|26761916|FG001|Risk Stratification Period|Development of second malignant neoplasm|1|||
13386421|NCT00720109|26761917|FG002|Risk Stratification Period|Development of second malignant neoplasm|0|||
13386422|NCT00720096|26761934|FG000|Overall Study|Withdrawal by Subject|0|||
13386423|NCT00720096|26761935|FG001|Overall Study|Withdrawal by Subject|2|||
13386424|NCT00720083|26761948|FG000|Overall Study|Ineligible|1|||
13386425|NCT00720083|26761949|FG001|Overall Study|Ineligible|2|||
13386426|NCT00720057|26761972|FG000|Overall Study|Lost to Follow-up|0|||
13386427|NCT00720057|26761973|FG001|Overall Study|Lost to Follow-up|2|||
13386428|NCT00720057|26761972|FG000|Overall Study|Protocol Violation|1|||
13386429|NCT00720057|26761973|FG001|Overall Study|Protocol Violation|0|||
13386430|NCT00720057|26761972|FG000|Overall Study|Withdrawal by Subject|0|||
13386431|NCT00720057|26761973|FG001|Overall Study|Withdrawal by Subject|1|||
13386432|NCT00719953|26761979|FG000|Overall Study|Adverse Event|4|||
13386433|NCT00719901|26761991|FG000|Overall Study|Adverse Event|5|||
13386434|NCT00719901|26761991|FG000|Overall Study|Withdrawal by Subject|1|||
13386435|NCT00719901|26761991|FG000|Overall Study|Alternate Treatment|1|||
13386436|NCT00719901|26761991|FG000|Overall Study|Disease Progression|3|||
13386437|NCT00719901|26761991|FG000|Overall Study|Availability of Study Drug|1|||
13386438|NCT00719862|26762014|FG000|Overall Study|Adverse Event|1|||
13386439|NCT00719862|26762015|FG001|Overall Study|Adverse Event|2|||
13386440|NCT00719862|26762014|FG000|Overall Study|Lack of Efficacy|3|||
13386441|NCT00719862|26762015|FG001|Overall Study|Lack of Efficacy|0|||
13386442|NCT00719862|26762014|FG000|Overall Study|Non-Compliance|1|||
13386443|NCT00719862|26762015|FG001|Overall Study|Non-Compliance|0|||
13386444|NCT00719862|26762014|FG000|Overall Study|Withdrawal by Subject|1|||
13386445|NCT00719862|26762015|FG001|Overall Study|Withdrawal by Subject|0|||
13386446|NCT00719862|26762014|FG000|Overall Study|Lost to Follow-up|0|||
13386447|NCT00719862|26762015|FG001|Overall Study|Lost to Follow-up|1|||
13386448|NCT00719862|26762014|FG000|Overall Study|Other|2|||
13386449|NCT00719862|26762015|FG001|Overall Study|Other|3|||
13386450|NCT00719849|26762058|FG000|Overall Study|Death|0|||
13386451|NCT00719849|26762059|FG001|Overall Study|Death|1|||
13386452|NCT00719810|26762080|FG000|Overall Study|Adverse Event|0|||
13386453|NCT00719810|26762081|FG001|Overall Study|Adverse Event|2|||
13386454|NCT00719810|26762082|FG002|Overall Study|Adverse Event|3|||
13386455|NCT00719810|26762080|FG000|Overall Study|Lost to Follow-up|2|||
13386456|NCT00719810|26762081|FG001|Overall Study|Lost to Follow-up|0|||
13386457|NCT00719810|26762082|FG002|Overall Study|Lost to Follow-up|3|||
13386458|NCT00719810|26762080|FG000|Overall Study|Physician Decision|0|||
13386459|NCT00719810|26762081|FG001|Overall Study|Physician Decision|1|||
13386460|NCT00719810|26762082|FG002|Overall Study|Physician Decision|0|||
13386461|NCT00719810|26762080|FG000|Overall Study|Withdrawal by Subject|1|||
13386462|NCT00719810|26762081|FG001|Overall Study|Withdrawal by Subject|1|||
13386463|NCT00719810|26762082|FG002|Overall Study|Withdrawal by Subject|2|||
13386464|NCT00719732|26762088|FG000|Overall Study|Lost to Follow-up|20|||
13386465|NCT00719732|26762088|FG000|Overall Study|Unilateral (not bilateral) implantation|1|||
13386466|NCT00719732|26762088|FG000|Overall Study|Illness not associated with device|1|||
13386467|NCT00719706|26762109|FG000|Overall Study|Adverse Event|5|||
13386468|NCT00719706|26762110|FG001|Overall Study|Adverse Event|4|||
13386469|NCT00719706|26762109|FG000|Overall Study|Withdrawal by Subject|1|||
13386470|NCT00719706|26762110|FG001|Overall Study|Withdrawal by Subject|2|||
13386471|NCT00719706|26762109|FG000|Overall Study|Protocol Violation|3|||
13386472|NCT00719706|26762110|FG001|Overall Study|Protocol Violation|0|||
13386473|NCT00719680|26762132|FG000|Overall Study|Adverse Event|1|||
13386474|NCT00719680|26762132|FG000|Overall Study|Lost to Follow-up|1|||
13386475|NCT00719680|26762132|FG000|Overall Study|Withdrawal by Subject|3|||
13386476|NCT00719563|26762169|FG000|Overall Study|Adverse Event|16|||
13386477|NCT00719563|26762170|FG001|Overall Study|Adverse Event|13|||
13386478|NCT00719563|26762169|FG000|Overall Study|Medical condition changed|3|||
13386479|NCT00719563|26762170|FG001|Overall Study|Medical condition changed|5|||
13386480|NCT00719563|26762169|FG000|Overall Study|Lack of Efficacy|3|||
13386481|NCT00719563|26762170|FG001|Overall Study|Lack of Efficacy|7|||
13386482|NCT00719563|26762169|FG000|Overall Study|Personal reasons|6|||
13386483|NCT00719563|26762170|FG001|Overall Study|Personal reasons|7|||
13386484|NCT00719563|26762169|FG000|Overall Study|Unknown reasons|4|||
13386485|NCT00719563|26762170|FG001|Overall Study|Unknown reasons|6|||
13386486|NCT00719563|26762169|FG000|Overall Study|Noncompliant|1|||
13386487|NCT00719563|26762170|FG001|Overall Study|Noncompliant|1|||
13386488|NCT00719563|26762169|FG000|Overall Study|Lost to Follow-up|5|||
13386489|NCT00719563|26762170|FG001|Overall Study|Lost to Follow-up|3|||
13386490|NCT00719537|26762183|FG000|Overall Study|Withdrawal by Subject|1|||
13386491|NCT00719537|26762184|FG001|Overall Study|Withdrawal by Subject|0|||
13386492|NCT00719537|26762183|FG000|Overall Study|Lost to Follow-up|0|||
13386493|NCT00719537|26762184|FG001|Overall Study|Lost to Follow-up|1|||
13386494|NCT00719472|26762195|FG000|Enrolled in Study|Physician decision to withdraw patient|1|||
13386495|NCT00719472|26762195|FG000|Enrolled in Study|Subject decision to withdraw|8|||
13386496|NCT00719472|26762195|FG000|Enrolled in Study|Various Reasons|17|||
13386497|NCT00719472|26762195|FG000|Received Cycle 1 Treatment|Adverse Event|8|||
13386498|NCT00719472|26762195|FG000|Received Cycle 1 Treatment|Death|5|||
13386499|NCT00719472|26762195|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11|||
13386500|NCT00719472|26762195|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7|||
13386501|NCT00719472|26762195|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9|||
13386502|NCT00719472|26762195|FG000|Received Cycle 1 Treatment|Various Reasons|13|||
13386503|NCT00719472|26762195|FG000|Received Cycle 2 Treatment|Adverse Event|12|||
13386504|NCT00719472|26762195|FG000|Received Cycle 2 Treatment|Death|6|||
13386505|NCT00719472|26762195|FG000|Received Cycle 2 Treatment|Disease progression|3|||
13386506|NCT00719472|26762195|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3|||
13386507|NCT00719472|26762195|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13|||
13386508|NCT00719472|26762195|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6|||
13386509|NCT00719472|26762195|FG000|Received Cycle 2 Treatment|Various Reasons|25|||
13386510|NCT00719355|26762210|FG000|Overall Study|Death|0|||
13386511|NCT00719355|26762211|FG001|Overall Study|Death|1|||
13386512|NCT00719355|26762210|FG000|Overall Study|Medical|14|||
13386513|NCT00719355|26762211|FG001|Overall Study|Medical|5|||
13386514|NCT00719355|26762210|FG000|Overall Study|Compliance|4|||
13386515|NCT00719355|26762211|FG001|Overall Study|Compliance|6|||
13386516|NCT00719355|26762210|FG000|Overall Study|Moved|0|||
13386517|NCT00719355|26762211|FG001|Overall Study|Moved|1|||
13386518|NCT00719264|26762237|FG000|Overall Study|Adverse Event|41|||
13386519|NCT00719264|26762238|FG001|Overall Study|Adverse Event|49|||
13386520|NCT00719264|26762237|FG000|Overall Study|Death|13|||
13386521|NCT00719264|26762238|FG001|Overall Study|Death|10|||
13386522|NCT00719264|26762237|FG000|Overall Study|Administrative Problems|6|||
13386523|NCT00719264|26762238|FG001|Overall Study|Administrative Problems|4|||
13386524|NCT00719264|26762237|FG000|Overall Study|Lost to Follow-up|1|||
13386525|NCT00719264|26762238|FG001|Overall Study|Lost to Follow-up|1|||
13386526|NCT00719264|26762237|FG000|Overall Study|Withdrawal by Subject|12|||
13386527|NCT00719264|26762238|FG001|Overall Study|Withdrawal by Subject|7|||
13386528|NCT00719264|26762237|FG000|Overall Study|Protocol Deviation|1|||
13386529|NCT00719264|26762238|FG001|Overall Study|Protocol Deviation|3|||
13386530|NCT00719264|26762237|FG000|Overall Study|New Cancer Therapy|4|||
13386531|NCT00719264|26762238|FG001|Overall Study|New Cancer Therapy|2|||
13386532|NCT00719264|26762237|FG000|Overall Study|Disease Progression|104|||
13386533|NCT00719264|26762238|FG001|Overall Study|Disease Progression|107|||
13386534|NCT00719212|26762250|FG000|Overall Study|Death|41|||
13386535|NCT00719212|26762250|FG000|Overall Study|Lost to Follow-up|2|||
13386536|NCT00719212|26762250|FG000|Overall Study|Withdrawal by Subject|1|||
13386537|NCT00719043|26762394|FG000|Overall Study|Adverse Event|5|||
13386538|NCT00719043|26762395|FG001|Overall Study|Adverse Event|1|||
13386539|NCT00719043|26762396|FG002|Overall Study|Adverse Event|2|||
13386540|NCT00719043|26762397|FG003|Overall Study|Adverse Event|2|||
13386541|NCT00719043|26762398|FG004|Overall Study|Adverse Event|1|||
13386542|NCT00719043|26762399|FG005|Overall Study|Adverse Event|4|||
13386543|NCT00719043|26762400|FG006|Overall Study|Adverse Event|4|||
13386544|NCT00719043|26762394|FG000|Overall Study|Lost to Follow-up|14|||
13386545|NCT00719043|26762395|FG001|Overall Study|Lost to Follow-up|10|||
13386546|NCT00719043|26762396|FG002|Overall Study|Lost to Follow-up|8|||
13386547|NCT00719043|26762397|FG003|Overall Study|Lost to Follow-up|9|||
13386548|NCT00719043|26762398|FG004|Overall Study|Lost to Follow-up|10|||
13386549|NCT00719043|26762399|FG005|Overall Study|Lost to Follow-up|9|||
13386550|NCT00719043|26762400|FG006|Overall Study|Lost to Follow-up|9|||
13386551|NCT00719043|26762394|FG000|Overall Study|Protocol Violation|0|||
13386552|NCT00719043|26762395|FG001|Overall Study|Protocol Violation|0|||
13386553|NCT00719043|26762396|FG002|Overall Study|Protocol Violation|0|||
13386554|NCT00719043|26762397|FG003|Overall Study|Protocol Violation|0|||
13386555|NCT00719043|26762398|FG004|Overall Study|Protocol Violation|0|||
13386556|NCT00719043|26762399|FG005|Overall Study|Protocol Violation|1|||
13386557|NCT00719043|26762400|FG006|Overall Study|Protocol Violation|0|||
13386558|NCT00719043|26762394|FG000|Overall Study|Other|1|||
13386559|NCT00719043|26762395|FG001|Overall Study|Other|0|||
13386560|NCT00719043|26762396|FG002|Overall Study|Other|1|||
13386561|NCT00719043|26762397|FG003|Overall Study|Other|2|||
13386562|NCT00719043|26762398|FG004|Overall Study|Other|0|||
13386563|NCT00719043|26762399|FG005|Overall Study|Other|2|||
13386564|NCT00719043|26762400|FG006|Overall Study|Other|1|||
13386565|NCT00719043|26762394|FG000|Overall Study|Withdrawal by Subject|12|||
13386566|NCT00719043|26762395|FG001|Overall Study|Withdrawal by Subject|14|||
13386567|NCT00719043|26762396|FG002|Overall Study|Withdrawal by Subject|9|||
13386568|NCT00719043|26762397|FG003|Overall Study|Withdrawal by Subject|10|||
13386569|NCT00719043|26762398|FG004|Overall Study|Withdrawal by Subject|16|||
13386570|NCT00719043|26762399|FG005|Overall Study|Withdrawal by Subject|18|||
13386571|NCT00719043|26762400|FG006|Overall Study|Withdrawal by Subject|14|||
13386572|NCT00718887|26762429|FG000|Overall Study|Withdrawal by Subject|3|||
13386573|NCT00718887|26762430|FG001|Overall Study|Withdrawal by Subject|2|||
13386574|NCT00718887|26762429|FG000|Overall Study|Not identified|2|||
13386575|NCT00718887|26762430|FG001|Overall Study|Not identified|7|||
13386576|NCT00718861|26762463|FG000|Overall Study|Withdrawal by Subject|15|||
13386577|NCT00718861|26762464|FG001|Overall Study|Withdrawal by Subject|10|||
13386578|NCT00718861|26762463|FG000|Overall Study|Adverse Event|2|||
13386579|NCT00718861|26762464|FG001|Overall Study|Adverse Event|1|||
13386580|NCT00718861|26762463|FG000|Overall Study|Lost to Follow-up|2|||
13386581|NCT00718861|26762464|FG001|Overall Study|Lost to Follow-up|1|||
13386582|NCT00718861|26762463|FG000|Overall Study|Administrative Problems|1|||
13386583|NCT00718861|26762464|FG001|Overall Study|Administrative Problems|1|||
13386584|NCT00718861|26762463|FG000|Overall Study|Death|1|||
13386585|NCT00718861|26762464|FG001|Overall Study|Death|5|||
13386586|NCT00718809|26762485|FG000|Overall Study|Disease progression|9|||
13386587|NCT00718809|26762486|FG001|Overall Study|Disease progression|7|||
13386588|NCT00718809|26762485|FG000|Overall Study|Adverse Event|1|||
13386589|NCT00718809|26762486|FG001|Overall Study|Adverse Event|1|||
13386590|NCT00718809|26762485|FG000|Overall Study|Withdrawal by Subject|0|||
13386591|NCT00718809|26762486|FG001|Overall Study|Withdrawal by Subject|1|||
13386592|NCT00718809|26762485|FG000|Overall Study|Lost to Follow-up|1|||
13386593|NCT00718809|26762486|FG001|Overall Study|Lost to Follow-up|0|||
13386594|NCT00718809|26762485|FG000|Overall Study|Noncompliance|1|||
13386595|NCT00718809|26762486|FG001|Overall Study|Noncompliance|0|||
13386596|NCT00718770|26762492|FG000|Overall Study|Adverse Event|1|||
13386597|NCT00718770|26762492|FG000|Overall Study|Lack of Efficacy|1|||
13386598|NCT00718770|26762492|FG000|Overall Study|Lack of Efficacy|1|||
13386599|NCT00718770|26762492|FG000|Overall Study|Adverse Event|1|||
13386600|NCT00718770|26762492|FG000|Overall Study|Lack of Efficacy|1|||
13386601|NCT00718770|26762492|FG000|Overall Study|Adverse Event|1|||
13386602|NCT00718770|26762492|FG000|Overall Study|Lack of Efficacy|1|||
13386603|NCT00718770|26762492|FG000|Overall Study|Adverse Event|1|||
13386604|NCT00718718|26762557|FG000|Prior to Week 12|Adverse Event|0|||
13386605|NCT00718718|26762558|FG001|Prior to Week 12|Adverse Event|0|||
13386606|NCT00718718|26762559|FG002|Prior to Week 12|Adverse Event|0|||
13386607|NCT00718718|26762560|FG003|Prior to Week 12|Adverse Event|0|||
13386608|NCT00718718|26762561|FG004|Prior to Week 12|Adverse Event|0|||
13386609|NCT00718718|26762562|FG005|Prior to Week 12|Adverse Event|0|||
13386610|NCT00718718|26762563|FG006|Prior to Week 12|Adverse Event|0|||
13386611|NCT00718718|26762564|FG007|Prior to Week 12|Adverse Event|1|||
13386612|NCT00718718|26762565|FG008|Prior to Week 12|Adverse Event|1|||
13386613|NCT00718718|26762566|FG009|Prior to Week 12|Adverse Event|0|||
13386614|NCT00718718|26762557|FG000|Prior to Week 12|Withdrawal by Subject|0|||
13386615|NCT00718718|26762558|FG001|Prior to Week 12|Withdrawal by Subject|0|||
13386616|NCT00718718|26762559|FG002|Prior to Week 12|Withdrawal by Subject|0|||
13386617|NCT00718718|26762560|FG003|Prior to Week 12|Withdrawal by Subject|0|||
13386618|NCT00718718|26762561|FG004|Prior to Week 12|Withdrawal by Subject|3|||
13386619|NCT00718718|26762562|FG005|Prior to Week 12|Withdrawal by Subject|0|||
13386620|NCT00718718|26762563|FG006|Prior to Week 12|Withdrawal by Subject|1|||
13386621|NCT00718718|26762564|FG007|Prior to Week 12|Withdrawal by Subject|1|||
13386622|NCT00718718|26762565|FG008|Prior to Week 12|Withdrawal by Subject|1|||
13386623|NCT00718718|26762566|FG009|Prior to Week 12|Withdrawal by Subject|0|||
13386624|NCT00718718|26762557|FG000|Prior to Week 12|Other|1|||
13386625|NCT00718718|26762558|FG001|Prior to Week 12|Other|0|||
13386626|NCT00718718|26762559|FG002|Prior to Week 12|Other|1|||
13386627|NCT00718718|26762560|FG003|Prior to Week 12|Other|0|||
13386628|NCT00718718|26762561|FG004|Prior to Week 12|Other|0|||
13386629|NCT00718718|26762562|FG005|Prior to Week 12|Other|0|||
13386630|NCT00718718|26762563|FG006|Prior to Week 12|Other|0|||
13386631|NCT00718718|26762564|FG007|Prior to Week 12|Other|0|||
13386632|NCT00718718|26762565|FG008|Prior to Week 12|Other|0|||
13386633|NCT00718718|26762566|FG009|Prior to Week 12|Other|0|||
13386634|NCT00718718|26762557|FG000|Week 12 to End of Study|Adverse Event|0|||
13386635|NCT00718718|26762558|FG001|Week 12 to End of Study|Adverse Event|0|||
13386636|NCT00718718|26762559|FG002|Week 12 to End of Study|Adverse Event|0|||
13386637|NCT00718718|26762560|FG003|Week 12 to End of Study|Adverse Event|0|||
13386638|NCT00718718|26762561|FG004|Week 12 to End of Study|Adverse Event|0|||
13386639|NCT00718718|26762562|FG005|Week 12 to End of Study|Adverse Event|0|||
13386640|NCT00718718|26762563|FG006|Week 12 to End of Study|Adverse Event|0|||
13386641|NCT00718718|26762564|FG007|Week 12 to End of Study|Adverse Event|1|||
13386642|NCT00718718|26762565|FG008|Week 12 to End of Study|Adverse Event|0|||
13386643|NCT00718718|26762566|FG009|Week 12 to End of Study|Adverse Event|0|||
13386644|NCT00718718|26762557|FG000|Week 12 to End of Study|Death|0|||
13386645|NCT00718718|26762558|FG001|Week 12 to End of Study|Death|0|||
13386646|NCT00718718|26762559|FG002|Week 12 to End of Study|Death|0|||
13386647|NCT00718718|26762560|FG003|Week 12 to End of Study|Death|0|||
13386648|NCT00718718|26762561|FG004|Week 12 to End of Study|Death|0|||
13386649|NCT00718718|26762562|FG005|Week 12 to End of Study|Death|1|||
13386650|NCT00718718|26762563|FG006|Week 12 to End of Study|Death|0|||
13386651|NCT00718718|26762564|FG007|Week 12 to End of Study|Death|0|||
13386652|NCT00718718|26762565|FG008|Week 12 to End of Study|Death|0|||
13386653|NCT00718718|26762566|FG009|Week 12 to End of Study|Death|0|||
13386654|NCT00718718|26762557|FG000|Week 12 to End of Study|Withdrawal by Subject|0|||
13386655|NCT00718718|26762558|FG001|Week 12 to End of Study|Withdrawal by Subject|0|||
13386656|NCT00718718|26762559|FG002|Week 12 to End of Study|Withdrawal by Subject|0|||
13386657|NCT00718718|26762560|FG003|Week 12 to End of Study|Withdrawal by Subject|0|||
13386658|NCT00718718|26762561|FG004|Week 12 to End of Study|Withdrawal by Subject|0|||
13386659|NCT00718718|26762562|FG005|Week 12 to End of Study|Withdrawal by Subject|2|||
13386660|NCT00718718|26762563|FG006|Week 12 to End of Study|Withdrawal by Subject|1|||
13386661|NCT00718718|26762564|FG007|Week 12 to End of Study|Withdrawal by Subject|0|||
13386662|NCT00718718|26762565|FG008|Week 12 to End of Study|Withdrawal by Subject|0|||
13386663|NCT00718718|26762566|FG009|Week 12 to End of Study|Withdrawal by Subject|0|||
13386664|NCT00718718|26762557|FG000|Week 12 to End of Study|Lost to Follow-up|0|||
13386665|NCT00718718|26762558|FG001|Week 12 to End of Study|Lost to Follow-up|0|||
13386666|NCT00718718|26762559|FG002|Week 12 to End of Study|Lost to Follow-up|0|||
13386667|NCT00718718|26762560|FG003|Week 12 to End of Study|Lost to Follow-up|0|||
13386668|NCT00718718|26762561|FG004|Week 12 to End of Study|Lost to Follow-up|0|||
13386669|NCT00718718|26762562|FG005|Week 12 to End of Study|Lost to Follow-up|0|||
13386670|NCT00718718|26762563|FG006|Week 12 to End of Study|Lost to Follow-up|0|||
13386671|NCT00718718|26762564|FG007|Week 12 to End of Study|Lost to Follow-up|0|||
13386672|NCT00718718|26762565|FG008|Week 12 to End of Study|Lost to Follow-up|1|||
13386673|NCT00718718|26762566|FG009|Week 12 to End of Study|Lost to Follow-up|0|||
13386674|NCT00718718|26762557|FG000|Week 12 to End of Study|Other|0|||
13386675|NCT00718718|26762558|FG001|Week 12 to End of Study|Other|1|||
13386676|NCT00718718|26762559|FG002|Week 12 to End of Study|Other|0|||
13386677|NCT00718718|26762560|FG003|Week 12 to End of Study|Other|1|||
13386678|NCT00718718|26762561|FG004|Week 12 to End of Study|Other|0|||
13386679|NCT00718718|26762562|FG005|Week 12 to End of Study|Other|0|||
13386680|NCT00718718|26762563|FG006|Week 12 to End of Study|Other|1|||
13386681|NCT00718718|26762564|FG007|Week 12 to End of Study|Other|0|||
13386682|NCT00718718|26762565|FG008|Week 12 to End of Study|Other|0|||
13386683|NCT00718718|26762566|FG009|Week 12 to End of Study|Other|0|||
13386684|NCT00718666|26762660|FG000|Booster Phase Year 5|No active participation request|0|||
13386685|NCT00718666|26762661|FG001|Booster Phase Year 5|No active participation request|0|||
13386686|NCT00718666|26762662|FG002|Booster Phase Year 5|No active participation request|1|||
13386687|NCT00718666|26762660|FG000|Booster Phase Year 5|Declined v-4 serology|1|||
13386688|NCT00718666|26762661|FG001|Booster Phase Year 5|Declined v-4 serology|0|||
13386689|NCT00718666|26762662|FG002|Booster Phase Year 5|Declined v-4 serology|0|||
13386690|NCT00718666|26762660|FG000|Booster Phase Year 5|Withdrawal by Subject|0|||
13386691|NCT00718666|26762661|FG001|Booster Phase Year 5|Withdrawal by Subject|0|||
13386692|NCT00718666|26762662|FG002|Booster Phase Year 5|Withdrawal by Subject|1|||
13386693|NCT00718666|26762660|FG000|Booster Phase Year 5|Lost to Follow-up|1|||
13386694|NCT00718666|26762661|FG001|Booster Phase Year 5|Lost to Follow-up|0|||
13386695|NCT00718666|26762662|FG002|Booster Phase Year 5|Lost to Follow-up|4|||
13386696|NCT00718640|26762676|FG000|Overall Study|Adverse Event|4|||
13386697|NCT00718640|26762676|FG000|Overall Study|Death|1|||
13386698|NCT00718640|26762676|FG000|Overall Study|Unresolved toxicity after 2 weeks|2|||
13386699|NCT00718549|26762703|FG000|Induction Phase|Disease Progression|1|||
13386700|NCT00718549|26762704|FG001|Induction Phase|Disease Progression|0|||
13386701|NCT00718549|26762705|FG002|Induction Phase|Disease Progression|0|||
13386702|NCT00718549|26762703|FG000|Induction Phase|Eligibility Criteria Violation|2|||
13386703|NCT00718549|26762704|FG001|Induction Phase|Eligibility Criteria Violation|0|||
13386704|NCT00718549|26762705|FG002|Induction Phase|Eligibility Criteria Violation|0|||
13386705|NCT00718549|26762703|FG000|Induction Phase|Early Termination - No Additional Info|59|||
13386706|NCT00718549|26762704|FG001|Induction Phase|Early Termination - No Additional Info|0|||
13386707|NCT00718549|26762705|FG002|Induction Phase|Early Termination - No Additional Info|0|||
13386708|NCT00718549|26762703|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0|||
13386709|NCT00718549|26762704|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15|||
13386710|NCT00718549|26762705|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8|||
13386711|NCT00718549|26762703|FG000|Maintenance/ Observation Phase|Death|0|||
13386712|NCT00718549|26762704|FG001|Maintenance/ Observation Phase|Death|1|||
13386713|NCT00718549|26762705|FG002|Maintenance/ Observation Phase|Death|2|||
13386714|NCT00718549|26762703|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0|||
13386715|NCT00718549|26762704|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4|||
13386716|NCT00718549|26762705|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4|||
13386717|NCT00718549|26762703|FG000|Maintenance/ Observation Phase|Progression|0|||
13386718|NCT00718549|26762704|FG001|Maintenance/ Observation Phase|Progression|5|||
13386719|NCT00718549|26762705|FG002|Maintenance/ Observation Phase|Progression|14|||
13386720|NCT00718549|26762703|FG000|Maintenance/ Observation Phase|Relapse|0|||
13386721|NCT00718549|26762704|FG001|Maintenance/ Observation Phase|Relapse|3|||
13386722|NCT00718549|26762705|FG002|Maintenance/ Observation Phase|Relapse|2|||
13386723|NCT00718523|26762722|FG000|Overall Study|Withdrawal by Subject|5|||
13386724|NCT00718523|26762723|FG001|Overall Study|Withdrawal by Subject|7|||
13386725|NCT00718523|26762722|FG000|Overall Study|Death|13|||
13386726|NCT00718523|26762723|FG001|Overall Study|Death|17|||
13386727|NCT00718510|26762740|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
13386728|NCT00718510|26762741|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
13386729|NCT00718510|26762740|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
13386730|NCT00718510|26762741|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
13386731|NCT00718419|26762762|FG000|Overall Study|Adverse Event|2|||
13386732|NCT00718419|26762763|FG001|Overall Study|Adverse Event|1|||
13386733|NCT00718419|26762762|FG000|Overall Study|Physician Decision|1|||
13386734|NCT00718419|26762763|FG001|Overall Study|Physician Decision|6|||
13386735|NCT00718419|26762762|FG000|Overall Study|Sponsor decision|0|||
13386736|NCT00718419|26762763|FG001|Overall Study|Sponsor decision|1|||
13386737|NCT00718419|26762762|FG000|Overall Study|Withdrawal by Subject|0|||
13386738|NCT00718419|26762763|FG001|Overall Study|Withdrawal by Subject|5|||
13386739|NCT00718419|26762762|FG000|Overall Study|Progressive Disease|7|||
13386740|NCT00718419|26762763|FG001|Overall Study|Progressive Disease|25|||
13386741|NCT00718419|26762762|FG000|Overall Study|Death Due to Progressive Disease|2|||
13386742|NCT00718419|26762763|FG001|Overall Study|Death Due to Progressive Disease|0|||
13386743|NCT00718419|26762762|FG000|Overall Study|Death Due to Study Drug Related|0|||
13386744|NCT00718419|26762763|FG001|Overall Study|Death Due to Study Drug Related|1|||
13386745|NCT00718419|26762762|FG000|Overall Study|Death Due to Adverse Events|1|||
13386746|NCT00718419|26762763|FG001|Overall Study|Death Due to Adverse Events|0|||
13386747|NCT00718328|26762776|FG000|Overall Study|Lost to Follow-up|1|||
13386748|NCT00718328|26762777|FG001|Overall Study|Lost to Follow-up|0|||
13386749|NCT00718315|26762819|FG000|Overall Study|Adverse Event|1|||
13386750|NCT00718315|26762820|FG001|Overall Study|Adverse Event|2|||
13386751|NCT00718315|26762821|FG002|Overall Study|Adverse Event|3|||
13386752|NCT00718315|26762819|FG000|Overall Study|Death|6|||
13386753|NCT00718315|26762820|FG001|Overall Study|Death|6|||
13386754|NCT00718315|26762821|FG002|Overall Study|Death|5|||
13386755|NCT00718315|26762819|FG000|Overall Study|Lost to Follow-up|2|||
13386756|NCT00718315|26762820|FG001|Overall Study|Lost to Follow-up|3|||
13386757|NCT00718315|26762821|FG002|Overall Study|Lost to Follow-up|4|||
13386758|NCT00718315|26762819|FG000|Overall Study|Protocol Violation|5|||
13386759|NCT00718315|26762820|FG001|Overall Study|Protocol Violation|5|||
13386760|NCT00718315|26762821|FG002|Overall Study|Protocol Violation|3|||
13386761|NCT00718315|26762819|FG000|Overall Study|Erlotinib dose decreased|4|||
13386762|NCT00718315|26762820|FG001|Overall Study|Erlotinib dose decreased|3|||
13386763|NCT00718315|26762821|FG002|Overall Study|Erlotinib dose decreased|1|||
13386764|NCT00718315|26762819|FG000|Overall Study|Use of Minocyclin|1|||
13386765|NCT00718315|26762820|FG001|Overall Study|Use of Minocyclin|1|||
13386766|NCT00718315|26762821|FG002|Overall Study|Use of Minocyclin|1|||
13386767|NCT00718315|26762819|FG000|Overall Study|Disease progression|0|||
13386768|NCT00718315|26762820|FG001|Overall Study|Disease progression|1|||
13386769|NCT00718315|26762821|FG002|Overall Study|Disease progression|1|||
13386770|NCT00718315|26762819|FG000|Overall Study|Other|0|||
13386771|NCT00718315|26762820|FG001|Overall Study|Other|0|||
13386772|NCT00718315|26762821|FG002|Overall Study|Other|1|||
13386773|NCT00718315|26762819|FG000|Overall Study|Use of ATB and Corticoids|0|||
13386774|NCT00718315|26762820|FG001|Overall Study|Use of ATB and Corticoids|1|||
13386775|NCT00718315|26762821|FG002|Overall Study|Use of ATB and Corticoids|2|||
13386776|NCT00718237|26762838|FG000|Overall Study|Adverse Event|1|||
13386777|NCT00718237|26762839|FG001|Overall Study|Adverse Event|3|||
13386778|NCT00718237|26762838|FG000|Overall Study|Lost to Follow-up|2|||
13386779|NCT00718237|26762839|FG001|Overall Study|Lost to Follow-up|2|||
13386780|NCT00718237|26762838|FG000|Overall Study|Physician Decision|1|||
13386781|NCT00718237|26762839|FG001|Overall Study|Physician Decision|0|||
13386782|NCT00718237|26762838|FG000|Overall Study|Withdrawal by Subject|9|||
13386783|NCT00718237|26762839|FG001|Overall Study|Withdrawal by Subject|10|||
13386784|NCT00718159|26762885|FG000|Overall Study|Progressive Disease|3|||
13386785|NCT00718159|26762886|FG001|Overall Study|Progressive Disease|3|||
13386786|NCT00718159|26762887|FG002|Overall Study|Progressive Disease|2|||
13386787|NCT00718159|26762888|FG003|Overall Study|Progressive Disease|0|||
13386788|NCT00718159|26762889|FG004|Overall Study|Progressive Disease|6|||
13386789|NCT00718159|26762890|FG005|Overall Study|Progressive Disease|0|||
13386790|NCT00718159|26762891|FG006|Overall Study|Progressive Disease|0|||
13386791|NCT00718159|26762885|FG000|Overall Study|Death due to Adverse Event|0|||
13386792|NCT00718159|26762886|FG001|Overall Study|Death due to Adverse Event|0|||
13386793|NCT00718159|26762887|FG002|Overall Study|Death due to Adverse Event|0|||
13386794|NCT00718159|26762888|FG003|Overall Study|Death due to Adverse Event|2|||
13386795|NCT00718159|26762889|FG004|Overall Study|Death due to Adverse Event|2|||
13386796|NCT00718159|26762890|FG005|Overall Study|Death due to Adverse Event|0|||
13386797|NCT00718159|26762891|FG006|Overall Study|Death due to Adverse Event|0|||
13386798|NCT00718159|26762885|FG000|Overall Study|Death due to Study Drug Toxicity|0|||
13386799|NCT00718159|26762886|FG001|Overall Study|Death due to Study Drug Toxicity|0|||
13386800|NCT00718159|26762887|FG002|Overall Study|Death due to Study Drug Toxicity|1|||
13386801|NCT00718159|26762888|FG003|Overall Study|Death due to Study Drug Toxicity|2|||
13386802|NCT00718159|26762889|FG004|Overall Study|Death due to Study Drug Toxicity|0|||
13386803|NCT00718159|26762890|FG005|Overall Study|Death due to Study Drug Toxicity|0|||
13386804|NCT00718159|26762891|FG006|Overall Study|Death due to Study Drug Toxicity|0|||
13386805|NCT00718159|26762885|FG000|Overall Study|Investigator Decision|0|||
13386806|NCT00718159|26762886|FG001|Overall Study|Investigator Decision|0|||
13386807|NCT00718159|26762887|FG002|Overall Study|Investigator Decision|0|||
13386808|NCT00718159|26762888|FG003|Overall Study|Investigator Decision|0|||
13386809|NCT00718159|26762889|FG004|Overall Study|Investigator Decision|0|||
13386810|NCT00718159|26762890|FG005|Overall Study|Investigator Decision|1|||
13386811|NCT00718159|26762891|FG006|Overall Study|Investigator Decision|1|||
13386812|NCT00718081|26762912|FG000|Overall Study|Adverse Event|0|||
13386813|NCT00718081|26762913|FG001|Overall Study|Adverse Event|1|||
13386814|NCT00718081|26762914|FG002|Overall Study|Adverse Event|0|||
13386815|NCT00718081|26762912|FG000|Overall Study|Lack of Efficacy|7|||
13386816|NCT00718081|26762913|FG001|Overall Study|Lack of Efficacy|3|||
13386817|NCT00718081|26762914|FG002|Overall Study|Lack of Efficacy|21|||
13386818|NCT00718042|26762945|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
13386819|NCT00718042|26762946|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
13386820|NCT00718042|26762947|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
13386821|NCT00718042|26762948|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
13386822|NCT00718042|26762949|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2|||
13386823|NCT00718042|26762950|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
13386824|NCT00718042|26762945|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64|||
13386825|NCT00718042|26762946|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
13386826|NCT00718042|26762947|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
13386827|NCT00718042|26762948|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
13386828|NCT00718042|26762949|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36|||
13386829|NCT00718042|26762950|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
13386830|NCT00718042|26762945|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
13386831|NCT00718042|26762946|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
13386832|NCT00718042|26762947|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
13386833|NCT00718042|26762948|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
13386834|NCT00718042|26762949|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
13386835|NCT00718042|26762950|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
13386836|NCT00718042|26762945|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
13386837|NCT00718042|26762946|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1|||
13386838|NCT00718042|26762947|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
13386839|NCT00718042|26762948|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
13386840|NCT00718042|26762949|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
13386841|NCT00718042|26762950|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
13386842|NCT00718042|26762945|FG000|Donor Follow-up|Lost to Follow-up|13|||
13386843|NCT00718042|26762946|FG001|Donor Follow-up|Lost to Follow-up|0|||
13386844|NCT00718042|26762947|FG002|Donor Follow-up|Lost to Follow-up|0|||
13386845|NCT00718042|26762948|FG003|Donor Follow-up|Lost to Follow-up|0|||
13386846|NCT00718042|26762949|FG004|Donor Follow-up|Lost to Follow-up|19|||
13386847|NCT00718042|26762950|FG005|Donor Follow-up|Lost to Follow-up|0|||
13386848|NCT00717886|26762956|FG000|Overall Study|Withdrawal by Subject|3|||
13386849|NCT00717886|26762956|FG000|Overall Study|Treatment Failure|1|||
13386850|NCT00717860|26762973|FG000|Overall Study|Clinical adverse experience|5|||
13386851|NCT00717860|26762974|FG001|Overall Study|Clinical adverse experience|9|||
13386852|NCT00717860|26762973|FG000|Overall Study|Laboratory adverse experience|2|||
13386853|NCT00717860|26762974|FG001|Overall Study|Laboratory adverse experience|2|||
13386854|NCT00717860|26762973|FG000|Overall Study|Lack of Efficacy|7|||
13386855|NCT00717860|26762974|FG001|Overall Study|Lack of Efficacy|13|||
13386856|NCT00717860|26762973|FG000|Overall Study|Discontinued for other reason|6|||
13386857|NCT00717860|26762974|FG001|Overall Study|Discontinued for other reason|1|||
13386858|NCT00717860|26762973|FG000|Overall Study|Withdrew consent|7|||
13386859|NCT00717860|26762974|FG001|Overall Study|Withdrew consent|3|||
13386860|NCT00717769|26763029|FG000|Overall Study|Adverse Event|9|||
13386861|NCT00717769|26763030|FG001|Overall Study|Adverse Event|6|||
13386862|NCT00717769|26763031|FG002|Overall Study|Adverse Event|1|||
13386863|NCT00717769|26763029|FG000|Overall Study|Lack of compliance|0|||
13386864|NCT00717769|26763030|FG001|Overall Study|Lack of compliance|2|||
13386865|NCT00717769|26763031|FG002|Overall Study|Lack of compliance|0|||
13386866|NCT00717769|26763029|FG000|Overall Study|Lost to Follow-up|3|||
13386867|NCT00717769|26763030|FG001|Overall Study|Lost to Follow-up|4|||
13386868|NCT00717769|26763031|FG002|Overall Study|Lost to Follow-up|0|||
13386869|NCT00717769|26763029|FG000|Overall Study|Lack of Efficacy|1|||
13386870|NCT00717769|26763030|FG001|Overall Study|Lack of Efficacy|2|||
13386871|NCT00717769|26763031|FG002|Overall Study|Lack of Efficacy|0|||
13386872|NCT00717769|26763029|FG000|Overall Study|Protocol Violation|0|||
13386873|NCT00717769|26763030|FG001|Overall Study|Protocol Violation|2|||
13386874|NCT00717769|26763031|FG002|Overall Study|Protocol Violation|0|||
13386875|NCT00717769|26763029|FG000|Overall Study|Sponsor decision|1|||
13386876|NCT00717769|26763030|FG001|Overall Study|Sponsor decision|0|||
13386877|NCT00717769|26763031|FG002|Overall Study|Sponsor decision|10|||
13386878|NCT00717769|26763029|FG000|Overall Study|Withdrew consent|2|||
13386879|NCT00717769|26763030|FG001|Overall Study|Withdrew consent|2|||
13386880|NCT00717769|26763031|FG002|Overall Study|Withdrew consent|0|||
13386881|NCT00717756|26763037|FG000|Overall Study|Withdrawal by Subject|1|||
13386882|NCT00717522|26763044|FG000|Overall Study|Disease Progression|5|||
13386883|NCT00717522|26763044|FG000|Overall Study|Adverse Event|1|||
13386884|NCT00717522|26763044|FG000|Overall Study|Death|1|||
13386885|NCT00717366|26763073|FG000|Core Study Period (20 Weeks)|Renal transplant|4|||
13386886|NCT00717366|26763074|FG001|Core Study Period (20 Weeks)|Renal transplant|9|||
13386887|NCT00717366|26763073|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0|||
13386888|NCT00717366|26763074|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2|||
13386889|NCT00717366|26763073|FG000|Core Study Period (20 Weeks)|Death|0|||
13386890|NCT00717366|26763074|FG001|Core Study Period (20 Weeks)|Death|1|||
13386891|NCT00717366|26763073|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0|||
13386892|NCT00717366|26763074|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1|||
13386893|NCT00717366|26763073|FG000|Extension Period (52 Weeks)|Renal transplant|3|||
13386894|NCT00717366|26763074|FG001|Extension Period (52 Weeks)|Renal transplant|13|||
13386895|NCT00717366|26763073|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0|||
13386896|NCT00717366|26763074|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2|||
13386897|NCT00717366|26763073|FG000|Extension Period (52 Weeks)|Withdrew consent|1|||
13386898|NCT00717366|26763074|FG001|Extension Period (52 Weeks)|Withdrew consent|1|||
13386899|NCT00717314|26763099|FG000|Overall Study|Adverse Event|3|||
13386900|NCT00717314|26763100|FG001|Overall Study|Adverse Event|2|||
13386901|NCT00717314|26763099|FG000|Overall Study|Protocol Violation|1|||
13386902|NCT00717314|26763100|FG001|Overall Study|Protocol Violation|0|||
13386903|NCT00717314|26763099|FG000|Overall Study|Lost to Follow-up|1|||
13386904|NCT00717314|26763100|FG001|Overall Study|Lost to Follow-up|5|||
13386905|NCT00717314|26763099|FG000|Overall Study|Withdrawal by Subject|1|||
13386906|NCT00717314|26763100|FG001|Overall Study|Withdrawal by Subject|3|||
13386907|NCT00717275|26763106|FG000|Overall Study|Premature study termination.|3|||
13386908|NCT00717249|26763125|FG000|Overall Study|Lens Discomfort|4|||
13386909|NCT00717249|26763126|FG001|Overall Study|Lens Discomfort|1|||
13386910|NCT00717249|26763125|FG000|Overall Study|Unsatisfactory visual Response|0|||
13386911|NCT00717249|26763126|FG001|Overall Study|Unsatisfactory visual Response|2|||
13386912|NCT00717249|26763125|FG000|Overall Study|Adverse Event|4|||
13386913|NCT00717249|26763126|FG001|Overall Study|Adverse Event|2|||
13386914|NCT00717249|26763125|FG000|Overall Study|Lost to Follow-up|2|||
13386915|NCT00717249|26763126|FG001|Overall Study|Lost to Follow-up|0|||
13386916|NCT00717249|26763125|FG000|Overall Study|Withdrawal by Subject|1|||
13386917|NCT00717249|26763126|FG001|Overall Study|Withdrawal by Subject|2|||
13386918|NCT00717249|26763125|FG000|Overall Study|Pregnancy|6|||
13386919|NCT00717249|26763126|FG001|Overall Study|Pregnancy|3|||
13386920|NCT00717249|26763125|FG000|Overall Study|Protocol Violation|0|||
13386921|NCT00717249|26763126|FG001|Overall Study|Protocol Violation|2|||
13386922|NCT00717249|26763125|FG000|Overall Study|Subject became Ineligible|1|||
13386923|NCT00717249|26763126|FG001|Overall Study|Subject became Ineligible|1|||
13386924|NCT00717249|26763125|FG000|Overall Study|Unsatisfactory Physiological Response|0|||
13386925|NCT00717249|26763126|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
13386926|NCT00717249|26763125|FG000|Overall Study|Gastric Surgery|0|||
13386927|NCT00717249|26763126|FG001|Overall Study|Gastric Surgery|1|||
13386928|NCT00717249|26763125|FG000|Overall Study|Diagnosed with Diabetes|1|||
13386929|NCT00717249|26763126|FG001|Overall Study|Diagnosed with Diabetes|0|||
13386930|NCT00717249|26763125|FG000|Overall Study|Diagnosed with Multiple Scletosis|1|||
13386931|NCT00717249|26763126|FG001|Overall Study|Diagnosed with Multiple Scletosis|0|||
13386932|NCT00717249|26763125|FG000|Overall Study|Subject relocated|1|||
13386933|NCT00717249|26763126|FG001|Overall Study|Subject relocated|0|||
13386934|NCT00717249|26763125|FG000|Overall Study|Headaches|1|||
13386935|NCT00717249|26763126|FG001|Overall Study|Headaches|0|||
13386936|NCT00717236|26763202|FG000|Double-Blind Period|Adverse Event|33|||
13386937|NCT00717236|26763203|FG001|Double-Blind Period|Adverse Event|6|||
13386938|NCT00717236|26763202|FG000|Double-Blind Period|Lack of Efficacy|6|||
13386939|NCT00717236|26763203|FG001|Double-Blind Period|Lack of Efficacy|6|||
13386940|NCT00717236|26763202|FG000|Double-Blind Period|Lost to Follow-up|3|||
13386941|NCT00717236|26763203|FG001|Double-Blind Period|Lost to Follow-up|5|||
13386942|NCT00717236|26763202|FG000|Double-Blind Period|Withdrawal by Subject|10|||
13386943|NCT00717236|26763203|FG001|Double-Blind Period|Withdrawal by Subject|2|||
13386944|NCT00717236|26763202|FG000|Double-Blind Period|Loss of efficacy|3|||
13386945|NCT00717236|26763203|FG001|Double-Blind Period|Loss of efficacy|0|||
13386946|NCT00717236|26763202|FG000|Double-Blind Period|Other: Death|1|||
13386947|NCT00717236|26763203|FG001|Double-Blind Period|Other: Death|0|||
13386948|NCT00717236|26763202|FG000|Double-Blind Period|Other: Pregnancy|1|||
13386949|NCT00717236|26763203|FG001|Double-Blind Period|Other: Pregnancy|0|||
13386950|NCT00717236|26763202|FG000|Double-Blind Period|Other: Protocol Violation|2|||
13386951|NCT00717236|26763203|FG001|Double-Blind Period|Other: Protocol Violation|0|||
13386952|NCT00717236|26763202|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6|||
13386953|NCT00717236|26763203|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2|||
13386954|NCT00717236|26763202|FG000|Double-Blind Period|Other: Site withdrew|2|||
13386955|NCT00717236|26763203|FG001|Double-Blind Period|Other: Site withdrew|0|||
13386956|NCT00717236|26763202|FG000|Double-Blind Period|Other: Screening failure|1|||
13386957|NCT00717236|26763203|FG001|Double-Blind Period|Other: Screening failure|0|||
13386958|NCT00717236|26763202|FG000|Double-Blind Period|Other: subject withdrew consent|1|||
13386959|NCT00717236|26763203|FG001|Double-Blind Period|Other: subject withdrew consent|1|||
13386960|NCT00717236|26763202|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2|||
13386961|NCT00717236|26763203|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1|||
13386962|NCT00717236|26763202|FG000|Double-Blind Period|Other: History of adenoid grown|1|||
13386963|NCT00717236|26763203|FG001|Double-Blind Period|Other: History of adenoid grown|0|||
13386964|NCT00717236|26763202|FG000|Double-Blind Period|Other: History of cancer|1|||
13386965|NCT00717236|26763203|FG001|Double-Blind Period|Other: History of cancer|0|||
13386966|NCT00717236|26763202|FG000|Double-Blind Period|Other: Sponsor request|1|||
13386967|NCT00717236|26763203|FG001|Double-Blind Period|Other: Sponsor request|0|||
13386968|NCT00717236|26763202|FG000|Double-Blind Period|Other: Inappropriate randomization|1|||
13386969|NCT00717236|26763203|FG001|Double-Blind Period|Other: Inappropriate randomization|0|||
13386970|NCT00717236|26763202|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1|||
13386971|NCT00717236|26763203|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0|||
13386972|NCT00717236|26763202|FG000|Double-Blind Period|Other: Subject moved|1|||
13386973|NCT00717236|26763203|FG001|Double-Blind Period|Other: Subject moved|1|||
13386974|NCT00717236|26763202|FG000|Double-Blind Period|Other: Stopped taking DMARD|1|||
13386975|NCT00717236|26763203|FG001|Double-Blind Period|Other: Stopped taking DMARD|0|||
13386976|NCT00717236|26763202|FG000|Double-Blind Period|Other: Prohibited medication taken|2|||
13386977|NCT00717236|26763203|FG001|Double-Blind Period|Other: Prohibited medication taken|2|||
13386978|NCT00717236|26763202|FG000|Double-Blind Period|Other: Transportation problems|0|||
13386979|NCT00717236|26763203|FG001|Double-Blind Period|Other: Transportation problems|1|||
13386980|NCT00717236|26763202|FG000|Double-Blind Period|Other: Investigator Decision|0|||
13386981|NCT00717236|26763203|FG001|Double-Blind Period|Other: Investigator Decision|1|||
13386982|NCT00717236|26763202|FG000|Open-Label Period|Adverse Event|29|||
13386983|NCT00717236|26763203|FG001|Open-Label Period|Adverse Event|4|||
13386984|NCT00717236|26763202|FG000|Open-Label Period|Lack of Efficacy|30|||
13386985|NCT00717236|26763203|FG001|Open-Label Period|Lack of Efficacy|8|||
13386986|NCT00717236|26763202|FG000|Open-Label Period|Lost to Follow-up|28|||
13386987|NCT00717236|26763203|FG001|Open-Label Period|Lost to Follow-up|4|||
13386988|NCT00717236|26763202|FG000|Open-Label Period|Withdrawal by Subject|20|||
13386989|NCT00717236|26763203|FG001|Open-Label Period|Withdrawal by Subject|2|||
13386990|NCT00717236|26763202|FG000|Open-Label Period|Loss of Efficacy|6|||
13386991|NCT00717236|26763203|FG001|Open-Label Period|Loss of Efficacy|1|||
13386992|NCT00717236|26763202|FG000|Open-Label Period|Other: Peripheral Neuropathy|0|||
13386993|NCT00717236|26763203|FG001|Open-Label Period|Other: Peripheral Neuropathy|1|||
13386994|NCT00717236|26763202|FG000|Open-Label Period|Other: Lack of Compliance|1|||
13386995|NCT00717236|26763203|FG001|Open-Label Period|Other: Lack of Compliance|1|||
13386996|NCT00717236|26763202|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1|||
13386997|NCT00717236|26763203|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0|||
13386998|NCT00717236|26763202|FG000|Open-Label Period|Other: Moved|1|||
13386999|NCT00717236|26763203|FG001|Open-Label Period|Other: Moved|0|||
13387000|NCT00717236|26763202|FG000|Open-Label Period|Other: Investigator Decision|1|||
13387001|NCT00717236|26763203|FG001|Open-Label Period|Other: Investigator Decision|0|||
13387002|NCT00717236|26763202|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1|||
13387003|NCT00717236|26763203|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0|||
13387004|NCT00717236|26763202|FG000|Open-Label Period|Other: Sponsor Request|3|||
13387005|NCT00717236|26763203|FG001|Open-Label Period|Other: Sponsor Request|0|||
13387006|NCT00717236|26763202|FG000|Open-Label Period|Other: Cataract Surgery|1|||
13387007|NCT00717236|26763203|FG001|Open-Label Period|Other: Cataract Surgery|0|||
13387008|NCT00717236|26763202|FG000|Open-Label Period|Other: Administration of Golimumab|1|||
13387009|NCT00717236|26763203|FG001|Open-Label Period|Other: Administration of Golimumab|0|||
13387010|NCT00717236|26763202|FG000|Open-Label Period|Other: Completion Accidently Performed|1|||
13387011|NCT00717236|26763203|FG001|Open-Label Period|Other: Completion Accidently Performed|0|||
13387012|NCT00717236|26763202|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1|||
13387013|NCT00717236|26763203|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0|||
13387014|NCT00717197|26763209|FG000|Overall Study|Unable to purchase study drug|5|||
13387015|NCT00717197|26763209|FG000|Overall Study|Tumor Progression|1|||
13387016|NCT00717197|26763209|FG000|Overall Study|Physician Decision|1|||
13387017|NCT00717093|26763228|FG000|Overall Study|Adverse Event|19|||
13387018|NCT00717093|26763229|FG001|Overall Study|Adverse Event|9|||
13387019|NCT00717093|26763228|FG000|Overall Study|Lack of Efficacy|3|||
13387020|NCT00717093|26763229|FG001|Overall Study|Lack of Efficacy|13|||
13387021|NCT00717093|26763228|FG000|Overall Study|Lost to Follow-up|9|||
13387022|NCT00717093|26763229|FG001|Overall Study|Lost to Follow-up|6|||
13387023|NCT00717093|26763228|FG000|Overall Study|Withdrawal by Subject|12|||
13387024|NCT00717093|26763229|FG001|Overall Study|Withdrawal by Subject|19|||
13387025|NCT00717093|26763228|FG000|Overall Study|Other|0|||
13387026|NCT00717093|26763229|FG001|Overall Study|Other|1|||
13387027|NCT00717093|26763228|FG000|Overall Study|Randomized but not treated|1|||
13387028|NCT00717093|26763229|FG001|Overall Study|Randomized but not treated|0|||
13387029|NCT00717067|26763327|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
13387030|NCT00717067|26763328|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
13387031|NCT00717067|26763329|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1|||
13387032|NCT00717067|26763330|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
13387033|NCT00717067|26763331|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
13387034|NCT00716976|26763360|FG000|Overall Study|Adverse Event|2|||
13387035|NCT00716976|26763361|FG001|Overall Study|Adverse Event|0|||
13387036|NCT00716976|26763360|FG000|Overall Study|Death|1|||
13387037|NCT00716976|26763361|FG001|Overall Study|Death|0|||
13387038|NCT00716976|26763360|FG000|Overall Study|Physician Decision|2|||
13387039|NCT00716976|26763361|FG001|Overall Study|Physician Decision|2|||
13387040|NCT00716976|26763360|FG000|Overall Study|Withdrawal by Subject|5|||
13387041|NCT00716976|26763361|FG001|Overall Study|Withdrawal by Subject|1|||
13387042|NCT00716976|26763360|FG000|Overall Study|Premature discontinuation cisplatin|5|||
13387043|NCT00716976|26763361|FG001|Overall Study|Premature discontinuation cisplatin|4|||
13387044|NCT00716976|26763360|FG000|Overall Study|Radiation during protocol|1|||
13387045|NCT00716976|26763361|FG001|Overall Study|Radiation during protocol|0|||
13387046|NCT00716976|26763360|FG000|Overall Study|Ineligibles|4|||
13387047|NCT00716976|26763361|FG001|Overall Study|Ineligibles|2|||
13387048|NCT00716859|26763392|FG000|Overall Study|Adverse Event|4|||
13387049|NCT00716859|26763393|FG001|Overall Study|Adverse Event|1|||
13387050|NCT00716859|26763392|FG000|Overall Study|Lack of Efficacy|3|||
13387051|NCT00716859|26763393|FG001|Overall Study|Lack of Efficacy|0|||
13387052|NCT00716859|26763392|FG000|Overall Study|Withdrawal by Subject|1|||
13387053|NCT00716859|26763393|FG001|Overall Study|Withdrawal by Subject|3|||
13387054|NCT00716859|26763392|FG000|Overall Study|Not treated|1|||
13387055|NCT00716859|26763393|FG001|Overall Study|Not treated|1|||
13387056|NCT00716625|26763420|FG000|Overall Study|Safety was not Assessable|1|||
13387057|NCT00716482|26763432|FG000|Overall Study|Lost to Follow-up|6|||
13387058|NCT00716482|26763432|FG000|Overall Study|Inadequate acquisition or analysis|50|||
13387059|NCT00716482|26763432|FG000|Overall Study|no pathology obtained|10|||
13387060|NCT00716482|26763432|FG000|Overall Study|technical/machine error|28|||
13387061|NCT00716482|26763432|FG000|Overall Study|inclusion/exclusion criteria not met|25|||
13387062|NCT00716456|26763450|FG000|Overall Study|Adverse Event|0|||
13387063|NCT00716456|26763451|FG001|Overall Study|Adverse Event|2|||
13387064|NCT00716456|26763452|FG002|Overall Study|Adverse Event|0|||
13387065|NCT00716417|26763527|FG000|Overall Study|Adverse Event|0|||
13387066|NCT00716417|26763528|FG001|Overall Study|Adverse Event|0|||
13387067|NCT00716417|26763529|FG002|Overall Study|Adverse Event|2|||
13387068|NCT00716417|26763530|FG003|Overall Study|Adverse Event|1|||
13387069|NCT00716417|26763531|FG004|Overall Study|Adverse Event|0|||
13387070|NCT00716417|26763532|FG005|Overall Study|Adverse Event|0|||
13387071|NCT00716417|26763533|FG006|Overall Study|Adverse Event|3|||
13387072|NCT00716417|26763534|FG007|Overall Study|Adverse Event|1|||
13387073|NCT00716417|26763535|FG008|Overall Study|Adverse Event|0|||
13387074|NCT00716417|26763536|FG009|Overall Study|Adverse Event|3|||
13387075|NCT00716417|26763527|FG000|Overall Study|Withdrawal by Subject|0|||
13387076|NCT00716417|26763528|FG001|Overall Study|Withdrawal by Subject|1|||
13387077|NCT00716417|26763529|FG002|Overall Study|Withdrawal by Subject|0|||
13387078|NCT00716417|26763530|FG003|Overall Study|Withdrawal by Subject|2|||
13387079|NCT00716417|26763531|FG004|Overall Study|Withdrawal by Subject|0|||
13387080|NCT00716417|26763532|FG005|Overall Study|Withdrawal by Subject|0|||
13387081|NCT00716417|26763533|FG006|Overall Study|Withdrawal by Subject|1|||
13387082|NCT00716417|26763534|FG007|Overall Study|Withdrawal by Subject|0|||
13387083|NCT00716417|26763535|FG008|Overall Study|Withdrawal by Subject|0|||
13387084|NCT00716417|26763536|FG009|Overall Study|Withdrawal by Subject|0|||
13387085|NCT00716417|26763527|FG000|Overall Study|Progressive disease|3|||
13387086|NCT00716417|26763528|FG001|Overall Study|Progressive disease|5|||
13387087|NCT00716417|26763529|FG002|Overall Study|Progressive disease|3|||
13387088|NCT00716417|26763530|FG003|Overall Study|Progressive disease|8|||
13387089|NCT00716417|26763531|FG004|Overall Study|Progressive disease|0|||
13387090|NCT00716417|26763532|FG005|Overall Study|Progressive disease|3|||
13387091|NCT00716417|26763533|FG006|Overall Study|Progressive disease|3|||
13387092|NCT00716417|26763534|FG007|Overall Study|Progressive disease|1|||
13387093|NCT00716417|26763535|FG008|Overall Study|Progressive disease|5|||
13387094|NCT00716417|26763536|FG009|Overall Study|Progressive disease|0|||
13387095|NCT00716417|26763527|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
13387096|NCT00716417|26763528|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
13387097|NCT00716417|26763529|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
13387098|NCT00716417|26763530|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
13387099|NCT00716417|26763531|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
13387100|NCT00716417|26763532|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
13387101|NCT00716417|26763533|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
13387102|NCT00716417|26763534|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
13387103|NCT00716417|26763535|FG008|Overall Study|Dose limiting toxicity (DLT)|0|||
13387104|NCT00716417|26763536|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
13387105|NCT00716417|26763527|FG000|Overall Study|On patient request due to toxicities|0|||
13387106|NCT00716417|26763528|FG001|Overall Study|On patient request due to toxicities|0|||
13387107|NCT00716417|26763529|FG002|Overall Study|On patient request due to toxicities|0|||
13387108|NCT00716417|26763530|FG003|Overall Study|On patient request due to toxicities|0|||
13387109|NCT00716417|26763531|FG004|Overall Study|On patient request due to toxicities|0|||
13387110|NCT00716417|26763532|FG005|Overall Study|On patient request due to toxicities|0|||
13387111|NCT00716417|26763533|FG006|Overall Study|On patient request due to toxicities|0|||
13387112|NCT00716417|26763534|FG007|Overall Study|On patient request due to toxicities|1|||
13387113|NCT00716417|26763535|FG008|Overall Study|On patient request due to toxicities|0|||
13387114|NCT00716417|26763536|FG009|Overall Study|On patient request due to toxicities|0|||
13387115|NCT00716274|26763695|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2|||
13387116|NCT00716274|26763696|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
13387117|NCT00716274|26763697|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
13387118|NCT00716274|26763698|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
13387119|NCT00716274|26763699|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
13387120|NCT00716274|26763700|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
13387121|NCT00716274|26763695|FG000|Study Period II (16-Weeks)|Protocol Violation|0|||
13387122|NCT00716274|26763696|FG001|Study Period II (16-Weeks)|Protocol Violation|3|||
13387123|NCT00716274|26763697|FG002|Study Period II (16-Weeks)|Protocol Violation|0|||
13387124|NCT00716274|26763698|FG003|Study Period II (16-Weeks)|Protocol Violation|0|||
13387125|NCT00716274|26763699|FG004|Study Period II (16-Weeks)|Protocol Violation|0|||
13387126|NCT00716274|26763700|FG005|Study Period II (16-Weeks)|Protocol Violation|1|||
13387127|NCT00716274|26763695|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1|||
13387128|NCT00716274|26763696|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
13387129|NCT00716274|26763697|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
13387130|NCT00716274|26763698|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
13387131|NCT00716274|26763699|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
13387132|NCT00716274|26763700|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
13387133|NCT00716274|26763695|FG000|Study Period II (16-Weeks)|Physician Decision|3|||
13387134|NCT00716274|26763696|FG001|Study Period II (16-Weeks)|Physician Decision|1|||
13387135|NCT00716274|26763697|FG002|Study Period II (16-Weeks)|Physician Decision|0|||
13387136|NCT00716274|26763698|FG003|Study Period II (16-Weeks)|Physician Decision|0|||
13387137|NCT00716274|26763699|FG004|Study Period II (16-Weeks)|Physician Decision|0|||
13387138|NCT00716274|26763700|FG005|Study Period II (16-Weeks)|Physician Decision|1|||
13387139|NCT00716274|26763695|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
13387140|NCT00716274|26763696|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
13387141|NCT00716274|26763697|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
13387142|NCT00716274|26763698|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
13387143|NCT00716274|26763699|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
13387144|NCT00716274|26763700|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
13387145|NCT00716274|26763695|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0|||
13387146|NCT00716274|26763696|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2|||
13387147|NCT00716274|26763697|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0|||
13387148|NCT00716274|26763698|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0|||
13387149|NCT00716274|26763699|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0|||
13387150|NCT00716274|26763700|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0|||
13387151|NCT00716274|26763695|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
13387152|NCT00716274|26763696|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
13387153|NCT00716274|26763697|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2|||
13387154|NCT00716274|26763698|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
13387155|NCT00716274|26763699|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
13387156|NCT00716274|26763700|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
13387157|NCT00716274|26763695|FG000|Study Period III (16-Weeks)|Physician Decision|0|||
13387158|NCT00716274|26763696|FG001|Study Period III (16-Weeks)|Physician Decision|0|||
13387159|NCT00716274|26763697|FG002|Study Period III (16-Weeks)|Physician Decision|0|||
13387160|NCT00716274|26763698|FG003|Study Period III (16-Weeks)|Physician Decision|0|||
13387161|NCT00716274|26763699|FG004|Study Period III (16-Weeks)|Physician Decision|1|||
13387162|NCT00716274|26763700|FG005|Study Period III (16-Weeks)|Physician Decision|0|||
13387163|NCT00716274|26763695|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
13387164|NCT00716274|26763696|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
13387165|NCT00716274|26763697|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
13387166|NCT00716274|26763698|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
13387167|NCT00716274|26763699|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
13387168|NCT00716274|26763700|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
13387169|NCT00716274|26763695|FG000|Study Period III (16-Weeks)|Adverse Event|0|||
13387170|NCT00716274|26763696|FG001|Study Period III (16-Weeks)|Adverse Event|0|||
13387171|NCT00716274|26763697|FG002|Study Period III (16-Weeks)|Adverse Event|0|||
13387172|NCT00716274|26763698|FG003|Study Period III (16-Weeks)|Adverse Event|0|||
13387173|NCT00716274|26763699|FG004|Study Period III (16-Weeks)|Adverse Event|1|||
13387174|NCT00716274|26763700|FG005|Study Period III (16-Weeks)|Adverse Event|0|||
13387175|NCT00716144|26763735|FG000|Overall Study|Withdrawal by Subject|4|||
13387176|NCT00716144|26763736|FG001|Overall Study|Withdrawal by Subject|2|||
13387177|NCT00716144|26763737|FG002|Overall Study|Withdrawal by Subject|6|||
13387178|NCT00716144|26763738|FG003|Overall Study|Withdrawal by Subject|6|||
13387179|NCT00716144|26763735|FG000|Overall Study|Lost to Follow-up|2|||
13387180|NCT00716144|26763736|FG001|Overall Study|Lost to Follow-up|2|||
13387181|NCT00716144|26763737|FG002|Overall Study|Lost to Follow-up|1|||
13387182|NCT00716144|26763738|FG003|Overall Study|Lost to Follow-up|2|||
13387183|NCT00716144|26763735|FG000|Overall Study|Adverse Event|0|||
13387184|NCT00716144|26763736|FG001|Overall Study|Adverse Event|0|||
13387185|NCT00716144|26763737|FG002|Overall Study|Adverse Event|0|||
13387186|NCT00716144|26763738|FG003|Overall Study|Adverse Event|2|||
13387187|NCT00716144|26763735|FG000|Overall Study|Non-compliance|1|||
13387188|NCT00716144|26763736|FG001|Overall Study|Non-compliance|0|||
13387189|NCT00716144|26763737|FG002|Overall Study|Non-compliance|0|||
13387190|NCT00716144|26763738|FG003|Overall Study|Non-compliance|0|||
13387191|NCT00716144|26763735|FG000|Overall Study|Protocol Violation|2|||
13387192|NCT00716144|26763736|FG001|Overall Study|Protocol Violation|0|||
13387193|NCT00716144|26763737|FG002|Overall Study|Protocol Violation|1|||
13387194|NCT00716144|26763738|FG003|Overall Study|Protocol Violation|0|||
13387195|NCT00716144|26763735|FG000|Overall Study|Physician Decision|0|||
13387196|NCT00716144|26763736|FG001|Overall Study|Physician Decision|1|||
13387197|NCT00716144|26763737|FG002|Overall Study|Physician Decision|2|||
13387198|NCT00716144|26763738|FG003|Overall Study|Physician Decision|2|||
13387199|NCT00716144|26763735|FG000|Overall Study|Intercurrent illness|0|||
13387200|NCT00716144|26763736|FG001|Overall Study|Intercurrent illness|0|||
13387201|NCT00716144|26763737|FG002|Overall Study|Intercurrent illness|1|||
13387202|NCT00716144|26763738|FG003|Overall Study|Intercurrent illness|0|||
13387203|NCT00716144|26763735|FG000|Overall Study|Withdrew consent, allowed use of data|0|||
13387204|NCT00716144|26763736|FG001|Overall Study|Withdrew consent, allowed use of data|0|||
13387205|NCT00716144|26763737|FG002|Overall Study|Withdrew consent, allowed use of data|1|||
13387206|NCT00716144|26763738|FG003|Overall Study|Withdrew consent, allowed use of data|0|||
13387207|NCT00716144|26763735|FG000|Overall Study|Adverse event: left foot pain|0|||
13387208|NCT00716144|26763736|FG001|Overall Study|Adverse event: left foot pain|1|||
13387209|NCT00716144|26763737|FG002|Overall Study|Adverse event: left foot pain|0|||
13387210|NCT00716144|26763738|FG003|Overall Study|Adverse event: left foot pain|0|||
13387211|NCT00716144|26763735|FG000|Overall Study|Clinical Depression|0|||
13387212|NCT00716144|26763736|FG001|Overall Study|Clinical Depression|1|||
13387213|NCT00716144|26763737|FG002|Overall Study|Clinical Depression|0|||
13387214|NCT00716144|26763738|FG003|Overall Study|Clinical Depression|0|||
13387215|NCT00716092|26763777|FG000|Overall Study|Other incl. Lack of Efficacy|2|||
13387216|NCT00716092|26763778|FG001|Overall Study|Other incl. Lack of Efficacy|1|||
13387217|NCT00716092|26763779|FG002|Overall Study|Other incl. Lack of Efficacy|0|||
13387218|NCT00715949|26763785|FG000|Overall Study|could not finish first test|4|||
13387219|NCT00715910|26763874|FG000|Booster and ESFU Phase|Lost to Follow-up|0|||
13387220|NCT00715910|26763875|FG001|Booster and ESFU Phase|Lost to Follow-up|0|||
13387221|NCT00715910|26763876|FG002|Booster and ESFU Phase|Lost to Follow-up|0|||
13387222|NCT00715910|26763877|FG003|Booster and ESFU Phase|Lost to Follow-up|6|||
13387223|NCT00715910|26763878|FG004|Booster and ESFU Phase|Lost to Follow-up|1|||
13387224|NCT00715910|26763879|FG005|Booster and ESFU Phase|Lost to Follow-up|13|||
13387225|NCT00715910|26763874|FG000|Booster and ESFU Phase|Other|0|||
13387226|NCT00715910|26763875|FG001|Booster and ESFU Phase|Other|0|||
13387227|NCT00715910|26763876|FG002|Booster and ESFU Phase|Other|0|||
13395309|NCT00649428|26790210|FG000|Overall Study|Adverse Event|2|||
13395310|NCT00649428|26790211|FG001|Overall Study|Adverse Event|2|||
13395311|NCT00649428|26790210|FG000|Overall Study|Withdrawal by Subject|6|||
13395312|NCT00649428|26790211|FG001|Overall Study|Withdrawal by Subject|6|||
13395313|NCT00649428|26790210|FG000|Overall Study|Lost to Follow-up|1|||
13395314|NCT00649428|26790211|FG001|Overall Study|Lost to Follow-up|3|||
13395315|NCT00649428|26790210|FG000|Overall Study|Insufficient manufacturing yield|5|||
13395316|NCT00649428|26790211|FG001|Overall Study|Insufficient manufacturing yield|1|||
13395317|NCT00649428|26790210|FG000|Overall Study|Protocol Violation|6|||
13395318|NCT00649428|26790211|FG001|Overall Study|Protocol Violation|2|||
13395319|NCT00649428|26790210|FG000|Overall Study|Physician Decision|0|||
13395320|NCT00649428|26790211|FG001|Overall Study|Physician Decision|1|||
13395321|NCT00649389|26790246|FG000|Overall Study|Adverse Event|22|||
13395322|NCT00649389|26790247|FG001|Overall Study|Adverse Event|46|||
13395323|NCT00649389|26790248|FG002|Overall Study|Adverse Event|38|||
13395324|NCT00649389|26790249|FG003|Overall Study|Adverse Event|48|||
13395325|NCT00649389|26790246|FG000|Overall Study|Lost to Follow-up|15|||
13395326|NCT00649389|26790247|FG001|Overall Study|Lost to Follow-up|17|||
13395327|NCT00649389|26790248|FG002|Overall Study|Lost to Follow-up|21|||
13395328|NCT00649389|26790249|FG003|Overall Study|Lost to Follow-up|26|||
13395329|NCT00649389|26790246|FG000|Overall Study|Protocol Violation|11|||
13395330|NCT00649389|26790247|FG001|Overall Study|Protocol Violation|13|||
13395331|NCT00649389|26790248|FG002|Overall Study|Protocol Violation|9|||
13395332|NCT00649389|26790249|FG003|Overall Study|Protocol Violation|8|||
13395333|NCT00649389|26790246|FG000|Overall Study|Withdrawal by Subject|20|||
13395334|NCT00649389|26790247|FG001|Overall Study|Withdrawal by Subject|21|||
13395335|NCT00649389|26790248|FG002|Overall Study|Withdrawal by Subject|19|||
13395336|NCT00649389|26790249|FG003|Overall Study|Withdrawal by Subject|23|||
13395337|NCT00649389|26790246|FG000|Overall Study|Other|3|||
13395338|NCT00649389|26790247|FG001|Overall Study|Other|9|||
13395339|NCT00649389|26790248|FG002|Overall Study|Other|1|||
13395340|NCT00649389|26790249|FG003|Overall Study|Other|6|||
13395341|NCT00649220|26790262|FG000|Overall Study|Adverse Event|2|||
13395342|NCT00649220|26790262|FG000|Overall Study|Withdrawal by Subject|1|||
13395343|NCT00648895|26790275|FG000|Overall Study|Lack of Efficacy|0|||
13395344|NCT00648895|26790276|FG001|Overall Study|Lack of Efficacy|1|||
13395345|NCT00648739|26790322|FG000|Overall Study|Adverse Event|1|||
13395346|NCT00648739|26790323|FG001|Overall Study|Adverse Event|0|||
13395347|NCT00648739|26790324|FG002|Overall Study|Adverse Event|1|||
13395348|NCT00648739|26790325|FG003|Overall Study|Adverse Event|2|||
13395349|NCT00648739|26790326|FG004|Overall Study|Adverse Event|1|||
13395350|NCT00648739|26790327|FG005|Overall Study|Adverse Event|0|||
13395351|NCT00648739|26790328|FG006|Overall Study|Adverse Event|0|||
13395352|NCT00648739|26790322|FG000|Overall Study|Withdrawal by Subject|1|||
13395353|NCT00648739|26790323|FG001|Overall Study|Withdrawal by Subject|0|||
13395354|NCT00648739|26790324|FG002|Overall Study|Withdrawal by Subject|1|||
13395355|NCT00648739|26790325|FG003|Overall Study|Withdrawal by Subject|0|||
13395356|NCT00648739|26790326|FG004|Overall Study|Withdrawal by Subject|0|||
13395357|NCT00648739|26790327|FG005|Overall Study|Withdrawal by Subject|2|||
13306222|NCT01292603|26525395|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
13306223|NCT01292603|26525396|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
13306224|NCT01292603|26525397|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
13306225|NCT01292603|26525398|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4|||
13306226|NCT01292603|26525399|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
13306227|NCT01292603|26525400|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
13306228|NCT01292603|26525395|FG000|Part 1: Pilot Dose Selection Period|Death|0|||
13387228|NCT00715910|26763877|FG003|Booster and ESFU Phase|Other|5|||
13387229|NCT00715910|26763878|FG004|Booster and ESFU Phase|Other|1|||
13387230|NCT00715910|26763879|FG005|Booster and ESFU Phase|Other|0|||
13387231|NCT00715793|26763894|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1|||
13387232|NCT00715793|26763895|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0|||
13387233|NCT00715793|26763894|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0|||
13387234|NCT00715793|26763895|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2|||
13387235|NCT00715676|26763931|FG000|Overall Study|Adverse Event|3|||
13387236|NCT00715676|26763932|FG001|Overall Study|Adverse Event|5|||
13387237|NCT00715676|26763933|FG002|Overall Study|Adverse Event|21|||
13387238|NCT00715676|26763931|FG000|Overall Study|Withdrawal by Subject|1|||
13387239|NCT00715676|26763932|FG001|Overall Study|Withdrawal by Subject|3|||
13387240|NCT00715676|26763933|FG002|Overall Study|Withdrawal by Subject|8|||
13387241|NCT00715676|26763931|FG000|Overall Study|Lost to Follow-up|1|||
13387242|NCT00715676|26763932|FG001|Overall Study|Lost to Follow-up|2|||
13387243|NCT00715676|26763933|FG002|Overall Study|Lost to Follow-up|1|||
13387244|NCT00715676|26763931|FG000|Overall Study|Terminated by Sponsor|1|||
13387245|NCT00715676|26763932|FG001|Overall Study|Terminated by Sponsor|0|||
13387246|NCT00715676|26763933|FG002|Overall Study|Terminated by Sponsor|0|||
13387247|NCT00715676|26763931|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
13387248|NCT00715676|26763932|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
13387249|NCT00715676|26763933|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
13387250|NCT00715676|26763931|FG000|Overall Study|Use of Exclusionary Medication|0|||
13387251|NCT00715676|26763932|FG001|Overall Study|Use of Exclusionary Medication|0|||
13387252|NCT00715676|26763933|FG002|Overall Study|Use of Exclusionary Medication|1|||
13387253|NCT00715676|26763931|FG000|Overall Study|Elevated Blood Glucose|0|||
13387254|NCT00715676|26763932|FG001|Overall Study|Elevated Blood Glucose|1|||
13387255|NCT00715676|26763933|FG002|Overall Study|Elevated Blood Glucose|0|||
13387256|NCT00715624|26763968|FG000|Overall Study|Adverse Event|12|||
13387257|NCT00715624|26763969|FG001|Overall Study|Adverse Event|37|||
13387258|NCT00715624|26763968|FG000|Overall Study|Lack of Efficacy|11|||
13387259|NCT00715624|26763969|FG001|Overall Study|Lack of Efficacy|11|||
13387260|NCT00715624|26763968|FG000|Overall Study|Lost to Follow-up|1|||
13387261|NCT00715624|26763969|FG001|Overall Study|Lost to Follow-up|2|||
13387262|NCT00715624|26763968|FG000|Overall Study|Protocol Violation|1|||
13387263|NCT00715624|26763969|FG001|Overall Study|Protocol Violation|0|||
13387264|NCT00715624|26763968|FG000|Overall Study|Withdrawal by Subject|11|||
13387265|NCT00715624|26763969|FG001|Overall Study|Withdrawal by Subject|25|||
13387266|NCT00715624|26763968|FG000|Overall Study|Familial and personal reasons|10|||
13387267|NCT00715624|26763969|FG001|Overall Study|Familial and personal reasons|22|||
13387268|NCT00715624|26763968|FG000|Overall Study|Poor compliance|6|||
13387269|NCT00715624|26763969|FG001|Overall Study|Poor compliance|13|||
13387270|NCT00715624|26763968|FG000|Overall Study|Sponsor decision|0|||
13387271|NCT00715624|26763969|FG001|Overall Study|Sponsor decision|4|||
13387272|NCT00715624|26763968|FG000|Overall Study|Incorrect randomization (not treated)|0|||
13387273|NCT00715624|26763969|FG001|Overall Study|Incorrect randomization (not treated)|1|||
13387274|NCT00715624|26763968|FG000|Overall Study|Other|0|||
13387275|NCT00715624|26763969|FG001|Overall Study|Other|1|||
13387276|NCT00715559|26763978|FG000|Overall Study|medication not tolerated - nausea|1|||
13387277|NCT00715520|26764001|FG000|Overall Study|Screen failure|8|||
13387278|NCT00715520|26764002|FG001|Overall Study|Screen failure|1|||
13387279|NCT00715520|26764003|FG002|Overall Study|Screen failure|1|||
13387280|NCT00715520|26764001|FG000|Overall Study|Withdrawal by Subject|2|||
13387281|NCT00715520|26764002|FG001|Overall Study|Withdrawal by Subject|0|||
13387282|NCT00715520|26764003|FG002|Overall Study|Withdrawal by Subject|1|||
13387283|NCT00715429|26764018|FG000|Overall Study|Did not complete the study diary|0|||
13387284|NCT00715429|26764019|FG001|Overall Study|Did not complete the study diary|1|||
13387285|NCT00715403|26764176|FG000|Overall Study|Progressive disease|0|||
13387286|NCT00715403|26764177|FG001|Overall Study|Progressive disease|1|||
13387287|NCT00715403|26764178|FG002|Overall Study|Progressive disease|3|||
13387288|NCT00715403|26764179|FG003|Overall Study|Progressive disease|9|||
13387289|NCT00715403|26764180|FG004|Overall Study|Progressive disease|5|||
13387290|NCT00715403|26764181|FG005|Overall Study|Progressive disease|14|||
13387291|NCT00715403|26764182|FG006|Overall Study|Progressive disease|1|||
13387292|NCT00715403|26764176|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
13387293|NCT00715403|26764177|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
13387294|NCT00715403|26764178|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
13387295|NCT00715403|26764179|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
13387296|NCT00715403|26764180|FG004|Overall Study|Dose limiting Toxicity (DLT)|0|||
13387297|NCT00715403|26764181|FG005|Overall Study|Dose limiting Toxicity (DLT)|1|||
13387298|NCT00715403|26764182|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
13387299|NCT00715403|26764176|FG000|Overall Study|Other Adverse Event than DLT|1|||
13387300|NCT00715403|26764177|FG001|Overall Study|Other Adverse Event than DLT|0|||
13387301|NCT00715403|26764178|FG002|Overall Study|Other Adverse Event than DLT|0|||
13387302|NCT00715403|26764179|FG003|Overall Study|Other Adverse Event than DLT|0|||
13387303|NCT00715403|26764180|FG004|Overall Study|Other Adverse Event than DLT|0|||
13387304|NCT00715403|26764181|FG005|Overall Study|Other Adverse Event than DLT|2|||
13387305|NCT00715403|26764182|FG006|Overall Study|Other Adverse Event than DLT|0|||
13387306|NCT00715403|26764176|FG000|Overall Study|Protocol Violation|0|||
13387307|NCT00715403|26764177|FG001|Overall Study|Protocol Violation|0|||
13387308|NCT00715403|26764178|FG002|Overall Study|Protocol Violation|0|||
13387309|NCT00715403|26764179|FG003|Overall Study|Protocol Violation|0|||
13387310|NCT00715403|26764180|FG004|Overall Study|Protocol Violation|0|||
13387311|NCT00715403|26764181|FG005|Overall Study|Protocol Violation|1|||
13387312|NCT00715403|26764182|FG006|Overall Study|Protocol Violation|0|||
13387313|NCT00715403|26764176|FG000|Overall Study|Other reason not defined above|0|||
13387314|NCT00715403|26764177|FG001|Overall Study|Other reason not defined above|0|||
13387315|NCT00715403|26764178|FG002|Overall Study|Other reason not defined above|1|||
13387316|NCT00715403|26764179|FG003|Overall Study|Other reason not defined above|0|||
13387317|NCT00715403|26764180|FG004|Overall Study|Other reason not defined above|1|||
13387318|NCT00715403|26764181|FG005|Overall Study|Other reason not defined above|1|||
13387319|NCT00715403|26764182|FG006|Overall Study|Other reason not defined above|0|||
13387320|NCT00715299|26764188|FG000|Overall Study|Withdrawal by Subject|1|||
13387321|NCT00715299|26764188|FG000|Overall Study|Adverse Event|3|||
13387322|NCT00715299|26764188|FG000|Overall Study|failed the pre-screen exercise test|2|||
13387323|NCT00715208|26764209|FG000|Overall Study|Withdrawal by Subject|1|||
13387324|NCT00715208|26764210|FG001|Overall Study|Withdrawal by Subject|1|||
13387325|NCT00715208|26764209|FG000|Overall Study|Adverse Event|0|||
13387326|NCT00715208|26764210|FG001|Overall Study|Adverse Event|6|||
13387327|NCT00715208|26764209|FG000|Overall Study|Lack of Efficacy|0|||
13387328|NCT00715208|26764210|FG001|Overall Study|Lack of Efficacy|2|||
13387329|NCT00715117|26764228|FG000|Overall Study|Crohn's flare and rescue with steroids|0|||
13387330|NCT00715117|26764229|FG001|Overall Study|Crohn's flare and rescue with steroids|1|||
13387331|NCT00715078|26764247|FG000|Overall Study|Death|29|||
13387332|NCT00715078|26764248|FG001|Overall Study|Death|36|||
13387333|NCT00715078|26764249|FG002|Overall Study|Death|36|||
13387334|NCT00715078|26764247|FG000|Overall Study|Withdrawal by Subject|1|||
13387335|NCT00715078|26764248|FG001|Overall Study|Withdrawal by Subject|0|||
13387336|NCT00715078|26764249|FG002|Overall Study|Withdrawal by Subject|1|||
13387337|NCT00715078|26764247|FG000|Overall Study|Unable to start due to disease prog.|0|||
13387338|NCT00715078|26764248|FG001|Overall Study|Unable to start due to disease prog.|0|||
13387339|NCT00715078|26764249|FG002|Overall Study|Unable to start due to disease prog.|1|||
13387340|NCT00715026|26764256|FG000|Overall Study|Withdrawal by Subject|5|||
13387341|NCT00715026|26764256|FG000|Overall Study|Lost to Follow-up|3|||
13387342|NCT00715026|26764256|FG000|Overall Study|Protocol Violation|1|||
13387343|NCT00715026|26764256|FG000|Overall Study|Surgery done on non-study consented hip|1|||
13387344|NCT00714948|26764262|FG000|Overall Study|Adverse Event|2|||
13387345|NCT00714870|26764275|FG000|Overall Study|Lost to Follow-up|22|||
13387346|NCT00714870|26764276|FG001|Overall Study|Lost to Follow-up|5|||
13387347|NCT00714870|26764275|FG000|Overall Study|patient unable to come b/c back pain|1|||
13387348|NCT00714870|26764276|FG001|Overall Study|patient unable to come b/c back pain|0|||
13387349|NCT00714870|26764275|FG000|Overall Study|did not attend minimum of 4 sessions|4|||
13387350|NCT00714870|26764276|FG001|Overall Study|did not attend minimum of 4 sessions|0|||
13387351|NCT00714714|26764284|FG000|Overall Study|Adverse Event|1|||
13387352|NCT00714688|26764311|FG000|Overall Study|Lack of Efficacy|14|||
13387353|NCT00714688|26764312|FG001|Overall Study|Lack of Efficacy|1|||
13387354|NCT00714688|26764313|FG002|Overall Study|Lack of Efficacy|4|||
13387355|NCT00714688|26764311|FG000|Overall Study|Withdrawal by Subject|4|||
13387356|NCT00714688|26764312|FG001|Overall Study|Withdrawal by Subject|3|||
13387357|NCT00714688|26764313|FG002|Overall Study|Withdrawal by Subject|3|||
13387358|NCT00714688|26764311|FG000|Overall Study|Lost to Follow-up|5|||
13387359|NCT00714688|26764312|FG001|Overall Study|Lost to Follow-up|2|||
13395358|NCT00648739|26790328|FG006|Overall Study|Withdrawal by Subject|0|||
13395359|NCT00648739|26790322|FG000|Overall Study|Lack of Efficacy|0|||
13395360|NCT00648739|26790323|FG001|Overall Study|Lack of Efficacy|0|||
13395361|NCT00648739|26790324|FG002|Overall Study|Lack of Efficacy|0|||
13395362|NCT00648739|26790325|FG003|Overall Study|Lack of Efficacy|0|||
13395363|NCT00648739|26790326|FG004|Overall Study|Lack of Efficacy|1|||
13395364|NCT00648739|26790327|FG005|Overall Study|Lack of Efficacy|2|||
13395365|NCT00648739|26790328|FG006|Overall Study|Lack of Efficacy|0|||
13395366|NCT00648739|26790322|FG000|Overall Study|Investigator Considered it Advisable|0|||
13395367|NCT00648739|26790323|FG001|Overall Study|Investigator Considered it Advisable|0|||
13395368|NCT00648739|26790324|FG002|Overall Study|Investigator Considered it Advisable|0|||
13395369|NCT00648739|26790325|FG003|Overall Study|Investigator Considered it Advisable|0|||
13395370|NCT00648739|26790326|FG004|Overall Study|Investigator Considered it Advisable|0|||
13395371|NCT00648739|26790327|FG005|Overall Study|Investigator Considered it Advisable|1|||
13395372|NCT00648739|26790328|FG006|Overall Study|Investigator Considered it Advisable|1|||
13395373|NCT00648739|26790322|FG000|Overall Study|Death|0|||
13395374|NCT00648739|26790323|FG001|Overall Study|Death|1|||
13395375|NCT00648739|26790324|FG002|Overall Study|Death|0|||
13387360|NCT00714688|26764313|FG002|Overall Study|Lost to Follow-up|0|||
13387361|NCT00714688|26764311|FG000|Overall Study|Adverse Event|2|||
13387362|NCT00714688|26764312|FG001|Overall Study|Adverse Event|15|||
13387363|NCT00714688|26764313|FG002|Overall Study|Adverse Event|19|||
13387364|NCT00714688|26764311|FG000|Overall Study|Subject Non-compliant|3|||
13387365|NCT00714688|26764312|FG001|Overall Study|Subject Non-compliant|5|||
13387366|NCT00714688|26764313|FG002|Overall Study|Subject Non-compliant|5|||
13387367|NCT00714688|26764311|FG000|Overall Study|Ineligible to Continue the Study|0|||
13387368|NCT00714688|26764312|FG001|Overall Study|Ineligible to Continue the Study|1|||
13387369|NCT00714688|26764313|FG002|Overall Study|Ineligible to Continue the Study|1|||
13387370|NCT00714688|26764311|FG000|Overall Study|Sponsor's Decision|0|||
13387371|NCT00714688|26764312|FG001|Overall Study|Sponsor's Decision|2|||
13387372|NCT00714688|26764313|FG002|Overall Study|Sponsor's Decision|0|||
13387373|NCT00714688|26764311|FG000|Overall Study|Other|1|||
13387374|NCT00714688|26764312|FG001|Overall Study|Other|6|||
13387375|NCT00714688|26764313|FG002|Overall Study|Other|5|||
13387376|NCT00714493|26764325|FG000|Overall Study|Adverse Event|11|||
13387377|NCT00714493|26764325|FG000|Overall Study|Death|3|||
13387378|NCT00714493|26764325|FG000|Overall Study|Lack of Efficacy|10|||
13387379|NCT00714493|26764325|FG000|Overall Study|Lost to Follow-up|3|||
13387380|NCT00714493|26764325|FG000|Overall Study|Protocol Violation|12|||
13387381|NCT00714493|26764325|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8|||
13387382|NCT00714493|26764325|FG000|Overall Study|OTHER|2|||
13387383|NCT00714415|26764364|FG000|Overall Study|Lack of Efficacy|1|||
13387384|NCT00714415|26764365|FG001|Overall Study|Lack of Efficacy|0|||
13387385|NCT00714415|26764364|FG000|Overall Study|Death|1|||
13387386|NCT00714415|26764365|FG001|Overall Study|Death|0|||
13387387|NCT00714285|26764428|FG000|Overall Study|Lost to Follow-up|0|||
13387388|NCT00714285|26764429|FG001|Overall Study|Lost to Follow-up|2|||
13387389|NCT00714285|26764430|FG002|Overall Study|Lost to Follow-up|0|||
13387390|NCT00714285|26764431|FG003|Overall Study|Lost to Follow-up|1|||
13387391|NCT00714285|26764428|FG000|Overall Study|Migrated/moved from study area|0|||
13387392|NCT00714285|26764429|FG001|Overall Study|Migrated/moved from study area|1|||
13387393|NCT00714285|26764430|FG002|Overall Study|Migrated/moved from study area|0|||
13387394|NCT00714285|26764431|FG003|Overall Study|Migrated/moved from study area|0|||
13387395|NCT00714259|26764443|FG000|Overall Study|Death|2|||
13387396|NCT00714168|26764464|FG000|Overall Study|Pregnancy|5|||
13387397|NCT00714168|26764465|FG001|Overall Study|Pregnancy|4|||
13387398|NCT00714168|26764464|FG000|Overall Study|Lost to Follow-up|32|||
13387399|NCT00714168|26764465|FG001|Overall Study|Lost to Follow-up|50|||
13387400|NCT00714168|26764464|FG000|Overall Study|Relocation|4|||
13387401|NCT00714168|26764465|FG001|Overall Study|Relocation|3|||
13387402|NCT00714168|26764464|FG000|Overall Study|Non-study medical condition|3|||
13387403|NCT00714168|26764465|FG001|Overall Study|Non-study medical condition|2|||
13387404|NCT00714051|26764478|FG000|Overall Study|Withdrawal by Subject|1|||
13387405|NCT00714051|26764479|FG001|Overall Study|Withdrawal by Subject|0|||
13387406|NCT00714051|26764478|FG000|Overall Study|Death|0|||
13387407|NCT00714051|26764479|FG001|Overall Study|Death|1|||
13387408|NCT00713830|26764522|FG000|Overall Study|Adverse Event|23|||
13387409|NCT00713830|26764523|FG001|Overall Study|Adverse Event|71|||
13387410|NCT00713830|26764522|FG000|Overall Study|Lack of Efficacy|24|||
13387411|NCT00713830|26764523|FG001|Overall Study|Lack of Efficacy|16|||
13387412|NCT00713830|26764522|FG000|Overall Study|Lost to Follow-up|2|||
13387413|NCT00713830|26764523|FG001|Overall Study|Lost to Follow-up|9|||
13387414|NCT00713830|26764522|FG000|Overall Study|Withdrawal by Subject|13|||
13387415|NCT00713830|26764523|FG001|Overall Study|Withdrawal by Subject|23|||
13387416|NCT00713830|26764522|FG000|Overall Study|Poor Compliance to Protocol|7|||
13387417|NCT00713830|26764523|FG001|Overall Study|Poor Compliance to Protocol|14|||
13387418|NCT00713830|26764522|FG000|Overall Study|Familial and Personal Reasons|9|||
13387419|NCT00713830|26764523|FG001|Overall Study|Familial and Personal Reasons|34|||
13387420|NCT00713830|26764522|FG000|Overall Study|Sponsor Decision|4|||
13387421|NCT00713830|26764523|FG001|Overall Study|Sponsor Decision|10|||
13387422|NCT00713700|26764530|FG000|Overall Study|Lost to Follow-up|3|||
13387423|NCT00713700|26764530|FG000|Overall Study|Withdrawal by Subject|1|||
13387424|NCT00713648|26764539|FG000|Overall Study|Adverse Event|1|||
13387425|NCT00713648|26764539|FG000|Overall Study|Unclassified|2|||
13387426|NCT00713648|26764539|FG000|Overall Study|According to Protocol|2|||
13387427|NCT00713648|26764539|FG000|Overall Study|Development of antibodies|3|||
13387428|NCT00713609|26764590|FG000|Overall Study|Adverse Event|2|||
13387429|NCT00713609|26764591|FG001|Overall Study|Adverse Event|0|||
13387430|NCT00713609|26764592|FG002|Overall Study|Adverse Event|2|||
13387431|NCT00713609|26764593|FG003|Overall Study|Adverse Event|2|||
13387432|NCT00713609|26764594|FG004|Overall Study|Adverse Event|3|||
13387433|NCT00713609|26764595|FG005|Overall Study|Adverse Event|1|||
13387434|NCT00713609|26764590|FG000|Overall Study|Lost to Follow-up|5|||
13387435|NCT00713609|26764591|FG001|Overall Study|Lost to Follow-up|7|||
13387436|NCT00713609|26764592|FG002|Overall Study|Lost to Follow-up|5|||
13387437|NCT00713609|26764593|FG003|Overall Study|Lost to Follow-up|5|||
13387438|NCT00713609|26764594|FG004|Overall Study|Lost to Follow-up|7|||
13387439|NCT00713609|26764595|FG005|Overall Study|Lost to Follow-up|0|||
13387440|NCT00713609|26764590|FG000|Overall Study|Lack of Efficacy|1|||
13387441|NCT00713609|26764591|FG001|Overall Study|Lack of Efficacy|3|||
13387442|NCT00713609|26764592|FG002|Overall Study|Lack of Efficacy|0|||
13387443|NCT00713609|26764593|FG003|Overall Study|Lack of Efficacy|0|||
13387444|NCT00713609|26764594|FG004|Overall Study|Lack of Efficacy|1|||
13387445|NCT00713609|26764595|FG005|Overall Study|Lack of Efficacy|0|||
13387446|NCT00713609|26764590|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
13387447|NCT00713609|26764591|FG001|Overall Study|Non-Compliance with Study Treatment|1|||
13387448|NCT00713609|26764592|FG002|Overall Study|Non-Compliance with Study Treatment|2|||
13387449|NCT00713609|26764593|FG003|Overall Study|Non-Compliance with Study Treatment|0|||
13387450|NCT00713609|26764594|FG004|Overall Study|Non-Compliance with Study Treatment|1|||
13387451|NCT00713609|26764595|FG005|Overall Study|Non-Compliance with Study Treatment|0|||
13387452|NCT00713609|26764590|FG000|Overall Study|Withdrawal by Subject|6|||
13387453|NCT00713609|26764591|FG001|Overall Study|Withdrawal by Subject|1|||
13387454|NCT00713609|26764592|FG002|Overall Study|Withdrawal by Subject|5|||
13387455|NCT00713609|26764593|FG003|Overall Study|Withdrawal by Subject|1|||
13387456|NCT00713609|26764594|FG004|Overall Study|Withdrawal by Subject|5|||
13387457|NCT00713609|26764595|FG005|Overall Study|Withdrawal by Subject|7|||
13387458|NCT00713609|26764590|FG000|Overall Study|Protocol Violation|6|||
13387459|NCT00713609|26764591|FG001|Overall Study|Protocol Violation|3|||
13387460|NCT00713609|26764592|FG002|Overall Study|Protocol Violation|1|||
13387461|NCT00713609|26764593|FG003|Overall Study|Protocol Violation|1|||
13387462|NCT00713609|26764594|FG004|Overall Study|Protocol Violation|2|||
13387463|NCT00713609|26764595|FG005|Overall Study|Protocol Violation|0|||
13395376|NCT00648739|26790325|FG003|Overall Study|Death|0|||
13395377|NCT00648739|26790326|FG004|Overall Study|Death|0|||
13395378|NCT00648739|26790327|FG005|Overall Study|Death|0|||
13395379|NCT00648739|26790328|FG006|Overall Study|Death|0|||
13395380|NCT00648739|26790322|FG000|Overall Study|Positive Human Anti-human Antibody|0|||
13395381|NCT00648739|26790323|FG001|Overall Study|Positive Human Anti-human Antibody|0|||
13395382|NCT00648739|26790324|FG002|Overall Study|Positive Human Anti-human Antibody|1|||
13395383|NCT00648739|26790325|FG003|Overall Study|Positive Human Anti-human Antibody|0|||
13395384|NCT00648739|26790326|FG004|Overall Study|Positive Human Anti-human Antibody|0|||
13395385|NCT00648739|26790327|FG005|Overall Study|Positive Human Anti-human Antibody|0|||
13395386|NCT00648739|26790328|FG006|Overall Study|Positive Human Anti-human Antibody|0|||
13395387|NCT00648739|26790322|FG000|Overall Study|Follow-up Visits Not Completed|0|||
13395388|NCT00648739|26790323|FG001|Overall Study|Follow-up Visits Not Completed|1|||
13395389|NCT00648739|26790324|FG002|Overall Study|Follow-up Visits Not Completed|0|||
13395390|NCT00648739|26790325|FG003|Overall Study|Follow-up Visits Not Completed|0|||
13395391|NCT00648739|26790326|FG004|Overall Study|Follow-up Visits Not Completed|0|||
13395392|NCT00648739|26790327|FG005|Overall Study|Follow-up Visits Not Completed|0|||
13395393|NCT00648739|26790328|FG006|Overall Study|Follow-up Visits Not Completed|0|||
13395394|NCT00648167|26790334|FG000|Overall Study|Adverse Event|6|||
13395395|NCT00648167|26790334|FG000|Overall Study|unable to swallow tablets|1|||
13395396|NCT00648037|26790340|FG000|Overall Study|Not Treated|1|||
13395397|NCT00648037|26790340|FG000|Overall Study|Withdrawal by Subject|1|||
13395398|NCT00648037|26790340|FG000|Overall Study|Adverse Event|11|||
13395399|NCT00648037|26790340|FG000|Overall Study|Relapse|2|||
13395400|NCT00648037|26790340|FG000|Overall Study|Other|1|||
13395401|NCT00647699|26790353|FG000|Overall Study|Lost to Follow-up|5|||
13395402|NCT00647699|26790354|FG001|Overall Study|Lost to Follow-up|4|||
13395403|NCT00647699|26790353|FG000|Overall Study|Withdrawal by Subject|3|||
13395404|NCT00647699|26790354|FG001|Overall Study|Withdrawal by Subject|8|||
13395405|NCT00647556|26790375|FG000|Overall Study|Adverse Event|0|||
13395406|NCT00647556|26790376|FG001|Overall Study|Adverse Event|1|||
13395407|NCT00647556|26790375|FG000|Overall Study|Lost to Follow-up|1|||
13395408|NCT00647556|26790376|FG001|Overall Study|Lost to Follow-up|0|||
13395409|NCT00647556|26790375|FG000|Overall Study|Protocol Violation|0|||
13395410|NCT00647556|26790376|FG001|Overall Study|Protocol Violation|1|||
13395411|NCT00647556|26790375|FG000|Overall Study|Withdrawal by Subject|1|||
13395412|NCT00647556|26790376|FG001|Overall Study|Withdrawal by Subject|0|||
13395413|NCT00647556|26790375|FG000|Overall Study|Surgery for pre-existing neck pain|1|||
13395414|NCT00647556|26790376|FG001|Overall Study|Surgery for pre-existing neck pain|0|||
13395415|NCT00647426|26790385|FG000|Overall Study|Withdrawal by Subject|2|||
13395416|NCT00647348|26790414|FG000|Overall Study|Lost to Follow-up|3|||
13395417|NCT00647348|26790415|FG001|Overall Study|Lost to Follow-up|6|||
13395418|NCT00647296|26790479|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
13395419|NCT00647296|26790480|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
13395420|NCT00647296|26790481|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
13395421|NCT00647296|26790482|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1|||
13395422|NCT00647296|26790479|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
13395423|NCT00647296|26790480|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
13395424|NCT00647296|26790481|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
13395425|NCT00647296|26790482|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
13395426|NCT00647296|26790479|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
13387464|NCT04679051|26764620|FG000|Overall Study|felt tired after restricted time in bed|3|||
13387465|NCT04679051|26764621|FG001|Overall Study|felt tired after restricted time in bed|0|||
13387466|NCT04679051|26764620|FG000|Overall Study|discomfort with blood pressure cuff|2|||
13387467|NCT04679051|26764621|FG001|Overall Study|discomfort with blood pressure cuff|0|||
13387468|NCT04679051|26764620|FG000|Overall Study|scheduling conflict|1|||
13387469|NCT04679051|26764621|FG001|Overall Study|scheduling conflict|1|||
13387470|NCT04679051|26764620|FG000|Overall Study|Protocol Violation|0|||
13387471|NCT04679051|26764621|FG001|Overall Study|Protocol Violation|4|||
13387472|NCT04089553|26764668|FG000|Overall Study|Death|12|||
13387473|NCT04089553|26764669|FG001|Overall Study|Death|11|||
13387474|NCT04089553|26764668|FG000|Overall Study|Lost to Follow-up|2|||
13387475|NCT04089553|26764669|FG001|Overall Study|Lost to Follow-up|2|||
13387476|NCT04089553|26764668|FG000|Overall Study|Progressive disease|0|||
13387477|NCT04089553|26764669|FG001|Overall Study|Progressive disease|1|||
13387478|NCT04089553|26764668|FG000|Overall Study|Withdrawal by Subject|5|||
13387479|NCT04089553|26764669|FG001|Overall Study|Withdrawal by Subject|2|||
13387480|NCT04089553|26764668|FG000|Overall Study|Other|6|||
13387481|NCT04089553|26764669|FG001|Overall Study|Other|2|||
13387482|NCT04081363|26764686|FG000|Overall Study|Withdrawal by Subject|1|||
13387483|NCT04081363|26764687|FG001|Overall Study|Withdrawal by Subject|0|||
13387484|NCT03885934|26764774|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
13387485|NCT03885934|26764775|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
13387486|NCT03885934|26764776|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
13387487|NCT03885934|26764777|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
13387488|NCT03885934|26764778|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
13387489|NCT03885934|26764779|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
13387490|NCT03823300|26764871|FG000|Overall Study|Withdrawal by Subject|16|||
13387491|NCT03823300|26764872|FG001|Overall Study|Withdrawal by Subject|22|||
13387492|NCT03823300|26764871|FG000|Overall Study|Death|10|||
13387493|NCT03823300|26764872|FG001|Overall Study|Death|14|||
13387494|NCT03823300|26764871|FG000|Overall Study|Adverse Event|3|||
13387495|NCT03823300|26764872|FG001|Overall Study|Adverse Event|5|||
13387496|NCT03823300|26764871|FG000|Overall Study|Physician Decision|1|||
13387497|NCT03823300|26764872|FG001|Overall Study|Physician Decision|7|||
13387498|NCT03823300|26764871|FG000|Overall Study|Lost to Follow-up|1|||
13387499|NCT03823300|26764872|FG001|Overall Study|Lost to Follow-up|3|||
13387500|NCT03823300|26764871|FG000|Overall Study|Protocol Violation|1|||
13387501|NCT03823300|26764872|FG001|Overall Study|Protocol Violation|1|||
13387502|NCT03823300|26764871|FG000|Overall Study|Lack of Efficacy|1|||
13387503|NCT03823300|26764872|FG001|Overall Study|Lack of Efficacy|1|||
13387504|NCT03823300|26764871|FG000|Overall Study|Not Eligible|0|||
13387505|NCT03823300|26764872|FG001|Overall Study|Not Eligible|1|||
13387506|NCT03823300|26764871|FG000|Overall Study|Other|1|||
13387507|NCT03823300|26764872|FG001|Overall Study|Other|0|||
13387508|NCT03483103|26764932|FG000|Pre-Treatment Phase|Other reasons|1|||
13387509|NCT03483103|26764932|FG000|Pre-Treatment Phase|No longer meets eligibility criteria|4|||
13387510|NCT03483103|26764932|FG000|Pre-Treatment Phase|Disease-related complications|1|||
13387511|NCT03483103|26764932|FG000|Pre-Treatment Phase|Death|5|||
13387512|NCT03483103|26764932|FG000|Treatment Phase|Withdrawal by Subject|6|||
13387513|NCT03483103|26764932|FG000|Treatment Phase|Other reasons|2|||
13387514|NCT03483103|26764932|FG000|Treatment Phase|Death|20|||
13387515|NCT03483103|26764932|FG000|Treatment Phase|Ongoing in study|26|||
13387516|NCT03483103|26764932|FG000|Treatment Phase|Did not receive either JAR017 or nonconforming product|1|||
13387517|NCT03483103|26764932|FG000|Treatment Phase|Received nonconforming product|1|||
13387518|NCT02879448|26765018|FG000|Overall Study|No implant attempt|17|||
13387519|NCT02879448|26765019|FG001|Overall Study|No implant attempt|28|||
13387520|NCT02879448|26765018|FG000|Overall Study|Withdrawal by Subject|20|||
13387521|NCT02879448|26765019|FG001|Overall Study|Withdrawal by Subject|46|||
13387522|NCT02879448|26765018|FG000|Overall Study|Death|63|||
13387523|NCT02879448|26765019|FG001|Overall Study|Death|85|||
13387524|NCT02879448|26765018|FG000|Overall Study|Lost to Follow-up|3|||
13387525|NCT02879448|26765019|FG001|Overall Study|Lost to Follow-up|4|||
13387526|NCT02879448|26765018|FG000|Overall Study|Missing visit|34|||
13387527|NCT02879448|26765019|FG001|Overall Study|Missing visit|39|||
13387528|NCT02879448|26765018|FG000|Overall Study|Pending evaluation|1|||
13387529|NCT02879448|26765019|FG001|Overall Study|Pending evaluation|0|||
13387530|NCT02794285|26765046|FG000|Overall Study|Adverse Event|11|||
13387531|NCT02794285|26765047|FG001|Overall Study|Adverse Event|4|||
13387532|NCT02794285|26765048|FG002|Overall Study|Adverse Event|5|||
13387533|NCT02794285|26765049|FG003|Overall Study|Adverse Event|8|||
13387534|NCT02794285|26765046|FG000|Overall Study|Condition Under Investigation Improved|1|||
13387535|NCT02794285|26765047|FG001|Overall Study|Condition Under Investigation Improved|0|||
13387536|NCT02794285|26765048|FG002|Overall Study|Condition Under Investigation Improved|0|||
13387537|NCT02794285|26765049|FG003|Overall Study|Condition Under Investigation Improved|0|||
13306229|NCT01292603|26525396|FG001|Part 1: Pilot Dose Selection Period|Death|0|||
13387538|NCT02794285|26765046|FG000|Overall Study|Condition Under Investigation Worsened|0|||
13387539|NCT02794285|26765047|FG001|Overall Study|Condition Under Investigation Worsened|2|||
13387540|NCT02794285|26765048|FG002|Overall Study|Condition Under Investigation Worsened|1|||
13387541|NCT02794285|26765049|FG003|Overall Study|Condition Under Investigation Worsened|0|||
13387542|NCT02794285|26765046|FG000|Overall Study|Death|2|||
13387543|NCT02794285|26765047|FG001|Overall Study|Death|1|||
13387544|NCT02794285|26765048|FG002|Overall Study|Death|2|||
13387545|NCT02794285|26765049|FG003|Overall Study|Death|0|||
13387546|NCT02794285|26765046|FG000|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
13387547|NCT02794285|26765047|FG001|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
13387548|NCT02794285|26765048|FG002|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
13387549|NCT02794285|26765049|FG003|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
13387550|NCT02794285|26765046|FG000|Overall Study|Failure to Meet Randomisation Criteria|0|||
13387551|NCT02794285|26765047|FG001|Overall Study|Failure to Meet Randomisation Criteria|0|||
13387552|NCT02794285|26765048|FG002|Overall Study|Failure to Meet Randomisation Criteria|1|||
13387553|NCT02794285|26765049|FG003|Overall Study|Failure to Meet Randomisation Criteria|0|||
13387554|NCT02794285|26765046|FG000|Overall Study|Lack of Efficacy|10|||
13387555|NCT02794285|26765047|FG001|Overall Study|Lack of Efficacy|6|||
13387556|NCT02794285|26765048|FG002|Overall Study|Lack of Efficacy|3|||
13387557|NCT02794285|26765049|FG003|Overall Study|Lack of Efficacy|3|||
13387558|NCT02794285|26765046|FG000|Overall Study|Lost to Follow-up|5|||
13387559|NCT02794285|26765047|FG001|Overall Study|Lost to Follow-up|6|||
13387560|NCT02794285|26765048|FG002|Overall Study|Lost to Follow-up|3|||
13387561|NCT02794285|26765049|FG003|Overall Study|Lost to Follow-up|1|||
13387562|NCT02794285|26765046|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
13387563|NCT02794285|26765047|FG001|Overall Study|Severe Non-compliance to Protocol|2|||
13387564|NCT02794285|26765048|FG002|Overall Study|Severe Non-compliance to Protocol|1|||
13387565|NCT02794285|26765049|FG003|Overall Study|Severe Non-compliance to Protocol|0|||
13387566|NCT02794285|26765046|FG000|Overall Study|Withdrawal by Subject|38|||
13387567|NCT02794285|26765047|FG001|Overall Study|Withdrawal by Subject|29|||
13387568|NCT02794285|26765048|FG002|Overall Study|Withdrawal by Subject|20|||
13387569|NCT02794285|26765049|FG003|Overall Study|Withdrawal by Subject|12|||
13387570|NCT02794285|26765046|FG000|Overall Study|Missing|1|||
13387571|NCT02794285|26765047|FG001|Overall Study|Missing|0|||
13387572|NCT02794285|26765048|FG002|Overall Study|Missing|0|||
13387573|NCT02794285|26765049|FG003|Overall Study|Missing|0|||
13387574|NCT02794285|26765046|FG000|Overall Study|Due to COVID-19 Pandemic|7|||
13387575|NCT02794285|26765047|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
13387576|NCT02794285|26765048|FG002|Overall Study|Due to COVID-19 Pandemic|4|||
13387577|NCT02794285|26765049|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
13387578|NCT02794285|26765046|FG000|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
13387579|NCT02794285|26765047|FG001|Overall Study|Other - Not Due to COVID-19 Pandemic|6|||
13387580|NCT02794285|26765048|FG002|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
13387581|NCT02794285|26765049|FG003|Overall Study|Other - Not Due to COVID-19 Pandemic|1|||
13387582|NCT02738853|26765067|FG000|Enrollment|Inclusion/Exclusion not met|21|||
13387583|NCT02738853|26765067|FG000|Enrollment|Withdrawal by Subject|3|||
13387584|NCT02738853|26765067|FG000|Enrollment|Subject treated with commercially available device|6|||
13387585|NCT02738853|26765067|FG000|Enrollment|Study Enrollment Closed|3|||
13387586|NCT02738853|26765067|FG000|Procedure|Death|1|||
13387587|NCT02738853|26765067|FG000|1 Month|Death|2|||
13387588|NCT02738853|26765067|FG000|6 Month|Death|4|||
13387589|NCT02738853|26765067|FG000|6 Month|Withdrawal by Subject|2|||
13387590|NCT02738853|26765067|FG000|1 Year|Death|6|||
13387591|NCT02738853|26765067|FG000|1 Year|Withdrawal by Subject|1|||
13387592|NCT02738853|26765067|FG000|2 Year|Death|2|||
13387593|NCT02738853|26765067|FG000|2 Year|Lost to Follow-up|1|||
13387594|NCT02738853|26765067|FG000|3 Year|Death|2|||
13387595|NCT02738853|26765067|FG000|3 Year|Withdrawal by Subject|1|||
13387596|NCT02738853|26765067|FG000|4 Year|Death|9|||
13387597|NCT02738853|26765067|FG000|5 Year|Lost to Follow-up|4|||
13387598|NCT02717442|26765094|FG000|Overall Study|Study Terminated by Sponsor|31|||
13387599|NCT02717442|26765095|FG001|Overall Study|Study Terminated by Sponsor|29|||
13387600|NCT02717442|26765094|FG000|Overall Study|Subject Randomized, but Did not Receive Drug|2|||
13387601|NCT02717442|26765095|FG001|Overall Study|Subject Randomized, but Did not Receive Drug|0|||
13387602|NCT02717442|26765094|FG000|Overall Study|Other - Not Specified|2|||
13387603|NCT02717442|26765095|FG001|Overall Study|Other - Not Specified|0|||
13387604|NCT02620579|26765130|FG000|Overall Study|Physician Decision|0|||
13387605|NCT02620579|26765131|FG001|Overall Study|Physician Decision|0|||
13387606|NCT02620579|26765132|FG002|Overall Study|Physician Decision|0|||
13387607|NCT02620579|26765133|FG003|Overall Study|Physician Decision|1|||
13387608|NCT02620579|26765130|FG000|Overall Study|Withdrawal by Subject|0|||
13387609|NCT02620579|26765131|FG001|Overall Study|Withdrawal by Subject|1|||
13387610|NCT02620579|26765132|FG002|Overall Study|Withdrawal by Subject|1|||
13387611|NCT02620579|26765133|FG003|Overall Study|Withdrawal by Subject|0|||
13387612|NCT02611960|26765165|FG000|Overall Study|COVID-19 Association Unspecified Adverse Event|7|||
13475855|NCT02924064|27001310|FG000|Overall Study|Other|17|||
13387613|NCT02611960|26765166|FG001|Overall Study|COVID-19 Association Unspecified Adverse Event|8|||
13387614|NCT02611960|26765165|FG000|Overall Study|Death|87|||
13387615|NCT02611960|26765166|FG001|Overall Study|Death|85|||
13387616|NCT02611960|26765165|FG000|Overall Study|Withdrawal by Subject|0|||
13387617|NCT02611960|26765166|FG001|Overall Study|Withdrawal by Subject|1|||
13387618|NCT02611960|26765165|FG000|Overall Study|COVID-19 Association Unspecified Withdrawal By Participant|1|||
13387619|NCT02611960|26765166|FG001|Overall Study|COVID-19 Association Unspecified Withdrawal By Participant|4|||
13387620|NCT02611960|26765165|FG000|Overall Study|Participants Ongoing|22|||
13387621|NCT02611960|26765166|FG001|Overall Study|Participants Ongoing|18|||
13387622|NCT02422615|26765179|FG000|Overall Study|Progressive disease|193|||
13387623|NCT02422615|26765180|FG001|Overall Study|Progressive disease|142|||
13387624|NCT02422615|26765179|FG000|Overall Study|Adverse Event|41|||
13387625|NCT02422615|26765180|FG001|Overall Study|Adverse Event|10|||
13387626|NCT02422615|26765179|FG000|Overall Study|Physician Decision|22|||
13387627|NCT02422615|26765180|FG001|Overall Study|Physician Decision|7|||
13387628|NCT02422615|26765179|FG000|Overall Study|Subject/guardian decision|21|||
13387629|NCT02422615|26765180|FG001|Overall Study|Subject/guardian decision|5|||
13387630|NCT02422615|26765179|FG000|Overall Study|Death|2|||
13387631|NCT02422615|26765180|FG001|Overall Study|Death|0|||
13387632|NCT02422615|26765179|FG000|Overall Study|Protocol Violation|1|||
13387633|NCT02422615|26765180|FG001|Overall Study|Protocol Violation|1|||
13387634|NCT02422615|26765179|FG000|Overall Study|Technical problems|0|||
13387635|NCT02422615|26765180|FG001|Overall Study|Technical problems|1|||
13387636|NCT02253316|26765207|FG000|Consolidation|Progression|4|||
13387637|NCT02253316|26765208|FG001|Consolidation|Progression|0|||
13387638|NCT02253316|26765209|FG002|Consolidation|Progression|0|||
13387639|NCT02253316|26765207|FG000|Consolidation|Non-Compliance|1|||
13387640|NCT02253316|26765208|FG001|Consolidation|Non-Compliance|0|||
13387641|NCT02253316|26765209|FG002|Consolidation|Non-Compliance|0|||
13387642|NCT02253316|26765207|FG000|Consolidation|Patient Withdrew Logistical Concerns|2|||
13387643|NCT02253316|26765208|FG001|Consolidation|Patient Withdrew Logistical Concerns|0|||
13387644|NCT02253316|26765209|FG002|Consolidation|Patient Withdrew Logistical Concerns|0|||
13387645|NCT02253316|26765207|FG000|Consolidation|Secondary Malignancy|2|||
13387646|NCT02253316|26765208|FG001|Consolidation|Secondary Malignancy|0|||
13387647|NCT02253316|26765209|FG002|Consolidation|Secondary Malignancy|0|||
13387648|NCT02253316|26765207|FG000|Consolidation|Adverse Event|7|||
13387649|NCT02253316|26765208|FG001|Consolidation|Adverse Event|0|||
13387650|NCT02253316|26765209|FG002|Consolidation|Adverse Event|0|||
13387651|NCT02253316|26765207|FG000|Maintenance|Patient Withdrew Logistical Concerns|0|||
13387652|NCT02253316|26765208|FG001|Maintenance|Patient Withdrew Logistical Concerns|7|||
13387653|NCT02253316|26765209|FG002|Maintenance|Patient Withdrew Logistical Concerns|7|||
13387654|NCT02253316|26765207|FG000|Maintenance|Physician Decision|0|||
13387655|NCT02253316|26765208|FG001|Maintenance|Physician Decision|5|||
13387656|NCT02253316|26765209|FG002|Maintenance|Physician Decision|16|||
13387657|NCT02253316|26765207|FG000|Maintenance|Non-Compliance|0|||
13387658|NCT02253316|26765208|FG001|Maintenance|Non-Compliance|1|||
13387659|NCT02253316|26765209|FG002|Maintenance|Non-Compliance|0|||
13387660|NCT02253316|26765207|FG000|Maintenance|Secondary Malignancy|0|||
13387661|NCT02253316|26765208|FG001|Maintenance|Secondary Malignancy|1|||
13387662|NCT02253316|26765209|FG002|Maintenance|Secondary Malignancy|5|||
13387663|NCT02253316|26765207|FG000|Maintenance|Adverse Event|0|||
13387664|NCT02253316|26765208|FG001|Maintenance|Adverse Event|8|||
13387665|NCT02253316|26765209|FG002|Maintenance|Adverse Event|12|||
13387666|NCT02253316|26765207|FG000|Maintenance|Still receiving active treatment|0|||
13387667|NCT02253316|26765208|FG001|Maintenance|Still receiving active treatment|23|||
13387668|NCT02253316|26765209|FG002|Maintenance|Still receiving active treatment|26|||
13387675|NCT00186888|26765406|FG000|Overall Study|Toxicity|0|||
13387676|NCT00186888|26765407|FG001|Overall Study|Toxicity|1|||
13387677|NCT00186888|26765408|FG002|Overall Study|Toxicity|0|||
13387678|NCT00186888|26765406|FG000|Overall Study|Relapse or progression of disease|4|||
13387679|NCT00186888|26765407|FG001|Overall Study|Relapse or progression of disease|2|||
13387680|NCT00186888|26765408|FG002|Overall Study|Relapse or progression of disease|0|||
13387681|NCT00713596|26765454|FG000|Overall Study|Study was terminated|2|||
13387682|NCT00713596|26765455|FG001|Overall Study|Study was terminated|3|||
13387683|NCT00713596|26765456|FG002|Overall Study|Study was terminated|2|||
13387684|NCT00713544|26765513|FG000|Overall Study|Adverse Event|5|||
13387685|NCT00713544|26765514|FG001|Overall Study|Adverse Event|3|||
13387686|NCT00713544|26765515|FG002|Overall Study|Adverse Event|7|||
13387687|NCT00713544|26765516|FG003|Overall Study|Adverse Event|7|||
13387688|NCT00713544|26765517|FG004|Overall Study|Adverse Event|3|||
13387689|NCT00713544|26765518|FG005|Overall Study|Adverse Event|5|||
13387690|NCT00713544|26765513|FG000|Overall Study|Withdrawal by Subject|2|||
13387691|NCT00713544|26765514|FG001|Overall Study|Withdrawal by Subject|0|||
13387692|NCT00713544|26765515|FG002|Overall Study|Withdrawal by Subject|3|||
13387693|NCT00713544|26765516|FG003|Overall Study|Withdrawal by Subject|2|||
13387694|NCT00713544|26765517|FG004|Overall Study|Withdrawal by Subject|3|||
13387695|NCT00713544|26765518|FG005|Overall Study|Withdrawal by Subject|1|||
13387696|NCT00713544|26765513|FG000|Overall Study|Protocol Violation|0|||
13387697|NCT00713544|26765514|FG001|Overall Study|Protocol Violation|0|||
13387698|NCT00713544|26765515|FG002|Overall Study|Protocol Violation|0|||
13387699|NCT00713544|26765516|FG003|Overall Study|Protocol Violation|0|||
13387700|NCT00713544|26765517|FG004|Overall Study|Protocol Violation|0|||
13387701|NCT00713544|26765518|FG005|Overall Study|Protocol Violation|1|||
13387702|NCT00713544|26765513|FG000|Overall Study|Physician Decision|0|||
13387703|NCT00713544|26765514|FG001|Overall Study|Physician Decision|0|||
13387704|NCT00713544|26765515|FG002|Overall Study|Physician Decision|0|||
13387705|NCT00713544|26765516|FG003|Overall Study|Physician Decision|0|||
13387706|NCT00713544|26765517|FG004|Overall Study|Physician Decision|0|||
13387707|NCT00713544|26765518|FG005|Overall Study|Physician Decision|2|||
13387708|NCT00713544|26765513|FG000|Overall Study|Lack of Efficacy|0|||
13387709|NCT00713544|26765514|FG001|Overall Study|Lack of Efficacy|1|||
13387710|NCT00713544|26765515|FG002|Overall Study|Lack of Efficacy|0|||
13387711|NCT00713544|26765516|FG003|Overall Study|Lack of Efficacy|1|||
13387712|NCT00713544|26765517|FG004|Overall Study|Lack of Efficacy|1|||
13387713|NCT00713544|26765518|FG005|Overall Study|Lack of Efficacy|0|||
13387714|NCT00713544|26765513|FG000|Overall Study|Lost to Follow-up|0|||
13387715|NCT00713544|26765514|FG001|Overall Study|Lost to Follow-up|0|||
13387716|NCT00713544|26765515|FG002|Overall Study|Lost to Follow-up|1|||
13387717|NCT00713544|26765516|FG003|Overall Study|Lost to Follow-up|0|||
13387718|NCT00713544|26765517|FG004|Overall Study|Lost to Follow-up|0|||
13387719|NCT00713544|26765518|FG005|Overall Study|Lost to Follow-up|0|||
13387720|NCT00713544|26765513|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
13387721|NCT00713544|26765514|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1|||
13387722|NCT00713544|26765515|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
13387723|NCT00713544|26765516|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
13387724|NCT00713544|26765517|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
13387725|NCT00713544|26765518|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
13387726|NCT00713544|26765513|FG000|Overall Study|Incorrect enrollment|0|||
13387727|NCT00713544|26765514|FG001|Overall Study|Incorrect enrollment|1|||
13387728|NCT00713544|26765515|FG002|Overall Study|Incorrect enrollment|0|||
13387729|NCT00713544|26765516|FG003|Overall Study|Incorrect enrollment|0|||
13387730|NCT00713544|26765517|FG004|Overall Study|Incorrect enrollment|0|||
13387731|NCT00713544|26765518|FG005|Overall Study|Incorrect enrollment|0|||
13387732|NCT00713544|26765513|FG000|Overall Study|Hepatotoxicity - not an AE|0|||
13387733|NCT00713544|26765514|FG001|Overall Study|Hepatotoxicity - not an AE|0|||
13387734|NCT00713544|26765515|FG002|Overall Study|Hepatotoxicity - not an AE|0|||
13387735|NCT00713544|26765516|FG003|Overall Study|Hepatotoxicity - not an AE|0|||
13387736|NCT00713544|26765517|FG004|Overall Study|Hepatotoxicity - not an AE|1|||
13387737|NCT00713544|26765518|FG005|Overall Study|Hepatotoxicity - not an AE|0|||
13387738|NCT00713349|26765526|FG000|Overall Study|Protocol Violation|1|||
13387739|NCT00713323|26765539|FG000|Overall Study|Adverse Event|75|||
13387740|NCT00713323|26765539|FG000|Overall Study|Withdrawal by Subject|15|||
13387741|NCT00713323|26765539|FG000|Overall Study|Lost to Follow-up|11|||
13387742|NCT00713323|26765539|FG000|Overall Study|Lack of Efficacy|36|||
13387743|NCT00713323|26765539|FG000|Overall Study|Low creatine clearance at screening|1|||
13387744|NCT00713323|26765539|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1|||
13387745|NCT00713323|26765539|FG000|Overall Study|Surgery cured allodynic pain|1|||
13387746|NCT00713323|26765539|FG000|Overall Study|Pain free|1|||
13387747|NCT00713323|26765539|FG000|Overall Study|Non-compliance|1|||
13387748|NCT00713323|26765539|FG000|Overall Study|Pain resolved|1|||
13387749|NCT00713323|26765539|FG000|Overall Study|Subject travelling to USA|1|||
13387750|NCT00713323|26765539|FG000|Overall Study|Subject travelling to Dominica Republic|1|||
13387751|NCT00713323|26765539|FG000|Overall Study|Treatment that may interact with Sativex|1|||
13387752|NCT00713310|26765554|FG000|Overall Study|Adverse Event|5|||
13387753|NCT00713310|26765555|FG001|Overall Study|Adverse Event|2|||
13387754|NCT00713310|26765554|FG000|Overall Study|Lack of Efficacy|0|||
13387755|NCT00713310|26765555|FG001|Overall Study|Lack of Efficacy|2|||
13387756|NCT00713310|26765554|FG000|Overall Study|Withdrawal by Subject|0|||
13387757|NCT00713310|26765555|FG001|Overall Study|Withdrawal by Subject|2|||
13387758|NCT00713258|26765570|FG000|Overall Study|Adverse Event|2|||
13387759|NCT00713258|26765571|FG001|Overall Study|Adverse Event|4|||
13387760|NCT00713258|26765570|FG000|Overall Study|Non-Compliance|2|||
13387761|NCT00713258|26765571|FG001|Overall Study|Non-Compliance|1|||
13387762|NCT00713258|26765570|FG000|Overall Study|Other|1|||
13387763|NCT00713258|26765571|FG001|Overall Study|Other|1|||
13395427|NCT00647296|26790480|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1|||
13395428|NCT00647296|26790481|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
13395429|NCT00647296|26790482|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
13395430|NCT00647296|26790479|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1|||
13395431|NCT00647296|26790480|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
13387764|NCT00713219|26765577|FG000|Overall Study|Death|1|||
13387765|NCT00713219|26765577|FG000|Overall Study|Protocol Violation|1|||
13387766|NCT00713206|26765590|FG000|Overall Study|Lost to Follow-up|4|||
13387767|NCT00713206|26765591|FG001|Overall Study|Lost to Follow-up|4|||
13387768|NCT00713206|26765590|FG000|Overall Study|Death|1|||
13387769|NCT00713206|26765591|FG001|Overall Study|Death|0|||
13387770|NCT00712985|26765597|FG000|Overall Study|1 withdrew prior to start of drug|1|||
13387771|NCT00712985|26765597|FG000|Overall Study|1 patient moved out of state|1|||
13387772|NCT00712985|26765597|FG000|Overall Study|Lack of Efficacy|3|||
13387773|NCT00712959|26765622|FG000|Overall Study|Protocol Violation|3|||
13387774|NCT00712959|26765623|FG001|Overall Study|Protocol Violation|1|||
13387775|NCT00712959|26765622|FG000|Overall Study|Lost to Follow-up|13|||
13387776|NCT00712959|26765623|FG001|Overall Study|Lost to Follow-up|2|||
13387777|NCT00712959|26765622|FG000|Overall Study|Withdrawal by Subject|3|||
13387778|NCT00712959|26765623|FG001|Overall Study|Withdrawal by Subject|0|||
13387779|NCT00712933|26765652|FG000|Overall Study|Adverse Event|69|||
13387780|NCT00712933|26765652|FG000|Overall Study|Lack of Efficacy|6|||
13387781|NCT00712933|26765652|FG000|Overall Study|Lost to Follow-up|22|||
13387782|NCT00712933|26765652|FG000|Overall Study|Non-compliance with study drug|13|||
13387783|NCT00712933|26765652|FG000|Overall Study|Other Pregnancy|37|||
13387784|NCT00712933|26765652|FG000|Overall Study|Sponsor decision|14|||
13387785|NCT00712933|26765652|FG000|Overall Study|Withdrew consent|4|||
13387786|NCT00712933|26765652|FG000|Overall Study|Hip replacement surgery|1|||
13387787|NCT00712933|26765652|FG000|Overall Study|Involved in Clinical research|3|||
13387788|NCT00712933|26765652|FG000|Overall Study|Participant hospitalized|1|||
13387789|NCT00712933|26765652|FG000|Overall Study|Participant travelled overseas|2|||
13387790|NCT00712933|26765652|FG000|Overall Study|Death of patient|1|||
13387791|NCT00712933|26765652|FG000|Overall Study|Other Physician decision|1|||
13387792|NCT00712933|26765652|FG000|Overall Study|Not committed to contraception|1|||
13387793|NCT00712933|26765652|FG000|Overall Study|Participant received medication|1|||
13387794|NCT00712933|26765652|FG000|Overall Study|Physician Decision|36|||
13387795|NCT00712933|26765652|FG000|Overall Study|Protocol Violation|4|||
13387796|NCT00712933|26765652|FG000|Overall Study|Withdrawal by Subject|151|||
13387797|NCT00712920|26765682|FG000|Overall Study|Adverse Event|3|||
13387798|NCT00712920|26765683|FG001|Overall Study|Adverse Event|4|||
13387799|NCT00712920|26765684|FG002|Overall Study|Adverse Event|7|||
13387800|NCT00712920|26765682|FG000|Overall Study|Withdrawal by Subject|4|||
13387801|NCT00712920|26765683|FG001|Overall Study|Withdrawal by Subject|2|||
13387802|NCT00712920|26765684|FG002|Overall Study|Withdrawal by Subject|1|||
13387803|NCT00712920|26765682|FG000|Overall Study|Lost to Follow-up|1|||
13387804|NCT00712920|26765683|FG001|Overall Study|Lost to Follow-up|4|||
13387805|NCT00712920|26765684|FG002|Overall Study|Lost to Follow-up|0|||
13387806|NCT00712920|26765682|FG000|Overall Study|Lack of Efficacy|1|||
13387807|NCT00712920|26765683|FG001|Overall Study|Lack of Efficacy|0|||
13387808|NCT00712920|26765684|FG002|Overall Study|Lack of Efficacy|1|||
13387809|NCT00712920|26765682|FG000|Overall Study|Other|5|||
13387810|NCT00712920|26765683|FG001|Overall Study|Other|7|||
13387811|NCT00712920|26765684|FG002|Overall Study|Other|3|||
13387812|NCT00712920|26765682|FG000|Overall Study|Non-compliance|3|||
13387813|NCT00712920|26765683|FG001|Overall Study|Non-compliance|0|||
13387814|NCT00712920|26765684|FG002|Overall Study|Non-compliance|0|||
13387815|NCT00712725|26765767|FG000|Overall Study|Adverse Event|1|||
13387816|NCT00712725|26765768|FG001|Overall Study|Adverse Event|0|||
13387817|NCT00712725|26765769|FG002|Overall Study|Adverse Event|0|||
13387818|NCT00712725|26765770|FG003|Overall Study|Adverse Event|1|||
13387819|NCT00712725|26765771|FG004|Overall Study|Adverse Event|0|||
13387820|NCT00712725|26765772|FG005|Overall Study|Adverse Event|0|||
13387821|NCT00712725|26765773|FG006|Overall Study|Adverse Event|0|||
13387822|NCT00712725|26765774|FG007|Overall Study|Adverse Event|0|||
13387823|NCT00712725|26765767|FG000|Overall Study|Lost to Follow-up|3|||
13387824|NCT00712725|26765768|FG001|Overall Study|Lost to Follow-up|2|||
13387825|NCT00712725|26765769|FG002|Overall Study|Lost to Follow-up|1|||
13387826|NCT00712725|26765770|FG003|Overall Study|Lost to Follow-up|1|||
13387827|NCT00712725|26765771|FG004|Overall Study|Lost to Follow-up|2|||
13387828|NCT00712725|26765772|FG005|Overall Study|Lost to Follow-up|2|||
13387829|NCT00712725|26765773|FG006|Overall Study|Lost to Follow-up|3|||
13387830|NCT00712725|26765774|FG007|Overall Study|Lost to Follow-up|1|||
13387831|NCT00712725|26765767|FG000|Overall Study|Physician Decision|2|||
13387832|NCT00712725|26765768|FG001|Overall Study|Physician Decision|0|||
13387833|NCT00712725|26765769|FG002|Overall Study|Physician Decision|0|||
13387834|NCT00712725|26765770|FG003|Overall Study|Physician Decision|0|||
13387835|NCT00712725|26765771|FG004|Overall Study|Physician Decision|1|||
13387836|NCT00712725|26765772|FG005|Overall Study|Physician Decision|0|||
13387837|NCT00712725|26765773|FG006|Overall Study|Physician Decision|2|||
13387838|NCT00712725|26765774|FG007|Overall Study|Physician Decision|0|||
13387839|NCT00712725|26765767|FG000|Overall Study|Pregnancy|0|||
13387840|NCT00712725|26765768|FG001|Overall Study|Pregnancy|1|||
13387841|NCT00712725|26765769|FG002|Overall Study|Pregnancy|0|||
13387842|NCT00712725|26765770|FG003|Overall Study|Pregnancy|0|||
13387843|NCT00712725|26765771|FG004|Overall Study|Pregnancy|1|||
13387844|NCT00712725|26765772|FG005|Overall Study|Pregnancy|0|||
13387845|NCT00712725|26765773|FG006|Overall Study|Pregnancy|2|||
13387846|NCT00712725|26765774|FG007|Overall Study|Pregnancy|0|||
13387847|NCT00712725|26765767|FG000|Overall Study|Protocol Violation|2|||
13387848|NCT00712725|26765768|FG001|Overall Study|Protocol Violation|0|||
13387849|NCT00712725|26765769|FG002|Overall Study|Protocol Violation|1|||
13387850|NCT00712725|26765770|FG003|Overall Study|Protocol Violation|3|||
13387851|NCT00712725|26765771|FG004|Overall Study|Protocol Violation|2|||
13387852|NCT00712725|26765772|FG005|Overall Study|Protocol Violation|0|||
13387853|NCT00712725|26765773|FG006|Overall Study|Protocol Violation|1|||
13387854|NCT00712725|26765774|FG007|Overall Study|Protocol Violation|1|||
13387855|NCT00712725|26765767|FG000|Overall Study|Withdrawal by Subject|2|||
13387856|NCT00712725|26765768|FG001|Overall Study|Withdrawal by Subject|1|||
13387857|NCT00712725|26765769|FG002|Overall Study|Withdrawal by Subject|1|||
13387858|NCT00712725|26765770|FG003|Overall Study|Withdrawal by Subject|2|||
13387859|NCT00712725|26765771|FG004|Overall Study|Withdrawal by Subject|1|||
13387860|NCT00712725|26765772|FG005|Overall Study|Withdrawal by Subject|1|||
13387861|NCT00712725|26765773|FG006|Overall Study|Withdrawal by Subject|1|||
13387862|NCT00712725|26765774|FG007|Overall Study|Withdrawal by Subject|2|||
13387863|NCT00712725|26765767|FG000|Overall Study|Lack of Qualifying Event|16|||
13387864|NCT00712725|26765768|FG001|Overall Study|Lack of Qualifying Event|2|||
13387865|NCT00712725|26765769|FG002|Overall Study|Lack of Qualifying Event|6|||
13387866|NCT00712725|26765770|FG003|Overall Study|Lack of Qualifying Event|8|||
13387867|NCT00712725|26765771|FG004|Overall Study|Lack of Qualifying Event|11|||
13387868|NCT00712725|26765772|FG005|Overall Study|Lack of Qualifying Event|13|||
13387869|NCT00712725|26765773|FG006|Overall Study|Lack of Qualifying Event|11|||
13387870|NCT00712725|26765774|FG007|Overall Study|Lack of Qualifying Event|6|||
13387871|NCT00712725|26765767|FG000|Overall Study|Protocol Specified Criteria|3|||
13387872|NCT00712725|26765768|FG001|Overall Study|Protocol Specified Criteria|0|||
13387873|NCT00712725|26765769|FG002|Overall Study|Protocol Specified Criteria|1|||
13387874|NCT00712725|26765770|FG003|Overall Study|Protocol Specified Criteria|2|||
13387875|NCT00712725|26765771|FG004|Overall Study|Protocol Specified Criteria|1|||
13387876|NCT00712725|26765772|FG005|Overall Study|Protocol Specified Criteria|0|||
13387877|NCT00712725|26765773|FG006|Overall Study|Protocol Specified Criteria|2|||
13387878|NCT00712725|26765774|FG007|Overall Study|Protocol Specified Criteria|1|||
13387879|NCT00712712|26765802|FG000|Overall Study|Protocol Violation|11|||
13387880|NCT00712712|26765802|FG000|Overall Study|Radiofrequency not done|3|||
13387881|NCT00712712|26765802|FG000|Overall Study|Death|8|||
13387882|NCT00712712|26765802|FG000|Overall Study|Withdrawal by Subject|1|||
13387883|NCT00712673|26765875|FG000|Overall Study|Adverse Event|3|||
13387884|NCT00712673|26765876|FG001|Overall Study|Adverse Event|3|||
13387885|NCT00712673|26765877|FG002|Overall Study|Adverse Event|21|||
13387886|NCT00712673|26765878|FG003|Overall Study|Adverse Event|26|||
13387887|NCT00712673|26765875|FG000|Overall Study|Lack of Efficacy|2|||
13387888|NCT00712673|26765876|FG001|Overall Study|Lack of Efficacy|8|||
13387889|NCT00712673|26765877|FG002|Overall Study|Lack of Efficacy|8|||
13387890|NCT00712673|26765878|FG003|Overall Study|Lack of Efficacy|6|||
13387891|NCT00712673|26765875|FG000|Overall Study|Poor Compliance to Protocol|3|||
13387892|NCT00712673|26765876|FG001|Overall Study|Poor Compliance to Protocol|3|||
13387893|NCT00712673|26765877|FG002|Overall Study|Poor Compliance to Protocol|4|||
13387894|NCT00712673|26765878|FG003|Overall Study|Poor Compliance to Protocol|16|||
13387895|NCT00712673|26765875|FG000|Overall Study|Lost to Follow-up|1|||
13387896|NCT00712673|26765876|FG001|Overall Study|Lost to Follow-up|0|||
13387897|NCT00712673|26765877|FG002|Overall Study|Lost to Follow-up|2|||
13387898|NCT00712673|26765878|FG003|Overall Study|Lost to Follow-up|0|||
13387899|NCT00712673|26765875|FG000|Overall Study|Withdrawal by Subject|6|||
13387900|NCT00712673|26765876|FG001|Overall Study|Withdrawal by Subject|7|||
13387901|NCT00712673|26765877|FG002|Overall Study|Withdrawal by Subject|15|||
13387902|NCT00712673|26765878|FG003|Overall Study|Withdrawal by Subject|20|||
13387903|NCT00712673|26765875|FG000|Overall Study|Familial and Personal Reasons|5|||
13387904|NCT00712673|26765876|FG001|Overall Study|Familial and Personal Reasons|0|||
13387905|NCT00712673|26765877|FG002|Overall Study|Familial and Personal Reasons|5|||
13387906|NCT00712673|26765878|FG003|Overall Study|Familial and Personal Reasons|2|||
13387907|NCT00712673|26765875|FG000|Overall Study|Investigator's Decision|1|||
13387908|NCT00712673|26765876|FG001|Overall Study|Investigator's Decision|0|||
13387909|NCT00712673|26765877|FG002|Overall Study|Investigator's Decision|0|||
13387910|NCT00712673|26765878|FG003|Overall Study|Investigator's Decision|0|||
13387911|NCT00712673|26765875|FG000|Overall Study|Protocol Violation|0|||
13387912|NCT00712673|26765876|FG001|Overall Study|Protocol Violation|0|||
13387913|NCT00712673|26765877|FG002|Overall Study|Protocol Violation|2|||
13387914|NCT00712673|26765878|FG003|Overall Study|Protocol Violation|0|||
13387915|NCT00712543|26765891|FG000|Day 8-14|Lost to Follow-up|0|||
13387916|NCT00712543|26765892|FG001|Day 8-14|Lost to Follow-up|2|||
13387917|NCT00712348|26765901|FG000|Overall Study|Withdrawal by Subject|1|||
13387918|NCT00712335|26765959|FG000|Overall Study|Withdrawal by Subject|0|||
13387919|NCT00712335|26765960|FG001|Overall Study|Withdrawal by Subject|7|||
13387920|NCT00712335|26765961|FG002|Overall Study|Withdrawal by Subject|2|||
13387921|NCT00712335|26765962|FG003|Overall Study|Withdrawal by Subject|3|||
13387922|NCT00712335|26765963|FG004|Overall Study|Withdrawal by Subject|0|||
13387923|NCT00712335|26765959|FG000|Overall Study|Lost to Follow-up|2|||
13387924|NCT00712335|26765960|FG001|Overall Study|Lost to Follow-up|5|||
13387925|NCT00712335|26765961|FG002|Overall Study|Lost to Follow-up|0|||
13387926|NCT00712335|26765962|FG003|Overall Study|Lost to Follow-up|1|||
13387927|NCT00712335|26765963|FG004|Overall Study|Lost to Follow-up|0|||
13387928|NCT00712335|26765959|FG000|Overall Study|Protocol Violation|1|||
13387929|NCT00712335|26765960|FG001|Overall Study|Protocol Violation|2|||
13387930|NCT00712335|26765961|FG002|Overall Study|Protocol Violation|1|||
13387931|NCT00712335|26765962|FG003|Overall Study|Protocol Violation|0|||
13387932|NCT00712335|26765963|FG004|Overall Study|Protocol Violation|0|||
13387933|NCT00712335|26765959|FG000|Overall Study|Lack of Efficacy|0|||
13387934|NCT00712335|26765960|FG001|Overall Study|Lack of Efficacy|0|||
13387935|NCT00712335|26765961|FG002|Overall Study|Lack of Efficacy|1|||
13387936|NCT00712335|26765962|FG003|Overall Study|Lack of Efficacy|1|||
13387937|NCT00712335|26765963|FG004|Overall Study|Lack of Efficacy|0|||
13387938|NCT00712335|26765959|FG000|Overall Study|Other Reason|0|||
13387939|NCT00712335|26765960|FG001|Overall Study|Other Reason|3|||
13387940|NCT00712335|26765961|FG002|Overall Study|Other Reason|1|||
13387941|NCT00712335|26765962|FG003|Overall Study|Other Reason|0|||
13387942|NCT00712335|26765963|FG004|Overall Study|Other Reason|0|||
13387943|NCT00712270|26765980|FG000|Overall Study|Withdrawal by Subject|11|||
13387944|NCT00712270|26765980|FG000|Overall Study|Screen Failure|3|||
13387945|NCT00712166|26766011|FG000|Overall Study|Noncompliance|0|||
13387946|NCT00712166|26766012|FG001|Overall Study|Noncompliance|1|||
13387947|NCT00712010|26766037|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
13387948|NCT00711971|26766079|FG000|Overall Study|Lost to Follow-up|3|||
13387949|NCT00711971|26766080|FG001|Overall Study|Lost to Follow-up|4|||
13387950|NCT00711971|26766081|FG002|Overall Study|Lost to Follow-up|1|||
13387951|NCT00711958|26766094|FG000|Overall Study|Withdrawal by Subject|6|||
13387952|NCT00711958|26766095|FG001|Overall Study|Withdrawal by Subject|8|||
13387953|NCT00711958|26766094|FG000|Overall Study|Lack of Efficacy|3|||
13387954|NCT00711958|26766095|FG001|Overall Study|Lack of Efficacy|1|||
13387955|NCT00711958|26766094|FG000|Overall Study|Clinical deterioration|1|||
13387956|NCT00711958|26766095|FG001|Overall Study|Clinical deterioration|0|||
13387957|NCT00711958|26766094|FG000|Overall Study|Adverse Event|9|||
13387958|NCT00711958|26766095|FG001|Overall Study|Adverse Event|7|||
13387959|NCT00711958|26766094|FG000|Overall Study|Protocol Violation|1|||
13387960|NCT00711958|26766095|FG001|Overall Study|Protocol Violation|0|||
13387961|NCT00711958|26766094|FG000|Overall Study|Lost to Follow-up|2|||
13387962|NCT00711958|26766095|FG001|Overall Study|Lost to Follow-up|2|||
13387963|NCT00711958|26766094|FG000|Overall Study|Death|10|||
13387964|NCT00711958|26766095|FG001|Overall Study|Death|5|||
13387965|NCT00711958|26766094|FG000|Overall Study|Progression of disease|1|||
13387966|NCT00711958|26766095|FG001|Overall Study|Progression of disease|0|||
13387967|NCT00711880|26766138|FG000|Overall Study|Adverse Event|11|||
13387968|NCT00711880|26766139|FG001|Overall Study|Adverse Event|2|||
13387969|NCT00711880|26766138|FG000|Overall Study|Patient non-compliance|1|||
13387970|NCT00711880|26766139|FG001|Overall Study|Patient non-compliance|0|||
13387971|NCT00711880|26766138|FG000|Overall Study|Lack of Efficacy|1|||
13387972|NCT00711880|26766139|FG001|Overall Study|Lack of Efficacy|5|||
13387973|NCT00711802|26766194|FG000|Overall Study|Not treated (no further detail)|2|||
13387974|NCT00711802|26766195|FG001|Overall Study|Not treated (no further detail)|1|||
13387975|NCT00711802|26766196|FG002|Overall Study|Not treated (no further detail)|2|||
13387976|NCT00711802|26766197|FG003|Overall Study|Not treated (no further detail)|0|||
13387977|NCT00711802|26766198|FG004|Overall Study|Not treated (no further detail)|2|||
13387978|NCT00711802|26766199|FG005|Overall Study|Not treated (no further detail)|0|||
13387979|NCT00711802|26766200|FG006|Overall Study|Not treated (no further detail)|0|||
13387980|NCT00711802|26766201|FG007|Overall Study|Not treated (no further detail)|0|||
13387981|NCT00711802|26766194|FG000|Overall Study|Adverse Event|0|||
13387982|NCT00711802|26766195|FG001|Overall Study|Adverse Event|0|||
13387983|NCT00711802|26766196|FG002|Overall Study|Adverse Event|0|||
13387984|NCT00711802|26766197|FG003|Overall Study|Adverse Event|0|||
13387985|NCT00711802|26766198|FG004|Overall Study|Adverse Event|1|||
13387986|NCT00711802|26766199|FG005|Overall Study|Adverse Event|1|||
13387987|NCT00711802|26766200|FG006|Overall Study|Adverse Event|0|||
13387988|NCT00711802|26766201|FG007|Overall Study|Adverse Event|0|||
13387989|NCT00711802|26766194|FG000|Overall Study|Microbiological failure|0|||
13387990|NCT00711802|26766195|FG001|Overall Study|Microbiological failure|1|||
13387991|NCT00711802|26766196|FG002|Overall Study|Microbiological failure|0|||
13387992|NCT00711802|26766197|FG003|Overall Study|Microbiological failure|0|||
13387993|NCT00711802|26766198|FG004|Overall Study|Microbiological failure|0|||
13387994|NCT00711802|26766199|FG005|Overall Study|Microbiological failure|1|||
13387995|NCT00711802|26766200|FG006|Overall Study|Microbiological failure|0|||
13387996|NCT00711802|26766201|FG007|Overall Study|Microbiological failure|0|||
13387997|NCT00711802|26766194|FG000|Overall Study|Protocol Violation|0|||
13387998|NCT00711802|26766195|FG001|Overall Study|Protocol Violation|0|||
13387999|NCT00711802|26766196|FG002|Overall Study|Protocol Violation|0|||
13388000|NCT00711802|26766197|FG003|Overall Study|Protocol Violation|1|||
13388001|NCT00711802|26766198|FG004|Overall Study|Protocol Violation|0|||
13388002|NCT00711802|26766199|FG005|Overall Study|Protocol Violation|0|||
13388003|NCT00711802|26766200|FG006|Overall Study|Protocol Violation|0|||
13388004|NCT00711802|26766201|FG007|Overall Study|Protocol Violation|0|||
13388005|NCT00711802|26766194|FG000|Overall Study|Physician Decision|0|||
13388006|NCT00711802|26766195|FG001|Overall Study|Physician Decision|2|||
13388007|NCT00711802|26766196|FG002|Overall Study|Physician Decision|0|||
13388008|NCT00711802|26766197|FG003|Overall Study|Physician Decision|0|||
13388009|NCT00711802|26766198|FG004|Overall Study|Physician Decision|0|||
13388010|NCT00711802|26766199|FG005|Overall Study|Physician Decision|0|||
13388011|NCT00711802|26766200|FG006|Overall Study|Physician Decision|0|||
13388012|NCT00711802|26766201|FG007|Overall Study|Physician Decision|0|||
13388013|NCT00711802|26766194|FG000|Overall Study|Withdrawal by Subject|0|||
13388014|NCT00711802|26766195|FG001|Overall Study|Withdrawal by Subject|1|||
13388015|NCT00711802|26766196|FG002|Overall Study|Withdrawal by Subject|0|||
13388016|NCT00711802|26766197|FG003|Overall Study|Withdrawal by Subject|1|||
13388017|NCT00711802|26766198|FG004|Overall Study|Withdrawal by Subject|0|||
13388018|NCT00711802|26766199|FG005|Overall Study|Withdrawal by Subject|0|||
13388019|NCT00711802|26766200|FG006|Overall Study|Withdrawal by Subject|0|||
13388020|NCT00711802|26766201|FG007|Overall Study|Withdrawal by Subject|0|||
13388021|NCT00711802|26766194|FG000|Overall Study|Lost to Follow-up|0|||
13388022|NCT00711802|26766195|FG001|Overall Study|Lost to Follow-up|0|||
13388023|NCT00711802|26766196|FG002|Overall Study|Lost to Follow-up|3|||
13388024|NCT00711802|26766197|FG003|Overall Study|Lost to Follow-up|1|||
13388025|NCT00711802|26766198|FG004|Overall Study|Lost to Follow-up|10|||
13388026|NCT00711802|26766199|FG005|Overall Study|Lost to Follow-up|6|||
13388027|NCT00711802|26766200|FG006|Overall Study|Lost to Follow-up|4|||
13388028|NCT00711802|26766201|FG007|Overall Study|Lost to Follow-up|2|||
13388029|NCT00711802|26766194|FG000|Overall Study|Reason not reported|0|||
13388030|NCT00711802|26766195|FG001|Overall Study|Reason not reported|1|||
13388031|NCT00711802|26766196|FG002|Overall Study|Reason not reported|1|||
13388032|NCT00711802|26766197|FG003|Overall Study|Reason not reported|0|||
13388033|NCT00711802|26766198|FG004|Overall Study|Reason not reported|1|||
13388034|NCT00711802|26766199|FG005|Overall Study|Reason not reported|0|||
13388035|NCT00711802|26766200|FG006|Overall Study|Reason not reported|1|||
13388036|NCT00711802|26766201|FG007|Overall Study|Reason not reported|0|||
13388037|NCT00711646|26766226|FG000|Overall Study|Adverse Event|6|||
13388038|NCT00711646|26766227|FG001|Overall Study|Adverse Event|1|||
13388039|NCT00711646|26766226|FG000|Overall Study|Withdrawal by Subject|4|||
13388040|NCT00711646|26766227|FG001|Overall Study|Withdrawal by Subject|0|||
13388041|NCT00711646|26766226|FG000|Overall Study|Protocol Violation|0|||
13388042|NCT00711646|26766227|FG001|Overall Study|Protocol Violation|1|||
13388043|NCT00711646|26766226|FG000|Overall Study|Lost to Follow-up|1|||
13388044|NCT00711646|26766227|FG001|Overall Study|Lost to Follow-up|0|||
13388045|NCT00711646|26766226|FG000|Overall Study|administrative decision|0|||
13388046|NCT00711646|26766227|FG001|Overall Study|administrative decision|1|||
13388047|NCT00711646|26766226|FG000|Overall Study|patient non-compliance|1|||
13388048|NCT00711646|26766227|FG001|Overall Study|patient non-compliance|0|||
13388049|NCT00711594|26766277|FG000|Overall Study|Progressive disease|2|||
13388050|NCT00711594|26766278|FG001|Overall Study|Progressive disease|2|||
13388051|NCT00711594|26766279|FG002|Overall Study|Progressive disease|6|||
13388052|NCT00711594|26766280|FG003|Overall Study|Progressive disease|44|||
13388053|NCT00711594|26766277|FG000|Overall Study|Other Adverse Event|1|||
13388054|NCT00711594|26766278|FG001|Overall Study|Other Adverse Event|0|||
13388055|NCT00711594|26766279|FG002|Overall Study|Other Adverse Event|0|||
13388056|NCT00711594|26766280|FG003|Overall Study|Other Adverse Event|16|||
13388057|NCT00711594|26766277|FG000|Overall Study|Withdrawal by Subject|0|||
13388058|NCT00711594|26766278|FG001|Overall Study|Withdrawal by Subject|1|||
13388059|NCT00711594|26766279|FG002|Overall Study|Withdrawal by Subject|0|||
13388060|NCT00711594|26766280|FG003|Overall Study|Withdrawal by Subject|2|||
13388061|NCT00711529|26766309|FG000|Overall Study|Protocol Violation|2|||
13388062|NCT00711529|26766310|FG001|Overall Study|Protocol Violation|0|||
13388063|NCT00711529|26766309|FG000|Overall Study|Withdrawal by Subject|2|||
13388064|NCT00711529|26766310|FG001|Overall Study|Withdrawal by Subject|6|||
13388065|NCT00711516|26766411|FG000|Overall Study|Adverse Event|1|||
13388066|NCT00711516|26766412|FG001|Overall Study|Adverse Event|1|||
13388067|NCT00711516|26766411|FG000|Overall Study|Withdrawal by Subject|0|||
13388068|NCT00711516|26766412|FG001|Overall Study|Withdrawal by Subject|1|||
13388069|NCT00711516|26766411|FG000|Overall Study|Protocol Violation|0|||
13388070|NCT00711516|26766412|FG001|Overall Study|Protocol Violation|1|||
13388071|NCT00711477|26766447|FG000|Overall Study|Adverse Event|3|||
13388072|NCT00711477|26766448|FG001|Overall Study|Adverse Event|1|||
13388073|NCT00711477|26766447|FG000|Overall Study|Lost to Follow-up|0|||
13388074|NCT00711477|26766448|FG001|Overall Study|Lost to Follow-up|1|||
13388075|NCT00711477|26766447|FG000|Overall Study|Noncompliance|0|||
13388076|NCT00711477|26766448|FG001|Overall Study|Noncompliance|1|||
13388077|NCT00711425|26766456|FG000|Overall Study|Protocol Violation|1|||
13388078|NCT00711425|26766456|FG000|Overall Study|Death|2|||
13388079|NCT00711425|26766456|FG000|Overall Study|Lost to Follow-up|1|||
13388080|NCT00711412|26766470|FG000|Induction Treatment|Death|2|||
13388081|NCT00711412|26766470|FG000|Induction Treatment|Adverse Event|1|||
13388082|NCT00711412|26766470|FG000|Induction Treatment|Other|1|||
13388083|NCT00711412|26766470|FG000|Evaluated for Combination Treatment|Adverse Event|2|||
13388084|NCT00711412|26766470|FG000|Evaluated for Combination Treatment|Death|1|||
13388085|NCT00711412|26766470|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1|||
13388086|NCT00711412|26766470|FG000|Evaluated for Combination Treatment|Progressive disease|2|||
13388087|NCT00711412|26766470|FG000|Combination Treatment|Progressive Disease|1|||
13388088|NCT00711412|26766470|FG000|Evaluation for Response and Surgery|Progressive Disease|2|||
13388089|NCT00711412|26766470|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2|||
13388090|NCT00711412|26766470|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1|||
13388091|NCT00711412|26766470|FG000|Evaluation for Response and Surgery|Death|1|||
13388092|NCT00711412|26766470|FG000|Survival Follow up Until Death|Other|12|||
13388093|NCT00711243|26766509|FG000|Registed and Started Treatment|Withdrawal by Subject|0|||
13388094|NCT00711243|26766510|FG001|Registed and Started Treatment|Withdrawal by Subject|0|||
13388095|NCT00711243|26766511|FG002|Registed and Started Treatment|Withdrawal by Subject|0|||
13388096|NCT00711243|26766512|FG003|Registed and Started Treatment|Withdrawal by Subject|0|||
13388097|NCT00711243|26766513|FG004|Registed and Started Treatment|Withdrawal by Subject|0|||
13388098|NCT00711243|26766514|FG005|Registed and Started Treatment|Withdrawal by Subject|1|||
13388099|NCT00711243|26766509|FG000|Reached First Response/4 Cycles|Death|0|||
13388100|NCT00711243|26766510|FG001|Reached First Response/4 Cycles|Death|0|||
13388101|NCT00711243|26766511|FG002|Reached First Response/4 Cycles|Death|0|||
13388102|NCT00711243|26766512|FG003|Reached First Response/4 Cycles|Death|0|||
13388103|NCT00711243|26766513|FG004|Reached First Response/4 Cycles|Death|0|||
13388104|NCT00711243|26766514|FG005|Reached First Response/4 Cycles|Death|2|||
13388105|NCT00711243|26766509|FG000|Reached First Response/4 Cycles|Progressive disease|0|||
13388106|NCT00711243|26766510|FG001|Reached First Response/4 Cycles|Progressive disease|0|||
13388107|NCT00711243|26766511|FG002|Reached First Response/4 Cycles|Progressive disease|0|||
13388108|NCT00711243|26766512|FG003|Reached First Response/4 Cycles|Progressive disease|1|||
13388109|NCT00711243|26766513|FG004|Reached First Response/4 Cycles|Progressive disease|0|||
13388110|NCT00711243|26766514|FG005|Reached First Response/4 Cycles|Progressive disease|0|||
13388111|NCT00711243|26766509|FG000|Treated Cycle 5 After First Response|Progressive disease|1|||
13388112|NCT00711243|26766510|FG001|Treated Cycle 5 After First Response|Progressive disease|2|||
13388113|NCT00711243|26766511|FG002|Treated Cycle 5 After First Response|Progressive disease|0|||
13388114|NCT00711243|26766512|FG003|Treated Cycle 5 After First Response|Progressive disease|0|||
13388115|NCT00711243|26766513|FG004|Treated Cycle 5 After First Response|Progressive disease|1|||
13388116|NCT00711243|26766514|FG005|Treated Cycle 5 After First Response|Progressive disease|1|||
13388117|NCT00711243|26766509|FG000|Treated Cycle 5 After First Response|Death|0|||
13388118|NCT00711243|26766510|FG001|Treated Cycle 5 After First Response|Death|0|||
13388119|NCT00711243|26766511|FG002|Treated Cycle 5 After First Response|Death|0|||
13388120|NCT00711243|26766512|FG003|Treated Cycle 5 After First Response|Death|0|||
13388121|NCT00711243|26766513|FG004|Treated Cycle 5 After First Response|Death|0|||
13388122|NCT00711243|26766514|FG005|Treated Cycle 5 After First Response|Death|2|||
13388123|NCT00711243|26766509|FG000|Treated Cycle 5 After First Response|Decline in performance status|0|||
13388124|NCT00711243|26766510|FG001|Treated Cycle 5 After First Response|Decline in performance status|0|||
13388125|NCT00711243|26766511|FG002|Treated Cycle 5 After First Response|Decline in performance status|0|||
13388126|NCT00711243|26766512|FG003|Treated Cycle 5 After First Response|Decline in performance status|0|||
13388127|NCT00711243|26766513|FG004|Treated Cycle 5 After First Response|Decline in performance status|0|||
13388128|NCT00711243|26766514|FG005|Treated Cycle 5 After First Response|Decline in performance status|1|||
13388129|NCT00711243|26766509|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
13388130|NCT00711243|26766510|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
13388131|NCT00711243|26766511|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
13388132|NCT00711243|26766512|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
13388133|NCT00711243|26766513|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
13388134|NCT00711243|26766514|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2|||
13388135|NCT00711191|26766561|FG000|Overall Study|Adverse Event|1|||
13388136|NCT00711191|26766562|FG001|Overall Study|Adverse Event|1|||
13388137|NCT00711191|26766563|FG002|Overall Study|Adverse Event|2|||
13388138|NCT00711191|26766561|FG000|Overall Study|Objective progression or relapse|2|||
13388139|NCT00711191|26766562|FG001|Overall Study|Objective progression or relapse|3|||
13388140|NCT00711191|26766563|FG002|Overall Study|Objective progression or relapse|7|||
13388141|NCT00711191|26766561|FG000|Overall Study|Withdrawal by Subject|0|||
13388142|NCT00711191|26766562|FG001|Overall Study|Withdrawal by Subject|1|||
13388143|NCT00711191|26766563|FG002|Overall Study|Withdrawal by Subject|3|||
13388144|NCT00711113|26766571|FG000|Overall Study|Lost to Follow-up|9|||
13388145|NCT00711113|26766571|FG000|Overall Study|Implant lost|2|||
13388146|NCT00711100|26766589|FG000|Overall Study|Lack of Efficacy|5|||
13388147|NCT00711100|26766589|FG000|Overall Study|Withdrawal by Subject|8|||
13388148|NCT00711087|26766602|FG000|Overall Study|Lost to Follow-up|1|||
13388149|NCT00711087|26766603|FG001|Overall Study|Lost to Follow-up|0|||
13388150|NCT00711009|26766778|FG000|Overall Study|Adverse Event/HIV-Related Event|4|||
13388151|NCT00711009|26766779|FG001|Overall Study|Adverse Event/HIV-Related Event|5|||
13388152|NCT00711009|26766778|FG000|Overall Study|Withdrawal by Subject|4|||
13388153|NCT00711009|26766779|FG001|Overall Study|Withdrawal by Subject|2|||
13388154|NCT00711009|26766778|FG000|Overall Study|Lost to Follow-up|3|||
13388155|NCT00711009|26766779|FG001|Overall Study|Lost to Follow-up|9|||
13388156|NCT00711009|26766778|FG000|Overall Study|Participant Noncompliant|0|||
13388157|NCT00711009|26766779|FG001|Overall Study|Participant Noncompliant|1|||
13388158|NCT00711009|26766778|FG000|Overall Study|Virologic Failure|2|||
13388159|NCT00711009|26766779|FG001|Overall Study|Virologic Failure|1|||
13388160|NCT00711009|26766778|FG000|Overall Study|Pregnancy|1|||
13388161|NCT00711009|26766779|FG001|Overall Study|Pregnancy|0|||
13388162|NCT00711009|26766778|FG000|Overall Study|Site closing|0|||
13388163|NCT00711009|26766779|FG001|Overall Study|Site closing|1|||
13388164|NCT00711009|26766778|FG000|Overall Study|Dose adjustment|1|||
13388165|NCT00711009|26766779|FG001|Overall Study|Dose adjustment|0|||
13388166|NCT00710879|26766796|FG000|Overall Study|Lost to Follow-up|2|||
13388167|NCT00710879|26766797|FG001|Overall Study|Lost to Follow-up|1|||
13388168|NCT00710879|26766796|FG000|Overall Study|Protocol Violation|0|||
13388169|NCT00710879|26766797|FG001|Overall Study|Protocol Violation|3|||
13388170|NCT00710866|26766824|FG000|Overall Study|Protocol Violation|5|||
13388171|NCT00710866|26766825|FG001|Overall Study|Protocol Violation|4|||
13388172|NCT00710866|26766824|FG000|Overall Study|Withdrawal by Subject|2|||
13388173|NCT00710866|26766825|FG001|Overall Study|Withdrawal by Subject|1|||
13388174|NCT00710866|26766824|FG000|Overall Study|Lost to Follow-up|1|||
13388175|NCT00710866|26766825|FG001|Overall Study|Lost to Follow-up|0|||
13388176|NCT00710866|26766824|FG000|Overall Study|Failed to meet eligibility|1|||
13388177|NCT00710866|26766825|FG001|Overall Study|Failed to meet eligibility|1|||
13388178|NCT00710762|26766848|FG000|Overall Study|Progressive disease|27|||
13388179|NCT00710762|26766849|FG001|Overall Study|Progressive disease|30|||
13388180|NCT00710762|26766848|FG000|Overall Study|Adverse Event other disease worsening|2|||
13388181|NCT00710762|26766849|FG001|Overall Study|Adverse Event other disease worsening|1|||
13388182|NCT00710762|26766848|FG000|Overall Study|Other Adverse Event|7|||
13388183|NCT00710762|26766849|FG001|Overall Study|Other Adverse Event|7|||
13388184|NCT00710762|26766848|FG000|Overall Study|Lost to Follow-up|1|||
13388185|NCT00710762|26766849|FG001|Overall Study|Lost to Follow-up|0|||
13388186|NCT00710762|26766848|FG000|Overall Study|Reason other than listed above|2|||
13388187|NCT00710762|26766849|FG001|Overall Study|Reason other than listed above|2|||
13388188|NCT00710749|26766860|FG000|First Intervention|Withdrawal by Subject|1|||
13388189|NCT00710749|26766861|FG001|First Intervention|Withdrawal by Subject|0|||
13388190|NCT00710710|26766896|FG000|Overall Study|Consent withdrawn|2|||
13388191|NCT00710710|26766897|FG001|Overall Study|Consent withdrawn|2|||
13388192|NCT00710710|26766896|FG000|Overall Study|Protocol Violation|0|||
13388193|NCT00710710|26766897|FG001|Overall Study|Protocol Violation|1|||
13388194|NCT00710710|26766896|FG000|Overall Study|Adverse Event|3|||
13388195|NCT00710710|26766897|FG001|Overall Study|Adverse Event|3|||
13388196|NCT00710710|26766896|FG000|Overall Study|Progressive disease|40|||
13388197|NCT00710710|26766897|FG001|Overall Study|Progressive disease|38|||
13388198|NCT00710684|26766962|FG000|Overall Study|Adverse Event|11|||
13388199|NCT00710684|26766963|FG001|Overall Study|Adverse Event|19|||
13388200|NCT00710684|26766964|FG002|Overall Study|Adverse Event|16|||
13388201|NCT00710684|26766962|FG000|Overall Study|Lack of Efficacy|4|||
13388202|NCT00710684|26766963|FG001|Overall Study|Lack of Efficacy|3|||
13388203|NCT00710684|26766964|FG002|Overall Study|Lack of Efficacy|5|||
13388204|NCT00710684|26766962|FG000|Overall Study|Protocol Violation|5|||
13388205|NCT00710684|26766963|FG001|Overall Study|Protocol Violation|5|||
13388206|NCT00710684|26766964|FG002|Overall Study|Protocol Violation|5|||
13388207|NCT00710684|26766962|FG000|Overall Study|Lost to Follow-up|4|||
13388208|NCT00710684|26766963|FG001|Overall Study|Lost to Follow-up|6|||
13388209|NCT00710684|26766964|FG002|Overall Study|Lost to Follow-up|7|||
13388210|NCT00710684|26766962|FG000|Overall Study|Physician Decision|0|||
13388211|NCT00710684|26766963|FG001|Overall Study|Physician Decision|2|||
13388212|NCT00710684|26766964|FG002|Overall Study|Physician Decision|4|||
13388213|NCT00710684|26766962|FG000|Overall Study|Withdrawal by Subject|24|||
13388214|NCT00710684|26766963|FG001|Overall Study|Withdrawal by Subject|18|||
13388215|NCT00710684|26766964|FG002|Overall Study|Withdrawal by Subject|11|||
13388216|NCT00710684|26766962|FG000|Overall Study|Missing|1|||
13388217|NCT00710684|26766963|FG001|Overall Study|Missing|0|||
13388218|NCT00710684|26766964|FG002|Overall Study|Missing|0|||
13388219|NCT00710684|26766962|FG000|Overall Study|Did not continue after week 24|25|||
13388220|NCT00710684|26766963|FG001|Overall Study|Did not continue after week 24|21|||
13388221|NCT00710684|26766964|FG002|Overall Study|Did not continue after week 24|16|||
13388222|NCT00710606|26766981|FG000|Overall Study|Adverse Event|0|||
13388223|NCT00710606|26766982|FG001|Overall Study|Adverse Event|2|||
13388224|NCT00710593|26767030|FG000|Overall Study|Incarceration|1|||
13388225|NCT00710593|26767031|FG001|Overall Study|Incarceration|0|||
13388226|NCT00710593|26767030|FG000|Overall Study|Unable to complete Wk 48 within window|2|||
13388227|NCT00710593|26767031|FG001|Overall Study|Unable to complete Wk 48 within window|0|||
13388228|NCT00710593|26767030|FG000|Overall Study|Lost to Follow-up|3|||
13388229|NCT00710593|26767031|FG001|Overall Study|Lost to Follow-up|1|||
13388230|NCT00710593|26767030|FG000|Overall Study|Moved out of area|1|||
13388231|NCT00710593|26767031|FG001|Overall Study|Moved out of area|0|||
13388232|NCT00710593|26767030|FG000|Overall Study|Failure to adhere or complete study eval|1|||
13388233|NCT00710593|26767031|FG001|Overall Study|Failure to adhere or complete study eval|1|||
13388234|NCT00710593|26767030|FG000|Overall Study|Protocol Violation|1|||
13388235|NCT00710593|26767031|FG001|Overall Study|Protocol Violation|1|||
13388236|NCT00710593|26767030|FG000|Overall Study|Prem disc vaccine, completed all visits|6|||
13388237|NCT00710593|26767031|FG001|Overall Study|Prem disc vaccine, completed all visits|2|||
13388238|NCT00710554|26767064|FG000|Overall Study|Adverse Event|24|||
13388239|NCT00710554|26767065|FG001|Overall Study|Adverse Event|7|||
13388240|NCT00710554|26767064|FG000|Overall Study|Withdrawal by Subject|7|||
13388241|NCT00710554|26767065|FG001|Overall Study|Withdrawal by Subject|3|||
13388242|NCT00710554|26767064|FG000|Overall Study|Lost to Follow-up|7|||
13388243|NCT00710554|26767065|FG001|Overall Study|Lost to Follow-up|1|||
13388244|NCT00710554|26767064|FG000|Overall Study|Lack of Efficacy|11|||
13388245|NCT00710554|26767065|FG001|Overall Study|Lack of Efficacy|12|||
13388246|NCT00710554|26767064|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0|||
13388247|NCT00710554|26767065|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1|||
13388248|NCT00710424|26767096|FG000|Overall Study|Adverse Event|30|||
13388249|NCT00710424|26767097|FG001|Overall Study|Adverse Event|12|||
13388250|NCT00710424|26767096|FG000|Overall Study|Lack of Efficacy|4|||
13388251|NCT00710424|26767097|FG001|Overall Study|Lack of Efficacy|5|||
13388252|NCT00710424|26767096|FG000|Overall Study|Withdrawal by Subject|5|||
13388253|NCT00710424|26767097|FG001|Overall Study|Withdrawal by Subject|3|||
13388254|NCT00710424|26767096|FG000|Overall Study|Lost to Follow-up|0|||
13388255|NCT00710424|26767097|FG001|Overall Study|Lost to Follow-up|1|||
13388256|NCT00710424|26767096|FG000|Overall Study|Refused medication, no side effects|1|||
13388257|NCT00710424|26767097|FG001|Overall Study|Refused medication, no side effects|0|||
13388258|NCT00710424|26767096|FG000|Overall Study|Non-compliance with stable analgesia|1|||
13388259|NCT00710424|26767097|FG001|Overall Study|Non-compliance with stable analgesia|0|||
13388260|NCT00710424|26767096|FG000|Overall Study|Did not meet entry criteria at visit 1|1|||
13395432|NCT00647296|26790481|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
13395433|NCT00647296|26790482|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
13395434|NCT00647296|26790479|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1|||
13395435|NCT00647296|26790480|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
13395436|NCT00647296|26790481|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
13395437|NCT00647296|26790482|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
13395438|NCT00647296|26790479|FG000|Part 2: 4-week Placebo Washout|Death|3|||
13395439|NCT00647296|26790480|FG001|Part 2: 4-week Placebo Washout|Death|0|||
13395440|NCT00647296|26790481|FG002|Part 2: 4-week Placebo Washout|Death|0|||
13395441|NCT00647296|26790482|FG003|Part 2: 4-week Placebo Washout|Death|0|||
13395442|NCT00647296|26790479|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
13395443|NCT00647296|26790480|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5|||
13395444|NCT00647296|26790481|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
13395445|NCT00647296|26790482|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4|||
13395446|NCT00647296|26790479|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
13395447|NCT00647296|26790480|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1|||
13395448|NCT00647296|26790481|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
13395449|NCT00647296|26790482|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4|||
13395450|NCT00647296|26790479|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
13395451|NCT00647296|26790480|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1|||
13395452|NCT00647296|26790481|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
13395453|NCT00647296|26790482|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
13395454|NCT00647296|26790479|FG000|Part 2: 76-week Double-Blind Treatment|Death|0|||
13395455|NCT00647296|26790480|FG001|Part 2: 76-week Double-Blind Treatment|Death|7|||
13395456|NCT00647296|26790481|FG002|Part 2: 76-week Double-Blind Treatment|Death|0|||
13395457|NCT00647296|26790482|FG003|Part 2: 76-week Double-Blind Treatment|Death|5|||
13388261|NCT00710424|26767097|FG001|Overall Study|Did not meet entry criteria at visit 1|0|||
13388262|NCT00710424|26767096|FG000|Overall Study|Subject thought medication changed|1|||
13388263|NCT00710424|26767097|FG001|Overall Study|Subject thought medication changed|0|||
13388264|NCT00710424|26767096|FG000|Overall Study|Ceased treatment due to travel|1|||
13388265|NCT00710424|26767097|FG001|Overall Study|Ceased treatment due to travel|0|||
13388266|NCT00710424|26767096|FG000|Overall Study|Subject preferred paracetamol|0|||
13388267|NCT00710424|26767097|FG001|Overall Study|Subject preferred paracetamol|1|||
13388268|NCT00710424|26767096|FG000|Overall Study|Felt good so stopped treatment|0|||
13388269|NCT00710424|26767097|FG001|Overall Study|Felt good so stopped treatment|1|||
13388270|NCT00710385|26767116|FG000|Overall Study|Did not qualify|1|||
13388271|NCT00710385|26767116|FG000|Overall Study|Withdrawal by Subject|1|||
13388272|NCT00710385|26767116|FG000|Overall Study|Undisclosed back pain|1|||
13388273|NCT00710385|26767116|FG000|Overall Study|Physician Decision|1|||
13388274|NCT00710385|26767116|FG000|Overall Study|Undisclosed excessive methadone use|1|||
13388275|NCT00710034|26767137|FG000|Completed 6 Weeks of Treatment|Adverse Event|5|||
13388276|NCT00710034|26767138|FG001|Completed 6 Weeks of Treatment|Adverse Event|12|||
13388277|NCT00710034|26767137|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12|||
13388278|NCT00710034|26767138|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8|||
13388279|NCT00710034|26767137|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15|||
13388280|NCT00710034|26767138|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17|||
13388281|NCT00710034|26767137|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2|||
13388282|NCT00710034|26767138|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6|||
13388283|NCT00710034|26767137|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6|||
13388284|NCT00710034|26767138|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4|||
13388285|NCT00710034|26767137|FG000|Completed 6 Weeks of Treatment|Physician Decision|1|||
13388286|NCT00710034|26767138|FG001|Completed 6 Weeks of Treatment|Physician Decision|0|||
13388287|NCT00710034|26767137|FG000|Completed 12 Weeks of Treatment|Adverse Event|0|||
13388288|NCT00710034|26767138|FG001|Completed 12 Weeks of Treatment|Adverse Event|1|||
13388289|NCT00710034|26767137|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0|||
13388290|NCT00710034|26767138|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2|||
13388291|NCT00710034|26767137|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
13388292|NCT00710034|26767138|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
13388293|NCT00710034|26767137|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0|||
13388294|NCT00710034|26767138|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1|||
13388295|NCT00710034|26767137|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8|||
13388296|NCT00710034|26767138|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2|||
13388297|NCT00710021|26767261|FG000|Overall Study|Lost to Follow-up|1|||
13388298|NCT00710021|26767262|FG001|Overall Study|Lost to Follow-up|0|||
13388299|NCT00710021|26767263|FG002|Overall Study|Lost to Follow-up|0|||
13388300|NCT00710021|26767261|FG000|Overall Study|Subject's Decision|0|||
13388301|NCT00710021|26767262|FG001|Overall Study|Subject's Decision|1|||
13388302|NCT00710021|26767263|FG002|Overall Study|Subject's Decision|0|||
13388303|NCT00710021|26767261|FG000|Overall Study|Subject misrandomized|0|||
13388304|NCT00710021|26767262|FG001|Overall Study|Subject misrandomized|1|||
13388305|NCT00710021|26767263|FG002|Overall Study|Subject misrandomized|1|||
13388306|NCT00710021|26767261|FG000|Overall Study|Physician Decision|0|||
13388307|NCT00710021|26767262|FG001|Overall Study|Physician Decision|1|||
13388308|NCT00710021|26767263|FG002|Overall Study|Physician Decision|0|||
13388309|NCT00709111|26767303|FG000|Overall Study|Withdrawal by Subject|1|||
13388310|NCT00709111|26767303|FG000|Overall Study|Unable to attend clinic visits|1|||
13388311|NCT00708708|26767353|FG000|Overall Study|Another therapy instead of Enbrel|141|||
13388312|NCT00708708|26767353|FG000|Overall Study|Lost to Follow-up|52|||
13388313|NCT00708708|26767353|FG000|Overall Study|Withdrawal by Subject|51|||
13388314|NCT00708708|26767353|FG000|Overall Study|Intolerance|42|||
13388315|NCT00708708|26767353|FG000|Overall Study|Another therapy along with Enbrel|15|||
13388316|NCT00708708|26767353|FG000|Overall Study|Other unspecified|11|||
13388317|NCT00708708|26767353|FG000|Overall Study|Good effectiveness|9|||
13388318|NCT00708708|26767353|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9|||
13388319|NCT00708708|26767353|FG000|Overall Study|Administrative reasons|7|||
13388320|NCT00708708|26767353|FG000|Overall Study|Lack of effectiveness|4|||
13388321|NCT00708708|26767353|FG000|Overall Study|Lack of compliance|3|||
13388322|NCT00708708|26767353|FG000|Overall Study|Pregnancy|3|||
13388323|NCT00708708|26767353|FG000|Overall Study|Adverse Event|3|||
13388324|NCT00708708|26767353|FG000|Overall Study|Missing values|392|||
13388325|NCT00708682|26767374|FG000|Infant Series|Adverse Event|1|||
13388326|NCT00708682|26767374|FG000|Infant Series|Lost to Follow-up|4|||
13388327|NCT00708682|26767374|FG000|Infant Series|Protocol Violation|1|||
13388328|NCT00708682|26767374|FG000|Infant Series|Parent/legal guardian request|6|||
13388329|NCT00708682|26767374|FG000|Infant Series|Failed to return|2|||
13388330|NCT00708682|26767374|FG000|Infant Series|Other|19|||
13388331|NCT00708682|26767374|FG000|After Infant Series|Parent/Legal Guardian Request|1|||
13388332|NCT00708682|26767374|FG000|Toddler Dose|Parent/Legal Guardian Request|1|||
13388333|NCT00708682|26767374|FG000|Toddler Dose|Lost to Follow-up|3|||
13388334|NCT00708682|26767374|FG000|Toddler Dose|Failed to Return|4|||
13388335|NCT00708175|26767395|FG000|Overall Study|Adverse Event|4|||
13388336|NCT00708175|26767396|FG001|Overall Study|Adverse Event|5|||
13388337|NCT00708175|26767395|FG000|Overall Study|Protocol Violation|2|||
13388338|NCT00708175|26767396|FG001|Overall Study|Protocol Violation|3|||
13388339|NCT00708175|26767395|FG000|Overall Study|Lost to Follow-up|5|||
13388340|NCT00708175|26767396|FG001|Overall Study|Lost to Follow-up|3|||
13388341|NCT00708175|26767395|FG000|Overall Study|Withdrawal by Subject|5|||
13388342|NCT00708175|26767396|FG001|Overall Study|Withdrawal by Subject|7|||
13388343|NCT00708175|26767395|FG000|Overall Study|BMD loss >7%|2|||
13388344|NCT00708175|26767396|FG001|Overall Study|BMD loss >7%|3|||
13388345|NCT00707746|26767449|FG000|Treatment Period|Adverse Event|2|||
13388346|NCT00707746|26767450|FG001|Treatment Period|Adverse Event|4|||
13388347|NCT00707746|26767449|FG000|Treatment Period|Ineligibility|0|||
13388348|NCT00707746|26767450|FG001|Treatment Period|Ineligibility|1|||
13388349|NCT00707239|26767506|FG000|Overall Study|Adverse Event|5|||
13388350|NCT00707239|26767507|FG001|Overall Study|Adverse Event|3|||
13388351|NCT00707239|26767508|FG002|Overall Study|Adverse Event|2|||
13388352|NCT00707239|26767506|FG000|Overall Study|Death|3|||
13388353|NCT00707239|26767507|FG001|Overall Study|Death|1|||
13388354|NCT00707239|26767508|FG002|Overall Study|Death|3|||
13388355|NCT00707239|26767506|FG000|Overall Study|Physician Decision|1|||
13388356|NCT00707239|26767507|FG001|Overall Study|Physician Decision|1|||
13388357|NCT00707239|26767508|FG002|Overall Study|Physician Decision|2|||
13388358|NCT00707239|26767506|FG000|Overall Study|Protocol Violation|0|||
13388359|NCT00707239|26767507|FG001|Overall Study|Protocol Violation|0|||
13388360|NCT00707239|26767508|FG002|Overall Study|Protocol Violation|1|||
13388361|NCT00707239|26767506|FG000|Overall Study|Lack of Efficacy|1|||
13388362|NCT00707239|26767507|FG001|Overall Study|Lack of Efficacy|2|||
13388363|NCT00707239|26767508|FG002|Overall Study|Lack of Efficacy|0|||
13388364|NCT00707239|26767506|FG000|Overall Study|Randomized, but not treated|1|||
13388365|NCT00707239|26767507|FG001|Overall Study|Randomized, but not treated|1|||
13388366|NCT00707239|26767508|FG002|Overall Study|Randomized, but not treated|1|||
13388367|NCT00707239|26767506|FG000|Overall Study|Other|8|||
13388368|NCT00707239|26767507|FG001|Overall Study|Other|3|||
13388369|NCT00707239|26767508|FG002|Overall Study|Other|5|||
13388370|NCT00707031|26767537|FG000|Overall Study|Adverse Event|45|||
13388371|NCT00707031|26767538|FG001|Overall Study|Adverse Event|45|||
13388372|NCT00707031|26767537|FG000|Overall Study|Lack of Efficacy|19|||
13388373|NCT00707031|26767538|FG001|Overall Study|Lack of Efficacy|6|||
13388374|NCT00707031|26767537|FG000|Overall Study|Lost to Follow-up|2|||
13388375|NCT00707031|26767538|FG001|Overall Study|Lost to Follow-up|1|||
13388376|NCT00707031|26767537|FG000|Overall Study|Protocol Violation|1|||
13388377|NCT00707031|26767538|FG001|Overall Study|Protocol Violation|0|||
13388378|NCT00707031|26767537|FG000|Overall Study|Withdrawal by Subject|7|||
13388379|NCT00707031|26767538|FG001|Overall Study|Withdrawal by Subject|8|||
13388380|NCT00707031|26767537|FG000|Overall Study|Poor Compliance to Protocol|7|||
13388381|NCT00707031|26767538|FG001|Overall Study|Poor Compliance to Protocol|13|||
13388382|NCT00707031|26767537|FG000|Overall Study|Familial or Personal Reasons|12|||
13388383|NCT00707031|26767538|FG001|Overall Study|Familial or Personal Reasons|15|||
13388384|NCT00707031|26767537|FG000|Overall Study|Serious Noncompliance|2|||
13388385|NCT00707031|26767538|FG001|Overall Study|Serious Noncompliance|3|||
13388386|NCT00707031|26767537|FG000|Overall Study|Sponsor Decision|9|||
13388387|NCT00707031|26767538|FG001|Overall Study|Sponsor Decision|8|||
13388388|NCT00706706|26767547|FG000|Overall Study|Death|53|||
13388389|NCT00706706|26767547|FG000|Overall Study|Lost to Follow-up|7|||
13388390|NCT00706706|26767547|FG000|Overall Study|Study endpoint had reached|45|||
13388391|NCT00706511|26767592|FG000|Overall Study|Withdrawal by Subject|1|||
13388392|NCT00706511|26767593|FG001|Overall Study|Withdrawal by Subject|0|||
13388393|NCT00706511|26767594|FG002|Overall Study|Withdrawal by Subject|0|||
13388394|NCT00706511|26767595|FG003|Overall Study|Withdrawal by Subject|0|||
13388395|NCT00706381|26767625|FG000|Overall Study|Lost to Follow-up|0|||
13388396|NCT00706381|26767626|FG001|Overall Study|Lost to Follow-up|1|||
13388397|NCT00706381|26767627|FG002|Overall Study|Lost to Follow-up|1|||
13388398|NCT00706381|26767628|FG003|Overall Study|Lost to Follow-up|0|||
13388399|NCT00706355|26767693|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1|||
13388400|NCT00706355|26767694|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
13388401|NCT00706355|26767695|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
13388402|NCT00706355|26767696|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
13388403|NCT00706355|26767693|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2|||
13388404|NCT00706355|26767694|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
13388405|NCT00706355|26767695|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
13388406|NCT00706355|26767696|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
13388407|NCT00706355|26767693|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
13388408|NCT00706355|26767694|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1|||
13388409|NCT00706355|26767695|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
13388410|NCT00706355|26767696|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
13388411|NCT00706355|26767693|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
13388412|NCT00706355|26767694|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1|||
13388413|NCT00706355|26767695|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
13388414|NCT00706355|26767696|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
13388415|NCT00706355|26767693|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
13388416|NCT00706355|26767694|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5|||
13388417|NCT00706355|26767695|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
13388418|NCT00706355|26767696|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
13388419|NCT00706355|26767693|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0|||
13388420|NCT00706355|26767694|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0|||
13388421|NCT00706355|26767695|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1|||
13388422|NCT00706355|26767696|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0|||
13388423|NCT00706355|26767693|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
13388424|NCT00706355|26767694|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
13388425|NCT00706355|26767695|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1|||
13388426|NCT00706355|26767696|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
13388427|NCT00706355|26767693|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0|||
13388428|NCT00706355|26767694|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0|||
13388429|NCT00706355|26767695|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0|||
13388430|NCT00706355|26767696|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2|||
13388431|NCT00706355|26767693|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
13388432|NCT00706355|26767694|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
13388433|NCT00706355|26767695|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
13388434|NCT00706355|26767696|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2|||
13388435|NCT00705939|26767729|FG000|Overall Study|Protocol Violation|0|||
13388436|NCT00705939|26767730|FG001|Overall Study|Protocol Violation|0|||
13388437|NCT00705939|26767731|FG002|Overall Study|Protocol Violation|1|||
13388438|NCT00705939|26767729|FG000|Overall Study|Withdrawal by Subject|0|||
13388439|NCT00705939|26767730|FG001|Overall Study|Withdrawal by Subject|1|||
13388440|NCT00705939|26767731|FG002|Overall Study|Withdrawal by Subject|3|||
13388441|NCT00705939|26767729|FG000|Overall Study|Physician Decision|0|||
13388442|NCT00705939|26767730|FG001|Overall Study|Physician Decision|1|||
13388443|NCT00705939|26767731|FG002|Overall Study|Physician Decision|0|||
13388444|NCT00705757|26767749|FG000|Overall Study|Lack of Efficacy|5|||
13388445|NCT00705757|26767750|FG001|Overall Study|Lack of Efficacy|1|||
13388446|NCT00705757|26767751|FG002|Overall Study|Lack of Efficacy|3|||
13388447|NCT00705757|26767749|FG000|Overall Study|Lost to Follow-up|7|||
13388448|NCT00705757|26767750|FG001|Overall Study|Lost to Follow-up|6|||
13388449|NCT00705757|26767751|FG002|Overall Study|Lost to Follow-up|6|||
13388450|NCT00705757|26767749|FG000|Overall Study|Withdrawal by Subject|1|||
13388451|NCT00705757|26767750|FG001|Overall Study|Withdrawal by Subject|1|||
13388452|NCT00705757|26767751|FG002|Overall Study|Withdrawal by Subject|2|||
13388453|NCT00705679|26767802|FG000|Overall Study|Adverse Event|1|||
13388454|NCT00705679|26767803|FG001|Overall Study|Adverse Event|1|||
13388455|NCT00705679|26767804|FG002|Overall Study|Adverse Event|0|||
13388456|NCT00705679|26767805|FG003|Overall Study|Adverse Event|0|||
13388457|NCT00705679|26767806|FG004|Overall Study|Adverse Event|0|||
13388458|NCT00705679|26767802|FG000|Overall Study|Death|0|||
13388459|NCT00705679|26767803|FG001|Overall Study|Death|0|||
13388460|NCT00705679|26767804|FG002|Overall Study|Death|3|||
13388461|NCT00705679|26767805|FG003|Overall Study|Death|2|||
13388462|NCT00705679|26767806|FG004|Overall Study|Death|1|||
13388463|NCT00705679|26767802|FG000|Overall Study|Lost to Follow-up|32|||
13388464|NCT00705679|26767803|FG001|Overall Study|Lost to Follow-up|60|||
13388465|NCT00705679|26767804|FG002|Overall Study|Lost to Follow-up|44|||
13388466|NCT00705679|26767805|FG003|Overall Study|Lost to Follow-up|30|||
13388467|NCT00705679|26767806|FG004|Overall Study|Lost to Follow-up|35|||
13388468|NCT00705679|26767802|FG000|Overall Study|Physician Decision|0|||
13388469|NCT00705679|26767803|FG001|Overall Study|Physician Decision|1|||
13388470|NCT00705679|26767804|FG002|Overall Study|Physician Decision|0|||
13388471|NCT00705679|26767805|FG003|Overall Study|Physician Decision|1|||
13388472|NCT00705679|26767806|FG004|Overall Study|Physician Decision|0|||
13388473|NCT00705679|26767802|FG000|Overall Study|Withdrawal by Subject|32|||
13388474|NCT00705679|26767803|FG001|Overall Study|Withdrawal by Subject|77|||
13388475|NCT00705679|26767804|FG002|Overall Study|Withdrawal by Subject|68|||
13388476|NCT00705679|26767805|FG003|Overall Study|Withdrawal by Subject|47|||
13388477|NCT00705679|26767806|FG004|Overall Study|Withdrawal by Subject|33|||
13388478|NCT00705614|26767860|FG000|Initial Intervention|Adverse Event|40|||
13388479|NCT00705614|26767861|FG001|Initial Intervention|Adverse Event|21|||
13388480|NCT00705614|26767860|FG000|Initial Intervention|Lost to Follow-up|310|||
13388481|NCT00705614|26767861|FG001|Initial Intervention|Lost to Follow-up|191|||
13388482|NCT00705614|26767860|FG000|Initial Intervention|Withdrawal by Subject|114|||
13388483|NCT00705614|26767861|FG001|Initial Intervention|Withdrawal by Subject|71|||
13388484|NCT00705614|26767860|FG000|Initial Intervention|Administrative Reason|51|||
13388485|NCT00705614|26767861|FG001|Initial Intervention|Administrative Reason|38|||
13388486|NCT00705614|26767860|FG000|Initial Intervention|Status completion unknown|3|||
13388487|NCT00705614|26767861|FG001|Initial Intervention|Status completion unknown|0|||
13388488|NCT00705614|26767860|FG000|Switch to Remicade|Adverse Event|0|||
13388489|NCT00705614|26767861|FG001|Switch to Remicade|Adverse Event|5|||
13388490|NCT00705614|26767860|FG000|Switch to Remicade|Lost to Follow-up|0|||
13388491|NCT00705614|26767861|FG001|Switch to Remicade|Lost to Follow-up|23|||
13388492|NCT00705614|26767860|FG000|Switch to Remicade|Withdrawal by Subject|0|||
13388493|NCT00705614|26767861|FG001|Switch to Remicade|Withdrawal by Subject|12|||
13388494|NCT00705614|26767860|FG000|Switch to Remicade|Administrative Reason|0|||
13388495|NCT00705614|26767861|FG001|Switch to Remicade|Administrative Reason|9|||
13388496|NCT00705016|26767897|FG000|Overall Study|Adverse Event|6|||
13388497|NCT00705016|26767898|FG001|Overall Study|Adverse Event|11|||
13388498|NCT00705016|26767899|FG002|Overall Study|Adverse Event|10|||
13388499|NCT00705016|26767897|FG000|Overall Study|Death|5|||
13388500|NCT00705016|26767898|FG001|Overall Study|Death|7|||
13388501|NCT00705016|26767899|FG002|Overall Study|Death|5|||
13388502|NCT00705016|26767897|FG000|Overall Study|Protocol Violation|0|||
13388503|NCT00705016|26767898|FG001|Overall Study|Protocol Violation|1|||
13388504|NCT00705016|26767899|FG002|Overall Study|Protocol Violation|1|||
13388505|NCT00705016|26767897|FG000|Overall Study|Withdrawal by Subject|4|||
13388506|NCT00705016|26767898|FG001|Overall Study|Withdrawal by Subject|3|||
13388507|NCT00705016|26767899|FG002|Overall Study|Withdrawal by Subject|2|||
13388508|NCT00705016|26767897|FG000|Overall Study|Progressive Disease|33|||
13388509|NCT00705016|26767898|FG001|Overall Study|Progressive Disease|29|||
13388510|NCT00705016|26767899|FG002|Overall Study|Progressive Disease|33|||
13388511|NCT00705016|26767897|FG000|Overall Study|Symptomatic Deterioration|3|||
13388512|NCT00705016|26767898|FG001|Overall Study|Symptomatic Deterioration|1|||
13388513|NCT00705016|26767899|FG002|Overall Study|Symptomatic Deterioration|1|||
13388514|NCT00705016|26767897|FG000|Overall Study|Other|9|||
13388515|NCT00705016|26767898|FG001|Overall Study|Other|6|||
13388516|NCT00705016|26767899|FG002|Overall Study|Other|6|||
13388517|NCT00704730|26767922|FG000|Overall Study|Adverse Event|35|||
13388518|NCT00704730|26767923|FG001|Overall Study|Adverse Event|9|||
13388519|NCT00704730|26767922|FG000|Overall Study|Death|11|||
13388520|NCT00704730|26767923|FG001|Overall Study|Death|5|||
13388521|NCT00704730|26767922|FG000|Overall Study|Physician Decision|2|||
13388522|NCT00704730|26767923|FG001|Overall Study|Physician Decision|0|||
13388523|NCT00704730|26767922|FG000|Overall Study|Did not receive drug|5|||
13388524|NCT00704730|26767923|FG001|Overall Study|Did not receive drug|2|||
13388525|NCT00704730|26767922|FG000|Overall Study|Disease progression per PI|58|||
13388526|NCT00704730|26767923|FG001|Overall Study|Disease progression per PI|67|||
13388527|NCT00704730|26767922|FG000|Overall Study|data unavailable|1|||
13388528|NCT00704730|26767923|FG001|Overall Study|data unavailable|0|||
13388529|NCT00704730|26767922|FG000|Overall Study|Withdrawal by Subject|9|||
13388530|NCT00704730|26767923|FG001|Overall Study|Withdrawal by Subject|13|||
13388531|NCT00704184|26767976|FG000|Double-Blind Treatment|Withdrawal by Subject|1|||
13388532|NCT00704184|26767977|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
13388533|NCT00704184|26767978|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
13388534|NCT00704184|26767979|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
13388535|NCT00704184|26767980|FG004|Double-Blind Treatment|Withdrawal by Subject|0|||
13388536|NCT00704184|26767976|FG000|Open-Label Treatment|Adverse Event|0|||
13388537|NCT00704184|26767977|FG001|Open-Label Treatment|Adverse Event|0|||
13388538|NCT00704184|26767978|FG002|Open-Label Treatment|Adverse Event|2|||
13388539|NCT00704184|26767979|FG003|Open-Label Treatment|Adverse Event|0|||
13388540|NCT00704184|26767980|FG004|Open-Label Treatment|Adverse Event|1|||
13388541|NCT00704184|26767976|FG000|Open-Label Treatment|Lack of Efficacy|0|||
13388542|NCT00704184|26767977|FG001|Open-Label Treatment|Lack of Efficacy|2|||
13388543|NCT00704184|26767978|FG002|Open-Label Treatment|Lack of Efficacy|2|||
13388544|NCT00704184|26767979|FG003|Open-Label Treatment|Lack of Efficacy|2|||
13388545|NCT00704184|26767980|FG004|Open-Label Treatment|Lack of Efficacy|1|||
13388546|NCT00704184|26767976|FG000|Open-Label Treatment|Physician Decision|0|||
13388547|NCT00704184|26767977|FG001|Open-Label Treatment|Physician Decision|0|||
13388548|NCT00704184|26767978|FG002|Open-Label Treatment|Physician Decision|0|||
13388549|NCT00704184|26767979|FG003|Open-Label Treatment|Physician Decision|0|||
13388550|NCT00704184|26767980|FG004|Open-Label Treatment|Physician Decision|1|||
13388551|NCT00704184|26767976|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
13388552|NCT00704184|26767977|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
13388553|NCT00704184|26767978|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
13388554|NCT00704184|26767979|FG003|Open-Label Treatment|Withdrawal by Subject|3|||
13388555|NCT00704184|26767980|FG004|Open-Label Treatment|Withdrawal by Subject|0|||
13388556|NCT00703534|26767993|FG000|Overall Study|Adverse Event|14|||
13388557|NCT00703534|26767994|FG001|Overall Study|Adverse Event|3|||
13388558|NCT00703534|26767993|FG000|Overall Study|Withdrawal by Subject|8|||
13388559|NCT00703534|26767994|FG001|Overall Study|Withdrawal by Subject|7|||
13388560|NCT00703534|26767993|FG000|Overall Study|Incorrect Enrollment|6|||
13388561|NCT00703534|26767994|FG001|Overall Study|Incorrect Enrollment|6|||
13388562|NCT00703534|26767993|FG000|Overall Study|Lost to Follow-up|1|||
13388563|NCT00703534|26767994|FG001|Overall Study|Lost to Follow-up|4|||
13388564|NCT00703534|26767993|FG000|Overall Study|Severe Non Compliance|1|||
13388565|NCT00703534|26767994|FG001|Overall Study|Severe Non Compliance|5|||
13388566|NCT00701415|26768011|FG000|Overall Study|Adverse Event|0|||
13388567|NCT00701415|26768012|FG001|Overall Study|Adverse Event|1|||
13388568|NCT00701415|26768011|FG000|Overall Study|Social/family issues and needle phobia|1|||
13388569|NCT00701415|26768012|FG001|Overall Study|Social/family issues and needle phobia|0|||
13388570|NCT00701038|26768025|FG000|Overall Study|study amended pilot group of patients|4|||
13388571|NCT00701038|26768026|FG001|Overall Study|study amended pilot group of patients|4|||
13388572|NCT00700115|26768041|FG000|Overall Study|Withdrawal by Subject|1|||
13388573|NCT00700115|26768042|FG001|Overall Study|Withdrawal by Subject|0|||
13388574|NCT00700115|26768041|FG000|Overall Study|Lost to Follow-up|0|||
13388575|NCT00700115|26768042|FG001|Overall Study|Lost to Follow-up|1|||
13388576|NCT00700102|26768065|FG000|Overall Study|Died|394|||
13388577|NCT00700102|26768066|FG001|Overall Study|Died|385|||
13388578|NCT00700102|26768065|FG000|Overall Study|Lost to Follow-up|8|||
13388579|NCT00700102|26768066|FG001|Overall Study|Lost to Follow-up|10|||
13388580|NCT00700011|26768085|FG000|Overall Study|Death|0|||
13388581|NCT00700011|26768086|FG001|Overall Study|Death|1|||
13388582|NCT00699998|26768141|FG000|Overall Study|Withdrawal by Subject|194|||
13388583|NCT00699998|26768142|FG001|Overall Study|Withdrawal by Subject|83|||
13388584|NCT00699998|26768143|FG002|Overall Study|Withdrawal by Subject|202|||
13388585|NCT00699998|26768144|FG003|Overall Study|Withdrawal by Subject|80|||
13388586|NCT00699998|26768141|FG000|Overall Study|Physician Decision|3|||
13388587|NCT00699998|26768142|FG001|Overall Study|Physician Decision|2|||
13388588|NCT00699998|26768143|FG002|Overall Study|Physician Decision|1|||
13388589|NCT00699998|26768144|FG003|Overall Study|Physician Decision|1|||
13388590|NCT00699998|26768141|FG000|Overall Study|Lost to Follow-up|2|||
13388591|NCT00699998|26768142|FG001|Overall Study|Lost to Follow-up|1|||
13388592|NCT00699998|26768143|FG002|Overall Study|Lost to Follow-up|3|||
13388593|NCT00699998|26768144|FG003|Overall Study|Lost to Follow-up|1|||
13388594|NCT00699972|26768168|FG000|Overall Study|Adverse Event|7|||
13388595|NCT00699972|26768169|FG001|Overall Study|Adverse Event|9|||
13388596|NCT00699972|26768170|FG002|Overall Study|Adverse Event|24|||
13388597|NCT00699972|26768168|FG000|Overall Study|Lost to Follow-up|0|||
13388598|NCT00699972|26768169|FG001|Overall Study|Lost to Follow-up|2|||
13388599|NCT00699972|26768170|FG002|Overall Study|Lost to Follow-up|0|||
13388600|NCT00699972|26768168|FG000|Overall Study|Withdrawal by Subject|3|||
13388601|NCT00699972|26768169|FG001|Overall Study|Withdrawal by Subject|7|||
13388602|NCT00699972|26768170|FG002|Overall Study|Withdrawal by Subject|4|||
13388603|NCT00699972|26768168|FG000|Overall Study|Lack of Efficacy|2|||
13388604|NCT00699972|26768169|FG001|Overall Study|Lack of Efficacy|0|||
13388605|NCT00699972|26768170|FG002|Overall Study|Lack of Efficacy|2|||
13388606|NCT00699972|26768168|FG000|Overall Study|Administrative/Other|3|||
13388607|NCT00699972|26768169|FG001|Overall Study|Administrative/Other|1|||
13388608|NCT00699972|26768170|FG002|Overall Study|Administrative/Other|4|||
13388609|NCT00699972|26768168|FG000|Overall Study|Randomized, Not Treated|1|||
13388610|NCT00699972|26768169|FG001|Overall Study|Randomized, Not Treated|0|||
13388611|NCT00699972|26768170|FG002|Overall Study|Randomized, Not Treated|1|||
13388612|NCT00699907|26768212|FG000|Overall Study|Withdrawal by Subject|2|||
13388613|NCT00699907|26768213|FG001|Overall Study|Withdrawal by Subject|1|||
13388614|NCT00699907|26768214|FG002|Overall Study|Withdrawal by Subject|0|||
13388615|NCT00699907|26768212|FG000|Overall Study|No usable sample|0|||
13388616|NCT00699907|26768213|FG001|Overall Study|No usable sample|9|||
13388617|NCT00699907|26768214|FG002|Overall Study|No usable sample|8|||
13388618|NCT00699842|26768235|FG000|Overall Study|Death|0|||
13388619|NCT00699842|26768236|FG001|Overall Study|Death|1|||
13388620|NCT00699842|26768237|FG002|Overall Study|Death|0|||
13388621|NCT00699816|26768260|FG000|Overall Study|Protocol Violation|1|||
13388622|NCT00699816|26768261|FG001|Overall Study|Protocol Violation|3|||
13388623|NCT00699751|26768353|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27|||
13388624|NCT00699751|26768354|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27|||
13388625|NCT00699751|26768353|FG000|Period 1: Without/Before Drug Switch|Death|28|||
13388626|NCT00699751|26768354|FG001|Period 1: Without/Before Drug Switch|Death|29|||
13388627|NCT00699751|26768353|FG000|Period 1: Without/Before Drug Switch|Subject Request|43|||
13388628|NCT00699751|26768354|FG001|Period 1: Without/Before Drug Switch|Subject Request|23|||
13388629|NCT00699751|26768353|FG000|Period 1: Without/Before Drug Switch|Other|30|||
13388630|NCT00699751|26768354|FG001|Period 1: Without/Before Drug Switch|Other|20|||
13388631|NCT00699751|26768353|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97|||
13388632|NCT00699751|26768354|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63|||
13388633|NCT00699751|26768353|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0|||
13388634|NCT00699751|26768354|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4|||
13388635|NCT00699751|26768353|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0|||
13388636|NCT00699751|26768354|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1|||
13388637|NCT00699751|26768353|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0|||
13388638|NCT00699751|26768354|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4|||
13388639|NCT00699699|26768363|FG000|Overall Study|Adverse Event|36|||
13388640|NCT00699699|26768363|FG000|Overall Study|Individual different reasons|21|||
13388641|NCT00699660|26768382|FG000|Overall Study|Lost to Follow-up|4|||
13388642|NCT00699660|26768383|FG001|Overall Study|Lost to Follow-up|2|||
13388643|NCT00699660|26768382|FG000|Overall Study|missing reports and recording failures|10|||
13388644|NCT00699660|26768383|FG001|Overall Study|missing reports and recording failures|6|||
13388645|NCT00699608|26768440|FG000|First Intervention|Withdrawal by Subject|0|||
13388646|NCT00699608|26768441|FG001|First Intervention|Withdrawal by Subject|0|||
13388647|NCT00699608|26768442|FG002|First Intervention|Withdrawal by Subject|1|||
13388648|NCT00699608|26768443|FG003|First Intervention|Withdrawal by Subject|0|||
13388649|NCT00699608|26768444|FG004|First Intervention|Withdrawal by Subject|0|||
13388650|NCT00699608|26768445|FG005|First Intervention|Withdrawal by Subject|0|||
13388651|NCT00699608|26768440|FG000|First Intervention|Protocol Violation|0|||
13388652|NCT00699608|26768441|FG001|First Intervention|Protocol Violation|0|||
13388653|NCT00699608|26768442|FG002|First Intervention|Protocol Violation|0|||
13388654|NCT00699608|26768443|FG003|First Intervention|Protocol Violation|0|||
13388655|NCT00699608|26768444|FG004|First Intervention|Protocol Violation|1|||
13388656|NCT00699608|26768445|FG005|First Intervention|Protocol Violation|0|||
13388657|NCT00699608|26768440|FG000|Second Intervention|Adverse Event|0|||
13388658|NCT00699608|26768441|FG001|Second Intervention|Adverse Event|0|||
13388659|NCT00699608|26768442|FG002|Second Intervention|Adverse Event|1|||
13388660|NCT00699608|26768443|FG003|Second Intervention|Adverse Event|0|||
13388661|NCT00699608|26768444|FG004|Second Intervention|Adverse Event|0|||
13388662|NCT00699608|26768445|FG005|Second Intervention|Adverse Event|0|||
13388663|NCT00699608|26768440|FG000|Second Intervention|Withdrawal by Subject|0|||
13388664|NCT00699608|26768441|FG001|Second Intervention|Withdrawal by Subject|0|||
13388665|NCT00699608|26768442|FG002|Second Intervention|Withdrawal by Subject|0|||
13388666|NCT00699608|26768443|FG003|Second Intervention|Withdrawal by Subject|1|||
13388667|NCT00699608|26768444|FG004|Second Intervention|Withdrawal by Subject|0|||
13388668|NCT00699608|26768445|FG005|Second Intervention|Withdrawal by Subject|0|||
13388669|NCT00699582|26768469|FG000|Overall Study|Adverse Event|4|||
13388670|NCT00699582|26768470|FG001|Overall Study|Adverse Event|11|||
13388671|NCT00699582|26768471|FG002|Overall Study|Adverse Event|23|||
13388672|NCT00699582|26768469|FG000|Overall Study|Withdrawal by Subject|6|||
13388673|NCT00699582|26768470|FG001|Overall Study|Withdrawal by Subject|7|||
13388674|NCT00699582|26768471|FG002|Overall Study|Withdrawal by Subject|4|||
13388675|NCT00699582|26768469|FG000|Overall Study|Lack of Efficacy|1|||
13388676|NCT00699582|26768470|FG001|Overall Study|Lack of Efficacy|0|||
13388677|NCT00699582|26768471|FG002|Overall Study|Lack of Efficacy|1|||
13388678|NCT00699582|26768469|FG000|Overall Study|Progressive Disease|1|||
13388679|NCT00699582|26768470|FG001|Overall Study|Progressive Disease|0|||
13388680|NCT00699582|26768471|FG002|Overall Study|Progressive Disease|0|||
13388681|NCT00699582|26768469|FG000|Overall Study|Administrative/Other|4|||
13388682|NCT00699582|26768470|FG001|Overall Study|Administrative/Other|3|||
13388683|NCT00699582|26768471|FG002|Overall Study|Administrative/Other|0|||
13388684|NCT00699582|26768469|FG000|Overall Study|Randomized, Not Treated|2|||
13388685|NCT00699582|26768470|FG001|Overall Study|Randomized, Not Treated|1|||
13388686|NCT00699582|26768471|FG002|Overall Study|Randomized, Not Treated|0|||
13388687|NCT00699413|26768490|FG000|Overall Study|Withdrawal by Subject|0|||
13388688|NCT00699413|26768491|FG001|Overall Study|Withdrawal by Subject|2|||
13388689|NCT00699413|26768490|FG000|Overall Study|Study terminated by sponsor|4|||
13388690|NCT00699413|26768491|FG001|Overall Study|Study terminated by sponsor|2|||
13388691|NCT00699374|26768510|FG000|Overall Study|Death|93|||
13388692|NCT00699374|26768511|FG001|Overall Study|Death|83|||
13388693|NCT00699374|26768510|FG000|Overall Study|Adverse Event|70|||
13388694|NCT00699374|26768511|FG001|Overall Study|Adverse Event|67|||
13388695|NCT00699374|26768510|FG000|Overall Study|Global deterioration of health status|7|||
13388696|NCT00699374|26768511|FG001|Overall Study|Global deterioration of health status|8|||
13388697|NCT00699374|26768510|FG000|Overall Study|Lost to Follow-up|3|||
13388698|NCT00699374|26768511|FG001|Overall Study|Lost to Follow-up|5|||
13388699|NCT00699374|26768510|FG000|Overall Study|Withdrawal by Subject|34|||
13388700|NCT00699374|26768511|FG001|Overall Study|Withdrawal by Subject|44|||
13388701|NCT00699374|26768510|FG000|Overall Study|Objective progression or relapse|281|||
13388702|NCT00699374|26768511|FG001|Overall Study|Objective progression or relapse|277|||
13388703|NCT00699374|26768510|FG000|Overall Study|Other|18|||
13388704|NCT00699374|26768511|FG001|Overall Study|Other|15|||
13388705|NCT00699374|26768510|FG000|Overall Study|Protocol Violation|2|||
13388706|NCT00699374|26768511|FG001|Overall Study|Protocol Violation|6|||
13388707|NCT00699374|26768510|FG000|Overall Study|Study terminated by sponsor|13|||
13388708|NCT00699374|26768511|FG001|Overall Study|Study terminated by sponsor|28|||
13388709|NCT00699374|26768510|FG000|Overall Study|Randomized but not treated|4|||
13388710|NCT00699374|26768511|FG001|Overall Study|Randomized but not treated|2|||
13388711|NCT00699374|26768510|FG000|Overall Study|Died 28 days after last dose|5|||
13388712|NCT00699374|26768511|FG001|Overall Study|Died 28 days after last dose|9|||
13388713|NCT00699348|26768522|FG000|Overall Study|Death|6|||
13388714|NCT00699348|26768522|FG000|Overall Study|Adverse Event|15|||
13388715|NCT00699348|26768522|FG000|Overall Study|Withdrawal by Subject|11|||
13388716|NCT00699348|26768522|FG000|Overall Study|Protocol Violation|10|||
13388717|NCT00699348|26768522|FG000|Overall Study|Lack of Efficacy|8|||
13388718|NCT00699348|26768522|FG000|Overall Study|Failure to return|1|||
13388719|NCT00699348|26768522|FG000|Overall Study|Blood transfusion|24|||
13388720|NCT00699348|26768522|FG000|Overall Study|Renal transplantation|10|||
13388721|NCT00699348|26768522|FG000|Overall Study|Other|5|||
13388722|NCT00699335|26768555|FG000|Overall Study|Combination of multiple reasons|176|||
13388723|NCT00699335|26768555|FG000|Overall Study|Missing data|52|||
13388724|NCT00699283|26768567|FG000|Overall Study|Lack of Efficacy|15|||
13388725|NCT00699283|26768568|FG001|Overall Study|Lack of Efficacy|5|||
13388726|NCT00699283|26768567|FG000|Overall Study|Lost to Follow-up|2|||
13388727|NCT00699283|26768568|FG001|Overall Study|Lost to Follow-up|0|||
13388728|NCT00699283|26768567|FG000|Overall Study|Withdrawal by Subject|1|||
13388729|NCT00699283|26768568|FG001|Overall Study|Withdrawal by Subject|0|||
13388730|NCT00699283|26768567|FG000|Overall Study|Other Reason|5|||
13388731|NCT00699283|26768568|FG001|Overall Study|Other Reason|1|||
13388732|NCT00699283|26768567|FG000|Overall Study|SAE, non-fatal|1|||
13388733|NCT00699283|26768568|FG001|Overall Study|SAE, non-fatal|1|||
13388734|NCT00699283|26768567|FG000|Overall Study|AE, non-serious non-fatal|8|||
13388735|NCT00699283|26768568|FG001|Overall Study|AE, non-serious non-fatal|1|||
13388736|NCT00699283|26768567|FG000|Overall Study|AE of unknown type|1|||
13388737|NCT00699283|26768568|FG001|Overall Study|AE of unknown type|0|||
13388738|NCT00699192|26768598|FG000|Overall Study|Missing|1|||
13388739|NCT00699192|26768599|FG001|Overall Study|Missing|1|||
13395458|NCT00647296|26790479|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
13395459|NCT00647296|26790480|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
13395460|NCT00647296|26790481|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
13395461|NCT00647296|26790482|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
13395462|NCT00647270|26790515|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2|||
13395463|NCT00647270|26790516|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
13395464|NCT00647270|26790517|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
13395465|NCT00647270|26790515|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0|||
13395466|NCT00647270|26790516|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
13395467|NCT00647270|26790517|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
13395468|NCT00647270|26790515|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2|||
13395469|NCT00647270|26790516|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1|||
13395470|NCT00647270|26790517|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7|||
13395471|NCT00647270|26790515|FG000|Period 1, Placebo-control (12 Weeks)|Other|4|||
13395472|NCT00647270|26790516|FG001|Period 1, Placebo-control (12 Weeks)|Other|4|||
13395473|NCT00647270|26790517|FG002|Period 1, Placebo-control (12 Weeks)|Other|8|||
13395474|NCT00647270|26790515|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1|||
13395475|NCT00647270|26790516|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
13395476|NCT00647270|26790517|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
13395477|NCT00647270|26790515|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
13395478|NCT00647270|26790516|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
13395479|NCT00647270|26790517|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4|||
13395480|NCT00647270|26790515|FG000|Period 2, Placebo Switched to Adalimumab|Other|2|||
13395481|NCT00647270|26790516|FG001|Period 2, Placebo Switched to Adalimumab|Other|6|||
13395482|NCT00647270|26790517|FG002|Period 2, Placebo Switched to Adalimumab|Other|0|||
13395483|NCT00646958|26790538|FG000|Overall Study|Lack of Efficacy|1|||
13395484|NCT00646958|26790539|FG001|Overall Study|Lack of Efficacy|0|||
13395485|NCT00646958|26790540|FG002|Overall Study|Lack of Efficacy|0|||
13395486|NCT00646958|26790538|FG000|Overall Study|Adverse Event|4|||
13395487|NCT00646958|26790539|FG001|Overall Study|Adverse Event|0|||
13395488|NCT00646958|26790540|FG002|Overall Study|Adverse Event|0|||
13395489|NCT00646958|26790538|FG000|Overall Study|Lost to Follow-up|1|||
13395490|NCT00646958|26790539|FG001|Overall Study|Lost to Follow-up|5|||
13395491|NCT00646958|26790540|FG002|Overall Study|Lost to Follow-up|7|||
13395492|NCT00646958|26790538|FG000|Overall Study|Protocol Violation|1|||
13395493|NCT00646958|26790539|FG001|Overall Study|Protocol Violation|1|||
13395494|NCT00646958|26790540|FG002|Overall Study|Protocol Violation|0|||
13395495|NCT00646958|26790538|FG000|Overall Study|Abnormal screening lab tests|1|||
13395496|NCT00646958|26790539|FG001|Overall Study|Abnormal screening lab tests|1|||
13395497|NCT00646958|26790540|FG002|Overall Study|Abnormal screening lab tests|0|||
13395498|NCT00646958|26790538|FG000|Overall Study|Withdrawal by Subject|1|||
13395499|NCT00646958|26790539|FG001|Overall Study|Withdrawal by Subject|2|||
13395500|NCT00646958|26790540|FG002|Overall Study|Withdrawal by Subject|0|||
13395501|NCT00646958|26790538|FG000|Overall Study|Did not receive study drug|2|||
13395502|NCT00646958|26790539|FG001|Overall Study|Did not receive study drug|0|||
13388740|NCT00699192|26768600|FG002|Overall Study|Missing|1|||
13388741|NCT00699192|26768598|FG000|Overall Study|Adverse Event|9|||
13388742|NCT00699192|26768599|FG001|Overall Study|Adverse Event|4|||
13388743|NCT00699192|26768600|FG002|Overall Study|Adverse Event|3|||
13388744|NCT00699192|26768598|FG000|Overall Study|Abnormal test procedure result(s)|0|||
13388745|NCT00699192|26768599|FG001|Overall Study|Abnormal test procedure result(s)|0|||
13388746|NCT00699192|26768600|FG002|Overall Study|Abnormal test procedure result(s)|1|||
13388747|NCT00699192|26768598|FG000|Overall Study|Lack of Efficacy|0|||
13388748|NCT00699192|26768599|FG001|Overall Study|Lack of Efficacy|0|||
13388749|NCT00699192|26768600|FG002|Overall Study|Lack of Efficacy|1|||
13388750|NCT00699192|26768598|FG000|Overall Study|Withdrawal by Subject|3|||
13388751|NCT00699192|26768599|FG001|Overall Study|Withdrawal by Subject|2|||
13388752|NCT00699192|26768600|FG002|Overall Study|Withdrawal by Subject|4|||
13388753|NCT00699192|26768598|FG000|Overall Study|Administrative problems|1|||
13388754|NCT00699192|26768599|FG001|Overall Study|Administrative problems|3|||
13388755|NCT00699192|26768600|FG002|Overall Study|Administrative problems|1|||
13388756|NCT00699192|26768598|FG000|Overall Study|Protocol Violation|2|||
13388757|NCT00699192|26768599|FG001|Overall Study|Protocol Violation|2|||
13388758|NCT00699192|26768600|FG002|Overall Study|Protocol Violation|0|||
13388759|NCT00699153|26768619|FG000|Overall Study|Lost to Follow-up|1|||
13388760|NCT00699153|26768620|FG001|Overall Study|Lost to Follow-up|0|||
13388761|NCT00699153|26768619|FG000|Overall Study|Adverse Event|0|||
13388762|NCT00699153|26768620|FG001|Overall Study|Adverse Event|2|||
13388763|NCT00699153|26768619|FG000|Overall Study|Protocol Violation|1|||
13388764|NCT00699153|26768620|FG001|Overall Study|Protocol Violation|0|||
13388765|NCT00699153|26768619|FG000|Overall Study|Travel Problem|1|||
13388766|NCT00699153|26768620|FG001|Overall Study|Travel Problem|0|||
13388767|NCT00698997|26768639|FG000|Overall Study|Lost to Follow-up|3|||
13388768|NCT00698997|26768640|FG001|Overall Study|Lost to Follow-up|0|||
13388769|NCT00698997|26768639|FG000|Overall Study|Withdrawal by Subject|7|||
13388770|NCT00698997|26768640|FG001|Overall Study|Withdrawal by Subject|27|||
13388771|NCT00698932|26768663|FG000|Overall Study|Adverse Event|0|||
13388772|NCT00698932|26768664|FG001|Overall Study|Adverse Event|2|||
13388773|NCT00698932|26768663|FG000|Overall Study|Incorrect enrollment|0|||
13388774|NCT00698932|26768664|FG001|Overall Study|Incorrect enrollment|2|||
13388775|NCT00698932|26768663|FG000|Overall Study|Study specific discontinuation criteria|3|||
13388776|NCT00698932|26768664|FG001|Overall Study|Study specific discontinuation criteria|4|||
13388777|NCT00698932|26768663|FG000|Overall Study|Withdrawal by Subject|11|||
13388778|NCT00698932|26768664|FG001|Overall Study|Withdrawal by Subject|23|||
13388779|NCT00698932|26768663|FG000|Overall Study|Lost to Follow-up|6|||
13388780|NCT00698932|26768664|FG001|Overall Study|Lost to Follow-up|1|||
13388781|NCT00698932|26768663|FG000|Overall Study|Severe non-compliance to protocol|1|||
13388782|NCT00698932|26768664|FG001|Overall Study|Severe non-compliance to protocol|2|||
13388783|NCT00698932|26768663|FG000|Overall Study|Safety reasons|0|||
13388784|NCT00698932|26768664|FG001|Overall Study|Safety reasons|2|||
13388785|NCT00698932|26768663|FG000|Overall Study|Death|1|||
13388786|NCT00698932|26768664|FG001|Overall Study|Death|0|||
13388787|NCT00698841|26768677|FG000|Overall Study|Withdrawal by Subject|2|||
13388788|NCT00698841|26768677|FG000|Overall Study|Adverse Event|3|||
13388789|NCT00698841|26768677|FG000|Overall Study|Disease progression|7|||
13388790|NCT00698841|26768677|FG000|Overall Study|Failure to meet eligibility criteria|2|||
13388791|NCT00698841|26768677|FG000|Overall Study|Study drug toxicity|2|||
13388792|NCT00698841|26768677|FG000|Overall Study|Other|2|||
13388793|NCT00698828|26768719|FG000|Overall Study|Adverse Event|3|||
13388794|NCT00698828|26768720|FG001|Overall Study|Adverse Event|4|||
13388795|NCT00698828|26768721|FG002|Overall Study|Adverse Event|4|||
13388796|NCT00698828|26768719|FG000|Overall Study|Death|0|||
13388797|NCT00698828|26768720|FG001|Overall Study|Death|0|||
13388798|NCT00698828|26768721|FG002|Overall Study|Death|1|||
13388799|NCT00698828|26768719|FG000|Overall Study|Exacerbation of COPD|1|||
13388800|NCT00698828|26768720|FG001|Overall Study|Exacerbation of COPD|3|||
13388801|NCT00698828|26768721|FG002|Overall Study|Exacerbation of COPD|0|||
13388802|NCT00698828|26768719|FG000|Overall Study|Exacerbation of COPD (Not treated)|1|||
13388803|NCT00698828|26768720|FG001|Overall Study|Exacerbation of COPD (Not treated)|0|||
13388804|NCT00698828|26768721|FG002|Overall Study|Exacerbation of COPD (Not treated)|0|||
13388805|NCT00698828|26768719|FG000|Overall Study|Investigator/Sponsor decision|1|||
13388806|NCT00698828|26768720|FG001|Overall Study|Investigator/Sponsor decision|0|||
13388807|NCT00698828|26768721|FG002|Overall Study|Investigator/Sponsor decision|2|||
13388808|NCT00698828|26768719|FG000|Overall Study|Lost to Follow-up|1|||
13388809|NCT00698828|26768720|FG001|Overall Study|Lost to Follow-up|1|||
13388810|NCT00698828|26768721|FG002|Overall Study|Lost to Follow-up|0|||
13388811|NCT00698828|26768719|FG000|Overall Study|Withdrew consent|0|||
13388812|NCT00698828|26768720|FG001|Overall Study|Withdrew consent|7|||
13388813|NCT00698828|26768721|FG002|Overall Study|Withdrew consent|4|||
13388814|NCT00698828|26768719|FG000|Overall Study|Withdrew consent (not treated)|2|||
13388815|NCT00698828|26768720|FG001|Overall Study|Withdrew consent (not treated)|0|||
13388816|NCT00698828|26768721|FG002|Overall Study|Withdrew consent (not treated)|0|||
13388817|NCT00698815|26768748|FG000|Overall Study|Death|1|||
13388818|NCT00698815|26768749|FG001|Overall Study|Death|2|||
13388819|NCT00698815|26768750|FG002|Overall Study|Death|4|||
13388820|NCT00698815|26768748|FG000|Overall Study|Withdrawal by Subject|6|||
13388821|NCT00698815|26768749|FG001|Overall Study|Withdrawal by Subject|3|||
13388822|NCT00698815|26768750|FG002|Overall Study|Withdrawal by Subject|2|||
13388823|NCT00698815|26768748|FG000|Overall Study|MD discretion|2|||
13388824|NCT00698815|26768749|FG001|Overall Study|MD discretion|7|||
13388825|NCT00698815|26768750|FG002|Overall Study|MD discretion|2|||
13388826|NCT00698815|26768748|FG000|Overall Study|Did not receive protocol treatment|1|||
13388827|NCT00698815|26768749|FG001|Overall Study|Did not receive protocol treatment|2|||
13388828|NCT00698815|26768750|FG002|Overall Study|Did not receive protocol treatment|2|||
13388829|NCT00698685|26768757|FG000|Overall Study|Sister withdrew as donor|1|||
13388830|NCT00698685|26768757|FG000|Overall Study|Off study pre transplant by clinic MD|1|||
13388831|NCT00698646|26768790|FG000|Overall Study|Adverse Event|8|||
13388832|NCT00698646|26768791|FG001|Overall Study|Adverse Event|7|||
13388833|NCT00698646|26768792|FG002|Overall Study|Adverse Event|8|||
13388834|NCT00698646|26768790|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11|||
13388835|NCT00698646|26768791|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11|||
13388836|NCT00698646|26768792|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7|||
13388837|NCT00698646|26768790|FG000|Overall Study|Protocol Deviation|6|||
13388838|NCT00698646|26768791|FG001|Overall Study|Protocol Deviation|2|||
13388839|NCT00698646|26768792|FG002|Overall Study|Protocol Deviation|3|||
13388840|NCT00698646|26768790|FG000|Overall Study|Withdrawal by Subject|10|||
13388841|NCT00698646|26768791|FG001|Overall Study|Withdrawal by Subject|11|||
13388842|NCT00698646|26768792|FG002|Overall Study|Withdrawal by Subject|8|||
13388843|NCT00698646|26768790|FG000|Overall Study|Lost to Follow-up|0|||
13388844|NCT00698646|26768791|FG001|Overall Study|Lost to Follow-up|0|||
13388845|NCT00698646|26768792|FG002|Overall Study|Lost to Follow-up|2|||
13388846|NCT00698646|26768790|FG000|Overall Study|Administrative problems|1|||
13388847|NCT00698646|26768791|FG001|Overall Study|Administrative problems|0|||
13388848|NCT00698646|26768792|FG002|Overall Study|Administrative problems|1|||
13388849|NCT00698581|26768810|FG000|Overall Study|Lack of Efficacy|23|||
13388850|NCT00698581|26768811|FG001|Overall Study|Lack of Efficacy|11|||
13388851|NCT00698581|26768810|FG000|Overall Study|Withdrawal by Subject|6|||
13388852|NCT00698581|26768811|FG001|Overall Study|Withdrawal by Subject|0|||
13388853|NCT00698581|26768810|FG000|Overall Study|Other reason|9|||
13388854|NCT00698581|26768811|FG001|Overall Study|Other reason|1|||
13388855|NCT00698581|26768810|FG000|Overall Study|SAE, non-fatal|1|||
13388856|NCT00698581|26768811|FG001|Overall Study|SAE, non-fatal|0|||
13388857|NCT00698581|26768810|FG000|Overall Study|AE, non-serious non-fatal|4|||
13388858|NCT00698581|26768811|FG001|Overall Study|AE, non-serious non-fatal|0|||
13388859|NCT00698581|26768810|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
13388860|NCT00698581|26768811|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
13388861|NCT00698581|26768810|FG000|Overall Study|AE of unknown type|1|||
13388862|NCT00698581|26768811|FG001|Overall Study|AE of unknown type|0|||
13388863|NCT00698516|26768831|FG000|Overall Study|Study Termination|2|||
13388864|NCT00698516|26768831|FG000|Overall Study|Withdrawal by Subject|3|||
13388865|NCT00698451|26768838|FG000|Overall Study|Adverse Event|22|||
13388866|NCT00698451|26768838|FG000|Overall Study|Physician Decision|2|||
13388867|NCT00698451|26768838|FG000|Overall Study|Protocol Violation|6|||
13388868|NCT00698451|26768838|FG000|Overall Study|Withdrawal by Subject|6|||
13388869|NCT00698451|26768838|FG000|Overall Study|Disease progression|3|||
13388870|NCT00698204|26768853|FG000|Overall Study|Withdrawal by Subject|1|||
13388871|NCT00698204|26768854|FG001|Overall Study|Withdrawal by Subject|0|||
13388872|NCT00698009|26768860|FG000|Overall Study|Withdrawal by Subject|1|||
13388873|NCT00697827|26768875|FG000|Overall Study|enrolled but not treated|2|||
13388874|NCT00697827|26768876|FG001|Overall Study|enrolled but not treated|1|||
13388875|NCT00697788|26768927|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
13388876|NCT00697788|26768928|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2|||
13388877|NCT00697788|26768929|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
13388878|NCT00697788|26768930|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
13388879|NCT00697788|26768931|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
13388880|NCT00697788|26768932|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
13388881|NCT00697788|26768933|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
13388882|NCT00697788|26768934|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
13388883|NCT00697788|26768927|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
13388884|NCT00697788|26768928|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
13388885|NCT00697788|26768929|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
13388886|NCT00697788|26768930|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
13388887|NCT00697788|26768931|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1|||
13388888|NCT00697788|26768932|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
13388889|NCT00697788|26768933|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
13388890|NCT00697788|26768934|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
13395503|NCT00646958|26790540|FG002|Overall Study|Did not receive study drug|2|||
13395504|NCT00646906|26790573|FG000|Crossover Period 1|Withdrawal by Subject|1|||
13395505|NCT00646906|26790574|FG001|Crossover Period 1|Withdrawal by Subject|0|||
13388891|NCT00697619|26768947|FG000|Overall Study|Lack of Efficacy|2|||
13388892|NCT00697619|26768948|FG001|Overall Study|Lack of Efficacy|2|||
13388893|NCT00697619|26768947|FG000|Overall Study|Adverse Event|4|||
13388894|NCT00697619|26768948|FG001|Overall Study|Adverse Event|6|||
13388895|NCT00697593|26768981|FG000|Overall Study|Adverse Event|3|||
13388896|NCT00697593|26768981|FG000|Overall Study|Protocol Violation|1|||
13388897|NCT00697593|26768981|FG000|Overall Study|Lack of Efficacy|3|||
13388898|NCT00697593|26768981|FG000|Overall Study|Suspension of the study by sponsor|12|||
13388899|NCT00697515|26769012|FG000|Dose Optimization Period|Adverse Event|4|||
13388900|NCT00697515|26769013|FG001|Dose Optimization Period|Adverse Event|0|||
13388901|NCT00697515|26769012|FG000|Dose Optimization Period|Withdrawal by Subject|5|||
13388902|NCT00697515|26769013|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
13388903|NCT00697515|26769012|FG000|Dose Optimization Period|Lost to Follow-up|2|||
13388904|NCT00697515|26769013|FG001|Dose Optimization Period|Lost to Follow-up|0|||
13388905|NCT00697515|26769012|FG000|Dose Optimization Period|sponsor request|2|||
13388906|NCT00697515|26769013|FG001|Dose Optimization Period|sponsor request|0|||
13388907|NCT00697515|26769012|FG000|Dose Optimization Period|called to active duty|1|||
13388908|NCT00697515|26769013|FG001|Dose Optimization Period|called to active duty|0|||
13388909|NCT00697515|26769012|FG000|Dose Optimization Period|elevated QTc|1|||
13388910|NCT00697515|26769013|FG001|Dose Optimization Period|elevated QTc|0|||
13388911|NCT00697515|26769012|FG000|First Intervention (Crossover Period)|Natural disaster|8|||
13388912|NCT00697515|26769013|FG001|First Intervention (Crossover Period)|Natural disaster|9|||
13388913|NCT00697515|26769012|FG000|First Intervention (Crossover Period)|Adverse Event|0|||
13388914|NCT00697515|26769013|FG001|First Intervention (Crossover Period)|Adverse Event|2|||
13388915|NCT00697515|26769012|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2|||
13388916|NCT00697515|26769013|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1|||
13388917|NCT00697515|26769012|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
13388918|NCT00697515|26769013|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
13388919|NCT00697463|26769019|FG000|Overall Study|Withdrawal by Subject|1|||
13388920|NCT00697346|26769135|FG000|Overall Study|Adverse Event|4|||
13388921|NCT00697346|26769136|FG001|Overall Study|Adverse Event|5|||
13388922|NCT00697346|26769137|FG002|Overall Study|Adverse Event|0|||
13388923|NCT00697346|26769135|FG000|Overall Study|Progressive Disease|19|||
13388924|NCT00697346|26769136|FG001|Overall Study|Progressive Disease|18|||
13388925|NCT00697346|26769137|FG002|Overall Study|Progressive Disease|0|||
13388926|NCT00697346|26769135|FG000|Overall Study|Symptomatic Deterioration|0|||
13388927|NCT00697346|26769136|FG001|Overall Study|Symptomatic Deterioration|1|||
13388928|NCT00697346|26769137|FG002|Overall Study|Symptomatic Deterioration|0|||
13388929|NCT00697346|26769135|FG000|Overall Study|Withdrawal by Subject|2|||
13388930|NCT00697346|26769136|FG001|Overall Study|Withdrawal by Subject|2|||
13388931|NCT00697346|26769137|FG002|Overall Study|Withdrawal by Subject|0|||
13388932|NCT00697346|26769135|FG000|Overall Study|Reason not Specified|3|||
13388933|NCT00697346|26769136|FG001|Overall Study|Reason not Specified|0|||
13388934|NCT00697346|26769137|FG002|Overall Study|Reason not Specified|1|||
13388935|NCT00697112|26769163|FG000|Overall Study|Adverse Event|8|||
13388936|NCT00697112|26769163|FG000|Overall Study|Lost to Follow-up|1|||
13388937|NCT00697112|26769163|FG000|Overall Study|Did not meet inclusion criteria|1|||
13388938|NCT00697073|26769169|FG000|Overall Study|Withdrawal by Subject|2|||
13388939|NCT00697073|26769169|FG000|Overall Study|Pregnancy|1|||
13388940|NCT00697073|26769169|FG000|Overall Study|non compliance and other|6|||
13388941|NCT00696787|26769190|FG000|Overall Study|Adverse Event|1|||
13388942|NCT00696787|26769191|FG001|Overall Study|Adverse Event|0|||
13388943|NCT00696787|26769192|FG002|Overall Study|Adverse Event|6|||
13388944|NCT00696787|26769190|FG000|Overall Study|Discontinuation by Sponsor|9|||
13388945|NCT00696787|26769191|FG001|Overall Study|Discontinuation by Sponsor|13|||
13388946|NCT00696787|26769192|FG002|Overall Study|Discontinuation by Sponsor|14|||
13388947|NCT00696787|26769190|FG000|Overall Study|Lack of Efficacy|0|||
13388948|NCT00696787|26769191|FG001|Overall Study|Lack of Efficacy|1|||
13388949|NCT00696787|26769192|FG002|Overall Study|Lack of Efficacy|0|||
13388950|NCT00696787|26769190|FG000|Overall Study|Lost to Follow-up|4|||
13388951|NCT00696787|26769191|FG001|Overall Study|Lost to Follow-up|0|||
13388952|NCT00696787|26769192|FG002|Overall Study|Lost to Follow-up|3|||
13388953|NCT00696787|26769190|FG000|Overall Study|Withdrawal by Subject|0|||
13388954|NCT00696787|26769191|FG001|Overall Study|Withdrawal by Subject|3|||
13388955|NCT00696787|26769192|FG002|Overall Study|Withdrawal by Subject|2|||
13388956|NCT00696787|26769190|FG000|Overall Study|Failed to return|1|||
13388957|NCT00696787|26769191|FG001|Overall Study|Failed to return|3|||
13388958|NCT00696787|26769192|FG002|Overall Study|Failed to return|1|||
13388959|NCT00696774|26769236|FG000|Period II|Adverse Event|0|||
13388960|NCT00696774|26769237|FG001|Period II|Adverse Event|0|||
13388961|NCT00696774|26769238|FG002|Period II|Adverse Event|15|||
13388962|NCT00696774|26769236|FG000|Period II|Lost to Follow-up|0|||
13388963|NCT00696774|26769237|FG001|Period II|Lost to Follow-up|0|||
13388964|NCT00696774|26769238|FG002|Period II|Lost to Follow-up|4|||
13388965|NCT00696774|26769236|FG000|Period II|Protocol Violation|0|||
13388966|NCT00696774|26769237|FG001|Period II|Protocol Violation|0|||
13388967|NCT00696774|26769238|FG002|Period II|Protocol Violation|11|||
13388968|NCT00696774|26769236|FG000|Period II|Withdrawal by Subject|0|||
13388969|NCT00696774|26769237|FG001|Period II|Withdrawal by Subject|0|||
13388970|NCT00696774|26769238|FG002|Period II|Withdrawal by Subject|4|||
13388971|NCT00696774|26769236|FG000|Period II|Sponsor Decision|0|||
13388972|NCT00696774|26769237|FG001|Period II|Sponsor Decision|0|||
13388973|NCT00696774|26769238|FG002|Period II|Sponsor Decision|0|||
13388974|NCT00696774|26769236|FG000|Period II|Lack of Efficacy|0|||
13388975|NCT00696774|26769237|FG001|Period II|Lack of Efficacy|0|||
13388976|NCT00696774|26769238|FG002|Period II|Lack of Efficacy|2|||
13388977|NCT00696774|26769236|FG000|Period III|Adverse Event|1|||
13388978|NCT00696774|26769237|FG001|Period III|Adverse Event|1|||
13388979|NCT00696774|26769238|FG002|Period III|Adverse Event|0|||
13388980|NCT00696774|26769236|FG000|Period III|Lost to Follow-up|2|||
13388981|NCT00696774|26769237|FG001|Period III|Lost to Follow-up|1|||
13388982|NCT00696774|26769238|FG002|Period III|Lost to Follow-up|0|||
13388983|NCT00696774|26769236|FG000|Period III|Protocol Violation|1|||
13388984|NCT00696774|26769237|FG001|Period III|Protocol Violation|1|||
13388985|NCT00696774|26769238|FG002|Period III|Protocol Violation|0|||
13388986|NCT00696774|26769236|FG000|Period III|Withdrawal by Subject|1|||
13388987|NCT00696774|26769237|FG001|Period III|Withdrawal by Subject|2|||
13388988|NCT00696774|26769238|FG002|Period III|Withdrawal by Subject|0|||
13388989|NCT00696774|26769236|FG000|Period III|Sponsor Decision|2|||
13388990|NCT00696774|26769237|FG001|Period III|Sponsor Decision|0|||
13388991|NCT00696774|26769238|FG002|Period III|Sponsor Decision|0|||
13388992|NCT00696774|26769236|FG000|Period III|Lack of Efficacy|0|||
13388993|NCT00696774|26769237|FG001|Period III|Lack of Efficacy|2|||
13388994|NCT00696774|26769238|FG002|Period III|Lack of Efficacy|0|||
13388995|NCT00696709|26769290|FG000|Overall Study|Withdrawal by Subject|1|||
13388996|NCT00696709|26769291|FG001|Overall Study|Withdrawal by Subject|2|||
13388997|NCT00696709|26769292|FG002|Overall Study|Withdrawal by Subject|1|||
13388998|NCT00696709|26769293|FG003|Overall Study|Withdrawal by Subject|4|||
13388999|NCT00696709|26769294|FG004|Overall Study|Withdrawal by Subject|3|||
13389000|NCT00696709|26769290|FG000|Overall Study|Protocol Violation|1|||
13389001|NCT00696709|26769291|FG001|Overall Study|Protocol Violation|0|||
13389002|NCT00696709|26769292|FG002|Overall Study|Protocol Violation|0|||
13389003|NCT00696709|26769293|FG003|Overall Study|Protocol Violation|0|||
13389004|NCT00696709|26769294|FG004|Overall Study|Protocol Violation|0|||
13389005|NCT00696709|26769290|FG000|Overall Study|Lost to Follow-up|1|||
13389006|NCT00696709|26769291|FG001|Overall Study|Lost to Follow-up|1|||
13389007|NCT00696709|26769292|FG002|Overall Study|Lost to Follow-up|0|||
13389008|NCT00696709|26769293|FG003|Overall Study|Lost to Follow-up|0|||
13389009|NCT00696709|26769294|FG004|Overall Study|Lost to Follow-up|0|||
13389010|NCT00696709|26769290|FG000|Overall Study|Adverse Event|0|||
13389011|NCT00696709|26769291|FG001|Overall Study|Adverse Event|0|||
13389012|NCT00696709|26769292|FG002|Overall Study|Adverse Event|0|||
13389013|NCT00696709|26769293|FG003|Overall Study|Adverse Event|1|||
13389014|NCT00696709|26769294|FG004|Overall Study|Adverse Event|0|||
13389015|NCT00696696|26769302|FG000|Overall Study|Adverse Event|5|||
13389016|NCT00696696|26769302|FG000|Overall Study|Withdrawal by Subject|8|||
13389017|NCT00696696|26769302|FG000|Overall Study|Physician Decision|2|||
13389018|NCT00696696|26769302|FG000|Overall Study|Death|3|||
13389019|NCT00696657|26769654|FG000|Overall Study|Protocol Violation|0|||
13389020|NCT00696657|26769655|FG001|Overall Study|Protocol Violation|0|||
13389021|NCT00696657|26769656|FG002|Overall Study|Protocol Violation|0|||
13389022|NCT00696657|26769657|FG003|Overall Study|Protocol Violation|0|||
13389023|NCT00696657|26769658|FG004|Overall Study|Protocol Violation|0|||
13389024|NCT00696657|26769659|FG005|Overall Study|Protocol Violation|1|||
13389025|NCT00696657|26769660|FG006|Overall Study|Protocol Violation|0|||
13389026|NCT00696657|26769661|FG007|Overall Study|Protocol Violation|0|||
13389027|NCT00696657|26769662|FG008|Overall Study|Protocol Violation|1|||
13389028|NCT00696657|26769654|FG000|Overall Study|Lack of Efficacy|0|||
13389029|NCT00696657|26769655|FG001|Overall Study|Lack of Efficacy|1|||
13389030|NCT00696657|26769656|FG002|Overall Study|Lack of Efficacy|0|||
13389031|NCT00696657|26769657|FG003|Overall Study|Lack of Efficacy|0|||
13389032|NCT00696657|26769658|FG004|Overall Study|Lack of Efficacy|0|||
13389033|NCT00696657|26769659|FG005|Overall Study|Lack of Efficacy|0|||
13389034|NCT00696657|26769660|FG006|Overall Study|Lack of Efficacy|0|||
13389035|NCT00696657|26769661|FG007|Overall Study|Lack of Efficacy|0|||
13389036|NCT00696657|26769662|FG008|Overall Study|Lack of Efficacy|0|||
13389037|NCT00696657|26769654|FG000|Overall Study|Withdrawal criteria|1|||
13389038|NCT00696657|26769655|FG001|Overall Study|Withdrawal criteria|3|||
13389039|NCT00696657|26769656|FG002|Overall Study|Withdrawal criteria|2|||
13389040|NCT00696657|26769657|FG003|Overall Study|Withdrawal criteria|2|||
13389041|NCT00696657|26769658|FG004|Overall Study|Withdrawal criteria|0|||
13389042|NCT00696657|26769659|FG005|Overall Study|Withdrawal criteria|0|||
13389043|NCT00696657|26769660|FG006|Overall Study|Withdrawal criteria|1|||
13389044|NCT00696657|26769661|FG007|Overall Study|Withdrawal criteria|1|||
13389045|NCT00696657|26769662|FG008|Overall Study|Withdrawal criteria|2|||
13389046|NCT00696657|26769654|FG000|Overall Study|Unclassified|0|||
13389047|NCT00696657|26769655|FG001|Overall Study|Unclassified|1|||
13389048|NCT00696657|26769656|FG002|Overall Study|Unclassified|3|||
13389049|NCT00696657|26769657|FG003|Overall Study|Unclassified|2|||
13389050|NCT00696657|26769658|FG004|Overall Study|Unclassified|4|||
13389051|NCT00696657|26769659|FG005|Overall Study|Unclassified|2|||
13389052|NCT00696657|26769660|FG006|Overall Study|Unclassified|0|||
13389053|NCT00696657|26769661|FG007|Overall Study|Unclassified|0|||
13389054|NCT00696657|26769662|FG008|Overall Study|Unclassified|1|||
13389055|NCT00696657|26769654|FG000|Overall Study|Adverse Event|0|||
13389056|NCT00696657|26769655|FG001|Overall Study|Adverse Event|0|||
13389057|NCT00696657|26769656|FG002|Overall Study|Adverse Event|3|||
13389058|NCT00696657|26769657|FG003|Overall Study|Adverse Event|7|||
13389059|NCT00696657|26769658|FG004|Overall Study|Adverse Event|6|||
13389060|NCT00696657|26769659|FG005|Overall Study|Adverse Event|9|||
13389061|NCT00696657|26769660|FG006|Overall Study|Adverse Event|14|||
13389062|NCT00696657|26769661|FG007|Overall Study|Adverse Event|2|||
13389063|NCT00696657|26769662|FG008|Overall Study|Adverse Event|5|||
13389064|NCT00696436|26769760|FG000|Overall Study|Adverse Event|7|||
13389065|NCT00696436|26769761|FG001|Overall Study|Adverse Event|9|||
13389066|NCT00696436|26769762|FG002|Overall Study|Adverse Event|8|||
13389067|NCT00696436|26769763|FG003|Overall Study|Adverse Event|6|||
13389068|NCT00696436|26769764|FG004|Overall Study|Adverse Event|4|||
13389069|NCT00696436|26769760|FG000|Overall Study|Protocol Violation|3|||
13389070|NCT00696436|26769761|FG001|Overall Study|Protocol Violation|2|||
13389071|NCT00696436|26769762|FG002|Overall Study|Protocol Violation|2|||
13389072|NCT00696436|26769763|FG003|Overall Study|Protocol Violation|0|||
13389073|NCT00696436|26769764|FG004|Overall Study|Protocol Violation|1|||
13389074|NCT00696436|26769760|FG000|Overall Study|Lost to Follow-up|1|||
13389075|NCT00696436|26769761|FG001|Overall Study|Lost to Follow-up|6|||
13389076|NCT00696436|26769762|FG002|Overall Study|Lost to Follow-up|2|||
13389077|NCT00696436|26769763|FG003|Overall Study|Lost to Follow-up|4|||
13389078|NCT00696436|26769764|FG004|Overall Study|Lost to Follow-up|3|||
13389079|NCT00696436|26769760|FG000|Overall Study|Withdrawal by Subject|4|||
13389080|NCT00696436|26769761|FG001|Overall Study|Withdrawal by Subject|11|||
13389081|NCT00696436|26769762|FG002|Overall Study|Withdrawal by Subject|5|||
13389082|NCT00696436|26769763|FG003|Overall Study|Withdrawal by Subject|7|||
13389083|NCT00696436|26769764|FG004|Overall Study|Withdrawal by Subject|1|||
13389084|NCT00696436|26769760|FG000|Overall Study|Lack of Efficacy|3|||
13389085|NCT00696436|26769761|FG001|Overall Study|Lack of Efficacy|1|||
13389086|NCT00696436|26769762|FG002|Overall Study|Lack of Efficacy|5|||
13389087|NCT00696436|26769763|FG003|Overall Study|Lack of Efficacy|2|||
13389088|NCT00696436|26769764|FG004|Overall Study|Lack of Efficacy|4|||
13389089|NCT00696436|26769760|FG000|Overall Study|Participant Unavailability|2|||
13389090|NCT00696436|26769761|FG001|Overall Study|Participant Unavailability|0|||
13389091|NCT00696436|26769762|FG002|Overall Study|Participant Unavailability|2|||
13389092|NCT00696436|26769763|FG003|Overall Study|Participant Unavailability|1|||
13389093|NCT00696436|26769764|FG004|Overall Study|Participant Unavailability|0|||
13389094|NCT00696436|26769760|FG000|Overall Study|Administrative Error|2|||
13389095|NCT00696436|26769761|FG001|Overall Study|Administrative Error|0|||
13389096|NCT00696436|26769762|FG002|Overall Study|Administrative Error|2|||
13389097|NCT00696436|26769763|FG003|Overall Study|Administrative Error|0|||
13389098|NCT00696436|26769764|FG004|Overall Study|Administrative Error|0|||
13389099|NCT00696436|26769760|FG000|Overall Study|Participant Non-compliance|0|||
13389100|NCT00696436|26769761|FG001|Overall Study|Participant Non-compliance|0|||
13389101|NCT00696436|26769762|FG002|Overall Study|Participant Non-compliance|1|||
13389102|NCT00696436|26769763|FG003|Overall Study|Participant Non-compliance|2|||
13389103|NCT00696436|26769764|FG004|Overall Study|Participant Non-compliance|0|||
13389104|NCT00696436|26769760|FG000|Overall Study|Administrative Decision|1|||
13389105|NCT00696436|26769761|FG001|Overall Study|Administrative Decision|0|||
13389106|NCT00696436|26769762|FG002|Overall Study|Administrative Decision|0|||
13389107|NCT00696436|26769763|FG003|Overall Study|Administrative Decision|0|||
13389108|NCT00696436|26769764|FG004|Overall Study|Administrative Decision|0|||
13389109|NCT00696436|26769760|FG000|Overall Study|Missing|0|||
13389110|NCT00696436|26769761|FG001|Overall Study|Missing|1|||
13389111|NCT00696436|26769762|FG002|Overall Study|Missing|1|||
13389112|NCT00696436|26769763|FG003|Overall Study|Missing|0|||
13389113|NCT00696436|26769764|FG004|Overall Study|Missing|0|||
13389114|NCT00696423|26769801|FG000|Overall Study|Lost to Follow-up|0|||
13389115|NCT00696423|26769802|FG001|Overall Study|Lost to Follow-up|5|||
13389116|NCT00696410|26769823|FG000|Overall Study|Lost to Follow-up|2|||
13389117|NCT00696410|26769824|FG001|Overall Study|Lost to Follow-up|0|||
13389118|NCT00696410|26769823|FG000|Overall Study|Withdrawal by Subject|8|||
13389119|NCT00696410|26769824|FG001|Overall Study|Withdrawal by Subject|0|||
13389120|NCT00696410|26769823|FG000|Overall Study|Physician Decision|3|||
13389121|NCT00696410|26769824|FG001|Overall Study|Physician Decision|0|||
13389122|NCT00696384|26769842|FG000|Open Label Phase|Adverse Event|27|||
13389123|NCT00696384|26769843|FG001|Open Label Phase|Adverse Event|0|||
13389124|NCT00696384|26769844|FG002|Open Label Phase|Adverse Event|0|||
13389125|NCT00696384|26769842|FG000|Open Label Phase|Protocol Violation|18|||
13389126|NCT00696384|26769843|FG001|Open Label Phase|Protocol Violation|0|||
13389127|NCT00696384|26769844|FG002|Open Label Phase|Protocol Violation|0|||
13389128|NCT00696384|26769842|FG000|Open Label Phase|Lost to Follow-up|24|||
13389129|NCT00696384|26769843|FG001|Open Label Phase|Lost to Follow-up|0|||
13389130|NCT00696384|26769844|FG002|Open Label Phase|Lost to Follow-up|0|||
13389131|NCT00696384|26769842|FG000|Open Label Phase|Withdrawal by Subject|37|||
13389132|NCT00696384|26769843|FG001|Open Label Phase|Withdrawal by Subject|0|||
13389133|NCT00696384|26769844|FG002|Open Label Phase|Withdrawal by Subject|0|||
13389134|NCT00696384|26769842|FG000|Open Label Phase|Other|6|||
13389135|NCT00696384|26769843|FG001|Open Label Phase|Other|0|||
13389136|NCT00696384|26769844|FG002|Open Label Phase|Other|0|||
13389137|NCT00696384|26769842|FG000|Open Label Phase|Lack of Efficacy|3|||
13389138|NCT00696384|26769843|FG001|Open Label Phase|Lack of Efficacy|0|||
13389139|NCT00696384|26769844|FG002|Open Label Phase|Lack of Efficacy|0|||
13389140|NCT00696384|26769842|FG000|Open Label Phase|Physician Decision|4|||
13389141|NCT00696384|26769843|FG001|Open Label Phase|Physician Decision|0|||
13389142|NCT00696384|26769844|FG002|Open Label Phase|Physician Decision|0|||
13389143|NCT00696384|26769842|FG000|Double Blind Phase|Adverse Event|0|||
13389144|NCT00696384|26769843|FG001|Double Blind Phase|Adverse Event|2|||
13389145|NCT00696384|26769844|FG002|Double Blind Phase|Adverse Event|2|||
13389146|NCT00696384|26769842|FG000|Double Blind Phase|Lost to Follow-up|0|||
13389147|NCT00696384|26769843|FG001|Double Blind Phase|Lost to Follow-up|2|||
13389148|NCT00696384|26769844|FG002|Double Blind Phase|Lost to Follow-up|1|||
13389149|NCT00696384|26769842|FG000|Double Blind Phase|Withdrawal by Subject|0|||
13389150|NCT00696384|26769843|FG001|Double Blind Phase|Withdrawal by Subject|4|||
13389151|NCT00696384|26769844|FG002|Double Blind Phase|Withdrawal by Subject|3|||
13389152|NCT00696384|26769842|FG000|Double Blind Phase|Lack of Efficacy|0|||
13389153|NCT00696384|26769843|FG001|Double Blind Phase|Lack of Efficacy|1|||
13389154|NCT00696384|26769844|FG002|Double Blind Phase|Lack of Efficacy|0|||
13389155|NCT00696384|26769842|FG000|Double Blind Phase|Physician Decision|0|||
13389156|NCT00696384|26769843|FG001|Double Blind Phase|Physician Decision|2|||
13389157|NCT00696384|26769844|FG002|Double Blind Phase|Physician Decision|0|||
13389158|NCT00696241|26769942|FG000|Overall Study|Adverse Event|11|||
13389159|NCT00696241|26769943|FG001|Overall Study|Adverse Event|3|||
13389160|NCT00696241|26769944|FG002|Overall Study|Adverse Event|6|||
13389161|NCT00696241|26769945|FG003|Overall Study|Adverse Event|4|||
13389162|NCT00696241|26769946|FG004|Overall Study|Adverse Event|5|||
13389163|NCT00696241|26769942|FG000|Overall Study|Protocol Violation|1|||
13389164|NCT00696241|26769943|FG001|Overall Study|Protocol Violation|1|||
13389165|NCT00696241|26769944|FG002|Overall Study|Protocol Violation|2|||
13389166|NCT00696241|26769945|FG003|Overall Study|Protocol Violation|0|||
13389167|NCT00696241|26769946|FG004|Overall Study|Protocol Violation|3|||
13389168|NCT00696241|26769942|FG000|Overall Study|Lost to Follow-up|1|||
13389169|NCT00696241|26769943|FG001|Overall Study|Lost to Follow-up|4|||
13389170|NCT00696241|26769944|FG002|Overall Study|Lost to Follow-up|1|||
13389171|NCT00696241|26769945|FG003|Overall Study|Lost to Follow-up|2|||
13389172|NCT00696241|26769946|FG004|Overall Study|Lost to Follow-up|0|||
13389173|NCT00696241|26769942|FG000|Overall Study|Withdrawal by Subject|4|||
13389174|NCT00696241|26769943|FG001|Overall Study|Withdrawal by Subject|8|||
13389175|NCT00696241|26769944|FG002|Overall Study|Withdrawal by Subject|6|||
13389176|NCT00696241|26769945|FG003|Overall Study|Withdrawal by Subject|1|||
13389177|NCT00696241|26769946|FG004|Overall Study|Withdrawal by Subject|0|||
13389178|NCT00696241|26769942|FG000|Overall Study|Lack of Efficacy|1|||
13389179|NCT00696241|26769943|FG001|Overall Study|Lack of Efficacy|5|||
13389180|NCT00696241|26769944|FG002|Overall Study|Lack of Efficacy|4|||
13389181|NCT00696241|26769945|FG003|Overall Study|Lack of Efficacy|5|||
13389182|NCT00696241|26769946|FG004|Overall Study|Lack of Efficacy|3|||
13389183|NCT00696241|26769942|FG000|Overall Study|Other|6|||
13389184|NCT00696241|26769943|FG001|Overall Study|Other|1|||
13389185|NCT00696241|26769944|FG002|Overall Study|Other|5|||
13389186|NCT00696241|26769945|FG003|Overall Study|Other|2|||
13389187|NCT00696241|26769946|FG004|Overall Study|Other|1|||
13389188|NCT00696137|26769952|FG000|Overall Study|Withdrawal by Subject|2|||
13389189|NCT00696072|26769976|FG000|Overall Study|continuing active treatment|10|||
13389190|NCT00696072|26769977|FG001|Overall Study|continuing active treatment|13|||
13389191|NCT00696072|26769976|FG000|Overall Study|Adverse Event|10|||
13389192|NCT00696072|26769977|FG001|Overall Study|Adverse Event|6|||
13389193|NCT00696072|26769976|FG000|Overall Study|Patient Request|3|||
13389194|NCT00696072|26769977|FG001|Overall Study|Patient Request|7|||
13389195|NCT00696072|26769976|FG000|Overall Study|Investigator Request|1|||
13389196|NCT00696072|26769977|FG001|Overall Study|Investigator Request|4|||
13389197|NCT00696072|26769976|FG000|Overall Study|Sponsor Request|0|||
13389198|NCT00696072|26769977|FG001|Overall Study|Sponsor Request|1|||
13389199|NCT00696072|26769976|FG000|Overall Study|Disease Progression|32|||
13389200|NCT00696072|26769977|FG001|Overall Study|Disease Progression|30|||
13389201|NCT00696072|26769976|FG000|Overall Study|Non-specified|1|||
13389202|NCT00696072|26769977|FG001|Overall Study|Non-specified|2|||
13389203|NCT00696020|26770098|FG000|Overall Study|Adverse Event|3|||
13389204|NCT00696020|26770099|FG001|Overall Study|Adverse Event|1|||
13389205|NCT00696020|26770100|FG002|Overall Study|Adverse Event|2|||
13389206|NCT00696020|26770101|FG003|Overall Study|Adverse Event|1|||
13389207|NCT00696020|26770098|FG000|Overall Study|Lack of Efficacy|1|||
13389208|NCT00696020|26770099|FG001|Overall Study|Lack of Efficacy|0|||
13389209|NCT00696020|26770100|FG002|Overall Study|Lack of Efficacy|0|||
13389210|NCT00696020|26770101|FG003|Overall Study|Lack of Efficacy|0|||
13389211|NCT00696020|26770098|FG000|Overall Study|Protocol Violation|0|||
13389212|NCT00696020|26770099|FG001|Overall Study|Protocol Violation|0|||
13389213|NCT00696020|26770100|FG002|Overall Study|Protocol Violation|0|||
13389214|NCT00696020|26770101|FG003|Overall Study|Protocol Violation|1|||
13389215|NCT00696020|26770098|FG000|Overall Study|Withdrawal by Subject|0|||
13389216|NCT00696020|26770099|FG001|Overall Study|Withdrawal by Subject|1|||
13389217|NCT00696020|26770100|FG002|Overall Study|Withdrawal by Subject|0|||
13389218|NCT00696020|26770101|FG003|Overall Study|Withdrawal by Subject|1|||
13389219|NCT00696020|26770098|FG000|Overall Study|Other not stated above|0|||
13389220|NCT00696020|26770099|FG001|Overall Study|Other not stated above|0|||
13389221|NCT00696020|26770100|FG002|Overall Study|Other not stated above|1|||
13389222|NCT00696020|26770101|FG003|Overall Study|Other not stated above|1|||
13389223|NCT00695955|26770113|FG000|Cohort 1|Adverse Event|26|||
13389224|NCT00695955|26770113|FG000|Cohort 1|Protocol Violation|2|||
13389225|NCT00695955|26770113|FG000|Cohort 1|Lost to Follow-up|30|||
13389226|NCT00695955|26770113|FG000|Cohort 1|Withdrawal by Subject|25|||
13389227|NCT00695955|26770113|FG000|Cohort 1|Lack of Efficacy|3|||
13389228|NCT00695955|26770113|FG000|Cohort 1|Other|16|||
13389229|NCT00695955|26770113|FG000|Cohort 2|Adverse Event|24|||
13389230|NCT00695955|26770113|FG000|Cohort 2|Protocol Violation|5|||
13389231|NCT00695955|26770113|FG000|Cohort 2|Lost to Follow-up|38|||
13389232|NCT00695955|26770113|FG000|Cohort 2|Withdrawal by Subject|28|||
13389233|NCT00695955|26770113|FG000|Cohort 2|Lack of Efficacy|4|||
13389234|NCT00695955|26770113|FG000|Cohort 2|Other|5|||
13389235|NCT00695903|26770132|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0|||
13389236|NCT00695903|26770133|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2|||
13389237|NCT00695903|26770132|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
13389238|NCT00695903|26770133|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
13389239|NCT00695903|26770132|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1|||
13389240|NCT00695903|26770133|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0|||
13389241|NCT00695903|26770132|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
13389242|NCT00695903|26770133|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
13389243|NCT00695903|26770132|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0|||
13389244|NCT00695903|26770133|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1|||
13389245|NCT00695903|26770132|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1|||
13389246|NCT00695903|26770133|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2|||
13389247|NCT00695903|26770132|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1|||
13389248|NCT00695903|26770133|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0|||
13389249|NCT00695903|26770132|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1|||
13389250|NCT00695903|26770133|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0|||
13389251|NCT00695903|26770132|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0|||
13389252|NCT00695903|26770133|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1|||
13389253|NCT00695864|26770141|FG000|Placebo|Withdrawal by Subject|1|||
13389254|NCT00695864|26770141|FG000|Placebo|Physician Decision|4|||
13389255|NCT00695786|26770164|FG000|Overall Study|Adverse Event|0|||
13389256|NCT00695786|26770165|FG001|Overall Study|Adverse Event|3|||
13389257|NCT00695786|26770166|FG002|Overall Study|Adverse Event|4|||
13389258|NCT00695786|26770167|FG003|Overall Study|Adverse Event|2|||
13389259|NCT00695786|26770164|FG000|Overall Study|Lost to Follow-up|0|||
13389260|NCT00695786|26770165|FG001|Overall Study|Lost to Follow-up|5|||
13389261|NCT00695786|26770166|FG002|Overall Study|Lost to Follow-up|1|||
13389262|NCT00695786|26770167|FG003|Overall Study|Lost to Follow-up|1|||
13389263|NCT00695786|26770164|FG000|Overall Study|Withdrawal by Subject|0|||
13389264|NCT00695786|26770165|FG001|Overall Study|Withdrawal by Subject|4|||
13389265|NCT00695786|26770166|FG002|Overall Study|Withdrawal by Subject|3|||
13389266|NCT00695786|26770167|FG003|Overall Study|Withdrawal by Subject|1|||
13389267|NCT00695786|26770164|FG000|Overall Study|Deemed Ineligible|1|||
13389268|NCT00695786|26770165|FG001|Overall Study|Deemed Ineligible|0|||
13389269|NCT00695786|26770166|FG002|Overall Study|Deemed Ineligible|0|||
13389270|NCT00695786|26770167|FG003|Overall Study|Deemed Ineligible|0|||
13389271|NCT00695786|26770164|FG000|Overall Study|Lack of Efficacy|0|||
13389272|NCT00695786|26770165|FG001|Overall Study|Lack of Efficacy|0|||
13389273|NCT00695786|26770166|FG002|Overall Study|Lack of Efficacy|0|||
13389274|NCT00695786|26770167|FG003|Overall Study|Lack of Efficacy|4|||
13389275|NCT00695669|26770254|FG000|Overall Study|Adverse Event|0|||
13389276|NCT00695669|26770255|FG001|Overall Study|Adverse Event|0|||
13389277|NCT00695669|26770256|FG002|Overall Study|Adverse Event|2|||
13389278|NCT00695669|26770257|FG003|Overall Study|Adverse Event|0|||
13389279|NCT00695669|26770254|FG000|Overall Study|Lost to Follow-up|4|||
13389280|NCT00695669|26770255|FG001|Overall Study|Lost to Follow-up|4|||
13389281|NCT00695669|26770256|FG002|Overall Study|Lost to Follow-up|1|||
13389282|NCT00695669|26770257|FG003|Overall Study|Lost to Follow-up|4|||
13389283|NCT00695565|26770296|FG000|Overall Study|Lost to Follow-up|4|||
13389284|NCT00695565|26770297|FG001|Overall Study|Lost to Follow-up|4|||
13389285|NCT00695565|26770296|FG000|Overall Study|Adverse Event|3|||
13389286|NCT00695565|26770297|FG001|Overall Study|Adverse Event|1|||
13389287|NCT00695565|26770296|FG000|Overall Study|Protocol Violation|3|||
13389288|NCT00695565|26770297|FG001|Overall Study|Protocol Violation|1|||
13389289|NCT00695565|26770296|FG000|Overall Study|Withdrawal by Subject|1|||
13389290|NCT00695565|26770297|FG001|Overall Study|Withdrawal by Subject|1|||
13389291|NCT00695565|26770296|FG000|Overall Study|Lack of Efficacy|1|||
13389292|NCT00695565|26770297|FG001|Overall Study|Lack of Efficacy|1|||
13389293|NCT00695565|26770296|FG000|Overall Study|Subject did not follow instructions|1|||
13389294|NCT00695565|26770297|FG001|Overall Study|Subject did not follow instructions|1|||
13389295|NCT00695396|26770321|FG000|Overall Study|Study Closed Prematurely|5|||
13389296|NCT00695396|26770322|FG001|Overall Study|Study Closed Prematurely|6|||
13389297|NCT00695396|26770323|FG002|Overall Study|Study Closed Prematurely|8|||
13389298|NCT00695396|26770321|FG000|Overall Study|Withdrawal by Subject|2|||
13389299|NCT00695396|26770322|FG001|Overall Study|Withdrawal by Subject|2|||
13389300|NCT00695396|26770323|FG002|Overall Study|Withdrawal by Subject|0|||
13389301|NCT00695318|26770341|FG000|Overall Study|Lost to Follow-up|1|||
13389302|NCT00695318|26770342|FG001|Overall Study|Lost to Follow-up|0|||
13389303|NCT00695318|26770341|FG000|Overall Study|Withdrawal by Subject|2|||
13389304|NCT00695318|26770342|FG001|Overall Study|Withdrawal by Subject|0|||
13389305|NCT00695318|26770341|FG000|Overall Study|Death|1|||
13389306|NCT00695318|26770342|FG001|Overall Study|Death|1|||
13389307|NCT00695318|26770341|FG000|Overall Study|Study Terminated|1|||
13389308|NCT00695318|26770342|FG001|Overall Study|Study Terminated|0|||
13389309|NCT00695136|26770348|FG000|Overall Study|Withdrawal by Subject|1|||
13389310|NCT00695136|26770348|FG000|Overall Study|unrelated adverse event|1|||
13389311|NCT00695110|26770361|FG000|Treatment Period 1|Adverse Event|1|||
13389312|NCT00695110|26770361|FG000|Treatment Period 1|Withdrawal by Subject|2|||
13389313|NCT00695110|26770361|FG000|Treatment Period 3|Withdrawal by Subject|1|||
13389314|NCT00695110|26770361|FG000|Treatment Period 4|Adverse Event|1|||
13389315|NCT00695019|26770400|FG000|Overall Study|Withdrawal by Subject|8|||
13389316|NCT00695019|26770401|FG001|Overall Study|Withdrawal by Subject|6|||
13389317|NCT00695019|26770402|FG002|Overall Study|Withdrawal by Subject|4|||
13389318|NCT00695019|26770400|FG000|Overall Study|Protocol Violation|1|||
13389319|NCT00695019|26770401|FG001|Overall Study|Protocol Violation|3|||
13389320|NCT00695019|26770402|FG002|Overall Study|Protocol Violation|1|||
13389321|NCT00695019|26770400|FG000|Overall Study|Lack of Efficacy|0|||
13389322|NCT00695019|26770401|FG001|Overall Study|Lack of Efficacy|0|||
13389323|NCT00695019|26770402|FG002|Overall Study|Lack of Efficacy|1|||
13389324|NCT00695019|26770400|FG000|Overall Study|Various|4|||
13389325|NCT00695019|26770401|FG001|Overall Study|Various|5|||
13389326|NCT00695019|26770402|FG002|Overall Study|Various|4|||
13389327|NCT00694707|26770435|FG000|Overall Study|Did Not Receive Treatment|0|||
13389328|NCT00694707|26770436|FG001|Overall Study|Did Not Receive Treatment|0|||
13389329|NCT00694707|26770437|FG002|Overall Study|Did Not Receive Treatment|1|||
13389330|NCT00694707|26770438|FG003|Overall Study|Did Not Receive Treatment|1|||
13389331|NCT00694707|26770439|FG004|Overall Study|Did Not Receive Treatment|1|||
13389332|NCT00694707|26770435|FG000|Overall Study|Adverse Event|22|||
13389333|NCT00694707|26770436|FG001|Overall Study|Adverse Event|14|||
13389334|NCT00694707|26770437|FG002|Overall Study|Adverse Event|8|||
13389335|NCT00694707|26770438|FG003|Overall Study|Adverse Event|12|||
13389336|NCT00694707|26770439|FG004|Overall Study|Adverse Event|13|||
13389337|NCT00694707|26770435|FG000|Overall Study|Insufficient Therapeutic Response|33|||
13389338|NCT00694707|26770436|FG001|Overall Study|Insufficient Therapeutic Response|18|||
13389339|NCT00694707|26770437|FG002|Overall Study|Insufficient Therapeutic Response|17|||
13389340|NCT00694707|26770438|FG003|Overall Study|Insufficient Therapeutic Response|15|||
13389341|NCT00694707|26770439|FG004|Overall Study|Insufficient Therapeutic Response|10|||
13389342|NCT00694707|26770435|FG000|Overall Study|Protocol Violation|1|||
13389343|NCT00694707|26770436|FG001|Overall Study|Protocol Violation|2|||
13389344|NCT00694707|26770437|FG002|Overall Study|Protocol Violation|1|||
13389345|NCT00694707|26770438|FG003|Overall Study|Protocol Violation|3|||
13389346|NCT00694707|26770439|FG004|Overall Study|Protocol Violation|1|||
13389347|NCT00694707|26770435|FG000|Overall Study|Withdrawal of Consent|14|||
13389348|NCT00694707|26770436|FG001|Overall Study|Withdrawal of Consent|18|||
13389349|NCT00694707|26770437|FG002|Overall Study|Withdrawal of Consent|22|||
13389350|NCT00694707|26770438|FG003|Overall Study|Withdrawal of Consent|16|||
13389351|NCT00694707|26770439|FG004|Overall Study|Withdrawal of Consent|15|||
13389352|NCT00694707|26770435|FG000|Overall Study|Lost to Follow-up|0|||
13389353|NCT00694707|26770436|FG001|Overall Study|Lost to Follow-up|1|||
13389354|NCT00694707|26770437|FG002|Overall Study|Lost to Follow-up|2|||
13389355|NCT00694707|26770438|FG003|Overall Study|Lost to Follow-up|0|||
13389356|NCT00694707|26770439|FG004|Overall Study|Lost to Follow-up|0|||
13389357|NCT00694707|26770435|FG000|Overall Study|Jeopardizing Parole Status|1|||
13389358|NCT00694707|26770436|FG001|Overall Study|Jeopardizing Parole Status|0|||
13389359|NCT00694707|26770437|FG002|Overall Study|Jeopardizing Parole Status|0|||
13389360|NCT00694707|26770438|FG003|Overall Study|Jeopardizing Parole Status|0|||
13389361|NCT00694707|26770439|FG004|Overall Study|Jeopardizing Parole Status|0|||
13389362|NCT00694707|26770435|FG000|Overall Study|Death in the Family|1|||
13389363|NCT00694707|26770436|FG001|Overall Study|Death in the Family|0|||
13389364|NCT00694707|26770437|FG002|Overall Study|Death in the Family|0|||
13389365|NCT00694707|26770438|FG003|Overall Study|Death in the Family|0|||
13389366|NCT00694707|26770439|FG004|Overall Study|Death in the Family|0|||
13389367|NCT00694707|26770435|FG000|Overall Study|Arrest by Police|0|||
13389368|NCT00694707|26770436|FG001|Overall Study|Arrest by Police|1|||
13389369|NCT00694707|26770437|FG002|Overall Study|Arrest by Police|0|||
13389370|NCT00694707|26770438|FG003|Overall Study|Arrest by Police|0|||
13389371|NCT00694707|26770439|FG004|Overall Study|Arrest by Police|0|||
13389372|NCT00694707|26770435|FG000|Overall Study|Administrative Reasons|0|||
13389373|NCT00694707|26770436|FG001|Overall Study|Administrative Reasons|1|||
13389374|NCT00694707|26770437|FG002|Overall Study|Administrative Reasons|0|||
13389375|NCT00694707|26770438|FG003|Overall Study|Administrative Reasons|2|||
13389376|NCT00694707|26770439|FG004|Overall Study|Administrative Reasons|0|||
13389377|NCT00694707|26770435|FG000|Overall Study|Notification of Past Head Injury|0|||
13389378|NCT00694707|26770436|FG001|Overall Study|Notification of Past Head Injury|0|||
13389379|NCT00694707|26770437|FG002|Overall Study|Notification of Past Head Injury|0|||
13389380|NCT00694707|26770438|FG003|Overall Study|Notification of Past Head Injury|1|||
13389381|NCT00694707|26770439|FG004|Overall Study|Notification of Past Head Injury|0|||
13389382|NCT00694551|26770463|FG000|Overall Study|Disease Progression|1|||
13389383|NCT00694551|26770464|FG001|Overall Study|Disease Progression|0|||
13389384|NCT00694551|26770465|FG002|Overall Study|Disease Progression|1|||
13395506|NCT00646906|26790575|FG002|Crossover Period 1|Withdrawal by Subject|0|||
13395507|NCT00646906|26790576|FG003|Crossover Period 1|Withdrawal by Subject|0|||
13395508|NCT00646906|26790577|FG004|Crossover Period 1|Withdrawal by Subject|0|||
13395509|NCT00646906|26790578|FG005|Crossover Period 1|Withdrawal by Subject|1|||
13395510|NCT00646906|26790579|FG006|Crossover Period 1|Withdrawal by Subject|0|||
13395511|NCT00646906|26790573|FG000|Crossover Period 2|Withdrawal by Subject|0|||
13395512|NCT00646906|26790574|FG001|Crossover Period 2|Withdrawal by Subject|1|||
13395513|NCT00646906|26790575|FG002|Crossover Period 2|Withdrawal by Subject|2|||
13395514|NCT00646906|26790576|FG003|Crossover Period 2|Withdrawal by Subject|1|||
13395515|NCT00646906|26790577|FG004|Crossover Period 2|Withdrawal by Subject|0|||
13395516|NCT00646906|26790578|FG005|Crossover Period 2|Withdrawal by Subject|0|||
13395517|NCT00646906|26790579|FG006|Crossover Period 2|Withdrawal by Subject|0|||
13395518|NCT00646906|26790573|FG000|Crossover Period 2|Physician Decision|0|||
13395519|NCT00646906|26790574|FG001|Crossover Period 2|Physician Decision|0|||
13395520|NCT00646906|26790575|FG002|Crossover Period 2|Physician Decision|0|||
13395521|NCT00646906|26790576|FG003|Crossover Period 2|Physician Decision|0|||
13395522|NCT00646906|26790577|FG004|Crossover Period 2|Physician Decision|0|||
13395523|NCT00646906|26790578|FG005|Crossover Period 2|Physician Decision|0|||
13395524|NCT00646906|26790579|FG006|Crossover Period 2|Physician Decision|1|||
13395525|NCT00646776|26790633|FG000|Overall Study|Adverse Event|1|||
13395526|NCT00646776|26790634|FG001|Overall Study|Adverse Event|9|||
13395527|NCT00646776|26790633|FG000|Overall Study|Investigator discretion|0|||
13395528|NCT00646776|26790634|FG001|Overall Study|Investigator discretion|4|||
13395529|NCT00646451|26790645|FG000|Overall Study|Adverse Event|3|||
13395530|NCT00646451|26790646|FG001|Overall Study|Adverse Event|0|||
13395531|NCT00646451|26790645|FG000|Overall Study|Exacerbation of pre-existing condition|1|||
13395532|NCT00646451|26790646|FG001|Overall Study|Exacerbation of pre-existing condition|0|||
13395533|NCT00646399|26790659|FG000|Overall Study|Death|63|||
13395534|NCT00646399|26790660|FG001|Overall Study|Death|53|||
13395535|NCT00646399|26790659|FG000|Overall Study|Withdrawal by Subject|9|||
13395536|NCT00646399|26790660|FG001|Overall Study|Withdrawal by Subject|10|||
13395537|NCT00646399|26790659|FG000|Overall Study|Other Reason|11|||
13395538|NCT00646399|26790660|FG001|Overall Study|Other Reason|11|||
13395539|NCT00646282|26790673|FG000|Overall Study|Protocol terminated|4|||
13395540|NCT00646282|26790674|FG001|Overall Study|Protocol terminated|4|||
13395541|NCT00646113|26790680|FG000|Overall Study|Lost to Follow-up|5|||
13395542|NCT00646113|26790680|FG000|Overall Study|Adverse Event|3|||
13395543|NCT00645944|26790693|FG000|Randomized|Withdrawal by Subject|1|||
13395544|NCT00645944|26790694|FG001|Randomized|Withdrawal by Subject|2|||
13395545|NCT00645944|26790693|FG000|Received Medication|Adverse Event|2|||
13395546|NCT00645944|26790694|FG001|Received Medication|Adverse Event|1|||
13395547|NCT00645944|26790693|FG000|Received Medication|Withdrawal by Subject|1|||
13395548|NCT00645944|26790694|FG001|Received Medication|Withdrawal by Subject|1|||
13395549|NCT00645944|26790693|FG000|Received Medication|Lost to Follow-up|1|||
13395550|NCT00645944|26790694|FG001|Received Medication|Lost to Follow-up|0|||
13395551|NCT00645944|26790693|FG000|Received Medication|Protocol Violation|2|||
13395552|NCT00645944|26790694|FG001|Received Medication|Protocol Violation|1|||
13395553|NCT00645853|26790719|FG000|Overall Study|Adverse Event|18|||
13395554|NCT00645853|26790720|FG001|Overall Study|Adverse Event|7|||
13395555|NCT00645853|26790719|FG000|Overall Study|AZ study closure in Hungary|60|||
13389385|NCT00694369|26770498|FG000|Overall Study|Adverse Event|0|||
13389386|NCT00694369|26770499|FG001|Overall Study|Adverse Event|1|||
13389387|NCT00694369|26770500|FG002|Overall Study|Adverse Event|0|||
13389388|NCT00694369|26770501|FG003|Overall Study|Adverse Event|1|||
13389389|NCT00694369|26770502|FG004|Overall Study|Adverse Event|3|||
13389390|NCT00694369|26770498|FG000|Overall Study|Lost to Follow-up|0|||
13389391|NCT00694369|26770499|FG001|Overall Study|Lost to Follow-up|0|||
13389392|NCT00694369|26770500|FG002|Overall Study|Lost to Follow-up|1|||
13389393|NCT00694369|26770501|FG003|Overall Study|Lost to Follow-up|1|||
13389394|NCT00694369|26770502|FG004|Overall Study|Lost to Follow-up|0|||
13389395|NCT00694369|26770498|FG000|Overall Study|Physician Decision|0|||
13389396|NCT00694369|26770499|FG001|Overall Study|Physician Decision|0|||
13389397|NCT00694369|26770500|FG002|Overall Study|Physician Decision|0|||
13389398|NCT00694369|26770501|FG003|Overall Study|Physician Decision|0|||
13389399|NCT00694369|26770502|FG004|Overall Study|Physician Decision|1|||
13389400|NCT00694369|26770498|FG000|Overall Study|Protocol Violation|0|||
13389401|NCT00694369|26770499|FG001|Overall Study|Protocol Violation|1|||
13389402|NCT00694369|26770500|FG002|Overall Study|Protocol Violation|0|||
13389403|NCT00694369|26770501|FG003|Overall Study|Protocol Violation|0|||
13389404|NCT00694369|26770502|FG004|Overall Study|Protocol Violation|0|||
13389405|NCT00694369|26770498|FG000|Overall Study|Withdrawal by Subject|1|||
13389406|NCT00694369|26770499|FG001|Overall Study|Withdrawal by Subject|1|||
13389407|NCT00694369|26770500|FG002|Overall Study|Withdrawal by Subject|1|||
13389408|NCT00694369|26770501|FG003|Overall Study|Withdrawal by Subject|1|||
13389409|NCT00694369|26770502|FG004|Overall Study|Withdrawal by Subject|2|||
13389410|NCT00694356|26770547|FG000|Overall Study|Adverse Event|1|||
13389411|NCT00694356|26770548|FG001|Overall Study|Adverse Event|0|||
13389412|NCT00694356|26770549|FG002|Overall Study|Adverse Event|0|||
13389413|NCT00694356|26770547|FG000|Overall Study|Progressive Disease|2|||
13389414|NCT00694356|26770548|FG001|Overall Study|Progressive Disease|6|||
13389415|NCT00694356|26770549|FG002|Overall Study|Progressive Disease|6|||
13389416|NCT00694304|26770564|FG000|Overall Study|Adverse Event|42|||
13389417|NCT00694304|26770564|FG000|Overall Study|Lack of Efficacy|35|||
13389418|NCT00694304|26770564|FG000|Overall Study|Non-compliance With Study Product|16|||
13389419|NCT00694304|26770564|FG000|Overall Study|Protocol Violation|6|||
13389420|NCT00694304|26770564|FG000|Overall Study|Withdrawal of Consent|61|||
13389421|NCT00694304|26770564|FG000|Overall Study|Lost to Follow-up|15|||
13389422|NCT00694304|26770564|FG000|Overall Study|Administrative or Other Reasons|32|||
13389423|NCT00694161|26770605|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1|||
13389424|NCT00694161|26770605|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1|||
13389425|NCT00694161|26770605|FG000|Part 2 (After Week 6 up to Month 12)|Death|1|||
13389426|NCT00694122|26770624|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7|||
13389427|NCT00694122|26770625|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0|||
13389428|NCT00694122|26770624|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
13389429|NCT00694122|26770625|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
13389430|NCT00694122|26770624|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2|||
13389431|NCT00694122|26770625|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1|||
13389432|NCT00694109|26770651|FG000|Overall Study|Physician Decision|3|||
13389433|NCT00694109|26770651|FG000|Overall Study|Adverse Event|74|||
13389434|NCT00694109|26770651|FG000|Overall Study|Not consent of more 2 years of treatment|18|||
13389435|NCT00694109|26770651|FG000|Overall Study|Lack of Efficacy|2|||
13389436|NCT00694109|26770651|FG000|Overall Study|Withdrawal by Subject|13|||
13389437|NCT00694109|26770651|FG000|Overall Study|Pregnancy|1|||
13389438|NCT00694109|26770651|FG000|Overall Study|Enrolled but not treated|1|||
13389439|NCT00694109|26770651|FG000|Overall Study|Other|2|||
13389440|NCT00694109|26770651|FG000|Overall Study|Consented but no additional treatment|3|||
13389441|NCT00694096|26770659|FG000|Overall Study|Withdrawal by Subject|5|||
13389442|NCT00693784|26770667|FG000|Overall Study|Lost to Follow-up|2|||
13389443|NCT00693784|26770667|FG000|Overall Study|Withdrawal by Subject|2|||
13389444|NCT00693706|26770698|FG000|Overall Study|Protocol Violation|0|||
13389445|NCT00693706|26770699|FG001|Overall Study|Protocol Violation|1|||
13389446|NCT00693693|26770717|FG000|Overall Study|Lost to Follow-up|1|||
13389447|NCT00693693|26770718|FG001|Overall Study|Lost to Follow-up|1|||
13389448|NCT00693693|26770719|FG002|Overall Study|Lost to Follow-up|2|||
13389449|NCT00693472|26770750|FG000|Part 1|Adverse Event|1|||
13389450|NCT00693472|26770751|FG001|Part 1|Adverse Event|1|||
13389451|NCT00693472|26770752|FG002|Part 1|Adverse Event|0|||
13389452|NCT00693472|26770753|FG003|Part 1|Adverse Event|0|||
13389453|NCT00693472|26770750|FG000|Part 1|Lost to Follow-up|0|||
13389454|NCT00693472|26770751|FG001|Part 1|Lost to Follow-up|1|||
13389455|NCT00693472|26770752|FG002|Part 1|Lost to Follow-up|0|||
13389456|NCT00693472|26770753|FG003|Part 1|Lost to Follow-up|0|||
13389457|NCT00693472|26770750|FG000|Part 1|Withdrew - reason unrelated to treatment|5|||
13389458|NCT00693472|26770751|FG001|Part 1|Withdrew - reason unrelated to treatment|2|||
13389459|NCT00693472|26770752|FG002|Part 1|Withdrew - reason unrelated to treatment|0|||
13389460|NCT00693472|26770753|FG003|Part 1|Withdrew - reason unrelated to treatment|0|||
13389461|NCT00693472|26770750|FG000|Part 2|Adverse Event|0|||
13389462|NCT00693472|26770751|FG001|Part 2|Adverse Event|0|||
13389463|NCT00693472|26770752|FG002|Part 2|Adverse Event|1|||
13389464|NCT00693472|26770753|FG003|Part 2|Adverse Event|0|||
13389465|NCT00693472|26770750|FG000|Part 2|Withdrew - reason unrelated to treatment|0|||
13389466|NCT00693472|26770751|FG001|Part 2|Withdrew - reason unrelated to treatment|0|||
13389467|NCT00693472|26770752|FG002|Part 2|Withdrew - reason unrelated to treatment|1|||
13389468|NCT00693472|26770753|FG003|Part 2|Withdrew - reason unrelated to treatment|2|||
13389469|NCT00693420|26770784|FG000|Overall Study|Adverse Event|4|||
13389470|NCT00693420|26770785|FG001|Overall Study|Adverse Event|4|||
13389471|NCT00693420|26770784|FG000|Overall Study|Lost to Follow-up|0|||
13389472|NCT00693420|26770785|FG001|Overall Study|Lost to Follow-up|3|||
13389473|NCT00693420|26770784|FG000|Overall Study|Withdrawal by Subject|1|||
13389474|NCT00693420|26770785|FG001|Overall Study|Withdrawal by Subject|0|||
13389475|NCT00693420|26770784|FG000|Overall Study|Protocol Violation|0|||
13389476|NCT00693420|26770785|FG001|Overall Study|Protocol Violation|2|||
13389477|NCT00693420|26770784|FG000|Overall Study|Sponsor Request - Conflict of Interest|0|||
13389478|NCT00693420|26770785|FG001|Overall Study|Sponsor Request - Conflict of Interest|2|||
13389479|NCT00693420|26770784|FG000|Overall Study|Personal Reasons|1|||
13389480|NCT00693420|26770785|FG001|Overall Study|Personal Reasons|4|||
13389481|NCT00693225|26770802|FG000|Overall Study|Lost to Follow-up|1|||
13389482|NCT00693225|26770803|FG001|Overall Study|Lost to Follow-up|2|||
13389483|NCT00693225|26770802|FG000|Overall Study|Adverse Event|1|||
13389484|NCT00693225|26770803|FG001|Overall Study|Adverse Event|3|||
13389485|NCT00693017|26770818|FG000|Overall Study|Sponsor Decision|2|||
13389486|NCT00693017|26770819|FG001|Overall Study|Sponsor Decision|1|||
13389487|NCT00693017|26770818|FG000|Overall Study|Death|0|||
13389488|NCT00693017|26770819|FG001|Overall Study|Death|1|||
13389489|NCT00692913|26770846|FG000|Overall Study|Adverse Event|8|||
13389490|NCT00692913|26770847|FG001|Overall Study|Adverse Event|4|||
13389491|NCT00692913|26770846|FG000|Overall Study|Lost to Follow-up|3|||
13389492|NCT00692913|26770847|FG001|Overall Study|Lost to Follow-up|5|||
13389493|NCT00692913|26770846|FG000|Overall Study|Physician Decision|2|||
13389494|NCT00692913|26770847|FG001|Overall Study|Physician Decision|0|||
13389495|NCT00692913|26770846|FG000|Overall Study|Protocol Violation|1|||
13389496|NCT00692913|26770847|FG001|Overall Study|Protocol Violation|1|||
13389497|NCT00692913|26770846|FG000|Overall Study|Withdrawal by Subject|15|||
13389498|NCT00692913|26770847|FG001|Overall Study|Withdrawal by Subject|20|||
13389499|NCT00692770|26770878|FG000|Overall Study|Protocol Violation|2|||
13389500|NCT00692770|26770879|FG001|Overall Study|Protocol Violation|7|||
13389501|NCT00692770|26770878|FG000|Overall Study|Withdrawal by Subject|97|||
13389502|NCT00692770|26770879|FG001|Overall Study|Withdrawal by Subject|36|||
13389503|NCT00692770|26770878|FG000|Overall Study|Adverse Event|136|||
13389504|NCT00692770|26770879|FG001|Overall Study|Adverse Event|41|||
13389505|NCT00692770|26770878|FG000|Overall Study|Death|10|||
13389506|NCT00692770|26770879|FG001|Overall Study|Death|5|||
13389507|NCT00692770|26770878|FG000|Overall Study|Lost to Follow-up|7|||
13389508|NCT00692770|26770879|FG001|Overall Study|Lost to Follow-up|3|||
13389509|NCT00692770|26770878|FG000|Overall Study|Non-compliant with study medication|11|||
13389510|NCT00692770|26770879|FG001|Overall Study|Non-compliant with study medication|5|||
13389511|NCT00692770|26770878|FG000|Overall Study|Progression by clinical judgment|2|||
13389512|NCT00692770|26770879|FG001|Overall Study|Progression by clinical judgment|3|||
13389513|NCT00692770|26770878|FG000|Overall Study|Physician decision not protocol driven|10|||
13389514|NCT00692770|26770879|FG001|Overall Study|Physician decision not protocol driven|14|||
13389515|NCT00692770|26770878|FG000|Overall Study|Disease progression, recurrence/relapse|170|||
13389516|NCT00692770|26770879|FG001|Overall Study|Disease progression, recurrence/relapse|279|||
13389517|NCT00692770|26770878|FG000|Overall Study|Protocol driven decision point|3|||
13389518|NCT00692770|26770879|FG001|Overall Study|Protocol driven decision point|7|||
13389519|NCT00692770|26770878|FG000|Overall Study|Completed all planned assessments|79|||
13389520|NCT00692770|26770879|FG001|Overall Study|Completed all planned assessments|101|||
13389521|NCT00692770|26770878|FG000|Overall Study|Radiological and clinical progression|8|||
13389522|NCT00692770|26770879|FG001|Overall Study|Radiological and clinical progression|8|||
13389523|NCT00692770|26770878|FG000|Overall Study|Clinical endpoint reached|16|||
13389524|NCT00692770|26770879|FG001|Overall Study|Clinical endpoint reached|43|||
13389525|NCT00692770|26770878|FG000|Overall Study|Study terminated by sponsor|2|||
13389526|NCT00692770|26770879|FG001|Overall Study|Study terminated by sponsor|2|||
13389527|NCT00692770|26770878|FG000|Overall Study|Randomized but not treated|3|||
13389528|NCT00692770|26770879|FG001|Overall Study|Randomized but not treated|4|||
13389529|NCT00692406|26770892|FG000|Overall Study|PI dropped, bad data|57|||
13389530|NCT00692237|26770907|FG000|Overall Study|Withdrawal by Subject|1|||
13389531|NCT00692237|26770908|FG001|Overall Study|Withdrawal by Subject|3|||
13389532|NCT00692237|26770907|FG000|Overall Study|Adverse Event|0|||
13389533|NCT00692237|26770908|FG001|Overall Study|Adverse Event|1|||
13389534|NCT00692003|26770923|FG000|Overall Study|Sponsor Decision|5|||
13389535|NCT00692003|26770924|FG001|Overall Study|Sponsor Decision|1|||
13389536|NCT00691938|26770967|FG000|Overall Study|QTc prolongation|1|||
13389537|NCT00691938|26770968|FG001|Overall Study|QTc prolongation|0|||
13389538|NCT00691938|26770969|FG002|Overall Study|QTc prolongation|0|||
13389539|NCT00691938|26770970|FG003|Overall Study|QTc prolongation|0|||
13389540|NCT00691938|26770971|FG004|Overall Study|QTc prolongation|0|||
13389541|NCT00691938|26770972|FG005|Overall Study|QTc prolongation|0|||
13389542|NCT00691938|26770973|FG006|Overall Study|QTc prolongation|0|||
13389543|NCT00691704|26770983|FG000|Induction Therapy|Disease Progression|1|||
13389544|NCT00691704|26770983|FG000|Induction Therapy|Active Hepatitis|1|||
13389545|NCT00691704|26770983|FG000|Two Years of Maintenance Therapy|Disease Progression|8|||
13389546|NCT00691704|26770983|FG000|Two Years of Maintenance Therapy|Physician Decision|4|||
13389547|NCT00691704|26770983|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1|||
13389548|NCT00691483|26771006|FG000|Overall Study|Adverse Event|14|||
13389549|NCT00691483|26771007|FG001|Overall Study|Adverse Event|6|||
13389550|NCT00691483|26771006|FG000|Overall Study|Lost to Follow-up|17|||
13389551|NCT00691483|26771007|FG001|Overall Study|Lost to Follow-up|10|||
13389552|NCT00691483|26771006|FG000|Overall Study|Withdrawal by Subject|24|||
13389553|NCT00691483|26771007|FG001|Overall Study|Withdrawal by Subject|7|||
13389554|NCT00691483|26771006|FG000|Overall Study|Other known cause|6|||
13389555|NCT00691483|26771007|FG001|Overall Study|Other known cause|1|||
13389556|NCT00691483|26771006|FG000|Overall Study|Randomized by not treated|7|||
13389557|NCT00691483|26771007|FG001|Overall Study|Randomized by not treated|1|||
13389558|NCT00691301|26771021|FG000|Overall Study|Adverse Event|10|||
13389559|NCT00691301|26771021|FG000|Overall Study|Death|2|||
13389560|NCT00691301|26771021|FG000|Overall Study|Lack of Efficacy|32|||
13389561|NCT00691301|26771021|FG000|Overall Study|Withdrawal by Subject|4|||
13389562|NCT00691301|26771021|FG000|Overall Study|Concurrent illness|2|||
13389563|NCT00691301|26771021|FG000|Overall Study|other reason|3|||
13389564|NCT00691301|26771021|FG000|Overall Study|Did not initiate study treatment|1|||
13389565|NCT00691210|26771064|FG000|Overall Study|Progression of Disease|0|||
13389566|NCT00691210|26771065|FG001|Overall Study|Progression of Disease|0|||
13389567|NCT00691210|26771066|FG002|Overall Study|Progression of Disease|0|||
13389568|NCT00691210|26771067|FG003|Overall Study|Progression of Disease|2|||
13389569|NCT00691210|26771068|FG004|Overall Study|Progression of Disease|0|||
13389570|NCT00691210|26771069|FG005|Overall Study|Progression of Disease|0|||
13389571|NCT00691210|26771070|FG006|Overall Study|Progression of Disease|0|||
13389572|NCT00691210|26771071|FG007|Overall Study|Progression of Disease|0|||
13389573|NCT00691210|26771064|FG000|Overall Study|Lack of Efficacy|0|||
13389574|NCT00691210|26771065|FG001|Overall Study|Lack of Efficacy|0|||
13389575|NCT00691210|26771066|FG002|Overall Study|Lack of Efficacy|0|||
13389576|NCT00691210|26771067|FG003|Overall Study|Lack of Efficacy|1|||
13389577|NCT00691210|26771068|FG004|Overall Study|Lack of Efficacy|0|||
13389578|NCT00691210|26771069|FG005|Overall Study|Lack of Efficacy|1|||
13389579|NCT00691210|26771070|FG006|Overall Study|Lack of Efficacy|0|||
13389580|NCT00691210|26771071|FG007|Overall Study|Lack of Efficacy|0|||
13389581|NCT00691132|26771097|FG000|Overall Study|Adverse Event|2|||
13389582|NCT00691132|26771098|FG001|Overall Study|Adverse Event|3|||
13389583|NCT00691132|26771097|FG000|Overall Study|Withdrawal by Subject|10|||
13389584|NCT00691132|26771098|FG001|Overall Study|Withdrawal by Subject|10|||
13389585|NCT00691093|26771134|FG000|Overall Study|Adverse Event|1|||
13389586|NCT00691093|26771134|FG000|Overall Study|Lost to Follow-up|1|||
13389587|NCT00691093|26771134|FG000|Overall Study|Lack of Efficacy|1|||
13389588|NCT00691093|26771134|FG000|Overall Study|Ongoing at Date of Cut-Off|4|||
13389589|NCT00691054|26771145|FG000|Overall Study|Withdrawal by Subject|1|||
13389590|NCT00691028|26771189|FG000|Open-label Period|Adverse Event|0|||
13389591|NCT00691028|26771190|FG001|Open-label Period|Adverse Event|0|||
13389592|NCT00691028|26771191|FG002|Open-label Period|Adverse Event|0|||
13389593|NCT00691028|26771192|FG003|Open-label Period|Adverse Event|16|||
13389594|NCT00691028|26771189|FG000|Open-label Period|Withdrawal by Subject|0|||
13389595|NCT00691028|26771190|FG001|Open-label Period|Withdrawal by Subject|0|||
13389596|NCT00691028|26771191|FG002|Open-label Period|Withdrawal by Subject|0|||
13389597|NCT00691028|26771192|FG003|Open-label Period|Withdrawal by Subject|3|||
13389598|NCT00691028|26771189|FG000|Open-label Period|not come to a hospital|0|||
13389599|NCT00691028|26771190|FG001|Open-label Period|not come to a hospital|0|||
13389600|NCT00691028|26771191|FG002|Open-label Period|not come to a hospital|0|||
13389601|NCT00691028|26771192|FG003|Open-label Period|not come to a hospital|1|||
13389602|NCT00691028|26771189|FG000|Double-blind Period|Adverse Event|8|||
13389603|NCT00691028|26771190|FG001|Double-blind Period|Adverse Event|9|||
13389604|NCT00691028|26771191|FG002|Double-blind Period|Adverse Event|6|||
13389605|NCT00691028|26771192|FG003|Double-blind Period|Adverse Event|0|||
13389606|NCT00691028|26771189|FG000|Double-blind Period|Lack of Efficacy|4|||
13389607|NCT00691028|26771190|FG001|Double-blind Period|Lack of Efficacy|3|||
13389608|NCT00691028|26771191|FG002|Double-blind Period|Lack of Efficacy|2|||
13389609|NCT00691028|26771192|FG003|Double-blind Period|Lack of Efficacy|0|||
13389610|NCT00691028|26771189|FG000|Double-blind Period|Withdrawal by Subject|1|||
13389611|NCT00691028|26771190|FG001|Double-blind Period|Withdrawal by Subject|0|||
13389612|NCT00691028|26771191|FG002|Double-blind Period|Withdrawal by Subject|1|||
13389613|NCT00691028|26771192|FG003|Double-blind Period|Withdrawal by Subject|0|||
13389614|NCT00691028|26771189|FG000|Double-blind Period|not come to a hospital.|0|||
13389615|NCT00691028|26771190|FG001|Double-blind Period|not come to a hospital.|1|||
13389616|NCT00691028|26771191|FG002|Double-blind Period|not come to a hospital.|0|||
13389617|NCT00691028|26771192|FG003|Double-blind Period|not come to a hospital.|0|||
13389618|NCT00691015|26771205|FG000|Overall Study|Refused further treatment|1|||
13389619|NCT00690820|26771232|FG000|Period 1|Withdrawal by Subject|0|||
13389620|NCT00690820|26771233|FG001|Period 1|Withdrawal by Subject|1|||
13389621|NCT00690794|26771248|FG000|Overall Study|Adverse Event|12|||
13389622|NCT00690794|26771249|FG001|Overall Study|Adverse Event|10|||
13389623|NCT00690794|26771248|FG000|Overall Study|Lost to Follow-up|1|||
13389624|NCT00690794|26771249|FG001|Overall Study|Lost to Follow-up|4|||
13389625|NCT00690794|26771248|FG000|Overall Study|Withdrawal by Subject|0|||
13389626|NCT00690794|26771249|FG001|Overall Study|Withdrawal by Subject|9|||
13389627|NCT00690794|26771248|FG000|Overall Study|Protocol Violation|6|||
13389628|NCT00690794|26771249|FG001|Overall Study|Protocol Violation|7|||
13389629|NCT00690794|26771248|FG000|Overall Study|Noncompliance|1|||
13389630|NCT00690794|26771249|FG001|Overall Study|Noncompliance|2|||
13389631|NCT00690794|26771248|FG000|Overall Study|Other not specified|1|||
13389632|NCT00690794|26771249|FG001|Overall Study|Other not specified|3|||
13389633|NCT00690755|26771287|FG000|Overall Study|Physician Decision|2|||
13389634|NCT00690755|26771288|FG001|Overall Study|Physician Decision|0|||
13389635|NCT00690755|26771289|FG002|Overall Study|Physician Decision|46|||
13389636|NCT00690755|26771290|FG003|Overall Study|Physician Decision|5|||
13389637|NCT00690755|26771291|FG004|Overall Study|Physician Decision|0|||
13389638|NCT00690755|26771292|FG005|Overall Study|Physician Decision|4|||
13389639|NCT00690755|26771293|FG006|Overall Study|Physician Decision|0|||
13389640|NCT00690612|26771300|FG000|Overall Study|Adverse Event|1|||
13389641|NCT00690612|26771300|FG000|Overall Study|Withdrawal by Subject|2|||
13389642|NCT00690573|26771310|FG000|Overall Study|Lack of Efficacy|8|||
13389643|NCT00690573|26771310|FG000|Overall Study|Withdrawal by Subject|1|||
13389644|NCT00690482|26771349|FG000|Overall Study|Adverse Event|2|||
13389645|NCT00690482|26771350|FG001|Overall Study|Adverse Event|1|||
13389646|NCT00690482|26771349|FG000|Overall Study|Incorrect enrolment|0|||
13389647|NCT00690482|26771350|FG001|Overall Study|Incorrect enrolment|1|||
13389648|NCT00690482|26771349|FG000|Overall Study|Study-specific discontinuation criteria|1|||
13389649|NCT00690482|26771350|FG001|Overall Study|Study-specific discontinuation criteria|0|||
13389650|NCT00690482|26771349|FG000|Overall Study|Intake of prohibited medicine|1|||
13389651|NCT00690482|26771350|FG001|Overall Study|Intake of prohibited medicine|0|||
13389652|NCT00690482|26771349|FG000|Overall Study|withdrew consent at rand.day|0|||
13389653|NCT00690482|26771350|FG001|Overall Study|withdrew consent at rand.day|1|||
13389654|NCT00690443|26771365|FG000|Overall Study|Adverse Event|1|||
13389655|NCT00690443|26771366|FG001|Overall Study|Adverse Event|2|||
13389656|NCT00690430|26771401|FG000|Core Phase|Abnormal Laboratory value|0|||
13389657|NCT00690430|26771402|FG001|Core Phase|Abnormal Laboratory value|1|||
13389658|NCT00690430|26771403|FG002|Core Phase|Abnormal Laboratory value|0|||
13389659|NCT00690430|26771401|FG000|Core Phase|Adverse Event|5|||
13389660|NCT00690430|26771402|FG001|Core Phase|Adverse Event|1|||
13389661|NCT00690430|26771403|FG002|Core Phase|Adverse Event|0|||
13389662|NCT00690430|26771401|FG000|Core Phase|Death|0|||
13389663|NCT00690430|26771402|FG001|Core Phase|Death|2|||
13389664|NCT00690430|26771403|FG002|Core Phase|Death|0|||
13389665|NCT00690430|26771401|FG000|Core Phase|Protocol Violation|1|||
13389666|NCT00690430|26771402|FG001|Core Phase|Protocol Violation|0|||
13389667|NCT00690430|26771403|FG002|Core Phase|Protocol Violation|0|||
13389668|NCT00690430|26771401|FG000|Core Phase|Withdrawal by Subject|3|||
13389669|NCT00690430|26771402|FG001|Core Phase|Withdrawal by Subject|3|||
13389670|NCT00690430|26771403|FG002|Core Phase|Withdrawal by Subject|0|||
13389671|NCT00690430|26771401|FG000|Core Phase|Subject no longer requires study drug|1|||
13389672|NCT00690430|26771402|FG001|Core Phase|Subject no longer requires study drug|0|||
13389673|NCT00690430|26771403|FG002|Core Phase|Subject no longer requires study drug|0|||
13389674|NCT00690430|26771401|FG000|Core Phase|Lack of Efficacy|8|||
13389675|NCT00690430|26771402|FG001|Core Phase|Lack of Efficacy|10|||
13389676|NCT00690430|26771403|FG002|Core Phase|Lack of Efficacy|0|||
13389677|NCT00690430|26771401|FG000|Core Phase|Administrative Problems|0|||
13389678|NCT00690430|26771402|FG001|Core Phase|Administrative Problems|1|||
13389679|NCT00690430|26771403|FG002|Core Phase|Administrative Problems|0|||
13389680|NCT00690430|26771401|FG000|Core Phase|Early Termination|0|||
13389681|NCT00690430|26771402|FG001|Core Phase|Early Termination|5|||
13389682|NCT00690430|26771403|FG002|Core Phase|Early Termination|0|||
13389683|NCT00690430|26771401|FG000|Extension Phase|Lack of Efficacy|3|||
13389684|NCT00690430|26771402|FG001|Extension Phase|Lack of Efficacy|1|||
13389685|NCT00690430|26771403|FG002|Extension Phase|Lack of Efficacy|4|||
13389686|NCT00690430|26771401|FG000|Extension Phase|Abnormal Lab Values|1|||
13389687|NCT00690430|26771402|FG001|Extension Phase|Abnormal Lab Values|0|||
13306230|NCT01292603|26525397|FG002|Part 1: Pilot Dose Selection Period|Death|0|||
13306231|NCT01292603|26525398|FG003|Part 1: Pilot Dose Selection Period|Death|1|||
13306232|NCT01292603|26525399|FG004|Part 1: Pilot Dose Selection Period|Death|0|||
13306233|NCT01292603|26525400|FG005|Part 1: Pilot Dose Selection Period|Death|0|||
13306234|NCT01292603|26525395|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
13306235|NCT01292603|26525396|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
13306236|NCT01292603|26525397|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
13389688|NCT00690430|26771403|FG002|Extension Phase|Abnormal Lab Values|0|||
13389689|NCT00690430|26771401|FG000|Extension Phase|Abnormal test procedure results|1|||
13389690|NCT00690430|26771402|FG001|Extension Phase|Abnormal test procedure results|0|||
13389691|NCT00690430|26771403|FG002|Extension Phase|Abnormal test procedure results|0|||
13389692|NCT00690430|26771401|FG000|Extension Phase|Administrative Problems|0|||
13389693|NCT00690430|26771402|FG001|Extension Phase|Administrative Problems|1|||
13389694|NCT00690430|26771403|FG002|Extension Phase|Administrative Problems|1|||
13389695|NCT00690430|26771401|FG000|Extension Phase|Adverse Event|2|||
13389696|NCT00690430|26771402|FG001|Extension Phase|Adverse Event|1|||
13389697|NCT00690430|26771403|FG002|Extension Phase|Adverse Event|2|||
13389698|NCT00690430|26771401|FG000|Extension Phase|Death|1|||
13389699|NCT00690430|26771402|FG001|Extension Phase|Death|1|||
13389700|NCT00690430|26771403|FG002|Extension Phase|Death|1|||
13389701|NCT00690430|26771401|FG000|Extension Phase|Withdrawal by Subject|0|||
13389702|NCT00690430|26771402|FG001|Extension Phase|Withdrawal by Subject|0|||
13389703|NCT00690430|26771403|FG002|Extension Phase|Withdrawal by Subject|2|||
13389704|NCT00690430|26771401|FG000|Extension Phase|Early Termination|10|||
13389705|NCT00690430|26771402|FG001|Extension Phase|Early Termination|1|||
13389706|NCT00690430|26771403|FG002|Extension Phase|Early Termination|3|||
13389707|NCT00690378|26771454|FG000|Overall Study|Adverse Event|1|||
13389708|NCT00690378|26771455|FG001|Overall Study|Adverse Event|0|||
13389709|NCT00690378|26771454|FG000|Overall Study|Withdrawal by Subject|2|||
13389710|NCT00690378|26771455|FG001|Overall Study|Withdrawal by Subject|0|||
13389711|NCT00690378|26771454|FG000|Overall Study|Protocol Violation|1|||
13389712|NCT00690378|26771455|FG001|Overall Study|Protocol Violation|0|||
13389713|NCT00690378|26771454|FG000|Overall Study|Lost to Follow-up|2|||
13389714|NCT00690378|26771455|FG001|Overall Study|Lost to Follow-up|3|||
13389715|NCT00690378|26771454|FG000|Overall Study|Did not meet inc/exc criteria|13|||
13389716|NCT00690378|26771455|FG001|Overall Study|Did not meet inc/exc criteria|11|||
13389717|NCT00690378|26771454|FG000|Overall Study|Social problem|1|||
13389718|NCT00690378|26771455|FG001|Overall Study|Social problem|0|||
13389719|NCT00689936|26771605|FG000|Active Treatment Phase|Adverse Event|68|||
13389720|NCT00689936|26771606|FG001|Active Treatment Phase|Adverse Event|71|||
13389721|NCT00689936|26771607|FG002|Active Treatment Phase|Adverse Event|76|||
13389722|NCT00689936|26771605|FG000|Active Treatment Phase|Disease Progression|273|||
13389723|NCT00689936|26771606|FG001|Active Treatment Phase|Disease Progression|362|||
13389724|NCT00689936|26771607|FG002|Active Treatment Phase|Disease Progression|339|||
13389725|NCT00689936|26771605|FG000|Active Treatment Phase|Withdrawal by Subject|16|||
13389726|NCT00689936|26771606|FG001|Active Treatment Phase|Withdrawal by Subject|16|||
13389727|NCT00689936|26771607|FG002|Active Treatment Phase|Withdrawal by Subject|21|||
13389728|NCT00689936|26771605|FG000|Active Treatment Phase|Death|60|||
13389729|NCT00689936|26771606|FG001|Active Treatment Phase|Death|28|||
13389730|NCT00689936|26771607|FG002|Active Treatment Phase|Death|37|||
13389731|NCT00689936|26771605|FG000|Active Treatment Phase|Lost to Follow-up|0|||
13389732|NCT00689936|26771606|FG001|Active Treatment Phase|Lost to Follow-up|2|||
13389733|NCT00689936|26771607|FG002|Active Treatment Phase|Lost to Follow-up|2|||
13389734|NCT00689936|26771605|FG000|Active Treatment Phase|Protocol Violation|2|||
13389735|NCT00689936|26771606|FG001|Active Treatment Phase|Protocol Violation|2|||
13389736|NCT00689936|26771607|FG002|Active Treatment Phase|Protocol Violation|4|||
13389737|NCT00689936|26771605|FG000|Active Treatment Phase|Study Close Out|64|||
13389738|NCT00689936|26771606|FG001|Active Treatment Phase|Study Close Out|26|||
13389739|NCT00689936|26771607|FG002|Active Treatment Phase|Study Close Out|21|||
13389740|NCT00689936|26771605|FG000|Active Treatment Phase|Miscellaneous|52|||
13389741|NCT00689936|26771606|FG001|Active Treatment Phase|Miscellaneous|34|||
13389742|NCT00689936|26771607|FG002|Active Treatment Phase|Miscellaneous|47|||
13389743|NCT00689936|26771605|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127|||
13389744|NCT00689936|26771606|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188|||
13389745|NCT00689936|26771607|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144|||
13389746|NCT00689871|26771634|FG000|Overall Study|Lost to Follow-up|123|||
13389747|NCT00689871|26771635|FG001|Overall Study|Lost to Follow-up|13|||
13389748|NCT00689871|26771636|FG002|Overall Study|Lost to Follow-up|37|||
13389749|NCT00689871|26771637|FG003|Overall Study|Lost to Follow-up|1|||
13389750|NCT00689871|26771634|FG000|Overall Study|Explanted of All Study Devices|36|||
13389751|NCT00689871|26771635|FG001|Overall Study|Explanted of All Study Devices|25|||
13389752|NCT00689871|26771636|FG002|Overall Study|Explanted of All Study Devices|29|||
13389753|NCT00689871|26771637|FG003|Overall Study|Explanted of All Study Devices|3|||
13389754|NCT00689871|26771634|FG000|Overall Study|Withdrawal by Subject|13|||
13389755|NCT00689871|26771635|FG001|Overall Study|Withdrawal by Subject|3|||
13389756|NCT00689871|26771636|FG002|Overall Study|Withdrawal by Subject|4|||
13389757|NCT00689871|26771637|FG003|Overall Study|Withdrawal by Subject|1|||
13389758|NCT00689871|26771634|FG000|Overall Study|Death|1|||
13389759|NCT00689871|26771635|FG001|Overall Study|Death|10|||
13389760|NCT00689871|26771636|FG002|Overall Study|Death|2|||
13389761|NCT00689871|26771637|FG003|Overall Study|Death|2|||
13389762|NCT00689871|26771634|FG000|Overall Study|Physician Decision|2|||
13389763|NCT00689871|26771635|FG001|Overall Study|Physician Decision|1|||
13389764|NCT00689871|26771636|FG002|Overall Study|Physician Decision|1|||
13389765|NCT00689871|26771637|FG003|Overall Study|Physician Decision|0|||
13389766|NCT00689793|26771660|FG000|Overall Study|Lost to Follow-up|4|||
13389767|NCT00689793|26771661|FG001|Overall Study|Lost to Follow-up|5|||
13389768|NCT00689728|26771752|FG000|Double-Blind Treatment|Adverse Event|1|||
13389769|NCT00689728|26771753|FG001|Double-Blind Treatment|Adverse Event|0|||
13389770|NCT00689728|26771754|FG002|Double-Blind Treatment|Adverse Event|0|||
13389771|NCT00689728|26771752|FG000|Double-Blind Treatment|Protocol Violation|0|||
13389772|NCT00689728|26771753|FG001|Double-Blind Treatment|Protocol Violation|0|||
13389773|NCT00689728|26771754|FG002|Double-Blind Treatment|Protocol Violation|1|||
13389774|NCT00689728|26771752|FG000|Double-Blind Treatment|Withdrawal by Subject|3|||
13389775|NCT00689728|26771753|FG001|Double-Blind Treatment|Withdrawal by Subject|3|||
13389776|NCT00689728|26771754|FG002|Double-Blind Treatment|Withdrawal by Subject|2|||
13389777|NCT00689728|26771752|FG000|Double-Blind Treatment|Lack of Efficacy|0|||
13389778|NCT00689728|26771753|FG001|Double-Blind Treatment|Lack of Efficacy|1|||
13389779|NCT00689728|26771754|FG002|Double-Blind Treatment|Lack of Efficacy|2|||
13389780|NCT00689728|26771752|FG000|Rescue|Adverse Event|0|||
13389781|NCT00689728|26771753|FG001|Rescue|Adverse Event|1|||
13389782|NCT00689728|26771754|FG002|Rescue|Adverse Event|0|||
13389783|NCT00689728|26771752|FG000|Rescue|Withdrawal by Subject|1|||
13389784|NCT00689728|26771753|FG001|Rescue|Withdrawal by Subject|1|||
13389785|NCT00689728|26771754|FG002|Rescue|Withdrawal by Subject|1|||
13389786|NCT00689728|26771752|FG000|Optional Follow-Up|Adverse Event|1|||
13389787|NCT00689728|26771753|FG001|Optional Follow-Up|Adverse Event|0|||
13389788|NCT00689728|26771754|FG002|Optional Follow-Up|Adverse Event|0|||
13389789|NCT00689728|26771752|FG000|Optional Follow-Up|Lack of Efficacy|0|||
13389790|NCT00689728|26771753|FG001|Optional Follow-Up|Lack of Efficacy|1|||
13389791|NCT00689728|26771754|FG002|Optional Follow-Up|Lack of Efficacy|1|||
13389792|NCT00689728|26771752|FG000|Optional Follow-Up|Lost to Follow-up|0|||
13389793|NCT00689728|26771753|FG001|Optional Follow-Up|Lost to Follow-up|1|||
13389794|NCT00689728|26771754|FG002|Optional Follow-Up|Lost to Follow-up|1|||
13389795|NCT00689728|26771752|FG000|Optional Follow-Up|Protocol Violation|0|||
13389796|NCT00689728|26771753|FG001|Optional Follow-Up|Protocol Violation|0|||
13389797|NCT00689728|26771754|FG002|Optional Follow-Up|Protocol Violation|1|||
13389798|NCT00689728|26771752|FG000|Optional Follow-Up|Withdrawal by Subject|2|||
13389799|NCT00689728|26771753|FG001|Optional Follow-Up|Withdrawal by Subject|4|||
13389800|NCT00689728|26771754|FG002|Optional Follow-Up|Withdrawal by Subject|3|||
13389801|NCT00689611|26771769|FG000|Overall Study|Death|6|||
13389802|NCT00689611|26771770|FG001|Overall Study|Death|9|||
13389803|NCT00689611|26771769|FG000|Overall Study|Withdrawal by Subject|8|||
13389804|NCT00689611|26771770|FG001|Overall Study|Withdrawal by Subject|9|||
13389805|NCT00689611|26771769|FG000|Overall Study|Lost to Follow-up|27|||
13389806|NCT00689611|26771770|FG001|Overall Study|Lost to Follow-up|28|||
13389807|NCT00689481|26771793|FG000|Overall Study|Adverse Event|7|||
13389808|NCT00689481|26771794|FG001|Overall Study|Adverse Event|1|||
13389809|NCT00689481|26771793|FG000|Overall Study|Lost to Follow-up|4|||
13389810|NCT00689481|26771794|FG001|Overall Study|Lost to Follow-up|3|||
13389811|NCT00689481|26771793|FG000|Overall Study|Lack of Efficacy|4|||
13389812|NCT00689481|26771794|FG001|Overall Study|Lack of Efficacy|3|||
13389813|NCT00689481|26771793|FG000|Overall Study|Non-compliance with study treatment|1|||
13389814|NCT00689481|26771794|FG001|Overall Study|Non-compliance with study treatment|1|||
13389815|NCT00689481|26771793|FG000|Overall Study|Withdrawal by Subject|8|||
13389816|NCT00689481|26771794|FG001|Overall Study|Withdrawal by Subject|4|||
13389817|NCT00689481|26771793|FG000|Overall Study|Excluded medication started during study|0|||
13389818|NCT00689481|26771794|FG001|Overall Study|Excluded medication started during study|1|||
13389819|NCT00689481|26771793|FG000|Overall Study|Subject early term, left on vacation|0|||
13389820|NCT00689481|26771794|FG001|Overall Study|Subject early term, left on vacation|1|||
13389821|NCT00689390|26771817|FG000|Overall Study|Adverse Event|19|||
13389822|NCT00689390|26771818|FG001|Overall Study|Adverse Event|0|||
13389823|NCT00689390|26771817|FG000|Overall Study|Lost to Follow-up|179|||
13389824|NCT00689390|26771818|FG001|Overall Study|Lost to Follow-up|7|||
13389825|NCT00689390|26771817|FG000|Overall Study|Withdrawal by Subject|117|||
13389826|NCT00689390|26771818|FG001|Overall Study|Withdrawal by Subject|3|||
13389827|NCT00689390|26771817|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52|||
13389828|NCT00689390|26771818|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0|||
13389829|NCT00689390|26771817|FG000|Overall Study|Non-Compliance With Protocol|21|||
13389830|NCT00689390|26771818|FG001|Overall Study|Non-Compliance With Protocol|0|||
13389831|NCT00689390|26771817|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
13389832|NCT00689390|26771818|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
13389833|NCT00689390|26771817|FG000|Overall Study|Administrative|37|||
13389834|NCT00689390|26771818|FG001|Overall Study|Administrative|0|||
13389835|NCT00689351|26771857|FG000|Infant Series of Dosing|Parent/legal guardian request|5|||
13389836|NCT00689351|26771858|FG001|Infant Series of Dosing|Parent/legal guardian request|0|||
13389837|NCT00689351|26771857|FG000|Infant Series of Dosing|Adverse Event|1|||
13389838|NCT00689351|26771858|FG001|Infant Series of Dosing|Adverse Event|0|||
13389839|NCT00689351|26771857|FG000|Infant Series of Dosing|Lost to Follow-up|0|||
13389840|NCT00689351|26771858|FG001|Infant Series of Dosing|Lost to Follow-up|1|||
13389841|NCT00689351|26771857|FG000|After Infant Series|Parent/legal guardian request|1|||
13389842|NCT00689351|26771858|FG001|After Infant Series|Parent/legal guardian request|0|||
13389843|NCT00689338|26771870|FG000|Overall Study|Death|65|||
13389844|NCT00689338|26771870|FG000|Overall Study|Adverse Event|13|||
13389845|NCT00689338|26771870|FG000|Overall Study|Insufficient Clinical Response|1|||
13389846|NCT00689338|26771870|FG000|Overall Study|Lack of Efficacy|6|||
13389847|NCT00689338|26771870|FG000|Overall Study|Other|8|||
13389848|NCT00689338|26771870|FG000|Overall Study|Did not Meet Entrance Criteria|27|||
13389849|NCT00689338|26771870|FG000|Overall Study|Lost to Follow-up|5|||
13389850|NCT00689338|26771870|FG000|Overall Study|Withdrawal by Subject|3|||
13389851|NCT00689338|26771870|FG000|Overall Study|Protocol Violation|15|||
13389852|NCT00689299|26771888|FG000|Overall Study|Adverse Event|2|||
13389853|NCT00689299|26771889|FG001|Overall Study|Adverse Event|1|||
13389854|NCT00689299|26771890|FG002|Overall Study|Adverse Event|1|||
13389855|NCT00689299|26771888|FG000|Overall Study|Lost to Follow-up|0|||
13389856|NCT00689299|26771889|FG001|Overall Study|Lost to Follow-up|1|||
13389857|NCT00689299|26771890|FG002|Overall Study|Lost to Follow-up|1|||
13389858|NCT00689299|26771888|FG000|Overall Study|Withdrawal by Subject|4|||
13389859|NCT00689299|26771889|FG001|Overall Study|Withdrawal by Subject|1|||
13389860|NCT00689299|26771890|FG002|Overall Study|Withdrawal by Subject|3|||
13389861|NCT00689299|26771888|FG000|Overall Study|Protocol Violation|1|||
13389862|NCT00689299|26771889|FG001|Overall Study|Protocol Violation|0|||
13389863|NCT00689299|26771890|FG002|Overall Study|Protocol Violation|0|||
13389864|NCT00689273|26771942|FG000|Overall Study|Adverse Event|3|||
13389865|NCT00689273|26771943|FG001|Overall Study|Adverse Event|1|||
13389866|NCT00689273|26771942|FG000|Overall Study|Lack of Efficacy|3|||
13389867|NCT00689273|26771943|FG001|Overall Study|Lack of Efficacy|0|||
13389868|NCT00689273|26771942|FG000|Overall Study|Lost to Follow-up|0|||
13389869|NCT00689273|26771943|FG001|Overall Study|Lost to Follow-up|2|||
13389870|NCT00689273|26771942|FG000|Overall Study|Other|6|||
13389871|NCT00689273|26771943|FG001|Overall Study|Other|2|||
13389872|NCT00689273|26771942|FG000|Overall Study|Randomized but not Treated|1|||
13389873|NCT00689273|26771943|FG001|Overall Study|Randomized but not Treated|0|||
13389874|NCT00689221|26771975|FG000|Overall Study|Ongoing at cut-off date|39|||
13389875|NCT00689221|26771976|FG001|Overall Study|Ongoing at cut-off date|36|||
13389876|NCT00689117|26772015|FG000|Overall Study|Adverse Event|6|||
13389877|NCT00689117|26772016|FG001|Overall Study|Adverse Event|0|||
13389878|NCT00689117|26772017|FG002|Overall Study|Adverse Event|5|||
13389879|NCT00689117|26772018|FG003|Overall Study|Adverse Event|0|||
13389880|NCT00689117|26772015|FG000|Overall Study|Lost to Follow-up|26|||
13389881|NCT00689117|26772016|FG001|Overall Study|Lost to Follow-up|19|||
13389882|NCT00689117|26772017|FG002|Overall Study|Lost to Follow-up|17|||
13389883|NCT00689117|26772018|FG003|Overall Study|Lost to Follow-up|11|||
13389884|NCT00689117|26772015|FG000|Overall Study|Lack of Efficacy|1|||
13389885|NCT00689117|26772016|FG001|Overall Study|Lack of Efficacy|2|||
13389886|NCT00689117|26772017|FG002|Overall Study|Lack of Efficacy|2|||
13389887|NCT00689117|26772018|FG003|Overall Study|Lack of Efficacy|2|||
13389888|NCT00689117|26772015|FG000|Overall Study|Non-Compliance with Study Treatment|3|||
13389889|NCT00689117|26772016|FG001|Overall Study|Non-Compliance with Study Treatment|3|||
13389890|NCT00689117|26772017|FG002|Overall Study|Non-Compliance with Study Treatment|3|||
13389891|NCT00689117|26772018|FG003|Overall Study|Non-Compliance with Study Treatment|1|||
13389892|NCT00689117|26772015|FG000|Overall Study|Withdrawal by Subject|19|||
13389893|NCT00689117|26772016|FG001|Overall Study|Withdrawal by Subject|18|||
13389894|NCT00689117|26772017|FG002|Overall Study|Withdrawal by Subject|26|||
13389895|NCT00689117|26772018|FG003|Overall Study|Withdrawal by Subject|13|||
13389896|NCT00689117|26772015|FG000|Overall Study|Unable to Comply with Visit Schedule|0|||
13389897|NCT00689117|26772016|FG001|Overall Study|Unable to Comply with Visit Schedule|0|||
13389898|NCT00689117|26772017|FG002|Overall Study|Unable to Comply with Visit Schedule|1|||
13389899|NCT00689117|26772018|FG003|Overall Study|Unable to Comply with Visit Schedule|1|||
13389900|NCT00689117|26772015|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
13389901|NCT00689117|26772016|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
13389902|NCT00689117|26772017|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
13389903|NCT00689117|26772018|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
13389904|NCT00689117|26772015|FG000|Overall Study|Non-compliance with Treatment Regimen|0|||
13389905|NCT00689117|26772016|FG001|Overall Study|Non-compliance with Treatment Regimen|1|||
13389906|NCT00689117|26772017|FG002|Overall Study|Non-compliance with Treatment Regimen|0|||
13389907|NCT00689117|26772018|FG003|Overall Study|Non-compliance with Treatment Regimen|0|||
13389908|NCT00689117|26772015|FG000|Overall Study|Change/Discontinuation of Birth Control|1|||
13389909|NCT00689117|26772016|FG001|Overall Study|Change/Discontinuation of Birth Control|1|||
13389910|NCT00689117|26772017|FG002|Overall Study|Change/Discontinuation of Birth Control|1|||
13389911|NCT00689117|26772018|FG003|Overall Study|Change/Discontinuation of Birth Control|0|||
13389912|NCT00689117|26772015|FG000|Overall Study|Use of Prohibitive Medication|2|||
13389913|NCT00689117|26772016|FG001|Overall Study|Use of Prohibitive Medication|1|||
13389914|NCT00689117|26772017|FG002|Overall Study|Use of Prohibitive Medication|3|||
13389915|NCT00689117|26772018|FG003|Overall Study|Use of Prohibitive Medication|0|||
13389916|NCT00689117|26772015|FG000|Overall Study|Pregnancy|0|||
13389917|NCT00689117|26772016|FG001|Overall Study|Pregnancy|2|||
13389918|NCT00689117|26772017|FG002|Overall Study|Pregnancy|0|||
13389919|NCT00689117|26772018|FG003|Overall Study|Pregnancy|2|||
13389920|NCT00689117|26772015|FG000|Overall Study|Incarceration|2|||
13389921|NCT00689117|26772016|FG001|Overall Study|Incarceration|0|||
13389922|NCT00689117|26772017|FG002|Overall Study|Incarceration|0|||
13389923|NCT00689117|26772018|FG003|Overall Study|Incarceration|0|||
13389924|NCT00689117|26772015|FG000|Overall Study|Fear of Birth Defects|0|||
13389925|NCT00689117|26772016|FG001|Overall Study|Fear of Birth Defects|0|||
13389926|NCT00689117|26772017|FG002|Overall Study|Fear of Birth Defects|1|||
13389927|NCT00689117|26772018|FG003|Overall Study|Fear of Birth Defects|0|||
13389928|NCT00689117|26772015|FG000|Overall Study|Transportation|1|||
13389929|NCT00689117|26772016|FG001|Overall Study|Transportation|0|||
13389930|NCT00689117|26772017|FG002|Overall Study|Transportation|0|||
13389931|NCT00689117|26772018|FG003|Overall Study|Transportation|0|||
13389932|NCT00689117|26772015|FG000|Overall Study|Patient Withdrew from Study|0|||
13389933|NCT00689117|26772016|FG001|Overall Study|Patient Withdrew from Study|0|||
13389934|NCT00689117|26772017|FG002|Overall Study|Patient Withdrew from Study|0|||
13389935|NCT00689117|26772018|FG003|Overall Study|Patient Withdrew from Study|1|||
13389936|NCT00689117|26772015|FG000|Overall Study|Personal Reason|0|||
13389937|NCT00689117|26772016|FG001|Overall Study|Personal Reason|1|||
13389938|NCT00689117|26772017|FG002|Overall Study|Personal Reason|0|||
13389939|NCT00689117|26772018|FG003|Overall Study|Personal Reason|0|||
13389940|NCT00689117|26772015|FG000|Overall Study|Dispensing Error|0|||
13389941|NCT00689117|26772016|FG001|Overall Study|Dispensing Error|1|||
13389942|NCT00689117|26772017|FG002|Overall Study|Dispensing Error|0|||
13389943|NCT00689117|26772018|FG003|Overall Study|Dispensing Error|0|||
13389944|NCT00689104|26772161|FG000|Overall Study|Eligibility criterion not met|5|||
13389945|NCT00689104|26772162|FG001|Overall Study|Eligibility criterion not met|8|||
13389946|NCT00689104|26772163|FG002|Overall Study|Eligibility criterion not met|0|||
13389947|NCT00689104|26772164|FG003|Overall Study|Eligibility criterion not met|4|||
13389948|NCT00689104|26772161|FG000|Overall Study|Adverse Event|13|||
13389949|NCT00689104|26772162|FG001|Overall Study|Adverse Event|25|||
13389950|NCT00689104|26772163|FG002|Overall Study|Adverse Event|16|||
13389951|NCT00689104|26772164|FG003|Overall Study|Adverse Event|24|||
13389952|NCT00689104|26772161|FG000|Overall Study|Lack of Efficacy|5|||
13389953|NCT00689104|26772162|FG001|Overall Study|Lack of Efficacy|6|||
13389954|NCT00689104|26772163|FG002|Overall Study|Lack of Efficacy|2|||
13389955|NCT00689104|26772164|FG003|Overall Study|Lack of Efficacy|3|||
13389956|NCT00689104|26772161|FG000|Overall Study|Withdrawal by Subject|12|||
13389957|NCT00689104|26772162|FG001|Overall Study|Withdrawal by Subject|11|||
13389958|NCT00689104|26772163|FG002|Overall Study|Withdrawal by Subject|18|||
13389959|NCT00689104|26772164|FG003|Overall Study|Withdrawal by Subject|11|||
13389960|NCT00689104|26772161|FG000|Overall Study|Lost to Follow-up|4|||
13389961|NCT00689104|26772162|FG001|Overall Study|Lost to Follow-up|3|||
13389962|NCT00689104|26772163|FG002|Overall Study|Lost to Follow-up|2|||
13389963|NCT00689104|26772164|FG003|Overall Study|Lost to Follow-up|5|||
13389964|NCT00689104|26772161|FG000|Overall Study|Protocol Violation|2|||
13389965|NCT00689104|26772162|FG001|Overall Study|Protocol Violation|3|||
13389966|NCT00689104|26772163|FG002|Overall Study|Protocol Violation|5|||
13389967|NCT00689104|26772164|FG003|Overall Study|Protocol Violation|3|||
13389968|NCT00689104|26772161|FG000|Overall Study|Randomized but never received study drug|2|||
13389969|NCT00689104|26772162|FG001|Overall Study|Randomized but never received study drug|1|||
13389970|NCT00689104|26772163|FG002|Overall Study|Randomized but never received study drug|1|||
13389971|NCT00689104|26772164|FG003|Overall Study|Randomized but never received study drug|0|||
13389972|NCT00689104|26772161|FG000|Overall Study|Physician Decision|1|||
13389973|NCT00689104|26772162|FG001|Overall Study|Physician Decision|0|||
13389974|NCT00689104|26772163|FG002|Overall Study|Physician Decision|0|||
13389975|NCT00689104|26772164|FG003|Overall Study|Physician Decision|0|||
13389976|NCT00689104|26772161|FG000|Overall Study|Non-compliance with study procedures|0|||
13389977|NCT00689104|26772162|FG001|Overall Study|Non-compliance with study procedures|0|||
13395556|NCT00645853|26790720|FG001|Overall Study|AZ study closure in Hungary|40|||
13395557|NCT00645853|26790719|FG000|Overall Study|Withdrawal by Subject|5|||
13395558|NCT00645853|26790720|FG001|Overall Study|Withdrawal by Subject|2|||
13395559|NCT00645853|26790719|FG000|Overall Study|Protocol Violation|0|||
13395560|NCT00645853|26790720|FG001|Overall Study|Protocol Violation|2|||
13395561|NCT00645853|26790719|FG000|Overall Study|Discontinuation criteria|2|||
13395562|NCT00645853|26790720|FG001|Overall Study|Discontinuation criteria|2|||
13395563|NCT00645853|26790719|FG000|Overall Study|recall of ICF, planned operation, death|7|||
13395564|NCT00645853|26790720|FG001|Overall Study|recall of ICF, planned operation, death|4|||
13395565|NCT00645840|26790727|FG000|Overall Study|Protocol Violation|3|||
13395566|NCT00645788|26790790|FG000|Overall Study|Did not receive study drug|1|||
13395567|NCT00645788|26790791|FG001|Overall Study|Did not receive study drug|1|||
13395568|NCT00645788|26790792|FG002|Overall Study|Did not receive study drug|0|||
13395569|NCT00645788|26790793|FG003|Overall Study|Did not receive study drug|0|||
13389978|NCT00689104|26772163|FG002|Overall Study|Non-compliance with study procedures|1|||
13389979|NCT00689104|26772164|FG003|Overall Study|Non-compliance with study procedures|0|||
13389980|NCT00689052|26772201|FG000|Overall Study|Adverse Event|4|||
13389981|NCT00689052|26772202|FG001|Overall Study|Adverse Event|6|||
13389982|NCT00689052|26772201|FG000|Overall Study|Protocol Violation|1|||
13389983|NCT00689052|26772202|FG001|Overall Study|Protocol Violation|0|||
13389984|NCT00689052|26772201|FG000|Overall Study|Lost to Follow-up|2|||
13389985|NCT00689052|26772202|FG001|Overall Study|Lost to Follow-up|0|||
13389986|NCT00689052|26772201|FG000|Overall Study|Withdrawal by Subject|2|||
13389987|NCT00689052|26772202|FG001|Overall Study|Withdrawal by Subject|0|||
13389988|NCT00689052|26772201|FG000|Overall Study|Early termination of the trial|22|||
13389989|NCT00689052|26772202|FG001|Overall Study|Early termination of the trial|24|||
13389990|NCT00689026|26772215|FG000|Overall Study|Withdrawal by Subject|13|||
13389991|NCT00689026|26772216|FG001|Overall Study|Withdrawal by Subject|6|||
13389992|NCT00688909|26772227|FG000|Overall Study|Adverse Event|28|||
13389993|NCT00688909|26772227|FG000|Overall Study|Patient withdrew consent|2|||
13389994|NCT00688909|26772227|FG000|Overall Study|Administrative problems|1|||
13389995|NCT00688909|26772227|FG000|Overall Study|Protocol Violation|2|||
13389996|NCT00688844|26772239|FG000|Overall Study|Lost to Follow-up|10|||
13389997|NCT00688753|26772250|FG000|Overall Study|Disease progression|55|||
13389998|NCT00688753|26772250|FG000|Overall Study|Missing|1|||
13389999|NCT00688753|26772250|FG000|Overall Study|Death|9|||
13390000|NCT00688753|26772250|FG000|Overall Study|Withdrawal by Subject|3|||
13390001|NCT00688753|26772250|FG000|Overall Study|Adverse Event|20|||
13390002|NCT00688753|26772250|FG000|Overall Study|Protocol Violation|1|||
13390003|NCT00688753|26772250|FG000|Overall Study|Lost to Follow-up|3|||
13390004|NCT00688740|26772267|FG000|Overall Study|Adverse Event|45|||
13390005|NCT00688740|26772268|FG001|Overall Study|Adverse Event|8|||
13390006|NCT00688740|26772267|FG000|Overall Study|Death|2|||
13390007|NCT00688740|26772268|FG001|Overall Study|Death|2|||
13390008|NCT00688740|26772267|FG000|Overall Study|Lost to Follow-up|0|||
13390009|NCT00688740|26772268|FG001|Overall Study|Lost to Follow-up|1|||
13390010|NCT00688740|26772267|FG000|Overall Study|Consent Withdrawn|17|||
13390011|NCT00688740|26772268|FG001|Overall Study|Consent Withdrawn|17|||
13390012|NCT00688740|26772267|FG000|Overall Study|Breast Cancer Relapse|1|||
13390013|NCT00688740|26772268|FG001|Overall Study|Breast Cancer Relapse|4|||
13390014|NCT00688740|26772267|FG000|Overall Study|Violation of Inclusion Criteria|1|||
13390015|NCT00688740|26772268|FG001|Overall Study|Violation of Inclusion Criteria|3|||
13390016|NCT00688701|26772317|FG000|Overall Study|Adverse Event|1|||
13390017|NCT00688701|26772318|FG001|Overall Study|Adverse Event|0|||
13390018|NCT00688701|26772319|FG002|Overall Study|Adverse Event|5|||
13390019|NCT00688701|26772320|FG003|Overall Study|Adverse Event|3|||
13390020|NCT00688701|26772317|FG000|Overall Study|Lack of Efficacy|0|||
13390021|NCT00688701|26772318|FG001|Overall Study|Lack of Efficacy|1|||
13390022|NCT00688701|26772319|FG002|Overall Study|Lack of Efficacy|0|||
13390023|NCT00688701|26772320|FG003|Overall Study|Lack of Efficacy|0|||
13390024|NCT00688701|26772317|FG000|Overall Study|Withdrawal by Subject|3|||
13390025|NCT00688701|26772318|FG001|Overall Study|Withdrawal by Subject|3|||
13390026|NCT00688701|26772319|FG002|Overall Study|Withdrawal by Subject|4|||
13390027|NCT00688701|26772320|FG003|Overall Study|Withdrawal by Subject|8|||
13390028|NCT00688701|26772317|FG000|Overall Study|Poor compliance to protocol|0|||
13390029|NCT00688701|26772318|FG001|Overall Study|Poor compliance to protocol|1|||
13390030|NCT00688701|26772319|FG002|Overall Study|Poor compliance to protocol|1|||
13390031|NCT00688701|26772320|FG003|Overall Study|Poor compliance to protocol|0|||
13390032|NCT00688688|26772419|FG000|Overall Study|Eligibility criterion not met|7|||
13390033|NCT00688688|26772420|FG001|Overall Study|Eligibility criterion not met|7|||
13390034|NCT00688688|26772421|FG002|Overall Study|Eligibility criterion not met|10|||
13390035|NCT00688688|26772419|FG000|Overall Study|Adverse Event|52|||
13390036|NCT00688688|26772420|FG001|Overall Study|Adverse Event|51|||
13390037|NCT00688688|26772421|FG002|Overall Study|Adverse Event|50|||
13390038|NCT00688688|26772419|FG000|Overall Study|Lack of Efficacy|34|||
13390039|NCT00688688|26772420|FG001|Overall Study|Lack of Efficacy|25|||
13390040|NCT00688688|26772421|FG002|Overall Study|Lack of Efficacy|45|||
13390041|NCT00688688|26772419|FG000|Overall Study|Withdrawal by Subject|66|||
13390042|NCT00688688|26772420|FG001|Overall Study|Withdrawal by Subject|75|||
13390043|NCT00688688|26772421|FG002|Overall Study|Withdrawal by Subject|65|||
13390044|NCT00688688|26772419|FG000|Overall Study|Lost to Follow-up|14|||
13390045|NCT00688688|26772420|FG001|Overall Study|Lost to Follow-up|7|||
13390046|NCT00688688|26772421|FG002|Overall Study|Lost to Follow-up|7|||
13390047|NCT00688688|26772419|FG000|Overall Study|Protocol Violation|6|||
13390048|NCT00688688|26772420|FG001|Overall Study|Protocol Violation|9|||
13390049|NCT00688688|26772421|FG002|Overall Study|Protocol Violation|11|||
13390050|NCT00688688|26772419|FG000|Overall Study|Randomized but never received study drug|1|||
13390051|NCT00688688|26772420|FG001|Overall Study|Randomized but never received study drug|0|||
13390052|NCT00688688|26772421|FG002|Overall Study|Randomized but never received study drug|0|||
13390053|NCT00688688|26772419|FG000|Overall Study|Non-compliance with study procedures|5|||
13390054|NCT00688688|26772420|FG001|Overall Study|Non-compliance with study procedures|3|||
13390055|NCT00688688|26772421|FG002|Overall Study|Non-compliance with study procedures|4|||
13390056|NCT00688688|26772419|FG000|Overall Study|Taking exclusionary medications|1|||
13390057|NCT00688688|26772420|FG001|Overall Study|Taking exclusionary medications|0|||
13390058|NCT00688688|26772421|FG002|Overall Study|Taking exclusionary medications|0|||
13390059|NCT00688688|26772419|FG000|Overall Study|Site closure|0|||
13390060|NCT00688688|26772420|FG001|Overall Study|Site closure|1|||
13390061|NCT00688688|26772421|FG002|Overall Study|Site closure|0|||
13390062|NCT00688688|26772419|FG000|Overall Study|Violation of exclusion criterion|0|||
13390063|NCT00688688|26772420|FG001|Overall Study|Violation of exclusion criterion|1|||
13390064|NCT00688688|26772421|FG002|Overall Study|Violation of exclusion criterion|0|||
13390065|NCT00688636|26772442|FG000|Overall Study|Adverse Event|2|||
13390066|NCT00688636|26772443|FG001|Overall Study|Adverse Event|1|||
13390067|NCT00688623|26772456|FG000|Overall Study|Adverse Event|22|||
13390068|NCT00688623|26772456|FG000|Overall Study|abnormal lab value|1|||
13390069|NCT00688623|26772456|FG000|Overall Study|Withdrawal by Subject|4|||
13390070|NCT00688623|26772456|FG000|Overall Study|Death|3|||
13390071|NCT00688623|26772456|FG000|Overall Study|disease progression|23|||
13390072|NCT00688623|26772456|FG000|Overall Study|Protocol Violation|2|||
13390073|NCT00688597|26772477|FG000|Overall Study|Adverse Event|2|||
13390074|NCT00688597|26772478|FG001|Overall Study|Adverse Event|0|||
13390075|NCT00688597|26772479|FG002|Overall Study|Adverse Event|0|||
13390076|NCT00688597|26772477|FG000|Overall Study|Physician Decision|1|||
13390077|NCT00688597|26772478|FG001|Overall Study|Physician Decision|0|||
13390078|NCT00688597|26772479|FG002|Overall Study|Physician Decision|0|||
13219848|NCT01830543|26278437|FG001|Overall Study|Other|17|||
13219849|NCT01830543|26278438|FG002|Overall Study|Other|37|||
13219850|NCT01830127|26278453|FG000|Overall Study|Adverse Event|1|||
13219851|NCT01830127|26278454|FG001|Overall Study|Adverse Event|6|||
13219852|NCT01830127|26278453|FG000|Overall Study|Lack of Efficacy|3|||
13219853|NCT01830127|26278454|FG001|Overall Study|Lack of Efficacy|0|||
13219854|NCT01830127|26278453|FG000|Overall Study|Withdrawal by Subject|1|||
13219855|NCT01830127|26278454|FG001|Overall Study|Withdrawal by Subject|1|||
13219856|NCT01830127|26278453|FG000|Overall Study|Other reason not defined above|0|||
13219857|NCT01830127|26278454|FG001|Overall Study|Other reason not defined above|2|||
13219858|NCT01829477|26278471|FG000|Overall Study|Study Terminated by Sponsor|15|||
13219859|NCT01829477|26278472|FG001|Overall Study|Study Terminated by Sponsor|15|||
13219860|NCT01829477|26278471|FG000|Overall Study|Withdrawal by Subject|1|||
13219861|NCT01829477|26278472|FG001|Overall Study|Withdrawal by Subject|0|||
13219862|NCT01829464|26278496|FG000|Overall Study|Adverse Event|1|||
13219863|NCT01829464|26278497|FG001|Overall Study|Adverse Event|0|||
13219864|NCT01829464|26278498|FG002|Overall Study|Adverse Event|0|||
13219865|NCT01829464|26278496|FG000|Overall Study|Lost to Follow-up|0|||
13219866|NCT01829464|26278497|FG001|Overall Study|Lost to Follow-up|0|||
13219867|NCT01829464|26278498|FG002|Overall Study|Lost to Follow-up|1|||
13219868|NCT01829464|26278496|FG000|Overall Study|Withdrawal by Subject|2|||
13219869|NCT01829464|26278497|FG001|Overall Study|Withdrawal by Subject|0|||
13219870|NCT01829464|26278498|FG002|Overall Study|Withdrawal by Subject|0|||
13219871|NCT01829464|26278496|FG000|Overall Study|Study terminated by sponsor|25|||
13219872|NCT01829464|26278497|FG001|Overall Study|Study terminated by sponsor|28|||
13219873|NCT01829464|26278498|FG002|Overall Study|Study terminated by sponsor|25|||
13219874|NCT01829464|26278496|FG000|Overall Study|Lack of Efficacy|0|||
13219875|NCT01829464|26278497|FG001|Overall Study|Lack of Efficacy|1|||
13219876|NCT01829464|26278498|FG002|Overall Study|Lack of Efficacy|0|||
13219877|NCT01829425|26278533|FG000|Overall Study|Withdrawal by Subject|4|||
13219878|NCT01829425|26278534|FG001|Overall Study|Withdrawal by Subject|3|||
13219879|NCT01829425|26278533|FG000|Overall Study|Lost to Follow-up|2|||
13219880|NCT01829425|26278534|FG001|Overall Study|Lost to Follow-up|1|||
13219881|NCT01829360|26278565|FG000|Overall Study|Protocol Violation|0|||
13219882|NCT01829360|26278566|FG001|Overall Study|Protocol Violation|0|||
13219883|NCT01829360|26278567|FG002|Overall Study|Protocol Violation|1|||
13219884|NCT01829360|26278568|FG003|Overall Study|Protocol Violation|0|||
13219885|NCT01829347|26278583|FG000|VTI-210|Death|5|||
13219886|NCT01829347|26278584|FG001|VTI-210|Death|3|||
13219887|NCT01829347|26278583|FG000|VTI-210|Withdrawal by Subject|1|||
13219888|NCT01829347|26278584|FG001|VTI-210|Withdrawal by Subject|0|||
13219889|NCT01829347|26278583|FG000|VTI-210E|Death|2|||
13219890|NCT01829347|26278584|FG001|VTI-210E|Death|1|||
13219891|NCT01829347|26278583|FG000|VTI-210E|Study terminated prematurely|1|||
13219892|NCT01829347|26278584|FG001|VTI-210E|Study terminated prematurely|5|||
13219893|NCT01829295|26278603|FG000|6-12 Months|Did not want to switch antimetabolites|0|||
13219894|NCT01829295|26278604|FG001|6-12 Months|Did not want to switch antimetabolites|0|||
13219895|NCT01829295|26278605|FG002|6-12 Months|Did not want to switch antimetabolites|9|||
13390079|NCT00688545|26772494|FG000|Overall Study|Lost to Follow-up|1|||
13390080|NCT00688545|26772495|FG001|Overall Study|Lost to Follow-up|4|||
13390081|NCT00688545|26772494|FG000|Overall Study|Insurance/cost of drug|0|||
13390082|NCT00688545|26772495|FG001|Overall Study|Insurance/cost of drug|1|||
13390083|NCT00688545|26772494|FG000|Overall Study|Withdrawal by Subject|2|||
13390084|NCT00688545|26772495|FG001|Overall Study|Withdrawal by Subject|3|||
13390085|NCT00688545|26772494|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2|||
13390086|NCT00688545|26772495|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7|||
13219896|NCT01829295|26278606|FG003|6-12 Months|Did not want to switch antimetabolites|11|||
13390087|NCT00688519|26772518|FG000|Overall Study|Adverse Event|2|||
13390088|NCT00688519|26772519|FG001|Overall Study|Adverse Event|3|||
13390089|NCT00688519|26772518|FG000|Overall Study|Lost to Follow-up|3|||
13390090|NCT00688519|26772519|FG001|Overall Study|Lost to Follow-up|3|||
13390091|NCT00688519|26772518|FG000|Overall Study|Lack of Efficacy|3|||
13390092|NCT00688519|26772519|FG001|Overall Study|Lack of Efficacy|1|||
13390093|NCT00688519|26772518|FG000|Overall Study|Withdrawal by Subject|7|||
13390094|NCT00688519|26772519|FG001|Overall Study|Withdrawal by Subject|6|||
13390095|NCT00688519|26772518|FG000|Overall Study|Prohibited medication|1|||
13390096|NCT00688519|26772519|FG001|Overall Study|Prohibited medication|0|||
13390097|NCT00688519|26772518|FG000|Overall Study|Non-compliance|0|||
13390098|NCT00688519|26772519|FG001|Overall Study|Non-compliance|1|||
13390099|NCT00688519|26772518|FG000|Overall Study|Subject moved out of state|1|||
13390100|NCT00688519|26772519|FG001|Overall Study|Subject moved out of state|0|||
13390101|NCT00688519|26772518|FG000|Overall Study|Investigator decision|1|||
13390102|NCT00688519|26772519|FG001|Overall Study|Investigator decision|0|||
13390103|NCT00688519|26772518|FG000|Overall Study|Subject moved out of area|1|||
13390104|NCT00688519|26772519|FG001|Overall Study|Subject moved out of area|0|||
13390105|NCT00688519|26772518|FG000|Overall Study|Pregnancy|0|||
13390106|NCT00688519|26772519|FG001|Overall Study|Pregnancy|1|||
13390107|NCT00688467|26772556|FG000|Treatment Period 1|Adverse Event|2|||
13390108|NCT00688467|26772557|FG001|Treatment Period 1|Adverse Event|1|||
13390109|NCT00688467|26772556|FG000|Treatment Period 1|Did not meet protocol eligibility|0|||
13390110|NCT00688467|26772557|FG001|Treatment Period 1|Did not meet protocol eligibility|1|||
13390111|NCT00688467|26772556|FG000|Treatment Period 2|Protocol Violation|0|||
13390112|NCT00688467|26772557|FG001|Treatment Period 2|Protocol Violation|1|||
13390113|NCT00688467|26772556|FG000|Treatment Period 2|Adverse Event|0|||
13390114|NCT00688467|26772557|FG001|Treatment Period 2|Adverse Event|1|||
13390115|NCT00688324|26772602|FG000|Overall Study|Withdrawal by Subject|2|||
13390116|NCT00688324|26772602|FG000|Overall Study|Physician Decision|5|||
13390117|NCT00688324|26772602|FG000|Overall Study|Lost to Follow-up|1|||
13395570|NCT00645788|26790790|FG000|Overall Study|Adverse Event|4|||
13395571|NCT00645788|26790791|FG001|Overall Study|Adverse Event|9|||
13395572|NCT00645788|26790792|FG002|Overall Study|Adverse Event|5|||
13395573|NCT00645788|26790793|FG003|Overall Study|Adverse Event|3|||
13395574|NCT00645788|26790790|FG000|Overall Study|Lost to Follow-up|1|||
13395575|NCT00645788|26790791|FG001|Overall Study|Lost to Follow-up|0|||
13395576|NCT00645788|26790792|FG002|Overall Study|Lost to Follow-up|0|||
13395577|NCT00645788|26790793|FG003|Overall Study|Lost to Follow-up|0|||
13395578|NCT00645788|26790790|FG000|Overall Study|Protocol Violation|1|||
13395579|NCT00645788|26790791|FG001|Overall Study|Protocol Violation|0|||
13395580|NCT00645788|26790792|FG002|Overall Study|Protocol Violation|2|||
13395581|NCT00645788|26790793|FG003|Overall Study|Protocol Violation|0|||
13395582|NCT00645788|26790790|FG000|Overall Study|Withdrawal by Subject|0|||
13395583|NCT00645788|26790791|FG001|Overall Study|Withdrawal by Subject|1|||
13395584|NCT00645788|26790792|FG002|Overall Study|Withdrawal by Subject|0|||
13395585|NCT00645788|26790793|FG003|Overall Study|Withdrawal by Subject|2|||
13395586|NCT00645788|26790790|FG000|Overall Study|Pulmonary exacerbation|13|||
13395587|NCT00645788|26790791|FG001|Overall Study|Pulmonary exacerbation|16|||
13395588|NCT00645788|26790792|FG002|Overall Study|Pulmonary exacerbation|11|||
13395589|NCT00645788|26790793|FG003|Overall Study|Pulmonary exacerbation|9|||
13395590|NCT00645671|26790812|FG000|Overall Study|Protocol Violation|1|||
13395591|NCT00645671|26790813|FG001|Overall Study|Protocol Violation|0|||
13395592|NCT00645671|26790812|FG000|Overall Study|Withdrawal by Subject|0|||
13395593|NCT00645671|26790813|FG001|Overall Study|Withdrawal by Subject|4|||
13395594|NCT00645671|26790812|FG000|Overall Study|Adverse Event|0|||
13395595|NCT00645671|26790813|FG001|Overall Study|Adverse Event|1|||
13395596|NCT00645671|26790812|FG000|Overall Study|Physician Decision|0|||
13395597|NCT00645671|26790813|FG001|Overall Study|Physician Decision|1|||
13395598|NCT00645593|26790832|FG000|Overall Study|Later found to be ineligible|1|||
13395599|NCT00645593|26790833|FG001|Overall Study|Later found to be ineligible|0|||
13395600|NCT00645567|26790843|FG000|Overall Study|Adverse Event|1|||
13395601|NCT00645528|26790854|FG000|Overall Study|Did not show up for Visit 2|7|||
13395602|NCT00645411|26790899|FG000|Overall Study|Adverse Event|0|||
13395603|NCT00645411|26790900|FG001|Overall Study|Adverse Event|0|||
13395604|NCT00645411|26790901|FG002|Overall Study|Adverse Event|0|||
13395605|NCT00645411|26790902|FG003|Overall Study|Adverse Event|2|||
13395606|NCT00645411|26790899|FG000|Overall Study|Withdrawal by Subject|2|||
13395607|NCT00645411|26790900|FG001|Overall Study|Withdrawal by Subject|1|||
13395608|NCT00645411|26790901|FG002|Overall Study|Withdrawal by Subject|19|||
13395609|NCT00645411|26790902|FG003|Overall Study|Withdrawal by Subject|21|||
13395610|NCT00645411|26790899|FG000|Overall Study|Lost to Follow-up|10|||
13395611|NCT00645411|26790900|FG001|Overall Study|Lost to Follow-up|5|||
13395612|NCT00645411|26790901|FG002|Overall Study|Lost to Follow-up|124|||
13395613|NCT00645411|26790902|FG003|Overall Study|Lost to Follow-up|75|||
13395614|NCT00645411|26790899|FG000|Overall Study|Protocol Violation|1|||
13395615|NCT00645411|26790900|FG001|Overall Study|Protocol Violation|0|||
13395616|NCT00645411|26790901|FG002|Overall Study|Protocol Violation|1|||
13395617|NCT00645411|26790902|FG003|Overall Study|Protocol Violation|0|||
13390118|NCT00688259|26772625|FG000|Overall Study|Lost to Follow-up|2|||
13390119|NCT00688259|26772626|FG001|Overall Study|Lost to Follow-up|4|||
13390120|NCT00688259|26772625|FG000|Overall Study|Physician Decision|1|||
13390121|NCT00688259|26772626|FG001|Overall Study|Physician Decision|0|||
13390122|NCT00688259|26772625|FG000|Overall Study|Withdrawal by Subject|2|||
13390123|NCT00688259|26772626|FG001|Overall Study|Withdrawal by Subject|0|||
13390124|NCT00688259|26772625|FG000|Overall Study|Declined Interview|2|||
13390125|NCT00688259|26772626|FG001|Overall Study|Declined Interview|3|||
13390126|NCT00688259|26772625|FG000|Overall Study|Hospitalized at Follow-up|0|||
13390127|NCT00688259|26772626|FG001|Overall Study|Hospitalized at Follow-up|1|||
13390128|NCT00688181|26772635|FG000|Overall Study|Lost to Follow-up|17|||
13390129|NCT00688181|26772635|FG000|Overall Study|Unknown Reason|4|||
13390130|NCT00688181|26772635|FG000|Overall Study|Non-clinical Reason|2|||
13390131|NCT00688155|26772666|FG000|Overall Study|Withdrawal by Subject|2|||
13390132|NCT00688155|26772667|FG001|Overall Study|Withdrawal by Subject|2|||
13390133|NCT00688155|26772668|FG002|Overall Study|Withdrawal by Subject|1|||
13390134|NCT00688155|26772669|FG003|Overall Study|Withdrawal by Subject|1|||
13390135|NCT00688103|26772686|FG000|Overall Study|Adverse Event|4|||
13390136|NCT00688103|26772687|FG001|Overall Study|Adverse Event|1|||
13390137|NCT00688103|26772686|FG000|Overall Study|Lack of Efficacy|11|||
13390138|NCT00688103|26772687|FG001|Overall Study|Lack of Efficacy|1|||
13390139|NCT00688103|26772686|FG000|Overall Study|Withdrawal by Subject|4|||
13390140|NCT00688103|26772687|FG001|Overall Study|Withdrawal by Subject|2|||
13390141|NCT00688103|26772686|FG000|Overall Study|complex reasons|11|||
13390142|NCT00688103|26772687|FG001|Overall Study|complex reasons|9|||
13390143|NCT00688064|26772708|FG000|Overall Study|Protocol Violation|0|||
13390144|NCT00688064|26772709|FG001|Overall Study|Protocol Violation|1|||
13390145|NCT00688064|26772708|FG000|Overall Study|Adverse Event|2|||
13390146|NCT00688064|26772709|FG001|Overall Study|Adverse Event|4|||
13390147|NCT00688064|26772708|FG000|Overall Study|Withdrawal by Subject|7|||
13390148|NCT00688064|26772709|FG001|Overall Study|Withdrawal by Subject|7|||
13390149|NCT00688064|26772708|FG000|Overall Study|Lost to Follow-up|10|||
13390150|NCT00688064|26772709|FG001|Overall Study|Lost to Follow-up|10|||
13390151|NCT00688064|26772708|FG000|Overall Study|Lack of Efficacy|0|||
13390152|NCT00688064|26772709|FG001|Overall Study|Lack of Efficacy|1|||
13390153|NCT00688064|26772708|FG000|Overall Study|Pregnancy|1|||
13390154|NCT00688064|26772709|FG001|Overall Study|Pregnancy|0|||
13390155|NCT00688064|26772708|FG000|Overall Study|Any other reasons|1|||
13390156|NCT00688064|26772709|FG001|Overall Study|Any other reasons|3|||
13390157|NCT00687973|26772743|FG000|Overall Study|Adverse Event|18|||
13390158|NCT00687973|26772744|FG001|Overall Study|Adverse Event|28|||
13390159|NCT00687973|26772743|FG000|Overall Study|Lack of Efficacy|2|||
13390160|NCT00687973|26772744|FG001|Overall Study|Lack of Efficacy|3|||
13390161|NCT00687973|26772743|FG000|Overall Study|Protocol Violation|1|||
13390162|NCT00687973|26772744|FG001|Overall Study|Protocol Violation|2|||
13390163|NCT00687973|26772743|FG000|Overall Study|Administrative Reasons|0|||
13390164|NCT00687973|26772744|FG001|Overall Study|Administrative Reasons|2|||
13390165|NCT00687973|26772743|FG000|Overall Study|Withdrawal by Subject|3|||
13390166|NCT00687973|26772744|FG001|Overall Study|Withdrawal by Subject|3|||
13390167|NCT00687804|26772797|FG000|Core Study|Adverse Event|5|||
13390168|NCT00687804|26772798|FG001|Core Study|Adverse Event|3|||
13390169|NCT00687804|26772799|FG002|Core Study|Adverse Event|3|||
13390170|NCT00687804|26772797|FG000|Core Study|Abnormal laboratory value(s)|1|||
13390171|NCT00687804|26772798|FG001|Core Study|Abnormal laboratory value(s)|0|||
13390172|NCT00687804|26772799|FG002|Core Study|Abnormal laboratory value(s)|0|||
13390173|NCT00687804|26772797|FG000|Core Study|Lack of Efficacy|1|||
13390174|NCT00687804|26772798|FG001|Core Study|Lack of Efficacy|1|||
13390175|NCT00687804|26772799|FG002|Core Study|Lack of Efficacy|1|||
13390176|NCT00687804|26772797|FG000|Core Study|Withdrawal by Subject|4|||
13390177|NCT00687804|26772798|FG001|Core Study|Withdrawal by Subject|7|||
13390178|NCT00687804|26772799|FG002|Core Study|Withdrawal by Subject|7|||
13390179|NCT00687804|26772797|FG000|Core Study|Lost to Follow-up|0|||
13390180|NCT00687804|26772798|FG001|Core Study|Lost to Follow-up|1|||
13390181|NCT00687804|26772799|FG002|Core Study|Lost to Follow-up|0|||
13390182|NCT00687804|26772797|FG000|Core Study|Death|2|||
13390183|NCT00687804|26772798|FG001|Core Study|Death|2|||
13390184|NCT00687804|26772799|FG002|Core Study|Death|2|||
13390185|NCT00687804|26772797|FG000|Core Study|Protocol Violation|1|||
13390186|NCT00687804|26772798|FG001|Core Study|Protocol Violation|1|||
13390187|NCT00687804|26772799|FG002|Core Study|Protocol Violation|0|||
13390188|NCT00687804|26772797|FG000|Open-Label Extension Study|Adverse Event|2|||
13390189|NCT00687804|26772798|FG001|Open-Label Extension Study|Adverse Event|2|||
13390190|NCT00687804|26772799|FG002|Open-Label Extension Study|Adverse Event|2|||
13390191|NCT00687804|26772797|FG000|Open-Label Extension Study|Subject withdrew consent|3|||
13390192|NCT00687804|26772798|FG001|Open-Label Extension Study|Subject withdrew consent|4|||
13390193|NCT00687804|26772799|FG002|Open-Label Extension Study|Subject withdrew consent|4|||
13390194|NCT00687804|26772797|FG000|Open-Label Extension Study|Lost to Follow-up|2|||
13390195|NCT00687804|26772798|FG001|Open-Label Extension Study|Lost to Follow-up|1|||
13390196|NCT00687804|26772799|FG002|Open-Label Extension Study|Lost to Follow-up|2|||
13390197|NCT00687804|26772797|FG000|Open-Label Extension Study|Administrative problems|1|||
13390198|NCT00687804|26772798|FG001|Open-Label Extension Study|Administrative problems|1|||
13390199|NCT00687804|26772799|FG002|Open-Label Extension Study|Administrative problems|0|||
13390200|NCT00687804|26772797|FG000|Open-Label Extension Study|Death|2|||
13390201|NCT00687804|26772798|FG001|Open-Label Extension Study|Death|3|||
13390202|NCT00687804|26772799|FG002|Open-Label Extension Study|Death|3|||
13390203|NCT00687739|26772836|FG000|Overall Study|Lost to Follow-up|2|||
13390204|NCT00687739|26772837|FG001|Overall Study|Lost to Follow-up|2|||
13390205|NCT00687739|26772838|FG002|Overall Study|Lost to Follow-up|1|||
13390206|NCT00687739|26772839|FG003|Overall Study|Lost to Follow-up|2|||
13390207|NCT00687739|26772836|FG000|Overall Study|Adverse Event|0|||
13390208|NCT00687739|26772837|FG001|Overall Study|Adverse Event|1|||
13390209|NCT00687739|26772838|FG002|Overall Study|Adverse Event|1|||
13390210|NCT00687739|26772839|FG003|Overall Study|Adverse Event|0|||
13390211|NCT00687609|26772855|FG000|Overall Study|Physician Decision|1|||
13390212|NCT00687609|26772855|FG000|Overall Study|Withdrawal by Subject|2|||
13390213|NCT00687440|26772861|FG000|Overall Study|Adverse Event|3|||
13390214|NCT00687440|26772861|FG000|Overall Study|Lost to Follow-up|3|||
13390215|NCT00687440|26772861|FG000|Overall Study|Lack of Efficacy|2|||
13390216|NCT00687440|26772861|FG000|Overall Study|Death|2|||
13390217|NCT00687440|26772861|FG000|Overall Study|Other|1|||
13390218|NCT00687440|26772861|FG000|Overall Study|Missing|1|||
13390219|NCT00687401|26772868|FG000|Overall Study|Protocol Violation|7|||
13390220|NCT00687401|26772868|FG000|Overall Study|Adverse Event|6|||
13390221|NCT00687401|26772868|FG000|Overall Study|Lack of Efficacy|6|||
13390222|NCT00687401|26772868|FG000|Overall Study|Withdrawal by Subject|4|||
13390223|NCT00687401|26772868|FG000|Overall Study|Did not return for visit|3|||
13390224|NCT00687401|26772868|FG000|Overall Study|For reasons different from those above|4|||
13390225|NCT00687362|26772874|FG000|Overall Study|Protocol Violation|2|||
13390226|NCT00687362|26772874|FG000|Overall Study|Withdrawal by Subject|1|||
13390227|NCT00687323|26772890|FG000|Overall Study|Death|25|||
13390228|NCT00687323|26772890|FG000|Overall Study|Withdrawal by Subject|1|||
13390229|NCT00687323|26772890|FG000|Overall Study|Excluded from efficacy evaluations|6|||
13390230|NCT00687323|26772890|FG000|Overall Study|Screen failure|148|||
13390231|NCT00687297|26772907|FG000|Randomization|Withdrawal by Subject|2|||
13390232|NCT00687297|26772908|FG001|Randomization|Withdrawal by Subject|0|||
13390233|NCT00687297|26772907|FG000|Randomization|Withdrew before treatment, ineligible|1|||
13390234|NCT00687297|26772908|FG001|Randomization|Withdrew before treatment, ineligible|1|||
13390235|NCT00687297|26772907|FG000|Induction|Withdrawal by Subject|4|||
13390236|NCT00687297|26772908|FG001|Induction|Withdrawal by Subject|4|||
13390237|NCT00687297|26772907|FG000|Induction|Adverse Event|16|||
13390238|NCT00687297|26772908|FG001|Induction|Adverse Event|15|||
13390239|NCT00687297|26772907|FG000|Induction|Death|7|||
13390240|NCT00687297|26772908|FG001|Induction|Death|11|||
13390241|NCT00687297|26772907|FG000|Induction|Lack of Efficacy|17|||
13390242|NCT00687297|26772908|FG001|Induction|Lack of Efficacy|21|||
13390243|NCT00687297|26772907|FG000|Induction|Ineligible|0|||
13390244|NCT00687297|26772908|FG001|Induction|Ineligible|1|||
13390245|NCT00687297|26772907|FG000|Induction|Patient Noncompliance|1|||
13390246|NCT00687297|26772908|FG001|Induction|Patient Noncompliance|0|||
13390247|NCT00687297|26772907|FG000|Induction|Physician Decision|0|||
13390248|NCT00687297|26772908|FG001|Induction|Physician Decision|2|||
13390249|NCT00687297|26772907|FG000|Induction|Other|0|||
13390250|NCT00687297|26772908|FG001|Induction|Other|1|||
13390251|NCT00687271|26772959|FG000|Overall Study|Adverse Event|1|||
13390252|NCT00687271|26772960|FG001|Overall Study|Adverse Event|3|||
13390253|NCT00687271|26772961|FG002|Overall Study|Adverse Event|1|||
13390254|NCT00687271|26772962|FG003|Overall Study|Adverse Event|0|||
13390255|NCT00687271|26772959|FG000|Overall Study|Lost to Follow-up|0|||
13390256|NCT00687271|26772960|FG001|Overall Study|Lost to Follow-up|1|||
13390257|NCT00687271|26772961|FG002|Overall Study|Lost to Follow-up|0|||
13390258|NCT00687271|26772962|FG003|Overall Study|Lost to Follow-up|0|||
13390259|NCT00687271|26772959|FG000|Overall Study|Protocol Violation|2|||
13390260|NCT00687271|26772960|FG001|Overall Study|Protocol Violation|1|||
13390261|NCT00687271|26772961|FG002|Overall Study|Protocol Violation|1|||
13390262|NCT00687271|26772962|FG003|Overall Study|Protocol Violation|0|||
13390263|NCT00687271|26772959|FG000|Overall Study|Withdrawal by Subject|0|||
13390264|NCT00687271|26772960|FG001|Overall Study|Withdrawal by Subject|1|||
13390265|NCT00687271|26772961|FG002|Overall Study|Withdrawal by Subject|3|||
13390266|NCT00687271|26772962|FG003|Overall Study|Withdrawal by Subject|0|||
13390267|NCT00687219|26772970|FG000|Overall Study|Adverse Event|8|||
13390268|NCT00687219|26772970|FG000|Overall Study|Discontinuance criteria met|7|||
13390269|NCT00687219|26772970|FG000|Overall Study|HCV-RNA positive conversion|34|||
13390270|NCT00687219|26772970|FG000|Overall Study|Withdrawal by Subject|1|||
13390271|NCT00687219|26772970|FG000|Overall Study|Lack of Efficacy|1|||
13390272|NCT00687193|26773153|FG000|Overall Study|Adverse Event|0|||
13390273|NCT00687193|26773154|FG001|Overall Study|Adverse Event|1|||
13390274|NCT00687193|26773155|FG002|Overall Study|Adverse Event|2|||
13390275|NCT00687193|26773156|FG003|Overall Study|Adverse Event|3|||
13390276|NCT00687193|26773157|FG004|Overall Study|Adverse Event|0|||
13390277|NCT00687193|26773158|FG005|Overall Study|Adverse Event|2|||
13390278|NCT00687193|26773153|FG000|Overall Study|Lack of Efficacy|1|||
13390279|NCT00687193|26773154|FG001|Overall Study|Lack of Efficacy|1|||
13390280|NCT00687193|26773155|FG002|Overall Study|Lack of Efficacy|0|||
13390281|NCT00687193|26773156|FG003|Overall Study|Lack of Efficacy|0|||
13390282|NCT00687193|26773157|FG004|Overall Study|Lack of Efficacy|0|||
13390283|NCT00687193|26773158|FG005|Overall Study|Lack of Efficacy|2|||
13390284|NCT00687193|26773153|FG000|Overall Study|Protocol Violation|1|||
13390285|NCT00687193|26773154|FG001|Overall Study|Protocol Violation|2|||
13390286|NCT00687193|26773155|FG002|Overall Study|Protocol Violation|0|||
13390287|NCT00687193|26773156|FG003|Overall Study|Protocol Violation|1|||
13390288|NCT00687193|26773157|FG004|Overall Study|Protocol Violation|2|||
13390289|NCT00687193|26773158|FG005|Overall Study|Protocol Violation|0|||
13390290|NCT00686998|26773176|FG000|Overall Study|Adverse Event|3|||
13395618|NCT00645411|26790899|FG000|Overall Study|Inappropriate enrollment|0|||
13395619|NCT00645411|26790900|FG001|Overall Study|Inappropriate enrollment|0|||
13395620|NCT00645411|26790901|FG002|Overall Study|Inappropriate enrollment|4|||
13395621|NCT00645411|26790902|FG003|Overall Study|Inappropriate enrollment|1|||
13395622|NCT00645411|26790899|FG000|Overall Study|Unable to classify|0|||
13395623|NCT00645411|26790900|FG001|Overall Study|Unable to classify|0|||
13395624|NCT00645411|26790901|FG002|Overall Study|Unable to classify|3|||
13395625|NCT00645411|26790902|FG003|Overall Study|Unable to classify|4|||
13395626|NCT00645164|26790908|FG000|Overall Study|Lost to Follow-up|2|||
13395627|NCT00645164|26790908|FG000|Overall Study|Withdrawal by Subject|4|||
13395628|NCT00645164|26790908|FG000|Overall Study|Protocol Violation|1|||
13395629|NCT00645099|26790957|FG000|Overall Study|Lack of Efficacy|15|||
13395630|NCT00645099|26790958|FG001|Overall Study|Lack of Efficacy|6|||
13395631|NCT00645099|26790957|FG000|Overall Study|Withdrawal by Subject|30|||
13395632|NCT00645099|26790958|FG001|Overall Study|Withdrawal by Subject|22|||
13395633|NCT00645099|26790957|FG000|Overall Study|Lost to Follow-up|6|||
13395634|NCT00645099|26790958|FG001|Overall Study|Lost to Follow-up|4|||
13395635|NCT00645099|26790957|FG000|Overall Study|Adverse Event|11|||
13395636|NCT00645099|26790958|FG001|Overall Study|Adverse Event|5|||
13395637|NCT00645099|26790957|FG000|Overall Study|Other|9|||
13395638|NCT00645099|26790958|FG001|Overall Study|Other|5|||
13395639|NCT00644995|26790983|FG000|Overall Study|Lost to Follow-up|1|||
13395640|NCT00644995|26790984|FG001|Overall Study|Lost to Follow-up|4|||
13395641|NCT00644995|26790983|FG000|Overall Study|Refused|1|||
13395642|NCT00644995|26790984|FG001|Overall Study|Refused|0|||
13395643|NCT00644969|26791037|FG000|Treatment Phase|Randomized, not treated|1|||
13395644|NCT00644969|26791038|FG001|Treatment Phase|Randomized, not treated|0|||
13395645|NCT00644969|26791037|FG000|Treatment Phase|Adverse Event|3|||
13395646|NCT00644969|26791038|FG001|Treatment Phase|Adverse Event|0|||
13395647|NCT00644969|26791037|FG000|Treatment Phase|Withdrawal by Subject|4|||
13395648|NCT00644969|26791038|FG001|Treatment Phase|Withdrawal by Subject|0|||
13395649|NCT00644969|26791037|FG000|Treatment Phase|Lost to Follow-up|2|||
13395650|NCT00644969|26791038|FG001|Treatment Phase|Lost to Follow-up|2|||
13395651|NCT00644969|26791037|FG000|Treatment Phase|Other|4|||
13395652|NCT00644969|26791038|FG001|Treatment Phase|Other|1|||
13395653|NCT00644969|26791037|FG000|Post Treatment Phase|Death|1|||
13395654|NCT00644969|26791038|FG001|Post Treatment Phase|Death|0|||
13395655|NCT00644969|26791037|FG000|Post Treatment Phase|Withdrawal by Subject|4|||
13395656|NCT00644969|26791038|FG001|Post Treatment Phase|Withdrawal by Subject|2|||
13395657|NCT00644969|26791037|FG000|Post Treatment Phase|Lost to Follow-up|4|||
13395658|NCT00644969|26791038|FG001|Post Treatment Phase|Lost to Follow-up|1|||
13395659|NCT00644969|26791037|FG000|Post Treatment Phase|Other|1|||
13395660|NCT00644969|26791038|FG001|Post Treatment Phase|Other|0|||
13395661|NCT00644917|26791048|FG000|Overall Study|Withdrawal by Subject|2|||
13395662|NCT00644878|26791061|FG000|Overall Study|Adverse Event|2|||
13395663|NCT00644878|26791061|FG000|Overall Study|Abnormal laboratory value|3|||
13395664|NCT00644878|26791061|FG000|Overall Study|Protocol deviation|2|||
13395665|NCT00644878|26791061|FG000|Overall Study|Treatment duration completed as per protocol|11|||
13395666|NCT00644787|26791093|FG000|Period 1: Titration Phase|Adverse Event|11|||
13395667|NCT00644787|26791094|FG001|Period 1: Titration Phase|Adverse Event|0|||
13395668|NCT00644787|26791095|FG002|Period 1: Titration Phase|Adverse Event|0|||
13395669|NCT00644787|26791093|FG000|Period 1: Titration Phase|Withdrawal by Subject|2|||
13395670|NCT00644787|26791094|FG001|Period 1: Titration Phase|Withdrawal by Subject|0|||
13395671|NCT00644787|26791095|FG002|Period 1: Titration Phase|Withdrawal by Subject|0|||
13395672|NCT00644787|26791093|FG000|Period 1: Titration Phase|Physician Decision|1|||
13395673|NCT00644787|26791094|FG001|Period 1: Titration Phase|Physician Decision|0|||
13395674|NCT00644787|26791095|FG002|Period 1: Titration Phase|Physician Decision|0|||
13395675|NCT00644787|26791093|FG000|Period 1: Titration Phase|Worsening of underlying disease|5|||
13395676|NCT00644787|26791094|FG001|Period 1: Titration Phase|Worsening of underlying disease|0|||
13395677|NCT00644787|26791095|FG002|Period 1: Titration Phase|Worsening of underlying disease|0|||
13395678|NCT00644787|26791093|FG000|Period 1: Titration Phase|Worsening of complications|1|||
13475856|NCT02924064|27001311|FG001|Overall Study|Other|29|||
13390291|NCT00686998|26773177|FG001|Overall Study|Adverse Event|2|||
13390292|NCT00686998|26773178|FG002|Overall Study|Adverse Event|1|||
13390293|NCT00686998|26773176|FG000|Overall Study|Withdrawal by Subject|2|||
13390294|NCT00686998|26773177|FG001|Overall Study|Withdrawal by Subject|1|||
13390295|NCT00686998|26773178|FG002|Overall Study|Withdrawal by Subject|2|||
13390296|NCT00686998|26773176|FG000|Overall Study|Lack of Efficacy|7|||
13390297|NCT00686998|26773177|FG001|Overall Study|Lack of Efficacy|5|||
13390298|NCT00686998|26773178|FG002|Overall Study|Lack of Efficacy|0|||
13390299|NCT00686998|26773176|FG000|Overall Study|Other|0|||
13390300|NCT00686998|26773177|FG001|Overall Study|Other|0|||
13390301|NCT00686998|26773178|FG002|Overall Study|Other|1|||
13390302|NCT00686998|26773176|FG000|Overall Study|Safety Reasons|1|||
13390303|NCT00686998|26773177|FG001|Overall Study|Safety Reasons|0|||
13390304|NCT00686998|26773178|FG002|Overall Study|Safety Reasons|0|||
13390305|NCT00686972|26773184|FG000|Overall Study|P.I, Left institution. Study terminated|51|||
13390306|NCT00686959|26773209|FG000|Overall Study|Participants censored (no death events)|124|||
13390307|NCT00686959|26773210|FG001|Overall Study|Participants censored (no death events)|117|||
13390308|NCT00686920|26773229|FG000|Overall Study|Death|45|||
13390309|NCT00686920|26773230|FG001|Overall Study|Death|14|||
13390310|NCT00686920|26773229|FG000|Overall Study|Liver Transplant|23|||
13390311|NCT00686920|26773230|FG001|Overall Study|Liver Transplant|8|||
13390312|NCT00686920|26773229|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1|||
13390313|NCT00686920|26773230|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2|||
13390314|NCT00686920|26773229|FG000|Overall Study|Withdrawal by Subject|23|||
13390315|NCT00686920|26773230|FG001|Overall Study|Withdrawal by Subject|5|||
13390316|NCT00686920|26773229|FG000|Overall Study|Protocol Violation|2|||
13390317|NCT00686920|26773230|FG001|Overall Study|Protocol Violation|1|||
13390318|NCT00686920|26773229|FG000|Overall Study|Adverse Event|10|||
13390319|NCT00686920|26773230|FG001|Overall Study|Adverse Event|2|||
13390320|NCT00686920|26773229|FG000|Overall Study|Personal Reason|0|||
13390321|NCT00686920|26773230|FG001|Overall Study|Personal Reason|1|||
13390322|NCT00686920|26773229|FG000|Overall Study|Lost to Follow-up|15|||
13390323|NCT00686920|26773230|FG001|Overall Study|Lost to Follow-up|3|||
13390324|NCT00686920|26773229|FG000|Overall Study|Moved to Another State|1|||
13390325|NCT00686920|26773230|FG001|Overall Study|Moved to Another State|0|||
13390326|NCT00686920|26773229|FG000|Overall Study|Transferred to Nursing Home|1|||
13390327|NCT00686920|26773230|FG001|Overall Study|Transferred to Nursing Home|0|||
13390328|NCT00686920|26773229|FG000|Overall Study|Noncompliance|9|||
13390329|NCT00686920|26773230|FG001|Overall Study|Noncompliance|0|||
13390330|NCT00686920|26773229|FG000|Overall Study|Principal Investigator Decision|2|||
13390331|NCT00686920|26773230|FG001|Overall Study|Principal Investigator Decision|0|||
13390332|NCT00686894|26773236|FG000|Overall Study|Relapse|2|||
13390333|NCT00686894|26773236|FG000|Overall Study|Protocol Violation|4|||
13390334|NCT00686881|26773253|FG000|Overall Study|Withdrawal by Subject|11|||
13390335|NCT00686881|26773254|FG001|Overall Study|Withdrawal by Subject|18|||
13390336|NCT00686881|26773253|FG000|Overall Study|Lost to Follow-up|0|||
13390337|NCT00686881|26773254|FG001|Overall Study|Lost to Follow-up|1|||
13390338|NCT00686881|26773253|FG000|Overall Study|Treatment-related adverse event|10|||
13390339|NCT00686881|26773254|FG001|Overall Study|Treatment-related adverse event|9|||
13390340|NCT00686881|26773253|FG000|Overall Study|Met discontinuation criteria|5|||
13390341|NCT00686881|26773254|FG001|Overall Study|Met discontinuation criteria|0|||
13390342|NCT00686881|26773253|FG000|Overall Study|Onset of malignant tumor|11|||
13390343|NCT00686881|26773254|FG001|Overall Study|Onset of malignant tumor|11|||
13390344|NCT00686881|26773253|FG000|Overall Study|Lack of Efficacy|4|||
13390345|NCT00686881|26773254|FG001|Overall Study|Lack of Efficacy|3|||
13395679|NCT00644787|26791094|FG001|Period 1: Titration Phase|Worsening of complications|0|||
13395680|NCT00644787|26791095|FG002|Period 1: Titration Phase|Worsening of complications|0|||
13395681|NCT00644787|26791093|FG000|Period 1: Titration Phase|Worsening of symptoms|1|||
13395682|NCT00644787|26791094|FG001|Period 1: Titration Phase|Worsening of symptoms|0|||
13395683|NCT00644787|26791095|FG002|Period 1: Titration Phase|Worsening of symptoms|0|||
13395684|NCT00644787|26791093|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3|||
13395685|NCT00644787|26791094|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
13395686|NCT00644787|26791095|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
13395687|NCT00644787|26791093|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3|||
13395688|NCT00644787|26791094|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0|||
13395689|NCT00644787|26791095|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0|||
13395690|NCT00644787|26791093|FG000|Period 2: Double Blind Phase|Adverse Event|0|||
13395691|NCT00644787|26791094|FG001|Period 2: Double Blind Phase|Adverse Event|2|||
13395692|NCT00644787|26791095|FG002|Period 2: Double Blind Phase|Adverse Event|4|||
13395693|NCT00644787|26791093|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
13395694|NCT00644787|26791094|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1|||
13395695|NCT00644787|26791095|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
13395696|NCT00644787|26791093|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0|||
13395697|NCT00644787|26791094|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6|||
13390346|NCT00686881|26773253|FG000|Overall Study|Physician Decision|1|||
13395698|NCT00644787|26791095|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2|||
13395699|NCT00644787|26791093|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0|||
13395700|NCT00644787|26791094|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0|||
13395701|NCT00644787|26791095|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1|||
13395702|NCT00644423|26791120|FG000|Overall Study|Lost to Follow-up|1|||
13395703|NCT00644423|26791121|FG001|Overall Study|Lost to Follow-up|1|||
13395704|NCT00644358|26791130|FG000|Overall Study|Adverse Event|124|||
13395705|NCT00644358|26791130|FG000|Overall Study|Lost to Follow-up|105|||
13395706|NCT00644358|26791130|FG000|Overall Study|Consent Withdrawal|64|||
13395707|NCT00644358|26791130|FG000|Overall Study|Lack of Effectiveness|39|||
13395708|NCT00644358|26791130|FG000|Overall Study|Protocol Violation|5|||
13395709|NCT00644358|26791130|FG000|Overall Study|Noncompliance|14|||
13395710|NCT00644358|26791130|FG000|Overall Study|Other Unspecified|11|||
13395711|NCT00644332|26791145|FG000|Overall Study|Adverse Event|11|||
13395712|NCT00644332|26791145|FG000|Overall Study|Withdrawal by Subject|6|||
13395713|NCT00644332|26791145|FG000|Overall Study|Completion Status Unknown|2|||
13395714|NCT00644332|26791145|FG000|Overall Study|Did Not Meet Eligibility Requirements|1|||
13395715|NCT00644332|26791145|FG000|Overall Study|Could Not Attend Scheduled Visits|1|||
13395744|NCT00644059|26791257|FG000|Overall Study|Lost to Follow-up|37|||
13395745|NCT00644059|26791258|FG001|Overall Study|Lost to Follow-up|34|||
13395746|NCT00644059|26791259|FG002|Overall Study|Lost to Follow-up|16|||
13395747|NCT00644059|26791257|FG000|Overall Study|Withdrawal by Subject|52|||
13395748|NCT00644059|26791258|FG001|Overall Study|Withdrawal by Subject|60|||
13395749|NCT00644059|26791259|FG002|Overall Study|Withdrawal by Subject|30|||
13395750|NCT00644059|26791257|FG000|Overall Study|Adverse Event|8|||
13395751|NCT00644059|26791258|FG001|Overall Study|Adverse Event|5|||
13395752|NCT00644059|26791259|FG002|Overall Study|Adverse Event|1|||
13395753|NCT00644059|26791257|FG000|Overall Study|Inappropriate Enrollment|1|||
13395754|NCT00644059|26791258|FG001|Overall Study|Inappropriate Enrollment|3|||
13395755|NCT00644059|26791259|FG002|Overall Study|Inappropriate Enrollment|0|||
13395756|NCT00644059|26791257|FG000|Overall Study|Protocol Deviation/violation|20|||
13395757|NCT00644059|26791258|FG001|Overall Study|Protocol Deviation/violation|19|||
13395758|NCT00644059|26791259|FG002|Overall Study|Protocol Deviation/violation|15|||
13395759|NCT00644059|26791257|FG000|Overall Study|Unable to classify|6|||
13395760|NCT00644059|26791258|FG001|Overall Study|Unable to classify|2|||
13395761|NCT00644059|26791259|FG002|Overall Study|Unable to classify|3|||
13395762|NCT00643916|26791298|FG000|Overall Study|Protocol Violation|0|||
13395763|NCT00643916|26791299|FG001|Overall Study|Protocol Violation|1|||
13395764|NCT00643916|26791300|FG002|Overall Study|Protocol Violation|1|||
13395765|NCT00643916|26791301|FG003|Overall Study|Protocol Violation|1|||
13395766|NCT00643916|26791302|FG004|Overall Study|Protocol Violation|0|||
13395767|NCT00643916|26791303|FG005|Overall Study|Protocol Violation|0|||
13395768|NCT00643916|26791298|FG000|Overall Study|Lost to Follow-up|0|||
13395769|NCT00643916|26791299|FG001|Overall Study|Lost to Follow-up|1|||
13395770|NCT00643916|26791300|FG002|Overall Study|Lost to Follow-up|0|||
13395771|NCT00643916|26791301|FG003|Overall Study|Lost to Follow-up|0|||
13395772|NCT00643916|26791302|FG004|Overall Study|Lost to Follow-up|0|||
13395773|NCT00643916|26791303|FG005|Overall Study|Lost to Follow-up|0|||
13395774|NCT00643916|26791298|FG000|Overall Study|Withdrawal by Subject|2|||
13395775|NCT00643916|26791299|FG001|Overall Study|Withdrawal by Subject|2|||
13395776|NCT00643916|26791300|FG002|Overall Study|Withdrawal by Subject|2|||
13395777|NCT00643916|26791301|FG003|Overall Study|Withdrawal by Subject|1|||
13395778|NCT00643916|26791302|FG004|Overall Study|Withdrawal by Subject|0|||
13395779|NCT00643916|26791303|FG005|Overall Study|Withdrawal by Subject|1|||
13395780|NCT00643916|26791298|FG000|Overall Study|Not Vaccinated|2|||
13395781|NCT00643916|26791299|FG001|Overall Study|Not Vaccinated|2|||
13395782|NCT00643916|26791300|FG002|Overall Study|Not Vaccinated|3|||
13395783|NCT00643916|26791301|FG003|Overall Study|Not Vaccinated|0|||
13395784|NCT00643916|26791302|FG004|Overall Study|Not Vaccinated|2|||
13395785|NCT00643916|26791303|FG005|Overall Study|Not Vaccinated|0|||
13395786|NCT00643851|26791336|FG000|Overall Study|Death|0|||
13395787|NCT00643851|26791337|FG001|Overall Study|Death|1|||
13395788|NCT00643851|26791338|FG002|Overall Study|Death|0|||
13395789|NCT00643851|26791336|FG000|Overall Study|Lack of Efficacy|0|||
13395790|NCT00643851|26791337|FG001|Overall Study|Lack of Efficacy|1|||
13395791|NCT00643851|26791338|FG002|Overall Study|Lack of Efficacy|0|||
13395792|NCT00643851|26791336|FG000|Overall Study|Adverse Event|2|||
13395793|NCT00643851|26791337|FG001|Overall Study|Adverse Event|6|||
13395794|NCT00643851|26791338|FG002|Overall Study|Adverse Event|6|||
13395795|NCT00643851|26791336|FG000|Overall Study|Lost to Follow-up|4|||
13395796|NCT00643851|26791337|FG001|Overall Study|Lost to Follow-up|6|||
13395797|NCT00643851|26791338|FG002|Overall Study|Lost to Follow-up|9|||
13395798|NCT00643851|26791336|FG000|Overall Study|Withdrawal by Subject|8|||
13395799|NCT00643851|26791337|FG001|Overall Study|Withdrawal by Subject|15|||
13395800|NCT00643851|26791338|FG002|Overall Study|Withdrawal by Subject|9|||
13395801|NCT00643851|26791336|FG000|Overall Study|Non-compl., not met criteria, etc.|3|||
13395802|NCT00643851|26791337|FG001|Overall Study|Non-compl., not met criteria, etc.|4|||
13395803|NCT00643851|26791338|FG002|Overall Study|Non-compl., not met criteria, etc.|6|||
13395804|NCT00643760|26791456|FG000|Overall Study|Adverse Event|11|||
13395805|NCT00643760|26791457|FG001|Overall Study|Adverse Event|5|||
13395806|NCT00643760|26791458|FG002|Overall Study|Adverse Event|12|||
13395807|NCT00643760|26791459|FG003|Overall Study|Adverse Event|21|||
13395808|NCT00643760|26791460|FG004|Overall Study|Adverse Event|6|||
13395809|NCT00643760|26791456|FG000|Overall Study|Lack of Efficacy|3|||
13395810|NCT00643760|26791457|FG001|Overall Study|Lack of Efficacy|1|||
13395811|NCT00643760|26791458|FG002|Overall Study|Lack of Efficacy|0|||
13395812|NCT00643760|26791459|FG003|Overall Study|Lack of Efficacy|4|||
13395813|NCT00643760|26791460|FG004|Overall Study|Lack of Efficacy|3|||
13395814|NCT00643760|26791456|FG000|Overall Study|Protocol Violation|7|||
13395815|NCT00643760|26791457|FG001|Overall Study|Protocol Violation|6|||
13395816|NCT00643760|26791458|FG002|Overall Study|Protocol Violation|4|||
13395817|NCT00643760|26791459|FG003|Overall Study|Protocol Violation|4|||
13395818|NCT00643760|26791460|FG004|Overall Study|Protocol Violation|6|||
13395819|NCT00643760|26791456|FG000|Overall Study|Lost to Follow-up|6|||
13395820|NCT00643760|26791457|FG001|Overall Study|Lost to Follow-up|2|||
13395821|NCT00643760|26791458|FG002|Overall Study|Lost to Follow-up|1|||
13395822|NCT00643760|26791459|FG003|Overall Study|Lost to Follow-up|3|||
13395823|NCT00643760|26791460|FG004|Overall Study|Lost to Follow-up|3|||
13395824|NCT00643760|26791456|FG000|Overall Study|Investigator Discretion|0|||
13395825|NCT00643760|26791457|FG001|Overall Study|Investigator Discretion|0|||
13395826|NCT00643760|26791458|FG002|Overall Study|Investigator Discretion|0|||
13395827|NCT00643760|26791459|FG003|Overall Study|Investigator Discretion|2|||
13395828|NCT00643760|26791460|FG004|Overall Study|Investigator Discretion|0|||
13395829|NCT00643760|26791456|FG000|Overall Study|Withdrawal by Subject|3|||
13395830|NCT00643760|26791457|FG001|Overall Study|Withdrawal by Subject|1|||
13395831|NCT00643760|26791458|FG002|Overall Study|Withdrawal by Subject|2|||
13395832|NCT00643760|26791459|FG003|Overall Study|Withdrawal by Subject|4|||
13395833|NCT00643760|26791460|FG004|Overall Study|Withdrawal by Subject|1|||
13395834|NCT00643682|26791479|FG000|Overall Study|did not keep appointment|522|||
13395835|NCT00643682|26791480|FG001|Overall Study|did not keep appointment|509|||
13395836|NCT00643604|26791499|FG000|Overall Study|Death|1|||
13395837|NCT00643565|26791528|FG000|Overall Study|Death|12|||
13395838|NCT00643565|26791529|FG001|Overall Study|Death|11|||
13395839|NCT00643565|26791528|FG000|Overall Study|Withdrawal by Subject|4|||
13395840|NCT00643565|26791529|FG001|Overall Study|Withdrawal by Subject|1|||
13395841|NCT00643565|26791528|FG000|Overall Study|Lost to Follow-up|0|||
13395842|NCT00643565|26791529|FG001|Overall Study|Lost to Follow-up|6|||
13395843|NCT00643565|26791528|FG000|Overall Study|Other|7|||
13395844|NCT00643565|26791529|FG001|Overall Study|Other|8|||
13395845|NCT00643565|26791528|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0|||
13395846|NCT00643565|26791529|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1|||
13395847|NCT00643565|26791528|FG000|Overall Study|Recurrence of Disease|2|||
13395848|NCT00643565|26791529|FG001|Overall Study|Recurrence of Disease|1|||
13395849|NCT00643565|26791528|FG000|Overall Study|Progression of Disease|18|||
13395850|NCT00643565|26791529|FG001|Overall Study|Progression of Disease|14|||
13395851|NCT00643565|26791528|FG000|Overall Study|Protocol Violation|3|||
13395852|NCT00643565|26791529|FG001|Overall Study|Protocol Violation|0|||
13395853|NCT00643565|26791528|FG000|Overall Study|Did Not Cooperate|0|||
13395854|NCT00643565|26791529|FG001|Overall Study|Did Not Cooperate|1|||
13395855|NCT00643565|26791528|FG000|Overall Study|Administrative|22|||
13395856|NCT00643565|26791529|FG001|Overall Study|Administrative|16|||
13395857|NCT00643565|26791528|FG000|Overall Study|Adverse Event|5|||
13395858|NCT00643565|26791529|FG001|Overall Study|Adverse Event|8|||
13395859|NCT00643487|26791535|FG000|Overall Study|Technical difficulty|3|||
13395860|NCT00643448|26791560|FG000|Overall Study|Lack of Efficacy|2|||
13395861|NCT00643448|26791561|FG001|Overall Study|Lack of Efficacy|0|||
13395862|NCT00643448|26791562|FG002|Overall Study|Lack of Efficacy|4|||
13395863|NCT00643448|26791560|FG000|Overall Study|Adverse Event|2|||
13395864|NCT00643448|26791561|FG001|Overall Study|Adverse Event|2|||
13395865|NCT00643448|26791562|FG002|Overall Study|Adverse Event|2|||
13395866|NCT00643448|26791560|FG000|Overall Study|QTcF>550 ms|0|||
13395867|NCT00643448|26791561|FG001|Overall Study|QTcF>550 ms|3|||
13395868|NCT00643448|26791562|FG002|Overall Study|QTcF>550 ms|0|||
13395869|NCT00643279|26791589|FG000|Overall Study|Death|13|||
13395870|NCT00643279|26791590|FG001|Overall Study|Death|11|||
13395871|NCT00643279|26791589|FG000|Overall Study|Withdrawal by Subject|3|||
13395872|NCT00643279|26791590|FG001|Overall Study|Withdrawal by Subject|0|||
13395873|NCT00643279|26791589|FG000|Overall Study|Lost to Follow-up|0|||
13395874|NCT00643279|26791590|FG001|Overall Study|Lost to Follow-up|1|||
13395875|NCT00643279|26791589|FG000|Overall Study|Physician Decision|0|||
13395876|NCT00643279|26791590|FG001|Overall Study|Physician Decision|1|||
13395877|NCT00643201|26791643|FG000|Randomized, Completed 6 Months of Study|Death|20|||
13395878|NCT00643201|26791644|FG001|Randomized, Completed 6 Months of Study|Death|26|||
13395879|NCT00643201|26791643|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150|||
13395880|NCT00643201|26791644|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182|||
13395881|NCT00643201|26791643|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
13395882|NCT00643201|26791644|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
13395883|NCT00643201|26791643|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
13395884|NCT00643201|26791644|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
13395885|NCT00643201|26791643|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20|||
13395886|NCT00643201|26791644|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23|||
13395887|NCT00643201|26791643|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3|||
13395888|NCT00643201|26791644|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2|||
13395889|NCT00643201|26791643|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13|||
13395890|NCT00643201|26791644|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9|||
13395891|NCT00643201|26791643|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1|||
13395892|NCT00643201|26791644|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1|||
13395893|NCT00643201|26791643|FG000|Randomized, Completed 6 Months of Study|Other|107|||
13395894|NCT00643201|26791644|FG001|Randomized, Completed 6 Months of Study|Other|107|||
13395895|NCT00643201|26791643|FG000|Completed Study Follow Up|Death|28|||
13395896|NCT00643201|26791644|FG001|Completed Study Follow Up|Death|34|||
13395897|NCT00643201|26791643|FG000|Completed Study Follow Up|Withdrawal by Subject|23|||
13395898|NCT00643201|26791644|FG001|Completed Study Follow Up|Withdrawal by Subject|29|||
13395899|NCT00643201|26791643|FG000|Completed Study Follow Up|Lost to Follow-up|18|||
13395900|NCT00643201|26791644|FG001|Completed Study Follow Up|Lost to Follow-up|16|||
13395901|NCT00643201|26791643|FG000|Completed Study Follow Up|non-specified|1|||
13395902|NCT00643201|26791644|FG001|Completed Study Follow Up|non-specified|0|||
13395903|NCT00643162|26791661|FG000|Overall Study|Withdrawal by Subject|1|||
13395904|NCT00643162|26791662|FG001|Overall Study|Withdrawal by Subject|1|||
13395905|NCT00643123|26791677|FG000|Overall Study|Lost to Follow-up|4|||
13395906|NCT00643123|26791678|FG001|Overall Study|Lost to Follow-up|0|||
13395907|NCT00643123|26791677|FG000|Overall Study|Withdrawal by Subject|1|||
13395908|NCT00643123|26791678|FG001|Overall Study|Withdrawal by Subject|1|||
13395909|NCT00643006|26791693|FG000|Overall Study|Lost to Follow-up|5|||
13395910|NCT00643006|26791694|FG001|Overall Study|Lost to Follow-up|4|||
13395911|NCT00642993|26791715|FG000|Overall Study|Adverse Event|85|||
13395912|NCT00642993|26791716|FG001|Overall Study|Adverse Event|4|||
13395913|NCT00642993|26791715|FG000|Overall Study|Lost to Follow-up|8|||
13395914|NCT00642993|26791716|FG001|Overall Study|Lost to Follow-up|4|||
13395915|NCT00642993|26791715|FG000|Overall Study|Withdrew - reason unrelated to treatment|11|||
13395916|NCT00642993|26791716|FG001|Overall Study|Withdrew - reason unrelated to treatment|3|||
13395917|NCT00642993|26791715|FG000|Overall Study|Protocol Violation|1|||
13395918|NCT00642993|26791716|FG001|Overall Study|Protocol Violation|4|||
13395919|NCT00642993|26791715|FG000|Overall Study|Did not meet protocol eligibility|0|||
13395920|NCT00642993|26791716|FG001|Overall Study|Did not meet protocol eligibility|1|||
13395921|NCT00642993|26791715|FG000|Overall Study|Administrative|1|||
13395922|NCT00642993|26791716|FG001|Overall Study|Administrative|0|||
13395923|NCT00642954|26791754|FG000|Overall Study|Progressive Disease|3|||
13395924|NCT00642954|26791755|FG001|Overall Study|Progressive Disease|3|||
13395925|NCT00642954|26791756|FG002|Overall Study|Progressive Disease|3|||
13395926|NCT00642954|26791757|FG003|Overall Study|Progressive Disease|3|||
13395927|NCT00642954|26791758|FG004|Overall Study|Progressive Disease|9|||
13395928|NCT00642954|26791754|FG000|Overall Study|Withdrawal by Subject|0|||
13395929|NCT00642954|26791755|FG001|Overall Study|Withdrawal by Subject|0|||
13395930|NCT00642954|26791756|FG002|Overall Study|Withdrawal by Subject|0|||
13395931|NCT00642954|26791757|FG003|Overall Study|Withdrawal by Subject|0|||
13395932|NCT00642954|26791758|FG004|Overall Study|Withdrawal by Subject|1|||
13395933|NCT00642954|26791754|FG000|Overall Study|Adverse Event|1|||
13395934|NCT00642954|26791755|FG001|Overall Study|Adverse Event|1|||
13395935|NCT00642954|26791756|FG002|Overall Study|Adverse Event|0|||
13395936|NCT00642954|26791757|FG003|Overall Study|Adverse Event|0|||
13395937|NCT00642954|26791758|FG004|Overall Study|Adverse Event|6|||
13395938|NCT00642941|26791929|FG000|Overall Study|Physician Decision|3|||
13395939|NCT00642941|26791930|FG001|Overall Study|Physician Decision|1|||
13395940|NCT00642941|26791931|FG002|Overall Study|Physician Decision|0|||
13395941|NCT00642941|26791932|FG003|Overall Study|Physician Decision|0|||
13395942|NCT00642941|26791933|FG004|Overall Study|Physician Decision|0|||
13395943|NCT00642941|26791934|FG005|Overall Study|Physician Decision|0|||
13395944|NCT00642941|26791935|FG006|Overall Study|Physician Decision|1|||
13395945|NCT00642941|26791936|FG007|Overall Study|Physician Decision|0|||
13395946|NCT00642941|26791937|FG008|Overall Study|Physician Decision|0|||
13395947|NCT00642941|26791938|FG009|Overall Study|Physician Decision|1|||
13395948|NCT00642941|26791939|FG010|Overall Study|Physician Decision|0|||
13395949|NCT00642941|26791940|FG011|Overall Study|Physician Decision|1|||
13395950|NCT00642941|26791929|FG000|Overall Study|Death|4|||
13395951|NCT00642941|26791930|FG001|Overall Study|Death|0|||
13395952|NCT00642941|26791931|FG002|Overall Study|Death|1|||
13395953|NCT00642941|26791932|FG003|Overall Study|Death|1|||
13395954|NCT00642941|26791933|FG004|Overall Study|Death|2|||
13395955|NCT00642941|26791934|FG005|Overall Study|Death|1|||
13395956|NCT00642941|26791935|FG006|Overall Study|Death|0|||
13395957|NCT00642941|26791936|FG007|Overall Study|Death|0|||
13395958|NCT00642941|26791937|FG008|Overall Study|Death|0|||
13395959|NCT00642941|26791938|FG009|Overall Study|Death|0|||
13395960|NCT00642941|26791939|FG010|Overall Study|Death|0|||
13395961|NCT00642941|26791940|FG011|Overall Study|Death|1|||
13395962|NCT00642941|26791929|FG000|Overall Study|Study closed by Sponsor|0|||
13395963|NCT00642941|26791930|FG001|Overall Study|Study closed by Sponsor|1|||
13395964|NCT00642941|26791931|FG002|Overall Study|Study closed by Sponsor|0|||
13395965|NCT00642941|26791932|FG003|Overall Study|Study closed by Sponsor|0|||
13395966|NCT00642941|26791933|FG004|Overall Study|Study closed by Sponsor|0|||
13395967|NCT00642941|26791934|FG005|Overall Study|Study closed by Sponsor|0|||
13395968|NCT00642941|26791935|FG006|Overall Study|Study closed by Sponsor|0|||
13395969|NCT00642941|26791936|FG007|Overall Study|Study closed by Sponsor|0|||
13395970|NCT00642941|26791937|FG008|Overall Study|Study closed by Sponsor|0|||
13395971|NCT00642941|26791938|FG009|Overall Study|Study closed by Sponsor|0|||
13395972|NCT00642941|26791939|FG010|Overall Study|Study closed by Sponsor|0|||
13395973|NCT00642941|26791940|FG011|Overall Study|Study closed by Sponsor|0|||
13395974|NCT00642941|26791929|FG000|Overall Study|Withdrawal by Subject|1|||
13395975|NCT00642941|26791930|FG001|Overall Study|Withdrawal by Subject|0|||
13395976|NCT00642941|26791931|FG002|Overall Study|Withdrawal by Subject|0|||
13395977|NCT00642941|26791932|FG003|Overall Study|Withdrawal by Subject|2|||
13395978|NCT00642941|26791933|FG004|Overall Study|Withdrawal by Subject|0|||
13395979|NCT00642941|26791934|FG005|Overall Study|Withdrawal by Subject|0|||
13395980|NCT00642941|26791935|FG006|Overall Study|Withdrawal by Subject|2|||
13395981|NCT00642941|26791936|FG007|Overall Study|Withdrawal by Subject|0|||
13395982|NCT00642941|26791937|FG008|Overall Study|Withdrawal by Subject|1|||
13395983|NCT00642941|26791938|FG009|Overall Study|Withdrawal by Subject|0|||
13395984|NCT00642941|26791939|FG010|Overall Study|Withdrawal by Subject|0|||
13395985|NCT00642941|26791940|FG011|Overall Study|Withdrawal by Subject|1|||
13395986|NCT00642941|26791929|FG000|Overall Study|Protocol Violation|0|||
13395987|NCT00642941|26791930|FG001|Overall Study|Protocol Violation|0|||
13395988|NCT00642941|26791931|FG002|Overall Study|Protocol Violation|0|||
13395989|NCT00642941|26791932|FG003|Overall Study|Protocol Violation|0|||
13390347|NCT00686881|26773254|FG001|Overall Study|Physician Decision|0|||
13390348|NCT00686881|26773253|FG000|Overall Study|Circumstances of site|1|||
13390349|NCT00686881|26773254|FG001|Overall Study|Circumstances of site|1|||
13390350|NCT00686881|26773253|FG000|Overall Study|Did not meet protocol eligibility|1|||
13390351|NCT00686881|26773254|FG001|Overall Study|Did not meet protocol eligibility|0|||
13390352|NCT00686881|26773253|FG000|Overall Study|Irregular visits|1|||
13390353|NCT00686881|26773254|FG001|Overall Study|Irregular visits|0|||
13390354|NCT00686881|26773253|FG000|Overall Study|Study discontinuation|35|||
13390355|NCT00686881|26773254|FG001|Overall Study|Study discontinuation|32|||
13390356|NCT00686881|26773253|FG000|Overall Study|Never received study drug|2|||
13395990|NCT00642941|26791933|FG004|Overall Study|Protocol Violation|0|||
13395991|NCT00642941|26791934|FG005|Overall Study|Protocol Violation|0|||
13395992|NCT00642941|26791935|FG006|Overall Study|Protocol Violation|1|||
13395993|NCT00642941|26791936|FG007|Overall Study|Protocol Violation|0|||
13395994|NCT00642941|26791937|FG008|Overall Study|Protocol Violation|0|||
13395995|NCT00642941|26791938|FG009|Overall Study|Protocol Violation|0|||
13395996|NCT00642941|26791939|FG010|Overall Study|Protocol Violation|0|||
13395997|NCT00642941|26791940|FG011|Overall Study|Protocol Violation|0|||
13395998|NCT00642941|26791929|FG000|Overall Study|Adverse Event|1|||
13395999|NCT00642941|26791930|FG001|Overall Study|Adverse Event|1|||
13396000|NCT00642941|26791931|FG002|Overall Study|Adverse Event|0|||
13396001|NCT00642941|26791932|FG003|Overall Study|Adverse Event|0|||
13396002|NCT00642941|26791933|FG004|Overall Study|Adverse Event|0|||
13396003|NCT00642941|26791934|FG005|Overall Study|Adverse Event|0|||
13396004|NCT00642941|26791935|FG006|Overall Study|Adverse Event|1|||
13396005|NCT00642941|26791936|FG007|Overall Study|Adverse Event|1|||
13396006|NCT00642941|26791937|FG008|Overall Study|Adverse Event|0|||
13396007|NCT00642941|26791938|FG009|Overall Study|Adverse Event|1|||
13396008|NCT00642941|26791939|FG010|Overall Study|Adverse Event|0|||
13396009|NCT00642941|26791940|FG011|Overall Study|Adverse Event|0|||
13396010|NCT00642941|26791929|FG000|Overall Study|Other|1|||
13396011|NCT00642941|26791930|FG001|Overall Study|Other|1|||
13396012|NCT00642941|26791931|FG002|Overall Study|Other|1|||
13396013|NCT00642941|26791932|FG003|Overall Study|Other|1|||
13396014|NCT00642941|26791933|FG004|Overall Study|Other|0|||
13396015|NCT00642941|26791934|FG005|Overall Study|Other|1|||
13396016|NCT00642941|26791935|FG006|Overall Study|Other|0|||
13396017|NCT00642941|26791936|FG007|Overall Study|Other|1|||
13396018|NCT00642941|26791937|FG008|Overall Study|Other|0|||
13396019|NCT00642941|26791938|FG009|Overall Study|Other|0|||
13396020|NCT00642941|26791939|FG010|Overall Study|Other|0|||
13396021|NCT00642941|26791940|FG011|Overall Study|Other|1|||
13396022|NCT00642941|26791929|FG000|Overall Study|Disease progression|60|||
13396023|NCT00642941|26791930|FG001|Overall Study|Disease progression|50|||
13396024|NCT00642941|26791931|FG002|Overall Study|Disease progression|5|||
13396025|NCT00642941|26791932|FG003|Overall Study|Disease progression|36|||
13396026|NCT00642941|26791933|FG004|Overall Study|Disease progression|23|||
13396027|NCT00642941|26791934|FG005|Overall Study|Disease progression|39|||
13396028|NCT00642941|26791935|FG006|Overall Study|Disease progression|18|||
13396029|NCT00642941|26791936|FG007|Overall Study|Disease progression|12|||
13396030|NCT00642941|26791937|FG008|Overall Study|Disease progression|10|||
13396031|NCT00642941|26791938|FG009|Overall Study|Disease progression|7|||
13396032|NCT00642941|26791939|FG010|Overall Study|Disease progression|12|||
13396033|NCT00642941|26791940|FG011|Overall Study|Disease progression|7|||
13396034|NCT00642902|26791975|FG000|Overall Study|Adverse Event|0|||
13396035|NCT00642902|26791976|FG001|Overall Study|Adverse Event|1|||
13396036|NCT00642902|26791977|FG002|Overall Study|Adverse Event|3|||
13396037|NCT00642902|26791978|FG003|Overall Study|Adverse Event|1|||
13396038|NCT00642902|26791975|FG000|Overall Study|Lost to Follow-up|1|||
13396039|NCT00642902|26791976|FG001|Overall Study|Lost to Follow-up|1|||
13396040|NCT00642902|26791977|FG002|Overall Study|Lost to Follow-up|0|||
13396041|NCT00642902|26791978|FG003|Overall Study|Lost to Follow-up|0|||
13396042|NCT00642902|26791975|FG000|Overall Study|Lack of Efficacy|0|||
13396043|NCT00642902|26791976|FG001|Overall Study|Lack of Efficacy|3|||
13396044|NCT00642902|26791977|FG002|Overall Study|Lack of Efficacy|3|||
13396045|NCT00642902|26791978|FG003|Overall Study|Lack of Efficacy|0|||
13396046|NCT00642902|26791975|FG000|Overall Study|Death|1|||
13396047|NCT00642902|26791976|FG001|Overall Study|Death|0|||
13396048|NCT00642902|26791977|FG002|Overall Study|Death|0|||
13396049|NCT00642902|26791978|FG003|Overall Study|Death|0|||
13396050|NCT00642902|26791975|FG000|Overall Study|Premature termination of clinical trial|37|||
13396051|NCT00642902|26791976|FG001|Overall Study|Premature termination of clinical trial|32|||
13396052|NCT00642902|26791977|FG002|Overall Study|Premature termination of clinical trial|35|||
13396053|NCT00642902|26791978|FG003|Overall Study|Premature termination of clinical trial|35|||
13396054|NCT00642902|26791975|FG000|Overall Study|Randomized, but not treated|0|||
13396055|NCT00642902|26791976|FG001|Overall Study|Randomized, but not treated|0|||
13396056|NCT00642902|26791977|FG002|Overall Study|Randomized, but not treated|1|||
13396057|NCT00642902|26791978|FG003|Overall Study|Randomized, but not treated|0|||
13396058|NCT00642902|26791975|FG000|Overall Study|Other|1|||
13396059|NCT00642902|26791976|FG001|Overall Study|Other|5|||
13396060|NCT00642902|26791977|FG002|Overall Study|Other|1|||
13396061|NCT00642902|26791978|FG003|Overall Study|Other|4|||
13396062|NCT00642850|26791990|FG000|Overall Study|Death|7|||
13396063|NCT00642850|26791990|FG000|Overall Study|Adverse Event|2|||
13396064|NCT00642850|26791990|FG000|Overall Study|Lack of Efficacy|1|||
13396065|NCT00642850|26791990|FG000|Overall Study|Protocol Violation|2|||
13396066|NCT00642850|26791990|FG000|Overall Study|Kidney transplantation|8|||
13396067|NCT00642850|26791990|FG000|Overall Study|Blood transfusion|6|||
13396068|NCT00642850|26791990|FG000|Overall Study|Other reasons|7|||
13396069|NCT00642811|26792031|FG000|Overall Study|Adverse Event|2|||
13396070|NCT00642811|26792032|FG001|Overall Study|Adverse Event|3|||
13396071|NCT00642811|26792033|FG002|Overall Study|Adverse Event|0|||
13396072|NCT00642811|26792034|FG003|Overall Study|Adverse Event|0|||
13396073|NCT00642811|26792035|FG004|Overall Study|Adverse Event|0|||
13396074|NCT00642811|26792036|FG005|Overall Study|Adverse Event|1|||
13396075|NCT00642811|26792031|FG000|Overall Study|Developement of discontinuation criteria|0|||
13396076|NCT00642811|26792032|FG001|Overall Study|Developement of discontinuation criteria|0|||
13396077|NCT00642811|26792033|FG002|Overall Study|Developement of discontinuation criteria|0|||
13396078|NCT00642811|26792034|FG003|Overall Study|Developement of discontinuation criteria|0|||
13396079|NCT00642811|26792035|FG004|Overall Study|Developement of discontinuation criteria|1|||
13396080|NCT00642811|26792036|FG005|Overall Study|Developement of discontinuation criteria|0|||
13396081|NCT00642811|26792031|FG000|Overall Study|Severe Non-compliance to protocol|1|||
13396082|NCT00642811|26792032|FG001|Overall Study|Severe Non-compliance to protocol|0|||
13396083|NCT00642811|26792033|FG002|Overall Study|Severe Non-compliance to protocol|0|||
13396084|NCT00642811|26792034|FG003|Overall Study|Severe Non-compliance to protocol|0|||
13396085|NCT00642811|26792035|FG004|Overall Study|Severe Non-compliance to protocol|0|||
13396086|NCT00642811|26792036|FG005|Overall Study|Severe Non-compliance to protocol|0|||
13396087|NCT00642811|26792031|FG000|Overall Study|Other|0|||
13396088|NCT00642811|26792032|FG001|Overall Study|Other|1|||
13396089|NCT00642811|26792033|FG002|Overall Study|Other|0|||
13396090|NCT00642811|26792034|FG003|Overall Study|Other|1|||
13396091|NCT00642811|26792035|FG004|Overall Study|Other|0|||
13396092|NCT00642811|26792036|FG005|Overall Study|Other|0|||
13396093|NCT00642772|26792042|FG000|Overall Study|Lost to Follow-up|3|||
13396094|NCT00642772|26792042|FG000|Overall Study|Withdrawal by Subject|7|||
13396095|NCT00642759|26792051|FG000|Overall Study|Protocol Violation|1|||
13396096|NCT00642746|26792068|FG000|Overall Study|Patient unevaluable|1|||
13396097|NCT00642746|26792069|FG001|Overall Study|Patient unevaluable|0|||
13396098|NCT00642707|26792092|FG000|Overall Study|Adverse Event|0|||
13396099|NCT00642707|26792093|FG001|Overall Study|Adverse Event|0|||
13396100|NCT00642707|26792094|FG002|Overall Study|Adverse Event|0|||
13396101|NCT00642707|26792095|FG003|Overall Study|Adverse Event|2|||
13396102|NCT00642707|26792092|FG000|Overall Study|Withdrawal by Subject|1|||
13396103|NCT00642707|26792093|FG001|Overall Study|Withdrawal by Subject|0|||
13396104|NCT00642707|26792094|FG002|Overall Study|Withdrawal by Subject|0|||
13396105|NCT00642707|26792095|FG003|Overall Study|Withdrawal by Subject|0|||
13396106|NCT00642668|26792105|FG000|Overall Study|Lost to Follow-up|1|||
13396107|NCT00642668|26792105|FG000|Overall Study|Adverse Event|2|||
13396108|NCT00642668|26792105|FG000|Overall Study|Death|2|||
13396109|NCT00642668|26792105|FG000|Overall Study|Insufficient Therapeutic Response|1|||
13396110|NCT00642668|26792105|FG000|Overall Study|Failure to Return|1|||
13396111|NCT00642668|26792105|FG000|Overall Study|Dialysis Initiation|5|||
13396112|NCT00642668|26792105|FG000|Overall Study|Blood Transfusion|2|||
13396113|NCT00642642|26792120|FG000|Treatment & Follow Up|Adverse Event|2|||
13396114|NCT00642642|26792120|FG000|Treatment & Follow Up|Withdrawal by Subject|5|||
13396115|NCT00642642|26792120|FG000|Treatment & Follow Up|Lost to Follow-up|10|||
13396116|NCT00642616|26792155|FG000|Overall Study|Adverse Event|2|||
13396117|NCT00642616|26792156|FG001|Overall Study|Adverse Event|0|||
13396118|NCT00642616|26792157|FG002|Overall Study|Adverse Event|1|||
13396119|NCT00642616|26792158|FG003|Overall Study|Adverse Event|0|||
13396120|NCT00642616|26792155|FG000|Overall Study|Study Terminated by Sponsor|7|||
13396121|NCT00642616|26792156|FG001|Overall Study|Study Terminated by Sponsor|6|||
13396122|NCT00642616|26792157|FG002|Overall Study|Study Terminated by Sponsor|4|||
13396123|NCT00642616|26792158|FG003|Overall Study|Study Terminated by Sponsor|5|||
13396124|NCT00642616|26792155|FG000|Overall Study|Withdrawal by Subject|0|||
13396125|NCT00642616|26792156|FG001|Overall Study|Withdrawal by Subject|1|||
13396126|NCT00642616|26792157|FG002|Overall Study|Withdrawal by Subject|1|||
13396127|NCT00642616|26792158|FG003|Overall Study|Withdrawal by Subject|1|||
13396128|NCT00642616|26792155|FG000|Overall Study|Protocol Violation|0|||
13396129|NCT00642616|26792156|FG001|Overall Study|Protocol Violation|0|||
13396130|NCT00642616|26792157|FG002|Overall Study|Protocol Violation|2|||
13396131|NCT00642616|26792158|FG003|Overall Study|Protocol Violation|0|||
13396132|NCT00642616|26792155|FG000|Overall Study|Physician Decision|0|||
13396133|NCT00642616|26792156|FG001|Overall Study|Physician Decision|0|||
13396134|NCT00642616|26792157|FG002|Overall Study|Physician Decision|1|||
13396135|NCT00642616|26792158|FG003|Overall Study|Physician Decision|1|||
13396136|NCT00642473|26792177|FG000|Overall Study|Withdrawal by Subject|0|||
13396137|NCT00642473|26792178|FG001|Overall Study|Withdrawal by Subject|5|||
13396138|NCT00642473|26792177|FG000|Overall Study|Progression or death|2|||
13396139|NCT00642473|26792178|FG001|Overall Study|Progression or death|4|||
13396140|NCT00642473|26792177|FG000|Overall Study|Other|2|||
13396141|NCT00642473|26792178|FG001|Overall Study|Other|2|||
13396142|NCT00642460|26792253|FG000|Part I: 12 Week Double-Blind|Adverse Event|0|||
13396143|NCT00642460|26792254|FG001|Part I: 12 Week Double-Blind|Adverse Event|1|||
13396144|NCT00642460|26792255|FG002|Part I: 12 Week Double-Blind|Adverse Event|1|||
13396145|NCT00642460|26792256|FG003|Part I: 12 Week Double-Blind|Adverse Event|0|||
13396146|NCT00642460|26792257|FG004|Part I: 12 Week Double-Blind|Adverse Event|0|||
13396147|NCT00642460|26792258|FG005|Part I: 12 Week Double-Blind|Adverse Event|0|||
13396148|NCT00642460|26792253|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1|||
13396149|NCT00642460|26792254|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0|||
13396150|NCT00642460|26792255|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0|||
13396151|NCT00642460|26792256|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0|||
13396152|NCT00642460|26792257|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0|||
13396153|NCT00642460|26792258|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0|||
13396154|NCT00642460|26792253|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4|||
13396155|NCT00642460|26792254|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2|||
13396156|NCT00642460|26792255|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0|||
13396157|NCT00642460|26792256|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0|||
13396158|NCT00642460|26792257|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0|||
13396159|NCT00642460|26792258|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0|||
13396160|NCT00642460|26792253|FG000|Part II: Open-Label Up to Week 92|Death|0|||
13396161|NCT00642460|26792254|FG001|Part II: Open-Label Up to Week 92|Death|1|||
13396162|NCT00642460|26792255|FG002|Part II: Open-Label Up to Week 92|Death|0|||
13396163|NCT00642460|26792256|FG003|Part II: Open-Label Up to Week 92|Death|2|||
13396164|NCT00642460|26792257|FG004|Part II: Open-Label Up to Week 92|Death|0|||
13396165|NCT00642460|26792258|FG005|Part II: Open-Label Up to Week 92|Death|0|||
13396166|NCT00642460|26792253|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2|||
13396167|NCT00642460|26792254|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3|||
13396168|NCT00642460|26792255|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
13396169|NCT00642460|26792256|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
13396170|NCT00642460|26792257|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
13396171|NCT00642460|26792258|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
13396172|NCT00642460|26792253|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3|||
13396173|NCT00642460|26792254|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1|||
13396174|NCT00642460|26792255|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0|||
13396175|NCT00642460|26792256|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0|||
13396176|NCT00642460|26792257|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0|||
13396177|NCT00642460|26792258|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0|||
13396178|NCT00642460|26792253|FG000|Part II: Open-Label Up to Week 92|Failure to return|0|||
13396179|NCT00642460|26792254|FG001|Part II: Open-Label Up to Week 92|Failure to return|1|||
13396180|NCT00642460|26792255|FG002|Part II: Open-Label Up to Week 92|Failure to return|0|||
13396181|NCT00642460|26792256|FG003|Part II: Open-Label Up to Week 92|Failure to return|0|||
13396182|NCT00642460|26792257|FG004|Part II: Open-Label Up to Week 92|Failure to return|0|||
13396183|NCT00642460|26792258|FG005|Part II: Open-Label Up to Week 92|Failure to return|0|||
13396184|NCT00642460|26792253|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
13396185|NCT00642460|26792254|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
13396186|NCT00642460|26792255|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
13396187|NCT00642460|26792256|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1|||
13396188|NCT00642460|26792257|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
13396189|NCT00642460|26792258|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
13396190|NCT00642460|26792253|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0|||
13396191|NCT00642460|26792254|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0|||
13396192|NCT00642460|26792255|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0|||
13396193|NCT00642460|26792256|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0|||
13396194|NCT00642460|26792257|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7|||
13396195|NCT00642460|26792258|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6|||
13396196|NCT00642460|26792253|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
13396197|NCT00642460|26792254|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
13396198|NCT00642460|26792255|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
13396199|NCT00642460|26792256|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
13396200|NCT00642460|26792257|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3|||
13396201|NCT00642460|26792258|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4|||
13396202|NCT00642460|26792253|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
13396203|NCT00642460|26792254|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
13396204|NCT00642460|26792255|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
13396205|NCT00642460|26792256|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
13396206|NCT00642460|26792257|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4|||
13396207|NCT00642460|26792258|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1|||
13396208|NCT00642460|26792253|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
13396209|NCT00642460|26792254|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
13396210|NCT00642460|26792255|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
13396211|NCT00642460|26792256|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
13396212|NCT00642460|26792257|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
13396213|NCT00642460|26792258|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
13396214|NCT00642460|26792253|FG000|Part III: Open-Label Up to Week 260|Other|0|||
13396215|NCT00642460|26792254|FG001|Part III: Open-Label Up to Week 260|Other|0|||
13396216|NCT00642460|26792255|FG002|Part III: Open-Label Up to Week 260|Other|0|||
13396217|NCT00642460|26792256|FG003|Part III: Open-Label Up to Week 260|Other|0|||
13396218|NCT00642460|26792257|FG004|Part III: Open-Label Up to Week 260|Other|2|||
13396219|NCT00642460|26792258|FG005|Part III: Open-Label Up to Week 260|Other|2|||
13396220|NCT00642460|26792253|FG000|Part III: Open-Label Up to Week 260|Death|0|||
13396221|NCT00642460|26792254|FG001|Part III: Open-Label Up to Week 260|Death|0|||
13396222|NCT00642460|26792255|FG002|Part III: Open-Label Up to Week 260|Death|0|||
13396223|NCT00642460|26792256|FG003|Part III: Open-Label Up to Week 260|Death|0|||
13396224|NCT00642460|26792257|FG004|Part III: Open-Label Up to Week 260|Death|0|||
13396225|NCT00642460|26792258|FG005|Part III: Open-Label Up to Week 260|Death|3|||
13396226|NCT00642460|26792253|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0|||
13396227|NCT00642460|26792254|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0|||
13396228|NCT00642460|26792255|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0|||
13396229|NCT00642460|26792256|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0|||
13396230|NCT00642460|26792257|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0|||
13396231|NCT00642460|26792258|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1|||
13396232|NCT00642460|26792253|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0|||
13396233|NCT00642460|26792254|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0|||
13396234|NCT00642460|26792255|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0|||
13396235|NCT00642460|26792256|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0|||
13396236|NCT00642460|26792257|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8|||
13396237|NCT00642460|26792258|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3|||
13396238|NCT00642369|26792273|FG000|Overall Study|Adverse Event|2|||
13396239|NCT00642369|26792274|FG001|Overall Study|Adverse Event|3|||
13396240|NCT00642369|26792273|FG000|Overall Study|Withdrawal by Subject|1|||
13396241|NCT00642369|26792274|FG001|Overall Study|Withdrawal by Subject|0|||
13396242|NCT00642369|26792273|FG000|Overall Study|misdiagnosis|0|||
13396243|NCT00642369|26792274|FG001|Overall Study|misdiagnosis|1|||
13396244|NCT00642369|26792273|FG000|Overall Study|Lack of Efficacy|2|||
13396245|NCT00642369|26792274|FG001|Overall Study|Lack of Efficacy|2|||
13396246|NCT00642356|26792289|FG000|Overall Study|Adverse Event|1|||
13396247|NCT00642356|26792290|FG001|Overall Study|Adverse Event|0|||
13396248|NCT00642356|26792289|FG000|Overall Study|Protocol Violation|0|||
13396249|NCT00642356|26792290|FG001|Overall Study|Protocol Violation|3|||
13396250|NCT00642356|26792289|FG000|Overall Study|Lack of Efficacy|1|||
13396251|NCT00642356|26792290|FG001|Overall Study|Lack of Efficacy|0|||
13396252|NCT00642304|26792301|FG000|Overall Study|Adverse Event|1|||
13396253|NCT00642304|26792301|FG000|Overall Study|Death|1|||
13396254|NCT00642304|26792301|FG000|Overall Study|Blood transfusion|2|||
13396255|NCT00642304|26792301|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1|||
13396256|NCT00642304|26792301|FG000|Overall Study|Transplantation|1|||
13396257|NCT00642278|26792374|FG000|Overall Study|Adverse Event|2|||
13396258|NCT00642278|26792375|FG001|Overall Study|Adverse Event|1|||
13396259|NCT00642278|26792376|FG002|Overall Study|Adverse Event|3|||
13396260|NCT00642278|26792377|FG003|Overall Study|Adverse Event|1|||
13396261|NCT00642278|26792378|FG004|Overall Study|Adverse Event|2|||
13396262|NCT00642278|26792379|FG005|Overall Study|Adverse Event|2|||
13396263|NCT00642278|26792380|FG006|Overall Study|Adverse Event|0|||
13396264|NCT00642278|26792374|FG000|Overall Study|Lack of Efficacy|0|||
13396265|NCT00642278|26792375|FG001|Overall Study|Lack of Efficacy|1|||
13396266|NCT00642278|26792376|FG002|Overall Study|Lack of Efficacy|0|||
13396267|NCT00642278|26792377|FG003|Overall Study|Lack of Efficacy|0|||
13396268|NCT00642278|26792378|FG004|Overall Study|Lack of Efficacy|0|||
13396269|NCT00642278|26792379|FG005|Overall Study|Lack of Efficacy|0|||
13396270|NCT00642278|26792380|FG006|Overall Study|Lack of Efficacy|0|||
13396271|NCT00642278|26792374|FG000|Overall Study|Lost to Follow-up|5|||
13396272|NCT00642278|26792375|FG001|Overall Study|Lost to Follow-up|1|||
13396273|NCT00642278|26792376|FG002|Overall Study|Lost to Follow-up|0|||
13396274|NCT00642278|26792377|FG003|Overall Study|Lost to Follow-up|1|||
13396275|NCT00642278|26792378|FG004|Overall Study|Lost to Follow-up|0|||
13396276|NCT00642278|26792379|FG005|Overall Study|Lost to Follow-up|1|||
13396277|NCT00642278|26792380|FG006|Overall Study|Lost to Follow-up|1|||
13396278|NCT00642278|26792374|FG000|Overall Study|Physician Decision|0|||
13396279|NCT00642278|26792375|FG001|Overall Study|Physician Decision|0|||
13396280|NCT00642278|26792376|FG002|Overall Study|Physician Decision|0|||
13396281|NCT00642278|26792377|FG003|Overall Study|Physician Decision|1|||
13396282|NCT00642278|26792378|FG004|Overall Study|Physician Decision|0|||
13396283|NCT00642278|26792379|FG005|Overall Study|Physician Decision|0|||
13396284|NCT00642278|26792380|FG006|Overall Study|Physician Decision|0|||
13396285|NCT00642278|26792374|FG000|Overall Study|Protocol Violation|0|||
13396286|NCT00642278|26792375|FG001|Overall Study|Protocol Violation|0|||
13396287|NCT00642278|26792376|FG002|Overall Study|Protocol Violation|1|||
13396288|NCT00642278|26792377|FG003|Overall Study|Protocol Violation|1|||
13396289|NCT00642278|26792378|FG004|Overall Study|Protocol Violation|0|||
13396290|NCT00642278|26792379|FG005|Overall Study|Protocol Violation|1|||
13396291|NCT00642278|26792380|FG006|Overall Study|Protocol Violation|2|||
13396292|NCT00642278|26792374|FG000|Overall Study|Withdrawal by Subject|1|||
13396293|NCT00642278|26792375|FG001|Overall Study|Withdrawal by Subject|1|||
13219897|NCT01829295|26278603|FG000|6-12 Months|Adverse Event|0|||
13396294|NCT00642278|26792376|FG002|Overall Study|Withdrawal by Subject|1|||
13396295|NCT00642278|26792377|FG003|Overall Study|Withdrawal by Subject|3|||
13396296|NCT00642278|26792378|FG004|Overall Study|Withdrawal by Subject|6|||
13396297|NCT00642278|26792379|FG005|Overall Study|Withdrawal by Subject|2|||
13396298|NCT00642278|26792380|FG006|Overall Study|Withdrawal by Subject|2|||
13396299|NCT00642278|26792374|FG000|Overall Study|Noncompliance with study drug regimen|0|||
13396300|NCT00642278|26792375|FG001|Overall Study|Noncompliance with study drug regimen|0|||
13396301|NCT00642278|26792376|FG002|Overall Study|Noncompliance with study drug regimen|0|||
13396302|NCT00642278|26792377|FG003|Overall Study|Noncompliance with study drug regimen|1|||
13396303|NCT00642278|26792378|FG004|Overall Study|Noncompliance with study drug regimen|0|||
13396304|NCT00642278|26792379|FG005|Overall Study|Noncompliance with study drug regimen|0|||
13396305|NCT00642278|26792380|FG006|Overall Study|Noncompliance with study drug regimen|0|||
13396306|NCT00642278|26792374|FG000|Overall Study|Other|2|||
13396307|NCT00642278|26792375|FG001|Overall Study|Other|1|||
13396308|NCT00642278|26792376|FG002|Overall Study|Other|0|||
13396309|NCT00642278|26792377|FG003|Overall Study|Other|1|||
13396310|NCT00642278|26792378|FG004|Overall Study|Other|0|||
13396311|NCT00642278|26792379|FG005|Overall Study|Other|1|||
13396312|NCT00642278|26792380|FG006|Overall Study|Other|0|||
13396313|NCT00642174|26792401|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0|||
13396314|NCT00642174|26792402|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1|||
13396315|NCT00642018|26792437|FG000|Overall Study|Adverse Event|11|||
13396316|NCT00642018|26792438|FG001|Overall Study|Adverse Event|36|||
13396317|NCT00642018|26792437|FG000|Overall Study|Withdrawal by Subject|4|||
13396318|NCT00642018|26792438|FG001|Overall Study|Withdrawal by Subject|10|||
13396319|NCT00642018|26792437|FG000|Overall Study|Progressive Disease|13|||
13396320|NCT00642018|26792438|FG001|Overall Study|Progressive Disease|18|||
13396321|NCT00642018|26792437|FG000|Overall Study|Physician Decision|0|||
13396322|NCT00642018|26792438|FG001|Overall Study|Physician Decision|10|||
13396323|NCT00642018|26792437|FG000|Overall Study|Protocol Violation|0|||
13396324|NCT00642018|26792438|FG001|Overall Study|Protocol Violation|1|||
13396325|NCT00642018|26792437|FG000|Overall Study|Death|0|||
13396326|NCT00642018|26792438|FG001|Overall Study|Death|3|||
13396327|NCT00642018|26792437|FG000|Overall Study|Entry Criteria Not Met|0|||
13396328|NCT00642018|26792438|FG001|Overall Study|Entry Criteria Not Met|1|||
13396329|NCT00641719|26792467|FG000|Overall Study|Lack of Efficacy|1|||
13396330|NCT00641719|26792468|FG001|Overall Study|Lack of Efficacy|2|||
13396331|NCT00641719|26792467|FG000|Overall Study|Adverse Event|24|||
13396332|NCT00641719|26792468|FG001|Overall Study|Adverse Event|29|||
13396333|NCT00641719|26792467|FG000|Overall Study|Withdrawal by Subject|4|||
13396334|NCT00641719|26792468|FG001|Overall Study|Withdrawal by Subject|4|||
13396335|NCT00641719|26792467|FG000|Overall Study|Reason Not Specified|1|||
13396336|NCT00641719|26792468|FG001|Overall Study|Reason Not Specified|2|||
13396337|NCT00641706|26792487|FG000|Overall Study|Adverse Event|2|||
13396338|NCT00641706|26792488|FG001|Overall Study|Adverse Event|1|||
13396339|NCT00641706|26792487|FG000|Overall Study|Withdrawal by Subject|6|||
13396340|NCT00641706|26792488|FG001|Overall Study|Withdrawal by Subject|1|||
13396341|NCT00641706|26792487|FG000|Overall Study|Clinical Decline|1|||
13396342|NCT00641706|26792488|FG001|Overall Study|Clinical Decline|0|||
13396343|NCT00641706|26792487|FG000|Overall Study|Lead Investigator Decision|0|||
13396344|NCT00641706|26792488|FG001|Overall Study|Lead Investigator Decision|1|||
13396345|NCT00641667|26792500|FG000|Overall Study|Withdrawal by Subject|1|||
13396346|NCT00641667|26792500|FG000|Overall Study|Adverse Event|1|||
13396347|NCT00641667|26792500|FG000|Overall Study|Physician Decision|1|||
13396348|NCT00641667|26792500|FG000|Overall Study|Worsening of underlying disease|3|||
13396349|NCT00641537|26792605|FG000|96-week Period|Adverse Event|0|||
13396350|NCT00641537|26792606|FG001|96-week Period|Adverse Event|1|||
13396351|NCT00641537|26792607|FG002|96-week Period|Adverse Event|3|||
13396352|NCT00641537|26792608|FG003|96-week Period|Adverse Event|0|||
13396353|NCT00641537|26792609|FG004|96-week Period|Adverse Event|2|||
13396354|NCT00641537|26792610|FG005|96-week Period|Adverse Event|0|||
13396355|NCT00641537|26792611|FG006|96-week Period|Adverse Event|0|||
13396356|NCT00641537|26792612|FG007|96-week Period|Adverse Event|0|||
13396357|NCT00641537|26792605|FG000|96-week Period|Lost to Follow-up|3|||
13396358|NCT00641537|26792606|FG001|96-week Period|Lost to Follow-up|1|||
13396359|NCT00641537|26792607|FG002|96-week Period|Lost to Follow-up|2|||
13396360|NCT00641537|26792608|FG003|96-week Period|Lost to Follow-up|2|||
13396361|NCT00641537|26792609|FG004|96-week Period|Lost to Follow-up|4|||
13396362|NCT00641537|26792610|FG005|96-week Period|Lost to Follow-up|0|||
13396363|NCT00641537|26792611|FG006|96-week Period|Lost to Follow-up|1|||
13396364|NCT00641537|26792612|FG007|96-week Period|Lost to Follow-up|0|||
13396365|NCT00641537|26792605|FG000|96-week Period|Protocol Violation|0|||
13396366|NCT00641537|26792606|FG001|96-week Period|Protocol Violation|1|||
13396367|NCT00641537|26792607|FG002|96-week Period|Protocol Violation|0|||
13396368|NCT00641537|26792608|FG003|96-week Period|Protocol Violation|1|||
13396369|NCT00641537|26792609|FG004|96-week Period|Protocol Violation|0|||
13396370|NCT00641537|26792610|FG005|96-week Period|Protocol Violation|1|||
13396371|NCT00641537|26792611|FG006|96-week Period|Protocol Violation|0|||
13396372|NCT00641537|26792612|FG007|96-week Period|Protocol Violation|0|||
13396373|NCT00641537|26792605|FG000|96-week Period|Death|2|||
13396374|NCT00641537|26792606|FG001|96-week Period|Death|0|||
13396375|NCT00641537|26792607|FG002|96-week Period|Death|1|||
13396376|NCT00641537|26792608|FG003|96-week Period|Death|0|||
13396377|NCT00641537|26792609|FG004|96-week Period|Death|0|||
13396378|NCT00641537|26792610|FG005|96-week Period|Death|0|||
13396379|NCT00641537|26792611|FG006|96-week Period|Death|0|||
13396380|NCT00641537|26792612|FG007|96-week Period|Death|0|||
13396381|NCT00641537|26792605|FG000|96-week Period|Other|4|||
13396382|NCT00641537|26792606|FG001|96-week Period|Other|7|||
13396383|NCT00641537|26792607|FG002|96-week Period|Other|14|||
13396384|NCT00641537|26792608|FG003|96-week Period|Other|9|||
13396385|NCT00641537|26792609|FG004|96-week Period|Other|11|||
13396386|NCT00641537|26792610|FG005|96-week Period|Other|6|||
13396387|NCT00641537|26792611|FG006|96-week Period|Other|4|||
13396388|NCT00641537|26792612|FG007|96-week Period|Other|6|||
13396389|NCT00641537|26792605|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
13396390|NCT00641537|26792606|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
13396391|NCT00641537|26792607|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
13396392|NCT00641537|26792608|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3|||
13396393|NCT00641537|26792609|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2|||
13396394|NCT00641537|26792610|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
13396395|NCT00641537|26792611|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
13396396|NCT00641537|26792612|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
13396397|NCT00641537|26792605|FG000|24-Week Supplemental Follow-up Period|Other|0|||
13396398|NCT00641537|26792606|FG001|24-Week Supplemental Follow-up Period|Other|2|||
13396399|NCT00641537|26792607|FG002|24-Week Supplemental Follow-up Period|Other|2|||
13396400|NCT00641537|26792608|FG003|24-Week Supplemental Follow-up Period|Other|1|||
13396401|NCT00641537|26792609|FG004|24-Week Supplemental Follow-up Period|Other|3|||
13396402|NCT00641537|26792610|FG005|24-Week Supplemental Follow-up Period|Other|0|||
13396403|NCT00641537|26792611|FG006|24-Week Supplemental Follow-up Period|Other|1|||
13396404|NCT00641537|26792612|FG007|24-Week Supplemental Follow-up Period|Other|1|||
13396405|NCT00641147|26792661|FG000|Completed 4 Months.|Physician Decision|1|||
13396406|NCT00641147|26792662|FG001|Completed 4 Months.|Physician Decision|0|||
13396407|NCT00641147|26792661|FG000|Completed 4 Months.|Adverse Event|1|||
13396408|NCT00641147|26792662|FG001|Completed 4 Months.|Adverse Event|0|||
13396409|NCT00641147|26792661|FG000|Completed 8 Months.|Physician Decision|2|||
13396410|NCT00641147|26792662|FG001|Completed 8 Months.|Physician Decision|1|||
13396411|NCT00641147|26792661|FG000|Completed 8 Months.|non compliance|1|||
13396412|NCT00641147|26792662|FG001|Completed 8 Months.|non compliance|0|||
13396413|NCT00641147|26792661|FG000|Completed 8 Months.|Withdrawal by Subject|0|||
13396414|NCT00641147|26792662|FG001|Completed 8 Months.|Withdrawal by Subject|1|||
13396415|NCT00641147|26792661|FG000|Completed 12 Months.|Physician Decision|1|||
13396416|NCT00641147|26792662|FG001|Completed 12 Months.|Physician Decision|1|||
13396417|NCT00641147|26792661|FG000|Completed 12 Months.|Withdrawal by Subject|0|||
13396418|NCT00641147|26792662|FG001|Completed 12 Months.|Withdrawal by Subject|1|||
13396419|NCT00641147|26792661|FG000|Completed 16 Months.|Physician Decision|1|||
13396420|NCT00641147|26792662|FG001|Completed 16 Months.|Physician Decision|0|||
13396421|NCT00641147|26792661|FG000|Completed 16 Months.|Lost to Follow-up|1|||
13396422|NCT00641147|26792662|FG001|Completed 16 Months.|Lost to Follow-up|0|||
13396423|NCT00641056|26792695|FG000|Overall Study|Adverse Event|12|||
13396424|NCT00641056|26792696|FG001|Overall Study|Adverse Event|2|||
13396425|NCT00641056|26792695|FG000|Overall Study|Lost to Follow-up|2|||
13396426|NCT00641056|26792696|FG001|Overall Study|Lost to Follow-up|1|||
13396427|NCT00641056|26792695|FG000|Overall Study|Physician Decision|3|||
13396428|NCT00641056|26792696|FG001|Overall Study|Physician Decision|1|||
13396429|NCT00641056|26792695|FG000|Overall Study|Protocol Violation|2|||
13396430|NCT00641056|26792696|FG001|Overall Study|Protocol Violation|0|||
13396431|NCT00641056|26792695|FG000|Overall Study|Entry Criteria Not Met|3|||
13396432|NCT00641056|26792696|FG001|Overall Study|Entry Criteria Not Met|0|||
13396433|NCT00641056|26792695|FG000|Overall Study|Subject Decision|6|||
13396434|NCT00641056|26792696|FG001|Overall Study|Subject Decision|19|||
13396435|NCT00641056|26792695|FG000|Overall Study|Sponsor Decision|1|||
13396436|NCT00641056|26792696|FG001|Overall Study|Sponsor Decision|2|||
13396437|NCT00641043|26792733|FG000|Overall Study|Adverse Event|6|||
13396438|NCT00641043|26792734|FG001|Overall Study|Adverse Event|4|||
13396439|NCT00641043|26792733|FG000|Overall Study|Protocol Violation|2|||
13396440|NCT00641043|26792734|FG001|Overall Study|Protocol Violation|3|||
13396441|NCT00641043|26792733|FG000|Overall Study|Lost to Follow-up|3|||
13396442|NCT00641043|26792734|FG001|Overall Study|Lost to Follow-up|2|||
13396443|NCT00641043|26792733|FG000|Overall Study|Withdrawal by Subject|4|||
13396444|NCT00641043|26792734|FG001|Overall Study|Withdrawal by Subject|4|||
13396445|NCT00641043|26792733|FG000|Overall Study|Other incl. lack of efficacy|4|||
13396446|NCT00641043|26792734|FG001|Overall Study|Other incl. lack of efficacy|2|||
13396447|NCT00640926|26792755|FG000|Overall Study|Adverse Event|2|||
13396448|NCT00640926|26792756|FG001|Overall Study|Adverse Event|3|||
13396449|NCT00640926|26792757|FG002|Overall Study|Adverse Event|2|||
13396450|NCT00640926|26792755|FG000|Overall Study|Lack of Efficacy|0|||
13396451|NCT00640926|26792756|FG001|Overall Study|Lack of Efficacy|2|||
13396452|NCT00640926|26792757|FG002|Overall Study|Lack of Efficacy|1|||
13396453|NCT00640926|26792755|FG000|Overall Study|Protocol Violation|2|||
13396454|NCT00640926|26792756|FG001|Overall Study|Protocol Violation|0|||
13396455|NCT00640926|26792757|FG002|Overall Study|Protocol Violation|2|||
13396456|NCT00640926|26792755|FG000|Overall Study|Lost to Follow-up|3|||
13396457|NCT00640926|26792756|FG001|Overall Study|Lost to Follow-up|1|||
13396458|NCT00640926|26792757|FG002|Overall Study|Lost to Follow-up|2|||
13396459|NCT00640926|26792755|FG000|Overall Study|Withdrawal by Subject|1|||
13396460|NCT00640926|26792756|FG001|Overall Study|Withdrawal by Subject|0|||
13396461|NCT00640926|26792757|FG002|Overall Study|Withdrawal by Subject|1|||
13396462|NCT00640835|26792772|FG000|Overall Study|Adverse Event|5|||
13396463|NCT00640835|26792773|FG001|Overall Study|Adverse Event|3|||
13396464|NCT00640835|26792772|FG000|Overall Study|Withdrawal by Subject|12|||
13396465|NCT00640835|26792773|FG001|Overall Study|Withdrawal by Subject|14|||
13396466|NCT00640835|26792772|FG000|Overall Study|Physician Decision|10|||
13396467|NCT00640835|26792773|FG001|Overall Study|Physician Decision|14|||
13396468|NCT00640835|26792772|FG000|Overall Study|Sponsor's Decision|11|||
13396469|NCT00640835|26792773|FG001|Overall Study|Sponsor's Decision|7|||
13396470|NCT00640835|26792772|FG000|Overall Study|Protocol Violation|2|||
13396471|NCT00640835|26792773|FG001|Overall Study|Protocol Violation|2|||
13396472|NCT00640835|26792772|FG000|Overall Study|Lost to Follow-up|17|||
13396473|NCT00640835|26792773|FG001|Overall Study|Lost to Follow-up|13|||
13396474|NCT00640835|26792772|FG000|Overall Study|Other Reason|19|||
13396475|NCT00640835|26792773|FG001|Overall Study|Other Reason|4|||
13396476|NCT00640614|26792822|FG000|Overall Study|Lost to Follow-up|1|||
13396477|NCT00640614|26792823|FG001|Overall Study|Lost to Follow-up|0|||
13396478|NCT00640601|26792839|FG000|Overall Study|Adverse Event|43|||
13396479|NCT00640601|26792839|FG000|Overall Study|Withdrawal by Subject|20|||
13396480|NCT00640601|26792839|FG000|Overall Study|Protocol Violation|6|||
13396481|NCT00640601|26792839|FG000|Overall Study|Lack of Efficacy|16|||
13396482|NCT00640601|26792839|FG000|Overall Study|Lost to Follow-up|9|||
13396483|NCT00640601|26792839|FG000|Overall Study|Physician Decision|8|||
13396484|NCT00640601|26792839|FG000|Overall Study|treatment naive, combination therapy|10|||
13396485|NCT00640562|26792872|FG000|Overall Study|Adverse Event|8|||
13396486|NCT00640562|26792873|FG001|Overall Study|Adverse Event|5|||
13396487|NCT00640562|26792872|FG000|Overall Study|Lack of Efficacy|1|||
13396488|NCT00640562|26792873|FG001|Overall Study|Lack of Efficacy|4|||
13396489|NCT00640562|26792872|FG000|Overall Study|Protocol Violation|2|||
13396490|NCT00640562|26792873|FG001|Overall Study|Protocol Violation|4|||
13396491|NCT00640562|26792872|FG000|Overall Study|Withdrawal by Subject|6|||
13396492|NCT00640562|26792873|FG001|Overall Study|Withdrawal by Subject|10|||
13396493|NCT00640562|26792872|FG000|Overall Study|Known risperidone intolerance|0|||
13396494|NCT00640562|26792873|FG001|Overall Study|Known risperidone intolerance|1|||
13396495|NCT00640562|26792872|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0|||
13396496|NCT00640562|26792873|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1|||
13396497|NCT00640562|26792872|FG000|Overall Study|Low study drug dose|0|||
13396498|NCT00640562|26792873|FG001|Overall Study|Low study drug dose|1|||
13396499|NCT00640562|26792872|FG000|Overall Study|Glycosylated Hemoglobin >8|1|||
13396500|NCT00640562|26792873|FG001|Overall Study|Glycosylated Hemoglobin >8|0|||
13396501|NCT00640510|26792892|FG000|Overall Study|Lack of Efficacy|0|||
13396502|NCT00640510|26792893|FG001|Overall Study|Lack of Efficacy|1|||
13396503|NCT00640510|26792892|FG000|Overall Study|Protocol Violation|1|||
13396504|NCT00640510|26792893|FG001|Overall Study|Protocol Violation|0|||
13396505|NCT00640510|26792892|FG000|Overall Study|Physician Decision|0|||
13396506|NCT00640510|26792893|FG001|Overall Study|Physician Decision|1|||
13396507|NCT00640393|26792959|FG000|Part 1|Lost to Follow-up|2|||
13396508|NCT00640393|26792960|FG001|Part 1|Lost to Follow-up|0|||
13396509|NCT00640393|26792961|FG002|Part 1|Lost to Follow-up|0|||
13396510|NCT00640393|26792959|FG000|Part 1|Withdrawal by Subject|3|||
13396511|NCT00640393|26792960|FG001|Part 1|Withdrawal by Subject|0|||
13396512|NCT00640393|26792961|FG002|Part 1|Withdrawal by Subject|0|||
13396513|NCT00640393|26792959|FG000|Randomization|Withdrawn per protocol|17|||
13396514|NCT00640393|26792960|FG001|Randomization|Withdrawn per protocol|0|||
13396515|NCT00640393|26792961|FG002|Randomization|Withdrawn per protocol|0|||
13396516|NCT00640393|26792959|FG000|Randomization|Never randomized by site|2|||
13396517|NCT00640393|26792960|FG001|Randomization|Never randomized by site|0|||
13396518|NCT00640393|26792961|FG002|Randomization|Never randomized by site|0|||
13396519|NCT00640393|26792959|FG000|Part 2|Lost to Follow-up|0|||
13396520|NCT00640393|26792960|FG001|Part 2|Lost to Follow-up|2|||
13396521|NCT00640393|26792961|FG002|Part 2|Lost to Follow-up|2|||
13396522|NCT00640393|26792959|FG000|Part 2|Withdrawal by Subject|0|||
13396523|NCT00640393|26792960|FG001|Part 2|Withdrawal by Subject|6|||
13396524|NCT00640393|26792961|FG002|Part 2|Withdrawal by Subject|1|||
13396525|NCT00640393|26792959|FG000|Part 2|Non-adherence|0|||
13396526|NCT00640393|26792960|FG001|Part 2|Non-adherence|1|||
13396527|NCT00640393|26792961|FG002|Part 2|Non-adherence|0|||
13396528|NCT00640393|26792959|FG000|Part 2|Adverse Event|0|||
13396529|NCT00640393|26792960|FG001|Part 2|Adverse Event|1|||
13396530|NCT00640393|26792961|FG002|Part 2|Adverse Event|0|||
13396531|NCT00640341|26792985|FG000|Overall Study|Adverse Event|0|||
13396532|NCT00640341|26792986|FG001|Overall Study|Adverse Event|0|||
13396533|NCT00640341|26792987|FG002|Overall Study|Adverse Event|1|||
13396534|NCT00640341|26792985|FG000|Overall Study|Positive Slit Lamp Findings|0|||
13396535|NCT00640341|26792986|FG001|Overall Study|Positive Slit Lamp Findings|0|||
13396536|NCT00640341|26792987|FG002|Overall Study|Positive Slit Lamp Findings|1|||
13396537|NCT00640341|26792985|FG000|Overall Study|Study Related Symptoms/Complaints|2|||
13396538|NCT00640341|26792986|FG001|Overall Study|Study Related Symptoms/Complaints|1|||
13396539|NCT00640341|26792987|FG002|Overall Study|Study Related Symptoms/Complaints|2|||
13396540|NCT00640341|26792985|FG000|Overall Study|Inability to Maintain Wearing Schedule|1|||
13396541|NCT00640341|26792986|FG001|Overall Study|Inability to Maintain Wearing Schedule|1|||
13396542|NCT00640341|26792987|FG002|Overall Study|Inability to Maintain Wearing Schedule|0|||
13396543|NCT00640341|26792985|FG000|Overall Study|Failure to Follow Subject Instructions|1|||
13396544|NCT00640341|26792986|FG001|Overall Study|Failure to Follow Subject Instructions|0|||
13396545|NCT00640341|26792987|FG002|Overall Study|Failure to Follow Subject Instructions|0|||
13396546|NCT00640341|26792985|FG000|Overall Study|Lost to Follow-up|2|||
13396547|NCT00640341|26792986|FG001|Overall Study|Lost to Follow-up|0|||
13396548|NCT00640341|26792987|FG002|Overall Study|Lost to Follow-up|0|||
13396549|NCT00640341|26792985|FG000|Overall Study|Withdrawal by Subject|4|||
13396550|NCT00640341|26792986|FG001|Overall Study|Withdrawal by Subject|0|||
13396551|NCT00640341|26792987|FG002|Overall Study|Withdrawal by Subject|1|||
13396552|NCT00640341|26792985|FG000|Overall Study|Unacceptable Lens Movement|1|||
13396553|NCT00640341|26792986|FG001|Overall Study|Unacceptable Lens Movement|0|||
13396554|NCT00640341|26792987|FG002|Overall Study|Unacceptable Lens Movement|0|||
13396555|NCT00640341|26792985|FG000|Overall Study|Poor fit/Uncomfortable|4|||
13396556|NCT00640341|26792986|FG001|Overall Study|Poor fit/Uncomfortable|0|||
13396557|NCT00640341|26792987|FG002|Overall Study|Poor fit/Uncomfortable|0|||
13396558|NCT00640341|26792985|FG000|Overall Study|Ineligable at Baseline|5|||
13396559|NCT00640341|26792986|FG001|Overall Study|Ineligable at Baseline|3|||
13396560|NCT00640341|26792987|FG002|Overall Study|Ineligable at Baseline|2|||
13396561|NCT00640341|26792985|FG000|Overall Study|Adverse event and positive slit lamp|1|||
13396562|NCT00640341|26792986|FG001|Overall Study|Adverse event and positive slit lamp|0|||
13396563|NCT00640341|26792987|FG002|Overall Study|Adverse event and positive slit lamp|0|||
13396564|NCT00640328|26793170|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
13396565|NCT00640328|26793171|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1|||
13396566|NCT00640328|26793172|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
13396567|NCT00640328|26793173|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
13396568|NCT00640328|26793174|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
13396569|NCT00640328|26793175|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
13396570|NCT00640328|26793170|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
13396571|NCT00640328|26793171|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
13396572|NCT00640328|26793172|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
13396573|NCT00640328|26793173|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
13396574|NCT00640328|26793174|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1|||
13396575|NCT00640328|26793175|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
13396576|NCT00640328|26793170|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
13396577|NCT00640328|26793171|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
13396578|NCT00640328|26793172|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1|||
13396579|NCT00640328|26793173|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
13396580|NCT00640328|26793174|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
13396581|NCT00640328|26793175|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
13396582|NCT00640328|26793170|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
13396583|NCT00640328|26793171|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
13396584|NCT00640328|26793172|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
13396585|NCT00640328|26793173|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
13396586|NCT00640328|26793174|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
13396587|NCT00640328|26793175|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
13396588|NCT00640315|26793308|FG000|Overall Study|Withdrawal by Subject|0|||
13396589|NCT00640315|26793309|FG001|Overall Study|Withdrawal by Subject|1|||
13396590|NCT00640289|26793316|FG000|Overall Study|Death|3|||
13396591|NCT00640289|26793316|FG000|Overall Study|Withdrawal by Subject|1|||
13396592|NCT00640289|26793316|FG000|Overall Study|Lost to Follow-up|1|||
13396593|NCT00640289|26793316|FG000|Overall Study|Data collected under different amendment|2|||
13396594|NCT00640289|26793316|FG000|Overall Study|Transferred to another center|1|||
13396595|NCT00640289|26793316|FG000|Overall Study|Missing status|5|||
13396596|NCT00640224|26793427|FG000|Overall Study|Lost to Follow-up|5|||
13396597|NCT00640224|26793428|FG001|Overall Study|Lost to Follow-up|2|||
13219898|NCT01829295|26278604|FG001|6-12 Months|Adverse Event|0|||
13396598|NCT00640224|26793429|FG002|Overall Study|Lost to Follow-up|0|||
13396599|NCT00640224|26793430|FG003|Overall Study|Lost to Follow-up|0|||
13396600|NCT00640224|26793427|FG000|Overall Study|Withdrawal by Subject|1|||
13396601|NCT00640224|26793428|FG001|Overall Study|Withdrawal by Subject|0|||
13396602|NCT00640224|26793429|FG002|Overall Study|Withdrawal by Subject|0|||
13396603|NCT00640224|26793430|FG003|Overall Study|Withdrawal by Subject|0|||
13396604|NCT00640224|26793427|FG000|Overall Study|Headaches|0|||
13396605|NCT00640224|26793428|FG001|Overall Study|Headaches|1|||
13396606|NCT00640224|26793429|FG002|Overall Study|Headaches|0|||
13396607|NCT00640224|26793430|FG003|Overall Study|Headaches|0|||
13396608|NCT00640146|26793447|FG000|Overall Study|Adverse Event|2|||
13396609|NCT00640146|26793448|FG001|Overall Study|Adverse Event|0|||
13396610|NCT00640146|26793447|FG000|Overall Study|Lost to Follow-up|0|||
13396611|NCT00640146|26793448|FG001|Overall Study|Lost to Follow-up|1|||
13396612|NCT00640146|26793447|FG000|Overall Study|Lack of Efficacy|0|||
13396613|NCT00640146|26793448|FG001|Overall Study|Lack of Efficacy|1|||
13396614|NCT00640146|26793447|FG000|Overall Study|Withdrawal by Subject|1|||
13396615|NCT00640146|26793448|FG001|Overall Study|Withdrawal by Subject|1|||
13396616|NCT00640146|26793447|FG000|Overall Study|Randomized but not treated|1|||
13396617|NCT00640146|26793448|FG001|Overall Study|Randomized but not treated|3|||
13396618|NCT00640042|26793462|FG000|Enrollment|Did not receive study drug|83|||
13396619|NCT00640016|26793519|FG000|Overall Study|Withdrawal by Subject|0|||
13396620|NCT00640016|26793520|FG001|Overall Study|Withdrawal by Subject|1|||
13396621|NCT00640016|26793521|FG002|Overall Study|Withdrawal by Subject|0|||
13396622|NCT00640016|26793522|FG003|Overall Study|Withdrawal by Subject|0|||
13396623|NCT00640016|26793519|FG000|Overall Study|Study termination|2|||
13396624|NCT00640016|26793520|FG001|Overall Study|Study termination|1|||
13396625|NCT00640016|26793521|FG002|Overall Study|Study termination|3|||
13396626|NCT00640016|26793522|FG003|Overall Study|Study termination|2|||
13396627|NCT00640016|26793519|FG000|Overall Study|Adverse Event|0|||
13396628|NCT00640016|26793520|FG001|Overall Study|Adverse Event|0|||
13396629|NCT00640016|26793521|FG002|Overall Study|Adverse Event|0|||
13396630|NCT00640016|26793522|FG003|Overall Study|Adverse Event|1|||
13396631|NCT00638690|26793542|FG000|Overall Study|Death|655|||
13396632|NCT00638690|26793543|FG001|Overall Study|Death|335|||
13396633|NCT00638690|26793542|FG000|Overall Study|Withdrawal by Subject|22|||
13396634|NCT00638690|26793543|FG001|Overall Study|Withdrawal by Subject|5|||
13396635|NCT00638690|26793542|FG000|Overall Study|Lost to Follow-up|4|||
13396636|NCT00638690|26793543|FG001|Overall Study|Lost to Follow-up|2|||
13396637|NCT00638443|26793574|FG000|First Intervention|Adverse Event|2|||
13396638|NCT00638443|26793575|FG001|First Intervention|Adverse Event|1|||
13396639|NCT00636675|26793592|FG000|Overall Study|Lost to Follow-up|121|||
13396640|NCT00636675|26793593|FG001|Overall Study|Lost to Follow-up|31|||
13396641|NCT00636675|26793592|FG000|Overall Study|Withdrawal by Subject|19|||
13396642|NCT00636675|26793593|FG001|Overall Study|Withdrawal by Subject|10|||
13475857|NCT02916706|27001326|FG000|Overall Study|Adverse Event|0|||
13475858|NCT02916706|27001327|FG001|Overall Study|Adverse Event|1|||
13475859|NCT02916706|27001326|FG000|Overall Study|Lost to Follow-up|0|||
13475860|NCT02916706|27001327|FG001|Overall Study|Lost to Follow-up|1|||
13475861|NCT02916706|27001326|FG000|Overall Study|Physician Decision|1|||
13475862|NCT02916706|27001327|FG001|Overall Study|Physician Decision|0|||
13475863|NCT02916706|27001326|FG000|Overall Study|Protocol Violation|3|||
13475864|NCT02916706|27001327|FG001|Overall Study|Protocol Violation|1|||
13475865|NCT02916706|27001326|FG000|Overall Study|Withdrawal by Subject|6|||
13475866|NCT02916706|27001327|FG001|Overall Study|Withdrawal by Subject|9|||
13475867|NCT02916706|27001326|FG000|Overall Study|Other|5|||
13475868|NCT02916706|27001327|FG001|Overall Study|Other|19|||
13475869|NCT02889900|27001341|FG000|Overall Study|Adverse Event|11|||
13475870|NCT02889900|27001341|FG000|Overall Study|Condition under investigation worsened|32|||
13475871|NCT02889900|27001341|FG000|Overall Study|Other|5|||
13475872|NCT02889900|27001341|FG000|Overall Study|Withdrawal by Subject|7|||
13475873|NCT02889900|27001341|FG000|Overall Study|Not treated|2|||
13475874|NCT02866695|27001349|FG000|Overall Study|Adverse Event|1|||
13475875|NCT02866695|27001349|FG000|Overall Study|Lost to Follow-up|1|||
13475876|NCT02834793|27001392|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2|||
13475877|NCT02834793|27001393|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1|||
13475878|NCT02834793|27001394|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
13475879|NCT02834793|27001395|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
13475880|NCT02834793|27001392|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1|||
13475881|NCT02834793|27001393|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
13475882|NCT02834793|27001394|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
13475883|NCT02834793|27001395|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
13475884|NCT02834793|27001392|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1|||
13475885|NCT02834793|27001393|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
13475886|NCT02834793|27001394|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
13475887|NCT02834793|27001395|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
13475888|NCT02834793|27001392|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0|||
13475889|NCT02834793|27001393|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3|||
13396643|NCT00636181|26793629|FG000|Overall Study|Withdrawal by Subject|8|||
13396644|NCT00636181|26793630|FG001|Overall Study|Withdrawal by Subject|6|||
13396645|NCT00636181|26793631|FG002|Overall Study|Withdrawal by Subject|10|||
13396646|NCT00636168|26793666|FG000|Randomized to Study Drug|Withdrawal by Subject|2|||
13396647|NCT00636168|26793667|FG001|Randomized to Study Drug|Withdrawal by Subject|2|||
13396648|NCT00636168|26793666|FG000|Randomized to Study Drug|Adverse Event|1|||
13396649|NCT00636168|26793667|FG001|Randomized to Study Drug|Adverse Event|0|||
13396650|NCT00636168|26793666|FG000|Randomized to Study Drug|No longer meets study criteria|1|||
13396651|NCT00636168|26793667|FG001|Randomized to Study Drug|No longer meets study criteria|0|||
13396652|NCT00636168|26793666|FG000|Treated With Study Drug|Recurrence of disease|135|||
13396653|NCT00636168|26793667|FG001|Treated With Study Drug|Recurrence of disease|282|||
13396654|NCT00636168|26793666|FG000|Treated With Study Drug|Adverse Event|250|||
13396655|NCT00636168|26793667|FG001|Treated With Study Drug|Adverse Event|22|||
13396656|NCT00636168|26793666|FG000|Treated With Study Drug|Participant withdrew consent|16|||
13396657|NCT00636168|26793667|FG001|Treated With Study Drug|Participant withdrew consent|21|||
13396658|NCT00636168|26793666|FG000|Treated With Study Drug|Poor/non-compliance|1|||
13396659|NCT00636168|26793667|FG001|Treated With Study Drug|Poor/non-compliance|3|||
13396660|NCT00636168|26793666|FG000|Treated With Study Drug|Death|3|||
13396661|NCT00636168|26793667|FG001|Treated With Study Drug|Death|0|||
13396662|NCT00636168|26793666|FG000|Treated With Study Drug|Pregnancy|1|||
13396663|NCT00636168|26793667|FG001|Treated With Study Drug|Pregnancy|0|||
13396664|NCT00636168|26793666|FG000|Treated With Study Drug|No longer meets study criteria|1|||
13396665|NCT00636168|26793667|FG001|Treated With Study Drug|No longer meets study criteria|0|||
13396666|NCT00636168|26793666|FG000|Treated With Study Drug|Other reason|1|||
13396667|NCT00636168|26793667|FG001|Treated With Study Drug|Other reason|3|||
13396668|NCT00636168|26793666|FG000|Long Term Follow-Up|Lost to Follow-up|3|||
13396669|NCT00636168|26793667|FG001|Long Term Follow-Up|Lost to Follow-up|3|||
13396670|NCT00636168|26793666|FG000|Long Term Follow-Up|Participant withdrew consent|0|||
13396671|NCT00636168|26793667|FG001|Long Term Follow-Up|Participant withdrew consent|2|||
13396672|NCT00636168|26793666|FG000|Long Term Follow-Up|Death|8|||
13396673|NCT00636168|26793667|FG001|Long Term Follow-Up|Death|9|||
13396674|NCT00635999|26793688|FG000|Overall Study|Withdrawal by Subject|4|||
13396675|NCT00635999|26793689|FG001|Overall Study|Withdrawal by Subject|2|||
13396676|NCT00635999|26793690|FG002|Overall Study|Withdrawal by Subject|1|||
13396677|NCT00635570|26793709|FG000|Overall Study|Lost to Follow-up|8|||
13396678|NCT00635570|26793710|FG001|Overall Study|Lost to Follow-up|8|||
13396679|NCT00635570|26793709|FG000|Overall Study|Withdrawal by Subject|1|||
13396680|NCT00635570|26793710|FG001|Overall Study|Withdrawal by Subject|1|||
13396681|NCT00635570|26793709|FG000|Overall Study|Adverse Event|2|||
13396682|NCT00635570|26793710|FG001|Overall Study|Adverse Event|0|||
13396683|NCT00635570|26793709|FG000|Overall Study|Physician Decision|1|||
13396684|NCT00635570|26793710|FG001|Overall Study|Physician Decision|0|||
13396685|NCT00635570|26793709|FG000|Overall Study|Did not complete survey|2|||
13396686|NCT00635570|26793710|FG001|Overall Study|Did not complete survey|1|||
13396687|NCT00635570|26793709|FG000|Overall Study|Early termination(No sexual activity)|1|||
13396688|NCT00635570|26793710|FG001|Overall Study|Early termination(No sexual activity)|1|||
13396689|NCT00635492|26793761|FG000|Overall Study|Death|12|||
13396690|NCT00635492|26793762|FG001|Overall Study|Death|40|||
13396691|NCT00635492|26793761|FG000|Overall Study|Lost to Follow-up|151|||
13396692|NCT00635492|26793762|FG001|Overall Study|Lost to Follow-up|172|||
13396693|NCT00635492|26793761|FG000|Overall Study|Physician Decision|32|||
13396694|NCT00635492|26793762|FG001|Overall Study|Physician Decision|22|||
13396695|NCT00635492|26793761|FG000|Overall Study|Sponsor decision|2|||
13396696|NCT00635492|26793762|FG001|Overall Study|Sponsor decision|3|||
13396697|NCT00635492|26793761|FG000|Overall Study|Withdrawal by Subject|82|||
13396698|NCT00635492|26793762|FG001|Overall Study|Withdrawal by Subject|45|||
13396699|NCT00635219|26793835|FG000|Overall Study|Adverse Event|12|||
13396700|NCT00635219|26793836|FG001|Overall Study|Adverse Event|10|||
13396701|NCT00635219|26793837|FG002|Overall Study|Adverse Event|18|||
13396702|NCT00635219|26793838|FG003|Overall Study|Adverse Event|15|||
13396703|NCT00635219|26793839|FG004|Overall Study|Adverse Event|19|||
13396704|NCT00635219|26793835|FG000|Overall Study|Lack of Efficacy|5|||
13396705|NCT00635219|26793836|FG001|Overall Study|Lack of Efficacy|6|||
13396706|NCT00635219|26793837|FG002|Overall Study|Lack of Efficacy|3|||
13396707|NCT00635219|26793838|FG003|Overall Study|Lack of Efficacy|4|||
13396708|NCT00635219|26793839|FG004|Overall Study|Lack of Efficacy|6|||
13396709|NCT00635219|26793835|FG000|Overall Study|Non-compliance With Study Product|0|||
13396710|NCT00635219|26793836|FG001|Overall Study|Non-compliance With Study Product|0|||
13396711|NCT00635219|26793837|FG002|Overall Study|Non-compliance With Study Product|0|||
13396712|NCT00635219|26793838|FG003|Overall Study|Non-compliance With Study Product|2|||
13396713|NCT00635219|26793839|FG004|Overall Study|Non-compliance With Study Product|1|||
13396714|NCT00635219|26793835|FG000|Overall Study|Protocol Violation|0|||
13396715|NCT00635219|26793836|FG001|Overall Study|Protocol Violation|2|||
13396716|NCT00635219|26793837|FG002|Overall Study|Protocol Violation|3|||
13396717|NCT00635219|26793838|FG003|Overall Study|Protocol Violation|2|||
13396718|NCT00635219|26793839|FG004|Overall Study|Protocol Violation|4|||
13396719|NCT00635219|26793835|FG000|Overall Study|Withdrawal of Consent|8|||
13396720|NCT00635219|26793836|FG001|Overall Study|Withdrawal of Consent|6|||
13396721|NCT00635219|26793837|FG002|Overall Study|Withdrawal of Consent|8|||
13396722|NCT00635219|26793838|FG003|Overall Study|Withdrawal of Consent|11|||
13396723|NCT00635219|26793839|FG004|Overall Study|Withdrawal of Consent|8|||
13396724|NCT00635219|26793835|FG000|Overall Study|Lost to Follow-up|0|||
13396725|NCT00635219|26793836|FG001|Overall Study|Lost to Follow-up|0|||
13396726|NCT00635219|26793837|FG002|Overall Study|Lost to Follow-up|2|||
13396727|NCT00635219|26793838|FG003|Overall Study|Lost to Follow-up|0|||
13396728|NCT00635219|26793839|FG004|Overall Study|Lost to Follow-up|3|||
13396729|NCT00635219|26793835|FG000|Overall Study|Administrative or Other Reasons|0|||
13396730|NCT00635219|26793836|FG001|Overall Study|Administrative or Other Reasons|1|||
13396731|NCT00635219|26793837|FG002|Overall Study|Administrative or Other Reasons|1|||
13396732|NCT00635219|26793838|FG003|Overall Study|Administrative or Other Reasons|0|||
13396733|NCT00635219|26793839|FG004|Overall Study|Administrative or Other Reasons|1|||
13396734|NCT00635154|26793851|FG000|Overall Study|Alternative Treatment|8|||
13396735|NCT00635154|26793851|FG000|Overall Study|Other|4|||
13396736|NCT00635154|26793851|FG000|Overall Study|Still on treatment|21|||
13396737|NCT00634933|26793929|FG000|Part A: Baseline to Week 24|Adverse Event|4|||
13396738|NCT00634933|26793930|FG001|Part A: Baseline to Week 24|Adverse Event|4|||
13396739|NCT00634933|26793931|FG002|Part A: Baseline to Week 24|Adverse Event|8|||
13396740|NCT00634933|26793932|FG003|Part A: Baseline to Week 24|Adverse Event|0|||
13396741|NCT00634933|26793933|FG004|Part A: Baseline to Week 24|Adverse Event|0|||
13396742|NCT00634933|26793929|FG000|Part A: Baseline to Week 24|Death|1|||
13396743|NCT00634933|26793930|FG001|Part A: Baseline to Week 24|Death|0|||
13396744|NCT00634933|26793931|FG002|Part A: Baseline to Week 24|Death|0|||
13396745|NCT00634933|26793932|FG003|Part A: Baseline to Week 24|Death|0|||
13396746|NCT00634933|26793933|FG004|Part A: Baseline to Week 24|Death|0|||
13396747|NCT00634933|26793929|FG000|Part A: Baseline to Week 24|Failed to Return|1|||
13396748|NCT00634933|26793930|FG001|Part A: Baseline to Week 24|Failed to Return|0|||
13396749|NCT00634933|26793931|FG002|Part A: Baseline to Week 24|Failed to Return|0|||
13396750|NCT00634933|26793932|FG003|Part A: Baseline to Week 24|Failed to Return|0|||
13396751|NCT00634933|26793933|FG004|Part A: Baseline to Week 24|Failed to Return|0|||
13396752|NCT00634933|26793929|FG000|Part A: Baseline to Week 24|Investigator Request|1|||
13396753|NCT00634933|26793930|FG001|Part A: Baseline to Week 24|Investigator Request|1|||
13396754|NCT00634933|26793931|FG002|Part A: Baseline to Week 24|Investigator Request|1|||
13396755|NCT00634933|26793932|FG003|Part A: Baseline to Week 24|Investigator Request|0|||
13396756|NCT00634933|26793933|FG004|Part A: Baseline to Week 24|Investigator Request|0|||
13396757|NCT00634933|26793929|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0|||
13396758|NCT00634933|26793930|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1|||
13396759|NCT00634933|26793931|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1|||
13396760|NCT00634933|26793932|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0|||
13396761|NCT00634933|26793933|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0|||
13396762|NCT00634933|26793929|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
13396763|NCT00634933|26793930|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
13396764|NCT00634933|26793931|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
13396765|NCT00634933|26793932|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
13396766|NCT00634933|26793933|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
13396767|NCT00634933|26793929|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3|||
13396768|NCT00634933|26793930|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1|||
13396769|NCT00634933|26793931|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0|||
13396770|NCT00634933|26793932|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0|||
13396771|NCT00634933|26793933|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0|||
13396772|NCT00634933|26793929|FG000|Part A: Baseline to Week 24|Other|1|||
13396773|NCT00634933|26793930|FG001|Part A: Baseline to Week 24|Other|8|||
13396774|NCT00634933|26793931|FG002|Part A: Baseline to Week 24|Other|5|||
13396775|NCT00634933|26793932|FG003|Part A: Baseline to Week 24|Other|0|||
13396776|NCT00634933|26793933|FG004|Part A: Baseline to Week 24|Other|0|||
13396777|NCT00634933|26793929|FG000|Between Part A and Part B|Physician Decision|0|||
13396778|NCT00634933|26793930|FG001|Between Part A and Part B|Physician Decision|1|||
13396779|NCT00634933|26793931|FG002|Between Part A and Part B|Physician Decision|0|||
13396780|NCT00634933|26793932|FG003|Between Part A and Part B|Physician Decision|0|||
13396781|NCT00634933|26793933|FG004|Between Part A and Part B|Physician Decision|0|||
13396782|NCT00634933|26793929|FG000|Part B: Week 24 to Week 52|Adverse Event|0|||
13396783|NCT00634933|26793930|FG001|Part B: Week 24 to Week 52|Adverse Event|1|||
13396784|NCT00634933|26793931|FG002|Part B: Week 24 to Week 52|Adverse Event|1|||
13396785|NCT00634933|26793932|FG003|Part B: Week 24 to Week 52|Adverse Event|1|||
13396786|NCT00634933|26793933|FG004|Part B: Week 24 to Week 52|Adverse Event|0|||
13396787|NCT00634933|26793929|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0|||
13396788|NCT00634933|26793930|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11|||
13396789|NCT00634933|26793931|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14|||
13396790|NCT00634933|26793932|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3|||
13396791|NCT00634933|26793933|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7|||
13396792|NCT00634933|26793929|FG000|Part B: Week 24 to Week 52|Physician Decision|0|||
13396793|NCT00634933|26793930|FG001|Part B: Week 24 to Week 52|Physician Decision|1|||
13396794|NCT00634933|26793931|FG002|Part B: Week 24 to Week 52|Physician Decision|1|||
13396795|NCT00634933|26793932|FG003|Part B: Week 24 to Week 52|Physician Decision|0|||
13396796|NCT00634933|26793933|FG004|Part B: Week 24 to Week 52|Physician Decision|0|||
13396797|NCT00634933|26793929|FG000|Part B: Week 24 to Week 52|Protocol Violation|0|||
13396798|NCT00634933|26793930|FG001|Part B: Week 24 to Week 52|Protocol Violation|0|||
13396799|NCT00634933|26793931|FG002|Part B: Week 24 to Week 52|Protocol Violation|0|||
13396800|NCT00634933|26793932|FG003|Part B: Week 24 to Week 52|Protocol Violation|0|||
13396801|NCT00634933|26793933|FG004|Part B: Week 24 to Week 52|Protocol Violation|1|||
13396802|NCT00634933|26793929|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
13396803|NCT00634933|26793930|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
13396804|NCT00634933|26793931|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
13396805|NCT00634933|26793932|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2|||
13396806|NCT00634933|26793933|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1|||
13396807|NCT00634933|26793929|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
13396808|NCT00634933|26793930|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
13396809|NCT00634933|26793931|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
13396810|NCT00634933|26793932|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
13396811|NCT00634933|26793933|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
13396812|NCT00634933|26793929|FG000|Part B: Week 24 to Week 52|Other|0|||
13396813|NCT00634933|26793930|FG001|Part B: Week 24 to Week 52|Other|0|||
13396814|NCT00634933|26793931|FG002|Part B: Week 24 to Week 52|Other|5|||
13396815|NCT00634933|26793932|FG003|Part B: Week 24 to Week 52|Other|0|||
13396816|NCT00634933|26793933|FG004|Part B: Week 24 to Week 52|Other|1|||
13396817|NCT00634647|26793941|FG000|Overall Study|death on study|3|||
13396818|NCT00634647|26793941|FG000|Overall Study|refused further treatment|3|||
13396819|NCT00634647|26793941|FG000|Overall Study|declined to participate before treatment|1|||
13396820|NCT00633893|26794022|FG000|Overall Study|Death|1|||
13396821|NCT00633893|26794023|FG001|Overall Study|Death|3|||
13396822|NCT00633893|26794024|FG002|Overall Study|Death|9|||
13396823|NCT00633893|26794022|FG000|Overall Study|Adverse Event|65|||
13396824|NCT00633893|26794023|FG001|Overall Study|Adverse Event|58|||
13396825|NCT00633893|26794024|FG002|Overall Study|Adverse Event|126|||
13396826|NCT00633893|26794022|FG000|Overall Study|Withdrawal by Subject|7|||
13396827|NCT00633893|26794023|FG001|Overall Study|Withdrawal by Subject|12|||
13396828|NCT00633893|26794024|FG002|Overall Study|Withdrawal by Subject|6|||
13396829|NCT00633893|26794022|FG000|Overall Study|Lost to Follow-up|2|||
13396830|NCT00633893|26794023|FG001|Overall Study|Lost to Follow-up|4|||
13396831|NCT00633893|26794024|FG002|Overall Study|Lost to Follow-up|8|||
13396832|NCT00633893|26794022|FG000|Overall Study|Poor/non-compliance|5|||
13396833|NCT00633893|26794023|FG001|Overall Study|Poor/non-compliance|12|||
13396834|NCT00633893|26794024|FG002|Overall Study|Poor/non-compliance|3|||
13396835|NCT00633893|26794022|FG000|Overall Study|Pregnancy|2|||
13396836|NCT00633893|26794023|FG001|Overall Study|Pregnancy|1|||
13396837|NCT00633893|26794024|FG002|Overall Study|Pregnancy|1|||
13396838|NCT00633893|26794022|FG000|Overall Study|Not meet/no longer meets criteria|4|||
13396839|NCT00633893|26794023|FG001|Overall Study|Not meet/no longer meets criteria|6|||
13396840|NCT00633893|26794024|FG002|Overall Study|Not meet/no longer meets criteria|4|||
13396841|NCT00633893|26794022|FG000|Overall Study|Other|28|||
13396842|NCT00633893|26794023|FG001|Overall Study|Other|33|||
13396843|NCT00633893|26794024|FG002|Overall Study|Other|31|||
13396844|NCT00633880|26794061|FG000|Open Label Titration|Lack of Efficacy|1|||
13396845|NCT00633880|26794062|FG001|Open Label Titration|Lack of Efficacy|0|||
13396846|NCT00633880|26794063|FG002|Open Label Titration|Lack of Efficacy|0|||
13396847|NCT00633880|26794061|FG000|Open Label Titration|Adverse Event|13|||
13396848|NCT00633880|26794062|FG001|Open Label Titration|Adverse Event|0|||
13396849|NCT00633880|26794063|FG002|Open Label Titration|Adverse Event|0|||
13396850|NCT00633880|26794061|FG000|Open Label Titration|Treatment Failure|55|||
13396851|NCT00633880|26794062|FG001|Open Label Titration|Treatment Failure|0|||
13396852|NCT00633880|26794063|FG002|Open Label Titration|Treatment Failure|0|||
13396853|NCT00633880|26794061|FG000|Open Label Titration|Protocol Violation|6|||
13396854|NCT00633880|26794062|FG001|Open Label Titration|Protocol Violation|0|||
13396855|NCT00633880|26794063|FG002|Open Label Titration|Protocol Violation|0|||
13396856|NCT00633880|26794061|FG000|Open Label Titration|Physician Decision|1|||
13396857|NCT00633880|26794062|FG001|Open Label Titration|Physician Decision|0|||
13396858|NCT00633880|26794063|FG002|Open Label Titration|Physician Decision|0|||
13396859|NCT00633880|26794061|FG000|Open Label Titration|Withdrawal by Subject|4|||
13396860|NCT00633880|26794062|FG001|Open Label Titration|Withdrawal by Subject|0|||
13396861|NCT00633880|26794063|FG002|Open Label Titration|Withdrawal by Subject|0|||
13396862|NCT00633594|26794100|FG000|Overall Study|Adverse Event|0|||
13396863|NCT00633594|26794101|FG001|Overall Study|Adverse Event|4|||
13396864|NCT00633594|26794102|FG002|Overall Study|Adverse Event|7|||
13396865|NCT00633594|26794100|FG000|Overall Study|Death|0|||
13396866|NCT00633594|26794101|FG001|Overall Study|Death|1|||
13306237|NCT01292603|26525398|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2|||
13396867|NCT00633594|26794102|FG002|Overall Study|Death|2|||
13396868|NCT00633594|26794100|FG000|Overall Study|Disease Progression|0|||
13396869|NCT00633594|26794101|FG001|Overall Study|Disease Progression|0|||
13396870|NCT00633594|26794102|FG002|Overall Study|Disease Progression|1|||
13396871|NCT00633139|26794126|FG000|Overall Study|Non compliance|0|||
13396872|NCT00633139|26794127|FG001|Overall Study|Non compliance|0|||
13396873|NCT00633139|26794128|FG002|Overall Study|Non compliance|1|||
13396874|NCT00633139|26794126|FG000|Overall Study|Withdrawal by Subject|0|||
13396875|NCT00633139|26794127|FG001|Overall Study|Withdrawal by Subject|1|||
13396876|NCT00633139|26794128|FG002|Overall Study|Withdrawal by Subject|0|||
13396877|NCT00632125|26794134|FG000|Overall Study|Death|82|||
13396878|NCT00632125|26794134|FG000|Overall Study|Withdrawal by Subject|44|||
13396879|NCT00632125|26794134|FG000|Overall Study|Adverse Event|36|||
13396880|NCT00632125|26794134|FG000|Overall Study|Renal transplantation|17|||
13396881|NCT00632125|26794134|FG000|Overall Study|Need for systemic immunosuppressive medi|8|||
13396882|NCT00632125|26794134|FG000|Overall Study|Non-compliance|8|||
13396883|NCT00632125|26794134|FG000|Overall Study|Development of uncontrolled hypertension|5|||
13396884|NCT00632125|26794134|FG000|Overall Study|Moved to other dialysis unit, etc.|102|||
13396885|NCT00631917|26794155|FG000|Overall Study|Adverse Event|34|||
13396886|NCT00631917|26794156|FG001|Overall Study|Adverse Event|45|||
13396887|NCT00631917|26794155|FG000|Overall Study|Abnormal laboratory value(s)|2|||
13396888|NCT00631917|26794156|FG001|Overall Study|Abnormal laboratory value(s)|1|||
13396889|NCT00631917|26794155|FG000|Overall Study|Abnormal test procedure result(s)|3|||
13396890|NCT00631917|26794156|FG001|Overall Study|Abnormal test procedure result(s)|2|||
13396891|NCT00631917|26794155|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
13396892|NCT00631917|26794156|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
13396893|NCT00631917|26794155|FG000|Overall Study|No longer required study drug|0|||
13396894|NCT00631917|26794156|FG001|Overall Study|No longer required study drug|1|||
13396895|NCT00631917|26794155|FG000|Overall Study|Protocol deviation|6|||
13396896|NCT00631917|26794156|FG001|Overall Study|Protocol deviation|5|||
13396897|NCT00631917|26794155|FG000|Overall Study|Subject withdrew consent|25|||
13396898|NCT00631917|26794156|FG001|Overall Study|Subject withdrew consent|33|||
13396899|NCT00631917|26794155|FG000|Overall Study|Lost to Follow-up|7|||
13396900|NCT00631917|26794156|FG001|Overall Study|Lost to Follow-up|7|||
13396901|NCT00631917|26794155|FG000|Overall Study|Administrative problems|2|||
13396902|NCT00631917|26794156|FG001|Overall Study|Administrative problems|0|||
13396903|NCT00631917|26794155|FG000|Overall Study|Death|1|||
13396904|NCT00631917|26794156|FG001|Overall Study|Death|0|||
13396905|NCT00631696|26794187|FG000|Overall Study|Entered, not randomized to treatment|1|||
13396906|NCT00631696|26794188|FG001|Overall Study|Entered, not randomized to treatment|1|||
13396907|NCT00631696|26794187|FG000|Overall Study|Discontinued after database release date|1|||
13396908|NCT00631696|26794188|FG001|Overall Study|Discontinued after database release date|0|||
13396909|NCT00631696|26794187|FG000|Overall Study|Follow up after database release date|1|||
13396910|NCT00631696|26794188|FG001|Overall Study|Follow up after database release date|0|||
13396911|NCT00631696|26794187|FG000|Overall Study|Lost to Follow-up|7|||
13396912|NCT00631696|26794188|FG001|Overall Study|Lost to Follow-up|10|||
13396913|NCT00631696|26794187|FG000|Overall Study|Withdrawal by Subject|2|||
13396914|NCT00631696|26794188|FG001|Overall Study|Withdrawal by Subject|9|||
13396915|NCT00631696|26794187|FG000|Overall Study|Other|8|||
13396916|NCT00631696|26794188|FG001|Overall Study|Other|8|||
13396917|NCT00631696|26794187|FG000|Overall Study|Protocol Violation|9|||
13396918|NCT00631696|26794188|FG001|Overall Study|Protocol Violation|9|||
13396919|NCT00631696|26794187|FG000|Overall Study|Study terminated by sponsor|3|||
13396920|NCT00631696|26794188|FG001|Overall Study|Study terminated by sponsor|3|||
13396921|NCT00631696|26794187|FG000|Overall Study|Adverse Event|5|||
13396922|NCT00631696|26794188|FG001|Overall Study|Adverse Event|0|||
13396923|NCT00631540|26794199|FG000|Overall Study|Withdrawal by Subject|5|||
13396924|NCT00631540|26794199|FG000|Overall Study|Death|4|||
13396925|NCT00631540|26794199|FG000|Overall Study|Lost to Follow-up|2|||
13396926|NCT00631540|26794199|FG000|Overall Study|Core Lab Data Unavailable|3|||
13396927|NCT00631410|26794223|FG000|Overall Study|Adverse Event|1|||
13396928|NCT00631410|26794224|FG001|Overall Study|Adverse Event|3|||
13396929|NCT00631410|26794223|FG000|Overall Study|Objective Progression or Relapse|4|||
13396930|NCT00631410|26794224|FG001|Overall Study|Objective Progression or Relapse|3|||
13396931|NCT00631410|26794223|FG000|Overall Study|Surgery|1|||
13396932|NCT00631410|26794224|FG001|Overall Study|Surgery|0|||
13396933|NCT00631371|26794243|FG000|Overall Study|Lost to Follow-up|24|||
13396934|NCT00631371|26794244|FG001|Overall Study|Lost to Follow-up|19|||
13396935|NCT00631371|26794243|FG000|Overall Study|Other reason|5|||
13396936|NCT00631371|26794244|FG001|Overall Study|Other reason|12|||
13396937|NCT00631371|26794243|FG000|Overall Study|subject request|38|||
13396938|NCT00631371|26794244|FG001|Overall Study|subject request|45|||
13396939|NCT00631371|26794243|FG000|Overall Study|Discontinuation of study by Sponsor|70|||
13396940|NCT00631371|26794244|FG001|Overall Study|Discontinuation of study by Sponsor|76|||
13396941|NCT00631371|26794243|FG000|Overall Study|Death|263|||
13396942|NCT00631371|26794244|FG001|Overall Study|Death|239|||
13396943|NCT00630916|26794253|FG000|Overall Study|Death|110|||
13396944|NCT00630916|26794253|FG000|Overall Study|Explant|8|||
13396945|NCT00630916|26794253|FG000|Overall Study|Lost to Follow-up|5|||
13396946|NCT00630916|26794253|FG000|Overall Study|Withdrawal by Subject|30|||
13396947|NCT00630916|26794253|FG000|Overall Study|Protocol Violation|7|||
13396948|NCT00630916|26794253|FG000|Overall Study|Physician Decision|47|||
13396949|NCT00630916|26794253|FG000|Overall Study|Lack of Efficacy|3|||
13396950|NCT00630812|26794282|FG000|Randomisation to First Dose|Adverse Event|1|||
13396951|NCT00630812|26794283|FG001|Randomisation to First Dose|Adverse Event|1|||
13396952|NCT00630812|26794282|FG000|Randomisation to First Dose|Withdrawal by Subject|2|||
13396953|NCT00630812|26794283|FG001|Randomisation to First Dose|Withdrawal by Subject|3|||
13396954|NCT00630812|26794282|FG000|Randomisation to First Dose|Lost to Follow-up|1|||
13396955|NCT00630812|26794283|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
13396956|NCT00630812|26794282|FG000|Randomisation to First Dose|Protocol Violation|4|||
13396957|NCT00630812|26794283|FG001|Randomisation to First Dose|Protocol Violation|1|||
13396958|NCT00630812|26794282|FG000|Double Blind Treatment Period|Adverse Event|13|||
13396959|NCT00630812|26794283|FG001|Double Blind Treatment Period|Adverse Event|5|||
13396960|NCT00630812|26794282|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
13396961|NCT00630812|26794283|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
13396962|NCT00630812|26794282|FG000|Double Blind Treatment Period|Physician Decision|2|||
13396963|NCT00630812|26794283|FG001|Double Blind Treatment Period|Physician Decision|1|||
13396964|NCT00630812|26794282|FG000|Double Blind Treatment Period|Protocol Violation|1|||
13396965|NCT00630812|26794283|FG001|Double Blind Treatment Period|Protocol Violation|0|||
13396966|NCT00630812|26794282|FG000|Double Blind Treatment Period|Withdrawal by Subject|13|||
13396967|NCT00630812|26794283|FG001|Double Blind Treatment Period|Withdrawal by Subject|7|||
13396968|NCT00630812|26794282|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1|||
13396969|NCT00630812|26794283|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0|||
13396970|NCT00630812|26794282|FG000|Double Blind Treatment Period|Non-compliance|0|||
13396971|NCT00630812|26794283|FG001|Double Blind Treatment Period|Non-compliance|1|||
13396972|NCT00630747|26794294|FG000|Overall Study|Death|1|||
13396973|NCT00630747|26794294|FG000|Overall Study|Transferred to Study TKT031NPU|7|||
13396974|NCT00630747|26794294|FG000|Overall Study|Returned to country of origin|1|||
13396975|NCT00630292|26794300|FG000|Overall Study|Withdrawal by Subject|1|||
13396976|NCT00629798|26794308|FG000|Overall Study|Not Treated|4|||
13396977|NCT00629772|26794333|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1|||
13396978|NCT00629772|26794334|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1|||
13396979|NCT00629772|26794333|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0|||
13396980|NCT00629772|26794334|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1|||
13396981|NCT00629707|26794347|FG000|Overall Study|Withdrawal by Subject|0|||
13396982|NCT00629707|26794348|FG001|Overall Study|Withdrawal by Subject|1|||
13396983|NCT00629707|26794347|FG000|Overall Study|Physician Decision|0|||
13396984|NCT00629707|26794348|FG001|Overall Study|Physician Decision|1|||
13396985|NCT00629265|26794363|FG000|Overall Study|Lost to Follow-up|4|||
13396986|NCT00629265|26794364|FG001|Overall Study|Lost to Follow-up|5|||
13396987|NCT00629265|26794363|FG000|Overall Study|Withdrawal by Subject|11|||
13396988|NCT00629265|26794364|FG001|Overall Study|Withdrawal by Subject|8|||
13396989|NCT00629265|26794363|FG000|Overall Study|Death|1|||
13396990|NCT00629265|26794364|FG001|Overall Study|Death|0|||
13396991|NCT00629265|26794363|FG000|Overall Study|Adverse Event|2|||
13396992|NCT00629265|26794364|FG001|Overall Study|Adverse Event|0|||
13396993|NCT00629265|26794363|FG000|Overall Study|HNC Recurrence|4|||
13396994|NCT00629265|26794364|FG001|Overall Study|HNC Recurrence|0|||
13396995|NCT00629265|26794363|FG000|Overall Study|Other CA Requiring Treatment|1|||
13396996|NCT00629265|26794364|FG001|Overall Study|Other CA Requiring Treatment|3|||
13396997|NCT00629265|26794363|FG000|Overall Study|Needed Esophageal Dilation|4|||
13396998|NCT00629265|26794364|FG001|Overall Study|Needed Esophageal Dilation|1|||
13396999|NCT00629265|26794363|FG000|Overall Study|Unrelated Medical Complications|3|||
13397000|NCT00629265|26794364|FG001|Overall Study|Unrelated Medical Complications|1|||
13397001|NCT00629265|26794363|FG000|Overall Study|Unknown Reason|2|||
13397002|NCT00629265|26794364|FG001|Overall Study|Unknown Reason|2|||
13397003|NCT00629239|26794403|FG000|Overall Study|Adverse Event|7|||
13397004|NCT00629239|26794404|FG001|Overall Study|Adverse Event|4|||
13397005|NCT00629239|26794403|FG000|Overall Study|Physician Decision|1|||
13397006|NCT00629239|26794404|FG001|Overall Study|Physician Decision|0|||
13397007|NCT00629083|26794429|FG000|Overall Study|Adverse Event|0|||
13397008|NCT00629083|26794430|FG001|Overall Study|Adverse Event|2|||
13397009|NCT00629083|26794429|FG000|Overall Study|Lack of Efficacy|3|||
13397010|NCT00629083|26794430|FG001|Overall Study|Lack of Efficacy|1|||
13397011|NCT00629083|26794429|FG000|Overall Study|Withdrawal by Subject|10|||
13397012|NCT00629083|26794430|FG001|Overall Study|Withdrawal by Subject|2|||
13397013|NCT00629083|26794429|FG000|Overall Study|Lost to Follow-up|12|||
13397014|NCT00629083|26794430|FG001|Overall Study|Lost to Follow-up|8|||
13397015|NCT00629083|26794429|FG000|Overall Study|Moved out of country/state|2|||
13397016|NCT00629083|26794430|FG001|Overall Study|Moved out of country/state|1|||
13397017|NCT00629083|26794429|FG000|Overall Study|Refused to return for 12 month visit|1|||
13397018|NCT00629083|26794430|FG001|Overall Study|Refused to return for 12 month visit|0|||
13397019|NCT00628927|26794448|FG000|Overall Study|Problems performing blood draw|6|||
13397020|NCT00628927|26794449|FG001|Overall Study|Problems performing blood draw|0|||
13397021|NCT00628927|26794448|FG000|Overall Study|Lost to Follow-up|1|||
13397022|NCT00628927|26794449|FG001|Overall Study|Lost to Follow-up|0|||
13397023|NCT00628927|26794448|FG000|Overall Study|Equipment failure|1|||
13397024|NCT00628927|26794449|FG001|Overall Study|Equipment failure|0|||
13397025|NCT00628862|26794503|FG000|Overall Study|Adverse Event|6|||
13397026|NCT00628862|26794504|FG001|Overall Study|Adverse Event|8|||
13397027|NCT00628862|26794505|FG002|Overall Study|Adverse Event|10|||
13397028|NCT00628862|26794503|FG000|Overall Study|Withdrawal by Subject|4|||
13397029|NCT00628862|26794504|FG001|Overall Study|Withdrawal by Subject|6|||
13397030|NCT00628862|26794505|FG002|Overall Study|Withdrawal by Subject|11|||
13397031|NCT00628862|26794503|FG000|Overall Study|Lost to Follow-up|0|||
13397032|NCT00628862|26794504|FG001|Overall Study|Lost to Follow-up|2|||
13397033|NCT00628862|26794505|FG002|Overall Study|Lost to Follow-up|1|||
13397034|NCT00628862|26794503|FG000|Overall Study|Protocol Violation|1|||
13397035|NCT00628862|26794504|FG001|Overall Study|Protocol Violation|0|||
13397036|NCT00628862|26794505|FG002|Overall Study|Protocol Violation|0|||
13397037|NCT00628862|26794503|FG000|Overall Study|COPD Exacerbation|0|||
13397038|NCT00628862|26794504|FG001|Overall Study|COPD Exacerbation|1|||
13397039|NCT00628862|26794505|FG002|Overall Study|COPD Exacerbation|0|||
13397040|NCT00628758|26794524|FG000|Overall Study|Adverse Event|2|||
13397041|NCT00628758|26794525|FG001|Overall Study|Adverse Event|3|||
13397042|NCT00628758|26794524|FG000|Overall Study|Withdrawal by Subject|6|||
13397043|NCT00628758|26794525|FG001|Overall Study|Withdrawal by Subject|3|||
13397044|NCT00628758|26794524|FG000|Overall Study|Death|1|||
13397045|NCT00628758|26794525|FG001|Overall Study|Death|0|||
13397046|NCT00628758|26794524|FG000|Overall Study|Protocol Violation|5|||
13397047|NCT00628758|26794525|FG001|Overall Study|Protocol Violation|1|||
13397048|NCT00628758|26794524|FG000|Overall Study|Lost to Follow-up|25|||
13397049|NCT00628758|26794525|FG001|Overall Study|Lost to Follow-up|31|||
13397050|NCT00628758|26794524|FG000|Overall Study|Pregnancy|2|||
13397051|NCT00628758|26794525|FG001|Overall Study|Pregnancy|2|||
13397052|NCT00628758|26794524|FG000|Overall Study|Investigator Moved|3|||
13397053|NCT00628758|26794525|FG001|Overall Study|Investigator Moved|0|||
13397054|NCT00628758|26794524|FG000|Overall Study|Treatment Failure|0|||
13397055|NCT00628758|26794525|FG001|Overall Study|Treatment Failure|2|||
13397056|NCT00628446|26794532|FG000|Overall Study|Lost to Follow-up|3|||
13397057|NCT00628446|26794532|FG000|Overall Study|Withdrawal by Subject|1|||
13397058|NCT00628446|26794532|FG000|Overall Study|Protocol Violation|3|||
13397059|NCT00628355|26794547|FG000|Overall Study|Withdrawal by Subject|1|||
13397060|NCT00628355|26794548|FG001|Overall Study|Withdrawal by Subject|1|||
13397061|NCT00628251|26794600|FG000|Randomised Part|Withdrawal by Subject|0|||
13397062|NCT00628251|26794601|FG001|Randomised Part|Withdrawal by Subject|0|||
13397063|NCT00628251|26794602|FG002|Randomised Part|Withdrawal by Subject|1|||
13397064|NCT00628251|26794600|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1|||
13397065|NCT00628251|26794601|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2|||
13397066|NCT00628251|26794602|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3|||
13397067|NCT00628251|26794600|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19|||
13397068|NCT00628251|26794601|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15|||
13397069|NCT00628251|26794602|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13|||
13397070|NCT00628251|26794600|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
13397071|NCT00628251|26794601|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2|||
13397072|NCT00628251|26794602|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
13397073|NCT00628251|26794600|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0|||
13397074|NCT00628251|26794601|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1|||
13397075|NCT00628251|26794602|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6|||
13397076|NCT00628251|26794600|FG000|Ongoing Initial Study Treatment at DCO|Other|1|||
13397077|NCT00628251|26794601|FG001|Ongoing Initial Study Treatment at DCO|Other|0|||
13397078|NCT00628251|26794602|FG002|Ongoing Initial Study Treatment at DCO|Other|2|||
13397079|NCT00628212|26794637|FG000|Overall Study|Adverse Event|2|||
13397080|NCT00628212|26794638|FG001|Overall Study|Adverse Event|0|||
13397081|NCT00628212|26794639|FG002|Overall Study|Adverse Event|1|||
13397082|NCT00628212|26794640|FG003|Overall Study|Adverse Event|2|||
13397083|NCT00628212|26794637|FG000|Overall Study|Physician Decision|1|||
13397084|NCT00628212|26794638|FG001|Overall Study|Physician Decision|1|||
13397085|NCT00628212|26794639|FG002|Overall Study|Physician Decision|2|||
13397086|NCT00628212|26794640|FG003|Overall Study|Physician Decision|3|||
13397087|NCT00628108|26794677|FG000|Overall Study|Adverse Event|0|||
13397088|NCT00628108|26794678|FG001|Overall Study|Adverse Event|3|||
13397089|NCT00628108|26794677|FG000|Overall Study|Withdrawal by Subject|1|||
13397090|NCT00628108|26794678|FG001|Overall Study|Withdrawal by Subject|0|||
13397091|NCT00628030|26794699|FG000|Baseline to Post-Assessment|Lost to Follow-up|28|||
13397092|NCT00628030|26794700|FG001|Baseline to Post-Assessment|Lost to Follow-up|29|||
13397093|NCT00628030|26794699|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5|||
13397094|NCT00628030|26794700|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0|||
13397095|NCT00628030|26794699|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32|||
13397096|NCT00628030|26794700|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30|||
13397097|NCT00627926|26794754|FG000|Overall Study|Adverse Event|26|||
13397098|NCT00627926|26794755|FG001|Overall Study|Adverse Event|37|||
13397099|NCT00627926|26794756|FG002|Overall Study|Adverse Event|36|||
13397100|NCT00627926|26794754|FG000|Overall Study|Death|1|||
13397101|NCT00627926|26794755|FG001|Overall Study|Death|0|||
13397102|NCT00627926|26794756|FG002|Overall Study|Death|0|||
13397103|NCT00627926|26794754|FG000|Overall Study|Lost to Follow-up|4|||
13397104|NCT00627926|26794755|FG001|Overall Study|Lost to Follow-up|3|||
13397105|NCT00627926|26794756|FG002|Overall Study|Lost to Follow-up|4|||
13397106|NCT00627926|26794754|FG000|Overall Study|Withdrawal by Subject|2|||
13397107|NCT00627926|26794755|FG001|Overall Study|Withdrawal by Subject|1|||
13397108|NCT00627926|26794756|FG002|Overall Study|Withdrawal by Subject|0|||
13397109|NCT00627926|26794754|FG000|Overall Study|Lack of Efficacy|118|||
13397110|NCT00627926|26794755|FG001|Overall Study|Lack of Efficacy|40|||
13397111|NCT00627926|26794756|FG002|Overall Study|Lack of Efficacy|38|||
13397112|NCT00627926|26794754|FG000|Overall Study|Noncompliance/unspecified|8|||
13397113|NCT00627926|26794755|FG001|Overall Study|Noncompliance/unspecified|23|||
13397114|NCT00627926|26794756|FG002|Overall Study|Noncompliance/unspecified|17|||
13397115|NCT00627705|26794783|FG000|Overall Study|Unwilling to take the compound (taste)|1|||
13397116|NCT00627705|26794784|FG001|Overall Study|Unwilling to take the compound (taste)|3|||
13397117|NCT00627705|26794783|FG000|Overall Study|Adverse Event|1|||
13397118|NCT00627705|26794784|FG001|Overall Study|Adverse Event|0|||
13397119|NCT00627705|26794783|FG000|Overall Study|Withdrawal by Subject|0|||
13397120|NCT00627705|26794784|FG001|Overall Study|Withdrawal by Subject|2|||
13397121|NCT00627705|26794783|FG000|Overall Study|Lost to Follow-up|0|||
13397122|NCT00627705|26794784|FG001|Overall Study|Lost to Follow-up|1|||
13397123|NCT00627523|26794815|FG000|Overall Study|Lack of Efficacy|1|||
13397124|NCT00627523|26794816|FG001|Overall Study|Lack of Efficacy|0|||
13397125|NCT00627523|26794815|FG000|Overall Study|Withdrawal by Subject|0|||
13397126|NCT00627523|26794816|FG001|Overall Study|Withdrawal by Subject|2|||
13397127|NCT00627523|26794815|FG000|Overall Study|Other|1|||
13397128|NCT00627523|26794816|FG001|Overall Study|Other|0|||
13397129|NCT00627497|26794887|FG000|Overall Study|Lost to Follow-up|1|||
13397130|NCT00627497|26794888|FG001|Overall Study|Lost to Follow-up|1|||
13397131|NCT00627497|26794889|FG002|Overall Study|Lost to Follow-up|0|||
13397132|NCT00627497|26794890|FG003|Overall Study|Lost to Follow-up|0|||
13397133|NCT00627458|26794973|FG000|Overall Study|Migrated from study area|1|||
13397134|NCT00627458|26794974|FG001|Overall Study|Migrated from study area|0|||
13397135|NCT00627458|26794975|FG002|Overall Study|Migrated from study area|1|||
13397136|NCT00627458|26794973|FG000|Overall Study|Withdrawal by Subject|2|||
13397137|NCT00627458|26794974|FG001|Overall Study|Withdrawal by Subject|6|||
13397138|NCT00627458|26794975|FG002|Overall Study|Withdrawal by Subject|5|||
13397139|NCT00627458|26794973|FG000|Overall Study|Lost to Follow-up|1|||
13397140|NCT00627458|26794974|FG001|Overall Study|Lost to Follow-up|1|||
13397141|NCT00627458|26794975|FG002|Overall Study|Lost to Follow-up|0|||
13397142|NCT00627445|26795002|FG000|Overall Study|Adverse Event|3|||
13397143|NCT00627445|26795003|FG001|Overall Study|Adverse Event|3|||
13397144|NCT00627445|26795002|FG000|Overall Study|Lack of Efficacy|0|||
13397145|NCT00627445|26795003|FG001|Overall Study|Lack of Efficacy|1|||
13397146|NCT00627445|26795002|FG000|Overall Study|Other|6|||
13397147|NCT00627445|26795003|FG001|Overall Study|Other|8|||
13397148|NCT00627393|26795029|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5|||
13397149|NCT00627393|26795030|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3|||
13397150|NCT00627393|26795029|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4|||
13397151|NCT00627393|26795030|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5|||
13397152|NCT00627393|26795029|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6|||
13397153|NCT00627393|26795030|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3|||
13397154|NCT00627393|26795029|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4|||
13397155|NCT00627393|26795030|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10|||
13397156|NCT00627094|26795049|FG000|Overall Study|Adverse Event|8|||
13397157|NCT00627094|26795050|FG001|Overall Study|Adverse Event|7|||
13397158|NCT00627094|26795049|FG000|Overall Study|Lost to Follow-up|1|||
13397159|NCT00627094|26795050|FG001|Overall Study|Lost to Follow-up|0|||
13397160|NCT00627094|26795049|FG000|Overall Study|Withdrawal by Subject|1|||
13397161|NCT00627094|26795050|FG001|Overall Study|Withdrawal by Subject|1|||
13397162|NCT00627094|26795049|FG000|Overall Study|ulcer healed|1|||
13397163|NCT00627094|26795050|FG001|Overall Study|ulcer healed|7|||
13397164|NCT00627094|26795049|FG000|Overall Study|Other reason|1|||
13397165|NCT00627094|26795050|FG001|Overall Study|Other reason|0|||
13397166|NCT00627042|26795062|FG000|Overall Study|Withdrawal by Subject|2|||
13397167|NCT00627016|26795079|FG000|Overall Study|Adverse Event|1|||
13397168|NCT00627016|26795080|FG001|Overall Study|Adverse Event|1|||
13397169|NCT00627016|26795079|FG000|Overall Study|Protocol Violation|0|||
13397170|NCT00627016|26795080|FG001|Overall Study|Protocol Violation|2|||
13397171|NCT00627016|26795079|FG000|Overall Study|Lost to Follow-up|0|||
13397172|NCT00627016|26795080|FG001|Overall Study|Lost to Follow-up|1|||
13397173|NCT00627016|26795079|FG000|Overall Study|Withdrawal by Subject|2|||
13397174|NCT00627016|26795080|FG001|Overall Study|Withdrawal by Subject|1|||
13397175|NCT00627016|26795079|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
13397176|NCT00627016|26795080|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
13397177|NCT00627016|26795079|FG000|Overall Study|Lack of Efficacy|1|||
13397178|NCT00627016|26795080|FG001|Overall Study|Lack of Efficacy|0|||
13397179|NCT00627016|26795079|FG000|Overall Study|Placed on Excluded Drugs|1|||
13397180|NCT00627016|26795080|FG001|Overall Study|Placed on Excluded Drugs|0|||
13397181|NCT00627016|26795079|FG000|Overall Study|Pregnancy|1|||
13397182|NCT00627016|26795080|FG001|Overall Study|Pregnancy|0|||
13397183|NCT00626925|26795119|FG000|Overall Study|Lost to Follow-up|1|||
13397184|NCT00626925|26795120|FG001|Overall Study|Lost to Follow-up|2|||
13397185|NCT00626925|26795119|FG000|Overall Study|relapse|1|||
13397186|NCT00626925|26795120|FG001|Overall Study|relapse|0|||
13397187|NCT00626925|26795119|FG000|Overall Study|Adverse effect|6|||
13397188|NCT00626925|26795120|FG001|Overall Study|Adverse effect|2|||
13397189|NCT00626925|26795119|FG000|Overall Study|Lack of Efficacy|1|||
13397190|NCT00626925|26795120|FG001|Overall Study|Lack of Efficacy|4|||
13397191|NCT00626925|26795119|FG000|Overall Study|Time constraints|3|||
13397192|NCT00626925|26795120|FG001|Overall Study|Time constraints|1|||
13397193|NCT00626821|26795126|FG000|Overall Study|Adverse Event|44|||
13397194|NCT00626821|26795126|FG000|Overall Study|Protocol Violation|33|||
13397195|NCT00626821|26795126|FG000|Overall Study|Withdrawal by Subject|10|||
13397196|NCT00626821|26795126|FG000|Overall Study|Physician Decision|9|||
13397197|NCT00626821|26795126|FG000|Overall Study|Product dysfunction|21|||
13397198|NCT00626821|26795126|FG000|Overall Study|other/unknown reason|104|||
13397199|NCT00626795|26795163|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
13397200|NCT00626795|26795164|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1|||
13397201|NCT00626795|26795165|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
13397202|NCT00626795|26795163|FG000|Blinded Treatment|Lack of Efficacy|2|||
13397203|NCT00626795|26795164|FG001|Blinded Treatment|Lack of Efficacy|0|||
13397204|NCT00626795|26795165|FG002|Blinded Treatment|Lack of Efficacy|0|||
13397205|NCT00626795|26795163|FG000|Blinded Treatment|Unacceptable adverse event|0|||
13397206|NCT00626795|26795164|FG001|Blinded Treatment|Unacceptable adverse event|0|||
13397207|NCT00626795|26795165|FG002|Blinded Treatment|Unacceptable adverse event|1|||
13397208|NCT00626795|26795163|FG000|Blinded Treatment|Protocol Violation|0|||
13397209|NCT00626795|26795164|FG001|Blinded Treatment|Protocol Violation|1|||
13397210|NCT00626795|26795165|FG002|Blinded Treatment|Protocol Violation|1|||
13397211|NCT00626795|26795163|FG000|Blinded Treatment|Withdrawal by Subject|1|||
13397212|NCT00626795|26795164|FG001|Blinded Treatment|Withdrawal by Subject|1|||
13397213|NCT00626795|26795165|FG002|Blinded Treatment|Withdrawal by Subject|0|||
13397214|NCT00626795|26795163|FG000|Blinded Treatment|Other reasons|2|||
13397215|NCT00626795|26795164|FG001|Blinded Treatment|Other reasons|0|||
13397216|NCT00626795|26795165|FG002|Blinded Treatment|Other reasons|2|||
13397217|NCT00626795|26795163|FG000|Blinded Treatment|Missing reason for withdrawal|5|||
13397218|NCT00626795|26795164|FG001|Blinded Treatment|Missing reason for withdrawal|3|||
13397219|NCT00626795|26795165|FG002|Blinded Treatment|Missing reason for withdrawal|5|||
13397220|NCT00626639|26795190|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2|||
13397221|NCT00626639|26795191|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2|||
13397222|NCT00626561|26795197|FG000|Overall Study|Withdrawal by Subject|2|||
13397223|NCT00626561|26795197|FG000|Overall Study|Disease Progression|2|||
13397224|NCT00626548|26795212|FG000|Overall Study|Adverse Event|164|||
13397225|NCT00626548|26795213|FG001|Overall Study|Adverse Event|44|||
13397226|NCT00626548|26795212|FG000|Overall Study|Withdrawal by Subject|42|||
13397227|NCT00626548|26795213|FG001|Overall Study|Withdrawal by Subject|46|||
13397228|NCT00626548|26795212|FG000|Overall Study|Protocol Violation|4|||
13397229|NCT00626548|26795213|FG001|Overall Study|Protocol Violation|11|||
13397230|NCT00626548|26795212|FG000|Overall Study|Lost to Follow-up|2|||
13397231|NCT00626548|26795213|FG001|Overall Study|Lost to Follow-up|2|||
13397232|NCT00626548|26795212|FG000|Overall Study|Other termination reason|493|||
13397233|NCT00626548|26795213|FG001|Overall Study|Other termination reason|613|||
13397234|NCT00626522|26795270|FG000|Overall Study|Protocol Violation|0|||
13397235|NCT00626522|26795271|FG001|Overall Study|Protocol Violation|0|||
13397236|NCT00626522|26795272|FG002|Overall Study|Protocol Violation|0|||
13397237|NCT00626522|26795273|FG003|Overall Study|Protocol Violation|0|||
13397238|NCT00626522|26795274|FG004|Overall Study|Protocol Violation|1|||
13397239|NCT00626522|26795275|FG005|Overall Study|Protocol Violation|0|||
13397240|NCT00626522|26795270|FG000|Overall Study|Adverse Event|2|||
13397241|NCT00626522|26795271|FG001|Overall Study|Adverse Event|1|||
13397242|NCT00626522|26795272|FG002|Overall Study|Adverse Event|2|||
13397243|NCT00626522|26795273|FG003|Overall Study|Adverse Event|0|||
13397244|NCT00626522|26795274|FG004|Overall Study|Adverse Event|1|||
13397245|NCT00626522|26795275|FG005|Overall Study|Adverse Event|1|||
13397246|NCT00626522|26795270|FG000|Overall Study|Withdrawal by Subject|2|||
13397247|NCT00626522|26795271|FG001|Overall Study|Withdrawal by Subject|5|||
13397248|NCT00626522|26795272|FG002|Overall Study|Withdrawal by Subject|5|||
13397249|NCT00626522|26795273|FG003|Overall Study|Withdrawal by Subject|0|||
13397250|NCT00626522|26795274|FG004|Overall Study|Withdrawal by Subject|4|||
13397251|NCT00626522|26795275|FG005|Overall Study|Withdrawal by Subject|1|||
13397252|NCT00626522|26795270|FG000|Overall Study|COPD exacerbation|0|||
13397253|NCT00626522|26795271|FG001|Overall Study|COPD exacerbation|0|||
13397254|NCT00626522|26795272|FG002|Overall Study|COPD exacerbation|0|||
13397255|NCT00626522|26795273|FG003|Overall Study|COPD exacerbation|1|||
13397256|NCT00626522|26795274|FG004|Overall Study|COPD exacerbation|1|||
13397257|NCT00626522|26795275|FG005|Overall Study|COPD exacerbation|0|||
13397258|NCT00626522|26795270|FG000|Overall Study|Lost to Follow-up|0|||
13397259|NCT00626522|26795271|FG001|Overall Study|Lost to Follow-up|1|||
13397260|NCT00626522|26795272|FG002|Overall Study|Lost to Follow-up|0|||
13219899|NCT01829295|26278605|FG002|6-12 Months|Adverse Event|3|||
13219900|NCT01829295|26278606|FG003|6-12 Months|Adverse Event|2|||
13219901|NCT01829295|26278603|FG000|6-12 Months|Lost to Follow-up|2|||
13219902|NCT01829295|26278604|FG001|6-12 Months|Lost to Follow-up|0|||
13219903|NCT01829295|26278605|FG002|6-12 Months|Lost to Follow-up|0|||
13219904|NCT01829295|26278606|FG003|6-12 Months|Lost to Follow-up|0|||
13397261|NCT00626522|26795273|FG003|Overall Study|Lost to Follow-up|0|||
13397262|NCT00626522|26795274|FG004|Overall Study|Lost to Follow-up|0|||
13397263|NCT00626522|26795275|FG005|Overall Study|Lost to Follow-up|0|||
13397264|NCT00626522|26795270|FG000|Overall Study|Inconsistent reason reported|1|||
13397265|NCT00626522|26795271|FG001|Overall Study|Inconsistent reason reported|0|||
13397266|NCT00626522|26795272|FG002|Overall Study|Inconsistent reason reported|0|||
13397267|NCT00626522|26795273|FG003|Overall Study|Inconsistent reason reported|0|||
13397268|NCT00626522|26795274|FG004|Overall Study|Inconsistent reason reported|0|||
13397269|NCT00626522|26795275|FG005|Overall Study|Inconsistent reason reported|0|||
13397270|NCT00626522|26795270|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
13397271|NCT00626522|26795271|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
13397272|NCT00626522|26795272|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
13397273|NCT00626522|26795273|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
13397274|NCT00626522|26795274|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
13397275|NCT00626522|26795275|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
13397276|NCT00626405|26795292|FG000|Overall Study|Deemed Ineligible|1|||
13397277|NCT00626405|26795293|FG001|Overall Study|Deemed Ineligible|0|||
13397278|NCT00626405|26795292|FG000|Overall Study|Withdrawal by Subject|0|||
13397279|NCT00626405|26795293|FG001|Overall Study|Withdrawal by Subject|1|||
13397280|NCT00626392|26795324|FG000|Run-in Period|Adverse Event|0|||
13397281|NCT00626392|26795325|FG001|Run-in Period|Adverse Event|0|||
13397282|NCT00626392|26795326|FG002|Run-in Period|Adverse Event|1|||
13397283|NCT00626392|26795327|FG003|Run-in Period|Adverse Event|0|||
13397284|NCT00626392|26795328|FG004|Run-in Period|Adverse Event|1|||
13397285|NCT00626392|26795329|FG005|Run-in Period|Adverse Event|0|||
13397286|NCT00626392|26795324|FG000|Run-in Period|Withdrawal by Subject|0|||
13397287|NCT00626392|26795325|FG001|Run-in Period|Withdrawal by Subject|1|||
13397288|NCT00626392|26795326|FG002|Run-in Period|Withdrawal by Subject|1|||
13397289|NCT00626392|26795327|FG003|Run-in Period|Withdrawal by Subject|1|||
13397290|NCT00626392|26795328|FG004|Run-in Period|Withdrawal by Subject|3|||
13397291|NCT00626392|26795329|FG005|Run-in Period|Withdrawal by Subject|1|||
13397292|NCT00626392|26795324|FG000|Run-in Period|Noncompliance|1|||
13397293|NCT00626392|26795325|FG001|Run-in Period|Noncompliance|0|||
13397294|NCT00626392|26795326|FG002|Run-in Period|Noncompliance|1|||
13397295|NCT00626392|26795327|FG003|Run-in Period|Noncompliance|0|||
13397296|NCT00626392|26795328|FG004|Run-in Period|Noncompliance|0|||
13397297|NCT00626392|26795329|FG005|Run-in Period|Noncompliance|0|||
13397298|NCT00626392|26795324|FG000|Coadministration Period|Adverse Event|3|||
13397299|NCT00626392|26795325|FG001|Coadministration Period|Adverse Event|1|||
13397300|NCT00626392|26795326|FG002|Coadministration Period|Adverse Event|7|||
13397301|NCT00626392|26795327|FG003|Coadministration Period|Adverse Event|4|||
13397302|NCT00626392|26795328|FG004|Coadministration Period|Adverse Event|3|||
13397303|NCT00626392|26795329|FG005|Coadministration Period|Adverse Event|4|||
13397304|NCT00626392|26795324|FG000|Coadministration Period|Withdrawal by Subject|1|||
13397305|NCT00626392|26795325|FG001|Coadministration Period|Withdrawal by Subject|1|||
13397306|NCT00626392|26795326|FG002|Coadministration Period|Withdrawal by Subject|0|||
13397307|NCT00626392|26795327|FG003|Coadministration Period|Withdrawal by Subject|1|||
13397308|NCT00626392|26795328|FG004|Coadministration Period|Withdrawal by Subject|0|||
13397309|NCT00626392|26795329|FG005|Coadministration Period|Withdrawal by Subject|1|||
13397310|NCT00626392|26795324|FG000|Coadministration Period|Protocol Violation|0|||
13397311|NCT00626392|26795325|FG001|Coadministration Period|Protocol Violation|1|||
13397312|NCT00626392|26795326|FG002|Coadministration Period|Protocol Violation|0|||
13397313|NCT00626392|26795327|FG003|Coadministration Period|Protocol Violation|1|||
13397314|NCT00626392|26795328|FG004|Coadministration Period|Protocol Violation|1|||
13397315|NCT00626392|26795329|FG005|Coadministration Period|Protocol Violation|0|||
13397316|NCT00626392|26795324|FG000|Coadministration Period|Other|0|||
13397317|NCT00626392|26795325|FG001|Coadministration Period|Other|2|||
13397318|NCT00626392|26795326|FG002|Coadministration Period|Other|3|||
13397319|NCT00626392|26795327|FG003|Coadministration Period|Other|1|||
13397320|NCT00626392|26795328|FG004|Coadministration Period|Other|1|||
13397321|NCT00626392|26795329|FG005|Coadministration Period|Other|1|||
13397322|NCT00626327|26795365|FG000|Overall Study|Withdrawal by Subject|21|||
13397323|NCT00626327|26795366|FG001|Overall Study|Withdrawal by Subject|29|||
13397324|NCT00626327|26795367|FG002|Overall Study|Withdrawal by Subject|30|||
13397325|NCT00626327|26795365|FG000|Overall Study|Adverse Event|1|||
13397326|NCT00626327|26795366|FG001|Overall Study|Adverse Event|0|||
13397327|NCT00626327|26795367|FG002|Overall Study|Adverse Event|0|||
13397328|NCT00626327|26795365|FG000|Overall Study|Lost to Follow-up|24|||
13397329|NCT00626327|26795366|FG001|Overall Study|Lost to Follow-up|21|||
13397330|NCT00626327|26795367|FG002|Overall Study|Lost to Follow-up|23|||
13397331|NCT00626327|26795365|FG000|Overall Study|Inappropriate enrollment|4|||
13397332|NCT00626327|26795366|FG001|Overall Study|Inappropriate enrollment|5|||
13397333|NCT00626327|26795367|FG002|Overall Study|Inappropriate enrollment|3|||
13397334|NCT00626327|26795365|FG000|Overall Study|Administrative Reason|2|||
13397335|NCT00626327|26795366|FG001|Overall Study|Administrative Reason|0|||
13397336|NCT00626327|26795367|FG002|Overall Study|Administrative Reason|6|||
13397337|NCT00626327|26795365|FG000|Overall Study|Protocol Violation|26|||
13397338|NCT00626327|26795366|FG001|Overall Study|Protocol Violation|4|||
13397339|NCT00626327|26795367|FG002|Overall Study|Protocol Violation|26|||
13397340|NCT00626275|26795416|FG000|Part A - Treatment Period 1|Adverse Event|1|||
13397341|NCT00626275|26795417|FG001|Part A - Treatment Period 1|Adverse Event|0|||
13397342|NCT00626275|26795418|FG002|Part A - Treatment Period 1|Adverse Event|0|||
13397343|NCT00626275|26795419|FG003|Part A - Treatment Period 1|Adverse Event|0|||
13397344|NCT00626275|26795420|FG004|Part A - Treatment Period 1|Adverse Event|0|||
13397345|NCT00626275|26795421|FG005|Part A - Treatment Period 1|Adverse Event|0|||
13397346|NCT00626275|26795422|FG006|Part A - Treatment Period 1|Adverse Event|0|||
13397347|NCT00626275|26795423|FG007|Part A - Treatment Period 1|Adverse Event|0|||
13397348|NCT00626275|26795416|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0|||
13397349|NCT00626275|26795417|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0|||
13397350|NCT00626275|26795418|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1|||
13397351|NCT00626275|26795419|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0|||
13397352|NCT00626275|26795420|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0|||
13397353|NCT00626275|26795421|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0|||
13397354|NCT00626275|26795422|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0|||
13397355|NCT00626275|26795423|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0|||
13397356|NCT00626275|26795416|FG000|Part B|Lost to Follow-up|0|||
13397357|NCT00626275|26795417|FG001|Part B|Lost to Follow-up|0|||
13397358|NCT00626275|26795418|FG002|Part B|Lost to Follow-up|0|||
13397359|NCT00626275|26795419|FG003|Part B|Lost to Follow-up|0|||
13397360|NCT00626275|26795420|FG004|Part B|Lost to Follow-up|0|||
13397361|NCT00626275|26795421|FG005|Part B|Lost to Follow-up|0|||
13397362|NCT00626275|26795422|FG006|Part B|Lost to Follow-up|1|||
13397363|NCT00626275|26795423|FG007|Part B|Lost to Follow-up|0|||
13397364|NCT00626275|26795416|FG000|Part B|Withdrawal by Subject|0|||
13397365|NCT00626275|26795417|FG001|Part B|Withdrawal by Subject|0|||
13397366|NCT00626275|26795418|FG002|Part B|Withdrawal by Subject|0|||
13397367|NCT00626275|26795419|FG003|Part B|Withdrawal by Subject|0|||
13397368|NCT00626275|26795420|FG004|Part B|Withdrawal by Subject|0|||
13397369|NCT00626275|26795421|FG005|Part B|Withdrawal by Subject|0|||
13397370|NCT00626275|26795422|FG006|Part B|Withdrawal by Subject|0|||
13397371|NCT00626275|26795423|FG007|Part B|Withdrawal by Subject|1|||
13397372|NCT00626197|26795510|FG000|Overall Study|Did not cooperate|2|||
13397373|NCT00626197|26795511|FG001|Overall Study|Did not cooperate|6|||
13397374|NCT00626197|26795512|FG002|Overall Study|Did not cooperate|1|||
13397375|NCT00626197|26795510|FG000|Overall Study|Failure to return|6|||
13397376|NCT00626197|26795511|FG001|Overall Study|Failure to return|5|||
13397377|NCT00626197|26795512|FG002|Overall Study|Failure to return|6|||
13397378|NCT00626197|26795510|FG000|Overall Study|Adverse event, serious fatal|3|||
13397379|NCT00626197|26795511|FG001|Overall Study|Adverse event, serious fatal|6|||
13397380|NCT00626197|26795512|FG002|Overall Study|Adverse event, serious fatal|6|||
13397381|NCT00626197|26795510|FG000|Overall Study|Adverse Event|1|||
13397382|NCT00626197|26795511|FG001|Overall Study|Adverse Event|1|||
13397383|NCT00626197|26795512|FG002|Overall Study|Adverse Event|2|||
13397384|NCT00626197|26795510|FG000|Overall Study|Withdrawal by Subject|17|||
13397385|NCT00626197|26795511|FG001|Overall Study|Withdrawal by Subject|17|||
13397386|NCT00626197|26795512|FG002|Overall Study|Withdrawal by Subject|7|||
13397387|NCT00626197|26795510|FG000|Overall Study|Administrative reasons|15|||
13397388|NCT00626197|26795511|FG001|Overall Study|Administrative reasons|19|||
13397389|NCT00626197|26795512|FG002|Overall Study|Administrative reasons|55|||
13397390|NCT00626093|26795519|FG000|Overall Study|Lost to Follow-up|5|||
13397391|NCT00626093|26795519|FG000|Overall Study|Death|1|||
13397392|NCT00626093|26795519|FG000|Overall Study|Physician Decision|4|||
13397393|NCT00626093|26795519|FG000|Overall Study|Withdrawal by Subject|6|||
13397394|NCT00626093|26795519|FG000|Overall Study|Protocol Violation|1|||
13397395|NCT00626093|26795519|FG000|Overall Study|One of the required devices not implante|6|||
13397396|NCT00626028|26795540|FG000|Overall Study|Adverse Event|1|||
13397397|NCT00626028|26795541|FG001|Overall Study|Adverse Event|1|||
13397398|NCT00626028|26795540|FG000|Overall Study|Device Failure|0|||
13397399|NCT00626028|26795541|FG001|Overall Study|Device Failure|1|||
13397400|NCT00626028|26795540|FG000|Overall Study|Physician Decision|2|||
13397401|NCT00626028|26795541|FG001|Overall Study|Physician Decision|1|||
13397402|NCT00626028|26795540|FG000|Overall Study|Inclusion/Exclusion Criteria|3|||
13397403|NCT00626028|26795541|FG001|Overall Study|Inclusion/Exclusion Criteria|6|||
13397404|NCT00625872|26795658|FG000|Overall Study|Withdrawal by Subject|1|||
13397405|NCT00625872|26795659|FG001|Overall Study|Withdrawal by Subject|0|||
13397406|NCT00625872|26795658|FG000|Overall Study|Does not meet inclusion criteria|1|||
13397407|NCT00625872|26795659|FG001|Overall Study|Does not meet inclusion criteria|0|||
13397408|NCT00625872|26795658|FG000|Overall Study|Terminated by sponsor|2|||
13397409|NCT00625872|26795659|FG001|Overall Study|Terminated by sponsor|5|||
13397410|NCT00625872|26795658|FG000|Overall Study|Randomized but not treated|0|||
13397411|NCT00625872|26795659|FG001|Overall Study|Randomized but not treated|1|||
13397412|NCT00625846|26795698|FG000|Overall Study|Withdrawal by Subject|2|||
13397413|NCT00625846|26795699|FG001|Overall Study|Withdrawal by Subject|0|||
13397414|NCT00625846|26795700|FG002|Overall Study|Withdrawal by Subject|1|||
13397415|NCT00625846|26795701|FG003|Overall Study|Withdrawal by Subject|2|||
13397416|NCT00625820|26795709|FG000|Overall Study|Withdrawal by Subject|1|||
13397417|NCT00625807|26795732|FG000|Overall Study|schedule conflict|2|||
13397418|NCT00625807|26795733|FG001|Overall Study|schedule conflict|8|||
13397419|NCT00625742|26795740|FG000|Overall Study|Disease Progression|2|||
13397420|NCT00625742|26795740|FG000|Overall Study|Withdrawal by Subject|1|||
13397421|NCT00625742|26795740|FG000|Overall Study|Adverse Event|4|||
13397422|NCT00625742|26795740|FG000|Overall Study|Lost to Follow-up|4|||
13397423|NCT00625742|26795740|FG000|Overall Study|Ineligible|1|||
13397424|NCT00625586|26795752|FG000|Overall Study|Adverse Event|1|||
13397425|NCT00625443|26795790|FG000|Overall Study|Adverse Event|1|||
13397426|NCT00625443|26795791|FG001|Overall Study|Adverse Event|4|||
13397427|NCT00625443|26795792|FG002|Overall Study|Adverse Event|0|||
13397428|NCT00625443|26795790|FG000|Overall Study|Non-compliance with protocol|0|||
13397429|NCT00625443|26795791|FG001|Overall Study|Non-compliance with protocol|1|||
13397430|NCT00625443|26795792|FG002|Overall Study|Non-compliance with protocol|0|||
13397431|NCT00625443|26795790|FG000|Overall Study|Platelet count increase >=500,000/mm3|1|||
13397432|NCT00625443|26795791|FG001|Overall Study|Platelet count increase >=500,000/mm3|0|||
13397433|NCT00625443|26795792|FG002|Overall Study|Platelet count increase >=500,000/mm3|0|||
13397434|NCT00625443|26795790|FG000|Overall Study|Withdrawal by Subject|0|||
13397435|NCT00625443|26795791|FG001|Overall Study|Withdrawal by Subject|1|||
13397436|NCT00625443|26795792|FG002|Overall Study|Withdrawal by Subject|2|||
13397437|NCT00625443|26795790|FG000|Overall Study|Physician Decision|0|||
13397438|NCT00625443|26795791|FG001|Overall Study|Physician Decision|4|||
13397439|NCT00625443|26795792|FG002|Overall Study|Physician Decision|2|||
13397440|NCT00625443|26795790|FG000|Overall Study|Other|0|||
13397441|NCT00625443|26795791|FG001|Overall Study|Other|1|||
13397442|NCT00625443|26795792|FG002|Overall Study|Other|1|||
13397443|NCT00625378|26795823|FG000|Overall Study|Adverse Event|22|||
13397444|NCT00625378|26795824|FG001|Overall Study|Adverse Event|0|||
13397445|NCT00625378|26795823|FG000|Overall Study|Withdrawal by Subject|16|||
13397446|NCT00625378|26795824|FG001|Overall Study|Withdrawal by Subject|0|||
13397447|NCT00625378|26795823|FG000|Overall Study|Death|38|||
13397448|NCT00625378|26795824|FG001|Overall Study|Death|0|||
13397449|NCT00625378|26795823|FG000|Overall Study|Disease progression, recurrence or relapse|88|||
13397450|NCT00625378|26795824|FG001|Overall Study|Disease progression, recurrence or relapse|0|||
13397451|NCT00625378|26795823|FG000|Overall Study|Lost to Follow-up|17|||
13397452|NCT00625378|26795824|FG001|Overall Study|Lost to Follow-up|0|||
13397453|NCT00625378|26795823|FG000|Overall Study|Non-compliant with study medication|3|||
13397454|NCT00625378|26795824|FG001|Overall Study|Non-compliant with study medication|0|||
13397455|NCT00625378|26795823|FG000|Overall Study|Investigator's judgement (no need to continue treatment)|1|||
13397456|NCT00625378|26795824|FG001|Overall Study|Investigator's judgement (no need to continue treatment)|0|||
13397457|NCT00625378|26795823|FG000|Overall Study|Medical decision|1|||
13397458|NCT00625378|26795824|FG001|Overall Study|Medical decision|0|||
13397459|NCT00625378|26795823|FG000|Overall Study|Multiple toxicities|1|||
13397460|NCT00625378|26795824|FG001|Overall Study|Multiple toxicities|0|||
13397461|NCT00625378|26795823|FG000|Overall Study|New cancer|1|||
13397462|NCT00625378|26795824|FG001|Overall Study|New cancer|0|||
13397463|NCT00625378|26795823|FG000|Overall Study|PTA program|2|||
13397464|NCT00625378|26795824|FG001|Overall Study|PTA program|0|||
13397465|NCT00625378|26795823|FG000|Overall Study|Recurrent rise in amylase and lipase|1|||
13397466|NCT00625378|26795824|FG001|Overall Study|Recurrent rise in amylase and lipase|0|||
13397467|NCT00625378|26795823|FG000|Overall Study|Sponsor decision|1|||
13397468|NCT00625378|26795824|FG001|Overall Study|Sponsor decision|0|||
13397469|NCT00625378|26795823|FG000|Overall Study|Sponsor's decision to stop the trial|1|||
13397470|NCT00625378|26795824|FG001|Overall Study|Sponsor's decision to stop the trial|0|||
13397471|NCT00625378|26795823|FG000|Overall Study|Switch to commercial drug|6|||
13397472|NCT00625378|26795824|FG001|Overall Study|Switch to commercial drug|1|||
13397473|NCT00625378|26795823|FG000|Overall Study|Missing|2|||
13397474|NCT00625378|26795824|FG001|Overall Study|Missing|0|||
13397475|NCT00625378|26795823|FG000|Overall Study|End of treatment not available|2|||
13397476|NCT00625378|26795824|FG001|Overall Study|End of treatment not available|0|||
13397477|NCT00625378|26795823|FG000|Overall Study|Never treated|2|||
13397478|NCT00625378|26795824|FG001|Overall Study|Never treated|0|||
13397479|NCT00625365|26795832|FG000|Overall Study|Withdrawal by Subject|1|||
13397480|NCT00625365|26795832|FG000|Overall Study|No IV access|5|||
13397481|NCT00625365|26795832|FG000|Overall Study|VSD|1|||
13397482|NCT00625183|26795843|FG000|Overall Study|Disease Progression|1|||
13397483|NCT00625131|26795861|FG000|Overall Study|Lost to Follow-up|3|||
13397484|NCT00625131|26795862|FG001|Overall Study|Lost to Follow-up|2|||
13397485|NCT00625131|26795863|FG002|Overall Study|Lost to Follow-up|0|||
13397486|NCT00625131|26795861|FG000|Overall Study|Withdrawal by Subject|1|||
13397487|NCT00625131|26795862|FG001|Overall Study|Withdrawal by Subject|0|||
13397488|NCT00625131|26795863|FG002|Overall Study|Withdrawal by Subject|5|||
13397489|NCT00624832|26795888|FG000|Overall Study|Adverse Event|0|||
13397490|NCT00624832|26795889|FG001|Overall Study|Adverse Event|1|||
13397491|NCT00624832|26795890|FG002|Overall Study|Adverse Event|0|||
13397492|NCT00624832|26795891|FG003|Overall Study|Adverse Event|1|||
13397493|NCT00624832|26795888|FG000|Overall Study|Abnormal Laboratory Value|2|||
13397494|NCT00624832|26795889|FG001|Overall Study|Abnormal Laboratory Value|0|||
13397495|NCT00624832|26795890|FG002|Overall Study|Abnormal Laboratory Value|0|||
13397496|NCT00624832|26795891|FG003|Overall Study|Abnormal Laboratory Value|0|||
13397497|NCT00624819|26796062|FG000|Follow-up Period: Year 4|Parents decision|0|||
13397498|NCT00624819|26796063|FG001|Follow-up Period: Year 4|Parents decision|0|||
13397499|NCT00624819|26796064|FG002|Follow-up Period: Year 4|Parents decision|1|||
13397500|NCT00624819|26796065|FG003|Follow-up Period: Year 4|Parents decision|0|||
13397501|NCT00624819|26796062|FG000|Follow-up Period: Year 4|Lost to Follow-up|1|||
13397502|NCT00624819|26796063|FG001|Follow-up Period: Year 4|Lost to Follow-up|1|||
13397503|NCT00624819|26796064|FG002|Follow-up Period: Year 4|Lost to Follow-up|0|||
13397504|NCT00624819|26796065|FG003|Follow-up Period: Year 4|Lost to Follow-up|0|||
13397505|NCT00624780|26796266|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7|||
13397506|NCT00624780|26796267|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
13397507|NCT00624780|26796268|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15|||
13397508|NCT00624780|26796269|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3|||
13397509|NCT00624780|26796270|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9|||
13397510|NCT00624780|26796271|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
13397511|NCT00624780|26796266|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
13397512|NCT00624780|26796267|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2|||
13397513|NCT00624780|26796268|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10|||
13397514|NCT00624780|26796269|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
13397515|NCT00624780|26796270|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9|||
13397516|NCT00624780|26796271|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1|||
13397517|NCT00624780|26796266|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
13397518|NCT00624780|26796267|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
13397519|NCT00624780|26796268|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
13397520|NCT00624780|26796269|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
13397521|NCT00624780|26796270|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
13397522|NCT00624780|26796271|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
13397523|NCT00624780|26796266|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
13397524|NCT00624780|26796267|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2|||
13397525|NCT00624780|26796268|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7|||
13397526|NCT00624780|26796269|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
13397527|NCT00624780|26796270|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
13397528|NCT00624780|26796271|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
13397529|NCT00624780|26796266|FG000|Treatment Optimization (Up to Week 12)|Other|10|||
13397530|NCT00624780|26796267|FG001|Treatment Optimization (Up to Week 12)|Other|4|||
13397531|NCT00624780|26796268|FG002|Treatment Optimization (Up to Week 12)|Other|8|||
13397532|NCT00624780|26796269|FG003|Treatment Optimization (Up to Week 12)|Other|2|||
13397533|NCT00624780|26796270|FG004|Treatment Optimization (Up to Week 12)|Other|9|||
13397534|NCT00624780|26796271|FG005|Treatment Optimization (Up to Week 12)|Other|0|||
13397535|NCT00624780|26796266|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
13397536|NCT00624780|26796267|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4|||
13397537|NCT00624780|26796268|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
13397538|NCT00624780|26796269|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2|||
13397539|NCT00624780|26796270|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3|||
13397540|NCT00624780|26796271|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1|||
13397541|NCT00624780|26796266|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
13397542|NCT00624780|26796267|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1|||
13397543|NCT00624780|26796268|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
13397544|NCT00624780|26796269|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
13397545|NCT00624780|26796270|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
13397546|NCT00624780|26796271|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
13397547|NCT00624780|26796266|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
13397548|NCT00624780|26796267|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
13397549|NCT00624780|26796268|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
13397550|NCT00624780|26796269|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
13397551|NCT00624780|26796270|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
13397552|NCT00624780|26796271|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
13397553|NCT00624780|26796266|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
13397554|NCT00624780|26796267|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
13397555|NCT00624780|26796268|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
13397556|NCT00624780|26796269|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
13397557|NCT00624780|26796270|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
13397558|NCT00624780|26796271|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
13397559|NCT00624780|26796266|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5|||
13397560|NCT00624780|26796267|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3|||
13397561|NCT00624780|26796268|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4|||
13397562|NCT00624780|26796269|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1|||
13397563|NCT00624780|26796270|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4|||
13397564|NCT00624780|26796271|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3|||
13397565|NCT00624780|26796266|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1|||
13397566|NCT00624780|26796267|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0|||
13397567|NCT00624780|26796268|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2|||
13397568|NCT00624780|26796269|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1|||
13397569|NCT00624780|26796270|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0|||
13397570|NCT00624780|26796271|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1|||
13397571|NCT00624780|26796266|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1|||
13397572|NCT00624780|26796267|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
13397573|NCT00624780|26796268|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
13397574|NCT00624780|26796269|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
13397575|NCT00624780|26796270|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
13397576|NCT00624780|26796271|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
13397577|NCT00624780|26796266|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
13397578|NCT00624780|26796267|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
13397579|NCT00624780|26796268|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1|||
13397580|NCT00624780|26796269|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
13397581|NCT00624780|26796270|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
13397582|NCT00624780|26796271|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
13397583|NCT00624780|26796266|FG000|Follow-up (Week 26)|Death|0|||
13397584|NCT00624780|26796267|FG001|Follow-up (Week 26)|Death|0|||
13397585|NCT00624780|26796268|FG002|Follow-up (Week 26)|Death|1|||
13397586|NCT00624780|26796269|FG003|Follow-up (Week 26)|Death|0|||
13397587|NCT00624780|26796270|FG004|Follow-up (Week 26)|Death|0|||
13397588|NCT00624780|26796271|FG005|Follow-up (Week 26)|Death|0|||
13397589|NCT00624780|26796266|FG000|Follow-up (Week 26)|Adverse Event|0|||
13397590|NCT00624780|26796267|FG001|Follow-up (Week 26)|Adverse Event|0|||
13397591|NCT00624780|26796268|FG002|Follow-up (Week 26)|Adverse Event|0|||
13397592|NCT00624780|26796269|FG003|Follow-up (Week 26)|Adverse Event|0|||
13397593|NCT00624780|26796270|FG004|Follow-up (Week 26)|Adverse Event|1|||
13397594|NCT00624780|26796271|FG005|Follow-up (Week 26)|Adverse Event|0|||
13397595|NCT00624780|26796266|FG000|Follow-up (Week 26)|Lost to Follow-up|0|||
13397596|NCT00624780|26796267|FG001|Follow-up (Week 26)|Lost to Follow-up|0|||
13397597|NCT00624780|26796268|FG002|Follow-up (Week 26)|Lost to Follow-up|1|||
13397598|NCT00624780|26796269|FG003|Follow-up (Week 26)|Lost to Follow-up|0|||
13397599|NCT00624780|26796270|FG004|Follow-up (Week 26)|Lost to Follow-up|1|||
13397600|NCT00624780|26796271|FG005|Follow-up (Week 26)|Lost to Follow-up|0|||
13397601|NCT00624780|26796266|FG000|Follow-up (Week 26)|Withdrawal by Subject|1|||
13397602|NCT00624780|26796267|FG001|Follow-up (Week 26)|Withdrawal by Subject|0|||
13397603|NCT00624780|26796268|FG002|Follow-up (Week 26)|Withdrawal by Subject|0|||
13397604|NCT00624780|26796269|FG003|Follow-up (Week 26)|Withdrawal by Subject|0|||
13397605|NCT00624780|26796270|FG004|Follow-up (Week 26)|Withdrawal by Subject|0|||
13397606|NCT00624780|26796271|FG005|Follow-up (Week 26)|Withdrawal by Subject|0|||
13397607|NCT00624780|26796266|FG000|Follow-up (Week 26)|Other|1|||
13397608|NCT00624780|26796267|FG001|Follow-up (Week 26)|Other|1|||
13397609|NCT00624780|26796268|FG002|Follow-up (Week 26)|Other|0|||
13397610|NCT00624780|26796269|FG003|Follow-up (Week 26)|Other|0|||
13397611|NCT00624780|26796270|FG004|Follow-up (Week 26)|Other|0|||
13397612|NCT00624780|26796271|FG005|Follow-up (Week 26)|Other|0|||
13397613|NCT00624585|26796280|FG000|Overall Study|Death|3|||
13397614|NCT00624585|26796280|FG000|Overall Study|Disease Progression|6|||
13397615|NCT00624585|26796280|FG000|Overall Study|Adverse Event|3|||
13397616|NCT00624520|26796312|FG000|Overall Study|Withdrawal by Subject|12|||
13397617|NCT00624520|26796313|FG001|Overall Study|Withdrawal by Subject|7|||
13397618|NCT00624520|26796312|FG000|Overall Study|Death|0|||
13397619|NCT00624520|26796313|FG001|Overall Study|Death|1|||
13397620|NCT00624468|26796348|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13|||
13397621|NCT00624468|26796349|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12|||
13397622|NCT00624468|26796350|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0|||
13397623|NCT00624468|26796351|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0|||
13397624|NCT00624468|26796348|FG000|Double-blind Period|Withdrew Prematurely|1|||
13397625|NCT00624468|26796349|FG001|Double-blind Period|Withdrew Prematurely|1|||
13397626|NCT00624468|26796350|FG002|Double-blind Period|Withdrew Prematurely|0|||
13397627|NCT00624468|26796351|FG003|Double-blind Period|Withdrew Prematurely|0|||
13397628|NCT00624468|26796348|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
13397629|NCT00624468|26796349|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
13397630|NCT00624468|26796350|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1|||
13397631|NCT00624468|26796351|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2|||
13397632|NCT00624468|26796348|FG000|Safety Follow-up (SFU) Period|Other|0|||
13397633|NCT00624468|26796349|FG001|Safety Follow-up (SFU) Period|Other|0|||
13397634|NCT00624468|26796350|FG002|Safety Follow-up (SFU) Period|Other|1|||
13397635|NCT00624468|26796351|FG003|Safety Follow-up (SFU) Period|Other|1|||
13397636|NCT00624377|26796364|FG000|Overall Study|Lost to Follow-up|355|||
13397637|NCT00624377|26796364|FG000|Overall Study|Withdrawal by Subject|100|||
13397638|NCT00624377|26796364|FG000|Overall Study|Adverse Event|14|||
13397639|NCT00624377|26796364|FG000|Overall Study|Other|91|||
13397640|NCT00624377|26796364|FG000|Overall Study|Non-evaluable population|84|||
13397641|NCT00624338|26796394|FG000|Overall Study|Adverse Event|14|||
13397642|NCT00624338|26796395|FG001|Overall Study|Adverse Event|14|||
13397643|NCT00624338|26796396|FG002|Overall Study|Adverse Event|18|||
13397644|NCT00624338|26796394|FG000|Overall Study|Lost to Follow-up|1|||
13397645|NCT00624338|26796395|FG001|Overall Study|Lost to Follow-up|0|||
13397646|NCT00624338|26796396|FG002|Overall Study|Lost to Follow-up|0|||
13397647|NCT00624338|26796394|FG000|Overall Study|Lack of Efficacy|11|||
13397648|NCT00624338|26796395|FG001|Overall Study|Lack of Efficacy|3|||
13397649|NCT00624338|26796396|FG002|Overall Study|Lack of Efficacy|14|||
13397650|NCT00624338|26796394|FG000|Overall Study|Protocol Violation|3|||
13397651|NCT00624338|26796395|FG001|Overall Study|Protocol Violation|3|||
13397652|NCT00624338|26796396|FG002|Overall Study|Protocol Violation|2|||
13397653|NCT00624338|26796394|FG000|Overall Study|Death|0|||
13397654|NCT00624338|26796395|FG001|Overall Study|Death|2|||
13397655|NCT00624338|26796396|FG002|Overall Study|Death|0|||
13397656|NCT00624338|26796394|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1|||
13397657|NCT00624338|26796395|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0|||
13397658|NCT00624338|26796396|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0|||
13397659|NCT00624338|26796394|FG000|Overall Study|Termination of 150 mg group by Sponsor|0|||
13397660|NCT00624338|26796395|FG001|Overall Study|Termination of 150 mg group by Sponsor|55|||
13397661|NCT00624338|26796396|FG002|Overall Study|Termination of 150 mg group by Sponsor|0|||
13397662|NCT00624338|26796394|FG000|Overall Study|Other|15|||
13397663|NCT00624338|26796395|FG001|Overall Study|Other|5|||
13397664|NCT00624338|26796396|FG002|Overall Study|Other|9|||
13397665|NCT00624338|26796394|FG000|Overall Study|Randomized but not treated|2|||
13397666|NCT00624338|26796395|FG001|Overall Study|Randomized but not treated|1|||
13397667|NCT00624338|26796396|FG002|Overall Study|Randomized but not treated|3|||
13397668|NCT00624286|26796411|FG000|Overall Study|Protocol Deviation|7|||
13397669|NCT00624286|26796412|FG001|Overall Study|Protocol Deviation|9|||
13397670|NCT00624286|26796411|FG000|Overall Study|Adverse Event|6|||
13397671|NCT00624286|26796412|FG001|Overall Study|Adverse Event|3|||
13397672|NCT00624286|26796411|FG000|Overall Study|Withdrawal by Subject|5|||
13397673|NCT00624286|26796412|FG001|Overall Study|Withdrawal by Subject|4|||
13397674|NCT00624286|26796411|FG000|Overall Study|Lost to Follow-up|3|||
13397675|NCT00624286|26796412|FG001|Overall Study|Lost to Follow-up|2|||
13397676|NCT00624286|26796411|FG000|Overall Study|Administrative problems|3|||
13397677|NCT00624286|26796412|FG001|Overall Study|Administrative problems|0|||
13397678|NCT00624286|26796411|FG000|Overall Study|Lack of Efficacy|1|||
13397679|NCT00624286|26796412|FG001|Overall Study|Lack of Efficacy|6|||
13397680|NCT00624286|26796411|FG000|Overall Study|Not stated|0|||
13397681|NCT00624286|26796412|FG001|Overall Study|Not stated|1|||
13397682|NCT00624286|26796411|FG000|Overall Study|Abnormal test procedure result(s)|0|||
13397683|NCT00624286|26796412|FG001|Overall Study|Abnormal test procedure result(s)|1|||
13397684|NCT00624286|26796411|FG000|Overall Study|Death|0|||
13397685|NCT00624286|26796412|FG001|Overall Study|Death|1|||
13397686|NCT00624065|26796427|FG000|Overall Study|Adverse Event|5|||
13397687|NCT00624065|26796428|FG001|Overall Study|Adverse Event|6|||
13397688|NCT00624065|26796427|FG000|Overall Study|Lost to Follow-up|4|||
13397689|NCT00624065|26796428|FG001|Overall Study|Lost to Follow-up|1|||
13397690|NCT00624065|26796427|FG000|Overall Study|Consent withdrawn|6|||
13397691|NCT00624065|26796428|FG001|Overall Study|Consent withdrawn|5|||
13397692|NCT00624065|26796427|FG000|Overall Study|Lack of Efficacy|0|||
13397693|NCT00624065|26796428|FG001|Overall Study|Lack of Efficacy|3|||
13397694|NCT00624065|26796427|FG000|Overall Study|Met protocol-defined stopping criteria|4|||
13397695|NCT00624065|26796428|FG001|Overall Study|Met protocol-defined stopping criteria|9|||
13397696|NCT00624052|26796490|FG000|Overall Study|Adverse Event|7|||
13397697|NCT00624052|26796491|FG001|Overall Study|Adverse Event|6|||
13397698|NCT00624052|26796492|FG002|Overall Study|Adverse Event|0|||
13397699|NCT00624052|26796493|FG003|Overall Study|Adverse Event|3|||
13397700|NCT00624052|26796490|FG000|Overall Study|Lack of Efficacy|1|||
13397701|NCT00624052|26796491|FG001|Overall Study|Lack of Efficacy|1|||
13397702|NCT00624052|26796492|FG002|Overall Study|Lack of Efficacy|0|||
13397703|NCT00624052|26796493|FG003|Overall Study|Lack of Efficacy|0|||
13397704|NCT00624052|26796490|FG000|Overall Study|Lost to Follow-up|2|||
13397705|NCT00624052|26796491|FG001|Overall Study|Lost to Follow-up|3|||
13397706|NCT00624052|26796492|FG002|Overall Study|Lost to Follow-up|1|||
13397707|NCT00624052|26796493|FG003|Overall Study|Lost to Follow-up|0|||
13397708|NCT00624052|26796490|FG000|Overall Study|Non compliant with the protocol|2|||
13397709|NCT00624052|26796491|FG001|Overall Study|Non compliant with the protocol|1|||
13397710|NCT00624052|26796492|FG002|Overall Study|Non compliant with the protocol|1|||
13397711|NCT00624052|26796493|FG003|Overall Study|Non compliant with the protocol|1|||
13397712|NCT00624052|26796490|FG000|Overall Study|Consent withdrawn|3|||
13397713|NCT00624052|26796491|FG001|Overall Study|Consent withdrawn|1|||
13397714|NCT00624052|26796492|FG002|Overall Study|Consent withdrawn|1|||
13397715|NCT00624052|26796493|FG003|Overall Study|Consent withdrawn|0|||
13397716|NCT00624052|26796490|FG000|Overall Study|Changed job/ran out if meds|0|||
13397717|NCT00624052|26796491|FG001|Overall Study|Changed job/ran out if meds|2|||
13397718|NCT00624052|26796492|FG002|Overall Study|Changed job/ran out if meds|0|||
13397719|NCT00624052|26796493|FG003|Overall Study|Changed job/ran out if meds|0|||
13397720|NCT00623935|26796500|FG000|Overall Study|Death|1|||
13397721|NCT00623935|26796500|FG000|Overall Study|Patient Declined Transplant|1|||
13397722|NCT00623831|26796517|FG000|Overall Study|Withdrawal by Subject|1|||
13397723|NCT00623831|26796518|FG001|Overall Study|Withdrawal by Subject|0|||
13397724|NCT00623831|26796517|FG000|Overall Study|Progressive Disease|0|||
13397725|NCT00623831|26796518|FG001|Overall Study|Progressive Disease|1|||
13397726|NCT00623805|26796539|FG000|Overall Study|Adverse Event|9|||
13397727|NCT00623805|26796540|FG001|Overall Study|Adverse Event|6|||
13397728|NCT00623805|26796539|FG000|Overall Study|Death|2|||
13397729|NCT00623805|26796540|FG001|Overall Study|Death|0|||
13397730|NCT00623805|26796539|FG000|Overall Study|Lack of Efficacy|3|||
13397731|NCT00623805|26796540|FG001|Overall Study|Lack of Efficacy|7|||
13397732|NCT00623805|26796539|FG000|Overall Study|Lost to Follow-up|2|||
13397733|NCT00623805|26796540|FG001|Overall Study|Lost to Follow-up|2|||
13397734|NCT00623805|26796539|FG000|Overall Study|Protocol Violation|1|||
13397735|NCT00623805|26796540|FG001|Overall Study|Protocol Violation|1|||
13397736|NCT00623805|26796539|FG000|Overall Study|Reason not Specified|3|||
13397737|NCT00623805|26796540|FG001|Overall Study|Reason not Specified|6|||
13397738|NCT00623779|26796597|FG000|Overall Study|Adverse Event|1|||
13397739|NCT00623779|26796598|FG001|Overall Study|Adverse Event|3|||
13397740|NCT00623779|26796599|FG002|Overall Study|Adverse Event|0|||
13397741|NCT00623779|26796597|FG000|Overall Study|Criteria from CSR|2|||
13397742|NCT00623779|26796598|FG001|Overall Study|Criteria from CSR|0|||
13397743|NCT00623779|26796599|FG002|Overall Study|Criteria from CSR|1|||
13397744|NCT00623766|26796628|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36|||
13397745|NCT00623766|26796629|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16|||
13397746|NCT00623766|26796628|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4|||
13397747|NCT00623766|26796629|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0|||
13397748|NCT00623766|26796628|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4|||
13397749|NCT00623766|26796629|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0|||
13397750|NCT00623766|26796628|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1|||
13397751|NCT00623766|26796629|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2|||
13397752|NCT00623766|26796628|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1|||
13397753|NCT00623766|26796629|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0|||
13397754|NCT00623727|26796656|FG000|Double Blind (DB)|Adverse Event|1|||
13397755|NCT00623727|26796657|FG001|Double Blind (DB)|Adverse Event|3|||
13397756|NCT00623727|26796656|FG000|Double Blind (DB)|Physician Decision|0|||
13397757|NCT00623727|26796657|FG001|Double Blind (DB)|Physician Decision|1|||
13397758|NCT00623727|26796656|FG000|Double Blind (DB)|Withdrawal by Subject|8|||
13397759|NCT00623727|26796657|FG001|Double Blind (DB)|Withdrawal by Subject|2|||
13397760|NCT00623727|26796656|FG000|Double Blind (DB)|Lack of Efficacy|2|||
13397761|NCT00623727|26796657|FG001|Double Blind (DB)|Lack of Efficacy|2|||
13397762|NCT00623727|26796656|FG000|Double Blind (DB)|Termination of the double-blind period|22|||
13397763|NCT00623727|26796657|FG001|Double Blind (DB)|Termination of the double-blind period|21|||
13397764|NCT00623727|26796656|FG000|Double Blind (DB)|Lost to Follow-up|1|||
13397765|NCT00623727|26796657|FG001|Double Blind (DB)|Lost to Follow-up|1|||
13397766|NCT00623727|26796656|FG000|Double Blind (DB)|Protocol Violation|2|||
13397767|NCT00623727|26796657|FG001|Double Blind (DB)|Protocol Violation|2|||
13397768|NCT00623727|26796656|FG000|Open Label Follow-up|Withdrawal by Subject|0|||
13397769|NCT00623727|26796657|FG001|Open Label Follow-up|Withdrawal by Subject|1|||
13397770|NCT00623727|26796656|FG000|Open Label Follow-up|Study termination|0|||
13397771|NCT00623727|26796657|FG001|Open Label Follow-up|Study termination|6|||
13397772|NCT00623727|26796656|FG000|Open Label Follow-up|Participant convenience|0|||
13397773|NCT00623727|26796657|FG001|Open Label Follow-up|Participant convenience|1|||
13397774|NCT00623623|26796718|FG000|Overall Study|Previous enrolment into this study|1|||
13397775|NCT00623623|26796719|FG001|Overall Study|Previous enrolment into this study|1|||
13397776|NCT00623597|26796789|FG000|Overall Study|Failed to return|1|||
13397777|NCT00623597|26796790|FG001|Overall Study|Failed to return|0|||
13397778|NCT00623545|26796797|FG000|Overall Study|Adverse Event|6|||
13397779|NCT00623545|26796797|FG000|Overall Study|Withdrawal by Subject|4|||
13397780|NCT00623480|26796816|FG000|Overall Study|Lost to Follow-up|0|||
13397781|NCT00623480|26796817|FG001|Overall Study|Lost to Follow-up|1|||
13397782|NCT00623480|26796816|FG000|Overall Study|Withdrawal by Subject|2|||
13397783|NCT00623480|26796817|FG001|Overall Study|Withdrawal by Subject|4|||
13397784|NCT00623480|26796816|FG000|Overall Study|Lack of Efficacy|1|||
13397785|NCT00623480|26796817|FG001|Overall Study|Lack of Efficacy|0|||
13397786|NCT00623480|26796816|FG000|Overall Study|Non-compliant with study medication|4|||
13397787|NCT00623480|26796817|FG001|Overall Study|Non-compliant with study medication|0|||
13397788|NCT00623480|26796816|FG000|Overall Study|Protocol Violation|0|||
13397789|NCT00623480|26796817|FG001|Overall Study|Protocol Violation|1|||
13397790|NCT00623480|26796816|FG000|Overall Study|Site closed by sponsor|0|||
13397791|NCT00623480|26796817|FG001|Overall Study|Site closed by sponsor|1|||
13397792|NCT00623467|26796883|FG000|Overall Study|Lost to Follow-up|1|||
13397793|NCT00623467|26796883|FG000|Overall Study|Protocol Violation|4|||
13397794|NCT00623467|26796883|FG000|Overall Study|Withdrawal by Subject|2|||
13397795|NCT00623428|26796908|FG000|Treatment Period|Adverse event/intercurrent illness|0|||
13397796|NCT00623428|26796909|FG001|Treatment Period|Adverse event/intercurrent illness|9|||
13397797|NCT00623428|26796908|FG000|Treatment Period|Death|0|||
13397798|NCT00623428|26796909|FG001|Treatment Period|Death|1|||
13397799|NCT00623428|26796908|FG000|Treatment Period|Did not cooperate / refused treatment|0|||
13397800|NCT00623428|26796909|FG001|Treatment Period|Did not cooperate / refused treatment|13|||
13397801|NCT00623428|26796908|FG000|Treatment Period|Insufficient therapeutic response|0|||
13397802|NCT00623428|26796909|FG001|Treatment Period|Insufficient therapeutic response|2|||
13397803|NCT00623428|26796908|FG000|Treatment Period|Other|0|||
13397804|NCT00623428|26796909|FG001|Treatment Period|Other|1|||
13397805|NCT00623428|26796908|FG000|Treatment Period|Withdrawal by Subject|0|||
13397806|NCT00623428|26796909|FG001|Treatment Period|Withdrawal by Subject|1|||
13397807|NCT00623428|26796908|FG000|Follow-up Period|Relapse post-treatment|11|||
13397808|NCT00623428|26796909|FG001|Follow-up Period|Relapse post-treatment|3|||
13397809|NCT00623428|26796908|FG000|Follow-up Period|Failure to return|10|||
13397810|NCT00623428|26796909|FG001|Follow-up Period|Failure to return|2|||
13397811|NCT00623428|26796908|FG000|Follow-up Period|Patient withdrew consent|5|||
13397812|NCT00623428|26796909|FG001|Follow-up Period|Patient withdrew consent|4|||
13397813|NCT00623428|26796908|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2|||
13397814|NCT00623428|26796909|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1|||
13397815|NCT00623428|26796908|FG000|Follow-up Period|Did not cooperate|0|||
13397816|NCT00623428|26796909|FG001|Follow-up Period|Did not cooperate|3|||
13397817|NCT00623428|26796908|FG000|Follow-up Period|Reason not specified|1|||
13397818|NCT00623428|26796909|FG001|Follow-up Period|Reason not specified|1|||
13397819|NCT00623428|26796908|FG000|Follow-up Period|Death|0|||
13397820|NCT00623428|26796909|FG001|Follow-up Period|Death|1|||
13397821|NCT00623363|26796947|FG000|Overall Study|Adverse Event|2|||
13397822|NCT00623363|26796948|FG001|Overall Study|Adverse Event|2|||
13397823|NCT00623233|26796957|FG000|Overall Study|Adverse Event|10|||
13397824|NCT00623233|26796957|FG000|Overall Study|Physician Decision|10|||
13397825|NCT00623233|26796957|FG000|Overall Study|Lost to Follow-up|1|||
13397826|NCT00623233|26796957|FG000|Overall Study|Withdrawal by Subject|3|||
13397827|NCT00623194|26796979|FG000|Overall Study|Lack of Efficacy|1|||
13397828|NCT00623194|26796979|FG000|Overall Study|Protocol Violation|3|||
13397829|NCT00623194|26796979|FG000|Overall Study|Unclassified|1|||
13397830|NCT00623103|26797006|FG000|Overall Study|Adverse Event|70|||
13397831|NCT00623103|26797007|FG001|Overall Study|Adverse Event|60|||
13397832|NCT00623103|26797006|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
13397833|NCT00623103|26797007|FG001|Overall Study|Unsatisfactory therapeutic effect|12|||
13397834|NCT00623103|26797006|FG000|Overall Study|Withdrawal by Subject|18|||
13397835|NCT00623103|26797007|FG001|Overall Study|Withdrawal by Subject|24|||
13397836|NCT00623103|26797006|FG000|Overall Study|Lost to Follow-up|4|||
13397837|NCT00623103|26797007|FG001|Overall Study|Lost to Follow-up|1|||
13397838|NCT00623103|26797006|FG000|Overall Study|Administrative problems|2|||
13397839|NCT00623103|26797007|FG001|Overall Study|Administrative problems|4|||
13397840|NCT00623103|26797006|FG000|Overall Study|Death|11|||
13397841|NCT00623103|26797007|FG001|Overall Study|Death|11|||
13397842|NCT00623103|26797006|FG000|Overall Study|Protocol deviation|2|||
13397843|NCT00623103|26797007|FG001|Overall Study|Protocol deviation|1|||
13475890|NCT02834793|27001394|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0|||
13475891|NCT02834793|27001395|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0|||
13475892|NCT02834793|27001392|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
13475893|NCT02834793|27001393|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1|||
13475894|NCT02834793|27001394|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
13475895|NCT02834793|27001395|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
13475896|NCT02834793|27001392|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
13475897|NCT02834793|27001393|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
13475898|NCT02834793|27001394|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7|||
13475899|NCT02834793|27001395|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
13475900|NCT02834793|27001392|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
13475901|NCT02834793|27001393|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
13475902|NCT02834793|27001394|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4|||
13475903|NCT02834793|27001395|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
13475904|NCT02834793|27001392|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
13475905|NCT02834793|27001393|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
13475906|NCT02834793|27001394|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5|||
13475907|NCT02834793|27001395|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
13475908|NCT02834793|27001392|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
13475909|NCT02834793|27001393|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
13475910|NCT02834793|27001394|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9|||
13475911|NCT02834793|27001395|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
13475912|NCT02834793|27001392|FG000|Extension Phase A (up to 52 Weeks)|Other|0|||
13475913|NCT02834793|27001393|FG001|Extension Phase A (up to 52 Weeks)|Other|0|||
13475914|NCT02834793|27001394|FG002|Extension Phase A (up to 52 Weeks)|Other|1|||
13475915|NCT02834793|27001395|FG003|Extension Phase A (up to 52 Weeks)|Other|0|||
13475916|NCT02834793|27001392|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
13475917|NCT02834793|27001393|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
13475918|NCT02834793|27001394|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
13475919|NCT02834793|27001395|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1|||
13475920|NCT02834793|27001392|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
13475921|NCT02834793|27001393|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
13475922|NCT02834793|27001394|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
13475923|NCT02834793|27001395|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1|||
13475924|NCT02834793|27001392|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
13475925|NCT02834793|27001393|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
13475926|NCT02834793|27001394|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
13475927|NCT02834793|27001395|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8|||
13475928|NCT02834793|27001392|FG000|Extension Phase B (up to 188 Weeks)|Other|0|||
13475929|NCT02834793|27001393|FG001|Extension Phase B (up to 188 Weeks)|Other|0|||
13475930|NCT02834793|27001394|FG002|Extension Phase B (up to 188 Weeks)|Other|0|||
13475931|NCT02834793|27001395|FG003|Extension Phase B (up to 188 Weeks)|Other|1|||
13475932|NCT02834793|27001392|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
13475933|NCT02834793|27001393|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
13475934|NCT02834793|27001394|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
13475935|NCT02834793|27001395|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1|||
13475936|NCT02810457|27001422|FG000|Overall Study|Randomised but no treatment received|2|||
13475937|NCT02810457|27001423|FG001|Overall Study|Randomised but no treatment received|1|||
13475938|NCT02810457|27001422|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191|||
13475939|NCT02810457|27001423|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199|||
13475940|NCT02810457|27001422|FG000|Overall Study|Adverse Event|37|||
13475941|NCT02810457|27001423|FG001|Overall Study|Adverse Event|43|||
13475942|NCT02810457|27001422|FG000|Overall Study|Patient decision|31|||
13475943|NCT02810457|27001423|FG001|Overall Study|Patient decision|35|||
13475944|NCT02810457|27001422|FG000|Overall Study|Patient lost to follow-up|2|||
13475945|NCT02810457|27001423|FG001|Overall Study|Patient lost to follow-up|2|||
13475946|NCT02810457|27001422|FG000|Overall Study|Death|39|||
13475947|NCT02810457|27001423|FG001|Overall Study|Death|28|||
13475948|NCT02810457|27001422|FG000|Overall Study|Ongoing at data cutoff and discontinued|3|||
13475949|NCT02810457|27001423|FG001|Overall Study|Ongoing at data cutoff and discontinued|2|||
13475950|NCT02810457|27001422|FG000|Overall Study|Clinical progression|15|||
13475951|NCT02810457|27001423|FG001|Overall Study|Clinical progression|16|||
13475952|NCT02810457|27001422|FG000|Overall Study|Investigator decision|3|||
13475953|NCT02810457|27001423|FG001|Overall Study|Investigator decision|2|||
13475954|NCT02810457|27001422|FG000|Overall Study|Patient ineligibility|3|||
13475955|NCT02810457|27001423|FG001|Overall Study|Patient ineligibility|0|||
13475956|NCT02810457|27001422|FG000|Overall Study|Miscalculated PD|1|||
13475957|NCT02810457|27001423|FG001|Overall Study|Miscalculated PD|0|||
13475958|NCT02810457|27001422|FG000|Overall Study|Physician Decision|0|||
13397844|NCT00622908|26797026|FG000|Overall Study|Protocol Violation|1|||
13397845|NCT00622908|26797027|FG001|Overall Study|Protocol Violation|0|||
13397846|NCT00622908|26797026|FG000|Overall Study|Adverse Event|0|||
13397847|NCT00622908|26797027|FG001|Overall Study|Adverse Event|1|||
13397848|NCT00622908|26797026|FG000|Overall Study|Lack of Efficacy|1|||
13397849|NCT00622908|26797027|FG001|Overall Study|Lack of Efficacy|7|||
13397850|NCT00622908|26797026|FG000|Overall Study|Lost to Follow-up|1|||
13397851|NCT00622908|26797027|FG001|Overall Study|Lost to Follow-up|0|||
13397852|NCT00622908|26797026|FG000|Overall Study|Refusal|0|||
13397853|NCT00622908|26797027|FG001|Overall Study|Refusal|1|||
13397854|NCT00622908|26797026|FG000|Overall Study|Termination by study sponser|0|||
13397855|NCT00622908|26797027|FG001|Overall Study|Termination by study sponser|1|||
13397856|NCT00622869|26797054|FG000|Overall Study|Subject Withdrew Consent|13|||
13397857|NCT00622869|26797055|FG001|Overall Study|Subject Withdrew Consent|17|||
13397858|NCT00622869|26797056|FG002|Overall Study|Subject Withdrew Consent|11|||
13397859|NCT00622869|26797054|FG000|Overall Study|Administrative Problems|11|||
13397860|NCT00622869|26797055|FG001|Overall Study|Administrative Problems|17|||
13397861|NCT00622869|26797056|FG002|Overall Study|Administrative Problems|13|||
13397862|NCT00622869|26797054|FG000|Overall Study|Death|12|||
13397863|NCT00622869|26797055|FG001|Overall Study|Death|15|||
13397864|NCT00622869|26797056|FG002|Overall Study|Death|10|||
13397865|NCT00622869|26797054|FG000|Overall Study|Lost to Follow-up|2|||
13397866|NCT00622869|26797055|FG001|Overall Study|Lost to Follow-up|4|||
13397867|NCT00622869|26797056|FG002|Overall Study|Lost to Follow-up|2|||
13397868|NCT00622869|26797054|FG000|Overall Study|Graft Loss|5|||
13397869|NCT00622869|26797055|FG001|Overall Study|Graft Loss|3|||
13397870|NCT00622869|26797056|FG002|Overall Study|Graft Loss|2|||
13397871|NCT00622869|26797054|FG000|Overall Study|Missing|0|||
13397872|NCT00622869|26797055|FG001|Overall Study|Missing|1|||
13397873|NCT00622869|26797056|FG002|Overall Study|Missing|1|||
13397874|NCT00622739|26797079|FG000|Overall Study|Physician Decision|1|||
13397875|NCT00622739|26797080|FG001|Overall Study|Physician Decision|0|||
13397876|NCT00622739|26797079|FG000|Overall Study|Adverse Event|1|||
13397877|NCT00622739|26797080|FG001|Overall Study|Adverse Event|2|||
13397878|NCT00622739|26797079|FG000|Overall Study|Lack of Efficacy|0|||
13397879|NCT00622739|26797080|FG001|Overall Study|Lack of Efficacy|2|||
13397880|NCT00622739|26797079|FG000|Overall Study|Withdrawal by Subject|0|||
13397881|NCT00622739|26797080|FG001|Overall Study|Withdrawal by Subject|1|||
13397882|NCT00622739|26797079|FG000|Overall Study|Lost to Follow-up|0|||
13397883|NCT00622739|26797080|FG001|Overall Study|Lost to Follow-up|1|||
13397884|NCT00622726|26797097|FG000|March, 2008 to August, 2010|Death|5|||
13397885|NCT00622726|26797098|FG001|March, 2008 to August, 2010|Death|2|||
13397886|NCT00622726|26797097|FG000|August, 2010 to April, 2013|Death|1|||
13397887|NCT00622726|26797098|FG001|August, 2010 to April, 2013|Death|5|||
13397888|NCT00622713|26797108|FG000|Overall Study|Adverse Event|35|||
13397889|NCT00622713|26797108|FG000|Overall Study|Administrative problems|4|||
13397890|NCT00622713|26797108|FG000|Overall Study|Withdrawal by Subject|11|||
13397891|NCT00622713|26797108|FG000|Overall Study|Lost to Follow-up|5|||
13397892|NCT00622713|26797108|FG000|Overall Study|Death|2|||
13397893|NCT00622713|26797108|FG000|Overall Study|Subject no longer required study drug|1|||
13397894|NCT00622713|26797108|FG000|Overall Study|Did not meet eligibility criteria|1|||
13397895|NCT00622700|26797181|FG000|Core Treatment Period|Randomized but Not Treated|0|||
13397896|NCT00622700|26797182|FG001|Core Treatment Period|Randomized but Not Treated|2|||
13397897|NCT00622700|26797183|FG002|Core Treatment Period|Randomized but Not Treated|2|||
13397898|NCT00622700|26797184|FG003|Core Treatment Period|Randomized but Not Treated|0|||
13397899|NCT00622700|26797185|FG004|Core Treatment Period|Randomized but Not Treated|0|||
13397900|NCT00622700|26797186|FG005|Core Treatment Period|Randomized but Not Treated|0|||
13397901|NCT00622700|26797187|FG006|Core Treatment Period|Randomized but Not Treated|0|||
13397902|NCT00622700|26797181|FG000|Core Treatment Period|Adverse Event|18|||
13397903|NCT00622700|26797182|FG001|Core Treatment Period|Adverse Event|25|||
13397904|NCT00622700|26797183|FG002|Core Treatment Period|Adverse Event|18|||
13397905|NCT00622700|26797184|FG003|Core Treatment Period|Adverse Event|0|||
13397906|NCT00622700|26797185|FG004|Core Treatment Period|Adverse Event|0|||
13397907|NCT00622700|26797186|FG005|Core Treatment Period|Adverse Event|0|||
13397908|NCT00622700|26797187|FG006|Core Treatment Period|Adverse Event|0|||
13397909|NCT00622700|26797181|FG000|Core Treatment Period|Lack of Efficacy|19|||
13397910|NCT00622700|26797182|FG001|Core Treatment Period|Lack of Efficacy|6|||
13397911|NCT00622700|26797183|FG002|Core Treatment Period|Lack of Efficacy|12|||
13397912|NCT00622700|26797184|FG003|Core Treatment Period|Lack of Efficacy|0|||
13397913|NCT00622700|26797185|FG004|Core Treatment Period|Lack of Efficacy|0|||
13397914|NCT00622700|26797186|FG005|Core Treatment Period|Lack of Efficacy|0|||
13397915|NCT00622700|26797187|FG006|Core Treatment Period|Lack of Efficacy|0|||
13397916|NCT00622700|26797181|FG000|Core Treatment Period|Lost to Follow-up|1|||
13397917|NCT00622700|26797182|FG001|Core Treatment Period|Lost to Follow-up|1|||
13397918|NCT00622700|26797183|FG002|Core Treatment Period|Lost to Follow-up|1|||
13397919|NCT00622700|26797184|FG003|Core Treatment Period|Lost to Follow-up|0|||
13397920|NCT00622700|26797185|FG004|Core Treatment Period|Lost to Follow-up|0|||
13397921|NCT00622700|26797186|FG005|Core Treatment Period|Lost to Follow-up|0|||
13397922|NCT00622700|26797187|FG006|Core Treatment Period|Lost to Follow-up|0|||
13397923|NCT00622700|26797181|FG000|Core Treatment Period|Death|1|||
13397924|NCT00622700|26797182|FG001|Core Treatment Period|Death|0|||
13397925|NCT00622700|26797183|FG002|Core Treatment Period|Death|0|||
13397926|NCT00622700|26797184|FG003|Core Treatment Period|Death|0|||
13397927|NCT00622700|26797185|FG004|Core Treatment Period|Death|0|||
13397928|NCT00622700|26797186|FG005|Core Treatment Period|Death|0|||
13397929|NCT00622700|26797187|FG006|Core Treatment Period|Death|0|||
13397930|NCT00622700|26797181|FG000|Core Treatment Period|Progressive Disease|3|||
13397931|NCT00622700|26797182|FG001|Core Treatment Period|Progressive Disease|1|||
13397932|NCT00622700|26797183|FG002|Core Treatment Period|Progressive Disease|0|||
13397933|NCT00622700|26797184|FG003|Core Treatment Period|Progressive Disease|0|||
13397934|NCT00622700|26797185|FG004|Core Treatment Period|Progressive Disease|0|||
13397935|NCT00622700|26797186|FG005|Core Treatment Period|Progressive Disease|0|||
13397936|NCT00622700|26797187|FG006|Core Treatment Period|Progressive Disease|0|||
13397937|NCT00622700|26797181|FG000|Core Treatment Period|Withdrawal by Subject|12|||
13397938|NCT00622700|26797182|FG001|Core Treatment Period|Withdrawal by Subject|18|||
13397939|NCT00622700|26797183|FG002|Core Treatment Period|Withdrawal by Subject|15|||
13397940|NCT00622700|26797184|FG003|Core Treatment Period|Withdrawal by Subject|0|||
13397941|NCT00622700|26797185|FG004|Core Treatment Period|Withdrawal by Subject|0|||
13397942|NCT00622700|26797186|FG005|Core Treatment Period|Withdrawal by Subject|0|||
13397943|NCT00622700|26797187|FG006|Core Treatment Period|Withdrawal by Subject|0|||
13397944|NCT00622700|26797181|FG000|Core Treatment Period|Other than specified above|2|||
13397945|NCT00622700|26797182|FG001|Core Treatment Period|Other than specified above|2|||
13397946|NCT00622700|26797183|FG002|Core Treatment Period|Other than specified above|5|||
13397947|NCT00622700|26797184|FG003|Core Treatment Period|Other than specified above|0|||
13397948|NCT00622700|26797185|FG004|Core Treatment Period|Other than specified above|0|||
13397949|NCT00622700|26797186|FG005|Core Treatment Period|Other than specified above|0|||
13397950|NCT00622700|26797187|FG006|Core Treatment Period|Other than specified above|0|||
13397951|NCT00622700|26797181|FG000|Extension Treatment Period|Adverse Event|0|||
13397952|NCT00622700|26797182|FG001|Extension Treatment Period|Adverse Event|0|||
13397953|NCT00622700|26797183|FG002|Extension Treatment Period|Adverse Event|0|||
13397954|NCT00622700|26797184|FG003|Extension Treatment Period|Adverse Event|5|||
13397955|NCT00622700|26797185|FG004|Extension Treatment Period|Adverse Event|9|||
13397956|NCT00622700|26797186|FG005|Extension Treatment Period|Adverse Event|6|||
13397957|NCT00622700|26797187|FG006|Extension Treatment Period|Adverse Event|8|||
13397958|NCT00622700|26797181|FG000|Extension Treatment Period|Lack of Efficacy|0|||
13397959|NCT00622700|26797182|FG001|Extension Treatment Period|Lack of Efficacy|0|||
13397960|NCT00622700|26797183|FG002|Extension Treatment Period|Lack of Efficacy|0|||
13397961|NCT00622700|26797184|FG003|Extension Treatment Period|Lack of Efficacy|2|||
13397962|NCT00622700|26797185|FG004|Extension Treatment Period|Lack of Efficacy|8|||
13397963|NCT00622700|26797186|FG005|Extension Treatment Period|Lack of Efficacy|1|||
13397964|NCT00622700|26797187|FG006|Extension Treatment Period|Lack of Efficacy|9|||
13397965|NCT00622700|26797181|FG000|Extension Treatment Period|Protocol Violation|0|||
13397966|NCT00622700|26797182|FG001|Extension Treatment Period|Protocol Violation|0|||
13397967|NCT00622700|26797183|FG002|Extension Treatment Period|Protocol Violation|0|||
13397968|NCT00622700|26797184|FG003|Extension Treatment Period|Protocol Violation|0|||
13397969|NCT00622700|26797185|FG004|Extension Treatment Period|Protocol Violation|0|||
13397970|NCT00622700|26797186|FG005|Extension Treatment Period|Protocol Violation|2|||
13397971|NCT00622700|26797187|FG006|Extension Treatment Period|Protocol Violation|0|||
13397972|NCT00622700|26797181|FG000|Extension Treatment Period|Lost to Follow-up|0|||
13397973|NCT00622700|26797182|FG001|Extension Treatment Period|Lost to Follow-up|0|||
13397974|NCT00622700|26797183|FG002|Extension Treatment Period|Lost to Follow-up|0|||
13397975|NCT00622700|26797184|FG003|Extension Treatment Period|Lost to Follow-up|0|||
13397976|NCT00622700|26797185|FG004|Extension Treatment Period|Lost to Follow-up|1|||
13397977|NCT00622700|26797186|FG005|Extension Treatment Period|Lost to Follow-up|0|||
13397978|NCT00622700|26797187|FG006|Extension Treatment Period|Lost to Follow-up|0|||
13397979|NCT00622700|26797181|FG000|Extension Treatment Period|Progressive Disease|0|||
13397980|NCT00622700|26797182|FG001|Extension Treatment Period|Progressive Disease|0|||
13397981|NCT00622700|26797183|FG002|Extension Treatment Period|Progressive Disease|0|||
13397982|NCT00622700|26797184|FG003|Extension Treatment Period|Progressive Disease|1|||
13397983|NCT00622700|26797185|FG004|Extension Treatment Period|Progressive Disease|2|||
13397984|NCT00622700|26797186|FG005|Extension Treatment Period|Progressive Disease|0|||
13397985|NCT00622700|26797187|FG006|Extension Treatment Period|Progressive Disease|2|||
13397986|NCT00622700|26797181|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
13397987|NCT00622700|26797182|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
13397988|NCT00622700|26797183|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
13397989|NCT00622700|26797184|FG003|Extension Treatment Period|Withdrawal by Subject|11|||
13397990|NCT00622700|26797185|FG004|Extension Treatment Period|Withdrawal by Subject|16|||
13397991|NCT00622700|26797186|FG005|Extension Treatment Period|Withdrawal by Subject|6|||
13397992|NCT00622700|26797187|FG006|Extension Treatment Period|Withdrawal by Subject|10|||
13397993|NCT00622700|26797181|FG000|Extension Treatment Period|Missing|0|||
13397994|NCT00622700|26797182|FG001|Extension Treatment Period|Missing|0|||
13397995|NCT00622700|26797183|FG002|Extension Treatment Period|Missing|0|||
13397996|NCT00622700|26797184|FG003|Extension Treatment Period|Missing|2|||
13397997|NCT00622700|26797185|FG004|Extension Treatment Period|Missing|3|||
13397998|NCT00622700|26797186|FG005|Extension Treatment Period|Missing|1|||
13397999|NCT00622700|26797187|FG006|Extension Treatment Period|Missing|0|||
13398000|NCT00622700|26797181|FG000|Extension Treatment Period|Other than specified above|0|||
13398001|NCT00622700|26797182|FG001|Extension Treatment Period|Other than specified above|0|||
13398002|NCT00622700|26797183|FG002|Extension Treatment Period|Other than specified above|0|||
13398003|NCT00622700|26797184|FG003|Extension Treatment Period|Other than specified above|0|||
13398004|NCT00622700|26797185|FG004|Extension Treatment Period|Other than specified above|0|||
13398005|NCT00622700|26797186|FG005|Extension Treatment Period|Other than specified above|1|||
13398006|NCT00622700|26797187|FG006|Extension Treatment Period|Other than specified above|1|||
13398007|NCT00622635|26797259|FG000|Treatment Period 1|Adverse Event|0|||
13398008|NCT00622635|26797260|FG001|Treatment Period 1|Adverse Event|0|||
13398009|NCT00622635|26797261|FG002|Treatment Period 1|Adverse Event|1|||
13398010|NCT00622635|26797262|FG003|Treatment Period 1|Adverse Event|0|||
13398011|NCT00622635|26797263|FG004|Treatment Period 1|Adverse Event|0|||
13398012|NCT00622635|26797264|FG005|Treatment Period 1|Adverse Event|0|||
13398013|NCT00622635|26797259|FG000|Treatment Period 1|Withdrawal by Subject|0|||
13398014|NCT00622635|26797260|FG001|Treatment Period 1|Withdrawal by Subject|1|||
13398015|NCT00622635|26797261|FG002|Treatment Period 1|Withdrawal by Subject|0|||
13398016|NCT00622635|26797262|FG003|Treatment Period 1|Withdrawal by Subject|0|||
13398017|NCT00622635|26797263|FG004|Treatment Period 1|Withdrawal by Subject|0|||
13398018|NCT00622635|26797264|FG005|Treatment Period 1|Withdrawal by Subject|0|||
13398019|NCT00622635|26797259|FG000|Treatment Period 1|Abnormal test procedure result(s)|0|||
13398020|NCT00622635|26797260|FG001|Treatment Period 1|Abnormal test procedure result(s)|0|||
13398021|NCT00622635|26797261|FG002|Treatment Period 1|Abnormal test procedure result(s)|0|||
13398022|NCT00622635|26797262|FG003|Treatment Period 1|Abnormal test procedure result(s)|0|||
13398023|NCT00622635|26797263|FG004|Treatment Period 1|Abnormal test procedure result(s)|1|||
13398024|NCT00622635|26797264|FG005|Treatment Period 1|Abnormal test procedure result(s)|0|||
13398025|NCT00622635|26797259|FG000|Treatment Period 2|Adverse Event|1|||
13398026|NCT00622635|26797260|FG001|Treatment Period 2|Adverse Event|0|||
13398027|NCT00622635|26797261|FG002|Treatment Period 2|Adverse Event|0|||
13398028|NCT00622635|26797262|FG003|Treatment Period 2|Adverse Event|0|||
13398029|NCT00622635|26797263|FG004|Treatment Period 2|Adverse Event|0|||
13398030|NCT00622635|26797264|FG005|Treatment Period 2|Adverse Event|0|||
13398031|NCT00622635|26797259|FG000|Treatment Period 3|Adverse Event|0|||
13398032|NCT00622635|26797260|FG001|Treatment Period 3|Adverse Event|0|||
13398033|NCT00622635|26797261|FG002|Treatment Period 3|Adverse Event|0|||
13398034|NCT00622635|26797262|FG003|Treatment Period 3|Adverse Event|2|||
13398035|NCT00622635|26797263|FG004|Treatment Period 3|Adverse Event|0|||
13398036|NCT00622635|26797264|FG005|Treatment Period 3|Adverse Event|0|||
13398037|NCT00622635|26797259|FG000|Treatment Period 3|Withdrawal by Subject|0|||
13398038|NCT00622635|26797260|FG001|Treatment Period 3|Withdrawal by Subject|0|||
13398039|NCT00622635|26797261|FG002|Treatment Period 3|Withdrawal by Subject|0|||
13398040|NCT00622635|26797262|FG003|Treatment Period 3|Withdrawal by Subject|1|||
13398041|NCT00622635|26797263|FG004|Treatment Period 3|Withdrawal by Subject|0|||
13398042|NCT00622635|26797264|FG005|Treatment Period 3|Withdrawal by Subject|0|||
13398043|NCT00622505|26797295|FG000|Overall Study|Adverse Event|9|||
13398044|NCT00622505|26797296|FG001|Overall Study|Adverse Event|7|||
13398045|NCT00622505|26797295|FG000|Overall Study|Abnormal Laboratory Value(s)|3|||
13398046|NCT00622505|26797296|FG001|Overall Study|Abnormal Laboratory Value(s)|5|||
13398047|NCT00622505|26797295|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
13398048|NCT00622505|26797296|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
13398049|NCT00622505|26797295|FG000|Overall Study|Withdrawal by Subject|12|||
13398050|NCT00622505|26797296|FG001|Overall Study|Withdrawal by Subject|5|||
13398051|NCT00622505|26797295|FG000|Overall Study|Administrative Problems|2|||
13398052|NCT00622505|26797296|FG001|Overall Study|Administrative Problems|4|||
13398053|NCT00622505|26797295|FG000|Overall Study|Death|2|||
13398054|NCT00622505|26797296|FG001|Overall Study|Death|2|||
13398055|NCT00622466|26797309|FG000|Overall Study|Death|1|||
13398056|NCT00622466|26797309|FG000|Overall Study|Adverse Event|1|||
13398057|NCT00622466|26797309|FG000|Overall Study|Withdrawal by Subject|2|||
13398058|NCT00622440|26797328|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4|||
13398059|NCT00622440|26797329|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1|||
13398060|NCT00622440|26797328|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3|||
13398061|NCT00622440|26797329|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5|||
13398062|NCT00622440|26797328|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0|||
13398063|NCT00622440|26797329|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1|||
13398064|NCT00622440|26797328|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0|||
13398065|NCT00622440|26797329|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1|||
13398066|NCT00622401|26797346|FG000|Overall Study|Disease progression prior to treatment|3|||
13398067|NCT00622401|26797347|FG001|Overall Study|Disease progression prior to treatment|2|||
13398068|NCT00622401|26797348|FG002|Overall Study|Disease progression prior to treatment|0|||
13398069|NCT00622388|26797368|FG000|Overall Study|Disease Progression|47|||
13398070|NCT00622388|26797368|FG000|Overall Study|Adverse Event|6|||
13398071|NCT00622388|26797368|FG000|Overall Study|Protocol Violation|3|||
13398072|NCT00622388|26797368|FG000|Overall Study|Participant Refusal|1|||
13398073|NCT00622388|26797368|FG000|Overall Study|Death|3|||
13398074|NCT00622388|26797368|FG000|Overall Study|Received Alternate Anticancer Therapy|8|||
13398075|NCT00622388|26797368|FG000|Overall Study|Took Prohibited Medication|2|||
13398076|NCT00622388|26797368|FG000|Overall Study|Withdrew Consent|1|||
13398077|NCT00622388|26797368|FG000|Overall Study|Insurance Expired|1|||
13398078|NCT00622336|26797379|FG000|Treatment Phase|Progression of Disease|181|||
13398079|NCT00622336|26797379|FG000|Treatment Phase|Adverse Event|46|||
13398080|NCT00622336|26797379|FG000|Treatment Phase|Other|40|||
13398081|NCT00622336|26797379|FG000|Treatment Phase|Death|14|||
13398082|NCT00622336|26797379|FG000|Treatment Phase|Lack of therapeutic effect|13|||
13398083|NCT00622336|26797379|FG000|Treatment Phase|Withdrawal by Subject|13|||
13398084|NCT00622336|26797379|FG000|Treatment Phase|Lost to Follow-up|2|||
13398085|NCT00622336|26797379|FG000|Extension Phase|Adverse Event|2|||
13398086|NCT00622336|26797379|FG000|Extension Phase|Progressive Disease|6|||
13398087|NCT00622336|26797379|FG000|Extension Phase|Lack of therapeutic effect|2|||
13398088|NCT00622336|26797379|FG000|Extension Phase|Withdrawal by Subject|1|||
13398089|NCT00622336|26797379|FG000|Extension Phase|Lost to Follow-up|1|||
13398090|NCT00622336|26797379|FG000|Extension Phase|Other|9|||
13398091|NCT00622284|26797448|FG000|Overall Study|Lack of Efficacy|45|||
13398092|NCT00622284|26797449|FG001|Overall Study|Lack of Efficacy|15|||
13398093|NCT00622284|26797448|FG000|Overall Study|Adverse Event|61|||
13398094|NCT00622284|26797449|FG001|Overall Study|Adverse Event|90|||
13398095|NCT00622284|26797448|FG000|Overall Study|Protocol Violation|12|||
13398096|NCT00622284|26797449|FG001|Overall Study|Protocol Violation|5|||
13398097|NCT00622284|26797448|FG000|Overall Study|Lost to Follow-up|11|||
13398098|NCT00622284|26797449|FG001|Overall Study|Lost to Follow-up|13|||
13398099|NCT00622284|26797448|FG000|Overall Study|Withdrawal by Subject|27|||
13398100|NCT00622284|26797449|FG001|Overall Study|Withdrawal by Subject|24|||
13398101|NCT00622284|26797448|FG000|Overall Study|Other reason (not specified)|33|||
13398102|NCT00622284|26797449|FG001|Overall Study|Other reason (not specified)|24|||
13398103|NCT00622180|26797458|FG000|Overall Study|Lost to Follow-up|1|||
13398104|NCT00622180|26797459|FG001|Overall Study|Lost to Follow-up|2|||
13398105|NCT00622167|26797465|FG000|Overall Study|Did not meet angiographic criteria|20|||
13398106|NCT00621985|26797473|FG000|Dexamethasone Admission|Adverse Event|1|||
13398107|NCT00621959|26797488|FG000|Overall Study|Adverse Event|4|||
13398108|NCT00621959|26797489|FG001|Overall Study|Adverse Event|2|||
13398109|NCT00621959|26797488|FG000|Overall Study|Lack of Efficacy|1|||
13398110|NCT00621959|26797489|FG001|Overall Study|Lack of Efficacy|1|||
13398111|NCT00621959|26797488|FG000|Overall Study|Lost to Follow-up|0|||
13398112|NCT00621959|26797489|FG001|Overall Study|Lost to Follow-up|2|||
13398113|NCT00621959|26797488|FG000|Overall Study|Withdrawal by Subject|1|||
13398114|NCT00621959|26797489|FG001|Overall Study|Withdrawal by Subject|1|||
13398115|NCT00621959|26797488|FG000|Overall Study|Other|1|||
13398116|NCT00621959|26797489|FG001|Overall Study|Other|3|||
13398117|NCT00621855|26797547|FG000|Overall Study|Adverse Event|32|||
13398118|NCT00621855|26797548|FG001|Overall Study|Adverse Event|31|||
13398119|NCT00621855|26797549|FG002|Overall Study|Adverse Event|48|||
13398120|NCT00621855|26797550|FG003|Overall Study|Adverse Event|34|||
13398121|NCT00621855|26797551|FG004|Overall Study|Adverse Event|31|||
13398122|NCT00621855|26797547|FG000|Overall Study|Lost to Follow-up|0|||
13398123|NCT00621855|26797548|FG001|Overall Study|Lost to Follow-up|1|||
13398124|NCT00621855|26797549|FG002|Overall Study|Lost to Follow-up|3|||
13398125|NCT00621855|26797550|FG003|Overall Study|Lost to Follow-up|4|||
13398126|NCT00621855|26797551|FG004|Overall Study|Lost to Follow-up|1|||
13398127|NCT00621855|26797547|FG000|Overall Study|Protocol Violation|16|||
13398128|NCT00621855|26797548|FG001|Overall Study|Protocol Violation|8|||
13398129|NCT00621855|26797549|FG002|Overall Study|Protocol Violation|6|||
13398130|NCT00621855|26797550|FG003|Overall Study|Protocol Violation|7|||
13398131|NCT00621855|26797551|FG004|Overall Study|Protocol Violation|8|||
13398132|NCT00621855|26797547|FG000|Overall Study|Withdrawal by Subject|16|||
13398133|NCT00621855|26797548|FG001|Overall Study|Withdrawal by Subject|11|||
13398134|NCT00621855|26797549|FG002|Overall Study|Withdrawal by Subject|13|||
13398135|NCT00621855|26797550|FG003|Overall Study|Withdrawal by Subject|13|||
13398136|NCT00621855|26797551|FG004|Overall Study|Withdrawal by Subject|9|||
13398137|NCT00621855|26797547|FG000|Overall Study|Other|9|||
13398138|NCT00621855|26797548|FG001|Overall Study|Other|7|||
13398139|NCT00621855|26797549|FG002|Overall Study|Other|6|||
13398140|NCT00621855|26797550|FG003|Overall Study|Other|5|||
13398141|NCT00621855|26797551|FG004|Overall Study|Other|4|||
13398142|NCT00621855|26797547|FG000|Overall Study|Patients did not receive study drug|3|||
13398143|NCT00621855|26797548|FG001|Overall Study|Patients did not receive study drug|3|||
13398144|NCT00621855|26797549|FG002|Overall Study|Patients did not receive study drug|5|||
13398145|NCT00621855|26797550|FG003|Overall Study|Patients did not receive study drug|4|||
13398146|NCT00621855|26797551|FG004|Overall Study|Patients did not receive study drug|2|||
13398147|NCT00621842|26797568|FG000|Overall Study|Adverse Event|6|||
13398148|NCT00621842|26797568|FG000|Overall Study|Withdrawal by Subject|7|||
13398149|NCT00621842|26797568|FG000|Overall Study|Protocol Violation|4|||
13398150|NCT00621842|26797568|FG000|Overall Study|Lack of Efficacy|2|||
13398151|NCT00621777|26797586|FG000|Open Phase|Adverse Event|20|||
13398152|NCT00621777|26797587|FG001|Open Phase|Adverse Event|0|||
13398153|NCT00621777|26797586|FG000|Open Phase|Did not abstain during open phase|56|||
13398154|NCT00621777|26797587|FG001|Open Phase|Did not abstain during open phase|0|||
13398155|NCT00621777|26797586|FG000|Open Phase|Withdrawal by Subject|17|||
13398156|NCT00621777|26797587|FG001|Open Phase|Withdrawal by Subject|0|||
13398157|NCT00621777|26797586|FG000|Open Phase|administrative|13|||
13398158|NCT00621777|26797587|FG001|Open Phase|administrative|0|||
13398159|NCT00621777|26797586|FG000|Open Phase|Lost to Follow-up|10|||
13398160|NCT00621777|26797587|FG001|Open Phase|Lost to Follow-up|0|||
13398161|NCT00621777|26797586|FG000|Randomized Phase|Adverse Event|3|||
13398162|NCT00621777|26797587|FG001|Randomized Phase|Adverse Event|3|||
13398163|NCT00621777|26797586|FG000|Randomized Phase|Lost to Follow-up|3|||
13398164|NCT00621777|26797587|FG001|Randomized Phase|Lost to Follow-up|3|||
13398165|NCT00621777|26797586|FG000|Randomized Phase|Withdrawal by Subject|1|||
13398166|NCT00621777|26797587|FG001|Randomized Phase|Withdrawal by Subject|9|||
13398167|NCT00621777|26797586|FG000|Randomized Phase|administrative|0|||
13398168|NCT00621777|26797587|FG001|Randomized Phase|administrative|3|||
13398169|NCT00621777|26797586|FG000|Randomized Phase|Death|0|||
13398170|NCT00621777|26797587|FG001|Randomized Phase|Death|1|||
13398171|NCT00621764|26797630|FG000|Overall Study|Protocol Violation|0|||
13398172|NCT00621764|26797631|FG001|Overall Study|Protocol Violation|0|||
13398173|NCT00621764|26797632|FG002|Overall Study|Protocol Violation|0|||
13398174|NCT00621764|26797633|FG003|Overall Study|Protocol Violation|1|||
13398175|NCT00621751|26797658|FG000|Overall Study|Adverse Event|0|||
13398176|NCT00621751|26797659|FG001|Overall Study|Adverse Event|1|||
13398177|NCT00621621|26797676|FG000|Overall Study|Subjects were exited at EP study|30|||
13398178|NCT00621621|26797677|FG001|Overall Study|Subjects were exited at EP study|0|||
13398179|NCT00621582|26797686|FG000|Overall Study|Adverse Event|7|||
13398180|NCT00621582|26797686|FG000|Overall Study|Protocol Violation|57|||
13398181|NCT00621582|26797686|FG000|Overall Study|Lost to Follow-up|24|||
13398182|NCT00621582|26797686|FG000|Overall Study|issues not identified by investigators|18|||
13398183|NCT00621543|26797693|FG000|Overall Study|Lost to Follow-up|23|||
13398184|NCT00621517|26797710|FG000|Overall Study|Lost to Follow-up|3|||
13398185|NCT00621517|26797711|FG001|Overall Study|Lost to Follow-up|3|||
13398186|NCT00621517|26797710|FG000|Overall Study|Withdrawal by Subject|3|||
13398187|NCT00621517|26797711|FG001|Overall Study|Withdrawal by Subject|4|||
13398188|NCT00621517|26797710|FG000|Overall Study|Adverse Event|1|||
13398189|NCT00621517|26797711|FG001|Overall Study|Adverse Event|0|||
13398190|NCT00621504|26797724|FG000|Overall Study|Adverse Event|1|||
13398191|NCT00621504|26797725|FG001|Overall Study|Adverse Event|3|||
13398192|NCT00621504|26797724|FG000|Overall Study|At the request of sponsor/investigator|1|||
13398193|NCT00621504|26797725|FG001|Overall Study|At the request of sponsor/investigator|0|||
13398194|NCT00621504|26797724|FG000|Overall Study|Withdrew consent|9|||
13398195|NCT00621504|26797725|FG001|Overall Study|Withdrew consent|6|||
13398196|NCT00621504|26797724|FG000|Overall Study|Lost to Follow-up|8|||
13398197|NCT00621504|26797725|FG001|Overall Study|Lost to Follow-up|10|||
13398198|NCT00621504|26797724|FG000|Overall Study|Other|1|||
13398199|NCT00621504|26797725|FG001|Overall Study|Other|0|||
13398200|NCT00621504|26797724|FG000|Overall Study|Death|6|||
13398201|NCT00621504|26797725|FG001|Overall Study|Death|6|||
13398202|NCT00621322|26797824|FG000|Overall Study|Lost to Follow-up|0|||
13398203|NCT00621322|26797825|FG001|Overall Study|Lost to Follow-up|0|||
13398204|NCT00621322|26797826|FG002|Overall Study|Lost to Follow-up|0|||
13398205|NCT00621322|26797827|FG003|Overall Study|Lost to Follow-up|0|||
13398206|NCT00621322|26797828|FG004|Overall Study|Lost to Follow-up|1|||
13398207|NCT00621322|26797829|FG005|Overall Study|Lost to Follow-up|0|||
13398208|NCT00621322|26797824|FG000|Overall Study|Physician Decision|0|||
13398209|NCT00621322|26797825|FG001|Overall Study|Physician Decision|0|||
13398210|NCT00621322|26797826|FG002|Overall Study|Physician Decision|1|||
13398211|NCT00621322|26797827|FG003|Overall Study|Physician Decision|1|||
13398212|NCT00621322|26797828|FG004|Overall Study|Physician Decision|0|||
13398213|NCT00621322|26797829|FG005|Overall Study|Physician Decision|0|||
13398214|NCT00621322|26797824|FG000|Overall Study|Withdrawal by Subject|0|||
13398215|NCT00621322|26797825|FG001|Overall Study|Withdrawal by Subject|0|||
13398216|NCT00621322|26797826|FG002|Overall Study|Withdrawal by Subject|0|||
13398217|NCT00621322|26797827|FG003|Overall Study|Withdrawal by Subject|1|||
13398218|NCT00621322|26797828|FG004|Overall Study|Withdrawal by Subject|0|||
13398219|NCT00621322|26797829|FG005|Overall Study|Withdrawal by Subject|2|||
13398220|NCT00621322|26797824|FG000|Overall Study|Migrated/moved from study area|1|||
13398221|NCT00621322|26797825|FG001|Overall Study|Migrated/moved from study area|0|||
13398222|NCT00621322|26797826|FG002|Overall Study|Migrated/moved from study area|1|||
13398223|NCT00621322|26797827|FG003|Overall Study|Migrated/moved from study area|1|||
13398224|NCT00621322|26797828|FG004|Overall Study|Migrated/moved from study area|0|||
13398225|NCT00621322|26797829|FG005|Overall Study|Migrated/moved from study area|2|||
13398226|NCT00621309|26797842|FG000|Overall Study|Withdrawal by Subject|2|||
13398227|NCT00621309|26797843|FG001|Overall Study|Withdrawal by Subject|0|||
13398228|NCT00621309|26797844|FG002|Overall Study|Withdrawal by Subject|1|||
13398229|NCT00621309|26797845|FG003|Overall Study|Withdrawal by Subject|1|||
13398230|NCT00621309|26797846|FG004|Overall Study|Withdrawal by Subject|1|||
13398231|NCT00621309|26797847|FG005|Overall Study|Withdrawal by Subject|1|||
13398232|NCT00621296|26797853|FG000|Overall Study|Adverse Event|2|||
13398233|NCT00621296|26797853|FG000|Overall Study|Lack of Efficacy|1|||
13398234|NCT00621296|26797853|FG000|Overall Study|Physician Decision|7|||
13398235|NCT00621296|26797853|FG000|Overall Study|Unmatch Criteria|1|||
13398236|NCT00621296|26797853|FG000|Overall Study|Stopping Criteria|3|||
13398237|NCT00621257|26797881|FG000|Overall Study|Lost to Follow-up|4|||
13398238|NCT00621257|26797882|FG001|Overall Study|Lost to Follow-up|0|||
13398239|NCT00621257|26797883|FG002|Overall Study|Lost to Follow-up|2|||
13398240|NCT00621257|26797884|FG003|Overall Study|Lost to Follow-up|4|||
13398241|NCT00621257|26797885|FG004|Overall Study|Lost to Follow-up|7|||
13398242|NCT00621257|26797881|FG000|Overall Study|Adverse Event|0|||
13398243|NCT00621257|26797882|FG001|Overall Study|Adverse Event|1|||
13398244|NCT00621257|26797883|FG002|Overall Study|Adverse Event|1|||
13398245|NCT00621257|26797884|FG003|Overall Study|Adverse Event|0|||
13398246|NCT00621257|26797885|FG004|Overall Study|Adverse Event|0|||
13398247|NCT00621257|26797881|FG000|Overall Study|Physician Decision|0|||
13398248|NCT00621257|26797882|FG001|Overall Study|Physician Decision|2|||
13398249|NCT00621257|26797883|FG002|Overall Study|Physician Decision|0|||
13398250|NCT00621257|26797884|FG003|Overall Study|Physician Decision|1|||
13398251|NCT00621257|26797885|FG004|Overall Study|Physician Decision|1|||
13398252|NCT00621257|26797881|FG000|Overall Study|Withdrawal by Subject|0|||
13398253|NCT00621257|26797882|FG001|Overall Study|Withdrawal by Subject|0|||
13398254|NCT00621257|26797883|FG002|Overall Study|Withdrawal by Subject|0|||
13398255|NCT00621257|26797884|FG003|Overall Study|Withdrawal by Subject|1|||
13398256|NCT00621257|26797885|FG004|Overall Study|Withdrawal by Subject|1|||
13398257|NCT00621244|26797998|FG000|Overall Study|Withdrawal by Subject|7|||
13398258|NCT00621244|26797999|FG001|Overall Study|Withdrawal by Subject|3|||
13398259|NCT00621244|26798000|FG002|Overall Study|Withdrawal by Subject|3|||
13398260|NCT00621244|26798001|FG003|Overall Study|Withdrawal by Subject|3|||
13398261|NCT00621244|26797998|FG000|Overall Study|Disease progression|44|||
13398262|NCT00621244|26797999|FG001|Overall Study|Disease progression|20|||
13398263|NCT00621244|26798000|FG002|Overall Study|Disease progression|20|||
13398264|NCT00621244|26798001|FG003|Overall Study|Disease progression|15|||
13398265|NCT00621244|26797998|FG000|Overall Study|Death|3|||
13398266|NCT00621244|26797999|FG001|Overall Study|Death|3|||
13398267|NCT00621244|26798000|FG002|Overall Study|Death|1|||
13398268|NCT00621244|26798001|FG003|Overall Study|Death|1|||
13398269|NCT00621244|26797998|FG000|Overall Study|Adverse Event|27|||
13398270|NCT00621244|26797999|FG001|Overall Study|Adverse Event|7|||
13398271|NCT00621244|26798000|FG002|Overall Study|Adverse Event|9|||
13398272|NCT00621244|26798001|FG003|Overall Study|Adverse Event|2|||
13398273|NCT00621244|26797998|FG000|Overall Study|Administrative problems|5|||
13398274|NCT00621244|26797999|FG001|Overall Study|Administrative problems|1|||
13398275|NCT00621244|26798000|FG002|Overall Study|Administrative problems|0|||
13398276|NCT00621244|26798001|FG003|Overall Study|Administrative problems|2|||
13398277|NCT00621192|26798036|FG000|Overall Study|Withdrawal by Subject|0|||
13398278|NCT00621192|26798037|FG001|Overall Study|Withdrawal by Subject|0|||
13398279|NCT00621192|26798038|FG002|Overall Study|Withdrawal by Subject|2|||
13398280|NCT00621192|26798039|FG003|Overall Study|Withdrawal by Subject|0|||
13398281|NCT00621192|26798036|FG000|Overall Study|Physician Decision|1|||
13398282|NCT00621192|26798037|FG001|Overall Study|Physician Decision|3|||
13398283|NCT00621192|26798038|FG002|Overall Study|Physician Decision|0|||
13398284|NCT00621192|26798039|FG003|Overall Study|Physician Decision|0|||
13398285|NCT00621192|26798036|FG000|Overall Study|Protocol Violation|1|||
13398286|NCT00621192|26798037|FG001|Overall Study|Protocol Violation|0|||
13398287|NCT00621192|26798038|FG002|Overall Study|Protocol Violation|0|||
13398288|NCT00621192|26798039|FG003|Overall Study|Protocol Violation|1|||
13398289|NCT00621192|26798036|FG000|Overall Study|Adverse Event|0|||
13398290|NCT00621192|26798037|FG001|Overall Study|Adverse Event|1|||
13398291|NCT00621192|26798038|FG002|Overall Study|Adverse Event|0|||
13398292|NCT00621192|26798039|FG003|Overall Study|Adverse Event|1|||
13398293|NCT00621192|26798036|FG000|Overall Study|Death|2|||
13398294|NCT00621192|26798037|FG001|Overall Study|Death|5|||
13398295|NCT00621192|26798038|FG002|Overall Study|Death|0|||
13398296|NCT00621192|26798039|FG003|Overall Study|Death|0|||
13398297|NCT00621192|26798036|FG000|Overall Study|Final Assessments not Completed|0|||
13398298|NCT00621192|26798037|FG001|Overall Study|Final Assessments not Completed|0|||
13398299|NCT00621192|26798038|FG002|Overall Study|Final Assessments not Completed|3|||
13398300|NCT00621192|26798039|FG003|Overall Study|Final Assessments not Completed|1|||
13398301|NCT00621153|26798052|FG000|Overall Study|Safety Reason|8|||
13398302|NCT00621153|26798053|FG001|Overall Study|Safety Reason|7|||
13398303|NCT00621153|26798052|FG000|Overall Study|Adverse Event|3|||
13398304|NCT00621153|26798053|FG001|Overall Study|Adverse Event|2|||
13398305|NCT00621153|26798052|FG000|Overall Study|Lost to Follow-up|5|||
13398306|NCT00621153|26798053|FG001|Overall Study|Lost to Follow-up|1|||
13398307|NCT00621153|26798052|FG000|Overall Study|Withdrawal by Subject|4|||
13398308|NCT00621153|26798053|FG001|Overall Study|Withdrawal by Subject|5|||
13398309|NCT00621140|26798092|FG000|Overall Study|Adverse Event|4|||
13398310|NCT00621140|26798093|FG001|Overall Study|Adverse Event|5|||
13398311|NCT00621140|26798092|FG000|Overall Study|Lost to Follow-up|1|||
13398312|NCT00621140|26798093|FG001|Overall Study|Lost to Follow-up|2|||
13398313|NCT00621140|26798092|FG000|Overall Study|Withdrawal by Subject|4|||
13398314|NCT00621140|26798093|FG001|Overall Study|Withdrawal by Subject|6|||
13398315|NCT00621140|26798092|FG000|Overall Study|Other incl. lack of efficacy|6|||
13398316|NCT00621140|26798093|FG001|Overall Study|Other incl. lack of efficacy|5|||
13398317|NCT00621023|26798101|FG000|Overall Study|Death|5|||
13398318|NCT00621023|26798101|FG000|Overall Study|Follow up discontinued|1|||
13398319|NCT00620854|26798131|FG000|Washout 1|Withdrawal by Subject|0|||
13398320|NCT00620854|26798132|FG001|Washout 1|Withdrawal by Subject|0|||
13398321|NCT00620854|26798133|FG002|Washout 1|Withdrawal by Subject|1|||
13398322|NCT00620854|26798134|FG003|Washout 1|Withdrawal by Subject|1|||
13398323|NCT00620854|26798135|FG004|Washout 1|Withdrawal by Subject|0|||
13398324|NCT00620854|26798136|FG005|Washout 1|Withdrawal by Subject|0|||
13398325|NCT00620815|26798184|FG000|Overall Study|Adverse Event|1|||
13398326|NCT00620815|26798185|FG001|Overall Study|Adverse Event|1|||
13398327|NCT00620815|26798186|FG002|Overall Study|Adverse Event|2|||
13398328|NCT00620815|26798184|FG000|Overall Study|Withdrawal by Subject|1|||
13398329|NCT00620815|26798185|FG001|Overall Study|Withdrawal by Subject|2|||
13398330|NCT00620815|26798186|FG002|Overall Study|Withdrawal by Subject|0|||
13398331|NCT00620815|26798184|FG000|Overall Study|Lost to Follow-up|1|||
13398332|NCT00620815|26798185|FG001|Overall Study|Lost to Follow-up|6|||
13398333|NCT00620815|26798186|FG002|Overall Study|Lost to Follow-up|3|||
13398334|NCT00620815|26798184|FG000|Overall Study|Inappropriate enrolment|0|||
13398335|NCT00620815|26798185|FG001|Overall Study|Inappropriate enrolment|0|||
13398336|NCT00620815|26798186|FG002|Overall Study|Inappropriate enrolment|1|||
13398337|NCT00620815|26798184|FG000|Overall Study|Protocol Violation|1|||
13398338|NCT00620815|26798185|FG001|Overall Study|Protocol Violation|2|||
13398339|NCT00620815|26798186|FG002|Overall Study|Protocol Violation|1|||
13398340|NCT00620776|26798221|FG000|Overall Study|Did not receive treatment|3|||
13398341|NCT00620776|26798222|FG001|Overall Study|Did not receive treatment|5|||
13398342|NCT00620776|26798221|FG000|Overall Study|Adverse Event|2|||
13398343|NCT00620776|26798222|FG001|Overall Study|Adverse Event|3|||
13398344|NCT00620776|26798221|FG000|Overall Study|Lack of Efficacy|2|||
13398345|NCT00620776|26798222|FG001|Overall Study|Lack of Efficacy|1|||
13398346|NCT00620776|26798221|FG000|Overall Study|Lost to Follow-up|2|||
13398347|NCT00620776|26798222|FG001|Overall Study|Lost to Follow-up|5|||
13398348|NCT00620776|26798221|FG000|Overall Study|Withdrawal by Subject|3|||
13398349|NCT00620776|26798222|FG001|Overall Study|Withdrawal by Subject|2|||
13398350|NCT00620763|26798231|FG000|Period: First Intervention|Withdrawal by Subject|0|||
13398351|NCT00620763|26798232|FG001|Period: First Intervention|Withdrawal by Subject|2|||
13398352|NCT00620763|26798231|FG000|Period: First Intervention|Protocol Violation|0|||
13398353|NCT00620763|26798232|FG001|Period: First Intervention|Protocol Violation|3|||
13398354|NCT00620763|26798231|FG000|Period: Second Intervention|Withdrawal by Subject|1|||
13398355|NCT00620763|26798232|FG001|Period: Second Intervention|Withdrawal by Subject|0|||
13398356|NCT00620750|26798238|FG000|Overall Study|Lost to Follow-up|25|||
13398357|NCT00620659|26798263|FG000|Treatment Period 1|Adverse Event|1|||
13398358|NCT00620659|26798264|FG001|Treatment Period 1|Adverse Event|0|||
13398359|NCT00620659|26798265|FG002|Treatment Period 1|Adverse Event|0|||
13398360|NCT00620659|26798266|FG003|Treatment Period 1|Adverse Event|3|||
13398361|NCT00620659|26798267|FG004|Treatment Period 1|Adverse Event|0|||
13398362|NCT00620659|26798268|FG005|Treatment Period 1|Adverse Event|0|||
13398363|NCT00620659|26798263|FG000|Treatment Period 1|Protocol Violation|1|||
13398364|NCT00620659|26798264|FG001|Treatment Period 1|Protocol Violation|0|||
13398365|NCT00620659|26798265|FG002|Treatment Period 1|Protocol Violation|0|||
13398366|NCT00620659|26798266|FG003|Treatment Period 1|Protocol Violation|0|||
13398367|NCT00620659|26798267|FG004|Treatment Period 1|Protocol Violation|0|||
13398368|NCT00620659|26798268|FG005|Treatment Period 1|Protocol Violation|0|||
13398369|NCT00620659|26798263|FG000|Treatment Period 1|Withdrawal by Subject|1|||
13398370|NCT00620659|26798264|FG001|Treatment Period 1|Withdrawal by Subject|0|||
13398371|NCT00620659|26798265|FG002|Treatment Period 1|Withdrawal by Subject|1|||
13398372|NCT00620659|26798266|FG003|Treatment Period 1|Withdrawal by Subject|0|||
13398373|NCT00620659|26798267|FG004|Treatment Period 1|Withdrawal by Subject|1|||
13398374|NCT00620659|26798268|FG005|Treatment Period 1|Withdrawal by Subject|0|||
13398375|NCT00620659|26798263|FG000|Placebo Washout Period 1|Withdrawal by Subject|0|||
13398376|NCT00620659|26798264|FG001|Placebo Washout Period 1|Withdrawal by Subject|0|||
13398377|NCT00620659|26798265|FG002|Placebo Washout Period 1|Withdrawal by Subject|0|||
13398378|NCT00620659|26798266|FG003|Placebo Washout Period 1|Withdrawal by Subject|1|||
13398379|NCT00620659|26798267|FG004|Placebo Washout Period 1|Withdrawal by Subject|0|||
13398380|NCT00620659|26798268|FG005|Placebo Washout Period 1|Withdrawal by Subject|0|||
13398381|NCT00620659|26798263|FG000|Treatment Period 2|Adverse Event|0|||
13398382|NCT00620659|26798264|FG001|Treatment Period 2|Adverse Event|3|||
13398383|NCT00620659|26798265|FG002|Treatment Period 2|Adverse Event|0|||
13398384|NCT00620659|26798266|FG003|Treatment Period 2|Adverse Event|0|||
13398385|NCT00620659|26798267|FG004|Treatment Period 2|Adverse Event|2|||
13398386|NCT00620659|26798268|FG005|Treatment Period 2|Adverse Event|0|||
13398387|NCT00620659|26798263|FG000|Treatment Period 2|Withdrawal by Subject|0|||
13398388|NCT00620659|26798264|FG001|Treatment Period 2|Withdrawal by Subject|0|||
13398389|NCT00620659|26798265|FG002|Treatment Period 2|Withdrawal by Subject|1|||
13398390|NCT00620659|26798266|FG003|Treatment Period 2|Withdrawal by Subject|0|||
13398391|NCT00620659|26798267|FG004|Treatment Period 2|Withdrawal by Subject|3|||
13398392|NCT00620659|26798268|FG005|Treatment Period 2|Withdrawal by Subject|0|||
13398393|NCT00620659|26798263|FG000|Placebo Washout Period 2|Adverse Event|2|||
13398394|NCT00620659|26798264|FG001|Placebo Washout Period 2|Adverse Event|0|||
13398395|NCT00620659|26798265|FG002|Placebo Washout Period 2|Adverse Event|0|||
13398396|NCT00620659|26798266|FG003|Placebo Washout Period 2|Adverse Event|0|||
13398397|NCT00620659|26798267|FG004|Placebo Washout Period 2|Adverse Event|0|||
13398398|NCT00620659|26798268|FG005|Placebo Washout Period 2|Adverse Event|0|||
13398399|NCT00620659|26798263|FG000|Treatment Period 3|Adverse Event|0|||
13398400|NCT00620659|26798264|FG001|Treatment Period 3|Adverse Event|2|||
13398401|NCT00620659|26798265|FG002|Treatment Period 3|Adverse Event|0|||
13398402|NCT00620659|26798266|FG003|Treatment Period 3|Adverse Event|0|||
13398403|NCT00620659|26798267|FG004|Treatment Period 3|Adverse Event|0|||
13398404|NCT00620659|26798268|FG005|Treatment Period 3|Adverse Event|0|||
13398405|NCT00620659|26798263|FG000|Treatment Period 3|Withdrawal by Subject|0|||
13398406|NCT00620659|26798264|FG001|Treatment Period 3|Withdrawal by Subject|0|||
13398407|NCT00620659|26798265|FG002|Treatment Period 3|Withdrawal by Subject|0|||
13398408|NCT00620659|26798266|FG003|Treatment Period 3|Withdrawal by Subject|1|||
13398409|NCT00620659|26798267|FG004|Treatment Period 3|Withdrawal by Subject|0|||
13398410|NCT00620659|26798268|FG005|Treatment Period 3|Withdrawal by Subject|0|||
13398411|NCT00620555|26798277|FG000|Overall Study|Adverse Event|4|||
13398412|NCT00620555|26798277|FG000|Overall Study|Protocol Violation|2|||
13398413|NCT00620555|26798277|FG000|Overall Study|Lack of Efficacy|12|||
13398414|NCT00620555|26798277|FG000|Overall Study|Withdrawal by Subject|1|||
13398415|NCT00620555|26798277|FG000|Overall Study|Choice of other treatment|1|||
13398416|NCT00620555|26798277|FG000|Overall Study|Visit failure against planned|1|||
13398417|NCT00620542|26798324|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12|||
13398418|NCT00620542|26798325|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15|||
13398419|NCT00620542|26798326|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
13398420|NCT00620542|26798327|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
13398421|NCT00620542|26798324|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406|||
13398422|NCT00620542|26798325|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409|||
13398423|NCT00620542|26798326|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
13398424|NCT00620542|26798327|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
13398425|NCT00620542|26798324|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43|||
13398426|NCT00620542|26798325|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40|||
13398427|NCT00620542|26798326|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
13398428|NCT00620542|26798327|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
13398429|NCT00620542|26798324|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7|||
13398430|NCT00620542|26798325|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6|||
13398431|NCT00620542|26798326|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
13398432|NCT00620542|26798327|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
13398433|NCT00620542|26798324|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
13398434|NCT00620542|26798325|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1|||
13398435|NCT00620542|26798326|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
13398436|NCT00620542|26798327|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
13398437|NCT00620542|26798324|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
13398438|NCT00620542|26798325|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1|||
13398439|NCT00620542|26798326|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
13398440|NCT00620542|26798327|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
13398441|NCT00620542|26798324|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
13398442|NCT00620542|26798325|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
13398443|NCT00620542|26798326|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
13398444|NCT00620542|26798327|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
13398445|NCT00620542|26798324|FG000|Part B (2 Year Core Study)|Adverse Event|0|||
13398446|NCT00620542|26798325|FG001|Part B (2 Year Core Study)|Adverse Event|0|||
13398447|NCT00620542|26798326|FG002|Part B (2 Year Core Study)|Adverse Event|46|||
13398448|NCT00620542|26798327|FG003|Part B (2 Year Core Study)|Adverse Event|49|||
13398449|NCT00620542|26798324|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
13398450|NCT00620542|26798325|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
13398451|NCT00620542|26798326|FG002|Part B (2 Year Core Study)|Protocol Violation|3|||
13398452|NCT00620542|26798327|FG003|Part B (2 Year Core Study)|Protocol Violation|5|||
13398453|NCT00620542|26798324|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
13398454|NCT00620542|26798325|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
13398455|NCT00620542|26798326|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55|||
13398456|NCT00620542|26798327|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54|||
13398457|NCT00620542|26798324|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0|||
13398458|NCT00620542|26798325|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0|||
13398459|NCT00620542|26798326|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20|||
13398460|NCT00620542|26798327|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9|||
13398461|NCT00620542|26798324|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
13398462|NCT00620542|26798325|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
13398463|NCT00620542|26798326|FG002|Part B (2 Year Core Study)|Protocol Violation|13|||
13398464|NCT00620542|26798327|FG003|Part B (2 Year Core Study)|Protocol Violation|16|||
13398465|NCT00620542|26798324|FG000|Part B (2 Year Core Study)|Safety reasons|0|||
13398466|NCT00620542|26798325|FG001|Part B (2 Year Core Study)|Safety reasons|0|||
13398467|NCT00620542|26798326|FG002|Part B (2 Year Core Study)|Safety reasons|2|||
13398468|NCT00620542|26798327|FG003|Part B (2 Year Core Study)|Safety reasons|3|||
13398469|NCT00620542|26798324|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
13398470|NCT00620542|26798325|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
13398471|NCT00620542|26798326|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
13398472|NCT00620542|26798327|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
13398473|NCT00620542|26798324|FG000|Part B (2 Year Core Study)|IVUS not available|0|||
13398474|NCT00620542|26798325|FG001|Part B (2 Year Core Study)|IVUS not available|0|||
13398475|NCT00620542|26798326|FG002|Part B (2 Year Core Study)|IVUS not available|3|||
13398476|NCT00620542|26798327|FG003|Part B (2 Year Core Study)|IVUS not available|2|||
13398477|NCT00620373|26798345|FG000|Overall Study|Unverified cancer status|33|||
13398478|NCT00620321|26798368|FG000|Overall Study|Adverse Event|1|||
13398479|NCT00620321|26798369|FG001|Overall Study|Adverse Event|1|||
13398480|NCT00620321|26798368|FG000|Overall Study|Death|1|||
13398481|NCT00620321|26798369|FG001|Overall Study|Death|1|||
13398482|NCT00620321|26798368|FG000|Overall Study|Physician Decision|0|||
13398483|NCT00620321|26798369|FG001|Overall Study|Physician Decision|7|||
13398484|NCT00620321|26798368|FG000|Overall Study|Progressive Disease|5|||
13398485|NCT00620321|26798369|FG001|Overall Study|Progressive Disease|5|||
13398486|NCT00620321|26798368|FG000|Overall Study|Sponsor Decision|0|||
13398487|NCT00620321|26798369|FG001|Overall Study|Sponsor Decision|1|||
13398488|NCT00620321|26798368|FG000|Overall Study|Withdrawal by Subject|1|||
13398489|NCT00620321|26798369|FG001|Overall Study|Withdrawal by Subject|1|||
13398490|NCT00620282|26798426|FG000|Overall Study|Adverse Event|0|||
13398491|NCT00620282|26798427|FG001|Overall Study|Adverse Event|1|||
13398492|NCT00620282|26798428|FG002|Overall Study|Adverse Event|0|||
13398493|NCT00620282|26798426|FG000|Overall Study|Arterial line unable to be placed|0|||
13398494|NCT00620282|26798427|FG001|Overall Study|Arterial line unable to be placed|0|||
13398495|NCT00620282|26798428|FG002|Overall Study|Arterial line unable to be placed|1|||
13398496|NCT00620282|26798426|FG000|Overall Study|Withdrawal by Subject|0|||
13398497|NCT00620282|26798427|FG001|Overall Study|Withdrawal by Subject|1|||
13398498|NCT00620282|26798428|FG002|Overall Study|Withdrawal by Subject|0|||
13398499|NCT00620113|26798491|FG000|Overall Study|Adverse Event|3|||
13398500|NCT00620113|26798492|FG001|Overall Study|Adverse Event|2|||
13398501|NCT00620113|26798493|FG002|Overall Study|Adverse Event|2|||
13398502|NCT00620113|26798494|FG003|Overall Study|Adverse Event|1|||
13398503|NCT00620113|26798491|FG000|Overall Study|Lack of Efficacy|2|||
13398504|NCT00620113|26798492|FG001|Overall Study|Lack of Efficacy|3|||
13398505|NCT00620113|26798493|FG002|Overall Study|Lack of Efficacy|0|||
13398506|NCT00620113|26798494|FG003|Overall Study|Lack of Efficacy|2|||
13398507|NCT00620113|26798491|FG000|Overall Study|Physician Decision|1|||
13398508|NCT00620113|26798492|FG001|Overall Study|Physician Decision|0|||
13398509|NCT00620113|26798493|FG002|Overall Study|Physician Decision|0|||
13398510|NCT00620113|26798494|FG003|Overall Study|Physician Decision|2|||
13398511|NCT00620113|26798491|FG000|Overall Study|Protocol Violation|2|||
13398512|NCT00620113|26798492|FG001|Overall Study|Protocol Violation|1|||
13398513|NCT00620113|26798493|FG002|Overall Study|Protocol Violation|0|||
13398514|NCT00620113|26798494|FG003|Overall Study|Protocol Violation|0|||
13398515|NCT00620113|26798491|FG000|Overall Study|Withdrawal by Subject|5|||
13398516|NCT00620113|26798492|FG001|Overall Study|Withdrawal by Subject|1|||
13398517|NCT00620113|26798493|FG002|Overall Study|Withdrawal by Subject|3|||
13398518|NCT00620113|26798494|FG003|Overall Study|Withdrawal by Subject|5|||
13398519|NCT00620074|26798504|FG000|Overall Study|Adverse Event|1|||
13398520|NCT00620022|26798515|FG000|Treatment Period 1|Adverse Event|4|||
13398521|NCT00620022|26798516|FG001|Treatment Period 1|Adverse Event|6|||
13398522|NCT00620022|26798515|FG000|Treatment Period 1|Subject withdrew consent|1|||
13398523|NCT00620022|26798516|FG001|Treatment Period 1|Subject withdrew consent|0|||
13398524|NCT00620022|26798515|FG000|Treatment Period 2|Adverse Event|2|||
13398525|NCT00620022|26798516|FG001|Treatment Period 2|Adverse Event|2|||
13398526|NCT00619983|26798539|FG000|Test Drug Alone|Withdrawal by Subject|1|||
13398527|NCT00619983|26798540|FG001|Test Drug Alone|Withdrawal by Subject|0|||
13398528|NCT00619983|26798541|FG002|Test Drug Alone|Withdrawal by Subject|0|||
13398529|NCT00619983|26798542|FG003|Test Drug Alone|Withdrawal by Subject|1|||
13398530|NCT00619983|26798539|FG000|Test Drug Alone|Failure of daily diary device|1|||
13398531|NCT00619983|26798540|FG001|Test Drug Alone|Failure of daily diary device|1|||
13398532|NCT00619983|26798541|FG002|Test Drug Alone|Failure of daily diary device|2|||
13398533|NCT00619983|26798542|FG003|Test Drug Alone|Failure of daily diary device|2|||
13398534|NCT00619957|26798629|FG000|Month 24 Double-Blind|Adverse Event|9|||
13398535|NCT00619957|26798630|FG001|Month 24 Double-Blind|Adverse Event|7|||
13398536|NCT00619957|26798629|FG000|Month 24 Double-Blind|Protocol Violation|1|||
13398537|NCT00619957|26798630|FG001|Month 24 Double-Blind|Protocol Violation|0|||
13398538|NCT00619957|26798629|FG000|Month 24 Double-Blind|Withdrawal by Subject|7|||
13398539|NCT00619957|26798630|FG001|Month 24 Double-Blind|Withdrawal by Subject|9|||
13398540|NCT00619957|26798629|FG000|Month 24 Double-Blind|Lost to Follow-up|1|||
13398541|NCT00619957|26798630|FG001|Month 24 Double-Blind|Lost to Follow-up|0|||
13398542|NCT00619957|26798629|FG000|Month 24 Double-Blind|Did not take any study medication|0|||
13398543|NCT00619957|26798630|FG001|Month 24 Double-Blind|Did not take any study medication|1|||
13398544|NCT00619957|26798629|FG000|Month 48 Open-Label|Adverse Event|4|||
13398545|NCT00619957|26798630|FG001|Month 48 Open-Label|Adverse Event|4|||
13398546|NCT00619957|26798629|FG000|Month 48 Open-Label|Lost to Follow-up|2|||
13398547|NCT00619957|26798630|FG001|Month 48 Open-Label|Lost to Follow-up|4|||
13398548|NCT00619957|26798629|FG000|Month 48 Open-Label|Withdrawal by Subject|6|||
13398549|NCT00619957|26798630|FG001|Month 48 Open-Label|Withdrawal by Subject|9|||
13398550|NCT00619918|26798645|FG000|Overall Study|Withdrawal by Subject|4|||
13398551|NCT00619918|26798646|FG001|Overall Study|Withdrawal by Subject|3|||
13398552|NCT00619918|26798645|FG000|Overall Study|Physician Decision|8|||
13398553|NCT00619918|26798646|FG001|Overall Study|Physician Decision|8|||
13398554|NCT00619918|26798645|FG000|Overall Study|Transfer to outside facility|3|||
13398555|NCT00619918|26798646|FG001|Overall Study|Transfer to outside facility|3|||
13398556|NCT00619918|26798645|FG000|Overall Study|Left before receiving first dose|5|||
13398557|NCT00619918|26798646|FG001|Overall Study|Left before receiving first dose|8|||
13398558|NCT00619892|26798661|FG000|Overall Study|Adverse Event|3|||
13398559|NCT00619892|26798662|FG001|Overall Study|Adverse Event|0|||
13398560|NCT00619892|26798661|FG000|Overall Study|Lost to Follow-up|0|||
13398561|NCT00619892|26798662|FG001|Overall Study|Lost to Follow-up|1|||
13398562|NCT00619892|26798661|FG000|Overall Study|Intercurrent illness|0|||
13398563|NCT00619892|26798662|FG001|Overall Study|Intercurrent illness|1|||
13398564|NCT00619866|26798759|FG000|Weeks 1 - 12|Adverse Event|0|||
13398565|NCT00619866|26798760|FG001|Weeks 1 - 12|Adverse Event|1|||
13398566|NCT00619866|26798761|FG002|Weeks 1 - 12|Adverse Event|2|||
13398567|NCT00619866|26798762|FG003|Weeks 1 - 12|Adverse Event|0|||
13398568|NCT00619866|26798763|FG004|Weeks 1 - 12|Adverse Event|0|||
13398569|NCT00619866|26798759|FG000|Weeks 1 - 12|Non-compliance|0|||
13398570|NCT00619866|26798760|FG001|Weeks 1 - 12|Non-compliance|0|||
13398571|NCT00619866|26798761|FG002|Weeks 1 - 12|Non-compliance|1|||
13398572|NCT00619866|26798762|FG003|Weeks 1 - 12|Non-compliance|0|||
13398573|NCT00619866|26798763|FG004|Weeks 1 - 12|Non-compliance|0|||
13398574|NCT00619866|26798759|FG000|Weeks 1 - 12|Withdrawal by Subject|7|||
13398575|NCT00619866|26798760|FG001|Weeks 1 - 12|Withdrawal by Subject|2|||
13398576|NCT00619866|26798761|FG002|Weeks 1 - 12|Withdrawal by Subject|4|||
13398577|NCT00619866|26798762|FG003|Weeks 1 - 12|Withdrawal by Subject|0|||
13398578|NCT00619866|26798763|FG004|Weeks 1 - 12|Withdrawal by Subject|0|||
13398579|NCT00619866|26798759|FG000|Weeks 1 - 12|Lack of Efficacy|3|||
13398580|NCT00619866|26798760|FG001|Weeks 1 - 12|Lack of Efficacy|2|||
13398581|NCT00619866|26798761|FG002|Weeks 1 - 12|Lack of Efficacy|1|||
13398582|NCT00619866|26798762|FG003|Weeks 1 - 12|Lack of Efficacy|0|||
13398583|NCT00619866|26798763|FG004|Weeks 1 - 12|Lack of Efficacy|0|||
13398584|NCT00619866|26798759|FG000|Weeks 1 - 12|Lost to Follow-up|4|||
13398585|NCT00619866|26798760|FG001|Weeks 1 - 12|Lost to Follow-up|0|||
13398586|NCT00619866|26798761|FG002|Weeks 1 - 12|Lost to Follow-up|2|||
13398587|NCT00619866|26798762|FG003|Weeks 1 - 12|Lost to Follow-up|0|||
13398588|NCT00619866|26798763|FG004|Weeks 1 - 12|Lost to Follow-up|0|||
13398589|NCT00619866|26798759|FG000|Weeks 1 - 12|Sponsor Decision|0|||
13398590|NCT00619866|26798760|FG001|Weeks 1 - 12|Sponsor Decision|1|||
13398591|NCT00619866|26798761|FG002|Weeks 1 - 12|Sponsor Decision|0|||
13398592|NCT00619866|26798762|FG003|Weeks 1 - 12|Sponsor Decision|0|||
13398593|NCT00619866|26798763|FG004|Weeks 1 - 12|Sponsor Decision|0|||
13398594|NCT00619866|26798759|FG000|Weeks 13 - 24|Adverse Event|0|||
13398595|NCT00619866|26798760|FG001|Weeks 13 - 24|Adverse Event|0|||
13398596|NCT00619866|26798761|FG002|Weeks 13 - 24|Adverse Event|2|||
13398597|NCT00619866|26798762|FG003|Weeks 13 - 24|Adverse Event|1|||
13398598|NCT00619866|26798763|FG004|Weeks 13 - 24|Adverse Event|0|||
13398599|NCT00619866|26798759|FG000|Weeks 13 - 24|Protocol Deviation|0|||
13398600|NCT00619866|26798760|FG001|Weeks 13 - 24|Protocol Deviation|0|||
13398601|NCT00619866|26798761|FG002|Weeks 13 - 24|Protocol Deviation|0|||
13398602|NCT00619866|26798762|FG003|Weeks 13 - 24|Protocol Deviation|1|||
13398603|NCT00619866|26798763|FG004|Weeks 13 - 24|Protocol Deviation|0|||
13398604|NCT00619866|26798759|FG000|Weeks 13 - 24|Withdrawal by Subject|0|||
13398605|NCT00619866|26798760|FG001|Weeks 13 - 24|Withdrawal by Subject|3|||
13398606|NCT00619866|26798761|FG002|Weeks 13 - 24|Withdrawal by Subject|2|||
13398607|NCT00619866|26798762|FG003|Weeks 13 - 24|Withdrawal by Subject|2|||
13398608|NCT00619866|26798763|FG004|Weeks 13 - 24|Withdrawal by Subject|2|||
13398609|NCT00619866|26798759|FG000|Weeks 13 - 24|Non-compliance|0|||
13398610|NCT00619866|26798760|FG001|Weeks 13 - 24|Non-compliance|1|||
13398611|NCT00619866|26798761|FG002|Weeks 13 - 24|Non-compliance|1|||
13398612|NCT00619866|26798762|FG003|Weeks 13 - 24|Non-compliance|0|||
13398613|NCT00619866|26798763|FG004|Weeks 13 - 24|Non-compliance|0|||
13398614|NCT00619866|26798759|FG000|Weeks 13 - 24|Lost to Follow-up|0|||
13398615|NCT00619866|26798760|FG001|Weeks 13 - 24|Lost to Follow-up|3|||
13398616|NCT00619866|26798761|FG002|Weeks 13 - 24|Lost to Follow-up|0|||
13398617|NCT00619866|26798762|FG003|Weeks 13 - 24|Lost to Follow-up|0|||
13398618|NCT00619866|26798763|FG004|Weeks 13 - 24|Lost to Follow-up|0|||
13398619|NCT00619827|26798776|FG000|Overall Study|Adverse Event|1|||
13398620|NCT00619827|26798777|FG001|Overall Study|Adverse Event|2|||
13398621|NCT00619827|26798776|FG000|Overall Study|Withdrawal by Subject|2|||
13398622|NCT00619827|26798777|FG001|Overall Study|Withdrawal by Subject|2|||
13398623|NCT00619801|26798814|FG000|Overall Study|Lack of Efficacy|0|||
13398624|NCT00619801|26798815|FG001|Overall Study|Lack of Efficacy|1|||
13398625|NCT00619801|26798814|FG000|Overall Study|Withdrawal by Subject|1|||
13398626|NCT00619801|26798815|FG001|Overall Study|Withdrawal by Subject|1|||
13398627|NCT00619801|26798814|FG000|Overall Study|Loss of efficacy|0|||
13398628|NCT00619801|26798815|FG001|Overall Study|Loss of efficacy|1|||
13398629|NCT00619645|26798823|FG000|Overall Study|Adverse Event|1|||
13398630|NCT00619619|26798933|FG000|Overall Study|Physician Decision|0|||
13398631|NCT00619619|26798934|FG001|Overall Study|Physician Decision|0|||
13398632|NCT00619619|26798935|FG002|Overall Study|Physician Decision|1|||
13398633|NCT00619619|26798936|FG003|Overall Study|Physician Decision|0|||
13398634|NCT00619619|26798937|FG004|Overall Study|Physician Decision|0|||
13398635|NCT00619619|26798938|FG005|Overall Study|Physician Decision|0|||
13398636|NCT00619619|26798939|FG006|Overall Study|Physician Decision|0|||
13398637|NCT00619619|26798940|FG007|Overall Study|Physician Decision|0|||
13398638|NCT00619619|26798933|FG000|Overall Study|Protocol Violation|0|||
13398639|NCT00619619|26798934|FG001|Overall Study|Protocol Violation|0|||
13398640|NCT00619619|26798935|FG002|Overall Study|Protocol Violation|0|||
13398641|NCT00619619|26798936|FG003|Overall Study|Protocol Violation|1|||
13398642|NCT00619619|26798937|FG004|Overall Study|Protocol Violation|0|||
13398643|NCT00619619|26798938|FG005|Overall Study|Protocol Violation|0|||
13398644|NCT00619619|26798939|FG006|Overall Study|Protocol Violation|1|||
13398645|NCT00619619|26798940|FG007|Overall Study|Protocol Violation|1|||
13398646|NCT00619619|26798933|FG000|Overall Study|Adverse Event|0|||
13398647|NCT00619619|26798934|FG001|Overall Study|Adverse Event|0|||
13398648|NCT00619619|26798935|FG002|Overall Study|Adverse Event|0|||
13398649|NCT00619619|26798936|FG003|Overall Study|Adverse Event|0|||
13398650|NCT00619619|26798937|FG004|Overall Study|Adverse Event|2|||
13398651|NCT00619619|26798938|FG005|Overall Study|Adverse Event|0|||
13398652|NCT00619619|26798939|FG006|Overall Study|Adverse Event|0|||
13398653|NCT00619619|26798940|FG007|Overall Study|Adverse Event|2|||
13398654|NCT00619515|26798954|FG000|Overall Study|Study Termination by IRB|73|||
13398655|NCT00619502|26798971|FG000|Overall Study|Lost to Follow-up|8|||
13398656|NCT00619502|26798972|FG001|Overall Study|Lost to Follow-up|10|||
13398657|NCT00619489|26798997|FG000|Overall Study|Adverse Event|0|||
13398658|NCT00619489|26798998|FG001|Overall Study|Adverse Event|7|||
13398659|NCT00619489|26798997|FG000|Overall Study|Withdrawal by Subject|1|||
13398660|NCT00619489|26798998|FG001|Overall Study|Withdrawal by Subject|1|||
13398661|NCT00619489|26798997|FG000|Overall Study|Lack of Efficacy|0|||
13398662|NCT00619489|26798998|FG001|Overall Study|Lack of Efficacy|11|||
13398663|NCT00619489|26798997|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22|||
13398664|NCT00619489|26798998|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15|||
13398665|NCT00619476|26799093|FG000|Overall Study|Adverse Event|12|||
13398666|NCT00619476|26799094|FG001|Overall Study|Adverse Event|6|||
13398667|NCT00619476|26799095|FG002|Overall Study|Adverse Event|12|||
13398668|NCT00619476|26799096|FG003|Overall Study|Adverse Event|16|||
13398669|NCT00619476|26799093|FG000|Overall Study|Lack of Efficacy|6|||
13398670|NCT00619476|26799094|FG001|Overall Study|Lack of Efficacy|1|||
13398671|NCT00619476|26799095|FG002|Overall Study|Lack of Efficacy|1|||
13398672|NCT00619476|26799096|FG003|Overall Study|Lack of Efficacy|4|||
13398673|NCT00619476|26799093|FG000|Overall Study|Protocol Violation|5|||
13398674|NCT00619476|26799094|FG001|Overall Study|Protocol Violation|4|||
13398675|NCT00619476|26799095|FG002|Overall Study|Protocol Violation|4|||
13398676|NCT00619476|26799096|FG003|Overall Study|Protocol Violation|9|||
13398677|NCT00619476|26799093|FG000|Overall Study|Lost to Follow-up|1|||
13398678|NCT00619476|26799094|FG001|Overall Study|Lost to Follow-up|2|||
13398679|NCT00619476|26799095|FG002|Overall Study|Lost to Follow-up|0|||
13398680|NCT00619476|26799096|FG003|Overall Study|Lost to Follow-up|1|||
13398681|NCT00619476|26799093|FG000|Overall Study|Investigator Discretion|2|||
13398682|NCT00619476|26799094|FG001|Overall Study|Investigator Discretion|2|||
13398683|NCT00619476|26799095|FG002|Overall Study|Investigator Discretion|2|||
13398684|NCT00619476|26799096|FG003|Overall Study|Investigator Discretion|0|||
13398685|NCT00619476|26799093|FG000|Overall Study|Withdrawal by Subject|5|||
13398686|NCT00619476|26799094|FG001|Overall Study|Withdrawal by Subject|7|||
13398687|NCT00619476|26799095|FG002|Overall Study|Withdrawal by Subject|5|||
13398688|NCT00619476|26799096|FG003|Overall Study|Withdrawal by Subject|4|||
13398689|NCT00619385|26799119|FG000|Overall Study|Adverse Event|0|||
13398690|NCT00619385|26799120|FG001|Overall Study|Adverse Event|0|||
13398691|NCT00619385|26799121|FG002|Overall Study|Adverse Event|3|||
13398692|NCT00619385|26799119|FG000|Overall Study|Other|1|||
13398693|NCT00619385|26799120|FG001|Overall Study|Other|2|||
13398694|NCT00619385|26799121|FG002|Overall Study|Other|1|||
13398695|NCT00619359|26799138|FG000|Overall Study|Adverse Event|32|||
13398696|NCT00619359|26799139|FG001|Overall Study|Adverse Event|36|||
13398697|NCT00619359|26799138|FG000|Overall Study|Lost to Follow-up|12|||
13398698|NCT00619359|26799139|FG001|Overall Study|Lost to Follow-up|16|||
13398699|NCT00619359|26799138|FG000|Overall Study|Physician Decision|0|||
13398700|NCT00619359|26799139|FG001|Overall Study|Physician Decision|7|||
13398701|NCT00619359|26799138|FG000|Overall Study|Protocol Violation|1|||
13398702|NCT00619359|26799139|FG001|Overall Study|Protocol Violation|1|||
13398703|NCT00619359|26799138|FG000|Overall Study|Withdrawal by Subject|19|||
13398704|NCT00619359|26799139|FG001|Overall Study|Withdrawal by Subject|20|||
13398705|NCT00619359|26799138|FG000|Overall Study|Progressive Disease|3|||
13398706|NCT00619359|26799139|FG001|Overall Study|Progressive Disease|1|||
13398707|NCT00619307|26799160|FG000|Overall Study|Adverse Event|0|||
13398708|NCT00619307|26799161|FG001|Overall Study|Adverse Event|1|||
13398709|NCT00619307|26799160|FG000|Overall Study|Lost to Follow-up|0|||
13398710|NCT00619307|26799161|FG001|Overall Study|Lost to Follow-up|1|||
13398711|NCT00619307|26799160|FG000|Overall Study|Protocol Violation|3|||
13398712|NCT00619307|26799161|FG001|Overall Study|Protocol Violation|0|||
13398713|NCT00619307|26799160|FG000|Overall Study|Withdrew consent|1|||
13398714|NCT00619307|26799161|FG001|Overall Study|Withdrew consent|0|||
13398715|NCT00619307|26799160|FG000|Overall Study|Severe migraine|0|||
13398716|NCT00619307|26799161|FG001|Overall Study|Severe migraine|1|||
13398717|NCT00619307|26799160|FG000|Overall Study|MS attack plus steroids|0|||
13398718|NCT00619307|26799161|FG001|Overall Study|MS attack plus steroids|1|||
13398719|NCT00619229|26799194|FG000|Overall Study|Withdrawal by Subject|1|||
13398720|NCT00619229|26799195|FG001|Overall Study|Withdrawal by Subject|1|||
13398721|NCT00619229|26799194|FG000|Overall Study|Lost to Follow-up|1|||
13398722|NCT00619229|26799195|FG001|Overall Study|Lost to Follow-up|0|||
13398723|NCT00619229|26799194|FG000|Overall Study|Termination of the Study by the Sponsor|1|||
13398724|NCT00619229|26799195|FG001|Overall Study|Termination of the Study by the Sponsor|1|||
13398725|NCT00619229|26799194|FG000|Overall Study|Investigator planned Cataract Operation|1|||
13398726|NCT00619229|26799195|FG001|Overall Study|Investigator planned Cataract Operation|0|||
13398727|NCT00619177|26799205|FG000|Overall Study|Adverse Event|18|||
13398728|NCT00619177|26799205|FG000|Overall Study|Lost to Follow-up|2|||
13398729|NCT00619177|26799205|FG000|Overall Study|Lack of Efficacy|1|||
13398730|NCT00619177|26799205|FG000|Overall Study|Missing termination information|481|||
13398731|NCT00619177|26799205|FG000|Overall Study|Not specified reasons|6|||
13398732|NCT00619151|26799220|FG000|Overall Study|Study terminated prior to followup|1|||
13398733|NCT00619151|26799221|FG001|Overall Study|Study terminated prior to followup|0|||
13398734|NCT00619112|26799247|FG000|Overall Study|Adverse Event|1|||
13398735|NCT00619112|26799248|FG001|Overall Study|Adverse Event|2|||
13398736|NCT00619099|26799261|FG000|Overall Study|Progressive Disease|7|||
13398737|NCT00619099|26799262|FG001|Overall Study|Progressive Disease|5|||
13398738|NCT00619099|26799261|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2|||
13398739|NCT00619099|26799262|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1|||
13398740|NCT00619099|26799261|FG000|Overall Study|Adverse Event|4|||
13398741|NCT00619099|26799262|FG001|Overall Study|Adverse Event|3|||
13398742|NCT00619099|26799261|FG000|Overall Study|Emergence of Clinically Significant Lab|1|||
13398743|NCT00619099|26799262|FG001|Overall Study|Emergence of Clinically Significant Lab|2|||
13398744|NCT00619099|26799261|FG000|Overall Study|Withdrawal by Subject|10|||
13398745|NCT00619099|26799262|FG001|Overall Study|Withdrawal by Subject|2|||
13398746|NCT00619099|26799261|FG000|Overall Study|Physician Decision|9|||
13398747|NCT00619099|26799262|FG001|Overall Study|Physician Decision|6|||
13398748|NCT00618995|26799281|FG000|Period 1|Adverse Event|0|||
13398749|NCT00618995|26799282|FG001|Period 1|Adverse Event|0|||
13398750|NCT00618995|26799283|FG002|Period 1|Adverse Event|1|||
13398751|NCT00618995|26799284|FG003|Period 1|Adverse Event|0|||
13398752|NCT00618995|26799281|FG000|Period 1|Protocol Violation|0|||
13398753|NCT00618995|26799282|FG001|Period 1|Protocol Violation|1|||
13398754|NCT00618995|26799283|FG002|Period 1|Protocol Violation|1|||
13398755|NCT00618995|26799284|FG003|Period 1|Protocol Violation|0|||
13398756|NCT00618995|26799281|FG000|Period 2|Protocol Violation|0|||
13398757|NCT00618995|26799282|FG001|Period 2|Protocol Violation|0|||
13398758|NCT00618995|26799283|FG002|Period 2|Protocol Violation|1|||
13398759|NCT00618995|26799284|FG003|Period 2|Protocol Violation|0|||
13398760|NCT00618995|26799281|FG000|Period 4|Adverse Event|1|||
13398761|NCT00618995|26799282|FG001|Period 4|Adverse Event|0|||
13398762|NCT00618995|26799283|FG002|Period 4|Adverse Event|0|||
13398763|NCT00618995|26799284|FG003|Period 4|Adverse Event|0|||
13398764|NCT00618982|26799307|FG000|Overall Study|Adverse Event|23|||
13398765|NCT00618982|26799307|FG000|Overall Study|Withdrawal by Subject|1|||
13398766|NCT00618982|26799307|FG000|Overall Study|Protocol Violation|1|||
13398767|NCT00618982|26799307|FG000|Overall Study|ongoing, still treated with study med.|25|||
13398768|NCT00618956|26799330|FG000|Overall Study|Adverse Event|10|||
13398769|NCT00618956|26799331|FG001|Overall Study|Adverse Event|34|||
13398770|NCT00618956|26799330|FG000|Overall Study|Lack of Efficacy|2|||
13398771|NCT00618956|26799331|FG001|Overall Study|Lack of Efficacy|1|||
13398772|NCT00618956|26799330|FG000|Overall Study|Withdrawal by Subject|5|||
13398773|NCT00618956|26799331|FG001|Overall Study|Withdrawal by Subject|7|||
13398774|NCT00618956|26799330|FG000|Overall Study|Lost to Follow-up|4|||
13398775|NCT00618956|26799331|FG001|Overall Study|Lost to Follow-up|5|||
13398776|NCT00618956|26799330|FG000|Overall Study|Protocol Violation|2|||
13398777|NCT00618956|26799331|FG001|Overall Study|Protocol Violation|2|||
13398778|NCT00618956|26799330|FG000|Overall Study|did not meet criteria, non-compliance|2|||
13398779|NCT00618956|26799331|FG001|Overall Study|did not meet criteria, non-compliance|1|||
13398780|NCT00618826|26799338|FG000|Overall Study|Adverse Event|1|||
13398781|NCT00618813|26799348|FG000|Overall Study|Lack of Efficacy|1|||
13398782|NCT00618813|26799348|FG000|Overall Study|Physician Decision|2|||
13398783|NCT00618813|26799348|FG000|Overall Study|Withdrawal by Subject|1|||
13398784|NCT00618787|26799361|FG000|Overall Study|Adverse Event|0|||
13398785|NCT00618787|26799362|FG001|Overall Study|Adverse Event|1|||
13398786|NCT00618787|26799361|FG000|Overall Study|Withdrawal by Subject|2|||
13398787|NCT00618787|26799362|FG001|Overall Study|Withdrawal by Subject|1|||
13398788|NCT00618787|26799361|FG000|Overall Study|Lost to Follow-up|1|||
13398789|NCT00618787|26799362|FG001|Overall Study|Lost to Follow-up|0|||
13398790|NCT00618774|26799399|FG000|Overall Study|Adverse Event|5|||
13398791|NCT00618774|26799400|FG001|Overall Study|Adverse Event|3|||
13398792|NCT00618774|26799399|FG000|Overall Study|Withdrawal by Subject|1|||
13398793|NCT00618774|26799400|FG001|Overall Study|Withdrawal by Subject|0|||
13398794|NCT00618748|26799451|FG000|Overall Study|Adverse Event|4|||
13398795|NCT00618748|26799452|FG001|Overall Study|Adverse Event|3|||
13398796|NCT00618748|26799453|FG002|Overall Study|Adverse Event|8|||
13398797|NCT00618748|26799451|FG000|Overall Study|Physician Decision|3|||
13398798|NCT00618748|26799452|FG001|Overall Study|Physician Decision|1|||
13398799|NCT00618748|26799453|FG002|Overall Study|Physician Decision|1|||
13398800|NCT00618748|26799451|FG000|Overall Study|Withdrawal by Subject|4|||
13398801|NCT00618748|26799452|FG001|Overall Study|Withdrawal by Subject|1|||
13398802|NCT00618748|26799453|FG002|Overall Study|Withdrawal by Subject|5|||
13398803|NCT00618722|26799500|FG000|Overall Study|Refusal of Treatment|0|||
13398804|NCT00618722|26799501|FG001|Overall Study|Refusal of Treatment|0|||
13398805|NCT00618722|26799502|FG002|Overall Study|Refusal of Treatment|1|||
13398806|NCT00618722|26799503|FG003|Overall Study|Refusal of Treatment|0|||
13398807|NCT00618722|26799500|FG000|Overall Study|Patient Request|1|||
13398808|NCT00618722|26799501|FG001|Overall Study|Patient Request|1|||
13398809|NCT00618722|26799502|FG002|Overall Study|Patient Request|1|||
13398810|NCT00618722|26799503|FG003|Overall Study|Patient Request|1|||
13398811|NCT00618722|26799500|FG000|Overall Study|Inability to Complete Study Procedure|0|||
13398812|NCT00618722|26799501|FG001|Overall Study|Inability to Complete Study Procedure|1|||
13398813|NCT00618722|26799502|FG002|Overall Study|Inability to Complete Study Procedure|0|||
13398814|NCT00618722|26799503|FG003|Overall Study|Inability to Complete Study Procedure|0|||
13398815|NCT00618722|26799500|FG000|Overall Study|Lost to Follow-up|2|||
13398816|NCT00618722|26799501|FG001|Overall Study|Lost to Follow-up|0|||
13398817|NCT00618722|26799502|FG002|Overall Study|Lost to Follow-up|0|||
13398818|NCT00618722|26799503|FG003|Overall Study|Lost to Follow-up|2|||
13398819|NCT00618722|26799500|FG000|Overall Study|Miscellaneous Reasons|0|||
13398820|NCT00618722|26799501|FG001|Overall Study|Miscellaneous Reasons|0|||
13398821|NCT00618722|26799502|FG002|Overall Study|Miscellaneous Reasons|1|||
13398822|NCT00618722|26799503|FG003|Overall Study|Miscellaneous Reasons|1|||
13398823|NCT00618618|26799562|FG000|Overall Study|Patient Request|0|||
13398824|NCT00618618|26799563|FG001|Overall Study|Patient Request|0|||
13398825|NCT00618618|26799564|FG002|Overall Study|Patient Request|2|||
13398826|NCT00618618|26799565|FG003|Overall Study|Patient Request|0|||
13398827|NCT00618618|26799562|FG000|Overall Study|Inability to Complete Study Procedures|0|||
13398828|NCT00618618|26799563|FG001|Overall Study|Inability to Complete Study Procedures|1|||
13398829|NCT00618618|26799564|FG002|Overall Study|Inability to Complete Study Procedures|0|||
13398830|NCT00618618|26799565|FG003|Overall Study|Inability to Complete Study Procedures|0|||
13398831|NCT00618618|26799562|FG000|Overall Study|Lost to Follow-up|3|||
13398832|NCT00618618|26799563|FG001|Overall Study|Lost to Follow-up|0|||
13398833|NCT00618618|26799564|FG002|Overall Study|Lost to Follow-up|0|||
13398834|NCT00618618|26799565|FG003|Overall Study|Lost to Follow-up|1|||
13398835|NCT00618618|26799562|FG000|Overall Study|Non-compliance|1|||
13398836|NCT00618618|26799563|FG001|Overall Study|Non-compliance|1|||
13398837|NCT00618618|26799564|FG002|Overall Study|Non-compliance|0|||
13398838|NCT00618618|26799565|FG003|Overall Study|Non-compliance|0|||
13398839|NCT00618618|26799562|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
13398840|NCT00618618|26799563|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
13398841|NCT00618618|26799564|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
13398842|NCT00618618|26799565|FG003|Overall Study|Did Not Meet Entry Criteria|0|||
13398843|NCT00618618|26799562|FG000|Overall Study|Death|0|||
13398844|NCT00618618|26799563|FG001|Overall Study|Death|1|||
13398845|NCT00618618|26799564|FG002|Overall Study|Death|0|||
13398846|NCT00618618|26799565|FG003|Overall Study|Death|0|||
13398847|NCT00618514|26799591|FG000|Overall Study|Lost to Follow-up|11|||
13398848|NCT00618514|26799592|FG001|Overall Study|Lost to Follow-up|12|||
13398849|NCT00618514|26799593|FG002|Overall Study|Lost to Follow-up|4|||
13398850|NCT00618449|26799606|FG000|Overall Study|Lost to Follow-up|98|||
13398851|NCT00618449|26799607|FG001|Overall Study|Lost to Follow-up|110|||
13398852|NCT00618410|26799626|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
13398853|NCT00618410|26799627|FG001|Washout Period (2 Weeks)|Physician Decision|1|||
13398854|NCT00618371|26799634|FG000|Overall Study|Withdrawal by Subject|2|||
13398855|NCT00618072|26799676|FG000|Overall Study|Lost to Follow-up|2|||
13398856|NCT00618072|26799677|FG001|Overall Study|Lost to Follow-up|0|||
13398857|NCT00618072|26799678|FG002|Overall Study|Lost to Follow-up|3|||
13398858|NCT00618072|26799676|FG000|Overall Study|Physician Decision|0|||
13398859|NCT00618072|26799677|FG001|Overall Study|Physician Decision|1|||
13398860|NCT00618072|26799678|FG002|Overall Study|Physician Decision|1|||
13398861|NCT00617929|26799690|FG000|Overall Study|Physician Decision|1|||
13398862|NCT00617903|26799739|FG000|Overall Study|Withdrawal by Subject|2|||
13398863|NCT00617903|26799740|FG001|Overall Study|Withdrawal by Subject|3|||
13398864|NCT00617903|26799739|FG000|Overall Study|Lost to Follow-up|1|||
13398865|NCT00617903|26799740|FG001|Overall Study|Lost to Follow-up|1|||
13398866|NCT00617903|26799739|FG000|Overall Study|Lack of Efficacy|0|||
13398867|NCT00617903|26799740|FG001|Overall Study|Lack of Efficacy|1|||
13398868|NCT00617903|26799739|FG000|Overall Study|Adverse Event|0|||
13398869|NCT00617903|26799740|FG001|Overall Study|Adverse Event|1|||
13398870|NCT00617903|26799739|FG000|Overall Study|noncompliance|0|||
13398871|NCT00617903|26799740|FG001|Overall Study|noncompliance|1|||
13398872|NCT00617890|26799785|FG000|Overall Study|Treatment ongoing at data cut-off|0|||
13398873|NCT00617890|26799786|FG001|Overall Study|Treatment ongoing at data cut-off|0|||
13398874|NCT00617890|26799787|FG002|Overall Study|Treatment ongoing at data cut-off|0|||
13398875|NCT00617890|26799788|FG003|Overall Study|Treatment ongoing at data cut-off|5|||
13398876|NCT00617890|26799785|FG000|Overall Study|Lack of Efficacy|23|||
13398877|NCT00617890|26799786|FG001|Overall Study|Lack of Efficacy|26|||
13398878|NCT00617890|26799787|FG002|Overall Study|Lack of Efficacy|30|||
13398879|NCT00617890|26799788|FG003|Overall Study|Lack of Efficacy|97|||
13398880|NCT00617890|26799785|FG000|Overall Study|Lost to Follow-up|0|||
13398881|NCT00617890|26799786|FG001|Overall Study|Lost to Follow-up|0|||
13398882|NCT00617890|26799787|FG002|Overall Study|Lost to Follow-up|1|||
13398883|NCT00617890|26799788|FG003|Overall Study|Lost to Follow-up|2|||
13398884|NCT00617890|26799785|FG000|Overall Study|Withdrawal by Subject|4|||
13398885|NCT00617890|26799786|FG001|Overall Study|Withdrawal by Subject|1|||
13398886|NCT00617890|26799787|FG002|Overall Study|Withdrawal by Subject|0|||
13398887|NCT00617890|26799788|FG003|Overall Study|Withdrawal by Subject|2|||
13398888|NCT00617890|26799785|FG000|Overall Study|Protocol Violation|2|||
13398889|NCT00617890|26799786|FG001|Overall Study|Protocol Violation|1|||
13398890|NCT00617890|26799787|FG002|Overall Study|Protocol Violation|0|||
13398891|NCT00617890|26799788|FG003|Overall Study|Protocol Violation|0|||
13398892|NCT00617890|26799785|FG000|Overall Study|Adverse Event|1|||
13398893|NCT00617890|26799786|FG001|Overall Study|Adverse Event|0|||
13398894|NCT00617890|26799787|FG002|Overall Study|Adverse Event|3|||
13398895|NCT00617890|26799788|FG003|Overall Study|Adverse Event|8|||
13398896|NCT00617890|26799785|FG000|Overall Study|Not treated|1|||
13398897|NCT00617890|26799786|FG001|Overall Study|Not treated|0|||
13398898|NCT00617890|26799787|FG002|Overall Study|Not treated|1|||
13398899|NCT00617890|26799788|FG003|Overall Study|Not treated|1|||
13398900|NCT00617851|26799839|FG000|Overall Study|Death|0|||
13398901|NCT00617851|26799840|FG001|Overall Study|Death|0|||
13398902|NCT00617851|26799841|FG002|Overall Study|Death|0|||
13398903|NCT00617851|26799842|FG003|Overall Study|Death|1|||
13398904|NCT00617851|26799839|FG000|Overall Study|Withdrawal by Subject|14|||
13398905|NCT00617851|26799840|FG001|Overall Study|Withdrawal by Subject|7|||
13398906|NCT00617851|26799841|FG002|Overall Study|Withdrawal by Subject|12|||
13398907|NCT00617851|26799842|FG003|Overall Study|Withdrawal by Subject|4|||
13398908|NCT00617851|26799839|FG000|Overall Study|Lost to Follow-up|27|||
13398909|NCT00617851|26799840|FG001|Overall Study|Lost to Follow-up|29|||
13398910|NCT00617851|26799841|FG002|Overall Study|Lost to Follow-up|31|||
13398911|NCT00617851|26799842|FG003|Overall Study|Lost to Follow-up|19|||
13398912|NCT00617851|26799839|FG000|Overall Study|Inappropriate Enrollment|5|||
13398913|NCT00617851|26799840|FG001|Overall Study|Inappropriate Enrollment|4|||
13398914|NCT00617851|26799841|FG002|Overall Study|Inappropriate Enrollment|1|||
13398915|NCT00617851|26799842|FG003|Overall Study|Inappropriate Enrollment|1|||
13398916|NCT00617851|26799839|FG000|Overall Study|Unable to classify|1|||
13398917|NCT00617851|26799840|FG001|Overall Study|Unable to classify|0|||
13398918|NCT00617851|26799841|FG002|Overall Study|Unable to classify|1|||
13398919|NCT00617851|26799842|FG003|Overall Study|Unable to classify|0|||
13398920|NCT00617773|26799859|FG000|Overall Study|Physician Decision|1|||
13398921|NCT00617773|26799859|FG000|Overall Study|Lack of compliance with the protocol|1|||
13398922|NCT00617773|26799859|FG000|Overall Study|Withdrawal by Subject|1|||
13398923|NCT00617773|26799859|FG000|Overall Study|Death|1|||
13398924|NCT00617773|26799859|FG000|Overall Study|Progressive disease|19|||
13398925|NCT00617773|26799859|FG000|Overall Study|Protocol Violation|1|||
13398926|NCT00617734|26799884|FG000|Overall Study|Withdrew Consent|2|||
13398927|NCT00617734|26799885|FG001|Overall Study|Withdrew Consent|0|||
13398928|NCT00617734|26799884|FG000|Overall Study|Adverse Event|4|||
13398929|NCT00617734|26799885|FG001|Overall Study|Adverse Event|1|||
13398930|NCT00617734|26799884|FG000|Overall Study|Protocol Violation|1|||
13398931|NCT00617734|26799885|FG001|Overall Study|Protocol Violation|0|||
13398932|NCT00617734|26799884|FG000|Overall Study|Found Ineligible After Randomization|1|||
13398933|NCT00617734|26799885|FG001|Overall Study|Found Ineligible After Randomization|4|||
13398934|NCT00617734|26799884|FG000|Overall Study|Lost to Follow-up|0|||
13398935|NCT00617734|26799885|FG001|Overall Study|Lost to Follow-up|1|||
13398936|NCT00617708|26799910|FG000|Overall Study|Adverse Event|0|||
13398937|NCT00617708|26799911|FG001|Overall Study|Adverse Event|6|||
13398938|NCT00617708|26799912|FG002|Overall Study|Adverse Event|9|||
13398939|NCT00617708|26799910|FG000|Overall Study|Withdrawal by Subject|1|||
13398940|NCT00617708|26799911|FG001|Overall Study|Withdrawal by Subject|1|||
13398941|NCT00617708|26799912|FG002|Overall Study|Withdrawal by Subject|7|||
13398942|NCT00617708|26799910|FG000|Overall Study|Death|0|||
13398943|NCT00617708|26799911|FG001|Overall Study|Death|6|||
13398944|NCT00617708|26799912|FG002|Overall Study|Death|5|||
13398945|NCT00617708|26799910|FG000|Overall Study|Progression/Relapse|7|||
13398946|NCT00617708|26799911|FG001|Overall Study|Progression/Relapse|40|||
13398947|NCT00617708|26799912|FG002|Overall Study|Progression/Relapse|36|||
13398948|NCT00617708|26799910|FG000|Overall Study|Not protocol specified|1|||
13398949|NCT00617708|26799911|FG001|Overall Study|Not protocol specified|4|||
13398950|NCT00617708|26799912|FG002|Overall Study|Not protocol specified|2|||
13398951|NCT00617708|26799910|FG000|Overall Study|Not eligible|1|||
13398952|NCT00617708|26799911|FG001|Overall Study|Not eligible|3|||
13398953|NCT00617708|26799912|FG002|Overall Study|Not eligible|5|||
13398954|NCT00617669|26799939|FG000|Overall Study|Withdrawal by Subject|71|||
13398955|NCT00617669|26799940|FG001|Overall Study|Withdrawal by Subject|77|||
13398956|NCT00617669|26799939|FG000|Overall Study|Lost to Follow-up|3|||
13398957|NCT00617669|26799940|FG001|Overall Study|Lost to Follow-up|2|||
13398958|NCT00617669|26799939|FG000|Overall Study|Adverse Event|87|||
13398959|NCT00617669|26799940|FG001|Overall Study|Adverse Event|76|||
13398960|NCT00617669|26799939|FG000|Overall Study|Protocol Violation|2|||
13398961|NCT00617669|26799940|FG001|Overall Study|Protocol Violation|3|||
13398962|NCT00617669|26799939|FG000|Overall Study|Reason not otherwise captured, eg; death|265|||
13398963|NCT00617669|26799940|FG001|Overall Study|Reason not otherwise captured, eg; death|290|||
13398964|NCT00617669|26799939|FG000|Overall Study|Patients randomized but not treated|2|||
13398965|NCT00617669|26799940|FG001|Overall Study|Patients randomized but not treated|3|||
13398966|NCT00617604|26799991|FG000|Overall Study|Death|2|||
13398967|NCT00617604|26799992|FG001|Overall Study|Death|1|||
13398968|NCT00617604|26799991|FG000|Overall Study|Lost to Follow-up|1|||
13398969|NCT00617604|26799992|FG001|Overall Study|Lost to Follow-up|0|||
13398970|NCT00617604|26799991|FG000|Overall Study|Miscellaneous Reasons|8|||
13398971|NCT00617604|26799992|FG001|Overall Study|Miscellaneous Reasons|10|||
13398972|NCT00617604|26799991|FG000|Overall Study|Withdrawal by Subject|4|||
13398973|NCT00617604|26799992|FG001|Overall Study|Withdrawal by Subject|6|||
13398974|NCT00617604|26799991|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
13398975|NCT00617604|26799992|FG001|Overall Study|Randomized but Never Received Study Drug|3|||
13398976|NCT00617591|26800002|FG000|Overall Study|Withdrew consent during Induction|4|||
13398977|NCT00617591|26800002|FG000|Overall Study|Withdrew consent during Maintenance|6|||
13398978|NCT00617461|26800058|FG000|First Treatment Intervention Period|Adverse Event|2|||
13398979|NCT00617461|26800059|FG001|First Treatment Intervention Period|Adverse Event|0|||
13398980|NCT00617461|26800058|FG000|First Treatment Intervention Period|Lack of Efficacy|1|||
13398981|NCT00617461|26800059|FG001|First Treatment Intervention Period|Lack of Efficacy|0|||
13398982|NCT00617461|26800058|FG000|First Treatment Intervention Period|Protocol Violation|2|||
13398983|NCT00617461|26800059|FG001|First Treatment Intervention Period|Protocol Violation|1|||
13398984|NCT00617461|26800058|FG000|First Treatment Intervention Period|Lost to Follow-up|0|||
13398985|NCT00617461|26800059|FG001|First Treatment Intervention Period|Lost to Follow-up|1|||
13398986|NCT00617461|26800058|FG000|First Treatment Intervention Period|Investigator Discretion|1|||
13398987|NCT00617461|26800059|FG001|First Treatment Intervention Period|Investigator Discretion|1|||
13398988|NCT00617461|26800058|FG000|First Treatment Intervention Period|Withdrawal by Subject|4|||
13398989|NCT00617461|26800059|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
13398990|NCT00617461|26800058|FG000|4-Day Crossover Period|Withdrawal by Subject|1|||
13398991|NCT00617461|26800059|FG001|4-Day Crossover Period|Withdrawal by Subject|0|||
13398992|NCT00617461|26800058|FG000|Second Treatment Intervention Period|Adverse Event|0|||
13398993|NCT00617461|26800059|FG001|Second Treatment Intervention Period|Adverse Event|1|||
13398994|NCT00617461|26800058|FG000|Second Treatment Intervention Period|Lack of Efficacy|0|||
13398995|NCT00617461|26800059|FG001|Second Treatment Intervention Period|Lack of Efficacy|3|||
13398996|NCT00617461|26800058|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1|||
13398997|NCT00617461|26800059|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0|||
13398998|NCT00617461|26800058|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1|||
13398999|NCT00617461|26800059|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2|||
13399000|NCT00617409|26800080|FG000|Overall Study|Withdrawal by Subject|4|||
13399001|NCT00617409|26800081|FG001|Overall Study|Withdrawal by Subject|1|||
13399002|NCT00617409|26800082|FG002|Overall Study|Withdrawal by Subject|2|||
13399003|NCT00617409|26800080|FG000|Overall Study|Adverse Event|0|||
13399004|NCT00617409|26800081|FG001|Overall Study|Adverse Event|2|||
13399005|NCT00617409|26800082|FG002|Overall Study|Adverse Event|3|||
13399006|NCT00617409|26800080|FG000|Overall Study|Disease Progression|8|||
13399007|NCT00617409|26800081|FG001|Overall Study|Disease Progression|8|||
13399008|NCT00617409|26800082|FG002|Overall Study|Disease Progression|18|||
13399009|NCT00617409|26800080|FG000|Overall Study|Death|3|||
13399010|NCT00617409|26800081|FG001|Overall Study|Death|5|||
13399011|NCT00617409|26800082|FG002|Overall Study|Death|4|||
13399012|NCT00617409|26800080|FG000|Overall Study|Alternative Therapy|1|||
13399013|NCT00617409|26800081|FG001|Overall Study|Alternative Therapy|2|||
13399014|NCT00617409|26800082|FG002|Overall Study|Alternative Therapy|0|||
13399015|NCT00617357|26800094|FG000|Overall Study|Lost to Follow-up|7|||
13399016|NCT00617357|26800094|FG000|Overall Study|Death|5|||
13399017|NCT00617357|26800094|FG000|Overall Study|insurance concerns|2|||
13399018|NCT00617357|26800094|FG000|Overall Study|Withdrawal by Subject|1|||
13399019|NCT00617357|26800094|FG000|Overall Study|Physician Decision|1|||
13475959|NCT02810457|27001423|FG001|Overall Study|Physician Decision|1|||
13475960|NCT02745535|27001485|FG000|Overall Study|Death|1|||
13475961|NCT02745535|27001485|FG000|Overall Study|Adverse Event|3|||
13475962|NCT02745535|27001485|FG000|Overall Study|Lost to Follow-up|2|||
13475963|NCT02625090|27001567|FG000|Overall Study|Participant wants to be pregnant|2|||
13475964|NCT02625090|27001567|FG000|Overall Study|For the Promoter|1|||
13475965|NCT02625090|27001567|FG000|Overall Study|Sponsor's Decision|9|||
13475966|NCT02625090|27001567|FG000|Overall Study|Somnolence|1|||
13475967|NCT02625090|27001567|FG000|Overall Study|Study terminated by Sponsor|7|||
13475968|NCT02625090|27001567|FG000|Overall Study|Negative Benefit/Risk|1|||
13475969|NCT02625090|27001567|FG000|Overall Study|Protocol Deviation|2|||
13475970|NCT02625090|27001567|FG000|Overall Study|Lack of Efficacy|16|||
13475971|NCT02625090|27001567|FG000|Overall Study|Adverse Event|3|||
13399020|NCT00617344|26800129|FG000|Overall Study|Serious adverse event|1|||
13399021|NCT00617344|26800130|FG001|Overall Study|Serious adverse event|0|||
13399022|NCT00617344|26800131|FG002|Overall Study|Serious adverse event|0|||
13399023|NCT00617344|26800129|FG000|Overall Study|Other Adverse Event|1|||
13399024|NCT00617344|26800130|FG001|Overall Study|Other Adverse Event|1|||
13399025|NCT00617344|26800131|FG002|Overall Study|Other Adverse Event|0|||
13399026|NCT00617344|26800129|FG000|Overall Study|Protocol Violation|10|||
13399027|NCT00617344|26800130|FG001|Overall Study|Protocol Violation|8|||
13399028|NCT00617344|26800131|FG002|Overall Study|Protocol Violation|5|||
13399029|NCT00617344|26800129|FG000|Overall Study|Lost to Follow-up|5|||
13399030|NCT00617344|26800130|FG001|Overall Study|Lost to Follow-up|4|||
13399031|NCT00617344|26800131|FG002|Overall Study|Lost to Follow-up|1|||
13399032|NCT00617344|26800129|FG000|Overall Study|Withdrawal by Subject|8|||
13399033|NCT00617344|26800130|FG001|Overall Study|Withdrawal by Subject|9|||
13399034|NCT00617344|26800131|FG002|Overall Study|Withdrawal by Subject|2|||
13399035|NCT00617305|26800195|FG000|Overall Study|Adverse Event|4|||
13399036|NCT00617305|26800196|FG001|Overall Study|Adverse Event|0|||
13399037|NCT00617305|26800197|FG002|Overall Study|Adverse Event|0|||
13399038|NCT00617305|26800195|FG000|Overall Study|Death|1|||
13399039|NCT00617305|26800196|FG001|Overall Study|Death|0|||
13399040|NCT00617305|26800197|FG002|Overall Study|Death|0|||
13399041|NCT00617305|26800195|FG000|Overall Study|Physician Decision|1|||
13399042|NCT00617305|26800196|FG001|Overall Study|Physician Decision|0|||
13399043|NCT00617305|26800197|FG002|Overall Study|Physician Decision|0|||
13399044|NCT00617305|26800195|FG000|Overall Study|Protocol Violation|1|||
13399045|NCT00617305|26800196|FG001|Overall Study|Protocol Violation|0|||
13399046|NCT00617305|26800197|FG002|Overall Study|Protocol Violation|1|||
13399047|NCT00617305|26800195|FG000|Overall Study|Withdrawal by Subject|1|||
13399048|NCT00617305|26800196|FG001|Overall Study|Withdrawal by Subject|0|||
13399049|NCT00617305|26800197|FG002|Overall Study|Withdrawal by Subject|0|||
13399050|NCT00617279|26800258|FG000|Overall Study|Study terminated by Sponsor|10|||
13399051|NCT00617279|26800259|FG001|Overall Study|Study terminated by Sponsor|15|||
13399052|NCT00617279|26800258|FG000|Overall Study|Graft abandonment|2|||
13399053|NCT00617279|26800259|FG001|Overall Study|Graft abandonment|0|||
13399054|NCT00617279|26800258|FG000|Overall Study|Lost to Follow-up|1|||
13399055|NCT00617279|26800259|FG001|Overall Study|Lost to Follow-up|0|||
13399056|NCT00617279|26800258|FG000|Overall Study|Death|1|||
13399057|NCT00617279|26800259|FG001|Overall Study|Death|2|||
13399058|NCT00617240|26800284|FG000|Overall Study|Lack of Efficacy|1|||
13399059|NCT00617240|26800285|FG001|Overall Study|Lack of Efficacy|0|||
13399060|NCT00617201|26800300|FG000|Overall Study|Lost to Follow-up|9|||
13399061|NCT00617201|26800301|FG001|Overall Study|Lost to Follow-up|13|||
13399062|NCT00617123|26800322|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36|||
13399063|NCT00617123|26800323|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24|||
13399064|NCT00617123|26800322|FG000|Referral Screening Period|Did Not Wish To Continue|3|||
13399065|NCT00617123|26800323|FG001|Referral Screening Period|Did Not Wish To Continue|1|||
13399066|NCT00617123|26800322|FG000|Referral Screening Period|Adverse Event|0|||
13399067|NCT00617123|26800323|FG001|Referral Screening Period|Adverse Event|1|||
13399068|NCT00617123|26800322|FG000|Study Treatment Period|Withdrawal by Subject|8|||
13399069|NCT00617123|26800323|FG001|Study Treatment Period|Withdrawal by Subject|12|||
13399070|NCT00617123|26800322|FG000|Study Treatment Period|Adverse Event|7|||
13399071|NCT00617123|26800323|FG001|Study Treatment Period|Adverse Event|3|||
13399072|NCT00617123|26800322|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2|||
13399073|NCT00617123|26800323|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0|||
13399074|NCT00617123|26800322|FG000|Study Treatment Period|Noncompliance with Protocol|0|||
13399075|NCT00617123|26800323|FG001|Study Treatment Period|Noncompliance with Protocol|1|||
13399076|NCT00617084|26800338|FG000|Overall Study|Withdrawal by Subject|5|||
13399077|NCT00617084|26800339|FG001|Overall Study|Withdrawal by Subject|7|||
13399078|NCT00617084|26800338|FG000|Overall Study|Missed 12 Months visit|16|||
13399079|NCT00617084|26800339|FG001|Overall Study|Missed 12 Months visit|19|||
13399080|NCT00616928|26800414|FG000|Overall Study|Adverse Event|6|||
13399081|NCT00616928|26800415|FG001|Overall Study|Adverse Event|3|||
13399082|NCT00616928|26800416|FG002|Overall Study|Adverse Event|2|||
13399083|NCT00616928|26800417|FG003|Overall Study|Adverse Event|2|||
13399084|NCT00616928|26800414|FG000|Overall Study|Other|51|||
13399085|NCT00616928|26800415|FG001|Overall Study|Other|8|||
13399086|NCT00616928|26800416|FG002|Overall Study|Other|15|||
13399087|NCT00616928|26800417|FG003|Overall Study|Other|5|||
13399088|NCT00616928|26800414|FG000|Overall Study|Lost to Follow-up|5|||
13399089|NCT00616928|26800415|FG001|Overall Study|Lost to Follow-up|7|||
13399090|NCT00616928|26800416|FG002|Overall Study|Lost to Follow-up|0|||
13399091|NCT00616928|26800417|FG003|Overall Study|Lost to Follow-up|0|||
13399092|NCT00616902|26800448|FG000|Overall Study|Termination of study|6|||
13399093|NCT00616902|26800449|FG001|Overall Study|Termination of study|6|||
13399094|NCT00616759|26800462|FG000|Overall Study|Physician Decision|2|||
13399095|NCT00616759|26800463|FG001|Overall Study|Physician Decision|0|||
13399096|NCT00616759|26800462|FG000|Overall Study|Withdrawal by Subject|1|||
13399097|NCT00616759|26800463|FG001|Overall Study|Withdrawal by Subject|2|||
13399098|NCT00616655|26800511|FG000|Overall Study|Adverse Event|10|||
13399099|NCT00616655|26800512|FG001|Overall Study|Adverse Event|7|||
13399100|NCT00616655|26800513|FG002|Overall Study|Adverse Event|12|||
13399101|NCT00616655|26800511|FG000|Overall Study|Lack of Efficacy|5|||
13399102|NCT00616655|26800512|FG001|Overall Study|Lack of Efficacy|5|||
13399103|NCT00616655|26800513|FG002|Overall Study|Lack of Efficacy|5|||
13399104|NCT00616655|26800511|FG000|Overall Study|Lost to Follow-up|3|||
13399105|NCT00616655|26800512|FG001|Overall Study|Lost to Follow-up|12|||
13399106|NCT00616655|26800513|FG002|Overall Study|Lost to Follow-up|10|||
13399107|NCT00616655|26800511|FG000|Overall Study|Protocol Violation|2|||
13399108|NCT00616655|26800512|FG001|Overall Study|Protocol Violation|4|||
13399109|NCT00616655|26800513|FG002|Overall Study|Protocol Violation|3|||
13399110|NCT00616655|26800511|FG000|Overall Study|Withdrawal by Subject|9|||
13399111|NCT00616655|26800512|FG001|Overall Study|Withdrawal by Subject|7|||
13399112|NCT00616655|26800513|FG002|Overall Study|Withdrawal by Subject|11|||
13399113|NCT00616655|26800511|FG000|Overall Study|Does not meet in/ex criteria|0|||
13399114|NCT00616655|26800512|FG001|Overall Study|Does not meet in/ex criteria|0|||
13399115|NCT00616655|26800513|FG002|Overall Study|Does not meet in/ex criteria|2|||
13399116|NCT00616655|26800511|FG000|Overall Study|Other|6|||
13399117|NCT00616655|26800512|FG001|Overall Study|Other|6|||
13399118|NCT00616655|26800513|FG002|Overall Study|Other|5|||
13399119|NCT00616642|26800526|FG000|Overall Study|Withdrawal by Subject|0|||
13399120|NCT00616642|26800527|FG001|Overall Study|Withdrawal by Subject|1|||
13399121|NCT00616629|26800585|FG000|Overall Study|Protocol Violation|1|||
13399122|NCT00616629|26800586|FG001|Overall Study|Protocol Violation|2|||
13399123|NCT00616629|26800587|FG002|Overall Study|Protocol Violation|1|||
13399124|NCT00616629|26800588|FG003|Overall Study|Protocol Violation|0|||
13399125|NCT00616629|26800589|FG004|Overall Study|Protocol Violation|0|||
13399126|NCT00616629|26800585|FG000|Overall Study|AV-block|1|||
13399127|NCT00616629|26800586|FG001|Overall Study|AV-block|0|||
13399128|NCT00616629|26800587|FG002|Overall Study|AV-block|0|||
13399129|NCT00616629|26800588|FG003|Overall Study|AV-block|0|||
13399130|NCT00616629|26800589|FG004|Overall Study|AV-block|0|||
13399131|NCT00616603|26800607|FG000|Overall Study|Physician Decision|2|||
13399132|NCT00616603|26800608|FG001|Overall Study|Physician Decision|0|||
13399133|NCT00616603|26800609|FG002|Overall Study|Physician Decision|2|||
13399134|NCT00616434|26800626|FG000|Overall Study|Adverse Event|5|||
13399135|NCT00616434|26800627|FG001|Overall Study|Adverse Event|2|||
13399136|NCT00616434|26800626|FG000|Overall Study|Physician Decision|0|||
13399137|NCT00616434|26800627|FG001|Overall Study|Physician Decision|4|||
13399138|NCT00616434|26800626|FG000|Overall Study|Withdrawal by Subject|1|||
13399139|NCT00616434|26800627|FG001|Overall Study|Withdrawal by Subject|1|||
13399140|NCT00616434|26800626|FG000|Overall Study|Protocol deviation|0|||
13399141|NCT00616434|26800627|FG001|Overall Study|Protocol deviation|1|||
13399142|NCT00616421|26800674|FG000|Overall Study|Withdrawal by Subject|9|||
13399143|NCT00616421|26800675|FG001|Overall Study|Withdrawal by Subject|11|||
13399144|NCT00616421|26800676|FG002|Overall Study|Withdrawal by Subject|8|||
13399145|NCT00616421|26800674|FG000|Overall Study|Lost to Follow-up|12|||
13399146|NCT00616421|26800675|FG001|Overall Study|Lost to Follow-up|26|||
13399147|NCT00616421|26800676|FG002|Overall Study|Lost to Follow-up|30|||
13399148|NCT00616421|26800674|FG000|Overall Study|Inappropriate enrollment|3|||
13399149|NCT00616421|26800675|FG001|Overall Study|Inappropriate enrollment|0|||
13399150|NCT00616421|26800676|FG002|Overall Study|Inappropriate enrollment|1|||
13399151|NCT00616421|26800674|FG000|Overall Study|Administrative reason|1|||
13399152|NCT00616421|26800675|FG001|Overall Study|Administrative reason|0|||
13399153|NCT00616421|26800676|FG002|Overall Study|Administrative reason|0|||
13399154|NCT00616421|26800674|FG000|Overall Study|Protocol Violation|0|||
13399155|NCT00616421|26800675|FG001|Overall Study|Protocol Violation|1|||
13399156|NCT00616421|26800676|FG002|Overall Study|Protocol Violation|2|||
13399157|NCT00616421|26800674|FG000|Overall Study|Unable to classify|1|||
13399158|NCT00616421|26800675|FG001|Overall Study|Unable to classify|0|||
13399159|NCT00616421|26800676|FG002|Overall Study|Unable to classify|0|||
13399160|NCT00616239|26800682|FG000|Overall Study|Withdrawal by Subject|2|||
13399161|NCT00616018|26800689|FG000|Overall Study|Protocol Violation|3|||
13399162|NCT00615992|26800700|FG000|Overall Study|Protocol Violation|67|||
13399163|NCT00615914|26800709|FG000|Overall Study|Adverse Event|274|||
13399164|NCT00615914|26800709|FG000|Overall Study|Death|20|||
13399165|NCT00615914|26800709|FG000|Overall Study|Lack of Efficacy|59|||
13399166|NCT00615914|26800709|FG000|Overall Study|Lost to Follow-up|187|||
13399167|NCT00615914|26800709|FG000|Overall Study|Withdrawal by Subject|16|||
13399168|NCT00615914|26800709|FG000|Overall Study|Physician Decision|4|||
13399169|NCT00615914|26800709|FG000|Overall Study|No data was collected.|65|||
13399170|NCT00615914|26800709|FG000|Overall Study|No treatment|2|||
13399171|NCT00615914|26800709|FG000|Overall Study|Irregularly enrolled patients|10|||
13399172|NCT00615901|26800715|FG000|Overall Study|Withdrawal by Subject|2|||
13399173|NCT00615901|26800715|FG000|Overall Study|Adverse Event|7|||
13399174|NCT00615836|26800789|FG000|Extension Study (FE992026 CS31)|Adverse Event|7|||
13399175|NCT00615836|26800790|FG001|Extension Study (FE992026 CS31)|Adverse Event|12|||
13399176|NCT00615836|26800791|FG002|Extension Study (FE992026 CS31)|Adverse Event|15|||
13399177|NCT00615836|26800792|FG003|Extension Study (FE992026 CS31)|Adverse Event|13|||
13399178|NCT00615836|26800793|FG004|Extension Study (FE992026 CS31)|Adverse Event|0|||
13399179|NCT00615836|26800789|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1|||
13399180|NCT00615836|26800790|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
13399181|NCT00615836|26800791|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
13399182|NCT00615836|26800792|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
13399183|NCT00615836|26800793|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
13399184|NCT00615836|26800789|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
13399185|NCT00615836|26800790|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2|||
13399186|NCT00615836|26800791|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
13399187|NCT00615836|26800792|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
13399188|NCT00615836|26800793|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
13399189|NCT00615836|26800789|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4|||
13399190|NCT00615836|26800790|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5|||
13399191|NCT00615836|26800791|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2|||
13399192|NCT00615836|26800792|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3|||
13399193|NCT00615836|26800793|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0|||
13399194|NCT00615836|26800789|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37|||
13399195|NCT00615836|26800790|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42|||
13399196|NCT00615836|26800791|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38|||
13399197|NCT00615836|26800792|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43|||
13399198|NCT00615836|26800793|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0|||
13399199|NCT00615836|26800789|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
13399200|NCT00615836|26800790|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14|||
13399201|NCT00615836|26800791|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5|||
13399202|NCT00615836|26800792|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
13399203|NCT00615836|26800793|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0|||
13399204|NCT00615836|26800789|FG000|Extension Study (FE992026 CS31)|Other|10|||
13399205|NCT00615836|26800790|FG001|Extension Study (FE992026 CS31)|Other|7|||
13399206|NCT00615836|26800791|FG002|Extension Study (FE992026 CS31)|Other|8|||
13399207|NCT00615836|26800792|FG003|Extension Study (FE992026 CS31)|Other|8|||
13399208|NCT00615836|26800793|FG004|Extension Study (FE992026 CS31)|Other|0|||
13399209|NCT00615836|26800789|FG000|Extension Study (FE992026 CS31)|Not reported|6|||
13399210|NCT00615836|26800790|FG001|Extension Study (FE992026 CS31)|Not reported|4|||
13399211|NCT00615836|26800791|FG002|Extension Study (FE992026 CS31)|Not reported|1|||
13399212|NCT00615836|26800792|FG003|Extension Study (FE992026 CS31)|Not reported|4|||
13399213|NCT00615836|26800793|FG004|Extension Study (FE992026 CS31)|Not reported|0|||
13399214|NCT00615836|26800789|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65|||
13399215|NCT00615836|26800790|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
13399216|NCT00615836|26800791|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
13399217|NCT00615836|26800792|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
13399218|NCT00615836|26800793|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
13399219|NCT00615719|26800799|FG000|Overall Study|Physician Decision|5|||
13399220|NCT00615550|26800820|FG000|Overall Study|Lost to Follow-up|6|||
13399221|NCT00615550|26800821|FG001|Overall Study|Lost to Follow-up|1|||
13399222|NCT00615459|26800840|FG000|Period I|Adverse Event|2|||
13399223|NCT00615459|26800841|FG001|Period I|Adverse Event|0|||
13399224|NCT00615459|26800842|FG002|Period I|Adverse Event|1|||
13399225|NCT00615459|26800843|FG003|Period I|Adverse Event|0|||
13399226|NCT00615459|26800840|FG000|Period I|Subject withdrew consent|1|||
13399227|NCT00615459|26800841|FG001|Period I|Subject withdrew consent|0|||
13399228|NCT00615459|26800842|FG002|Period I|Subject withdrew consent|0|||
13399229|NCT00615459|26800843|FG003|Period I|Subject withdrew consent|1|||
13399230|NCT00615459|26800840|FG000|Period I|Abnormal test procedure results|1|||
13399231|NCT00615459|26800841|FG001|Period I|Abnormal test procedure results|1|||
13399232|NCT00615459|26800842|FG002|Period I|Abnormal test procedure results|1|||
13399233|NCT00615459|26800843|FG003|Period I|Abnormal test procedure results|0|||
13399234|NCT00615459|26800840|FG000|Period II|Adverse Event|1|||
13399235|NCT00615459|26800841|FG001|Period II|Adverse Event|0|||
13399236|NCT00615459|26800842|FG002|Period II|Adverse Event|0|||
13399237|NCT00615459|26800843|FG003|Period II|Adverse Event|0|||
13399238|NCT00615459|26800840|FG000|Period II|Lost to Follow-up|0|||
13399239|NCT00615459|26800841|FG001|Period II|Lost to Follow-up|0|||
13399240|NCT00615459|26800842|FG002|Period II|Lost to Follow-up|0|||
13399241|NCT00615459|26800843|FG003|Period II|Lost to Follow-up|1|||
13399242|NCT00615459|26800840|FG000|Period III|Adverse Event|0|||
13399243|NCT00615459|26800841|FG001|Period III|Adverse Event|1|||
13399244|NCT00615459|26800842|FG002|Period III|Adverse Event|0|||
13399245|NCT00615459|26800843|FG003|Period III|Adverse Event|0|||
13399246|NCT00615459|26800840|FG000|Period III|Administrative problems|0|||
13399247|NCT00615459|26800841|FG001|Period III|Administrative problems|1|||
13399248|NCT00615459|26800842|FG002|Period III|Administrative problems|1|||
13399249|NCT00615459|26800843|FG003|Period III|Administrative problems|0|||
13399250|NCT00615459|26800840|FG000|Period III|Unsatisfactory therapeutic effect|0|||
13399251|NCT00615459|26800841|FG001|Period III|Unsatisfactory therapeutic effect|1|||
13399252|NCT00615459|26800842|FG002|Period III|Unsatisfactory therapeutic effect|0|||
13399253|NCT00615459|26800843|FG003|Period III|Unsatisfactory therapeutic effect|0|||
13399254|NCT00615290|26800857|FG000|Overall Study|Adverse Event|2|||
13399255|NCT00615290|26800857|FG000|Overall Study|Lost to Follow-up|3|||
13399256|NCT00615290|26800857|FG000|Overall Study|Withdrawal by Subject|1|||
13399257|NCT00615290|26800857|FG000|Overall Study|Other|2|||
13399258|NCT00615264|26800872|FG000|Overall Study|Withdrawal by Subject|17|||
13399259|NCT00615264|26800873|FG001|Overall Study|Withdrawal by Subject|19|||
13399260|NCT00615264|26800872|FG000|Overall Study|Lost to Follow-up|6|||
13399261|NCT00615264|26800873|FG001|Overall Study|Lost to Follow-up|13|||
13399262|NCT00615264|26800872|FG000|Overall Study|Adverse Event|8|||
13399263|NCT00615264|26800873|FG001|Overall Study|Adverse Event|5|||
13399264|NCT00615264|26800872|FG000|Overall Study|Death|1|||
13399265|NCT00615264|26800873|FG001|Overall Study|Death|1|||
13399266|NCT00615264|26800872|FG000|Overall Study|Protocol Violation|11|||
13399267|NCT00615264|26800873|FG001|Overall Study|Protocol Violation|7|||
13399268|NCT00615264|26800872|FG000|Overall Study|Not defined|7|||
13399269|NCT00615264|26800873|FG001|Overall Study|Not defined|4|||
13399270|NCT00615264|26800872|FG000|Overall Study|Dermal Hypersensitivity|0|||
13399271|NCT00615264|26800873|FG001|Overall Study|Dermal Hypersensitivity|3|||
13399272|NCT00615199|26800920|FG000|Overall Study|Adverse Event|3|||
13399273|NCT00615199|26800921|FG001|Overall Study|Adverse Event|1|||
13399274|NCT00615199|26800922|FG002|Overall Study|Adverse Event|1|||
13399275|NCT00615199|26800923|FG003|Overall Study|Adverse Event|0|||
13399276|NCT00615199|26800920|FG000|Overall Study|Lack of Efficacy|2|||
13399277|NCT00615199|26800921|FG001|Overall Study|Lack of Efficacy|0|||
13399278|NCT00615199|26800922|FG002|Overall Study|Lack of Efficacy|0|||
13399279|NCT00615199|26800923|FG003|Overall Study|Lack of Efficacy|1|||
13399280|NCT00615199|26800920|FG000|Overall Study|Lost to Follow-up|1|||
13399281|NCT00615199|26800921|FG001|Overall Study|Lost to Follow-up|0|||
13399282|NCT00615199|26800922|FG002|Overall Study|Lost to Follow-up|0|||
13399283|NCT00615199|26800923|FG003|Overall Study|Lost to Follow-up|0|||
13399284|NCT00615199|26800920|FG000|Overall Study|Other|0|||
13399285|NCT00615199|26800921|FG001|Overall Study|Other|0|||
13399286|NCT00615199|26800922|FG002|Overall Study|Other|0|||
13399287|NCT00615199|26800923|FG003|Overall Study|Other|1|||
13399288|NCT00615199|26800920|FG000|Overall Study|Withdrawal by Subject|2|||
13399289|NCT00615199|26800921|FG001|Overall Study|Withdrawal by Subject|1|||
13399290|NCT00615199|26800922|FG002|Overall Study|Withdrawal by Subject|0|||
13399291|NCT00615199|26800923|FG003|Overall Study|Withdrawal by Subject|0|||
13399292|NCT00615108|26800940|FG000|Overall Study|Adverse Event|122|||
13399293|NCT00615108|26800940|FG000|Overall Study|Other|370|||
13399294|NCT00615108|26800940|FG000|Overall Study|Lost to Follow-up|15|||
13399295|NCT00615069|26800947|FG000|Overall Study|Death|10|||
13399296|NCT00615069|26800947|FG000|Overall Study|Physician Decision|2|||
13399297|NCT00615069|26800947|FG000|Overall Study|Withdrawal by Subject|4|||
13399298|NCT00615056|26800990|FG000|Overall Study|Death|31|||
13399299|NCT00615056|26800991|FG001|Overall Study|Death|31|||
13399300|NCT00615056|26800992|FG002|Overall Study|Death|21|||
13399301|NCT00615056|26800993|FG003|Overall Study|Death|23|||
13399302|NCT00615056|26800990|FG000|Overall Study|Lost to Follow-up|1|||
13399303|NCT00615056|26800991|FG001|Overall Study|Lost to Follow-up|2|||
13399304|NCT00615056|26800992|FG002|Overall Study|Lost to Follow-up|4|||
13399305|NCT00615056|26800993|FG003|Overall Study|Lost to Follow-up|5|||
13399306|NCT00615056|26800990|FG000|Overall Study|Other|13|||
13399307|NCT00615056|26800991|FG001|Overall Study|Other|15|||
13399308|NCT00615056|26800992|FG002|Overall Study|Other|10|||
13399309|NCT00615056|26800993|FG003|Overall Study|Other|7|||
13399310|NCT00615056|26800990|FG000|Overall Study|Objective progression or relapse|0|||
13399311|NCT00615056|26800991|FG001|Overall Study|Objective progression or relapse|2|||
13399312|NCT00615056|26800992|FG002|Overall Study|Objective progression or relapse|0|||
13399313|NCT00615056|26800993|FG003|Overall Study|Objective progression or relapse|0|||
13399314|NCT00615056|26800990|FG000|Overall Study|Withdrawal by Subject|0|||
13399315|NCT00615056|26800991|FG001|Overall Study|Withdrawal by Subject|1|||
13399316|NCT00615056|26800992|FG002|Overall Study|Withdrawal by Subject|1|||
13399317|NCT00615056|26800993|FG003|Overall Study|Withdrawal by Subject|0|||
13399318|NCT00615056|26800990|FG000|Overall Study|Discontinued by Sponsor|1|||
13399319|NCT00615056|26800991|FG001|Overall Study|Discontinued by Sponsor|0|||
13399320|NCT00615056|26800992|FG002|Overall Study|Discontinued by Sponsor|0|||
13399321|NCT00615056|26800993|FG003|Overall Study|Discontinued by Sponsor|0|||
13399322|NCT00615056|26800990|FG000|Overall Study|Randomized but not treated|3|||
13399323|NCT00615056|26800991|FG001|Overall Study|Randomized but not treated|0|||
13399324|NCT00615056|26800992|FG002|Overall Study|Randomized but not treated|0|||
13399325|NCT00615056|26800993|FG003|Overall Study|Randomized but not treated|0|||
13399326|NCT00615030|26801020|FG000|Period I|Administrative problem|0|||
13399327|NCT00615030|26801021|FG001|Period I|Administrative problem|0|||
13399328|NCT00615030|26801022|FG002|Period I|Administrative problem|0|||
13399329|NCT00615030|26801023|FG003|Period I|Administrative problem|0|||
13399330|NCT00615030|26801024|FG004|Period I|Administrative problem|1|||
13399331|NCT00615030|26801025|FG005|Period I|Administrative problem|0|||
13399332|NCT00615030|26801026|FG006|Period I|Administrative problem|0|||
13399333|NCT00615030|26801027|FG007|Period I|Administrative problem|0|||
13399334|NCT00615030|26801028|FG008|Period I|Administrative problem|0|||
13399335|NCT00615030|26801029|FG009|Period I|Administrative problem|0|||
13399336|NCT00615030|26801030|FG010|Period I|Administrative problem|0|||
13399337|NCT00615030|26801031|FG011|Period I|Administrative problem|0|||
13399338|NCT00615030|26801020|FG000|Period I|Protocol deviation|1|||
13399339|NCT00615030|26801021|FG001|Period I|Protocol deviation|0|||
13399340|NCT00615030|26801022|FG002|Period I|Protocol deviation|0|||
13399341|NCT00615030|26801023|FG003|Period I|Protocol deviation|0|||
13399342|NCT00615030|26801024|FG004|Period I|Protocol deviation|0|||
13399343|NCT00615030|26801025|FG005|Period I|Protocol deviation|0|||
13399344|NCT00615030|26801026|FG006|Period I|Protocol deviation|0|||
13399345|NCT00615030|26801027|FG007|Period I|Protocol deviation|0|||
13399346|NCT00615030|26801028|FG008|Period I|Protocol deviation|0|||
13399347|NCT00615030|26801029|FG009|Period I|Protocol deviation|0|||
13399348|NCT00615030|26801030|FG010|Period I|Protocol deviation|0|||
13399349|NCT00615030|26801031|FG011|Period I|Protocol deviation|0|||
13399350|NCT00615030|26801020|FG000|Period I|Subject withdrew consent|0|||
13399351|NCT00615030|26801021|FG001|Period I|Subject withdrew consent|0|||
13399352|NCT00615030|26801022|FG002|Period I|Subject withdrew consent|0|||
13399353|NCT00615030|26801023|FG003|Period I|Subject withdrew consent|0|||
13399354|NCT00615030|26801024|FG004|Period I|Subject withdrew consent|0|||
13399355|NCT00615030|26801025|FG005|Period I|Subject withdrew consent|0|||
13399356|NCT00615030|26801026|FG006|Period I|Subject withdrew consent|0|||
13399357|NCT00615030|26801027|FG007|Period I|Subject withdrew consent|0|||
13399358|NCT00615030|26801028|FG008|Period I|Subject withdrew consent|1|||
13399359|NCT00615030|26801029|FG009|Period I|Subject withdrew consent|0|||
13399360|NCT00615030|26801030|FG010|Period I|Subject withdrew consent|1|||
13399361|NCT00615030|26801031|FG011|Period I|Subject withdrew consent|1|||
13399362|NCT00615030|26801020|FG000|Period I|Abnormal laboratory value(s)|0|||
13399363|NCT00615030|26801021|FG001|Period I|Abnormal laboratory value(s)|0|||
13399364|NCT00615030|26801022|FG002|Period I|Abnormal laboratory value(s)|0|||
13399365|NCT00615030|26801023|FG003|Period I|Abnormal laboratory value(s)|0|||
13399366|NCT00615030|26801024|FG004|Period I|Abnormal laboratory value(s)|0|||
13399367|NCT00615030|26801025|FG005|Period I|Abnormal laboratory value(s)|1|||
13399368|NCT00615030|26801026|FG006|Period I|Abnormal laboratory value(s)|0|||
13399369|NCT00615030|26801027|FG007|Period I|Abnormal laboratory value(s)|0|||
13399370|NCT00615030|26801028|FG008|Period I|Abnormal laboratory value(s)|0|||
13399371|NCT00615030|26801029|FG009|Period I|Abnormal laboratory value(s)|0|||
13399372|NCT00615030|26801030|FG010|Period I|Abnormal laboratory value(s)|0|||
13399373|NCT00615030|26801031|FG011|Period I|Abnormal laboratory value(s)|0|||
13399374|NCT00615030|26801020|FG000|Period II|Adverse Event|0|||
13399375|NCT00615030|26801021|FG001|Period II|Adverse Event|0|||
13399376|NCT00615030|26801022|FG002|Period II|Adverse Event|1|||
13399377|NCT00615030|26801023|FG003|Period II|Adverse Event|0|||
13399378|NCT00615030|26801024|FG004|Period II|Adverse Event|0|||
13399379|NCT00615030|26801025|FG005|Period II|Adverse Event|0|||
13399380|NCT00615030|26801026|FG006|Period II|Adverse Event|0|||
13399381|NCT00615030|26801027|FG007|Period II|Adverse Event|0|||
13399382|NCT00615030|26801028|FG008|Period II|Adverse Event|1|||
13399383|NCT00615030|26801029|FG009|Period II|Adverse Event|0|||
13399384|NCT00615030|26801030|FG010|Period II|Adverse Event|0|||
13399385|NCT00615030|26801031|FG011|Period II|Adverse Event|0|||
13399386|NCT00615030|26801020|FG000|Period II|Subject withdrew consent|0|||
13399387|NCT00615030|26801021|FG001|Period II|Subject withdrew consent|0|||
13399388|NCT00615030|26801022|FG002|Period II|Subject withdrew consent|0|||
13399389|NCT00615030|26801023|FG003|Period II|Subject withdrew consent|1|||
13399390|NCT00615030|26801024|FG004|Period II|Subject withdrew consent|0|||
13399391|NCT00615030|26801025|FG005|Period II|Subject withdrew consent|0|||
13399392|NCT00615030|26801026|FG006|Period II|Subject withdrew consent|1|||
13399393|NCT00615030|26801027|FG007|Period II|Subject withdrew consent|0|||
13399394|NCT00615030|26801028|FG008|Period II|Subject withdrew consent|0|||
13399395|NCT00615030|26801029|FG009|Period II|Subject withdrew consent|0|||
13399396|NCT00615030|26801030|FG010|Period II|Subject withdrew consent|0|||
13399397|NCT00615030|26801031|FG011|Period II|Subject withdrew consent|0|||
13399398|NCT00615030|26801020|FG000|Period III|Administrative problems|1|||
13399399|NCT00615030|26801021|FG001|Period III|Administrative problems|0|||
13399400|NCT00615030|26801022|FG002|Period III|Administrative problems|0|||
13399401|NCT00615030|26801023|FG003|Period III|Administrative problems|1|||
13399402|NCT00615030|26801024|FG004|Period III|Administrative problems|0|||
13399403|NCT00615030|26801025|FG005|Period III|Administrative problems|0|||
13399404|NCT00615030|26801026|FG006|Period III|Administrative problems|0|||
13399405|NCT00615030|26801027|FG007|Period III|Administrative problems|0|||
13399406|NCT00615030|26801028|FG008|Period III|Administrative problems|0|||
13399407|NCT00615030|26801029|FG009|Period III|Administrative problems|0|||
13399408|NCT00615030|26801030|FG010|Period III|Administrative problems|0|||
13399409|NCT00615030|26801031|FG011|Period III|Administrative problems|0|||
13399410|NCT00615017|26801202|FG000|Overall Study|Adverse Event|0|||
13399411|NCT00615017|26801203|FG001|Overall Study|Adverse Event|1|||
13399412|NCT00615017|26801204|FG002|Overall Study|Adverse Event|2|||
13399413|NCT00615017|26801205|FG003|Overall Study|Adverse Event|0|||
13399414|NCT00615017|26801206|FG004|Overall Study|Adverse Event|0|||
13399415|NCT00615017|26801207|FG005|Overall Study|Adverse Event|1|||
13399416|NCT00615017|26801202|FG000|Overall Study|Death|0|||
13399417|NCT00615017|26801203|FG001|Overall Study|Death|0|||
13399418|NCT00615017|26801204|FG002|Overall Study|Death|2|||
13399419|NCT00615017|26801205|FG003|Overall Study|Death|0|||
13399420|NCT00615017|26801206|FG004|Overall Study|Death|1|||
13399421|NCT00615017|26801207|FG005|Overall Study|Death|1|||
13399422|NCT00615017|26801202|FG000|Overall Study|Sepsis resolved|0|||
13399423|NCT00615017|26801203|FG001|Overall Study|Sepsis resolved|0|||
13399424|NCT00615017|26801204|FG002|Overall Study|Sepsis resolved|1|||
13399425|NCT00615017|26801205|FG003|Overall Study|Sepsis resolved|0|||
13399426|NCT00615017|26801206|FG004|Overall Study|Sepsis resolved|0|||
13399427|NCT00615017|26801207|FG005|Overall Study|Sepsis resolved|0|||
13399428|NCT00615017|26801202|FG000|Overall Study|Transferred out of Intensive Care Unit|0|||
13399429|NCT00615017|26801203|FG001|Overall Study|Transferred out of Intensive Care Unit|0|||
13399430|NCT00615017|26801204|FG002|Overall Study|Transferred out of Intensive Care Unit|0|||
13399431|NCT00615017|26801205|FG003|Overall Study|Transferred out of Intensive Care Unit|1|||
13399432|NCT00615017|26801206|FG004|Overall Study|Transferred out of Intensive Care Unit|0|||
13399433|NCT00615017|26801207|FG005|Overall Study|Transferred out of Intensive Care Unit|0|||
13399434|NCT00615017|26801202|FG000|Overall Study|Physician discontinued drug|0|||
13399435|NCT00615017|26801203|FG001|Overall Study|Physician discontinued drug|0|||
13399436|NCT00615017|26801204|FG002|Overall Study|Physician discontinued drug|0|||
13399437|NCT00615017|26801205|FG003|Overall Study|Physician discontinued drug|0|||
13399438|NCT00615017|26801206|FG004|Overall Study|Physician discontinued drug|0|||
13399439|NCT00615017|26801207|FG005|Overall Study|Physician discontinued drug|1|||
13399440|NCT00614991|26801258|FG000|Overall Study|Adverse Event|3|||
13399441|NCT00614991|26801259|FG001|Overall Study|Adverse Event|3|||
13399442|NCT00614991|26801260|FG002|Overall Study|Adverse Event|0|||
13399443|NCT00614991|26801261|FG003|Overall Study|Adverse Event|0|||
13399444|NCT00614991|26801262|FG004|Overall Study|Adverse Event|1|||
13399445|NCT00614991|26801263|FG005|Overall Study|Adverse Event|0|||
13399446|NCT00614939|26801302|FG000|Overall Study|Withdrawal by Subject|10|||
13399447|NCT00614939|26801303|FG001|Overall Study|Withdrawal by Subject|17|||
13399448|NCT00614939|26801302|FG000|Overall Study|Study specific discontinuation criteris|13|||
13399449|NCT00614939|26801303|FG001|Overall Study|Study specific discontinuation criteris|16|||
13399450|NCT00614939|26801302|FG000|Overall Study|Adverse Event|2|||
13399451|NCT00614939|26801303|FG001|Overall Study|Adverse Event|5|||
13399452|NCT00614939|26801302|FG000|Overall Study|Incorrect enrollment|1|||
13399453|NCT00614939|26801303|FG001|Overall Study|Incorrect enrollment|2|||
13399454|NCT00614939|26801302|FG000|Overall Study|Death|4|||
13399455|NCT00614939|26801303|FG001|Overall Study|Death|3|||
13399456|NCT00614939|26801302|FG000|Overall Study|Poor/non-compliance|4|||
13399457|NCT00614939|26801303|FG001|Overall Study|Poor/non-compliance|0|||
13399458|NCT00614939|26801302|FG000|Overall Study|Hospitalized due to kidney transplant|1|||
13399459|NCT00614939|26801303|FG001|Overall Study|Hospitalized due to kidney transplant|0|||
13399460|NCT00614926|26801318|FG000|Overall Study|Burden of travel|1|||
13399461|NCT00614926|26801319|FG001|Overall Study|Burden of travel|0|||
13399462|NCT00614926|26801318|FG000|Overall Study|Adverse Event|3|||
13399463|NCT00614926|26801319|FG001|Overall Study|Adverse Event|0|||
13399464|NCT00614874|26801328|FG000|Overall Study|Protocol Violation|1|||
13399465|NCT00614874|26801328|FG000|Overall Study|Withdrawal by Subject|1|||
13399466|NCT00614822|26801337|FG000|Overall Study|Adverse Event|3|||
13399467|NCT00614744|26801368|FG000|Overall Study|Lost to Follow-up|5|||
13399468|NCT00614744|26801369|FG001|Overall Study|Lost to Follow-up|4|||
13399469|NCT00614744|26801368|FG000|Overall Study|Incomplete for Behavior Issues|0|||
13399470|NCT00614744|26801369|FG001|Overall Study|Incomplete for Behavior Issues|2|||
13399471|NCT00614614|26801502|FG000|Primary Vaccination Phase|Adverse Event|6|||
13399472|NCT00614614|26801503|FG001|Primary Vaccination Phase|Adverse Event|0|||
13399473|NCT00614614|26801504|FG002|Primary Vaccination Phase|Adverse Event|0|||
13399474|NCT00614614|26801505|FG003|Primary Vaccination Phase|Adverse Event|0|||
13399475|NCT00614614|26801506|FG004|Primary Vaccination Phase|Adverse Event|0|||
13399476|NCT00614614|26801502|FG000|Primary Vaccination Phase|Withdrawal by Subject|45|||
13399477|NCT00614614|26801503|FG001|Primary Vaccination Phase|Withdrawal by Subject|6|||
13399478|NCT00614614|26801504|FG002|Primary Vaccination Phase|Withdrawal by Subject|0|||
13399479|NCT00614614|26801505|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
13399480|NCT00614614|26801506|FG004|Primary Vaccination Phase|Withdrawal by Subject|0|||
13399481|NCT00614614|26801502|FG000|Primary Vaccination Phase|Lost to Follow-up|26|||
13399482|NCT00614614|26801503|FG001|Primary Vaccination Phase|Lost to Follow-up|8|||
13399483|NCT00614614|26801504|FG002|Primary Vaccination Phase|Lost to Follow-up|0|||
13399484|NCT00614614|26801505|FG003|Primary Vaccination Phase|Lost to Follow-up|0|||
13399485|NCT00614614|26801506|FG004|Primary Vaccination Phase|Lost to Follow-up|0|||
13399486|NCT00614614|26801502|FG000|Primary Vaccination Phase|Protocol Violation|9|||
13399487|NCT00614614|26801503|FG001|Primary Vaccination Phase|Protocol Violation|3|||
13399488|NCT00614614|26801504|FG002|Primary Vaccination Phase|Protocol Violation|0|||
13399489|NCT00614614|26801505|FG003|Primary Vaccination Phase|Protocol Violation|0|||
13399490|NCT00614614|26801506|FG004|Primary Vaccination Phase|Protocol Violation|0|||
13399491|NCT00614614|26801502|FG000|Primary Vaccination Phase|Other|4|||
13399492|NCT00614614|26801503|FG001|Primary Vaccination Phase|Other|0|||
13399493|NCT00614614|26801504|FG002|Primary Vaccination Phase|Other|0|||
13399494|NCT00614614|26801505|FG003|Primary Vaccination Phase|Other|0|||
13399495|NCT00614614|26801506|FG004|Primary Vaccination Phase|Other|0|||
13399496|NCT00614614|26801502|FG000|Booster Vaccination Phase|Adverse Event|0|||
13399497|NCT00614614|26801503|FG001|Booster Vaccination Phase|Adverse Event|0|||
13399498|NCT00614614|26801504|FG002|Booster Vaccination Phase|Adverse Event|1|||
13399499|NCT00614614|26801505|FG003|Booster Vaccination Phase|Adverse Event|1|||
13399500|NCT00614614|26801506|FG004|Booster Vaccination Phase|Adverse Event|0|||
13399501|NCT00614614|26801502|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
13399502|NCT00614614|26801503|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
13399503|NCT00614614|26801504|FG002|Booster Vaccination Phase|Withdrawal by Subject|4|||
13399504|NCT00614614|26801505|FG003|Booster Vaccination Phase|Withdrawal by Subject|3|||
13399505|NCT00614614|26801506|FG004|Booster Vaccination Phase|Withdrawal by Subject|4|||
13399506|NCT00614614|26801502|FG000|Booster Vaccination Phase|Lost to Follow-up|0|||
13399507|NCT00614614|26801503|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
13399508|NCT00614614|26801504|FG002|Booster Vaccination Phase|Lost to Follow-up|17|||
13399509|NCT00614614|26801505|FG003|Booster Vaccination Phase|Lost to Follow-up|10|||
13399510|NCT00614614|26801506|FG004|Booster Vaccination Phase|Lost to Follow-up|8|||
13399511|NCT00614614|26801502|FG000|Booster Vaccination Phase|Protocol Violation|0|||
13399512|NCT00614614|26801503|FG001|Booster Vaccination Phase|Protocol Violation|0|||
13399513|NCT00614614|26801504|FG002|Booster Vaccination Phase|Protocol Violation|2|||
13399514|NCT00614614|26801505|FG003|Booster Vaccination Phase|Protocol Violation|3|||
13399515|NCT00614614|26801506|FG004|Booster Vaccination Phase|Protocol Violation|0|||
13399516|NCT00614614|26801502|FG000|Booster Vaccination Phase|Other|0|||
13399517|NCT00614614|26801503|FG001|Booster Vaccination Phase|Other|1|||
13399518|NCT00614614|26801504|FG002|Booster Vaccination Phase|Other|3|||
13399519|NCT00614614|26801505|FG003|Booster Vaccination Phase|Other|2|||
13399520|NCT00614614|26801506|FG004|Booster Vaccination Phase|Other|1|||
13399521|NCT00614575|26801517|FG000|Overall Study|Adverse Event|106|||
13399522|NCT00614575|26801517|FG000|Overall Study|Lost to Follow-up|55|||
13399523|NCT00614575|26801517|FG000|Overall Study|Lack of Efficacy|14|||
13399524|NCT00614575|26801517|FG000|Overall Study|Withdrawal by Subject|6|||
13399525|NCT00614575|26801517|FG000|Overall Study|Death|3|||
13399526|NCT00614575|26801517|FG000|Overall Study|Physician Decision|2|||
13399527|NCT00614575|26801517|FG000|Overall Study|No data were collected.|18|||
13399528|NCT00614575|26801517|FG000|Overall Study|Irregularly enrolled patients|23|||
13399529|NCT00614575|26801517|FG000|Overall Study|No treatment|1|||
13399530|NCT00614393|26801575|FG000|Overall Study|Adverse Event|20|||
13399531|NCT00614393|26801576|FG001|Overall Study|Adverse Event|2|||
13399532|NCT00614393|26801577|FG002|Overall Study|Adverse Event|3|||
13399533|NCT00614393|26801578|FG003|Overall Study|Adverse Event|13|||
13399534|NCT00614393|26801579|FG004|Overall Study|Adverse Event|21|||
13399535|NCT00614393|26801575|FG000|Overall Study|Lost to Follow-up|0|||
13399536|NCT00614393|26801576|FG001|Overall Study|Lost to Follow-up|0|||
13399537|NCT00614393|26801577|FG002|Overall Study|Lost to Follow-up|0|||
13399538|NCT00614393|26801578|FG003|Overall Study|Lost to Follow-up|1|||
13399539|NCT00614393|26801579|FG004|Overall Study|Lost to Follow-up|2|||
13399540|NCT00614393|26801575|FG000|Overall Study|Physician Decision|17|||
13399541|NCT00614393|26801576|FG001|Overall Study|Physician Decision|0|||
13399542|NCT00614393|26801577|FG002|Overall Study|Physician Decision|1|||
13399543|NCT00614393|26801578|FG003|Overall Study|Physician Decision|8|||
13399544|NCT00614393|26801579|FG004|Overall Study|Physician Decision|9|||
13399545|NCT00614393|26801575|FG000|Overall Study|Progressive Disease|118|||
13399546|NCT00614393|26801576|FG001|Overall Study|Progressive Disease|5|||
13399547|NCT00614393|26801577|FG002|Overall Study|Progressive Disease|5|||
13399548|NCT00614393|26801578|FG003|Overall Study|Progressive Disease|138|||
13399549|NCT00614393|26801579|FG004|Overall Study|Progressive Disease|130|||
13399550|NCT00614393|26801575|FG000|Overall Study|Protocol Violation|1|||
13399551|NCT00614393|26801576|FG001|Overall Study|Protocol Violation|0|||
13399552|NCT00614393|26801577|FG002|Overall Study|Protocol Violation|0|||
13399553|NCT00614393|26801578|FG003|Overall Study|Protocol Violation|0|||
13399554|NCT00614393|26801579|FG004|Overall Study|Protocol Violation|0|||
13399555|NCT00614393|26801575|FG000|Overall Study|Terminated by Sponsor|0|||
13399556|NCT00614393|26801576|FG001|Overall Study|Terminated by Sponsor|0|||
13399557|NCT00614393|26801577|FG002|Overall Study|Terminated by Sponsor|0|||
13399558|NCT00614393|26801578|FG003|Overall Study|Terminated by Sponsor|0|||
13399559|NCT00614393|26801579|FG004|Overall Study|Terminated by Sponsor|1|||
13399560|NCT00614393|26801575|FG000|Overall Study|Withdrawal by Subject|20|||
13399561|NCT00614393|26801576|FG001|Overall Study|Withdrawal by Subject|1|||
13399562|NCT00614393|26801577|FG002|Overall Study|Withdrawal by Subject|1|||
13399563|NCT00614393|26801578|FG003|Overall Study|Withdrawal by Subject|16|||
13399564|NCT00614393|26801579|FG004|Overall Study|Withdrawal by Subject|13|||
13399565|NCT00614393|26801575|FG000|Overall Study|Other|4|||
13399566|NCT00614393|26801576|FG001|Overall Study|Other|0|||
13399567|NCT00614393|26801577|FG002|Overall Study|Other|0|||
13399568|NCT00614393|26801578|FG003|Overall Study|Other|4|||
13399569|NCT00614393|26801579|FG004|Overall Study|Other|2|||
13399570|NCT00614393|26801575|FG000|Overall Study|Not Treated|0|||
13399571|NCT00614393|26801576|FG001|Overall Study|Not Treated|0|||
13399572|NCT00614393|26801577|FG002|Overall Study|Not Treated|0|||
13399573|NCT00614393|26801578|FG003|Overall Study|Not Treated|0|||
13399574|NCT00614393|26801579|FG004|Overall Study|Not Treated|2|||
13399575|NCT00614380|26801641|FG000|Overall Study|Adverse Event|14|||
13399576|NCT00614380|26801642|FG001|Overall Study|Adverse Event|4|||
13399577|NCT00614380|26801643|FG002|Overall Study|Adverse Event|0|||
13399578|NCT00614380|26801644|FG003|Overall Study|Adverse Event|0|||
13399579|NCT00614380|26801641|FG000|Overall Study|Lost to Follow-up|6|||
13399580|NCT00614380|26801642|FG001|Overall Study|Lost to Follow-up|1|||
13399581|NCT00614380|26801643|FG002|Overall Study|Lost to Follow-up|0|||
13399582|NCT00614380|26801644|FG003|Overall Study|Lost to Follow-up|0|||
13399583|NCT00614380|26801641|FG000|Overall Study|Non compliant with the protocol|12|||
13399584|NCT00614380|26801642|FG001|Overall Study|Non compliant with the protocol|2|||
13399585|NCT00614380|26801643|FG002|Overall Study|Non compliant with the protocol|1|||
13399586|NCT00614380|26801644|FG003|Overall Study|Non compliant with the protocol|2|||
13399587|NCT00614380|26801641|FG000|Overall Study|Consent withdrawn|3|||
13399588|NCT00614380|26801642|FG001|Overall Study|Consent withdrawn|1|||
13399589|NCT00614380|26801643|FG002|Overall Study|Consent withdrawn|0|||
13399590|NCT00614380|26801644|FG003|Overall Study|Consent withdrawn|0|||
13399591|NCT00614120|26801695|FG000|Overall Study|Adverse Event|9|||
13399592|NCT00614120|26801696|FG001|Overall Study|Adverse Event|22|||
13399593|NCT00614120|26801697|FG002|Overall Study|Adverse Event|30|||
13399594|NCT00614120|26801698|FG003|Overall Study|Adverse Event|3|||
13399595|NCT00614120|26801695|FG000|Overall Study|Lack of Efficacy|3|||
13399596|NCT00614120|26801696|FG001|Overall Study|Lack of Efficacy|3|||
13399597|NCT00614120|26801697|FG002|Overall Study|Lack of Efficacy|2|||
13399598|NCT00614120|26801698|FG003|Overall Study|Lack of Efficacy|2|||
13399599|NCT00614120|26801695|FG000|Overall Study|Protocol Violation|2|||
13399600|NCT00614120|26801696|FG001|Overall Study|Protocol Violation|5|||
13399601|NCT00614120|26801697|FG002|Overall Study|Protocol Violation|3|||
13399602|NCT00614120|26801698|FG003|Overall Study|Protocol Violation|1|||
13399603|NCT00614120|26801695|FG000|Overall Study|Withdrawal criteria|1|||
13399604|NCT00614120|26801696|FG001|Overall Study|Withdrawal criteria|0|||
13399605|NCT00614120|26801697|FG002|Overall Study|Withdrawal criteria|0|||
13399606|NCT00614120|26801698|FG003|Overall Study|Withdrawal criteria|0|||
13399607|NCT00614120|26801695|FG000|Overall Study|Withdrawal by Subject|9|||
13399608|NCT00614120|26801696|FG001|Overall Study|Withdrawal by Subject|10|||
13399609|NCT00614120|26801697|FG002|Overall Study|Withdrawal by Subject|16|||
13399610|NCT00614120|26801698|FG003|Overall Study|Withdrawal by Subject|3|||
13399611|NCT00614120|26801695|FG000|Overall Study|Did not meet trial criteria|0|||
13399612|NCT00614120|26801696|FG001|Overall Study|Did not meet trial criteria|1|||
13399613|NCT00614120|26801697|FG002|Overall Study|Did not meet trial criteria|1|||
13399614|NCT00614120|26801698|FG003|Overall Study|Did not meet trial criteria|1|||
13399615|NCT00614120|26801695|FG000|Overall Study|hCG positive (not pregnant)|0|||
13399616|NCT00614120|26801696|FG001|Overall Study|hCG positive (not pregnant)|0|||
13399617|NCT00614120|26801697|FG002|Overall Study|hCG positive (not pregnant)|1|||
13399618|NCT00614120|26801698|FG003|Overall Study|hCG positive (not pregnant)|0|||
13399619|NCT00614120|26801695|FG000|Overall Study|Hypoglycaemia|0|||
13399620|NCT00614120|26801696|FG001|Overall Study|Hypoglycaemia|0|||
13399621|NCT00614120|26801697|FG002|Overall Study|Hypoglycaemia|0|||
13399622|NCT00614120|26801698|FG003|Overall Study|Hypoglycaemia|1|||
13399623|NCT00614120|26801695|FG000|Overall Study|Lack of trial product|3|||
13399624|NCT00614120|26801696|FG001|Overall Study|Lack of trial product|3|||
13399625|NCT00614120|26801697|FG002|Overall Study|Lack of trial product|2|||
13399626|NCT00614120|26801698|FG003|Overall Study|Lack of trial product|0|||
13399627|NCT00614120|26801695|FG000|Overall Study|Late syphilis, latent|1|||
13399628|NCT00614120|26801696|FG001|Overall Study|Late syphilis, latent|0|||
13399629|NCT00614120|26801697|FG002|Overall Study|Late syphilis, latent|0|||
13399630|NCT00614120|26801698|FG003|Overall Study|Late syphilis, latent|0|||
13399631|NCT00614120|26801695|FG000|Overall Study|Taken inhibition medication eg Prandin|0|||
13399632|NCT00614120|26801696|FG001|Overall Study|Taken inhibition medication eg Prandin|0|||
13399633|NCT00614120|26801697|FG002|Overall Study|Taken inhibition medication eg Prandin|1|||
13399634|NCT00614120|26801698|FG003|Overall Study|Taken inhibition medication eg Prandin|1|||
13399635|NCT00614120|26801695|FG000|Overall Study|Lost to Follow-up|1|||
13399636|NCT00614120|26801696|FG001|Overall Study|Lost to Follow-up|2|||
13399637|NCT00614120|26801697|FG002|Overall Study|Lost to Follow-up|3|||
13399638|NCT00614120|26801698|FG003|Overall Study|Lost to Follow-up|4|||
13399639|NCT00614055|26801752|FG000|Overall Study|Adverse Event|1|||
13399640|NCT00614055|26801753|FG001|Overall Study|Adverse Event|0|||
13399641|NCT00614055|26801754|FG002|Overall Study|Adverse Event|0|||
13399642|NCT00614055|26801752|FG000|Overall Study|Protocol Violation|2|||
13399643|NCT00614055|26801753|FG001|Overall Study|Protocol Violation|2|||
13399644|NCT00614055|26801754|FG002|Overall Study|Protocol Violation|1|||
13399645|NCT00614055|26801752|FG000|Overall Study|Lack of Efficacy|0|||
13399646|NCT00614055|26801753|FG001|Overall Study|Lack of Efficacy|0|||
13399647|NCT00614055|26801754|FG002|Overall Study|Lack of Efficacy|2|||
13399648|NCT00614055|26801752|FG000|Overall Study|Unclassified|1|||
13399649|NCT00614055|26801753|FG001|Overall Study|Unclassified|4|||
13399650|NCT00614055|26801754|FG002|Overall Study|Unclassified|2|||
13399651|NCT00613951|26801805|FG000|Overall Study|Adverse Event|1|||
13399652|NCT00613951|26801806|FG001|Overall Study|Adverse Event|0|||
13399653|NCT00613951|26801807|FG002|Overall Study|Adverse Event|1|||
13399654|NCT00613951|26801805|FG000|Overall Study|Lack of Efficacy|0|||
13399655|NCT00613951|26801806|FG001|Overall Study|Lack of Efficacy|1|||
13399656|NCT00613951|26801807|FG002|Overall Study|Lack of Efficacy|1|||
13399657|NCT00613951|26801805|FG000|Overall Study|Protocol Violation|1|||
13399658|NCT00613951|26801806|FG001|Overall Study|Protocol Violation|1|||
13399659|NCT00613951|26801807|FG002|Overall Study|Protocol Violation|1|||
13399660|NCT00613951|26801805|FG000|Overall Study|Unclassified|5|||
13399661|NCT00613951|26801806|FG001|Overall Study|Unclassified|3|||
13399662|NCT00613951|26801807|FG002|Overall Study|Unclassified|2|||
13399663|NCT00613938|26801850|FG000|Overall Study|Withdrawal by Subject|2|||
13399664|NCT00613938|26801851|FG001|Overall Study|Withdrawal by Subject|4|||
13399665|NCT00613938|26801852|FG002|Overall Study|Withdrawal by Subject|9|||
13399666|NCT00613938|26801853|FG003|Overall Study|Withdrawal by Subject|9|||
13399667|NCT00613938|26801850|FG000|Overall Study|Adverse Event|1|||
13399668|NCT00613938|26801851|FG001|Overall Study|Adverse Event|4|||
13399669|NCT00613938|26801852|FG002|Overall Study|Adverse Event|8|||
13399670|NCT00613938|26801853|FG003|Overall Study|Adverse Event|5|||
13399671|NCT00613938|26801850|FG000|Overall Study|Lack of Efficacy|16|||
13399672|NCT00613938|26801851|FG001|Overall Study|Lack of Efficacy|18|||
13399673|NCT00613938|26801852|FG002|Overall Study|Lack of Efficacy|5|||
13399674|NCT00613938|26801853|FG003|Overall Study|Lack of Efficacy|9|||
13399675|NCT00613938|26801850|FG000|Overall Study|Other|1|||
13399676|NCT00613938|26801851|FG001|Overall Study|Other|2|||
13399677|NCT00613938|26801852|FG002|Overall Study|Other|1|||
13399678|NCT00613938|26801853|FG003|Overall Study|Other|3|||
13399679|NCT00613925|26801868|FG000|Overall Study|1 did not tolerate outpatient biopsy|0|||
13399680|NCT00613925|26801869|FG001|Overall Study|1 did not tolerate outpatient biopsy|1|||
13399681|NCT00613834|26801886|FG000|Overall Study|Withdrawal by Subject|0|||
13399682|NCT00613834|26801887|FG001|Overall Study|Withdrawal by Subject|3|||
13399683|NCT00613821|26801900|FG000|Overall Study|Withdrawal by Subject|1|||
13399684|NCT00613821|26801901|FG001|Overall Study|Withdrawal by Subject|0|||
13399685|NCT00613821|26801900|FG000|Overall Study|Physician Decision|1|||
13399686|NCT00613821|26801901|FG001|Overall Study|Physician Decision|1|||
13399687|NCT00613730|26801909|FG000|Overall Study|Disease progression|2|||
13399688|NCT00613730|26801909|FG000|Overall Study|Administrative decision|1|||
13399689|NCT00613626|26801935|FG000|Overall Study|Ineligible|0|||
13399690|NCT00613626|26801936|FG001|Overall Study|Ineligible|1|||
13399691|NCT00613626|26801937|FG002|Overall Study|Ineligible|0|||
13399692|NCT00613574|26801949|FG000|Overall Study|Adverse Event|3|||
13399693|NCT00613574|26801949|FG000|Overall Study|Lost to Follow-up|2|||
13399694|NCT00613574|26801949|FG000|Overall Study|Other|1|||
13399695|NCT00613509|26801978|FG000|Cycle 1|Adverse Event|2|||
13399696|NCT00613509|26801979|FG001|Cycle 1|Adverse Event|1|||
13399697|NCT00613509|26801978|FG000|Cycle 1|Disease Progression|2|||
13399698|NCT00613509|26801979|FG001|Cycle 1|Disease Progression|6|||
13399699|NCT00613509|26801978|FG000|Cycle 1|Unacceptable Toxicity|1|||
13399700|NCT00613509|26801979|FG001|Cycle 1|Unacceptable Toxicity|0|||
13399701|NCT00613509|26801978|FG000|Cycle 1|Other administrative reason|0|||
13399702|NCT00613509|26801979|FG001|Cycle 1|Other administrative reason|1|||
13399703|NCT00613366|26801994|FG000|Overall Study|Withdrawal by Subject|3|||
13399704|NCT00613366|26801995|FG001|Overall Study|Withdrawal by Subject|2|||
13399705|NCT00613327|26802016|FG000|Overall Study|Adverse Event|38|||
13399706|NCT00613327|26802016|FG000|Overall Study|Lost to Follow-up|8|||
13399707|NCT00613327|26802016|FG000|Overall Study|Withdrawal by Subject|6|||
13399708|NCT00613327|26802016|FG000|Overall Study|Protocol Violation|2|||
13399709|NCT00613327|26802016|FG000|Overall Study|Other|47|||
13399710|NCT00613314|26802026|FG000|Overall Study|Adverse Event|5|||
13399711|NCT00613314|26802026|FG000|Overall Study|Protocol Violation|14|||
13399712|NCT00613314|26802026|FG000|Overall Study|Lost to Follow-up|46|||
13399713|NCT00613314|26802026|FG000|Overall Study|Other reason not defined above|90|||
13399714|NCT00613301|26802035|FG000|Overall Study|Adverse Event|49|||
13399715|NCT00613301|26802035|FG000|Overall Study|Lost to Follow-up|88|||
13399716|NCT00613301|26802035|FG000|Overall Study|Withdrawal by Subject|5|||
13399717|NCT00613301|26802035|FG000|Overall Study|Death|6|||
13399718|NCT00613301|26802035|FG000|Overall Study|Lack of Efficacy|13|||
13399719|NCT00613301|26802035|FG000|Overall Study|Physician Decision|2|||
13399720|NCT00613301|26802035|FG000|Overall Study|No data was collected|53|||
13399721|NCT00613301|26802035|FG000|Overall Study|Irregularly enrolled patients|12|||
13399722|NCT00613171|26802043|FG000|Overall Study|Adverse Event|7|||
13399723|NCT00613171|26802043|FG000|Overall Study|Withdrawal by Subject|3|||
13399724|NCT00613171|26802043|FG000|Overall Study|Reason not Specified|4|||
13399725|NCT00613106|26802056|FG000|Overall Study|Adverse Event|3|||
13399726|NCT00613106|26802057|FG001|Overall Study|Adverse Event|1|||
13399727|NCT00613106|26802056|FG000|Overall Study|Withdrawal by Subject|6|||
13399728|NCT00613106|26802057|FG001|Overall Study|Withdrawal by Subject|3|||
13399729|NCT00613106|26802056|FG000|Overall Study|Lost to Follow-up|7|||
13399730|NCT00613106|26802057|FG001|Overall Study|Lost to Follow-up|2|||
13399731|NCT00613106|26802056|FG000|Overall Study|misc|4|||
13399732|NCT00613106|26802057|FG001|Overall Study|misc|3|||
13399733|NCT00613080|26802071|FG000|Overall Study|Ineligible / no protocol treatment|11|||
13399734|NCT00613015|26802110|FG000|Overall Study|Lost to Follow-up|0|||
13399735|NCT00613015|26802111|FG001|Overall Study|Lost to Follow-up|1|||
13399736|NCT00613015|26802112|FG002|Overall Study|Lost to Follow-up|3|||
13399737|NCT00613015|26802113|FG003|Overall Study|Lost to Follow-up|3|||
13399738|NCT00613015|26802114|FG004|Overall Study|Lost to Follow-up|2|||
13399739|NCT00613015|26802115|FG005|Overall Study|Lost to Follow-up|3|||
13399740|NCT00612807|26802130|FG000|Overall Study|Withdrawal by Subject|2|||
13399741|NCT00612807|26802131|FG001|Overall Study|Withdrawal by Subject|0|||
13399742|NCT00612690|26802146|FG000|Overall Study|Lost to Follow-up|72|||
13399743|NCT00612690|26802147|FG001|Overall Study|Lost to Follow-up|98|||
13399744|NCT00612690|26802146|FG000|Overall Study|Withdrawal by Subject|32|||
13399745|NCT00612690|26802147|FG001|Overall Study|Withdrawal by Subject|20|||
13399746|NCT00612690|26802146|FG000|Overall Study|Withdrawal by Site|11|||
13399747|NCT00612690|26802147|FG001|Overall Study|Withdrawal by Site|0|||
13399748|NCT00612677|26802155|FG000|Overall Study|study closed before treatment started|1|||
13399749|NCT00612586|26802176|FG000|Overall Study|Adverse Event|6|||
13399750|NCT00612586|26802177|FG001|Overall Study|Adverse Event|2|||
13399751|NCT00612586|26802176|FG000|Overall Study|Death|1|||
13399752|NCT00612586|26802177|FG001|Overall Study|Death|0|||
13399753|NCT00612586|26802176|FG000|Overall Study|Entry Criteria Not Met|0|||
13399754|NCT00612586|26802177|FG001|Overall Study|Entry Criteria Not Met|2|||
13399755|NCT00612586|26802176|FG000|Overall Study|Withdrawal by Subject|7|||
13399756|NCT00612586|26802177|FG001|Overall Study|Withdrawal by Subject|9|||
13399757|NCT00612586|26802176|FG000|Overall Study|Physician Decision|1|||
13399758|NCT00612586|26802177|FG001|Overall Study|Physician Decision|2|||
13399759|NCT00612586|26802176|FG000|Overall Study|Sponsor Decision|1|||
13399760|NCT00612586|26802177|FG001|Overall Study|Sponsor Decision|1|||
13399761|NCT00612586|26802176|FG000|Overall Study|Progressive Disease|26|||
13399762|NCT00612586|26802177|FG001|Overall Study|Progressive Disease|24|||
13399763|NCT00612586|26802176|FG000|Overall Study|Randomized and Not Treated|1|||
13399764|NCT00612586|26802177|FG001|Overall Study|Randomized and Not Treated|1|||
13399765|NCT00612534|26802200|FG000|Overall Study|Adverse Event|0|||
13399766|NCT00612534|26802201|FG001|Overall Study|Adverse Event|4|||
13399767|NCT00612534|26802202|FG002|Overall Study|Adverse Event|2|||
13399768|NCT00612534|26802203|FG003|Overall Study|Adverse Event|1|||
13399769|NCT00612534|26802200|FG000|Overall Study|Lack of Efficacy|13|||
13399770|NCT00612534|26802201|FG001|Overall Study|Lack of Efficacy|12|||
13399771|NCT00612534|26802202|FG002|Overall Study|Lack of Efficacy|5|||
13399772|NCT00612534|26802203|FG003|Overall Study|Lack of Efficacy|16|||
13399773|NCT00612534|26802200|FG000|Overall Study|Other Reason|0|||
13399774|NCT00612534|26802201|FG001|Overall Study|Other Reason|1|||
13399775|NCT00612534|26802202|FG002|Overall Study|Other Reason|0|||
13399776|NCT00612534|26802203|FG003|Overall Study|Other Reason|0|||
13399777|NCT00612508|26802218|FG000|Overall Study|Withdrawal by Subject|3|||
13399778|NCT00612508|26802219|FG001|Overall Study|Withdrawal by Subject|4|||
13399779|NCT00612456|26802273|FG000|Overall Study|Adverse Event|1|||
13399780|NCT00612456|26802274|FG001|Overall Study|Adverse Event|0|||
13399781|NCT00612456|26802275|FG002|Overall Study|Adverse Event|0|||
13399782|NCT00612456|26802273|FG000|Overall Study|Lack of Efficacy|1|||
13399783|NCT00612456|26802274|FG001|Overall Study|Lack of Efficacy|1|||
13399784|NCT00612456|26802275|FG002|Overall Study|Lack of Efficacy|0|||
13399785|NCT00612456|26802273|FG000|Overall Study|Withdrawal by Subject|0|||
13399786|NCT00612456|26802274|FG001|Overall Study|Withdrawal by Subject|1|||
13399787|NCT00612456|26802275|FG002|Overall Study|Withdrawal by Subject|0|||
13399788|NCT00612352|26802396|FG000|Overall Study|Adverse Event|1|||
13399789|NCT00612352|26802397|FG001|Overall Study|Adverse Event|0|||
13399790|NCT00612352|26802396|FG000|Overall Study|Withdrawal by Subject|3|||
13399791|NCT00612352|26802397|FG001|Overall Study|Withdrawal by Subject|5|||
13399792|NCT00612352|26802396|FG000|Overall Study|moved out of state|1|||
13399793|NCT00612352|26802397|FG001|Overall Study|moved out of state|0|||
13399794|NCT00612352|26802396|FG000|Overall Study|didn't return calls/show up on test date|4|||
13399795|NCT00612352|26802397|FG001|Overall Study|didn't return calls/show up on test date|1|||
13399796|NCT00612313|26802420|FG000|Overall Study|Withdrawal by Subject|6|||
13399797|NCT00612313|26802421|FG001|Overall Study|Withdrawal by Subject|9|||
13399798|NCT00612313|26802420|FG000|Overall Study|Lost to Follow-up|11|||
13399799|NCT00612313|26802421|FG001|Overall Study|Lost to Follow-up|4|||
13399800|NCT00612105|26802478|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18|||
13399801|NCT00612105|26802479|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1|||
13399802|NCT00612105|26802478|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6|||
13399803|NCT00612105|26802479|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1|||
13399804|NCT00612105|26802478|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2|||
13399805|NCT00612105|26802479|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0|||
13399806|NCT00612105|26802478|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
13399807|NCT00612105|26802479|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
13399808|NCT00612105|26802478|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1|||
13399809|NCT00612105|26802479|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0|||
13399810|NCT00612105|26802478|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3|||
13399811|NCT00612105|26802479|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1|||
13399812|NCT00612105|26802478|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5|||
13399813|NCT00612105|26802479|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0|||
13399814|NCT00612105|26802478|FG000|Period Title 1: 6-Week Titration Phase|Other|0|||
13399815|NCT00612105|26802479|FG001|Period Title 1: 6-Week Titration Phase|Other|1|||
13399816|NCT00612105|26802478|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9|||
13399817|NCT00612105|26802479|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1|||
13399818|NCT00612105|26802478|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
13399819|NCT00612105|26802479|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
13399820|NCT00612105|26802478|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1|||
13399821|NCT00612105|26802479|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0|||
13399822|NCT00612105|26802478|FG000|Period Title 3: 3-Week Taper Phase|Other|1|||
13399823|NCT00612105|26802479|FG001|Period Title 3: 3-Week Taper Phase|Other|0|||
13399824|NCT00612066|26802485|FG000|Overall Study|Adverse Event|1|||
13399825|NCT00612040|26802539|FG000|Overall Study|Adverse Event|0|||
13399826|NCT00612040|26802540|FG001|Overall Study|Adverse Event|2|||
13399827|NCT00612040|26802541|FG002|Overall Study|Adverse Event|1|||
13399828|NCT00612040|26802539|FG000|Overall Study|Protocol Violation|1|||
13399829|NCT00612040|26802540|FG001|Overall Study|Protocol Violation|2|||
13399830|NCT00612040|26802541|FG002|Overall Study|Protocol Violation|1|||
13399831|NCT00612040|26802539|FG000|Overall Study|Lack of Efficacy|2|||
13399832|NCT00612040|26802540|FG001|Overall Study|Lack of Efficacy|1|||
13399833|NCT00612040|26802541|FG002|Overall Study|Lack of Efficacy|0|||
13399834|NCT00612040|26802539|FG000|Overall Study|Unclassified|2|||
13399835|NCT00612040|26802540|FG001|Overall Study|Unclassified|2|||
13399836|NCT00612040|26802541|FG002|Overall Study|Unclassified|5|||
13399837|NCT00611975|26802574|FG000|Overall Study|Withdrawal by Subject|3|||
13399838|NCT00611975|26802575|FG001|Overall Study|Withdrawal by Subject|7|||
13399839|NCT00611975|26802574|FG000|Overall Study|Pregnancy|2|||
13399840|NCT00611975|26802575|FG001|Overall Study|Pregnancy|1|||
13399841|NCT00611923|26802598|FG000|Overall Study|Withdrawal by Subject|2|||
13399842|NCT00611923|26802599|FG001|Overall Study|Withdrawal by Subject|2|||
13399843|NCT00611884|26802666|FG000|Overall Study|Adverse Event|1|||
13399844|NCT00611884|26802667|FG001|Overall Study|Adverse Event|0|||
13399845|NCT00611884|26802668|FG002|Overall Study|Adverse Event|0|||
13399846|NCT00611884|26802669|FG003|Overall Study|Adverse Event|1|||
13399847|NCT00611884|26802666|FG000|Overall Study|Non-Compliance|1|||
13399848|NCT00611884|26802667|FG001|Overall Study|Non-Compliance|4|||
13399849|NCT00611884|26802668|FG002|Overall Study|Non-Compliance|2|||
13399850|NCT00611884|26802669|FG003|Overall Study|Non-Compliance|2|||
13399851|NCT00611884|26802666|FG000|Overall Study|Lack of Efficacy|0|||
13399852|NCT00611884|26802667|FG001|Overall Study|Lack of Efficacy|1|||
13399853|NCT00611884|26802668|FG002|Overall Study|Lack of Efficacy|0|||
13399854|NCT00611884|26802669|FG003|Overall Study|Lack of Efficacy|0|||
13399855|NCT00611884|26802666|FG000|Overall Study|Unclassified|7|||
13399856|NCT00611884|26802667|FG001|Overall Study|Unclassified|4|||
13399857|NCT00611884|26802668|FG002|Overall Study|Unclassified|2|||
13399858|NCT00611884|26802669|FG003|Overall Study|Unclassified|3|||
13399859|NCT00611858|26802681|FG000|Overall Study|Adverse Event|2|||
13399860|NCT00611858|26802681|FG000|Overall Study|Withdrawal by Subject|2|||
13399861|NCT00611806|26802700|FG000|Overall Study|Withdrawal by Subject|8|||
13399862|NCT00611806|26802701|FG001|Overall Study|Withdrawal by Subject|2|||
13399863|NCT00611806|26802700|FG000|Overall Study|Adverse Event|2|||
13399864|NCT00611806|26802701|FG001|Overall Study|Adverse Event|1|||
13399865|NCT00611806|26802700|FG000|Overall Study|Lost to Follow-up|6|||
13399866|NCT00611806|26802701|FG001|Overall Study|Lost to Follow-up|0|||
13399867|NCT00611767|26802868|FG000|Overall Study|Withdrawal by Subject|4|||
13399868|NCT00611767|26802869|FG001|Overall Study|Withdrawal by Subject|1|||
13399869|NCT00611767|26802868|FG000|Overall Study|Thiopental not available|3|||
13399870|NCT00611767|26802869|FG001|Overall Study|Thiopental not available|0|||
13399871|NCT00611767|26802868|FG000|Overall Study|didn't like the medication|1|||
13399872|NCT00611767|26802869|FG001|Overall Study|didn't like the medication|1|||
13399873|NCT00611767|26802868|FG000|Overall Study|Physician Decision|1|||
13399874|NCT00611767|26802869|FG001|Overall Study|Physician Decision|0|||
13399875|NCT00611715|26802888|FG000|Overall Study|Disease Progression|24|||
13399876|NCT00611715|26802889|FG001|Overall Study|Disease Progression|4|||
13399877|NCT00611715|26802888|FG000|Overall Study|Withdrawal by Subject|5|||
13399878|NCT00611715|26802889|FG001|Overall Study|Withdrawal by Subject|1|||
13399879|NCT00611715|26802888|FG000|Overall Study|Adverse Event|9|||
13399880|NCT00611715|26802889|FG001|Overall Study|Adverse Event|1|||
13399881|NCT00611715|26802888|FG000|Overall Study|Death|1|||
13399882|NCT00611715|26802889|FG001|Overall Study|Death|0|||
13399883|NCT00611715|26802888|FG000|Overall Study|two patients are still on treatment|2|||
13399884|NCT00611715|26802889|FG001|Overall Study|two patients are still on treatment|0|||
13399885|NCT00611559|26802958|FG000|Overall Study|Lost to Follow-up|0|||
13399886|NCT00611559|26802959|FG001|Overall Study|Lost to Follow-up|1|||
13399887|NCT00611559|26802960|FG002|Overall Study|Lost to Follow-up|0|||
13399888|NCT00611559|26802958|FG000|Overall Study|Protocol Violation|1|||
13399889|NCT00611559|26802959|FG001|Overall Study|Protocol Violation|0|||
13399890|NCT00611559|26802960|FG002|Overall Study|Protocol Violation|1|||
13399891|NCT00611533|26802982|FG000|First Intervention (6 Weeks)|Never started study|0|||
13399892|NCT00611533|26802983|FG001|First Intervention (6 Weeks)|Never started study|1|||
13399893|NCT00611533|26802982|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
13399894|NCT00611533|26802983|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
13399895|NCT00611533|26802982|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
13399896|NCT00611533|26802983|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
13399897|NCT00611455|26803117|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2|||
13399898|NCT00611455|26803118|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8|||
13399899|NCT00611455|26803119|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
13399900|NCT00611455|26803117|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2|||
13399901|NCT00611455|26803118|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
13399902|NCT00611455|26803119|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
13399903|NCT00611455|26803117|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4|||
13399904|NCT00611455|26803118|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
13399905|NCT00611455|26803119|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
13399906|NCT00611455|26803117|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
13399907|NCT00611455|26803118|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
13399908|NCT00611455|26803119|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
13399909|NCT00611455|26803117|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
13399910|NCT00611455|26803118|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
13399911|NCT00611455|26803119|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0|||
13399912|NCT00611455|26803117|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1|||
13399913|NCT00611455|26803118|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
13399914|NCT00611455|26803119|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
13399915|NCT00611455|26803117|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
13399916|NCT00611455|26803118|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17|||
13399917|NCT00611455|26803119|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
13399918|NCT00611455|26803117|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
13399919|NCT00611455|26803118|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9|||
13399920|NCT00611455|26803119|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
13399921|NCT00611455|26803117|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
13399922|NCT00611455|26803118|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3|||
13399923|NCT00611455|26803119|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
13399924|NCT00611455|26803117|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
13399925|NCT00611455|26803118|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12|||
13399926|NCT00611455|26803119|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
13399927|NCT00611455|26803117|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
13399928|NCT00611455|26803118|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110|||
13399929|NCT00611455|26803119|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
13399930|NCT00611455|26803117|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
13399931|NCT00611455|26803118|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5|||
13399932|NCT00611455|26803119|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
13399933|NCT00611455|26803117|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
13399934|NCT00611455|26803118|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5|||
13399935|NCT00611455|26803119|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
13399936|NCT00611455|26803117|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
13399937|NCT00611455|26803118|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18|||
13399938|NCT00611455|26803119|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
13399939|NCT00611455|26803117|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
13399940|NCT00611455|26803118|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
13399941|NCT00611455|26803119|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30|||
13399942|NCT00611455|26803117|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
13399943|NCT00611455|26803118|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
13399944|NCT00611455|26803119|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12|||
13399945|NCT00611455|26803117|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
13399946|NCT00611455|26803118|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
13399947|NCT00611455|26803119|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4|||
13399948|NCT00611455|26803117|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
13399949|NCT00611455|26803118|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
13399950|NCT00611455|26803119|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23|||
13399951|NCT00611455|26803117|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
13399952|NCT00611455|26803118|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
13399953|NCT00611455|26803119|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80|||
13399954|NCT00611455|26803117|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
13399955|NCT00611455|26803118|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
13399956|NCT00611455|26803119|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13|||
13399957|NCT00611455|26803117|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
13399958|NCT00611455|26803118|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
13399959|NCT00611455|26803119|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49|||
13399960|NCT00611247|26803136|FG000|Overall Study|Death|1|||
13399961|NCT00611247|26803137|FG001|Overall Study|Death|5|||
13399962|NCT00611247|26803136|FG000|Overall Study|Lack of Efficacy|1|||
13399963|NCT00611247|26803137|FG001|Overall Study|Lack of Efficacy|16|||
13399964|NCT00611130|26803151|FG000|Overall Study|Lost to Follow-up|25|||
13399965|NCT00611130|26803152|FG001|Overall Study|Lost to Follow-up|29|||
13399966|NCT00611130|26803151|FG000|Overall Study|Protocol noncompliance|7|||
13399967|NCT00611130|26803152|FG001|Overall Study|Protocol noncompliance|6|||
13399968|NCT00611130|26803151|FG000|Overall Study|Withdrawal by Subject|6|||
13399969|NCT00611130|26803152|FG001|Overall Study|Withdrawal by Subject|5|||
13399970|NCT00611130|26803151|FG000|Overall Study|Other|5|||
13399971|NCT00611130|26803152|FG001|Overall Study|Other|4|||
13399972|NCT00611130|26803151|FG000|Overall Study|Incarceration|3|||
13399973|NCT00611130|26803152|FG001|Overall Study|Incarceration|2|||
13399974|NCT00611130|26803151|FG000|Overall Study|Administrative|1|||
13399975|NCT00611130|26803152|FG001|Overall Study|Administrative|1|||
13399976|NCT00611130|26803151|FG000|Overall Study|Adverse Event|1|||
13399977|NCT00611130|26803152|FG001|Overall Study|Adverse Event|0|||
13399978|NCT00611130|26803151|FG000|Overall Study|Death|1|||
13399979|NCT00611130|26803152|FG001|Overall Study|Death|0|||
13399980|NCT00611026|26803226|FG000|Randomized to Double-blind Treatment|Not treated|2|||
13399981|NCT00611026|26803227|FG001|Randomized to Double-blind Treatment|Not treated|1|||
13399982|NCT00611026|26803228|FG002|Randomized to Double-blind Treatment|Not treated|3|||
13399983|NCT00611026|26803226|FG000|Double-blind Treatment Period|Death|1|||
13399984|NCT00611026|26803227|FG001|Double-blind Treatment Period|Death|0|||
13399985|NCT00611026|26803228|FG002|Double-blind Treatment Period|Death|0|||
13399986|NCT00611026|26803226|FG000|Double-blind Treatment Period|Adverse Event|9|||
13399987|NCT00611026|26803227|FG001|Double-blind Treatment Period|Adverse Event|28|||
13399988|NCT00611026|26803228|FG002|Double-blind Treatment Period|Adverse Event|46|||
13399989|NCT00611026|26803226|FG000|Double-blind Treatment Period|Lack of Efficacy|11|||
13399990|NCT00611026|26803227|FG001|Double-blind Treatment Period|Lack of Efficacy|10|||
13399991|NCT00611026|26803228|FG002|Double-blind Treatment Period|Lack of Efficacy|4|||
13399992|NCT00611026|26803226|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
13399993|NCT00611026|26803227|FG001|Double-blind Treatment Period|Lost to Follow-up|11|||
13399994|NCT00611026|26803228|FG002|Double-blind Treatment Period|Lost to Follow-up|14|||
13399995|NCT00611026|26803226|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
13399996|NCT00611026|26803227|FG001|Double-blind Treatment Period|Withdrawal by Subject|19|||
13399997|NCT00611026|26803228|FG002|Double-blind Treatment Period|Withdrawal by Subject|16|||
13399998|NCT00611026|26803226|FG000|Double-blind Treatment Period|Other|13|||
13399999|NCT00611026|26803227|FG001|Double-blind Treatment Period|Other|20|||
13400000|NCT00611026|26803228|FG002|Double-blind Treatment Period|Other|18|||
13400001|NCT00610935|26803243|FG000|Overall Study|Lost to Follow-up|0|||
13400002|NCT00610935|26803244|FG001|Overall Study|Lost to Follow-up|1|||
13400003|NCT00610935|26803243|FG000|Overall Study|Withdrawal by Subject|0|||
13400004|NCT00610935|26803244|FG001|Overall Study|Withdrawal by Subject|2|||
13400005|NCT00610935|26803243|FG000|Overall Study|Sponsor Discontinuation|1|||
13400006|NCT00610935|26803244|FG001|Overall Study|Sponsor Discontinuation|0|||
13400007|NCT00610857|26803253|FG000|Overall Study|Not evaluable for response|2|||
13400008|NCT00610714|26803270|FG000|Overall Study|Adverse Event|3|||
13400009|NCT00610714|26803271|FG001|Overall Study|Adverse Event|1|||
13400010|NCT00610714|26803270|FG000|Overall Study|Death|12|||
13400011|NCT00610714|26803271|FG001|Overall Study|Death|18|||
13400012|NCT00610714|26803270|FG000|Overall Study|Withdrawal by Subject|9|||
13400013|NCT00610714|26803271|FG001|Overall Study|Withdrawal by Subject|3|||
13400014|NCT00610714|26803270|FG000|Overall Study|Study completion at 120 PFS events|2|||
13400015|NCT00610714|26803271|FG001|Overall Study|Study completion at 120 PFS events|2|||
13400016|NCT00610675|26803284|FG000|Overall Study|Untreated|4|||
13400017|NCT00610675|26803284|FG000|Overall Study|Adverse Event|67|||
13400018|NCT00610675|26803284|FG000|Overall Study|Insufficient Effect|31|||
13400019|NCT00610675|26803284|FG000|Overall Study|Withdrawal by Subject|28|||
13400020|NCT00610675|26803284|FG000|Overall Study|Reasons unrelated to trial|27|||
13400021|NCT00610675|26803284|FG000|Overall Study|Lack of Compliance|7|||
13400022|NCT00610675|26803284|FG000|Overall Study|Lost to Follow-up|31|||
13400023|NCT00610675|26803284|FG000|Overall Study|Other reason (not specified)|25|||
13400024|NCT00610649|26803372|FG000|Overall Study|Adverse Event|1|||
13400025|NCT00610649|26803373|FG001|Overall Study|Adverse Event|0|||
13400026|NCT00610649|26803374|FG002|Overall Study|Adverse Event|0|||
13400027|NCT00610649|26803375|FG003|Overall Study|Adverse Event|0|||
13400028|NCT00610649|26803376|FG004|Overall Study|Adverse Event|0|||
13400029|NCT00610649|26803377|FG005|Overall Study|Adverse Event|0|||
13400030|NCT00610649|26803378|FG006|Overall Study|Adverse Event|0|||
13400031|NCT00610649|26803379|FG007|Overall Study|Adverse Event|0|||
13400032|NCT00610649|26803380|FG008|Overall Study|Adverse Event|0|||
13400033|NCT00610649|26803381|FG009|Overall Study|Adverse Event|0|||
13400034|NCT00610649|26803382|FG010|Overall Study|Adverse Event|1|||
13400035|NCT00610649|26803372|FG000|Overall Study|Family Emergency|0|||
13400036|NCT00610649|26803373|FG001|Overall Study|Family Emergency|1|||
13400037|NCT00610649|26803374|FG002|Overall Study|Family Emergency|0|||
13400038|NCT00610649|26803375|FG003|Overall Study|Family Emergency|0|||
13400039|NCT00610649|26803376|FG004|Overall Study|Family Emergency|0|||
13400040|NCT00610649|26803377|FG005|Overall Study|Family Emergency|0|||
13400041|NCT00610649|26803378|FG006|Overall Study|Family Emergency|0|||
13400042|NCT00610649|26803379|FG007|Overall Study|Family Emergency|0|||
13400043|NCT00610649|26803380|FG008|Overall Study|Family Emergency|0|||
13400044|NCT00610649|26803381|FG009|Overall Study|Family Emergency|0|||
13400045|NCT00610649|26803382|FG010|Overall Study|Family Emergency|0|||
13400046|NCT00610649|26803372|FG000|Overall Study|Withdrawal by Subject|0|||
13400047|NCT00610649|26803373|FG001|Overall Study|Withdrawal by Subject|0|||
13400048|NCT00610649|26803374|FG002|Overall Study|Withdrawal by Subject|0|||
13400049|NCT00610649|26803375|FG003|Overall Study|Withdrawal by Subject|0|||
13400050|NCT00610649|26803376|FG004|Overall Study|Withdrawal by Subject|0|||
13400051|NCT00610649|26803377|FG005|Overall Study|Withdrawal by Subject|0|||
13400052|NCT00610649|26803378|FG006|Overall Study|Withdrawal by Subject|0|||
13400053|NCT00610649|26803379|FG007|Overall Study|Withdrawal by Subject|0|||
13400054|NCT00610649|26803380|FG008|Overall Study|Withdrawal by Subject|0|||
13400055|NCT00610649|26803381|FG009|Overall Study|Withdrawal by Subject|1|||
13400056|NCT00610649|26803382|FG010|Overall Study|Withdrawal by Subject|0|||
13400057|NCT00610441|26803486|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
13400058|NCT00610441|26803487|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
13400059|NCT00610441|26803488|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4|||
13400060|NCT00610441|26803489|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
13400061|NCT00610441|26803486|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
13400062|NCT00610441|26803487|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
13400063|NCT00610441|26803488|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1|||
13400064|NCT00610441|26803489|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
13400065|NCT00610441|26803486|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
13400066|NCT00610441|26803487|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
13400067|NCT00610441|26803488|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
13400068|NCT00610441|26803489|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0|||
13400069|NCT00610441|26803486|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
13400070|NCT00610441|26803487|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0|||
13400071|NCT00610441|26803488|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
13400072|NCT00610441|26803489|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
13400073|NCT00610441|26803486|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
13400074|NCT00610441|26803487|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
13400075|NCT00610441|26803488|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2|||
13400076|NCT00610441|26803489|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
13400077|NCT00610441|26803486|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
13400078|NCT00610441|26803487|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1|||
13400079|NCT00610441|26803488|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
13400080|NCT00610441|26803489|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
13400081|NCT00610441|26803486|FG000|Treatment Period 2 - 3 Weeks|Other|1|||
13400082|NCT00610441|26803487|FG001|Treatment Period 2 - 3 Weeks|Other|1|||
13400083|NCT00610441|26803488|FG002|Treatment Period 2 - 3 Weeks|Other|0|||
13400084|NCT00610441|26803489|FG003|Treatment Period 2 - 3 Weeks|Other|1|||
13400085|NCT00610441|26803486|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
13400086|NCT00610441|26803487|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
13400087|NCT00610441|26803488|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
13400088|NCT00610441|26803489|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1|||
13400089|NCT00610441|26803486|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1|||
13400090|NCT00610441|26803487|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
13400091|NCT00610441|26803488|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
13400092|NCT00610441|26803489|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
13400093|NCT00610363|26803514|FG000|Overall Study|Non-compliance with protocol|0|||
13400094|NCT00610363|26803515|FG001|Overall Study|Non-compliance with protocol|1|||
13400095|NCT00610363|26803514|FG000|Overall Study|Adverse Event|3|||
13400096|NCT00610363|26803515|FG001|Overall Study|Adverse Event|1|||
13400097|NCT00610363|26803514|FG000|Overall Study|Lack of Efficacy|2|||
13400098|NCT00610363|26803515|FG001|Overall Study|Lack of Efficacy|0|||
13400099|NCT00610363|26803514|FG000|Overall Study|Lost to Follow-up|4|||
13400100|NCT00610363|26803515|FG001|Overall Study|Lost to Follow-up|0|||
13400101|NCT00610363|26803514|FG000|Overall Study|Withdrawal by Subject|1|||
13400102|NCT00610363|26803515|FG001|Overall Study|Withdrawal by Subject|0|||
13400103|NCT00610363|26803514|FG000|Overall Study|Other than specified above|1|||
13400104|NCT00610363|26803515|FG001|Overall Study|Other than specified above|1|||
13400105|NCT00610207|26803522|FG000|Overall Study|Lost to Follow-up|3|||
13400106|NCT00610168|26803548|FG000|Overall Study|Withdrawal by Subject|2|||
13400107|NCT00610168|26803549|FG001|Overall Study|Withdrawal by Subject|0|||
13400108|NCT00610155|26803603|FG000|Period 1|Withdrawal by Subject|0|||
13400109|NCT00610155|26803604|FG001|Period 1|Withdrawal by Subject|0|||
13400110|NCT00610155|26803605|FG002|Period 1|Withdrawal by Subject|1|||
13400111|NCT00610155|26803606|FG003|Period 1|Withdrawal by Subject|0|||
13400112|NCT00610155|26803607|FG004|Period 1|Withdrawal by Subject|0|||
13400113|NCT00610155|26803608|FG005|Period 1|Withdrawal by Subject|0|||
13400114|NCT00610155|26803603|FG000|Period 3|Adverse Event|1|||
13400115|NCT00610155|26803604|FG001|Period 3|Adverse Event|0|||
13400116|NCT00610155|26803605|FG002|Period 3|Adverse Event|0|||
13400117|NCT00610155|26803606|FG003|Period 3|Adverse Event|0|||
13400118|NCT00610155|26803607|FG004|Period 3|Adverse Event|0|||
13400119|NCT00610155|26803608|FG005|Period 3|Adverse Event|0|||
13400120|NCT00610129|26803614|FG000|Overall Study|Not treated since patients ineligible|3|||
13400121|NCT00609986|26803633|FG000|Overall Study|Did not receive transplant or treatment|8|||
13400122|NCT00609986|26803634|FG001|Overall Study|Did not receive transplant or treatment|3|||
13400123|NCT00609973|26803649|FG000|Overall Study|Adverse Event|2|||
13400124|NCT00609973|26803650|FG001|Overall Study|Adverse Event|1|||
13400125|NCT00609973|26803649|FG000|Overall Study|Protocol Violation|4|||
13400126|NCT00609973|26803650|FG001|Overall Study|Protocol Violation|3|||
13400127|NCT00609973|26803649|FG000|Overall Study|Lost to Follow-up|2|||
13400128|NCT00609973|26803650|FG001|Overall Study|Lost to Follow-up|1|||
13400129|NCT00609973|26803649|FG000|Overall Study|Withdrawal by Subject|0|||
13400130|NCT00609973|26803650|FG001|Overall Study|Withdrawal by Subject|1|||
13475972|NCT02539225|27001595|FG000|Part A|Adverse Event|13|||
13475973|NCT02539225|27001596|FG001|Part A|Adverse Event|4|||
13475974|NCT02539225|27001595|FG000|Part A|Withdrawal by Subject|2|||
13475975|NCT02539225|27001596|FG001|Part A|Withdrawal by Subject|4|||
13475976|NCT02539225|27001595|FG000|Part A|Physician Decision|4|||
13475977|NCT02539225|27001596|FG001|Part A|Physician Decision|7|||
13475978|NCT02539225|27001595|FG000|Part A|Did Not Receive study Drug|1|||
13475979|NCT02539225|27001596|FG001|Part A|Did Not Receive study Drug|1|||
13475980|NCT02539225|27001595|FG000|Pre Treatment for Part B|Progressive disease|1|||
13475981|NCT02539225|27001596|FG001|Pre Treatment for Part B|Progressive disease|1|||
13475982|NCT02539225|27001595|FG000|Pre Treatment for Part B|Adverse Event|1|||
13475983|NCT02539225|27001596|FG001|Pre Treatment for Part B|Adverse Event|1|||
13475984|NCT02539225|27001595|FG000|Pre Treatment for Part B|Withdrawal by Subject|1|||
13475985|NCT02539225|27001596|FG001|Pre Treatment for Part B|Withdrawal by Subject|0|||
13475986|NCT02539225|27001595|FG000|Pre Treatment for Part B|Physician Decision|2|||
13475987|NCT02539225|27001596|FG001|Pre Treatment for Part B|Physician Decision|0|||
13475988|NCT02539225|27001595|FG000|Part B|Adverse Event|4|||
13475989|NCT02539225|27001596|FG001|Part B|Adverse Event|4|||
13475990|NCT02539225|27001595|FG000|Part B|Withdrawal by Subject|0|||
13475991|NCT02539225|27001596|FG001|Part B|Withdrawal by Subject|3|||
13475992|NCT02539225|27001595|FG000|Part B|Physician Decision|0|||
13475993|NCT02539225|27001596|FG001|Part B|Physician Decision|9|||
13475994|NCT02526017|27001753|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
13475995|NCT02526017|27001754|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
13475996|NCT02526017|27001755|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
13475997|NCT02526017|27001756|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
13475998|NCT02526017|27001757|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1|||
13475999|NCT02526017|27001758|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
13476000|NCT02526017|27001759|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
13476001|NCT02526017|27001760|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
13476002|NCT02526017|27001761|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
13476003|NCT02369653|27001834|FG000|Overall Study|Lost to Follow-up|0|||
13476004|NCT02369653|27001835|FG001|Overall Study|Lost to Follow-up|1|||
13400131|NCT00609947|26803657|FG000|Overall Study|Death|1|||
13400132|NCT00609869|26803665|FG000|Overall Study|Withdrawn, ischemic stroke|1|||
13400133|NCT00609869|26803665|FG000|Overall Study|Severe hematologic toxicity|1|||
13400134|NCT00609869|26803665|FG000|Overall Study|Withdrawal by Subject|1|||
13400135|NCT00609869|26803665|FG000|Overall Study|Seizures|1|||
13400136|NCT00609869|26803665|FG000|Overall Study|Severe tumor flare reaction|1|||
13400137|NCT00609869|26803665|FG000|Overall Study|Hepatitis B infection|1|||
13400138|NCT00609869|26803665|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1|||
13400139|NCT00609869|26803665|FG000|Overall Study|Mantle cell: not evaluable|4|||
13400140|NCT00609791|26803678|FG000|Overall Study|Subject was deemed ineligible after starting study procedures|1|||
13400141|NCT00609765|26803685|FG000|Overall Study|Study ended prior to 12 months|1|||
13400142|NCT00609674|26803726|FG000|Overall Study|Adverse Event|1|||
13400143|NCT00609674|26803727|FG001|Overall Study|Adverse Event|1|||
13400144|NCT00609674|26803726|FG000|Overall Study|Protocol Violation|3|||
13400145|NCT00609674|26803727|FG001|Overall Study|Protocol Violation|5|||
13400146|NCT00609674|26803726|FG000|Overall Study|Lost to Follow-up|1|||
13400147|NCT00609674|26803727|FG001|Overall Study|Lost to Follow-up|0|||
13400148|NCT00609674|26803726|FG000|Overall Study|Withdrew consent|2|||
13400149|NCT00609674|26803727|FG001|Overall Study|Withdrew consent|1|||
13400150|NCT00609622|26803754|FG000|Overall Study|Adverse Event|14|||
13400151|NCT00609622|26803755|FG001|Overall Study|Adverse Event|10|||
13400152|NCT00609622|26803754|FG000|Overall Study|Withdrawal by Subject|4|||
13400153|NCT00609622|26803755|FG001|Overall Study|Withdrawal by Subject|20|||
13400154|NCT00609622|26803754|FG000|Overall Study|Death|1|||
13400155|NCT00609622|26803755|FG001|Overall Study|Death|4|||
13400156|NCT00609622|26803754|FG000|Overall Study|Protocol Violation|1|||
13400157|NCT00609622|26803755|FG001|Overall Study|Protocol Violation|1|||
13400158|NCT00609622|26803754|FG000|Overall Study|Objective progression or relapse|47|||
13400159|NCT00609622|26803755|FG001|Overall Study|Objective progression or relapse|41|||
13400160|NCT00609622|26803754|FG000|Overall Study|Study terminated by sponsor|16|||
13400161|NCT00609622|26803755|FG001|Overall Study|Study terminated by sponsor|3|||
13400162|NCT00609622|26803754|FG000|Overall Study|Other|7|||
13400163|NCT00609622|26803755|FG001|Overall Study|Other|14|||
13400164|NCT00609622|26803754|FG000|Overall Study|Global deterioration of health status|6|||
13400165|NCT00609622|26803755|FG001|Overall Study|Global deterioration of health status|2|||
13400166|NCT00609609|26803772|FG000|Overall Study|Withdrawal by Subject|2|||
13400167|NCT00609609|26803773|FG001|Overall Study|Withdrawal by Subject|0|||
13400168|NCT00609609|26803772|FG000|Overall Study|Progression|4|||
13400169|NCT00609609|26803773|FG001|Overall Study|Progression|2|||
13400170|NCT00609518|26803792|FG000|Overall Study|Death from Study Disease|32|||
13400171|NCT00609518|26803793|FG001|Overall Study|Death from Study Disease|32|||
13400172|NCT00609518|26803792|FG000|Overall Study|Withdrawal by Subject|5|||
13400173|NCT00609518|26803793|FG001|Overall Study|Withdrawal by Subject|3|||
13400174|NCT00609518|26803792|FG000|Overall Study|Lost to Follow-up|3|||
13400175|NCT00609518|26803793|FG001|Overall Study|Lost to Follow-up|0|||
13400176|NCT00609518|26803792|FG000|Overall Study|Physician Decision|1|||
13400177|NCT00609518|26803793|FG001|Overall Study|Physician Decision|3|||
13400178|NCT00609518|26803792|FG000|Overall Study|Death from Adverse Event|2|||
13400179|NCT00609518|26803793|FG001|Overall Study|Death from Adverse Event|2|||
13400180|NCT00609492|26803885|FG000|Overall Study|Withdrawal by Subject|0|||
13400181|NCT00609492|26803886|FG001|Overall Study|Withdrawal by Subject|2|||
13400182|NCT00609492|26803887|FG002|Overall Study|Withdrawal by Subject|3|||
13400183|NCT00609492|26803885|FG000|Overall Study|Lost to Follow-up|1|||
13400184|NCT00609492|26803886|FG001|Overall Study|Lost to Follow-up|1|||
13400185|NCT00609492|26803887|FG002|Overall Study|Lost to Follow-up|4|||
13400186|NCT00609466|26803923|FG000|Overall Study|Withdrawal by Subject|0|||
13400187|NCT00609466|26803924|FG001|Overall Study|Withdrawal by Subject|1|||
13400188|NCT00609466|26803925|FG002|Overall Study|Withdrawal by Subject|1|||
13400189|NCT00609466|26803923|FG000|Overall Study|Adverse Event|2|||
13400190|NCT00609466|26803924|FG001|Overall Study|Adverse Event|3|||
13400191|NCT00609466|26803925|FG002|Overall Study|Adverse Event|1|||
13400192|NCT00609466|26803923|FG000|Overall Study|Lack of Efficacy|0|||
13400193|NCT00609466|26803924|FG001|Overall Study|Lack of Efficacy|2|||
13400194|NCT00609466|26803925|FG002|Overall Study|Lack of Efficacy|2|||
13400195|NCT00609362|26803942|FG000|Overall Study|Withdrawal by Subject|2|||
13400196|NCT00609362|26803943|FG001|Overall Study|Withdrawal by Subject|1|||
13400197|NCT00609362|26803942|FG000|Overall Study|Adverse Event|1|||
13400198|NCT00609362|26803943|FG001|Overall Study|Adverse Event|0|||
13400199|NCT00609336|26803957|FG000|Overall Study|Protocol Violation|3|||
13400200|NCT00609336|26803957|FG000|Overall Study|Death|1|||
13400201|NCT00609336|26803957|FG000|Overall Study|LA or Met at Surgery|9|||
13400202|NCT00609245|26803965|FG000|Overall Study|Adverse Event|1|||
13400203|NCT00609167|26803994|FG000|Overall Study|Withdrawal by Subject|1|||
13400204|NCT00609167|26803995|FG001|Overall Study|Withdrawal by Subject|0|||
13400205|NCT00609167|26803994|FG000|Overall Study|Lack of Efficacy|1|||
13400206|NCT00609167|26803995|FG001|Overall Study|Lack of Efficacy|0|||
13400207|NCT00609167|26803994|FG000|Overall Study|Adverse Event|5|||
13400208|NCT00609167|26803995|FG001|Overall Study|Adverse Event|1|||
13400209|NCT00609167|26803994|FG000|Overall Study|Disease Progression|1|||
13400210|NCT00609167|26803995|FG001|Overall Study|Disease Progression|0|||
13400211|NCT00609167|26803994|FG000|Overall Study|Stem Cell Transplant|0|||
13400212|NCT00609167|26803995|FG001|Overall Study|Stem Cell Transplant|6|||
13400213|NCT00608985|26804038|FG000|Overall Study|Adverse Event|2|||
13400214|NCT00608985|26804039|FG001|Overall Study|Adverse Event|7|||
13400215|NCT00608985|26804040|FG002|Overall Study|Adverse Event|4|||
13400216|NCT00608985|26804041|FG003|Overall Study|Adverse Event|6|||
13400217|NCT00608985|26804038|FG000|Overall Study|Administrative/Other|7|||
13400218|NCT00608985|26804039|FG001|Overall Study|Administrative/Other|4|||
13400219|NCT00608985|26804040|FG002|Overall Study|Administrative/Other|1|||
13400220|NCT00608985|26804041|FG003|Overall Study|Administrative/Other|2|||
13400221|NCT00608985|26804038|FG000|Overall Study|Withdrawal of Consent|5|||
13400222|NCT00608985|26804039|FG001|Overall Study|Withdrawal of Consent|1|||
13400223|NCT00608985|26804040|FG002|Overall Study|Withdrawal of Consent|1|||
13400224|NCT00608985|26804041|FG003|Overall Study|Withdrawal of Consent|1|||
13400225|NCT00608985|26804038|FG000|Overall Study|Lost to Follow-up|2|||
13400226|NCT00608985|26804039|FG001|Overall Study|Lost to Follow-up|1|||
13400227|NCT00608985|26804040|FG002|Overall Study|Lost to Follow-up|0|||
13400228|NCT00608985|26804041|FG003|Overall Study|Lost to Follow-up|0|||
13400229|NCT00608959|26804057|FG000|Part 1|Did not meet eligibility criteria|1|||
13400230|NCT00608907|26804075|FG000|Overall Study|Adverse Event|6|||
13400231|NCT00608907|26804076|FG001|Overall Study|Adverse Event|0|||
13400232|NCT00608907|26804077|FG002|Overall Study|Adverse Event|1|||
13400233|NCT00608907|26804075|FG000|Overall Study|Death|1|||
13400234|NCT00608907|26804076|FG001|Overall Study|Death|0|||
13400235|NCT00608907|26804077|FG002|Overall Study|Death|0|||
13400236|NCT00608907|26804075|FG000|Overall Study|Withdrawal by Subject|4|||
13400237|NCT00608907|26804076|FG001|Overall Study|Withdrawal by Subject|0|||
13400238|NCT00608907|26804077|FG002|Overall Study|Withdrawal by Subject|0|||
13400239|NCT00608907|26804075|FG000|Overall Study|Progressive Disease|1|||
13400240|NCT00608907|26804076|FG001|Overall Study|Progressive Disease|0|||
13400241|NCT00608907|26804077|FG002|Overall Study|Progressive Disease|0|||
13400242|NCT00608894|26804094|FG000|Overall Study|Withdrawal by Subject|0|||
13400243|NCT00608894|26804095|FG001|Overall Study|Withdrawal by Subject|2|||
13400244|NCT00608881|26804136|FG000|Overall Study|Death|22|||
13400245|NCT00608881|26804137|FG001|Overall Study|Death|13|||
13400246|NCT00608881|26804136|FG000|Overall Study|Adverse Event|5|||
13400247|NCT00608881|26804137|FG001|Overall Study|Adverse Event|3|||
13400248|NCT00608881|26804136|FG000|Overall Study|Lost to Follow-up|28|||
13400249|NCT00608881|26804137|FG001|Overall Study|Lost to Follow-up|14|||
13400250|NCT00608881|26804136|FG000|Overall Study|Withdrawal by Subject|18|||
13400251|NCT00608881|26804137|FG001|Overall Study|Withdrawal by Subject|29|||
13400252|NCT00608881|26804136|FG000|Overall Study|Physician Decision|5|||
13400253|NCT00608881|26804137|FG001|Overall Study|Physician Decision|5|||
13400254|NCT00608881|26804136|FG000|Overall Study|Institutionalized|1|||
13400255|NCT00608881|26804137|FG001|Overall Study|Institutionalized|2|||
13400256|NCT00608868|26804146|FG000|Overall Study|Withdrawal by Subject|7|||
13400257|NCT00608868|26804146|FG000|Overall Study|Protocol Violation|3|||
13400258|NCT00608868|26804146|FG000|Overall Study|Lost to Follow-up|2|||
13400259|NCT00608868|26804146|FG000|Overall Study|Adverse Event|1|||
13400260|NCT00608868|26804146|FG000|Overall Study|Physician Decision|2|||
13400261|NCT00608842|26804193|FG000|Overall Study|Participant's Request|0|||
13400262|NCT00608842|26804194|FG001|Overall Study|Participant's Request|1|||
13400263|NCT00608842|26804195|FG002|Overall Study|Participant's Request|2|||
13400264|NCT00608842|26804196|FG003|Overall Study|Participant's Request|1|||
13400265|NCT00608842|26804193|FG000|Overall Study|Lost to Follow-up|1|||
13400266|NCT00608842|26804194|FG001|Overall Study|Lost to Follow-up|0|||
13400267|NCT00608842|26804195|FG002|Overall Study|Lost to Follow-up|0|||
13400268|NCT00608842|26804196|FG003|Overall Study|Lost to Follow-up|0|||
13400269|NCT00608829|26804202|FG000|Overall Study|Death|6|||
13400270|NCT00608829|26804202|FG000|Overall Study|Withdrawal by Subject|4|||
13400271|NCT00608829|26804202|FG000|Overall Study|Subject refuses to follow up or return.|5|||
13400272|NCT00608582|26804217|FG000|Overall Study|Lost to Follow-up|2|||
13400273|NCT00608582|26804218|FG001|Overall Study|Lost to Follow-up|0|||
13400274|NCT00608582|26804217|FG000|Overall Study|No Best Response in Phase 1 located|1|||
13400275|NCT00608582|26804218|FG001|Overall Study|No Best Response in Phase 1 located|1|||
13400276|NCT00608582|26804217|FG000|Overall Study|Illicit Drug Use|1|||
13400277|NCT00608582|26804218|FG001|Overall Study|Illicit Drug Use|0|||
13400278|NCT00608582|26804217|FG000|Overall Study|Early stage Design Change|0|||
13400279|NCT00608582|26804218|FG001|Overall Study|Early stage Design Change|3|||
13400280|NCT00608569|26804245|FG000|Overall Study|Death|4|||
13400281|NCT00608569|26804246|FG001|Overall Study|Death|3|||
13400282|NCT00608569|26804245|FG000|Overall Study|Lost to Follow-up|4|||
13400283|NCT00608569|26804246|FG001|Overall Study|Lost to Follow-up|5|||
13400284|NCT00608569|26804245|FG000|Overall Study|Withdrawal by Subject|1|||
13400285|NCT00608569|26804246|FG001|Overall Study|Withdrawal by Subject|0|||
13400286|NCT00608569|26804245|FG000|Overall Study|Adverse Event|1|||
13400287|NCT00608569|26804246|FG001|Overall Study|Adverse Event|0|||
13400288|NCT00608569|26804245|FG000|Overall Study|Unable to adhere with study requirements|0|||
13400289|NCT00608569|26804246|FG001|Overall Study|Unable to adhere with study requirements|1|||
13400290|NCT00608543|26804257|FG000|Overall Study|Adverse Event|4|||
13400291|NCT00608530|26804288|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11|||
13400292|NCT00608530|26804289|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5|||
13400293|NCT00608530|26804290|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
13400294|NCT00608530|26804291|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
13400295|NCT00608530|26804288|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
13400296|NCT00608530|26804289|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
13400297|NCT00608530|26804290|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
13400298|NCT00608530|26804291|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
13400299|NCT00608530|26804288|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
13400300|NCT00608530|26804289|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
13400301|NCT00608530|26804290|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2|||
13400302|NCT00608530|26804291|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3|||
13400303|NCT00608530|26804288|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
13400304|NCT00608530|26804289|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
13400305|NCT00608530|26804290|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2|||
13400306|NCT00608530|26804291|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
13400307|NCT00608530|26804288|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
13400308|NCT00608530|26804289|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
13400309|NCT00608530|26804290|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4|||
13400310|NCT00608530|26804291|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1|||
13400311|NCT00608530|26804288|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
13400312|NCT00608530|26804289|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
13400313|NCT00608530|26804290|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1|||
13400314|NCT00608530|26804291|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
13400315|NCT00608517|26804327|FG000|Overall Study|Death|1|||
13400316|NCT00608517|26804328|FG001|Overall Study|Death|0|||
13400317|NCT00608517|26804329|FG002|Overall Study|Death|0|||
13400318|NCT00608426|26804346|FG000|Overall Study|Death|32|||
13400319|NCT00608426|26804347|FG001|Overall Study|Death|36|||
13400320|NCT00608426|26804346|FG000|Overall Study|Lost to Follow-up|485|||
13400321|NCT00608426|26804347|FG001|Overall Study|Lost to Follow-up|521|||
13400322|NCT00608426|26804346|FG000|Overall Study|refused, health issues, wrong address|319|||
13400323|NCT00608426|26804347|FG001|Overall Study|refused, health issues, wrong address|348|||
13400324|NCT00608322|26804360|FG000|Overall Study|Death|2|||
13400325|NCT00608322|26804361|FG001|Overall Study|Death|1|||
13400326|NCT00608244|26804372|FG000|Overall Study|Adverse Event|1|||
13400327|NCT00608244|26804372|FG000|Overall Study|Low trough levels|1|||
13400328|NCT00608205|26804467|FG000|Overall Study|Adverse Event|3|||
13400329|NCT00608205|26804468|FG001|Overall Study|Adverse Event|2|||
13400330|NCT00608205|26804467|FG000|Overall Study|Patient non-compliant|0|||
13400331|NCT00608205|26804468|FG001|Overall Study|Patient non-compliant|1|||
13400332|NCT00608023|26804498|FG000|Overall Study|Withdrawal by Subject|8|||
13400333|NCT00608023|26804499|FG001|Overall Study|Withdrawal by Subject|10|||
13400334|NCT00608023|26804500|FG002|Overall Study|Withdrawal by Subject|7|||
13400335|NCT00608023|26804498|FG000|Overall Study|Adverse Event|1|||
13400336|NCT00608023|26804499|FG001|Overall Study|Adverse Event|4|||
13400337|NCT00608023|26804500|FG002|Overall Study|Adverse Event|5|||
13400338|NCT00608023|26804498|FG000|Overall Study|Lost to Follow-up|2|||
13400339|NCT00608023|26804499|FG001|Overall Study|Lost to Follow-up|2|||
13400340|NCT00608023|26804500|FG002|Overall Study|Lost to Follow-up|1|||
13400341|NCT00608023|26804498|FG000|Overall Study|Protocol Violation|1|||
13400342|NCT00608023|26804499|FG001|Overall Study|Protocol Violation|3|||
13400343|NCT00608023|26804500|FG002|Overall Study|Protocol Violation|1|||
13400344|NCT00608023|26804498|FG000|Overall Study|Unknown reason|0|||
13400345|NCT00608023|26804499|FG001|Overall Study|Unknown reason|3|||
13400346|NCT00608023|26804500|FG002|Overall Study|Unknown reason|0|||
13400347|NCT00607997|26804569|FG000|Overall Study|Lack of Efficacy|6|||
13400348|NCT00607997|26804570|FG001|Overall Study|Lack of Efficacy|20|||
13400349|NCT00607997|26804571|FG002|Overall Study|Lack of Efficacy|14|||
13400350|NCT00607997|26804572|FG003|Overall Study|Lack of Efficacy|10|||
13400351|NCT00607997|26804569|FG000|Overall Study|Death|8|||
13400352|NCT00607997|26804570|FG001|Overall Study|Death|5|||
13400353|NCT00607997|26804571|FG002|Overall Study|Death|2|||
13400354|NCT00607997|26804572|FG003|Overall Study|Death|5|||
13400355|NCT00607997|26804569|FG000|Overall Study|Adverse Event|3|||
13400356|NCT00607997|26804570|FG001|Overall Study|Adverse Event|1|||
13400357|NCT00607997|26804571|FG002|Overall Study|Adverse Event|2|||
13400358|NCT00607997|26804572|FG003|Overall Study|Adverse Event|0|||
13400359|NCT00607997|26804569|FG000|Overall Study|Physician Decision|4|||
13400360|NCT00607997|26804570|FG001|Overall Study|Physician Decision|1|||
13400361|NCT00607997|26804571|FG002|Overall Study|Physician Decision|0|||
13400362|NCT00607997|26804572|FG003|Overall Study|Physician Decision|0|||
13400363|NCT00607997|26804569|FG000|Overall Study|Relapse, recurrent illness|4|||
13400364|NCT00607997|26804570|FG001|Overall Study|Relapse, recurrent illness|0|||
13400365|NCT00607997|26804571|FG002|Overall Study|Relapse, recurrent illness|2|||
13400366|NCT00607997|26804572|FG003|Overall Study|Relapse, recurrent illness|0|||
13400367|NCT00607997|26804569|FG000|Overall Study|Other without explanation|2|||
13400368|NCT00607997|26804570|FG001|Overall Study|Other without explanation|0|||
13400369|NCT00607997|26804571|FG002|Overall Study|Other without explanation|4|||
13400370|NCT00607997|26804572|FG003|Overall Study|Other without explanation|1|||
13400371|NCT00607919|26804635|FG000|Acute Phase|Adverse Event|9|||
13400372|NCT00607919|26804636|FG001|Acute Phase|Adverse Event|2|||
13400373|NCT00607919|26804635|FG000|Acute Phase|Entry Criteria Not Met|1|||
13400374|NCT00607919|26804636|FG001|Acute Phase|Entry Criteria Not Met|1|||
13400375|NCT00607919|26804635|FG000|Acute Phase|Lack of Efficacy|1|||
13400376|NCT00607919|26804636|FG001|Acute Phase|Lack of Efficacy|2|||
13400377|NCT00607919|26804635|FG000|Acute Phase|Lost to Follow-up|9|||
13400378|NCT00607919|26804636|FG001|Acute Phase|Lost to Follow-up|3|||
13400379|NCT00607919|26804635|FG000|Acute Phase|Parent/Caregiver Decision|6|||
13400380|NCT00607919|26804636|FG001|Acute Phase|Parent/Caregiver Decision|4|||
13400381|NCT00607919|26804635|FG000|Acute Phase|Protocol Violation|5|||
13400382|NCT00607919|26804636|FG001|Acute Phase|Protocol Violation|1|||
13400383|NCT00607919|26804635|FG000|Acute Phase|Withdrawal by Subject|3|||
13400384|NCT00607919|26804636|FG001|Acute Phase|Withdrawal by Subject|3|||
13400385|NCT00607919|26804635|FG000|Open-Label Phase|Adverse Event|1|||
13400386|NCT00607919|26804636|FG001|Open-Label Phase|Adverse Event|5|||
13400387|NCT00607919|26804635|FG000|Open-Label Phase|Lost to Follow-up|4|||
13400388|NCT00607919|26804636|FG001|Open-Label Phase|Lost to Follow-up|1|||
13400389|NCT00607919|26804635|FG000|Open-Label Phase|Protocol Violation|2|||
13400390|NCT00607919|26804636|FG001|Open-Label Phase|Protocol Violation|2|||
13400391|NCT00607919|26804635|FG000|Open-Label Phase|Withdrawal by Subject|2|||
13400392|NCT00607919|26804636|FG001|Open-Label Phase|Withdrawal by Subject|2|||
13400393|NCT00607919|26804635|FG000|Open-Label Phase|Parent/Caregiver Decision|1|||
13400394|NCT00607919|26804636|FG001|Open-Label Phase|Parent/Caregiver Decision|2|||
13400395|NCT00607893|26804669|FG000|Overall Study|Lost to Follow-up|4|||
13400396|NCT00607893|26804670|FG001|Overall Study|Lost to Follow-up|0|||
13400397|NCT00607893|26804669|FG000|Overall Study|withdrew due to loss of interest|0|||
13400398|NCT00607893|26804670|FG001|Overall Study|withdrew due to loss of interest|1|||
13400399|NCT00607893|26804669|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0|||
13400400|NCT00607893|26804670|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1|||
13400401|NCT00607893|26804669|FG000|Overall Study|withdrew could not tolerate CPAP|0|||
13400402|NCT00607893|26804670|FG001|Overall Study|withdrew could not tolerate CPAP|1|||
13400403|NCT00607893|26804669|FG000|Overall Study|Declined to be treated|1|||
13400404|NCT00607893|26804670|FG001|Overall Study|Declined to be treated|0|||
13400405|NCT00607893|26804669|FG000|Overall Study|Withdrew due to hypertensive urgency|1|||
13400406|NCT00607893|26804670|FG001|Overall Study|Withdrew due to hypertensive urgency|1|||
13400407|NCT00607880|26804689|FG000|Overall Study|Unable to place port due to occlusion|1|||
13400408|NCT00607880|26804690|FG001|Overall Study|Unable to place port due to occlusion|0|||
13400409|NCT00607789|26804705|FG000|Overall Study|Adverse Event|3|||
13400410|NCT00607789|26804706|FG001|Overall Study|Adverse Event|0|||
13400411|NCT00607789|26804705|FG000|Overall Study|Lack of Efficacy|0|||
13400412|NCT00607789|26804706|FG001|Overall Study|Lack of Efficacy|1|||
13400413|NCT00607789|26804705|FG000|Overall Study|Inadequate adherence|3|||
13400414|NCT00607789|26804706|FG001|Overall Study|Inadequate adherence|0|||
13400415|NCT00607789|26804705|FG000|Overall Study|Lost to Follow-up|0|||
13400416|NCT00607789|26804706|FG001|Overall Study|Lost to Follow-up|5|||
13400417|NCT00607789|26804705|FG000|Overall Study|Withdrawal by Subject|1|||
13400418|NCT00607789|26804706|FG001|Overall Study|Withdrawal by Subject|0|||
13400419|NCT00607724|26804804|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7|||
13400420|NCT00607724|26804805|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8|||
13400421|NCT00607724|26804806|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4|||
13400422|NCT00607724|26804807|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
13400423|NCT00607724|26804808|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
13400424|NCT00607724|26804809|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
13400425|NCT00607724|26804810|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
13400426|NCT00607724|26804804|FG000|Stage 2: Expanded Cohort|Adverse Event|0|||
13400427|NCT00607724|26804805|FG001|Stage 2: Expanded Cohort|Adverse Event|0|||
13400428|NCT00607724|26804806|FG002|Stage 2: Expanded Cohort|Adverse Event|0|||
13400429|NCT00607724|26804807|FG003|Stage 2: Expanded Cohort|Adverse Event|0|||
13400430|NCT00607724|26804808|FG004|Stage 2: Expanded Cohort|Adverse Event|0|||
13400431|NCT00607724|26804809|FG005|Stage 2: Expanded Cohort|Adverse Event|0|||
13400432|NCT00607724|26804810|FG006|Stage 2: Expanded Cohort|Adverse Event|1|||
13400433|NCT00607724|26804804|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
13400434|NCT00607724|26804805|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
13400435|NCT00607724|26804806|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
13400436|NCT00607724|26804807|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4|||
13400437|NCT00607724|26804808|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8|||
13400438|NCT00607724|26804809|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11|||
13400439|NCT00607724|26804810|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10|||
13400440|NCT00607724|26804804|FG000|Stage 2: Expanded Cohort|Physician Decision|0|||
13400441|NCT00607724|26804805|FG001|Stage 2: Expanded Cohort|Physician Decision|0|||
13400442|NCT00607724|26804806|FG002|Stage 2: Expanded Cohort|Physician Decision|0|||
13400443|NCT00607724|26804807|FG003|Stage 2: Expanded Cohort|Physician Decision|0|||
13400444|NCT00607724|26804808|FG004|Stage 2: Expanded Cohort|Physician Decision|1|||
13400445|NCT00607724|26804809|FG005|Stage 2: Expanded Cohort|Physician Decision|1|||
13400446|NCT00607724|26804810|FG006|Stage 2: Expanded Cohort|Physician Decision|0|||
13400447|NCT00607724|26804804|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
13400448|NCT00607724|26804805|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
13400449|NCT00607724|26804806|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
13400450|NCT00607724|26804807|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1|||
13400451|NCT00607724|26804808|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
13400452|NCT00607724|26804809|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
13400453|NCT00607724|26804810|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
13400454|NCT00607386|26804825|FG000|Overall Study|Physician Decision|1|||
13400455|NCT00607373|26804876|FG000|Treatment Period|Adverse Event|0|||
13400456|NCT00607373|26804877|FG001|Treatment Period|Adverse Event|4|||
13400457|NCT00607373|26804876|FG000|Treatment Period|Physician Decision|0|||
13400458|NCT00607373|26804877|FG001|Treatment Period|Physician Decision|1|||
13400459|NCT00607373|26804876|FG000|Treatment Period|Withdrawal by Subject|0|||
13400460|NCT00607373|26804877|FG001|Treatment Period|Withdrawal by Subject|1|||
13400461|NCT00607373|26804876|FG000|Follow-up Period|Other|0|||
13400462|NCT00607373|26804877|FG001|Follow-up Period|Other|1|||
13400463|NCT00607373|26804876|FG000|Follow-up Period|Protocol Violation|0|||
13400464|NCT00607373|26804877|FG001|Follow-up Period|Protocol Violation|1|||
13400465|NCT00607373|26804876|FG000|Follow-up Period|Withdrawal by Subject|1|||
13400466|NCT00607373|26804877|FG001|Follow-up Period|Withdrawal by Subject|3|||
13400467|NCT00607087|26804943|FG000|Overall Study|Withdrawal by Subject|9|||
13400468|NCT00607087|26804944|FG001|Overall Study|Withdrawal by Subject|4|||
13400469|NCT00607087|26804945|FG002|Overall Study|Withdrawal by Subject|4|||
13400470|NCT00607087|26804943|FG000|Overall Study|Adverse Event|3|||
13400471|NCT00607087|26804944|FG001|Overall Study|Adverse Event|2|||
13400472|NCT00607087|26804945|FG002|Overall Study|Adverse Event|3|||
13400473|NCT00607087|26804943|FG000|Overall Study|Other reason|1|||
13400474|NCT00607087|26804944|FG001|Overall Study|Other reason|5|||
13400475|NCT00607087|26804945|FG002|Overall Study|Other reason|2|||
13400476|NCT00607087|26804943|FG000|Overall Study|Poor compliance to protocol|1|||
13400477|NCT00607087|26804944|FG001|Overall Study|Poor compliance to protocol|0|||
13400478|NCT00607087|26804945|FG002|Overall Study|Poor compliance to protocol|1|||
13400479|NCT00607087|26804943|FG000|Overall Study|Lost to Follow-up|1|||
13400480|NCT00607087|26804944|FG001|Overall Study|Lost to Follow-up|0|||
13400481|NCT00607087|26804945|FG002|Overall Study|Lost to Follow-up|0|||
13400482|NCT00607087|26804943|FG000|Period 1|Withdrawal by Subject|7|||
13400483|NCT00607087|26804944|FG001|Period 1|Withdrawal by Subject|2|||
13400484|NCT00607087|26804945|FG002|Period 1|Withdrawal by Subject|3|||
13400485|NCT00607087|26804943|FG000|Period 1|Adverse Event|3|||
13400486|NCT00607087|26804944|FG001|Period 1|Adverse Event|0|||
13400487|NCT00607087|26804945|FG002|Period 1|Adverse Event|0|||
13400488|NCT00607087|26804943|FG000|Period 1|Poor compliance to protocol|1|||
13400489|NCT00607087|26804944|FG001|Period 1|Poor compliance to protocol|0|||
13400490|NCT00607087|26804945|FG002|Period 1|Poor compliance to protocol|0|||
13400491|NCT00607087|26804943|FG000|Period 1|Lost to Follow-up|1|||
13400492|NCT00607087|26804944|FG001|Period 1|Lost to Follow-up|0|||
13400493|NCT00607087|26804945|FG002|Period 1|Lost to Follow-up|0|||
13400494|NCT00607087|26804943|FG000|Period 1|Other reason|0|||
13400495|NCT00607087|26804944|FG001|Period 1|Other reason|4|||
13400496|NCT00607087|26804945|FG002|Period 1|Other reason|2|||
13400497|NCT00607087|26804943|FG000|Period 2|Withdrawal by Subject|0|||
13400498|NCT00607087|26804944|FG001|Period 2|Withdrawal by Subject|1|||
13400499|NCT00607087|26804945|FG002|Period 2|Withdrawal by Subject|1|||
13400500|NCT00607087|26804943|FG000|Period 2|Other reason|1|||
13400501|NCT00607087|26804944|FG001|Period 2|Other reason|1|||
13400502|NCT00607087|26804945|FG002|Period 2|Other reason|0|||
13400503|NCT00607087|26804943|FG000|Period 2|Adverse Event|0|||
13400504|NCT00607087|26804944|FG001|Period 2|Adverse Event|1|||
13400505|NCT00607087|26804945|FG002|Period 2|Adverse Event|3|||
13400506|NCT00607087|26804943|FG000|Period 2|Poor compliance to protocol|0|||
13400507|NCT00607087|26804944|FG001|Period 2|Poor compliance to protocol|0|||
13400508|NCT00607087|26804945|FG002|Period 2|Poor compliance to protocol|1|||
13400509|NCT00607087|26804943|FG000|Period 3|Withdrawal by Subject|2|||
13400510|NCT00607087|26804944|FG001|Period 3|Withdrawal by Subject|1|||
13400511|NCT00607087|26804945|FG002|Period 3|Withdrawal by Subject|0|||
13400512|NCT00607087|26804943|FG000|Period 3|Adverse Event|0|||
13400513|NCT00607087|26804944|FG001|Period 3|Adverse Event|1|||
13400514|NCT00607087|26804945|FG002|Period 3|Adverse Event|0|||
13400515|NCT00607048|26805038|FG000|Overall Study|Adverse Event|0|||
13400516|NCT00607048|26805039|FG001|Overall Study|Adverse Event|1|||
13400517|NCT00607048|26805040|FG002|Overall Study|Adverse Event|0|||
13400518|NCT00607048|26805041|FG003|Overall Study|Adverse Event|0|||
13400519|NCT00607048|26805042|FG004|Overall Study|Adverse Event|4|||
13400520|NCT00607048|26805043|FG005|Overall Study|Adverse Event|0|||
13400521|NCT00607048|26805038|FG000|Overall Study|Global deterioration of health|1|||
13400522|NCT00607048|26805039|FG001|Overall Study|Global deterioration of health|0|||
13400523|NCT00607048|26805040|FG002|Overall Study|Global deterioration of health|0|||
13400524|NCT00607048|26805041|FG003|Overall Study|Global deterioration of health|0|||
13400525|NCT00607048|26805042|FG004|Overall Study|Global deterioration of health|0|||
13400526|NCT00607048|26805043|FG005|Overall Study|Global deterioration of health|0|||
13400527|NCT00607048|26805038|FG000|Overall Study|Objective disease progression - relapse|1|||
13400528|NCT00607048|26805039|FG001|Overall Study|Objective disease progression - relapse|2|||
13400529|NCT00607048|26805040|FG002|Overall Study|Objective disease progression - relapse|4|||
13400530|NCT00607048|26805041|FG003|Overall Study|Objective disease progression - relapse|2|||
13400531|NCT00607048|26805042|FG004|Overall Study|Objective disease progression - relapse|2|||
13400532|NCT00607048|26805043|FG005|Overall Study|Objective disease progression - relapse|2|||
13400533|NCT00607048|26805038|FG000|Overall Study|Withdrawal by Subject|0|||
13400534|NCT00607048|26805039|FG001|Overall Study|Withdrawal by Subject|0|||
13400535|NCT00607048|26805040|FG002|Overall Study|Withdrawal by Subject|0|||
13400536|NCT00607048|26805041|FG003|Overall Study|Withdrawal by Subject|1|||
13400537|NCT00607048|26805042|FG004|Overall Study|Withdrawal by Subject|0|||
13400538|NCT00607048|26805043|FG005|Overall Study|Withdrawal by Subject|2|||
13400539|NCT00607048|26805038|FG000|Overall Study|Other|1|||
13400540|NCT00607048|26805039|FG001|Overall Study|Other|1|||
13400541|NCT00607048|26805040|FG002|Overall Study|Other|0|||
13400542|NCT00607048|26805041|FG003|Overall Study|Other|0|||
13400543|NCT00607048|26805042|FG004|Overall Study|Other|0|||
13400544|NCT00607048|26805043|FG005|Overall Study|Other|1|||
13400545|NCT00607022|26805061|FG000|Overall Study|Withdrawal by Subject|1|||
13400546|NCT00607022|26805062|FG001|Overall Study|Withdrawal by Subject|0|||
13400547|NCT00607022|26805063|FG002|Overall Study|Withdrawal by Subject|0|||
13400548|NCT00606931|26805071|FG000|Overall Study|Withdrawal by Subject|3|||
13400549|NCT00606905|26805084|FG000|Overall Study|No Pregnancy|9|||
13400550|NCT00606905|26805085|FG001|Overall Study|No Pregnancy|6|||
13400551|NCT00606905|26805084|FG000|Overall Study|Non-Index Pregnancy|1|||
13400552|NCT00606905|26805085|FG001|Overall Study|Non-Index Pregnancy|4|||
13400553|NCT00606905|26805084|FG000|Overall Study|Withdrew|5|||
13400554|NCT00606905|26805085|FG001|Overall Study|Withdrew|5|||
13400555|NCT00606892|26805120|FG000|First Intervention|Protocol Violation|1|||
13400556|NCT00606892|26805121|FG001|First Intervention|Protocol Violation|4|||
13400557|NCT00606801|26805162|FG000|Intervention|Protocol Violation|3|||
13400558|NCT00606801|26805163|FG001|Intervention|Protocol Violation|3|||
13400559|NCT00606684|26805215|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173|||
13400560|NCT00606684|26805216|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
13400561|NCT00606684|26805217|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
13400562|NCT00606684|26805218|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
13400563|NCT00606684|26805219|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
13400564|NCT00606684|26805220|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
13400565|NCT00606684|26805221|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
13400566|NCT00606684|26805215|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32|||
13400567|NCT00606684|26805216|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
13400568|NCT00606684|26805217|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
13400569|NCT00606684|26805218|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
13400570|NCT00606684|26805219|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
13400571|NCT00606684|26805220|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
13400572|NCT00606684|26805221|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
13400573|NCT00606684|26805215|FG000|2-week Single-Blind Run-in Period|Physician Decision|18|||
13400574|NCT00606684|26805216|FG001|2-week Single-Blind Run-in Period|Physician Decision|0|||
13400575|NCT00606684|26805217|FG002|2-week Single-Blind Run-in Period|Physician Decision|0|||
13400576|NCT00606684|26805218|FG003|2-week Single-Blind Run-in Period|Physician Decision|0|||
13400577|NCT00606684|26805219|FG004|2-week Single-Blind Run-in Period|Physician Decision|0|||
13400578|NCT00606684|26805220|FG005|2-week Single-Blind Run-in Period|Physician Decision|0|||
13400579|NCT00606684|26805221|FG006|2-week Single-Blind Run-in Period|Physician Decision|0|||
13400580|NCT00606684|26805215|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15|||
13400581|NCT00606684|26805216|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
13400582|NCT00606684|26805217|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
13400583|NCT00606684|26805218|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
13400584|NCT00606684|26805219|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
13400585|NCT00606684|26805220|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
13400586|NCT00606684|26805221|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
13400587|NCT00606684|26805215|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5|||
13400588|NCT00606684|26805216|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
13400589|NCT00606684|26805217|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
13400590|NCT00606684|26805218|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
13400591|NCT00606684|26805219|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
13400592|NCT00606684|26805220|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
13400593|NCT00606684|26805221|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
13400594|NCT00606684|26805215|FG000|2-week Single-Blind Run-in Period|Adverse Event|2|||
13400595|NCT00606684|26805216|FG001|2-week Single-Blind Run-in Period|Adverse Event|0|||
13400596|NCT00606684|26805217|FG002|2-week Single-Blind Run-in Period|Adverse Event|0|||
13400597|NCT00606684|26805218|FG003|2-week Single-Blind Run-in Period|Adverse Event|0|||
13400598|NCT00606684|26805219|FG004|2-week Single-Blind Run-in Period|Adverse Event|0|||
13400599|NCT00606684|26805220|FG005|2-week Single-Blind Run-in Period|Adverse Event|0|||
13400600|NCT00606684|26805221|FG006|2-week Single-Blind Run-in Period|Adverse Event|0|||
13400601|NCT00606684|26805215|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1|||
13400602|NCT00606684|26805216|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
13400603|NCT00606684|26805217|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
13400604|NCT00606684|26805218|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
13400605|NCT00606684|26805219|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
13400606|NCT00606684|26805220|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
13400607|NCT00606684|26805221|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
13400608|NCT00606684|26805215|FG000|Double-Blind Treatment Period|Adverse Event|0|||
13400609|NCT00606684|26805216|FG001|Double-Blind Treatment Period|Adverse Event|3|||
13400610|NCT00606684|26805217|FG002|Double-Blind Treatment Period|Adverse Event|2|||
13400611|NCT00606684|26805218|FG003|Double-Blind Treatment Period|Adverse Event|4|||
13400612|NCT00606684|26805219|FG004|Double-Blind Treatment Period|Adverse Event|2|||
13400613|NCT00606684|26805220|FG005|Double-Blind Treatment Period|Adverse Event|0|||
13400614|NCT00606684|26805221|FG006|Double-Blind Treatment Period|Adverse Event|1|||
13400615|NCT00606684|26805215|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
13400616|NCT00606684|26805216|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
13400617|NCT00606684|26805217|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
13400618|NCT00606684|26805218|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
13400619|NCT00606684|26805219|FG004|Double-Blind Treatment Period|Lack of Efficacy|1|||
13400620|NCT00606684|26805220|FG005|Double-Blind Treatment Period|Lack of Efficacy|0|||
13400621|NCT00606684|26805221|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
13400622|NCT00606684|26805215|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
13400623|NCT00606684|26805216|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
13400624|NCT00606684|26805217|FG002|Double-Blind Treatment Period|Protocol Violation|5|||
13400625|NCT00606684|26805218|FG003|Double-Blind Treatment Period|Protocol Violation|3|||
13400626|NCT00606684|26805219|FG004|Double-Blind Treatment Period|Protocol Violation|0|||
13400627|NCT00606684|26805220|FG005|Double-Blind Treatment Period|Protocol Violation|3|||
13400628|NCT00606684|26805221|FG006|Double-Blind Treatment Period|Protocol Violation|4|||
13400629|NCT00606684|26805215|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0|||
13400630|NCT00606684|26805216|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
13400631|NCT00606684|26805217|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
13400632|NCT00606684|26805218|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
13400633|NCT00606684|26805219|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
13400634|NCT00606684|26805220|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3|||
13400635|NCT00606684|26805221|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
13400636|NCT00606684|26805215|FG000|Double-Blind Treatment Period|Physician Decision|0|||
13400637|NCT00606684|26805216|FG001|Double-Blind Treatment Period|Physician Decision|5|||
13400638|NCT00606684|26805217|FG002|Double-Blind Treatment Period|Physician Decision|1|||
13400639|NCT00606684|26805218|FG003|Double-Blind Treatment Period|Physician Decision|0|||
13400640|NCT00606684|26805219|FG004|Double-Blind Treatment Period|Physician Decision|3|||
13400641|NCT00606684|26805220|FG005|Double-Blind Treatment Period|Physician Decision|1|||
13400642|NCT00606684|26805221|FG006|Double-Blind Treatment Period|Physician Decision|2|||
13400643|NCT00606684|26805215|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
13400644|NCT00606684|26805216|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
13400645|NCT00606684|26805217|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
13400646|NCT00606684|26805218|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2|||
13400647|NCT00606684|26805219|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1|||
13400648|NCT00606684|26805220|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
13400649|NCT00606684|26805221|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0|||
13400650|NCT00606632|26805236|FG000|Overall Study|Withdrawal by Subject|13|||
13400651|NCT00606632|26805236|FG000|Overall Study|Miscellaneous reasons|9|||
13400652|NCT00606593|26805265|FG000|Overall Study|Adverse Event|0|||
13400653|NCT00606593|26805266|FG001|Overall Study|Adverse Event|0|||
13400654|NCT00606593|26805267|FG002|Overall Study|Adverse Event|0|||
13400655|NCT00606593|26805268|FG003|Overall Study|Adverse Event|1|||
13400656|NCT00606593|26805269|FG004|Overall Study|Adverse Event|1|||
13400657|NCT00606593|26805270|FG005|Overall Study|Adverse Event|0|||
13400658|NCT00606593|26805271|FG006|Overall Study|Adverse Event|1|||
13400659|NCT00606593|26805272|FG007|Overall Study|Adverse Event|2|||
13400660|NCT00606593|26805273|FG008|Overall Study|Adverse Event|1|||
13400661|NCT00606593|26805274|FG009|Overall Study|Adverse Event|0|||
13400662|NCT00606593|26805265|FG000|Overall Study|Withdrawal of consent|1|||
13400663|NCT00606593|26805266|FG001|Overall Study|Withdrawal of consent|0|||
13400664|NCT00606593|26805267|FG002|Overall Study|Withdrawal of consent|1|||
13400665|NCT00606593|26805268|FG003|Overall Study|Withdrawal of consent|0|||
13400666|NCT00606593|26805269|FG004|Overall Study|Withdrawal of consent|0|||
13400667|NCT00606593|26805270|FG005|Overall Study|Withdrawal of consent|0|||
13400668|NCT00606593|26805271|FG006|Overall Study|Withdrawal of consent|0|||
13400669|NCT00606593|26805272|FG007|Overall Study|Withdrawal of consent|0|||
13400670|NCT00606593|26805273|FG008|Overall Study|Withdrawal of consent|0|||
13400671|NCT00606593|26805274|FG009|Overall Study|Withdrawal of consent|0|||
13400672|NCT00606593|26805265|FG000|Overall Study|Administrative/Other|0|||
13400673|NCT00606593|26805266|FG001|Overall Study|Administrative/Other|0|||
13400674|NCT00606593|26805267|FG002|Overall Study|Administrative/Other|1|||
13400675|NCT00606593|26805268|FG003|Overall Study|Administrative/Other|0|||
13400676|NCT00606593|26805269|FG004|Overall Study|Administrative/Other|0|||
13400677|NCT00606593|26805270|FG005|Overall Study|Administrative/Other|0|||
13400678|NCT00606593|26805271|FG006|Overall Study|Administrative/Other|0|||
13400679|NCT00606593|26805272|FG007|Overall Study|Administrative/Other|0|||
13400680|NCT00606593|26805273|FG008|Overall Study|Administrative/Other|0|||
13400681|NCT00606593|26805274|FG009|Overall Study|Administrative/Other|0|||
13400682|NCT00606580|26805325|FG000|Overall Study|Lost to Follow-up|1|||
13400683|NCT00606580|26805326|FG001|Overall Study|Lost to Follow-up|1|||
13400684|NCT00606580|26805327|FG002|Overall Study|Lost to Follow-up|4|||
13400685|NCT00606580|26805325|FG000|Overall Study|Clinical failures|1|||
13400686|NCT00606580|26805326|FG001|Overall Study|Clinical failures|0|||
13400687|NCT00606580|26805327|FG002|Overall Study|Clinical failures|12|||
13400688|NCT00606580|26805325|FG000|Overall Study|Withdrawal by investigator|0|||
13400689|NCT00606580|26805326|FG001|Overall Study|Withdrawal by investigator|1|||
13400690|NCT00606580|26805327|FG002|Overall Study|Withdrawal by investigator|6|||
13400691|NCT00606580|26805325|FG000|Overall Study|Withdrawal by Subject|0|||
13400692|NCT00606580|26805326|FG001|Overall Study|Withdrawal by Subject|1|||
13400693|NCT00606580|26805327|FG002|Overall Study|Withdrawal by Subject|0|||
13400694|NCT00606502|26805346|FG000|Randomization|Randomized but not treated|3|||
13400695|NCT00606502|26805347|FG001|Randomization|Randomized but not treated|0|||
13400696|NCT00606502|26805346|FG000|Treatment|Treatment ongoing at time of data cutoff|0|||
13400697|NCT00606502|26805347|FG001|Treatment|Treatment ongoing at time of data cutoff|3|||
13400698|NCT00606320|26805354|FG000|Overall Study|Adverse Event|3|||
13400699|NCT00606320|26805354|FG000|Overall Study|Lack of Efficacy|5|||
13400700|NCT00606320|26805354|FG000|Overall Study|Physician Decision|7|||
13400701|NCT00606320|26805354|FG000|Overall Study|Protocol Violation|8|||
13400702|NCT00606320|26805354|FG000|Overall Study|Withdrawal by Subject|10|||
13400703|NCT00606320|26805354|FG000|Overall Study|Progression to depressive phase|4|||
13400704|NCT00606307|26805362|FG000|Overall Study|Adverse Event|2|||
13400705|NCT00606307|26805362|FG000|Overall Study|Withdrawal by Subject|2|||
13400706|NCT00606307|26805362|FG000|Overall Study|Disease progression|6|||
13400707|NCT00606307|26805362|FG000|Overall Study|QTc prolongation|1|||
13400708|NCT00606294|26805381|FG000|Overall Study|Withdrawal by Subject|36|||
13400709|NCT00606294|26805382|FG001|Overall Study|Withdrawal by Subject|0|||
13400710|NCT00606281|26805397|FG000|Overall Study|Adverse Event|11|||
13400711|NCT00606281|26805398|FG001|Overall Study|Adverse Event|12|||
13400712|NCT00606281|26805397|FG000|Overall Study|Death|1|||
13400713|NCT00606281|26805398|FG001|Overall Study|Death|0|||
13400714|NCT00606281|26805397|FG000|Overall Study|Lack of Efficacy|28|||
13400715|NCT00606281|26805398|FG001|Overall Study|Lack of Efficacy|35|||
13400716|NCT00606281|26805397|FG000|Overall Study|Physician Decision|0|||
13400717|NCT00606281|26805398|FG001|Overall Study|Physician Decision|1|||
13400718|NCT00606281|26805397|FG000|Overall Study|Protocol Violation|3|||
13400719|NCT00606281|26805398|FG001|Overall Study|Protocol Violation|3|||
13400720|NCT00606281|26805397|FG000|Overall Study|Withdrawal by Subject|11|||
13400721|NCT00606281|26805398|FG001|Overall Study|Withdrawal by Subject|13|||
13400722|NCT00606281|26805397|FG000|Overall Study|Progression to depressive phase|1|||
13400723|NCT00606281|26805398|FG001|Overall Study|Progression to depressive phase|1|||
13400724|NCT00606281|26805397|FG000|Overall Study|Change of residence or other commitments|1|||
13400725|NCT00606281|26805398|FG001|Overall Study|Change of residence or other commitments|1|||
13400726|NCT00606229|26805405|FG000|Overall Study|Adverse Event|11|||
13400727|NCT00606229|26805405|FG000|Overall Study|Lack of Efficacy|1|||
13400728|NCT00606229|26805405|FG000|Overall Study|Withdrawal by Subject|4|||
13400729|NCT00606229|26805405|FG000|Overall Study|does not meet inclusion criterion 1-3|4|||
13400730|NCT00606229|26805405|FG000|Overall Study|change of residence or other commitments|2|||
13400731|NCT00606177|26805420|FG000|Overall Study|Adverse Event|9|||
13400732|NCT00606177|26805421|FG001|Overall Study|Adverse Event|5|||
13400733|NCT00606177|26805420|FG000|Overall Study|Lack of Efficacy|3|||
13400734|NCT00606177|26805421|FG001|Overall Study|Lack of Efficacy|7|||
13400735|NCT00606177|26805420|FG000|Overall Study|Physician Decision|1|||
13400736|NCT00606177|26805421|FG001|Overall Study|Physician Decision|0|||
13400737|NCT00606177|26805420|FG000|Overall Study|Protocol Violation|1|||
13400738|NCT00606177|26805421|FG001|Overall Study|Protocol Violation|4|||
13400739|NCT00606177|26805420|FG000|Overall Study|Withdrawal by Subject|5|||
13400740|NCT00606177|26805421|FG001|Overall Study|Withdrawal by Subject|6|||
13400741|NCT00606177|26805420|FG000|Overall Study|Progression to depressive phase|6|||
13400742|NCT00606177|26805421|FG001|Overall Study|Progression to depressive phase|1|||
13400743|NCT00606177|26805420|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
13400744|NCT00606177|26805421|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
13400745|NCT00606177|26805420|FG000|Overall Study|Change of residence or other commitments|1|||
13400746|NCT00606177|26805421|FG001|Overall Study|Change of residence or other commitments|1|||
13400747|NCT00606086|26805434|FG000|Overall Study|Adverse Event|1|||
13400748|NCT00606086|26805435|FG001|Overall Study|Adverse Event|1|||
13400749|NCT00606086|26805434|FG000|Overall Study|Lost to Follow-up|4|||
13400750|NCT00606086|26805435|FG001|Overall Study|Lost to Follow-up|8|||
13400751|NCT00606086|26805434|FG000|Overall Study|Protocol Violation|1|||
13400752|NCT00606086|26805435|FG001|Overall Study|Protocol Violation|0|||
13400753|NCT00606086|26805434|FG000|Overall Study|Withdrawal by Subject|5|||
13400754|NCT00606086|26805435|FG001|Overall Study|Withdrawal by Subject|3|||
13400755|NCT00606086|26805434|FG000|Overall Study|Non-compliance|0|||
13400756|NCT00606086|26805435|FG001|Overall Study|Non-compliance|1|||
13400757|NCT00606086|26805434|FG000|Overall Study|Randomized, not treated|1|||
13400758|NCT00606086|26805435|FG001|Overall Study|Randomized, not treated|2|||
13400759|NCT00606034|26805443|FG000|Overall Study|incarceration|1|||
13400760|NCT00606021|26805469|FG000|Induction Phase|Death|73|||
13400761|NCT00606021|26805470|FG001|Induction Phase|Death|0|||
13400762|NCT00606021|26805471|FG002|Induction Phase|Death|0|||
13400763|NCT00606021|26805469|FG000|Induction Phase|Physician Decision|2|||
13400764|NCT00606021|26805470|FG001|Induction Phase|Physician Decision|0|||
13400765|NCT00606021|26805471|FG002|Induction Phase|Physician Decision|0|||
13400766|NCT00606021|26805469|FG000|Induction Phase|Withdrawal by Subject|2|||
13400767|NCT00606021|26805470|FG001|Induction Phase|Withdrawal by Subject|0|||
13400768|NCT00606021|26805471|FG002|Induction Phase|Withdrawal by Subject|0|||
13400769|NCT00606021|26805469|FG000|Induction Phase|Lost to Follow-up|10|||
13400770|NCT00606021|26805470|FG001|Induction Phase|Lost to Follow-up|0|||
13400771|NCT00606021|26805471|FG002|Induction Phase|Lost to Follow-up|0|||
13400772|NCT00606021|26805469|FG000|Maintenance Phase|Death|0|||
13400773|NCT00606021|26805470|FG001|Maintenance Phase|Death|17|||
13400774|NCT00606021|26805471|FG002|Maintenance Phase|Death|15|||
13400775|NCT00606021|26805469|FG000|Maintenance Phase|Physician Decision|0|||
13400776|NCT00606021|26805470|FG001|Maintenance Phase|Physician Decision|1|||
13400777|NCT00606021|26805471|FG002|Maintenance Phase|Physician Decision|0|||
13400778|NCT00606021|26805469|FG000|Maintenance Phase|Lost to Follow-up|0|||
13400779|NCT00606021|26805470|FG001|Maintenance Phase|Lost to Follow-up|5|||
13400780|NCT00606021|26805471|FG002|Maintenance Phase|Lost to Follow-up|2|||
13400781|NCT00606008|26805487|FG000|Overall Study|Adverse Event|1|||
13400782|NCT00606008|26805487|FG000|Overall Study|Withdrawal by Subject|4|||
13400783|NCT00605917|26805528|FG000|Overall Study|Protocol Violation|79|||
13400784|NCT00605865|26805569|FG000|Overall Study|Protocol Violation|115|||
13400785|NCT00605839|26805587|FG000|Overall Study|Protocol Violation|1|||
13400786|NCT00605839|26805588|FG001|Overall Study|Protocol Violation|0|||
13400787|NCT00605839|26805589|FG002|Overall Study|Protocol Violation|0|||
13400788|NCT00605813|26805604|FG000|Overall Study|Protocol Violation|25|||
13400789|NCT00605722|26805616|FG000|Overall Study|Adverse Event|6|||
13400790|NCT00605722|26805616|FG000|Overall Study|Insufficient therapeutic response|44|||
13400791|NCT00605722|26805616|FG000|Overall Study|Failure to return|1|||
13400792|NCT00605657|26805623|FG000|Overall Study|Adverse Event|1|||
13400793|NCT00605657|26805623|FG000|Overall Study|Protocol Violation|1|||
13400794|NCT00605566|26805633|FG000|Overall Study|Adverse Event|1|||
13400795|NCT00605566|26805633|FG000|Overall Study|Clinical deterioration|1|||
13400796|NCT00605566|26805633|FG000|Overall Study|Poor compliance in run-in period|1|||
13400797|NCT00605540|26805643|FG000|Overall Study|Death|15|||
13400798|NCT00605540|26805643|FG000|Overall Study|Lost to Follow-up|23|||
13400799|NCT00605475|26805796|FG000|Overall Study|Abnormal Laboratory Values|0|||
13400800|NCT00605475|26805797|FG001|Overall Study|Abnormal Laboratory Values|0|||
13400801|NCT00605475|26805798|FG002|Overall Study|Abnormal Laboratory Values|0|||
13400802|NCT00605475|26805799|FG003|Overall Study|Abnormal Laboratory Values|0|||
13400803|NCT00605475|26805800|FG004|Overall Study|Abnormal Laboratory Values|0|||
13400804|NCT00605475|26805801|FG005|Overall Study|Abnormal Laboratory Values|0|||
13400805|NCT00605475|26805802|FG006|Overall Study|Abnormal Laboratory Values|0|||
13400806|NCT00605475|26805803|FG007|Overall Study|Abnormal Laboratory Values|0|||
13400807|NCT00605475|26805804|FG008|Overall Study|Abnormal Laboratory Values|1|||
13400808|NCT00605475|26805805|FG009|Overall Study|Abnormal Laboratory Values|0|||
13400809|NCT00605475|26805796|FG000|Overall Study|Administrative problems|0|||
13400810|NCT00605475|26805797|FG001|Overall Study|Administrative problems|0|||
13400811|NCT00605475|26805798|FG002|Overall Study|Administrative problems|0|||
13400812|NCT00605475|26805799|FG003|Overall Study|Administrative problems|0|||
13400813|NCT00605475|26805800|FG004|Overall Study|Administrative problems|0|||
13400814|NCT00605475|26805801|FG005|Overall Study|Administrative problems|0|||
13400815|NCT00605475|26805802|FG006|Overall Study|Administrative problems|1|||
13400816|NCT00605475|26805803|FG007|Overall Study|Administrative problems|0|||
13400817|NCT00605475|26805804|FG008|Overall Study|Administrative problems|0|||
13400818|NCT00605475|26805805|FG009|Overall Study|Administrative problems|0|||
13400819|NCT00605475|26805796|FG000|Overall Study|Lost to Follow-up|0|||
13400820|NCT00605475|26805797|FG001|Overall Study|Lost to Follow-up|0|||
13400821|NCT00605475|26805798|FG002|Overall Study|Lost to Follow-up|0|||
13400822|NCT00605475|26805799|FG003|Overall Study|Lost to Follow-up|0|||
13400823|NCT00605475|26805800|FG004|Overall Study|Lost to Follow-up|0|||
13400824|NCT00605475|26805801|FG005|Overall Study|Lost to Follow-up|0|||
13400825|NCT00605475|26805802|FG006|Overall Study|Lost to Follow-up|0|||
13400826|NCT00605475|26805803|FG007|Overall Study|Lost to Follow-up|0|||
13400827|NCT00605475|26805804|FG008|Overall Study|Lost to Follow-up|1|||
13400828|NCT00605475|26805805|FG009|Overall Study|Lost to Follow-up|1|||
13400829|NCT00605475|26805796|FG000|Overall Study|Protocol Violation|0|||
13400830|NCT00605475|26805797|FG001|Overall Study|Protocol Violation|0|||
13400831|NCT00605475|26805798|FG002|Overall Study|Protocol Violation|0|||
13400832|NCT00605475|26805799|FG003|Overall Study|Protocol Violation|0|||
13400833|NCT00605475|26805800|FG004|Overall Study|Protocol Violation|1|||
13400834|NCT00605475|26805801|FG005|Overall Study|Protocol Violation|0|||
13400835|NCT00605475|26805802|FG006|Overall Study|Protocol Violation|0|||
13400836|NCT00605475|26805803|FG007|Overall Study|Protocol Violation|0|||
13400837|NCT00605475|26805804|FG008|Overall Study|Protocol Violation|0|||
13400838|NCT00605475|26805805|FG009|Overall Study|Protocol Violation|0|||
13400839|NCT00605475|26805796|FG000|Overall Study|Withdrawal by Subject|0|||
13400840|NCT00605475|26805797|FG001|Overall Study|Withdrawal by Subject|0|||
13400841|NCT00605475|26805798|FG002|Overall Study|Withdrawal by Subject|0|||
13400842|NCT00605475|26805799|FG003|Overall Study|Withdrawal by Subject|0|||
13400843|NCT00605475|26805800|FG004|Overall Study|Withdrawal by Subject|0|||
13400844|NCT00605475|26805801|FG005|Overall Study|Withdrawal by Subject|2|||
13400845|NCT00605475|26805802|FG006|Overall Study|Withdrawal by Subject|0|||
13400846|NCT00605475|26805803|FG007|Overall Study|Withdrawal by Subject|0|||
13400847|NCT00605475|26805804|FG008|Overall Study|Withdrawal by Subject|0|||
13400848|NCT00605475|26805805|FG009|Overall Study|Withdrawal by Subject|1|||
13400849|NCT00605345|26805828|FG000|Overall Study|Withdrawal by Subject|1|||
13400850|NCT00605345|26805829|FG001|Overall Study|Withdrawal by Subject|0|||
13400851|NCT00605345|26805828|FG000|Overall Study|Adverse Event|0|||
13400852|NCT00605345|26805829|FG001|Overall Study|Adverse Event|1|||
13400853|NCT00605345|26805828|FG000|Overall Study|Protocol Violation|0|||
13400854|NCT00605345|26805829|FG001|Overall Study|Protocol Violation|2|||
13400855|NCT00605319|26805841|FG000|Overall Study|Adverse Event|6|||
13400856|NCT00605306|26805860|FG000|Overall Study|Adverse Event|0|||
13400857|NCT00605306|26805861|FG001|Overall Study|Adverse Event|1|||
13400858|NCT00605293|26805884|FG000|Overall Study|Death|2|||
13400859|NCT00605293|26805885|FG001|Overall Study|Death|1|||
13400860|NCT00605293|26805884|FG000|Overall Study|Insufficient Therapeutic Response|2|||
13400861|NCT00605293|26805885|FG001|Overall Study|Insufficient Therapeutic Response|0|||
13400862|NCT00605293|26805884|FG000|Overall Study|Adverse Event|1|||
13400863|NCT00605293|26805885|FG001|Overall Study|Adverse Event|0|||
13400864|NCT00605293|26805884|FG000|Overall Study|Holidays Dialysis Out|1|||
13400865|NCT00605293|26805885|FG001|Overall Study|Holidays Dialysis Out|0|||
13400866|NCT00605293|26805884|FG000|Overall Study|Blood Transfusion|7|||
13400867|NCT00605293|26805885|FG001|Overall Study|Blood Transfusion|1|||
13400868|NCT00605293|26805884|FG000|Overall Study|Renal Transplantation|3|||
13400869|NCT00605293|26805885|FG001|Overall Study|Renal Transplantation|1|||
13400870|NCT00605293|26805884|FG000|Overall Study|Incorrect Epoetin Beta Administration|1|||
13400871|NCT00605293|26805885|FG001|Overall Study|Incorrect Epoetin Beta Administration|0|||
13400872|NCT00605293|26805884|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0|||
13400873|NCT00605293|26805885|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1|||
13400874|NCT00605293|26805884|FG000|Overall Study|Principal Investigator Decision|0|||
13400875|NCT00605293|26805885|FG001|Overall Study|Principal Investigator Decision|1|||
13400876|NCT00605280|26805930|FG000|Year 1|Protocol Violation|0|||
13400877|NCT00605280|26805931|FG001|Year 1|Protocol Violation|0|||
13400878|NCT00605280|26805932|FG002|Year 1|Protocol Violation|0|||
13400879|NCT00605280|26805933|FG003|Year 1|Protocol Violation|1|||
13400880|NCT00605280|26805930|FG000|Year 1|Adverse Event|3|||
13400881|NCT00605280|26805931|FG001|Year 1|Adverse Event|1|||
13400882|NCT00605280|26805932|FG002|Year 1|Adverse Event|1|||
13400883|NCT00605280|26805933|FG003|Year 1|Adverse Event|5|||
13400884|NCT00605280|26805930|FG000|Year 1|Physician Decision|7|||
13400885|NCT00605280|26805931|FG001|Year 1|Physician Decision|4|||
13400886|NCT00605280|26805932|FG002|Year 1|Physician Decision|0|||
13400887|NCT00605280|26805933|FG003|Year 1|Physician Decision|6|||
13400888|NCT00605280|26805930|FG000|Year 1|Withdrawal by Subject|2|||
13400889|NCT00605280|26805931|FG001|Year 1|Withdrawal by Subject|4|||
13400890|NCT00605280|26805932|FG002|Year 1|Withdrawal by Subject|0|||
13400891|NCT00605280|26805933|FG003|Year 1|Withdrawal by Subject|4|||
13400892|NCT00605280|26805930|FG000|Year 1|Other|2|||
13400893|NCT00605280|26805931|FG001|Year 1|Other|1|||
13400894|NCT00605280|26805932|FG002|Year 1|Other|0|||
13400895|NCT00605280|26805933|FG003|Year 1|Other|1|||
13400896|NCT00605280|26805930|FG000|Year 1|Lost to Follow-up or Patient non-comply|5|||
13400897|NCT00605280|26805931|FG001|Year 1|Lost to Follow-up or Patient non-comply|1|||
13400898|NCT00605280|26805932|FG002|Year 1|Lost to Follow-up or Patient non-comply|0|||
13400899|NCT00605280|26805933|FG003|Year 1|Lost to Follow-up or Patient non-comply|2|||
13400900|NCT00605280|26805930|FG000|Year 2|Adverse Event|4|||
13400901|NCT00605280|26805931|FG001|Year 2|Adverse Event|0|||
13400902|NCT00605280|26805932|FG002|Year 2|Adverse Event|2|||
13400903|NCT00605280|26805933|FG003|Year 2|Adverse Event|4|||
13400904|NCT00605280|26805930|FG000|Year 2|Physician Decision|11|||
13400905|NCT00605280|26805931|FG001|Year 2|Physician Decision|6|||
13400906|NCT00605280|26805932|FG002|Year 2|Physician Decision|4|||
13400907|NCT00605280|26805933|FG003|Year 2|Physician Decision|11|||
13400908|NCT00605280|26805930|FG000|Year 2|Withdrawal by Subject|4|||
13400909|NCT00605280|26805931|FG001|Year 2|Withdrawal by Subject|0|||
13400910|NCT00605280|26805932|FG002|Year 2|Withdrawal by Subject|0|||
13400911|NCT00605280|26805933|FG003|Year 2|Withdrawal by Subject|4|||
13400912|NCT00605280|26805930|FG000|Year 2|Other|1|||
13400913|NCT00605280|26805931|FG001|Year 2|Other|0|||
13400914|NCT00605280|26805932|FG002|Year 2|Other|0|||
13400915|NCT00605280|26805933|FG003|Year 2|Other|1|||
13400916|NCT00605280|26805930|FG000|Year 2|Lost to Follow-up or Patient non-comply|4|||
13400917|NCT00605280|26805931|FG001|Year 2|Lost to Follow-up or Patient non-comply|0|||
13400918|NCT00605280|26805932|FG002|Year 2|Lost to Follow-up or Patient non-comply|0|||
13400919|NCT00605280|26805933|FG003|Year 2|Lost to Follow-up or Patient non-comply|2|||
13400920|NCT00605280|26805930|FG000|Year 3 Extension|Adverse Event|2|||
13400921|NCT00605280|26805931|FG001|Year 3 Extension|Adverse Event|0|||
13400922|NCT00605280|26805932|FG002|Year 3 Extension|Adverse Event|0|||
13400923|NCT00605280|26805933|FG003|Year 3 Extension|Adverse Event|2|||
13400924|NCT00605280|26805930|FG000|Year 3 Extension|Physician Decision|0|||
13400925|NCT00605280|26805931|FG001|Year 3 Extension|Physician Decision|0|||
13400926|NCT00605280|26805932|FG002|Year 3 Extension|Physician Decision|0|||
13400927|NCT00605280|26805933|FG003|Year 3 Extension|Physician Decision|2|||
13400928|NCT00605280|26805930|FG000|Year 3 Extension|Withdrawal by Subject|2|||
13400929|NCT00605280|26805931|FG001|Year 3 Extension|Withdrawal by Subject|0|||
13400930|NCT00605280|26805932|FG002|Year 3 Extension|Withdrawal by Subject|0|||
13400931|NCT00605280|26805933|FG003|Year 3 Extension|Withdrawal by Subject|5|||
13400932|NCT00605280|26805930|FG000|Year 3 Extension|Other|2|||
13400933|NCT00605280|26805931|FG001|Year 3 Extension|Other|0|||
13400934|NCT00605280|26805932|FG002|Year 3 Extension|Other|0|||
13400935|NCT00605280|26805933|FG003|Year 3 Extension|Other|0|||
13400936|NCT00605280|26805930|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2|||
13400937|NCT00605280|26805931|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
13400938|NCT00605280|26805932|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
13400939|NCT00605280|26805933|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
13400940|NCT00605267|26805978|FG000|Overall Study|Adverse Event|0|||
13400941|NCT00605267|26805979|FG001|Overall Study|Adverse Event|1|||
13400942|NCT00605267|26805978|FG000|Overall Study|Lack of Efficacy|1|||
13400943|NCT00605267|26805979|FG001|Overall Study|Lack of Efficacy|5|||
13400944|NCT00605267|26805978|FG000|Overall Study|Withdrawal by Subject|2|||
13400945|NCT00605267|26805979|FG001|Overall Study|Withdrawal by Subject|3|||
13400946|NCT00605215|26806018|FG000|Overall Study|Death|0|||
13400947|NCT00605215|26806019|FG001|Overall Study|Death|0|||
13400948|NCT00605215|26806020|FG002|Overall Study|Death|1|||
13400949|NCT00605215|26806018|FG000|Overall Study|Adverse Event|19|||
13400950|NCT00605215|26806019|FG001|Overall Study|Adverse Event|21|||
13400951|NCT00605215|26806020|FG002|Overall Study|Adverse Event|26|||
13400952|NCT00605215|26806018|FG000|Overall Study|Refusal to sign the re-consent form|8|||
13400953|NCT00605215|26806019|FG001|Overall Study|Refusal to sign the re-consent form|3|||
13400954|NCT00605215|26806020|FG002|Overall Study|Refusal to sign the re-consent form|3|||
13400955|NCT00605215|26806018|FG000|Overall Study|Withdrawal by Subject|39|||
13400956|NCT00605215|26806019|FG001|Overall Study|Withdrawal by Subject|37|||
13400957|NCT00605215|26806020|FG002|Overall Study|Withdrawal by Subject|27|||
13400958|NCT00605215|26806018|FG000|Overall Study|Request of Primary Care Physician or Investigator|6|||
13400959|NCT00605215|26806019|FG001|Overall Study|Request of Primary Care Physician or Investigator|4|||
13400960|NCT00605215|26806020|FG002|Overall Study|Request of Primary Care Physician or Investigator|4|||
13400961|NCT00605215|26806018|FG000|Overall Study|Protocol Violation|3|||
13400962|NCT00605215|26806019|FG001|Overall Study|Protocol Violation|4|||
13400963|NCT00605215|26806020|FG002|Overall Study|Protocol Violation|1|||
13400964|NCT00605215|26806018|FG000|Overall Study|Pregnancy|8|||
13400965|NCT00605215|26806019|FG001|Overall Study|Pregnancy|5|||
13400966|NCT00605215|26806020|FG002|Overall Study|Pregnancy|4|||
13400967|NCT00605215|26806018|FG000|Overall Study|Lost to Follow-up|8|||
13400968|NCT00605215|26806019|FG001|Overall Study|Lost to Follow-up|5|||
13400969|NCT00605215|26806020|FG002|Overall Study|Lost to Follow-up|2|||
13400970|NCT00605215|26806018|FG000|Overall Study|Other than specified|0|||
13400971|NCT00605215|26806019|FG001|Overall Study|Other than specified|2|||
13400972|NCT00605215|26806020|FG002|Overall Study|Other than specified|1|||
13400973|NCT00605189|26806038|FG000|Overall Study|Adverse Event|1|||
13400974|NCT00605189|26806039|FG001|Overall Study|Adverse Event|0|||
13400975|NCT00605189|26806040|FG002|Overall Study|Adverse Event|0|||
13400976|NCT00605189|26806038|FG000|Overall Study|Other|2|||
13400977|NCT00605189|26806039|FG001|Overall Study|Other|2|||
13400978|NCT00605189|26806040|FG002|Overall Study|Other|0|||
13400979|NCT00605176|26806067|FG000|Overall Study|Adverse Event|2|||
13400980|NCT00605176|26806068|FG001|Overall Study|Adverse Event|1|||
13400981|NCT00605176|26806069|FG002|Overall Study|Adverse Event|3|||
13400982|NCT00605176|26806067|FG000|Overall Study|Withdrawal by Subject|4|||
13400983|NCT00605176|26806068|FG001|Overall Study|Withdrawal by Subject|2|||
13400984|NCT00605176|26806069|FG002|Overall Study|Withdrawal by Subject|4|||
13400985|NCT00605176|26806067|FG000|Overall Study|Lost to Follow-up|2|||
13400986|NCT00605176|26806068|FG001|Overall Study|Lost to Follow-up|2|||
13400987|NCT00605176|26806069|FG002|Overall Study|Lost to Follow-up|1|||
13400988|NCT00605176|26806067|FG000|Overall Study|Non-complicance with study procedures|1|||
13400989|NCT00605176|26806068|FG001|Overall Study|Non-complicance with study procedures|0|||
13400990|NCT00605176|26806069|FG002|Overall Study|Non-complicance with study procedures|0|||
13400991|NCT00605176|26806067|FG000|Overall Study|Use of concomitant therapy|1|||
13400992|NCT00605176|26806068|FG001|Overall Study|Use of concomitant therapy|0|||
13400993|NCT00605176|26806069|FG002|Overall Study|Use of concomitant therapy|1|||
13400994|NCT00605176|26806067|FG000|Overall Study|Other (not due to AE)|1|||
13400995|NCT00605176|26806068|FG001|Overall Study|Other (not due to AE)|1|||
13400996|NCT00605176|26806069|FG002|Overall Study|Other (not due to AE)|0|||
13400997|NCT00605085|26806082|FG000|Overall Study|Withdrawal by Subject|8|||
13400998|NCT00605085|26806083|FG001|Overall Study|Withdrawal by Subject|5|||
13400999|NCT00605085|26806082|FG000|Overall Study|Adverse Event|9|||
13401000|NCT00605085|26806083|FG001|Overall Study|Adverse Event|5|||
13401001|NCT00605085|26806082|FG000|Overall Study|Pregnancy|2|||
13401002|NCT00605085|26806083|FG001|Overall Study|Pregnancy|0|||
13401003|NCT00605085|26806082|FG000|Overall Study|Protocol Violation|3|||
13401004|NCT00605085|26806083|FG001|Overall Study|Protocol Violation|2|||
13401005|NCT00605085|26806082|FG000|Overall Study|Lost to Follow-up|10|||
13401006|NCT00605085|26806083|FG001|Overall Study|Lost to Follow-up|5|||
13401007|NCT00605085|26806082|FG000|Overall Study|administrative reasons|18|||
13401008|NCT00605085|26806083|FG001|Overall Study|administrative reasons|8|||
13401009|NCT00605033|26806096|FG000|Overall Study|Adverse Event|2|||
13401010|NCT00605033|26806097|FG001|Overall Study|Adverse Event|2|||
13401011|NCT00605033|26806096|FG000|Overall Study|Lost to Follow-up|1|||
13401012|NCT00605033|26806097|FG001|Overall Study|Lost to Follow-up|1|||
13401013|NCT00605033|26806096|FG000|Overall Study|Withdrawal by Subject|3|||
13401014|NCT00605033|26806097|FG001|Overall Study|Withdrawal by Subject|4|||
13401015|NCT00605033|26806096|FG000|Overall Study|Protocol Violation|1|||
13401016|NCT00605033|26806097|FG001|Overall Study|Protocol Violation|1|||
13401017|NCT00604825|26806308|FG000|Overall Study|Adverse Event|2|||
13401018|NCT00604825|26806309|FG001|Overall Study|Adverse Event|6|||
13401019|NCT00604825|26806310|FG002|Overall Study|Adverse Event|7|||
13401020|NCT00604825|26806311|FG003|Overall Study|Adverse Event|4|||
13401021|NCT00604825|26806308|FG000|Overall Study|Lost to Follow-up|0|||
13401022|NCT00604825|26806309|FG001|Overall Study|Lost to Follow-up|3|||
13401023|NCT00604825|26806310|FG002|Overall Study|Lost to Follow-up|1|||
13401024|NCT00604825|26806311|FG003|Overall Study|Lost to Follow-up|0|||
13401025|NCT00604825|26806308|FG000|Overall Study|Protocol Violation|0|||
13401026|NCT00604825|26806309|FG001|Overall Study|Protocol Violation|1|||
13401027|NCT00604825|26806310|FG002|Overall Study|Protocol Violation|0|||
13401028|NCT00604825|26806311|FG003|Overall Study|Protocol Violation|0|||
13401029|NCT00604825|26806308|FG000|Overall Study|Withdrawal by Subject|4|||
13401030|NCT00604825|26806309|FG001|Overall Study|Withdrawal by Subject|3|||
13401031|NCT00604825|26806310|FG002|Overall Study|Withdrawal by Subject|5|||
13401032|NCT00604825|26806311|FG003|Overall Study|Withdrawal by Subject|5|||
13401033|NCT00604825|26806308|FG000|Overall Study|Lack of Efficacy|3|||
13401034|NCT00604825|26806309|FG001|Overall Study|Lack of Efficacy|2|||
13401035|NCT00604825|26806310|FG002|Overall Study|Lack of Efficacy|1|||
13401036|NCT00604825|26806311|FG003|Overall Study|Lack of Efficacy|0|||
13401037|NCT00604825|26806308|FG000|Overall Study|Did not meet eligibility criteria|0|||
13401038|NCT00604825|26806309|FG001|Overall Study|Did not meet eligibility criteria|0|||
13401039|NCT00604825|26806310|FG002|Overall Study|Did not meet eligibility criteria|2|||
13401040|NCT00604825|26806311|FG003|Overall Study|Did not meet eligibility criteria|0|||
13401041|NCT00604825|26806308|FG000|Overall Study|Physician Decision|0|||
13401042|NCT00604825|26806309|FG001|Overall Study|Physician Decision|0|||
13401043|NCT00604825|26806310|FG002|Overall Study|Physician Decision|0|||
13401044|NCT00604825|26806311|FG003|Overall Study|Physician Decision|1|||
13401045|NCT00604825|26806308|FG000|Overall Study|Exclusion criterion met|0|||
13401046|NCT00604825|26806309|FG001|Overall Study|Exclusion criterion met|0|||
13401047|NCT00604825|26806310|FG002|Overall Study|Exclusion criterion met|0|||
13401048|NCT00604825|26806311|FG003|Overall Study|Exclusion criterion met|1|||
13401049|NCT00604786|26806324|FG000|Overall Study|Lost to Follow-up|2|||
13401050|NCT00604786|26806325|FG001|Overall Study|Lost to Follow-up|0|||
13401051|NCT00604721|26806333|FG000|Overall Study|Physician Decision|1|||
13401052|NCT00604721|26806333|FG000|Overall Study|Withdrawal by Subject|1|||
13401053|NCT00604708|26806348|FG000|Overall Study|Withdrawal by Subject|9|||
13401054|NCT00604708|26806349|FG001|Overall Study|Withdrawal by Subject|10|||
13401055|NCT00604708|26806348|FG000|Overall Study|Protocol Violation|2|||
13401056|NCT00604708|26806349|FG001|Overall Study|Protocol Violation|8|||
13401057|NCT00604708|26806348|FG000|Overall Study|Lost to Follow-up|5|||
13401058|NCT00604708|26806349|FG001|Overall Study|Lost to Follow-up|5|||
13401059|NCT00604708|26806348|FG000|Overall Study|administrative reasons|9|||
13401060|NCT00604708|26806349|FG001|Overall Study|administrative reasons|11|||
13401061|NCT00604708|26806348|FG000|Overall Study|Adverse Event|6|||
13401062|NCT00604708|26806349|FG001|Overall Study|Adverse Event|6|||
13401063|NCT00604695|26806378|FG000|Overall Study|Did not receive first bolus.|0|||
13401064|NCT00604695|26806379|FG001|Overall Study|Did not receive first bolus.|4|||
13401065|NCT00604669|26806385|FG000|Overall Study|lack of information in chart|7|||
13401066|NCT00604565|26806400|FG000|Overall Study|Study terminated|0|||
13401067|NCT00604565|26806401|FG001|Overall Study|Study terminated|3|||
13401068|NCT00604500|26806410|FG000|Overall Study|Adverse Event|2|||
13401069|NCT00604500|26806410|FG000|Overall Study|Protocol Violation|2|||
13401070|NCT00604500|26806410|FG000|Overall Study|Treatment Failure|1|||
13401071|NCT00604500|26806410|FG000|Overall Study|Withdrawal by Subject|4|||
13401072|NCT00604500|26806410|FG000|Overall Study|Administrative|1|||
13401073|NCT00604500|26806410|FG000|Overall Study|Did not meet protocol eligibility|1|||
13401074|NCT00604383|26806431|FG000|Overall Study|Withdrawal by Subject|33|||
13401075|NCT00604383|26806432|FG001|Overall Study|Withdrawal by Subject|31|||
13401076|NCT00604383|26806431|FG000|Overall Study|Lost to Follow-up|24|||
13401077|NCT00604383|26806432|FG001|Overall Study|Lost to Follow-up|19|||
13401078|NCT00604383|26806431|FG000|Overall Study|Death|14|||
13401079|NCT00604383|26806432|FG001|Overall Study|Death|22|||
13401080|NCT00604383|26806431|FG000|Overall Study|Adverse Event|16|||
13401081|NCT00604383|26806432|FG001|Overall Study|Adverse Event|9|||
13401082|NCT00604383|26806431|FG000|Overall Study|Physician Decision|0|||
13401083|NCT00604383|26806432|FG001|Overall Study|Physician Decision|3|||
13401084|NCT00604279|26806453|FG000|Overall Study|Lack of Efficacy|22|||
13401085|NCT00604279|26806454|FG001|Overall Study|Lack of Efficacy|9|||
13401086|NCT00604279|26806453|FG000|Overall Study|Lost to Follow-up|9|||
13401087|NCT00604279|26806454|FG001|Overall Study|Lost to Follow-up|14|||
13401088|NCT00604279|26806453|FG000|Overall Study|Pregnancy|2|||
13401089|NCT00604279|26806454|FG001|Overall Study|Pregnancy|0|||
13401090|NCT00604279|26806453|FG000|Overall Study|Protocol Violation|3|||
13401091|NCT00604279|26806454|FG001|Overall Study|Protocol Violation|1|||
13401092|NCT00604279|26806453|FG000|Overall Study|Withdrawal by Subject|16|||
13401093|NCT00604279|26806454|FG001|Overall Study|Withdrawal by Subject|5|||
13401094|NCT00604279|26806453|FG000|Overall Study|Adverse Event|4|||
13401095|NCT00604279|26806454|FG001|Overall Study|Adverse Event|5|||
13401096|NCT00604279|26806453|FG000|Overall Study|Other|8|||
13401097|NCT00604279|26806454|FG001|Overall Study|Other|4|||
13401098|NCT00604214|26806491|FG000|Baseline to Day 28|Death|223|||
13401099|NCT00604214|26806492|FG001|Baseline to Day 28|Death|202|||
13401100|NCT00604214|26806491|FG000|Baseline to Day 28|Lost to Follow-up|2|||
13401101|NCT00604214|26806492|FG001|Baseline to Day 28|Lost to Follow-up|4|||
13401102|NCT00604214|26806491|FG000|Baseline to Day 28|Withdrawal by Subject|3|||
13401103|NCT00604214|26806492|FG001|Baseline to Day 28|Withdrawal by Subject|7|||
13401104|NCT00604214|26806491|FG000|Day 29 to Day 90|Death|64|||
13401105|NCT00604214|26806492|FG001|Day 29 to Day 90|Death|67|||
13401106|NCT00604214|26806491|FG000|Day 29 to Day 90|Lost to Follow-up|4|||
13401107|NCT00604214|26806492|FG001|Day 29 to Day 90|Lost to Follow-up|6|||
13401108|NCT00604214|26806491|FG000|Day 29 to Day 90|Withdrawal by Subject|0|||
13401109|NCT00604214|26806492|FG001|Day 29 to Day 90|Withdrawal by Subject|6|||
13401110|NCT00604214|26806491|FG000|Day 91 to Day 180|Death|19|||
13401111|NCT00604214|26806492|FG001|Day 91 to Day 180|Death|23|||
13401112|NCT00604214|26806491|FG000|Day 91 to Day 180|Lost to Follow-up|6|||
13401113|NCT00604214|26806492|FG001|Day 91 to Day 180|Lost to Follow-up|8|||
13401114|NCT00604214|26806491|FG000|Day 91 to Day 180|Withdrawal by Subject|1|||
13401115|NCT00604214|26806492|FG001|Day 91 to Day 180|Withdrawal by Subject|1|||
13401116|NCT00604188|26806519|FG000|Overall Study|Adverse Event|1|||
13401117|NCT00604188|26806520|FG001|Overall Study|Adverse Event|4|||
13401118|NCT00604188|26806519|FG000|Overall Study|Lost to Follow-up|17|||
13401119|NCT00604188|26806520|FG001|Overall Study|Lost to Follow-up|15|||
13401120|NCT00604188|26806519|FG000|Overall Study|Withdrawal by Subject|5|||
13401121|NCT00604188|26806520|FG001|Overall Study|Withdrawal by Subject|1|||
13401122|NCT00604188|26806519|FG000|Overall Study|Non-compliance with protocol|4|||
13401123|NCT00604188|26806520|FG001|Overall Study|Non-compliance with protocol|4|||
13401124|NCT00604188|26806519|FG000|Overall Study|Did not receive study drug|0|||
13401125|NCT00604188|26806520|FG001|Overall Study|Did not receive study drug|1|||
13401126|NCT00604175|26806583|FG000|Entry Through Week 28|Death|2|||
13401127|NCT00604175|26806584|FG001|Entry Through Week 28|Death|0|||
13401128|NCT00604175|26806585|FG002|Entry Through Week 28|Death|0|||
13401129|NCT00604175|26806583|FG000|Entry Through Week 28|Withdrawal by Subject|1|||
13401130|NCT00604175|26806584|FG001|Entry Through Week 28|Withdrawal by Subject|0|||
13401131|NCT00604175|26806585|FG002|Entry Through Week 28|Withdrawal by Subject|0|||
13401132|NCT00604175|26806583|FG000|Entry Through Week 28|Lost to Follow-up|4|||
13401133|NCT00604175|26806584|FG001|Entry Through Week 28|Lost to Follow-up|3|||
13401134|NCT00604175|26806585|FG002|Entry Through Week 28|Lost to Follow-up|0|||
13401135|NCT00604175|26806583|FG000|Entry Through Week 28|Ineligible|1|||
13401136|NCT00604175|26806584|FG001|Entry Through Week 28|Ineligible|0|||
13401137|NCT00604175|26806585|FG002|Entry Through Week 28|Ineligible|0|||
13401138|NCT00604175|26806583|FG000|Entry Through Week 28|Did not start intervention|2|||
13401139|NCT00604175|26806584|FG001|Entry Through Week 28|Did not start intervention|0|||
13401140|NCT00604175|26806585|FG002|Entry Through Week 28|Did not start intervention|1|||
13401141|NCT00604175|26806583|FG000|Week 29 Through Week 72|Death|0|||
13401142|NCT00604175|26806584|FG001|Week 29 Through Week 72|Death|0|||
13401143|NCT00604175|26806585|FG002|Week 29 Through Week 72|Death|1|||
13401144|NCT00604175|26806583|FG000|Week 29 Through Week 72|Lost to Follow-up|12|||
13401145|NCT00604175|26806584|FG001|Week 29 Through Week 72|Lost to Follow-up|6|||
13401146|NCT00604175|26806585|FG002|Week 29 Through Week 72|Lost to Follow-up|2|||
13401147|NCT00604175|26806583|FG000|Week 29 Through Week 72|Site closure|0|||
13401148|NCT00604175|26806584|FG001|Week 29 Through Week 72|Site closure|1|||
13401149|NCT00604175|26806585|FG002|Week 29 Through Week 72|Site closure|0|||
13401150|NCT00604175|26806583|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0|||
13401151|NCT00604175|26806584|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0|||
13401152|NCT00604175|26806585|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1|||
13401153|NCT00604162|26806598|FG000|Overall Study|Physician Decision|3|||
13401154|NCT00604162|26806598|FG000|Overall Study|Withdrawal by Subject|1|||
13401155|NCT00603980|26806716|FG000|Study Qualification|Protocol Violation|3|||
13401156|NCT00603980|26806716|FG000|Study Qualification|Inconsistent data reporting|13|||
13401157|NCT00603980|26806716|FG000|Main Study|14th subject completed trial|1|||
13401158|NCT00603941|26806737|FG000|Overall Study|Disease progression|6|||
13401159|NCT00603941|26806738|FG001|Overall Study|Disease progression|7|||
13401160|NCT00603941|26806739|FG002|Overall Study|Disease progression|1|||
13401161|NCT00603941|26806737|FG000|Overall Study|Adverse Event|1|||
13401162|NCT00603941|26806738|FG001|Overall Study|Adverse Event|0|||
13401163|NCT00603941|26806739|FG002|Overall Study|Adverse Event|1|||
13401164|NCT00603941|26806737|FG000|Overall Study|Physician Decision|0|||
13401165|NCT00603941|26806738|FG001|Overall Study|Physician Decision|1|||
13401166|NCT00603941|26806739|FG002|Overall Study|Physician Decision|0|||
13401167|NCT00603941|26806737|FG000|Overall Study|Withdrawal by Subject|0|||
13401168|NCT00603941|26806738|FG001|Overall Study|Withdrawal by Subject|2|||
13401169|NCT00603941|26806739|FG002|Overall Study|Withdrawal by Subject|0|||
13401170|NCT00603915|26806746|FG000|Overall Study|Physician Decision|1|||
13401171|NCT00603837|26806759|FG000|Overall Study|Physician Decision|3|||
13401172|NCT00603837|26806760|FG001|Overall Study|Physician Decision|0|||
13476005|NCT02369653|27001834|FG000|Overall Study|Administrative reason by sponsor|0|||
13476006|NCT02369653|27001835|FG001|Overall Study|Administrative reason by sponsor|1|||
13476007|NCT02369653|27001834|FG000|Overall Study|Death|1|||
13476008|NCT02369653|27001835|FG001|Overall Study|Death|2|||
13476009|NCT02369653|27001834|FG000|Overall Study|Participant withdrew consent|13|||
13476010|NCT02369653|27001835|FG001|Overall Study|Participant withdrew consent|3|||
13476011|NCT02326974|27001849|FG000|Overall Study|Withdrawal by Subject|2|||
13476012|NCT02326974|27001849|FG000|Overall Study|failed heterogenity evaluation|5|||
13476013|NCT02284568|27001885|FG000|Overall Study|Adverse Event|2|||
13476014|NCT02284568|27001886|FG001|Overall Study|Adverse Event|9|||
13476015|NCT02284568|27001887|FG002|Overall Study|Adverse Event|4|||
13476016|NCT02284568|27001885|FG000|Overall Study|Withdrawal by Subject|22|||
13476017|NCT02284568|27001886|FG001|Overall Study|Withdrawal by Subject|21|||
13476018|NCT02284568|27001887|FG002|Overall Study|Withdrawal by Subject|1|||
13476019|NCT02284568|27001885|FG000|Overall Study|Noncompliance with study drug admin|1|||
13476020|NCT02284568|27001886|FG001|Overall Study|Noncompliance with study drug admin|2|||
13476021|NCT02284568|27001887|FG002|Overall Study|Noncompliance with study drug admin|0|||
13476022|NCT02284568|27001885|FG000|Overall Study|Noncompliance|1|||
13476023|NCT02284568|27001886|FG001|Overall Study|Noncompliance|0|||
13476024|NCT02284568|27001887|FG002|Overall Study|Noncompliance|0|||
13476025|NCT02284568|27001885|FG000|Overall Study|Protocol Violation|0|||
13476026|NCT02284568|27001886|FG001|Overall Study|Protocol Violation|1|||
13476027|NCT02284568|27001887|FG002|Overall Study|Protocol Violation|0|||
13401173|NCT00603798|26806787|FG000|Overall Study|Adverse Event|4|||
13401174|NCT00603798|26806788|FG001|Overall Study|Adverse Event|2|||
13401175|NCT00603798|26806789|FG002|Overall Study|Adverse Event|1|||
13401176|NCT00603798|26806787|FG000|Overall Study|Withdrawal by Subject|4|||
13401177|NCT00603798|26806788|FG001|Overall Study|Withdrawal by Subject|3|||
13401178|NCT00603798|26806789|FG002|Overall Study|Withdrawal by Subject|4|||
13401179|NCT00603798|26806787|FG000|Overall Study|Lost to Follow-up|1|||
13401180|NCT00603798|26806788|FG001|Overall Study|Lost to Follow-up|0|||
13401181|NCT00603798|26806789|FG002|Overall Study|Lost to Follow-up|1|||
13401182|NCT00603798|26806787|FG000|Overall Study|Non-compliance with study procedures|0|||
13401183|NCT00603798|26806788|FG001|Overall Study|Non-compliance with study procedures|1|||
13401184|NCT00603798|26806789|FG002|Overall Study|Non-compliance with study procedures|0|||
13401185|NCT00603798|26806787|FG000|Overall Study|Not due to AE|1|||
13401186|NCT00603798|26806788|FG001|Overall Study|Not due to AE|1|||
13401187|NCT00603798|26806789|FG002|Overall Study|Not due to AE|4|||
13401188|NCT00603746|26806954|FG000|Overall Study|Adverse Event|2|||
13401189|NCT00603746|26806955|FG001|Overall Study|Adverse Event|3|||
13401190|NCT00603746|26806956|FG002|Overall Study|Adverse Event|0|||
13401191|NCT00603746|26806957|FG003|Overall Study|Adverse Event|1|||
13401192|NCT00603746|26806958|FG004|Overall Study|Adverse Event|0|||
13401193|NCT00603746|26806959|FG005|Overall Study|Adverse Event|4|||
13401194|NCT00603746|26806954|FG000|Overall Study|Lack of Efficacy|34|||
13401195|NCT00603746|26806955|FG001|Overall Study|Lack of Efficacy|11|||
13401196|NCT00603746|26806956|FG002|Overall Study|Lack of Efficacy|6|||
13401197|NCT00603746|26806957|FG003|Overall Study|Lack of Efficacy|11|||
13401198|NCT00603746|26806958|FG004|Overall Study|Lack of Efficacy|12|||
13401199|NCT00603746|26806959|FG005|Overall Study|Lack of Efficacy|8|||
13401200|NCT00603746|26806954|FG000|Overall Study|Protocol Violation|0|||
13401201|NCT00603746|26806955|FG001|Overall Study|Protocol Violation|3|||
13401202|NCT00603746|26806956|FG002|Overall Study|Protocol Violation|1|||
13401203|NCT00603746|26806957|FG003|Overall Study|Protocol Violation|0|||
13401204|NCT00603746|26806958|FG004|Overall Study|Protocol Violation|1|||
13401205|NCT00603746|26806959|FG005|Overall Study|Protocol Violation|0|||
13401206|NCT00603746|26806954|FG000|Overall Study|Lost to Follow-up|0|||
13401207|NCT00603746|26806955|FG001|Overall Study|Lost to Follow-up|1|||
13401208|NCT00603746|26806956|FG002|Overall Study|Lost to Follow-up|1|||
13401209|NCT00603746|26806957|FG003|Overall Study|Lost to Follow-up|0|||
13401210|NCT00603746|26806958|FG004|Overall Study|Lost to Follow-up|0|||
13401211|NCT00603746|26806959|FG005|Overall Study|Lost to Follow-up|0|||
13401212|NCT00603746|26806954|FG000|Overall Study|Physician Decision|1|||
13401213|NCT00603746|26806955|FG001|Overall Study|Physician Decision|0|||
13401214|NCT00603746|26806956|FG002|Overall Study|Physician Decision|0|||
13401215|NCT00603746|26806957|FG003|Overall Study|Physician Decision|0|||
13401216|NCT00603746|26806958|FG004|Overall Study|Physician Decision|1|||
13401217|NCT00603746|26806959|FG005|Overall Study|Physician Decision|0|||
13401218|NCT00603746|26806954|FG000|Overall Study|Withdrawal by Subject|1|||
13401219|NCT00603746|26806955|FG001|Overall Study|Withdrawal by Subject|0|||
13401220|NCT00603746|26806956|FG002|Overall Study|Withdrawal by Subject|0|||
13401221|NCT00603746|26806957|FG003|Overall Study|Withdrawal by Subject|1|||
13401222|NCT00603746|26806958|FG004|Overall Study|Withdrawal by Subject|3|||
13401223|NCT00603746|26806959|FG005|Overall Study|Withdrawal by Subject|1|||
13401224|NCT00603733|26806976|FG000|Active Phase ITT|Adverse Event|8|||
13401225|NCT00603733|26806977|FG001|Active Phase ITT|Adverse Event|7|||
13401226|NCT00603733|26806976|FG000|Active Phase ITT|Withdrawal by Subject|0|||
13401227|NCT00603733|26806977|FG001|Active Phase ITT|Withdrawal by Subject|3|||
13401228|NCT00603733|26806976|FG000|Active Phase ITT|Lost to Follow-up|0|||
13401229|NCT00603733|26806977|FG001|Active Phase ITT|Lost to Follow-up|1|||
13401230|NCT00603733|26806976|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1|||
13401231|NCT00603733|26806977|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3|||
13401232|NCT00603733|26806976|FG000|Active Phase ITT|Lack of Efficacy|1|||
13401233|NCT00603733|26806977|FG001|Active Phase ITT|Lack of Efficacy|2|||
13401234|NCT00603733|26806976|FG000|Active Phase ITT|Subject moved, site closed|1|||
13401235|NCT00603733|26806977|FG001|Active Phase ITT|Subject moved, site closed|1|||
13401236|NCT00603733|26806976|FG000|Run-In Phase - 4 Weeks|Adverse Event|2|||
13401237|NCT00603733|26806977|FG001|Run-In Phase - 4 Weeks|Adverse Event|1|||
13401238|NCT00603733|26806976|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4|||
13401239|NCT00603733|26806977|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1|||
13401240|NCT00603733|26806976|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1|||
13401241|NCT00603733|26806977|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0|||
13401242|NCT00603733|26806976|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5|||
13401243|NCT00603733|26806977|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10|||
13401244|NCT00603733|26806976|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2|||
13401245|NCT00603733|26806977|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1|||
13401246|NCT00603733|26806976|FG000|Maintenance Phase ITT|Adverse Event|3|||
13401247|NCT00603733|26806977|FG001|Maintenance Phase ITT|Adverse Event|6|||
13401248|NCT00603733|26806976|FG000|Maintenance Phase ITT|Withdrawal by Subject|1|||
13401249|NCT00603733|26806977|FG001|Maintenance Phase ITT|Withdrawal by Subject|0|||
13401250|NCT00603733|26806976|FG000|Maintenance Phase ITT|Protocol Violation|1|||
13401251|NCT00603733|26806977|FG001|Maintenance Phase ITT|Protocol Violation|1|||
13401252|NCT00603733|26806976|FG000|Maintenance Phase ITT|Lost to Follow-up|0|||
13401253|NCT00603733|26806977|FG001|Maintenance Phase ITT|Lost to Follow-up|1|||
13401254|NCT00603733|26806976|FG000|Maintenance Phase ITT|Lack of Efficacy|2|||
13401255|NCT00603733|26806977|FG001|Maintenance Phase ITT|Lack of Efficacy|2|||
13401256|NCT00603733|26806976|FG000|Maintenance Phase ITT|Physician Decision|0|||
13401257|NCT00603733|26806977|FG001|Maintenance Phase ITT|Physician Decision|1|||
13401258|NCT00603733|26806976|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3|||
13401259|NCT00603733|26806977|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5|||
13401260|NCT00603590|26806994|FG000|Overall Study|Did not attend study clinic|39|||
13401261|NCT00603590|26806995|FG001|Overall Study|Did not attend study clinic|30|||
13401262|NCT00603590|26806994|FG000|Overall Study|Refused blood test|5|||
13401263|NCT00603590|26806995|FG001|Overall Study|Refused blood test|1|||
13401264|NCT00603590|26806994|FG000|Overall Study|Patient discontinued study drug|22|||
13401265|NCT00603590|26806995|FG001|Overall Study|Patient discontinued study drug|15|||
13401266|NCT00603590|26806994|FG000|Overall Study|Adverse Event|2|||
13401267|NCT00603590|26806995|FG001|Overall Study|Adverse Event|0|||
13401268|NCT00603590|26806994|FG000|Overall Study|Lost to Follow-up|8|||
13401269|NCT00603590|26806995|FG001|Overall Study|Lost to Follow-up|4|||
13401270|NCT00603590|26806994|FG000|Overall Study|Cardiovascular event|0|||
13401271|NCT00603590|26806995|FG001|Overall Study|Cardiovascular event|1|||
13401272|NCT00603538|26807043|FG000|Overall Study|Adverse Event|0|||
13401273|NCT00603538|26807044|FG001|Overall Study|Adverse Event|4|||
13401274|NCT00603538|26807045|FG002|Overall Study|Adverse Event|2|||
13401275|NCT00603538|26807043|FG000|Overall Study|Objective progression or relapse|3|||
13401276|NCT00603538|26807044|FG001|Overall Study|Objective progression or relapse|0|||
13401277|NCT00603538|26807045|FG002|Overall Study|Objective progression or relapse|0|||
13401278|NCT00603525|26807180|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3|||
13401279|NCT00603525|26807181|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9|||
13401280|NCT00603525|26807182|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
13401281|NCT00603525|26807180|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7|||
13401282|NCT00603525|26807181|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
13401283|NCT00603525|26807182|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
13401284|NCT00603525|26807180|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
13401285|NCT00603525|26807181|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2|||
13401286|NCT00603525|26807182|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
13401287|NCT00603525|26807180|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
13401288|NCT00603525|26807181|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3|||
13401289|NCT00603525|26807182|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
13401290|NCT00603525|26807180|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
13401291|NCT00603525|26807181|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6|||
13401292|NCT00603525|26807182|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
13401293|NCT00603525|26807180|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0|||
13401294|NCT00603525|26807181|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1|||
13401295|NCT00603525|26807182|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0|||
13401296|NCT00603525|26807180|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
13401297|NCT00603525|26807181|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1|||
13401298|NCT00603525|26807182|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
13401299|NCT00603525|26807180|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
13401300|NCT00603525|26807181|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12|||
13401301|NCT00603525|26807182|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
13401302|NCT00603525|26807180|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
13401303|NCT00603525|26807181|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13|||
13401304|NCT00603525|26807182|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
13401305|NCT00603525|26807180|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
13401306|NCT00603525|26807181|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1|||
13401307|NCT00603525|26807182|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
13401308|NCT00603525|26807180|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
13401309|NCT00603525|26807181|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5|||
13401310|NCT00603525|26807182|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
13401311|NCT00603525|26807180|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
13401312|NCT00603525|26807181|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71|||
13401313|NCT00603525|26807182|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
13401314|NCT00603525|26807180|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
13401315|NCT00603525|26807181|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2|||
13401316|NCT00603525|26807182|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
13401317|NCT00603525|26807180|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
13401318|NCT00603525|26807181|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8|||
13401319|NCT00603525|26807182|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
13401320|NCT00603525|26807180|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
13401321|NCT00603525|26807181|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
13401322|NCT00603525|26807182|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111|||
13401323|NCT00603512|26807340|FG000|Overall Study|Adverse Event|0|||
13401324|NCT00603512|26807341|FG001|Overall Study|Adverse Event|2|||
13401325|NCT00603512|26807342|FG002|Overall Study|Adverse Event|4|||
13401326|NCT00603512|26807343|FG003|Overall Study|Adverse Event|4|||
13401327|NCT00603512|26807344|FG004|Overall Study|Adverse Event|2|||
13401328|NCT00603512|26807340|FG000|Overall Study|Lack of Efficacy|0|||
13401329|NCT00603512|26807341|FG001|Overall Study|Lack of Efficacy|1|||
13401330|NCT00603512|26807342|FG002|Overall Study|Lack of Efficacy|0|||
13401331|NCT00603512|26807343|FG003|Overall Study|Lack of Efficacy|0|||
13401332|NCT00603512|26807344|FG004|Overall Study|Lack of Efficacy|1|||
13401333|NCT00603512|26807340|FG000|Overall Study|Other|2|||
13401334|NCT00603512|26807341|FG001|Overall Study|Other|1|||
13401335|NCT00603512|26807342|FG002|Overall Study|Other|0|||
13401336|NCT00603512|26807343|FG003|Overall Study|Other|1|||
13401337|NCT00603512|26807344|FG004|Overall Study|Other|1|||
13401338|NCT00603512|26807340|FG000|Overall Study|Withdrawal by Subject|0|||
13401339|NCT00603512|26807341|FG001|Overall Study|Withdrawal by Subject|0|||
13401340|NCT00603512|26807342|FG002|Overall Study|Withdrawal by Subject|0|||
13401341|NCT00603512|26807343|FG003|Overall Study|Withdrawal by Subject|0|||
13401342|NCT00603512|26807344|FG004|Overall Study|Withdrawal by Subject|1|||
13401343|NCT00603512|26807340|FG000|Overall Study|Randomized but not treated|0|||
13401344|NCT00603512|26807341|FG001|Overall Study|Randomized but not treated|1|||
13401345|NCT00603512|26807342|FG002|Overall Study|Randomized but not treated|1|||
13401346|NCT00603512|26807343|FG003|Overall Study|Randomized but not treated|2|||
13401347|NCT00603512|26807344|FG004|Overall Study|Randomized but not treated|0|||
13401348|NCT00603473|26807352|FG000|Overall Study|Adverse Event|4|||
13401349|NCT00603473|26807352|FG000|Overall Study|Lack of Efficacy|4|||
13401350|NCT00603473|26807352|FG000|Overall Study|Protocol Violation|1|||
13401351|NCT00603447|26807396|FG000|Overall Study|Adverse Event|0|||
13401352|NCT00603447|26807397|FG001|Overall Study|Adverse Event|1|||
13401353|NCT00603447|26807398|FG002|Overall Study|Adverse Event|1|||
13401354|NCT00603447|26807399|FG003|Overall Study|Adverse Event|2|||
13401355|NCT00603447|26807400|FG004|Overall Study|Adverse Event|1|||
13401356|NCT00603447|26807401|FG005|Overall Study|Adverse Event|2|||
13401357|NCT00603447|26807402|FG006|Overall Study|Adverse Event|10|||
13401358|NCT00603447|26807396|FG000|Overall Study|Other|0|||
13401359|NCT00603447|26807397|FG001|Overall Study|Other|0|||
13401360|NCT00603447|26807398|FG002|Overall Study|Other|1|||
13401361|NCT00603447|26807399|FG003|Overall Study|Other|0|||
13401362|NCT00603447|26807400|FG004|Overall Study|Other|3|||
13401363|NCT00603447|26807401|FG005|Overall Study|Other|0|||
13401364|NCT00603447|26807402|FG006|Overall Study|Other|13|||
13401365|NCT00603447|26807396|FG000|Overall Study|Withdrew Consent|0|||
13401366|NCT00603447|26807397|FG001|Overall Study|Withdrew Consent|2|||
13401367|NCT00603447|26807398|FG002|Overall Study|Withdrew Consent|0|||
13401368|NCT00603447|26807399|FG003|Overall Study|Withdrew Consent|0|||
13401369|NCT00603447|26807400|FG004|Overall Study|Withdrew Consent|1|||
13401370|NCT00603447|26807401|FG005|Overall Study|Withdrew Consent|0|||
13401371|NCT00603447|26807402|FG006|Overall Study|Withdrew Consent|1|||
13401372|NCT00603382|26807567|FG000|Overall Study|Adverse Event|0|||
13401373|NCT00603382|26807568|FG001|Overall Study|Adverse Event|1|||
13401374|NCT00603382|26807569|FG002|Overall Study|Adverse Event|1|||
13401375|NCT00603382|26807570|FG003|Overall Study|Adverse Event|2|||
13401376|NCT00603382|26807571|FG004|Overall Study|Adverse Event|1|||
13401377|NCT00603382|26807572|FG005|Overall Study|Adverse Event|2|||
13401378|NCT00603382|26807567|FG000|Overall Study|Lack of Efficacy|14|||
13401379|NCT00603382|26807568|FG001|Overall Study|Lack of Efficacy|9|||
13401380|NCT00603382|26807569|FG002|Overall Study|Lack of Efficacy|3|||
13401381|NCT00603382|26807570|FG003|Overall Study|Lack of Efficacy|6|||
13401382|NCT00603382|26807571|FG004|Overall Study|Lack of Efficacy|6|||
13401383|NCT00603382|26807572|FG005|Overall Study|Lack of Efficacy|11|||
13401384|NCT00603382|26807567|FG000|Overall Study|Protocol Violation|1|||
13401385|NCT00603382|26807568|FG001|Overall Study|Protocol Violation|0|||
13401386|NCT00603382|26807569|FG002|Overall Study|Protocol Violation|1|||
13401387|NCT00603382|26807570|FG003|Overall Study|Protocol Violation|2|||
13401388|NCT00603382|26807571|FG004|Overall Study|Protocol Violation|1|||
13401389|NCT00603382|26807572|FG005|Overall Study|Protocol Violation|0|||
13401390|NCT00603382|26807567|FG000|Overall Study|Lost to Follow-up|0|||
13401391|NCT00603382|26807568|FG001|Overall Study|Lost to Follow-up|1|||
13401392|NCT00603382|26807569|FG002|Overall Study|Lost to Follow-up|1|||
13401393|NCT00603382|26807570|FG003|Overall Study|Lost to Follow-up|1|||
13401394|NCT00603382|26807571|FG004|Overall Study|Lost to Follow-up|0|||
13401395|NCT00603382|26807572|FG005|Overall Study|Lost to Follow-up|1|||
13401396|NCT00603382|26807567|FG000|Overall Study|Physician Decision|0|||
13401397|NCT00603382|26807568|FG001|Overall Study|Physician Decision|0|||
13401398|NCT00603382|26807569|FG002|Overall Study|Physician Decision|2|||
13401399|NCT00603382|26807570|FG003|Overall Study|Physician Decision|0|||
13401400|NCT00603382|26807571|FG004|Overall Study|Physician Decision|1|||
13401401|NCT00603382|26807572|FG005|Overall Study|Physician Decision|3|||
13401402|NCT00603382|26807567|FG000|Overall Study|Withdrawal by Subject|3|||
13401403|NCT00603382|26807568|FG001|Overall Study|Withdrawal by Subject|3|||
13401404|NCT00603382|26807569|FG002|Overall Study|Withdrawal by Subject|1|||
13401405|NCT00603382|26807570|FG003|Overall Study|Withdrawal by Subject|1|||
13401406|NCT00603382|26807571|FG004|Overall Study|Withdrawal by Subject|0|||
13401407|NCT00603382|26807572|FG005|Overall Study|Withdrawal by Subject|1|||
13401408|NCT00603304|26807613|FG000|Overall Study|Lost to Follow-up|5|||
13401409|NCT00603304|26807614|FG001|Overall Study|Lost to Follow-up|7|||
13401410|NCT00603304|26807613|FG000|Overall Study|Withdrawal by Subject|8|||
13401411|NCT00603304|26807614|FG001|Overall Study|Withdrawal by Subject|5|||
13401412|NCT00603304|26807613|FG000|Overall Study|Protocol Violation|1|||
13401413|NCT00603304|26807614|FG001|Overall Study|Protocol Violation|0|||
13401414|NCT00603304|26807613|FG000|Overall Study|Adverse Event|4|||
13401415|NCT00603304|26807614|FG001|Overall Study|Adverse Event|2|||
13401416|NCT00603304|26807613|FG000|Overall Study|Unacceptable Treatment Toxicity|5|||
13401417|NCT00603304|26807614|FG001|Overall Study|Unacceptable Treatment Toxicity|8|||
13401418|NCT00603304|26807613|FG000|Overall Study|Crossed Over to Open Label Therapy|3|||
13401419|NCT00603304|26807614|FG001|Overall Study|Crossed Over to Open Label Therapy|3|||
13401420|NCT00603304|26807613|FG000|Overall Study|Exclusionary Medication|2|||
13401421|NCT00603304|26807614|FG001|Overall Study|Exclusionary Medication|3|||
13401422|NCT00603304|26807613|FG000|Overall Study|Non-Compliant|0|||
13401423|NCT00603304|26807614|FG001|Overall Study|Non-Compliant|1|||
13401424|NCT00603304|26807613|FG000|Overall Study|Moved Away|0|||
13401425|NCT00603304|26807614|FG001|Overall Study|Moved Away|2|||
13401426|NCT00603304|26807613|FG000|Overall Study|Other|2|||
13401427|NCT00603304|26807614|FG001|Overall Study|Other|0|||
13401428|NCT00603304|26807613|FG000|Overall Study|Patient Decision|2|||
13401429|NCT00603304|26807614|FG001|Overall Study|Patient Decision|0|||
13401430|NCT00603278|26807779|FG000|Overall Study|Lack of Efficacy|35|||
13401431|NCT00603278|26807780|FG001|Overall Study|Lack of Efficacy|10|||
13401432|NCT00603278|26807781|FG002|Overall Study|Lack of Efficacy|11|||
13401433|NCT00603278|26807782|FG003|Overall Study|Lack of Efficacy|8|||
13401434|NCT00603278|26807783|FG004|Overall Study|Lack of Efficacy|7|||
13401435|NCT00603278|26807784|FG005|Overall Study|Lack of Efficacy|14|||
13401436|NCT00603278|26807779|FG000|Overall Study|Adverse Event|0|||
13401437|NCT00603278|26807780|FG001|Overall Study|Adverse Event|3|||
13401438|NCT00603278|26807781|FG002|Overall Study|Adverse Event|1|||
13401439|NCT00603278|26807782|FG003|Overall Study|Adverse Event|0|||
13401440|NCT00603278|26807783|FG004|Overall Study|Adverse Event|2|||
13401441|NCT00603278|26807784|FG005|Overall Study|Adverse Event|1|||
13401442|NCT00603278|26807779|FG000|Overall Study|Withdrawal by Subject|2|||
13401443|NCT00603278|26807780|FG001|Overall Study|Withdrawal by Subject|3|||
13401444|NCT00603278|26807781|FG002|Overall Study|Withdrawal by Subject|1|||
13401445|NCT00603278|26807782|FG003|Overall Study|Withdrawal by Subject|2|||
13401446|NCT00603278|26807783|FG004|Overall Study|Withdrawal by Subject|1|||
13401447|NCT00603278|26807784|FG005|Overall Study|Withdrawal by Subject|2|||
13401448|NCT00603278|26807779|FG000|Overall Study|Protocol Violation|3|||
13401449|NCT00603278|26807780|FG001|Overall Study|Protocol Violation|0|||
13401450|NCT00603278|26807781|FG002|Overall Study|Protocol Violation|1|||
13401451|NCT00603278|26807782|FG003|Overall Study|Protocol Violation|1|||
13401452|NCT00603278|26807783|FG004|Overall Study|Protocol Violation|0|||
13401453|NCT00603278|26807784|FG005|Overall Study|Protocol Violation|1|||
13401454|NCT00603278|26807779|FG000|Overall Study|Physician Decision|0|||
13401455|NCT00603278|26807780|FG001|Overall Study|Physician Decision|1|||
13401456|NCT00603278|26807781|FG002|Overall Study|Physician Decision|0|||
13401457|NCT00603278|26807782|FG003|Overall Study|Physician Decision|0|||
13401458|NCT00603278|26807783|FG004|Overall Study|Physician Decision|2|||
13401459|NCT00603278|26807784|FG005|Overall Study|Physician Decision|1|||
13401460|NCT00603278|26807779|FG000|Overall Study|Lost to Follow-up|1|||
13401461|NCT00603278|26807780|FG001|Overall Study|Lost to Follow-up|0|||
13401462|NCT00603278|26807781|FG002|Overall Study|Lost to Follow-up|0|||
13401463|NCT00603278|26807782|FG003|Overall Study|Lost to Follow-up|0|||
13401464|NCT00603278|26807783|FG004|Overall Study|Lost to Follow-up|1|||
13401465|NCT00603278|26807784|FG005|Overall Study|Lost to Follow-up|0|||
13401466|NCT00603265|26807820|FG000|Overall Study|Adverse Event|2|||
13401467|NCT00603265|26807821|FG001|Overall Study|Adverse Event|11|||
13401468|NCT00603265|26807822|FG002|Overall Study|Adverse Event|1|||
13401469|NCT00603265|26807820|FG000|Overall Study|Withdrawal by Subject|1|||
13401470|NCT00603265|26807821|FG001|Overall Study|Withdrawal by Subject|2|||
13401471|NCT00603265|26807822|FG002|Overall Study|Withdrawal by Subject|1|||
13401472|NCT00603265|26807820|FG000|Overall Study|Lack of Efficacy|3|||
13401473|NCT00603265|26807821|FG001|Overall Study|Lack of Efficacy|0|||
13401474|NCT00603265|26807822|FG002|Overall Study|Lack of Efficacy|3|||
13401475|NCT00603265|26807820|FG000|Overall Study|Lost to Follow-up|0|||
13401476|NCT00603265|26807821|FG001|Overall Study|Lost to Follow-up|1|||
13401477|NCT00603265|26807822|FG002|Overall Study|Lost to Follow-up|0|||
13401478|NCT00603265|26807820|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0|||
13401479|NCT00603265|26807821|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1|||
13401480|NCT00603265|26807822|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0|||
13401481|NCT00603265|26807820|FG000|Overall Study|Participant Left Country, No Responses|0|||
13401482|NCT00603265|26807821|FG001|Overall Study|Participant Left Country, No Responses|1|||
13401483|NCT00603265|26807822|FG002|Overall Study|Participant Left Country, No Responses|0|||
13401484|NCT00603265|26807820|FG000|Overall Study|Protocol Violation|1|||
13401485|NCT00603265|26807821|FG001|Overall Study|Protocol Violation|0|||
13401486|NCT00603265|26807822|FG002|Overall Study|Protocol Violation|0|||
13401487|NCT00603239|26807855|FG000|Overall Study|Adverse Event|4|||
13401488|NCT00603239|26807856|FG001|Overall Study|Adverse Event|1|||
13401489|NCT00603239|26807855|FG000|Overall Study|Entry criteria not met|0|||
13401490|NCT00603239|26807856|FG001|Overall Study|Entry criteria not met|1|||
13401491|NCT00603239|26807855|FG000|Overall Study|Loss of glucose control|3|||
13401492|NCT00603239|26807856|FG001|Overall Study|Loss of glucose control|0|||
13401493|NCT00603239|26807855|FG000|Overall Study|Lost to Follow-up|2|||
13401494|NCT00603239|26807856|FG001|Overall Study|Lost to Follow-up|1|||
13401495|NCT00603239|26807855|FG000|Overall Study|Physician Decision|2|||
13401496|NCT00603239|26807856|FG001|Overall Study|Physician Decision|0|||
13401497|NCT00603239|26807855|FG000|Overall Study|Protocol Violation|2|||
13401498|NCT00603239|26807856|FG001|Overall Study|Protocol Violation|0|||
13401499|NCT00603239|26807855|FG000|Overall Study|Subject decision|2|||
13401500|NCT00603239|26807856|FG001|Overall Study|Subject decision|1|||
13401501|NCT00602979|26807884|FG000|Overall Study|Lost to Follow-up|3|||
13401502|NCT00602979|26807885|FG001|Overall Study|Lost to Follow-up|2|||
13401503|NCT00602979|26807886|FG002|Overall Study|Lost to Follow-up|3|||
13401504|NCT00602979|26807887|FG003|Overall Study|Lost to Follow-up|2|||
13401505|NCT00602979|26807888|FG004|Overall Study|Lost to Follow-up|3|||
13401506|NCT00602979|26807884|FG000|Overall Study|Failed Intubation|0|||
13401507|NCT00602979|26807885|FG001|Overall Study|Failed Intubation|1|||
13401508|NCT00602979|26807886|FG002|Overall Study|Failed Intubation|0|||
13401509|NCT00602979|26807887|FG003|Overall Study|Failed Intubation|1|||
13401510|NCT00602979|26807888|FG004|Overall Study|Failed Intubation|0|||
13401511|NCT00602927|26807903|FG000|Period 1: 13 Days|Protocol Violation|2|||
13401512|NCT00602927|26807904|FG001|Period 1: 13 Days|Protocol Violation|4|||
13401513|NCT00602927|26807903|FG000|Period 1: 13 Days|MRI scanner technical issue|1|||
13401514|NCT00602927|26807904|FG001|Period 1: 13 Days|MRI scanner technical issue|0|||
13401515|NCT00602927|26807903|FG000|Period 1: 13 Days|Time|1|||
13401516|NCT00602927|26807904|FG001|Period 1: 13 Days|Time|0|||
13401517|NCT00602927|26807903|FG000|Period 1: 13 Days|Claustrophobia|0|||
13401518|NCT00602927|26807904|FG001|Period 1: 13 Days|Claustrophobia|1|||
13401519|NCT00602927|26807903|FG000|Period 2: 14 Days|Protocol Violation|0|||
13401520|NCT00602927|26807904|FG001|Period 2: 14 Days|Protocol Violation|2|||
13401521|NCT00602927|26807903|FG000|Period 3: 13 Days|Protocol Violation|0|||
13401522|NCT00602927|26807904|FG001|Period 3: 13 Days|Protocol Violation|1|||
13401523|NCT00602927|26807903|FG000|Period 3: 13 Days|MRI data quality|2|||
13401524|NCT00602927|26807904|FG001|Period 3: 13 Days|MRI data quality|2|||
13401525|NCT00602797|26807912|FG000|Overall Study|Adverse Event|1|||
13401526|NCT00602537|26807927|FG000|12 Week Double Blind Comparison|Adverse Event|2|||
13401527|NCT00602537|26807928|FG001|12 Week Double Blind Comparison|Adverse Event|5|||
13401528|NCT00602537|26807927|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13|||
13401529|NCT00602537|26807928|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23|||
13401530|NCT00602537|26807927|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5|||
13401531|NCT00602537|26807928|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6|||
13401532|NCT00602537|26807927|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3|||
13401533|NCT00602537|26807928|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13|||
13401534|NCT00602537|26807927|FG000|Follow Up Study Comparison|Adverse Event|1|||
13401535|NCT00602537|26807928|FG001|Follow Up Study Comparison|Adverse Event|0|||
13401536|NCT00602537|26807927|FG000|Follow Up Study Comparison|Lost to Follow-up|8|||
13401537|NCT00602537|26807928|FG001|Follow Up Study Comparison|Lost to Follow-up|1|||
13401538|NCT00602537|26807927|FG000|Follow Up Study Comparison|Withdrawal by Subject|2|||
13401539|NCT00602537|26807928|FG001|Follow Up Study Comparison|Withdrawal by Subject|2|||
13401540|NCT00602472|26807965|FG000|Overall Study|Adverse Event|5|||
13401541|NCT00602472|26807966|FG001|Overall Study|Adverse Event|23|||
13401542|NCT00602472|26807965|FG000|Overall Study|Protocol Violation|4|||
13401543|NCT00602472|26807966|FG001|Overall Study|Protocol Violation|19|||
13401544|NCT00602472|26807965|FG000|Overall Study|Withdrawal by Subject|8|||
13401545|NCT00602472|26807966|FG001|Overall Study|Withdrawal by Subject|14|||
13401546|NCT00602472|26807965|FG000|Overall Study|Other incl. lack of efficacy|4|||
13401547|NCT00602472|26807966|FG001|Overall Study|Other incl. lack of efficacy|2|||
13401548|NCT00602420|26807979|FG000|Overall Study|Death|1|||
13401549|NCT00602420|26807980|FG001|Overall Study|Death|4|||
13401550|NCT00602420|26807979|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5|||
13401551|NCT00602420|26807980|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3|||
13401552|NCT00602420|26807979|FG000|Overall Study|Withdrawal by Subject|18|||
13401553|NCT00602420|26807980|FG001|Overall Study|Withdrawal by Subject|17|||
13401554|NCT00602420|26807979|FG000|Overall Study|Adverse Event|1|||
13401555|NCT00602420|26807980|FG001|Overall Study|Adverse Event|0|||
13401556|NCT00602030|26808032|FG000|Lead-in Phase|Disease Progression|2|||
13401557|NCT00602030|26808033|FG001|Lead-in Phase|Disease Progression|3|||
13401558|NCT00602030|26808034|FG002|Lead-in Phase|Disease Progression|0|||
13401559|NCT00602030|26808035|FG003|Lead-in Phase|Disease Progression|0|||
13401560|NCT00602030|26808036|FG004|Lead-in Phase|Disease Progression|0|||
13401561|NCT00602030|26808032|FG000|Lead-in Phase|Adverse Event|0|||
13401562|NCT00602030|26808033|FG001|Lead-in Phase|Adverse Event|2|||
13401563|NCT00602030|26808034|FG002|Lead-in Phase|Adverse Event|0|||
13401564|NCT00602030|26808035|FG003|Lead-in Phase|Adverse Event|0|||
13401565|NCT00602030|26808036|FG004|Lead-in Phase|Adverse Event|0|||
13401566|NCT00602030|26808032|FG000|Double-blind Phase|Disease progression|0|||
13401567|NCT00602030|26808033|FG001|Double-blind Phase|Disease progression|0|||
13401568|NCT00602030|26808034|FG002|Double-blind Phase|Disease progression|33|||
13401569|NCT00602030|26808035|FG003|Double-blind Phase|Disease progression|30|||
13401570|NCT00602030|26808036|FG004|Double-blind Phase|Disease progression|0|||
13401571|NCT00602030|26808032|FG000|Double-blind Phase|Adverse Event|0|||
13401572|NCT00602030|26808033|FG001|Double-blind Phase|Adverse Event|0|||
13401573|NCT00602030|26808034|FG002|Double-blind Phase|Adverse Event|9|||
13401574|NCT00602030|26808035|FG003|Double-blind Phase|Adverse Event|18|||
13401575|NCT00602030|26808036|FG004|Double-blind Phase|Adverse Event|0|||
13401576|NCT00602030|26808032|FG000|Double-blind Phase|Consent withdrawal|0|||
13401577|NCT00602030|26808033|FG001|Double-blind Phase|Consent withdrawal|0|||
13401578|NCT00602030|26808034|FG002|Double-blind Phase|Consent withdrawal|4|||
13401579|NCT00602030|26808035|FG003|Double-blind Phase|Consent withdrawal|3|||
13401580|NCT00602030|26808036|FG004|Double-blind Phase|Consent withdrawal|0|||
13401581|NCT00602030|26808032|FG000|Double-blind Phase|Death|0|||
13401582|NCT00602030|26808033|FG001|Double-blind Phase|Death|0|||
13401583|NCT00602030|26808034|FG002|Double-blind Phase|Death|3|||
13401584|NCT00602030|26808035|FG003|Double-blind Phase|Death|3|||
13401585|NCT00602030|26808036|FG004|Double-blind Phase|Death|0|||
13401586|NCT00602030|26808032|FG000|Double-blind Phase|Administrative decision|0|||
13401587|NCT00602030|26808033|FG001|Double-blind Phase|Administrative decision|0|||
13401588|NCT00602030|26808034|FG002|Double-blind Phase|Administrative decision|0|||
13401589|NCT00602030|26808035|FG003|Double-blind Phase|Administrative decision|2|||
13401590|NCT00602030|26808036|FG004|Double-blind Phase|Administrative decision|0|||
13401591|NCT00602030|26808032|FG000|Double-blind Phase|Ineligibility|0|||
13401592|NCT00602030|26808033|FG001|Double-blind Phase|Ineligibility|0|||
13401593|NCT00602030|26808034|FG002|Double-blind Phase|Ineligibility|0|||
13401594|NCT00602030|26808035|FG003|Double-blind Phase|Ineligibility|1|||
13401595|NCT00602030|26808036|FG004|Double-blind Phase|Ineligibility|0|||
13401596|NCT00602030|26808032|FG000|Double-blind Phase|Protocol deviation/noncompliance|0|||
13401597|NCT00602030|26808033|FG001|Double-blind Phase|Protocol deviation/noncompliance|0|||
13401598|NCT00602030|26808034|FG002|Double-blind Phase|Protocol deviation/noncompliance|1|||
13401599|NCT00602030|26808035|FG003|Double-blind Phase|Protocol deviation/noncompliance|0|||
13401600|NCT00602030|26808036|FG004|Double-blind Phase|Protocol deviation/noncompliance|0|||
13401601|NCT00602030|26808032|FG000|Double-blind Phase|Reason not specified|0|||
13401602|NCT00602030|26808033|FG001|Double-blind Phase|Reason not specified|0|||
13401603|NCT00602030|26808034|FG002|Double-blind Phase|Reason not specified|4|||
13401604|NCT00602030|26808035|FG003|Double-blind Phase|Reason not specified|2|||
13401605|NCT00602030|26808036|FG004|Double-blind Phase|Reason not specified|0|||
13401606|NCT00602030|26808032|FG000|Crossover Phase|Disease Progression|0|||
13401607|NCT00602030|26808033|FG001|Crossover Phase|Disease Progression|0|||
13401608|NCT00602030|26808034|FG002|Crossover Phase|Disease Progression|0|||
13401609|NCT00602030|26808035|FG003|Crossover Phase|Disease Progression|0|||
13401610|NCT00602030|26808036|FG004|Crossover Phase|Disease Progression|11|||
13401611|NCT00602030|26808032|FG000|Crossover Phase|Adverse Event|0|||
13401612|NCT00602030|26808033|FG001|Crossover Phase|Adverse Event|0|||
13401613|NCT00602030|26808034|FG002|Crossover Phase|Adverse Event|0|||
13401614|NCT00602030|26808035|FG003|Crossover Phase|Adverse Event|0|||
13401615|NCT00602030|26808036|FG004|Crossover Phase|Adverse Event|3|||
13401616|NCT00602030|26808032|FG000|Crossover Phase|Consent withdrawal|0|||
13401617|NCT00602030|26808033|FG001|Crossover Phase|Consent withdrawal|0|||
13401618|NCT00602030|26808034|FG002|Crossover Phase|Consent withdrawal|0|||
13401619|NCT00602030|26808035|FG003|Crossover Phase|Consent withdrawal|0|||
13401620|NCT00602030|26808036|FG004|Crossover Phase|Consent withdrawal|2|||
13401621|NCT00601835|26808053|FG000|Overall Study|Withdrawal by Subject|9|||
13401622|NCT00601835|26808054|FG001|Overall Study|Withdrawal by Subject|6|||
13401623|NCT00601835|26808053|FG000|Overall Study|Physician Decision|1|||
13401624|NCT00601835|26808054|FG001|Overall Study|Physician Decision|0|||
13401625|NCT00601835|26808053|FG000|Overall Study|Lost to Follow-up|37|||
13401626|NCT00601835|26808054|FG001|Overall Study|Lost to Follow-up|5|||
13401627|NCT00601835|26808053|FG000|Overall Study|Adverse Event|1|||
13401628|NCT00601835|26808054|FG001|Overall Study|Adverse Event|1|||
13401629|NCT00601835|26808053|FG000|Overall Study|Relocate|12|||
13401630|NCT00601835|26808054|FG001|Overall Study|Relocate|2|||
13401631|NCT00601705|26808065|FG000|Overall Study|Withdrawal by Subject|1|||
13401632|NCT00601640|26808089|FG000|Overall Study|Withdrawal by Subject|3|||
13401633|NCT00601640|26808090|FG001|Overall Study|Withdrawal by Subject|0|||
13401634|NCT00601640|26808091|FG002|Overall Study|Withdrawal by Subject|7|||
13401635|NCT00601640|26808089|FG000|Overall Study|Death|1|||
13401636|NCT00601640|26808090|FG001|Overall Study|Death|0|||
13401637|NCT00601640|26808091|FG002|Overall Study|Death|0|||
13401638|NCT00601640|26808089|FG000|Overall Study|Adverse Event|0|||
13401639|NCT00601640|26808090|FG001|Overall Study|Adverse Event|4|||
13401640|NCT00601640|26808091|FG002|Overall Study|Adverse Event|2|||
13401641|NCT00601640|26808089|FG000|Overall Study|intercurrent illness|1|||
13401642|NCT00601640|26808090|FG001|Overall Study|intercurrent illness|0|||
13401643|NCT00601640|26808091|FG002|Overall Study|intercurrent illness|0|||
13401644|NCT00601640|26808089|FG000|Overall Study|change in eligibility status|0|||
13401645|NCT00601640|26808090|FG001|Overall Study|change in eligibility status|1|||
13401646|NCT00601640|26808091|FG002|Overall Study|change in eligibility status|1|||
13401647|NCT00601523|26808130|FG000|Overall Study|Adverse Event|42|||
13401648|NCT00601523|26808131|FG001|Overall Study|Adverse Event|14|||
13401649|NCT00601523|26808130|FG000|Overall Study|Lack of Efficacy|3|||
13401650|NCT00601523|26808131|FG001|Overall Study|Lack of Efficacy|0|||
13401651|NCT00601523|26808130|FG000|Overall Study|Protocol Violation|5|||
13401652|NCT00601523|26808131|FG001|Overall Study|Protocol Violation|1|||
13401653|NCT00601523|26808130|FG000|Overall Study|Lost to Follow-up|0|||
13401654|NCT00601523|26808131|FG001|Overall Study|Lost to Follow-up|1|||
13401655|NCT00601523|26808130|FG000|Overall Study|Withdrawal by Subject|18|||
13401656|NCT00601523|26808131|FG001|Overall Study|Withdrawal by Subject|9|||
13401657|NCT00601523|26808130|FG000|Overall Study|Other|9|||
13401658|NCT00601523|26808131|FG001|Overall Study|Other|1|||
13401659|NCT00601484|26808232|FG000|Overall Study|Adverse Event|0|||
13401660|NCT00601484|26808233|FG001|Overall Study|Adverse Event|1|||
13401661|NCT00601484|26808232|FG000|Overall Study|Lost to Follow-up|4|||
13401662|NCT00601484|26808233|FG001|Overall Study|Lost to Follow-up|3|||
13401663|NCT00601484|26808232|FG000|Overall Study|Lack of Efficacy|0|||
13401664|NCT00601484|26808233|FG001|Overall Study|Lack of Efficacy|2|||
13401665|NCT00601484|26808232|FG000|Overall Study|Withdrawal by Subject|1|||
13401666|NCT00601484|26808233|FG001|Overall Study|Withdrawal by Subject|1|||
13401667|NCT00601484|26808232|FG000|Overall Study|Randomized, but not treated|0|||
13401668|NCT00601484|26808233|FG001|Overall Study|Randomized, but not treated|1|||
13401669|NCT00601458|26808254|FG000|Overall Study|Dosing Error|1|||
13401670|NCT00601458|26808255|FG001|Overall Study|Dosing Error|0|||
13401671|NCT00601458|26808256|FG002|Overall Study|Dosing Error|0|||
13401672|NCT00601458|26808254|FG000|Overall Study|Incomplete Data|0|||
13401673|NCT00601458|26808255|FG001|Overall Study|Incomplete Data|2|||
13401674|NCT00601458|26808256|FG002|Overall Study|Incomplete Data|0|||
13401675|NCT00601458|26808254|FG000|Overall Study|Protocol Violation|3|||
13401676|NCT00601458|26808255|FG001|Overall Study|Protocol Violation|2|||
13401677|NCT00601458|26808256|FG002|Overall Study|Protocol Violation|1|||
13401678|NCT00601458|26808254|FG000|Overall Study|Early Termination|0|||
13401679|NCT00601458|26808255|FG001|Overall Study|Early Termination|1|||
13401680|NCT00601458|26808256|FG002|Overall Study|Early Termination|1|||
13401681|NCT00601419|26808282|FG000|Overall Study|Lost to Follow-up|3|||
13401682|NCT00601419|26808282|FG000|Overall Study|Missed Visits|1|||
13401683|NCT00601354|26808299|FG000|Overall Study|Lost to Follow-up|4|||
13401684|NCT00601354|26808300|FG001|Overall Study|Lost to Follow-up|5|||
13401685|NCT00601250|26808341|FG000|Overall Study|Adverse Event|3|||
13401686|NCT00601250|26808342|FG001|Overall Study|Adverse Event|9|||
13401687|NCT00601250|26808341|FG000|Overall Study|Protocol Violation|3|||
13401688|NCT00601250|26808342|FG001|Overall Study|Protocol Violation|2|||
13401689|NCT00601250|26808341|FG000|Overall Study|Lost to Follow-up|2|||
13401690|NCT00601250|26808342|FG001|Overall Study|Lost to Follow-up|6|||
13401691|NCT00601250|26808341|FG000|Overall Study|Withdrawal by Subject|4|||
13401692|NCT00601250|26808342|FG001|Overall Study|Withdrawal by Subject|13|||
13401693|NCT00601250|26808341|FG000|Overall Study|Other incl. lack of efficacy|2|||
13401694|NCT00601250|26808342|FG001|Overall Study|Other incl. lack of efficacy|9|||
13401695|NCT00601172|26808398|FG000|Overall Study|Adverse Event|43|||
13401696|NCT00601172|26808399|FG001|Overall Study|Adverse Event|32|||
13401697|NCT00601172|26808398|FG000|Overall Study|Lack of Efficacy|11|||
13401698|NCT00601172|26808399|FG001|Overall Study|Lack of Efficacy|12|||
13401699|NCT00601172|26808398|FG000|Overall Study|Protocol Violation|2|||
13401700|NCT00601172|26808399|FG001|Overall Study|Protocol Violation|5|||
13401701|NCT00601172|26808398|FG000|Overall Study|Lost to Follow-up|4|||
13401702|NCT00601172|26808399|FG001|Overall Study|Lost to Follow-up|3|||
13401703|NCT00601172|26808398|FG000|Overall Study|Physician Decision|27|||
13401704|NCT00601172|26808399|FG001|Overall Study|Physician Decision|28|||
13401705|NCT00601172|26808398|FG000|Overall Study|Withdrawal by Subject|35|||
13401706|NCT00601172|26808399|FG001|Overall Study|Withdrawal by Subject|27|||
13401707|NCT00601172|26808398|FG000|Overall Study|Did not meet continuation criteria|19|||
13401708|NCT00601172|26808399|FG001|Overall Study|Did not meet continuation criteria|20|||
13401709|NCT00601107|26808430|FG000|Overall Study|Adverse Event|0|||
13401710|NCT00601107|26808431|FG001|Overall Study|Adverse Event|1|||
13401711|NCT00601107|26808432|FG002|Overall Study|Adverse Event|3|||
13401712|NCT00601107|26808433|FG003|Overall Study|Adverse Event|0|||
13401713|NCT00601107|26808430|FG000|Overall Study|Withdrawal by Subject|5|||
13401714|NCT00601107|26808431|FG001|Overall Study|Withdrawal by Subject|4|||
13401715|NCT00601107|26808432|FG002|Overall Study|Withdrawal by Subject|7|||
13401716|NCT00601107|26808433|FG003|Overall Study|Withdrawal by Subject|4|||
13401717|NCT00601107|26808430|FG000|Overall Study|Lost to Follow-up|3|||
13401718|NCT00601107|26808431|FG001|Overall Study|Lost to Follow-up|3|||
13401719|NCT00601107|26808432|FG002|Overall Study|Lost to Follow-up|0|||
13401720|NCT00601107|26808433|FG003|Overall Study|Lost to Follow-up|3|||
13401721|NCT00601107|26808430|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
13401722|NCT00601107|26808431|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
13401723|NCT00601107|26808432|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
13401724|NCT00601107|26808433|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1|||
13401725|NCT00601107|26808430|FG000|Overall Study|Worsening of Psoriasis|4|||
13401726|NCT00601107|26808431|FG001|Overall Study|Worsening of Psoriasis|1|||
13401727|NCT00601107|26808432|FG002|Overall Study|Worsening of Psoriasis|1|||
13401728|NCT00601107|26808433|FG003|Overall Study|Worsening of Psoriasis|4|||
13401729|NCT00601107|26808430|FG000|Overall Study|Undefined|1|||
13401730|NCT00601107|26808431|FG001|Overall Study|Undefined|0|||
13401731|NCT00601107|26808432|FG002|Overall Study|Undefined|1|||
13401732|NCT00601107|26808433|FG003|Overall Study|Undefined|0|||
13401733|NCT00600938|26808504|FG000|Core Study|Abnormal test procedure result(s)|3|||
13401734|NCT00600938|26808505|FG001|Core Study|Abnormal test procedure result(s)|2|||
13401735|NCT00600938|26808506|FG002|Core Study|Abnormal test procedure result(s)|0|||
13401736|NCT00600938|26808507|FG003|Core Study|Abnormal test procedure result(s)|0|||
13401737|NCT00600938|26808504|FG000|Core Study|Unsatisfactory therapeutic effect|1|||
13401738|NCT00600938|26808505|FG001|Core Study|Unsatisfactory therapeutic effect|2|||
13401739|NCT00600938|26808506|FG002|Core Study|Unsatisfactory therapeutic effect|0|||
13401740|NCT00600938|26808507|FG003|Core Study|Unsatisfactory therapeutic effect|0|||
13401741|NCT00600938|26808504|FG000|Core Study|Patient withdrew consent|7|||
13401742|NCT00600938|26808505|FG001|Core Study|Patient withdrew consent|12|||
13401743|NCT00600938|26808506|FG002|Core Study|Patient withdrew consent|0|||
13401744|NCT00600938|26808507|FG003|Core Study|Patient withdrew consent|0|||
13401745|NCT00600938|26808504|FG000|Core Study|Lost to Follow-up|3|||
13401746|NCT00600938|26808505|FG001|Core Study|Lost to Follow-up|2|||
13401747|NCT00600938|26808506|FG002|Core Study|Lost to Follow-up|0|||
13401748|NCT00600938|26808507|FG003|Core Study|Lost to Follow-up|0|||
13401749|NCT00600938|26808504|FG000|Core Study|Death|1|||
13401750|NCT00600938|26808505|FG001|Core Study|Death|1|||
13401751|NCT00600938|26808506|FG002|Core Study|Death|0|||
13401752|NCT00600938|26808507|FG003|Core Study|Death|0|||
13401753|NCT00600938|26808504|FG000|Core Study|Protocol Violation|1|||
13401754|NCT00600938|26808505|FG001|Core Study|Protocol Violation|2|||
13401755|NCT00600938|26808506|FG002|Core Study|Protocol Violation|0|||
13401756|NCT00600938|26808507|FG003|Core Study|Protocol Violation|0|||
13401757|NCT00600938|26808504|FG000|Extension Study|Adverse Event|1|||
13401758|NCT00600938|26808505|FG001|Extension Study|Adverse Event|0|||
13401759|NCT00600938|26808506|FG002|Extension Study|Adverse Event|2|||
13401760|NCT00600938|26808507|FG003|Extension Study|Adverse Event|0|||
13401761|NCT00600938|26808504|FG000|Extension Study|Abnormal test procedure results|0|||
13401762|NCT00600938|26808505|FG001|Extension Study|Abnormal test procedure results|1|||
13401763|NCT00600938|26808506|FG002|Extension Study|Abnormal test procedure results|1|||
13401764|NCT00600938|26808507|FG003|Extension Study|Abnormal test procedure results|1|||
13401765|NCT00600938|26808504|FG000|Extension Study|Unsatisfactory therapeutic effect|4|||
13401766|NCT00600938|26808505|FG001|Extension Study|Unsatisfactory therapeutic effect|1|||
13401767|NCT00600938|26808506|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
13401768|NCT00600938|26808507|FG003|Extension Study|Unsatisfactory therapeutic effect|0|||
13401769|NCT00600938|26808504|FG000|Extension Study|Withdrawal by Subject|2|||
13401770|NCT00600938|26808505|FG001|Extension Study|Withdrawal by Subject|2|||
13401771|NCT00600938|26808506|FG002|Extension Study|Withdrawal by Subject|3|||
13401772|NCT00600938|26808507|FG003|Extension Study|Withdrawal by Subject|0|||
13401773|NCT00600938|26808504|FG000|Extension Study|Lost to Follow-up|1|||
13401774|NCT00600938|26808505|FG001|Extension Study|Lost to Follow-up|1|||
13401775|NCT00600938|26808506|FG002|Extension Study|Lost to Follow-up|2|||
13401776|NCT00600938|26808507|FG003|Extension Study|Lost to Follow-up|0|||
13401777|NCT00600938|26808504|FG000|Extension Study|Death|1|||
13401778|NCT00600938|26808505|FG001|Extension Study|Death|0|||
13401779|NCT00600938|26808506|FG002|Extension Study|Death|0|||
13401780|NCT00600938|26808507|FG003|Extension Study|Death|0|||
13401781|NCT00600886|26808576|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14|||
13401782|NCT00600886|26808577|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6|||
13401783|NCT00600886|26808576|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7|||
13401784|NCT00600886|26808577|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8|||
13401785|NCT00600886|26808576|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5|||
13401786|NCT00600886|26808577|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8|||
13401787|NCT00600886|26808576|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5|||
13401788|NCT00600886|26808577|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3|||
13401789|NCT00600886|26808576|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2|||
13401790|NCT00600886|26808577|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0|||
13401791|NCT00600886|26808576|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1|||
13401792|NCT00600886|26808577|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0|||
13401793|NCT00600886|26808576|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1|||
13401794|NCT00600886|26808577|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0|||
13401795|NCT00600886|26808576|FG000|Core Phase - Full Analysis Set (FAS)|Death|0|||
13401796|NCT00600886|26808577|FG001|Core Phase - Full Analysis Set (FAS)|Death|1|||
13401797|NCT00600886|26808576|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16|||
13401798|NCT00600886|26808577|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2|||
13401799|NCT00600886|26808576|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
13401800|NCT00600886|26808577|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
13401801|NCT00600886|26808576|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9|||
13401802|NCT00600886|26808577|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3|||
13401803|NCT00600886|26808576|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3|||
13401804|NCT00600886|26808577|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1|||
13401805|NCT00600886|26808576|FG000|Extension - Same Treatment (FAS)|Adverse Event|4|||
13401806|NCT00600886|26808577|FG001|Extension - Same Treatment (FAS)|Adverse Event|1|||
13401807|NCT00600886|26808576|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4|||
13401808|NCT00600886|26808577|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0|||
13401809|NCT00600886|26808576|FG000|Extension - Same Treatment (FAS)|Death|1|||
13401810|NCT00600886|26808577|FG001|Extension - Same Treatment (FAS)|Death|1|||
13401811|NCT00600886|26808576|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6|||
13401812|NCT00600886|26808577|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0|||
13401813|NCT00600886|26808576|FG000|Extension - After Crossover (CAS)|Adverse Event|19|||
13401814|NCT00600886|26808577|FG001|Extension - After Crossover (CAS)|Adverse Event|1|||
13401815|NCT00600886|26808576|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19|||
13401816|NCT00600886|26808577|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4|||
13401817|NCT00600886|26808576|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13|||
13401818|NCT00600886|26808577|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4|||
13401819|NCT00600886|26808576|FG000|Extension - After Crossover (CAS)|Administrative Problems|4|||
13401820|NCT00600886|26808577|FG001|Extension - After Crossover (CAS)|Administrative Problems|4|||
13401821|NCT00600886|26808576|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3|||
13401822|NCT00600886|26808577|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0|||
13401823|NCT00600886|26808576|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3|||
13401824|NCT00600886|26808577|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0|||
13401825|NCT00600886|26808576|FG000|Extension - After Crossover (CAS)|Death|1|||
13401826|NCT00600886|26808577|FG001|Extension - After Crossover (CAS)|Death|0|||
13401827|NCT00600821|26808610|FG000|Overall Study|Death|45|||
13401828|NCT00600821|26808611|FG001|Overall Study|Death|46|||
13401829|NCT00600821|26808610|FG000|Overall Study|Lost to Follow-up|2|||
13401830|NCT00600821|26808611|FG001|Overall Study|Lost to Follow-up|2|||
13401831|NCT00600821|26808610|FG000|Overall Study|Withdrawal by Subject|1|||
13401832|NCT00600821|26808611|FG001|Overall Study|Withdrawal by Subject|1|||
13401833|NCT00600821|26808610|FG000|Overall Study|Terminated by sponsor|8|||
13401834|NCT00600821|26808611|FG001|Overall Study|Terminated by sponsor|6|||
13401835|NCT00600821|26808610|FG000|Overall Study|Objective progression or relapse|0|||
13401836|NCT00600821|26808611|FG001|Overall Study|Objective progression or relapse|1|||
13401837|NCT00600821|26808610|FG000|Overall Study|Randomized but not treated|0|||
13401838|NCT00600821|26808611|FG001|Overall Study|Randomized but not treated|1|||
13401839|NCT00600821|26808610|FG000|Overall Study|Other|2|||
13401840|NCT00600821|26808611|FG001|Overall Study|Other|3|||
13401841|NCT00600756|26808684|FG000|Analysis After 6 Months|Adverse Event|43|||
13401842|NCT00600756|26808685|FG001|Analysis After 6 Months|Adverse Event|33|||
13401843|NCT00600756|26808684|FG000|Analysis After 6 Months|Withdrawal by Subject|38|||
13401844|NCT00600756|26808685|FG001|Analysis After 6 Months|Withdrawal by Subject|30|||
13401845|NCT00600756|26808684|FG000|Analysis After 6 Months|Incorrect Enrollment|12|||
13401846|NCT00600756|26808685|FG001|Analysis After 6 Months|Incorrect Enrollment|21|||
13401847|NCT00600756|26808684|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11|||
13401848|NCT00600756|26808685|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14|||
13401849|NCT00600756|26808684|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11|||
13401850|NCT00600756|26808685|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11|||
13401851|NCT00600756|26808684|FG000|Analysis After 6 Months|Lost to Follow-up|10|||
13401852|NCT00600756|26808685|FG001|Analysis After 6 Months|Lost to Follow-up|8|||
13401853|NCT00600756|26808684|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6|||
13401854|NCT00600756|26808685|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3|||
13401855|NCT00600756|26808684|FG000|Overall Study Analysis After 12 Months|Adverse Event|53|||
13401856|NCT00600756|26808685|FG001|Overall Study Analysis After 12 Months|Adverse Event|44|||
13401857|NCT00600756|26808684|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51|||
13401858|NCT00600756|26808685|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41|||
13401859|NCT00600756|26808684|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21|||
13401860|NCT00600756|26808685|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29|||
13401861|NCT00600756|26808684|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17|||
13401862|NCT00600756|26808685|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20|||
13401863|NCT00600756|26808684|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16|||
13401864|NCT00600756|26808685|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20|||
13401865|NCT00600756|26808684|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16|||
13401866|NCT00600756|26808685|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13|||
13401867|NCT00600756|26808684|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
13401868|NCT00600756|26808685|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
13401869|NCT00600613|26808691|FG000|Overall Study|Protocol Deviation|1|||
13401870|NCT00600483|26808716|FG000|Overall Study|Lost to Follow-up|26|||
13401871|NCT00600483|26808717|FG001|Overall Study|Lost to Follow-up|47|||
13401872|NCT00600483|26808716|FG000|Overall Study|Randomized but not treated|10|||
13401873|NCT00600483|26808717|FG001|Overall Study|Randomized but not treated|0|||
13401874|NCT00600353|26808736|FG000|Overall Study|history of malignancy within 5 years|1|||
13401875|NCT00600353|26808737|FG001|Overall Study|history of malignancy within 5 years|0|||
13401876|NCT00600353|26808736|FG000|Overall Study|History of prepartive regimen|0|||
13401877|NCT00600353|26808737|FG001|Overall Study|History of prepartive regimen|1|||
13401878|NCT00600171|26808824|FG000|Overall Study|Adverse Event|0|||
13401879|NCT00600171|26808825|FG001|Overall Study|Adverse Event|1|||
13401880|NCT00600171|26808826|FG002|Overall Study|Adverse Event|0|||
13401881|NCT00600171|26808827|FG003|Overall Study|Adverse Event|0|||
13401882|NCT00600171|26808828|FG004|Overall Study|Adverse Event|1|||
13401883|NCT00600171|26808829|FG005|Overall Study|Adverse Event|0|||
13401884|NCT00600171|26808824|FG000|Overall Study|Lack of Efficacy|9|||
13401885|NCT00600171|26808825|FG001|Overall Study|Lack of Efficacy|12|||
13401886|NCT00600171|26808826|FG002|Overall Study|Lack of Efficacy|3|||
13401887|NCT00600171|26808827|FG003|Overall Study|Lack of Efficacy|5|||
13401888|NCT00600171|26808828|FG004|Overall Study|Lack of Efficacy|4|||
13401889|NCT00600171|26808829|FG005|Overall Study|Lack of Efficacy|0|||
13401890|NCT00600171|26808824|FG000|Overall Study|Protocol Violation|1|||
13401891|NCT00600171|26808825|FG001|Overall Study|Protocol Violation|2|||
13401892|NCT00600171|26808826|FG002|Overall Study|Protocol Violation|0|||
13401893|NCT00600171|26808827|FG003|Overall Study|Protocol Violation|1|||
13401894|NCT00600171|26808828|FG004|Overall Study|Protocol Violation|0|||
13401895|NCT00600171|26808829|FG005|Overall Study|Protocol Violation|0|||
13401896|NCT00600171|26808824|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
13401897|NCT00600171|26808825|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
13401898|NCT00600171|26808826|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7|||
13401899|NCT00600171|26808827|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3|||
13401900|NCT00600171|26808828|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2|||
13401901|NCT00600171|26808829|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2|||
13401902|NCT00600171|26808824|FG000|Overall Study|Withdrawal by Subject|3|||
13401903|NCT00600171|26808825|FG001|Overall Study|Withdrawal by Subject|0|||
13401904|NCT00600171|26808826|FG002|Overall Study|Withdrawal by Subject|0|||
13401905|NCT00600171|26808827|FG003|Overall Study|Withdrawal by Subject|1|||
13401906|NCT00600171|26808828|FG004|Overall Study|Withdrawal by Subject|1|||
13401907|NCT00600171|26808829|FG005|Overall Study|Withdrawal by Subject|1|||
13401908|NCT00600171|26808824|FG000|Overall Study|Physician Decision|0|||
13401909|NCT00600171|26808825|FG001|Overall Study|Physician Decision|1|||
13401910|NCT00600171|26808826|FG002|Overall Study|Physician Decision|0|||
13401911|NCT00600171|26808827|FG003|Overall Study|Physician Decision|1|||
13401912|NCT00600171|26808828|FG004|Overall Study|Physician Decision|0|||
13401913|NCT00600171|26808829|FG005|Overall Study|Physician Decision|2|||
13401914|NCT00600171|26808824|FG000|Overall Study|Lost to Follow-up|0|||
13401915|NCT00600171|26808825|FG001|Overall Study|Lost to Follow-up|0|||
13401916|NCT00600171|26808826|FG002|Overall Study|Lost to Follow-up|0|||
13401917|NCT00600171|26808827|FG003|Overall Study|Lost to Follow-up|1|||
13401918|NCT00600171|26808828|FG004|Overall Study|Lost to Follow-up|0|||
13401919|NCT00600171|26808829|FG005|Overall Study|Lost to Follow-up|0|||
13401920|NCT00600119|26808880|FG000|Single-blind Placebo run-in Period|Other - Not specified|1|||
13401921|NCT00600119|26808881|FG001|Single-blind Placebo run-in Period|Other - Not specified|0|||
13401922|NCT00600119|26808882|FG002|Single-blind Placebo run-in Period|Other - Not specified|0|||
13401923|NCT00600119|26808883|FG003|Single-blind Placebo run-in Period|Other - Not specified|0|||
13401924|NCT00600119|26808884|FG004|Single-blind Placebo run-in Period|Other - Not specified|1|||
13401925|NCT00600119|26808885|FG005|Single-blind Placebo run-in Period|Other - Not specified|1|||
13401926|NCT00600119|26808880|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
13401927|NCT00600119|26808881|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
13401928|NCT00600119|26808882|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
13401929|NCT00600119|26808883|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
13401930|NCT00600119|26808884|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
13401931|NCT00600119|26808885|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
13401932|NCT00600119|26808880|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0|||
13401933|NCT00600119|26808881|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0|||
13401934|NCT00600119|26808882|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1|||
13401935|NCT00600119|26808883|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0|||
13401936|NCT00600119|26808884|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1|||
13401937|NCT00600119|26808885|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0|||
13401938|NCT00600119|26808880|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1|||
13401939|NCT00600119|26808881|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
13401940|NCT00600119|26808882|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
13401941|NCT00600119|26808883|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
13401942|NCT00600119|26808884|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
13401943|NCT00600119|26808885|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
13401944|NCT00600119|26808880|FG000|Single-blind Placebo run-in Period|Adverse Event|0|||
13401945|NCT00600119|26808881|FG001|Single-blind Placebo run-in Period|Adverse Event|0|||
13401946|NCT00600119|26808882|FG002|Single-blind Placebo run-in Period|Adverse Event|0|||
13401947|NCT00600119|26808883|FG003|Single-blind Placebo run-in Period|Adverse Event|1|||
13401948|NCT00600119|26808884|FG004|Single-blind Placebo run-in Period|Adverse Event|0|||
13401949|NCT00600119|26808885|FG005|Single-blind Placebo run-in Period|Adverse Event|1|||
13401950|NCT00600119|26808880|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2|||
13401951|NCT00600119|26808881|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1|||
13401952|NCT00600119|26808882|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
13401953|NCT00600119|26808883|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
13401954|NCT00600119|26808884|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
13401955|NCT00600119|26808885|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
13401956|NCT00600119|26808880|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
13401957|NCT00600119|26808881|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
13401958|NCT00600119|26808882|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
13401959|NCT00600119|26808883|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
13401960|NCT00600119|26808884|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
13401961|NCT00600119|26808885|FG005|Double-blind Treatment Period|Withdrawal by Subject|3|||
13401962|NCT00600119|26808880|FG000|Double-blind Treatment Period|Other|0|||
13401963|NCT00600119|26808881|FG001|Double-blind Treatment Period|Other|0|||
13401964|NCT00600119|26808882|FG002|Double-blind Treatment Period|Other|0|||
13401965|NCT00600119|26808883|FG003|Double-blind Treatment Period|Other|0|||
13401966|NCT00600119|26808884|FG004|Double-blind Treatment Period|Other|2|||
13401967|NCT00600119|26808885|FG005|Double-blind Treatment Period|Other|1|||
13401968|NCT00600119|26808880|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
13401969|NCT00600119|26808881|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
13401970|NCT00600119|26808882|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
13401971|NCT00600119|26808883|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
13401972|NCT00600119|26808884|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
13401973|NCT00600119|26808885|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
13401974|NCT00600119|26808880|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
13401975|NCT00600119|26808881|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1|||
13401976|NCT00600119|26808882|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
13401977|NCT00600119|26808883|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
13401978|NCT00600119|26808884|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
13401979|NCT00600119|26808885|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
13401980|NCT00600119|26808880|FG000|Double-blind Treatment Period|Sponsor Decision|0|||
13401981|NCT00600119|26808881|FG001|Double-blind Treatment Period|Sponsor Decision|1|||
13401982|NCT00600119|26808882|FG002|Double-blind Treatment Period|Sponsor Decision|0|||
13401983|NCT00600119|26808883|FG003|Double-blind Treatment Period|Sponsor Decision|0|||
13401984|NCT00600119|26808884|FG004|Double-blind Treatment Period|Sponsor Decision|1|||
13401985|NCT00600119|26808885|FG005|Double-blind Treatment Period|Sponsor Decision|0|||
13401986|NCT00600119|26808880|FG000|Double-blind Treatment Period|Physician Decision|2|||
13401987|NCT00600119|26808881|FG001|Double-blind Treatment Period|Physician Decision|0|||
13401988|NCT00600119|26808882|FG002|Double-blind Treatment Period|Physician Decision|0|||
13401989|NCT00600119|26808883|FG003|Double-blind Treatment Period|Physician Decision|0|||
13401990|NCT00600119|26808884|FG004|Double-blind Treatment Period|Physician Decision|0|||
13401991|NCT00600119|26808885|FG005|Double-blind Treatment Period|Physician Decision|0|||
13401992|NCT00600119|26808880|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
13401993|NCT00600119|26808881|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
13401994|NCT00600119|26808882|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
13401995|NCT00600119|26808883|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
13401996|NCT00600119|26808884|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
13401997|NCT00600119|26808885|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
13401998|NCT00600119|26808880|FG000|Double-blind Treatment Period|Adverse Event|1|||
13401999|NCT00600119|26808881|FG001|Double-blind Treatment Period|Adverse Event|1|||
13402000|NCT00600119|26808882|FG002|Double-blind Treatment Period|Adverse Event|0|||
13402001|NCT00600119|26808883|FG003|Double-blind Treatment Period|Adverse Event|1|||
13402002|NCT00600119|26808884|FG004|Double-blind Treatment Period|Adverse Event|2|||
13402003|NCT00600119|26808885|FG005|Double-blind Treatment Period|Adverse Event|10|||
13402004|NCT00600119|26808880|FG000|Follow-up Period|Adverse Event|0|||
13402005|NCT00600119|26808881|FG001|Follow-up Period|Adverse Event|0|||
13402006|NCT00600119|26808882|FG002|Follow-up Period|Adverse Event|0|||
13402007|NCT00600119|26808883|FG003|Follow-up Period|Adverse Event|0|||
13402008|NCT00600119|26808884|FG004|Follow-up Period|Adverse Event|0|||
13402009|NCT00600119|26808885|FG005|Follow-up Period|Adverse Event|1|||
13402010|NCT00600119|26808880|FG000|Follow-up Period|Other|1|||
13402011|NCT00600119|26808881|FG001|Follow-up Period|Other|0|||
13402012|NCT00600119|26808882|FG002|Follow-up Period|Other|0|||
13402013|NCT00600119|26808883|FG003|Follow-up Period|Other|0|||
13402014|NCT00600119|26808884|FG004|Follow-up Period|Other|0|||
13402015|NCT00600119|26808885|FG005|Follow-up Period|Other|0|||
13402016|NCT00600106|26808924|FG000|Overall Study|Withdrawal by Subject|1|||
13402017|NCT00600106|26808925|FG001|Overall Study|Withdrawal by Subject|1|||
13402018|NCT00600067|26808940|FG000|Overall Study|Adverse Event|0|||
13402019|NCT00600067|26808941|FG001|Overall Study|Adverse Event|1|||
13402020|NCT00600067|26808940|FG000|Overall Study|Lost to Follow-up|2|||
13402021|NCT00600067|26808941|FG001|Overall Study|Lost to Follow-up|3|||
13402022|NCT00600067|26808940|FG000|Overall Study|protocol non-compliance|0|||
13402023|NCT00600067|26808941|FG001|Overall Study|protocol non-compliance|3|||
13402024|NCT00600067|26808940|FG000|Overall Study|Lack of Efficacy|1|||
13402025|NCT00600067|26808941|FG001|Overall Study|Lack of Efficacy|0|||
13402026|NCT00600028|26808960|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
13402027|NCT00600028|26808961|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
13402028|NCT00600028|26808960|FG000|First Intervention (12 Weeks)|Adverse Event|0|||
13402029|NCT00600028|26808961|FG001|First Intervention (12 Weeks)|Adverse Event|1|||
13402030|NCT00600028|26808960|FG000|Second Intervention (12 Weeks)|Adverse Event|0|||
13402031|NCT00600028|26808961|FG001|Second Intervention (12 Weeks)|Adverse Event|2|||
13402032|NCT00599924|26809068|FG000|Overall Study|Lack of Efficacy|3|||
13402033|NCT00599924|26809069|FG001|Overall Study|Lack of Efficacy|5|||
13402034|NCT00599924|26809070|FG002|Overall Study|Lack of Efficacy|1|||
13402035|NCT00599924|26809071|FG003|Overall Study|Lack of Efficacy|2|||
13402036|NCT00599924|26809072|FG004|Overall Study|Lack of Efficacy|3|||
13402037|NCT00599924|26809073|FG005|Overall Study|Lack of Efficacy|2|||
13402038|NCT00599924|26809074|FG006|Overall Study|Lack of Efficacy|0|||
13402039|NCT00599924|26809068|FG000|Overall Study|Adverse Event|0|||
13402040|NCT00599924|26809069|FG001|Overall Study|Adverse Event|0|||
13402041|NCT00599924|26809070|FG002|Overall Study|Adverse Event|0|||
13402042|NCT00599924|26809071|FG003|Overall Study|Adverse Event|2|||
13402043|NCT00599924|26809072|FG004|Overall Study|Adverse Event|0|||
13402044|NCT00599924|26809073|FG005|Overall Study|Adverse Event|0|||
13402045|NCT00599924|26809074|FG006|Overall Study|Adverse Event|2|||
13402046|NCT00599924|26809068|FG000|Overall Study|Death|0|||
13402047|NCT00599924|26809069|FG001|Overall Study|Death|0|||
13402048|NCT00599924|26809070|FG002|Overall Study|Death|0|||
13402049|NCT00599924|26809071|FG003|Overall Study|Death|2|||
13402050|NCT00599924|26809072|FG004|Overall Study|Death|0|||
13402051|NCT00599924|26809073|FG005|Overall Study|Death|2|||
13402052|NCT00599924|26809074|FG006|Overall Study|Death|1|||
13402053|NCT00599924|26809068|FG000|Overall Study|Protocol Violation|0|||
13402054|NCT00599924|26809069|FG001|Overall Study|Protocol Violation|0|||
13402055|NCT00599924|26809070|FG002|Overall Study|Protocol Violation|0|||
13402056|NCT00599924|26809071|FG003|Overall Study|Protocol Violation|1|||
13402057|NCT00599924|26809072|FG004|Overall Study|Protocol Violation|0|||
13402058|NCT00599924|26809073|FG005|Overall Study|Protocol Violation|0|||
13402059|NCT00599924|26809074|FG006|Overall Study|Protocol Violation|0|||
13402060|NCT00599924|26809068|FG000|Overall Study|Withdrawal by Subject|0|||
13402061|NCT00599924|26809069|FG001|Overall Study|Withdrawal by Subject|0|||
13402062|NCT00599924|26809070|FG002|Overall Study|Withdrawal by Subject|1|||
13402063|NCT00599924|26809071|FG003|Overall Study|Withdrawal by Subject|0|||
13402064|NCT00599924|26809072|FG004|Overall Study|Withdrawal by Subject|1|||
13402065|NCT00599924|26809073|FG005|Overall Study|Withdrawal by Subject|0|||
13402066|NCT00599924|26809074|FG006|Overall Study|Withdrawal by Subject|0|||
13402067|NCT00599924|26809068|FG000|Overall Study|Other|0|||
13402068|NCT00599924|26809069|FG001|Overall Study|Other|0|||
13402069|NCT00599924|26809070|FG002|Overall Study|Other|0|||
13402070|NCT00599924|26809071|FG003|Overall Study|Other|1|||
13402071|NCT00599924|26809072|FG004|Overall Study|Other|2|||
13402072|NCT00599924|26809073|FG005|Overall Study|Other|0|||
13402073|NCT00599924|26809074|FG006|Overall Study|Other|2|||
13402074|NCT00599755|26809085|FG000|Overall Study|Adverse Event|11|||
13402075|NCT00599755|26809085|FG000|Overall Study|Withdrawal by Subject|2|||
13402076|NCT00599755|26809085|FG000|Overall Study|Progression of Disease|3|||
13402077|NCT00599755|26809085|FG000|Overall Study|Other Reason|2|||
13402078|NCT00599755|26809085|FG000|Overall Study|No data available|1|||
13402079|NCT00599638|26809130|FG000|First Intervention Period (2 Weeks)|Adverse Event|1|||
13402080|NCT00599638|26809131|FG001|First Intervention Period (2 Weeks)|Adverse Event|0|||
13402081|NCT00599638|26809132|FG002|First Intervention Period (2 Weeks)|Adverse Event|3|||
13402082|NCT00599638|26809133|FG003|First Intervention Period (2 Weeks)|Adverse Event|2|||
13402083|NCT00599638|26809130|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
13402084|NCT00599638|26809131|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
13402085|NCT00599638|26809132|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
13402086|NCT00599638|26809133|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
13402087|NCT00599638|26809130|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0|||
13402088|NCT00599638|26809131|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1|||
13402089|NCT00599638|26809132|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0|||
13402090|NCT00599638|26809133|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1|||
13402091|NCT00599638|26809130|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
13402092|NCT00599638|26809131|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
13402093|NCT00599638|26809132|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
13402094|NCT00599638|26809133|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
13402095|NCT00599638|26809130|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
13402096|NCT00599638|26809131|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
13402097|NCT00599638|26809132|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
13402098|NCT00599638|26809133|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
13402099|NCT00599638|26809130|FG000|Washout Period (2 Weeks)|Adverse Event|0|||
13402100|NCT00599638|26809131|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
13402101|NCT00599638|26809132|FG002|Washout Period (2 Weeks)|Adverse Event|0|||
13402102|NCT00599638|26809133|FG003|Washout Period (2 Weeks)|Adverse Event|1|||
13402103|NCT00599638|26809130|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0|||
13402104|NCT00599638|26809131|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0|||
13402105|NCT00599638|26809132|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0|||
13402106|NCT00599638|26809133|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1|||
13402107|NCT00599638|26809130|FG000|Washout Period (2 Weeks)|Protocol Violation|0|||
13402108|NCT00599638|26809131|FG001|Washout Period (2 Weeks)|Protocol Violation|1|||
13402109|NCT00599638|26809132|FG002|Washout Period (2 Weeks)|Protocol Violation|0|||
13402110|NCT00599638|26809133|FG003|Washout Period (2 Weeks)|Protocol Violation|0|||
13402111|NCT00599638|26809130|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1|||
13402112|NCT00599638|26809131|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
13402113|NCT00599638|26809132|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
13402114|NCT00599638|26809133|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
13402115|NCT00599521|26809154|FG000|Overall Study|Lack of Efficacy|4|||
13402116|NCT00599521|26809155|FG001|Overall Study|Lack of Efficacy|8|||
13402117|NCT00599521|26809154|FG000|Overall Study|Adverse Event|4|||
13402118|NCT00599521|26809155|FG001|Overall Study|Adverse Event|1|||
13402119|NCT00599521|26809154|FG000|Overall Study|Withdrawal by Subject|28|||
13402120|NCT00599521|26809155|FG001|Overall Study|Withdrawal by Subject|34|||
13402121|NCT00599521|26809154|FG000|Overall Study|Protocol Violation|1|||
13402122|NCT00599521|26809155|FG001|Overall Study|Protocol Violation|1|||
13402123|NCT00599521|26809154|FG000|Overall Study|Lost to Follow-up|23|||
13402124|NCT00599521|26809155|FG001|Overall Study|Lost to Follow-up|23|||
13402125|NCT00599521|26809154|FG000|Overall Study|Pregnancy|0|||
13402126|NCT00599521|26809155|FG001|Overall Study|Pregnancy|2|||
13402127|NCT00599339|26809259|FG000|Overall Study|Adverse Event|79|||
13402128|NCT00599339|26809259|FG000|Overall Study|Withdrawal by Subject|137|||
13402129|NCT00599339|26809259|FG000|Overall Study|Other Reason|179|||
13402130|NCT00599339|26809259|FG000|Overall Study|Lost to Follow-up|221|||
13402131|NCT00599339|26809259|FG000|Overall Study|No valid data consent|36|||
13402132|NCT00599339|26809259|FG000|Overall Study|Study Termination Status Unknown|12|||
13402133|NCT00599326|26809266|FG000|Overall Study|Lost to Follow-up|1|||
13402134|NCT00599326|26809266|FG000|Overall Study|Noncompliant|1|||
13402135|NCT00599313|26809277|FG000|Overall Study|Adverse Event|19|||
13402136|NCT00599313|26809277|FG000|Overall Study|Disease Progression|12|||
13402137|NCT00599313|26809277|FG000|Overall Study|Patient Request|4|||
13402138|NCT00599313|26809277|FG000|Overall Study|Ineligible|1|||
13402139|NCT00599196|26809285|FG000|Overall Study|Lack of Efficacy|22|||
13402140|NCT00599196|26809285|FG000|Overall Study|Adverse Event|93|||
13402141|NCT00599196|26809285|FG000|Overall Study|Unsatisfactory compliance of subject|3|||
13402142|NCT00599196|26809285|FG000|Overall Study|Subject withdrew consent|43|||
13402143|NCT00599196|26809285|FG000|Overall Study|Study ended per sponsor|197|||
13402144|NCT00599196|26809285|FG000|Overall Study|Lost to Follow-up|17|||
13402145|NCT00599196|26809285|FG000|Overall Study|Other: Patient Leaving For Israel|1|||
13402146|NCT00599196|26809285|FG000|Overall Study|Other: Spouse Withdrew Consent|1|||
13402147|NCT00599196|26809285|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1|||
13402148|NCT00599196|26809285|FG000|Overall Study|Other: Pt Moved To Australia|1|||
13402149|NCT00599196|26809285|FG000|Overall Study|Other: Patient Stopped Due To Moving|1|||
13402150|NCT00599196|26809285|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1|||
13402151|NCT00599027|26809298|FG000|Overall Study|Withdrawal by Subject|1|||
13402152|NCT00599027|26809299|FG001|Overall Study|Withdrawal by Subject|1|||
13402153|NCT00599027|26809298|FG000|Overall Study|Adverse Event|0|||
13402154|NCT00599027|26809299|FG001|Overall Study|Adverse Event|1|||
13402155|NCT00599027|26809298|FG000|Overall Study|Treatment Failure|0|||
13402156|NCT00599027|26809299|FG001|Overall Study|Treatment Failure|1|||
13402157|NCT00598975|26809320|FG000|Overall Study|Adverse Event|1|||
13402158|NCT00598975|26809321|FG001|Overall Study|Adverse Event|1|||
13402159|NCT00598975|26809320|FG000|Overall Study|Brain metastases|1|||
13402160|NCT00598975|26809321|FG001|Overall Study|Brain metastases|0|||
13402161|NCT00598975|26809320|FG000|Overall Study|Withdrawal by Subject|1|||
13402162|NCT00598975|26809321|FG001|Overall Study|Withdrawal by Subject|1|||
13402163|NCT00598975|26809320|FG000|Overall Study|Withdrawal of consent|0|||
13402164|NCT00598975|26809321|FG001|Overall Study|Withdrawal of consent|1|||
13402165|NCT00598975|26809320|FG000|Overall Study|Disease progression|8|||
13402166|NCT00598975|26809321|FG001|Overall Study|Disease progression|3|||
13402167|NCT00598975|26809320|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1|||
13402168|NCT00598975|26809321|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0|||
13402169|NCT00598871|26809336|FG000|Overall Study|Adverse Event|0|||
13402170|NCT00598871|26809337|FG001|Overall Study|Adverse Event|1|||
13402171|NCT00598832|26809358|FG000|Overall Study|Lack of Efficacy|3|||
13402172|NCT00598832|26809359|FG001|Overall Study|Lack of Efficacy|7|||
13402173|NCT00598832|26809358|FG000|Overall Study|Adverse Event|6|||
13402174|NCT00598832|26809359|FG001|Overall Study|Adverse Event|2|||
13402175|NCT00598832|26809358|FG000|Overall Study|Withdrawal by Subject|25|||
13402176|NCT00598832|26809359|FG001|Overall Study|Withdrawal by Subject|36|||
13402177|NCT00598832|26809358|FG000|Overall Study|Protocol Violation|0|||
13402178|NCT00598832|26809359|FG001|Overall Study|Protocol Violation|2|||
13402179|NCT00598832|26809358|FG000|Overall Study|Lost to Follow-up|24|||
13402180|NCT00598832|26809359|FG001|Overall Study|Lost to Follow-up|29|||
13402181|NCT00598832|26809358|FG000|Overall Study|Pregnancy|2|||
13402182|NCT00598832|26809359|FG001|Overall Study|Pregnancy|2|||
13402183|NCT00598832|26809358|FG000|Overall Study|Physician Decision|1|||
13402184|NCT00598832|26809359|FG001|Overall Study|Physician Decision|4|||
13402185|NCT00598832|26809358|FG000|Overall Study|Non compliance|1|||
13402186|NCT00598832|26809359|FG001|Overall Study|Non compliance|0|||
13402187|NCT00598702|26809426|FG000|Overall Study|Other|0|||
13402188|NCT00598702|26809427|FG001|Overall Study|Other|2|||
13402189|NCT00598702|26809428|FG002|Overall Study|Other|0|||
13402190|NCT00598702|26809429|FG003|Overall Study|Other|0|||
13402191|NCT00598702|26809430|FG004|Overall Study|Other|0|||
13402192|NCT00598702|26809431|FG005|Overall Study|Other|1|||
13402193|NCT00598702|26809432|FG006|Overall Study|Other|0|||
13402194|NCT00598702|26809433|FG007|Overall Study|Other|0|||
13402195|NCT00598702|26809426|FG000|Overall Study|Early discharge from hospital|0|||
13402196|NCT00598702|26809427|FG001|Overall Study|Early discharge from hospital|0|||
13402197|NCT00598702|26809428|FG002|Overall Study|Early discharge from hospital|2|||
13402198|NCT00598702|26809429|FG003|Overall Study|Early discharge from hospital|5|||
13402199|NCT00598702|26809430|FG004|Overall Study|Early discharge from hospital|0|||
13402200|NCT00598702|26809431|FG005|Overall Study|Early discharge from hospital|10|||
13402201|NCT00598702|26809432|FG006|Overall Study|Early discharge from hospital|1|||
13402202|NCT00598702|26809433|FG007|Overall Study|Early discharge from hospital|0|||
13402203|NCT00598702|26809426|FG000|Overall Study|Adverse Event|0|||
13402204|NCT00598702|26809427|FG001|Overall Study|Adverse Event|0|||
13402205|NCT00598702|26809428|FG002|Overall Study|Adverse Event|0|||
13402206|NCT00598702|26809429|FG003|Overall Study|Adverse Event|1|||
13402207|NCT00598702|26809430|FG004|Overall Study|Adverse Event|0|||
13402208|NCT00598702|26809431|FG005|Overall Study|Adverse Event|0|||
13402209|NCT00598702|26809432|FG006|Overall Study|Adverse Event|0|||
13402210|NCT00598702|26809433|FG007|Overall Study|Adverse Event|0|||
13402211|NCT00598702|26809426|FG000|Overall Study|Withdrawal by Subject|0|||
13402212|NCT00598702|26809427|FG001|Overall Study|Withdrawal by Subject|0|||
13402213|NCT00598702|26809428|FG002|Overall Study|Withdrawal by Subject|0|||
13402214|NCT00598702|26809429|FG003|Overall Study|Withdrawal by Subject|1|||
13402215|NCT00598702|26809430|FG004|Overall Study|Withdrawal by Subject|1|||
13402216|NCT00598702|26809431|FG005|Overall Study|Withdrawal by Subject|0|||
13402217|NCT00598702|26809432|FG006|Overall Study|Withdrawal by Subject|0|||
13402218|NCT00598702|26809433|FG007|Overall Study|Withdrawal by Subject|0|||
13402219|NCT00598702|26809426|FG000|Overall Study|Physician Decision|0|||
13402220|NCT00598702|26809427|FG001|Overall Study|Physician Decision|0|||
13402221|NCT00598702|26809428|FG002|Overall Study|Physician Decision|0|||
13402222|NCT00598702|26809429|FG003|Overall Study|Physician Decision|0|||
13402223|NCT00598702|26809430|FG004|Overall Study|Physician Decision|1|||
13402224|NCT00598702|26809431|FG005|Overall Study|Physician Decision|0|||
13402225|NCT00598702|26809432|FG006|Overall Study|Physician Decision|0|||
13402226|NCT00598702|26809433|FG007|Overall Study|Physician Decision|0|||
13402227|NCT00598702|26809426|FG000|Overall Study|Dose limiting toxicity|0|||
13402228|NCT00598702|26809427|FG001|Overall Study|Dose limiting toxicity|0|||
13402229|NCT00598702|26809428|FG002|Overall Study|Dose limiting toxicity|0|||
13402230|NCT00598702|26809429|FG003|Overall Study|Dose limiting toxicity|1|||
13402231|NCT00598702|26809430|FG004|Overall Study|Dose limiting toxicity|1|||
13402232|NCT00598702|26809431|FG005|Overall Study|Dose limiting toxicity|1|||
13402233|NCT00598702|26809432|FG006|Overall Study|Dose limiting toxicity|0|||
13402234|NCT00598702|26809433|FG007|Overall Study|Dose limiting toxicity|0|||
13402235|NCT00598650|26809442|FG000|Overall Study|Withdrawal by Subject|3|||
13402236|NCT00598650|26809442|FG000|Overall Study|Adverse Event|18|||
13402237|NCT00598650|26809442|FG000|Overall Study|No treatment for 3 weeks|1|||
13402238|NCT00598650|26809442|FG000|Overall Study|Not eligible|1|||
13402239|NCT00598650|26809442|FG000|Overall Study|Prohibited Concomitant Medication|2|||
13402240|NCT00598650|26809442|FG000|Overall Study|Physician Decision|2|||
13402241|NCT00598585|26809455|FG000|Overall Study|Lost to Follow-up|1|||
13402242|NCT00598585|26809456|FG001|Overall Study|Lost to Follow-up|0|||
13402243|NCT00598559|26809483|FG000|Overall Study|Adverse Event|11|||
13402244|NCT00598559|26809484|FG001|Overall Study|Adverse Event|7|||
13402245|NCT00598559|26809485|FG002|Overall Study|Adverse Event|0|||
13402246|NCT00598559|26809483|FG000|Overall Study|Withdrawal by Subject|2|||
13402247|NCT00598559|26809484|FG001|Overall Study|Withdrawal by Subject|2|||
13402248|NCT00598559|26809485|FG002|Overall Study|Withdrawal by Subject|0|||
13402249|NCT00598559|26809483|FG000|Overall Study|Protocol Non-compliance|1|||
13402250|NCT00598559|26809484|FG001|Overall Study|Protocol Non-compliance|0|||
13402251|NCT00598559|26809485|FG002|Overall Study|Protocol Non-compliance|0|||
13402252|NCT00598559|26809483|FG000|Overall Study|Early discharge from hospital|9|||
13402253|NCT00598559|26809484|FG001|Overall Study|Early discharge from hospital|12|||
13402254|NCT00598559|26809485|FG002|Overall Study|Early discharge from hospital|3|||
13402255|NCT00598559|26809483|FG000|Overall Study|Subject unable/unwilling to attend visit|4|||
13402256|NCT00598559|26809484|FG001|Overall Study|Subject unable/unwilling to attend visit|7|||
13402257|NCT00598559|26809485|FG002|Overall Study|Subject unable/unwilling to attend visit|0|||
13402258|NCT00598481|26809494|FG000|Treatment|Physician Decision|1|||
13402259|NCT00598442|26809518|FG000|Overall Study|Adverse Event|3|||
13402260|NCT00598442|26809519|FG001|Overall Study|Adverse Event|0|||
13402261|NCT00598442|26809520|FG002|Overall Study|Adverse Event|0|||
13402262|NCT00598442|26809518|FG000|Overall Study|Death|19|||
13402263|NCT00598442|26809519|FG001|Overall Study|Death|11|||
13402264|NCT00598442|26809520|FG002|Overall Study|Death|11|||
13402265|NCT00598442|26809518|FG000|Overall Study|Lost to Follow-up|4|||
13402266|NCT00598442|26809519|FG001|Overall Study|Lost to Follow-up|3|||
13402267|NCT00598442|26809520|FG002|Overall Study|Lost to Follow-up|3|||
13402268|NCT00598442|26809518|FG000|Overall Study|Physician Decision|2|||
13402269|NCT00598442|26809519|FG001|Overall Study|Physician Decision|1|||
13402270|NCT00598442|26809520|FG002|Overall Study|Physician Decision|1|||
13402271|NCT00598442|26809518|FG000|Overall Study|Withdrawal by Subject|8|||
13402272|NCT00598442|26809519|FG001|Overall Study|Withdrawal by Subject|16|||
13402273|NCT00598442|26809520|FG002|Overall Study|Withdrawal by Subject|6|||
13402274|NCT00598442|26809518|FG000|Overall Study|Noncompliance|0|||
13402275|NCT00598442|26809519|FG001|Overall Study|Noncompliance|2|||
13402276|NCT00598442|26809520|FG002|Overall Study|Noncompliance|1|||
13402277|NCT00598442|26809518|FG000|Overall Study|Relocation|1|||
13402278|NCT00598442|26809519|FG001|Overall Study|Relocation|4|||
13402279|NCT00598442|26809520|FG002|Overall Study|Relocation|0|||
13402280|NCT00598442|26809518|FG000|Overall Study|Renal transplant|0|||
13402281|NCT00598442|26809519|FG001|Overall Study|Renal transplant|0|||
13402282|NCT00598442|26809520|FG002|Overall Study|Renal transplant|1|||
13402283|NCT00598442|26809518|FG000|Overall Study|Site closed by sponsor|5|||
13402284|NCT00598442|26809519|FG001|Overall Study|Site closed by sponsor|2|||
13402285|NCT00598442|26809520|FG002|Overall Study|Site closed by sponsor|1|||
13402286|NCT00598442|26809518|FG000|Overall Study|Started dialysis|1|||
13402287|NCT00598442|26809519|FG001|Overall Study|Started dialysis|0|||
13402288|NCT00598442|26809520|FG002|Overall Study|Started dialysis|0|||
13402289|NCT00598273|26809544|FG000|Overall Study|Adverse Event|4|||
13402290|NCT00598273|26809545|FG001|Overall Study|Adverse Event|5|||
13402291|NCT00598273|26809546|FG002|Overall Study|Adverse Event|2|||
13402292|NCT00598273|26809544|FG000|Overall Study|Death|6|||
13402293|NCT00598273|26809545|FG001|Overall Study|Death|12|||
13402294|NCT00598273|26809546|FG002|Overall Study|Death|8|||
13402295|NCT00598273|26809544|FG000|Overall Study|Lost to Follow-up|8|||
13402296|NCT00598273|26809545|FG001|Overall Study|Lost to Follow-up|3|||
13402297|NCT00598273|26809546|FG002|Overall Study|Lost to Follow-up|5|||
13402298|NCT00598273|26809544|FG000|Overall Study|Physician Decision|0|||
13402299|NCT00598273|26809545|FG001|Overall Study|Physician Decision|0|||
13402300|NCT00598273|26809546|FG002|Overall Study|Physician Decision|1|||
13402301|NCT00598273|26809544|FG000|Overall Study|Withdrawal by Subject|12|||
13402302|NCT00598273|26809545|FG001|Overall Study|Withdrawal by Subject|10|||
13402303|NCT00598273|26809546|FG002|Overall Study|Withdrawal by Subject|10|||
13402304|NCT00598273|26809544|FG000|Overall Study|Noncompliance|3|||
13402305|NCT00598273|26809545|FG001|Overall Study|Noncompliance|2|||
13402306|NCT00598273|26809546|FG002|Overall Study|Noncompliance|3|||
13402307|NCT00598273|26809544|FG000|Overall Study|Relocation|0|||
13402308|NCT00598273|26809545|FG001|Overall Study|Relocation|2|||
13402309|NCT00598273|26809546|FG002|Overall Study|Relocation|4|||
13402310|NCT00598273|26809544|FG000|Overall Study|Renal transplant|1|||
13402311|NCT00598273|26809545|FG001|Overall Study|Renal transplant|0|||
13402312|NCT00598273|26809546|FG002|Overall Study|Renal transplant|1|||
13402313|NCT00598273|26809544|FG000|Overall Study|Site elected to close|1|||
13402314|NCT00598273|26809545|FG001|Overall Study|Site elected to close|0|||
13402315|NCT00598273|26809546|FG002|Overall Study|Site elected to close|0|||
13402316|NCT00598273|26809544|FG000|Overall Study|Started dialysis|6|||
13402317|NCT00598273|26809545|FG001|Overall Study|Started dialysis|4|||
13402318|NCT00598273|26809546|FG002|Overall Study|Started dialysis|5|||
13402319|NCT00598078|26809557|FG000|Period 2 (Day 2)|Adverse Event|1|||
13402320|NCT00598078|26809558|FG001|Period 2 (Day 2)|Adverse Event|0|||
13402321|NCT00597766|26809585|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1|||
13402322|NCT00597766|26809586|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0|||
13402323|NCT00597766|26809587|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0|||
13402324|NCT00597766|26809585|FG000|Follow-up 2, Week 8|Lost to Follow-up|0|||
13402325|NCT00597766|26809586|FG001|Follow-up 2, Week 8|Lost to Follow-up|0|||
13402326|NCT00597766|26809587|FG002|Follow-up 2, Week 8|Lost to Follow-up|1|||
13402327|NCT00597753|26809604|FG000|Overall Study|Adverse Event|6|||
13402328|NCT00597753|26809605|FG001|Overall Study|Adverse Event|2|||
13402329|NCT00597753|26809604|FG000|Overall Study|Death|55|||
13402330|NCT00597753|26809605|FG001|Overall Study|Death|29|||
13402331|NCT00597753|26809604|FG000|Overall Study|Lack of Efficacy|2|||
13402332|NCT00597753|26809605|FG001|Overall Study|Lack of Efficacy|0|||
13402333|NCT00597753|26809604|FG000|Overall Study|Lost to Follow-up|10|||
13402334|NCT00597753|26809605|FG001|Overall Study|Lost to Follow-up|3|||
13402335|NCT00597753|26809604|FG000|Overall Study|Physician Decision|5|||
13402336|NCT00597753|26809605|FG001|Overall Study|Physician Decision|1|||
13402337|NCT00597753|26809604|FG000|Overall Study|Pregnancy|1|||
13402338|NCT00597753|26809605|FG001|Overall Study|Pregnancy|0|||
13402339|NCT00597753|26809604|FG000|Overall Study|Withdrawal by Subject|35|||
13402340|NCT00597753|26809605|FG001|Overall Study|Withdrawal by Subject|12|||
13402341|NCT00597753|26809604|FG000|Overall Study|Discontinued Dialysis|0|||
13402342|NCT00597753|26809605|FG001|Overall Study|Discontinued Dialysis|1|||
13402343|NCT00597753|26809604|FG000|Overall Study|Never dosed|2|||
13402344|NCT00597753|26809605|FG001|Overall Study|Never dosed|0|||
13402345|NCT00597753|26809604|FG000|Overall Study|Noncompliance|2|||
13402346|NCT00597753|26809605|FG001|Overall Study|Noncompliance|1|||
13402347|NCT00597753|26809604|FG000|Overall Study|Relocation|17|||
13402348|NCT00597753|26809605|FG001|Overall Study|Relocation|6|||
13402349|NCT00597753|26809604|FG000|Overall Study|Renal transplant|10|||
13402350|NCT00597753|26809605|FG001|Overall Study|Renal transplant|3|||
13402351|NCT00597753|26809604|FG000|Overall Study|Site closed by sponsor|19|||
13402352|NCT00597753|26809605|FG001|Overall Study|Site closed by sponsor|7|||
13402353|NCT00597753|26809604|FG000|Overall Study|Site elected to close|2|||
13402354|NCT00597753|26809605|FG001|Overall Study|Site elected to close|4|||
13402355|NCT00597714|26809623|FG000|Overall Study|Death|56|||
13402356|NCT00597714|26809624|FG001|Overall Study|Death|46|||
13402357|NCT00597714|26809625|FG002|Overall Study|Death|0|||
13402358|NCT00597714|26809623|FG000|Overall Study|Recipient death|0|||
13402359|NCT00597714|26809624|FG001|Overall Study|Recipient death|0|||
13402360|NCT00597714|26809625|FG002|Overall Study|Recipient death|10|||
13402361|NCT00597701|26809638|FG000|Overall Study|Withdrawal by Subject|5|||
13402362|NCT00597701|26809639|FG001|Overall Study|Withdrawal by Subject|5|||
13402363|NCT00597701|26809638|FG000|Overall Study|Death|0|||
13402364|NCT00597701|26809639|FG001|Overall Study|Death|1|||
13402365|NCT00597701|26809638|FG000|Overall Study|Physician Decision|2|||
13402366|NCT00597701|26809639|FG001|Overall Study|Physician Decision|0|||
13402367|NCT00597701|26809638|FG000|Overall Study|Did not start intervention (pharmacy er)|0|||
13402368|NCT00597701|26809639|FG001|Overall Study|Did not start intervention (pharmacy er)|2|||
13402369|NCT00597584|26809656|FG000|Overall Study|Adverse Event|4|||
13402370|NCT00597584|26809657|FG001|Overall Study|Adverse Event|2|||
13402371|NCT00597584|26809656|FG000|Overall Study|Death|53|||
13402372|NCT00597584|26809657|FG001|Overall Study|Death|30|||
13402373|NCT00597584|26809656|FG000|Overall Study|Lack of Efficacy|1|||
13402374|NCT00597584|26809657|FG001|Overall Study|Lack of Efficacy|0|||
13402375|NCT00597584|26809656|FG000|Overall Study|Lost to Follow-up|2|||
13402376|NCT00597584|26809657|FG001|Overall Study|Lost to Follow-up|4|||
13402377|NCT00597584|26809656|FG000|Overall Study|Physician Decision|3|||
13402378|NCT00597584|26809657|FG001|Overall Study|Physician Decision|0|||
13402379|NCT00597584|26809656|FG000|Overall Study|Pregnancy|2|||
13402380|NCT00597584|26809657|FG001|Overall Study|Pregnancy|0|||
13402381|NCT00597584|26809656|FG000|Overall Study|Withdrawal by Subject|44|||
13402382|NCT00597584|26809657|FG001|Overall Study|Withdrawal by Subject|12|||
13402383|NCT00597584|26809656|FG000|Overall Study|Discontinued Dialysis|0|||
13402384|NCT00597584|26809657|FG001|Overall Study|Discontinued Dialysis|1|||
13402385|NCT00597584|26809656|FG000|Overall Study|Lost ability to consent|1|||
13402386|NCT00597584|26809657|FG001|Overall Study|Lost ability to consent|1|||
13402387|NCT00597584|26809656|FG000|Overall Study|Never dosed|1|||
13402388|NCT00597584|26809657|FG001|Overall Study|Never dosed|0|||
13402389|NCT00597584|26809656|FG000|Overall Study|Relocation|8|||
13402390|NCT00597584|26809657|FG001|Overall Study|Relocation|6|||
13402391|NCT00597584|26809656|FG000|Overall Study|Renal transplant|9|||
13402392|NCT00597584|26809657|FG001|Overall Study|Renal transplant|7|||
13402393|NCT00597519|26809663|FG000|Overall Study|Death|1|||
13402394|NCT00597506|26809670|FG000|Overall Study|Subject is being followed for survival|1|||
13402395|NCT00597376|26809687|FG000|Overall Study|Withdrawal by Subject|4|||
13402396|NCT00597376|26809688|FG001|Overall Study|Withdrawal by Subject|3|||
13402397|NCT00597376|26809687|FG000|Overall Study|Adverse Event|4|||
13402398|NCT00597376|26809688|FG001|Overall Study|Adverse Event|1|||
13402399|NCT00597207|26809701|FG000|Overall Study|Lost to Follow-up|5|||
13402400|NCT00597207|26809702|FG001|Overall Study|Lost to Follow-up|7|||
13402401|NCT00597116|26809721|FG000|Overall Study|Adverse Event|2|||
13402402|NCT00597116|26809722|FG001|Overall Study|Adverse Event|1|||
13402403|NCT00597116|26809721|FG000|Overall Study|Withdrawal by Subject|0|||
13402404|NCT00597116|26809722|FG001|Overall Study|Withdrawal by Subject|2|||
13402405|NCT00597116|26809721|FG000|Overall Study|Physician Decision|0|||
13402406|NCT00597116|26809722|FG001|Overall Study|Physician Decision|1|||
13402407|NCT00597116|26809721|FG000|Overall Study|Death|0|||
13402408|NCT00597116|26809722|FG001|Overall Study|Death|1|||
13402409|NCT00597116|26809721|FG000|Overall Study|Lost to Follow-up|1|||
13402410|NCT00597116|26809722|FG001|Overall Study|Lost to Follow-up|0|||
13402411|NCT00597116|26809721|FG000|Overall Study|Progressive disease|11|||
13402412|NCT00597116|26809722|FG001|Overall Study|Progressive disease|6|||
13402413|NCT00597012|26809743|FG000|Overall Study|Death|1|||
13402414|NCT00597012|26809744|FG001|Overall Study|Death|1|||
13402415|NCT00597012|26809743|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3|||
13402416|NCT00597012|26809744|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1|||
13402417|NCT00597012|26809743|FG000|Overall Study|Withdrawal by Subject|7|||
13402418|NCT00597012|26809744|FG001|Overall Study|Withdrawal by Subject|4|||
13402419|NCT00597012|26809743|FG000|Overall Study|Ineligible|2|||
13402420|NCT00597012|26809744|FG001|Overall Study|Ineligible|0|||
13402421|NCT00597012|26809743|FG000|Overall Study|Lost to Follow-up|0|||
13402422|NCT00597012|26809744|FG001|Overall Study|Lost to Follow-up|2|||
13402423|NCT00596960|26809761|FG000|Overall Study|Death|1|||
13402424|NCT00596960|26809762|FG001|Overall Study|Death|2|||
13402425|NCT00596960|26809761|FG000|Overall Study|Lost to Follow-up|6|||
13402426|NCT00596960|26809762|FG001|Overall Study|Lost to Follow-up|5|||
13402427|NCT00596960|26809761|FG000|Overall Study|Withdrawal by Subject|1|||
13402428|NCT00596960|26809762|FG001|Overall Study|Withdrawal by Subject|0|||
13402429|NCT00596960|26809761|FG000|Overall Study|Incarcerated|2|||
13402430|NCT00596960|26809762|FG001|Overall Study|Incarcerated|0|||
13402431|NCT00596960|26809761|FG000|Overall Study|Physician Decision|1|||
13402432|NCT00596960|26809762|FG001|Overall Study|Physician Decision|0|||
13402433|NCT00596960|26809761|FG000|Overall Study|Protocol Violation|0|||
13402434|NCT00596960|26809762|FG001|Overall Study|Protocol Violation|1|||
13402435|NCT00596960|26809761|FG000|Overall Study|No alcohol use data|0|||
13402436|NCT00596960|26809762|FG001|Overall Study|No alcohol use data|1|||
13402437|NCT00596947|26809809|FG000|Overall Study|study halted due to low enrollment|5|||
13402438|NCT00596947|26809810|FG001|Overall Study|study halted due to low enrollment|3|||
13402439|NCT00596947|26809809|FG000|Overall Study|Lost to Follow-up|1|||
13402440|NCT00596947|26809810|FG001|Overall Study|Lost to Follow-up|0|||
13402441|NCT00596934|26809823|FG000|Overall Study|Protocol Violation|1|||
13402442|NCT00596934|26809823|FG000|Overall Study|Withdrawal by Subject|1|||
13402443|NCT00596830|26809853|FG000|Overall Study|Death|258|||
13402444|NCT00596830|26809854|FG001|Overall Study|Death|247|||
13402445|NCT00596830|26809853|FG000|Overall Study|Lost to Follow-up|7|||
13402446|NCT00596830|26809854|FG001|Overall Study|Lost to Follow-up|11|||
13402447|NCT00596830|26809853|FG000|Overall Study|Withdrawal by Subject|22|||
13402448|NCT00596830|26809854|FG001|Overall Study|Withdrawal by Subject|12|||
13402449|NCT00596830|26809853|FG000|Overall Study|Study terminated by sponsor|51|||
13402450|NCT00596830|26809854|FG001|Overall Study|Study terminated by sponsor|62|||
13402451|NCT00596830|26809853|FG000|Overall Study|Follow-up was discontinued|1|||
13402452|NCT00596830|26809854|FG001|Overall Study|Follow-up was discontinued|0|||
13402453|NCT00596830|26809853|FG000|Overall Study|Randomized but not treated|3|||
13402454|NCT00596830|26809854|FG001|Overall Study|Randomized but not treated|7|||
13402455|NCT00596817|26809886|FG000|Open-label Period|Adverse Event|0|||
13402456|NCT00596817|26809887|FG001|Open-label Period|Adverse Event|49|||
13402457|NCT00596817|26809886|FG000|Open-label Period|Lack of Efficacy|0|||
13402458|NCT00596817|26809887|FG001|Open-label Period|Lack of Efficacy|33|||
13402459|NCT00596817|26809886|FG000|Open-label Period|Other Reasons|0|||
13402460|NCT00596817|26809887|FG001|Open-label Period|Other Reasons|65|||
13402461|NCT00596817|26809886|FG000|Open-label Period to Double-blind Period|Adverse Event|0|||
13402462|NCT00596817|26809887|FG001|Open-label Period to Double-blind Period|Adverse Event|5|||
13402463|NCT00596817|26809886|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0|||
13402464|NCT00596817|26809887|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24|||
13402465|NCT00596817|26809886|FG000|Open-label Period to Double-blind Period|Not Eligible|0|||
13402466|NCT00596817|26809887|FG001|Open-label Period to Double-blind Period|Not Eligible|49|||
13402467|NCT00596817|26809886|FG000|Open-label Period to Double-blind Period|Other Reasons|0|||
13402468|NCT00596817|26809887|FG001|Open-label Period to Double-blind Period|Other Reasons|14|||
13402469|NCT00596817|26809886|FG000|Double-blind Period|Adverse Event|5|||
13402470|NCT00596817|26809887|FG001|Double-blind Period|Adverse Event|16|||
13402471|NCT00596817|26809886|FG000|Double-blind Period|Lack of Efficacy|52|||
13402472|NCT00596817|26809887|FG001|Double-blind Period|Lack of Efficacy|28|||
13402473|NCT00596817|26809886|FG000|Double-blind Period|Non-compliance With Study Product|3|||
13402474|NCT00596817|26809887|FG001|Double-blind Period|Non-compliance With Study Product|4|||
13402475|NCT00596817|26809886|FG000|Double-blind Period|Protocol Violation|11|||
13402476|NCT00596817|26809887|FG001|Double-blind Period|Protocol Violation|8|||
13402477|NCT00596817|26809886|FG000|Double-blind Period|Withdrawal of Consent|7|||
13402478|NCT00596817|26809887|FG001|Double-blind Period|Withdrawal of Consent|3|||
13402479|NCT00596817|26809886|FG000|Double-blind Period|Lost to Follow-up|0|||
13402480|NCT00596817|26809887|FG001|Double-blind Period|Lost to Follow-up|2|||
13402481|NCT00596817|26809886|FG000|Double-blind Period|Other Reasons|10|||
13402482|NCT00596817|26809887|FG001|Double-blind Period|Other Reasons|18|||
13402483|NCT00596752|26809922|FG000|Overall Study|Other Reason|44|||
13402484|NCT00596752|26809923|FG001|Overall Study|Other Reason|49|||
13402485|NCT00596752|26809922|FG000|Overall Study|Adverse Event|34|||
13402486|NCT00596752|26809923|FG001|Overall Study|Adverse Event|34|||
13402487|NCT00596752|26809922|FG000|Overall Study|Lost to Follow-up|22|||
13402488|NCT00596752|26809923|FG001|Overall Study|Lost to Follow-up|38|||
13402489|NCT00596752|26809922|FG000|Overall Study|Withdrawal by Subject|12|||
13402490|NCT00596752|26809923|FG001|Overall Study|Withdrawal by Subject|9|||
13402491|NCT00596752|26809922|FG000|Overall Study|Unsatisfactory Compliance|9|||
13402492|NCT00596752|26809923|FG001|Overall Study|Unsatisfactory Compliance|6|||
13402493|NCT00596752|26809922|FG000|Overall Study|Lack of Efficacy|4|||
13402494|NCT00596752|26809923|FG001|Overall Study|Lack of Efficacy|7|||
13402495|NCT00596752|26809922|FG000|Overall Study|Protocol Violation|1|||
13402496|NCT00596752|26809923|FG001|Overall Study|Protocol Violation|0|||
13402497|NCT00596687|26809938|FG000|Overall Study|< 24 hours of insulin treatment|8|||
13402498|NCT00596687|26809939|FG001|Overall Study|< 24 hours of insulin treatment|6|||
13402499|NCT00596687|26809938|FG000|Overall Study|continuous insulin infusion during TPN|2|||
13402500|NCT00596687|26809939|FG001|Overall Study|continuous insulin infusion during TPN|1|||
13402501|NCT00596687|26809938|FG000|Overall Study|Withdrawal by Subject|3|||
13402502|NCT00596687|26809939|FG001|Overall Study|Withdrawal by Subject|1|||
13402503|NCT00596687|26809938|FG000|Overall Study|cancelled surgery|1|||
13402504|NCT00596687|26809939|FG001|Overall Study|cancelled surgery|1|||
13402505|NCT00596635|26809963|FG000|Overall Study|Lost to Follow-up|0|||
13402506|NCT00596635|26809964|FG001|Overall Study|Lost to Follow-up|2|||
13402507|NCT00596635|26809965|FG002|Overall Study|Lost to Follow-up|0|||
13402508|NCT00596635|26809963|FG000|Overall Study|Treatment for symptomatic UTI|4|||
13402509|NCT00596635|26809964|FG001|Overall Study|Treatment for symptomatic UTI|6|||
13402510|NCT00596635|26809965|FG002|Overall Study|Treatment for symptomatic UTI|3|||
13402511|NCT00596635|26809963|FG000|Overall Study|Hip fracture|2|||
13402512|NCT00596635|26809964|FG001|Overall Study|Hip fracture|3|||
13402513|NCT00596635|26809965|FG002|Overall Study|Hip fracture|3|||
13402514|NCT00596635|26809963|FG000|Overall Study|Could not provide urine specimen|1|||
13402515|NCT00596635|26809964|FG001|Overall Study|Could not provide urine specimen|2|||
13402516|NCT00596635|26809965|FG002|Overall Study|Could not provide urine specimen|2|||
13402517|NCT00596466|26809973|FG000|Overall Study|Lack of Efficacy|5|||
13402518|NCT00596466|26809973|FG000|Overall Study|Adverse Event|4|||
13402519|NCT00596466|26809973|FG000|Overall Study|Withdrawal by Subject|2|||
13402520|NCT00596466|26809973|FG000|Overall Study|Protocol Violation|2|||
13402521|NCT00596466|26809973|FG000|Overall Study|Unpecified|2|||
13402522|NCT00596466|26809973|FG000|Overall Study|Enrolled, not treated|2|||
13402523|NCT00596427|26810008|FG000|Overall Study|Withdrawal by Subject|2|||
13402524|NCT00596427|26810009|FG001|Overall Study|Withdrawal by Subject|2|||
13402525|NCT00596427|26810008|FG000|Overall Study|Increased Fasting Triacylglycerol level|1|||
13402526|NCT00596427|26810009|FG001|Overall Study|Increased Fasting Triacylglycerol level|0|||
13402527|NCT00596427|26810008|FG000|Overall Study|Protocol Violation|1|||
13402528|NCT00596427|26810009|FG001|Overall Study|Protocol Violation|0|||
13402529|NCT00596362|26810015|FG000|Overall Study|Progressive Disease|1|||
13402530|NCT00596011|26810038|FG000|Overall Study|Withdrawal by Subject|2|||
13402531|NCT00596011|26810039|FG001|Overall Study|Withdrawal by Subject|3|||
13402532|NCT00596011|26810038|FG000|Overall Study|Adverse Event|11|||
13402533|NCT00596011|26810039|FG001|Overall Study|Adverse Event|7|||
13402534|NCT00595959|26810056|FG000|Overall Study|Withdrawal by Subject|1|||
13402535|NCT00595959|26810056|FG000|Overall Study|Lost to Follow-up|1|||
13402536|NCT00595920|26810062|FG000|Overall Study|The OLTERMS study was discontinued by th|116|||
13402537|NCT00595868|26810077|FG000|Overall Study|Lost to Follow-up|45|||
13402538|NCT00595868|26810078|FG001|Overall Study|Lost to Follow-up|50|||
13402539|NCT00595764|26810099|FG000|Overall Study|Protocol Violation|24|||
13402540|NCT00595764|26810100|FG001|Overall Study|Protocol Violation|19|||
13402541|NCT00595764|26810099|FG000|Overall Study|Missed Medication >1 week|10|||
13402542|NCT00595764|26810100|FG001|Overall Study|Missed Medication >1 week|17|||
13402543|NCT00595764|26810099|FG000|Overall Study|Missed 3 PM visits|1|||
13402544|NCT00595764|26810100|FG001|Overall Study|Missed 3 PM visits|7|||
13402545|NCT00595764|26810099|FG000|Overall Study|Withdrawal by Subject|4|||
13402546|NCT00595764|26810100|FG001|Overall Study|Withdrawal by Subject|0|||
13402547|NCT00595621|26810124|FG000|Open Label Run in|Adverse Event|1|||
13402548|NCT00595621|26810125|FG001|Open Label Run in|Adverse Event|0|||
13402549|NCT00595621|26810124|FG000|Open Label Run in|Physician Decision|1|||
13402550|NCT00595621|26810125|FG001|Open Label Run in|Physician Decision|0|||
13402551|NCT00595621|26810124|FG000|Open Label Run in|Withdrawal by Subject|1|||
13402552|NCT00595621|26810125|FG001|Open Label Run in|Withdrawal by Subject|0|||
13402553|NCT00595621|26810124|FG000|Randomization and Study|Adverse Event|2|||
13402554|NCT00595621|26810125|FG001|Randomization and Study|Adverse Event|0|||
13402555|NCT00595621|26810124|FG000|Randomization and Study|Withdrawal by Subject|0|||
13402556|NCT00595621|26810125|FG001|Randomization and Study|Withdrawal by Subject|1|||
13402557|NCT00595582|26810131|FG000|Overall Study|Pilot study that PI terminated|2|||
13402558|NCT00595582|26810131|FG000|Overall Study|Lost to Follow-up|1|||
13402559|NCT00595582|26810131|FG000|Overall Study|Adverse Event|2|||
13402560|NCT00595582|26810131|FG000|Overall Study|Physician Decision|5|||
13402561|NCT00595517|26810140|FG000|Overall Study|Adverse Event|6|||
13402562|NCT00595517|26810140|FG000|Overall Study|Withdrawal by Subject|4|||
13402563|NCT00595517|26810140|FG000|Overall Study|Protocol Violation|2|||
13402564|NCT00595517|26810140|FG000|Overall Study|Recurrence of ulcer|5|||
13402565|NCT00595517|26810140|FG000|Overall Study|usage of prohibited treatment|1|||
13402566|NCT00595517|26810140|FG000|Overall Study|No intention to attend regularly|1|||
13402567|NCT00595504|26810157|FG000|Overall Study|Withdrawal by Subject|1|||
13402568|NCT00595504|26810158|FG001|Overall Study|Withdrawal by Subject|3|||
13402569|NCT00595504|26810157|FG000|Overall Study|Physician Decision|1|||
13402570|NCT00595504|26810158|FG001|Overall Study|Physician Decision|0|||
13402571|NCT00595478|26810173|FG000|36-week Follow-up Period|Lost to Follow-up|5|||
13402572|NCT00595478|26810174|FG001|36-week Follow-up Period|Lost to Follow-up|4|||
13402573|NCT00595478|26810173|FG000|36-week Follow-up Period|Withdrawal by Subject|4|||
13402574|NCT00595478|26810174|FG001|36-week Follow-up Period|Withdrawal by Subject|4|||
13402575|NCT00595465|26810192|FG000|Overall Study|Adverse Event|4|||
13402576|NCT00595465|26810193|FG001|Overall Study|Adverse Event|3|||
13402577|NCT00595465|26810194|FG002|Overall Study|Adverse Event|3|||
13402578|NCT00595465|26810192|FG000|Overall Study|Pregnancy|0|||
13402579|NCT00595465|26810193|FG001|Overall Study|Pregnancy|0|||
13402580|NCT00595465|26810194|FG002|Overall Study|Pregnancy|1|||
13402581|NCT00595465|26810192|FG000|Overall Study|Protocol Violation|2|||
13402582|NCT00595465|26810193|FG001|Overall Study|Protocol Violation|1|||
13402583|NCT00595465|26810194|FG002|Overall Study|Protocol Violation|0|||
13402584|NCT00595465|26810192|FG000|Overall Study|Lost to Follow-up|0|||
13402585|NCT00595465|26810193|FG001|Overall Study|Lost to Follow-up|0|||
13402586|NCT00595465|26810194|FG002|Overall Study|Lost to Follow-up|2|||
13402587|NCT00595465|26810192|FG000|Overall Study|administrative reason|0|||
13402588|NCT00595465|26810193|FG001|Overall Study|administrative reason|0|||
13402589|NCT00595465|26810194|FG002|Overall Study|administrative reason|1|||
13402590|NCT00595413|26810233|FG000|Overall Study|Adverse Event|0|||
13402591|NCT00595413|26810234|FG001|Overall Study|Adverse Event|2|||
13402592|NCT00595413|26810235|FG002|Overall Study|Adverse Event|1|||
13402593|NCT00595413|26810236|FG003|Overall Study|Adverse Event|1|||
13402594|NCT00595413|26810233|FG000|Overall Study|Lost to Follow-up|2|||
13402595|NCT00595413|26810234|FG001|Overall Study|Lost to Follow-up|2|||
13402596|NCT00595413|26810235|FG002|Overall Study|Lost to Follow-up|1|||
13402597|NCT00595413|26810236|FG003|Overall Study|Lost to Follow-up|3|||
13402598|NCT00595413|26810233|FG000|Overall Study|Death|0|||
13402599|NCT00595413|26810234|FG001|Overall Study|Death|0|||
13402600|NCT00595413|26810235|FG002|Overall Study|Death|1|||
13402601|NCT00595413|26810236|FG003|Overall Study|Death|0|||
13402602|NCT00595413|26810233|FG000|Overall Study|Other|5|||
13402603|NCT00595413|26810234|FG001|Overall Study|Other|1|||
13402604|NCT00595413|26810235|FG002|Overall Study|Other|5|||
13402605|NCT00595413|26810236|FG003|Overall Study|Other|0|||
13402606|NCT00595335|26810263|FG000|Baseline to Six Months|Withdrawal by Subject|0|||
13402607|NCT00595335|26810264|FG001|Baseline to Six Months|Withdrawal by Subject|1|||
13402608|NCT00595335|26810263|FG000|Baseline to Six Months|Disease Progression|1|||
13402609|NCT00595335|26810264|FG001|Baseline to Six Months|Disease Progression|1|||
13402610|NCT00595335|26810263|FG000|Baseline to Six Months|Adverse Event|1|||
13402611|NCT00595335|26810264|FG001|Baseline to Six Months|Adverse Event|0|||
13402612|NCT00595335|26810263|FG000|Six Months to Twelve Months|Withdrawal by Subject|0|||
13402613|NCT00595335|26810264|FG001|Six Months to Twelve Months|Withdrawal by Subject|1|||
13402614|NCT00595335|26810263|FG000|Six Months to Twelve Months|Disease Progression|1|||
13402615|NCT00595335|26810264|FG001|Six Months to Twelve Months|Disease Progression|0|||
13402616|NCT00595309|26810270|FG000|Overall Study|Lost to Follow-up|1|||
13402617|NCT00595309|26810270|FG000|Overall Study|planned vaccination against yellow fever|1|||
13402618|NCT00595309|26810270|FG000|Overall Study|acute infection after V0|1|||
13402619|NCT00595309|26810270|FG000|Overall Study|personal reason|1|||
13476028|NCT02284568|27001885|FG000|Overall Study|Sponsor requested patient stop treatment|0|||
13476029|NCT02284568|27001886|FG001|Overall Study|Sponsor requested patient stop treatment|0|||
13476030|NCT02284568|27001887|FG002|Overall Study|Sponsor requested patient stop treatment|90|||
13476031|NCT02284568|27001885|FG000|Overall Study|Lost to Follow-up|0|||
13476032|NCT02284568|27001886|FG001|Overall Study|Lost to Follow-up|3|||
13476033|NCT02284568|27001887|FG002|Overall Study|Lost to Follow-up|0|||
13476034|NCT02284568|27001885|FG000|Overall Study|Lack of Efficacy|4|||
13476035|NCT02284568|27001886|FG001|Overall Study|Lack of Efficacy|7|||
13476036|NCT02284568|27001887|FG002|Overall Study|Lack of Efficacy|0|||
13476037|NCT02284568|27001885|FG000|Overall Study|Other|1|||
13476038|NCT02284568|27001886|FG001|Overall Study|Other|2|||
13476039|NCT02284568|27001887|FG002|Overall Study|Other|0|||
13476040|NCT02284568|27001885|FG000|Overall Study|Withdrew before taking study drug|0|||
13476041|NCT02284568|27001886|FG001|Overall Study|Withdrew before taking study drug|1|||
13476042|NCT02284568|27001887|FG002|Overall Study|Withdrew before taking study drug|0|||
13476043|NCT02227238|27001967|FG000|Overall Study|Other: Reached stopping criteria|0|||
13476044|NCT02227238|27001968|FG001|Overall Study|Other: Reached stopping criteria|1|||
13476045|NCT02227238|27001967|FG000|Overall Study|Adverse Event|8|||
13476046|NCT02227238|27001968|FG001|Overall Study|Adverse Event|18|||
13476047|NCT02227238|27001967|FG000|Overall Study|Lack of Efficacy|10|||
13476048|NCT02227238|27001968|FG001|Overall Study|Lack of Efficacy|22|||
13476049|NCT02227238|27001967|FG000|Overall Study|Protocol Violation|7|||
13476050|NCT02227238|27001968|FG001|Overall Study|Protocol Violation|8|||
13476051|NCT02227238|27001967|FG000|Overall Study|Withdrawal by Subject|5|||
13476052|NCT02227238|27001968|FG001|Overall Study|Withdrawal by Subject|4|||
13476053|NCT02227238|27001967|FG000|Overall Study|Physician Decision|0|||
13476054|NCT02227238|27001968|FG001|Overall Study|Physician Decision|9|||
13476055|NCT02227238|27001967|FG000|Overall Study|Lost to Follow-up|7|||
13476056|NCT02227238|27001968|FG001|Overall Study|Lost to Follow-up|5|||
13476057|NCT02195986|27001993|FG000|Overall Study|Adverse Event|3|||
13476058|NCT02195986|27001994|FG001|Overall Study|Adverse Event|0|||
13476059|NCT02195986|27001995|FG002|Overall Study|Adverse Event|0|||
13476060|NCT02195986|27001993|FG000|Overall Study|Withdrawal by Subject|0|||
13476061|NCT02195986|27001994|FG001|Overall Study|Withdrawal by Subject|3|||
13476062|NCT02195986|27001995|FG002|Overall Study|Withdrawal by Subject|0|||
13476063|NCT02195986|27001993|FG000|Overall Study|Family Emergency|0|||
13476064|NCT02195986|27001994|FG001|Overall Study|Family Emergency|0|||
13476065|NCT02195986|27001995|FG002|Overall Study|Family Emergency|1|||
13476066|NCT02195986|27001993|FG000|Overall Study|Protocol Violation|0|||
13476067|NCT02195986|27001994|FG001|Overall Study|Protocol Violation|1|||
13476068|NCT02195986|27001995|FG002|Overall Study|Protocol Violation|1|||
13476069|NCT02195986|27001993|FG000|Overall Study|Non-compliance|0|||
13476070|NCT02195986|27001994|FG001|Overall Study|Non-compliance|1|||
13476071|NCT02195986|27001995|FG002|Overall Study|Non-compliance|0|||
13476072|NCT02086448|27002038|FG000|Overall Study|Withdrawal by Subject|1|||
13476073|NCT02086448|27002039|FG001|Overall Study|Withdrawal by Subject|0|||
13476074|NCT02086448|27002040|FG002|Overall Study|Withdrawal by Subject|0|||
13476075|NCT02086448|27002041|FG003|Overall Study|Withdrawal by Subject|2|||
13476076|NCT01982630|27002252|FG000|Overall Study|Adverse Event|2|||
13476077|NCT01982630|27002253|FG001|Overall Study|Adverse Event|0|||
13476078|NCT01982630|27002254|FG002|Overall Study|Adverse Event|1|||
13476079|NCT01982630|27002255|FG003|Overall Study|Adverse Event|0|||
13476080|NCT01982630|27002256|FG004|Overall Study|Adverse Event|1|||
13476081|NCT01982630|27002257|FG005|Overall Study|Adverse Event|2|||
13476082|NCT01982630|27002258|FG006|Overall Study|Adverse Event|1|||
13476083|NCT01982630|27002259|FG007|Overall Study|Adverse Event|0|||
13476084|NCT01982630|27002252|FG000|Overall Study|Physician Decision|1|||
13476085|NCT01982630|27002253|FG001|Overall Study|Physician Decision|0|||
13476086|NCT01982630|27002254|FG002|Overall Study|Physician Decision|2|||
13476087|NCT01982630|27002255|FG003|Overall Study|Physician Decision|1|||
13476088|NCT01982630|27002256|FG004|Overall Study|Physician Decision|2|||
13476089|NCT01982630|27002257|FG005|Overall Study|Physician Decision|0|||
13476090|NCT01982630|27002258|FG006|Overall Study|Physician Decision|0|||
13476091|NCT01982630|27002259|FG007|Overall Study|Physician Decision|0|||
13476092|NCT01982630|27002252|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0|||
13476093|NCT01982630|27002253|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0|||
13476094|NCT01982630|27002254|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2|||
13476095|NCT01982630|27002255|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0|||
13476096|NCT01982630|27002256|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0|||
13476097|NCT01982630|27002257|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0|||
13476098|NCT01982630|27002258|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0|||
13402620|NCT00595127|26810276|FG000|Overall Study|Death|6|||
13402621|NCT00595127|26810276|FG000|Overall Study|Relapsed|3|||
13402622|NCT00595127|26810276|FG000|Overall Study|joined another trial|1|||
13402623|NCT00595075|26810301|FG000|Overall Study|Withdrawal by Subject|1|||
13402624|NCT00595075|26810302|FG001|Overall Study|Withdrawal by Subject|0|||
13402625|NCT00594958|26810320|FG000|Overall Study|Withdrawal by Subject|1|||
13402626|NCT00594958|26810321|FG001|Overall Study|Withdrawal by Subject|0|||
13402627|NCT00594958|26810322|FG002|Overall Study|Withdrawal by Subject|1|||
13402628|NCT00594958|26810320|FG000|Overall Study|Adverse Event|4|||
13402629|NCT00594958|26810321|FG001|Overall Study|Adverse Event|1|||
13402630|NCT00594958|26810322|FG002|Overall Study|Adverse Event|2|||
13402631|NCT00594958|26810320|FG000|Overall Study|Pregnancy|0|||
13402632|NCT00594958|26810321|FG001|Overall Study|Pregnancy|2|||
13402633|NCT00594958|26810322|FG002|Overall Study|Pregnancy|0|||
13402634|NCT00594958|26810320|FG000|Overall Study|Protocol Violation|1|||
13402635|NCT00594958|26810321|FG001|Overall Study|Protocol Violation|0|||
13402636|NCT00594958|26810322|FG002|Overall Study|Protocol Violation|2|||
13402637|NCT00594958|26810320|FG000|Overall Study|Lost to Follow-up|5|||
13402638|NCT00594958|26810321|FG001|Overall Study|Lost to Follow-up|0|||
13402639|NCT00594958|26810322|FG002|Overall Study|Lost to Follow-up|3|||
13402640|NCT00594958|26810320|FG000|Overall Study|administrative|3|||
13402641|NCT00594958|26810321|FG001|Overall Study|administrative|0|||
13402642|NCT00594958|26810322|FG002|Overall Study|administrative|2|||
13402643|NCT00594932|26810339|FG000|First 3 Months|Withdrawal by Subject|1|||
13402644|NCT00594932|26810340|FG001|First 3 Months|Withdrawal by Subject|3|||
13402645|NCT00594932|26810339|FG000|Final 3 Months|Withdrawal by Subject|4|||
13402646|NCT00594932|26810340|FG001|Final 3 Months|Withdrawal by Subject|3|||
13402647|NCT00594906|26810353|FG000|Overall Study|Physician Decision|1|||
13402648|NCT00594906|26810354|FG001|Overall Study|Physician Decision|0|||
13402649|NCT00594906|26810353|FG000|Overall Study|Physician Decision|0|||
13402650|NCT00594906|26810354|FG001|Overall Study|Physician Decision|1|||
13402651|NCT00594906|26810353|FG000|Overall Study|Death|0|||
13402652|NCT00594906|26810354|FG001|Overall Study|Death|1|||
13402653|NCT00594880|26810371|FG000|Overall Study|Withdrawal by Subject|1|||
13402654|NCT00594880|26810372|FG001|Overall Study|Withdrawal by Subject|1|||
13402655|NCT00594880|26810371|FG000|Overall Study|Lost to Follow-up|1|||
13402656|NCT00594880|26810372|FG001|Overall Study|Lost to Follow-up|0|||
13402657|NCT00594854|26810389|FG000|Overall Study|Study terminated|7|||
13402658|NCT00594854|26810390|FG001|Overall Study|Study terminated|10|||
13402659|NCT00594815|26810397|FG000|Overall Study|Never Treated|3|||
13402660|NCT00594815|26810397|FG000|Overall Study|Withdrawal by Subject|2|||
13402661|NCT00594815|26810397|FG000|Overall Study|Toxicity|4|||
13402662|NCT00594659|26810418|FG000|Overall Study|Lost to Follow-up|13|||
13402663|NCT00594659|26810419|FG001|Overall Study|Lost to Follow-up|9|||
13402664|NCT00594659|26810420|FG002|Overall Study|Lost to Follow-up|7|||
13402665|NCT00594646|26810427|FG000|Overall Study|Withdrawal by Subject|1|||
13402666|NCT00594646|26810427|FG000|Overall Study|Lost to Follow-up|15|||
13402667|NCT00594568|26810525|FG000|Initial Treatment|Adverse Event|51|||
13402668|NCT00594568|26810526|FG001|Initial Treatment|Adverse Event|121|||
13402669|NCT00594568|26810527|FG002|Initial Treatment|Adverse Event|144|||
13402670|NCT00594568|26810525|FG000|Initial Treatment|Death|6|||
13402671|NCT00594568|26810526|FG001|Initial Treatment|Death|11|||
13402672|NCT00594568|26810527|FG002|Initial Treatment|Death|15|||
13402673|NCT00594568|26810525|FG000|Initial Treatment|Lost to Follow-up|4|||
13402674|NCT00594568|26810526|FG001|Initial Treatment|Lost to Follow-up|1|||
13402675|NCT00594568|26810527|FG002|Initial Treatment|Lost to Follow-up|4|||
13402676|NCT00594568|26810525|FG000|Initial Treatment|Physician Decision|3|||
13402677|NCT00594568|26810526|FG001|Initial Treatment|Physician Decision|2|||
13402678|NCT00594568|26810527|FG002|Initial Treatment|Physician Decision|4|||
13402679|NCT00594568|26810525|FG000|Initial Treatment|Protocol Violation|2|||
13402680|NCT00594568|26810526|FG001|Initial Treatment|Protocol Violation|2|||
13402681|NCT00594568|26810527|FG002|Initial Treatment|Protocol Violation|5|||
13402682|NCT00594568|26810525|FG000|Initial Treatment|Withdrawal by Subject|25|||
13402683|NCT00594568|26810526|FG001|Initial Treatment|Withdrawal by Subject|31|||
13402684|NCT00594568|26810527|FG002|Initial Treatment|Withdrawal by Subject|46|||
13402685|NCT00594568|26810525|FG000|Initial Treatment|Sponsor decision|193|||
13402686|NCT00594568|26810526|FG001|Initial Treatment|Sponsor decision|142|||
13402687|NCT00594568|26810527|FG002|Initial Treatment|Sponsor decision|147|||
13402688|NCT00594568|26810525|FG000|Initial Treatment|Caregiver decision|21|||
13402689|NCT00594568|26810526|FG001|Initial Treatment|Caregiver decision|36|||
13402690|NCT00594568|26810527|FG002|Initial Treatment|Caregiver decision|36|||
13402691|NCT00594568|26810525|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
13402692|NCT00594568|26810526|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
13402693|NCT00594568|26810527|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6|||
13402694|NCT00594568|26810525|FG000|Initial Treatment|Entry criteria exclusion|0|||
13402695|NCT00594568|26810526|FG001|Initial Treatment|Entry criteria exclusion|1|||
13402696|NCT00594568|26810527|FG002|Initial Treatment|Entry criteria exclusion|1|||
13402697|NCT00594568|26810525|FG000|Delayed Start|Death|0|||
13402698|NCT00594568|26810526|FG001|Delayed Start|Death|0|||
13402699|NCT00594568|26810527|FG002|Delayed Start|Death|1|||
13402700|NCT00594568|26810525|FG000|Delayed Start|Adverse Event|12|||
13402701|NCT00594568|26810526|FG001|Delayed Start|Adverse Event|2|||
13402702|NCT00594568|26810527|FG002|Delayed Start|Adverse Event|2|||
13402703|NCT00594568|26810525|FG000|Delayed Start|Withdrawal by Subject|4|||
13402704|NCT00594568|26810526|FG001|Delayed Start|Withdrawal by Subject|3|||
13402705|NCT00594568|26810527|FG002|Delayed Start|Withdrawal by Subject|0|||
13402706|NCT00594568|26810525|FG000|Delayed Start|Physician Decision|0|||
13402707|NCT00594568|26810526|FG001|Delayed Start|Physician Decision|0|||
13402708|NCT00594568|26810527|FG002|Delayed Start|Physician Decision|1|||
13402709|NCT00594568|26810525|FG000|Delayed Start|Lost to Follow-up|0|||
13402710|NCT00594568|26810526|FG001|Delayed Start|Lost to Follow-up|0|||
13402711|NCT00594568|26810527|FG002|Delayed Start|Lost to Follow-up|1|||
13402712|NCT00594568|26810525|FG000|Delayed Start|Caregiver Decision|5|||
13402713|NCT00594568|26810526|FG001|Delayed Start|Caregiver Decision|6|||
13402714|NCT00594568|26810527|FG002|Delayed Start|Caregiver Decision|2|||
13402715|NCT00594568|26810525|FG000|Delayed Start|Sponsor Decision|77|||
13402716|NCT00594568|26810526|FG001|Delayed Start|Sponsor Decision|66|||
13402717|NCT00594568|26810527|FG002|Delayed Start|Sponsor Decision|59|||
13402718|NCT00594568|26810525|FG000|Safety Follow Up (SFU)-Optional|Death|0|||
13402719|NCT00594568|26810526|FG001|Safety Follow Up (SFU)-Optional|Death|1|||
13402720|NCT00594568|26810527|FG002|Safety Follow Up (SFU)-Optional|Death|0|||
13402721|NCT00594568|26810525|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5|||
13402722|NCT00594568|26810526|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
13402723|NCT00594568|26810527|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
13402724|NCT00594568|26810525|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12|||
13402725|NCT00594568|26810526|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15|||
13402726|NCT00594568|26810527|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13|||
13402727|NCT00594568|26810525|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
13402728|NCT00594568|26810526|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
13402729|NCT00594568|26810527|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
13402730|NCT00594568|26810525|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17|||
13402731|NCT00594568|26810526|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16|||
13402732|NCT00594568|26810527|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9|||
13402733|NCT00594568|26810525|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25|||
13402734|NCT00594568|26810526|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22|||
13402735|NCT00594568|26810527|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18|||
13402736|NCT00594516|26810539|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4|||
13402737|NCT00594516|26810540|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
13402738|NCT00594516|26810541|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
13402739|NCT00594516|26810539|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2|||
13402740|NCT00594516|26810540|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
13402741|NCT00594516|26810541|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
13402742|NCT00594516|26810539|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16|||
13402743|NCT00594516|26810540|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0|||
13402744|NCT00594516|26810541|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0|||
13402745|NCT00594516|26810539|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1|||
13402746|NCT00594516|26810540|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
13402747|NCT00594516|26810541|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
13402748|NCT00594516|26810539|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6|||
13402749|NCT00594516|26810540|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
13402750|NCT00594516|26810541|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
13402751|NCT00594516|26810539|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0|||
13402752|NCT00594516|26810540|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
13402753|NCT00594516|26810541|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
13402754|NCT00594516|26810539|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0|||
13402755|NCT00594516|26810540|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3|||
13402756|NCT00594516|26810541|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2|||
13402757|NCT00594516|26810539|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0|||
13402758|NCT00594516|26810540|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
13402759|NCT00594516|26810541|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
13402760|NCT00594516|26810539|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
13402761|NCT00594516|26810540|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
13402762|NCT00594516|26810541|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2|||
13402763|NCT00594464|26810555|FG000|Overall Study|Withdrawal by Subject|1|||
13402764|NCT00594464|26810555|FG000|Overall Study|Delay in operation|2|||
13402765|NCT00594399|26810585|FG000|Initial 3 Month Counseling|Not ready to exercise|1|||
13402766|NCT00594399|26810586|FG001|Initial 3 Month Counseling|Not ready to exercise|0|||
13402767|NCT00594399|26810587|FG002|Initial 3 Month Counseling|Not ready to exercise|0|||
13402768|NCT00594399|26810585|FG000|Initial 3 Month Counseling|Lack of Interest|3|||
13402769|NCT00594399|26810586|FG001|Initial 3 Month Counseling|Lack of Interest|3|||
13402770|NCT00594399|26810587|FG002|Initial 3 Month Counseling|Lack of Interest|0|||
13402771|NCT00594399|26810585|FG000|Initial 3 Month Counseling|Personal issues|2|||
13402772|NCT00594399|26810586|FG001|Initial 3 Month Counseling|Personal issues|0|||
13402773|NCT00594399|26810587|FG002|Initial 3 Month Counseling|Personal issues|0|||
13402774|NCT00594399|26810585|FG000|Initial 3 Month Counseling|Too busy|7|||
13402775|NCT00594399|26810586|FG001|Initial 3 Month Counseling|Too busy|1|||
13402776|NCT00594399|26810587|FG002|Initial 3 Month Counseling|Too busy|0|||
13402777|NCT00594399|26810585|FG000|Initial 3 Month Counseling|Pain|2|||
13402778|NCT00594399|26810586|FG001|Initial 3 Month Counseling|Pain|0|||
13402779|NCT00594399|26810587|FG002|Initial 3 Month Counseling|Pain|0|||
13402780|NCT00594399|26810585|FG000|Initial 3 Month Counseling|Moved|1|||
13402781|NCT00594399|26810586|FG001|Initial 3 Month Counseling|Moved|0|||
13402782|NCT00594399|26810587|FG002|Initial 3 Month Counseling|Moved|0|||
13402783|NCT00594399|26810585|FG000|Initial 3 Month Counseling|Family illness|1|||
13402784|NCT00594399|26810586|FG001|Initial 3 Month Counseling|Family illness|0|||
13402785|NCT00594399|26810587|FG002|Initial 3 Month Counseling|Family illness|0|||
13402786|NCT00594399|26810585|FG000|Rerandomization Arm 1 Only|Death|2|||
13402787|NCT00594399|26810586|FG001|Rerandomization Arm 1 Only|Death|1|||
13402788|NCT00594399|26810587|FG002|Rerandomization Arm 1 Only|Death|0|||
13402789|NCT00594399|26810585|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
13402790|NCT00594399|26810586|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3|||
13402791|NCT00594399|26810587|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
13402792|NCT00594386|26810595|FG000|Overall Study|Major protocol violation|2|||
13402793|NCT00594386|26810595|FG000|Overall Study|Lack of Efficacy|12|||
13402794|NCT00594386|26810595|FG000|Overall Study|Adverse Event|68|||
13402795|NCT00594386|26810595|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
13402796|NCT00594386|26810595|FG000|Overall Study|Subject withdrew consent|35|||
13402797|NCT00594386|26810595|FG000|Overall Study|Study ended per sponsor|115|||
13402798|NCT00594386|26810595|FG000|Overall Study|Lost to Follow-up|6|||
13402799|NCT00594386|26810595|FG000|Overall Study|Other: Patient went off patch (hospital)|1|||
13402800|NCT00594386|26810595|FG000|Overall Study|Other: Subject moved to Seattle|1|||
13402801|NCT00594386|26810595|FG000|Overall Study|Other: Subject admitted to nursing home|1|||
13402802|NCT00594386|26810595|FG000|Overall Study|Other: Study terminated per investigator|2|||
13402803|NCT00594386|26810595|FG000|Overall Study|Other: Sponsor closure of study|1|||
13402804|NCT00594386|26810595|FG000|Overall Study|Other: Site terminated participation|1|||
13402805|NCT00594386|26810595|FG000|Overall Study|Other: Patient wants prescription Neupro|1|||
13402806|NCT00594386|26810595|FG000|Overall Study|Other: Loss of drivers license|1|||
13402807|NCT00594204|26810612|FG000|Overall Study|Adverse Event|15|||
13402808|NCT00594204|26810613|FG001|Overall Study|Adverse Event|3|||
13402809|NCT00594204|26810612|FG000|Overall Study|Lost to Follow-up|9|||
13402810|NCT00594204|26810613|FG001|Overall Study|Lost to Follow-up|5|||
13402811|NCT00594204|26810612|FG000|Overall Study|Withdrawal by Subject|23|||
13402812|NCT00594204|26810613|FG001|Overall Study|Withdrawal by Subject|29|||
13402813|NCT00594204|26810612|FG000|Overall Study|Other|4|||
13402814|NCT00594204|26810613|FG001|Overall Study|Other|3|||
13402815|NCT00594204|26810612|FG000|Overall Study|Lack of Efficacy|3|||
13402816|NCT00594204|26810613|FG001|Overall Study|Lack of Efficacy|4|||
13402817|NCT00594204|26810612|FG000|Overall Study|Randomized but not treated|4|||
13402818|NCT00594204|26810613|FG001|Overall Study|Randomized but not treated|1|||
13402819|NCT00594178|26810620|FG000|Overall Study|Physician Decision|5|||
13402820|NCT00594165|26810628|FG000|Overall Study|Major protocol violation|1|||
13402821|NCT00594165|26810628|FG000|Overall Study|Lack of Efficacy|12|||
13402822|NCT00594165|26810628|FG000|Overall Study|Adverse Event|52|||
13402823|NCT00594165|26810628|FG000|Overall Study|Unsatisfactory compliance of subject|6|||
13402824|NCT00594165|26810628|FG000|Overall Study|Subject withdrew consent|27|||
13402825|NCT00594165|26810628|FG000|Overall Study|Study ended per sponsor|102|||
13402826|NCT00594165|26810628|FG000|Overall Study|Lost to Follow-up|4|||
13402827|NCT00594165|26810628|FG000|Overall Study|Other: PI discretion|5|||
13402828|NCT00594165|26810628|FG000|Overall Study|Other: Subject moving|3|||
13402829|NCT00594165|26810628|FG000|Overall Study|Other: Brain surgery controlled symptoms|1|||
13402830|NCT00594165|26810628|FG000|Overall Study|Other: House bound; can't get to clinic|1|||
13402831|NCT00594165|26810628|FG000|Overall Study|Other: Subject enrolled in other trial|1|||
13402832|NCT00594165|26810628|FG000|Overall Study|Other: Site terminated participation|2|||
13402833|NCT00594100|26810639|FG000|Procedure|Technical Failure|9|||
13402834|NCT00594100|26810639|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2|||
13402835|NCT00594100|26810639|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6|||
13402836|NCT00594100|26810639|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4|||
13402837|NCT00594035|26810652|FG000|Overall Study|Lost to Follow-up|1|||
13402838|NCT00594035|26810653|FG001|Overall Study|Lost to Follow-up|1|||
13402839|NCT00594035|26810652|FG000|Overall Study|Withdrawal by Subject|1|||
13402840|NCT00594035|26810653|FG001|Overall Study|Withdrawal by Subject|0|||
13402841|NCT00594035|26810652|FG000|Overall Study|Subject transferred to nursing home|0|||
13402842|NCT00594035|26810653|FG001|Overall Study|Subject transferred to nursing home|1|||
13402843|NCT00594035|26810652|FG000|Overall Study|Subject couldn't return due to job|0|||
13402844|NCT00594035|26810653|FG001|Overall Study|Subject couldn't return due to job|1|||
13402845|NCT00593957|26810685|FG000|Overall Study|Physician Decision|0|||
13402846|NCT00593957|26810686|FG001|Overall Study|Physician Decision|1|||
13402847|NCT00593957|26810687|FG002|Overall Study|Physician Decision|2|||
13402848|NCT00593918|26810702|FG000|Overall Study|Withdrawal by Subject|5|||
13402849|NCT00593918|26810703|FG001|Overall Study|Withdrawal by Subject|24|||
13402850|NCT00593840|26810715|FG000|Overall Study|Withdrawal by Subject|1|||
13402851|NCT00593827|26810744|FG000|Overall Study|On Active Treatment/Pending|0|||
13402852|NCT00593827|26810745|FG001|Overall Study|On Active Treatment/Pending|2|||
13402853|NCT00593814|26810760|FG000|Overall Study|Death|7|||
13402854|NCT00593814|26810761|FG001|Overall Study|Death|0|||
13402855|NCT00593814|26810760|FG000|Overall Study|Withdrawal by Subject|7|||
13402856|NCT00593814|26810761|FG001|Overall Study|Withdrawal by Subject|0|||
13402857|NCT00593814|26810760|FG000|Overall Study|Lost to Follow-up|7|||
13402858|NCT00593814|26810761|FG001|Overall Study|Lost to Follow-up|0|||
13402859|NCT00593814|26810760|FG000|Overall Study|Physician Decision|3|||
13402860|NCT00593814|26810761|FG001|Overall Study|Physician Decision|0|||
13402861|NCT00593736|26811020|FG000|Screening Period and Placebo Run-in|Adverse Event|0|||
13402862|NCT00593736|26811021|FG001|Screening Period and Placebo Run-in|Adverse Event|0|||
13402863|NCT00593736|26811022|FG002|Screening Period and Placebo Run-in|Adverse Event|0|||
13402864|NCT00593736|26811023|FG003|Screening Period and Placebo Run-in|Adverse Event|3|||
13402865|NCT00593736|26811020|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
13402866|NCT00593736|26811021|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
13402867|NCT00593736|26811022|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
13402868|NCT00593736|26811023|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9|||
13402869|NCT00593736|26811020|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
13402870|NCT00593736|26811021|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
13402871|NCT00593736|26811022|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
13402872|NCT00593736|26811023|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43|||
13402873|NCT00593736|26811020|FG000|Screening Period and Placebo Run-in|Study Termination|0|||
13402874|NCT00593736|26811021|FG001|Screening Period and Placebo Run-in|Study Termination|0|||
13402875|NCT00593736|26811022|FG002|Screening Period and Placebo Run-in|Study Termination|0|||
13402876|NCT00593736|26811023|FG003|Screening Period and Placebo Run-in|Study Termination|15|||
13402877|NCT00593736|26811020|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
13402878|NCT00593736|26811021|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
13402879|NCT00593736|26811022|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
13402880|NCT00593736|26811023|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322|||
13402881|NCT00593736|26811020|FG000|Screening Period and Placebo Run-in|Various|0|||
13402882|NCT00593736|26811021|FG001|Screening Period and Placebo Run-in|Various|0|||
13402883|NCT00593736|26811022|FG002|Screening Period and Placebo Run-in|Various|0|||
13402884|NCT00593736|26811023|FG003|Screening Period and Placebo Run-in|Various|25|||
13402885|NCT00593736|26811020|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
13402886|NCT00593736|26811021|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1|||
13402887|NCT00593736|26811022|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
13402888|NCT00593736|26811023|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0|||
13402889|NCT00593736|26811020|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0|||
13402890|NCT00593736|26811021|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0|||
13402891|NCT00593736|26811022|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1|||
13402892|NCT00593736|26811023|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1|||
13402893|NCT00593736|26811020|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
13402894|NCT00593736|26811021|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
13402895|NCT00593736|26811022|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1|||
13402896|NCT00593736|26811023|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3|||
13402897|NCT00593736|26811020|FG000|Treatment Period and Placebo Run-out|Various|1|||
13402898|NCT00593736|26811021|FG001|Treatment Period and Placebo Run-out|Various|1|||
13402899|NCT00593736|26811022|FG002|Treatment Period and Placebo Run-out|Various|1|||
13402900|NCT00593736|26811023|FG003|Treatment Period and Placebo Run-out|Various|0|||
13402901|NCT00593684|26811042|FG000|Overall Study|Death|2|||
13402902|NCT00593684|26811043|FG001|Overall Study|Death|1|||
13402903|NCT00593606|26811141|FG000|Overall Study|Adverse Event|13|||
13402904|NCT00593606|26811141|FG000|Overall Study|Withdrawal by Subject|1|||
13402905|NCT00593606|26811141|FG000|Overall Study|Protocol Violation|3|||
13402906|NCT00593606|26811141|FG000|Overall Study|Lost to Follow-up|2|||
13402907|NCT00593606|26811141|FG000|Overall Study|Run-In Failure|5|||
13402908|NCT00593606|26811141|FG000|Overall Study|Screen Failure|3|||
13402909|NCT00593554|26811166|FG000|Overall Study|Death|1|||
13402910|NCT00593554|26811167|FG001|Overall Study|Death|2|||
13402911|NCT00593554|26811166|FG000|Overall Study|Physician Decision|0|||
13402912|NCT00593554|26811167|FG001|Overall Study|Physician Decision|1|||
13402913|NCT00593554|26811166|FG000|Overall Study|Withdrawal by Subject|1|||
13402914|NCT00593554|26811167|FG001|Overall Study|Withdrawal by Subject|0|||
13402915|NCT00593554|26811166|FG000|Overall Study|Disease Progression|1|||
13402916|NCT00593554|26811167|FG001|Overall Study|Disease Progression|2|||
13402917|NCT00593489|26811200|FG000|Allocation|did not attend workshop; allocation not|2|||
13402918|NCT00593489|26811201|FG001|Allocation|did not attend workshop; allocation not|1|||
13402919|NCT00593385|26811238|FG000|Overall Study|Death|14|||
13402920|NCT00593385|26811238|FG000|Overall Study|Lost to Follow-up|17|||
13402921|NCT00593385|26811238|FG000|Overall Study|Withdrawal by Subject|9|||
13402922|NCT00593333|26811251|FG000|Overall Study|Lost to Follow-up|10|||
13402923|NCT00593333|26811252|FG001|Overall Study|Lost to Follow-up|11|||
13402924|NCT00593112|26811269|FG000|Overall Study|Scan Anxiety|3|||
13402925|NCT00593112|26811270|FG001|Overall Study|Scan Anxiety|0|||
13402926|NCT00593112|26811269|FG000|Overall Study|Abnormal Scan|1|||
13402927|NCT00593112|26811270|FG001|Overall Study|Abnormal Scan|0|||
13402928|NCT00593112|26811269|FG000|Overall Study|Unreadable Scan|1|||
13402929|NCT00593112|26811270|FG001|Overall Study|Unreadable Scan|0|||
13402930|NCT00593112|26811269|FG000|Overall Study|Withdrawal by Subject|5|||
13402931|NCT00593112|26811270|FG001|Overall Study|Withdrawal by Subject|0|||
13402932|NCT00592904|26811309|FG000|Overall Study|Adverse Event|15|||
13402933|NCT00592904|26811310|FG001|Overall Study|Adverse Event|25|||
13402934|NCT00592904|26811311|FG002|Overall Study|Adverse Event|13|||
13402935|NCT00592904|26811312|FG003|Overall Study|Adverse Event|5|||
13402936|NCT00592904|26811309|FG000|Overall Study|Protocol Violation|1|||
13402937|NCT00592904|26811310|FG001|Overall Study|Protocol Violation|1|||
13402938|NCT00592904|26811311|FG002|Overall Study|Protocol Violation|0|||
13402939|NCT00592904|26811312|FG003|Overall Study|Protocol Violation|1|||
13402940|NCT00592904|26811309|FG000|Overall Study|Withdrawal by Subject|4|||
13402941|NCT00592904|26811310|FG001|Overall Study|Withdrawal by Subject|16|||
13402942|NCT00592904|26811311|FG002|Overall Study|Withdrawal by Subject|1|||
13402943|NCT00592904|26811312|FG003|Overall Study|Withdrawal by Subject|2|||
13402944|NCT00592904|26811309|FG000|Overall Study|Lack of Efficacy|2|||
13402945|NCT00592904|26811310|FG001|Overall Study|Lack of Efficacy|7|||
13402946|NCT00592904|26811311|FG002|Overall Study|Lack of Efficacy|2|||
13402947|NCT00592904|26811312|FG003|Overall Study|Lack of Efficacy|3|||
13402948|NCT00592904|26811309|FG000|Overall Study|Physician Decision|0|||
13402949|NCT00592904|26811310|FG001|Overall Study|Physician Decision|3|||
13402950|NCT00592904|26811311|FG002|Overall Study|Physician Decision|1|||
13402951|NCT00592904|26811312|FG003|Overall Study|Physician Decision|0|||
13402952|NCT00592904|26811309|FG000|Overall Study|Other|3|||
13402953|NCT00592904|26811310|FG001|Overall Study|Other|3|||
13402954|NCT00592904|26811311|FG002|Overall Study|Other|0|||
13402955|NCT00592904|26811312|FG003|Overall Study|Other|0|||
13402956|NCT00592852|26811319|FG000|Overall Study|Non-compliance|1|||
13402957|NCT00592852|26811319|FG000|Overall Study|Adverse Event|3|||
13402958|NCT00592852|26811319|FG000|Overall Study|Found ineligible|1|||
13402959|NCT00592852|26811319|FG000|Overall Study|Withdrawal by Subject|1|||
13402960|NCT00592839|26811352|FG000|Overall Study|Withdrawal by Subject|1|||
13402961|NCT00592839|26811353|FG001|Overall Study|Withdrawal by Subject|1|||
13402962|NCT00592839|26811354|FG002|Overall Study|Withdrawal by Subject|3|||
13402963|NCT00592839|26811352|FG000|Overall Study|Protocol Violation|1|||
13402964|NCT00592839|26811353|FG001|Overall Study|Protocol Violation|1|||
13402965|NCT00592839|26811354|FG002|Overall Study|Protocol Violation|2|||
13402966|NCT00592839|26811352|FG000|Overall Study|Adverse Event|0|||
13402967|NCT00592839|26811353|FG001|Overall Study|Adverse Event|1|||
13402968|NCT00592839|26811354|FG002|Overall Study|Adverse Event|0|||
13402969|NCT00592839|26811352|FG000|Overall Study|Lost to Follow-up|0|||
13402970|NCT00592839|26811353|FG001|Overall Study|Lost to Follow-up|1|||
13402971|NCT00592839|26811354|FG002|Overall Study|Lost to Follow-up|1|||
13402972|NCT00592774|26811427|FG000|Overall Study|Adverse Event|5|||
13402973|NCT00592774|26811428|FG001|Overall Study|Adverse Event|19|||
13402974|NCT00592774|26811429|FG002|Overall Study|Adverse Event|2|||
13402975|NCT00592774|26811430|FG003|Overall Study|Adverse Event|14|||
13402976|NCT00592774|26811431|FG004|Overall Study|Adverse Event|8|||
13402977|NCT00592774|26811427|FG000|Overall Study|Protocol Violation|0|||
13402978|NCT00592774|26811428|FG001|Overall Study|Protocol Violation|1|||
13402979|NCT00592774|26811429|FG002|Overall Study|Protocol Violation|0|||
13402980|NCT00592774|26811430|FG003|Overall Study|Protocol Violation|0|||
13402981|NCT00592774|26811431|FG004|Overall Study|Protocol Violation|1|||
13402982|NCT00592774|26811427|FG000|Overall Study|Withdrawal by Subject|3|||
13402983|NCT00592774|26811428|FG001|Overall Study|Withdrawal by Subject|7|||
13402984|NCT00592774|26811429|FG002|Overall Study|Withdrawal by Subject|0|||
13402985|NCT00592774|26811430|FG003|Overall Study|Withdrawal by Subject|0|||
13402986|NCT00592774|26811431|FG004|Overall Study|Withdrawal by Subject|0|||
13402987|NCT00592774|26811427|FG000|Overall Study|Lack of Efficacy|3|||
13402988|NCT00592774|26811428|FG001|Overall Study|Lack of Efficacy|3|||
13402989|NCT00592774|26811429|FG002|Overall Study|Lack of Efficacy|0|||
13402990|NCT00592774|26811430|FG003|Overall Study|Lack of Efficacy|0|||
13402991|NCT00592774|26811431|FG004|Overall Study|Lack of Efficacy|2|||
13402992|NCT00592774|26811427|FG000|Overall Study|Physician Decision|0|||
13402993|NCT00592774|26811428|FG001|Overall Study|Physician Decision|1|||
13402994|NCT00592774|26811429|FG002|Overall Study|Physician Decision|1|||
13402995|NCT00592774|26811430|FG003|Overall Study|Physician Decision|0|||
13402996|NCT00592774|26811431|FG004|Overall Study|Physician Decision|1|||
13402997|NCT00592774|26811427|FG000|Overall Study|Other|0|||
13402998|NCT00592774|26811428|FG001|Overall Study|Other|1|||
13402999|NCT00592774|26811429|FG002|Overall Study|Other|1|||
13403000|NCT00592774|26811430|FG003|Overall Study|Other|0|||
13403001|NCT00592774|26811431|FG004|Overall Study|Other|2|||
13403002|NCT00592683|26811446|FG000|Overall Study|Found ineligible|0|||
13403003|NCT00592683|26811447|FG001|Overall Study|Found ineligible|1|||
13403004|NCT00592683|26811446|FG000|Overall Study|Withdrawal by Subject|1|||
13403005|NCT00592683|26811447|FG001|Overall Study|Withdrawal by Subject|0|||
13403006|NCT00592683|26811446|FG000|Overall Study|Adverse Event|0|||
13403007|NCT00592683|26811447|FG001|Overall Study|Adverse Event|2|||
13403008|NCT00592683|26811446|FG000|Overall Study|Protocol Violation|1|||
13403009|NCT00592683|26811447|FG001|Overall Study|Protocol Violation|0|||
13403010|NCT00592683|26811446|FG000|Overall Study|Study drug expired|1|||
13403011|NCT00592683|26811447|FG001|Overall Study|Study drug expired|0|||
13403012|NCT00592683|26811446|FG000|Overall Study|Other|1|||
13403013|NCT00592683|26811447|FG001|Overall Study|Other|0|||
13403014|NCT00592683|26811446|FG000|Overall Study|Lost to Follow-up|0|||
13403015|NCT00592683|26811447|FG001|Overall Study|Lost to Follow-up|1|||
13403016|NCT00592631|26811460|FG000|Overall Study|Lost to Follow-up|0|||
13403017|NCT00592631|26811461|FG001|Overall Study|Lost to Follow-up|2|||
13403018|NCT00592553|26811545|FG000|Overall Study|Protocol Noncompliance|1|||
13403019|NCT00592553|26811546|FG001|Overall Study|Protocol Noncompliance|0|||
13403020|NCT00592553|26811547|FG002|Overall Study|Protocol Noncompliance|0|||
13403021|NCT00592501|26811562|FG000|Overall Study|Withdrawal by Subject|1|||
13403022|NCT00592501|26811562|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1|||
13403023|NCT00592384|26811577|FG000|Overall Study|Withdrawal by Subject|5|||
13403024|NCT00592384|26811578|FG001|Overall Study|Withdrawal by Subject|6|||
13403025|NCT00592358|26811585|FG000|Overall Study|Withdrawal by Subject|2|||
13403026|NCT00592358|26811585|FG000|Overall Study|Adverse Event|1|||
13403027|NCT00592358|26811585|FG000|Overall Study|Lack of Efficacy|2|||
13403028|NCT00592358|26811585|FG000|Overall Study|Inability to swallow pills|1|||
13403029|NCT00592319|26811600|FG000|Overall Study|Lost to Follow-up|0|||
13403030|NCT00592319|26811601|FG001|Overall Study|Lost to Follow-up|3|||
13403031|NCT00592072|26811626|FG000|Wash Out Period|Lost to Follow-up|1|||
13403032|NCT00592072|26811627|FG001|Wash Out Period|Lost to Follow-up|1|||
13403033|NCT00592007|26811634|FG000|Overall Study|Withdrawal by Subject|1|||
13403034|NCT00592007|26811634|FG000|Overall Study|patient ineligible (out of lab range)|1|||
13403035|NCT00591864|26811642|FG000|Overall Study|Incomplete Imaging|5|||
13403036|NCT00591851|26811648|FG000|Overall Study|Withdrawal by Subject|3|||
13403037|NCT00591851|26811648|FG000|Overall Study|Adverse Event|2|||
13403038|NCT00591851|26811648|FG000|Overall Study|Progressive Disease|1|||
13403039|NCT00591838|26811685|FG000|Overall Study|Withdrawal by Subject|0|||
13403040|NCT00591838|26811686|FG001|Overall Study|Withdrawal by Subject|0|||
13403041|NCT00591838|26811687|FG002|Overall Study|Withdrawal by Subject|0|||
13403042|NCT00591838|26811688|FG003|Overall Study|Withdrawal by Subject|1|||
13403043|NCT00591838|26811689|FG004|Overall Study|Withdrawal by Subject|0|||
13403044|NCT00591786|26811762|FG000|Overall Study|Withdrawal of Informed Consent|0|||
13403045|NCT00591786|26811763|FG001|Overall Study|Withdrawal of Informed Consent|0|||
13403046|NCT00591786|26811764|FG002|Overall Study|Withdrawal of Informed Consent|1|||
13403047|NCT00591786|26811765|FG003|Overall Study|Withdrawal of Informed Consent|0|||
13403048|NCT00591786|26811766|FG004|Overall Study|Withdrawal of Informed Consent|0|||
13403049|NCT00591786|26811767|FG005|Overall Study|Withdrawal of Informed Consent|0|||
13403050|NCT00591786|26811768|FG006|Overall Study|Withdrawal of Informed Consent|0|||
13403051|NCT00591786|26811769|FG007|Overall Study|Withdrawal of Informed Consent|0|||
13403052|NCT00591786|26811770|FG008|Overall Study|Withdrawal of Informed Consent|0|||
13403053|NCT00591786|26811771|FG009|Overall Study|Withdrawal of Informed Consent|0|||
13403054|NCT00591773|26811831|FG000|Overall Study|Adverse Event|9|||
13403055|NCT00591773|26811832|FG001|Overall Study|Adverse Event|9|||
13403056|NCT00591773|26811833|FG002|Overall Study|Adverse Event|6|||
13403057|NCT00591773|26811831|FG000|Overall Study|Protocol Violation|2|||
13403058|NCT00591773|26811832|FG001|Overall Study|Protocol Violation|3|||
13403059|NCT00591773|26811833|FG002|Overall Study|Protocol Violation|0|||
13403060|NCT00591773|26811831|FG000|Overall Study|Lost to Follow-up|1|||
13403061|NCT00591773|26811832|FG001|Overall Study|Lost to Follow-up|4|||
13403062|NCT00591773|26811833|FG002|Overall Study|Lost to Follow-up|1|||
13403063|NCT00591773|26811831|FG000|Overall Study|Withdrawal by Subject|2|||
13403064|NCT00591773|26811832|FG001|Overall Study|Withdrawal by Subject|5|||
13403065|NCT00591773|26811833|FG002|Overall Study|Withdrawal by Subject|3|||
13403066|NCT00591773|26811831|FG000|Overall Study|Lack of Efficacy|1|||
13403067|NCT00591773|26811832|FG001|Overall Study|Lack of Efficacy|2|||
13403068|NCT00591773|26811833|FG002|Overall Study|Lack of Efficacy|2|||
13403069|NCT00591773|26811831|FG000|Overall Study|Other|1|||
13403070|NCT00591773|26811832|FG001|Overall Study|Other|1|||
13403071|NCT00591773|26811833|FG002|Overall Study|Other|4|||
13403072|NCT00591734|26811841|FG000|Overall Study|Lack of Efficacy|35|||
13403073|NCT00591734|26811841|FG000|Overall Study|Adverse Event|5|||
13403074|NCT00591734|26811841|FG000|Overall Study|Physician Decision|5|||
13403075|NCT00591734|26811841|FG000|Overall Study|Intercurrent Illness|8|||
13403076|NCT00591721|26811854|FG000|Overall Study|Withdrawal by Subject|10|||
13403077|NCT00591721|26811855|FG001|Overall Study|Withdrawal by Subject|10|||
13403078|NCT00591721|26811854|FG000|Overall Study|Lost to Follow-up|1|||
13403079|NCT00591721|26811855|FG001|Overall Study|Lost to Follow-up|4|||
13403080|NCT00591721|26811854|FG000|Overall Study|Intervention not received|10|||
13403081|NCT00591721|26811855|FG001|Overall Study|Intervention not received|8|||
13403082|NCT00591630|26811878|FG000|Overall Study|Death|0|||
13403083|NCT00591630|26811879|FG001|Overall Study|Death|0|||
13403084|NCT00591630|26811880|FG002|Overall Study|Death|1|||
13403085|NCT00591630|26811881|FG003|Overall Study|Death|0|||
13403086|NCT00591591|26811902|FG000|Overall Study|Withdrawal by Subject|1|||
13403087|NCT00591591|26811903|FG001|Overall Study|Withdrawal by Subject|37|||
13403088|NCT00591591|26811902|FG000|Overall Study|Lack of Efficacy|10|||
13403089|NCT00591591|26811903|FG001|Overall Study|Lack of Efficacy|2|||
13403090|NCT00591578|26811964|FG000|Double-Blind Treatment Phase|Adverse Event|20|||
13403091|NCT00591578|26811965|FG001|Double-Blind Treatment Phase|Adverse Event|26|||
13403092|NCT00591578|26811966|FG002|Double-Blind Treatment Phase|Adverse Event|19|||
13403093|NCT00591578|26811964|FG000|Double-Blind Treatment Phase|Protocol Violation|3|||
13403094|NCT00591578|26811965|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
13403095|NCT00591578|26811966|FG002|Double-Blind Treatment Phase|Protocol Violation|3|||
13403096|NCT00591578|26811964|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12|||
13403097|NCT00591578|26811965|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12|||
13403098|NCT00591578|26811966|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11|||
13403099|NCT00591578|26811964|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
13403100|NCT00591578|26811965|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
13403101|NCT00591578|26811966|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
13403102|NCT00591578|26811964|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
13403103|NCT00591578|26811965|FG001|Double-Blind Treatment Phase|Pregnancy|0|||
13403104|NCT00591578|26811966|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
13403105|NCT00591578|26811964|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16|||
13403106|NCT00591578|26811965|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9|||
13403107|NCT00591578|26811966|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25|||
13403108|NCT00591578|26811964|FG000|Double-Blind Treatment Phase|Other|4|||
13403109|NCT00591578|26811965|FG001|Double-Blind Treatment Phase|Other|9|||
13403110|NCT00591578|26811966|FG002|Double-Blind Treatment Phase|Other|4|||
13403111|NCT00591578|26811964|FG000|Open-Label Extension Phase|Adverse Event|3|||
13403112|NCT00591578|26811965|FG001|Open-Label Extension Phase|Adverse Event|5|||
13403113|NCT00591578|26811966|FG002|Open-Label Extension Phase|Adverse Event|0|||
13403114|NCT00591578|26811964|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
13403115|NCT00591578|26811965|FG001|Open-Label Extension Phase|Lost to Follow-up|4|||
13403116|NCT00591578|26811966|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
13403117|NCT00591578|26811964|FG000|Open-Label Extension Phase|Withdrawal by Subject|1|||
13403118|NCT00591578|26811965|FG001|Open-Label Extension Phase|Withdrawal by Subject|1|||
13403119|NCT00591578|26811966|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
13403120|NCT00591578|26811964|FG000|Open-Label Extension Phase|Other|1|||
13403121|NCT00591578|26811965|FG001|Open-Label Extension Phase|Other|0|||
13403122|NCT00591578|26811966|FG002|Open-Label Extension Phase|Other|0|||
13403123|NCT00591565|26811972|FG000|Overall Study|lost follow up, withdrawn|5|||
13403124|NCT00591409|26812045|FG000|Overall Study|Not Treated|0|||
13403125|NCT00591409|26812046|FG001|Overall Study|Not Treated|0|||
13403126|NCT00591409|26812047|FG002|Overall Study|Not Treated|0|||
13403127|NCT00591409|26812048|FG003|Overall Study|Not Treated|0|||
13403128|NCT00591409|26812049|FG004|Overall Study|Not Treated|1|||
13403129|NCT00591409|26812050|FG005|Overall Study|Not Treated|0|||
13403130|NCT00591409|26812051|FG006|Overall Study|Not Treated|0|||
13403131|NCT00591409|26812052|FG007|Overall Study|Not Treated|0|||
13403132|NCT00591409|26812053|FG008|Overall Study|Not Treated|0|||
13403133|NCT00591409|26812054|FG009|Overall Study|Not Treated|1|||
13403134|NCT00591370|26812062|FG000|Overall Study|Not Treated|2|||
13403135|NCT00591344|26812079|FG000|Overall Study|Transportation issues|1|||
13403136|NCT00591344|26812080|FG001|Overall Study|Transportation issues|0|||
13403137|NCT00591344|26812079|FG000|Overall Study|Moved out of state|1|||
13403138|NCT00591344|26812080|FG001|Overall Study|Moved out of state|0|||
13403139|NCT00591344|26812079|FG000|Overall Study|Medical complications|1|||
13403140|NCT00591344|26812080|FG001|Overall Study|Medical complications|3|||
13403141|NCT00591344|26812079|FG000|Overall Study|Underwent DBS|2|||
13403142|NCT00591344|26812080|FG001|Overall Study|Underwent DBS|2|||
13403143|NCT00591344|26812079|FG000|Overall Study|Death|0|||
13403144|NCT00591344|26812080|FG001|Overall Study|Death|1|||
13403145|NCT00591344|26812079|FG000|Overall Study|Lost to Follow-up|0|||
13403146|NCT00591344|26812080|FG001|Overall Study|Lost to Follow-up|1|||
13403147|NCT00591344|26812079|FG000|Overall Study|Did not want to come off medication|0|||
13403148|NCT00591344|26812080|FG001|Overall Study|Did not want to come off medication|1|||
13403149|NCT00591266|26812140|FG000|Overall Study|Adverse Event|2|||
13403150|NCT00591266|26812141|FG001|Overall Study|Adverse Event|2|||
13403151|NCT00591266|26812142|FG002|Overall Study|Adverse Event|3|||
13403152|NCT00591266|26812140|FG000|Overall Study|Lost to Follow-up|0|||
13403153|NCT00591266|26812141|FG001|Overall Study|Lost to Follow-up|1|||
13403154|NCT00591266|26812142|FG002|Overall Study|Lost to Follow-up|0|||
13403155|NCT00591266|26812140|FG000|Overall Study|Protocol Violation|0|||
13403156|NCT00591266|26812141|FG001|Overall Study|Protocol Violation|0|||
13403157|NCT00591266|26812142|FG002|Overall Study|Protocol Violation|1|||
13403158|NCT00591266|26812140|FG000|Overall Study|Withdrawal by Subject|6|||
13403159|NCT00591266|26812141|FG001|Overall Study|Withdrawal by Subject|2|||
13403160|NCT00591266|26812142|FG002|Overall Study|Withdrawal by Subject|5|||
13403161|NCT00591266|26812140|FG000|Overall Study|Lack of Efficacy|0|||
13403162|NCT00591266|26812141|FG001|Overall Study|Lack of Efficacy|2|||
13403163|NCT00591266|26812142|FG002|Overall Study|Lack of Efficacy|0|||
13403164|NCT00591266|26812140|FG000|Overall Study|Other|1|||
13403165|NCT00591266|26812141|FG001|Overall Study|Other|4|||
13403166|NCT00591266|26812142|FG002|Overall Study|Other|5|||
13403167|NCT00591253|26812202|FG000|Overall Study|Adverse Event|3|||
13403168|NCT00591253|26812203|FG001|Overall Study|Adverse Event|3|||
13403169|NCT00591253|26812204|FG002|Overall Study|Adverse Event|1|||
13403170|NCT00591253|26812202|FG000|Overall Study|Protocol Violation|2|||
13403171|NCT00591253|26812203|FG001|Overall Study|Protocol Violation|2|||
13403172|NCT00591253|26812204|FG002|Overall Study|Protocol Violation|2|||
13403173|NCT00591253|26812202|FG000|Overall Study|Lost to Follow-up|2|||
13403174|NCT00591253|26812203|FG001|Overall Study|Lost to Follow-up|4|||
13403175|NCT00591253|26812204|FG002|Overall Study|Lost to Follow-up|0|||
13403176|NCT00591253|26812202|FG000|Overall Study|Withdrawal by Subject|1|||
13403177|NCT00591253|26812203|FG001|Overall Study|Withdrawal by Subject|7|||
13403178|NCT00591253|26812204|FG002|Overall Study|Withdrawal by Subject|6|||
13403179|NCT00591253|26812202|FG000|Overall Study|Lack of Efficacy|1|||
13403180|NCT00591253|26812203|FG001|Overall Study|Lack of Efficacy|0|||
13403181|NCT00591253|26812204|FG002|Overall Study|Lack of Efficacy|3|||
13403182|NCT00591253|26812202|FG000|Overall Study|Other|5|||
13403183|NCT00591253|26812203|FG001|Overall Study|Other|5|||
13403184|NCT00591253|26812204|FG002|Overall Study|Other|3|||
13403185|NCT00591214|26812215|FG000|Overall Study|Physician Decision|7|||
13403186|NCT00591214|26812215|FG000|Overall Study|Withdrawal by Subject|1|||
13403187|NCT00591149|26812221|FG000|Overall Study|Adverse Event|4|||
13403188|NCT00591149|26812221|FG000|Overall Study|Withdrawal by Subject|1|||
13403189|NCT00591006|26812264|FG000|Overall Study|Withdrawal by Subject|0|||
13403190|NCT00591006|26812265|FG001|Overall Study|Withdrawal by Subject|0|||
13403191|NCT00591006|26812266|FG002|Overall Study|Withdrawal by Subject|0|||
13403192|NCT00591006|26812267|FG003|Overall Study|Withdrawal by Subject|0|||
13403193|NCT00591006|26812268|FG004|Overall Study|Withdrawal by Subject|0|||
13403194|NCT00591006|26812269|FG005|Overall Study|Withdrawal by Subject|0|||
13403195|NCT00591006|26812270|FG006|Overall Study|Withdrawal by Subject|0|||
13403196|NCT00591006|26812271|FG007|Overall Study|Withdrawal by Subject|0|||
13403197|NCT00591006|26812272|FG008|Overall Study|Withdrawal by Subject|0|||
13403198|NCT00591006|26812273|FG009|Overall Study|Withdrawal by Subject|0|||
13403199|NCT00591006|26812274|FG010|Overall Study|Withdrawal by Subject|0|||
13403200|NCT00591006|26812275|FG011|Overall Study|Withdrawal by Subject|0|||
13403201|NCT00591006|26812276|FG012|Overall Study|Withdrawal by Subject|0|||
13403202|NCT00591006|26812277|FG013|Overall Study|Withdrawal by Subject|0|||
13403203|NCT00591006|26812278|FG014|Overall Study|Withdrawal by Subject|0|||
13403204|NCT00591006|26812279|FG015|Overall Study|Withdrawal by Subject|1|||
13403205|NCT00591006|26812280|FG016|Overall Study|Withdrawal by Subject|0|||
13403206|NCT00591006|26812281|FG017|Overall Study|Withdrawal by Subject|0|||
13403207|NCT00591006|26812282|FG018|Overall Study|Withdrawal by Subject|0|||
13403208|NCT00591006|26812283|FG019|Overall Study|Withdrawal by Subject|0|||
13403209|NCT00591006|26812284|FG020|Overall Study|Withdrawal by Subject|0|||
13403210|NCT00591006|26812285|FG021|Overall Study|Withdrawal by Subject|0|||
13403211|NCT00591006|26812286|FG022|Overall Study|Withdrawal by Subject|0|||
13403212|NCT00591006|26812287|FG023|Overall Study|Withdrawal by Subject|1|||
13403213|NCT00591006|26812264|FG000|Overall Study|Adverse Event|0|||
13403214|NCT00591006|26812265|FG001|Overall Study|Adverse Event|0|||
13403215|NCT00591006|26812266|FG002|Overall Study|Adverse Event|0|||
13403216|NCT00591006|26812267|FG003|Overall Study|Adverse Event|0|||
13403217|NCT00591006|26812268|FG004|Overall Study|Adverse Event|0|||
13403218|NCT00591006|26812269|FG005|Overall Study|Adverse Event|0|||
13403219|NCT00591006|26812270|FG006|Overall Study|Adverse Event|0|||
13403220|NCT00591006|26812271|FG007|Overall Study|Adverse Event|0|||
13403221|NCT00591006|26812272|FG008|Overall Study|Adverse Event|0|||
13403222|NCT00591006|26812273|FG009|Overall Study|Adverse Event|0|||
13403223|NCT00591006|26812274|FG010|Overall Study|Adverse Event|0|||
13403224|NCT00591006|26812275|FG011|Overall Study|Adverse Event|0|||
13403225|NCT00591006|26812276|FG012|Overall Study|Adverse Event|0|||
13403226|NCT00591006|26812277|FG013|Overall Study|Adverse Event|0|||
13403227|NCT00591006|26812278|FG014|Overall Study|Adverse Event|0|||
13403228|NCT00591006|26812279|FG015|Overall Study|Adverse Event|0|||
13403229|NCT00591006|26812280|FG016|Overall Study|Adverse Event|0|||
13403230|NCT00591006|26812281|FG017|Overall Study|Adverse Event|0|||
13403231|NCT00591006|26812282|FG018|Overall Study|Adverse Event|0|||
13403232|NCT00591006|26812283|FG019|Overall Study|Adverse Event|0|||
13403233|NCT00591006|26812284|FG020|Overall Study|Adverse Event|0|||
13403234|NCT00591006|26812285|FG021|Overall Study|Adverse Event|0|||
13403235|NCT00591006|26812286|FG022|Overall Study|Adverse Event|1|||
13403236|NCT00591006|26812287|FG023|Overall Study|Adverse Event|0|||
13403237|NCT00590980|26812293|FG000|Overall Study|Did not meet all inclusion criteria|10|||
13403238|NCT00590967|26812312|FG000|Overall Study|Withdrawal by Subject|1|||
13403239|NCT00590967|26812313|FG001|Overall Study|Withdrawal by Subject|1|||
13403240|NCT00590967|26812312|FG000|Overall Study|Ineligible|1|||
13403241|NCT00590967|26812313|FG001|Overall Study|Ineligible|0|||
13403242|NCT00590967|26812312|FG000|Overall Study|Poor performance status|0|||
13403243|NCT00590967|26812313|FG001|Overall Study|Poor performance status|1|||
13403244|NCT00590967|26812312|FG000|Overall Study|Non-compliant|0|||
13403245|NCT00590967|26812313|FG001|Overall Study|Non-compliant|2|||
13403246|NCT00590967|26812312|FG000|Overall Study|Did not sign consent form|0|||
13403247|NCT00590967|26812313|FG001|Overall Study|Did not sign consent form|1|||
13403248|NCT00590967|26812312|FG000|Overall Study|Did not receive chemo per protocol|1|||
13403249|NCT00590967|26812313|FG001|Overall Study|Did not receive chemo per protocol|0|||
13403250|NCT00590954|26812321|FG000|Overall Study|Inevaluable|2|||
13403251|NCT00590902|26812327|FG000|Overall Study|Death|1|||
13403252|NCT00590824|26812360|FG000|Overall Study|Disease could not be resected|0|||
13403253|NCT00590824|26812361|FG001|Overall Study|Disease could not be resected|2|||
13403254|NCT00590824|26812362|FG002|Overall Study|Disease could not be resected|1|||
13403255|NCT00590824|26812363|FG003|Overall Study|Disease could not be resected|0|||
13403256|NCT00590824|26812360|FG000|Overall Study|Adverse Event|0|||
13403257|NCT00590824|26812361|FG001|Overall Study|Adverse Event|0|||
13403258|NCT00590824|26812362|FG002|Overall Study|Adverse Event|0|||
13403259|NCT00590824|26812363|FG003|Overall Study|Adverse Event|1|||
13403260|NCT00590759|26812370|FG000|Overall Study|Death|52|||
13403261|NCT00590759|26812370|FG000|Overall Study|Lost to Follow-up|28|||
13403262|NCT00590720|26812419|FG000|Overall Study|Lost to Follow-up|1|||
13403263|NCT00590720|26812420|FG001|Overall Study|Lost to Follow-up|0|||
13403264|NCT00590720|26812419|FG000|Overall Study|Withdrawal by Subject|0|||
13403265|NCT00590720|26812420|FG001|Overall Study|Withdrawal by Subject|1|||
13403266|NCT00590681|26812431|FG000|Overall Study|Withdrawal by Subject|7|||
13403267|NCT00590681|26812431|FG000|Overall Study|Adverse Event|8|||
13403268|NCT00590681|26812431|FG000|Overall Study|Death|3|||
13403269|NCT00590681|26812431|FG000|Overall Study|Lost to Follow-up|1|||
13403270|NCT00590681|26812431|FG000|Overall Study|disease progression|1|||
13403271|NCT00590590|26812464|FG000|Overall Study|Lack of Efficacy|1|||
13403272|NCT00590590|26812465|FG001|Overall Study|Lack of Efficacy|2|||
13403273|NCT00590590|26812466|FG002|Overall Study|Lack of Efficacy|0|||
13403274|NCT00590590|26812464|FG000|Overall Study|Adverse Event|1|||
13403275|NCT00590590|26812465|FG001|Overall Study|Adverse Event|0|||
13403276|NCT00590590|26812466|FG002|Overall Study|Adverse Event|0|||
13403277|NCT00590590|26812464|FG000|Overall Study|Protocol Violation|0|||
13403278|NCT00590590|26812465|FG001|Overall Study|Protocol Violation|0|||
13403279|NCT00590590|26812466|FG002|Overall Study|Protocol Violation|2|||
13403280|NCT00590590|26812464|FG000|Overall Study|Lost to Follow-up|4|||
13403281|NCT00590590|26812465|FG001|Overall Study|Lost to Follow-up|1|||
13403282|NCT00590590|26812466|FG002|Overall Study|Lost to Follow-up|2|||
13403283|NCT00590590|26812464|FG000|Overall Study|Withdrawal by Subject|0|||
13403284|NCT00590590|26812465|FG001|Overall Study|Withdrawal by Subject|1|||
13403285|NCT00590590|26812466|FG002|Overall Study|Withdrawal by Subject|1|||
13403286|NCT00590590|26812464|FG000|Overall Study|Did not complete due to study closure|1|||
13403287|NCT00590590|26812465|FG001|Overall Study|Did not complete due to study closure|1|||
13403288|NCT00590590|26812466|FG002|Overall Study|Did not complete due to study closure|1|||
13403289|NCT00590590|26812464|FG000|Overall Study|Did not complete study|0|||
13403290|NCT00590590|26812465|FG001|Overall Study|Did not complete study|1|||
13403291|NCT00590590|26812466|FG002|Overall Study|Did not complete study|0|||
13403292|NCT00590577|26812497|FG000|Overall Study|Lack of Efficacy|31|||
13403293|NCT00590577|26812498|FG001|Overall Study|Lack of Efficacy|28|||
13403294|NCT00590577|26812499|FG002|Overall Study|Lack of Efficacy|23|||
13403295|NCT00590577|26812500|FG003|Overall Study|Lack of Efficacy|45|||
13403296|NCT00590577|26812497|FG000|Overall Study|Withdrawal by Subject|23|||
13403297|NCT00590577|26812498|FG001|Overall Study|Withdrawal by Subject|28|||
13403298|NCT00590577|26812499|FG002|Overall Study|Withdrawal by Subject|30|||
13403299|NCT00590577|26812500|FG003|Overall Study|Withdrawal by Subject|26|||
13403300|NCT00590577|26812497|FG000|Overall Study|Adverse Event|10|||
13403301|NCT00590577|26812498|FG001|Overall Study|Adverse Event|10|||
13403302|NCT00590577|26812499|FG002|Overall Study|Adverse Event|13|||
13403303|NCT00590577|26812500|FG003|Overall Study|Adverse Event|11|||
13403304|NCT00590577|26812497|FG000|Overall Study|Lost to Follow-up|12|||
13403305|NCT00590577|26812498|FG001|Overall Study|Lost to Follow-up|6|||
13403306|NCT00590577|26812499|FG002|Overall Study|Lost to Follow-up|6|||
13403307|NCT00590577|26812500|FG003|Overall Study|Lost to Follow-up|9|||
13403308|NCT00590577|26812497|FG000|Overall Study|Pregnancy|0|||
13403309|NCT00590577|26812498|FG001|Overall Study|Pregnancy|1|||
13403310|NCT00590577|26812499|FG002|Overall Study|Pregnancy|0|||
13403311|NCT00590577|26812500|FG003|Overall Study|Pregnancy|0|||
13403312|NCT00590577|26812497|FG000|Overall Study|Various reasons|1|||
13403313|NCT00590577|26812498|FG001|Overall Study|Various reasons|3|||
13403314|NCT00590577|26812499|FG002|Overall Study|Various reasons|1|||
13403315|NCT00590577|26812500|FG003|Overall Study|Various reasons|2|||
13403316|NCT00590564|26812506|FG000|Overall Study|Withdrawal by Subject|4|||
13403317|NCT00590564|26812506|FG000|Overall Study|Lost to Follow-up|6|||
13403318|NCT00590564|26812506|FG000|Overall Study|Protocol Violation|1|||
13403319|NCT00590564|26812506|FG000|Overall Study|Patient Found to be Ineligible|1|||
13403320|NCT00590564|26812506|FG000|Overall Study|Patient Non-compliance|6|||
13403321|NCT00590538|26812516|FG000|Overall Study|Study terminated before completed|2|||
13403322|NCT00590317|26812533|FG000|Overall Study|Lack of Efficacy|1|||
13403323|NCT00590317|26812534|FG001|Overall Study|Lack of Efficacy|5|||
13403324|NCT00590135|26812544|FG000|Overall Study|Primary endpoint measure not obtainable|59|||
13403325|NCT00590044|26812563|FG000|Overall Study|Withdrawal by Subject|2|||
13403326|NCT00590044|26812564|FG001|Overall Study|Withdrawal by Subject|2|||
13403327|NCT00590044|26812563|FG000|Overall Study|wrong insulin arm assigned|1|||
13403328|NCT00590044|26812564|FG001|Overall Study|wrong insulin arm assigned|0|||
13403329|NCT00590044|26812563|FG000|Overall Study|Protocol Violation|1|||
13403330|NCT00590044|26812564|FG001|Overall Study|Protocol Violation|0|||
13403331|NCT00590031|26812571|FG000|Overall Study|Adverse Event|3|||
13403332|NCT00590031|26812571|FG000|Overall Study|Withdrawal by Subject|1|||
13403333|NCT00590031|26812571|FG000|Overall Study|Metastatic Disease|1|||
13403334|NCT00590031|26812571|FG000|Overall Study|Admin Hold|1|||
13403335|NCT00589979|26812616|FG000|Run-In Period|Adverse Event|5|||
13403336|NCT00589979|26812617|FG001|Run-In Period|Adverse Event|0|||
13403337|NCT00589979|26812618|FG002|Run-In Period|Adverse Event|0|||
13403338|NCT00589979|26812616|FG000|Run-In Period|Protocol Violation|3|||
13403339|NCT00589979|26812617|FG001|Run-In Period|Protocol Violation|0|||
13403340|NCT00589979|26812618|FG002|Run-In Period|Protocol Violation|0|||
13403341|NCT00589979|26812616|FG000|Run-In Period|Did not qualify for randomization|54|||
13403342|NCT00589979|26812617|FG001|Run-In Period|Did not qualify for randomization|0|||
13403343|NCT00589979|26812618|FG002|Run-In Period|Did not qualify for randomization|0|||
13403344|NCT00589979|26812616|FG000|Run-In Period|Withdrawal by Subject|10|||
13403345|NCT00589979|26812617|FG001|Run-In Period|Withdrawal by Subject|0|||
13403346|NCT00589979|26812618|FG002|Run-In Period|Withdrawal by Subject|0|||
13403347|NCT00589979|26812616|FG000|Run-In Period|Informed Consent Withdrawn|4|||
13403348|NCT00589979|26812617|FG001|Run-In Period|Informed Consent Withdrawn|0|||
13403349|NCT00589979|26812618|FG002|Run-In Period|Informed Consent Withdrawn|0|||
13403350|NCT00589979|26812616|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
13403351|NCT00589979|26812617|FG001|Double-Blind Treatment Period 1|Adverse Event|1|||
13403352|NCT00589979|26812618|FG002|Double-Blind Treatment Period 1|Adverse Event|0|||
13403353|NCT00589979|26812616|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
13403354|NCT00589979|26812617|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
13403355|NCT00589979|26812618|FG002|Double-Blind Treatment Period 1|Protocol Violation|1|||
13403356|NCT00589979|26812616|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
13403357|NCT00589979|26812617|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
13403358|NCT00589979|26812618|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1|||
13403359|NCT00589979|26812616|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
13403360|NCT00589979|26812617|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
13403361|NCT00589979|26812618|FG002|Double-Blind Treatment Period 2|Adverse Event|0|||
13403362|NCT00589979|26812616|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
13403363|NCT00589979|26812617|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
13403364|NCT00589979|26812618|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
13403365|NCT00589979|26812616|FG000|Double-Blind Treatment Period 2|Other|0|||
13403366|NCT00589979|26812617|FG001|Double-Blind Treatment Period 2|Other|0|||
13403367|NCT00589979|26812618|FG002|Double-Blind Treatment Period 2|Other|1|||
13403368|NCT00589979|26812616|FG000|Double-Blind Treatment Period 3|Protocol Violation|0|||
13403369|NCT00589979|26812617|FG001|Double-Blind Treatment Period 3|Protocol Violation|1|||
13403370|NCT00589979|26812618|FG002|Double-Blind Treatment Period 3|Protocol Violation|0|||
13403371|NCT00589979|26812616|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
13403372|NCT00589979|26812617|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
13403373|NCT00589979|26812618|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1|||
13403374|NCT00589914|26812635|FG000|Overall Study|Adverse Event|19|||
13403375|NCT00589914|26812636|FG001|Overall Study|Adverse Event|10|||
13403376|NCT00589914|26812635|FG000|Overall Study|Death|2|||
13403377|NCT00589914|26812636|FG001|Overall Study|Death|0|||
13403378|NCT00589914|26812635|FG000|Overall Study|Lack of Efficacy|40|||
13403379|NCT00589914|26812636|FG001|Overall Study|Lack of Efficacy|43|||
13403380|NCT00589914|26812635|FG000|Overall Study|Lost to Follow-up|11|||
13403381|NCT00589914|26812636|FG001|Overall Study|Lost to Follow-up|18|||
13403382|NCT00589914|26812635|FG000|Overall Study|Pregnancy|1|||
13403383|NCT00589914|26812636|FG001|Overall Study|Pregnancy|0|||
13403384|NCT00589914|26812635|FG000|Overall Study|Withdrawal by Subject|55|||
13403385|NCT00589914|26812636|FG001|Overall Study|Withdrawal by Subject|49|||
13403386|NCT00589914|26812635|FG000|Overall Study|Other|22|||
13403387|NCT00589914|26812636|FG001|Overall Study|Other|17|||
13403388|NCT00589797|26812665|FG000|Overall Study|Death|1|||
13403389|NCT00589797|26812666|FG001|Overall Study|Death|0|||
13403390|NCT00589797|26812665|FG000|Overall Study|Lost to Follow-up|12|||
13403391|NCT00589797|26812666|FG001|Overall Study|Lost to Follow-up|9|||
13403392|NCT00589797|26812665|FG000|Overall Study|Physician Decision|8|||
13403393|NCT00589797|26812666|FG001|Overall Study|Physician Decision|3|||
13403394|NCT00589797|26812665|FG000|Overall Study|Withdrawal by Subject|6|||
13403395|NCT00589797|26812666|FG001|Overall Study|Withdrawal by Subject|5|||
13403396|NCT00589797|26812665|FG000|Overall Study|Non-Randomized Training Subjects|46|||
13403397|NCT00589797|26812666|FG001|Overall Study|Non-Randomized Training Subjects|6|||
13403398|NCT00589784|26812678|FG000|Overall Study|Withdrawal by Subject|0|||
13403399|NCT00589784|26812679|FG001|Overall Study|Withdrawal by Subject|6|||
13403400|NCT00589784|26812678|FG000|Overall Study|Patient inevaluable|1|||
13403401|NCT00589784|26812679|FG001|Overall Study|Patient inevaluable|0|||
13403402|NCT00589784|26812678|FG000|Overall Study|Adverse Event|0|||
13403403|NCT00589784|26812679|FG001|Overall Study|Adverse Event|4|||
13403404|NCT00589693|26812700|FG000|Overall Study|randomized in error|12|||
13403405|NCT00589693|26812701|FG001|Overall Study|randomized in error|6|||
13403406|NCT00589693|26812700|FG000|Overall Study|Adverse Event|4|||
13403407|NCT00589693|26812701|FG001|Overall Study|Adverse Event|4|||
13403408|NCT00589693|26812700|FG000|Overall Study|Death|26|||
13403409|NCT00589693|26812701|FG001|Overall Study|Death|16|||
13403410|NCT00589693|26812700|FG000|Overall Study|Lack of Efficacy|0|||
13403411|NCT00589693|26812701|FG001|Overall Study|Lack of Efficacy|1|||
13403412|NCT00589693|26812700|FG000|Overall Study|Lost to Follow-up|1|||
13403413|NCT00589693|26812701|FG001|Overall Study|Lost to Follow-up|0|||
13403414|NCT00589693|26812700|FG000|Overall Study|Physician Decision|0|||
13403415|NCT00589693|26812701|FG001|Overall Study|Physician Decision|1|||
13403416|NCT00589693|26812700|FG000|Overall Study|Protocol Violation|1|||
13403417|NCT00589693|26812701|FG001|Overall Study|Protocol Violation|1|||
13403418|NCT00589667|26812708|FG000|Overall Study|Adverse Event|2|||
13403419|NCT00589667|26812708|FG000|Overall Study|Withdrawal by Subject|1|||
13403420|NCT00589628|26812721|FG000|Overall Study|Lost to Follow-up|0|||
13403421|NCT00589628|26812722|FG001|Overall Study|Lost to Follow-up|1|||
13403422|NCT00589602|26812732|FG000|Overall Study|Did not collect enough CD34+ cells|1|||
13403423|NCT00589472|26812744|FG000|Overall Study|Adverse Event|1|||
13403424|NCT00589420|26812752|FG000|Overall Study|screen failure|1|||
13403425|NCT00589303|26812765|FG000|Overall Study|Withdrawal by Subject|2|||
13403426|NCT00589303|26812766|FG001|Overall Study|Withdrawal by Subject|1|||
13403427|NCT00589290|26812776|FG000|Overall Study|Withdrawal by Subject|1|||
13403428|NCT00589121|26812802|FG000|Overall Study|Protocol Violation|2|||
13403429|NCT00589121|26812803|FG001|Overall Study|Protocol Violation|6|||
13403430|NCT00589121|26812802|FG000|Overall Study|No protocol treatment received|0|||
13403431|NCT00589121|26812803|FG001|Overall Study|No protocol treatment received|1|||
13403432|NCT00589108|26812833|FG000|Overall Study|Lost to Follow-up|1|||
13403433|NCT00589108|26812834|FG001|Overall Study|Lost to Follow-up|1|||
13403434|NCT00589108|26812835|FG002|Overall Study|Lost to Follow-up|1|||
13403435|NCT00589108|26812833|FG000|Overall Study|Death|3|||
13403436|NCT00589108|26812834|FG001|Overall Study|Death|3|||
13403437|NCT00589108|26812835|FG002|Overall Study|Death|4|||
13403438|NCT00588952|26812862|FG000|Overall Study|Adverse Event|0|||
13403439|NCT00588952|26812863|FG001|Overall Study|Adverse Event|2|||
13403440|NCT00588952|26812862|FG000|Overall Study|Withdrawal by Subject|3|||
13403441|NCT00588952|26812863|FG001|Overall Study|Withdrawal by Subject|5|||
13403442|NCT00588861|26812878|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95|||
13403443|NCT00588861|26812879|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86|||
13403444|NCT00588861|26812878|FG000|6 Months|Patients did not return for follow-up|98|||
13403445|NCT00588861|26812879|FG001|6 Months|Patients did not return for follow-up|73|||
13403446|NCT00588861|26812878|FG000|1 Year|Patients did not return for follow-up|89|||
13403447|NCT00588861|26812879|FG001|1 Year|Patients did not return for follow-up|82|||
13403448|NCT00588861|26812878|FG000|2 Years|Patients did not return for follow-up|92|||
13403449|NCT00588861|26812879|FG001|2 Years|Patients did not return for follow-up|87|||
13403450|NCT00588861|26812878|FG000|4 Years|Patients did not return for follow-up|91|||
13403451|NCT00588861|26812879|FG001|4 Years|Patients did not return for follow-up|103|||
13403452|NCT00588861|26812878|FG000|6 Years|Patients did not return for follow-up|104|||
13403453|NCT00588861|26812879|FG001|6 Years|Patients did not return for follow-up|109|||
13403454|NCT00588861|26812878|FG000|8 Years|Patients did not return for follow-up|105|||
13403455|NCT00588861|26812879|FG001|8 Years|Patients did not return for follow-up|114|||
13403456|NCT00588861|26812878|FG000|10 Years|Incomplete due to study termination|107|||
13403457|NCT00588861|26812879|FG001|10 Years|Incomplete due to study termination|114|||
13403458|NCT00588848|26812896|FG000|Overall Study|Physician Decision|0|||
13403459|NCT00588848|26812897|FG001|Overall Study|Physician Decision|3|||
13403460|NCT00588822|26812908|FG000|Overall Study|progression of disease|8|||
13403461|NCT00588731|26812923|FG000|Overall Study|Withdrawal by Subject|3|||
13403462|NCT00588731|26812924|FG001|Overall Study|Withdrawal by Subject|2|||
13476099|NCT01982630|27002259|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0|||
13476100|NCT01982630|27002252|FG000|Overall Study|Withdrawal by Subject|0|||
13476101|NCT01982630|27002253|FG001|Overall Study|Withdrawal by Subject|0|||
13476102|NCT01982630|27002254|FG002|Overall Study|Withdrawal by Subject|0|||
13476103|NCT01982630|27002255|FG003|Overall Study|Withdrawal by Subject|0|||
13476104|NCT01982630|27002256|FG004|Overall Study|Withdrawal by Subject|0|||
13476105|NCT01982630|27002257|FG005|Overall Study|Withdrawal by Subject|1|||
13476106|NCT01982630|27002258|FG006|Overall Study|Withdrawal by Subject|0|||
13476107|NCT01982630|27002259|FG007|Overall Study|Withdrawal by Subject|0|||
13476108|NCT01982448|27002284|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
13476109|NCT01982448|27002285|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2|||
13476110|NCT01982448|27002284|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1|||
13476111|NCT01982448|27002285|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0|||
13476112|NCT01982448|27002284|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0|||
13476113|NCT01982448|27002285|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2|||
13476114|NCT01982448|27002284|FG000|Preoperative Chemotherapy|Lost to Follow-up|0|||
13476115|NCT01982448|27002285|FG001|Preoperative Chemotherapy|Lost to Follow-up|1|||
13476116|NCT01752920|27002334|FG000|Overall Study|Adverse Event|1|||
13476117|NCT01752920|27002335|FG001|Overall Study|Adverse Event|0|||
13476118|NCT01752920|27002336|FG002|Overall Study|Adverse Event|5|||
13476119|NCT01752920|27002337|FG003|Overall Study|Adverse Event|10|||
13476120|NCT01752920|27002334|FG000|Overall Study|Clinical Disease Progression|6|||
13476121|NCT01752920|27002335|FG001|Overall Study|Clinical Disease Progression|4|||
13476122|NCT01752920|27002336|FG002|Overall Study|Clinical Disease Progression|1|||
13476123|NCT01752920|27002337|FG003|Overall Study|Clinical Disease Progression|13|||
13476124|NCT01752920|27002334|FG000|Overall Study|Physician Decision|1|||
13476125|NCT01752920|27002335|FG001|Overall Study|Physician Decision|0|||
13476126|NCT01752920|27002336|FG002|Overall Study|Physician Decision|0|||
13476127|NCT01752920|27002337|FG003|Overall Study|Physician Decision|3|||
13476128|NCT01752920|27002334|FG000|Overall Study|Radiographic Disease Progression|20|||
13476129|NCT01752920|27002335|FG001|Overall Study|Radiographic Disease Progression|7|||
13476130|NCT01752920|27002336|FG002|Overall Study|Radiographic Disease Progression|12|||
13476131|NCT01752920|27002337|FG003|Overall Study|Radiographic Disease Progression|29|||
13476132|NCT01752920|27002334|FG000|Overall Study|Study Terminated by Sponsor|0|||
13476133|NCT01752920|27002335|FG001|Overall Study|Study Terminated by Sponsor|0|||
13476134|NCT01752920|27002336|FG002|Overall Study|Study Terminated by Sponsor|0|||
13476135|NCT01752920|27002337|FG003|Overall Study|Study Terminated by Sponsor|1|||
13476136|NCT01752920|27002334|FG000|Overall Study|Withdrawal by Subject|0|||
13476137|NCT01752920|27002335|FG001|Overall Study|Withdrawal by Subject|1|||
13476138|NCT01752920|27002336|FG002|Overall Study|Withdrawal by Subject|0|||
13476139|NCT01752920|27002337|FG003|Overall Study|Withdrawal by Subject|1|||
13476140|NCT01752920|27002334|FG000|Overall Study|Lack of clinical benefit|1|||
13476141|NCT01752920|27002335|FG001|Overall Study|Lack of clinical benefit|1|||
13476142|NCT01752920|27002336|FG002|Overall Study|Lack of clinical benefit|1|||
13476143|NCT01752920|27002337|FG003|Overall Study|Lack of clinical benefit|1|||
13476144|NCT01740297|27002383|FG000|Overall Study|Withdrawal by Subject|4|||
13476145|NCT01740297|27002384|FG001|Overall Study|Withdrawal by Subject|16|||
13476146|NCT01740297|27002385|FG002|Overall Study|Withdrawal by Subject|17|||
13476147|NCT01740297|27002383|FG000|Overall Study|Death|8|||
13476148|NCT01740297|27002384|FG001|Overall Study|Death|46|||
13476149|NCT01740297|27002385|FG002|Overall Study|Death|40|||
13476150|NCT01740297|27002383|FG000|Overall Study|Lost to Follow-up|1|||
13476151|NCT01740297|27002384|FG001|Overall Study|Lost to Follow-up|2|||
13476152|NCT01740297|27002385|FG002|Overall Study|Lost to Follow-up|4|||
13476153|NCT01729754|27002608|FG000|Part 1|Adverse Event|2|||
13476154|NCT01729754|27002609|FG001|Part 1|Adverse Event|0|||
13476155|NCT01729754|27002610|FG002|Part 1|Adverse Event|0|||
13476156|NCT01729754|27002611|FG003|Part 1|Adverse Event|1|||
13476157|NCT01729754|27002612|FG004|Part 1|Adverse Event|0|||
13476158|NCT01729754|27002613|FG005|Part 1|Adverse Event|0|||
13476159|NCT01729754|27002614|FG006|Part 1|Adverse Event|2|||
13476160|NCT01729754|27002615|FG007|Part 1|Adverse Event|0|||
13476161|NCT01729754|27002616|FG008|Part 1|Adverse Event|0|||
13476162|NCT01729754|27002617|FG009|Part 1|Adverse Event|5|||
13476163|NCT01729754|27002608|FG000|Part 1|Lack of Efficacy|1|||
13476164|NCT01729754|27002609|FG001|Part 1|Lack of Efficacy|0|||
13403463|NCT00588692|26812967|FG000|Overall Study|Withdrawal by Subject|4|||
13403464|NCT00588692|26812968|FG001|Overall Study|Withdrawal by Subject|2|||
13403465|NCT00588692|26812967|FG000|Overall Study|Hip Surgery|0|||
13403466|NCT00588692|26812968|FG001|Overall Study|Hip Surgery|1|||
13403467|NCT00588692|26812967|FG000|Overall Study|Severe Peptic Ulcer Disease|1|||
13403468|NCT00588692|26812968|FG001|Overall Study|Severe Peptic Ulcer Disease|0|||
13403469|NCT00588692|26812967|FG000|Overall Study|Cancer|1|||
13403470|NCT00588692|26812968|FG001|Overall Study|Cancer|0|||
13403471|NCT00588692|26812967|FG000|Overall Study|Death|1|||
13403472|NCT00588692|26812968|FG001|Overall Study|Death|0|||
13403473|NCT00588666|26812975|FG000|Overall Study|Adverse Event|4|||
13403474|NCT00588640|26812981|FG000|Overall Study|Physician Decision|1|||
13403475|NCT00588640|26812981|FG000|Overall Study|Ineligible Patient|1|||
13403476|NCT00588445|26812989|FG000|Overall Study|Protocol Violation|1|||
13403477|NCT00588445|26812989|FG000|Overall Study|Withdrawal by Subject|3|||
13403478|NCT00588445|26812989|FG000|Overall Study|Disease Progression|1|||
13403479|NCT00588445|26812989|FG000|Overall Study|Not Treated|10|||
13403480|NCT00588354|26813016|FG000|Baseline to 2 Weeks|Adverse Event|1|||
13403481|NCT00588354|26813017|FG001|Baseline to 2 Weeks|Adverse Event|0|||
13403482|NCT00588354|26813016|FG000|Baseline to 2 Weeks|Lack of Efficacy|1|||
13403483|NCT00588354|26813017|FG001|Baseline to 2 Weeks|Lack of Efficacy|0|||
13403484|NCT00588354|26813016|FG000|Baseline to 4 Weeks|Lost to Follow-up|0|||
13403485|NCT00588354|26813017|FG001|Baseline to 4 Weeks|Lost to Follow-up|1|||
13403486|NCT00588341|26813023|FG000|Overall Study|Withdrawal by Subject|3|||
13403487|NCT00588341|26813023|FG000|Overall Study|Not treated due to metastatic disease|1|||
13403488|NCT00588341|26813023|FG000|Overall Study|Patient ineligible|1|||
13403489|NCT00588237|26813029|FG000|Overall Study|Evaluable for toxicity only|3|||
13403490|NCT00588237|26813029|FG000|Overall Study|Patien not treated|1|||
13403491|NCT00588146|26813038|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4|||
13403492|NCT00588146|26813039|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3|||
13403493|NCT00588094|26813045|FG000|Overall Study|Adverse Event|3|||
13403494|NCT00588094|26813045|FG000|Overall Study|Progression of Disease|2|||
13403495|NCT00587990|26813098|FG000|Overall Study|Death|0|||
13403496|NCT00587990|26813099|FG001|Overall Study|Death|0|||
13403497|NCT00587990|26813100|FG002|Overall Study|Death|1|||
13403498|NCT00587964|26813106|FG000|Overall Study|Withdrawal by Subject|1|||
13403499|NCT00587964|26813106|FG000|Overall Study|Lost to Follow-up|1|||
13403500|NCT00587964|26813106|FG000|Overall Study|Patient found to be ineligible|1|||
13403501|NCT00587964|26813106|FG000|Overall Study|Patient did not receive intervention|5|||
13403502|NCT00587964|26813106|FG000|Overall Study|Progression of Disease|4|||
13403503|NCT00587860|26813133|FG000|Overall Study|Lost to Follow-up|2|||
13403504|NCT00587860|26813134|FG001|Overall Study|Lost to Follow-up|2|||
13403505|NCT00587860|26813133|FG000|Overall Study|Withdrawal by Subject|3|||
13403506|NCT00587860|26813134|FG001|Overall Study|Withdrawal by Subject|3|||
13403507|NCT00587847|26813141|FG000|Overall Study|Lack of Efficacy|5|||
13403508|NCT00587847|26813141|FG000|Overall Study|Adverse Event|2|||
13403509|NCT00587795|26813154|FG000|Overall Study|Withdrawal by Subject|1|||
13403510|NCT00587795|26813155|FG001|Overall Study|Withdrawal by Subject|0|||
13403511|NCT00587639|26813162|FG000|Overall Study|Withdrawal by Subject|1|||
13403512|NCT00587587|26813189|FG000|Overall Study|Lost to Follow-up|6|||
13403513|NCT00587587|26813190|FG001|Overall Study|Lost to Follow-up|1|||
13403514|NCT00587457|26813235|FG000|Overall Study|Adverse Event|1|||
13403515|NCT00587457|26813236|FG001|Overall Study|Adverse Event|2|||
13403516|NCT00587457|26813237|FG002|Overall Study|Adverse Event|1|||
13403517|NCT00587457|26813235|FG000|Overall Study|Disease progression|2|||
13403518|NCT00587457|26813236|FG001|Overall Study|Disease progression|0|||
13403519|NCT00587457|26813237|FG002|Overall Study|Disease progression|2|||
13403520|NCT00587457|26813235|FG000|Overall Study|Initiation of alternative therapy|0|||
13403521|NCT00587457|26813236|FG001|Overall Study|Initiation of alternative therapy|1|||
13403522|NCT00587457|26813237|FG002|Overall Study|Initiation of alternative therapy|0|||
13403523|NCT00587457|26813235|FG000|Overall Study|Undefined|0|||
13403524|NCT00587457|26813236|FG001|Overall Study|Undefined|0|||
13403525|NCT00587457|26813237|FG002|Overall Study|Undefined|1|||
13403526|NCT00587457|26813235|FG000|Overall Study|Development of neutralizing Abs|0|||
13403527|NCT00587457|26813236|FG001|Overall Study|Development of neutralizing Abs|0|||
13403528|NCT00587457|26813237|FG002|Overall Study|Development of neutralizing Abs|1|||
13403529|NCT00587431|26813253|FG000|Overall Study|Adverse Event|1|||
13403530|NCT00587431|26813254|FG001|Overall Study|Adverse Event|0|||
13403531|NCT00587431|26813253|FG000|Overall Study|Withdrawal by Subject|0|||
13403532|NCT00587431|26813254|FG001|Overall Study|Withdrawal by Subject|1|||
13403533|NCT00587288|26813279|FG000|Overall Study|Adverse Event|0|||
13403534|NCT00587288|26813280|FG001|Overall Study|Adverse Event|1|||
13403535|NCT00587288|26813279|FG000|Overall Study|Lack of Efficacy|2|||
13403536|NCT00587288|26813280|FG001|Overall Study|Lack of Efficacy|8|||
13403537|NCT00587288|26813279|FG000|Overall Study|Protocol Violation|1|||
13403538|NCT00587288|26813280|FG001|Overall Study|Protocol Violation|0|||
13403539|NCT00587223|26813297|FG000|Overall Study|Adverse Event|1|||
13403540|NCT00587171|26813332|FG000|Overall Study|Lost to Follow-up|1|||
13403541|NCT00587171|26813333|FG001|Overall Study|Lost to Follow-up|1|||
13403542|NCT00587158|26813370|FG000|Overall Study|Did not want to do 24 hr urine collect.|4|||
13403543|NCT00587158|26813371|FG001|Overall Study|Did not want to do 24 hr urine collect.|3|||
13403544|NCT00587158|26813370|FG000|Overall Study|Physician Decision|0|||
13403545|NCT00587158|26813371|FG001|Overall Study|Physician Decision|1|||
13403546|NCT00587158|26813370|FG000|Overall Study|Lost to Follow-up|1|||
13403547|NCT00587158|26813371|FG001|Overall Study|Lost to Follow-up|2|||
13403548|NCT00587158|26813370|FG000|Overall Study|Death|0|||
13403549|NCT00587158|26813371|FG001|Overall Study|Death|1|||
13403550|NCT00587158|26813370|FG000|Overall Study|Subject did not want to take study med|0|||
13403551|NCT00587158|26813371|FG001|Overall Study|Subject did not want to take study med|1|||
13403552|NCT00587054|26813377|FG000|Overall Study|Patient not treated|9|||
13403553|NCT00586924|26813596|FG000|Overall Study|Adverse event/serious adverse event|0|||
13403554|NCT00586924|26813597|FG001|Overall Study|Adverse event/serious adverse event|0|||
13403555|NCT00586924|26813598|FG002|Overall Study|Adverse event/serious adverse event|0|||
13403556|NCT00586924|26813599|FG003|Overall Study|Adverse event/serious adverse event|1|||
13403557|NCT00586924|26813600|FG004|Overall Study|Adverse event/serious adverse event|0|||
13403558|NCT00586924|26813601|FG005|Overall Study|Adverse event/serious adverse event|2|||
13403559|NCT00586924|26813596|FG000|Overall Study|Initiation of alternative cancer therapy|0|||
13403560|NCT00586924|26813597|FG001|Overall Study|Initiation of alternative cancer therapy|0|||
13403561|NCT00586924|26813598|FG002|Overall Study|Initiation of alternative cancer therapy|0|||
13403562|NCT00586924|26813599|FG003|Overall Study|Initiation of alternative cancer therapy|0|||
13403563|NCT00586924|26813600|FG004|Overall Study|Initiation of alternative cancer therapy|0|||
13403564|NCT00586924|26813601|FG005|Overall Study|Initiation of alternative cancer therapy|1|||
13403565|NCT00586924|26813596|FG000|Overall Study|Disease progression|0|||
13403566|NCT00586924|26813597|FG001|Overall Study|Disease progression|0|||
13403567|NCT00586924|26813598|FG002|Overall Study|Disease progression|0|||
13403568|NCT00586924|26813599|FG003|Overall Study|Disease progression|1|||
13403569|NCT00586924|26813600|FG004|Overall Study|Disease progression|1|||
13403570|NCT00586924|26813601|FG005|Overall Study|Disease progression|0|||
13403571|NCT00586924|26813596|FG000|Overall Study|Development of neutralizing antibodies|2|||
13403572|NCT00586924|26813597|FG001|Overall Study|Development of neutralizing antibodies|2|||
13403573|NCT00586924|26813598|FG002|Overall Study|Development of neutralizing antibodies|2|||
13403574|NCT00586924|26813599|FG003|Overall Study|Development of neutralizing antibodies|0|||
13403575|NCT00586924|26813600|FG004|Overall Study|Development of neutralizing antibodies|0|||
13403576|NCT00586924|26813601|FG005|Overall Study|Development of neutralizing antibodies|22|||
13403577|NCT00586924|26813596|FG000|Overall Study|Complete response|0|||
13403578|NCT00586924|26813597|FG001|Overall Study|Complete response|1|||
13403579|NCT00586924|26813598|FG002|Overall Study|Complete response|0|||
13403580|NCT00586924|26813599|FG003|Overall Study|Complete response|0|||
13403581|NCT00586924|26813600|FG004|Overall Study|Complete response|2|||
13403582|NCT00586924|26813601|FG005|Overall Study|Complete response|2|||
13403583|NCT00586924|26813596|FG000|Overall Study|Other|1|||
13403584|NCT00586924|26813597|FG001|Overall Study|Other|0|||
13403585|NCT00586924|26813598|FG002|Overall Study|Other|1|||
13403586|NCT00586924|26813599|FG003|Overall Study|Other|1|||
13403587|NCT00586924|26813600|FG004|Overall Study|Other|1|||
13403588|NCT00586924|26813601|FG005|Overall Study|Other|6|||
13403589|NCT00586898|26813607|FG000|Overall Study|Adverse Event|1|||
13403590|NCT00586898|26813607|FG000|Overall Study|Patiemt Non-compliance|1|||
13403591|NCT00586898|26813607|FG000|Overall Study|Evaluable for Toxicity Only|5|||
13403592|NCT00586846|26813613|FG000|Overall Study|Physician Decision|1|||
13403593|NCT00586846|26813613|FG000|Overall Study|Death|1|||
13403594|NCT00586846|26813613|FG000|Overall Study|Evaluable for Toxicity Only|4|||
13403595|NCT00586820|26813628|FG000|Overall Study|Unsuccessful PCI|1|||
13403596|NCT00586820|26813629|FG001|Overall Study|Unsuccessful PCI|0|||
13403597|NCT00586703|26813636|FG000|Overall Study|Death|12|||
13403598|NCT00586690|26813650|FG000|Overall Study|Death|2|||
13403599|NCT00586690|26813651|FG001|Overall Study|Death|0|||
13403600|NCT00586690|26813650|FG000|Overall Study|Disease Progression|10|||
13403601|NCT00586690|26813651|FG001|Overall Study|Disease Progression|0|||
13403602|NCT00586690|26813650|FG000|Overall Study|Adverse Event|1|||
13403603|NCT00586690|26813651|FG001|Overall Study|Adverse Event|0|||
13403604|NCT00586690|26813650|FG000|Overall Study|Lack of Efficacy|2|||
13403605|NCT00586690|26813651|FG001|Overall Study|Lack of Efficacy|0|||
13403606|NCT00586690|26813650|FG000|Overall Study|Lab can't accommodate|1|||
13403607|NCT00586690|26813651|FG001|Overall Study|Lab can't accommodate|0|||
13403608|NCT00586664|26813705|FG000|Overall Study|Withdrawal by Subject|3|||
13403609|NCT00586664|26813706|FG001|Overall Study|Withdrawal by Subject|7|||
13403610|NCT00586664|26813707|FG002|Overall Study|Withdrawal by Subject|1|||
13403611|NCT00586664|26813705|FG000|Overall Study|Exclusion criteria met|2|||
13403612|NCT00586664|26813706|FG001|Overall Study|Exclusion criteria met|0|||
13403613|NCT00586664|26813707|FG002|Overall Study|Exclusion criteria met|0|||
13403614|NCT00586625|26813720|FG000|Overall Study|Adverse Event|6|||
13403615|NCT00586625|26813721|FG001|Overall Study|Adverse Event|6|||
13403616|NCT00586625|26813720|FG000|Overall Study|Protocol Violation|3|||
13403617|NCT00586625|26813721|FG001|Overall Study|Protocol Violation|0|||
13403618|NCT00586625|26813720|FG000|Overall Study|Withdrawal by Subject|32|||
13403619|NCT00586625|26813721|FG001|Overall Study|Withdrawal by Subject|10|||
13403620|NCT00586625|26813720|FG000|Overall Study|Subject non-compliance|0|||
13403621|NCT00586625|26813721|FG001|Overall Study|Subject non-compliance|1|||
13403622|NCT00586625|26813720|FG000|Overall Study|Subject unable to return for visit|2|||
13403623|NCT00586625|26813721|FG001|Overall Study|Subject unable to return for visit|0|||
13403624|NCT00586612|26813794|FG000|Primary Phase|Protocol Violation|1|||
13403625|NCT00586612|26813795|FG001|Primary Phase|Protocol Violation|0|||
13403626|NCT00586612|26813794|FG000|Primary Phase|Lost to Follow-up|0|||
13403627|NCT00586612|26813795|FG001|Primary Phase|Lost to Follow-up|1|||
13403628|NCT00586612|26813794|FG000|Primary Phase|Withdrawal by Subject|0|||
13403629|NCT00586612|26813795|FG001|Primary Phase|Withdrawal by Subject|2|||
13403630|NCT00586612|26813794|FG000|Booster Phase|Lost to Follow-up|3|||
13403631|NCT00586612|26813795|FG001|Booster Phase|Lost to Follow-up|1|||
13403632|NCT00586521|26813804|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1|||
13403633|NCT00586508|26813827|FG000|Overall Study|Progressive disease|52|||
13403634|NCT00586508|26813828|FG001|Overall Study|Progressive disease|8|||
13403635|NCT00586508|26813827|FG000|Overall Study|Death|0|||
13403636|NCT00586508|26813828|FG001|Overall Study|Death|1|||
13403637|NCT00586508|26813827|FG000|Overall Study|Adverse Event|12|||
13403638|NCT00586508|26813828|FG001|Overall Study|Adverse Event|4|||
13403639|NCT00586508|26813827|FG000|Overall Study|Withdrawal by Subject|4|||
13403640|NCT00586508|26813828|FG001|Overall Study|Withdrawal by Subject|0|||
13403641|NCT00586495|26813840|FG000|Treatment Period|Adverse Event|11|||
13403642|NCT00586495|26813840|FG000|Treatment Period|Death|1|||
13403643|NCT00586495|26813840|FG000|Treatment Period|Protocol Violation|1|||
13403644|NCT00586495|26813840|FG000|Treatment Period|Withdrawal by Subject|1|||
13403645|NCT00586495|26813840|FG000|Treatment Period|Disease progression, recurrence/relapse|71|||
13403646|NCT00586495|26813840|FG000|Treatment Period|Switch to commercial drug|10|||
13403647|NCT00586495|26813840|FG000|Follow-up|Death|40|||
13403648|NCT00586495|26813840|FG000|Follow-up|Lost to Follow-up|1|||
13403649|NCT00586495|26813840|FG000|Follow-up|Withdrawal by Subject|4|||
13403650|NCT00586495|26813840|FG000|Follow-up|Protocol driven decision point|37|||
13403651|NCT00586495|26813840|FG000|Follow-up|Switch to commercial drug|10|||
13403652|NCT00586469|26813871|FG000|Overall Study|Adverse Event|0|||
13403653|NCT00586469|26813872|FG001|Overall Study|Adverse Event|1|||
13403654|NCT00586339|26813983|FG000|Overall Study|Withdrawal by Subject|1|||
13403655|NCT00586339|26813984|FG001|Overall Study|Withdrawal by Subject|3|||
13403656|NCT00586339|26813985|FG002|Overall Study|Withdrawal by Subject|1|||
13403657|NCT00586339|26813983|FG000|Overall Study|Migrated/moved from study area|3|||
13403658|NCT00586339|26813984|FG001|Overall Study|Migrated/moved from study area|2|||
13403659|NCT00586339|26813985|FG002|Overall Study|Migrated/moved from study area|4|||
13403660|NCT00586339|26813983|FG000|Overall Study|Lost to Follow-up|3|||
13403661|NCT00586339|26813984|FG001|Overall Study|Lost to Follow-up|2|||
13403662|NCT00586339|26813985|FG002|Overall Study|Lost to Follow-up|1|||
13403663|NCT00586326|26813998|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6|||
13403664|NCT00586326|26813998|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4|||
13403665|NCT00586326|26813998|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2|||
13403666|NCT00586326|26813998|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1|||
13403667|NCT00586326|26813998|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1|||
13403668|NCT00586326|26813998|FG000|Enrollment to Device Placement-Enrolled|Other|1|||
13403669|NCT00586326|26813998|FG000|Device Placed toTreatment-ITT|Skin Distance|7|||
13403670|NCT00586326|26813998|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6|||
13403671|NCT00586326|26813998|FG000|Device Placed toTreatment-ITT|Microinvasion|1|||
13403672|NCT00586326|26813998|FG000|Device Placed toTreatment-ITT|Positive Margins|3|||
13403673|NCT00586326|26813998|FG000|Device Placed toTreatment-ITT|Physician Decision|1|||
13403674|NCT00586326|26813998|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1|||
13403675|NCT00586326|26813998|FG000|Treated Through 5-yr Follow Up-Treated|Death|2|||
13403676|NCT00586326|26813998|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2|||
13403677|NCT00586326|26813998|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5|||
13403678|NCT00586326|26813998|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14|||
13403679|NCT00586326|26813998|FG000|Treated Through 5-yr Follow Up-Treated|Other|2|||
13403680|NCT00586313|26814005|FG000|Overall Study|Lack of Efficacy|2|||
13403681|NCT00586157|26814018|FG000|First Intervention|Worsening behavior|1|||
13403682|NCT00586157|26814019|FG001|First Intervention|Worsening behavior|0|||
13403683|NCT00586157|26814018|FG000|Second Intervention|Withdrawal by Subject|1|||
13403684|NCT00586157|26814019|FG001|Second Intervention|Withdrawal by Subject|0|||
13403685|NCT00586157|26814018|FG000|Second Intervention|Worsening behavior|1|||
13403686|NCT00586157|26814019|FG001|Second Intervention|Worsening behavior|0|||
13403687|NCT00586157|26814018|FG000|Second Intervention|Adverse Event|0|||
13403688|NCT00586157|26814019|FG001|Second Intervention|Adverse Event|1|||
13403689|NCT00586105|26814034|FG000|Overall Study|Adverse Event|4|||
13403690|NCT00586105|26814034|FG000|Overall Study|Death|2|||
13403691|NCT00586105|26814034|FG000|Overall Study|Protocol Violation|1|||
13403692|NCT00586105|26814034|FG000|Overall Study|Withdrawal by Subject|3|||
13403693|NCT00586105|26814034|FG000|Overall Study|Disease progression|19|||
13403694|NCT00586105|26814034|FG000|Overall Study|Switched to commercial drug|9|||
13403695|NCT00586105|26814034|FG000|Overall Study|Reason not reported|1|||
13403696|NCT00586066|26814051|FG000|Overall Study|Lost to Follow-up|6|||
13403697|NCT00586066|26814052|FG001|Overall Study|Lost to Follow-up|3|||
13403698|NCT00586066|26814051|FG000|Overall Study|Lack of Efficacy|5|||
13403699|NCT00586066|26814052|FG001|Overall Study|Lack of Efficacy|3|||
13403700|NCT00586066|26814051|FG000|Overall Study|Adverse Event|2|||
13403701|NCT00586066|26814052|FG001|Overall Study|Adverse Event|2|||
13403702|NCT00586066|26814051|FG000|Overall Study|Physician Decision|1|||
13403703|NCT00586066|26814052|FG001|Overall Study|Physician Decision|0|||
13403704|NCT00586066|26814051|FG000|Overall Study|Withdrawal of consent|4|||
13403705|NCT00586066|26814052|FG001|Overall Study|Withdrawal of consent|2|||
13403706|NCT00585975|26814067|FG000|Overall Study|Withdrawal by Subject|3|||
13403707|NCT00585975|26814068|FG001|Overall Study|Withdrawal by Subject|3|||
13403708|NCT00585975|26814067|FG000|Overall Study|Lost to Follow-up|2|||
13403709|NCT00585975|26814068|FG001|Overall Study|Lost to Follow-up|1|||
13403710|NCT00585975|26814067|FG000|Overall Study|Enrollment met/over-enrolled|10|||
13403711|NCT00585975|26814068|FG001|Overall Study|Enrollment met/over-enrolled|9|||
13403712|NCT00585923|26814089|FG000|Overall Study|Physician decided not to continue|31|||
13403713|NCT00585923|26814090|FG001|Overall Study|Physician decided not to continue|33|||
13403714|NCT00585689|26814096|FG000|Overall Study|Received different ABI-007 schedule|3|||
13403715|NCT00585689|26814096|FG000|Overall Study|Adverse Event|1|||
13403716|NCT00585689|26814096|FG000|Overall Study|Patient Declined Surgery|1|||
13403717|NCT00585689|26814096|FG000|Overall Study|Patient had unresectable disease|1|||
13403718|NCT00585689|26814096|FG000|Overall Study|Death|1|||
13403719|NCT00585585|26814102|FG000|Overall Study|Adverse Event|1|||
13403720|NCT00585546|26814118|FG000|Clenbuterol Treatment - up to 12 Months|Death|1|||
13403721|NCT00585546|26814118|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3|||
13403722|NCT00585533|26814125|FG000|Overall Study|objective or symptomatic progression|9|||
13403723|NCT00585468|26814148|FG000|First Intervention|Withdrawal by Subject|1|||
13403724|NCT00585468|26814149|FG001|First Intervention|Withdrawal by Subject|1|||
13403725|NCT00585351|26814184|FG000|Notification Period (Informed Consent)|Physician Decision|0|||
13403726|NCT00585351|26814185|FG001|Notification Period (Informed Consent)|Physician Decision|2|||
13403727|NCT00585351|26814186|FG002|Notification Period (Informed Consent)|Physician Decision|0|||
13403728|NCT00585351|26814187|FG003|Notification Period (Informed Consent)|Physician Decision|0|||
13403729|NCT00585351|26814188|FG004|Notification Period (Informed Consent)|Physician Decision|0|||
13403730|NCT00585351|26814189|FG005|Notification Period (Informed Consent)|Physician Decision|0|||
13403731|NCT00585351|26814190|FG006|Notification Period (Informed Consent)|Physician Decision|0|||
13403732|NCT00585351|26814191|FG007|Notification Period (Informed Consent)|Physician Decision|0|||
13403733|NCT00585351|26814184|FG000|Notification Period (Informed Consent)|Flight aborted|2|||
13403734|NCT00585351|26814185|FG001|Notification Period (Informed Consent)|Flight aborted|1|||
13403735|NCT00585351|26814186|FG002|Notification Period (Informed Consent)|Flight aborted|0|||
13403736|NCT00585351|26814187|FG003|Notification Period (Informed Consent)|Flight aborted|0|||
13403737|NCT00585351|26814188|FG004|Notification Period (Informed Consent)|Flight aborted|0|||
13403738|NCT00585351|26814189|FG005|Notification Period (Informed Consent)|Flight aborted|0|||
13403739|NCT00585351|26814190|FG006|Notification Period (Informed Consent)|Flight aborted|0|||
13403740|NCT00585351|26814191|FG007|Notification Period (Informed Consent)|Flight aborted|0|||
13403741|NCT00585351|26814184|FG000|Notification Period (Informed Consent)|No study medication on flight|0|||
13403742|NCT00585351|26814185|FG001|Notification Period (Informed Consent)|No study medication on flight|1|||
13403743|NCT00585351|26814186|FG002|Notification Period (Informed Consent)|No study medication on flight|0|||
13403744|NCT00585351|26814187|FG003|Notification Period (Informed Consent)|No study medication on flight|0|||
13403745|NCT00585351|26814188|FG004|Notification Period (Informed Consent)|No study medication on flight|0|||
13403746|NCT00585351|26814189|FG005|Notification Period (Informed Consent)|No study medication on flight|0|||
13403747|NCT00585351|26814190|FG006|Notification Period (Informed Consent)|No study medication on flight|0|||
13403748|NCT00585351|26814191|FG007|Notification Period (Informed Consent)|No study medication on flight|0|||
13403749|NCT00585351|26814184|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
13403750|NCT00585351|26814185|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
13403751|NCT00585351|26814186|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
13403752|NCT00585351|26814187|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
13403753|NCT00585351|26814188|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
13403754|NCT00585351|26814189|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
13403755|NCT00585351|26814190|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
13403756|NCT00585351|26814191|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
13403757|NCT00585351|26814184|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0|||
13403758|NCT00585351|26814185|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0|||
13403759|NCT00585351|26814186|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0|||
13403760|NCT00585351|26814187|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0|||
13403761|NCT00585351|26814188|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0|||
13403762|NCT00585351|26814189|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0|||
13403763|NCT00585351|26814190|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1|||
13403764|NCT00585351|26814191|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1|||
13403765|NCT00585351|26814184|FG000|Enrollment Period (Intervention)|Death|0|||
13403766|NCT00585351|26814185|FG001|Enrollment Period (Intervention)|Death|0|||
13403767|NCT00585351|26814186|FG002|Enrollment Period (Intervention)|Death|0|||
13403768|NCT00585351|26814187|FG003|Enrollment Period (Intervention)|Death|0|||
13403769|NCT00585351|26814188|FG004|Enrollment Period (Intervention)|Death|1|||
13403770|NCT00585351|26814189|FG005|Enrollment Period (Intervention)|Death|0|||
13403771|NCT00585351|26814190|FG006|Enrollment Period (Intervention)|Death|1|||
13403772|NCT00585351|26814191|FG007|Enrollment Period (Intervention)|Death|0|||
13403773|NCT00585351|26814184|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
13403774|NCT00585351|26814185|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
13403775|NCT00585351|26814186|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
13403776|NCT00585351|26814187|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
13403777|NCT00585351|26814188|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1|||
13403778|NCT00585351|26814189|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2|||
13403779|NCT00585351|26814190|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
13403780|NCT00585351|26814191|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
13403781|NCT00585325|26814204|FG000|Overall Study|Withdrawal by Subject|1|||
13403782|NCT00585325|26814205|FG001|Overall Study|Withdrawal by Subject|1|||
13403783|NCT00585312|26814224|FG000|Overall Study|Adverse Event|3|||
13403784|NCT00585312|26814225|FG001|Overall Study|Adverse Event|0|||
13403785|NCT00585312|26814224|FG000|Overall Study|Lack of Efficacy|6|||
13403786|NCT00585312|26814225|FG001|Overall Study|Lack of Efficacy|11|||
13403787|NCT00585312|26814224|FG000|Overall Study|Lost to Follow-up|1|||
13403788|NCT00585312|26814225|FG001|Overall Study|Lost to Follow-up|1|||
13403789|NCT00585312|26814224|FG000|Overall Study|Reason not specified|2|||
13403790|NCT00585312|26814225|FG001|Overall Study|Reason not specified|0|||
13403791|NCT00585312|26814224|FG000|Overall Study|Withdrawal by Subject|5|||
13403792|NCT00585312|26814225|FG001|Overall Study|Withdrawal by Subject|1|||
13403793|NCT00585312|26814224|FG000|Overall Study|Study terminated by the sponsor|34|||
13403794|NCT00585312|26814225|FG001|Overall Study|Study terminated by the sponsor|31|||
13403795|NCT00585286|26814234|FG000|Overall Study|Lost to Follow-up|1|||
13403796|NCT00585221|26814241|FG000|Overall Study|Protocol Violation|8|||
13403797|NCT00585169|26814249|FG000|Overall Study|Withdrawal by Subject|1|||
13403798|NCT00585078|26814258|FG000|Overall Study|Withdrawal by Subject|4|||
13403799|NCT00585078|26814258|FG000|Overall Study|Poor performance status|1|||
13403800|NCT00585078|26814258|FG000|Overall Study|Disease Progression|24|||
13403801|NCT00585078|26814258|FG000|Overall Study|Adverse Event|10|||
13403802|NCT00585078|26814258|FG000|Overall Study|Death|1|||
13403803|NCT00585052|26814265|FG000|Overall Study|Withdrawal by Subject|1|||
13403804|NCT00585039|26814280|FG000|Overall Study|medication spilled|2|||
13403805|NCT00585039|26814281|FG001|Overall Study|medication spilled|0|||
13403806|NCT00584987|26814324|FG000|Overall Study|Protocol Violation|1|||
13403807|NCT00584987|26814325|FG001|Overall Study|Protocol Violation|1|||
13403808|NCT00584987|26814326|FG002|Overall Study|Protocol Violation|1|||
13403809|NCT00584987|26814327|FG003|Overall Study|Protocol Violation|0|||
13403810|NCT00584987|26814324|FG000|Overall Study|Adverse Event|0|||
13403811|NCT00584987|26814325|FG001|Overall Study|Adverse Event|0|||
13403812|NCT00584987|26814326|FG002|Overall Study|Adverse Event|0|||
13403813|NCT00584987|26814327|FG003|Overall Study|Adverse Event|1|||
13403814|NCT00584909|26814334|FG000|Overall Study|Adverse Event|4|||
13403815|NCT00584870|26814413|FG000|Overall Study|Adverse Event|4|||
13403816|NCT00584870|26814414|FG001|Overall Study|Adverse Event|3|||
13403817|NCT00584870|26814415|FG002|Overall Study|Adverse Event|2|||
13403818|NCT00584870|26814413|FG000|Overall Study|Lost to Follow-up|4|||
13403819|NCT00584870|26814414|FG001|Overall Study|Lost to Follow-up|1|||
13403820|NCT00584870|26814415|FG002|Overall Study|Lost to Follow-up|1|||
13403821|NCT00584870|26814413|FG000|Overall Study|Lack of Efficacy|7|||
13403822|NCT00584870|26814414|FG001|Overall Study|Lack of Efficacy|14|||
13403823|NCT00584870|26814415|FG002|Overall Study|Lack of Efficacy|8|||
13403824|NCT00584870|26814413|FG000|Overall Study|Withdrawal by Subject|10|||
13403825|NCT00584870|26814414|FG001|Overall Study|Withdrawal by Subject|5|||
13403826|NCT00584870|26814415|FG002|Overall Study|Withdrawal by Subject|3|||
13403827|NCT00584870|26814413|FG000|Overall Study|Protocol Violation|1|||
13403828|NCT00584870|26814414|FG001|Overall Study|Protocol Violation|1|||
13403829|NCT00584870|26814415|FG002|Overall Study|Protocol Violation|2|||
13403830|NCT00584870|26814413|FG000|Overall Study|Did not met entrance criteria|1|||
13403831|NCT00584870|26814414|FG001|Overall Study|Did not met entrance criteria|0|||
13403832|NCT00584870|26814415|FG002|Overall Study|Did not met entrance criteria|0|||
13403833|NCT00584870|26814413|FG000|Overall Study|Other|2|||
13403834|NCT00584870|26814414|FG001|Overall Study|Other|0|||
13403835|NCT00584870|26814415|FG002|Overall Study|Other|0|||
13403836|NCT00584870|26814413|FG000|Overall Study|Randomized but not treated|0|||
13403837|NCT00584870|26814414|FG001|Overall Study|Randomized but not treated|1|||
13403838|NCT00584870|26814415|FG002|Overall Study|Randomized but not treated|2|||
13403839|NCT00584844|26814427|FG000|Overall Study|Withdrawal by Subject|59|||
13403840|NCT00584844|26814427|FG000|Overall Study|Screen Failure|20|||
13403841|NCT00584805|26814440|FG000|Overall Study|No longer at risk of exposure|39|||
13403842|NCT00584805|26814440|FG000|Overall Study|Relocation|36|||
13403843|NCT00584805|26814440|FG000|Overall Study|Withdrawal by Subject|18|||
13403844|NCT00584805|26814440|FG000|Overall Study|Non-compliance|1|||
13403845|NCT00584805|26814440|FG000|Overall Study|Lost to follow up|3|||
13403846|NCT00584805|26814440|FG000|Overall Study|Screen failures|2|||
13403847|NCT00584740|26814465|FG000|Overall Study|Adverse Event|1|||
13403848|NCT00584740|26814466|FG001|Overall Study|Adverse Event|1|||
13403849|NCT00584740|26814465|FG000|Overall Study|Lack of Efficacy|8|||
13403850|NCT00584740|26814466|FG001|Overall Study|Lack of Efficacy|2|||
13403851|NCT00584740|26814465|FG000|Overall Study|Withdrawal by Subject|3|||
13403852|NCT00584740|26814466|FG001|Overall Study|Withdrawal by Subject|2|||
13403853|NCT00584740|26814465|FG000|Overall Study|Lost to Follow-up|0|||
13403854|NCT00584740|26814466|FG001|Overall Study|Lost to Follow-up|1|||
13403855|NCT00584727|26814497|FG000|First Intervention|Discontinuation|0|||
13403856|NCT00584727|26814498|FG001|First Intervention|Discontinuation|0|||
13403857|NCT00584727|26814499|FG002|First Intervention|Discontinuation|1|||
13403858|NCT00584727|26814500|FG003|First Intervention|Discontinuation|0|||
13403859|NCT00584727|26814501|FG004|First Intervention|Discontinuation|0|||
13403860|NCT00584727|26814502|FG005|First Intervention|Discontinuation|0|||
13403861|NCT00584727|26814497|FG000|Third Intervention|Protocol Violation|0|||
13403862|NCT00584727|26814498|FG001|Third Intervention|Protocol Violation|0|||
13403863|NCT00584727|26814499|FG002|Third Intervention|Protocol Violation|1|||
13403864|NCT00584727|26814500|FG003|Third Intervention|Protocol Violation|0|||
13403865|NCT00584727|26814501|FG004|Third Intervention|Protocol Violation|4|||
13403866|NCT00584727|26814502|FG005|Third Intervention|Protocol Violation|2|||
13403867|NCT00584454|26814508|FG000|Overall Study|Adverse Event|1|||
13403868|NCT00584454|26814508|FG000|Overall Study|Relocation|1|||
13403869|NCT00584454|26814508|FG000|Overall Study|Clinical Hold|2|||
13403870|NCT00584415|26814515|FG000|Overall Study|Adverse Event|7|||
13403871|NCT00584194|26814525|FG000|Overall Study|Other|135|||
13403872|NCT00584012|26814531|FG000|Overall Study|Withdrawal by Subject|1|||
13403873|NCT00583947|26814588|FG000|Cross-over Period|Adverse Event|2|||
13403874|NCT00583947|26814589|FG001|Cross-over Period|Adverse Event|0|||
13403875|NCT00583947|26814588|FG000|Cross-over Period|Withdrawal by Subject|2|||
13403876|NCT00583947|26814589|FG001|Cross-over Period|Withdrawal by Subject|0|||
13403877|NCT00583947|26814588|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0|||
13403878|NCT00583947|26814589|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1|||
13403879|NCT00583947|26814588|FG000|Cross-over Period|Other|1|||
13403880|NCT00583947|26814589|FG001|Cross-over Period|Other|1|||
13403881|NCT00583791|26814595|FG000|Overall Study|Other|67|||
13403882|NCT00583791|26814595|FG000|Overall Study|Death|6|||
13403883|NCT00583596|26814602|FG000|Overall Study|Lost to Follow-up|110|||
13403884|NCT00583596|26814602|FG000|Overall Study|Excluded due to Hurricane Katrina|30|||
13403885|NCT00583596|26814602|FG000|Overall Study|Death|2|||
13403886|NCT00583596|26814602|FG000|Overall Study|Withdrawal by Subject|6|||
13403887|NCT00583596|26814602|FG000|Overall Study|Lost to Follow-up|94|||
13403888|NCT00583596|26814602|FG000|Overall Study|Data not complete|1|||
13403889|NCT00583596|26814602|FG000|Overall Study|Not consented|15|||
13403890|NCT00583596|26814602|FG000|Overall Study|Outside f-up window|26|||
13403891|NCT00583557|26814608|FG000|Overall Study|Withdrawal by Subject|18|||
13403892|NCT00583557|26814608|FG000|Overall Study|Adverse Event|9|||
13403893|NCT00583557|26814608|FG000|Overall Study|Lack of Efficacy|31|||
13403894|NCT00583557|26814608|FG000|Overall Study|Lack of Compliance|5|||
13403895|NCT00583557|26814608|FG000|Overall Study|Other|5|||
13403896|NCT00583557|26814608|FG000|Overall Study|Did not receive belimumab in LBRA99|2|||
13403897|NCT00583453|26814629|FG000|Overall Study|discontinued intervention|0|||
13403898|NCT00583453|26814630|FG001|Overall Study|discontinued intervention|2|||
13403899|NCT00583362|26814656|FG000|Overall Study|Adverse Event|44|||
13403900|NCT00583362|26814656|FG000|Overall Study|Lack of Efficacy|22|||
13403901|NCT00583362|26814656|FG000|Overall Study|Lost to Follow-up|4|||
13403902|NCT00583362|26814656|FG000|Overall Study|Non-compliance with study drug|28|||
13403903|NCT00583362|26814656|FG000|Overall Study|Pregnancy|7|||
13403904|NCT00583362|26814656|FG000|Overall Study|Miscommunication of visit window|5|||
13403905|NCT00583362|26814656|FG000|Overall Study|Current site closed|7|||
13403906|NCT00583362|26814656|FG000|Overall Study|Subject not dosed in LBSL99|1|||
13403907|NCT00583362|26814656|FG000|Overall Study|Subject moved out of the country/state|2|||
13403908|NCT00583362|26814656|FG000|Overall Study|Missed visits due to staff changes|1|||
13403909|NCT00583362|26814656|FG000|Overall Study|Misunderstanding of protocol|1|||
13403910|NCT00583362|26814656|FG000|Overall Study|Behavioral problems and non-compliance|1|||
13403911|NCT00583362|26814656|FG000|Overall Study|Sponsor request due to missed doses|1|||
13403912|NCT00583362|26814656|FG000|Overall Study|Physician Decision|19|||
13403913|NCT00583362|26814656|FG000|Overall Study|Protocol Violation|2|||
13403914|NCT00583362|26814656|FG000|Overall Study|Withdrawal by Subject|57|||
13403915|NCT00583219|26814675|FG000|Phase 2|Withdrawal by Subject|1|||
13403916|NCT00583115|26814682|FG000|Overall Study|Death|1|||
13403917|NCT00583102|26814688|FG000|Overall Study|Adverse Event|3|||
13403918|NCT00582972|26814695|FG000|Overall Study|Protocol Violation|2|||
13403919|NCT00582933|26814701|FG000|Overall Study|Physician Decision|3|||
13403920|NCT00582907|26814738|FG000|1st Course|Withdrawal by Subject|1|||
13403921|NCT00582907|26814739|FG001|1st Course|Withdrawal by Subject|0|||
13403922|NCT00582907|26814740|FG002|1st Course|Withdrawal by Subject|0|||
13403923|NCT00582907|26814741|FG003|1st Course|Withdrawal by Subject|0|||
13403924|NCT00582907|26814738|FG000|1st Course|Lost to Follow-up|0|||
13403925|NCT00582907|26814739|FG001|1st Course|Lost to Follow-up|0|||
13403926|NCT00582907|26814740|FG002|1st Course|Lost to Follow-up|0|||
13403927|NCT00582907|26814741|FG003|1st Course|Lost to Follow-up|1|||
13403928|NCT00582907|26814738|FG000|2nd Course|Lack of Efficacy|1|||
13403929|NCT00582907|26814739|FG001|2nd Course|Lack of Efficacy|0|||
13403930|NCT00582907|26814740|FG002|2nd Course|Lack of Efficacy|0|||
13403931|NCT00582907|26814741|FG003|2nd Course|Lack of Efficacy|0|||
13403932|NCT00582816|26814753|FG000|Overall Study|Engraftment Failure|3|||
13403933|NCT00582790|26814762|FG000|Overall Study|Rapid progression of disease|1|||
13403934|NCT00582738|26814793|FG000|Overall Study|Administrative Problems|7|||
13403935|NCT00582738|26814794|FG001|Overall Study|Administrative Problems|8|||
13403936|NCT00582738|26814793|FG000|Overall Study|Adverse Event|0|||
13403937|NCT00582738|26814794|FG001|Overall Study|Adverse Event|5|||
13403938|NCT00582738|26814793|FG000|Overall Study|Graft Lost|0|||
13403939|NCT00582738|26814794|FG001|Overall Study|Graft Lost|1|||
13403940|NCT00582738|26814793|FG000|Overall Study|Other|1|||
13403941|NCT00582738|26814794|FG001|Overall Study|Other|0|||
13403942|NCT00582738|26814793|FG000|Overall Study|Protocol Violation|1|||
13403943|NCT00582738|26814794|FG001|Overall Study|Protocol Violation|1|||
13403944|NCT00582738|26814793|FG000|Overall Study|Withdrawal by Subject|0|||
13403945|NCT00582738|26814794|FG001|Overall Study|Withdrawal by Subject|3|||
13403946|NCT00582712|26814800|FG000|Overall Study|Adverse Event|1|||
13403947|NCT00582712|26814800|FG000|Overall Study|Lack of Efficacy|1|||
13403948|NCT00582712|26814800|FG000|Overall Study|Withdrawal by Subject|1|||
13403949|NCT00582712|26814800|FG000|Overall Study|Complicating disease requiring treatment|1|||
13403950|NCT00582608|26814806|FG000|Overall Study|Not Treated|7|||
13403951|NCT00582608|26814806|FG000|Overall Study|Patient Ineligible|1|||
13403952|NCT00582608|26814806|FG000|Overall Study|Lack of accrual|4|||
13403953|NCT00582556|26814833|FG000|Overall Study|Withdrawal by Subject|0|||
13403954|NCT00582556|26814834|FG001|Overall Study|Withdrawal by Subject|1|||
13403955|NCT00582556|26814835|FG002|Overall Study|Withdrawal by Subject|1|||
13403956|NCT00582556|26814833|FG000|Overall Study|Physician Decision|0|||
13403957|NCT00582556|26814834|FG001|Overall Study|Physician Decision|0|||
13403958|NCT00582556|26814835|FG002|Overall Study|Physician Decision|1|||
13403959|NCT00582491|26814864|FG000|Overall Study|Withdrawal by Subject|1|||
13403960|NCT00582491|26814865|FG001|Overall Study|Withdrawal by Subject|0|||
13403961|NCT00582426|26814898|FG000|Overall Study|Lost to Follow-up|0|||
13403962|NCT00582426|26814899|FG001|Overall Study|Lost to Follow-up|2|||
13403963|NCT00582426|26814898|FG000|Overall Study|Adverse Event|4|||
13403964|NCT00582426|26814899|FG001|Overall Study|Adverse Event|2|||
13403965|NCT00582426|26814898|FG000|Overall Study|Protocol Violation|6|||
13403966|NCT00582426|26814899|FG001|Overall Study|Protocol Violation|2|||
13403967|NCT00582426|26814898|FG000|Overall Study|Death|4|||
13403968|NCT00582426|26814899|FG001|Overall Study|Death|3|||
13403969|NCT00582426|26814898|FG000|Overall Study|Withdrawal by Subject|3|||
13403970|NCT00582426|26814899|FG001|Overall Study|Withdrawal by Subject|2|||
13403971|NCT00582426|26814898|FG000|Overall Study|Disease Progression|2|||
13403972|NCT00582426|26814899|FG001|Overall Study|Disease Progression|2|||
13403973|NCT00582426|26814898|FG000|Overall Study|Use of illicit drugs|1|||
13403974|NCT00582426|26814899|FG001|Overall Study|Use of illicit drugs|0|||
13403975|NCT00582309|26814917|FG000|Overall Study|Protocol Violation|0|||
13403976|NCT00582309|26814918|FG001|Overall Study|Protocol Violation|0|||
13403977|NCT00582309|26814919|FG002|Overall Study|Protocol Violation|2|||
13403978|NCT00582166|26814929|FG000|Overall Study|Death|1|||
13403979|NCT00582166|26814929|FG000|Overall Study|Ineligible pathology|1|||
13403980|NCT00582114|26814944|FG000|Overall Study|Death|4|||
13403981|NCT00582114|26814945|FG001|Overall Study|Death|4|||
13403982|NCT00582114|26814944|FG000|Overall Study|Kidney Transplant|3|||
13403983|NCT00582114|26814945|FG001|Overall Study|Kidney Transplant|1|||
13403984|NCT00582114|26814944|FG000|Overall Study|Lost to Follow-up|7|||
13403985|NCT00582114|26814945|FG001|Overall Study|Lost to Follow-up|6|||
13403986|NCT00582114|26814944|FG000|Overall Study|Withdrawal by Subject|8|||
13403987|NCT00582114|26814945|FG001|Overall Study|Withdrawal by Subject|16|||
13403988|NCT00582114|26814944|FG000|Overall Study|Adverse Event|1|||
13403989|NCT00582114|26814945|FG001|Overall Study|Adverse Event|1|||
13403990|NCT00582114|26814944|FG000|Overall Study|Physician Decision|0|||
13403991|NCT00582114|26814945|FG001|Overall Study|Physician Decision|6|||
13403992|NCT00582114|26814944|FG000|Overall Study|Stopped by data safety monitoring board|19|||
13403993|NCT00582114|26814945|FG001|Overall Study|Stopped by data safety monitoring board|20|||
13403994|NCT00582036|26814958|FG000|Overall Study|Withdrawal by Subject|0|||
13403995|NCT00582036|26814959|FG001|Overall Study|Withdrawal by Subject|1|||
13403996|NCT00582010|26814988|FG000|Overall Study|Death|0|||
13403997|NCT00582010|26814989|FG001|Overall Study|Death|1|||
13403998|NCT00581945|26815012|FG000|Overall Study|Adverse Event|4|||
13403999|NCT00581945|26815013|FG001|Overall Study|Adverse Event|4|||
13404000|NCT00581945|26815012|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
13404001|NCT00581945|26815013|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
13404002|NCT00581945|26815012|FG000|Overall Study|Withdrawal by Subject|2|||
13404003|NCT00581945|26815013|FG001|Overall Study|Withdrawal by Subject|6|||
13404004|NCT00581945|26815012|FG000|Overall Study|Death|1|||
13404005|NCT00581945|26815013|FG001|Overall Study|Death|0|||
13404006|NCT00581919|26815021|FG000|Overall Study|Adverse Event|8|||
13404007|NCT00581919|26815021|FG000|Overall Study|Death|1|||
13404008|NCT00581919|26815021|FG000|Overall Study|Disease Progression|10|||
13404009|NCT00581919|26815021|FG000|Overall Study|Physician Decision|1|||
13404010|NCT00581919|26815021|FG000|Overall Study|Other Complicating Disease|1|||
13404011|NCT00581919|26815021|FG000|Overall Study|Started Non-Protocol Therapy|2|||
13404012|NCT00581919|26815021|FG000|Overall Study|Withdrawal by Subject|1|||
13404013|NCT00581893|26815030|FG000|Second Intervention (1 Month)|Lost to Follow-up|3|||
13404014|NCT00581893|26815031|FG001|Second Intervention (1 Month)|Lost to Follow-up|2|||
13404015|NCT00581828|26815037|FG000|Overall Study|Protocol Violation|1|||
13404016|NCT00581776|26815046|FG000|Overall Study|Disease progression or no response|3|||
13404017|NCT00581555|26815075|FG000|Overall Study|Adverse Event|4|||
13404018|NCT00581555|26815076|FG001|Overall Study|Adverse Event|3|||
13404019|NCT00581555|26815075|FG000|Overall Study|Physician Decision|3|||
13404020|NCT00581555|26815076|FG001|Overall Study|Physician Decision|2|||
13404021|NCT00581555|26815075|FG000|Overall Study|Withdrawal by Subject|18|||
13404022|NCT00581555|26815076|FG001|Overall Study|Withdrawal by Subject|9|||
13404023|NCT00581555|26815075|FG000|Overall Study|Lost to Follow-up|2|||
13404024|NCT00581555|26815076|FG001|Overall Study|Lost to Follow-up|2|||
13404025|NCT00581555|26815075|FG000|Overall Study|Other reasons|16|||
13404026|NCT00581555|26815076|FG001|Overall Study|Other reasons|4|||
13476165|NCT01729754|27002610|FG002|Part 1|Lack of Efficacy|0|||
13476166|NCT01729754|27002611|FG003|Part 1|Lack of Efficacy|0|||
13476167|NCT01729754|27002612|FG004|Part 1|Lack of Efficacy|0|||
13476168|NCT01729754|27002613|FG005|Part 1|Lack of Efficacy|0|||
13476169|NCT01729754|27002614|FG006|Part 1|Lack of Efficacy|2|||
13476170|NCT01729754|27002615|FG007|Part 1|Lack of Efficacy|0|||
13476171|NCT01729754|27002616|FG008|Part 1|Lack of Efficacy|0|||
13476172|NCT01729754|27002617|FG009|Part 1|Lack of Efficacy|0|||
13476173|NCT01729754|27002608|FG000|Part 1|Lost to Follow-up|1|||
13476174|NCT01729754|27002609|FG001|Part 1|Lost to Follow-up|0|||
13476175|NCT01729754|27002610|FG002|Part 1|Lost to Follow-up|0|||
13476176|NCT01729754|27002611|FG003|Part 1|Lost to Follow-up|2|||
13476177|NCT01729754|27002612|FG004|Part 1|Lost to Follow-up|0|||
13476178|NCT01729754|27002613|FG005|Part 1|Lost to Follow-up|0|||
13476179|NCT01729754|27002614|FG006|Part 1|Lost to Follow-up|3|||
13476180|NCT01729754|27002615|FG007|Part 1|Lost to Follow-up|0|||
13476181|NCT01729754|27002616|FG008|Part 1|Lost to Follow-up|0|||
13476182|NCT01729754|27002617|FG009|Part 1|Lost to Follow-up|3|||
13476183|NCT01729754|27002608|FG000|Part 1|Non-compliance with Study Drug|1|||
13476184|NCT01729754|27002609|FG001|Part 1|Non-compliance with Study Drug|0|||
13476185|NCT01729754|27002610|FG002|Part 1|Non-compliance with Study Drug|0|||
13476186|NCT01729754|27002611|FG003|Part 1|Non-compliance with Study Drug|0|||
13476187|NCT01729754|27002612|FG004|Part 1|Non-compliance with Study Drug|0|||
13476188|NCT01729754|27002613|FG005|Part 1|Non-compliance with Study Drug|0|||
13476189|NCT01729754|27002614|FG006|Part 1|Non-compliance with Study Drug|0|||
13476190|NCT01729754|27002615|FG007|Part 1|Non-compliance with Study Drug|0|||
13476191|NCT01729754|27002616|FG008|Part 1|Non-compliance with Study Drug|0|||
13476192|NCT01729754|27002617|FG009|Part 1|Non-compliance with Study Drug|0|||
13476193|NCT01729754|27002608|FG000|Part 1|Physician Decision|0|||
13476194|NCT01729754|27002609|FG001|Part 1|Physician Decision|0|||
13476195|NCT01729754|27002610|FG002|Part 1|Physician Decision|0|||
13476196|NCT01729754|27002611|FG003|Part 1|Physician Decision|0|||
13476197|NCT01729754|27002612|FG004|Part 1|Physician Decision|0|||
13476198|NCT01729754|27002613|FG005|Part 1|Physician Decision|0|||
13476199|NCT01729754|27002614|FG006|Part 1|Physician Decision|0|||
13476200|NCT01729754|27002615|FG007|Part 1|Physician Decision|0|||
13476201|NCT01729754|27002616|FG008|Part 1|Physician Decision|0|||
13476202|NCT01729754|27002617|FG009|Part 1|Physician Decision|4|||
13476203|NCT01729754|27002608|FG000|Part 1|Pregnancy|0|||
13476204|NCT01729754|27002609|FG001|Part 1|Pregnancy|0|||
13476205|NCT01729754|27002610|FG002|Part 1|Pregnancy|0|||
13476206|NCT01729754|27002611|FG003|Part 1|Pregnancy|1|||
13476207|NCT01729754|27002612|FG004|Part 1|Pregnancy|0|||
13476208|NCT01729754|27002613|FG005|Part 1|Pregnancy|0|||
13476209|NCT01729754|27002614|FG006|Part 1|Pregnancy|0|||
13404027|NCT00581542|26815091|FG000|Overall Study|they met an exclusion criteria|2|||
13404028|NCT00581542|26815092|FG001|Overall Study|they met an exclusion criteria|2|||
13404029|NCT00581542|26815091|FG000|Overall Study|Lost to Follow-up|9|||
13404030|NCT00581542|26815092|FG001|Overall Study|Lost to Follow-up|21|||
13404031|NCT00581360|26815102|FG000|Overall Study|Withdrawal by Subject|1|||
13404032|NCT00581308|26815111|FG000|Pre Discharge|Lost to Follow-up|1|||
13404033|NCT00581308|26815111|FG000|Pre Discharge|Device Removed|1|||
13404034|NCT00581308|26815111|FG000|Month 1|Lost to Follow-up|3|||
13404035|NCT00581308|26815111|FG000|Month 1|Withdrawal by Subject|2|||
13404036|NCT00581308|26815111|FG000|Month 1|Device Removed|2|||
13404037|NCT00581308|26815111|FG000|Month 1|Uknown|1|||
13404038|NCT00581308|26815111|FG000|Month 6|Lost to Follow-up|1|||
13404039|NCT00581308|26815111|FG000|Month 6|Withdrawal by Subject|2|||
13404040|NCT00581308|26815111|FG000|Month 12|Death|1|||
13404041|NCT00581308|26815111|FG000|Month 12|Lost to Follow-up|14|||
13404042|NCT00581308|26815111|FG000|Month 12|Withdrawal by Subject|3|||
13404043|NCT00581308|26815111|FG000|Month 12|Device Removed|1|||
13404044|NCT00581308|26815111|FG000|Month 12|Other|1|||
13404045|NCT00581113|26815126|FG000|Overall Study|Withdrawal by Subject|0|||
13404046|NCT00581113|26815127|FG001|Overall Study|Withdrawal by Subject|1|||
13404047|NCT00581100|26815170|FG000|Overall Study|Death|1|||
13404048|NCT00581100|26815171|FG001|Overall Study|Death|0|||
13404049|NCT00581100|26815170|FG000|Overall Study|Adverse Event|2|||
13404050|NCT00581100|26815171|FG001|Overall Study|Adverse Event|1|||
13404051|NCT00581100|26815170|FG000|Overall Study|Withdrawal by Subject|1|||
13404052|NCT00581100|26815171|FG001|Overall Study|Withdrawal by Subject|4|||
13404053|NCT00581100|26815170|FG000|Overall Study|Other|3|||
13404054|NCT00581100|26815171|FG001|Overall Study|Other|0|||
13404055|NCT00580983|26815178|FG000|Overall Study|Did not complete 12 mon post RT studies|7|||
13404056|NCT00580970|26815188|FG000|Pre-treatment|Non-compliance|1|||
13404057|NCT00580970|26815188|FG000|Treatment (Lovastatin)|Non-compliance|6|||
13404058|NCT00580970|26815188|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7|||
13404059|NCT00580970|26815188|FG000|Treatment (Lovastatin)|Physician Decision|4|||
13404060|NCT00580970|26815188|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1|||
13404061|NCT00580970|26815188|FG000|Treatment (Lovastatin)|Death|1|||
13404062|NCT00580866|26815203|FG000|Overall Study|Lost to Follow-up|2|||
13404063|NCT00580866|26815204|FG001|Overall Study|Lost to Follow-up|2|||
13404064|NCT00580840|26815314|FG000|Run-in|Adverse Event|17|||
13404065|NCT00580840|26815315|FG001|Run-in|Adverse Event|0|||
13404066|NCT00580840|26815316|FG002|Run-in|Adverse Event|0|||
13404067|NCT00580840|26815317|FG003|Run-in|Adverse Event|0|||
13404068|NCT00580840|26815314|FG000|Run-in|Lack of Efficacy|93|||
13404069|NCT00580840|26815315|FG001|Run-in|Lack of Efficacy|0|||
13404070|NCT00580840|26815316|FG002|Run-in|Lack of Efficacy|0|||
13404071|NCT00580840|26815317|FG003|Run-in|Lack of Efficacy|0|||
13404072|NCT00580840|26815314|FG000|Run-in|Loss of Efficacy|1|||
13404073|NCT00580840|26815315|FG001|Run-in|Loss of Efficacy|0|||
13404074|NCT00580840|26815316|FG002|Run-in|Loss of Efficacy|0|||
13404075|NCT00580840|26815317|FG003|Run-in|Loss of Efficacy|0|||
13404076|NCT00580840|26815314|FG000|Run-in|Lost to Follow-up|4|||
13404077|NCT00580840|26815315|FG001|Run-in|Lost to Follow-up|0|||
13404078|NCT00580840|26815316|FG002|Run-in|Lost to Follow-up|0|||
13404079|NCT00580840|26815317|FG003|Run-in|Lost to Follow-up|0|||
13404080|NCT00580840|26815314|FG000|Run-in|Withdrawal by Subject|5|||
13404081|NCT00580840|26815315|FG001|Run-in|Withdrawal by Subject|0|||
13404082|NCT00580840|26815316|FG002|Run-in|Withdrawal by Subject|0|||
13404083|NCT00580840|26815317|FG003|Run-in|Withdrawal by Subject|0|||
13404084|NCT00580840|26815314|FG000|Run-in|Other: Per Sponsor Request|2|||
13404085|NCT00580840|26815315|FG001|Run-in|Other: Per Sponsor Request|0|||
13404086|NCT00580840|26815316|FG002|Run-in|Other: Per Sponsor Request|0|||
13404087|NCT00580840|26815317|FG003|Run-in|Other: Per Sponsor Request|0|||
13404088|NCT00580840|26815314|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1|||
13404089|NCT00580840|26815315|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
13404090|NCT00580840|26815316|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
13404091|NCT00580840|26815317|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
13404092|NCT00580840|26815314|FG000|Run-in|Other: Exclusionary Lab Value|1|||
13404093|NCT00580840|26815315|FG001|Run-in|Other: Exclusionary Lab Value|0|||
13404094|NCT00580840|26815316|FG002|Run-in|Other: Exclusionary Lab Value|0|||
13404095|NCT00580840|26815317|FG003|Run-in|Other: Exclusionary Lab Value|0|||
13404096|NCT00580840|26815314|FG000|Double-Blind|Adverse Event|0|||
13404097|NCT00580840|26815315|FG001|Double-Blind|Adverse Event|3|||
13404098|NCT00580840|26815316|FG002|Double-Blind|Adverse Event|4|||
13404099|NCT00580840|26815317|FG003|Double-Blind|Adverse Event|1|||
13404100|NCT00580840|26815314|FG000|Double-Blind|Loss of Efficacy|0|||
13404101|NCT00580840|26815315|FG001|Double-Blind|Loss of Efficacy|1|||
13404102|NCT00580840|26815316|FG002|Double-Blind|Loss of Efficacy|2|||
13404103|NCT00580840|26815317|FG003|Double-Blind|Loss of Efficacy|10|||
13404104|NCT00580840|26815314|FG000|Double-Blind|Lost to Follow-up|0|||
13404105|NCT00580840|26815315|FG001|Double-Blind|Lost to Follow-up|1|||
13404106|NCT00580840|26815316|FG002|Double-Blind|Lost to Follow-up|0|||
13404107|NCT00580840|26815317|FG003|Double-Blind|Lost to Follow-up|2|||
13404108|NCT00580840|26815314|FG000|Double-Blind|Withdrawal by Subject|0|||
13404109|NCT00580840|26815315|FG001|Double-Blind|Withdrawal by Subject|1|||
13404110|NCT00580840|26815316|FG002|Double-Blind|Withdrawal by Subject|2|||
13404111|NCT00580840|26815317|FG003|Double-Blind|Withdrawal by Subject|2|||
13404112|NCT00580840|26815314|FG000|Double-Blind|Other: Discontinued Methotrexate|0|||
13404113|NCT00580840|26815315|FG001|Double-Blind|Other: Discontinued Methotrexate|1|||
13404114|NCT00580840|26815316|FG002|Double-Blind|Other: Discontinued Methotrexate|0|||
13404115|NCT00580840|26815317|FG003|Double-Blind|Other: Discontinued Methotrexate|0|||
13404116|NCT00580840|26815314|FG000|Double-Blind|Other: Forbidden Medication|0|||
13404117|NCT00580840|26815315|FG001|Double-Blind|Other: Forbidden Medication|0|||
13404118|NCT00580840|26815316|FG002|Double-Blind|Other: Forbidden Medication|1|||
13404119|NCT00580840|26815317|FG003|Double-Blind|Other: Forbidden Medication|0|||
13404120|NCT00580801|26815362|FG000|Overall Study|Physician Decision|1|||
13404121|NCT00580801|26815363|FG001|Overall Study|Physician Decision|0|||
13404122|NCT00580801|26815364|FG002|Overall Study|Physician Decision|0|||
13404123|NCT00580801|26815362|FG000|Overall Study|Adverse Event|2|||
13404124|NCT00580801|26815363|FG001|Overall Study|Adverse Event|0|||
13404125|NCT00580801|26815364|FG002|Overall Study|Adverse Event|0|||
13404126|NCT00580801|26815362|FG000|Overall Study|Lost to Follow-up|2|||
13404127|NCT00580801|26815363|FG001|Overall Study|Lost to Follow-up|0|||
13404128|NCT00580801|26815364|FG002|Overall Study|Lost to Follow-up|0|||
13404129|NCT00580801|26815362|FG000|Overall Study|Reached a virologic endpoint|0|||
13404130|NCT00580801|26815363|FG001|Overall Study|Reached a virologic endpoint|1|||
13404131|NCT00580801|26815364|FG002|Overall Study|Reached a virologic endpoint|2|||
13404132|NCT00580801|26815362|FG000|Overall Study|Participant non-compliant|0|||
13404133|NCT00580801|26815363|FG001|Overall Study|Participant non-compliant|0|||
13404134|NCT00580801|26815364|FG002|Overall Study|Participant non-compliant|1|||
13404135|NCT00580801|26815362|FG000|Overall Study|Travel|1|||
13404136|NCT00580801|26815363|FG001|Overall Study|Travel|0|||
13404137|NCT00580801|26815364|FG002|Overall Study|Travel|0|||
13404138|NCT00580788|26815435|FG000|Overall Study|Adverse Event|0|||
13404139|NCT00580788|26815436|FG001|Overall Study|Adverse Event|0|||
13404140|NCT00580788|26815437|FG002|Overall Study|Adverse Event|0|||
13404141|NCT00580788|26815438|FG003|Overall Study|Adverse Event|1|||
13404142|NCT00580723|26815446|FG000|Overall Study|Did not want to participate in extension|3|||
13404143|NCT00580723|26815446|FG000|Overall Study|Lost to Follow-up|5|||
13404144|NCT00580606|26815471|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2|||
13404145|NCT00580606|26815472|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1|||
13404146|NCT00580606|26815471|FG000|Open Label (OL)|Withdrawal by Subject|4|||
13404147|NCT00580606|26815472|FG001|Open Label (OL)|Withdrawal by Subject|6|||
13404148|NCT00580606|26815471|FG000|Open Label (OL)|Dosing Symptoms|0|||
13404149|NCT00580606|26815472|FG001|Open Label (OL)|Dosing Symptoms|1|||
13404150|NCT00580606|26815471|FG000|Open Label (OL)|Lost to Follow-up|0|||
13404151|NCT00580606|26815472|FG001|Open Label (OL)|Lost to Follow-up|1|||
13404152|NCT00580606|26815471|FG000|Open Label (OL)|Pregnancy|0|||
13404153|NCT00580606|26815472|FG001|Open Label (OL)|Pregnancy|1|||
13404154|NCT00580606|26815471|FG000|Open Label (OL)|Non-compliance|2|||
13404155|NCT00580606|26815472|FG001|Open Label (OL)|Non-compliance|0|||
13404156|NCT00580606|26815471|FG000|Open Label (OL)|Physician Decision|1|||
13404157|NCT00580606|26815472|FG001|Open Label (OL)|Physician Decision|1|||
13404158|NCT00580606|26815471|FG000|Open Label (OL)|Needed Prohibited Medication|0|||
13404159|NCT00580606|26815472|FG001|Open Label (OL)|Needed Prohibited Medication|1|||
13404160|NCT00580034|26815481|FG000|Overall Study|Toxicity|10|||
13404161|NCT00580034|26815482|FG001|Overall Study|Toxicity|0|||
13404162|NCT00579982|26815503|FG000|Overall Study|Adverse Event|4|||
13404163|NCT00579982|26815503|FG000|Overall Study|Protocol Violation|4|||
13404164|NCT00579670|26815731|FG000|Overall Study|Death|1|||
13404165|NCT00579670|26815732|FG001|Overall Study|Death|0|||
13404166|NCT00579670|26815733|FG002|Overall Study|Death|0|||
13404167|NCT00579670|26815734|FG003|Overall Study|Death|0|||
13404168|NCT00579670|26815735|FG004|Overall Study|Death|0|||
13404169|NCT00579670|26815731|FG000|Overall Study|Adverse Event|1|||
13404170|NCT00579670|26815732|FG001|Overall Study|Adverse Event|0|||
13404171|NCT00579670|26815733|FG002|Overall Study|Adverse Event|1|||
13404172|NCT00579670|26815734|FG003|Overall Study|Adverse Event|2|||
13404173|NCT00579670|26815735|FG004|Overall Study|Adverse Event|0|||
13404174|NCT00579670|26815731|FG000|Overall Study|Lack of Efficacy|0|||
13404175|NCT00579670|26815732|FG001|Overall Study|Lack of Efficacy|0|||
13404176|NCT00579670|26815733|FG002|Overall Study|Lack of Efficacy|1|||
13404177|NCT00579670|26815734|FG003|Overall Study|Lack of Efficacy|14|||
13404178|NCT00579670|26815735|FG004|Overall Study|Lack of Efficacy|0|||
13404179|NCT00579670|26815731|FG000|Overall Study|Lost to Follow-up|0|||
13404180|NCT00579670|26815732|FG001|Overall Study|Lost to Follow-up|1|||
13404181|NCT00579670|26815733|FG002|Overall Study|Lost to Follow-up|0|||
13404182|NCT00579670|26815734|FG003|Overall Study|Lost to Follow-up|4|||
13404183|NCT00579670|26815735|FG004|Overall Study|Lost to Follow-up|0|||
13404184|NCT00579670|26815731|FG000|Overall Study|Other|0|||
13404185|NCT00579670|26815732|FG001|Overall Study|Other|0|||
13404186|NCT00579670|26815733|FG002|Overall Study|Other|1|||
13404187|NCT00579670|26815734|FG003|Overall Study|Other|2|||
13404188|NCT00579670|26815735|FG004|Overall Study|Other|0|||
13404189|NCT00579670|26815731|FG000|Overall Study|Withdrawal by Subject|0|||
13404190|NCT00579670|26815732|FG001|Overall Study|Withdrawal by Subject|0|||
13404191|NCT00579670|26815733|FG002|Overall Study|Withdrawal by Subject|1|||
13404192|NCT00579670|26815734|FG003|Overall Study|Withdrawal by Subject|0|||
13404193|NCT00579670|26815735|FG004|Overall Study|Withdrawal by Subject|0|||
13404194|NCT00579553|26815754|FG000|Overall Study|Lost to Follow-up|16|||
13404195|NCT00579553|26815755|FG001|Overall Study|Lost to Follow-up|13|||
13404196|NCT00579501|26815762|FG000|Overall Study|Death|1|||
13404197|NCT00579501|26815762|FG000|Overall Study|End of neoadjuvant therapy|25|||
13404198|NCT00579501|26815762|FG000|Overall Study|toxicity|1|||
13404199|NCT00579501|26815762|FG000|Overall Study|Secondary lesion|1|||
13404200|NCT00579501|26815762|FG000|Overall Study|Radiation therapy before surgery|1|||
13404201|NCT00579345|26815819|FG000|Overall Study|Withdrawal by Subject|2|||
13404202|NCT00579345|26815820|FG001|Overall Study|Withdrawal by Subject|0|||
13404203|NCT00579345|26815821|FG002|Overall Study|Withdrawal by Subject|0|||
13404204|NCT00579345|26815822|FG003|Overall Study|Withdrawal by Subject|0|||
13404205|NCT00579345|26815823|FG004|Overall Study|Withdrawal by Subject|0|||
13404206|NCT00579345|26815824|FG005|Overall Study|Withdrawal by Subject|0|||
13404207|NCT00579345|26815825|FG006|Overall Study|Withdrawal by Subject|0|||
13404208|NCT00579345|26815826|FG007|Overall Study|Withdrawal by Subject|1|||
13404209|NCT00579345|26815819|FG000|Overall Study|Lost to Follow-up|1|||
13404210|NCT00579345|26815820|FG001|Overall Study|Lost to Follow-up|0|||
13404211|NCT00579345|26815821|FG002|Overall Study|Lost to Follow-up|0|||
13404212|NCT00579345|26815822|FG003|Overall Study|Lost to Follow-up|0|||
13404213|NCT00579345|26815823|FG004|Overall Study|Lost to Follow-up|0|||
13404214|NCT00579345|26815824|FG005|Overall Study|Lost to Follow-up|0|||
13404215|NCT00579345|26815825|FG006|Overall Study|Lost to Follow-up|0|||
13404216|NCT00579345|26815826|FG007|Overall Study|Lost to Follow-up|0|||
13404217|NCT00579345|26815819|FG000|Overall Study|Adverse Event|0|||
13404218|NCT00579345|26815820|FG001|Overall Study|Adverse Event|0|||
13404219|NCT00579345|26815821|FG002|Overall Study|Adverse Event|1|||
13404220|NCT00579345|26815822|FG003|Overall Study|Adverse Event|0|||
13404221|NCT00579345|26815823|FG004|Overall Study|Adverse Event|0|||
13404222|NCT00579345|26815824|FG005|Overall Study|Adverse Event|0|||
13404223|NCT00579345|26815825|FG006|Overall Study|Adverse Event|0|||
13404224|NCT00579345|26815826|FG007|Overall Study|Adverse Event|0|||
13404225|NCT00579345|26815819|FG000|Overall Study|Protocol Violation|1|||
13404226|NCT00579345|26815820|FG001|Overall Study|Protocol Violation|0|||
13404227|NCT00579345|26815821|FG002|Overall Study|Protocol Violation|0|||
13404228|NCT00579345|26815822|FG003|Overall Study|Protocol Violation|0|||
13404229|NCT00579345|26815823|FG004|Overall Study|Protocol Violation|0|||
13404230|NCT00579345|26815824|FG005|Overall Study|Protocol Violation|0|||
13404231|NCT00579345|26815825|FG006|Overall Study|Protocol Violation|0|||
13404232|NCT00579345|26815826|FG007|Overall Study|Protocol Violation|1|||
13404233|NCT00579345|26815819|FG000|Overall Study|Death|1|||
13404234|NCT00579345|26815820|FG001|Overall Study|Death|1|||
13404235|NCT00579345|26815821|FG002|Overall Study|Death|1|||
13404236|NCT00579345|26815822|FG003|Overall Study|Death|1|||
13404237|NCT00579345|26815823|FG004|Overall Study|Death|0|||
13404238|NCT00579345|26815824|FG005|Overall Study|Death|0|||
13404239|NCT00579345|26815825|FG006|Overall Study|Death|0|||
13404240|NCT00579345|26815826|FG007|Overall Study|Death|0|||
13404241|NCT00579254|26815832|FG000|Overall Study|Lost to Follow-up|39|||
13404242|NCT00579254|26815832|FG000|Overall Study|Discontinued when study terminated|73|||
13404243|NCT00579098|26815853|FG000|Overall Study|Lost to Follow-up|2|||
13404244|NCT00579098|26815854|FG001|Overall Study|Lost to Follow-up|0|||
13404245|NCT00579098|26815853|FG000|Overall Study|Adverse Event|2|||
13404246|NCT00579098|26815854|FG001|Overall Study|Adverse Event|3|||
13404247|NCT00579098|26815853|FG000|Overall Study|Withdrawal by Subject|2|||
13404248|NCT00579098|26815854|FG001|Overall Study|Withdrawal by Subject|3|||
13404249|NCT00579098|26815853|FG000|Overall Study|AF returned after ablation|3|||
13404250|NCT00579098|26815854|FG001|Overall Study|AF returned after ablation|2|||
13404251|NCT00579059|26815869|FG000|Overall Study|Study Canceled at 1 Year|21|||
13404252|NCT00579059|26815870|FG001|Overall Study|Study Canceled at 1 Year|10|||
13404253|NCT00578942|26815878|FG000|Overall Study|Lost to Follow-up|1|||
13404254|NCT00578877|26815891|FG000|Overall Study|Lost to Follow-up|8|||
13404255|NCT00578877|26815892|FG001|Overall Study|Lost to Follow-up|10|||
13404256|NCT00578877|26815891|FG000|Overall Study|early discontinue|61|||
13404257|NCT00578877|26815892|FG001|Overall Study|early discontinue|101|||
13404258|NCT00578877|26815891|FG000|Overall Study|did not provide follow-up data|12|||
13404259|NCT00578877|26815892|FG001|Overall Study|did not provide follow-up data|17|||
13404260|NCT00578864|26815913|FG000|Overall Study|Death|1|||
13404261|NCT00578864|26815914|FG001|Overall Study|Death|0|||
13404262|NCT00578812|26815957|FG000|Overall Study|Not treated|6|||
13404263|NCT00578812|26815958|FG001|Overall Study|Not treated|7|||
13404264|NCT00578786|26816047|FG000|Overall Study|Adverse Event|27|||
13404265|NCT00578786|26816048|FG001|Overall Study|Adverse Event|37|||
13404266|NCT00578786|26816049|FG002|Overall Study|Adverse Event|17|||
13404267|NCT00578786|26816047|FG000|Overall Study|Lack of Efficacy|2|||
13404268|NCT00578786|26816048|FG001|Overall Study|Lack of Efficacy|5|||
13404269|NCT00578786|26816049|FG002|Overall Study|Lack of Efficacy|2|||
13404270|NCT00578786|26816047|FG000|Overall Study|Early Escape from Prior Study|2|||
13404271|NCT00578786|26816048|FG001|Overall Study|Early Escape from Prior Study|1|||
13404272|NCT00578786|26816049|FG002|Overall Study|Early Escape from Prior Study|2|||
13404273|NCT00578786|26816047|FG000|Overall Study|Withdrawal by Subject|7|||
13404274|NCT00578786|26816048|FG001|Overall Study|Withdrawal by Subject|8|||
13404275|NCT00578786|26816049|FG002|Overall Study|Withdrawal by Subject|5|||
13404276|NCT00578786|26816047|FG000|Overall Study|Protocol Violation|0|||
13404277|NCT00578786|26816048|FG001|Overall Study|Protocol Violation|3|||
13404278|NCT00578786|26816049|FG002|Overall Study|Protocol Violation|1|||
13404279|NCT00578786|26816047|FG000|Overall Study|Physician Decision|1|||
13404280|NCT00578786|26816048|FG001|Overall Study|Physician Decision|0|||
13404281|NCT00578786|26816049|FG002|Overall Study|Physician Decision|1|||
13404282|NCT00578786|26816047|FG000|Overall Study|Sponsor Decision|0|||
13404283|NCT00578786|26816048|FG001|Overall Study|Sponsor Decision|0|||
13404284|NCT00578786|26816049|FG002|Overall Study|Sponsor Decision|1|||
13404285|NCT00578786|26816047|FG000|Overall Study|Lost to Follow-up|0|||
13404286|NCT00578786|26816048|FG001|Overall Study|Lost to Follow-up|4|||
13404287|NCT00578786|26816049|FG002|Overall Study|Lost to Follow-up|0|||
13404288|NCT00578786|26816047|FG000|Overall Study|Pregnancy|0|||
13404289|NCT00578786|26816048|FG001|Overall Study|Pregnancy|1|||
13404290|NCT00578786|26816049|FG002|Overall Study|Pregnancy|0|||
13404291|NCT00578786|26816047|FG000|Overall Study|Not Otherwise Specified|0|||
13404292|NCT00578786|26816048|FG001|Overall Study|Not Otherwise Specified|4|||
13404293|NCT00578786|26816049|FG002|Overall Study|Not Otherwise Specified|1|||
13404294|NCT00578786|26816047|FG000|Overall Study|Qualified but Not Enrolled in Extension|0|||
13404295|NCT00578786|26816048|FG001|Overall Study|Qualified but Not Enrolled in Extension|3|||
13404296|NCT00578786|26816049|FG002|Overall Study|Qualified but Not Enrolled in Extension|0|||
13404297|NCT00578643|26816058|FG000|Overall Study|Death|1|||
13404298|NCT00578643|26816058|FG000|Overall Study|Lost to Follow-up|1|||
13404299|NCT00578565|26816069|FG000|Overall Study|Adverse Event|3|||
13404300|NCT00578448|26816085|FG000|Day 1 up to 3 Years of Planned Study|Death|1|||
13404301|NCT00578448|26816085|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1|||
13404302|NCT00578448|26816085|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1|||
13404303|NCT00578448|26816085|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1|||
13404304|NCT00578344|26816093|FG000|Overall Study|Insurance problems|1|||
13404305|NCT00578344|26816093|FG000|Overall Study|Graft failure|1|||
13404306|NCT00578318|26816106|FG000|Overall Study|Lost to Follow-up|2|||
13404307|NCT00578318|26816107|FG001|Overall Study|Lost to Follow-up|0|||
13404308|NCT00578318|26816106|FG000|Overall Study|Physician Decision|1|||
13404309|NCT00578318|26816107|FG001|Overall Study|Physician Decision|0|||
13404310|NCT00578292|26816121|FG000|Overall Study|Death|1|||
13404311|NCT00578292|26816121|FG000|Overall Study|Graft failure|2|||
13404312|NCT00578227|26816201|FG000|Overall Study|Lost to Follow-up|0|||
13404313|NCT00578227|26816202|FG001|Overall Study|Lost to Follow-up|1|||
13404314|NCT00578227|26816203|FG002|Overall Study|Lost to Follow-up|1|||
13404315|NCT00578227|26816201|FG000|Overall Study|Withdrawal by Subject|5|||
13404316|NCT00578227|26816202|FG001|Overall Study|Withdrawal by Subject|1|||
13404317|NCT00578227|26816203|FG002|Overall Study|Withdrawal by Subject|3|||
13404318|NCT00578175|26816290|FG000|Overall Study|Adverse Event|0|||
13404319|NCT00578175|26816291|FG001|Overall Study|Adverse Event|1|||
13404320|NCT00578175|26816292|FG002|Overall Study|Adverse Event|1|||
13404321|NCT00578175|26816290|FG000|Overall Study|Other reasons|70|||
13404322|NCT00578175|26816291|FG001|Overall Study|Other reasons|42|||
13404323|NCT00578175|26816292|FG002|Overall Study|Other reasons|23|||
13404324|NCT00578136|26816307|FG000|Overall Study|Not given intervention|1|||
13404325|NCT00578136|26816308|FG001|Overall Study|Not given intervention|1|||
13404326|NCT00577993|26816326|FG000|Overall Study|Adverse Event|1|||
13404327|NCT00577993|26816327|FG001|Overall Study|Adverse Event|0|||
13404328|NCT00577993|26816328|FG002|Overall Study|Adverse Event|0|||
13404329|NCT00577993|26816326|FG000|Overall Study|Death|0|||
13404330|NCT00577993|26816327|FG001|Overall Study|Death|1|||
13404331|NCT00577993|26816328|FG002|Overall Study|Death|1|||
13404332|NCT00577993|26816326|FG000|Overall Study|Lack of Efficacy|0|||
13404333|NCT00577993|26816327|FG001|Overall Study|Lack of Efficacy|1|||
13404334|NCT00577993|26816328|FG002|Overall Study|Lack of Efficacy|0|||
13404335|NCT00577993|26816326|FG000|Overall Study|Protocol Violation|2|||
13404336|NCT00577993|26816327|FG001|Overall Study|Protocol Violation|3|||
13404337|NCT00577993|26816328|FG002|Overall Study|Protocol Violation|0|||
13404338|NCT00577993|26816326|FG000|Overall Study|Withdrawal by Subject|1|||
13404339|NCT00577993|26816327|FG001|Overall Study|Withdrawal by Subject|0|||
13404340|NCT00577993|26816328|FG002|Overall Study|Withdrawal by Subject|2|||
13404341|NCT00577993|26816326|FG000|Overall Study|Conversion|2|||
13404342|NCT00577993|26816327|FG001|Overall Study|Conversion|5|||
13404343|NCT00577993|26816328|FG002|Overall Study|Conversion|0|||
13404344|NCT00577993|26816326|FG000|Overall Study|Uninsured|1|||
13404345|NCT00577993|26816327|FG001|Overall Study|Uninsured|0|||
13404346|NCT00577993|26816328|FG002|Overall Study|Uninsured|0|||
13404347|NCT00577889|26816355|FG000|Overall Study|Withdrawal by Subject|1|||
13404348|NCT00577889|26816356|FG001|Overall Study|Withdrawal by Subject|0|||
13404349|NCT00577889|26816357|FG002|Overall Study|Withdrawal by Subject|0|||
13404350|NCT00577863|26816403|FG000|Overall Study|Adverse Event|4|||
13404351|NCT00577863|26816404|FG001|Overall Study|Adverse Event|2|||
13404352|NCT00577863|26816403|FG000|Overall Study|Death|1|||
13404353|NCT00577863|26816404|FG001|Overall Study|Death|0|||
13404354|NCT00577863|26816403|FG000|Overall Study|Lost to Follow-up|2|||
13404355|NCT00577863|26816404|FG001|Overall Study|Lost to Follow-up|2|||
13404356|NCT00577863|26816403|FG000|Overall Study|Entry Criteria Exclusion|1|||
13219905|NCT01829295|26278603|FG000|6-12 Months|Withdrawal by Subject|2|||
13219906|NCT01829295|26278604|FG001|6-12 Months|Withdrawal by Subject|2|||
13219907|NCT01829295|26278605|FG002|6-12 Months|Withdrawal by Subject|0|||
13219908|NCT01829295|26278606|FG003|6-12 Months|Withdrawal by Subject|0|||
13219909|NCT01829243|26278621|FG000|First Intervention|Screen Failure|4|||
13404357|NCT00577863|26816404|FG001|Overall Study|Entry Criteria Exclusion|0|||
13404358|NCT00577863|26816403|FG000|Overall Study|Withdrawal by Subject|0|||
13404359|NCT00577863|26816404|FG001|Overall Study|Withdrawal by Subject|2|||
13404360|NCT00577863|26816403|FG000|Overall Study|Sponsor Decision|2|||
13404361|NCT00577863|26816404|FG001|Overall Study|Sponsor Decision|7|||
13404362|NCT00577863|26816403|FG000|Overall Study|Did Not Receive at Least One Injection|0|||
13404363|NCT00577863|26816404|FG001|Overall Study|Did Not Receive at Least One Injection|1|||
13404364|NCT00577824|26816470|FG000|Overall Study|Adverse Event|6|||
13404365|NCT00577824|26816471|FG001|Overall Study|Adverse Event|18|||
13404366|NCT00577824|26816472|FG002|Overall Study|Adverse Event|1|||
13404367|NCT00577824|26816470|FG000|Overall Study|Patient decision|0|||
13404368|NCT00577824|26816471|FG001|Overall Study|Patient decision|1|||
13404369|NCT00577824|26816472|FG002|Overall Study|Patient decision|1|||
13404370|NCT00577824|26816470|FG000|Overall Study|Protocol Violation|1|||
13404371|NCT00577824|26816471|FG001|Overall Study|Protocol Violation|1|||
13404372|NCT00577824|26816472|FG002|Overall Study|Protocol Violation|0|||
13404373|NCT00577772|26816485|FG000|Overall Study|Lost to Follow-up|0|||
13404374|NCT00577772|26816486|FG001|Overall Study|Lost to Follow-up|1|||
13404375|NCT00577720|26816517|FG000|Overall Study|Adverse Event|2|||
13404376|NCT00577720|26816518|FG001|Overall Study|Adverse Event|1|||
13404377|NCT00577720|26816519|FG002|Overall Study|Adverse Event|0|||
13404378|NCT00577720|26816520|FG003|Overall Study|Adverse Event|4|||
13404379|NCT00577720|26816517|FG000|Overall Study|Lost to Follow-up|0|||
13404380|NCT00577720|26816518|FG001|Overall Study|Lost to Follow-up|0|||
13404381|NCT00577720|26816519|FG002|Overall Study|Lost to Follow-up|1|||
13404382|NCT00577720|26816520|FG003|Overall Study|Lost to Follow-up|0|||
13404383|NCT00577720|26816517|FG000|Overall Study|Protocol Violation|0|||
13404384|NCT00577720|26816518|FG001|Overall Study|Protocol Violation|0|||
13404385|NCT00577720|26816519|FG002|Overall Study|Protocol Violation|0|||
13404386|NCT00577720|26816520|FG003|Overall Study|Protocol Violation|1|||
13404387|NCT00577720|26816517|FG000|Overall Study|Withdrawal by Subject|2|||
13404388|NCT00577720|26816518|FG001|Overall Study|Withdrawal by Subject|0|||
13404389|NCT00577720|26816519|FG002|Overall Study|Withdrawal by Subject|0|||
13404390|NCT00577720|26816520|FG003|Overall Study|Withdrawal by Subject|2|||
13404391|NCT00577707|26816528|FG000|Overall Study|Withdrawal by Subject|3|||
13404392|NCT00577655|26816573|FG000|Overall Study|Patient Request|0|||
13404393|NCT00577655|26816574|FG001|Overall Study|Patient Request|2|||
13404394|NCT00577655|26816573|FG000|Overall Study|Protocol Violation|0|||
13404395|NCT00577655|26816574|FG001|Overall Study|Protocol Violation|1|||
13404396|NCT00577655|26816573|FG000|Overall Study|Lost to Follow-up|1|||
13404397|NCT00577655|26816574|FG001|Overall Study|Lost to Follow-up|1|||
13404398|NCT00577642|26816580|FG000|Overall Study|Clinical Disease Progression|1|||
13404399|NCT00577629|26816590|FG000|Treatment Period|Death|1|||
13404400|NCT00577629|26816590|FG000|Long Term Follow-Up|Death|15|||
13404401|NCT00577629|26816590|FG000|Long Term Follow-Up|Lost to Follow-up|5|||
13404402|NCT00577629|26816590|FG000|Long Term Follow-Up|Withdrawal by Subject|4|||
13404403|NCT00577629|26816590|FG000|Long Term Follow-Up|Physician Decision|1|||
13404404|NCT00577473|26816625|FG000|Overall Study|Protocol Violation|1|||
13404405|NCT00577473|26816626|FG001|Overall Study|Protocol Violation|4|||
13404406|NCT00577473|26816625|FG000|Overall Study|Adverse Event|8|||
13404407|NCT00577473|26816626|FG001|Overall Study|Adverse Event|5|||
13404408|NCT00577473|26816625|FG000|Overall Study|Withdrawal by Subject|2|||
13404409|NCT00577473|26816626|FG001|Overall Study|Withdrawal by Subject|6|||
13404410|NCT00577473|26816625|FG000|Overall Study|Physician Decision|2|||
13404411|NCT00577473|26816626|FG001|Overall Study|Physician Decision|2|||
13404412|NCT00577473|26816625|FG000|Overall Study|Lack of Efficacy|8|||
13404413|NCT00577473|26816626|FG001|Overall Study|Lack of Efficacy|7|||
13404414|NCT00577460|26816743|FG000|Overall Study|Adverse Event|11|||
13404415|NCT00577460|26816744|FG001|Overall Study|Adverse Event|7|||
13404416|NCT00577460|26816745|FG002|Overall Study|Adverse Event|14|||
13404417|NCT00577460|26816743|FG000|Overall Study|Protocol Violation|0|||
13404418|NCT00577460|26816744|FG001|Overall Study|Protocol Violation|1|||
13404419|NCT00577460|26816745|FG002|Overall Study|Protocol Violation|1|||
13404420|NCT00577460|26816743|FG000|Overall Study|Lost to Follow-up|0|||
13404421|NCT00577460|26816744|FG001|Overall Study|Lost to Follow-up|3|||
13404422|NCT00577460|26816745|FG002|Overall Study|Lost to Follow-up|4|||
13404423|NCT00577460|26816743|FG000|Overall Study|Withdrawal by Subject|5|||
13404424|NCT00577460|26816744|FG001|Overall Study|Withdrawal by Subject|5|||
13404425|NCT00577460|26816745|FG002|Overall Study|Withdrawal by Subject|6|||
13404426|NCT00577460|26816743|FG000|Overall Study|Other|0|||
13404427|NCT00577460|26816744|FG001|Overall Study|Other|3|||
13404428|NCT00577460|26816745|FG002|Overall Study|Other|2|||
13404429|NCT00577408|26816758|FG000|Overall Study|Stopped attending study visits|9|||
13404430|NCT00577408|26816759|FG001|Overall Study|Stopped attending study visits|11|||
13404431|NCT00577408|26816758|FG000|Overall Study|Continued opioid use|3|||
13404432|NCT00577408|26816759|FG001|Overall Study|Continued opioid use|2|||
13404433|NCT00577408|26816758|FG000|Overall Study|Non-compliance with study meds|0|||
13404434|NCT00577408|26816759|FG001|Overall Study|Non-compliance with study meds|3|||
13404435|NCT00577408|26816758|FG000|Overall Study|Refused Oral Naltrexone|0|||
13404436|NCT00577408|26816759|FG001|Overall Study|Refused Oral Naltrexone|1|||
13404437|NCT00577408|26816758|FG000|Overall Study|Moved out of state|0|||
13404438|NCT00577408|26816759|FG001|Overall Study|Moved out of state|1|||
13404439|NCT00577408|26816758|FG000|Overall Study|Scheduling Issues|0|||
13404440|NCT00577408|26816759|FG001|Overall Study|Scheduling Issues|3|||
13404441|NCT00577408|26816758|FG000|Overall Study|Death|0|||
13404442|NCT00577408|26816759|FG001|Overall Study|Death|1|||
13404443|NCT00577408|26816758|FG000|Overall Study|Psychiatric hospitalization|0|||
13404444|NCT00577408|26816759|FG001|Overall Study|Psychiatric hospitalization|1|||
13404445|NCT00577395|26816774|FG000|Overall Study|Study was terminated early by Sponsor|7|||
13404446|NCT00577395|26816775|FG001|Overall Study|Study was terminated early by Sponsor|6|||
13404447|NCT00577382|26816794|FG000|Overall Study|Adverse Event|0|||
13404448|NCT00577382|26816795|FG001|Overall Study|Adverse Event|6|||
13404449|NCT00577382|26816794|FG000|Overall Study|Withdrawal by Subject|0|||
13404450|NCT00577382|26816795|FG001|Overall Study|Withdrawal by Subject|1|||
13404451|NCT00577382|26816794|FG000|Overall Study|Progressive Disease|17|||
13404452|NCT00577382|26816795|FG001|Overall Study|Progressive Disease|19|||
13404453|NCT00577382|26816794|FG000|Overall Study|Intercurrent Illness|1|||
13404454|NCT00577382|26816795|FG001|Overall Study|Intercurrent Illness|2|||
13404455|NCT00577382|26816794|FG000|Overall Study|Death|1|||
13404456|NCT00577382|26816795|FG001|Overall Study|Death|1|||
13404457|NCT00577382|26816794|FG000|Overall Study|Lost to Follow-up|2|||
13404458|NCT00577382|26816795|FG001|Overall Study|Lost to Follow-up|2|||
13404459|NCT00577317|26816808|FG000|Overall Study|Study Terminated|0|||
13404460|NCT00577317|26816809|FG001|Overall Study|Study Terminated|2|||
13404461|NCT00577122|26816828|FG000|Overall Study|Adverse Event|0|||
13404462|NCT00577122|26816829|FG001|Overall Study|Adverse Event|2|||
13404463|NCT00577122|26816828|FG000|Overall Study|Progression, relapse during active trt|6|||
13404464|NCT00577122|26816829|FG001|Overall Study|Progression, relapse during active trt|8|||
13404465|NCT00577122|26816828|FG000|Overall Study|Prog, refract disease during active trt|8|||
13404466|NCT00577122|26816829|FG001|Overall Study|Prog, refract disease during active trt|5|||
13404467|NCT00577122|26816828|FG000|Overall Study|Alternative Therapy|0|||
13404468|NCT00577122|26816829|FG001|Overall Study|Alternative Therapy|1|||
13404469|NCT00577096|26816860|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3|||
13404470|NCT00577096|26816861|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2|||
13404471|NCT00577096|26816860|FG000|Short Term Participation|Withdrawal by Subject|3|||
13404472|NCT00577096|26816861|FG001|Short Term Participation|Withdrawal by Subject|5|||
13404473|NCT00577096|26816860|FG000|Short Term Participation|Death|1|||
13404474|NCT00577096|26816861|FG001|Short Term Participation|Death|1|||
13404475|NCT00577031|26816882|FG000|Overall Study|Adverse Event|52|||
13404476|NCT00577031|26816882|FG000|Overall Study|Progression of disease|93|||
13404477|NCT00577031|26816882|FG000|Overall Study|Protocol Violation|5|||
13404478|NCT00577031|26816882|FG000|Overall Study|Participant withdrew consent|13|||
13404479|NCT00577031|26816882|FG000|Overall Study|Participant non-compliance|5|||
13404480|NCT00577031|26816882|FG000|Overall Study|Need for surgery|17|||
13404481|NCT00577031|26816882|FG000|Overall Study|Medical decision|14|||
13404482|NCT00577031|26816882|FG000|Overall Study|Death|6|||
13404483|NCT00577005|26816901|FG000|Overall Study|Lost to Follow-up|3|||
13404484|NCT00577005|26816902|FG001|Overall Study|Lost to Follow-up|2|||
13404485|NCT00577005|26816901|FG000|Overall Study|Withdrawal by Subject|2|||
13404486|NCT00577005|26816902|FG001|Overall Study|Withdrawal by Subject|1|||
13404487|NCT00576927|26816920|FG000|Clinical Assessment|Lack of Efficacy|24|||
13404488|NCT00576927|26816920|FG000|Clinical Assessment|Death|1|||
13404489|NCT00576927|26816920|FG000|Clinical Assessment|Withdrawal by Subject|10|||
13404490|NCT00576927|26816920|FG000|Clinical Assessment|Physician Decision|1|||
13404491|NCT00576927|26816920|FG000|Baseline|Physician Decision|9|||
13404492|NCT00576927|26816920|FG000|Baseline|Medication Change by PCP of subject|1|||
13404493|NCT00576927|26816920|FG000|Baseline|Withdrawal by Subject|3|||
13404494|NCT00576927|26816920|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4|||
13404495|NCT00576927|26816920|FG000|Sleep Hygiene Behavioral Intervention|Death|1|||
13404496|NCT00576927|26816920|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1|||
13404497|NCT00576927|26816920|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1|||
13404498|NCT00576927|26816920|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1|||
13404499|NCT00576901|26816930|FG000|Overall Study|Withdrawal by Subject|1|||
13404500|NCT00576901|26816930|FG000|Overall Study|Disease course|1|||
13404501|NCT00576901|26816930|FG000|Overall Study|Protocol Violation|1|||
13404502|NCT00576823|26816954|FG000|12-week Efficacy Phase|Parent's schedule issue|1|||
13404503|NCT00576823|26816955|FG001|12-week Efficacy Phase|Parent's schedule issue|0|||
13404504|NCT00576823|26816956|FG002|12-week Efficacy Phase|Parent's schedule issue|0|||
13404505|NCT00576823|26816954|FG000|40-week Safety Extension Phase|Lack of Efficacy|1|||
13404506|NCT00576823|26816955|FG001|40-week Safety Extension Phase|Lack of Efficacy|0|||
13404507|NCT00576823|26816956|FG002|40-week Safety Extension Phase|Lack of Efficacy|0|||
13404508|NCT00576758|26817006|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
13404509|NCT00576758|26817007|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
13404510|NCT00576758|26817006|FG000|Induction Treatment Period|Insufficient therapeutic response|2|||
13404511|NCT00576758|26817007|FG001|Induction Treatment Period|Insufficient therapeutic response|0|||
13404512|NCT00576758|26817006|FG000|Induction Treatment Period|Violation of selection criteria at entry|1|||
13404513|NCT00576758|26817007|FG001|Induction Treatment Period|Violation of selection criteria at entry|1|||
13404514|NCT00576758|26817006|FG000|Induction Treatment Period|Death|1|||
13404515|NCT00576758|26817007|FG001|Induction Treatment Period|Death|0|||
13404516|NCT00576758|26817006|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0|||
13404517|NCT00576758|26817007|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1|||
13404518|NCT00576758|26817006|FG000|Induction Treatment Period|Withdrew consent|1|||
13404519|NCT00576758|26817007|FG001|Induction Treatment Period|Withdrew consent|0|||
13404520|NCT00576758|26817006|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6|||
13404521|NCT00576758|26817007|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7|||
13404522|NCT00576758|26817006|FG000|Extension Treatment Period|Death|1|||
13404523|NCT00576758|26817007|FG001|Extension Treatment Period|Death|1|||
13404524|NCT00576758|26817006|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2|||
13404525|NCT00576758|26817007|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1|||
13404526|NCT00576758|26817006|FG000|Extension Treatment Period|Insufficient therapeutic response|30|||
13404527|NCT00576758|26817007|FG001|Extension Treatment Period|Insufficient therapeutic response|33|||
13404528|NCT00576758|26817006|FG000|Extension Treatment Period|Administrative/Other|3|||
13404529|NCT00576758|26817007|FG001|Extension Treatment Period|Administrative/Other|1|||
13404530|NCT00576758|26817006|FG000|Follow-up Period|Administrative/Other|6|||
13404531|NCT00576758|26817007|FG001|Follow-up Period|Administrative/Other|8|||
13404532|NCT00576758|26817006|FG000|Follow-up Period|Death|3|||
13404533|NCT00576758|26817007|FG001|Follow-up Period|Death|3|||
13404534|NCT00576758|26817006|FG000|Follow-up Period|Insufficient therapeutic response|16|||
13404535|NCT00576758|26817007|FG001|Follow-up Period|Insufficient therapeutic response|5|||
13404536|NCT00576758|26817006|FG000|Follow-up Period|Withdrew consent|2|||
13404537|NCT00576758|26817007|FG001|Follow-up Period|Withdrew consent|1|||
13404538|NCT00576732|26817050|FG000|DOUBLE BLIND|Adverse Event|0|||
13404539|NCT00576732|26817051|FG001|DOUBLE BLIND|Adverse Event|0|||
13404540|NCT00576732|26817052|FG002|DOUBLE BLIND|Adverse Event|1|||
13404541|NCT00576732|26817053|FG003|DOUBLE BLIND|Adverse Event|0|||
13404542|NCT00576732|26817054|FG004|DOUBLE BLIND|Adverse Event|0|||
13404543|NCT00576732|26817055|FG005|DOUBLE BLIND|Adverse Event|0|||
13404544|NCT00576732|26817050|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
13404545|NCT00576732|26817051|FG001|DOUBLE BLIND|Lost to Follow-up|1|||
13404546|NCT00576732|26817052|FG002|DOUBLE BLIND|Lost to Follow-up|1|||
13404547|NCT00576732|26817053|FG003|DOUBLE BLIND|Lost to Follow-up|0|||
13404548|NCT00576732|26817054|FG004|DOUBLE BLIND|Lost to Follow-up|0|||
13404549|NCT00576732|26817055|FG005|DOUBLE BLIND|Lost to Follow-up|0|||
13404550|NCT00576732|26817050|FG000|DOUBLE BLIND|Withdrawal by Subject|1|||
13404551|NCT00576732|26817051|FG001|DOUBLE BLIND|Withdrawal by Subject|1|||
13404552|NCT00576732|26817052|FG002|DOUBLE BLIND|Withdrawal by Subject|3|||
13404553|NCT00576732|26817053|FG003|DOUBLE BLIND|Withdrawal by Subject|0|||
13404554|NCT00576732|26817054|FG004|DOUBLE BLIND|Withdrawal by Subject|0|||
13404555|NCT00576732|26817055|FG005|DOUBLE BLIND|Withdrawal by Subject|0|||
13404556|NCT00576732|26817050|FG000|DOUBLE BLIND|OTHER|0|||
13404557|NCT00576732|26817051|FG001|DOUBLE BLIND|OTHER|2|||
13404558|NCT00576732|26817052|FG002|DOUBLE BLIND|OTHER|1|||
13404559|NCT00576732|26817053|FG003|DOUBLE BLIND|OTHER|0|||
13404560|NCT00576732|26817054|FG004|DOUBLE BLIND|OTHER|0|||
13404561|NCT00576732|26817055|FG005|DOUBLE BLIND|OTHER|0|||
13404562|NCT00576732|26817050|FG000|DOUBLE BLIND|Lack of Efficacy|6|||
13404563|NCT00576732|26817051|FG001|DOUBLE BLIND|Lack of Efficacy|1|||
13404564|NCT00576732|26817052|FG002|DOUBLE BLIND|Lack of Efficacy|0|||
13404565|NCT00576732|26817053|FG003|DOUBLE BLIND|Lack of Efficacy|0|||
13404566|NCT00576732|26817054|FG004|DOUBLE BLIND|Lack of Efficacy|0|||
13404567|NCT00576732|26817055|FG005|DOUBLE BLIND|Lack of Efficacy|0|||
13404568|NCT00576732|26817050|FG000|DOUBLE BLIND|Protocol Violation|1|||
13404569|NCT00576732|26817051|FG001|DOUBLE BLIND|Protocol Violation|0|||
13404570|NCT00576732|26817052|FG002|DOUBLE BLIND|Protocol Violation|0|||
13404571|NCT00576732|26817053|FG003|DOUBLE BLIND|Protocol Violation|0|||
13404572|NCT00576732|26817054|FG004|DOUBLE BLIND|Protocol Violation|0|||
13404573|NCT00576732|26817055|FG005|DOUBLE BLIND|Protocol Violation|0|||
13404574|NCT00576732|26817050|FG000|OPEN LABEL|Adverse Event|0|||
13404575|NCT00576732|26817051|FG001|OPEN LABEL|Adverse Event|0|||
13404576|NCT00576732|26817052|FG002|OPEN LABEL|Adverse Event|0|||
13404577|NCT00576732|26817053|FG003|OPEN LABEL|Adverse Event|4|||
13404578|NCT00576732|26817054|FG004|OPEN LABEL|Adverse Event|0|||
13404579|NCT00576732|26817055|FG005|OPEN LABEL|Adverse Event|1|||
13404580|NCT00576732|26817050|FG000|OPEN LABEL|Lost to Follow-up|0|||
13404581|NCT00576732|26817051|FG001|OPEN LABEL|Lost to Follow-up|0|||
13404582|NCT00576732|26817052|FG002|OPEN LABEL|Lost to Follow-up|0|||
13404583|NCT00576732|26817053|FG003|OPEN LABEL|Lost to Follow-up|2|||
13404584|NCT00576732|26817054|FG004|OPEN LABEL|Lost to Follow-up|1|||
13404585|NCT00576732|26817055|FG005|OPEN LABEL|Lost to Follow-up|1|||
13404586|NCT00576732|26817050|FG000|OPEN LABEL|Withdrawal by Subject|0|||
13404587|NCT00576732|26817051|FG001|OPEN LABEL|Withdrawal by Subject|0|||
13404588|NCT00576732|26817052|FG002|OPEN LABEL|Withdrawal by Subject|0|||
13404589|NCT00576732|26817053|FG003|OPEN LABEL|Withdrawal by Subject|1|||
13404590|NCT00576732|26817054|FG004|OPEN LABEL|Withdrawal by Subject|0|||
13404591|NCT00576732|26817055|FG005|OPEN LABEL|Withdrawal by Subject|1|||
13404592|NCT00576732|26817050|FG000|OPEN LABEL|OTHER|0|||
13404593|NCT00576732|26817051|FG001|OPEN LABEL|OTHER|0|||
13404594|NCT00576732|26817052|FG002|OPEN LABEL|OTHER|0|||
13404595|NCT00576732|26817053|FG003|OPEN LABEL|OTHER|0|||
13404596|NCT00576732|26817054|FG004|OPEN LABEL|OTHER|0|||
13404597|NCT00576732|26817055|FG005|OPEN LABEL|OTHER|2|||
13404598|NCT00576732|26817050|FG000|OPEN LABEL|Lack of Efficacy|0|||
13404599|NCT00576732|26817051|FG001|OPEN LABEL|Lack of Efficacy|0|||
13404600|NCT00576732|26817052|FG002|OPEN LABEL|Lack of Efficacy|0|||
13404601|NCT00576732|26817053|FG003|OPEN LABEL|Lack of Efficacy|2|||
13404602|NCT00576732|26817054|FG004|OPEN LABEL|Lack of Efficacy|2|||
13404603|NCT00576732|26817055|FG005|OPEN LABEL|Lack of Efficacy|3|||
13404604|NCT00576732|26817050|FG000|OPEN LABEL|Protocol Violation|0|||
13404605|NCT00576732|26817051|FG001|OPEN LABEL|Protocol Violation|0|||
13404606|NCT00576732|26817052|FG002|OPEN LABEL|Protocol Violation|0|||
13404607|NCT00576732|26817053|FG003|OPEN LABEL|Protocol Violation|2|||
13404608|NCT00576732|26817054|FG004|OPEN LABEL|Protocol Violation|1|||
13404609|NCT00576732|26817055|FG005|OPEN LABEL|Protocol Violation|0|||
13404610|NCT00576693|26817068|FG000|Overall Study|Lost to Follow-up|7|||
13404611|NCT00576693|26817069|FG001|Overall Study|Lost to Follow-up|11|||
13404612|NCT00576693|26817068|FG000|Overall Study|Withdrawal by Subject|3|||
13404613|NCT00576693|26817069|FG001|Overall Study|Withdrawal by Subject|13|||
13404614|NCT00576628|26817091|FG000|Overall Study|Adverse Event|11|||
13404615|NCT00576628|26817091|FG000|Overall Study|Death|2|||
13404616|NCT00576628|26817091|FG000|Overall Study|Failure to return|1|||
13404617|NCT00576628|26817091|FG000|Overall Study|Refused Treatment|8|||
13404618|NCT00576628|26817091|FG000|Overall Study|Pregnancy|1|||
13404619|NCT00576628|26817091|FG000|Overall Study|RBC transfusion|1|||
13404620|NCT00576628|26817091|FG000|Overall Study|Progression of Kidney Disease|1|||
13404621|NCT00576628|26817091|FG000|Overall Study|Progression of Renal Failure|1|||
13404622|NCT00576628|26817091|FG000|Overall Study|The patient move into other town|1|||
13404623|NCT00576628|26817091|FG000|Overall Study|Transplantation|1|||
13404624|NCT00576628|26817091|FG000|Overall Study|Dialysis|15|||
13404625|NCT00576576|26817099|FG000|Overall Study|Lost to Follow-up|6|||
13404626|NCT00576576|26817099|FG000|Overall Study|Protocol Violation|1|||
13404627|NCT00576472|26817235|FG000|MPH In-Lab Phase|Declined participation in medication pha|0|||
13404628|NCT00576472|26817236|FG001|MPH In-Lab Phase|Declined participation in medication pha|0|||
13404629|NCT00576472|26817237|FG002|MPH In-Lab Phase|Declined participation in medication pha|0|||
13404630|NCT00576472|26817238|FG003|MPH In-Lab Phase|Declined participation in medication pha|75|||
13404631|NCT00576472|26817239|FG004|MPH In-Lab Phase|Declined participation in medication pha|0|||
13404632|NCT00576472|26817240|FG005|MPH In-Lab Phase|Declined participation in medication pha|0|||
13404633|NCT00576472|26817241|FG006|MPH In-Lab Phase|Declined participation in medication pha|0|||
13404634|NCT00576472|26817242|FG007|MPH In-Lab Phase|Declined participation in medication pha|0|||
13404635|NCT00576472|26817243|FG008|MPH In-Lab Phase|Declined participation in medication pha|0|||
13404636|NCT00576472|26817244|FG009|MPH In-Lab Phase|Declined participation in medication pha|0|||
13404637|NCT00576472|26817245|FG010|MPH In-Lab Phase|Declined participation in medication pha|0|||
13404638|NCT00576472|26817246|FG011|MPH In-Lab Phase|Declined participation in medication pha|0|||
13404639|NCT00576472|26817247|FG012|MPH In-Lab Phase|Declined participation in medication pha|0|||
13404640|NCT00576472|26817248|FG013|MPH In-Lab Phase|Declined participation in medication pha|0|||
13404641|NCT00576472|26817249|FG014|MPH In-Lab Phase|Declined participation in medication pha|0|||
13404642|NCT00576472|26817235|FG000|MPH In-Lab Phase|Lost to Follow-up|0|||
13404643|NCT00576472|26817236|FG001|MPH In-Lab Phase|Lost to Follow-up|0|||
13404644|NCT00576472|26817237|FG002|MPH In-Lab Phase|Lost to Follow-up|0|||
13404645|NCT00576472|26817238|FG003|MPH In-Lab Phase|Lost to Follow-up|1|||
13404646|NCT00576472|26817239|FG004|MPH In-Lab Phase|Lost to Follow-up|0|||
13404647|NCT00576472|26817240|FG005|MPH In-Lab Phase|Lost to Follow-up|0|||
13404648|NCT00576472|26817241|FG006|MPH In-Lab Phase|Lost to Follow-up|0|||
13404649|NCT00576472|26817242|FG007|MPH In-Lab Phase|Lost to Follow-up|0|||
13404650|NCT00576472|26817243|FG008|MPH In-Lab Phase|Lost to Follow-up|0|||
13404651|NCT00576472|26817244|FG009|MPH In-Lab Phase|Lost to Follow-up|0|||
13404652|NCT00576472|26817245|FG010|MPH In-Lab Phase|Lost to Follow-up|0|||
13404653|NCT00576472|26817246|FG011|MPH In-Lab Phase|Lost to Follow-up|0|||
13404654|NCT00576472|26817247|FG012|MPH In-Lab Phase|Lost to Follow-up|0|||
13404655|NCT00576472|26817248|FG013|MPH In-Lab Phase|Lost to Follow-up|0|||
13404656|NCT00576472|26817249|FG014|MPH In-Lab Phase|Lost to Follow-up|0|||
13404657|NCT00576472|26817235|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
13404658|NCT00576472|26817236|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
13404659|NCT00576472|26817237|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
13404660|NCT00576472|26817238|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4|||
13404661|NCT00576472|26817239|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
13404662|NCT00576472|26817240|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
13404663|NCT00576472|26817241|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
13404664|NCT00576472|26817242|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
13404665|NCT00576472|26817243|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
13404666|NCT00576472|26817244|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
13404667|NCT00576472|26817245|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
13404668|NCT00576472|26817246|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
13404669|NCT00576472|26817247|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
13404670|NCT00576472|26817248|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
13404671|NCT00576472|26817249|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
13404672|NCT00576472|26817235|FG000|MPH In-Lab Phase|No attention/academic problems|0|||
13404673|NCT00576472|26817236|FG001|MPH In-Lab Phase|No attention/academic problems|0|||
13404674|NCT00576472|26817237|FG002|MPH In-Lab Phase|No attention/academic problems|0|||
13404675|NCT00576472|26817238|FG003|MPH In-Lab Phase|No attention/academic problems|245|||
13404676|NCT00576472|26817239|FG004|MPH In-Lab Phase|No attention/academic problems|0|||
13404677|NCT00576472|26817240|FG005|MPH In-Lab Phase|No attention/academic problems|0|||
13404678|NCT00576472|26817241|FG006|MPH In-Lab Phase|No attention/academic problems|0|||
13404679|NCT00576472|26817242|FG007|MPH In-Lab Phase|No attention/academic problems|0|||
13404680|NCT00576472|26817243|FG008|MPH In-Lab Phase|No attention/academic problems|0|||
13404681|NCT00576472|26817244|FG009|MPH In-Lab Phase|No attention/academic problems|0|||
13404682|NCT00576472|26817245|FG010|MPH In-Lab Phase|No attention/academic problems|0|||
13404683|NCT00576472|26817246|FG011|MPH In-Lab Phase|No attention/academic problems|0|||
13404684|NCT00576472|26817247|FG012|MPH In-Lab Phase|No attention/academic problems|0|||
13404685|NCT00576472|26817248|FG013|MPH In-Lab Phase|No attention/academic problems|0|||
13404686|NCT00576472|26817249|FG014|MPH In-Lab Phase|No attention/academic problems|0|||
13404687|NCT00576472|26817235|FG000|MPH In-Lab Phase|Psychiatric exclusion|0|||
13404688|NCT00576472|26817236|FG001|MPH In-Lab Phase|Psychiatric exclusion|0|||
13404689|NCT00576472|26817237|FG002|MPH In-Lab Phase|Psychiatric exclusion|0|||
13404690|NCT00576472|26817238|FG003|MPH In-Lab Phase|Psychiatric exclusion|10|||
13404691|NCT00576472|26817239|FG004|MPH In-Lab Phase|Psychiatric exclusion|0|||
13404692|NCT00576472|26817240|FG005|MPH In-Lab Phase|Psychiatric exclusion|0|||
13404693|NCT00576472|26817241|FG006|MPH In-Lab Phase|Psychiatric exclusion|0|||
13404694|NCT00576472|26817242|FG007|MPH In-Lab Phase|Psychiatric exclusion|0|||
13404695|NCT00576472|26817243|FG008|MPH In-Lab Phase|Psychiatric exclusion|0|||
13404696|NCT00576472|26817244|FG009|MPH In-Lab Phase|Psychiatric exclusion|0|||
13404697|NCT00576472|26817245|FG010|MPH In-Lab Phase|Psychiatric exclusion|0|||
13404698|NCT00576472|26817246|FG011|MPH In-Lab Phase|Psychiatric exclusion|0|||
13404699|NCT00576472|26817247|FG012|MPH In-Lab Phase|Psychiatric exclusion|0|||
13404700|NCT00576472|26817248|FG013|MPH In-Lab Phase|Psychiatric exclusion|0|||
13404701|NCT00576472|26817249|FG014|MPH In-Lab Phase|Psychiatric exclusion|0|||
13404702|NCT00576472|26817235|FG000|MPH Cross Over Phase|Withdrawal by Subject|0|||
13404703|NCT00576472|26817236|FG001|MPH Cross Over Phase|Withdrawal by Subject|0|||
13404704|NCT00576472|26817237|FG002|MPH Cross Over Phase|Withdrawal by Subject|0|||
13404705|NCT00576472|26817238|FG003|MPH Cross Over Phase|Withdrawal by Subject|0|||
13404706|NCT00576472|26817239|FG004|MPH Cross Over Phase|Withdrawal by Subject|0|||
13404707|NCT00576472|26817240|FG005|MPH Cross Over Phase|Withdrawal by Subject|0|||
13404708|NCT00576472|26817241|FG006|MPH Cross Over Phase|Withdrawal by Subject|6|||
13404709|NCT00576472|26817242|FG007|MPH Cross Over Phase|Withdrawal by Subject|0|||
13404710|NCT00576472|26817243|FG008|MPH Cross Over Phase|Withdrawal by Subject|0|||
13404711|NCT00576472|26817244|FG009|MPH Cross Over Phase|Withdrawal by Subject|0|||
13404712|NCT00576472|26817245|FG010|MPH Cross Over Phase|Withdrawal by Subject|0|||
13404713|NCT00576472|26817246|FG011|MPH Cross Over Phase|Withdrawal by Subject|0|||
13404714|NCT00576472|26817247|FG012|MPH Cross Over Phase|Withdrawal by Subject|0|||
13404715|NCT00576472|26817248|FG013|MPH Cross Over Phase|Withdrawal by Subject|0|||
13404716|NCT00576472|26817249|FG014|MPH Cross Over Phase|Withdrawal by Subject|0|||
13404717|NCT00576472|26817235|FG000|MPH Cross Over Phase|Ineligible due to disease|0|||
13404718|NCT00576472|26817236|FG001|MPH Cross Over Phase|Ineligible due to disease|0|||
13476210|NCT01729754|27002615|FG007|Part 1|Pregnancy|0|||
13404719|NCT00576472|26817237|FG002|MPH Cross Over Phase|Ineligible due to disease|0|||
13404720|NCT00576472|26817238|FG003|MPH Cross Over Phase|Ineligible due to disease|0|||
13404721|NCT00576472|26817239|FG004|MPH Cross Over Phase|Ineligible due to disease|0|||
13404722|NCT00576472|26817240|FG005|MPH Cross Over Phase|Ineligible due to disease|0|||
13404723|NCT00576472|26817241|FG006|MPH Cross Over Phase|Ineligible due to disease|2|||
13404724|NCT00576472|26817242|FG007|MPH Cross Over Phase|Ineligible due to disease|0|||
13404725|NCT00576472|26817243|FG008|MPH Cross Over Phase|Ineligible due to disease|0|||
13404726|NCT00576472|26817244|FG009|MPH Cross Over Phase|Ineligible due to disease|0|||
13404727|NCT00576472|26817245|FG010|MPH Cross Over Phase|Ineligible due to disease|0|||
13404728|NCT00576472|26817246|FG011|MPH Cross Over Phase|Ineligible due to disease|0|||
13404729|NCT00576472|26817247|FG012|MPH Cross Over Phase|Ineligible due to disease|0|||
13404730|NCT00576472|26817248|FG013|MPH Cross Over Phase|Ineligible due to disease|0|||
13404731|NCT00576472|26817249|FG014|MPH Cross Over Phase|Ineligible due to disease|0|||
13404732|NCT00576472|26817235|FG000|MPH Cross Over Phase|Physician Decision|0|||
13404733|NCT00576472|26817236|FG001|MPH Cross Over Phase|Physician Decision|0|||
13404734|NCT00576472|26817237|FG002|MPH Cross Over Phase|Physician Decision|0|||
13404735|NCT00576472|26817238|FG003|MPH Cross Over Phase|Physician Decision|0|||
13404736|NCT00576472|26817239|FG004|MPH Cross Over Phase|Physician Decision|0|||
13404737|NCT00576472|26817240|FG005|MPH Cross Over Phase|Physician Decision|0|||
13404738|NCT00576472|26817241|FG006|MPH Cross Over Phase|Physician Decision|4|||
13404739|NCT00576472|26817242|FG007|MPH Cross Over Phase|Physician Decision|0|||
13404740|NCT00576472|26817243|FG008|MPH Cross Over Phase|Physician Decision|0|||
13404741|NCT00576472|26817244|FG009|MPH Cross Over Phase|Physician Decision|0|||
13404742|NCT00576472|26817245|FG010|MPH Cross Over Phase|Physician Decision|0|||
13404743|NCT00576472|26817246|FG011|MPH Cross Over Phase|Physician Decision|0|||
13404744|NCT00576472|26817247|FG012|MPH Cross Over Phase|Physician Decision|0|||
13404745|NCT00576472|26817248|FG013|MPH Cross Over Phase|Physician Decision|0|||
13404746|NCT00576472|26817249|FG014|MPH Cross Over Phase|Physician Decision|0|||
13404747|NCT00576472|26817235|FG000|MPH Cross Over Phase|Did not complete cross over phase|0|||
13404748|NCT00576472|26817236|FG001|MPH Cross Over Phase|Did not complete cross over phase|0|||
13404749|NCT00576472|26817237|FG002|MPH Cross Over Phase|Did not complete cross over phase|0|||
13404750|NCT00576472|26817238|FG003|MPH Cross Over Phase|Did not complete cross over phase|0|||
13404751|NCT00576472|26817239|FG004|MPH Cross Over Phase|Did not complete cross over phase|0|||
13404752|NCT00576472|26817240|FG005|MPH Cross Over Phase|Did not complete cross over phase|0|||
13404753|NCT00576472|26817241|FG006|MPH Cross Over Phase|Did not complete cross over phase|0|||
13404754|NCT00576472|26817242|FG007|MPH Cross Over Phase|Did not complete cross over phase|0|||
13404755|NCT00576472|26817243|FG008|MPH Cross Over Phase|Did not complete cross over phase|2|||
13404756|NCT00576472|26817244|FG009|MPH Cross Over Phase|Did not complete cross over phase|0|||
13404757|NCT00576472|26817245|FG010|MPH Cross Over Phase|Did not complete cross over phase|1|||
13404758|NCT00576472|26817246|FG011|MPH Cross Over Phase|Did not complete cross over phase|1|||
13404759|NCT00576472|26817247|FG012|MPH Cross Over Phase|Did not complete cross over phase|0|||
13404760|NCT00576472|26817248|FG013|MPH Cross Over Phase|Did not complete cross over phase|0|||
13404761|NCT00576472|26817249|FG014|MPH Cross Over Phase|Did not complete cross over phase|0|||
13404762|NCT00576472|26817235|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0|||
13404763|NCT00576472|26817236|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0|||
13404764|NCT00576472|26817237|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0|||
13404765|NCT00576472|26817238|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0|||
13404766|NCT00576472|26817239|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0|||
13404767|NCT00576472|26817240|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0|||
13404768|NCT00576472|26817241|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0|||
13404769|NCT00576472|26817242|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0|||
13404770|NCT00576472|26817243|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0|||
13404771|NCT00576472|26817244|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0|||
13404772|NCT00576472|26817245|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0|||
13404773|NCT00576472|26817246|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0|||
13404774|NCT00576472|26817247|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0|||
13404775|NCT00576472|26817248|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16|||
13404776|NCT00576472|26817249|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0|||
13404777|NCT00576472|26817235|FG000|MPH Home Maintenance Phase|Declined to participate|0|||
13404778|NCT00576472|26817236|FG001|MPH Home Maintenance Phase|Declined to participate|0|||
13404779|NCT00576472|26817237|FG002|MPH Home Maintenance Phase|Declined to participate|0|||
13404780|NCT00576472|26817238|FG003|MPH Home Maintenance Phase|Declined to participate|0|||
13404781|NCT00576472|26817239|FG004|MPH Home Maintenance Phase|Declined to participate|0|||
13404782|NCT00576472|26817240|FG005|MPH Home Maintenance Phase|Declined to participate|0|||
13404783|NCT00576472|26817241|FG006|MPH Home Maintenance Phase|Declined to participate|0|||
13404784|NCT00576472|26817242|FG007|MPH Home Maintenance Phase|Declined to participate|0|||
13404785|NCT00576472|26817243|FG008|MPH Home Maintenance Phase|Declined to participate|0|||
13404786|NCT00576472|26817244|FG009|MPH Home Maintenance Phase|Declined to participate|0|||
13404787|NCT00576472|26817245|FG010|MPH Home Maintenance Phase|Declined to participate|0|||
13404788|NCT00576472|26817246|FG011|MPH Home Maintenance Phase|Declined to participate|0|||
13404789|NCT00576472|26817247|FG012|MPH Home Maintenance Phase|Declined to participate|0|||
13404790|NCT00576472|26817248|FG013|MPH Home Maintenance Phase|Declined to participate|7|||
13404791|NCT00576472|26817249|FG014|MPH Home Maintenance Phase|Declined to participate|0|||
13404792|NCT00576472|26817235|FG000|MPH Home Maintenance Phase|Insufficient data|0|||
13404793|NCT00576472|26817236|FG001|MPH Home Maintenance Phase|Insufficient data|0|||
13404794|NCT00576472|26817237|FG002|MPH Home Maintenance Phase|Insufficient data|0|||
13404795|NCT00576472|26817238|FG003|MPH Home Maintenance Phase|Insufficient data|0|||
13404796|NCT00576472|26817239|FG004|MPH Home Maintenance Phase|Insufficient data|0|||
13404797|NCT00576472|26817240|FG005|MPH Home Maintenance Phase|Insufficient data|0|||
13404798|NCT00576472|26817241|FG006|MPH Home Maintenance Phase|Insufficient data|0|||
13404799|NCT00576472|26817242|FG007|MPH Home Maintenance Phase|Insufficient data|0|||
13404800|NCT00576472|26817243|FG008|MPH Home Maintenance Phase|Insufficient data|0|||
13404801|NCT00576472|26817244|FG009|MPH Home Maintenance Phase|Insufficient data|0|||
13404802|NCT00576472|26817245|FG010|MPH Home Maintenance Phase|Insufficient data|0|||
13404803|NCT00576472|26817246|FG011|MPH Home Maintenance Phase|Insufficient data|0|||
13404804|NCT00576472|26817247|FG012|MPH Home Maintenance Phase|Insufficient data|0|||
13404805|NCT00576472|26817248|FG013|MPH Home Maintenance Phase|Insufficient data|4|||
13404806|NCT00576472|26817249|FG014|MPH Home Maintenance Phase|Insufficient data|0|||
13404807|NCT00576472|26817235|FG000|MPH Home Maintenance Phase|Side effects|0|||
13404808|NCT00576472|26817236|FG001|MPH Home Maintenance Phase|Side effects|0|||
13404809|NCT00576472|26817237|FG002|MPH Home Maintenance Phase|Side effects|0|||
13404810|NCT00576472|26817238|FG003|MPH Home Maintenance Phase|Side effects|0|||
13404811|NCT00576472|26817239|FG004|MPH Home Maintenance Phase|Side effects|0|||
13404812|NCT00576472|26817240|FG005|MPH Home Maintenance Phase|Side effects|0|||
13404813|NCT00576472|26817241|FG006|MPH Home Maintenance Phase|Side effects|0|||
13404814|NCT00576472|26817242|FG007|MPH Home Maintenance Phase|Side effects|0|||
13404815|NCT00576472|26817243|FG008|MPH Home Maintenance Phase|Side effects|0|||
13404816|NCT00576472|26817244|FG009|MPH Home Maintenance Phase|Side effects|0|||
13404817|NCT00576472|26817245|FG010|MPH Home Maintenance Phase|Side effects|0|||
13404818|NCT00576472|26817246|FG011|MPH Home Maintenance Phase|Side effects|0|||
13404819|NCT00576472|26817247|FG012|MPH Home Maintenance Phase|Side effects|0|||
13404820|NCT00576472|26817248|FG013|MPH Home Maintenance Phase|Side effects|0|||
13404821|NCT00576472|26817249|FG014|MPH Home Maintenance Phase|Side effects|8|||
13404822|NCT00576472|26817235|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
13404823|NCT00576472|26817236|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
13404824|NCT00576472|26817237|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
13404825|NCT00576472|26817238|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
13404826|NCT00576472|26817239|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
13404827|NCT00576472|26817240|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
13404828|NCT00576472|26817241|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
13404829|NCT00576472|26817242|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
13404830|NCT00576472|26817243|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
13404831|NCT00576472|26817244|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
13404832|NCT00576472|26817245|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
13404833|NCT00576472|26817246|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
13404834|NCT00576472|26817247|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
13404835|NCT00576472|26817248|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
13404836|NCT00576472|26817249|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6|||
13404837|NCT00576472|26817235|FG000|MPH Home Maintenance Phase|Medical reasons|0|||
13404838|NCT00576472|26817236|FG001|MPH Home Maintenance Phase|Medical reasons|0|||
13404839|NCT00576472|26817237|FG002|MPH Home Maintenance Phase|Medical reasons|0|||
13404840|NCT00576472|26817238|FG003|MPH Home Maintenance Phase|Medical reasons|0|||
13404841|NCT00576472|26817239|FG004|MPH Home Maintenance Phase|Medical reasons|0|||
13404842|NCT00576472|26817240|FG005|MPH Home Maintenance Phase|Medical reasons|0|||
13404843|NCT00576472|26817241|FG006|MPH Home Maintenance Phase|Medical reasons|0|||
13404844|NCT00576472|26817242|FG007|MPH Home Maintenance Phase|Medical reasons|0|||
13404845|NCT00576472|26817243|FG008|MPH Home Maintenance Phase|Medical reasons|0|||
13404846|NCT00576472|26817244|FG009|MPH Home Maintenance Phase|Medical reasons|0|||
13404847|NCT00576472|26817245|FG010|MPH Home Maintenance Phase|Medical reasons|0|||
13404848|NCT00576472|26817246|FG011|MPH Home Maintenance Phase|Medical reasons|0|||
13404849|NCT00576472|26817247|FG012|MPH Home Maintenance Phase|Medical reasons|0|||
13404850|NCT00576472|26817248|FG013|MPH Home Maintenance Phase|Medical reasons|0|||
13404851|NCT00576472|26817249|FG014|MPH Home Maintenance Phase|Medical reasons|6|||
13404852|NCT00576472|26817235|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0|||
13404853|NCT00576472|26817236|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0|||
13404854|NCT00576472|26817237|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0|||
13404855|NCT00576472|26817238|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0|||
13404856|NCT00576472|26817239|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0|||
13404857|NCT00576472|26817240|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0|||
13404858|NCT00576472|26817241|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0|||
13404859|NCT00576472|26817242|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0|||
13404860|NCT00576472|26817243|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0|||
13404861|NCT00576472|26817244|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0|||
13404862|NCT00576472|26817245|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0|||
13404863|NCT00576472|26817246|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0|||
13404864|NCT00576472|26817247|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0|||
13404865|NCT00576472|26817248|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0|||
13404866|NCT00576472|26817249|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3|||
13404867|NCT00576420|26817424|FG000|Overall Study|Death|0|||
13404868|NCT00576420|26817425|FG001|Overall Study|Death|0|||
13404869|NCT00576420|26817426|FG002|Overall Study|Death|1|||
13404870|NCT00576381|26817432|FG000|Overall Study|Reoperation|3|||
13404871|NCT00576381|26817432|FG000|Overall Study|Adverse Event|4|||
13404872|NCT00576316|26817439|FG000|Overall Study|Adverse Event|9|||
13404873|NCT00576316|26817439|FG000|Overall Study|Withdrawal by Subject|2|||
13404874|NCT00576316|26817439|FG000|Overall Study|Protocol Violation|9|||
13404875|NCT00576303|26817450|FG000|Dose Titration Period|Early withdrawal|17|||
13404876|NCT00576303|26817450|FG000|Efficacy Evaluation Period|Early withdrawal|5|||
13404877|NCT00576303|26817450|FG000|Long Term Safety Period|Early withdrawal|16|||
13404878|NCT00576199|26817461|FG000|Overall Study|Adverse Event|12|||
13404879|NCT00576199|26817461|FG000|Overall Study|Insufficient Therapeutic Response|14|||
13404880|NCT00576199|26817461|FG000|Overall Study|Refused Treatment|2|||
13404881|NCT00576199|26817461|FG000|Overall Study|Reason Unspecified|2|||
13404882|NCT00576056|26817468|FG000|Overall Study|Adverse Event|1|||
13404883|NCT00576056|26817468|FG000|Overall Study|Death|1|||
13404884|NCT00576056|26817468|FG000|Overall Study|Lack of Efficacy|1|||
13404885|NCT00576056|26817468|FG000|Overall Study|Withdrawal by Subject|2|||
13404886|NCT00576056|26817468|FG000|Overall Study|did not meet eligibility criteria|8|||
13404887|NCT00576056|26817468|FG000|Overall Study|Physician Decision|1|||
13404888|NCT00575666|26817513|FG000|Overall Study|Withdrawal by Subject|3|||
13404889|NCT00575666|26817514|FG001|Overall Study|Withdrawal by Subject|2|||
13404890|NCT00575666|26817513|FG000|Overall Study|Physician Decision|1|||
13404891|NCT00575666|26817514|FG001|Overall Study|Physician Decision|1|||
13404892|NCT00575588|26817541|FG000|Overall Study|Adverse Event|11|||
13404893|NCT00575588|26817542|FG001|Overall Study|Adverse Event|13|||
13404894|NCT00575588|26817541|FG000|Overall Study|Withdrawal by Subject|27|||
13404895|NCT00575588|26817542|FG001|Overall Study|Withdrawal by Subject|31|||
13404896|NCT00575588|26817541|FG000|Overall Study|Lost to Follow-up|1|||
13404897|NCT00575588|26817542|FG001|Overall Study|Lost to Follow-up|3|||
13404898|NCT00575588|26817541|FG000|Overall Study|Death|4|||
13404899|NCT00575588|26817542|FG001|Overall Study|Death|2|||
13404900|NCT00575588|26817541|FG000|Overall Study|Incorrect enrollment|8|||
13404901|NCT00575588|26817542|FG001|Overall Study|Incorrect enrollment|4|||
13404902|NCT00575588|26817541|FG000|Overall Study|Study specific discontinuation criteria|203|||
13404903|NCT00575588|26817542|FG001|Overall Study|Study specific discontinuation criteria|218|||
13404904|NCT00575588|26817541|FG000|Overall Study|Severe non-compliance to protocol|5|||
13404905|NCT00575588|26817542|FG001|Overall Study|Severe non-compliance to protocol|7|||
13404906|NCT00575588|26817541|FG000|Overall Study|Safety reasons|2|||
13404907|NCT00575588|26817542|FG001|Overall Study|Safety reasons|1|||
13404908|NCT00575588|26817541|FG000|Overall Study|Elevated triglyceride|1|||
13404909|NCT00575588|26817542|FG001|Overall Study|Elevated triglyceride|0|||
13404910|NCT00575588|26817541|FG000|Overall Study|Patient moved|1|||
13404911|NCT00575588|26817542|FG001|Overall Study|Patient moved|3|||
13404912|NCT00575588|26817541|FG000|Overall Study|Impossible to determine HbA1c|0|||
13404913|NCT00575588|26817542|FG001|Overall Study|Impossible to determine HbA1c|1|||
13404914|NCT00575510|26817563|FG000|Overall Study|Lost to Follow-up|4|||
13404915|NCT00575510|26817564|FG001|Overall Study|Lost to Follow-up|6|||
13404916|NCT00575510|26817565|FG002|Overall Study|Lost to Follow-up|9|||
13404917|NCT00575510|26817563|FG000|Overall Study|Withdrawal by Subject|1|||
13404918|NCT00575510|26817564|FG001|Overall Study|Withdrawal by Subject|0|||
13404919|NCT00575510|26817565|FG002|Overall Study|Withdrawal by Subject|0|||
13404920|NCT00575510|26817563|FG000|Overall Study|Clinic Called Patient|7|||
13404921|NCT00575510|26817564|FG001|Overall Study|Clinic Called Patient|7|||
13404922|NCT00575510|26817565|FG002|Overall Study|Clinic Called Patient|7|||
13404923|NCT00575510|26817563|FG000|Overall Study|Pregnancy|0|||
13404924|NCT00575510|26817564|FG001|Overall Study|Pregnancy|0|||
13404925|NCT00575510|26817565|FG002|Overall Study|Pregnancy|1|||
13404926|NCT00575380|26817580|FG000|Overall Study|Withdrawal by Subject|1|||
13404927|NCT00575380|26817581|FG001|Overall Study|Withdrawal by Subject|0|||
13404928|NCT00575380|26817580|FG000|Overall Study|Adverse Event|0|||
13404929|NCT00575380|26817581|FG001|Overall Study|Adverse Event|1|||
13404930|NCT00575380|26817580|FG000|Overall Study|Various|0|||
13404931|NCT00575380|26817581|FG001|Overall Study|Various|2|||
13404932|NCT00575328|26817596|FG000|Overall Study|Adverse Event|1|||
13404933|NCT00575328|26817597|FG001|Overall Study|Adverse Event|1|||
13404934|NCT00575328|26817596|FG000|Overall Study|Lost to Follow-up|2|||
13404935|NCT00575328|26817597|FG001|Overall Study|Lost to Follow-up|1|||
13404936|NCT00575094|26817603|FG000|Overall Study|Adverse Event|2|||
13404937|NCT00575094|26817603|FG000|Overall Study|Withdrawal by Subject|1|||
13404938|NCT00575042|26817610|FG000|Overall Study|Adverse Event|2|||
13404939|NCT00575042|26817610|FG000|Overall Study|Lost to Follow-up|1|||
13404940|NCT00574951|26817620|FG000|Overall Study|Ineligible - improper prior treatment|1|||
13404941|NCT00574912|26817634|FG000|Overall Study|Could not place IV lines.|3|||
13404942|NCT00574912|26817634|FG000|Overall Study|scheduling conflicts|3|||
13404943|NCT00574912|26817634|FG000|Overall Study|Physician Decision|2|||
13404944|NCT00574873|26817657|FG000|Overall Study|Withdrawal by Subject|18|||
13404945|NCT00574873|26817658|FG001|Overall Study|Withdrawal by Subject|19|||
13404946|NCT00574873|26817657|FG000|Overall Study|Investigator request|18|||
13404947|NCT00574873|26817658|FG001|Overall Study|Investigator request|8|||
13404948|NCT00574873|26817657|FG000|Overall Study|Death|15|||
13404949|NCT00574873|26817658|FG001|Overall Study|Death|14|||
13404950|NCT00574873|26817657|FG000|Overall Study|Lost to Follow-up|14|||
13404951|NCT00574873|26817658|FG001|Overall Study|Lost to Follow-up|5|||
13404952|NCT00574873|26817657|FG000|Overall Study|Other|40|||
13404953|NCT00574873|26817658|FG001|Overall Study|Other|4|||
13404954|NCT00574873|26817657|FG000|Overall Study|Discontinuation of study by sponsor|5|||
13404955|NCT00574873|26817658|FG001|Overall Study|Discontinuation of study by sponsor|199|||
13404956|NCT00574873|26817657|FG000|Overall Study|Blank, site closed per local regulations|2|||
13404957|NCT00574873|26817658|FG001|Overall Study|Blank, site closed per local regulations|2|||
13404958|NCT00574873|26817657|FG000|Overall Study|Extension Study|126|||
13404959|NCT00574873|26817658|FG001|Overall Study|Extension Study|0|||
13404960|NCT00574847|26817697|FG000|Overall Study|Adverse Event|2|||
13404961|NCT00574847|26817698|FG001|Overall Study|Adverse Event|0|||
13404962|NCT00574847|26817697|FG000|Overall Study|Death|1|||
13404963|NCT00574847|26817698|FG001|Overall Study|Death|0|||
13404964|NCT00574847|26817697|FG000|Overall Study|Withdrawal by Subject|2|||
13404965|NCT00574847|26817698|FG001|Overall Study|Withdrawal by Subject|2|||
13404966|NCT00574847|26817697|FG000|Overall Study|Physician Decision|1|||
13404967|NCT00574847|26817698|FG001|Overall Study|Physician Decision|0|||
13404968|NCT00574847|26817697|FG000|Overall Study|Did not receive medication (declined)|2|||
13404969|NCT00574847|26817698|FG001|Overall Study|Did not receive medication (declined)|5|||
13404970|NCT00574795|26817717|FG000|Infant Series|Withdrawal by Subject|2|||
13404971|NCT00574795|26817717|FG000|Infant Series|Protocol Violation|2|||
13404972|NCT00574795|26817717|FG000|Infant Series|Adverse Event|1|||
13404973|NCT00574795|26817717|FG000|After Infant Series|Withdrawal by Subject|1|||
13404974|NCT00574795|26817717|FG000|After Infant Series|Adverse Event|2|||
13404975|NCT00574795|26817717|FG000|Toddler Dose|Withdrawal by Subject|1|||
13404976|NCT00574405|26817730|FG000|Overall Study|Withdrawal by Subject|3|||
13404977|NCT00574405|26817731|FG001|Overall Study|Withdrawal by Subject|2|||
13404978|NCT00574288|26817789|FG000|Overall Study|Adverse Event|2|||
13404979|NCT00574288|26817790|FG001|Overall Study|Adverse Event|0|||
13404980|NCT00574288|26817791|FG002|Overall Study|Adverse Event|0|||
13404981|NCT00574288|26817792|FG003|Overall Study|Adverse Event|0|||
13404982|NCT00574288|26817793|FG004|Overall Study|Adverse Event|1|||
13404983|NCT00574288|26817794|FG005|Overall Study|Adverse Event|0|||
13404984|NCT00574288|26817795|FG006|Overall Study|Adverse Event|0|||
13404985|NCT00574288|26817789|FG000|Overall Study|Death|0|||
13404986|NCT00574288|26817790|FG001|Overall Study|Death|0|||
13404987|NCT00574288|26817791|FG002|Overall Study|Death|0|||
13404988|NCT00574288|26817792|FG003|Overall Study|Death|0|||
13404989|NCT00574288|26817793|FG004|Overall Study|Death|0|||
13404990|NCT00574288|26817794|FG005|Overall Study|Death|25|||
13404991|NCT00574288|26817795|FG006|Overall Study|Death|21|||
13404992|NCT00574288|26817789|FG000|Overall Study|Lost to Follow-up|0|||
13404993|NCT00574288|26817790|FG001|Overall Study|Lost to Follow-up|0|||
13404994|NCT00574288|26817791|FG002|Overall Study|Lost to Follow-up|0|||
13404995|NCT00574288|26817792|FG003|Overall Study|Lost to Follow-up|0|||
13404996|NCT00574288|26817793|FG004|Overall Study|Lost to Follow-up|0|||
13404997|NCT00574288|26817794|FG005|Overall Study|Lost to Follow-up|1|||
13404998|NCT00574288|26817795|FG006|Overall Study|Lost to Follow-up|2|||
13404999|NCT00574288|26817789|FG000|Overall Study|Study Terminated By Sponsor|0|||
13405000|NCT00574288|26817790|FG001|Overall Study|Study Terminated By Sponsor|0|||
13405001|NCT00574288|26817791|FG002|Overall Study|Study Terminated By Sponsor|0|||
13405002|NCT00574288|26817792|FG003|Overall Study|Study Terminated By Sponsor|0|||
13405003|NCT00574288|26817793|FG004|Overall Study|Study Terminated By Sponsor|0|||
13405004|NCT00574288|26817794|FG005|Overall Study|Study Terminated By Sponsor|0|||
13405005|NCT00574288|26817795|FG006|Overall Study|Study Terminated By Sponsor|5|||
13405006|NCT00574288|26817789|FG000|Overall Study|Progressive Disease|17|||
13405007|NCT00574288|26817790|FG001|Overall Study|Progressive Disease|2|||
13405008|NCT00574288|26817791|FG002|Overall Study|Progressive Disease|3|||
13405009|NCT00574288|26817792|FG003|Overall Study|Progressive Disease|2|||
13405010|NCT00574288|26817793|FG004|Overall Study|Progressive Disease|1|||
13405011|NCT00574288|26817794|FG005|Overall Study|Progressive Disease|0|||
13405012|NCT00574288|26817795|FG006|Overall Study|Progressive Disease|0|||
13405013|NCT00574288|26817789|FG000|Overall Study|Other|1|||
13405014|NCT00574288|26817790|FG001|Overall Study|Other|1|||
13405015|NCT00574288|26817791|FG002|Overall Study|Other|0|||
13405016|NCT00574288|26817792|FG003|Overall Study|Other|0|||
13405017|NCT00574288|26817793|FG004|Overall Study|Other|0|||
13405018|NCT00574288|26817794|FG005|Overall Study|Other|0|||
13405019|NCT00574288|26817795|FG006|Overall Study|Other|0|||
13405020|NCT00574275|26817818|FG000|Overall Study|Randomized but not treated|2|||
13405021|NCT00574275|26817819|FG001|Overall Study|Randomized but not treated|3|||
13405022|NCT00574275|26817818|FG000|Overall Study|Adverse Event|32|||
13405023|NCT00574275|26817819|FG001|Overall Study|Adverse Event|76|||
13405024|NCT00574275|26817818|FG000|Overall Study|Disease progression|160|||
13405025|NCT00574275|26817819|FG001|Overall Study|Disease progression|146|||
13405026|NCT00574275|26817818|FG000|Overall Study|Lost to Follow-up|2|||
13405027|NCT00574275|26817819|FG001|Overall Study|Lost to Follow-up|1|||
13405028|NCT00574275|26817818|FG000|Overall Study|Study stopped based on DMC decision|62|||
13405029|NCT00574275|26817819|FG001|Overall Study|Study stopped based on DMC decision|23|||
13405030|NCT00574275|26817818|FG000|Overall Study|Withdrawal by Subject|15|||
13405031|NCT00574275|26817819|FG001|Overall Study|Withdrawal by Subject|17|||
13405032|NCT00574275|26817818|FG000|Overall Study|Error calculating tumor measurement|1|||
13405033|NCT00574275|26817819|FG001|Overall Study|Error calculating tumor measurement|0|||
13405034|NCT00574275|26817818|FG000|Overall Study|Physician Decision|1|||
13405035|NCT00574275|26817819|FG001|Overall Study|Physician Decision|1|||
13405036|NCT00574275|26817818|FG000|Overall Study|Protocol Violation|0|||
13405037|NCT00574275|26817819|FG001|Overall Study|Protocol Violation|1|||
13405038|NCT00574275|26817818|FG000|Overall Study|Patient and Investigator decision|0|||
13405039|NCT00574275|26817819|FG001|Overall Study|Patient and Investigator decision|1|||
13405040|NCT00574275|26817818|FG000|Overall Study|Insurance change|0|||
13405041|NCT00574275|26817819|FG001|Overall Study|Insurance change|1|||
13405042|NCT00574275|26817818|FG000|Overall Study|Operation for curative intent|0|||
13405043|NCT00574275|26817819|FG001|Overall Study|Operation for curative intent|1|||
13405044|NCT00574249|26817866|FG000|Overall Study|Adverse Event|6|||
13405045|NCT00574249|26817867|FG001|Overall Study|Adverse Event|18|||
13405046|NCT00574249|26817866|FG000|Overall Study|Lack of Efficacy|5|||
13405047|NCT00574249|26817867|FG001|Overall Study|Lack of Efficacy|3|||
13405048|NCT00574249|26817866|FG000|Overall Study|Lost to Follow-up|4|||
13405049|NCT00574249|26817867|FG001|Overall Study|Lost to Follow-up|3|||
13405050|NCT00574249|26817866|FG000|Overall Study|Protocol Violation|5|||
13405051|NCT00574249|26817867|FG001|Overall Study|Protocol Violation|2|||
13405052|NCT00574249|26817866|FG000|Overall Study|History of carcinoma|1|||
13405053|NCT00574249|26817867|FG001|Overall Study|History of carcinoma|0|||
13405054|NCT00574249|26817866|FG000|Overall Study|Withdrawal by Subject|3|||
13405055|NCT00574249|26817867|FG001|Overall Study|Withdrawal by Subject|0|||
13405056|NCT00574249|26817866|FG000|Overall Study|Physician Decision|1|||
13405057|NCT00574249|26817867|FG001|Overall Study|Physician Decision|0|||
13405058|NCT00574249|26817866|FG000|Overall Study|Pregnancy|1|||
13405059|NCT00574249|26817867|FG001|Overall Study|Pregnancy|0|||
13405060|NCT00574249|26817866|FG000|Overall Study|Excluded by company|0|||
13405061|NCT00574249|26817867|FG001|Overall Study|Excluded by company|1|||
13405062|NCT00574249|26817866|FG000|Overall Study|PPD test taken twice|0|||
13405063|NCT00574249|26817867|FG001|Overall Study|PPD test taken twice|1|||
13405064|NCT00574145|26817884|FG000|Overall Study|Withdrawal by Subject|2|||
13405065|NCT00574145|26817885|FG001|Overall Study|Withdrawal by Subject|1|||
13405066|NCT00574119|26817899|FG000|Overall Study|Adverse Event|1|||
13405067|NCT00574119|26817899|FG000|Overall Study|Protocol Violation|1|||
13405068|NCT00574119|26817899|FG000|Overall Study|Withdrawal by Subject|1|||
13405069|NCT00574119|26817899|FG000|Overall Study|Physician Decision|1|||
13405070|NCT00574080|26817912|FG000|Overall Study|Death|10|||
13405071|NCT00574080|26817913|FG001|Overall Study|Death|10|||
13405072|NCT00573937|26817928|FG000|Overall Study|Study Terminated|0|||
13405073|NCT00573937|26817929|FG001|Overall Study|Study Terminated|1|||
13405074|NCT00573859|26817937|FG000|Medication Versus Placebo|Scheduling conflicts|12|||
13405075|NCT00573859|26817937|FG000|Smoking Versus Abstinence|Scheduling conflicts|12|||
13405076|NCT00573833|26817946|FG000|Overall Study|Not Treated|2|||
13405077|NCT00573794|26817976|FG000|Overall Study|Adverse Event|81|||
13405078|NCT00573794|26817976|FG000|Overall Study|Withdrew Consent|90|||
13405079|NCT00573794|26817976|FG000|Overall Study|Lost to Follow-up|13|||
13405080|NCT00573794|26817976|FG000|Overall Study|Protocol Violation|6|||
13405081|NCT00573794|26817976|FG000|Overall Study|Lack of Efficacy|94|||
13405082|NCT00573794|26817976|FG000|Overall Study|Other|46|||
13405083|NCT00573768|26817994|FG000|Overall Study|Adverse Event|1|||
13405084|NCT00573768|26817995|FG001|Overall Study|Adverse Event|1|||
13405085|NCT00573768|26817996|FG002|Overall Study|Adverse Event|2|||
13405086|NCT00573768|26817994|FG000|Overall Study|Protocol Violation|1|||
13405087|NCT00573768|26817995|FG001|Overall Study|Protocol Violation|0|||
13405088|NCT00573768|26817996|FG002|Overall Study|Protocol Violation|1|||
13405089|NCT00573768|26817994|FG000|Overall Study|Withdrawal by Subject|0|||
13405090|NCT00573768|26817995|FG001|Overall Study|Withdrawal by Subject|1|||
13405091|NCT00573768|26817996|FG002|Overall Study|Withdrawal by Subject|0|||
13405092|NCT00573768|26817994|FG000|Overall Study|Lost to Follow-up|0|||
13405093|NCT00573768|26817995|FG001|Overall Study|Lost to Follow-up|0|||
13405094|NCT00573768|26817996|FG002|Overall Study|Lost to Follow-up|1|||
13405095|NCT00573755|26818019|FG000|Overall Study|Still receiving treatment|1|||
13405096|NCT00573755|26818020|FG001|Overall Study|Still receiving treatment|0|||
13405097|NCT00573534|26818027|FG000|Overall Study|oppositional behavior|3|||
13405098|NCT00573469|26818057|FG000|Overall Study|Adverse Event|1|||
13405099|NCT00573469|26818058|FG001|Overall Study|Adverse Event|1|||
13405100|NCT00573469|26818059|FG002|Overall Study|Adverse Event|1|||
13405101|NCT00573469|26818057|FG000|Overall Study|Withdrawal by Subject|0|||
13405102|NCT00573469|26818058|FG001|Overall Study|Withdrawal by Subject|2|||
13405103|NCT00573469|26818059|FG002|Overall Study|Withdrawal by Subject|0|||
13405104|NCT00573469|26818057|FG000|Overall Study|Other|5|||
13405105|NCT00573469|26818058|FG001|Overall Study|Other|1|||
13405106|NCT00573469|26818059|FG002|Overall Study|Other|3|||
13405107|NCT00573443|26818096|FG000|Double-Blind Phase|Lost to Follow-up|1|||
13405108|NCT00573443|26818097|FG001|Double-Blind Phase|Lost to Follow-up|3|||
13405109|NCT00573443|26818098|FG002|Double-Blind Phase|Lost to Follow-up|2|||
13405110|NCT00573443|26818096|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1|||
13405111|NCT00573443|26818097|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0|||
13405112|NCT00573443|26818098|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1|||
13405113|NCT00573443|26818096|FG000|Double-Blind Phase|Adverse Event|1|||
13405114|NCT00573443|26818097|FG001|Double-Blind Phase|Adverse Event|5|||
13405115|NCT00573443|26818098|FG002|Double-Blind Phase|Adverse Event|0|||
13405116|NCT00573443|26818096|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2|||
13405117|NCT00573443|26818097|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3|||
13405118|NCT00573443|26818098|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1|||
13405119|NCT00573443|26818096|FG000|Double-Blind Phase|Medication refusal due to AE|2|||
13405120|NCT00573443|26818097|FG001|Double-Blind Phase|Medication refusal due to AE|2|||
13405121|NCT00573443|26818098|FG002|Double-Blind Phase|Medication refusal due to AE|0|||
13405122|NCT00573443|26818096|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
13405123|NCT00573443|26818097|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
13405124|NCT00573443|26818098|FG002|Double-Blind Phase|Withdrawal by Subject|7|||
13405125|NCT00573443|26818096|FG000|Double-Blind Phase|Protocol Violation|0|||
13405126|NCT00573443|26818097|FG001|Double-Blind Phase|Protocol Violation|2|||
13405127|NCT00573443|26818098|FG002|Double-Blind Phase|Protocol Violation|1|||
13405128|NCT00573443|26818096|FG000|Double-Blind Phase|Other|0|||
13405129|NCT00573443|26818097|FG001|Double-Blind Phase|Other|2|||
13405130|NCT00573443|26818098|FG002|Double-Blind Phase|Other|3|||
13405131|NCT00573443|26818096|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
13405132|NCT00573443|26818097|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
13405133|NCT00573443|26818098|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
13405134|NCT00573443|26818096|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2|||
13405135|NCT00573443|26818097|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
13405136|NCT00573443|26818098|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
13405137|NCT00573443|26818096|FG000|Open-Label Extension Phase|Adverse Event|3|||
13405138|NCT00573443|26818097|FG001|Open-Label Extension Phase|Adverse Event|0|||
13405139|NCT00573443|26818098|FG002|Open-Label Extension Phase|Adverse Event|0|||
13405140|NCT00573443|26818096|FG000|Open-Label Extension Phase|Serious Adverse Event|5|||
13405141|NCT00573443|26818097|FG001|Open-Label Extension Phase|Serious Adverse Event|0|||
13405142|NCT00573443|26818098|FG002|Open-Label Extension Phase|Serious Adverse Event|0|||
13405143|NCT00573443|26818096|FG000|Open-Label Extension Phase|Withdrawal by Subject|3|||
13405144|NCT00573443|26818097|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
13405145|NCT00573443|26818098|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
13405146|NCT00573443|26818096|FG000|Open-Label Extension Phase|Protocol Violation|2|||
13405147|NCT00573443|26818097|FG001|Open-Label Extension Phase|Protocol Violation|0|||
13405148|NCT00573443|26818098|FG002|Open-Label Extension Phase|Protocol Violation|0|||
13405149|NCT00573443|26818096|FG000|Open-Label Extension Phase|Other|2|||
13405150|NCT00573443|26818097|FG001|Open-Label Extension Phase|Other|0|||
13405151|NCT00573443|26818098|FG002|Open-Label Extension Phase|Other|0|||
13405152|NCT00573430|26818128|FG000|Overall Study|Incorrect enrollment of randomization|0|||
13405153|NCT00573430|26818129|FG001|Overall Study|Incorrect enrollment of randomization|4|||
13405154|NCT00573430|26818130|FG002|Overall Study|Incorrect enrollment of randomization|3|||
13405155|NCT00573430|26818128|FG000|Overall Study|Adverse Event|0|||
13405156|NCT00573430|26818129|FG001|Overall Study|Adverse Event|0|||
13405157|NCT00573430|26818130|FG002|Overall Study|Adverse Event|2|||
13405158|NCT00573430|26818128|FG000|Overall Study|Withdrawal by Subject|1|||
13405159|NCT00573430|26818129|FG001|Overall Study|Withdrawal by Subject|0|||
13405160|NCT00573430|26818130|FG002|Overall Study|Withdrawal by Subject|1|||
13405161|NCT00573430|26818128|FG000|Overall Study|Protocol Violation|0|||
13405162|NCT00573430|26818129|FG001|Overall Study|Protocol Violation|1|||
13405163|NCT00573430|26818130|FG002|Overall Study|Protocol Violation|1|||
13405164|NCT00573430|26818128|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
13405165|NCT00573430|26818129|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
13405166|NCT00573430|26818130|FG002|Overall Study|Eligibility criteria not fulfilled|3|||
13476211|NCT01729754|27002616|FG008|Part 1|Pregnancy|0|||
13219910|NCT01829243|26278622|FG001|First Intervention|Screen Failure|2|||
13405167|NCT00573391|26818143|FG000|Overall Study|study stopped|2|||
13405168|NCT00573391|26818144|FG001|Overall Study|study stopped|2|||
13405169|NCT00573391|26818143|FG000|Overall Study|Death|1|||
13405170|NCT00573391|26818144|FG001|Overall Study|Death|0|||
13405171|NCT00573313|26818165|FG000|Overall Study|Protocol Violation|5|||
13405172|NCT00573313|26818166|FG001|Overall Study|Protocol Violation|0|||
13405173|NCT00573313|26818167|FG002|Overall Study|Protocol Violation|6|||
13405174|NCT00573313|26818168|FG003|Overall Study|Protocol Violation|0|||
13405175|NCT00573248|26818187|FG000|Overall Study|scheduling conflicts|15|||
13405176|NCT00573248|26818188|FG001|Overall Study|scheduling conflicts|11|||
13405177|NCT00573183|26818203|FG000|Overall Study|Lost to Follow-up|52|||
13405178|NCT00573183|26818204|FG001|Overall Study|Lost to Follow-up|50|||
13405179|NCT00573183|26818203|FG000|Overall Study|Withdrawal by Subject|8|||
13405180|NCT00573183|26818204|FG001|Overall Study|Withdrawal by Subject|2|||
13405181|NCT00573183|26818203|FG000|Overall Study|Death|0|||
13405182|NCT00573183|26818204|FG001|Overall Study|Death|1|||
13405183|NCT00573183|26818203|FG000|Overall Study|Adverse Event|2|||
13405184|NCT00573183|26818204|FG001|Overall Study|Adverse Event|0|||
13405185|NCT00573183|26818203|FG000|Overall Study|Incarceration|5|||
13405186|NCT00573183|26818204|FG001|Overall Study|Incarceration|8|||
13405187|NCT00573183|26818203|FG000|Overall Study|Other|5|||
13405188|NCT00573183|26818204|FG001|Overall Study|Other|2|||
13405189|NCT00573170|26818285|FG000|First Treatment Period|Did Not Treat Attack 1|0|||
13405190|NCT00573170|26818286|FG001|First Treatment Period|Did Not Treat Attack 1|0|||
13405191|NCT00573170|26818287|FG002|First Treatment Period|Did Not Treat Attack 1|0|||
13405192|NCT00573170|26818288|FG003|First Treatment Period|Did Not Treat Attack 1|0|||
13405193|NCT00573170|26818289|FG004|First Treatment Period|Did Not Treat Attack 1|1|||
13405194|NCT00573170|26818290|FG005|First Treatment Period|Did Not Treat Attack 1|0|||
13405195|NCT00573170|26818285|FG000|First Washout Period|Adverse Event|1|||
13405196|NCT00573170|26818286|FG001|First Washout Period|Adverse Event|1|||
13405197|NCT00573170|26818287|FG002|First Washout Period|Adverse Event|0|||
13405198|NCT00573170|26818288|FG003|First Washout Period|Adverse Event|0|||
13405199|NCT00573170|26818289|FG004|First Washout Period|Adverse Event|0|||
13405200|NCT00573170|26818290|FG005|First Washout Period|Adverse Event|1|||
13405201|NCT00573170|26818285|FG000|First Washout Period|Lack of Efficacy|0|||
13405202|NCT00573170|26818286|FG001|First Washout Period|Lack of Efficacy|0|||
13405203|NCT00573170|26818287|FG002|First Washout Period|Lack of Efficacy|0|||
13405204|NCT00573170|26818288|FG003|First Washout Period|Lack of Efficacy|0|||
13405205|NCT00573170|26818289|FG004|First Washout Period|Lack of Efficacy|0|||
13405206|NCT00573170|26818290|FG005|First Washout Period|Lack of Efficacy|1|||
13405207|NCT00573170|26818285|FG000|First Washout Period|Lost to Follow-up|1|||
13405208|NCT00573170|26818286|FG001|First Washout Period|Lost to Follow-up|1|||
13405209|NCT00573170|26818287|FG002|First Washout Period|Lost to Follow-up|0|||
13405210|NCT00573170|26818288|FG003|First Washout Period|Lost to Follow-up|2|||
13405211|NCT00573170|26818289|FG004|First Washout Period|Lost to Follow-up|0|||
13405212|NCT00573170|26818290|FG005|First Washout Period|Lost to Follow-up|2|||
13405213|NCT00573170|26818285|FG000|First Washout Period|Withdrawal by Subject|2|||
13405214|NCT00573170|26818286|FG001|First Washout Period|Withdrawal by Subject|0|||
13405215|NCT00573170|26818287|FG002|First Washout Period|Withdrawal by Subject|0|||
13405216|NCT00573170|26818288|FG003|First Washout Period|Withdrawal by Subject|2|||
13405217|NCT00573170|26818289|FG004|First Washout Period|Withdrawal by Subject|3|||
13405218|NCT00573170|26818290|FG005|First Washout Period|Withdrawal by Subject|3|||
13405219|NCT00573170|26818285|FG000|First Washout Period|Other|4|||
13405220|NCT00573170|26818286|FG001|First Washout Period|Other|0|||
13405221|NCT00573170|26818287|FG002|First Washout Period|Other|1|||
13405222|NCT00573170|26818288|FG003|First Washout Period|Other|1|||
13405223|NCT00573170|26818289|FG004|First Washout Period|Other|0|||
13405224|NCT00573170|26818290|FG005|First Washout Period|Other|0|||
13405225|NCT00573170|26818285|FG000|Second Washout Period|Adverse Event|1|||
13405226|NCT00573170|26818286|FG001|Second Washout Period|Adverse Event|0|||
13405227|NCT00573170|26818287|FG002|Second Washout Period|Adverse Event|0|||
13405228|NCT00573170|26818288|FG003|Second Washout Period|Adverse Event|0|||
13405229|NCT00573170|26818289|FG004|Second Washout Period|Adverse Event|1|||
13405230|NCT00573170|26818290|FG005|Second Washout Period|Adverse Event|0|||
13405231|NCT00573170|26818285|FG000|Second Washout Period|Protocol Violation|2|||
13405232|NCT00573170|26818286|FG001|Second Washout Period|Protocol Violation|1|||
13405233|NCT00573170|26818287|FG002|Second Washout Period|Protocol Violation|1|||
13405234|NCT00573170|26818288|FG003|Second Washout Period|Protocol Violation|0|||
13405235|NCT00573170|26818289|FG004|Second Washout Period|Protocol Violation|0|||
13405236|NCT00573170|26818290|FG005|Second Washout Period|Protocol Violation|0|||
13405237|NCT00573170|26818285|FG000|Second Washout Period|Withdrawal by Subject|1|||
13405238|NCT00573170|26818286|FG001|Second Washout Period|Withdrawal by Subject|1|||
13405239|NCT00573170|26818287|FG002|Second Washout Period|Withdrawal by Subject|2|||
13405240|NCT00573170|26818288|FG003|Second Washout Period|Withdrawal by Subject|0|||
13405241|NCT00573170|26818289|FG004|Second Washout Period|Withdrawal by Subject|1|||
13405242|NCT00573170|26818290|FG005|Second Washout Period|Withdrawal by Subject|0|||
13405243|NCT00573170|26818285|FG000|Second Washout Period|Lost to Follow-up|0|||
13405244|NCT00573170|26818286|FG001|Second Washout Period|Lost to Follow-up|0|||
13405245|NCT00573170|26818287|FG002|Second Washout Period|Lost to Follow-up|0|||
13405246|NCT00573170|26818288|FG003|Second Washout Period|Lost to Follow-up|1|||
13405247|NCT00573170|26818289|FG004|Second Washout Period|Lost to Follow-up|0|||
13405248|NCT00573170|26818290|FG005|Second Washout Period|Lost to Follow-up|0|||
13405249|NCT00573170|26818285|FG000|Second Washout Period|Other|1|||
13405250|NCT00573170|26818286|FG001|Second Washout Period|Other|2|||
13405251|NCT00573170|26818287|FG002|Second Washout Period|Other|1|||
13405252|NCT00573170|26818288|FG003|Second Washout Period|Other|4|||
13405253|NCT00573170|26818289|FG004|Second Washout Period|Other|6|||
13405254|NCT00573170|26818290|FG005|Second Washout Period|Other|2|||
13405255|NCT00573170|26818285|FG000|Third Treatment Period|Withdrawal by Subject|1|||
13405256|NCT00573170|26818286|FG001|Third Treatment Period|Withdrawal by Subject|0|||
13405257|NCT00573170|26818287|FG002|Third Treatment Period|Withdrawal by Subject|0|||
13405258|NCT00573170|26818288|FG003|Third Treatment Period|Withdrawal by Subject|0|||
13405259|NCT00573170|26818289|FG004|Third Treatment Period|Withdrawal by Subject|0|||
13405260|NCT00573170|26818290|FG005|Third Treatment Period|Withdrawal by Subject|0|||
13405261|NCT00573170|26818285|FG000|Third Treatment Period|Lost to Follow-up|0|||
13405262|NCT00573170|26818286|FG001|Third Treatment Period|Lost to Follow-up|0|||
13405263|NCT00573170|26818287|FG002|Third Treatment Period|Lost to Follow-up|0|||
13405264|NCT00573170|26818288|FG003|Third Treatment Period|Lost to Follow-up|0|||
13405265|NCT00573170|26818289|FG004|Third Treatment Period|Lost to Follow-up|0|||
13405266|NCT00573170|26818290|FG005|Third Treatment Period|Lost to Follow-up|2|||
13405267|NCT00573157|26818307|FG000|Overall Study|Adverse Event|3|||
13405268|NCT00573157|26818308|FG001|Overall Study|Adverse Event|1|||
13405269|NCT00573157|26818307|FG000|Overall Study|Other|1|||
13405270|NCT00573157|26818308|FG001|Overall Study|Other|1|||
13405271|NCT00573144|26818325|FG000|Overall Study|Withdrawal by Subject|2|||
13405272|NCT00573144|26818326|FG001|Overall Study|Withdrawal by Subject|3|||
13405273|NCT00573131|26818339|FG000|Overall Study|Withdrawal by Subject|10|||
13405274|NCT00573131|26818340|FG001|Overall Study|Withdrawal by Subject|8|||
13405275|NCT00573066|26818346|FG000|Overall Study|Exclusion criteria|18|||
13405276|NCT00573066|26818346|FG000|Overall Study|IV malfunction|1|||
13405277|NCT00573066|26818346|FG000|Overall Study|Postoperative bleeding|1|||
13405278|NCT00572910|26818416|FG000|Overall Study|Adverse Event|1|||
13405279|NCT00572910|26818417|FG001|Overall Study|Adverse Event|2|||
13405280|NCT00572910|26818418|FG002|Overall Study|Adverse Event|0|||
13405281|NCT00572910|26818419|FG003|Overall Study|Adverse Event|2|||
13405282|NCT00572910|26818420|FG004|Overall Study|Adverse Event|0|||
13405283|NCT00572910|26818421|FG005|Overall Study|Adverse Event|0|||
13405284|NCT00572910|26818422|FG006|Overall Study|Adverse Event|4|||
13405285|NCT00572910|26818423|FG007|Overall Study|Adverse Event|2|||
13405286|NCT00572910|26818424|FG008|Overall Study|Adverse Event|1|||
13405287|NCT00572910|26818425|FG009|Overall Study|Adverse Event|3|||
13405288|NCT00572910|26818426|FG010|Overall Study|Adverse Event|2|||
13405289|NCT00572910|26818416|FG000|Overall Study|Lost to Follow-up|0|||
13405290|NCT00572910|26818417|FG001|Overall Study|Lost to Follow-up|1|||
13405291|NCT00572910|26818418|FG002|Overall Study|Lost to Follow-up|1|||
13405292|NCT00572910|26818419|FG003|Overall Study|Lost to Follow-up|2|||
13405293|NCT00572910|26818420|FG004|Overall Study|Lost to Follow-up|1|||
13405294|NCT00572910|26818421|FG005|Overall Study|Lost to Follow-up|0|||
13405295|NCT00572910|26818422|FG006|Overall Study|Lost to Follow-up|0|||
13405296|NCT00572910|26818423|FG007|Overall Study|Lost to Follow-up|0|||
13405297|NCT00572910|26818424|FG008|Overall Study|Lost to Follow-up|0|||
13405298|NCT00572910|26818425|FG009|Overall Study|Lost to Follow-up|1|||
13405299|NCT00572910|26818426|FG010|Overall Study|Lost to Follow-up|0|||
13405300|NCT00572910|26818416|FG000|Overall Study|Withdrawal by Subject|3|||
13405301|NCT00572910|26818417|FG001|Overall Study|Withdrawal by Subject|0|||
13405302|NCT00572910|26818418|FG002|Overall Study|Withdrawal by Subject|1|||
13405303|NCT00572910|26818419|FG003|Overall Study|Withdrawal by Subject|0|||
13405304|NCT00572910|26818420|FG004|Overall Study|Withdrawal by Subject|1|||
13405305|NCT00572910|26818421|FG005|Overall Study|Withdrawal by Subject|3|||
13405306|NCT00572910|26818422|FG006|Overall Study|Withdrawal by Subject|0|||
13405307|NCT00572910|26818423|FG007|Overall Study|Withdrawal by Subject|2|||
13405308|NCT00572910|26818424|FG008|Overall Study|Withdrawal by Subject|2|||
13405309|NCT00572910|26818425|FG009|Overall Study|Withdrawal by Subject|2|||
13405310|NCT00572910|26818426|FG010|Overall Study|Withdrawal by Subject|1|||
13405311|NCT00572832|26818439|FG000|Overall Study|Lost to Follow-up|0|||
13405312|NCT00572832|26818440|FG001|Overall Study|Lost to Follow-up|11|||
13405313|NCT00572832|26818439|FG000|Overall Study|Pregnancy|0|||
13405314|NCT00572832|26818440|FG001|Overall Study|Pregnancy|1|||
13405315|NCT00572728|26818454|FG000|Overall Study|Withdrawal by Subject|10|||
13405316|NCT00572728|26818454|FG000|Overall Study|Ineligible|3|||
13405317|NCT00572728|26818454|FG000|Overall Study|Enrolled under Amendment 4|5|||
13405318|NCT00572728|26818454|FG000|Overall Study|Offstudy due to complicating disease|1|||
13405319|NCT00572728|26818454|FG000|Overall Study|FLT1 not completed|4|||
13405320|NCT00572728|26818454|FG000|Overall Study|First Chemotherapy not initiated|2|||
13405321|NCT00572728|26818454|FG000|Overall Study|FLT2 not completed|5|||
13405322|NCT00572728|26818454|FG000|Overall Study|Second chemotherapy not initiated|1|||
13405323|NCT00572728|26818454|FG000|Overall Study|FLT2 after second chemotherapy initiated|7|||
13405324|NCT00572728|26818454|FG000|Overall Study|Pathology missing|1|||
13405325|NCT00572624|26818487|FG000|Overall Study|Lost to Follow-up|10|||
13405326|NCT00572624|26818488|FG001|Overall Study|Lost to Follow-up|4|||
13405327|NCT00572624|26818487|FG000|Overall Study|Wanted to do a different diet program|1|||
13405328|NCT00572624|26818488|FG001|Overall Study|Wanted to do a different diet program|0|||
13405329|NCT00572624|26818487|FG000|Overall Study|Medication change|1|||
13405330|NCT00572624|26818488|FG001|Overall Study|Medication change|0|||
13405331|NCT00572624|26818487|FG000|Overall Study|Started a new job-- no time for study|1|||
13405332|NCT00572624|26818488|FG001|Overall Study|Started a new job-- no time for study|0|||
13405333|NCT00572624|26818487|FG000|Overall Study|Admitted to being a smoker|1|||
13405334|NCT00572624|26818488|FG001|Overall Study|Admitted to being a smoker|0|||
13405335|NCT00572624|26818487|FG000|Overall Study|Refused to do the stress test|1|||
13405336|NCT00572624|26818488|FG001|Overall Study|Refused to do the stress test|0|||
13405337|NCT00572624|26818487|FG000|Overall Study|Problem with vascular access|1|||
13405338|NCT00572624|26818488|FG001|Overall Study|Problem with vascular access|0|||
13405339|NCT00572624|26818487|FG000|Overall Study|Health issues unrelated to the study|1|||
13405340|NCT00572624|26818488|FG001|Overall Study|Health issues unrelated to the study|0|||
13405341|NCT00572572|26818511|FG000|Overall Study|Withdrawal by Subject|3|||
13405342|NCT00572572|26818512|FG001|Overall Study|Withdrawal by Subject|6|||
13405343|NCT00572533|26818539|FG000|Overall Study|Death|4|||
13405344|NCT00572533|26818540|FG001|Overall Study|Death|1|||
13405345|NCT00572533|26818539|FG000|Overall Study|Received Kidney Transplant|2|||
13405346|NCT00572533|26818540|FG001|Overall Study|Received Kidney Transplant|1|||
13405347|NCT00572533|26818539|FG000|Overall Study|Social Issues|1|||
13405348|NCT00572533|26818540|FG001|Overall Study|Social Issues|0|||
13405349|NCT00572533|26818539|FG000|Overall Study|Transfer out of Facility|0|||
13405350|NCT00572533|26818540|FG001|Overall Study|Transfer out of Facility|1|||
13405351|NCT00572455|26818669|FG000|Stage I (14 Days)|Adverse Event|0|||
13405352|NCT00572455|26818670|FG001|Stage I (14 Days)|Adverse Event|0|||
13405353|NCT00572455|26818671|FG002|Stage I (14 Days)|Adverse Event|0|||
13405354|NCT00572455|26818672|FG003|Stage I (14 Days)|Adverse Event|0|||
13405355|NCT00572455|26818673|FG004|Stage I (14 Days)|Adverse Event|0|||
13405356|NCT00572455|26818674|FG005|Stage I (14 Days)|Adverse Event|3|||
13405357|NCT00572455|26818675|FG006|Stage I (14 Days)|Adverse Event|0|||
13405358|NCT00572455|26818676|FG007|Stage I (14 Days)|Adverse Event|0|||
13405359|NCT00572455|26818677|FG008|Stage I (14 Days)|Adverse Event|0|||
13405360|NCT00572455|26818678|FG009|Stage I (14 Days)|Adverse Event|0|||
13405361|NCT00572455|26818679|FG010|Stage I (14 Days)|Adverse Event|0|||
13405362|NCT00572455|26818680|FG011|Stage I (14 Days)|Adverse Event|0|||
13405363|NCT00572455|26818681|FG012|Stage I (14 Days)|Adverse Event|0|||
13405364|NCT00572455|26818682|FG013|Stage I (14 Days)|Adverse Event|0|||
13405365|NCT00572455|26818669|FG000|Stage I (14 Days)|Other|0|||
13405366|NCT00572455|26818670|FG001|Stage I (14 Days)|Other|0|||
13405367|NCT00572455|26818671|FG002|Stage I (14 Days)|Other|0|||
13405368|NCT00572455|26818672|FG003|Stage I (14 Days)|Other|0|||
13405369|NCT00572455|26818673|FG004|Stage I (14 Days)|Other|1|||
13405370|NCT00572455|26818674|FG005|Stage I (14 Days)|Other|0|||
13405371|NCT00572455|26818675|FG006|Stage I (14 Days)|Other|0|||
13405372|NCT00572455|26818676|FG007|Stage I (14 Days)|Other|0|||
13405373|NCT00572455|26818677|FG008|Stage I (14 Days)|Other|0|||
13405374|NCT00572455|26818678|FG009|Stage I (14 Days)|Other|0|||
13405375|NCT00572455|26818679|FG010|Stage I (14 Days)|Other|0|||
13405376|NCT00572455|26818680|FG011|Stage I (14 Days)|Other|0|||
13405377|NCT00572455|26818681|FG012|Stage I (14 Days)|Other|0|||
13405378|NCT00572455|26818682|FG013|Stage I (14 Days)|Other|0|||
13405379|NCT00572455|26818669|FG000|Stage II (28 Days)|Adverse Event|0|||
13405380|NCT00572455|26818670|FG001|Stage II (28 Days)|Adverse Event|0|||
13405381|NCT00572455|26818671|FG002|Stage II (28 Days)|Adverse Event|0|||
13405382|NCT00572455|26818672|FG003|Stage II (28 Days)|Adverse Event|0|||
13405383|NCT00572455|26818673|FG004|Stage II (28 Days)|Adverse Event|0|||
13405384|NCT00572455|26818674|FG005|Stage II (28 Days)|Adverse Event|0|||
13405385|NCT00572455|26818675|FG006|Stage II (28 Days)|Adverse Event|0|||
13405386|NCT00572455|26818676|FG007|Stage II (28 Days)|Adverse Event|0|||
13405387|NCT00572455|26818677|FG008|Stage II (28 Days)|Adverse Event|1|||
13405388|NCT00572455|26818678|FG009|Stage II (28 Days)|Adverse Event|3|||
13405389|NCT00572455|26818679|FG010|Stage II (28 Days)|Adverse Event|3|||
13405390|NCT00572455|26818680|FG011|Stage II (28 Days)|Adverse Event|4|||
13405391|NCT00572455|26818681|FG012|Stage II (28 Days)|Adverse Event|5|||
13405392|NCT00572455|26818682|FG013|Stage II (28 Days)|Adverse Event|1|||
13405393|NCT00572455|26818669|FG000|Stage II (28 Days)|Death|0|||
13405394|NCT00572455|26818670|FG001|Stage II (28 Days)|Death|0|||
13405395|NCT00572455|26818671|FG002|Stage II (28 Days)|Death|0|||
13405396|NCT00572455|26818672|FG003|Stage II (28 Days)|Death|0|||
13405397|NCT00572455|26818673|FG004|Stage II (28 Days)|Death|0|||
13405398|NCT00572455|26818674|FG005|Stage II (28 Days)|Death|0|||
13405399|NCT00572455|26818675|FG006|Stage II (28 Days)|Death|0|||
13405400|NCT00572455|26818676|FG007|Stage II (28 Days)|Death|0|||
13405401|NCT00572455|26818677|FG008|Stage II (28 Days)|Death|1|||
13405402|NCT00572455|26818678|FG009|Stage II (28 Days)|Death|0|||
13405403|NCT00572455|26818679|FG010|Stage II (28 Days)|Death|0|||
13405404|NCT00572455|26818680|FG011|Stage II (28 Days)|Death|0|||
13405405|NCT00572455|26818681|FG012|Stage II (28 Days)|Death|0|||
13405406|NCT00572455|26818682|FG013|Stage II (28 Days)|Death|0|||
13405407|NCT00572455|26818669|FG000|Stage II (28 Days)|Withdrawal by Subject|0|||
13405408|NCT00572455|26818670|FG001|Stage II (28 Days)|Withdrawal by Subject|0|||
13405409|NCT00572455|26818671|FG002|Stage II (28 Days)|Withdrawal by Subject|0|||
13405410|NCT00572455|26818672|FG003|Stage II (28 Days)|Withdrawal by Subject|0|||
13405411|NCT00572455|26818673|FG004|Stage II (28 Days)|Withdrawal by Subject|0|||
13405412|NCT00572455|26818674|FG005|Stage II (28 Days)|Withdrawal by Subject|0|||
13405413|NCT00572455|26818675|FG006|Stage II (28 Days)|Withdrawal by Subject|0|||
13405414|NCT00572455|26818676|FG007|Stage II (28 Days)|Withdrawal by Subject|1|||
13405415|NCT00572455|26818677|FG008|Stage II (28 Days)|Withdrawal by Subject|0|||
13405416|NCT00572455|26818678|FG009|Stage II (28 Days)|Withdrawal by Subject|0|||
13405417|NCT00572455|26818679|FG010|Stage II (28 Days)|Withdrawal by Subject|2|||
13405418|NCT00572455|26818680|FG011|Stage II (28 Days)|Withdrawal by Subject|0|||
13405419|NCT00572455|26818681|FG012|Stage II (28 Days)|Withdrawal by Subject|0|||
13405420|NCT00572455|26818682|FG013|Stage II (28 Days)|Withdrawal by Subject|0|||
13405421|NCT00572455|26818669|FG000|Stage II (28 Days)|Other|0|||
13405422|NCT00572455|26818670|FG001|Stage II (28 Days)|Other|0|||
13405423|NCT00572455|26818671|FG002|Stage II (28 Days)|Other|0|||
13405424|NCT00572455|26818672|FG003|Stage II (28 Days)|Other|0|||
13405425|NCT00572455|26818673|FG004|Stage II (28 Days)|Other|0|||
13405426|NCT00572455|26818674|FG005|Stage II (28 Days)|Other|0|||
13405427|NCT00572455|26818675|FG006|Stage II (28 Days)|Other|0|||
13405428|NCT00572455|26818676|FG007|Stage II (28 Days)|Other|0|||
13405429|NCT00572455|26818677|FG008|Stage II (28 Days)|Other|1|||
13405430|NCT00572455|26818678|FG009|Stage II (28 Days)|Other|0|||
13405431|NCT00572455|26818679|FG010|Stage II (28 Days)|Other|0|||
13405432|NCT00572455|26818680|FG011|Stage II (28 Days)|Other|0|||
13405433|NCT00572455|26818681|FG012|Stage II (28 Days)|Other|0|||
13405434|NCT00572455|26818682|FG013|Stage II (28 Days)|Other|0|||
13405435|NCT00572455|26818669|FG000|Stage II (28 Days)|Randomized, but not treated|0|||
13405436|NCT00572455|26818670|FG001|Stage II (28 Days)|Randomized, but not treated|0|||
13405437|NCT00572455|26818671|FG002|Stage II (28 Days)|Randomized, but not treated|0|||
13405438|NCT00572455|26818672|FG003|Stage II (28 Days)|Randomized, but not treated|0|||
13405439|NCT00572455|26818673|FG004|Stage II (28 Days)|Randomized, but not treated|0|||
13405440|NCT00572455|26818674|FG005|Stage II (28 Days)|Randomized, but not treated|0|||
13405441|NCT00572455|26818675|FG006|Stage II (28 Days)|Randomized, but not treated|0|||
13405442|NCT00572455|26818676|FG007|Stage II (28 Days)|Randomized, but not treated|0|||
13405443|NCT00572455|26818677|FG008|Stage II (28 Days)|Randomized, but not treated|0|||
13405444|NCT00572455|26818678|FG009|Stage II (28 Days)|Randomized, but not treated|0|||
13405445|NCT00572455|26818679|FG010|Stage II (28 Days)|Randomized, but not treated|0|||
13405446|NCT00572455|26818680|FG011|Stage II (28 Days)|Randomized, but not treated|0|||
13405447|NCT00572455|26818681|FG012|Stage II (28 Days)|Randomized, but not treated|0|||
13405448|NCT00572455|26818682|FG013|Stage II (28 Days)|Randomized, but not treated|1|||
13405449|NCT00572195|26818692|FG000|Overall Study|Withdrawal by Subject|50|||
13405450|NCT00572195|26818692|FG000|Overall Study|Death|9|||
13405451|NCT00572195|26818692|FG000|Overall Study|Adverse Event|4|||
13405452|NCT00572195|26818692|FG000|Overall Study|Lost to Follow-up|5|||
13405453|NCT00572156|26818763|FG000|Overall Study|Adverse Event|3|||
13405454|NCT00572156|26818764|FG001|Overall Study|Adverse Event|1|||
13405455|NCT00572156|26818765|FG002|Overall Study|Adverse Event|5|||
13405456|NCT00572156|26818766|FG003|Overall Study|Adverse Event|1|||
13405457|NCT00572156|26818763|FG000|Overall Study|Lost to Follow-up|1|||
13405458|NCT00572156|26818764|FG001|Overall Study|Lost to Follow-up|1|||
13405459|NCT00572156|26818765|FG002|Overall Study|Lost to Follow-up|1|||
13405460|NCT00572156|26818766|FG003|Overall Study|Lost to Follow-up|0|||
13405461|NCT00572156|26818763|FG000|Overall Study|Protocol Violation|1|||
13405462|NCT00572156|26818764|FG001|Overall Study|Protocol Violation|2|||
13405463|NCT00572156|26818765|FG002|Overall Study|Protocol Violation|0|||
13405464|NCT00572156|26818766|FG003|Overall Study|Protocol Violation|2|||
13405465|NCT00572156|26818763|FG000|Overall Study|Patient/Parent Decision|1|||
13405466|NCT00572156|26818764|FG001|Overall Study|Patient/Parent Decision|6|||
13405467|NCT00572156|26818765|FG002|Overall Study|Patient/Parent Decision|4|||
13405468|NCT00572156|26818766|FG003|Overall Study|Patient/Parent Decision|3|||
13405469|NCT00572156|26818763|FG000|Overall Study|Sponsor Decision|20|||
13405470|NCT00572156|26818764|FG001|Overall Study|Sponsor Decision|16|||
13405471|NCT00572156|26818765|FG002|Overall Study|Sponsor Decision|17|||
13405472|NCT00572156|26818766|FG003|Overall Study|Sponsor Decision|19|||
13405473|NCT00572039|26818785|FG000|Overall Study|Withdrawal by Subject|9|||
13405474|NCT00572039|26818786|FG001|Overall Study|Withdrawal by Subject|6|||
13405475|NCT00572039|26818785|FG000|Overall Study|Death|2|||
13405476|NCT00572039|26818786|FG001|Overall Study|Death|3|||
13405477|NCT00572039|26818785|FG000|Overall Study|Ill|5|||
13405478|NCT00572039|26818786|FG001|Overall Study|Ill|1|||
13405479|NCT00571948|26818799|FG000|Overall Study|Lost to Follow-up|2|||
13405480|NCT00571948|26818800|FG001|Overall Study|Lost to Follow-up|0|||
13405481|NCT00571948|26818799|FG000|Overall Study|Withdrawal by Subject|1|||
13405482|NCT00571948|26818800|FG001|Overall Study|Withdrawal by Subject|2|||
13405483|NCT00571948|26818799|FG000|Overall Study|Protocol Violation|3|||
13405484|NCT00571948|26818800|FG001|Overall Study|Protocol Violation|3|||
13405485|NCT00571948|26818799|FG000|Overall Study|infant refused study meal|3|||
13405486|NCT00571948|26818800|FG001|Overall Study|infant refused study meal|4|||
13405487|NCT00571948|26818799|FG000|Overall Study|Parent were afraid of blood colection|2|||
13405488|NCT00571948|26818800|FG001|Overall Study|Parent were afraid of blood colection|5|||
13405489|NCT00571922|26818815|FG000|Overall Study|Completion unknown|36|||
13405490|NCT00571922|26818816|FG001|Overall Study|Completion unknown|36|||
13405491|NCT00571701|26818847|FG000|First Intervention 12 Months|Withdrawal by Subject|2|||
13405492|NCT00571701|26818848|FG001|First Intervention 12 Months|Withdrawal by Subject|1|||
13405493|NCT00571701|26818847|FG000|First Intervention 12 Months|Death|1|||
13405494|NCT00571701|26818848|FG001|First Intervention 12 Months|Death|0|||
13405495|NCT00571701|26818847|FG000|Second Intervention 12 Months|Adverse Event|0|||
13405496|NCT00571701|26818848|FG001|Second Intervention 12 Months|Adverse Event|1|||
13405497|NCT00571701|26818847|FG000|Second Intervention 12 Months|Withdrawal by Subject|3|||
13405498|NCT00571701|26818848|FG001|Second Intervention 12 Months|Withdrawal by Subject|0|||
13405499|NCT00571688|26818861|FG000|Overall Study|Lost to Follow-up|3|||
13405500|NCT00571688|26818862|FG001|Overall Study|Lost to Follow-up|6|||
13405501|NCT00571688|26818861|FG000|Overall Study|subject did not tolerate Consta|1|||
13405502|NCT00571688|26818862|FG001|Overall Study|subject did not tolerate Consta|0|||
13405503|NCT00571688|26818861|FG000|Overall Study|subject moved out of the area|1|||
13405504|NCT00571688|26818862|FG001|Overall Study|subject moved out of the area|0|||
13405505|NCT00571662|26818873|FG000|Overall Study|Withdrawal by Subject|2|||
13405506|NCT00571662|26818873|FG000|Overall Study|psychiatric instability|1|||
13405507|NCT00571662|26818873|FG000|Overall Study|Adverse Event|5|||
13405508|NCT00571649|26818912|FG000|Treatment Period|Adverse Event|438|||
13405509|NCT00571649|26818913|FG001|Treatment Period|Adverse Event|385|||
13405510|NCT00571649|26818912|FG000|Treatment Period|Clinical endpoint reached|50|||
13405511|NCT00571649|26818913|FG001|Treatment Period|Clinical endpoint reached|56|||
13405512|NCT00571649|26818912|FG000|Treatment Period|Withdrawal by Subject|285|||
13405513|NCT00571649|26818913|FG001|Treatment Period|Withdrawal by Subject|255|||
13405514|NCT00571649|26818912|FG000|Treatment Period|Death|76|||
13405515|NCT00571649|26818913|FG001|Treatment Period|Death|59|||
13405516|NCT00571649|26818912|FG000|Treatment Period|Physician Decision|8|||
13405517|NCT00571649|26818913|FG001|Treatment Period|Physician Decision|9|||
13405518|NCT00571649|26818912|FG000|Treatment Period|Lost to Follow-up|43|||
13405519|NCT00571649|26818913|FG001|Treatment Period|Lost to Follow-up|41|||
13405520|NCT00571649|26818912|FG000|Treatment Period|Non-compliant with study medication|88|||
13405521|NCT00571649|26818913|FG001|Treatment Period|Non-compliant with study medication|89|||
13405522|NCT00571649|26818912|FG000|Treatment Period|Patient convenience|11|||
13405523|NCT00571649|26818913|FG001|Treatment Period|Patient convenience|13|||
13405524|NCT00571649|26818912|FG000|Treatment Period|Protocol Violation|90|||
13405525|NCT00571649|26818913|FG001|Treatment Period|Protocol Violation|92|||
13405526|NCT00571649|26818912|FG000|Treatment Period|Technical problems|3|||
13405527|NCT00571649|26818913|FG001|Treatment Period|Technical problems|5|||
13405528|NCT00571649|26818912|FG000|Follow-up Period|Adverse Event|46|||
13405529|NCT00571649|26818913|FG001|Follow-up Period|Adverse Event|40|||
13405530|NCT00571649|26818912|FG000|Follow-up Period|Clinical endpoint reached|5|||
13405531|NCT00571649|26818913|FG001|Follow-up Period|Clinical endpoint reached|2|||
13405532|NCT00571649|26818912|FG000|Follow-up Period|Withdrawal by Subject|119|||
13405533|NCT00571649|26818913|FG001|Follow-up Period|Withdrawal by Subject|115|||
13405534|NCT00571649|26818912|FG000|Follow-up Period|Death|132|||
13405535|NCT00571649|26818913|FG001|Follow-up Period|Death|133|||
13405536|NCT00571649|26818912|FG000|Follow-up Period|Physician Decision|7|||
13405537|NCT00571649|26818913|FG001|Follow-up Period|Physician Decision|13|||
13405538|NCT00571649|26818912|FG000|Follow-up Period|Lost to Follow-up|95|||
13405539|NCT00571649|26818913|FG001|Follow-up Period|Lost to Follow-up|92|||
13405540|NCT00571649|26818912|FG000|Follow-up Period|Patient convenience|136|||
13405541|NCT00571649|26818913|FG001|Follow-up Period|Patient convenience|121|||
13405542|NCT00571649|26818912|FG000|Follow-up Period|Protocol Violation|5|||
13405543|NCT00571649|26818913|FG001|Follow-up Period|Protocol Violation|12|||
13405544|NCT00571519|26819049|FG000|Overall Study|Subject withdrew consent|0|||
13405545|NCT00571519|26819050|FG001|Overall Study|Subject withdrew consent|1|||
13405546|NCT00571519|26819051|FG002|Overall Study|Subject withdrew consent|0|||
13405547|NCT00571519|26819052|FG003|Overall Study|Subject withdrew consent|2|||
13405548|NCT00571519|26819053|FG004|Overall Study|Subject withdrew consent|1|||
13405549|NCT00571519|26819054|FG005|Overall Study|Subject withdrew consent|1|||
13405550|NCT00571519|26819055|FG006|Overall Study|Subject withdrew consent|2|||
13405551|NCT00571519|26819049|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
13219911|NCT01829230|26278637|FG000|Overall Study|Protocol Violation|0|||
13405552|NCT00571519|26819050|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
13405553|NCT00571519|26819051|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
13405554|NCT00571519|26819052|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
13405555|NCT00571519|26819053|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
13405556|NCT00571519|26819054|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
13405557|NCT00571519|26819055|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
13405558|NCT00571519|26819049|FG000|Overall Study|Therapeutic failure/lack of efficacy|0|||
13405559|NCT00571519|26819050|FG001|Overall Study|Therapeutic failure/lack of efficacy|1|||
13405560|NCT00571519|26819051|FG002|Overall Study|Therapeutic failure/lack of efficacy|0|||
13405561|NCT00571519|26819052|FG003|Overall Study|Therapeutic failure/lack of efficacy|0|||
13405562|NCT00571519|26819053|FG004|Overall Study|Therapeutic failure/lack of efficacy|0|||
13405563|NCT00571519|26819054|FG005|Overall Study|Therapeutic failure/lack of efficacy|0|||
13405564|NCT00571519|26819055|FG006|Overall Study|Therapeutic failure/lack of efficacy|0|||
13405565|NCT00571519|26819049|FG000|Overall Study|Termination of study by Sponsor|2|||
13405566|NCT00571519|26819050|FG001|Overall Study|Termination of study by Sponsor|7|||
13405567|NCT00571519|26819051|FG002|Overall Study|Termination of study by Sponsor|10|||
13405568|NCT00571519|26819052|FG003|Overall Study|Termination of study by Sponsor|24|||
13405569|NCT00571519|26819053|FG004|Overall Study|Termination of study by Sponsor|8|||
13405570|NCT00571519|26819054|FG005|Overall Study|Termination of study by Sponsor|9|||
13405571|NCT00571519|26819055|FG006|Overall Study|Termination of study by Sponsor|22|||
13405572|NCT00571519|26819049|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
13405573|NCT00571519|26819050|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
13405574|NCT00571519|26819051|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1|||
13405575|NCT00571519|26819052|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
13405576|NCT00571519|26819053|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
13405577|NCT00571519|26819054|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
13405578|NCT00571519|26819055|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
13405579|NCT00571103|26819062|FG000|Overall Study|Withdrawal by Subject|1|||
13405580|NCT00571103|26819062|FG000|Overall Study|Lost to Follow-up|1|||
13405581|NCT00571064|26819077|FG000|Overall Study|Adverse Event|13|||
13405582|NCT00571064|26819077|FG000|Overall Study|Protocol Violation|4|||
13405583|NCT00571064|26819077|FG000|Overall Study|Withdrawal by Subject|2|||
13405584|NCT00571064|26819077|FG000|Overall Study|Other|2|||
13405585|NCT00571038|26819130|FG000|Overall Study|Lost to Follow-up|1|||
13405586|NCT00571038|26819131|FG001|Overall Study|Lost to Follow-up|4|||
13405587|NCT00571038|26819130|FG000|Overall Study|Death|7|||
13405588|NCT00571038|26819131|FG001|Overall Study|Death|5|||
13405589|NCT00571038|26819130|FG000|Overall Study|Withdrawal by Subject|1|||
13405590|NCT00571038|26819131|FG001|Overall Study|Withdrawal by Subject|3|||
13405591|NCT00571038|26819130|FG000|Overall Study|Moved out of state|2|||
13405592|NCT00571038|26819131|FG001|Overall Study|Moved out of state|2|||
13405593|NCT00570921|26819139|FG000|Overall Study|Protocol Violation|1|||
13405594|NCT00570921|26819139|FG000|Overall Study|Physician Decision|1|||
13405595|NCT00570908|26819145|FG000|Overall Study|Adverse Event|5|||
13405596|NCT00570908|26819145|FG000|Overall Study|Withdrawal by Subject|2|||
13405597|NCT00570778|26819168|FG000|Overall Study|Protocol deviation|2|||
13405598|NCT00570778|26819169|FG001|Overall Study|Protocol deviation|1|||
13405599|NCT00570778|26819170|FG002|Overall Study|Protocol deviation|2|||
13405600|NCT00570778|26819171|FG003|Overall Study|Protocol deviation|2|||
13405601|NCT00570778|26819168|FG000|Overall Study|Adverse Event|0|||
13405602|NCT00570778|26819169|FG001|Overall Study|Adverse Event|1|||
13405603|NCT00570778|26819170|FG002|Overall Study|Adverse Event|4|||
13405604|NCT00570778|26819171|FG003|Overall Study|Adverse Event|1|||
13405605|NCT00570778|26819168|FG000|Overall Study|Subject withdrew consent|0|||
13405606|NCT00570778|26819169|FG001|Overall Study|Subject withdrew consent|1|||
13405607|NCT00570778|26819170|FG002|Overall Study|Subject withdrew consent|0|||
13405608|NCT00570778|26819171|FG003|Overall Study|Subject withdrew consent|1|||
13405609|NCT00570778|26819168|FG000|Overall Study|Abnormal test procedure|1|||
13405610|NCT00570778|26819169|FG001|Overall Study|Abnormal test procedure|0|||
13405611|NCT00570778|26819170|FG002|Overall Study|Abnormal test procedure|0|||
13405612|NCT00570778|26819171|FG003|Overall Study|Abnormal test procedure|0|||
13405613|NCT00570778|26819168|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
13405614|NCT00570778|26819169|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
13405615|NCT00570778|26819170|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
13405616|NCT00570778|26819171|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
13405617|NCT00570778|26819168|FG000|Overall Study|Lost to Follow-up|0|||
13405618|NCT00570778|26819169|FG001|Overall Study|Lost to Follow-up|0|||
13405619|NCT00570778|26819170|FG002|Overall Study|Lost to Follow-up|1|||
13405620|NCT00570778|26819171|FG003|Overall Study|Lost to Follow-up|0|||
13405621|NCT00570778|26819168|FG000|Overall Study|Subject no longer requires study drug|0|||
13405622|NCT00570778|26819169|FG001|Overall Study|Subject no longer requires study drug|1|||
13405623|NCT00570778|26819170|FG002|Overall Study|Subject no longer requires study drug|0|||
13405624|NCT00570778|26819171|FG003|Overall Study|Subject no longer requires study drug|0|||
13405625|NCT00570765|26819213|FG000|DB Phase|Withdrawal by Subject|1|||
13405626|NCT00570765|26819214|FG001|DB Phase|Withdrawal by Subject|0|||
13405627|NCT00570765|26819215|FG002|DB Phase|Withdrawal by Subject|0|||
13405628|NCT00570765|26819216|FG003|DB Phase|Withdrawal by Subject|0|||
13405629|NCT00570765|26819213|FG000|DB Phase|Protocol Violation|0|||
13405630|NCT00570765|26819214|FG001|DB Phase|Protocol Violation|1|||
13405631|NCT00570765|26819215|FG002|DB Phase|Protocol Violation|0|||
13405632|NCT00570765|26819216|FG003|DB Phase|Protocol Violation|0|||
13405633|NCT00570765|26819213|FG000|DB Phase|Adverse Event|3|||
13405634|NCT00570765|26819214|FG001|DB Phase|Adverse Event|6|||
13405635|NCT00570765|26819215|FG002|DB Phase|Adverse Event|0|||
13405636|NCT00570765|26819216|FG003|DB Phase|Adverse Event|0|||
13405637|NCT00570765|26819213|FG000|DB Phase|Did Not Receive Study Drug|0|||
13405638|NCT00570765|26819214|FG001|DB Phase|Did Not Receive Study Drug|0|||
13405639|NCT00570765|26819215|FG002|DB Phase|Did Not Receive Study Drug|1|||
13405640|NCT00570765|26819216|FG003|DB Phase|Did Not Receive Study Drug|0|||
13405641|NCT00570765|26819213|FG000|LTSE Phase|Withdrawal by Subject|0|||
13405642|NCT00570765|26819214|FG001|LTSE Phase|Withdrawal by Subject|0|||
13405643|NCT00570765|26819215|FG002|LTSE Phase|Withdrawal by Subject|0|||
13405644|NCT00570765|26819216|FG003|LTSE Phase|Withdrawal by Subject|1|||
13405645|NCT00570765|26819213|FG000|LTSE Phase|Adverse Event|0|||
13405646|NCT00570765|26819214|FG001|LTSE Phase|Adverse Event|0|||
13405647|NCT00570765|26819215|FG002|LTSE Phase|Adverse Event|0|||
13405648|NCT00570765|26819216|FG003|LTSE Phase|Adverse Event|7|||
13405649|NCT00570765|26819213|FG000|LTSE Phase|Physician Decision|0|||
13405650|NCT00570765|26819214|FG001|LTSE Phase|Physician Decision|0|||
13405651|NCT00570765|26819215|FG002|LTSE Phase|Physician Decision|0|||
13405652|NCT00570765|26819216|FG003|LTSE Phase|Physician Decision|4|||
13405653|NCT00570739|26819379|FG000|Overall Study|Adverse Event|8|||
13405654|NCT00570739|26819380|FG001|Overall Study|Adverse Event|6|||
13405655|NCT00570739|26819381|FG002|Overall Study|Adverse Event|2|||
13405656|NCT00570739|26819382|FG003|Overall Study|Adverse Event|2|||
13405657|NCT00570739|26819379|FG000|Overall Study|Lost to Follow-up|4|||
13405658|NCT00570739|26819380|FG001|Overall Study|Lost to Follow-up|5|||
13405659|NCT00570739|26819381|FG002|Overall Study|Lost to Follow-up|4|||
13405660|NCT00570739|26819382|FG003|Overall Study|Lost to Follow-up|1|||
13405661|NCT00570739|26819379|FG000|Overall Study|Physician Decision|1|||
13405662|NCT00570739|26819380|FG001|Overall Study|Physician Decision|1|||
13405663|NCT00570739|26819381|FG002|Overall Study|Physician Decision|0|||
13405664|NCT00570739|26819382|FG003|Overall Study|Physician Decision|0|||
13405665|NCT00570739|26819379|FG000|Overall Study|Withdrawal by Subject|7|||
13405666|NCT00570739|26819380|FG001|Overall Study|Withdrawal by Subject|7|||
13405667|NCT00570739|26819381|FG002|Overall Study|Withdrawal by Subject|3|||
13405668|NCT00570739|26819382|FG003|Overall Study|Withdrawal by Subject|5|||
13405669|NCT00570739|26819379|FG000|Overall Study|Required restricted medication|0|||
13405670|NCT00570739|26819380|FG001|Overall Study|Required restricted medication|0|||
13405671|NCT00570739|26819381|FG002|Overall Study|Required restricted medication|1|||
13405672|NCT00570739|26819382|FG003|Overall Study|Required restricted medication|0|||
13405673|NCT00570739|26819379|FG000|Overall Study|Met discontinuation criteria|1|||
13405674|NCT00570739|26819380|FG001|Overall Study|Met discontinuation criteria|0|||
13405675|NCT00570739|26819381|FG002|Overall Study|Met discontinuation criteria|1|||
13405676|NCT00570739|26819382|FG003|Overall Study|Met discontinuation criteria|1|||
13405677|NCT00570739|26819379|FG000|Overall Study|Other|0|||
13405678|NCT00570739|26819380|FG001|Overall Study|Other|2|||
13405679|NCT00570739|26819381|FG002|Overall Study|Other|5|||
13405680|NCT00570739|26819382|FG003|Overall Study|Other|3|||
13405681|NCT00570713|26819399|FG000|Overall Study|Adverse Event|16|||
13405682|NCT00570713|26819400|FG001|Overall Study|Adverse Event|9|||
13405683|NCT00570713|26819399|FG000|Overall Study|Death|7|||
13405684|NCT00570713|26819400|FG001|Overall Study|Death|7|||
13405685|NCT00570713|26819399|FG000|Overall Study|Lack of Efficacy|40|||
13405686|NCT00570713|26819400|FG001|Overall Study|Lack of Efficacy|49|||
13405687|NCT00570713|26819399|FG000|Overall Study|Physician Decision|2|||
13405688|NCT00570713|26819400|FG001|Overall Study|Physician Decision|2|||
13405689|NCT00570713|26819399|FG000|Overall Study|Withdrawal by Subject|3|||
13405690|NCT00570713|26819400|FG001|Overall Study|Withdrawal by Subject|3|||
13405691|NCT00570713|26819399|FG000|Overall Study|Discontinuation of Study by the Sponsor|10|||
13405692|NCT00570713|26819400|FG001|Overall Study|Discontinuation of Study by the Sponsor|7|||
13405693|NCT00570687|26819441|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
13405694|NCT00570687|26819442|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
13405695|NCT00570687|26819443|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
13405696|NCT00570687|26819444|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
13405697|NCT00570687|26819445|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
13405698|NCT00570687|26819446|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
13405699|NCT00570687|26819447|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
13405700|NCT00570687|26819448|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
13476212|NCT01729754|27002617|FG009|Part 1|Pregnancy|1|||
13405701|NCT00570687|26819449|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
13405702|NCT00570687|26819450|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
13405703|NCT00570687|26819441|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
13405704|NCT00570687|26819442|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
13405705|NCT00570687|26819443|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
13405706|NCT00570687|26819444|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
13405707|NCT00570687|26819445|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
13405708|NCT00570687|26819446|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
13405709|NCT00570687|26819447|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
13405710|NCT00570687|26819448|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
13405711|NCT00570687|26819449|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
13405712|NCT00570687|26819450|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
13405713|NCT00570687|26819441|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
13405714|NCT00570687|26819442|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
13405715|NCT00570687|26819443|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
13405716|NCT00570687|26819444|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
13405717|NCT00570687|26819445|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
13405718|NCT00570687|26819446|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
13405719|NCT00570687|26819447|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
13405720|NCT00570687|26819448|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
13405721|NCT00570687|26819449|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
13405722|NCT00570687|26819450|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
13405723|NCT00570674|26819475|FG000|Overall Study|Withdrawal by Subject|0|||
13405724|NCT00570674|26819476|FG001|Overall Study|Withdrawal by Subject|0|||
13405725|NCT00570674|26819477|FG002|Overall Study|Withdrawal by Subject|1|||
13405726|NCT00570674|26819478|FG003|Overall Study|Withdrawal by Subject|0|||
13405727|NCT00570674|26819479|FG004|Overall Study|Withdrawal by Subject|0|||
13405728|NCT00570674|26819480|FG005|Overall Study|Withdrawal by Subject|0|||
13405729|NCT00570674|26819481|FG006|Overall Study|Withdrawal by Subject|0|||
13405730|NCT00570661|26819526|FG000|Overall Study|Disease worsening|5|||
13405731|NCT00570661|26819526|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1|||
13405732|NCT00570661|26819526|FG000|Overall Study|Adverse Event|1|||
13405733|NCT00570505|26819539|FG000|Overall Study|Adverse Event|7|||
13405734|NCT00570505|26819539|FG000|Overall Study|Withdrawal by Subject|7|||
13405735|NCT00570505|26819539|FG000|Overall Study|Lost to Follow-up|23|||
13405736|NCT00570505|26819539|FG000|Overall Study|Other loss to follow-up|4|||
13405737|NCT00570492|26819585|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98|||
13405738|NCT00570492|26819586|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
13405739|NCT00570492|26819587|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
13405740|NCT00570492|26819585|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263|||
13405741|NCT00570492|26819586|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
13405742|NCT00570492|26819587|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
13405743|NCT00570492|26819585|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56|||
13405744|NCT00570492|26819586|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
13405745|NCT00570492|26819587|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
13405746|NCT00570492|26819585|FG000|16-week Single-blind Baseline Period|Protocol Violation|15|||
13405747|NCT00570492|26819586|FG001|16-week Single-blind Baseline Period|Protocol Violation|0|||
13405748|NCT00570492|26819587|FG002|16-week Single-blind Baseline Period|Protocol Violation|0|||
13405749|NCT00570492|26819585|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2|||
13405750|NCT00570492|26819586|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
13405751|NCT00570492|26819587|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
13405752|NCT00570492|26819585|FG000|16-week Single-blind Baseline Period|Adverse Event|1|||
13405753|NCT00570492|26819586|FG001|16-week Single-blind Baseline Period|Adverse Event|0|||
13405754|NCT00570492|26819587|FG002|16-week Single-blind Baseline Period|Adverse Event|0|||
13405755|NCT00570492|26819585|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1|||
13405756|NCT00570492|26819586|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
13405757|NCT00570492|26819587|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
13405758|NCT00570492|26819585|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
13405759|NCT00570492|26819586|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
13405760|NCT00570492|26819587|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
13405761|NCT00570492|26819585|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
13405762|NCT00570492|26819586|FG001|52-week Double-blind Treatment Period|Protocol Violation|12|||
13405763|NCT00570492|26819587|FG002|52-week Double-blind Treatment Period|Protocol Violation|15|||
13405764|NCT00570492|26819585|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
13405765|NCT00570492|26819586|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5|||
13476213|NCT01729754|27002608|FG000|Part 1|Progressive Disease|0|||
13405766|NCT00570492|26819587|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7|||
13405767|NCT00570492|26819585|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
13405768|NCT00570492|26819586|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
13405769|NCT00570492|26819587|FG002|52-week Double-blind Treatment Period|Adverse Event|5|||
13405770|NCT00570492|26819585|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
13405771|NCT00570492|26819586|FG001|52-week Double-blind Treatment Period|Physician Decision|2|||
13405772|NCT00570492|26819587|FG002|52-week Double-blind Treatment Period|Physician Decision|4|||
13405773|NCT00570492|26819585|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
13405774|NCT00570492|26819586|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3|||
13405775|NCT00570492|26819587|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
13405776|NCT00570492|26819585|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
13405777|NCT00570492|26819586|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3|||
13405778|NCT00570492|26819587|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
13405779|NCT00570401|26819593|FG000|Overall Study|Adverse Event|2|||
13405780|NCT00570323|26819610|FG000|Started Treatment After Randomization|Withdrawal by Subject|0|||
13405781|NCT00570323|26819611|FG001|Started Treatment After Randomization|Withdrawal by Subject|1|||
13405782|NCT00570323|26819610|FG000|Started Treatment After Randomization|Protocol Violation|1|||
13405783|NCT00570323|26819611|FG001|Started Treatment After Randomization|Protocol Violation|0|||
13405784|NCT00570323|26819610|FG000|Started Treatment After Randomization|Physician Decision|1|||
13405785|NCT00570323|26819611|FG001|Started Treatment After Randomization|Physician Decision|0|||
13405786|NCT00570323|26819610|FG000|Complete Study After Start|Lost to Follow-up|0|||
13405787|NCT00570323|26819611|FG001|Complete Study After Start|Lost to Follow-up|1|||
13405788|NCT00570323|26819610|FG000|Complete Study After Start|Withdrawal by Subject|2|||
13405789|NCT00570323|26819611|FG001|Complete Study After Start|Withdrawal by Subject|0|||
13405790|NCT00570323|26819610|FG000|Complete Study After Start|Physician Decision|1|||
13405791|NCT00570323|26819611|FG001|Complete Study After Start|Physician Decision|0|||
13405792|NCT00570310|26819626|FG000|Overall Study|Adverse Event|1|||
13405793|NCT00570310|26819627|FG001|Overall Study|Adverse Event|2|||
13405794|NCT00570310|26819626|FG000|Overall Study|Lack of Efficacy|1|||
13405795|NCT00570310|26819627|FG001|Overall Study|Lack of Efficacy|4|||
13405796|NCT00570232|26819635|FG000|Overall Study|Adverse Event|10|||
13405797|NCT00570232|26819635|FG000|Overall Study|discontinued due to medical condition|3|||
13405798|NCT00570232|26819635|FG000|Overall Study|discontinued due to recurrence|8|||
13405799|NCT00570232|26819635|FG000|Overall Study|discontinued due to noncompliance|2|||
13405800|NCT00570141|26819642|FG000|Overall Study|Adverse Event|1|||
13405801|NCT00570141|26819642|FG000|Overall Study|Missed visits|1|||
13405802|NCT00570141|26819642|FG000|Overall Study|Lost to Follow-up|1|||
13405803|NCT00570128|26819661|FG000|Overall Study|Adverse Event|1|||
13405804|NCT00570128|26819662|FG001|Overall Study|Adverse Event|0|||
13405805|NCT00570128|26819661|FG000|Overall Study|Lost to Follow-up|1|||
13405806|NCT00570128|26819662|FG001|Overall Study|Lost to Follow-up|0|||
13405807|NCT00570128|26819661|FG000|Overall Study|Withdrawal by Subject|2|||
13405808|NCT00570128|26819662|FG001|Overall Study|Withdrawal by Subject|0|||
13405809|NCT00570063|26819733|FG000|Overall Study|Adverse Event|4|||
13405810|NCT00570063|26819734|FG001|Overall Study|Adverse Event|1|||
13405811|NCT00570063|26819733|FG000|Overall Study|Lack of Efficacy|0|||
13405812|NCT00570063|26819734|FG001|Overall Study|Lack of Efficacy|1|||
13405813|NCT00570063|26819733|FG000|Overall Study|Withdrawal by Subject|4|||
13405814|NCT00570063|26819734|FG001|Overall Study|Withdrawal by Subject|3|||
13405815|NCT00570063|26819733|FG000|Overall Study|Sponsor's Decision|7|||
13405816|NCT00570063|26819734|FG001|Overall Study|Sponsor's Decision|3|||
13405817|NCT00570037|26819751|FG000|Overall Study|Could not reach for 6-8 week contact|44|||
13405818|NCT00570037|26819752|FG001|Overall Study|Could not reach for 6-8 week contact|69|||
13405819|NCT00569946|26819770|FG000|Overall Study|Adverse Event|16|||
13405820|NCT00569946|26819770|FG000|Overall Study|Objective Progression or Relapse|42|||
13405821|NCT00569946|26819770|FG000|Overall Study|Global Deterioration of Health Status|1|||
13405822|NCT00569803|26819920|FG000|Overall Study|Lost to Follow-up|1|||
13405823|NCT00569803|26819921|FG001|Overall Study|Lost to Follow-up|0|||
13405824|NCT00569803|26819922|FG002|Overall Study|Lost to Follow-up|0|||
13405825|NCT00569803|26819923|FG003|Overall Study|Lost to Follow-up|0|||
13405826|NCT00569803|26819924|FG004|Overall Study|Lost to Follow-up|0|||
13405827|NCT00569803|26819925|FG005|Overall Study|Lost to Follow-up|0|||
13405828|NCT00569803|26819926|FG006|Overall Study|Lost to Follow-up|0|||
13405829|NCT00569803|26819927|FG007|Overall Study|Lost to Follow-up|0|||
13405830|NCT00569803|26819920|FG000|Overall Study|injection syringe leaked during dosing|0|||
13405831|NCT00569803|26819921|FG001|Overall Study|injection syringe leaked during dosing|0|||
13405832|NCT00569803|26819922|FG002|Overall Study|injection syringe leaked during dosing|0|||
13405833|NCT00569803|26819923|FG003|Overall Study|injection syringe leaked during dosing|1|||
13405834|NCT00569803|26819924|FG004|Overall Study|injection syringe leaked during dosing|0|||
13405835|NCT00569803|26819925|FG005|Overall Study|injection syringe leaked during dosing|0|||
13405836|NCT00569803|26819926|FG006|Overall Study|injection syringe leaked during dosing|0|||
13405837|NCT00569803|26819927|FG007|Overall Study|injection syringe leaked during dosing|0|||
13405838|NCT00569803|26819920|FG000|Overall Study|Withdrawal by Subject|0|||
13405839|NCT00569803|26819921|FG001|Overall Study|Withdrawal by Subject|0|||
13405840|NCT00569803|26819922|FG002|Overall Study|Withdrawal by Subject|0|||
13405841|NCT00569803|26819923|FG003|Overall Study|Withdrawal by Subject|0|||
13405842|NCT00569803|26819924|FG004|Overall Study|Withdrawal by Subject|0|||
13405843|NCT00569803|26819925|FG005|Overall Study|Withdrawal by Subject|0|||
13405844|NCT00569803|26819926|FG006|Overall Study|Withdrawal by Subject|0|||
13405845|NCT00569803|26819927|FG007|Overall Study|Withdrawal by Subject|1|||
13405846|NCT00569777|26819976|FG000|Overall Study|Withdrawal by Subject|4|||
13405847|NCT00569777|26819977|FG001|Overall Study|Withdrawal by Subject|0|||
13405848|NCT00569777|26819976|FG000|Overall Study|Adverse Event|3|||
13405849|NCT00569777|26819977|FG001|Overall Study|Adverse Event|0|||
13405850|NCT00569777|26819976|FG000|Overall Study|Lost to Follow-up|1|||
13405851|NCT00569777|26819977|FG001|Overall Study|Lost to Follow-up|0|||
13405852|NCT00569777|26819976|FG000|Overall Study|scheduled eye surgery|0|||
13405853|NCT00569777|26819977|FG001|Overall Study|scheduled eye surgery|1|||
13405854|NCT00569777|26819976|FG000|Overall Study|did not meet exclusion criteria|1|||
13405855|NCT00569777|26819977|FG001|Overall Study|did not meet exclusion criteria|2|||
13405856|NCT00569777|26819976|FG000|Overall Study|pregnant|1|||
13405857|NCT00569777|26819977|FG001|Overall Study|pregnant|0|||
13405858|NCT00569582|26819984|FG000|Overall Study|Withdrawal by Subject|5|||
13405859|NCT00569582|26819984|FG000|Overall Study|Death|2|||
13405860|NCT00569582|26819984|FG000|Overall Study|Adverse Event|7|||
13405861|NCT00569582|26819984|FG000|Overall Study|Subject was too ill to travel.|1|||
13405862|NCT00569582|26819984|FG000|Overall Study|Subject was non-compliant.|1|||
13405863|NCT00569374|26819996|FG000|Overall Study|Withdrawal by Subject|4|||
13405864|NCT00569270|26820034|FG000|Period: First Intervention|Protocol Violation|0|||
13405865|NCT00569270|26820035|FG001|Period: First Intervention|Protocol Violation|1|||
13405866|NCT00569231|26820044|FG000|Overall Study|Study unrelated surgery|1|||
13405867|NCT00569231|26820044|FG000|Overall Study|Airfare expense|2|||
13405868|NCT00569231|26820044|FG000|Overall Study|Withdrawal by Subject|1|||
13405869|NCT00569231|26820044|FG000|Overall Study|Car accident injury|1|||
13405870|NCT00569231|26820044|FG000|Overall Study|Non-compliance|2|||
13405871|NCT00569166|26820086|FG000|Overall Study|Withdrawal by Subject|7|||
13405872|NCT00569166|26820087|FG001|Overall Study|Withdrawal by Subject|5|||
13405873|NCT00569166|26820088|FG002|Overall Study|Withdrawal by Subject|3|||
13405874|NCT00569166|26820086|FG000|Overall Study|Lost to Follow-up|2|||
13405875|NCT00569166|26820087|FG001|Overall Study|Lost to Follow-up|1|||
13405876|NCT00569166|26820088|FG002|Overall Study|Lost to Follow-up|1|||
13405877|NCT00569127|26820111|FG000|Overall Study|Adverse Event|57|||
13405878|NCT00569127|26820112|FG001|Overall Study|Adverse Event|47|||
13405879|NCT00569127|26820111|FG000|Overall Study|Withdrawal by Subject|13|||
13405880|NCT00569127|26820112|FG001|Overall Study|Withdrawal by Subject|27|||
13405881|NCT00569127|26820111|FG000|Overall Study|Progression|99|||
13405882|NCT00569127|26820112|FG001|Overall Study|Progression|100|||
13405883|NCT00569127|26820111|FG000|Overall Study|Death|4|||
13405884|NCT00569127|26820112|FG001|Overall Study|Death|3|||
13405885|NCT00569127|26820111|FG000|Overall Study|Other|20|||
13405886|NCT00569127|26820112|FG001|Overall Study|Other|19|||
13405887|NCT00569127|26820111|FG000|Overall Study|Lost to Follow-up|0|||
13405888|NCT00569127|26820112|FG001|Overall Study|Lost to Follow-up|3|||
13405889|NCT00569127|26820111|FG000|Overall Study|Not Eligible|14|||
13405890|NCT00569127|26820112|FG001|Overall Study|Not Eligible|11|||
13405891|NCT00569127|26820111|FG000|Overall Study|Still on Treatment|7|||
13405892|NCT00569127|26820112|FG001|Overall Study|Still on Treatment|3|||
13405893|NCT00568958|26820137|FG000|Allocation|Withdrawal by Subject|7|||
13405894|NCT00568958|26820138|FG001|Allocation|Withdrawal by Subject|3|||
13405895|NCT00568958|26820137|FG000|Allocation|Physician Decision|2|||
13405896|NCT00568958|26820138|FG001|Allocation|Physician Decision|0|||
13405897|NCT00568958|26820137|FG000|Follow-Up|Withdrawal by Subject|6|||
13405898|NCT00568958|26820138|FG001|Follow-Up|Withdrawal by Subject|6|||
13405899|NCT00568958|26820137|FG000|Follow-Up|Physician Decision|1|||
13405900|NCT00568958|26820138|FG001|Follow-Up|Physician Decision|1|||
13405901|NCT00568958|26820137|FG000|Follow-Up|Family Emergency|1|||
13405902|NCT00568958|26820138|FG001|Follow-Up|Family Emergency|0|||
13405903|NCT00568958|26820137|FG000|Follow-Up|Adverse Event|1|||
13405904|NCT00568958|26820138|FG001|Follow-Up|Adverse Event|0|||
13405905|NCT00568776|26820185|FG000|Overall Study|Adverse Event|8|||
13405906|NCT00568776|26820186|FG001|Overall Study|Adverse Event|8|||
13405907|NCT00568776|26820187|FG002|Overall Study|Adverse Event|10|||
13405908|NCT00568776|26820188|FG003|Overall Study|Adverse Event|8|||
13405909|NCT00568776|26820185|FG000|Overall Study|Death|0|||
13405910|NCT00568776|26820186|FG001|Overall Study|Death|1|||
13405911|NCT00568776|26820187|FG002|Overall Study|Death|4|||
13405912|NCT00568776|26820188|FG003|Overall Study|Death|3|||
13405913|NCT00568776|26820185|FG000|Overall Study|Physician Decision|0|||
13405914|NCT00568776|26820186|FG001|Overall Study|Physician Decision|2|||
13405915|NCT00568776|26820187|FG002|Overall Study|Physician Decision|0|||
13405916|NCT00568776|26820188|FG003|Overall Study|Physician Decision|0|||
13405917|NCT00568776|26820185|FG000|Overall Study|Lack of Efficacy|2|||
13405918|NCT00568776|26820186|FG001|Overall Study|Lack of Efficacy|2|||
13405919|NCT00568776|26820187|FG002|Overall Study|Lack of Efficacy|2|||
13405920|NCT00568776|26820188|FG003|Overall Study|Lack of Efficacy|4|||
13405921|NCT00568776|26820185|FG000|Overall Study|Lost to Follow-up|1|||
13405922|NCT00568776|26820186|FG001|Overall Study|Lost to Follow-up|1|||
13405923|NCT00568776|26820187|FG002|Overall Study|Lost to Follow-up|1|||
13405924|NCT00568776|26820188|FG003|Overall Study|Lost to Follow-up|1|||
13405925|NCT00568776|26820185|FG000|Overall Study|Protocol Violation|1|||
13405926|NCT00568776|26820186|FG001|Overall Study|Protocol Violation|0|||
13405927|NCT00568776|26820187|FG002|Overall Study|Protocol Violation|1|||
13405928|NCT00568776|26820188|FG003|Overall Study|Protocol Violation|1|||
13405929|NCT00568776|26820185|FG000|Overall Study|Withdrawal by Subject|13|||
13405930|NCT00568776|26820186|FG001|Overall Study|Withdrawal by Subject|15|||
13405931|NCT00568776|26820187|FG002|Overall Study|Withdrawal by Subject|13|||
13405932|NCT00568776|26820188|FG003|Overall Study|Withdrawal by Subject|7|||
13405933|NCT00568776|26820185|FG000|Overall Study|Loss of Caregiver|0|||
13405934|NCT00568776|26820186|FG001|Overall Study|Loss of Caregiver|2|||
13405935|NCT00568776|26820187|FG002|Overall Study|Loss of Caregiver|1|||
13405936|NCT00568776|26820188|FG003|Overall Study|Loss of Caregiver|2|||
13405937|NCT00568776|26820185|FG000|Overall Study|Sponsor Decision|2|||
13405938|NCT00568776|26820186|FG001|Overall Study|Sponsor Decision|2|||
13405939|NCT00568776|26820187|FG002|Overall Study|Sponsor Decision|41|||
13405940|NCT00568776|26820188|FG003|Overall Study|Sponsor Decision|42|||
13405941|NCT00568776|26820185|FG000|Overall Study|Miscellaeneous|3|||
13405942|NCT00568776|26820186|FG001|Overall Study|Miscellaeneous|3|||
13405943|NCT00568776|26820187|FG002|Overall Study|Miscellaeneous|1|||
13405944|NCT00568776|26820188|FG003|Overall Study|Miscellaeneous|4|||
13405945|NCT00568685|26820230|FG000|Overall Study|Adverse Event|2|||
13405946|NCT00568685|26820231|FG001|Overall Study|Adverse Event|3|||
13405947|NCT00568685|26820232|FG002|Overall Study|Adverse Event|3|||
13405948|NCT00568685|26820230|FG000|Overall Study|Withdrawal by Subject|7|||
13405949|NCT00568685|26820231|FG001|Overall Study|Withdrawal by Subject|2|||
13405950|NCT00568685|26820232|FG002|Overall Study|Withdrawal by Subject|2|||
13405951|NCT00568685|26820230|FG000|Overall Study|Protocol Violation|1|||
13405952|NCT00568685|26820231|FG001|Overall Study|Protocol Violation|0|||
13405953|NCT00568685|26820232|FG002|Overall Study|Protocol Violation|0|||
13405954|NCT00568555|26820253|FG000|Overall Study|Withdrawal by Subject|1|||
13405955|NCT00568555|26820254|FG001|Overall Study|Withdrawal by Subject|1|||
13405956|NCT00568451|26820283|FG000|Overall Study|Disease Progression|0|||
13405957|NCT00568451|26820284|FG001|Overall Study|Disease Progression|0|||
13405958|NCT00568451|26820285|FG002|Overall Study|Disease Progression|2|||
13405959|NCT00568451|26820286|FG003|Overall Study|Disease Progression|7|||
13405960|NCT00568399|26820292|FG000|Overall Study|Death|2|||
13405961|NCT00568399|26820292|FG000|Overall Study|Adverse Event|5|||
13405962|NCT00568399|26820292|FG000|Overall Study|Withdrawal by Subject|8|||
13405963|NCT00568334|26820323|FG000|Overall Study|Withdrawal by Subject|0|||
13405964|NCT00568334|26820324|FG001|Overall Study|Withdrawal by Subject|1|||
13405965|NCT00568334|26820323|FG000|Overall Study|Lost to Follow-up|1|||
13405966|NCT00568334|26820324|FG001|Overall Study|Lost to Follow-up|0|||
13405967|NCT00568321|26820434|FG000|Overall Study|Adverse Event|1|||
13405968|NCT00568321|26820435|FG001|Overall Study|Adverse Event|0|||
13405969|NCT00568321|26820436|FG002|Overall Study|Adverse Event|0|||
13405970|NCT00568321|26820434|FG000|Overall Study|Lack of Efficacy|8|||
13405971|NCT00568321|26820435|FG001|Overall Study|Lack of Efficacy|5|||
13405972|NCT00568321|26820436|FG002|Overall Study|Lack of Efficacy|6|||
13405973|NCT00568321|26820434|FG000|Overall Study|Lost to Follow-up|0|||
13405974|NCT00568321|26820435|FG001|Overall Study|Lost to Follow-up|0|||
13405975|NCT00568321|26820436|FG002|Overall Study|Lost to Follow-up|1|||
13405976|NCT00568321|26820434|FG000|Overall Study|Withdrawal by Subject|2|||
13405977|NCT00568321|26820435|FG001|Overall Study|Withdrawal by Subject|0|||
13405978|NCT00568321|26820436|FG002|Overall Study|Withdrawal by Subject|0|||
13405979|NCT00568321|26820434|FG000|Overall Study|Protocol Violation|0|||
13405980|NCT00568321|26820435|FG001|Overall Study|Protocol Violation|0|||
13405981|NCT00568321|26820436|FG002|Overall Study|Protocol Violation|1|||
13405982|NCT00568321|26820434|FG000|Overall Study|Randomized, not treated|2|||
13405983|NCT00568321|26820435|FG001|Overall Study|Randomized, not treated|0|||
13405984|NCT00568321|26820436|FG002|Overall Study|Randomized, not treated|1|||
13405985|NCT00568178|26820463|FG000|Double Blind Base Study|Adverse Event|0|||
13405986|NCT00568178|26820464|FG001|Double Blind Base Study|Adverse Event|2|||
13405987|NCT00568178|26820465|FG002|Double Blind Base Study|Adverse Event|1|||
13405988|NCT00568178|26820466|FG003|Double Blind Base Study|Adverse Event|2|||
13405989|NCT00568178|26820467|FG004|Double Blind Base Study|Adverse Event|0|||
13405990|NCT00568178|26820468|FG005|Double Blind Base Study|Adverse Event|0|||
13405991|NCT00568178|26820463|FG000|Double Blind Base Study|Lost to Follow-up|1|||
13219912|NCT01829230|26278638|FG001|Overall Study|Protocol Violation|2|||
13405992|NCT00568178|26820464|FG001|Double Blind Base Study|Lost to Follow-up|0|||
13405993|NCT00568178|26820465|FG002|Double Blind Base Study|Lost to Follow-up|0|||
13405994|NCT00568178|26820466|FG003|Double Blind Base Study|Lost to Follow-up|1|||
13405995|NCT00568178|26820467|FG004|Double Blind Base Study|Lost to Follow-up|0|||
13405996|NCT00568178|26820468|FG005|Double Blind Base Study|Lost to Follow-up|0|||
13405997|NCT00568178|26820463|FG000|Double Blind Base Study|Physician Decision|1|||
13405998|NCT00568178|26820464|FG001|Double Blind Base Study|Physician Decision|1|||
13405999|NCT00568178|26820465|FG002|Double Blind Base Study|Physician Decision|0|||
13406000|NCT00568178|26820466|FG003|Double Blind Base Study|Physician Decision|1|||
13406001|NCT00568178|26820467|FG004|Double Blind Base Study|Physician Decision|0|||
13406002|NCT00568178|26820468|FG005|Double Blind Base Study|Physician Decision|0|||
13406003|NCT00568178|26820463|FG000|Double Blind Base Study|Protocol Violation|3|||
13406004|NCT00568178|26820464|FG001|Double Blind Base Study|Protocol Violation|2|||
13406005|NCT00568178|26820465|FG002|Double Blind Base Study|Protocol Violation|0|||
13406006|NCT00568178|26820466|FG003|Double Blind Base Study|Protocol Violation|0|||
13406007|NCT00568178|26820467|FG004|Double Blind Base Study|Protocol Violation|0|||
13406008|NCT00568178|26820468|FG005|Double Blind Base Study|Protocol Violation|0|||
13406009|NCT00568178|26820463|FG000|Double Blind Base Study|Withdrawal by Subject|1|||
13406010|NCT00568178|26820464|FG001|Double Blind Base Study|Withdrawal by Subject|1|||
13406011|NCT00568178|26820465|FG002|Double Blind Base Study|Withdrawal by Subject|0|||
13406012|NCT00568178|26820466|FG003|Double Blind Base Study|Withdrawal by Subject|0|||
13406013|NCT00568178|26820467|FG004|Double Blind Base Study|Withdrawal by Subject|0|||
13406014|NCT00568178|26820468|FG005|Double Blind Base Study|Withdrawal by Subject|0|||
13406015|NCT00568178|26820463|FG000|Double Blind Base Study|Progressive Disease|0|||
13406016|NCT00568178|26820464|FG001|Double Blind Base Study|Progressive Disease|0|||
13406017|NCT00568178|26820465|FG002|Double Blind Base Study|Progressive Disease|0|||
13406018|NCT00568178|26820466|FG003|Double Blind Base Study|Progressive Disease|1|||
13406019|NCT00568178|26820467|FG004|Double Blind Base Study|Progressive Disease|0|||
13406020|NCT00568178|26820468|FG005|Double Blind Base Study|Progressive Disease|0|||
13406021|NCT00568178|26820463|FG000|Open Label Extension|Adverse Event|0|||
13406022|NCT00568178|26820464|FG001|Open Label Extension|Adverse Event|0|||
13406023|NCT00568178|26820465|FG002|Open Label Extension|Adverse Event|0|||
13406024|NCT00568178|26820466|FG003|Open Label Extension|Adverse Event|0|||
13406025|NCT00568178|26820467|FG004|Open Label Extension|Adverse Event|11|||
13406026|NCT00568178|26820468|FG005|Open Label Extension|Adverse Event|8|||
13406027|NCT00568178|26820463|FG000|Open Label Extension|Protocol Violation|0|||
13406028|NCT00568178|26820464|FG001|Open Label Extension|Protocol Violation|0|||
13406029|NCT00568178|26820465|FG002|Open Label Extension|Protocol Violation|0|||
13406030|NCT00568178|26820466|FG003|Open Label Extension|Protocol Violation|0|||
13406031|NCT00568178|26820467|FG004|Open Label Extension|Protocol Violation|1|||
13406032|NCT00568178|26820468|FG005|Open Label Extension|Protocol Violation|0|||
13406033|NCT00568178|26820463|FG000|Open Label Extension|Lost to Follow-up|0|||
13406034|NCT00568178|26820464|FG001|Open Label Extension|Lost to Follow-up|0|||
13406035|NCT00568178|26820465|FG002|Open Label Extension|Lost to Follow-up|0|||
13406036|NCT00568178|26820466|FG003|Open Label Extension|Lost to Follow-up|0|||
13406037|NCT00568178|26820467|FG004|Open Label Extension|Lost to Follow-up|6|||
13406038|NCT00568178|26820468|FG005|Open Label Extension|Lost to Follow-up|11|||
13406039|NCT00568178|26820463|FG000|Open Label Extension|Physician Decision|0|||
13406040|NCT00568178|26820464|FG001|Open Label Extension|Physician Decision|0|||
13406041|NCT00568178|26820465|FG002|Open Label Extension|Physician Decision|0|||
13406042|NCT00568178|26820466|FG003|Open Label Extension|Physician Decision|0|||
13406043|NCT00568178|26820467|FG004|Open Label Extension|Physician Decision|9|||
13406044|NCT00568178|26820468|FG005|Open Label Extension|Physician Decision|8|||
13406045|NCT00568178|26820463|FG000|Open Label Extension|Pregnancy|0|||
13406046|NCT00568178|26820464|FG001|Open Label Extension|Pregnancy|0|||
13406047|NCT00568178|26820465|FG002|Open Label Extension|Pregnancy|0|||
13406048|NCT00568178|26820466|FG003|Open Label Extension|Pregnancy|0|||
13406049|NCT00568178|26820467|FG004|Open Label Extension|Pregnancy|0|||
13406050|NCT00568178|26820468|FG005|Open Label Extension|Pregnancy|1|||
13406051|NCT00568178|26820463|FG000|Open Label Extension|Progressive Disease|0|||
13406052|NCT00568178|26820464|FG001|Open Label Extension|Progressive Disease|0|||
13406053|NCT00568178|26820465|FG002|Open Label Extension|Progressive Disease|0|||
13406054|NCT00568178|26820466|FG003|Open Label Extension|Progressive Disease|0|||
13406055|NCT00568178|26820467|FG004|Open Label Extension|Progressive Disease|3|||
13406056|NCT00568178|26820468|FG005|Open Label Extension|Progressive Disease|1|||
13406057|NCT00568178|26820463|FG000|Open Label Extension|Termination of Trial|0|||
13406058|NCT00568178|26820464|FG001|Open Label Extension|Termination of Trial|0|||
13406059|NCT00568178|26820465|FG002|Open Label Extension|Termination of Trial|0|||
13406060|NCT00568178|26820466|FG003|Open Label Extension|Termination of Trial|0|||
13406061|NCT00568178|26820467|FG004|Open Label Extension|Termination of Trial|45|||
13406062|NCT00568178|26820468|FG005|Open Label Extension|Termination of Trial|47|||
13406063|NCT00568178|26820463|FG000|Open Label Extension|Withdrawal by Subject|0|||
13406064|NCT00568178|26820464|FG001|Open Label Extension|Withdrawal by Subject|0|||
13406065|NCT00568178|26820465|FG002|Open Label Extension|Withdrawal by Subject|0|||
13406066|NCT00568178|26820466|FG003|Open Label Extension|Withdrawal by Subject|0|||
13406067|NCT00568178|26820467|FG004|Open Label Extension|Withdrawal by Subject|4|||
13476214|NCT01729754|27002609|FG001|Part 1|Progressive Disease|0|||
13406068|NCT00568178|26820468|FG005|Open Label Extension|Withdrawal by Subject|4|||
13406069|NCT00568126|26820483|FG000|Overall Study|Adverse Event|3|||
13406070|NCT00568126|26820484|FG001|Overall Study|Adverse Event|0|||
13406071|NCT00568126|26820483|FG000|Overall Study|Withdrawal by Subject|2|||
13406072|NCT00568126|26820484|FG001|Overall Study|Withdrawal by Subject|3|||
13406073|NCT00568126|26820483|FG000|Overall Study|Lost to Follow-up|4|||
13406074|NCT00568126|26820484|FG001|Overall Study|Lost to Follow-up|3|||
13406075|NCT00568126|26820483|FG000|Overall Study|Lack of Efficacy|0|||
13406076|NCT00568126|26820484|FG001|Overall Study|Lack of Efficacy|1|||
13406077|NCT00568126|26820483|FG000|Overall Study|Physician Decision|2|||
13406078|NCT00568126|26820484|FG001|Overall Study|Physician Decision|2|||
13406079|NCT00568061|26820516|FG000|Overall Study|Inclusion / exclusion criteria|5|||
13406080|NCT00568061|26820517|FG001|Overall Study|Inclusion / exclusion criteria|1|||
13406081|NCT00568061|26820516|FG000|Overall Study|Adverse Event|0|||
13406082|NCT00568061|26820517|FG001|Overall Study|Adverse Event|1|||
13406083|NCT00567996|26820541|FG000|Overall Study|Adverse Event|18|||
13406084|NCT00567996|26820542|FG001|Overall Study|Adverse Event|16|||
13406085|NCT00567996|26820543|FG002|Overall Study|Adverse Event|13|||
13406086|NCT00567996|26820541|FG000|Overall Study|Protocol Deviation|9|||
13406087|NCT00567996|26820542|FG001|Overall Study|Protocol Deviation|11|||
13406088|NCT00567996|26820543|FG002|Overall Study|Protocol Deviation|13|||
13406089|NCT00567996|26820541|FG000|Overall Study|Withdrawal by Subject|8|||
13406090|NCT00567996|26820542|FG001|Overall Study|Withdrawal by Subject|12|||
13406091|NCT00567996|26820543|FG002|Overall Study|Withdrawal by Subject|22|||
13406092|NCT00567996|26820541|FG000|Overall Study|Abnormal Lab value(s)|2|||
13406093|NCT00567996|26820542|FG001|Overall Study|Abnormal Lab value(s)|1|||
13406094|NCT00567996|26820543|FG002|Overall Study|Abnormal Lab value(s)|2|||
13406095|NCT00567996|26820541|FG000|Overall Study|Abnormal test procedure result(s)|2|||
13406096|NCT00567996|26820542|FG001|Overall Study|Abnormal test procedure result(s)|1|||
13406097|NCT00567996|26820543|FG002|Overall Study|Abnormal test procedure result(s)|1|||
13406098|NCT00567996|26820541|FG000|Overall Study|Lost to Follow-up|2|||
13406099|NCT00567996|26820542|FG001|Overall Study|Lost to Follow-up|5|||
13406100|NCT00567996|26820543|FG002|Overall Study|Lost to Follow-up|2|||
13406101|NCT00567996|26820541|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
13406102|NCT00567996|26820542|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
13406103|NCT00567996|26820543|FG002|Overall Study|Unsatisfactory therapeutic effect|15|||
13406104|NCT00567996|26820541|FG000|Overall Study|Administrative problems|1|||
13406105|NCT00567996|26820542|FG001|Overall Study|Administrative problems|1|||
13406106|NCT00567996|26820543|FG002|Overall Study|Administrative problems|0|||
13406107|NCT00567996|26820541|FG000|Overall Study|Death|1|||
13406108|NCT00567996|26820542|FG001|Overall Study|Death|0|||
13406109|NCT00567996|26820543|FG002|Overall Study|Death|2|||
13406110|NCT00567996|26820541|FG000|Overall Study|Patient's inability to use the device|0|||
13406111|NCT00567996|26820542|FG001|Overall Study|Patient's inability to use the device|1|||
13406112|NCT00567996|26820543|FG002|Overall Study|Patient's inability to use the device|0|||
13406113|NCT00567892|26820564|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
13406114|NCT00567892|26820565|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
13406115|NCT00567892|26820566|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
13406116|NCT00567892|26820567|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4|||
13406117|NCT00567892|26820564|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
13406118|NCT00567892|26820565|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
13406119|NCT00567892|26820566|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
13406120|NCT00567892|26820567|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
13406121|NCT00567879|26820607|FG000|Overall Study|Adverse Event|2|||
13406122|NCT00567879|26820608|FG001|Overall Study|Adverse Event|0|||
13406123|NCT00567879|26820609|FG002|Overall Study|Adverse Event|1|||
13406124|NCT00567879|26820610|FG003|Overall Study|Adverse Event|0|||
13406125|NCT00567879|26820611|FG004|Overall Study|Adverse Event|1|||
13406126|NCT00567879|26820612|FG005|Overall Study|Adverse Event|0|||
13406127|NCT00567879|26820607|FG000|Overall Study|Abnormal test procedure(s)|0|||
13406128|NCT00567879|26820608|FG001|Overall Study|Abnormal test procedure(s)|0|||
13406129|NCT00567879|26820609|FG002|Overall Study|Abnormal test procedure(s)|1|||
13406130|NCT00567879|26820610|FG003|Overall Study|Abnormal test procedure(s)|0|||
13406131|NCT00567879|26820611|FG004|Overall Study|Abnormal test procedure(s)|0|||
13406132|NCT00567879|26820612|FG005|Overall Study|Abnormal test procedure(s)|0|||
13406133|NCT00567879|26820607|FG000|Overall Study|Withdrawal by Subject|0|||
13406134|NCT00567879|26820608|FG001|Overall Study|Withdrawal by Subject|0|||
13406135|NCT00567879|26820609|FG002|Overall Study|Withdrawal by Subject|3|||
13406136|NCT00567879|26820610|FG003|Overall Study|Withdrawal by Subject|1|||
13406137|NCT00567879|26820611|FG004|Overall Study|Withdrawal by Subject|0|||
13406138|NCT00567879|26820612|FG005|Overall Study|Withdrawal by Subject|0|||
13406139|NCT00567879|26820607|FG000|Overall Study|New cancer therapy|0|||
13406140|NCT00567879|26820608|FG001|Overall Study|New cancer therapy|0|||
13406141|NCT00567879|26820609|FG002|Overall Study|New cancer therapy|1|||
13406142|NCT00567879|26820610|FG003|Overall Study|New cancer therapy|0|||
13406143|NCT00567879|26820611|FG004|Overall Study|New cancer therapy|0|||
13406144|NCT00567879|26820612|FG005|Overall Study|New cancer therapy|0|||
13406145|NCT00567879|26820607|FG000|Overall Study|Disease progression|5|||
13406146|NCT00567879|26820608|FG001|Overall Study|Disease progression|7|||
13406147|NCT00567879|26820609|FG002|Overall Study|Disease progression|15|||
13406148|NCT00567879|26820610|FG003|Overall Study|Disease progression|5|||
13406149|NCT00567879|26820611|FG004|Overall Study|Disease progression|11|||
13406150|NCT00567879|26820612|FG005|Overall Study|Disease progression|3|||
13406151|NCT00567593|26820618|FG000|Overall Study|Adverse Event|1|||
13406152|NCT00567593|26820618|FG000|Overall Study|Physician Decision|1|||
13406153|NCT00567580|26820660|FG000|Overall Study|Protocol Violation|28|||
13406154|NCT00567580|26820661|FG001|Overall Study|Protocol Violation|24|||
13406155|NCT00567580|26820662|FG002|Overall Study|Protocol Violation|24|||
13406156|NCT00567567|26820718|FG000|Overall Study|Adverse Event|0|||
13406157|NCT00567567|26820719|FG001|Overall Study|Adverse Event|2|||
13406158|NCT00567567|26820720|FG002|Overall Study|Adverse Event|5|||
13406159|NCT00567567|26820718|FG000|Overall Study|Death|8|||
13406160|NCT00567567|26820719|FG001|Overall Study|Death|1|||
13406161|NCT00567567|26820720|FG002|Overall Study|Death|5|||
13406162|NCT00567567|26820718|FG000|Overall Study|Lack of Efficacy|16|||
13406163|NCT00567567|26820719|FG001|Overall Study|Lack of Efficacy|17|||
13406164|NCT00567567|26820720|FG002|Overall Study|Lack of Efficacy|48|||
13406165|NCT00567567|26820718|FG000|Overall Study|Lost to Follow-up|0|||
13406166|NCT00567567|26820719|FG001|Overall Study|Lost to Follow-up|0|||
13406167|NCT00567567|26820720|FG002|Overall Study|Lost to Follow-up|1|||
13406168|NCT00567567|26820718|FG000|Overall Study|Physician Decision|16|||
13406169|NCT00567567|26820719|FG001|Overall Study|Physician Decision|18|||
13406170|NCT00567567|26820720|FG002|Overall Study|Physician Decision|84|||
13406171|NCT00567567|26820718|FG000|Overall Study|Withdrawal by Subject|0|||
13406172|NCT00567567|26820719|FG001|Overall Study|Withdrawal by Subject|0|||
13406173|NCT00567567|26820720|FG002|Overall Study|Withdrawal by Subject|2|||
13406174|NCT00567567|26820718|FG000|Overall Study|Ineligible|4|||
13406175|NCT00567567|26820719|FG001|Overall Study|Ineligible|0|||
13406176|NCT00567567|26820720|FG002|Overall Study|Ineligible|9|||
13406177|NCT00567567|26820718|FG000|Overall Study|Refusal by patient/parent/guardian|9|||
13406178|NCT00567567|26820719|FG001|Overall Study|Refusal by patient/parent/guardian|16|||
13406179|NCT00567567|26820720|FG002|Overall Study|Refusal by patient/parent/guardian|122|||
13406180|NCT00567567|26820718|FG000|Overall Study|Enrolled another COG therapeutic study|99|||
13406181|NCT00567567|26820719|FG001|Overall Study|Enrolled another COG therapeutic study|80|||
13406182|NCT00567567|26820720|FG002|Overall Study|Enrolled another COG therapeutic study|0|||
13406183|NCT00567567|26820718|FG000|Overall Study|Unable adequate stem cell for transplant|0|||
13406184|NCT00567567|26820719|FG001|Overall Study|Unable adequate stem cell for transplant|0|||
13406185|NCT00567567|26820720|FG002|Overall Study|Unable adequate stem cell for transplant|2|||
13406186|NCT00567541|26820733|FG000|Overall Study|Adverse Event|0|||
13406187|NCT00567541|26820734|FG001|Overall Study|Adverse Event|1|||
13406188|NCT00567502|26820782|FG000|Overall Study|Lost to Follow-up|91|||
13406189|NCT00567502|26820783|FG001|Overall Study|Lost to Follow-up|14|||
13406190|NCT00567502|26820784|FG002|Overall Study|Lost to Follow-up|351|||
13406191|NCT00567502|26820785|FG003|Overall Study|Lost to Follow-up|2|||
13406192|NCT00567502|26820782|FG000|Overall Study|Death|65|||
13406193|NCT00567502|26820783|FG001|Overall Study|Death|16|||
13406194|NCT00567502|26820784|FG002|Overall Study|Death|360|||
13406195|NCT00567502|26820785|FG003|Overall Study|Death|5|||
13406196|NCT00567502|26820782|FG000|Overall Study|Other|64|||
13406197|NCT00567502|26820783|FG001|Overall Study|Other|2|||
13406198|NCT00567502|26820784|FG002|Overall Study|Other|134|||
13406199|NCT00567502|26820785|FG003|Overall Study|Other|6|||
13406200|NCT00567502|26820782|FG000|Overall Study|Participant request|12|||
13406201|NCT00567502|26820783|FG001|Overall Study|Participant request|1|||
13406202|NCT00567502|26820784|FG002|Overall Study|Participant request|33|||
13406203|NCT00567502|26820785|FG003|Overall Study|Participant request|1|||
13406204|NCT00567502|26820782|FG000|Overall Study|Sponsor request|9|||
13406205|NCT00567502|26820783|FG001|Overall Study|Sponsor request|0|||
13406206|NCT00567502|26820784|FG002|Overall Study|Sponsor request|30|||
13406207|NCT00567502|26820785|FG003|Overall Study|Sponsor request|1|||
13406208|NCT00567502|26820782|FG000|Overall Study|Never Initiated Treatment|0|||
13406209|NCT00567502|26820783|FG001|Overall Study|Never Initiated Treatment|0|||
13406210|NCT00567502|26820784|FG002|Overall Study|Never Initiated Treatment|0|||
13406211|NCT00567502|26820785|FG003|Overall Study|Never Initiated Treatment|72|||
13406212|NCT00567489|26820840|FG000|Overall Study|Adverse Event|6|||
13406213|NCT00567489|26820841|FG001|Overall Study|Adverse Event|14|||
13406214|NCT00567489|26820840|FG000|Overall Study|Physician Decision|0|||
13406215|NCT00567489|26820841|FG001|Overall Study|Physician Decision|4|||
13406216|NCT00567489|26820840|FG000|Overall Study|Withdrawal by Subject|0|||
13406217|NCT00567489|26820841|FG001|Overall Study|Withdrawal by Subject|2|||
13406218|NCT00567489|26820840|FG000|Overall Study|Renal Transplantation|0|||
13406219|NCT00567489|26820841|FG001|Overall Study|Renal Transplantation|3|||
13406220|NCT00567489|26820840|FG000|Overall Study|Other|1|||
13406221|NCT00567489|26820841|FG001|Overall Study|Other|0|||
13406222|NCT00567476|26820872|FG000|Overall Study|Adverse Event|2|||
13406223|NCT00567476|26820873|FG001|Overall Study|Adverse Event|0|||
13406224|NCT00567476|26820872|FG000|Overall Study|Pregnancy|1|||
13406225|NCT00567476|26820873|FG001|Overall Study|Pregnancy|0|||
13406226|NCT00567476|26820872|FG000|Overall Study|Protocol Violation|4|||
13406227|NCT00567476|26820873|FG001|Overall Study|Protocol Violation|1|||
13406228|NCT00567476|26820872|FG000|Overall Study|Lost to Follow-up|0|||
13406229|NCT00567476|26820873|FG001|Overall Study|Lost to Follow-up|1|||
13406230|NCT00567476|26820872|FG000|Overall Study|Administrative issues|1|||
13406231|NCT00567476|26820873|FG001|Overall Study|Administrative issues|0|||
13406232|NCT00567476|26820872|FG000|Overall Study|Medical Decision|0|||
13406233|NCT00567476|26820873|FG001|Overall Study|Medical Decision|1|||
13406234|NCT00567476|26820872|FG000|Overall Study|Non-adherence to protocol|0|||
13406235|NCT00567476|26820873|FG001|Overall Study|Non-adherence to protocol|1|||
13406236|NCT00567398|26820928|FG000|Overall Study|Adverse Event|6|||
13406237|NCT00567398|26820929|FG001|Overall Study|Adverse Event|14|||
13406238|NCT00567398|26820928|FG000|Overall Study|Physician Decision|0|||
13406239|NCT00567398|26820929|FG001|Overall Study|Physician Decision|4|||
13406240|NCT00567398|26820928|FG000|Overall Study|Withdrawal by Subject|0|||
13406241|NCT00567398|26820929|FG001|Overall Study|Withdrawal by Subject|2|||
13406242|NCT00567398|26820928|FG000|Overall Study|Renal Transplantation|0|||
13406243|NCT00567398|26820929|FG001|Overall Study|Renal Transplantation|3|||
13406244|NCT00567398|26820928|FG000|Overall Study|Other|1|||
13406245|NCT00567398|26820929|FG001|Overall Study|Other|0|||
13406246|NCT00567359|26820938|FG000|Overall Study|Withdrawal by Subject|1|||
13406247|NCT00567268|26820989|FG000|Overall Study|Protocol Violation|7|||
13406248|NCT00567268|26820989|FG000|Overall Study|Lost to Follow-up|36|||
13406249|NCT00567268|26820989|FG000|Overall Study|No Visit After First Day of Treatment|2|||
13406250|NCT00567268|26820989|FG000|Overall Study|No Drug Administration|4|||
13406251|NCT00567268|26820989|FG000|Overall Study|"Safety Evaluation Not Assessable"|1|||
13406252|NCT00567255|26821040|FG000|Overall Study|Adverse Event|241|||
13406253|NCT00567255|26821041|FG001|Overall Study|Adverse Event|68|||
13406254|NCT00567255|26821040|FG000|Overall Study|Lost to Follow-up|77|||
13406255|NCT00567255|26821041|FG001|Overall Study|Lost to Follow-up|48|||
13406256|NCT00567255|26821040|FG000|Overall Study|Withdrawal by Subject|75|||
13406257|NCT00567255|26821041|FG001|Overall Study|Withdrawal by Subject|56|||
13406258|NCT00567255|26821040|FG000|Overall Study|Lack of Efficacy|19|||
13406259|NCT00567255|26821041|FG001|Overall Study|Lack of Efficacy|33|||
13406260|NCT00567255|26821040|FG000|Overall Study|Protocol Violation|20|||
13406261|NCT00567255|26821041|FG001|Overall Study|Protocol Violation|8|||
13406262|NCT00567255|26821040|FG000|Overall Study|Pregnancy|6|||
13406263|NCT00567255|26821041|FG001|Overall Study|Pregnancy|0|||
13406264|NCT00567255|26821040|FG000|Overall Study|Drug noncompliance,moved,other|25|||
13406265|NCT00567255|26821041|FG001|Overall Study|Drug noncompliance,moved,other|15|||
13406266|NCT00567190|26821096|FG000|Overall Study|Death|235|||
13406267|NCT00567190|26821097|FG001|Overall Study|Death|280|||
13406268|NCT00567190|26821096|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48|||
13406269|NCT00567190|26821097|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53|||
13406270|NCT00567164|26821179|FG000|Overall Study|Withdrawal by Subject|171|||
13406271|NCT00567164|26821180|FG001|Overall Study|Withdrawal by Subject|21|||
13406272|NCT00567164|26821181|FG002|Overall Study|Withdrawal by Subject|17|||
13406273|NCT00567164|26821179|FG000|Overall Study|Protocol Violation|23|||
13406274|NCT00567164|26821180|FG001|Overall Study|Protocol Violation|4|||
13406275|NCT00567164|26821181|FG002|Overall Study|Protocol Violation|2|||
13406276|NCT00567164|26821179|FG000|Overall Study|Adverse Event|92|||
13406277|NCT00567164|26821180|FG001|Overall Study|Adverse Event|13|||
13406278|NCT00567164|26821181|FG002|Overall Study|Adverse Event|9|||
13406279|NCT00567164|26821179|FG000|Overall Study|Death|0|||
13406280|NCT00567164|26821180|FG001|Overall Study|Death|0|||
13406281|NCT00567164|26821181|FG002|Overall Study|Death|1|||
13406282|NCT00567164|26821179|FG000|Overall Study|Lost to Follow-up|202|||
13406283|NCT00567164|26821180|FG001|Overall Study|Lost to Follow-up|23|||
13406284|NCT00567164|26821181|FG002|Overall Study|Lost to Follow-up|21|||
13406285|NCT00567164|26821179|FG000|Overall Study|Pregnancy|20|||
13406286|NCT00567164|26821180|FG001|Overall Study|Pregnancy|4|||
13406287|NCT00567164|26821181|FG002|Overall Study|Pregnancy|6|||
13406288|NCT00567164|26821179|FG000|Overall Study|Primary Reason coded as 'Other'|37|||
13406289|NCT00567164|26821180|FG001|Overall Study|Primary Reason coded as 'Other'|8|||
13406290|NCT00567164|26821181|FG002|Overall Study|Primary Reason coded as 'Other'|16|||
13406291|NCT00567164|26821179|FG000|Overall Study|Missing|1|||
13406292|NCT00567164|26821180|FG001|Overall Study|Missing|0|||
13406293|NCT00567164|26821181|FG002|Overall Study|Missing|0|||
13406294|NCT00567112|26821207|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0|||
13406295|NCT00567112|26821208|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1|||
13406296|NCT00567112|26821209|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0|||
13406297|NCT00567112|26821207|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2|||
13406298|NCT00567112|26821208|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
13406299|NCT00567112|26821209|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
13406300|NCT00567112|26821207|FG000|Washout Period 3 (3 Days)|Protocol Violation|1|||
13406301|NCT00567112|26821208|FG001|Washout Period 3 (3 Days)|Protocol Violation|0|||
13406302|NCT00567112|26821209|FG002|Washout Period 3 (3 Days)|Protocol Violation|0|||
13406303|NCT00566995|26821224|FG000|Overall Study|Toxicity|4|||
13406304|NCT00566995|26821224|FG000|Overall Study|Withdrew consent|3|||
13406305|NCT00566982|26821253|FG000|Overall Study|Adverse Event|6|||
13406306|NCT00566982|26821254|FG001|Overall Study|Adverse Event|48|||
13406307|NCT00566982|26821253|FG000|Overall Study|Withdrawal by Subject|1|||
13406308|NCT00566982|26821254|FG001|Overall Study|Withdrawal by Subject|14|||
13406309|NCT00566982|26821253|FG000|Overall Study|Protocol Violation|1|||
13406310|NCT00566982|26821254|FG001|Overall Study|Protocol Violation|4|||
13406311|NCT00566982|26821253|FG000|Overall Study|Lost to Follow-up|0|||
13406312|NCT00566982|26821254|FG001|Overall Study|Lost to Follow-up|1|||
13406313|NCT00566982|26821253|FG000|Overall Study|Other-family problems & doctor's request|0|||
13406314|NCT00566982|26821254|FG001|Overall Study|Other-family problems & doctor's request|2|||
13406315|NCT00566852|26821277|FG000|Overall Study|Protocol Violation|22|||
13406316|NCT00566852|26821278|FG001|Overall Study|Protocol Violation|24|||
13406317|NCT00566852|26821277|FG000|Overall Study|Death|95|||
13406318|NCT00566852|26821278|FG001|Overall Study|Death|78|||
13406319|NCT00566852|26821277|FG000|Overall Study|Withdrawal by Subject|30|||
13406320|NCT00566852|26821278|FG001|Overall Study|Withdrawal by Subject|25|||
13406321|NCT00566852|26821277|FG000|Overall Study|Patient refusal|37|||
13406322|NCT00566852|26821278|FG001|Overall Study|Patient refusal|37|||
13406323|NCT00566852|26821277|FG000|Overall Study|Not tested due to disability|6|||
13406324|NCT00566852|26821278|FG001|Overall Study|Not tested due to disability|12|||
13406325|NCT00566852|26821277|FG000|Overall Study|Missing reason not specified|1|||
13406326|NCT00566852|26821278|FG001|Overall Study|Missing reason not specified|2|||
13406327|NCT00566852|26821277|FG000|Overall Study|Missing reason not reported|16|||
13406328|NCT00566852|26821278|FG001|Overall Study|Missing reason not reported|20|||
13406329|NCT00566735|26821295|FG000|Overall Study|Withdrawal by Subject|0|||
13406330|NCT00566735|26821296|FG001|Overall Study|Withdrawal by Subject|1|||
13406331|NCT00566735|26821295|FG000|Overall Study|Refused neuropsychological testing|2|||
13406332|NCT00566735|26821296|FG001|Overall Study|Refused neuropsychological testing|5|||
13406333|NCT00566735|26821295|FG000|Overall Study|Switched into a manic episode|0|||
13406334|NCT00566735|26821296|FG001|Overall Study|Switched into a manic episode|1|||
13406335|NCT00566722|26821350|FG000|Overall Study|Adverse Event|0|||
13406336|NCT00566722|26821351|FG001|Overall Study|Adverse Event|1|||
13406337|NCT00566722|26821352|FG002|Overall Study|Adverse Event|0|||
13406338|NCT00566722|26821350|FG000|Overall Study|Withdrawal by Subject|0|||
13406339|NCT00566722|26821351|FG001|Overall Study|Withdrawal by Subject|0|||
13406340|NCT00566722|26821352|FG002|Overall Study|Withdrawal by Subject|1|||
13406341|NCT00566722|26821350|FG000|Overall Study|Lost to Follow-up|1|||
13406342|NCT00566722|26821351|FG001|Overall Study|Lost to Follow-up|1|||
13406343|NCT00566722|26821352|FG002|Overall Study|Lost to Follow-up|1|||
13406344|NCT00566722|26821350|FG000|Overall Study|Lack of Efficacy|1|||
13406345|NCT00566722|26821351|FG001|Overall Study|Lack of Efficacy|2|||
13406346|NCT00566722|26821352|FG002|Overall Study|Lack of Efficacy|4|||
13406347|NCT00566722|26821350|FG000|Overall Study|Did not meet exclusion criteria|0|||
13406348|NCT00566722|26821351|FG001|Overall Study|Did not meet exclusion criteria|0|||
13406349|NCT00566722|26821352|FG002|Overall Study|Did not meet exclusion criteria|2|||
13406350|NCT00566722|26821350|FG000|Overall Study|Serious adverse event|0|||
13406351|NCT00566722|26821351|FG001|Overall Study|Serious adverse event|1|||
13406352|NCT00566722|26821352|FG002|Overall Study|Serious adverse event|0|||
13406353|NCT00566722|26821350|FG000|Overall Study|Noncompliant with drug administration|0|||
13406354|NCT00566722|26821351|FG001|Overall Study|Noncompliant with drug administration|0|||
13406355|NCT00566722|26821352|FG002|Overall Study|Noncompliant with drug administration|1|||
13406356|NCT00566709|26821375|FG000|Overall Study|Protocol Violation|5|||
13406357|NCT00566709|26821376|FG001|Overall Study|Protocol Violation|0|||
13406358|NCT00566696|26821388|FG000|Overall Study|Met Exclusion Criteria|2|||
13406359|NCT00566696|26821388|FG000|Overall Study|Muromonab not available|1|||
13406360|NCT00566696|26821388|FG000|Overall Study|Health Status Change|1|||
13406361|NCT00566696|26821388|FG000|Overall Study|Physician Decision|1|||
13406362|NCT00566696|26821388|FG000|Overall Study|Non-Patient Donors|37|||
13406363|NCT00566631|26821405|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18|||
13406364|NCT00566631|26821405|FG000|Part 1: Core Treatment Phase|Physician Decision|1|||
13406365|NCT00566631|26821405|FG000|Part 1: Core Treatment Phase|Adverse Event|9|||
13406366|NCT00566631|26821405|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4|||
13406367|NCT00566631|26821405|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26|||
13406368|NCT00566631|26821405|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1|||
13406369|NCT00566631|26821405|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1|||
13406370|NCT00566631|26821405|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95|||
13406371|NCT00566631|26821405|FG000|Part 2: Extension Phase|Lack of Efficacy|25|||
13406372|NCT00566631|26821405|FG000|Part 2: Extension Phase|Withdrawal by Subject|34|||
13406373|NCT00566631|26821405|FG000|Part 2: Extension Phase|Adverse Event|11|||
13406374|NCT00566631|26821405|FG000|Part 2: Extension Phase|Lost to Follow-up|6|||
13406375|NCT00566631|26821405|FG000|Part 2: Extension Phase|Death|1|||
13406376|NCT00566631|26821405|FG000|Part 2: Extension Phase|Other|5|||
13406377|NCT00566527|26821454|FG000|Overall Study|Reason not provided|3|||
13406378|NCT00566527|26821455|FG001|Overall Study|Reason not provided|11|||
13406379|NCT00566527|26821456|FG002|Overall Study|Reason not provided|10|||
13406380|NCT00566527|26821454|FG000|Overall Study|Adverse Event|2|||
13406381|NCT00566527|26821455|FG001|Overall Study|Adverse Event|0|||
13406382|NCT00566527|26821456|FG002|Overall Study|Adverse Event|1|||
13406383|NCT00566527|26821454|FG000|Overall Study|Physician Decision|3|||
13406384|NCT00566527|26821455|FG001|Overall Study|Physician Decision|8|||
13406385|NCT00566527|26821456|FG002|Overall Study|Physician Decision|20|||
13406386|NCT00566527|26821454|FG000|Overall Study|Lost to Follow-up|3|||
13406387|NCT00566527|26821455|FG001|Overall Study|Lost to Follow-up|4|||
13406388|NCT00566527|26821456|FG002|Overall Study|Lost to Follow-up|4|||
13406389|NCT00566527|26821454|FG000|Overall Study|Withdrawal by Subject|6|||
13406390|NCT00566527|26821455|FG001|Overall Study|Withdrawal by Subject|43|||
13406391|NCT00566527|26821456|FG002|Overall Study|Withdrawal by Subject|43|||
13406392|NCT00566501|26821491|FG000|Overall Study|Adverse Event|68|||
13406393|NCT00566501|26821492|FG001|Overall Study|Adverse Event|59|||
13406394|NCT00566501|26821491|FG000|Overall Study|Medication Non-compliance|5|||
13406395|NCT00566501|26821492|FG001|Overall Study|Medication Non-compliance|0|||
13406396|NCT00566501|26821491|FG000|Overall Study|Protocol Violation|2|||
13406397|NCT00566501|26821492|FG001|Overall Study|Protocol Violation|2|||
13406398|NCT00566501|26821491|FG000|Overall Study|Request of Investigator or Sponsor|6|||
13406399|NCT00566501|26821492|FG001|Overall Study|Request of Investigator or Sponsor|7|||
13406400|NCT00566501|26821491|FG000|Overall Study|Withdrawal by Subject|33|||
13406401|NCT00566501|26821492|FG001|Overall Study|Withdrawal by Subject|30|||
13406402|NCT00566501|26821491|FG000|Overall Study|Lack of Efficacy|8|||
13406403|NCT00566501|26821492|FG001|Overall Study|Lack of Efficacy|3|||
13406404|NCT00566501|26821491|FG000|Overall Study|Other|25|||
13406405|NCT00566501|26821492|FG001|Overall Study|Other|21|||
13406406|NCT00566254|26821511|FG000|Overall Study|Adverse Event|3|||
13406407|NCT00566254|26821512|FG001|Overall Study|Adverse Event|1|||
13406408|NCT00566254|26821511|FG000|Overall Study|Protocol Violation|1|||
13406409|NCT00566254|26821512|FG001|Overall Study|Protocol Violation|3|||
13406410|NCT00566254|26821511|FG000|Overall Study|Withdrawal by Subject|1|||
13406411|NCT00566254|26821512|FG001|Overall Study|Withdrawal by Subject|2|||
13406412|NCT00566254|26821511|FG000|Overall Study|Lack of Efficacy|5|||
13406413|NCT00566254|26821512|FG001|Overall Study|Lack of Efficacy|6|||
13406414|NCT00566254|26821511|FG000|Overall Study|Other|0|||
13406415|NCT00566254|26821512|FG001|Overall Study|Other|2|||
13406416|NCT00566228|26821535|FG000|Overall Study|Withdrawal by Subject|1|||
13406417|NCT00566228|26821536|FG001|Overall Study|Withdrawal by Subject|0|||
13406418|NCT00566228|26821535|FG000|Overall Study|Attempt to mobilize stem cells failed|2|||
13406419|NCT00566228|26821536|FG001|Overall Study|Attempt to mobilize stem cells failed|2|||
13406420|NCT00566228|26821535|FG000|Overall Study|Unable to collect sufficient CD34 cells|3|||
13406421|NCT00566228|26821536|FG001|Overall Study|Unable to collect sufficient CD34 cells|2|||
13406422|NCT00566228|26821535|FG000|Overall Study|progressed before infusion could occur|0|||
13406423|NCT00566228|26821536|FG001|Overall Study|progressed before infusion could occur|1|||
13406424|NCT00566111|26821557|FG000|Overall Study|Adverse Event|0|||
13406425|NCT00566111|26821558|FG001|Overall Study|Adverse Event|2|||
13406426|NCT00566098|26821570|FG000|Collection of MILs|Withdrawal by Subject|1|||
13406427|NCT00566098|26821570|FG000|Collection of MILs|Relapsed|1|||
13406428|NCT00566098|26821570|FG000|Generation of MILs Product|Relapsed|1|||
13406429|NCT00566098|26821570|FG000|Administration of ASCT+MILs|Death|10|||
13406430|NCT00566098|26821570|FG000|Administration of ASCT+MILs|Lack of Efficacy|8|||
13476215|NCT01729754|27002610|FG002|Part 1|Progressive Disease|0|||
13476216|NCT01729754|27002611|FG003|Part 1|Progressive Disease|0|||
13476217|NCT01729754|27002612|FG004|Part 1|Progressive Disease|0|||
13476218|NCT01729754|27002613|FG005|Part 1|Progressive Disease|0|||
13476219|NCT01729754|27002614|FG006|Part 1|Progressive Disease|0|||
13476220|NCT01729754|27002615|FG007|Part 1|Progressive Disease|0|||
13476221|NCT01729754|27002616|FG008|Part 1|Progressive Disease|0|||
13476222|NCT01729754|27002617|FG009|Part 1|Progressive Disease|1|||
13476223|NCT01729754|27002608|FG000|Part 1|Protocol Violation|2|||
13476224|NCT01729754|27002609|FG001|Part 1|Protocol Violation|0|||
13476225|NCT01729754|27002610|FG002|Part 1|Protocol Violation|0|||
13476226|NCT01729754|27002611|FG003|Part 1|Protocol Violation|1|||
13476227|NCT01729754|27002612|FG004|Part 1|Protocol Violation|0|||
13476228|NCT01729754|27002613|FG005|Part 1|Protocol Violation|0|||
13476229|NCT01729754|27002614|FG006|Part 1|Protocol Violation|1|||
13476230|NCT01729754|27002615|FG007|Part 1|Protocol Violation|0|||
13476231|NCT01729754|27002616|FG008|Part 1|Protocol Violation|0|||
13476232|NCT01729754|27002617|FG009|Part 1|Protocol Violation|0|||
13476233|NCT01729754|27002608|FG000|Part 1|Withdrawal by Subject|5|||
13476234|NCT01729754|27002609|FG001|Part 1|Withdrawal by Subject|0|||
13476235|NCT01729754|27002610|FG002|Part 1|Withdrawal by Subject|0|||
13476236|NCT01729754|27002611|FG003|Part 1|Withdrawal by Subject|7|||
13476237|NCT01729754|27002612|FG004|Part 1|Withdrawal by Subject|0|||
13476238|NCT01729754|27002613|FG005|Part 1|Withdrawal by Subject|0|||
13476239|NCT01729754|27002614|FG006|Part 1|Withdrawal by Subject|5|||
13406431|NCT00566020|26821598|FG000|6-week Dosage Adjustment Phase|Adverse Event|5|||
13406432|NCT00566020|26821599|FG001|6-week Dosage Adjustment Phase|Adverse Event|0|||
13406433|NCT00566020|26821598|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2|||
13406434|NCT00566020|26821599|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0|||
13406435|NCT00566020|26821598|FG000|46-week Long-term Administration Phase|Adverse Event|0|||
13406436|NCT00566020|26821599|FG001|46-week Long-term Administration Phase|Adverse Event|7|||
13406437|NCT00566020|26821598|FG000|46-week Long-term Administration Phase|Physician Decision|0|||
13406438|NCT00566020|26821599|FG001|46-week Long-term Administration Phase|Physician Decision|7|||
13406439|NCT00566020|26821598|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0|||
13406440|NCT00566020|26821599|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2|||
13406441|NCT00566020|26821598|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0|||
13406442|NCT00566020|26821599|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1|||
13406443|NCT00565812|26821746|FG000|Overall Study|Death|2|||
13406444|NCT00565812|26821747|FG001|Overall Study|Death|1|||
13406445|NCT00565812|26821748|FG002|Overall Study|Death|3|||
13406446|NCT00565812|26821746|FG000|Overall Study|Did not Meet Entrance Criteria|1|||
13406447|NCT00565812|26821747|FG001|Overall Study|Did not Meet Entrance Criteria|0|||
13406448|NCT00565812|26821748|FG002|Overall Study|Did not Meet Entrance Criteria|1|||
13406449|NCT00565812|26821746|FG000|Overall Study|Lost to Follow-up|10|||
13406450|NCT00565812|26821747|FG001|Overall Study|Lost to Follow-up|8|||
13406451|NCT00565812|26821748|FG002|Overall Study|Lost to Follow-up|8|||
13406452|NCT00565812|26821746|FG000|Overall Study|Withdrawal by Subject|58|||
13406453|NCT00565812|26821747|FG001|Overall Study|Withdrawal by Subject|47|||
13406454|NCT00565812|26821748|FG002|Overall Study|Withdrawal by Subject|48|||
13406455|NCT00565812|26821746|FG000|Overall Study|Work Schedule|5|||
13406456|NCT00565812|26821747|FG001|Overall Study|Work Schedule|3|||
13406457|NCT00565812|26821748|FG002|Overall Study|Work Schedule|1|||
13406458|NCT00565812|26821746|FG000|Overall Study|Protocol Violation|2|||
13406459|NCT00565812|26821747|FG001|Overall Study|Protocol Violation|6|||
13406460|NCT00565812|26821748|FG002|Overall Study|Protocol Violation|4|||
13406461|NCT00565812|26821746|FG000|Overall Study|Adverse Event|41|||
13406462|NCT00565812|26821747|FG001|Overall Study|Adverse Event|54|||
13406463|NCT00565812|26821748|FG002|Overall Study|Adverse Event|40|||
13406464|NCT00565812|26821746|FG000|Overall Study|Jury Duty|1|||
13406465|NCT00565812|26821747|FG001|Overall Study|Jury Duty|0|||
13406466|NCT00565812|26821748|FG002|Overall Study|Jury Duty|0|||
13406467|NCT00565812|26821746|FG000|Overall Study|Relocated Out of Area|5|||
13406468|NCT00565812|26821747|FG001|Overall Study|Relocated Out of Area|8|||
13406469|NCT00565812|26821748|FG002|Overall Study|Relocated Out of Area|9|||
13406470|NCT00565812|26821746|FG000|Overall Study|Sponsor Decision|1|||
13406471|NCT00565812|26821747|FG001|Overall Study|Sponsor Decision|5|||
13406472|NCT00565812|26821748|FG002|Overall Study|Sponsor Decision|1|||
13406473|NCT00565812|26821746|FG000|Overall Study|Domestic Reasons|7|||
13406474|NCT00565812|26821747|FG001|Overall Study|Domestic Reasons|1|||
13406475|NCT00565812|26821748|FG002|Overall Study|Domestic Reasons|3|||
13406476|NCT00565812|26821746|FG000|Overall Study|Research Site Closure|6|||
13406477|NCT00565812|26821747|FG001|Overall Study|Research Site Closure|1|||
13406478|NCT00565812|26821748|FG002|Overall Study|Research Site Closure|8|||
13406479|NCT00565812|26821746|FG000|Overall Study|Surgical Intervention|0|||
13406480|NCT00565812|26821747|FG001|Overall Study|Surgical Intervention|1|||
13406481|NCT00565812|26821748|FG002|Overall Study|Surgical Intervention|2|||
13406482|NCT00565812|26821746|FG000|Overall Study|Low Compliance|1|||
13406483|NCT00565812|26821747|FG001|Overall Study|Low Compliance|0|||
13406484|NCT00565812|26821748|FG002|Overall Study|Low Compliance|1|||
13406485|NCT00565812|26821746|FG000|Overall Study|Follow-up Visit Not Completed|2|||
13406486|NCT00565812|26821747|FG001|Overall Study|Follow-up Visit Not Completed|0|||
13406487|NCT00565812|26821748|FG002|Overall Study|Follow-up Visit Not Completed|1|||
13406488|NCT00565812|26821746|FG000|Overall Study|Physician Decision|2|||
13406489|NCT00565812|26821747|FG001|Overall Study|Physician Decision|0|||
13406490|NCT00565812|26821748|FG002|Overall Study|Physician Decision|0|||
13406491|NCT00565773|26821760|FG000|Overall Study|Withdrawal by Subject|1|||
13406492|NCT00565773|26821760|FG000|Overall Study|Physician Decision|1|||
13406493|NCT00565747|26821777|FG000|Overall Study|No embryo transfer|67|||
13406494|NCT00565747|26821778|FG001|Overall Study|No embryo transfer|73|||
13406495|NCT00565721|26821799|FG000|Overall Study|Screen Failure|2|||
13406496|NCT00565721|26821799|FG000|Overall Study|Lost to Follow-up|6|||
13406497|NCT00565721|26821799|FG000|Overall Study|Technical Problems|1|||
13406498|NCT00565721|26821799|FG000|Overall Study|Physician Decision|2|||
13406499|NCT00565721|26821799|FG000|Overall Study|Other reasons|6|||
13406500|NCT00565617|26821805|FG000|Overall Study|Withdrawal by Subject|1|||
13406501|NCT00565604|26821814|FG000|Overall Study|Failure to treat|2|||
13406502|NCT00565604|26821814|FG000|Overall Study|Lost to Follow-up|2|||
13406503|NCT00565448|26821832|FG000|Overall Study|Adverse Event|1|||
13406504|NCT00565448|26821833|FG001|Overall Study|Adverse Event|2|||
13406505|NCT00565448|26821832|FG000|Overall Study|Disease progression|1|||
13406506|NCT00565448|26821833|FG001|Overall Study|Disease progression|0|||
13406507|NCT00565448|26821832|FG000|Overall Study|Withdrawal by Subject|1|||
13406508|NCT00565448|26821833|FG001|Overall Study|Withdrawal by Subject|0|||
13406509|NCT00565409|26821940|FG000|Period 1 Open Label|Adverse Event|17|||
13406510|NCT00565409|26821941|FG001|Period 1 Open Label|Adverse Event|0|||
13406511|NCT00565409|26821942|FG002|Period 1 Open Label|Adverse Event|0|||
13406512|NCT00565409|26821943|FG003|Period 1 Open Label|Adverse Event|0|||
13406513|NCT00565409|26821940|FG000|Period 1 Open Label|Death|2|||
13406514|NCT00565409|26821941|FG001|Period 1 Open Label|Death|0|||
13406515|NCT00565409|26821942|FG002|Period 1 Open Label|Death|0|||
13406516|NCT00565409|26821943|FG003|Period 1 Open Label|Death|0|||
13406517|NCT00565409|26821940|FG000|Period 1 Open Label|Lost to Follow-up|1|||
13406518|NCT00565409|26821941|FG001|Period 1 Open Label|Lost to Follow-up|0|||
13406519|NCT00565409|26821942|FG002|Period 1 Open Label|Lost to Follow-up|0|||
13406520|NCT00565409|26821943|FG003|Period 1 Open Label|Lost to Follow-up|0|||
13406521|NCT00565409|26821940|FG000|Period 1 Open Label|Other|21|||
13406522|NCT00565409|26821941|FG001|Period 1 Open Label|Other|0|||
13406523|NCT00565409|26821942|FG002|Period 1 Open Label|Other|0|||
13406524|NCT00565409|26821943|FG003|Period 1 Open Label|Other|0|||
13406525|NCT00565409|26821940|FG000|Period 1 Open Label|Protocol Violation|14|||
13406526|NCT00565409|26821941|FG001|Period 1 Open Label|Protocol Violation|0|||
13406527|NCT00565409|26821942|FG002|Period 1 Open Label|Protocol Violation|0|||
13406528|NCT00565409|26821943|FG003|Period 1 Open Label|Protocol Violation|0|||
13406529|NCT00565409|26821940|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22|||
13406530|NCT00565409|26821941|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
13406531|NCT00565409|26821942|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
13406532|NCT00565409|26821943|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
13406533|NCT00565409|26821940|FG000|Period 1 Open Label|no conclusion of participation record|1|||
13406534|NCT00565409|26821941|FG001|Period 1 Open Label|no conclusion of participation record|0|||
13406535|NCT00565409|26821942|FG002|Period 1 Open Label|no conclusion of participation record|0|||
13406536|NCT00565409|26821943|FG003|Period 1 Open Label|no conclusion of participation record|0|||
13406537|NCT00565409|26821940|FG000|After Period 1, Prior to Period 2|did not meet criteria|152|||
13406538|NCT00565409|26821941|FG001|After Period 1, Prior to Period 2|did not meet criteria|0|||
13406539|NCT00565409|26821942|FG002|After Period 1, Prior to Period 2|did not meet criteria|0|||
13406540|NCT00565409|26821943|FG003|After Period 1, Prior to Period 2|did not meet criteria|0|||
13406541|NCT00565409|26821940|FG000|Period 2 Double-Blind|Adverse Event|0|||
13406542|NCT00565409|26821941|FG001|Period 2 Double-Blind|Adverse Event|7|||
13406543|NCT00565409|26821942|FG002|Period 2 Double-Blind|Adverse Event|4|||
13406544|NCT00565409|26821943|FG003|Period 2 Double-Blind|Adverse Event|5|||
13406545|NCT00565409|26821940|FG000|Period 2 Double-Blind|Death|0|||
13406546|NCT00565409|26821941|FG001|Period 2 Double-Blind|Death|2|||
13406547|NCT00565409|26821942|FG002|Period 2 Double-Blind|Death|0|||
13406548|NCT00565409|26821943|FG003|Period 2 Double-Blind|Death|0|||
13406549|NCT00565409|26821940|FG000|Period 2 Double-Blind|Protocol Violation|0|||
13406550|NCT00565409|26821941|FG001|Period 2 Double-Blind|Protocol Violation|4|||
13406551|NCT00565409|26821942|FG002|Period 2 Double-Blind|Protocol Violation|6|||
13406552|NCT00565409|26821943|FG003|Period 2 Double-Blind|Protocol Violation|2|||
13406553|NCT00565409|26821940|FG000|Period 2 Double-Blind|Lost to Follow-up|0|||
13406554|NCT00565409|26821941|FG001|Period 2 Double-Blind|Lost to Follow-up|0|||
13406555|NCT00565409|26821942|FG002|Period 2 Double-Blind|Lost to Follow-up|1|||
13406556|NCT00565409|26821943|FG003|Period 2 Double-Blind|Lost to Follow-up|0|||
13406557|NCT00565409|26821940|FG000|Period 2 Double-Blind|Other|0|||
13406558|NCT00565409|26821941|FG001|Period 2 Double-Blind|Other|4|||
13406559|NCT00565409|26821942|FG002|Period 2 Double-Blind|Other|5|||
13406560|NCT00565409|26821943|FG003|Period 2 Double-Blind|Other|9|||
13406561|NCT00565409|26821940|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0|||
13406562|NCT00565409|26821941|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4|||
13406563|NCT00565409|26821942|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11|||
13406564|NCT00565409|26821943|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43|||
13406565|NCT00565136|26821963|FG000|Overall Study|Lost to Follow-up|1|||
13406566|NCT00565136|26821963|FG000|Overall Study|Withdrawal by Subject|1|||
13406567|NCT00565136|26821963|FG000|Overall Study|Protocol Violation|1|||
13406568|NCT00565058|26821978|FG000|Overall Study|Adverse Event|1|||
13406569|NCT00565058|26821979|FG001|Overall Study|Adverse Event|0|||
13406570|NCT00564902|26822021|FG000|Overall Study|Withdrawal by Subject|0|||
13406571|NCT00564902|26822022|FG001|Overall Study|Withdrawal by Subject|3|||
13406572|NCT00564902|26822023|FG002|Overall Study|Withdrawal by Subject|4|||
13406573|NCT00564902|26822021|FG000|Overall Study|Death|1|||
13406574|NCT00564902|26822022|FG001|Overall Study|Death|1|||
13406575|NCT00564902|26822023|FG002|Overall Study|Death|0|||
13406576|NCT00564889|26822033|FG000|Overall Study|Death|7|||
13406577|NCT00564889|26822033|FG000|Overall Study|Adverse Event|12|||
13406578|NCT00564889|26822033|FG000|Overall Study|Alternative treatment|3|||
13406579|NCT00564889|26822033|FG000|Overall Study|Disease progression|3|||
13406580|NCT00564889|26822033|FG000|Overall Study|Other, not specified|4|||
13406581|NCT00564733|26822039|FG000|Overall Study|Withdrawal by Subject|4|||
13406582|NCT00564733|26822039|FG000|Overall Study|Ineligible|5|||
13406583|NCT00564629|26822068|FG000|Overall Study|Vomited within 2 hours of receiving drug|15|||
13406584|NCT00564629|26822069|FG001|Overall Study|Vomited within 2 hours of receiving drug|9|||
13406585|NCT00564486|26822096|FG000|Overall Study|Adverse Event|0|||
13406586|NCT00564486|26822097|FG001|Overall Study|Adverse Event|1|||
13406587|NCT00564486|26822098|FG002|Overall Study|Adverse Event|0|||
13406588|NCT00564486|26822099|FG003|Overall Study|Adverse Event|0|||
13406589|NCT00564486|26822096|FG000|Overall Study|Withdrawal by Subject|4|||
13406590|NCT00564486|26822097|FG001|Overall Study|Withdrawal by Subject|0|||
13406591|NCT00564486|26822098|FG002|Overall Study|Withdrawal by Subject|0|||
13406592|NCT00564486|26822099|FG003|Overall Study|Withdrawal by Subject|5|||
13406593|NCT00564486|26822096|FG000|Overall Study|Subject refused to have blood drawn|0|||
13406594|NCT00564486|26822097|FG001|Overall Study|Subject refused to have blood drawn|0|||
13406595|NCT00564486|26822098|FG002|Overall Study|Subject refused to have blood drawn|1|||
13406596|NCT00564486|26822099|FG003|Overall Study|Subject refused to have blood drawn|0|||
13406597|NCT00564486|26822096|FG000|Overall Study|Lost to Follow-up|3|||
13406598|NCT00564486|26822097|FG001|Overall Study|Lost to Follow-up|0|||
13406599|NCT00564486|26822098|FG002|Overall Study|Lost to Follow-up|2|||
13406600|NCT00564486|26822099|FG003|Overall Study|Lost to Follow-up|2|||
13406601|NCT00564395|26822108|FG000|First Intervention (10 Days)|Withdrawal by Subject|1|||
13406602|NCT00564395|26822109|FG001|First Intervention (10 Days)|Withdrawal by Subject|0|||
13406603|NCT00564395|26822108|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1|||
13406604|NCT00564395|26822109|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2|||
13406605|NCT00564278|26822132|FG000|Overall Study|Lost to Follow-up|35|||
13406606|NCT00564278|26822133|FG001|Overall Study|Lost to Follow-up|33|||
13406607|NCT00564278|26822132|FG000|Overall Study|Physician Decision|1|||
13406608|NCT00564278|26822133|FG001|Overall Study|Physician Decision|2|||
13406609|NCT00564278|26822132|FG000|Overall Study|Withdrawal by Subject|11|||
13406610|NCT00564278|26822133|FG001|Overall Study|Withdrawal by Subject|7|||
13406611|NCT00564070|26822164|FG000|Overall Study|Lost to Follow-up|9|||
13406612|NCT00564070|26822165|FG001|Overall Study|Lost to Follow-up|7|||
13406613|NCT00564070|26822164|FG000|Overall Study|Worsening depression, referred to care|3|||
13406614|NCT00564070|26822165|FG001|Overall Study|Worsening depression, referred to care|0|||
13406615|NCT00564018|26822186|FG000|Overall Study|Withdrawal by Subject|2|||
13406616|NCT00564018|26822187|FG001|Overall Study|Withdrawal by Subject|3|||
13406617|NCT00564018|26822188|FG002|Overall Study|Withdrawal by Subject|1|||
13406618|NCT00563797|26822207|FG000|Overall Study|Lost to Follow-up|7|||
13406619|NCT00563797|26822208|FG001|Overall Study|Lost to Follow-up|2|||
13406620|NCT00563784|26822215|FG000|Overall Study|Withdrawal by Subject|2|||
13406621|NCT00563784|26822215|FG000|Overall Study|Screen Failures|20|||
13406622|NCT00563706|26822344|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4|||
13406623|NCT00563706|26822345|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
13406624|NCT00563706|26822346|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
13406625|NCT00563706|26822347|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
13406626|NCT00563706|26822348|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
13406627|NCT00563706|26822349|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
13406628|NCT00563706|26822350|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
13406629|NCT00563706|26822351|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
13406630|NCT00563706|26822352|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5|||
13406631|NCT00563706|26822344|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
13406632|NCT00563706|26822345|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
13406633|NCT00563706|26822346|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
13406634|NCT00563706|26822347|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4|||
13406635|NCT00563706|26822348|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
13406636|NCT00563706|26822349|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
13406637|NCT00563706|26822350|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
13406638|NCT00563706|26822351|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5|||
13406639|NCT00563706|26822352|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
13406640|NCT00563706|26822344|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9|||
13406641|NCT00563706|26822345|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
13406642|NCT00563706|26822346|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2|||
13406643|NCT00563706|26822347|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5|||
13406644|NCT00563706|26822348|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4|||
13406645|NCT00563706|26822349|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
13406646|NCT00563706|26822350|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1|||
13406647|NCT00563706|26822351|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6|||
13406648|NCT00563706|26822352|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
13406649|NCT00563706|26822344|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2|||
13406650|NCT00563706|26822345|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
13406651|NCT00563706|26822346|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
13406652|NCT00563706|26822347|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
13406653|NCT00563706|26822348|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
13406654|NCT00563706|26822349|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
13406655|NCT00563706|26822350|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
13406656|NCT00563706|26822351|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1|||
13406657|NCT00563706|26822352|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
13406658|NCT00563706|26822344|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
13406659|NCT00563706|26822345|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
13406660|NCT00563706|26822346|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
13406661|NCT00563706|26822347|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
13406662|NCT00563706|26822348|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
13406663|NCT00563706|26822349|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
13406664|NCT00563706|26822350|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
13406665|NCT00563706|26822351|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1|||
13406666|NCT00563706|26822352|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2|||
13406667|NCT00563381|26822425|FG000|Overall Study|Adverse Event|264|||
13406668|NCT00563381|26822426|FG001|Overall Study|Adverse Event|292|||
13406669|NCT00563381|26822425|FG000|Overall Study|Protocol Violation|66|||
13406670|NCT00563381|26822426|FG001|Overall Study|Protocol Violation|74|||
13406671|NCT00563381|26822425|FG000|Overall Study|Lost to Follow-up|7|||
13406672|NCT00563381|26822426|FG001|Overall Study|Lost to Follow-up|15|||
13406673|NCT00563381|26822425|FG000|Overall Study|Withdrawal by Subject|192|||
13406674|NCT00563381|26822426|FG001|Overall Study|Withdrawal by Subject|209|||
13406675|NCT00563381|26822425|FG000|Overall Study|Lack of Efficacy|32|||
13406676|NCT00563381|26822426|FG001|Overall Study|Lack of Efficacy|24|||
13406677|NCT00563381|26822425|FG000|Overall Study|Individual different reasons|24|||
13406678|NCT00563381|26822426|FG001|Overall Study|Individual different reasons|34|||
13406679|NCT00563368|26822471|FG000|Overall Study|Lost to Follow-up|14|||
13406680|NCT00563368|26822472|FG001|Overall Study|Lost to Follow-up|14|||
13406681|NCT00563368|26822473|FG002|Overall Study|Lost to Follow-up|12|||
13406682|NCT00563368|26822474|FG003|Overall Study|Lost to Follow-up|6|||
13406683|NCT00563368|26822475|FG004|Overall Study|Lost to Follow-up|9|||
13406684|NCT00563368|26822476|FG005|Overall Study|Lost to Follow-up|8|||
13406685|NCT00563368|26822477|FG006|Overall Study|Lost to Follow-up|9|||
13406686|NCT00563368|26822471|FG000|Overall Study|Adverse Event|3|||
13406687|NCT00563368|26822472|FG001|Overall Study|Adverse Event|4|||
13406688|NCT00563368|26822473|FG002|Overall Study|Adverse Event|5|||
13406689|NCT00563368|26822474|FG003|Overall Study|Adverse Event|9|||
13406690|NCT00563368|26822475|FG004|Overall Study|Adverse Event|6|||
13406691|NCT00563368|26822476|FG005|Overall Study|Adverse Event|10|||
13406692|NCT00563368|26822477|FG006|Overall Study|Adverse Event|17|||
13406693|NCT00563368|26822471|FG000|Overall Study|Withdrawal by Subject|11|||
13406694|NCT00563368|26822472|FG001|Overall Study|Withdrawal by Subject|6|||
13406695|NCT00563368|26822473|FG002|Overall Study|Withdrawal by Subject|5|||
13406696|NCT00563368|26822474|FG003|Overall Study|Withdrawal by Subject|7|||
13406697|NCT00563368|26822475|FG004|Overall Study|Withdrawal by Subject|8|||
13406698|NCT00563368|26822476|FG005|Overall Study|Withdrawal by Subject|5|||
13406699|NCT00563368|26822477|FG006|Overall Study|Withdrawal by Subject|4|||
13406700|NCT00563368|26822471|FG000|Overall Study|protocol non-compliance|1|||
13406701|NCT00563368|26822472|FG001|Overall Study|protocol non-compliance|1|||
13406702|NCT00563368|26822473|FG002|Overall Study|protocol non-compliance|2|||
13406703|NCT00563368|26822474|FG003|Overall Study|protocol non-compliance|1|||
13406704|NCT00563368|26822475|FG004|Overall Study|protocol non-compliance|0|||
13406705|NCT00563368|26822476|FG005|Overall Study|protocol non-compliance|1|||
13406706|NCT00563368|26822477|FG006|Overall Study|protocol non-compliance|3|||
13406707|NCT00563368|26822471|FG000|Overall Study|Pregnancy|1|||
13406708|NCT00563368|26822472|FG001|Overall Study|Pregnancy|0|||
13406709|NCT00563368|26822473|FG002|Overall Study|Pregnancy|1|||
13406710|NCT00563368|26822474|FG003|Overall Study|Pregnancy|2|||
13406711|NCT00563368|26822475|FG004|Overall Study|Pregnancy|1|||
13406712|NCT00563368|26822476|FG005|Overall Study|Pregnancy|2|||
13406713|NCT00563368|26822477|FG006|Overall Study|Pregnancy|0|||
13406714|NCT00563368|26822471|FG000|Overall Study|requirement for restricted medication|0|||
13406715|NCT00563368|26822472|FG001|Overall Study|requirement for restricted medication|0|||
13406716|NCT00563368|26822473|FG002|Overall Study|requirement for restricted medication|2|||
13406717|NCT00563368|26822474|FG003|Overall Study|requirement for restricted medication|0|||
13406718|NCT00563368|26822475|FG004|Overall Study|requirement for restricted medication|0|||
13406719|NCT00563368|26822476|FG005|Overall Study|requirement for restricted medication|0|||
13406720|NCT00563368|26822477|FG006|Overall Study|requirement for restricted medication|0|||
13406721|NCT00563368|26822471|FG000|Overall Study|Other|5|||
13406722|NCT00563368|26822472|FG001|Overall Study|Other|5|||
13406723|NCT00563368|26822473|FG002|Overall Study|Other|3|||
13406724|NCT00563368|26822474|FG003|Overall Study|Other|4|||
13406725|NCT00563368|26822475|FG004|Overall Study|Other|4|||
13406726|NCT00563368|26822476|FG005|Overall Study|Other|4|||
13406727|NCT00563368|26822477|FG006|Overall Study|Other|0|||
13406728|NCT00563316|26822490|FG000|Overall Study|Adverse Event|2|||
13406729|NCT00563316|26822490|FG000|Overall Study|Physician Decision|1|||
13406730|NCT00563316|26822490|FG000|Overall Study|Lost to Follow-up|2|||
13406731|NCT00563316|26822490|FG000|Overall Study|Death|1|||
13406732|NCT00563316|26822490|FG000|Overall Study|On-going in study as of 16 July 2009.|5|||
13406733|NCT00563316|26822490|FG000|Overall Study|Other|1|||
13406734|NCT00563186|26822506|FG000|Overall Study|LOS<48 hours|97|||
13406735|NCT00563186|26822507|FG001|Overall Study|LOS<48 hours|74|||
13406736|NCT00563186|26822506|FG000|Overall Study|Incomplete data|1|||
13406737|NCT00563186|26822507|FG001|Overall Study|Incomplete data|1|||
13406738|NCT00562978|26822526|FG000|Overall Study|Patient had imaging dose only|1|||
13406739|NCT00562978|26822527|FG001|Overall Study|Patient had imaging dose only|11|||
13406740|NCT00562965|26822553|FG000|Overall Study|Withdrawal by Subject|0|||
13406741|NCT00562965|26822554|FG001|Overall Study|Withdrawal by Subject|1|||
13406742|NCT00562965|26822553|FG000|Overall Study|Death|2|||
13406743|NCT00562965|26822554|FG001|Overall Study|Death|4|||
13406744|NCT00562965|26822553|FG000|Overall Study|Lost to Follow-up|1|||
13406745|NCT00562965|26822554|FG001|Overall Study|Lost to Follow-up|0|||
13406746|NCT00562965|26822553|FG000|Overall Study|Other|0|||
13406747|NCT00562965|26822554|FG001|Overall Study|Other|1|||
13406748|NCT00562861|26822567|FG000|Overall Study|Adverse Event|1|||
13406749|NCT00562861|26822568|FG001|Overall Study|Adverse Event|1|||
13406750|NCT00562861|26822567|FG000|Overall Study|Lack of Efficacy|5|||
13406751|NCT00562861|26822568|FG001|Overall Study|Lack of Efficacy|5|||
13406752|NCT00562861|26822567|FG000|Overall Study|noncompliance, moved|7|||
13406753|NCT00562861|26822568|FG001|Overall Study|noncompliance, moved|2|||
13406754|NCT00562861|26822567|FG000|Overall Study|Lost to Follow-up|7|||
13406755|NCT00562861|26822568|FG001|Overall Study|Lost to Follow-up|3|||
13406756|NCT00562718|26822576|FG000|Overall Study|Death|1|||
13406757|NCT00562718|26822576|FG000|Overall Study|Withdrawal by Subject|3|||
13406758|NCT00562718|26822576|FG000|Overall Study|Adverse Event|4|||
13406759|NCT00562718|26822576|FG000|Overall Study|Lack of Efficacy|2|||
13406760|NCT00562718|26822576|FG000|Overall Study|not stated|1|||
13406761|NCT00562627|26822600|FG000|Overall Study|Protocol Violation|1|||
13406762|NCT00562627|26822601|FG001|Overall Study|Protocol Violation|1|||
13406763|NCT00562627|26822602|FG002|Overall Study|Protocol Violation|1|||
13406764|NCT00562588|26822637|FG000|Overall Study|Adverse Event|40|||
13406765|NCT00562588|26822638|FG001|Overall Study|Adverse Event|58|||
13406766|NCT00562588|26822637|FG000|Overall Study|Protocol Violation|30|||
13406767|NCT00562588|26822638|FG001|Overall Study|Protocol Violation|26|||
13406768|NCT00562588|26822637|FG000|Overall Study|Lost to Follow-up|12|||
13406769|NCT00562588|26822638|FG001|Overall Study|Lost to Follow-up|4|||
13406770|NCT00562588|26822637|FG000|Overall Study|Withdrawal by Subject|10|||
13406771|NCT00562588|26822638|FG001|Overall Study|Withdrawal by Subject|9|||
13406772|NCT00562588|26822637|FG000|Overall Study|Other|0|||
13406773|NCT00562588|26822638|FG001|Overall Study|Other|2|||
13406774|NCT00562484|26822675|FG000|Overall Study|Adverse Event|6|||
13406775|NCT00562484|26822676|FG001|Overall Study|Adverse Event|1|||
13406776|NCT00562484|26822675|FG000|Overall Study|Protocol Violation|11|||
13406777|NCT00562484|26822676|FG001|Overall Study|Protocol Violation|2|||
13406778|NCT00562484|26822675|FG000|Overall Study|Withdrawal by Subject|12|||
13406779|NCT00562484|26822676|FG001|Overall Study|Withdrawal by Subject|9|||
13406780|NCT00562484|26822675|FG000|Overall Study|Moved away from the study area|20|||
13406781|NCT00562484|26822676|FG001|Overall Study|Moved away from the study area|9|||
13406782|NCT00562484|26822675|FG000|Overall Study|Lost to Follow-up|132|||
13406783|NCT00562484|26822676|FG001|Overall Study|Lost to Follow-up|71|||
13406784|NCT00562484|26822675|FG000|Overall Study|Reason not provided or not specified|25|||
13406785|NCT00562484|26822676|FG001|Overall Study|Reason not provided or not specified|12|||
13406786|NCT00562354|26822724|FG000|Overall Study|Physician Decision|0|||
13406787|NCT00562354|26822725|FG001|Overall Study|Physician Decision|1|||
13406788|NCT00562354|26822724|FG000|Overall Study|Lost to Follow-up|0|||
13406789|NCT00562354|26822725|FG001|Overall Study|Lost to Follow-up|1|||
13406790|NCT00562302|26822752|FG000|Overall Study|Lost to Follow-up|3|||
13406791|NCT00562302|26822753|FG001|Overall Study|Lost to Follow-up|3|||
13406792|NCT00562302|26822752|FG000|Overall Study|Adverse Event|0|||
13406793|NCT00562302|26822753|FG001|Overall Study|Adverse Event|6|||
13406794|NCT00562302|26822752|FG000|Overall Study|Non-compliance|1|||
13406795|NCT00562302|26822753|FG001|Overall Study|Non-compliance|2|||
13406796|NCT00562302|26822752|FG000|Overall Study|Withdrawal by Subject|7|||
13406797|NCT00562302|26822753|FG001|Overall Study|Withdrawal by Subject|8|||
13406798|NCT00562302|26822752|FG000|Overall Study|Death|1|||
13406799|NCT00562302|26822753|FG001|Overall Study|Death|2|||
13406800|NCT00562302|26822752|FG000|Overall Study|Lung resection prior to study completion|7|||
13406801|NCT00562302|26822753|FG001|Overall Study|Lung resection prior to study completion|7|||
13406802|NCT00562302|26822752|FG000|Overall Study|Not stated|1|||
13406803|NCT00562302|26822753|FG001|Overall Study|Not stated|4|||
13406804|NCT00562159|26822772|FG000|Overall Study|Adverse Event|11|||
13406805|NCT00562159|26822773|FG001|Overall Study|Adverse Event|8|||
13406806|NCT00562159|26822772|FG000|Overall Study|Lost to Follow-up|5|||
13406807|NCT00562159|26822773|FG001|Overall Study|Lost to Follow-up|4|||
13406808|NCT00562159|26822772|FG000|Overall Study|Withdrawal by Subject|9|||
13406809|NCT00562159|26822773|FG001|Overall Study|Withdrawal by Subject|8|||
13406810|NCT00562159|26822772|FG000|Overall Study|Protocol Violation|12|||
13406811|NCT00562159|26822773|FG001|Overall Study|Protocol Violation|12|||
13406812|NCT00562159|26822772|FG000|Overall Study|Did not meet protocol eligibility|1|||
13406813|NCT00562159|26822773|FG001|Overall Study|Did not meet protocol eligibility|1|||
13406814|NCT00562120|26822810|FG000|First Intervention Period|Adverse Event|1|||
13406815|NCT00562120|26822811|FG001|First Intervention Period|Adverse Event|0|||
13406816|NCT00562120|26822812|FG002|First Intervention Period|Adverse Event|0|||
13406817|NCT00562120|26822813|FG003|First Intervention Period|Adverse Event|0|||
13406818|NCT00562120|26822810|FG000|First Intervention Period|Randomized but not Treated|1|||
13406819|NCT00562120|26822811|FG001|First Intervention Period|Randomized but not Treated|0|||
13406820|NCT00562120|26822812|FG002|First Intervention Period|Randomized but not Treated|0|||
13406821|NCT00562120|26822813|FG003|First Intervention Period|Randomized but not Treated|0|||
13406822|NCT00562094|26822827|FG000|Overall Study|Lost to Follow-up|62|||
13406823|NCT00561977|26822860|FG000|Overall Study|Withdrawal by Subject|0|||
13406824|NCT00561977|26822861|FG001|Overall Study|Withdrawal by Subject|2|||
13406825|NCT00561977|26822862|FG002|Overall Study|Withdrawal by Subject|1|||
13406826|NCT00561977|26822860|FG000|Overall Study|Pregnancy|0|||
13406827|NCT00561977|26822861|FG001|Overall Study|Pregnancy|1|||
13406828|NCT00561977|26822862|FG002|Overall Study|Pregnancy|1|||
13406829|NCT00561951|26822925|FG000|Overall Study|Adverse Event|11|||
13406830|NCT00561951|26822926|FG001|Overall Study|Adverse Event|14|||
13406831|NCT00561951|26822927|FG002|Overall Study|Adverse Event|14|||
13406832|NCT00561951|26822925|FG000|Overall Study|Lack of Efficacy|5|||
13406833|NCT00561951|26822926|FG001|Overall Study|Lack of Efficacy|3|||
13406834|NCT00561951|26822927|FG002|Overall Study|Lack of Efficacy|2|||
13406835|NCT00561951|26822925|FG000|Overall Study|Lost to Follow-up|1|||
13406836|NCT00561951|26822926|FG001|Overall Study|Lost to Follow-up|1|||
13406837|NCT00561951|26822927|FG002|Overall Study|Lost to Follow-up|0|||
13406838|NCT00561951|26822925|FG000|Overall Study|Withdrawal by Subject|10|||
13406839|NCT00561951|26822926|FG001|Overall Study|Withdrawal by Subject|9|||
13406840|NCT00561951|26822927|FG002|Overall Study|Withdrawal by Subject|10|||
13406841|NCT00561951|26822925|FG000|Overall Study|Protocol Violation|4|||
13406842|NCT00561951|26822926|FG001|Overall Study|Protocol Violation|3|||
13406843|NCT00561951|26822927|FG002|Overall Study|Protocol Violation|4|||
13406844|NCT00561951|26822925|FG000|Overall Study|Physician Decision|1|||
13406845|NCT00561951|26822926|FG001|Overall Study|Physician Decision|0|||
13406846|NCT00561951|26822927|FG002|Overall Study|Physician Decision|0|||
13406847|NCT00561951|26822925|FG000|Overall Study|Pregnancy|0|||
13406848|NCT00561951|26822926|FG001|Overall Study|Pregnancy|1|||
13406849|NCT00561951|26822927|FG002|Overall Study|Pregnancy|0|||
13406850|NCT00561951|26822925|FG000|Overall Study|Meet Withdrawal Criterion|0|||
13406851|NCT00561951|26822926|FG001|Overall Study|Meet Withdrawal Criterion|1|||
13406852|NCT00561951|26822927|FG002|Overall Study|Meet Withdrawal Criterion|1|||
13406853|NCT00561951|26822925|FG000|Overall Study|Adverse Event Occured Before Treatment|1|||
13406854|NCT00561951|26822926|FG001|Overall Study|Adverse Event Occured Before Treatment|2|||
13406855|NCT00561951|26822927|FG002|Overall Study|Adverse Event Occured Before Treatment|1|||
13406856|NCT00561925|26822988|FG000|14 Day Lead-In Period|Adverse Event|38|||
13406857|NCT00561925|26822989|FG001|14 Day Lead-In Period|Adverse Event|0|||
13406858|NCT00561925|26822990|FG002|14 Day Lead-In Period|Adverse Event|0|||
13406859|NCT00561925|26822991|FG003|14 Day Lead-In Period|Adverse Event|0|||
13406860|NCT00561925|26822992|FG004|14 Day Lead-In Period|Adverse Event|0|||
13406861|NCT00561925|26822988|FG000|14 Day Lead-In Period|In/Exclusion criteria|4|||
13406862|NCT00561925|26822989|FG001|14 Day Lead-In Period|In/Exclusion criteria|0|||
13406863|NCT00561925|26822990|FG002|14 Day Lead-In Period|In/Exclusion criteria|0|||
13406864|NCT00561925|26822991|FG003|14 Day Lead-In Period|In/Exclusion criteria|0|||
13406865|NCT00561925|26822992|FG004|14 Day Lead-In Period|In/Exclusion criteria|0|||
13406866|NCT00561925|26822988|FG000|14 Day Lead-In Period|Lost to Follow-up|4|||
13406867|NCT00561925|26822989|FG001|14 Day Lead-In Period|Lost to Follow-up|0|||
13406868|NCT00561925|26822990|FG002|14 Day Lead-In Period|Lost to Follow-up|0|||
13406869|NCT00561925|26822991|FG003|14 Day Lead-In Period|Lost to Follow-up|0|||
13406870|NCT00561925|26822992|FG004|14 Day Lead-In Period|Lost to Follow-up|0|||
13406871|NCT00561925|26822988|FG000|14 Day Lead-In Period|Withdrawal by Subject|4|||
13406872|NCT00561925|26822989|FG001|14 Day Lead-In Period|Withdrawal by Subject|0|||
13406873|NCT00561925|26822990|FG002|14 Day Lead-In Period|Withdrawal by Subject|0|||
13406874|NCT00561925|26822991|FG003|14 Day Lead-In Period|Withdrawal by Subject|0|||
13406875|NCT00561925|26822992|FG004|14 Day Lead-In Period|Withdrawal by Subject|0|||
13406876|NCT00561925|26822988|FG000|14 Day Lead-In Period|Other|5|||
13406877|NCT00561925|26822989|FG001|14 Day Lead-In Period|Other|0|||
13406878|NCT00561925|26822990|FG002|14 Day Lead-In Period|Other|0|||
13406879|NCT00561925|26822991|FG003|14 Day Lead-In Period|Other|0|||
13406880|NCT00561925|26822992|FG004|14 Day Lead-In Period|Other|0|||
13406881|NCT00561925|26822988|FG000|144-week Double-blind, Double-dummy|Adverse Event|0|||
13406882|NCT00561925|26822989|FG001|144-week Double-blind, Double-dummy|Adverse Event|48|||
13406883|NCT00561925|26822990|FG002|144-week Double-blind, Double-dummy|Adverse Event|43|||
13406884|NCT00561925|26822991|FG003|144-week Double-blind, Double-dummy|Adverse Event|0|||
13406885|NCT00561925|26822992|FG004|144-week Double-blind, Double-dummy|Adverse Event|0|||
13406886|NCT00561925|26822988|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0|||
13406887|NCT00561925|26822989|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15|||
13406888|NCT00561925|26822990|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9|||
13406889|NCT00561925|26822991|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0|||
13406890|NCT00561925|26822992|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0|||
13406891|NCT00561925|26822988|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
13406892|NCT00561925|26822989|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15|||
13406893|NCT00561925|26822990|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12|||
13406894|NCT00561925|26822991|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
13406895|NCT00561925|26822992|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
13406896|NCT00561925|26822988|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
13406897|NCT00561925|26822989|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19|||
13406898|NCT00561925|26822990|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7|||
13406899|NCT00561925|26822991|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
13406900|NCT00561925|26822992|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
13406901|NCT00561925|26822988|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
13406902|NCT00561925|26822989|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36|||
13406903|NCT00561925|26822990|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33|||
13406904|NCT00561925|26822991|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
13406905|NCT00561925|26822992|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
13406906|NCT00561925|26822988|FG000|144-week Double-blind, Double-dummy|Pregnancy|0|||
13406907|NCT00561925|26822989|FG001|144-week Double-blind, Double-dummy|Pregnancy|1|||
13406908|NCT00561925|26822990|FG002|144-week Double-blind, Double-dummy|Pregnancy|9|||
13406909|NCT00561925|26822991|FG003|144-week Double-blind, Double-dummy|Pregnancy|0|||
13406910|NCT00561925|26822992|FG004|144-week Double-blind, Double-dummy|Pregnancy|0|||
13406911|NCT00561925|26822988|FG000|144-week Double-blind, Double-dummy|Death|0|||
13406912|NCT00561925|26822989|FG001|144-week Double-blind, Double-dummy|Death|6|||
13406913|NCT00561925|26822990|FG002|144-week Double-blind, Double-dummy|Death|3|||
13406914|NCT00561925|26822991|FG003|144-week Double-blind, Double-dummy|Death|0|||
13406915|NCT00561925|26822992|FG004|144-week Double-blind, Double-dummy|Death|0|||
13406916|NCT00561925|26822988|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
13406917|NCT00561925|26822989|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2|||
13406918|NCT00561925|26822990|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
13406919|NCT00561925|26822991|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
13406920|NCT00561925|26822992|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
13406921|NCT00561925|26822988|FG000|144-week Double-blind, Double-dummy|Other|0|||
13406922|NCT00561925|26822989|FG001|144-week Double-blind, Double-dummy|Other|8|||
13406923|NCT00561925|26822990|FG002|144-week Double-blind, Double-dummy|Other|11|||
13406924|NCT00561925|26822991|FG003|144-week Double-blind, Double-dummy|Other|0|||
13406925|NCT00561925|26822992|FG004|144-week Double-blind, Double-dummy|Other|0|||
13406926|NCT00561925|26822988|FG000|Open-Label Extension Period|Declined entry into extension period|0|||
13406927|NCT00561925|26822989|FG001|Open-Label Extension Period|Declined entry into extension period|0|||
13406928|NCT00561925|26822990|FG002|Open-Label Extension Period|Declined entry into extension period|0|||
13406929|NCT00561925|26822991|FG003|Open-Label Extension Period|Declined entry into extension period|43|||
13406930|NCT00561925|26822992|FG004|Open-Label Extension Period|Declined entry into extension period|50|||
13406931|NCT00561912|26822998|FG000|Overall Study|ineligible|1|||
13406932|NCT00561821|26823085|FG000|Overall Study|Not treated|0|||
13406933|NCT00561821|26823086|FG001|Overall Study|Not treated|0|||
13406934|NCT00561821|26823087|FG002|Overall Study|Not treated|1|||
13406935|NCT00561821|26823088|FG003|Overall Study|Not treated|0|||
13406936|NCT00561821|26823085|FG000|Overall Study|Withdrawal by Subject|0|||
13406937|NCT00561821|26823086|FG001|Overall Study|Withdrawal by Subject|1|||
13406938|NCT00561821|26823087|FG002|Overall Study|Withdrawal by Subject|0|||
13406939|NCT00561821|26823088|FG003|Overall Study|Withdrawal by Subject|2|||
13406940|NCT00561821|26823085|FG000|Overall Study|Reasons not related to trial|2|||
13406941|NCT00561821|26823086|FG001|Overall Study|Reasons not related to trial|1|||
13406942|NCT00561821|26823087|FG002|Overall Study|Reasons not related to trial|0|||
13406943|NCT00561821|26823088|FG003|Overall Study|Reasons not related to trial|0|||
13406944|NCT00561821|26823085|FG000|Overall Study|Other (reason not specified)|1|||
13406945|NCT00561821|26823086|FG001|Overall Study|Other (reason not specified)|1|||
13406946|NCT00561821|26823087|FG002|Overall Study|Other (reason not specified)|0|||
13406947|NCT00561821|26823088|FG003|Overall Study|Other (reason not specified)|0|||
13406948|NCT00561821|26823085|FG000|Overall Study|Adverse Event|2|||
13406949|NCT00561821|26823086|FG001|Overall Study|Adverse Event|3|||
13406950|NCT00561821|26823087|FG002|Overall Study|Adverse Event|1|||
13406951|NCT00561821|26823088|FG003|Overall Study|Adverse Event|1|||
13406952|NCT00561795|26823117|FG000|Overall Study|Adverse Event|3|||
13406953|NCT00561795|26823118|FG001|Overall Study|Adverse Event|3|||
13406954|NCT00561795|26823119|FG002|Overall Study|Adverse Event|0|||
13406955|NCT00561795|26823120|FG003|Overall Study|Adverse Event|0|||
13406956|NCT00561795|26823117|FG000|Overall Study|Study Closed/Terminated|0|||
13406957|NCT00561795|26823118|FG001|Overall Study|Study Closed/Terminated|3|||
13406958|NCT00561795|26823119|FG002|Overall Study|Study Closed/Terminated|0|||
13406959|NCT00561795|26823120|FG003|Overall Study|Study Closed/Terminated|0|||
13406960|NCT00561795|26823117|FG000|Overall Study|Physician Decision|1|||
13406961|NCT00561795|26823118|FG001|Overall Study|Physician Decision|0|||
13406962|NCT00561795|26823119|FG002|Overall Study|Physician Decision|0|||
13406963|NCT00561795|26823120|FG003|Overall Study|Physician Decision|0|||
13406964|NCT00561730|26823136|FG000|Overall Study|Adverse Event|2|||
13406965|NCT00561730|26823136|FG000|Overall Study|Handling of the drug|1|||
13406966|NCT00561730|26823136|FG000|Overall Study|Lost to Follow-up|5|||
13406967|NCT00561730|26823136|FG000|Overall Study|Not specified reasons|1|||
13406968|NCT00561678|26823159|FG000|Overall Study|Withdrawal by Subject|4|||
13406969|NCT00561678|26823160|FG001|Overall Study|Withdrawal by Subject|3|||
13406970|NCT00561678|26823159|FG000|Overall Study|surgery cancelled|1|||
13406971|NCT00561678|26823160|FG001|Overall Study|surgery cancelled|1|||
13406972|NCT00561678|26823159|FG000|Overall Study|surgery rescheduled to different site|2|||
13406973|NCT00561678|26823160|FG001|Overall Study|surgery rescheduled to different site|2|||
13406974|NCT00561678|26823159|FG000|Overall Study|anesthesia provider refusal|1|||
13406975|NCT00561678|26823160|FG001|Overall Study|anesthesia provider refusal|0|||
13406976|NCT00561652|26823185|FG000|Overall Study|Withdrawal by Subject|0|||
13406977|NCT00561652|26823186|FG001|Overall Study|Withdrawal by Subject|1|||
13406978|NCT00561574|26823217|FG000|Overall Study|Adverse Event|21|||
13406979|NCT00561574|26823218|FG001|Overall Study|Adverse Event|24|||
13406980|NCT00561574|26823217|FG000|Overall Study|Lack of Efficacy|11|||
13406981|NCT00561574|26823218|FG001|Overall Study|Lack of Efficacy|21|||
13406982|NCT00561574|26823217|FG000|Overall Study|Withdrawal by Subject|4|||
13406983|NCT00561574|26823218|FG001|Overall Study|Withdrawal by Subject|4|||
13406984|NCT00561574|26823217|FG000|Overall Study|Reason Unrelated to Trial|6|||
13406985|NCT00561574|26823218|FG001|Overall Study|Reason Unrelated to Trial|2|||
13406986|NCT00561574|26823217|FG000|Overall Study|Lost to Follow-up|1|||
13406987|NCT00561574|26823218|FG001|Overall Study|Lost to Follow-up|0|||
13406988|NCT00561574|26823217|FG000|Overall Study|Other|5|||
13406989|NCT00561574|26823218|FG001|Overall Study|Other|7|||
13406990|NCT00561470|26823239|FG000|Overall Study|Adverse Event|74|||
13406991|NCT00561470|26823240|FG001|Overall Study|Adverse Event|163|||
13406992|NCT00561470|26823239|FG000|Overall Study|Disease progression|437|||
13406993|NCT00561470|26823240|FG001|Overall Study|Disease progression|305|||
13406994|NCT00561470|26823239|FG000|Overall Study|poor compliance to protocol|4|||
13406995|NCT00561470|26823240|FG001|Overall Study|poor compliance to protocol|4|||
13406996|NCT00561470|26823239|FG000|Overall Study|Lost to Follow-up|2|||
13406997|NCT00561470|26823240|FG001|Overall Study|Lost to Follow-up|0|||
13406998|NCT00561470|26823239|FG000|Overall Study|Physician Decision|21|||
13406999|NCT00561470|26823240|FG001|Overall Study|Physician Decision|20|||
13407000|NCT00561470|26823239|FG000|Overall Study|Consent Withdrawn|2|||
13407001|NCT00561470|26823240|FG001|Overall Study|Consent Withdrawn|6|||
13407002|NCT00561470|26823239|FG000|Overall Study|Subject request|43|||
13407003|NCT00561470|26823240|FG001|Overall Study|Subject request|77|||
13407004|NCT00561470|26823239|FG000|Overall Study|Metastatic surgery|10|||
13407005|NCT00561470|26823240|FG001|Overall Study|Metastatic surgery|12|||
13407006|NCT00561470|26823239|FG000|Overall Study|Unauthorized procedure|3|||
13407007|NCT00561470|26823240|FG001|Overall Study|Unauthorized procedure|1|||
13407008|NCT00561470|26823239|FG000|Overall Study|Randomized but not treated|5|||
13407009|NCT00561470|26823240|FG001|Overall Study|Randomized but not treated|5|||
13407010|NCT00561470|26823239|FG000|Overall Study|Missed visit window|1|||
13407011|NCT00561470|26823240|FG001|Overall Study|Missed visit window|4|||
13407012|NCT00561470|26823239|FG000|Overall Study|Planning surgery|1|||
13407013|NCT00561470|26823240|FG001|Overall Study|Planning surgery|1|||
13407014|NCT00561470|26823239|FG000|Overall Study|Ongoing Treatment|11|||
13407015|NCT00561470|26823240|FG001|Overall Study|Ongoing Treatment|14|||
13407016|NCT00561392|26823254|FG000|Overall Study|Adverse Event|38|||
13407017|NCT00561392|26823254|FG000|Overall Study|Lack of Efficacy|2|||
13407018|NCT00561392|26823254|FG000|Overall Study|Protocol Violation|1|||
13407019|NCT00561392|26823254|FG000|Overall Study|Withdrawal by Subject|8|||
13407020|NCT00561392|26823254|FG000|Overall Study|Administrative problems|4|||
13407021|NCT00561353|26823438|FG000|Overall Study|Subject reached a virologic endpoint|2|||
13407022|NCT00561353|26823439|FG001|Overall Study|Subject reached a virologic endpoint|1|||
13407023|NCT00561353|26823440|FG002|Overall Study|Subject reached a virologic endpoint|1|||
13407024|NCT00561353|26823441|FG003|Overall Study|Subject reached a virologic endpoint|4|||
13407025|NCT00561353|26823442|FG004|Overall Study|Subject reached a virologic endpoint|1|||
13407026|NCT00561353|26823443|FG005|Overall Study|Subject reached a virologic endpoint|3|||
13407027|NCT00561353|26823444|FG006|Overall Study|Subject reached a virologic endpoint|4|||
13407028|NCT00561353|26823445|FG007|Overall Study|Subject reached a virologic endpoint|4|||
13407029|NCT00561353|26823446|FG008|Overall Study|Subject reached a virologic endpoint|5|||
13407030|NCT00561353|26823447|FG009|Overall Study|Subject reached a virologic endpoint|0|||
13407031|NCT00561353|26823438|FG000|Overall Study|Subject ineligible to continue the trial|0|||
13407032|NCT00561353|26823439|FG001|Overall Study|Subject ineligible to continue the trial|0|||
13407033|NCT00561353|26823440|FG002|Overall Study|Subject ineligible to continue the trial|0|||
13407034|NCT00561353|26823441|FG003|Overall Study|Subject ineligible to continue the trial|0|||
13407035|NCT00561353|26823442|FG004|Overall Study|Subject ineligible to continue the trial|0|||
13407036|NCT00561353|26823443|FG005|Overall Study|Subject ineligible to continue the trial|1|||
13407037|NCT00561353|26823444|FG006|Overall Study|Subject ineligible to continue the trial|1|||
13407038|NCT00561353|26823445|FG007|Overall Study|Subject ineligible to continue the trial|0|||
13407039|NCT00561353|26823446|FG008|Overall Study|Subject ineligible to continue the trial|2|||
13407040|NCT00561353|26823447|FG009|Overall Study|Subject ineligible to continue the trial|1|||
13407041|NCT00561353|26823438|FG000|Overall Study|Other|1|||
13407042|NCT00561353|26823439|FG001|Overall Study|Other|0|||
13407043|NCT00561353|26823440|FG002|Overall Study|Other|1|||
13407044|NCT00561353|26823441|FG003|Overall Study|Other|0|||
13407045|NCT00561353|26823442|FG004|Overall Study|Other|0|||
13407046|NCT00561353|26823443|FG005|Overall Study|Other|2|||
13407047|NCT00561353|26823444|FG006|Overall Study|Other|0|||
13407048|NCT00561353|26823445|FG007|Overall Study|Other|0|||
13407049|NCT00561353|26823446|FG008|Overall Study|Other|0|||
13407050|NCT00561353|26823447|FG009|Overall Study|Other|0|||
13407051|NCT00561353|26823438|FG000|Overall Study|Adverse Event|0|||
13407052|NCT00561353|26823439|FG001|Overall Study|Adverse Event|0|||
13407053|NCT00561353|26823440|FG002|Overall Study|Adverse Event|0|||
13407054|NCT00561353|26823441|FG003|Overall Study|Adverse Event|2|||
13407055|NCT00561353|26823442|FG004|Overall Study|Adverse Event|0|||
13407056|NCT00561353|26823443|FG005|Overall Study|Adverse Event|0|||
13407057|NCT00561353|26823444|FG006|Overall Study|Adverse Event|1|||
13407058|NCT00561353|26823445|FG007|Overall Study|Adverse Event|0|||
13407059|NCT00561353|26823446|FG008|Overall Study|Adverse Event|0|||
13407060|NCT00561353|26823447|FG009|Overall Study|Adverse Event|1|||
13407061|NCT00561353|26823438|FG000|Overall Study|Lost to Follow-up|2|||
13407062|NCT00561353|26823439|FG001|Overall Study|Lost to Follow-up|0|||
13407063|NCT00561353|26823440|FG002|Overall Study|Lost to Follow-up|1|||
13407064|NCT00561353|26823441|FG003|Overall Study|Lost to Follow-up|0|||
13407065|NCT00561353|26823442|FG004|Overall Study|Lost to Follow-up|0|||
13407066|NCT00561353|26823443|FG005|Overall Study|Lost to Follow-up|0|||
13407067|NCT00561353|26823444|FG006|Overall Study|Lost to Follow-up|0|||
13407068|NCT00561353|26823445|FG007|Overall Study|Lost to Follow-up|0|||
13407069|NCT00561353|26823446|FG008|Overall Study|Lost to Follow-up|0|||
13407070|NCT00561353|26823447|FG009|Overall Study|Lost to Follow-up|0|||
13407071|NCT00561353|26823438|FG000|Overall Study|Withdrawal by Subject|0|||
13407072|NCT00561353|26823439|FG001|Overall Study|Withdrawal by Subject|2|||
13407073|NCT00561353|26823440|FG002|Overall Study|Withdrawal by Subject|0|||
13407074|NCT00561353|26823441|FG003|Overall Study|Withdrawal by Subject|0|||
13407075|NCT00561353|26823442|FG004|Overall Study|Withdrawal by Subject|0|||
13407076|NCT00561353|26823443|FG005|Overall Study|Withdrawal by Subject|0|||
13407077|NCT00561353|26823444|FG006|Overall Study|Withdrawal by Subject|0|||
13407078|NCT00561353|26823445|FG007|Overall Study|Withdrawal by Subject|0|||
13407079|NCT00561353|26823446|FG008|Overall Study|Withdrawal by Subject|0|||
13407080|NCT00561353|26823447|FG009|Overall Study|Withdrawal by Subject|0|||
13407081|NCT00561080|26823528|FG000|Vaccination Period (up to Month 4)|Adverse Event|0|||
13407082|NCT00561080|26823529|FG001|Vaccination Period (up to Month 4)|Adverse Event|4|||
13407083|NCT00561080|26823530|FG002|Vaccination Period (up to Month 4)|Adverse Event|6|||
13407084|NCT00561080|26823528|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0|||
13407085|NCT00561080|26823529|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2|||
13407086|NCT00561080|26823530|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3|||
13407087|NCT00561080|26823528|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0|||
13407088|NCT00561080|26823529|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1|||
13407089|NCT00561080|26823530|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3|||
13407090|NCT00561080|26823528|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3|||
13407091|NCT00561080|26823529|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16|||
13407092|NCT00561080|26823530|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13|||
13407093|NCT00561080|26823528|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
13407094|NCT00561080|26823529|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1|||
13407095|NCT00561080|26823530|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
13407096|NCT00561080|26823528|FG000|Vaccination Period (up to Month 4)|Other|0|||
13407097|NCT00561080|26823529|FG001|Vaccination Period (up to Month 4)|Other|2|||
13407098|NCT00561080|26823530|FG002|Vaccination Period (up to Month 4)|Other|1|||
13407099|NCT00561080|26823528|FG000|12-month Post Last Dose Follow-up|Adverse Event|3|||
13407100|NCT00561080|26823529|FG001|12-month Post Last Dose Follow-up|Adverse Event|3|||
13407101|NCT00561080|26823530|FG002|12-month Post Last Dose Follow-up|Adverse Event|1|||
13407102|NCT00561080|26823528|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0|||
13407103|NCT00561080|26823529|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0|||
13407104|NCT00561080|26823530|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4|||
13407105|NCT00561080|26823528|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2|||
13407106|NCT00561080|26823529|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6|||
13407107|NCT00561080|26823530|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5|||
13407108|NCT00561080|26823528|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2|||
13407109|NCT00561080|26823529|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
13407110|NCT00561080|26823530|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
13407111|NCT00561015|26823623|FG000|Overall Study|Adverse Event|0|||
13407112|NCT00561015|26823624|FG001|Overall Study|Adverse Event|0|||
13407113|NCT00561015|26823625|FG002|Overall Study|Adverse Event|0|||
13407114|NCT00561015|26823626|FG003|Overall Study|Adverse Event|0|||
13407115|NCT00561015|26823627|FG004|Overall Study|Adverse Event|1|||
13407116|NCT00561015|26823628|FG005|Overall Study|Adverse Event|0|||
13407117|NCT00561015|26823623|FG000|Overall Study|Lost to Follow-up|2|||
13407118|NCT00561015|26823624|FG001|Overall Study|Lost to Follow-up|0|||
13407119|NCT00561015|26823625|FG002|Overall Study|Lost to Follow-up|0|||
13407120|NCT00561015|26823626|FG003|Overall Study|Lost to Follow-up|1|||
13407121|NCT00561015|26823627|FG004|Overall Study|Lost to Follow-up|0|||
13407122|NCT00561015|26823628|FG005|Overall Study|Lost to Follow-up|3|||
13407123|NCT00561015|26823623|FG000|Overall Study|Participant non-compliance|2|||
13407124|NCT00561015|26823624|FG001|Overall Study|Participant non-compliance|0|||
13407125|NCT00561015|26823625|FG002|Overall Study|Participant non-compliance|0|||
13407126|NCT00561015|26823626|FG003|Overall Study|Participant non-compliance|0|||
13407127|NCT00561015|26823627|FG004|Overall Study|Participant non-compliance|0|||
13407128|NCT00561015|26823628|FG005|Overall Study|Participant non-compliance|0|||
13407129|NCT00560950|26823671|FG000|Overall Study|Lost to Follow-up|1|||
13407130|NCT00560950|26823672|FG001|Overall Study|Lost to Follow-up|0|||
13407131|NCT00560937|26823695|FG000|Overall Study|Withdrawal by Subject|0|||
13407132|NCT00560937|26823696|FG001|Overall Study|Withdrawal by Subject|1|||
13407133|NCT00560937|26823695|FG000|Overall Study|Physician Decision|1|||
13407134|NCT00560937|26823696|FG001|Overall Study|Physician Decision|1|||
13407135|NCT00560885|26823705|FG000|Overall Study|Death|7|||
13407136|NCT00560885|26823705|FG000|Overall Study|Withdrawal by Subject|1|||
13407137|NCT00560833|26823753|FG000|Overall Study|Adverse Event|16|||
13407138|NCT00560833|26823754|FG001|Overall Study|Adverse Event|10|||
13407139|NCT00560833|26823755|FG002|Overall Study|Adverse Event|25|||
13407140|NCT00560833|26823756|FG003|Overall Study|Adverse Event|23|||
13407141|NCT00560833|26823757|FG004|Overall Study|Adverse Event|35|||
13407142|NCT00560833|26823753|FG000|Overall Study|Lost to Follow-up|0|||
13407143|NCT00560833|26823754|FG001|Overall Study|Lost to Follow-up|0|||
13407144|NCT00560833|26823755|FG002|Overall Study|Lost to Follow-up|1|||
13407145|NCT00560833|26823756|FG003|Overall Study|Lost to Follow-up|0|||
13407146|NCT00560833|26823757|FG004|Overall Study|Lost to Follow-up|0|||
13407147|NCT00560833|26823753|FG000|Overall Study|Lack of Efficacy|22|||
13407148|NCT00560833|26823754|FG001|Overall Study|Lack of Efficacy|9|||
13407149|NCT00560833|26823755|FG002|Overall Study|Lack of Efficacy|6|||
13407150|NCT00560833|26823756|FG003|Overall Study|Lack of Efficacy|4|||
13407151|NCT00560833|26823757|FG004|Overall Study|Lack of Efficacy|4|||
13407152|NCT00560833|26823753|FG000|Overall Study|Participant uncooperative|5|||
13407153|NCT00560833|26823754|FG001|Overall Study|Participant uncooperative|5|||
13407154|NCT00560833|26823755|FG002|Overall Study|Participant uncooperative|4|||
13407155|NCT00560833|26823756|FG003|Overall Study|Participant uncooperative|4|||
13407156|NCT00560833|26823757|FG004|Overall Study|Participant uncooperative|2|||
13407157|NCT00560833|26823753|FG000|Overall Study|Other|1|||
13407158|NCT00560833|26823754|FG001|Overall Study|Other|1|||
13407159|NCT00560833|26823755|FG002|Overall Study|Other|3|||
13407160|NCT00560833|26823756|FG003|Overall Study|Other|0|||
13407161|NCT00560833|26823757|FG004|Overall Study|Other|0|||
13407162|NCT00560833|26823753|FG000|Overall Study|Never received drug|0|||
13407163|NCT00560833|26823754|FG001|Overall Study|Never received drug|1|||
13407164|NCT00560833|26823755|FG002|Overall Study|Never received drug|0|||
13407165|NCT00560833|26823756|FG003|Overall Study|Never received drug|0|||
13407166|NCT00560833|26823757|FG004|Overall Study|Never received drug|1|||
13407167|NCT00560794|26823776|FG000|Overall Study|Adverse Event|2|||
13407168|NCT00560794|26823776|FG000|Overall Study|Patient was not Compliant|1|||
13407169|NCT00560794|26823776|FG000|Overall Study|Minimal Residual Disease Relapse|1|||
13407170|NCT00560794|26823776|FG000|Overall Study|Hematological Relapse|1|||
13407171|NCT00560794|26823776|FG000|Overall Study|Received Bone Marrow Transplant|6|||
13407172|NCT00560755|26823797|FG000|Overall Study|Protocol Violation|15|||
13407173|NCT00560755|26823797|FG000|Overall Study|Withdrawal by Subject|26|||
13407174|NCT00560755|26823797|FG000|Overall Study|Lost to Follow-up|9|||
13407175|NCT00560755|26823797|FG000|Overall Study|Adverse Event|8|||
13407176|NCT00560755|26823797|FG000|Overall Study|Physician Decision|2|||
13407177|NCT00560703|26823812|FG000|Overall Study|Adverse Event|0|||
13407178|NCT00560703|26823813|FG001|Overall Study|Adverse Event|2|||
13407179|NCT00560703|26823812|FG000|Overall Study|Protocol Violation|0|||
13407180|NCT00560703|26823813|FG001|Overall Study|Protocol Violation|2|||
13407181|NCT00560703|26823812|FG000|Overall Study|Withdrawal by Subject|0|||
13407182|NCT00560703|26823813|FG001|Overall Study|Withdrawal by Subject|1|||
13407183|NCT00560703|26823812|FG000|Overall Study|non-compliance|0|||
13407184|NCT00560703|26823813|FG001|Overall Study|non-compliance|1|||
13407185|NCT00560573|26823872|FG000|Overall Study|Death|4|||
13407186|NCT00560573|26823873|FG001|Overall Study|Death|1|||
13407187|NCT00560573|26823874|FG002|Overall Study|Death|4|||
13407188|NCT00560573|26823875|FG003|Overall Study|Death|5|||
13407189|NCT00560573|26823876|FG004|Overall Study|Death|1|||
13407190|NCT00560573|26823877|FG005|Overall Study|Death|10|||
13407191|NCT00560573|26823872|FG000|Overall Study|Lost to Follow-up|0|||
13407192|NCT00560573|26823873|FG001|Overall Study|Lost to Follow-up|0|||
13407193|NCT00560573|26823874|FG002|Overall Study|Lost to Follow-up|0|||
13407194|NCT00560573|26823875|FG003|Overall Study|Lost to Follow-up|1|||
13407195|NCT00560573|26823876|FG004|Overall Study|Lost to Follow-up|1|||
13407196|NCT00560573|26823877|FG005|Overall Study|Lost to Follow-up|0|||
13407197|NCT00560573|26823872|FG000|Overall Study|Withdrawal by Subject|0|||
13407198|NCT00560573|26823873|FG001|Overall Study|Withdrawal by Subject|0|||
13407199|NCT00560573|26823874|FG002|Overall Study|Withdrawal by Subject|0|||
13407200|NCT00560573|26823875|FG003|Overall Study|Withdrawal by Subject|1|||
13407201|NCT00560573|26823876|FG004|Overall Study|Withdrawal by Subject|1|||
13407202|NCT00560573|26823877|FG005|Overall Study|Withdrawal by Subject|0|||
13407203|NCT00560573|26823872|FG000|Overall Study|Other|2|||
13407204|NCT00560573|26823873|FG001|Overall Study|Other|2|||
13407205|NCT00560573|26823874|FG002|Overall Study|Other|2|||
13407206|NCT00560573|26823875|FG003|Overall Study|Other|3|||
13407207|NCT00560573|26823876|FG004|Overall Study|Other|3|||
13407208|NCT00560573|26823877|FG005|Overall Study|Other|3|||
13407209|NCT00560573|26823872|FG000|Overall Study|Enrolled, not treated|0|||
13407210|NCT00560573|26823873|FG001|Overall Study|Enrolled, not treated|0|||
13407211|NCT00560573|26823874|FG002|Overall Study|Enrolled, not treated|0|||
13407212|NCT00560573|26823875|FG003|Overall Study|Enrolled, not treated|0|||
13407213|NCT00560573|26823876|FG004|Overall Study|Enrolled, not treated|1|||
13407214|NCT00560573|26823877|FG005|Overall Study|Enrolled, not treated|0|||
13407215|NCT00560508|26823941|FG000|12 Week Double-blind Period|Adverse Event|3|||
13407216|NCT00560508|26823942|FG001|12 Week Double-blind Period|Adverse Event|2|||
13407217|NCT00560508|26823941|FG000|12 Week Double-blind Period|Protocol Violation|1|||
13407218|NCT00560508|26823942|FG001|12 Week Double-blind Period|Protocol Violation|0|||
13407219|NCT00560508|26823941|FG000|12 Week Double-blind Period|Withdrawal by Subject|1|||
13407220|NCT00560508|26823942|FG001|12 Week Double-blind Period|Withdrawal by Subject|1|||
13407221|NCT00560508|26823941|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
13407222|NCT00560508|26823942|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
13407223|NCT00560508|26823941|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
13407224|NCT00560508|26823942|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
13407225|NCT00560508|26823941|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0|||
13407226|NCT00560508|26823942|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3|||
13407227|NCT00560508|26823941|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
13407228|NCT00560508|26823942|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
13407229|NCT00560417|26823975|FG000|Overall Study|Adverse Event|3|||
13407230|NCT00560417|26823976|FG001|Overall Study|Adverse Event|2|||
13407231|NCT00560417|26823975|FG000|Overall Study|Entry Criteria Not Met|1|||
13407232|NCT00560417|26823976|FG001|Overall Study|Entry Criteria Not Met|0|||
13407233|NCT00560417|26823975|FG000|Overall Study|Lost to Follow-up|0|||
13407234|NCT00560417|26823976|FG001|Overall Study|Lost to Follow-up|1|||
13407235|NCT00560417|26823975|FG000|Overall Study|Physician Decision|2|||
13407236|NCT00560417|26823976|FG001|Overall Study|Physician Decision|6|||
13407237|NCT00560417|26823975|FG000|Overall Study|Protocol Violation|6|||
13407238|NCT00560417|26823976|FG001|Overall Study|Protocol Violation|5|||
13407239|NCT00560417|26823975|FG000|Overall Study|Sponsor Decision|2|||
13407240|NCT00560417|26823976|FG001|Overall Study|Sponsor Decision|0|||
13407241|NCT00560417|26823975|FG000|Overall Study|Withdrawal by Subject|3|||
13407242|NCT00560417|26823976|FG001|Overall Study|Withdrawal by Subject|3|||
13407243|NCT00560404|26824025|FG000|Overall Study|Adverse Event|2|||
13407244|NCT00560404|26824026|FG001|Overall Study|Adverse Event|3|||
13407245|NCT00560404|26824025|FG000|Overall Study|Death|3|||
13407246|NCT00560404|26824026|FG001|Overall Study|Death|3|||
13407247|NCT00560404|26824025|FG000|Overall Study|Protocol Violation|12|||
13407248|NCT00560404|26824026|FG001|Overall Study|Protocol Violation|7|||
13407249|NCT00560404|26824025|FG000|Overall Study|Administrative Reasons|1|||
13407250|NCT00560404|26824026|FG001|Overall Study|Administrative Reasons|1|||
13407251|NCT00560404|26824025|FG000|Overall Study|Withdrew Consent|4|||
13407252|NCT00560404|26824026|FG001|Overall Study|Withdrew Consent|0|||
13407253|NCT00560404|26824025|FG000|Overall Study|Failure to return|1|||
13407254|NCT00560404|26824026|FG001|Overall Study|Failure to return|2|||
13407255|NCT00560404|26824025|FG000|Overall Study|Other withdrawal reason|13|||
13407256|NCT00560404|26824026|FG001|Overall Study|Other withdrawal reason|5|||
13407257|NCT00560391|26824095|FG000|Overall Study|Still on treatment|0|||
13407258|NCT00560391|26824096|FG001|Overall Study|Still on treatment|0|||
13407259|NCT00560391|26824097|FG002|Overall Study|Still on treatment|0|||
13407260|NCT00560391|26824098|FG003|Overall Study|Still on treatment|1|||
13407261|NCT00560391|26824099|FG004|Overall Study|Still on treatment|2|||
13407262|NCT00560352|26824126|FG000|Overall Study|Adverse event unrelated to study drug|2|||
13407263|NCT00560352|26824127|FG001|Overall Study|Adverse event unrelated to study drug|1|||
13407264|NCT00560352|26824128|FG002|Overall Study|Adverse event unrelated to study drug|1|||
13407265|NCT00560352|26824126|FG000|Overall Study|Study drug toxicity|3|||
13407266|NCT00560352|26824127|FG001|Overall Study|Study drug toxicity|0|||
13407267|NCT00560352|26824128|FG002|Overall Study|Study drug toxicity|1|||
13407268|NCT00560352|26824126|FG000|Overall Study|Disease progression|0|||
13407269|NCT00560352|26824127|FG001|Overall Study|Disease progression|1|||
13407270|NCT00560352|26824128|FG002|Overall Study|Disease progression|1|||
13407271|NCT00560352|26824126|FG000|Overall Study|Withdrawal by Subject|1|||
13407272|NCT00560352|26824127|FG001|Overall Study|Withdrawal by Subject|1|||
13407273|NCT00560352|26824128|FG002|Overall Study|Withdrawal by Subject|1|||
13407274|NCT00560352|26824126|FG000|Overall Study|Maximum clinical benefit|1|||
13407275|NCT00560352|26824127|FG001|Overall Study|Maximum clinical benefit|0|||
13407276|NCT00560352|26824128|FG002|Overall Study|Maximum clinical benefit|0|||
13407277|NCT00560313|26824154|FG000|Overall Study|Adverse Events or Death|2|||
13407278|NCT00560313|26824154|FG000|Overall Study|Withdrawal by Subject|2|||
13407279|NCT00560313|26824154|FG000|Overall Study|Lost to Follow-up|1|||
13407280|NCT00560313|26824154|FG000|Overall Study|Protocol Violation|1|||
13407281|NCT00560235|26824193|FG000|Phase 1|Discontinued|8|||
13407282|NCT00560235|26824194|FG001|Phase 1|Discontinued|0|||
13407283|NCT00560235|26824195|FG002|Phase 1|Discontinued|0|||
13407284|NCT00560235|26824193|FG000|Phase 1B|Discontinued|0|||
13407285|NCT00560235|26824194|FG001|Phase 1B|Discontinued|19|||
13407286|NCT00560235|26824195|FG002|Phase 1B|Discontinued|0|||
13407287|NCT00560235|26824193|FG000|Phase 2|Discontinued|0|||
13407288|NCT00560235|26824194|FG001|Phase 2|Discontinued|0|||
13407289|NCT00560235|26824195|FG002|Phase 2|Discontinued|96|||
13407290|NCT00560235|26824193|FG000|Phase 2|Ongoing at Date of Cut-Off|0|||
13407291|NCT00560235|26824194|FG001|Phase 2|Ongoing at Date of Cut-Off|0|||
13407292|NCT00560235|26824195|FG002|Phase 2|Ongoing at Date of Cut-Off|1|||
13407293|NCT00560105|26824214|FG000|Overall Study|musculoskeletal chest discomfort with us|1|||
13407294|NCT00560105|26824215|FG001|Overall Study|musculoskeletal chest discomfort with us|2|||
13407295|NCT00560066|26824252|FG000|Overall Study|Death|2|||
13407296|NCT00560066|26824253|FG001|Overall Study|Death|1|||
13407297|NCT00560066|26824252|FG000|Overall Study|Withdrawal by Subject|0|||
13407298|NCT00560066|26824253|FG001|Overall Study|Withdrawal by Subject|3|||
13407299|NCT00560066|26824252|FG000|Overall Study|Lost to Follow-up|4|||
13407300|NCT00560066|26824253|FG001|Overall Study|Lost to Follow-up|10|||
13407301|NCT00560066|26824252|FG000|Overall Study|Protocol Violation|0|||
13407302|NCT00560066|26824253|FG001|Overall Study|Protocol Violation|1|||
13407303|NCT00560066|26824252|FG000|Overall Study|Administrative reason|0|||
13407304|NCT00560066|26824253|FG001|Overall Study|Administrative reason|5|||
13407305|NCT00560066|26824252|FG000|Overall Study|Missing primary reason|0|||
13407306|NCT00560066|26824253|FG001|Overall Study|Missing primary reason|2|||
13407307|NCT00558701|26824266|FG000|Overall Study|Protocol Deviations|1|||
13407308|NCT00558701|26824267|FG001|Overall Study|Protocol Deviations|4|||
13407309|NCT00558363|26824324|FG000|Overall Study|Physician Decision|18|||
13407310|NCT00558363|26824325|FG001|Overall Study|Physician Decision|4|||
13407311|NCT00558363|26824324|FG000|Overall Study|Withdrawal by Subject|11|||
13407312|NCT00558363|26824325|FG001|Overall Study|Withdrawal by Subject|4|||
13407313|NCT00558363|26824324|FG000|Overall Study|Adverse Event|5|||
13407314|NCT00558363|26824325|FG001|Overall Study|Adverse Event|5|||
13407315|NCT00558363|26824324|FG000|Overall Study|Lack of Efficacy|2|||
13407316|NCT00558363|26824325|FG001|Overall Study|Lack of Efficacy|2|||
13407317|NCT00558363|26824324|FG000|Overall Study|Protocol Violation|2|||
13407318|NCT00558363|26824325|FG001|Overall Study|Protocol Violation|1|||
13407319|NCT00558363|26824324|FG000|Overall Study|Lost to Follow-up|0|||
13407320|NCT00558363|26824325|FG001|Overall Study|Lost to Follow-up|1|||
13407321|NCT00558363|26824324|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32|||
13407322|NCT00558363|26824325|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16|||
13407323|NCT00558363|26824324|FG000|Overall Study|Randomized in Error|1|||
13407324|NCT00558363|26824325|FG001|Overall Study|Randomized in Error|2|||
13407325|NCT00558363|26824324|FG000|Overall Study|Hospitalized; Unable to Continue|0|||
13407326|NCT00558363|26824325|FG001|Overall Study|Hospitalized; Unable to Continue|1|||
13407327|NCT00557856|26824531|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
13407328|NCT00557856|26824532|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
13407329|NCT00557856|26824533|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
13407330|NCT00557856|26824534|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1|||
13407331|NCT00557856|26824535|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
13407332|NCT00557856|26824536|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2|||
13407333|NCT00557856|26824537|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
13407334|NCT00557856|26824538|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
13407335|NCT00557856|26824539|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0|||
13407336|NCT00557856|26824531|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
13407337|NCT00557856|26824532|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
13407338|NCT00557856|26824533|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
13407339|NCT00557856|26824534|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
13407340|NCT00557856|26824535|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
13407341|NCT00557856|26824536|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
13407342|NCT00557856|26824537|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
13407343|NCT00557856|26824538|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
13407344|NCT00557856|26824539|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
13407345|NCT00557856|26824531|FG000|Part 1: Dose Escalation Phase|Adverse Event|1|||
13407346|NCT00557856|26824532|FG001|Part 1: Dose Escalation Phase|Adverse Event|0|||
13407347|NCT00557856|26824533|FG002|Part 1: Dose Escalation Phase|Adverse Event|1|||
13407348|NCT00557856|26824534|FG003|Part 1: Dose Escalation Phase|Adverse Event|1|||
13407349|NCT00557856|26824535|FG004|Part 1: Dose Escalation Phase|Adverse Event|1|||
13407350|NCT00557856|26824536|FG005|Part 1: Dose Escalation Phase|Adverse Event|3|||
13407351|NCT00557856|26824537|FG006|Part 1: Dose Escalation Phase|Adverse Event|1|||
13407352|NCT00557856|26824538|FG007|Part 1: Dose Escalation Phase|Adverse Event|2|||
13407353|NCT00557856|26824539|FG008|Part 1: Dose Escalation Phase|Adverse Event|0|||
13407354|NCT00557856|26824531|FG000|Part 1: Dose Escalation Phase|Other|0|||
13407355|NCT00557856|26824532|FG001|Part 1: Dose Escalation Phase|Other|0|||
13407356|NCT00557856|26824533|FG002|Part 1: Dose Escalation Phase|Other|1|||
13407357|NCT00557856|26824534|FG003|Part 1: Dose Escalation Phase|Other|1|||
13407358|NCT00557856|26824535|FG004|Part 1: Dose Escalation Phase|Other|0|||
13407359|NCT00557856|26824536|FG005|Part 1: Dose Escalation Phase|Other|0|||
13407360|NCT00557856|26824537|FG006|Part 1: Dose Escalation Phase|Other|0|||
13407361|NCT00557856|26824538|FG007|Part 1: Dose Escalation Phase|Other|1|||
13407362|NCT00557856|26824539|FG008|Part 1: Dose Escalation Phase|Other|0|||
13407363|NCT00557856|26824531|FG000|Part 1: Dose Escalation Phase|Death|0|||
13407364|NCT00557856|26824532|FG001|Part 1: Dose Escalation Phase|Death|0|||
13407365|NCT00557856|26824533|FG002|Part 1: Dose Escalation Phase|Death|0|||
13407366|NCT00557856|26824534|FG003|Part 1: Dose Escalation Phase|Death|0|||
13407367|NCT00557856|26824535|FG004|Part 1: Dose Escalation Phase|Death|0|||
13407368|NCT00557856|26824536|FG005|Part 1: Dose Escalation Phase|Death|1|||
13407369|NCT00557856|26824537|FG006|Part 1: Dose Escalation Phase|Death|0|||
13407370|NCT00557856|26824538|FG007|Part 1: Dose Escalation Phase|Death|0|||
13407371|NCT00557856|26824539|FG008|Part 1: Dose Escalation Phase|Death|0|||
13407372|NCT00557856|26824531|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
13407373|NCT00557856|26824532|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
13407374|NCT00557856|26824533|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
13407375|NCT00557856|26824534|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
13407376|NCT00557856|26824535|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
13407377|NCT00557856|26824536|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2|||
13407378|NCT00557856|26824537|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1|||
13407379|NCT00557856|26824538|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
13407380|NCT00557856|26824539|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
13407381|NCT00557856|26824531|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2|||
13407382|NCT00557856|26824532|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0|||
13407383|NCT00557856|26824533|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0|||
13407384|NCT00557856|26824534|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0|||
13407385|NCT00557856|26824535|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0|||
13407386|NCT00557856|26824536|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0|||
13407387|NCT00557856|26824537|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0|||
13407388|NCT00557856|26824538|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0|||
13407389|NCT00557856|26824539|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0|||
13407390|NCT00557856|26824531|FG000|Part 2: Exploratory Phase|objective progression or relapse|0|||
13407391|NCT00557856|26824532|FG001|Part 2: Exploratory Phase|objective progression or relapse|0|||
13407392|NCT00557856|26824533|FG002|Part 2: Exploratory Phase|objective progression or relapse|0|||
13407393|NCT00557856|26824534|FG003|Part 2: Exploratory Phase|objective progression or relapse|0|||
13407394|NCT00557856|26824535|FG004|Part 2: Exploratory Phase|objective progression or relapse|0|||
13407395|NCT00557856|26824536|FG005|Part 2: Exploratory Phase|objective progression or relapse|0|||
13407396|NCT00557856|26824537|FG006|Part 2: Exploratory Phase|objective progression or relapse|0|||
13407397|NCT00557856|26824538|FG007|Part 2: Exploratory Phase|objective progression or relapse|0|||
13407398|NCT00557856|26824539|FG008|Part 2: Exploratory Phase|objective progression or relapse|15|||
13407399|NCT00557856|26824531|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
13407400|NCT00557856|26824532|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
13407401|NCT00557856|26824533|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
13407402|NCT00557856|26824534|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
13407403|NCT00557856|26824535|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
13407404|NCT00557856|26824536|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
13407405|NCT00557856|26824537|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
13407406|NCT00557856|26824538|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
13407407|NCT00557856|26824539|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1|||
13407408|NCT00557856|26824531|FG000|Part 2: Exploratory Phase|Adverse Event|0|||
13407409|NCT00557856|26824532|FG001|Part 2: Exploratory Phase|Adverse Event|0|||
13407410|NCT00557856|26824533|FG002|Part 2: Exploratory Phase|Adverse Event|0|||
13407411|NCT00557856|26824534|FG003|Part 2: Exploratory Phase|Adverse Event|0|||
13407412|NCT00557856|26824535|FG004|Part 2: Exploratory Phase|Adverse Event|0|||
13407413|NCT00557856|26824536|FG005|Part 2: Exploratory Phase|Adverse Event|0|||
13407414|NCT00557856|26824537|FG006|Part 2: Exploratory Phase|Adverse Event|0|||
13407415|NCT00557856|26824538|FG007|Part 2: Exploratory Phase|Adverse Event|0|||
13407416|NCT00557856|26824539|FG008|Part 2: Exploratory Phase|Adverse Event|4|||
13407417|NCT00557856|26824531|FG000|Part 2: Exploratory Phase|Other|0|||
13407418|NCT00557856|26824532|FG001|Part 2: Exploratory Phase|Other|0|||
13407419|NCT00557856|26824533|FG002|Part 2: Exploratory Phase|Other|0|||
13407420|NCT00557856|26824534|FG003|Part 2: Exploratory Phase|Other|0|||
13407421|NCT00557856|26824535|FG004|Part 2: Exploratory Phase|Other|0|||
13407422|NCT00557856|26824536|FG005|Part 2: Exploratory Phase|Other|0|||
13407423|NCT00557856|26824537|FG006|Part 2: Exploratory Phase|Other|0|||
13407424|NCT00557856|26824538|FG007|Part 2: Exploratory Phase|Other|0|||
13407425|NCT00557856|26824539|FG008|Part 2: Exploratory Phase|Other|1|||
13407426|NCT00557856|26824531|FG000|Part 2: Exploratory Phase|Death|0|||
13407427|NCT00557856|26824532|FG001|Part 2: Exploratory Phase|Death|0|||
13407428|NCT00557856|26824533|FG002|Part 2: Exploratory Phase|Death|0|||
13407429|NCT00557856|26824534|FG003|Part 2: Exploratory Phase|Death|0|||
13407430|NCT00557856|26824535|FG004|Part 2: Exploratory Phase|Death|0|||
13407431|NCT00557856|26824536|FG005|Part 2: Exploratory Phase|Death|0|||
13407432|NCT00557856|26824537|FG006|Part 2: Exploratory Phase|Death|0|||
13407433|NCT00557856|26824538|FG007|Part 2: Exploratory Phase|Death|0|||
13407434|NCT00557856|26824539|FG008|Part 2: Exploratory Phase|Death|2|||
13407435|NCT00557856|26824531|FG000|Part 2: Exploratory Phase|global deterioration of health status|0|||
13407436|NCT00557856|26824532|FG001|Part 2: Exploratory Phase|global deterioration of health status|0|||
13407437|NCT00557856|26824533|FG002|Part 2: Exploratory Phase|global deterioration of health status|0|||
13407438|NCT00557856|26824534|FG003|Part 2: Exploratory Phase|global deterioration of health status|0|||
13407439|NCT00557856|26824535|FG004|Part 2: Exploratory Phase|global deterioration of health status|0|||
13407440|NCT00557856|26824536|FG005|Part 2: Exploratory Phase|global deterioration of health status|0|||
13407441|NCT00557856|26824537|FG006|Part 2: Exploratory Phase|global deterioration of health status|0|||
13407442|NCT00557856|26824538|FG007|Part 2: Exploratory Phase|global deterioration of health status|0|||
13407443|NCT00557856|26824539|FG008|Part 2: Exploratory Phase|global deterioration of health status|1|||
13407444|NCT00557505|26824731|FG000|Overall Study|Death|0|||
13407445|NCT00557505|26824732|FG001|Overall Study|Death|0|||
13407446|NCT00557505|26824733|FG002|Overall Study|Death|0|||
13407447|NCT00557505|26824734|FG003|Overall Study|Death|0|||
13407448|NCT00557505|26824735|FG004|Overall Study|Death|0|||
13407449|NCT00557505|26824736|FG005|Overall Study|Death|0|||
13407450|NCT00557505|26824737|FG006|Overall Study|Death|0|||
13407451|NCT00557505|26824738|FG007|Overall Study|Death|0|||
13407452|NCT00557505|26824739|FG008|Overall Study|Death|1|||
13407453|NCT00557505|26824731|FG000|Overall Study|Adverse Event|0|||
13407454|NCT00557505|26824732|FG001|Overall Study|Adverse Event|0|||
13407455|NCT00557505|26824733|FG002|Overall Study|Adverse Event|1|||
13407456|NCT00557505|26824734|FG003|Overall Study|Adverse Event|0|||
13407457|NCT00557505|26824735|FG004|Overall Study|Adverse Event|0|||
13407458|NCT00557505|26824736|FG005|Overall Study|Adverse Event|0|||
13407459|NCT00557505|26824737|FG006|Overall Study|Adverse Event|1|||
13407460|NCT00557505|26824738|FG007|Overall Study|Adverse Event|0|||
13407461|NCT00557505|26824739|FG008|Overall Study|Adverse Event|0|||
13407462|NCT00557505|26824731|FG000|Overall Study|Global deterioration of health|1|||
13407463|NCT00557505|26824732|FG001|Overall Study|Global deterioration of health|0|||
13407464|NCT00557505|26824733|FG002|Overall Study|Global deterioration of health|0|||
13407465|NCT00557505|26824734|FG003|Overall Study|Global deterioration of health|0|||
13407466|NCT00557505|26824735|FG004|Overall Study|Global deterioration of health|0|||
13407467|NCT00557505|26824736|FG005|Overall Study|Global deterioration of health|0|||
13407468|NCT00557505|26824737|FG006|Overall Study|Global deterioration of health|0|||
13407469|NCT00557505|26824738|FG007|Overall Study|Global deterioration of health|0|||
13407470|NCT00557505|26824739|FG008|Overall Study|Global deterioration of health|0|||
13407471|NCT00557505|26824731|FG000|Overall Study|Objective progression or relapse|2|||
13407472|NCT00557505|26824732|FG001|Overall Study|Objective progression or relapse|3|||
13407473|NCT00557505|26824733|FG002|Overall Study|Objective progression or relapse|3|||
13407474|NCT00557505|26824734|FG003|Overall Study|Objective progression or relapse|2|||
13407475|NCT00557505|26824735|FG004|Overall Study|Objective progression or relapse|2|||
13407476|NCT00557505|26824736|FG005|Overall Study|Objective progression or relapse|3|||
13407477|NCT00557505|26824737|FG006|Overall Study|Objective progression or relapse|2|||
13407478|NCT00557505|26824738|FG007|Overall Study|Objective progression or relapse|5|||
13407479|NCT00557505|26824739|FG008|Overall Study|Objective progression or relapse|15|||
13407480|NCT00557505|26824731|FG000|Overall Study|Withdrawal by Subject|0|||
13407481|NCT00557505|26824732|FG001|Overall Study|Withdrawal by Subject|0|||
13407482|NCT00557505|26824733|FG002|Overall Study|Withdrawal by Subject|0|||
13407483|NCT00557505|26824734|FG003|Overall Study|Withdrawal by Subject|1|||
13407484|NCT00557505|26824735|FG004|Overall Study|Withdrawal by Subject|0|||
13407485|NCT00557505|26824736|FG005|Overall Study|Withdrawal by Subject|0|||
13407486|NCT00557505|26824737|FG006|Overall Study|Withdrawal by Subject|0|||
13407487|NCT00557505|26824738|FG007|Overall Study|Withdrawal by Subject|0|||
13407488|NCT00557505|26824739|FG008|Overall Study|Withdrawal by Subject|1|||
13407489|NCT00557076|26824754|FG000|Overall Study|Unblinding|0|||
13407490|NCT00557076|26824755|FG001|Overall Study|Unblinding|1|||
13407491|NCT00556998|26824777|FG000|Voriconazole Intravenous (IV)|Adverse Event|1|||
13407492|NCT00556998|26824777|FG000|Voriconazole Intravenous (IV)|Other|4|||
13407493|NCT00556998|26824777|FG000|Voriconazole Oral|Adverse Event|1|||
13407494|NCT00556998|26824777|FG000|Voriconazole Oral|Intolerant of oral treatment|1|||
13407495|NCT00556933|26824844|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2|||
13407496|NCT00556933|26824845|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
13407497|NCT00556933|26824846|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
13407498|NCT00556933|26824847|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0|||
13407499|NCT00556933|26824844|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
13407500|NCT00556933|26824845|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
13407501|NCT00556933|26824846|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1|||
13407502|NCT00556933|26824847|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
13407503|NCT00556933|26824844|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0|||
13407504|NCT00556933|26824845|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
13407505|NCT00556933|26824846|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
13407506|NCT00556933|26824847|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
13407507|NCT00556933|26824844|FG000|Single vs. Divided-dose rATG Induction|Death|0|||
13407508|NCT00556933|26824845|FG001|Single vs. Divided-dose rATG Induction|Death|1|||
13407509|NCT00556933|26824846|FG002|Single vs. Divided-dose rATG Induction|Death|0|||
13407510|NCT00556933|26824847|FG003|Single vs. Divided-dose rATG Induction|Death|0|||
13407511|NCT00556933|26824844|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
13407512|NCT00556933|26824845|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1|||
13407513|NCT00556933|26824846|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
13407514|NCT00556933|26824847|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
13407515|NCT00556933|26824844|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
13407516|NCT00556933|26824845|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1|||
13407517|NCT00556933|26824846|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
13407518|NCT00556933|26824847|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
13407519|NCT00556933|26824844|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
13407520|NCT00556933|26824845|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
13407521|NCT00556933|26824846|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
13407522|NCT00556933|26824847|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
13407523|NCT00556933|26824844|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
13407524|NCT00556933|26824845|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
13407525|NCT00556933|26824846|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
13407526|NCT00556933|26824847|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
13407527|NCT00556933|26824844|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
13407528|NCT00556933|26824845|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
13407529|NCT00556933|26824846|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
13407530|NCT00556933|26824847|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
13407531|NCT00556933|26824844|FG000|CNI Withdrawal vs. Minimization|Graft loss|0|||
13407532|NCT00556933|26824845|FG001|CNI Withdrawal vs. Minimization|Graft loss|1|||
13407533|NCT00556933|26824846|FG002|CNI Withdrawal vs. Minimization|Graft loss|2|||
13407534|NCT00556933|26824847|FG003|CNI Withdrawal vs. Minimization|Graft loss|0|||
13407535|NCT00556933|26824844|FG000|CNI Withdrawal vs. Minimization|Death|0|||
13407536|NCT00556933|26824845|FG001|CNI Withdrawal vs. Minimization|Death|0|||
13407537|NCT00556933|26824846|FG002|CNI Withdrawal vs. Minimization|Death|0|||
13407538|NCT00556933|26824847|FG003|CNI Withdrawal vs. Minimization|Death|1|||
13407539|NCT00556439|26824870|FG000|Study Entry to Week 12|Lack of Efficacy|5|||
13407540|NCT00556439|26824871|FG001|Study Entry to Week 12|Lack of Efficacy|0|||
13407541|NCT00556439|26824872|FG002|Study Entry to Week 12|Lack of Efficacy|6|||
13407542|NCT00556439|26824873|FG003|Study Entry to Week 12|Lack of Efficacy|0|||
13407543|NCT00556439|26824870|FG000|Study Entry to Week 12|Physician Decision|1|||
13407544|NCT00556439|26824871|FG001|Study Entry to Week 12|Physician Decision|0|||
13407545|NCT00556439|26824872|FG002|Study Entry to Week 12|Physician Decision|0|||
13407546|NCT00556439|26824873|FG003|Study Entry to Week 12|Physician Decision|0|||
13407547|NCT00556439|26824870|FG000|Study Entry to Week 12|Withdrawal by Subject|1|||
13407548|NCT00556439|26824871|FG001|Study Entry to Week 12|Withdrawal by Subject|0|||
13407549|NCT00556439|26824872|FG002|Study Entry to Week 12|Withdrawal by Subject|1|||
13407550|NCT00556439|26824873|FG003|Study Entry to Week 12|Withdrawal by Subject|0|||
13407551|NCT00556439|26824870|FG000|Study Entry to Week 12|Recurrent infection|1|||
13407552|NCT00556439|26824871|FG001|Study Entry to Week 12|Recurrent infection|0|||
13407553|NCT00556439|26824872|FG002|Study Entry to Week 12|Recurrent infection|0|||
13407554|NCT00556439|26824873|FG003|Study Entry to Week 12|Recurrent infection|0|||
13407555|NCT00556439|26824870|FG000|Study Entry to Week 12|Malignancy|0|||
13407556|NCT00556439|26824871|FG001|Study Entry to Week 12|Malignancy|0|||
13407557|NCT00556439|26824872|FG002|Study Entry to Week 12|Malignancy|1|||
13407558|NCT00556439|26824873|FG003|Study Entry to Week 12|Malignancy|0|||
13407559|NCT00556439|26824870|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1|||
13407560|NCT00556439|26824871|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3|||
13407561|NCT00556439|26824872|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
13407562|NCT00556439|26824873|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
13407563|NCT00556439|26824870|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1|||
13407564|NCT00556439|26824871|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0|||
13407565|NCT00556439|26824872|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0|||
13407566|NCT00556439|26824873|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0|||
13407567|NCT00556439|26824870|FG000|After Week 12 (Randomized Study Period)|Malignancy|0|||
13407568|NCT00556439|26824871|FG001|After Week 12 (Randomized Study Period)|Malignancy|1|||
13407569|NCT00556439|26824872|FG002|After Week 12 (Randomized Study Period)|Malignancy|0|||
13407570|NCT00556439|26824873|FG003|After Week 12 (Randomized Study Period)|Malignancy|1|||
13407571|NCT00556439|26824870|FG000|After Week 12 (Randomized Study Period)|Severe infection|1|||
13407572|NCT00556439|26824871|FG001|After Week 12 (Randomized Study Period)|Severe infection|0|||
13407573|NCT00556439|26824872|FG002|After Week 12 (Randomized Study Period)|Severe infection|0|||
13407574|NCT00556439|26824873|FG003|After Week 12 (Randomized Study Period)|Severe infection|0|||
13407575|NCT00555906|26824915|FG000|Phase 1|Objective Progression or Relapse|3|||
13407576|NCT00555906|26824916|FG001|Phase 1|Objective Progression or Relapse|5|||
13407577|NCT00555906|26824917|FG002|Phase 1|Objective Progression or Relapse|3|||
13407578|NCT00555906|26824918|FG003|Phase 1|Objective Progression or Relapse|1|||
13407579|NCT00555906|26824919|FG004|Phase 1|Objective Progression or Relapse|0|||
13407580|NCT00555906|26824915|FG000|Phase 1|Global Deterioration of Health Status|0|||
13407581|NCT00555906|26824916|FG001|Phase 1|Global Deterioration of Health Status|1|||
13407582|NCT00555906|26824917|FG002|Phase 1|Global Deterioration of Health Status|1|||
13407583|NCT00555906|26824918|FG003|Phase 1|Global Deterioration of Health Status|1|||
13407584|NCT00555906|26824919|FG004|Phase 1|Global Deterioration of Health Status|0|||
13407585|NCT00555906|26824915|FG000|Phase 1|Adverse Event|0|||
13407586|NCT00555906|26824916|FG001|Phase 1|Adverse Event|0|||
13407587|NCT00555906|26824917|FG002|Phase 1|Adverse Event|3|||
13407588|NCT00555906|26824918|FG003|Phase 1|Adverse Event|2|||
13407589|NCT00555906|26824919|FG004|Phase 1|Adverse Event|0|||
13407590|NCT00555906|26824915|FG000|Phase 1|Withdrawal by Subject|0|||
13407591|NCT00555906|26824916|FG001|Phase 1|Withdrawal by Subject|0|||
13407592|NCT00555906|26824917|FG002|Phase 1|Withdrawal by Subject|0|||
13407593|NCT00555906|26824918|FG003|Phase 1|Withdrawal by Subject|1|||
13407594|NCT00555906|26824919|FG004|Phase 1|Withdrawal by Subject|0|||
13407595|NCT00555906|26824915|FG000|Phase 2|Adverse Event|0|||
13407596|NCT00555906|26824916|FG001|Phase 2|Adverse Event|0|||
13407597|NCT00555906|26824917|FG002|Phase 2|Adverse Event|0|||
13407598|NCT00555906|26824918|FG003|Phase 2|Adverse Event|0|||
13407599|NCT00555906|26824919|FG004|Phase 2|Adverse Event|4|||
13407600|NCT00555906|26824915|FG000|Phase 2|Global Deterioration of Health Status|0|||
13407601|NCT00555906|26824916|FG001|Phase 2|Global Deterioration of Health Status|0|||
13407602|NCT00555906|26824917|FG002|Phase 2|Global Deterioration of Health Status|0|||
13407603|NCT00555906|26824918|FG003|Phase 2|Global Deterioration of Health Status|0|||
13407604|NCT00555906|26824919|FG004|Phase 2|Global Deterioration of Health Status|2|||
13407605|NCT00555906|26824915|FG000|Phase 2|Objective Progression or Relapse|0|||
13407606|NCT00555906|26824916|FG001|Phase 2|Objective Progression or Relapse|0|||
13407607|NCT00555906|26824917|FG002|Phase 2|Objective Progression or Relapse|0|||
13407608|NCT00555906|26824918|FG003|Phase 2|Objective Progression or Relapse|0|||
13407609|NCT00555906|26824919|FG004|Phase 2|Objective Progression or Relapse|16|||
13407610|NCT00555906|26824915|FG000|Phase 2|Withdrawal by Subject|0|||
13407611|NCT00555906|26824916|FG001|Phase 2|Withdrawal by Subject|0|||
13407612|NCT00555906|26824917|FG002|Phase 2|Withdrawal by Subject|0|||
13407613|NCT00555906|26824918|FG003|Phase 2|Withdrawal by Subject|0|||
13407614|NCT00555906|26824919|FG004|Phase 2|Withdrawal by Subject|2|||
13407615|NCT00555906|26824915|FG000|Phase 2|Other|0|||
13407616|NCT00555906|26824916|FG001|Phase 2|Other|0|||
13407617|NCT00555906|26824917|FG002|Phase 2|Other|0|||
13407618|NCT00555906|26824918|FG003|Phase 2|Other|0|||
13407619|NCT00555906|26824919|FG004|Phase 2|Other|6|||
13407620|NCT00555906|26824915|FG000|Phase 2|Randomized but not Treated|0|||
13476240|NCT01729754|27002615|FG007|Part 1|Withdrawal by Subject|0|||
13407621|NCT00555906|26824916|FG001|Phase 2|Randomized but not Treated|0|||
13407622|NCT00555906|26824917|FG002|Phase 2|Randomized but not Treated|0|||
13407623|NCT00555906|26824918|FG003|Phase 2|Randomized but not Treated|0|||
13407624|NCT00555906|26824919|FG004|Phase 2|Randomized but not Treated|2|||
13407625|NCT00555672|26824945|FG000|Overall Study|Death|0|||
13407626|NCT00555672|26824946|FG001|Overall Study|Death|2|||
13407627|NCT00555672|26824945|FG000|Overall Study|Adverse Event|8|||
13407628|NCT00555672|26824946|FG001|Overall Study|Adverse Event|2|||
13407629|NCT00555672|26824945|FG000|Overall Study|Objective progression or relapse|11|||
13407630|NCT00555672|26824946|FG001|Overall Study|Objective progression or relapse|5|||
13407631|NCT00555672|26824945|FG000|Overall Study|Other|3|||
13407632|NCT00555672|26824946|FG001|Overall Study|Other|1|||
13407633|NCT00555672|26824945|FG000|Overall Study|Participant refused|2|||
13407634|NCT00555672|26824946|FG001|Overall Study|Participant refused|0|||
13407635|NCT00555620|26825077|FG000|Overall Study|Death|0|||
13407636|NCT00555620|26825078|FG001|Overall Study|Death|1|||
13407637|NCT00555620|26825079|FG002|Overall Study|Death|0|||
13407638|NCT00555620|26825080|FG003|Overall Study|Death|0|||
13407639|NCT00555620|26825081|FG004|Overall Study|Death|0|||
13407640|NCT00555620|26825082|FG005|Overall Study|Death|1|||
13407641|NCT00555620|26825077|FG000|Overall Study|Study terminated by sponsor|0|||
13407642|NCT00555620|26825078|FG001|Overall Study|Study terminated by sponsor|0|||
13407643|NCT00555620|26825079|FG002|Overall Study|Study terminated by sponsor|1|||
13407644|NCT00555620|26825080|FG003|Overall Study|Study terminated by sponsor|0|||
13407645|NCT00555620|26825081|FG004|Overall Study|Study terminated by sponsor|0|||
13407646|NCT00555620|26825082|FG005|Overall Study|Study terminated by sponsor|0|||
13407647|NCT00555620|26825077|FG000|Overall Study|Adverse Event|0|||
13407648|NCT00555620|26825078|FG001|Overall Study|Adverse Event|0|||
13407649|NCT00555620|26825079|FG002|Overall Study|Adverse Event|1|||
13407650|NCT00555620|26825080|FG003|Overall Study|Adverse Event|5|||
13407651|NCT00555620|26825081|FG004|Overall Study|Adverse Event|0|||
13407652|NCT00555620|26825082|FG005|Overall Study|Adverse Event|1|||
13407653|NCT00555620|26825077|FG000|Overall Study|Objective progression or relapse|6|||
13407654|NCT00555620|26825078|FG001|Overall Study|Objective progression or relapse|5|||
13407655|NCT00555620|26825079|FG002|Overall Study|Objective progression or relapse|12|||
13407656|NCT00555620|26825080|FG003|Overall Study|Objective progression or relapse|17|||
13407657|NCT00555620|26825081|FG004|Overall Study|Objective progression or relapse|3|||
13407658|NCT00555620|26825082|FG005|Overall Study|Objective progression or relapse|16|||
13407659|NCT00555620|26825077|FG000|Overall Study|Participant refused treatment|0|||
13407660|NCT00555620|26825078|FG001|Overall Study|Participant refused treatment|1|||
13407661|NCT00555620|26825079|FG002|Overall Study|Participant refused treatment|1|||
13407662|NCT00555620|26825080|FG003|Overall Study|Participant refused treatment|0|||
13407663|NCT00555620|26825081|FG004|Overall Study|Participant refused treatment|0|||
13407664|NCT00555620|26825082|FG005|Overall Study|Participant refused treatment|1|||
13407665|NCT00555620|26825077|FG000|Overall Study|Other|0|||
13407666|NCT00555620|26825078|FG001|Overall Study|Other|0|||
13407667|NCT00555620|26825079|FG002|Overall Study|Other|0|||
13407668|NCT00555620|26825080|FG003|Overall Study|Other|1|||
13407669|NCT00555620|26825081|FG004|Overall Study|Other|0|||
13407670|NCT00555620|26825082|FG005|Overall Study|Other|3|||
13407671|NCT00555217|26825097|FG000|Overall Study|Withdrawal by Subject|35|||
13407672|NCT00555217|26825098|FG001|Overall Study|Withdrawal by Subject|31|||
13407673|NCT00555217|26825097|FG000|Overall Study|Lost to Follow-up|19|||
13407674|NCT00555217|26825098|FG001|Overall Study|Lost to Follow-up|20|||
13407675|NCT00555217|26825097|FG000|Overall Study|close out sites|21|||
13407676|NCT00555217|26825098|FG001|Overall Study|close out sites|17|||
13407677|NCT00555009|26825127|FG000|Overall Study|Withdrawal by Subject|0|||
13407678|NCT00555009|26825128|FG001|Overall Study|Withdrawal by Subject|1|||
13407679|NCT00555009|26825127|FG000|Overall Study|Terminated by Sponsor|2|||
13407680|NCT00555009|26825128|FG001|Overall Study|Terminated by Sponsor|5|||
13407681|NCT00554801|26825143|FG000|Overall Study|left area before completion|5|||
13407682|NCT00554801|26825144|FG001|Overall Study|left area before completion|0|||
13407683|NCT00554801|26825143|FG000|Overall Study|Withdrawal by Subject|14|||
13407684|NCT00554801|26825144|FG001|Overall Study|Withdrawal by Subject|0|||
13407685|NCT00554788|26825166|FG000|Overall Study|Adverse Event|0|||
13407686|NCT00554788|26825167|FG001|Overall Study|Adverse Event|1|||
13407687|NCT00554788|26825168|FG002|Overall Study|Adverse Event|2|||
13407688|NCT00554788|26825166|FG000|Overall Study|Lost to Follow-up|4|||
13407689|NCT00554788|26825167|FG001|Overall Study|Lost to Follow-up|3|||
13407690|NCT00554788|26825168|FG002|Overall Study|Lost to Follow-up|3|||
13407691|NCT00554788|26825166|FG000|Overall Study|Physician Decision|1|||
13407692|NCT00554788|26825167|FG001|Overall Study|Physician Decision|1|||
13407693|NCT00554788|26825168|FG002|Overall Study|Physician Decision|3|||
13407694|NCT00554788|26825166|FG000|Overall Study|Withdrawal by Subject|0|||
13407695|NCT00554788|26825167|FG001|Overall Study|Withdrawal by Subject|0|||
13407696|NCT00554788|26825168|FG002|Overall Study|Withdrawal by Subject|1|||
13407697|NCT00554788|26825166|FG000|Overall Study|Refusal of further protocol therapy|0|||
13407698|NCT00554788|26825167|FG001|Overall Study|Refusal of further protocol therapy|1|||
13407699|NCT00554788|26825168|FG002|Overall Study|Refusal of further protocol therapy|1|||
13407700|NCT00554788|26825166|FG000|Overall Study|Progressive disease|0|||
13407701|NCT00554788|26825167|FG001|Overall Study|Progressive disease|0|||
13407702|NCT00554788|26825168|FG002|Overall Study|Progressive disease|3|||
13407703|NCT00554788|26825166|FG000|Overall Study|Ineligible|2|||
13407704|NCT00554788|26825167|FG001|Overall Study|Ineligible|0|||
13407705|NCT00554788|26825168|FG002|Overall Study|Ineligible|1|||
13407706|NCT00554515|26825199|FG000|Overall Study|Withdrawal by Subject|3|||
13407707|NCT00554515|26825199|FG000|Overall Study|Disease progression|52|||
13407708|NCT00554515|26825199|FG000|Overall Study|Physician Decision|18|||
13407709|NCT00554515|26825199|FG000|Overall Study|Withdrawal by Subject|11|||
13407710|NCT00554515|26825199|FG000|Overall Study|Adverse Event|9|||
13407711|NCT00554515|26825199|FG000|Overall Study|Death|2|||
13407712|NCT00554515|26825199|FG000|Overall Study|Achieved Stable Disease|7|||
13407713|NCT00554515|26825199|FG000|Overall Study|Other|1|||
13407714|NCT00554515|26825199|FG000|Overall Study|Misc|15|||
13407715|NCT00553787|26825220|FG000|Overall Study|Adverse Event|34|||
13407716|NCT00553787|26825221|FG001|Overall Study|Adverse Event|21|||
13407717|NCT00553787|26825222|FG002|Overall Study|Adverse Event|67|||
13407718|NCT00553787|26825220|FG000|Overall Study|Lost to Follow-up|132|||
13407719|NCT00553787|26825221|FG001|Overall Study|Lost to Follow-up|44|||
13407720|NCT00553787|26825222|FG002|Overall Study|Lost to Follow-up|78|||
13407721|NCT00553787|26825220|FG000|Overall Study|Withdrawal by Subject|151|||
13407722|NCT00553787|26825221|FG001|Overall Study|Withdrawal by Subject|40|||
13407723|NCT00553787|26825222|FG002|Overall Study|Withdrawal by Subject|83|||
13407724|NCT00553787|26825220|FG000|Overall Study|Lack of Efficacy|31|||
13407725|NCT00553787|26825221|FG001|Overall Study|Lack of Efficacy|1|||
13407726|NCT00553787|26825222|FG002|Overall Study|Lack of Efficacy|3|||
13407727|NCT00553787|26825220|FG000|Overall Study|Pregnancy|0|||
13407728|NCT00553787|26825221|FG001|Overall Study|Pregnancy|1|||
13407729|NCT00553787|26825222|FG002|Overall Study|Pregnancy|2|||
13407730|NCT00553787|26825220|FG000|Overall Study|non compliance|4|||
13407731|NCT00553787|26825221|FG001|Overall Study|non compliance|0|||
13407732|NCT00553787|26825222|FG002|Overall Study|non compliance|11|||
13407733|NCT00553787|26825220|FG000|Overall Study|Requirement for restricted medication|8|||
13407734|NCT00553787|26825221|FG001|Overall Study|Requirement for restricted medication|7|||
13407735|NCT00553787|26825222|FG002|Overall Study|Requirement for restricted medication|5|||
13407736|NCT00553787|26825220|FG000|Overall Study|Other|18|||
13407737|NCT00553787|26825221|FG001|Overall Study|Other|10|||
13407738|NCT00553787|26825222|FG002|Overall Study|Other|13|||
13407739|NCT00553696|26825273|FG000|Overall Study|Adverse Event|2|||
13407740|NCT00553696|26825274|FG001|Overall Study|Adverse Event|4|||
13407741|NCT00553696|26825275|FG002|Overall Study|Adverse Event|0|||
13407742|NCT00553696|26825276|FG003|Overall Study|Adverse Event|1|||
13407743|NCT00553696|26825273|FG000|Overall Study|Global deterioration of health status|0|||
13407744|NCT00553696|26825274|FG001|Overall Study|Global deterioration of health status|2|||
13407745|NCT00553696|26825275|FG002|Overall Study|Global deterioration of health status|0|||
13407746|NCT00553696|26825276|FG003|Overall Study|Global deterioration of health status|0|||
13407747|NCT00553696|26825273|FG000|Overall Study|Objective progression or relapse|2|||
13407748|NCT00553696|26825274|FG001|Overall Study|Objective progression or relapse|9|||
13407749|NCT00553696|26825275|FG002|Overall Study|Objective progression or relapse|6|||
13407750|NCT00553696|26825276|FG003|Overall Study|Objective progression or relapse|0|||
13407751|NCT00553696|26825273|FG000|Overall Study|Withdrawal by Subject|0|||
13407752|NCT00553696|26825274|FG001|Overall Study|Withdrawal by Subject|1|||
13407753|NCT00553696|26825275|FG002|Overall Study|Withdrawal by Subject|0|||
13407754|NCT00553696|26825276|FG003|Overall Study|Withdrawal by Subject|0|||
13407755|NCT00553605|26825307|FG000|Overall Study|Did not meet entrance criteria|1|||
13407756|NCT00553605|26825308|FG001|Overall Study|Did not meet entrance criteria|3|||
13407757|NCT00553605|26825307|FG000|Overall Study|Did not receive full dose|1|||
13407758|NCT00553605|26825308|FG001|Overall Study|Did not receive full dose|0|||
13407759|NCT00553605|26825307|FG000|Overall Study|Randomized but not treated|2|||
13407760|NCT00553605|26825308|FG001|Overall Study|Randomized but not treated|0|||
13407761|NCT00553540|26825321|FG000|Overall Study|discharged after first visit|2|||
13407762|NCT00553540|26825322|FG001|Overall Study|discharged after first visit|5|||
13407763|NCT00553475|26825454|FG000|Overall Study|Adverse Event|7|||
13407764|NCT00553475|26825455|FG001|Overall Study|Adverse Event|17|||
13407765|NCT00553475|26825456|FG002|Overall Study|Adverse Event|13|||
13407766|NCT00553475|26825454|FG000|Overall Study|Lack of Efficacy|7|||
13407767|NCT00553475|26825455|FG001|Overall Study|Lack of Efficacy|1|||
13407768|NCT00553475|26825456|FG002|Overall Study|Lack of Efficacy|0|||
13407769|NCT00553475|26825454|FG000|Overall Study|Withdrawal by Subject|1|||
13407770|NCT00553475|26825455|FG001|Overall Study|Withdrawal by Subject|1|||
13407771|NCT00553475|26825456|FG002|Overall Study|Withdrawal by Subject|0|||
13407772|NCT00553475|26825454|FG000|Overall Study|Physician Decision|1|||
13407773|NCT00553475|26825455|FG001|Overall Study|Physician Decision|0|||
13407774|NCT00553475|26825456|FG002|Overall Study|Physician Decision|0|||
13407775|NCT00553475|26825454|FG000|Overall Study|Due to moving|0|||
13407776|NCT00553475|26825455|FG001|Overall Study|Due to moving|1|||
13407777|NCT00553475|26825456|FG002|Overall Study|Due to moving|0|||
13407778|NCT00553358|26825537|FG000|Overall Study|Randomized but did not receive treatment|3|||
13407779|NCT00553358|26825538|FG001|Overall Study|Randomized but did not receive treatment|3|||
13407780|NCT00553358|26825539|FG002|Overall Study|Randomized but did not receive treatment|1|||
13407781|NCT00553358|26825537|FG000|Overall Study|Lost to Follow-up|22|||
13407782|NCT00553358|26825538|FG001|Overall Study|Lost to Follow-up|26|||
13407783|NCT00553358|26825539|FG002|Overall Study|Lost to Follow-up|18|||
13407784|NCT00553358|26825537|FG000|Overall Study|Withdrew completely|23|||
13407785|NCT00553358|26825538|FG001|Overall Study|Withdrew completely|33|||
13407786|NCT00553358|26825539|FG002|Overall Study|Withdrew completely|34|||
13407787|NCT00553358|26825537|FG000|Overall Study|Died during clinical follow-up|25|||
13407788|NCT00553358|26825538|FG001|Overall Study|Died during clinical follow-up|29|||
13407789|NCT00553358|26825539|FG002|Overall Study|Died during clinical follow-up|32|||
13407790|NCT00553358|26825537|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4|||
13407791|NCT00553358|26825538|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
13407792|NCT00553358|26825539|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
13407793|NCT00553358|26825537|FG000|Overall Study|Died after clinical follow-up ended|1|||
13407794|NCT00553358|26825538|FG001|Overall Study|Died after clinical follow-up ended|2|||
13407795|NCT00553358|26825539|FG002|Overall Study|Died after clinical follow-up ended|0|||
13407796|NCT00553358|26825537|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
13407797|NCT00553358|26825538|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
13407798|NCT00553358|26825539|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
13407799|NCT00553280|26825550|FG000|Overall Study|Adverse Event|19|||
13407800|NCT00553280|26825550|FG000|Overall Study|Lack of Efficacy|3|||
13407801|NCT00553280|26825550|FG000|Overall Study|Withdrawal by Subject|3|||
13407802|NCT00553280|26825550|FG000|Overall Study|Physician Decision|1|||
13407803|NCT00553254|26825600|FG000|Overall Study|Death|3|||
13407804|NCT00553254|26825601|FG001|Overall Study|Death|6|||
13407805|NCT00553254|26825602|FG002|Overall Study|Death|25|||
13407806|NCT00553254|26825600|FG000|Overall Study|Lost to Follow-up|0|||
13407807|NCT00553254|26825601|FG001|Overall Study|Lost to Follow-up|0|||
13407808|NCT00553254|26825602|FG002|Overall Study|Lost to Follow-up|2|||
13407809|NCT00553254|26825600|FG000|Overall Study|Withdrawal by Subject|2|||
13407810|NCT00553254|26825601|FG001|Overall Study|Withdrawal by Subject|0|||
13407811|NCT00553254|26825602|FG002|Overall Study|Withdrawal by Subject|2|||
13407812|NCT00553254|26825600|FG000|Overall Study|Study terminated by Sponsor|0|||
13407813|NCT00553254|26825601|FG001|Overall Study|Study terminated by Sponsor|0|||
13407814|NCT00553254|26825602|FG002|Overall Study|Study terminated by Sponsor|1|||
13407815|NCT00553254|26825600|FG000|Overall Study|Other|1|||
13407816|NCT00553254|26825601|FG001|Overall Study|Other|0|||
13407817|NCT00553254|26825602|FG002|Overall Study|Other|13|||
13407818|NCT00552760|26825623|FG000|Overall Study|Adverse Event|3|||
13407819|NCT00552760|26825624|FG001|Overall Study|Adverse Event|5|||
13407820|NCT00552760|26825623|FG000|Overall Study|Relapsed- Depressed Event|10|||
13407821|NCT00552760|26825624|FG001|Overall Study|Relapsed- Depressed Event|16|||
13407822|NCT00552760|26825623|FG000|Overall Study|Relapse- Manic Event|3|||
13407823|NCT00552760|26825624|FG001|Overall Study|Relapse- Manic Event|3|||
13407824|NCT00552760|26825623|FG000|Overall Study|Relapsed- Mixed Event|3|||
13407825|NCT00552760|26825624|FG001|Overall Study|Relapsed- Mixed Event|5|||
13407826|NCT00552760|26825623|FG000|Overall Study|Protocol Violation|0|||
13407827|NCT00552760|26825624|FG001|Overall Study|Protocol Violation|1|||
13407828|NCT00552760|26825623|FG000|Overall Study|Lost to Follow-up|1|||
13407829|NCT00552760|26825624|FG001|Overall Study|Lost to Follow-up|1|||
13407830|NCT00552760|26825623|FG000|Overall Study|Non-compliance|1|||
13407831|NCT00552760|26825624|FG001|Overall Study|Non-compliance|1|||
13407832|NCT00552760|26825623|FG000|Overall Study|Medical Condition|1|||
13407833|NCT00552760|26825624|FG001|Overall Study|Medical Condition|1|||
13407834|NCT00552760|26825623|FG000|Overall Study|Withdrawal by Subject|3|||
13407835|NCT00552760|26825624|FG001|Overall Study|Withdrawal by Subject|0|||
13407836|NCT00552760|26825623|FG000|Overall Study|Medication Change|1|||
13407837|NCT00552760|26825624|FG001|Overall Study|Medication Change|0|||
13407838|NCT00552669|26825641|FG000|Overall Study|Death|3|||
13407839|NCT00552669|26825642|FG001|Overall Study|Death|7|||
13407840|NCT00552513|26825659|FG000|Overall Study|Lost to Follow-up|5|||
13407841|NCT00552513|26825660|FG001|Overall Study|Lost to Follow-up|1|||
13407842|NCT00551616|26825677|FG000|Overall Study|Lost to Follow-up|48|||
13407843|NCT00551616|26825678|FG001|Overall Study|Lost to Follow-up|40|||
13407844|NCT00551135|26825805|FG000|Overall Study|Adverse Event|1|||
13407845|NCT00551135|26825806|FG001|Overall Study|Adverse Event|0|||
13407846|NCT00551135|26825807|FG002|Overall Study|Adverse Event|1|||
13407847|NCT00551135|26825808|FG003|Overall Study|Adverse Event|1|||
13407848|NCT00551135|26825805|FG000|Overall Study|Lost to Follow-up|0|||
13407849|NCT00551135|26825806|FG001|Overall Study|Lost to Follow-up|0|||
13407850|NCT00551135|26825807|FG002|Overall Study|Lost to Follow-up|0|||
13407851|NCT00551135|26825808|FG003|Overall Study|Lost to Follow-up|1|||
13407852|NCT00551135|26825805|FG000|Overall Study|Other|3|||
13407853|NCT00551135|26825806|FG001|Overall Study|Other|2|||
13407854|NCT00551135|26825807|FG002|Overall Study|Other|1|||
13407855|NCT00551135|26825808|FG003|Overall Study|Other|2|||
13407856|NCT00551135|26825805|FG000|Overall Study|Withdrawal by Subject|1|||
13407857|NCT00551135|26825806|FG001|Overall Study|Withdrawal by Subject|0|||
13407858|NCT00551135|26825807|FG002|Overall Study|Withdrawal by Subject|3|||
13407859|NCT00551135|26825808|FG003|Overall Study|Withdrawal by Subject|1|||
13476241|NCT01729754|27002616|FG008|Part 1|Withdrawal by Subject|0|||
13476242|NCT01729754|27002617|FG009|Part 1|Withdrawal by Subject|6|||
13476243|NCT01729754|27002608|FG000|Part 1|Other Protocol Specified Criteria|2|||
13476244|NCT01729754|27002609|FG001|Part 1|Other Protocol Specified Criteria|0|||
13476245|NCT01729754|27002610|FG002|Part 1|Other Protocol Specified Criteria|0|||
13476246|NCT01729754|27002611|FG003|Part 1|Other Protocol Specified Criteria|0|||
13476247|NCT01729754|27002612|FG004|Part 1|Other Protocol Specified Criteria|0|||
13476248|NCT01729754|27002613|FG005|Part 1|Other Protocol Specified Criteria|0|||
13476249|NCT01729754|27002614|FG006|Part 1|Other Protocol Specified Criteria|1|||
13476250|NCT01729754|27002615|FG007|Part 1|Other Protocol Specified Criteria|0|||
13476251|NCT01729754|27002616|FG008|Part 1|Other Protocol Specified Criteria|0|||
13476252|NCT01729754|27002617|FG009|Part 1|Other Protocol Specified Criteria|4|||
13476253|NCT01729754|27002608|FG000|Part 2|Adverse Event|2|||
13476254|NCT01729754|27002609|FG001|Part 2|Adverse Event|0|||
13476255|NCT01729754|27002610|FG002|Part 2|Adverse Event|0|||
13476256|NCT01729754|27002611|FG003|Part 2|Adverse Event|0|||
13476257|NCT01729754|27002612|FG004|Part 2|Adverse Event|0|||
13476258|NCT01729754|27002613|FG005|Part 2|Adverse Event|0|||
13476259|NCT01729754|27002614|FG006|Part 2|Adverse Event|0|||
13476260|NCT01729754|27002615|FG007|Part 2|Adverse Event|0|||
13476261|NCT01729754|27002616|FG008|Part 2|Adverse Event|1|||
13476262|NCT01729754|27002617|FG009|Part 2|Adverse Event|2|||
13476263|NCT01729754|27002608|FG000|Part 2|Lack of Efficacy|0|||
13476264|NCT01729754|27002609|FG001|Part 2|Lack of Efficacy|0|||
13476265|NCT01729754|27002610|FG002|Part 2|Lack of Efficacy|0|||
13476266|NCT01729754|27002611|FG003|Part 2|Lack of Efficacy|0|||
13476267|NCT01729754|27002612|FG004|Part 2|Lack of Efficacy|0|||
13476268|NCT01729754|27002613|FG005|Part 2|Lack of Efficacy|0|||
13476269|NCT01729754|27002614|FG006|Part 2|Lack of Efficacy|0|||
13476270|NCT01729754|27002615|FG007|Part 2|Lack of Efficacy|0|||
13476271|NCT01729754|27002616|FG008|Part 2|Lack of Efficacy|2|||
13476272|NCT01729754|27002617|FG009|Part 2|Lack of Efficacy|2|||
13476273|NCT01729754|27002608|FG000|Part 2|Lost to Follow-up|0|||
13476274|NCT01729754|27002609|FG001|Part 2|Lost to Follow-up|0|||
13476275|NCT01729754|27002610|FG002|Part 2|Lost to Follow-up|0|||
13476276|NCT01729754|27002611|FG003|Part 2|Lost to Follow-up|2|||
13476277|NCT01729754|27002612|FG004|Part 2|Lost to Follow-up|0|||
13476278|NCT01729754|27002613|FG005|Part 2|Lost to Follow-up|0|||
13476279|NCT01729754|27002614|FG006|Part 2|Lost to Follow-up|0|||
13476280|NCT01729754|27002615|FG007|Part 2|Lost to Follow-up|1|||
13476281|NCT01729754|27002616|FG008|Part 2|Lost to Follow-up|0|||
13476282|NCT01729754|27002617|FG009|Part 2|Lost to Follow-up|2|||
13476283|NCT01729754|27002608|FG000|Part 2|Non-Compliance with Study Drug|0|||
13476284|NCT01729754|27002609|FG001|Part 2|Non-Compliance with Study Drug|0|||
13476285|NCT01729754|27002610|FG002|Part 2|Non-Compliance with Study Drug|0|||
13476286|NCT01729754|27002611|FG003|Part 2|Non-Compliance with Study Drug|0|||
13476287|NCT01729754|27002612|FG004|Part 2|Non-Compliance with Study Drug|0|||
13476288|NCT01729754|27002613|FG005|Part 2|Non-Compliance with Study Drug|0|||
13476289|NCT01729754|27002614|FG006|Part 2|Non-Compliance with Study Drug|0|||
13476290|NCT01729754|27002615|FG007|Part 2|Non-Compliance with Study Drug|0|||
13476291|NCT01729754|27002616|FG008|Part 2|Non-Compliance with Study Drug|0|||
13476292|NCT01729754|27002617|FG009|Part 2|Non-Compliance with Study Drug|1|||
13476293|NCT01729754|27002608|FG000|Part 2|Pregnancy|0|||
13476294|NCT01729754|27002609|FG001|Part 2|Pregnancy|0|||
13476295|NCT01729754|27002610|FG002|Part 2|Pregnancy|0|||
13476296|NCT01729754|27002611|FG003|Part 2|Pregnancy|1|||
13476297|NCT01729754|27002612|FG004|Part 2|Pregnancy|0|||
13476298|NCT01729754|27002613|FG005|Part 2|Pregnancy|0|||
13476299|NCT01729754|27002614|FG006|Part 2|Pregnancy|0|||
13476300|NCT01729754|27002615|FG007|Part 2|Pregnancy|0|||
13476301|NCT01729754|27002616|FG008|Part 2|Pregnancy|0|||
13476302|NCT01729754|27002617|FG009|Part 2|Pregnancy|1|||
13476303|NCT01729754|27002608|FG000|Part 2|Withdrawal by Subject|3|||
13476304|NCT01729754|27002609|FG001|Part 2|Withdrawal by Subject|0|||
13476305|NCT01729754|27002610|FG002|Part 2|Withdrawal by Subject|0|||
13476306|NCT01729754|27002611|FG003|Part 2|Withdrawal by Subject|2|||
13476307|NCT01729754|27002612|FG004|Part 2|Withdrawal by Subject|0|||
13476308|NCT01729754|27002613|FG005|Part 2|Withdrawal by Subject|0|||
13476309|NCT01729754|27002614|FG006|Part 2|Withdrawal by Subject|0|||
13476310|NCT01729754|27002615|FG007|Part 2|Withdrawal by Subject|1|||
13476311|NCT01729754|27002616|FG008|Part 2|Withdrawal by Subject|1|||
13476312|NCT01729754|27002617|FG009|Part 2|Withdrawal by Subject|4|||
13476313|NCT01729754|27002608|FG000|Part 2|Other Protocol Specified Criteria|1|||
13476314|NCT01729754|27002609|FG001|Part 2|Other Protocol Specified Criteria|0|||
13476315|NCT01729754|27002610|FG002|Part 2|Other Protocol Specified Criteria|0|||
13476316|NCT01729754|27002611|FG003|Part 2|Other Protocol Specified Criteria|0|||
13407860|NCT00550745|26825823|FG000|Overall Study|Death|20|||
13407861|NCT00550745|26825824|FG001|Overall Study|Death|16|||
13407862|NCT00550745|26825823|FG000|Overall Study|Lost to Follow-up|45|||
13407863|NCT00550745|26825824|FG001|Overall Study|Lost to Follow-up|30|||
13407864|NCT00550745|26825823|FG000|Overall Study|Physician Decision|0|||
13407865|NCT00550745|26825824|FG001|Overall Study|Physician Decision|2|||
13407866|NCT00550745|26825823|FG000|Overall Study|Protocol Violation|4|||
13407867|NCT00550745|26825824|FG001|Overall Study|Protocol Violation|2|||
13407868|NCT00550745|26825823|FG000|Overall Study|Withdrawal by Subject|17|||
13407869|NCT00550745|26825824|FG001|Overall Study|Withdrawal by Subject|10|||
13407870|NCT00550745|26825823|FG000|Overall Study|Screen failure|1|||
13407871|NCT00550745|26825824|FG001|Overall Study|Screen failure|0|||
13407872|NCT00550615|26825839|FG000|Overall Study|Withdrawal by Subject|0|||
13407873|NCT00550615|26825840|FG001|Overall Study|Withdrawal by Subject|0|||
13407874|NCT00550615|26825841|FG002|Overall Study|Withdrawal by Subject|2|||
13407875|NCT00550615|26825842|FG003|Overall Study|Withdrawal by Subject|3|||
13407876|NCT00550615|26825839|FG000|Overall Study|Not evaluable|0|||
13407877|NCT00550615|26825840|FG001|Overall Study|Not evaluable|0|||
13407878|NCT00550615|26825841|FG002|Overall Study|Not evaluable|2|||
13407879|NCT00550615|26825842|FG003|Overall Study|Not evaluable|7|||
13407880|NCT00550446|26826300|FG000|Up To Week 12|Adverse Event|2|||
13407881|NCT00550446|26826301|FG001|Up To Week 12|Adverse Event|2|||
13407882|NCT00550446|26826302|FG002|Up To Week 12|Adverse Event|0|||
13407883|NCT00550446|26826303|FG003|Up To Week 12|Adverse Event|0|||
13407884|NCT00550446|26826304|FG004|Up To Week 12|Adverse Event|2|||
13407885|NCT00550446|26826305|FG005|Up To Week 12|Adverse Event|2|||
13407886|NCT00550446|26826306|FG006|Up To Week 12|Adverse Event|1|||
13407887|NCT00550446|26826307|FG007|Up To Week 12|Adverse Event|0|||
13407888|NCT00550446|26826308|FG008|Up To Week 12|Adverse Event|0|||
13407889|NCT00550446|26826309|FG009|Up To Week 12|Adverse Event|0|||
13407890|NCT00550446|26826310|FG010|Up To Week 12|Adverse Event|0|||
13407891|NCT00550446|26826300|FG000|Up To Week 12|Lack of Efficacy|3|||
13407892|NCT00550446|26826301|FG001|Up To Week 12|Lack of Efficacy|1|||
13407893|NCT00550446|26826302|FG002|Up To Week 12|Lack of Efficacy|0|||
13407894|NCT00550446|26826303|FG003|Up To Week 12|Lack of Efficacy|1|||
13407895|NCT00550446|26826304|FG004|Up To Week 12|Lack of Efficacy|0|||
13407896|NCT00550446|26826305|FG005|Up To Week 12|Lack of Efficacy|3|||
13407897|NCT00550446|26826306|FG006|Up To Week 12|Lack of Efficacy|3|||
13407898|NCT00550446|26826307|FG007|Up To Week 12|Lack of Efficacy|0|||
13407899|NCT00550446|26826308|FG008|Up To Week 12|Lack of Efficacy|0|||
13407900|NCT00550446|26826309|FG009|Up To Week 12|Lack of Efficacy|0|||
13407901|NCT00550446|26826310|FG010|Up To Week 12|Lack of Efficacy|0|||
13407902|NCT00550446|26826300|FG000|Up To Week 12|Lost to Follow-up|0|||
13407903|NCT00550446|26826301|FG001|Up To Week 12|Lost to Follow-up|1|||
13407904|NCT00550446|26826302|FG002|Up To Week 12|Lost to Follow-up|0|||
13407905|NCT00550446|26826303|FG003|Up To Week 12|Lost to Follow-up|0|||
13407906|NCT00550446|26826304|FG004|Up To Week 12|Lost to Follow-up|1|||
13407907|NCT00550446|26826305|FG005|Up To Week 12|Lost to Follow-up|1|||
13407908|NCT00550446|26826306|FG006|Up To Week 12|Lost to Follow-up|2|||
13407909|NCT00550446|26826307|FG007|Up To Week 12|Lost to Follow-up|0|||
13407910|NCT00550446|26826308|FG008|Up To Week 12|Lost to Follow-up|0|||
13407911|NCT00550446|26826309|FG009|Up To Week 12|Lost to Follow-up|0|||
13407912|NCT00550446|26826310|FG010|Up To Week 12|Lost to Follow-up|0|||
13407913|NCT00550446|26826300|FG000|Up To Week 12|Withdrawal by Subject|2|||
13407914|NCT00550446|26826301|FG001|Up To Week 12|Withdrawal by Subject|0|||
13407915|NCT00550446|26826302|FG002|Up To Week 12|Withdrawal by Subject|3|||
13407916|NCT00550446|26826303|FG003|Up To Week 12|Withdrawal by Subject|2|||
13407917|NCT00550446|26826304|FG004|Up To Week 12|Withdrawal by Subject|0|||
13407918|NCT00550446|26826305|FG005|Up To Week 12|Withdrawal by Subject|1|||
13407919|NCT00550446|26826306|FG006|Up To Week 12|Withdrawal by Subject|3|||
13407920|NCT00550446|26826307|FG007|Up To Week 12|Withdrawal by Subject|0|||
13407921|NCT00550446|26826308|FG008|Up To Week 12|Withdrawal by Subject|0|||
13407922|NCT00550446|26826309|FG009|Up To Week 12|Withdrawal by Subject|0|||
13407923|NCT00550446|26826310|FG010|Up To Week 12|Withdrawal by Subject|0|||
13407924|NCT00550446|26826300|FG000|Up To Week 12|Other|3|||
13407925|NCT00550446|26826301|FG001|Up To Week 12|Other|0|||
13407926|NCT00550446|26826302|FG002|Up To Week 12|Other|0|||
13407927|NCT00550446|26826303|FG003|Up To Week 12|Other|0|||
13407928|NCT00550446|26826304|FG004|Up To Week 12|Other|0|||
13407929|NCT00550446|26826305|FG005|Up To Week 12|Other|1|||
13407930|NCT00550446|26826306|FG006|Up To Week 12|Other|4|||
13407931|NCT00550446|26826307|FG007|Up To Week 12|Other|0|||
13407932|NCT00550446|26826308|FG008|Up To Week 12|Other|0|||
13407933|NCT00550446|26826309|FG009|Up To Week 12|Other|0|||
13407934|NCT00550446|26826310|FG010|Up To Week 12|Other|0|||
13407935|NCT00550446|26826300|FG000|Up To Week 12|Randomized not treated|0|||
13407936|NCT00550446|26826301|FG001|Up To Week 12|Randomized not treated|1|||
13407937|NCT00550446|26826302|FG002|Up To Week 12|Randomized not treated|1|||
13407938|NCT00550446|26826303|FG003|Up To Week 12|Randomized not treated|0|||
13407939|NCT00550446|26826304|FG004|Up To Week 12|Randomized not treated|0|||
13407940|NCT00550446|26826305|FG005|Up To Week 12|Randomized not treated|0|||
13407941|NCT00550446|26826306|FG006|Up To Week 12|Randomized not treated|0|||
13407942|NCT00550446|26826307|FG007|Up To Week 12|Randomized not treated|0|||
13407943|NCT00550446|26826308|FG008|Up To Week 12|Randomized not treated|0|||
13407944|NCT00550446|26826309|FG009|Up To Week 12|Randomized not treated|0|||
13407945|NCT00550446|26826310|FG010|Up To Week 12|Randomized not treated|0|||
13407946|NCT00550446|26826300|FG000|Post Week 12|Adverse Event|2|||
13407947|NCT00550446|26826301|FG001|Post Week 12|Adverse Event|1|||
13407948|NCT00550446|26826302|FG002|Post Week 12|Adverse Event|1|||
13407949|NCT00550446|26826303|FG003|Post Week 12|Adverse Event|1|||
13407950|NCT00550446|26826304|FG004|Post Week 12|Adverse Event|1|||
13407951|NCT00550446|26826305|FG005|Post Week 12|Adverse Event|1|||
13407952|NCT00550446|26826306|FG006|Post Week 12|Adverse Event|0|||
13407953|NCT00550446|26826307|FG007|Post Week 12|Adverse Event|0|||
13407954|NCT00550446|26826308|FG008|Post Week 12|Adverse Event|0|||
13407955|NCT00550446|26826309|FG009|Post Week 12|Adverse Event|4|||
13407956|NCT00550446|26826310|FG010|Post Week 12|Adverse Event|0|||
13407957|NCT00550446|26826300|FG000|Post Week 12|Lack of Efficacy|0|||
13407958|NCT00550446|26826301|FG001|Post Week 12|Lack of Efficacy|0|||
13407959|NCT00550446|26826302|FG002|Post Week 12|Lack of Efficacy|1|||
13407960|NCT00550446|26826303|FG003|Post Week 12|Lack of Efficacy|0|||
13407961|NCT00550446|26826304|FG004|Post Week 12|Lack of Efficacy|0|||
13407962|NCT00550446|26826305|FG005|Post Week 12|Lack of Efficacy|0|||
13407963|NCT00550446|26826306|FG006|Post Week 12|Lack of Efficacy|0|||
13407964|NCT00550446|26826307|FG007|Post Week 12|Lack of Efficacy|1|||
13407965|NCT00550446|26826308|FG008|Post Week 12|Lack of Efficacy|1|||
13407966|NCT00550446|26826309|FG009|Post Week 12|Lack of Efficacy|2|||
13407967|NCT00550446|26826310|FG010|Post Week 12|Lack of Efficacy|1|||
13407968|NCT00550446|26826300|FG000|Post Week 12|Lost to Follow-up|0|||
13407969|NCT00550446|26826301|FG001|Post Week 12|Lost to Follow-up|0|||
13407970|NCT00550446|26826302|FG002|Post Week 12|Lost to Follow-up|1|||
13407971|NCT00550446|26826303|FG003|Post Week 12|Lost to Follow-up|1|||
13407972|NCT00550446|26826304|FG004|Post Week 12|Lost to Follow-up|0|||
13407973|NCT00550446|26826305|FG005|Post Week 12|Lost to Follow-up|0|||
13407974|NCT00550446|26826306|FG006|Post Week 12|Lost to Follow-up|1|||
13407975|NCT00550446|26826307|FG007|Post Week 12|Lost to Follow-up|0|||
13407976|NCT00550446|26826308|FG008|Post Week 12|Lost to Follow-up|0|||
13407977|NCT00550446|26826309|FG009|Post Week 12|Lost to Follow-up|0|||
13407978|NCT00550446|26826310|FG010|Post Week 12|Lost to Follow-up|0|||
13407979|NCT00550446|26826300|FG000|Post Week 12|Withdrawal by Subject|0|||
13407980|NCT00550446|26826301|FG001|Post Week 12|Withdrawal by Subject|0|||
13407981|NCT00550446|26826302|FG002|Post Week 12|Withdrawal by Subject|0|||
13407982|NCT00550446|26826303|FG003|Post Week 12|Withdrawal by Subject|0|||
13407983|NCT00550446|26826304|FG004|Post Week 12|Withdrawal by Subject|1|||
13407984|NCT00550446|26826305|FG005|Post Week 12|Withdrawal by Subject|0|||
13407985|NCT00550446|26826306|FG006|Post Week 12|Withdrawal by Subject|0|||
13407986|NCT00550446|26826307|FG007|Post Week 12|Withdrawal by Subject|0|||
13407987|NCT00550446|26826308|FG008|Post Week 12|Withdrawal by Subject|0|||
13407988|NCT00550446|26826309|FG009|Post Week 12|Withdrawal by Subject|0|||
13407989|NCT00550446|26826310|FG010|Post Week 12|Withdrawal by Subject|0|||
13407990|NCT00550446|26826300|FG000|Post Week 12|Other|1|||
13407991|NCT00550446|26826301|FG001|Post Week 12|Other|1|||
13407992|NCT00550446|26826302|FG002|Post Week 12|Other|0|||
13407993|NCT00550446|26826303|FG003|Post Week 12|Other|1|||
13407994|NCT00550446|26826304|FG004|Post Week 12|Other|0|||
13407995|NCT00550446|26826305|FG005|Post Week 12|Other|0|||
13407996|NCT00550446|26826306|FG006|Post Week 12|Other|1|||
13407997|NCT00550446|26826307|FG007|Post Week 12|Other|0|||
13407998|NCT00550446|26826308|FG008|Post Week 12|Other|1|||
13407999|NCT00550446|26826309|FG009|Post Week 12|Other|1|||
13408000|NCT00550446|26826310|FG010|Post Week 12|Other|0|||
13408001|NCT00550407|26826351|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55|||
13408002|NCT00550407|26826352|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
13408003|NCT00550407|26826353|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
13408004|NCT00550407|26826351|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39|||
13408005|NCT00550407|26826352|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
13408006|NCT00550407|26826353|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
13408007|NCT00550407|26826351|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1|||
13408008|NCT00550407|26826352|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
13408009|NCT00550407|26826353|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
13408010|NCT00550407|26826351|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1|||
13408011|NCT00550407|26826352|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
13408012|NCT00550407|26826353|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
13408013|NCT00550407|26826351|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1|||
13408014|NCT00550407|26826352|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
13408015|NCT00550407|26826353|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
13408016|NCT00550407|26826351|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8|||
13408017|NCT00550407|26826352|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
13408018|NCT00550407|26826353|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
13408019|NCT00550407|26826351|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6|||
13408020|NCT00550407|26826352|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
13408021|NCT00550407|26826353|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
13408022|NCT00550407|26826351|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1|||
13408023|NCT00550407|26826352|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
13408024|NCT00550407|26826353|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
13408025|NCT00550407|26826351|FG000|26-Week Randomized Phase|Adverse Event|0|||
13408026|NCT00550407|26826352|FG001|26-Week Randomized Phase|Adverse Event|5|||
13408027|NCT00550407|26826353|FG002|26-Week Randomized Phase|Adverse Event|2|||
13408028|NCT00550407|26826351|FG000|26-Week Randomized Phase|Lack of Efficacy|0|||
13408029|NCT00550407|26826352|FG001|26-Week Randomized Phase|Lack of Efficacy|36|||
13408030|NCT00550407|26826353|FG002|26-Week Randomized Phase|Lack of Efficacy|19|||
13408031|NCT00550407|26826351|FG000|26-Week Randomized Phase|Investigator Discretion|0|||
13408032|NCT00550407|26826352|FG001|26-Week Randomized Phase|Investigator Discretion|1|||
13408033|NCT00550407|26826353|FG002|26-Week Randomized Phase|Investigator Discretion|0|||
13408034|NCT00550407|26826351|FG000|26-Week Randomized Phase|Withdrawal by Subject|0|||
13408035|NCT00550407|26826352|FG001|26-Week Randomized Phase|Withdrawal by Subject|1|||
13408036|NCT00550407|26826353|FG002|26-Week Randomized Phase|Withdrawal by Subject|3|||
13408037|NCT00550238|26826359|FG000|Overall Study|Adverse Event|88|||
13408038|NCT00550238|26826359|FG000|Overall Study|Death|34|||
13408039|NCT00550238|26826359|FG000|Overall Study|Disease progression|46|||
13408040|NCT00550238|26826359|FG000|Overall Study|Withdrawal by Subject|167|||
13408041|NCT00550238|26826359|FG000|Overall Study|Physician Decision|31|||
13408042|NCT00550238|26826359|FG000|Overall Study|Patient noncompliance|25|||
13408043|NCT00550238|26826359|FG000|Overall Study|Lost to Follow-up|13|||
13408044|NCT00550238|26826359|FG000|Overall Study|Sponsor decision|55|||
13408045|NCT00549939|26826396|FG000|12-week Double Blind Treatment Period|Adverse Event|1|||
13408046|NCT00549939|26826397|FG001|12-week Double Blind Treatment Period|Adverse Event|1|||
13408047|NCT00549939|26826398|FG002|12-week Double Blind Treatment Period|Adverse Event|2|||
13408048|NCT00549939|26826396|FG000|12-week Double Blind Treatment Period|Too many blood draws|0|||
13408049|NCT00549939|26826397|FG001|12-week Double Blind Treatment Period|Too many blood draws|1|||
13408050|NCT00549939|26826398|FG002|12-week Double Blind Treatment Period|Too many blood draws|0|||
13408051|NCT00549939|26826396|FG000|40-week Open Label Treatment Period|Adverse Event|0|||
13408052|NCT00549939|26826397|FG001|40-week Open Label Treatment Period|Adverse Event|2|||
13408053|NCT00549939|26826398|FG002|40-week Open Label Treatment Period|Adverse Event|1|||
13408054|NCT00549939|26826396|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0|||
13408055|NCT00549939|26826397|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1|||
13408056|NCT00549939|26826398|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0|||
13408057|NCT00549939|26826396|FG000|40-week Open Label Treatment Period|Protocol Violation|0|||
13408058|NCT00549939|26826397|FG001|40-week Open Label Treatment Period|Protocol Violation|1|||
13408059|NCT00549939|26826398|FG002|40-week Open Label Treatment Period|Protocol Violation|0|||
13408060|NCT00549939|26826396|FG000|40-week Open Label Treatment Period|Other|0|||
13408061|NCT00549939|26826397|FG001|40-week Open Label Treatment Period|Other|1|||
13408062|NCT00549939|26826398|FG002|40-week Open Label Treatment Period|Other|4|||
13408063|NCT00549900|26826409|FG000|Overall Study|Adverse Event|1|||
13408064|NCT00549848|26826446|FG000|Overall Study|Death|1|||
13408065|NCT00549848|26826447|FG001|Overall Study|Death|4|||
13408066|NCT00549848|26826448|FG002|Overall Study|Death|13|||
13408067|NCT00549848|26826446|FG000|Overall Study|Physician Decision|0|||
13408068|NCT00549848|26826447|FG001|Overall Study|Physician Decision|0|||
13408069|NCT00549848|26826448|FG002|Overall Study|Physician Decision|4|||
13408070|NCT00549848|26826446|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3|||
13408071|NCT00549848|26826447|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
13408072|NCT00549848|26826448|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
13408073|NCT00549848|26826446|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1|||
13408074|NCT00549848|26826447|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0|||
13408075|NCT00549848|26826448|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1|||
13408076|NCT00549848|26826446|FG000|Overall Study|Participant/Family Withdraw|2|||
13408077|NCT00549848|26826447|FG001|Overall Study|Participant/Family Withdraw|3|||
13408078|NCT00549848|26826448|FG002|Overall Study|Participant/Family Withdraw|5|||
13408079|NCT00549848|26826446|FG000|Overall Study|Second Malignancy|1|||
13408080|NCT00549848|26826447|FG001|Overall Study|Second Malignancy|0|||
13408081|NCT00549848|26826448|FG002|Overall Study|Second Malignancy|0|||
13408082|NCT00549848|26826446|FG000|Overall Study|Transplant|3|||
13408083|NCT00549848|26826447|FG001|Overall Study|Transplant|3|||
13408084|NCT00549848|26826448|FG002|Overall Study|Transplant|18|||
13408085|NCT00549848|26826446|FG000|Overall Study|Unacceptable Toxicity|1|||
13408086|NCT00549848|26826447|FG001|Overall Study|Unacceptable Toxicity|6|||
13408087|NCT00549848|26826448|FG002|Overall Study|Unacceptable Toxicity|6|||
13408088|NCT00549770|26826555|FG000|Overall Study|Protocol deviation|1|||
13408089|NCT00549770|26826556|FG001|Overall Study|Protocol deviation|1|||
13408090|NCT00549770|26826557|FG002|Overall Study|Protocol deviation|1|||
13408091|NCT00549770|26826558|FG003|Overall Study|Protocol deviation|2|||
13408092|NCT00549770|26826559|FG004|Overall Study|Protocol deviation|2|||
13408093|NCT00549770|26826560|FG005|Overall Study|Protocol deviation|2|||
13408094|NCT00549770|26826561|FG006|Overall Study|Protocol deviation|1|||
13408095|NCT00549770|26826562|FG007|Overall Study|Protocol deviation|2|||
13408096|NCT00549770|26826555|FG000|Overall Study|Administrative problems|0|||
13408097|NCT00549770|26826556|FG001|Overall Study|Administrative problems|1|||
13408098|NCT00549770|26826557|FG002|Overall Study|Administrative problems|0|||
13408099|NCT00549770|26826558|FG003|Overall Study|Administrative problems|0|||
13408100|NCT00549770|26826559|FG004|Overall Study|Administrative problems|0|||
13408101|NCT00549770|26826560|FG005|Overall Study|Administrative problems|0|||
13408102|NCT00549770|26826561|FG006|Overall Study|Administrative problems|0|||
13408103|NCT00549770|26826562|FG007|Overall Study|Administrative problems|1|||
13408104|NCT00549770|26826555|FG000|Overall Study|Lost to Follow-up|0|||
13408105|NCT00549770|26826556|FG001|Overall Study|Lost to Follow-up|0|||
13408106|NCT00549770|26826557|FG002|Overall Study|Lost to Follow-up|2|||
13408107|NCT00549770|26826558|FG003|Overall Study|Lost to Follow-up|2|||
13408108|NCT00549770|26826559|FG004|Overall Study|Lost to Follow-up|3|||
13408109|NCT00549770|26826560|FG005|Overall Study|Lost to Follow-up|2|||
13408110|NCT00549770|26826561|FG006|Overall Study|Lost to Follow-up|0|||
13408111|NCT00549770|26826562|FG007|Overall Study|Lost to Follow-up|0|||
13408112|NCT00549770|26826555|FG000|Overall Study|Withdrawal by Subject|4|||
13408113|NCT00549770|26826556|FG001|Overall Study|Withdrawal by Subject|6|||
13408114|NCT00549770|26826557|FG002|Overall Study|Withdrawal by Subject|4|||
13408115|NCT00549770|26826558|FG003|Overall Study|Withdrawal by Subject|5|||
13408116|NCT00549770|26826559|FG004|Overall Study|Withdrawal by Subject|6|||
13408117|NCT00549770|26826560|FG005|Overall Study|Withdrawal by Subject|6|||
13408118|NCT00549770|26826561|FG006|Overall Study|Withdrawal by Subject|4|||
13408119|NCT00549770|26826562|FG007|Overall Study|Withdrawal by Subject|9|||
13408120|NCT00549770|26826555|FG000|Overall Study|Lack of Efficacy|1|||
13408121|NCT00549770|26826556|FG001|Overall Study|Lack of Efficacy|0|||
13408122|NCT00549770|26826557|FG002|Overall Study|Lack of Efficacy|2|||
13408123|NCT00549770|26826558|FG003|Overall Study|Lack of Efficacy|3|||
13408124|NCT00549770|26826559|FG004|Overall Study|Lack of Efficacy|5|||
13408125|NCT00549770|26826560|FG005|Overall Study|Lack of Efficacy|1|||
13408126|NCT00549770|26826561|FG006|Overall Study|Lack of Efficacy|3|||
13408127|NCT00549770|26826562|FG007|Overall Study|Lack of Efficacy|8|||
13408128|NCT00549770|26826555|FG000|Overall Study|Abnormal test procedure results|0|||
13408129|NCT00549770|26826556|FG001|Overall Study|Abnormal test procedure results|0|||
13408130|NCT00549770|26826557|FG002|Overall Study|Abnormal test procedure results|0|||
13408131|NCT00549770|26826558|FG003|Overall Study|Abnormal test procedure results|2|||
13408132|NCT00549770|26826559|FG004|Overall Study|Abnormal test procedure results|0|||
13408133|NCT00549770|26826560|FG005|Overall Study|Abnormal test procedure results|1|||
13408134|NCT00549770|26826561|FG006|Overall Study|Abnormal test procedure results|1|||
13408135|NCT00549770|26826562|FG007|Overall Study|Abnormal test procedure results|1|||
13408136|NCT00549770|26826555|FG000|Overall Study|Abnormal laboratory values|0|||
13408137|NCT00549770|26826556|FG001|Overall Study|Abnormal laboratory values|0|||
13408138|NCT00549770|26826557|FG002|Overall Study|Abnormal laboratory values|0|||
13408139|NCT00549770|26826558|FG003|Overall Study|Abnormal laboratory values|0|||
13408140|NCT00549770|26826559|FG004|Overall Study|Abnormal laboratory values|0|||
13408141|NCT00549770|26826560|FG005|Overall Study|Abnormal laboratory values|1|||
13408142|NCT00549770|26826561|FG006|Overall Study|Abnormal laboratory values|0|||
13408143|NCT00549770|26826562|FG007|Overall Study|Abnormal laboratory values|0|||
13408144|NCT00549770|26826555|FG000|Overall Study|Adverse Event|1|||
13408145|NCT00549770|26826556|FG001|Overall Study|Adverse Event|3|||
13408146|NCT00549770|26826557|FG002|Overall Study|Adverse Event|1|||
13408147|NCT00549770|26826558|FG003|Overall Study|Adverse Event|2|||
13408148|NCT00549770|26826559|FG004|Overall Study|Adverse Event|1|||
13408149|NCT00549770|26826560|FG005|Overall Study|Adverse Event|0|||
13408150|NCT00549770|26826561|FG006|Overall Study|Adverse Event|5|||
13408151|NCT00549770|26826562|FG007|Overall Study|Adverse Event|4|||
13408152|NCT00549757|26826627|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590|||
13408153|NCT00549757|26826628|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462|||
13408154|NCT00549757|26826627|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98|||
13408155|NCT00549757|26826628|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58|||
13408156|NCT00549757|26826627|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
13408157|NCT00549757|26826628|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
13408158|NCT00549757|26826627|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47|||
13408159|NCT00549757|26826628|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53|||
13408160|NCT00549757|26826627|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
13408161|NCT00549757|26826628|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
13408162|NCT00549757|26826627|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41|||
13408163|NCT00549757|26826628|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29|||
13408164|NCT00549757|26826627|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857|||
13408165|NCT00549757|26826628|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019|||
13408166|NCT00549757|26826627|FG000|Active Treatment Phase: Max. 50 Months|Death|188|||
13408167|NCT00549757|26826628|FG001|Active Treatment Phase: Max. 50 Months|Death|200|||
13408168|NCT00549757|26826627|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353|||
13408169|NCT00549757|26826628|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380|||
13408170|NCT00549757|26826627|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69|||
13408171|NCT00549757|26826628|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55|||
13408172|NCT00549757|26826627|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8|||
13408173|NCT00549757|26826628|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9|||
13408174|NCT00549757|26826627|FG000|Extension Period (in Average 9 Months)|Death|143|||
13408175|NCT00549757|26826628|FG001|Extension Period (in Average 9 Months)|Death|136|||
13408176|NCT00549757|26826627|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52|||
13408177|NCT00549757|26826628|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47|||
13408178|NCT00549757|26826627|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9|||
13408179|NCT00549757|26826628|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16|||
13408180|NCT00549757|26826627|FG000|Extension Period (in Average 9 Months)|Patient's request|421|||
13408181|NCT00549757|26826628|FG001|Extension Period (in Average 9 Months)|Patient's request|436|||
13408182|NCT00549718|26826655|FG000|Overall Study|Insufficient clinical response|20|||
13408183|NCT00549718|26826656|FG001|Overall Study|Insufficient clinical response|7|||
13408184|NCT00549718|26826657|FG002|Overall Study|Insufficient clinical response|18|||
13408185|NCT00549718|26826658|FG003|Overall Study|Insufficient clinical response|32|||
13408186|NCT00549718|26826655|FG000|Overall Study|Adverse Event|6|||
13408187|NCT00549718|26826656|FG001|Overall Study|Adverse Event|8|||
13408188|NCT00549718|26826657|FG002|Overall Study|Adverse Event|7|||
13408189|NCT00549718|26826658|FG003|Overall Study|Adverse Event|3|||
13408190|NCT00549718|26826655|FG000|Overall Study|Lost to Follow-up|4|||
13408191|NCT00549718|26826656|FG001|Overall Study|Lost to Follow-up|2|||
13408192|NCT00549718|26826657|FG002|Overall Study|Lost to Follow-up|0|||
13408193|NCT00549718|26826658|FG003|Overall Study|Lost to Follow-up|6|||
13408194|NCT00549718|26826655|FG000|Overall Study|Withdrawal by Subject|9|||
13408195|NCT00549718|26826656|FG001|Overall Study|Withdrawal by Subject|18|||
13408196|NCT00549718|26826657|FG002|Overall Study|Withdrawal by Subject|12|||
13408197|NCT00549718|26826658|FG003|Overall Study|Withdrawal by Subject|13|||
13408198|NCT00549718|26826655|FG000|Overall Study|Administrative|2|||
13408199|NCT00549718|26826656|FG001|Overall Study|Administrative|2|||
13408200|NCT00549718|26826657|FG002|Overall Study|Administrative|2|||
13408201|NCT00549718|26826658|FG003|Overall Study|Administrative|1|||
13408202|NCT00549640|26826675|FG000|Overall Study|Withdrawal by Subject|6|||
13408203|NCT00549640|26826676|FG001|Overall Study|Withdrawal by Subject|12|||
13408204|NCT00549640|26826675|FG000|Overall Study|Adverse Event|5|||
13408205|NCT00549640|26826676|FG001|Overall Study|Adverse Event|0|||
13408206|NCT00549640|26826675|FG000|Overall Study|Lost to Follow-up|7|||
13408207|NCT00549640|26826676|FG001|Overall Study|Lost to Follow-up|4|||
13408208|NCT00549601|26826708|FG000|Randomized|Protocol Violation|0|||
13408209|NCT00549601|26826709|FG001|Randomized|Protocol Violation|0|||
13408210|NCT00549601|26826710|FG002|Randomized|Protocol Violation|1|||
13408211|NCT00549601|26826708|FG000|Randomized|Withdrawal by Subject|0|||
13408212|NCT00549601|26826709|FG001|Randomized|Withdrawal by Subject|1|||
13408213|NCT00549601|26826710|FG002|Randomized|Withdrawal by Subject|1|||
13408214|NCT00549601|26826708|FG000|Received Study Drug|Adverse Event|2|||
13408215|NCT00549601|26826709|FG001|Received Study Drug|Adverse Event|5|||
13408216|NCT00549601|26826710|FG002|Received Study Drug|Adverse Event|1|||
13408217|NCT00549601|26826708|FG000|Received Study Drug|Death|0|||
13408218|NCT00549601|26826709|FG001|Received Study Drug|Death|1|||
13408219|NCT00549601|26826710|FG002|Received Study Drug|Death|0|||
13408220|NCT00549601|26826708|FG000|Received Study Drug|Lost to Follow-up|0|||
13408221|NCT00549601|26826709|FG001|Received Study Drug|Lost to Follow-up|1|||
13408222|NCT00549601|26826710|FG002|Received Study Drug|Lost to Follow-up|1|||
13408223|NCT00549601|26826708|FG000|Received Study Drug|Protocol Violation|3|||
13408224|NCT00549601|26826709|FG001|Received Study Drug|Protocol Violation|4|||
13408225|NCT00549601|26826710|FG002|Received Study Drug|Protocol Violation|1|||
13408226|NCT00549601|26826708|FG000|Received Study Drug|Withdrawal by Subject|2|||
13408227|NCT00549601|26826709|FG001|Received Study Drug|Withdrawal by Subject|0|||
13408228|NCT00549601|26826710|FG002|Received Study Drug|Withdrawal by Subject|1|||
13408229|NCT00549562|26826720|FG000|Overall Study|Adverse Event|1|||
13408230|NCT00549562|26826720|FG000|Overall Study|Lack of Efficacy|1|||
13408231|NCT00549549|26826799|FG000|Overall Study|Adverse Event|5|||
13408232|NCT00549549|26826800|FG001|Overall Study|Adverse Event|3|||
13408233|NCT00549549|26826801|FG002|Overall Study|Adverse Event|1|||
13408234|NCT00549549|26826802|FG003|Overall Study|Adverse Event|9|||
13408235|NCT00549549|26826799|FG000|Overall Study|Lack of Efficacy|9|||
13408236|NCT00549549|26826800|FG001|Overall Study|Lack of Efficacy|6|||
13408237|NCT00549549|26826801|FG002|Overall Study|Lack of Efficacy|4|||
13408238|NCT00549549|26826802|FG003|Overall Study|Lack of Efficacy|2|||
13408239|NCT00549549|26826799|FG000|Overall Study|Lost to Follow-up|1|||
13408240|NCT00549549|26826800|FG001|Overall Study|Lost to Follow-up|0|||
13408241|NCT00549549|26826801|FG002|Overall Study|Lost to Follow-up|1|||
13408242|NCT00549549|26826802|FG003|Overall Study|Lost to Follow-up|2|||
13408243|NCT00549549|26826799|FG000|Overall Study|Withdrawal by Subject|0|||
13408244|NCT00549549|26826800|FG001|Overall Study|Withdrawal by Subject|4|||
13408245|NCT00549549|26826801|FG002|Overall Study|Withdrawal by Subject|1|||
13408246|NCT00549549|26826802|FG003|Overall Study|Withdrawal by Subject|0|||
13408247|NCT00549549|26826799|FG000|Overall Study|Other|9|||
13408248|NCT00549549|26826800|FG001|Overall Study|Other|9|||
13408249|NCT00549549|26826801|FG002|Overall Study|Other|9|||
13408250|NCT00549549|26826802|FG003|Overall Study|Other|11|||
13408251|NCT00549549|26826799|FG000|Overall Study|Randomized but not treated|0|||
13408252|NCT00549549|26826800|FG001|Overall Study|Randomized but not treated|0|||
13408253|NCT00549549|26826801|FG002|Overall Study|Randomized but not treated|1|||
13408254|NCT00549549|26826802|FG003|Overall Study|Randomized but not treated|1|||
13408255|NCT00549445|26826815|FG000|Overall Study|Sputum & Blood Samples Not Available|15|||
13408256|NCT00549445|26826816|FG001|Overall Study|Sputum & Blood Samples Not Available|17|||
13408257|NCT00549328|26826827|FG000|Overall Study|Adverse Event|2|||
13408258|NCT00549328|26826827|FG000|Overall Study|Disease Progression|10|||
13408259|NCT00549328|26826827|FG000|Overall Study|Death|1|||
13408260|NCT00549328|26826827|FG000|Overall Study|Use of Prohibited Medication|1|||
13408261|NCT00549302|26826845|FG000|Double-Blind|Death|2|||
13408262|NCT00549302|26826846|FG001|Double-Blind|Death|9|||
13408263|NCT00549302|26826847|FG002|Double-Blind|Death|0|||
13408264|NCT00549302|26826845|FG000|Double-Blind|Adverse Event|3|||
13408265|NCT00549302|26826846|FG001|Double-Blind|Adverse Event|16|||
13408266|NCT00549302|26826847|FG002|Double-Blind|Adverse Event|0|||
13408267|NCT00549302|26826845|FG000|Double-Blind|Withdrawal by Subject|3|||
13408268|NCT00549302|26826846|FG001|Double-Blind|Withdrawal by Subject|8|||
13408269|NCT00549302|26826847|FG002|Double-Blind|Withdrawal by Subject|0|||
13408270|NCT00549302|26826845|FG000|Double-Blind|Investigator Decision|1|||
13408271|NCT00549302|26826846|FG001|Double-Blind|Investigator Decision|5|||
13408272|NCT00549302|26826847|FG002|Double-Blind|Investigator Decision|0|||
13408273|NCT00549302|26826845|FG000|Double-Blind|Sponsor Decision|0|||
13408274|NCT00549302|26826846|FG001|Double-Blind|Sponsor Decision|1|||
13408275|NCT00549302|26826847|FG002|Double-Blind|Sponsor Decision|0|||
13408276|NCT00549302|26826845|FG000|Double-Blind|Lost to Follow-up|1|||
13408277|NCT00549302|26826846|FG001|Double-Blind|Lost to Follow-up|2|||
13408278|NCT00549302|26826847|FG002|Double-Blind|Lost to Follow-up|0|||
13408279|NCT00549302|26826845|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1|||
13408280|NCT00549302|26826846|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10|||
13408281|NCT00549302|26826847|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0|||
13408282|NCT00549302|26826845|FG000|Double-Blind|New condition or starts new therapy|0|||
13408283|NCT00549302|26826846|FG001|Double-Blind|New condition or starts new therapy|2|||
13408284|NCT00549302|26826847|FG002|Double-Blind|New condition or starts new therapy|0|||
13408285|NCT00549302|26826845|FG000|Open-Label|Adverse Event|0|||
13408286|NCT00549302|26826846|FG001|Open-Label|Adverse Event|0|||
13408287|NCT00549302|26826847|FG002|Open-Label|Adverse Event|11|||
13408288|NCT00549302|26826845|FG000|Open-Label|Death|0|||
13408289|NCT00549302|26826846|FG001|Open-Label|Death|0|||
13408290|NCT00549302|26826847|FG002|Open-Label|Death|40|||
13408291|NCT00549302|26826845|FG000|Open-Label|Investigator Decision|0|||
13408292|NCT00549302|26826846|FG001|Open-Label|Investigator Decision|0|||
13408293|NCT00549302|26826847|FG002|Open-Label|Investigator Decision|5|||
13408294|NCT00549302|26826845|FG000|Open-Label|Lost to Follow-up|0|||
13408295|NCT00549302|26826846|FG001|Open-Label|Lost to Follow-up|0|||
13408296|NCT00549302|26826847|FG002|Open-Label|Lost to Follow-up|2|||
13408297|NCT00549302|26826845|FG000|Open-Label|Other|0|||
13408298|NCT00549302|26826846|FG001|Open-Label|Other|0|||
13408299|NCT00549302|26826847|FG002|Open-Label|Other|3|||
13408300|NCT00549302|26826845|FG000|Open-Label|New drug pulmonary atrial hypertension|0|||
13408301|NCT00549302|26826846|FG001|Open-Label|New drug pulmonary atrial hypertension|0|||
13408302|NCT00549302|26826847|FG002|Open-Label|New drug pulmonary atrial hypertension|2|||
13408303|NCT00549302|26826845|FG000|Open-Label|Withdrawal by Subject|0|||
13408304|NCT00549302|26826846|FG001|Open-Label|Withdrawal by Subject|0|||
13408305|NCT00549302|26826847|FG002|Open-Label|Withdrawal by Subject|6|||
13408306|NCT00549198|26826974|FG000|Overall Study|Adverse Event|28|||
13408307|NCT00549198|26826975|FG001|Overall Study|Adverse Event|26|||
13408308|NCT00549198|26826974|FG000|Overall Study|Insufficient Viral Load Response|4|||
13408309|NCT00549198|26826975|FG001|Overall Study|Insufficient Viral Load Response|2|||
13408310|NCT00549198|26826974|FG000|Overall Study|Protocol-defined Virological Failure|7|||
13408311|NCT00549198|26826975|FG001|Overall Study|Protocol-defined Virological Failure|0|||
13408312|NCT00549198|26826974|FG000|Overall Study|Non-compliance|2|||
13408313|NCT00549198|26826975|FG001|Overall Study|Non-compliance|4|||
13408314|NCT00549198|26826974|FG000|Overall Study|Lost to Follow-up|7|||
13408315|NCT00549198|26826975|FG001|Overall Study|Lost to Follow-up|8|||
13408316|NCT00549198|26826974|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3|||
13408317|NCT00549198|26826975|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0|||
13408318|NCT00549198|26826974|FG000|Overall Study|Protocol Violation|7|||
13408319|NCT00549198|26826975|FG001|Overall Study|Protocol Violation|2|||
13408320|NCT00549198|26826974|FG000|Overall Study|Investigator Decision|4|||
13408321|NCT00549198|26826975|FG001|Overall Study|Investigator Decision|3|||
13408322|NCT00549198|26826974|FG000|Overall Study|Withdrawal by Subject|7|||
13408323|NCT00549198|26826975|FG001|Overall Study|Withdrawal by Subject|7|||
13408324|NCT00549198|26826974|FG000|Overall Study|Disease Progression|1|||
13408325|NCT00549198|26826975|FG001|Overall Study|Disease Progression|0|||
13408326|NCT00549198|26826974|FG000|Overall Study|Participant Moved|2|||
13408327|NCT00549198|26826975|FG001|Overall Study|Participant Moved|0|||
13408328|NCT00549198|26826974|FG000|Overall Study|Participant not able to perform Week 96|1|||
13408329|NCT00549198|26826975|FG001|Overall Study|Participant not able to perform Week 96|0|||
13408330|NCT00549198|26826974|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1|||
13408331|NCT00549198|26826975|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0|||
13408332|NCT00549198|26826974|FG000|Overall Study|Prohibited Medication|1|||
13408333|NCT00549198|26826975|FG001|Overall Study|Prohibited Medication|2|||
13408334|NCT00549198|26826974|FG000|Overall Study|Participant planning pregnancy|1|||
13408335|NCT00549198|26826975|FG001|Overall Study|Participant planning pregnancy|0|||
13408336|NCT00549198|26826974|FG000|Overall Study|Participant overweight, no scan possible|1|||
13408337|NCT00549198|26826975|FG001|Overall Study|Participant overweight, no scan possible|0|||
13408338|NCT00549198|26826974|FG000|Overall Study|No scan facilities|0|||
13408339|NCT00549198|26826975|FG001|Overall Study|No scan facilities|2|||
13408340|NCT00549198|26826974|FG000|Overall Study|Pregnancy|0|||
13408341|NCT00549198|26826975|FG001|Overall Study|Pregnancy|3|||
13408342|NCT00549198|26826974|FG000|Overall Study|Not Exposed to Study Drug|3|||
13408343|NCT00549198|26826975|FG001|Overall Study|Not Exposed to Study Drug|4|||
13408344|NCT00549055|26826987|FG000|Overall Study|Adverse Event|4|||
13408345|NCT00549055|26826987|FG000|Overall Study|Lack of Efficacy|18|||
13408346|NCT00549055|26826987|FG000|Overall Study|Stabilization|5|||
13408347|NCT00549055|26826987|FG000|Overall Study|Progression to fibrosis|2|||
13408348|NCT00549055|26826987|FG000|Overall Study|Decrease of size|1|||
13408349|NCT00549055|26826987|FG000|Overall Study|Active choroidal neovascula increased|1|||
13408350|NCT00549055|26826987|FG000|Overall Study|Vitreous hemorrhage|1|||
13408351|NCT00549055|26826987|FG000|Overall Study|Growth choroidal neovascularisation|1|||
13408352|NCT00549055|26826987|FG000|Overall Study|Choroidal neovascularization|1|||
13408353|NCT00549055|26826987|FG000|Overall Study|Very low visual acuity (VA)|1|||
13408354|NCT00548847|26826994|FG000|Overall Study|Disease progression|7|||
13408355|NCT00548808|26827023|FG000|Overall Study|Lost to Follow-up|9|||
13408356|NCT00548808|26827024|FG001|Overall Study|Lost to Follow-up|3|||
13408357|NCT00548808|26827023|FG000|Overall Study|Protocol Violation|8|||
13408358|NCT00548808|26827024|FG001|Overall Study|Protocol Violation|8|||
13408359|NCT00548808|26827023|FG000|Overall Study|Withdrawal by Subject|8|||
13408360|NCT00548808|26827024|FG001|Overall Study|Withdrawal by Subject|4|||
13408361|NCT00548808|26827023|FG000|Overall Study|Physician Decision|6|||
13408362|NCT00548808|26827024|FG001|Overall Study|Physician Decision|3|||
13408363|NCT00548808|26827023|FG000|Overall Study|Adverse Event|4|||
13408364|NCT00548808|26827024|FG001|Overall Study|Adverse Event|5|||
13408365|NCT00548808|26827023|FG000|Overall Study|Death|2|||
13408366|NCT00548808|26827024|FG001|Overall Study|Death|0|||
13408367|NCT00548808|26827023|FG000|Overall Study|Entry Criteria Not Met|2|||
13408368|NCT00548808|26827024|FG001|Overall Study|Entry Criteria Not Met|2|||
13408369|NCT00548808|26827023|FG000|Overall Study|Lack of Efficacy|2|||
13408370|NCT00548808|26827024|FG001|Overall Study|Lack of Efficacy|0|||
13408371|NCT00548808|26827023|FG000|Overall Study|Sponsor Decision|1|||
13408372|NCT00548808|26827024|FG001|Overall Study|Sponsor Decision|1|||
13408373|NCT00548717|26827048|FG000|Overall Study|Death|5|||
13408374|NCT00548717|26827049|FG001|Overall Study|Death|2|||
13408375|NCT00548717|26827048|FG000|Overall Study|Relapse|3|||
13408376|NCT00548717|26827049|FG001|Overall Study|Relapse|0|||
13408377|NCT00548717|26827048|FG000|Overall Study|Alternative treatment for GVHD|1|||
13408378|NCT00548717|26827049|FG001|Overall Study|Alternative treatment for GVHD|0|||
13408379|NCT00548548|26827076|FG000|Overall Study|Death|345|||
13408380|NCT00548548|26827077|FG001|Overall Study|Death|348|||
13408381|NCT00548548|26827076|FG000|Overall Study|Lost to Follow-up|17|||
13408382|NCT00548548|26827077|FG001|Overall Study|Lost to Follow-up|18|||
13408383|NCT00548405|26827105|FG000|Overall Study|Adverse Event|6|||
13408384|NCT00548405|26827106|FG001|Overall Study|Adverse Event|2|||
13408385|NCT00548405|26827107|FG002|Overall Study|Adverse Event|0|||
13408386|NCT00548405|26827105|FG000|Overall Study|Lack of Efficacy|6|||
13408387|NCT00548405|26827106|FG001|Overall Study|Lack of Efficacy|0|||
13408388|NCT00548405|26827107|FG002|Overall Study|Lack of Efficacy|0|||
13408389|NCT00548405|26827105|FG000|Overall Study|Physician Decision|3|||
13408390|NCT00548405|26827106|FG001|Overall Study|Physician Decision|4|||
13408391|NCT00548405|26827107|FG002|Overall Study|Physician Decision|1|||
13408392|NCT00548405|26827105|FG000|Overall Study|Pregnancy|1|||
13408393|NCT00548405|26827106|FG001|Overall Study|Pregnancy|0|||
13408394|NCT00548405|26827107|FG002|Overall Study|Pregnancy|0|||
13408395|NCT00548405|26827105|FG000|Overall Study|Protocol Violation|1|||
13408396|NCT00548405|26827106|FG001|Overall Study|Protocol Violation|0|||
13408397|NCT00548405|26827107|FG002|Overall Study|Protocol Violation|0|||
13408398|NCT00548405|26827105|FG000|Overall Study|Withdrawal by Subject|36|||
13408399|NCT00548405|26827106|FG001|Overall Study|Withdrawal by Subject|12|||
13408400|NCT00548405|26827107|FG002|Overall Study|Withdrawal by Subject|5|||
13408401|NCT00548405|26827105|FG000|Overall Study|Lost to Follow-up|1|||
13408402|NCT00548405|26827106|FG001|Overall Study|Lost to Follow-up|1|||
13408403|NCT00548405|26827107|FG002|Overall Study|Lost to Follow-up|2|||
13408404|NCT00548405|26827105|FG000|Overall Study|Death|0|||
13408405|NCT00548405|26827106|FG001|Overall Study|Death|1|||
13408406|NCT00548405|26827107|FG002|Overall Study|Death|1|||
13408407|NCT00548405|26827105|FG000|Overall Study|Sponsor decision|1|||
13408408|NCT00548405|26827106|FG001|Overall Study|Sponsor decision|0|||
13408409|NCT00548405|26827107|FG002|Overall Study|Sponsor decision|0|||
13408410|NCT00548405|26827105|FG000|Overall Study|Randomized but not treated|1|||
13408411|NCT00548405|26827106|FG001|Overall Study|Randomized but not treated|0|||
13408412|NCT00548405|26827107|FG002|Overall Study|Randomized but not treated|0|||
13408413|NCT00548340|26827134|FG000|Overall Study|Protocol Violation|2|||
13408414|NCT00548340|26827135|FG001|Overall Study|Protocol Violation|3|||
13408415|NCT00548340|26827136|FG002|Overall Study|Protocol Violation|3|||
13408416|NCT00548340|26827134|FG000|Overall Study|Adverse Event|2|||
13408417|NCT00548340|26827135|FG001|Overall Study|Adverse Event|2|||
13408418|NCT00548340|26827136|FG002|Overall Study|Adverse Event|2|||
13408419|NCT00548340|26827134|FG000|Overall Study|Lost to Follow-up|1|||
13408420|NCT00548340|26827135|FG001|Overall Study|Lost to Follow-up|1|||
13408421|NCT00548340|26827136|FG002|Overall Study|Lost to Follow-up|0|||
13408422|NCT00548340|26827134|FG000|Overall Study|Withdrawal by Subject|2|||
13408423|NCT00548340|26827135|FG001|Overall Study|Withdrawal by Subject|4|||
13408424|NCT00548340|26827136|FG002|Overall Study|Withdrawal by Subject|3|||
13408425|NCT00548340|26827134|FG000|Overall Study|Other|1|||
13408426|NCT00548340|26827135|FG001|Overall Study|Other|1|||
13408427|NCT00548340|26827136|FG002|Overall Study|Other|1|||
13408428|NCT00548327|26827161|FG000|Overall Study|Adverse Event|0|||
13408429|NCT00548327|26827162|FG001|Overall Study|Adverse Event|1|||
13408430|NCT00548262|26827189|FG000|Overall Study|Death|21|||
13408431|NCT00548262|26827189|FG000|Overall Study|Adverse Event|2|||
13408432|NCT00548262|26827189|FG000|Overall Study|Lack of Efficacy|4|||
13408433|NCT00548262|26827189|FG000|Overall Study|Lost to Follow-up|1|||
13408434|NCT00548262|26827189|FG000|Overall Study|Other|3|||
13408435|NCT00548262|26827189|FG000|Overall Study|Withdrawal by Subject|1|||
13408436|NCT00548249|26827242|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3|||
13408437|NCT00548249|26827243|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
13408438|NCT00548249|26827244|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
13408439|NCT00548249|26827245|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2|||
13408440|NCT00548249|26827246|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
13408441|NCT00548249|26827242|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5|||
13408442|NCT00548249|26827243|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
13408443|NCT00548249|26827244|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3|||
13408444|NCT00548249|26827245|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
13408445|NCT00548249|26827246|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2|||
13408446|NCT00548249|26827242|FG000|Overall Study|Protocol Violation|1|||
13408447|NCT00548249|26827243|FG001|Overall Study|Protocol Violation|1|||
13408448|NCT00548249|26827244|FG002|Overall Study|Protocol Violation|4|||
13408449|NCT00548249|26827245|FG003|Overall Study|Protocol Violation|0|||
13408450|NCT00548249|26827246|FG004|Overall Study|Protocol Violation|3|||
13408451|NCT00548249|26827242|FG000|Overall Study|Miscellaneous|2|||
13408452|NCT00548249|26827243|FG001|Overall Study|Miscellaneous|3|||
13408453|NCT00548249|26827244|FG002|Overall Study|Miscellaneous|2|||
13408454|NCT00548249|26827245|FG003|Overall Study|Miscellaneous|0|||
13408455|NCT00548249|26827246|FG004|Overall Study|Miscellaneous|2|||
13408456|NCT00548249|26827242|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
13408457|NCT00548249|26827243|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
13408458|NCT00548249|26827244|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2|||
13408459|NCT00548249|26827245|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1|||
13408460|NCT00548249|26827246|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4|||
13408461|NCT00548249|26827242|FG000|Overall Study|Adverse Event|2|||
13408462|NCT00548249|26827243|FG001|Overall Study|Adverse Event|2|||
13408463|NCT00548249|26827244|FG002|Overall Study|Adverse Event|0|||
13408464|NCT00548249|26827245|FG003|Overall Study|Adverse Event|1|||
13408465|NCT00548249|26827246|FG004|Overall Study|Adverse Event|1|||
13408466|NCT00548249|26827242|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
13408467|NCT00548249|26827243|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
13408468|NCT00548249|26827244|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1|||
13408469|NCT00548249|26827245|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3|||
13408470|NCT00548249|26827246|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2|||
13408471|NCT00548249|26827242|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
13408472|NCT00548249|26827243|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
13408473|NCT00548249|26827244|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1|||
13408474|NCT00548249|26827245|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
13408475|NCT00548249|26827246|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
13408476|NCT00548249|26827242|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
13408477|NCT00548249|26827243|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
13408478|NCT00548249|26827244|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
13408479|NCT00548249|26827245|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
13408480|NCT00548249|26827246|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0|||
13408481|NCT00548249|26827242|FG000|Overall Study|Prolonged hospitalization|0|||
13408482|NCT00548249|26827243|FG001|Overall Study|Prolonged hospitalization|0|||
13408483|NCT00548249|26827244|FG002|Overall Study|Prolonged hospitalization|2|||
13408484|NCT00548249|26827245|FG003|Overall Study|Prolonged hospitalization|1|||
13408485|NCT00548249|26827246|FG004|Overall Study|Prolonged hospitalization|0|||
13408486|NCT00548249|26827242|FG000|Overall Study|Withdrawal by Subject|2|||
13408487|NCT00548249|26827243|FG001|Overall Study|Withdrawal by Subject|0|||
13408488|NCT00548249|26827244|FG002|Overall Study|Withdrawal by Subject|0|||
13408489|NCT00548249|26827245|FG003|Overall Study|Withdrawal by Subject|0|||
13408490|NCT00548249|26827246|FG004|Overall Study|Withdrawal by Subject|0|||
13408491|NCT00548249|26827242|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
13408492|NCT00548249|26827243|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
13408493|NCT00548249|26827244|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
13408494|NCT00548249|26827245|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
13408495|NCT00548249|26827246|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
13408496|NCT00548249|26827242|FG000|Overall Study|Sponsor's request|0|||
13408497|NCT00548249|26827243|FG001|Overall Study|Sponsor's request|0|||
13408498|NCT00548249|26827244|FG002|Overall Study|Sponsor's request|0|||
13408499|NCT00548249|26827245|FG003|Overall Study|Sponsor's request|1|||
13408500|NCT00548249|26827246|FG004|Overall Study|Sponsor's request|0|||
13408501|NCT00548184|26827252|FG000|Overall Study|Adverse Event|3|||
13408502|NCT00548184|26827252|FG000|Overall Study|took other drug|1|||
13408503|NCT00548184|26827252|FG000|Overall Study|Found Her2 negative|1|||
13408504|NCT00548145|26827265|FG000|Overall Study|Death|0|||
13408505|NCT00548145|26827266|FG001|Overall Study|Death|1|||
13408506|NCT00548145|26827265|FG000|Overall Study|Withdrawal by Subject|0|||
13408507|NCT00548145|26827266|FG001|Overall Study|Withdrawal by Subject|2|||
13408508|NCT00548145|26827265|FG000|Overall Study|Physician Decision|1|||
13408509|NCT00548145|26827266|FG001|Overall Study|Physician Decision|1|||
13408510|NCT00548093|26827303|FG000|Overall Study|Death|33|||
13408511|NCT00548093|26827304|FG001|Overall Study|Death|13|||
13408512|NCT00548093|26827303|FG000|Overall Study|Lost to Follow-up|3|||
13408513|NCT00548093|26827304|FG001|Overall Study|Lost to Follow-up|1|||
13408514|NCT00548093|26827303|FG000|Overall Study|Objective progression or relapse|1|||
13408515|NCT00548093|26827304|FG001|Overall Study|Objective progression or relapse|1|||
13408516|NCT00548093|26827303|FG000|Overall Study|Other|11|||
13408517|NCT00548093|26827304|FG001|Overall Study|Other|1|||
13408518|NCT00548093|26827303|FG000|Overall Study|Withdrawal by Subject|1|||
13408519|NCT00548093|26827304|FG001|Overall Study|Withdrawal by Subject|0|||
13408520|NCT00548093|26827303|FG000|Overall Study|Completed post-treatment follow-up|1|||
13408521|NCT00548093|26827304|FG001|Overall Study|Completed post-treatment follow-up|0|||
13408522|NCT00547911|26827348|FG000|Overall Study|Adverse Event|0|||
13408523|NCT00547911|26827349|FG001|Overall Study|Adverse Event|0|||
13408524|NCT00547911|26827350|FG002|Overall Study|Adverse Event|0|||
13408525|NCT00547911|26827351|FG003|Overall Study|Adverse Event|1|||
13408526|NCT00547911|26827352|FG004|Overall Study|Adverse Event|0|||
13408527|NCT00547911|26827353|FG005|Overall Study|Adverse Event|0|||
13408528|NCT00547703|26827366|FG000|Overall Study|Lost to Follow-up|1|||
13408529|NCT00547703|26827367|FG001|Overall Study|Lost to Follow-up|0|||
13408530|NCT00547534|26827375|FG000|Overall Study|Adverse Event|7|||
13408531|NCT00547534|26827375|FG000|Overall Study|Disease Progression|4|||
13408532|NCT00547521|26827452|FG000|Short Term Study (4 Months)|Adverse Event|1|||
13408533|NCT00547521|26827453|FG001|Short Term Study (4 Months)|Adverse Event|0|||
13408534|NCT00547521|26827452|FG000|Short Term Study (4 Months)|Lack of Efficacy|0|||
13408535|NCT00547521|26827453|FG001|Short Term Study (4 Months)|Lack of Efficacy|2|||
13408536|NCT00547521|26827452|FG000|Short Term Study (4 Months)|Withdrawal of consent|0|||
13408537|NCT00547521|26827453|FG001|Short Term Study (4 Months)|Withdrawal of consent|1|||
13408538|NCT00547521|26827452|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0|||
13408539|NCT00547521|26827453|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1|||
13408540|NCT00547521|26827452|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0|||
13408541|NCT00547521|26827453|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14|||
13408542|NCT00547521|26827452|FG000|Long Term Extension (LTE) Study|Adverse Event|0|||
13408543|NCT00547521|26827453|FG001|Long Term Extension (LTE) Study|Adverse Event|9|||
13408544|NCT00547521|26827452|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0|||
13408545|NCT00547521|26827453|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3|||
13408546|NCT00547521|26827452|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0|||
13408547|NCT00547521|26827453|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2|||
13408548|NCT00547521|26827452|FG000|Long Term Extension (LTE) Study|Other|0|||
13408549|NCT00547521|26827453|FG001|Long Term Extension (LTE) Study|Other|2|||
13408550|NCT00547521|26827452|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0|||
13408551|NCT00547521|26827453|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1|||
13408552|NCT00547378|26827473|FG000|Randomized Cohort|Withdrawal by Subject|7|||
13408553|NCT00547378|26827474|FG001|Randomized Cohort|Withdrawal by Subject|5|||
13408554|NCT00547378|26827475|FG002|Randomized Cohort|Withdrawal by Subject|0|||
13408555|NCT00547378|26827473|FG000|Randomized Cohort|Death|0|||
13408556|NCT00547378|26827474|FG001|Randomized Cohort|Death|1|||
13408557|NCT00547378|26827475|FG002|Randomized Cohort|Death|0|||
13408558|NCT00547378|26827473|FG000|Randomized Cohort|Lost to Follow-up|1|||
13408559|NCT00547378|26827474|FG001|Randomized Cohort|Lost to Follow-up|0|||
13408560|NCT00547378|26827475|FG002|Randomized Cohort|Lost to Follow-up|0|||
13408561|NCT00547378|26827473|FG000|Randomized Cohort|Adverse Event|1|||
13408562|NCT00547378|26827474|FG001|Randomized Cohort|Adverse Event|0|||
13408563|NCT00547378|26827475|FG002|Randomized Cohort|Adverse Event|0|||
13408564|NCT00547378|26827473|FG000|Randomized Cohort|Other reasons|2|||
13408565|NCT00547378|26827474|FG001|Randomized Cohort|Other reasons|0|||
13408566|NCT00547378|26827475|FG002|Randomized Cohort|Other reasons|0|||
13408567|NCT00547378|26827473|FG000|All Implanted Cohort|Withdrawal by Subject|5|||
13408568|NCT00547378|26827474|FG001|All Implanted Cohort|Withdrawal by Subject|4|||
13408569|NCT00547378|26827475|FG002|All Implanted Cohort|Withdrawal by Subject|27|||
13408570|NCT00547378|26827473|FG000|All Implanted Cohort|Adverse Event|4|||
13408571|NCT00547378|26827474|FG001|All Implanted Cohort|Adverse Event|10|||
13408572|NCT00547378|26827475|FG002|All Implanted Cohort|Adverse Event|17|||
13408573|NCT00547378|26827473|FG000|All Implanted Cohort|Lost to Follow-up|0|||
13408574|NCT00547378|26827474|FG001|All Implanted Cohort|Lost to Follow-up|1|||
13408575|NCT00547378|26827475|FG002|All Implanted Cohort|Lost to Follow-up|14|||
13408576|NCT00547378|26827473|FG000|All Implanted Cohort|Death|3|||
13408577|NCT00547378|26827474|FG001|All Implanted Cohort|Death|1|||
13408578|NCT00547378|26827475|FG002|All Implanted Cohort|Death|4|||
13408579|NCT00547378|26827473|FG000|All Implanted Cohort|Physician Decision|0|||
13408580|NCT00547378|26827474|FG001|All Implanted Cohort|Physician Decision|2|||
13408581|NCT00547378|26827475|FG002|All Implanted Cohort|Physician Decision|6|||
13408582|NCT00547378|26827473|FG000|All Implanted Cohort|Site closure|2|||
13408583|NCT00547378|26827474|FG001|All Implanted Cohort|Site closure|0|||
13408584|NCT00547378|26827475|FG002|All Implanted Cohort|Site closure|1|||
13408585|NCT00547378|26827473|FG000|All Implanted Cohort|Other reasons|1|||
13408586|NCT00547378|26827474|FG001|All Implanted Cohort|Other reasons|0|||
13408587|NCT00547378|26827475|FG002|All Implanted Cohort|Other reasons|1|||
13408588|NCT00547365|26827482|FG000|Overall Study|Physician Decision|1|||
13408589|NCT00547365|26827482|FG000|Overall Study|Lost to Follow-up|1|||
13408590|NCT00547365|26827482|FG000|Overall Study|Protocol Violation|2|||
13408591|NCT00547365|26827482|FG000|Overall Study|death (not related to study)|4|||
13408592|NCT00547300|26827499|FG000|Overall Study|Study was Administratively Terminated|25|||
13408593|NCT00547300|26827500|FG001|Overall Study|Study was Administratively Terminated|24|||
13408594|NCT00547300|26827499|FG000|Overall Study|Did not Meet Entry Criteria|0|||
13408595|NCT00547300|26827500|FG001|Overall Study|Did not Meet Entry Criteria|2|||
13408596|NCT00547248|26827629|FG000|Overall Study|Protocol Violation|0|||
13408597|NCT00547248|26827630|FG001|Overall Study|Protocol Violation|0|||
13408598|NCT00547248|26827631|FG002|Overall Study|Protocol Violation|1|||
13408599|NCT00547248|26827632|FG003|Overall Study|Protocol Violation|1|||
13408600|NCT00547248|26827629|FG000|Overall Study|Migrated/moved from study area|0|||
13408601|NCT00547248|26827630|FG001|Overall Study|Migrated/moved from study area|0|||
13408602|NCT00547248|26827631|FG002|Overall Study|Migrated/moved from study area|2|||
13408603|NCT00547248|26827632|FG003|Overall Study|Migrated/moved from study area|0|||
13408604|NCT00547248|26827629|FG000|Overall Study|Withdrawal by Subject|0|||
13408605|NCT00547248|26827630|FG001|Overall Study|Withdrawal by Subject|0|||
13408606|NCT00547248|26827631|FG002|Overall Study|Withdrawal by Subject|7|||
13408607|NCT00547248|26827632|FG003|Overall Study|Withdrawal by Subject|1|||
13408608|NCT00547157|26827655|FG000|Overall Study|Other|1|||
13408609|NCT00547157|26827656|FG001|Overall Study|Other|0|||
13408610|NCT00547157|26827655|FG000|Overall Study|Death|38|||
13408611|NCT00547157|26827656|FG001|Overall Study|Death|18|||
13408612|NCT00547157|26827655|FG000|Overall Study|Withdrawal by Subject|3|||
13408613|NCT00547157|26827656|FG001|Overall Study|Withdrawal by Subject|1|||
13408614|NCT00547157|26827655|FG000|Overall Study|Administrative decision|3|||
13408615|NCT00547157|26827656|FG001|Overall Study|Administrative decision|2|||
13408616|NCT00547157|26827655|FG000|Overall Study|Lost to Follow-up|4|||
13408617|NCT00547157|26827656|FG001|Overall Study|Lost to Follow-up|2|||
13408618|NCT00547118|26827695|FG000|Overall Study|Did not qualify prior to starting drug|1|||
13408619|NCT00547118|26827696|FG001|Overall Study|Did not qualify prior to starting drug|1|||
13408620|NCT00547118|26827695|FG000|Overall Study|Study suspended|7|||
13408621|NCT00547118|26827696|FG001|Overall Study|Study suspended|8|||
13408622|NCT00546910|26827721|FG000|Overall Study|Adverse Event|2|||
13408623|NCT00546910|26827722|FG001|Overall Study|Adverse Event|3|||
13408624|NCT00546910|26827721|FG000|Overall Study|Lack of Efficacy|5|||
13408625|NCT00546910|26827722|FG001|Overall Study|Lack of Efficacy|7|||
13408626|NCT00546910|26827721|FG000|Overall Study|Physician Decision|0|||
13408627|NCT00546910|26827722|FG001|Overall Study|Physician Decision|1|||
13408628|NCT00546910|26827721|FG000|Overall Study|Withdrawal by Subject|2|||
13408629|NCT00546910|26827722|FG001|Overall Study|Withdrawal by Subject|0|||
13408630|NCT00546871|26827828|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1|||
13408631|NCT00546871|26827829|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0|||
13408632|NCT00546871|26827828|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1|||
13408633|NCT00546871|26827829|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2|||
13408634|NCT00546871|26827828|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0|||
13408635|NCT00546871|26827829|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1|||
13408636|NCT00546871|26827828|FG000|Study Extension Period|Protocol Violation|1|||
13408637|NCT00546871|26827829|FG001|Study Extension Period|Protocol Violation|0|||
13408638|NCT00546871|26827828|FG000|Study Extension Period|Withdrawal by Subject|0|||
13408639|NCT00546871|26827829|FG001|Study Extension Period|Withdrawal by Subject|1|||
13408640|NCT00546819|26827846|FG000|Overall Study|Adverse Event|2|||
13408641|NCT00546819|26827847|FG001|Overall Study|Adverse Event|3|||
13408642|NCT00546819|26827846|FG000|Overall Study|Lost to Follow-up|2|||
13408643|NCT00546819|26827847|FG001|Overall Study|Lost to Follow-up|1|||
13408644|NCT00546819|26827846|FG000|Overall Study|Withdrawal by Subject|4|||
13408645|NCT00546819|26827847|FG001|Overall Study|Withdrawal by Subject|2|||
13408646|NCT00546715|26827913|FG000|Overall Study|Withdrawal by Subject|0|||
13408647|NCT00546715|26827914|FG001|Overall Study|Withdrawal by Subject|1|||
13408648|NCT00546715|26827915|FG002|Overall Study|Withdrawal by Subject|0|||
13408649|NCT00546715|26827916|FG003|Overall Study|Withdrawal by Subject|0|||
13408650|NCT00546637|26827995|FG000|Overall Study|Adverse Event|46|||
13408651|NCT00546637|26827996|FG001|Overall Study|Adverse Event|20|||
13408652|NCT00546637|26827995|FG000|Overall Study|Lack of Efficacy|5|||
13408653|NCT00546637|26827996|FG001|Overall Study|Lack of Efficacy|5|||
13408654|NCT00546637|26827995|FG000|Overall Study|Lost to Follow-up|2|||
13408655|NCT00546637|26827996|FG001|Overall Study|Lost to Follow-up|2|||
13408656|NCT00546637|26827995|FG000|Overall Study|Other|10|||
13408657|NCT00546637|26827996|FG001|Overall Study|Other|12|||
13408658|NCT00546637|26827995|FG000|Overall Study|Withdrawal by Subject|7|||
13408659|NCT00546637|26827996|FG001|Overall Study|Withdrawal by Subject|9|||
13408660|NCT00546637|26827995|FG000|Overall Study|Randomized, but not treated|3|||
13408661|NCT00546637|26827996|FG001|Overall Study|Randomized, but not treated|1|||
13408662|NCT00546572|26828045|FG000|Vax 1 / Year 0|Randomized, not treated|1|||
13408663|NCT00546572|26828046|FG001|Vax 1 / Year 0|Randomized, not treated|1|||
13408664|NCT00546572|26828045|FG000|Vax 1 / Year 0|Withdrawal by Subject|3|||
13408665|NCT00546572|26828046|FG001|Vax 1 / Year 0|Withdrawal by Subject|2|||
13408666|NCT00546572|26828045|FG000|Vax 1 / Year 0|Protocol Violation|3|||
13408667|NCT00546572|26828046|FG001|Vax 1 / Year 0|Protocol Violation|4|||
13408668|NCT00546572|26828045|FG000|Vax 1 / Year 0|Death|2|||
13408669|NCT00546572|26828046|FG001|Vax 1 / Year 0|Death|2|||
13408670|NCT00546572|26828045|FG000|Vax 1 / Year 0|Adverse Event|0|||
13408671|NCT00546572|26828046|FG001|Vax 1 / Year 0|Adverse Event|1|||
13408672|NCT00546572|26828045|FG000|Vax 1 / Year 0|Lost to Follow-up|0|||
13408673|NCT00546572|26828046|FG001|Vax 1 / Year 0|Lost to Follow-up|1|||
13408674|NCT00546572|26828045|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64|||
13408675|NCT00546572|26828046|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59|||
13408676|NCT00546572|26828045|FG000|Vax 2 / Year 1|Other|1|||
13408677|NCT00546572|26828046|FG001|Vax 2 / Year 1|Other|1|||
13408678|NCT00546572|26828045|FG000|Vax 2 / Year 1|Adverse Event|1|||
13408679|NCT00546572|26828046|FG001|Vax 2 / Year 1|Adverse Event|0|||
13408680|NCT00546572|26828045|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2|||
13408681|NCT00546572|26828046|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1|||
13408682|NCT00546481|26828077|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1|||
13408683|NCT00546481|26828078|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
13408684|NCT00546481|26828079|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
13408685|NCT00546481|26828077|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1|||
13408686|NCT00546481|26828078|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3|||
13408687|NCT00546481|26828079|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0|||
13408688|NCT00546481|26828077|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1|||
13408689|NCT00546481|26828078|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
13408690|NCT00546481|26828079|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
13408691|NCT00546481|26828077|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2|||
13408692|NCT00546481|26828078|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
13408693|NCT00546481|26828079|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
13408694|NCT00546481|26828077|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
13408695|NCT00546481|26828078|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
13408696|NCT00546481|26828079|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0|||
13408697|NCT00546481|26828077|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
13408698|NCT00546481|26828078|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1|||
13408699|NCT00546481|26828079|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
13408700|NCT00546481|26828077|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
13408701|NCT00546481|26828078|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
13408702|NCT00546481|26828079|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2|||
13408703|NCT00546481|26828077|FG000|Maintenance Phase (CERA)|Kidney transplantation|0|||
13408704|NCT00546481|26828078|FG001|Maintenance Phase (CERA)|Kidney transplantation|0|||
13408705|NCT00546481|26828079|FG002|Maintenance Phase (CERA)|Kidney transplantation|1|||
13408706|NCT00546481|26828077|FG000|Maintenance Phase (CERA)|Other Reason|0|||
13408707|NCT00546481|26828078|FG001|Maintenance Phase (CERA)|Other Reason|0|||
13408708|NCT00546481|26828079|FG002|Maintenance Phase (CERA)|Other Reason|1|||
13408709|NCT00546377|26828086|FG000|Overall Study|Deemed ineligible|1|||
13408710|NCT00546377|26828086|FG000|Overall Study|Adverse Event|6|||
13408711|NCT00546364|26828131|FG000|Overall Study|Disease progression|5|||
13408712|NCT00546364|26828132|FG001|Overall Study|Disease progression|11|||
13408713|NCT00546364|26828133|FG002|Overall Study|Disease progression|8|||
13408714|NCT00546364|26828131|FG000|Overall Study|Completed and off treatment|1|||
13408715|NCT00546364|26828132|FG001|Overall Study|Completed and off treatment|0|||
13408716|NCT00546364|26828133|FG002|Overall Study|Completed and off treatment|2|||
13408717|NCT00546364|26828131|FG000|Overall Study|Administrative reason by sponsor|1|||
13408718|NCT00546364|26828132|FG001|Overall Study|Administrative reason by sponsor|0|||
13408719|NCT00546364|26828133|FG002|Overall Study|Administrative reason by sponsor|0|||
13408720|NCT00546364|26828131|FG000|Overall Study|Poor compliance/noncompliance|0|||
13408721|NCT00546364|26828132|FG001|Overall Study|Poor compliance/noncompliance|0|||
13408722|NCT00546364|26828133|FG002|Overall Study|Poor compliance/noncompliance|1|||
13408723|NCT00546364|26828131|FG000|Overall Study|No longer meets study criteria|1|||
13408724|NCT00546364|26828132|FG001|Overall Study|No longer meets study criteria|1|||
13408725|NCT00546364|26828133|FG002|Overall Study|No longer meets study criteria|0|||
13408726|NCT00546364|26828131|FG000|Overall Study|Withdrawal by Subject|5|||
13408727|NCT00546364|26828132|FG001|Overall Study|Withdrawal by Subject|6|||
13408728|NCT00546364|26828133|FG002|Overall Study|Withdrawal by Subject|3|||
13408729|NCT00546364|26828131|FG000|Overall Study|Prior taxotere|1|||
13408730|NCT00546364|26828132|FG001|Overall Study|Prior taxotere|0|||
13408731|NCT00546364|26828133|FG002|Overall Study|Prior taxotere|0|||
13408732|NCT00546364|26828131|FG000|Overall Study|Mixed response|1|||
13408733|NCT00546364|26828132|FG001|Overall Study|Mixed response|0|||
13408734|NCT00546364|26828133|FG002|Overall Study|Mixed response|0|||
13408735|NCT00546364|26828131|FG000|Overall Study|Palliative treatment|1|||
13408736|NCT00546364|26828132|FG001|Overall Study|Palliative treatment|0|||
13408737|NCT00546364|26828133|FG002|Overall Study|Palliative treatment|1|||
13408738|NCT00546364|26828131|FG000|Overall Study|Target lesions resected|1|||
13408739|NCT00546364|26828132|FG001|Overall Study|Target lesions resected|0|||
13408740|NCT00546364|26828133|FG002|Overall Study|Target lesions resected|0|||
13408741|NCT00546364|26828131|FG000|Overall Study|Physician Decision|0|||
13408742|NCT00546364|26828132|FG001|Overall Study|Physician Decision|0|||
13408743|NCT00546364|26828133|FG002|Overall Study|Physician Decision|1|||
13408744|NCT00546364|26828131|FG000|Overall Study|Sponsor decision|0|||
13408745|NCT00546364|26828132|FG001|Overall Study|Sponsor decision|0|||
13408746|NCT00546364|26828133|FG002|Overall Study|Sponsor decision|1|||
13408747|NCT00546351|26828163|FG000|Overall Study|Adverse Event|76|||
13408748|NCT00546351|26828163|FG000|Overall Study|Lack of Efficacy|15|||
13408749|NCT00546351|26828163|FG000|Overall Study|Withdrawal by Subject|109|||
13408750|NCT00546351|26828163|FG000|Overall Study|Lost to Follow-up|9|||
13408751|NCT00546351|26828163|FG000|Overall Study|Protocol Deviation|1|||
13408752|NCT00546351|26828163|FG000|Overall Study|Unsatisfactory compliance|9|||
13408753|NCT00546351|26828163|FG000|Overall Study|Other reasons for premature termination|17|||
13408754|NCT00546260|26828180|FG000|Overall Study|Drug not given pre diagnostic angiogr|8|||
13408755|NCT00546260|26828181|FG001|Overall Study|Drug not given pre diagnostic angiogr|2|||
13408756|NCT00546117|26828202|FG000|Overall Study|Withdrawal by Subject|3|||
13408757|NCT00546117|26828203|FG001|Overall Study|Withdrawal by Subject|0|||
13408758|NCT00546117|26828202|FG000|Overall Study|Inability to schedule follow-up visit|1|||
13408759|NCT00546117|26828203|FG001|Overall Study|Inability to schedule follow-up visit|0|||
13408760|NCT00546078|26828248|FG000|Overall Study|Lost to Follow-up|1|||
13408761|NCT00546078|26828249|FG001|Overall Study|Lost to Follow-up|3|||
13408762|NCT00546078|26828248|FG000|Overall Study|Withdrawal by Subject|2|||
13408763|NCT00546078|26828249|FG001|Overall Study|Withdrawal by Subject|3|||
13408764|NCT00546078|26828248|FG000|Overall Study|Other reason|1|||
13408765|NCT00546078|26828249|FG001|Overall Study|Other reason|1|||
13408766|NCT00546052|26828269|FG000|Overall Study|Adverse Event|47|||
13408767|NCT00546052|26828269|FG000|Overall Study|Lost to Follow-up|144|||
13408768|NCT00546052|26828269|FG000|Overall Study|Protocol Violation|9|||
13408769|NCT00546052|26828269|FG000|Overall Study|Withdrawal by Subject|20|||
13408770|NCT00546052|26828269|FG000|Overall Study|Non Compliance|7|||
13408771|NCT00546000|26828276|FG000|Overall Study|Adverse Event|1|||
13408772|NCT00546000|26828276|FG000|Overall Study|Lost to Follow-up|1|||
13408773|NCT00546000|26828276|FG000|Overall Study|Baseline HPA Axis Supression|2|||
13408774|NCT00545948|26828296|FG000|Overall Study|Not Treated|1|||
13408775|NCT00545948|26828297|FG001|Overall Study|Not Treated|1|||
13408776|NCT00545948|26828298|FG002|Overall Study|Not Treated|7|||
13408777|NCT00545844|26828314|FG000|Overall Study|Lost to Follow-up|9|||
13408778|NCT00545844|26828314|FG000|Overall Study|Protocol Violation|1|||
13408779|NCT00545844|26828314|FG000|Overall Study|Withdrawal by Subject|2|||
13408780|NCT00545818|26828335|FG000|Overall Study|Protocol Violation|1|||
13408781|NCT00545818|26828336|FG001|Overall Study|Protocol Violation|0|||
13408782|NCT00545818|26828335|FG000|Overall Study|Adverse Event|1|||
13408783|NCT00545818|26828336|FG001|Overall Study|Adverse Event|1|||
13408784|NCT00545818|26828335|FG000|Overall Study|Lost to Follow-up|1|||
13408785|NCT00545818|26828336|FG001|Overall Study|Lost to Follow-up|6|||
13408786|NCT00545792|26828343|FG000|Overall Study|Withdrawal by Subject|1|||
13408787|NCT00545779|26828358|FG000|Overall Study|Violation of selection criteria at entry|8|||
13408788|NCT00545779|26828358|FG000|Overall Study|Other protocol violation|1|||
13408789|NCT00545779|26828358|FG000|Overall Study|Did not cooperate|7|||
13408790|NCT00545779|26828358|FG000|Overall Study|Withdrawal by Subject|20|||
13408791|NCT00545779|26828358|FG000|Overall Study|Adverse Event/intercurrent illness|5|||
13408792|NCT00545779|26828358|FG000|Overall Study|Failure to return|3|||
13408793|NCT00545753|26828377|FG000|Overall Study|Withdrawal by Subject|0|||
13408794|NCT00545753|26828378|FG001|Overall Study|Withdrawal by Subject|1|||
13408795|NCT00545753|26828379|FG002|Overall Study|Withdrawal by Subject|10|||
13408796|NCT00545753|26828377|FG000|Overall Study|Lost to Follow-up|13|||
13408797|NCT00545753|26828378|FG001|Overall Study|Lost to Follow-up|3|||
13408798|NCT00545753|26828379|FG002|Overall Study|Lost to Follow-up|12|||
13408799|NCT00545753|26828377|FG000|Overall Study|Protocol Violation|3|||
13408800|NCT00545753|26828378|FG001|Overall Study|Protocol Violation|1|||
13408801|NCT00545753|26828379|FG002|Overall Study|Protocol Violation|4|||
13408802|NCT00545740|26828426|FG000|Overall Study|Lack of Efficacy|34|||
13408803|NCT00545740|26828427|FG001|Overall Study|Lack of Efficacy|35|||
13408804|NCT00545740|26828428|FG002|Overall Study|Lack of Efficacy|47|||
13408805|NCT00545740|26828429|FG003|Overall Study|Lack of Efficacy|36|||
13408806|NCT00545740|26828426|FG000|Overall Study|Withdrawal by Subject|17|||
13408807|NCT00545740|26828427|FG001|Overall Study|Withdrawal by Subject|15|||
13408808|NCT00545740|26828428|FG002|Overall Study|Withdrawal by Subject|16|||
13408809|NCT00545740|26828429|FG003|Overall Study|Withdrawal by Subject|18|||
13408810|NCT00545740|26828426|FG000|Overall Study|Adverse Event|10|||
13408811|NCT00545740|26828427|FG001|Overall Study|Adverse Event|18|||
13408812|NCT00545740|26828428|FG002|Overall Study|Adverse Event|19|||
13408813|NCT00545740|26828429|FG003|Overall Study|Adverse Event|9|||
13408814|NCT00545740|26828426|FG000|Overall Study|Lost to Follow-up|7|||
13408815|NCT00545740|26828427|FG001|Overall Study|Lost to Follow-up|5|||
13408816|NCT00545740|26828428|FG002|Overall Study|Lost to Follow-up|5|||
13408817|NCT00545740|26828429|FG003|Overall Study|Lost to Follow-up|6|||
13408818|NCT00545740|26828426|FG000|Overall Study|Protocol Violation|1|||
13408819|NCT00545740|26828427|FG001|Overall Study|Protocol Violation|3|||
13408820|NCT00545740|26828428|FG002|Overall Study|Protocol Violation|1|||
13408821|NCT00545740|26828429|FG003|Overall Study|Protocol Violation|0|||
13408822|NCT00545740|26828426|FG000|Overall Study|Non-compliance|0|||
13408823|NCT00545740|26828427|FG001|Overall Study|Non-compliance|2|||
13408824|NCT00545740|26828428|FG002|Overall Study|Non-compliance|1|||
13408825|NCT00545740|26828429|FG003|Overall Study|Non-compliance|0|||
13408826|NCT00545740|26828426|FG000|Overall Study|Moved|2|||
13408827|NCT00545740|26828427|FG001|Overall Study|Moved|0|||
13408828|NCT00545740|26828428|FG002|Overall Study|Moved|1|||
13408829|NCT00545740|26828429|FG003|Overall Study|Moved|0|||
13408830|NCT00545740|26828426|FG000|Overall Study|Diverticulitis attack|0|||
13408831|NCT00545740|26828427|FG001|Overall Study|Diverticulitis attack|0|||
13408832|NCT00545740|26828428|FG002|Overall Study|Diverticulitis attack|1|||
13408833|NCT00545740|26828429|FG003|Overall Study|Diverticulitis attack|1|||
13408834|NCT00545740|26828426|FG000|Overall Study|Suspected Diverticulitis Recurrence|1|||
13408835|NCT00545740|26828427|FG001|Overall Study|Suspected Diverticulitis Recurrence|1|||
13408836|NCT00545740|26828428|FG002|Overall Study|Suspected Diverticulitis Recurrence|1|||
13408837|NCT00545740|26828429|FG003|Overall Study|Suspected Diverticulitis Recurrence|1|||
13408838|NCT00545740|26828426|FG000|Overall Study|Site closure|1|||
13408839|NCT00545740|26828427|FG001|Overall Study|Site closure|0|||
13408840|NCT00545740|26828428|FG002|Overall Study|Site closure|0|||
13408841|NCT00545740|26828429|FG003|Overall Study|Site closure|0|||
13408842|NCT00545740|26828426|FG000|Overall Study|Missed visit|1|||
13408843|NCT00545740|26828427|FG001|Overall Study|Missed visit|0|||
13408844|NCT00545740|26828428|FG002|Overall Study|Missed visit|0|||
13408845|NCT00545740|26828429|FG003|Overall Study|Missed visit|0|||
13408846|NCT00545740|26828426|FG000|Overall Study|Physician Decision|0|||
13408847|NCT00545740|26828427|FG001|Overall Study|Physician Decision|0|||
13408848|NCT00545740|26828428|FG002|Overall Study|Physician Decision|3|||
13408849|NCT00545740|26828429|FG003|Overall Study|Physician Decision|0|||
13408850|NCT00545740|26828426|FG000|Overall Study|Accepted only monthly telephone calls|1|||
13408851|NCT00545740|26828427|FG001|Overall Study|Accepted only monthly telephone calls|0|||
13408852|NCT00545740|26828428|FG002|Overall Study|Accepted only monthly telephone calls|0|||
13408853|NCT00545740|26828429|FG003|Overall Study|Accepted only monthly telephone calls|0|||
13408854|NCT00545740|26828426|FG000|Overall Study|Sponsor decision|0|||
13408855|NCT00545740|26828427|FG001|Overall Study|Sponsor decision|1|||
13408856|NCT00545740|26828428|FG002|Overall Study|Sponsor decision|0|||
13408857|NCT00545740|26828429|FG003|Overall Study|Sponsor decision|0|||
13408858|NCT00545740|26828426|FG000|Overall Study|Lack of time|0|||
13408859|NCT00545740|26828427|FG001|Overall Study|Lack of time|1|||
13408860|NCT00545740|26828428|FG002|Overall Study|Lack of time|0|||
13408861|NCT00545740|26828429|FG003|Overall Study|Lack of time|0|||
13408862|NCT00545740|26828426|FG000|Overall Study|Non-adherence to visits|0|||
13408863|NCT00545740|26828427|FG001|Overall Study|Non-adherence to visits|1|||
13408864|NCT00545740|26828428|FG002|Overall Study|Non-adherence to visits|0|||
13408865|NCT00545740|26828429|FG003|Overall Study|Non-adherence to visits|0|||
13408866|NCT00545740|26828426|FG000|Overall Study|Patient difficulties|0|||
13408867|NCT00545740|26828427|FG001|Overall Study|Patient difficulties|1|||
13408868|NCT00545740|26828428|FG002|Overall Study|Patient difficulties|0|||
13408869|NCT00545740|26828429|FG003|Overall Study|Patient difficulties|0|||
13408870|NCT00545740|26828426|FG000|Overall Study|Husband against study|0|||
13408871|NCT00545740|26828427|FG001|Overall Study|Husband against study|0|||
13408872|NCT00545740|26828428|FG002|Overall Study|Husband against study|1|||
13408873|NCT00545740|26828429|FG003|Overall Study|Husband against study|0|||
13408874|NCT00545714|26828448|FG000|Induction Phase (6 Months)|Physician Decision|3|||
13408875|NCT00545714|26828448|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6|||
13408876|NCT00545714|26828448|FG000|Induction Phase (6 Months)|Disease Progression|1|||
13408877|NCT00545714|26828448|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2|||
13408878|NCT00545714|26828448|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16|||
13408879|NCT00545714|26828448|FG000|Maintenance Phase (36 Months)|Disease Progression|9|||
13408880|NCT00545714|26828448|FG000|Maintenance Phase (36 Months)|Physician Decision|1|||
13408881|NCT00545714|26828448|FG000|Maintenance Phase (36 Months)|Protocol Violation|1|||
13408882|NCT00545714|26828448|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3|||
13408883|NCT00545714|26828448|FG000|Maintenance Phase (36 Months)|Death|2|||
13408884|NCT00545688|26828531|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
13408885|NCT00545688|26828532|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2|||
13408886|NCT00545688|26828533|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
13408887|NCT00545688|26828534|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
13408888|NCT00545688|26828531|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
13408889|NCT00545688|26828532|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
13408890|NCT00545688|26828533|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4|||
13408891|NCT00545688|26828534|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
13408892|NCT00545688|26828531|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1|||
13408893|NCT00545688|26828532|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
13408894|NCT00545688|26828533|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
13408895|NCT00545688|26828534|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
13408896|NCT00545688|26828531|FG000|Neo-Adjuvant Treatment Period|Death|0|||
13408897|NCT00545688|26828532|FG001|Neo-Adjuvant Treatment Period|Death|1|||
13408898|NCT00545688|26828533|FG002|Neo-Adjuvant Treatment Period|Death|0|||
13408899|NCT00545688|26828534|FG003|Neo-Adjuvant Treatment Period|Death|0|||
13408900|NCT00545688|26828531|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0|||
13408901|NCT00545688|26828532|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1|||
13408902|NCT00545688|26828533|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7|||
13408903|NCT00545688|26828534|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2|||
13408904|NCT00545688|26828531|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1|||
13408905|NCT00545688|26828532|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
13408906|NCT00545688|26828533|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
13408907|NCT00545688|26828534|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
13408908|NCT00545688|26828531|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0|||
13408909|NCT00545688|26828532|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0|||
13408910|NCT00545688|26828533|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2|||
13408911|NCT00545688|26828534|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2|||
13408912|NCT00545688|26828531|FG000|Adjuvant Treatment Period|Disease Progression|3|||
13408913|NCT00545688|26828532|FG001|Adjuvant Treatment Period|Disease Progression|3|||
13408914|NCT00545688|26828533|FG002|Adjuvant Treatment Period|Disease Progression|0|||
13408915|NCT00545688|26828534|FG003|Adjuvant Treatment Period|Disease Progression|7|||
13408916|NCT00545688|26828531|FG000|Adjuvant Treatment Period|Refused Treatment|1|||
13408917|NCT00545688|26828532|FG001|Adjuvant Treatment Period|Refused Treatment|1|||
13408918|NCT00545688|26828533|FG002|Adjuvant Treatment Period|Refused Treatment|1|||
13408919|NCT00545688|26828534|FG003|Adjuvant Treatment Period|Refused Treatment|5|||
13408920|NCT00545688|26828531|FG000|Adjuvant Treatment Period|Lost to Follow-up|1|||
13408921|NCT00545688|26828532|FG001|Adjuvant Treatment Period|Lost to Follow-up|0|||
13408922|NCT00545688|26828533|FG002|Adjuvant Treatment Period|Lost to Follow-up|1|||
13408923|NCT00545688|26828534|FG003|Adjuvant Treatment Period|Lost to Follow-up|0|||
13408924|NCT00545688|26828531|FG000|Adjuvant Treatment Period|Adverse Event|0|||
13408925|NCT00545688|26828532|FG001|Adjuvant Treatment Period|Adverse Event|3|||
13408926|NCT00545688|26828533|FG002|Adjuvant Treatment Period|Adverse Event|2|||
13408927|NCT00545688|26828534|FG003|Adjuvant Treatment Period|Adverse Event|2|||
13408928|NCT00545688|26828531|FG000|Adjuvant Treatment Period|Unknown Reason|0|||
13408929|NCT00545688|26828532|FG001|Adjuvant Treatment Period|Unknown Reason|1|||
13408930|NCT00545688|26828533|FG002|Adjuvant Treatment Period|Unknown Reason|0|||
13408931|NCT00545688|26828534|FG003|Adjuvant Treatment Period|Unknown Reason|0|||
13408932|NCT00545688|26828531|FG000|Follow-Up Period|Death|4|||
13408933|NCT00545688|26828532|FG001|Follow-Up Period|Death|2|||
13408934|NCT00545688|26828533|FG002|Follow-Up Period|Death|2|||
13408935|NCT00545688|26828534|FG003|Follow-Up Period|Death|6|||
13408936|NCT00545688|26828531|FG000|Follow-Up Period|Disease Progression|6|||
13408937|NCT00545688|26828532|FG001|Follow-Up Period|Disease Progression|5|||
13408938|NCT00545688|26828533|FG002|Follow-Up Period|Disease Progression|9|||
13408939|NCT00545688|26828534|FG003|Follow-Up Period|Disease Progression|9|||
13408940|NCT00545688|26828531|FG000|Follow-Up Period|Refused Treatment|6|||
13408941|NCT00545688|26828532|FG001|Follow-Up Period|Refused Treatment|2|||
13408942|NCT00545688|26828533|FG002|Follow-Up Period|Refused Treatment|0|||
13408943|NCT00545688|26828534|FG003|Follow-Up Period|Refused Treatment|2|||
13408944|NCT00545688|26828531|FG000|Follow-Up Period|Lost to Follow-up|3|||
13408945|NCT00545688|26828532|FG001|Follow-Up Period|Lost to Follow-up|3|||
13408946|NCT00545688|26828533|FG002|Follow-Up Period|Lost to Follow-up|3|||
13408947|NCT00545688|26828534|FG003|Follow-Up Period|Lost to Follow-up|1|||
13408948|NCT00545688|26828531|FG000|Follow-Up Period|Unspecified Reason|2|||
13408949|NCT00545688|26828532|FG001|Follow-Up Period|Unspecified Reason|5|||
13408950|NCT00545688|26828533|FG002|Follow-Up Period|Unspecified Reason|6|||
13408951|NCT00545688|26828534|FG003|Follow-Up Period|Unspecified Reason|8|||
13408952|NCT00545688|26828531|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
13408953|NCT00545688|26828532|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2|||
13408954|NCT00545688|26828533|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
13408955|NCT00545688|26828534|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1|||
13408956|NCT00545584|26828555|FG000|Overall Study|Only one reason for discontinuation|62|||
13408957|NCT00545584|26828556|FG001|Overall Study|Only one reason for discontinuation|61|||
13408958|NCT00545584|26828557|FG002|Overall Study|Only one reason for discontinuation|48|||
13408959|NCT00545584|26828555|FG000|Overall Study|Two or more reasons for discontinuation|17|||
13408960|NCT00545584|26828556|FG001|Overall Study|Two or more reasons for discontinuation|19|||
13408961|NCT00545584|26828557|FG002|Overall Study|Two or more reasons for discontinuation|8|||
13408962|NCT00545571|26828572|FG000|Overall Study|Administrative Reasons|1|||
13408963|NCT00545571|26828572|FG000|Overall Study|Adverse Event|2|||
13408964|NCT00545571|26828572|FG000|Overall Study|Death|5|||
13408965|NCT00545571|26828572|FG000|Overall Study|Lack of Efficacy|1|||
13408966|NCT00545571|26828572|FG000|Overall Study|Protocol Violation|2|||
13408967|NCT00545571|26828572|FG000|Overall Study|Refused Treatment|1|||
13408968|NCT00545571|26828572|FG000|Overall Study|Screen Failure|16|||
13408969|NCT00545571|26828572|FG000|Overall Study|Transfusion|12|||
13408970|NCT00545571|26828572|FG000|Overall Study|Early Termination of Study|24|||
13408971|NCT00545571|26828572|FG000|Overall Study|Kidney Transplantation|3|||
13408972|NCT00545532|26828659|FG000|Overall Study|Withdrawal by Subject|1|||
13408973|NCT00545532|26828660|FG001|Overall Study|Withdrawal by Subject|3|||
13408974|NCT00545532|26828659|FG000|Overall Study|Lost to Follow-up|5|||
13408975|NCT00545532|26828660|FG001|Overall Study|Lost to Follow-up|6|||
13408976|NCT00545532|26828659|FG000|Overall Study|Death|0|||
13408977|NCT00545532|26828660|FG001|Overall Study|Death|1|||
13408978|NCT00545441|26828673|FG000|Overall Study|Fistula draining at 6 months|2|||
13408979|NCT00545441|26828674|FG001|Overall Study|Fistula draining at 6 months|4|||
13408980|NCT00545441|26828673|FG000|Overall Study|Lost to Follow-up|9|||
13408981|NCT00545441|26828674|FG001|Overall Study|Lost to Follow-up|5|||
13408982|NCT00545441|26828673|FG000|Overall Study|Technical failure|0|||
13408983|NCT00545441|26828674|FG001|Overall Study|Technical failure|1|||
13408984|NCT00545441|26828673|FG000|Overall Study|Withdrawal by Subject|1|||
13408985|NCT00545441|26828674|FG001|Overall Study|Withdrawal by Subject|1|||
13408986|NCT00545441|26828673|FG000|Overall Study|Persistence or recurrence of fistula|5|||
13408987|NCT00545441|26828674|FG001|Overall Study|Persistence or recurrence of fistula|2|||
13408988|NCT00545441|26828673|FG000|Overall Study|Patients were not treated|1|||
13408989|NCT00545441|26828674|FG001|Overall Study|Patients were not treated|3|||
13408990|NCT00545402|26828697|FG000|Overall Study|Discontinuation of treatment|17|||
13408991|NCT00545402|26828698|FG001|Overall Study|Discontinuation of treatment|9|||
13408992|NCT00545402|26828697|FG000|Overall Study|Use of unauthorized immunosuppressant|8|||
13408993|NCT00545402|26828698|FG001|Overall Study|Use of unauthorized immunosuppressant|7|||
13408994|NCT00545402|26828697|FG000|Overall Study|Death|5|||
13408995|NCT00545402|26828698|FG001|Overall Study|Death|7|||
13408996|NCT00545402|26828697|FG000|Overall Study|Graft loss|2|||
13408997|NCT00545402|26828698|FG001|Overall Study|Graft loss|4|||
13408998|NCT00545402|26828697|FG000|Overall Study|Withdrawal by Subject|0|||
13408999|NCT00545402|26828698|FG001|Overall Study|Withdrawal by Subject|1|||
13409000|NCT00545402|26828697|FG000|Overall Study|Protocol Violation|1|||
13409001|NCT00545402|26828698|FG001|Overall Study|Protocol Violation|0|||
13409002|NCT00545402|26828697|FG000|Overall Study|Reason not specified|1|||
13409003|NCT00545402|26828698|FG001|Overall Study|Reason not specified|1|||
13409004|NCT00545363|26828717|FG000|Overall Study|Adverse Event|6|||
13409005|NCT00545363|26828718|FG001|Overall Study|Adverse Event|7|||
13409006|NCT00545363|26828717|FG000|Overall Study|Withdrawal by Subject|6|||
13409007|NCT00545363|26828718|FG001|Overall Study|Withdrawal by Subject|5|||
13409008|NCT00545363|26828717|FG000|Overall Study|Non-compliance|3|||
13409009|NCT00545363|26828718|FG001|Overall Study|Non-compliance|1|||
13409010|NCT00545363|26828717|FG000|Overall Study|Did not meet entry criteria|1|||
13409011|NCT00545363|26828718|FG001|Overall Study|Did not meet entry criteria|1|||
13409012|NCT00545363|26828717|FG000|Overall Study|Lost to Follow-up|2|||
13409013|NCT00545363|26828718|FG001|Overall Study|Lost to Follow-up|0|||
13409014|NCT00545363|26828717|FG000|Overall Study|Other|1|||
13409015|NCT00545363|26828718|FG001|Overall Study|Other|1|||
13409016|NCT00545298|26828739|FG000|Overall Study|Issues with Standard of Care|2|||
13409017|NCT00545298|26828740|FG001|Overall Study|Issues with Standard of Care|0|||
13409018|NCT00545298|26828741|FG002|Overall Study|Issues with Standard of Care|1|||
13409019|NCT00545272|26828810|FG000|Overall Study|Protocol deviation|0|||
13409020|NCT00545272|26828811|FG001|Overall Study|Protocol deviation|1|||
13409021|NCT00545272|26828812|FG002|Overall Study|Protocol deviation|0|||
13409022|NCT00545272|26828813|FG003|Overall Study|Protocol deviation|1|||
13409023|NCT00545272|26828814|FG004|Overall Study|Protocol deviation|0|||
13409024|NCT00545272|26828815|FG005|Overall Study|Protocol deviation|1|||
13409025|NCT00545272|26828810|FG000|Overall Study|Adverse Event|0|||
13409026|NCT00545272|26828811|FG001|Overall Study|Adverse Event|0|||
13409027|NCT00545272|26828812|FG002|Overall Study|Adverse Event|1|||
13409028|NCT00545272|26828813|FG003|Overall Study|Adverse Event|0|||
13409029|NCT00545272|26828814|FG004|Overall Study|Adverse Event|0|||
13409030|NCT00545272|26828815|FG005|Overall Study|Adverse Event|1|||
13409031|NCT00545272|26828810|FG000|Overall Study|Abnormal laboratory value(s)|0|||
13409032|NCT00545272|26828811|FG001|Overall Study|Abnormal laboratory value(s)|0|||
13409033|NCT00545272|26828812|FG002|Overall Study|Abnormal laboratory value(s)|0|||
13409034|NCT00545272|26828813|FG003|Overall Study|Abnormal laboratory value(s)|0|||
13409035|NCT00545272|26828814|FG004|Overall Study|Abnormal laboratory value(s)|0|||
13409036|NCT00545272|26828815|FG005|Overall Study|Abnormal laboratory value(s)|1|||
13409037|NCT00545272|26828810|FG000|Overall Study|Abnormal test procedure result(s)|0|||
13409038|NCT00545272|26828811|FG001|Overall Study|Abnormal test procedure result(s)|0|||
13409039|NCT00545272|26828812|FG002|Overall Study|Abnormal test procedure result(s)|0|||
13409040|NCT00545272|26828813|FG003|Overall Study|Abnormal test procedure result(s)|0|||
13409041|NCT00545272|26828814|FG004|Overall Study|Abnormal test procedure result(s)|1|||
13409042|NCT00545272|26828815|FG005|Overall Study|Abnormal test procedure result(s)|0|||
13409043|NCT00545272|26828810|FG000|Overall Study|Lost to Follow-up|0|||
13409044|NCT00545272|26828811|FG001|Overall Study|Lost to Follow-up|0|||
13409045|NCT00545272|26828812|FG002|Overall Study|Lost to Follow-up|0|||
13409046|NCT00545272|26828813|FG003|Overall Study|Lost to Follow-up|0|||
13409047|NCT00545272|26828814|FG004|Overall Study|Lost to Follow-up|1|||
13409048|NCT00545272|26828815|FG005|Overall Study|Lost to Follow-up|0|||
13409049|NCT00545233|26828869|FG000|Overall Study|Adverse Event|10|||
13409050|NCT00545233|26828870|FG001|Overall Study|Adverse Event|5|||
13409051|NCT00545233|26828869|FG000|Overall Study|Violation of Selection Criteria at Entry|5|||
13409052|NCT00545233|26828870|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
13409053|NCT00545233|26828869|FG000|Overall Study|Protocol Violation|2|||
13409054|NCT00545233|26828870|FG001|Overall Study|Protocol Violation|0|||
13409055|NCT00545233|26828869|FG000|Overall Study|Refused Treatment|9|||
13409056|NCT00545233|26828870|FG001|Overall Study|Refused Treatment|7|||
13409057|NCT00545233|26828869|FG000|Overall Study|Failure to Return|4|||
13409058|NCT00545233|26828870|FG001|Overall Study|Failure to Return|6|||
13409059|NCT00545233|26828869|FG000|Overall Study|Insufficient response|14|||
13409060|NCT00545233|26828870|FG001|Overall Study|Insufficient response|15|||
13409061|NCT00545233|26828869|FG000|Overall Study|Physician Decision|2|||
13409062|NCT00545233|26828870|FG001|Overall Study|Physician Decision|1|||
13409063|NCT00545168|26828889|FG000|Overall Study|Lost to Follow-up|5|||
13409064|NCT00545168|26828890|FG001|Overall Study|Lost to Follow-up|5|||
13409065|NCT00545168|26828891|FG002|Overall Study|Lost to Follow-up|5|||
13409066|NCT00545168|26828889|FG000|Overall Study|Withdrawal by Subject|9|||
13409067|NCT00545168|26828890|FG001|Overall Study|Withdrawal by Subject|0|||
13409068|NCT00545168|26828891|FG002|Overall Study|Withdrawal by Subject|13|||
13409069|NCT00545168|26828889|FG000|Overall Study|Protocol Violation|1|||
13409070|NCT00545168|26828890|FG001|Overall Study|Protocol Violation|0|||
13409071|NCT00545168|26828891|FG002|Overall Study|Protocol Violation|1|||
13409072|NCT00545168|26828889|FG000|Overall Study|Visit for Day 21 was not done in error|1|||
13409073|NCT00545168|26828890|FG001|Overall Study|Visit for Day 21 was not done in error|0|||
13409074|NCT00545168|26828891|FG002|Overall Study|Visit for Day 21 was not done in error|2|||
13409075|NCT00545129|26828965|FG000|Overall Study|Lack of Efficacy|2|||
13409076|NCT00545129|26828966|FG001|Overall Study|Lack of Efficacy|5|||
13409077|NCT00545129|26828965|FG000|Overall Study|Death|2|||
13409078|NCT00545129|26828966|FG001|Overall Study|Death|1|||
13409079|NCT00545129|26828965|FG000|Overall Study|Adverse Event|1|||
13409080|NCT00545129|26828966|FG001|Overall Study|Adverse Event|1|||
13409081|NCT00545129|26828965|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9|||
13409082|NCT00545129|26828966|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14|||
13409083|NCT00545129|26828965|FG000|Overall Study|Other|3|||
13409084|NCT00545129|26828966|FG001|Overall Study|Other|3|||
13409085|NCT00545103|26829013|FG000|Overall Study|Lack of Efficacy|48|||
13409086|NCT00545103|26829014|FG001|Overall Study|Lack of Efficacy|45|||
13409087|NCT00545103|26829015|FG002|Overall Study|Lack of Efficacy|31|||
13409088|NCT00545103|26829016|FG003|Overall Study|Lack of Efficacy|27|||
13409089|NCT00545103|26829013|FG000|Overall Study|Withdrawal by Subject|6|||
13409090|NCT00545103|26829014|FG001|Overall Study|Withdrawal by Subject|10|||
13409091|NCT00545103|26829015|FG002|Overall Study|Withdrawal by Subject|18|||
13409092|NCT00545103|26829016|FG003|Overall Study|Withdrawal by Subject|22|||
13409093|NCT00545103|26829013|FG000|Overall Study|Adverse Event|11|||
13409094|NCT00545103|26829014|FG001|Overall Study|Adverse Event|12|||
13409095|NCT00545103|26829015|FG002|Overall Study|Adverse Event|17|||
13409096|NCT00545103|26829016|FG003|Overall Study|Adverse Event|10|||
13409097|NCT00545103|26829013|FG000|Overall Study|Lost to Follow-up|4|||
13409098|NCT00545103|26829014|FG001|Overall Study|Lost to Follow-up|6|||
13409099|NCT00545103|26829015|FG002|Overall Study|Lost to Follow-up|3|||
13409100|NCT00545103|26829016|FG003|Overall Study|Lost to Follow-up|4|||
13409101|NCT00545103|26829013|FG000|Overall Study|Protocol Violation|1|||
13409102|NCT00545103|26829014|FG001|Overall Study|Protocol Violation|2|||
13409103|NCT00545103|26829015|FG002|Overall Study|Protocol Violation|3|||
13409104|NCT00545103|26829016|FG003|Overall Study|Protocol Violation|0|||
13409105|NCT00545103|26829013|FG000|Overall Study|Suspected recurrence of diverticulitis|1|||
13409106|NCT00545103|26829014|FG001|Overall Study|Suspected recurrence of diverticulitis|0|||
13409107|NCT00545103|26829015|FG002|Overall Study|Suspected recurrence of diverticulitis|0|||
13409108|NCT00545103|26829016|FG003|Overall Study|Suspected recurrence of diverticulitis|3|||
13409109|NCT00545103|26829013|FG000|Overall Study|Difficult to open package|0|||
13409110|NCT00545103|26829014|FG001|Overall Study|Difficult to open package|0|||
13409111|NCT00545103|26829015|FG002|Overall Study|Difficult to open package|0|||
13409112|NCT00545103|26829016|FG003|Overall Study|Difficult to open package|1|||
13409113|NCT00545103|26829013|FG000|Overall Study|Investigational product not taken|1|||
13409114|NCT00545103|26829014|FG001|Overall Study|Investigational product not taken|0|||
13409115|NCT00545103|26829015|FG002|Overall Study|Investigational product not taken|0|||
13409116|NCT00545103|26829016|FG003|Overall Study|Investigational product not taken|1|||
13409117|NCT00545103|26829013|FG000|Overall Study|Wish to start a family|0|||
13409118|NCT00545103|26829014|FG001|Overall Study|Wish to start a family|0|||
13409119|NCT00545103|26829015|FG002|Overall Study|Wish to start a family|0|||
13409120|NCT00545103|26829016|FG003|Overall Study|Wish to start a family|1|||
13409121|NCT00545103|26829013|FG000|Overall Study|Diverticulitis crisis|0|||
13409122|NCT00545103|26829014|FG001|Overall Study|Diverticulitis crisis|0|||
13409123|NCT00545103|26829015|FG002|Overall Study|Diverticulitis crisis|0|||
13409124|NCT00545103|26829016|FG003|Overall Study|Diverticulitis crisis|1|||
13409125|NCT00545103|26829013|FG000|Overall Study|Personal reasons|1|||
13409126|NCT00545103|26829014|FG001|Overall Study|Personal reasons|0|||
13409127|NCT00545103|26829015|FG002|Overall Study|Personal reasons|0|||
13409128|NCT00545103|26829016|FG003|Overall Study|Personal reasons|0|||
13409129|NCT00545103|26829013|FG000|Overall Study|Subject's decision|1|||
13409130|NCT00545103|26829014|FG001|Overall Study|Subject's decision|0|||
13409131|NCT00545103|26829015|FG002|Overall Study|Subject's decision|0|||
13409132|NCT00545103|26829016|FG003|Overall Study|Subject's decision|0|||
13409133|NCT00545103|26829013|FG000|Overall Study|Noncompliance|0|||
13409134|NCT00545103|26829014|FG001|Overall Study|Noncompliance|1|||
13409135|NCT00545103|26829015|FG002|Overall Study|Noncompliance|0|||
13409136|NCT00545103|26829016|FG003|Overall Study|Noncompliance|0|||
13409137|NCT00545103|26829013|FG000|Overall Study|Investigator decision|0|||
13409138|NCT00545103|26829014|FG001|Overall Study|Investigator decision|0|||
13409139|NCT00545103|26829015|FG002|Overall Study|Investigator decision|1|||
13409140|NCT00545103|26829016|FG003|Overall Study|Investigator decision|0|||
13409141|NCT00545103|26829013|FG000|Overall Study|Subject moved|0|||
13409142|NCT00545103|26829014|FG001|Overall Study|Subject moved|1|||
13409143|NCT00545103|26829015|FG002|Overall Study|Subject moved|0|||
13409144|NCT00545103|26829016|FG003|Overall Study|Subject moved|0|||
13409145|NCT00545103|26829013|FG000|Overall Study|Use of prohibited medication|0|||
13409146|NCT00545103|26829014|FG001|Overall Study|Use of prohibited medication|0|||
13409147|NCT00545103|26829015|FG002|Overall Study|Use of prohibited medication|1|||
13409148|NCT00545103|26829016|FG003|Overall Study|Use of prohibited medication|0|||
13409149|NCT00545103|26829013|FG000|Overall Study|Does not want to take study drug anymore|1|||
13409150|NCT00545103|26829014|FG001|Overall Study|Does not want to take study drug anymore|0|||
13409151|NCT00545103|26829015|FG002|Overall Study|Does not want to take study drug anymore|1|||
13409152|NCT00545103|26829016|FG003|Overall Study|Does not want to take study drug anymore|0|||
13409153|NCT00545103|26829013|FG000|Overall Study|Subject met endpoint under protocol v. 1|0|||
13409154|NCT00545103|26829014|FG001|Overall Study|Subject met endpoint under protocol v. 1|0|||
13409155|NCT00545103|26829015|FG002|Overall Study|Subject met endpoint under protocol v. 1|1|||
13409156|NCT00545103|26829016|FG003|Overall Study|Subject met endpoint under protocol v. 1|0|||
13409157|NCT00545103|26829013|FG000|Overall Study|Death|0|||
13409158|NCT00545103|26829014|FG001|Overall Study|Death|1|||
13409159|NCT00545103|26829015|FG002|Overall Study|Death|0|||
13409160|NCT00545103|26829016|FG003|Overall Study|Death|0|||
13409161|NCT00545077|26829039|FG000|Overall Study|Treatment not received|5|||
13409162|NCT00545077|26829040|FG001|Overall Study|Treatment not received|1|||
13409163|NCT00545077|26829039|FG000|Overall Study|Disease Progression|131|||
13409164|NCT00545077|26829040|FG001|Overall Study|Disease Progression|98|||
13409165|NCT00545077|26829039|FG000|Overall Study|Withdrawal by Subject|3|||
13409166|NCT00545077|26829040|FG001|Overall Study|Withdrawal by Subject|14|||
13409167|NCT00545077|26829039|FG000|Overall Study|Physician Decision|6|||
13409168|NCT00545077|26829040|FG001|Overall Study|Physician Decision|3|||
13409169|NCT00545077|26829039|FG000|Overall Study|Lost to Follow-up|2|||
13409170|NCT00545077|26829040|FG001|Overall Study|Lost to Follow-up|0|||
13409171|NCT00545077|26829039|FG000|Overall Study|Protocol Violation|1|||
13409172|NCT00545077|26829040|FG001|Overall Study|Protocol Violation|0|||
13409173|NCT00545077|26829039|FG000|Overall Study|Adverse Event|0|||
13409174|NCT00545077|26829040|FG001|Overall Study|Adverse Event|31|||
13409175|NCT00545077|26829039|FG000|Overall Study|Death|0|||
13409176|NCT00545077|26829040|FG001|Overall Study|Death|8|||
13409177|NCT00545064|26829051|FG000|Overall Study|Lost to Follow-up|3|||
13409178|NCT00545064|26829051|FG000|Overall Study|Withdrawal by Subject|2|||
13409179|NCT00545064|26829051|FG000|Overall Study|did not complete course of treatment|1|||
13409180|NCT00545064|26829051|FG000|Overall Study|cancel all appointments, no rebooking|1|||
13409181|NCT00545064|26829051|FG000|Overall Study|inclement weather|1|||
13409182|NCT00545051|26829072|FG000|Overall Study|Adverse Event|7|||
13409183|NCT00545051|26829073|FG001|Overall Study|Adverse Event|3|||
13409184|NCT00545051|26829072|FG000|Overall Study|Death|1|||
13409185|NCT00545051|26829073|FG001|Overall Study|Death|0|||
13409186|NCT00545051|26829072|FG000|Overall Study|Violation of inclusion/exclusion|0|||
13409187|NCT00545051|26829073|FG001|Overall Study|Violation of inclusion/exclusion|2|||
13409188|NCT00545051|26829072|FG000|Overall Study|Protocol Violation|1|||
13409189|NCT00545051|26829073|FG001|Overall Study|Protocol Violation|0|||
13409190|NCT00545051|26829072|FG000|Overall Study|Withdrawal by Subject|0|||
13409191|NCT00545051|26829073|FG001|Overall Study|Withdrawal by Subject|1|||
13409192|NCT00545051|26829072|FG000|Overall Study|Administrative reasons|0|||
13409193|NCT00545051|26829073|FG001|Overall Study|Administrative reasons|1|||
13409194|NCT00544882|26829103|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2|||
13409195|NCT00544882|26829104|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
13409196|NCT00544882|26829105|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
13409197|NCT00544882|26829103|FG000|Cycle 1: Run-in Cycle|Adverse Event|1|||
13409198|NCT00544882|26829104|FG001|Cycle 1: Run-in Cycle|Adverse Event|0|||
13409199|NCT00544882|26829105|FG002|Cycle 1: Run-in Cycle|Adverse Event|0|||
13409200|NCT00544882|26829103|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
13409201|NCT00544882|26829104|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1|||
13409202|NCT00544882|26829105|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
13409203|NCT00544882|26829103|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
13409204|NCT00544882|26829104|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
13409205|NCT00544882|26829105|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1|||
13409206|NCT00544882|26829103|FG000|Cycle 3: Follow-up|Noncompliance|0|||
13409207|NCT00544882|26829104|FG001|Cycle 3: Follow-up|Noncompliance|1|||
13409208|NCT00544882|26829105|FG002|Cycle 3: Follow-up|Noncompliance|0|||
13409209|NCT00544882|26829103|FG000|Cycle 3: Follow-up|Pregnancy|0|||
13409210|NCT00544882|26829104|FG001|Cycle 3: Follow-up|Pregnancy|1|||
13409211|NCT00544882|26829105|FG002|Cycle 3: Follow-up|Pregnancy|0|||
13409212|NCT00544869|26829123|FG000|Overall Study|Rsolution of congenitive symptoms|3|||
13409213|NCT00544869|26829124|FG001|Overall Study|Rsolution of congenitive symptoms|0|||
13409214|NCT00544869|26829125|FG002|Overall Study|Rsolution of congenitive symptoms|0|||
13409215|NCT00544869|26829123|FG000|Overall Study|Adverse Event|6|||
13409216|NCT00544869|26829124|FG001|Overall Study|Adverse Event|1|||
13409217|NCT00544869|26829125|FG002|Overall Study|Adverse Event|0|||
13409218|NCT00544869|26829123|FG000|Overall Study|Lack of Efficacy|1|||
13409219|NCT00544869|26829124|FG001|Overall Study|Lack of Efficacy|1|||
13409220|NCT00544869|26829125|FG002|Overall Study|Lack of Efficacy|0|||
13409221|NCT00544869|26829123|FG000|Overall Study|Physician Decision|2|||
13409222|NCT00544869|26829124|FG001|Overall Study|Physician Decision|0|||
13409223|NCT00544869|26829125|FG002|Overall Study|Physician Decision|0|||
13409224|NCT00544817|26829133|FG000|Combined Modality|Lack of Efficacy|2|||
13409225|NCT00544817|26829133|FG000|Combined Modality|Worsening Neurologic Symptoms|2|||
13409226|NCT00544817|26829133|FG000|Combined Modality|Adverse Event|2|||
13409227|NCT00544817|26829133|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1|||
13409228|NCT00544817|26829133|FG000|No Treatment Interval|Lack of Efficacy|8|||
13409229|NCT00544817|26829133|FG000|No Treatment Interval|Physician Decision|3|||
13409230|NCT00544817|26829133|FG000|No Treatment Interval|Adverse Event|1|||
13409231|NCT00544817|26829133|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15|||
13409232|NCT00544817|26829133|FG000|Follow-up Systemic Therapy|Physician Decision|3|||
13409233|NCT00544817|26829133|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1|||
13409234|NCT00544648|26829154|FG000|Overall Study|Withdrawal by Subject|1|||
13409235|NCT00544648|26829155|FG001|Overall Study|Withdrawal by Subject|0|||
13409236|NCT00544648|26829154|FG000|Overall Study|Adverse Event|1|||
13409237|NCT00544648|26829155|FG001|Overall Study|Adverse Event|1|||
13409238|NCT00544648|26829154|FG000|Overall Study|progression of disease|1|||
13409239|NCT00544648|26829155|FG001|Overall Study|progression of disease|0|||
13409240|NCT00544557|26829188|FG000|Overall Study|Adverse Event|140|||
13409241|NCT00544557|26829188|FG000|Overall Study|Lack of Efficacy|196|||
13409242|NCT00544557|26829188|FG000|Overall Study|Other|98|||
13409243|NCT00544544|26829197|FG000|Overall Study|Withdrawal by Subject|1|||
13409244|NCT00544544|26829197|FG000|Overall Study|Adverse Event|1|||
13409245|NCT00544544|26829197|FG000|Overall Study|Lost to Follow-up|1|||
13409246|NCT00544440|26829206|FG000|Overall Study|Other|1|||
13409247|NCT00544440|26829206|FG000|Overall Study|Adverse Event|1|||
13409248|NCT00544440|26829206|FG000|Overall Study|Withdrawal by Subject|2|||
13409249|NCT00544440|26829206|FG000|Overall Study|Subject Non-compliance|1|||
13409250|NCT00544440|26829206|FG000|Overall Study|Progressive Disease|47|||
13409251|NCT00544440|26829206|FG000|Overall Study|Other|5|||
13409252|NCT00544167|26829212|FG000|Overall Study|Adverse Event|21|||
13409253|NCT00544167|26829212|FG000|Overall Study|Physician Decision|8|||
13409254|NCT00543985|26829221|FG000|Overall Study|Withdrawal by Subject|4|||
13409255|NCT00543855|26829256|FG000|Overall Study|Adverse Event|3|||
13409256|NCT00543855|26829257|FG001|Overall Study|Adverse Event|1|||
13409257|NCT00543855|26829258|FG002|Overall Study|Adverse Event|3|||
13409258|NCT00543855|26829259|FG003|Overall Study|Adverse Event|4|||
13409259|NCT00543855|26829256|FG000|Overall Study|Lost to Follow-up|0|||
13409260|NCT00543855|26829257|FG001|Overall Study|Lost to Follow-up|0|||
13409261|NCT00543855|26829258|FG002|Overall Study|Lost to Follow-up|1|||
13409262|NCT00543855|26829259|FG003|Overall Study|Lost to Follow-up|0|||
13409263|NCT00543855|26829256|FG000|Overall Study|Withdrawal by Subject|0|||
13409264|NCT00543855|26829257|FG001|Overall Study|Withdrawal by Subject|1|||
13409265|NCT00543855|26829258|FG002|Overall Study|Withdrawal by Subject|2|||
13409266|NCT00543855|26829259|FG003|Overall Study|Withdrawal by Subject|0|||
13409267|NCT00543855|26829256|FG000|Overall Study|Protocol Violation|1|||
13409268|NCT00543855|26829257|FG001|Overall Study|Protocol Violation|0|||
13409269|NCT00543855|26829258|FG002|Overall Study|Protocol Violation|0|||
13409270|NCT00543855|26829259|FG003|Overall Study|Protocol Violation|0|||
13409271|NCT00543803|26829278|FG000|Overall Study|Adverse Event|14|||
13409272|NCT00543803|26829278|FG000|Overall Study|Lack of Efficacy|22|||
13409273|NCT00543803|26829278|FG000|Overall Study|Lost to Follow-up|20|||
13409274|NCT00543803|26829278|FG000|Overall Study|Other|86|||
13409275|NCT00543725|26829307|FG000|Overall Study|Adverse Event|18|||
13409276|NCT00543725|26829308|FG001|Overall Study|Adverse Event|27|||
13409277|NCT00543725|26829307|FG000|Overall Study|Sponsor's Decision|0|||
13409278|NCT00543725|26829308|FG001|Overall Study|Sponsor's Decision|1|||
13409279|NCT00543725|26829307|FG000|Overall Study|Subject Non-Compliant|4|||
13409280|NCT00543725|26829308|FG001|Overall Study|Subject Non-Compliant|4|||
13409281|NCT00543725|26829307|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
13409282|NCT00543725|26829308|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
13409283|NCT00543725|26829307|FG000|Overall Study|Subject Reached A Virologic Endpoint|22|||
13409284|NCT00543725|26829308|FG001|Overall Study|Subject Reached A Virologic Endpoint|14|||
13409285|NCT00543725|26829307|FG000|Overall Study|Protocol Violation|0|||
13409286|NCT00543725|26829308|FG001|Overall Study|Protocol Violation|1|||
13409287|NCT00543725|26829307|FG000|Overall Study|Withdrawal by Subject|4|||
13409288|NCT00543725|26829308|FG001|Overall Study|Withdrawal by Subject|13|||
13409289|NCT00543725|26829307|FG000|Overall Study|Lost to Follow-up|15|||
13409290|NCT00543725|26829308|FG001|Overall Study|Lost to Follow-up|11|||
13409291|NCT00543725|26829307|FG000|Overall Study|Other|3|||
13409292|NCT00543725|26829308|FG001|Overall Study|Other|3|||
13409293|NCT00543569|26829423|FG000|Overall Study|Death|2|||
13409294|NCT00543569|26829424|FG001|Overall Study|Death|2|||
13409295|NCT00543569|26829425|FG002|Overall Study|Death|3|||
13409296|NCT00543569|26829426|FG003|Overall Study|Death|1|||
13409297|NCT00543569|26829423|FG000|Overall Study|Lost to Follow-up|0|||
13409298|NCT00543569|26829424|FG001|Overall Study|Lost to Follow-up|0|||
13409299|NCT00543569|26829425|FG002|Overall Study|Lost to Follow-up|1|||
13409300|NCT00543569|26829426|FG003|Overall Study|Lost to Follow-up|1|||
13409301|NCT00543569|26829423|FG000|Overall Study|Miscellaneous Reasons|7|||
13409302|NCT00543569|26829424|FG001|Overall Study|Miscellaneous Reasons|3|||
13409303|NCT00543569|26829425|FG002|Overall Study|Miscellaneous Reasons|11|||
13409304|NCT00543569|26829426|FG003|Overall Study|Miscellaneous Reasons|4|||
13409305|NCT00543569|26829423|FG000|Overall Study|Randomized but never received study drug|3|||
13409306|NCT00543569|26829424|FG001|Overall Study|Randomized but never received study drug|3|||
13409307|NCT00543569|26829425|FG002|Overall Study|Randomized but never received study drug|5|||
13409308|NCT00543569|26829426|FG003|Overall Study|Randomized but never received study drug|3|||
13409309|NCT00543543|26829480|FG000|Base Study|Adverse Event|1|||
13409310|NCT00543543|26829481|FG001|Base Study|Adverse Event|11|||
13409311|NCT00543543|26829482|FG002|Base Study|Adverse Event|0|||
13409312|NCT00543543|26829483|FG003|Base Study|Adverse Event|5|||
13409313|NCT00543543|26829480|FG000|Base Study|Lost to Follow-up|12|||
13409314|NCT00543543|26829481|FG001|Base Study|Lost to Follow-up|749|||
13409315|NCT00543543|26829482|FG002|Base Study|Lost to Follow-up|9|||
13409316|NCT00543543|26829483|FG003|Base Study|Lost to Follow-up|701|||
13409317|NCT00543543|26829480|FG000|Base Study|Physician Decision|0|||
13409318|NCT00543543|26829481|FG001|Base Study|Physician Decision|4|||
13409319|NCT00543543|26829482|FG002|Base Study|Physician Decision|0|||
13409320|NCT00543543|26829483|FG003|Base Study|Physician Decision|7|||
13409321|NCT00543543|26829480|FG000|Base Study|Protocol Violation|0|||
13409322|NCT00543543|26829481|FG001|Base Study|Protocol Violation|6|||
13409323|NCT00543543|26829482|FG002|Base Study|Protocol Violation|0|||
13409324|NCT00543543|26829483|FG003|Base Study|Protocol Violation|6|||
13409325|NCT00543543|26829480|FG000|Base Study|Withdrawal by Subject|7|||
13409326|NCT00543543|26829481|FG001|Base Study|Withdrawal by Subject|482|||
13409327|NCT00543543|26829482|FG002|Base Study|Withdrawal by Subject|5|||
13409328|NCT00543543|26829483|FG003|Base Study|Withdrawal by Subject|503|||
13409329|NCT00543543|26829480|FG000|Extension Study|Adverse Event|0|||
13409330|NCT00543543|26829481|FG001|Extension Study|Adverse Event|0|||
13409331|NCT00543543|26829482|FG002|Extension Study|Adverse Event|0|||
13409332|NCT00543543|26829483|FG003|Extension Study|Adverse Event|5|||
13409333|NCT00543543|26829480|FG000|Extension Study|Lost to Follow-up|0|||
13409334|NCT00543543|26829481|FG001|Extension Study|Lost to Follow-up|0|||
13409335|NCT00543543|26829482|FG002|Extension Study|Lost to Follow-up|0|||
13409336|NCT00543543|26829483|FG003|Extension Study|Lost to Follow-up|77|||
13409337|NCT00543543|26829480|FG000|Extension Study|Physician Decision|0|||
13409338|NCT00543543|26829481|FG001|Extension Study|Physician Decision|0|||
13409339|NCT00543543|26829482|FG002|Extension Study|Physician Decision|0|||
13409340|NCT00543543|26829483|FG003|Extension Study|Physician Decision|7|||
13409341|NCT00543543|26829480|FG000|Extension Study|Pregnancy|0|||
13409342|NCT00543543|26829481|FG001|Extension Study|Pregnancy|0|||
13409343|NCT00543543|26829482|FG002|Extension Study|Pregnancy|0|||
13409344|NCT00543543|26829483|FG003|Extension Study|Pregnancy|6|||
13409345|NCT00543543|26829480|FG000|Extension Study|Protocol Violation|0|||
13409346|NCT00543543|26829481|FG001|Extension Study|Protocol Violation|0|||
13409347|NCT00543543|26829482|FG002|Extension Study|Protocol Violation|0|||
13409348|NCT00543543|26829483|FG003|Extension Study|Protocol Violation|11|||
13409349|NCT00543543|26829480|FG000|Extension Study|Withdrawal by Subject|0|||
13409350|NCT00543543|26829481|FG001|Extension Study|Withdrawal by Subject|0|||
13409351|NCT00543543|26829482|FG002|Extension Study|Withdrawal by Subject|0|||
13409352|NCT00543543|26829483|FG003|Extension Study|Withdrawal by Subject|120|||
13409353|NCT00543439|26829536|FG000|Period 1|Adverse Event|0|||
13409354|NCT00543439|26829537|FG001|Period 1|Adverse Event|2|||
13409355|NCT00543439|26829538|FG002|Period 1|Adverse Event|1|||
13409356|NCT00543439|26829536|FG000|Period 1|Withdrawal by Subject|1|||
13409357|NCT00543439|26829537|FG001|Period 1|Withdrawal by Subject|1|||
13409358|NCT00543439|26829538|FG002|Period 1|Withdrawal by Subject|0|||
13409359|NCT00543439|26829536|FG000|Period 1|Physician Decision|0|||
13409360|NCT00543439|26829537|FG001|Period 1|Physician Decision|0|||
13409361|NCT00543439|26829538|FG002|Period 1|Physician Decision|1|||
13409362|NCT00543439|26829536|FG000|Period 2|Protocol Violation|1|||
13409363|NCT00543439|26829537|FG001|Period 2|Protocol Violation|0|||
13409364|NCT00543439|26829538|FG002|Period 2|Protocol Violation|1|||
13409365|NCT00543439|26829536|FG000|Period 2|Adverse Event|0|||
13409366|NCT00543439|26829537|FG001|Period 2|Adverse Event|1|||
13409367|NCT00543439|26829538|FG002|Period 2|Adverse Event|1|||
13409368|NCT00543387|26829603|FG000|Panel 1 + Panel 2|Adverse Event|0|||
13409369|NCT00543387|26829604|FG001|Panel 1 + Panel 2|Adverse Event|1|||
13409370|NCT00543387|26829605|FG002|Panel 1 + Panel 2|Adverse Event|0|||
13409371|NCT00543387|26829606|FG003|Panel 1 + Panel 2|Adverse Event|0|||
13409372|NCT00543387|26829607|FG004|Panel 1 + Panel 2|Adverse Event|0|||
13409373|NCT00543387|26829608|FG005|Panel 1 + Panel 2|Adverse Event|0|||
13409374|NCT00543387|26829609|FG006|Panel 1 + Panel 2|Adverse Event|0|||
13409375|NCT00543387|26829610|FG007|Panel 1 + Panel 2|Adverse Event|1|||
13409376|NCT00543387|26829611|FG008|Panel 1 + Panel 2|Adverse Event|1|||
13409377|NCT00543387|26829612|FG009|Panel 1 + Panel 2|Adverse Event|0|||
13409378|NCT00543387|26829613|FG010|Panel 1 + Panel 2|Adverse Event|0|||
13409379|NCT00543387|26829603|FG000|Panel 1 + Panel 2|Physician Decision|0|||
13409380|NCT00543387|26829604|FG001|Panel 1 + Panel 2|Physician Decision|0|||
13409381|NCT00543387|26829605|FG002|Panel 1 + Panel 2|Physician Decision|1|||
13409382|NCT00543387|26829606|FG003|Panel 1 + Panel 2|Physician Decision|0|||
13409383|NCT00543387|26829607|FG004|Panel 1 + Panel 2|Physician Decision|0|||
13409384|NCT00543387|26829608|FG005|Panel 1 + Panel 2|Physician Decision|0|||
13409385|NCT00543387|26829609|FG006|Panel 1 + Panel 2|Physician Decision|0|||
13409386|NCT00543387|26829610|FG007|Panel 1 + Panel 2|Physician Decision|1|||
13409387|NCT00543387|26829611|FG008|Panel 1 + Panel 2|Physician Decision|0|||
13409388|NCT00543387|26829612|FG009|Panel 1 + Panel 2|Physician Decision|0|||
13409389|NCT00543387|26829613|FG010|Panel 1 + Panel 2|Physician Decision|0|||
13409390|NCT00543387|26829603|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
13409391|NCT00543387|26829604|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
13409392|NCT00543387|26829605|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
13409393|NCT00543387|26829606|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
13409394|NCT00543387|26829607|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
13409395|NCT00543387|26829608|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
13409396|NCT00543387|26829609|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5|||
13409397|NCT00543387|26829610|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
13409398|NCT00543387|26829611|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
13409399|NCT00543387|26829612|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
13409400|NCT00543387|26829613|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
13409401|NCT00543387|26829603|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0|||
13409402|NCT00543387|26829604|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0|||
13409403|NCT00543387|26829605|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0|||
13409404|NCT00543387|26829606|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0|||
13409405|NCT00543387|26829607|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0|||
13409406|NCT00543387|26829608|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0|||
13409407|NCT00543387|26829609|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1|||
13409408|NCT00543387|26829610|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0|||
13409409|NCT00543387|26829611|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0|||
13409410|NCT00543387|26829612|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0|||
13409411|NCT00543387|26829613|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0|||
13409412|NCT00543387|26829603|FG000|Crossover Participants|Progressive Disease|0|||
13409413|NCT00543387|26829604|FG001|Crossover Participants|Progressive Disease|0|||
13409414|NCT00543387|26829605|FG002|Crossover Participants|Progressive Disease|0|||
13409415|NCT00543387|26829606|FG003|Crossover Participants|Progressive Disease|0|||
13409416|NCT00543387|26829607|FG004|Crossover Participants|Progressive Disease|0|||
13409417|NCT00543387|26829608|FG005|Crossover Participants|Progressive Disease|0|||
13409418|NCT00543387|26829609|FG006|Crossover Participants|Progressive Disease|0|||
13409419|NCT00543387|26829610|FG007|Crossover Participants|Progressive Disease|0|||
13409420|NCT00543387|26829611|FG008|Crossover Participants|Progressive Disease|0|||
13409421|NCT00543387|26829612|FG009|Crossover Participants|Progressive Disease|1|||
13409422|NCT00543387|26829613|FG010|Crossover Participants|Progressive Disease|2|||
13409423|NCT00543387|26829603|FG000|Crossover Participants|Study Terminated by Sponsor|0|||
13409424|NCT00543387|26829604|FG001|Crossover Participants|Study Terminated by Sponsor|0|||
13409425|NCT00543387|26829605|FG002|Crossover Participants|Study Terminated by Sponsor|0|||
13409426|NCT00543387|26829606|FG003|Crossover Participants|Study Terminated by Sponsor|0|||
13409427|NCT00543387|26829607|FG004|Crossover Participants|Study Terminated by Sponsor|0|||
13409428|NCT00543387|26829608|FG005|Crossover Participants|Study Terminated by Sponsor|0|||
13409429|NCT00543387|26829609|FG006|Crossover Participants|Study Terminated by Sponsor|0|||
13409430|NCT00543387|26829610|FG007|Crossover Participants|Study Terminated by Sponsor|0|||
13409431|NCT00543387|26829611|FG008|Crossover Participants|Study Terminated by Sponsor|0|||
13409432|NCT00543387|26829612|FG009|Crossover Participants|Study Terminated by Sponsor|0|||
13409433|NCT00543387|26829613|FG010|Crossover Participants|Study Terminated by Sponsor|1|||
13409434|NCT00543309|26829673|FG000|Overall Study|Physician Decision|0|||
13409435|NCT00543309|26829674|FG001|Overall Study|Physician Decision|1|||
13409436|NCT00543309|26829675|FG002|Overall Study|Physician Decision|0|||
13409437|NCT00543296|26829684|FG000|Overall Study|Physician Decision|7|||
13409438|NCT00543140|26829694|FG000|Overall Study|Lost to Follow-up|33|||
13409439|NCT00543140|26829694|FG000|Overall Study|Withdrawal by Subject|13|||
13409440|NCT00543140|26829694|FG000|Overall Study|Protocol Violation|10|||
13409441|NCT00543140|26829694|FG000|Overall Study|Insufficient weight loss|10|||
13409442|NCT00543140|26829694|FG000|Overall Study|SAE leading to explant of SAGB|3|||
13409443|NCT00543140|26829694|FG000|Overall Study|Death|1|||
13409444|NCT00543140|26829694|FG000|Overall Study|Subject moved|1|||
13409445|NCT00543140|26829694|FG000|Overall Study|Conversion to different procedure|1|||
13476317|NCT01729754|27002612|FG004|Part 2|Other Protocol Specified Criteria|0|||
13476318|NCT01729754|27002613|FG005|Part 2|Other Protocol Specified Criteria|0|||
13476319|NCT01729754|27002614|FG006|Part 2|Other Protocol Specified Criteria|0|||
13476320|NCT01729754|27002615|FG007|Part 2|Other Protocol Specified Criteria|1|||
13476321|NCT01729754|27002616|FG008|Part 2|Other Protocol Specified Criteria|0|||
13476322|NCT01729754|27002617|FG009|Part 2|Other Protocol Specified Criteria|0|||
13476323|NCT01729754|27002608|FG000|Part 3|Adverse Event|0|||
13476324|NCT01729754|27002609|FG001|Part 3|Adverse Event|0|||
13476325|NCT01729754|27002610|FG002|Part 3|Adverse Event|1|||
13476326|NCT01729754|27002611|FG003|Part 3|Adverse Event|0|||
13476327|NCT01729754|27002612|FG004|Part 3|Adverse Event|0|||
13476328|NCT01729754|27002613|FG005|Part 3|Adverse Event|5|||
13476329|NCT01729754|27002614|FG006|Part 3|Adverse Event|0|||
13476330|NCT01729754|27002615|FG007|Part 3|Adverse Event|0|||
13476331|NCT01729754|27002616|FG008|Part 3|Adverse Event|0|||
13476332|NCT01729754|27002617|FG009|Part 3|Adverse Event|3|||
13476333|NCT01729754|27002608|FG000|Part 3|Death|0|||
13476334|NCT01729754|27002609|FG001|Part 3|Death|0|||
13476335|NCT01729754|27002610|FG002|Part 3|Death|0|||
13476336|NCT01729754|27002611|FG003|Part 3|Death|0|||
13476337|NCT01729754|27002612|FG004|Part 3|Death|0|||
13476338|NCT01729754|27002613|FG005|Part 3|Death|2|||
13476339|NCT01729754|27002614|FG006|Part 3|Death|0|||
13476340|NCT01729754|27002615|FG007|Part 3|Death|0|||
13476341|NCT01729754|27002616|FG008|Part 3|Death|0|||
13476342|NCT01729754|27002617|FG009|Part 3|Death|0|||
13476343|NCT01729754|27002608|FG000|Part 3|Lack of Efficacy|0|||
13476344|NCT01729754|27002609|FG001|Part 3|Lack of Efficacy|0|||
13476345|NCT01729754|27002610|FG002|Part 3|Lack of Efficacy|0|||
13476346|NCT01729754|27002611|FG003|Part 3|Lack of Efficacy|0|||
13476347|NCT01729754|27002612|FG004|Part 3|Lack of Efficacy|2|||
13476348|NCT01729754|27002613|FG005|Part 3|Lack of Efficacy|0|||
13476349|NCT01729754|27002614|FG006|Part 3|Lack of Efficacy|0|||
13476350|NCT01729754|27002615|FG007|Part 3|Lack of Efficacy|0|||
13476351|NCT01729754|27002616|FG008|Part 3|Lack of Efficacy|0|||
13476352|NCT01729754|27002617|FG009|Part 3|Lack of Efficacy|4|||
13476353|NCT01729754|27002608|FG000|Part 3|Lost to Follow-up|0|||
13476354|NCT01729754|27002609|FG001|Part 3|Lost to Follow-up|1|||
13476355|NCT01729754|27002610|FG002|Part 3|Lost to Follow-up|2|||
13476356|NCT01729754|27002611|FG003|Part 3|Lost to Follow-up|0|||
13476357|NCT01729754|27002612|FG004|Part 3|Lost to Follow-up|0|||
13476358|NCT01729754|27002613|FG005|Part 3|Lost to Follow-up|3|||
13476359|NCT01729754|27002614|FG006|Part 3|Lost to Follow-up|0|||
13476360|NCT01729754|27002615|FG007|Part 3|Lost to Follow-up|0|||
13476361|NCT01729754|27002616|FG008|Part 3|Lost to Follow-up|1|||
13476362|NCT01729754|27002617|FG009|Part 3|Lost to Follow-up|0|||
13476363|NCT01729754|27002608|FG000|Part 3|Physician Decision|0|||
13476364|NCT01729754|27002609|FG001|Part 3|Physician Decision|0|||
13476365|NCT01729754|27002610|FG002|Part 3|Physician Decision|1|||
13476366|NCT01729754|27002611|FG003|Part 3|Physician Decision|0|||
13476367|NCT01729754|27002612|FG004|Part 3|Physician Decision|0|||
13476368|NCT01729754|27002613|FG005|Part 3|Physician Decision|0|||
13409446|NCT00543062|26829721|FG000|Overall Study|Withdrawal by Subject|1|||
13409447|NCT00543062|26829722|FG001|Overall Study|Withdrawal by Subject|0|||
13409448|NCT00543062|26829723|FG002|Overall Study|Withdrawal by Subject|2|||
13409449|NCT00543062|26829724|FG003|Overall Study|Withdrawal by Subject|0|||
13409450|NCT00543062|26829721|FG000|Overall Study|Adverse Event|0|||
13409451|NCT00543062|26829722|FG001|Overall Study|Adverse Event|1|||
13409452|NCT00543062|26829723|FG002|Overall Study|Adverse Event|1|||
13409453|NCT00543062|26829724|FG003|Overall Study|Adverse Event|1|||
13409454|NCT00543062|26829721|FG000|Overall Study|Protocol Violation|1|||
13409455|NCT00543062|26829722|FG001|Overall Study|Protocol Violation|0|||
13409456|NCT00543062|26829723|FG002|Overall Study|Protocol Violation|0|||
13409457|NCT00543062|26829724|FG003|Overall Study|Protocol Violation|0|||
13409458|NCT00542997|26829741|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2|||
13409459|NCT00542997|26829741|FG000|Wash in / Wash Out Period|Adverse Event|3|||
13409460|NCT00542997|26829741|FG000|Efficacy Period|Adverse Event|3|||
13409461|NCT00542919|26829794|FG000|Overall Study|Adverse Event|1|||
13409462|NCT00542919|26829795|FG001|Overall Study|Adverse Event|5|||
13409463|NCT00542919|26829796|FG002|Overall Study|Adverse Event|1|||
13409464|NCT00542919|26829794|FG000|Overall Study|Withdrawal by Subject|1|||
13409465|NCT00542919|26829795|FG001|Overall Study|Withdrawal by Subject|0|||
13409466|NCT00542919|26829796|FG002|Overall Study|Withdrawal by Subject|3|||
13409467|NCT00542919|26829794|FG000|Overall Study|Physician Decision|2|||
13409468|NCT00542919|26829795|FG001|Overall Study|Physician Decision|2|||
13409469|NCT00542919|26829796|FG002|Overall Study|Physician Decision|1|||
13409470|NCT00542919|26829794|FG000|Overall Study|Sponsor Decision|1|||
13409471|NCT00542919|26829795|FG001|Overall Study|Sponsor Decision|0|||
13409472|NCT00542919|26829796|FG002|Overall Study|Sponsor Decision|0|||
13409473|NCT00542919|26829794|FG000|Overall Study|Lost to Follow-up|2|||
13409474|NCT00542919|26829795|FG001|Overall Study|Lost to Follow-up|0|||
13409475|NCT00542919|26829796|FG002|Overall Study|Lost to Follow-up|1|||
13409476|NCT00542880|26829839|FG000|Period 1|Eligibility criteria not fulfilled|2|||
13409477|NCT00542880|26829840|FG001|Period 1|Eligibility criteria not fulfilled|6|||
13409478|NCT00542880|26829839|FG000|Period 1|Adverse Event|2|||
13409479|NCT00542880|26829840|FG001|Period 1|Adverse Event|2|||
13409480|NCT00542880|26829839|FG000|Period 1|Development of study-specific criteria|1|||
13409481|NCT00542880|26829840|FG001|Period 1|Development of study-specific criteria|2|||
13409482|NCT00542880|26829839|FG000|Period 1|Withdrawal by Subject|1|||
13409483|NCT00542880|26829840|FG001|Period 1|Withdrawal by Subject|1|||
13409484|NCT00542880|26829839|FG000|Period 1|Protocol Violation|0|||
13409485|NCT00542880|26829840|FG001|Period 1|Protocol Violation|1|||
13409486|NCT00542880|26829839|FG000|Period 2|Adverse Event|5|||
13409487|NCT00542880|26829840|FG001|Period 2|Adverse Event|7|||
13409488|NCT00542880|26829839|FG000|Period 2|Eligibility not fulfilled|0|||
13409489|NCT00542880|26829840|FG001|Period 2|Eligibility not fulfilled|1|||
13409490|NCT00542880|26829839|FG000|Period 2|Discontinuation criteria|2|||
13409491|NCT00542880|26829840|FG001|Period 2|Discontinuation criteria|0|||
13409492|NCT00542880|26829839|FG000|Period 2|Severe non-compliance|0|||
13409493|NCT00542880|26829840|FG001|Period 2|Severe non-compliance|1|||
13409494|NCT00542880|26829839|FG000|Period 2|Other|0|||
13409495|NCT00542880|26829840|FG001|Period 2|Other|1|||
13409496|NCT00542880|26829839|FG000|Period 3|Adverse Event|0|||
13409497|NCT00542880|26829840|FG001|Period 3|Adverse Event|2|||
13409498|NCT00542828|26829857|FG000|Overall Study|Physician Decision|1|||
13409499|NCT00542828|26829857|FG000|Overall Study|Need for Prohibited Treatment|3|||
13409500|NCT00542828|26829857|FG000|Overall Study|Study Prematurely Discontinued|7|||
13409501|NCT00542828|26829857|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2|||
13409502|NCT00542815|26829878|FG000|Overall Study|Adverse Event|19|||
13409503|NCT00542815|26829879|FG001|Overall Study|Adverse Event|6|||
13409504|NCT00542815|26829880|FG002|Overall Study|Adverse Event|9|||
13409505|NCT00542815|26829878|FG000|Overall Study|Death|10|||
13409506|NCT00542815|26829879|FG001|Overall Study|Death|7|||
13409507|NCT00542815|26829880|FG002|Overall Study|Death|3|||
13409508|NCT00542815|26829878|FG000|Overall Study|Lack of Efficacy|9|||
13409509|NCT00542815|26829879|FG001|Overall Study|Lack of Efficacy|2|||
13409510|NCT00542815|26829880|FG002|Overall Study|Lack of Efficacy|0|||
13409511|NCT00542815|26829878|FG000|Overall Study|Physician Decision|2|||
13409512|NCT00542815|26829879|FG001|Overall Study|Physician Decision|1|||
13409513|NCT00542815|26829880|FG002|Overall Study|Physician Decision|0|||
13409514|NCT00542815|26829878|FG000|Overall Study|Protocol Violation|1|||
13409515|NCT00542815|26829879|FG001|Overall Study|Protocol Violation|1|||
13409516|NCT00542815|26829880|FG002|Overall Study|Protocol Violation|2|||
13409517|NCT00542815|26829878|FG000|Overall Study|Withdrawal by Subject|41|||
13409518|NCT00542815|26829879|FG001|Overall Study|Withdrawal by Subject|5|||
13409519|NCT00542815|26829880|FG002|Overall Study|Withdrawal by Subject|8|||
13409520|NCT00542815|26829878|FG000|Overall Study|Other reasons|24|||
13409521|NCT00542815|26829879|FG001|Overall Study|Other reasons|10|||
13409522|NCT00542815|26829880|FG002|Overall Study|Other reasons|10|||
13409523|NCT00542789|26829897|FG000|Overall Study|Adverse Event|18|||
13409524|NCT00542789|26829898|FG001|Overall Study|Adverse Event|17|||
13409525|NCT00542789|26829897|FG000|Overall Study|Withdrawal by Subject|7|||
13409526|NCT00542789|26829898|FG001|Overall Study|Withdrawal by Subject|3|||
13409527|NCT00542789|26829897|FG000|Overall Study|Protocol Violation|8|||
13409528|NCT00542789|26829898|FG001|Overall Study|Protocol Violation|1|||
13409529|NCT00542789|26829897|FG000|Overall Study|Recurrence of Gastric Ulcer|8|||
13409530|NCT00542789|26829898|FG001|Overall Study|Recurrence of Gastric Ulcer|57|||
13409531|NCT00542425|26829946|FG000|Initial 24 Weeks|Administrative reasons|0|||
13409532|NCT00542425|26829947|FG001|Initial 24 Weeks|Administrative reasons|0|||
13409533|NCT00542425|26829948|FG002|Initial 24 Weeks|Administrative reasons|1|||
13409534|NCT00542425|26829949|FG003|Initial 24 Weeks|Administrative reasons|1|||
13409535|NCT00542425|26829950|FG004|Initial 24 Weeks|Administrative reasons|0|||
13409536|NCT00542425|26829946|FG000|Initial 24 Weeks|Adverse Event|0|||
13409537|NCT00542425|26829947|FG001|Initial 24 Weeks|Adverse Event|1|||
13409538|NCT00542425|26829948|FG002|Initial 24 Weeks|Adverse Event|1|||
13409539|NCT00542425|26829949|FG003|Initial 24 Weeks|Adverse Event|3|||
13409540|NCT00542425|26829950|FG004|Initial 24 Weeks|Adverse Event|2|||
13409541|NCT00542425|26829946|FG000|Initial 24 Weeks|Inability to complete procedures|0|||
13409542|NCT00542425|26829947|FG001|Initial 24 Weeks|Inability to complete procedures|3|||
13409543|NCT00542425|26829948|FG002|Initial 24 Weeks|Inability to complete procedures|2|||
13409544|NCT00542425|26829949|FG003|Initial 24 Weeks|Inability to complete procedures|1|||
13409545|NCT00542425|26829950|FG004|Initial 24 Weeks|Inability to complete procedures|2|||
13409546|NCT00542425|26829946|FG000|Initial 24 Weeks|Lost to Follow-up|2|||
13409547|NCT00542425|26829947|FG001|Initial 24 Weeks|Lost to Follow-up|2|||
13409548|NCT00542425|26829948|FG002|Initial 24 Weeks|Lost to Follow-up|1|||
13409549|NCT00542425|26829949|FG003|Initial 24 Weeks|Lost to Follow-up|0|||
13409550|NCT00542425|26829950|FG004|Initial 24 Weeks|Lost to Follow-up|0|||
13409551|NCT00542425|26829946|FG000|Initial 24 Weeks|Non-compliance|0|||
13409552|NCT00542425|26829947|FG001|Initial 24 Weeks|Non-compliance|0|||
13409553|NCT00542425|26829948|FG002|Initial 24 Weeks|Non-compliance|0|||
13409554|NCT00542425|26829949|FG003|Initial 24 Weeks|Non-compliance|1|||
13409555|NCT00542425|26829950|FG004|Initial 24 Weeks|Non-compliance|1|||
13409556|NCT00542425|26829946|FG000|Initial 24 Weeks|Protocol Violation|0|||
13409557|NCT00542425|26829947|FG001|Initial 24 Weeks|Protocol Violation|0|||
13409558|NCT00542425|26829948|FG002|Initial 24 Weeks|Protocol Violation|0|||
13409559|NCT00542425|26829949|FG003|Initial 24 Weeks|Protocol Violation|1|||
13409560|NCT00542425|26829950|FG004|Initial 24 Weeks|Protocol Violation|0|||
13409561|NCT00542425|26829946|FG000|Initial 24 Weeks|Refusal of treatment|2|||
13409562|NCT00542425|26829947|FG001|Initial 24 Weeks|Refusal of treatment|2|||
13409563|NCT00542425|26829948|FG002|Initial 24 Weeks|Refusal of treatment|1|||
13409564|NCT00542425|26829949|FG003|Initial 24 Weeks|Refusal of treatment|4|||
13409565|NCT00542425|26829950|FG004|Initial 24 Weeks|Refusal of treatment|1|||
13409566|NCT00542425|26829946|FG000|Initial 24 Weeks|Other|0|||
13409567|NCT00542425|26829947|FG001|Initial 24 Weeks|Other|2|||
13409568|NCT00542425|26829948|FG002|Initial 24 Weeks|Other|1|||
13409569|NCT00542425|26829949|FG003|Initial 24 Weeks|Other|0|||
13409570|NCT00542425|26829950|FG004|Initial 24 Weeks|Other|0|||
13409571|NCT00542425|26829946|FG000|Extended 24 Weeks of Treatment|Adverse Event|0|||
13409572|NCT00542425|26829947|FG001|Extended 24 Weeks of Treatment|Adverse Event|0|||
13409573|NCT00542425|26829948|FG002|Extended 24 Weeks of Treatment|Adverse Event|1|||
13409574|NCT00542425|26829949|FG003|Extended 24 Weeks of Treatment|Adverse Event|1|||
13409575|NCT00542425|26829950|FG004|Extended 24 Weeks of Treatment|Adverse Event|0|||
13409576|NCT00542425|26829946|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0|||
13409577|NCT00542425|26829947|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0|||
13409578|NCT00542425|26829948|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1|||
13409579|NCT00542425|26829949|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0|||
13409580|NCT00542425|26829950|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0|||
13409581|NCT00542425|26829946|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
13409582|NCT00542425|26829947|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1|||
13409583|NCT00542425|26829948|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
13409584|NCT00542425|26829949|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
13409585|NCT00542425|26829950|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
13409586|NCT00542425|26829946|FG000|Extended 24 Weeks of Treatment|Other|1|||
13409587|NCT00542425|26829947|FG001|Extended 24 Weeks of Treatment|Other|1|||
13409588|NCT00542425|26829948|FG002|Extended 24 Weeks of Treatment|Other|0|||
13409589|NCT00542425|26829949|FG003|Extended 24 Weeks of Treatment|Other|0|||
13409590|NCT00542425|26829950|FG004|Extended 24 Weeks of Treatment|Other|1|||
13409591|NCT00542386|26829989|FG000|Overall Study|Adverse Event|1|||
13409592|NCT00542386|26829990|FG001|Overall Study|Adverse Event|7|||
13409593|NCT00542386|26829991|FG002|Overall Study|Adverse Event|7|||
13409594|NCT00542386|26829992|FG003|Overall Study|Adverse Event|8|||
13409595|NCT00542386|26829993|FG004|Overall Study|Adverse Event|13|||
13409596|NCT00542386|26829994|FG005|Overall Study|Adverse Event|4|||
13409597|NCT00542386|26829989|FG000|Overall Study|Death|0|||
13409598|NCT00542386|26829990|FG001|Overall Study|Death|0|||
13409599|NCT00542386|26829991|FG002|Overall Study|Death|1|||
13409600|NCT00542386|26829992|FG003|Overall Study|Death|2|||
13409601|NCT00542386|26829993|FG004|Overall Study|Death|1|||
13409602|NCT00542386|26829994|FG005|Overall Study|Death|2|||
13409603|NCT00542386|26829989|FG000|Overall Study|Lack of Efficacy|32|||
13409604|NCT00542386|26829990|FG001|Overall Study|Lack of Efficacy|12|||
13409605|NCT00542386|26829991|FG002|Overall Study|Lack of Efficacy|10|||
13409606|NCT00542386|26829992|FG003|Overall Study|Lack of Efficacy|13|||
13409607|NCT00542386|26829993|FG004|Overall Study|Lack of Efficacy|7|||
13409608|NCT00542386|26829994|FG005|Overall Study|Lack of Efficacy|31|||
13409609|NCT00542386|26829989|FG000|Overall Study|Physician Decision|1|||
13409610|NCT00542386|26829990|FG001|Overall Study|Physician Decision|0|||
13409611|NCT00542386|26829991|FG002|Overall Study|Physician Decision|0|||
13409612|NCT00542386|26829992|FG003|Overall Study|Physician Decision|1|||
13409613|NCT00542386|26829993|FG004|Overall Study|Physician Decision|0|||
13409614|NCT00542386|26829994|FG005|Overall Study|Physician Decision|0|||
13409615|NCT00542386|26829989|FG000|Overall Study|Protocol Violation|0|||
13409616|NCT00542386|26829990|FG001|Overall Study|Protocol Violation|0|||
13409617|NCT00542386|26829991|FG002|Overall Study|Protocol Violation|1|||
13409618|NCT00542386|26829992|FG003|Overall Study|Protocol Violation|0|||
13409619|NCT00542386|26829993|FG004|Overall Study|Protocol Violation|0|||
13409620|NCT00542386|26829994|FG005|Overall Study|Protocol Violation|4|||
13409621|NCT00542386|26829989|FG000|Overall Study|Withdrawal by Subject|5|||
13409622|NCT00542386|26829990|FG001|Overall Study|Withdrawal by Subject|8|||
13409623|NCT00542386|26829991|FG002|Overall Study|Withdrawal by Subject|10|||
13409624|NCT00542386|26829992|FG003|Overall Study|Withdrawal by Subject|11|||
13409625|NCT00542386|26829993|FG004|Overall Study|Withdrawal by Subject|15|||
13409626|NCT00542386|26829994|FG005|Overall Study|Withdrawal by Subject|7|||
13409627|NCT00542386|26829989|FG000|Overall Study|Other Reasons|4|||
13409628|NCT00542386|26829990|FG001|Overall Study|Other Reasons|1|||
13409629|NCT00542386|26829991|FG002|Overall Study|Other Reasons|4|||
13409630|NCT00542386|26829992|FG003|Overall Study|Other Reasons|3|||
13409631|NCT00542386|26829993|FG004|Overall Study|Other Reasons|4|||
13409632|NCT00542386|26829994|FG005|Overall Study|Other Reasons|2|||
13409633|NCT00542321|26830015|FG000|Overall Study|Death|0|||
13409634|NCT00542321|26830016|FG001|Overall Study|Death|1|||
13409635|NCT00542269|26830055|FG000|Overall Study|Adverse Event|10|||
13409636|NCT00542269|26830056|FG001|Overall Study|Adverse Event|4|||
13409637|NCT00542269|26830057|FG002|Overall Study|Adverse Event|5|||
13409638|NCT00542269|26830055|FG000|Overall Study|Protocol Violation|1|||
13409639|NCT00542269|26830056|FG001|Overall Study|Protocol Violation|1|||
13409640|NCT00542269|26830057|FG002|Overall Study|Protocol Violation|0|||
13409641|NCT00542269|26830055|FG000|Overall Study|Withdrawal by Subject|1|||
13409642|NCT00542269|26830056|FG001|Overall Study|Withdrawal by Subject|0|||
13409643|NCT00542269|26830057|FG002|Overall Study|Withdrawal by Subject|0|||
13409644|NCT00542269|26830055|FG000|Overall Study|Administrative problems|1|||
13409645|NCT00542269|26830056|FG001|Overall Study|Administrative problems|1|||
13409646|NCT00542269|26830057|FG002|Overall Study|Administrative problems|1|||
13409647|NCT00542191|26830063|FG000|Overall Study|Death|3|||
13409648|NCT00542178|26830116|FG000|Overall Study|did not complete year 4 follow-up|75|||
13409649|NCT00542178|26830117|FG001|Overall Study|did not complete year 4 follow-up|80|||
13409650|NCT00542178|26830118|FG002|Overall Study|did not complete year 4 follow-up|74|||
13409651|NCT00542178|26830119|FG003|Overall Study|did not complete year 4 follow-up|62|||
13409652|NCT00542178|26830120|FG004|Overall Study|did not complete year 4 follow-up|64|||
13409653|NCT00542178|26830121|FG005|Overall Study|did not complete year 4 follow-up|89|||
13409654|NCT00542178|26830122|FG006|Overall Study|did not complete year 4 follow-up|87|||
13409655|NCT00542178|26830123|FG007|Overall Study|did not complete year 4 follow-up|85|||
13409656|NCT00541970|26830285|FG000|Month 7|Protocol Violation|9|||
13409657|NCT00541970|26830286|FG001|Month 7|Protocol Violation|13|||
13409658|NCT00541970|26830287|FG002|Month 7|Protocol Violation|11|||
13409659|NCT00541970|26830288|FG003|Month 7|Protocol Violation|5|||
13409660|NCT00541970|26830285|FG000|Month 12|Adverse Event|0|||
13409661|NCT00541970|26830286|FG001|Month 12|Adverse Event|1|||
13409662|NCT00541970|26830287|FG002|Month 12|Adverse Event|1|||
13409663|NCT00541970|26830288|FG003|Month 12|Adverse Event|1|||
13409664|NCT00541970|26830285|FG000|Month 12|Protocol Violation|12|||
13409665|NCT00541970|26830286|FG001|Month 12|Protocol Violation|21|||
13409666|NCT00541970|26830287|FG002|Month 12|Protocol Violation|20|||
13409667|NCT00541970|26830288|FG003|Month 12|Protocol Violation|15|||
13409668|NCT00541970|26830285|FG000|Month 18|Adverse Event|0|||
13409669|NCT00541970|26830286|FG001|Month 18|Adverse Event|1|||
13409670|NCT00541970|26830287|FG002|Month 18|Adverse Event|1|||
13409671|NCT00541970|26830288|FG003|Month 18|Adverse Event|1|||
13409672|NCT00541970|26830285|FG000|Month 18|Protocol Violation|14|||
13409673|NCT00541970|26830286|FG001|Month 18|Protocol Violation|23|||
13409674|NCT00541970|26830287|FG002|Month 18|Protocol Violation|24|||
13409675|NCT00541970|26830288|FG003|Month 18|Protocol Violation|16|||
13409676|NCT00541970|26830285|FG000|Month 24|Adverse Event|0|||
13409677|NCT00541970|26830286|FG001|Month 24|Adverse Event|1|||
13409678|NCT00541970|26830287|FG002|Month 24|Adverse Event|1|||
13409679|NCT00541970|26830288|FG003|Month 24|Adverse Event|1|||
13409680|NCT00541970|26830285|FG000|Month 24|Protocol Violation|29|||
13409681|NCT00541970|26830286|FG001|Month 24|Protocol Violation|31|||
13409682|NCT00541970|26830287|FG002|Month 24|Protocol Violation|31|||
13409683|NCT00541970|26830288|FG003|Month 24|Protocol Violation|21|||
13409684|NCT00541970|26830285|FG000|Month 36|Protocol Violation|61|||
13409685|NCT00541970|26830286|FG001|Month 36|Protocol Violation|66|||
13409686|NCT00541970|26830287|FG002|Month 36|Protocol Violation|66|||
13409687|NCT00541970|26830288|FG003|Month 36|Protocol Violation|60|||
13409688|NCT00541970|26830285|FG000|Month 48|Withdrawal by Subject|2|||
13409689|NCT00541970|26830286|FG001|Month 48|Withdrawal by Subject|4|||
13409690|NCT00541970|26830287|FG002|Month 48|Withdrawal by Subject|4|||
13409691|NCT00541970|26830288|FG003|Month 48|Withdrawal by Subject|2|||
13409692|NCT00541970|26830285|FG000|Month 48|Other|3|||
13409693|NCT00541970|26830286|FG001|Month 48|Other|1|||
13409694|NCT00541970|26830287|FG002|Month 48|Other|1|||
13409695|NCT00541970|26830288|FG003|Month 48|Other|0|||
13409696|NCT00541970|26830285|FG000|Month 48|Lost to Follow-up|66|||
13409697|NCT00541970|26830286|FG001|Month 48|Lost to Follow-up|68|||
13409698|NCT00541970|26830287|FG002|Month 48|Lost to Follow-up|68|||
13409699|NCT00541970|26830288|FG003|Month 48|Lost to Follow-up|73|||
13409700|NCT00541970|26830285|FG000|Month 60|Protocol Violation|78|||
13409701|NCT00541970|26830286|FG001|Month 60|Protocol Violation|77|||
13409702|NCT00541970|26830287|FG002|Month 60|Protocol Violation|82|||
13409703|NCT00541970|26830288|FG003|Month 60|Protocol Violation|72|||
13409704|NCT00541931|26830303|FG000|Overall Study|Adverse Event|1|||
13409705|NCT00541931|26830304|FG001|Overall Study|Adverse Event|0|||
13409706|NCT00541931|26830303|FG000|Overall Study|Lost to Follow-up|3|||
13409707|NCT00541931|26830304|FG001|Overall Study|Lost to Follow-up|3|||
13409708|NCT00541931|26830303|FG000|Overall Study|Withdrawal by Subject|1|||
13409709|NCT00541931|26830304|FG001|Overall Study|Withdrawal by Subject|0|||
13409710|NCT00541931|26830303|FG000|Overall Study|Transportation Issue|0|||
13409711|NCT00541931|26830304|FG001|Overall Study|Transportation Issue|1|||
13409712|NCT00541866|26830358|FG000|Overall Study|Adverse Event|3|||
13409713|NCT00541866|26830359|FG001|Overall Study|Adverse Event|0|||
13409714|NCT00541866|26830360|FG002|Overall Study|Adverse Event|0|||
13409715|NCT00541866|26830361|FG003|Overall Study|Adverse Event|0|||
13409716|NCT00541866|26830362|FG004|Overall Study|Adverse Event|0|||
13409717|NCT00541866|26830358|FG000|Overall Study|Death|1|||
13409718|NCT00541866|26830359|FG001|Overall Study|Death|0|||
13409719|NCT00541866|26830360|FG002|Overall Study|Death|0|||
13409720|NCT00541866|26830361|FG003|Overall Study|Death|0|||
13409721|NCT00541866|26830362|FG004|Overall Study|Death|0|||
13409722|NCT00541866|26830358|FG000|Overall Study|Lack of Efficacy|19|||
13409723|NCT00541866|26830359|FG001|Overall Study|Lack of Efficacy|15|||
13409724|NCT00541866|26830360|FG002|Overall Study|Lack of Efficacy|10|||
13409725|NCT00541866|26830361|FG003|Overall Study|Lack of Efficacy|12|||
13409726|NCT00541866|26830362|FG004|Overall Study|Lack of Efficacy|14|||
13409727|NCT00541866|26830358|FG000|Overall Study|Not Reported or Other|11|||
13409728|NCT00541866|26830359|FG001|Overall Study|Not Reported or Other|3|||
13409729|NCT00541866|26830360|FG002|Overall Study|Not Reported or Other|3|||
13409730|NCT00541866|26830361|FG003|Overall Study|Not Reported or Other|3|||
13409731|NCT00541866|26830362|FG004|Overall Study|Not Reported or Other|1|||
13409732|NCT00541866|26830358|FG000|Overall Study|Physician Decision|0|||
13409733|NCT00541866|26830359|FG001|Overall Study|Physician Decision|0|||
13409734|NCT00541866|26830360|FG002|Overall Study|Physician Decision|2|||
13409735|NCT00541866|26830361|FG003|Overall Study|Physician Decision|1|||
13409736|NCT00541866|26830362|FG004|Overall Study|Physician Decision|0|||
13409737|NCT00541775|26830386|FG000|Overall Study|Adverse Event|3|||
13409738|NCT00541775|26830387|FG001|Overall Study|Adverse Event|2|||
13409739|NCT00541775|26830388|FG002|Overall Study|Adverse Event|1|||
13409740|NCT00541775|26830386|FG000|Overall Study|Lack of Efficacy|0|||
13409741|NCT00541775|26830387|FG001|Overall Study|Lack of Efficacy|0|||
13409742|NCT00541775|26830388|FG002|Overall Study|Lack of Efficacy|3|||
13409743|NCT00541775|26830386|FG000|Overall Study|Lost to Follow-up|0|||
13409744|NCT00541775|26830387|FG001|Overall Study|Lost to Follow-up|0|||
13409745|NCT00541775|26830388|FG002|Overall Study|Lost to Follow-up|2|||
13409746|NCT00541775|26830386|FG000|Overall Study|Protocol Violation|1|||
13409747|NCT00541775|26830387|FG001|Overall Study|Protocol Violation|0|||
13409748|NCT00541775|26830388|FG002|Overall Study|Protocol Violation|0|||
13409749|NCT00541775|26830386|FG000|Overall Study|Withdrawal by Subject and Other|5|||
13409750|NCT00541775|26830387|FG001|Overall Study|Withdrawal by Subject and Other|0|||
13409751|NCT00541775|26830388|FG002|Overall Study|Withdrawal by Subject and Other|2|||
13409752|NCT00541658|26830555|FG000|Overall Study|Adverse Event|28|||
13409753|NCT00541658|26830556|FG001|Overall Study|Adverse Event|37|||
13409754|NCT00541658|26830557|FG002|Overall Study|Adverse Event|25|||
13409755|NCT00541658|26830555|FG000|Overall Study|Physician Decision|0|||
13409756|NCT00541658|26830556|FG001|Overall Study|Physician Decision|0|||
13409757|NCT00541658|26830557|FG002|Overall Study|Physician Decision|4|||
13409758|NCT00541658|26830555|FG000|Overall Study|Lost to Follow-up|3|||
13409759|NCT00541658|26830556|FG001|Overall Study|Lost to Follow-up|3|||
13409760|NCT00541658|26830557|FG002|Overall Study|Lost to Follow-up|6|||
13409761|NCT00541658|26830555|FG000|Overall Study|Protocol Violation|0|||
13409762|NCT00541658|26830556|FG001|Overall Study|Protocol Violation|1|||
13409763|NCT00541658|26830557|FG002|Overall Study|Protocol Violation|1|||
13409764|NCT00541658|26830555|FG000|Overall Study|Withdrawal by Subject|28|||
13409765|NCT00541658|26830556|FG001|Overall Study|Withdrawal by Subject|32|||
13409766|NCT00541658|26830557|FG002|Overall Study|Withdrawal by Subject|32|||
13409767|NCT00541658|26830555|FG000|Overall Study|Took No Study Drug|1|||
13409768|NCT00541658|26830556|FG001|Overall Study|Took No Study Drug|0|||
13409769|NCT00541658|26830557|FG002|Overall Study|Took No Study Drug|0|||
13409770|NCT00541450|26830582|FG000|Phase A|Adverse Event|3|||
13409771|NCT00541450|26830583|FG001|Phase A|Adverse Event|0|||
13409772|NCT00541450|26830582|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0|||
13409773|NCT00541450|26830583|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2|||
13409774|NCT00541450|26830582|FG000|Phase A|Hyperglycemia|0|||
13409775|NCT00541450|26830583|FG001|Phase A|Hyperglycemia|1|||
13409776|NCT00541450|26830582|FG000|Phase A|Lost to Follow-up|6|||
13409777|NCT00541450|26830583|FG001|Phase A|Lost to Follow-up|4|||
13409778|NCT00541450|26830582|FG000|Phase A|Physician Decision|2|||
13409779|NCT00541450|26830583|FG001|Phase A|Physician Decision|0|||
13409780|NCT00541450|26830582|FG000|Phase A|Protocol Violation|2|||
13409781|NCT00541450|26830583|FG001|Phase A|Protocol Violation|3|||
13409782|NCT00541450|26830582|FG000|Phase A|Withdrawal by Subject|7|||
13409783|NCT00541450|26830583|FG001|Phase A|Withdrawal by Subject|7|||
13409784|NCT00541450|26830582|FG000|Phase B|Adverse Event|6|||
13409785|NCT00541450|26830583|FG001|Phase B|Adverse Event|6|||
13409786|NCT00541450|26830582|FG000|Phase B|Hyperglycemia|10|||
13409787|NCT00541450|26830583|FG001|Phase B|Hyperglycemia|9|||
13409788|NCT00541450|26830582|FG000|Phase B|Lost to Follow-up|6|||
13409789|NCT00541450|26830583|FG001|Phase B|Lost to Follow-up|4|||
13409790|NCT00541450|26830582|FG000|Phase B|Physician Decision|4|||
13409791|NCT00541450|26830583|FG001|Phase B|Physician Decision|2|||
13409792|NCT00541450|26830582|FG000|Phase B|Pregnancy|0|||
13409793|NCT00541450|26830583|FG001|Phase B|Pregnancy|1|||
13409794|NCT00541450|26830582|FG000|Phase B|Protocol Violation|3|||
13409795|NCT00541450|26830583|FG001|Phase B|Protocol Violation|3|||
13409796|NCT00541450|26830582|FG000|Phase B|Withdrawal by Subject|8|||
13409797|NCT00541450|26830583|FG001|Phase B|Withdrawal by Subject|6|||
13409798|NCT00541385|26830610|FG000|Overall Study|Adverse Event|6|||
13409799|NCT00541385|26830611|FG001|Overall Study|Adverse Event|3|||
13409800|NCT00541385|26830610|FG000|Overall Study|Withdrawal by Subject|2|||
13409801|NCT00541385|26830611|FG001|Overall Study|Withdrawal by Subject|2|||
13409802|NCT00541385|26830610|FG000|Overall Study|Lost to Follow-up|6|||
13409803|NCT00541385|26830611|FG001|Overall Study|Lost to Follow-up|1|||
13409804|NCT00541385|26830610|FG000|Overall Study|Parasite reappearance/malaria|67|||
13409805|NCT00541385|26830611|FG001|Overall Study|Parasite reappearance/malaria|32|||
13409806|NCT00541346|26830627|FG000|Follow-up|Adverse Event|1|||
13409807|NCT00541307|26830637|FG000|Overall Study|Death|5|||
13409808|NCT00541307|26830637|FG000|Overall Study|Physician Decision|3|||
13409809|NCT00541307|26830637|FG000|Overall Study|Withdrawal by Subject|6|||
13409810|NCT00541307|26830637|FG000|Overall Study|Lost to Follow-up|4|||
13409811|NCT00541307|26830637|FG000|Overall Study|Subject returned early (outside window)|1|||
13409812|NCT00541307|26830637|FG000|Overall Study|Surgical Bypass|5|||
13409813|NCT00541229|26830664|FG000|Treatment Period I (Week 1)|Physician Decision|0|||
13409814|NCT00541229|26830665|FG001|Treatment Period I (Week 1)|Physician Decision|0|||
13409815|NCT00541229|26830666|FG002|Treatment Period I (Week 1)|Physician Decision|1|||
13409816|NCT00541229|26830667|FG003|Treatment Period I (Week 1)|Physician Decision|0|||
13409817|NCT00541229|26830668|FG004|Treatment Period I (Week 1)|Physician Decision|0|||
13409818|NCT00541229|26830669|FG005|Treatment Period I (Week 1)|Physician Decision|0|||
13409819|NCT00541229|26830664|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
13409820|NCT00541229|26830665|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
13409821|NCT00541229|26830666|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
13409822|NCT00541229|26830667|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
13409823|NCT00541229|26830668|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
13409824|NCT00541229|26830669|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1|||
13409825|NCT00541229|26830664|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
13409826|NCT00541229|26830665|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
13409827|NCT00541229|26830666|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
13409828|NCT00541229|26830667|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
13409829|NCT00541229|26830668|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
13409830|NCT00541229|26830669|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1|||
13409831|NCT00541229|26830664|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
13409832|NCT00541229|26830665|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
13409833|NCT00541229|26830666|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2|||
13409834|NCT00541229|26830667|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
13409835|NCT00541229|26830668|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
13409836|NCT00541229|26830669|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
13409837|NCT00541229|26830664|FG000|Washout Period I (Week 2-5)|Adverse Event|1|||
13409838|NCT00541229|26830665|FG001|Washout Period I (Week 2-5)|Adverse Event|0|||
13409839|NCT00541229|26830666|FG002|Washout Period I (Week 2-5)|Adverse Event|1|||
13409840|NCT00541229|26830667|FG003|Washout Period I (Week 2-5)|Adverse Event|0|||
13409841|NCT00541229|26830668|FG004|Washout Period I (Week 2-5)|Adverse Event|0|||
13409842|NCT00541229|26830669|FG005|Washout Period I (Week 2-5)|Adverse Event|0|||
13409843|NCT00541229|26830664|FG000|Washout Period I (Week 2-5)|Physician Decision|0|||
13409844|NCT00541229|26830665|FG001|Washout Period I (Week 2-5)|Physician Decision|0|||
13409845|NCT00541229|26830666|FG002|Washout Period I (Week 2-5)|Physician Decision|0|||
13409846|NCT00541229|26830667|FG003|Washout Period I (Week 2-5)|Physician Decision|1|||
13409847|NCT00541229|26830668|FG004|Washout Period I (Week 2-5)|Physician Decision|0|||
13409848|NCT00541229|26830669|FG005|Washout Period I (Week 2-5)|Physician Decision|0|||
13409849|NCT00541229|26830664|FG000|Washout Period I (Week 2-5)|Protocol Violation|0|||
13409850|NCT00541229|26830665|FG001|Washout Period I (Week 2-5)|Protocol Violation|0|||
13409851|NCT00541229|26830666|FG002|Washout Period I (Week 2-5)|Protocol Violation|0|||
13409852|NCT00541229|26830667|FG003|Washout Period I (Week 2-5)|Protocol Violation|0|||
13409853|NCT00541229|26830668|FG004|Washout Period I (Week 2-5)|Protocol Violation|0|||
13409854|NCT00541229|26830669|FG005|Washout Period I (Week 2-5)|Protocol Violation|1|||
13409855|NCT00541229|26830664|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
13409856|NCT00541229|26830665|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2|||
13409857|NCT00541229|26830666|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
13409858|NCT00541229|26830667|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
13409859|NCT00541229|26830668|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1|||
13409860|NCT00541229|26830669|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4|||
13409861|NCT00541229|26830664|FG000|Treatment Period II (Week 6)|Protocol Violation|0|||
13409862|NCT00541229|26830665|FG001|Treatment Period II (Week 6)|Protocol Violation|0|||
13409863|NCT00541229|26830666|FG002|Treatment Period II (Week 6)|Protocol Violation|0|||
13409864|NCT00541229|26830667|FG003|Treatment Period II (Week 6)|Protocol Violation|0|||
13409865|NCT00541229|26830668|FG004|Treatment Period II (Week 6)|Protocol Violation|1|||
13409866|NCT00541229|26830669|FG005|Treatment Period II (Week 6)|Protocol Violation|1|||
13409867|NCT00541229|26830664|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
13409868|NCT00541229|26830665|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
13409869|NCT00541229|26830666|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
13409870|NCT00541229|26830667|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
13409871|NCT00541229|26830668|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
13409872|NCT00541229|26830669|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
13409873|NCT00541229|26830664|FG000|Washout Period II (Week 7-10)|Protocol Violation|1|||
13409874|NCT00541229|26830665|FG001|Washout Period II (Week 7-10)|Protocol Violation|0|||
13409875|NCT00541229|26830666|FG002|Washout Period II (Week 7-10)|Protocol Violation|0|||
13409876|NCT00541229|26830667|FG003|Washout Period II (Week 7-10)|Protocol Violation|0|||
13409877|NCT00541229|26830668|FG004|Washout Period II (Week 7-10)|Protocol Violation|0|||
13409878|NCT00541229|26830669|FG005|Washout Period II (Week 7-10)|Protocol Violation|0|||
13409879|NCT00541229|26830664|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
13409880|NCT00541229|26830665|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
13409881|NCT00541229|26830666|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
13409882|NCT00541229|26830667|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
13409883|NCT00541229|26830668|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1|||
13409884|NCT00541229|26830669|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
13409885|NCT00541229|26830664|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
13409886|NCT00541229|26830665|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
13409887|NCT00541229|26830666|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2|||
13409888|NCT00541229|26830667|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
13409889|NCT00541229|26830668|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
13409890|NCT00541229|26830669|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
13409891|NCT00541229|26830664|FG000|Treatment Period III (Week 11)|Adverse Event|0|||
13409892|NCT00541229|26830665|FG001|Treatment Period III (Week 11)|Adverse Event|0|||
13409893|NCT00541229|26830666|FG002|Treatment Period III (Week 11)|Adverse Event|0|||
13409894|NCT00541229|26830667|FG003|Treatment Period III (Week 11)|Adverse Event|0|||
13409895|NCT00541229|26830668|FG004|Treatment Period III (Week 11)|Adverse Event|1|||
13409896|NCT00541229|26830669|FG005|Treatment Period III (Week 11)|Adverse Event|0|||
13409897|NCT00541229|26830664|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
13409898|NCT00541229|26830665|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
13409899|NCT00541229|26830666|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
13409900|NCT00541229|26830667|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
13409901|NCT00541229|26830668|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
13409902|NCT00541229|26830669|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1|||
13409903|NCT00541229|26830664|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
13409904|NCT00541229|26830665|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
13409905|NCT00541229|26830666|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1|||
13409906|NCT00541229|26830667|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
13409907|NCT00541229|26830668|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
13409908|NCT00541229|26830669|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
13409909|NCT00541099|26830679|FG000|Overall Study|Ineligible|3|||
13409910|NCT00541034|26830685|FG000|Overall Study|Non-Compliance|3|||
13409911|NCT00540644|26830702|FG000|Overall Study|Adverse Event|3|||
13409912|NCT00540644|26830703|FG001|Overall Study|Adverse Event|1|||
13409913|NCT00540644|26830702|FG000|Overall Study|Disease Progression|3|||
13409914|NCT00540644|26830703|FG001|Overall Study|Disease Progression|1|||
13409915|NCT00540644|26830702|FG000|Overall Study|Physician Decision|0|||
13409916|NCT00540644|26830703|FG001|Overall Study|Physician Decision|5|||
13409917|NCT00540644|26830702|FG000|Overall Study|Withdrawal by Subject|2|||
13409918|NCT00540644|26830703|FG001|Overall Study|Withdrawal by Subject|2|||
13409919|NCT00540644|26830702|FG000|Overall Study|Noncomplilance|1|||
13409920|NCT00540644|26830703|FG001|Overall Study|Noncomplilance|0|||
13409921|NCT00540592|26830966|FG000|Overall Study|Adverse Event|0|||
13409922|NCT00540592|26830967|FG001|Overall Study|Adverse Event|1|||
13409923|NCT00540592|26830968|FG002|Overall Study|Adverse Event|0|||
13409924|NCT00540592|26830969|FG003|Overall Study|Adverse Event|0|||
13409925|NCT00540592|26830970|FG004|Overall Study|Adverse Event|1|||
13409926|NCT00540592|26830971|FG005|Overall Study|Adverse Event|0|||
13409927|NCT00540592|26830972|FG006|Overall Study|Adverse Event|0|||
13409928|NCT00540592|26830973|FG007|Overall Study|Adverse Event|1|||
13409929|NCT00540592|26830974|FG008|Overall Study|Adverse Event|1|||
13409930|NCT00540592|26830975|FG009|Overall Study|Adverse Event|2|||
13409931|NCT00540592|26830966|FG000|Overall Study|Lost to Follow-up|2|||
13409932|NCT00540592|26830967|FG001|Overall Study|Lost to Follow-up|0|||
13409933|NCT00540592|26830968|FG002|Overall Study|Lost to Follow-up|0|||
13409934|NCT00540592|26830969|FG003|Overall Study|Lost to Follow-up|0|||
13409935|NCT00540592|26830970|FG004|Overall Study|Lost to Follow-up|0|||
13409936|NCT00540592|26830971|FG005|Overall Study|Lost to Follow-up|0|||
13409937|NCT00540592|26830972|FG006|Overall Study|Lost to Follow-up|0|||
13409938|NCT00540592|26830973|FG007|Overall Study|Lost to Follow-up|0|||
13409939|NCT00540592|26830974|FG008|Overall Study|Lost to Follow-up|0|||
13409940|NCT00540592|26830975|FG009|Overall Study|Lost to Follow-up|0|||
13409941|NCT00540592|26830966|FG000|Overall Study|Withdrawal by Subject|0|||
13409942|NCT00540592|26830967|FG001|Overall Study|Withdrawal by Subject|0|||
13409943|NCT00540592|26830968|FG002|Overall Study|Withdrawal by Subject|1|||
13409944|NCT00540592|26830969|FG003|Overall Study|Withdrawal by Subject|1|||
13409945|NCT00540592|26830970|FG004|Overall Study|Withdrawal by Subject|0|||
13409946|NCT00540592|26830971|FG005|Overall Study|Withdrawal by Subject|0|||
13409947|NCT00540592|26830972|FG006|Overall Study|Withdrawal by Subject|0|||
13409948|NCT00540592|26830973|FG007|Overall Study|Withdrawal by Subject|0|||
13409949|NCT00540592|26830974|FG008|Overall Study|Withdrawal by Subject|0|||
13409950|NCT00540592|26830975|FG009|Overall Study|Withdrawal by Subject|0|||
13409951|NCT00540514|26831012|FG000|Overall Study|Still on treatment|3|||
13409952|NCT00540514|26831013|FG001|Overall Study|Still on treatment|0|||
13409953|NCT00540514|26831012|FG000|Overall Study|Unacceptable Toxicity|61|||
13409954|NCT00540514|26831013|FG001|Overall Study|Unacceptable Toxicity|62|||
13409955|NCT00540514|26831012|FG000|Overall Study|Adverse Event|20|||
13409956|NCT00540514|26831013|FG001|Overall Study|Adverse Event|24|||
13409957|NCT00540514|26831012|FG000|Overall Study|Physician Decision|86|||
13409958|NCT00540514|26831013|FG001|Overall Study|Physician Decision|99|||
13409959|NCT00540514|26831012|FG000|Overall Study|Protocol Deviation|3|||
13409960|NCT00540514|26831013|FG001|Overall Study|Protocol Deviation|4|||
13409961|NCT00540514|26831012|FG000|Overall Study|Lost to Follow-up|1|||
13409962|NCT00540514|26831013|FG001|Overall Study|Lost to Follow-up|1|||
13409963|NCT00540514|26831012|FG000|Overall Study|Withdrawal by Subject|65|||
13409964|NCT00540514|26831013|FG001|Overall Study|Withdrawal by Subject|67|||
13409965|NCT00540514|26831012|FG000|Overall Study|Excluded prior to treatment|7|||
13409966|NCT00540514|26831013|FG001|Overall Study|Excluded prior to treatment|7|||
13409967|NCT00540514|26831012|FG000|Overall Study|Paclitaxel not available|0|||
13409968|NCT00540514|26831013|FG001|Overall Study|Paclitaxel not available|2|||
13409969|NCT00540449|26831042|FG000|Overall Study|Adverse Event|12|||
13409970|NCT00540449|26831043|FG001|Overall Study|Adverse Event|32|||
13409971|NCT00540449|26831042|FG000|Overall Study|Sponsor's Decision|1|||
13409972|NCT00540449|26831043|FG001|Overall Study|Sponsor's Decision|1|||
13409973|NCT00540449|26831042|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
13409974|NCT00540449|26831043|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
13409975|NCT00540449|26831042|FG000|Overall Study|Lost to Follow-up|19|||
13409976|NCT00540449|26831043|FG001|Overall Study|Lost to Follow-up|17|||
13409977|NCT00540449|26831042|FG000|Overall Study|Subject Non-Compliant|7|||
13409978|NCT00540449|26831043|FG001|Overall Study|Subject Non-Compliant|5|||
13409979|NCT00540449|26831042|FG000|Overall Study|Subject Reached A Virologic Endpoint|32|||
13409980|NCT00540449|26831043|FG001|Overall Study|Subject Reached A Virologic Endpoint|8|||
13409981|NCT00540449|26831042|FG000|Overall Study|Withdrawal by Subject|10|||
13409982|NCT00540449|26831043|FG001|Overall Study|Withdrawal by Subject|10|||
13409983|NCT00540449|26831042|FG000|Overall Study|Other|1|||
13409984|NCT00540449|26831043|FG001|Overall Study|Other|4|||
13409985|NCT00540436|26831058|FG000|First 12-Week Treatment Period|Adverse Event|1|||
13409986|NCT00540436|26831058|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1|||
13409987|NCT00540436|26831058|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1|||
13409988|NCT00540436|26831058|FG000|Second 12-Week Treatment Period|Adverse Event|1|||
13409989|NCT00540423|26831116|FG000|Double-Blind Treatment Period|Adverse Event|0|||
13409990|NCT00540423|26831117|FG001|Double-Blind Treatment Period|Adverse Event|1|||
13409991|NCT00540423|26831118|FG002|Double-Blind Treatment Period|Adverse Event|0|||
13409992|NCT00540423|26831116|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
13409993|NCT00540423|26831117|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
13409994|NCT00540423|26831118|FG002|Open-Label Treatment Period|Lack of Efficacy|2|||
13409995|NCT00540293|26831163|FG000|Overall Study|Adverse event related to study drug|10|||
13409996|NCT00540293|26831163|FG000|Overall Study|Adverse event not related to study drug|7|||
13409997|NCT00540293|26831163|FG000|Overall Study|Withdrawal by Subject|6|||
13409998|NCT00540293|26831163|FG000|Overall Study|Protocol violation, & subject schedule|12|||
13409999|NCT00540228|26831246|FG000|Overall Study|Adverse Event|2|||
13410000|NCT00540228|26831247|FG001|Overall Study|Adverse Event|0|||
13410001|NCT00540228|26831248|FG002|Overall Study|Adverse Event|0|||
13410002|NCT00540228|26831249|FG003|Overall Study|Adverse Event|0|||
13410003|NCT00540228|26831250|FG004|Overall Study|Adverse Event|0|||
13410004|NCT00540228|26831246|FG000|Overall Study|Lost to Follow-up|1|||
13410005|NCT00540228|26831247|FG001|Overall Study|Lost to Follow-up|1|||
13410006|NCT00540228|26831248|FG002|Overall Study|Lost to Follow-up|0|||
13410007|NCT00540228|26831249|FG003|Overall Study|Lost to Follow-up|0|||
13410008|NCT00540228|26831250|FG004|Overall Study|Lost to Follow-up|0|||
13410009|NCT00540124|26831304|FG000|Overall Study|Adverse Event|0|||
13410010|NCT00540124|26831305|FG001|Overall Study|Adverse Event|2|||
13410011|NCT00540124|26831306|FG002|Overall Study|Adverse Event|1|||
13410012|NCT00540124|26831304|FG000|Overall Study|Entry Criteria Not Met|2|||
13410013|NCT00540124|26831305|FG001|Overall Study|Entry Criteria Not Met|0|||
13410014|NCT00540124|26831306|FG002|Overall Study|Entry Criteria Not Met|0|||
13410015|NCT00540124|26831304|FG000|Overall Study|Lack of Efficacy|1|||
13410016|NCT00540124|26831305|FG001|Overall Study|Lack of Efficacy|0|||
13410017|NCT00540124|26831306|FG002|Overall Study|Lack of Efficacy|0|||
13410018|NCT00540124|26831304|FG000|Overall Study|Withdrawal by Subject|1|||
13410019|NCT00540124|26831305|FG001|Overall Study|Withdrawal by Subject|1|||
13410020|NCT00540124|26831306|FG002|Overall Study|Withdrawal by Subject|0|||
13410021|NCT00540046|26831321|FG000|Overall Study|Lost to Follow-up|33|||
13410022|NCT00540046|26831322|FG001|Overall Study|Lost to Follow-up|23|||
13410023|NCT00539994|26831369|FG000|Overall Study|Lost to Follow-up|2|||
13410024|NCT00539994|26831370|FG001|Overall Study|Lost to Follow-up|1|||
13410025|NCT00539994|26831371|FG002|Overall Study|Lost to Follow-up|0|||
13410026|NCT00539994|26831369|FG000|Overall Study|Withdrawal by Subject|1|||
13410027|NCT00539994|26831370|FG001|Overall Study|Withdrawal by Subject|0|||
13410028|NCT00539994|26831371|FG002|Overall Study|Withdrawal by Subject|1|||
13410029|NCT00539994|26831369|FG000|Overall Study|Physician Decision|0|||
13410030|NCT00539994|26831370|FG001|Overall Study|Physician Decision|0|||
13410031|NCT00539994|26831371|FG002|Overall Study|Physician Decision|1|||
13410032|NCT00539981|26831395|FG000|Overall Study|Adverse events (AE)|3|||
13410033|NCT00539981|26831396|FG001|Overall Study|Adverse events (AE)|3|||
13410034|NCT00539981|26831395|FG000|Overall Study|Lost to Follow-up|260|||
13410035|NCT00539981|26831396|FG001|Overall Study|Lost to Follow-up|251|||
13410036|NCT00539981|26831395|FG000|Overall Study|Withdrew consent|22|||
13410037|NCT00539981|26831396|FG001|Overall Study|Withdrew consent|14|||
13410038|NCT00539981|26831395|FG000|Overall Study|Death|1|||
13410039|NCT00539981|26831396|FG001|Overall Study|Death|1|||
13410040|NCT00539981|26831395|FG000|Overall Study|Other reason-unspecified|9|||
13410041|NCT00539981|26831396|FG001|Overall Study|Other reason-unspecified|13|||
13410042|NCT00539864|26831415|FG000|Overall Study|Lost to Follow-up|0|||
13410043|NCT00539864|26831416|FG001|Overall Study|Lost to Follow-up|1|||
13410044|NCT00539864|26831415|FG000|Overall Study|Withdrawal by Subject|1|||
13410045|NCT00539864|26831416|FG001|Overall Study|Withdrawal by Subject|1|||
13410046|NCT00539838|26831476|FG000|Overall Study|Fail to return|2|||
13410047|NCT00539838|26831477|FG001|Overall Study|Fail to return|0|||
13410048|NCT00539838|26831478|FG002|Overall Study|Fail to return|0|||
13410049|NCT00539838|26831476|FG000|Overall Study|Withdrawal by Subject|0|||
13410050|NCT00539838|26831477|FG001|Overall Study|Withdrawal by Subject|4|||
13410051|NCT00539838|26831478|FG002|Overall Study|Withdrawal by Subject|0|||
13410052|NCT00539838|26831476|FG000|Overall Study|Death|0|||
13410053|NCT00539838|26831477|FG001|Overall Study|Death|2|||
13410054|NCT00539838|26831478|FG002|Overall Study|Death|0|||
13410055|NCT00539838|26831476|FG000|Overall Study|Did not cooperate|1|||
13410056|NCT00539838|26831477|FG001|Overall Study|Did not cooperate|0|||
13410057|NCT00539838|26831478|FG002|Overall Study|Did not cooperate|1|||
13410058|NCT00539838|26831476|FG000|Overall Study|Administrative|4|||
13410059|NCT00539838|26831477|FG001|Overall Study|Administrative|0|||
13410060|NCT00539838|26831478|FG002|Overall Study|Administrative|8|||
13410061|NCT00539734|26831485|FG000|Overall Study|Protocol Violation|1|||
13410062|NCT00539591|26831603|FG000|Overall Study|Toxicity|3|||
13410063|NCT00539591|26831604|FG001|Overall Study|Toxicity|0|||
13410064|NCT00539591|26831605|FG002|Overall Study|Toxicity|0|||
13410065|NCT00539591|26831603|FG000|Overall Study|Disease progression|2|||
13410066|NCT00539591|26831604|FG001|Overall Study|Disease progression|2|||
13410067|NCT00539591|26831605|FG002|Overall Study|Disease progression|3|||
13410068|NCT00539513|26831624|FG000|Overall Study|Withdrawal by Subject|2|||
13410069|NCT00539513|26831625|FG001|Overall Study|Withdrawal by Subject|1|||
13410070|NCT00539513|26831624|FG000|Overall Study|Lost to Follow-up|0|||
13410071|NCT00539513|26831625|FG001|Overall Study|Lost to Follow-up|1|||
13410072|NCT00539500|26831633|FG000|Overall Study|Disease Progression|1|||
13410073|NCT00539500|26831633|FG000|Overall Study|Lost to Follow-up|2|||
13410074|NCT00539305|26831652|FG000|Overall Study|Adverse Event|1|||
13410075|NCT00539305|26831653|FG001|Overall Study|Adverse Event|0|||
13410076|NCT00539305|26831652|FG000|Overall Study|Substance Use|0|||
13410077|NCT00539305|26831653|FG001|Overall Study|Substance Use|1|||
13410078|NCT00539305|26831652|FG000|Overall Study|Withdrawal by Subject|0|||
13410079|NCT00539305|26831653|FG001|Overall Study|Withdrawal by Subject|1|||
13410080|NCT00539279|26831678|FG000|Treatment|Withdrawal by Subject|10|||
13410081|NCT00539279|26831679|FG001|Treatment|Withdrawal by Subject|8|||
13410082|NCT00539279|26831678|FG000|Treatment|Death|1|||
13410083|NCT00539279|26831679|FG001|Treatment|Death|0|||
13410084|NCT00539279|26831678|FG000|Post-Treatment Assessment|Lost to Follow-up|12|||
13410085|NCT00539279|26831679|FG001|Post-Treatment Assessment|Lost to Follow-up|9|||
13410086|NCT00539279|26831678|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1|||
13410087|NCT00539279|26831679|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7|||
13410088|NCT00539240|26831706|FG000|Overall Study|Withdrawal by Subject|0|||
13410089|NCT00539240|26831707|FG001|Overall Study|Withdrawal by Subject|2|||
13410090|NCT00539240|26831708|FG002|Overall Study|Withdrawal by Subject|0|||
13410091|NCT00539240|26831706|FG000|Overall Study|Protocol Violation|1|||
13410092|NCT00539240|26831707|FG001|Overall Study|Protocol Violation|1|||
13410093|NCT00539240|26831708|FG002|Overall Study|Protocol Violation|4|||
13410094|NCT00539240|26831706|FG000|Overall Study|Lost to Follow-up|2|||
13410095|NCT00539240|26831707|FG001|Overall Study|Lost to Follow-up|3|||
13410096|NCT00539240|26831708|FG002|Overall Study|Lost to Follow-up|1|||
13410097|NCT00539240|26831706|FG000|Overall Study|Adverse Event|3|||
13410098|NCT00539240|26831707|FG001|Overall Study|Adverse Event|1|||
13410099|NCT00539240|26831708|FG002|Overall Study|Adverse Event|10|||
13410100|NCT00539188|26831727|FG000|Overall Study|Withdrawal by Subject|1|||
13410101|NCT00539188|26831728|FG001|Overall Study|Withdrawal by Subject|0|||
13410102|NCT00539188|26831727|FG000|Overall Study|Lost to Follow-up|2|||
13410103|NCT00539188|26831728|FG001|Overall Study|Lost to Follow-up|1|||
13410104|NCT00539032|26831745|FG000|Overall Study|Withdrawal by Subject|2|||
13410105|NCT00539032|26831746|FG001|Overall Study|Withdrawal by Subject|1|||
13410106|NCT00539006|26831789|FG000|Pre-treatment|Other|0|||
13410107|NCT00539006|26831790|FG001|Pre-treatment|Other|1|||
13410108|NCT00539006|26831791|FG002|Pre-treatment|Other|0|||
13410109|NCT00539006|26831792|FG003|Pre-treatment|Other|0|||
13410110|NCT00539006|26831789|FG000|Treatment Period 1|Lost to Follow-up|0|||
13410111|NCT00539006|26831790|FG001|Treatment Period 1|Lost to Follow-up|0|||
13410112|NCT00539006|26831791|FG002|Treatment Period 1|Lost to Follow-up|1|||
13410113|NCT00539006|26831792|FG003|Treatment Period 1|Lost to Follow-up|0|||
13410114|NCT00539006|26831789|FG000|Treatment Period 1|Protocol Violation|0|||
13410115|NCT00539006|26831790|FG001|Treatment Period 1|Protocol Violation|0|||
13410116|NCT00539006|26831791|FG002|Treatment Period 1|Protocol Violation|1|||
13410117|NCT00539006|26831792|FG003|Treatment Period 1|Protocol Violation|0|||
13410118|NCT00539006|26831789|FG000|Treatment Period 1|Lack of Efficacy|0|||
13410119|NCT00539006|26831790|FG001|Treatment Period 1|Lack of Efficacy|0|||
13410120|NCT00539006|26831791|FG002|Treatment Period 1|Lack of Efficacy|0|||
13410121|NCT00539006|26831792|FG003|Treatment Period 1|Lack of Efficacy|1|||
13410122|NCT00539006|26831789|FG000|Washout|Adverse Event|2|||
13410123|NCT00539006|26831790|FG001|Washout|Adverse Event|1|||
13410124|NCT00539006|26831791|FG002|Washout|Adverse Event|0|||
13410125|NCT00539006|26831792|FG003|Washout|Adverse Event|0|||
13410126|NCT00539006|26831789|FG000|Washout|Protocol Violation|1|||
13410127|NCT00539006|26831790|FG001|Washout|Protocol Violation|1|||
13410128|NCT00539006|26831791|FG002|Washout|Protocol Violation|0|||
13410129|NCT00539006|26831792|FG003|Washout|Protocol Violation|0|||
13410130|NCT00539006|26831789|FG000|Washout|Withdrawal by Subject|0|||
13410131|NCT00539006|26831790|FG001|Washout|Withdrawal by Subject|2|||
13410132|NCT00539006|26831791|FG002|Washout|Withdrawal by Subject|0|||
13410133|NCT00539006|26831792|FG003|Washout|Withdrawal by Subject|0|||
13410134|NCT00539006|26831789|FG000|Washout|Failed to meet continuation criteria|16|||
13410135|NCT00539006|26831790|FG001|Washout|Failed to meet continuation criteria|5|||
13410136|NCT00539006|26831791|FG002|Washout|Failed to meet continuation criteria|14|||
13410137|NCT00539006|26831792|FG003|Washout|Failed to meet continuation criteria|6|||
13410138|NCT00539006|26831789|FG000|Washout|Other|1|||
13410139|NCT00539006|26831790|FG001|Washout|Other|1|||
13410140|NCT00539006|26831791|FG002|Washout|Other|2|||
13410141|NCT00539006|26831792|FG003|Washout|Other|3|||
13410142|NCT00539006|26831789|FG000|Treatment Period 2|Protocol Violation|1|||
13410143|NCT00539006|26831790|FG001|Treatment Period 2|Protocol Violation|0|||
13410144|NCT00539006|26831791|FG002|Treatment Period 2|Protocol Violation|0|||
13410145|NCT00539006|26831792|FG003|Treatment Period 2|Protocol Violation|0|||
13410146|NCT00539006|26831789|FG000|Treatment Period 2|Other|0|||
13410147|NCT00539006|26831790|FG001|Treatment Period 2|Other|1|||
13410148|NCT00539006|26831791|FG002|Treatment Period 2|Other|0|||
13410149|NCT00539006|26831792|FG003|Treatment Period 2|Other|0|||
13410150|NCT00538902|26831837|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1|||
13410151|NCT00538902|26831838|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2|||
13410152|NCT00538902|26831839|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3|||
13410153|NCT00538902|26831837|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
13410154|NCT00538902|26831838|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
13410155|NCT00538902|26831839|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1|||
13410156|NCT00538902|26831837|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
13410157|NCT00538902|26831838|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
13410158|NCT00538902|26831839|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1|||
13410159|NCT00538902|26831837|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
13410160|NCT00538902|26831838|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
13410161|NCT00538902|26831839|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
13410162|NCT00538902|26831837|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2|||
13410163|NCT00538902|26831838|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10|||
13410164|NCT00538902|26831839|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11|||
13410165|NCT00538902|26831837|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15|||
13410166|NCT00538902|26831838|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19|||
13410167|NCT00538902|26831839|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25|||
13410168|NCT00538902|26831837|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1|||
13410169|NCT00538902|26831838|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10|||
13410170|NCT00538902|26831839|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6|||
13410171|NCT00538902|26831837|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18|||
13410172|NCT00538902|26831838|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25|||
13410173|NCT00538902|26831839|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22|||
13410174|NCT00538785|26831867|FG000|Overall Study|Death|9|||
13410175|NCT00538785|26831868|FG001|Overall Study|Death|10|||
13410176|NCT00538785|26831867|FG000|Overall Study|Withdrawal of consent|9|||
13410177|NCT00538785|26831868|FG001|Overall Study|Withdrawal of consent|7|||
13410178|NCT00538785|26831867|FG000|Overall Study|Lost to Follow-up|1|||
13410179|NCT00538785|26831868|FG001|Overall Study|Lost to Follow-up|0|||
13410180|NCT00538733|26831877|FG000|Overall Study|Adverse Event|8|||
13410181|NCT00538733|26831877|FG000|Overall Study|Death|1|||
13410182|NCT00538733|26831877|FG000|Overall Study|declined to participate|2|||
13410183|NCT00538733|26831877|FG000|Overall Study|still on therapy|1|||
13410184|NCT00538681|26831915|FG000|Overall Study|Progressive Disease|7|||
13410185|NCT00538681|26831916|FG001|Overall Study|Progressive Disease|0|||
13410186|NCT00538681|26831917|FG002|Overall Study|Progressive Disease|1|||
13410187|NCT00538681|26831918|FG003|Overall Study|Progressive Disease|0|||
13410188|NCT00538681|26831915|FG000|Overall Study|Sponsor Decision|1|||
13410189|NCT00538681|26831916|FG001|Overall Study|Sponsor Decision|3|||
13410190|NCT00538681|26831917|FG002|Overall Study|Sponsor Decision|8|||
13410191|NCT00538681|26831918|FG003|Overall Study|Sponsor Decision|9|||
13410192|NCT00538681|26831915|FG000|Overall Study|Adverse Event|1|||
13410193|NCT00538681|26831916|FG001|Overall Study|Adverse Event|1|||
13410194|NCT00538681|26831917|FG002|Overall Study|Adverse Event|1|||
13410195|NCT00538681|26831918|FG003|Overall Study|Adverse Event|0|||
13410196|NCT00538681|26831915|FG000|Overall Study|Death|0|||
13410197|NCT00538681|26831916|FG001|Overall Study|Death|0|||
13410198|NCT00538681|26831917|FG002|Overall Study|Death|1|||
13410199|NCT00538681|26831918|FG003|Overall Study|Death|1|||
13410200|NCT00538681|26831915|FG000|Overall Study|Investigator Decision|0|||
13410201|NCT00538681|26831916|FG001|Overall Study|Investigator Decision|0|||
13410202|NCT00538681|26831917|FG002|Overall Study|Investigator Decision|0|||
13410203|NCT00538681|26831918|FG003|Overall Study|Investigator Decision|1|||
13410204|NCT00538629|26831965|FG000|Overall Study|At subject's request|1|||
13410205|NCT00538629|26831965|FG000|Overall Study|Adverse Event|2|||
13410206|NCT00538629|26831965|FG000|Overall Study|Lack of Efficacy|12|||
13410207|NCT00538629|26831965|FG000|Overall Study|Lost to Follow-up|6|||
13410208|NCT00538629|26831965|FG000|Overall Study|Subject's untimely distrust of medicine|1|||
13410209|NCT00538590|26831986|FG000|Overall Study|Death|1|||
13410210|NCT00538590|26831987|FG001|Overall Study|Death|0|||
13410211|NCT00538473|26832026|FG000|Overall Study|Adverse Event|1|||
13410212|NCT00538473|26832027|FG001|Overall Study|Adverse Event|0|||
13410213|NCT00538291|26832033|FG000|Overall Study|Adverse Event|2|||
13410214|NCT00538291|26832033|FG000|Overall Study|Withdrawal by Subject|1|||
13410215|NCT00537979|26832054|FG000|Overall Study|Adverse Event|2|||
13410216|NCT00537979|26832055|FG001|Overall Study|Adverse Event|2|||
13410217|NCT00537979|26832054|FG000|Overall Study|Withdrawal by Subject|1|||
13410218|NCT00537979|26832055|FG001|Overall Study|Withdrawal by Subject|4|||
13410219|NCT00537979|26832054|FG000|Overall Study|Lost to Follow-up|1|||
13410220|NCT00537979|26832055|FG001|Overall Study|Lost to Follow-up|4|||
13410221|NCT00537979|26832054|FG000|Overall Study|Lack of Efficacy|0|||
13410222|NCT00537979|26832055|FG001|Overall Study|Lack of Efficacy|1|||
13410223|NCT00537979|26832054|FG000|Overall Study|Non-compliance with treatment/procedure|2|||
13410224|NCT00537979|26832055|FG001|Overall Study|Non-compliance with treatment/procedure|2|||
13410225|NCT00537979|26832054|FG000|Overall Study|Death|0|||
13410226|NCT00537979|26832055|FG001|Overall Study|Death|3|||
13410227|NCT00537979|26832054|FG000|Overall Study|Kidney transplant|0|||
13410228|NCT00537979|26832055|FG001|Overall Study|Kidney transplant|3|||
13410229|NCT00537979|26832054|FG000|Overall Study|Heart failure|0|||
13410230|NCT00537979|26832055|FG001|Overall Study|Heart failure|1|||
13410231|NCT00537940|26832084|FG000|Overall Study|Adverse Event|20|||
13410232|NCT00537940|26832085|FG001|Overall Study|Adverse Event|19|||
13410233|NCT00537940|26832084|FG000|Overall Study|Lack of Efficacy|8|||
13410234|NCT00537940|26832085|FG001|Overall Study|Lack of Efficacy|16|||
13410235|NCT00537940|26832084|FG000|Overall Study|Lost to Follow-up|23|||
13410236|NCT00537940|26832085|FG001|Overall Study|Lost to Follow-up|29|||
13410237|NCT00537940|26832084|FG000|Overall Study|Withdrawal by Subject|113|||
13410238|NCT00537940|26832085|FG001|Overall Study|Withdrawal by Subject|95|||
13410239|NCT00537940|26832084|FG000|Overall Study|Protocol Violation|6|||
13410240|NCT00537940|26832085|FG001|Overall Study|Protocol Violation|4|||
13410241|NCT00537940|26832084|FG000|Overall Study|Pregnancy|1|||
13410242|NCT00537940|26832085|FG001|Overall Study|Pregnancy|1|||
13410243|NCT00537940|26832084|FG000|Overall Study|Study terminated by sponsor|2|||
13410244|NCT00537940|26832085|FG001|Overall Study|Study terminated by sponsor|3|||
13410245|NCT00537940|26832084|FG000|Overall Study|Other|10|||
13410246|NCT00537940|26832085|FG001|Overall Study|Other|12|||
13410247|NCT00537823|26832114|FG000|Overall Study|Adverse Event|2|||
13410248|NCT00537823|26832115|FG001|Overall Study|Adverse Event|0|||
13410249|NCT00537810|26832142|FG000|Overall Study|Withdrawal by Subject|4|||
13410250|NCT00537810|26832143|FG001|Overall Study|Withdrawal by Subject|11|||
13410251|NCT00537810|26832144|FG002|Overall Study|Withdrawal by Subject|4|||
13410252|NCT00537810|26832145|FG003|Overall Study|Withdrawal by Subject|3|||
13410253|NCT00537810|26832142|FG000|Overall Study|Medically withdrawn|2|||
13410254|NCT00537810|26832143|FG001|Overall Study|Medically withdrawn|2|||
13410255|NCT00537810|26832144|FG002|Overall Study|Medically withdrawn|0|||
13410256|NCT00537810|26832145|FG003|Overall Study|Medically withdrawn|1|||
13410257|NCT00537771|26832162|FG000|Overall Study|Withdrawal by Subject|6|||
13410258|NCT00537771|26832163|FG001|Overall Study|Withdrawal by Subject|23|||
13410259|NCT00537771|26832162|FG000|Overall Study|Adverse Event|8|||
13410260|NCT00537771|26832163|FG001|Overall Study|Adverse Event|15|||
13410261|NCT00537771|26832162|FG000|Overall Study|Lost to Follow-up|9|||
13410262|NCT00537771|26832163|FG001|Overall Study|Lost to Follow-up|15|||
13410263|NCT00537771|26832162|FG000|Overall Study|Protocol Violation|2|||
13410264|NCT00537771|26832163|FG001|Overall Study|Protocol Violation|6|||
13410265|NCT00537771|26832162|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
13410266|NCT00537771|26832163|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
13410267|NCT00537745|26832170|FG000|Overall Study|Did not meet eligibility criteria|2|||
13410268|NCT00537745|26832170|FG000|Overall Study|Withdrawal by Subject|2|||
13410269|NCT00537745|26832170|FG000|Overall Study|Subject unable to provide Interlock info|1|||
13410270|NCT00537485|26832201|FG000|Overall Study|Adverse Event|10|||
13410271|NCT00537485|26832202|FG001|Overall Study|Adverse Event|5|||
13410272|NCT00537485|26832201|FG000|Overall Study|Withdrawal by Subject|3|||
13410273|NCT00537485|26832202|FG001|Overall Study|Withdrawal by Subject|2|||
13410274|NCT00537485|26832201|FG000|Overall Study|Withdrawal by Subject|1|||
13410275|NCT00537485|26832202|FG001|Overall Study|Withdrawal by Subject|3|||
13410276|NCT00537485|26832201|FG000|Overall Study|Physician Decision|1|||
13410277|NCT00537485|26832202|FG001|Overall Study|Physician Decision|0|||
13410278|NCT00537394|26832246|FG000|First Year of Follow-up|Death|7|||
13410279|NCT00537394|26832247|FG001|First Year of Follow-up|Death|0|||
13410280|NCT00537394|26832248|FG002|First Year of Follow-up|Death|0|||
13410281|NCT00537394|26832246|FG000|First Year of Follow-up|Severe debilitation|1|||
13410282|NCT00537394|26832247|FG001|First Year of Follow-up|Severe debilitation|0|||
13410283|NCT00537394|26832248|FG002|First Year of Follow-up|Severe debilitation|1|||
13410284|NCT00537394|26832246|FG000|First Year of Follow-up|Withdrawal by Subject|3|||
13410285|NCT00537394|26832247|FG001|First Year of Follow-up|Withdrawal by Subject|6|||
13410286|NCT00537394|26832248|FG002|First Year of Follow-up|Withdrawal by Subject|1|||
13410287|NCT00537394|26832246|FG000|First Year of Follow-up|Lost to Follow-up|1|||
13410288|NCT00537394|26832247|FG001|First Year of Follow-up|Lost to Follow-up|5|||
13410289|NCT00537394|26832248|FG002|First Year of Follow-up|Lost to Follow-up|1|||
13410290|NCT00537394|26832246|FG000|2nd Year of Follow-up|Death|4|||
13410291|NCT00537394|26832247|FG001|2nd Year of Follow-up|Death|1|||
13410292|NCT00537394|26832248|FG002|2nd Year of Follow-up|Death|2|||
13410293|NCT00537394|26832246|FG000|2nd Year of Follow-up|Withdrawal by Subject|0|||
13410294|NCT00537394|26832247|FG001|2nd Year of Follow-up|Withdrawal by Subject|1|||
13410295|NCT00537394|26832248|FG002|2nd Year of Follow-up|Withdrawal by Subject|2|||
13410296|NCT00537394|26832246|FG000|2nd Year of Follow-up|Lost to Follow-up|6|||
13410297|NCT00537394|26832247|FG001|2nd Year of Follow-up|Lost to Follow-up|7|||
13410298|NCT00537394|26832248|FG002|2nd Year of Follow-up|Lost to Follow-up|2|||
13410299|NCT00537394|26832246|FG000|2nd Year of Follow-up|Clinic site closure|1|||
13410300|NCT00537394|26832247|FG001|2nd Year of Follow-up|Clinic site closure|0|||
13410301|NCT00537394|26832248|FG002|2nd Year of Follow-up|Clinic site closure|0|||
13410302|NCT00537381|26832275|FG000|Overall Study|Adverse Event|13|||
13410303|NCT00537381|26832276|FG001|Overall Study|Adverse Event|9|||
13410304|NCT00537381|26832275|FG000|Overall Study|Death|3|||
13410305|NCT00537381|26832276|FG001|Overall Study|Death|3|||
13410306|NCT00537381|26832275|FG000|Overall Study|Withdrawal by Subject|5|||
13410307|NCT00537381|26832276|FG001|Overall Study|Withdrawal by Subject|14|||
13410308|NCT00537381|26832275|FG000|Overall Study|Physician Decision|7|||
13410309|NCT00537381|26832276|FG001|Overall Study|Physician Decision|6|||
13410310|NCT00537381|26832275|FG000|Overall Study|Disease Progression|9|||
13410311|NCT00537381|26832276|FG001|Overall Study|Disease Progression|18|||
13410312|NCT00537381|26832275|FG000|Overall Study|Sponsor decision|14|||
13410313|NCT00537381|26832276|FG001|Overall Study|Sponsor decision|9|||
13410314|NCT00537381|26832275|FG000|Overall Study|Other|5|||
13410315|NCT00537381|26832276|FG001|Overall Study|Other|3|||
13410316|NCT00537329|26832292|FG000|Overall Study|Death|10|||
13410317|NCT00537329|26832292|FG000|Overall Study|Adverse Event|3|||
13410318|NCT00537329|26832292|FG000|Overall Study|Lack of Efficacy|2|||
13410319|NCT00537329|26832292|FG000|Overall Study|Lost to Follow-up|6|||
13410320|NCT00537329|26832292|FG000|Overall Study|Withdrawal by Subject|4|||
13410321|NCT00537329|26832292|FG000|Overall Study|Other|1|||
13410322|NCT00537316|26832337|FG000|Part 1|Adverse Event|7|||
13410323|NCT00537316|26832338|FG001|Part 1|Adverse Event|11|||
13410324|NCT00537316|26832339|FG002|Part 1|Adverse Event|8|||
13410325|NCT00537316|26832340|FG003|Part 1|Adverse Event|0|||
13410326|NCT00537316|26832341|FG004|Part 1|Adverse Event|0|||
13410327|NCT00537316|26832342|FG005|Part 1|Adverse Event|0|||
13410328|NCT00537316|26832343|FG006|Part 1|Adverse Event|0|||
13410329|NCT00537316|26832337|FG000|Part 1|Protocol defined clinical event|1|||
13410330|NCT00537316|26832338|FG001|Part 1|Protocol defined clinical event|0|||
13410331|NCT00537316|26832339|FG002|Part 1|Protocol defined clinical event|0|||
13410332|NCT00537316|26832340|FG003|Part 1|Protocol defined clinical event|0|||
13410333|NCT00537316|26832341|FG004|Part 1|Protocol defined clinical event|0|||
13410334|NCT00537316|26832342|FG005|Part 1|Protocol defined clinical event|0|||
13410335|NCT00537316|26832343|FG006|Part 1|Protocol defined clinical event|0|||
13410336|NCT00537316|26832337|FG000|Part 1|Lost to Follow-up|1|||
13410337|NCT00537316|26832338|FG001|Part 1|Lost to Follow-up|0|||
13410338|NCT00537316|26832339|FG002|Part 1|Lost to Follow-up|0|||
13410339|NCT00537316|26832340|FG003|Part 1|Lost to Follow-up|0|||
13410340|NCT00537316|26832341|FG004|Part 1|Lost to Follow-up|0|||
13410341|NCT00537316|26832342|FG005|Part 1|Lost to Follow-up|0|||
13410342|NCT00537316|26832343|FG006|Part 1|Lost to Follow-up|0|||
13410343|NCT00537316|26832337|FG000|Part 1|Withdrawal by Subject|3|||
13410344|NCT00537316|26832338|FG001|Part 1|Withdrawal by Subject|8|||
13410345|NCT00537316|26832339|FG002|Part 1|Withdrawal by Subject|4|||
13410346|NCT00537316|26832340|FG003|Part 1|Withdrawal by Subject|0|||
13410347|NCT00537316|26832341|FG004|Part 1|Withdrawal by Subject|0|||
13410348|NCT00537316|26832342|FG005|Part 1|Withdrawal by Subject|0|||
13410349|NCT00537316|26832343|FG006|Part 1|Withdrawal by Subject|0|||
13410350|NCT00537316|26832337|FG000|Part 1|Protocol Violation|1|||
13410351|NCT00537316|26832338|FG001|Part 1|Protocol Violation|5|||
13410352|NCT00537316|26832339|FG002|Part 1|Protocol Violation|1|||
13410353|NCT00537316|26832340|FG003|Part 1|Protocol Violation|0|||
13410354|NCT00537316|26832341|FG004|Part 1|Protocol Violation|0|||
13410355|NCT00537316|26832342|FG005|Part 1|Protocol Violation|0|||
13410356|NCT00537316|26832343|FG006|Part 1|Protocol Violation|0|||
13410357|NCT00537316|26832337|FG000|Part 1|Did not meet protocol eligibility|1|||
13410358|NCT00537316|26832338|FG001|Part 1|Did not meet protocol eligibility|3|||
13410359|NCT00537316|26832339|FG002|Part 1|Did not meet protocol eligibility|2|||
13410360|NCT00537316|26832340|FG003|Part 1|Did not meet protocol eligibility|0|||
13410361|NCT00537316|26832341|FG004|Part 1|Did not meet protocol eligibility|0|||
13410362|NCT00537316|26832342|FG005|Part 1|Did not meet protocol eligibility|0|||
13410363|NCT00537316|26832343|FG006|Part 1|Did not meet protocol eligibility|0|||
13410364|NCT00537316|26832337|FG000|Part 1|Administrative|0|||
13410365|NCT00537316|26832338|FG001|Part 1|Administrative|0|||
13410366|NCT00537316|26832339|FG002|Part 1|Administrative|2|||
13410367|NCT00537316|26832340|FG003|Part 1|Administrative|0|||
13410368|NCT00537316|26832341|FG004|Part 1|Administrative|0|||
13410369|NCT00537316|26832342|FG005|Part 1|Administrative|0|||
13410370|NCT00537316|26832343|FG006|Part 1|Administrative|0|||
13410371|NCT00537316|26832337|FG000|Part 2|Never entered follow-up|0|||
13410372|NCT00537316|26832338|FG001|Part 2|Never entered follow-up|0|||
13410373|NCT00537316|26832339|FG002|Part 2|Never entered follow-up|0|||
13410374|NCT00537316|26832340|FG003|Part 2|Never entered follow-up|0|||
13410375|NCT00537316|26832341|FG004|Part 2|Never entered follow-up|0|||
13410376|NCT00537316|26832342|FG005|Part 2|Never entered follow-up|0|||
13410377|NCT00537316|26832343|FG006|Part 2|Never entered follow-up|1|||
13410378|NCT00537316|26832337|FG000|Part 2|Adverse Event|4|||
13410379|NCT00537316|26832338|FG001|Part 2|Adverse Event|0|||
13410380|NCT00537316|26832339|FG002|Part 2|Adverse Event|2|||
13410381|NCT00537316|26832340|FG003|Part 2|Adverse Event|0|||
13410382|NCT00537316|26832341|FG004|Part 2|Adverse Event|0|||
13410383|NCT00537316|26832342|FG005|Part 2|Adverse Event|0|||
13410384|NCT00537316|26832343|FG006|Part 2|Adverse Event|0|||
13410385|NCT00537316|26832337|FG000|Part 2|Lost to Follow-up|1|||
13410386|NCT00537316|26832338|FG001|Part 2|Lost to Follow-up|0|||
13410387|NCT00537316|26832339|FG002|Part 2|Lost to Follow-up|2|||
13410388|NCT00537316|26832340|FG003|Part 2|Lost to Follow-up|0|||
13410389|NCT00537316|26832341|FG004|Part 2|Lost to Follow-up|0|||
13410390|NCT00537316|26832342|FG005|Part 2|Lost to Follow-up|0|||
13410391|NCT00537316|26832343|FG006|Part 2|Lost to Follow-up|0|||
13410392|NCT00537316|26832337|FG000|Part 2|Withdrawal by Subject|5|||
13410393|NCT00537316|26832338|FG001|Part 2|Withdrawal by Subject|1|||
13410394|NCT00537316|26832339|FG002|Part 2|Withdrawal by Subject|4|||
13410395|NCT00537316|26832340|FG003|Part 2|Withdrawal by Subject|0|||
13410396|NCT00537316|26832341|FG004|Part 2|Withdrawal by Subject|0|||
13410397|NCT00537316|26832342|FG005|Part 2|Withdrawal by Subject|0|||
13410398|NCT00537316|26832343|FG006|Part 2|Withdrawal by Subject|0|||
13410399|NCT00537316|26832337|FG000|Part 2|Administrative|16|||
13410400|NCT00537316|26832338|FG001|Part 2|Administrative|8|||
13410401|NCT00537316|26832339|FG002|Part 2|Administrative|24|||
13410402|NCT00537316|26832340|FG003|Part 2|Administrative|3|||
13410403|NCT00537316|26832341|FG004|Part 2|Administrative|1|||
13410404|NCT00537316|26832342|FG005|Part 2|Administrative|4|||
13410405|NCT00537316|26832343|FG006|Part 2|Administrative|1|||
13410406|NCT00537303|26832366|FG000|Overall Study|Adverse Event|1|||
13410407|NCT00537303|26832367|FG001|Overall Study|Adverse Event|4|||
13410408|NCT00537303|26832366|FG000|Overall Study|Lack of Efficacy|6|||
13410409|NCT00537303|26832367|FG001|Overall Study|Lack of Efficacy|7|||
13410410|NCT00537303|26832366|FG000|Overall Study|Protocol Violation|8|||
13410411|NCT00537303|26832367|FG001|Overall Study|Protocol Violation|4|||
13410412|NCT00537303|26832366|FG000|Overall Study|Withdrawal criteria|3|||
13410413|NCT00537303|26832367|FG001|Overall Study|Withdrawal criteria|3|||
13410414|NCT00537303|26832366|FG000|Overall Study|Unclassified|8|||
13410415|NCT00537303|26832367|FG001|Overall Study|Unclassified|7|||
13410416|NCT00537277|26832378|FG000|Overall Study|Adverse Event|1|||
13410417|NCT00537277|26832378|FG000|Overall Study|Lack of Efficacy|2|||
13410418|NCT00537277|26832378|FG000|Overall Study|Lost to Follow-up|12|||
13410419|NCT00537277|26832378|FG000|Overall Study|Protocol Violation|11|||
13410420|NCT00537277|26832378|FG000|Overall Study|Unclassified|4|||
13410421|NCT00537277|26832378|FG000|Overall Study|Inability to tolerate trial medication|4|||
13410422|NCT00537277|26832378|FG000|Overall Study|Non-compliance with trial procedures|15|||
13410423|NCT00537238|26832405|FG000|Overall Study|Death|1|||
13410424|NCT00537238|26832406|FG001|Overall Study|Death|2|||
13410425|NCT00537238|26832405|FG000|Overall Study|Adverse Event|31|||
13410426|NCT00537238|26832406|FG001|Overall Study|Adverse Event|22|||
13410427|NCT00537238|26832405|FG000|Overall Study|Lack of Efficacy|20|||
13410428|NCT00537238|26832406|FG001|Overall Study|Lack of Efficacy|21|||
13410429|NCT00537238|26832405|FG000|Overall Study|Lost to Follow-up|12|||
13410430|NCT00537238|26832406|FG001|Overall Study|Lost to Follow-up|8|||
13410431|NCT00537238|26832405|FG000|Overall Study|Withdrawal by Subject|51|||
13410432|NCT00537238|26832406|FG001|Overall Study|Withdrawal by Subject|47|||
13410433|NCT00537238|26832405|FG000|Overall Study|Protocol Violation|15|||
13410434|NCT00537238|26832406|FG001|Overall Study|Protocol Violation|19|||
13410435|NCT00537238|26832405|FG000|Overall Study|Does not meet entrance criteria|0|||
13410436|NCT00537238|26832406|FG001|Overall Study|Does not meet entrance criteria|2|||
13410437|NCT00537238|26832405|FG000|Overall Study|Other|44|||
13410438|NCT00537238|26832406|FG001|Overall Study|Other|52|||
13410439|NCT00537199|26832412|FG000|Overall Study|Study Terminated|1|||
13410440|NCT00537095|26832431|FG000|Overall Study|surgery|1|||
13410441|NCT00537095|26832432|FG001|Overall Study|surgery|0|||
13410442|NCT00537095|26832431|FG000|Overall Study|Adverse Event|24|||
13410443|NCT00537095|26832432|FG001|Overall Study|Adverse Event|4|||
13410444|NCT00537095|26832431|FG000|Overall Study|disease progression|21|||
13410445|NCT00537095|26832432|FG001|Overall Study|disease progression|48|||
13410446|NCT00537095|26832431|FG000|Overall Study|Death|3|||
13410447|NCT00537095|26832432|FG001|Overall Study|Death|1|||
13410448|NCT00537095|26832431|FG000|Overall Study|Withdrawal by Subject|2|||
13410449|NCT00537095|26832432|FG001|Overall Study|Withdrawal by Subject|2|||
13410450|NCT00537095|26832431|FG000|Overall Study|subjective disease progression|0|||
13410451|NCT00537095|26832432|FG001|Overall Study|subjective disease progression|1|||
13410452|NCT00537095|26832431|FG000|Overall Study|Incorrect enrolment|0|||
13410453|NCT00537095|26832432|FG001|Overall Study|Incorrect enrolment|1|||
13410454|NCT00537082|26832459|FG000|Overall Study|Adverse Event|6|||
13410455|NCT00537082|26832460|FG001|Overall Study|Adverse Event|6|||
13410456|NCT00537082|26832461|FG002|Overall Study|Adverse Event|3|||
13410457|NCT00537082|26832459|FG000|Overall Study|Protocol Violation|0|||
13410458|NCT00537082|26832460|FG001|Overall Study|Protocol Violation|2|||
13410459|NCT00537082|26832461|FG002|Overall Study|Protocol Violation|1|||
13410460|NCT00537082|26832459|FG000|Overall Study|Lack of Efficacy|0|||
13410461|NCT00537082|26832460|FG001|Overall Study|Lack of Efficacy|0|||
13410462|NCT00537082|26832461|FG002|Overall Study|Lack of Efficacy|2|||
13410463|NCT00537082|26832459|FG000|Overall Study|Withdrawal by Subject|0|||
13410464|NCT00537082|26832460|FG001|Overall Study|Withdrawal by Subject|1|||
13410465|NCT00537082|26832461|FG002|Overall Study|Withdrawal by Subject|0|||
13410466|NCT00537082|26832459|FG000|Overall Study|Discontinued before initiating treatment|3|||
13410467|NCT00537082|26832460|FG001|Overall Study|Discontinued before initiating treatment|0|||
13410468|NCT00537082|26832461|FG002|Overall Study|Discontinued before initiating treatment|0|||
13410469|NCT00537056|26832475|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5|||
13410470|NCT00537030|26832484|FG000|Overall Study|Physician Decision|2|||
13410471|NCT00537030|26832484|FG000|Overall Study|Withdrawal by Subject|2|||
13410472|NCT00537030|26832484|FG000|Overall Study|≥ Grade 2 allergy|7|||
13410473|NCT00537030|26832484|FG000|Overall Study|Disease progression/ relapse during Tx|1|||
13410474|NCT00537030|26832484|FG000|Overall Study|Ineligible|2|||
13410475|NCT00537030|26832484|FG000|Overall Study|Inevaluable|2|||
13410476|NCT00537017|26832497|FG000|Treatment Phase|Adverse Event|19|||
13410477|NCT00537017|26832497|FG000|Treatment Phase|Withdrawal by Subject|13|||
13410478|NCT00537017|26832497|FG000|Treatment Phase|Protocol Violation|2|||
13410479|NCT00537017|26832497|FG000|Follow-up Phase|Withdrawal by Subject|9|||
13410480|NCT00536991|26832506|FG000|Overall Study|Withdrawal by Subject|10|||
13410481|NCT00536991|26832506|FG000|Overall Study|Physician Decision|1|||
13410482|NCT00536991|26832506|FG000|Overall Study|patient ineligible|2|||
13410483|NCT00536978|26832512|FG000|Overall Study|Not eligible for Adback Infusion|22|||
13410484|NCT00536939|26832521|FG000|Overall Study|Withdrawal by Subject|1|||
13410485|NCT00536939|26832522|FG001|Overall Study|Withdrawal by Subject|0|||
13410486|NCT00536939|26832521|FG000|Overall Study|Other Complicating Disease|1|||
13410487|NCT00536939|26832522|FG001|Overall Study|Other Complicating Disease|0|||
13410488|NCT00536874|26832534|FG000|Overall Study|Adverse Event|1|||
13410489|NCT00536874|26832534|FG000|Overall Study|Death|2|||
13410490|NCT00536874|26832534|FG000|Overall Study|Withdrawal by Subject|1|||
13410491|NCT00536809|26832557|FG000|Phase II|Adverse Event|1|||
13410492|NCT00536809|26832557|FG000|Phase II|Referred for surgical resection|1|||
13410493|NCT00536744|26832570|FG000|Overall Study|Adverse Event|13|||
13410494|NCT00536744|26832571|FG001|Overall Study|Adverse Event|10|||
13410495|NCT00536744|26832570|FG000|Overall Study|Death|2|||
13410496|NCT00536744|26832571|FG001|Overall Study|Death|1|||
13410497|NCT00536744|26832570|FG000|Overall Study|Physician Decision|3|||
13410498|NCT00536744|26832571|FG001|Overall Study|Physician Decision|1|||
13410499|NCT00536744|26832570|FG000|Overall Study|Lost to Follow-up|3|||
13410500|NCT00536744|26832571|FG001|Overall Study|Lost to Follow-up|5|||
13410501|NCT00536744|26832570|FG000|Overall Study|Withdrawal by Subject|7|||
13410502|NCT00536744|26832571|FG001|Overall Study|Withdrawal by Subject|8|||
13410503|NCT00536744|26832570|FG000|Overall Study|PI tried alternative treatment|1|||
13410504|NCT00536744|26832571|FG001|Overall Study|PI tried alternative treatment|3|||
13410505|NCT00536731|26832625|FG000|Overall Study|Adverse Event|3|||
13410506|NCT00536731|26832626|FG001|Overall Study|Adverse Event|2|||
13410507|NCT00536731|26832627|FG002|Overall Study|Adverse Event|3|||
13410508|NCT00536731|26832625|FG000|Overall Study|Withdrawal by Subject|0|||
13410509|NCT00536731|26832626|FG001|Overall Study|Withdrawal by Subject|2|||
13410510|NCT00536731|26832627|FG002|Overall Study|Withdrawal by Subject|0|||
13410511|NCT00536731|26832625|FG000|Overall Study|Intake of prohibited conc. medication|0|||
13410512|NCT00536731|26832626|FG001|Overall Study|Intake of prohibited conc. medication|0|||
13410513|NCT00536731|26832627|FG002|Overall Study|Intake of prohibited conc. medication|1|||
13410514|NCT00536731|26832625|FG000|Overall Study|Safety reasons|0|||
13410515|NCT00536731|26832626|FG001|Overall Study|Safety reasons|0|||
13410516|NCT00536731|26832627|FG002|Overall Study|Safety reasons|1|||
13410517|NCT00536731|26832625|FG000|Overall Study|Other|1|||
13410518|NCT00536731|26832626|FG001|Overall Study|Other|1|||
13410519|NCT00536731|26832627|FG002|Overall Study|Other|0|||
13410520|NCT00536575|26832633|FG000|Overall Study|Withdrawal by Subject|1|||
13410521|NCT00536575|26832633|FG000|Overall Study|Death|1|||
13410522|NCT00536510|26832648|FG000|Overall Study|Adverse Event|27|||
13410523|NCT00536510|26832649|FG001|Overall Study|Adverse Event|4|||
13410524|NCT00536510|26832648|FG000|Overall Study|Lost to Follow-up|11|||
13410525|NCT00536510|26832649|FG001|Overall Study|Lost to Follow-up|8|||
13410526|NCT00536510|26832648|FG000|Overall Study|Protocol Violation|4|||
13410527|NCT00536510|26832649|FG001|Overall Study|Protocol Violation|5|||
13410528|NCT00536510|26832648|FG000|Overall Study|Withdrawal by Subject|16|||
13410529|NCT00536510|26832649|FG001|Overall Study|Withdrawal by Subject|9|||
13410530|NCT00536510|26832648|FG000|Overall Study|Flushing with Product|20|||
13410531|NCT00536510|26832649|FG001|Overall Study|Flushing with Product|0|||
13410532|NCT00536510|26832648|FG000|Overall Study|Laboratory Adverse Event|2|||
13410533|NCT00536510|26832649|FG001|Overall Study|Laboratory Adverse Event|1|||
13410534|NCT00536510|26832648|FG000|Overall Study|Patient Discontinued for Other Reasons|2|||
13410535|NCT00536510|26832649|FG001|Overall Study|Patient Discontinued for Other Reasons|2|||
13410536|NCT00536484|26832686|FG000|Overall Study|Adverse Event|21|||
13410537|NCT00536484|26832687|FG001|Overall Study|Adverse Event|34|||
13410538|NCT00536484|26832686|FG000|Overall Study|Withdrawal by Subject|11|||
13410539|NCT00536484|26832687|FG001|Overall Study|Withdrawal by Subject|11|||
13410540|NCT00536484|26832686|FG000|Overall Study|Lost to Follow-up|8|||
13410541|NCT00536484|26832687|FG001|Overall Study|Lost to Follow-up|6|||
13410542|NCT00536484|26832686|FG000|Overall Study|Lack of Efficacy|16|||
13410543|NCT00536484|26832687|FG001|Overall Study|Lack of Efficacy|5|||
13410544|NCT00536484|26832686|FG000|Overall Study|Other|4|||
13410545|NCT00536484|26832687|FG001|Overall Study|Other|0|||
13410546|NCT00536471|26832942|FG000|Overall Study|Lost to Follow-up|48|||
13410547|NCT00536471|26832943|FG001|Overall Study|Lost to Follow-up|23|||
13410548|NCT00536471|26832944|FG002|Overall Study|Lost to Follow-up|48|||
13410549|NCT00536471|26832945|FG003|Overall Study|Lost to Follow-up|22|||
13410550|NCT00536471|26832942|FG000|Overall Study|Adverse Event|32|||
13410551|NCT00536471|26832943|FG001|Overall Study|Adverse Event|16|||
13410552|NCT00536471|26832944|FG002|Overall Study|Adverse Event|28|||
13410553|NCT00536471|26832945|FG003|Overall Study|Adverse Event|13|||
13410554|NCT00536471|26832942|FG000|Overall Study|Withdrawal by Subject|40|||
13410555|NCT00536471|26832943|FG001|Overall Study|Withdrawal by Subject|24|||
13410556|NCT00536471|26832944|FG002|Overall Study|Withdrawal by Subject|43|||
13410557|NCT00536471|26832945|FG003|Overall Study|Withdrawal by Subject|21|||
13410558|NCT00536471|26832942|FG000|Overall Study|Lack of Efficacy|17|||
13410559|NCT00536471|26832943|FG001|Overall Study|Lack of Efficacy|18|||
13410560|NCT00536471|26832944|FG002|Overall Study|Lack of Efficacy|11|||
13410561|NCT00536471|26832945|FG003|Overall Study|Lack of Efficacy|9|||
13410562|NCT00536471|26832942|FG000|Overall Study|Protocol Violation|8|||
13410563|NCT00536471|26832943|FG001|Overall Study|Protocol Violation|1|||
13410564|NCT00536471|26832944|FG002|Overall Study|Protocol Violation|2|||
13410565|NCT00536471|26832945|FG003|Overall Study|Protocol Violation|3|||
13410566|NCT00536471|26832942|FG000|Overall Study|Physician Decision|11|||
13410567|NCT00536471|26832943|FG001|Overall Study|Physician Decision|1|||
13410568|NCT00536471|26832944|FG002|Overall Study|Physician Decision|3|||
13410569|NCT00536471|26832945|FG003|Overall Study|Physician Decision|2|||
13410570|NCT00536471|26832942|FG000|Overall Study|Death|0|||
13410571|NCT00536471|26832943|FG001|Overall Study|Death|0|||
13410572|NCT00536471|26832944|FG002|Overall Study|Death|1|||
13410573|NCT00536471|26832945|FG003|Overall Study|Death|2|||
13410574|NCT00536471|26832942|FG000|Overall Study|Sponsor Decision|0|||
13410575|NCT00536471|26832943|FG001|Overall Study|Sponsor Decision|1|||
13410576|NCT00536471|26832944|FG002|Overall Study|Sponsor Decision|3|||
13410577|NCT00536471|26832945|FG003|Overall Study|Sponsor Decision|2|||
13410578|NCT00536263|26832993|FG000|Overall Study|Adverse Event|5|||
13410579|NCT00536263|26832994|FG001|Overall Study|Adverse Event|5|||
13410580|NCT00536263|26832995|FG002|Overall Study|Adverse Event|7|||
13410581|NCT00536263|26832993|FG000|Overall Study|Lost to Follow-up|3|||
13410582|NCT00536263|26832994|FG001|Overall Study|Lost to Follow-up|4|||
13410583|NCT00536263|26832995|FG002|Overall Study|Lost to Follow-up|4|||
13410584|NCT00536263|26832993|FG000|Overall Study|Subject withdrew - not treatment related|2|||
13410585|NCT00536263|26832994|FG001|Overall Study|Subject withdrew - not treatment related|0|||
13410586|NCT00536263|26832995|FG002|Overall Study|Subject withdrew - not treatment related|5|||
13410587|NCT00536263|26832993|FG000|Overall Study|Subject withdrew - treatment related|0|||
13410588|NCT00536263|26832994|FG001|Overall Study|Subject withdrew - treatment related|3|||
13410589|NCT00536263|26832995|FG002|Overall Study|Subject withdrew - treatment related|2|||
13410590|NCT00536263|26832993|FG000|Overall Study|Noncompliance with protocol|0|||
13410591|NCT00536263|26832994|FG001|Overall Study|Noncompliance with protocol|0|||
13410592|NCT00536263|26832995|FG002|Overall Study|Noncompliance with protocol|1|||
13410593|NCT00536263|26832993|FG000|Overall Study|Did not meet protocol eligibility|1|||
13410594|NCT00536263|26832994|FG001|Overall Study|Did not meet protocol eligibility|2|||
13410595|NCT00536263|26832995|FG002|Overall Study|Did not meet protocol eligibility|2|||
13410596|NCT00536198|26833030|FG000|Overall Study|Lost to Follow-up|15|||
13410597|NCT00536198|26833031|FG001|Overall Study|Lost to Follow-up|14|||
13410598|NCT00536198|26833030|FG000|Overall Study|Withdrawal by Subject|16|||
13410599|NCT00536198|26833031|FG001|Overall Study|Withdrawal by Subject|12|||
13410600|NCT00536198|26833030|FG000|Overall Study|Adverse Event|2|||
13410601|NCT00536198|26833031|FG001|Overall Study|Adverse Event|2|||
13410602|NCT00536198|26833030|FG000|Overall Study|Rescue|3|||
13410603|NCT00536198|26833031|FG001|Overall Study|Rescue|9|||
13410604|NCT00536198|26833030|FG000|Overall Study|Pregnancy|1|||
13410605|NCT00536198|26833031|FG001|Overall Study|Pregnancy|1|||
13410606|NCT00536198|26833030|FG000|Overall Study|Protocol Violation|0|||
13410607|NCT00536198|26833031|FG001|Overall Study|Protocol Violation|1|||
13410608|NCT00536120|26833050|FG000|Overall Study|Lost to Follow-up|1|||
13410609|NCT00536120|26833051|FG001|Overall Study|Lost to Follow-up|0|||
13410610|NCT00536120|26833050|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3|||
13410611|NCT00536120|26833051|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0|||
13410612|NCT00536120|26833050|FG000|Overall Study|Non-compliance|1|||
13410613|NCT00536120|26833051|FG001|Overall Study|Non-compliance|0|||
13410614|NCT00536120|26833050|FG000|Overall Study|Sponsor Decision Due to Lab Values|1|||
13410615|NCT00536120|26833051|FG001|Overall Study|Sponsor Decision Due to Lab Values|0|||
13410616|NCT00536120|26833050|FG000|Overall Study|Steroid Use|0|||
13410617|NCT00536120|26833051|FG001|Overall Study|Steroid Use|2|||
13410618|NCT00536120|26833050|FG000|Overall Study|Missed Study Visit|0|||
13410619|NCT00536120|26833051|FG001|Overall Study|Missed Study Visit|1|||
13410620|NCT00536107|26833066|FG000|Overall Study|Death|5|||
13410621|NCT00536107|26833067|FG001|Overall Study|Death|1|||
13410622|NCT00536107|26833066|FG000|Overall Study|Incorrect enrolment|1|||
13410623|NCT00536107|26833067|FG001|Overall Study|Incorrect enrolment|0|||
13410624|NCT00536107|26833066|FG000|Overall Study|Withdrawal by Subject|0|||
13410625|NCT00536107|26833067|FG001|Overall Study|Withdrawal by Subject|1|||
13410626|NCT00536107|26833066|FG000|Overall Study|Study Termination|2|||
13410627|NCT00536107|26833067|FG001|Overall Study|Study Termination|4|||
13410628|NCT00535847|26833101|FG000|Overall Study|Adverse Event|5|||
13410629|NCT00535847|26833102|FG001|Overall Study|Adverse Event|3|||
13410630|NCT00535847|26833103|FG002|Overall Study|Adverse Event|2|||
13410631|NCT00535847|26833101|FG000|Overall Study|Non compliance|1|||
13410632|NCT00535847|26833102|FG001|Overall Study|Non compliance|1|||
13410633|NCT00535847|26833103|FG002|Overall Study|Non compliance|0|||
13410634|NCT00535847|26833101|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16|||
13410635|NCT00535847|26833102|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10|||
13410636|NCT00535847|26833103|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0|||
13410637|NCT00535730|26833127|FG000|Overall Study|Adverse Event|1|||
13410638|NCT00535730|26833128|FG001|Overall Study|Adverse Event|1|||
13410639|NCT00535730|26833127|FG000|Overall Study|Lost to Follow-up|0|||
13410640|NCT00535730|26833128|FG001|Overall Study|Lost to Follow-up|1|||
13410641|NCT00535730|26833127|FG000|Overall Study|Physician Decision|0|||
13410642|NCT00535730|26833128|FG001|Overall Study|Physician Decision|1|||
13410643|NCT00535730|26833127|FG000|Overall Study|Protocol Violation|1|||
13410644|NCT00535730|26833128|FG001|Overall Study|Protocol Violation|0|||
13410645|NCT00535730|26833127|FG000|Overall Study|Withdrawal by Subject|0|||
13410646|NCT00535730|26833128|FG001|Overall Study|Withdrawal by Subject|4|||
13410647|NCT00535626|26833140|FG000|Overall Study|Death|15|||
13410648|NCT00535626|26833140|FG000|Overall Study|Lost to Follow-up|29|||
13410649|NCT00535626|26833140|FG000|Overall Study|Withdrawal by Subject|20|||
13410650|NCT00535626|26833140|FG000|Overall Study|Removal/revision of study component|8|||
13410651|NCT00535626|26833140|FG000|Overall Study|Subject terminated|31|||
13410652|NCT00535626|26833140|FG000|Overall Study|Unable to return|2|||
13410653|NCT00535496|26833164|FG000|Overall Study|Lost to Follow-up|0|||
13410654|NCT00535496|26833165|FG001|Overall Study|Lost to Follow-up|1|||
13410655|NCT00535496|26833166|FG002|Overall Study|Lost to Follow-up|0|||
13410656|NCT00535496|26833167|FG003|Overall Study|Lost to Follow-up|0|||
13410657|NCT00535496|26833164|FG000|Overall Study|Not treated with sugammadex|0|||
13410658|NCT00535496|26833165|FG001|Overall Study|Not treated with sugammadex|1|||
13410659|NCT00535496|26833166|FG002|Overall Study|Not treated with sugammadex|0|||
13410660|NCT00535496|26833167|FG003|Overall Study|Not treated with sugammadex|0|||
13410661|NCT00535288|26833260|FG000|Overall Study|Adverse Event|20|||
13410662|NCT00535288|26833261|FG001|Overall Study|Adverse Event|19|||
13410663|NCT00535288|26833262|FG002|Overall Study|Adverse Event|25|||
13410664|NCT00535288|26833263|FG003|Overall Study|Adverse Event|20|||
13410665|NCT00535288|26833264|FG004|Overall Study|Adverse Event|30|||
13410666|NCT00535288|26833260|FG000|Overall Study|Lost to Follow-up|0|||
13410667|NCT00535288|26833261|FG001|Overall Study|Lost to Follow-up|3|||
13410668|NCT00535288|26833262|FG002|Overall Study|Lost to Follow-up|0|||
13410669|NCT00535288|26833263|FG003|Overall Study|Lost to Follow-up|0|||
13410670|NCT00535288|26833264|FG004|Overall Study|Lost to Follow-up|0|||
13410671|NCT00535288|26833260|FG000|Overall Study|Lack of Efficacy|26|||
13410672|NCT00535288|26833261|FG001|Overall Study|Lack of Efficacy|3|||
13410673|NCT00535288|26833262|FG002|Overall Study|Lack of Efficacy|4|||
13410674|NCT00535288|26833263|FG003|Overall Study|Lack of Efficacy|4|||
13410675|NCT00535288|26833264|FG004|Overall Study|Lack of Efficacy|7|||
13410676|NCT00535288|26833260|FG000|Overall Study|Unwilling to cooperate|6|||
13410677|NCT00535288|26833261|FG001|Overall Study|Unwilling to cooperate|6|||
13410678|NCT00535288|26833262|FG002|Overall Study|Unwilling to cooperate|3|||
13410679|NCT00535288|26833263|FG003|Overall Study|Unwilling to cooperate|3|||
13410680|NCT00535288|26833264|FG004|Overall Study|Unwilling to cooperate|4|||
13410681|NCT00535288|26833260|FG000|Overall Study|Other|2|||
13410682|NCT00535288|26833261|FG001|Overall Study|Other|1|||
13410683|NCT00535288|26833262|FG002|Overall Study|Other|1|||
13410684|NCT00535288|26833263|FG003|Overall Study|Other|2|||
13410685|NCT00535288|26833264|FG004|Overall Study|Other|1|||
13410686|NCT00535262|26833270|FG000|Overall Study|No funding|3|||
13410687|NCT00535236|26833359|FG000|Overall Study|Adverse Event|1|||
13410688|NCT00535236|26833360|FG001|Overall Study|Adverse Event|0|||
13410689|NCT00535236|26833361|FG002|Overall Study|Adverse Event|9|||
13410690|NCT00535236|26833362|FG003|Overall Study|Adverse Event|3|||
13410691|NCT00535236|26833363|FG004|Overall Study|Adverse Event|3|||
13410692|NCT00535236|26833364|FG005|Overall Study|Adverse Event|0|||
13410693|NCT00535236|26833365|FG006|Overall Study|Adverse Event|5|||
13410694|NCT00535236|26833366|FG007|Overall Study|Adverse Event|1|||
13410695|NCT00535236|26833367|FG008|Overall Study|Adverse Event|2|||
13410696|NCT00535236|26833368|FG009|Overall Study|Adverse Event|1|||
13410697|NCT00535236|26833359|FG000|Overall Study|Lost to Follow-up|1|||
13410698|NCT00535236|26833360|FG001|Overall Study|Lost to Follow-up|2|||
13410699|NCT00535236|26833361|FG002|Overall Study|Lost to Follow-up|0|||
13410700|NCT00535236|26833362|FG003|Overall Study|Lost to Follow-up|0|||
13410701|NCT00535236|26833363|FG004|Overall Study|Lost to Follow-up|2|||
13410702|NCT00535236|26833364|FG005|Overall Study|Lost to Follow-up|0|||
13410703|NCT00535236|26833365|FG006|Overall Study|Lost to Follow-up|0|||
13410704|NCT00535236|26833366|FG007|Overall Study|Lost to Follow-up|0|||
13410705|NCT00535236|26833367|FG008|Overall Study|Lost to Follow-up|6|||
13410706|NCT00535236|26833368|FG009|Overall Study|Lost to Follow-up|1|||
13410707|NCT00535236|26833359|FG000|Overall Study|Physician Decision|0|||
13410708|NCT00535236|26833360|FG001|Overall Study|Physician Decision|0|||
13410709|NCT00535236|26833361|FG002|Overall Study|Physician Decision|0|||
13410710|NCT00535236|26833362|FG003|Overall Study|Physician Decision|0|||
13410711|NCT00535236|26833363|FG004|Overall Study|Physician Decision|1|||
13410712|NCT00535236|26833364|FG005|Overall Study|Physician Decision|0|||
13410713|NCT00535236|26833365|FG006|Overall Study|Physician Decision|1|||
13410714|NCT00535236|26833366|FG007|Overall Study|Physician Decision|0|||
13410715|NCT00535236|26833367|FG008|Overall Study|Physician Decision|0|||
13410716|NCT00535236|26833368|FG009|Overall Study|Physician Decision|0|||
13410717|NCT00535236|26833359|FG000|Overall Study|Protocol Violation|2|||
13410718|NCT00535236|26833360|FG001|Overall Study|Protocol Violation|0|||
13410719|NCT00535236|26833361|FG002|Overall Study|Protocol Violation|1|||
13410720|NCT00535236|26833362|FG003|Overall Study|Protocol Violation|0|||
13410721|NCT00535236|26833363|FG004|Overall Study|Protocol Violation|0|||
13410722|NCT00535236|26833364|FG005|Overall Study|Protocol Violation|0|||
13410723|NCT00535236|26833365|FG006|Overall Study|Protocol Violation|0|||
13410724|NCT00535236|26833366|FG007|Overall Study|Protocol Violation|0|||
13410725|NCT00535236|26833367|FG008|Overall Study|Protocol Violation|1|||
13410726|NCT00535236|26833368|FG009|Overall Study|Protocol Violation|0|||
13410727|NCT00535236|26833359|FG000|Overall Study|Withdrawal by Subject|3|||
13410728|NCT00535236|26833360|FG001|Overall Study|Withdrawal by Subject|0|||
13410729|NCT00535236|26833361|FG002|Overall Study|Withdrawal by Subject|2|||
13410730|NCT00535236|26833362|FG003|Overall Study|Withdrawal by Subject|1|||
13410731|NCT00535236|26833363|FG004|Overall Study|Withdrawal by Subject|6|||
13410732|NCT00535236|26833364|FG005|Overall Study|Withdrawal by Subject|1|||
13410733|NCT00535236|26833365|FG006|Overall Study|Withdrawal by Subject|5|||
13410734|NCT00535236|26833366|FG007|Overall Study|Withdrawal by Subject|0|||
13410735|NCT00535236|26833367|FG008|Overall Study|Withdrawal by Subject|4|||
13410736|NCT00535236|26833368|FG009|Overall Study|Withdrawal by Subject|2|||
13410737|NCT00535223|26833383|FG000|Overall Study|Withdrawal by Subject|4|||
13410738|NCT00535223|26833384|FG001|Overall Study|Withdrawal by Subject|1|||
13476369|NCT01729754|27002614|FG006|Part 3|Physician Decision|0|||
13476370|NCT01729754|27002615|FG007|Part 3|Physician Decision|0|||
13476371|NCT01729754|27002616|FG008|Part 3|Physician Decision|0|||
13476372|NCT01729754|27002617|FG009|Part 3|Physician Decision|0|||
13476373|NCT01729754|27002608|FG000|Part 3|Withdrawal by Subject|0|||
13476374|NCT01729754|27002609|FG001|Part 3|Withdrawal by Subject|4|||
13476375|NCT01729754|27002610|FG002|Part 3|Withdrawal by Subject|1|||
13476376|NCT01729754|27002611|FG003|Part 3|Withdrawal by Subject|0|||
13476377|NCT01729754|27002612|FG004|Part 3|Withdrawal by Subject|2|||
13476378|NCT01729754|27002613|FG005|Part 3|Withdrawal by Subject|1|||
13476379|NCT01729754|27002614|FG006|Part 3|Withdrawal by Subject|0|||
13476380|NCT01729754|27002615|FG007|Part 3|Withdrawal by Subject|2|||
13476381|NCT01729754|27002616|FG008|Part 3|Withdrawal by Subject|0|||
13476382|NCT01729754|27002617|FG009|Part 3|Withdrawal by Subject|0|||
13476383|NCT01729754|27002608|FG000|Part 3|Other Protocol Specified Criteria|0|||
13476384|NCT01729754|27002609|FG001|Part 3|Other Protocol Specified Criteria|0|||
13476385|NCT01729754|27002610|FG002|Part 3|Other Protocol Specified Criteria|0|||
13476386|NCT01729754|27002611|FG003|Part 3|Other Protocol Specified Criteria|0|||
13476387|NCT01729754|27002612|FG004|Part 3|Other Protocol Specified Criteria|0|||
13476388|NCT01729754|27002613|FG005|Part 3|Other Protocol Specified Criteria|2|||
13476389|NCT01729754|27002614|FG006|Part 3|Other Protocol Specified Criteria|0|||
13476390|NCT01729754|27002615|FG007|Part 3|Other Protocol Specified Criteria|1|||
13476391|NCT01729754|27002616|FG008|Part 3|Other Protocol Specified Criteria|0|||
13476392|NCT01729754|27002617|FG009|Part 3|Other Protocol Specified Criteria|0|||
13476393|NCT01515306|27002677|FG000|Overall Study|Adverse Event|3|||
13476394|NCT01515306|27002678|FG001|Overall Study|Adverse Event|2|||
13476395|NCT01515306|27002677|FG000|Overall Study|Progressive Disease|19|||
13476396|NCT01515306|27002678|FG001|Overall Study|Progressive Disease|9|||
13476397|NCT01515306|27002677|FG000|Overall Study|Withdrawal by Subject|1|||
13476398|NCT01515306|27002678|FG001|Overall Study|Withdrawal by Subject|2|||
13476399|NCT01515306|27002677|FG000|Overall Study|Physician Decision|1|||
13476400|NCT01515306|27002678|FG001|Overall Study|Physician Decision|1|||
13476401|NCT01423851|27002847|FG000|Whole Study|Disease progression|2|||
13476402|NCT01423851|27002848|FG001|Whole Study|Disease progression|1|||
13476403|NCT01423851|27002849|FG002|Whole Study|Disease progression|1|||
13476404|NCT01423851|27002850|FG003|Whole Study|Disease progression|4|||
13410739|NCT00535145|26833396|FG000|Phase I|Adverse Event|3|||
13410740|NCT00535145|26833396|FG000|Phase I|Lost to Follow-up|7|||
13410741|NCT00535145|26833396|FG000|Phase I|Withdrawal by Subject|6|||
13410742|NCT00535145|26833396|FG000|Phase I|(eligibility)|8|||
13410743|NCT00535145|26833396|FG000|Phase I|(protocol violation)|1|||
13410744|NCT00535145|26833396|FG000|Phase I|(PI decision)|1|||
13410745|NCT00535145|26833396|FG000|Phase I|(diagnosis)|3|||
13410746|NCT00535145|26833396|FG000|Phase II|Adverse Event|2|||
13410747|NCT00535145|26833396|FG000|Phase II|Lack of Efficacy|1|||
13410748|NCT00535145|26833396|FG000|Phase II|Lost to Follow-up|5|||
13410749|NCT00535145|26833396|FG000|Phase II|Withdrawal by Subject|5|||
13410750|NCT00535145|26833396|FG000|Phase II|Subject non-compliance|2|||
13410751|NCT00535132|26833453|FG000|Safety Analysis Set|Did Not Receive Study Medication|2|||
13410752|NCT00535132|26833454|FG001|Safety Analysis Set|Did Not Receive Study Medication|2|||
13410753|NCT00535132|26833453|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
13410754|NCT00535132|26833454|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
13410755|NCT00534976|26833481|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0|||
13410756|NCT00534976|26833482|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1|||
13410757|NCT00534976|26833481|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1|||
13410758|NCT00534976|26833482|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0|||
13410759|NCT00534976|26833481|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1|||
13410760|NCT00534976|26833482|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0|||
13410761|NCT00534638|26833525|FG000|Overall Study|Withdrawal by Subject|3|||
13410762|NCT00534638|26833526|FG001|Overall Study|Withdrawal by Subject|4|||
13410763|NCT00534638|26833525|FG000|Overall Study|Migrated/moved from study area|13|||
13410764|NCT00534638|26833526|FG001|Overall Study|Migrated/moved from study area|11|||
13410765|NCT00534638|26833525|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83|||
13410766|NCT00534638|26833526|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117|||
13410767|NCT00534638|26833525|FG000|Overall Study|Lost to follow-up, complete vaccination|4707|||
13410768|NCT00534638|26833526|FG001|Overall Study|Lost to follow-up, complete vaccination|10757|||
13410769|NCT00534638|26833525|FG000|Overall Study|Other|1685|||
13410770|NCT00534638|26833526|FG001|Overall Study|Other|902|||
13410771|NCT00534599|26833567|FG000|Overall Study|Adverse Event|25|||
13410772|NCT00534599|26833568|FG001|Overall Study|Adverse Event|4|||
13410773|NCT00534599|26833567|FG000|Overall Study|Incorrect enrollment|2|||
13410774|NCT00534599|26833568|FG001|Overall Study|Incorrect enrollment|1|||
13410775|NCT00534599|26833567|FG000|Overall Study|Mis-randomization|2|||
13410776|NCT00534599|26833568|FG001|Overall Study|Mis-randomization|2|||
13410777|NCT00534599|26833567|FG000|Overall Study|Developed study-specific d/c criteria|5|||
13410778|NCT00534599|26833568|FG001|Overall Study|Developed study-specific d/c criteria|0|||
13410779|NCT00534599|26833567|FG000|Overall Study|Lack of Efficacy|0|||
13410780|NCT00534599|26833568|FG001|Overall Study|Lack of Efficacy|1|||
13410781|NCT00534599|26833567|FG000|Overall Study|Generalized anxiety disorder worsened|0|||
13410782|NCT00534599|26833568|FG001|Overall Study|Generalized anxiety disorder worsened|1|||
13410783|NCT00534599|26833567|FG000|Overall Study|Protocol Violation|1|||
13410784|NCT00534599|26833568|FG001|Overall Study|Protocol Violation|3|||
13410785|NCT00534599|26833567|FG000|Overall Study|Lost to Follow-up|11|||
13410786|NCT00534599|26833568|FG001|Overall Study|Lost to Follow-up|14|||
13410787|NCT00534599|26833567|FG000|Overall Study|Withdrawal by Subject|4|||
13410788|NCT00534599|26833568|FG001|Overall Study|Withdrawal by Subject|6|||
13410789|NCT00534599|26833567|FG000|Overall Study|Other|7|||
13410790|NCT00534599|26833568|FG001|Overall Study|Other|0|||
13410791|NCT00534495|26833599|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
13410792|NCT00534495|26833600|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1|||
13410793|NCT00534495|26833601|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
13410794|NCT00534495|26833599|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1|||
13410795|NCT00534495|26833600|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0|||
13410796|NCT00534495|26833601|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0|||
13410797|NCT00534495|26833599|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1|||
13410798|NCT00534495|26833600|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7|||
13410799|NCT00534495|26833601|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0|||
13410800|NCT00534495|26833599|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
13410801|NCT00534495|26833600|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
13410802|NCT00534495|26833601|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0|||
13410803|NCT00534495|26833599|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
13410804|NCT00534495|26833600|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
13410805|NCT00534495|26833601|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0|||
13410806|NCT00534495|26833599|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
13410807|NCT00534495|26833600|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
13410808|NCT00534495|26833601|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1|||
13410809|NCT00534495|26833599|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
13476405|NCT01423851|27002851|FG004|Whole Study|Disease progression|1|||
13410810|NCT00534495|26833600|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
13410811|NCT00534495|26833601|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5|||
13410812|NCT00534495|26833599|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
13410813|NCT00534495|26833600|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
13410814|NCT00534495|26833601|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3|||
13410815|NCT00534495|26833599|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
13410816|NCT00534495|26833600|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
13410817|NCT00534495|26833601|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2|||
13410818|NCT00534404|26833625|FG000|Overall Study|Death|0|||
13410819|NCT00534404|26833626|FG001|Overall Study|Death|0|||
13410820|NCT00534404|26833627|FG002|Overall Study|Death|2|||
13410821|NCT00534404|26833625|FG000|Overall Study|Withdrawal by Subject|8|||
13410822|NCT00534404|26833626|FG001|Overall Study|Withdrawal by Subject|2|||
13410823|NCT00534404|26833627|FG002|Overall Study|Withdrawal by Subject|38|||
13410824|NCT00534404|26833625|FG000|Overall Study|Removed by study staff|2|||
13410825|NCT00534404|26833626|FG001|Overall Study|Removed by study staff|3|||
13410826|NCT00534404|26833627|FG002|Overall Study|Removed by study staff|1|||
13410827|NCT00534404|26833625|FG000|Overall Study|Lost to Follow-up|170|||
13410828|NCT00534404|26833626|FG001|Overall Study|Lost to Follow-up|138|||
13410829|NCT00534404|26833627|FG002|Overall Study|Lost to Follow-up|201|||
13410830|NCT00534352|26833669|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1|||
13410831|NCT00534352|26833669|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1|||
13410832|NCT00534352|26833669|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1|||
13410833|NCT00534352|26833669|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1|||
13410834|NCT00534352|26833669|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2|||
13410835|NCT00534352|26833669|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1|||
13410836|NCT00534313|26833775|FG000|Short-term Period|Adverse Event|1|||
13410837|NCT00534313|26833776|FG001|Short-term Period|Adverse Event|2|||
13410838|NCT00534313|26833777|FG002|Short-term Period|Adverse Event|1|||
13410839|NCT00534313|26833778|FG003|Short-term Period|Adverse Event|3|||
13410840|NCT00534313|26833775|FG000|Short-term Period|Lack of Efficacy|3|||
13410841|NCT00534313|26833776|FG001|Short-term Period|Lack of Efficacy|4|||
13410842|NCT00534313|26833777|FG002|Short-term Period|Lack of Efficacy|0|||
13410843|NCT00534313|26833778|FG003|Short-term Period|Lack of Efficacy|3|||
13410844|NCT00534313|26833775|FG000|Short-term Period|Participant not meeting study criteria|0|||
13410845|NCT00534313|26833776|FG001|Short-term Period|Participant not meeting study criteria|0|||
13410846|NCT00534313|26833777|FG002|Short-term Period|Participant not meeting study criteria|0|||
13410847|NCT00534313|26833778|FG003|Short-term Period|Participant not meeting study criteria|1|||
13410848|NCT00534313|26833775|FG000|Short-term Period|Participant withdrew consent|2|||
13410849|NCT00534313|26833776|FG001|Short-term Period|Participant withdrew consent|0|||
13410850|NCT00534313|26833777|FG002|Short-term Period|Participant withdrew consent|0|||
13410851|NCT00534313|26833778|FG003|Short-term Period|Participant withdrew consent|2|||
13410852|NCT00534313|26833775|FG000|Short-term Period|Pregnancy|0|||
13410853|NCT00534313|26833776|FG001|Short-term Period|Pregnancy|0|||
13410854|NCT00534313|26833777|FG002|Short-term Period|Pregnancy|1|||
13410855|NCT00534313|26833778|FG003|Short-term Period|Pregnancy|0|||
13410856|NCT00534313|26833775|FG000|Long-term Period|Adverse Event|2|||
13410857|NCT00534313|26833776|FG001|Long-term Period|Adverse Event|1|||
13410858|NCT00534313|26833777|FG002|Long-term Period|Adverse Event|0|||
13410859|NCT00534313|26833778|FG003|Long-term Period|Adverse Event|1|||
13410860|NCT00534313|26833775|FG000|Long-term Period|Lack of Efficacy|14|||
13410861|NCT00534313|26833776|FG001|Long-term Period|Lack of Efficacy|10|||
13410862|NCT00534313|26833777|FG002|Long-term Period|Lack of Efficacy|14|||
13410863|NCT00534313|26833778|FG003|Long-term Period|Lack of Efficacy|12|||
13410864|NCT00534313|26833775|FG000|Long-term Period|Lost to Follow-up|1|||
13410865|NCT00534313|26833776|FG001|Long-term Period|Lost to Follow-up|2|||
13410866|NCT00534313|26833777|FG002|Long-term Period|Lost to Follow-up|0|||
13410867|NCT00534313|26833778|FG003|Long-term Period|Lost to Follow-up|0|||
13410868|NCT00534313|26833775|FG000|Long-term Period|Withdrawal by Subject|2|||
13410869|NCT00534313|26833776|FG001|Long-term Period|Withdrawal by Subject|2|||
13410870|NCT00534313|26833777|FG002|Long-term Period|Withdrawal by Subject|0|||
13410871|NCT00534313|26833778|FG003|Long-term Period|Withdrawal by Subject|0|||
13410872|NCT00534313|26833775|FG000|Long-term Period|No longer meets study criteria|0|||
13410873|NCT00534313|26833776|FG001|Long-term Period|No longer meets study criteria|1|||
13410874|NCT00534313|26833777|FG002|Long-term Period|No longer meets study criteria|0|||
13410875|NCT00534313|26833778|FG003|Long-term Period|No longer meets study criteria|0|||
13410876|NCT00534313|26833775|FG000|Long-term Period|Poor compliance/noncompliance|0|||
13410877|NCT00534313|26833776|FG001|Long-term Period|Poor compliance/noncompliance|1|||
13410878|NCT00534313|26833777|FG002|Long-term Period|Poor compliance/noncompliance|1|||
13410879|NCT00534313|26833778|FG003|Long-term Period|Poor compliance/noncompliance|0|||
13410880|NCT00534313|26833775|FG000|Long-term Period|Administrative reason by sponsor|17|||
13410881|NCT00534313|26833776|FG001|Long-term Period|Administrative reason by sponsor|15|||
13410882|NCT00534313|26833777|FG002|Long-term Period|Administrative reason by sponsor|26|||
13410883|NCT00534313|26833778|FG003|Long-term Period|Administrative reason by sponsor|18|||
13410884|NCT00534313|26833775|FG000|Long-term Period|Other|1|||
13410885|NCT00534313|26833776|FG001|Long-term Period|Other|2|||
13410886|NCT00534313|26833777|FG002|Long-term Period|Other|2|||
13410887|NCT00534313|26833778|FG003|Long-term Period|Other|2|||
13410888|NCT00534248|26833795|FG000|Overall Study|Adverse Event|19|||
13410889|NCT00534248|26833796|FG001|Overall Study|Adverse Event|29|||
13410890|NCT00534248|26833795|FG000|Overall Study|Lost to Follow-up|353|||
13410891|NCT00534248|26833796|FG001|Overall Study|Lost to Follow-up|375|||
13410892|NCT00534248|26833795|FG000|Overall Study|Other protocol specified criteria|13|||
13410893|NCT00534248|26833796|FG001|Overall Study|Other protocol specified criteria|3|||
13410894|NCT00534248|26833795|FG000|Overall Study|Physician Decision|10|||
13410895|NCT00534248|26833796|FG001|Overall Study|Physician Decision|7|||
13410896|NCT00534248|26833795|FG000|Overall Study|Protocol Violation|3|||
13410897|NCT00534248|26833796|FG001|Overall Study|Protocol Violation|4|||
13410898|NCT00534248|26833795|FG000|Overall Study|Withdrawal by Subject|263|||
13410899|NCT00534248|26833796|FG001|Overall Study|Withdrawal by Subject|255|||
13410900|NCT00534105|26833815|FG000|Overall Study|Lost to Follow-up|23|||
13410901|NCT00534105|26833816|FG001|Overall Study|Lost to Follow-up|39|||
13410902|NCT00534092|26833846|FG000|Overall Study|Lost to Follow-up|1|||
13410903|NCT00534092|26833847|FG001|Overall Study|Lost to Follow-up|0|||
13410904|NCT00534092|26833846|FG000|Overall Study|personal reasons/family concerns|1|||
13410905|NCT00534092|26833847|FG001|Overall Study|personal reasons/family concerns|0|||
13410906|NCT00533949|26833898|FG000|Overall Study|Protocol Violation|12|||
13410907|NCT00533949|26833899|FG001|Overall Study|Protocol Violation|12|||
13410908|NCT00533949|26833900|FG002|Overall Study|Protocol Violation|9|||
13410909|NCT00533949|26833901|FG003|Overall Study|Protocol Violation|9|||
13410910|NCT00533949|26833898|FG000|Overall Study|Withdrawal by Subject|3|||
13410911|NCT00533949|26833899|FG001|Overall Study|Withdrawal by Subject|2|||
13410912|NCT00533949|26833900|FG002|Overall Study|Withdrawal by Subject|1|||
13410913|NCT00533949|26833901|FG003|Overall Study|Withdrawal by Subject|1|||
13410914|NCT00533897|26834054|FG000|Lead-in (LI) Period 1|Adverse Event|1|||
13410915|NCT00533897|26834055|FG001|Lead-in (LI) Period 1|Adverse Event|0|||
13410916|NCT00533897|26834056|FG002|Lead-in (LI) Period 1|Adverse Event|0|||
13410917|NCT00533897|26834057|FG003|Lead-in (LI) Period 1|Adverse Event|0|||
13410918|NCT00533897|26834058|FG004|Lead-in (LI) Period 1|Adverse Event|0|||
13410919|NCT00533897|26834059|FG005|Lead-in (LI) Period 1|Adverse Event|0|||
13410920|NCT00533897|26834060|FG006|Lead-in (LI) Period 1|Adverse Event|0|||
13410921|NCT00533897|26834061|FG007|Lead-in (LI) Period 1|Adverse Event|0|||
13410922|NCT00533897|26834054|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2|||
13410923|NCT00533897|26834055|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
13410924|NCT00533897|26834056|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
13410925|NCT00533897|26834057|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
13410926|NCT00533897|26834058|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
13410927|NCT00533897|26834059|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
13410928|NCT00533897|26834060|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
13410929|NCT00533897|26834061|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
13410930|NCT00533897|26834054|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1|||
13410931|NCT00533897|26834055|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0|||
13410932|NCT00533897|26834056|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0|||
13410933|NCT00533897|26834057|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0|||
13410934|NCT00533897|26834058|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0|||
13410935|NCT00533897|26834059|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0|||
13410936|NCT00533897|26834060|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0|||
13410937|NCT00533897|26834061|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0|||
13410938|NCT00533897|26834054|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2|||
13410939|NCT00533897|26834055|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
13410940|NCT00533897|26834056|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
13410941|NCT00533897|26834057|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
13410942|NCT00533897|26834058|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
13410943|NCT00533897|26834059|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
13410944|NCT00533897|26834060|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
13410945|NCT00533897|26834061|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
13410946|NCT00533897|26834054|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3|||
13410947|NCT00533897|26834055|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0|||
13410948|NCT00533897|26834056|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0|||
13410949|NCT00533897|26834057|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0|||
13410950|NCT00533897|26834058|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0|||
13410951|NCT00533897|26834059|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0|||
13410952|NCT00533897|26834060|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0|||
13410953|NCT00533897|26834061|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0|||
13410954|NCT00533897|26834054|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1|||
13410955|NCT00533897|26834055|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
13410956|NCT00533897|26834056|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
13410957|NCT00533897|26834057|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
13410958|NCT00533897|26834058|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
13410959|NCT00533897|26834059|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
13410960|NCT00533897|26834060|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
13410961|NCT00533897|26834061|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
13410962|NCT00533897|26834054|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
13410963|NCT00533897|26834055|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1|||
13410964|NCT00533897|26834056|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2|||
13410965|NCT00533897|26834057|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
13410966|NCT00533897|26834058|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
13410967|NCT00533897|26834059|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
13410968|NCT00533897|26834060|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
13410969|NCT00533897|26834061|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
13410970|NCT00533897|26834054|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
13410971|NCT00533897|26834055|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
13410972|NCT00533897|26834056|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1|||
13410973|NCT00533897|26834057|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
13410974|NCT00533897|26834058|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
13410975|NCT00533897|26834059|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
13410976|NCT00533897|26834060|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
13410977|NCT00533897|26834061|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
13410978|NCT00533897|26834054|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
13410979|NCT00533897|26834055|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
13410980|NCT00533897|26834056|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
13410981|NCT00533897|26834057|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
13410982|NCT00533897|26834058|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
13410983|NCT00533897|26834059|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1|||
13410984|NCT00533897|26834060|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
13410985|NCT00533897|26834061|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
13410986|NCT00533897|26834054|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
13410987|NCT00533897|26834055|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
13410988|NCT00533897|26834056|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
13410989|NCT00533897|26834057|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
13410990|NCT00533897|26834058|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
13410991|NCT00533897|26834059|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1|||
13410992|NCT00533897|26834060|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
13410993|NCT00533897|26834061|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
13410994|NCT00533897|26834054|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
13410995|NCT00533897|26834055|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
13410996|NCT00533897|26834056|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
13410997|NCT00533897|26834057|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
13410998|NCT00533897|26834058|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
13410999|NCT00533897|26834059|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
13411000|NCT00533897|26834060|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2|||
13411001|NCT00533897|26834061|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5|||
13411002|NCT00533897|26834054|FG000|Long Term Extension (LTE)|Death|0|||
13411003|NCT00533897|26834055|FG001|Long Term Extension (LTE)|Death|0|||
13411004|NCT00533897|26834056|FG002|Long Term Extension (LTE)|Death|0|||
13411005|NCT00533897|26834057|FG003|Long Term Extension (LTE)|Death|0|||
13411006|NCT00533897|26834058|FG004|Long Term Extension (LTE)|Death|0|||
13411007|NCT00533897|26834059|FG005|Long Term Extension (LTE)|Death|0|||
13411008|NCT00533897|26834060|FG006|Long Term Extension (LTE)|Death|1|||
13411009|NCT00533897|26834061|FG007|Long Term Extension (LTE)|Death|3|||
13411010|NCT00533897|26834054|FG000|Long Term Extension (LTE)|Lack of Efficacy|0|||
13411011|NCT00533897|26834055|FG001|Long Term Extension (LTE)|Lack of Efficacy|0|||
13411012|NCT00533897|26834056|FG002|Long Term Extension (LTE)|Lack of Efficacy|0|||
13411013|NCT00533897|26834057|FG003|Long Term Extension (LTE)|Lack of Efficacy|0|||
13411014|NCT00533897|26834058|FG004|Long Term Extension (LTE)|Lack of Efficacy|0|||
13411015|NCT00533897|26834059|FG005|Long Term Extension (LTE)|Lack of Efficacy|0|||
13411016|NCT00533897|26834060|FG006|Long Term Extension (LTE)|Lack of Efficacy|5|||
13411017|NCT00533897|26834061|FG007|Long Term Extension (LTE)|Lack of Efficacy|3|||
13411018|NCT00533897|26834054|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0|||
13411019|NCT00533897|26834055|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0|||
13411020|NCT00533897|26834056|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0|||
13411021|NCT00533897|26834057|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0|||
13411022|NCT00533897|26834058|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0|||
13411023|NCT00533897|26834059|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0|||
13411024|NCT00533897|26834060|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1|||
13411025|NCT00533897|26834061|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0|||
13411026|NCT00533897|26834054|FG000|Long Term Extension (LTE)|Adverse Event|0|||
13411027|NCT00533897|26834055|FG001|Long Term Extension (LTE)|Adverse Event|0|||
13411028|NCT00533897|26834056|FG002|Long Term Extension (LTE)|Adverse Event|0|||
13411029|NCT00533897|26834057|FG003|Long Term Extension (LTE)|Adverse Event|0|||
13411030|NCT00533897|26834058|FG004|Long Term Extension (LTE)|Adverse Event|0|||
13411031|NCT00533897|26834059|FG005|Long Term Extension (LTE)|Adverse Event|0|||
13411032|NCT00533897|26834060|FG006|Long Term Extension (LTE)|Adverse Event|2|||
13411033|NCT00533897|26834061|FG007|Long Term Extension (LTE)|Adverse Event|5|||
13411034|NCT00533897|26834054|FG000|Long Term Extension (LTE)|Pregnancy|0|||
13411035|NCT00533897|26834055|FG001|Long Term Extension (LTE)|Pregnancy|0|||
13411036|NCT00533897|26834056|FG002|Long Term Extension (LTE)|Pregnancy|0|||
13411037|NCT00533897|26834057|FG003|Long Term Extension (LTE)|Pregnancy|0|||
13411038|NCT00533897|26834058|FG004|Long Term Extension (LTE)|Pregnancy|0|||
13411039|NCT00533897|26834059|FG005|Long Term Extension (LTE)|Pregnancy|0|||
13411040|NCT00533897|26834060|FG006|Long Term Extension (LTE)|Pregnancy|0|||
13411041|NCT00533897|26834061|FG007|Long Term Extension (LTE)|Pregnancy|2|||
13411042|NCT00533897|26834054|FG000|Long Term Extension (LTE)|Lost to Follow-up|0|||
13411043|NCT00533897|26834055|FG001|Long Term Extension (LTE)|Lost to Follow-up|0|||
13411044|NCT00533897|26834056|FG002|Long Term Extension (LTE)|Lost to Follow-up|0|||
13411045|NCT00533897|26834057|FG003|Long Term Extension (LTE)|Lost to Follow-up|0|||
13411046|NCT00533897|26834058|FG004|Long Term Extension (LTE)|Lost to Follow-up|0|||
13411047|NCT00533897|26834059|FG005|Long Term Extension (LTE)|Lost to Follow-up|0|||
13411048|NCT00533897|26834060|FG006|Long Term Extension (LTE)|Lost to Follow-up|1|||
13411049|NCT00533897|26834061|FG007|Long Term Extension (LTE)|Lost to Follow-up|1|||
13411050|NCT00533897|26834054|FG000|Long Term Extension (LTE)|Other|0|||
13411051|NCT00533897|26834055|FG001|Long Term Extension (LTE)|Other|0|||
13411052|NCT00533897|26834056|FG002|Long Term Extension (LTE)|Other|0|||
13411053|NCT00533897|26834057|FG003|Long Term Extension (LTE)|Other|0|||
13411054|NCT00533897|26834058|FG004|Long Term Extension (LTE)|Other|0|||
13411055|NCT00533897|26834059|FG005|Long Term Extension (LTE)|Other|0|||
13411056|NCT00533897|26834060|FG006|Long Term Extension (LTE)|Other|1|||
13411057|NCT00533897|26834061|FG007|Long Term Extension (LTE)|Other|6|||
13411058|NCT00533845|26834074|FG000|Overall Study|Physician Decision|1|||
13411059|NCT00533845|26834075|FG001|Overall Study|Physician Decision|0|||
13411060|NCT00533702|26834106|FG000|Overall Study|Withdrawal by Subject|3|||
13411061|NCT00533702|26834107|FG001|Overall Study|Withdrawal by Subject|1|||
13411062|NCT00533702|26834106|FG000|Overall Study|Found ineligible after randomization|2|||
13411063|NCT00533702|26834107|FG001|Overall Study|Found ineligible after randomization|1|||
13411064|NCT00533507|26834128|FG000|Overall Study|Withdrawal by Subject|1|||
13411065|NCT00533429|26834151|FG000|Overall Study|Adverse Event|3|||
13411066|NCT00533429|26834152|FG001|Overall Study|Adverse Event|1|||
13411067|NCT00533429|26834151|FG000|Overall Study|Death|1|||
13411068|NCT00533429|26834152|FG001|Overall Study|Death|0|||
13411069|NCT00533429|26834151|FG000|Overall Study|Withdrawal by Subject|2|||
13411070|NCT00533429|26834152|FG001|Overall Study|Withdrawal by Subject|0|||
13411071|NCT00533429|26834151|FG000|Overall Study|Progressive Disease|12|||
13411072|NCT00533429|26834152|FG001|Overall Study|Progressive Disease|13|||
13411073|NCT00533429|26834151|FG000|Overall Study|Symptomatic deterioration|1|||
13411074|NCT00533429|26834152|FG001|Overall Study|Symptomatic deterioration|2|||
13411075|NCT00533273|26834190|FG000|Double-blind|Withdrew consent|0|||
13411076|NCT00533273|26834191|FG001|Double-blind|Withdrew consent|2|||
13411077|NCT00533273|26834190|FG000|Open-label|Withdrawal by Subject|6|||
13411078|NCT00533273|26834191|FG001|Open-label|Withdrawal by Subject|0|||
13411079|NCT00532948|26834231|FG000|Overall Study|Protocol Violation|1|||
13411080|NCT00532948|26834232|FG001|Overall Study|Protocol Violation|0|||
13411081|NCT00532948|26834233|FG002|Overall Study|Protocol Violation|0|||
13411082|NCT00532948|26834231|FG000|Overall Study|Death|3|||
13411083|NCT00532948|26834232|FG001|Overall Study|Death|3|||
13411084|NCT00532948|26834233|FG002|Overall Study|Death|4|||
13411085|NCT00532948|26834231|FG000|Overall Study|Violation of selection criteria at entry|0|||
13411086|NCT00532948|26834232|FG001|Overall Study|Violation of selection criteria at entry|1|||
13411087|NCT00532948|26834233|FG002|Overall Study|Violation of selection criteria at entry|0|||
13411088|NCT00532948|26834231|FG000|Overall Study|Failure to return|0|||
13411089|NCT00532948|26834232|FG001|Overall Study|Failure to return|1|||
13411090|NCT00532948|26834233|FG002|Overall Study|Failure to return|0|||
13411091|NCT00532935|26834254|FG000|Overall Study|Adverse Event|11|||
13411092|NCT00532935|26834255|FG001|Overall Study|Adverse Event|12|||
13411093|NCT00532935|26834254|FG000|Overall Study|Lack of Efficacy|0|||
13411094|NCT00532935|26834255|FG001|Overall Study|Lack of Efficacy|3|||
13411095|NCT00532935|26834254|FG000|Overall Study|Lost to Follow-up|10|||
13411096|NCT00532935|26834255|FG001|Overall Study|Lost to Follow-up|6|||
13411097|NCT00532935|26834254|FG000|Overall Study|Physician Decision|4|||
13411098|NCT00532935|26834255|FG001|Overall Study|Physician Decision|5|||
13411099|NCT00532935|26834254|FG000|Overall Study|Pregnancy|1|||
13411100|NCT00532935|26834255|FG001|Overall Study|Pregnancy|0|||
13411101|NCT00532935|26834254|FG000|Overall Study|Protocol Violation|4|||
13411102|NCT00532935|26834255|FG001|Overall Study|Protocol Violation|2|||
13411103|NCT00532935|26834254|FG000|Overall Study|Withdrawal by Subject|10|||
13411104|NCT00532935|26834255|FG001|Overall Study|Withdrawal by Subject|9|||
13411105|NCT00532935|26834254|FG000|Overall Study|Protocol Specific Criteria|11|||
13411106|NCT00532935|26834255|FG001|Overall Study|Protocol Specific Criteria|15|||
13411107|NCT00532883|26834278|FG000|Overall Study|Adverse Event|1|||
13411108|NCT00532883|26834279|FG001|Overall Study|Adverse Event|0|||
13411109|NCT00532883|26834280|FG002|Overall Study|Adverse Event|0|||
13411110|NCT00532883|26834281|FG003|Overall Study|Adverse Event|1|||
13411111|NCT00532883|26834278|FG000|Overall Study|Lost to Follow-up|1|||
13411112|NCT00532883|26834279|FG001|Overall Study|Lost to Follow-up|1|||
13411113|NCT00532883|26834280|FG002|Overall Study|Lost to Follow-up|1|||
13411114|NCT00532883|26834281|FG003|Overall Study|Lost to Follow-up|0|||
13411115|NCT00532883|26834278|FG000|Overall Study|Withdrawal by Subject|0|||
13390357|NCT00686881|26773254|FG001|Overall Study|Never received study drug|6|||
13390358|NCT00686855|26773267|FG000|Overall Study|Lost to Follow-up|1|||
13390359|NCT00686855|26773268|FG001|Overall Study|Lost to Follow-up|0|||
13390360|NCT00686855|26773267|FG000|Overall Study|Progressive GVHD|0|||
13390361|NCT00686855|26773268|FG001|Overall Study|Progressive GVHD|1|||
13390362|NCT00686829|26773284|FG000|Overall Study|Adverse Event|5|||
13390363|NCT00686829|26773284|FG000|Overall Study|Lack of Efficacy|6|||
13390364|NCT00686829|26773284|FG000|Overall Study|Lost to Follow-up|4|||
13390365|NCT00686829|26773284|FG000|Overall Study|Withdrawal by Subject|14|||
13390366|NCT00686829|26773284|FG000|Overall Study|Protocol Violation|3|||
13390367|NCT00686829|26773284|FG000|Overall Study|Sponsor discontinued VCV|47|||
13390368|NCT00686790|26773294|FG000|Overall Study|Adverse Event|2|||
13390369|NCT00686790|26773294|FG000|Overall Study|Withdrawal by Subject|1|||
13390370|NCT00686790|26773294|FG000|Overall Study|Death|1|||
13390371|NCT00686790|26773294|FG000|Overall Study|Lost to Follow-up|12|||
13390372|NCT00686777|26773302|FG000|Overall Study|Adverse Event|2|||
13390373|NCT00686777|26773302|FG000|Overall Study|Pregnancy|1|||
13390374|NCT00686777|26773302|FG000|Overall Study|Withdrawal by Subject|2|||
13390375|NCT00686777|26773302|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4|||
13390376|NCT00686777|26773302|FG000|Overall Study|No Visit|1|||
13390377|NCT00686725|26773331|FG000|Overall Study|Adverse Event|1|||
13390378|NCT00686725|26773332|FG001|Overall Study|Adverse Event|1|||
13390379|NCT00686725|26773331|FG000|Overall Study|Progressive Disease|17|||
13390380|NCT00686725|26773332|FG001|Overall Study|Progressive Disease|23|||
13390381|NCT00686725|26773331|FG000|Overall Study|Lost to Follow-up|7|||
13390382|NCT00686725|26773332|FG001|Overall Study|Lost to Follow-up|5|||
13390383|NCT00686725|26773331|FG000|Overall Study|Death|6|||
13411116|NCT00532883|26834279|FG001|Overall Study|Withdrawal by Subject|1|||
13411117|NCT00532883|26834280|FG002|Overall Study|Withdrawal by Subject|1|||
13411118|NCT00532883|26834281|FG003|Overall Study|Withdrawal by Subject|0|||
13411119|NCT00532883|26834278|FG000|Overall Study|Subject was Nonadherent|0|||
13411120|NCT00532883|26834279|FG001|Overall Study|Subject was Nonadherent|1|||
13411121|NCT00532883|26834280|FG002|Overall Study|Subject was Nonadherent|1|||
13411122|NCT00532883|26834281|FG003|Overall Study|Subject was Nonadherent|0|||
13411123|NCT00532883|26834278|FG000|Overall Study|Early Study Termination|4|||
13411124|NCT00532883|26834279|FG001|Overall Study|Early Study Termination|4|||
13411125|NCT00532883|26834280|FG002|Overall Study|Early Study Termination|1|||
13411126|NCT00532883|26834281|FG003|Overall Study|Early Study Termination|4|||
13411127|NCT00532844|26834315|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0|||
13411128|NCT00532844|26834316|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1|||
13411129|NCT00532844|26834315|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1|||
13411130|NCT00532844|26834316|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0|||
13411131|NCT00532844|26834315|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1|||
13411132|NCT00532844|26834316|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0|||
13411133|NCT00532844|26834315|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1|||
13411134|NCT00532844|26834316|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0|||
13411135|NCT00532844|26834315|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1|||
13411136|NCT00532844|26834316|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0|||
13411137|NCT00532779|26834385|FG000|Overall Study|Adverse Event|122|||
13411138|NCT00532779|26834386|FG001|Overall Study|Adverse Event|112|||
13411139|NCT00532779|26834387|FG002|Overall Study|Adverse Event|56|||
13411140|NCT00532779|26834385|FG000|Overall Study|Lost to Follow-up|76|||
13390384|NCT00686725|26773332|FG001|Overall Study|Death|3|||
13390385|NCT00686725|26773331|FG000|Overall Study|Withdrawal by Subject|13|||
13411141|NCT00532779|26834386|FG001|Overall Study|Lost to Follow-up|65|||
13411142|NCT00532779|26834387|FG002|Overall Study|Lost to Follow-up|66|||
13411143|NCT00532779|26834385|FG000|Overall Study|Withdrawal by Subject|63|||
13411144|NCT00532779|26834386|FG001|Overall Study|Withdrawal by Subject|60|||
13411145|NCT00532779|26834387|FG002|Overall Study|Withdrawal by Subject|90|||
13411146|NCT00532779|26834385|FG000|Overall Study|Lack of Efficacy|12|||
13411147|NCT00532779|26834386|FG001|Overall Study|Lack of Efficacy|12|||
13411148|NCT00532779|26834387|FG002|Overall Study|Lack of Efficacy|40|||
13411149|NCT00532779|26834385|FG000|Overall Study|Protocol Violation|5|||
13411150|NCT00532779|26834386|FG001|Overall Study|Protocol Violation|9|||
13411151|NCT00532779|26834387|FG002|Overall Study|Protocol Violation|7|||
13411152|NCT00532779|26834385|FG000|Overall Study|Pregnancy|2|||
13411153|NCT00532779|26834386|FG001|Overall Study|Pregnancy|5|||
13411154|NCT00532779|26834387|FG002|Overall Study|Pregnancy|3|||
13411155|NCT00532779|26834385|FG000|Overall Study|Death|0|||
13411156|NCT00532779|26834386|FG001|Overall Study|Death|1|||
13411157|NCT00532779|26834387|FG002|Overall Study|Death|0|||
13411158|NCT00532779|26834385|FG000|Overall Study|Drug noncompliance, moved, other|14|||
13411159|NCT00532779|26834386|FG001|Overall Study|Drug noncompliance, moved, other|23|||
13411160|NCT00532779|26834387|FG002|Overall Study|Drug noncompliance, moved, other|29|||
13411161|NCT00532493|26834424|FG000|Overall Study|Death|1|||
13411162|NCT00532493|26834425|FG001|Overall Study|Death|1|||
13411163|NCT00532493|26834424|FG000|Overall Study|Lost to Follow-up|10|||
13411164|NCT00532493|26834425|FG001|Overall Study|Lost to Follow-up|7|||
13411165|NCT00532493|26834424|FG000|Overall Study|Withdrawal by Subject|7|||
13411166|NCT00532493|26834425|FG001|Overall Study|Withdrawal by Subject|9|||
13411167|NCT00532493|26834424|FG000|Overall Study|Physician Decision|1|||
13411168|NCT00532493|26834425|FG001|Overall Study|Physician Decision|6|||
13411169|NCT00532493|26834424|FG000|Overall Study|Adverse Event|6|||
13411170|NCT00532493|26834425|FG001|Overall Study|Adverse Event|5|||
13411171|NCT00532493|26834424|FG000|Overall Study|Protocol Deviation|1|||
13411172|NCT00532493|26834425|FG001|Overall Study|Protocol Deviation|0|||
13411173|NCT00532493|26834424|FG000|Overall Study|Subject Moved Away|3|||
13411174|NCT00532493|26834425|FG001|Overall Study|Subject Moved Away|1|||
13411175|NCT00532493|26834424|FG000|Overall Study|Contraindicative Medication|1|||
13411176|NCT00532493|26834425|FG001|Overall Study|Contraindicative Medication|0|||
13411177|NCT00532441|26834437|FG000|Overall Study|Death|1|||
13411178|NCT00532441|26834438|FG001|Overall Study|Death|0|||
13411179|NCT00532298|26834537|FG000|Overall Study|Adverse Event|1|||
13411180|NCT00532298|26834538|FG001|Overall Study|Adverse Event|0|||
13411181|NCT00532298|26834539|FG002|Overall Study|Adverse Event|0|||
13411182|NCT00532298|26834540|FG003|Overall Study|Adverse Event|0|||
13411183|NCT00532298|26834541|FG004|Overall Study|Adverse Event|1|||
13411184|NCT00532298|26834542|FG005|Overall Study|Adverse Event|1|||
13411185|NCT00532298|26834537|FG000|Overall Study|Lost to Follow-up|1|||
13411186|NCT00532298|26834538|FG001|Overall Study|Lost to Follow-up|1|||
13411187|NCT00532298|26834539|FG002|Overall Study|Lost to Follow-up|1|||
13411188|NCT00532298|26834540|FG003|Overall Study|Lost to Follow-up|0|||
13411189|NCT00532298|26834541|FG004|Overall Study|Lost to Follow-up|0|||
13411190|NCT00532298|26834542|FG005|Overall Study|Lost to Follow-up|1|||
13411191|NCT00532259|26834549|FG000|Overall Study|Withdrawal by Subject|2|||
13411192|NCT00532259|26834549|FG000|Overall Study|Adverse Event|1|||
13411193|NCT00532259|26834549|FG000|Overall Study|Death|1|||
13411194|NCT00532259|26834549|FG000|Overall Study|Lack of Efficacy|21|||
13411195|NCT00532259|26834549|FG000|Overall Study|Lost to Follow-up|3|||
13411196|NCT00532259|26834549|FG000|Overall Study|Physician Decision|3|||
13411197|NCT00532259|26834549|FG000|Overall Study|Protocol Violation|1|||
13411198|NCT00532155|26834570|FG000|Overall Study|Adverse Event|66|||
13411199|NCT00532155|26834571|FG001|Overall Study|Adverse Event|123|||
13411200|NCT00532155|26834570|FG000|Overall Study|Lack of Efficacy|332|||
13411201|NCT00532155|26834571|FG001|Overall Study|Lack of Efficacy|255|||
13411202|NCT00532155|26834570|FG000|Overall Study|Protocol Violation|1|||
13411203|NCT00532155|26834571|FG001|Overall Study|Protocol Violation|3|||
13411204|NCT00532155|26834570|FG000|Overall Study|Lost to Follow-up|2|||
13411205|NCT00532155|26834571|FG001|Overall Study|Lost to Follow-up|0|||
13411206|NCT00532155|26834570|FG000|Overall Study|Physician Decision|16|||
13411207|NCT00532155|26834571|FG001|Overall Study|Physician Decision|15|||
13411208|NCT00532155|26834570|FG000|Overall Study|Withdrawal by Subject|23|||
13411209|NCT00532155|26834571|FG001|Overall Study|Withdrawal by Subject|44|||
13411210|NCT00532155|26834570|FG000|Overall Study|Consent withdrawn|5|||
13411211|NCT00532155|26834571|FG001|Overall Study|Consent withdrawn|7|||
13411212|NCT00532155|26834570|FG000|Overall Study|Moved|1|||
13411213|NCT00532155|26834571|FG001|Overall Study|Moved|0|||
13411214|NCT00532155|26834570|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1|||
13411215|NCT00532155|26834571|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0|||
13411216|NCT00532155|26834570|FG000|Overall Study|Occurence of a second cancer|0|||
13411217|NCT00532155|26834571|FG001|Overall Study|Occurence of a second cancer|1|||
13411218|NCT00532155|26834570|FG000|Overall Study|Occurence of a secondary cancer|0|||
13411219|NCT00532155|26834571|FG001|Overall Study|Occurence of a secondary cancer|1|||
13411220|NCT00532155|26834570|FG000|Overall Study|Promotor ended study|1|||
13411221|NCT00532155|26834571|FG001|Overall Study|Promotor ended study|0|||
13411222|NCT00532155|26834570|FG000|Overall Study|Progressive disease (by incorrect scan)|0|||
13411223|NCT00532155|26834571|FG001|Overall Study|Progressive disease (by incorrect scan)|1|||
13411224|NCT00532155|26834570|FG000|Overall Study|Had brain metastasis, was mis-randomized|1|||
13411225|NCT00532155|26834571|FG001|Overall Study|Had brain metastasis, was mis-randomized|0|||
13411226|NCT00532155|26834570|FG000|Overall Study|Study stopped|1|||
13411227|NCT00532155|26834571|FG001|Overall Study|Study stopped|0|||
13411228|NCT00532155|26834570|FG000|Overall Study|Study terminated by sponsor|1|||
13411229|NCT00532155|26834571|FG001|Overall Study|Study terminated by sponsor|0|||
13411230|NCT00532155|26834570|FG000|Overall Study|Study termination stop further treatment|4|||
13411231|NCT00532155|26834571|FG001|Overall Study|Study termination stop further treatment|0|||
13411232|NCT00532155|26834570|FG000|Overall Study|Did not receive study medication|2|||
13411233|NCT00532155|26834571|FG001|Overall Study|Did not receive study medication|6|||
13411234|NCT00532129|26834591|FG000|Treatment Period|Adverse event/Serious adverse event|25|||
13411235|NCT00532129|26834591|FG000|Treatment Period|Physician Decision|15|||
13411236|NCT00532129|26834591|FG000|Treatment Period|Disease progression|3|||
13411237|NCT00532129|26834591|FG000|Treatment Period|Protocol Violation|1|||
13411238|NCT00532129|26834591|FG000|Treatment Period|Other|5|||
13411239|NCT00532129|26834591|FG000|Follow-up Period|Adverse event/Serious adverse event|1|||
13411240|NCT00532129|26834591|FG000|Follow-up Period|Disease progression|57|||
13411241|NCT00532129|26834591|FG000|Follow-up Period|Lost to Follow-up|1|||
13411242|NCT00532129|26834591|FG000|Follow-up Period|Other|6|||
13411243|NCT00531960|26834614|FG000|Overall Study|Adverse Event|5|||
13411244|NCT00531960|26834615|FG001|Overall Study|Adverse Event|4|||
13411245|NCT00531960|26834614|FG000|Overall Study|Death|3|||
13411246|NCT00531960|26834615|FG001|Overall Study|Death|2|||
13411247|NCT00531960|26834614|FG000|Overall Study|Lack of Efficacy|42|||
13411248|NCT00531960|26834615|FG001|Overall Study|Lack of Efficacy|41|||
13411249|NCT00531960|26834614|FG000|Overall Study|Violation of Selection Criteria|2|||
13411250|NCT00531960|26834615|FG001|Overall Study|Violation of Selection Criteria|0|||
13411251|NCT00531960|26834614|FG000|Overall Study|Refused Treatment|5|||
13411252|NCT00531960|26834615|FG001|Overall Study|Refused Treatment|6|||
13411253|NCT00531960|26834614|FG000|Overall Study|Other|4|||
13411254|NCT00531960|26834615|FG001|Overall Study|Other|10|||
13411255|NCT00531947|26834664|FG000|Overall Study|Adverse Event|5|||
13411256|NCT00531947|26834665|FG001|Overall Study|Adverse Event|10|||
13411257|NCT00531947|26834664|FG000|Overall Study|Lost to Follow-up|12|||
13411258|NCT00531947|26834665|FG001|Overall Study|Lost to Follow-up|9|||
13411259|NCT00531947|26834664|FG000|Overall Study|Withdrawal by Subject|14|||
13411260|NCT00531947|26834665|FG001|Overall Study|Withdrawal by Subject|19|||
13411261|NCT00531947|26834664|FG000|Overall Study|Protocol Violation|2|||
13411262|NCT00531947|26834665|FG001|Overall Study|Protocol Violation|1|||
13411263|NCT00531947|26834664|FG000|Overall Study|Non-Compliance|4|||
13411264|NCT00531947|26834665|FG001|Overall Study|Non-Compliance|7|||
13411265|NCT00531947|26834664|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5|||
13411266|NCT00531947|26834665|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5|||
13411267|NCT00531934|26834740|FG000|Overall Study|Adverse Event|4|||
13411268|NCT00531934|26834741|FG001|Overall Study|Adverse Event|8|||
13411269|NCT00531934|26834740|FG000|Overall Study|Progression|52|||
13411270|NCT00531934|26834741|FG001|Overall Study|Progression|42|||
13411271|NCT00531934|26834740|FG000|Overall Study|Death|7|||
13411272|NCT00531934|26834741|FG001|Overall Study|Death|10|||
13411273|NCT00531934|26834740|FG000|Overall Study|Withdrawal by Subject|1|||
13411274|NCT00531934|26834741|FG001|Overall Study|Withdrawal by Subject|1|||
13411275|NCT00531934|26834740|FG000|Overall Study|Other|2|||
13411276|NCT00531934|26834741|FG001|Overall Study|Other|2|||
13411277|NCT00531752|26834831|FG000|First Double-blind Intervention Period|Adverse Event|2|||
13411278|NCT00531752|26834832|FG001|First Double-blind Intervention Period|Adverse Event|0|||
13411279|NCT00531752|26834833|FG002|First Double-blind Intervention Period|Adverse Event|1|||
13411280|NCT00531752|26834834|FG003|First Double-blind Intervention Period|Adverse Event|1|||
13411281|NCT00531752|26834831|FG000|First Double-blind Intervention Period|Other|1|||
13411282|NCT00531752|26834832|FG001|First Double-blind Intervention Period|Other|4|||
13411283|NCT00531752|26834833|FG002|First Double-blind Intervention Period|Other|4|||
13411284|NCT00531752|26834834|FG003|First Double-blind Intervention Period|Other|0|||
13411285|NCT00531752|26834831|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2|||
13411286|NCT00531752|26834832|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0|||
13411287|NCT00531752|26834833|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1|||
13411288|NCT00531752|26834834|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1|||
13411289|NCT00531752|26834831|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
13411290|NCT00531752|26834832|FG001|First Double-blind Intervention Period|Lost to Follow-up|0|||
13411291|NCT00531752|26834833|FG002|First Double-blind Intervention Period|Lost to Follow-up|1|||
13411292|NCT00531752|26834834|FG003|First Double-blind Intervention Period|Lost to Follow-up|1|||
13411293|NCT00531752|26834831|FG000|First Double-blind Intervention Period|Randomized but not treated|1|||
13411294|NCT00531752|26834832|FG001|First Double-blind Intervention Period|Randomized but not treated|0|||
13411295|NCT00531752|26834833|FG002|First Double-blind Intervention Period|Randomized but not treated|0|||
13411296|NCT00531752|26834834|FG003|First Double-blind Intervention Period|Randomized but not treated|0|||
13411297|NCT00531752|26834831|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
13411298|NCT00531752|26834832|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
13411299|NCT00531752|26834833|FG002|Second Double-blind Intervention Period|Adverse Event|0|||
13411300|NCT00531752|26834834|FG003|Second Double-blind Intervention Period|Adverse Event|0|||
13411301|NCT00531752|26834831|FG000|Second Double-blind Intervention Period|Other|1|||
13411302|NCT00531752|26834832|FG001|Second Double-blind Intervention Period|Other|1|||
13411303|NCT00531752|26834833|FG002|Second Double-blind Intervention Period|Other|0|||
13411304|NCT00531752|26834834|FG003|Second Double-blind Intervention Period|Other|0|||
13411305|NCT00531752|26834831|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
13411306|NCT00531752|26834832|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
13411307|NCT00531752|26834833|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
13411308|NCT00531752|26834834|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1|||
13411309|NCT00531752|26834831|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
13411310|NCT00531752|26834832|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0|||
13411311|NCT00531752|26834833|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0|||
13411312|NCT00531752|26834834|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1|||
13411313|NCT00531479|26834859|FG000|Overall Study|Death|68|||
13411314|NCT00531479|26834860|FG001|Overall Study|Death|71|||
13411315|NCT00531479|26834859|FG000|Overall Study|Lost to Follow-up|0|||
13411316|NCT00531479|26834860|FG001|Overall Study|Lost to Follow-up|2|||
13411317|NCT00531479|26834859|FG000|Overall Study|Other|0|||
13411318|NCT00531479|26834860|FG001|Overall Study|Other|1|||
13411319|NCT00531479|26834859|FG000|Overall Study|Withdrawal by Subject|6|||
13411320|NCT00531479|26834860|FG001|Overall Study|Withdrawal by Subject|6|||
13411321|NCT00531479|26834859|FG000|Overall Study|Did not receive treatment|2|||
13411322|NCT00531479|26834860|FG001|Overall Study|Did not receive treatment|3|||
13411323|NCT00531427|26834878|FG000|Overall Study|Withdrawal by Subject|7|||
13411324|NCT00531427|26834879|FG001|Overall Study|Withdrawal by Subject|13|||
13411325|NCT00531427|26834878|FG000|Overall Study|Adverse Event|44|||
13411326|NCT00531427|26834879|FG001|Overall Study|Adverse Event|30|||
13411327|NCT00531427|26834878|FG000|Overall Study|Lost to Follow-up|4|||
13411328|NCT00531427|26834879|FG001|Overall Study|Lost to Follow-up|3|||
13411329|NCT00531427|26834878|FG000|Overall Study|Lack of Efficacy|14|||
13411330|NCT00531427|26834879|FG001|Overall Study|Lack of Efficacy|39|||
13411331|NCT00531427|26834878|FG000|Overall Study|Administrative|4|||
13411332|NCT00531427|26834879|FG001|Overall Study|Administrative|9|||
13411333|NCT00531284|26835081|FG000|Overall Study|Progressive Disease|1|||
13411334|NCT00531284|26835082|FG001|Overall Study|Progressive Disease|3|||
13411335|NCT00531284|26835083|FG002|Overall Study|Progressive Disease|5|||
13411336|NCT00531284|26835084|FG003|Overall Study|Progressive Disease|42|||
13411337|NCT00531284|26835085|FG004|Overall Study|Progressive Disease|4|||
13411338|NCT00531284|26835086|FG005|Overall Study|Progressive Disease|4|||
13411339|NCT00531284|26835087|FG006|Overall Study|Progressive Disease|3|||
13411340|NCT00531284|26835088|FG007|Overall Study|Progressive Disease|8|||
13411341|NCT00531284|26835089|FG008|Overall Study|Progressive Disease|6|||
13411342|NCT00531284|26835090|FG009|Overall Study|Progressive Disease|3|||
13411343|NCT00531284|26835091|FG010|Overall Study|Progressive Disease|3|||
13411344|NCT00531284|26835092|FG011|Overall Study|Progressive Disease|14|||
13411345|NCT00531284|26835093|FG012|Overall Study|Progressive Disease|2|||
13411346|NCT00531284|26835094|FG013|Overall Study|Progressive Disease|1|||
13411347|NCT00531284|26835095|FG014|Overall Study|Progressive Disease|2|||
13411348|NCT00531284|26835096|FG015|Overall Study|Progressive Disease|11|||
13411349|NCT00531284|26835097|FG016|Overall Study|Progressive Disease|5|||
13411350|NCT00531284|26835081|FG000|Overall Study|Adverse Event|0|||
13411351|NCT00531284|26835082|FG001|Overall Study|Adverse Event|1|||
13411352|NCT00531284|26835083|FG002|Overall Study|Adverse Event|1|||
13411353|NCT00531284|26835084|FG003|Overall Study|Adverse Event|7|||
13411354|NCT00531284|26835085|FG004|Overall Study|Adverse Event|0|||
13411355|NCT00531284|26835086|FG005|Overall Study|Adverse Event|2|||
13411356|NCT00531284|26835087|FG006|Overall Study|Adverse Event|3|||
13411357|NCT00531284|26835088|FG007|Overall Study|Adverse Event|2|||
13411358|NCT00531284|26835089|FG008|Overall Study|Adverse Event|3|||
13411359|NCT00531284|26835090|FG009|Overall Study|Adverse Event|0|||
13411360|NCT00531284|26835091|FG010|Overall Study|Adverse Event|0|||
13411361|NCT00531284|26835092|FG011|Overall Study|Adverse Event|5|||
13411362|NCT00531284|26835093|FG012|Overall Study|Adverse Event|0|||
13411363|NCT00531284|26835094|FG013|Overall Study|Adverse Event|1|||
13411364|NCT00531284|26835095|FG014|Overall Study|Adverse Event|1|||
13411365|NCT00531284|26835096|FG015|Overall Study|Adverse Event|0|||
13411366|NCT00531284|26835097|FG016|Overall Study|Adverse Event|2|||
13411367|NCT00531284|26835081|FG000|Overall Study|Withdrawal by Subject|1|||
13411368|NCT00531284|26835082|FG001|Overall Study|Withdrawal by Subject|0|||
13411369|NCT00531284|26835083|FG002|Overall Study|Withdrawal by Subject|0|||
13411370|NCT00531284|26835084|FG003|Overall Study|Withdrawal by Subject|4|||
13411371|NCT00531284|26835085|FG004|Overall Study|Withdrawal by Subject|0|||
13411372|NCT00531284|26835086|FG005|Overall Study|Withdrawal by Subject|0|||
13411373|NCT00531284|26835087|FG006|Overall Study|Withdrawal by Subject|0|||
13411374|NCT00531284|26835088|FG007|Overall Study|Withdrawal by Subject|0|||
13411375|NCT00531284|26835089|FG008|Overall Study|Withdrawal by Subject|0|||
13411376|NCT00531284|26835090|FG009|Overall Study|Withdrawal by Subject|0|||
13411377|NCT00531284|26835091|FG010|Overall Study|Withdrawal by Subject|0|||
13411378|NCT00531284|26835092|FG011|Overall Study|Withdrawal by Subject|3|||
13411379|NCT00531284|26835093|FG012|Overall Study|Withdrawal by Subject|0|||
13411380|NCT00531284|26835094|FG013|Overall Study|Withdrawal by Subject|1|||
13411381|NCT00531284|26835095|FG014|Overall Study|Withdrawal by Subject|0|||
13411382|NCT00531284|26835096|FG015|Overall Study|Withdrawal by Subject|1|||
13411383|NCT00531284|26835097|FG016|Overall Study|Withdrawal by Subject|1|||
13411384|NCT00531284|26835081|FG000|Overall Study|Other|1|||
13411385|NCT00531284|26835082|FG001|Overall Study|Other|0|||
13411386|NCT00531284|26835083|FG002|Overall Study|Other|0|||
13411387|NCT00531284|26835084|FG003|Overall Study|Other|10|||
13411388|NCT00531284|26835085|FG004|Overall Study|Other|2|||
13411389|NCT00531284|26835086|FG005|Overall Study|Other|1|||
13411390|NCT00531284|26835087|FG006|Overall Study|Other|0|||
13411391|NCT00531284|26835088|FG007|Overall Study|Other|0|||
13411392|NCT00531284|26835089|FG008|Overall Study|Other|2|||
13411393|NCT00531284|26835090|FG009|Overall Study|Other|1|||
13411394|NCT00531284|26835091|FG010|Overall Study|Other|0|||
13411395|NCT00531284|26835092|FG011|Overall Study|Other|2|||
13411396|NCT00531284|26835093|FG012|Overall Study|Other|0|||
13411397|NCT00531284|26835094|FG013|Overall Study|Other|0|||
13411398|NCT00531284|26835095|FG014|Overall Study|Other|1|||
13411399|NCT00531284|26835096|FG015|Overall Study|Other|0|||
13411400|NCT00531284|26835097|FG016|Overall Study|Other|0|||
13411401|NCT00531206|26835123|FG000|Overall Study|Adverse Event related|5|||
13411402|NCT00531206|26835123|FG000|Overall Study|Lack of Efficacy|2|||
13411403|NCT00531206|26835123|FG000|Overall Study|Lost to Follow-up|5|||
13411404|NCT00531206|26835123|FG000|Overall Study|including non-related adverse events|8|||
13411405|NCT00531050|26835169|FG000|Part 1: Period 1|Adverse Event|0|||
13411406|NCT00531050|26835170|FG001|Part 1: Period 1|Adverse Event|1|||
13411407|NCT00531050|26835171|FG002|Part 1: Period 1|Adverse Event|0|||
13411408|NCT00531050|26835172|FG003|Part 1: Period 1|Adverse Event|0|||
13411409|NCT00531050|26835173|FG004|Part 1: Period 1|Adverse Event|0|||
13411410|NCT00531050|26835174|FG005|Part 1: Period 1|Adverse Event|0|||
13411411|NCT00531050|26835169|FG000|Part 1: Period 1|Protocol Deviation|0|||
13411412|NCT00531050|26835170|FG001|Part 1: Period 1|Protocol Deviation|0|||
13411413|NCT00531050|26835171|FG002|Part 1: Period 1|Protocol Deviation|0|||
13411414|NCT00531050|26835172|FG003|Part 1: Period 1|Protocol Deviation|1|||
13411415|NCT00531050|26835173|FG004|Part 1: Period 1|Protocol Deviation|0|||
13411416|NCT00531050|26835174|FG005|Part 1: Period 1|Protocol Deviation|0|||
13411417|NCT00531050|26835169|FG000|Part 1: Period 3|Adverse Event|1|||
13411418|NCT00531050|26835170|FG001|Part 1: Period 3|Adverse Event|0|||
13411419|NCT00531050|26835171|FG002|Part 1: Period 3|Adverse Event|0|||
13411420|NCT00531050|26835172|FG003|Part 1: Period 3|Adverse Event|0|||
13411421|NCT00531050|26835173|FG004|Part 1: Period 3|Adverse Event|0|||
13411422|NCT00531050|26835174|FG005|Part 1: Period 3|Adverse Event|0|||
13411423|NCT00531050|26835169|FG000|Part 2: Period 1|Adverse Event|0|||
13411424|NCT00531050|26835170|FG001|Part 2: Period 1|Adverse Event|0|||
13411425|NCT00531050|26835171|FG002|Part 2: Period 1|Adverse Event|0|||
13411426|NCT00531050|26835172|FG003|Part 2: Period 1|Adverse Event|0|||
13411427|NCT00531050|26835173|FG004|Part 2: Period 1|Adverse Event|0|||
13411428|NCT00531050|26835174|FG005|Part 2: Period 1|Adverse Event|1|||
13411429|NCT00531050|26835169|FG000|Part 2: Period 3|Abnormal test procedure|1|||
13411430|NCT00531050|26835170|FG001|Part 2: Period 3|Abnormal test procedure|0|||
13411431|NCT00531050|26835171|FG002|Part 2: Period 3|Abnormal test procedure|0|||
13411432|NCT00531050|26835172|FG003|Part 2: Period 3|Abnormal test procedure|0|||
13411433|NCT00531050|26835173|FG004|Part 2: Period 3|Abnormal test procedure|0|||
13411434|NCT00531050|26835174|FG005|Part 2: Period 3|Abnormal test procedure|1|||
13411435|NCT00531011|26835223|FG000|Overall Study|Withdrawal by Subject|2|||
13411436|NCT00531011|26835224|FG001|Overall Study|Withdrawal by Subject|4|||
13411437|NCT00531011|26835223|FG000|Overall Study|Death|1|||
13411438|NCT00531011|26835224|FG001|Overall Study|Death|0|||
13411439|NCT00531011|26835223|FG000|Overall Study|Lost to Follow-up|1|||
13411440|NCT00531011|26835224|FG001|Overall Study|Lost to Follow-up|0|||
13411441|NCT00531011|26835223|FG000|Overall Study|Physician Decision|0|||
13411442|NCT00531011|26835224|FG001|Overall Study|Physician Decision|3|||
13411443|NCT00530946|26835287|FG000|Overall Study|Adverse Event|1|||
13411444|NCT00530946|26835288|FG001|Overall Study|Adverse Event|2|||
13411445|NCT00530946|26835289|FG002|Overall Study|Adverse Event|1|||
13411446|NCT00530946|26835290|FG003|Overall Study|Adverse Event|1|||
13411447|NCT00530946|26835287|FG000|Overall Study|Protocol Violation|0|||
13411448|NCT00530946|26835288|FG001|Overall Study|Protocol Violation|0|||
13411449|NCT00530946|26835289|FG002|Overall Study|Protocol Violation|0|||
13411450|NCT00530946|26835290|FG003|Overall Study|Protocol Violation|1|||
13411451|NCT00530946|26835287|FG000|Overall Study|Noncompliance|1|||
13411452|NCT00530946|26835288|FG001|Overall Study|Noncompliance|0|||
13411453|NCT00530946|26835289|FG002|Overall Study|Noncompliance|0|||
13411454|NCT00530946|26835290|FG003|Overall Study|Noncompliance|0|||
13411455|NCT00530920|26835356|FG000|Overall Study|Randomized but not treated|0|||
13411456|NCT00530920|26835357|FG001|Overall Study|Randomized but not treated|2|||
13411457|NCT00530920|26835358|FG002|Overall Study|Randomized but not treated|0|||
13411458|NCT00530920|26835356|FG000|Overall Study|Adverse Event|0|||
13411459|NCT00530920|26835357|FG001|Overall Study|Adverse Event|0|||
13411460|NCT00530920|26835358|FG002|Overall Study|Adverse Event|3|||
13411461|NCT00530920|26835356|FG000|Overall Study|Withdrawal by Subject|0|||
13411462|NCT00530920|26835357|FG001|Overall Study|Withdrawal by Subject|0|||
13411463|NCT00530920|26835358|FG002|Overall Study|Withdrawal by Subject|1|||
13411464|NCT00530894|26835399|FG000|Overall Study|Death|84|||
13411465|NCT00530894|26835400|FG001|Overall Study|Death|89|||
13411466|NCT00530894|26835401|FG002|Overall Study|Death|55|||
13411467|NCT00530894|26835402|FG003|Overall Study|Death|89|||
13411468|NCT00530894|26835399|FG000|Overall Study|Lost to Follow-up|1|||
13411469|NCT00530894|26835400|FG001|Overall Study|Lost to Follow-up|3|||
13411470|NCT00530894|26835401|FG002|Overall Study|Lost to Follow-up|0|||
13411471|NCT00530894|26835402|FG003|Overall Study|Lost to Follow-up|0|||
13411472|NCT00530894|26835399|FG000|Overall Study|Withdrawal by Subject|1|||
13411473|NCT00530894|26835400|FG001|Overall Study|Withdrawal by Subject|23|||
13411474|NCT00530894|26835401|FG002|Overall Study|Withdrawal by Subject|0|||
13411475|NCT00530894|26835402|FG003|Overall Study|Withdrawal by Subject|5|||
13411476|NCT00530894|26835399|FG000|Overall Study|Alive and censored prior to 1 year|2|||
13411477|NCT00530894|26835400|FG001|Overall Study|Alive and censored prior to 1 year|0|||
13411478|NCT00530894|26835401|FG002|Overall Study|Alive and censored prior to 1 year|0|||
13411479|NCT00530894|26835402|FG003|Overall Study|Alive and censored prior to 1 year|0|||
13411480|NCT00530855|26835411|FG000|Overall Study|Lack of Efficacy|20|||
13411481|NCT00530855|26835411|FG000|Overall Study|Withdrawal by Subject|30|||
13411482|NCT00530855|26835411|FG000|Overall Study|Fatal Serious AE|3|||
13411483|NCT00530855|26835411|FG000|Overall Study|Non Fatal Serious AE|7|||
13411484|NCT00530855|26835411|FG000|Overall Study|Non Fatal Non Serious AE|12|||
13411485|NCT00530855|26835411|FG000|Overall Study|Protocol Violation|3|||
13411486|NCT00530855|26835411|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
13411487|NCT00530855|26835411|FG000|Overall Study|Lost to Follow-up|9|||
13411488|NCT00530855|26835411|FG000|Overall Study|Other reason for premature termination|17|||
13411489|NCT00530842|26835542|FG000|Overall Study|Adverse Event|10|||
13411490|NCT00530842|26835543|FG001|Overall Study|Adverse Event|6|||
13411491|NCT00530842|26835542|FG000|Overall Study|Lack of Efficacy|2|||
13411492|NCT00530842|26835543|FG001|Overall Study|Lack of Efficacy|1|||
13411493|NCT00530842|26835542|FG000|Overall Study|Lost to Follow-up|0|||
13411494|NCT00530842|26835543|FG001|Overall Study|Lost to Follow-up|4|||
13411495|NCT00530842|26835542|FG000|Overall Study|Protocol Violation|3|||
13411496|NCT00530842|26835543|FG001|Overall Study|Protocol Violation|2|||
13411497|NCT00530842|26835542|FG000|Overall Study|Withdrawal by Subject|4|||
13411498|NCT00530842|26835543|FG001|Overall Study|Withdrawal by Subject|5|||
13411499|NCT00530842|26835542|FG000|Overall Study|Individual different reasons|4|||
13411500|NCT00530842|26835543|FG001|Overall Study|Individual different reasons|3|||
13411501|NCT00530842|26835542|FG000|Period 1|Adverse Event|7|||
13411502|NCT00530842|26835543|FG001|Period 1|Adverse Event|3|||
13411503|NCT00530842|26835542|FG000|Period 1|Lack of Efficacy|1|||
13411504|NCT00530842|26835543|FG001|Period 1|Lack of Efficacy|1|||
13411505|NCT00530842|26835542|FG000|Period 1|Protocol Violation|2|||
13411506|NCT00530842|26835543|FG001|Period 1|Protocol Violation|1|||
13411507|NCT00530842|26835542|FG000|Period 1|Withdrawal by Subject|2|||
13411508|NCT00530842|26835543|FG001|Period 1|Withdrawal by Subject|3|||
13411509|NCT00530842|26835542|FG000|Period 1|Individual different reasons|2|||
13411510|NCT00530842|26835543|FG001|Period 1|Individual different reasons|3|||
13411511|NCT00530842|26835542|FG000|Period 2|Adverse Event|3|||
13411512|NCT00530842|26835543|FG001|Period 2|Adverse Event|3|||
13411513|NCT00530842|26835542|FG000|Period 2|Lack of Efficacy|1|||
13411514|NCT00530842|26835543|FG001|Period 2|Lack of Efficacy|0|||
13411515|NCT00530842|26835542|FG000|Period 2|Lost to Follow-up|0|||
13411516|NCT00530842|26835543|FG001|Period 2|Lost to Follow-up|4|||
13411517|NCT00530842|26835542|FG000|Period 2|Protocol Violation|1|||
13411518|NCT00530842|26835543|FG001|Period 2|Protocol Violation|0|||
13411519|NCT00530842|26835542|FG000|Period 2|Withdrawal by Subject|1|||
13411520|NCT00530842|26835543|FG001|Period 2|Withdrawal by Subject|2|||
13411521|NCT00530842|26835542|FG000|Period 2|Individual different reasons|2|||
13411522|NCT00530842|26835543|FG001|Period 2|Individual different reasons|0|||
13411523|NCT00530816|26835579|FG000|Overall Study|Progressive Disease|16|||
13411524|NCT00530816|26835580|FG001|Overall Study|Progressive Disease|24|||
13411525|NCT00530816|26835581|FG002|Overall Study|Progressive Disease|24|||
13411526|NCT00530816|26835579|FG000|Overall Study|Adverse Event|6|||
13411527|NCT00530816|26835580|FG001|Overall Study|Adverse Event|13|||
13411528|NCT00530816|26835581|FG002|Overall Study|Adverse Event|7|||
13411529|NCT00530816|26835579|FG000|Overall Study|Other|3|||
13411530|NCT00530816|26835580|FG001|Overall Study|Other|3|||
13411531|NCT00530816|26835581|FG002|Overall Study|Other|4|||
13411532|NCT00530816|26835579|FG000|Overall Study|Withdrawal by Subject|1|||
13411533|NCT00530816|26835580|FG001|Overall Study|Withdrawal by Subject|2|||
13411534|NCT00530816|26835581|FG002|Overall Study|Withdrawal by Subject|6|||
13411535|NCT00530790|26835603|FG000|Overall Study|Adverse Event|2|||
13411536|NCT00530790|26835603|FG000|Overall Study|Withdrawal by Subject|2|||
13411537|NCT00530790|26835603|FG000|Overall Study|Physician Decision|1|||
13411538|NCT00530777|26835618|FG000|Overall Study|Lost to Follow-up|0|||
13411539|NCT00530777|26835619|FG001|Overall Study|Lost to Follow-up|1|||
13411540|NCT00530777|26835618|FG000|Overall Study|Death|1|||
13411541|NCT00530777|26835619|FG001|Overall Study|Death|2|||
13411542|NCT00530777|26835618|FG000|Overall Study|Physician Decision|1|||
13411543|NCT00530777|26835619|FG001|Overall Study|Physician Decision|0|||
13411544|NCT00530777|26835618|FG000|Overall Study|Withdrawal by Subject|0|||
13411545|NCT00530777|26835619|FG001|Overall Study|Withdrawal by Subject|1|||
13411546|NCT00530777|26835618|FG000|Overall Study|Unable to adhere to visit schedule|5|||
13411547|NCT00530777|26835619|FG001|Overall Study|Unable to adhere to visit schedule|1|||
13411548|NCT00530712|26835638|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2|||
13411549|NCT00530712|26835638|FG000|30 Day Follow-up Visit|Missed Visit|5|||
13411550|NCT00530712|26835638|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4|||
13411551|NCT00530712|26835638|FG000|6 Month Follow-up Visit|Missed Visit|3|||
13411552|NCT00530712|26835638|FG000|6 Month Follow-up Visit|Lost to Follow-up|3|||
13411553|NCT00530712|26835638|FG000|6 Month Follow-up Visit|Death|2|||
13411554|NCT00530712|26835638|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5|||
13411555|NCT00530712|26835638|FG000|12 Month Follow-up Visit|Missed Visit|3|||
13411556|NCT00530712|26835638|FG000|12 Month Follow-up Visit|Lost to Follow-up|7|||
13411557|NCT00530712|26835638|FG000|12 Month Follow-up Visit|Death|9|||
13411558|NCT00530621|26835666|FG000|Overall Study|Adverse Event|11|||
13411559|NCT00530621|26835667|FG001|Overall Study|Adverse Event|8|||
13411560|NCT00530621|26835666|FG000|Overall Study|Physician Decision|2|||
13411561|NCT00530621|26835667|FG001|Overall Study|Physician Decision|4|||
13411562|NCT00530621|26835666|FG000|Overall Study|Progressive Disease (PD)|47|||
13411563|NCT00530621|26835667|FG001|Overall Study|Progressive Disease (PD)|40|||
13411564|NCT00530621|26835666|FG000|Overall Study|Sponsor Decision|12|||
13411565|NCT00530621|26835667|FG001|Overall Study|Sponsor Decision|15|||
13411566|NCT00530621|26835666|FG000|Overall Study|Subject Decision|4|||
13411567|NCT00530621|26835667|FG001|Overall Study|Subject Decision|7|||
13411568|NCT00530621|26835666|FG000|Overall Study|Death|3|||
13411569|NCT00530621|26835667|FG001|Overall Study|Death|6|||
13411570|NCT00530621|26835666|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1|||
13411571|NCT00530621|26835667|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0|||
13411572|NCT00530504|26835673|FG000|Overall Study|Death|54|||
13411573|NCT00530504|26835673|FG000|Overall Study|Lost to Follow-up|26|||
13411574|NCT00530504|26835673|FG000|Overall Study|Withdrawal by Subject|39|||
13411575|NCT00530504|26835673|FG000|Overall Study|Exited study due to other reasons|33|||
13411576|NCT00530439|26835686|FG000|Overall Study|GDM|9|||
13411577|NCT00530439|26835687|FG001|Overall Study|GDM|3|||
13411578|NCT00530439|26835686|FG000|Overall Study|Withdraw|18|||
13411579|NCT00530439|26835687|FG001|Overall Study|Withdraw|14|||
13411580|NCT00530439|26835686|FG000|Overall Study|Missed abortion|1|||
13411581|NCT00530439|26835687|FG001|Overall Study|Missed abortion|4|||
13411582|NCT00530439|26835686|FG000|Overall Study|Misclassification|2|||
13411583|NCT00530439|26835687|FG001|Overall Study|Misclassification|0|||
13411584|NCT00530439|26835686|FG000|Overall Study|Twin pregnancy|0|||
13411585|NCT00530439|26835687|FG001|Overall Study|Twin pregnancy|2|||
13411586|NCT00530439|26835686|FG000|Overall Study|Severe malformation/abortion|0|||
13411587|NCT00530439|26835687|FG001|Overall Study|Severe malformation/abortion|3|||
13411588|NCT00530348|26835710|FG000|Overall Study|Adverse Event|5|||
13411589|NCT00530348|26835711|FG001|Overall Study|Adverse Event|1|||
13411590|NCT00530348|26835710|FG000|Overall Study|Death|0|||
13411591|NCT00530348|26835711|FG001|Overall Study|Death|1|||
13411592|NCT00530348|26835710|FG000|Overall Study|Lack of Efficacy|2|||
13411593|NCT00530348|26835711|FG001|Overall Study|Lack of Efficacy|0|||
13411594|NCT00530348|26835710|FG000|Overall Study|Lost to Follow-up|0|||
13411595|NCT00530348|26835711|FG001|Overall Study|Lost to Follow-up|2|||
13411596|NCT00530348|26835710|FG000|Overall Study|Physician Decision|1|||
13411597|NCT00530348|26835711|FG001|Overall Study|Physician Decision|2|||
13411598|NCT00530348|26835710|FG000|Overall Study|Pregnancy|1|||
13411599|NCT00530348|26835711|FG001|Overall Study|Pregnancy|0|||
13411600|NCT00530348|26835710|FG000|Overall Study|Withdrawal by Subject|12|||
13411601|NCT00530348|26835711|FG001|Overall Study|Withdrawal by Subject|12|||
13411602|NCT00530348|26835710|FG000|Overall Study|Randomised in error|1|||
13411603|NCT00530348|26835711|FG001|Overall Study|Randomised in error|0|||
13411604|NCT00530348|26835710|FG000|Overall Study|Noncompliance with inclusion criterion 3|0|||
13411605|NCT00530348|26835711|FG001|Overall Study|Noncompliance with inclusion criterion 3|1|||
13411606|NCT00530335|26835728|FG000|Overall Study|Adverse Event|3|||
13411607|NCT00530335|26835728|FG000|Overall Study|Protocol Violation|1|||
13411608|NCT00530335|26835728|FG000|Overall Study|Withdrawal by Subject|1|||
13411609|NCT00530335|26835728|FG000|Overall Study|Physician Decision|1|||
13411610|NCT00530270|26835749|FG000|Overall Study|Protocol Violation|1|||
13411611|NCT00530270|26835750|FG001|Overall Study|Protocol Violation|0|||
13411612|NCT00530257|26835780|FG000|Overall Study|Lost to Follow-up|1|||
13411613|NCT00530218|26835789|FG000|Overall Study|CMV Not Detected|13|||
13411614|NCT00530218|26835789|FG000|Overall Study|Death|12|||
13411615|NCT00530088|26835796|FG000|Overall Study|Disease Progression|4|||
13411616|NCT00530088|26835796|FG000|Overall Study|Physician Decision|4|||
13411617|NCT00530088|26835796|FG000|Overall Study|Other Not Specified|2|||
13411618|NCT00530075|26835809|FG000|Overall Study|Adverse Event|1|||
13411619|NCT00530075|26835809|FG000|Overall Study|Death|1|||
13411620|NCT00530075|26835809|FG000|Overall Study|Lack of Efficacy|3|||
13411621|NCT00530075|26835809|FG000|Overall Study|Protocol Violation|1|||
13411622|NCT00530075|26835809|FG000|Overall Study|Withdrawal by Subject|1|||
13411623|NCT00530023|26835830|FG000|Overall Study|Withdrawal by Subject|0|||
13411624|NCT00530023|26835831|FG001|Overall Study|Withdrawal by Subject|1|||
13411625|NCT00529958|26835882|FG000|2-Year Follow-up|Lost to Follow-up|1|||
13411626|NCT00529958|26835883|FG001|2-Year Follow-up|Lost to Follow-up|2|||
13411627|NCT00529958|26835884|FG002|2-Year Follow-up|Lost to Follow-up|2|||
13411628|NCT00529958|26835882|FG000|2-Year Follow-up|Withdrawal by Subject|3|||
13411629|NCT00529958|26835883|FG001|2-Year Follow-up|Withdrawal by Subject|0|||
13411630|NCT00529958|26835884|FG002|2-Year Follow-up|Withdrawal by Subject|0|||
13411631|NCT00529958|26835882|FG000|5-Year Follow-up|Lost to Follow-up|2|||
13411632|NCT00529958|26835883|FG001|5-Year Follow-up|Lost to Follow-up|3|||
13411633|NCT00529958|26835884|FG002|5-Year Follow-up|Lost to Follow-up|1|||
13411634|NCT00529958|26835882|FG000|5-Year Follow-up|Withdrawal by Subject|1|||
13411635|NCT00529958|26835883|FG001|5-Year Follow-up|Withdrawal by Subject|0|||
13411636|NCT00529958|26835884|FG002|5-Year Follow-up|Withdrawal by Subject|0|||
13411637|NCT00529802|26835892|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3|||
13411638|NCT00529802|26835892|FG000|Evaluable for Primary Endpoint|Worsening performance status|2|||
13411639|NCT00529802|26835892|FG000|Evaluable for Primary Endpoint|Adverse Event|2|||
13411640|NCT00529802|26835892|FG000|Evaluable for Primary Endpoint|Death|1|||
13411641|NCT00529802|26835892|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1|||
13411642|NCT00529802|26835892|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1|||
13411643|NCT00529802|26835892|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2|||
13411644|NCT00529789|26835916|FG000|Study Period II/III|Parent/Caregiver Decision|9|||
13411645|NCT00529789|26835916|FG000|Study Period II/III|Adverse Event|3|||
13411646|NCT00529789|26835916|FG000|Study Period II/III|Lack of Efficacy|2|||
13411647|NCT00529789|26835916|FG000|Study Period II/III|Withdrawal by Subject|1|||
13411648|NCT00529789|26835916|FG000|Study Period II/III|Protocol Violation|3|||
13411649|NCT00529789|26835916|FG000|Study Period II/III|Physician Decision|3|||
13411650|NCT00529789|26835916|FG000|Study Period II/III|Lost to Follow-up|3|||
13411651|NCT00529789|26835916|FG000|Study Period IV|Parent/Caregiver Decision|1|||
13411652|NCT00529789|26835916|FG000|Study Period IV|Adverse Event|1|||
13411653|NCT00529789|26835916|FG000|Study Period IV|Lack of Efficacy|1|||
13411654|NCT00529789|26835916|FG000|Study Period IV|Lost to Follow-up|3|||
13411655|NCT00529763|26835962|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
13411656|NCT00529763|26835963|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
13411657|NCT00529763|26835964|FG002|Overall Study|Adverse Event Unrelated to Study Drug|1|||
13411658|NCT00529763|26835962|FG000|Overall Study|Death|0|||
13411659|NCT00529763|26835963|FG001|Overall Study|Death|1|||
13411660|NCT00529763|26835964|FG002|Overall Study|Death|1|||
13411661|NCT00529763|26835962|FG000|Overall Study|Disease Progression|6|||
13411662|NCT00529763|26835963|FG001|Overall Study|Disease Progression|16|||
13411663|NCT00529763|26835964|FG002|Overall Study|Disease Progression|1|||
13411664|NCT00529763|26835962|FG000|Overall Study|Lost to Follow-up|0|||
13411665|NCT00529763|26835963|FG001|Overall Study|Lost to Follow-up|1|||
13411666|NCT00529763|26835964|FG002|Overall Study|Lost to Follow-up|1|||
13411667|NCT00529763|26835962|FG000|Overall Study|Stem Cell Transplant|0|||
13411668|NCT00529763|26835963|FG001|Overall Study|Stem Cell Transplant|3|||
13411669|NCT00529763|26835964|FG002|Overall Study|Stem Cell Transplant|0|||
13411670|NCT00529763|26835962|FG000|Overall Study|Study Drug Toxicity|1|||
13411671|NCT00529763|26835963|FG001|Overall Study|Study Drug Toxicity|6|||
13411672|NCT00529763|26835964|FG002|Overall Study|Study Drug Toxicity|1|||
13411673|NCT00529763|26835962|FG000|Overall Study|Patient Withdrew Consent|2|||
13411674|NCT00529763|26835963|FG001|Overall Study|Patient Withdrew Consent|3|||
13411675|NCT00529763|26835964|FG002|Overall Study|Patient Withdrew Consent|2|||
13411676|NCT00529659|26835987|FG000|Overall Study|Adverse Event|8|||
13411677|NCT00529659|26835988|FG001|Overall Study|Adverse Event|7|||
13411678|NCT00529659|26835987|FG000|Overall Study|Lost to Follow-up|0|||
13411679|NCT00529659|26835988|FG001|Overall Study|Lost to Follow-up|2|||
13411680|NCT00529659|26835987|FG000|Overall Study|Physician Decision|0|||
13411681|NCT00529659|26835988|FG001|Overall Study|Physician Decision|2|||
13411682|NCT00529659|26835987|FG000|Overall Study|Protocol Violation|2|||
13411683|NCT00529659|26835988|FG001|Overall Study|Protocol Violation|6|||
13411684|NCT00529659|26835987|FG000|Overall Study|Withdrawal by Subject|1|||
13411685|NCT00529659|26835988|FG001|Overall Study|Withdrawal by Subject|6|||
13411686|NCT00529633|26836005|FG000|Overall Study|Withdrawal by Subject|1|||
13411687|NCT00529633|26836006|FG001|Overall Study|Withdrawal by Subject|1|||
13411688|NCT00529568|26836062|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5|||
13411689|NCT00529568|26836063|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
13411690|NCT00529568|26836064|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
13411691|NCT00529568|26836062|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12|||
13411692|NCT00529568|26836063|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
13411693|NCT00529568|26836064|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
13411694|NCT00529568|26836062|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5|||
13411695|NCT00529568|26836063|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
13411696|NCT00529568|26836064|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
13411697|NCT00529568|26836062|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8|||
13411698|NCT00529568|26836063|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
13411699|NCT00529568|26836064|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
13411700|NCT00529568|26836062|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13|||
13411701|NCT00529568|26836063|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
13411702|NCT00529568|26836064|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
13411703|NCT00529568|26836062|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3|||
13411704|NCT00529568|26836063|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
13411705|NCT00529568|26836064|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
13411706|NCT00529568|26836062|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0|||
13411707|NCT00529568|26836063|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10|||
13411708|NCT00529568|26836064|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27|||
13411709|NCT00529568|26836062|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
13411710|NCT00529568|26836063|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1|||
13411711|NCT00529568|26836064|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
13411712|NCT00529568|26836062|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0|||
13411713|NCT00529568|26836063|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15|||
13411714|NCT00529568|26836064|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48|||
13411715|NCT00529568|26836062|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0|||
13411716|NCT00529568|26836063|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5|||
13411717|NCT00529568|26836064|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8|||
13411718|NCT00529568|26836062|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0|||
13411719|NCT00529568|26836063|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17|||
13411720|NCT00529568|26836064|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19|||
13411721|NCT00529542|26836111|FG000|Overall Study|Withdrawal by Subject|1|||
13411722|NCT00529542|26836112|FG001|Overall Study|Withdrawal by Subject|0|||
13411723|NCT00529542|26836111|FG000|Overall Study|Lost to Follow-up|0|||
13411724|NCT00529542|26836112|FG001|Overall Study|Lost to Follow-up|1|||
13411725|NCT00529529|26836178|FG000|Overall Study|Adverse Event|12|||
13411726|NCT00529529|26836179|FG001|Overall Study|Adverse Event|17|||
13411727|NCT00529529|26836180|FG002|Overall Study|Adverse Event|8|||
13411728|NCT00529529|26836178|FG000|Overall Study|Subject withdrew consent|12|||
13411729|NCT00529529|26836179|FG001|Overall Study|Subject withdrew consent|9|||
13411730|NCT00529529|26836180|FG002|Overall Study|Subject withdrew consent|12|||
13411731|NCT00529529|26836178|FG000|Overall Study|Protocol deviation|8|||
13411732|NCT00529529|26836179|FG001|Overall Study|Protocol deviation|12|||
13411733|NCT00529529|26836180|FG002|Overall Study|Protocol deviation|5|||
13411734|NCT00529529|26836178|FG000|Overall Study|Lost to Follow-up|5|||
13411735|NCT00529529|26836179|FG001|Overall Study|Lost to Follow-up|3|||
13411736|NCT00529529|26836180|FG002|Overall Study|Lost to Follow-up|1|||
13411737|NCT00529529|26836178|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
13411738|NCT00529529|26836179|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
13411739|NCT00529529|26836180|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
13411740|NCT00529529|26836178|FG000|Overall Study|Death|2|||
13411741|NCT00529529|26836179|FG001|Overall Study|Death|0|||
13411742|NCT00529529|26836180|FG002|Overall Study|Death|0|||
13411743|NCT00529529|26836178|FG000|Overall Study|Abnormal test procedure result(s)|1|||
13411744|NCT00529529|26836179|FG001|Overall Study|Abnormal test procedure result(s)|0|||
13411745|NCT00529529|26836180|FG002|Overall Study|Abnormal test procedure result(s)|0|||
13411746|NCT00529529|26836178|FG000|Overall Study|Administrative problems|1|||
13411747|NCT00529529|26836179|FG001|Overall Study|Administrative problems|0|||
13411748|NCT00529529|26836180|FG002|Overall Study|Administrative problems|3|||
13411749|NCT00529516|26836258|FG000|Overall Study|Adverse Event|2|||
13411750|NCT00529516|26836259|FG001|Overall Study|Adverse Event|1|||
13411751|NCT00529516|26836260|FG002|Overall Study|Adverse Event|0|||
13411752|NCT00529516|26836258|FG000|Overall Study|Withdrawal by Subject|1|||
13411753|NCT00529516|26836259|FG001|Overall Study|Withdrawal by Subject|1|||
13411754|NCT00529516|26836260|FG002|Overall Study|Withdrawal by Subject|0|||
13411755|NCT00529516|26836258|FG000|Overall Study|Lost to Follow-up|0|||
13411756|NCT00529516|26836259|FG001|Overall Study|Lost to Follow-up|0|||
13411757|NCT00529516|26836260|FG002|Overall Study|Lost to Follow-up|1|||
13411758|NCT00529451|26836297|FG000|Overall Study|Subject withdrew consent|16|||
13411759|NCT00529451|26836298|FG001|Overall Study|Subject withdrew consent|21|||
13411760|NCT00529451|26836299|FG002|Overall Study|Subject withdrew consent|13|||
13411761|NCT00529451|26836300|FG003|Overall Study|Subject withdrew consent|12|||
13411762|NCT00529451|26836297|FG000|Overall Study|Adverse Event|9|||
13411763|NCT00529451|26836298|FG001|Overall Study|Adverse Event|16|||
13411764|NCT00529451|26836299|FG002|Overall Study|Adverse Event|14|||
13411765|NCT00529451|26836300|FG003|Overall Study|Adverse Event|8|||
13411766|NCT00529451|26836297|FG000|Overall Study|Unsatisfactory therapeutic response|6|||
13411767|NCT00529451|26836298|FG001|Overall Study|Unsatisfactory therapeutic response|2|||
13411768|NCT00529451|26836299|FG002|Overall Study|Unsatisfactory therapeutic response|5|||
13411769|NCT00529451|26836300|FG003|Overall Study|Unsatisfactory therapeutic response|4|||
13411770|NCT00529451|26836297|FG000|Overall Study|Lost to Follow-up|4|||
13411771|NCT00529451|26836298|FG001|Overall Study|Lost to Follow-up|7|||
13411772|NCT00529451|26836299|FG002|Overall Study|Lost to Follow-up|4|||
13411773|NCT00529451|26836300|FG003|Overall Study|Lost to Follow-up|4|||
13411774|NCT00529451|26836297|FG000|Overall Study|Protocol deviation|1|||
13411775|NCT00529451|26836298|FG001|Overall Study|Protocol deviation|1|||
13411776|NCT00529451|26836299|FG002|Overall Study|Protocol deviation|4|||
13411777|NCT00529451|26836300|FG003|Overall Study|Protocol deviation|1|||
13411778|NCT00529451|26836297|FG000|Overall Study|Administrative problems|1|||
13411779|NCT00529451|26836298|FG001|Overall Study|Administrative problems|1|||
13411780|NCT00529451|26836299|FG002|Overall Study|Administrative problems|0|||
13411781|NCT00529451|26836300|FG003|Overall Study|Administrative problems|2|||
13411782|NCT00529399|26836318|FG000|Overall Study|Lost to Follow-up|1|||
13411783|NCT00529399|26836319|FG001|Overall Study|Lost to Follow-up|0|||
13411784|NCT00529399|26836320|FG002|Overall Study|Lost to Follow-up|1|||
13411785|NCT00529399|26836318|FG000|Overall Study|Withdrawal by Subject|1|||
13411786|NCT00529399|26836319|FG001|Overall Study|Withdrawal by Subject|0|||
13411787|NCT00529399|26836320|FG002|Overall Study|Withdrawal by Subject|1|||
13411788|NCT00529399|26836318|FG000|Overall Study|Non-compliant|0|||
13411789|NCT00529399|26836319|FG001|Overall Study|Non-compliant|1|||
13411790|NCT00529399|26836320|FG002|Overall Study|Non-compliant|0|||
13411791|NCT00529386|26836326|FG000|Overall Study|Lost to Follow-up|1|||
13411792|NCT00529373|26836525|FG000|Base Study|Adverse Event|525|||
13411793|NCT00529373|26836526|FG001|Base Study|Adverse Event|470|||
13411794|NCT00529373|26836525|FG000|Base Study|Lack of Efficacy|16|||
13411795|NCT00529373|26836526|FG001|Base Study|Lack of Efficacy|75|||
13411796|NCT00529373|26836525|FG000|Base Study|Lost to Follow-up|221|||
13411797|NCT00529373|26836526|FG001|Base Study|Lost to Follow-up|208|||
13411798|NCT00529373|26836525|FG000|Base Study|Other Protocol Specified Criteria|19|||
13411799|NCT00529373|26836526|FG001|Base Study|Other Protocol Specified Criteria|20|||
13411800|NCT00529373|26836525|FG000|Base Study|Physician Decision|60|||
13411801|NCT00529373|26836526|FG001|Base Study|Physician Decision|52|||
13411802|NCT00529373|26836525|FG000|Base Study|Protocol Violation|48|||
13411803|NCT00529373|26836526|FG001|Base Study|Protocol Violation|38|||
13411804|NCT00529373|26836525|FG000|Base Study|Withdrawal by Subject|1062|||
13411805|NCT00529373|26836526|FG001|Base Study|Withdrawal by Subject|967|||
13411806|NCT00529373|26836525|FG000|Base Study|Did not continue into Extension|1795|||
13411807|NCT00529373|26836526|FG001|Base Study|Did not continue into Extension|2238|||
13411808|NCT00529373|26836525|FG000|First Extension Study|Adverse Event|162|||
13411809|NCT00529373|26836526|FG001|First Extension Study|Adverse Event|142|||
13411810|NCT00529373|26836525|FG000|First Extension Study|Lack of Efficacy|65|||
13411811|NCT00529373|26836526|FG001|First Extension Study|Lack of Efficacy|427|||
13411812|NCT00529373|26836525|FG000|First Extension Study|Lost to Follow-up|41|||
13411813|NCT00529373|26836526|FG001|First Extension Study|Lost to Follow-up|37|||
13411814|NCT00529373|26836525|FG000|First Extension Study|Other|27|||
13411815|NCT00529373|26836526|FG001|First Extension Study|Other|47|||
13411816|NCT00529373|26836525|FG000|First Extension Study|Physician Decision|50|||
13411817|NCT00529373|26836526|FG001|First Extension Study|Physician Decision|45|||
13411818|NCT00529373|26836525|FG000|First Extension Study|Protocol Violation|16|||
13411819|NCT00529373|26836526|FG001|First Extension Study|Protocol Violation|13|||
13411820|NCT00529373|26836525|FG000|First Extension Study|Withdrawal by Subject|296|||
13411821|NCT00529373|26836526|FG001|First Extension Study|Withdrawal by Subject|287|||
13411822|NCT00529373|26836525|FG000|First Extension Study|Disposition record non-existing|0|||
13411823|NCT00529373|26836526|FG001|First Extension Study|Disposition record non-existing|1|||
13411824|NCT00529373|26836525|FG000|First Extension Study|Discontinued after 5 years completion|208|||
13411825|NCT00529373|26836526|FG001|First Extension Study|Discontinued after 5 years completion|346|||
13411826|NCT00529373|26836525|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256|||
13411827|NCT00529373|26836526|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281|||
13411828|NCT00529373|26836525|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32|||
13411829|NCT00529373|26836526|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25|||
13411830|NCT00529373|26836525|FG000|Second Extension Study|Adverse Event|101|||
13411831|NCT00529373|26836526|FG001|Second Extension Study|Adverse Event|51|||
13411832|NCT00529373|26836525|FG000|Second Extension Study|Lack of Efficacy|7|||
13411833|NCT00529373|26836526|FG001|Second Extension Study|Lack of Efficacy|15|||
13411834|NCT00529373|26836525|FG000|Second Extension Study|Lost to Follow-up|18|||
13411835|NCT00529373|26836526|FG001|Second Extension Study|Lost to Follow-up|12|||
13411836|NCT00529373|26836525|FG000|Second Extension Study|Other|7|||
13411837|NCT00529373|26836526|FG001|Second Extension Study|Other|12|||
13411838|NCT00529373|26836525|FG000|Second Extension Study|Physician Decision|63|||
13411839|NCT00529373|26836526|FG001|Second Extension Study|Physician Decision|26|||
13411840|NCT00529373|26836525|FG000|Second Extension Study|Protocol Violation|2|||
13411841|NCT00529373|26836526|FG001|Second Extension Study|Protocol Violation|1|||
13411842|NCT00529373|26836525|FG000|Second Extension Study|Withdrawal by Subject|97|||
13411843|NCT00529373|26836526|FG001|Second Extension Study|Withdrawal by Subject|75|||
13411844|NCT00529373|26836525|FG000|Second Extension Study|Status Missing|5|||
13411845|NCT00529373|26836526|FG001|Second Extension Study|Status Missing|5|||
13411846|NCT00529308|26836547|FG000|Overall Study|Withdrawal by Subject|1|||
13411847|NCT00529308|26836548|FG001|Overall Study|Withdrawal by Subject|1|||
13411848|NCT00529243|26836555|FG000|Overall Study|Adverse Event|1|||
13411849|NCT00529243|26836555|FG000|Overall Study|Death|1|||
13411850|NCT00529243|26836555|FG000|Overall Study|Relocated|1|||
13411851|NCT00529217|26836562|FG000|Overall Study|Lack of Efficacy|2|||
13411852|NCT00529217|26836562|FG000|Overall Study|Unable to adhere to study schedule|2|||
13411853|NCT00529100|26836585|FG000|Overall Study|Adverse Event|0|||
13411854|NCT00529100|26836586|FG001|Overall Study|Adverse Event|5|||
13411855|NCT00529100|26836585|FG000|Overall Study|Protocol Violation|0|||
13411856|NCT00529100|26836586|FG001|Overall Study|Protocol Violation|1|||
13411857|NCT00529100|26836585|FG000|Overall Study|Progressive Disease|0|||
13411858|NCT00529100|26836586|FG001|Overall Study|Progressive Disease|1|||
13411859|NCT00529100|26836585|FG000|Overall Study|Withdrawal by Subject|0|||
13411860|NCT00529100|26836586|FG001|Overall Study|Withdrawal by Subject|1|||
13411861|NCT00529100|26836585|FG000|Overall Study|Participant Ineligibility|0|||
13411862|NCT00529100|26836586|FG001|Overall Study|Participant Ineligibility|1|||
13411863|NCT00529087|26836660|FG000|Overall Study|Adverse Event|10|||
13411864|NCT00529087|26836661|FG001|Overall Study|Adverse Event|13|||
13411865|NCT00529087|26836662|FG002|Overall Study|Adverse Event|4|||
13411866|NCT00529087|26836660|FG000|Overall Study|Lost to Follow-up|6|||
13411867|NCT00529087|26836661|FG001|Overall Study|Lost to Follow-up|4|||
13411868|NCT00529087|26836662|FG002|Overall Study|Lost to Follow-up|1|||
13411869|NCT00529087|26836660|FG000|Overall Study|Protocol Violation|8|||
13411870|NCT00529087|26836661|FG001|Overall Study|Protocol Violation|7|||
13411871|NCT00529087|26836662|FG002|Overall Study|Protocol Violation|6|||
13411872|NCT00529087|26836660|FG000|Overall Study|Withdrawal by Subject|3|||
13411873|NCT00529087|26836661|FG001|Overall Study|Withdrawal by Subject|3|||
13411874|NCT00529087|26836662|FG002|Overall Study|Withdrawal by Subject|3|||
13411875|NCT00529087|26836660|FG000|Overall Study|Protocol deviation|1|||
13411876|NCT00529087|26836661|FG001|Overall Study|Protocol deviation|1|||
13411877|NCT00529087|26836662|FG002|Overall Study|Protocol deviation|2|||
13411878|NCT00529035|26836675|FG000|Overall Study|Withdrawal by Subject|1|||
13411879|NCT00528996|26836853|FG000|Overall Study|Other reasons than listing|6|||
13411880|NCT00528996|26836854|FG001|Overall Study|Other reasons than listing|7|||
13411881|NCT00528996|26836855|FG002|Overall Study|Other reasons than listing|14|||
13411882|NCT00528996|26836856|FG003|Overall Study|Other reasons than listing|11|||
13411883|NCT00528996|26836857|FG004|Overall Study|Other reasons than listing|5|||
13411884|NCT00528996|26836853|FG000|Overall Study|Refused continue medication|16|||
13411885|NCT00528996|26836854|FG001|Overall Study|Refused continue medication|0|||
13411886|NCT00528996|26836855|FG002|Overall Study|Refused continue medication|3|||
13411887|NCT00528996|26836856|FG003|Overall Study|Refused continue medication|3|||
13411888|NCT00528996|26836857|FG004|Overall Study|Refused continue medication|6|||
13411889|NCT00528996|26836853|FG000|Overall Study|Lost to Follow-up|2|||
13411890|NCT00528996|26836854|FG001|Overall Study|Lost to Follow-up|0|||
13411891|NCT00528996|26836855|FG002|Overall Study|Lost to Follow-up|4|||
13411892|NCT00528996|26836856|FG003|Overall Study|Lost to Follow-up|1|||
13411893|NCT00528996|26836857|FG004|Overall Study|Lost to Follow-up|3|||
13411894|NCT00528996|26836853|FG000|Overall Study|Protocol Violation|1|||
13411895|NCT00528996|26836854|FG001|Overall Study|Protocol Violation|2|||
13411896|NCT00528996|26836855|FG002|Overall Study|Protocol Violation|3|||
13411897|NCT00528996|26836856|FG003|Overall Study|Protocol Violation|3|||
13411898|NCT00528996|26836857|FG004|Overall Study|Protocol Violation|2|||
13411899|NCT00528996|26836853|FG000|Overall Study|Lack of Efficacy|7|||
13411900|NCT00528996|26836854|FG001|Overall Study|Lack of Efficacy|2|||
13411901|NCT00528996|26836855|FG002|Overall Study|Lack of Efficacy|1|||
13411902|NCT00528996|26836856|FG003|Overall Study|Lack of Efficacy|3|||
13411903|NCT00528996|26836857|FG004|Overall Study|Lack of Efficacy|3|||
13411904|NCT00528996|26836853|FG000|Overall Study|Adverse Event|32|||
13411905|NCT00528996|26836854|FG001|Overall Study|Adverse Event|13|||
13411906|NCT00528996|26836855|FG002|Overall Study|Adverse Event|18|||
13411907|NCT00528996|26836856|FG003|Overall Study|Adverse Event|29|||
13411908|NCT00528996|26836857|FG004|Overall Study|Adverse Event|18|||
13411909|NCT00528970|26836884|FG000|Overall Study|Adverse Event|6|||
13411910|NCT00528970|26836885|FG001|Overall Study|Adverse Event|8|||
13411911|NCT00528970|26836886|FG002|Overall Study|Adverse Event|5|||
13411912|NCT00528970|26836884|FG000|Overall Study|Lost to Follow-up|0|||
13411913|NCT00528970|26836885|FG001|Overall Study|Lost to Follow-up|0|||
13411914|NCT00528970|26836886|FG002|Overall Study|Lost to Follow-up|1|||
13411915|NCT00528970|26836884|FG000|Overall Study|Other than specified|2|||
13411916|NCT00528970|26836885|FG001|Overall Study|Other than specified|3|||
13411917|NCT00528970|26836886|FG002|Overall Study|Other than specified|3|||
13411918|NCT00528970|26836884|FG000|Overall Study|Protocol Violation|2|||
13411919|NCT00528970|26836885|FG001|Overall Study|Protocol Violation|1|||
13411920|NCT00528970|26836886|FG002|Overall Study|Protocol Violation|4|||
13411921|NCT00528970|26836884|FG000|Overall Study|Lack of Efficacy|0|||
13411922|NCT00528970|26836885|FG001|Overall Study|Lack of Efficacy|0|||
13411923|NCT00528970|26836886|FG002|Overall Study|Lack of Efficacy|1|||
13411924|NCT00528970|26836884|FG000|Overall Study|Withdrawal by Subject|4|||
13411925|NCT00528970|26836885|FG001|Overall Study|Withdrawal by Subject|3|||
13411926|NCT00528970|26836886|FG002|Overall Study|Withdrawal by Subject|5|||
13411927|NCT00528970|26836884|FG000|Overall Study|Randomized but not treated|0|||
13411928|NCT00528970|26836885|FG001|Overall Study|Randomized but not treated|0|||
13411929|NCT00528970|26836886|FG002|Overall Study|Randomized but not treated|1|||
13411930|NCT00528957|26837034|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2|||
13411931|NCT00528957|26837035|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1|||
13411932|NCT00528957|26837034|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2|||
13411933|NCT00528957|26837035|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0|||
13411934|NCT00528957|26837034|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2|||
13411935|NCT00528957|26837035|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0|||
13411936|NCT00528957|26837034|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1|||
13411937|NCT00528957|26837035|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0|||
13411938|NCT00528957|26837034|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0|||
13411939|NCT00528957|26837035|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1|||
13411940|NCT00528957|26837034|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4|||
13411941|NCT00528957|26837035|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3|||
13411942|NCT00528957|26837034|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3|||
13411943|NCT00528957|26837035|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0|||
13411944|NCT00528957|26837034|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5|||
13411945|NCT00528957|26837035|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4|||
13411946|NCT00528957|26837034|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0|||
13411947|NCT00528957|26837035|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3|||
13411948|NCT00528957|26837034|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
13411949|NCT00528957|26837035|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
13411950|NCT00528957|26837034|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0|||
13411951|NCT00528957|26837035|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1|||
13411952|NCT00528957|26837034|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0|||
13411953|NCT00528957|26837035|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1|||
13411954|NCT00528957|26837034|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4|||
13411955|NCT00528957|26837035|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10|||
13411956|NCT00528957|26837034|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3|||
13411957|NCT00528957|26837035|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5|||
13411958|NCT00528957|26837034|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2|||
13411959|NCT00528957|26837035|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1|||
13411960|NCT00528957|26837034|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
13411961|NCT00528957|26837035|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
13411962|NCT00528931|26837045|FG000|Overall Study|Lost to Follow-up|1|||
13411963|NCT00528879|26837124|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3|||
13476406|NCT01423851|27002852|FG005|Whole Study|Disease progression|3|||
13411964|NCT00528879|26837125|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
13411965|NCT00528879|26837126|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1|||
13411966|NCT00528879|26837127|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
13411967|NCT00528879|26837124|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
13411968|NCT00528879|26837125|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
13411969|NCT00528879|26837126|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2|||
13411970|NCT00528879|26837127|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
13411971|NCT00528879|26837124|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7|||
13411972|NCT00528879|26837125|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
13411973|NCT00528879|26837126|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
13411974|NCT00528879|26837127|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3|||
13411975|NCT00528879|26837124|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
13411976|NCT00528879|26837125|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
13411977|NCT00528879|26837126|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
13411978|NCT00528879|26837127|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
13411979|NCT00528879|26837124|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
13411980|NCT00528879|26837125|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
13411981|NCT00528879|26837126|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2|||
13411982|NCT00528879|26837127|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
13411983|NCT00528879|26837124|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
13411984|NCT00528879|26837125|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3|||
13411985|NCT00528879|26837126|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
13411986|NCT00528879|26837127|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
13411987|NCT00528879|26837124|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
13411988|NCT00528879|26837125|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
13411989|NCT00528879|26837126|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0|||
13411990|NCT00528879|26837127|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
13411991|NCT00528879|26837124|FG000|Short-term Period (Day 1 to Week 24)|Other|0|||
13411992|NCT00528879|26837125|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
13411993|NCT00528879|26837126|FG002|Short-term Period (Day 1 to Week 24)|Other|1|||
13411994|NCT00528879|26837127|FG003|Short-term Period (Day 1 to Week 24)|Other|1|||
13411995|NCT00528879|26837124|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27|||
13411996|NCT00528879|26837125|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16|||
13411997|NCT00528879|26837126|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17|||
13411998|NCT00528879|26837127|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9|||
13411999|NCT00528879|26837124|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5|||
13412000|NCT00528879|26837125|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4|||
13412001|NCT00528879|26837126|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3|||
13412002|NCT00528879|26837127|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2|||
13412003|NCT00528879|26837124|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
13412004|NCT00528879|26837125|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6|||
13412005|NCT00528879|26837126|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8|||
13412006|NCT00528879|26837127|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
13412007|NCT00528879|26837124|FG000|Long-term Period (Weeks 24 to 102)|Death|0|||
13412008|NCT00528879|26837125|FG001|Long-term Period (Weeks 24 to 102)|Death|1|||
13412009|NCT00528879|26837126|FG002|Long-term Period (Weeks 24 to 102)|Death|0|||
13412010|NCT00528879|26837127|FG003|Long-term Period (Weeks 24 to 102)|Death|0|||
13412011|NCT00528879|26837124|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4|||
13412012|NCT00528879|26837125|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5|||
13412013|NCT00528879|26837126|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3|||
13412014|NCT00528879|26837127|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7|||
13412015|NCT00528879|26837124|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0|||
13412016|NCT00528879|26837125|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5|||
13412017|NCT00528879|26837126|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1|||
13412018|NCT00528879|26837127|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2|||
13412019|NCT00528879|26837124|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1|||
13412020|NCT00528879|26837125|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
13412021|NCT00528879|26837126|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
13412022|NCT00528879|26837127|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
13412023|NCT00528879|26837124|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
13412024|NCT00528879|26837125|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
13412025|NCT00528879|26837126|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
13412026|NCT00528879|26837127|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0|||
13412027|NCT00528866|26837142|FG000|Overall Study|Protocol Violation|6|||
13412028|NCT00528840|26837156|FG000|Overall Study|Lost to Follow-up|10|||
13412029|NCT00528840|26837156|FG000|Overall Study|Adverse Event|1|||
13412030|NCT00528840|26837156|FG000|Overall Study|Withdrawal by Subject|17|||
13412031|NCT00528840|26837156|FG000|Overall Study|Death|2|||
13412032|NCT00528840|26837156|FG000|Overall Study|Administrative Reasons|1|||
13412033|NCT00528840|26837156|FG000|Overall Study|Other|2|||
13412034|NCT00528801|26837173|FG000|Overall Study|Withdrawal by Subject|1|||
13412035|NCT00528801|26837174|FG001|Overall Study|Withdrawal by Subject|1|||
13412036|NCT00528801|26837173|FG000|Overall Study|Protocol Violation|11|||
13412037|NCT00528801|26837174|FG001|Overall Study|Protocol Violation|5|||
13412038|NCT00528801|26837173|FG000|Overall Study|Lost to Follow-up|15|||
13412039|NCT00528801|26837174|FG001|Overall Study|Lost to Follow-up|4|||
13412040|NCT00528801|26837173|FG000|Overall Study|Administrative Reasons|0|||
13412041|NCT00528801|26837174|FG001|Overall Study|Administrative Reasons|1|||
13412042|NCT00528775|26837184|FG000|Overall Study|Other not specified|1|||
13412043|NCT00528645|26837193|FG000|Overall Study|Adverse Event|3|||
13412044|NCT00528606|26837222|FG000|Overall Study|Withdrew consent|4|||
13412045|NCT00528606|26837223|FG001|Overall Study|Withdrew consent|3|||
13412046|NCT00528606|26837222|FG000|Overall Study|Lost to Follow-up|4|||
13412047|NCT00528606|26837223|FG001|Overall Study|Lost to Follow-up|1|||
13412048|NCT00528606|26837222|FG000|Overall Study|Adverse Event|3|||
13412049|NCT00528606|26837223|FG001|Overall Study|Adverse Event|0|||
13412050|NCT00528606|26837222|FG000|Overall Study|Other|2|||
13412051|NCT00528606|26837223|FG001|Overall Study|Other|0|||
13412052|NCT00528567|26837268|FG000|Overall Study|Death|4|||
13412053|NCT00528567|26837269|FG001|Overall Study|Death|5|||
13412054|NCT00528567|26837268|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30|||
13412055|NCT00528567|26837269|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60|||
13412056|NCT00528567|26837268|FG000|Overall Study|Adverse Event/Intermittent Illness|255|||
13412057|NCT00528567|26837269|FG001|Overall Study|Adverse Event/Intermittent Illness|29|||
13412058|NCT00528567|26837268|FG000|Overall Study|Violation Criteria at Entry|3|||
13412059|NCT00528567|26837269|FG001|Overall Study|Violation Criteria at Entry|17|||
13412060|NCT00528567|26837268|FG000|Overall Study|Withdrew Consent|59|||
13412061|NCT00528567|26837269|FG001|Overall Study|Withdrew Consent|55|||
13412062|NCT00528567|26837268|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52|||
13412063|NCT00528567|26837269|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42|||
13412064|NCT00528567|26837268|FG000|Overall Study|Failure to Return|1|||
13412065|NCT00528567|26837269|FG001|Overall Study|Failure to Return|4|||
13412066|NCT00528567|26837268|FG000|Overall Study|Other Protocol Violation|5|||
13412067|NCT00528567|26837269|FG001|Overall Study|Other Protocol Violation|21|||
13412068|NCT00528567|26837268|FG000|Overall Study|Administrative/Other|22|||
13412069|NCT00528567|26837269|FG001|Overall Study|Administrative/Other|75|||
13412070|NCT00528528|26837316|FG000|Overall Study|Lost to Follow-up|0|||
13412071|NCT00528528|26837317|FG001|Overall Study|Lost to Follow-up|0|||
13412072|NCT00528528|26837318|FG002|Overall Study|Lost to Follow-up|1|||
13412073|NCT00528528|26837319|FG003|Overall Study|Lost to Follow-up|1|||
13412074|NCT00528528|26837316|FG000|Overall Study|Ineligible to continue the trial|0|||
13412075|NCT00528528|26837317|FG001|Overall Study|Ineligible to continue the trial|0|||
13412076|NCT00528528|26837318|FG002|Overall Study|Ineligible to continue the trial|0|||
13412077|NCT00528528|26837319|FG003|Overall Study|Ineligible to continue the trial|1|||
13412078|NCT00528528|26837316|FG000|Overall Study|Other|0|||
13412079|NCT00528528|26837317|FG001|Overall Study|Other|1|||
13412080|NCT00528528|26837318|FG002|Overall Study|Other|0|||
13412081|NCT00528528|26837319|FG003|Overall Study|Other|0|||
13412082|NCT00528528|26837316|FG000|Overall Study|Withdrawal by Subject|3|||
13412083|NCT00528528|26837317|FG001|Overall Study|Withdrawal by Subject|2|||
13412084|NCT00528528|26837318|FG002|Overall Study|Withdrawal by Subject|1|||
13412085|NCT00528528|26837319|FG003|Overall Study|Withdrawal by Subject|1|||
13412086|NCT00528528|26837316|FG000|Overall Study|Ongoing participant|0|||
13412087|NCT00528528|26837317|FG001|Overall Study|Ongoing participant|0|||
13412088|NCT00528528|26837318|FG002|Overall Study|Ongoing participant|1|||
13412089|NCT00528528|26837319|FG003|Overall Study|Ongoing participant|0|||
13412090|NCT00528424|26837333|FG000|Overall Study|Lost to Follow-up|13|||
13412091|NCT00528424|26837333|FG000|Overall Study|Withdrew consent|2|||
13412092|NCT00528424|26837333|FG000|Overall Study|Administrative reason|2|||
13412093|NCT00528424|26837333|FG000|Overall Study|Other|12|||
13412094|NCT00528411|26837466|FG000|Overall Study|Adverse Event|4|||
13412095|NCT00528411|26837467|FG001|Overall Study|Adverse Event|0|||
13412096|NCT00528411|26837468|FG002|Overall Study|Adverse Event|1|||
13412097|NCT00528411|26837466|FG000|Overall Study|Incorrect Enrolment|1|||
13412098|NCT00528411|26837467|FG001|Overall Study|Incorrect Enrolment|1|||
13412099|NCT00528411|26837468|FG002|Overall Study|Incorrect Enrolment|0|||
13412100|NCT00528411|26837466|FG000|Overall Study|Severe non-compliance to protocol|0|||
13412101|NCT00528411|26837467|FG001|Overall Study|Severe non-compliance to protocol|1|||
13412102|NCT00528411|26837468|FG002|Overall Study|Severe non-compliance to protocol|0|||
13412103|NCT00528411|26837466|FG000|Overall Study|Prior commitment medication|0|||
13412104|NCT00528411|26837467|FG001|Overall Study|Prior commitment medication|1|||
13412105|NCT00528411|26837468|FG002|Overall Study|Prior commitment medication|0|||
13412106|NCT00528372|26837608|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2|||
13412107|NCT00528372|26837609|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
13412108|NCT00528372|26837610|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
13412109|NCT00528372|26837611|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
13412110|NCT00528372|26837612|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
13412111|NCT00528372|26837613|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
13412112|NCT00528372|26837614|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
13412113|NCT00528372|26837615|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
13412114|NCT00528372|26837616|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
13412115|NCT00528372|26837608|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
13412116|NCT00528372|26837609|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
13412117|NCT00528372|26837610|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
13412118|NCT00528372|26837611|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6|||
13412119|NCT00528372|26837612|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
13412120|NCT00528372|26837613|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
13412121|NCT00528372|26837614|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
13412122|NCT00528372|26837615|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
13412123|NCT00528372|26837616|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
13412124|NCT00528372|26837608|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
13412125|NCT00528372|26837609|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
13412126|NCT00528372|26837610|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7|||
13412127|NCT00528372|26837611|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
13412128|NCT00528372|26837612|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
13412129|NCT00528372|26837613|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
13412130|NCT00528372|26837614|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
13412131|NCT00528372|26837615|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
13412132|NCT00528372|26837616|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
13412133|NCT00528372|26837608|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5|||
13412134|NCT00528372|26837609|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
13412135|NCT00528372|26837610|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
13412136|NCT00528372|26837611|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
13412137|NCT00528372|26837612|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
13412138|NCT00528372|26837613|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
13412139|NCT00528372|26837614|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
13412140|NCT00528372|26837615|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
13412141|NCT00528372|26837616|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
13412142|NCT00528372|26837608|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
13412143|NCT00528372|26837609|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
13412144|NCT00528372|26837610|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
13412145|NCT00528372|26837611|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2|||
13412146|NCT00528372|26837612|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
13412147|NCT00528372|26837613|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1|||
13412148|NCT00528372|26837614|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
13412149|NCT00528372|26837615|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
13412150|NCT00528372|26837616|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
13412151|NCT00528372|26837608|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
13412152|NCT00528372|26837609|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
13412153|NCT00528372|26837610|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
13412154|NCT00528372|26837611|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
13412155|NCT00528372|26837612|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
13412156|NCT00528372|26837613|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
13412157|NCT00528372|26837614|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
13412158|NCT00528372|26837615|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
13412159|NCT00528372|26837616|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
13412160|NCT00528372|26837608|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3|||
13412161|NCT00528372|26837609|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
13412162|NCT00528372|26837610|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
13412163|NCT00528372|26837611|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
13412164|NCT00528372|26837612|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
13412165|NCT00528372|26837613|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
13412166|NCT00528372|26837614|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
13412167|NCT00528372|26837615|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
13412168|NCT00528372|26837616|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
13412169|NCT00528372|26837608|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
13412170|NCT00528372|26837609|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
13412171|NCT00528372|26837610|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1|||
13412172|NCT00528372|26837611|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
13412173|NCT00528372|26837612|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
13412174|NCT00528372|26837613|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
13412175|NCT00528372|26837614|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2|||
13412176|NCT00528372|26837615|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
13412177|NCT00528372|26837616|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
13412178|NCT00528372|26837608|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
13412179|NCT00528372|26837609|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
13412180|NCT00528372|26837610|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
13412181|NCT00528372|26837611|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
13412182|NCT00528372|26837612|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2|||
13412183|NCT00528372|26837613|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
13412184|NCT00528372|26837614|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4|||
13412185|NCT00528372|26837615|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
13412186|NCT00528372|26837616|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
13412187|NCT00528372|26837608|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
13412188|NCT00528372|26837609|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
13412189|NCT00528372|26837610|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
13412190|NCT00528372|26837611|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
13412191|NCT00528372|26837612|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7|||
13412192|NCT00528372|26837613|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0|||
13412193|NCT00528372|26837614|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
13412194|NCT00528372|26837615|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2|||
13412195|NCT00528372|26837616|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
13412196|NCT00528372|26837608|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
13412197|NCT00528372|26837609|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
13412198|NCT00528372|26837610|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
13412199|NCT00528372|26837611|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
13412200|NCT00528372|26837612|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0|||
13412201|NCT00528372|26837613|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4|||
13412202|NCT00528372|26837614|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
13412203|NCT00528372|26837615|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
13412204|NCT00528372|26837616|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
13412205|NCT00528372|26837608|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
13412206|NCT00528372|26837609|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
13412207|NCT00528372|26837610|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
13412208|NCT00528372|26837611|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
13412209|NCT00528372|26837612|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
13412210|NCT00528372|26837613|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
13412211|NCT00528372|26837614|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
13412212|NCT00528372|26837615|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
13412213|NCT00528372|26837616|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
13412214|NCT00528372|26837608|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
13412215|NCT00528372|26837609|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
13412216|NCT00528372|26837610|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
13412217|NCT00528372|26837611|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
13412218|NCT00528372|26837612|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2|||
13412219|NCT00528372|26837613|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1|||
13412220|NCT00528372|26837614|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
13412221|NCT00528372|26837615|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
13412222|NCT00528372|26837616|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
13412223|NCT00528372|26837608|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
13412224|NCT00528372|26837609|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
13412225|NCT00528372|26837610|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
13412226|NCT00528372|26837611|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
13412227|NCT00528372|26837612|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
13412228|NCT00528372|26837613|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
13412229|NCT00528372|26837614|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
13412230|NCT00528372|26837615|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
13412231|NCT00528372|26837616|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
13412232|NCT00528372|26837608|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2|||
13412233|NCT00528372|26837609|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2|||
13412234|NCT00528372|26837610|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1|||
13412235|NCT00528372|26837611|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2|||
13412236|NCT00528372|26837612|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3|||
13412237|NCT00528372|26837613|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0|||
13412238|NCT00528372|26837614|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3|||
13412239|NCT00528372|26837615|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1|||
13412240|NCT00528372|26837616|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0|||
13412241|NCT00528112|26837677|FG000|Treatment up to 3 Years|Adverse Event|313|||
13412242|NCT00528112|26837678|FG001|Treatment up to 3 Years|Adverse Event|278|||
13412243|NCT00528112|26837677|FG000|Treatment up to 3 Years|Withdrawal by Subject|26|||
13412244|NCT00528112|26837678|FG001|Treatment up to 3 Years|Withdrawal by Subject|31|||
13412245|NCT00528112|26837677|FG000|Treatment up to 3 Years|Protocol Violation|16|||
13412246|NCT00528112|26837678|FG001|Treatment up to 3 Years|Protocol Violation|16|||
13412247|NCT00528112|26837677|FG000|Treatment up to 3 Years|Death|0|||
13412248|NCT00528112|26837678|FG001|Treatment up to 3 Years|Death|1|||
13412249|NCT00528112|26837677|FG000|Treatment up to 3 Years|Lost to Follow-up|63|||
13412250|NCT00528112|26837678|FG001|Treatment up to 3 Years|Lost to Follow-up|61|||
13412251|NCT00528112|26837677|FG000|Treatment up to 3 Years|Pregnancy|9|||
13412252|NCT00528112|26837678|FG001|Treatment up to 3 Years|Pregnancy|10|||
13412253|NCT00528112|26837677|FG000|Treatment up to 3 Years|Other reasons|186|||
13412254|NCT00528112|26837678|FG001|Treatment up to 3 Years|Other reasons|186|||
13412255|NCT00528112|26837677|FG000|Extension Phase|Withdrawal by Subject|0|||
13412256|NCT00528112|26837678|FG001|Extension Phase|Withdrawal by Subject|3|||
13412257|NCT00528112|26837677|FG000|Extension Phase|Other reasons|0|||
13412258|NCT00528112|26837678|FG001|Extension Phase|Other reasons|100|||
13412259|NCT00528112|26837677|FG000|Extension Phase|Pregnancy|0|||
13412260|NCT00528112|26837678|FG001|Extension Phase|Pregnancy|3|||
13412261|NCT00528112|26837677|FG000|Extension Phase|Lost to Follow-up|0|||
13412262|NCT00528112|26837678|FG001|Extension Phase|Lost to Follow-up|12|||
13412263|NCT00528112|26837677|FG000|Extension Phase|Death|0|||
13412264|NCT00528112|26837678|FG001|Extension Phase|Death|1|||
13412265|NCT00528112|26837677|FG000|Extension Phase|Adverse Event|0|||
13412266|NCT00528112|26837678|FG001|Extension Phase|Adverse Event|36|||
13412267|NCT00528112|26837677|FG000|Extension Phase|Protocol Violation|0|||
13412268|NCT00528112|26837678|FG001|Extension Phase|Protocol Violation|2|||
13412269|NCT00528021|26837701|FG000|Overall Study|Lack of Efficacy|17|||
13412270|NCT00528021|26837702|FG001|Overall Study|Lack of Efficacy|13|||
13412271|NCT00528021|26837703|FG002|Overall Study|Lack of Efficacy|7|||
13412272|NCT00528021|26837704|FG003|Overall Study|Lack of Efficacy|9|||
13412273|NCT00527982|26837717|FG000|Overall Study|Physician Decision|1|||
13412274|NCT00527982|26837718|FG001|Overall Study|Physician Decision|0|||
13412275|NCT00527904|26837724|FG000|Overall Study|Adverse Event|45|||
13412276|NCT00527904|26837724|FG000|Overall Study|Withdrawal by Subject|21|||
13412277|NCT00527904|26837724|FG000|Overall Study|Lost to Follow-up|8|||
13412278|NCT00527904|26837724|FG000|Overall Study|misc|22|||
13476407|NCT01423851|27002853|FG006|Whole Study|Disease progression|1|||
13476408|NCT01423851|27002854|FG007|Whole Study|Disease progression|4|||
13476409|NCT01423851|27002855|FG008|Whole Study|Disease progression|0|||
13476410|NCT01423851|27002856|FG009|Whole Study|Disease progression|2|||
13476411|NCT01423851|27002857|FG010|Whole Study|Disease progression|10|||
13476412|NCT01423851|27002847|FG000|Whole Study|Physician Decision|0|||
13476413|NCT01423851|27002848|FG001|Whole Study|Physician Decision|1|||
13476414|NCT01423851|27002849|FG002|Whole Study|Physician Decision|2|||
13476415|NCT01423851|27002850|FG003|Whole Study|Physician Decision|0|||
13476416|NCT01423851|27002851|FG004|Whole Study|Physician Decision|2|||
13476417|NCT01423851|27002852|FG005|Whole Study|Physician Decision|0|||
13476418|NCT01423851|27002853|FG006|Whole Study|Physician Decision|2|||
13476419|NCT01423851|27002854|FG007|Whole Study|Physician Decision|1|||
13476420|NCT01423851|27002855|FG008|Whole Study|Physician Decision|3|||
13476421|NCT01423851|27002856|FG009|Whole Study|Physician Decision|4|||
13476422|NCT01423851|27002857|FG010|Whole Study|Physician Decision|12|||
13476423|NCT01423851|27002847|FG000|Whole Study|Withdrawal by Subject|1|||
13476424|NCT01423851|27002848|FG001|Whole Study|Withdrawal by Subject|1|||
13476425|NCT01423851|27002849|FG002|Whole Study|Withdrawal by Subject|0|||
13476426|NCT01423851|27002850|FG003|Whole Study|Withdrawal by Subject|0|||
13476427|NCT01423851|27002851|FG004|Whole Study|Withdrawal by Subject|0|||
13476428|NCT01423851|27002852|FG005|Whole Study|Withdrawal by Subject|0|||
13476429|NCT01423851|27002853|FG006|Whole Study|Withdrawal by Subject|0|||
13476430|NCT01423851|27002854|FG007|Whole Study|Withdrawal by Subject|0|||
13476431|NCT01423851|27002855|FG008|Whole Study|Withdrawal by Subject|2|||
13476432|NCT01423851|27002856|FG009|Whole Study|Withdrawal by Subject|0|||
13476433|NCT01423851|27002857|FG010|Whole Study|Withdrawal by Subject|4|||
13476434|NCT01423851|27002847|FG000|Whole Study|Adverse Event|0|||
13476435|NCT01423851|27002848|FG001|Whole Study|Adverse Event|0|||
13476436|NCT01423851|27002849|FG002|Whole Study|Adverse Event|0|||
13476437|NCT01423851|27002850|FG003|Whole Study|Adverse Event|2|||
13476438|NCT01423851|27002851|FG004|Whole Study|Adverse Event|0|||
13476439|NCT01423851|27002852|FG005|Whole Study|Adverse Event|0|||
13412279|NCT00527826|26837778|FG000|Overall Study|Adverse Event|10|||
13412280|NCT00527826|26837779|FG001|Overall Study|Adverse Event|10|||
13412281|NCT00527826|26837778|FG000|Overall Study|Lost to Follow-up|3|||
13412282|NCT00527826|26837779|FG001|Overall Study|Lost to Follow-up|2|||
13412283|NCT00527826|26837778|FG000|Overall Study|Withdrawal by Subject|5|||
13412284|NCT00527826|26837779|FG001|Overall Study|Withdrawal by Subject|8|||
13412285|NCT00527826|26837778|FG000|Overall Study|Inclusion Criteria Not Met|3|||
13412286|NCT00527826|26837779|FG001|Overall Study|Inclusion Criteria Not Met|3|||
13412287|NCT00527826|26837778|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0|||
13412288|NCT00527826|26837779|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1|||
13412289|NCT00527826|26837778|FG000|Overall Study|Additional Intake of Viani forte|0|||
13412290|NCT00527826|26837779|FG001|Overall Study|Additional Intake of Viani forte|1|||
13412291|NCT00527826|26837778|FG000|Overall Study|Participant moved away|0|||
13412292|NCT00527826|26837779|FG001|Overall Study|Participant moved away|1|||
13412293|NCT00527787|26837808|FG000|Overall Study|Adverse Event|14|||
13412294|NCT00527787|26837809|FG001|Overall Study|Adverse Event|24|||
13412295|NCT00527787|26837808|FG000|Overall Study|Withdrawal by Subject|13|||
13412296|NCT00527787|26837809|FG001|Overall Study|Withdrawal by Subject|25|||
13412297|NCT00527787|26837808|FG000|Overall Study|Lost to Follow-up|5|||
13412298|NCT00527787|26837809|FG001|Overall Study|Lost to Follow-up|2|||
13412299|NCT00527787|26837808|FG000|Overall Study|Duodenal Ulcer|1|||
13412300|NCT00527787|26837809|FG001|Overall Study|Duodenal Ulcer|10|||
13412301|NCT00527787|26837808|FG000|Overall Study|misc|5|||
13412302|NCT00527787|26837809|FG001|Overall Study|misc|2|||
13412303|NCT00527748|26837815|FG000|Overall Study|Other|3|||
13412304|NCT00527735|26837897|FG000|Overall Study|Disease progression|47|||
13412305|NCT00527735|26837898|FG001|Overall Study|Disease progression|61|||
13412306|NCT00527735|26837899|FG002|Overall Study|Disease progression|53|||
13412307|NCT00527735|26837897|FG000|Overall Study|Death|23|||
13412308|NCT00527735|26837898|FG001|Overall Study|Death|13|||
13412309|NCT00527735|26837899|FG002|Overall Study|Death|15|||
13412310|NCT00527735|26837897|FG000|Overall Study|Completed treatment in treatment phase|14|||
13412311|NCT00527735|26837898|FG001|Overall Study|Completed treatment in treatment phase|13|||
13412312|NCT00527735|26837899|FG002|Overall Study|Completed treatment in treatment phase|18|||
13412313|NCT00527735|26837897|FG000|Overall Study|Adverse Event|10|||
13412314|NCT00527735|26837898|FG001|Overall Study|Adverse Event|6|||
13412315|NCT00527735|26837899|FG002|Overall Study|Adverse Event|7|||
13412316|NCT00527735|26837897|FG000|Overall Study|Not identified|5|||
13412317|NCT00527735|26837898|FG001|Overall Study|Not identified|5|||
13412318|NCT00527735|26837899|FG002|Overall Study|Not identified|5|||
13412319|NCT00527735|26837897|FG000|Overall Study|Withdrawal by Subject|5|||
13412320|NCT00527735|26837898|FG001|Overall Study|Withdrawal by Subject|4|||
13412321|NCT00527735|26837899|FG002|Overall Study|Withdrawal by Subject|3|||
13412322|NCT00527735|26837897|FG000|Overall Study|No longer met study criteria|2|||
13412323|NCT00527735|26837898|FG001|Overall Study|No longer met study criteria|2|||
13412324|NCT00527735|26837899|FG002|Overall Study|No longer met study criteria|1|||
13412325|NCT00527735|26837897|FG000|Overall Study|Lost to Follow-up|0|||
13412326|NCT00527735|26837898|FG001|Overall Study|Lost to Follow-up|0|||
13412327|NCT00527735|26837899|FG002|Overall Study|Lost to Follow-up|3|||
13412328|NCT00527735|26837897|FG000|Overall Study|Poor compliance or noncompliance|0|||
13412329|NCT00527735|26837898|FG001|Overall Study|Poor compliance or noncompliance|1|||
13412330|NCT00527735|26837899|FG002|Overall Study|Poor compliance or noncompliance|1|||
13412331|NCT00527735|26837897|FG000|Overall Study|Completed treatment during maintenance|2|||
13412332|NCT00527735|26837898|FG001|Overall Study|Completed treatment during maintenance|2|||
13412333|NCT00527735|26837899|FG002|Overall Study|Completed treatment during maintenance|1|||
13412334|NCT00527618|26837915|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3|||
13412335|NCT00527618|26837916|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1|||
13412336|NCT00527618|26837915|FG000|Week 1-12 (First Intervention)|Adverse Event|0|||
13412337|NCT00527618|26837916|FG001|Week 1-12 (First Intervention)|Adverse Event|1|||
13412338|NCT00527618|26837915|FG000|Week 13-14 (Washout)|Lost to Follow-up|1|||
13412339|NCT00527618|26837916|FG001|Week 13-14 (Washout)|Lost to Follow-up|0|||
13412340|NCT00527618|26837915|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0|||
13412341|NCT00527618|26837916|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1|||
13412342|NCT00527618|26837915|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0|||
13412343|NCT00527618|26837916|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1|||
13412344|NCT00527618|26837915|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0|||
13412345|NCT00527618|26837916|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1|||
13412346|NCT00527605|26837959|FG000|Overall Study|Adverse Event|3|||
13412347|NCT00527605|26837960|FG001|Overall Study|Adverse Event|0|||
13412348|NCT00527605|26837959|FG000|Overall Study|Withdrawal by Subject|3|||
13412349|NCT00527605|26837960|FG001|Overall Study|Withdrawal by Subject|7|||
13412350|NCT00527605|26837959|FG000|Overall Study|Lost to Follow-up|6|||
13412351|NCT00527605|26837960|FG001|Overall Study|Lost to Follow-up|2|||
13412352|NCT00527605|26837959|FG000|Overall Study|Protocol Violation|1|||
13412353|NCT00527605|26837960|FG001|Overall Study|Protocol Violation|2|||
13412354|NCT00527514|26837974|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1|||
13412355|NCT00527514|26837974|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2|||
13412356|NCT00527514|26837974|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1|||
13412357|NCT00527514|26837974|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1|||
13412358|NCT00527514|26837974|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1|||
13412359|NCT00527514|26837974|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1|||
13412360|NCT00527514|26837974|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1|||
13412361|NCT00527488|26838061|FG000|Overall Study|Withdrawn prior to dosing|0|||
13412362|NCT00527488|26838062|FG001|Overall Study|Withdrawn prior to dosing|1|||
13412363|NCT00527488|26838063|FG002|Overall Study|Withdrawn prior to dosing|1|||
13412364|NCT00527488|26838064|FG003|Overall Study|Withdrawn prior to dosing|0|||
13412365|NCT00527423|26838072|FG000|Overall Study|Protocol Violation|1|||
13412366|NCT00527423|26838072|FG000|Overall Study|Adverse Event|5|||
13412367|NCT00527423|26838072|FG000|Overall Study|Physician Decision|4|||
13412368|NCT00527423|26838072|FG000|Overall Study|Withdrawal by Subject|10|||
13412369|NCT00527423|26838072|FG000|Overall Study|Lost to Follow-up|4|||
13412370|NCT00527423|26838072|FG000|Overall Study|OTHER|4|||
13412371|NCT00527423|26838072|FG000|Overall Study|Death|9|||
13412372|NCT00527397|26838098|FG000|Overall Study|Adverse Event|3|||
13412373|NCT00527397|26838098|FG000|Overall Study|Lack of Efficacy|1|||
13412374|NCT00527397|26838098|FG000|Overall Study|Protocol Violation|1|||
13412375|NCT00527397|26838098|FG000|Overall Study|Withdrawal by Subject|6|||
13412376|NCT00527397|26838098|FG000|Overall Study|Study terminated by sponsor|13|||
13412377|NCT00527332|26838111|FG000|Overall Study|Protocol Violation|4|||
13412378|NCT00527332|26838112|FG001|Overall Study|Protocol Violation|8|||
13412379|NCT00527332|26838111|FG000|Overall Study|Withdrew consent|5|||
13412380|NCT00527332|26838112|FG001|Overall Study|Withdrew consent|1|||
13412381|NCT00527319|26838133|FG000|Overall Study|Withdrawal by Subject|5|||
13412382|NCT00527319|26838134|FG001|Overall Study|Withdrawal by Subject|0|||
13412383|NCT00527319|26838135|FG002|Overall Study|Withdrawal by Subject|1|||
13412384|NCT00527319|26838133|FG000|Overall Study|Lost to Follow-up|1|||
13412385|NCT00527319|26838134|FG001|Overall Study|Lost to Follow-up|0|||
13412386|NCT00527319|26838135|FG002|Overall Study|Lost to Follow-up|0|||
13412387|NCT00527319|26838133|FG000|Overall Study|Death|0|||
13412388|NCT00527319|26838134|FG001|Overall Study|Death|3|||
13412389|NCT00527319|26838135|FG002|Overall Study|Death|1|||
13412390|NCT00527319|26838133|FG000|Overall Study|Intercurrent Medical Illness|0|||
13412391|NCT00527319|26838134|FG001|Overall Study|Intercurrent Medical Illness|1|||
13412392|NCT00527319|26838135|FG002|Overall Study|Intercurrent Medical Illness|3|||
13412393|NCT00527319|26838133|FG000|Overall Study|Adverse Event|0|||
13412394|NCT00527319|26838134|FG001|Overall Study|Adverse Event|0|||
13412395|NCT00527319|26838135|FG002|Overall Study|Adverse Event|1|||
13412396|NCT00527111|26838156|FG000|Overall Study|Adverse Event|14|||
13412397|NCT00527111|26838157|FG001|Overall Study|Adverse Event|13|||
13412398|NCT00527111|26838156|FG000|Overall Study|Death|0|||
13412399|NCT00527111|26838157|FG001|Overall Study|Death|1|||
13412400|NCT00527111|26838156|FG000|Overall Study|Investigator Request|2|||
13412401|NCT00527111|26838157|FG001|Overall Study|Investigator Request|1|||
13412402|NCT00527111|26838156|FG000|Overall Study|Patient Request|2|||
13412403|NCT00527111|26838157|FG001|Overall Study|Patient Request|5|||
13412404|NCT00527111|26838156|FG000|Overall Study|Other|2|||
13412405|NCT00527111|26838157|FG001|Overall Study|Other|2|||
13412406|NCT00527072|26838165|FG000|Overall Study|Adverse Event|13|||
13412407|NCT00527072|26838165|FG000|Overall Study|Lack of Efficacy|11|||
13412408|NCT00527072|26838165|FG000|Overall Study|Lost to Follow-up|3|||
13412409|NCT00527072|26838165|FG000|Overall Study|Protocol Violation|2|||
13412410|NCT00527072|26838165|FG000|Overall Study|Withdrawal by Subject|7|||
13412411|NCT00526994|26838192|FG000|Overall Study|Lost to Follow-up|98|||
13412412|NCT00526994|26838193|FG001|Overall Study|Lost to Follow-up|108|||
13412413|NCT00526994|26838194|FG002|Overall Study|Lost to Follow-up|96|||
13412414|NCT00526994|26838192|FG000|Overall Study|Death|4|||
13412415|NCT00526994|26838193|FG001|Overall Study|Death|3|||
13412416|NCT00526994|26838194|FG002|Overall Study|Death|3|||
13412417|NCT00526994|26838192|FG000|Overall Study|Withdrawal by Subject|2|||
13412418|NCT00526994|26838193|FG001|Overall Study|Withdrawal by Subject|7|||
13412419|NCT00526994|26838194|FG002|Overall Study|Withdrawal by Subject|5|||
13412420|NCT00526994|26838192|FG000|Overall Study|incarcerated, impaired, incomplete|4|||
13412421|NCT00526994|26838193|FG001|Overall Study|incarcerated, impaired, incomplete|3|||
13412422|NCT00526994|26838194|FG002|Overall Study|incarcerated, impaired, incomplete|3|||
13412423|NCT00526890|26838206|FG000|Overall Study|Adverse Event|2|||
13412424|NCT00526799|26838221|FG000|Overall Study|Withdrawal by Subject|1|||
13412425|NCT00526799|26838222|FG001|Overall Study|Withdrawal by Subject|0|||
13412426|NCT00526799|26838221|FG000|Overall Study|Intercurrent Complicating Disease|0|||
13412427|NCT00526799|26838222|FG001|Overall Study|Intercurrent Complicating Disease|1|||
13412428|NCT00526669|26838254|FG000|Combined Treatment Phase|Lost to Follow-up|0|||
13412429|NCT00526669|26838255|FG001|Combined Treatment Phase|Lost to Follow-up|2|||
13412430|NCT00526669|26838254|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
13412431|NCT00526669|26838255|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
13412432|NCT00526669|26838254|FG000|Combined Treatment Phase|Sponsor Terminated Study|0|||
13412433|NCT00526669|26838255|FG001|Combined Treatment Phase|Sponsor Terminated Study|2|||
13412434|NCT00526669|26838254|FG000|Combined Treatment Phase|Death|0|||
13412435|NCT00526669|26838255|FG001|Combined Treatment Phase|Death|2|||
13412436|NCT00526656|26838263|FG000|Overall Study|Death|1|||
13412437|NCT00526656|26838263|FG000|Overall Study|Refused surgery|1|||
13412438|NCT00526630|26838294|FG000|First Intervention Period - 12 Weeks|Withdrawn|0|||
13412439|NCT00526630|26838295|FG001|First Intervention Period - 12 Weeks|Withdrawn|3|||
13412440|NCT00526630|26838294|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2|||
13412441|NCT00526630|26838295|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1|||
13412442|NCT00526331|26838301|FG000|Overall Study|Sponsor Termination|55|||
13412443|NCT00526162|26838311|FG000|Overall Study|Device not implanted|3|||
13412444|NCT00526110|26838325|FG000|Overall Study|Adverse Event|2|||
13412445|NCT00526110|26838326|FG001|Overall Study|Adverse Event|9|||
13412446|NCT00526110|26838325|FG000|Overall Study|Disease Progression|0|||
13412447|NCT00526110|26838326|FG001|Overall Study|Disease Progression|19|||
13412448|NCT00526110|26838325|FG000|Overall Study|Maximal Response|0|||
13412449|NCT00526110|26838326|FG001|Overall Study|Maximal Response|6|||
13412450|NCT00526110|26838325|FG000|Overall Study|Withdrawal by Subject|0|||
13412451|NCT00526110|26838326|FG001|Overall Study|Withdrawal by Subject|2|||
13412452|NCT00526110|26838325|FG000|Overall Study|Poor Tolerance|0|||
13412453|NCT00526110|26838326|FG001|Overall Study|Poor Tolerance|5|||
13412454|NCT00526097|26838509|FG000|Overall Study|Adverse Event|6|||
13412455|NCT00526097|26838510|FG001|Overall Study|Adverse Event|44|||
13412456|NCT00526097|26838509|FG000|Overall Study|Protocol Violation|4|||
13412457|NCT00526097|26838510|FG001|Overall Study|Protocol Violation|10|||
13412458|NCT00526097|26838509|FG000|Overall Study|Withdrawal by Subject|3|||
13412459|NCT00526097|26838510|FG001|Overall Study|Withdrawal by Subject|1|||
13412460|NCT00526097|26838509|FG000|Overall Study|Other|2|||
13412461|NCT00526097|26838510|FG001|Overall Study|Other|1|||
13412462|NCT00526071|26838521|FG000|Overall Study|Adverse Event|1|||
13412463|NCT00526071|26838521|FG000|Overall Study|Withdrawal by Subject|1|||
13412464|NCT00526071|26838521|FG000|Overall Study|Lack of Response to Study Drug|4|||
13412465|NCT00525915|26838534|FG000|Overall Study|Non-Compliance|0|||
13412466|NCT00525915|26838535|FG001|Overall Study|Non-Compliance|1|||
13412467|NCT00525915|26838534|FG000|Overall Study|Disease Progression|5|||
13412468|NCT00525915|26838535|FG001|Overall Study|Disease Progression|6|||
13412469|NCT00525915|26838534|FG000|Overall Study|Withdrawal by Subject|1|||
13412470|NCT00525915|26838535|FG001|Overall Study|Withdrawal by Subject|0|||
13412471|NCT00525915|26838534|FG000|Overall Study|Refused Surgery|1|||
13412472|NCT00525915|26838535|FG001|Overall Study|Refused Surgery|2|||
13412473|NCT00525915|26838534|FG000|Overall Study|Unrelated illness|1|||
13412474|NCT00525915|26838535|FG001|Overall Study|Unrelated illness|0|||
13412475|NCT00525902|26838542|FG000|Overall Study|Lack of Efficacy|1|||
13412476|NCT00525824|26838617|FG000|Overall Study|Adverse Event|7|||
13412477|NCT00525824|26838618|FG001|Overall Study|Adverse Event|11|||
13412478|NCT00525824|26838619|FG002|Overall Study|Adverse Event|6|||
13412479|NCT00525824|26838620|FG003|Overall Study|Adverse Event|7|||
13412480|NCT00525824|26838617|FG000|Overall Study|Withdrawal by Subject|5|||
13412481|NCT00525824|26838618|FG001|Overall Study|Withdrawal by Subject|9|||
13412482|NCT00525824|26838619|FG002|Overall Study|Withdrawal by Subject|3|||
13412483|NCT00525824|26838620|FG003|Overall Study|Withdrawal by Subject|4|||
13412484|NCT00525824|26838617|FG000|Overall Study|Lost to Follow-up|4|||
13412485|NCT00525824|26838618|FG001|Overall Study|Lost to Follow-up|2|||
13412486|NCT00525824|26838619|FG002|Overall Study|Lost to Follow-up|4|||
13412487|NCT00525824|26838620|FG003|Overall Study|Lost to Follow-up|0|||
13412488|NCT00525824|26838617|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1|||
13412489|NCT00525824|26838618|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2|||
13412490|NCT00525824|26838619|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1|||
13412491|NCT00525824|26838620|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2|||
13412492|NCT00525824|26838617|FG000|Overall Study|Severe non-compliance|0|||
13412493|NCT00525824|26838618|FG001|Overall Study|Severe non-compliance|1|||
13412494|NCT00525824|26838619|FG002|Overall Study|Severe non-compliance|1|||
13412495|NCT00525824|26838620|FG003|Overall Study|Severe non-compliance|1|||
13412496|NCT00525824|26838617|FG000|Overall Study|Safety reasons|1|||
13412497|NCT00525824|26838618|FG001|Overall Study|Safety reasons|0|||
13412498|NCT00525824|26838619|FG002|Overall Study|Safety reasons|1|||
13412499|NCT00525824|26838620|FG003|Overall Study|Safety reasons|0|||
13412500|NCT00525824|26838617|FG000|Overall Study|Other|1|||
13412501|NCT00525824|26838618|FG001|Overall Study|Other|3|||
13412502|NCT00525824|26838619|FG002|Overall Study|Other|3|||
13412503|NCT00525824|26838620|FG003|Overall Study|Other|1|||
13412504|NCT00525785|26838626|FG000|Overall Study|Withdrawal by Subject|1|||
13412505|NCT00525785|26838626|FG000|Overall Study|Lack of Efficacy|1|||
13412506|NCT00525785|26838626|FG000|Overall Study|Physician Decision|1|||
13412507|NCT00525590|26838644|FG000|Overall Study|Adverse Event|3|||
13412508|NCT00525590|26838644|FG000|Overall Study|Physician Decision|3|||
13412509|NCT00525590|26838644|FG000|Overall Study|Withdrawal by Subject|16|||
13412510|NCT00525590|26838644|FG000|Overall Study|Lost to Follow-up|1|||
13412511|NCT00525590|26838644|FG000|Overall Study|Death|9|||
13412512|NCT00525590|26838644|FG000|Overall Study|Other|13|||
13412513|NCT00525512|26838791|FG000|Double-Blind Phase|Adverse Event|48|||
13412514|NCT00525512|26838792|FG001|Double-Blind Phase|Adverse Event|28|||
13412515|NCT00525512|26838793|FG002|Double-Blind Phase|Adverse Event|0|||
13412516|NCT00525512|26838794|FG003|Double-Blind Phase|Adverse Event|0|||
13412517|NCT00525512|26838791|FG000|Double-Blind Phase|Protocol Violation|3|||
13412518|NCT00525512|26838792|FG001|Double-Blind Phase|Protocol Violation|1|||
13412519|NCT00525512|26838793|FG002|Double-Blind Phase|Protocol Violation|0|||
13412520|NCT00525512|26838794|FG003|Double-Blind Phase|Protocol Violation|0|||
13412521|NCT00525512|26838791|FG000|Double-Blind Phase|Lost to Follow-up|3|||
13412522|NCT00525512|26838792|FG001|Double-Blind Phase|Lost to Follow-up|7|||
13412523|NCT00525512|26838793|FG002|Double-Blind Phase|Lost to Follow-up|0|||
13412524|NCT00525512|26838794|FG003|Double-Blind Phase|Lost to Follow-up|0|||
13412525|NCT00525512|26838791|FG000|Double-Blind Phase|Withdrawal by Subject|17|||
13412526|NCT00525512|26838792|FG001|Double-Blind Phase|Withdrawal by Subject|12|||
13412527|NCT00525512|26838793|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
13412528|NCT00525512|26838794|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
13412529|NCT00525512|26838791|FG000|Double-Blind Phase|Lack of Efficacy|13|||
13412530|NCT00525512|26838792|FG001|Double-Blind Phase|Lack of Efficacy|5|||
13412531|NCT00525512|26838793|FG002|Double-Blind Phase|Lack of Efficacy|0|||
13412532|NCT00525512|26838794|FG003|Double-Blind Phase|Lack of Efficacy|0|||
13412533|NCT00525512|26838791|FG000|Double-Blind Phase|Other reason (not specified)|12|||
13412534|NCT00525512|26838792|FG001|Double-Blind Phase|Other reason (not specified)|13|||
13412535|NCT00525512|26838793|FG002|Double-Blind Phase|Other reason (not specified)|0|||
13412536|NCT00525512|26838794|FG003|Double-Blind Phase|Other reason (not specified)|0|||
13412537|NCT00525512|26838791|FG000|Open-Label Phase|Adverse Event|0|||
13412538|NCT00525512|26838792|FG001|Open-Label Phase|Adverse Event|0|||
13412539|NCT00525512|26838793|FG002|Open-Label Phase|Adverse Event|1|||
13412540|NCT00525512|26838794|FG003|Open-Label Phase|Adverse Event|0|||
13412541|NCT00525512|26838791|FG000|Open-Label Phase|Lost to Follow-up|0|||
13412542|NCT00525512|26838792|FG001|Open-Label Phase|Lost to Follow-up|0|||
13412543|NCT00525512|26838793|FG002|Open-Label Phase|Lost to Follow-up|1|||
13412544|NCT00525512|26838794|FG003|Open-Label Phase|Lost to Follow-up|0|||
13412545|NCT00525512|26838791|FG000|Open-Label Phase|Other reason (not specified)|0|||
13412546|NCT00525512|26838792|FG001|Open-Label Phase|Other reason (not specified)|0|||
13412547|NCT00525512|26838793|FG002|Open-Label Phase|Other reason (not specified)|4|||
13412548|NCT00525512|26838794|FG003|Open-Label Phase|Other reason (not specified)|5|||
13412549|NCT00525499|26838821|FG000|Overall Study|Lost to Follow-up|2|||
13412550|NCT00525499|26838822|FG001|Overall Study|Lost to Follow-up|4|||
13412551|NCT00525499|26838823|FG002|Overall Study|Lost to Follow-up|1|||
13412552|NCT00525499|26838824|FG003|Overall Study|Lost to Follow-up|4|||
13412553|NCT00525499|26838821|FG000|Overall Study|Adverse Event|0|||
13412554|NCT00525499|26838822|FG001|Overall Study|Adverse Event|1|||
13412555|NCT00525499|26838823|FG002|Overall Study|Adverse Event|0|||
13412556|NCT00525499|26838824|FG003|Overall Study|Adverse Event|1|||
13412557|NCT00525499|26838821|FG000|Overall Study|Withdrawal by Subject|5|||
13412558|NCT00525499|26838822|FG001|Overall Study|Withdrawal by Subject|1|||
13412559|NCT00525499|26838823|FG002|Overall Study|Withdrawal by Subject|5|||
13412560|NCT00525499|26838824|FG003|Overall Study|Withdrawal by Subject|2|||
13412561|NCT00525499|26838821|FG000|Overall Study|Protocol Violation|0|||
13412562|NCT00525499|26838822|FG001|Overall Study|Protocol Violation|1|||
13412563|NCT00525499|26838823|FG002|Overall Study|Protocol Violation|1|||
13412564|NCT00525499|26838824|FG003|Overall Study|Protocol Violation|0|||
13412565|NCT00525265|26838837|FG000|Overall Study|Protocol Violation|1|||
13412566|NCT00525265|26838838|FG001|Overall Study|Protocol Violation|0|||
13412567|NCT00525161|26838846|FG000|Overall Study|Adverse Event|1|||
13412568|NCT00525148|26838877|FG000|Overall Study|Other Adverse Event|3|||
13412569|NCT00525148|26838878|FG001|Overall Study|Other Adverse Event|5|||
13412570|NCT00525148|26838879|FG002|Overall Study|Other Adverse Event|1|||
13412571|NCT00525148|26838880|FG003|Overall Study|Other Adverse Event|8|||
13412572|NCT00525148|26838877|FG000|Overall Study|Progressive disease|18|||
13412573|NCT00525148|26838878|FG001|Overall Study|Progressive disease|30|||
13412574|NCT00525148|26838879|FG002|Overall Study|Progressive disease|6|||
13412575|NCT00525148|26838880|FG003|Overall Study|Progressive disease|49|||
13412576|NCT00525148|26838877|FG000|Overall Study|Refused continuation of study medication|0|||
13412577|NCT00525148|26838878|FG001|Overall Study|Refused continuation of study medication|2|||
13412578|NCT00525148|26838879|FG002|Overall Study|Refused continuation of study medication|0|||
13412579|NCT00525148|26838880|FG003|Overall Study|Refused continuation of study medication|1|||
13412580|NCT00525148|26838877|FG000|Overall Study|Other than stated|2|||
13412581|NCT00525148|26838878|FG001|Overall Study|Other than stated|1|||
13412582|NCT00525148|26838879|FG002|Overall Study|Other than stated|0|||
13412583|NCT00525148|26838880|FG003|Overall Study|Other than stated|3|||
13412584|NCT00525044|26838901|FG000|Overall Study|Lost to Follow-up|0|||
13412585|NCT00525044|26838902|FG001|Overall Study|Lost to Follow-up|1|||
13412586|NCT00525031|26838916|FG000|Overall Study|Disease Progression|1|||
13412587|NCT00525031|26838917|FG001|Overall Study|Disease Progression|1|||
13412588|NCT00524771|26838934|FG000|Overall Study|Protocol Violation|220|||
13412589|NCT00524771|26838935|FG001|Overall Study|Protocol Violation|585|||
13412590|NCT00524745|26838970|FG000|Overall Study|subject withdrawal or lost to follow up|34|||
13412591|NCT00524745|26838971|FG001|Overall Study|subject withdrawal or lost to follow up|13|||
13412592|NCT00524745|26838972|FG002|Overall Study|subject withdrawal or lost to follow up|29|||
13412593|NCT00524745|26838973|FG003|Overall Study|subject withdrawal or lost to follow up|22|||
13412594|NCT00524680|26839008|FG000|Overall Study|progression|0|||
13412595|NCT00524680|26839009|FG001|Overall Study|progression|0|||
13412596|NCT00524680|26839010|FG002|Overall Study|progression|0|||
13412597|NCT00524680|26839011|FG003|Overall Study|progression|1|||
13412598|NCT00524680|26839008|FG000|Overall Study|Adverse Event|2|||
13412599|NCT00524680|26839009|FG001|Overall Study|Adverse Event|0|||
13412600|NCT00524680|26839010|FG002|Overall Study|Adverse Event|0|||
13412601|NCT00524680|26839011|FG003|Overall Study|Adverse Event|1|||
13412602|NCT00524680|26839008|FG000|Overall Study|Other|0|||
13412603|NCT00524680|26839009|FG001|Overall Study|Other|1|||
13412604|NCT00524680|26839010|FG002|Overall Study|Other|2|||
13412605|NCT00524680|26839011|FG003|Overall Study|Other|3|||
13412606|NCT00524680|26839008|FG000|Overall Study|Withdrawal by Subject|1|||
13412607|NCT00524680|26839009|FG001|Overall Study|Withdrawal by Subject|0|||
13412608|NCT00524680|26839010|FG002|Overall Study|Withdrawal by Subject|1|||
13412609|NCT00524680|26839011|FG003|Overall Study|Withdrawal by Subject|1|||
13412610|NCT00524589|26839018|FG000|Overall Study|Withdrawal by Subject|2|||
13412611|NCT00524589|26839018|FG000|Overall Study|Disease Progression|16|||
13412612|NCT00524485|26839030|FG000|Overall Study|Withdrawal by Subject|5|||
13412613|NCT00524459|26839040|FG000|Overall Study|Withdrawal by Subject|1|||
13412614|NCT00524459|26839040|FG000|Overall Study|Other|1|||
13412615|NCT00524420|26839059|FG000|Overall Study|Lack of Efficacy|1|||
13412616|NCT00524420|26839060|FG001|Overall Study|Lack of Efficacy|0|||
13412617|NCT00524368|26839095|FG000|Overall Study|Adverse Event|10|||
13412618|NCT00524368|26839096|FG001|Overall Study|Adverse Event|12|||
13412619|NCT00524368|26839095|FG000|Overall Study|Lost to Follow-up|9|||
13412620|NCT00524368|26839096|FG001|Overall Study|Lost to Follow-up|13|||
13412621|NCT00524368|26839095|FG000|Overall Study|Withdrawal by Subject|4|||
13412622|NCT00524368|26839096|FG001|Overall Study|Withdrawal by Subject|5|||
13412623|NCT00524368|26839095|FG000|Overall Study|Non-compliant|8|||
13412624|NCT00524368|26839096|FG001|Overall Study|Non-compliant|9|||
13412625|NCT00524368|26839095|FG000|Overall Study|Reached a Virologic Endpoint|3|||
13412626|NCT00524368|26839096|FG001|Overall Study|Reached a Virologic Endpoint|2|||
13412627|NCT00524368|26839095|FG000|Overall Study|Sponsor's Decision|2|||
13412628|NCT00524368|26839096|FG001|Overall Study|Sponsor's Decision|0|||
13412629|NCT00524368|26839095|FG000|Overall Study|Ineligible to Continue the study|2|||
13412630|NCT00524368|26839096|FG001|Overall Study|Ineligible to Continue the study|5|||
13412631|NCT00524368|26839095|FG000|Overall Study|Other|3|||
13412632|NCT00524368|26839096|FG001|Overall Study|Other|2|||
13412633|NCT00524316|26839107|FG000|Overall Study|Withdrawal by Subject|2|||
13412634|NCT00524316|26839107|FG000|Overall Study|Adverse Event|7|||
13412635|NCT00524316|26839107|FG000|Overall Study|Disease Progression|7|||
13412636|NCT00524303|26839145|FG000|Overall Study|Lost to Follow-up|6|||
13412637|NCT00524303|26839146|FG001|Overall Study|Lost to Follow-up|0|||
13412638|NCT00524303|26839147|FG002|Overall Study|Lost to Follow-up|3|||
13412639|NCT00524303|26839145|FG000|Overall Study|Protocol Violation|0|||
13412640|NCT00524303|26839146|FG001|Overall Study|Protocol Violation|1|||
13412641|NCT00524303|26839147|FG002|Overall Study|Protocol Violation|1|||
13412642|NCT00524303|26839145|FG000|Overall Study|Withdrawal by Subject|3|||
13412643|NCT00524303|26839146|FG001|Overall Study|Withdrawal by Subject|0|||
13412644|NCT00524303|26839147|FG002|Overall Study|Withdrawal by Subject|4|||
13412645|NCT00524303|26839145|FG000|Overall Study|Death|0|||
13412646|NCT00524303|26839146|FG001|Overall Study|Death|2|||
13412647|NCT00524303|26839147|FG002|Overall Study|Death|3|||
13412648|NCT00524303|26839145|FG000|Overall Study|Adverse Event|1|||
13412649|NCT00524303|26839146|FG001|Overall Study|Adverse Event|2|||
13412650|NCT00524303|26839147|FG002|Overall Study|Adverse Event|3|||
13412651|NCT00524303|26839145|FG000|Overall Study|Did not Complete Study Dosing|1|||
13412652|NCT00524303|26839146|FG001|Overall Study|Did not Complete Study Dosing|0|||
13412653|NCT00524303|26839147|FG002|Overall Study|Did not Complete Study Dosing|0|||
13412654|NCT00524303|26839145|FG000|Overall Study|Worsening Peripheral Neuropathy|1|||
13412655|NCT00524303|26839146|FG001|Overall Study|Worsening Peripheral Neuropathy|0|||
13412656|NCT00524303|26839147|FG002|Overall Study|Worsening Peripheral Neuropathy|0|||
13412657|NCT00524303|26839145|FG000|Overall Study|Disease Progression|0|||
13412658|NCT00524303|26839146|FG001|Overall Study|Disease Progression|4|||
13412659|NCT00524303|26839147|FG002|Overall Study|Disease Progression|1|||
13412660|NCT00524303|26839145|FG000|Overall Study|Disease Recurrence|0|||
13412661|NCT00524303|26839146|FG001|Overall Study|Disease Recurrence|1|||
13412662|NCT00524303|26839147|FG002|Overall Study|Disease Recurrence|0|||
13412663|NCT00524303|26839145|FG000|Overall Study|Sponsor Request|0|||
13412664|NCT00524303|26839146|FG001|Overall Study|Sponsor Request|0|||
13412665|NCT00524303|26839147|FG002|Overall Study|Sponsor Request|1|||
13412666|NCT00524303|26839145|FG000|Overall Study|Physician Decision|0|||
13412667|NCT00524303|26839146|FG001|Overall Study|Physician Decision|0|||
13412668|NCT00524303|26839147|FG002|Overall Study|Physician Decision|1|||
13412669|NCT00524303|26839145|FG000|Overall Study|Completed 5 years|0|||
13412670|NCT00524303|26839146|FG001|Overall Study|Completed 5 years|0|||
13412671|NCT00524303|26839147|FG002|Overall Study|Completed 5 years|1|||
13412672|NCT00524173|26839166|FG000|Overall Study|Lost to Follow-up|0|||
13412673|NCT00524173|26839167|FG001|Overall Study|Lost to Follow-up|1|||
13412674|NCT00524173|26839166|FG000|Overall Study|Death|1|||
13412675|NCT00524173|26839167|FG001|Overall Study|Death|0|||
13412676|NCT00524173|26839166|FG000|Overall Study|Had not reached endpoint at study close|4|||
13412677|NCT00524173|26839167|FG001|Overall Study|Had not reached endpoint at study close|1|||
13412678|NCT00524134|26839176|FG000|Overall Study|Withdrawal by Subject|1|||
13412679|NCT00524134|26839176|FG000|Overall Study|Physician Decision|1|||
13412680|NCT00524121|26839195|FG000|Overall Study|Disease progression|6|||
13412681|NCT00524121|26839195|FG000|Overall Study|Adverse Event|4|||
13412682|NCT00524121|26839195|FG000|Overall Study|Patient refused|2|||
13412683|NCT00524121|26839195|FG000|Overall Study|Other|1|||
13412684|NCT00524121|26839195|FG000|Overall Study|Death|1|||
13412685|NCT00524121|26839195|FG000|Overall Study|Not treated (became ineligible)|4|||
13412686|NCT00524121|26839195|FG000|Overall Study|Not treated (changed mind)|1|||
13412687|NCT00524043|26839225|FG000|Overall Study|Lack of Efficacy|15|||
13412688|NCT00524043|26839226|FG001|Overall Study|Lack of Efficacy|13|||
13412689|NCT00524043|26839227|FG002|Overall Study|Lack of Efficacy|14|||
13412690|NCT00524043|26839225|FG000|Overall Study|Withdrawal by Subject|5|||
13412691|NCT00524043|26839226|FG001|Overall Study|Withdrawal by Subject|7|||
13412692|NCT00524043|26839227|FG002|Overall Study|Withdrawal by Subject|7|||
13412693|NCT00524043|26839225|FG000|Overall Study|Adverse Event|5|||
13412694|NCT00524043|26839226|FG001|Overall Study|Adverse Event|2|||
13412695|NCT00524043|26839227|FG002|Overall Study|Adverse Event|7|||
13412696|NCT00524043|26839225|FG000|Overall Study|Lost to Follow-up|3|||
13412697|NCT00524043|26839226|FG001|Overall Study|Lost to Follow-up|5|||
13412698|NCT00524043|26839227|FG002|Overall Study|Lost to Follow-up|3|||
13412699|NCT00524043|26839225|FG000|Overall Study|Various (eg, incarceration)|2|||
13412700|NCT00524043|26839226|FG001|Overall Study|Various (eg, incarceration)|1|||
13412701|NCT00524043|26839227|FG002|Overall Study|Various (eg, incarceration)|0|||
13412702|NCT00524030|26839252|FG000|Overall Study|Lack of Efficacy|10|||
13412703|NCT00524030|26839253|FG001|Overall Study|Lack of Efficacy|24|||
13412704|NCT00524030|26839252|FG000|Overall Study|Lost to Follow-up|0|||
13412705|NCT00524030|26839253|FG001|Overall Study|Lost to Follow-up|2|||
13412706|NCT00524030|26839252|FG000|Overall Study|Withdrawal by Subject|3|||
13412707|NCT00524030|26839253|FG001|Overall Study|Withdrawal by Subject|8|||
13412708|NCT00524030|26839252|FG000|Overall Study|Noncompliance/Investigator discretion|0|||
13412709|NCT00524030|26839253|FG001|Overall Study|Noncompliance/Investigator discretion|2|||
13412710|NCT00524030|26839252|FG000|Overall Study|Protocol Violation|0|||
13412711|NCT00524030|26839253|FG001|Overall Study|Protocol Violation|1|||
13412712|NCT00524030|26839252|FG000|Overall Study|Pregnancy|1|||
13412713|NCT00524030|26839253|FG001|Overall Study|Pregnancy|0|||
13412714|NCT00524030|26839252|FG000|Overall Study|Adverse Event|3|||
13412715|NCT00524030|26839253|FG001|Overall Study|Adverse Event|21|||
13412716|NCT00524030|26839252|FG000|Overall Study|Death|0|||
13412717|NCT00524030|26839253|FG001|Overall Study|Death|1|||
13412718|NCT00523991|26839538|FG000|Overall Study|Adverse Event|6|||
13412719|NCT00523991|26839539|FG001|Overall Study|Adverse Event|5|||
13412720|NCT00523991|26839538|FG000|Overall Study|Protocol Violation|1|||
13412721|NCT00523991|26839539|FG001|Overall Study|Protocol Violation|4|||
13412722|NCT00523991|26839538|FG000|Overall Study|Lost to Follow-up|4|||
13412723|NCT00523991|26839539|FG001|Overall Study|Lost to Follow-up|1|||
13412724|NCT00523991|26839538|FG000|Overall Study|Withdrawal by Subject|7|||
13412725|NCT00523991|26839539|FG001|Overall Study|Withdrawal by Subject|17|||
13412726|NCT00523991|26839538|FG000|Overall Study|Other reason (not specified)|3|||
13412727|NCT00523991|26839539|FG001|Overall Study|Other reason (not specified)|0|||
13412728|NCT00523978|26839558|FG000|Overall Study|Withdrawal by Subject|3|||
13412729|NCT00523978|26839559|FG001|Overall Study|Withdrawal by Subject|7|||
13412730|NCT00523978|26839558|FG000|Overall Study|Screen Failures|5|||
13412731|NCT00523978|26839559|FG001|Overall Study|Screen Failures|1|||
13412732|NCT00523978|26839558|FG000|Overall Study|Death|1|||
13412733|NCT00523978|26839559|FG001|Overall Study|Death|0|||
13412734|NCT00523848|26839567|FG000|Overall Study|Adverse Event|11|||
13412735|NCT00523848|26839567|FG000|Overall Study|Withdrawal by Subject|2|||
13412736|NCT00523848|26839567|FG000|Overall Study|NOT TREATED (Became ineligible)|2|||
13412737|NCT00523848|26839567|FG000|Overall Study|Disease Progression|5|||
13412738|NCT00523848|26839567|FG000|Overall Study|Other, unspecified|4|||
13412739|NCT00523744|26839586|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2|||
13412740|NCT00523744|26839586|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1|||
13412741|NCT00523744|26839586|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2|||
13412742|NCT00523744|26839586|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1|||
13412743|NCT00523744|26839586|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2|||
13412744|NCT00523744|26839586|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1|||
13412745|NCT00523718|26839605|FG000|Overall Study|Withdrawal by Subject|1|||
13412746|NCT00523718|26839606|FG001|Overall Study|Withdrawal by Subject|0|||
13412747|NCT00523718|26839605|FG000|Overall Study|Protocol Violation|2|||
13412748|NCT00523718|26839606|FG001|Overall Study|Protocol Violation|0|||
13412749|NCT00523705|26839625|FG000|Overall Study|No time for study.|0|||
13412750|NCT00523705|26839626|FG001|Overall Study|No time for study.|1|||
13412751|NCT00523640|26839634|FG000|Overall Study|Death|1|||
13412752|NCT00523549|26839659|FG000|Overall Study|Adverse Event|6|||
13412753|NCT00523549|26839660|FG001|Overall Study|Adverse Event|3|||
13412754|NCT00523549|26839659|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
13412755|NCT00523549|26839660|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
13412756|NCT00523549|26839659|FG000|Overall Study|Protocol Deviation|3|||
13412757|NCT00523549|26839660|FG001|Overall Study|Protocol Deviation|1|||
13412758|NCT00523549|26839659|FG000|Overall Study|Patient withdrew consent|7|||
13412759|NCT00523549|26839660|FG001|Overall Study|Patient withdrew consent|6|||
13412760|NCT00523549|26839659|FG000|Overall Study|Lost to Follow-up|3|||
13412761|NCT00523549|26839660|FG001|Overall Study|Lost to Follow-up|5|||
13412762|NCT00523419|26839672|FG000|Overall Study|Adverse Event|1|||
13412763|NCT00523419|26839672|FG000|Overall Study|Withdrawal by Subject|1|||
13412764|NCT00523419|26839672|FG000|Overall Study|Physician Decision|2|||
13412765|NCT00523419|26839672|FG000|Overall Study|Progressive Disease|22|||
13412766|NCT00523419|26839672|FG000|Overall Study|Death due to Study Disease|4|||
13412767|NCT00523419|26839672|FG000|Overall Study|Death due to Adverse Event|2|||
13412768|NCT00523367|26839678|FG000|Overall Study|19 screen failures|19|||
13412769|NCT00523367|26839678|FG000|Overall Study|4 Withdrawn by PI|4|||
13412770|NCT00522951|26839721|FG000|Period 1|body motion|0|||
13412771|NCT00522951|26839722|FG001|Period 1|body motion|1|||
13412772|NCT00522951|26839721|FG000|Washout Period|Adverse Event|0|||
13412773|NCT00522951|26839722|FG001|Washout Period|Adverse Event|1|||
13412774|NCT00522951|26839721|FG000|Washout Period|Death|0|||
13412775|NCT00522951|26839722|FG001|Washout Period|Death|1|||
13412776|NCT00522951|26839721|FG000|Period 2|Withdrawal by Subject|1|||
13412777|NCT00522951|26839722|FG001|Period 2|Withdrawal by Subject|0|||
13412778|NCT00522951|26839721|FG000|Period 2|residual contrast medium|1|||
13412779|NCT00522951|26839722|FG001|Period 2|residual contrast medium|1|||
13412780|NCT00522873|26839738|FG000|Overall Study|Adverse Event|41|||
13412781|NCT00522873|26839739|FG001|Overall Study|Adverse Event|26|||
13412782|NCT00522873|26839738|FG000|Overall Study|Withdrawal by Subject|20|||
13412783|NCT00522873|26839739|FG001|Overall Study|Withdrawal by Subject|9|||
13412784|NCT00522873|26839738|FG000|Overall Study|Protocol Violation|14|||
13412785|NCT00522873|26839739|FG001|Overall Study|Protocol Violation|4|||
13412786|NCT00522873|26839738|FG000|Overall Study|Lost to Follow-up|11|||
13412787|NCT00522873|26839739|FG001|Overall Study|Lost to Follow-up|3|||
13412788|NCT00522873|26839738|FG000|Overall Study|Personal Reasons|8|||
13412789|NCT00522873|26839739|FG001|Overall Study|Personal Reasons|1|||
13412790|NCT00522873|26839738|FG000|Overall Study|Medication Errors|1|||
13412791|NCT00522873|26839739|FG001|Overall Study|Medication Errors|1|||
13412792|NCT00522873|26839738|FG000|Overall Study|Never Received Medication|1|||
13412793|NCT00522873|26839739|FG001|Overall Study|Never Received Medication|0|||
13412794|NCT00522626|26839745|FG000|Overall Study|Lost to Follow-up|7|||
13412795|NCT00522548|26839780|FG000|Overall Study|Adverse Event|2|||
13412796|NCT00522548|26839781|FG001|Overall Study|Adverse Event|2|||
13412797|NCT00522548|26839780|FG000|Overall Study|Withdrawal by Subject|0|||
13412798|NCT00522548|26839781|FG001|Overall Study|Withdrawal by Subject|2|||
13412799|NCT00522457|26839789|FG000|Overall Study|Due to disease progression|16|||
13412800|NCT00522457|26839789|FG000|Overall Study|Adverse Event|2|||
13412801|NCT00522431|26839796|FG000|Overall Study|Adverse Event|5|||
13412802|NCT00522431|26839796|FG000|Overall Study|Protocol Violation|2|||
13412803|NCT00522431|26839796|FG000|Overall Study|Withdrawal by Subject|2|||
13412804|NCT00522431|26839796|FG000|Overall Study|Subject non-compliance|1|||
13412805|NCT00522431|26839796|FG000|Overall Study|Other/unknown|1|||
13412806|NCT00522418|26839849|FG000|Overall Study|Local IRB Consent Violation|5|||
13412807|NCT00522418|26839850|FG001|Overall Study|Local IRB Consent Violation|5|||
13412808|NCT00522418|26839849|FG000|Overall Study|Early Study Termination|46|||
13412809|NCT00522418|26839850|FG001|Overall Study|Early Study Termination|47|||
13412810|NCT00522418|26839849|FG000|Overall Study|Noncompliance|2|||
13412811|NCT00522418|26839850|FG001|Overall Study|Noncompliance|2|||
13412812|NCT00522418|26839849|FG000|Overall Study|Reason Not Specified|3|||
13412813|NCT00522418|26839850|FG001|Overall Study|Reason Not Specified|1|||
13412814|NCT00522418|26839849|FG000|Overall Study|Consent Withdraw|1|||
13412815|NCT00522418|26839850|FG001|Overall Study|Consent Withdraw|2|||
13412816|NCT00522418|26839849|FG000|Overall Study|Lack of Efficacy|0|||
13412817|NCT00522418|26839850|FG001|Overall Study|Lack of Efficacy|1|||
13412818|NCT00522392|26839869|FG000|Overall Study|Disease progression|0|||
13412819|NCT00522392|26839870|FG001|Overall Study|Disease progression|3|||
13412820|NCT00522392|26839869|FG000|Overall Study|Adverse Event|7|||
13412821|NCT00522392|26839870|FG001|Overall Study|Adverse Event|7|||
13412822|NCT00522392|26839869|FG000|Overall Study|Withdrawal by Subject|1|||
13412823|NCT00522392|26839870|FG001|Overall Study|Withdrawal by Subject|1|||
13412824|NCT00522392|26839869|FG000|Overall Study|Physician Decision|0|||
13412825|NCT00522392|26839870|FG001|Overall Study|Physician Decision|1|||
13412826|NCT00522392|26839869|FG000|Overall Study|Non-compliance|0|||
13412827|NCT00522392|26839870|FG001|Overall Study|Non-compliance|1|||
13412828|NCT00522379|26839988|FG000|Overall Study|Adverse Event|12|||
13412829|NCT00522379|26839989|FG001|Overall Study|Adverse Event|15|||
13412830|NCT00522379|26839990|FG002|Overall Study|Adverse Event|12|||
13412831|NCT00522379|26839991|FG003|Overall Study|Adverse Event|5|||
13412832|NCT00522379|26839992|FG004|Overall Study|Adverse Event|17|||
13412833|NCT00522379|26839988|FG000|Overall Study|Lack of Efficacy|3|||
13412834|NCT00522379|26839989|FG001|Overall Study|Lack of Efficacy|0|||
13412835|NCT00522379|26839990|FG002|Overall Study|Lack of Efficacy|2|||
13412836|NCT00522379|26839991|FG003|Overall Study|Lack of Efficacy|2|||
13412837|NCT00522379|26839992|FG004|Overall Study|Lack of Efficacy|7|||
13412838|NCT00522379|26839988|FG000|Overall Study|Withdrawal by Subject|2|||
13412839|NCT00522379|26839989|FG001|Overall Study|Withdrawal by Subject|3|||
13412840|NCT00522379|26839990|FG002|Overall Study|Withdrawal by Subject|1|||
13412841|NCT00522379|26839991|FG003|Overall Study|Withdrawal by Subject|2|||
13412842|NCT00522379|26839992|FG004|Overall Study|Withdrawal by Subject|0|||
13412843|NCT00522379|26839988|FG000|Overall Study|Protocol Violation|1|||
13412844|NCT00522379|26839989|FG001|Overall Study|Protocol Violation|1|||
13412845|NCT00522379|26839990|FG002|Overall Study|Protocol Violation|2|||
13412846|NCT00522379|26839991|FG003|Overall Study|Protocol Violation|0|||
13412847|NCT00522379|26839992|FG004|Overall Study|Protocol Violation|0|||
13412848|NCT00522379|26839988|FG000|Overall Study|Unsatisfactory Subject Compliance|1|||
13412849|NCT00522379|26839989|FG001|Overall Study|Unsatisfactory Subject Compliance|2|||
13412850|NCT00522379|26839990|FG002|Overall Study|Unsatisfactory Subject Compliance|0|||
13412851|NCT00522379|26839991|FG003|Overall Study|Unsatisfactory Subject Compliance|0|||
13412852|NCT00522379|26839992|FG004|Overall Study|Unsatisfactory Subject Compliance|0|||
13412853|NCT00522379|26839988|FG000|Overall Study|Lost to Follow-up|1|||
13412854|NCT00522379|26839989|FG001|Overall Study|Lost to Follow-up|0|||
13412855|NCT00522379|26839990|FG002|Overall Study|Lost to Follow-up|4|||
13412856|NCT00522379|26839991|FG003|Overall Study|Lost to Follow-up|2|||
13412857|NCT00522379|26839992|FG004|Overall Study|Lost to Follow-up|2|||
13412858|NCT00522379|26839988|FG000|Overall Study|Randomization error|0|||
13412859|NCT00522379|26839989|FG001|Overall Study|Randomization error|0|||
13412860|NCT00522379|26839990|FG002|Overall Study|Randomization error|0|||
13412861|NCT00522379|26839991|FG003|Overall Study|Randomization error|0|||
13412862|NCT00522379|26839992|FG004|Overall Study|Randomization error|1|||
13412863|NCT00522379|26839988|FG000|Overall Study|Dispensing error|1|||
13412864|NCT00522379|26839989|FG001|Overall Study|Dispensing error|0|||
13412865|NCT00522379|26839990|FG002|Overall Study|Dispensing error|0|||
13412866|NCT00522379|26839991|FG003|Overall Study|Dispensing error|1|||
13412867|NCT00522379|26839992|FG004|Overall Study|Dispensing error|0|||
13412868|NCT00522379|26839988|FG000|Overall Study|Subject Moved|1|||
13412869|NCT00522379|26839989|FG001|Overall Study|Subject Moved|1|||
13412870|NCT00522379|26839990|FG002|Overall Study|Subject Moved|0|||
13412871|NCT00522379|26839991|FG003|Overall Study|Subject Moved|0|||
13412872|NCT00522379|26839992|FG004|Overall Study|Subject Moved|0|||
13412873|NCT00522379|26839988|FG000|Overall Study|Sponsor Request|0|||
13412874|NCT00522379|26839989|FG001|Overall Study|Sponsor Request|1|||
13412875|NCT00522379|26839990|FG002|Overall Study|Sponsor Request|0|||
13412876|NCT00522379|26839991|FG003|Overall Study|Sponsor Request|0|||
13412877|NCT00522379|26839992|FG004|Overall Study|Sponsor Request|0|||
13412878|NCT00522379|26839988|FG000|Overall Study|Family Problem|0|||
13412879|NCT00522379|26839989|FG001|Overall Study|Family Problem|0|||
13412880|NCT00522379|26839990|FG002|Overall Study|Family Problem|1|||
13412881|NCT00522379|26839991|FG003|Overall Study|Family Problem|0|||
13412882|NCT00522379|26839992|FG004|Overall Study|Family Problem|0|||
13412883|NCT00522379|26839988|FG000|Overall Study|Site Closed|0|||
13412884|NCT00522379|26839989|FG001|Overall Study|Site Closed|0|||
13412885|NCT00522379|26839990|FG002|Overall Study|Site Closed|0|||
13412886|NCT00522379|26839991|FG003|Overall Study|Site Closed|1|||
13412887|NCT00522379|26839992|FG004|Overall Study|Site Closed|0|||
13412888|NCT00522379|26839988|FG000|Overall Study|Subject Withdrawal|0|||
13412889|NCT00522379|26839989|FG001|Overall Study|Subject Withdrawal|0|||
13412890|NCT00522379|26839990|FG002|Overall Study|Subject Withdrawal|0|||
13412891|NCT00522379|26839991|FG003|Overall Study|Subject Withdrawal|1|||
13412892|NCT00522379|26839992|FG004|Overall Study|Subject Withdrawal|0|||
13412893|NCT00522301|26839998|FG000|Overall Study|Withdrawal by Subject|1|||
13412894|NCT00522301|26839998|FG000|Overall Study|Adverse Event|5|||
13412895|NCT00522275|26840008|FG000|Overall Study|Adverse Event|35|||
13412896|NCT00522275|26840008|FG000|Overall Study|Lack of Efficacy|80|||
13412897|NCT00522275|26840008|FG000|Overall Study|Subject withdrew consent|16|||
13412898|NCT00522275|26840008|FG000|Overall Study|Protocol deviation|1|||
13412899|NCT00522275|26840008|FG000|Overall Study|Unsatisfactory compliance|11|||
13412900|NCT00522275|26840008|FG000|Overall Study|Lost to Follow-up|8|||
13412901|NCT00522275|26840008|FG000|Overall Study|Other: Subject wants to become pregnant|2|||
13412902|NCT00522275|26840008|FG000|Overall Study|Other: Subject is pregnant|2|||
13412903|NCT00522275|26840008|FG000|Overall Study|Other: Subject relocated|2|||
13412904|NCT00522275|26840008|FG000|Overall Study|Other: Subject arrested|1|||
13412905|NCT00522275|26840008|FG000|Overall Study|Other: Site / clinic closed|4|||
13412906|NCT00522275|26840008|FG000|Overall Study|Other: Travel to / from site difficulty|3|||
13412907|NCT00522275|26840008|FG000|Overall Study|Other: Sponsor request|2|||
13412908|NCT00522275|26840008|FG000|Overall Study|Other: Subject ran out of medication|1|||
13412909|NCT00522275|26840008|FG000|Overall Study|Other: Subject had surgery for epilepsy|2|||
13412910|NCT00522041|26840025|FG000|Overall Study|Adverse Event|9|||
13412911|NCT00522041|26840026|FG001|Overall Study|Adverse Event|3|||
13412912|NCT00522041|26840025|FG000|Overall Study|Protocol Violation|2|||
13412913|NCT00522041|26840026|FG001|Overall Study|Protocol Violation|0|||
13412914|NCT00522041|26840025|FG000|Overall Study|Lost to Follow-up|1|||
13412915|NCT00522041|26840026|FG001|Overall Study|Lost to Follow-up|4|||
13412916|NCT00522041|26840025|FG000|Overall Study|Voluntary withdrawal|5|||
13412917|NCT00522041|26840026|FG001|Overall Study|Voluntary withdrawal|4|||
13412918|NCT00522041|26840025|FG000|Overall Study|Did not receive treatment|0|||
13412919|NCT00522041|26840026|FG001|Overall Study|Did not receive treatment|1|||
13412920|NCT00521586|26840091|FG000|Initial Vaccination (Year 0)|Subject request|8|||
13412921|NCT00521586|26840092|FG001|Initial Vaccination (Year 0)|Subject request|11|||
13412922|NCT00521586|26840091|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5|||
13412923|NCT00521586|26840092|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10|||
13412924|NCT00521586|26840091|FG000|Initial Vaccination (Year 0)|Protocol Violation|2|||
13412925|NCT00521586|26840092|FG001|Initial Vaccination (Year 0)|Protocol Violation|5|||
13412926|NCT00521586|26840091|FG000|Initial Vaccination (Year 0)|Other, unspecified|3|||
13412927|NCT00521586|26840092|FG001|Initial Vaccination (Year 0)|Other, unspecified|1|||
13412928|NCT00521586|26840091|FG000|Initial Vaccination (Year 0)|Investigator request|2|||
13412929|NCT00521586|26840092|FG001|Initial Vaccination (Year 0)|Investigator request|0|||
13412930|NCT00521586|26840091|FG000|Initial Vaccination (Year 0)|Adverse Event|0|||
13412931|NCT00521586|26840092|FG001|Initial Vaccination (Year 0)|Adverse Event|1|||
13412932|NCT00521586|26840091|FG000|Initial Vaccination (Year 0)|Death|1|||
13412933|NCT00521586|26840092|FG001|Initial Vaccination (Year 0)|Death|0|||
13412934|NCT00521586|26840091|FG000|Initial Vaccination (Year 0)|Failed to return|0|||
13412935|NCT00521586|26840092|FG001|Initial Vaccination (Year 0)|Failed to return|1|||
13412936|NCT00521586|26840091|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5|||
13412937|NCT00521586|26840092|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1|||
13412938|NCT00521586|26840091|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5|||
13412939|NCT00521586|26840092|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2|||
13412940|NCT00521586|26840091|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7|||
13412941|NCT00521586|26840092|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3|||
13412942|NCT00521586|26840091|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
13412943|NCT00521586|26840092|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
13412944|NCT00521586|26840091|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55|||
13412945|NCT00521586|26840092|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56|||
13412946|NCT00521586|26840091|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22|||
13412947|NCT00521586|26840092|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26|||
13412948|NCT00521586|26840091|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18|||
13412949|NCT00521586|26840092|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22|||
13412950|NCT00521586|26840091|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54|||
13412951|NCT00521586|26840092|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57|||
13412952|NCT00521586|26840091|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0|||
13412953|NCT00521586|26840092|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1|||
13412954|NCT00521586|26840091|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1|||
13412955|NCT00521586|26840092|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4|||
13412956|NCT00521586|26840091|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2|||
13412957|NCT00521586|26840092|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7|||
13412958|NCT00521404|26840103|FG000|Overall Study|Adverse Event|13|||
13412959|NCT00521404|26840103|FG000|Overall Study|Disease Progression|33|||
13412960|NCT00521404|26840103|FG000|Overall Study|Investigator decision|5|||
13412961|NCT00521404|26840103|FG000|Overall Study|Withdrawal of consent|3|||
13412962|NCT00521404|26840103|FG000|Overall Study|Noncompliance or lack of cooperation|1|||
13412963|NCT00521404|26840103|FG000|Overall Study|Other|7|||
13412964|NCT00521365|26840122|FG000|Overall Study|Adverse Event|3|||
13412965|NCT00521365|26840122|FG000|Overall Study|Lost to Follow-up|6|||
13412966|NCT00521365|26840122|FG000|Overall Study|Protocol deviation|2|||
13412967|NCT00521365|26840122|FG000|Overall Study|Drug compliance|3|||
13412968|NCT00521365|26840122|FG000|Overall Study|Usage of not allowed drugs|6|||
13412969|NCT00521339|26840189|FG000|Treatment Phase|Adverse Event|2|||
13412970|NCT00521339|26840190|FG001|Treatment Phase|Adverse Event|0|||
13412971|NCT00521339|26840191|FG002|Treatment Phase|Adverse Event|0|||
13412972|NCT00521339|26840189|FG000|Treatment Phase|Intolerability to study drug|2|||
13476440|NCT01423851|27002853|FG006|Whole Study|Adverse Event|0|||
13412973|NCT00521339|26840190|FG001|Treatment Phase|Intolerability to study drug|0|||
13412974|NCT00521339|26840191|FG002|Treatment Phase|Intolerability to study drug|0|||
13412975|NCT00521339|26840189|FG000|Treatment Phase|Lack of Efficacy|3|||
13412976|NCT00521339|26840190|FG001|Treatment Phase|Lack of Efficacy|0|||
13412977|NCT00521339|26840191|FG002|Treatment Phase|Lack of Efficacy|0|||
13412978|NCT00521339|26840189|FG000|Treatment Phase|Withdrawal by Subject|3|||
13412979|NCT00521339|26840190|FG001|Treatment Phase|Withdrawal by Subject|0|||
13412980|NCT00521339|26840191|FG002|Treatment Phase|Withdrawal by Subject|0|||
13412981|NCT00521339|26840189|FG000|Treatment Phase|Lost to Follow-up|1|||
13412982|NCT00521339|26840190|FG001|Treatment Phase|Lost to Follow-up|0|||
13412983|NCT00521339|26840191|FG002|Treatment Phase|Lost to Follow-up|0|||
13412984|NCT00521339|26840189|FG000|Treatment Phase|Protocol Violation|1|||
13412985|NCT00521339|26840190|FG001|Treatment Phase|Protocol Violation|0|||
13412986|NCT00521339|26840191|FG002|Treatment Phase|Protocol Violation|0|||
13412987|NCT00521339|26840189|FG000|Treatment Extension Phase|Withdrawal by Subject|0|||
13412988|NCT00521339|26840190|FG001|Treatment Extension Phase|Withdrawal by Subject|0|||
13412989|NCT00521339|26840191|FG002|Treatment Extension Phase|Withdrawal by Subject|2|||
13412990|NCT00521339|26840189|FG000|Treatment Extension Phase|Death|0|||
13412991|NCT00521339|26840190|FG001|Treatment Extension Phase|Death|0|||
13412992|NCT00521339|26840191|FG002|Treatment Extension Phase|Death|1|||
13412993|NCT00521144|26840219|FG000|Overall Study|Not Treated|0|||
13412994|NCT00521144|26840220|FG001|Overall Study|Not Treated|0|||
13412995|NCT00521144|26840221|FG002|Overall Study|Not Treated|0|||
13412996|NCT00521144|26840222|FG003|Overall Study|Not Treated|1|||
13412997|NCT00521144|26840223|FG004|Overall Study|Not Treated|0|||
13412998|NCT00521144|26840219|FG000|Overall Study|Adverse Event|0|||
13412999|NCT00521144|26840220|FG001|Overall Study|Adverse Event|1|||
13413000|NCT00521144|26840221|FG002|Overall Study|Adverse Event|0|||
13413001|NCT00521144|26840222|FG003|Overall Study|Adverse Event|0|||
13413002|NCT00521144|26840223|FG004|Overall Study|Adverse Event|1|||
13413003|NCT00521144|26840219|FG000|Overall Study|Progressive Disease|4|||
13413004|NCT00521144|26840220|FG001|Overall Study|Progressive Disease|2|||
13413005|NCT00521144|26840221|FG002|Overall Study|Progressive Disease|2|||
13413006|NCT00521144|26840222|FG003|Overall Study|Progressive Disease|0|||
13413007|NCT00521144|26840223|FG004|Overall Study|Progressive Disease|6|||
13413008|NCT00521079|26840240|FG000|Overall Study|Adverse Event|7|||
13413009|NCT00521079|26840241|FG001|Overall Study|Adverse Event|1|||
13413010|NCT00521079|26840240|FG000|Overall Study|Lost to Follow-up|2|||
13413011|NCT00521079|26840241|FG001|Overall Study|Lost to Follow-up|1|||
13413012|NCT00521079|26840240|FG000|Overall Study|Withdrawal by Subject|5|||
13413013|NCT00521079|26840241|FG001|Overall Study|Withdrawal by Subject|3|||
13413014|NCT00521053|26840253|FG000|Observation Phase|Disease Progression|55|||
13413015|NCT00521053|26840253|FG000|Observation Phase|Additional PV-10 via alternate protocol|8|||
13413016|NCT00521053|26840253|FG000|Observation Phase|Death|2|||
13413017|NCT00521053|26840253|FG000|Observation Phase|Adverse Event|1|||
13413018|NCT00521053|26840253|FG000|Observation Phase|Other non-study melanoma treatment|1|||
13413019|NCT00521053|26840253|FG000|Observation Phase|Physician Decision|1|||
13413020|NCT00521014|26840259|FG000|Overall Study|Inevaluable, not treated|1|||
13413021|NCT00521001|26840268|FG000|Overall Study|Ineligible|1|||
13413022|NCT00520975|26840299|FG000|Overall Study|Disease progression|31|||
13413023|NCT00520975|26840300|FG001|Overall Study|Disease progression|23|||
13413024|NCT00520975|26840299|FG000|Overall Study|Adverse Event|7|||
13413025|NCT00520975|26840300|FG001|Overall Study|Adverse Event|10|||
13413026|NCT00520975|26840299|FG000|Overall Study|Death|0|||
13413027|NCT00520975|26840300|FG001|Overall Study|Death|2|||
13413028|NCT00520975|26840299|FG000|Overall Study|Withdrawal by Subject|3|||
13413029|NCT00520975|26840300|FG001|Overall Study|Withdrawal by Subject|5|||
13413030|NCT00520975|26840299|FG000|Overall Study|Other therapy|2|||
13413031|NCT00520975|26840300|FG001|Overall Study|Other therapy|4|||
13413032|NCT00520975|26840299|FG000|Overall Study|Other reasons|4|||
13413033|NCT00520975|26840300|FG001|Overall Study|Other reasons|2|||
13413034|NCT00520975|26840299|FG000|Overall Study|Not start protocol therapy|1|||
13413035|NCT00520975|26840300|FG001|Overall Study|Not start protocol therapy|2|||
13413036|NCT00520936|26840352|FG000|Overall Study|Physician Decision|0|||
13413037|NCT00520936|26840353|FG001|Overall Study|Physician Decision|2|||
13413038|NCT00520936|26840354|FG002|Overall Study|Physician Decision|1|||
13413039|NCT00520936|26840355|FG003|Overall Study|Physician Decision|0|||
13413040|NCT00520936|26840356|FG004|Overall Study|Physician Decision|0|||
13413041|NCT00520936|26840357|FG005|Overall Study|Physician Decision|0|||
13413042|NCT00520936|26840358|FG006|Overall Study|Physician Decision|0|||
13413043|NCT00520936|26840359|FG007|Overall Study|Physician Decision|0|||
13413044|NCT00520936|26840352|FG000|Overall Study|Withdrawal by Subject|0|||
13413045|NCT00520936|26840353|FG001|Overall Study|Withdrawal by Subject|0|||
13413046|NCT00520936|26840354|FG002|Overall Study|Withdrawal by Subject|0|||
13413047|NCT00520936|26840355|FG003|Overall Study|Withdrawal by Subject|0|||
13413048|NCT00520936|26840356|FG004|Overall Study|Withdrawal by Subject|0|||
13413049|NCT00520936|26840357|FG005|Overall Study|Withdrawal by Subject|0|||
13413050|NCT00520936|26840358|FG006|Overall Study|Withdrawal by Subject|0|||
13413051|NCT00520936|26840359|FG007|Overall Study|Withdrawal by Subject|1|||
13413052|NCT00520936|26840352|FG000|Overall Study|Toxicity Requiring Removal from Study|0|||
13413053|NCT00520936|26840353|FG001|Overall Study|Toxicity Requiring Removal from Study|1|||
13413054|NCT00520936|26840354|FG002|Overall Study|Toxicity Requiring Removal from Study|0|||
13413055|NCT00520936|26840355|FG003|Overall Study|Toxicity Requiring Removal from Study|0|||
13413056|NCT00520936|26840356|FG004|Overall Study|Toxicity Requiring Removal from Study|0|||
13413057|NCT00520936|26840357|FG005|Overall Study|Toxicity Requiring Removal from Study|0|||
13413058|NCT00520936|26840358|FG006|Overall Study|Toxicity Requiring Removal from Study|2|||
13413059|NCT00520936|26840359|FG007|Overall Study|Toxicity Requiring Removal from Study|0|||
13413060|NCT00520936|26840352|FG000|Overall Study|Death|0|||
13413061|NCT00520936|26840353|FG001|Overall Study|Death|0|||
13413062|NCT00520936|26840354|FG002|Overall Study|Death|0|||
13413063|NCT00520936|26840355|FG003|Overall Study|Death|0|||
13413064|NCT00520936|26840356|FG004|Overall Study|Death|0|||
13413065|NCT00520936|26840357|FG005|Overall Study|Death|0|||
13413066|NCT00520936|26840358|FG006|Overall Study|Death|1|||
13413067|NCT00520936|26840359|FG007|Overall Study|Death|0|||
13413068|NCT00520936|26840352|FG000|Overall Study|Protocol Violation|0|||
13413069|NCT00520936|26840353|FG001|Overall Study|Protocol Violation|1|||
13413070|NCT00520936|26840354|FG002|Overall Study|Protocol Violation|1|||
13413071|NCT00520936|26840355|FG003|Overall Study|Protocol Violation|0|||
13413072|NCT00520936|26840356|FG004|Overall Study|Protocol Violation|1|||
13413073|NCT00520936|26840357|FG005|Overall Study|Protocol Violation|0|||
13413074|NCT00520936|26840358|FG006|Overall Study|Protocol Violation|1|||
13413075|NCT00520936|26840359|FG007|Overall Study|Protocol Violation|0|||
13413076|NCT00520845|26840369|FG000|Overall Study|Death|3|||
13413077|NCT00520845|26840369|FG000|Overall Study|Adverse Event|4|||
13413078|NCT00520845|26840369|FG000|Overall Study|Disease Progression, relapse|13|||
13413079|NCT00520845|26840369|FG000|Overall Study|Withdrawal by Subject|1|||
13413080|NCT00520845|26840369|FG000|Overall Study|Alternative Therapy|1|||
13413081|NCT00520767|26840375|FG000|Overall Study|Death|2|||
13413082|NCT00520741|26840398|FG000|Overall Study|Adverse Event|16|||
13413083|NCT00520741|26840399|FG001|Overall Study|Adverse Event|56|||
13413084|NCT00520741|26840398|FG000|Overall Study|Lack of Efficacy|11|||
13413085|NCT00520741|26840399|FG001|Overall Study|Lack of Efficacy|30|||
13413086|NCT00520741|26840398|FG000|Overall Study|Withdrawal by Subject|0|||
13413087|NCT00520741|26840399|FG001|Overall Study|Withdrawal by Subject|11|||
13413088|NCT00520741|26840398|FG000|Overall Study|Protocol Violation|2|||
13413089|NCT00520741|26840399|FG001|Overall Study|Protocol Violation|15|||
13413090|NCT00520741|26840398|FG000|Overall Study|Unsatisfactory compliance of subject|4|||
13413091|NCT00520741|26840399|FG001|Overall Study|Unsatisfactory compliance of subject|3|||
13413092|NCT00520741|26840398|FG000|Overall Study|Lost to Follow-up|4|||
13413093|NCT00520741|26840399|FG001|Overall Study|Lost to Follow-up|4|||
13413094|NCT00520741|26840398|FG000|Overall Study|Other reasons for premature termination|0|||
13413095|NCT00520741|26840399|FG001|Overall Study|Other reasons for premature termination|6|||
13413096|NCT00520676|26840426|FG000|Overall Study|Death|84|||
13413097|NCT00520676|26840427|FG001|Overall Study|Death|81|||
13413098|NCT00520676|26840426|FG000|Overall Study|Lost to Follow-up|6|||
13413099|NCT00520676|26840427|FG001|Overall Study|Lost to Follow-up|10|||
13413100|NCT00520676|26840426|FG000|Overall Study|Physician Decision|4|||
13413101|NCT00520676|26840427|FG001|Overall Study|Physician Decision|1|||
13413102|NCT00520676|26840426|FG000|Overall Study|Withdrawal by Subject|7|||
13413103|NCT00520676|26840427|FG001|Overall Study|Withdrawal by Subject|11|||
13413104|NCT00520572|26840484|FG000|Overall Study|Adverse Event|9|||
13413105|NCT00520572|26840485|FG001|Overall Study|Adverse Event|3|||
13413106|NCT00520572|26840486|FG002|Overall Study|Adverse Event|6|||
13413107|NCT00520572|26840487|FG003|Overall Study|Adverse Event|9|||
13413108|NCT00520572|26840488|FG004|Overall Study|Adverse Event|7|||
13413109|NCT00520572|26840489|FG005|Overall Study|Adverse Event|2|||
13413110|NCT00520572|26840484|FG000|Overall Study|Withdrawal by Subject|0|||
13413111|NCT00520572|26840485|FG001|Overall Study|Withdrawal by Subject|9|||
13413112|NCT00520572|26840486|FG002|Overall Study|Withdrawal by Subject|5|||
13413113|NCT00520572|26840487|FG003|Overall Study|Withdrawal by Subject|2|||
13413114|NCT00520572|26840488|FG004|Overall Study|Withdrawal by Subject|2|||
13413115|NCT00520572|26840489|FG005|Overall Study|Withdrawal by Subject|0|||
13413116|NCT00520572|26840484|FG000|Overall Study|Protocol Violation|0|||
13413117|NCT00520572|26840485|FG001|Overall Study|Protocol Violation|0|||
13413118|NCT00520572|26840486|FG002|Overall Study|Protocol Violation|1|||
13413119|NCT00520572|26840487|FG003|Overall Study|Protocol Violation|0|||
13413120|NCT00520572|26840488|FG004|Overall Study|Protocol Violation|0|||
13413121|NCT00520572|26840489|FG005|Overall Study|Protocol Violation|0|||
13413122|NCT00520572|26840484|FG000|Overall Study|Lack of Efficacy|1|||
13413123|NCT00520572|26840485|FG001|Overall Study|Lack of Efficacy|1|||
13413124|NCT00520572|26840486|FG002|Overall Study|Lack of Efficacy|1|||
13413125|NCT00520572|26840487|FG003|Overall Study|Lack of Efficacy|2|||
13413126|NCT00520572|26840488|FG004|Overall Study|Lack of Efficacy|1|||
13413127|NCT00520572|26840489|FG005|Overall Study|Lack of Efficacy|0|||
13413128|NCT00520572|26840484|FG000|Overall Study|Lost to Follow-up|0|||
13413129|NCT00520572|26840485|FG001|Overall Study|Lost to Follow-up|0|||
13413130|NCT00520572|26840486|FG002|Overall Study|Lost to Follow-up|0|||
13413131|NCT00520572|26840487|FG003|Overall Study|Lost to Follow-up|0|||
13413132|NCT00520572|26840488|FG004|Overall Study|Lost to Follow-up|1|||
13413133|NCT00520572|26840489|FG005|Overall Study|Lost to Follow-up|0|||
13413134|NCT00520572|26840484|FG000|Overall Study|Incorrect enrollment|1|||
13413135|NCT00520572|26840485|FG001|Overall Study|Incorrect enrollment|0|||
13413136|NCT00520572|26840486|FG002|Overall Study|Incorrect enrollment|1|||
13413137|NCT00520572|26840487|FG003|Overall Study|Incorrect enrollment|0|||
13413138|NCT00520572|26840488|FG004|Overall Study|Incorrect enrollment|1|||
13413139|NCT00520572|26840489|FG005|Overall Study|Incorrect enrollment|0|||
13413140|NCT00520572|26840484|FG000|Overall Study|Oral corticotherapy for acute urticaria|0|||
13413141|NCT00520572|26840485|FG001|Overall Study|Oral corticotherapy for acute urticaria|1|||
13413142|NCT00520572|26840486|FG002|Overall Study|Oral corticotherapy for acute urticaria|0|||
13413143|NCT00520572|26840487|FG003|Overall Study|Oral corticotherapy for acute urticaria|0|||
13413144|NCT00520572|26840488|FG004|Overall Study|Oral corticotherapy for acute urticaria|0|||
13413145|NCT00520572|26840489|FG005|Overall Study|Oral corticotherapy for acute urticaria|0|||
13413146|NCT00520572|26840484|FG000|Overall Study|Long break in taking Medication|0|||
13413147|NCT00520572|26840485|FG001|Overall Study|Long break in taking Medication|0|||
13413148|NCT00520572|26840486|FG002|Overall Study|Long break in taking Medication|0|||
13413149|NCT00520572|26840487|FG003|Overall Study|Long break in taking Medication|1|||
13413150|NCT00520572|26840488|FG004|Overall Study|Long break in taking Medication|0|||
13413151|NCT00520572|26840489|FG005|Overall Study|Long break in taking Medication|0|||
13413152|NCT00520572|26840484|FG000|Overall Study|Did not receive Treatment|1|||
13413153|NCT00520572|26840485|FG001|Overall Study|Did not receive Treatment|0|||
13413154|NCT00520572|26840486|FG002|Overall Study|Did not receive Treatment|1|||
13413155|NCT00520572|26840487|FG003|Overall Study|Did not receive Treatment|0|||
13413156|NCT00520572|26840488|FG004|Overall Study|Did not receive Treatment|0|||
13413157|NCT00520572|26840489|FG005|Overall Study|Did not receive Treatment|0|||
13413158|NCT00520546|26840506|FG000|Overall Study|Withdrawal by Subject|1|||
13413159|NCT00520546|26840506|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5|||
13413160|NCT00520494|26840531|FG000|Overall Study|Withdrawal by Subject|1|||
13413161|NCT00520481|26840558|FG000|Overall Study|Adverse Event|4|||
13413162|NCT00520481|26840559|FG001|Overall Study|Adverse Event|1|||
13413163|NCT00520481|26840558|FG000|Overall Study|Withdrawal by Subject|3|||
13413164|NCT00520481|26840559|FG001|Overall Study|Withdrawal by Subject|0|||
13413165|NCT00520403|26840568|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6|||
13413166|NCT00520403|26840568|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4|||
13413167|NCT00520403|26840568|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4|||
13413168|NCT00520403|26840568|FG000|Bevacizumab + IFN/Vinblastine|Death|2|||
13413169|NCT00520403|26840568|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1|||
13413170|NCT00520403|26840568|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1|||
13413171|NCT00520403|26840568|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1|||
13413172|NCT00520403|26840568|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1|||
13413173|NCT00520351|26840587|FG000|First Intervention|Withdrawal by Subject|1|||
13413174|NCT00520351|26840588|FG001|First Intervention|Withdrawal by Subject|1|||
13413175|NCT00520299|26840627|FG000|Overall Study|Withdrawal by Subject|0|||
13413176|NCT00520299|26840628|FG001|Overall Study|Withdrawal by Subject|0|||
13413177|NCT00520299|26840629|FG002|Overall Study|Withdrawal by Subject|2|||
13413178|NCT00520299|26840627|FG000|Overall Study|Progressive disease|0|||
13413179|NCT00520299|26840628|FG001|Overall Study|Progressive disease|3|||
13413180|NCT00520299|26840629|FG002|Overall Study|Progressive disease|4|||
13413181|NCT00520130|26840676|FG000|Overall Study|Disease progression on study|4|||
13413182|NCT00520130|26840677|FG001|Overall Study|Disease progression on study|0|||
13413183|NCT00520130|26840676|FG000|Overall Study|Physician Decision|1|||
13413184|NCT00520130|26840677|FG001|Overall Study|Physician Decision|1|||
13413185|NCT00520039|26840694|FG000|Overall Study|Exclusion criteria met at first visit|7|||
13413186|NCT00520039|26840695|FG001|Overall Study|Exclusion criteria met at first visit|5|||
13413187|NCT00520013|26840715|FG000|Overall Study|Withdrawal by Subject|0|||
13413188|NCT00520013|26840716|FG001|Overall Study|Withdrawal by Subject|0|||
13413189|NCT00520013|26840717|FG002|Overall Study|Withdrawal by Subject|1|||
13413190|NCT00520013|26840715|FG000|Overall Study|Adverse Event|2|||
13413191|NCT00520013|26840716|FG001|Overall Study|Adverse Event|10|||
13413192|NCT00520013|26840717|FG002|Overall Study|Adverse Event|7|||
13413193|NCT00520013|26840715|FG000|Overall Study|Progressive Disease|7|||
13413194|NCT00520013|26840716|FG001|Overall Study|Progressive Disease|3|||
13413195|NCT00520013|26840717|FG002|Overall Study|Progressive Disease|0|||
13413196|NCT00520013|26840715|FG000|Overall Study|Clinical Progression|3|||
13413197|NCT00520013|26840716|FG001|Overall Study|Clinical Progression|1|||
13413198|NCT00520013|26840717|FG002|Overall Study|Clinical Progression|0|||
13413199|NCT00520013|26840715|FG000|Overall Study|Death|0|||
13413200|NCT00520013|26840716|FG001|Overall Study|Death|1|||
13413201|NCT00520013|26840717|FG002|Overall Study|Death|0|||
13413202|NCT00520013|26840715|FG000|Overall Study|Physician Decision|0|||
13413203|NCT00520013|26840716|FG001|Overall Study|Physician Decision|0|||
13413204|NCT00520013|26840717|FG002|Overall Study|Physician Decision|3|||
13413205|NCT00519896|26840725|FG000|Overall Study|Protocol Violation|1|||
13413206|NCT00519896|26840725|FG000|Overall Study|Adverse Event|1|||
13476441|NCT01423851|27002854|FG007|Whole Study|Adverse Event|3|||
13476442|NCT01423851|27002855|FG008|Whole Study|Adverse Event|3|||
13476443|NCT01423851|27002856|FG009|Whole Study|Adverse Event|2|||
13476444|NCT01423851|27002857|FG010|Whole Study|Adverse Event|3|||
13476445|NCT01334606|27002902|FG000|Overall Study|Study Terminated due to slow enrolment|18|||
13476446|NCT01317875|27002974|FG000|Overall Study|Other|0|||
13476447|NCT01317875|27002975|FG001|Overall Study|Other|0|||
13476448|NCT01317875|27002976|FG002|Overall Study|Other|1|||
13476449|NCT01317875|27002977|FG003|Overall Study|Other|0|||
13476450|NCT01317875|27002978|FG004|Overall Study|Other|0|||
13476451|NCT01317875|27002979|FG005|Overall Study|Other|0|||
13476452|NCT01317875|27002980|FG006|Overall Study|Other|0|||
13476453|NCT01317875|27002981|FG007|Overall Study|Other|0|||
13476454|NCT01317875|27002982|FG008|Overall Study|Other|0|||
13476455|NCT01317875|27002983|FG009|Overall Study|Other|0|||
13476456|NCT01317875|27002974|FG000|Overall Study|Noncompliance with study drug|0|||
13476457|NCT01317875|27002975|FG001|Overall Study|Noncompliance with study drug|0|||
13476458|NCT01317875|27002976|FG002|Overall Study|Noncompliance with study drug|1|||
13476459|NCT01317875|27002977|FG003|Overall Study|Noncompliance with study drug|0|||
13476460|NCT01317875|27002978|FG004|Overall Study|Noncompliance with study drug|0|||
13476461|NCT01317875|27002979|FG005|Overall Study|Noncompliance with study drug|0|||
13476462|NCT01317875|27002980|FG006|Overall Study|Noncompliance with study drug|0|||
13476463|NCT01317875|27002981|FG007|Overall Study|Noncompliance with study drug|0|||
13476464|NCT01317875|27002982|FG008|Overall Study|Noncompliance with study drug|0|||
13476465|NCT01317875|27002983|FG009|Overall Study|Noncompliance with study drug|0|||
13476466|NCT01317875|27002974|FG000|Overall Study|Progressive Disease|1|||
13476467|NCT01317875|27002975|FG001|Overall Study|Progressive Disease|0|||
13476468|NCT01317875|27002976|FG002|Overall Study|Progressive Disease|2|||
13476469|NCT01317875|27002977|FG003|Overall Study|Progressive Disease|0|||
13476470|NCT01317875|27002978|FG004|Overall Study|Progressive Disease|1|||
13476471|NCT01317875|27002979|FG005|Overall Study|Progressive Disease|0|||
13476472|NCT01317875|27002980|FG006|Overall Study|Progressive Disease|0|||
13476473|NCT01317875|27002981|FG007|Overall Study|Progressive Disease|1|||
13476474|NCT01317875|27002982|FG008|Overall Study|Progressive Disease|0|||
13476475|NCT01317875|27002983|FG009|Overall Study|Progressive Disease|0|||
13476476|NCT01317875|27002974|FG000|Overall Study|Withdrawal by Subject|0|||
13476477|NCT01317875|27002975|FG001|Overall Study|Withdrawal by Subject|0|||
13476478|NCT01317875|27002976|FG002|Overall Study|Withdrawal by Subject|0|||
13476479|NCT01317875|27002977|FG003|Overall Study|Withdrawal by Subject|0|||
13476480|NCT01317875|27002978|FG004|Overall Study|Withdrawal by Subject|1|||
13476481|NCT01317875|27002979|FG005|Overall Study|Withdrawal by Subject|0|||
13476482|NCT01317875|27002980|FG006|Overall Study|Withdrawal by Subject|0|||
13476483|NCT01317875|27002981|FG007|Overall Study|Withdrawal by Subject|3|||
13476484|NCT01317875|27002982|FG008|Overall Study|Withdrawal by Subject|0|||
13476485|NCT01317875|27002983|FG009|Overall Study|Withdrawal by Subject|0|||
13476486|NCT01317875|27002974|FG000|Overall Study|Physician Decision|0|||
13476487|NCT01317875|27002975|FG001|Overall Study|Physician Decision|1|||
13476488|NCT01317875|27002976|FG002|Overall Study|Physician Decision|1|||
13476489|NCT01317875|27002977|FG003|Overall Study|Physician Decision|0|||
13476490|NCT01317875|27002978|FG004|Overall Study|Physician Decision|2|||
13476491|NCT01317875|27002979|FG005|Overall Study|Physician Decision|0|||
13476492|NCT01317875|27002980|FG006|Overall Study|Physician Decision|0|||
13476493|NCT01317875|27002981|FG007|Overall Study|Physician Decision|2|||
13476494|NCT01317875|27002982|FG008|Overall Study|Physician Decision|0|||
13476495|NCT01317875|27002983|FG009|Overall Study|Physician Decision|0|||
13476496|NCT01317875|27002974|FG000|Overall Study|Death|0|||
13476497|NCT01317875|27002975|FG001|Overall Study|Death|0|||
13476498|NCT01317875|27002976|FG002|Overall Study|Death|2|||
13476499|NCT01317875|27002977|FG003|Overall Study|Death|1|||
13476500|NCT01317875|27002978|FG004|Overall Study|Death|0|||
13476501|NCT01317875|27002979|FG005|Overall Study|Death|1|||
13476502|NCT01317875|27002980|FG006|Overall Study|Death|0|||
13476503|NCT01317875|27002981|FG007|Overall Study|Death|4|||
13476504|NCT01317875|27002982|FG008|Overall Study|Death|0|||
13476505|NCT01317875|27002983|FG009|Overall Study|Death|0|||
13476506|NCT01317875|27002974|FG000|Overall Study|Adverse Event|2|||
13476507|NCT01317875|27002975|FG001|Overall Study|Adverse Event|1|||
13476508|NCT01317875|27002976|FG002|Overall Study|Adverse Event|2|||
13476509|NCT01317875|27002977|FG003|Overall Study|Adverse Event|1|||
13476510|NCT01317875|27002978|FG004|Overall Study|Adverse Event|5|||
13476511|NCT01317875|27002979|FG005|Overall Study|Adverse Event|1|||
13476512|NCT01317875|27002980|FG006|Overall Study|Adverse Event|2|||
13476513|NCT01317875|27002981|FG007|Overall Study|Adverse Event|5|||
13476514|NCT01317875|27002982|FG008|Overall Study|Adverse Event|0|||
13476515|NCT01317875|27002983|FG009|Overall Study|Adverse Event|0|||
13476516|NCT00920621|27003071|FG000|Overall Study|Lost to Follow-up|16|||
13476517|NCT00920621|27003072|FG001|Overall Study|Lost to Follow-up|17|||
13413207|NCT00519831|26840734|FG000|Overall Study|Adverse Event|3|||
13413208|NCT00519779|26840757|FG000|Overall Study|Withdrawal by Subject|0|||
13413209|NCT00519779|26840758|FG001|Overall Study|Withdrawal by Subject|1|||
13413210|NCT00519649|26840769|FG000|Overall Study|Withdrawal by Subject|1|||
13413211|NCT00519636|26840812|FG000|Treatment Period 1|Adverse Event|1|||
13413212|NCT00519636|26840813|FG001|Treatment Period 1|Adverse Event|0|||
13413213|NCT00519636|26840814|FG002|Treatment Period 1|Adverse Event|1|||
13413214|NCT00519636|26840815|FG003|Treatment Period 1|Adverse Event|0|||
13413215|NCT00519636|26840812|FG000|Treatment Period 1|Sponsor request due to missed visit|1|||
13413216|NCT00519636|26840813|FG001|Treatment Period 1|Sponsor request due to missed visit|0|||
13413217|NCT00519636|26840814|FG002|Treatment Period 1|Sponsor request due to missed visit|0|||
13413218|NCT00519636|26840815|FG003|Treatment Period 1|Sponsor request due to missed visit|0|||
13413219|NCT00519636|26840812|FG000|Washout Period|Adverse Event|2|||
13413220|NCT00519636|26840813|FG001|Washout Period|Adverse Event|1|||
13413221|NCT00519636|26840814|FG002|Washout Period|Adverse Event|1|||
13413222|NCT00519636|26840815|FG003|Washout Period|Adverse Event|0|||
13413223|NCT00519636|26840812|FG000|Washout Period|Lost to Follow-up|1|||
13413224|NCT00519636|26840813|FG001|Washout Period|Lost to Follow-up|0|||
13413225|NCT00519636|26840814|FG002|Washout Period|Lost to Follow-up|0|||
13413226|NCT00519636|26840815|FG003|Washout Period|Lost to Follow-up|0|||
13413227|NCT00519636|26840812|FG000|Washout Period|Protocol Violation|0|||
13413228|NCT00519636|26840813|FG001|Washout Period|Protocol Violation|0|||
13413229|NCT00519636|26840814|FG002|Washout Period|Protocol Violation|1|||
13413230|NCT00519636|26840815|FG003|Washout Period|Protocol Violation|2|||
13413231|NCT00519636|26840812|FG000|Washout Period|Withdrawal by Subject|1|||
13413232|NCT00519636|26840813|FG001|Washout Period|Withdrawal by Subject|0|||
13413233|NCT00519636|26840814|FG002|Washout Period|Withdrawal by Subject|1|||
13413234|NCT00519636|26840815|FG003|Washout Period|Withdrawal by Subject|0|||
13413235|NCT00519636|26840812|FG000|Washout Period|Failed to meet continuation criteria|14|||
13413236|NCT00519636|26840813|FG001|Washout Period|Failed to meet continuation criteria|11|||
13413237|NCT00519636|26840814|FG002|Washout Period|Failed to meet continuation criteria|9|||
13413238|NCT00519636|26840815|FG003|Washout Period|Failed to meet continuation criteria|3|||
13413239|NCT00519636|26840812|FG000|Washout Period|Out of pollen area > 48 hours|1|||
13413240|NCT00519636|26840813|FG001|Washout Period|Out of pollen area > 48 hours|0|||
13413241|NCT00519636|26840814|FG002|Washout Period|Out of pollen area > 48 hours|0|||
13413242|NCT00519636|26840815|FG003|Washout Period|Out of pollen area > 48 hours|0|||
13413243|NCT00519636|26840812|FG000|Washout Period|Participating in study at another site|1|||
13413244|NCT00519636|26840813|FG001|Washout Period|Participating in study at another site|0|||
13413245|NCT00519636|26840814|FG002|Washout Period|Participating in study at another site|0|||
13413246|NCT00519636|26840815|FG003|Washout Period|Participating in study at another site|0|||
13413247|NCT00519636|26840812|FG000|Washout Period|Non-compliant|0|||
13413248|NCT00519636|26840813|FG001|Washout Period|Non-compliant|1|||
13413249|NCT00519636|26840814|FG002|Washout Period|Non-compliant|0|||
13413250|NCT00519636|26840815|FG003|Washout Period|Non-compliant|0|||
13413251|NCT00519636|26840812|FG000|Washout Period|Per doctors request|0|||
13413252|NCT00519636|26840813|FG001|Washout Period|Per doctors request|1|||
13413253|NCT00519636|26840814|FG002|Washout Period|Per doctors request|0|||
13413254|NCT00519636|26840815|FG003|Washout Period|Per doctors request|0|||
13413255|NCT00519636|26840812|FG000|Washout Period|Subject randomized in error|0|||
13413256|NCT00519636|26840813|FG001|Washout Period|Subject randomized in error|0|||
13413257|NCT00519636|26840814|FG002|Washout Period|Subject randomized in error|1|||
13413258|NCT00519636|26840815|FG003|Washout Period|Subject randomized in error|0|||
13413259|NCT00519636|26840812|FG000|Washout Period|Prohibited medications|0|||
13413260|NCT00519636|26840813|FG001|Washout Period|Prohibited medications|0|||
13413261|NCT00519636|26840814|FG002|Washout Period|Prohibited medications|1|||
13413262|NCT00519636|26840815|FG003|Washout Period|Prohibited medications|0|||
13413263|NCT00519636|26840812|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
13413264|NCT00519636|26840813|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
13413265|NCT00519636|26840814|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
13413266|NCT00519636|26840815|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1|||
13413267|NCT00519636|26840812|FG000|Treatment Period 2|Subject randomized in error|0|||
13413268|NCT00519636|26840813|FG001|Treatment Period 2|Subject randomized in error|1|||
13413269|NCT00519636|26840814|FG002|Treatment Period 2|Subject randomized in error|0|||
13413270|NCT00519636|26840815|FG003|Treatment Period 2|Subject randomized in error|0|||
13413271|NCT00519636|26840812|FG000|Treatment Period 2|Per doctors request|0|||
13413272|NCT00519636|26840813|FG001|Treatment Period 2|Per doctors request|0|||
13413273|NCT00519636|26840814|FG002|Treatment Period 2|Per doctors request|1|||
13413274|NCT00519636|26840815|FG003|Treatment Period 2|Per doctors request|0|||
13413275|NCT00519636|26840812|FG000|Treatment Period 2|Subject misrandomized|0|||
13413276|NCT00519636|26840813|FG001|Treatment Period 2|Subject misrandomized|0|||
13413277|NCT00519636|26840814|FG002|Treatment Period 2|Subject misrandomized|0|||
13413278|NCT00519636|26840815|FG003|Treatment Period 2|Subject misrandomized|1|||
13413279|NCT00519636|26840812|FG000|Post Study Period|Subject randomized in error|0|||
13413280|NCT00519636|26840813|FG001|Post Study Period|Subject randomized in error|0|||
13413281|NCT00519636|26840814|FG002|Post Study Period|Subject randomized in error|0|||
13413282|NCT00519636|26840815|FG003|Post Study Period|Subject randomized in error|1|||
13413283|NCT00519623|26840822|FG000|Overall Study|Adverse Event|1|||
13413284|NCT00519532|26840831|FG000|Overall Study|Adverse Event|11|||
13413285|NCT00519532|26840831|FG000|Overall Study|Withdrawal by Subject|5|||
13413286|NCT00519532|26840831|FG000|Overall Study|Lost to Follow-up|2|||
13413287|NCT00519428|26840861|FG000|Overall Study|Adverse Event|5|||
13413288|NCT00519428|26840862|FG001|Overall Study|Adverse Event|2|||
13413289|NCT00519428|26840863|FG002|Overall Study|Adverse Event|10|||
13413290|NCT00519428|26840861|FG000|Overall Study|Lost to Follow-up|7|||
13413291|NCT00519428|26840862|FG001|Overall Study|Lost to Follow-up|7|||
13413292|NCT00519428|26840863|FG002|Overall Study|Lost to Follow-up|6|||
13413293|NCT00519428|26840861|FG000|Overall Study|Withdrawal by Subject|8|||
13413294|NCT00519428|26840862|FG001|Overall Study|Withdrawal by Subject|3|||
13413295|NCT00519428|26840863|FG002|Overall Study|Withdrawal by Subject|7|||
13413296|NCT00519428|26840861|FG000|Overall Study|unstated|1|||
13413297|NCT00519428|26840862|FG001|Overall Study|unstated|3|||
13413298|NCT00519428|26840863|FG002|Overall Study|unstated|2|||
13413299|NCT00519376|26841002|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
13413300|NCT00519376|26841003|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
13413301|NCT00519376|26841004|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
13413302|NCT00519376|26841005|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
13413303|NCT00519376|26841006|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
13413304|NCT00519376|26841007|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
13413305|NCT00519376|26841008|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
13413306|NCT00519376|26841009|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
13413307|NCT00519376|26841010|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
13413308|NCT00519376|26841011|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
13413309|NCT00519376|26841012|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
13413310|NCT00519376|26841013|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
13413311|NCT00519376|26841014|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1|||
13413312|NCT00519376|26841015|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
13413313|NCT00519376|26841016|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
13413314|NCT00519376|26841017|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
13413315|NCT00519376|26841002|FG000|Treatment Period 4|Lost to Follow-up|0|||
13413316|NCT00519376|26841003|FG001|Treatment Period 4|Lost to Follow-up|0|||
13413317|NCT00519376|26841004|FG002|Treatment Period 4|Lost to Follow-up|1|||
13413318|NCT00519376|26841005|FG003|Treatment Period 4|Lost to Follow-up|0|||
13413319|NCT00519376|26841006|FG004|Treatment Period 4|Lost to Follow-up|0|||
13413320|NCT00519376|26841007|FG005|Treatment Period 4|Lost to Follow-up|0|||
13413321|NCT00519376|26841008|FG006|Treatment Period 4|Lost to Follow-up|0|||
13413322|NCT00519376|26841009|FG007|Treatment Period 4|Lost to Follow-up|0|||
13413323|NCT00519376|26841010|FG008|Treatment Period 4|Lost to Follow-up|0|||
13413324|NCT00519376|26841011|FG009|Treatment Period 4|Lost to Follow-up|0|||
13413325|NCT00519376|26841012|FG010|Treatment Period 4|Lost to Follow-up|0|||
13413326|NCT00519376|26841013|FG011|Treatment Period 4|Lost to Follow-up|0|||
13413327|NCT00519376|26841014|FG012|Treatment Period 4|Lost to Follow-up|0|||
13413328|NCT00519376|26841015|FG013|Treatment Period 4|Lost to Follow-up|0|||
13413329|NCT00519376|26841016|FG014|Treatment Period 4|Lost to Follow-up|0|||
13413330|NCT00519376|26841017|FG015|Treatment Period 4|Lost to Follow-up|0|||
13413331|NCT00519285|26841050|FG000|Overall Study|Adverse Event|127|||
13413332|NCT00519285|26841051|FG001|Overall Study|Adverse Event|266|||
13413333|NCT00519285|26841050|FG000|Overall Study|Disease progression|334|||
13413334|NCT00519285|26841051|FG001|Overall Study|Disease progression|186|||
13413335|NCT00519285|26841050|FG000|Overall Study|Physician Decision|75|||
13413336|NCT00519285|26841051|FG001|Overall Study|Physician Decision|47|||
13413337|NCT00519285|26841050|FG000|Overall Study|Participant's request|53|||
13413338|NCT00519285|26841051|FG001|Overall Study|Participant's request|84|||
13413339|NCT00519285|26841050|FG000|Overall Study|Consent withdrawn|4|||
13413340|NCT00519285|26841051|FG001|Overall Study|Consent withdrawn|5|||
13413341|NCT00519285|26841050|FG000|Overall Study|Poor compliance to protocol|5|||
13413342|NCT00519285|26841051|FG001|Overall Study|Poor compliance to protocol|7|||
13413343|NCT00519285|26841050|FG000|Overall Study|Reason unspecified|5|||
13413344|NCT00519285|26841051|FG001|Overall Study|Reason unspecified|8|||
13413345|NCT00519285|26841050|FG000|Overall Study|Not treated|8|||
13413346|NCT00519285|26841051|FG001|Overall Study|Not treated|7|||
13413347|NCT00519285|26841050|FG000|Overall Study|Treatment ongoing|1|||
13413348|NCT00519285|26841051|FG001|Overall Study|Treatment ongoing|2|||
13413349|NCT00519194|26841057|FG000|Overall Study|Withdrawal by Subject|9|||
13413350|NCT00519194|26841057|FG000|Overall Study|Death|9|||
13413351|NCT00519194|26841057|FG000|Overall Study|Lost to Follow-up|3|||
13413352|NCT00519077|26841064|FG000|Overall Study|Death|6|||
13413353|NCT00519077|26841064|FG000|Overall Study|Other|2|||
13413354|NCT00518986|26841195|FG000|Overall Study|Adverse Event|12|||
13413355|NCT00518986|26841196|FG001|Overall Study|Adverse Event|7|||
13413356|NCT00518986|26841195|FG000|Overall Study|Lack of Efficacy|0|||
13413357|NCT00518986|26841196|FG001|Overall Study|Lack of Efficacy|2|||
13413358|NCT00518986|26841195|FG000|Overall Study|Lost to Follow-up|3|||
13413359|NCT00518986|26841196|FG001|Overall Study|Lost to Follow-up|2|||
13413360|NCT00518986|26841195|FG000|Overall Study|Physician Decision|0|||
13413361|NCT00518986|26841196|FG001|Overall Study|Physician Decision|3|||
13413362|NCT00518986|26841195|FG000|Overall Study|Protocol Violation|5|||
13413363|NCT00518986|26841196|FG001|Overall Study|Protocol Violation|7|||
13413364|NCT00518986|26841195|FG000|Overall Study|Withdrawal by Subject|4|||
13413365|NCT00518986|26841196|FG001|Overall Study|Withdrawal by Subject|4|||
13413366|NCT00518986|26841195|FG000|Overall Study|Non-Specific|2|||
13413367|NCT00518986|26841196|FG001|Overall Study|Non-Specific|1|||
13413368|NCT00518973|26841217|FG000|Overall Study|Withdrawal by Subject|3|||
13413369|NCT00518973|26841218|FG001|Overall Study|Withdrawal by Subject|2|||
13413370|NCT00518882|26841339|FG000|Double-Blind, Week 0-26|Adverse Event|23|||
13413371|NCT00518882|26841340|FG001|Double-Blind, Week 0-26|Adverse Event|31|||
13413372|NCT00518882|26841339|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1|||
13413373|NCT00518882|26841340|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0|||
13413374|NCT00518882|26841339|FG000|Double-Blind, Week 0-26|Protocol Violation|4|||
13413375|NCT00518882|26841340|FG001|Double-Blind, Week 0-26|Protocol Violation|3|||
13413376|NCT00518882|26841339|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1|||
13413377|NCT00518882|26841340|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1|||
13413378|NCT00518882|26841339|FG000|Double-Blind, Week 0-26|Lost to follow up|2|||
13413379|NCT00518882|26841340|FG001|Double-Blind, Week 0-26|Lost to follow up|1|||
13413380|NCT00518882|26841339|FG000|Double-Blind, Week 0-26|Subject decision|1|||
13413381|NCT00518882|26841340|FG001|Double-Blind, Week 0-26|Subject decision|1|||
13413382|NCT00518882|26841339|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1|||
13413383|NCT00518882|26841340|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3|||
13413384|NCT00518882|26841339|FG000|Double-Blind, Week 0-26|Loss of trust|0|||
13413385|NCT00518882|26841340|FG001|Double-Blind, Week 0-26|Loss of trust|1|||
13413386|NCT00518882|26841339|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0|||
13413387|NCT00518882|26841340|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1|||
13413388|NCT00518882|26841339|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0|||
13413389|NCT00518882|26841340|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2|||
13413390|NCT00518882|26841339|FG000|Double-Blind, Week 0-26|Mutual consent|0|||
13413391|NCT00518882|26841340|FG001|Double-Blind, Week 0-26|Mutual consent|1|||
13413392|NCT00518882|26841339|FG000|Open-Label Extension, Week 26-78|Adverse Event|3|||
13413393|NCT00518882|26841340|FG001|Open-Label Extension, Week 26-78|Adverse Event|9|||
13413394|NCT00518882|26841339|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6|||
13413395|NCT00518882|26841340|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5|||
13413396|NCT00518882|26841339|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3|||
13413397|NCT00518882|26841340|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4|||
13413398|NCT00518882|26841339|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1|||
13413399|NCT00518882|26841340|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2|||
13413400|NCT00518882|26841339|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0|||
13413401|NCT00518882|26841340|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1|||
13413402|NCT00518882|26841339|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1|||
13413403|NCT00518882|26841340|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1|||
13413404|NCT00518882|26841339|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2|||
13413405|NCT00518882|26841340|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1|||
13413406|NCT00518882|26841339|FG000|Open-Label Extension, Week 26-78|Change in treatment|1|||
13413407|NCT00518882|26841340|FG001|Open-Label Extension, Week 26-78|Change in treatment|1|||
13413408|NCT00518882|26841339|FG000|Open-Label Extension, Week 26-78|Creatine increased|1|||
13413409|NCT00518882|26841340|FG001|Open-Label Extension, Week 26-78|Creatine increased|0|||
13413410|NCT00518882|26841339|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1|||
13413411|NCT00518882|26841340|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0|||
13413412|NCT00518882|26841339|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2|||
13413413|NCT00518882|26841340|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0|||
13413414|NCT00518882|26841339|FG000|Open-Label Extension, Week 26-78|Subject decision|2|||
13413415|NCT00518882|26841340|FG001|Open-Label Extension, Week 26-78|Subject decision|0|||
13413416|NCT00518882|26841339|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18|||
13413417|NCT00518882|26841340|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25|||
13413418|NCT00518687|26841359|FG000|Overall Study|Adverse Event|201|||
13413419|NCT00518687|26841360|FG001|Overall Study|Adverse Event|177|||
13413420|NCT00518687|26841359|FG000|Overall Study|Lost to Follow-up|144|||
13413421|NCT00518687|26841360|FG001|Overall Study|Lost to Follow-up|155|||
13413422|NCT00518687|26841359|FG000|Overall Study|Physician Decision|42|||
13413423|NCT00518687|26841360|FG001|Overall Study|Physician Decision|48|||
13413424|NCT00518687|26841359|FG000|Overall Study|Progressive disease|2|||
13413425|NCT00518687|26841360|FG001|Overall Study|Progressive disease|2|||
13413426|NCT00518687|26841359|FG000|Overall Study|Protocol Violation|8|||
13413427|NCT00518687|26841360|FG001|Overall Study|Protocol Violation|10|||
13413428|NCT00518687|26841359|FG000|Overall Study|Study terminated by sponsor|930|||
13413429|NCT00518687|26841360|FG001|Overall Study|Study terminated by sponsor|918|||
13413430|NCT00518687|26841359|FG000|Overall Study|Withdrawal by Subject|110|||
13413431|NCT00518687|26841360|FG001|Overall Study|Withdrawal by Subject|110|||
13413432|NCT00518622|26841411|FG000|Overall Study|Lost to Follow-up|0|||
13413433|NCT00518622|26841412|FG001|Overall Study|Lost to Follow-up|0|||
13413434|NCT00518622|26841413|FG002|Overall Study|Lost to Follow-up|1|||
13413435|NCT00518622|26841414|FG003|Overall Study|Lost to Follow-up|0|||
13413436|NCT00518622|26841415|FG004|Overall Study|Lost to Follow-up|0|||
13413437|NCT00518622|26841416|FG005|Overall Study|Lost to Follow-up|0|||
13413438|NCT00518622|26841417|FG006|Overall Study|Lost to Follow-up|0|||
13413439|NCT00518622|26841418|FG007|Overall Study|Lost to Follow-up|0|||
13413440|NCT00518622|26841411|FG000|Overall Study|Study medication taken incorrectly|0|||
13413441|NCT00518622|26841412|FG001|Overall Study|Study medication taken incorrectly|1|||
13413442|NCT00518622|26841413|FG002|Overall Study|Study medication taken incorrectly|0|||
13413443|NCT00518622|26841414|FG003|Overall Study|Study medication taken incorrectly|0|||
13413444|NCT00518622|26841415|FG004|Overall Study|Study medication taken incorrectly|0|||
13413445|NCT00518622|26841416|FG005|Overall Study|Study medication taken incorrectly|0|||
13413446|NCT00518622|26841417|FG006|Overall Study|Study medication taken incorrectly|0|||
13413447|NCT00518622|26841418|FG007|Overall Study|Study medication taken incorrectly|0|||
13413448|NCT00518531|26841459|FG000|Treatment Period 1|Adverse Event|5|||
13413449|NCT00518531|26841460|FG001|Treatment Period 1|Adverse Event|0|||
13413450|NCT00518531|26841459|FG000|Treatment Period 1|Lost to Follow-up|5|||
13413451|NCT00518531|26841460|FG001|Treatment Period 1|Lost to Follow-up|3|||
13413452|NCT00518531|26841459|FG000|Treatment Period 1|Physician Decision|1|||
13413453|NCT00518531|26841460|FG001|Treatment Period 1|Physician Decision|0|||
13413454|NCT00518531|26841459|FG000|Treatment Period 1|Protocol Violation|2|||
13413455|NCT00518531|26841460|FG001|Treatment Period 1|Protocol Violation|0|||
13413456|NCT00518531|26841459|FG000|Treatment Period 1|Withdrawal by Subject|4|||
13413457|NCT00518531|26841460|FG001|Treatment Period 1|Withdrawal by Subject|6|||
13413458|NCT00518531|26841459|FG000|Treatment Period 1|Early crossover|1|||
13413459|NCT00518531|26841460|FG001|Treatment Period 1|Early crossover|3|||
13413460|NCT00518531|26841459|FG000|Treatment Period 2|Withdrawal by Subject|0|||
13413461|NCT00518531|26841460|FG001|Treatment Period 2|Withdrawal by Subject|8|||
13413462|NCT00518531|26841459|FG000|Treatment Period 2|Complete out of scheduled visit window|1|||
13413463|NCT00518531|26841460|FG001|Treatment Period 2|Complete out of scheduled visit window|2|||
13413464|NCT00518531|26841459|FG000|Treatment Period 2|Adverse Event|1|||
13413465|NCT00518531|26841460|FG001|Treatment Period 2|Adverse Event|7|||
13413466|NCT00518531|26841459|FG000|Treatment Period 2|Protocol-specified criteria|0|||
13413467|NCT00518531|26841460|FG001|Treatment Period 2|Protocol-specified criteria|1|||
13413468|NCT00518531|26841459|FG000|Treatment Period 2|Non-compliance|1|||
13413469|NCT00518531|26841460|FG001|Treatment Period 2|Non-compliance|2|||
13413470|NCT00518336|26841629|FG000|Year 7|Lost to Follow-up|2|||
13413471|NCT00518336|26841630|FG001|Year 7|Lost to Follow-up|0|||
13413472|NCT00518336|26841629|FG000|Year 7|Could not attend in time|0|||
13413473|NCT00518336|26841630|FG001|Year 7|Could not attend in time|3|||
13413474|NCT00518336|26841629|FG000|Year 8|Lost to Follow-up|1|||
13413475|NCT00518336|26841630|FG001|Year 8|Lost to Follow-up|1|||
13413476|NCT00518336|26841629|FG000|Year 8|Could not attend in time|0|||
13413477|NCT00518336|26841630|FG001|Year 8|Could not attend in time|1|||
13413478|NCT00518336|26841629|FG000|Year 9|Migrated/moved from study area|1|||
13413479|NCT00518336|26841630|FG001|Year 9|Migrated/moved from study area|1|||
13413480|NCT00518336|26841629|FG000|Year 9|Lost to Follow-up|3|||
13413481|NCT00518336|26841630|FG001|Year 9|Lost to Follow-up|0|||
13413482|NCT00518336|26841629|FG000|Year 9|Personal reasons|1|||
13413483|NCT00518336|26841630|FG001|Year 9|Personal reasons|0|||
13413484|NCT00518323|26841669|FG000|Overall Study|Lack of Efficacy|14|||
13413485|NCT00518323|26841670|FG001|Overall Study|Lack of Efficacy|2|||
13413486|NCT00518323|26841671|FG002|Overall Study|Lack of Efficacy|4|||
13413487|NCT00518323|26841672|FG003|Overall Study|Lack of Efficacy|20|||
13413488|NCT00518323|26841669|FG000|Overall Study|Withdrawal by Subject|1|||
13413489|NCT00518323|26841670|FG001|Overall Study|Withdrawal by Subject|2|||
13413490|NCT00518323|26841671|FG002|Overall Study|Withdrawal by Subject|4|||
13413491|NCT00518323|26841672|FG003|Overall Study|Withdrawal by Subject|2|||
13413492|NCT00518323|26841669|FG000|Overall Study|Lost to Follow-up|0|||
13413493|NCT00518323|26841670|FG001|Overall Study|Lost to Follow-up|2|||
13413494|NCT00518323|26841671|FG002|Overall Study|Lost to Follow-up|1|||
13413495|NCT00518323|26841672|FG003|Overall Study|Lost to Follow-up|3|||
13413496|NCT00518323|26841669|FG000|Overall Study|Adverse Event|1|||
13413497|NCT00518323|26841670|FG001|Overall Study|Adverse Event|1|||
13413498|NCT00518323|26841671|FG002|Overall Study|Adverse Event|1|||
13413499|NCT00518323|26841672|FG003|Overall Study|Adverse Event|0|||
13413500|NCT00518323|26841669|FG000|Overall Study|Prohibited medication and others|3|||
13413501|NCT00518323|26841670|FG001|Overall Study|Prohibited medication and others|1|||
13413502|NCT00518323|26841671|FG002|Overall Study|Prohibited medication and others|1|||
13476518|NCT00920621|27003073|FG002|Overall Study|Lost to Follow-up|19|||
13413503|NCT00518323|26841672|FG003|Overall Study|Prohibited medication and others|0|||
13413504|NCT00518284|26841739|FG000|Overall Study|Adverse Event|0|||
13413505|NCT00518284|26841740|FG001|Overall Study|Adverse Event|1|||
13413506|NCT00518284|26841741|FG002|Overall Study|Adverse Event|0|||
13413507|NCT00518284|26841742|FG003|Overall Study|Adverse Event|0|||
13413508|NCT00518284|26841739|FG000|Overall Study|Study Termination|0|||
13413509|NCT00518284|26841740|FG001|Overall Study|Study Termination|2|||
13413510|NCT00518284|26841741|FG002|Overall Study|Study Termination|1|||
13413511|NCT00518284|26841742|FG003|Overall Study|Study Termination|2|||
13413512|NCT00518206|26841763|FG000|Overall Study|Disease Progression Requiring Therapy|6|||
13413513|NCT00518206|26841764|FG001|Overall Study|Disease Progression Requiring Therapy|6|||
13413514|NCT00518206|26841763|FG000|Overall Study|Withdrawal by Subject|2|||
13413515|NCT00518206|26841764|FG001|Overall Study|Withdrawal by Subject|0|||
13413516|NCT00518206|26841763|FG000|Overall Study|Drug Supply Issue|1|||
13413517|NCT00518206|26841764|FG001|Overall Study|Drug Supply Issue|0|||
13413518|NCT00518206|26841763|FG000|Overall Study|Reason Unknown|1|||
13413519|NCT00518206|26841764|FG001|Overall Study|Reason Unknown|0|||
13413520|NCT00518206|26841763|FG000|Overall Study|Completion Status Unknown|1|||
13413521|NCT00518206|26841764|FG001|Overall Study|Completion Status Unknown|0|||
13413522|NCT00518180|26841816|FG000|Overall Study|Withdrawal by Subject|29|||
13413523|NCT00518180|26841817|FG001|Overall Study|Withdrawal by Subject|30|||
13413524|NCT00518180|26841818|FG002|Overall Study|Withdrawal by Subject|42|||
13413525|NCT00518180|26841816|FG000|Overall Study|Lost to Follow-up|30|||
13413526|NCT00518180|26841817|FG001|Overall Study|Lost to Follow-up|28|||
13413527|NCT00518180|26841818|FG002|Overall Study|Lost to Follow-up|34|||
13413528|NCT00518180|26841816|FG000|Overall Study|Administrative reason|0|||
13413529|NCT00518180|26841817|FG001|Overall Study|Administrative reason|2|||
13413530|NCT00518180|26841818|FG002|Overall Study|Administrative reason|2|||
13413531|NCT00518180|26841816|FG000|Overall Study|Protocol Violation|5|||
13413532|NCT00518180|26841817|FG001|Overall Study|Protocol Violation|7|||
13413533|NCT00518180|26841818|FG002|Overall Study|Protocol Violation|4|||
13413534|NCT00518180|26841816|FG000|Overall Study|Unable to classify|0|||
13413535|NCT00518180|26841817|FG001|Overall Study|Unable to classify|2|||
13413536|NCT00518180|26841818|FG002|Overall Study|Unable to classify|0|||
13413537|NCT00518180|26841816|FG000|Overall Study|Adverse Event|1|||
13413538|NCT00518180|26841817|FG001|Overall Study|Adverse Event|0|||
13413539|NCT00518180|26841818|FG002|Overall Study|Adverse Event|0|||
13413540|NCT00518115|26842005|FG000|Overall Study|Adverse Event|6|||
13413541|NCT00518115|26842006|FG001|Overall Study|Adverse Event|1|||
13413542|NCT00518115|26842007|FG002|Overall Study|Adverse Event|5|||
13413543|NCT00518115|26842008|FG003|Overall Study|Adverse Event|6|||
13413544|NCT00518115|26842009|FG004|Overall Study|Adverse Event|5|||
13413545|NCT00518115|26842010|FG005|Overall Study|Adverse Event|5|||
13413546|NCT00518115|26842011|FG006|Overall Study|Adverse Event|5|||
13413547|NCT00518115|26842012|FG007|Overall Study|Adverse Event|10|||
13413548|NCT00518115|26842013|FG008|Overall Study|Adverse Event|2|||
13413549|NCT00518115|26842014|FG009|Overall Study|Adverse Event|9|||
13413550|NCT00518115|26842005|FG000|Overall Study|Lost to Follow-up|0|||
13413551|NCT00518115|26842006|FG001|Overall Study|Lost to Follow-up|0|||
13413552|NCT00518115|26842007|FG002|Overall Study|Lost to Follow-up|2|||
13413553|NCT00518115|26842008|FG003|Overall Study|Lost to Follow-up|3|||
13413554|NCT00518115|26842009|FG004|Overall Study|Lost to Follow-up|1|||
13413555|NCT00518115|26842010|FG005|Overall Study|Lost to Follow-up|3|||
13413556|NCT00518115|26842011|FG006|Overall Study|Lost to Follow-up|0|||
13413557|NCT00518115|26842012|FG007|Overall Study|Lost to Follow-up|1|||
13413558|NCT00518115|26842013|FG008|Overall Study|Lost to Follow-up|1|||
13413559|NCT00518115|26842014|FG009|Overall Study|Lost to Follow-up|1|||
13413560|NCT00518115|26842005|FG000|Overall Study|Protocol Violation|1|||
13413561|NCT00518115|26842006|FG001|Overall Study|Protocol Violation|3|||
13413562|NCT00518115|26842007|FG002|Overall Study|Protocol Violation|1|||
13413563|NCT00518115|26842008|FG003|Overall Study|Protocol Violation|0|||
13413564|NCT00518115|26842009|FG004|Overall Study|Protocol Violation|0|||
13413565|NCT00518115|26842010|FG005|Overall Study|Protocol Violation|0|||
13413566|NCT00518115|26842011|FG006|Overall Study|Protocol Violation|0|||
13413567|NCT00518115|26842012|FG007|Overall Study|Protocol Violation|0|||
13413568|NCT00518115|26842013|FG008|Overall Study|Protocol Violation|0|||
13413569|NCT00518115|26842014|FG009|Overall Study|Protocol Violation|0|||
13413570|NCT00518115|26842005|FG000|Overall Study|Withdrawal by Subject|1|||
13413571|NCT00518115|26842006|FG001|Overall Study|Withdrawal by Subject|1|||
13413572|NCT00518115|26842007|FG002|Overall Study|Withdrawal by Subject|5|||
13413573|NCT00518115|26842008|FG003|Overall Study|Withdrawal by Subject|0|||
13413574|NCT00518115|26842009|FG004|Overall Study|Withdrawal by Subject|2|||
13413575|NCT00518115|26842010|FG005|Overall Study|Withdrawal by Subject|1|||
13413576|NCT00518115|26842011|FG006|Overall Study|Withdrawal by Subject|0|||
13413577|NCT00518115|26842012|FG007|Overall Study|Withdrawal by Subject|2|||
13413578|NCT00518115|26842013|FG008|Overall Study|Withdrawal by Subject|1|||
13413579|NCT00518115|26842014|FG009|Overall Study|Withdrawal by Subject|3|||
13413580|NCT00518115|26842005|FG000|Overall Study|Lack of Efficacy|1|||
13413581|NCT00518115|26842006|FG001|Overall Study|Lack of Efficacy|0|||
13413582|NCT00518115|26842007|FG002|Overall Study|Lack of Efficacy|1|||
13413583|NCT00518115|26842008|FG003|Overall Study|Lack of Efficacy|1|||
13413584|NCT00518115|26842009|FG004|Overall Study|Lack of Efficacy|0|||
13413585|NCT00518115|26842010|FG005|Overall Study|Lack of Efficacy|0|||
13413586|NCT00518115|26842011|FG006|Overall Study|Lack of Efficacy|0|||
13413587|NCT00518115|26842012|FG007|Overall Study|Lack of Efficacy|1|||
13413588|NCT00518115|26842013|FG008|Overall Study|Lack of Efficacy|0|||
13413589|NCT00518115|26842014|FG009|Overall Study|Lack of Efficacy|0|||
13413590|NCT00518115|26842005|FG000|Overall Study|Non-Compliance|1|||
13413591|NCT00518115|26842006|FG001|Overall Study|Non-Compliance|0|||
13413592|NCT00518115|26842007|FG002|Overall Study|Non-Compliance|1|||
13413593|NCT00518115|26842008|FG003|Overall Study|Non-Compliance|0|||
13413594|NCT00518115|26842009|FG004|Overall Study|Non-Compliance|1|||
13413595|NCT00518115|26842010|FG005|Overall Study|Non-Compliance|1|||
13413596|NCT00518115|26842011|FG006|Overall Study|Non-Compliance|1|||
13413597|NCT00518115|26842012|FG007|Overall Study|Non-Compliance|1|||
13413598|NCT00518115|26842013|FG008|Overall Study|Non-Compliance|0|||
13413599|NCT00518115|26842014|FG009|Overall Study|Non-Compliance|1|||
13413600|NCT00518115|26842005|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1|||
13413601|NCT00518115|26842006|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1|||
13413602|NCT00518115|26842007|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0|||
13413603|NCT00518115|26842008|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0|||
13413604|NCT00518115|26842009|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0|||
13413605|NCT00518115|26842010|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4|||
13413606|NCT00518115|26842011|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0|||
13413607|NCT00518115|26842012|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0|||
13413608|NCT00518115|26842013|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0|||
13413609|NCT00518115|26842014|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0|||
13413610|NCT00518115|26842005|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1|||
13413611|NCT00518115|26842006|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
13413612|NCT00518115|26842007|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
13413613|NCT00518115|26842008|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
13413614|NCT00518115|26842009|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
13413615|NCT00518115|26842010|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
13413616|NCT00518115|26842011|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
13413617|NCT00518115|26842012|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
13413618|NCT00518115|26842013|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
13413619|NCT00518115|26842014|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
13413620|NCT00518115|26842005|FG000|Overall Study|Different Monotherapy Diabetic Drug|0|||
13413621|NCT00518115|26842006|FG001|Overall Study|Different Monotherapy Diabetic Drug|0|||
13413622|NCT00518115|26842007|FG002|Overall Study|Different Monotherapy Diabetic Drug|1|||
13413623|NCT00518115|26842008|FG003|Overall Study|Different Monotherapy Diabetic Drug|0|||
13413624|NCT00518115|26842009|FG004|Overall Study|Different Monotherapy Diabetic Drug|0|||
13413625|NCT00518115|26842010|FG005|Overall Study|Different Monotherapy Diabetic Drug|0|||
13413626|NCT00518115|26842011|FG006|Overall Study|Different Monotherapy Diabetic Drug|0|||
13413627|NCT00518115|26842012|FG007|Overall Study|Different Monotherapy Diabetic Drug|0|||
13413628|NCT00518115|26842013|FG008|Overall Study|Different Monotherapy Diabetic Drug|1|||
13413629|NCT00518115|26842014|FG009|Overall Study|Different Monotherapy Diabetic Drug|0|||
13413630|NCT00518115|26842005|FG000|Overall Study|Wrong Monotherapy Administered|0|||
13413631|NCT00518115|26842006|FG001|Overall Study|Wrong Monotherapy Administered|0|||
13413632|NCT00518115|26842007|FG002|Overall Study|Wrong Monotherapy Administered|1|||
13413633|NCT00518115|26842008|FG003|Overall Study|Wrong Monotherapy Administered|0|||
13413634|NCT00518115|26842009|FG004|Overall Study|Wrong Monotherapy Administered|0|||
13413635|NCT00518115|26842010|FG005|Overall Study|Wrong Monotherapy Administered|0|||
13413636|NCT00518115|26842011|FG006|Overall Study|Wrong Monotherapy Administered|1|||
13413637|NCT00518115|26842012|FG007|Overall Study|Wrong Monotherapy Administered|0|||
13413638|NCT00518115|26842013|FG008|Overall Study|Wrong Monotherapy Administered|0|||
13413639|NCT00518115|26842014|FG009|Overall Study|Wrong Monotherapy Administered|0|||
13413640|NCT00518115|26842005|FG000|Overall Study|Violation of Exclusion Criteria|0|||
13413641|NCT00518115|26842006|FG001|Overall Study|Violation of Exclusion Criteria|0|||
13413642|NCT00518115|26842007|FG002|Overall Study|Violation of Exclusion Criteria|0|||
13413643|NCT00518115|26842008|FG003|Overall Study|Violation of Exclusion Criteria|1|||
13413644|NCT00518115|26842009|FG004|Overall Study|Violation of Exclusion Criteria|0|||
13413645|NCT00518115|26842010|FG005|Overall Study|Violation of Exclusion Criteria|0|||
13413646|NCT00518115|26842011|FG006|Overall Study|Violation of Exclusion Criteria|1|||
13413647|NCT00518115|26842012|FG007|Overall Study|Violation of Exclusion Criteria|0|||
13413648|NCT00518115|26842013|FG008|Overall Study|Violation of Exclusion Criteria|0|||
13413649|NCT00518115|26842014|FG009|Overall Study|Violation of Exclusion Criteria|0|||
13413650|NCT00518115|26842005|FG000|Overall Study|Family Emergency; Had to Go to England|0|||
13413651|NCT00518115|26842006|FG001|Overall Study|Family Emergency; Had to Go to England|0|||
13413652|NCT00518115|26842007|FG002|Overall Study|Family Emergency; Had to Go to England|0|||
13413653|NCT00518115|26842008|FG003|Overall Study|Family Emergency; Had to Go to England|0|||
13413654|NCT00518115|26842009|FG004|Overall Study|Family Emergency; Had to Go to England|1|||
13413655|NCT00518115|26842010|FG005|Overall Study|Family Emergency; Had to Go to England|0|||
13413656|NCT00518115|26842011|FG006|Overall Study|Family Emergency; Had to Go to England|0|||
13413657|NCT00518115|26842012|FG007|Overall Study|Family Emergency; Had to Go to England|0|||
13413658|NCT00518115|26842013|FG008|Overall Study|Family Emergency; Had to Go to England|0|||
13413659|NCT00518115|26842014|FG009|Overall Study|Family Emergency; Had to Go to England|0|||
13413660|NCT00518115|26842005|FG000|Overall Study|Withdrew Consent|0|||
13413661|NCT00518115|26842006|FG001|Overall Study|Withdrew Consent|0|||
13413662|NCT00518115|26842007|FG002|Overall Study|Withdrew Consent|0|||
13413663|NCT00518115|26842008|FG003|Overall Study|Withdrew Consent|0|||
13413664|NCT00518115|26842009|FG004|Overall Study|Withdrew Consent|0|||
13413665|NCT00518115|26842010|FG005|Overall Study|Withdrew Consent|1|||
13413666|NCT00518115|26842011|FG006|Overall Study|Withdrew Consent|0|||
13413667|NCT00518115|26842012|FG007|Overall Study|Withdrew Consent|0|||
13413668|NCT00518115|26842013|FG008|Overall Study|Withdrew Consent|0|||
13413669|NCT00518115|26842014|FG009|Overall Study|Withdrew Consent|0|||
13413670|NCT00518115|26842005|FG000|Overall Study|Moved Out of State|0|||
13413671|NCT00518115|26842006|FG001|Overall Study|Moved Out of State|0|||
13413672|NCT00518115|26842007|FG002|Overall Study|Moved Out of State|0|||
13413673|NCT00518115|26842008|FG003|Overall Study|Moved Out of State|0|||
13413674|NCT00518115|26842009|FG004|Overall Study|Moved Out of State|0|||
13413675|NCT00518115|26842010|FG005|Overall Study|Moved Out of State|0|||
13413676|NCT00518115|26842011|FG006|Overall Study|Moved Out of State|0|||
13413677|NCT00518115|26842012|FG007|Overall Study|Moved Out of State|0|||
13413678|NCT00518115|26842013|FG008|Overall Study|Moved Out of State|0|||
13413679|NCT00518115|26842014|FG009|Overall Study|Moved Out of State|1|||
13413680|NCT00518011|26842041|FG000|Overall Study|Death|1|||
13413681|NCT00518011|26842042|FG001|Overall Study|Death|1|||
13413682|NCT00518011|26842041|FG000|Overall Study|Adverse Event|2|||
13413683|NCT00518011|26842042|FG001|Overall Study|Adverse Event|3|||
13413684|NCT00518011|26842041|FG000|Overall Study|Disease Progression|2|||
13413685|NCT00518011|26842042|FG001|Overall Study|Disease Progression|2|||
13413686|NCT00518011|26842041|FG000|Overall Study|Other Reasons|3|||
13413687|NCT00518011|26842042|FG001|Overall Study|Other Reasons|2|||
13413688|NCT00518011|26842041|FG000|Overall Study|Withdrawal by Subject|1|||
13413689|NCT00518011|26842042|FG001|Overall Study|Withdrawal by Subject|0|||
13413690|NCT00517933|26842113|FG000|Period 1|Death|2|||
13413691|NCT00517933|26842114|FG001|Period 1|Death|1|||
13413692|NCT00517933|26842113|FG000|Period 1|Adverse Event|4|||
13413693|NCT00517933|26842114|FG001|Period 1|Adverse Event|4|||
13413694|NCT00517933|26842113|FG000|Period 1|Lost to Follow-up|2|||
13413695|NCT00517933|26842114|FG001|Period 1|Lost to Follow-up|0|||
13413696|NCT00517933|26842113|FG000|Period 1|Underwent lung transplant|0|||
13413697|NCT00517933|26842114|FG001|Period 1|Underwent lung transplant|1|||
13413698|NCT00517933|26842113|FG000|Period 2|Death|2|||
13413699|NCT00517933|26842114|FG001|Period 2|Death|4|||
13413700|NCT00517933|26842113|FG000|Period 2|Adverse Event|2|||
13413701|NCT00517933|26842114|FG001|Period 2|Adverse Event|4|||
13413702|NCT00517933|26842113|FG000|Period 2|Physician Decision|1|||
13413703|NCT00517933|26842114|FG001|Period 2|Physician Decision|0|||
13413704|NCT00517933|26842113|FG000|Period 2|Withdrawal by Subject|1|||
13413705|NCT00517933|26842114|FG001|Period 2|Withdrawal by Subject|3|||
13413706|NCT00517933|26842113|FG000|Period 2|Underwent lung transplant|0|||
13413707|NCT00517933|26842114|FG001|Period 2|Underwent lung transplant|2|||
13413708|NCT00517881|26842126|FG000|Overall Study|Protocol Violation|2|||
13413709|NCT00517881|26842126|FG000|Overall Study|Adverse Event|1|||
13413710|NCT00517881|26842126|FG000|Overall Study|Renal transplantation|2|||
13413711|NCT00517829|26842147|FG000|Overall Study|Adverse Event|22|||
13413712|NCT00517829|26842148|FG001|Overall Study|Adverse Event|34|||
13413713|NCT00517829|26842147|FG000|Overall Study|Disease Progression|39|||
13413714|NCT00517829|26842148|FG001|Overall Study|Disease Progression|32|||
13413715|NCT00517829|26842147|FG000|Overall Study|Patient Request|6|||
13413716|NCT00517829|26842148|FG001|Overall Study|Patient Request|5|||
13413717|NCT00517829|26842147|FG000|Overall Study|Investigator Request|5|||
13413718|NCT00517829|26842148|FG001|Overall Study|Investigator Request|3|||
13413719|NCT00517829|26842147|FG000|Overall Study|Other|3|||
13413720|NCT00517829|26842148|FG001|Overall Study|Other|1|||
13413721|NCT00517751|26842173|FG000|Overall Study|Death|3|||
13413722|NCT00517751|26842173|FG000|Overall Study|Withdrawal by Subject|37|||
13413723|NCT00517751|26842173|FG000|Overall Study|Lost to Follow-up|4|||
13413724|NCT00517751|26842173|FG000|Overall Study|patient not over due|6|||
13413725|NCT00517751|26842173|FG000|Overall Study|Patient not due for visit|76|||
13413726|NCT00517751|26842173|FG000|Overall Study|Missing|3|||
13413727|NCT00517699|26842183|FG000|Overall Study|Withdrawal by Subject|1|||
13413728|NCT00517699|26842183|FG000|Overall Study|Lack of Efficacy|1|||
13413729|NCT00517699|26842183|FG000|Overall Study|Administrative error|1|||
13413730|NCT00517699|26842183|FG000|Overall Study|Study terminated by Sponsor|2|||
13476519|NCT00920621|27003074|FG003|Overall Study|Lost to Follow-up|21|||
13413731|NCT00517634|26842201|FG000|Second Treatment Period|Withdrawal by Subject|0|||
13413732|NCT00517634|26842202|FG001|Second Treatment Period|Withdrawal by Subject|0|||
13413733|NCT00517634|26842203|FG002|Second Treatment Period|Withdrawal by Subject|0|||
13413734|NCT00517634|26842204|FG003|Second Treatment Period|Withdrawal by Subject|0|||
13413735|NCT00517634|26842205|FG004|Second Treatment Period|Withdrawal by Subject|1|||
13413736|NCT00517634|26842206|FG005|Second Treatment Period|Withdrawal by Subject|0|||
13413737|NCT00517413|26842229|FG000|Overall Study|Adverse Event|7|||
13413738|NCT00517413|26842229|FG000|Overall Study|Death|13|||
13413739|NCT00517413|26842229|FG000|Overall Study|Protocol Violation|15|||
13413740|NCT00517413|26842229|FG000|Overall Study|Withdrawal by Subject|2|||
13413741|NCT00517413|26842229|FG000|Overall Study|Failure to return|1|||
13413742|NCT00517413|26842229|FG000|Overall Study|Other-Reasons|23|||
13413743|NCT00517361|26842238|FG000|Overall Study|Death|6|||
13413744|NCT00517361|26842238|FG000|Overall Study|The study was terminated|5|||
13413745|NCT00517296|26842255|FG000|Overall Study|Withdrawal by Subject|1|||
13413746|NCT00517296|26842256|FG001|Overall Study|Withdrawal by Subject|0|||
13413747|NCT00517192|26842311|FG000|Overall Study|Adverse Event|1|||
13413748|NCT00517192|26842312|FG001|Overall Study|Adverse Event|1|||
13413749|NCT00517192|26842311|FG000|Overall Study|Lost to Follow-up|1|||
13413750|NCT00517192|26842312|FG001|Overall Study|Lost to Follow-up|1|||
13413751|NCT00517192|26842311|FG000|Overall Study|Withdrawal by Subject|1|||
13413752|NCT00517192|26842312|FG001|Overall Study|Withdrawal by Subject|0|||
13413753|NCT00517192|26842311|FG000|Overall Study|Early termination of the trial|16|||
13413754|NCT00517192|26842312|FG001|Overall Study|Early termination of the trial|18|||
13413755|NCT00516906|26842329|FG000|Overall Study|Final Dressing Removal Data not captured|6|||
13413756|NCT00516906|26842330|FG001|Overall Study|Final Dressing Removal Data not captured|2|||
13413757|NCT00516893|26842339|FG000|Overall Study|Lost to Follow-up|4|||
13413758|NCT00516893|26842339|FG000|Overall Study|Adverse Event|3|||
13413759|NCT00516893|26842339|FG000|Overall Study|Withdrawal by Subject|2|||
13413760|NCT00516893|26842339|FG000|Overall Study|Noncompliance|2|||
13413761|NCT00516893|26842339|FG000|Overall Study|Death|1|||
13413762|NCT00516893|26842339|FG000|Overall Study|Persistent Antibodies per Protocol|6|||
13413763|NCT00516893|26842339|FG000|Overall Study|Relocated|1|||
13413764|NCT00516893|26842339|FG000|Overall Study|Pregnancy|1|||
13413765|NCT00516893|26842339|FG000|Overall Study|Received Medication From Another Study|1|||
13413766|NCT00516737|26842364|FG000|Overall Study|Lost to Follow-up|2|||
13413767|NCT00516737|26842365|FG001|Overall Study|Lost to Follow-up|0|||
13413768|NCT00516737|26842364|FG000|Overall Study|Physician Decision|0|||
13413769|NCT00516737|26842365|FG001|Overall Study|Physician Decision|1|||
13413770|NCT00516737|26842364|FG000|Overall Study|Withdrawal by Subject|0|||
13413771|NCT00516737|26842365|FG001|Overall Study|Withdrawal by Subject|1|||
13413772|NCT00516737|26842364|FG000|Overall Study|Lack of Qualifying Event|9|||
13413773|NCT00516737|26842365|FG001|Overall Study|Lack of Qualifying Event|6|||
13413774|NCT00516386|26842372|FG000|Overall Study|not interested in the study|4|||
13413775|NCT00516386|26842372|FG000|Overall Study|Lost to Follow-up|2|||
13413776|NCT00516321|26842428|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11|||
13413777|NCT00516321|26842429|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
13413778|NCT00516321|26842430|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
13413779|NCT00516321|26842428|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9|||
13413780|NCT00516321|26842429|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
13413781|NCT00516321|26842430|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
13413782|NCT00516321|26842428|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1|||
13413783|NCT00516321|26842429|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
13413784|NCT00516321|26842430|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
13413785|NCT00516321|26842428|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2|||
13413786|NCT00516321|26842429|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
13413787|NCT00516321|26842430|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
13413788|NCT00516321|26842428|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7|||
13413789|NCT00516321|26842429|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
13413790|NCT00516321|26842430|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
13413791|NCT00516321|26842428|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3|||
13413792|NCT00516321|26842429|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
13413793|NCT00516321|26842430|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
13413794|NCT00516321|26842428|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0|||
13413795|NCT00516321|26842429|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12|||
13413796|NCT00516321|26842430|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22|||
13413797|NCT00516321|26842428|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0|||
13413798|NCT00516321|26842429|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13|||
13413799|NCT00516321|26842430|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18|||
13413800|NCT00516321|26842428|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0|||
13413801|NCT00516321|26842429|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8|||
13413802|NCT00516321|26842430|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13|||
13413803|NCT00516321|26842428|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
13413804|NCT00516321|26842429|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
13413805|NCT00516321|26842430|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1|||
13413806|NCT00516321|26842428|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
13413807|NCT00516321|26842429|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2|||
13413808|NCT00516321|26842430|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
13413809|NCT00516295|26842451|FG000|Overall Study|Lack of Efficacy|2|||
13413810|NCT00516295|26842452|FG001|Overall Study|Lack of Efficacy|0|||
13413811|NCT00516295|26842453|FG002|Overall Study|Lack of Efficacy|0|||
13413812|NCT00516295|26842451|FG000|Overall Study|Ineligible|1|||
13413813|NCT00516295|26842452|FG001|Overall Study|Ineligible|0|||
13413814|NCT00516295|26842453|FG002|Overall Study|Ineligible|0|||
13413815|NCT00516269|26842466|FG000|Overall Study|Adverse Event|2|||
13413816|NCT00516269|26842467|FG001|Overall Study|Adverse Event|1|||
13413817|NCT00516269|26842466|FG000|Overall Study|Lost to Follow-up|0|||
13413818|NCT00516269|26842467|FG001|Overall Study|Lost to Follow-up|1|||
13413819|NCT00516269|26842466|FG000|Overall Study|Protocol Violation|0|||
13413820|NCT00516269|26842467|FG001|Overall Study|Protocol Violation|1|||
13413821|NCT00516139|26842498|FG000|Overall Study|Adverse Event|27|||
13413822|NCT00516139|26842498|FG000|Overall Study|Lost to Follow-up|1|||
13413823|NCT00516139|26842498|FG000|Overall Study|Protocol Violation|1|||
13413824|NCT00516139|26842498|FG000|Overall Study|Withdrawal by Subject|8|||
13413825|NCT00516139|26842498|FG000|Overall Study|Lack of Efficacy|1|||
13413826|NCT00516074|26842521|FG000|Overall Study|Adverse Event|0|||
13413827|NCT00516074|26842522|FG001|Overall Study|Adverse Event|1|||
13413828|NCT00516074|26842521|FG000|Overall Study|Subject Decision|4|||
13413829|NCT00516074|26842522|FG001|Overall Study|Subject Decision|2|||
13413830|NCT00516074|26842521|FG000|Overall Study|Loss of Glucose Control|2|||
13413831|NCT00516074|26842522|FG001|Overall Study|Loss of Glucose Control|0|||
13413832|NCT00516048|26842544|FG000|Overall Study|Death|0|||
13413833|NCT00516048|26842545|FG001|Overall Study|Death|0|||
13413834|NCT00516048|26842546|FG002|Overall Study|Death|1|||
13413835|NCT00516048|26842544|FG000|Overall Study|Subject Decision|0|||
13413836|NCT00516048|26842545|FG001|Overall Study|Subject Decision|2|||
13413837|NCT00516048|26842546|FG002|Overall Study|Subject Decision|0|||
13413838|NCT00515827|26842575|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
13413839|NCT00515827|26842576|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
13413840|NCT00515827|26842575|FG000|Second Intervention (12 Weeks)|Consent withdraw|1|||
13413841|NCT00515827|26842576|FG001|Second Intervention (12 Weeks)|Consent withdraw|0|||
13413842|NCT00515619|26842586|FG000|Overall Study|Adverse Event|34|||
13413843|NCT00515619|26842586|FG000|Overall Study|Lack of Efficacy|92|||
13413844|NCT00515619|26842586|FG000|Overall Study|Withdrawal by Subject|66|||
13413845|NCT00515619|26842586|FG000|Overall Study|Protocol Violation|3|||
13413846|NCT00515619|26842586|FG000|Overall Study|Lost to Follow-up|4|||
13413847|NCT00515619|26842586|FG000|Overall Study|Unsatisfactory compliance|6|||
13413848|NCT00515619|26842586|FG000|Overall Study|Other: Site discontinuing trials|2|||
13413849|NCT00515619|26842586|FG000|Overall Study|Other: Subject cannot attend visits|2|||
13413850|NCT00515619|26842586|FG000|Overall Study|Other: Subject required surgery|1|||
13413851|NCT00515619|26842586|FG000|Overall Study|Other: Subject moved to another country|1|||
13413852|NCT00515619|26842586|FG000|Overall Study|Other: Investigator decision|1|||
13413853|NCT00515619|26842586|FG000|Overall Study|Other: Subject became pregnant|1|||
13413854|NCT00515619|26842586|FG000|Overall Study|Other: Request from sponsor|1|||
13413855|NCT00515619|26842586|FG000|Overall Study|Other: Drug available on license|1|||
13413856|NCT00515619|26842586|FG000|Overall Study|Other: Subject interested in other AED|1|||
13413857|NCT00515541|26842621|FG000|Overall Study|Physician Decision|0|||
13413858|NCT00515541|26842622|FG001|Overall Study|Physician Decision|2|||
13413859|NCT00515541|26842623|FG002|Overall Study|Physician Decision|0|||
13413860|NCT00515541|26842624|FG003|Overall Study|Physician Decision|1|||
13413861|NCT00515541|26842621|FG000|Overall Study|No show for appointments|0|||
13413862|NCT00515541|26842622|FG001|Overall Study|No show for appointments|1|||
13413863|NCT00515541|26842623|FG002|Overall Study|No show for appointments|0|||
13413864|NCT00515541|26842624|FG003|Overall Study|No show for appointments|2|||
13413865|NCT00515541|26842621|FG000|Overall Study|Withdrawal by Subject|0|||
13413866|NCT00515541|26842622|FG001|Overall Study|Withdrawal by Subject|2|||
13413867|NCT00515541|26842623|FG002|Overall Study|Withdrawal by Subject|0|||
13413868|NCT00515541|26842624|FG003|Overall Study|Withdrawal by Subject|2|||
13413869|NCT00515502|26842795|FG000|Treatment Period 1|Adverse Event|0|||
13413870|NCT00515502|26842796|FG001|Treatment Period 1|Adverse Event|0|||
13413871|NCT00515502|26842797|FG002|Treatment Period 1|Adverse Event|0|||
13413872|NCT00515502|26842798|FG003|Treatment Period 1|Adverse Event|0|||
13413873|NCT00515502|26842799|FG004|Treatment Period 1|Adverse Event|0|||
13413874|NCT00515502|26842800|FG005|Treatment Period 1|Adverse Event|0|||
13413875|NCT00515502|26842801|FG006|Treatment Period 1|Adverse Event|1|||
13413876|NCT00515502|26842802|FG007|Treatment Period 1|Adverse Event|0|||
13413877|NCT00515502|26842803|FG008|Treatment Period 1|Adverse Event|1|||
13413878|NCT00515502|26842804|FG009|Treatment Period 1|Adverse Event|0|||
13413879|NCT00515502|26842805|FG010|Treatment Period 1|Adverse Event|0|||
13413880|NCT00515502|26842806|FG011|Treatment Period 1|Adverse Event|1|||
13413881|NCT00515502|26842795|FG000|Treatment Period 2|Adverse Event|0|||
13413882|NCT00515502|26842796|FG001|Treatment Period 2|Adverse Event|1|||
13413883|NCT00515502|26842797|FG002|Treatment Period 2|Adverse Event|0|||
13413884|NCT00515502|26842798|FG003|Treatment Period 2|Adverse Event|0|||
13413885|NCT00515502|26842799|FG004|Treatment Period 2|Adverse Event|0|||
13413886|NCT00515502|26842800|FG005|Treatment Period 2|Adverse Event|0|||
13413887|NCT00515502|26842801|FG006|Treatment Period 2|Adverse Event|0|||
13413888|NCT00515502|26842802|FG007|Treatment Period 2|Adverse Event|0|||
13413889|NCT00515502|26842803|FG008|Treatment Period 2|Adverse Event|0|||
13413890|NCT00515502|26842804|FG009|Treatment Period 2|Adverse Event|0|||
13413891|NCT00515502|26842805|FG010|Treatment Period 2|Adverse Event|0|||
13413892|NCT00515502|26842806|FG011|Treatment Period 2|Adverse Event|0|||
13413893|NCT00515463|26842963|FG000|Overall Study|Physician Decision|4|||
13413894|NCT00515463|26842964|FG001|Overall Study|Physician Decision|2|||
13413895|NCT00515463|26842963|FG000|Overall Study|Adverse Event|1|||
13413896|NCT00515463|26842964|FG001|Overall Study|Adverse Event|2|||
13413897|NCT00515463|26842963|FG000|Overall Study|Withdrawal by Subject|3|||
13413898|NCT00515463|26842964|FG001|Overall Study|Withdrawal by Subject|4|||
13413899|NCT00515463|26842963|FG000|Overall Study|Lost to Follow-up|6|||
13413900|NCT00515463|26842964|FG001|Overall Study|Lost to Follow-up|5|||
13413901|NCT00515463|26842963|FG000|Overall Study|Other|0|||
13413902|NCT00515463|26842964|FG001|Overall Study|Other|1|||
13413903|NCT00515294|26842991|FG000|Overall Study|Lost to Follow-up|3|||
13413904|NCT00515294|26842992|FG001|Overall Study|Lost to Follow-up|2|||
13413905|NCT00515294|26842993|FG002|Overall Study|Lost to Follow-up|3|||
13413906|NCT00515294|26842994|FG003|Overall Study|Lost to Follow-up|1|||
13413907|NCT00515294|26842991|FG000|Overall Study|Driver simulator problems|1|||
13413908|NCT00515294|26842992|FG001|Overall Study|Driver simulator problems|1|||
13413909|NCT00515294|26842993|FG002|Overall Study|Driver simulator problems|1|||
13413910|NCT00515294|26842994|FG003|Overall Study|Driver simulator problems|3|||
13413911|NCT00515294|26842991|FG000|Overall Study|Caffeine amount inaccurate|5|||
13413912|NCT00515294|26842992|FG001|Overall Study|Caffeine amount inaccurate|0|||
13413913|NCT00515294|26842993|FG002|Overall Study|Caffeine amount inaccurate|7|||
13413914|NCT00515294|26842994|FG003|Overall Study|Caffeine amount inaccurate|0|||
13413915|NCT00515216|26843018|FG000|Overall Study|Withdrawal by Subject|1|||
13413916|NCT00515112|26843033|FG000|Overall Study|Death|0|||
13413917|NCT00515112|26843034|FG001|Overall Study|Death|1|||
13413918|NCT00515112|26843033|FG000|Overall Study|The study was terminated|3|||
13413919|NCT00515112|26843034|FG001|Overall Study|The study was terminated|2|||
13413920|NCT00515099|26843059|FG000|Overall Study|Lost to Follow-up|0|||
13413921|NCT00515099|26843060|FG001|Overall Study|Lost to Follow-up|4|||
13413922|NCT00515099|26843059|FG000|Overall Study|Withdrawal by Subject|2|||
13413923|NCT00515099|26843060|FG001|Overall Study|Withdrawal by Subject|0|||
13413924|NCT00515099|26843059|FG000|Overall Study|IRB Recommendation|1|||
13413925|NCT00515099|26843060|FG001|Overall Study|IRB Recommendation|0|||
13413926|NCT00515086|26843100|FG000|Overall Study|Adverse Event|1|||
13413927|NCT00515086|26843101|FG001|Overall Study|Adverse Event|1|||
13413928|NCT00515086|26843102|FG002|Overall Study|Adverse Event|2|||
13413929|NCT00515086|26843103|FG003|Overall Study|Adverse Event|3|||
13413930|NCT00515086|26843100|FG000|Overall Study|Administrative|1|||
13413931|NCT00515086|26843101|FG001|Overall Study|Administrative|1|||
13413932|NCT00515086|26843102|FG002|Overall Study|Administrative|0|||
13413933|NCT00515086|26843103|FG003|Overall Study|Administrative|0|||
13413934|NCT00515086|26843100|FG000|Overall Study|Withdrawal by Subject|1|||
13413935|NCT00515086|26843101|FG001|Overall Study|Withdrawal by Subject|0|||
13413936|NCT00515086|26843102|FG002|Overall Study|Withdrawal by Subject|0|||
13413937|NCT00515086|26843103|FG003|Overall Study|Withdrawal by Subject|1|||
13413938|NCT00515086|26843100|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
13413939|NCT00515086|26843101|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
13413940|NCT00515086|26843102|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
13413941|NCT00515086|26843103|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
13413942|NCT00515086|26843100|FG000|Overall Study|Lost to Follow-up|1|||
13413943|NCT00515086|26843101|FG001|Overall Study|Lost to Follow-up|0|||
13413944|NCT00515086|26843102|FG002|Overall Study|Lost to Follow-up|0|||
13413945|NCT00515086|26843103|FG003|Overall Study|Lost to Follow-up|0|||
13413946|NCT00515086|26843100|FG000|Overall Study|Study drug no longer required|0|||
13413947|NCT00515086|26843101|FG001|Overall Study|Study drug no longer required|1|||
13413948|NCT00515086|26843102|FG002|Overall Study|Study drug no longer required|0|||
13413949|NCT00515086|26843103|FG003|Overall Study|Study drug no longer required|0|||
13413950|NCT00515086|26843100|FG000|Overall Study|Death|2|||
13413951|NCT00515086|26843101|FG001|Overall Study|Death|0|||
13413952|NCT00515086|26843102|FG002|Overall Study|Death|0|||
13413953|NCT00515086|26843103|FG003|Overall Study|Death|0|||
13413954|NCT00515073|26843109|FG000|Overall Study|Withdrawal by Subject|1|||
13413955|NCT00515073|26843109|FG000|Overall Study|Physician Decision|1|||
13413956|NCT00515034|26843140|FG000|Overall Study|Adverse Event|2|||
13413957|NCT00515034|26843141|FG001|Overall Study|Adverse Event|0|||
13413958|NCT00515034|26843142|FG002|Overall Study|Adverse Event|1|||
13413959|NCT00515034|26843143|FG003|Overall Study|Adverse Event|0|||
13413960|NCT00515034|26843140|FG000|Overall Study|Death|4|||
13413961|NCT00515034|26843141|FG001|Overall Study|Death|2|||
13413962|NCT00515034|26843142|FG002|Overall Study|Death|1|||
13413963|NCT00515034|26843143|FG003|Overall Study|Death|3|||
13413964|NCT00515034|26843140|FG000|Overall Study|Withdrawal by Subject|1|||
13413965|NCT00515034|26843141|FG001|Overall Study|Withdrawal by Subject|0|||
13413966|NCT00515034|26843142|FG002|Overall Study|Withdrawal by Subject|3|||
13413967|NCT00515034|26843143|FG003|Overall Study|Withdrawal by Subject|0|||
13413968|NCT00515034|26843140|FG000|Overall Study|Physician Decision|0|||
13413969|NCT00515034|26843141|FG001|Overall Study|Physician Decision|0|||
13413970|NCT00515034|26843142|FG002|Overall Study|Physician Decision|1|||
13413971|NCT00515034|26843143|FG003|Overall Study|Physician Decision|1|||
13413972|NCT00515034|26843140|FG000|Overall Study|Other|1|||
13413973|NCT00515034|26843141|FG001|Overall Study|Other|0|||
13413974|NCT00515034|26843142|FG002|Overall Study|Other|2|||
13413975|NCT00515034|26843143|FG003|Overall Study|Other|1|||
13413976|NCT00515008|26843172|FG000|Overall Study|Lost to Follow-up|1|||
13413977|NCT00515008|26843173|FG001|Overall Study|Lost to Follow-up|0|||
13413978|NCT00515008|26843172|FG000|Overall Study|Declined|0|||
13413979|NCT00515008|26843173|FG001|Overall Study|Declined|3|||
13413980|NCT00515008|26843172|FG000|Overall Study|Left the Boston Area|1|||
13413981|NCT00515008|26843173|FG001|Overall Study|Left the Boston Area|1|||
13413982|NCT00515008|26843172|FG000|Overall Study|Scheduling conflict|1|||
13413983|NCT00515008|26843173|FG001|Overall Study|Scheduling conflict|0|||
13413984|NCT00514943|26843236|FG000|Stage 1|Progressive disease|4|||
13413985|NCT00514943|26843237|FG001|Stage 1|Progressive disease|8|||
13413986|NCT00514943|26843236|FG000|Stage 1|Other Adverse Event|16|||
13413987|NCT00514943|26843237|FG001|Stage 1|Other Adverse Event|6|||
13413988|NCT00514943|26843236|FG000|Stage 1|Not treated|1|||
13413989|NCT00514943|26843237|FG001|Stage 1|Not treated|2|||
13413990|NCT00514943|26843236|FG000|Stage 1|Patient refused to continue study meds|8|||
13413991|NCT00514943|26843237|FG001|Stage 1|Patient refused to continue study meds|3|||
13413992|NCT00514943|26843236|FG000|Stage 1|Other than stated above|1|||
13413993|NCT00514943|26843237|FG001|Stage 1|Other than stated above|7|||
13413994|NCT00514943|26843236|FG000|Stage 2|Progressive disease|27|||
13413995|NCT00514943|26843237|FG001|Stage 2|Progressive disease|24|||
13413996|NCT00514943|26843236|FG000|Stage 2|Other Adverse Event|3|||
13413997|NCT00514943|26843237|FG001|Stage 2|Other Adverse Event|10|||
13413998|NCT00514943|26843236|FG000|Stage 2|Patient refused to continue study meds|2|||
13413999|NCT00514943|26843237|FG001|Stage 2|Patient refused to continue study meds|0|||
13414000|NCT00514943|26843236|FG000|Stage 2|Other than stated above|0|||
13414001|NCT00514943|26843237|FG001|Stage 2|Other than stated above|2|||
13476520|NCT00920621|27003071|FG000|Overall Study|Fetal/neonatal deaths|16|||
13476521|NCT00920621|27003072|FG001|Overall Study|Fetal/neonatal deaths|14|||
13476522|NCT00920621|27003073|FG002|Overall Study|Fetal/neonatal deaths|16|||
13476523|NCT00920621|27003074|FG003|Overall Study|Fetal/neonatal deaths|14|||
13476524|NCT00920621|27003071|FG000|Overall Study|Blood sample not collected|22|||
13476525|NCT00920621|27003072|FG001|Overall Study|Blood sample not collected|14|||
13476526|NCT00920621|27003073|FG002|Overall Study|Blood sample not collected|0|||
13476527|NCT00920621|27003074|FG003|Overall Study|Blood sample not collected|0|||
13414002|NCT00514917|26843270|FG000|Overall Study|Death|4|||
13414003|NCT00514917|26843271|FG001|Overall Study|Death|10|||
13414004|NCT00514917|26843270|FG000|Overall Study|Protocol Violation|1|||
13414005|NCT00514917|26843271|FG001|Overall Study|Protocol Violation|0|||
13414006|NCT00514917|26843270|FG000|Overall Study|Lost to Follow-up|4|||
13414007|NCT00514917|26843271|FG001|Overall Study|Lost to Follow-up|3|||
13414008|NCT00514917|26843270|FG000|Overall Study|Withdrawal by Subject|18|||
13414009|NCT00514917|26843271|FG001|Overall Study|Withdrawal by Subject|16|||
13414010|NCT00514917|26843270|FG000|Overall Study|Discontinued due to study closure|88|||
13414011|NCT00514917|26843271|FG001|Overall Study|Discontinued due to study closure|81|||
13414012|NCT00514917|26843270|FG000|Overall Study|Undefined|11|||
13414013|NCT00514917|26843271|FG001|Overall Study|Undefined|5|||
13414014|NCT00514904|26843312|FG000|Overall Study|Withdrawal by Subject|3|||
13414015|NCT00514904|26843313|FG001|Overall Study|Withdrawal by Subject|2|||
13414016|NCT00514904|26843312|FG000|Overall Study|Lost to Follow-up|21|||
13414017|NCT00514904|26843313|FG001|Overall Study|Lost to Follow-up|3|||
13414018|NCT00514813|26843344|FG000|Overall Study|Study terminated|14|||
13414019|NCT00514813|26843345|FG001|Overall Study|Study terminated|74|||
13414020|NCT00514813|26843346|FG002|Overall Study|Study terminated|40|||
13414021|NCT00514813|26843347|FG003|Overall Study|Study terminated|2|||
13414022|NCT00514813|26843344|FG000|Overall Study|Adverse Event|0|||
13414023|NCT00514813|26843345|FG001|Overall Study|Adverse Event|2|||
13414024|NCT00514813|26843346|FG002|Overall Study|Adverse Event|2|||
13414025|NCT00514813|26843347|FG003|Overall Study|Adverse Event|0|||
13414026|NCT00514813|26843344|FG000|Overall Study|Protocol Violation|1|||
13414027|NCT00514813|26843345|FG001|Overall Study|Protocol Violation|0|||
13414028|NCT00514813|26843346|FG002|Overall Study|Protocol Violation|0|||
13414029|NCT00514813|26843347|FG003|Overall Study|Protocol Violation|0|||
13414030|NCT00514813|26843344|FG000|Overall Study|Withdrawal by Subject|0|||
13414031|NCT00514813|26843345|FG001|Overall Study|Withdrawal by Subject|1|||
13414032|NCT00514813|26843346|FG002|Overall Study|Withdrawal by Subject|0|||
13414033|NCT00514813|26843347|FG003|Overall Study|Withdrawal by Subject|0|||
13414034|NCT00514813|26843344|FG000|Overall Study|Lack of Efficacy|0|||
13414035|NCT00514813|26843345|FG001|Overall Study|Lack of Efficacy|1|||
13414036|NCT00514813|26843346|FG002|Overall Study|Lack of Efficacy|0|||
13414037|NCT00514813|26843347|FG003|Overall Study|Lack of Efficacy|0|||
13414038|NCT00514813|26843344|FG000|Overall Study|Kidney transplant|0|||
13414039|NCT00514813|26843345|FG001|Overall Study|Kidney transplant|6|||
13414040|NCT00514813|26843346|FG002|Overall Study|Kidney transplant|2|||
13414041|NCT00514813|26843347|FG003|Overall Study|Kidney transplant|0|||
13414042|NCT00514813|26843344|FG000|Overall Study|Death|0|||
13414043|NCT00514813|26843345|FG001|Overall Study|Death|2|||
13414044|NCT00514813|26843346|FG002|Overall Study|Death|3|||
13414045|NCT00514813|26843347|FG003|Overall Study|Death|2|||
13414046|NCT00514735|26843372|FG000|Overall Study|Withdrawal by Subject|13|||
13414047|NCT00514735|26843373|FG001|Overall Study|Withdrawal by Subject|5|||
13414048|NCT00514735|26843372|FG000|Overall Study|Death|1|||
13414049|NCT00514735|26843373|FG001|Overall Study|Death|0|||
13414050|NCT00514735|26843372|FG000|Overall Study|Lost to Follow-up|0|||
13414051|NCT00514735|26843373|FG001|Overall Study|Lost to Follow-up|1|||
13414052|NCT00514683|26843580|FG000|Overall Study|Not treated|2|||
13414053|NCT00514683|26843581|FG001|Overall Study|Not treated|1|||
13414054|NCT00514683|26843582|FG002|Overall Study|Not treated|0|||
13414055|NCT00514683|26843583|FG003|Overall Study|Not treated|0|||
13414056|NCT00514683|26843584|FG004|Overall Study|Not treated|1|||
13414057|NCT00514683|26843580|FG000|Overall Study|Adverse Event|21|||
13414058|NCT00514683|26843581|FG001|Overall Study|Adverse Event|20|||
13414059|NCT00514683|26843582|FG002|Overall Study|Adverse Event|15|||
13414060|NCT00514683|26843583|FG003|Overall Study|Adverse Event|13|||
13414061|NCT00514683|26843584|FG004|Overall Study|Adverse Event|27|||
13414062|NCT00514683|26843580|FG000|Overall Study|Protocol Violation|1|||
13414063|NCT00514683|26843581|FG001|Overall Study|Protocol Violation|1|||
13414064|NCT00514683|26843582|FG002|Overall Study|Protocol Violation|0|||
13414065|NCT00514683|26843583|FG003|Overall Study|Protocol Violation|1|||
13414066|NCT00514683|26843584|FG004|Overall Study|Protocol Violation|0|||
13414067|NCT00514683|26843580|FG000|Overall Study|Withdrawal by Subject|2|||
13414068|NCT00514683|26843581|FG001|Overall Study|Withdrawal by Subject|2|||
13414069|NCT00514683|26843582|FG002|Overall Study|Withdrawal by Subject|1|||
13414070|NCT00514683|26843583|FG003|Overall Study|Withdrawal by Subject|0|||
13414071|NCT00514683|26843584|FG004|Overall Study|Withdrawal by Subject|4|||
13414072|NCT00514683|26843580|FG000|Overall Study|Reason other than listed above|0|||
13414073|NCT00514683|26843581|FG001|Overall Study|Reason other than listed above|1|||
13414074|NCT00514683|26843582|FG002|Overall Study|Reason other than listed above|2|||
13414075|NCT00514683|26843583|FG003|Overall Study|Reason other than listed above|0|||
13414076|NCT00514683|26843584|FG004|Overall Study|Reason other than listed above|1|||
13414077|NCT00514540|26843594|FG000|First-Line Chemo|Withdrawal by Subject|1|||
13414078|NCT00514540|26843594|FG000|First-Line Chemo|Protocol Violation|7|||
13414079|NCT00514540|26843594|FG000|Second-Line|Physician/Patient Decision|31|||
13414080|NCT00514514|26843648|FG000|Pre-phase|Death|10|||
13414081|NCT00514514|26843649|FG001|Pre-phase|Death|0|||
13414082|NCT00514514|26843650|FG002|Pre-phase|Death|0|||
13414083|NCT00514514|26843648|FG000|Pre-phase|administrative problems|2|||
13414084|NCT00514514|26843649|FG001|Pre-phase|administrative problems|0|||
13414085|NCT00514514|26843650|FG002|Pre-phase|administrative problems|0|||
13414086|NCT00514514|26843648|FG000|Pre-phase|Protocol Violation|6|||
13414087|NCT00514514|26843649|FG001|Pre-phase|Protocol Violation|0|||
13414088|NCT00514514|26843650|FG002|Pre-phase|Protocol Violation|0|||
13414089|NCT00514514|26843648|FG000|Pre-phase|condition no longer requires study drug|7|||
13414090|NCT00514514|26843649|FG001|Pre-phase|condition no longer requires study drug|0|||
13414091|NCT00514514|26843650|FG002|Pre-phase|condition no longer requires study drug|0|||
13414092|NCT00514514|26843648|FG000|Pre-phase|abnormal test procedure results|15|||
13414093|NCT00514514|26843649|FG001|Pre-phase|abnormal test procedure results|0|||
13414094|NCT00514514|26843650|FG002|Pre-phase|abnormal test procedure results|0|||
13414095|NCT00514514|26843648|FG000|Pre-phase|Lost to Follow-up|2|||
13414096|NCT00514514|26843649|FG001|Pre-phase|Lost to Follow-up|0|||
13414097|NCT00514514|26843650|FG002|Pre-phase|Lost to Follow-up|0|||
13414098|NCT00514514|26843648|FG000|Pre-phase|abnormal lab values|23|||
13414099|NCT00514514|26843649|FG001|Pre-phase|abnormal lab values|0|||
13414100|NCT00514514|26843650|FG002|Pre-phase|abnormal lab values|0|||
13414101|NCT00514514|26843648|FG000|Pre-phase|Lack of Efficacy|35|||
13414102|NCT00514514|26843649|FG001|Pre-phase|Lack of Efficacy|0|||
13414103|NCT00514514|26843650|FG002|Pre-phase|Lack of Efficacy|0|||
13414104|NCT00514514|26843648|FG000|Pre-phase|Adverse Event|137|||
13414105|NCT00514514|26843649|FG001|Pre-phase|Adverse Event|0|||
13414106|NCT00514514|26843650|FG002|Pre-phase|Adverse Event|0|||
13414107|NCT00514514|26843648|FG000|Pre-phase|Withdrawal by Subject|66|||
13414108|NCT00514514|26843649|FG001|Pre-phase|Withdrawal by Subject|0|||
13414109|NCT00514514|26843650|FG002|Pre-phase|Withdrawal by Subject|0|||
13414110|NCT00514514|26843648|FG000|Randomized - 9 Month|Death|3|||
13414111|NCT00514514|26843649|FG001|Randomized - 9 Month|Death|2|||
13414112|NCT00514514|26843650|FG002|Randomized - 9 Month|Death|2|||
13414113|NCT00514514|26843648|FG000|Randomized - 9 Month|Administrative problems|1|||
13414114|NCT00514514|26843649|FG001|Randomized - 9 Month|Administrative problems|1|||
13414115|NCT00514514|26843650|FG002|Randomized - 9 Month|Administrative problems|2|||
13414116|NCT00514514|26843648|FG000|Randomized - 9 Month|Withdrawal by Subject|7|||
13414117|NCT00514514|26843649|FG001|Randomized - 9 Month|Withdrawal by Subject|7|||
13414118|NCT00514514|26843650|FG002|Randomized - 9 Month|Withdrawal by Subject|5|||
13414119|NCT00514514|26843648|FG000|Randomized - 9 Month|Protocol Violation|1|||
13414120|NCT00514514|26843649|FG001|Randomized - 9 Month|Protocol Violation|1|||
13414121|NCT00514514|26843650|FG002|Randomized - 9 Month|Protocol Violation|0|||
13414122|NCT00514514|26843648|FG000|Randomized - 9 Month|Lack of Efficacy|2|||
13414123|NCT00514514|26843649|FG001|Randomized - 9 Month|Lack of Efficacy|3|||
13414124|NCT00514514|26843650|FG002|Randomized - 9 Month|Lack of Efficacy|1|||
13414125|NCT00514514|26843648|FG000|Randomized - 9 Month|Abnormal laboratory values|0|||
13414126|NCT00514514|26843649|FG001|Randomized - 9 Month|Abnormal laboratory values|3|||
13414127|NCT00514514|26843650|FG002|Randomized - 9 Month|Abnormal laboratory values|1|||
13414128|NCT00514514|26843648|FG000|Randomized - 9 Month|Adverse Event|25|||
13414129|NCT00514514|26843649|FG001|Randomized - 9 Month|Adverse Event|44|||
13414130|NCT00514514|26843650|FG002|Randomized - 9 Month|Adverse Event|27|||
13414131|NCT00514514|26843648|FG000|Extension - 4 Years|Withdrawal by Subject|5|||
13414132|NCT00514514|26843649|FG001|Extension - 4 Years|Withdrawal by Subject|2|||
13414133|NCT00514514|26843650|FG002|Extension - 4 Years|Withdrawal by Subject|2|||
13414134|NCT00514514|26843648|FG000|Extension - 4 Years|Lost to Follow-up|12|||
13414135|NCT00514514|26843649|FG001|Extension - 4 Years|Lost to Follow-up|10|||
13414136|NCT00514514|26843650|FG002|Extension - 4 Years|Lost to Follow-up|9|||
13414137|NCT00514514|26843648|FG000|Extension - 4 Years|Administrative problems|3|||
13414138|NCT00514514|26843649|FG001|Extension - 4 Years|Administrative problems|1|||
13414139|NCT00514514|26843650|FG002|Extension - 4 Years|Administrative problems|1|||
13414140|NCT00514514|26843648|FG000|Extension - 4 Years|Death|8|||
13414141|NCT00514514|26843649|FG001|Extension - 4 Years|Death|3|||
13414142|NCT00514514|26843650|FG002|Extension - 4 Years|Death|6|||
13414143|NCT00514514|26843648|FG000|Extension - 4 Years|Adverse Event|9|||
13414144|NCT00514514|26843649|FG001|Extension - 4 Years|Adverse Event|6|||
13414145|NCT00514514|26843650|FG002|Extension - 4 Years|Adverse Event|3|||
13414146|NCT00514449|26843667|FG000|Overall Study|Withdrawal by Subject|1|||
13414147|NCT00514449|26843668|FG001|Overall Study|Withdrawal by Subject|2|||
13414148|NCT00514449|26843667|FG000|Overall Study|Protocol Violation|1|||
13414149|NCT00514449|26843668|FG001|Overall Study|Protocol Violation|2|||
13414150|NCT00514449|26843667|FG000|Overall Study|Lost to Follow-up|1|||
13414151|NCT00514449|26843668|FG001|Overall Study|Lost to Follow-up|0|||
13414152|NCT00514046|26843738|FG000|Overall Study|transferred to another protocol|2|||
13414153|NCT00514046|26843739|FG001|Overall Study|transferred to another protocol|1|||
13414154|NCT00514046|26843740|FG002|Overall Study|transferred to another protocol|3|||
13414155|NCT00514046|26843741|FG003|Overall Study|transferred to another protocol|0|||
13414156|NCT00514046|26843742|FG004|Overall Study|transferred to another protocol|1|||
13414157|NCT00514046|26843743|FG005|Overall Study|transferred to another protocol|0|||
13414158|NCT00514046|26843744|FG006|Overall Study|transferred to another protocol|0|||
13414159|NCT00514046|26843745|FG007|Overall Study|transferred to another protocol|0|||
13414160|NCT00514046|26843746|FG008|Overall Study|transferred to another protocol|0|||
13414161|NCT00514046|26843738|FG000|Overall Study|Getting vandetanib via the REMS program|1|||
13414162|NCT00514046|26843739|FG001|Overall Study|Getting vandetanib via the REMS program|0|||
13414163|NCT00514046|26843740|FG002|Overall Study|Getting vandetanib via the REMS program|0|||
13414164|NCT00514046|26843741|FG003|Overall Study|Getting vandetanib via the REMS program|0|||
13414165|NCT00514046|26843742|FG004|Overall Study|Getting vandetanib via the REMS program|0|||
13414166|NCT00514046|26843743|FG005|Overall Study|Getting vandetanib via the REMS program|0|||
13414167|NCT00514046|26843744|FG006|Overall Study|Getting vandetanib via the REMS program|0|||
13414168|NCT00514046|26843745|FG007|Overall Study|Getting vandetanib via the REMS program|1|||
13414169|NCT00514046|26843746|FG008|Overall Study|Getting vandetanib via the REMS program|1|||
13414170|NCT00514046|26843738|FG000|Overall Study|Disease progression on study|0|||
13414171|NCT00514046|26843739|FG001|Overall Study|Disease progression on study|0|||
13414172|NCT00514046|26843740|FG002|Overall Study|Disease progression on study|2|||
13414173|NCT00514046|26843741|FG003|Overall Study|Disease progression on study|0|||
13414174|NCT00514046|26843742|FG004|Overall Study|Disease progression on study|0|||
13414175|NCT00514046|26843743|FG005|Overall Study|Disease progression on study|1|||
13414176|NCT00514046|26843744|FG006|Overall Study|Disease progression on study|0|||
13414177|NCT00514046|26843745|FG007|Overall Study|Disease progression on study|0|||
13414178|NCT00514046|26843746|FG008|Overall Study|Disease progression on study|0|||
13414179|NCT00514020|26843752|FG000|Overall Study|Adverse Event|6|||
13414180|NCT00514020|26843752|FG000|Overall Study|Withdrawal by Subject|3|||
13414181|NCT00514020|26843752|FG000|Overall Study|Physician Decision|1|||
13414182|NCT00514020|26843752|FG000|Overall Study|disease progression|9|||
13414183|NCT00514020|26843752|FG000|Overall Study|other complicating disease|2|||
13414184|NCT00514020|26843752|FG000|Overall Study|patient went to radiation treatment|1|||
13414185|NCT00514020|26843752|FG000|Overall Study|"patients moved to the no tx group"|6|||
13414186|NCT00513708|26843776|FG000|Overall Study|Lost to Follow-up|4|||
13414187|NCT00513708|26843777|FG001|Overall Study|Lost to Follow-up|4|||
13414188|NCT00513708|26843778|FG002|Overall Study|Lost to Follow-up|4|||
13414189|NCT00513695|26843789|FG000|Overall Study|Discontinued therapy|2|||
13414190|NCT00513695|26843789|FG000|Overall Study|Progression prior to surgery|3|||
13414191|NCT00513682|26843800|FG000|Washout Phase|Adverse Event|2|||
13414192|NCT00513604|26843833|FG000|Overall Study|Not treated|2|||
13414193|NCT00513604|26843834|FG001|Overall Study|Not treated|0|||
13414194|NCT00513604|26843835|FG002|Overall Study|Not treated|1|||
13414195|NCT00513604|26843836|FG003|Overall Study|Not treated|0|||
13414196|NCT00513604|26843837|FG004|Overall Study|Not treated|0|||
13414197|NCT00513604|26843833|FG000|Overall Study|Death during treatment|0|||
13414198|NCT00513604|26843834|FG001|Overall Study|Death during treatment|3|||
13414199|NCT00513604|26843835|FG002|Overall Study|Death during treatment|2|||
13414200|NCT00513604|26843836|FG003|Overall Study|Death during treatment|0|||
13414201|NCT00513604|26843837|FG004|Overall Study|Death during treatment|0|||
13414202|NCT00513500|26843854|FG000|Overall Study|Lost to Follow-up|35|||
13414203|NCT00513500|26843855|FG001|Overall Study|Lost to Follow-up|39|||
13414204|NCT00513500|26843854|FG000|Overall Study|Death|2|||
13414205|NCT00513500|26843855|FG001|Overall Study|Death|1|||
13414206|NCT00513500|26843854|FG000|Overall Study|Hospitalized|4|||
13414207|NCT00513500|26843855|FG001|Overall Study|Hospitalized|14|||
13414208|NCT00513474|26843874|FG000|Overall Study|Death|6|||
13414209|NCT00513474|26843875|FG001|Overall Study|Death|9|||
13414210|NCT00513474|26843874|FG000|Overall Study|Participant Withdrew Consent|1|||
13414211|NCT00513474|26843875|FG001|Overall Study|Participant Withdrew Consent|0|||
13414212|NCT00513409|26843908|FG000|Overall Study|Adverse Event|0|||
13414213|NCT00513409|26843909|FG001|Overall Study|Adverse Event|1|||
13414214|NCT00513409|26843908|FG000|Overall Study|Withdrawal by Subject|0|||
13414215|NCT00513409|26843909|FG001|Overall Study|Withdrawal by Subject|2|||
13414216|NCT00513409|26843908|FG000|Overall Study|Lost to Follow-up|0|||
13414217|NCT00513409|26843909|FG001|Overall Study|Lost to Follow-up|1|||
13414218|NCT00513409|26843908|FG000|Overall Study|Physician Decision|1|||
13414219|NCT00513409|26843909|FG001|Overall Study|Physician Decision|0|||
13414220|NCT00513409|26843908|FG000|Overall Study|Visit 3 not done|1|||
13414221|NCT00513409|26843909|FG001|Overall Study|Visit 3 not done|2|||
13414222|NCT00513357|26843922|FG000|Overall Study|did not receive allocated placebo|2|||
13414223|NCT00513357|26843923|FG001|Overall Study|did not receive allocated placebo|3|||
13414224|NCT00513357|26843922|FG000|Overall Study|Adverse Event|4|||
13414225|NCT00513357|26843923|FG001|Overall Study|Adverse Event|2|||
13414226|NCT00513357|26843922|FG000|Overall Study|Death|2|||
13414227|NCT00513357|26843923|FG001|Overall Study|Death|0|||
13414228|NCT00513357|26843922|FG000|Overall Study|Withdrawal by Subject|5|||
13414229|NCT00513357|26843923|FG001|Overall Study|Withdrawal by Subject|4|||
13414230|NCT00513357|26843922|FG000|Overall Study|Disease Progression|2|||
13414231|NCT00513357|26843923|FG001|Overall Study|Disease Progression|1|||
13414232|NCT00513305|26843946|FG000|Overall Study|Adverse Event|6|||
13414233|NCT00513305|26843947|FG001|Overall Study|Adverse Event|2|||
13414234|NCT00513305|26843946|FG000|Overall Study|Death (through Consolidation Treatment)|2|||
13414235|NCT00513305|26843947|FG001|Overall Study|Death (through Consolidation Treatment)|2|||
13414236|NCT00513305|26843946|FG000|Overall Study|Lack of Efficacy|8|||
13414237|NCT00513305|26843947|FG001|Overall Study|Lack of Efficacy|13|||
13414238|NCT00513305|26843946|FG000|Overall Study|Withdrawal by Subject|1|||
13414239|NCT00513305|26843947|FG001|Overall Study|Withdrawal by Subject|2|||
13414240|NCT00513305|26843946|FG000|Overall Study|Disease progression|8|||
13414241|NCT00513305|26843947|FG001|Overall Study|Disease progression|5|||
13414242|NCT00513305|26843946|FG000|Overall Study|Eligible for stem cell transplant|1|||
13414243|NCT00513305|26843947|FG001|Overall Study|Eligible for stem cell transplant|0|||
13414244|NCT00513305|26843946|FG000|Overall Study|Hematologic counts did not recover|1|||
13414245|NCT00513305|26843947|FG001|Overall Study|Hematologic counts did not recover|0|||
13414246|NCT00513305|26843946|FG000|Overall Study|Physician Decision|1|||
13414247|NCT00513305|26843947|FG001|Overall Study|Physician Decision|0|||
13414248|NCT00513305|26843946|FG000|Overall Study|Persistent hypocellularity|0|||
13414249|NCT00513305|26843947|FG001|Overall Study|Persistent hypocellularity|1|||
13414250|NCT00513305|26843946|FG000|Overall Study|Sponsor Decision|0|||
13414251|NCT00513305|26843947|FG001|Overall Study|Sponsor Decision|2|||
13414252|NCT00513240|26843967|FG000|Overall Study|Did not have intended surgery|3|||
13414253|NCT00513240|26843968|FG001|Overall Study|Did not have intended surgery|0|||
13414254|NCT00513240|26843967|FG000|Overall Study|Death|3|||
13414255|NCT00513240|26843968|FG001|Overall Study|Death|3|||
13414256|NCT00513240|26843967|FG000|Overall Study|Withdrawal by Subject|7|||
13414257|NCT00513240|26843968|FG001|Overall Study|Withdrawal by Subject|4|||
13414258|NCT00513071|26843980|FG000|Overall Study|Adverse Event|1|||
13414259|NCT00513071|26843980|FG000|Overall Study|Withdrawal by Subject|1|||
13414260|NCT00513071|26843980|FG000|Overall Study|Physician Decision|3|||
13414261|NCT00513019|26843993|FG000|Overall Study|Adverse Event|1|||
13414262|NCT00513019|26843994|FG001|Overall Study|Adverse Event|0|||
13414263|NCT00513019|26843993|FG000|Overall Study|Withdrawal by Subject|4|||
13414264|NCT00513019|26843994|FG001|Overall Study|Withdrawal by Subject|5|||
13414265|NCT00512902|26844004|FG000|Overall Study|Adverse Event|7|||
13414266|NCT00512902|26844004|FG000|Overall Study|Lost to Follow-up|1|||
13414267|NCT00512798|26844020|FG000|Overall Study|Death|0|||
13414268|NCT00512798|26844021|FG001|Overall Study|Death|3|||
13414269|NCT00512798|26844020|FG000|Overall Study|Adverse Event|2|||
13414270|NCT00512798|26844021|FG001|Overall Study|Adverse Event|4|||
13414271|NCT00512798|26844020|FG000|Overall Study|Progression of disease|14|||
13414272|NCT00512798|26844021|FG001|Overall Study|Progression of disease|20|||
13414273|NCT00512798|26844020|FG000|Overall Study|Withdrawal by Subject|3|||
13414274|NCT00512798|26844021|FG001|Overall Study|Withdrawal by Subject|0|||
13414275|NCT00512707|26844058|FG000|Overall Study|Lost to Follow-up|5|||
13414276|NCT00512707|26844059|FG001|Overall Study|Lost to Follow-up|11|||
13414277|NCT00512707|26844058|FG000|Overall Study|Developed skin irritation|2|||
13414278|NCT00512707|26844059|FG001|Overall Study|Developed skin irritation|1|||
13414279|NCT00512707|26844058|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2|||
13414280|NCT00512707|26844059|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0|||
13414281|NCT00512707|26844058|FG000|Overall Study|Unable to tolerate the smell of the gel|1|||
13414282|NCT00512707|26844059|FG001|Overall Study|Unable to tolerate the smell of the gel|0|||
13414283|NCT00512252|26844097|FG000|Overall Study|Lost to Follow-up|0|||
13414284|NCT00512252|26844098|FG001|Overall Study|Lost to Follow-up|0|||
13414285|NCT00512252|26844099|FG002|Overall Study|Lost to Follow-up|1|||
13414286|NCT00512252|26844097|FG000|Overall Study|Protocol Violation|0|||
13414287|NCT00512252|26844098|FG001|Overall Study|Protocol Violation|0|||
13414288|NCT00512252|26844099|FG002|Overall Study|Protocol Violation|1|||
13414289|NCT00512252|26844097|FG000|Overall Study|Death|0|||
13414290|NCT00512252|26844098|FG001|Overall Study|Death|0|||
13414291|NCT00512252|26844099|FG002|Overall Study|Death|1|||
13414292|NCT00512148|26844107|FG000|Primay Study Period|Withdrawal by Subject|1|||
13414293|NCT00512135|26844121|FG000|Overall Study|Not Treated|5|||
13414294|NCT00512135|26844121|FG000|Overall Study|Lack of Efficacy|2|||
13414295|NCT00512135|26844121|FG000|Overall Study|Adverse Event|6|||
13414296|NCT00512135|26844121|FG000|Overall Study|Withdrawal by Subject|22|||
13414297|NCT00512135|26844121|FG000|Overall Study|Lost to Follow-up|27|||
13414298|NCT00512135|26844121|FG000|Overall Study|Other|22|||
13414299|NCT00512096|26844127|FG000|Overall Study|Adverse Event|2|||
13414300|NCT00512096|26844127|FG000|Overall Study|Withdrawal by Subject|2|||
13414301|NCT00512096|26844127|FG000|Overall Study|Lack of Efficacy|3|||
13414302|NCT00511901|26844154|FG000|Overall Study|Withdrawal by Subject|1|||
13414303|NCT00511901|26844155|FG001|Overall Study|Withdrawal by Subject|3|||
13414304|NCT00511875|26844184|FG000|Overall Study|Lost to Follow-up|4|||
13414305|NCT00511875|26844185|FG001|Overall Study|Lost to Follow-up|0|||
13414306|NCT00511875|26844184|FG000|Overall Study|Missing variables|1|||
13414307|NCT00511875|26844185|FG001|Overall Study|Missing variables|0|||
13414308|NCT00511836|26844207|FG000|Double-blind Period|Lost to Follow-up|1|||
13414309|NCT00511836|26844208|FG001|Double-blind Period|Lost to Follow-up|0|||
13414310|NCT00511810|26844221|FG000|Overall Study|Lost to Follow-up|1|||
13414311|NCT00511810|26844222|FG001|Overall Study|Lost to Follow-up|2|||
13414312|NCT00511810|26844221|FG000|Overall Study|Lack of Efficacy|0|||
13414313|NCT00511810|26844222|FG001|Overall Study|Lack of Efficacy|2|||
13414314|NCT00511810|26844221|FG000|Overall Study|Refused second scn|0|||
13414315|NCT00511810|26844222|FG001|Overall Study|Refused second scn|1|||
13414316|NCT00511797|26844337|FG000|Overall Study|Adverse Event|1|||
13414317|NCT00511797|26844338|FG001|Overall Study|Adverse Event|2|||
13414318|NCT00511797|26844339|FG002|Overall Study|Adverse Event|2|||
13414319|NCT00511797|26844340|FG003|Overall Study|Adverse Event|2|||
13414320|NCT00511797|26844337|FG000|Overall Study|Lost to Follow-up|1|||
13414321|NCT00511797|26844338|FG001|Overall Study|Lost to Follow-up|0|||
13414322|NCT00511797|26844339|FG002|Overall Study|Lost to Follow-up|0|||
13414323|NCT00511797|26844340|FG003|Overall Study|Lost to Follow-up|1|||
13414324|NCT00511797|26844337|FG000|Overall Study|Pregnancy|0|||
13414325|NCT00511797|26844338|FG001|Overall Study|Pregnancy|0|||
13414326|NCT00511797|26844339|FG002|Overall Study|Pregnancy|0|||
13390386|NCT00686725|26773332|FG001|Overall Study|Withdrawal by Subject|4|||
13390387|NCT00686725|26773331|FG000|Overall Study|Protocol Violation|1|||
13390388|NCT00686725|26773332|FG001|Overall Study|Protocol Violation|3|||
13390389|NCT00686725|26773331|FG000|Overall Study|Other|1|||
13390390|NCT00686725|26773332|FG001|Overall Study|Other|3|||
13390391|NCT00686712|26773368|FG000|Overall Study|Protocol Violation|8|||
13390392|NCT00686712|26773369|FG001|Overall Study|Protocol Violation|8|||
13390393|NCT00686712|26773370|FG002|Overall Study|Protocol Violation|10|||
13390394|NCT00686712|26773368|FG000|Overall Study|Lost to Follow-up|1|||
13414327|NCT00511797|26844340|FG003|Overall Study|Pregnancy|1|||
13414328|NCT00511797|26844337|FG000|Overall Study|Protocol Violation|0|||
13414329|NCT00511797|26844338|FG001|Overall Study|Protocol Violation|2|||
13414330|NCT00511797|26844339|FG002|Overall Study|Protocol Violation|2|||
13414331|NCT00511797|26844340|FG003|Overall Study|Protocol Violation|3|||
13414332|NCT00511797|26844337|FG000|Overall Study|Withdrawal by Subject|3|||
13414333|NCT00511797|26844338|FG001|Overall Study|Withdrawal by Subject|3|||
13414334|NCT00511797|26844339|FG002|Overall Study|Withdrawal by Subject|4|||
13414335|NCT00511797|26844340|FG003|Overall Study|Withdrawal by Subject|2|||
13414336|NCT00511797|26844337|FG000|Overall Study|Never dispensed|1|||
13414337|NCT00511797|26844338|FG001|Overall Study|Never dispensed|0|||
13414338|NCT00511797|26844339|FG002|Overall Study|Never dispensed|1|||
13414339|NCT00511797|26844340|FG003|Overall Study|Never dispensed|3|||
13414340|NCT00511797|26844337|FG000|Overall Study|Study drug not taken|0|||
13414341|NCT00511797|26844338|FG001|Overall Study|Study drug not taken|1|||
13414342|NCT00511797|26844339|FG002|Overall Study|Study drug not taken|0|||
13414343|NCT00511797|26844340|FG003|Overall Study|Study drug not taken|1|||
13414344|NCT00511797|26844337|FG000|Overall Study|Partially missing diary|0|||
13414345|NCT00511797|26844338|FG001|Overall Study|Partially missing diary|0|||
13414346|NCT00511797|26844339|FG002|Overall Study|Partially missing diary|1|||
13414347|NCT00511797|26844340|FG003|Overall Study|Partially missing diary|0|||
13414348|NCT00511797|26844337|FG000|Overall Study|Other (moving etc)|1|||
13414349|NCT00511797|26844338|FG001|Overall Study|Other (moving etc)|0|||
13414350|NCT00511797|26844339|FG002|Overall Study|Other (moving etc)|1|||
13414351|NCT00511797|26844340|FG003|Overall Study|Other (moving etc)|2|||
13414352|NCT00511667|26844380|FG000|Overall Study|Adverse Event|1|||
13414353|NCT00511667|26844381|FG001|Overall Study|Adverse Event|0|||
13414354|NCT00511667|26844380|FG000|Overall Study|Protocol Violation|1|||
13414355|NCT00511667|26844381|FG001|Overall Study|Protocol Violation|1|||
13414356|NCT00511667|26844380|FG000|Overall Study|Withdrawal by Subject|2|||
13414357|NCT00511667|26844381|FG001|Overall Study|Withdrawal by Subject|0|||
13414358|NCT00511667|26844380|FG000|Overall Study|Site terminated|6|||
13414359|NCT00511667|26844381|FG001|Overall Study|Site terminated|1|||
13414360|NCT00511667|26844380|FG000|Overall Study|Other|2|||
13414361|NCT00511667|26844381|FG001|Overall Study|Other|1|||
13414362|NCT00511472|26844405|FG000|Overall Study|Clinical Adverse Event|1|||
13414363|NCT00511472|26844406|FG001|Overall Study|Clinical Adverse Event|2|||
13414364|NCT00511472|26844405|FG000|Overall Study|Laboratory Adverse Event|0|||
13414365|NCT00511472|26844406|FG001|Overall Study|Laboratory Adverse Event|2|||
13414366|NCT00511472|26844405|FG000|Overall Study|Not reported|2|||
13414367|NCT00511472|26844406|FG001|Overall Study|Not reported|2|||
13414368|NCT00511433|26844451|FG000|Overall Study|Adverse Event|5|||
13414369|NCT00511433|26844452|FG001|Overall Study|Adverse Event|0|||
13414370|NCT00511433|26844451|FG000|Overall Study|Other Reason|1|||
13414371|NCT00511433|26844452|FG001|Overall Study|Other Reason|1|||
13414372|NCT00511355|26844557|FG000|Overall Study|Adverse Event|4|||
13414373|NCT00511355|26844558|FG001|Overall Study|Adverse Event|4|||
13414374|NCT00511355|26844557|FG000|Overall Study|Pregnancy Wish|1|||
13414375|NCT00511355|26844558|FG001|Overall Study|Pregnancy Wish|0|||
13414376|NCT00511355|26844557|FG000|Overall Study|Lost to Follow-up|2|||
13414377|NCT00511355|26844558|FG001|Overall Study|Lost to Follow-up|1|||
13414378|NCT00511355|26844557|FG000|Overall Study|Other Reason|0|||
13414379|NCT00511355|26844558|FG001|Overall Study|Other Reason|1|||
13414380|NCT00511355|26844557|FG000|Overall Study|Pre-treatment (serious) adverse event|0|||
13390395|NCT00686712|26773369|FG001|Overall Study|Lost to Follow-up|2|||
13414381|NCT00511355|26844558|FG001|Overall Study|Pre-treatment (serious) adverse event|1|||
13414382|NCT00511355|26844557|FG000|Overall Study|Withdrawal of informed consent|0|||
13414383|NCT00511355|26844558|FG001|Overall Study|Withdrawal of informed consent|1|||
13414384|NCT00511355|26844557|FG000|Overall Study|Other reason pre-treatment|0|||
13414385|NCT00511355|26844558|FG001|Overall Study|Other reason pre-treatment|1|||
13414386|NCT00511342|26844589|FG000|Overall Study|Unacceptable vaginal bleeding|2|||
13414387|NCT00511342|26844590|FG001|Overall Study|Unacceptable vaginal bleeding|1|||
13414388|NCT00511342|26844589|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8|||
13414389|NCT00511342|26844590|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12|||
13414390|NCT00511342|26844589|FG000|Overall Study|Pregnancy|0|||
13414391|NCT00511342|26844590|FG001|Overall Study|Pregnancy|1|||
13414392|NCT00511342|26844589|FG000|Overall Study|Pregnancy wish|0|||
13414393|NCT00511342|26844590|FG001|Overall Study|Pregnancy wish|1|||
13414394|NCT00511342|26844589|FG000|Overall Study|Lost to Follow-up|1|||
13414395|NCT00511342|26844590|FG001|Overall Study|Lost to Follow-up|5|||
13414396|NCT00511342|26844589|FG000|Overall Study|Other Reason|2|||
13414397|NCT00511342|26844590|FG001|Overall Study|Other Reason|2|||
13414398|NCT00511238|26844614|FG000|Overall Study|Adverse Event|13|||
13414399|NCT00511238|26844615|FG001|Overall Study|Adverse Event|33|||
13414400|NCT00511238|26844614|FG000|Overall Study|Withdrawal by Subject|2|||
13414401|NCT00511238|26844615|FG001|Overall Study|Withdrawal by Subject|22|||
13414402|NCT00511238|26844614|FG000|Overall Study|Progressive Disease|23|||
13414403|NCT00511238|26844615|FG001|Overall Study|Progressive Disease|157|||
13414404|NCT00511238|26844614|FG000|Overall Study|various reasons|4|||
13414405|NCT00511238|26844615|FG001|Overall Study|various reasons|14|||
13414406|NCT00511199|26844646|FG000|Overall Study|Unacceptable Vaginal Bleeding|63|||
13414407|NCT00511199|26844647|FG001|Overall Study|Unacceptable Vaginal Bleeding|4|||
13414408|NCT00511199|26844646|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227|||
13414409|NCT00511199|26844647|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52|||
13414410|NCT00511199|26844646|FG000|Overall Study|Withdrawal of Informed Consent|19|||
13414411|NCT00511199|26844647|FG001|Overall Study|Withdrawal of Informed Consent|4|||
13414412|NCT00511199|26844646|FG000|Overall Study|Pregnancy|6|||
13414413|NCT00511199|26844647|FG001|Overall Study|Pregnancy|3|||
13414414|NCT00511199|26844646|FG000|Overall Study|Pregnancy Wish|16|||
13414415|NCT00511199|26844647|FG001|Overall Study|Pregnancy Wish|8|||
13414416|NCT00511199|26844646|FG000|Overall Study|Lost to Follow-up|40|||
13414417|NCT00511199|26844647|FG001|Overall Study|Lost to Follow-up|17|||
13414418|NCT00511199|26844646|FG000|Overall Study|Other Reason|78|||
13414419|NCT00511199|26844647|FG001|Overall Study|Other Reason|37|||
13476528|NCT00500071|27003114|FG000|Screening and Washout Phase|Protocol Violation|1|||
13476529|NCT00500071|27003114|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13|||
13476530|NCT00500071|27003114|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2|||
13476531|NCT00500071|27003114|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2|||
13390396|NCT00686712|26773370|FG002|Overall Study|Lost to Follow-up|3|||
13390397|NCT00686712|26773368|FG000|Overall Study|Adverse Event|1|||
13390398|NCT00686712|26773369|FG001|Overall Study|Adverse Event|1|||
13390399|NCT00686712|26773370|FG002|Overall Study|Adverse Event|0|||
13390400|NCT00686699|26773401|FG000|Treatment Period 1|Adverse Event|0|||
13390401|NCT00686699|26773402|FG001|Treatment Period 1|Adverse Event|2|||
13390402|NCT00686686|26773412|FG000|Overall Study|Non-compliance|1|||
13390403|NCT00686686|26773412|FG000|Overall Study|Adverse Event|2|||
13390404|NCT00686686|26773412|FG000|Overall Study|Lost to Follow-up|3|||
13390405|NCT00686647|26773420|FG000|Overall Study|Lost to Follow-up|1|||
13390406|NCT00686647|26773420|FG000|Overall Study|Death|1|||
13390407|NCT00686634|26773429|FG000|Overall Study|Protocol Violation|6|||
13390408|NCT00686595|26773456|FG000|Overall Study|Adverse Event|3|||
13390409|NCT00686595|26773456|FG000|Overall Study|Protocol Violation|1|||
13390410|NCT00686595|26773456|FG000|Overall Study|Lost to Follow-up|1|||
13390411|NCT00686595|26773456|FG000|Overall Study|Lack of Efficacy|1|||
13390412|NCT00686595|26773456|FG000|Overall Study|Poor Compliance|1|||
13390413|NCT00686543|26773487|FG000|Overall Study|Adverse Event|9|||
13390414|NCT00686543|26773488|FG001|Overall Study|Adverse Event|1|||
13390415|NCT00686543|26773489|FG002|Overall Study|Adverse Event|3|||
13390416|NCT00686543|26773490|FG003|Overall Study|Adverse Event|2|||
13390417|NCT00686543|26773487|FG000|Overall Study|Withdrawal by Subject|2|||
13390418|NCT00686543|26773488|FG001|Overall Study|Withdrawal by Subject|0|||
13390419|NCT00686543|26773489|FG002|Overall Study|Withdrawal by Subject|0|||
13390420|NCT00686543|26773490|FG003|Overall Study|Withdrawal by Subject|0|||
13390421|NCT00686543|26773487|FG000|Overall Study|Protocol Violation|3|||
13390422|NCT00686543|26773488|FG001|Overall Study|Protocol Violation|0|||
13390423|NCT00686543|26773489|FG002|Overall Study|Protocol Violation|2|||
13390424|NCT00686543|26773490|FG003|Overall Study|Protocol Violation|1|||
13390425|NCT00686517|26773523|FG000|Treatment|Serious Adverse Event|1|||
13390426|NCT00686517|26773524|FG001|Treatment|Serious Adverse Event|2|||
13390427|NCT00686517|26773525|FG002|Treatment|Serious Adverse Event|1|||
13390428|NCT00686517|26773523|FG000|Treatment|Adverse Event|2|||
13390429|NCT00686517|26773524|FG001|Treatment|Adverse Event|0|||
13390430|NCT00686517|26773525|FG002|Treatment|Adverse Event|0|||
13390431|NCT00686517|26773523|FG000|Treatment|Poor Protocol Compliance|1|||
13414420|NCT00511147|26844656|FG000|Overall Study|Withdrawal by Subject|1|||
13414421|NCT00511147|26844656|FG000|Overall Study|Disease progression|5|||
13414422|NCT00511147|26844656|FG000|Overall Study|Required platelet transfusion|1|||
13414423|NCT00511108|26844687|FG000|Overall Study|Adverse Event|2|||
13414424|NCT00511108|26844688|FG001|Overall Study|Adverse Event|0|||
13414425|NCT00511108|26844689|FG002|Overall Study|Adverse Event|1|||
13414426|NCT00511108|26844690|FG003|Overall Study|Adverse Event|2|||
13414427|NCT00511108|26844687|FG000|Overall Study|Lost to Follow-up|0|||
13414428|NCT00511108|26844688|FG001|Overall Study|Lost to Follow-up|2|||
13414429|NCT00511108|26844689|FG002|Overall Study|Lost to Follow-up|1|||
13414430|NCT00511108|26844690|FG003|Overall Study|Lost to Follow-up|0|||
13414431|NCT00511108|26844687|FG000|Overall Study|Physician Decision|0|||
13414432|NCT00511108|26844688|FG001|Overall Study|Physician Decision|0|||
13414433|NCT00511108|26844689|FG002|Overall Study|Physician Decision|0|||
13414434|NCT00511108|26844690|FG003|Overall Study|Physician Decision|1|||
13414435|NCT00511108|26844687|FG000|Overall Study|Withdrawal by Subject|4|||
13414436|NCT00511108|26844688|FG001|Overall Study|Withdrawal by Subject|0|||
13414437|NCT00511108|26844689|FG002|Overall Study|Withdrawal by Subject|3|||
13414438|NCT00511108|26844690|FG003|Overall Study|Withdrawal by Subject|2|||
13414439|NCT00511004|26844717|FG000|Overall Study|Lost to Follow-up|0|||
13414440|NCT00511004|26844718|FG001|Overall Study|Lost to Follow-up|0|||
13414441|NCT00511004|26844719|FG002|Overall Study|Lost to Follow-up|4|||
13414442|NCT00510952|26844752|FG000|Overall Study|Adverse Event|1|||
13414443|NCT00510952|26844753|FG001|Overall Study|Adverse Event|0|||
13414444|NCT00510952|26844752|FG000|Overall Study|Entry Criteria Not Met|3|||
13414445|NCT00510952|26844753|FG001|Overall Study|Entry Criteria Not Met|1|||
13414446|NCT00510952|26844752|FG000|Overall Study|Lost to Follow-up|5|||
13414447|NCT00510952|26844753|FG001|Overall Study|Lost to Follow-up|3|||
13414448|NCT00510952|26844752|FG000|Overall Study|Physician Decision|1|||
13414449|NCT00510952|26844753|FG001|Overall Study|Physician Decision|1|||
13414450|NCT00510952|26844752|FG000|Overall Study|Protocol Violation|7|||
13414451|NCT00510952|26844753|FG001|Overall Study|Protocol Violation|4|||
13414452|NCT00510952|26844752|FG000|Overall Study|Sponsor Decision|1|||
13414453|NCT00510952|26844753|FG001|Overall Study|Sponsor Decision|0|||
13414454|NCT00510952|26844752|FG000|Overall Study|Withdrawal by Subject|6|||
13414455|NCT00510952|26844753|FG001|Overall Study|Withdrawal by Subject|7|||
13414456|NCT00510952|26844752|FG000|Overall Study|Did Not Receive Study Drug|2|||
13414457|NCT00510952|26844753|FG001|Overall Study|Did Not Receive Study Drug|0|||
13414458|NCT00510887|26844764|FG000|Overall Study|Lost to Follow-up|1|||
13414459|NCT00510874|26844886|FG000|Overall Study|Withdrawal by Subject|1|||
13414460|NCT00510874|26844887|FG001|Overall Study|Withdrawal by Subject|1|||
13414461|NCT00510874|26844888|FG002|Overall Study|Withdrawal by Subject|0|||
13414462|NCT00510874|26844889|FG003|Overall Study|Withdrawal by Subject|0|||
13414463|NCT00510874|26844890|FG004|Overall Study|Withdrawal by Subject|3|||
13414464|NCT00510874|26844891|FG005|Overall Study|Withdrawal by Subject|0|||
13414465|NCT00510874|26844892|FG006|Overall Study|Withdrawal by Subject|0|||
13414466|NCT00510874|26844886|FG000|Overall Study|Lost to Follow-up|2|||
13414467|NCT00510874|26844887|FG001|Overall Study|Lost to Follow-up|3|||
13414468|NCT00510874|26844888|FG002|Overall Study|Lost to Follow-up|1|||
13414469|NCT00510874|26844889|FG003|Overall Study|Lost to Follow-up|3|||
13414470|NCT00510874|26844890|FG004|Overall Study|Lost to Follow-up|4|||
13414471|NCT00510874|26844891|FG005|Overall Study|Lost to Follow-up|0|||
13414472|NCT00510874|26844892|FG006|Overall Study|Lost to Follow-up|1|||
13414473|NCT00510835|26844910|FG000|Overall Study|Withdrawal by Subject|6|||
13414474|NCT00510835|26844911|FG001|Overall Study|Withdrawal by Subject|2|||
13414475|NCT00510835|26844912|FG002|Overall Study|Withdrawal by Subject|2|||
13414476|NCT00510783|26844925|FG000|Overall Study|Lost to Follow-up|29|||
13414477|NCT00510783|26844926|FG001|Overall Study|Lost to Follow-up|25|||
13414478|NCT00510783|26844925|FG000|Overall Study|Withdrawal by Subject|2|||
13414479|NCT00510783|26844926|FG001|Overall Study|Withdrawal by Subject|3|||
13414480|NCT00510783|26844925|FG000|Overall Study|Protocol Violation|0|||
13414481|NCT00510783|26844926|FG001|Overall Study|Protocol Violation|1|||
13414482|NCT00510718|26845067|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1|||
13414483|NCT00510718|26845068|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8|||
13414484|NCT00510718|26845067|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3|||
13414485|NCT00510718|26845068|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6|||
13414486|NCT00510718|26845067|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8|||
13414487|NCT00510718|26845068|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11|||
13414488|NCT00510718|26845067|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1|||
13414489|NCT00510718|26845068|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3|||
13414490|NCT00510718|26845067|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1|||
13414491|NCT00510718|26845068|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3|||
13414492|NCT00510718|26845067|FG000|Multiple Dose Period: 12 Weeks|Other|1|||
13414493|NCT00510718|26845068|FG001|Multiple Dose Period: 12 Weeks|Other|1|||
13414494|NCT00510692|26845089|FG000|Overall Study|Adverse Event|1|||
13414495|NCT00510692|26845090|FG001|Overall Study|Adverse Event|3|||
13414496|NCT00510692|26845089|FG000|Overall Study|Withdrawal by Subject|1|||
13414497|NCT00510692|26845090|FG001|Overall Study|Withdrawal by Subject|0|||
13414498|NCT00510653|26845096|FG000|Overall Study|Withdrawal by Subject|8|||
13414499|NCT00510653|26845096|FG000|Overall Study|Monetary|3|||
13414500|NCT00510510|26845117|FG000|Overall Study|Adverse Event|4|||
13414501|NCT00510510|26845118|FG001|Overall Study|Adverse Event|3|||
13414502|NCT00510510|26845119|FG002|Overall Study|Adverse Event|6|||
13414503|NCT00510510|26845117|FG000|Overall Study|Lack of Efficacy|0|||
13414504|NCT00510510|26845118|FG001|Overall Study|Lack of Efficacy|1|||
13414505|NCT00510510|26845119|FG002|Overall Study|Lack of Efficacy|1|||
13414506|NCT00510510|26845117|FG000|Overall Study|Subjects no longer requires study drug|0|||
13414507|NCT00510510|26845118|FG001|Overall Study|Subjects no longer requires study drug|0|||
13414508|NCT00510510|26845119|FG002|Overall Study|Subjects no longer requires study drug|2|||
13414509|NCT00510510|26845117|FG000|Overall Study|Withdrawal by Subject|1|||
13414510|NCT00510510|26845118|FG001|Overall Study|Withdrawal by Subject|2|||
13414511|NCT00510510|26845119|FG002|Overall Study|Withdrawal by Subject|3|||
13414512|NCT00510510|26845117|FG000|Overall Study|Lost to Follow-up|0|||
13414513|NCT00510510|26845118|FG001|Overall Study|Lost to Follow-up|0|||
13414514|NCT00510510|26845119|FG002|Overall Study|Lost to Follow-up|1|||
13414515|NCT00510510|26845117|FG000|Overall Study|Protocol Violation|0|||
13414516|NCT00510510|26845118|FG001|Overall Study|Protocol Violation|3|||
13414517|NCT00510510|26845119|FG002|Overall Study|Protocol Violation|4|||
13414518|NCT00510484|26845146|FG000|Wash-out Period|Adverse Event|0|||
13414519|NCT00510484|26845147|FG001|Wash-out Period|Adverse Event|1|||
13414520|NCT00510458|26845162|FG000|Overall Study|5 year not evaluable/missed|21|||
13414521|NCT00510458|26845162|FG000|Overall Study|Death|1|||
13414522|NCT00510458|26845162|FG000|Overall Study|Terminated|14|||
13414523|NCT00510458|26845162|FG000|Overall Study|Lost to Follow-up|6|||
13414524|NCT00510458|26845162|FG000|Overall Study|Withdrawal by Subject|3|||
13414525|NCT00510458|26845162|FG000|Overall Study|Revision|2|||
13414526|NCT00510289|26845172|FG000|Overall Study|Withdrawal by Subject|7|||
13414527|NCT00510289|26845172|FG000|Overall Study|Refused bone marrow biopsy|2|||
13414528|NCT00510289|26845172|FG000|Overall Study|Lost to Follow-up|1|||
13414529|NCT00510289|26845172|FG000|Overall Study|Progressed prior to starting drug|2|||
13414530|NCT00510276|26845264|FG000|Acute Double-Blind Phase|Adverse Event|21|||
13414531|NCT00510276|26845265|FG001|Acute Double-Blind Phase|Adverse Event|6|||
13414532|NCT00510276|26845264|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
13414533|NCT00510276|26845265|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
13414534|NCT00510276|26845264|FG000|Acute Double-Blind Phase|Lack of Efficacy|3|||
13414535|NCT00510276|26845265|FG001|Acute Double-Blind Phase|Lack of Efficacy|4|||
13414536|NCT00510276|26845264|FG000|Acute Double-Blind Phase|Lost to Follow-up|48|||
13414537|NCT00510276|26845265|FG001|Acute Double-Blind Phase|Lost to Follow-up|49|||
13414538|NCT00510276|26845264|FG000|Acute Double-Blind Phase|Physician Decision|0|||
13414539|NCT00510276|26845265|FG001|Acute Double-Blind Phase|Physician Decision|3|||
13414540|NCT00510276|26845264|FG000|Acute Double-Blind Phase|Protocol Violation|4|||
13414541|NCT00510276|26845265|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
13414542|NCT00510276|26845264|FG000|Acute Double-Blind Phase|Sponsor Decision|2|||
13414543|NCT00510276|26845265|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
13414544|NCT00510276|26845264|FG000|Acute Double-Blind Phase|Subject Decision|26|||
13414545|NCT00510276|26845265|FG001|Acute Double-Blind Phase|Subject Decision|28|||
13414546|NCT00510276|26845264|FG000|Extension Open-Label Phase|Adverse Event|9|||
13414547|NCT00510276|26845265|FG001|Extension Open-Label Phase|Adverse Event|18|||
13414548|NCT00510276|26845264|FG000|Extension Open-Label Phase|Lack of Efficacy|2|||
13414549|NCT00510276|26845265|FG001|Extension Open-Label Phase|Lack of Efficacy|7|||
13414550|NCT00510276|26845264|FG000|Extension Open-Label Phase|Lost to Follow-up|12|||
13414551|NCT00510276|26845265|FG001|Extension Open-Label Phase|Lost to Follow-up|10|||
13414552|NCT00510276|26845264|FG000|Extension Open-Label Phase|Physician Decision|2|||
13414553|NCT00510276|26845265|FG001|Extension Open-Label Phase|Physician Decision|3|||
13414554|NCT00510276|26845264|FG000|Extension Open-Label Phase|Protocol Violation|0|||
13414555|NCT00510276|26845265|FG001|Extension Open-Label Phase|Protocol Violation|1|||
13414556|NCT00510276|26845264|FG000|Extension Open-Label Phase|Sponsor Decision|1|||
13414557|NCT00510276|26845265|FG001|Extension Open-Label Phase|Sponsor Decision|0|||
13414558|NCT00510276|26845264|FG000|Extension Open-Label Phase|Subject Decision|7|||
13414559|NCT00510276|26845265|FG001|Extension Open-Label Phase|Subject Decision|9|||
13414560|NCT00510198|26845284|FG000|Overall Study|Withdrawal by Subject|5|||
13414561|NCT00510198|26845285|FG001|Overall Study|Withdrawal by Subject|4|||
13414562|NCT00510146|26845379|FG000|Double-Blind Treatment|Adverse Event|30|||
13414563|NCT00510146|26845380|FG001|Double-Blind Treatment|Adverse Event|13|||
13414564|NCT00510146|26845379|FG000|Double-Blind Treatment|Lack of Efficacy|6|||
13414565|NCT00510146|26845380|FG001|Double-Blind Treatment|Lack of Efficacy|13|||
13414566|NCT00510146|26845379|FG000|Double-Blind Treatment|Lost to Follow-up|3|||
13414567|NCT00510146|26845380|FG001|Double-Blind Treatment|Lost to Follow-up|7|||
13414568|NCT00510146|26845379|FG000|Double-Blind Treatment|Physician Decision|6|||
13414569|NCT00510146|26845380|FG001|Double-Blind Treatment|Physician Decision|0|||
13414570|NCT00510146|26845379|FG000|Double-Blind Treatment|Protocol Violation|1|||
13414571|NCT00510146|26845380|FG001|Double-Blind Treatment|Protocol Violation|2|||
13414572|NCT00510146|26845379|FG000|Double-Blind Treatment|Withdrawal by Subject|27|||
13414573|NCT00510146|26845380|FG001|Double-Blind Treatment|Withdrawal by Subject|13|||
13414574|NCT00510146|26845379|FG000|Double-Blind Treatment|Clinical Relapse|0|||
13414575|NCT00510146|26845380|FG001|Double-Blind Treatment|Clinical Relapse|1|||
13414576|NCT00510146|26845379|FG000|Double-Blind Treatment|Entry Criteria Not Met|3|||
13414577|NCT00510146|26845380|FG001|Double-Blind Treatment|Entry Criteria Not Met|0|||
13414578|NCT00510146|26845379|FG000|Open-Label Treatment|Adverse Event|22|||
13414579|NCT00510146|26845380|FG001|Open-Label Treatment|Adverse Event|8|||
13414580|NCT00510146|26845379|FG000|Open-Label Treatment|Death|1|||
13414581|NCT00510146|26845380|FG001|Open-Label Treatment|Death|1|||
13414582|NCT00510146|26845379|FG000|Open-Label Treatment|Lack of Efficacy|4|||
13414583|NCT00510146|26845380|FG001|Open-Label Treatment|Lack of Efficacy|0|||
13414584|NCT00510146|26845379|FG000|Open-Label Treatment|Lost to Follow-up|10|||
13414585|NCT00510146|26845380|FG001|Open-Label Treatment|Lost to Follow-up|1|||
13414586|NCT00510146|26845379|FG000|Open-Label Treatment|Physician Decision|3|||
13414587|NCT00510146|26845380|FG001|Open-Label Treatment|Physician Decision|1|||
13414588|NCT00510146|26845379|FG000|Open-Label Treatment|Protocol Violation|4|||
13414589|NCT00510146|26845380|FG001|Open-Label Treatment|Protocol Violation|2|||
13414590|NCT00510146|26845379|FG000|Open-Label Treatment|Withdrawal by Subject|24|||
13414591|NCT00510146|26845380|FG001|Open-Label Treatment|Withdrawal by Subject|12|||
13414592|NCT00510146|26845379|FG000|Open-Label Treatment|Clinical Relapse|1|||
13414593|NCT00510146|26845380|FG001|Open-Label Treatment|Clinical Relapse|1|||
13414594|NCT00510146|26845379|FG000|Open-Label Treatment|Sponsor Decision|2|||
13414595|NCT00510146|26845380|FG001|Open-Label Treatment|Sponsor Decision|0|||
13414596|NCT00510068|26845428|FG000|Double-blind Period|Disease progression|98|||
13414597|NCT00510068|26845429|FG001|Double-blind Period|Disease progression|169|||
13414598|NCT00510068|26845428|FG000|Double-blind Period|Final primary analysis|52|||
13414599|NCT00510068|26845429|FG001|Double-blind Period|Final primary analysis|18|||
13414600|NCT00510068|26845428|FG000|Double-blind Period|Adverse Event|37|||
13414601|NCT00510068|26845429|FG001|Double-blind Period|Adverse Event|7|||
13414602|NCT00510068|26845428|FG000|Double-blind Period|Withdrawal by Subject|8|||
13414603|NCT00510068|26845429|FG001|Double-blind Period|Withdrawal by Subject|6|||
13414604|NCT00510068|26845428|FG000|Double-blind Period|Death|4|||
13414605|NCT00510068|26845429|FG001|Double-blind Period|Death|3|||
13414606|NCT00510068|26845428|FG000|Double-blind Period|Abnormal test result (s)|1|||
13414607|NCT00510068|26845429|FG001|Double-blind Period|Abnormal test result (s)|0|||
13414608|NCT00510068|26845428|FG000|Double-blind Period|Lost to Follow-up|1|||
13414609|NCT00510068|26845429|FG001|Double-blind Period|Lost to Follow-up|0|||
13414610|NCT00510068|26845428|FG000|Double-blind Period|Protocol Violation|6|||
13414611|NCT00510068|26845429|FG001|Double-blind Period|Protocol Violation|0|||
13414612|NCT00510068|26845428|FG000|Open-label Period|Disease Progression|124|||
13414613|NCT00510068|26845429|FG001|Open-label Period|Disease Progression|0|||
13414614|NCT00510068|26845428|FG000|Open-label Period|Adverse Event|46|||
13414615|NCT00510068|26845429|FG001|Open-label Period|Adverse Event|0|||
13414616|NCT00510068|26845428|FG000|Open-label Period|Withdrawal by Subject|21|||
13414617|NCT00510068|26845429|FG001|Open-label Period|Withdrawal by Subject|0|||
13414618|NCT00510068|26845428|FG000|Open-label Period|Administrative problems|17|||
13414619|NCT00510068|26845429|FG001|Open-label Period|Administrative problems|0|||
13414620|NCT00510068|26845428|FG000|Open-label Period|Death|7|||
13414621|NCT00510068|26845429|FG001|Open-label Period|Death|0|||
13414622|NCT00510068|26845428|FG000|Open-label Period|New cancer therapy|7|||
13414623|NCT00510068|26845429|FG001|Open-label Period|New cancer therapy|0|||
13414624|NCT00510068|26845428|FG000|Open-label Period|Protocol Violation|2|||
13414625|NCT00510068|26845429|FG001|Open-label Period|Protocol Violation|0|||
13414626|NCT00510068|26845428|FG000|Open-label Period|Abnormal laboratory value (s)|1|||
13414627|NCT00510068|26845429|FG001|Open-label Period|Abnormal laboratory value (s)|0|||
13414628|NCT00509925|26845472|FG000|Overall Study|Personal reasons|0|||
13414629|NCT00509925|26845473|FG001|Overall Study|Personal reasons|1|||
13414630|NCT00509899|26845536|FG000|Overall Study|Progressive disease|1|||
13414631|NCT00509899|26845537|FG001|Overall Study|Progressive disease|3|||
13414632|NCT00509899|26845538|FG002|Overall Study|Progressive disease|5|||
13414633|NCT00509899|26845539|FG003|Overall Study|Progressive disease|1|||
13414634|NCT00509899|26845540|FG004|Overall Study|Progressive disease|0|||
13414635|NCT00509899|26845541|FG005|Overall Study|Progressive disease|1|||
13414636|NCT00509899|26845542|FG006|Overall Study|Progressive disease|0|||
13414637|NCT00509899|26845543|FG007|Overall Study|Progressive disease|0|||
13414638|NCT00509899|26845536|FG000|Overall Study|Unacceptable Toxicity|1|||
13414639|NCT00509899|26845537|FG001|Overall Study|Unacceptable Toxicity|0|||
13414640|NCT00509899|26845538|FG002|Overall Study|Unacceptable Toxicity|0|||
13414641|NCT00509899|26845539|FG003|Overall Study|Unacceptable Toxicity|2|||
13414642|NCT00509899|26845540|FG004|Overall Study|Unacceptable Toxicity|0|||
13414643|NCT00509899|26845541|FG005|Overall Study|Unacceptable Toxicity|0|||
13414644|NCT00509899|26845542|FG006|Overall Study|Unacceptable Toxicity|0|||
13414645|NCT00509899|26845543|FG007|Overall Study|Unacceptable Toxicity|0|||
13414646|NCT00509899|26845536|FG000|Overall Study|Withdrawal by Subject|6|||
13414647|NCT00509899|26845537|FG001|Overall Study|Withdrawal by Subject|2|||
13414648|NCT00509899|26845538|FG002|Overall Study|Withdrawal by Subject|3|||
13414649|NCT00509899|26845539|FG003|Overall Study|Withdrawal by Subject|0|||
13414650|NCT00509899|26845540|FG004|Overall Study|Withdrawal by Subject|3|||
13414651|NCT00509899|26845541|FG005|Overall Study|Withdrawal by Subject|2|||
13414652|NCT00509899|26845542|FG006|Overall Study|Withdrawal by Subject|0|||
13414653|NCT00509899|26845543|FG007|Overall Study|Withdrawal by Subject|0|||
13414654|NCT00509899|26845536|FG000|Overall Study|Physician Decision|4|||
13414655|NCT00509899|26845537|FG001|Overall Study|Physician Decision|2|||
13414656|NCT00509899|26845538|FG002|Overall Study|Physician Decision|7|||
13414657|NCT00509899|26845539|FG003|Overall Study|Physician Decision|0|||
13414658|NCT00509899|26845540|FG004|Overall Study|Physician Decision|1|||
13414659|NCT00509899|26845541|FG005|Overall Study|Physician Decision|4|||
13414660|NCT00509899|26845542|FG006|Overall Study|Physician Decision|0|||
13414661|NCT00509899|26845543|FG007|Overall Study|Physician Decision|0|||
13414662|NCT00509899|26845536|FG000|Overall Study|Intercurrent Illness|1|||
13414663|NCT00509899|26845537|FG001|Overall Study|Intercurrent Illness|0|||
13414664|NCT00509899|26845538|FG002|Overall Study|Intercurrent Illness|0|||
13414665|NCT00509899|26845539|FG003|Overall Study|Intercurrent Illness|1|||
13414666|NCT00509899|26845540|FG004|Overall Study|Intercurrent Illness|0|||
13414667|NCT00509899|26845541|FG005|Overall Study|Intercurrent Illness|1|||
13414668|NCT00509899|26845542|FG006|Overall Study|Intercurrent Illness|0|||
13414669|NCT00509899|26845543|FG007|Overall Study|Intercurrent Illness|0|||
13414670|NCT00509899|26845536|FG000|Overall Study|Death|2|||
13414671|NCT00509899|26845537|FG001|Overall Study|Death|2|||
13414672|NCT00509899|26845538|FG002|Overall Study|Death|3|||
13414673|NCT00509899|26845539|FG003|Overall Study|Death|0|||
13414674|NCT00509899|26845540|FG004|Overall Study|Death|1|||
13414675|NCT00509899|26845541|FG005|Overall Study|Death|1|||
13414676|NCT00509899|26845542|FG006|Overall Study|Death|1|||
13414677|NCT00509899|26845543|FG007|Overall Study|Death|1|||
13414678|NCT00509899|26845536|FG000|Overall Study|Lack of Efficacy|1|||
13414679|NCT00509899|26845537|FG001|Overall Study|Lack of Efficacy|0|||
13414680|NCT00509899|26845538|FG002|Overall Study|Lack of Efficacy|2|||
13414681|NCT00509899|26845539|FG003|Overall Study|Lack of Efficacy|0|||
13414682|NCT00509899|26845540|FG004|Overall Study|Lack of Efficacy|0|||
13414683|NCT00509899|26845541|FG005|Overall Study|Lack of Efficacy|1|||
13414684|NCT00509899|26845542|FG006|Overall Study|Lack of Efficacy|0|||
13414685|NCT00509899|26845543|FG007|Overall Study|Lack of Efficacy|0|||
13414686|NCT00509821|26845564|FG000|Study Period 1 (Induction)|Death|0|||
13414687|NCT00509821|26845565|FG001|Study Period 1 (Induction)|Death|1|||
13414688|NCT00509821|26845564|FG000|Study Period 1 (Induction)|Adverse Event|0|||
13414689|NCT00509821|26845565|FG001|Study Period 1 (Induction)|Adverse Event|2|||
13414690|NCT00509821|26845564|FG000|Study Period 1 (Induction)|Progressive Disease|0|||
13414691|NCT00509821|26845565|FG001|Study Period 1 (Induction)|Progressive Disease|1|||
13414692|NCT00509795|26845609|FG000|Overall Study|Adverse Event|4|||
13414693|NCT00509795|26845610|FG001|Overall Study|Adverse Event|3|||
13414694|NCT00509795|26845611|FG002|Overall Study|Adverse Event|5|||
13414695|NCT00509795|26845612|FG003|Overall Study|Adverse Event|4|||
13414696|NCT00509795|26845609|FG000|Overall Study|Death|3|||
13414697|NCT00509795|26845610|FG001|Overall Study|Death|1|||
13414698|NCT00509795|26845611|FG002|Overall Study|Death|2|||
13414699|NCT00509795|26845612|FG003|Overall Study|Death|7|||
13414700|NCT00509795|26845609|FG000|Overall Study|Lack of Efficacy|0|||
13414701|NCT00509795|26845610|FG001|Overall Study|Lack of Efficacy|0|||
13414702|NCT00509795|26845611|FG002|Overall Study|Lack of Efficacy|2|||
13414703|NCT00509795|26845612|FG003|Overall Study|Lack of Efficacy|2|||
13414704|NCT00509795|26845609|FG000|Overall Study|Lost to Follow-up|1|||
13414705|NCT00509795|26845610|FG001|Overall Study|Lost to Follow-up|2|||
13414706|NCT00509795|26845611|FG002|Overall Study|Lost to Follow-up|4|||
13414707|NCT00509795|26845612|FG003|Overall Study|Lost to Follow-up|4|||
13414708|NCT00509795|26845609|FG000|Overall Study|OTHER|1|||
13414709|NCT00509795|26845610|FG001|Overall Study|OTHER|0|||
13414710|NCT00509795|26845611|FG002|Overall Study|OTHER|4|||
13414711|NCT00509795|26845612|FG003|Overall Study|OTHER|1|||
13414712|NCT00509795|26845609|FG000|Overall Study|Protocol Violation|3|||
13414713|NCT00509795|26845610|FG001|Overall Study|Protocol Violation|0|||
13414714|NCT00509795|26845611|FG002|Overall Study|Protocol Violation|3|||
13414715|NCT00509795|26845612|FG003|Overall Study|Protocol Violation|1|||
13414716|NCT00509795|26845609|FG000|Overall Study|Withdrawal by Subject|10|||
13414717|NCT00509795|26845610|FG001|Overall Study|Withdrawal by Subject|5|||
13414718|NCT00509795|26845611|FG002|Overall Study|Withdrawal by Subject|7|||
13414719|NCT00509795|26845612|FG003|Overall Study|Withdrawal by Subject|8|||
13414720|NCT00509769|26845623|FG000|Overall Study|Progressive disease|77|||
13414721|NCT00509769|26845623|FG000|Overall Study|Adverse Event|4|||
13414722|NCT00509769|26845623|FG000|Overall Study|Patient's decision|1|||
13414723|NCT00509769|26845623|FG000|Overall Study|Physician Decision|8|||
13414724|NCT00509769|26845623|FG000|Overall Study|Use of prohibited therapies during study|1|||
13414725|NCT00509600|26845629|FG000|Overall Study|Adverse Event|1|||
13414726|NCT00509366|26845656|FG000|Overall Study|Not Treated (Screen Failure)|1|||
13414727|NCT00509366|26845657|FG001|Overall Study|Not Treated (Screen Failure)|1|||
13414728|NCT00509366|26845658|FG002|Overall Study|Not Treated (Screen Failure)|1|||
13414729|NCT00509366|26845659|FG003|Overall Study|Not Treated (Screen Failure)|0|||
13414730|NCT00509366|26845660|FG004|Overall Study|Not Treated (Screen Failure)|0|||
13414731|NCT00509262|26845679|FG000|Overall Study|Adverse Event|16|||
13414732|NCT00509262|26845680|FG001|Overall Study|Adverse Event|18|||
13414733|NCT00509262|26845679|FG000|Overall Study|Other|2|||
13414734|NCT00509262|26845680|FG001|Overall Study|Other|2|||
13414735|NCT00509262|26845679|FG000|Overall Study|Lack of Efficacy|1|||
13414736|NCT00509262|26845680|FG001|Overall Study|Lack of Efficacy|0|||
13414737|NCT00509262|26845679|FG000|Overall Study|Lost to Follow-up|1|||
13414738|NCT00509262|26845680|FG001|Overall Study|Lost to Follow-up|6|||
13414739|NCT00509262|26845679|FG000|Overall Study|Physician Decision|1|||
13414740|NCT00509262|26845680|FG001|Overall Study|Physician Decision|3|||
13414741|NCT00509262|26845679|FG000|Overall Study|Protocol Violation|2|||
13414742|NCT00509262|26845680|FG001|Overall Study|Protocol Violation|2|||
13414743|NCT00509262|26845679|FG000|Overall Study|Withdrawal by Subject|24|||
13414744|NCT00509262|26845680|FG001|Overall Study|Withdrawal by Subject|11|||
13414745|NCT00509236|26845700|FG000|Overall Study|Adverse Event|7|||
13414746|NCT00509236|26845701|FG001|Overall Study|Adverse Event|9|||
13414747|NCT00509236|26845700|FG000|Overall Study|Withdrawal by Subject|5|||
13414748|NCT00509236|26845701|FG001|Overall Study|Withdrawal by Subject|10|||
13414749|NCT00509236|26845700|FG000|Overall Study|Protocol Violation|3|||
13414750|NCT00509236|26845701|FG001|Overall Study|Protocol Violation|0|||
13414751|NCT00509236|26845700|FG000|Overall Study|Excluded Medication|1|||
13414752|NCT00509236|26845701|FG001|Overall Study|Excluded Medication|1|||
13414753|NCT00509236|26845700|FG000|Overall Study|Scheduled Kidney Transplant|1|||
13414754|NCT00509236|26845701|FG001|Overall Study|Scheduled Kidney Transplant|0|||
13414755|NCT00509223|26845714|FG000|Overall Study|Lost to Follow-up|1|||
13414756|NCT00509223|26845715|FG001|Overall Study|Lost to Follow-up|1|||
13414757|NCT00509223|26845714|FG000|Overall Study|Adverse Event|1|||
13414758|NCT00509223|26845715|FG001|Overall Study|Adverse Event|1|||
13414759|NCT00509223|26845714|FG000|Overall Study|Withdrawal by Subject|25|||
13414760|NCT00509223|26845715|FG001|Overall Study|Withdrawal by Subject|6|||
13414761|NCT00509223|26845714|FG000|Overall Study|Including: subject change of address|5|||
13414762|NCT00509223|26845715|FG001|Overall Study|Including: subject change of address|2|||
13414763|NCT00509223|26845714|FG000|Overall Study|Did not meet revised inclusion criteria|56|||
13414764|NCT00509223|26845715|FG001|Overall Study|Did not meet revised inclusion criteria|62|||
13414765|NCT00509145|26845736|FG000|Overall Study|Death|0|||
13414766|NCT00509145|26845737|FG001|Overall Study|Death|2|||
13414767|NCT00509145|26845736|FG000|Overall Study|Adverse Event|42|||
13414768|NCT00509145|26845737|FG001|Overall Study|Adverse Event|28|||
13414769|NCT00509145|26845736|FG000|Overall Study|Withdrawal by Subject|32|||
13414770|NCT00509145|26845737|FG001|Overall Study|Withdrawal by Subject|38|||
13414771|NCT00509145|26845736|FG000|Overall Study|Physician Decision|11|||
13414772|NCT00509145|26845737|FG001|Overall Study|Physician Decision|14|||
13414773|NCT00509145|26845736|FG000|Overall Study|Protocol Violation|1|||
13414774|NCT00509145|26845737|FG001|Overall Study|Protocol Violation|6|||
13414775|NCT00509145|26845736|FG000|Overall Study|Pregnancy|3|||
13414776|NCT00509145|26845737|FG001|Overall Study|Pregnancy|8|||
13414777|NCT00509145|26845736|FG000|Overall Study|Lost to Follow-up|6|||
13414778|NCT00509145|26845737|FG001|Overall Study|Lost to Follow-up|5|||
13414779|NCT00509145|26845736|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12|||
13414780|NCT00509145|26845737|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22|||
13390432|NCT00686517|26773524|FG001|Treatment|Poor Protocol Compliance|0|||
13390433|NCT00686517|26773525|FG002|Treatment|Poor Protocol Compliance|0|||
13390434|NCT00686517|26773523|FG000|Treatment|Protocol Violation|2|||
13390435|NCT00686517|26773524|FG001|Treatment|Protocol Violation|1|||
13390436|NCT00686517|26773525|FG002|Treatment|Protocol Violation|0|||
13390437|NCT00686374|26773538|FG000|Overall Study|Lack of Efficacy|10|||
13390438|NCT00686374|26773538|FG000|Overall Study|Adverse Event|8|||
13390439|NCT00686374|26773538|FG000|Overall Study|Withdrew consent|5|||
13390440|NCT00686374|26773538|FG000|Overall Study|Lost to Follow-up|1|||
13390441|NCT00686374|26773538|FG000|Overall Study|Missing reason|33|||
13390442|NCT00686374|26773538|FG000|Overall Study|Other, not specified|4|||
13390443|NCT00686335|26773546|FG000|Run-in Period|Adverse Event|1|||
13390444|NCT00686335|26773546|FG000|Run-in Period|asthma exacerbation|1|||
13390445|NCT00686335|26773546|FG000|Run-in Period|violation of inclusion/exclusion criteri|3|||
13390446|NCT00686205|26773559|FG000|Overall Study|Protocol Violation|127|||
13390447|NCT00686205|26773560|FG001|Overall Study|Protocol Violation|0|||
13390448|NCT00686205|26773559|FG000|Overall Study|Withdrawal by Subject|2|||
13390449|NCT00686205|26773560|FG001|Overall Study|Withdrawal by Subject|0|||
13390450|NCT00686205|26773559|FG000|Overall Study|Specimen handling procedure altered|5878|||
13390451|NCT00686205|26773560|FG001|Overall Study|Specimen handling procedure altered|0|||
13390452|NCT00686205|26773559|FG000|Overall Study|Specimens not confirmed HIV positive|0|||
13390453|NCT00686205|26773560|FG001|Overall Study|Specimens not confirmed HIV positive|981|||
13390454|NCT00686166|26773572|FG000|Overall Study|Adverse Event|7|||
13414781|NCT00509145|26845736|FG000|Overall Study|Other|6|||
13414782|NCT00509145|26845737|FG001|Overall Study|Other|6|||
13414783|NCT00509106|26845750|FG000|Overall Study|Adverse Event|3|||
13414784|NCT00509106|26845751|FG001|Overall Study|Adverse Event|2|||
13414785|NCT00509106|26845750|FG000|Overall Study|Noncompliance|0|||
13414786|NCT00509106|26845751|FG001|Overall Study|Noncompliance|1|||
13414787|NCT00509106|26845750|FG000|Overall Study|At the request of sponsor/investigator|1|||
13414788|NCT00509106|26845751|FG001|Overall Study|At the request of sponsor/investigator|2|||
13414789|NCT00509106|26845750|FG000|Overall Study|Withdrew consent|4|||
13414790|NCT00509106|26845751|FG001|Overall Study|Withdrew consent|8|||
13414791|NCT00509106|26845750|FG000|Overall Study|Lost to Follow-up|16|||
13414792|NCT00509106|26845751|FG001|Overall Study|Lost to Follow-up|10|||
13414793|NCT00509106|26845750|FG000|Overall Study|Other|1|||
13414794|NCT00509106|26845751|FG001|Overall Study|Other|0|||
13414795|NCT00509106|26845750|FG000|Overall Study|Death|6|||
13414796|NCT00509106|26845751|FG001|Overall Study|Death|6|||
13414797|NCT00509093|26845761|FG000|Overall Study|Adverse Event|10|||
13414798|NCT00509093|26845761|FG000|Overall Study|Disease Progression|9|||
13414799|NCT00509093|26845761|FG000|Overall Study|Transformed into MDS|1|||
13414800|NCT00509093|26845761|FG000|Overall Study|Withdrawal by Subject|3|||
13414801|NCT00509093|26845761|FG000|Overall Study|Physician Decision|1|||
13414802|NCT00509067|26845778|FG000|Overall Study|Lost to Follow-up|1|||
13414803|NCT00509067|26845779|FG001|Overall Study|Lost to Follow-up|1|||
13414804|NCT00509067|26845778|FG000|Overall Study|Adverse Event|3|||
13414805|NCT00509067|26845779|FG001|Overall Study|Adverse Event|1|||
13414806|NCT00509067|26845778|FG000|Overall Study|Protocol Violation|0|||
13414807|NCT00509067|26845779|FG001|Overall Study|Protocol Violation|3|||
13414808|NCT00509028|26845818|FG000|Overall Study|Adverse Event|2|||
13414809|NCT00509028|26845819|FG001|Overall Study|Adverse Event|0|||
13414810|NCT00509028|26845818|FG000|Overall Study|Withdrawal by Subject|4|||
13414811|NCT00509028|26845819|FG001|Overall Study|Withdrawal by Subject|3|||
13414812|NCT00509028|26845818|FG000|Overall Study|Lost to Follow-up|0|||
13414813|NCT00509028|26845819|FG001|Overall Study|Lost to Follow-up|1|||
13414814|NCT00509028|26845818|FG000|Overall Study|Protocol Violation|4|||
13414815|NCT00509028|26845819|FG001|Overall Study|Protocol Violation|2|||
13414816|NCT00509028|26845818|FG000|Overall Study|Non-compliance|2|||
13414817|NCT00509028|26845819|FG001|Overall Study|Non-compliance|1|||
13414818|NCT00508924|26845846|FG000|Overall Study|Protocol Violation|0|||
13414819|NCT00508924|26845847|FG001|Overall Study|Protocol Violation|0|||
13414820|NCT00508924|26845848|FG002|Overall Study|Protocol Violation|1|||
13414821|NCT00508924|26845849|FG003|Overall Study|Protocol Violation|1|||
13414822|NCT00508872|26845855|FG000|Overall Study|Lost to Follow-up|1|||
13414823|NCT00508872|26845855|FG000|Overall Study|Physician Decision|1|||
13414824|NCT00508820|26845872|FG000|Overall Study|Adverse Event|6|||
13414825|NCT00508820|26845873|FG001|Overall Study|Adverse Event|10|||
13414826|NCT00508820|26845872|FG000|Overall Study|Death|6|||
13414827|NCT00508820|26845873|FG001|Overall Study|Death|8|||
13414828|NCT00508820|26845872|FG000|Overall Study|Lost to Follow-up|1|||
13414829|NCT00508820|26845873|FG001|Overall Study|Lost to Follow-up|1|||
13414830|NCT00508820|26845872|FG000|Overall Study|Physician Decision|8|||
13414831|NCT00508820|26845873|FG001|Overall Study|Physician Decision|2|||
13414832|NCT00508820|26845872|FG000|Overall Study|Pregnancy|0|||
13414833|NCT00508820|26845873|FG001|Overall Study|Pregnancy|2|||
13414834|NCT00508820|26845872|FG000|Overall Study|Protocol Violation|2|||
13414835|NCT00508820|26845873|FG001|Overall Study|Protocol Violation|0|||
13414836|NCT00508820|26845872|FG000|Overall Study|Withdrawal by Subject|10|||
13414837|NCT00508820|26845873|FG001|Overall Study|Withdrawal by Subject|12|||
13414838|NCT00508820|26845872|FG000|Overall Study|Other|11|||
13414839|NCT00508820|26845873|FG001|Overall Study|Other|2|||
13414840|NCT00508820|26845872|FG000|Overall Study|Noncompliance|1|||
13414841|NCT00508820|26845873|FG001|Overall Study|Noncompliance|0|||
13414842|NCT00508820|26845872|FG000|Overall Study|Requirement for alternative therapy|7|||
13414843|NCT00508820|26845873|FG001|Overall Study|Requirement for alternative therapy|15|||
13414844|NCT00508820|26845872|FG000|Overall Study|Protocol-specified Criteria|3|||
13414845|NCT00508820|26845873|FG001|Overall Study|Protocol-specified Criteria|12|||
13414846|NCT00508755|26845881|FG000|Overall Study|Withdrawal by Subject|1|||
13414847|NCT00508742|26845902|FG000|Period 1: Infant Series|Adverse Event|5|||
13414848|NCT00508742|26845903|FG001|Period 1: Infant Series|Adverse Event|4|||
13414849|NCT00508742|26845902|FG000|Period 1: Infant Series|Protocol Violation|1|||
13414850|NCT00508742|26845903|FG001|Period 1: Infant Series|Protocol Violation|0|||
13414851|NCT00508742|26845902|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31|||
13414852|NCT00508742|26845903|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40|||
13414853|NCT00508742|26845902|FG000|Period 1: Infant Series|Physician Decision|1|||
13414854|NCT00508742|26845903|FG001|Period 1: Infant Series|Physician Decision|0|||
13414855|NCT00508742|26845902|FG000|Period 1: Infant Series|Other|4|||
13414856|NCT00508742|26845903|FG001|Period 1: Infant Series|Other|1|||
13414857|NCT00508742|26845902|FG000|Period 2: After Infant Series|Adverse Event|2|||
13414858|NCT00508742|26845903|FG001|Period 2: After Infant Series|Adverse Event|6|||
13414859|NCT00508742|26845902|FG000|Period 2: After Infant Series|Lost to Follow-up|1|||
13414860|NCT00508742|26845903|FG001|Period 2: After Infant Series|Lost to Follow-up|1|||
13414861|NCT00508742|26845902|FG000|Period 2: After Infant Series|Protocol Violation|1|||
13414862|NCT00508742|26845903|FG001|Period 2: After Infant Series|Protocol Violation|0|||
13414863|NCT00508742|26845902|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0|||
13414864|NCT00508742|26845903|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3|||
13414865|NCT00508742|26845902|FG000|Period 2: After Infant Series|Failed to Return|1|||
13414866|NCT00508742|26845903|FG001|Period 2: After Infant Series|Failed to Return|0|||
13414867|NCT00508742|26845902|FG000|Period 2: After Infant Series|Other|2|||
13414868|NCT00508742|26845903|FG001|Period 2: After Infant Series|Other|1|||
13414869|NCT00508742|26845902|FG000|Period 3: Toddler Dose|Adverse Event|1|||
13414870|NCT00508742|26845903|FG001|Period 3: Toddler Dose|Adverse Event|0|||
13414871|NCT00508742|26845902|FG000|Period 3: Toddler Dose|Lost to Follow-up|2|||
13414872|NCT00508742|26845903|FG001|Period 3: Toddler Dose|Lost to Follow-up|3|||
13414873|NCT00508742|26845902|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17|||
13414874|NCT00508742|26845903|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8|||
13414875|NCT00508742|26845902|FG000|Period 3: Toddler Dose|Other|5|||
13414876|NCT00508742|26845903|FG001|Period 3: Toddler Dose|Other|4|||
13414877|NCT00508651|26845984|FG000|Overall Study|Lost to Follow-up|3|||
13414878|NCT00508651|26845985|FG001|Overall Study|Lost to Follow-up|1|||
13414879|NCT00508651|26845984|FG000|Overall Study|Withdrawal by Subject|1|||
13414880|NCT00508651|26845985|FG001|Overall Study|Withdrawal by Subject|1|||
13414881|NCT00508482|26846030|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9|||
13414882|NCT00508482|26846031|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7|||
13414883|NCT00508482|26846032|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4|||
13414884|NCT00508482|26846030|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12|||
13414885|NCT00508482|26846031|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10|||
13414886|NCT00508482|26846032|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16|||
13414887|NCT00508482|26846030|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20|||
13414888|NCT00508482|26846031|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6|||
13414889|NCT00508482|26846032|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1|||
13414890|NCT00508404|26846059|FG000|Overall Study|Ongoing at Data Cut-off|12|||
13414891|NCT00508404|26846059|FG000|Overall Study|Adverse Event|2|||
13414892|NCT00508404|26846059|FG000|Overall Study|Death|16|||
13414893|NCT00508404|26846059|FG000|Overall Study|Physician Decision|2|||
13414894|NCT00508404|26846059|FG000|Overall Study|Withdrawal by Subject|3|||
13414895|NCT00508404|26846059|FG000|Overall Study|Protocol-specified Criteria|2|||
13414896|NCT00508404|26846059|FG000|Overall Study|Lost to Follow-up|2|||
13414897|NCT00508404|26846059|FG000|Overall Study|Other - Not Specified|3|||
13414898|NCT00508391|26846077|FG000|First Treatment|Withdrawal by Subject|6|||
13414899|NCT00508391|26846078|FG001|First Treatment|Withdrawal by Subject|3|||
13414900|NCT00508391|26846077|FG000|Second Treatment|Withdrawal by Subject|2|||
13414901|NCT00508391|26846078|FG001|Second Treatment|Withdrawal by Subject|0|||
13414902|NCT00508274|26846090|FG000|Overall Study|Adverse Event|5|||
13414903|NCT00508274|26846090|FG000|Overall Study|Death|7|||
13414904|NCT00508274|26846090|FG000|Overall Study|Disease progression|32|||
13414905|NCT00508274|26846090|FG000|Overall Study|Withdrawal by Subject|1|||
13414906|NCT00508274|26846090|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2|||
13414907|NCT00508274|26846090|FG000|Overall Study|Missing|3|||
13414908|NCT00508261|26846213|FG000|Overall Study|Other|0|||
13414909|NCT00508261|26846214|FG001|Overall Study|Other|1|||
13414910|NCT00508261|26846215|FG002|Overall Study|Other|1|||
13414911|NCT00508261|26846216|FG003|Overall Study|Other|0|||
13414912|NCT00508261|26846213|FG000|Overall Study|Serious Adverse Event|0|||
13414913|NCT00508261|26846214|FG001|Overall Study|Serious Adverse Event|1|||
13414914|NCT00508261|26846215|FG002|Overall Study|Serious Adverse Event|0|||
13414915|NCT00508261|26846216|FG003|Overall Study|Serious Adverse Event|0|||
13414916|NCT00508261|26846213|FG000|Overall Study|Withdrawal by Subject|3|||
13414917|NCT00508261|26846214|FG001|Overall Study|Withdrawal by Subject|4|||
13414918|NCT00508261|26846215|FG002|Overall Study|Withdrawal by Subject|4|||
13414919|NCT00508261|26846216|FG003|Overall Study|Withdrawal by Subject|0|||
13414920|NCT00508261|26846213|FG000|Overall Study|Migrated/ moved from study area|0|||
13414921|NCT00508261|26846214|FG001|Overall Study|Migrated/ moved from study area|1|||
13414922|NCT00508261|26846215|FG002|Overall Study|Migrated/ moved from study area|0|||
13414923|NCT00508261|26846216|FG003|Overall Study|Migrated/ moved from study area|0|||
13414924|NCT00508261|26846213|FG000|Overall Study|Lost to Follow-up|0|||
13414925|NCT00508261|26846214|FG001|Overall Study|Lost to Follow-up|1|||
13414926|NCT00508261|26846215|FG002|Overall Study|Lost to Follow-up|1|||
13414927|NCT00508261|26846216|FG003|Overall Study|Lost to Follow-up|1|||
13414928|NCT00508157|26846245|FG000|Overall Study|Adverse Event|0|||
13414929|NCT00508157|26846246|FG001|Overall Study|Adverse Event|1|||
13414930|NCT00508157|26846245|FG000|Overall Study|Subject Withdrew Consent|1|||
13414931|NCT00508157|26846246|FG001|Overall Study|Subject Withdrew Consent|0|||
13414932|NCT00508157|26846245|FG000|Overall Study|Lost to Follow-up|1|||
13414933|NCT00508157|26846246|FG001|Overall Study|Lost to Follow-up|0|||
13414934|NCT00508157|26846245|FG000|Overall Study|Subject no longer met study criteria|0|||
13414935|NCT00508157|26846246|FG001|Overall Study|Subject no longer met study criteria|1|||
13414936|NCT00508157|26846245|FG000|Overall Study|Other known cause|0|||
13414937|NCT00508157|26846246|FG001|Overall Study|Other known cause|1|||
13414938|NCT00508144|26846252|FG000|Overall Study|Not eligible|6|||
13414939|NCT00508144|26846252|FG000|Overall Study|Death|5|||
13414940|NCT00508027|26846292|FG000|Dose Level 1|Lost to Follow-up|4|||
13414941|NCT00508027|26846292|FG000|Dose Level 1|Withdrawal by Subject|2|||
13414942|NCT00508027|26846292|FG000|Dose Level 1|Physician Decision|2|||
13414943|NCT00508027|26846292|FG000|Dose Level 2|Lost to Follow-up|2|||
13414944|NCT00508027|26846292|FG000|Dose Level 2|Withdrawal by Subject|2|||
13414945|NCT00508001|26846319|FG000|Overall Study|Adverse Event|2|||
13414946|NCT00508001|26846320|FG001|Overall Study|Adverse Event|0|||
13414947|NCT00508001|26846321|FG002|Overall Study|Adverse Event|4|||
13414948|NCT00508001|26846319|FG000|Overall Study|condition under investigation worsened|13|||
13414949|NCT00508001|26846320|FG001|Overall Study|condition under investigation worsened|7|||
13414950|NCT00508001|26846321|FG002|Overall Study|condition under investigation worsened|1|||
13414951|NCT00508001|26846319|FG000|Overall Study|Death|0|||
13414952|NCT00508001|26846320|FG001|Overall Study|Death|1|||
13414953|NCT00508001|26846321|FG002|Overall Study|Death|1|||
13414954|NCT00508001|26846319|FG000|Overall Study|Withdrawal by Subject|4|||
13414955|NCT00508001|26846320|FG001|Overall Study|Withdrawal by Subject|4|||
13414956|NCT00508001|26846321|FG002|Overall Study|Withdrawal by Subject|1|||
13414957|NCT00507819|26846336|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
13414958|NCT00507819|26846337|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
13414959|NCT00507728|26846415|FG000|Randomization to Month 3|Lost to Follow-up|15|||
13414960|NCT00507728|26846416|FG001|Randomization to Month 3|Lost to Follow-up|14|||
13414961|NCT00507728|26846417|FG002|Randomization to Month 3|Lost to Follow-up|20|||
13414962|NCT00507728|26846415|FG000|From 3 Months to 6 Months|Lost to Follow-up|6|||
13414963|NCT00507728|26846416|FG001|From 3 Months to 6 Months|Lost to Follow-up|10|||
13414964|NCT00507728|26846417|FG002|From 3 Months to 6 Months|Lost to Follow-up|9|||
13414965|NCT00507689|26846443|FG000|Pre-Randomization Period|Adverse Event|1|||
13414966|NCT00507689|26846444|FG001|Pre-Randomization Period|Adverse Event|0|||
13414967|NCT00507689|26846443|FG000|Pre-Randomization Period|Physician Decision|1|||
13414968|NCT00507689|26846444|FG001|Pre-Randomization Period|Physician Decision|0|||
13414969|NCT00507689|26846443|FG000|Pre-Randomization Period|Withdrawal by Subject|1|||
13414970|NCT00507689|26846444|FG001|Pre-Randomization Period|Withdrawal by Subject|0|||
13414971|NCT00507689|26846443|FG000|Randomized Period|Adverse Event|1|||
13414972|NCT00507689|26846444|FG001|Randomized Period|Adverse Event|1|||
13414973|NCT00507689|26846443|FG000|Randomized Period|Withdrawal by Subject|0|||
13414974|NCT00507689|26846444|FG001|Randomized Period|Withdrawal by Subject|1|||
13414975|NCT00507546|26846459|FG000|Overall Study|Withdrawal by Subject|1|||
13414976|NCT00507546|26846460|FG001|Overall Study|Withdrawal by Subject|0|||
13414977|NCT00507546|26846459|FG000|Overall Study|Protocol Violation|1|||
13414978|NCT00507546|26846460|FG001|Overall Study|Protocol Violation|0|||
13414979|NCT00507546|26846459|FG000|Overall Study|Physician Decision|0|||
13414980|NCT00507546|26846460|FG001|Overall Study|Physician Decision|1|||
13414981|NCT00507507|26846499|FG000|Treatment Period|Lost to Follow-up|0|||
13414982|NCT00507507|26846500|FG001|Treatment Period|Lost to Follow-up|2|||
13414983|NCT00507507|26846499|FG000|Treatment Period|Physician Decision|4|||
13414984|NCT00507507|26846500|FG001|Treatment Period|Physician Decision|1|||
13414985|NCT00507507|26846499|FG000|Treatment Period|Protocol Violation|1|||
13414986|NCT00507507|26846500|FG001|Treatment Period|Protocol Violation|2|||
13414987|NCT00507507|26846499|FG000|Treatment Period|Adverse Event|1|||
13414988|NCT00507507|26846500|FG001|Treatment Period|Adverse Event|1|||
13414989|NCT00507507|26846499|FG000|Treatment Period|Withdrawal by Subject|46|||
13414990|NCT00507507|26846500|FG001|Treatment Period|Withdrawal by Subject|47|||
13414991|NCT00507507|26846499|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1|||
13414992|NCT00507507|26846500|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0|||
13414993|NCT00507507|26846499|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0|||
13414994|NCT00507507|26846500|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1|||
13414995|NCT00507507|26846499|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9|||
13414996|NCT00507507|26846500|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16|||
13414997|NCT00507455|26846569|FG000|Overall Study|Adverse Event|3|||
13414998|NCT00507455|26846570|FG001|Overall Study|Adverse Event|3|||
13414999|NCT00507455|26846571|FG002|Overall Study|Adverse Event|6|||
13415000|NCT00507455|26846569|FG000|Overall Study|Withdrawal by Subject|2|||
13415001|NCT00507455|26846570|FG001|Overall Study|Withdrawal by Subject|1|||
13415002|NCT00507455|26846571|FG002|Overall Study|Withdrawal by Subject|2|||
13415003|NCT00507455|26846569|FG000|Overall Study|Protocol Violation|4|||
13415004|NCT00507455|26846570|FG001|Overall Study|Protocol Violation|1|||
13415005|NCT00507455|26846571|FG002|Overall Study|Protocol Violation|1|||
13415006|NCT00507455|26846569|FG000|Overall Study|Lost to Follow-up|2|||
13415007|NCT00507455|26846570|FG001|Overall Study|Lost to Follow-up|0|||
13415008|NCT00507455|26846571|FG002|Overall Study|Lost to Follow-up|2|||
13415009|NCT00507455|26846569|FG000|Overall Study|Lack of Efficacy|0|||
13415010|NCT00507455|26846570|FG001|Overall Study|Lack of Efficacy|1|||
13415011|NCT00507455|26846571|FG002|Overall Study|Lack of Efficacy|0|||
13415012|NCT00507455|26846569|FG000|Overall Study|Other - miscellaneous reason|1|||
13415013|NCT00507455|26846570|FG001|Overall Study|Other - miscellaneous reason|0|||
13415014|NCT00507455|26846571|FG002|Overall Study|Other - miscellaneous reason|1|||
13415015|NCT00507442|26846634|FG000|Overall Study|Adverse Event|8|||
13415016|NCT00507442|26846635|FG001|Overall Study|Adverse Event|11|||
13415017|NCT00507442|26846636|FG002|Overall Study|Adverse Event|4|||
13415018|NCT00507442|26846637|FG003|Overall Study|Adverse Event|1|||
13415019|NCT00507442|26846634|FG000|Overall Study|Protocol Violation|0|||
13415020|NCT00507442|26846635|FG001|Overall Study|Protocol Violation|1|||
13415021|NCT00507442|26846636|FG002|Overall Study|Protocol Violation|0|||
13415022|NCT00507442|26846637|FG003|Overall Study|Protocol Violation|0|||
13415023|NCT00507442|26846634|FG000|Overall Study|Lost to Follow-up|0|||
13415024|NCT00507442|26846635|FG001|Overall Study|Lost to Follow-up|0|||
13415025|NCT00507442|26846636|FG002|Overall Study|Lost to Follow-up|1|||
13415026|NCT00507442|26846637|FG003|Overall Study|Lost to Follow-up|0|||
13415027|NCT00507442|26846634|FG000|Overall Study|Physician Decision|0|||
13415028|NCT00507442|26846635|FG001|Overall Study|Physician Decision|2|||
13415029|NCT00507442|26846636|FG002|Overall Study|Physician Decision|4|||
13415030|NCT00507442|26846637|FG003|Overall Study|Physician Decision|1|||
13415031|NCT00507442|26846634|FG000|Overall Study|Progressive Disease|2|||
13415032|NCT00507442|26846635|FG001|Overall Study|Progressive Disease|4|||
13415033|NCT00507442|26846636|FG002|Overall Study|Progressive Disease|2|||
13415034|NCT00507442|26846637|FG003|Overall Study|Progressive Disease|0|||
13415035|NCT00507442|26846634|FG000|Overall Study|Withdrawal by Subject|4|||
13415036|NCT00507442|26846635|FG001|Overall Study|Withdrawal by Subject|4|||
13415037|NCT00507442|26846636|FG002|Overall Study|Withdrawal by Subject|2|||
13415038|NCT00507442|26846637|FG003|Overall Study|Withdrawal by Subject|1|||
13415039|NCT00507442|26846634|FG000|Overall Study|Other|2|||
13415040|NCT00507442|26846635|FG001|Overall Study|Other|5|||
13415041|NCT00507442|26846636|FG002|Overall Study|Other|2|||
13415042|NCT00507442|26846637|FG003|Overall Study|Other|2|||
13415043|NCT00507429|26846652|FG000|Treatment Phase|Disease Progression|12|||
13415044|NCT00507429|26846653|FG001|Treatment Phase|Disease Progression|5|||
13415045|NCT00507429|26846652|FG000|Treatment Phase|Adverse Event|12|||
13415046|NCT00507429|26846653|FG001|Treatment Phase|Adverse Event|5|||
13415047|NCT00507429|26846652|FG000|Treatment Phase|Withdrawal by Subject|3|||
13415048|NCT00507429|26846653|FG001|Treatment Phase|Withdrawal by Subject|3|||
13415049|NCT00507429|26846652|FG000|Treatment Phase|Physician Decision|4|||
13415050|NCT00507429|26846653|FG001|Treatment Phase|Physician Decision|2|||
13415051|NCT00507429|26846652|FG000|Treatment Phase|Other|6|||
13415052|NCT00507429|26846653|FG001|Treatment Phase|Other|3|||
13415053|NCT00507429|26846652|FG000|Maintenance Phase|Progressive Disease|14|||
13415054|NCT00507429|26846653|FG001|Maintenance Phase|Progressive Disease|0|||
13415055|NCT00507416|26846692|FG000|Overall Study|Adverse Event|58|||
13415056|NCT00507416|26846693|FG001|Overall Study|Adverse Event|67|||
13415057|NCT00507416|26846694|FG002|Overall Study|Adverse Event|65|||
13415058|NCT00507416|26846692|FG000|Overall Study|Protocol Violation|1|||
13415059|NCT00507416|26846693|FG001|Overall Study|Protocol Violation|2|||
13415060|NCT00507416|26846694|FG002|Overall Study|Protocol Violation|0|||
13415061|NCT00507416|26846692|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7|||
13415062|NCT00507416|26846693|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7|||
13415063|NCT00507416|26846694|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8|||
13415064|NCT00507416|26846692|FG000|Overall Study|Progressive Disease|20|||
13415065|NCT00507416|26846693|FG001|Overall Study|Progressive Disease|10|||
13415066|NCT00507416|26846694|FG002|Overall Study|Progressive Disease|13|||
13415067|NCT00507416|26846692|FG000|Overall Study|Patient declined further treatment|18|||
13415068|NCT00507416|26846693|FG001|Overall Study|Patient declined further treatment|14|||
13415069|NCT00507416|26846694|FG002|Overall Study|Patient declined further treatment|11|||
13415070|NCT00507416|26846692|FG000|Overall Study|Other|11|||
13415071|NCT00507416|26846693|FG001|Overall Study|Other|16|||
13415072|NCT00507416|26846694|FG002|Overall Study|Other|13|||
13415073|NCT00507416|26846692|FG000|Overall Study|Did not Receive Study Treatment|3|||
13415074|NCT00507416|26846693|FG001|Overall Study|Did not Receive Study Treatment|9|||
13415075|NCT00507416|26846694|FG002|Overall Study|Did not Receive Study Treatment|4|||
13415076|NCT00507130|26846749|FG000|Overall Study|Lost to Follow-up|0|||
13415077|NCT00507130|26846750|FG001|Overall Study|Lost to Follow-up|0|||
13415078|NCT00507130|26846751|FG002|Overall Study|Lost to Follow-up|1|||
13415079|NCT00507130|26846752|FG003|Overall Study|Lost to Follow-up|1|||
13415080|NCT00507130|26846749|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1|||
13415081|NCT00507130|26846750|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
13415082|NCT00507130|26846751|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
13415083|NCT00507130|26846752|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
13415084|NCT00507026|26846812|FG000|Overall Study|Lack of Efficacy|6|||
13415085|NCT00507026|26846813|FG001|Overall Study|Lack of Efficacy|4|||
13415086|NCT00507026|26846814|FG002|Overall Study|Lack of Efficacy|21|||
13415087|NCT00507026|26846812|FG000|Overall Study|Withdrawal by Subject|2|||
13415088|NCT00507026|26846813|FG001|Overall Study|Withdrawal by Subject|0|||
13415089|NCT00507026|26846814|FG002|Overall Study|Withdrawal by Subject|0|||
13415090|NCT00507026|26846812|FG000|Overall Study|Investigator Decision|1|||
13415091|NCT00507026|26846813|FG001|Overall Study|Investigator Decision|0|||
13415092|NCT00507026|26846814|FG002|Overall Study|Investigator Decision|0|||
13415093|NCT00507026|26846812|FG000|Overall Study|Adverse Event|2|||
13415094|NCT00507026|26846813|FG001|Overall Study|Adverse Event|0|||
13415095|NCT00507026|26846814|FG002|Overall Study|Adverse Event|0|||
13415096|NCT00507026|26846812|FG000|Overall Study|Protocol Violation|1|||
13415097|NCT00507026|26846813|FG001|Overall Study|Protocol Violation|0|||
13415098|NCT00507026|26846814|FG002|Overall Study|Protocol Violation|0|||
13415099|NCT00507026|26846812|FG000|Overall Study|Other|1|||
13415100|NCT00507026|26846813|FG001|Overall Study|Other|0|||
13415101|NCT00507026|26846814|FG002|Overall Study|Other|0|||
13415102|NCT00506948|26846820|FG000|Overall Study|Death|4|||
13415103|NCT00506948|26846820|FG000|Overall Study|Adverse Event|5|||
13415104|NCT00506948|26846820|FG000|Overall Study|Physician Decision|1|||
13415105|NCT00506922|26846844|FG000|Overall Study|Physician Decision|0|||
13415106|NCT00506922|26846845|FG001|Overall Study|Physician Decision|0|||
13415107|NCT00506922|26846846|FG002|Overall Study|Physician Decision|0|||
13415108|NCT00506922|26846847|FG003|Overall Study|Physician Decision|2|||
13415109|NCT00506922|26846848|FG004|Overall Study|Physician Decision|0|||
13415110|NCT00506922|26846844|FG000|Overall Study|Withdrawal by Subject|0|||
13415111|NCT00506922|26846845|FG001|Overall Study|Withdrawal by Subject|0|||
13415112|NCT00506922|26846846|FG002|Overall Study|Withdrawal by Subject|0|||
13415113|NCT00506922|26846847|FG003|Overall Study|Withdrawal by Subject|0|||
13415114|NCT00506922|26846848|FG004|Overall Study|Withdrawal by Subject|1|||
13415115|NCT00506883|26846866|FG000|Overall Study|Lost to Follow-up|1|||
13415116|NCT00506883|26846867|FG001|Overall Study|Lost to Follow-up|1|||
13415117|NCT00506883|26846868|FG002|Overall Study|Lost to Follow-up|1|||
13415118|NCT00506883|26846866|FG000|Overall Study|Withdrawal by Subject|1|||
13415119|NCT00506883|26846867|FG001|Overall Study|Withdrawal by Subject|0|||
13415120|NCT00506883|26846868|FG002|Overall Study|Withdrawal by Subject|1|||
13415121|NCT00506883|26846866|FG000|Overall Study|Lack of Efficacy|0|||
13415122|NCT00506883|26846867|FG001|Overall Study|Lack of Efficacy|1|||
13415123|NCT00506883|26846868|FG002|Overall Study|Lack of Efficacy|1|||
13415124|NCT00506883|26846866|FG000|Overall Study|Other|5|||
13415125|NCT00506883|26846867|FG001|Overall Study|Other|1|||
13415126|NCT00506883|26846868|FG002|Overall Study|Other|1|||
13415127|NCT00506831|26846881|FG000|Overall Study|Death|1|||
13415128|NCT00506831|26846881|FG000|Overall Study|Withdrawal by Subject|1|||
13415129|NCT00506779|26846903|FG000|Overall Study|Withdrawal by Subject|1|||
13415130|NCT00506779|26846904|FG001|Overall Study|Withdrawal by Subject|0|||
13415131|NCT00506779|26846905|FG002|Overall Study|Withdrawal by Subject|1|||
13415132|NCT00506779|26846906|FG003|Overall Study|Withdrawal by Subject|0|||
13415133|NCT00506779|26846903|FG000|Overall Study|Adverse Event|0|||
13415134|NCT00506779|26846904|FG001|Overall Study|Adverse Event|1|||
13415135|NCT00506779|26846905|FG002|Overall Study|Adverse Event|1|||
13415136|NCT00506779|26846906|FG003|Overall Study|Adverse Event|1|||
13415137|NCT00506753|26846923|FG000|Overall Study|Lost to Follow-up|21|||
13415138|NCT00506753|26846924|FG001|Overall Study|Lost to Follow-up|15|||
13415139|NCT00506662|26846961|FG000|Overall Study|Adverse Event|0|||
13415140|NCT00506662|26846962|FG001|Overall Study|Adverse Event|2|||
13415141|NCT00506662|26846961|FG000|Overall Study|Lack of Efficacy|1|||
13415142|NCT00506662|26846962|FG001|Overall Study|Lack of Efficacy|0|||
13415143|NCT00506662|26846961|FG000|Overall Study|Protocol Violation|2|||
13415144|NCT00506662|26846962|FG001|Overall Study|Protocol Violation|4|||
13415145|NCT00506662|26846961|FG000|Overall Study|Trial terminated|10|||
13415146|NCT00506662|26846962|FG001|Overall Study|Trial terminated|16|||
13415147|NCT00506662|26846961|FG000|Overall Study|Not recorded|4|||
13415148|NCT00506662|26846962|FG001|Overall Study|Not recorded|6|||
13415149|NCT00506519|26847013|FG000|Overall Study|Death|4|||
13415150|NCT00506519|26847014|FG001|Overall Study|Death|6|||
13415151|NCT00506519|26847015|FG002|Overall Study|Death|0|||
13415152|NCT00506519|26847013|FG000|Overall Study|Adverse Event|1|||
13415153|NCT00506519|26847014|FG001|Overall Study|Adverse Event|0|||
13415154|NCT00506519|26847015|FG002|Overall Study|Adverse Event|0|||
13415155|NCT00506493|26847024|FG000|Overall Study|Death|6|||
13415156|NCT00506493|26847024|FG000|Overall Study|Withdrawal by Subject|5|||
13415157|NCT00506454|26847037|FG000|Overall Study|Withdrawal by Subject|1|||
13415158|NCT00506454|26847038|FG001|Overall Study|Withdrawal by Subject|1|||
13415159|NCT00506441|26847049|FG000|Period 1; Open-label Period|Adverse Event|21|||
13415160|NCT00506441|26847050|FG001|Period 1; Open-label Period|Adverse Event|0|||
13415161|NCT00506441|26847049|FG000|Period 1; Open-label Period|Lack of Efficacy|13|||
13415162|NCT00506441|26847050|FG001|Period 1; Open-label Period|Lack of Efficacy|0|||
13415163|NCT00506441|26847049|FG000|Period 1; Open-label Period|Lost to Follow-up|2|||
13415164|NCT00506441|26847050|FG001|Period 1; Open-label Period|Lost to Follow-up|0|||
13415165|NCT00506441|26847049|FG000|Period 1; Open-label Period|Physician Decision|5|||
13415166|NCT00506441|26847050|FG001|Period 1; Open-label Period|Physician Decision|0|||
13415167|NCT00506441|26847049|FG000|Period 1; Open-label Period|Protocol Violation|9|||
13415168|NCT00506441|26847050|FG001|Period 1; Open-label Period|Protocol Violation|0|||
13415169|NCT00506441|26847049|FG000|Period 1; Open-label Period|Withdrawal by Subject|13|||
13415170|NCT00506441|26847050|FG001|Period 1; Open-label Period|Withdrawal by Subject|0|||
13415171|NCT00506441|26847049|FG000|Period 1; Open-label Period|Other Reasons|13|||
13415172|NCT00506441|26847050|FG001|Period 1; Open-label Period|Other Reasons|0|||
13415173|NCT00506441|26847049|FG000|Period 2; Double-blind Period|Adverse Event|0|||
13415174|NCT00506441|26847050|FG001|Period 2; Double-blind Period|Adverse Event|1|||
13415175|NCT00506441|26847049|FG000|Period 2; Double-blind Period|Lack of Efficacy|0|||
13415176|NCT00506441|26847050|FG001|Period 2; Double-blind Period|Lack of Efficacy|2|||
13415177|NCT00506441|26847049|FG000|Period 2; Double-blind Period|Physician Decision|1|||
13415178|NCT00506441|26847050|FG001|Period 2; Double-blind Period|Physician Decision|1|||
13415179|NCT00506441|26847049|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1|||
13415180|NCT00506441|26847050|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0|||
13415181|NCT00506441|26847049|FG000|Period 2; Double-blind Period|Other Reason|1|||
13415182|NCT00506441|26847050|FG001|Period 2; Double-blind Period|Other Reason|1|||
13415183|NCT00506415|26847077|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272|||
13415184|NCT00506415|26847078|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
13415185|NCT00506415|26847079|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
13415186|NCT00506415|26847080|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
13415187|NCT00506415|26847077|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1|||
13415188|NCT00506415|26847078|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
13415189|NCT00506415|26847079|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
13415190|NCT00506415|26847080|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
13415191|NCT00506415|26847077|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1|||
13415192|NCT00506415|26847078|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
13415193|NCT00506415|26847079|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
13415194|NCT00506415|26847080|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
13415195|NCT00506415|26847077|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58|||
13415196|NCT00506415|26847078|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
13415197|NCT00506415|26847079|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
13415198|NCT00506415|26847080|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
13415199|NCT00506415|26847077|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88|||
13415200|NCT00506415|26847078|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
13415201|NCT00506415|26847079|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
13415202|NCT00506415|26847080|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
13415203|NCT00506415|26847077|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22|||
13415204|NCT00506415|26847078|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
13415205|NCT00506415|26847079|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
13415206|NCT00506415|26847080|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
13415207|NCT00506415|26847077|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7|||
13415208|NCT00506415|26847078|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
13415209|NCT00506415|26847079|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
13415210|NCT00506415|26847080|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
13415211|NCT00506415|26847077|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22|||
13415212|NCT00506415|26847078|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0|||
13415213|NCT00506415|26847079|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0|||
13415214|NCT00506415|26847080|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0|||
13415215|NCT00506415|26847077|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28|||
13415216|NCT00506415|26847078|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
13415217|NCT00506415|26847079|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
13415218|NCT00506415|26847080|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
13415219|NCT00506415|26847077|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
13415220|NCT00506415|26847078|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33|||
13415221|NCT00506415|26847079|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28|||
13415222|NCT00506415|26847080|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
13415223|NCT00506415|26847077|FG000|Double Blind (Maximum 48 Weeks )|Death|0|||
13415224|NCT00506415|26847078|FG001|Double Blind (Maximum 48 Weeks )|Death|5|||
13415225|NCT00506415|26847079|FG002|Double Blind (Maximum 48 Weeks )|Death|3|||
13415226|NCT00506415|26847080|FG003|Double Blind (Maximum 48 Weeks )|Death|0|||
13415227|NCT00506415|26847077|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
13415228|NCT00506415|26847078|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
13415229|NCT00506415|26847079|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
13415230|NCT00506415|26847080|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
13415231|NCT00506415|26847077|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
13415232|NCT00506415|26847078|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5|||
13415233|NCT00506415|26847079|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3|||
13415234|NCT00506415|26847080|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
13415235|NCT00506415|26847077|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
13415236|NCT00506415|26847078|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4|||
13415237|NCT00506415|26847079|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6|||
13415238|NCT00506415|26847080|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
13415239|NCT00506415|26847077|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
13415240|NCT00506415|26847078|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20|||
13415241|NCT00506415|26847079|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17|||
13415242|NCT00506415|26847080|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
13415243|NCT00506415|26847077|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
13415244|NCT00506415|26847078|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3|||
13415245|NCT00506415|26847079|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2|||
13415246|NCT00506415|26847080|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
13415247|NCT00506415|26847077|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
13415248|NCT00506415|26847078|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
13415249|NCT00506415|26847079|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1|||
13415250|NCT00506415|26847080|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
13415251|NCT00506415|26847077|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
13415252|NCT00506415|26847078|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
13415253|NCT00506415|26847079|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
13415254|NCT00506415|26847080|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4|||
13415255|NCT00506415|26847077|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
13415256|NCT00506415|26847078|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
13415257|NCT00506415|26847079|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
13415258|NCT00506415|26847080|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18|||
13415259|NCT00506415|26847077|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
13415260|NCT00506415|26847078|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
13415261|NCT00506415|26847079|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
13415262|NCT00506415|26847080|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8|||
13415263|NCT00506415|26847077|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
13415264|NCT00506415|26847078|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
13415265|NCT00506415|26847079|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
13415266|NCT00506415|26847080|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14|||
13415267|NCT00506415|26847077|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
13415268|NCT00506415|26847078|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
13415269|NCT00506415|26847079|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
13415270|NCT00506415|26847080|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5|||
13415271|NCT00506415|26847077|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
13415272|NCT00506415|26847078|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
13415273|NCT00506415|26847079|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
13415274|NCT00506415|26847080|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6|||
13415275|NCT00506415|26847077|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0|||
13415276|NCT00506415|26847078|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0|||
13415277|NCT00506415|26847079|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0|||
13415278|NCT00506415|26847080|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7|||
13415279|NCT00506389|26847107|FG000|In-treatment Period|Other|3|||
13415280|NCT00506389|26847108|FG001|In-treatment Period|Other|3|||
13415281|NCT00506389|26847109|FG002|In-treatment Period|Other|4|||
13415282|NCT00506389|26847107|FG000|In-treatment Period|Lost to Follow-up|0|||
13415283|NCT00506389|26847108|FG001|In-treatment Period|Lost to Follow-up|0|||
13415284|NCT00506389|26847109|FG002|In-treatment Period|Lost to Follow-up|1|||
13415285|NCT00506389|26847107|FG000|In-treatment Period|Lack of compliance|1|||
13415286|NCT00506389|26847108|FG001|In-treatment Period|Lack of compliance|0|||
13415287|NCT00506389|26847109|FG002|In-treatment Period|Lack of compliance|0|||
13415288|NCT00506389|26847107|FG000|In-treatment Period|Reasons not related to trial|4|||
13415289|NCT00506389|26847108|FG001|In-treatment Period|Reasons not related to trial|1|||
13415290|NCT00506389|26847109|FG002|In-treatment Period|Reasons not related to trial|0|||
13415291|NCT00506389|26847107|FG000|In-treatment Period|Withdrawal by Subject|3|||
13415292|NCT00506389|26847108|FG001|In-treatment Period|Withdrawal by Subject|3|||
13415293|NCT00506389|26847109|FG002|In-treatment Period|Withdrawal by Subject|4|||
13415294|NCT00506389|26847107|FG000|In-treatment Period|Lack of Efficacy|0|||
13415295|NCT00506389|26847108|FG001|In-treatment Period|Lack of Efficacy|2|||
13415296|NCT00506389|26847109|FG002|In-treatment Period|Lack of Efficacy|0|||
13415297|NCT00506389|26847107|FG000|In-treatment Period|Adverse Event|11|||
13415298|NCT00506389|26847108|FG001|In-treatment Period|Adverse Event|5|||
13415299|NCT00506389|26847109|FG002|In-treatment Period|Adverse Event|2|||
13415300|NCT00506389|26847107|FG000|In-treatment Period|Randomized but not treated|4|||
13415301|NCT00506389|26847108|FG001|In-treatment Period|Randomized but not treated|1|||
13415302|NCT00506389|26847109|FG002|In-treatment Period|Randomized but not treated|1|||
13415303|NCT00506350|26847282|FG000|Overall Study|Serious Adverse Event|1|||
13415304|NCT00506350|26847283|FG001|Overall Study|Serious Adverse Event|0|||
13415305|NCT00506350|26847284|FG002|Overall Study|Serious Adverse Event|0|||
13415306|NCT00506350|26847285|FG003|Overall Study|Serious Adverse Event|0|||
13415307|NCT00506350|26847286|FG004|Overall Study|Serious Adverse Event|0|||
13415308|NCT00506350|26847287|FG005|Overall Study|Serious Adverse Event|0|||
13415309|NCT00506350|26847288|FG006|Overall Study|Serious Adverse Event|0|||
13415310|NCT00506350|26847289|FG007|Overall Study|Serious Adverse Event|0|||
13415311|NCT00506350|26847290|FG008|Overall Study|Serious Adverse Event|0|||
13415312|NCT00506350|26847282|FG000|Overall Study|Adverse Event|0|||
13415313|NCT00506350|26847283|FG001|Overall Study|Adverse Event|0|||
13415314|NCT00506350|26847284|FG002|Overall Study|Adverse Event|0|||
13415315|NCT00506350|26847285|FG003|Overall Study|Adverse Event|0|||
13415316|NCT00506350|26847286|FG004|Overall Study|Adverse Event|0|||
13415317|NCT00506350|26847287|FG005|Overall Study|Adverse Event|0|||
13415318|NCT00506350|26847288|FG006|Overall Study|Adverse Event|0|||
13415319|NCT00506350|26847289|FG007|Overall Study|Adverse Event|1|||
13415320|NCT00506350|26847290|FG008|Overall Study|Adverse Event|1|||
13415321|NCT00506350|26847282|FG000|Overall Study|Protocol Violation|0|||
13415322|NCT00506350|26847283|FG001|Overall Study|Protocol Violation|0|||
13415323|NCT00506350|26847284|FG002|Overall Study|Protocol Violation|1|||
13415324|NCT00506350|26847285|FG003|Overall Study|Protocol Violation|0|||
13415325|NCT00506350|26847286|FG004|Overall Study|Protocol Violation|0|||
13415326|NCT00506350|26847287|FG005|Overall Study|Protocol Violation|0|||
13415327|NCT00506350|26847288|FG006|Overall Study|Protocol Violation|1|||
13415328|NCT00506350|26847289|FG007|Overall Study|Protocol Violation|0|||
13415329|NCT00506350|26847290|FG008|Overall Study|Protocol Violation|0|||
13390455|NCT00686166|26773572|FG000|Overall Study|Withdrawal by Subject|1|||
13390456|NCT00686166|26773572|FG000|Overall Study|Progression/Relapse|1|||
13390457|NCT00686166|26773572|FG000|Overall Study|Death|1|||
13390458|NCT00686166|26773572|FG000|Overall Study|Not Protocol Specified|1|||
13390459|NCT00686166|26773572|FG000|Overall Study|Ineligible|5|||
13390460|NCT00686166|26773572|FG000|Overall Study|Did not begin protocol therapy|4|||
13390461|NCT00686127|26773585|FG000|Overall Study|Withdrawal by Subject|14|||
13390462|NCT00686127|26773586|FG001|Overall Study|Withdrawal by Subject|6|||
13390463|NCT00686075|26773809|FG000|Overall Study|Withdrawal by Subject|4|||
13390464|NCT00686075|26773810|FG001|Overall Study|Withdrawal by Subject|3|||
13390465|NCT00686075|26773811|FG002|Overall Study|Withdrawal by Subject|3|||
13390466|NCT00686075|26773812|FG003|Overall Study|Withdrawal by Subject|7|||
13390467|NCT00686075|26773813|FG004|Overall Study|Withdrawal by Subject|1|||
13390468|NCT00686075|26773814|FG005|Overall Study|Withdrawal by Subject|0|||
13390469|NCT00686075|26773815|FG006|Overall Study|Withdrawal by Subject|0|||
13390470|NCT00686075|26773816|FG007|Overall Study|Withdrawal by Subject|2|||
13390471|NCT00686075|26773817|FG008|Overall Study|Withdrawal by Subject|4|||
13390472|NCT00686075|26773818|FG009|Overall Study|Withdrawal by Subject|6|||
13390473|NCT00686075|26773809|FG000|Overall Study|Lost to Follow-up|3|||
13390474|NCT00686075|26773810|FG001|Overall Study|Lost to Follow-up|6|||
13390475|NCT00686075|26773811|FG002|Overall Study|Lost to Follow-up|3|||
13390476|NCT00686075|26773812|FG003|Overall Study|Lost to Follow-up|2|||
13390477|NCT00686075|26773813|FG004|Overall Study|Lost to Follow-up|3|||
13390478|NCT00686075|26773814|FG005|Overall Study|Lost to Follow-up|3|||
13390479|NCT00686075|26773815|FG006|Overall Study|Lost to Follow-up|0|||
13390480|NCT00686075|26773816|FG007|Overall Study|Lost to Follow-up|0|||
13390481|NCT00686075|26773817|FG008|Overall Study|Lost to Follow-up|2|||
13390482|NCT00686075|26773818|FG009|Overall Study|Lost to Follow-up|3|||
13390483|NCT00686075|26773809|FG000|Overall Study|Other|1|||
13390484|NCT00686075|26773810|FG001|Overall Study|Other|1|||
13390485|NCT00686075|26773811|FG002|Overall Study|Other|0|||
13390486|NCT00686075|26773812|FG003|Overall Study|Other|0|||
13390487|NCT00686075|26773813|FG004|Overall Study|Other|0|||
13390488|NCT00686075|26773814|FG005|Overall Study|Other|0|||
13390489|NCT00686075|26773815|FG006|Overall Study|Other|0|||
13390490|NCT00686075|26773816|FG007|Overall Study|Other|0|||
13390491|NCT00686075|26773817|FG008|Overall Study|Other|0|||
13390492|NCT00686075|26773818|FG009|Overall Study|Other|1|||
13390493|NCT00686036|26773837|FG000|Overall Study|Adverse Event|3|||
13390494|NCT00686036|26773838|FG001|Overall Study|Adverse Event|0|||
13390495|NCT00686036|26773837|FG000|Overall Study|Withdrawal by Subject|3|||
13390496|NCT00686036|26773838|FG001|Overall Study|Withdrawal by Subject|1|||
13390497|NCT00686036|26773837|FG000|Overall Study|Study terminated by AstraZeneca|2|||
13390498|NCT00686036|26773838|FG001|Overall Study|Study terminated by AstraZeneca|1|||
13390499|NCT00686036|26773837|FG000|Overall Study|PSA ≥ 10ng/mL|1|||
13415330|NCT00506350|26847282|FG000|Overall Study|Withdrawal by Subject|0|||
13415331|NCT00506350|26847283|FG001|Overall Study|Withdrawal by Subject|1|||
13415332|NCT00506350|26847284|FG002|Overall Study|Withdrawal by Subject|1|||
13415333|NCT00506350|26847285|FG003|Overall Study|Withdrawal by Subject|1|||
13415334|NCT00506350|26847286|FG004|Overall Study|Withdrawal by Subject|4|||
13415335|NCT00506350|26847287|FG005|Overall Study|Withdrawal by Subject|1|||
13415336|NCT00506350|26847288|FG006|Overall Study|Withdrawal by Subject|1|||
13415337|NCT00506350|26847289|FG007|Overall Study|Withdrawal by Subject|2|||
13415338|NCT00506350|26847290|FG008|Overall Study|Withdrawal by Subject|0|||
13415339|NCT00506350|26847282|FG000|Overall Study|Lost to Follow-up|1|||
13415340|NCT00506350|26847283|FG001|Overall Study|Lost to Follow-up|1|||
13415341|NCT00506350|26847284|FG002|Overall Study|Lost to Follow-up|1|||
13415342|NCT00506350|26847285|FG003|Overall Study|Lost to Follow-up|1|||
13415343|NCT00506350|26847286|FG004|Overall Study|Lost to Follow-up|2|||
13415344|NCT00506350|26847287|FG005|Overall Study|Lost to Follow-up|1|||
13415345|NCT00506350|26847288|FG006|Overall Study|Lost to Follow-up|0|||
13415346|NCT00506350|26847289|FG007|Overall Study|Lost to Follow-up|0|||
13415347|NCT00506350|26847290|FG008|Overall Study|Lost to Follow-up|2|||
13415348|NCT00506350|26847282|FG000|Overall Study|Medical Reason|0|||
13415349|NCT00506350|26847283|FG001|Overall Study|Medical Reason|0|||
13415350|NCT00506350|26847284|FG002|Overall Study|Medical Reason|0|||
13415351|NCT00506350|26847285|FG003|Overall Study|Medical Reason|0|||
13415352|NCT00506350|26847286|FG004|Overall Study|Medical Reason|1|||
13415353|NCT00506350|26847287|FG005|Overall Study|Medical Reason|0|||
13415354|NCT00506350|26847288|FG006|Overall Study|Medical Reason|0|||
13415355|NCT00506350|26847289|FG007|Overall Study|Medical Reason|0|||
13415356|NCT00506350|26847290|FG008|Overall Study|Medical Reason|0|||
13415357|NCT00506350|26847282|FG000|Overall Study|Other|1|||
13415358|NCT00506350|26847283|FG001|Overall Study|Other|1|||
13415359|NCT00506350|26847284|FG002|Overall Study|Other|3|||
13415360|NCT00506350|26847285|FG003|Overall Study|Other|0|||
13415361|NCT00506350|26847286|FG004|Overall Study|Other|3|||
13415362|NCT00506350|26847287|FG005|Overall Study|Other|0|||
13415363|NCT00506350|26847288|FG006|Overall Study|Other|0|||
13415364|NCT00506350|26847289|FG007|Overall Study|Other|2|||
13415365|NCT00506350|26847290|FG008|Overall Study|Other|2|||
13415366|NCT00506285|26847305|FG000|3 Week Screening Phase|Withdrawal by Subject|17|||
13415367|NCT00506285|26847306|FG001|3 Week Screening Phase|Withdrawal by Subject|10|||
13415368|NCT00506285|26847305|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4|||
13415369|NCT00506285|26847306|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3|||
13415370|NCT00506285|26847305|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5|||
13415371|NCT00506285|26847306|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2|||
13415372|NCT00506285|26847305|FG000|6-month Open Label Phase|Lost to Follow-up|1|||
13415373|NCT00506285|26847306|FG001|6-month Open Label Phase|Lost to Follow-up|7|||
13415374|NCT00506285|26847305|FG000|6-month Open Label Phase|Withdrawal by Subject|9|||
13415375|NCT00506285|26847306|FG001|6-month Open Label Phase|Withdrawal by Subject|5|||
13415376|NCT00506142|26847319|FG000|Overall Study|Adverse Event|8|||
13415377|NCT00506142|26847320|FG001|Overall Study|Adverse Event|7|||
13415378|NCT00506142|26847319|FG000|Overall Study|Lack of Efficacy|21|||
13415379|NCT00506142|26847320|FG001|Overall Study|Lack of Efficacy|7|||
13415380|NCT00506142|26847319|FG000|Overall Study|Withdrawal by Subject|4|||
13415381|NCT00506142|26847320|FG001|Overall Study|Withdrawal by Subject|5|||
13415382|NCT00506142|26847319|FG000|Overall Study|Physician Decision|1|||
13415383|NCT00506142|26847320|FG001|Overall Study|Physician Decision|0|||
13415384|NCT00506142|26847319|FG000|Overall Study|New health condition|1|||
13415385|NCT00506142|26847320|FG001|Overall Study|New health condition|0|||
13415386|NCT00506129|26847327|FG000|Overall Study|Disease Progression/Relapse|15|||
13415387|NCT00506129|26847327|FG000|Overall Study|Death|7|||
13415388|NCT00506077|26847354|FG000|Treatment Period 1|Adverse Event|2|||
13415389|NCT00506077|26847355|FG001|Treatment Period 1|Adverse Event|1|||
13415390|NCT00506077|26847354|FG000|Treatment Period 1|Lost to Follow-up|0|||
13415391|NCT00506077|26847355|FG001|Treatment Period 1|Lost to Follow-up|2|||
13415392|NCT00506077|26847354|FG000|Treatment Period 1|Withdrawal by Subject|2|||
13415393|NCT00506077|26847355|FG001|Treatment Period 1|Withdrawal by Subject|0|||
13415394|NCT00506077|26847354|FG000|Treatment Period 2|Adverse Event|0|||
13415395|NCT00506077|26847355|FG001|Treatment Period 2|Adverse Event|1|||
13415396|NCT00506077|26847354|FG000|Treatment Period 2|Withdrawal by Subject|1|||
13415397|NCT00506077|26847355|FG001|Treatment Period 2|Withdrawal by Subject|0|||
13415398|NCT00505934|26847363|FG000|Overall Study|Adverse Event|1|||
13415399|NCT00505934|26847363|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1|||
13415400|NCT00505934|26847363|FG000|Overall Study|Other: IV dose needed to be changed|1|||
13415401|NCT00505921|26847369|FG000|Overall Study|Ineligible|1|||
13415402|NCT00505921|26847369|FG000|Overall Study|Failed to Mobilize|8|||
13415403|NCT00505778|26847392|FG000|Overall Study|Adverse Event|2|||
13415404|NCT00505778|26847393|FG001|Overall Study|Adverse Event|7|||
13415405|NCT00505778|26847392|FG000|Overall Study|Physician Decision|8|||
13415406|NCT00505778|26847393|FG001|Overall Study|Physician Decision|14|||
13415407|NCT00505778|26847392|FG000|Overall Study|Lost to Follow-up|17|||
13415408|NCT00505778|26847393|FG001|Overall Study|Lost to Follow-up|23|||
13415409|NCT00505778|26847392|FG000|Overall Study|Unable to Meet Protocol Criteria|4|||
13415410|NCT00505778|26847393|FG001|Overall Study|Unable to Meet Protocol Criteria|1|||
13415411|NCT00505778|26847392|FG000|Overall Study|Protocol Violation|7|||
13415412|NCT00505778|26847393|FG001|Overall Study|Protocol Violation|9|||
13415413|NCT00505778|26847392|FG000|Overall Study|Withdrawal by Subject|29|||
13415414|NCT00505778|26847393|FG001|Overall Study|Withdrawal by Subject|14|||
13415415|NCT00505778|26847392|FG000|Overall Study|Relapse|65|||
13415416|NCT00505778|26847393|FG001|Overall Study|Relapse|65|||
13415417|NCT00505778|26847392|FG000|Overall Study|Took No Study Drug|2|||
13415418|NCT00505778|26847393|FG001|Overall Study|Took No Study Drug|2|||
13415419|NCT00505765|26847426|FG000|Overall Study|Withdrawal by Subject|1|||
13415420|NCT00505765|26847427|FG001|Overall Study|Withdrawal by Subject|0|||
13415421|NCT00505765|26847428|FG002|Overall Study|Withdrawal by Subject|0|||
13415422|NCT00505765|26847426|FG000|Overall Study|Adverse Event|1|||
13415423|NCT00505765|26847427|FG001|Overall Study|Adverse Event|2|||
13415424|NCT00505765|26847428|FG002|Overall Study|Adverse Event|0|||
13415425|NCT00505765|26847426|FG000|Overall Study|Noncompliance|0|||
13415426|NCT00505765|26847427|FG001|Overall Study|Noncompliance|1|||
13415427|NCT00505765|26847428|FG002|Overall Study|Noncompliance|3|||
13415428|NCT00505752|26847455|FG000|Overall Study|Adverse Event|1|||
13415429|NCT00505752|26847456|FG001|Overall Study|Adverse Event|0|||
13415430|NCT00505752|26847457|FG002|Overall Study|Adverse Event|1|||
13415431|NCT00505752|26847458|FG003|Overall Study|Adverse Event|0|||
13415432|NCT00505752|26847455|FG000|Overall Study|Lost to Follow-up|1|||
13415433|NCT00505752|26847456|FG001|Overall Study|Lost to Follow-up|0|||
13415434|NCT00505752|26847457|FG002|Overall Study|Lost to Follow-up|0|||
13415435|NCT00505752|26847458|FG003|Overall Study|Lost to Follow-up|0|||
13415436|NCT00505752|26847455|FG000|Overall Study|Lack of ovarian response|1|||
13415437|NCT00505752|26847456|FG001|Overall Study|Lack of ovarian response|3|||
13415438|NCT00505752|26847457|FG002|Overall Study|Lack of ovarian response|0|||
13415439|NCT00505752|26847458|FG003|Overall Study|Lack of ovarian response|0|||
13415440|NCT00505752|26847455|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
13415441|NCT00505752|26847456|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
13415442|NCT00505752|26847457|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
13415443|NCT00505752|26847458|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
13415444|NCT00505752|26847455|FG000|Overall Study|No oocytes retrieved|0|||
13415445|NCT00505752|26847456|FG001|Overall Study|No oocytes retrieved|2|||
13415446|NCT00505752|26847457|FG002|Overall Study|No oocytes retrieved|0|||
13415447|NCT00505752|26847458|FG003|Overall Study|No oocytes retrieved|1|||
13415448|NCT00505752|26847455|FG000|Overall Study|No Fertilization|1|||
13415449|NCT00505752|26847456|FG001|Overall Study|No Fertilization|1|||
13415450|NCT00505752|26847457|FG002|Overall Study|No Fertilization|2|||
13415451|NCT00505752|26847458|FG003|Overall Study|No Fertilization|1|||
13415452|NCT00505752|26847455|FG000|Overall Study|All embryos/blastocysts discarded|0|||
13415453|NCT00505752|26847456|FG001|Overall Study|All embryos/blastocysts discarded|0|||
13415454|NCT00505752|26847457|FG002|Overall Study|All embryos/blastocysts discarded|1|||
13415455|NCT00505752|26847458|FG003|Overall Study|All embryos/blastocysts discarded|1|||
13415456|NCT00505752|26847455|FG000|Overall Study|Other|1|||
13415457|NCT00505752|26847456|FG001|Overall Study|Other|2|||
13415458|NCT00505752|26847457|FG002|Overall Study|Other|1|||
13415459|NCT00505752|26847458|FG003|Overall Study|Other|2|||
13415460|NCT00505687|26847466|FG000|Overall Study|Important protocol violation|2|||
13415461|NCT00505687|26847466|FG000|Overall Study|Lack of Efficacy|15|||
13415462|NCT00505687|26847466|FG000|Overall Study|Adverse Event|48|||
13415463|NCT00505687|26847466|FG000|Overall Study|Subject withdrew consent|15|||
13415464|NCT00505687|26847466|FG000|Overall Study|Lost to Follow-up|1|||
13415465|NCT00505687|26847466|FG000|Overall Study|Other: Underwent Implantation Of DBS|1|||
13415466|NCT00505687|26847466|FG000|Overall Study|Other: Scheduled DBS Surgery|1|||
13415467|NCT00505687|26847466|FG000|Overall Study|Other: Prolonged Hospitalization|1|||
13415468|NCT00505687|26847466|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1|||
13415469|NCT00505687|26847466|FG000|Overall Study|Other: Neupro Given In Hospital|1|||
13415470|NCT00505687|26847466|FG000|Overall Study|Other: Disease Progression|1|||
13415471|NCT00505687|26847466|FG000|Overall Study|Other: As Per Sponsor|8|||
13415472|NCT00505661|26847472|FG000|Overall Study|Not Eligible|4|||
13415473|NCT00505622|26847499|FG000|Overall Study|Adverse Event|5|||
13415474|NCT00505622|26847500|FG001|Overall Study|Adverse Event|6|||
13415475|NCT00505622|26847501|FG002|Overall Study|Adverse Event|4|||
13415476|NCT00505622|26847499|FG000|Overall Study|Protocol Violation|1|||
13415477|NCT00505622|26847500|FG001|Overall Study|Protocol Violation|1|||
13415478|NCT00505622|26847501|FG002|Overall Study|Protocol Violation|0|||
13415479|NCT00505622|26847499|FG000|Overall Study|Withdrawal by Subject|0|||
13415480|NCT00505622|26847500|FG001|Overall Study|Withdrawal by Subject|3|||
13415481|NCT00505622|26847501|FG002|Overall Study|Withdrawal by Subject|2|||
13415482|NCT00505622|26847499|FG000|Overall Study|Study termination by sponsor|115|||
13415483|NCT00505622|26847500|FG001|Overall Study|Study termination by sponsor|98|||
13415484|NCT00505622|26847501|FG002|Overall Study|Study termination by sponsor|90|||
13415485|NCT00505414|26847526|FG000|Titration Phase|Adverse Event|0|||
13415486|NCT00505414|26847527|FG001|Titration Phase|Adverse Event|0|||
13415487|NCT00505414|26847528|FG002|Titration Phase|Adverse Event|0|||
13415488|NCT00505414|26847529|FG003|Titration Phase|Adverse Event|8|||
13415489|NCT00505414|26847530|FG004|Titration Phase|Adverse Event|3|||
13415490|NCT00505414|26847526|FG000|Titration Phase|Death|0|||
13415491|NCT00505414|26847527|FG001|Titration Phase|Death|0|||
13415492|NCT00505414|26847528|FG002|Titration Phase|Death|0|||
13415493|NCT00505414|26847529|FG003|Titration Phase|Death|2|||
13415494|NCT00505414|26847530|FG004|Titration Phase|Death|0|||
13415495|NCT00505414|26847526|FG000|Titration Phase|Lack of Efficacy|0|||
13415496|NCT00505414|26847527|FG001|Titration Phase|Lack of Efficacy|0|||
13415497|NCT00505414|26847528|FG002|Titration Phase|Lack of Efficacy|0|||
13415498|NCT00505414|26847529|FG003|Titration Phase|Lack of Efficacy|10|||
13415499|NCT00505414|26847530|FG004|Titration Phase|Lack of Efficacy|1|||
13415500|NCT00505414|26847526|FG000|Titration Phase|Protocol Violation|0|||
13415501|NCT00505414|26847527|FG001|Titration Phase|Protocol Violation|0|||
13415502|NCT00505414|26847528|FG002|Titration Phase|Protocol Violation|0|||
13415503|NCT00505414|26847529|FG003|Titration Phase|Protocol Violation|0|||
13415504|NCT00505414|26847530|FG004|Titration Phase|Protocol Violation|1|||
13415505|NCT00505414|26847526|FG000|Titration Phase|Withdrawal by Subject|0|||
13415506|NCT00505414|26847527|FG001|Titration Phase|Withdrawal by Subject|0|||
13415507|NCT00505414|26847528|FG002|Titration Phase|Withdrawal by Subject|0|||
13415508|NCT00505414|26847529|FG003|Titration Phase|Withdrawal by Subject|3|||
13415509|NCT00505414|26847530|FG004|Titration Phase|Withdrawal by Subject|4|||
13415510|NCT00505414|26847526|FG000|Titration Phase|Underlying disease and therapy required|0|||
13415511|NCT00505414|26847527|FG001|Titration Phase|Underlying disease and therapy required|0|||
13415512|NCT00505414|26847528|FG002|Titration Phase|Underlying disease and therapy required|0|||
13415513|NCT00505414|26847529|FG003|Titration Phase|Underlying disease and therapy required|7|||
13415514|NCT00505414|26847530|FG004|Titration Phase|Underlying disease and therapy required|3|||
13415515|NCT00505414|26847526|FG000|Maintenance Phase|Adverse Event|2|||
13415516|NCT00505414|26847527|FG001|Maintenance Phase|Adverse Event|2|||
13415517|NCT00505414|26847528|FG002|Maintenance Phase|Adverse Event|3|||
13415518|NCT00505414|26847529|FG003|Maintenance Phase|Adverse Event|0|||
13415519|NCT00505414|26847530|FG004|Maintenance Phase|Adverse Event|0|||
13415520|NCT00505414|26847526|FG000|Maintenance Phase|Death|2|||
13415521|NCT00505414|26847527|FG001|Maintenance Phase|Death|0|||
13415522|NCT00505414|26847528|FG002|Maintenance Phase|Death|1|||
13415523|NCT00505414|26847529|FG003|Maintenance Phase|Death|0|||
13415524|NCT00505414|26847530|FG004|Maintenance Phase|Death|0|||
13415525|NCT00505414|26847526|FG000|Maintenance Phase|Lack of Efficacy|2|||
13415526|NCT00505414|26847527|FG001|Maintenance Phase|Lack of Efficacy|1|||
13415527|NCT00505414|26847528|FG002|Maintenance Phase|Lack of Efficacy|1|||
13415528|NCT00505414|26847529|FG003|Maintenance Phase|Lack of Efficacy|0|||
13415529|NCT00505414|26847530|FG004|Maintenance Phase|Lack of Efficacy|0|||
13415530|NCT00505414|26847526|FG000|Maintenance Phase|Withdrawal by Subject|0|||
13415531|NCT00505414|26847527|FG001|Maintenance Phase|Withdrawal by Subject|0|||
13415532|NCT00505414|26847528|FG002|Maintenance Phase|Withdrawal by Subject|1|||
13415533|NCT00505414|26847529|FG003|Maintenance Phase|Withdrawal by Subject|0|||
13415534|NCT00505414|26847530|FG004|Maintenance Phase|Withdrawal by Subject|0|||
13415535|NCT00505414|26847526|FG000|Maintenance Phase|underlying disease and therapy required|0|||
13415536|NCT00505414|26847527|FG001|Maintenance Phase|underlying disease and therapy required|2|||
13415537|NCT00505414|26847528|FG002|Maintenance Phase|underlying disease and therapy required|2|||
13415538|NCT00505414|26847529|FG003|Maintenance Phase|underlying disease and therapy required|0|||
13415539|NCT00505414|26847530|FG004|Maintenance Phase|underlying disease and therapy required|0|||
13415540|NCT00505375|26847543|FG000|Overall Study|Death|1|||
13415541|NCT00505375|26847544|FG001|Overall Study|Death|0|||
13415542|NCT00505375|26847543|FG000|Overall Study|Withdrawal by Subject|2|||
13415543|NCT00505375|26847544|FG001|Overall Study|Withdrawal by Subject|2|||
13415544|NCT00505375|26847543|FG000|Overall Study|Lost to Follow-up|0|||
13415545|NCT00505375|26847544|FG001|Overall Study|Lost to Follow-up|2|||
13415546|NCT00505375|26847543|FG000|Overall Study|Pregnancy|1|||
13415547|NCT00505375|26847544|FG001|Overall Study|Pregnancy|0|||
13415548|NCT00505375|26847543|FG000|Overall Study|Travel issues|0|||
13415549|NCT00505375|26847544|FG001|Overall Study|Travel issues|1|||
13415550|NCT00505284|26847627|FG000|Overall Study|Adverse Event|3|||
13415551|NCT00505284|26847628|FG001|Overall Study|Adverse Event|7|||
13415552|NCT00505284|26847629|FG002|Overall Study|Adverse Event|9|||
13415553|NCT00505284|26847630|FG003|Overall Study|Adverse Event|14|||
13415554|NCT00505284|26847631|FG004|Overall Study|Adverse Event|22|||
13415555|NCT00505284|26847627|FG000|Overall Study|Protocol Violation|0|||
13415556|NCT00505284|26847628|FG001|Overall Study|Protocol Violation|1|||
13415557|NCT00505284|26847629|FG002|Overall Study|Protocol Violation|1|||
13415558|NCT00505284|26847630|FG003|Overall Study|Protocol Violation|0|||
13415559|NCT00505284|26847631|FG004|Overall Study|Protocol Violation|0|||
13415560|NCT00505284|26847627|FG000|Overall Study|Withdrawal by Subject|2|||
13415561|NCT00505284|26847628|FG001|Overall Study|Withdrawal by Subject|6|||
13415562|NCT00505284|26847629|FG002|Overall Study|Withdrawal by Subject|1|||
13415563|NCT00505284|26847630|FG003|Overall Study|Withdrawal by Subject|0|||
13415564|NCT00505284|26847631|FG004|Overall Study|Withdrawal by Subject|6|||
13415565|NCT00505284|26847627|FG000|Overall Study|Lack of Efficacy|0|||
13415566|NCT00505284|26847628|FG001|Overall Study|Lack of Efficacy|1|||
13415567|NCT00505284|26847629|FG002|Overall Study|Lack of Efficacy|1|||
13415568|NCT00505284|26847630|FG003|Overall Study|Lack of Efficacy|1|||
13415569|NCT00505284|26847631|FG004|Overall Study|Lack of Efficacy|1|||
13415570|NCT00505284|26847627|FG000|Overall Study|Physician Decision|0|||
13415571|NCT00505284|26847628|FG001|Overall Study|Physician Decision|1|||
13415572|NCT00505284|26847629|FG002|Overall Study|Physician Decision|0|||
13415573|NCT00505284|26847630|FG003|Overall Study|Physician Decision|0|||
13415574|NCT00505284|26847631|FG004|Overall Study|Physician Decision|0|||
13415575|NCT00505284|26847627|FG000|Overall Study|Other|5|||
13415576|NCT00505284|26847628|FG001|Overall Study|Other|0|||
13415577|NCT00505284|26847629|FG002|Overall Study|Other|0|||
13415578|NCT00505284|26847630|FG003|Overall Study|Other|4|||
13415579|NCT00505284|26847631|FG004|Overall Study|Other|4|||
13415580|NCT00505076|26847655|FG000|Overall Study|Adverse Event|1|||
13415581|NCT00505076|26847656|FG001|Overall Study|Adverse Event|0|||
13415582|NCT00505076|26847657|FG002|Overall Study|Adverse Event|1|||
13415583|NCT00505076|26847655|FG000|Overall Study|Protocol Violation|2|||
13415584|NCT00505076|26847656|FG001|Overall Study|Protocol Violation|1|||
13415585|NCT00505076|26847657|FG002|Overall Study|Protocol Violation|2|||
13415586|NCT00505076|26847655|FG000|Overall Study|Withdrawal by Subject|0|||
13415587|NCT00505076|26847656|FG001|Overall Study|Withdrawal by Subject|1|||
13415588|NCT00505076|26847657|FG002|Overall Study|Withdrawal by Subject|2|||
13415589|NCT00504894|26847678|FG000|Overall Study|fMRI technical problems|1|||
13415590|NCT00504894|26847679|FG001|Overall Study|fMRI technical problems|1|||
13415591|NCT00504894|26847680|FG002|Overall Study|fMRI technical problems|0|||
13415592|NCT00504894|26847678|FG000|Overall Study|Withdrawal by Subject|0|||
13415593|NCT00504894|26847679|FG001|Overall Study|Withdrawal by Subject|1|||
13415594|NCT00504894|26847680|FG002|Overall Study|Withdrawal by Subject|0|||
13415595|NCT00504894|26847678|FG000|Overall Study|Infusion technical problems|0|||
13415596|NCT00504894|26847679|FG001|Overall Study|Infusion technical problems|1|||
13415597|NCT00504894|26847680|FG002|Overall Study|Infusion technical problems|0|||
13415598|NCT00504894|26847678|FG000|Overall Study|poor subject data|2|||
13415599|NCT00504894|26847679|FG001|Overall Study|poor subject data|0|||
13415600|NCT00504894|26847680|FG002|Overall Study|poor subject data|0|||
13415601|NCT00504881|26847737|FG000|Overall Study|Lack of Efficacy|1|||
13415602|NCT00504881|26847738|FG001|Overall Study|Lack of Efficacy|5|||
13415603|NCT00504881|26847737|FG000|Overall Study|Lost to Follow-up|0|||
13415604|NCT00504881|26847738|FG001|Overall Study|Lost to Follow-up|2|||
13415605|NCT00504881|26847737|FG000|Overall Study|Withdrawal by Subject|1|||
13415606|NCT00504881|26847738|FG001|Overall Study|Withdrawal by Subject|4|||
13415607|NCT00504881|26847737|FG000|Overall Study|Non-Compliance|1|||
13415608|NCT00504881|26847738|FG001|Overall Study|Non-Compliance|0|||
13415609|NCT00504881|26847737|FG000|Overall Study|No Birth Control|0|||
13415610|NCT00504881|26847738|FG001|Overall Study|No Birth Control|1|||
13415611|NCT00504881|26847737|FG000|Overall Study|Safety Visit not performed|0|||
13415612|NCT00504881|26847738|FG001|Overall Study|Safety Visit not performed|1|||
13415613|NCT00504881|26847737|FG000|Overall Study|AE, serious fatal|0|||
13415614|NCT00504881|26847738|FG001|Overall Study|AE, serious fatal|1|||
13415615|NCT00504881|26847737|FG000|Overall Study|SAE, non-fatal|2|||
13415616|NCT00504881|26847738|FG001|Overall Study|SAE, non-fatal|6|||
13415617|NCT00504881|26847737|FG000|Overall Study|AE, non-serious non-fatal|4|||
13415618|NCT00504881|26847738|FG001|Overall Study|AE, non-serious non-fatal|14|||
13415619|NCT00504881|26847737|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
13415620|NCT00504881|26847738|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2|||
13415621|NCT00504881|26847737|FG000|Overall Study|AE of unknown type|1|||
13415622|NCT00504881|26847738|FG001|Overall Study|AE of unknown type|0|||
13415623|NCT00504829|26847757|FG000|Overall Study|Protocol Violation|6|||
13415624|NCT00504829|26847758|FG001|Overall Study|Protocol Violation|4|||
13415625|NCT00504829|26847759|FG002|Overall Study|Protocol Violation|10|||
13415626|NCT00504777|26847768|FG000|Overall Study|Adverse Event|1|||
13415627|NCT00504725|26847785|FG000|Overall Study|Protocol Violation|1|||
13415628|NCT00504725|26847786|FG001|Overall Study|Protocol Violation|0|||
13415629|NCT00504595|26847811|FG000|Overall Study|Lack of Efficacy|1|||
13415630|NCT00504595|26847812|FG001|Overall Study|Lack of Efficacy|0|||
13415631|NCT00504595|26847813|FG002|Overall Study|Lack of Efficacy|0|||
13415632|NCT00504595|26847814|FG003|Overall Study|Lack of Efficacy|0|||
13415633|NCT00504595|26847811|FG000|Overall Study|Other|0|||
13415634|NCT00504595|26847812|FG001|Overall Study|Other|0|||
13415635|NCT00504595|26847813|FG002|Overall Study|Other|2|||
13415636|NCT00504595|26847814|FG003|Overall Study|Other|0|||
13415637|NCT00504582|26847835|FG000|Overall Study|Lost to Follow-up|1|||
13415638|NCT00504582|26847836|FG001|Overall Study|Lost to Follow-up|0|||
13415639|NCT00504582|26847837|FG002|Overall Study|Lost to Follow-up|0|||
13415640|NCT00504556|26847913|FG000|Overall Study|Adverse Event|11|||
13415641|NCT00504556|26847914|FG001|Overall Study|Adverse Event|11|||
13415642|NCT00504556|26847915|FG002|Overall Study|Adverse Event|14|||
13415643|NCT00504556|26847916|FG003|Overall Study|Adverse Event|13|||
13415644|NCT00504556|26847917|FG004|Overall Study|Adverse Event|5|||
13415645|NCT00504556|26847913|FG000|Overall Study|Death|3|||
13415646|NCT00504556|26847914|FG001|Overall Study|Death|3|||
13415647|NCT00504556|26847915|FG002|Overall Study|Death|1|||
13415648|NCT00504556|26847916|FG003|Overall Study|Death|0|||
13415649|NCT00504556|26847917|FG004|Overall Study|Death|2|||
13415650|NCT00504556|26847913|FG000|Overall Study|Protocol Violation|1|||
13415651|NCT00504556|26847914|FG001|Overall Study|Protocol Violation|3|||
13415652|NCT00504556|26847915|FG002|Overall Study|Protocol Violation|2|||
13415653|NCT00504556|26847916|FG003|Overall Study|Protocol Violation|1|||
13415654|NCT00504556|26847917|FG004|Overall Study|Protocol Violation|2|||
13415655|NCT00504556|26847913|FG000|Overall Study|Lost to Follow-up|0|||
13415656|NCT00504556|26847914|FG001|Overall Study|Lost to Follow-up|0|||
13415657|NCT00504556|26847915|FG002|Overall Study|Lost to Follow-up|1|||
13415658|NCT00504556|26847916|FG003|Overall Study|Lost to Follow-up|1|||
13415659|NCT00504556|26847917|FG004|Overall Study|Lost to Follow-up|1|||
13415660|NCT00504556|26847913|FG000|Overall Study|Withdrawal by Subject|16|||
13415661|NCT00504556|26847914|FG001|Overall Study|Withdrawal by Subject|16|||
13415662|NCT00504556|26847915|FG002|Overall Study|Withdrawal by Subject|7|||
13415663|NCT00504556|26847916|FG003|Overall Study|Withdrawal by Subject|8|||
13415664|NCT00504556|26847917|FG004|Overall Study|Withdrawal by Subject|12|||
13415665|NCT00504556|26847913|FG000|Overall Study|administrative reasons|0|||
13415666|NCT00504556|26847914|FG001|Overall Study|administrative reasons|2|||
13415667|NCT00504556|26847915|FG002|Overall Study|administrative reasons|2|||
13415668|NCT00504556|26847916|FG003|Overall Study|administrative reasons|1|||
13415669|NCT00504556|26847917|FG004|Overall Study|administrative reasons|2|||
13415670|NCT00504556|26847913|FG000|Overall Study|did not meet entry criteria|2|||
13415671|NCT00504556|26847914|FG001|Overall Study|did not meet entry criteria|0|||
13415672|NCT00504556|26847915|FG002|Overall Study|did not meet entry criteria|1|||
13415673|NCT00504556|26847916|FG003|Overall Study|did not meet entry criteria|1|||
13415674|NCT00504556|26847917|FG004|Overall Study|did not meet entry criteria|0|||
13415675|NCT00504556|26847913|FG000|Overall Study|data monitor committee decision|0|||
13415676|NCT00504556|26847914|FG001|Overall Study|data monitor committee decision|0|||
13415677|NCT00504556|26847915|FG002|Overall Study|data monitor committee decision|0|||
13415678|NCT00504556|26847916|FG003|Overall Study|data monitor committee decision|100|||
13415679|NCT00504556|26847917|FG004|Overall Study|data monitor committee decision|0|||
13415680|NCT00504556|26847913|FG000|Overall Study|Other|2|||
13415681|NCT00504556|26847914|FG001|Overall Study|Other|2|||
13415682|NCT00504556|26847915|FG002|Overall Study|Other|2|||
13415683|NCT00504556|26847916|FG003|Overall Study|Other|3|||
13415684|NCT00504556|26847917|FG004|Overall Study|Other|0|||
13415685|NCT00504556|26847913|FG000|Overall Study|not in safety analysis set|0|||
13415686|NCT00504556|26847914|FG001|Overall Study|not in safety analysis set|1|||
13415687|NCT00504556|26847915|FG002|Overall Study|not in safety analysis set|1|||
13415688|NCT00504556|26847916|FG003|Overall Study|not in safety analysis set|0|||
13415689|NCT00504556|26847917|FG004|Overall Study|not in safety analysis set|1|||
13415690|NCT00504426|26847944|FG000|Overall Study|Adverse Event|0|||
13415691|NCT00504426|26847945|FG001|Overall Study|Adverse Event|0|||
13415692|NCT00504426|26847946|FG002|Overall Study|Adverse Event|2|||
13415693|NCT00504426|26847947|FG003|Overall Study|Adverse Event|0|||
13415694|NCT00504426|26847944|FG000|Overall Study|Protocol Violation|1|||
13415695|NCT00504426|26847945|FG001|Overall Study|Protocol Violation|1|||
13415696|NCT00504426|26847946|FG002|Overall Study|Protocol Violation|2|||
13415697|NCT00504426|26847947|FG003|Overall Study|Protocol Violation|0|||
13415698|NCT00504426|26847944|FG000|Overall Study|Withdrawal by Subject|2|||
13415699|NCT00504426|26847945|FG001|Overall Study|Withdrawal by Subject|0|||
13415700|NCT00504426|26847946|FG002|Overall Study|Withdrawal by Subject|0|||
13415701|NCT00504426|26847947|FG003|Overall Study|Withdrawal by Subject|0|||
13415702|NCT00504348|26847954|FG000|Overall Study|Adverse Event|3|||
13415703|NCT00504348|26847954|FG000|Overall Study|Lack of Efficacy|4|||
13415704|NCT00504348|26847954|FG000|Overall Study|Physician Decision|1|||
13476532|NCT00500071|27003114|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1|||
13476533|NCT00500071|27003114|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4|||
13476534|NCT00500071|27003114|FG000|30-day Safety Follow-up|Lost to Follow-up|17|||
13476535|NCT00447122|27003137|FG000|Overall Study|worsening medical condition -came off|0|||
13476536|NCT00447122|27003138|FG001|Overall Study|worsening medical condition -came off|1|||
13476537|NCT00447122|27003139|FG002|Overall Study|worsening medical condition -came off|0|||
13476538|NCT00447122|27003140|FG003|Overall Study|worsening medical condition -came off|0|||
13476539|NCT00382252|27003148|FG000|Overall Study|Death|4|||
13476540|NCT00382252|27003148|FG000|Overall Study|Protocol Violation|8|||
13476541|NCT00382252|27003148|FG000|Overall Study|Not treated by RFA|1|||
13476542|NCT00309985|27003171|FG000|Overall Study|Disease progression|12|||
13476543|NCT00309985|27003172|FG001|Overall Study|Disease progression|0|||
13476544|NCT00309985|27003171|FG000|Overall Study|Adverse Event|30|||
13476545|NCT00309985|27003172|FG001|Overall Study|Adverse Event|0|||
13476546|NCT00309985|27003171|FG000|Overall Study|Death|2|||
13476547|NCT00309985|27003172|FG001|Overall Study|Death|0|||
13415705|NCT00504309|26848011|FG000|Overall Study|Death|0|||
13415706|NCT00504309|26848012|FG001|Overall Study|Death|0|||
13415707|NCT00504309|26848013|FG002|Overall Study|Death|0|||
13415708|NCT00504309|26848014|FG003|Overall Study|Death|0|||
13415709|NCT00504309|26848015|FG004|Overall Study|Death|1|||
13415710|NCT00504309|26848016|FG005|Overall Study|Death|0|||
13415711|NCT00504309|26848011|FG000|Overall Study|Withdrawal by Subject|0|||
13415712|NCT00504309|26848012|FG001|Overall Study|Withdrawal by Subject|0|||
13415713|NCT00504309|26848013|FG002|Overall Study|Withdrawal by Subject|1|||
13415714|NCT00504309|26848014|FG003|Overall Study|Withdrawal by Subject|0|||
13415715|NCT00504309|26848015|FG004|Overall Study|Withdrawal by Subject|0|||
13415716|NCT00504309|26848016|FG005|Overall Study|Withdrawal by Subject|0|||
13415717|NCT00504257|26848026|FG000|Overall Study|Withdrawal by Subject|2|||
13415718|NCT00504257|26848026|FG000|Overall Study|ineligible histology|2|||
13415719|NCT00504231|26848057|FG000|Overall Study|Discrepant chart documentation re route|0|||
13415720|NCT00504231|26848058|FG001|Overall Study|Discrepant chart documentation re route|0|||
13415721|NCT00504231|26848059|FG002|Overall Study|Discrepant chart documentation re route|1|||
13415722|NCT00504231|26848060|FG003|Overall Study|Discrepant chart documentation re route|0|||
13415723|NCT00504166|26848073|FG000|Overall Study|Adverse Event|1|||
13415724|NCT00504166|26848074|FG001|Overall Study|Adverse Event|4|||
13415725|NCT00504166|26848073|FG000|Overall Study|Withdrawal by Subject|3|||
13415726|NCT00504166|26848074|FG001|Overall Study|Withdrawal by Subject|6|||
13415727|NCT00504166|26848073|FG000|Overall Study|Physician Decision|1|||
13415728|NCT00504166|26848074|FG001|Overall Study|Physician Decision|1|||
13415729|NCT00504166|26848073|FG000|Overall Study|Lost to Follow-up|1|||
13415730|NCT00504166|26848074|FG001|Overall Study|Lost to Follow-up|3|||
13415731|NCT00504153|26848084|FG000|Overall Study|Withdrawal by Subject|1|||
13415732|NCT00504153|26848084|FG000|Overall Study|Adverse Event|4|||
13415733|NCT00504153|26848084|FG000|Overall Study|Death|1|||
13415734|NCT00504075|26848092|FG000|Overall Study|Adverse Event|1|||
13415735|NCT00504075|26848092|FG000|Overall Study|Lost to Follow-up|5|||
13415736|NCT00504075|26848092|FG000|Overall Study|Withdrawal by Subject|1|||
13415737|NCT00504075|26848092|FG000|Overall Study|Required other therapeutic intervention|1|||
13415738|NCT00503997|26848098|FG000|Overall Study|disease progression|1|||
13415739|NCT00503997|26848098|FG000|Overall Study|Adverse Event|5|||
13415740|NCT00503997|26848098|FG000|Overall Study|Death|1|||
13415741|NCT00503997|26848098|FG000|Overall Study|Withdrawal by Subject|1|||
13415742|NCT00503984|26848135|FG000|Overall Study|Protocol Violation|0|||
13415743|NCT00503984|26848136|FG001|Overall Study|Protocol Violation|1|||
13415744|NCT00503984|26848137|FG002|Overall Study|Protocol Violation|0|||
13415745|NCT00503984|26848138|FG003|Overall Study|Protocol Violation|0|||
13415746|NCT00503984|26848139|FG004|Overall Study|Protocol Violation|0|||
13415747|NCT00503984|26848140|FG005|Overall Study|Protocol Violation|0|||
13415748|NCT00503984|26848135|FG000|Overall Study|Adverse Event|0|||
13415749|NCT00503984|26848136|FG001|Overall Study|Adverse Event|1|||
13415750|NCT00503984|26848137|FG002|Overall Study|Adverse Event|0|||
13415751|NCT00503984|26848138|FG003|Overall Study|Adverse Event|0|||
13415752|NCT00503984|26848139|FG004|Overall Study|Adverse Event|0|||
13415753|NCT00503984|26848140|FG005|Overall Study|Adverse Event|0|||
13415754|NCT00503984|26848135|FG000|Overall Study|Death|0|||
13415755|NCT00503984|26848136|FG001|Overall Study|Death|0|||
13415756|NCT00503984|26848137|FG002|Overall Study|Death|0|||
13415757|NCT00503984|26848138|FG003|Overall Study|Death|0|||
13415758|NCT00503984|26848139|FG004|Overall Study|Death|1|||
13415759|NCT00503984|26848140|FG005|Overall Study|Death|0|||
13415760|NCT00503906|26848151|FG000|Overall Study|Withdrawal by Subject|1|||
13415761|NCT00503867|26848161|FG000|Overall Study|Lost to Follow-up|1|||
13415762|NCT00503867|26848161|FG000|Overall Study|Adverse Event|1|||
13415763|NCT00503841|26848170|FG000|Overall Study|All screen failures|44|||
13415764|NCT00503776|26848209|FG000|Overall Study|Withdrawal by Subject|1|||
13415765|NCT00503776|26848210|FG001|Overall Study|Withdrawal by Subject|0|||
13415766|NCT00503776|26848211|FG002|Overall Study|Withdrawal by Subject|1|||
13415767|NCT00503776|26848212|FG003|Overall Study|Withdrawal by Subject|1|||
13415768|NCT00503776|26848209|FG000|Overall Study|Physician Decision|0|||
13415769|NCT00503776|26848210|FG001|Overall Study|Physician Decision|0|||
13415770|NCT00503776|26848211|FG002|Overall Study|Physician Decision|1|||
13415771|NCT00503776|26848212|FG003|Overall Study|Physician Decision|1|||
13415772|NCT00503698|26848233|FG000|Overall Study|Protocol Violation|5|||
13415773|NCT00503698|26848234|FG001|Overall Study|Protocol Violation|6|||
13415774|NCT00503698|26848233|FG000|Overall Study|Adverse Event|52|||
13415775|NCT00503698|26848234|FG001|Overall Study|Adverse Event|41|||
13415776|NCT00503698|26848233|FG000|Overall Study|Death|1|||
13415777|NCT00503698|26848234|FG001|Overall Study|Death|0|||
13415778|NCT00503698|26848233|FG000|Overall Study|Lack of Efficacy|3|||
13415779|NCT00503698|26848234|FG001|Overall Study|Lack of Efficacy|4|||
13415780|NCT00503698|26848233|FG000|Overall Study|Trial terminated|216|||
13415781|NCT00503698|26848234|FG001|Overall Study|Trial terminated|253|||
13415782|NCT00503698|26848233|FG000|Overall Study|End hemodialysis due to renal transplant|10|||
13415783|NCT00503698|26848234|FG001|Overall Study|End hemodialysis due to renal transplant|4|||
13415784|NCT00503698|26848233|FG000|Overall Study|Pregnancy/intention to become pregnant|1|||
13415785|NCT00503698|26848234|FG001|Overall Study|Pregnancy/intention to become pregnant|0|||
13415786|NCT00503698|26848233|FG000|Overall Study|Any condition in exclusion criteria|4|||
13415787|NCT00503698|26848234|FG001|Overall Study|Any condition in exclusion criteria|6|||
13415788|NCT00503698|26848233|FG000|Overall Study|Switch to peritoneal or home dialysis|2|||
13415789|NCT00503698|26848234|FG001|Overall Study|Switch to peritoneal or home dialysis|2|||
13415790|NCT00503698|26848233|FG000|Overall Study|Move to nonparticipating dialysis center|2|||
13415791|NCT00503698|26848234|FG001|Overall Study|Move to nonparticipating dialysis center|1|||
13415792|NCT00503698|26848233|FG000|Overall Study|Critically ill|2|||
13415793|NCT00503698|26848234|FG001|Overall Study|Critically ill|0|||
13415794|NCT00503698|26848233|FG000|Overall Study|Unclassified|48|||
13415795|NCT00503698|26848234|FG001|Overall Study|Unclassified|32|||
13415796|NCT00503698|26848233|FG000|Overall Study|Not exposed to trial drug|11|||
13415797|NCT00503698|26848234|FG001|Overall Study|Not exposed to trial drug|6|||
13415798|NCT00503685|26848286|FG000|Overall Study|Adverse Event|0|||
13415799|NCT00503685|26848287|FG001|Overall Study|Adverse Event|0|||
13415800|NCT00503685|26848288|FG002|Overall Study|Adverse Event|2|||
13415801|NCT00503685|26848286|FG000|Overall Study|Withdrawal by Subject|0|||
13415802|NCT00503685|26848287|FG001|Overall Study|Withdrawal by Subject|1|||
13415803|NCT00503685|26848288|FG002|Overall Study|Withdrawal by Subject|0|||
13415804|NCT00503685|26848286|FG000|Overall Study|Protocol Violation|0|||
13415805|NCT00503685|26848287|FG001|Overall Study|Protocol Violation|1|||
13415806|NCT00503685|26848288|FG002|Overall Study|Protocol Violation|0|||
13415807|NCT00503685|26848286|FG000|Overall Study|Eligibility Criteria Not Met|0|||
13415808|NCT00503685|26848287|FG001|Overall Study|Eligibility Criteria Not Met|1|||
13415809|NCT00503685|26848288|FG002|Overall Study|Eligibility Criteria Not Met|0|||
13415810|NCT00503581|26848309|FG000|Overall Study|Study closed|3|||
13415811|NCT00503581|26848310|FG001|Overall Study|Study closed|4|||
13415812|NCT00503581|26848311|FG002|Overall Study|Study closed|2|||
13415813|NCT00503425|26848321|FG000|Overall Study|Participant files lost|6|||
13415814|NCT00503425|26848321|FG000|Overall Study|Adverse Event|5|||
13415815|NCT00503425|26848321|FG000|Overall Study|Lack of Efficacy|25|||
13415816|NCT00503425|26848321|FG000|Overall Study|Withdrawal by Subject|8|||
13415817|NCT00503425|26848321|FG000|Overall Study|Lost to Follow-up|3|||
13415818|NCT00503425|26848321|FG000|Overall Study|Death|3|||
13415819|NCT00503425|26848321|FG000|Overall Study|Missing Data/Unknown|4|||
13415820|NCT00503399|26848350|FG000|Overall Study|Death|2|||
13415821|NCT00503399|26848351|FG001|Overall Study|Death|1|||
13415822|NCT00503399|26848350|FG000|Overall Study|Protocol Violation|1|||
13415823|NCT00503399|26848351|FG001|Overall Study|Protocol Violation|0|||
13415824|NCT00503399|26848350|FG000|Overall Study|Withdrawal by Subject|4|||
13415825|NCT00503399|26848351|FG001|Overall Study|Withdrawal by Subject|2|||
13415826|NCT00503399|26848350|FG000|Overall Study|Adverse Event|0|||
13415827|NCT00503399|26848351|FG001|Overall Study|Adverse Event|3|||
13415828|NCT00503399|26848350|FG000|Overall Study|Lost to Follow-up|0|||
13415829|NCT00503399|26848351|FG001|Overall Study|Lost to Follow-up|2|||
13415830|NCT00503308|26848364|FG000|Overall Study|Protocol Violation|2|||
13415831|NCT00503308|26848365|FG001|Overall Study|Protocol Violation|1|||
13415832|NCT00503139|26848378|FG000|Overall Study|Case Report Forms were not collected|4|||
13415833|NCT00503139|26848378|FG000|Overall Study|Protocol Violation|4|||
13415834|NCT00503009|26848405|FG000|Overall Study|Protocol Violation|1|||
13415835|NCT00503009|26848406|FG001|Overall Study|Protocol Violation|0|||
13415836|NCT00503009|26848407|FG002|Overall Study|Protocol Violation|1|||
13415837|NCT00503009|26848405|FG000|Overall Study|Withdrawal by Subject|0|||
13415838|NCT00503009|26848406|FG001|Overall Study|Withdrawal by Subject|1|||
13415839|NCT00503009|26848407|FG002|Overall Study|Withdrawal by Subject|1|||
13415840|NCT00503009|26848405|FG000|Overall Study|Physician Decision|0|||
13415841|NCT00503009|26848406|FG001|Overall Study|Physician Decision|1|||
13415842|NCT00503009|26848407|FG002|Overall Study|Physician Decision|1|||
13415843|NCT00502996|26848433|FG000|Overall Study|Lost to Follow-up|9|||
13415844|NCT00502996|26848433|FG000|Overall Study|Protocol Violation|2|||
13415845|NCT00502996|26848433|FG000|Overall Study|Treatment failure|25|||
13415846|NCT00502996|26848433|FG000|Overall Study|Withdrawal Informed Consent|6|||
13415847|NCT00502996|26848433|FG000|Overall Study|Adverse Event|2|||
13415848|NCT00502840|26848463|FG000|Overall Study|Adverse Event|5|||
13415849|NCT00502840|26848463|FG000|Overall Study|Additional or changed therapy|48|||
13415850|NCT00502840|26848463|FG000|Overall Study|Lack of Efficacy|11|||
13415851|NCT00502840|26848463|FG000|Overall Study|Protocol Violation|4|||
13415852|NCT00502840|26848463|FG000|Overall Study|Withdrawal by Subject|5|||
13415853|NCT00502840|26848463|FG000|Overall Study|Lost to Follow-up|6|||
13415854|NCT00502840|26848463|FG000|Overall Study|Administrative problems|1|||
13415855|NCT00502840|26848463|FG000|Overall Study|Other|20|||
13415856|NCT00502801|26848470|FG000|Treatment Period|Withdrawal by Subject|3|||
13415857|NCT00502801|26848470|FG000|Treatment Period|Adverse Event|7|||
13415858|NCT00502801|26848470|FG000|Treatment Period|Death|14|||
13415859|NCT00502801|26848470|FG000|Treatment Period|OTHER|30|||
13415860|NCT00502801|26848470|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1|||
13415861|NCT00502801|26848470|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2|||
13415862|NCT00502801|26848470|FG000|End of Therapy to Test of Cure|Death|3|||
13415863|NCT00502801|26848470|FG000|End of Therapy to Test of Cure|OTHER|2|||
13415864|NCT00502775|26848521|FG000|Overall Study|Adverse Event|1|||
13415865|NCT00502775|26848522|FG001|Overall Study|Adverse Event|2|||
13415866|NCT00502775|26848523|FG002|Overall Study|Adverse Event|1|||
13415867|NCT00502775|26848521|FG000|Overall Study|Protocol Violation|1|||
13415868|NCT00502775|26848522|FG001|Overall Study|Protocol Violation|5|||
13415869|NCT00502775|26848523|FG002|Overall Study|Protocol Violation|2|||
13415870|NCT00502775|26848521|FG000|Overall Study|Withdrawal by Subject|1|||
13415871|NCT00502775|26848522|FG001|Overall Study|Withdrawal by Subject|1|||
13415872|NCT00502775|26848523|FG002|Overall Study|Withdrawal by Subject|2|||
13415873|NCT00502775|26848521|FG000|Overall Study|Sponsor Terminated Study|1|||
13415874|NCT00502775|26848522|FG001|Overall Study|Sponsor Terminated Study|0|||
13415875|NCT00502775|26848523|FG002|Overall Study|Sponsor Terminated Study|1|||
13415876|NCT00502775|26848521|FG000|Overall Study|Non-compliance with eDiary|4|||
13415877|NCT00502775|26848522|FG001|Overall Study|Non-compliance with eDiary|1|||
13415878|NCT00502775|26848523|FG002|Overall Study|Non-compliance with eDiary|1|||
13415879|NCT00502775|26848521|FG000|Overall Study|Subject unable to swallow capsule|1|||
13415880|NCT00502775|26848522|FG001|Overall Study|Subject unable to swallow capsule|0|||
13415881|NCT00502775|26848523|FG002|Overall Study|Subject unable to swallow capsule|1|||
13415882|NCT00502775|26848521|FG000|Overall Study|Logpad compliance <80%|1|||
13415883|NCT00502775|26848522|FG001|Overall Study|Logpad compliance <80%|0|||
13415884|NCT00502775|26848523|FG002|Overall Study|Logpad compliance <80%|0|||
13415885|NCT00502775|26848521|FG000|Overall Study|Randomized in error|0|||
13415886|NCT00502775|26848522|FG001|Overall Study|Randomized in error|1|||
13415887|NCT00502775|26848523|FG002|Overall Study|Randomized in error|1|||
13415888|NCT00502775|26848521|FG000|Overall Study|Non-compliance|0|||
13415889|NCT00502775|26848522|FG001|Overall Study|Non-compliance|2|||
13415890|NCT00502775|26848523|FG002|Overall Study|Non-compliance|2|||
13415891|NCT00502775|26848521|FG000|Overall Study|Outside pollen area more than 48 hours|0|||
13415892|NCT00502775|26848522|FG001|Overall Study|Outside pollen area more than 48 hours|1|||
13415893|NCT00502775|26848523|FG002|Overall Study|Outside pollen area more than 48 hours|0|||
13415894|NCT00502775|26848521|FG000|Overall Study|Declining pollen counts|0|||
13415895|NCT00502775|26848522|FG001|Overall Study|Declining pollen counts|1|||
13415896|NCT00502775|26848523|FG002|Overall Study|Declining pollen counts|1|||
13415897|NCT00502775|26848521|FG000|Overall Study|Subject in jail|0|||
13415898|NCT00502775|26848522|FG001|Overall Study|Subject in jail|1|||
13415899|NCT00502775|26848523|FG002|Overall Study|Subject in jail|0|||
13415900|NCT00502775|26848521|FG000|Overall Study|Subject took disallowed drug|0|||
13415901|NCT00502775|26848522|FG001|Overall Study|Subject took disallowed drug|0|||
13415902|NCT00502775|26848523|FG002|Overall Study|Subject took disallowed drug|1|||
13415903|NCT00502697|26848538|FG000|Overall Study|Withdrawal by Subject|3|||
13415904|NCT00502697|26848539|FG001|Overall Study|Withdrawal by Subject|1|||
13415905|NCT00502697|26848538|FG000|Overall Study|disenrolled due to pregnancy loss|3|||
13415906|NCT00502697|26848539|FG001|Overall Study|disenrolled due to pregnancy loss|5|||
13415907|NCT00502697|26848538|FG000|Overall Study|found not to meet eligibility criteria|3|||
13415908|NCT00502697|26848539|FG001|Overall Study|found not to meet eligibility criteria|4|||
13415909|NCT00502697|26848538|FG000|Overall Study|did not meet assignment criteria|4|||
13415910|NCT00502697|26848539|FG001|Overall Study|did not meet assignment criteria|2|||
13415911|NCT00502671|26848546|FG000|Overall Study|Disease Progression|13|||
13415912|NCT00502671|26848546|FG000|Overall Study|Personal Reasons|22|||
13415913|NCT00502671|26848546|FG000|Overall Study|Lost to Follow-up|7|||
13415914|NCT00502671|26848546|FG000|Overall Study|Protocol Violation|16|||
13415915|NCT00502671|26848546|FG000|Overall Study|Adverse Event|19|||
13415916|NCT00502593|26849097|FG000|Overall Study|Withdrawn unspecified reason|1|||
13415917|NCT00502593|26849098|FG001|Overall Study|Withdrawn unspecified reason|1|||
13415918|NCT00502593|26849099|FG002|Overall Study|Withdrawn unspecified reason|3|||
13415919|NCT00502593|26849100|FG003|Overall Study|Withdrawn unspecified reason|1|||
13415920|NCT00502593|26849101|FG004|Overall Study|Withdrawn unspecified reason|2|||
13415921|NCT00502593|26849102|FG005|Overall Study|Withdrawn unspecified reason|0|||
13415922|NCT00502593|26849103|FG006|Overall Study|Withdrawn unspecified reason|2|||
13415923|NCT00502593|26849104|FG007|Overall Study|Withdrawn unspecified reason|0|||
13415924|NCT00502593|26849105|FG008|Overall Study|Withdrawn unspecified reason|0|||
13415925|NCT00502593|26849106|FG009|Overall Study|Withdrawn unspecified reason|0|||
13415926|NCT00502593|26849107|FG010|Overall Study|Withdrawn unspecified reason|0|||
13415927|NCT00502593|26849108|FG011|Overall Study|Withdrawn unspecified reason|0|||
13415928|NCT00502593|26849097|FG000|Overall Study|Withdrawal by Subject|0|||
13415929|NCT00502593|26849098|FG001|Overall Study|Withdrawal by Subject|0|||
13415930|NCT00502593|26849099|FG002|Overall Study|Withdrawal by Subject|6|||
13415931|NCT00502593|26849100|FG003|Overall Study|Withdrawal by Subject|2|||
13415932|NCT00502593|26849101|FG004|Overall Study|Withdrawal by Subject|2|||
13415933|NCT00502593|26849102|FG005|Overall Study|Withdrawal by Subject|0|||
13415934|NCT00502593|26849103|FG006|Overall Study|Withdrawal by Subject|3|||
13415935|NCT00502593|26849104|FG007|Overall Study|Withdrawal by Subject|0|||
13415936|NCT00502593|26849105|FG008|Overall Study|Withdrawal by Subject|3|||
13415937|NCT00502593|26849106|FG009|Overall Study|Withdrawal by Subject|0|||
13415938|NCT00502593|26849107|FG010|Overall Study|Withdrawal by Subject|1|||
13415939|NCT00502593|26849108|FG011|Overall Study|Withdrawal by Subject|0|||
13415940|NCT00502593|26849097|FG000|Overall Study|Lost to Follow-up|2|||
13415941|NCT00502593|26849098|FG001|Overall Study|Lost to Follow-up|1|||
13415942|NCT00502593|26849099|FG002|Overall Study|Lost to Follow-up|1|||
13415943|NCT00502593|26849100|FG003|Overall Study|Lost to Follow-up|1|||
13415944|NCT00502593|26849101|FG004|Overall Study|Lost to Follow-up|0|||
13415945|NCT00502593|26849102|FG005|Overall Study|Lost to Follow-up|0|||
13415946|NCT00502593|26849103|FG006|Overall Study|Lost to Follow-up|0|||
13415947|NCT00502593|26849104|FG007|Overall Study|Lost to Follow-up|0|||
13415948|NCT00502593|26849105|FG008|Overall Study|Lost to Follow-up|3|||
13415949|NCT00502593|26849106|FG009|Overall Study|Lost to Follow-up|0|||
13415950|NCT00502593|26849107|FG010|Overall Study|Lost to Follow-up|1|||
13415951|NCT00502593|26849108|FG011|Overall Study|Lost to Follow-up|0|||
13415952|NCT00502320|26849125|FG000|Overall Study|Lost to Follow-up|1|||
13415953|NCT00502320|26849126|FG001|Overall Study|Lost to Follow-up|1|||
13415954|NCT00502320|26849125|FG000|Overall Study|Withdrew Consent|1|||
13415955|NCT00502320|26849126|FG001|Overall Study|Withdrew Consent|0|||
13415956|NCT00502320|26849125|FG000|Overall Study|No longer met criteria|1|||
13415957|NCT00502320|26849126|FG001|Overall Study|No longer met criteria|0|||
13415958|NCT00502320|26849125|FG000|Overall Study|Screen Failure|0|||
13415959|NCT00502320|26849126|FG001|Overall Study|Screen Failure|1|||
13415960|NCT00502320|26849125|FG000|Overall Study|Adverse Event|3|||
13415961|NCT00502320|26849126|FG001|Overall Study|Adverse Event|5|||
13415962|NCT00502307|26849155|FG000|Open Label Period (16 Weeks)|Progressive disease|50|||
13415963|NCT00502307|26849156|FG001|Open Label Period (16 Weeks)|Progressive disease|0|||
13415964|NCT00502307|26849157|FG002|Open Label Period (16 Weeks)|Progressive disease|0|||
13415965|NCT00502307|26849155|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26|||
13415966|NCT00502307|26849156|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
13415967|NCT00502307|26849157|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
13415968|NCT00502307|26849155|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0|||
13415969|NCT00502307|26849156|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23|||
13415970|NCT00502307|26849157|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2|||
13415971|NCT00502307|26849155|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0|||
13415972|NCT00502307|26849156|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3|||
13415973|NCT00502307|26849157|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7|||
13415974|NCT00502307|26849155|FG000|Maintenance Period|Progressive disease|80|||
13415975|NCT00502307|26849156|FG001|Maintenance Period|Progressive disease|0|||
13415976|NCT00502307|26849157|FG002|Maintenance Period|Progressive disease|0|||
13415977|NCT00502307|26849155|FG000|Maintenance Period|Discontinued due to other reasons|68|||
13415978|NCT00502307|26849156|FG001|Maintenance Period|Discontinued due to other reasons|0|||
13415979|NCT00502307|26849157|FG002|Maintenance Period|Discontinued due to other reasons|0|||
13415980|NCT00502242|26849215|FG000|Overall Study|Lack of Efficacy|1|||
13415981|NCT00502242|26849216|FG001|Overall Study|Lack of Efficacy|11|||
13415982|NCT00502242|26849215|FG000|Overall Study|Adverse Event|31|||
13415983|NCT00502242|26849216|FG001|Overall Study|Adverse Event|20|||
13415984|NCT00502242|26849215|FG000|Overall Study|Physician Decision|2|||
13415985|NCT00502242|26849216|FG001|Overall Study|Physician Decision|3|||
13415986|NCT00502242|26849215|FG000|Overall Study|Other - Unspecified|8|||
13415987|NCT00502242|26849216|FG001|Overall Study|Other - Unspecified|14|||
13415988|NCT00502242|26849215|FG000|Overall Study|Protocol Violation|3|||
13415989|NCT00502242|26849216|FG001|Overall Study|Protocol Violation|1|||
13415990|NCT00502242|26849215|FG000|Overall Study|Withdrawal by Subject|6|||
13415991|NCT00502242|26849216|FG001|Overall Study|Withdrawal by Subject|7|||
13415992|NCT00502203|26849222|FG000|Overall Study|Inevaluable|1|||
13415993|NCT00501969|26849230|FG000|Overall Study|Major Protocol Violation|4|||
13415994|NCT00501969|26849230|FG000|Overall Study|Lack of Efficacy|29|||
13415995|NCT00501969|26849230|FG000|Overall Study|Adverse Event|76|||
13415996|NCT00501969|26849230|FG000|Overall Study|Unsatisfactory compliance of subject|7|||
13415997|NCT00501969|26849230|FG000|Overall Study|Subject withdrew consent|51|||
13415998|NCT00501969|26849230|FG000|Overall Study|Lost to Follow-up|4|||
13415999|NCT00501969|26849230|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1|||
13416000|NCT00501969|26849230|FG000|Overall Study|Other: Sponsors Request|10|||
13416001|NCT00501969|26849230|FG000|Overall Study|Other: Sponsor Termination at Site|1|||
13416002|NCT00501969|26849230|FG000|Overall Study|Other: Sponsor Stopped Study|12|||
13416003|NCT00501969|26849230|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1|||
13416004|NCT00501969|26849230|FG000|Overall Study|Other: Patients + Investigator Agreement|1|||
13416005|NCT00501969|26849230|FG000|Overall Study|Other: Patient is Going to Have DBS|1|||
13416006|NCT00501969|26849230|FG000|Overall Study|Other: Pat Pending Surgery for PD|1|||
13416007|NCT00501969|26849230|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1|||
13416008|NCT00501969|26849230|FG000|Overall Study|Other: As Required by Local EC|2|||
13416009|NCT00501969|26849230|FG000|Overall Study|Other: Admin Request from the Sponsor|3|||
13416010|NCT00501969|26849230|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1|||
13416011|NCT00501852|26849252|FG000|Overall Study|Adverse Event|3|||
13416012|NCT00501852|26849252|FG000|Overall Study|Withdrawal by Subject|2|||
13416013|NCT00501644|26849258|FG000|Overall Study|Adverse Event|4|||
13416014|NCT00501644|26849258|FG000|Overall Study|Withdrawal by Subject|1|||
13416015|NCT00501540|26849266|FG000|Overall Study|Death|5|||
13416016|NCT00501293|26849300|FG000|Optimization Period|Enrolled in error|1|||
13416017|NCT00501293|26849301|FG001|Optimization Period|Enrolled in error|0|||
13416018|NCT00501293|26849300|FG000|Maintenance Period|Withdrawal by Subject|14|||
13416019|NCT00501293|26849301|FG001|Maintenance Period|Withdrawal by Subject|13|||
13416020|NCT00501293|26849300|FG000|Maintenance Period|Lost to Follow-up|12|||
13416021|NCT00501293|26849301|FG001|Maintenance Period|Lost to Follow-up|7|||
13416022|NCT00501293|26849300|FG000|Maintenance Period|Adverse Event|6|||
13416023|NCT00501293|26849301|FG001|Maintenance Period|Adverse Event|6|||
13416024|NCT00501293|26849300|FG000|Maintenance Period|Protocol Violation|2|||
13416025|NCT00501293|26849301|FG001|Maintenance Period|Protocol Violation|1|||
13416026|NCT00501293|26849300|FG000|Maintenance Period|Lack of Efficacy|4|||
13416027|NCT00501293|26849301|FG001|Maintenance Period|Lack of Efficacy|1|||
13416028|NCT00501293|26849300|FG000|Maintenance Period|Noncompliant with study medication|5|||
13416029|NCT00501293|26849301|FG001|Maintenance Period|Noncompliant with study medication|0|||
13416030|NCT00501293|26849300|FG000|Maintenance Period|Went into rehabilitation|1|||
13416031|NCT00501293|26849301|FG001|Maintenance Period|Went into rehabilitation|0|||
13416032|NCT00501293|26849300|FG000|Maintenance Period|Would not wear patch|1|||
13416033|NCT00501293|26849301|FG001|Maintenance Period|Would not wear patch|0|||
13416034|NCT00501293|26849300|FG000|Maintenance Period|Application site reaction|1|||
13416035|NCT00501293|26849301|FG001|Maintenance Period|Application site reaction|0|||
13416036|NCT00501228|26849307|FG000|Overall Study|Withdrawal by Subject|1|||
13416037|NCT00501085|26849317|FG000|Overall Study|Lost to Follow-up|195|||
13416038|NCT00501085|26849317|FG000|Overall Study|Withdrawal by Subject|34|||
13416039|NCT00501085|26849317|FG000|Overall Study|Subject Decision|1|||
13416040|NCT00501085|26849317|FG000|Overall Study|Revision Surgery|7|||
13416041|NCT00501085|26849317|FG000|Overall Study|Explantation Surgery|26|||
13416042|NCT00501085|26849317|FG000|Overall Study|Adverse Event|4|||
13416043|NCT00501085|26849317|FG000|Overall Study|Non-Compliance|24|||
13416044|NCT00501085|26849317|FG000|Overall Study|Study closed by sponsor|109|||
13416045|NCT00501085|26849317|FG000|Overall Study|Other loss to follow-up|32|||
13416046|NCT00501059|26849346|FG000|Overall Study|Protocol Violation|80|||
13416047|NCT00501059|26849347|FG001|Overall Study|Protocol Violation|69|||
13416048|NCT00501059|26849346|FG000|Overall Study|Death|140|||
13416049|NCT00501059|26849347|FG001|Overall Study|Death|137|||
13416050|NCT00501059|26849346|FG000|Overall Study|Other|236|||
13416051|NCT00501059|26849347|FG001|Overall Study|Other|239|||
13416052|NCT00501059|26849346|FG000|Overall Study|Missing end-of-study page|91|||
13416053|NCT00501059|26849347|FG001|Overall Study|Missing end-of-study page|92|||
13416054|NCT00501059|26849346|FG000|Overall Study|Clinical endpoint reached|110|||
13416055|NCT00501059|26849347|FG001|Overall Study|Clinical endpoint reached|123|||
13416056|NCT00501059|26849346|FG000|Overall Study|Insufficient therapeutic effect|4|||
13416057|NCT00501059|26849347|FG001|Overall Study|Insufficient therapeutic effect|5|||
13416058|NCT00501059|26849346|FG000|Overall Study|Consent withdrawn by subject|817|||
13416059|NCT00501059|26849347|FG001|Overall Study|Consent withdrawn by subject|873|||
13416060|NCT00501059|26849346|FG000|Overall Study|Non-compliant with study treatment|23|||
13416061|NCT00501059|26849347|FG001|Overall Study|Non-compliant with study treatment|16|||
13416062|NCT00501059|26849346|FG000|Overall Study|Reason not given|3|||
13416063|NCT00501059|26849347|FG001|Overall Study|Reason not given|1|||
13416064|NCT00501059|26849346|FG000|Overall Study|Adverse Event|129|||
13416065|NCT00501059|26849347|FG001|Overall Study|Adverse Event|122|||
13416066|NCT00501059|26849346|FG000|Overall Study|Lost to Follow-up|210|||
13416067|NCT00501059|26849347|FG001|Overall Study|Lost to Follow-up|198|||
13416068|NCT00501059|26849346|FG000|Overall Study|Not treated|25|||
13416069|NCT00501059|26849347|FG001|Overall Study|Not treated|17|||
13416070|NCT00501046|26849376|FG000|Overall Study|Adverse Event|21|||
13416071|NCT00501046|26849377|FG001|Overall Study|Adverse Event|25|||
13416072|NCT00501046|26849376|FG000|Overall Study|Death|23|||
13416073|NCT00501046|26849377|FG001|Overall Study|Death|30|||
13416074|NCT00501046|26849376|FG000|Overall Study|Lost to Follow-up|14|||
13416075|NCT00501046|26849377|FG001|Overall Study|Lost to Follow-up|13|||
13416076|NCT00501046|26849376|FG000|Overall Study|Physician Decision|7|||
13416077|NCT00501046|26849377|FG001|Overall Study|Physician Decision|2|||
13416078|NCT00501046|26849376|FG000|Overall Study|Pregnancy|0|||
13416079|NCT00501046|26849377|FG001|Overall Study|Pregnancy|3|||
13416080|NCT00501046|26849376|FG000|Overall Study|Protocol Violation|2|||
13416081|NCT00501046|26849377|FG001|Overall Study|Protocol Violation|1|||
13416082|NCT00501046|26849376|FG000|Overall Study|Withdrawal by Subject|84|||
13416083|NCT00501046|26849377|FG001|Overall Study|Withdrawal by Subject|83|||
13416084|NCT00501046|26849376|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119|||
13416085|NCT00501046|26849377|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137|||
13416086|NCT00501007|26849386|FG000|Overall Study|Inclusion criteria not met.|29|||
13416087|NCT00501007|26849387|FG001|Overall Study|Inclusion criteria not met.|25|||
13416088|NCT00500903|26849576|FG000|Overall Study|Occurrence of Adverse Event(s)|10|||
13416089|NCT00500903|26849577|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
13416090|NCT00500903|26849578|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
13416091|NCT00500903|26849576|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
13416092|NCT00500903|26849577|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
13416093|NCT00500903|26849578|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
13416094|NCT00500903|26849576|FG000|Overall Study|Progressive Disease|41|||
13416095|NCT00500903|26849577|FG001|Overall Study|Progressive Disease|2|||
13416096|NCT00500903|26849578|FG002|Overall Study|Progressive Disease|15|||
13416097|NCT00500903|26849576|FG000|Overall Study|Patient Declined Further Treatment|0|||
13416098|NCT00500903|26849577|FG001|Overall Study|Patient Declined Further Treatment|0|||
13416099|NCT00500903|26849578|FG002|Overall Study|Patient Declined Further Treatment|3|||
13416100|NCT00500903|26849576|FG000|Overall Study|Symptomatic Deterioration|2|||
13416101|NCT00500903|26849577|FG001|Overall Study|Symptomatic Deterioration|0|||
13416102|NCT00500903|26849578|FG002|Overall Study|Symptomatic Deterioration|0|||
13416103|NCT00500903|26849576|FG000|Overall Study|Reason Not Specified|10|||
13416104|NCT00500903|26849577|FG001|Overall Study|Reason Not Specified|0|||
13416105|NCT00500903|26849578|FG002|Overall Study|Reason Not Specified|2|||
13416106|NCT00500760|26849603|FG000|Overall Study|Death|32|||
13416107|NCT00500760|26849604|FG001|Overall Study|Death|15|||
13416108|NCT00500760|26849603|FG000|Overall Study|Withdrawal by Subject|5|||
13416109|NCT00500760|26849604|FG001|Overall Study|Withdrawal by Subject|7|||
13416110|NCT00500760|26849603|FG000|Overall Study|Administrative decision|2|||
13416111|NCT00500760|26849604|FG001|Overall Study|Administrative decision|0|||
13416112|NCT00500760|26849603|FG000|Overall Study|Lost to Follow-up|3|||
13416113|NCT00500760|26849604|FG001|Overall Study|Lost to Follow-up|0|||
13416114|NCT00500760|26849603|FG000|Overall Study|Other|1|||
13416115|NCT00500760|26849604|FG001|Overall Study|Other|2|||
13416116|NCT00500682|26849633|FG000|Overall Study|Adverse Event|37|||
13416117|NCT00500682|26849634|FG001|Overall Study|Adverse Event|29|||
13416118|NCT00500682|26849633|FG000|Overall Study|Death|25|||
13416119|NCT00500682|26849634|FG001|Overall Study|Death|16|||
13416120|NCT00500682|26849633|FG000|Overall Study|Lost to Follow-up|11|||
13416121|NCT00500682|26849634|FG001|Overall Study|Lost to Follow-up|11|||
13416122|NCT00500682|26849633|FG000|Overall Study|Physician Decision|6|||
13416123|NCT00500682|26849634|FG001|Overall Study|Physician Decision|10|||
13416124|NCT00500682|26849633|FG000|Overall Study|Pregnancy|2|||
13416125|NCT00500682|26849634|FG001|Overall Study|Pregnancy|0|||
13416126|NCT00500682|26849633|FG000|Overall Study|Protocol Violation|1|||
13416127|NCT00500682|26849634|FG001|Overall Study|Protocol Violation|3|||
13416128|NCT00500682|26849633|FG000|Overall Study|Withdrawal by Subject|80|||
13416129|NCT00500682|26849634|FG001|Overall Study|Withdrawal by Subject|74|||
13416130|NCT00500682|26849633|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
13416131|NCT00500682|26849634|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
13416132|NCT00500539|26849643|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
13416133|NCT00500539|26849643|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1|||
13416134|NCT00500539|26849643|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1|||
13416135|NCT00500539|26849643|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2|||
13416136|NCT00500539|26849643|FG000|Treatment Period (24 Weeks)|Administrative problems|2|||
13416137|NCT00500539|26849643|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5|||
13416138|NCT00500539|26849643|FG000|Follow-up Period (16 Weeks)|Adverse Event|1|||
13416139|NCT00500539|26849643|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2|||
13416140|NCT00500539|26849643|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3|||
13416141|NCT00500539|26849643|FG000|Follow-up Period (16 Weeks)|Administrative problems|1|||
13416142|NCT00500539|26849643|FG000|Follow-up Period (16 Weeks)|Death|1|||
13416143|NCT00500539|26849643|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1|||
13416144|NCT00500539|26849643|FG000|Follow-up Period (16 Weeks)|Missing|3|||
13416145|NCT00500370|26849686|FG000|Overall Study|Adverse Event|9|||
13416146|NCT00500370|26849687|FG001|Overall Study|Adverse Event|3|||
13416147|NCT00500370|26849686|FG000|Overall Study|Lost to Follow-up|10|||
13416148|NCT00500370|26849687|FG001|Overall Study|Lost to Follow-up|10|||
13416149|NCT00500370|26849686|FG000|Overall Study|Protocol Violation|2|||
13416150|NCT00500370|26849687|FG001|Overall Study|Protocol Violation|4|||
13416151|NCT00500370|26849686|FG000|Overall Study|Sponsor Decision|2|||
13416152|NCT00500370|26849687|FG001|Overall Study|Sponsor Decision|0|||
13416153|NCT00500370|26849686|FG000|Overall Study|Subject Decision|10|||
13416154|NCT00500370|26849687|FG001|Overall Study|Subject Decision|17|||
13416155|NCT00500357|26849708|FG000|Overall Study|Death|1|||
13416156|NCT00500331|26849865|FG000|Overall Study|Adverse Event|0|||
13416157|NCT00500331|26849866|FG001|Overall Study|Adverse Event|2|||
13416158|NCT00500331|26849867|FG002|Overall Study|Adverse Event|0|||
13416159|NCT00500331|26849868|FG003|Overall Study|Adverse Event|1|||
13416160|NCT00500331|26849869|FG004|Overall Study|Adverse Event|2|||
13416161|NCT00500331|26849870|FG005|Overall Study|Adverse Event|2|||
13416162|NCT00500331|26849871|FG006|Overall Study|Adverse Event|0|||
13416163|NCT00500331|26849865|FG000|Overall Study|Lost to Follow-up|1|||
13416164|NCT00500331|26849866|FG001|Overall Study|Lost to Follow-up|1|||
13416165|NCT00500331|26849867|FG002|Overall Study|Lost to Follow-up|1|||
13416166|NCT00500331|26849868|FG003|Overall Study|Lost to Follow-up|2|||
13416167|NCT00500331|26849869|FG004|Overall Study|Lost to Follow-up|1|||
13416168|NCT00500331|26849870|FG005|Overall Study|Lost to Follow-up|0|||
13416169|NCT00500331|26849871|FG006|Overall Study|Lost to Follow-up|0|||
13416170|NCT00500331|26849865|FG000|Overall Study|Protocol Violation|3|||
13416171|NCT00500331|26849866|FG001|Overall Study|Protocol Violation|1|||
13416172|NCT00500331|26849867|FG002|Overall Study|Protocol Violation|1|||
13416173|NCT00500331|26849868|FG003|Overall Study|Protocol Violation|0|||
13416174|NCT00500331|26849869|FG004|Overall Study|Protocol Violation|1|||
13416175|NCT00500331|26849870|FG005|Overall Study|Protocol Violation|1|||
13416176|NCT00500331|26849871|FG006|Overall Study|Protocol Violation|1|||
13416177|NCT00500331|26849865|FG000|Overall Study|Withdrawal by Subject|4|||
13416178|NCT00500331|26849866|FG001|Overall Study|Withdrawal by Subject|0|||
13416179|NCT00500331|26849867|FG002|Overall Study|Withdrawal by Subject|1|||
13416180|NCT00500331|26849868|FG003|Overall Study|Withdrawal by Subject|5|||
13416181|NCT00500331|26849869|FG004|Overall Study|Withdrawal by Subject|0|||
13416182|NCT00500331|26849870|FG005|Overall Study|Withdrawal by Subject|1|||
13416183|NCT00500331|26849871|FG006|Overall Study|Withdrawal by Subject|1|||
13416184|NCT00500331|26849865|FG000|Overall Study|Lack of Efficacy|3|||
13416185|NCT00500331|26849866|FG001|Overall Study|Lack of Efficacy|1|||
13416186|NCT00500331|26849867|FG002|Overall Study|Lack of Efficacy|0|||
13416187|NCT00500331|26849868|FG003|Overall Study|Lack of Efficacy|0|||
13416188|NCT00500331|26849869|FG004|Overall Study|Lack of Efficacy|0|||
13416189|NCT00500331|26849870|FG005|Overall Study|Lack of Efficacy|0|||
13416190|NCT00500331|26849871|FG006|Overall Study|Lack of Efficacy|0|||
13416191|NCT00500331|26849865|FG000|Overall Study|Liver function test abnormality|0|||
13416192|NCT00500331|26849866|FG001|Overall Study|Liver function test abnormality|0|||
13416193|NCT00500331|26849867|FG002|Overall Study|Liver function test abnormality|1|||
13416194|NCT00500331|26849868|FG003|Overall Study|Liver function test abnormality|0|||
13416195|NCT00500331|26849869|FG004|Overall Study|Liver function test abnormality|0|||
13416196|NCT00500331|26849870|FG005|Overall Study|Liver function test abnormality|0|||
13416197|NCT00500331|26849871|FG006|Overall Study|Liver function test abnormality|0|||
13416198|NCT00500331|26849865|FG000|Overall Study|Increased serum creatinine from Baseline|0|||
13416199|NCT00500331|26849866|FG001|Overall Study|Increased serum creatinine from Baseline|0|||
13416200|NCT00500331|26849867|FG002|Overall Study|Increased serum creatinine from Baseline|0|||
13416201|NCT00500331|26849868|FG003|Overall Study|Increased serum creatinine from Baseline|0|||
13416202|NCT00500331|26849869|FG004|Overall Study|Increased serum creatinine from Baseline|0|||
13416203|NCT00500331|26849870|FG005|Overall Study|Increased serum creatinine from Baseline|1|||
13416204|NCT00500331|26849871|FG006|Overall Study|Increased serum creatinine from Baseline|0|||
13416205|NCT00500331|26849865|FG000|Overall Study|Didn't return for continuation of study|1|||
13416206|NCT00500331|26849866|FG001|Overall Study|Didn't return for continuation of study|0|||
13416207|NCT00500331|26849867|FG002|Overall Study|Didn't return for continuation of study|0|||
13416208|NCT00500331|26849868|FG003|Overall Study|Didn't return for continuation of study|0|||
13416209|NCT00500331|26849869|FG004|Overall Study|Didn't return for continuation of study|0|||
13416210|NCT00500331|26849870|FG005|Overall Study|Didn't return for continuation of study|0|||
13416211|NCT00500331|26849871|FG006|Overall Study|Didn't return for continuation of study|0|||
13416212|NCT00500331|26849865|FG000|Overall Study|Exclusion citeria not met on Visit 4|1|||
13416213|NCT00500331|26849866|FG001|Overall Study|Exclusion citeria not met on Visit 4|0|||
13416214|NCT00500331|26849867|FG002|Overall Study|Exclusion citeria not met on Visit 4|0|||
13416215|NCT00500331|26849868|FG003|Overall Study|Exclusion citeria not met on Visit 4|0|||
13416216|NCT00500331|26849869|FG004|Overall Study|Exclusion citeria not met on Visit 4|0|||
13416217|NCT00500331|26849870|FG005|Overall Study|Exclusion citeria not met on Visit 4|0|||
13416218|NCT00500331|26849871|FG006|Overall Study|Exclusion citeria not met on Visit 4|0|||
13416219|NCT00500331|26849865|FG000|Overall Study|Sponsor decided to withdraw participant|1|||
13416220|NCT00500331|26849866|FG001|Overall Study|Sponsor decided to withdraw participant|0|||
13416221|NCT00500331|26849867|FG002|Overall Study|Sponsor decided to withdraw participant|0|||
13416222|NCT00500331|26849868|FG003|Overall Study|Sponsor decided to withdraw participant|0|||
13416223|NCT00500331|26849869|FG004|Overall Study|Sponsor decided to withdraw participant|0|||
13416224|NCT00500331|26849870|FG005|Overall Study|Sponsor decided to withdraw participant|0|||
13416225|NCT00500331|26849871|FG006|Overall Study|Sponsor decided to withdraw participant|0|||
13416226|NCT00500331|26849865|FG000|Overall Study|Participant was randomized by mistake|1|||
13416227|NCT00500331|26849866|FG001|Overall Study|Participant was randomized by mistake|0|||
13416228|NCT00500331|26849867|FG002|Overall Study|Participant was randomized by mistake|0|||
13416229|NCT00500331|26849868|FG003|Overall Study|Participant was randomized by mistake|0|||
13416230|NCT00500331|26849869|FG004|Overall Study|Participant was randomized by mistake|0|||
13416231|NCT00500331|26849870|FG005|Overall Study|Participant was randomized by mistake|0|||
13416232|NCT00500331|26849871|FG006|Overall Study|Participant was randomized by mistake|0|||
13416233|NCT00500331|26849865|FG000|Overall Study|Diabetologist nurse in the study|0|||
13416234|NCT00500331|26849866|FG001|Overall Study|Diabetologist nurse in the study|0|||
13416235|NCT00500331|26849867|FG002|Overall Study|Diabetologist nurse in the study|1|||
13416236|NCT00500331|26849868|FG003|Overall Study|Diabetologist nurse in the study|0|||
13416237|NCT00500331|26849869|FG004|Overall Study|Diabetologist nurse in the study|0|||
13416238|NCT00500331|26849870|FG005|Overall Study|Diabetologist nurse in the study|0|||
13416239|NCT00500331|26849871|FG006|Overall Study|Diabetologist nurse in the study|0|||
13416240|NCT00500331|26849865|FG000|Overall Study|State ban of biological samples export|0|||
13416241|NCT00500331|26849866|FG001|Overall Study|State ban of biological samples export|0|||
13416242|NCT00500331|26849867|FG002|Overall Study|State ban of biological samples export|0|||
13416243|NCT00500331|26849868|FG003|Overall Study|State ban of biological samples export|1|||
13416244|NCT00500331|26849869|FG004|Overall Study|State ban of biological samples export|0|||
13416245|NCT00500331|26849870|FG005|Overall Study|State ban of biological samples export|0|||
13416246|NCT00500331|26849871|FG006|Overall Study|State ban of biological samples export|0|||
13416247|NCT00500331|26849865|FG000|Overall Study|Protocol violated|0|||
13416248|NCT00500331|26849866|FG001|Overall Study|Protocol violated|0|||
13416249|NCT00500331|26849867|FG002|Overall Study|Protocol violated|0|||
13416250|NCT00500331|26849868|FG003|Overall Study|Protocol violated|1|||
13416251|NCT00500331|26849869|FG004|Overall Study|Protocol violated|0|||
13416252|NCT00500331|26849870|FG005|Overall Study|Protocol violated|0|||
13416253|NCT00500331|26849871|FG006|Overall Study|Protocol violated|0|||
13416254|NCT00500318|26849892|FG000|Overall Study|Adverse Event|3|||
13416255|NCT00500318|26849893|FG001|Overall Study|Adverse Event|8|||
13416256|NCT00500318|26849892|FG000|Overall Study|Protocol Violation|1|||
13416257|NCT00500318|26849893|FG001|Overall Study|Protocol Violation|3|||
13416258|NCT00500318|26849892|FG000|Overall Study|Withdrawal by Subject|1|||
13416259|NCT00500318|26849893|FG001|Overall Study|Withdrawal by Subject|2|||
13416260|NCT00500318|26849892|FG000|Overall Study|Lack of Efficacy|0|||
13416261|NCT00500318|26849893|FG001|Overall Study|Lack of Efficacy|3|||
13416262|NCT00500318|26849892|FG000|Overall Study|Other Reason|0|||
13416263|NCT00500318|26849893|FG001|Overall Study|Other Reason|1|||
13416264|NCT00500292|26849911|FG000|Overall Study|Adverse Event|3|||
13416265|NCT00500292|26849912|FG001|Overall Study|Adverse Event|6|||
13416266|NCT00500292|26849913|FG002|Overall Study|Adverse Event|4|||
13416267|NCT00500292|26849911|FG000|Overall Study|Condition under investigation worsened|21|||
13416268|NCT00500292|26849912|FG001|Overall Study|Condition under investigation worsened|23|||
13416269|NCT00500292|26849913|FG002|Overall Study|Condition under investigation worsened|19|||
13416270|NCT00500292|26849911|FG000|Overall Study|Withdrawal by Subject|0|||
13416271|NCT00500292|26849912|FG001|Overall Study|Withdrawal by Subject|1|||
13416272|NCT00500292|26849913|FG002|Overall Study|Withdrawal by Subject|0|||
13416273|NCT00500292|26849911|FG000|Overall Study|Other|1|||
13416274|NCT00500292|26849912|FG001|Overall Study|Other|1|||
13416275|NCT00500292|26849913|FG002|Overall Study|Other|4|||
13416276|NCT00500266|26849922|FG000|Overall Study|Death|3|||
13416277|NCT00500266|26849922|FG000|Overall Study|Lost to Follow-up|3|||
13416278|NCT00500266|26849922|FG000|Overall Study|Withdrawal by Subject|3|||
13416279|NCT00500266|26849922|FG000|Overall Study|Assigned, not treated|4|||
13416280|NCT00500149|26849933|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3|||
13416281|NCT00500149|26849934|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0|||
13416282|NCT00500149|26849933|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8|||
13416283|NCT00500149|26849934|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0|||
13416284|NCT00500149|26849933|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1|||
13416285|NCT00500149|26849934|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0|||
13416286|NCT00500149|26849933|FG000|First Intervention (Cross-over Phase)|Adverse Event|0|||
13416287|NCT00500149|26849934|FG001|First Intervention (Cross-over Phase)|Adverse Event|1|||
13416288|NCT00500149|26849933|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
13416289|NCT00500149|26849934|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
13416290|NCT00500149|26849933|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1|||
13416291|NCT00500149|26849934|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0|||
13416292|NCT00500149|26849933|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2|||
13416293|NCT00500149|26849934|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0|||
13416294|NCT00500110|26849940|FG000|Overall Study|Withdrawal by Subject|3|||
13416295|NCT00499889|26849948|FG000|Overall Study|Infection prior to treatment|1|||
13416296|NCT00499863|26849983|FG000|Overall Study|Lack of Efficacy|21|||
13416297|NCT00499863|26849984|FG001|Overall Study|Lack of Efficacy|27|||
13416298|NCT00499863|26849983|FG000|Overall Study|Protocol Violation|12|||
13416299|NCT00499863|26849984|FG001|Overall Study|Protocol Violation|7|||
13416300|NCT00499863|26849983|FG000|Overall Study|Withdrawal by Subject|6|||
13416301|NCT00499863|26849984|FG001|Overall Study|Withdrawal by Subject|4|||
13416302|NCT00499863|26849983|FG000|Overall Study|Adverse Event|8|||
13416303|NCT00499863|26849984|FG001|Overall Study|Adverse Event|2|||
13416304|NCT00499863|26849983|FG000|Overall Study|Sponsor decision|2|||
13416305|NCT00499863|26849984|FG001|Overall Study|Sponsor decision|2|||
13416306|NCT00499863|26849983|FG000|Overall Study|Lost to Follow-up|1|||
13416307|NCT00499863|26849984|FG001|Overall Study|Lost to Follow-up|1|||
13416308|NCT00499746|26850055|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7|||
13416309|NCT00499746|26850055|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3|||
13416310|NCT00499746|26850055|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1|||
13416311|NCT00499746|26850055|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1|||
13416312|NCT00499694|26850064|FG000|Overall Study|Patient never received treatment.|1|||
13416313|NCT00499681|26850077|FG000|Overall Study|toxicity|0|||
13416314|NCT00499681|26850078|FG001|Overall Study|toxicity|1|||
13416315|NCT00499681|26850077|FG000|Overall Study|disease progression|0|||
13416316|NCT00499681|26850078|FG001|Overall Study|disease progression|1|||
13416317|NCT00499616|26850134|FG000|Overall Study|Death|1|||
13416318|NCT00499616|26850135|FG001|Overall Study|Death|5|||
13416319|NCT00499616|26850136|FG002|Overall Study|Death|3|||
13416320|NCT00499616|26850137|FG003|Overall Study|Death|1|||
13416321|NCT00499616|26850134|FG000|Overall Study|Lack of Efficacy|5|||
13416322|NCT00499616|26850135|FG001|Overall Study|Lack of Efficacy|0|||
13416323|NCT00499616|26850136|FG002|Overall Study|Lack of Efficacy|19|||
13416324|NCT00499616|26850137|FG003|Overall Study|Lack of Efficacy|0|||
13416325|NCT00499616|26850134|FG000|Overall Study|Lost to Follow-up|0|||
13416326|NCT00499616|26850135|FG001|Overall Study|Lost to Follow-up|0|||
13416327|NCT00499616|26850136|FG002|Overall Study|Lost to Follow-up|1|||
13416328|NCT00499616|26850137|FG003|Overall Study|Lost to Follow-up|0|||
13416329|NCT00499616|26850134|FG000|Overall Study|Physician Decision|6|||
13416330|NCT00499616|26850135|FG001|Overall Study|Physician Decision|16|||
13416331|NCT00499616|26850136|FG002|Overall Study|Physician Decision|9|||
13416332|NCT00499616|26850137|FG003|Overall Study|Physician Decision|0|||
13416333|NCT00499616|26850134|FG000|Overall Study|Withdrawal by Subject|1|||
13416334|NCT00499616|26850135|FG001|Overall Study|Withdrawal by Subject|0|||
13416335|NCT00499616|26850136|FG002|Overall Study|Withdrawal by Subject|1|||
13416336|NCT00499616|26850137|FG003|Overall Study|Withdrawal by Subject|0|||
13416337|NCT00499616|26850134|FG000|Overall Study|Ineligible|1|||
13416338|NCT00499616|26850135|FG001|Overall Study|Ineligible|2|||
13416339|NCT00499616|26850136|FG002|Overall Study|Ineligible|0|||
13416340|NCT00499616|26850137|FG003|Overall Study|Ineligible|15|||
13416341|NCT00499616|26850134|FG000|Overall Study|Not evaluable|0|||
13416342|NCT00499616|26850135|FG001|Overall Study|Not evaluable|0|||
13416343|NCT00499616|26850136|FG002|Overall Study|Not evaluable|0|||
13416344|NCT00499616|26850137|FG003|Overall Study|Not evaluable|41|||
13416345|NCT00499616|26850134|FG000|Overall Study|Patient/Parent Refusal|1|||
13416346|NCT00499616|26850135|FG001|Overall Study|Patient/Parent Refusal|5|||
13416347|NCT00499616|26850136|FG002|Overall Study|Patient/Parent Refusal|3|||
13416348|NCT00499616|26850137|FG003|Overall Study|Patient/Parent Refusal|0|||
13416349|NCT00499603|26850154|FG000|Overall Study|Adverse Event|0|||
13416350|NCT00499603|26850155|FG001|Overall Study|Adverse Event|1|||
13416351|NCT00499590|26850176|FG000|Overall Study|Study Terminated|112|||
13416352|NCT00499590|26850177|FG001|Overall Study|Study Terminated|112|||
13416353|NCT00499590|26850178|FG002|Overall Study|Study Terminated|112|||
13416354|NCT00499590|26850176|FG000|Overall Study|Not treated|1|||
13416355|NCT00499590|26850177|FG001|Overall Study|Not treated|0|||
13416356|NCT00499590|26850178|FG002|Overall Study|Not treated|1|||
13416357|NCT00499486|26850186|FG000|Overall Study|Withdrawal by Subject|16|||
13416358|NCT00499460|26850209|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1|||
13416359|NCT00499460|26850210|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0|||
13416360|NCT00499460|26850209|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1|||
13416361|NCT00499460|26850210|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0|||
13416362|NCT00499460|26850209|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0|||
13416363|NCT00499460|26850210|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1|||
13416364|NCT00499369|26850253|FG000|Overall Study|Adverse Event|2|||
13416365|NCT00499369|26850254|FG001|Overall Study|Adverse Event|2|||
13416366|NCT00499369|26850255|FG002|Overall Study|Adverse Event|3|||
13416367|NCT00499369|26850256|FG003|Overall Study|Adverse Event|1|||
13416368|NCT00499369|26850257|FG004|Overall Study|Adverse Event|2|||
13416369|NCT00499369|26850253|FG000|Overall Study|Withdrawal by Subject|0|||
13416370|NCT00499369|26850254|FG001|Overall Study|Withdrawal by Subject|1|||
13416371|NCT00499369|26850255|FG002|Overall Study|Withdrawal by Subject|1|||
13416372|NCT00499369|26850256|FG003|Overall Study|Withdrawal by Subject|0|||
13416373|NCT00499369|26850257|FG004|Overall Study|Withdrawal by Subject|0|||
13416374|NCT00499369|26850253|FG000|Overall Study|Progression|10|||
13416375|NCT00499369|26850254|FG001|Overall Study|Progression|12|||
13416376|NCT00499369|26850255|FG002|Overall Study|Progression|9|||
13416377|NCT00499369|26850256|FG003|Overall Study|Progression|6|||
13416378|NCT00499369|26850257|FG004|Overall Study|Progression|10|||
13416379|NCT00499369|26850253|FG000|Overall Study|Death|0|||
13416380|NCT00499369|26850254|FG001|Overall Study|Death|1|||
13416381|NCT00499369|26850255|FG002|Overall Study|Death|0|||
13416382|NCT00499369|26850256|FG003|Overall Study|Death|0|||
13416383|NCT00499369|26850257|FG004|Overall Study|Death|0|||
13416384|NCT00499369|26850253|FG000|Overall Study|Not protocol specified|2|||
13416385|NCT00499369|26850254|FG001|Overall Study|Not protocol specified|0|||
13416386|NCT00499369|26850255|FG002|Overall Study|Not protocol specified|3|||
13416387|NCT00499369|26850256|FG003|Overall Study|Not protocol specified|1|||
13416388|NCT00499369|26850257|FG004|Overall Study|Not protocol specified|0|||
13416389|NCT00499369|26850253|FG000|Overall Study|Ineligible|2|||
13416390|NCT00499369|26850254|FG001|Overall Study|Ineligible|2|||
13416391|NCT00499369|26850255|FG002|Overall Study|Ineligible|1|||
13416392|NCT00499369|26850256|FG003|Overall Study|Ineligible|1|||
13416393|NCT00499369|26850257|FG004|Overall Study|Ineligible|0|||
13416394|NCT00499252|26850269|FG000|Overall Study|Adverse Event|3|||
13416395|NCT00499252|26850269|FG000|Overall Study|Refused further treatment|2|||
13416396|NCT00499252|26850269|FG000|Overall Study|Ineligible|4|||
13416397|NCT00499252|26850269|FG000|Overall Study|<no further label>|3|||
13416398|NCT00499174|26850284|FG000|Overall Study|Physician Decision|78|||
13416399|NCT00499174|26850285|FG001|Overall Study|Physician Decision|9|||
13416400|NCT00499122|26850293|FG000|Overall Study|Withdrawal by Subject|2|||
13416401|NCT00499083|26850302|FG000|Overall Study|Not evaluable|3|||
13416402|NCT00499031|26850309|FG000|Overall Study|Improper pre-protocol treatment|1|||
13416403|NCT00499031|26850309|FG000|Overall Study|Required test not done|1|||
13416404|NCT00499031|26850309|FG000|Overall Study|Never treated|1|||
13416405|NCT00498797|26850324|FG000|Overall Study|Withdrawal by Subject|4|||
13416406|NCT00498797|26850325|FG001|Overall Study|Withdrawal by Subject|2|||
13416407|NCT00498797|26850324|FG000|Overall Study|Adverse Event|12|||
13416408|NCT00498797|26850325|FG001|Overall Study|Adverse Event|5|||
13416409|NCT00498797|26850324|FG000|Overall Study|Condition under investigation worsened|19|||
13416410|NCT00498797|26850325|FG001|Overall Study|Condition under investigation worsened|21|||
13416411|NCT00498797|26850324|FG000|Overall Study|Other|3|||
13416412|NCT00498797|26850325|FG001|Overall Study|Other|1|||
13416413|NCT00498602|26850384|FG000|Overall Study|Death|0|||
13416414|NCT00498602|26850385|FG001|Overall Study|Death|0|||
13416415|NCT00498602|26850386|FG002|Overall Study|Death|0|||
13416416|NCT00498602|26850387|FG003|Overall Study|Death|0|||
13416417|NCT00498602|26850388|FG004|Overall Study|Death|0|||
13416418|NCT00498602|26850389|FG005|Overall Study|Death|1|||
13416419|NCT00498602|26850390|FG006|Overall Study|Death|0|||
13416420|NCT00498602|26850384|FG000|Overall Study|Lack of Efficacy|1|||
13416421|NCT00498602|26850385|FG001|Overall Study|Lack of Efficacy|0|||
13416422|NCT00498602|26850386|FG002|Overall Study|Lack of Efficacy|0|||
13416423|NCT00498602|26850387|FG003|Overall Study|Lack of Efficacy|0|||
13416424|NCT00498602|26850388|FG004|Overall Study|Lack of Efficacy|0|||
13416425|NCT00498602|26850389|FG005|Overall Study|Lack of Efficacy|0|||
13416426|NCT00498602|26850390|FG006|Overall Study|Lack of Efficacy|0|||
13416427|NCT00498602|26850384|FG000|Overall Study|Lost to Follow-up|0|||
13416428|NCT00498602|26850385|FG001|Overall Study|Lost to Follow-up|2|||
13416429|NCT00498602|26850386|FG002|Overall Study|Lost to Follow-up|0|||
13416430|NCT00498602|26850387|FG003|Overall Study|Lost to Follow-up|2|||
13416431|NCT00498602|26850388|FG004|Overall Study|Lost to Follow-up|0|||
13416432|NCT00498602|26850389|FG005|Overall Study|Lost to Follow-up|0|||
13416433|NCT00498602|26850390|FG006|Overall Study|Lost to Follow-up|0|||
13416434|NCT00498602|26850384|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
13416435|NCT00498602|26850385|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
13416436|NCT00498602|26850386|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
13416437|NCT00498602|26850387|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
13416438|NCT00498602|26850388|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
13416439|NCT00498602|26850389|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
13416440|NCT00498602|26850390|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
13416441|NCT00498602|26850384|FG000|Overall Study|AE not related to Study Drug|1|||
13416442|NCT00498602|26850385|FG001|Overall Study|AE not related to Study Drug|3|||
13416443|NCT00498602|26850386|FG002|Overall Study|AE not related to Study Drug|0|||
13416444|NCT00498602|26850387|FG003|Overall Study|AE not related to Study Drug|0|||
13416445|NCT00498602|26850388|FG004|Overall Study|AE not related to Study Drug|2|||
13416446|NCT00498602|26850389|FG005|Overall Study|AE not related to Study Drug|2|||
13416447|NCT00498602|26850390|FG006|Overall Study|AE not related to Study Drug|1|||
13416448|NCT00498602|26850384|FG000|Overall Study|Caregiver Request|2|||
13416449|NCT00498602|26850385|FG001|Overall Study|Caregiver Request|2|||
13416450|NCT00498602|26850386|FG002|Overall Study|Caregiver Request|2|||
13416451|NCT00498602|26850387|FG003|Overall Study|Caregiver Request|0|||
13416452|NCT00498602|26850388|FG004|Overall Study|Caregiver Request|1|||
13416453|NCT00498602|26850389|FG005|Overall Study|Caregiver Request|2|||
13416454|NCT00498602|26850390|FG006|Overall Study|Caregiver Request|0|||
13416455|NCT00498602|26850384|FG000|Overall Study|Investigator Request|0|||
13416456|NCT00498602|26850385|FG001|Overall Study|Investigator Request|0|||
13416457|NCT00498602|26850386|FG002|Overall Study|Investigator Request|1|||
13416458|NCT00498602|26850387|FG003|Overall Study|Investigator Request|0|||
13416459|NCT00498602|26850388|FG004|Overall Study|Investigator Request|0|||
13416460|NCT00498602|26850389|FG005|Overall Study|Investigator Request|0|||
13416461|NCT00498602|26850390|FG006|Overall Study|Investigator Request|0|||
13416462|NCT00498602|26850384|FG000|Overall Study|Subject Request|3|||
13416463|NCT00498602|26850385|FG001|Overall Study|Subject Request|0|||
13416464|NCT00498602|26850386|FG002|Overall Study|Subject Request|1|||
13416465|NCT00498602|26850387|FG003|Overall Study|Subject Request|1|||
13416466|NCT00498602|26850388|FG004|Overall Study|Subject Request|1|||
13416467|NCT00498602|26850389|FG005|Overall Study|Subject Request|4|||
13416468|NCT00498602|26850390|FG006|Overall Study|Subject Request|1|||
13416469|NCT00498602|26850384|FG000|Overall Study|Other|2|||
13416470|NCT00498602|26850385|FG001|Overall Study|Other|3|||
13416471|NCT00498602|26850386|FG002|Overall Study|Other|1|||
13416472|NCT00498602|26850387|FG003|Overall Study|Other|0|||
13416473|NCT00498602|26850388|FG004|Overall Study|Other|0|||
13416474|NCT00498602|26850389|FG005|Overall Study|Other|3|||
13416475|NCT00498602|26850390|FG006|Overall Study|Other|0|||
13416476|NCT00498485|26850405|FG000|Overall Study|Adverse Event|1|||
13416477|NCT00498485|26850406|FG001|Overall Study|Adverse Event|5|||
13416478|NCT00498433|26850459|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2|||
13416479|NCT00498433|26850460|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
13416480|NCT00498433|26850461|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
13416481|NCT00498433|26850459|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2|||
13416482|NCT00498433|26850460|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
13416483|NCT00498433|26850461|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
13416484|NCT00498433|26850459|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15|||
13416485|NCT00498433|26850460|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
13416486|NCT00498433|26850461|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
13416487|NCT00498433|26850459|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1|||
13416488|NCT00498433|26850460|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
13416489|NCT00498433|26850461|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
13416490|NCT00498368|26850480|FG000|Overall Study|Withdrawal by Subject|3|||
13416491|NCT00498368|26850481|FG001|Overall Study|Withdrawal by Subject|2|||
13416492|NCT00498355|26850491|FG000|Overall Study|Lost to Follow-up|1|||
13416493|NCT00498186|26850498|FG000|Overall Study|Protocol Violation|10|||
13416494|NCT00498186|26850498|FG000|Overall Study|Lack of Efficacy|31|||
13416495|NCT00498186|26850498|FG000|Overall Study|Adverse Event|89|||
13416496|NCT00498186|26850498|FG000|Overall Study|Unsatisfactory compliance of subject|12|||
13416497|NCT00498186|26850498|FG000|Overall Study|Withdrawal by Subject|18|||
13416498|NCT00498186|26850498|FG000|Overall Study|Lost to Follow-up|3|||
13416499|NCT00498186|26850498|FG000|Overall Study|Other|10|||
13416500|NCT00498173|26850534|FG000|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|2|||
13416501|NCT00498173|26850535|FG001|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|1|||
13416502|NCT00498173|26850536|FG002|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|0|||
13416503|NCT00497874|26850559|FG000|Overall Study|Withdrawal by Subject|48|||
13416504|NCT00497874|26850560|FG001|Overall Study|Withdrawal by Subject|17|||
13416505|NCT00497874|26850559|FG000|Overall Study|Illness|8|||
13416506|NCT00497874|26850560|FG001|Overall Study|Illness|4|||
13416507|NCT00497874|26850559|FG000|Overall Study|Death|2|||
13416508|NCT00497874|26850560|FG001|Overall Study|Death|4|||
13416509|NCT00497874|26850559|FG000|Overall Study|Unable to contact|52|||
13416510|NCT00497874|26850560|FG001|Overall Study|Unable to contact|67|||
13416511|NCT00497874|26850559|FG000|Overall Study|Unable to schedule|37|||
13416512|NCT00497874|26850560|FG001|Overall Study|Unable to schedule|24|||
13416513|NCT00497796|26850595|FG000|Overall Study|Adverse event (not related)|9|||
13416514|NCT00497796|26850596|FG001|Overall Study|Adverse event (not related)|9|||
13416515|NCT00497796|26850595|FG000|Overall Study|Adverse event (related)|5|||
13416516|NCT00497796|26850596|FG001|Overall Study|Adverse event (related)|4|||
13416517|NCT00497796|26850595|FG000|Overall Study|CMV infection or disease treatment|30|||
13416518|NCT00497796|26850596|FG001|Overall Study|CMV infection or disease treatment|4|||
13416519|NCT00497796|26850595|FG000|Overall Study|Consent withdrawn|10|||
13416520|NCT00497796|26850596|FG001|Overall Study|Consent withdrawn|3|||
13416521|NCT00497796|26850595|FG000|Overall Study|Investigator/sponsor discretion|31|||
13416522|NCT00497796|26850596|FG001|Overall Study|Investigator/sponsor discretion|34|||
13416523|NCT00497796|26850595|FG000|Overall Study|Lost to Follow-up|0|||
13416524|NCT00497796|26850596|FG001|Overall Study|Lost to Follow-up|1|||
13416525|NCT00497796|26850595|FG000|Overall Study|Not applicable (randomized not treated)|0|||
13416526|NCT00497796|26850596|FG001|Overall Study|Not applicable (randomized not treated)|4|||
13416527|NCT00497198|26850617|FG000|Overall Study|Adverse Event|4|||
13416528|NCT00497198|26850618|FG001|Overall Study|Adverse Event|2|||
13416529|NCT00497198|26850617|FG000|Overall Study|Physician Decision|1|||
13416530|NCT00497198|26850618|FG001|Overall Study|Physician Decision|2|||
13416531|NCT00497198|26850617|FG000|Overall Study|Withdrawal by Subject|0|||
13416532|NCT00497198|26850618|FG001|Overall Study|Withdrawal by Subject|1|||
13416533|NCT00497146|26850665|FG000|Treatment Period|Adverse Event|6|||
13416534|NCT00497146|26850666|FG001|Treatment Period|Adverse Event|2|||
13416535|NCT00497146|26850665|FG000|Treatment Period|Withdrawal by Subject|5|||
13416536|NCT00497146|26850666|FG001|Treatment Period|Withdrawal by Subject|9|||
13416537|NCT00497146|26850665|FG000|Treatment Period|Lost to Follow-up|1|||
13416538|NCT00497146|26850666|FG001|Treatment Period|Lost to Follow-up|3|||
13416539|NCT00497146|26850665|FG000|Treatment Period|Required dialysis|4|||
13416540|NCT00497146|26850666|FG001|Treatment Period|Required dialysis|1|||
13416541|NCT00497146|26850665|FG000|Treatment Period|Change in RAAS inhibitor therapy|5|||
13416542|NCT00497146|26850666|FG001|Treatment Period|Change in RAAS inhibitor therapy|2|||
13416543|NCT00497146|26850665|FG000|Treatment Period|Unable to dose reduce per protocol|4|||
13416544|NCT00497146|26850666|FG001|Treatment Period|Unable to dose reduce per protocol|1|||
13416545|NCT00497146|26850665|FG000|Treatment Period|Other Reason|2|||
13416546|NCT00497146|26850666|FG001|Treatment Period|Other Reason|3|||
13416547|NCT00497146|26850665|FG000|Long-term Follow-up Period|Adverse Event|2|||
13416548|NCT00497146|26850666|FG001|Long-term Follow-up Period|Adverse Event|2|||
13416549|NCT00497146|26850665|FG000|Long-term Follow-up Period|Withdrawal by Subject|8|||
13416550|NCT00497146|26850666|FG001|Long-term Follow-up Period|Withdrawal by Subject|2|||
13416551|NCT00497146|26850665|FG000|Long-term Follow-up Period|Lost to Follow-up|5|||
13416552|NCT00497146|26850666|FG001|Long-term Follow-up Period|Lost to Follow-up|1|||
13416553|NCT00497146|26850665|FG000|Long-term Follow-up Period|Other|0|||
13416554|NCT00497146|26850666|FG001|Long-term Follow-up Period|Other|1|||
13416555|NCT00496964|26850691|FG000|Overall Study|Withdrawal by Subject|0|||
13416556|NCT00496964|26850692|FG001|Overall Study|Withdrawal by Subject|1|||
13416557|NCT00496873|26850700|FG000|Overall Study|Ineligible|2|||
13416558|NCT00496873|26850700|FG000|Overall Study|Death|2|||
13416559|NCT00496873|26850700|FG000|Overall Study|Withdrawal by Subject|3|||
13416560|NCT00496782|26850739|FG000|Overall Study|Protocol Violation|1|||
13416561|NCT00496782|26850740|FG001|Overall Study|Protocol Violation|2|||
13416562|NCT00496769|26850771|FG000|Double Blind|>=1 reason assigned per patient|558|||
13416563|NCT00496769|26850772|FG001|Double Blind|>=1 reason assigned per patient|649|||
13416564|NCT00496769|26850773|FG002|Double Blind|>=1 reason assigned per patient|0|||
13416565|NCT00496769|26850771|FG000|Open Label|>=1 reason assigned per patient|0|||
13416566|NCT00496769|26850772|FG001|Open Label|>=1 reason assigned per patient|0|||
13416567|NCT00496769|26850773|FG002|Open Label|>=1 reason assigned per patient|1011|||
13416568|NCT00496626|26850792|FG000|Overall Study|Lost to Follow-up|0|||
13416569|NCT00496626|26850793|FG001|Overall Study|Lost to Follow-up|1|||
13416570|NCT00496626|26850792|FG000|Overall Study|Protocol Violation|1|||
13416571|NCT00496626|26850793|FG001|Overall Study|Protocol Violation|0|||
13416572|NCT00496626|26850792|FG000|Overall Study|Withdrawal by Subject|5|||
13416573|NCT00496626|26850793|FG001|Overall Study|Withdrawal by Subject|4|||
13416574|NCT00496626|26850792|FG000|Overall Study|Relocated|0|||
13416575|NCT00496626|26850793|FG001|Overall Study|Relocated|1|||
13416576|NCT00496587|26850801|FG000|Overall Study|Adverse Event|2|||
13416577|NCT00496587|26850801|FG000|Overall Study|Progressive Disease|24|||
13416578|NCT00496587|26850801|FG000|Overall Study|Withdrawal by Subject|2|||
13416579|NCT00496587|26850801|FG000|Overall Study|Death|1|||
13416580|NCT00496587|26850801|FG000|Overall Study|Complications unrelated|2|||
13416581|NCT00496483|26850818|FG000|Overall Study|Not dosed|9|||
13416582|NCT00496483|26850818|FG000|Overall Study|Adverse Event|2|||
13416583|NCT00496483|26850818|FG000|Overall Study|Lack of Efficacy|1|||
13416584|NCT00496470|26850903|FG000|Overall Study|Adverse Event|8|||
13416585|NCT00496470|26850904|FG001|Overall Study|Adverse Event|10|||
13416586|NCT00496470|26850903|FG000|Overall Study|Withdrawal by Subject|5|||
13416587|NCT00496470|26850904|FG001|Overall Study|Withdrawal by Subject|12|||
13416588|NCT00496470|26850903|FG000|Overall Study|Incorrectly enrolled|13|||
13416589|NCT00496470|26850904|FG001|Overall Study|Incorrectly enrolled|5|||
13416590|NCT00496470|26850903|FG000|Overall Study|Other reason|0|||
13416591|NCT00496470|26850904|FG001|Overall Study|Other reason|2|||
13416592|NCT00496366|26850911|FG000|Overall Study|Death|1|||
13416593|NCT00496197|26850940|FG000|Overall Study|Discontinued study due to death|43|||
13416594|NCT00496197|26850940|FG000|Overall Study|Adverse Event|13|||
13416595|NCT00496197|26850940|FG000|Overall Study|Does not meet entrance criteria|5|||
13416596|NCT00496197|26850940|FG000|Overall Study|Insufficient clinical response|3|||
13416597|NCT00496197|26850940|FG000|Overall Study|Insufficient bacteriological response|10|||
13416598|NCT00496197|26850940|FG000|Overall Study|Lost to Follow-up|11|||
13416599|NCT00496197|26850940|FG000|Overall Study|Withdrawal by Subject|11|||
13416600|NCT00496197|26850940|FG000|Overall Study|Pathogen not isolated baseline specimen|4|||
13416601|NCT00496197|26850940|FG000|Overall Study|Other|14|||
13416602|NCT00496197|26850940|FG000|Overall Study|Protocol Violation|8|||
13416603|NCT00496080|26850952|FG000|Overall Study|Lost to Follow-up|9|||
13416604|NCT00496080|26850952|FG000|Overall Study|Surgical re-intervention|7|||
13416605|NCT00496080|26850952|FG000|Overall Study|Withdrawal by Subject|5|||
13416606|NCT00496080|26850952|FG000|Overall Study|Physician Decision|6|||
13416607|NCT00496054|26850981|FG000|Overall Study|Adverse Event|1|||
13416608|NCT00496054|26850981|FG000|Overall Study|Lost to Follow-up|7|||
13416609|NCT00496015|26851119|FG000|Overall Study|Other|1|||
13416610|NCT00496015|26851120|FG001|Overall Study|Other|0|||
13416611|NCT00496015|26851121|FG002|Overall Study|Other|0|||
13416612|NCT00496015|26851122|FG003|Overall Study|Other|1|||
13416613|NCT00496015|26851123|FG004|Overall Study|Other|0|||
13416614|NCT00495820|26851140|FG000|Overall Study|Adverse Event|1|||
13416615|NCT00495820|26851141|FG001|Overall Study|Adverse Event|1|||
13416616|NCT00495794|26851158|FG000|Overall Study|Pharmacist did not activate patient|522|||
13416617|NCT00495794|26851159|FG001|Overall Study|Pharmacist did not activate patient|0|||
13416618|NCT00495755|26851166|FG000|Overall Study|Adverse Event|3|||
13416619|NCT00495677|26851243|FG000|Stage 1 (25 Days)|Adverse Event|0|||
13416620|NCT00495677|26851244|FG001|Stage 1 (25 Days)|Adverse Event|0|||
13416621|NCT00495677|26851245|FG002|Stage 1 (25 Days)|Adverse Event|1|||
13416622|NCT00495677|26851246|FG003|Stage 1 (25 Days)|Adverse Event|0|||
13416623|NCT00495677|26851247|FG004|Stage 1 (25 Days)|Adverse Event|0|||
13416624|NCT00495677|26851248|FG005|Stage 1 (25 Days)|Adverse Event|0|||
13416625|NCT00495677|26851249|FG006|Stage 1 (25 Days)|Adverse Event|0|||
13416626|NCT00495625|26851260|FG000|Overall Study|Did not complete at least 1 42 day cycle|10|||
13416627|NCT00495612|26851283|FG000|Overall Study|Lost to Follow-up|1|||
13416628|NCT00495612|26851284|FG001|Overall Study|Lost to Follow-up|0|||
13416629|NCT00495612|26851283|FG000|Overall Study|Subject's Decision to Withdraw|3|||
13416630|NCT00495612|26851284|FG001|Overall Study|Subject's Decision to Withdraw|0|||
13476548|NCT00309985|27003171|FG000|Overall Study|Withdrawal by Subject|5|||
13476549|NCT00309985|27003172|FG001|Overall Study|Withdrawal by Subject|1|||
13476550|NCT00309985|27003171|FG000|Overall Study|Physician Decision|3|||
13476551|NCT00309985|27003172|FG001|Overall Study|Physician Decision|0|||
13476552|NCT00309985|27003171|FG000|Overall Study|Never started treatment|7|||
13476553|NCT00309985|27003172|FG001|Overall Study|Never started treatment|0|||
13476554|NCT00309985|27003171|FG000|Overall Study|Complicating disease|1|||
13476555|NCT00309985|27003172|FG001|Overall Study|Complicating disease|0|||
13476556|NCT00309985|27003171|FG000|Overall Study|Non-compliance|1|||
13476557|NCT00309985|27003172|FG001|Overall Study|Non-compliance|0|||
13476558|NCT00309985|27003171|FG000|Overall Study|Chemotherapy discontinued only|1|||
13476559|NCT00309985|27003172|FG001|Overall Study|Chemotherapy discontinued only|0|||
13476560|NCT00290251|27003198|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
13476561|NCT00290251|27003199|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
13476562|NCT00290251|27003200|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
13476563|NCT00290251|27003201|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
13476564|NCT00290251|27003202|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
13476565|NCT00290251|27003203|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2|||
13476566|NCT00290251|27003198|FG000|Treatment 1 (Months 2-4)|headache|0|||
13476567|NCT00290251|27003199|FG001|Treatment 1 (Months 2-4)|headache|0|||
13476568|NCT00290251|27003200|FG002|Treatment 1 (Months 2-4)|headache|0|||
13476569|NCT00290251|27003201|FG003|Treatment 1 (Months 2-4)|headache|0|||
13476570|NCT00290251|27003202|FG004|Treatment 1 (Months 2-4)|headache|1|||
13476571|NCT00290251|27003203|FG005|Treatment 1 (Months 2-4)|headache|0|||
13476572|NCT00290251|27003198|FG000|Treatment 1 (Months 2-4)|Out of body experience|0|||
13476573|NCT00290251|27003199|FG001|Treatment 1 (Months 2-4)|Out of body experience|0|||
13476574|NCT00290251|27003200|FG002|Treatment 1 (Months 2-4)|Out of body experience|0|||
13476575|NCT00290251|27003201|FG003|Treatment 1 (Months 2-4)|Out of body experience|1|||
13476576|NCT00290251|27003202|FG004|Treatment 1 (Months 2-4)|Out of body experience|0|||
13476577|NCT00290251|27003203|FG005|Treatment 1 (Months 2-4)|Out of body experience|0|||
13416631|NCT00495586|26851299|FG000|Overall Study|Withdrawal by Subject|4|||
13416632|NCT00495586|26851300|FG001|Overall Study|Withdrawal by Subject|4|||
13416633|NCT00495521|26851337|FG000|Overall Study|Physician Decision|0|||
13416634|NCT00495521|26851338|FG001|Overall Study|Physician Decision|1|||
13416635|NCT00495495|26851353|FG000|Overall Study|Protocol Violation|99|||
13416636|NCT00495469|26851517|FG000|Overall Study|Adverse Event|0|||
13416637|NCT00495469|26851518|FG001|Overall Study|Adverse Event|1|||
13416638|NCT00495469|26851519|FG002|Overall Study|Adverse Event|3|||
13416639|NCT00495469|26851520|FG003|Overall Study|Adverse Event|0|||
13416640|NCT00495469|26851521|FG004|Overall Study|Adverse Event|1|||
13416641|NCT00495469|26851522|FG005|Overall Study|Adverse Event|1|||
13416642|NCT00495469|26851523|FG006|Overall Study|Adverse Event|1|||
13416643|NCT00495469|26851517|FG000|Overall Study|Lost to Follow-up|1|||
13416644|NCT00495469|26851518|FG001|Overall Study|Lost to Follow-up|1|||
13416645|NCT00495469|26851519|FG002|Overall Study|Lost to Follow-up|3|||
13416646|NCT00495469|26851520|FG003|Overall Study|Lost to Follow-up|1|||
13416647|NCT00495469|26851521|FG004|Overall Study|Lost to Follow-up|0|||
13416648|NCT00495469|26851522|FG005|Overall Study|Lost to Follow-up|0|||
13416649|NCT00495469|26851523|FG006|Overall Study|Lost to Follow-up|0|||
13416650|NCT00495469|26851517|FG000|Overall Study|Protocol Violation|0|||
13416651|NCT00495469|26851518|FG001|Overall Study|Protocol Violation|0|||
13416652|NCT00495469|26851519|FG002|Overall Study|Protocol Violation|0|||
13416653|NCT00495469|26851520|FG003|Overall Study|Protocol Violation|0|||
13416654|NCT00495469|26851521|FG004|Overall Study|Protocol Violation|1|||
13416655|NCT00495469|26851522|FG005|Overall Study|Protocol Violation|2|||
13416656|NCT00495469|26851523|FG006|Overall Study|Protocol Violation|0|||
13416657|NCT00495469|26851517|FG000|Overall Study|Withdrawal by Subject|5|||
13416658|NCT00495469|26851518|FG001|Overall Study|Withdrawal by Subject|3|||
13416659|NCT00495469|26851519|FG002|Overall Study|Withdrawal by Subject|1|||
13416660|NCT00495469|26851520|FG003|Overall Study|Withdrawal by Subject|3|||
13416661|NCT00495469|26851521|FG004|Overall Study|Withdrawal by Subject|3|||
13416662|NCT00495469|26851522|FG005|Overall Study|Withdrawal by Subject|2|||
13416663|NCT00495469|26851523|FG006|Overall Study|Withdrawal by Subject|3|||
13416664|NCT00495469|26851517|FG000|Overall Study|Lack of Efficacy|0|||
13416665|NCT00495469|26851518|FG001|Overall Study|Lack of Efficacy|0|||
13416666|NCT00495469|26851519|FG002|Overall Study|Lack of Efficacy|0|||
13416667|NCT00495469|26851520|FG003|Overall Study|Lack of Efficacy|0|||
13416668|NCT00495469|26851521|FG004|Overall Study|Lack of Efficacy|0|||
13416669|NCT00495469|26851522|FG005|Overall Study|Lack of Efficacy|0|||
13416670|NCT00495469|26851523|FG006|Overall Study|Lack of Efficacy|1|||
13416671|NCT00495469|26851517|FG000|Overall Study|Liver function test abnormality|0|||
13416672|NCT00495469|26851518|FG001|Overall Study|Liver function test abnormality|1|||
13416673|NCT00495469|26851519|FG002|Overall Study|Liver function test abnormality|0|||
13416674|NCT00495469|26851520|FG003|Overall Study|Liver function test abnormality|0|||
13416675|NCT00495469|26851521|FG004|Overall Study|Liver function test abnormality|0|||
13416676|NCT00495469|26851522|FG005|Overall Study|Liver function test abnormality|0|||
13416677|NCT00495469|26851523|FG006|Overall Study|Liver function test abnormality|0|||
13416678|NCT00495469|26851517|FG000|Overall Study|ST depression at randomisation in ECG|0|||
13416679|NCT00495469|26851518|FG001|Overall Study|ST depression at randomisation in ECG|1|||
13416680|NCT00495469|26851519|FG002|Overall Study|ST depression at randomisation in ECG|0|||
13416681|NCT00495469|26851520|FG003|Overall Study|ST depression at randomisation in ECG|0|||
13416682|NCT00495469|26851521|FG004|Overall Study|ST depression at randomisation in ECG|0|||
13416683|NCT00495469|26851522|FG005|Overall Study|ST depression at randomisation in ECG|0|||
13416684|NCT00495469|26851523|FG006|Overall Study|ST depression at randomisation in ECG|0|||
13416685|NCT00495391|26851550|FG000|Overall Study|Lack of Efficacy|34|||
13416686|NCT00495391|26851551|FG001|Overall Study|Lack of Efficacy|18|||
13416687|NCT00495391|26851550|FG000|Overall Study|Withdrawal by Subject|2|||
13416688|NCT00495391|26851551|FG001|Overall Study|Withdrawal by Subject|3|||
13416689|NCT00495170|26851557|FG000|Overall Study|Lost to Follow-up|9|||
13416690|NCT00495170|26851557|FG000|Overall Study|Withdrawal by Subject|3|||
13416691|NCT00495170|26851557|FG000|Overall Study|Inappropriate staging|8|||
13416692|NCT00495040|26851563|FG000|Overall Study|Withdrawal by Subject|3|||
13416693|NCT00494871|26851600|FG000|Double-blind (DB) Treatment Period|Adverse Event|73|||
13416694|NCT00494871|26851601|FG001|Double-blind (DB) Treatment Period|Adverse Event|70|||
13416695|NCT00494871|26851600|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26|||
13416696|NCT00494871|26851601|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35|||
13416697|NCT00494871|26851600|FG000|Double-blind (DB) Treatment Period|Death|8|||
13416698|NCT00494871|26851601|FG001|Double-blind (DB) Treatment Period|Death|3|||
13416699|NCT00494871|26851600|FG000|Double-blind (DB) Treatment Period|Physician Decision|4|||
13416700|NCT00494871|26851601|FG001|Double-blind (DB) Treatment Period|Physician Decision|13|||
13416701|NCT00494871|26851600|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4|||
13416702|NCT00494871|26851601|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1|||
13416703|NCT00494871|26851600|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9|||
13416704|NCT00494871|26851601|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9|||
13416705|NCT00494871|26851600|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18|||
13416706|NCT00494871|26851601|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28|||
13416707|NCT00494871|26851600|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3|||
13416708|NCT00494871|26851601|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1|||
13416709|NCT00494871|26851600|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12|||
13416710|NCT00494871|26851601|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8|||
13416711|NCT00494871|26851600|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1|||
13416712|NCT00494871|26851601|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2|||
13416713|NCT00494871|26851600|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
13416714|NCT00494871|26851601|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
13416715|NCT00494871|26851600|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
13416716|NCT00494871|26851601|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
13416717|NCT00494871|26851600|FG000|Follow-up (FU) Period|Adverse Event|1|||
13416718|NCT00494871|26851601|FG001|Follow-up (FU) Period|Adverse Event|1|||
13416719|NCT00494871|26851600|FG000|Follow-up (FU) Period|Death|13|||
13416720|NCT00494871|26851601|FG001|Follow-up (FU) Period|Death|12|||
13416721|NCT00494871|26851600|FG000|Follow-up (FU) Period|Lost to Follow-up|6|||
13416722|NCT00494871|26851601|FG001|Follow-up (FU) Period|Lost to Follow-up|2|||
13416723|NCT00494871|26851600|FG000|Follow-up (FU) Period|Physician Decision|0|||
13416724|NCT00494871|26851601|FG001|Follow-up (FU) Period|Physician Decision|1|||
13416725|NCT00494871|26851600|FG000|Follow-up (FU) Period|Protocol Violation|1|||
13416726|NCT00494871|26851601|FG001|Follow-up (FU) Period|Protocol Violation|0|||
13416727|NCT00494871|26851600|FG000|Follow-up (FU) Period|Withdrawal by Subject|5|||
13416728|NCT00494871|26851601|FG001|Follow-up (FU) Period|Withdrawal by Subject|5|||
13416729|NCT00494871|26851600|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3|||
13416730|NCT00494871|26851601|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2|||
13416731|NCT00494780|26851646|FG000|Overall Study|Adverse Event|1|||
13416732|NCT00494780|26851647|FG001|Overall Study|Adverse Event|0|||
13416733|NCT00494780|26851646|FG000|Overall Study|Withdrew before Dosed|0|||
13416734|NCT00494780|26851647|FG001|Overall Study|Withdrew before Dosed|1|||
13416735|NCT00494780|26851646|FG000|Overall Study|Progression of Study Disease|7|||
13416736|NCT00494780|26851647|FG001|Overall Study|Progression of Study Disease|8|||
13416737|NCT00494780|26851646|FG000|Overall Study|New Treatment|2|||
13416738|NCT00494780|26851647|FG001|Overall Study|New Treatment|2|||
13416739|NCT00494780|26851646|FG000|Overall Study|Non-compliance|1|||
13416740|NCT00494780|26851647|FG001|Overall Study|Non-compliance|0|||
13416741|NCT00494780|26851646|FG000|Overall Study|Residual Tumour Mass|0|||
13416742|NCT00494780|26851647|FG001|Overall Study|Residual Tumour Mass|1|||
13416743|NCT00494780|26851646|FG000|Overall Study|Insurance Issues|0|||
13416744|NCT00494780|26851647|FG001|Overall Study|Insurance Issues|1|||
13416745|NCT00494676|26851657|FG000|Allocation|Withdrawal by Subject|2|||
13416746|NCT00494676|26851658|FG001|Allocation|Withdrawal by Subject|4|||
13416747|NCT00494676|26851657|FG000|First Intervention|Withdrawal by Subject|1|||
13416748|NCT00494676|26851658|FG001|First Intervention|Withdrawal by Subject|3|||
13416749|NCT00494676|26851657|FG000|Second Intervention|Withdrawal by Subject|1|||
13416750|NCT00494676|26851658|FG001|Second Intervention|Withdrawal by Subject|1|||
13416751|NCT00494507|26851719|FG000|Double-Blind Phase|Adverse Event|2|||
13416752|NCT00494507|26851720|FG001|Double-Blind Phase|Adverse Event|0|||
13416753|NCT00494507|26851721|FG002|Double-Blind Phase|Adverse Event|1|||
13416754|NCT00494507|26851722|FG003|Double-Blind Phase|Adverse Event|0|||
13416755|NCT00494507|26851719|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
13416756|NCT00494507|26851720|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
13416757|NCT00494507|26851721|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
13416758|NCT00494507|26851722|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
13416759|NCT00494507|26851719|FG000|Double-Blind Phase|Subject Non-compliance|0|||
13416760|NCT00494507|26851720|FG001|Double-Blind Phase|Subject Non-compliance|0|||
13416761|NCT00494507|26851721|FG002|Double-Blind Phase|Subject Non-compliance|1|||
13416762|NCT00494507|26851722|FG003|Double-Blind Phase|Subject Non-compliance|0|||
13416763|NCT00494507|26851719|FG000|Double-Blind Phase|Negative DNA test|0|||
13416764|NCT00494507|26851720|FG001|Double-Blind Phase|Negative DNA test|0|||
13416765|NCT00494507|26851721|FG002|Double-Blind Phase|Negative DNA test|0|||
13416766|NCT00494507|26851722|FG003|Double-Blind Phase|Negative DNA test|1|||
13416767|NCT00494507|26851719|FG000|Open-Label Phase|Adverse Event|0|||
13416768|NCT00494507|26851720|FG001|Open-Label Phase|Adverse Event|1|||
13416769|NCT00494507|26851721|FG002|Open-Label Phase|Adverse Event|5|||
13416770|NCT00494507|26851722|FG003|Open-Label Phase|Adverse Event|3|||
13416771|NCT00494507|26851719|FG000|Open-Label Phase|Worsening Disease|0|||
13416772|NCT00494507|26851720|FG001|Open-Label Phase|Worsening Disease|0|||
13416773|NCT00494507|26851721|FG002|Open-Label Phase|Worsening Disease|0|||
13416774|NCT00494507|26851722|FG003|Open-Label Phase|Worsening Disease|2|||
13416775|NCT00494481|26851735|FG000|Overall Study|Condition under investigation worsened|11|||
13416776|NCT00494481|26851736|FG001|Overall Study|Condition under investigation worsened|13|||
13416777|NCT00494481|26851735|FG000|Overall Study|Adverse Event|15|||
13416778|NCT00494481|26851736|FG001|Overall Study|Adverse Event|11|||
13416779|NCT00494481|26851735|FG000|Overall Study|Other|1|||
13416780|NCT00494481|26851736|FG001|Overall Study|Other|0|||
13416781|NCT00494481|26851735|FG000|Overall Study|Never received IP|2|||
13416782|NCT00494481|26851736|FG001|Overall Study|Never received IP|0|||
13416783|NCT00494442|26851757|FG000|Overall Study|Death|1|||
13416784|NCT00494442|26851758|FG001|Overall Study|Death|1|||
13416785|NCT00494442|26851757|FG000|Overall Study|Lack of Efficacy|16|||
13416786|NCT00494442|26851758|FG001|Overall Study|Lack of Efficacy|10|||
13416787|NCT00494442|26851757|FG000|Overall Study|Adverse Event|0|||
13416788|NCT00494442|26851758|FG001|Overall Study|Adverse Event|2|||
13416789|NCT00494442|26851757|FG000|Overall Study|Physician Decision|0|||
13416790|NCT00494442|26851758|FG001|Overall Study|Physician Decision|1|||
13416791|NCT00494442|26851757|FG000|Overall Study|Non-compliance|0|||
13416792|NCT00494442|26851758|FG001|Overall Study|Non-compliance|1|||
13416793|NCT00494442|26851757|FG000|Overall Study|Intercurrent illness|0|||
13416794|NCT00494442|26851758|FG001|Overall Study|Intercurrent illness|1|||
13416795|NCT00494299|26851775|FG000|Overall Study|Adverse Event|93|||
13416796|NCT00494299|26851776|FG001|Overall Study|Adverse Event|13|||
13416797|NCT00494299|26851775|FG000|Overall Study|Lost to Follow-up|1|||
13416798|NCT00494299|26851776|FG001|Overall Study|Lost to Follow-up|0|||
13416799|NCT00494299|26851775|FG000|Overall Study|Physician Decision|0|||
13416800|NCT00494299|26851776|FG001|Overall Study|Physician Decision|2|||
13416801|NCT00494299|26851775|FG000|Overall Study|Protocol Violation|1|||
13416802|NCT00494299|26851776|FG001|Overall Study|Protocol Violation|2|||
13416803|NCT00494299|26851775|FG000|Overall Study|Withdrawal by Subject|8|||
13416804|NCT00494299|26851776|FG001|Overall Study|Withdrawal by Subject|3|||
13416805|NCT00494299|26851775|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109|||
13416806|NCT00494299|26851776|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185|||
13416807|NCT00494299|26851775|FG000|Overall Study|Participant Did Not Take Study Drug|0|||
13416808|NCT00494299|26851776|FG001|Overall Study|Participant Did Not Take Study Drug|2|||
13416809|NCT00494299|26851775|FG000|Overall Study|Site Closed by Sponsor|6|||
13416810|NCT00494299|26851776|FG001|Overall Study|Site Closed by Sponsor|0|||
13416811|NCT00494299|26851775|FG000|Overall Study|Protocol Driven Decision Point|11|||
13416812|NCT00494299|26851776|FG001|Overall Study|Protocol Driven Decision Point|22|||
13416813|NCT00494221|26851806|FG000|Overall Study|Death|15|||
13416814|NCT00494221|26851807|FG001|Overall Study|Death|9|||
13416815|NCT00494221|26851808|FG002|Overall Study|Death|14|||
13416816|NCT00494221|26851806|FG000|Overall Study|Withdrawal by Subject|1|||
13416817|NCT00494221|26851807|FG001|Overall Study|Withdrawal by Subject|2|||
13416818|NCT00494221|26851808|FG002|Overall Study|Withdrawal by Subject|0|||
13416819|NCT00494091|26851837|FG000|Overall Study|Death|5|||
13416820|NCT00494091|26851838|FG001|Overall Study|Death|54|||
13416821|NCT00494091|26851837|FG000|Overall Study|Lost to Follow-up|0|||
13416822|NCT00494091|26851838|FG001|Overall Study|Lost to Follow-up|4|||
13416823|NCT00494091|26851837|FG000|Overall Study|Other|1|||
13416824|NCT00494091|26851838|FG001|Overall Study|Other|11|||
13416825|NCT00494091|26851837|FG000|Overall Study|Withdrawal by Subject|0|||
13416826|NCT00494091|26851838|FG001|Overall Study|Withdrawal by Subject|7|||
13416827|NCT00494026|26851848|FG000|Overall Study|Sponsor Decision|4|||
13416828|NCT00494013|26851883|FG000|Overall Study|Adverse Event|0|||
13416829|NCT00494013|26851884|FG001|Overall Study|Adverse Event|1|||
13416830|NCT00494013|26851883|FG000|Overall Study|Entry Criteria Not Met|1|||
13416831|NCT00494013|26851884|FG001|Overall Study|Entry Criteria Not Met|4|||
13416832|NCT00494013|26851883|FG000|Overall Study|Lost to Follow-up|5|||
13416833|NCT00494013|26851884|FG001|Overall Study|Lost to Follow-up|6|||
13416834|NCT00494013|26851883|FG000|Overall Study|Physician Decision|3|||
13416835|NCT00494013|26851884|FG001|Overall Study|Physician Decision|5|||
13416836|NCT00494013|26851883|FG000|Overall Study|Protocol Violation|8|||
13416837|NCT00494013|26851884|FG001|Overall Study|Protocol Violation|5|||
13416838|NCT00494013|26851883|FG000|Overall Study|Withdrawal by Subject|13|||
13416839|NCT00494013|26851884|FG001|Overall Study|Withdrawal by Subject|14|||
13416840|NCT00494013|26851883|FG000|Overall Study|Sponsor Decision|0|||
13416841|NCT00494013|26851884|FG001|Overall Study|Sponsor Decision|1|||
13416842|NCT00493974|26851909|FG000|Overall Study|Death|1|||
13416843|NCT00493974|26851910|FG001|Overall Study|Death|2|||
13416844|NCT00493974|26851909|FG000|Overall Study|Withdrawal by Subject|8|||
13416845|NCT00493974|26851910|FG001|Overall Study|Withdrawal by Subject|6|||
13416846|NCT00493974|26851909|FG000|Overall Study|Lost to Follow-up|4|||
13416847|NCT00493974|26851910|FG001|Overall Study|Lost to Follow-up|6|||
13416848|NCT00493779|26851919|FG000|Overall Study|Logistical issue at site|1|||
13416849|NCT00493649|26851932|FG000|Overall Study|Adverse Event|44|||
13416850|NCT00493649|26851932|FG000|Overall Study|Patient Request|21|||
13416851|NCT00493649|26851932|FG000|Overall Study|Investigator Request|2|||
13416852|NCT00493649|26851932|FG000|Overall Study|Disease Progression|1|||
13416853|NCT00493649|26851932|FG000|Overall Study|Lost to Follow-up|1|||
13416854|NCT00493649|26851932|FG000|Overall Study|Other|13|||
13416855|NCT00493636|26851953|FG000|Overall Study|Withdrawal by Subject|1|||
13416856|NCT00493636|26851954|FG001|Overall Study|Withdrawal by Subject|0|||
13416857|NCT00493636|26851953|FG000|Overall Study|Disease progression/recurrence/relapse|0|||
13416858|NCT00493636|26851954|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
13416859|NCT00493636|26851953|FG000|Overall Study|Mis-randomization|1|||
13416860|NCT00493636|26851954|FG001|Overall Study|Mis-randomization|1|||
13416861|NCT00493467|26851961|FG000|Overall Study|Death|1|||
13416862|NCT00493454|26851967|FG000|Overall Study|Withdrawal by Subject|1|||
13416863|NCT00493311|26851988|FG000|Overall Study|Need for rescue medication|2|||
13416864|NCT00493311|26851989|FG001|Overall Study|Need for rescue medication|2|||
13416865|NCT00493285|26852232|FG000|Overall Study|Lost to Follow-up|0|||
13416866|NCT00493285|26852233|FG001|Overall Study|Lost to Follow-up|0|||
13416867|NCT00493285|26852234|FG002|Overall Study|Lost to Follow-up|0|||
13416868|NCT00493285|26852235|FG003|Overall Study|Lost to Follow-up|0|||
13416869|NCT00493285|26852236|FG004|Overall Study|Lost to Follow-up|1|||
13416870|NCT00493285|26852237|FG005|Overall Study|Lost to Follow-up|0|||
13416871|NCT00493246|26852320|FG000|Overall Study|Withdrawal by Subject|0|||
13416872|NCT00493246|26852321|FG001|Overall Study|Withdrawal by Subject|0|||
13416873|NCT00493246|26852322|FG002|Overall Study|Withdrawal by Subject|0|||
13416874|NCT00493246|26852323|FG003|Overall Study|Withdrawal by Subject|0|||
13416875|NCT00493246|26852324|FG004|Overall Study|Withdrawal by Subject|1|||
13416876|NCT00493246|26852325|FG005|Overall Study|Withdrawal by Subject|0|||
13416877|NCT00493246|26852326|FG006|Overall Study|Withdrawal by Subject|0|||
13416878|NCT00493246|26852327|FG007|Overall Study|Withdrawal by Subject|0|||
13416879|NCT00493246|26852320|FG000|Overall Study|No access to draw blood|0|||
13416880|NCT00493246|26852321|FG001|Overall Study|No access to draw blood|0|||
13416881|NCT00493246|26852322|FG002|Overall Study|No access to draw blood|0|||
13416882|NCT00493246|26852323|FG003|Overall Study|No access to draw blood|0|||
13416883|NCT00493246|26852324|FG004|Overall Study|No access to draw blood|0|||
13416884|NCT00493246|26852325|FG005|Overall Study|No access to draw blood|1|||
13416885|NCT00493246|26852326|FG006|Overall Study|No access to draw blood|0|||
13416886|NCT00493246|26852327|FG007|Overall Study|No access to draw blood|0|||
13416887|NCT00493246|26852320|FG000|Overall Study|Lost to Follow-up|0|||
13416888|NCT00493246|26852321|FG001|Overall Study|Lost to Follow-up|0|||
13416889|NCT00493246|26852322|FG002|Overall Study|Lost to Follow-up|0|||
13416890|NCT00493246|26852323|FG003|Overall Study|Lost to Follow-up|0|||
13416891|NCT00493246|26852324|FG004|Overall Study|Lost to Follow-up|0|||
13416892|NCT00493246|26852325|FG005|Overall Study|Lost to Follow-up|0|||
13416893|NCT00493246|26852326|FG006|Overall Study|Lost to Follow-up|1|||
13416894|NCT00493246|26852327|FG007|Overall Study|Lost to Follow-up|0|||
13416895|NCT00493220|26852363|FG000|Third Intervention|Withdrawal by Subject|1|||
13416896|NCT00493220|26852364|FG001|Third Intervention|Withdrawal by Subject|0|||
13416897|NCT00493220|26852365|FG002|Third Intervention|Withdrawal by Subject|0|||
13416898|NCT00493220|26852366|FG003|Third Intervention|Withdrawal by Subject|0|||
13416899|NCT00493220|26852367|FG004|Third Intervention|Withdrawal by Subject|0|||
13416900|NCT00493220|26852368|FG005|Third Intervention|Withdrawal by Subject|0|||
13416901|NCT00493038|26852389|FG000|Treatment|Adverse Event|8|||
13416902|NCT00493038|26852390|FG001|Treatment|Adverse Event|4|||
13416903|NCT00493038|26852389|FG000|Treatment|Lost to Follow-up|5|||
13416904|NCT00493038|26852390|FG001|Treatment|Lost to Follow-up|3|||
13416905|NCT00493038|26852389|FG000|Treatment|Withdrawal by Subject|11|||
13416906|NCT00493038|26852390|FG001|Treatment|Withdrawal by Subject|12|||
13416907|NCT00493038|26852389|FG000|Treatment|Other|0|||
13416908|NCT00493038|26852390|FG001|Treatment|Other|1|||
13416909|NCT00493038|26852389|FG000|Follow-up|Lost to Follow-up|1|||
13416910|NCT00493038|26852390|FG001|Follow-up|Lost to Follow-up|0|||
13416911|NCT00493025|26852401|FG000|Overall Study|Physician Decision|19|||
13416912|NCT00493012|26852434|FG000|Overall Study|Lost to Follow-up|18|||
13416913|NCT00493012|26852435|FG001|Overall Study|Lost to Follow-up|17|||
13416914|NCT00492921|26852450|FG000|Overall Study|Death|1|||
13416915|NCT00492921|26852451|FG001|Overall Study|Death|0|||
13416916|NCT00492921|26852452|FG002|Overall Study|Death|1|||
13416917|NCT00492752|26852494|FG000|Double Blind Treatment|Death|13|||
13416918|NCT00492752|26852495|FG001|Double Blind Treatment|Death|0|||
13416919|NCT00492752|26852496|FG002|Double Blind Treatment|Death|2|||
13416920|NCT00492752|26852497|FG003|Double Blind Treatment|Death|0|||
13416921|NCT00492752|26852494|FG000|Double Blind Treatment|Adverse Event|1|||
13416922|NCT00492752|26852495|FG001|Double Blind Treatment|Adverse Event|0|||
13416923|NCT00492752|26852496|FG002|Double Blind Treatment|Adverse Event|0|||
13416924|NCT00492752|26852497|FG003|Double Blind Treatment|Adverse Event|0|||
13416925|NCT00492752|26852494|FG000|Double Blind Treatment|Protocol Violation|0|||
13416926|NCT00492752|26852495|FG001|Double Blind Treatment|Protocol Violation|0|||
13416927|NCT00492752|26852496|FG002|Double Blind Treatment|Protocol Violation|1|||
13416928|NCT00492752|26852497|FG003|Double Blind Treatment|Protocol Violation|0|||
13416929|NCT00492752|26852494|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
13416930|NCT00492752|26852495|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
13416931|NCT00492752|26852496|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
13416932|NCT00492752|26852497|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
13416933|NCT00492752|26852494|FG000|Follow-up and/or Open Label Sorafenib|Death|75|||
13416934|NCT00492752|26852495|FG001|Follow-up and/or Open Label Sorafenib|Death|5|||
13416935|NCT00492752|26852496|FG002|Follow-up and/or Open Label Sorafenib|Death|45|||
13416936|NCT00492752|26852497|FG003|Follow-up and/or Open Label Sorafenib|Death|1|||
13416937|NCT00492752|26852494|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8|||
13416938|NCT00492752|26852495|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1|||
13416939|NCT00492752|26852496|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2|||
13416940|NCT00492752|26852497|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0|||
13416941|NCT00492752|26852494|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2|||
13416942|NCT00492752|26852495|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1|||
13416943|NCT00492752|26852496|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
13416944|NCT00492752|26852497|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
13416945|NCT00492752|26852494|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
13416946|NCT00492752|26852495|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1|||
13416947|NCT00492752|26852496|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
13416948|NCT00492752|26852497|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2|||
13416949|NCT00492752|26852494|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
13416950|NCT00492752|26852495|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
13416951|NCT00492752|26852496|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
13416952|NCT00492752|26852497|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1|||
13416953|NCT00492752|26852494|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
13416954|NCT00492752|26852495|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6|||
13416955|NCT00492752|26852496|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
13416956|NCT00492752|26852497|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
13416957|NCT00492752|26852494|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1|||
13416958|NCT00492752|26852495|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
13416959|NCT00492752|26852496|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
13416960|NCT00492752|26852497|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
13416961|NCT00492726|26852528|FG000|Overall Study|Adverse Event|10|||
13416962|NCT00492726|26852529|FG001|Overall Study|Adverse Event|6|||
13416963|NCT00492726|26852528|FG000|Overall Study|Death|7|||
13416964|NCT00492726|26852529|FG001|Overall Study|Death|2|||
13416965|NCT00492726|26852528|FG000|Overall Study|Lack of Efficacy|0|||
13416966|NCT00492726|26852529|FG001|Overall Study|Lack of Efficacy|2|||
13416967|NCT00492726|26852528|FG000|Overall Study|Lost to Follow-up|27|||
13416968|NCT00492726|26852529|FG001|Overall Study|Lost to Follow-up|19|||
13416969|NCT00492726|26852528|FG000|Overall Study|Physician Decision|0|||
13416970|NCT00492726|26852529|FG001|Overall Study|Physician Decision|1|||
13416971|NCT00492726|26852528|FG000|Overall Study|Withdrawal by Subject|6|||
13416972|NCT00492726|26852529|FG001|Overall Study|Withdrawal by Subject|3|||
13416973|NCT00492726|26852528|FG000|Overall Study|Non compliant with study medication|0|||
13416974|NCT00492726|26852529|FG001|Overall Study|Non compliant with study medication|3|||
13416975|NCT00492648|26852562|FG000|Month 30 (109671 Study)|Protocol Violation|0|||
13416976|NCT00492648|26852563|FG001|Month 30 (109671 Study)|Protocol Violation|1|||
13416977|NCT00492557|26852586|FG000|Overall Study|Subject request|12|||
13416978|NCT00492557|26852587|FG001|Overall Study|Subject request|11|||
13416979|NCT00492557|26852586|FG000|Overall Study|Protocol Violation|7|||
13416980|NCT00492557|26852587|FG001|Overall Study|Protocol Violation|8|||
13416981|NCT00492557|26852586|FG000|Overall Study|Other|2|||
13416982|NCT00492557|26852587|FG001|Overall Study|Other|2|||
13416983|NCT00492557|26852586|FG000|Overall Study|Death|1|||
13416984|NCT00492557|26852587|FG001|Overall Study|Death|1|||
13416985|NCT00492557|26852586|FG000|Overall Study|Adverse Event|1|||
13416986|NCT00492557|26852587|FG001|Overall Study|Adverse Event|0|||
13416987|NCT00492557|26852586|FG000|Overall Study|Failed to return|1|||
13416988|NCT00492557|26852587|FG001|Overall Study|Failed to return|0|||
13416989|NCT00492557|26852586|FG000|Overall Study|Lost to Follow-up|0|||
13416990|NCT00492557|26852587|FG001|Overall Study|Lost to Follow-up|1|||
13416991|NCT00492531|26852606|FG000|Overall Study|Withdrawn(More than one reason selected)|22|||
13416992|NCT00492531|26852607|FG001|Overall Study|Withdrawn(More than one reason selected)|23|||
13416993|NCT00492297|26852623|FG000|Treatment|Death|2|||
13416994|NCT00492297|26852623|FG000|Treatment|Study terminated by sponsor|3|||
13416995|NCT00492297|26852623|FG000|Active Follow-up 30(+4) Days Duration|Death|17|||
13416996|NCT00492297|26852623|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2|||
13416997|NCT00492297|26852623|FG000|Survival Only Follow-up|Death|46|||
13416998|NCT00492297|26852623|FG000|Survival Only Follow-up|Lack of Efficacy|1|||
13416999|NCT00492297|26852623|FG000|Survival Only Follow-up|Study terminated by sponsor|12|||
13417000|NCT00492284|26852678|FG000|Overall Study|Adverse Event|0|||
13417001|NCT00492284|26852679|FG001|Overall Study|Adverse Event|1|||
13417002|NCT00492284|26852680|FG002|Overall Study|Adverse Event|1|||
13417003|NCT00492284|26852681|FG003|Overall Study|Adverse Event|2|||
13417004|NCT00492284|26852678|FG000|Overall Study|Lost to Follow-up|0|||
13417005|NCT00492284|26852679|FG001|Overall Study|Lost to Follow-up|0|||
13417006|NCT00492284|26852680|FG002|Overall Study|Lost to Follow-up|3|||
13417007|NCT00492284|26852681|FG003|Overall Study|Lost to Follow-up|1|||
13417008|NCT00492284|26852678|FG000|Overall Study|Death|0|||
13417009|NCT00492284|26852679|FG001|Overall Study|Death|3|||
13417010|NCT00492284|26852680|FG002|Overall Study|Death|2|||
13417011|NCT00492284|26852681|FG003|Overall Study|Death|5|||
13417012|NCT00492284|26852678|FG000|Overall Study|Withdrawal by Subject|1|||
13417013|NCT00492284|26852679|FG001|Overall Study|Withdrawal by Subject|0|||
13417014|NCT00492284|26852680|FG002|Overall Study|Withdrawal by Subject|0|||
13417015|NCT00492284|26852681|FG003|Overall Study|Withdrawal by Subject|2|||
13417016|NCT00492232|26852720|FG000|Placebo Run-in|Adverse Event|0|||
13417017|NCT00492232|26852721|FG001|Placebo Run-in|Adverse Event|2|||
13417018|NCT00492232|26852720|FG000|Placebo Run-in|Protocol Violation|0|||
13417019|NCT00492232|26852721|FG001|Placebo Run-in|Protocol Violation|3|||
13417020|NCT00492232|26852720|FG000|Placebo Run-in|Lost to Follow-up|0|||
13417021|NCT00492232|26852721|FG001|Placebo Run-in|Lost to Follow-up|3|||
13417022|NCT00492232|26852720|FG000|Placebo Run-in|Withdrawal by Subject|0|||
13417023|NCT00492232|26852721|FG001|Placebo Run-in|Withdrawal by Subject|8|||
13417024|NCT00492232|26852720|FG000|Placebo Run-in|Pregnancy|0|||
13417025|NCT00492232|26852721|FG001|Placebo Run-in|Pregnancy|1|||
13417026|NCT00492232|26852720|FG000|Placebo Run-in|Entrance criteria not met|0|||
13417027|NCT00492232|26852721|FG001|Placebo Run-in|Entrance criteria not met|45|||
13417028|NCT00492232|26852720|FG000|Placebo Run-in|Other|0|||
13417029|NCT00492232|26852721|FG001|Placebo Run-in|Other|6|||
13417030|NCT00492232|26852720|FG000|Placebo Run-in|Missing|0|||
13417031|NCT00492232|26852721|FG001|Placebo Run-in|Missing|2|||
13417032|NCT00492232|26852720|FG000|Double-Blind Treatment|Adverse Event|1|||
13417033|NCT00492232|26852721|FG001|Double-Blind Treatment|Adverse Event|2|||
13417034|NCT00492232|26852720|FG000|Double-Blind Treatment|Protocol Violation|3|||
13417035|NCT00492232|26852721|FG001|Double-Blind Treatment|Protocol Violation|7|||
13417036|NCT00492232|26852720|FG000|Double-Blind Treatment|Lost to Follow-up|2|||
13417037|NCT00492232|26852721|FG001|Double-Blind Treatment|Lost to Follow-up|3|||
13417038|NCT00492232|26852720|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
13417039|NCT00492232|26852721|FG001|Double-Blind Treatment|Withdrawal by Subject|8|||
13417040|NCT00492232|26852720|FG000|Double-Blind Treatment|Lack of Efficacy|1|||
13417041|NCT00492232|26852721|FG001|Double-Blind Treatment|Lack of Efficacy|0|||
13417042|NCT00492232|26852720|FG000|Double-Blind Treatment|Other|6|||
13417043|NCT00492232|26852721|FG001|Double-Blind Treatment|Other|5|||
13417044|NCT00492232|26852720|FG000|Double-Blind Treatment|Randomized not treated|1|||
13417045|NCT00492232|26852721|FG001|Double-Blind Treatment|Randomized not treated|0|||
13417046|NCT00492232|26852720|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
13417047|NCT00492232|26852721|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
13417048|NCT00492115|26852736|FG000|Overall Study|Withdrawal by Subject|3|||
13417049|NCT00492115|26852737|FG001|Overall Study|Withdrawal by Subject|4|||
13417050|NCT00492063|26852772|FG000|Overall Study|Death|0|||
13417051|NCT00492063|26852773|FG001|Overall Study|Death|0|||
13417052|NCT00492063|26852774|FG002|Overall Study|Death|1|||
13417053|NCT00492063|26852775|FG003|Overall Study|Death|2|||
13417054|NCT00492063|26852772|FG000|Overall Study|Withdrawal by Subject|4|||
13417055|NCT00492063|26852773|FG001|Overall Study|Withdrawal by Subject|3|||
13417056|NCT00492063|26852774|FG002|Overall Study|Withdrawal by Subject|5|||
13417057|NCT00492063|26852775|FG003|Overall Study|Withdrawal by Subject|4|||
13417058|NCT00492063|26852772|FG000|Overall Study|Lost to Follow-up|6|||
13417059|NCT00492063|26852773|FG001|Overall Study|Lost to Follow-up|11|||
13417060|NCT00492063|26852774|FG002|Overall Study|Lost to Follow-up|5|||
13417061|NCT00492063|26852775|FG003|Overall Study|Lost to Follow-up|3|||
13417062|NCT00492063|26852772|FG000|Overall Study|Protocol Violation|0|||
13417063|NCT00492063|26852773|FG001|Overall Study|Protocol Violation|0|||
13417064|NCT00492063|26852774|FG002|Overall Study|Protocol Violation|0|||
13417065|NCT00492063|26852775|FG003|Overall Study|Protocol Violation|1|||
13417066|NCT00492024|26852798|FG000|Treatment|Adverse Event|3|||
13417067|NCT00492024|26852799|FG001|Treatment|Adverse Event|1|||
13417068|NCT00492024|26852798|FG000|Treatment|Lack of Efficacy|21|||
13417069|NCT00492024|26852799|FG001|Treatment|Lack of Efficacy|20|||
13417070|NCT00492024|26852798|FG000|Treatment|Lost to Follow-up|3|||
13417071|NCT00492024|26852799|FG001|Treatment|Lost to Follow-up|1|||
13417072|NCT00492024|26852798|FG000|Treatment|Withdrawal by Subject|2|||
13417073|NCT00492024|26852799|FG001|Treatment|Withdrawal by Subject|0|||
13417074|NCT00492024|26852798|FG000|Follow up|Lack of Efficacy|0|||
13417075|NCT00492024|26852799|FG001|Follow up|Lack of Efficacy|1|||
13417076|NCT00492024|26852798|FG000|Follow up|Lost to Follow-up|1|||
13417077|NCT00492024|26852799|FG001|Follow up|Lost to Follow-up|1|||
13417078|NCT00491894|26852809|FG000|Overall Study|Adverse Event|14|||
13417079|NCT00491894|26852809|FG000|Overall Study|Withdrawal by Subject|5|||
13417080|NCT00491894|26852809|FG000|Overall Study|Death|3|||
13417081|NCT00491894|26852809|FG000|Overall Study|Lost to Follow-up|3|||
13417082|NCT00491894|26852809|FG000|Overall Study|Lack of Efficacy|2|||
13417083|NCT00491894|26852809|FG000|Overall Study|Other-Failed to meet any criteria|2|||
13417084|NCT00491894|26852809|FG000|Overall Study|Physician Decision|2|||
13417085|NCT00491894|26852809|FG000|Overall Study|Protocol Violation|2|||
13417086|NCT00491894|26852809|FG000|Overall Study|Other-Intake of prohibited medication|1|||
13417087|NCT00491764|26852854|FG000|Overall Study|Adverse Event|1|||
13417088|NCT00491764|26852855|FG001|Overall Study|Adverse Event|2|||
13417089|NCT00491764|26852856|FG002|Overall Study|Adverse Event|4|||
13417090|NCT00491764|26852857|FG003|Overall Study|Adverse Event|4|||
13417091|NCT00491764|26852858|FG004|Overall Study|Adverse Event|0|||
13417092|NCT00491764|26852859|FG005|Overall Study|Adverse Event|1|||
13417093|NCT00491764|26852854|FG000|Overall Study|Lost to Follow-up|0|||
13417094|NCT00491764|26852855|FG001|Overall Study|Lost to Follow-up|1|||
13417095|NCT00491764|26852856|FG002|Overall Study|Lost to Follow-up|0|||
13417096|NCT00491764|26852857|FG003|Overall Study|Lost to Follow-up|1|||
13417097|NCT00491764|26852858|FG004|Overall Study|Lost to Follow-up|0|||
13417098|NCT00491764|26852859|FG005|Overall Study|Lost to Follow-up|3|||
13417099|NCT00491764|26852854|FG000|Overall Study|Withdrawal by Subject|2|||
13417100|NCT00491764|26852855|FG001|Overall Study|Withdrawal by Subject|3|||
13417101|NCT00491764|26852856|FG002|Overall Study|Withdrawal by Subject|1|||
13417102|NCT00491764|26852857|FG003|Overall Study|Withdrawal by Subject|2|||
13417103|NCT00491764|26852858|FG004|Overall Study|Withdrawal by Subject|2|||
13417104|NCT00491764|26852859|FG005|Overall Study|Withdrawal by Subject|4|||
13417105|NCT00491764|26852854|FG000|Overall Study|Non Compliance with the Protocol|1|||
13417106|NCT00491764|26852855|FG001|Overall Study|Non Compliance with the Protocol|0|||
13417107|NCT00491764|26852856|FG002|Overall Study|Non Compliance with the Protocol|0|||
13417108|NCT00491764|26852857|FG003|Overall Study|Non Compliance with the Protocol|0|||
13417109|NCT00491764|26852858|FG004|Overall Study|Non Compliance with the Protocol|0|||
13417110|NCT00491764|26852859|FG005|Overall Study|Non Compliance with the Protocol|0|||
13417111|NCT00491764|26852854|FG000|Overall Study|Did not Meet Protocol Eligibility|0|||
13417112|NCT00491764|26852855|FG001|Overall Study|Did not Meet Protocol Eligibility|1|||
13417113|NCT00491764|26852856|FG002|Overall Study|Did not Meet Protocol Eligibility|1|||
13417114|NCT00491764|26852857|FG003|Overall Study|Did not Meet Protocol Eligibility|0|||
13417115|NCT00491764|26852858|FG004|Overall Study|Did not Meet Protocol Eligibility|1|||
13417116|NCT00491764|26852859|FG005|Overall Study|Did not Meet Protocol Eligibility|1|||
13417117|NCT00491764|26852854|FG000|Overall Study|Administrative|1|||
13417118|NCT00491764|26852855|FG001|Overall Study|Administrative|0|||
13417119|NCT00491764|26852856|FG002|Overall Study|Administrative|2|||
13417120|NCT00491764|26852857|FG003|Overall Study|Administrative|1|||
13417121|NCT00491764|26852858|FG004|Overall Study|Administrative|0|||
13417122|NCT00491764|26852859|FG005|Overall Study|Administrative|0|||
13417123|NCT00491608|26852870|FG000|Overall Study|Death|2|||
13417124|NCT00491608|26852870|FG000|Overall Study|Withdrawal by Subject|1|||
13417125|NCT00491556|26852933|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1|||
13417126|NCT00491556|26852934|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0|||
13417127|NCT00491556|26852933|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1|||
13417128|NCT00491556|26852934|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0|||
13417129|NCT00491556|26852933|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1|||
13417130|NCT00491556|26852934|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0|||
13417131|NCT00491556|26852933|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2|||
13417132|NCT00491556|26852934|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0|||
13417133|NCT00491556|26852933|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11|||
13417134|NCT00491556|26852934|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0|||
13417135|NCT00491556|26852933|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2|||
13417136|NCT00491556|26852934|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0|||
13417137|NCT00491556|26852933|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2|||
13417138|NCT00491556|26852934|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0|||
13417139|NCT00491556|26852933|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3|||
13417140|NCT00491556|26852934|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0|||
13417141|NCT00491556|26852933|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3|||
13417142|NCT00491556|26852934|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0|||
13417143|NCT00491556|26852933|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
13417144|NCT00491556|26852934|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
13417145|NCT00491556|26852933|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2|||
13417146|NCT00491556|26852934|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0|||
13417147|NCT00491556|26852933|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2|||
13417148|NCT00491556|26852934|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1|||
13417149|NCT00491556|26852933|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5|||
13417150|NCT00491556|26852934|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0|||
13417151|NCT00491556|26852933|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2|||
13417152|NCT00491556|26852934|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0|||
13417153|NCT00491556|26852933|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5|||
13417154|NCT00491556|26852934|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0|||
13417155|NCT00491556|26852933|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2|||
13417156|NCT00491556|26852934|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0|||
13417157|NCT00491556|26852933|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2|||
13417158|NCT00491556|26852934|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0|||
13417159|NCT00491556|26852933|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2|||
13417160|NCT00491556|26852934|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0|||
13417161|NCT00491556|26852933|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0|||
13417162|NCT00491556|26852934|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1|||
13417163|NCT00491556|26852933|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0|||
13417164|NCT00491556|26852934|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1|||
13417165|NCT00491530|26852970|FG000|Overall Study|Adverse Event|6|||
13417166|NCT00491530|26852971|FG001|Overall Study|Adverse Event|1|||
13417167|NCT00491530|26852972|FG002|Overall Study|Adverse Event|2|||
13417168|NCT00491530|26852970|FG000|Overall Study|Withdrawal by Subject|3|||
13417169|NCT00491530|26852971|FG001|Overall Study|Withdrawal by Subject|0|||
13417170|NCT00491530|26852972|FG002|Overall Study|Withdrawal by Subject|0|||
13417171|NCT00491530|26852970|FG000|Overall Study|Lost to Follow-up|3|||
13417172|NCT00491530|26852971|FG001|Overall Study|Lost to Follow-up|2|||
13417173|NCT00491530|26852972|FG002|Overall Study|Lost to Follow-up|2|||
13417174|NCT00491530|26852970|FG000|Overall Study|Lack of Efficacy|0|||
13417175|NCT00491530|26852971|FG001|Overall Study|Lack of Efficacy|1|||
13417176|NCT00491530|26852972|FG002|Overall Study|Lack of Efficacy|0|||
13417177|NCT00491530|26852970|FG000|Overall Study|Investigator Discretion|0|||
13417178|NCT00491530|26852971|FG001|Overall Study|Investigator Discretion|1|||
13417179|NCT00491530|26852972|FG002|Overall Study|Investigator Discretion|0|||
13417180|NCT00491530|26852970|FG000|Overall Study|Patient Request|0|||
13417181|NCT00491530|26852971|FG001|Overall Study|Patient Request|1|||
13417182|NCT00491530|26852972|FG002|Overall Study|Patient Request|0|||
13417183|NCT00491530|26852970|FG000|Overall Study|Use of Prohibited Medication|0|||
13417184|NCT00491530|26852971|FG001|Overall Study|Use of Prohibited Medication|0|||
13417185|NCT00491530|26852972|FG002|Overall Study|Use of Prohibited Medication|1|||
13417186|NCT00491504|26852993|FG000|Overall Study|Adverse Event|0|||
13417187|NCT00491504|26852994|FG001|Overall Study|Adverse Event|1|||
13417188|NCT00491504|26852995|FG002|Overall Study|Adverse Event|0|||
13417189|NCT00491504|26852996|FG003|Overall Study|Adverse Event|0|||
13417190|NCT00491504|26852993|FG000|Overall Study|Withdrawal by Subject|0|||
13417191|NCT00491504|26852994|FG001|Overall Study|Withdrawal by Subject|0|||
13417192|NCT00491504|26852995|FG002|Overall Study|Withdrawal by Subject|1|||
13417193|NCT00491504|26852996|FG003|Overall Study|Withdrawal by Subject|2|||
13417194|NCT00491504|26852993|FG000|Overall Study|Protocol Violation|0|||
13417195|NCT00491504|26852994|FG001|Overall Study|Protocol Violation|0|||
13417196|NCT00491504|26852995|FG002|Overall Study|Protocol Violation|3|||
13417197|NCT00491504|26852996|FG003|Overall Study|Protocol Violation|2|||
13417198|NCT00491400|26853011|FG000|Overall Study|Withdrawal by Subject|5|||
13417199|NCT00491400|26853012|FG001|Overall Study|Withdrawal by Subject|4|||
13417200|NCT00491387|26853018|FG000|Overall Study|study terminated|20|||
13417201|NCT00491322|26853031|FG000|Overall Study|Protocol Violation|1|||
13417202|NCT00491322|26853032|FG001|Overall Study|Protocol Violation|0|||
13417203|NCT00491322|26853031|FG000|Overall Study|Pregnancy|0|||
13417204|NCT00491322|26853032|FG001|Overall Study|Pregnancy|1|||
13417205|NCT00491179|26853047|FG000|Overall Study|Adverse Event|5|||
13417206|NCT00491179|26853048|FG001|Overall Study|Adverse Event|1|||
13417207|NCT00491179|26853047|FG000|Overall Study|Withdrawal by Subject|2|||
13417208|NCT00491179|26853048|FG001|Overall Study|Withdrawal by Subject|1|||
13417209|NCT00491075|26853054|FG000|Overall Study|Withdrawal by Subject|1|||
13417210|NCT00491075|26853054|FG000|Overall Study|Physician Decision|1|||
13417211|NCT00490971|26853106|FG000|Acute/Continuation|Adverse Event|62|||
13417212|NCT00490971|26853107|FG001|Acute/Continuation|Adverse Event|13|||
13417213|NCT00490971|26853108|FG002|Acute/Continuation|Adverse Event|0|||
13417214|NCT00490971|26853109|FG003|Acute/Continuation|Adverse Event|0|||
13417215|NCT00490971|26853110|FG004|Acute/Continuation|Adverse Event|0|||
13417216|NCT00490971|26853106|FG000|Acute/Continuation|Death|2|||
13417217|NCT00490971|26853107|FG001|Acute/Continuation|Death|0|||
13417218|NCT00490971|26853108|FG002|Acute/Continuation|Death|0|||
13417219|NCT00490971|26853109|FG003|Acute/Continuation|Death|0|||
13417220|NCT00490971|26853110|FG004|Acute/Continuation|Death|0|||
13417221|NCT00490971|26853106|FG000|Acute/Continuation|Lack of Efficacy|106|||
13417222|NCT00490971|26853107|FG001|Acute/Continuation|Lack of Efficacy|12|||
13417223|NCT00490971|26853108|FG002|Acute/Continuation|Lack of Efficacy|0|||
13417224|NCT00490971|26853109|FG003|Acute/Continuation|Lack of Efficacy|0|||
13417225|NCT00490971|26853110|FG004|Acute/Continuation|Lack of Efficacy|0|||
13417226|NCT00490971|26853106|FG000|Acute/Continuation|Lost to Follow-up|23|||
13417227|NCT00490971|26853107|FG001|Acute/Continuation|Lost to Follow-up|7|||
13417228|NCT00490971|26853108|FG002|Acute/Continuation|Lost to Follow-up|0|||
13417229|NCT00490971|26853109|FG003|Acute/Continuation|Lost to Follow-up|0|||
13417230|NCT00490971|26853110|FG004|Acute/Continuation|Lost to Follow-up|0|||
13417231|NCT00490971|26853106|FG000|Acute/Continuation|Protocol Violation|10|||
13417232|NCT00490971|26853107|FG001|Acute/Continuation|Protocol Violation|2|||
13417233|NCT00490971|26853108|FG002|Acute/Continuation|Protocol Violation|0|||
13417234|NCT00490971|26853109|FG003|Acute/Continuation|Protocol Violation|0|||
13417235|NCT00490971|26853110|FG004|Acute/Continuation|Protocol Violation|0|||
13417236|NCT00490971|26853106|FG000|Acute/Continuation|Withdrawal by Subject|92|||
13417237|NCT00490971|26853107|FG001|Acute/Continuation|Withdrawal by Subject|24|||
13417238|NCT00490971|26853108|FG002|Acute/Continuation|Withdrawal by Subject|0|||
13417239|NCT00490971|26853109|FG003|Acute/Continuation|Withdrawal by Subject|0|||
13417240|NCT00490971|26853110|FG004|Acute/Continuation|Withdrawal by Subject|0|||
13417241|NCT00490971|26853106|FG000|Acute/Continuation|Other|11|||
13417242|NCT00490971|26853107|FG001|Acute/Continuation|Other|4|||
13417243|NCT00490971|26853108|FG002|Acute/Continuation|Other|0|||
13417244|NCT00490971|26853109|FG003|Acute/Continuation|Other|0|||
13417245|NCT00490971|26853110|FG004|Acute/Continuation|Other|0|||
13417246|NCT00490971|26853106|FG000|Maintenance|Adverse Event|0|||
13417247|NCT00490971|26853107|FG001|Maintenance|Adverse Event|0|||
13417248|NCT00490971|26853108|FG002|Maintenance|Adverse Event|4|||
13417249|NCT00490971|26853109|FG003|Maintenance|Adverse Event|5|||
13417250|NCT00490971|26853110|FG004|Maintenance|Adverse Event|7|||
13417251|NCT00490971|26853106|FG000|Maintenance|Death|0|||
13417252|NCT00490971|26853107|FG001|Maintenance|Death|0|||
13417253|NCT00490971|26853108|FG002|Maintenance|Death|0|||
13417254|NCT00490971|26853109|FG003|Maintenance|Death|2|||
13417255|NCT00490971|26853110|FG004|Maintenance|Death|0|||
13417256|NCT00490971|26853106|FG000|Maintenance|Lost to Follow-up|0|||
13417257|NCT00490971|26853107|FG001|Maintenance|Lost to Follow-up|0|||
13417258|NCT00490971|26853108|FG002|Maintenance|Lost to Follow-up|5|||
13417259|NCT00490971|26853109|FG003|Maintenance|Lost to Follow-up|8|||
13417260|NCT00490971|26853110|FG004|Maintenance|Lost to Follow-up|10|||
13417261|NCT00490971|26853106|FG000|Maintenance|Pregnancy|0|||
13417262|NCT00490971|26853107|FG001|Maintenance|Pregnancy|0|||
13417263|NCT00490971|26853108|FG002|Maintenance|Pregnancy|1|||
13417264|NCT00490971|26853109|FG003|Maintenance|Pregnancy|0|||
13417265|NCT00490971|26853110|FG004|Maintenance|Pregnancy|0|||
13417266|NCT00490971|26853106|FG000|Maintenance|Protocol Violation|0|||
13417267|NCT00490971|26853107|FG001|Maintenance|Protocol Violation|0|||
13417268|NCT00490971|26853108|FG002|Maintenance|Protocol Violation|4|||
13417269|NCT00490971|26853109|FG003|Maintenance|Protocol Violation|1|||
13417270|NCT00490971|26853110|FG004|Maintenance|Protocol Violation|1|||
13417271|NCT00490971|26853106|FG000|Maintenance|Withdrawal by Subject|0|||
13417272|NCT00490971|26853107|FG001|Maintenance|Withdrawal by Subject|0|||
13417273|NCT00490971|26853108|FG002|Maintenance|Withdrawal by Subject|26|||
13417274|NCT00490971|26853109|FG003|Maintenance|Withdrawal by Subject|28|||
13417275|NCT00490971|26853110|FG004|Maintenance|Withdrawal by Subject|18|||
13417276|NCT00490971|26853106|FG000|Maintenance|Other|0|||
13417277|NCT00490971|26853107|FG001|Maintenance|Other|0|||
13417278|NCT00490971|26853108|FG002|Maintenance|Other|11|||
13417279|NCT00490971|26853109|FG003|Maintenance|Other|9|||
13417280|NCT00490971|26853110|FG004|Maintenance|Other|3|||
13417281|NCT00490945|26853160|FG000|Overall Study|Adverse Event|0|||
13417282|NCT00490945|26853161|FG001|Overall Study|Adverse Event|1|||
13417283|NCT00490945|26853162|FG002|Overall Study|Adverse Event|0|||
13417284|NCT00490945|26853163|FG003|Overall Study|Adverse Event|0|||
13417285|NCT00490945|26853164|FG004|Overall Study|Adverse Event|0|||
13417286|NCT00490919|26853183|FG000|Open-label Run-in Period|Adverse Event|239|||
13417287|NCT00490919|26853184|FG001|Open-label Run-in Period|Adverse Event|0|||
13417288|NCT00490919|26853185|FG002|Open-label Run-in Period|Adverse Event|0|||
13417289|NCT00490919|26853183|FG000|Open-label Run-in Period|Withdrawal by Subject|37|||
13417290|NCT00490919|26853184|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
13417291|NCT00490919|26853185|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
13417292|NCT00490919|26853183|FG000|Open-label Run-in Period|Lost to Follow-up|21|||
13417293|NCT00490919|26853184|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
13417294|NCT00490919|26853185|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
13417295|NCT00490919|26853183|FG000|Open-label Run-in Period|Lack of Efficacy|143|||
13417296|NCT00490919|26853184|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
13417297|NCT00490919|26853185|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
13417298|NCT00490919|26853183|FG000|Open-label Run-in Period|Administrative|40|||
13417299|NCT00490919|26853184|FG001|Open-label Run-in Period|Administrative|0|||
13417300|NCT00490919|26853185|FG002|Open-label Run-in Period|Administrative|0|||
13417301|NCT00490919|26853183|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3|||
13417302|NCT00490919|26853184|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0|||
13417303|NCT00490919|26853185|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0|||
13417304|NCT00490919|26853183|FG000|Double-blind Phase|Adverse Event|0|||
13417305|NCT00490919|26853184|FG001|Double-blind Phase|Adverse Event|40|||
13417306|NCT00490919|26853185|FG002|Double-blind Phase|Adverse Event|20|||
13417307|NCT00490919|26853183|FG000|Double-blind Phase|Withdrawal by Subject|0|||
13417308|NCT00490919|26853184|FG001|Double-blind Phase|Withdrawal by Subject|10|||
13417309|NCT00490919|26853185|FG002|Double-blind Phase|Withdrawal by Subject|11|||
13417310|NCT00490919|26853183|FG000|Double-blind Phase|Lost to Follow-up|0|||
13417311|NCT00490919|26853184|FG001|Double-blind Phase|Lost to Follow-up|8|||
13417312|NCT00490919|26853185|FG002|Double-blind Phase|Lost to Follow-up|11|||
13417313|NCT00490919|26853183|FG000|Double-blind Phase|Lack of Efficacy|0|||
13417314|NCT00490919|26853184|FG001|Double-blind Phase|Lack of Efficacy|22|||
13417315|NCT00490919|26853185|FG002|Double-blind Phase|Lack of Efficacy|36|||
13417316|NCT00490919|26853183|FG000|Double-blind Phase|Administrative|0|||
13417317|NCT00490919|26853184|FG001|Double-blind Phase|Administrative|6|||
13417318|NCT00490919|26853185|FG002|Double-blind Phase|Administrative|6|||
13417319|NCT00490841|26853207|FG000|Overall Study|Death|5|||
13417320|NCT00490841|26853207|FG000|Overall Study|Withdrawal by Subject|4|||
13417321|NCT00490841|26853207|FG000|Overall Study|Lost to Follow-up|1|||
13417322|NCT00490841|26853207|FG000|Overall Study|30 day f/u, only non-study stent used|3|||
13417323|NCT00490815|26853222|FG000|Overall Study|Adverse Event|2|||
13417324|NCT00490815|26853223|FG001|Overall Study|Adverse Event|3|||
13417325|NCT00490815|26853222|FG000|Overall Study|Withdrawal by Subject|4|||
13417326|NCT00490815|26853223|FG001|Overall Study|Withdrawal by Subject|0|||
13417327|NCT00490815|26853222|FG000|Overall Study|Lost to Follow-up|1|||
13417328|NCT00490815|26853223|FG001|Overall Study|Lost to Follow-up|3|||
13417329|NCT00490815|26853222|FG000|Overall Study|Death|1|||
13417330|NCT00490815|26853223|FG001|Overall Study|Death|3|||
13417331|NCT00490776|26853236|FG000|Overall Study|Withdrawal by Subject|1|||
13417332|NCT00490776|26853236|FG000|Overall Study|Administrative Problems|1|||
13417333|NCT00490776|26853236|FG000|Overall Study|Death|1|||
13417334|NCT00490776|26853236|FG000|Overall Study|New Cancer Therapy|1|||
13417335|NCT00490776|26853236|FG000|Overall Study|Disease Progression|5|||
13417336|NCT00490724|26853311|FG000|Period I|Physician Decision|0|||
13417337|NCT00490724|26853312|FG001|Period I|Physician Decision|0|||
13417338|NCT00490724|26853313|FG002|Period I|Physician Decision|1|||
13417339|NCT00490724|26853311|FG000|Period II|Treatment Discontinuation|3|||
13417340|NCT00490724|26853312|FG001|Period II|Treatment Discontinuation|1|||
13417341|NCT00490724|26853313|FG002|Period II|Treatment Discontinuation|3|||
13417342|NCT00490698|26853319|FG000|Overall Study|Withdrawal by Subject|1|||
13417343|NCT00490698|26853319|FG000|Overall Study|Disease Progression|7|||
13417344|NCT00490698|26853319|FG000|Overall Study|Physician Decision|2|||
13417345|NCT00490646|26853346|FG000|Overall Study|Still on trastuzumab monotherapy|1|||
13417346|NCT00490646|26853347|FG001|Overall Study|Still on trastuzumab monotherapy|1|||
13417347|NCT00490646|26853346|FG000|Overall Study|Never Treated (had an adverse event)|1|||
13417348|NCT00490646|26853347|FG001|Overall Study|Never Treated (had an adverse event)|0|||
13417349|NCT00490646|26853346|FG000|Overall Study|Never Treated (withdrew consent)|0|||
13417350|NCT00490646|26853347|FG001|Overall Study|Never Treated (withdrew consent)|1|||
13417351|NCT00490568|26853369|FG000|Overall Study|Adverse Event|116|||
13417352|NCT00490568|26853369|FG000|Overall Study|Lost to Follow-up|13|||
13417353|NCT00490568|26853369|FG000|Overall Study|Protocol Violation|45|||
13417354|NCT00490568|26853369|FG000|Overall Study|Withdrawal by Subject|135|||
13417355|NCT00490568|26853369|FG000|Overall Study|Still in the study at termination|974|||
13417356|NCT00490568|26853369|FG000|Overall Study|Other|1|||
13417357|NCT00490568|26853369|FG000|Overall Study|Exclusion criteria met|1|||
13417358|NCT00490568|26853369|FG000|Overall Study|Caregiver related|20|||
13417359|NCT00490568|26853369|FG000|Overall Study|Abnormal ECG|25|||
13417360|NCT00490568|26853369|FG000|Overall Study|Participant refused follow-up|9|||
13417361|NCT00490568|26853369|FG000|Overall Study|Legal representative withdrew consent|1|||
13417362|NCT00490568|26853369|FG000|Overall Study|Disease progression|4|||
13417363|NCT00490568|26853369|FG000|Overall Study|Unmet inclusion-exclusion criteria|5|||
13417364|NCT00490568|26853369|FG000|Overall Study|Investigator decision|3|||
13417365|NCT00490568|26853369|FG000|Overall Study|Non-Compliance|7|||
13417366|NCT00490568|26853369|FG000|Overall Study|Efficacy related|3|||
13417367|NCT00490568|26853369|FG000|Overall Study|Participant died|1|||
13417368|NCT00490568|26853369|FG000|Overall Study|Participant withdrawal due to surgery|1|||
13417369|NCT00490555|26853408|FG000|Overall Study|noncompliant with drug administration|0|||
13417370|NCT00490555|26853409|FG001|Overall Study|noncompliant with drug administration|0|||
13417371|NCT00490555|26853410|FG002|Overall Study|noncompliant with drug administration|2|||
13417372|NCT00490555|26853411|FG003|Overall Study|noncompliant with drug administration|0|||
13417373|NCT00490542|26853424|FG000|Overall Study|Lost to Follow-up|3|||
13417374|NCT00490542|26853425|FG001|Overall Study|Lost to Follow-up|0|||
13417375|NCT00490542|26853424|FG000|Overall Study|Adverse Event|3|||
13417376|NCT00490542|26853425|FG001|Overall Study|Adverse Event|3|||
13417377|NCT00490542|26853424|FG000|Overall Study|Lack of Efficacy|1|||
13417378|NCT00490542|26853425|FG001|Overall Study|Lack of Efficacy|1|||
13417379|NCT00490529|26853435|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4|||
13417380|NCT00490529|26853435|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4|||
13417381|NCT00490529|26853435|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1|||
13417382|NCT00490529|26853435|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1|||
13417383|NCT00490529|26853435|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1|||
13417384|NCT00490529|26853435|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1|||
13417385|NCT00490490|26853443|FG000|Completed Assessment for TTP|Withdrawal by Subject|1|||
13417386|NCT00490490|26853443|FG000|Completed Assessment for TTP|Lost to Follow-up|2|||
13417387|NCT00490451|26853470|FG000|Overall Study|Adverse Event|3|||
13417388|NCT00490451|26853471|FG001|Overall Study|Adverse Event|3|||
13417389|NCT00490451|26853470|FG000|Overall Study|Death|3|||
13417390|NCT00490451|26853471|FG001|Overall Study|Death|1|||
13417391|NCT00490451|26853470|FG000|Overall Study|Withdrawal by Subject|2|||
13417392|NCT00490451|26853471|FG001|Overall Study|Withdrawal by Subject|0|||
13417393|NCT00490451|26853470|FG000|Overall Study|Investigator Decision|1|||
13417394|NCT00490451|26853471|FG001|Overall Study|Investigator Decision|0|||
13417395|NCT00490451|26853470|FG000|Overall Study|Protocol Violation|1|||
13417396|NCT00490451|26853471|FG001|Overall Study|Protocol Violation|0|||
13417397|NCT00490451|26853470|FG000|Overall Study|Progressive Disease|53|||
13417398|NCT00490451|26853471|FG001|Overall Study|Progressive Disease|34|||
13417399|NCT00490282|26853479|FG000|Overall Study|Withdrawal by Subject|3|||
13417400|NCT00490139|26853522|FG000|Overall Study|Death|106|||
13417401|NCT00490139|26853523|FG001|Overall Study|Death|119|||
13417402|NCT00490139|26853524|FG002|Overall Study|Death|168|||
13417403|NCT00490139|26853525|FG003|Overall Study|Death|135|||
13417404|NCT00490139|26853522|FG000|Overall Study|Lost to Follow-up|56|||
13417405|NCT00490139|26853523|FG001|Overall Study|Lost to Follow-up|46|||
13417406|NCT00490139|26853524|FG002|Overall Study|Lost to Follow-up|58|||
13417407|NCT00490139|26853525|FG003|Overall Study|Lost to Follow-up|56|||
13417408|NCT00490139|26853522|FG000|Overall Study|Participant Withdrew Consent|146|||
13417409|NCT00490139|26853523|FG001|Overall Study|Participant Withdrew Consent|110|||
13417410|NCT00490139|26853524|FG002|Overall Study|Participant Withdrew Consent|208|||
13417411|NCT00490139|26853525|FG003|Overall Study|Participant Withdrew Consent|116|||
13417412|NCT00490061|26853532|FG000|Overall Study|Physician Decision|1|||
13417413|NCT00490035|26853643|FG000|Overall Study|AE, non-serious non-fatal|3|||
13417414|NCT00490035|26853644|FG001|Overall Study|AE, non-serious non-fatal|4|||
13417415|NCT00490035|26853645|FG002|Overall Study|AE, non-serious non-fatal|4|||
13417416|NCT00490035|26853646|FG003|Overall Study|AE, non-serious non-fatal|5|||
13417417|NCT00490035|26853643|FG000|Overall Study|Lost to Follow-up|2|||
13417418|NCT00490035|26853644|FG001|Overall Study|Lost to Follow-up|0|||
13417419|NCT00490035|26853645|FG002|Overall Study|Lost to Follow-up|1|||
13417420|NCT00490035|26853646|FG003|Overall Study|Lost to Follow-up|0|||
13417421|NCT00490035|26853643|FG000|Overall Study|Withdrawal by Subject|2|||
13417422|NCT00490035|26853644|FG001|Overall Study|Withdrawal by Subject|1|||
13417423|NCT00490035|26853645|FG002|Overall Study|Withdrawal by Subject|1|||
13417424|NCT00490035|26853646|FG003|Overall Study|Withdrawal by Subject|0|||
13417425|NCT00490035|26853643|FG000|Overall Study|Other reason|0|||
13417426|NCT00490035|26853644|FG001|Overall Study|Other reason|1|||
13417427|NCT00490035|26853645|FG002|Overall Study|Other reason|3|||
13417428|NCT00490035|26853646|FG003|Overall Study|Other reason|1|||
13417429|NCT00490035|26853643|FG000|Overall Study|AE, serious fatal|1|||
13417430|NCT00490035|26853644|FG001|Overall Study|AE, serious fatal|0|||
13417431|NCT00490035|26853645|FG002|Overall Study|AE, serious fatal|0|||
13417432|NCT00490035|26853646|FG003|Overall Study|AE, serious fatal|0|||
13417433|NCT00490035|26853643|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0|||
13417434|NCT00490035|26853644|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0|||
13417435|NCT00490035|26853645|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1|||
13417436|NCT00490035|26853646|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0|||
13417437|NCT00490035|26853643|FG000|Overall Study|AE of unknown type|0|||
13417438|NCT00490035|26853644|FG001|Overall Study|AE of unknown type|0|||
13417439|NCT00490035|26853645|FG002|Overall Study|AE of unknown type|2|||
13417440|NCT00490035|26853646|FG003|Overall Study|AE of unknown type|0|||
13417441|NCT00490022|26853661|FG000|Overall Study|Adverse Event|0|||
13417442|NCT00490022|26853662|FG001|Overall Study|Adverse Event|2|||
13417443|NCT00490022|26853661|FG000|Overall Study|Withdrawal by Subject|1|||
13417444|NCT00490022|26853662|FG001|Overall Study|Withdrawal by Subject|0|||
13417445|NCT00490022|26853661|FG000|Overall Study|Subject failed to disclose concommitant|0|||
13417446|NCT00490022|26853662|FG001|Overall Study|Subject failed to disclose concommitant|1|||
13417447|NCT00489970|26853771|FG000|Persistence Year 9|Lost to Follow-up|2|||
13417448|NCT00489970|26853772|FG001|Persistence Year 9|Lost to Follow-up|2|||
13417449|NCT00489970|26853773|FG002|Persistence Year 9|Lost to Follow-up|3|||
13417450|NCT00489970|26853771|FG000|Persistence Year 9|Other|1|||
13390500|NCT00686036|26773838|FG001|Overall Study|PSA ≥ 10ng/mL|0|||
13390501|NCT00686036|26773837|FG000|Overall Study|Other reasons not identified|0|||
13390502|NCT00686036|26773838|FG001|Overall Study|Other reasons not identified|4|||
13390503|NCT00685945|26773855|FG000|L-NMMA + Bradykinin|Physician Decision|1|||
13390504|NCT00685802|26773868|FG000|Washout Period of 7 Days|Protocol Violation|2|||
13390505|NCT00685802|26773869|FG001|Washout Period of 7 Days|Protocol Violation|0|||
13390506|NCT00685802|26773868|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
13390507|NCT00685802|26773869|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
13390508|NCT00685763|26773875|FG000|Overall Study|Intercurrent death-incomplete treatment|1|||
13390509|NCT00685763|26773875|FG000|Overall Study|Protocol Violation|1|||
13390510|NCT00685750|26773925|FG000|Overall Study|Tumor sampling failure|0|||
13390511|NCT00685750|26773926|FG001|Overall Study|Tumor sampling failure|0|||
13390512|NCT00685750|26773927|FG002|Overall Study|Tumor sampling failure|1|||
13390513|NCT00685750|26773928|FG003|Overall Study|Tumor sampling failure|0|||
13417451|NCT00489970|26853772|FG001|Persistence Year 9|Other|0|||
13417452|NCT00489970|26853773|FG002|Persistence Year 9|Other|2|||
13417453|NCT00489918|26853821|FG000|Overall Study|Withdrawal by Subject|2|||
13417454|NCT00489918|26853822|FG001|Overall Study|Withdrawal by Subject|1|||
13417455|NCT00489918|26853823|FG002|Overall Study|Withdrawal by Subject|1|||
13417456|NCT00489918|26853824|FG003|Overall Study|Withdrawal by Subject|0|||
13417457|NCT00489918|26853825|FG004|Overall Study|Withdrawal by Subject|1|||
13417458|NCT00489918|26853821|FG000|Overall Study|Adverse Event|0|||
13417459|NCT00489918|26853822|FG001|Overall Study|Adverse Event|1|||
13417460|NCT00489918|26853823|FG002|Overall Study|Adverse Event|1|||
13417461|NCT00489918|26853824|FG003|Overall Study|Adverse Event|0|||
13417462|NCT00489918|26853825|FG004|Overall Study|Adverse Event|0|||
13417463|NCT00489918|26853821|FG000|Overall Study|Lost to Follow-up|0|||
13417464|NCT00489918|26853822|FG001|Overall Study|Lost to Follow-up|0|||
13417465|NCT00489918|26853823|FG002|Overall Study|Lost to Follow-up|1|||
13417466|NCT00489918|26853824|FG003|Overall Study|Lost to Follow-up|1|||
13417467|NCT00489918|26853825|FG004|Overall Study|Lost to Follow-up|0|||
13417468|NCT00489918|26853821|FG000|Overall Study|Physician Decision|0|||
13417469|NCT00489918|26853822|FG001|Overall Study|Physician Decision|0|||
13417470|NCT00489918|26853823|FG002|Overall Study|Physician Decision|1|||
13417471|NCT00489918|26853824|FG003|Overall Study|Physician Decision|0|||
13417472|NCT00489918|26853825|FG004|Overall Study|Physician Decision|0|||
13417473|NCT00489853|26853924|FG000|Wash-out Period 1|Withdrawal by Subject|1|||
13417474|NCT00489853|26853925|FG001|Wash-out Period 1|Withdrawal by Subject|0|||
13417475|NCT00489853|26853926|FG002|Wash-out Period 1|Withdrawal by Subject|0|||
13417476|NCT00489853|26853924|FG000|Wash-out Period 1|Adverse Event|0|||
13417477|NCT00489853|26853925|FG001|Wash-out Period 1|Adverse Event|1|||
13417478|NCT00489853|26853926|FG002|Wash-out Period 1|Adverse Event|1|||
13417479|NCT00489853|26853924|FG000|Wash-out Period 1|Protocol Violation|0|||
13417480|NCT00489853|26853925|FG001|Wash-out Period 1|Protocol Violation|1|||
13417481|NCT00489853|26853926|FG002|Wash-out Period 1|Protocol Violation|1|||
13417482|NCT00489853|26853924|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0|||
13417483|NCT00489853|26853925|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1|||
13417484|NCT00489853|26853926|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4|||
13417485|NCT00489853|26853924|FG000|Wash-out Period 2|Adverse Event|1|||
13417486|NCT00489853|26853925|FG001|Wash-out Period 2|Adverse Event|1|||
13417487|NCT00489853|26853926|FG002|Wash-out Period 2|Adverse Event|0|||
13417488|NCT00489853|26853924|FG000|Wash-out Period 2|Study specific discontinuation criteria|3|||
13417489|NCT00489853|26853925|FG001|Wash-out Period 2|Study specific discontinuation criteria|2|||
13417490|NCT00489853|26853926|FG002|Wash-out Period 2|Study specific discontinuation criteria|2|||
13417491|NCT00489853|26853924|FG000|Treatment Period 3|Study specific discontinuation criteria|0|||
13417492|NCT00489853|26853925|FG001|Treatment Period 3|Study specific discontinuation criteria|1|||
13417493|NCT00489853|26853926|FG002|Treatment Period 3|Study specific discontinuation criteria|0|||
13417494|NCT00489736|26853943|FG000|Overall Study|Lack of Efficacy|53|||
13417495|NCT00489736|26853944|FG001|Overall Study|Lack of Efficacy|14|||
13417496|NCT00489736|26853943|FG000|Overall Study|Adverse Event|32|||
13417497|NCT00489736|26853944|FG001|Overall Study|Adverse Event|45|||
13417498|NCT00489736|26853943|FG000|Overall Study|Poor compliance|6|||
13417499|NCT00489736|26853944|FG001|Overall Study|Poor compliance|2|||
13417500|NCT00489736|26853943|FG000|Overall Study|Not coded/ Not pre-specified|5|||
13417501|NCT00489736|26853944|FG001|Overall Study|Not coded/ Not pre-specified|8|||
13417502|NCT00489554|26853964|FG000|Overall Study|Adverse Event|2|||
13417503|NCT00489554|26853964|FG000|Overall Study|Withdrawal by Subject|1|||
13417504|NCT00489554|26853964|FG000|Overall Study|Lost to Follow-up|1|||
13417505|NCT00489541|26853979|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2|||
13417506|NCT00489541|26853980|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3|||
13417507|NCT00489541|26853979|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
13417508|NCT00489541|26853980|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0|||
13417509|NCT00489541|26853979|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2|||
13417510|NCT00489541|26853980|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0|||
13417511|NCT00489541|26853979|FG000|12-Month Clinical Follow-up|Death|3|||
13417512|NCT00489541|26853980|FG001|12-Month Clinical Follow-up|Death|2|||
13417513|NCT00489541|26853979|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23|||
13417514|NCT00489541|26853980|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12|||
13417515|NCT00489541|26853979|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4|||
13417516|NCT00489541|26853980|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5|||
13417517|NCT00489489|26854018|FG000|Overall Study|Not treated due to protocol violation|0|||
13417518|NCT00489489|26854019|FG001|Overall Study|Not treated due to protocol violation|1|||
13417519|NCT00489489|26854020|FG002|Overall Study|Not treated due to protocol violation|1|||
13417520|NCT00489489|26854018|FG000|Overall Study|Adverse Event|1|||
13417521|NCT00489489|26854019|FG001|Overall Study|Adverse Event|1|||
13417522|NCT00489489|26854020|FG002|Overall Study|Adverse Event|1|||
13417523|NCT00489489|26854018|FG000|Overall Study|Protocol Violation|1|||
13417524|NCT00489489|26854019|FG001|Overall Study|Protocol Violation|0|||
13417525|NCT00489489|26854020|FG002|Overall Study|Protocol Violation|1|||
13417526|NCT00489489|26854018|FG000|Overall Study|Progressive disease|0|||
13417527|NCT00489489|26854019|FG001|Overall Study|Progressive disease|1|||
13417528|NCT00489489|26854020|FG002|Overall Study|Progressive disease|0|||
13417529|NCT00489489|26854018|FG000|Overall Study|Participant did not wish to continue|1|||
13417530|NCT00489489|26854019|FG001|Overall Study|Participant did not wish to continue|1|||
13417531|NCT00489489|26854020|FG002|Overall Study|Participant did not wish to continue|0|||
13417532|NCT00489489|26854018|FG000|Overall Study|Other than above|0|||
13417533|NCT00489489|26854019|FG001|Overall Study|Other than above|1|||
13417534|NCT00489489|26854020|FG002|Overall Study|Other than above|0|||
13417535|NCT00489476|26854051|FG000|Overall Study|Lost to Follow-up|0|||
13417536|NCT00489476|26854052|FG001|Overall Study|Lost to Follow-up|1|||
13417537|NCT00489476|26854053|FG002|Overall Study|Lost to Follow-up|0|||
13417538|NCT00489476|26854054|FG003|Overall Study|Lost to Follow-up|0|||
13417539|NCT00489424|26854093|FG000|Overall Study|Adverse Event|3|||
13417540|NCT00489424|26854094|FG001|Overall Study|Adverse Event|3|||
13417541|NCT00489424|26854095|FG002|Overall Study|Adverse Event|4|||
13417542|NCT00489424|26854093|FG000|Overall Study|Lack of Efficacy|1|||
13417543|NCT00489424|26854094|FG001|Overall Study|Lack of Efficacy|0|||
13417544|NCT00489424|26854095|FG002|Overall Study|Lack of Efficacy|0|||
13417545|NCT00489424|26854093|FG000|Overall Study|Administrative problems|0|||
13417546|NCT00489424|26854094|FG001|Overall Study|Administrative problems|2|||
13417547|NCT00489424|26854095|FG002|Overall Study|Administrative problems|1|||
13417548|NCT00489411|26854114|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6|||
13417549|NCT00489411|26854115|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5|||
13417550|NCT00489411|26854114|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21|||
13417551|NCT00489411|26854115|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12|||
13417552|NCT00489411|26854114|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1|||
13417553|NCT00489411|26854115|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5|||
13417554|NCT00489411|26854114|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11|||
13417555|NCT00489411|26854115|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12|||
13417556|NCT00489411|26854114|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
13417557|NCT00489411|26854115|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
13417558|NCT00489359|26854145|FG000|Overall Study|Death|0|||
13417559|NCT00489359|26854146|FG001|Overall Study|Death|2|||
13417560|NCT00489359|26854145|FG000|Overall Study|Progressive Disease|5|||
13417561|NCT00489359|26854146|FG001|Overall Study|Progressive Disease|6|||
13417562|NCT00489359|26854145|FG000|Overall Study|Lost to Follow-up|1|||
13417563|NCT00489359|26854146|FG001|Overall Study|Lost to Follow-up|0|||
13417564|NCT00489359|26854145|FG000|Overall Study|Withdrawal by Subject|1|||
13417565|NCT00489359|26854146|FG001|Overall Study|Withdrawal by Subject|5|||
13417566|NCT00489359|26854145|FG000|Overall Study|Adverse Event|0|||
13417567|NCT00489359|26854146|FG001|Overall Study|Adverse Event|16|||
13417568|NCT00489255|26854201|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9|||
13417569|NCT00489255|26854202|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3|||
13417570|NCT00489255|26854201|FG000|Period 1: Days 1 to 28|Adverse Event|21|||
13417571|NCT00489255|26854202|FG001|Period 1: Days 1 to 28|Adverse Event|8|||
13417572|NCT00489255|26854201|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5|||
13417573|NCT00489255|26854202|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0|||
13417574|NCT00489255|26854201|FG000|Period 1: Days 1 to 28|Physician Decision|1|||
13417575|NCT00489255|26854202|FG001|Period 1: Days 1 to 28|Physician Decision|4|||
13417576|NCT00489255|26854201|FG000|Period 1: Days 1 to 28|Noncompliance|2|||
13417577|NCT00489255|26854202|FG001|Period 1: Days 1 to 28|Noncompliance|0|||
13417578|NCT00489255|26854201|FG000|Period 2: Days 29 to 56|Adverse Event|3|||
13417579|NCT00489255|26854202|FG001|Period 2: Days 29 to 56|Adverse Event|1|||
13417580|NCT00489255|26854201|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0|||
13417581|NCT00489255|26854202|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3|||
13417582|NCT00489255|26854201|FG000|Period 3: Days 57 to 84|Adverse Event|3|||
13417583|NCT00489255|26854202|FG001|Period 3: Days 57 to 84|Adverse Event|3|||
13417584|NCT00489255|26854201|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1|||
13417585|NCT00489255|26854202|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0|||
13417586|NCT00489255|26854201|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0|||
13417587|NCT00489255|26854202|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1|||
13417588|NCT00489216|26854213|FG000|Overall Study|Adverse Event|1|||
13417589|NCT00488982|26854231|FG000|Course 1|Physician Decision|0|||
13417590|NCT00488982|26854232|FG001|Course 1|Physician Decision|2|||
13417591|NCT00488982|26854233|FG002|Course 1|Physician Decision|4|||
13417592|NCT00488982|26854231|FG000|Course 1|Withdrawal by Subject|0|||
13417593|NCT00488982|26854232|FG001|Course 1|Withdrawal by Subject|8|||
13417594|NCT00488982|26854233|FG002|Course 1|Withdrawal by Subject|2|||
13417595|NCT00488982|26854231|FG000|Course 1|nonprotocol therapy|0|||
13417596|NCT00488982|26854232|FG001|Course 1|nonprotocol therapy|2|||
13417597|NCT00488982|26854233|FG002|Course 1|nonprotocol therapy|2|||
13417598|NCT00488982|26854231|FG000|Course 1|Adverse Event|0|||
13417599|NCT00488982|26854232|FG001|Course 1|Adverse Event|0|||
13417600|NCT00488982|26854233|FG002|Course 1|Adverse Event|6|||
13417601|NCT00488826|26854254|FG000|Overall Study|Withdrawal by Subject|40|||
13417602|NCT00488826|26854255|FG001|Overall Study|Withdrawal by Subject|35|||
13417603|NCT00488826|26854256|FG002|Overall Study|Withdrawal by Subject|19|||
13417604|NCT00488826|26854254|FG000|Overall Study|Protocol Violation|0|||
13417605|NCT00488826|26854255|FG001|Overall Study|Protocol Violation|0|||
13417606|NCT00488826|26854256|FG002|Overall Study|Protocol Violation|2|||
13417607|NCT00488826|26854254|FG000|Overall Study|Adverse Event|9|||
13417608|NCT00488826|26854255|FG001|Overall Study|Adverse Event|15|||
13417609|NCT00488826|26854256|FG002|Overall Study|Adverse Event|4|||
13417610|NCT00488826|26854254|FG000|Overall Study|Lost to Follow-up|5|||
13417611|NCT00488826|26854255|FG001|Overall Study|Lost to Follow-up|1|||
13417612|NCT00488826|26854256|FG002|Overall Study|Lost to Follow-up|0|||
13417613|NCT00488826|26854254|FG000|Overall Study|Protocol Deviations|2|||
13417614|NCT00488826|26854255|FG001|Overall Study|Protocol Deviations|1|||
13417615|NCT00488826|26854256|FG002|Overall Study|Protocol Deviations|1|||
13417616|NCT00488774|26854283|FG000|Overall Study|Withdrawal of consent|2|||
13417617|NCT00488774|26854284|FG001|Overall Study|Withdrawal of consent|2|||
13417618|NCT00488774|26854285|FG002|Overall Study|Withdrawal of consent|2|||
13417619|NCT00488774|26854286|FG003|Overall Study|Withdrawal of consent|0|||
13417620|NCT00488774|26854283|FG000|Overall Study|Other|6|||
13417621|NCT00488774|26854284|FG001|Overall Study|Other|3|||
13417622|NCT00488774|26854285|FG002|Overall Study|Other|2|||
13417623|NCT00488774|26854286|FG003|Overall Study|Other|2|||
13417624|NCT00488774|26854283|FG000|Overall Study|Lost to Follow-up|0|||
13417625|NCT00488774|26854284|FG001|Overall Study|Lost to Follow-up|0|||
13417626|NCT00488774|26854285|FG002|Overall Study|Lost to Follow-up|1|||
13417627|NCT00488774|26854286|FG003|Overall Study|Lost to Follow-up|1|||
13417628|NCT00488683|26854355|FG000|Overall Study|Withdrawal by Subject|1|||
13417629|NCT00488683|26854356|FG001|Overall Study|Withdrawal by Subject|2|||
13417630|NCT00488683|26854357|FG002|Overall Study|Withdrawal by Subject|2|||
13417631|NCT00488683|26854355|FG000|Overall Study|Lost to Follow-up|5|||
13417632|NCT00488683|26854356|FG001|Overall Study|Lost to Follow-up|3|||
13417633|NCT00488683|26854357|FG002|Overall Study|Lost to Follow-up|0|||
13417634|NCT00488683|26854355|FG000|Overall Study|Protocol Violation|5|||
13417635|NCT00488683|26854356|FG001|Overall Study|Protocol Violation|1|||
13417636|NCT00488683|26854357|FG002|Overall Study|Protocol Violation|0|||
13417637|NCT00488683|26854355|FG000|Overall Study|Unable to Classify|1|||
13417638|NCT00488683|26854356|FG001|Overall Study|Unable to Classify|0|||
13417639|NCT00488683|26854357|FG002|Overall Study|Unable to Classify|0|||
13417640|NCT00488644|26854363|FG000|Overall Study|Not Eligible|1|||
13417641|NCT00488644|26854363|FG000|Overall Study|Not Evaluable|1|||
13417642|NCT00488631|26854421|FG000|Double Blind Period (Week 0-54)|Adverse Event|17|||
13417643|NCT00488631|26854422|FG001|Double Blind Period (Week 0-54)|Adverse Event|12|||
13417644|NCT00488631|26854423|FG002|Double Blind Period (Week 0-54)|Adverse Event|12|||
13417645|NCT00488631|26854424|FG003|Double Blind Period (Week 0-54)|Adverse Event|12|||
13417646|NCT00488631|26854425|FG004|Double Blind Period (Week 0-54)|Adverse Event|30|||
13417647|NCT00488631|26854426|FG005|Double Blind Period (Week 0-54)|Adverse Event|50|||
13417648|NCT00488631|26854427|FG006|Double Blind Period (Week 0-54)|Adverse Event|0|||
13417649|NCT00488631|26854428|FG007|Double Blind Period (Week 0-54)|Adverse Event|0|||
13417650|NCT00488631|26854429|FG008|Double Blind Period (Week 0-54)|Adverse Event|0|||
13417651|NCT00488631|26854430|FG009|Double Blind Period (Week 0-54)|Adverse Event|0|||
13417652|NCT00488631|26854421|FG000|Double Blind Period (Week 0-54)|Death|0|||
13417653|NCT00488631|26854422|FG001|Double Blind Period (Week 0-54)|Death|0|||
13417654|NCT00488631|26854423|FG002|Double Blind Period (Week 0-54)|Death|0|||
13417655|NCT00488631|26854424|FG003|Double Blind Period (Week 0-54)|Death|0|||
13417656|NCT00488631|26854425|FG004|Double Blind Period (Week 0-54)|Death|0|||
13417657|NCT00488631|26854426|FG005|Double Blind Period (Week 0-54)|Death|1|||
13417658|NCT00488631|26854427|FG006|Double Blind Period (Week 0-54)|Death|0|||
13417659|NCT00488631|26854428|FG007|Double Blind Period (Week 0-54)|Death|0|||
13417660|NCT00488631|26854429|FG008|Double Blind Period (Week 0-54)|Death|0|||
13417661|NCT00488631|26854430|FG009|Double Blind Period (Week 0-54)|Death|0|||
13417662|NCT00488631|26854421|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19|||
13417663|NCT00488631|26854422|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17|||
13417664|NCT00488631|26854423|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22|||
13417665|NCT00488631|26854424|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18|||
13417666|NCT00488631|26854425|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56|||
13417667|NCT00488631|26854426|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124|||
13417668|NCT00488631|26854427|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
13417669|NCT00488631|26854428|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
13417670|NCT00488631|26854429|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
13417671|NCT00488631|26854430|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
13417672|NCT00488631|26854421|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
13417673|NCT00488631|26854422|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2|||
13417674|NCT00488631|26854423|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
13417675|NCT00488631|26854424|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
13417676|NCT00488631|26854425|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3|||
13417677|NCT00488631|26854426|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7|||
13417678|NCT00488631|26854427|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
13417679|NCT00488631|26854428|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
13417680|NCT00488631|26854429|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
13417681|NCT00488631|26854430|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
13417682|NCT00488631|26854421|FG000|Double Blind Period (Week 0-54)|Other|6|||
13417683|NCT00488631|26854422|FG001|Double Blind Period (Week 0-54)|Other|12|||
13417684|NCT00488631|26854423|FG002|Double Blind Period (Week 0-54)|Other|10|||
13417685|NCT00488631|26854424|FG003|Double Blind Period (Week 0-54)|Other|11|||
13417686|NCT00488631|26854425|FG004|Double Blind Period (Week 0-54)|Other|14|||
13417687|NCT00488631|26854426|FG005|Double Blind Period (Week 0-54)|Other|34|||
13417688|NCT00488631|26854427|FG006|Double Blind Period (Week 0-54)|Other|0|||
13417689|NCT00488631|26854428|FG007|Double Blind Period (Week 0-54)|Other|0|||
13417690|NCT00488631|26854429|FG008|Double Blind Period (Week 0-54)|Other|0|||
13417691|NCT00488631|26854430|FG009|Double Blind Period (Week 0-54)|Other|0|||
13417692|NCT00488631|26854421|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
13417693|NCT00488631|26854422|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
13417694|NCT00488631|26854423|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
13417695|NCT00488631|26854424|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
13417696|NCT00488631|26854425|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
13417697|NCT00488631|26854426|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
13417698|NCT00488631|26854427|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10|||
13417699|NCT00488631|26854428|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8|||
13417700|NCT00488631|26854429|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54|||
13417701|NCT00488631|26854430|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
13417702|NCT00488631|26854421|FG000|Open Label Study Extension (Week 54-228)|Death|0|||
13417703|NCT00488631|26854422|FG001|Open Label Study Extension (Week 54-228)|Death|0|||
13417704|NCT00488631|26854423|FG002|Open Label Study Extension (Week 54-228)|Death|0|||
13417705|NCT00488631|26854424|FG003|Open Label Study Extension (Week 54-228)|Death|0|||
13417706|NCT00488631|26854425|FG004|Open Label Study Extension (Week 54-228)|Death|0|||
13417707|NCT00488631|26854426|FG005|Open Label Study Extension (Week 54-228)|Death|0|||
13417708|NCT00488631|26854427|FG006|Open Label Study Extension (Week 54-228)|Death|0|||
13417709|NCT00488631|26854428|FG007|Open Label Study Extension (Week 54-228)|Death|0|||
13417710|NCT00488631|26854429|FG008|Open Label Study Extension (Week 54-228)|Death|1|||
13417711|NCT00488631|26854430|FG009|Open Label Study Extension (Week 54-228)|Death|0|||
13417712|NCT00488631|26854421|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
13417713|NCT00488631|26854422|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
13417714|NCT00488631|26854423|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
13417715|NCT00488631|26854424|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
13417716|NCT00488631|26854425|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
13417717|NCT00488631|26854426|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
13417718|NCT00488631|26854427|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
13417719|NCT00488631|26854428|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
13417720|NCT00488631|26854429|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34|||
13417721|NCT00488631|26854430|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3|||
13417722|NCT00488631|26854421|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
13417723|NCT00488631|26854422|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
13417724|NCT00488631|26854423|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
13417725|NCT00488631|26854424|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
13417726|NCT00488631|26854425|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
13417727|NCT00488631|26854426|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
13417728|NCT00488631|26854427|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2|||
13417729|NCT00488631|26854428|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
13417730|NCT00488631|26854429|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6|||
13417731|NCT00488631|26854430|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
13417732|NCT00488631|26854421|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
13417733|NCT00488631|26854422|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
13417734|NCT00488631|26854423|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
13417735|NCT00488631|26854424|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
13417736|NCT00488631|26854425|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
13417737|NCT00488631|26854426|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
13417738|NCT00488631|26854427|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63|||
13417739|NCT00488631|26854428|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14|||
13417740|NCT00488631|26854429|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87|||
13417741|NCT00488631|26854430|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
13417742|NCT00488618|26854445|FG000|Overall Study|Adverse Event|13|||
13417743|NCT00488618|26854446|FG001|Overall Study|Adverse Event|17|||
13417744|NCT00488618|26854445|FG000|Overall Study|Insufficient Therapeutic Response|18|||
13417745|NCT00488618|26854446|FG001|Overall Study|Insufficient Therapeutic Response|11|||
13417746|NCT00488618|26854445|FG000|Overall Study|Protocol Violation|0|||
13417747|NCT00488618|26854446|FG001|Overall Study|Protocol Violation|2|||
13417748|NCT00488618|26854445|FG000|Overall Study|Withdrawal of Consent|15|||
13417749|NCT00488618|26854446|FG001|Overall Study|Withdrawal of Consent|13|||
13417750|NCT00488618|26854445|FG000|Overall Study|Lost to Follow-up|1|||
13417751|NCT00488618|26854446|FG001|Overall Study|Lost to Follow-up|0|||
13417752|NCT00488592|26854453|FG000|Overall Study|Withdrawal by Subject|1|||
13417753|NCT00488592|26854453|FG000|Overall Study|Disease progression|1|||
13417754|NCT00488592|26854453|FG000|Overall Study|Enrolled but not treated|1|||
13417755|NCT00488514|26854528|FG000|Overall Study|Adverse Event|41|||
13417756|NCT00488514|26854528|FG000|Overall Study|Lost to Follow-up|44|||
13417757|NCT00488514|26854528|FG000|Overall Study|Protocol Violation|32|||
13417758|NCT00488514|26854528|FG000|Overall Study|Withdrawal by Subject|106|||
13417759|NCT00488514|26854528|FG000|Overall Study|Lack of Efficacy|28|||
13417760|NCT00488514|26854528|FG000|Overall Study|Did not meet criteria for treatment|30|||
13417761|NCT00488514|26854528|FG000|Overall Study|Postive drug screen|1|||
13417762|NCT00488514|26854528|FG000|Overall Study|Withdrawn per medical monitor decision|2|||
13417763|NCT00488514|26854528|FG000|Overall Study|Investigator decision|1|||
13417764|NCT00488514|26854528|FG000|Overall Study|Participant had too few migraines|5|||
13417765|NCT00488514|26854528|FG000|Overall Study|Increase in number of migraines|2|||
13417766|NCT00488514|26854528|FG000|Overall Study|Increased use of concomitant medication|1|||
13417767|NCT00488475|26854556|FG000|Overall Study|Other|1754|||
13417768|NCT00488345|26854589|FG000|Overall Study|Adverse Event|0|||
13417769|NCT00488345|26854590|FG001|Overall Study|Adverse Event|1|||
13417770|NCT00488345|26854591|FG002|Overall Study|Adverse Event|1|||
13417771|NCT00488345|26854589|FG000|Overall Study|Unable to administer antibiotics at home|0|||
13417772|NCT00488345|26854590|FG001|Overall Study|Unable to administer antibiotics at home|1|||
13417773|NCT00488345|26854591|FG002|Overall Study|Unable to administer antibiotics at home|0|||
13417774|NCT00488345|26854589|FG000|Overall Study|Institutional Review Board review|0|||
13417775|NCT00488345|26854590|FG001|Overall Study|Institutional Review Board review|0|||
13417776|NCT00488345|26854591|FG002|Overall Study|Institutional Review Board review|1|||
13417777|NCT00488345|26854589|FG000|Overall Study|Surgical team recommendation|0|||
13417778|NCT00488345|26854590|FG001|Overall Study|Surgical team recommendation|1|||
13417779|NCT00488345|26854591|FG002|Overall Study|Surgical team recommendation|0|||
13417780|NCT00488345|26854589|FG000|Overall Study|Parent/legal guardian request|0|||
13417781|NCT00488345|26854590|FG001|Overall Study|Parent/legal guardian request|1|||
13417782|NCT00488345|26854591|FG002|Overall Study|Parent/legal guardian request|1|||
13417783|NCT00488319|26854686|FG000|Overall Study|Adverse Event|1|||
13417784|NCT00488319|26854687|FG001|Overall Study|Adverse Event|2|||
13417785|NCT00488319|26854688|FG002|Overall Study|Adverse Event|23|||
13417786|NCT00488319|26854686|FG000|Overall Study|Lack of Efficacy|6|||
13417787|NCT00488319|26854687|FG001|Overall Study|Lack of Efficacy|12|||
13417788|NCT00488319|26854688|FG002|Overall Study|Lack of Efficacy|27|||
13417789|NCT00488319|26854686|FG000|Overall Study|Lost to Follow-up|3|||
13417790|NCT00488319|26854687|FG001|Overall Study|Lost to Follow-up|5|||
13417791|NCT00488319|26854688|FG002|Overall Study|Lost to Follow-up|16|||
13417792|NCT00488319|26854686|FG000|Overall Study|Withdrawal by Subject|5|||
13417793|NCT00488319|26854687|FG001|Overall Study|Withdrawal by Subject|20|||
13417794|NCT00488319|26854688|FG002|Overall Study|Withdrawal by Subject|44|||
13417795|NCT00488319|26854686|FG000|Overall Study|Other reasons for withdrawal|0|||
13417796|NCT00488319|26854687|FG001|Overall Study|Other reasons for withdrawal|4|||
13417797|NCT00488319|26854688|FG002|Overall Study|Other reasons for withdrawal|12|||
13417798|NCT00488293|26854719|FG000|Overall Study|Lost to Follow-up|28|||
13417799|NCT00488293|26854720|FG001|Overall Study|Lost to Follow-up|25|||
13417800|NCT00488293|26854719|FG000|Overall Study|Withdrawal by Subject|5|||
13417801|NCT00488293|26854720|FG001|Overall Study|Withdrawal by Subject|3|||
13417802|NCT00488293|26854719|FG000|Overall Study|Death|2|||
13417803|NCT00488293|26854720|FG001|Overall Study|Death|1|||
13417804|NCT00488293|26854719|FG000|Overall Study|Misrandomization/Other Unspecified|1|||
13417805|NCT00488293|26854720|FG001|Overall Study|Misrandomization/Other Unspecified|1|||
13476578|NCT01403948|27003325|FG000|Overall Study|Progressive disease|0|||
13476579|NCT01403948|27003326|FG001|Overall Study|Progressive disease|2|||
13476580|NCT01403948|27003327|FG002|Overall Study|Progressive disease|2|||
13476581|NCT01403948|27003328|FG003|Overall Study|Progressive disease|4|||
13476582|NCT01403948|27003329|FG004|Overall Study|Progressive disease|2|||
13476583|NCT01403948|27003330|FG005|Overall Study|Progressive disease|6|||
13476584|NCT01403948|27003331|FG006|Overall Study|Progressive disease|2|||
13476585|NCT01403948|27003332|FG007|Overall Study|Progressive disease|4|||
13476586|NCT01403948|27003333|FG008|Overall Study|Progressive disease|5|||
13476587|NCT01403948|27003334|FG009|Overall Study|Progressive disease|5|||
13476588|NCT01403948|27003325|FG000|Overall Study|Other Adverse Event (Other than DLT)|0|||
13476589|NCT01403948|27003326|FG001|Overall Study|Other Adverse Event (Other than DLT)|0|||
13476590|NCT01403948|27003327|FG002|Overall Study|Other Adverse Event (Other than DLT)|0|||
13476591|NCT01403948|27003328|FG003|Overall Study|Other Adverse Event (Other than DLT)|0|||
13476592|NCT01403948|27003329|FG004|Overall Study|Other Adverse Event (Other than DLT)|2|||
13476593|NCT01403948|27003330|FG005|Overall Study|Other Adverse Event (Other than DLT)|0|||
13476594|NCT01403948|27003331|FG006|Overall Study|Other Adverse Event (Other than DLT)|2|||
13476595|NCT01403948|27003332|FG007|Overall Study|Other Adverse Event (Other than DLT)|0|||
13476596|NCT01403948|27003333|FG008|Overall Study|Other Adverse Event (Other than DLT)|1|||
13476597|NCT01403948|27003334|FG009|Overall Study|Other Adverse Event (Other than DLT)|0|||
13476598|NCT01403948|27003325|FG000|Overall Study|Lost to Follow-up|0|||
13476599|NCT01403948|27003326|FG001|Overall Study|Lost to Follow-up|0|||
13476600|NCT01403948|27003327|FG002|Overall Study|Lost to Follow-up|0|||
13476601|NCT01403948|27003328|FG003|Overall Study|Lost to Follow-up|0|||
13476602|NCT01403948|27003329|FG004|Overall Study|Lost to Follow-up|0|||
13476603|NCT01403948|27003330|FG005|Overall Study|Lost to Follow-up|0|||
13476604|NCT01403948|27003331|FG006|Overall Study|Lost to Follow-up|0|||
13476605|NCT01403948|27003332|FG007|Overall Study|Lost to Follow-up|0|||
13476606|NCT01403948|27003333|FG008|Overall Study|Lost to Follow-up|0|||
13476607|NCT01403948|27003334|FG009|Overall Study|Lost to Follow-up|1|||
13476608|NCT01403948|27003325|FG000|Overall Study|Refused cont. medication|0|||
13476609|NCT01403948|27003326|FG001|Overall Study|Refused cont. medication|0|||
13476610|NCT01403948|27003327|FG002|Overall Study|Refused cont. medication|0|||
13476611|NCT01403948|27003328|FG003|Overall Study|Refused cont. medication|0|||
13476612|NCT01403948|27003329|FG004|Overall Study|Refused cont. medication|1|||
13476613|NCT01403948|27003330|FG005|Overall Study|Refused cont. medication|0|||
13476614|NCT01403948|27003331|FG006|Overall Study|Refused cont. medication|0|||
13476615|NCT01403948|27003332|FG007|Overall Study|Refused cont. medication|0|||
13476616|NCT01403948|27003333|FG008|Overall Study|Refused cont. medication|0|||
13476617|NCT01403948|27003334|FG009|Overall Study|Refused cont. medication|1|||
13476618|NCT01403948|27003325|FG000|Overall Study|other than above|1|||
13476619|NCT01403948|27003326|FG001|Overall Study|other than above|2|||
13476620|NCT01403948|27003327|FG002|Overall Study|other than above|1|||
13476621|NCT01403948|27003328|FG003|Overall Study|other than above|0|||
13476622|NCT01403948|27003329|FG004|Overall Study|other than above|1|||
13476623|NCT01403948|27003330|FG005|Overall Study|other than above|1|||
13476624|NCT01403948|27003331|FG006|Overall Study|other than above|2|||
13476625|NCT01403948|27003332|FG007|Overall Study|other than above|0|||
13476626|NCT01403948|27003333|FG008|Overall Study|other than above|0|||
13476627|NCT01403948|27003334|FG009|Overall Study|other than above|0|||
13476628|NCT01404312|27003362|FG000|Overall Study|Death|21|||
13476629|NCT01404312|27003363|FG001|Overall Study|Death|27|||
13476630|NCT01404312|27003362|FG000|Overall Study|Withdrawal by Subject|15|||
13476631|NCT01404312|27003363|FG001|Overall Study|Withdrawal by Subject|18|||
13476632|NCT01404312|27003362|FG000|Overall Study|Participant Unable to get to clinic|93|||
13476633|NCT01404312|27003363|FG001|Overall Study|Participant Unable to get to clinic|103|||
13476634|NCT01404312|27003362|FG000|Overall Study|Lost to Follow-up|115|||
13476635|NCT01404312|27003363|FG001|Overall Study|Lost to Follow-up|111|||
13476636|NCT01404312|27003362|FG000|Overall Study|Site closed|22|||
13476637|NCT01404312|27003363|FG001|Overall Study|Site closed|21|||
13476638|NCT01404312|27003362|FG000|Overall Study|Participant not willing to adhere to req|31|||
13476639|NCT01404312|27003363|FG001|Overall Study|Participant not willing to adhere to req|29|||
13476640|NCT01404312|27003362|FG000|Overall Study|Severe debilitation, unable to continue|1|||
13476641|NCT01404312|27003363|FG001|Overall Study|Severe debilitation, unable to continue|2|||
13476642|NCT01414608|27003386|FG000|Overall Study|Ineligible|5|||
13476643|NCT01414608|27003387|FG001|Overall Study|Ineligible|2|||
13476644|NCT01425008|27003729|FG000|Dose Escalation Phase|Progressive Disease|2|||
13476645|NCT01425008|27003730|FG001|Dose Escalation Phase|Progressive Disease|3|||
13476646|NCT01425008|27003731|FG002|Dose Escalation Phase|Progressive Disease|2|||
13476647|NCT01425008|27003732|FG003|Dose Escalation Phase|Progressive Disease|3|||
13476648|NCT01425008|27003733|FG004|Dose Escalation Phase|Progressive Disease|5|||
13476649|NCT01425008|27003734|FG005|Dose Escalation Phase|Progressive Disease|4|||
13476650|NCT01425008|27003735|FG006|Dose Escalation Phase|Progressive Disease|0|||
13417806|NCT00488033|26854743|FG000|Overall Study|Withdrawal by Subject|1|||
13417807|NCT00488033|26854744|FG001|Overall Study|Withdrawal by Subject|0|||
13417808|NCT00487981|26854750|FG000|Overall Study|Hypothyroidism diagnosis|1|||
13417809|NCT00487942|26855145|FG000|Overall Study|Adverse Event|1|||
13417810|NCT00487942|26855146|FG001|Overall Study|Adverse Event|1|||
13417811|NCT00487942|26855147|FG002|Overall Study|Adverse Event|1|||
13417812|NCT00487942|26855148|FG003|Overall Study|Adverse Event|1|||
13417813|NCT00487942|26855145|FG000|Overall Study|Lost to Follow-up|1|||
13417814|NCT00487942|26855146|FG001|Overall Study|Lost to Follow-up|0|||
13417815|NCT00487942|26855147|FG002|Overall Study|Lost to Follow-up|0|||
13417816|NCT00487942|26855148|FG003|Overall Study|Lost to Follow-up|1|||
13417817|NCT00487942|26855145|FG000|Overall Study|Protocol Violation|1|||
13417818|NCT00487942|26855146|FG001|Overall Study|Protocol Violation|1|||
13417819|NCT00487942|26855147|FG002|Overall Study|Protocol Violation|0|||
13417820|NCT00487942|26855148|FG003|Overall Study|Protocol Violation|0|||
13417821|NCT00487942|26855145|FG000|Overall Study|Withdrawal by Subject|0|||
13417822|NCT00487942|26855146|FG001|Overall Study|Withdrawal by Subject|1|||
13417823|NCT00487942|26855147|FG002|Overall Study|Withdrawal by Subject|2|||
13417824|NCT00487942|26855148|FG003|Overall Study|Withdrawal by Subject|0|||
13417825|NCT00487825|26855167|FG000|Overall Study|Adverse Event|2|||
13417826|NCT00487825|26855168|FG001|Overall Study|Adverse Event|2|||
13417827|NCT00487825|26855167|FG000|Overall Study|Lack of Efficacy|1|||
13417828|NCT00487825|26855168|FG001|Overall Study|Lack of Efficacy|1|||
13417829|NCT00487825|26855167|FG000|Overall Study|Other|3|||
13417830|NCT00487825|26855168|FG001|Overall Study|Other|2|||
13417831|NCT00487747|26855179|FG000|Overall Study|Adverse Event|1|||
13417832|NCT00487747|26855179|FG000|Overall Study|Lost to Follow-up|9|||
13417833|NCT00487747|26855179|FG000|Overall Study|Lack of Efficacy|1|||
13417834|NCT00487695|26855198|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1|||
13417835|NCT00487695|26855199|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0|||
13417836|NCT00487695|26855198|FG000|First Procedure|active wheezing (did not have procedure)|1|||
13417837|NCT00487695|26855199|FG001|First Procedure|active wheezing (did not have procedure)|0|||
13417838|NCT00487695|26855198|FG000|First Procedure|esophageal stricture found (excl crit)|1|||
13417839|NCT00487695|26855199|FG001|First Procedure|esophageal stricture found (excl crit)|0|||
13417840|NCT00487695|26855198|FG000|Second Procedure|active wheezing|0|||
13417841|NCT00487695|26855199|FG001|Second Procedure|active wheezing|1|||
13417842|NCT00487695|26855198|FG000|Second Procedure|Withdrawal by Subject|1|||
13417843|NCT00487695|26855199|FG001|Second Procedure|Withdrawal by Subject|2|||
13417844|NCT00487578|26855222|FG000|Overall Study|Adverse Event|1|||
13417845|NCT00487578|26855223|FG001|Overall Study|Adverse Event|2|||
13417846|NCT00487578|26855222|FG000|Overall Study|Lack of Efficacy|0|||
13417847|NCT00487578|26855223|FG001|Overall Study|Lack of Efficacy|1|||
13417848|NCT00487578|26855222|FG000|Overall Study|Lost to Follow-up|0|||
13417849|NCT00487578|26855223|FG001|Overall Study|Lost to Follow-up|1|||
13417850|NCT00487552|26855230|FG000|Overall Study|Unsuccessful magnet placements|3|||
13417851|NCT00487552|26855230|FG000|Overall Study|Death due to progressive malignancy|2|||
13417852|NCT00487552|26855230|FG000|Overall Study|Stent not placed|1|||
13417853|NCT00487539|26855261|FG000|Overall Study|Adverse Event|3|||
13417854|NCT00487539|26855262|FG001|Overall Study|Adverse Event|2|||
13417855|NCT00487539|26855263|FG002|Overall Study|Adverse Event|1|||
13417856|NCT00487539|26855264|FG003|Overall Study|Adverse Event|1|||
13417857|NCT00487539|26855261|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
13417858|NCT00487539|26855262|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
13417859|NCT00487539|26855263|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
13417860|NCT00487539|26855264|FG003|Overall Study|Unsatisfactory therapeutic effect|1|||
13417861|NCT00487539|26855261|FG000|Overall Study|Other|3|||
13417862|NCT00487539|26855262|FG001|Overall Study|Other|1|||
13417863|NCT00487539|26855263|FG002|Overall Study|Other|2|||
13417864|NCT00487539|26855264|FG003|Overall Study|Other|2|||
13417865|NCT00487435|26855271|FG000|Overall Study|Adverse Event|146|||
13417866|NCT00487435|26855271|FG000|Overall Study|Death|2|||
13417867|NCT00487435|26855271|FG000|Overall Study|Lack of Efficacy|33|||
13417868|NCT00487435|26855271|FG000|Overall Study|Lost to Follow-up|54|||
13417869|NCT00487435|26855271|FG000|Overall Study|Pregnancy|2|||
13417870|NCT00487435|26855271|FG000|Overall Study|Withdrawal by Subject|132|||
13417871|NCT00487435|26855271|FG000|Overall Study|Resolution Of Pain|1|||
13417872|NCT00487435|26855271|FG000|Overall Study|Study Medication Non-Compliant|32|||
13417873|NCT00487435|26855271|FG000|Overall Study|Other|83|||
13417874|NCT00487279|26855286|FG000|Overall Study|Death|1|||
13417875|NCT00487279|26855287|FG001|Overall Study|Death|0|||
13417876|NCT00487279|26855286|FG000|Overall Study|Withdrawal by Subject|0|||
13417877|NCT00487279|26855287|FG001|Overall Study|Withdrawal by Subject|2|||
13417878|NCT00487240|26855320|FG000|Overall Study|Withdrawal by Subject|12|||
13417879|NCT00487240|26855321|FG001|Overall Study|Withdrawal by Subject|6|||
13417880|NCT00487240|26855320|FG000|Overall Study|Lost to Follow-up|7|||
13417881|NCT00487240|26855321|FG001|Overall Study|Lost to Follow-up|6|||
13417882|NCT00487240|26855320|FG000|Overall Study|Adverse Event|0|||
13417883|NCT00487240|26855321|FG001|Overall Study|Adverse Event|4|||
13417884|NCT00487240|26855320|FG000|Overall Study|Protocol Violation|5|||
13417885|NCT00487240|26855321|FG001|Overall Study|Protocol Violation|5|||
13417886|NCT00487240|26855320|FG000|Overall Study|Entry Criteria Not Met|3|||
13417887|NCT00487240|26855321|FG001|Overall Study|Entry Criteria Not Met|4|||
13417888|NCT00487240|26855320|FG000|Overall Study|Sponsor Decision|2|||
13417889|NCT00487240|26855321|FG001|Overall Study|Sponsor Decision|1|||
13417890|NCT00487240|26855320|FG000|Overall Study|Physician Decision|2|||
13417891|NCT00487240|26855321|FG001|Overall Study|Physician Decision|0|||
13417892|NCT00487188|26855366|FG000|Induction Phase|Abnormality of Laboratory Test|0|||
13417893|NCT00487188|26855367|FG001|Induction Phase|Abnormality of Laboratory Test|1|||
13417894|NCT00487188|26855368|FG002|Induction Phase|Abnormality of Laboratory Test|0|||
13417895|NCT00487188|26855366|FG000|Induction Phase|Adverse Event|5|||
13417896|NCT00487188|26855367|FG001|Induction Phase|Adverse Event|0|||
13417897|NCT00487188|26855368|FG002|Induction Phase|Adverse Event|0|||
13417898|NCT00487188|26855366|FG000|Induction Phase|Lack of Efficacy|0|||
13417899|NCT00487188|26855367|FG001|Induction Phase|Lack of Efficacy|1|||
13417900|NCT00487188|26855368|FG002|Induction Phase|Lack of Efficacy|0|||
13417901|NCT00487188|26855366|FG000|Induction Phase|Protocol Violation|1|||
13417902|NCT00487188|26855367|FG001|Induction Phase|Protocol Violation|0|||
13417903|NCT00487188|26855368|FG002|Induction Phase|Protocol Violation|0|||
13417904|NCT00487188|26855366|FG000|Induction Phase|Refused Treatment|1|||
13417905|NCT00487188|26855367|FG001|Induction Phase|Refused Treatment|2|||
13417906|NCT00487188|26855368|FG002|Induction Phase|Refused Treatment|0|||
13417907|NCT00487188|26855366|FG000|Induction Phase|Lost to Follow-up|2|||
13417908|NCT00487188|26855367|FG001|Induction Phase|Lost to Follow-up|2|||
13417909|NCT00487188|26855368|FG002|Induction Phase|Lost to Follow-up|0|||
13417910|NCT00487188|26855366|FG000|Induction Phase|Administrative|0|||
13417911|NCT00487188|26855367|FG001|Induction Phase|Administrative|1|||
13417912|NCT00487188|26855368|FG002|Induction Phase|Administrative|0|||
13417913|NCT00487188|26855366|FG000|Maintenance Phase|Adverse Event|1|||
13417914|NCT00487188|26855367|FG001|Maintenance Phase|Adverse Event|0|||
13417915|NCT00487188|26855368|FG002|Maintenance Phase|Adverse Event|0|||
13417916|NCT00487188|26855366|FG000|Maintenance Phase|Death|1|||
13417917|NCT00487188|26855367|FG001|Maintenance Phase|Death|0|||
13417918|NCT00487188|26855368|FG002|Maintenance Phase|Death|0|||
13417919|NCT00487188|26855366|FG000|Maintenance Phase|Lost to Follow-up|1|||
13417920|NCT00487188|26855367|FG001|Maintenance Phase|Lost to Follow-up|0|||
13417921|NCT00487188|26855368|FG002|Maintenance Phase|Lost to Follow-up|0|||
13417922|NCT00487188|26855366|FG000|Maintenance Phase|Administrative|0|||
13417923|NCT00487188|26855367|FG001|Maintenance Phase|Administrative|0|||
13417924|NCT00487188|26855368|FG002|Maintenance Phase|Administrative|1|||
13417925|NCT00487162|26855383|FG000|Overall Study|Adverse Event|0|||
13417926|NCT00487162|26855384|FG001|Overall Study|Adverse Event|1|||
13417927|NCT00487162|26855383|FG000|Overall Study|Physician Decision|0|||
13417928|NCT00487162|26855384|FG001|Overall Study|Physician Decision|1|||
13417929|NCT00487162|26855383|FG000|Overall Study|Withdrawal by Subject|2|||
13417930|NCT00487162|26855384|FG001|Overall Study|Withdrawal by Subject|3|||
13417931|NCT00487084|26855411|FG000|Overall Study|Did not receive intervention|4|||
13417932|NCT00487084|26855412|FG001|Overall Study|Did not receive intervention|3|||
13417933|NCT00487084|26855413|FG002|Overall Study|Did not receive intervention|5|||
13417934|NCT00486954|26855523|FG000|Pilot Part|Adverse Event|4|||
13417935|NCT00486954|26855524|FG001|Pilot Part|Adverse Event|0|||
13417936|NCT00486954|26855525|FG002|Pilot Part|Adverse Event|5|||
13417937|NCT00486954|26855526|FG003|Pilot Part|Adverse Event|0|||
13417938|NCT00486954|26855527|FG004|Pilot Part|Adverse Event|0|||
13417939|NCT00486954|26855523|FG000|Pilot Part|Disease Progression|2|||
13417940|NCT00486954|26855524|FG001|Pilot Part|Disease Progression|0|||
13417941|NCT00486954|26855525|FG002|Pilot Part|Disease Progression|1|||
13417942|NCT00486954|26855526|FG003|Pilot Part|Disease Progression|0|||
13417943|NCT00486954|26855527|FG004|Pilot Part|Disease Progression|0|||
13417944|NCT00486954|26855523|FG000|Randomized Part|Lost to Follow-up|0|||
13417945|NCT00486954|26855524|FG001|Randomized Part|Lost to Follow-up|0|||
13417946|NCT00486954|26855525|FG002|Randomized Part|Lost to Follow-up|0|||
13417947|NCT00486954|26855526|FG003|Randomized Part|Lost to Follow-up|0|||
13417948|NCT00486954|26855527|FG004|Randomized Part|Lost to Follow-up|1|||
13417949|NCT00486954|26855523|FG000|Randomized Part|Withdrawal by Subject|0|||
13417950|NCT00486954|26855524|FG001|Randomized Part|Withdrawal by Subject|0|||
13417951|NCT00486954|26855525|FG002|Randomized Part|Withdrawal by Subject|0|||
13417952|NCT00486954|26855526|FG003|Randomized Part|Withdrawal by Subject|1|||
13417953|NCT00486954|26855527|FG004|Randomized Part|Withdrawal by Subject|0|||
13417954|NCT00486954|26855523|FG000|Randomized Part|Sponsor Terminated Study|0|||
13417955|NCT00486954|26855524|FG001|Randomized Part|Sponsor Terminated Study|0|||
13417956|NCT00486954|26855525|FG002|Randomized Part|Sponsor Terminated Study|0|||
13417957|NCT00486954|26855526|FG003|Randomized Part|Sponsor Terminated Study|19|||
13417958|NCT00486954|26855527|FG004|Randomized Part|Sponsor Terminated Study|13|||
13417959|NCT00486902|26855554|FG000|Overall Study|Withdrawal by Subject|1|||
13417960|NCT00486902|26855555|FG001|Overall Study|Withdrawal by Subject|2|||
13417961|NCT00486902|26855554|FG000|Overall Study|decision for postpartum tubal ligation|3|||
13417962|NCT00486902|26855555|FG001|Overall Study|decision for postpartum tubal ligation|1|||
13417963|NCT00486902|26855554|FG000|Overall Study|spinal anesthetic protocal violation|1|||
13417964|NCT00486902|26855555|FG001|Overall Study|spinal anesthetic protocal violation|1|||
13417965|NCT00486902|26855554|FG000|Overall Study|Did not meet inclusion criteria|1|||
13417966|NCT00486902|26855555|FG001|Overall Study|Did not meet inclusion criteria|0|||
13417967|NCT00486902|26855554|FG000|Overall Study|No toradol due to hemmorhage or allergy|3|||
13417968|NCT00486902|26855555|FG001|Overall Study|No toradol due to hemmorhage or allergy|1|||
13417969|NCT00486889|26855570|FG000|Overall Study|Death|3|||
13417970|NCT00486889|26855570|FG000|Overall Study|Non-compliant|2|||
13417971|NCT00486889|26855570|FG000|Overall Study|Withdrawal by Subject|6|||
13417972|NCT00486837|26855593|FG000|Overall Study|Withdrawal by Subject|1|||
13417973|NCT00486837|26855594|FG001|Overall Study|Withdrawal by Subject|0|||
13417974|NCT00486837|26855593|FG000|Overall Study|Adverse Event|1|||
13417975|NCT00486837|26855594|FG001|Overall Study|Adverse Event|1|||
13417976|NCT00486837|26855593|FG000|Overall Study|Protocol Violation|4|||
13417977|NCT00486837|26855594|FG001|Overall Study|Protocol Violation|2|||
13417978|NCT00486837|26855593|FG000|Overall Study|No sputum, devise issues, exacerbation|3|||
13417979|NCT00486837|26855594|FG001|Overall Study|No sputum, devise issues, exacerbation|4|||
13417980|NCT00486811|26855645|FG000|Overall Study|Adverse Event|28|||
13417981|NCT00486811|26855646|FG001|Overall Study|Adverse Event|60|||
13417982|NCT00486811|26855647|FG002|Overall Study|Adverse Event|135|||
13417983|NCT00486811|26855645|FG000|Overall Study|Lack of Efficacy|34|||
13417984|NCT00486811|26855646|FG001|Overall Study|Lack of Efficacy|14|||
13417985|NCT00486811|26855647|FG002|Overall Study|Lack of Efficacy|7|||
13417986|NCT00486811|26855645|FG000|Overall Study|Lost to Follow-up|4|||
13417987|NCT00486811|26855646|FG001|Overall Study|Lost to Follow-up|6|||
13417988|NCT00486811|26855647|FG002|Overall Study|Lost to Follow-up|4|||
13417989|NCT00486811|26855645|FG000|Overall Study|Withdrawal by Subject|33|||
13417990|NCT00486811|26855646|FG001|Overall Study|Withdrawal by Subject|44|||
13417991|NCT00486811|26855647|FG002|Overall Study|Withdrawal by Subject|58|||
13417992|NCT00486811|26855645|FG000|Overall Study|Study drug non-compliant|5|||
13417993|NCT00486811|26855646|FG001|Overall Study|Study drug non-compliant|6|||
13417994|NCT00486811|26855647|FG002|Overall Study|Study drug non-compliant|3|||
13417995|NCT00486811|26855645|FG000|Overall Study|All other|18|||
13417996|NCT00486811|26855646|FG001|Overall Study|All other|11|||
13417997|NCT00486811|26855647|FG002|Overall Study|All other|7|||
13417998|NCT00486759|26855664|FG000|Treatment|Adverse event/intercurrent illness|86|||
13417999|NCT00486759|26855665|FG001|Treatment|Adverse event/intercurrent illness|39|||
13418000|NCT00486759|26855664|FG000|Treatment|Insufficient therapeutic response|37|||
13418001|NCT00486759|26855665|FG001|Treatment|Insufficient therapeutic response|39|||
13418002|NCT00486759|26855664|FG000|Treatment|Death|17|||
13418003|NCT00486759|26855665|FG001|Treatment|Death|10|||
13418004|NCT00486759|26855664|FG000|Treatment|Withdrew consent|15|||
13418005|NCT00486759|26855665|FG001|Treatment|Withdrew consent|12|||
13418006|NCT00486759|26855664|FG000|Treatment|Administrative/reason not specified|17|||
13418007|NCT00486759|26855665|FG001|Treatment|Administrative/reason not specified|21|||
13418008|NCT00486759|26855664|FG000|Treatment|Refused treatment|10|||
13418009|NCT00486759|26855665|FG001|Treatment|Refused treatment|7|||
13418010|NCT00486759|26855664|FG000|Treatment|Violation of selection criteria at entry|3|||
13418011|NCT00486759|26855665|FG001|Treatment|Violation of selection criteria at entry|3|||
13418012|NCT00486759|26855664|FG000|Treatment|Other protocol violation|1|||
13418013|NCT00486759|26855665|FG001|Treatment|Other protocol violation|5|||
13418014|NCT00486759|26855664|FG000|Treatment|Failure to return|1|||
13418015|NCT00486759|26855665|FG001|Treatment|Failure to return|1|||
13418016|NCT00486759|26855664|FG000|Safety Follow-up|Insufficient therapeutic response|40|||
13418017|NCT00486759|26855665|FG001|Safety Follow-up|Insufficient therapeutic response|50|||
13418018|NCT00486759|26855664|FG000|Safety Follow-up|Death|40|||
13418019|NCT00486759|26855665|FG001|Safety Follow-up|Death|29|||
13418020|NCT00486759|26855664|FG000|Safety Follow-up|Withdrew consent|32|||
13418021|NCT00486759|26855665|FG001|Safety Follow-up|Withdrew consent|23|||
13418022|NCT00486759|26855664|FG000|Safety Follow-up|Failure to return|9|||
13418023|NCT00486759|26855665|FG001|Safety Follow-up|Failure to return|6|||
13418024|NCT00486759|26855664|FG000|Safety Follow-up|Administrative/not specified|8|||
13418025|NCT00486759|26855665|FG001|Safety Follow-up|Administrative/not specified|6|||
13418026|NCT00486759|26855664|FG000|Safety Follow-up|Refused treatment/did not cooperate|6|||
13418027|NCT00486759|26855665|FG001|Safety Follow-up|Refused treatment/did not cooperate|4|||
13418028|NCT00486759|26855664|FG000|Safety Follow-up|Adverse event/intercurrent illness|4|||
13418029|NCT00486759|26855665|FG001|Safety Follow-up|Adverse event/intercurrent illness|0|||
13418030|NCT00486720|26855680|FG000|Overall Study|Adverse Event|1|||
13418031|NCT00486720|26855681|FG001|Overall Study|Adverse Event|2|||
13418032|NCT00486720|26855680|FG000|Overall Study|Lack of Efficacy|4|||
13418033|NCT00486720|26855681|FG001|Overall Study|Lack of Efficacy|6|||
13418034|NCT00486720|26855680|FG000|Overall Study|Physician Decision|1|||
13418035|NCT00486720|26855681|FG001|Overall Study|Physician Decision|2|||
13418036|NCT00486720|26855680|FG000|Overall Study|Protocol Violation|1|||
13418037|NCT00486720|26855681|FG001|Overall Study|Protocol Violation|0|||
13418038|NCT00486720|26855680|FG000|Overall Study|Withdrawal by Subject|3|||
13418039|NCT00486720|26855681|FG001|Overall Study|Withdrawal by Subject|1|||
13418040|NCT00486720|26855680|FG000|Overall Study|Progressive Disease|0|||
13418041|NCT00486720|26855681|FG001|Overall Study|Progressive Disease|1|||
13418042|NCT00486603|26855713|FG000|Overall Study|Withdrawal by Subject|1|||
13418043|NCT00486603|26855714|FG001|Overall Study|Withdrawal by Subject|0|||
13418044|NCT00486603|26855715|FG002|Overall Study|Withdrawal by Subject|0|||
13418045|NCT00486603|26855716|FG003|Overall Study|Withdrawal by Subject|0|||
13418046|NCT00486603|26855717|FG004|Overall Study|Withdrawal by Subject|0|||
13418047|NCT00486603|26855713|FG000|Overall Study|Physician Decision|0|||
13418048|NCT00486603|26855714|FG001|Overall Study|Physician Decision|1|||
13418049|NCT00486603|26855715|FG002|Overall Study|Physician Decision|0|||
13418050|NCT00486603|26855716|FG003|Overall Study|Physician Decision|0|||
13418051|NCT00486603|26855717|FG004|Overall Study|Physician Decision|0|||
13418052|NCT00486434|26855743|FG000|Overall Study|Withdrawal by Subject|34|||
13418053|NCT00486434|26855744|FG001|Overall Study|Withdrawal by Subject|39|||
13418054|NCT00486434|26855743|FG000|Overall Study|Adverse Event|118|||
13418055|NCT00486434|26855744|FG001|Overall Study|Adverse Event|44|||
13418056|NCT00486434|26855743|FG000|Overall Study|Protocol Violation|22|||
13418057|NCT00486434|26855744|FG001|Overall Study|Protocol Violation|21|||
13418058|NCT00486434|26855743|FG000|Overall Study|Lack of Efficacy|12|||
13418059|NCT00486434|26855744|FG001|Overall Study|Lack of Efficacy|19|||
13418060|NCT00486434|26855743|FG000|Overall Study|Lost to Follow-up|2|||
13418061|NCT00486434|26855744|FG001|Overall Study|Lost to Follow-up|3|||
13418062|NCT00486434|26855743|FG000|Overall Study|Death|1|||
13418063|NCT00486434|26855744|FG001|Overall Study|Death|2|||
13418064|NCT00486434|26855743|FG000|Overall Study|Personal reasons|5|||
13418065|NCT00486434|26855744|FG001|Overall Study|Personal reasons|6|||
13418066|NCT00486330|26855750|FG000|Overall Study|Adverse Event|2|||
13418067|NCT00486291|26855765|FG000|Overall Study|Adverse Event|3|||
13418068|NCT00486291|26855766|FG001|Overall Study|Adverse Event|4|||
13418069|NCT00486291|26855765|FG000|Overall Study|Lost to Follow-up|3|||
13418070|NCT00486291|26855766|FG001|Overall Study|Lost to Follow-up|7|||
13418071|NCT00486291|26855765|FG000|Overall Study|protocol non-compliance|10|||
13418072|NCT00486291|26855766|FG001|Overall Study|protocol non-compliance|15|||
13418073|NCT00486291|26855765|FG000|Overall Study|requirement for restricted medication|0|||
13418074|NCT00486291|26855766|FG001|Overall Study|requirement for restricted medication|3|||
13418075|NCT00486278|26855902|FG000|Overall Study|Adverse Event|5|||
13418076|NCT00486278|26855902|FG000|Overall Study|Withdrawal by Subject|2|||
13418077|NCT00486278|26855902|FG000|Overall Study|Physician Decision|2|||
13418078|NCT00486265|26855908|FG000|Overall Study|Adverse Event|1|||
13418079|NCT00486265|26855908|FG000|Overall Study|Lack of Efficacy|8|||
13418080|NCT00486252|26855925|FG000|Overall Study|Adverse Event|7|||
13418081|NCT00486252|26855925|FG000|Overall Study|Lack of Efficacy|9|||
13418082|NCT00486252|26855925|FG000|Overall Study|Lost to Follow-up|24|||
13418083|NCT00486252|26855925|FG000|Overall Study|Other|18|||
13418084|NCT00486226|26855935|FG000|Overall Study|Death|3|||
13418085|NCT00486226|26855935|FG000|Overall Study|Adverse Event|1|||
13418086|NCT00486226|26855935|FG000|Overall Study|Withdrawal by Subject|1|||
13418087|NCT00486226|26855935|FG000|Overall Study|Lost to Follow-up|8|||
13418088|NCT00486044|26855954|FG000|Overall Study|Withdrawal by Subject|2|||
13418089|NCT00486044|26855955|FG001|Overall Study|Withdrawal by Subject|1|||
13418090|NCT00486044|26855954|FG000|Overall Study|Adverse Event|0|||
13418091|NCT00486044|26855955|FG001|Overall Study|Adverse Event|1|||
13418092|NCT00486044|26855954|FG000|Overall Study|Lost to Follow-up|0|||
13418093|NCT00486044|26855955|FG001|Overall Study|Lost to Follow-up|1|||
13418094|NCT00485758|26855972|FG000|Overall Study|Adverse Event|102|||
13418095|NCT00485758|26855973|FG001|Overall Study|Adverse Event|31|||
13418096|NCT00485758|26855972|FG000|Overall Study|Death|0|||
13418097|NCT00485758|26855973|FG001|Overall Study|Death|1|||
13418098|NCT00485758|26855972|FG000|Overall Study|Lost to Follow-up|5|||
13418099|NCT00485758|26855973|FG001|Overall Study|Lost to Follow-up|1|||
13418100|NCT00485758|26855972|FG000|Overall Study|Physician Decision|3|||
13418101|NCT00485758|26855973|FG001|Overall Study|Physician Decision|3|||
13418102|NCT00485758|26855972|FG000|Overall Study|Protocol Violation|11|||
13418103|NCT00485758|26855973|FG001|Overall Study|Protocol Violation|2|||
13418104|NCT00485758|26855972|FG000|Overall Study|Withdrawal by Subject|32|||
13418105|NCT00485758|26855973|FG001|Overall Study|Withdrawal by Subject|27|||
13418106|NCT00485758|26855972|FG000|Overall Study|Study Terminated by Sponsor|3|||
13418107|NCT00485758|26855973|FG001|Overall Study|Study Terminated by Sponsor|0|||
13418108|NCT00485732|26856000|FG000|Overall Study|Protocol Violation|1|||
13418109|NCT00485732|26856001|FG001|Overall Study|Protocol Violation|3|||
13418110|NCT00485732|26856000|FG000|Overall Study|Withdrawal by Subject|5|||
13418111|NCT00485732|26856001|FG001|Overall Study|Withdrawal by Subject|4|||
13418112|NCT00485732|26856000|FG000|Overall Study|Lost to Follow-up|2|||
13418113|NCT00485732|26856001|FG001|Overall Study|Lost to Follow-up|2|||
13418114|NCT00485589|26856037|FG000|Overall Study|Death|2|||
13418115|NCT00485589|26856038|FG001|Overall Study|Death|2|||
13418116|NCT00485589|26856039|FG002|Overall Study|Death|0|||
13418117|NCT00485589|26856037|FG000|Overall Study|Failure to return|6|||
13418118|NCT00485589|26856038|FG001|Overall Study|Failure to return|5|||
13418119|NCT00485589|26856039|FG002|Overall Study|Failure to return|1|||
13418120|NCT00485589|26856037|FG000|Overall Study|Protocol Violation|1|||
13418121|NCT00485589|26856038|FG001|Overall Study|Protocol Violation|0|||
13418122|NCT00485589|26856039|FG002|Overall Study|Protocol Violation|0|||
13418123|NCT00485589|26856037|FG000|Overall Study|Violation of selection criteria at entry|0|||
13418124|NCT00485589|26856038|FG001|Overall Study|Violation of selection criteria at entry|3|||
13418125|NCT00485589|26856039|FG002|Overall Study|Violation of selection criteria at entry|1|||
13418126|NCT00485589|26856037|FG000|Overall Study|Administrative/Other|1|||
13418127|NCT00485589|26856038|FG001|Overall Study|Administrative/Other|2|||
13418128|NCT00485589|26856039|FG002|Overall Study|Administrative/Other|1|||
13418129|NCT00485589|26856037|FG000|Overall Study|Insufficient therapeutic response|10|||
13418130|NCT00485589|26856038|FG001|Overall Study|Insufficient therapeutic response|3|||
13418131|NCT00485589|26856039|FG002|Overall Study|Insufficient therapeutic response|1|||
13418132|NCT00485589|26856037|FG000|Overall Study|Refused treatment/did not cooperate|1|||
13418133|NCT00485589|26856038|FG001|Overall Study|Refused treatment/did not cooperate|0|||
13418134|NCT00485589|26856039|FG002|Overall Study|Refused treatment/did not cooperate|2|||
13418135|NCT00485589|26856037|FG000|Overall Study|Withdrawal by Subject|3|||
13418136|NCT00485589|26856038|FG001|Overall Study|Withdrawal by Subject|2|||
13418137|NCT00485589|26856039|FG002|Overall Study|Withdrawal by Subject|2|||
13418138|NCT00485589|26856037|FG000|Overall Study|Adverse Event|3|||
13418139|NCT00485589|26856038|FG001|Overall Study|Adverse Event|3|||
13418140|NCT00485589|26856039|FG002|Overall Study|Adverse Event|10|||
13418141|NCT00485472|26856068|FG000|Overall Study|Adverse Event|8|||
13418142|NCT00485472|26856069|FG001|Overall Study|Adverse Event|5|||
13418143|NCT00485472|26856068|FG000|Overall Study|Lack of Efficacy|5|||
13418144|NCT00485472|26856069|FG001|Overall Study|Lack of Efficacy|4|||
13418145|NCT00485472|26856068|FG000|Overall Study|Withdrawal by Subject|1|||
13418146|NCT00485472|26856069|FG001|Overall Study|Withdrawal by Subject|0|||
13418147|NCT00485472|26856068|FG000|Overall Study|Protocol Violation|0|||
13418148|NCT00485472|26856069|FG001|Overall Study|Protocol Violation|1|||
13418149|NCT00485472|26856068|FG000|Overall Study|Other|2|||
13418150|NCT00485472|26856069|FG001|Overall Study|Other|1|||
13418151|NCT00485472|26856068|FG000|Overall Study|Lost to Follow-up|0|||
13418152|NCT00485472|26856069|FG001|Overall Study|Lost to Follow-up|1|||
13418153|NCT00485303|26856083|FG000|Overall Study|Adverse Event|5|||
13418154|NCT00485303|26856083|FG000|Overall Study|Progressive Disease|44|||
13418155|NCT00485303|26856083|FG000|Overall Study|Other|3|||
13418156|NCT00485303|26856083|FG000|Overall Study|Initiation of new anti-cancer treatment|2|||
13418157|NCT00485303|26856083|FG000|Overall Study|Treatment ongoing at cutoff date|2|||
13418158|NCT00485264|26856188|FG000|Overall Study|Enrolled But Not Given Treatment|0|||
13418159|NCT00485264|26856189|FG001|Overall Study|Enrolled But Not Given Treatment|0|||
13418160|NCT00485264|26856190|FG002|Overall Study|Enrolled But Not Given Treatment|0|||
13418161|NCT00485264|26856191|FG003|Overall Study|Enrolled But Not Given Treatment|0|||
13418162|NCT00485264|26856192|FG004|Overall Study|Enrolled But Not Given Treatment|1|||
13418163|NCT00485264|26856193|FG005|Overall Study|Enrolled But Not Given Treatment|0|||
13418164|NCT00485264|26856188|FG000|Overall Study|Death|1|||
13418165|NCT00485264|26856189|FG001|Overall Study|Death|0|||
13418166|NCT00485264|26856190|FG002|Overall Study|Death|0|||
13418167|NCT00485264|26856191|FG003|Overall Study|Death|0|||
13418168|NCT00485264|26856192|FG004|Overall Study|Death|1|||
13418169|NCT00485264|26856193|FG005|Overall Study|Death|0|||
13418170|NCT00485264|26856188|FG000|Overall Study|Adverse Event|1|||
13418171|NCT00485264|26856189|FG001|Overall Study|Adverse Event|0|||
13418172|NCT00485264|26856190|FG002|Overall Study|Adverse Event|2|||
13418173|NCT00485264|26856191|FG003|Overall Study|Adverse Event|3|||
13418174|NCT00485264|26856192|FG004|Overall Study|Adverse Event|1|||
13418175|NCT00485264|26856193|FG005|Overall Study|Adverse Event|3|||
13418176|NCT00485264|26856188|FG000|Overall Study|Pregnancy|4|||
13418177|NCT00485264|26856189|FG001|Overall Study|Pregnancy|0|||
13418178|NCT00485264|26856190|FG002|Overall Study|Pregnancy|0|||
13418179|NCT00485264|26856191|FG003|Overall Study|Pregnancy|0|||
13418180|NCT00485264|26856192|FG004|Overall Study|Pregnancy|0|||
13418181|NCT00485264|26856193|FG005|Overall Study|Pregnancy|0|||
13418182|NCT00485264|26856188|FG000|Overall Study|Disallowed Medication|0|||
13418183|NCT00485264|26856189|FG001|Overall Study|Disallowed Medication|0|||
13418184|NCT00485264|26856190|FG002|Overall Study|Disallowed Medication|0|||
13418185|NCT00485264|26856191|FG003|Overall Study|Disallowed Medication|0|||
13418186|NCT00485264|26856192|FG004|Overall Study|Disallowed Medication|0|||
13418187|NCT00485264|26856193|FG005|Overall Study|Disallowed Medication|1|||
13418188|NCT00485264|26856188|FG000|Overall Study|Number/Volume/Timing of Study Meds|2|||
13418189|NCT00485264|26856189|FG001|Overall Study|Number/Volume/Timing of Study Meds|1|||
13418190|NCT00485264|26856190|FG002|Overall Study|Number/Volume/Timing of Study Meds|1|||
13418191|NCT00485264|26856191|FG003|Overall Study|Number/Volume/Timing of Study Meds|0|||
13418192|NCT00485264|26856192|FG004|Overall Study|Number/Volume/Timing of Study Meds|0|||
13418193|NCT00485264|26856193|FG005|Overall Study|Number/Volume/Timing of Study Meds|0|||
13418194|NCT00485264|26856188|FG000|Overall Study|Lack of Efficacy|0|||
13418195|NCT00485264|26856189|FG001|Overall Study|Lack of Efficacy|1|||
13418196|NCT00485264|26856190|FG002|Overall Study|Lack of Efficacy|0|||
13418197|NCT00485264|26856191|FG003|Overall Study|Lack of Efficacy|0|||
13418198|NCT00485264|26856192|FG004|Overall Study|Lack of Efficacy|0|||
13418199|NCT00485264|26856193|FG005|Overall Study|Lack of Efficacy|0|||
13418200|NCT00485264|26856188|FG000|Overall Study|Guardian Consent Withdrawn|1|||
13418201|NCT00485264|26856189|FG001|Overall Study|Guardian Consent Withdrawn|0|||
13418202|NCT00485264|26856190|FG002|Overall Study|Guardian Consent Withdrawn|0|||
13418203|NCT00485264|26856191|FG003|Overall Study|Guardian Consent Withdrawn|0|||
13418204|NCT00485264|26856192|FG004|Overall Study|Guardian Consent Withdrawn|1|||
13418205|NCT00485264|26856193|FG005|Overall Study|Guardian Consent Withdrawn|0|||
13418206|NCT00485264|26856188|FG000|Overall Study|Physician Decision|0|||
13418207|NCT00485264|26856189|FG001|Overall Study|Physician Decision|2|||
13418208|NCT00485264|26856190|FG002|Overall Study|Physician Decision|0|||
13418209|NCT00485264|26856191|FG003|Overall Study|Physician Decision|0|||
13418210|NCT00485264|26856192|FG004|Overall Study|Physician Decision|0|||
13418211|NCT00485264|26856193|FG005|Overall Study|Physician Decision|0|||
13418212|NCT00485264|26856188|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
13418213|NCT00485264|26856189|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
13418214|NCT00485264|26856190|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1|||
13418215|NCT00485264|26856191|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
13418216|NCT00485264|26856192|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
13418217|NCT00485264|26856193|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
13418218|NCT00485264|26856188|FG000|Overall Study|Not Able to Attend Clinic|5|||
13418219|NCT00485264|26856189|FG001|Overall Study|Not Able to Attend Clinic|0|||
13418220|NCT00485264|26856190|FG002|Overall Study|Not Able to Attend Clinic|0|||
13418221|NCT00485264|26856191|FG003|Overall Study|Not Able to Attend Clinic|1|||
13418222|NCT00485264|26856192|FG004|Overall Study|Not Able to Attend Clinic|1|||
13418223|NCT00485264|26856193|FG005|Overall Study|Not Able to Attend Clinic|2|||
13418224|NCT00485264|26856188|FG000|Overall Study|Non-Compliant|17|||
13418225|NCT00485264|26856189|FG001|Overall Study|Non-Compliant|2|||
13418226|NCT00485264|26856190|FG002|Overall Study|Non-Compliant|1|||
13418227|NCT00485264|26856191|FG003|Overall Study|Non-Compliant|0|||
13418228|NCT00485264|26856192|FG004|Overall Study|Non-Compliant|1|||
13418229|NCT00485264|26856193|FG005|Overall Study|Non-Compliant|0|||
13418230|NCT00485264|26856188|FG000|Overall Study|Lost to Follow-up|2|||
13418231|NCT00485264|26856189|FG001|Overall Study|Lost to Follow-up|1|||
13418232|NCT00485264|26856190|FG002|Overall Study|Lost to Follow-up|1|||
13418233|NCT00485264|26856191|FG003|Overall Study|Lost to Follow-up|0|||
13418234|NCT00485264|26856192|FG004|Overall Study|Lost to Follow-up|0|||
13418235|NCT00485264|26856193|FG005|Overall Study|Lost to Follow-up|1|||
13418236|NCT00485264|26856188|FG000|Overall Study|Other Reason|3|||
13418237|NCT00485264|26856189|FG001|Overall Study|Other Reason|0|||
13418238|NCT00485264|26856190|FG002|Overall Study|Other Reason|0|||
13418239|NCT00485264|26856191|FG003|Overall Study|Other Reason|0|||
13418240|NCT00485264|26856192|FG004|Overall Study|Other Reason|0|||
13418241|NCT00485264|26856193|FG005|Overall Study|Other Reason|0|||
13418242|NCT00485173|26856240|FG000|Overall Study|Death|4|||
13418243|NCT00485173|26856241|FG001|Overall Study|Death|3|||
13418244|NCT00485173|26856240|FG000|Overall Study|Lost to Follow-up|32|||
13418245|NCT00485173|26856241|FG001|Overall Study|Lost to Follow-up|61|||
13418246|NCT00485134|26856286|FG000|Overall Study|Lost to Follow-up|1|||
13418247|NCT00485134|26856287|FG001|Overall Study|Lost to Follow-up|0|||
13418248|NCT00485134|26856288|FG002|Overall Study|Lost to Follow-up|0|||
13418249|NCT00485134|26856289|FG003|Overall Study|Lost to Follow-up|0|||
13418250|NCT00485134|26856290|FG004|Overall Study|Lost to Follow-up|0|||
13418251|NCT00485134|26856291|FG005|Overall Study|Lost to Follow-up|0|||
13418252|NCT00485134|26856292|FG006|Overall Study|Lost to Follow-up|0|||
13418253|NCT00485134|26856293|FG007|Overall Study|Lost to Follow-up|0|||
13418254|NCT00485134|26856286|FG000|Overall Study|Withdrawal by Subject|0|||
13418255|NCT00485134|26856287|FG001|Overall Study|Withdrawal by Subject|1|||
13418256|NCT00485134|26856288|FG002|Overall Study|Withdrawal by Subject|0|||
13418257|NCT00485134|26856289|FG003|Overall Study|Withdrawal by Subject|0|||
13418258|NCT00485134|26856290|FG004|Overall Study|Withdrawal by Subject|0|||
13418259|NCT00485134|26856291|FG005|Overall Study|Withdrawal by Subject|0|||
13418260|NCT00485134|26856292|FG006|Overall Study|Withdrawal by Subject|0|||
13418261|NCT00485134|26856293|FG007|Overall Study|Withdrawal by Subject|0|||
13418262|NCT00485134|26856286|FG000|Overall Study|Change in health status|0|||
13418263|NCT00485134|26856287|FG001|Overall Study|Change in health status|1|||
13418264|NCT00485134|26856288|FG002|Overall Study|Change in health status|2|||
13418265|NCT00485134|26856289|FG003|Overall Study|Change in health status|1|||
13418266|NCT00485134|26856290|FG004|Overall Study|Change in health status|0|||
13418267|NCT00485134|26856291|FG005|Overall Study|Change in health status|1|||
13418268|NCT00485134|26856292|FG006|Overall Study|Change in health status|0|||
13418269|NCT00485134|26856293|FG007|Overall Study|Change in health status|0|||
13418270|NCT00485134|26856286|FG000|Overall Study|Withdrew for adverse event|0|||
13418271|NCT00485134|26856287|FG001|Overall Study|Withdrew for adverse event|0|||
13418272|NCT00485134|26856288|FG002|Overall Study|Withdrew for adverse event|1|||
13418273|NCT00485134|26856289|FG003|Overall Study|Withdrew for adverse event|0|||
13418274|NCT00485134|26856290|FG004|Overall Study|Withdrew for adverse event|0|||
13418275|NCT00485134|26856291|FG005|Overall Study|Withdrew for adverse event|0|||
13418276|NCT00485134|26856292|FG006|Overall Study|Withdrew for adverse event|0|||
13418277|NCT00485134|26856293|FG007|Overall Study|Withdrew for adverse event|0|||
13418278|NCT00485134|26856286|FG000|Overall Study|Positive drug test|0|||
13418279|NCT00485134|26856287|FG001|Overall Study|Positive drug test|0|||
13418280|NCT00485134|26856288|FG002|Overall Study|Positive drug test|0|||
13418281|NCT00485134|26856289|FG003|Overall Study|Positive drug test|0|||
13418282|NCT00485134|26856290|FG004|Overall Study|Positive drug test|2|||
13418283|NCT00485134|26856291|FG005|Overall Study|Positive drug test|1|||
13418284|NCT00485134|26856292|FG006|Overall Study|Positive drug test|0|||
13418285|NCT00485134|26856293|FG007|Overall Study|Positive drug test|0|||
13418286|NCT00485134|26856286|FG000|Overall Study|Non-compliance|0|||
13418287|NCT00485134|26856287|FG001|Overall Study|Non-compliance|0|||
13418288|NCT00485134|26856288|FG002|Overall Study|Non-compliance|0|||
13418289|NCT00485134|26856289|FG003|Overall Study|Non-compliance|0|||
13418290|NCT00485134|26856290|FG004|Overall Study|Non-compliance|1|||
13418291|NCT00485134|26856291|FG005|Overall Study|Non-compliance|2|||
13418292|NCT00485134|26856292|FG006|Overall Study|Non-compliance|2|||
13418293|NCT00485134|26856293|FG007|Overall Study|Non-compliance|0|||
13418294|NCT00485134|26856286|FG000|Overall Study|Unable to comply with study schedule|0|||
13418295|NCT00485134|26856287|FG001|Overall Study|Unable to comply with study schedule|0|||
13418296|NCT00485134|26856288|FG002|Overall Study|Unable to comply with study schedule|0|||
13418297|NCT00485134|26856289|FG003|Overall Study|Unable to comply with study schedule|0|||
13418298|NCT00485134|26856290|FG004|Overall Study|Unable to comply with study schedule|0|||
13418299|NCT00485134|26856291|FG005|Overall Study|Unable to comply with study schedule|0|||
13418300|NCT00485134|26856292|FG006|Overall Study|Unable to comply with study schedule|0|||
13418301|NCT00485134|26856293|FG007|Overall Study|Unable to comply with study schedule|1|||
13418302|NCT00485134|26856286|FG000|Overall Study|Pregnancy|0|||
13418303|NCT00485134|26856287|FG001|Overall Study|Pregnancy|0|||
13418304|NCT00485134|26856288|FG002|Overall Study|Pregnancy|0|||
13418305|NCT00485134|26856289|FG003|Overall Study|Pregnancy|0|||
13418306|NCT00485134|26856290|FG004|Overall Study|Pregnancy|0|||
13418307|NCT00485134|26856291|FG005|Overall Study|Pregnancy|0|||
13418308|NCT00485134|26856292|FG006|Overall Study|Pregnancy|1|||
13418309|NCT00485134|26856293|FG007|Overall Study|Pregnancy|0|||
13418310|NCT00485069|26856343|FG000|Overall Study|Adverse Event|10|||
13418311|NCT00485069|26856344|FG001|Overall Study|Adverse Event|4|||
13418312|NCT00485069|26856343|FG000|Overall Study|Lack of Efficacy|2|||
13418313|NCT00485069|26856344|FG001|Overall Study|Lack of Efficacy|1|||
13418314|NCT00485069|26856343|FG000|Overall Study|Protocol Violation|0|||
13418315|NCT00485069|26856344|FG001|Overall Study|Protocol Violation|1|||
13418316|NCT00485069|26856343|FG000|Overall Study|Withdrawal by Subject|6|||
13418317|NCT00485069|26856344|FG001|Overall Study|Withdrawal by Subject|6|||
13418318|NCT00484939|26856371|FG000|Overall Study|Death|9|||
13418319|NCT00484939|26856372|FG001|Overall Study|Death|13|||
13418320|NCT00484939|26856371|FG000|Overall Study|Adverse Event|22|||
13418321|NCT00484939|26856372|FG001|Overall Study|Adverse Event|12|||
13418322|NCT00484939|26856371|FG000|Overall Study|Patient Withdrew Consent|19|||
13418323|NCT00484939|26856372|FG001|Overall Study|Patient Withdrew Consent|10|||
13418324|NCT00484939|26856371|FG000|Overall Study|Protocol Violation|3|||
13418325|NCT00484939|26856372|FG001|Overall Study|Protocol Violation|3|||
13418326|NCT00484939|26856371|FG000|Overall Study|Lost to Follow-up|0|||
13418327|NCT00484939|26856372|FG001|Overall Study|Lost to Follow-up|3|||
13418328|NCT00484939|26856371|FG000|Overall Study|Discretion of Investigator or Sponsor|7|||
13418329|NCT00484939|26856372|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
13418330|NCT00484939|26856371|FG000|Overall Study|Disease progression|67|||
13418331|NCT00484939|26856372|FG001|Overall Study|Disease progression|88|||
13418332|NCT00484939|26856371|FG000|Overall Study|Screen Failure|2|||
13418333|NCT00484939|26856372|FG001|Overall Study|Screen Failure|2|||
13418334|NCT00484939|26856371|FG000|Overall Study|Reason Not Specified|11|||
13418335|NCT00484939|26856372|FG001|Overall Study|Reason Not Specified|6|||
13418336|NCT00484679|26856378|FG000|Overall Study|Withdrawal by Subject|3|||
13418337|NCT00484315|26856393|FG000|12-Month Clinical Follow-up|Death|6|||
13418338|NCT00484315|26856394|FG001|12-Month Clinical Follow-up|Death|2|||
13418339|NCT00484315|26856393|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4|||
13418340|NCT00484315|26856394|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0|||
13418341|NCT00484315|26856393|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
13418342|NCT00484315|26856394|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1|||
13418343|NCT00484315|26856393|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13|||
13418344|NCT00484315|26856394|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4|||
13418345|NCT00484315|26856393|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3|||
13418346|NCT00484315|26856394|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2|||
13418347|NCT00484315|26856393|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25|||
13418348|NCT00484315|26856394|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11|||
13418349|NCT00484315|26856393|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3|||
13418350|NCT00484315|26856394|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2|||
13418351|NCT00484289|26856476|FG000|Long Term Phase|Adverse Event|1|||
13418352|NCT00484289|26856477|FG001|Long Term Phase|Adverse Event|17|||
13418353|NCT00484289|26856478|FG002|Long Term Phase|Adverse Event|5|||
13418354|NCT00484289|26856476|FG000|Long Term Phase|Withdrawal by Subject|0|||
13418355|NCT00484289|26856477|FG001|Long Term Phase|Withdrawal by Subject|7|||
13418356|NCT00484289|26856478|FG002|Long Term Phase|Withdrawal by Subject|6|||
13418357|NCT00484289|26856476|FG000|Long Term Phase|Inadequate response|2|||
13418358|NCT00484289|26856477|FG001|Long Term Phase|Inadequate response|7|||
13418359|NCT00484289|26856478|FG002|Long Term Phase|Inadequate response|4|||
13418360|NCT00484289|26856476|FG000|Long Term Phase|Other Reason|0|||
13418361|NCT00484289|26856477|FG001|Long Term Phase|Other Reason|5|||
13418362|NCT00484289|26856478|FG002|Long Term Phase|Other Reason|1|||
13418363|NCT00484289|26856476|FG000|Post Marketing Phase|Adverse Event|0|||
13418364|NCT00484289|26856477|FG001|Post Marketing Phase|Adverse Event|1|||
13418365|NCT00484289|26856478|FG002|Post Marketing Phase|Adverse Event|0|||
13418366|NCT00484198|26856589|FG000|Overall Study|Participant Withdrew Consent|12|||
13418367|NCT00484198|26856590|FG001|Overall Study|Participant Withdrew Consent|21|||
13418368|NCT00484198|26856591|FG002|Overall Study|Participant Withdrew Consent|47|||
13418369|NCT00484198|26856592|FG003|Overall Study|Participant Withdrew Consent|59|||
13418370|NCT00484198|26856589|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16|||
13418371|NCT00484198|26856590|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17|||
13418372|NCT00484198|26856591|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29|||
13418373|NCT00484198|26856592|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38|||
13418374|NCT00484198|26856589|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3|||
13418375|NCT00484198|26856590|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2|||
13418376|NCT00484198|26856591|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6|||
13418377|NCT00484198|26856592|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8|||
13418378|NCT00484198|26856589|FG000|Overall Study|Adverse Event|3|||
13418379|NCT00484198|26856590|FG001|Overall Study|Adverse Event|11|||
13418380|NCT00484198|26856591|FG002|Overall Study|Adverse Event|32|||
13418381|NCT00484198|26856592|FG003|Overall Study|Adverse Event|31|||
13418382|NCT00484198|26856589|FG000|Overall Study|Protocol Violation|0|||
13418383|NCT00484198|26856590|FG001|Overall Study|Protocol Violation|5|||
13418384|NCT00484198|26856591|FG002|Overall Study|Protocol Violation|6|||
13418385|NCT00484198|26856592|FG003|Overall Study|Protocol Violation|8|||
13418386|NCT00484198|26856589|FG000|Overall Study|Other|7|||
13418387|NCT00484198|26856590|FG001|Overall Study|Other|10|||
13418388|NCT00484198|26856591|FG002|Overall Study|Other|31|||
13418389|NCT00484198|26856592|FG003|Overall Study|Other|28|||
13418390|NCT00484185|26856613|FG000|Overall Study|Lost to Follow-up|44|||
13418391|NCT00484185|26856613|FG000|Overall Study|Other|20|||
13418392|NCT00484185|26856613|FG000|Overall Study|Randomized but not treated|5|||
13418393|NCT00484185|26856613|FG000|Overall Study|Death|2|||
13418394|NCT00484159|26856634|FG000|Overall Study|Lost to Follow-up|1|||
13418395|NCT00484159|26856635|FG001|Overall Study|Lost to Follow-up|1|||
13418396|NCT00484159|26856636|FG002|Overall Study|Lost to Follow-up|0|||
13418397|NCT00484094|26856647|FG000|Overall Study|Discontinued|39|||
13418398|NCT00484094|26856647|FG000|Overall Study|Other|3|||
13418399|NCT00483938|26856690|FG000|Overall Study|Protocol Violation|0|||
13418400|NCT00483938|26856691|FG001|Overall Study|Protocol Violation|0|||
13418401|NCT00483938|26856692|FG002|Overall Study|Protocol Violation|0|||
13418402|NCT00483938|26856693|FG003|Overall Study|Protocol Violation|0|||
13418403|NCT00483938|26856694|FG004|Overall Study|Protocol Violation|0|||
13418404|NCT00483938|26856695|FG005|Overall Study|Protocol Violation|0|||
13418405|NCT00483938|26856696|FG006|Overall Study|Protocol Violation|3|||
13418406|NCT00483938|26856690|FG000|Overall Study|Withdrawal by Subject|1|||
13418407|NCT00483938|26856691|FG001|Overall Study|Withdrawal by Subject|6|||
13418408|NCT00483938|26856692|FG002|Overall Study|Withdrawal by Subject|0|||
13418409|NCT00483938|26856693|FG003|Overall Study|Withdrawal by Subject|0|||
13418410|NCT00483938|26856694|FG004|Overall Study|Withdrawal by Subject|1|||
13418411|NCT00483938|26856695|FG005|Overall Study|Withdrawal by Subject|3|||
13418412|NCT00483938|26856696|FG006|Overall Study|Withdrawal by Subject|2|||
13418413|NCT00483938|26856690|FG000|Overall Study|Lost to Follow-up|1|||
13418414|NCT00483938|26856691|FG001|Overall Study|Lost to Follow-up|2|||
13418415|NCT00483938|26856692|FG002|Overall Study|Lost to Follow-up|0|||
13418416|NCT00483938|26856693|FG003|Overall Study|Lost to Follow-up|2|||
13418417|NCT00483938|26856694|FG004|Overall Study|Lost to Follow-up|1|||
13418418|NCT00483938|26856695|FG005|Overall Study|Lost to Follow-up|1|||
13418419|NCT00483938|26856696|FG006|Overall Study|Lost to Follow-up|3|||
13418420|NCT00483938|26856690|FG000|Overall Study|Death|0|||
13418421|NCT00483938|26856691|FG001|Overall Study|Death|2|||
13418422|NCT00483938|26856692|FG002|Overall Study|Death|0|||
13418423|NCT00483938|26856693|FG003|Overall Study|Death|0|||
13418424|NCT00483938|26856694|FG004|Overall Study|Death|0|||
13418425|NCT00483938|26856695|FG005|Overall Study|Death|0|||
13418426|NCT00483938|26856696|FG006|Overall Study|Death|0|||
13418427|NCT00483938|26856690|FG000|Overall Study|Other|3|||
13418428|NCT00483938|26856691|FG001|Overall Study|Other|9|||
13418429|NCT00483938|26856692|FG002|Overall Study|Other|0|||
13418430|NCT00483938|26856693|FG003|Overall Study|Other|4|||
13418431|NCT00483938|26856694|FG004|Overall Study|Other|0|||
13418432|NCT00483938|26856695|FG005|Overall Study|Other|4|||
13418433|NCT00483938|26856696|FG006|Overall Study|Other|32|||
13418434|NCT00483756|26856768|FG000|Overall Study|Death|2|||
13418435|NCT00483756|26856769|FG001|Overall Study|Death|0|||
13418436|NCT00483756|26856770|FG002|Overall Study|Death|1|||
13418437|NCT00483756|26856768|FG000|Overall Study|Adverse Event|19|||
13418438|NCT00483756|26856769|FG001|Overall Study|Adverse Event|38|||
13418439|NCT00483756|26856770|FG002|Overall Study|Adverse Event|40|||
13418440|NCT00483756|26856768|FG000|Overall Study|Lack of Efficacy|1|||
13418441|NCT00483756|26856769|FG001|Overall Study|Lack of Efficacy|0|||
13418442|NCT00483756|26856770|FG002|Overall Study|Lack of Efficacy|0|||
13418443|NCT00483756|26856768|FG000|Overall Study|Lost to Follow-up|3|||
13418444|NCT00483756|26856769|FG001|Overall Study|Lost to Follow-up|1|||
13418445|NCT00483756|26856770|FG002|Overall Study|Lost to Follow-up|0|||
13418446|NCT00483756|26856768|FG000|Overall Study|Withdrawal by Subject|5|||
13418447|NCT00483756|26856769|FG001|Overall Study|Withdrawal by Subject|3|||
13418448|NCT00483756|26856770|FG002|Overall Study|Withdrawal by Subject|4|||
13418449|NCT00483756|26856768|FG000|Overall Study|Other|2|||
13418450|NCT00483756|26856769|FG001|Overall Study|Other|4|||
13418451|NCT00483756|26856770|FG002|Overall Study|Other|3|||
13418452|NCT00483756|26856768|FG000|Overall Study|Randomized, Not Treated|1|||
13418453|NCT00483756|26856769|FG001|Overall Study|Randomized, Not Treated|4|||
13418454|NCT00483756|26856770|FG002|Overall Study|Randomized, Not Treated|4|||
13418455|NCT00483717|26856797|FG000|Overall Study|Protocol Violation|5|||
13418456|NCT00483717|26856798|FG001|Overall Study|Protocol Violation|7|||
13418457|NCT00483717|26856797|FG000|Overall Study|Time of dosing missing|1|||
13418458|NCT00483717|26856798|FG001|Overall Study|Time of dosing missing|1|||
13418459|NCT00483717|26856797|FG000|Overall Study|No treatment for migraine|16|||
13418460|NCT00483717|26856798|FG001|Overall Study|No treatment for migraine|13|||
13418461|NCT00483717|26856797|FG000|Overall Study|Lost to Follow-up|1|||
13418462|NCT00483717|26856798|FG001|Overall Study|Lost to Follow-up|0|||
13418463|NCT00483717|26856797|FG000|Overall Study|Withdrawal by Subject|1|||
13418464|NCT00483717|26856798|FG001|Overall Study|Withdrawal by Subject|0|||
13418465|NCT00483704|26856852|FG000|Randomization|Withdrawal by Subject|19|||
13418466|NCT00483704|26856853|FG001|Randomization|Withdrawal by Subject|28|||
13418467|NCT00483704|26856854|FG002|Randomization|Withdrawal by Subject|18|||
13418468|NCT00483704|26856852|FG000|Randomization|Protocol Violation|14|||
13418469|NCT00483704|26856853|FG001|Randomization|Protocol Violation|25|||
13418470|NCT00483704|26856854|FG002|Randomization|Protocol Violation|22|||
13418471|NCT00483704|26856852|FG000|Randomization|Lost to Follow-up|14|||
13418472|NCT00483704|26856853|FG001|Randomization|Lost to Follow-up|14|||
13418473|NCT00483704|26856854|FG002|Randomization|Lost to Follow-up|19|||
13418474|NCT00483704|26856852|FG000|Randomization|Pregnancy|1|||
13418475|NCT00483704|26856853|FG001|Randomization|Pregnancy|0|||
13418476|NCT00483704|26856854|FG002|Randomization|Pregnancy|0|||
13418477|NCT00483704|26856852|FG000|Randomization|Physician Decision|2|||
13418478|NCT00483704|26856853|FG001|Randomization|Physician Decision|4|||
13418479|NCT00483704|26856854|FG002|Randomization|Physician Decision|0|||
13418480|NCT00483704|26856852|FG000|Randomization|Progressive disease|0|||
13418481|NCT00483704|26856853|FG001|Randomization|Progressive disease|0|||
13418482|NCT00483704|26856854|FG002|Randomization|Progressive disease|1|||
13418483|NCT00483704|26856852|FG000|Randomization|Lack of qualifying migraines|21|||
13418484|NCT00483704|26856853|FG001|Randomization|Lack of qualifying migraines|25|||
13418485|NCT00483704|26856854|FG002|Randomization|Lack of qualifying migraines|31|||
13418486|NCT00483704|26856852|FG000|Treatment|Lack of qualifying migraines|101|||
13418487|NCT00483704|26856853|FG001|Treatment|Lack of qualifying migraines|99|||
13418488|NCT00483704|26856854|FG002|Treatment|Lack of qualifying migraines|116|||
13418489|NCT00483704|26856852|FG000|Treatment|Adverse Event|3|||
13418490|NCT00483704|26856853|FG001|Treatment|Adverse Event|5|||
13418491|NCT00483704|26856854|FG002|Treatment|Adverse Event|4|||
13418492|NCT00483704|26856852|FG000|Treatment|Withdrawal by Subject|16|||
13418493|NCT00483704|26856853|FG001|Treatment|Withdrawal by Subject|12|||
13418494|NCT00483704|26856854|FG002|Treatment|Withdrawal by Subject|21|||
13418495|NCT00483704|26856852|FG000|Treatment|Protocol Violation|6|||
13418496|NCT00483704|26856853|FG001|Treatment|Protocol Violation|3|||
13418497|NCT00483704|26856854|FG002|Treatment|Protocol Violation|5|||
13418498|NCT00483704|26856852|FG000|Treatment|Lost to Follow-up|2|||
13418499|NCT00483704|26856853|FG001|Treatment|Lost to Follow-up|7|||
13418500|NCT00483704|26856854|FG002|Treatment|Lost to Follow-up|5|||
13418501|NCT00483704|26856852|FG000|Treatment|Lack of Efficacy|1|||
13418502|NCT00483704|26856853|FG001|Treatment|Lack of Efficacy|1|||
13418503|NCT00483704|26856854|FG002|Treatment|Lack of Efficacy|1|||
13418504|NCT00483704|26856852|FG000|Treatment|Pregnancy|0|||
13418505|NCT00483704|26856853|FG001|Treatment|Pregnancy|1|||
13418506|NCT00483704|26856854|FG002|Treatment|Pregnancy|0|||
13418507|NCT00483704|26856852|FG000|Treatment|Physician Decision|0|||
13418508|NCT00483704|26856853|FG001|Treatment|Physician Decision|1|||
13418509|NCT00483704|26856854|FG002|Treatment|Physician Decision|4|||
13418510|NCT00483652|26856869|FG000|Double-blind Treatment Period|Protocol Violation|2|||
13418511|NCT00483652|26856870|FG001|Double-blind Treatment Period|Protocol Violation|1|||
13418512|NCT00483652|26856869|FG000|Double-blind Treatment Period|Adverse Event|3|||
13418513|NCT00483652|26856870|FG001|Double-blind Treatment Period|Adverse Event|4|||
13418514|NCT00483652|26856869|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1|||
13418515|NCT00483652|26856870|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0|||
13418516|NCT00483652|26856869|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1|||
13418517|NCT00483652|26856870|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0|||
13418518|NCT00483574|26856885|FG000|Overall Study|Adverse Event|6|||
13418519|NCT00483574|26856886|FG001|Overall Study|Adverse Event|0|||
13418520|NCT00483574|26856885|FG000|Overall Study|Protocol Violation|28|||
13418521|NCT00483574|26856886|FG001|Overall Study|Protocol Violation|9|||
13418522|NCT00483574|26856885|FG000|Overall Study|Lost to Follow-up|16|||
13418523|NCT00483574|26856886|FG001|Overall Study|Lost to Follow-up|4|||
13418524|NCT00483574|26856885|FG000|Overall Study|Withdrawal by Subject|52|||
13418525|NCT00483574|26856886|FG001|Overall Study|Withdrawal by Subject|0|||
13418526|NCT00483548|26856931|FG000|Overall Study|Randomized; not treated with study drug|1|||
13418527|NCT00483548|26856932|FG001|Overall Study|Randomized; not treated with study drug|3|||
13418528|NCT00483548|26856931|FG000|Overall Study|Adverse Event|25|||
13418529|NCT00483548|26856932|FG001|Overall Study|Adverse Event|14|||
13418530|NCT00483548|26856931|FG000|Overall Study|Laboratory abnormality|1|||
13418531|NCT00483548|26856932|FG001|Overall Study|Laboratory abnormality|2|||
13418532|NCT00483548|26856931|FG000|Overall Study|Lack of Efficacy|4|||
13418533|NCT00483548|26856932|FG001|Overall Study|Lack of Efficacy|8|||
13418534|NCT00483548|26856931|FG000|Overall Study|Protocol Violation|11|||
13418535|NCT00483548|26856932|FG001|Overall Study|Protocol Violation|7|||
13418536|NCT00483548|26856931|FG000|Overall Study|Pregnancy|1|||
13418537|NCT00483548|26856932|FG001|Overall Study|Pregnancy|0|||
13418538|NCT00483548|26856931|FG000|Overall Study|Protocol required discontinuation|6|||
13418539|NCT00483548|26856932|FG001|Overall Study|Protocol required discontinuation|6|||
13418540|NCT00483548|26856931|FG000|Overall Study|Unable to comply with protocol schedule|1|||
13418541|NCT00483548|26856932|FG001|Overall Study|Unable to comply with protocol schedule|0|||
13418542|NCT00483548|26856931|FG000|Overall Study|Non-compliance with medication|2|||
13418543|NCT00483548|26856932|FG001|Overall Study|Non-compliance with medication|0|||
13418544|NCT00483548|26856931|FG000|Overall Study|Lost to Follow-up|3|||
13418545|NCT00483548|26856932|FG001|Overall Study|Lost to Follow-up|4|||
13418546|NCT00483548|26856931|FG000|Overall Study|Withdrawal by Subject|5|||
13418547|NCT00483548|26856932|FG001|Overall Study|Withdrawal by Subject|2|||
13418548|NCT00483405|26856941|FG000|Overall Study|Adverse Event|8|||
13418549|NCT00483405|26856941|FG000|Overall Study|Lack of Efficacy|14|||
13418550|NCT00483405|26856941|FG000|Overall Study|Death|3|||
13418551|NCT00483405|26856941|FG000|Overall Study|Withdrawal by Subject|2|||
13418552|NCT00483405|26856941|FG000|Overall Study|Other complicating disease|1|||
13418553|NCT00483379|26856984|FG000|Treatment Period|Adverse Event|1|||
13418554|NCT00483379|26856985|FG001|Treatment Period|Adverse Event|0|||
13418555|NCT00483379|26856984|FG000|Treatment Period|Withdrawal by Subject|1|||
13418556|NCT00483379|26856985|FG001|Treatment Period|Withdrawal by Subject|0|||
13418557|NCT00483327|26856996|FG000|Overall Study|Adverse Event|1|||
13418558|NCT00483327|26856996|FG000|Overall Study|Withdrawal by Subject|3|||
13418559|NCT00483327|26856996|FG000|Overall Study|Lost to Follow-up|4|||
13418560|NCT00483327|26856996|FG000|Overall Study|Patient Non Compliance|2|||
13418561|NCT00483184|26857014|FG000|Overall Study|Withdrawal by Subject|2|||
13418562|NCT00483184|26857015|FG001|Overall Study|Withdrawal by Subject|2|||
13418563|NCT00483184|26857016|FG002|Overall Study|Withdrawal by Subject|0|||
13418564|NCT00483184|26857014|FG000|Overall Study|Lost to Follow-up|1|||
13418565|NCT00483184|26857015|FG001|Overall Study|Lost to Follow-up|0|||
13418566|NCT00483184|26857016|FG002|Overall Study|Lost to Follow-up|0|||
13418567|NCT00483184|26857014|FG000|Overall Study|Adverse Event|1|||
13418568|NCT00483184|26857015|FG001|Overall Study|Adverse Event|2|||
13418569|NCT00483184|26857016|FG002|Overall Study|Adverse Event|2|||
13418570|NCT00483184|26857014|FG000|Overall Study|Protocol Violation|1|||
13418571|NCT00483184|26857015|FG001|Overall Study|Protocol Violation|0|||
13418572|NCT00483184|26857016|FG002|Overall Study|Protocol Violation|1|||
13418573|NCT00483119|26857035|FG000|Overall Study|Adverse Event|0|||
13418574|NCT00483119|26857036|FG001|Overall Study|Adverse Event|1|||
13418575|NCT00483119|26857035|FG000|Overall Study|Physician Decision|1|||
13418576|NCT00483119|26857036|FG001|Overall Study|Physician Decision|0|||
13418577|NCT00483041|26857073|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0|||
13418578|NCT00483041|26857074|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1|||
13418579|NCT00483002|26857082|FG000|Overall Study|Adverse Event|68|||
13418580|NCT00483002|26857082|FG000|Overall Study|Lack of Efficacy|555|||
13418581|NCT00483002|26857082|FG000|Overall Study|Lost to Follow-up|962|||
13418582|NCT00483002|26857082|FG000|Overall Study|Other|2|||
13418583|NCT00483002|26857082|FG000|Overall Study|Other|967|||
13418584|NCT00482729|26857103|FG000|Overall Study|Adverse Event|29|||
13418585|NCT00482729|26857104|FG001|Overall Study|Adverse Event|33|||
13418586|NCT00482729|26857103|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0|||
13418587|NCT00482729|26857104|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2|||
13418588|NCT00482729|26857103|FG000|Overall Study|Hyperglycemia Criteria|7|||
13418589|NCT00482729|26857104|FG001|Overall Study|Hyperglycemia Criteria|5|||
13418590|NCT00482729|26857103|FG000|Overall Study|Lack of Efficacy|4|||
13418591|NCT00482729|26857104|FG001|Overall Study|Lack of Efficacy|16|||
13418592|NCT00482729|26857103|FG000|Overall Study|Lost to Follow-up|86|||
13418593|NCT00482729|26857104|FG001|Overall Study|Lost to Follow-up|66|||
13418594|NCT00482729|26857103|FG000|Overall Study|Physician Decision|10|||
13418595|NCT00482729|26857104|FG001|Overall Study|Physician Decision|7|||
13418596|NCT00482729|26857103|FG000|Overall Study|Pregnancy|4|||
13418597|NCT00482729|26857104|FG001|Overall Study|Pregnancy|2|||
13418598|NCT00482729|26857103|FG000|Overall Study|Protocol Violation|10|||
13418599|NCT00482729|26857104|FG001|Overall Study|Protocol Violation|18|||
13418600|NCT00482729|26857103|FG000|Overall Study|Withdrawal by Subject|67|||
13418601|NCT00482729|26857104|FG001|Overall Study|Withdrawal by Subject|69|||
13418602|NCT00482703|26857156|FG000|Overall Study|Poor compliance|1|||
13418603|NCT00482703|26857157|FG001|Overall Study|Poor compliance|0|||
13418604|NCT00482612|26857196|FG000|In-treatment Period|No study medication administered|0|||
13418605|NCT00482612|26857197|FG001|In-treatment Period|No study medication administered|0|||
13418606|NCT00482612|26857198|FG002|In-treatment Period|No study medication administered|1|||
13418607|NCT00482612|26857199|FG003|In-treatment Period|No study medication administered|0|||
13418608|NCT00482612|26857196|FG000|Follow-up Period|Other|4|||
13418609|NCT00482612|26857197|FG001|Follow-up Period|Other|2|||
13418610|NCT00482612|26857198|FG002|Follow-up Period|Other|1|||
13418611|NCT00482612|26857199|FG003|Follow-up Period|Other|2|||
13418612|NCT00482612|26857196|FG000|Follow-up Period|Lack of compliance|0|||
13418613|NCT00482612|26857197|FG001|Follow-up Period|Lack of compliance|0|||
13418614|NCT00482612|26857198|FG002|Follow-up Period|Lack of compliance|1|||
13418615|NCT00482612|26857199|FG003|Follow-up Period|Lack of compliance|0|||
13418616|NCT00482612|26857196|FG000|Follow-up Period|Lost to Follow-up|0|||
13418617|NCT00482612|26857197|FG001|Follow-up Period|Lost to Follow-up|4|||
13418618|NCT00482612|26857198|FG002|Follow-up Period|Lost to Follow-up|2|||
13418619|NCT00482612|26857199|FG003|Follow-up Period|Lost to Follow-up|1|||
13418620|NCT00482612|26857196|FG000|Follow-up Period|Adverse Event|4|||
13418621|NCT00482612|26857197|FG001|Follow-up Period|Adverse Event|7|||
13418622|NCT00482612|26857198|FG002|Follow-up Period|Adverse Event|9|||
13418623|NCT00482612|26857199|FG003|Follow-up Period|Adverse Event|0|||
13418624|NCT00482612|26857196|FG000|Follow-up Period|Lack of Efficacy|2|||
13418625|NCT00482612|26857197|FG001|Follow-up Period|Lack of Efficacy|0|||
13418626|NCT00482612|26857198|FG002|Follow-up Period|Lack of Efficacy|1|||
13418627|NCT00482612|26857199|FG003|Follow-up Period|Lack of Efficacy|0|||
13418628|NCT00482612|26857196|FG000|Follow-up Period|Withdrawal by Subject|3|||
13418629|NCT00482612|26857197|FG001|Follow-up Period|Withdrawal by Subject|5|||
13418630|NCT00482612|26857198|FG002|Follow-up Period|Withdrawal by Subject|7|||
13418631|NCT00482612|26857199|FG003|Follow-up Period|Withdrawal by Subject|2|||
13418632|NCT00482612|26857196|FG000|Follow-up Period|Reasons not related to trial|1|||
13418633|NCT00482612|26857197|FG001|Follow-up Period|Reasons not related to trial|0|||
13418634|NCT00482612|26857198|FG002|Follow-up Period|Reasons not related to trial|1|||
13418635|NCT00482612|26857199|FG003|Follow-up Period|Reasons not related to trial|3|||
13418636|NCT00482391|26857206|FG000|Overall Study|Withdrawal by Subject|1|||
13418637|NCT00482391|26857206|FG000|Overall Study|Adverse Event|1|||
13418638|NCT00482391|26857206|FG000|Overall Study|Death|1|||
13418639|NCT00482274|26857216|FG000|Overall Study|Adverse Event|1|||
13418640|NCT00482170|26857341|FG000|Overall Study|Adverse Event|5|||
13418641|NCT00482170|26857342|FG001|Overall Study|Adverse Event|14|||
13418642|NCT00482170|26857341|FG000|Overall Study|Withdrawal by Subject|6|||
13418643|NCT00482170|26857342|FG001|Overall Study|Withdrawal by Subject|1|||
13418644|NCT00482170|26857341|FG000|Overall Study|Protocol Violation|2|||
13418645|NCT00482170|26857342|FG001|Overall Study|Protocol Violation|3|||
13418646|NCT00482170|26857341|FG000|Overall Study|Lost to Follow-up|2|||
13418647|NCT00482170|26857342|FG001|Overall Study|Lost to Follow-up|0|||
13418648|NCT00482170|26857341|FG000|Overall Study|Unspecified reason|0|||
13418649|NCT00482170|26857342|FG001|Overall Study|Unspecified reason|2|||
13418650|NCT00482053|26857354|FG000|Inter-treatment Period|Disease progression|1|||
13418651|NCT00482014|26857389|FG000|Overall Study|Withdrawal by Subject|1|||
13418652|NCT00482014|26857390|FG001|Overall Study|Withdrawal by Subject|2|||
13418653|NCT00482014|26857391|FG002|Overall Study|Withdrawal by Subject|3|||
13418654|NCT00482014|26857392|FG003|Overall Study|Withdrawal by Subject|4|||
13418655|NCT00482014|26857389|FG000|Overall Study|Adverse Event|3|||
13418656|NCT00482014|26857390|FG001|Overall Study|Adverse Event|0|||
13418657|NCT00482014|26857391|FG002|Overall Study|Adverse Event|2|||
13418658|NCT00482014|26857392|FG003|Overall Study|Adverse Event|8|||
13418659|NCT00482014|26857389|FG000|Overall Study|Death|1|||
13418660|NCT00482014|26857390|FG001|Overall Study|Death|2|||
13418661|NCT00482014|26857391|FG002|Overall Study|Death|1|||
13418662|NCT00482014|26857392|FG003|Overall Study|Death|4|||
13418663|NCT00482014|26857389|FG000|Overall Study|Lack of Efficacy|1|||
13418664|NCT00482014|26857390|FG001|Overall Study|Lack of Efficacy|0|||
13418665|NCT00482014|26857391|FG002|Overall Study|Lack of Efficacy|4|||
13418666|NCT00482014|26857392|FG003|Overall Study|Lack of Efficacy|6|||
13418667|NCT00482014|26857389|FG000|Overall Study|Sponsor Decision|1|||
13418668|NCT00482014|26857390|FG001|Overall Study|Sponsor Decision|2|||
13418669|NCT00482014|26857391|FG002|Overall Study|Sponsor Decision|1|||
13418670|NCT00482014|26857392|FG003|Overall Study|Sponsor Decision|1|||
13418671|NCT00482001|26857417|FG000|Overall Study|Protocol Violation|1|||
13418672|NCT00482001|26857418|FG001|Overall Study|Protocol Violation|1|||
13418673|NCT00481988|26857433|FG000|Overall Study|Withdrawal by Subject|1|||
13418674|NCT00481988|26857434|FG001|Overall Study|Withdrawal by Subject|1|||
13418675|NCT00481871|26857464|FG000|Overall Study|Progressive Disease - pt withdrew|0|||
13418676|NCT00481871|26857465|FG001|Overall Study|Progressive Disease - pt withdrew|0|||
13418677|NCT00481871|26857466|FG002|Overall Study|Progressive Disease - pt withdrew|1|||
13418678|NCT00481871|26857467|FG003|Overall Study|Progressive Disease - pt withdrew|0|||
13418679|NCT00481871|26857468|FG004|Overall Study|Progressive Disease - pt withdrew|0|||
13418680|NCT00481832|26857483|FG000|Enrollment|Physician Decision|8|||
13418681|NCT00481832|26857483|FG000|Enrollment|Unable to collect enough stem cells|2|||
13418682|NCT00481832|26857483|FG000|Inter-transplant Period|Adverse Event|4|||
13418683|NCT00481832|26857483|FG000|Inter-transplant Period|Death|3|||
13418684|NCT00481832|26857483|FG000|Inter-transplant Period|Physician Decision|4|||
13418685|NCT00481832|26857483|FG000|Inter-transplant Period|Disease relapse|11|||
13418686|NCT00481832|26857483|FG000|Inter-transplant Period|Lack of allogeneic donor|5|||
13418687|NCT00481767|26857522|FG000|Overall Study|Withdrawal by Subject|16|||
13418688|NCT00481767|26857523|FG001|Overall Study|Withdrawal by Subject|11|||
13418689|NCT00481767|26857522|FG000|Overall Study|Lost to Follow-up|16|||
13418690|NCT00481767|26857523|FG001|Overall Study|Lost to Follow-up|10|||
13418691|NCT00481676|26857552|FG000|Overall Study|Adverse Event|0|||
13418692|NCT00481676|26857553|FG001|Overall Study|Adverse Event|1|||
13418693|NCT00481676|26857552|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
13418694|NCT00481676|26857553|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
13418695|NCT00481676|26857552|FG000|Overall Study|Administrative problem|1|||
13418696|NCT00481676|26857553|FG001|Overall Study|Administrative problem|0|||
13418697|NCT00481247|26857582|FG000|Overall Study|Death|0|||
13418698|NCT00481247|26857583|FG001|Overall Study|Death|1|||
13418699|NCT00481247|26857582|FG000|Overall Study|Disease progression|18|||
13418700|NCT00481247|26857583|FG001|Overall Study|Disease progression|22|||
13418701|NCT00481247|26857582|FG000|Overall Study|Intolerance|42|||
13418702|NCT00481247|26857583|FG001|Overall Study|Intolerance|17|||
13418703|NCT00481247|26857582|FG000|Overall Study|Treatment failure|10|||
13418704|NCT00481247|26857583|FG001|Overall Study|Treatment failure|14|||
13418705|NCT00481247|26857582|FG000|Overall Study|AE unrelated to study drug|13|||
13418706|NCT00481247|26857583|FG001|Overall Study|AE unrelated to study drug|4|||
13418707|NCT00481247|26857582|FG000|Overall Study|Withdrawal by Subject|8|||
13418708|NCT00481247|26857583|FG001|Overall Study|Withdrawal by Subject|13|||
13418709|NCT00481247|26857582|FG000|Overall Study|Pregnancy|2|||
13418710|NCT00481247|26857583|FG001|Overall Study|Pregnancy|1|||
13418711|NCT00481247|26857582|FG000|Overall Study|Lost to Follow-up|1|||
13418712|NCT00481247|26857583|FG001|Overall Study|Lost to Follow-up|2|||
13418713|NCT00481247|26857582|FG000|Overall Study|Poor compliance/noncompliance|1|||
13418714|NCT00481247|26857583|FG001|Overall Study|Poor compliance/noncompliance|7|||
13418715|NCT00481247|26857582|FG000|Overall Study|Administrative reason by sponsor|157|||
13418716|NCT00481247|26857583|FG001|Overall Study|Administrative reason by sponsor|162|||
13418717|NCT00481247|26857582|FG000|Overall Study|Varied|6|||
13418718|NCT00481247|26857583|FG001|Overall Study|Varied|15|||
13418719|NCT00481247|26857582|FG000|Overall Study|Did not receive treatment|1|||
13418720|NCT00481247|26857583|FG001|Overall Study|Did not receive treatment|2|||
13418721|NCT00481195|26857674|FG000|Overall Study|Adverse Event|16|||
13418722|NCT00481195|26857675|FG001|Overall Study|Adverse Event|11|||
13418723|NCT00481195|26857674|FG000|Overall Study|Lack of Efficacy|1|||
13418724|NCT00481195|26857675|FG001|Overall Study|Lack of Efficacy|3|||
13418725|NCT00481195|26857674|FG000|Overall Study|Lost to Follow-up|4|||
13418726|NCT00481195|26857675|FG001|Overall Study|Lost to Follow-up|6|||
13418727|NCT00481195|26857674|FG000|Overall Study|Physician Decision|3|||
13418728|NCT00481195|26857675|FG001|Overall Study|Physician Decision|1|||
13418729|NCT00481195|26857674|FG000|Overall Study|Protocol Violation|10|||
13418730|NCT00481195|26857675|FG001|Overall Study|Protocol Violation|7|||
13418731|NCT00481195|26857674|FG000|Overall Study|Withdrawal by Subject|3|||
13418732|NCT00481195|26857675|FG001|Overall Study|Withdrawal by Subject|9|||
13418733|NCT00481195|26857674|FG000|Overall Study|Miscellaneous|2|||
13418734|NCT00481195|26857675|FG001|Overall Study|Miscellaneous|2|||
13418735|NCT00481078|26857692|FG000|Overall Study|Progression of disease|11|||
13418736|NCT00481078|26857693|FG001|Overall Study|Progression of disease|11|||
13418737|NCT00481078|26857692|FG000|Overall Study|Adverse Event|15|||
13418738|NCT00481078|26857693|FG001|Overall Study|Adverse Event|3|||
13418739|NCT00481078|26857692|FG000|Overall Study|Death|5|||
13418740|NCT00481078|26857693|FG001|Overall Study|Death|3|||
13418741|NCT00481078|26857692|FG000|Overall Study|Intercurrent illness|1|||
13418742|NCT00481078|26857693|FG001|Overall Study|Intercurrent illness|0|||
13418743|NCT00481078|26857692|FG000|Overall Study|Withdrawal by Subject|7|||
13418744|NCT00481078|26857693|FG001|Overall Study|Withdrawal by Subject|1|||
13418745|NCT00481078|26857692|FG000|Overall Study|Information not available|1|||
13418746|NCT00481078|26857693|FG001|Overall Study|Information not available|0|||
13418747|NCT00481078|26857692|FG000|Overall Study|Received other treatment|2|||
13418748|NCT00481078|26857693|FG001|Overall Study|Received other treatment|1|||
13418749|NCT00481078|26857692|FG000|Overall Study|Brain metastasis|0|||
13418750|NCT00481078|26857693|FG001|Overall Study|Brain metastasis|1|||
13418751|NCT00481065|26857804|FG000|Overall Study|Adverse event or death|1|||
13418752|NCT00481065|26857805|FG001|Overall Study|Adverse event or death|1|||
13418753|NCT00481065|26857806|FG002|Overall Study|Adverse event or death|3|||
13418754|NCT00481065|26857807|FG003|Overall Study|Adverse event or death|0|||
13418755|NCT00481065|26857808|FG004|Overall Study|Adverse event or death|2|||
13418756|NCT00481065|26857809|FG005|Overall Study|Adverse event or death|0|||
13418757|NCT00481065|26857810|FG006|Overall Study|Adverse event or death|1|||
13418758|NCT00481065|26857811|FG007|Overall Study|Adverse event or death|1|||
13418759|NCT00481065|26857804|FG000|Overall Study|Withdrawal by Subject|11|||
13418760|NCT00481065|26857805|FG001|Overall Study|Withdrawal by Subject|12|||
13418761|NCT00481065|26857806|FG002|Overall Study|Withdrawal by Subject|7|||
13418762|NCT00481065|26857807|FG003|Overall Study|Withdrawal by Subject|11|||
13418763|NCT00481065|26857808|FG004|Overall Study|Withdrawal by Subject|13|||
13418764|NCT00481065|26857809|FG005|Overall Study|Withdrawal by Subject|12|||
13418765|NCT00481065|26857810|FG006|Overall Study|Withdrawal by Subject|9|||
13418766|NCT00481065|26857811|FG007|Overall Study|Withdrawal by Subject|10|||
13418767|NCT00481065|26857804|FG000|Overall Study|Lost to Follow-up|4|||
13418768|NCT00481065|26857805|FG001|Overall Study|Lost to Follow-up|2|||
13418769|NCT00481065|26857806|FG002|Overall Study|Lost to Follow-up|4|||
13418770|NCT00481065|26857807|FG003|Overall Study|Lost to Follow-up|3|||
13418771|NCT00481065|26857808|FG004|Overall Study|Lost to Follow-up|3|||
13418772|NCT00481065|26857809|FG005|Overall Study|Lost to Follow-up|3|||
13418773|NCT00481065|26857810|FG006|Overall Study|Lost to Follow-up|2|||
13418774|NCT00481065|26857811|FG007|Overall Study|Lost to Follow-up|5|||
13418775|NCT00481065|26857804|FG000|Overall Study|Inappropriate enrollment|4|||
13418776|NCT00481065|26857805|FG001|Overall Study|Inappropriate enrollment|0|||
13418777|NCT00481065|26857806|FG002|Overall Study|Inappropriate enrollment|2|||
13418778|NCT00481065|26857807|FG003|Overall Study|Inappropriate enrollment|0|||
13418779|NCT00481065|26857808|FG004|Overall Study|Inappropriate enrollment|2|||
13418780|NCT00481065|26857809|FG005|Overall Study|Inappropriate enrollment|1|||
13418781|NCT00481065|26857810|FG006|Overall Study|Inappropriate enrollment|0|||
13418782|NCT00481065|26857811|FG007|Overall Study|Inappropriate enrollment|1|||
13418783|NCT00481065|26857804|FG000|Overall Study|Administrative reason|0|||
13418784|NCT00481065|26857805|FG001|Overall Study|Administrative reason|0|||
13418785|NCT00481065|26857806|FG002|Overall Study|Administrative reason|0|||
13418786|NCT00481065|26857807|FG003|Overall Study|Administrative reason|0|||
13418787|NCT00481065|26857808|FG004|Overall Study|Administrative reason|0|||
13418788|NCT00481065|26857809|FG005|Overall Study|Administrative reason|2|||
13418789|NCT00481065|26857810|FG006|Overall Study|Administrative reason|1|||
13418790|NCT00481065|26857811|FG007|Overall Study|Administrative reason|0|||
13418791|NCT00481065|26857804|FG000|Overall Study|Protocol Violation|2|||
13418792|NCT00481065|26857805|FG001|Overall Study|Protocol Violation|1|||
13418793|NCT00481065|26857806|FG002|Overall Study|Protocol Violation|1|||
13418794|NCT00481065|26857807|FG003|Overall Study|Protocol Violation|1|||
13418795|NCT00481065|26857808|FG004|Overall Study|Protocol Violation|2|||
13418796|NCT00481065|26857809|FG005|Overall Study|Protocol Violation|6|||
13418797|NCT00481065|26857810|FG006|Overall Study|Protocol Violation|3|||
13418798|NCT00481065|26857811|FG007|Overall Study|Protocol Violation|2|||
13418799|NCT00481065|26857804|FG000|Overall Study|Unable to classify|0|||
13418800|NCT00481065|26857805|FG001|Overall Study|Unable to classify|1|||
13418801|NCT00481065|26857806|FG002|Overall Study|Unable to classify|2|||
13418802|NCT00481065|26857807|FG003|Overall Study|Unable to classify|0|||
13418803|NCT00481065|26857808|FG004|Overall Study|Unable to classify|1|||
13418804|NCT00481065|26857809|FG005|Overall Study|Unable to classify|0|||
13418805|NCT00481065|26857810|FG006|Overall Study|Unable to classify|0|||
13418806|NCT00481065|26857811|FG007|Overall Study|Unable to classify|0|||
13418807|NCT00480857|26857821|FG000|Overall Study|Lack of Efficacy|2|||
13418808|NCT00480779|26857852|FG000|Overall Study|Other|2|||
13418809|NCT00480779|26857853|FG001|Overall Study|Other|0|||
13418810|NCT00480779|26857852|FG000|Overall Study|Job and Health-related|0|||
13418811|NCT00480779|26857853|FG001|Overall Study|Job and Health-related|3|||
13418812|NCT00480636|26857863|FG000|Overall Study|Death|12|||
13418813|NCT00480636|26857863|FG000|Overall Study|Lost to Follow-up|4|||
13418814|NCT00480636|26857863|FG000|Overall Study|Other|2|||
13418815|NCT00480636|26857863|FG000|Overall Study|Lost to follow-up; subsequently died|1|||
13418816|NCT00480532|26857894|FG000|Overall Study|Withdrawal by Subject|2|||
13418817|NCT00480532|26857895|FG001|Overall Study|Withdrawal by Subject|4|||
13418818|NCT00480532|26857896|FG002|Overall Study|Withdrawal by Subject|3|||
13418819|NCT00480532|26857897|FG003|Overall Study|Withdrawal by Subject|1|||
13418820|NCT00480532|26857894|FG000|Overall Study|Protocol Violation|0|||
13418821|NCT00480532|26857895|FG001|Overall Study|Protocol Violation|0|||
13418822|NCT00480532|26857896|FG002|Overall Study|Protocol Violation|1|||
13418823|NCT00480532|26857897|FG003|Overall Study|Protocol Violation|0|||
13418824|NCT00480493|26857914|FG000|Overall Study|moved|2|||
13418825|NCT00480493|26857915|FG001|Overall Study|moved|7|||
13418826|NCT00480441|26857930|FG000|Screening|Not Eligible|37|||
13418827|NCT00480441|26857931|FG001|Screening|Not Eligible|0|||
13418828|NCT00480441|26857932|FG002|Screening|Not Eligible|0|||
13418829|NCT00480441|26857930|FG000|Baseline Functional MRI|Functional MRI data not usable|4|||
13418830|NCT00480441|26857931|FG001|Baseline Functional MRI|Functional MRI data not usable|0|||
13418831|NCT00480441|26857932|FG002|Baseline Functional MRI|Functional MRI data not usable|0|||
13418832|NCT00480441|26857930|FG000|Baseline Functional MRI|Lost to Follow-up|4|||
13418833|NCT00480441|26857931|FG001|Baseline Functional MRI|Lost to Follow-up|0|||
13418834|NCT00480441|26857932|FG002|Baseline Functional MRI|Lost to Follow-up|0|||
13418835|NCT00480441|26857930|FG000|Baseline Functional MRI|physical contraindication|4|||
13418836|NCT00480441|26857931|FG001|Baseline Functional MRI|physical contraindication|0|||
13418837|NCT00480441|26857932|FG002|Baseline Functional MRI|physical contraindication|0|||
13418838|NCT00480441|26857930|FG000|Randomization|Lost to Follow-up|0|||
13418839|NCT00480441|26857931|FG001|Randomization|Lost to Follow-up|7|||
13418840|NCT00480441|26857932|FG002|Randomization|Lost to Follow-up|2|||
13418841|NCT00480324|26857965|FG000|Overall Study|Adverse Event|1|||
13418842|NCT00480324|26857966|FG001|Overall Study|Adverse Event|1|||
13418843|NCT00480324|26857965|FG000|Overall Study|Protocol Violation|0|||
13418844|NCT00480324|26857966|FG001|Overall Study|Protocol Violation|1|||
13418845|NCT00480324|26857965|FG000|Overall Study|Withdrawal by Subject|14|||
13418846|NCT00480324|26857966|FG001|Overall Study|Withdrawal by Subject|5|||
13418847|NCT00480324|26857965|FG000|Overall Study|Lost to Follow-up|17|||
13418848|NCT00480324|26857966|FG001|Overall Study|Lost to Follow-up|8|||
13418849|NCT00480324|26857965|FG000|Overall Study|Subject's mother pregnant|0|||
13418850|NCT00480324|26857966|FG001|Overall Study|Subject's mother pregnant|1|||
13418851|NCT00480077|26857979|FG000|Overall Study|Death|19|||
13418852|NCT00480077|26857980|FG001|Overall Study|Death|15|||
13418853|NCT00480077|26857979|FG000|Overall Study|early exit|12|||
13418854|NCT00480077|26857980|FG001|Overall Study|early exit|11|||
13418855|NCT00480025|26858055|FG000|Overall Study|Protocol Violation|12|||
13418856|NCT00480025|26858056|FG001|Overall Study|Protocol Violation|7|||
13418857|NCT00480025|26858055|FG000|Overall Study|Patients remaining ongoing at Data Lock|101|||
13418858|NCT00480025|26858056|FG001|Overall Study|Patients remaining ongoing at Data Lock|55|||
13418859|NCT00480025|26858055|FG000|Overall Study|Disease Progression / Recurrence|449|||
13418860|NCT00480025|26858056|FG001|Overall Study|Disease Progression / Recurrence|224|||
13418861|NCT00480025|26858055|FG000|Overall Study|Adverse Event|44|||
13418862|NCT00480025|26858056|FG001|Overall Study|Adverse Event|12|||
13418863|NCT00480025|26858055|FG000|Overall Study|Other|70|||
13418864|NCT00480025|26858056|FG001|Overall Study|Other|29|||
13418865|NCT00480025|26858055|FG000|Overall Study|SAE including intercurrent illness|76|||
13418866|NCT00480025|26858056|FG001|Overall Study|SAE including intercurrent illness|42|||
13418867|NCT00479557|26858115|FG000|Overall Study|Death|0|||
13418868|NCT00479557|26858116|FG001|Overall Study|Death|0|||
13418869|NCT00479557|26858117|FG002|Overall Study|Death|0|||
13418870|NCT00479557|26858118|FG003|Overall Study|Death|0|||
13418871|NCT00479557|26858119|FG004|Overall Study|Death|0|||
13418872|NCT00479557|26858120|FG005|Overall Study|Death|1|||
13418873|NCT00479557|26858121|FG006|Overall Study|Death|0|||
13418874|NCT00479557|26858115|FG000|Overall Study|Lack of Efficacy|1|||
13418875|NCT00479557|26858116|FG001|Overall Study|Lack of Efficacy|0|||
13418876|NCT00479557|26858117|FG002|Overall Study|Lack of Efficacy|0|||
13418877|NCT00479557|26858118|FG003|Overall Study|Lack of Efficacy|0|||
13418878|NCT00479557|26858119|FG004|Overall Study|Lack of Efficacy|0|||
13418879|NCT00479557|26858120|FG005|Overall Study|Lack of Efficacy|0|||
13418880|NCT00479557|26858121|FG006|Overall Study|Lack of Efficacy|0|||
13418881|NCT00479557|26858115|FG000|Overall Study|Lost to Follow-up|0|||
13418882|NCT00479557|26858116|FG001|Overall Study|Lost to Follow-up|2|||
13418883|NCT00479557|26858117|FG002|Overall Study|Lost to Follow-up|0|||
13418884|NCT00479557|26858118|FG003|Overall Study|Lost to Follow-up|2|||
13418885|NCT00479557|26858119|FG004|Overall Study|Lost to Follow-up|0|||
13418886|NCT00479557|26858120|FG005|Overall Study|Lost to Follow-up|0|||
13418887|NCT00479557|26858121|FG006|Overall Study|Lost to Follow-up|0|||
13418888|NCT00479557|26858115|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
13418889|NCT00479557|26858116|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
13418890|NCT00479557|26858117|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
13418891|NCT00479557|26858118|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
13418892|NCT00479557|26858119|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
13418893|NCT00479557|26858120|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
13418894|NCT00479557|26858121|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
13418895|NCT00479557|26858115|FG000|Overall Study|AE not related to Study Drug|1|||
13418896|NCT00479557|26858116|FG001|Overall Study|AE not related to Study Drug|3|||
13418897|NCT00479557|26858117|FG002|Overall Study|AE not related to Study Drug|0|||
13418898|NCT00479557|26858118|FG003|Overall Study|AE not related to Study Drug|0|||
13418899|NCT00479557|26858119|FG004|Overall Study|AE not related to Study Drug|2|||
13418900|NCT00479557|26858120|FG005|Overall Study|AE not related to Study Drug|2|||
13418901|NCT00479557|26858121|FG006|Overall Study|AE not related to Study Drug|1|||
13418902|NCT00479557|26858115|FG000|Overall Study|Caregiver Request|2|||
13418903|NCT00479557|26858116|FG001|Overall Study|Caregiver Request|2|||
13418904|NCT00479557|26858117|FG002|Overall Study|Caregiver Request|2|||
13418905|NCT00479557|26858118|FG003|Overall Study|Caregiver Request|0|||
13418906|NCT00479557|26858119|FG004|Overall Study|Caregiver Request|1|||
13418907|NCT00479557|26858120|FG005|Overall Study|Caregiver Request|2|||
13418908|NCT00479557|26858121|FG006|Overall Study|Caregiver Request|0|||
13418909|NCT00479557|26858115|FG000|Overall Study|Investigator Request|0|||
13418910|NCT00479557|26858116|FG001|Overall Study|Investigator Request|0|||
13418911|NCT00479557|26858117|FG002|Overall Study|Investigator Request|1|||
13418912|NCT00479557|26858118|FG003|Overall Study|Investigator Request|0|||
13418913|NCT00479557|26858119|FG004|Overall Study|Investigator Request|0|||
13418914|NCT00479557|26858120|FG005|Overall Study|Investigator Request|0|||
13418915|NCT00479557|26858121|FG006|Overall Study|Investigator Request|0|||
13418916|NCT00479557|26858115|FG000|Overall Study|Subject Request|3|||
13418917|NCT00479557|26858116|FG001|Overall Study|Subject Request|0|||
13418918|NCT00479557|26858117|FG002|Overall Study|Subject Request|1|||
13418919|NCT00479557|26858118|FG003|Overall Study|Subject Request|1|||
13418920|NCT00479557|26858119|FG004|Overall Study|Subject Request|1|||
13418921|NCT00479557|26858120|FG005|Overall Study|Subject Request|4|||
13418922|NCT00479557|26858121|FG006|Overall Study|Subject Request|1|||
13418923|NCT00479557|26858115|FG000|Overall Study|Other|2|||
13418924|NCT00479557|26858116|FG001|Overall Study|Other|3|||
13418925|NCT00479557|26858117|FG002|Overall Study|Other|1|||
13418926|NCT00479557|26858118|FG003|Overall Study|Other|0|||
13418927|NCT00479557|26858119|FG004|Overall Study|Other|0|||
13418928|NCT00479557|26858120|FG005|Overall Study|Other|3|||
13418929|NCT00479557|26858121|FG006|Overall Study|Other|0|||
13418930|NCT00479167|26858128|FG000|Overall Study|Withdrawal by Subject|1|||
13418931|NCT00478933|26858154|FG000|Overall Study|Protocol Violation|22|||
13418932|NCT00478933|26858154|FG000|Overall Study|Informed consent not verified|3|||
13418933|NCT00478933|26858154|FG000|Overall Study|Inadequate data available|53|||
13418934|NCT00478673|26858161|FG000|30-Days Post-Procedure|Death|2|||
13418935|NCT00478673|26858161|FG000|30-Days Post-Procedure|Withdrawal by Subject|1|||
13418936|NCT00478673|26858161|FG000|30-Days Post-Procedure|Missed Visit|7|||
13418937|NCT00478673|26858161|FG000|12-Months Post-Procedure|Death|23|||
13418938|NCT00478673|26858161|FG000|12-Months Post-Procedure|Lost to Follow-up|4|||
13418939|NCT00478673|26858161|FG000|12-Months Post-Procedure|Withdrawal by Subject|6|||
13418940|NCT00478673|26858161|FG000|12-Months Post-Procedure|Missed Visit|25|||
13418941|NCT00478673|26858161|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6|||
13418942|NCT00478231|26858182|FG000|Overall Study|Death|7|||
13418943|NCT00478231|26858182|FG000|Overall Study|Lack of Efficacy|47|||
13418944|NCT00478231|26858182|FG000|Overall Study|Lost to Follow-up|7|||
13418945|NCT00478231|26858182|FG000|Overall Study|Withdrawal by Subject|6|||
13418946|NCT00478231|26858182|FG000|Overall Study|Other|9|||
13418947|NCT00478231|26858182|FG000|Overall Study|Adverse Event|5|||
13418948|NCT00478231|26858182|FG000|Overall Study|Randomized, not treated|3|||
13418949|NCT00477594|26858245|FG000|Year 1 and Year 2|Adverse Event|4|||
13418950|NCT00477594|26858246|FG001|Year 1 and Year 2|Adverse Event|2|||
13418951|NCT00477594|26858245|FG000|Year 1 and Year 2|Physician Decision|2|||
13418952|NCT00477594|26858246|FG001|Year 1 and Year 2|Physician Decision|1|||
13418953|NCT00477594|26858245|FG000|Year 1 and Year 2|Withdrawal by Subject|2|||
13418954|NCT00477594|26858246|FG001|Year 1 and Year 2|Withdrawal by Subject|1|||
13418955|NCT00477594|26858245|FG000|Year 1 and Year 2|Other|1|||
13418956|NCT00477594|26858246|FG001|Year 1 and Year 2|Other|0|||
13418957|NCT00477594|26858245|FG000|Year 3|Adverse Event|1|||
13418958|NCT00477594|26858246|FG001|Year 3|Adverse Event|0|||
13418959|NCT00477594|26858245|FG000|Year 3|Withdrawal by Subject|1|||
13418960|NCT00477594|26858246|FG001|Year 3|Withdrawal by Subject|0|||
13418961|NCT00477594|26858245|FG000|Follow-up Period|Withdrawal by Subject|2|||
13418962|NCT00477594|26858246|FG001|Follow-up Period|Withdrawal by Subject|1|||
13418963|NCT00477594|26858245|FG000|Follow-up Period|Other|1|||
13418964|NCT00477594|26858246|FG001|Follow-up Period|Other|0|||
13418965|NCT00475852|26858281|FG000|Overall Study|Death|444|||
13418966|NCT00475852|26858282|FG001|Overall Study|Death|456|||
13418967|NCT00475852|26858281|FG000|Overall Study|Withdrawal by Subject|19|||
13418968|NCT00475852|26858282|FG001|Overall Study|Withdrawal by Subject|24|||
13418969|NCT00475852|26858281|FG000|Overall Study|Lost to Follow-up|54|||
13418970|NCT00475852|26858282|FG001|Overall Study|Lost to Follow-up|68|||
13418971|NCT00475722|26858295|FG000|Overall Study|Withdrawal by Subject|12|||
13418972|NCT00475722|26858296|FG001|Overall Study|Withdrawal by Subject|12|||
13418973|NCT00475722|26858295|FG000|Overall Study|Protocol Violation|3|||
13418974|NCT00475722|26858296|FG001|Overall Study|Protocol Violation|0|||
13418975|NCT00475176|26858303|FG000|Overall Study|Adverse Event|2|||
13418976|NCT00475176|26858303|FG000|Overall Study|Withdrawal by Subject|1|||
13418977|NCT00475176|26858303|FG000|Overall Study|Protocol Violation|1|||
13418978|NCT00474786|26858328|FG000|Overall Study|Not Meeting Study Criteria|0|||
13418979|NCT00474786|26858329|FG001|Overall Study|Not Meeting Study Criteria|1|||
13418980|NCT00474786|26858328|FG000|Overall Study|Investigator Request|2|||
13418981|NCT00474786|26858329|FG001|Overall Study|Investigator Request|1|||
13418982|NCT00474786|26858328|FG000|Overall Study|Death|189|||
13418983|NCT00474786|26858329|FG001|Overall Study|Death|170|||
13418984|NCT00474786|26858328|FG000|Overall Study|Discontinuation of Study by Sponsor|42|||
13418985|NCT00474786|26858329|FG001|Overall Study|Discontinuation of Study by Sponsor|59|||
13418986|NCT00474786|26858328|FG000|Overall Study|Lost to Follow-up|4|||
13418987|NCT00474786|26858329|FG001|Overall Study|Lost to Follow-up|7|||
13418988|NCT00474786|26858328|FG000|Overall Study|Protocol Violation|2|||
13418989|NCT00474786|26858329|FG001|Overall Study|Protocol Violation|0|||
13418990|NCT00474786|26858328|FG000|Overall Study|Withdrawal by Subject|15|||
13418991|NCT00474786|26858329|FG001|Overall Study|Withdrawal by Subject|15|||
13418992|NCT00474786|26858328|FG000|Overall Study|Other|5|||
13418993|NCT00474786|26858329|FG001|Overall Study|Other|0|||
13418994|NCT00474760|26858456|FG000|Overall Study|Death|0|||
13418995|NCT00474760|26858457|FG001|Overall Study|Death|0|||
13418996|NCT00474760|26858458|FG002|Overall Study|Death|0|||
13418997|NCT00474760|26858459|FG003|Overall Study|Death|0|||
13418998|NCT00474760|26858460|FG004|Overall Study|Death|2|||
13418999|NCT00474760|26858461|FG005|Overall Study|Death|0|||
13419000|NCT00474760|26858462|FG006|Overall Study|Death|0|||
13419001|NCT00474760|26858456|FG000|Overall Study|Adverse Event|0|||
13419002|NCT00474760|26858457|FG001|Overall Study|Adverse Event|0|||
13419003|NCT00474760|26858458|FG002|Overall Study|Adverse Event|0|||
13419004|NCT00474760|26858459|FG003|Overall Study|Adverse Event|0|||
13419005|NCT00474760|26858460|FG004|Overall Study|Adverse Event|1|||
13419006|NCT00474760|26858461|FG005|Overall Study|Adverse Event|7|||
13419007|NCT00474760|26858462|FG006|Overall Study|Adverse Event|0|||
13419008|NCT00474760|26858456|FG000|Overall Study|Laboratory abnormality|0|||
13419009|NCT00474760|26858457|FG001|Overall Study|Laboratory abnormality|0|||
13419010|NCT00474760|26858458|FG002|Overall Study|Laboratory abnormality|0|||
13419011|NCT00474760|26858459|FG003|Overall Study|Laboratory abnormality|0|||
13419012|NCT00474760|26858460|FG004|Overall Study|Laboratory abnormality|0|||
13419013|NCT00474760|26858461|FG005|Overall Study|Laboratory abnormality|1|||
13419014|NCT00474760|26858462|FG006|Overall Study|Laboratory abnormality|0|||
13419015|NCT00474760|26858456|FG000|Overall Study|Withdrawal by Subject|0|||
13419016|NCT00474760|26858457|FG001|Overall Study|Withdrawal by Subject|0|||
13419017|NCT00474760|26858458|FG002|Overall Study|Withdrawal by Subject|0|||
13419018|NCT00474760|26858459|FG003|Overall Study|Withdrawal by Subject|1|||
13419019|NCT00474760|26858460|FG004|Overall Study|Withdrawal by Subject|0|||
13419020|NCT00474760|26858461|FG005|Overall Study|Withdrawal by Subject|1|||
13419021|NCT00474760|26858462|FG006|Overall Study|Withdrawal by Subject|1|||
13419022|NCT00474760|26858456|FG000|Overall Study|Other|0|||
13419023|NCT00474760|26858457|FG001|Overall Study|Other|1|||
13419024|NCT00474760|26858458|FG002|Overall Study|Other|0|||
13419025|NCT00474760|26858459|FG003|Overall Study|Other|0|||
13419026|NCT00474760|26858460|FG004|Overall Study|Other|1|||
13419027|NCT00474760|26858461|FG005|Overall Study|Other|0|||
13419028|NCT00474760|26858462|FG006|Overall Study|Other|0|||
13419029|NCT00474760|26858456|FG000|Overall Study|Progressive disease|3|||
13419030|NCT00474760|26858457|FG001|Overall Study|Progressive disease|2|||
13419031|NCT00474760|26858458|FG002|Overall Study|Progressive disease|3|||
13419032|NCT00474760|26858459|FG003|Overall Study|Progressive disease|2|||
13419033|NCT00474760|26858460|FG004|Overall Study|Progressive disease|8|||
13419034|NCT00474760|26858461|FG005|Overall Study|Progressive disease|20|||
13419035|NCT00474760|26858462|FG006|Overall Study|Progressive disease|7|||
13419036|NCT00474760|26858456|FG000|Overall Study|Terminated by sponsor|0|||
13419037|NCT00474760|26858457|FG001|Overall Study|Terminated by sponsor|0|||
13419038|NCT00474760|26858458|FG002|Overall Study|Terminated by sponsor|0|||
13419039|NCT00474760|26858459|FG003|Overall Study|Terminated by sponsor|0|||
13419040|NCT00474760|26858460|FG004|Overall Study|Terminated by sponsor|0|||
13419041|NCT00474760|26858461|FG005|Overall Study|Terminated by sponsor|0|||
13419042|NCT00474760|26858462|FG006|Overall Study|Terminated by sponsor|2|||
13476651|NCT01425008|27003736|FG007|Dose Escalation Phase|Progressive Disease|2|||
13476652|NCT01425008|27003737|FG008|Dose Escalation Phase|Progressive Disease|6|||
13476653|NCT01425008|27003738|FG009|Dose Escalation Phase|Progressive Disease|2|||
13419043|NCT00474630|26858523|FG000|Overall Study|Adverse Event|98|||
13419044|NCT00474630|26858524|FG001|Overall Study|Adverse Event|26|||
13419045|NCT00474630|26858523|FG000|Overall Study|Lost to Follow-up|22|||
13419046|NCT00474630|26858524|FG001|Overall Study|Lost to Follow-up|15|||
13419047|NCT00474630|26858523|FG000|Overall Study|Withdrawal by Subject|21|||
13419048|NCT00474630|26858524|FG001|Overall Study|Withdrawal by Subject|15|||
13419049|NCT00474630|26858523|FG000|Overall Study|Protocol Violation|3|||
13419050|NCT00474630|26858524|FG001|Overall Study|Protocol Violation|4|||
13419051|NCT00474630|26858523|FG000|Overall Study|Lack of Efficacy|5|||
13419052|NCT00474630|26858524|FG001|Overall Study|Lack of Efficacy|6|||
13419053|NCT00474630|26858523|FG000|Overall Study|Drug noncompliance, other|11|||
13419054|NCT00474630|26858524|FG001|Overall Study|Drug noncompliance, other|4|||
13419055|NCT00474539|26858579|FG000|Infant Series|Withdrawal by Subject|3|||
13419056|NCT00474539|26858580|FG001|Infant Series|Withdrawal by Subject|4|||
13419057|NCT00474539|26858579|FG000|Infant Series|Randomization error|5|||
13419058|NCT00474539|26858580|FG001|Infant Series|Randomization error|0|||
13419059|NCT00474539|26858579|FG000|Infant Series|Lost to Follow-up|2|||
13419060|NCT00474539|26858580|FG001|Infant Series|Lost to Follow-up|1|||
13419061|NCT00474539|26858579|FG000|Infant Series|Protocol Violation|0|||
13419062|NCT00474539|26858580|FG001|Infant Series|Protocol Violation|1|||
13419063|NCT00474539|26858579|FG000|After Infant Series|Lost to Follow-up|3|||
13419064|NCT00474539|26858580|FG001|After Infant Series|Lost to Follow-up|0|||
13419065|NCT00474539|26858579|FG000|After Infant Series|Withdrawal by Subject|1|||
13419066|NCT00474539|26858580|FG001|After Infant Series|Withdrawal by Subject|0|||
13419067|NCT00474539|26858579|FG000|Toddler Dose|Protocol Violation|1|||
13419068|NCT00474539|26858580|FG001|Toddler Dose|Protocol Violation|0|||
13419069|NCT00474175|26858625|FG000|Overall Study|Lack of Efficacy|0|||
13419070|NCT00474175|26858626|FG001|Overall Study|Lack of Efficacy|0|||
13419071|NCT00474175|26858627|FG002|Overall Study|Lack of Efficacy|1|||
13419072|NCT00474175|26858625|FG000|Overall Study|Withdrawal by Subject|0|||
13419073|NCT00474175|26858626|FG001|Overall Study|Withdrawal by Subject|1|||
13419074|NCT00474175|26858627|FG002|Overall Study|Withdrawal by Subject|1|||
13419075|NCT00474175|26858625|FG000|Overall Study|Ineligible|1|||
13419076|NCT00474175|26858626|FG001|Overall Study|Ineligible|3|||
13419077|NCT00474175|26858627|FG002|Overall Study|Ineligible|1|||
13419078|NCT00474175|26858625|FG000|Overall Study|Protocol Violation|0|||
13419079|NCT00474175|26858626|FG001|Overall Study|Protocol Violation|2|||
13419080|NCT00474175|26858627|FG002|Overall Study|Protocol Violation|1|||
13419081|NCT00474175|26858625|FG000|Overall Study|Administrative|0|||
13419082|NCT00474175|26858626|FG001|Overall Study|Administrative|1|||
13419083|NCT00474175|26858627|FG002|Overall Study|Administrative|0|||
13419084|NCT00474045|26858732|FG000|Overall Study|Adverse Event|18|||
13419085|NCT00474045|26858733|FG001|Overall Study|Adverse Event|8|||
13419086|NCT00474045|26858732|FG000|Overall Study|Unclassified|1|||
13419087|NCT00474045|26858733|FG001|Overall Study|Unclassified|3|||
13419088|NCT00474045|26858732|FG000|Overall Study|Lack of Efficacy|0|||
13419089|NCT00474045|26858733|FG001|Overall Study|Lack of Efficacy|9|||
13419090|NCT00474045|26858732|FG000|Overall Study|Lost to Follow-up|1|||
13419091|NCT00474045|26858733|FG001|Overall Study|Lost to Follow-up|1|||
13419092|NCT00474045|26858732|FG000|Overall Study|Protocol Violation|10|||
13419093|NCT00474045|26858733|FG001|Overall Study|Protocol Violation|12|||
13419094|NCT00474045|26858732|FG000|Overall Study|Withdrawal by Subject|16|||
13419095|NCT00474045|26858733|FG001|Overall Study|Withdrawal by Subject|18|||
13419096|NCT00474045|26858732|FG000|Overall Study|Withdrawal criteria|60|||
13419097|NCT00474045|26858733|FG001|Overall Study|Withdrawal criteria|50|||
13419098|NCT00473876|26858748|FG000|Overall Study|Lost to Follow-up|3|||
13419099|NCT00473876|26858749|FG001|Overall Study|Lost to Follow-up|1|||
13419100|NCT00473330|26858814|FG000|Core Study|Adverse Event|4|||
13419101|NCT00473330|26858815|FG001|Core Study|Adverse Event|4|||
13419102|NCT00473330|26858816|FG002|Core Study|Adverse Event|1|||
13419103|NCT00473330|26858814|FG000|Core Study|Death|6|||
13419104|NCT00473330|26858815|FG001|Core Study|Death|4|||
13419105|NCT00473330|26858816|FG002|Core Study|Death|4|||
13419106|NCT00473330|26858814|FG000|Core Study|Lost to Follow-up|5|||
13419107|NCT00473330|26858815|FG001|Core Study|Lost to Follow-up|5|||
13419108|NCT00473330|26858816|FG002|Core Study|Lost to Follow-up|10|||
13419109|NCT00473330|26858814|FG000|Core Study|Physician Decision|2|||
13419110|NCT00473330|26858815|FG001|Core Study|Physician Decision|1|||
13419111|NCT00473330|26858816|FG002|Core Study|Physician Decision|3|||
13419112|NCT00473330|26858814|FG000|Core Study|Subject Non-compliance|1|||
13419113|NCT00473330|26858815|FG001|Core Study|Subject Non-compliance|2|||
13419114|NCT00473330|26858816|FG002|Core Study|Subject Non-compliance|1|||
13419115|NCT00473330|26858814|FG000|Core Study|Subject Required Other Therapy|0|||
13419116|NCT00473330|26858815|FG001|Core Study|Subject Required Other Therapy|1|||
13419117|NCT00473330|26858816|FG002|Core Study|Subject Required Other Therapy|3|||
13419118|NCT00473330|26858814|FG000|Core Study|Subject's Decision|9|||
13419119|NCT00473330|26858815|FG001|Core Study|Subject's Decision|8|||
13419120|NCT00473330|26858816|FG002|Core Study|Subject's Decision|19|||
13419121|NCT00473330|26858814|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
13419122|NCT00473330|26858815|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
13419123|NCT00473330|26858816|FG002|Open-label Extension Through Month 48|Adverse Event|2|||
13419124|NCT00473330|26858814|FG000|Open-label Extension Through Month 48|Death|2|||
13419125|NCT00473330|26858815|FG001|Open-label Extension Through Month 48|Death|0|||
13419126|NCT00473330|26858816|FG002|Open-label Extension Through Month 48|Death|0|||
13419127|NCT00473330|26858814|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
13419128|NCT00473330|26858815|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0|||
13419129|NCT00473330|26858816|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2|||
13419130|NCT00473330|26858814|FG000|Open-label Extension Through Month 48|Physician's Decision|2|||
13419131|NCT00473330|26858815|FG001|Open-label Extension Through Month 48|Physician's Decision|1|||
13419132|NCT00473330|26858816|FG002|Open-label Extension Through Month 48|Physician's Decision|3|||
13419133|NCT00473330|26858814|FG000|Open-label Extension Through Month 48|Subject's Decision|1|||
13419134|NCT00473330|26858815|FG001|Open-label Extension Through Month 48|Subject's Decision|3|||
13419135|NCT00473330|26858816|FG002|Open-label Extension Through Month 48|Subject's Decision|3|||
13419136|NCT00473330|26858814|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18|||
13419137|NCT00473330|26858815|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15|||
13419138|NCT00473330|26858816|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16|||
13419139|NCT00473330|26858814|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2|||
13419140|NCT00473330|26858815|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1|||
13419141|NCT00473330|26858816|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0|||
13419142|NCT00473330|26858814|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
13419143|NCT00473330|26858815|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
13419144|NCT00473330|26858816|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1|||
13419145|NCT00473330|26858814|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
13419146|NCT00473330|26858815|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
13419147|NCT00473330|26858816|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
13419148|NCT00473330|26858814|FG000|Open-label Extension Through Month 60|Death|2|||
13419149|NCT00473330|26858815|FG001|Open-label Extension Through Month 60|Death|2|||
13419150|NCT00473330|26858816|FG002|Open-label Extension Through Month 60|Death|1|||
13419151|NCT00473330|26858814|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3|||
13419152|NCT00473330|26858815|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0|||
13419153|NCT00473330|26858816|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4|||
13419154|NCT00473330|26858814|FG000|Open-label Extension Through Month 60|Physician's Decision|2|||
13419155|NCT00473330|26858815|FG001|Open-label Extension Through Month 60|Physician's Decision|1|||
13419156|NCT00473330|26858816|FG002|Open-label Extension Through Month 60|Physician's Decision|3|||
13419157|NCT00473330|26858814|FG000|Open-label Extension Through Month 60|Subject's Decision|1|||
13419158|NCT00473330|26858815|FG001|Open-label Extension Through Month 60|Subject's Decision|3|||
13419159|NCT00473330|26858816|FG002|Open-label Extension Through Month 60|Subject's Decision|4|||
13419160|NCT00473330|26858814|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77|||
13419161|NCT00473330|26858815|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71|||
13419162|NCT00473330|26858816|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62|||
13419163|NCT00473330|26858814|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2|||
13419164|NCT00473330|26858815|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1|||
13419165|NCT00473330|26858816|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0|||
13419166|NCT00473330|26858814|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
13419167|NCT00473330|26858815|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0|||
13419168|NCT00473330|26858816|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
13419169|NCT00472030|26858839|FG000|Overall Study|Physician Decision|1|||
13419170|NCT00472030|26858840|FG001|Overall Study|Physician Decision|0|||
13419171|NCT00471822|26858850|FG000|Overall Study|Protocol Violation|2|||
13419172|NCT00471497|26858954|FG000|Core Treatment Phase|Abnormal Laboratory Values|3|||
13419173|NCT00471497|26858955|FG001|Core Treatment Phase|Abnormal Laboratory Values|9|||
13419174|NCT00471497|26858956|FG002|Core Treatment Phase|Abnormal Laboratory Values|9|||
13419175|NCT00471497|26858954|FG000|Core Treatment Phase|Abnormal Test Procedures|1|||
13419176|NCT00471497|26858955|FG001|Core Treatment Phase|Abnormal Test Procedures|0|||
13419177|NCT00471497|26858956|FG002|Core Treatment Phase|Abnormal Test Procedures|1|||
13419178|NCT00471497|26858954|FG000|Core Treatment Phase|Condition no longer requires study drug|0|||
13419179|NCT00471497|26858955|FG001|Core Treatment Phase|Condition no longer requires study drug|1|||
13419180|NCT00471497|26858956|FG002|Core Treatment Phase|Condition no longer requires study drug|0|||
13419181|NCT00471497|26858954|FG000|Core Treatment Phase|Withdrawal by Subject|31|||
13419182|NCT00471497|26858955|FG001|Core Treatment Phase|Withdrawal by Subject|29|||
13419183|NCT00471497|26858956|FG002|Core Treatment Phase|Withdrawal by Subject|34|||
13419184|NCT00471497|26858954|FG000|Core Treatment Phase|Lost to Follow-up|6|||
13419185|NCT00471497|26858955|FG001|Core Treatment Phase|Lost to Follow-up|6|||
13419186|NCT00471497|26858956|FG002|Core Treatment Phase|Lost to Follow-up|3|||
13419187|NCT00471497|26858954|FG000|Core Treatment Phase|Death|3|||
13419188|NCT00471497|26858955|FG001|Core Treatment Phase|Death|9|||
13419189|NCT00471497|26858956|FG002|Core Treatment Phase|Death|3|||
13419190|NCT00471497|26858954|FG000|Core Treatment Phase|Disease Progression|10|||
13419191|NCT00471497|26858955|FG001|Core Treatment Phase|Disease Progression|2|||
13419192|NCT00471497|26858956|FG002|Core Treatment Phase|Disease Progression|4|||
13419193|NCT00471497|26858954|FG000|Core Treatment Phase|Protocol Violation|6|||
13419194|NCT00471497|26858955|FG001|Core Treatment Phase|Protocol Violation|15|||
13419195|NCT00471497|26858956|FG002|Core Treatment Phase|Protocol Violation|11|||
13419196|NCT00471497|26858954|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19|||
13419197|NCT00471497|26858955|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11|||
13419198|NCT00471497|26858956|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13|||
13419199|NCT00471497|26858954|FG000|Core Treatment Phase|Administrative problems|14|||
13419200|NCT00471497|26858955|FG001|Core Treatment Phase|Administrative problems|14|||
13419201|NCT00471497|26858956|FG002|Core Treatment Phase|Administrative problems|12|||
13419202|NCT00471497|26858954|FG000|Core Treatment Phase|Adverse Event|43|||
13419203|NCT00471497|26858955|FG001|Core Treatment Phase|Adverse Event|53|||
13419204|NCT00471497|26858956|FG002|Core Treatment Phase|Adverse Event|89|||
13419205|NCT00471497|26858954|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2|||
13419206|NCT00471497|26858955|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
13419207|NCT00471497|26858956|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
13419208|NCT00471497|26858954|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46|||
13419209|NCT00471497|26858955|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26|||
13419210|NCT00471497|26858956|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3|||
13419211|NCT00471497|26858954|FG000|Extension Phase|Adverse Event|9|||
13419212|NCT00471497|26858955|FG001|Extension Phase|Adverse Event|5|||
13419213|NCT00471497|26858956|FG002|Extension Phase|Adverse Event|1|||
13419214|NCT00471497|26858954|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
13419215|NCT00471497|26858955|FG001|Extension Phase|Unsatisfactory therapeutic effect|6|||
13419216|NCT00471497|26858956|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
13419217|NCT00471497|26858954|FG000|Extension Phase|Withdrawal by Subject|3|||
13419218|NCT00471497|26858955|FG001|Extension Phase|Withdrawal by Subject|1|||
13419219|NCT00471497|26858956|FG002|Extension Phase|Withdrawal by Subject|0|||
13419220|NCT00471497|26858954|FG000|Extension Phase|Lost to Follow-up|2|||
13419221|NCT00471497|26858955|FG001|Extension Phase|Lost to Follow-up|0|||
13419222|NCT00471497|26858956|FG002|Extension Phase|Lost to Follow-up|0|||
13419223|NCT00471497|26858954|FG000|Extension Phase|Death|1|||
13419224|NCT00471497|26858955|FG001|Extension Phase|Death|0|||
13419225|NCT00471497|26858956|FG002|Extension Phase|Death|0|||
13419226|NCT00471497|26858954|FG000|Extension Phase|Disease progression|2|||
13419227|NCT00471497|26858955|FG001|Extension Phase|Disease progression|0|||
13419228|NCT00471497|26858956|FG002|Extension Phase|Disease progression|0|||
13419229|NCT00471497|26858954|FG000|Extension Phase|Protocol Violation|2|||
13419230|NCT00471497|26858955|FG001|Extension Phase|Protocol Violation|2|||
13419231|NCT00471497|26858956|FG002|Extension Phase|Protocol Violation|0|||
13419232|NCT00471276|26858981|FG000|Overall Study|Death|2|||
13419233|NCT00471276|26858981|FG000|Overall Study|Adverse Event|16|||
13419234|NCT00471276|26858981|FG000|Overall Study|Protocol Violation|1|||
13419235|NCT00471276|26858981|FG000|Overall Study|Objective progression or relapse|54|||
13419236|NCT00471276|26858981|FG000|Overall Study|Global deterioration of health status|1|||
13419237|NCT00471276|26858981|FG000|Overall Study|Other|3|||
13419238|NCT00471276|26858981|FG000|Overall Study|Refused treatment|6|||
13419239|NCT00471146|26859010|FG000|Overall Study|Adverse Event|32|||
13419240|NCT00471146|26859011|FG001|Overall Study|Adverse Event|33|||
13419241|NCT00471146|26859010|FG000|Overall Study|Withdrawal by Subject|14|||
13419242|NCT00471146|26859011|FG001|Overall Study|Withdrawal by Subject|11|||
13419243|NCT00471146|26859010|FG000|Overall Study|Death|11|||
13419244|NCT00471146|26859011|FG001|Overall Study|Death|12|||
13419245|NCT00471146|26859010|FG000|Overall Study|Lost to Follow-up|4|||
13419246|NCT00471146|26859011|FG001|Overall Study|Lost to Follow-up|2|||
13419247|NCT00471146|26859010|FG000|Overall Study|Protocol Violation|2|||
13419248|NCT00471146|26859011|FG001|Overall Study|Protocol Violation|2|||
13419249|NCT00471146|26859010|FG000|Overall Study|Objective progression or relapse|84|||
13419250|NCT00471146|26859011|FG001|Overall Study|Objective progression or relapse|87|||
13419251|NCT00471146|26859010|FG000|Overall Study|Global deterioration of health status|12|||
13419252|NCT00471146|26859011|FG001|Overall Study|Global deterioration of health status|14|||
13419253|NCT00471146|26859010|FG000|Overall Study|Randomized but not treated|9|||
13419254|NCT00471146|26859011|FG001|Overall Study|Randomized but not treated|8|||
13419255|NCT00471146|26859010|FG000|Overall Study|Other|4|||
13419256|NCT00471146|26859011|FG001|Overall Study|Other|5|||
13419257|NCT00471107|26859029|FG000|Overall Study|Technical problems/data loss|3|||
13419258|NCT00471107|26859030|FG001|Overall Study|Technical problems/data loss|1|||
13419259|NCT00471107|26859031|FG002|Overall Study|Technical problems/data loss|3|||
13419260|NCT00470626|26859039|FG000|Overall Study|Lost to Follow-up|10|||
13419261|NCT00470626|26859039|FG000|Overall Study|Withdrawal by Subject|7|||
13419262|NCT00470262|26859054|FG000|Overall Study|Withdrawal by Subject|2|||
13419263|NCT00470262|26859055|FG001|Overall Study|Withdrawal by Subject|0|||
13419264|NCT00469898|26859064|FG000|Overall Study|Adverse Event|7|||
13419265|NCT00469898|26859064|FG000|Overall Study|Withdrawal by Subject|4|||
13419266|NCT00469898|26859064|FG000|Overall Study|Death|4|||
13419267|NCT00469898|26859064|FG000|Overall Study|Disease progression|9|||
13419268|NCT00469898|26859064|FG000|Overall Study|Decreased performance status|1|||
13419269|NCT00469859|26859079|FG000|Overall Study|Inevaluable|0|||
13419270|NCT00469859|26859080|FG001|Overall Study|Inevaluable|2|||
13419271|NCT00469833|26859092|FG000|Overall Study|No IV access|2|||
13419272|NCT00469612|26859109|FG000|Overall Study|Study terminated before data collected|2|||
13419273|NCT00469612|26859110|FG001|Overall Study|Study terminated before data collected|0|||
13419274|NCT00469456|26859125|FG000|Overall Study|Adverse Event|4|||
13419275|NCT00469456|26859126|FG001|Overall Study|Adverse Event|3|||
13419276|NCT00469456|26859125|FG000|Overall Study|Protocol Violation|1|||
13419277|NCT00469456|26859126|FG001|Overall Study|Protocol Violation|0|||
13419278|NCT00469456|26859125|FG000|Overall Study|Withdrawal by Subject|4|||
13419279|NCT00469456|26859126|FG001|Overall Study|Withdrawal by Subject|1|||
13419280|NCT00469209|26859144|FG000|Overall Study|Adverse Event|1|||
13419281|NCT00469209|26859145|FG001|Overall Study|Adverse Event|0|||
13419282|NCT00469209|26859146|FG002|Overall Study|Adverse Event|1|||
13419283|NCT00469144|26859163|FG000|Overall Study|Death|0|||
13419284|NCT00469144|26859164|FG001|Overall Study|Death|1|||
13419285|NCT00469144|26859163|FG000|Overall Study|No Response|5|||
13419286|NCT00469144|26859164|FG001|Overall Study|No Response|5|||
13419287|NCT00469144|26859163|FG000|Overall Study|Progressive Disease|1|||
13419288|NCT00469144|26859164|FG001|Overall Study|Progressive Disease|0|||
13419289|NCT00469092|26859187|FG000|Overall Study|Adverse Event|5|||
13419290|NCT00469092|26859188|FG001|Overall Study|Adverse Event|4|||
13419291|NCT00469092|26859187|FG000|Overall Study|Lack of Efficacy|1|||
13419292|NCT00469092|26859188|FG001|Overall Study|Lack of Efficacy|0|||
13419293|NCT00469092|26859187|FG000|Overall Study|Lost to Follow-up|1|||
13419294|NCT00469092|26859188|FG001|Overall Study|Lost to Follow-up|2|||
13419295|NCT00469092|26859187|FG000|Overall Study|Protocol Violation|3|||
13419296|NCT00469092|26859188|FG001|Overall Study|Protocol Violation|3|||
13419297|NCT00469092|26859187|FG000|Overall Study|Withdrawal by Subject|4|||
13419298|NCT00469092|26859188|FG001|Overall Study|Withdrawal by Subject|4|||
13419299|NCT00469092|26859187|FG000|Overall Study|Withdrawal Criteria|3|||
13419300|NCT00469092|26859188|FG001|Overall Study|Withdrawal Criteria|4|||
13419301|NCT00469092|26859187|FG000|Overall Study|Incorrectly Randomised|4|||
13419302|NCT00469092|26859188|FG001|Overall Study|Incorrectly Randomised|3|||
13419303|NCT00469092|26859187|FG000|Overall Study|Contraindication metformin/glimepiride|1|||
13419304|NCT00469092|26859188|FG001|Overall Study|Contraindication metformin/glimepiride|0|||
13419305|NCT00469092|26859187|FG000|Overall Study|Use of lipid lowering drug|1|||
13419306|NCT00469092|26859188|FG001|Overall Study|Use of lipid lowering drug|0|||
13419307|NCT00469092|26859187|FG000|Overall Study|Hypoglycaemic Episodes|1|||
13419308|NCT00469092|26859188|FG001|Overall Study|Hypoglycaemic Episodes|1|||
13419309|NCT00469092|26859187|FG000|Overall Study|Abnormal lab value|1|||
13419310|NCT00469092|26859188|FG001|Overall Study|Abnormal lab value|0|||
13419311|NCT00469092|26859187|FG000|Overall Study|Use of Corticosteroid|1|||
13419312|NCT00469092|26859188|FG001|Overall Study|Use of Corticosteroid|0|||
13419313|NCT00469079|26859215|FG000|Overall Study|Lack of Efficacy|3|||
13419314|NCT00469079|26859216|FG001|Overall Study|Lack of Efficacy|8|||
13419315|NCT00469079|26859217|FG002|Overall Study|Lack of Efficacy|5|||
13419316|NCT00469079|26859215|FG000|Overall Study|Adverse Event|1|||
13419317|NCT00469079|26859216|FG001|Overall Study|Adverse Event|3|||
13419318|NCT00469079|26859217|FG002|Overall Study|Adverse Event|2|||
13419319|NCT00469079|26859215|FG000|Overall Study|Lost to Follow-up|4|||
13419320|NCT00469079|26859216|FG001|Overall Study|Lost to Follow-up|8|||
13419321|NCT00469079|26859217|FG002|Overall Study|Lost to Follow-up|10|||
13419322|NCT00469079|26859215|FG000|Overall Study|Withdrawal by Subject|1|||
13419323|NCT00469079|26859216|FG001|Overall Study|Withdrawal by Subject|2|||
13419324|NCT00469079|26859217|FG002|Overall Study|Withdrawal by Subject|2|||
13419325|NCT00469079|26859215|FG000|Overall Study|Ineligible|0|||
13419326|NCT00469079|26859216|FG001|Overall Study|Ineligible|1|||
13419327|NCT00469079|26859217|FG002|Overall Study|Ineligible|0|||
13419328|NCT00469014|26859240|FG000|Initial Phase Randomization|Disease Progression|0|||
13419329|NCT00469014|26859241|FG001|Initial Phase Randomization|Disease Progression|1|||
13419330|NCT00469014|26859242|FG002|Initial Phase Randomization|Disease Progression|1|||
13419331|NCT00469014|26859243|FG003|Initial Phase Randomization|Disease Progression|0|||
13419332|NCT00469014|26859240|FG000|Initial Phase Randomization|No Response|1|||
13419333|NCT00469014|26859241|FG001|Initial Phase Randomization|No Response|0|||
13419334|NCT00469014|26859242|FG002|Initial Phase Randomization|No Response|0|||
13419335|NCT00469014|26859243|FG003|Initial Phase Randomization|No Response|1|||
13419336|NCT00469014|26859240|FG000|Adaptive Randomization|Not Evaluable|1|||
13419337|NCT00469014|26859241|FG001|Adaptive Randomization|Not Evaluable|0|||
13419338|NCT00469014|26859242|FG002|Adaptive Randomization|Not Evaluable|0|||
13419339|NCT00469014|26859243|FG003|Adaptive Randomization|Not Evaluable|1|||
13419340|NCT00469014|26859240|FG000|Adaptive Randomization|No Response|0|||
13419341|NCT00469014|26859241|FG001|Adaptive Randomization|No Response|1|||
13419342|NCT00469014|26859242|FG002|Adaptive Randomization|No Response|0|||
13419343|NCT00469014|26859243|FG003|Adaptive Randomization|No Response|0|||
13419344|NCT00469014|26859240|FG000|Adaptive Randomization|Death|0|||
13419345|NCT00469014|26859241|FG001|Adaptive Randomization|Death|0|||
13419346|NCT00469014|26859242|FG002|Adaptive Randomization|Death|1|||
13419347|NCT00469014|26859243|FG003|Adaptive Randomization|Death|0|||
13419348|NCT00468910|26859266|FG000|Overall Study|Lost to Follow-up|2|||
13419349|NCT00468910|26859267|FG001|Overall Study|Lost to Follow-up|1|||
13419350|NCT00468910|26859266|FG000|Overall Study|Withdrawal by Subject|2|||
13419351|NCT00468910|26859267|FG001|Overall Study|Withdrawal by Subject|1|||
13419352|NCT00468910|26859266|FG000|Overall Study|Medical Contraindication|0|||
13419353|NCT00468910|26859267|FG001|Overall Study|Medical Contraindication|1|||
13419354|NCT00468858|26859395|FG000|Overall Study|Adverse Event|0|||
13419355|NCT00468858|26859396|FG001|Overall Study|Adverse Event|1|||
13419356|NCT00468858|26859397|FG002|Overall Study|Adverse Event|0|||
13419357|NCT00468858|26859395|FG000|Overall Study|Withdrawal by Subject|7|||
13419358|NCT00468858|26859396|FG001|Overall Study|Withdrawal by Subject|4|||
13419359|NCT00468858|26859397|FG002|Overall Study|Withdrawal by Subject|5|||
13419360|NCT00468858|26859395|FG000|Overall Study|Relocation|1|||
13419361|NCT00468858|26859396|FG001|Overall Study|Relocation|3|||
13419362|NCT00468858|26859397|FG002|Overall Study|Relocation|3|||
13419363|NCT00468858|26859395|FG000|Overall Study|Lost to Follow-up|1|||
13419364|NCT00468858|26859396|FG001|Overall Study|Lost to Follow-up|2|||
13419365|NCT00468858|26859397|FG002|Overall Study|Lost to Follow-up|5|||
13419366|NCT00468858|26859395|FG000|Overall Study|Other|0|||
13419367|NCT00468858|26859396|FG001|Overall Study|Other|0|||
13419368|NCT00468858|26859397|FG002|Overall Study|Other|1|||
13419369|NCT00468845|26859541|FG000|Overall Study|Adverse Event|9|||
13419370|NCT00468845|26859542|FG001|Overall Study|Adverse Event|14|||
13419371|NCT00468845|26859543|FG002|Overall Study|Adverse Event|11|||
13419372|NCT00468845|26859541|FG000|Overall Study|Lost to Follow-up|2|||
13419373|NCT00468845|26859542|FG001|Overall Study|Lost to Follow-up|1|||
13419374|NCT00468845|26859543|FG002|Overall Study|Lost to Follow-up|2|||
13419375|NCT00468845|26859541|FG000|Overall Study|Other|4|||
13419376|NCT00468845|26859542|FG001|Overall Study|Other|9|||
13419377|NCT00468845|26859543|FG002|Overall Study|Other|5|||
13419378|NCT00468845|26859541|FG000|Overall Study|No longer willing to participate|5|||
13419379|NCT00468845|26859542|FG001|Overall Study|No longer willing to participate|6|||
13419380|NCT00468845|26859543|FG002|Overall Study|No longer willing to participate|10|||
13419381|NCT00468845|26859541|FG000|Overall Study|Randomized, not treated|1|||
13419382|NCT00468845|26859542|FG001|Overall Study|Randomized, not treated|4|||
13419383|NCT00468845|26859543|FG002|Overall Study|Randomized, not treated|2|||
13419384|NCT00468819|26859631|FG000|Overall Study|Withdrawal by Subject|4|||
13419385|NCT00468819|26859632|FG001|Overall Study|Withdrawal by Subject|0|||
13419386|NCT00468819|26859633|FG002|Overall Study|Withdrawal by Subject|1|||
13419387|NCT00468819|26859631|FG000|Overall Study|Lost to Follow-up|0|||
13419388|NCT00468819|26859632|FG001|Overall Study|Lost to Follow-up|0|||
13419389|NCT00468819|26859633|FG002|Overall Study|Lost to Follow-up|1|||
13419390|NCT00468819|26859631|FG000|Overall Study|Drop-outs (Treatment never received)|2|||
13419391|NCT00468819|26859632|FG001|Overall Study|Drop-outs (Treatment never received)|0|||
13419392|NCT00468819|26859633|FG002|Overall Study|Drop-outs (Treatment never received)|0|||
13419393|NCT00468728|26859650|FG000|Treatment|criteria for mITT population|4|||
13419394|NCT00468728|26859651|FG001|Treatment|criteria for mITT population|11|||
13419395|NCT00468728|26859650|FG000|Follow-up|mITT failure|34|||
13419396|NCT00468728|26859651|FG001|Follow-up|mITT failure|31|||
13419397|NCT00468676|26859675|FG000|Overall Study|Lost to Follow-up|14|||
13419398|NCT00468676|26859676|FG001|Overall Study|Lost to Follow-up|11|||
13419399|NCT00468676|26859675|FG000|Overall Study|Death|2|||
13419400|NCT00468676|26859676|FG001|Overall Study|Death|1|||
13419401|NCT00468650|26859722|FG000|Overall Study|Lost to Follow-up|4|||
13419402|NCT00468650|26859722|FG000|Overall Study|Withdrawal by Subject|2|||
13419403|NCT00468650|26859722|FG000|Overall Study|Protocol Violation|1|||
13419404|NCT00468585|26859745|FG000|Overall Study|Patient not treated|1|||
13419405|NCT00468585|26859746|FG001|Overall Study|Patient not treated|0|||
13419406|NCT00468585|26859747|FG002|Overall Study|Patient not treated|1|||
13419407|NCT00468585|26859748|FG003|Overall Study|Patient not treated|0|||
13419408|NCT00468585|26859745|FG000|Overall Study|Patient found to be ineligible|0|||
13419409|NCT00468585|26859746|FG001|Overall Study|Patient found to be ineligible|0|||
13419410|NCT00468585|26859747|FG002|Overall Study|Patient found to be ineligible|1|||
13419411|NCT00468585|26859748|FG003|Overall Study|Patient found to be ineligible|0|||
13419412|NCT00468585|26859745|FG000|Overall Study|Adverse Event|0|||
13419413|NCT00468585|26859746|FG001|Overall Study|Adverse Event|0|||
13419414|NCT00468585|26859747|FG002|Overall Study|Adverse Event|1|||
13419415|NCT00468585|26859748|FG003|Overall Study|Adverse Event|0|||
13419416|NCT00468585|26859745|FG000|Overall Study|Withdrawal by Subject|0|||
13419417|NCT00468585|26859746|FG001|Overall Study|Withdrawal by Subject|0|||
13419418|NCT00468585|26859747|FG002|Overall Study|Withdrawal by Subject|2|||
13419419|NCT00468585|26859748|FG003|Overall Study|Withdrawal by Subject|1|||
13419420|NCT00468559|26859782|FG000|Open-label Treatment Phase|Adverse Event|5|||
13419421|NCT00468559|26859783|FG001|Open-label Treatment Phase|Adverse Event|0|||
13419422|NCT00468559|26859784|FG002|Open-label Treatment Phase|Adverse Event|0|||
13419423|NCT00468559|26859782|FG000|Open-label Treatment Phase|Lack of Efficacy|9|||
13419424|NCT00468559|26859783|FG001|Open-label Treatment Phase|Lack of Efficacy|0|||
13419425|NCT00468559|26859784|FG002|Open-label Treatment Phase|Lack of Efficacy|0|||
13419426|NCT00468559|26859782|FG000|Open-label Treatment Phase|Withdrawal by Subject|4|||
13419427|NCT00468559|26859783|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
13419428|NCT00468559|26859784|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
13419429|NCT00468559|26859782|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0|||
13419430|NCT00468559|26859783|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8|||
13419431|NCT00468559|26859784|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17|||
13419432|NCT00468559|26859782|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
13419433|NCT00468559|26859783|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2|||
13419434|NCT00468559|26859784|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
13419435|NCT00468546|26859819|FG000|Week 24 Analysis|Lack of Efficacy|83|||
13419436|NCT00468546|26859820|FG001|Week 24 Analysis|Lack of Efficacy|37|||
13419437|NCT00468546|26859819|FG000|Week 24 Analysis|Refused treatment|5|||
13419438|NCT00468546|26859820|FG001|Week 24 Analysis|Refused treatment|5|||
13419439|NCT00468546|26859819|FG000|Week 24 Analysis|Adverse Event|1|||
13419440|NCT00468546|26859820|FG001|Week 24 Analysis|Adverse Event|8|||
13419441|NCT00468546|26859819|FG000|Week 24 Analysis|Failure to return|3|||
13419442|NCT00468546|26859820|FG001|Week 24 Analysis|Failure to return|4|||
13419443|NCT00468546|26859819|FG000|Week 24 Analysis|Rescue therapy|2|||
13419444|NCT00468546|26859820|FG001|Week 24 Analysis|Rescue therapy|0|||
13419445|NCT00468546|26859819|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0|||
13419446|NCT00468546|26859820|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1|||
13419447|NCT00468546|26859819|FG000|Week 24 Analysis|Due to clinical hold|1|||
13419448|NCT00468546|26859820|FG001|Week 24 Analysis|Due to clinical hold|0|||
13419449|NCT00468546|26859819|FG000|Week 24 Analysis|Went onto rescue therapy|1|||
13419450|NCT00468546|26859820|FG001|Week 24 Analysis|Went onto rescue therapy|0|||
13419451|NCT00468546|26859819|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1|||
13419452|NCT00468546|26859820|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0|||
13419453|NCT00468546|26859819|FG000|Week 24 to Week 104 Analysis|Adverse Event|2|||
13419454|NCT00468546|26859820|FG001|Week 24 to Week 104 Analysis|Adverse Event|5|||
13419455|NCT00468546|26859819|FG000|Week 24 to Week 104 Analysis|Death|1|||
13419456|NCT00468546|26859820|FG001|Week 24 to Week 104 Analysis|Death|0|||
13419457|NCT00468546|26859819|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3|||
13419458|NCT00468546|26859820|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12|||
13419459|NCT00468546|26859819|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0|||
13419460|NCT00468546|26859820|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2|||
13419461|NCT00468546|26859819|FG000|Week 24 to Week 104 Analysis|Refused treatment|4|||
13419462|NCT00468546|26859820|FG001|Week 24 to Week 104 Analysis|Refused treatment|7|||
13419463|NCT00468546|26859819|FG000|Week 24 to Week 104 Analysis|Failure to return|1|||
13419464|NCT00468546|26859820|FG001|Week 24 to Week 104 Analysis|Failure to return|2|||
13419465|NCT00468546|26859819|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77|||
13419466|NCT00468546|26859820|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183|||
13419467|NCT00468546|26859819|FG000|Week 24 to Week 104 Analysis|Other|17|||
13419468|NCT00468546|26859820|FG001|Week 24 to Week 104 Analysis|Other|14|||
13419469|NCT00468481|26859925|FG000|Overall Study|Adverse Event|13|||
13419470|NCT00468481|26859926|FG001|Overall Study|Adverse Event|3|||
13419471|NCT00468481|26859925|FG000|Overall Study|Lost to Follow-up|25|||
13419472|NCT00468481|26859926|FG001|Overall Study|Lost to Follow-up|8|||
13419473|NCT00468481|26859925|FG000|Overall Study|Pregnancy|2|||
13419474|NCT00468481|26859926|FG001|Overall Study|Pregnancy|0|||
13419475|NCT00468481|26859925|FG000|Overall Study|Protocol Violation|18|||
13419476|NCT00468481|26859926|FG001|Overall Study|Protocol Violation|8|||
13419477|NCT00468481|26859925|FG000|Overall Study|Withdrawal by Subject|12|||
13419478|NCT00468481|26859926|FG001|Overall Study|Withdrawal by Subject|3|||
13419479|NCT00468481|26859925|FG000|Overall Study|susp/diag malignant/premalignant disease|1|||
13419480|NCT00468481|26859926|FG001|Overall Study|susp/diag malignant/premalignant disease|0|||
13419481|NCT00468481|26859925|FG000|Overall Study|Prohibited Medication|1|||
13419482|NCT00468481|26859926|FG001|Overall Study|Prohibited Medication|1|||
13419483|NCT00468481|26859925|FG000|Overall Study|Egg Donor|1|||
13419484|NCT00468481|26859926|FG001|Overall Study|Egg Donor|0|||
13419485|NCT00468481|26859925|FG000|Overall Study|Moved out of area|4|||
13419486|NCT00468481|26859926|FG001|Overall Study|Moved out of area|1|||
13419487|NCT00468481|26859925|FG000|Overall Study|Non-Compliance|5|||
13419488|NCT00468481|26859926|FG001|Overall Study|Non-Compliance|0|||
13419489|NCT00468481|26859925|FG000|Overall Study|Other|6|||
13419490|NCT00468481|26859926|FG001|Overall Study|Other|0|||
13419491|NCT00468312|26859947|FG000|Overall Study|Adverse Event|2|||
13419492|NCT00468312|26859948|FG001|Overall Study|Adverse Event|1|||
13419493|NCT00468312|26859947|FG000|Overall Study|Lack of Efficacy|0|||
13419494|NCT00468312|26859948|FG001|Overall Study|Lack of Efficacy|1|||
13419495|NCT00468312|26859947|FG000|Overall Study|Withdrawal by Subject|0|||
13419496|NCT00468312|26859948|FG001|Overall Study|Withdrawal by Subject|1|||
13419497|NCT00468312|26859947|FG000|Overall Study|Protocol Violation|2|||
13419498|NCT00468312|26859948|FG001|Overall Study|Protocol Violation|1|||
13419499|NCT00468312|26859947|FG000|Overall Study|Did not meet protocol eligibility|0|||
13419500|NCT00468312|26859948|FG001|Overall Study|Did not meet protocol eligibility|1|||
13419501|NCT00468299|26859963|FG000|Overall Study|Withdrawal by Subject|0|||
13419502|NCT00468299|26859964|FG001|Overall Study|Withdrawal by Subject|1|||
13419503|NCT00468286|26859993|FG000|Overall Study|Adverse Event|1|||
13419504|NCT00468286|26859994|FG001|Overall Study|Adverse Event|6|||
13419505|NCT00468286|26859993|FG000|Overall Study|Protocol Violation|2|||
13419506|NCT00468286|26859994|FG001|Overall Study|Protocol Violation|2|||
13419507|NCT00468286|26859993|FG000|Overall Study|Withdrawal by Subject|4|||
13419508|NCT00468286|26859994|FG001|Overall Study|Withdrawal by Subject|3|||
13419509|NCT00468286|26859993|FG000|Overall Study|Physician Decision|0|||
13419510|NCT00468286|26859994|FG001|Overall Study|Physician Decision|1|||
13419511|NCT00468169|26860017|FG000|Overall Study|Withdrawal by Subject|1|||
13419512|NCT00468169|26860018|FG001|Overall Study|Withdrawal by Subject|0|||
13419513|NCT00468143|26860035|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3|||
13419514|NCT00468143|26860036|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4|||
13419515|NCT00468143|26860035|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
13419516|NCT00468143|26860036|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
13419517|NCT00468104|26860054|FG000|First Intervention|Protocol Violation|2|||
13419518|NCT00468104|26860055|FG001|First Intervention|Protocol Violation|1|||
13419519|NCT00468104|26860054|FG000|First Intervention|bleeding at chest tube site--first dose|1|||
13419520|NCT00468104|26860055|FG001|First Intervention|bleeding at chest tube site--first dose|0|||
13419521|NCT00468104|26860054|FG000|First Intervention|died within 3 weeks|1|||
13419522|NCT00468104|26860055|FG001|First Intervention|died within 3 weeks|0|||
13419523|NCT00468104|26860054|FG000|First Intervention|malposition/blocked chest tube tube|2|||
13419524|NCT00468104|26860055|FG001|First Intervention|malposition/blocked chest tube tube|0|||
13419525|NCT00468104|26860054|FG000|First Intervention|large lung mass with minimal effusion|1|||
13419526|NCT00468104|26860055|FG001|First Intervention|large lung mass with minimal effusion|0|||
13419527|NCT00468104|26860054|FG000|First Intervention|associated prolonged pneumothorax|1|||
13419528|NCT00468104|26860055|FG001|First Intervention|associated prolonged pneumothorax|0|||
13419529|NCT00468104|26860054|FG000|First Intervention|trapped lung|1|||
13419530|NCT00468104|26860055|FG001|First Intervention|trapped lung|0|||
13419531|NCT00468104|26860054|FG000|Second Intervention|Withdrawal by Subject|5|||
13419532|NCT00468104|26860055|FG001|Second Intervention|Withdrawal by Subject|2|||
13419533|NCT00468104|26860054|FG000|Second Intervention|discarded for malposition of chest tube|0|||
13419534|NCT00468104|26860055|FG001|Second Intervention|discarded for malposition of chest tube|2|||
13419535|NCT00468052|26860080|FG000|Overall Study|Protocol Violation|7|||
13419536|NCT00468052|26860081|FG001|Overall Study|Protocol Violation|8|||
13419537|NCT00467961|26860087|FG000|Overall Study|Technical Failures|5|||
13419538|NCT00467961|26860087|FG000|Overall Study|Disease Progression|2|||
13419539|NCT00467896|26860109|FG000|Overall Study|Consent Withdrawal|18|||
13419540|NCT00467896|26860109|FG000|Overall Study|Adverse Event|7|||
13419541|NCT00467896|26860109|FG000|Overall Study|Serious Adverse Event|13|||
13419542|NCT00467896|26860109|FG000|Overall Study|Non-compliance|3|||
13419543|NCT00467896|26860109|FG000|Overall Study|Changed therapy|2|||
13419544|NCT00467896|26860109|FG000|Overall Study|Patient received transplant|2|||
13419545|NCT00467896|26860109|FG000|Overall Study|Patient had atrial septostomy|1|||
13419546|NCT00467896|26860109|FG000|Overall Study|Patient weaned off iloprost|1|||
13419547|NCT00467896|26860109|FG000|Overall Study|Mainly used Prodose not I-neb® device|1|||
13419548|NCT00467896|26860109|FG000|Overall Study|Started intravenous prostacyclin|1|||
13419549|NCT00467896|26860109|FG000|Overall Study|Started inhaled Remodulin|1|||
13419550|NCT00467896|26860109|FG000|Overall Study|Patient had no improvement|1|||
13419551|NCT00467870|26860169|FG000|Overall Study|Adverse Event|13|||
13419552|NCT00467870|26860170|FG001|Overall Study|Adverse Event|9|||
13419553|NCT00467870|26860171|FG002|Overall Study|Adverse Event|1|||
13419554|NCT00467870|26860172|FG003|Overall Study|Adverse Event|15|||
13419555|NCT00467870|26860173|FG004|Overall Study|Adverse Event|15|||
13419556|NCT00467870|26860174|FG005|Overall Study|Adverse Event|1|||
13419557|NCT00467870|26860169|FG000|Overall Study|Protocol Violation|2|||
13419558|NCT00467870|26860170|FG001|Overall Study|Protocol Violation|1|||
13419559|NCT00467870|26860171|FG002|Overall Study|Protocol Violation|1|||
13419560|NCT00467870|26860172|FG003|Overall Study|Protocol Violation|2|||
13419561|NCT00467870|26860173|FG004|Overall Study|Protocol Violation|0|||
13419562|NCT00467870|26860174|FG005|Overall Study|Protocol Violation|0|||
13419563|NCT00467870|26860169|FG000|Overall Study|Withdrawal by Subject|14|||
13419564|NCT00467870|26860170|FG001|Overall Study|Withdrawal by Subject|21|||
13419565|NCT00467870|26860171|FG002|Overall Study|Withdrawal by Subject|0|||
13419566|NCT00467870|26860172|FG003|Overall Study|Withdrawal by Subject|9|||
13419567|NCT00467870|26860173|FG004|Overall Study|Withdrawal by Subject|10|||
13419568|NCT00467870|26860174|FG005|Overall Study|Withdrawal by Subject|1|||
13419569|NCT00467870|26860169|FG000|Overall Study|Lost to Follow-up|5|||
13419570|NCT00467870|26860170|FG001|Overall Study|Lost to Follow-up|3|||
13419571|NCT00467870|26860171|FG002|Overall Study|Lost to Follow-up|1|||
13419572|NCT00467870|26860172|FG003|Overall Study|Lost to Follow-up|1|||
13419573|NCT00467870|26860173|FG004|Overall Study|Lost to Follow-up|3|||
13419574|NCT00467870|26860174|FG005|Overall Study|Lost to Follow-up|0|||
13419575|NCT00467870|26860169|FG000|Overall Study|Subject Non-compliance|3|||
13419576|NCT00467870|26860170|FG001|Overall Study|Subject Non-compliance|4|||
13419577|NCT00467870|26860171|FG002|Overall Study|Subject Non-compliance|0|||
13419578|NCT00467870|26860172|FG003|Overall Study|Subject Non-compliance|1|||
13419579|NCT00467870|26860173|FG004|Overall Study|Subject Non-compliance|5|||
13419580|NCT00467870|26860174|FG005|Overall Study|Subject Non-compliance|0|||
13419581|NCT00467870|26860169|FG000|Overall Study|Other/Unknown|8|||
13419582|NCT00467870|26860170|FG001|Overall Study|Other/Unknown|5|||
13419583|NCT00467870|26860171|FG002|Overall Study|Other/Unknown|1|||
13419584|NCT00467870|26860172|FG003|Overall Study|Other/Unknown|5|||
13419585|NCT00467870|26860173|FG004|Overall Study|Other/Unknown|4|||
13419586|NCT00467870|26860174|FG005|Overall Study|Other/Unknown|0|||
13419587|NCT00467857|26860213|FG000|Overall Study|Adverse Event|1|||
13419588|NCT00467857|26860214|FG001|Overall Study|Adverse Event|0|||
13419589|NCT00467857|26860213|FG000|Overall Study|Withdrew consent|2|||
13419590|NCT00467857|26860214|FG001|Overall Study|Withdrew consent|0|||
13419591|NCT00467857|26860213|FG000|Overall Study|Death|0|||
13419592|NCT00467857|26860214|FG001|Overall Study|Death|1|||
13419593|NCT00467857|26860213|FG000|Overall Study|Discharged from court service|0|||
13419594|NCT00467857|26860214|FG001|Overall Study|Discharged from court service|1|||
13419595|NCT00467857|26860213|FG000|Overall Study|Emergency care required|0|||
13419596|NCT00467857|26860214|FG001|Overall Study|Emergency care required|1|||
13419597|NCT00467857|26860213|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0|||
13419598|NCT00467857|26860214|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2|||
13419599|NCT00467857|26860213|FG000|Overall Study|Discontinuation reason missing|0|||
13419600|NCT00467857|26860214|FG001|Overall Study|Discontinuation reason missing|3|||
13419601|NCT00467831|26860220|FG000|Overall Study|Death|2|||
13419602|NCT00467831|26860220|FG000|Overall Study|Withdrawal by Subject|1|||
13419603|NCT00467818|26860241|FG000|Overall Study|Adverse Event|1|||
13419604|NCT00467818|26860242|FG001|Overall Study|Adverse Event|0|||
13419605|NCT00467818|26860241|FG000|Overall Study|Lost to Follow-up|2|||
13419606|NCT00467818|26860242|FG001|Overall Study|Lost to Follow-up|2|||
13419607|NCT00467779|26860460|FG000|Stage 1|Adverse Event|1|||
13419608|NCT00467779|26860461|FG001|Stage 1|Adverse Event|0|||
13419609|NCT00467779|26860462|FG002|Stage 1|Adverse Event|0|||
13419610|NCT00467779|26860463|FG003|Stage 1|Adverse Event|0|||
13419611|NCT00467779|26860464|FG004|Stage 1|Adverse Event|0|||
13419612|NCT00467779|26860465|FG005|Stage 1|Adverse Event|1|||
13419613|NCT00467779|26860466|FG006|Stage 1|Adverse Event|2|||
13419614|NCT00467779|26860467|FG007|Stage 1|Adverse Event|1|||
13419615|NCT00467779|26860468|FG008|Stage 1|Adverse Event|0|||
13419616|NCT00467779|26860469|FG009|Stage 1|Adverse Event|0|||
13419617|NCT00467779|26860470|FG010|Stage 1|Adverse Event|0|||
13419618|NCT00467779|26860471|FG011|Stage 1|Adverse Event|0|||
13419619|NCT00467779|26860472|FG012|Stage 1|Adverse Event|0|||
13419620|NCT00467779|26860473|FG013|Stage 1|Adverse Event|0|||
13419621|NCT00467779|26860474|FG014|Stage 1|Adverse Event|0|||
13419622|NCT00467779|26860460|FG000|Stage 1|Disease Progression|2|||
13419623|NCT00467779|26860461|FG001|Stage 1|Disease Progression|2|||
13419624|NCT00467779|26860462|FG002|Stage 1|Disease Progression|2|||
13419625|NCT00467779|26860463|FG003|Stage 1|Disease Progression|3|||
13419626|NCT00467779|26860464|FG004|Stage 1|Disease Progression|2|||
13419627|NCT00467779|26860465|FG005|Stage 1|Disease Progression|2|||
13419628|NCT00467779|26860466|FG006|Stage 1|Disease Progression|4|||
13419629|NCT00467779|26860467|FG007|Stage 1|Disease Progression|5|||
13419630|NCT00467779|26860468|FG008|Stage 1|Disease Progression|0|||
13419631|NCT00467779|26860469|FG009|Stage 1|Disease Progression|0|||
13419632|NCT00467779|26860470|FG010|Stage 1|Disease Progression|0|||
13419633|NCT00467779|26860471|FG011|Stage 1|Disease Progression|0|||
13419634|NCT00467779|26860472|FG012|Stage 1|Disease Progression|0|||
13419635|NCT00467779|26860473|FG013|Stage 1|Disease Progression|0|||
13419636|NCT00467779|26860474|FG014|Stage 1|Disease Progression|0|||
13419637|NCT00467779|26860460|FG000|Stage 1|Unspecified Reason|1|||
13419638|NCT00467779|26860461|FG001|Stage 1|Unspecified Reason|0|||
13419639|NCT00467779|26860462|FG002|Stage 1|Unspecified Reason|1|||
13419640|NCT00467779|26860463|FG003|Stage 1|Unspecified Reason|0|||
13419641|NCT00467779|26860464|FG004|Stage 1|Unspecified Reason|1|||
13419642|NCT00467779|26860465|FG005|Stage 1|Unspecified Reason|2|||
13419643|NCT00467779|26860466|FG006|Stage 1|Unspecified Reason|0|||
13419644|NCT00467779|26860467|FG007|Stage 1|Unspecified Reason|0|||
13419645|NCT00467779|26860468|FG008|Stage 1|Unspecified Reason|0|||
13419646|NCT00467779|26860469|FG009|Stage 1|Unspecified Reason|0|||
13419647|NCT00467779|26860470|FG010|Stage 1|Unspecified Reason|0|||
13419648|NCT00467779|26860471|FG011|Stage 1|Unspecified Reason|0|||
13419649|NCT00467779|26860472|FG012|Stage 1|Unspecified Reason|0|||
13419650|NCT00467779|26860473|FG013|Stage 1|Unspecified Reason|0|||
13419651|NCT00467779|26860474|FG014|Stage 1|Unspecified Reason|0|||
13419652|NCT00467779|26860460|FG000|Stage 1|Physician Decision|0|||
13419653|NCT00467779|26860461|FG001|Stage 1|Physician Decision|1|||
13419654|NCT00467779|26860462|FG002|Stage 1|Physician Decision|0|||
13419655|NCT00467779|26860463|FG003|Stage 1|Physician Decision|0|||
13419656|NCT00467779|26860464|FG004|Stage 1|Physician Decision|0|||
13419657|NCT00467779|26860465|FG005|Stage 1|Physician Decision|0|||
13419658|NCT00467779|26860466|FG006|Stage 1|Physician Decision|0|||
13419659|NCT00467779|26860467|FG007|Stage 1|Physician Decision|0|||
13419660|NCT00467779|26860468|FG008|Stage 1|Physician Decision|0|||
13419661|NCT00467779|26860469|FG009|Stage 1|Physician Decision|0|||
13419662|NCT00467779|26860470|FG010|Stage 1|Physician Decision|0|||
13419663|NCT00467779|26860471|FG011|Stage 1|Physician Decision|0|||
13419664|NCT00467779|26860472|FG012|Stage 1|Physician Decision|0|||
13419665|NCT00467779|26860473|FG013|Stage 1|Physician Decision|0|||
13419666|NCT00467779|26860474|FG014|Stage 1|Physician Decision|0|||
13419667|NCT00467779|26860460|FG000|Stage 1|Withdrawal by Subject|0|||
13419668|NCT00467779|26860461|FG001|Stage 1|Withdrawal by Subject|0|||
13419669|NCT00467779|26860462|FG002|Stage 1|Withdrawal by Subject|0|||
13419670|NCT00467779|26860463|FG003|Stage 1|Withdrawal by Subject|0|||
13419671|NCT00467779|26860464|FG004|Stage 1|Withdrawal by Subject|0|||
13419672|NCT00467779|26860465|FG005|Stage 1|Withdrawal by Subject|0|||
13419673|NCT00467779|26860466|FG006|Stage 1|Withdrawal by Subject|1|||
13419674|NCT00467779|26860467|FG007|Stage 1|Withdrawal by Subject|1|||
13419675|NCT00467779|26860468|FG008|Stage 1|Withdrawal by Subject|0|||
13419676|NCT00467779|26860469|FG009|Stage 1|Withdrawal by Subject|0|||
13419677|NCT00467779|26860470|FG010|Stage 1|Withdrawal by Subject|0|||
13419678|NCT00467779|26860471|FG011|Stage 1|Withdrawal by Subject|0|||
13419679|NCT00467779|26860472|FG012|Stage 1|Withdrawal by Subject|0|||
13419680|NCT00467779|26860473|FG013|Stage 1|Withdrawal by Subject|0|||
13419681|NCT00467779|26860474|FG014|Stage 1|Withdrawal by Subject|0|||
13419682|NCT00467779|26860460|FG000|Stage 1A|Adverse Event|0|||
13419683|NCT00467779|26860461|FG001|Stage 1A|Adverse Event|0|||
13419684|NCT00467779|26860462|FG002|Stage 1A|Adverse Event|0|||
13419685|NCT00467779|26860463|FG003|Stage 1A|Adverse Event|0|||
13419686|NCT00467779|26860464|FG004|Stage 1A|Adverse Event|0|||
13419687|NCT00467779|26860465|FG005|Stage 1A|Adverse Event|0|||
13419688|NCT00467779|26860466|FG006|Stage 1A|Adverse Event|0|||
13419689|NCT00467779|26860467|FG007|Stage 1A|Adverse Event|0|||
13419690|NCT00467779|26860468|FG008|Stage 1A|Adverse Event|0|||
13419691|NCT00467779|26860469|FG009|Stage 1A|Adverse Event|0|||
13419692|NCT00467779|26860470|FG010|Stage 1A|Adverse Event|0|||
13419693|NCT00467779|26860471|FG011|Stage 1A|Adverse Event|0|||
13419694|NCT00467779|26860472|FG012|Stage 1A|Adverse Event|1|||
13419695|NCT00467779|26860473|FG013|Stage 1A|Adverse Event|0|||
13419696|NCT00467779|26860474|FG014|Stage 1A|Adverse Event|0|||
13419697|NCT00467779|26860460|FG000|Stage 1A|Death|0|||
13419698|NCT00467779|26860461|FG001|Stage 1A|Death|0|||
13419699|NCT00467779|26860462|FG002|Stage 1A|Death|0|||
13419700|NCT00467779|26860463|FG003|Stage 1A|Death|0|||
13419701|NCT00467779|26860464|FG004|Stage 1A|Death|0|||
13419702|NCT00467779|26860465|FG005|Stage 1A|Death|0|||
13419703|NCT00467779|26860466|FG006|Stage 1A|Death|0|||
13419704|NCT00467779|26860467|FG007|Stage 1A|Death|0|||
13419705|NCT00467779|26860468|FG008|Stage 1A|Death|0|||
13419706|NCT00467779|26860469|FG009|Stage 1A|Death|0|||
13419707|NCT00467779|26860470|FG010|Stage 1A|Death|0|||
13419708|NCT00467779|26860471|FG011|Stage 1A|Death|1|||
13419709|NCT00467779|26860472|FG012|Stage 1A|Death|1|||
13419710|NCT00467779|26860473|FG013|Stage 1A|Death|0|||
13419711|NCT00467779|26860474|FG014|Stage 1A|Death|0|||
13419712|NCT00467779|26860460|FG000|Stage 1A|Disease Progression|0|||
13419713|NCT00467779|26860461|FG001|Stage 1A|Disease Progression|0|||
13419714|NCT00467779|26860462|FG002|Stage 1A|Disease Progression|0|||
13419715|NCT00467779|26860463|FG003|Stage 1A|Disease Progression|0|||
13419716|NCT00467779|26860464|FG004|Stage 1A|Disease Progression|0|||
13419717|NCT00467779|26860465|FG005|Stage 1A|Disease Progression|0|||
13419718|NCT00467779|26860466|FG006|Stage 1A|Disease Progression|0|||
13419719|NCT00467779|26860467|FG007|Stage 1A|Disease Progression|0|||
13419720|NCT00467779|26860468|FG008|Stage 1A|Disease Progression|0|||
13419721|NCT00467779|26860469|FG009|Stage 1A|Disease Progression|2|||
13419722|NCT00467779|26860470|FG010|Stage 1A|Disease Progression|2|||
13419723|NCT00467779|26860471|FG011|Stage 1A|Disease Progression|5|||
13419724|NCT00467779|26860472|FG012|Stage 1A|Disease Progression|2|||
13419725|NCT00467779|26860473|FG013|Stage 1A|Disease Progression|0|||
13419726|NCT00467779|26860474|FG014|Stage 1A|Disease Progression|0|||
13419727|NCT00467779|26860460|FG000|Stage 1A|Physician Decision|0|||
13419728|NCT00467779|26860461|FG001|Stage 1A|Physician Decision|0|||
13419729|NCT00467779|26860462|FG002|Stage 1A|Physician Decision|0|||
13419730|NCT00467779|26860463|FG003|Stage 1A|Physician Decision|0|||
13419731|NCT00467779|26860464|FG004|Stage 1A|Physician Decision|0|||
13419732|NCT00467779|26860465|FG005|Stage 1A|Physician Decision|0|||
13419733|NCT00467779|26860466|FG006|Stage 1A|Physician Decision|0|||
13419734|NCT00467779|26860467|FG007|Stage 1A|Physician Decision|0|||
13419735|NCT00467779|26860468|FG008|Stage 1A|Physician Decision|0|||
13419736|NCT00467779|26860469|FG009|Stage 1A|Physician Decision|1|||
13419737|NCT00467779|26860470|FG010|Stage 1A|Physician Decision|0|||
13419738|NCT00467779|26860471|FG011|Stage 1A|Physician Decision|0|||
13419739|NCT00467779|26860472|FG012|Stage 1A|Physician Decision|0|||
13419740|NCT00467779|26860473|FG013|Stage 1A|Physician Decision|0|||
13419741|NCT00467779|26860474|FG014|Stage 1A|Physician Decision|0|||
13419742|NCT00467779|26860460|FG000|Stage 1A|Withdrawal by Subject|0|||
13419743|NCT00467779|26860461|FG001|Stage 1A|Withdrawal by Subject|0|||
13419744|NCT00467779|26860462|FG002|Stage 1A|Withdrawal by Subject|0|||
13419745|NCT00467779|26860463|FG003|Stage 1A|Withdrawal by Subject|0|||
13419746|NCT00467779|26860464|FG004|Stage 1A|Withdrawal by Subject|0|||
13419747|NCT00467779|26860465|FG005|Stage 1A|Withdrawal by Subject|0|||
13419748|NCT00467779|26860466|FG006|Stage 1A|Withdrawal by Subject|0|||
13419749|NCT00467779|26860467|FG007|Stage 1A|Withdrawal by Subject|0|||
13419750|NCT00467779|26860468|FG008|Stage 1A|Withdrawal by Subject|0|||
13419751|NCT00467779|26860469|FG009|Stage 1A|Withdrawal by Subject|0|||
13419752|NCT00467779|26860470|FG010|Stage 1A|Withdrawal by Subject|1|||
13419753|NCT00467779|26860471|FG011|Stage 1A|Withdrawal by Subject|1|||
13419754|NCT00467779|26860472|FG012|Stage 1A|Withdrawal by Subject|1|||
13419755|NCT00467779|26860473|FG013|Stage 1A|Withdrawal by Subject|0|||
13419756|NCT00467779|26860474|FG014|Stage 1A|Withdrawal by Subject|0|||
13419757|NCT00467779|26860460|FG000|Stage 1A|Unspecified Reason|0|||
13419758|NCT00467779|26860461|FG001|Stage 1A|Unspecified Reason|0|||
13419759|NCT00467779|26860462|FG002|Stage 1A|Unspecified Reason|0|||
13419760|NCT00467779|26860463|FG003|Stage 1A|Unspecified Reason|0|||
13419761|NCT00467779|26860464|FG004|Stage 1A|Unspecified Reason|0|||
13419762|NCT00467779|26860465|FG005|Stage 1A|Unspecified Reason|0|||
13419763|NCT00467779|26860466|FG006|Stage 1A|Unspecified Reason|0|||
13419764|NCT00467779|26860467|FG007|Stage 1A|Unspecified Reason|0|||
13419765|NCT00467779|26860468|FG008|Stage 1A|Unspecified Reason|0|||
13419766|NCT00467779|26860469|FG009|Stage 1A|Unspecified Reason|0|||
13419767|NCT00467779|26860470|FG010|Stage 1A|Unspecified Reason|0|||
13419768|NCT00467779|26860471|FG011|Stage 1A|Unspecified Reason|1|||
13419769|NCT00467779|26860472|FG012|Stage 1A|Unspecified Reason|1|||
13419770|NCT00467779|26860473|FG013|Stage 1A|Unspecified Reason|0|||
13419771|NCT00467779|26860474|FG014|Stage 1A|Unspecified Reason|0|||
13419772|NCT00467779|26860460|FG000|Stage 2|Adverse Event|0|||
13419773|NCT00467779|26860461|FG001|Stage 2|Adverse Event|0|||
13419774|NCT00467779|26860462|FG002|Stage 2|Adverse Event|0|||
13419775|NCT00467779|26860463|FG003|Stage 2|Adverse Event|0|||
13419776|NCT00467779|26860464|FG004|Stage 2|Adverse Event|0|||
13419777|NCT00467779|26860465|FG005|Stage 2|Adverse Event|0|||
13419778|NCT00467779|26860466|FG006|Stage 2|Adverse Event|0|||
13419779|NCT00467779|26860467|FG007|Stage 2|Adverse Event|0|||
13419780|NCT00467779|26860468|FG008|Stage 2|Adverse Event|1|||
13419781|NCT00467779|26860469|FG009|Stage 2|Adverse Event|0|||
13419782|NCT00467779|26860470|FG010|Stage 2|Adverse Event|0|||
13419783|NCT00467779|26860471|FG011|Stage 2|Adverse Event|0|||
13419784|NCT00467779|26860472|FG012|Stage 2|Adverse Event|0|||
13419785|NCT00467779|26860473|FG013|Stage 2|Adverse Event|0|||
13419786|NCT00467779|26860474|FG014|Stage 2|Adverse Event|0|||
13419787|NCT00467779|26860460|FG000|Stage 2|Death|0|||
13419788|NCT00467779|26860461|FG001|Stage 2|Death|0|||
13419789|NCT00467779|26860462|FG002|Stage 2|Death|0|||
13419790|NCT00467779|26860463|FG003|Stage 2|Death|0|||
13419791|NCT00467779|26860464|FG004|Stage 2|Death|0|||
13419792|NCT00467779|26860465|FG005|Stage 2|Death|0|||
13419793|NCT00467779|26860466|FG006|Stage 2|Death|0|||
13419794|NCT00467779|26860467|FG007|Stage 2|Death|0|||
13419795|NCT00467779|26860468|FG008|Stage 2|Death|1|||
13419796|NCT00467779|26860469|FG009|Stage 2|Death|0|||
13419797|NCT00467779|26860470|FG010|Stage 2|Death|0|||
13419798|NCT00467779|26860471|FG011|Stage 2|Death|0|||
13419799|NCT00467779|26860472|FG012|Stage 2|Death|0|||
13419800|NCT00467779|26860473|FG013|Stage 2|Death|0|||
13419801|NCT00467779|26860474|FG014|Stage 2|Death|0|||
13419802|NCT00467779|26860460|FG000|Stage 2|Disease Progression|0|||
13419803|NCT00467779|26860461|FG001|Stage 2|Disease Progression|0|||
13419804|NCT00467779|26860462|FG002|Stage 2|Disease Progression|0|||
13419805|NCT00467779|26860463|FG003|Stage 2|Disease Progression|0|||
13419806|NCT00467779|26860464|FG004|Stage 2|Disease Progression|0|||
13419807|NCT00467779|26860465|FG005|Stage 2|Disease Progression|0|||
13419808|NCT00467779|26860466|FG006|Stage 2|Disease Progression|0|||
13419809|NCT00467779|26860467|FG007|Stage 2|Disease Progression|0|||
13419810|NCT00467779|26860468|FG008|Stage 2|Disease Progression|16|||
13419811|NCT00467779|26860469|FG009|Stage 2|Disease Progression|0|||
13419812|NCT00467779|26860470|FG010|Stage 2|Disease Progression|0|||
13419813|NCT00467779|26860471|FG011|Stage 2|Disease Progression|0|||
13419814|NCT00467779|26860472|FG012|Stage 2|Disease Progression|0|||
13419815|NCT00467779|26860473|FG013|Stage 2|Disease Progression|0|||
13419816|NCT00467779|26860474|FG014|Stage 2|Disease Progression|0|||
13419817|NCT00467779|26860460|FG000|Stage 2|Unspecified Reason|0|||
13419818|NCT00467779|26860461|FG001|Stage 2|Unspecified Reason|0|||
13419819|NCT00467779|26860462|FG002|Stage 2|Unspecified Reason|0|||
13419820|NCT00467779|26860463|FG003|Stage 2|Unspecified Reason|0|||
13419821|NCT00467779|26860464|FG004|Stage 2|Unspecified Reason|0|||
13419822|NCT00467779|26860465|FG005|Stage 2|Unspecified Reason|0|||
13419823|NCT00467779|26860466|FG006|Stage 2|Unspecified Reason|0|||
13419824|NCT00467779|26860467|FG007|Stage 2|Unspecified Reason|0|||
13419825|NCT00467779|26860468|FG008|Stage 2|Unspecified Reason|3|||
13419826|NCT00467779|26860469|FG009|Stage 2|Unspecified Reason|0|||
13419827|NCT00467779|26860470|FG010|Stage 2|Unspecified Reason|0|||
13419828|NCT00467779|26860471|FG011|Stage 2|Unspecified Reason|0|||
13419829|NCT00467779|26860472|FG012|Stage 2|Unspecified Reason|0|||
13419830|NCT00467779|26860473|FG013|Stage 2|Unspecified Reason|0|||
13419831|NCT00467779|26860474|FG014|Stage 2|Unspecified Reason|0|||
13419832|NCT00467779|26860460|FG000|Stage 2A|Adverse Event|0|||
13419833|NCT00467779|26860461|FG001|Stage 2A|Adverse Event|0|||
13419834|NCT00467779|26860462|FG002|Stage 2A|Adverse Event|0|||
13419835|NCT00467779|26860463|FG003|Stage 2A|Adverse Event|0|||
13419836|NCT00467779|26860464|FG004|Stage 2A|Adverse Event|0|||
13419837|NCT00467779|26860465|FG005|Stage 2A|Adverse Event|0|||
13419838|NCT00467779|26860466|FG006|Stage 2A|Adverse Event|0|||
13419839|NCT00467779|26860467|FG007|Stage 2A|Adverse Event|0|||
13419840|NCT00467779|26860468|FG008|Stage 2A|Adverse Event|0|||
13419841|NCT00467779|26860469|FG009|Stage 2A|Adverse Event|0|||
13419842|NCT00467779|26860470|FG010|Stage 2A|Adverse Event|0|||
13419843|NCT00467779|26860471|FG011|Stage 2A|Adverse Event|0|||
13419844|NCT00467779|26860472|FG012|Stage 2A|Adverse Event|0|||
13419845|NCT00467779|26860473|FG013|Stage 2A|Adverse Event|2|||
13419846|NCT00467779|26860474|FG014|Stage 2A|Adverse Event|0|||
13419847|NCT00467779|26860460|FG000|Stage 2A|Death|0|||
13419848|NCT00467779|26860461|FG001|Stage 2A|Death|0|||
13419849|NCT00467779|26860462|FG002|Stage 2A|Death|0|||
13419850|NCT00467779|26860463|FG003|Stage 2A|Death|0|||
13419851|NCT00467779|26860464|FG004|Stage 2A|Death|0|||
13419852|NCT00467779|26860465|FG005|Stage 2A|Death|0|||
13419853|NCT00467779|26860466|FG006|Stage 2A|Death|0|||
13419854|NCT00467779|26860467|FG007|Stage 2A|Death|0|||
13419855|NCT00467779|26860468|FG008|Stage 2A|Death|0|||
13419856|NCT00467779|26860469|FG009|Stage 2A|Death|0|||
13419857|NCT00467779|26860470|FG010|Stage 2A|Death|0|||
13419858|NCT00467779|26860471|FG011|Stage 2A|Death|0|||
13419859|NCT00467779|26860472|FG012|Stage 2A|Death|0|||
13419860|NCT00467779|26860473|FG013|Stage 2A|Death|1|||
13419861|NCT00467779|26860474|FG014|Stage 2A|Death|0|||
13419862|NCT00467779|26860460|FG000|Stage 2A|Disease Progression|0|||
13419863|NCT00467779|26860461|FG001|Stage 2A|Disease Progression|0|||
13419864|NCT00467779|26860462|FG002|Stage 2A|Disease Progression|0|||
13419865|NCT00467779|26860463|FG003|Stage 2A|Disease Progression|0|||
13419866|NCT00467779|26860464|FG004|Stage 2A|Disease Progression|0|||
13419867|NCT00467779|26860465|FG005|Stage 2A|Disease Progression|0|||
13419868|NCT00467779|26860466|FG006|Stage 2A|Disease Progression|0|||
13419869|NCT00467779|26860467|FG007|Stage 2A|Disease Progression|0|||
13419870|NCT00467779|26860468|FG008|Stage 2A|Disease Progression|0|||
13419871|NCT00467779|26860469|FG009|Stage 2A|Disease Progression|0|||
13419872|NCT00467779|26860470|FG010|Stage 2A|Disease Progression|0|||
13419873|NCT00467779|26860471|FG011|Stage 2A|Disease Progression|0|||
13419874|NCT00467779|26860472|FG012|Stage 2A|Disease Progression|0|||
13419875|NCT00467779|26860473|FG013|Stage 2A|Disease Progression|10|||
13419876|NCT00467779|26860474|FG014|Stage 2A|Disease Progression|0|||
13419877|NCT00467779|26860460|FG000|Stage 2A|Unspecified Reason|0|||
13419878|NCT00467779|26860461|FG001|Stage 2A|Unspecified Reason|0|||
13419879|NCT00467779|26860462|FG002|Stage 2A|Unspecified Reason|0|||
13419880|NCT00467779|26860463|FG003|Stage 2A|Unspecified Reason|0|||
13419881|NCT00467779|26860464|FG004|Stage 2A|Unspecified Reason|0|||
13419882|NCT00467779|26860465|FG005|Stage 2A|Unspecified Reason|0|||
13419883|NCT00467779|26860466|FG006|Stage 2A|Unspecified Reason|0|||
13419884|NCT00467779|26860467|FG007|Stage 2A|Unspecified Reason|0|||
13419885|NCT00467779|26860468|FG008|Stage 2A|Unspecified Reason|0|||
13419886|NCT00467779|26860469|FG009|Stage 2A|Unspecified Reason|0|||
13419887|NCT00467779|26860470|FG010|Stage 2A|Unspecified Reason|0|||
13419888|NCT00467779|26860471|FG011|Stage 2A|Unspecified Reason|0|||
13419889|NCT00467779|26860472|FG012|Stage 2A|Unspecified Reason|0|||
13419890|NCT00467779|26860473|FG013|Stage 2A|Unspecified Reason|7|||
13419891|NCT00467779|26860474|FG014|Stage 2A|Unspecified Reason|0|||
13419892|NCT00467779|26860460|FG000|Stage 2A|Withdrawal by Subject|0|||
13419893|NCT00467779|26860461|FG001|Stage 2A|Withdrawal by Subject|0|||
13419894|NCT00467779|26860462|FG002|Stage 2A|Withdrawal by Subject|0|||
13419895|NCT00467779|26860463|FG003|Stage 2A|Withdrawal by Subject|0|||
13419896|NCT00467779|26860464|FG004|Stage 2A|Withdrawal by Subject|0|||
13419897|NCT00467779|26860465|FG005|Stage 2A|Withdrawal by Subject|0|||
13419898|NCT00467779|26860466|FG006|Stage 2A|Withdrawal by Subject|0|||
13419899|NCT00467779|26860467|FG007|Stage 2A|Withdrawal by Subject|0|||
13419900|NCT00467779|26860468|FG008|Stage 2A|Withdrawal by Subject|0|||
13419901|NCT00467779|26860469|FG009|Stage 2A|Withdrawal by Subject|0|||
13419902|NCT00467779|26860470|FG010|Stage 2A|Withdrawal by Subject|0|||
13419903|NCT00467779|26860471|FG011|Stage 2A|Withdrawal by Subject|0|||
13419904|NCT00467779|26860472|FG012|Stage 2A|Withdrawal by Subject|0|||
13419905|NCT00467779|26860473|FG013|Stage 2A|Withdrawal by Subject|1|||
13419906|NCT00467779|26860474|FG014|Stage 2A|Withdrawal by Subject|0|||
13419907|NCT00467779|26860460|FG000|Stage 3|Adverse Event|0|||
13419908|NCT00467779|26860461|FG001|Stage 3|Adverse Event|0|||
13419909|NCT00467779|26860462|FG002|Stage 3|Adverse Event|0|||
13419910|NCT00467779|26860463|FG003|Stage 3|Adverse Event|0|||
13419911|NCT00467779|26860464|FG004|Stage 3|Adverse Event|0|||
13419912|NCT00467779|26860465|FG005|Stage 3|Adverse Event|0|||
13419913|NCT00467779|26860466|FG006|Stage 3|Adverse Event|0|||
13419914|NCT00467779|26860467|FG007|Stage 3|Adverse Event|0|||
13419915|NCT00467779|26860468|FG008|Stage 3|Adverse Event|0|||
13419916|NCT00467779|26860469|FG009|Stage 3|Adverse Event|0|||
13419917|NCT00467779|26860470|FG010|Stage 3|Adverse Event|0|||
13419918|NCT00467779|26860471|FG011|Stage 3|Adverse Event|0|||
13419919|NCT00467779|26860472|FG012|Stage 3|Adverse Event|0|||
13419920|NCT00467779|26860473|FG013|Stage 3|Adverse Event|0|||
13419921|NCT00467779|26860474|FG014|Stage 3|Adverse Event|2|||
13419922|NCT00467779|26860460|FG000|Stage 3|Death|0|||
13419923|NCT00467779|26860461|FG001|Stage 3|Death|0|||
13419924|NCT00467779|26860462|FG002|Stage 3|Death|0|||
13419925|NCT00467779|26860463|FG003|Stage 3|Death|0|||
13419926|NCT00467779|26860464|FG004|Stage 3|Death|0|||
13419927|NCT00467779|26860465|FG005|Stage 3|Death|0|||
13419928|NCT00467779|26860466|FG006|Stage 3|Death|0|||
13419929|NCT00467779|26860467|FG007|Stage 3|Death|0|||
13419930|NCT00467779|26860468|FG008|Stage 3|Death|0|||
13419931|NCT00467779|26860469|FG009|Stage 3|Death|0|||
13419932|NCT00467779|26860470|FG010|Stage 3|Death|0|||
13419933|NCT00467779|26860471|FG011|Stage 3|Death|0|||
13419934|NCT00467779|26860472|FG012|Stage 3|Death|0|||
13419935|NCT00467779|26860473|FG013|Stage 3|Death|0|||
13419936|NCT00467779|26860474|FG014|Stage 3|Death|1|||
13419937|NCT00467779|26860460|FG000|Stage 3|Disease Progression|0|||
13419938|NCT00467779|26860461|FG001|Stage 3|Disease Progression|0|||
13419939|NCT00467779|26860462|FG002|Stage 3|Disease Progression|0|||
13419940|NCT00467779|26860463|FG003|Stage 3|Disease Progression|0|||
13419941|NCT00467779|26860464|FG004|Stage 3|Disease Progression|0|||
13419942|NCT00467779|26860465|FG005|Stage 3|Disease Progression|0|||
13419943|NCT00467779|26860466|FG006|Stage 3|Disease Progression|0|||
13419944|NCT00467779|26860467|FG007|Stage 3|Disease Progression|0|||
13419945|NCT00467779|26860468|FG008|Stage 3|Disease Progression|0|||
13419946|NCT00467779|26860469|FG009|Stage 3|Disease Progression|0|||
13419947|NCT00467779|26860470|FG010|Stage 3|Disease Progression|0|||
13419948|NCT00467779|26860471|FG011|Stage 3|Disease Progression|0|||
13419949|NCT00467779|26860472|FG012|Stage 3|Disease Progression|0|||
13419950|NCT00467779|26860473|FG013|Stage 3|Disease Progression|0|||
13419951|NCT00467779|26860474|FG014|Stage 3|Disease Progression|9|||
13419952|NCT00467779|26860460|FG000|Stage 3|Unspecified Reason|0|||
13419953|NCT00467779|26860461|FG001|Stage 3|Unspecified Reason|0|||
13419954|NCT00467779|26860462|FG002|Stage 3|Unspecified Reason|0|||
13419955|NCT00467779|26860463|FG003|Stage 3|Unspecified Reason|0|||
13419956|NCT00467779|26860464|FG004|Stage 3|Unspecified Reason|0|||
13419957|NCT00467779|26860465|FG005|Stage 3|Unspecified Reason|0|||
13419958|NCT00467779|26860466|FG006|Stage 3|Unspecified Reason|0|||
13419959|NCT00467779|26860467|FG007|Stage 3|Unspecified Reason|0|||
13419960|NCT00467779|26860468|FG008|Stage 3|Unspecified Reason|0|||
13419961|NCT00467779|26860469|FG009|Stage 3|Unspecified Reason|0|||
13419962|NCT00467779|26860470|FG010|Stage 3|Unspecified Reason|0|||
13419963|NCT00467779|26860471|FG011|Stage 3|Unspecified Reason|0|||
13419964|NCT00467779|26860472|FG012|Stage 3|Unspecified Reason|0|||
13419965|NCT00467779|26860473|FG013|Stage 3|Unspecified Reason|0|||
13419966|NCT00467779|26860474|FG014|Stage 3|Unspecified Reason|5|||
13419967|NCT00467753|26860493|FG000|Overall Study|Lost to Follow-up|1|||
13419968|NCT00467753|26860494|FG001|Overall Study|Lost to Follow-up|2|||
13419969|NCT00467753|26860493|FG000|Overall Study|Adverse Event|2|||
13419970|NCT00467753|26860494|FG001|Overall Study|Adverse Event|0|||
13419971|NCT00467740|26860697|FG000|Overall Study|Adverse Event|0|||
13419972|NCT00467740|26860698|FG001|Overall Study|Adverse Event|0|||
13419973|NCT00467740|26860699|FG002|Overall Study|Adverse Event|1|||
13419974|NCT00467740|26860700|FG003|Overall Study|Adverse Event|0|||
13419975|NCT00467740|26860701|FG004|Overall Study|Adverse Event|0|||
13419976|NCT00467740|26860697|FG000|Overall Study|Protocol Violation|0|||
13419977|NCT00467740|26860698|FG001|Overall Study|Protocol Violation|0|||
13419978|NCT00467740|26860699|FG002|Overall Study|Protocol Violation|1|||
13419979|NCT00467740|26860700|FG003|Overall Study|Protocol Violation|0|||
13419980|NCT00467740|26860701|FG004|Overall Study|Protocol Violation|0|||
13419981|NCT00467740|26860697|FG000|Overall Study|Lost to Follow-up|0|||
13419982|NCT00467740|26860698|FG001|Overall Study|Lost to Follow-up|1|||
13419983|NCT00467740|26860699|FG002|Overall Study|Lost to Follow-up|0|||
13419984|NCT00467740|26860700|FG003|Overall Study|Lost to Follow-up|0|||
13419985|NCT00467740|26860701|FG004|Overall Study|Lost to Follow-up|0|||
13419986|NCT00467740|26860697|FG000|Overall Study|Withdrawal by Subject|1|||
13419987|NCT00467740|26860698|FG001|Overall Study|Withdrawal by Subject|1|||
13419988|NCT00467740|26860699|FG002|Overall Study|Withdrawal by Subject|0|||
13419989|NCT00467740|26860700|FG003|Overall Study|Withdrawal by Subject|1|||
13419990|NCT00467740|26860701|FG004|Overall Study|Withdrawal by Subject|0|||
13419991|NCT00467740|26860697|FG000|Overall Study|Lack of Efficacy|0|||
13419992|NCT00467740|26860698|FG001|Overall Study|Lack of Efficacy|1|||
13419993|NCT00467740|26860699|FG002|Overall Study|Lack of Efficacy|0|||
13419994|NCT00467740|26860700|FG003|Overall Study|Lack of Efficacy|0|||
13419995|NCT00467740|26860701|FG004|Overall Study|Lack of Efficacy|0|||
13419996|NCT00467649|26860752|FG000|Phase 1 (Randomized Population)|Adverse Event|2|||
13419997|NCT00467649|26860753|FG001|Phase 1 (Randomized Population)|Adverse Event|0|||
13419998|NCT00467649|26860754|FG002|Phase 1 (Randomized Population)|Adverse Event|0|||
13419999|NCT00467649|26860755|FG003|Phase 1 (Randomized Population)|Adverse Event|0|||
13420000|NCT00467649|26860756|FG004|Phase 1 (Randomized Population)|Adverse Event|0|||
13420001|NCT00467649|26860757|FG005|Phase 1 (Randomized Population)|Adverse Event|0|||
13420002|NCT00467649|26860752|FG000|Phase 1 (Randomized Population)|Investigator Decision|1|||
13420003|NCT00467649|26860753|FG001|Phase 1 (Randomized Population)|Investigator Decision|0|||
13420004|NCT00467649|26860754|FG002|Phase 1 (Randomized Population)|Investigator Decision|0|||
13420005|NCT00467649|26860755|FG003|Phase 1 (Randomized Population)|Investigator Decision|0|||
13420006|NCT00467649|26860756|FG004|Phase 1 (Randomized Population)|Investigator Decision|0|||
13420007|NCT00467649|26860757|FG005|Phase 1 (Randomized Population)|Investigator Decision|0|||
13420008|NCT00467649|26860752|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2|||
13420009|NCT00467649|26860753|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4|||
13420010|NCT00467649|26860754|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
13420011|NCT00467649|26860755|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
13420012|NCT00467649|26860756|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
13420013|NCT00467649|26860757|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
13420014|NCT00467649|26860752|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4|||
13420015|NCT00467649|26860753|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2|||
13420016|NCT00467649|26860754|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
13420017|NCT00467649|26860755|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
13420018|NCT00467649|26860756|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
13420019|NCT00467649|26860757|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
13133947|NCT02761733|25989841|FG003|Overall Study|Cognitive Impairment|0|||
13133948|NCT02761642|25989854|FG000|Overall Study|Did not Receive Study Treatment|3|||
13133949|NCT02761642|25989854|FG000|Overall Study|Adverse Event|13|||
13133950|NCT02761642|25989854|FG000|Overall Study|Withdrawal by Subject|2|||
13133951|NCT02761642|25989854|FG000|Overall Study|Non-compliant|7|||
13133952|NCT02761642|25989854|FG000|Overall Study|Death|3|||
13133953|NCT02761642|25989854|FG000|Overall Study|Lack of Efficacy|20|||
13133954|NCT02761642|25989854|FG000|Overall Study|Physician Decision|1|||
13133955|NCT02761642|25989854|FG000|Overall Study|Reason Unspecified|21|||
13420020|NCT00467649|26860752|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
13420021|NCT00467649|26860753|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
13420022|NCT00467649|26860754|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
13420023|NCT00467649|26860755|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1|||
13420024|NCT00467649|26860756|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
13420025|NCT00467649|26860757|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
13420026|NCT00467649|26860752|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
13420027|NCT00467649|26860753|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
13420028|NCT00467649|26860754|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
13420029|NCT00467649|26860755|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1|||
13420030|NCT00467649|26860756|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
13420031|NCT00467649|26860757|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
13420032|NCT00467649|26860752|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
13420033|NCT00467649|26860753|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
13420034|NCT00467649|26860754|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
13420035|NCT00467649|26860755|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
13420036|NCT00467649|26860756|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
13420037|NCT00467649|26860757|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1|||
13420038|NCT00467610|26860766|FG000|Overall Study|Withdrawal by Subject|1|||
13420039|NCT00467597|26860787|FG000|Overall Study|Withdrawal by Subject|2|||
13420040|NCT00467597|26860788|FG001|Overall Study|Withdrawal by Subject|0|||
13420041|NCT00467584|26860806|FG000|Overall Study|Withdrawal by Subject|4|||
13420042|NCT00467584|26860807|FG001|Overall Study|Withdrawal by Subject|5|||
13420043|NCT00467584|26860808|FG002|Overall Study|Withdrawal by Subject|1|||
13420044|NCT00467558|26860823|FG000|Overall Study|Lost to Follow-up|2|||
13420045|NCT00467558|26860824|FG001|Overall Study|Lost to Follow-up|0|||
13420046|NCT00467519|26860847|FG000|Overall Study|Protocol Violation|8|||
13420047|NCT00467519|26860848|FG001|Overall Study|Protocol Violation|4|||
13420048|NCT00467519|26860847|FG000|Overall Study|Lost to Follow-up|2|||
13420049|NCT00467519|26860848|FG001|Overall Study|Lost to Follow-up|9|||
13420050|NCT00467519|26860847|FG000|Overall Study|Withdrawal by Subject|4|||
13420051|NCT00467519|26860848|FG001|Overall Study|Withdrawal by Subject|10|||
13420052|NCT00467363|26860889|FG000|Overall Study|Lost to Follow-up|80|||
13420053|NCT00467363|26860890|FG001|Overall Study|Lost to Follow-up|70|||
13420054|NCT00467285|26860915|FG000|Overall Study|Lost to Follow-up|4|||
13420055|NCT00467285|26860916|FG001|Overall Study|Lost to Follow-up|4|||
13420056|NCT00467272|26860927|FG000|Overall Study|Pneumonia|2|||
13420057|NCT00467272|26860927|FG000|Overall Study|Thrombophlebitis|1|||
13420058|NCT00467259|26860944|FG000|Overall Study|Adverse Event|24|||
13420059|NCT00467259|26860945|FG001|Overall Study|Adverse Event|90|||
13420060|NCT00467259|26860944|FG000|Overall Study|Protocol Violation|1|||
13420061|NCT00467259|26860945|FG001|Overall Study|Protocol Violation|7|||
13420062|NCT00467259|26860944|FG000|Overall Study|Withdrawal by Subject|34|||
13420063|NCT00467259|26860945|FG001|Overall Study|Withdrawal by Subject|108|||
13420064|NCT00467259|26860944|FG000|Overall Study|Physician Decision|0|||
13420065|NCT00467259|26860945|FG001|Overall Study|Physician Decision|2|||
13420066|NCT00467259|26860944|FG000|Overall Study|Lost to Follow-up|14|||
13420067|NCT00467259|26860945|FG001|Overall Study|Lost to Follow-up|34|||
13420068|NCT00467259|26860944|FG000|Overall Study|Site Closed|2|||
13420069|NCT00467259|26860945|FG001|Overall Study|Site Closed|1|||
13420070|NCT00467142|26860952|FG000|Overall Study|Withdrawal by Subject|1|||
13420071|NCT00467142|26860952|FG000|Overall Study|Adverse Event|1|||
13420072|NCT00467142|26860952|FG000|Overall Study|Protocol Violation|1|||
13420073|NCT00467051|26860959|FG000|Overall Study|Adverse Event|2|||
13420074|NCT00466947|26861088|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875|||
13420075|NCT00466947|26861089|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863|||
13420076|NCT00466947|26861088|FG000|Study End Analysis Period|Adverse Event|35|||
13420077|NCT00466947|26861089|FG001|Study End Analysis Period|Adverse Event|43|||
13420078|NCT00466947|26861088|FG000|Study End Analysis Period|Lost to Follow-up|1137|||
13420079|NCT00466947|26861089|FG001|Study End Analysis Period|Lost to Follow-up|1167|||
13420080|NCT00466947|26861088|FG000|Study End Analysis Period|Physician Decision|29|||
13420081|NCT00466947|26861089|FG001|Study End Analysis Period|Physician Decision|29|||
13420082|NCT00466947|26861088|FG000|Study End Analysis Period|Protocol Violation|9|||
13420083|NCT00466947|26861089|FG001|Study End Analysis Period|Protocol Violation|17|||
13420084|NCT00466947|26861088|FG000|Study End Analysis Period|Withdrawal by Subject|1264|||
13420085|NCT00466947|26861089|FG001|Study End Analysis Period|Withdrawal by Subject|1267|||
13420086|NCT00466947|26861088|FG000|Study End Analysis Period|Other - Forbidden vaccination|21|||
13420087|NCT00466947|26861089|FG001|Study End Analysis Period|Other - Forbidden vaccination|10|||
13420088|NCT00466947|26861088|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1|||
13420089|NCT00466947|26861089|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0|||
13420090|NCT00466947|26861088|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0|||
13420091|NCT00466947|26861089|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1|||
13420092|NCT00466921|26861098|FG000|First 3 Cycles of Treatment|Adverse Event|2|||
13420093|NCT00466921|26861098|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5|||
13420094|NCT00466921|26861098|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2|||
13420095|NCT00466921|26861098|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2|||
13420096|NCT00466921|26861098|FG000|Completed 4 Cycles/Reached 1st Response|Other|1|||
13420097|NCT00466921|26861098|FG000|Follow up for a Minimum of 1 Year|Death|6|||
13420098|NCT00466726|26861106|FG000|Overall Study|Not evaluable for response|14|||
13420099|NCT00466687|26861115|FG000|Overall Study|Adverse Event|1|||
13420100|NCT00466687|26861115|FG000|Overall Study|Other complicating illness|3|||
13420101|NCT00466687|26861115|FG000|Overall Study|Withdrawal by Subject|1|||
13420102|NCT00466687|26861115|FG000|Overall Study|Disease progression|29|||
13420103|NCT00466505|26861129|FG000|Overall Study|disease progression|13|||
13420104|NCT00466505|26861129|FG000|Overall Study|Adverse Event|4|||
13420105|NCT00466440|26861176|FG000|Overall Study|Adverse Event|0|||
13420106|NCT00466440|26861177|FG001|Overall Study|Adverse Event|3|||
13420107|NCT00466440|26861178|FG002|Overall Study|Adverse Event|1|||
13420108|NCT00466440|26861176|FG000|Overall Study|Death|1|||
13420109|NCT00466440|26861177|FG001|Overall Study|Death|1|||
13420110|NCT00466440|26861178|FG002|Overall Study|Death|0|||
13420111|NCT00466440|26861176|FG000|Overall Study|Progressive disease|13|||
13420112|NCT00466440|26861177|FG001|Overall Study|Progressive disease|5|||
13420113|NCT00466440|26861178|FG002|Overall Study|Progressive disease|4|||
13420114|NCT00466440|26861176|FG000|Overall Study|Lost to Follow-up|0|||
13420115|NCT00466440|26861177|FG001|Overall Study|Lost to Follow-up|1|||
13420116|NCT00466440|26861178|FG002|Overall Study|Lost to Follow-up|0|||
13420117|NCT00466440|26861176|FG000|Overall Study|Physician Decision|0|||
13420118|NCT00466440|26861177|FG001|Overall Study|Physician Decision|1|||
13420119|NCT00466440|26861178|FG002|Overall Study|Physician Decision|2|||
13420120|NCT00466440|26861176|FG000|Overall Study|Protocol entry criteria not met|0|||
13420121|NCT00466440|26861177|FG001|Overall Study|Protocol entry criteria not met|0|||
13420122|NCT00466440|26861178|FG002|Overall Study|Protocol entry criteria not met|4|||
13420123|NCT00466440|26861176|FG000|Overall Study|Withdrawal by Subject|0|||
13420124|NCT00466440|26861177|FG001|Overall Study|Withdrawal by Subject|1|||
13420125|NCT00466440|26861178|FG002|Overall Study|Withdrawal by Subject|0|||
13420126|NCT00466440|26861176|FG000|Overall Study|Sponsor decision|0|||
13420127|NCT00466440|26861177|FG001|Overall Study|Sponsor decision|0|||
13420128|NCT00466440|26861178|FG002|Overall Study|Sponsor decision|1|||
13420129|NCT00466193|26861209|FG000|Overall Study|Adverse Event|0|||
13420130|NCT00466193|26861210|FG001|Overall Study|Adverse Event|1|||
13420131|NCT00466193|26861209|FG000|Overall Study|Lost to Follow-up|2|||
13420132|NCT00466193|26861210|FG001|Overall Study|Lost to Follow-up|4|||
13420133|NCT00466193|26861209|FG000|Overall Study|Physician Decision|1|||
13420134|NCT00466193|26861210|FG001|Overall Study|Physician Decision|0|||
13420135|NCT00466193|26861209|FG000|Overall Study|Protocol Violation|1|||
13420136|NCT00466193|26861210|FG001|Overall Study|Protocol Violation|1|||
13420137|NCT00466193|26861209|FG000|Overall Study|Withdrawal by Subject|7|||
13420138|NCT00466193|26861210|FG001|Overall Study|Withdrawal by Subject|2|||
13420139|NCT00466193|26861209|FG000|Overall Study|Patient refused Visit 4 procedures|1|||
13420140|NCT00466193|26861210|FG001|Overall Study|Patient refused Visit 4 procedures|0|||
13420141|NCT00466167|26861276|FG000|Overall Study|Adverse Event|8|||
13420142|NCT00466167|26861277|FG001|Overall Study|Adverse Event|8|||
13420143|NCT00466167|26861278|FG002|Overall Study|Adverse Event|7|||
13420144|NCT00466167|26861276|FG000|Overall Study|Lack of Efficacy|2|||
13420145|NCT00466167|26861277|FG001|Overall Study|Lack of Efficacy|0|||
13420146|NCT00466167|26861278|FG002|Overall Study|Lack of Efficacy|3|||
13420147|NCT00466167|26861276|FG000|Overall Study|Protocol Violation|1|||
13420148|NCT00466167|26861277|FG001|Overall Study|Protocol Violation|1|||
13420149|NCT00466167|26861278|FG002|Overall Study|Protocol Violation|2|||
13420150|NCT00466167|26861276|FG000|Overall Study|Lost to Follow-up|3|||
13420151|NCT00466167|26861277|FG001|Overall Study|Lost to Follow-up|2|||
13420152|NCT00466167|26861278|FG002|Overall Study|Lost to Follow-up|2|||
13420153|NCT00466167|26861276|FG000|Overall Study|Withdrawal by Subject|4|||
13420154|NCT00466167|26861277|FG001|Overall Study|Withdrawal by Subject|1|||
13420155|NCT00466167|26861278|FG002|Overall Study|Withdrawal by Subject|6|||
13420156|NCT00466167|26861276|FG000|Overall Study|patient did not meet inclusion criteria|1|||
13420157|NCT00466167|26861277|FG001|Overall Study|patient did not meet inclusion criteria|0|||
13420158|NCT00466167|26861278|FG002|Overall Study|patient did not meet inclusion criteria|1|||
13420159|NCT00466167|26861276|FG000|Overall Study|Not treated|1|||
13420160|NCT00466167|26861277|FG001|Overall Study|Not treated|0|||
13420161|NCT00466167|26861278|FG002|Overall Study|Not treated|0|||
13420162|NCT00465985|26861302|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4|||
13420163|NCT00465985|26861303|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
13420164|NCT00465985|26861302|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0|||
13420165|NCT00465985|26861303|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12|||
13420166|NCT00465985|26861302|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1|||
13420167|NCT00465985|26861303|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
13420168|NCT00465985|26861302|FG000|Part III - Open-label Treatment Period|Adverse Event|1|||
13420169|NCT00465985|26861303|FG001|Part III - Open-label Treatment Period|Adverse Event|0|||
13420170|NCT00465972|26861318|FG000|Overall Study|Withdrawal by Subject|2|||
13420171|NCT00465972|26861319|FG001|Overall Study|Withdrawal by Subject|1|||
13420172|NCT00465894|26861356|FG000|Treatment For 12 Weeks|Lost to Follow-up|4|||
13420173|NCT00465894|26861357|FG001|Treatment For 12 Weeks|Lost to Follow-up|1|||
13420174|NCT00465894|26861356|FG000|Treatment For 12 Weeks|Family Issues|1|||
13420175|NCT00465894|26861357|FG001|Treatment For 12 Weeks|Family Issues|1|||
13420176|NCT00465894|26861356|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0|||
13420177|NCT00465894|26861357|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1|||
13420178|NCT00465816|26861428|FG000|Overall Study|Lost to Follow-up|0|||
13420179|NCT00465816|26861429|FG001|Overall Study|Lost to Follow-up|0|||
13420180|NCT00465816|26861430|FG002|Overall Study|Lost to Follow-up|2|||
13420181|NCT00465738|26861527|FG000|Overall Study|Lost to Follow-up|2|||
13420182|NCT00465738|26861528|FG001|Overall Study|Lost to Follow-up|0|||
13420183|NCT00465738|26861527|FG000|Overall Study|Adverse Event|0|||
13420184|NCT00465738|26861528|FG001|Overall Study|Adverse Event|1|||
13420185|NCT00465738|26861527|FG000|Overall Study|Withdrawal by Subject|2|||
13420186|NCT00465738|26861528|FG001|Overall Study|Withdrawal by Subject|0|||
13420187|NCT00465738|26861527|FG000|Overall Study|Other|2|||
13420188|NCT00465738|26861528|FG001|Overall Study|Other|5|||
13420189|NCT00465647|26861564|FG000|Overall Study|Administrative|2|||
13420190|NCT00465647|26861565|FG001|Overall Study|Administrative|2|||
13420191|NCT00465647|26861566|FG002|Overall Study|Administrative|3|||
13420192|NCT00465647|26861567|FG003|Overall Study|Administrative|2|||
13420193|NCT00465647|26861564|FG000|Overall Study|Adverse Event|2|||
13420194|NCT00465647|26861565|FG001|Overall Study|Adverse Event|0|||
13420195|NCT00465647|26861566|FG002|Overall Study|Adverse Event|3|||
13420196|NCT00465647|26861567|FG003|Overall Study|Adverse Event|2|||
13420197|NCT00465647|26861564|FG000|Overall Study|Withdrawal by Subject|1|||
13420198|NCT00465647|26861565|FG001|Overall Study|Withdrawal by Subject|2|||
13420199|NCT00465647|26861566|FG002|Overall Study|Withdrawal by Subject|2|||
13420200|NCT00465647|26861567|FG003|Overall Study|Withdrawal by Subject|7|||
13420201|NCT00465647|26861564|FG000|Overall Study|"The other reasons included loss of IV"|8|||
13420202|NCT00465647|26861565|FG001|Overall Study|"The other reasons included loss of IV"|4|||
13420203|NCT00465647|26861566|FG002|Overall Study|"The other reasons included loss of IV"|3|||
13420204|NCT00465647|26861567|FG003|Overall Study|"The other reasons included loss of IV"|2|||
13420205|NCT00465569|26861584|FG000|Overall Study|persistent eczema during dose escalation|1|||
13420206|NCT00465569|26861585|FG001|Overall Study|persistent eczema during dose escalation|0|||
13420207|NCT00465361|26861591|FG000|Baseline Assessment|Personal Issues/Scheduling|4|||
13420208|NCT00465270|26861607|FG000|Overall Study|Death|7|||
13420209|NCT00465270|26861608|FG001|Overall Study|Death|11|||
13420210|NCT00465270|26861607|FG000|Overall Study|Withdrawal by Subject|34|||
13420211|NCT00465270|26861608|FG001|Overall Study|Withdrawal by Subject|78|||
13420212|NCT00465270|26861607|FG000|Overall Study|Lost to Follow-up|60|||
13420213|NCT00465270|26861608|FG001|Overall Study|Lost to Follow-up|67|||
13420214|NCT00465270|26861607|FG000|Overall Study|Investigator request|3|||
13420215|NCT00465270|26861608|FG001|Overall Study|Investigator request|4|||
13420216|NCT00465179|26861616|FG000|Overall Study|Adverse Event|4|||
13420217|NCT00465179|26861616|FG000|Overall Study|Withdrawal by Subject|2|||
13420218|NCT00465179|26861616|FG000|Overall Study|Progression of Disease|47|||
13420219|NCT00465101|26861651|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3|||
13420220|NCT00465101|26861651|FG000|Overall Study|Change in health precluded follow up|4|||
13420221|NCT00465101|26861651|FG000|Overall Study|Did not meet study criteria|4|||
13420222|NCT00465101|26861651|FG000|Overall Study|Lost to Follow-up|5|||
13420223|NCT00465101|26861651|FG000|Overall Study|Other|6|||
13420224|NCT00465101|26861651|FG000|Overall Study|Pt. Insurance not accepted at center|2|||
13420225|NCT00465101|26861651|FG000|Overall Study|Patient postponed procedure|1|||
13420226|NCT00465101|26861651|FG000|Overall Study|Site closed due to IRB expiration|1|||
13420227|NCT00465101|26861651|FG000|Overall Study|Unable to obtain IRB approval|1|||
13420228|NCT00465101|26861651|FG000|Overall Study|Death|3|||
13420229|NCT00465101|26861651|FG000|Overall Study|Withdrawal by Subject|25|||
13420230|NCT00465101|26861651|FG000|Overall Study|Physician Decision|1|||
13420231|NCT00465101|26861651|FG000|Overall Study|Withdrew consent prior to procedure|3|||
13420232|NCT00464945|26861686|FG000|Infant Series|Withdrawal by parent/guardian request|2|||
13420233|NCT00464945|26861687|FG001|Infant Series|Withdrawal by parent/guardian request|1|||
13420234|NCT00464945|26861686|FG000|Infant Series|Protocol Violation|1|||
13420235|NCT00464945|26861687|FG001|Infant Series|Protocol Violation|0|||
13420236|NCT00464945|26861686|FG000|Infant Series|Lost to Follow-up|1|||
13420237|NCT00464945|26861687|FG001|Infant Series|Lost to Follow-up|0|||
13420238|NCT00464945|26861686|FG000|After Infant Series|Withdrawal by Subject|0|||
13420239|NCT00464945|26861687|FG001|After Infant Series|Withdrawal by Subject|2|||
13420240|NCT00464945|26861686|FG000|Toddler Dose|Lost to Follow-up|0|||
13420241|NCT00464945|26861687|FG001|Toddler Dose|Lost to Follow-up|1|||
13420242|NCT00464815|26861724|FG000|Overall Study|Withdrawal by Subject|6|||
13420243|NCT00464815|26861725|FG001|Overall Study|Withdrawal by Subject|3|||
13420244|NCT00464737|26861782|FG000|Overall Study|Adverse Event|12|||
13420245|NCT00464737|26861783|FG001|Overall Study|Adverse Event|17|||
13420246|NCT00464737|26861784|FG002|Overall Study|Adverse Event|33|||
13420247|NCT00464737|26861782|FG000|Overall Study|Lack of Efficacy|7|||
13420248|NCT00464737|26861783|FG001|Overall Study|Lack of Efficacy|7|||
13420249|NCT00464737|26861784|FG002|Overall Study|Lack of Efficacy|4|||
13420250|NCT00464737|26861782|FG000|Overall Study|Withdrawal by Subject|5|||
13420251|NCT00464737|26861783|FG001|Overall Study|Withdrawal by Subject|3|||
13420252|NCT00464737|26861784|FG002|Overall Study|Withdrawal by Subject|5|||
13420253|NCT00464737|26861782|FG000|Overall Study|Protocol Violation|1|||
13420254|NCT00464737|26861783|FG001|Overall Study|Protocol Violation|1|||
13420255|NCT00464737|26861784|FG002|Overall Study|Protocol Violation|5|||
13420256|NCT00464737|26861782|FG000|Overall Study|Non-compliance|0|||
13420257|NCT00464737|26861783|FG001|Overall Study|Non-compliance|1|||
13420258|NCT00464737|26861784|FG002|Overall Study|Non-compliance|1|||
13420259|NCT00464737|26861782|FG000|Overall Study|Lost to Follow-up|5|||
13420260|NCT00464737|26861783|FG001|Overall Study|Lost to Follow-up|2|||
13420261|NCT00464737|26861784|FG002|Overall Study|Lost to Follow-up|5|||
13420262|NCT00464737|26861782|FG000|Overall Study|Other: Subject's schedule doesn't permit|1|||
13420263|NCT00464737|26861783|FG001|Overall Study|Other: Subject's schedule doesn't permit|0|||
13420264|NCT00464737|26861784|FG002|Overall Study|Other: Subject's schedule doesn't permit|0|||
13420265|NCT00464737|26861782|FG000|Overall Study|Other: Subject left town; family illness|1|||
13420266|NCT00464737|26861783|FG001|Overall Study|Other: Subject left town; family illness|0|||
13420267|NCT00464737|26861784|FG002|Overall Study|Other: Subject left town; family illness|0|||
13420268|NCT00464737|26861782|FG000|Overall Study|Other: Study demands too great|0|||
13420269|NCT00464737|26861783|FG001|Overall Study|Other: Study demands too great|1|||
13420270|NCT00464737|26861784|FG002|Overall Study|Other: Study demands too great|0|||
13420271|NCT00464737|26861782|FG000|Overall Study|Other: Personal family reasons|0|||
13420272|NCT00464737|26861783|FG001|Overall Study|Other: Personal family reasons|0|||
13420273|NCT00464737|26861784|FG002|Overall Study|Other: Personal family reasons|1|||
13420274|NCT00464737|26861782|FG000|Overall Study|Other: Subject's disability per sponsor|0|||
13420275|NCT00464737|26861783|FG001|Overall Study|Other: Subject's disability per sponsor|0|||
13420276|NCT00464737|26861784|FG002|Overall Study|Other: Subject's disability per sponsor|1|||
13420277|NCT00464672|26861865|FG000|Overall Study|withdrawal of consent|0|||
13420278|NCT00464672|26861866|FG001|Overall Study|withdrawal of consent|0|||
13420279|NCT00464672|26861867|FG002|Overall Study|withdrawal of consent|0|||
13420280|NCT00464672|26861868|FG003|Overall Study|withdrawal of consent|1|||
13420281|NCT00464672|26861869|FG004|Overall Study|withdrawal of consent|9|||
13420282|NCT00464672|26861870|FG005|Overall Study|withdrawal of consent|4|||
13420283|NCT00464672|26861865|FG000|Overall Study|Lost to Follow-up|25|||
13420284|NCT00464672|26861866|FG001|Overall Study|Lost to Follow-up|10|||
13420285|NCT00464672|26861867|FG002|Overall Study|Lost to Follow-up|0|||
13420286|NCT00464672|26861868|FG003|Overall Study|Lost to Follow-up|0|||
13420287|NCT00464672|26861869|FG004|Overall Study|Lost to Follow-up|1|||
13420288|NCT00464672|26861870|FG005|Overall Study|Lost to Follow-up|0|||
13420289|NCT00464620|26861901|FG000|Overall Study|Physician Decision|1|||
13420290|NCT00464620|26861902|FG001|Overall Study|Physician Decision|0|||
13420291|NCT00464620|26861903|FG002|Overall Study|Physician Decision|0|||
13420292|NCT00464620|26861901|FG000|Overall Study|Withdrawal by Subject|1|||
13420293|NCT00464620|26861902|FG001|Overall Study|Withdrawal by Subject|0|||
13420294|NCT00464620|26861903|FG002|Overall Study|Withdrawal by Subject|3|||
13420295|NCT00464620|26861901|FG000|Overall Study|Ineligible sarcoma subtype|0|||
13420296|NCT00464620|26861902|FG001|Overall Study|Ineligible sarcoma subtype|2|||
13420297|NCT00464620|26861903|FG002|Overall Study|Ineligible sarcoma subtype|2|||
13420298|NCT00464620|26861901|FG000|Overall Study|Use of prohibited concomitant medication|0|||
13420299|NCT00464620|26861902|FG001|Overall Study|Use of prohibited concomitant medication|0|||
13420300|NCT00464620|26861903|FG002|Overall Study|Use of prohibited concomitant medication|2|||
13420301|NCT00464568|26861978|FG000|Overall Study|Adverse Event|2|||
13420302|NCT00464542|26861985|FG000|Pre-treatment|Withdrawal by Subject|2|||
13420303|NCT00464490|26861998|FG000|Overall Study|Physician Decision|11|||
13420304|NCT00464490|26861999|FG001|Overall Study|Physician Decision|11|||
13420305|NCT00464334|26862090|FG000|Overall Study|Adverse Event|0|||
13420306|NCT00464334|26862091|FG001|Overall Study|Adverse Event|0|||
13420307|NCT00464334|26862092|FG002|Overall Study|Adverse Event|0|||
13420308|NCT00464334|26862093|FG003|Overall Study|Adverse Event|1|||
13420309|NCT00464334|26862094|FG004|Overall Study|Adverse Event|1|||
13420310|NCT00464334|26862095|FG005|Overall Study|Adverse Event|1|||
13420311|NCT00464334|26862096|FG006|Overall Study|Adverse Event|0|||
13420312|NCT00464334|26862097|FG007|Overall Study|Adverse Event|0|||
13420313|NCT00464334|26862098|FG008|Overall Study|Adverse Event|2|||
13420314|NCT00464334|26862099|FG009|Overall Study|Adverse Event|1|||
13420315|NCT00464334|26862100|FG010|Overall Study|Adverse Event|2|||
13420316|NCT00464334|26862090|FG000|Overall Study|Lack of Efficacy|0|||
13420317|NCT00464334|26862091|FG001|Overall Study|Lack of Efficacy|1|||
13420318|NCT00464334|26862092|FG002|Overall Study|Lack of Efficacy|0|||
13420319|NCT00464334|26862093|FG003|Overall Study|Lack of Efficacy|0|||
13420320|NCT00464334|26862094|FG004|Overall Study|Lack of Efficacy|0|||
13420321|NCT00464334|26862095|FG005|Overall Study|Lack of Efficacy|0|||
13420322|NCT00464334|26862096|FG006|Overall Study|Lack of Efficacy|0|||
13420323|NCT00464334|26862097|FG007|Overall Study|Lack of Efficacy|0|||
13420324|NCT00464334|26862098|FG008|Overall Study|Lack of Efficacy|0|||
13420325|NCT00464334|26862099|FG009|Overall Study|Lack of Efficacy|0|||
13420326|NCT00464334|26862100|FG010|Overall Study|Lack of Efficacy|0|||
13420327|NCT00464334|26862090|FG000|Overall Study|Lost to Follow-up|0|||
13420328|NCT00464334|26862091|FG001|Overall Study|Lost to Follow-up|0|||
13420329|NCT00464334|26862092|FG002|Overall Study|Lost to Follow-up|1|||
13420330|NCT00464334|26862093|FG003|Overall Study|Lost to Follow-up|0|||
13420331|NCT00464334|26862094|FG004|Overall Study|Lost to Follow-up|1|||
13420332|NCT00464334|26862095|FG005|Overall Study|Lost to Follow-up|0|||
13420333|NCT00464334|26862096|FG006|Overall Study|Lost to Follow-up|1|||
13420334|NCT00464334|26862097|FG007|Overall Study|Lost to Follow-up|0|||
13420335|NCT00464334|26862098|FG008|Overall Study|Lost to Follow-up|0|||
13420336|NCT00464334|26862099|FG009|Overall Study|Lost to Follow-up|0|||
13420337|NCT00464334|26862100|FG010|Overall Study|Lost to Follow-up|2|||
13420338|NCT00464334|26862090|FG000|Overall Study|Progressive Disease|0|||
13420339|NCT00464334|26862091|FG001|Overall Study|Progressive Disease|0|||
13420340|NCT00464334|26862092|FG002|Overall Study|Progressive Disease|0|||
13420341|NCT00464334|26862093|FG003|Overall Study|Progressive Disease|0|||
13420342|NCT00464334|26862094|FG004|Overall Study|Progressive Disease|0|||
13420343|NCT00464334|26862095|FG005|Overall Study|Progressive Disease|1|||
13420344|NCT00464334|26862096|FG006|Overall Study|Progressive Disease|0|||
13420345|NCT00464334|26862097|FG007|Overall Study|Progressive Disease|0|||
13420346|NCT00464334|26862098|FG008|Overall Study|Progressive Disease|1|||
13420347|NCT00464334|26862099|FG009|Overall Study|Progressive Disease|0|||
13420348|NCT00464334|26862100|FG010|Overall Study|Progressive Disease|0|||
13420349|NCT00464334|26862090|FG000|Overall Study|Study Terminated by Sponsor|0|||
13420350|NCT00464334|26862091|FG001|Overall Study|Study Terminated by Sponsor|0|||
13420351|NCT00464334|26862092|FG002|Overall Study|Study Terminated by Sponsor|0|||
13420352|NCT00464334|26862093|FG003|Overall Study|Study Terminated by Sponsor|1|||
13420353|NCT00464334|26862094|FG004|Overall Study|Study Terminated by Sponsor|0|||
13420354|NCT00464334|26862095|FG005|Overall Study|Study Terminated by Sponsor|0|||
13420355|NCT00464334|26862096|FG006|Overall Study|Study Terminated by Sponsor|0|||
13420356|NCT00464334|26862097|FG007|Overall Study|Study Terminated by Sponsor|0|||
13420357|NCT00464334|26862098|FG008|Overall Study|Study Terminated by Sponsor|0|||
13420358|NCT00464334|26862099|FG009|Overall Study|Study Terminated by Sponsor|0|||
13420359|NCT00464334|26862100|FG010|Overall Study|Study Terminated by Sponsor|0|||
13420360|NCT00464334|26862090|FG000|Overall Study|Withdrawal by Subject|1|||
13420361|NCT00464334|26862091|FG001|Overall Study|Withdrawal by Subject|7|||
13420362|NCT00464334|26862092|FG002|Overall Study|Withdrawal by Subject|4|||
13420363|NCT00464334|26862093|FG003|Overall Study|Withdrawal by Subject|2|||
13420364|NCT00464334|26862094|FG004|Overall Study|Withdrawal by Subject|2|||
13420365|NCT00464334|26862095|FG005|Overall Study|Withdrawal by Subject|2|||
13420366|NCT00464334|26862096|FG006|Overall Study|Withdrawal by Subject|2|||
13420367|NCT00464334|26862097|FG007|Overall Study|Withdrawal by Subject|1|||
13420368|NCT00464334|26862098|FG008|Overall Study|Withdrawal by Subject|3|||
13420369|NCT00464334|26862099|FG009|Overall Study|Withdrawal by Subject|0|||
13420370|NCT00464334|26862100|FG010|Overall Study|Withdrawal by Subject|0|||
13420371|NCT00464308|26862136|FG000|Overall Study|Adverse Event|22|||
13420372|NCT00464308|26862137|FG001|Overall Study|Adverse Event|27|||
13420373|NCT00464308|26862138|FG002|Overall Study|Adverse Event|16|||
13420374|NCT00464308|26862136|FG000|Overall Study|Lost to Follow-up|29|||
13420375|NCT00464308|26862137|FG001|Overall Study|Lost to Follow-up|19|||
13420376|NCT00464308|26862138|FG002|Overall Study|Lost to Follow-up|20|||
13420377|NCT00464308|26862136|FG000|Overall Study|Patient discontinued and other reasons|17|||
13420378|NCT00464308|26862137|FG001|Overall Study|Patient discontinued and other reasons|17|||
13420379|NCT00464308|26862138|FG002|Overall Study|Patient discontinued and other reasons|23|||
13420380|NCT00464308|26862136|FG000|Overall Study|Physician Decision|1|||
13420381|NCT00464308|26862137|FG001|Overall Study|Physician Decision|0|||
13420382|NCT00464308|26862138|FG002|Overall Study|Physician Decision|0|||
13420383|NCT00464269|26862249|FG000|Overall Study|Lack of Efficacy|1|||
13420384|NCT00464269|26862250|FG001|Overall Study|Lack of Efficacy|0|||
13420385|NCT00464269|26862251|FG002|Overall Study|Lack of Efficacy|0|||
13420386|NCT00464269|26862252|FG003|Overall Study|Lack of Efficacy|0|||
13420387|NCT00464269|26862249|FG000|Overall Study|Lost to Follow-up|0|||
13420388|NCT00464269|26862250|FG001|Overall Study|Lost to Follow-up|4|||
13420389|NCT00464269|26862251|FG002|Overall Study|Lost to Follow-up|0|||
13420390|NCT00464269|26862252|FG003|Overall Study|Lost to Follow-up|1|||
13420391|NCT00464269|26862249|FG000|Overall Study|Withdrawal by Subject|0|||
13420392|NCT00464269|26862250|FG001|Overall Study|Withdrawal by Subject|2|||
13420393|NCT00464269|26862251|FG002|Overall Study|Withdrawal by Subject|1|||
13420394|NCT00464269|26862252|FG003|Overall Study|Withdrawal by Subject|1|||
13420395|NCT00464269|26862249|FG000|Overall Study|Other reason|3|||
13420396|NCT00464269|26862250|FG001|Overall Study|Other reason|3|||
13420397|NCT00464269|26862251|FG002|Overall Study|Other reason|1|||
13420398|NCT00464269|26862252|FG003|Overall Study|Other reason|1|||
13420399|NCT00464269|26862249|FG000|Overall Study|AE, serious fatal|0|||
13420400|NCT00464269|26862250|FG001|Overall Study|AE, serious fatal|0|||
13420401|NCT00464269|26862251|FG002|Overall Study|AE, serious fatal|1|||
13420402|NCT00464269|26862252|FG003|Overall Study|AE, serious fatal|1|||
13420403|NCT00464269|26862249|FG000|Overall Study|SAE, non-fatal|0|||
13420404|NCT00464269|26862250|FG001|Overall Study|SAE, non-fatal|0|||
13420405|NCT00464269|26862251|FG002|Overall Study|SAE, non-fatal|0|||
13420406|NCT00464269|26862252|FG003|Overall Study|SAE, non-fatal|1|||
13420407|NCT00464269|26862249|FG000|Overall Study|AE, non-serious non-fatal|2|||
13420408|NCT00464269|26862250|FG001|Overall Study|AE, non-serious non-fatal|8|||
13420409|NCT00464269|26862251|FG002|Overall Study|AE, non-serious non-fatal|3|||
13420410|NCT00464269|26862252|FG003|Overall Study|AE, non-serious non-fatal|4|||
13420411|NCT00464269|26862249|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
13420412|NCT00464269|26862250|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
13420413|NCT00464269|26862251|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
13420414|NCT00464269|26862252|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
13420415|NCT00464178|26862259|FG000|Overall Study|Protocol Violation|1|||
13420416|NCT00464178|26862259|FG000|Overall Study|Withdrawal by Subject|1|||
13420417|NCT00464087|26862285|FG000|Overall Study|No PCI per inclusion criteria|0|||
13420418|NCT00464087|26862286|FG001|Overall Study|No PCI per inclusion criteria|0|||
13420419|NCT00464087|26862287|FG002|Overall Study|No PCI per inclusion criteria|29|||
13420420|NCT00463866|26862314|FG000|Overall Study|Adverse Event|70|||
13420421|NCT00463866|26862315|FG001|Overall Study|Adverse Event|93|||
13420422|NCT00463866|26862314|FG000|Overall Study|Withdrawal by Subject|81|||
13420423|NCT00463866|26862315|FG001|Overall Study|Withdrawal by Subject|79|||
13420424|NCT00463866|26862314|FG000|Overall Study|Lost to Follow-up|46|||
13420425|NCT00463866|26862315|FG001|Overall Study|Lost to Follow-up|55|||
13420426|NCT00463866|26862314|FG000|Overall Study|Incorrect Enrolment|64|||
13420427|NCT00463866|26862315|FG001|Overall Study|Incorrect Enrolment|66|||
13420428|NCT00463866|26862314|FG000|Overall Study|Severe Non-Compliance to Protocol|25|||
13420429|NCT00463866|26862315|FG001|Overall Study|Severe Non-Compliance to Protocol|21|||
13420430|NCT00463866|26862314|FG000|Overall Study|Safety Reason|1|||
13420431|NCT00463866|26862315|FG001|Overall Study|Safety Reason|3|||
13420432|NCT00463866|26862314|FG000|Overall Study|Mis-Randomization of subject|0|||
13420433|NCT00463866|26862315|FG001|Overall Study|Mis-Randomization of subject|1|||
13420434|NCT00463866|26862314|FG000|Overall Study|Other|22|||
13420435|NCT00463866|26862315|FG001|Overall Study|Other|22|||
13420436|NCT00463840|26862322|FG000|Overall Study|Disease progression|7|||
13420437|NCT00463840|26862322|FG000|Overall Study|Withdrawal by Subject|2|||
13420438|NCT00463840|26862322|FG000|Overall Study|Adverse Event|3|||
13420439|NCT00463801|26862328|FG000|Overall Study|Protocol Violation|1|||
13420440|NCT00463801|26862328|FG000|Overall Study|Lack of Efficacy|2|||
13420441|NCT00463801|26862328|FG000|Overall Study|Adverse Event|4|||
13420442|NCT00463801|26862328|FG000|Overall Study|Lost to Follow-up|5|||
13420443|NCT00463801|26862328|FG000|Overall Study|No longer require therapy|1|||
13420444|NCT00463788|26862350|FG000|Overall Study|Progressive Disease|86|||
13420445|NCT00463788|26862351|FG001|Overall Study|Progressive Disease|42|||
13420446|NCT00463788|26862350|FG000|Overall Study|Adverse Event|6|||
13420447|NCT00463788|26862351|FG001|Overall Study|Adverse Event|2|||
13420448|NCT00463788|26862350|FG000|Overall Study|Withdrawal by Subject|6|||
13420449|NCT00463788|26862351|FG001|Overall Study|Withdrawal by Subject|2|||
13420450|NCT00463788|26862350|FG000|Overall Study|Death|4|||
13420451|NCT00463788|26862351|FG001|Overall Study|Death|3|||
13420452|NCT00463788|26862350|FG000|Overall Study|Symptomatic Deterioration|2|||
13420453|NCT00463788|26862351|FG001|Overall Study|Symptomatic Deterioration|3|||
13420454|NCT00463788|26862350|FG000|Overall Study|Lost to Follow-up|1|||
13420455|NCT00463788|26862351|FG001|Overall Study|Lost to Follow-up|0|||
13420456|NCT00463788|26862350|FG000|Overall Study|Protocol Violation|0|||
13420457|NCT00463788|26862351|FG001|Overall Study|Protocol Violation|1|||
13420458|NCT00463788|26862350|FG000|Overall Study|Other|3|||
13420459|NCT00463788|26862351|FG001|Overall Study|Other|0|||
13420460|NCT00463788|26862350|FG000|Overall Study|Randomized but not treated|1|||
13420461|NCT00463788|26862351|FG001|Overall Study|Randomized but not treated|1|||
13476654|NCT01425008|27003739|FG010|Dose Escalation Phase|Progressive Disease|0|||
13476655|NCT01425008|27003740|FG011|Dose Escalation Phase|Progressive Disease|0|||
13476656|NCT01425008|27003741|FG012|Dose Escalation Phase|Progressive Disease|0|||
13476657|NCT01425008|27003742|FG013|Dose Escalation Phase|Progressive Disease|0|||
13476658|NCT01425008|27003743|FG014|Dose Escalation Phase|Progressive Disease|0|||
13476659|NCT01425008|27003744|FG015|Dose Escalation Phase|Progressive Disease|0|||
13476660|NCT01425008|27003745|FG016|Dose Escalation Phase|Progressive Disease|0|||
13476661|NCT01425008|27003746|FG017|Dose Escalation Phase|Progressive Disease|0|||
13476662|NCT01425008|27003747|FG018|Dose Escalation Phase|Progressive Disease|0|||
13476663|NCT01425008|27003729|FG000|Dose Escalation Phase|Adverse Event|2|||
13476664|NCT01425008|27003730|FG001|Dose Escalation Phase|Adverse Event|0|||
13476665|NCT01425008|27003731|FG002|Dose Escalation Phase|Adverse Event|0|||
13476666|NCT01425008|27003732|FG003|Dose Escalation Phase|Adverse Event|0|||
13476667|NCT01425008|27003733|FG004|Dose Escalation Phase|Adverse Event|0|||
13476668|NCT01425008|27003734|FG005|Dose Escalation Phase|Adverse Event|2|||
13476669|NCT01425008|27003735|FG006|Dose Escalation Phase|Adverse Event|0|||
13476670|NCT01425008|27003736|FG007|Dose Escalation Phase|Adverse Event|0|||
13476671|NCT01425008|27003737|FG008|Dose Escalation Phase|Adverse Event|2|||
13476672|NCT01425008|27003738|FG009|Dose Escalation Phase|Adverse Event|0|||
13476673|NCT01425008|27003739|FG010|Dose Escalation Phase|Adverse Event|0|||
13476674|NCT01425008|27003740|FG011|Dose Escalation Phase|Adverse Event|0|||
13476675|NCT01425008|27003741|FG012|Dose Escalation Phase|Adverse Event|0|||
13476676|NCT01425008|27003742|FG013|Dose Escalation Phase|Adverse Event|0|||
13476677|NCT01425008|27003743|FG014|Dose Escalation Phase|Adverse Event|0|||
13476678|NCT01425008|27003744|FG015|Dose Escalation Phase|Adverse Event|0|||
13420462|NCT00463684|26862368|FG000|Overall Study|Withdrawal by Subject|1|||
13420463|NCT00463684|26862368|FG000|Overall Study|Lost to Follow-up|3|||
13420464|NCT00463606|26862401|FG000|Overall Study|Adverse Event|21|||
13420465|NCT00463606|26862402|FG001|Overall Study|Adverse Event|18|||
13420466|NCT00463606|26862403|FG002|Overall Study|Adverse Event|11|||
13420467|NCT00463606|26862401|FG000|Overall Study|Withdrawal by Subject|11|||
13420468|NCT00463606|26862402|FG001|Overall Study|Withdrawal by Subject|11|||
13420469|NCT00463606|26862403|FG002|Overall Study|Withdrawal by Subject|5|||
13420470|NCT00463606|26862401|FG000|Overall Study|Lost to Follow-up|2|||
13420471|NCT00463606|26862402|FG001|Overall Study|Lost to Follow-up|2|||
13420472|NCT00463606|26862403|FG002|Overall Study|Lost to Follow-up|3|||
13420473|NCT00463606|26862401|FG000|Overall Study|Subject noncompliance|1|||
13420474|NCT00463606|26862402|FG001|Overall Study|Subject noncompliance|1|||
13420475|NCT00463606|26862403|FG002|Overall Study|Subject noncompliance|0|||
13420476|NCT00463606|26862401|FG000|Overall Study|Subject moved out of town|1|||
13420477|NCT00463606|26862402|FG001|Overall Study|Subject moved out of town|0|||
13420478|NCT00463606|26862403|FG002|Overall Study|Subject moved out of town|0|||
13420479|NCT00463606|26862401|FG000|Overall Study|Physician Decision|0|||
13420480|NCT00463606|26862402|FG001|Overall Study|Physician Decision|1|||
13420481|NCT00463606|26862403|FG002|Overall Study|Physician Decision|0|||
13420482|NCT00463606|26862401|FG000|Overall Study|Sponsor request|0|||
13420483|NCT00463606|26862402|FG001|Overall Study|Sponsor request|1|||
13420484|NCT00463606|26862403|FG002|Overall Study|Sponsor request|0|||
13420485|NCT00463606|26862401|FG000|Overall Study|Exclusion criteria violation|2|||
13420486|NCT00463606|26862402|FG001|Overall Study|Exclusion criteria violation|0|||
13420487|NCT00463606|26862403|FG002|Overall Study|Exclusion criteria violation|0|||
13420488|NCT00463606|26862401|FG000|Overall Study|Coordinator error|1|||
13420489|NCT00463606|26862402|FG001|Overall Study|Coordinator error|0|||
13420490|NCT00463606|26862403|FG002|Overall Study|Coordinator error|0|||
13420491|NCT00463606|26862401|FG000|Overall Study|Patient randomized in error|1|||
13420492|NCT00463606|26862402|FG001|Overall Study|Patient randomized in error|0|||
13420493|NCT00463606|26862403|FG002|Overall Study|Patient randomized in error|0|||
13420494|NCT00463606|26862401|FG000|Overall Study|Participation in another ABT-335 trial|1|||
13420495|NCT00463606|26862402|FG001|Overall Study|Participation in another ABT-335 trial|0|||
13420496|NCT00463606|26862403|FG002|Overall Study|Participation in another ABT-335 trial|0|||
13420497|NCT00463606|26862401|FG000|Overall Study|Protocol Violation|0|||
13420498|NCT00463606|26862402|FG001|Overall Study|Protocol Violation|0|||
13420499|NCT00463606|26862403|FG002|Overall Study|Protocol Violation|1|||
13420500|NCT00463580|26862436|FG000|Overall Study|Lost to Follow-up|1|||
13420501|NCT00463580|26862437|FG001|Overall Study|Lost to Follow-up|0|||
13420502|NCT00463580|26862436|FG000|Overall Study|Schedule conflict|2|||
13420503|NCT00463580|26862437|FG001|Overall Study|Schedule conflict|0|||
13420504|NCT00463580|26862436|FG000|Overall Study|Medical/psychiatric complications|0|||
13420505|NCT00463580|26862437|FG001|Overall Study|Medical/psychiatric complications|2|||
13420506|NCT00463567|26862490|FG000|Overall Study|Adverse Event|29|||
13420507|NCT00463567|26862491|FG001|Overall Study|Adverse Event|26|||
13420508|NCT00463567|26862492|FG002|Overall Study|Adverse Event|17|||
13420509|NCT00463567|26862493|FG003|Overall Study|Adverse Event|46|||
13420510|NCT00463567|26862494|FG004|Overall Study|Adverse Event|10|||
13420511|NCT00463567|26862495|FG005|Overall Study|Adverse Event|10|||
13420512|NCT00463567|26862496|FG006|Overall Study|Adverse Event|4|||
13420513|NCT00463567|26862490|FG000|Overall Study|Withdrawal by Subject|29|||
13420514|NCT00463567|26862491|FG001|Overall Study|Withdrawal by Subject|22|||
13420515|NCT00463567|26862492|FG002|Overall Study|Withdrawal by Subject|20|||
13420516|NCT00463567|26862493|FG003|Overall Study|Withdrawal by Subject|37|||
13420517|NCT00463567|26862494|FG004|Overall Study|Withdrawal by Subject|6|||
13420518|NCT00463567|26862495|FG005|Overall Study|Withdrawal by Subject|5|||
13420519|NCT00463567|26862496|FG006|Overall Study|Withdrawal by Subject|1|||
13420520|NCT00463567|26862490|FG000|Overall Study|Protocol Deviation|13|||
13420521|NCT00463567|26862491|FG001|Overall Study|Protocol Deviation|9|||
13420522|NCT00463567|26862492|FG002|Overall Study|Protocol Deviation|14|||
13420523|NCT00463567|26862493|FG003|Overall Study|Protocol Deviation|11|||
13420524|NCT00463567|26862494|FG004|Overall Study|Protocol Deviation|1|||
13420525|NCT00463567|26862495|FG005|Overall Study|Protocol Deviation|1|||
13420526|NCT00463567|26862496|FG006|Overall Study|Protocol Deviation|2|||
13420527|NCT00463567|26862490|FG000|Overall Study|Lost to Follow-up|12|||
13420528|NCT00463567|26862491|FG001|Overall Study|Lost to Follow-up|6|||
13420529|NCT00463567|26862492|FG002|Overall Study|Lost to Follow-up|13|||
13420530|NCT00463567|26862493|FG003|Overall Study|Lost to Follow-up|8|||
13420531|NCT00463567|26862494|FG004|Overall Study|Lost to Follow-up|1|||
13420532|NCT00463567|26862495|FG005|Overall Study|Lost to Follow-up|1|||
13420533|NCT00463567|26862496|FG006|Overall Study|Lost to Follow-up|1|||
13420534|NCT00463567|26862490|FG000|Overall Study|Administrative problems|5|||
13420535|NCT00463567|26862491|FG001|Overall Study|Administrative problems|3|||
13420536|NCT00463567|26862492|FG002|Overall Study|Administrative problems|6|||
13420537|NCT00463567|26862493|FG003|Overall Study|Administrative problems|9|||
13420538|NCT00463567|26862494|FG004|Overall Study|Administrative problems|3|||
13420539|NCT00463567|26862495|FG005|Overall Study|Administrative problems|2|||
13420540|NCT00463567|26862496|FG006|Overall Study|Administrative problems|2|||
13420541|NCT00463567|26862490|FG000|Overall Study|Lack of Efficacy|4|||
13420542|NCT00463567|26862491|FG001|Overall Study|Lack of Efficacy|9|||
13420543|NCT00463567|26862492|FG002|Overall Study|Lack of Efficacy|9|||
13420544|NCT00463567|26862493|FG003|Overall Study|Lack of Efficacy|17|||
13420545|NCT00463567|26862494|FG004|Overall Study|Lack of Efficacy|1|||
13420546|NCT00463567|26862495|FG005|Overall Study|Lack of Efficacy|0|||
13420547|NCT00463567|26862496|FG006|Overall Study|Lack of Efficacy|1|||
13420548|NCT00463567|26862490|FG000|Overall Study|Abnormal lab value(s)|1|||
13420549|NCT00463567|26862491|FG001|Overall Study|Abnormal lab value(s)|1|||
13420550|NCT00463567|26862492|FG002|Overall Study|Abnormal lab value(s)|2|||
13420551|NCT00463567|26862493|FG003|Overall Study|Abnormal lab value(s)|1|||
13420552|NCT00463567|26862494|FG004|Overall Study|Abnormal lab value(s)|1|||
13420553|NCT00463567|26862495|FG005|Overall Study|Abnormal lab value(s)|0|||
13420554|NCT00463567|26862496|FG006|Overall Study|Abnormal lab value(s)|0|||
13420555|NCT00463567|26862490|FG000|Overall Study|Abnormal test procedure result(s)|1|||
13420556|NCT00463567|26862491|FG001|Overall Study|Abnormal test procedure result(s)|1|||
13420557|NCT00463567|26862492|FG002|Overall Study|Abnormal test procedure result(s)|6|||
13420558|NCT00463567|26862493|FG003|Overall Study|Abnormal test procedure result(s)|2|||
13420559|NCT00463567|26862494|FG004|Overall Study|Abnormal test procedure result(s)|0|||
13420560|NCT00463567|26862495|FG005|Overall Study|Abnormal test procedure result(s)|2|||
13420561|NCT00463567|26862496|FG006|Overall Study|Abnormal test procedure result(s)|0|||
13420562|NCT00463567|26862490|FG000|Overall Study|Death|1|||
13420563|NCT00463567|26862491|FG001|Overall Study|Death|0|||
13420564|NCT00463567|26862492|FG002|Overall Study|Death|2|||
13420565|NCT00463567|26862493|FG003|Overall Study|Death|0|||
13420566|NCT00463567|26862494|FG004|Overall Study|Death|0|||
13420567|NCT00463567|26862495|FG005|Overall Study|Death|0|||
13420568|NCT00463567|26862496|FG006|Overall Study|Death|0|||
13420569|NCT00463476|26862519|FG000|Overall Study|Withdrawal by Subject|1|||
13420570|NCT00463476|26862520|FG001|Overall Study|Withdrawal by Subject|2|||
13420571|NCT00463476|26862519|FG000|Overall Study|Lost to Follow-up|1|||
13420572|NCT00463476|26862520|FG001|Overall Study|Lost to Follow-up|1|||
13420573|NCT00463385|26862583|FG000|Overall Study|Other|4|||
13420574|NCT00463385|26862584|FG001|Overall Study|Other|3|||
13420575|NCT00463385|26862585|FG002|Overall Study|Other|6|||
13420576|NCT00463385|26862586|FG003|Overall Study|Other|4|||
13420577|NCT00463385|26862583|FG000|Overall Study|Adverse Event|5|||
13420578|NCT00463385|26862584|FG001|Overall Study|Adverse Event|8|||
13420579|NCT00463385|26862585|FG002|Overall Study|Adverse Event|4|||
13420580|NCT00463385|26862586|FG003|Overall Study|Adverse Event|2|||
13420581|NCT00463385|26862583|FG000|Overall Study|Lack of Efficacy|6|||
13420582|NCT00463385|26862584|FG001|Overall Study|Lack of Efficacy|6|||
13420583|NCT00463385|26862585|FG002|Overall Study|Lack of Efficacy|7|||
13420584|NCT00463385|26862586|FG003|Overall Study|Lack of Efficacy|9|||
13420585|NCT00463385|26862583|FG000|Overall Study|Withdrawal by Subject|3|||
13420586|NCT00463385|26862584|FG001|Overall Study|Withdrawal by Subject|3|||
13420587|NCT00463385|26862585|FG002|Overall Study|Withdrawal by Subject|3|||
13420588|NCT00463385|26862586|FG003|Overall Study|Withdrawal by Subject|4|||
13420589|NCT00463385|26862583|FG000|Overall Study|Lost to Follow-up|0|||
13420590|NCT00463385|26862584|FG001|Overall Study|Lost to Follow-up|0|||
13420591|NCT00463385|26862585|FG002|Overall Study|Lost to Follow-up|0|||
13420592|NCT00463385|26862586|FG003|Overall Study|Lost to Follow-up|1|||
13420593|NCT00463385|26862583|FG000|Overall Study|Death|2|||
13420594|NCT00463385|26862584|FG001|Overall Study|Death|1|||
13420595|NCT00463385|26862585|FG002|Overall Study|Death|2|||
13420596|NCT00463385|26862586|FG003|Overall Study|Death|0|||
13420597|NCT00463385|26862583|FG000|Overall Study|Missing|2|||
13420598|NCT00463385|26862584|FG001|Overall Study|Missing|0|||
13420599|NCT00463385|26862585|FG002|Overall Study|Missing|0|||
13420600|NCT00463385|26862586|FG003|Overall Study|Missing|2|||
13420601|NCT00463385|26862583|FG000|Overall Study|1 participant received commercial drug|0|||
13420602|NCT00463385|26862584|FG001|Overall Study|1 participant received commercial drug|1|||
13420603|NCT00463385|26862585|FG002|Overall Study|1 participant received commercial drug|0|||
13420604|NCT00463385|26862586|FG003|Overall Study|1 participant received commercial drug|0|||
13420605|NCT00463346|26862601|FG000|Overall Study|Withdrawal by Subject|3|||
13420606|NCT00463346|26862602|FG001|Overall Study|Withdrawal by Subject|3|||
13420607|NCT00463229|26862627|FG000|Overall Study|Lost to Follow-up|5|||
13420608|NCT00463229|26862628|FG001|Overall Study|Lost to Follow-up|7|||
13420609|NCT00463229|26862627|FG000|Overall Study|Death|4|||
13420610|NCT00463229|26862628|FG001|Overall Study|Death|3|||
13420611|NCT00463151|26862667|FG000|Overall Study|Adverse Event|0|||
13420612|NCT00463151|26862668|FG001|Overall Study|Adverse Event|0|||
13420613|NCT00463151|26862669|FG002|Overall Study|Adverse Event|1|||
13420614|NCT00463151|26862670|FG003|Overall Study|Adverse Event|0|||
13420615|NCT00463151|26862667|FG000|Overall Study|Lack of Efficacy|2|||
13420616|NCT00463151|26862668|FG001|Overall Study|Lack of Efficacy|5|||
13420617|NCT00463151|26862669|FG002|Overall Study|Lack of Efficacy|2|||
13420618|NCT00463151|26862670|FG003|Overall Study|Lack of Efficacy|5|||
13420619|NCT00463151|26862667|FG000|Overall Study|Protocol Violation|0|||
13420620|NCT00463151|26862668|FG001|Overall Study|Protocol Violation|0|||
13420621|NCT00463151|26862669|FG002|Overall Study|Protocol Violation|0|||
13420622|NCT00463151|26862670|FG003|Overall Study|Protocol Violation|1|||
13420623|NCT00463151|26862667|FG000|Overall Study|Withdrawal by Subject|0|||
13420624|NCT00463151|26862668|FG001|Overall Study|Withdrawal by Subject|0|||
13420625|NCT00463151|26862669|FG002|Overall Study|Withdrawal by Subject|0|||
13420626|NCT00463151|26862670|FG003|Overall Study|Withdrawal by Subject|1|||
13420627|NCT00463060|26862690|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5|||
13420628|NCT00463060|26862690|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1|||
13420629|NCT00463047|26862778|FG000|Titration Period 1|Adverse Event|10|||
13420630|NCT00463047|26862779|FG001|Titration Period 1|Adverse Event|8|||
13420631|NCT00463047|26862778|FG000|Titration Period 1|Lack of Efficacy|10|||
13420632|NCT00463047|26862779|FG001|Titration Period 1|Lack of Efficacy|4|||
13420633|NCT00463047|26862778|FG000|Titration Period 1|Lost to Follow-up|2|||
13420634|NCT00463047|26862779|FG001|Titration Period 1|Lost to Follow-up|0|||
13420635|NCT00463047|26862778|FG000|Titration Period 1|Non-compliance with study medication|3|||
13420636|NCT00463047|26862779|FG001|Titration Period 1|Non-compliance with study medication|5|||
13420637|NCT00463047|26862778|FG000|Titration Period 1|Protocol Violation|5|||
13420638|NCT00463047|26862779|FG001|Titration Period 1|Protocol Violation|5|||
13420639|NCT00463047|26862778|FG000|Titration Period 1|Withdrawal by Subject|3|||
13420640|NCT00463047|26862779|FG001|Titration Period 1|Withdrawal by Subject|5|||
13420641|NCT00463047|26862778|FG000|Titration Period 1|Non-compliance procedures|4|||
13420642|NCT00463047|26862779|FG001|Titration Period 1|Non-compliance procedures|10|||
13420643|NCT00463047|26862778|FG000|Titration Period 1|Other|0|||
13420644|NCT00463047|26862779|FG001|Titration Period 1|Other|2|||
13420645|NCT00463047|26862778|FG000|Titration Period 2|Adverse Event|9|||
13420646|NCT00463047|26862779|FG001|Titration Period 2|Adverse Event|9|||
13420647|NCT00463047|26862778|FG000|Titration Period 2|Lack of Efficacy|6|||
13420648|NCT00463047|26862779|FG001|Titration Period 2|Lack of Efficacy|4|||
13420649|NCT00463047|26862778|FG000|Titration Period 2|Withdrawal by Subject|1|||
13420650|NCT00463047|26862779|FG001|Titration Period 2|Withdrawal by Subject|0|||
13420651|NCT00463047|26862778|FG000|Titration Period 2|Protocol Violation|2|||
13420652|NCT00463047|26862779|FG001|Titration Period 2|Protocol Violation|3|||
13420653|NCT00463047|26862778|FG000|Titration Period 2|Lost to Follow-up|1|||
13420654|NCT00463047|26862779|FG001|Titration Period 2|Lost to Follow-up|2|||
13420655|NCT00463047|26862778|FG000|Titration Period 2|Non-compliance study medication|4|||
13420656|NCT00463047|26862779|FG001|Titration Period 2|Non-compliance study medication|2|||
13420657|NCT00463047|26862778|FG000|Titration Period 2|Non-compliance procedures|4|||
13420658|NCT00463047|26862779|FG001|Titration Period 2|Non-compliance procedures|1|||
13420659|NCT00463047|26862778|FG000|Titration Period 2|Other|3|||
13420660|NCT00463047|26862779|FG001|Titration Period 2|Other|2|||
13420661|NCT00463047|26862778|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
13420662|NCT00463047|26862779|FG001|Double-Blind Treatment Period 1|Adverse Event|2|||
13420663|NCT00463047|26862778|FG000|Double-Blind Treatment Period 1|Protocol Violation|1|||
13420664|NCT00463047|26862779|FG001|Double-Blind Treatment Period 1|Protocol Violation|2|||
13420665|NCT00463047|26862778|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1|||
13420666|NCT00463047|26862779|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0|||
13420667|NCT00463047|26862778|FG000|Double-Blind Treatment Period 1|Other|1|||
13420668|NCT00463047|26862779|FG001|Double-Blind Treatment Period 1|Other|0|||
13420669|NCT00463047|26862778|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
13420670|NCT00463047|26862779|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
13420671|NCT00463047|26862778|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
13420672|NCT00463047|26862779|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
13420673|NCT00463047|26862778|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1|||
13420674|NCT00463047|26862779|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0|||
13420675|NCT00462982|26862785|FG000|Overall Study|Adverse Event|1|||
13420676|NCT00462982|26862785|FG000|Overall Study|Patient Not Treated|2|||
13420677|NCT00462904|26862792|FG000|Overall Study|Lost to Follow-up|1|||
13420678|NCT00462865|26862799|FG000|Overall Study|Adverse Event|1|||
13420679|NCT00462826|26862814|FG000|Overall Study|Ineligible - second primary|1|||
13420680|NCT00462826|26862814|FG000|Overall Study|Ineligible - wrong cell type|1|||
13420681|NCT00462826|26862814|FG000|Overall Study|Ineligible - wrong primary|2|||
13420682|NCT00462826|26862814|FG000|Overall Study|Never treated|1|||
13420683|NCT00462761|26862888|FG000|Overall Study|Adverse Event|6|||
13420684|NCT00462761|26862888|FG000|Overall Study|Withdrawal by Subject|9|||
13420685|NCT00462761|26862888|FG000|Overall Study|Physician Decision|5|||
13420686|NCT00462761|26862888|FG000|Overall Study|Disease progression|43|||
13420687|NCT00462761|26862888|FG000|Overall Study|Death|12|||
13420688|NCT00462761|26862888|FG000|Overall Study|Other|1|||
13420689|NCT00462709|26862897|FG000|Overall Study|Transitioned to commercial C1INH-nf|40|||
13420690|NCT00462709|26862897|FG000|Overall Study|Lost to Follow-up|10|||
13420691|NCT00462709|26862897|FG000|Overall Study|Withdrawal by Subject|8|||
13420692|NCT00462709|26862897|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3|||
13420693|NCT00462709|26862897|FG000|Overall Study|Death|2|||
13420694|NCT00462709|26862897|FG000|Overall Study|Logistical reasons|2|||
13420695|NCT00462709|26862897|FG000|Overall Study|Physician Decision|1|||
13420696|NCT00462709|26862897|FG000|Overall Study|Withdrew to start treatment with Cetor|1|||
13420697|NCT00462670|26862912|FG000|Overall Study|Adverse Event|3|||
13420698|NCT00462670|26862913|FG001|Overall Study|Adverse Event|5|||
13420699|NCT00462670|26862912|FG000|Overall Study|Lack of Efficacy|1|||
13420700|NCT00462670|26862913|FG001|Overall Study|Lack of Efficacy|0|||
13420701|NCT00462670|26862912|FG000|Overall Study|Protocol Violation|1|||
13420702|NCT00462670|26862913|FG001|Overall Study|Protocol Violation|0|||
13420703|NCT00462670|26862912|FG000|Overall Study|Resolution of signs and symptoms|0|||
13420704|NCT00462670|26862913|FG001|Overall Study|Resolution of signs and symptoms|2|||
13420705|NCT00462501|26862919|FG000|Overall Study|Not treated|3|||
13420706|NCT00462501|26862919|FG000|Overall Study|Adverse Event|2|||
13420707|NCT00462488|26862932|FG000|Overall Study|Protocol Violation|1|||
13420708|NCT00462488|26862933|FG001|Overall Study|Protocol Violation|0|||
13420709|NCT00462488|26862932|FG000|Overall Study|Lack of Efficacy|19|||
13420710|NCT00462488|26862933|FG001|Overall Study|Lack of Efficacy|17|||
13420711|NCT00462462|26862948|FG000|Overall Study|Physician Decision|0|||
13420712|NCT00462462|26862949|FG001|Overall Study|Physician Decision|1|||
13420713|NCT00462384|26862959|FG000|Overall Study|Adverse Event|2|||
13420714|NCT00462384|26862959|FG000|Overall Study|Death|2|||
13420715|NCT00462384|26862959|FG000|Overall Study|Withdrawal by Subject|1|||
13420716|NCT00462384|26862959|FG000|Overall Study|Other|4|||
13420717|NCT00462345|26862983|FG000|Overall Study|Withdrawal by Subject|2|||
13420718|NCT00462345|26862983|FG000|Overall Study|Did not complete second course|1|||
13420719|NCT00462306|26862998|FG000|Overall Study|insufficient data|0|||
13420720|NCT00462306|26862999|FG001|Overall Study|insufficient data|13|||
13420721|NCT00461981|26863116|FG000|Overall Study|Lost to Follow-up|9|||
13420722|NCT00461981|26863117|FG001|Overall Study|Lost to Follow-up|6|||
13420723|NCT00461981|26863116|FG000|Overall Study|Withdrawal by Subject|2|||
13420724|NCT00461981|26863117|FG001|Overall Study|Withdrawal by Subject|3|||
13420725|NCT00461812|26863124|FG000|Overall Study|study terminated|10|||
13420726|NCT00461786|26863134|FG000|Overall Study|Entry Criteria Not Met|2|||
13420727|NCT00461786|26863134|FG000|Overall Study|Inevaluable (Never Treated)|1|||
13420728|NCT00461708|26863167|FG000|Overall Study|Adverse Event|17|||
13420729|NCT00461708|26863168|FG001|Overall Study|Adverse Event|7|||
13420730|NCT00461708|26863167|FG000|Overall Study|Lack of Efficacy|68|||
13420731|NCT00461708|26863168|FG001|Overall Study|Lack of Efficacy|20|||
13420732|NCT00461708|26863167|FG000|Overall Study|Physician Decision|10|||
13420733|NCT00461708|26863168|FG001|Overall Study|Physician Decision|4|||
13420734|NCT00461708|26863167|FG000|Overall Study|Withdrawal by Subject|8|||
13420735|NCT00461708|26863168|FG001|Overall Study|Withdrawal by Subject|2|||
13420736|NCT00461708|26863167|FG000|Overall Study|Other|4|||
13420737|NCT00461708|26863168|FG001|Overall Study|Other|4|||
13420738|NCT00461708|26863167|FG000|Overall Study|Death|8|||
13420739|NCT00461708|26863168|FG001|Overall Study|Death|1|||
13420740|NCT00461682|26863196|FG000|Overall Study|Protocol Violation|1|||
13420741|NCT00461630|26863217|FG000|Overall Study|Death|798|||
13420742|NCT00461630|26863218|FG001|Overall Study|Death|732|||
13420743|NCT00461630|26863217|FG000|Overall Study|Lost to Follow-up|108|||
13420744|NCT00461630|26863218|FG001|Overall Study|Lost to Follow-up|95|||
13420745|NCT00461552|26863233|FG000|Overall Study|Drug Dispensing error|0|||
13420746|NCT00461552|26863234|FG001|Overall Study|Drug Dispensing error|2|||
13420747|NCT00461500|26863271|FG000|Overall Study|Adverse Event|1|||
13420748|NCT00461500|26863272|FG001|Overall Study|Adverse Event|0|||
13420749|NCT00461500|26863271|FG000|Overall Study|Lack of Efficacy|0|||
13420750|NCT00461500|26863272|FG001|Overall Study|Lack of Efficacy|1|||
13420751|NCT00461500|26863271|FG000|Overall Study|Expired Drug Treatment|1|||
13420752|NCT00461500|26863272|FG001|Overall Study|Expired Drug Treatment|1|||
13420753|NCT00461500|26863271|FG000|Overall Study|Study Stopped|1|||
13420754|NCT00461500|26863272|FG001|Overall Study|Study Stopped|2|||
13420755|NCT00461500|26863271|FG000|Overall Study|Drug Treatment Misuse|1|||
13420756|NCT00461500|26863272|FG001|Overall Study|Drug Treatment Misuse|0|||
13420757|NCT00461500|26863271|FG000|Overall Study|No Longer Willing to Take Part in Study|1|||
13420758|NCT00461500|26863272|FG001|Overall Study|No Longer Willing to Take Part in Study|0|||
13420759|NCT00461500|26863271|FG000|Overall Study|Lost to Follow-up|2|||
13420760|NCT00461500|26863272|FG001|Overall Study|Lost to Follow-up|2|||
13420761|NCT00461305|26863339|FG000|Treatment|Adverse Event|26|||
13420762|NCT00461305|26863340|FG001|Treatment|Adverse Event|3|||
13420763|NCT00461305|26863339|FG000|Treatment|Lost to Follow-up|4|||
13420764|NCT00461305|26863340|FG001|Treatment|Lost to Follow-up|2|||
13420765|NCT00461305|26863339|FG000|Treatment|Protocol Violation|13|||
13420766|NCT00461305|26863340|FG001|Treatment|Protocol Violation|2|||
13420767|NCT00461305|26863339|FG000|Treatment|Withdrawal by Subject|48|||
13420768|NCT00461305|26863340|FG001|Treatment|Withdrawal by Subject|2|||
13420769|NCT00461305|26863339|FG000|Treatment|Never dispensed|5|||
13420770|NCT00461305|26863340|FG001|Treatment|Never dispensed|0|||
13420771|NCT00461305|26863339|FG000|Treatment|Study drug not taken|1|||
13420772|NCT00461305|26863340|FG001|Treatment|Study drug not taken|0|||
13420773|NCT00461305|26863339|FG000|Treatment|Partially missing diary|2|||
13420774|NCT00461305|26863340|FG001|Treatment|Partially missing diary|0|||
13420775|NCT00461305|26863339|FG000|Treatment|Other (missing drug etc)|2|||
13420776|NCT00461305|26863340|FG001|Treatment|Other (missing drug etc)|0|||
13420777|NCT00461305|26863339|FG000|Continued Treatment|Adverse Event|26|||
13420778|NCT00461305|26863340|FG001|Continued Treatment|Adverse Event|0|||
13420779|NCT00461305|26863339|FG000|Continued Treatment|Lost to Follow-up|4|||
13420780|NCT00461305|26863340|FG001|Continued Treatment|Lost to Follow-up|0|||
13420781|NCT00461305|26863339|FG000|Continued Treatment|Protocol Violation|13|||
13420782|NCT00461305|26863340|FG001|Continued Treatment|Protocol Violation|0|||
13420783|NCT00461305|26863339|FG000|Continued Treatment|Withdrawal by Subject|48|||
13420784|NCT00461305|26863340|FG001|Continued Treatment|Withdrawal by Subject|0|||
13420785|NCT00461305|26863339|FG000|Continued Treatment|Partially missing diary|2|||
13420786|NCT00461305|26863340|FG001|Continued Treatment|Partially missing diary|0|||
13420787|NCT00461305|26863339|FG000|Continued Treatment|Other (missing drug etc)|2|||
13420788|NCT00461305|26863340|FG001|Continued Treatment|Other (missing drug etc)|0|||
13420789|NCT00461253|26863353|FG000|Overall Study|Death|985|||
13420790|NCT00461253|26863354|FG001|Overall Study|Death|0|||
13420791|NCT00461253|26863353|FG000|Overall Study|Protocol Violation|613|||
13420792|NCT00461253|26863354|FG001|Overall Study|Protocol Violation|236|||
13420793|NCT00461253|26863353|FG000|Overall Study|no response|2609|||
13420794|NCT00461253|26863354|FG001|Overall Study|no response|11789|||
13420795|NCT00461253|26863353|FG000|Overall Study|administrative|773|||
13420796|NCT00461253|26863354|FG001|Overall Study|administrative|7773|||
13420797|NCT00461175|26863369|FG000|Overall Study|Protocol Violation|522|||
13420798|NCT00461175|26863370|FG001|Overall Study|Protocol Violation|365|||
13420799|NCT00461123|26863391|FG000|Overall Study|Adverse Event|1|||
13420800|NCT00461123|26863392|FG001|Overall Study|Adverse Event|0|||
13420801|NCT00461123|26863391|FG000|Overall Study|Lost to Follow-up|1|||
13420802|NCT00461123|26863392|FG001|Overall Study|Lost to Follow-up|1|||
13420803|NCT00461123|26863391|FG000|Overall Study|Protocol Violation|3|||
13420804|NCT00461123|26863392|FG001|Overall Study|Protocol Violation|2|||
13420805|NCT00461123|26863391|FG000|Overall Study|Withdrawal by Subject|1|||
13420806|NCT00461123|26863392|FG001|Overall Study|Withdrawal by Subject|3|||
13420807|NCT00460811|26863450|FG000|Overall Study|Adverse Event|4|||
13420808|NCT00460811|26863451|FG001|Overall Study|Adverse Event|6|||
13420809|NCT00460811|26863452|FG002|Overall Study|Adverse Event|3|||
13420810|NCT00460811|26863453|FG003|Overall Study|Adverse Event|10|||
13420811|NCT00460811|26863454|FG004|Overall Study|Adverse Event|2|||
13420812|NCT00460811|26863450|FG000|Overall Study|Noncompliance|1|||
13420813|NCT00460811|26863451|FG001|Overall Study|Noncompliance|0|||
13420814|NCT00460811|26863452|FG002|Overall Study|Noncompliance|0|||
13420815|NCT00460811|26863453|FG003|Overall Study|Noncompliance|2|||
13420816|NCT00460811|26863454|FG004|Overall Study|Noncompliance|1|||
13420817|NCT00460811|26863450|FG000|Overall Study|Withdrawal by Subject|7|||
13420818|NCT00460811|26863451|FG001|Overall Study|Withdrawal by Subject|7|||
13420819|NCT00460811|26863452|FG002|Overall Study|Withdrawal by Subject|6|||
13420820|NCT00460811|26863453|FG003|Overall Study|Withdrawal by Subject|3|||
13420821|NCT00460811|26863454|FG004|Overall Study|Withdrawal by Subject|11|||
13420822|NCT00460811|26863450|FG000|Overall Study|Physician Decision|1|||
13420823|NCT00460811|26863451|FG001|Overall Study|Physician Decision|0|||
13420824|NCT00460811|26863452|FG002|Overall Study|Physician Decision|0|||
13420825|NCT00460811|26863453|FG003|Overall Study|Physician Decision|0|||
13420826|NCT00460811|26863454|FG004|Overall Study|Physician Decision|0|||
13420827|NCT00460811|26863450|FG000|Overall Study|Lost to Follow-up|3|||
13420828|NCT00460811|26863451|FG001|Overall Study|Lost to Follow-up|2|||
13420829|NCT00460811|26863452|FG002|Overall Study|Lost to Follow-up|5|||
13420830|NCT00460811|26863453|FG003|Overall Study|Lost to Follow-up|3|||
13420831|NCT00460811|26863454|FG004|Overall Study|Lost to Follow-up|6|||
13420832|NCT00460798|26863464|FG000|Overall Study|Death|59|||
13420833|NCT00460798|26863464|FG000|Overall Study|Adverse Event|27|||
13420834|NCT00460798|26863464|FG000|Overall Study|Lost to Follow-up|19|||
13420835|NCT00460798|26863464|FG000|Overall Study|Progressive Disease|99|||
13420836|NCT00460798|26863464|FG000|Overall Study|Other|27|||
13420837|NCT00460798|26863464|FG000|Overall Study|Ongoing at Date of Cut-Off|82|||
13420838|NCT00460798|26863464|FG000|Overall Study|Missing/Incomplete Dosing Information|27|||
13420839|NCT00460746|26863479|FG000|Overall Study|Adverse Event|1|||
13420840|NCT00460746|26863479|FG000|Overall Study|Lost to Follow-up|1|||
13420841|NCT00460655|26863520|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
13420842|NCT00460655|26863521|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
13420843|NCT00460655|26863522|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
13420844|NCT00460655|26863523|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
13420845|NCT00460655|26863520|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3|||
13420846|NCT00460655|26863521|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
13420847|NCT00460655|26863522|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
13420848|NCT00460655|26863523|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
13420849|NCT00460655|26863520|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
13420850|NCT00460655|26863521|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1|||
13420851|NCT00460655|26863522|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
13420852|NCT00460655|26863523|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
13420853|NCT00460655|26863520|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
13420854|NCT00460655|26863521|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
13420855|NCT00460655|26863522|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1|||
13420856|NCT00460655|26863523|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6|||
13420857|NCT00460655|26863520|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
13420858|NCT00460655|26863521|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
13420859|NCT00460655|26863522|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6|||
13420860|NCT00460655|26863523|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2|||
13420861|NCT00460655|26863520|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
13420862|NCT00460655|26863521|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
13420863|NCT00460655|26863522|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
13420864|NCT00460655|26863523|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1|||
13420865|NCT00460603|26863652|FG000|Phase 1|Death|1|||
13420866|NCT00460603|26863653|FG001|Phase 1|Death|0|||
13420867|NCT00460603|26863654|FG002|Phase 1|Death|0|||
13420868|NCT00460603|26863655|FG003|Phase 1|Death|2|||
13420869|NCT00460603|26863656|FG004|Phase 1|Death|0|||
13420870|NCT00460603|26863657|FG005|Phase 1|Death|0|||
13420871|NCT00460603|26863658|FG006|Phase 1|Death|0|||
13420872|NCT00460603|26863659|FG007|Phase 1|Death|0|||
13420873|NCT00460603|26863660|FG008|Phase 1|Death|1|||
13420874|NCT00460603|26863661|FG009|Phase 1|Death|0|||
13420875|NCT00460603|26863662|FG010|Phase 1|Death|0|||
13420876|NCT00460603|26863663|FG011|Phase 1|Death|0|||
13420877|NCT00460603|26863652|FG000|Phase 1|Adverse Event|3|||
13420878|NCT00460603|26863653|FG001|Phase 1|Adverse Event|1|||
13420879|NCT00460603|26863654|FG002|Phase 1|Adverse Event|1|||
13420880|NCT00460603|26863655|FG003|Phase 1|Adverse Event|2|||
13420881|NCT00460603|26863656|FG004|Phase 1|Adverse Event|0|||
13420882|NCT00460603|26863657|FG005|Phase 1|Adverse Event|0|||
13420883|NCT00460603|26863658|FG006|Phase 1|Adverse Event|3|||
13420884|NCT00460603|26863659|FG007|Phase 1|Adverse Event|0|||
13420885|NCT00460603|26863660|FG008|Phase 1|Adverse Event|4|||
13420886|NCT00460603|26863661|FG009|Phase 1|Adverse Event|0|||
13420887|NCT00460603|26863662|FG010|Phase 1|Adverse Event|0|||
13420888|NCT00460603|26863663|FG011|Phase 1|Adverse Event|0|||
13420889|NCT00460603|26863652|FG000|Phase 1|Lack of Efficacy|1|||
13420890|NCT00460603|26863653|FG001|Phase 1|Lack of Efficacy|0|||
13420891|NCT00460603|26863654|FG002|Phase 1|Lack of Efficacy|1|||
13420892|NCT00460603|26863655|FG003|Phase 1|Lack of Efficacy|2|||
13420893|NCT00460603|26863656|FG004|Phase 1|Lack of Efficacy|2|||
13420894|NCT00460603|26863657|FG005|Phase 1|Lack of Efficacy|2|||
13420895|NCT00460603|26863658|FG006|Phase 1|Lack of Efficacy|2|||
13420896|NCT00460603|26863659|FG007|Phase 1|Lack of Efficacy|2|||
13420897|NCT00460603|26863660|FG008|Phase 1|Lack of Efficacy|11|||
13420898|NCT00460603|26863661|FG009|Phase 1|Lack of Efficacy|0|||
13420899|NCT00460603|26863662|FG010|Phase 1|Lack of Efficacy|0|||
13420900|NCT00460603|26863663|FG011|Phase 1|Lack of Efficacy|0|||
13420901|NCT00460603|26863652|FG000|Phase 1|Withdrawal by Subject|1|||
13420902|NCT00460603|26863653|FG001|Phase 1|Withdrawal by Subject|2|||
13420903|NCT00460603|26863654|FG002|Phase 1|Withdrawal by Subject|1|||
13420904|NCT00460603|26863655|FG003|Phase 1|Withdrawal by Subject|1|||
13420905|NCT00460603|26863656|FG004|Phase 1|Withdrawal by Subject|3|||
13420906|NCT00460603|26863657|FG005|Phase 1|Withdrawal by Subject|0|||
13420907|NCT00460603|26863658|FG006|Phase 1|Withdrawal by Subject|1|||
13420908|NCT00460603|26863659|FG007|Phase 1|Withdrawal by Subject|0|||
13420909|NCT00460603|26863660|FG008|Phase 1|Withdrawal by Subject|2|||
13420910|NCT00460603|26863661|FG009|Phase 1|Withdrawal by Subject|0|||
13420911|NCT00460603|26863662|FG010|Phase 1|Withdrawal by Subject|0|||
13420912|NCT00460603|26863663|FG011|Phase 1|Withdrawal by Subject|0|||
13420913|NCT00460603|26863652|FG000|Phase 1|Other|0|||
13420914|NCT00460603|26863653|FG001|Phase 1|Other|3|||
13420915|NCT00460603|26863654|FG002|Phase 1|Other|1|||
13420916|NCT00460603|26863655|FG003|Phase 1|Other|1|||
13420917|NCT00460603|26863656|FG004|Phase 1|Other|1|||
13420918|NCT00460603|26863657|FG005|Phase 1|Other|2|||
13420919|NCT00460603|26863658|FG006|Phase 1|Other|0|||
13420920|NCT00460603|26863659|FG007|Phase 1|Other|1|||
13420921|NCT00460603|26863660|FG008|Phase 1|Other|0|||
13420922|NCT00460603|26863661|FG009|Phase 1|Other|0|||
13420923|NCT00460603|26863662|FG010|Phase 1|Other|0|||
13420924|NCT00460603|26863663|FG011|Phase 1|Other|0|||
13420925|NCT00460603|26863652|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
13420926|NCT00460603|26863653|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
13420927|NCT00460603|26863654|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
13420928|NCT00460603|26863655|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
13420929|NCT00460603|26863656|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
13420930|NCT00460603|26863657|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
13420931|NCT00460603|26863658|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
13420932|NCT00460603|26863659|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
13420933|NCT00460603|26863660|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
13420934|NCT00460603|26863661|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1|||
13420935|NCT00460603|26863662|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
13420936|NCT00460603|26863663|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
13420937|NCT00460603|26863652|FG000|Phase 2|Adverse Event|0|||
13420938|NCT00460603|26863653|FG001|Phase 2|Adverse Event|0|||
13420939|NCT00460603|26863654|FG002|Phase 2|Adverse Event|0|||
13420940|NCT00460603|26863655|FG003|Phase 2|Adverse Event|0|||
13420941|NCT00460603|26863656|FG004|Phase 2|Adverse Event|0|||
13420942|NCT00460603|26863657|FG005|Phase 2|Adverse Event|0|||
13420943|NCT00460603|26863658|FG006|Phase 2|Adverse Event|0|||
13420944|NCT00460603|26863659|FG007|Phase 2|Adverse Event|0|||
13420945|NCT00460603|26863660|FG008|Phase 2|Adverse Event|0|||
13420946|NCT00460603|26863661|FG009|Phase 2|Adverse Event|12|||
13420947|NCT00460603|26863662|FG010|Phase 2|Adverse Event|9|||
13420948|NCT00460603|26863663|FG011|Phase 2|Adverse Event|10|||
13420949|NCT00460603|26863652|FG000|Phase 2|Death|0|||
13420950|NCT00460603|26863653|FG001|Phase 2|Death|0|||
13420951|NCT00460603|26863654|FG002|Phase 2|Death|0|||
13420952|NCT00460603|26863655|FG003|Phase 2|Death|0|||
13420953|NCT00460603|26863656|FG004|Phase 2|Death|0|||
13420954|NCT00460603|26863657|FG005|Phase 2|Death|0|||
13420955|NCT00460603|26863658|FG006|Phase 2|Death|0|||
13420956|NCT00460603|26863659|FG007|Phase 2|Death|0|||
13420957|NCT00460603|26863660|FG008|Phase 2|Death|0|||
13420958|NCT00460603|26863661|FG009|Phase 2|Death|4|||
13420959|NCT00460603|26863662|FG010|Phase 2|Death|2|||
13420960|NCT00460603|26863663|FG011|Phase 2|Death|2|||
13420961|NCT00460603|26863652|FG000|Phase 2|Protocol Violation|0|||
13420962|NCT00460603|26863653|FG001|Phase 2|Protocol Violation|0|||
13420963|NCT00460603|26863654|FG002|Phase 2|Protocol Violation|0|||
13420964|NCT00460603|26863655|FG003|Phase 2|Protocol Violation|0|||
13420965|NCT00460603|26863656|FG004|Phase 2|Protocol Violation|0|||
13420966|NCT00460603|26863657|FG005|Phase 2|Protocol Violation|0|||
13420967|NCT00460603|26863658|FG006|Phase 2|Protocol Violation|0|||
13420968|NCT00460603|26863659|FG007|Phase 2|Protocol Violation|0|||
13420969|NCT00460603|26863660|FG008|Phase 2|Protocol Violation|0|||
13420970|NCT00460603|26863661|FG009|Phase 2|Protocol Violation|1|||
13420971|NCT00460603|26863662|FG010|Phase 2|Protocol Violation|1|||
13420972|NCT00460603|26863663|FG011|Phase 2|Protocol Violation|0|||
13420973|NCT00460603|26863652|FG000|Phase 2|Lost to Follow-up|0|||
13420974|NCT00460603|26863653|FG001|Phase 2|Lost to Follow-up|0|||
13420975|NCT00460603|26863654|FG002|Phase 2|Lost to Follow-up|0|||
13420976|NCT00460603|26863655|FG003|Phase 2|Lost to Follow-up|0|||
13420977|NCT00460603|26863656|FG004|Phase 2|Lost to Follow-up|0|||
13420978|NCT00460603|26863657|FG005|Phase 2|Lost to Follow-up|0|||
13420979|NCT00460603|26863658|FG006|Phase 2|Lost to Follow-up|0|||
13420980|NCT00460603|26863659|FG007|Phase 2|Lost to Follow-up|0|||
13420981|NCT00460603|26863660|FG008|Phase 2|Lost to Follow-up|0|||
13420982|NCT00460603|26863661|FG009|Phase 2|Lost to Follow-up|1|||
13420983|NCT00460603|26863662|FG010|Phase 2|Lost to Follow-up|0|||
13420984|NCT00460603|26863663|FG011|Phase 2|Lost to Follow-up|0|||
13420985|NCT00460603|26863652|FG000|Phase 2|Other|0|||
13420986|NCT00460603|26863653|FG001|Phase 2|Other|0|||
13420987|NCT00460603|26863654|FG002|Phase 2|Other|0|||
13420988|NCT00460603|26863655|FG003|Phase 2|Other|0|||
13420989|NCT00460603|26863656|FG004|Phase 2|Other|0|||
13420990|NCT00460603|26863657|FG005|Phase 2|Other|0|||
13420991|NCT00460603|26863658|FG006|Phase 2|Other|0|||
13420992|NCT00460603|26863659|FG007|Phase 2|Other|0|||
13420993|NCT00460603|26863660|FG008|Phase 2|Other|0|||
13420994|NCT00460603|26863661|FG009|Phase 2|Other|6|||
13420995|NCT00460603|26863662|FG010|Phase 2|Other|16|||
13420996|NCT00460603|26863663|FG011|Phase 2|Other|7|||
13420997|NCT00460603|26863652|FG000|Phase 2|Objective Progression or Relapse|0|||
13420998|NCT00460603|26863653|FG001|Phase 2|Objective Progression or Relapse|0|||
13420999|NCT00460603|26863654|FG002|Phase 2|Objective Progression or Relapse|0|||
13421000|NCT00460603|26863655|FG003|Phase 2|Objective Progression or Relapse|0|||
13421001|NCT00460603|26863656|FG004|Phase 2|Objective Progression or Relapse|0|||
13421002|NCT00460603|26863657|FG005|Phase 2|Objective Progression or Relapse|0|||
13421003|NCT00460603|26863658|FG006|Phase 2|Objective Progression or Relapse|0|||
13421004|NCT00460603|26863659|FG007|Phase 2|Objective Progression or Relapse|0|||
13421005|NCT00460603|26863660|FG008|Phase 2|Objective Progression or Relapse|0|||
13421006|NCT00460603|26863661|FG009|Phase 2|Objective Progression or Relapse|9|||
13421007|NCT00460603|26863662|FG010|Phase 2|Objective Progression or Relapse|10|||
13421008|NCT00460603|26863663|FG011|Phase 2|Objective Progression or Relapse|17|||
13421009|NCT00460603|26863652|FG000|Phase 2|Global Deterioration of Health Status|0|||
13421010|NCT00460603|26863653|FG001|Phase 2|Global Deterioration of Health Status|0|||
13421011|NCT00460603|26863654|FG002|Phase 2|Global Deterioration of Health Status|0|||
13421012|NCT00460603|26863655|FG003|Phase 2|Global Deterioration of Health Status|0|||
13421013|NCT00460603|26863656|FG004|Phase 2|Global Deterioration of Health Status|0|||
13421014|NCT00460603|26863657|FG005|Phase 2|Global Deterioration of Health Status|0|||
13421015|NCT00460603|26863658|FG006|Phase 2|Global Deterioration of Health Status|0|||
13421016|NCT00460603|26863659|FG007|Phase 2|Global Deterioration of Health Status|0|||
13421017|NCT00460603|26863660|FG008|Phase 2|Global Deterioration of Health Status|0|||
13421018|NCT00460603|26863661|FG009|Phase 2|Global Deterioration of Health Status|0|||
13421019|NCT00460603|26863662|FG010|Phase 2|Global Deterioration of Health Status|1|||
13421020|NCT00460603|26863663|FG011|Phase 2|Global Deterioration of Health Status|0|||
13421021|NCT00460603|26863652|FG000|Phase 2|Withdrawal by Subject|0|||
13421022|NCT00460603|26863653|FG001|Phase 2|Withdrawal by Subject|0|||
13421023|NCT00460603|26863654|FG002|Phase 2|Withdrawal by Subject|0|||
13421024|NCT00460603|26863655|FG003|Phase 2|Withdrawal by Subject|0|||
13421025|NCT00460603|26863656|FG004|Phase 2|Withdrawal by Subject|0|||
13421026|NCT00460603|26863657|FG005|Phase 2|Withdrawal by Subject|0|||
13421027|NCT00460603|26863658|FG006|Phase 2|Withdrawal by Subject|0|||
13421028|NCT00460603|26863659|FG007|Phase 2|Withdrawal by Subject|0|||
13421029|NCT00460603|26863660|FG008|Phase 2|Withdrawal by Subject|0|||
13421030|NCT00460603|26863661|FG009|Phase 2|Withdrawal by Subject|5|||
13421031|NCT00460603|26863662|FG010|Phase 2|Withdrawal by Subject|4|||
13421032|NCT00460603|26863663|FG011|Phase 2|Withdrawal by Subject|5|||
13421033|NCT00460603|26863652|FG000|Phase 2|Randomized, but not treated|0|||
13421034|NCT00460603|26863653|FG001|Phase 2|Randomized, but not treated|0|||
13421035|NCT00460603|26863654|FG002|Phase 2|Randomized, but not treated|0|||
13421036|NCT00460603|26863655|FG003|Phase 2|Randomized, but not treated|0|||
13421037|NCT00460603|26863656|FG004|Phase 2|Randomized, but not treated|0|||
13421038|NCT00460603|26863657|FG005|Phase 2|Randomized, but not treated|0|||
13421039|NCT00460603|26863658|FG006|Phase 2|Randomized, but not treated|0|||
13421040|NCT00460603|26863659|FG007|Phase 2|Randomized, but not treated|0|||
13421041|NCT00460603|26863660|FG008|Phase 2|Randomized, but not treated|0|||
13421042|NCT00460603|26863661|FG009|Phase 2|Randomized, but not treated|3|||
13421043|NCT00460603|26863662|FG010|Phase 2|Randomized, but not treated|0|||
13421044|NCT00460603|26863663|FG011|Phase 2|Randomized, but not treated|0|||
13421045|NCT00460577|26863684|FG000|Overall Study|Protocol Violation|2|||
13421046|NCT00460577|26863685|FG001|Overall Study|Protocol Violation|6|||
13421047|NCT00460564|26863796|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
13421048|NCT00460564|26863797|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1|||
13421049|NCT00460564|26863798|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
13421050|NCT00460564|26863799|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
13421051|NCT00460564|26863800|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
13421052|NCT00460564|26863801|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
13421053|NCT00460564|26863802|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
13421054|NCT00460564|26863803|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
13421055|NCT00460564|26863796|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1|||
13421056|NCT00460564|26863797|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
13421057|NCT00460564|26863798|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
13421058|NCT00460564|26863799|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
13421059|NCT00460564|26863800|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
13421060|NCT00460564|26863801|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
13421061|NCT00460564|26863802|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
13421062|NCT00460564|26863803|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
13421063|NCT00460564|26863796|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
13421064|NCT00460564|26863797|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
13421065|NCT00460564|26863798|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0|||
13421066|NCT00460564|26863799|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0|||
13421067|NCT00460564|26863800|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3|||
13421068|NCT00460564|26863801|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5|||
13421069|NCT00460564|26863802|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2|||
13421070|NCT00460564|26863803|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0|||
13421071|NCT00460564|26863796|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
13421072|NCT00460564|26863797|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
13421073|NCT00460564|26863798|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
13421074|NCT00460564|26863799|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
13421075|NCT00460564|26863800|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5|||
13421076|NCT00460564|26863801|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1|||
13421077|NCT00460564|26863802|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
13421078|NCT00460564|26863803|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
13421079|NCT00460564|26863796|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
13421080|NCT00460564|26863797|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
13421081|NCT00460564|26863798|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
13421082|NCT00460564|26863799|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
13421083|NCT00460564|26863800|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1|||
13421084|NCT00460564|26863801|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
13421085|NCT00460564|26863802|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
13421086|NCT00460564|26863803|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
13421087|NCT00460434|26863836|FG000|Overall Study|Lost to Follow-up|3|||
13421088|NCT00460434|26863837|FG001|Overall Study|Lost to Follow-up|7|||
13421089|NCT00460408|26863885|FG000|Overall Study|Adverse Event|1|||
13421090|NCT00460408|26863886|FG001|Overall Study|Adverse Event|0|||
13421091|NCT00460408|26863887|FG002|Overall Study|Adverse Event|0|||
13421092|NCT00460408|26863888|FG003|Overall Study|Adverse Event|0|||
13421093|NCT00460408|26863885|FG000|Overall Study|Death|7|||
13421094|NCT00460408|26863886|FG001|Overall Study|Death|0|||
13421095|NCT00460408|26863887|FG002|Overall Study|Death|0|||
13421096|NCT00460408|26863888|FG003|Overall Study|Death|0|||
13421097|NCT00460408|26863885|FG000|Overall Study|Lost to Follow-up|11|||
13421098|NCT00460408|26863886|FG001|Overall Study|Lost to Follow-up|0|||
13421099|NCT00460408|26863887|FG002|Overall Study|Lost to Follow-up|1|||
13421100|NCT00460408|26863888|FG003|Overall Study|Lost to Follow-up|0|||
13421101|NCT00460408|26863885|FG000|Overall Study|Withdrawal by Subject|31|||
13421102|NCT00460408|26863886|FG001|Overall Study|Withdrawal by Subject|0|||
13421103|NCT00460408|26863887|FG002|Overall Study|Withdrawal by Subject|0|||
13421104|NCT00460408|26863888|FG003|Overall Study|Withdrawal by Subject|0|||
13421105|NCT00460408|26863885|FG000|Overall Study|Insufficient clinical response|5|||
13421106|NCT00460408|26863886|FG001|Overall Study|Insufficient clinical response|1|||
13421107|NCT00460408|26863887|FG002|Overall Study|Insufficient clinical response|5|||
13421108|NCT00460408|26863888|FG003|Overall Study|Insufficient clinical response|0|||
13421109|NCT00460408|26863885|FG000|Overall Study|Other|12|||
13421110|NCT00460408|26863886|FG001|Overall Study|Other|2|||
13421111|NCT00460408|26863887|FG002|Overall Study|Other|0|||
13421112|NCT00460408|26863888|FG003|Overall Study|Other|0|||
13421113|NCT00460265|26863911|FG000|Overall Study|Lost to Follow-up|14|||
13421114|NCT00460265|26863912|FG001|Overall Study|Lost to Follow-up|15|||
13421115|NCT00460265|26863911|FG000|Overall Study|Physician Decision|1|||
13421116|NCT00460265|26863912|FG001|Overall Study|Physician Decision|2|||
13421117|NCT00460265|26863911|FG000|Overall Study|Withdrawal by Subject|10|||
13421118|NCT00460265|26863912|FG001|Overall Study|Withdrawal by Subject|25|||
13421119|NCT00460265|26863911|FG000|Overall Study|Ongoing|60|||
13421120|NCT00460265|26863912|FG001|Overall Study|Ongoing|47|||
13421121|NCT00460239|26863991|FG000|Overall Study|Physician Decision|0|||
13421122|NCT00460239|26863992|FG001|Overall Study|Physician Decision|1|||
13421123|NCT00460239|26863993|FG002|Overall Study|Physician Decision|0|||
13421124|NCT00460239|26863994|FG003|Overall Study|Physician Decision|0|||
13421125|NCT00460239|26863995|FG004|Overall Study|Physician Decision|0|||
13421126|NCT00460239|26863996|FG005|Overall Study|Physician Decision|2|||
13421127|NCT00460239|26863997|FG006|Overall Study|Physician Decision|0|||
13421128|NCT00460239|26863998|FG007|Overall Study|Physician Decision|0|||
13421129|NCT00460239|26863999|FG008|Overall Study|Physician Decision|0|||
13421130|NCT00460239|26863991|FG000|Overall Study|Withdrawal by Subject|0|||
13421131|NCT00460239|26863992|FG001|Overall Study|Withdrawal by Subject|0|||
13421132|NCT00460239|26863993|FG002|Overall Study|Withdrawal by Subject|0|||
13421133|NCT00460239|26863994|FG003|Overall Study|Withdrawal by Subject|0|||
13421134|NCT00460239|26863995|FG004|Overall Study|Withdrawal by Subject|0|||
13421135|NCT00460239|26863996|FG005|Overall Study|Withdrawal by Subject|1|||
13421136|NCT00460239|26863997|FG006|Overall Study|Withdrawal by Subject|0|||
13421137|NCT00460239|26863998|FG007|Overall Study|Withdrawal by Subject|0|||
13421138|NCT00460239|26863999|FG008|Overall Study|Withdrawal by Subject|0|||
13421139|NCT00460109|26864009|FG000|Overall Study|Death|1|||
13421140|NCT00460031|26864019|FG000|Overall Study|Adverse Event|5|||
13421141|NCT00460031|26864019|FG000|Overall Study|Withdrawal by Subject|5|||
13421142|NCT00460031|26864019|FG000|Overall Study|Death|1|||
13421143|NCT00459979|26864031|FG000|Overall Study|Withdrawal by Subject|1|||
13421144|NCT00459979|26864031|FG000|Overall Study|Protocol Violation|1|||
13421145|NCT00459953|26864044|FG000|Overall Study|not analyzed-household member in study|1|||
13421146|NCT00459953|26864045|FG001|Overall Study|not analyzed-household member in study|1|||
13421147|NCT00459875|26864051|FG000|Overall Study|Ineligible participant|1|||
13421148|NCT00459875|26864051|FG000|Overall Study|Adverse Event|2|||
13421149|NCT00459706|26864198|FG000|Overall Study|Adverse Event|19|||
13421150|NCT00459706|26864199|FG001|Overall Study|Adverse Event|13|||
13421151|NCT00459706|26864198|FG000|Overall Study|Withdrawal by Subject|1|||
13421152|NCT00459706|26864199|FG001|Overall Study|Withdrawal by Subject|6|||
13421153|NCT00459706|26864198|FG000|Overall Study|Physician Decision|2|||
13421154|NCT00459706|26864199|FG001|Overall Study|Physician Decision|0|||
13421155|NCT00459706|26864198|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
13421156|NCT00459706|26864199|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
13421157|NCT00459706|26864198|FG000|Overall Study|Protocol Violation|2|||
13421158|NCT00459706|26864199|FG001|Overall Study|Protocol Violation|1|||
13421159|NCT00459706|26864198|FG000|Overall Study|Failed to Return|1|||
13421160|NCT00459706|26864199|FG001|Overall Study|Failed to Return|0|||
13421161|NCT00459706|26864198|FG000|Overall Study|Other|0|||
13421162|NCT00459706|26864199|FG001|Overall Study|Other|1|||
13421163|NCT00459667|26864229|FG000|Overall Study|Adverse Event|9|||
13421164|NCT00459667|26864230|FG001|Overall Study|Adverse Event|12|||
13421165|NCT00459667|26864231|FG002|Overall Study|Adverse Event|8|||
13421166|NCT00459667|26864229|FG000|Overall Study|Lost to Follow-up|5|||
13421167|NCT00459667|26864230|FG001|Overall Study|Lost to Follow-up|9|||
13421168|NCT00459667|26864231|FG002|Overall Study|Lost to Follow-up|3|||
13421169|NCT00459667|26864229|FG000|Overall Study|Pregnancy|1|||
13421170|NCT00459667|26864230|FG001|Overall Study|Pregnancy|1|||
13421171|NCT00459667|26864231|FG002|Overall Study|Pregnancy|1|||
13421172|NCT00459667|26864229|FG000|Overall Study|Protocol Violation|1|||
13421173|NCT00459667|26864230|FG001|Overall Study|Protocol Violation|0|||
13421174|NCT00459667|26864231|FG002|Overall Study|Protocol Violation|0|||
13421175|NCT00459667|26864229|FG000|Overall Study|Withdrawal by Subject|3|||
13421176|NCT00459667|26864230|FG001|Overall Study|Withdrawal by Subject|5|||
13421177|NCT00459667|26864231|FG002|Overall Study|Withdrawal by Subject|5|||
13421178|NCT00459667|26864229|FG000|Overall Study|Other disease modifying treatment|1|||
13421179|NCT00459667|26864230|FG001|Overall Study|Other disease modifying treatment|2|||
13421180|NCT00459667|26864231|FG002|Overall Study|Other disease modifying treatment|1|||
13421181|NCT00459667|26864229|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12|||
13421182|NCT00459667|26864230|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15|||
13421183|NCT00459667|26864231|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1|||
13421184|NCT00459667|26864229|FG000|Overall Study|No treatment administered|6|||
13421185|NCT00459667|26864230|FG001|Overall Study|No treatment administered|3|||
13421186|NCT00459667|26864231|FG002|Overall Study|No treatment administered|1|||
13421187|NCT00459537|26864252|FG000|Overall Study|Adverse Event|1|||
13421188|NCT00459537|26864253|FG001|Overall Study|Adverse Event|6|||
13421189|NCT00459537|26864252|FG000|Overall Study|Lack of Efficacy|10|||
13421190|NCT00459537|26864253|FG001|Overall Study|Lack of Efficacy|11|||
13421191|NCT00459537|26864252|FG000|Overall Study|Withdrawal by Subject|20|||
13421192|NCT00459537|26864253|FG001|Overall Study|Withdrawal by Subject|26|||
13421193|NCT00459537|26864252|FG000|Overall Study|Lost to Follow-up|27|||
13421194|NCT00459537|26864253|FG001|Overall Study|Lost to Follow-up|30|||
13421195|NCT00459537|26864252|FG000|Overall Study|Administrative problems|3|||
13421196|NCT00459537|26864253|FG001|Overall Study|Administrative problems|0|||
13421197|NCT00459537|26864252|FG000|Overall Study|Protocol Violation|4|||
13421198|NCT00459537|26864253|FG001|Overall Study|Protocol Violation|3|||
13421199|NCT00459537|26864252|FG000|Overall Study|Missing|1|||
13421200|NCT00459537|26864253|FG001|Overall Study|Missing|0|||
13421201|NCT00459355|26864272|FG000|Overall Study|Subject no longer met inc criteria|20|||
13421202|NCT00459355|26864273|FG001|Overall Study|Subject no longer met inc criteria|18|||
13421203|NCT00459342|26864284|FG000|Overall Study|Not eligible|1|||
13421204|NCT00459316|26864350|FG000|Steps 1 & 2|Other eligibility failure|1|||
13421205|NCT00459316|26864351|FG001|Steps 1 & 2|Other eligibility failure|1|||
13421206|NCT00459316|26864352|FG002|Steps 1 & 2|Other eligibility failure|0|||
13421207|NCT00459316|26864350|FG000|Steps 1 & 2|Death|1|||
13421208|NCT00459316|26864351|FG001|Steps 1 & 2|Death|1|||
13421209|NCT00459316|26864352|FG002|Steps 1 & 2|Death|0|||
13421210|NCT00459316|26864350|FG000|Steps 1 & 2|Not able to get to clinic|7|||
13421211|NCT00459316|26864351|FG001|Steps 1 & 2|Not able to get to clinic|4|||
13421212|NCT00459316|26864352|FG002|Steps 1 & 2|Not able to get to clinic|0|||
13421213|NCT00459316|26864350|FG000|Steps 1 & 2|Withdrawal by Subject|6|||
13421214|NCT00459316|26864351|FG001|Steps 1 & 2|Withdrawal by Subject|1|||
13421215|NCT00459316|26864352|FG002|Steps 1 & 2|Withdrawal by Subject|0|||
13421216|NCT00459316|26864350|FG000|Steps 1 & 2|Not willing to adhere to regulations|1|||
13421217|NCT00459316|26864351|FG001|Steps 1 & 2|Not willing to adhere to regulations|0|||
13421218|NCT00459316|26864352|FG002|Steps 1 & 2|Not willing to adhere to regulations|0|||
13421219|NCT00459316|26864350|FG000|Steps 1 & 2|Lost to Follow-up|5|||
13421220|NCT00459316|26864351|FG001|Steps 1 & 2|Lost to Follow-up|0|||
13421221|NCT00459316|26864352|FG002|Steps 1 & 2|Lost to Follow-up|2|||
13421222|NCT00459316|26864350|FG000|Step 3|Withdrawal by Subject|3|||
13421223|NCT00459316|26864351|FG001|Step 3|Withdrawal by Subject|0|||
13421224|NCT00459316|26864352|FG002|Step 3|Withdrawal by Subject|1|||
13421225|NCT00459290|26864369|FG000|Overall Study|Adverse Event|3|||
13421226|NCT00459290|26864369|FG000|Overall Study|Ineligible|2|||
13421227|NCT00459186|26864376|FG000|Single Agent RAD001|Withdrawal by Subject|1|||
13421228|NCT00459186|26864376|FG000|PET Imaging and Assessment|Adverse Event|3|||
13421229|NCT00459134|26864391|FG000|Overall Study|Physician Decision|1|||
13421230|NCT00459134|26864392|FG001|Overall Study|Physician Decision|1|||
13421231|NCT00459134|26864391|FG000|Overall Study|Withdrawal by Subject|8|||
13421232|NCT00459134|26864392|FG001|Overall Study|Withdrawal by Subject|7|||
13421233|NCT00459134|26864391|FG000|Overall Study|Lost to Follow-up|6|||
13421234|NCT00459134|26864392|FG001|Overall Study|Lost to Follow-up|7|||
13421235|NCT00459134|26864391|FG000|Overall Study|Surgery|1|||
13421236|NCT00459134|26864392|FG001|Overall Study|Surgery|2|||
13421237|NCT00459134|26864391|FG000|Overall Study|Toxicity|4|||
13421238|NCT00459134|26864392|FG001|Overall Study|Toxicity|5|||
13421239|NCT00459134|26864391|FG000|Overall Study|Progression|1|||
13421240|NCT00459134|26864392|FG001|Overall Study|Progression|0|||
13421241|NCT00459134|26864391|FG000|Overall Study|Multiple Reasons|2|||
13421242|NCT00459134|26864392|FG001|Overall Study|Multiple Reasons|3|||
13421243|NCT00459108|26864402|FG000|Overall Study|Withdrawal by Subject|5|||
13421244|NCT00459108|26864402|FG000|Overall Study|Adverse Event|3|||
13421245|NCT00459108|26864402|FG000|Overall Study|Death|2|||
13421246|NCT00459108|26864402|FG000|Overall Study|Progression|1|||
13421247|NCT00459056|26864415|FG000|First Intervention (First Three Months)|Lost to Follow-up|1|||
13421248|NCT00459056|26864416|FG001|First Intervention (First Three Months)|Lost to Follow-up|1|||
13421249|NCT00459043|26864433|FG000|Overall Study|Withdrawal by Subject|1|||
13421250|NCT00459043|26864434|FG001|Overall Study|Withdrawal by Subject|0|||
13421251|NCT00458783|26864471|FG000|Overall Study|Protocol Violation|1228|||
13421252|NCT00458783|26864472|FG001|Overall Study|Protocol Violation|1220|||
13421253|NCT00458705|26864478|FG000|Overall Study|Adverse Event|4|||
13421254|NCT00458705|26864478|FG000|Overall Study|Not Treated|1|||
13421255|NCT00458484|26864539|FG000|Overall Study|Not eligible b/c prior radiation history|0|||
13421256|NCT00458484|26864540|FG001|Overall Study|Not eligible b/c prior radiation history|0|||
13421257|NCT00458484|26864541|FG002|Overall Study|Not eligible b/c prior radiation history|0|||
13421258|NCT00458484|26864542|FG003|Overall Study|Not eligible b/c prior radiation history|0|||
13421259|NCT00458484|26864543|FG004|Overall Study|Not eligible b/c prior radiation history|0|||
13421260|NCT00458484|26864544|FG005|Overall Study|Not eligible b/c prior radiation history|1|||
13421261|NCT00458484|26864545|FG006|Overall Study|Not eligible b/c prior radiation history|0|||
13421262|NCT00458393|26864598|FG000|Overall Study|Withdrawal by Subject|67|||
13421263|NCT00458393|26864599|FG001|Overall Study|Withdrawal by Subject|80|||
13421264|NCT00458393|26864598|FG000|Overall Study|Physician Decision|31|||
13421265|NCT00458393|26864599|FG001|Overall Study|Physician Decision|22|||
13421266|NCT00458393|26864598|FG000|Overall Study|Relocated|77|||
13421267|NCT00458393|26864599|FG001|Overall Study|Relocated|81|||
13421268|NCT00458393|26864598|FG000|Overall Study|Lost to Follow-up|115|||
13421269|NCT00458393|26864599|FG001|Overall Study|Lost to Follow-up|92|||
13421270|NCT00458393|26864598|FG000|Overall Study|Sites marked other on the form.|19|||
13421271|NCT00458393|26864599|FG001|Overall Study|Sites marked other on the form.|20|||
13421272|NCT00458341|26864644|FG000|Cycle 1|Adverse Event|1|||
13421273|NCT00458341|26864645|FG001|Cycle 1|Adverse Event|0|||
13421274|NCT00458302|26864683|FG000|Overall Study|Adverse Event|4|||
13421275|NCT00458302|26864684|FG001|Overall Study|Adverse Event|14|||
13421276|NCT00458302|26864683|FG000|Overall Study|Pregnancy|2|||
13421277|NCT00458302|26864684|FG001|Overall Study|Pregnancy|1|||
13421278|NCT00458302|26864683|FG000|Overall Study|Protocol Violation|0|||
13421279|NCT00458302|26864684|FG001|Overall Study|Protocol Violation|2|||
13421280|NCT00458302|26864683|FG000|Overall Study|Withdrawal by Subject|6|||
13421281|NCT00458302|26864684|FG001|Overall Study|Withdrawal by Subject|4|||
13421282|NCT00458302|26864683|FG000|Overall Study|Inc/Exc Criteria Not Met|1|||
13421283|NCT00458302|26864684|FG001|Overall Study|Inc/Exc Criteria Not Met|1|||
13421284|NCT00458302|26864683|FG000|Overall Study|Study Termination By Sponsor|1|||
13421285|NCT00458302|26864684|FG001|Overall Study|Study Termination By Sponsor|0|||
13421286|NCT00458302|26864683|FG000|Overall Study|Lost to Follow-up|2|||
13421287|NCT00458302|26864684|FG001|Overall Study|Lost to Follow-up|0|||
13421288|NCT00458302|26864683|FG000|Overall Study|Other|4|||
13421289|NCT00458302|26864684|FG001|Overall Study|Other|2|||
13421290|NCT00458211|26864705|FG000|Overall Study|Lack of Efficacy|12|||
13421291|NCT00458211|26864705|FG000|Overall Study|Withdrawal by Subject|2|||
13421292|NCT00458211|26864705|FG000|Overall Study|Protocol Violation|2|||
13421293|NCT00457821|26864759|FG000|Part 2|Withdrawal by Subject|0|||
13421294|NCT00457821|26864760|FG001|Part 2|Withdrawal by Subject|0|||
13421295|NCT00457821|26864761|FG002|Part 2|Withdrawal by Subject|0|||
13421296|NCT00457821|26864762|FG003|Part 2|Withdrawal by Subject|0|||
13421297|NCT00457821|26864763|FG004|Part 2|Withdrawal by Subject|0|||
13421298|NCT00457821|26864764|FG005|Part 2|Withdrawal by Subject|0|||
13421299|NCT00457821|26864765|FG006|Part 2|Withdrawal by Subject|0|||
13421300|NCT00457821|26864766|FG007|Part 2|Withdrawal by Subject|1|||
13421301|NCT00457743|26864818|FG000|Overall Study|Adverse Event|0|||
13421302|NCT00457743|26864819|FG001|Overall Study|Adverse Event|4|||
13421303|NCT00457743|26864820|FG002|Overall Study|Adverse Event|0|||
13421304|NCT00457743|26864818|FG000|Overall Study|Lack of Efficacy|3|||
13421305|NCT00457743|26864819|FG001|Overall Study|Lack of Efficacy|23|||
13421306|NCT00457743|26864820|FG002|Overall Study|Lack of Efficacy|3|||
13421307|NCT00457691|26864847|FG000|Overall Study|Adverse Event|4|||
13421308|NCT00457691|26864848|FG001|Overall Study|Adverse Event|1|||
13421309|NCT00457691|26864847|FG000|Overall Study|Death|163|||
13421310|NCT00457691|26864848|FG001|Overall Study|Death|148|||
13421311|NCT00457691|26864847|FG000|Overall Study|Protocol Violation|1|||
13421312|NCT00457691|26864848|FG001|Overall Study|Protocol Violation|3|||
13421313|NCT00457691|26864847|FG000|Overall Study|Lost to Follow-up|23|||
13421314|NCT00457691|26864848|FG001|Overall Study|Lost to Follow-up|14|||
13421315|NCT00457691|26864847|FG000|Overall Study|Study terminated by Sponsor|1|||
13421316|NCT00457691|26864848|FG001|Overall Study|Study terminated by Sponsor|1|||
13421317|NCT00457691|26864847|FG000|Overall Study|Subject refused (reason other than AE)|14|||
13421318|NCT00457691|26864848|FG001|Overall Study|Subject refused (reason other than AE)|19|||
13421319|NCT00457691|26864847|FG000|Overall Study|Disease progression, study terminated|180|||
13421320|NCT00457691|26864848|FG001|Overall Study|Disease progression, study terminated|196|||
13421321|NCT00457665|26864861|FG000|12 Months|Drug allergy|1|||
13421322|NCT00457665|26864862|FG001|12 Months|Drug allergy|1|||
13421323|NCT00457665|26864861|FG000|12 Months|High HIV viral load|5|||
13421324|NCT00457665|26864862|FG001|12 Months|High HIV viral load|1|||
13421325|NCT00457665|26864861|FG000|12 Months|Lipodystrophy|2|||
13421326|NCT00457665|26864862|FG001|12 Months|Lipodystrophy|0|||
13421327|NCT00457665|26864861|FG000|12 Months|Withdrawal by Subject|0|||
13421328|NCT00457665|26864862|FG001|12 Months|Withdrawal by Subject|2|||
13421329|NCT00457665|26864861|FG000|12 Months|Abnormal Liver function tests|0|||
13421330|NCT00457665|26864862|FG001|12 Months|Abnormal Liver function tests|5|||
13421331|NCT00457665|26864861|FG000|24 Months|Withdrawal by Subject|3|||
13421332|NCT00457665|26864862|FG001|24 Months|Withdrawal by Subject|2|||
13421333|NCT00457665|26864861|FG000|24 Months|Lipodystrophy|1|||
13421334|NCT00457665|26864862|FG001|24 Months|Lipodystrophy|1|||
13421335|NCT00457665|26864861|FG000|24 Months|Abnormal liver function tests|1|||
13421336|NCT00457665|26864862|FG001|24 Months|Abnormal liver function tests|5|||
13421337|NCT00457639|26864873|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3|||
13421338|NCT00457639|26864874|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0|||
13421339|NCT00457639|26864873|FG000|Intervention 1 (6 Months)|unrelated illness|0|||
13421340|NCT00457639|26864874|FG001|Intervention 1 (6 Months)|unrelated illness|2|||
13421341|NCT00457639|26864873|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0|||
13421342|NCT00457639|26864874|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1|||
13421343|NCT00457626|26864882|FG000|Overall Study|Adverse Event|3|||
13421344|NCT00457626|26864882|FG000|Overall Study|Administrative Problems|2|||
13421345|NCT00457626|26864882|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1|||
13421346|NCT00457418|26864894|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2|||
13421347|NCT00457418|26864894|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1|||
13421348|NCT00457418|26864894|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2|||
13421349|NCT00457418|26864894|FG000|Post PK Maintenance|Adverse Event|10|||
13421350|NCT00457418|26864894|FG000|Post PK Maintenance|Progression of Disease|6|||
13421351|NCT00457418|26864894|FG000|Post PK Maintenance|Withdrawal by Subject|11|||
13421352|NCT00457418|26864894|FG000|Post PK Maintenance|Lost to Follow-up|1|||
13421353|NCT00457392|26864917|FG000|Overall Study|Objective Progression or Relapse|229|||
13421354|NCT00457392|26864918|FG001|Overall Study|Objective Progression or Relapse|296|||
13421355|NCT00457392|26864917|FG000|Overall Study|Death|106|||
13421356|NCT00457392|26864918|FG001|Overall Study|Death|106|||
13421357|NCT00457392|26864917|FG000|Overall Study|Adverse Event|84|||
13421358|NCT00457392|26864918|FG001|Overall Study|Adverse Event|41|||
13421359|NCT00457392|26864917|FG000|Overall Study|Global Deterioration of Health Status|22|||
13421360|NCT00457392|26864918|FG001|Overall Study|Global Deterioration of Health Status|8|||
13421361|NCT00457392|26864917|FG000|Overall Study|Withdrawal by Subject|14|||
13421362|NCT00457392|26864918|FG001|Overall Study|Withdrawal by Subject|8|||
13421363|NCT00457392|26864917|FG000|Overall Study|Lost to Follow-up|6|||
13421364|NCT00457392|26864918|FG001|Overall Study|Lost to Follow-up|7|||
13421365|NCT00457392|26864917|FG000|Overall Study|Protocol Violation|4|||
13421366|NCT00457392|26864918|FG001|Overall Study|Protocol Violation|3|||
13421367|NCT00457392|26864917|FG000|Overall Study|Other|7|||
13421368|NCT00457392|26864918|FG001|Overall Study|Other|4|||
13421369|NCT00457392|26864917|FG000|Overall Study|Study Terminated by Sponsor|1|||
13421370|NCT00457392|26864918|FG001|Overall Study|Study Terminated by Sponsor|4|||
13421371|NCT00457392|26864917|FG000|Overall Study|Randomized, Not Treated|7|||
13421372|NCT00457392|26864918|FG001|Overall Study|Randomized, Not Treated|3|||
13421373|NCT00457301|26864937|FG000|Overall Study|Withdrawal by Subject|3|||
13421374|NCT00457301|26864938|FG001|Overall Study|Withdrawal by Subject|3|||
13421375|NCT00457301|26864937|FG000|Overall Study|Censored out of the study|15|||
13421376|NCT00457301|26864938|FG001|Overall Study|Censored out of the study|14|||
13421377|NCT00457301|26864937|FG000|Overall Study|Death|5|||
13421378|NCT00457301|26864938|FG001|Overall Study|Death|7|||
13421379|NCT00457249|26864957|FG000|Overall Study|Lost to Follow-up|3|||
13421380|NCT00457249|26864958|FG001|Overall Study|Lost to Follow-up|0|||
13421381|NCT00457249|26864957|FG000|Overall Study|Protocol Violation|4|||
13421382|NCT00457249|26864958|FG001|Overall Study|Protocol Violation|1|||
13421383|NCT00457249|26864957|FG000|Overall Study|Withdrawal by Subject|3|||
13421384|NCT00457249|26864958|FG001|Overall Study|Withdrawal by Subject|1|||
13421385|NCT00457249|26864957|FG000|Overall Study|Serious Adverse Events|2|||
13421386|NCT00457249|26864958|FG001|Overall Study|Serious Adverse Events|0|||
13421387|NCT00457015|26864979|FG000|Overall Study|Left study site against medical advice|0|||
13421388|NCT00457015|26864980|FG001|Overall Study|Left study site against medical advice|1|||
13421389|NCT00457002|26865055|FG000|Overall Study|Death|40|||
13421390|NCT00457002|26865056|FG001|Overall Study|Death|47|||
13421391|NCT00457002|26865055|FG000|Overall Study|Adverse Event|284|||
13421392|NCT00457002|26865056|FG001|Overall Study|Adverse Event|260|||
13421393|NCT00457002|26865055|FG000|Overall Study|Withdrawal by Subject|299|||
13421394|NCT00457002|26865056|FG001|Overall Study|Withdrawal by Subject|271|||
13421395|NCT00457002|26865055|FG000|Overall Study|Lost to Follow-up|72|||
13421396|NCT00457002|26865056|FG001|Overall Study|Lost to Follow-up|71|||
13421397|NCT00457002|26865055|FG000|Overall Study|Poor/Non-compliance|46|||
13421398|NCT00457002|26865056|FG001|Overall Study|Poor/Non-compliance|33|||
13421399|NCT00457002|26865055|FG000|Overall Study|No longer met criteria|41|||
13421400|NCT00457002|26865056|FG001|Overall Study|No longer met criteria|37|||
13421401|NCT00457002|26865055|FG000|Overall Study|Administrative reason by Sponsor|1|||
13421402|NCT00457002|26865056|FG001|Overall Study|Administrative reason by Sponsor|0|||
13421403|NCT00457002|26865055|FG000|Overall Study|non-specified|29|||
13421404|NCT00457002|26865056|FG001|Overall Study|non-specified|38|||
13421405|NCT00457002|26865055|FG000|Overall Study|treated for 1 day; missing status/reason|1|||
13421406|NCT00457002|26865056|FG001|Overall Study|treated for 1 day; missing status/reason|0|||
13421407|NCT00456846|26865083|FG000|Overall Study|Adverse Event|2|||
13421408|NCT00456846|26865084|FG001|Overall Study|Adverse Event|15|||
13421409|NCT00456846|26865083|FG000|Overall Study|Physician Decision|11|||
13421410|NCT00456846|26865084|FG001|Overall Study|Physician Decision|6|||
13421411|NCT00456846|26865083|FG000|Overall Study|Protocol Deviation|2|||
13421412|NCT00456846|26865084|FG001|Overall Study|Protocol Deviation|0|||
13421413|NCT00456846|26865083|FG000|Overall Study|Participant Discretion|1|||
13421414|NCT00456846|26865084|FG001|Overall Study|Participant Discretion|5|||
13421415|NCT00456846|26865083|FG000|Overall Study|Other|0|||
13421416|NCT00456846|26865084|FG001|Overall Study|Other|2|||
13421417|NCT00456755|26865099|FG000|Overall Study|Lost to Follow-up|2|||
13421418|NCT00456755|26865100|FG001|Overall Study|Lost to Follow-up|1|||
13421419|NCT00456612|26865107|FG000|Overall Study|Withdrawal by Subject|3|||
13421420|NCT00456599|26865115|FG000|Overall Study|Non-compliance|1|||
13421421|NCT00456599|26865115|FG000|Overall Study|Withdrawal by Subject|2|||
13421422|NCT00456521|26865162|FG000|Overall Study|Adverse Event|150|||
13421423|NCT00456521|26865163|FG001|Overall Study|Adverse Event|25|||
13421424|NCT00456521|26865162|FG000|Overall Study|Withdrawal by Subject|43|||
13421425|NCT00456521|26865163|FG001|Overall Study|Withdrawal by Subject|24|||
13421426|NCT00456521|26865162|FG000|Overall Study|Lost to Follow-up|22|||
13421427|NCT00456521|26865163|FG001|Overall Study|Lost to Follow-up|17|||
13421428|NCT00456521|26865162|FG000|Overall Study|Lack of Efficacy|3|||
13421429|NCT00456521|26865163|FG001|Overall Study|Lack of Efficacy|6|||
13421430|NCT00456521|26865162|FG000|Overall Study|Protocol Violation|4|||
13421431|NCT00456521|26865163|FG001|Overall Study|Protocol Violation|0|||
13421432|NCT00456521|26865162|FG000|Overall Study|Pregnancy|1|||
13421433|NCT00456521|26865163|FG001|Overall Study|Pregnancy|1|||
13421434|NCT00456521|26865162|FG000|Overall Study|Drug non-compliance, moved, other|26|||
13421435|NCT00456521|26865163|FG001|Overall Study|Drug non-compliance, moved, other|11|||
13421436|NCT00456495|26865170|FG000|Overall Study|Physician Decision|2|||
13421437|NCT00456365|26865189|FG000|Overall Study|Lost to Follow-up|1|||
13421438|NCT00456365|26865190|FG001|Overall Study|Lost to Follow-up|3|||
13421439|NCT00456365|26865189|FG000|Overall Study|Withdrawal by Subject|4|||
13421440|NCT00456365|26865190|FG001|Overall Study|Withdrawal by Subject|7|||
13421441|NCT00456365|26865189|FG000|Overall Study|Pregnancy|1|||
13421442|NCT00456365|26865190|FG001|Overall Study|Pregnancy|1|||
13421443|NCT00456365|26865189|FG000|Overall Study|oncologic diagnosis|1|||
13421444|NCT00456365|26865190|FG001|Overall Study|oncologic diagnosis|1|||
13421445|NCT00456300|26865201|FG000|Overall Study|Adverse Event|1|||
13421446|NCT00456300|26865202|FG001|Overall Study|Adverse Event|0|||
13421447|NCT00456092|26865364|FG000|Extension Phase|Grade 2 or Greater AE|2|||
13421448|NCT00456092|26865365|FG001|Extension Phase|Grade 2 or Greater AE|2|||
13421449|NCT00456092|26865366|FG002|Extension Phase|Grade 2 or Greater AE|0|||
13421450|NCT00456092|26865367|FG003|Extension Phase|Grade 2 or Greater AE|0|||
13421451|NCT00456092|26865368|FG004|Extension Phase|Grade 2 or Greater AE|2|||
13421452|NCT00456092|26865364|FG000|Extension Phase|Flare of Psoriatic Arthritis|1|||
13421453|NCT00456092|26865365|FG001|Extension Phase|Flare of Psoriatic Arthritis|0|||
13421454|NCT00456092|26865366|FG002|Extension Phase|Flare of Psoriatic Arthritis|0|||
13421455|NCT00456092|26865367|FG003|Extension Phase|Flare of Psoriatic Arthritis|0|||
13421456|NCT00456092|26865368|FG004|Extension Phase|Flare of Psoriatic Arthritis|1|||
13421457|NCT00456092|26865364|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3|||
13421458|NCT00456092|26865365|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1|||
13421459|NCT00456092|26865366|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0|||
13421460|NCT00456092|26865367|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0|||
13421461|NCT00456092|26865368|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2|||
13421462|NCT00456092|26865364|FG000|Extension Phase|Withdrew Consent|2|||
13421463|NCT00456092|26865365|FG001|Extension Phase|Withdrew Consent|0|||
13421464|NCT00456092|26865366|FG002|Extension Phase|Withdrew Consent|0|||
13421465|NCT00456092|26865367|FG003|Extension Phase|Withdrew Consent|0|||
13421466|NCT00456092|26865368|FG004|Extension Phase|Withdrew Consent|0|||
13421467|NCT00456092|26865364|FG000|Extension Phase|Lost to Follow-up|1|||
13421468|NCT00456092|26865365|FG001|Extension Phase|Lost to Follow-up|1|||
13421469|NCT00456092|26865366|FG002|Extension Phase|Lost to Follow-up|0|||
13421470|NCT00456092|26865367|FG003|Extension Phase|Lost to Follow-up|0|||
13421471|NCT00456092|26865368|FG004|Extension Phase|Lost to Follow-up|1|||
13421472|NCT00456092|26865364|FG000|Extension Phase|Other|2|||
13421473|NCT00456092|26865365|FG001|Extension Phase|Other|0|||
13421474|NCT00456092|26865366|FG002|Extension Phase|Other|0|||
13421475|NCT00456092|26865367|FG003|Extension Phase|Other|1|||
13421476|NCT00456092|26865368|FG004|Extension Phase|Other|1|||
13421477|NCT00456092|26865364|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3|||
13421478|NCT00456092|26865365|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4|||
13421479|NCT00456092|26865366|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2|||
13421480|NCT00456092|26865367|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
13421481|NCT00456092|26865368|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
13421482|NCT00456092|26865364|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1|||
13421483|NCT00456092|26865365|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2|||
13421484|NCT00456092|26865366|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
13421485|NCT00456092|26865367|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
13421486|NCT00456092|26865368|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
13421487|NCT00456092|26865364|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2|||
13421488|NCT00456092|26865365|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
13421489|NCT00456092|26865366|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
13421490|NCT00456092|26865367|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
13421491|NCT00456092|26865368|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
13421492|NCT00456092|26865364|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
13421493|NCT00456092|26865365|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1|||
13421494|NCT00456092|26865366|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2|||
13421495|NCT00456092|26865367|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
13421496|NCT00456092|26865368|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
13421497|NCT00456092|26865364|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
13421498|NCT00456092|26865365|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
13421499|NCT00456092|26865366|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
13421500|NCT00456092|26865367|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
13421501|NCT00456092|26865368|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
13421502|NCT00456092|26865364|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
13421503|NCT00456092|26865365|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2|||
13421504|NCT00456092|26865366|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7|||
13421505|NCT00456092|26865367|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
13421506|NCT00456092|26865368|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
13421507|NCT00456092|26865364|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
13421508|NCT00456092|26865365|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1|||
13421509|NCT00456092|26865366|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2|||
13421510|NCT00456092|26865367|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
13421511|NCT00456092|26865368|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
13421512|NCT00456092|26865364|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
13421513|NCT00456092|26865365|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
13421514|NCT00456092|26865366|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
13421515|NCT00456092|26865367|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
13421516|NCT00456092|26865368|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
13421517|NCT00456092|26865364|FG000|Treatment Phase (12 Weeks)|Other|1|||
13421518|NCT00456092|26865365|FG001|Treatment Phase (12 Weeks)|Other|0|||
13421519|NCT00456092|26865366|FG002|Treatment Phase (12 Weeks)|Other|1|||
13421520|NCT00456092|26865367|FG003|Treatment Phase (12 Weeks)|Other|0|||
13421521|NCT00456092|26865368|FG004|Treatment Phase (12 Weeks)|Other|0|||
13421522|NCT00455923|26865391|FG000|Overall Study|Pregnancy|0|||
13421523|NCT00455923|26865392|FG001|Overall Study|Pregnancy|2|||
13421524|NCT00455923|26865391|FG000|Overall Study|Other|3|||
13421525|NCT00455923|26865392|FG001|Overall Study|Other|1|||
13421526|NCT00455858|26865402|FG000|Overall Study|Lost to Follow-up|2|||
13421527|NCT00455858|26865402|FG000|Overall Study|Protocol Violation|1|||
13421528|NCT00455858|26865402|FG000|Overall Study|Lack of Efficacy|1|||
13421529|NCT00455858|26865402|FG000|Overall Study|Well controlled FPG without insulin|1|||
13421530|NCT00455858|26865402|FG000|Overall Study|Withdrawal|1|||
13421531|NCT00455741|26865425|FG000|Overall Study|Physician Decision|0|||
13421532|NCT00455741|26865426|FG001|Overall Study|Physician Decision|1|||
13421533|NCT00455533|26865481|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1|||
13421534|NCT00455533|26865482|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
13421535|NCT00455533|26865483|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
13421536|NCT00455533|26865481|FG000|Period One: Initial Chemotherapy|Disease Progression|5|||
13421537|NCT00455533|26865482|FG001|Period One: Initial Chemotherapy|Disease Progression|0|||
13421538|NCT00455533|26865483|FG002|Period One: Initial Chemotherapy|Disease Progression|0|||
13421539|NCT00455533|26865481|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2|||
13421540|NCT00455533|26865482|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
13421541|NCT00455533|26865483|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
13421542|NCT00455533|26865481|FG000|Period One: Initial Chemotherapy|Not Reported|1|||
13421543|NCT00455533|26865482|FG001|Period One: Initial Chemotherapy|Not Reported|0|||
13421544|NCT00455533|26865483|FG002|Period One: Initial Chemotherapy|Not Reported|0|||
13421545|NCT00455533|26865481|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2|||
13421546|NCT00455533|26865482|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
13219913|NCT01829230|26278637|FG000|Overall Study|Withdrawal by Subject|0|||
13219914|NCT01829230|26278638|FG001|Overall Study|Withdrawal by Subject|1|||
13306238|NCT01292603|26525399|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
13306239|NCT01292603|26525400|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
13306240|NCT01292603|26525395|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
13306241|NCT01292603|26525396|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
13306242|NCT01292603|26525397|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
13306243|NCT01292603|26525398|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1|||
13306244|NCT01292603|26525399|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
13306245|NCT01292603|26525400|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
13306246|NCT01292603|26525395|FG000|Part 1: Regular Follow-Up Period|Death|3|||
13421547|NCT00455533|26865483|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
13421548|NCT00455533|26865481|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2|||
13421549|NCT00455533|26865482|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
13421550|NCT00455533|26865483|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
13421551|NCT00455533|26865481|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1|||
13421552|NCT00455533|26865482|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
13421553|NCT00455533|26865483|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
13421554|NCT00455533|26865481|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2|||
13421555|NCT00455533|26865482|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
13421556|NCT00455533|26865483|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
13421557|NCT00455533|26865481|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2|||
13421558|NCT00455533|26865482|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
13421559|NCT00455533|26865483|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
13421560|NCT00455533|26865481|FG000|Period Two: Randomized Period|Death|0|||
13421561|NCT00455533|26865482|FG001|Period Two: Randomized Period|Death|0|||
13421562|NCT00455533|26865483|FG002|Period Two: Randomized Period|Death|3|||
13421563|NCT00455533|26865481|FG000|Period Two: Randomized Period|Disease Progression|0|||
13421564|NCT00455533|26865482|FG001|Period Two: Randomized Period|Disease Progression|1|||
13421565|NCT00455533|26865483|FG002|Period Two: Randomized Period|Disease Progression|1|||
13421566|NCT00455533|26865481|FG000|Period Two: Randomized Period|Lost to Follow-up|0|||
13421567|NCT00455533|26865482|FG001|Period Two: Randomized Period|Lost to Follow-up|0|||
13421568|NCT00455533|26865483|FG002|Period Two: Randomized Period|Lost to Follow-up|1|||
13421569|NCT00455533|26865481|FG000|Period Two: Randomized Period|Other - need reasons|0|||
13421570|NCT00455533|26865482|FG001|Period Two: Randomized Period|Other - need reasons|1|||
13421571|NCT00455533|26865483|FG002|Period Two: Randomized Period|Other - need reasons|0|||
13421572|NCT00455533|26865481|FG000|Period Two: Randomized Period|Study Drug Toxicity|0|||
13421573|NCT00455533|26865482|FG001|Period Two: Randomized Period|Study Drug Toxicity|2|||
13421574|NCT00455533|26865483|FG002|Period Two: Randomized Period|Study Drug Toxicity|0|||
13421575|NCT00455533|26865481|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0|||
13421576|NCT00455533|26865482|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2|||
13421577|NCT00455533|26865483|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1|||
13421578|NCT00455520|26865506|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24|||
13421579|NCT00455520|26865507|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0|||
13421580|NCT00455520|26865506|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3|||
13421581|NCT00455520|26865507|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0|||
13421582|NCT00455520|26865506|FG000|Open Label Tapentadol Extended Release|Adverse Event|100|||
13421583|NCT00455520|26865507|FG001|Open Label Tapentadol Extended Release|Adverse Event|0|||
13421584|NCT00455520|26865506|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23|||
13421585|NCT00455520|26865507|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0|||
13421586|NCT00455520|26865506|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13|||
13421587|NCT00455520|26865507|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0|||
13421588|NCT00455520|26865506|FG000|Open Label Tapentadol Extended Release|All other|33|||
13421589|NCT00455520|26865507|FG001|Open Label Tapentadol Extended Release|All other|0|||
13421590|NCT00455520|26865506|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29|||
13421591|NCT00455520|26865507|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15|||
13421592|NCT00455520|26865506|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8|||
13421593|NCT00455520|26865507|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29|||
13421594|NCT00455520|26865506|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15|||
13421595|NCT00455520|26865507|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7|||
13421596|NCT00455520|26865506|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
13421597|NCT00455520|26865507|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
13421598|NCT00455520|26865506|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4|||
13421599|NCT00455520|26865507|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2|||
13421600|NCT00455520|26865506|FG000|Double Blind Tapentadol ER vs Placebo|All other|4|||
13421601|NCT00455520|26865507|FG001|Double Blind Tapentadol ER vs Placebo|All other|6|||
13421602|NCT00455455|26865526|FG000|Washout|Withdrawal by Subject|0|||
13421603|NCT00455455|26865527|FG001|Washout|Withdrawal by Subject|1|||
13421604|NCT00455455|26865526|FG000|Washout|Withdrawal by Subject|1|||
13421605|NCT00455455|26865527|FG001|Washout|Withdrawal by Subject|0|||
13421606|NCT00455429|26865597|FG000|Overall Study|Study Terminated by Sponsor|0|||
13421607|NCT00455429|26865598|FG001|Overall Study|Study Terminated by Sponsor|0|||
13421608|NCT00455429|26865599|FG002|Overall Study|Study Terminated by Sponsor|0|||
13421609|NCT00455429|26865600|FG003|Overall Study|Study Terminated by Sponsor|3|||
13421610|NCT00455429|26865597|FG000|Overall Study|Lost to Follow-up|1|||
13421611|NCT00455429|26865598|FG001|Overall Study|Lost to Follow-up|0|||
13421612|NCT00455429|26865599|FG002|Overall Study|Lost to Follow-up|0|||
13421613|NCT00455429|26865600|FG003|Overall Study|Lost to Follow-up|3|||
13421614|NCT00455429|26865597|FG000|Overall Study|Withdrawal by Subject|0|||
13421615|NCT00455429|26865598|FG001|Overall Study|Withdrawal by Subject|1|||
13421616|NCT00455429|26865599|FG002|Overall Study|Withdrawal by Subject|1|||
13421617|NCT00455429|26865600|FG003|Overall Study|Withdrawal by Subject|0|||
13421618|NCT00455429|26865597|FG000|Overall Study|Lack of Efficacy|0|||
13421619|NCT00455429|26865598|FG001|Overall Study|Lack of Efficacy|1|||
13421620|NCT00455429|26865599|FG002|Overall Study|Lack of Efficacy|0|||
13421621|NCT00455429|26865600|FG003|Overall Study|Lack of Efficacy|1|||
13421622|NCT00455429|26865597|FG000|Overall Study|Adverse Event|0|||
13421623|NCT00455429|26865598|FG001|Overall Study|Adverse Event|1|||
13421624|NCT00455429|26865599|FG002|Overall Study|Adverse Event|0|||
13421625|NCT00455429|26865600|FG003|Overall Study|Adverse Event|3|||
13421626|NCT00455429|26865597|FG000|Overall Study|Randomly assigned but not treated|0|||
13421627|NCT00455429|26865598|FG001|Overall Study|Randomly assigned but not treated|0|||
13421628|NCT00455429|26865599|FG002|Overall Study|Randomly assigned but not treated|0|||
13421629|NCT00455429|26865600|FG003|Overall Study|Randomly assigned but not treated|2|||
13421630|NCT00455429|26865597|FG000|Overall Study|Personal Reason|1|||
13421631|NCT00455429|26865598|FG001|Overall Study|Personal Reason|0|||
13421632|NCT00455429|26865599|FG002|Overall Study|Personal Reason|0|||
13421633|NCT00455429|26865600|FG003|Overall Study|Personal Reason|0|||
13421634|NCT00455429|26865597|FG000|Overall Study|Non-compliance|0|||
13421635|NCT00455429|26865598|FG001|Overall Study|Non-compliance|0|||
13421636|NCT00455429|26865599|FG002|Overall Study|Non-compliance|0|||
13421637|NCT00455429|26865600|FG003|Overall Study|Non-compliance|1|||
13421638|NCT00455429|26865597|FG000|Overall Study|Other|0|||
13421639|NCT00455429|26865598|FG001|Overall Study|Other|2|||
13421640|NCT00455429|26865599|FG002|Overall Study|Other|0|||
13421641|NCT00455429|26865600|FG003|Overall Study|Other|1|||
13421642|NCT00455325|26865639|FG000|Cohort 1: Placebo|Started exclusionary drug|1|||
13421643|NCT00455325|26865640|FG001|Cohort 1: Placebo|Started exclusionary drug|0|||
13421644|NCT00455325|26865641|FG002|Cohort 1: Placebo|Started exclusionary drug|0|||
13421645|NCT00455325|26865642|FG003|Cohort 1: Placebo|Started exclusionary drug|0|||
13421646|NCT00455325|26865639|FG000|Cohort 1: Placebo|Withdrawal by Subject|4|||
13421647|NCT00455325|26865640|FG001|Cohort 1: Placebo|Withdrawal by Subject|0|||
13421648|NCT00455325|26865641|FG002|Cohort 1: Placebo|Withdrawal by Subject|0|||
13421649|NCT00455325|26865642|FG003|Cohort 1: Placebo|Withdrawal by Subject|0|||
13421650|NCT00455325|26865639|FG000|Cohort 1: Placebo|Lost to Follow-up|1|||
13421651|NCT00455325|26865640|FG001|Cohort 1: Placebo|Lost to Follow-up|0|||
13421652|NCT00455325|26865641|FG002|Cohort 1: Placebo|Lost to Follow-up|0|||
13421653|NCT00455325|26865642|FG003|Cohort 1: Placebo|Lost to Follow-up|0|||
13421654|NCT00455325|26865639|FG000|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|1|||
13421655|NCT00455325|26865640|FG001|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
13421656|NCT00455325|26865641|FG002|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
13421657|NCT00455325|26865642|FG003|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
13421658|NCT00455325|26865639|FG000|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|1|||
13421659|NCT00455325|26865640|FG001|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
13421660|NCT00455325|26865641|FG002|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
13421661|NCT00455325|26865642|FG003|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
13421662|NCT00455325|26865639|FG000|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
13421663|NCT00455325|26865640|FG001|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|1|||
13421664|NCT00455325|26865641|FG002|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
13421665|NCT00455325|26865642|FG003|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
13421666|NCT00455325|26865639|FG000|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
13421667|NCT00455325|26865640|FG001|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
13421668|NCT00455325|26865641|FG002|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|1|||
13421669|NCT00455325|26865642|FG003|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
13476679|NCT01425008|27003745|FG016|Dose Escalation Phase|Adverse Event|0|||
13476680|NCT01425008|27003746|FG017|Dose Escalation Phase|Adverse Event|0|||
13476681|NCT01425008|27003747|FG018|Dose Escalation Phase|Adverse Event|0|||
13476682|NCT01425008|27003729|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
13476683|NCT01425008|27003730|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
13476684|NCT01425008|27003731|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
13421670|NCT00455312|26865673|FG000|Overall Study|Death|0|||
13421671|NCT00455312|26865674|FG001|Overall Study|Death|1|||
13421672|NCT00455195|26865695|FG000|Double-blind Study AGLU02704|Adverse Event|2|||
13421673|NCT00455195|26865696|FG001|Double-blind Study AGLU02704|Adverse Event|1|||
13421674|NCT00455195|26865695|FG000|Double-blind Study AGLU02704|Death|1|||
13421675|NCT00455195|26865696|FG001|Double-blind Study AGLU02704|Death|0|||
13421676|NCT00455195|26865695|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
13421677|NCT00455195|26865696|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
13421678|NCT00455195|26865695|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0|||
13421679|NCT00455195|26865696|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1|||
13421680|NCT00455143|26865719|FG000|Overall Study|Physician Decision|1|||
13421681|NCT00455143|26865719|FG000|Overall Study|Withdrawal by Subject|1|||
13421682|NCT00455143|26865719|FG000|Overall Study|Staff was not avail to follow patient|2|||
13421683|NCT00455143|26865719|FG000|Overall Study|No longer met Inclusion Criteria|1|||
13421684|NCT00455143|26865719|FG000|Overall Study|Surgical time, staff not available|1|||
13421685|NCT00455013|26865794|FG000|Short Term Period|Adverse Event|2|||
13421686|NCT00455013|26865795|FG001|Short Term Period|Adverse Event|5|||
13421687|NCT00455013|26865796|FG002|Short Term Period|Adverse Event|0|||
13421688|NCT00455013|26865794|FG000|Short Term Period|Withdrawal by Subject|0|||
13421689|NCT00455013|26865795|FG001|Short Term Period|Withdrawal by Subject|0|||
13421690|NCT00455013|26865796|FG002|Short Term Period|Withdrawal by Subject|1|||
13421691|NCT00455013|26865794|FG000|Short Term Period|Lack of Efficacy|4|||
13421692|NCT00455013|26865795|FG001|Short Term Period|Lack of Efficacy|0|||
13421693|NCT00455013|26865796|FG002|Short Term Period|Lack of Efficacy|0|||
13421694|NCT00455013|26865794|FG000|Short Term Period|Other|0|||
13421695|NCT00455013|26865795|FG001|Short Term Period|Other|0|||
13421696|NCT00455013|26865796|FG002|Short Term Period|Other|1|||
13421697|NCT00455013|26865794|FG000|Long Term Extension (LTE)|Adverse Event|0|||
13421698|NCT00455013|26865795|FG001|Long Term Extension (LTE)|Adverse Event|1|||
13421699|NCT00455013|26865796|FG002|Long Term Extension (LTE)|Adverse Event|1|||
13421700|NCT00455013|26865794|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1|||
13421701|NCT00455013|26865795|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0|||
13421702|NCT00455013|26865796|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1|||
13421703|NCT00455013|26865794|FG000|Long Term Extension (LTE)|Death|1|||
13421704|NCT00455013|26865795|FG001|Long Term Extension (LTE)|Death|1|||
13421705|NCT00455013|26865796|FG002|Long Term Extension (LTE)|Death|0|||
13421706|NCT00455013|26865794|FG000|Long Term Extension (LTE)|No longer met criteria|0|||
13421707|NCT00455013|26865795|FG001|Long Term Extension (LTE)|No longer met criteria|0|||
13421708|NCT00455013|26865796|FG002|Long Term Extension (LTE)|No longer met criteria|1|||
13421709|NCT00455013|26865794|FG000|Long Term Extension (LTE)|Subject Request or refused|0|||
13421710|NCT00455013|26865795|FG001|Long Term Extension (LTE)|Subject Request or refused|0|||
13421711|NCT00455013|26865796|FG002|Long Term Extension (LTE)|Subject Request or refused|3|||
13421712|NCT00455013|26865794|FG000|Long Term Extension (LTE)|Poor non-compliance|0|||
13421713|NCT00455013|26865795|FG001|Long Term Extension (LTE)|Poor non-compliance|1|||
13421714|NCT00455013|26865796|FG002|Long Term Extension (LTE)|Poor non-compliance|0|||
13421715|NCT00455013|26865794|FG000|Long Term Extension (LTE)|non-specified|0|||
13421716|NCT00455013|26865795|FG001|Long Term Extension (LTE)|non-specified|0|||
13421717|NCT00455013|26865796|FG002|Long Term Extension (LTE)|non-specified|1|||
13421718|NCT00454987|26865877|FG000|Booster Period (NCT00258700)|Adverse Event|1|||
13421719|NCT00454987|26865878|FG001|Booster Period (NCT00258700)|Adverse Event|0|||
13421720|NCT00454987|26865879|FG002|Booster Period (NCT00258700)|Adverse Event|0|||
13421721|NCT00454987|26865877|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
13421722|NCT00454987|26865878|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1|||
13421723|NCT00454987|26865879|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
13421724|NCT00454987|26865877|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1|||
13421725|NCT00454987|26865878|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0|||
13421726|NCT00454987|26865879|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0|||
13421727|NCT00454909|26865927|FG000|Overall Study|Withdrawal by Subject|1|||
13421728|NCT00454909|26865928|FG001|Overall Study|Withdrawal by Subject|0|||
13421729|NCT00454909|26865929|FG002|Overall Study|Withdrawal by Subject|0|||
13421730|NCT00454909|26865927|FG000|Overall Study|Migrated/moved from study area|0|||
13421731|NCT00454909|26865928|FG001|Overall Study|Migrated/moved from study area|0|||
13421732|NCT00454909|26865929|FG002|Overall Study|Migrated/moved from study area|1|||
13421733|NCT00454909|26865927|FG000|Overall Study|Lost to follow-up (complete vaccination)|5|||
13421734|NCT00454909|26865928|FG001|Overall Study|Lost to follow-up (complete vaccination)|3|||
13421735|NCT00454909|26865929|FG002|Overall Study|Lost to follow-up (complete vaccination)|1|||
13421736|NCT00454909|26865927|FG000|Overall Study|Others|1|||
13421737|NCT00454909|26865928|FG001|Overall Study|Others|0|||
13421738|NCT00454909|26865929|FG002|Overall Study|Others|0|||
13421739|NCT00454857|26865948|FG000|Overall Study|Withdrawal by Subject|15|||
13421740|NCT00454857|26865948|FG000|Overall Study|Lost to Follow-up|16|||
13421741|NCT00454857|26865948|FG000|Overall Study|Noncompliance|6|||
13421742|NCT00454857|26865948|FG000|Overall Study|Death|5|||
13421743|NCT00454857|26865948|FG000|Overall Study|Other|11|||
13421744|NCT00454857|26865948|FG000|Overall Study|Reason unknown|1|||
13421745|NCT00454818|26866047|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1|||
13421746|NCT00454818|26866048|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
13421747|NCT00454818|26866049|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
13421748|NCT00454818|26866050|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
13421749|NCT00454818|26866051|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
13421750|NCT00454818|26866047|FG000|Phase I: Open-label Dose-escalation|Death|0|||
13421751|NCT00454818|26866048|FG001|Phase I: Open-label Dose-escalation|Death|1|||
13421752|NCT00454818|26866049|FG002|Phase I: Open-label Dose-escalation|Death|0|||
13421753|NCT00454818|26866050|FG003|Phase I: Open-label Dose-escalation|Death|0|||
13421754|NCT00454818|26866051|FG004|Phase I: Open-label Dose-escalation|Death|0|||
13421755|NCT00454818|26866047|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
13421756|NCT00454818|26866048|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
13421757|NCT00454818|26866049|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
13421758|NCT00454818|26866050|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
13421759|NCT00454818|26866051|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
13421760|NCT00454818|26866047|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
13421761|NCT00454818|26866048|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
13421762|NCT00454818|26866049|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
13421763|NCT00454818|26866050|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
13421764|NCT00454818|26866051|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
13421765|NCT00454818|26866047|FG000|Phase 2: Randomized Double-blind|Death|0|||
13421766|NCT00454818|26866048|FG001|Phase 2: Randomized Double-blind|Death|1|||
13421767|NCT00454818|26866049|FG002|Phase 2: Randomized Double-blind|Death|0|||
13421768|NCT00454818|26866050|FG003|Phase 2: Randomized Double-blind|Death|0|||
13421769|NCT00454818|26866051|FG004|Phase 2: Randomized Double-blind|Death|1|||
13421770|NCT00454818|26866047|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
13421771|NCT00454818|26866048|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
13421772|NCT00454818|26866049|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2|||
13421773|NCT00454818|26866050|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
13421774|NCT00454818|26866051|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1|||
13421775|NCT00454818|26866047|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
13421776|NCT00454818|26866048|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
13421777|NCT00454818|26866049|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1|||
13421778|NCT00454818|26866050|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
13421779|NCT00454818|26866051|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2|||
13421780|NCT00454805|26866072|FG000|Overall Study|Withdrawal by Subject|9|||
13421781|NCT00454805|26866073|FG001|Overall Study|Withdrawal by Subject|2|||
13421782|NCT00454805|26866072|FG000|Overall Study|Death|0|||
13421783|NCT00454805|26866073|FG001|Overall Study|Death|2|||
13421784|NCT00454805|26866072|FG000|Overall Study|Disease progression|16|||
13421785|NCT00454805|26866073|FG001|Overall Study|Disease progression|19|||
13421786|NCT00454805|26866072|FG000|Overall Study|In order to begin radiotherapy|1|||
13421787|NCT00454805|26866073|FG001|Overall Study|In order to begin radiotherapy|0|||
13421788|NCT00454779|26866108|FG000|First-line Treatment Phase|Lack of Efficacy|0|||
13421789|NCT00454779|26866109|FG001|First-line Treatment Phase|Lack of Efficacy|2|||
13421790|NCT00454779|26866108|FG000|First-line Treatment Phase|Withdrawal by Subject|2|||
13421791|NCT00454779|26866109|FG001|First-line Treatment Phase|Withdrawal by Subject|4|||
13421792|NCT00454779|26866108|FG000|First-line Treatment Phase|Lost to Follow-up|1|||
13421793|NCT00454779|26866109|FG001|First-line Treatment Phase|Lost to Follow-up|0|||
13421794|NCT00454779|26866108|FG000|First-line Treatment Phase|Protocol Violation|0|||
13421795|NCT00454779|26866109|FG001|First-line Treatment Phase|Protocol Violation|1|||
13421796|NCT00454779|26866108|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
13421797|NCT00454779|26866109|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
13421798|NCT00454779|26866108|FG000|First-line Treatment Phase|Ongoing|1|||
13421799|NCT00454779|26866109|FG001|First-line Treatment Phase|Ongoing|0|||
13421800|NCT00454779|26866108|FG000|Second-line Treatment Phase|Withdrawal by Subject|0|||
13421801|NCT00454779|26866109|FG001|Second-line Treatment Phase|Withdrawal by Subject|1|||
13421802|NCT00454779|26866108|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0|||
13421803|NCT00454779|26866109|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1|||
13421804|NCT00454779|26866108|FG000|Second-line Treatment Phase|Ongoing|0|||
13421805|NCT00454779|26866109|FG001|Second-line Treatment Phase|Ongoing|1|||
13421806|NCT00454649|26866265|FG000|Overall Study|Lack of Efficacy|2|||
13421807|NCT00454649|26866266|FG001|Overall Study|Lack of Efficacy|2|||
13421808|NCT00454649|26866267|FG002|Overall Study|Lack of Efficacy|10|||
13421809|NCT00454649|26866268|FG003|Overall Study|Lack of Efficacy|3|||
13421810|NCT00454649|26866269|FG004|Overall Study|Lack of Efficacy|0|||
13421811|NCT00454649|26866270|FG005|Overall Study|Lack of Efficacy|4|||
13421812|NCT00454649|26866271|FG006|Overall Study|Lack of Efficacy|5|||
13421813|NCT00454649|26866272|FG007|Overall Study|Lack of Efficacy|13|||
13421814|NCT00454649|26866273|FG008|Overall Study|Lack of Efficacy|10|||
13421815|NCT00454649|26866274|FG009|Overall Study|Lack of Efficacy|2|||
13421816|NCT00454649|26866265|FG000|Overall Study|Adverse Event|0|||
13421817|NCT00454649|26866266|FG001|Overall Study|Adverse Event|1|||
13421818|NCT00454649|26866267|FG002|Overall Study|Adverse Event|3|||
13421819|NCT00454649|26866268|FG003|Overall Study|Adverse Event|0|||
13421820|NCT00454649|26866269|FG004|Overall Study|Adverse Event|1|||
13421821|NCT00454649|26866270|FG005|Overall Study|Adverse Event|2|||
13421822|NCT00454649|26866271|FG006|Overall Study|Adverse Event|3|||
13421823|NCT00454649|26866272|FG007|Overall Study|Adverse Event|4|||
13421824|NCT00454649|26866273|FG008|Overall Study|Adverse Event|6|||
13421825|NCT00454649|26866274|FG009|Overall Study|Adverse Event|2|||
13421826|NCT00454649|26866265|FG000|Overall Study|Lost to Follow-up|0|||
13421827|NCT00454649|26866266|FG001|Overall Study|Lost to Follow-up|0|||
13421828|NCT00454649|26866267|FG002|Overall Study|Lost to Follow-up|1|||
13421829|NCT00454649|26866268|FG003|Overall Study|Lost to Follow-up|0|||
13421830|NCT00454649|26866269|FG004|Overall Study|Lost to Follow-up|0|||
13421831|NCT00454649|26866270|FG005|Overall Study|Lost to Follow-up|0|||
13421832|NCT00454649|26866271|FG006|Overall Study|Lost to Follow-up|1|||
13421833|NCT00454649|26866272|FG007|Overall Study|Lost to Follow-up|0|||
13421834|NCT00454649|26866273|FG008|Overall Study|Lost to Follow-up|0|||
13421835|NCT00454649|26866274|FG009|Overall Study|Lost to Follow-up|0|||
13421836|NCT00454649|26866265|FG000|Overall Study|Other|1|||
13421837|NCT00454649|26866266|FG001|Overall Study|Other|1|||
13421838|NCT00454649|26866267|FG002|Overall Study|Other|5|||
13421839|NCT00454649|26866268|FG003|Overall Study|Other|3|||
13421840|NCT00454649|26866269|FG004|Overall Study|Other|0|||
13421841|NCT00454649|26866270|FG005|Overall Study|Other|0|||
13421842|NCT00454649|26866271|FG006|Overall Study|Other|0|||
13421843|NCT00454649|26866272|FG007|Overall Study|Other|0|||
13421844|NCT00454649|26866273|FG008|Overall Study|Other|3|||
13421845|NCT00454649|26866274|FG009|Overall Study|Other|1|||
13421846|NCT00454649|26866265|FG000|Overall Study|Withdrawal by Subject|0|||
13421847|NCT00454649|26866266|FG001|Overall Study|Withdrawal by Subject|0|||
13421848|NCT00454649|26866267|FG002|Overall Study|Withdrawal by Subject|0|||
13421849|NCT00454649|26866268|FG003|Overall Study|Withdrawal by Subject|0|||
13421850|NCT00454649|26866269|FG004|Overall Study|Withdrawal by Subject|0|||
13421851|NCT00454649|26866270|FG005|Overall Study|Withdrawal by Subject|1|||
13421852|NCT00454649|26866271|FG006|Overall Study|Withdrawal by Subject|0|||
13421853|NCT00454649|26866272|FG007|Overall Study|Withdrawal by Subject|2|||
13421854|NCT00454649|26866273|FG008|Overall Study|Withdrawal by Subject|1|||
13421855|NCT00454649|26866274|FG009|Overall Study|Withdrawal by Subject|0|||
13421856|NCT00454636|26866317|FG000|Overall Study|Adverse Event|10|||
13421857|NCT00454636|26866318|FG001|Overall Study|Adverse Event|6|||
13421858|NCT00454636|26866319|FG002|Overall Study|Adverse Event|9|||
13421859|NCT00454636|26866320|FG003|Overall Study|Adverse Event|15|||
13421860|NCT00454636|26866317|FG000|Overall Study|Disease Progression|11|||
13421861|NCT00454636|26866318|FG001|Overall Study|Disease Progression|12|||
13421862|NCT00454636|26866319|FG002|Overall Study|Disease Progression|4|||
13421863|NCT00454636|26866320|FG003|Overall Study|Disease Progression|11|||
13421864|NCT00454636|26866317|FG000|Overall Study|Protocol Violation|3|||
13421865|NCT00454636|26866318|FG001|Overall Study|Protocol Violation|2|||
13421866|NCT00454636|26866319|FG002|Overall Study|Protocol Violation|3|||
13421867|NCT00454636|26866320|FG003|Overall Study|Protocol Violation|3|||
13421868|NCT00454636|26866317|FG000|Overall Study|Death|6|||
13421869|NCT00454636|26866318|FG001|Overall Study|Death|1|||
13421870|NCT00454636|26866319|FG002|Overall Study|Death|1|||
13421871|NCT00454636|26866320|FG003|Overall Study|Death|1|||
13421872|NCT00454636|26866317|FG000|Overall Study|Patient refusal|1|||
13421873|NCT00454636|26866318|FG001|Overall Study|Patient refusal|1|||
13421874|NCT00454636|26866319|FG002|Overall Study|Patient refusal|3|||
13421875|NCT00454636|26866320|FG003|Overall Study|Patient refusal|2|||
13421876|NCT00454636|26866317|FG000|Overall Study|Lost to Follow-up|0|||
13421877|NCT00454636|26866318|FG001|Overall Study|Lost to Follow-up|1|||
13421878|NCT00454636|26866319|FG002|Overall Study|Lost to Follow-up|0|||
13421879|NCT00454636|26866320|FG003|Overall Study|Lost to Follow-up|0|||
13421880|NCT00454584|26866353|FG000|Controlled Period|Adverse Event|5|||
13421881|NCT00454584|26866354|FG001|Controlled Period|Adverse Event|2|||
13421882|NCT00454584|26866355|FG002|Controlled Period|Adverse Event|1|||
13421883|NCT00454584|26866356|FG003|Controlled Period|Adverse Event|0|||
13421884|NCT00454584|26866357|FG004|Controlled Period|Adverse Event|0|||
13421885|NCT00454584|26866358|FG005|Controlled Period|Adverse Event|0|||
13421886|NCT00454584|26866353|FG000|Controlled Period|Lost to Follow-up|1|||
13421887|NCT00454584|26866354|FG001|Controlled Period|Lost to Follow-up|2|||
13421888|NCT00454584|26866355|FG002|Controlled Period|Lost to Follow-up|2|||
13421889|NCT00454584|26866356|FG003|Controlled Period|Lost to Follow-up|0|||
13421890|NCT00454584|26866357|FG004|Controlled Period|Lost to Follow-up|0|||
13421891|NCT00454584|26866358|FG005|Controlled Period|Lost to Follow-up|0|||
13421892|NCT00454584|26866353|FG000|Controlled Period|Other|5|||
13421893|NCT00454584|26866354|FG001|Controlled Period|Other|4|||
13421894|NCT00454584|26866355|FG002|Controlled Period|Other|2|||
13421895|NCT00454584|26866356|FG003|Controlled Period|Other|0|||
13421896|NCT00454584|26866357|FG004|Controlled Period|Other|0|||
13421897|NCT00454584|26866358|FG005|Controlled Period|Other|0|||
13421898|NCT00454584|26866353|FG000|After Controlled Period|Adverse Event|0|||
13421899|NCT00454584|26866354|FG001|After Controlled Period|Adverse Event|0|||
13421900|NCT00454584|26866355|FG002|After Controlled Period|Adverse Event|0|||
13421901|NCT00454584|26866356|FG003|After Controlled Period|Adverse Event|9|||
13421902|NCT00454584|26866357|FG004|After Controlled Period|Adverse Event|3|||
13421903|NCT00454584|26866358|FG005|After Controlled Period|Adverse Event|9|||
13421904|NCT00454584|26866353|FG000|After Controlled Period|Lack of Efficacy|0|||
13421905|NCT00454584|26866354|FG001|After Controlled Period|Lack of Efficacy|0|||
13421906|NCT00454584|26866355|FG002|After Controlled Period|Lack of Efficacy|0|||
13421907|NCT00454584|26866356|FG003|After Controlled Period|Lack of Efficacy|1|||
13421908|NCT00454584|26866357|FG004|After Controlled Period|Lack of Efficacy|0|||
13421909|NCT00454584|26866358|FG005|After Controlled Period|Lack of Efficacy|0|||
13421910|NCT00454584|26866353|FG000|After Controlled Period|Lost to Follow-up|0|||
13421911|NCT00454584|26866354|FG001|After Controlled Period|Lost to Follow-up|0|||
13421912|NCT00454584|26866355|FG002|After Controlled Period|Lost to Follow-up|0|||
13421913|NCT00454584|26866356|FG003|After Controlled Period|Lost to Follow-up|2|||
13421914|NCT00454584|26866357|FG004|After Controlled Period|Lost to Follow-up|4|||
13421915|NCT00454584|26866358|FG005|After Controlled Period|Lost to Follow-up|6|||
13421916|NCT00454584|26866353|FG000|After Controlled Period|Other|0|||
13421917|NCT00454584|26866354|FG001|After Controlled Period|Other|0|||
13421918|NCT00454584|26866355|FG002|After Controlled Period|Other|0|||
13421919|NCT00454584|26866356|FG003|After Controlled Period|Other|1|||
13421920|NCT00454584|26866357|FG004|After Controlled Period|Other|0|||
13421921|NCT00454584|26866358|FG005|After Controlled Period|Other|0|||
13421922|NCT00454584|26866353|FG000|After Controlled Period|Other|0|||
13421923|NCT00454584|26866354|FG001|After Controlled Period|Other|0|||
13421924|NCT00454584|26866355|FG002|After Controlled Period|Other|0|||
13421925|NCT00454584|26866356|FG003|After Controlled Period|Other|13|||
13421926|NCT00454584|26866357|FG004|After Controlled Period|Other|5|||
13421927|NCT00454584|26866358|FG005|After Controlled Period|Other|17|||
13421928|NCT00454571|26866373|FG000|Overall Study|Adverse Event|2|||
13421929|NCT00454571|26866374|FG001|Overall Study|Adverse Event|0|||
13421930|NCT00454571|26866373|FG000|Overall Study|Physician Decision|0|||
13421931|NCT00454571|26866374|FG001|Overall Study|Physician Decision|1|||
13421932|NCT00454571|26866373|FG000|Overall Study|Protocol Violation|1|||
13421933|NCT00454571|26866374|FG001|Overall Study|Protocol Violation|0|||
13421934|NCT00454571|26866373|FG000|Overall Study|Withdrawal by Subject|10|||
13421935|NCT00454571|26866374|FG001|Overall Study|Withdrawal by Subject|5|||
13421936|NCT00454363|26866392|FG000|Overall Study|Adverse Event|1|||
13421937|NCT00454363|26866393|FG001|Overall Study|Adverse Event|2|||
13421938|NCT00454363|26866392|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4|||
13421939|NCT00454363|26866393|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0|||
13421940|NCT00454246|26866417|FG000|Overall Study|Adverse Event|2|||
13421941|NCT00454246|26866418|FG001|Overall Study|Adverse Event|2|||
13421942|NCT00454246|26866419|FG002|Overall Study|Adverse Event|0|||
13421943|NCT00454246|26866417|FG000|Overall Study|Violation of selection criteria at entry|6|||
13421944|NCT00454246|26866418|FG001|Overall Study|Violation of selection criteria at entry|0|||
13421945|NCT00454246|26866419|FG002|Overall Study|Violation of selection criteria at entry|0|||
13421946|NCT00454246|26866417|FG000|Overall Study|Protocol Violation|1|||
13421947|NCT00454246|26866418|FG001|Overall Study|Protocol Violation|0|||
13421948|NCT00454246|26866419|FG002|Overall Study|Protocol Violation|0|||
13421949|NCT00454246|26866417|FG000|Overall Study|Refused Treatment|1|||
13421950|NCT00454246|26866418|FG001|Overall Study|Refused Treatment|1|||
13421951|NCT00454246|26866419|FG002|Overall Study|Refused Treatment|0|||
13421952|NCT00454246|26866417|FG000|Overall Study|Failure to return|1|||
13421953|NCT00454246|26866418|FG001|Overall Study|Failure to return|0|||
13421954|NCT00454246|26866419|FG002|Overall Study|Failure to return|0|||
13421955|NCT00454246|26866417|FG000|Overall Study|Early termination of study|62|||
13421956|NCT00454246|26866418|FG001|Overall Study|Early termination of study|26|||
13421957|NCT00454246|26866419|FG002|Overall Study|Early termination of study|9|||
13421958|NCT00454207|26866469|FG000|Overall Study|Adverse Event|3|||
13421959|NCT00454207|26866470|FG001|Overall Study|Adverse Event|1|||
13421960|NCT00454207|26866469|FG000|Overall Study|Lack of Efficacy|1|||
13421961|NCT00454207|26866470|FG001|Overall Study|Lack of Efficacy|0|||
13421962|NCT00454207|26866469|FG000|Overall Study|Protocol Violation|0|||
13421963|NCT00454207|26866470|FG001|Overall Study|Protocol Violation|1|||
13421964|NCT00454194|26866493|FG000|Overall Study|Adverse Event|7|||
13421965|NCT00454194|26866494|FG001|Overall Study|Adverse Event|2|||
13421966|NCT00454194|26866493|FG000|Overall Study|Withdrawal by Subject|12|||
13421967|NCT00454194|26866494|FG001|Overall Study|Withdrawal by Subject|8|||
13421968|NCT00454194|26866493|FG000|Overall Study|Other Medical Problems|1|||
13421969|NCT00454194|26866494|FG001|Overall Study|Other Medical Problems|2|||
13421970|NCT00454194|26866493|FG000|Overall Study|Other Unspecified Reason|2|||
13421971|NCT00454194|26866494|FG001|Overall Study|Other Unspecified Reason|2|||
13421972|NCT00454181|26866517|FG000|Overall Study|Adverse Event|1|||
13421973|NCT00454181|26866518|FG001|Overall Study|Adverse Event|1|||
13421974|NCT00454181|26866517|FG000|Overall Study|Lost to Follow-up|11|||
13421975|NCT00454181|26866518|FG001|Overall Study|Lost to Follow-up|1|||
13421976|NCT00454181|26866517|FG000|Overall Study|Protocol Violation|1|||
13421977|NCT00454181|26866518|FG001|Overall Study|Protocol Violation|1|||
13421978|NCT00454181|26866517|FG000|Overall Study|Withdrawal by Subject|2|||
13421979|NCT00454181|26866518|FG001|Overall Study|Withdrawal by Subject|0|||
13421980|NCT00454142|26866535|FG000|Overall Study|Withdrawal by Subject|1|||
13421981|NCT00454116|26866553|FG000|Overall Study|Adverse Event|5|||
13421982|NCT00454116|26866554|FG001|Overall Study|Adverse Event|11|||
13421983|NCT00454116|26866555|FG002|Overall Study|Adverse Event|9|||
13421984|NCT00454116|26866553|FG000|Overall Study|Condition under investigation worsened|17|||
13421985|NCT00454116|26866554|FG001|Overall Study|Condition under investigation worsened|13|||
13421986|NCT00454116|26866555|FG002|Overall Study|Condition under investigation worsened|18|||
13421987|NCT00454116|26866553|FG000|Overall Study|Withdrawal by Subject|3|||
13421988|NCT00454116|26866554|FG001|Overall Study|Withdrawal by Subject|3|||
13421989|NCT00454116|26866555|FG002|Overall Study|Withdrawal by Subject|1|||
13421990|NCT00454116|26866553|FG000|Overall Study|Other|2|||
13421991|NCT00454116|26866554|FG001|Overall Study|Other|2|||
13421992|NCT00454116|26866555|FG002|Overall Study|Other|0|||
13421993|NCT00454051|26866592|FG000|Overall Study|Adverse Event|1|||
13421994|NCT00454051|26866593|FG001|Overall Study|Adverse Event|2|||
13421995|NCT00454051|26866592|FG000|Overall Study|Withdrawal by Subject|1|||
13421996|NCT00454051|26866593|FG001|Overall Study|Withdrawal by Subject|0|||
13421997|NCT00454051|26866592|FG000|Overall Study|Protocol Violation|1|||
13421998|NCT00454051|26866593|FG001|Overall Study|Protocol Violation|1|||
13421999|NCT00453999|26866626|FG000|Overall Study|Adverse Event|1|||
13422000|NCT00453999|26866627|FG001|Overall Study|Adverse Event|2|||
13422001|NCT00453999|26866628|FG002|Overall Study|Adverse Event|1|||
13422002|NCT00453999|26866626|FG000|Overall Study|Lost to Follow-up|0|||
13422003|NCT00453999|26866627|FG001|Overall Study|Lost to Follow-up|1|||
13422004|NCT00453999|26866628|FG002|Overall Study|Lost to Follow-up|1|||
13422005|NCT00453999|26866626|FG000|Overall Study|Withdrawal by Subject|2|||
13422006|NCT00453999|26866627|FG001|Overall Study|Withdrawal by Subject|1|||
13422007|NCT00453999|26866628|FG002|Overall Study|Withdrawal by Subject|1|||
13422008|NCT00453999|26866626|FG000|Overall Study|Subject Request|2|||
13422009|NCT00453999|26866627|FG001|Overall Study|Subject Request|1|||
13422010|NCT00453999|26866628|FG002|Overall Study|Subject Request|0|||
13422011|NCT00453986|26866735|FG000|Overall Study|Lost to Follow-up|6|||
13422012|NCT00453986|26866736|FG001|Overall Study|Lost to Follow-up|5|||
13422013|NCT00453986|26866737|FG002|Overall Study|Lost to Follow-up|6|||
13422014|NCT00453986|26866738|FG003|Overall Study|Lost to Follow-up|2|||
13422015|NCT00453986|26866739|FG004|Overall Study|Lost to Follow-up|0|||
13422016|NCT00453973|26866752|FG000|Overall Study|Adverse Event|4|||
13422017|NCT00453973|26866753|FG001|Overall Study|Adverse Event|9|||
13422018|NCT00453973|26866752|FG000|Overall Study|Withdrawal by Subject|7|||
13422019|NCT00453973|26866753|FG001|Overall Study|Withdrawal by Subject|6|||
13422020|NCT00453973|26866752|FG000|Overall Study|PI Decision|0|||
13422021|NCT00453973|26866753|FG001|Overall Study|PI Decision|2|||
13422022|NCT00453973|26866752|FG000|Overall Study|Relocation|1|||
13422023|NCT00453973|26866753|FG001|Overall Study|Relocation|0|||
13422024|NCT00453973|26866752|FG000|Overall Study|Renal transplant|1|||
13422025|NCT00453973|26866753|FG001|Overall Study|Renal transplant|1|||
13422026|NCT00453973|26866752|FG000|Overall Study|Site closed by sponsor|3|||
13422027|NCT00453973|26866753|FG001|Overall Study|Site closed by sponsor|0|||
13422028|NCT00453973|26866752|FG000|Overall Study|Sponsor Decision to Terminate Study|35|||
13422029|NCT00453973|26866753|FG001|Overall Study|Sponsor Decision to Terminate Study|30|||
13422030|NCT00453921|26866800|FG000|Overall Study|Withdrawal by Subject|1|||
13422031|NCT00453921|26866801|FG001|Overall Study|Withdrawal by Subject|1|||
13422032|NCT00453921|26866802|FG002|Overall Study|Withdrawal by Subject|1|||
13422033|NCT00453921|26866803|FG003|Overall Study|Withdrawal by Subject|1|||
13422034|NCT00453921|26866800|FG000|Overall Study|Lost to Follow-up|0|||
13422035|NCT00453921|26866801|FG001|Overall Study|Lost to Follow-up|0|||
13422036|NCT00453921|26866802|FG002|Overall Study|Lost to Follow-up|1|||
13422037|NCT00453921|26866803|FG003|Overall Study|Lost to Follow-up|0|||
13422038|NCT00453362|26866829|FG000|Overall Study|Adverse Event|5|||
13422039|NCT00453362|26866829|FG000|Overall Study|Death|7|||
13422040|NCT00453362|26866829|FG000|Overall Study|Physician Decision|2|||
13422041|NCT00453362|26866829|FG000|Overall Study|Withdrawal by Subject|3|||
13422042|NCT00453362|26866829|FG000|Overall Study|Progression of disease|56|||
13422043|NCT00453362|26866829|FG000|Overall Study|Screening Failure|14|||
13422044|NCT00453349|26866862|FG000|Randomized|Adverse Event|12|||
13422045|NCT00453349|26866863|FG001|Randomized|Adverse Event|11|||
13422046|NCT00453349|26866862|FG000|Randomized|Lack of Efficacy|2|||
13422047|NCT00453349|26866863|FG001|Randomized|Lack of Efficacy|1|||
13422048|NCT00453349|26866862|FG000|Randomized|Lost to Follow-up|7|||
13422049|NCT00453349|26866863|FG001|Randomized|Lost to Follow-up|5|||
13422050|NCT00453349|26866862|FG000|Randomized|Protocol Violation|1|||
13422051|NCT00453349|26866863|FG001|Randomized|Protocol Violation|1|||
13422052|NCT00453349|26866862|FG000|Randomized|Withdrawal by Subject|3|||
13422053|NCT00453349|26866863|FG001|Randomized|Withdrawal by Subject|5|||
13422054|NCT00453349|26866862|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10|||
13422055|NCT00453349|26866863|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11|||
13422056|NCT00453349|26866862|FG000|Completed Study|Adverse Event|12|||
13422057|NCT00453349|26866863|FG001|Completed Study|Adverse Event|11|||
13422058|NCT00453349|26866862|FG000|Completed Study|Lack of Efficacy|2|||
13422059|NCT00453349|26866863|FG001|Completed Study|Lack of Efficacy|1|||
13422060|NCT00453349|26866862|FG000|Completed Study|Lost to Follow-up|7|||
13422061|NCT00453349|26866863|FG001|Completed Study|Lost to Follow-up|5|||
13422062|NCT00453349|26866862|FG000|Completed Study|Protocol Violation|1|||
13422063|NCT00453349|26866863|FG001|Completed Study|Protocol Violation|1|||
13422064|NCT00453349|26866862|FG000|Completed Study|Withdrawal by Subject|3|||
13422065|NCT00453349|26866863|FG001|Completed Study|Withdrawal by Subject|5|||
13422066|NCT00453349|26866862|FG000|Completed Study|Lost to follow up after study treatment|2|||
13422067|NCT00453349|26866863|FG001|Completed Study|Lost to follow up after study treatment|11|||
13422068|NCT00453310|26866869|FG000|Overall Study|Progression of Disease|10|||
13422069|NCT00453206|26866875|FG000|Overall Study|Death|1|||
13422070|NCT00453180|26866898|FG000|Overall Study|Lost to Follow-up|2|||
13422071|NCT00453180|26866899|FG001|Overall Study|Lost to Follow-up|1|||
13422072|NCT00453180|26866898|FG000|Overall Study|Adverse Event|1|||
13422073|NCT00453180|26866899|FG001|Overall Study|Adverse Event|2|||
13422074|NCT00453154|26866923|FG000|Double BIind Maintenance|Adverse Event|0|||
13422075|NCT00453154|26866924|FG001|Double BIind Maintenance|Adverse Event|0|||
13422076|NCT00453154|26866925|FG002|Double BIind Maintenance|Adverse Event|3|||
13422077|NCT00453154|26866926|FG003|Double BIind Maintenance|Adverse Event|12|||
13422078|NCT00453154|26866923|FG000|Double BIind Maintenance|Death|0|||
13422079|NCT00453154|26866924|FG001|Double BIind Maintenance|Death|0|||
13422080|NCT00453154|26866925|FG002|Double BIind Maintenance|Death|2|||
13422081|NCT00453154|26866926|FG003|Double BIind Maintenance|Death|1|||
13422082|NCT00453154|26866923|FG000|Double BIind Maintenance|Withdrawal by Subject|0|||
13422083|NCT00453154|26866924|FG001|Double BIind Maintenance|Withdrawal by Subject|0|||
13422084|NCT00453154|26866925|FG002|Double BIind Maintenance|Withdrawal by Subject|4|||
13422085|NCT00453154|26866926|FG003|Double BIind Maintenance|Withdrawal by Subject|4|||
13422086|NCT00453154|26866923|FG000|Double BIind Maintenance|Progression|0|||
13422087|NCT00453154|26866924|FG001|Double BIind Maintenance|Progression|0|||
13422088|NCT00453154|26866925|FG002|Double BIind Maintenance|Progression|29|||
13422089|NCT00453154|26866926|FG003|Double BIind Maintenance|Progression|26|||
13422090|NCT00453154|26866923|FG000|Double BIind Maintenance|Medical Issues|0|||
13422091|NCT00453154|26866924|FG001|Double BIind Maintenance|Medical Issues|0|||
13422092|NCT00453154|26866925|FG002|Double BIind Maintenance|Medical Issues|3|||
13422093|NCT00453154|26866926|FG003|Double BIind Maintenance|Medical Issues|1|||
13422094|NCT00453154|26866923|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0|||
13422095|NCT00453154|26866924|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0|||
13422096|NCT00453154|26866925|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5|||
13422097|NCT00453154|26866926|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5|||
13422098|NCT00453102|26866937|FG000|Overall Study|Withdrawal by Subject|2|||
13422099|NCT00453063|26866958|FG000|Overall Study|Adverse Event|1|||
13422100|NCT00453063|26866959|FG001|Overall Study|Adverse Event|2|||
13422101|NCT00453063|26866958|FG000|Overall Study|Withdrawal by Subject|1|||
13422102|NCT00453063|26866959|FG001|Overall Study|Withdrawal by Subject|1|||
13422103|NCT00453063|26866958|FG000|Overall Study|Protocol Violation|1|||
13422104|NCT00453063|26866959|FG001|Overall Study|Protocol Violation|0|||
13422105|NCT00452790|26867000|FG000|Infant Series|Clinical hold - consent withdrawn|118|||
13422106|NCT00452790|26867001|FG001|Infant Series|Clinical hold - consent withdrawn|123|||
13422107|NCT00452790|26867000|FG000|Infant Series|Parent/legal guardian request|8|||
13422108|NCT00452790|26867001|FG001|Infant Series|Parent/legal guardian request|6|||
13422109|NCT00452790|26867000|FG000|Infant Series|Failed to return|4|||
13422110|NCT00452790|26867001|FG001|Infant Series|Failed to return|1|||
13422111|NCT00452790|26867000|FG000|Infant Series|Protocol Violation|1|||
13422112|NCT00452790|26867001|FG001|Infant Series|Protocol Violation|3|||
13422113|NCT00452790|26867000|FG000|Infant Series|Lost to Follow-up|2|||
13422114|NCT00452790|26867001|FG001|Infant Series|Lost to Follow-up|2|||
13422115|NCT00452790|26867000|FG000|Infant Series|Adverse Event|1|||
13422116|NCT00452790|26867001|FG001|Infant Series|Adverse Event|2|||
13422117|NCT00452790|26867000|FG000|Infant Series|Other reasons|1|||
13422118|NCT00452790|26867001|FG001|Infant Series|Other reasons|2|||
13422119|NCT00452790|26867000|FG000|Infant Series|Investigator request|0|||
13422120|NCT00452790|26867001|FG001|Infant Series|Investigator request|1|||
13422121|NCT00452790|26867000|FG000|Infant Series|Death|0|||
13422122|NCT00452790|26867001|FG001|Infant Series|Death|1|||
13422123|NCT00452790|26867000|FG000|After Infant Series|Investigator request|10|||
13422124|NCT00452790|26867001|FG001|After Infant Series|Investigator request|10|||
13422125|NCT00452790|26867000|FG000|After Infant Series|Adverse Event|4|||
13422126|NCT00452790|26867001|FG001|After Infant Series|Adverse Event|1|||
13422127|NCT00452790|26867000|FG000|After Infant Series|Parent/legal guardian request|1|||
13422128|NCT00452790|26867001|FG001|After Infant Series|Parent/legal guardian request|3|||
13422129|NCT00452790|26867000|FG000|After Infant Series|Lost to Follow-up|4|||
13422130|NCT00452790|26867001|FG001|After Infant Series|Lost to Follow-up|0|||
13422131|NCT00452790|26867000|FG000|After Infant Series|Failed to return|1|||
13422132|NCT00452790|26867001|FG001|After Infant Series|Failed to return|0|||
13422133|NCT00452790|26867000|FG000|After Infant Series|Other reasons|1|||
13422134|NCT00452790|26867001|FG001|After Infant Series|Other reasons|0|||
13422135|NCT00452790|26867000|FG000|Toddler Dose|Failed to return|0|||
13422136|NCT00452790|26867001|FG001|Toddler Dose|Failed to return|1|||
13422137|NCT00452790|26867000|FG000|Toddler Dose|Parent/legal guardian request|0|||
13422138|NCT00452790|26867001|FG001|Toddler Dose|Parent/legal guardian request|1|||
13422139|NCT00452699|26867020|FG000|Overall Study|Adverse Event|10|||
13422140|NCT00452699|26867021|FG001|Overall Study|Adverse Event|3|||
13422141|NCT00452699|26867020|FG000|Overall Study|Lack of Efficacy|6|||
13422142|NCT00452699|26867021|FG001|Overall Study|Lack of Efficacy|4|||
13422143|NCT00452699|26867020|FG000|Overall Study|Lost to Follow-up|6|||
13422144|NCT00452699|26867021|FG001|Overall Study|Lost to Follow-up|9|||
13422145|NCT00452699|26867020|FG000|Overall Study|Protocol Violation|21|||
13422146|NCT00452699|26867021|FG001|Overall Study|Protocol Violation|25|||
13422147|NCT00452699|26867020|FG000|Overall Study|Withdrawal by Subject|26|||
13422148|NCT00452699|26867021|FG001|Overall Study|Withdrawal by Subject|25|||
13422149|NCT00452699|26867020|FG000|Overall Study|Other|12|||
13422150|NCT00452699|26867021|FG001|Overall Study|Other|7|||
13422151|NCT00452673|26867065|FG000|Dose Escalation Period|Disease Progression|6|||
13422152|NCT00452673|26867066|FG001|Dose Escalation Period|Disease Progression|6|||
13422153|NCT00452673|26867067|FG002|Dose Escalation Period|Disease Progression|2|||
13422154|NCT00452673|26867068|FG003|Dose Escalation Period|Disease Progression|6|||
13422155|NCT00452673|26867069|FG004|Dose Escalation Period|Disease Progression|0|||
13422156|NCT00452673|26867065|FG000|Dose Escalation Period|study drug toxicity|1|||
13422157|NCT00452673|26867066|FG001|Dose Escalation Period|study drug toxicity|3|||
13422158|NCT00452673|26867067|FG002|Dose Escalation Period|study drug toxicity|3|||
13422159|NCT00452673|26867068|FG003|Dose Escalation Period|study drug toxicity|1|||
13422160|NCT00452673|26867069|FG004|Dose Escalation Period|study drug toxicity|0|||
13422161|NCT00452673|26867065|FG000|Dose Escalation Period|Other|0|||
13422162|NCT00452673|26867066|FG001|Dose Escalation Period|Other|0|||
13422163|NCT00452673|26867067|FG002|Dose Escalation Period|Other|1|||
13422164|NCT00452673|26867068|FG003|Dose Escalation Period|Other|0|||
13422165|NCT00452673|26867069|FG004|Dose Escalation Period|Other|0|||
13422166|NCT00452673|26867065|FG000|Dose Escalation Period|Adverse Event|0|||
13422167|NCT00452673|26867066|FG001|Dose Escalation Period|Adverse Event|0|||
13422168|NCT00452673|26867067|FG002|Dose Escalation Period|Adverse Event|0|||
13422169|NCT00452673|26867068|FG003|Dose Escalation Period|Adverse Event|1|||
13422170|NCT00452673|26867069|FG004|Dose Escalation Period|Adverse Event|0|||
13422171|NCT00452673|26867065|FG000|Dose Escalation Period|Withdrawal by Subject|0|||
13422172|NCT00452673|26867066|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
13422173|NCT00452673|26867067|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
13422174|NCT00452673|26867068|FG003|Dose Escalation Period|Withdrawal by Subject|1|||
13422175|NCT00452673|26867069|FG004|Dose Escalation Period|Withdrawal by Subject|0|||
13422176|NCT00452673|26867065|FG000|Dose Expansion Period|Disease Progression|0|||
13422177|NCT00452673|26867066|FG001|Dose Expansion Period|Disease Progression|0|||
13422178|NCT00452673|26867067|FG002|Dose Expansion Period|Disease Progression|0|||
13422179|NCT00452673|26867068|FG003|Dose Expansion Period|Disease Progression|0|||
13422180|NCT00452673|26867069|FG004|Dose Expansion Period|Disease Progression|19|||
13422181|NCT00452673|26867065|FG000|Dose Expansion Period|Other|0|||
13422182|NCT00452673|26867066|FG001|Dose Expansion Period|Other|0|||
13422183|NCT00452673|26867067|FG002|Dose Expansion Period|Other|0|||
13422184|NCT00452673|26867068|FG003|Dose Expansion Period|Other|0|||
13422185|NCT00452673|26867069|FG004|Dose Expansion Period|Other|2|||
13422186|NCT00452530|26867094|FG000|Overall Study|Death|1|||
13422187|NCT00452530|26867095|FG001|Overall Study|Death|0|||
13422188|NCT00452530|26867094|FG000|Overall Study|Adverse Event|40|||
13422189|NCT00452530|26867095|FG001|Overall Study|Adverse Event|44|||
13422190|NCT00452530|26867094|FG000|Overall Study|Withdrawal by Subject|68|||
13422191|NCT00452530|26867095|FG001|Overall Study|Withdrawal by Subject|57|||
13422192|NCT00452530|26867094|FG000|Overall Study|Lost to Follow-up|1|||
13422193|NCT00452530|26867095|FG001|Overall Study|Lost to Follow-up|0|||
13422194|NCT00452530|26867094|FG000|Overall Study|Poor compliance/noncompliance|1|||
13422195|NCT00452530|26867095|FG001|Overall Study|Poor compliance/noncompliance|2|||
13422196|NCT00452530|26867094|FG000|Overall Study|No longer met study criteria|18|||
13422197|NCT00452530|26867095|FG001|Overall Study|No longer met study criteria|22|||
13422198|NCT00452530|26867094|FG000|Overall Study|Other|7|||
13422199|NCT00452530|26867095|FG001|Overall Study|Other|11|||
13422200|NCT00452452|26867128|FG000|Overall Study|Protocol Violation|0|||
13422201|NCT00452452|26867129|FG001|Overall Study|Protocol Violation|0|||
13422202|NCT00452452|26867130|FG002|Overall Study|Protocol Violation|1|||
13422203|NCT00452452|26867128|FG000|Overall Study|Withdrawal by Subject|1|||
13422204|NCT00452452|26867129|FG001|Overall Study|Withdrawal by Subject|0|||
13422205|NCT00452452|26867130|FG002|Overall Study|Withdrawal by Subject|0|||
13422206|NCT00452452|26867128|FG000|Overall Study|Lost to Follow-up|1|||
13422207|NCT00452452|26867129|FG001|Overall Study|Lost to Follow-up|0|||
13422208|NCT00452452|26867130|FG002|Overall Study|Lost to Follow-up|0|||
13422209|NCT00452439|26867145|FG000|Overall Study|Lost to Follow-up|1|||
13422210|NCT00452439|26867146|FG001|Overall Study|Lost to Follow-up|1|||
13422211|NCT00452439|26867145|FG000|Overall Study|Refused Treatment|4|||
13422212|NCT00452439|26867146|FG001|Overall Study|Refused Treatment|3|||
13422213|NCT00452439|26867145|FG000|Overall Study|Death|3|||
13422214|NCT00452439|26867146|FG001|Overall Study|Death|1|||
13422215|NCT00452439|26867145|FG000|Overall Study|Bone Marrow Transplant|0|||
13422216|NCT00452439|26867146|FG001|Overall Study|Bone Marrow Transplant|1|||
13422217|NCT00452439|26867145|FG000|Overall Study|Too Ill to Continue|0|||
13422218|NCT00452439|26867146|FG001|Overall Study|Too Ill to Continue|1|||
13422219|NCT00452439|26867145|FG000|Overall Study|Failed to achieve complete response|2|||
13422220|NCT00452439|26867146|FG001|Overall Study|Failed to achieve complete response|0|||
13422221|NCT00452439|26867145|FG000|Overall Study|Relapse|3|||
13422222|NCT00452439|26867146|FG001|Overall Study|Relapse|0|||
13422223|NCT00452439|26867145|FG000|Overall Study|Fracture|1|||
13422224|NCT00452439|26867146|FG001|Overall Study|Fracture|0|||
13422225|NCT00452413|26867175|FG000|Overall Study|Progressive Disease|4|||
13422226|NCT00452413|26867176|FG001|Overall Study|Progressive Disease|11|||
13422227|NCT00452413|26867177|FG002|Overall Study|Progressive Disease|30|||
13422228|NCT00452413|26867175|FG000|Overall Study|Withdrawal by Subject|0|||
13422229|NCT00452413|26867176|FG001|Overall Study|Withdrawal by Subject|1|||
13422230|NCT00452413|26867177|FG002|Overall Study|Withdrawal by Subject|4|||
13422231|NCT00452413|26867175|FG000|Overall Study|Adverse Event|0|||
13422232|NCT00452413|26867176|FG001|Overall Study|Adverse Event|0|||
13422233|NCT00452413|26867177|FG002|Overall Study|Adverse Event|5|||
13422234|NCT00452413|26867175|FG000|Overall Study|Physician Decision|0|||
13422235|NCT00452413|26867176|FG001|Overall Study|Physician Decision|0|||
13422236|NCT00452413|26867177|FG002|Overall Study|Physician Decision|4|||
13422237|NCT00452413|26867175|FG000|Overall Study|Death due to study disease|0|||
13422238|NCT00452413|26867176|FG001|Overall Study|Death due to study disease|0|||
13422239|NCT00452413|26867177|FG002|Overall Study|Death due to study disease|2|||
13422240|NCT00452413|26867175|FG000|Overall Study|Death due to adverse event (AE)|0|||
13422241|NCT00452413|26867176|FG001|Overall Study|Death due to adverse event (AE)|0|||
13422242|NCT00452413|26867177|FG002|Overall Study|Death due to adverse event (AE)|1|||
13422243|NCT00452413|26867175|FG000|Overall Study|On treatment|0|||
13422244|NCT00452413|26867176|FG001|Overall Study|On treatment|0|||
13422245|NCT00452413|26867177|FG002|Overall Study|On treatment|3|||
13422246|NCT00452400|26867365|FG000|Overall Study|Adverse Event|1|||
13422247|NCT00452400|26867366|FG001|Overall Study|Adverse Event|1|||
13422248|NCT00452400|26867367|FG002|Overall Study|Adverse Event|5|||
13422249|NCT00452400|26867368|FG003|Overall Study|Adverse Event|0|||
13422250|NCT00452400|26867369|FG004|Overall Study|Adverse Event|2|||
13422251|NCT00452400|26867365|FG000|Overall Study|Protocol Violation|0|||
13422252|NCT00452400|26867366|FG001|Overall Study|Protocol Violation|0|||
13422253|NCT00452400|26867367|FG002|Overall Study|Protocol Violation|1|||
13422254|NCT00452400|26867368|FG003|Overall Study|Protocol Violation|0|||
13422255|NCT00452400|26867369|FG004|Overall Study|Protocol Violation|0|||
13422256|NCT00452400|26867365|FG000|Overall Study|Lost to Follow-up|1|||
13422257|NCT00452400|26867366|FG001|Overall Study|Lost to Follow-up|0|||
13422258|NCT00452400|26867367|FG002|Overall Study|Lost to Follow-up|0|||
13422259|NCT00452400|26867368|FG003|Overall Study|Lost to Follow-up|0|||
13422260|NCT00452400|26867369|FG004|Overall Study|Lost to Follow-up|0|||
13422261|NCT00452400|26867365|FG000|Overall Study|Withdrawal by Subject|1|||
13422262|NCT00452400|26867366|FG001|Overall Study|Withdrawal by Subject|0|||
13422263|NCT00452400|26867367|FG002|Overall Study|Withdrawal by Subject|1|||
13422264|NCT00452400|26867368|FG003|Overall Study|Withdrawal by Subject|0|||
13422265|NCT00452400|26867369|FG004|Overall Study|Withdrawal by Subject|0|||
13422266|NCT00452400|26867365|FG000|Overall Study|Lack of Efficacy|2|||
13422267|NCT00452400|26867366|FG001|Overall Study|Lack of Efficacy|0|||
13422268|NCT00452400|26867367|FG002|Overall Study|Lack of Efficacy|0|||
13422269|NCT00452400|26867368|FG003|Overall Study|Lack of Efficacy|0|||
13422270|NCT00452400|26867369|FG004|Overall Study|Lack of Efficacy|0|||
13422271|NCT00452400|26867365|FG000|Overall Study|Other reasons not listed above|0|||
13422272|NCT00452400|26867366|FG001|Overall Study|Other reasons not listed above|0|||
13422273|NCT00452400|26867367|FG002|Overall Study|Other reasons not listed above|0|||
13422274|NCT00452400|26867368|FG003|Overall Study|Other reasons not listed above|1|||
13422275|NCT00452400|26867369|FG004|Overall Study|Other reasons not listed above|1|||
13422276|NCT00452361|26867418|FG000|Overall Study|Adverse Event|8|||
13422277|NCT00452361|26867419|FG001|Overall Study|Adverse Event|0|||
13422278|NCT00452361|26867418|FG000|Overall Study|Withdrawal by Subject|0|||
13422279|NCT00452361|26867419|FG001|Overall Study|Withdrawal by Subject|1|||
13422280|NCT00452361|26867418|FG000|Overall Study|Premature termination|13|||
13422281|NCT00452361|26867419|FG001|Overall Study|Premature termination|9|||
13422282|NCT00452348|26867438|FG000|Overall Study|Adverse Event|6|||
13422283|NCT00452348|26867439|FG001|Overall Study|Adverse Event|9|||
13422284|NCT00452348|26867438|FG000|Overall Study|Lack of Efficacy|10|||
13422285|NCT00452348|26867439|FG001|Overall Study|Lack of Efficacy|9|||
13422286|NCT00452348|26867438|FG000|Overall Study|Lost to Follow-up|14|||
13422287|NCT00452348|26867439|FG001|Overall Study|Lost to Follow-up|8|||
13422288|NCT00452348|26867438|FG000|Overall Study|Protocol Violation|22|||
13422289|NCT00452348|26867439|FG001|Overall Study|Protocol Violation|28|||
13422290|NCT00452348|26867438|FG000|Overall Study|Withdrawal by Subject|18|||
13422291|NCT00452348|26867439|FG001|Overall Study|Withdrawal by Subject|21|||
13422292|NCT00452348|26867438|FG000|Overall Study|Other|9|||
13422293|NCT00452348|26867439|FG001|Overall Study|Other|9|||
13422294|NCT00452114|26867458|FG000|Overall Study|Physician Decision|3|||
13422295|NCT00452114|26867459|FG001|Overall Study|Physician Decision|3|||
13422296|NCT00451958|26867503|FG000|CS21A (NCT00451958)|Adverse Event|21|||
13422297|NCT00451958|26867504|FG001|CS21A (NCT00451958)|Adverse Event|34|||
13422298|NCT00451958|26867505|FG002|CS21A (NCT00451958)|Adverse Event|14|||
13422299|NCT00451958|26867506|FG003|CS21A (NCT00451958)|Adverse Event|17|||
13422300|NCT00451958|26867507|FG004|CS21A (NCT00451958)|Adverse Event|0|||
13422301|NCT00451958|26867503|FG000|CS21A (NCT00451958)|Lost to Follow-up|6|||
13422302|NCT00451958|26867504|FG001|CS21A (NCT00451958)|Lost to Follow-up|5|||
13422303|NCT00451958|26867505|FG002|CS21A (NCT00451958)|Lost to Follow-up|1|||
13422304|NCT00451958|26867506|FG003|CS21A (NCT00451958)|Lost to Follow-up|1|||
13422305|NCT00451958|26867507|FG004|CS21A (NCT00451958)|Lost to Follow-up|0|||
13422306|NCT00451958|26867503|FG000|CS21A (NCT00451958)|Protocol Violation|1|||
13422307|NCT00451958|26867504|FG001|CS21A (NCT00451958)|Protocol Violation|3|||
13422308|NCT00451958|26867505|FG002|CS21A (NCT00451958)|Protocol Violation|2|||
13422309|NCT00451958|26867506|FG003|CS21A (NCT00451958)|Protocol Violation|0|||
13422310|NCT00451958|26867507|FG004|CS21A (NCT00451958)|Protocol Violation|0|||
13422311|NCT00451958|26867503|FG000|CS21A (NCT00451958)|Physician Decision|2|||
13422312|NCT00451958|26867504|FG001|CS21A (NCT00451958)|Physician Decision|4|||
13422313|NCT00451958|26867505|FG002|CS21A (NCT00451958)|Physician Decision|4|||
13422314|NCT00451958|26867506|FG003|CS21A (NCT00451958)|Physician Decision|4|||
13422315|NCT00451958|26867507|FG004|CS21A (NCT00451958)|Physician Decision|0|||
13422316|NCT00451958|26867503|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7|||
13422317|NCT00451958|26867504|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4|||
13422318|NCT00451958|26867505|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4|||
13422319|NCT00451958|26867506|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3|||
13422320|NCT00451958|26867507|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0|||
13422321|NCT00451958|26867503|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28|||
13422322|NCT00451958|26867504|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27|||
13422323|NCT00451958|26867505|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17|||
13422324|NCT00451958|26867506|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14|||
13422325|NCT00451958|26867507|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0|||
13422326|NCT00451906|26867517|FG000|Overall Study|Adverse Event|515|||
13422327|NCT00451906|26867517|FG000|Overall Study|Lost to Follow-up|31|||
13422328|NCT00451906|26867517|FG000|Overall Study|Withdrawal by Subject|111|||
13422329|NCT00451906|26867517|FG000|Overall Study|Protocol Violation|21|||
13422330|NCT00451906|26867517|FG000|Overall Study|Progressive disease|1328|||
13422331|NCT00451906|26867517|FG000|Overall Study|Termination of the study|108|||
13422332|NCT00451906|26867517|FG000|Overall Study|Other Reasons|121|||
13422333|NCT00451906|26867517|FG000|Overall Study|Did not complete final visit|4|||
13422334|NCT00451555|26867556|FG000|Overall Study|Protocol Violation|2|||
13422335|NCT00451555|26867557|FG001|Overall Study|Protocol Violation|2|||
13422336|NCT00451555|26867556|FG000|Overall Study|Adverse Event|3|||
13422337|NCT00451555|26867557|FG001|Overall Study|Adverse Event|1|||
13422338|NCT00451555|26867556|FG000|Overall Study|Withdrawal by Subject|6|||
13422339|NCT00451555|26867557|FG001|Overall Study|Withdrawal by Subject|0|||
13422340|NCT00451555|26867556|FG000|Overall Study|Physician Decision|2|||
13422341|NCT00451555|26867557|FG001|Overall Study|Physician Decision|1|||
13422342|NCT00451451|26867597|FG000|Overall Study|Adverse Event|11|||
13422343|NCT00451451|26867598|FG001|Overall Study|Adverse Event|21|||
13422344|NCT00451451|26867599|FG002|Overall Study|Adverse Event|26|||
13422345|NCT00451451|26867600|FG003|Overall Study|Adverse Event|10|||
13422346|NCT00451451|26867597|FG000|Overall Study|Lost to Follow-up|11|||
13422347|NCT00451451|26867598|FG001|Overall Study|Lost to Follow-up|9|||
13422348|NCT00451451|26867599|FG002|Overall Study|Lost to Follow-up|8|||
13422349|NCT00451451|26867600|FG003|Overall Study|Lost to Follow-up|11|||
13422350|NCT00451451|26867597|FG000|Overall Study|Consent Withdrawn|14|||
13422351|NCT00451451|26867598|FG001|Overall Study|Consent Withdrawn|9|||
13422352|NCT00451451|26867599|FG002|Overall Study|Consent Withdrawn|17|||
13422353|NCT00451451|26867600|FG003|Overall Study|Consent Withdrawn|17|||
13422354|NCT00451451|26867597|FG000|Overall Study|Investigator Decision|6|||
13422355|NCT00451451|26867598|FG001|Overall Study|Investigator Decision|2|||
13422356|NCT00451451|26867599|FG002|Overall Study|Investigator Decision|1|||
13422357|NCT00451451|26867600|FG003|Overall Study|Investigator Decision|2|||
13422358|NCT00451451|26867597|FG000|Overall Study|Subject Non-Compliance|8|||
13422359|NCT00451451|26867598|FG001|Overall Study|Subject Non-Compliance|4|||
13422360|NCT00451451|26867599|FG002|Overall Study|Subject Non-Compliance|3|||
13422361|NCT00451451|26867600|FG003|Overall Study|Subject Non-Compliance|3|||
13422362|NCT00451451|26867597|FG000|Overall Study|Death|1|||
13422363|NCT00451451|26867598|FG001|Overall Study|Death|0|||
13422364|NCT00451451|26867599|FG002|Overall Study|Death|0|||
13422365|NCT00451451|26867600|FG003|Overall Study|Death|1|||
13422366|NCT00451451|26867597|FG000|Overall Study|Other Reasons for Not Completing Study|34|||
13422367|NCT00451451|26867598|FG001|Overall Study|Other Reasons for Not Completing Study|30|||
13422368|NCT00451451|26867599|FG002|Overall Study|Other Reasons for Not Completing Study|17|||
13422369|NCT00451451|26867600|FG003|Overall Study|Other Reasons for Not Completing Study|14|||
13422370|NCT00451321|26867795|FG000|Overall Study|Lost to Follow-up|3|||
13422371|NCT00451321|26867796|FG001|Overall Study|Lost to Follow-up|3|||
13422372|NCT00451321|26867797|FG002|Overall Study|Lost to Follow-up|1|||
13422373|NCT00451321|26867798|FG003|Overall Study|Lost to Follow-up|3|||
13422374|NCT00451321|26867799|FG004|Overall Study|Lost to Follow-up|0|||
13422375|NCT00451321|26867800|FG005|Overall Study|Lost to Follow-up|1|||
13422376|NCT00451321|26867801|FG006|Overall Study|Lost to Follow-up|0|||
13422377|NCT00451321|26867802|FG007|Overall Study|Lost to Follow-up|0|||
13422378|NCT00451321|26867795|FG000|Overall Study|Withdrawal by Subject|3|||
13422379|NCT00451321|26867796|FG001|Overall Study|Withdrawal by Subject|1|||
13422380|NCT00451321|26867797|FG002|Overall Study|Withdrawal by Subject|0|||
13422381|NCT00451321|26867798|FG003|Overall Study|Withdrawal by Subject|4|||
13422382|NCT00451321|26867799|FG004|Overall Study|Withdrawal by Subject|0|||
13422383|NCT00451321|26867800|FG005|Overall Study|Withdrawal by Subject|0|||
13422384|NCT00451321|26867801|FG006|Overall Study|Withdrawal by Subject|0|||
13422385|NCT00451321|26867802|FG007|Overall Study|Withdrawal by Subject|0|||
13422386|NCT00451321|26867795|FG000|Overall Study|Study closed/terminated|1|||
13422387|NCT00451321|26867796|FG001|Overall Study|Study closed/terminated|1|||
13422388|NCT00451321|26867797|FG002|Overall Study|Study closed/terminated|17|||
13422389|NCT00451321|26867798|FG003|Overall Study|Study closed/terminated|5|||
13422390|NCT00451321|26867799|FG004|Overall Study|Study closed/terminated|7|||
13422391|NCT00451321|26867800|FG005|Overall Study|Study closed/terminated|7|||
13422392|NCT00451321|26867801|FG006|Overall Study|Study closed/terminated|5|||
13422393|NCT00451321|26867802|FG007|Overall Study|Study closed/terminated|3|||
13422394|NCT00451321|26867795|FG000|Overall Study|Sponsor decision to amend protocol|0|||
13422395|NCT00451321|26867796|FG001|Overall Study|Sponsor decision to amend protocol|0|||
13422396|NCT00451321|26867797|FG002|Overall Study|Sponsor decision to amend protocol|0|||
13422397|NCT00451321|26867798|FG003|Overall Study|Sponsor decision to amend protocol|0|||
13422398|NCT00451321|26867799|FG004|Overall Study|Sponsor decision to amend protocol|0|||
13422399|NCT00451321|26867800|FG005|Overall Study|Sponsor decision to amend protocol|1|||
13422400|NCT00451321|26867801|FG006|Overall Study|Sponsor decision to amend protocol|1|||
13422401|NCT00451321|26867802|FG007|Overall Study|Sponsor decision to amend protocol|3|||
13422402|NCT00451282|26867821|FG000|Overall Study|Lost to Follow-up|6|||
13422403|NCT00451282|26867822|FG001|Overall Study|Lost to Follow-up|5|||
13422404|NCT00451217|26867861|FG000|Overall Study|Lost to Follow-up|0|||
13422405|NCT00451217|26867862|FG001|Overall Study|Lost to Follow-up|1|||
13422406|NCT00451217|26867863|FG002|Overall Study|Lost to Follow-up|1|||
13422407|NCT00451217|26867864|FG003|Overall Study|Lost to Follow-up|1|||
13422408|NCT00451217|26867861|FG000|Overall Study|Withdrawal by Subject|1|||
13422409|NCT00451217|26867862|FG001|Overall Study|Withdrawal by Subject|0|||
13422410|NCT00451217|26867863|FG002|Overall Study|Withdrawal by Subject|0|||
13422411|NCT00451217|26867864|FG003|Overall Study|Withdrawal by Subject|0|||
13422412|NCT00451217|26867861|FG000|Overall Study|Not Treated|1|||
13422413|NCT00451217|26867862|FG001|Overall Study|Not Treated|1|||
13422414|NCT00451217|26867863|FG002|Overall Study|Not Treated|3|||
13422415|NCT00451217|26867864|FG003|Overall Study|Not Treated|4|||
13422416|NCT00451204|26867887|FG000|Overall Study|Adverse Event|4|||
13422417|NCT00451204|26867888|FG001|Overall Study|Adverse Event|6|||
13422418|NCT00451204|26867887|FG000|Overall Study|Lack of Efficacy|4|||
13422419|NCT00451204|26867888|FG001|Overall Study|Lack of Efficacy|4|||
13422420|NCT00451204|26867887|FG000|Overall Study|Lost to Follow-up|4|||
13422421|NCT00451204|26867888|FG001|Overall Study|Lost to Follow-up|4|||
13422422|NCT00451204|26867887|FG000|Overall Study|Protocol Violation|1|||
13422423|NCT00451204|26867888|FG001|Overall Study|Protocol Violation|0|||
13422424|NCT00451204|26867887|FG000|Overall Study|Patient refusal|8|||
13422425|NCT00451204|26867888|FG001|Overall Study|Patient refusal|4|||
13422426|NCT00451204|26867887|FG000|Overall Study|Other|1|||
13422427|NCT00451204|26867888|FG001|Overall Study|Other|2|||
13422428|NCT00451191|26867901|FG000|Overall Study|withdrawal or received alternate tx|15|||
13422429|NCT00451191|26867902|FG001|Overall Study|withdrawal or received alternate tx|11|||
13422430|NCT00451178|26867935|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
13422431|NCT00451178|26867936|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
13422432|NCT00451178|26867935|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4|||
13422433|NCT00451178|26867936|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3|||
13422434|NCT00451178|26867935|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2|||
13422435|NCT00451178|26867936|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1|||
13422436|NCT00451178|26867935|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1|||
13422437|NCT00451178|26867936|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2|||
13422438|NCT00451178|26867935|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4|||
13422439|NCT00451178|26867936|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3|||
13422440|NCT00451178|26867935|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1|||
13422441|NCT00451178|26867936|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2|||
13422442|NCT00451178|26867935|FG000|Prior to Maintenance Therapy|Physician Decision|2|||
13422443|NCT00451178|26867936|FG001|Prior to Maintenance Therapy|Physician Decision|0|||
13422444|NCT00451178|26867935|FG000|Prior to Maintenance Therapy|PD|2|||
13422445|NCT00451178|26867936|FG001|Prior to Maintenance Therapy|PD|0|||
13422446|NCT00451178|26867935|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4|||
13422447|NCT00451178|26867936|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0|||
13422448|NCT00451178|26867935|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5|||
13422449|NCT00451178|26867936|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0|||
13422450|NCT00451178|26867935|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1|||
13422451|NCT00451178|26867936|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0|||
13422452|NCT00451178|26867935|FG000|Maintenance Therapy (up to 3 Years)|Death|1|||
13422453|NCT00451178|26867936|FG001|Maintenance Therapy (up to 3 Years)|Death|0|||
13422454|NCT00451178|26867935|FG000|Maintenance Therapy (up to 3 Years)|PD|10|||
13422455|NCT00451178|26867936|FG001|Maintenance Therapy (up to 3 Years)|PD|0|||
13422456|NCT00451178|26867935|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9|||
13422457|NCT00451178|26867936|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0|||
13422458|NCT00451178|26867935|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6|||
13422459|NCT00451178|26867936|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26|||
13422460|NCT00451035|26867955|FG000|Overall Study|Disease progression|11|||
13422461|NCT00451035|26867955|FG000|Overall Study|Death|3|||
13422462|NCT00451035|26867955|FG000|Overall Study|New anti-neoplastic therapy|3|||
13422463|NCT00450866|26867968|FG000|Overall Study|Adverse Event|0|||
13422464|NCT00450866|26867969|FG001|Overall Study|Adverse Event|1|||
13422465|NCT00450866|26867968|FG000|Overall Study|Withdrawal by Subject|5|||
13422466|NCT00450866|26867969|FG001|Overall Study|Withdrawal by Subject|2|||
13422467|NCT00450866|26867968|FG000|Overall Study|Death|1|||
13422468|NCT00450866|26867969|FG001|Overall Study|Death|0|||
13422469|NCT00450866|26867968|FG000|Overall Study|Physician Decision|1|||
13422470|NCT00450866|26867969|FG001|Overall Study|Physician Decision|0|||
13422471|NCT00450814|26868035|FG000|Overall Study|Failed to complete the initial therapy|0|||
13422472|NCT00450814|26868036|FG001|Overall Study|Failed to complete the initial therapy|0|||
13422473|NCT00450814|26868037|FG002|Overall Study|Failed to complete the initial therapy|0|||
13422474|NCT00450814|26868038|FG003|Overall Study|Failed to complete the initial therapy|1|||
13422475|NCT00450814|26868039|FG004|Overall Study|Failed to complete the initial therapy|1|||
13422476|NCT00450814|26868040|FG005|Overall Study|Failed to complete the initial therapy|1|||
13422477|NCT00450814|26868041|FG006|Overall Study|Failed to complete the initial therapy|0|||
13422478|NCT00450814|26868042|FG007|Overall Study|Failed to complete the initial therapy|0|||
13422479|NCT00450814|26868043|FG008|Overall Study|Failed to complete the initial therapy|0|||
13422480|NCT00450814|26868044|FG009|Overall Study|Failed to complete the initial therapy|0|||
13422481|NCT00450814|26868045|FG010|Overall Study|Failed to complete the initial therapy|0|||
13422482|NCT00450814|26868035|FG000|Overall Study|Patient withdrawal prior to treatment|0|||
13422483|NCT00450814|26868036|FG001|Overall Study|Patient withdrawal prior to treatment|0|||
13422484|NCT00450814|26868037|FG002|Overall Study|Patient withdrawal prior to treatment|0|||
13422485|NCT00450814|26868038|FG003|Overall Study|Patient withdrawal prior to treatment|0|||
13422486|NCT00450814|26868039|FG004|Overall Study|Patient withdrawal prior to treatment|0|||
13422487|NCT00450814|26868040|FG005|Overall Study|Patient withdrawal prior to treatment|0|||
13422488|NCT00450814|26868041|FG006|Overall Study|Patient withdrawal prior to treatment|0|||
13422489|NCT00450814|26868042|FG007|Overall Study|Patient withdrawal prior to treatment|0|||
13422490|NCT00450814|26868043|FG008|Overall Study|Patient withdrawal prior to treatment|0|||
13422491|NCT00450814|26868044|FG009|Overall Study|Patient withdrawal prior to treatment|1|||
13422492|NCT00450814|26868045|FG010|Overall Study|Patient withdrawal prior to treatment|0|||
13422493|NCT00450801|26868058|FG000|Overall Study|Death|1|||
13422494|NCT00450749|26868106|FG000|Overall Study|Withdrawal by Subject|0|||
13422495|NCT00450749|26868107|FG001|Overall Study|Withdrawal by Subject|0|||
13422496|NCT00450749|26868108|FG002|Overall Study|Withdrawal by Subject|2|||
13422497|NCT00450749|26868106|FG000|Overall Study|Noncompliant|0|||
13422498|NCT00450749|26868107|FG001|Overall Study|Noncompliant|1|||
13422499|NCT00450749|26868108|FG002|Overall Study|Noncompliant|0|||
13422500|NCT00450723|26868116|FG000|Overall Study|Physician Decision|5|||
13422501|NCT00450658|26868135|FG000|Overall Study|Adverse Event|24|||
13422502|NCT00450658|26868136|FG001|Overall Study|Adverse Event|15|||
13422503|NCT00450658|26868135|FG000|Overall Study|Withdrawal by Subject|43|||
13422504|NCT00450658|26868136|FG001|Overall Study|Withdrawal by Subject|26|||
13422505|NCT00450658|26868135|FG000|Overall Study|Lost to Follow-up|22|||
13422506|NCT00450658|26868136|FG001|Overall Study|Lost to Follow-up|5|||
13422507|NCT00450658|26868135|FG000|Overall Study|UGI ulcer|33|||
13422508|NCT00450658|26868136|FG001|Overall Study|UGI ulcer|34|||
13422509|NCT00450658|26868135|FG000|Overall Study|misc|21|||
13422510|NCT00450658|26868136|FG001|Overall Study|misc|10|||
13422511|NCT00450619|26868167|FG000|Overall Study|refused treatment after randomization|2|||
13422512|NCT00450619|26868168|FG001|Overall Study|refused treatment after randomization|0|||
13422513|NCT00450619|26868167|FG000|Overall Study|did not progress; refused further trmt|1|||
13422514|NCT00450619|26868168|FG001|Overall Study|did not progress; refused further trmt|1|||
13422515|NCT00450619|26868167|FG000|Overall Study|Adverse Event|1|||
13422516|NCT00450619|26868168|FG001|Overall Study|Adverse Event|0|||
13422517|NCT00450580|26868193|FG000|Overall Study|Adverse Event|5|||
13422518|NCT00450580|26868194|FG001|Overall Study|Adverse Event|7|||
13422519|NCT00450580|26868193|FG000|Overall Study|Lost to Follow-up|4|||
13422520|NCT00450580|26868194|FG001|Overall Study|Lost to Follow-up|5|||
13422521|NCT00450580|26868193|FG000|Overall Study|Withdrawal by Subject|2|||
13422522|NCT00450580|26868194|FG001|Overall Study|Withdrawal by Subject|2|||
13422523|NCT00450580|26868193|FG000|Overall Study|Protocol Violation|1|||
13422524|NCT00450580|26868194|FG001|Overall Study|Protocol Violation|1|||
13422525|NCT00450580|26868193|FG000|Overall Study|Protocol-defined virologic failure|1|||
13422526|NCT00450580|26868194|FG001|Overall Study|Protocol-defined virologic failure|0|||
13422527|NCT00450580|26868193|FG000|Overall Study|Could not comply with scheduled visits|1|||
13422528|NCT00450580|26868194|FG001|Overall Study|Could not comply with scheduled visits|0|||
13422529|NCT00450580|26868193|FG000|Overall Study|Patient went to Brazil|1|||
13422530|NCT00450580|26868194|FG001|Overall Study|Patient went to Brazil|0|||
13422531|NCT00450580|26868193|FG000|Overall Study|Patient could not swallow Norvir|1|||
13422532|NCT00450580|26868194|FG001|Overall Study|Patient could not swallow Norvir|0|||
13422533|NCT00450580|26868193|FG000|Overall Study|Withdrawal due to pregnancy|0|||
13422534|NCT00450580|26868194|FG001|Overall Study|Withdrawal due to pregnancy|1|||
13422535|NCT00450450|26868223|FG000|Overall Study|Death|1|||
13422536|NCT00450450|26868224|FG001|Overall Study|Death|3|||
13422537|NCT00450450|26868223|FG000|Overall Study|Relapse|2|||
13422538|NCT00450450|26868224|FG001|Overall Study|Relapse|0|||
13422539|NCT00450450|26868223|FG000|Overall Study|Missing Data|2|||
13422540|NCT00450450|26868224|FG001|Overall Study|Missing Data|0|||
13422541|NCT00450437|26868255|FG000|Overall Study|Withdrawal by Subject|10|||
13422542|NCT00450437|26868256|FG001|Overall Study|Withdrawal by Subject|2|||
13422543|NCT00450437|26868257|FG002|Overall Study|Withdrawal by Subject|0|||
13422544|NCT00450437|26868258|FG003|Overall Study|Withdrawal by Subject|1|||
13422545|NCT00450437|26868255|FG000|Overall Study|Lost to Follow-up|31|||
13422546|NCT00450437|26868256|FG001|Overall Study|Lost to Follow-up|12|||
13422547|NCT00450437|26868257|FG002|Overall Study|Lost to Follow-up|19|||
13422548|NCT00450437|26868258|FG003|Overall Study|Lost to Follow-up|9|||
13422549|NCT00450437|26868255|FG000|Overall Study|Protocol Violation|0|||
13422550|NCT00450437|26868256|FG001|Overall Study|Protocol Violation|1|||
13422551|NCT00450437|26868257|FG002|Overall Study|Protocol Violation|0|||
13422552|NCT00450437|26868258|FG003|Overall Study|Protocol Violation|1|||
13422553|NCT00450437|26868255|FG000|Overall Study|Inappropriate enrollment|4|||
13422554|NCT00450437|26868256|FG001|Overall Study|Inappropriate enrollment|1|||
13422555|NCT00450437|26868257|FG002|Overall Study|Inappropriate enrollment|3|||
13422556|NCT00450437|26868258|FG003|Overall Study|Inappropriate enrollment|0|||
13422557|NCT00450437|26868255|FG000|Overall Study|Administrative reason|0|||
13422558|NCT00450437|26868256|FG001|Overall Study|Administrative reason|0|||
13422559|NCT00450437|26868257|FG002|Overall Study|Administrative reason|1|||
13422560|NCT00450437|26868258|FG003|Overall Study|Administrative reason|0|||
13422561|NCT00450437|26868255|FG000|Overall Study|Unable to Classify|1|||
13422562|NCT00450437|26868256|FG001|Overall Study|Unable to Classify|0|||
13422563|NCT00450437|26868257|FG002|Overall Study|Unable to Classify|1|||
13422564|NCT00450437|26868258|FG003|Overall Study|Unable to Classify|0|||
13422565|NCT00450411|26868271|FG000|Overall Study|Protocol Violation|6|||
13422566|NCT00450411|26868271|FG000|Overall Study|No protocol treatment|2|||
13422567|NCT00450385|26868282|FG000|Overall Study|Death|3|||
13422568|NCT00450385|26868282|FG000|Overall Study|Protocol Violation|1|||
13422569|NCT00450385|26868282|FG000|Overall Study|Withdrawal by Subject|2|||
13422570|NCT00450385|26868282|FG000|Overall Study|Lack of Efficacy|2|||
13422571|NCT00450385|26868282|FG000|Overall Study|Adverse Event|1|||
13422572|NCT00450385|26868282|FG000|Overall Study|Physician Decision|1|||
13422573|NCT00450385|26868282|FG000|Overall Study|Other|3|||
13422574|NCT00450372|26868293|FG000|Overall Study|Physician Decision|1|||
13422575|NCT00450333|26868324|FG000|Overall Study|Study terminated|47|||
13422576|NCT00450333|26868325|FG001|Overall Study|Study terminated|54|||
13422577|NCT00450333|26868326|FG002|Overall Study|Study terminated|16|||
13422578|NCT00450333|26868327|FG003|Overall Study|Study terminated|21|||
13422579|NCT00450333|26868324|FG000|Overall Study|Adverse Event|1|||
13422580|NCT00450333|26868325|FG001|Overall Study|Adverse Event|7|||
13422581|NCT00450333|26868326|FG002|Overall Study|Adverse Event|2|||
13422582|NCT00450333|26868327|FG003|Overall Study|Adverse Event|2|||
13422583|NCT00450333|26868324|FG000|Overall Study|Protocol Violation|1|||
13422584|NCT00450333|26868325|FG001|Overall Study|Protocol Violation|0|||
13422585|NCT00450333|26868326|FG002|Overall Study|Protocol Violation|1|||
13422586|NCT00450333|26868327|FG003|Overall Study|Protocol Violation|0|||
13422587|NCT00450333|26868324|FG000|Overall Study|Withdrawal by Subject|1|||
13422588|NCT00450333|26868325|FG001|Overall Study|Withdrawal by Subject|0|||
13422589|NCT00450333|26868326|FG002|Overall Study|Withdrawal by Subject|3|||
13422590|NCT00450333|26868327|FG003|Overall Study|Withdrawal by Subject|0|||
13422591|NCT00450333|26868324|FG000|Overall Study|Kidney transplant|1|||
13422592|NCT00450333|26868325|FG001|Overall Study|Kidney transplant|0|||
13422593|NCT00450333|26868326|FG002|Overall Study|Kidney transplant|1|||
13422594|NCT00450333|26868327|FG003|Overall Study|Kidney transplant|3|||
13422595|NCT00450333|26868324|FG000|Overall Study|Death|3|||
13422596|NCT00450333|26868325|FG001|Overall Study|Death|2|||
13422597|NCT00450333|26868326|FG002|Overall Study|Death|2|||
13422598|NCT00450333|26868327|FG003|Overall Study|Death|2|||
13422599|NCT00450255|26868337|FG000|Overall Study|Prior RFA ablation of liver|1|||
13422600|NCT00450216|26868356|FG000|Overall Study|Adverse Event|38|||
13422601|NCT00450216|26868357|FG001|Overall Study|Adverse Event|23|||
13422602|NCT00450216|26868356|FG000|Overall Study|Withdrawal by Subject|48|||
13422603|NCT00450216|26868357|FG001|Overall Study|Withdrawal by Subject|26|||
13422604|NCT00450216|26868356|FG000|Overall Study|Lost to Follow-up|16|||
13422605|NCT00450216|26868357|FG001|Overall Study|Lost to Follow-up|9|||
13422606|NCT00450216|26868356|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
13422607|NCT00450216|26868357|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
13422608|NCT00450216|26868356|FG000|Overall Study|misc|21|||
13422609|NCT00450216|26868357|FG001|Overall Study|misc|20|||
13422610|NCT00450190|26868367|FG000|Overall Study|Withdrawal by Subject|2|||
13422611|NCT00450177|26868398|FG000|Overall Study|Adverse Event|7|||
13422612|NCT00450177|26868399|FG001|Overall Study|Adverse Event|4|||
13422613|NCT00450177|26868398|FG000|Overall Study|Withdrawal by Subject|1|||
13422614|NCT00450177|26868399|FG001|Overall Study|Withdrawal by Subject|6|||
13422615|NCT00450177|26868398|FG000|Overall Study|Withdrawal by Primary Team|1|||
13422616|NCT00450177|26868399|FG001|Overall Study|Withdrawal by Primary Team|1|||
13422617|NCT00450112|26868428|FG000|Overall Study|Other Treatment Required|5|||
13422618|NCT00450112|26868429|FG001|Overall Study|Other Treatment Required|1|||
13422619|NCT00450112|26868428|FG000|Overall Study|Withdrawal by Subject|4|||
13422620|NCT00450112|26868429|FG001|Overall Study|Withdrawal by Subject|1|||
13422621|NCT00450112|26868428|FG000|Overall Study|Lost to Follow-up|2|||
13422622|NCT00450112|26868429|FG001|Overall Study|Lost to Follow-up|1|||
13422623|NCT00450112|26868428|FG000|Overall Study|Others|2|||
13422624|NCT00450112|26868429|FG001|Overall Study|Others|3|||
13422625|NCT00449956|26868453|FG000|Overall Study|Adverse Event|7|||
13422626|NCT00449956|26868454|FG001|Overall Study|Adverse Event|1|||
13422627|NCT00449956|26868455|FG002|Overall Study|Adverse Event|6|||
13422628|NCT00449956|26868453|FG000|Overall Study|Lack of Efficacy|0|||
13422629|NCT00449956|26868454|FG001|Overall Study|Lack of Efficacy|0|||
13422630|NCT00449956|26868455|FG002|Overall Study|Lack of Efficacy|1|||
13422631|NCT00449956|26868453|FG000|Overall Study|Protocol Violation|1|||
13422632|NCT00449956|26868454|FG001|Overall Study|Protocol Violation|1|||
13422633|NCT00449956|26868455|FG002|Overall Study|Protocol Violation|1|||
13422634|NCT00449956|26868453|FG000|Overall Study|Withdrawal by Subject|0|||
13422635|NCT00449956|26868454|FG001|Overall Study|Withdrawal by Subject|1|||
13422636|NCT00449956|26868455|FG002|Overall Study|Withdrawal by Subject|0|||
13422637|NCT00449956|26868453|FG000|Overall Study|Physician Decision|2|||
13422638|NCT00449956|26868454|FG001|Overall Study|Physician Decision|1|||
13422639|NCT00449956|26868455|FG002|Overall Study|Physician Decision|1|||
13422640|NCT00449930|26868476|FG000|Overall Study|Adverse Event|9|||
13422641|NCT00449930|26868477|FG001|Overall Study|Adverse Event|19|||
13422642|NCT00449930|26868476|FG000|Overall Study|Trial Terminated ( Site Closed)|1|||
13422643|NCT00449930|26868477|FG001|Overall Study|Trial Terminated ( Site Closed)|0|||
13422644|NCT00449930|26868476|FG000|Overall Study|Lack of Efficacy|10|||
13422645|NCT00449930|26868477|FG001|Overall Study|Lack of Efficacy|1|||
13422646|NCT00449930|26868476|FG000|Overall Study|Lost to Follow-up|9|||
13422647|NCT00449930|26868477|FG001|Overall Study|Lost to Follow-up|14|||
13422648|NCT00449930|26868476|FG000|Overall Study|Physician Decision|1|||
13422649|NCT00449930|26868477|FG001|Overall Study|Physician Decision|2|||
13422650|NCT00449930|26868476|FG000|Overall Study|Protocol Violation|14|||
13422651|NCT00449930|26868477|FG001|Overall Study|Protocol Violation|15|||
13422652|NCT00449930|26868476|FG000|Overall Study|Withdrawal by Subject|16|||
13422653|NCT00449930|26868477|FG001|Overall Study|Withdrawal by Subject|23|||
13422654|NCT00449930|26868476|FG000|Overall Study|Glycemic discontinuation criteria|1|||
13422655|NCT00449930|26868477|FG001|Overall Study|Glycemic discontinuation criteria|1|||
13422656|NCT00449865|26868490|FG000|Overall Study|Withdrawal by Subject|110|||
13422657|NCT00449865|26868491|FG001|Overall Study|Withdrawal by Subject|110|||
13422658|NCT00449865|26868490|FG000|Overall Study|Lost to Follow-up|36|||
13422659|NCT00449865|26868491|FG001|Overall Study|Lost to Follow-up|37|||
13422660|NCT00449865|26868490|FG000|Overall Study|Physician Decision|13|||
13422661|NCT00449865|26868491|FG001|Overall Study|Physician Decision|12|||
13422662|NCT00449865|26868490|FG000|Overall Study|Death|31|||
13422663|NCT00449865|26868491|FG001|Overall Study|Death|40|||
13422664|NCT00449865|26868490|FG000|Overall Study|Protocol Violation|8|||
13422665|NCT00449865|26868491|FG001|Overall Study|Protocol Violation|7|||
13422666|NCT00449865|26868490|FG000|Overall Study|Study was stopped|324|||
13422667|NCT00449865|26868491|FG001|Overall Study|Study was stopped|328|||
13422668|NCT00449787|26868508|FG000|Overall Study|Lost to Follow-up|10|||
13422669|NCT00449787|26868509|FG001|Overall Study|Lost to Follow-up|8|||
13422670|NCT00449787|26868508|FG000|Overall Study|Did not require medication|95|||
13422671|NCT00449787|26868509|FG001|Overall Study|Did not require medication|92|||
13422672|NCT00449761|26868531|FG000|Overall Study|Disease progression|12|||
13422673|NCT00449761|26868531|FG000|Overall Study|Death|5|||
13422674|NCT00449761|26868531|FG000|Overall Study|New cancer therapy|1|||
13422675|NCT00449696|26868560|FG000|Overall Study|Other Treatment Required|6|||
13422676|NCT00449696|26868561|FG001|Overall Study|Other Treatment Required|1|||
13422677|NCT00449696|26868560|FG000|Overall Study|Withdrawal by Subject|5|||
13422678|NCT00449696|26868561|FG001|Overall Study|Withdrawal by Subject|5|||
13422679|NCT00449696|26868560|FG000|Overall Study|Lost to Follow-up|2|||
13422680|NCT00449696|26868561|FG001|Overall Study|Lost to Follow-up|3|||
13422681|NCT00449696|26868560|FG000|Overall Study|Others|7|||
13422682|NCT00449696|26868561|FG001|Overall Study|Others|0|||
13422683|NCT00449670|26868677|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1|||
13422684|NCT00449670|26868678|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0|||
13422685|NCT00449670|26868677|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4|||
13422686|NCT00449670|26868678|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0|||
13422687|NCT00449670|26868677|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4|||
13422688|NCT00449670|26868678|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1|||
13422689|NCT00449670|26868677|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5|||
13422690|NCT00449670|26868678|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1|||
13422691|NCT00449670|26868677|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0|||
13422692|NCT00449670|26868678|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1|||
13422693|NCT00449670|26868677|FG000|Booster Phase (Study no.109873)|Other|0|||
13422694|NCT00449670|26868678|FG001|Booster Phase (Study no.109873)|Other|2|||
13422695|NCT00449644|26868709|FG000|Overall Study|Adverse Event|0|||
13422696|NCT00449644|26868710|FG001|Overall Study|Adverse Event|0|||
13422697|NCT00449644|26868711|FG002|Overall Study|Adverse Event|3|||
13422698|NCT00449644|26868712|FG003|Overall Study|Adverse Event|5|||
13422699|NCT00449644|26868709|FG000|Overall Study|Death|1|||
13422700|NCT00449644|26868710|FG001|Overall Study|Death|0|||
13422701|NCT00449644|26868711|FG002|Overall Study|Death|6|||
13422702|NCT00449644|26868712|FG003|Overall Study|Death|1|||
13422703|NCT00449644|26868709|FG000|Overall Study|Lost to Follow-up|1|||
13422704|NCT00449644|26868710|FG001|Overall Study|Lost to Follow-up|1|||
13422705|NCT00449644|26868711|FG002|Overall Study|Lost to Follow-up|5|||
13422706|NCT00449644|26868712|FG003|Overall Study|Lost to Follow-up|3|||
13422707|NCT00449644|26868709|FG000|Overall Study|Pregnancy|0|||
13422708|NCT00449644|26868710|FG001|Overall Study|Pregnancy|0|||
13422709|NCT00449644|26868711|FG002|Overall Study|Pregnancy|3|||
13422710|NCT00449644|26868712|FG003|Overall Study|Pregnancy|2|||
13422711|NCT00449644|26868709|FG000|Overall Study|Protocol Violation|4|||
13422712|NCT00449644|26868710|FG001|Overall Study|Protocol Violation|4|||
13422713|NCT00449644|26868711|FG002|Overall Study|Protocol Violation|3|||
13422714|NCT00449644|26868712|FG003|Overall Study|Protocol Violation|7|||
13422715|NCT00449644|26868709|FG000|Overall Study|Withdrawal by Subject|3|||
13422716|NCT00449644|26868710|FG001|Overall Study|Withdrawal by Subject|4|||
13422717|NCT00449644|26868711|FG002|Overall Study|Withdrawal by Subject|6|||
13422718|NCT00449644|26868712|FG003|Overall Study|Withdrawal by Subject|7|||
13422719|NCT00449644|26868709|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
13422720|NCT00449644|26868710|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
13422721|NCT00449644|26868711|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
13422722|NCT00449644|26868712|FG003|Overall Study|Inclusion/exclusion criteria not met|6|||
13422723|NCT00449644|26868709|FG000|Overall Study|Other|1|||
13422724|NCT00449644|26868710|FG001|Overall Study|Other|4|||
13422725|NCT00449644|26868711|FG002|Overall Study|Other|1|||
13422726|NCT00449644|26868712|FG003|Overall Study|Other|0|||
13422727|NCT00449644|26868709|FG000|Overall Study|Rolled-over to treatment with TMC207|0|||
13422728|NCT00449644|26868710|FG001|Overall Study|Rolled-over to treatment with TMC207|0|||
13422729|NCT00449644|26868711|FG002|Overall Study|Rolled-over to treatment with TMC207|0|||
13422730|NCT00449644|26868712|FG003|Overall Study|Rolled-over to treatment with TMC207|1|||
13422731|NCT00449540|26868734|FG000|Pretreatment Phase|No migraine experienced|66|||
13422732|NCT00449540|26868735|FG001|Pretreatment Phase|No migraine experienced|0|||
13422733|NCT00449540|26868736|FG002|Pretreatment Phase|No migraine experienced|0|||
13422734|NCT00449540|26868734|FG000|Treatment Phase|did not experience or treat migraine|0|||
13422735|NCT00449540|26868735|FG001|Treatment Phase|did not experience or treat migraine|20|||
13422736|NCT00449540|26868736|FG002|Treatment Phase|did not experience or treat migraine|17|||
13422737|NCT00449176|26868772|FG000|Overall Study|Withdrawal by Subject|39|||
13422738|NCT00449176|26868773|FG001|Overall Study|Withdrawal by Subject|43|||
13422739|NCT00449176|26868774|FG002|Overall Study|Withdrawal by Subject|59|||
13422740|NCT00449176|26868772|FG000|Overall Study|Lost to Follow-up|13|||
13422741|NCT00449176|26868773|FG001|Overall Study|Lost to Follow-up|8|||
13422742|NCT00449176|26868774|FG002|Overall Study|Lost to Follow-up|12|||
13422743|NCT00449176|26868772|FG000|Overall Study|Adverse Event|51|||
13422744|NCT00449176|26868773|FG001|Overall Study|Adverse Event|107|||
13422745|NCT00449176|26868774|FG002|Overall Study|Adverse Event|15|||
13422746|NCT00449176|26868772|FG000|Overall Study|Lack of Efficacy|13|||
13422747|NCT00449176|26868773|FG001|Overall Study|Lack of Efficacy|7|||
13422748|NCT00449176|26868774|FG002|Overall Study|Lack of Efficacy|50|||
13422749|NCT00449176|26868772|FG000|Overall Study|Study drug non-compliant|14|||
13422750|NCT00449176|26868773|FG001|Overall Study|Study drug non-compliant|11|||
13422751|NCT00449176|26868774|FG002|Overall Study|Study drug non-compliant|11|||
13422752|NCT00449176|26868772|FG000|Overall Study|all other|22|||
13422753|NCT00449176|26868773|FG001|Overall Study|all other|19|||
13422754|NCT00449176|26868774|FG002|Overall Study|all other|20|||
13422755|NCT00449163|26868783|FG000|Overall Study|Physician Decision|3|||
13422756|NCT00449150|26868804|FG000|Overall Study|Adverse Event|11|||
13422757|NCT00449150|26868805|FG001|Overall Study|Adverse Event|18|||
13422758|NCT00449150|26868806|FG002|Overall Study|Adverse Event|9|||
13422759|NCT00449150|26868804|FG000|Overall Study|Lack of Efficacy|1|||
13422760|NCT00449150|26868805|FG001|Overall Study|Lack of Efficacy|2|||
13422761|NCT00449150|26868806|FG002|Overall Study|Lack of Efficacy|2|||
13422762|NCT00449150|26868804|FG000|Overall Study|Other|16|||
13422763|NCT00449150|26868805|FG001|Overall Study|Other|13|||
13422764|NCT00449150|26868806|FG002|Overall Study|Other|14|||
13422765|NCT00449150|26868804|FG000|Overall Study|Withdrawal by Subject|17|||
13422766|NCT00449150|26868805|FG001|Overall Study|Withdrawal by Subject|18|||
13422767|NCT00449150|26868806|FG002|Overall Study|Withdrawal by Subject|21|||
13422768|NCT00449150|26868804|FG000|Overall Study|Protocol Violation|1|||
13422769|NCT00449150|26868805|FG001|Overall Study|Protocol Violation|2|||
13422770|NCT00449150|26868806|FG002|Overall Study|Protocol Violation|1|||
13422771|NCT00449072|26868837|FG000|Overall Study|Adverse Event|3|||
13422772|NCT00449072|26868838|FG001|Overall Study|Adverse Event|1|||
13422773|NCT00449072|26868837|FG000|Overall Study|Protocol Violation|14|||
13422774|NCT00449072|26868838|FG001|Overall Study|Protocol Violation|12|||
13422775|NCT00449072|26868837|FG000|Overall Study|Lost to Follow-up|5|||
13422776|NCT00449072|26868838|FG001|Overall Study|Lost to Follow-up|7|||
13422777|NCT00449072|26868837|FG000|Overall Study|Withdrawal by Subject|11|||
13422778|NCT00449072|26868838|FG001|Overall Study|Withdrawal by Subject|8|||
13422779|NCT00449072|26868837|FG000|Overall Study|Lack of Efficacy|1|||
13422780|NCT00449072|26868838|FG001|Overall Study|Lack of Efficacy|1|||
13422781|NCT00449072|26868837|FG000|Overall Study|Physician Decision|1|||
13422782|NCT00449072|26868838|FG001|Overall Study|Physician Decision|0|||
13422783|NCT00449072|26868837|FG000|Overall Study|Not treated|0|||
13422784|NCT00449072|26868838|FG001|Overall Study|Not treated|1|||
13422785|NCT00449072|26868837|FG000|Overall Study|Excluded medication|0|||
13422786|NCT00449072|26868838|FG001|Overall Study|Excluded medication|2|||
13422787|NCT00449072|26868837|FG000|Overall Study|Non-compliance|2|||
13422788|NCT00449072|26868838|FG001|Overall Study|Non-compliance|5|||
13422789|NCT00449072|26868837|FG000|Overall Study|Sponsor decision|1|||
13422790|NCT00449072|26868838|FG001|Overall Study|Sponsor decision|3|||
13422791|NCT00449072|26868837|FG000|Overall Study|Relocation|3|||
13422792|NCT00449072|26868838|FG001|Overall Study|Relocation|2|||
13422793|NCT00449033|26868879|FG000|Treatment Period|Adverse Event|117|||
13422794|NCT00449033|26868880|FG001|Treatment Period|Adverse Event|83|||
13422795|NCT00449033|26868879|FG000|Treatment Period|Death|21|||
13422796|NCT00449033|26868880|FG001|Treatment Period|Death|12|||
13422797|NCT00449033|26868879|FG000|Treatment Period|Lost to Follow-up|0|||
13422798|NCT00449033|26868880|FG001|Treatment Period|Lost to Follow-up|2|||
13422799|NCT00449033|26868879|FG000|Treatment Period|Physician Decision|4|||
13422800|NCT00449033|26868880|FG001|Treatment Period|Physician Decision|5|||
13422801|NCT00449033|26868879|FG000|Treatment Period|Protocol Violation|8|||
13422802|NCT00449033|26868880|FG001|Treatment Period|Protocol Violation|7|||
13422803|NCT00449033|26868879|FG000|Treatment Period|Disease Progression|231|||
13422804|NCT00449033|26868880|FG001|Treatment Period|Disease Progression|288|||
13422805|NCT00449033|26868879|FG000|Treatment Period|Consent Withdrawn|36|||
13422806|NCT00449033|26868880|FG001|Treatment Period|Consent Withdrawn|20|||
13422807|NCT00449033|26868879|FG000|Treatment Period|Amended Protocol Criteria|22|||
13422808|NCT00449033|26868880|FG001|Treatment Period|Amended Protocol Criteria|18|||
13422809|NCT00449033|26868879|FG000|Treatment Period|Non-compliance|7|||
13422810|NCT00449033|26868880|FG001|Treatment Period|Non-compliance|8|||
13422811|NCT00449033|26868879|FG000|Treatment Period|Second Malignancy|0|||
13422812|NCT00449033|26868880|FG001|Treatment Period|Second Malignancy|1|||
13422813|NCT00449033|26868879|FG000|Treatment Period|Reason Missing|0|||
13422814|NCT00449033|26868880|FG001|Treatment Period|Reason Missing|4|||
13422815|NCT00449033|26868879|FG000|Treatment Period|Treatment Ongoing|6|||
13422816|NCT00449033|26868880|FG001|Treatment Period|Treatment Ongoing|4|||
13422817|NCT00449033|26868879|FG000|Follow-up Period|Death|299|||
13422818|NCT00449033|26868880|FG001|Follow-up Period|Death|311|||
13422819|NCT00449033|26868879|FG000|Follow-up Period|Lost to Follow-up|6|||
13422820|NCT00449033|26868880|FG001|Follow-up Period|Lost to Follow-up|10|||
13422821|NCT00449033|26868879|FG000|Follow-up Period|Reason Missing|120|||
13422822|NCT00449033|26868880|FG001|Follow-up Period|Reason Missing|113|||
13422823|NCT00448916|26868964|FG000|Overall Study|Adverse Event|2|||
13422824|NCT00448916|26868965|FG001|Overall Study|Adverse Event|2|||
13422825|NCT00448916|26868966|FG002|Overall Study|Adverse Event|3|||
13422826|NCT00448916|26868967|FG003|Overall Study|Adverse Event|2|||
13422827|NCT00448916|26868964|FG000|Overall Study|Lack of Efficacy|1|||
13422828|NCT00448916|26868965|FG001|Overall Study|Lack of Efficacy|0|||
13422829|NCT00448916|26868966|FG002|Overall Study|Lack of Efficacy|2|||
13422830|NCT00448916|26868967|FG003|Overall Study|Lack of Efficacy|1|||
13422831|NCT00448916|26868964|FG000|Overall Study|Withdrawal by Subject|3|||
13422832|NCT00448916|26868965|FG001|Overall Study|Withdrawal by Subject|3|||
13422833|NCT00448916|26868966|FG002|Overall Study|Withdrawal by Subject|1|||
13422834|NCT00448916|26868967|FG003|Overall Study|Withdrawal by Subject|1|||
13422835|NCT00448916|26868964|FG000|Overall Study|Other|1|||
13422836|NCT00448916|26868965|FG001|Overall Study|Other|0|||
13422837|NCT00448916|26868966|FG002|Overall Study|Other|0|||
13422838|NCT00448916|26868967|FG003|Overall Study|Other|0|||
13422839|NCT00448916|26868964|FG000|Overall Study|Lost to Follow-up|0|||
13422840|NCT00448916|26868965|FG001|Overall Study|Lost to Follow-up|1|||
13422841|NCT00448916|26868966|FG002|Overall Study|Lost to Follow-up|0|||
13422842|NCT00448916|26868967|FG003|Overall Study|Lost to Follow-up|1|||
13422843|NCT00448916|26868964|FG000|Overall Study|Protocol Violation|0|||
13422844|NCT00448916|26868965|FG001|Overall Study|Protocol Violation|0|||
13422845|NCT00448916|26868966|FG002|Overall Study|Protocol Violation|0|||
13422846|NCT00448916|26868967|FG003|Overall Study|Protocol Violation|1|||
13422847|NCT00448864|26868993|FG000|Overall Study|Death|1|||
13422848|NCT00448864|26868994|FG001|Overall Study|Death|0|||
13422849|NCT00448864|26868995|FG002|Overall Study|Death|0|||
13422850|NCT00448864|26868993|FG000|Overall Study|Lost to Follow-up|3|||
13422851|NCT00448864|26868994|FG001|Overall Study|Lost to Follow-up|1|||
13422852|NCT00448864|26868995|FG002|Overall Study|Lost to Follow-up|0|||
13422853|NCT00448864|26868993|FG000|Overall Study|Physician Decision|1|||
13422854|NCT00448864|26868994|FG001|Overall Study|Physician Decision|0|||
13422855|NCT00448864|26868995|FG002|Overall Study|Physician Decision|1|||
13422856|NCT00448864|26868993|FG000|Overall Study|Withdrawal by Subject|0|||
13422857|NCT00448864|26868994|FG001|Overall Study|Withdrawal by Subject|2|||
13422858|NCT00448864|26868995|FG002|Overall Study|Withdrawal by Subject|0|||
13422859|NCT00448864|26868993|FG000|Overall Study|Protocol Violation|0|||
13422860|NCT00448864|26868994|FG001|Overall Study|Protocol Violation|2|||
13422861|NCT00448864|26868995|FG002|Overall Study|Protocol Violation|0|||
13422862|NCT00448812|26869044|FG000|Year 2|Missed visit but remained in study|4|||
13422863|NCT00448812|26869045|FG001|Year 2|Missed visit but remained in study|1|||
13422864|NCT00448812|26869044|FG000|Year 3|Withdrawal by Subject|1|||
13422865|NCT00448812|26869045|FG001|Year 3|Withdrawal by Subject|3|||
13422866|NCT00448812|26869044|FG000|Year 3|Lost to Follow-up|1|||
13422867|NCT00448812|26869045|FG001|Year 3|Lost to Follow-up|0|||
13422868|NCT00448812|26869044|FG000|Year 3|Missed visit but remained in study|2|||
13422869|NCT00448812|26869045|FG001|Year 3|Missed visit but remained in study|0|||
13422870|NCT00448812|26869044|FG000|Year 5|Missed visit but remained in study|1|||
13422871|NCT00448812|26869045|FG001|Year 5|Missed visit but remained in study|0|||
13422872|NCT00448760|26869054|FG000|Overall Study|Death|3|||
13422873|NCT00448747|26869077|FG000|Overall Study|collapsed veins|1|||
13422874|NCT00448747|26869078|FG001|Overall Study|collapsed veins|0|||
13422875|NCT00448708|26869093|FG000|Overall Study|Death|21|||
13422876|NCT00448708|26869094|FG001|Overall Study|Death|17|||
13422877|NCT00448708|26869093|FG000|Overall Study|Withdrawal by Subject|8|||
13422878|NCT00448708|26869094|FG001|Overall Study|Withdrawal by Subject|4|||
13422879|NCT00448708|26869093|FG000|Overall Study|Lost to Follow-up|6|||
13422880|NCT00448708|26869094|FG001|Overall Study|Lost to Follow-up|8|||
13422881|NCT00448708|26869093|FG000|Overall Study|not listed|0|||
13422882|NCT00448708|26869094|FG001|Overall Study|not listed|2|||
13422883|NCT00448669|26869117|FG000|Overall Study|Lost to Follow-up|52|||
13422884|NCT00448669|26869118|FG001|Overall Study|Lost to Follow-up|63|||
13422885|NCT00448669|26869117|FG000|Overall Study|Withdrawal by Subject|90|||
13422886|NCT00448669|26869118|FG001|Overall Study|Withdrawal by Subject|74|||
13422887|NCT00448669|26869117|FG000|Overall Study|Relocated|49|||
13422888|NCT00448669|26869118|FG001|Overall Study|Relocated|36|||
13422889|NCT00448669|26869117|FG000|Overall Study|Were withdrawn by investigator|10|||
13422890|NCT00448669|26869118|FG001|Overall Study|Were withdrawn by investigator|6|||
13422891|NCT00448669|26869117|FG000|Overall Study|Death|2|||
13422892|NCT00448669|26869118|FG001|Overall Study|Death|4|||
13422893|NCT00448669|26869117|FG000|Overall Study|Had other reasons|5|||
13422894|NCT00448669|26869118|FG001|Overall Study|Had other reasons|6|||
13422895|NCT00448669|26869117|FG000|Overall Study|HIV-infected at enrollment|1|||
13422896|NCT00448669|26869118|FG001|Overall Study|HIV-infected at enrollment|2|||
13422897|NCT00448669|26869117|FG000|Overall Study|Never started drug|9|||
13422898|NCT00448669|26869118|FG001|Overall Study|Never started drug|7|||
13422899|NCT00448591|26869129|FG000|Overall Study|Withdrawal by Subject|178|||
13422900|NCT00448591|26869129|FG000|Overall Study|Progressive Disease|1382|||
13422901|NCT00448591|26869129|FG000|Overall Study|Adverse Event|382|||
13422902|NCT00448591|26869129|FG000|Overall Study|Protocol Violation|41|||
13422903|NCT00448591|26869129|FG000|Overall Study|Lost to Follow-up|19|||
13422904|NCT00448591|26869129|FG000|Overall Study|Treatment Regimen Completed|70|||
13422905|NCT00448591|26869129|FG000|Overall Study|Other|154|||
13422906|NCT00448591|26869129|FG000|Overall Study|Termination of Study|70|||
13422907|NCT00448539|26869142|FG000|Overall Study|Medication non-compliance|4|||
13422908|NCT00448539|26869143|FG001|Overall Study|Medication non-compliance|1|||
13422909|NCT00448539|26869142|FG000|Overall Study|Protocol Violation|1|||
13422910|NCT00448539|26869143|FG001|Overall Study|Protocol Violation|0|||
13422911|NCT00448539|26869142|FG000|Overall Study|Request of the investigator or sponsor|67|||
13422912|NCT00448539|26869143|FG001|Overall Study|Request of the investigator or sponsor|54|||
13422913|NCT00448539|26869142|FG000|Overall Study|Withdrawal by Subject|20|||
13422914|NCT00448539|26869143|FG001|Overall Study|Withdrawal by Subject|24|||
13422915|NCT00448539|26869142|FG000|Overall Study|Diary non-compliance|1|||
13422916|NCT00448539|26869143|FG001|Overall Study|Diary non-compliance|0|||
13422917|NCT00448539|26869142|FG000|Overall Study|Adverse Event|9|||
13422918|NCT00448539|26869143|FG001|Overall Study|Adverse Event|26|||
13422919|NCT00448539|26869142|FG000|Overall Study|Lack of Efficacy|27|||
13422920|NCT00448539|26869143|FG001|Overall Study|Lack of Efficacy|40|||
13422921|NCT00448539|26869142|FG000|Overall Study|Miscellaneous|2|||
13422922|NCT00448539|26869143|FG001|Overall Study|Miscellaneous|1|||
13422923|NCT00448539|26869142|FG000|Overall Study|Change of meds|2|||
13422924|NCT00448539|26869143|FG001|Overall Study|Change of meds|3|||
13422925|NCT00448539|26869142|FG000|Overall Study|Lost to Follow-up|1|||
13422926|NCT00448539|26869143|FG001|Overall Study|Lost to Follow-up|3|||
13422927|NCT00448448|26869156|FG000|Overall Study|Withdrawal by Subject|13|||
13422928|NCT00448448|26869157|FG001|Overall Study|Withdrawal by Subject|2|||
13422929|NCT00448448|26869156|FG000|Overall Study|On protocol when study ended|83|||
13422930|NCT00448448|26869157|FG001|Overall Study|On protocol when study ended|36|||
13422931|NCT00448448|26869156|FG000|Overall Study|Lost to Follow-up|2|||
13422932|NCT00448448|26869157|FG001|Overall Study|Lost to Follow-up|1|||
13422933|NCT00448448|26869156|FG000|Overall Study|Wrong diagnosis (n=3) or other|2|||
13422934|NCT00448448|26869157|FG001|Overall Study|Wrong diagnosis (n=3) or other|1|||
13422935|NCT00448448|26869156|FG000|Overall Study|Signed consent lost|0|||
13422936|NCT00448448|26869157|FG001|Overall Study|Signed consent lost|1|||
13422937|NCT00448435|26869186|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1|||
13422938|NCT00448435|26869187|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0|||
13476685|NCT01425008|27003732|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
13476686|NCT01425008|27003733|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
13476687|NCT01425008|27003734|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
13476688|NCT01425008|27003735|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2|||
13476689|NCT01425008|27003736|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
13476690|NCT01425008|27003737|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
13476691|NCT01425008|27003738|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
13476692|NCT01425008|27003739|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
13476693|NCT01425008|27003740|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
13476694|NCT01425008|27003741|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
13476695|NCT01425008|27003742|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
13476696|NCT01425008|27003743|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
13476697|NCT01425008|27003744|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
13476698|NCT01425008|27003745|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
13476699|NCT01425008|27003746|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
13476700|NCT01425008|27003747|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
13476701|NCT01425008|27003729|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
13476702|NCT01425008|27003730|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
13476703|NCT01425008|27003731|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
13476704|NCT01425008|27003732|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
13476705|NCT01425008|27003733|FG004|Dose Escalation Phase|Withdrawal by Subject|1|||
13476706|NCT01425008|27003734|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
13476707|NCT01425008|27003735|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
13476708|NCT01425008|27003736|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
13476709|NCT01425008|27003737|FG008|Dose Escalation Phase|Withdrawal by Subject|1|||
13476710|NCT01425008|27003738|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
13476711|NCT01425008|27003739|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
13476712|NCT01425008|27003740|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
13476713|NCT01425008|27003741|FG012|Dose Escalation Phase|Withdrawal by Subject|0|||
13476714|NCT01425008|27003742|FG013|Dose Escalation Phase|Withdrawal by Subject|0|||
13476715|NCT01425008|27003743|FG014|Dose Escalation Phase|Withdrawal by Subject|0|||
13476716|NCT01425008|27003744|FG015|Dose Escalation Phase|Withdrawal by Subject|0|||
13476717|NCT01425008|27003745|FG016|Dose Escalation Phase|Withdrawal by Subject|0|||
13422939|NCT00448344|26869202|FG000|Overall Study|Lost to Follow-up|20|||
13422940|NCT00448344|26869203|FG001|Overall Study|Lost to Follow-up|22|||
13422941|NCT00448344|26869202|FG000|Overall Study|Withdrawal by Subject|6|||
13422942|NCT00448344|26869203|FG001|Overall Study|Withdrawal by Subject|8|||
13422943|NCT00448344|26869202|FG000|Overall Study|Death|3|||
13422944|NCT00448344|26869203|FG001|Overall Study|Death|4|||
13422945|NCT00448344|26869202|FG000|Overall Study|Physician Decision|1|||
13422946|NCT00448344|26869203|FG001|Overall Study|Physician Decision|2|||
13422947|NCT00448279|26869226|FG000|Overall Study|Lost to Follow-up|2|||
13422948|NCT00448279|26869227|FG001|Overall Study|Lost to Follow-up|2|||
13422949|NCT00448279|26869226|FG000|Overall Study|Adverse Event|1|||
13422950|NCT00448279|26869227|FG001|Overall Study|Adverse Event|1|||
13422951|NCT00448279|26869226|FG000|Overall Study|Disease progression|16|||
13422952|NCT00448279|26869227|FG001|Overall Study|Disease progression|18|||
13422953|NCT00448279|26869226|FG000|Overall Study|Withdrawal by Subject|4|||
13422954|NCT00448279|26869227|FG001|Overall Study|Withdrawal by Subject|3|||
13422955|NCT00448279|26869226|FG000|Overall Study|Other|6|||
13422956|NCT00448279|26869227|FG001|Overall Study|Other|4|||
13422957|NCT00448279|26869226|FG000|Overall Study|Protocol Violation|0|||
13422958|NCT00448279|26869227|FG001|Overall Study|Protocol Violation|1|||
13422959|NCT00448136|26869270|FG000|Overall Study|Death|3|||
13422960|NCT00448136|26869271|FG001|Overall Study|Death|8|||
13422961|NCT00448136|26869270|FG000|Overall Study|Investigator's decision (progression)|1|||
13422962|NCT00448136|26869271|FG001|Overall Study|Investigator's decision (progression)|0|||
13422963|NCT00448123|26869288|FG000|Overall Study|Lost to Follow-up|9|||
13422964|NCT00448123|26869289|FG001|Overall Study|Lost to Follow-up|6|||
13422965|NCT00448123|26869288|FG000|Overall Study|Physician Decision|6|||
13422966|NCT00448123|26869289|FG001|Overall Study|Physician Decision|6|||
13422967|NCT00448019|26869297|FG000|Overall Study|Withdrawal by Subject|3|||
13422968|NCT00448019|26869297|FG000|Overall Study|Disease progression|1|||
13422969|NCT00448019|26869297|FG000|Overall Study|Death|2|||
13422970|NCT00448019|26869297|FG000|Overall Study|Insurance Issues|1|||
13422971|NCT00447902|26869344|FG000|Overall Study|Adverse Event|0|||
13422972|NCT00447902|26869345|FG001|Overall Study|Adverse Event|3|||
13422973|NCT00447902|26869344|FG000|Overall Study|Protocol Violation|1|||
13422974|NCT00447902|26869345|FG001|Overall Study|Protocol Violation|0|||
13422975|NCT00447902|26869344|FG000|Overall Study|Withdrawal by Subject|0|||
13422976|NCT00447902|26869345|FG001|Overall Study|Withdrawal by Subject|1|||
13422977|NCT00447902|26869344|FG000|Overall Study|included patients who discontinued|1|||
13422978|NCT00447902|26869345|FG001|Overall Study|included patients who discontinued|1|||
13422979|NCT00447902|26869344|FG000|Overall Study|Lack of Efficacy|2|||
13422980|NCT00447902|26869345|FG001|Overall Study|Lack of Efficacy|1|||
13422981|NCT00447876|26869382|FG000|Overall Study|Withdrawal by Subject|1|||
13422982|NCT00447876|26869383|FG001|Overall Study|Withdrawal by Subject|4|||
13422983|NCT00447876|26869382|FG000|Overall Study|Lost to Follow-up|1|||
13422984|NCT00447876|26869383|FG001|Overall Study|Lost to Follow-up|0|||
13422985|NCT00447876|26869382|FG000|Overall Study|Deterioration of symptomology|1|||
13422986|NCT00447876|26869383|FG001|Overall Study|Deterioration of symptomology|0|||
13422987|NCT00447772|26869405|FG000|Overall Study|Lack of Efficacy|3|||
13422988|NCT00447772|26869405|FG000|Overall Study|Insufficient compliance|6|||
13422989|NCT00447772|26869405|FG000|Overall Study|Discontinuation of drug therapy|1|||
13422990|NCT00447772|26869405|FG000|Overall Study|Lost to Follow-up|9|||
13422991|NCT00447772|26869405|FG000|Overall Study|Withdrawal by Subject|1|||
13422992|NCT00447772|26869405|FG000|Overall Study|Unable to attend all study visits|2|||
13422993|NCT00447772|26869405|FG000|Overall Study|Adverse Event|1|||
13422994|NCT00447772|26869405|FG000|Overall Study|Patient relocated|1|||
13422995|NCT00447772|26869405|FG000|Overall Study|Incomplete documentation at visit 1|1|||
13422996|NCT00447772|26869405|FG000|Overall Study|Chemotherapy for lung cancer|1|||
13422997|NCT00447772|26869405|FG000|Overall Study|Premature re-injection required|1|||
13422998|NCT00447694|26869414|FG000|Overall Study|Adverse Event|2|||
13422999|NCT00447694|26869414|FG000|Overall Study|Abnormal laboratory value|1|||
13423000|NCT00447694|26869414|FG000|Overall Study|Abnormal test procedure result|1|||
13423001|NCT00447694|26869414|FG000|Overall Study|Withdrawal by Subject|2|||
13423002|NCT00447603|26869438|FG000|Screening|Withdrawal by Subject|1|||
13423003|NCT00447603|26869439|FG001|Screening|Withdrawal by Subject|0|||
13423004|NCT00447603|26869440|FG002|Screening|Withdrawal by Subject|0|||
13423005|NCT00447603|26869438|FG000|Screening|Protocol Violation|1|||
13423006|NCT00447603|26869439|FG001|Screening|Protocol Violation|0|||
13423007|NCT00447603|26869440|FG002|Screening|Protocol Violation|0|||
13423008|NCT00447603|26869438|FG000|Screening|Screen Failure|4|||
13423009|NCT00447603|26869439|FG001|Screening|Screen Failure|0|||
13423010|NCT00447603|26869440|FG002|Screening|Screen Failure|0|||
13423011|NCT00447603|26869438|FG000|Screening|Study Terminated by Sponsor|15|||
13423012|NCT00447603|26869439|FG001|Screening|Study Terminated by Sponsor|0|||
13423013|NCT00447603|26869440|FG002|Screening|Study Terminated by Sponsor|0|||
13423014|NCT00447603|26869438|FG000|Filter Period|Adverse Event|0|||
13423015|NCT00447603|26869439|FG001|Filter Period|Adverse Event|0|||
13423016|NCT00447603|26869440|FG002|Filter Period|Adverse Event|1|||
13423017|NCT00447603|26869438|FG000|Filter Period|Screen Failure|0|||
13423018|NCT00447603|26869439|FG001|Filter Period|Screen Failure|3|||
13423019|NCT00447603|26869440|FG002|Filter Period|Screen Failure|4|||
13423020|NCT00447603|26869438|FG000|Filter Period|Study terminated by Sponsor|0|||
13423021|NCT00447603|26869439|FG001|Filter Period|Study terminated by Sponsor|1|||
13423022|NCT00447603|26869440|FG002|Filter Period|Study terminated by Sponsor|10|||
13423023|NCT00447590|26869451|FG000|Overall Study|Withdrawal by Subject|26|||
13423024|NCT00447590|26869451|FG000|Overall Study|Lost to Follow-up|24|||
13423025|NCT00447590|26869451|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10|||
13423026|NCT00447499|26869463|FG000|Overall Study|Adverse Event|1|||
13423027|NCT00447499|26869463|FG000|Overall Study|Patient Decision|4|||
13423028|NCT00447499|26869463|FG000|Overall Study|Sponsor Decision|1|||
13423029|NCT00447499|26869463|FG000|Overall Study|Physician Decision|1|||
13423030|NCT00447421|26869475|FG000|Overall Study|Lack of Efficacy|1|||
13423031|NCT00447421|26869475|FG000|Overall Study|Adverse Event|3|||
13423032|NCT00447421|26869475|FG000|Overall Study|Sponsor Decision|2|||
13423033|NCT00447382|26869534|FG000|Overall Study|Adverse Event|1|||
13423034|NCT00447382|26869535|FG001|Overall Study|Adverse Event|1|||
13423035|NCT00447382|26869534|FG000|Overall Study|Lack of Efficacy|1|||
13423036|NCT00447382|26869535|FG001|Overall Study|Lack of Efficacy|0|||
13423037|NCT00447382|26869534|FG000|Overall Study|Protocol Violation|2|||
13423038|NCT00447382|26869535|FG001|Overall Study|Protocol Violation|0|||
13423039|NCT00447382|26869534|FG000|Overall Study|Unclassified|2|||
13423040|NCT00447382|26869535|FG001|Overall Study|Unclassified|5|||
13423041|NCT00447278|26869563|FG000|Period II (6 Month Open-Label)|Adverse Event|7|||
13423042|NCT00447278|26869564|FG001|Period II (6 Month Open-Label)|Adverse Event|3|||
13423043|NCT00447278|26869563|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0|||
13423044|NCT00447278|26869564|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4|||
13423045|NCT00447278|26869563|FG000|Period II (6 Month Open-Label)|Protocol Violation|10|||
13423046|NCT00447278|26869564|FG001|Period II (6 Month Open-Label)|Protocol Violation|7|||
13423047|NCT00447278|26869563|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1|||
13423048|NCT00447278|26869564|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3|||
13423049|NCT00447278|26869563|FG000|Period II (6 Month Open-Label)|Physician Decision|4|||
13423050|NCT00447278|26869564|FG001|Period II (6 Month Open-Label)|Physician Decision|1|||
13423051|NCT00447278|26869563|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11|||
13423052|NCT00447278|26869564|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1|||
13423053|NCT00447278|26869563|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9|||
13423054|NCT00447278|26869564|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10|||
13423055|NCT00447278|26869563|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2|||
13423056|NCT00447278|26869564|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2|||
13423057|NCT00447278|26869563|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
13423058|NCT00447278|26869564|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
13423059|NCT00447278|26869563|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6|||
13423060|NCT00447278|26869564|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1|||
13423061|NCT00447278|26869563|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4|||
13423062|NCT00447278|26869564|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1|||
13423063|NCT00447278|26869563|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1|||
13423064|NCT00447278|26869564|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1|||
13423065|NCT00447278|26869563|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4|||
13423066|NCT00447278|26869564|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0|||
13423067|NCT00447278|26869563|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11|||
13423068|NCT00447278|26869564|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8|||
13423069|NCT00447265|26869580|FG000|Overall Study|Physician Decision|1|||
13423070|NCT00447265|26869581|FG001|Overall Study|Physician Decision|0|||
13423071|NCT00447226|26869602|FG000|12-Week Open-label Phase|Adverse Event|0|||
13423072|NCT00447226|26869603|FG001|12-Week Open-label Phase|Adverse Event|3|||
13423073|NCT00447226|26869602|FG000|12-Week Open-label Phase|Protocol Violation|0|||
13423074|NCT00447226|26869603|FG001|12-Week Open-label Phase|Protocol Violation|1|||
13423075|NCT00447226|26869602|FG000|12-Week Open-label Phase|Disease Progression|0|||
13423076|NCT00447226|26869603|FG001|12-Week Open-label Phase|Disease Progression|20|||
13423077|NCT00447226|26869602|FG000|12-Week Open-label Phase|Physician Decision|0|||
13423078|NCT00447226|26869603|FG001|12-Week Open-label Phase|Physician Decision|1|||
13423079|NCT00447226|26869602|FG000|Double-blind Phase|Disease Progression|4|||
13423080|NCT00447226|26869603|FG001|Double-blind Phase|Disease Progression|3|||
13423081|NCT00447057|26869634|FG000|Overall Study|Adverse Event|4|||
13423082|NCT00447057|26869635|FG001|Overall Study|Adverse Event|10|||
13423083|NCT00447057|26869636|FG002|Overall Study|Adverse Event|0|||
13423084|NCT00447057|26869637|FG003|Overall Study|Adverse Event|3|||
13423085|NCT00447057|26869634|FG000|Overall Study|Death due to study disease|6|||
13423086|NCT00447057|26869635|FG001|Overall Study|Death due to study disease|4|||
13423087|NCT00447057|26869636|FG002|Overall Study|Death due to study disease|1|||
13423088|NCT00447057|26869637|FG003|Overall Study|Death due to study disease|1|||
13423089|NCT00447057|26869634|FG000|Overall Study|Lost to Follow-up|0|||
13423090|NCT00447057|26869635|FG001|Overall Study|Lost to Follow-up|1|||
13423091|NCT00447057|26869636|FG002|Overall Study|Lost to Follow-up|0|||
13423092|NCT00447057|26869637|FG003|Overall Study|Lost to Follow-up|0|||
13423093|NCT00447057|26869634|FG000|Overall Study|Entry criteria not met|1|||
13423094|NCT00447057|26869635|FG001|Overall Study|Entry criteria not met|1|||
13423095|NCT00447057|26869636|FG002|Overall Study|Entry criteria not met|0|||
13423096|NCT00447057|26869637|FG003|Overall Study|Entry criteria not met|0|||
13423097|NCT00447057|26869634|FG000|Overall Study|Protocol Violation|0|||
13423098|NCT00447057|26869635|FG001|Overall Study|Protocol Violation|1|||
13423099|NCT00447057|26869636|FG002|Overall Study|Protocol Violation|0|||
13423100|NCT00447057|26869637|FG003|Overall Study|Protocol Violation|0|||
13423101|NCT00447057|26869634|FG000|Overall Study|Withdrawal by Subject|4|||
13423102|NCT00447057|26869635|FG001|Overall Study|Withdrawal by Subject|5|||
13423103|NCT00447057|26869636|FG002|Overall Study|Withdrawal by Subject|1|||
13423104|NCT00447057|26869637|FG003|Overall Study|Withdrawal by Subject|1|||
13423105|NCT00447057|26869634|FG000|Overall Study|Physician Decision|9|||
13423106|NCT00447057|26869635|FG001|Overall Study|Physician Decision|6|||
13423107|NCT00447057|26869636|FG002|Overall Study|Physician Decision|3|||
13423108|NCT00447057|26869637|FG003|Overall Study|Physician Decision|1|||
13423109|NCT00447057|26869634|FG000|Overall Study|Sponsor decision|1|||
13423110|NCT00447057|26869635|FG001|Overall Study|Sponsor decision|1|||
13423111|NCT00447057|26869636|FG002|Overall Study|Sponsor decision|0|||
13423112|NCT00447057|26869637|FG003|Overall Study|Sponsor decision|0|||
13423113|NCT00447057|26869634|FG000|Overall Study|Progressive disease|58|||
13423114|NCT00447057|26869635|FG001|Overall Study|Progressive disease|43|||
13423115|NCT00447057|26869636|FG002|Overall Study|Progressive disease|13|||
13423116|NCT00447057|26869637|FG003|Overall Study|Progressive disease|18|||
13423117|NCT00447057|26869634|FG000|Overall Study|Death due to adverse event|0|||
13423118|NCT00447057|26869635|FG001|Overall Study|Death due to adverse event|0|||
13423119|NCT00447057|26869636|FG002|Overall Study|Death due to adverse event|1|||
13423120|NCT00447057|26869637|FG003|Overall Study|Death due to adverse event|2|||
13423121|NCT00447057|26869634|FG000|Overall Study|Death, study drug related|0|||
13423122|NCT00447057|26869635|FG001|Overall Study|Death, study drug related|1|||
13423123|NCT00447057|26869636|FG002|Overall Study|Death, study drug related|0|||
13423124|NCT00447057|26869637|FG003|Overall Study|Death, study drug related|0|||
13423125|NCT00447005|26869653|FG000|Overall Study|Adverse Event|1|||
13423126|NCT00447005|26869653|FG000|Overall Study|Lack of Efficacy|11|||
13423127|NCT00446992|26869667|FG000|Overall Study|Adverse Event|11|||
13423128|NCT00446992|26869667|FG000|Overall Study|Lost to Follow-up|5|||
13423129|NCT00446966|26869680|FG000|Overall Study|Lost to Follow-up|10|||
13423130|NCT00446966|26869681|FG001|Overall Study|Lost to Follow-up|7|||
13423131|NCT00446849|26869693|FG000|Acute Phase|Lack of Efficacy|64|||
13423132|NCT00446849|26869693|FG000|Acute Phase|Protocol Violation|10|||
13423133|NCT00446849|26869693|FG000|Acute Phase|Consent withdrawn|4|||
13423134|NCT00446849|26869693|FG000|Acute Phase|Lost to Follow-up|2|||
13423135|NCT00446849|26869693|FG000|Acute Phase|Physician Decision|1|||
13423136|NCT00446849|26869693|FG000|Acute Phase|noncompliance|1|||
13423137|NCT00446849|26869693|FG000|Maintenance Phase|Lack of Efficacy|40|||
13423138|NCT00446849|26869693|FG000|Maintenance Phase|Protocol Violation|7|||
13423139|NCT00446849|26869693|FG000|Maintenance Phase|Adverse Event|6|||
13423140|NCT00446849|26869693|FG000|Maintenance Phase|Consent withdrawn|5|||
13423141|NCT00446849|26869693|FG000|Maintenance Phase|Lost to Follow-up|3|||
13423142|NCT00446849|26869693|FG000|Maintenance Phase|Pregnancy|1|||
13423143|NCT00446849|26869693|FG000|Maintenance Phase|noncompliance|2|||
13423144|NCT00446849|26869693|FG000|Maintenance Phase|prohibited medication use|2|||
13423145|NCT00446849|26869693|FG000|Maintenance Phase|antibiotic use|1|||
13423146|NCT00446849|26869693|FG000|Maintenance Phase|study closure|1|||
13423147|NCT00446849|26869693|FG000|Maintenance Phase|hydrocodone use|1|||
13423148|NCT00446849|26869693|FG000|Maintenance Phase|concomitant medication use|1|||
13423149|NCT00446797|26869744|FG000|Overall Study|Lack of Efficacy|0|||
13423150|NCT00446797|26869745|FG001|Overall Study|Lack of Efficacy|2|||
13423151|NCT00446797|26869744|FG000|Overall Study|Lost to Follow-up|5|||
13423152|NCT00446797|26869745|FG001|Overall Study|Lost to Follow-up|3|||
13423153|NCT00446797|26869744|FG000|Overall Study|Withdrawal by Subject|2|||
13423154|NCT00446797|26869745|FG001|Overall Study|Withdrawal by Subject|2|||
13423155|NCT00446797|26869744|FG000|Overall Study|Protocol Violation|1|||
13423156|NCT00446797|26869745|FG001|Overall Study|Protocol Violation|3|||
13423157|NCT00446797|26869744|FG000|Overall Study|subject entered at another site|0|||
13423158|NCT00446797|26869745|FG001|Overall Study|subject entered at another site|1|||
13423159|NCT00446797|26869744|FG000|Overall Study|did not meet entrance criteria|0|||
13423160|NCT00446797|26869745|FG001|Overall Study|did not meet entrance criteria|1|||
13423161|NCT00446654|26869758|FG000|Overall Study|Withdrawal by Subject|1|||
13423162|NCT00446654|26869759|FG001|Overall Study|Withdrawal by Subject|0|||
13423163|NCT00446654|26869758|FG000|Overall Study|Adverse Event|1|||
13423164|NCT00446654|26869759|FG001|Overall Study|Adverse Event|0|||
13423165|NCT00446641|26869784|FG000|Overall Study|Withdrawal by Subject|8|||
13423166|NCT00446641|26869785|FG001|Overall Study|Withdrawal by Subject|3|||
13423167|NCT00446641|26869784|FG000|Overall Study|poor compliance|8|||
13423168|NCT00446641|26869785|FG001|Overall Study|poor compliance|6|||
13423169|NCT00446641|26869784|FG000|Overall Study|Lost to Follow-up|1|||
13423170|NCT00446641|26869785|FG001|Overall Study|Lost to Follow-up|1|||
13423171|NCT00446563|26869826|FG000|Overall Study|Adverse Event|4|||
13423172|NCT00446563|26869827|FG001|Overall Study|Adverse Event|3|||
13423173|NCT00446563|26869826|FG000|Overall Study|Abnormal laboratory value(s)|0|||
13423174|NCT00446563|26869827|FG001|Overall Study|Abnormal laboratory value(s)|1|||
13423175|NCT00446563|26869826|FG000|Overall Study|Abnormal test procedure result(s)|1|||
13423176|NCT00446563|26869827|FG001|Overall Study|Abnormal test procedure result(s)|0|||
13423177|NCT00446563|26869826|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
13423178|NCT00446563|26869827|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
13423179|NCT00446563|26869826|FG000|Overall Study|Withdrawal by Subject|2|||
13423180|NCT00446563|26869827|FG001|Overall Study|Withdrawal by Subject|1|||
13423181|NCT00446563|26869826|FG000|Overall Study|Administrative problems|0|||
13423182|NCT00446563|26869827|FG001|Overall Study|Administrative problems|1|||
13423183|NCT00446550|26869842|FG000|Overall Study|Adverse Event|1|||
13423184|NCT00446550|26869843|FG001|Overall Study|Adverse Event|0|||
13423185|NCT00446511|26869880|FG000|Overall Study|Adverse Event|7|||
13423186|NCT00446511|26869881|FG001|Overall Study|Adverse Event|2|||
13423187|NCT00446511|26869882|FG002|Overall Study|Adverse Event|3|||
13423188|NCT00446511|26869883|FG003|Overall Study|Adverse Event|1|||
13423189|NCT00446511|26869880|FG000|Overall Study|Protocol Violation|0|||
13423190|NCT00446511|26869881|FG001|Overall Study|Protocol Violation|0|||
13423191|NCT00446511|26869882|FG002|Overall Study|Protocol Violation|0|||
13423192|NCT00446511|26869883|FG003|Overall Study|Protocol Violation|1|||
13423193|NCT00446511|26869880|FG000|Overall Study|Withdrawal by Subject|0|||
13423194|NCT00446511|26869881|FG001|Overall Study|Withdrawal by Subject|0|||
13423195|NCT00446511|26869882|FG002|Overall Study|Withdrawal by Subject|0|||
13423196|NCT00446511|26869883|FG003|Overall Study|Withdrawal by Subject|3|||
13423197|NCT00446511|26869880|FG000|Overall Study|Administrative Problems|3|||
13423198|NCT00446511|26869881|FG001|Overall Study|Administrative Problems|0|||
13423199|NCT00446511|26869882|FG002|Overall Study|Administrative Problems|4|||
13423200|NCT00446511|26869883|FG003|Overall Study|Administrative Problems|1|||
13423201|NCT00446459|26869893|FG000|8 Months|Protocol Violation|12|||
13423202|NCT00446459|26869893|FG000|12 Months|Protocol Violation|4|||
13423203|NCT00446459|26869893|FG000|12 Months|14 subjects to MMF + Rituximab Study|14|||
13423204|NCT00446446|26869906|FG000|Overall Study|Death|10|||
13423205|NCT00446446|26869906|FG000|Overall Study|Withdrawal by Subject|6|||
13423206|NCT00446446|26869906|FG000|Overall Study|Other|4|||
13423207|NCT00446446|26869906|FG000|Overall Study|Disease Progession|2|||
13423208|NCT00446446|26869906|FG000|Overall Study|Adverse Event|1|||
13423209|NCT00446446|26869906|FG000|Overall Study|On Treatment at Time of Data Cut-off|1|||
13423210|NCT00446251|26869914|FG000|Overall Study|On-study Transplants|2|||
13423211|NCT00446251|26869914|FG000|Overall Study|Rituximab Infusion Reaction|2|||
13423212|NCT00446251|26869914|FG000|Overall Study|Lost to Follow-up|1|||
13423213|NCT00446199|26870005|FG000|Overall Study|Adverse Event|7|||
13423214|NCT00446199|26870006|FG001|Overall Study|Adverse Event|4|||
13423215|NCT00446199|26870007|FG002|Overall Study|Adverse Event|6|||
13423216|NCT00446199|26870008|FG003|Overall Study|Adverse Event|4|||
13423217|NCT00446199|26870005|FG000|Overall Study|Lost to Follow-up|4|||
13423218|NCT00446199|26870006|FG001|Overall Study|Lost to Follow-up|5|||
13423219|NCT00446199|26870007|FG002|Overall Study|Lost to Follow-up|2|||
13423220|NCT00446199|26870008|FG003|Overall Study|Lost to Follow-up|6|||
13423221|NCT00446199|26870005|FG000|Overall Study|Protocol Violation|1|||
13423222|NCT00446199|26870006|FG001|Overall Study|Protocol Violation|2|||
13423223|NCT00446199|26870007|FG002|Overall Study|Protocol Violation|1|||
13423224|NCT00446199|26870008|FG003|Overall Study|Protocol Violation|3|||
13423225|NCT00446199|26870005|FG000|Overall Study|Withdrawal by Subject|2|||
13423226|NCT00446199|26870006|FG001|Overall Study|Withdrawal by Subject|5|||
13423227|NCT00446199|26870007|FG002|Overall Study|Withdrawal by Subject|9|||
13423228|NCT00446199|26870008|FG003|Overall Study|Withdrawal by Subject|10|||
13423229|NCT00446199|26870005|FG000|Overall Study|Site termination|2|||
13423230|NCT00446199|26870006|FG001|Overall Study|Site termination|0|||
13423231|NCT00446199|26870007|FG002|Overall Study|Site termination|0|||
13423232|NCT00446199|26870008|FG003|Overall Study|Site termination|1|||
13423233|NCT00446199|26870005|FG000|Overall Study|Randomization in Error|2|||
13423234|NCT00446199|26870006|FG001|Overall Study|Randomization in Error|0|||
13423235|NCT00446199|26870007|FG002|Overall Study|Randomization in Error|1|||
13423236|NCT00446199|26870008|FG003|Overall Study|Randomization in Error|1|||
13423237|NCT00446199|26870005|FG000|Overall Study|Lack of Efficacy|1|||
13423238|NCT00446199|26870006|FG001|Overall Study|Lack of Efficacy|0|||
13423239|NCT00446199|26870007|FG002|Overall Study|Lack of Efficacy|0|||
13423240|NCT00446199|26870008|FG003|Overall Study|Lack of Efficacy|1|||
13423241|NCT00446199|26870005|FG000|Overall Study|Non-compliant with study drug|1|||
13423242|NCT00446199|26870006|FG001|Overall Study|Non-compliant with study drug|0|||
13423243|NCT00446199|26870007|FG002|Overall Study|Non-compliant with study drug|5|||
13423244|NCT00446199|26870008|FG003|Overall Study|Non-compliant with study drug|0|||
13423245|NCT00446199|26870005|FG000|Overall Study|Non-compliant with visit schedule|1|||
13423246|NCT00446199|26870006|FG001|Overall Study|Non-compliant with visit schedule|1|||
13423247|NCT00446199|26870007|FG002|Overall Study|Non-compliant with visit schedule|1|||
13423248|NCT00446199|26870008|FG003|Overall Study|Non-compliant with visit schedule|2|||
13423249|NCT00446199|26870005|FG000|Overall Study|Hormone fear|0|||
13423250|NCT00446199|26870006|FG001|Overall Study|Hormone fear|0|||
13423251|NCT00446199|26870007|FG002|Overall Study|Hormone fear|0|||
13423252|NCT00446199|26870008|FG003|Overall Study|Hormone fear|1|||
13423253|NCT00446199|26870005|FG000|Overall Study|Lost interest in study participation|0|||
13423254|NCT00446199|26870006|FG001|Overall Study|Lost interest in study participation|1|||
13423255|NCT00446199|26870007|FG002|Overall Study|Lost interest in study participation|0|||
13423256|NCT00446199|26870008|FG003|Overall Study|Lost interest in study participation|0|||
13423257|NCT00446199|26870005|FG000|Overall Study|In-/Exclusion criterion violated|2|||
13423258|NCT00446199|26870006|FG001|Overall Study|In-/Exclusion criterion violated|1|||
13423259|NCT00446199|26870007|FG002|Overall Study|In-/Exclusion criterion violated|2|||
13423260|NCT00446199|26870008|FG003|Overall Study|In-/Exclusion criterion violated|1|||
13423261|NCT00446199|26870005|FG000|Overall Study|Move|0|||
13423262|NCT00446199|26870006|FG001|Overall Study|Move|1|||
13423263|NCT00446199|26870007|FG002|Overall Study|Move|0|||
13423264|NCT00446199|26870008|FG003|Overall Study|Move|0|||
13423265|NCT00446134|26870043|FG000|Overall Study|Adverse Event|7|||
13423266|NCT00446134|26870044|FG001|Overall Study|Adverse Event|17|||
13423267|NCT00446134|26870045|FG002|Overall Study|Adverse Event|13|||
13423268|NCT00446134|26870046|FG003|Overall Study|Adverse Event|18|||
13423269|NCT00446134|26870043|FG000|Overall Study|Lack of Efficacy|19|||
13423270|NCT00446134|26870044|FG001|Overall Study|Lack of Efficacy|19|||
13423271|NCT00446134|26870045|FG002|Overall Study|Lack of Efficacy|24|||
13423272|NCT00446134|26870046|FG003|Overall Study|Lack of Efficacy|19|||
13423273|NCT00446134|26870043|FG000|Overall Study|Protocol Violation|0|||
13423274|NCT00446134|26870044|FG001|Overall Study|Protocol Violation|2|||
13423275|NCT00446134|26870045|FG002|Overall Study|Protocol Violation|1|||
13423276|NCT00446134|26870046|FG003|Overall Study|Protocol Violation|0|||
13423277|NCT00446134|26870043|FG000|Overall Study|Lost to Follow-up|1|||
13423278|NCT00446134|26870044|FG001|Overall Study|Lost to Follow-up|3|||
13423279|NCT00446134|26870045|FG002|Overall Study|Lost to Follow-up|1|||
13423280|NCT00446134|26870046|FG003|Overall Study|Lost to Follow-up|1|||
13423281|NCT00446134|26870043|FG000|Overall Study|Withdrawal by Subject|3|||
13423282|NCT00446134|26870044|FG001|Overall Study|Withdrawal by Subject|3|||
13423283|NCT00446134|26870045|FG002|Overall Study|Withdrawal by Subject|1|||
13423284|NCT00446134|26870046|FG003|Overall Study|Withdrawal by Subject|3|||
13423285|NCT00446134|26870043|FG000|Overall Study|Physician Decision|0|||
13423286|NCT00446134|26870044|FG001|Overall Study|Physician Decision|0|||
13423287|NCT00446134|26870045|FG002|Overall Study|Physician Decision|0|||
13423288|NCT00446134|26870046|FG003|Overall Study|Physician Decision|2|||
13423289|NCT00446134|26870043|FG000|Overall Study|Adverse Event-Diarrhea|1|||
13423290|NCT00446134|26870044|FG001|Overall Study|Adverse Event-Diarrhea|1|||
13423291|NCT00446134|26870045|FG002|Overall Study|Adverse Event-Diarrhea|2|||
13423292|NCT00446134|26870046|FG003|Overall Study|Adverse Event-Diarrhea|0|||
13423293|NCT00446134|26870043|FG000|Overall Study|Reason Not Completed|3|||
13423294|NCT00446134|26870044|FG001|Overall Study|Reason Not Completed|0|||
13423295|NCT00446134|26870045|FG002|Overall Study|Reason Not Completed|1|||
13423296|NCT00446134|26870046|FG003|Overall Study|Reason Not Completed|2|||
13423297|NCT00446095|26870083|FG000|Phase II (8 Weeks)|Lost to Follow-up|1|||
13423298|NCT00446095|26870084|FG001|Phase II (8 Weeks)|Lost to Follow-up|0|||
13423299|NCT00446095|26870085|FG002|Phase II (8 Weeks)|Lost to Follow-up|0|||
13423300|NCT00446095|26870086|FG003|Phase II (8 Weeks)|Lost to Follow-up|0|||
13423301|NCT00446095|26870087|FG004|Phase II (8 Weeks)|Lost to Follow-up|0|||
13423302|NCT00446095|26870083|FG000|Phase II (8 Weeks)|Adverse Event|0|||
13423303|NCT00446095|26870084|FG001|Phase II (8 Weeks)|Adverse Event|1|||
13423304|NCT00446095|26870085|FG002|Phase II (8 Weeks)|Adverse Event|1|||
13423305|NCT00446095|26870086|FG003|Phase II (8 Weeks)|Adverse Event|0|||
13423306|NCT00446095|26870087|FG004|Phase II (8 Weeks)|Adverse Event|0|||
13423307|NCT00446095|26870083|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1|||
13423308|NCT00446095|26870084|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0|||
13423309|NCT00446095|26870085|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0|||
13423310|NCT00446095|26870086|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0|||
13423311|NCT00446095|26870087|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0|||
13423312|NCT00446095|26870083|FG000|Phase II (8 Weeks)|Physician Decision|1|||
13423313|NCT00446095|26870084|FG001|Phase II (8 Weeks)|Physician Decision|0|||
13423314|NCT00446095|26870085|FG002|Phase II (8 Weeks)|Physician Decision|0|||
13423315|NCT00446095|26870086|FG003|Phase II (8 Weeks)|Physician Decision|0|||
13423316|NCT00446095|26870087|FG004|Phase II (8 Weeks)|Physician Decision|0|||
13423317|NCT00446095|26870083|FG000|Phase II (8 Weeks)|Lack of Efficacy|9|||
13423318|NCT00446095|26870084|FG001|Phase II (8 Weeks)|Lack of Efficacy|2|||
13423319|NCT00446095|26870085|FG002|Phase II (8 Weeks)|Lack of Efficacy|1|||
13423320|NCT00446095|26870086|FG003|Phase II (8 Weeks)|Lack of Efficacy|0|||
13423321|NCT00446095|26870087|FG004|Phase II (8 Weeks)|Lack of Efficacy|0|||
13423322|NCT00446095|26870083|FG000|Phase II (8 Weeks)|Ongoing|0|||
13423323|NCT00446095|26870084|FG001|Phase II (8 Weeks)|Ongoing|0|||
13423324|NCT00446095|26870085|FG002|Phase II (8 Weeks)|Ongoing|1|||
13423325|NCT00446095|26870086|FG003|Phase II (8 Weeks)|Ongoing|0|||
13423326|NCT00446095|26870087|FG004|Phase II (8 Weeks)|Ongoing|0|||
13423327|NCT00446095|26870083|FG000|Phase I (28 Days)|Adverse Event|0|||
13423328|NCT00446095|26870084|FG001|Phase I (28 Days)|Adverse Event|0|||
13423329|NCT00446095|26870085|FG002|Phase I (28 Days)|Adverse Event|0|||
13423330|NCT00446095|26870086|FG003|Phase I (28 Days)|Adverse Event|1|||
13423331|NCT00446095|26870087|FG004|Phase I (28 Days)|Adverse Event|0|||
13423332|NCT00446095|26870083|FG000|Phase I (28 Days)|Lack of Efficacy|0|||
13423333|NCT00446095|26870084|FG001|Phase I (28 Days)|Lack of Efficacy|0|||
13423334|NCT00446095|26870085|FG002|Phase I (28 Days)|Lack of Efficacy|0|||
13423335|NCT00446095|26870086|FG003|Phase I (28 Days)|Lack of Efficacy|0|||
13423336|NCT00446095|26870087|FG004|Phase I (28 Days)|Lack of Efficacy|3|||
13423337|NCT00446030|26870102|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29|||
13423338|NCT00446030|26870103|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8|||
13423339|NCT00446030|26870102|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9|||
13423340|NCT00446030|26870103|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1|||
13423341|NCT00446030|26870102|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1|||
13423342|NCT00446030|26870103|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0|||
13423343|NCT00446030|26870102|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1|||
13423344|NCT00446030|26870103|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0|||
13423345|NCT00446030|26870102|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1|||
13423346|NCT00446030|26870103|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0|||
13423347|NCT00446030|26870102|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1|||
13423348|NCT00446030|26870103|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0|||
13423349|NCT00446030|26870102|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1|||
13423350|NCT00446030|26870103|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0|||
13423351|NCT00446030|26870102|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1|||
13423352|NCT00446030|26870103|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0|||
13423353|NCT00446030|26870102|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9|||
13423354|NCT00446030|26870103|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4|||
13423355|NCT00446030|26870102|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5|||
13423356|NCT00446030|26870103|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0|||
13423357|NCT00446030|26870102|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4|||
13423358|NCT00446030|26870103|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0|||
13423359|NCT00446030|26870102|FG000|FOLLOW-UP (up to 2-years)|Death|2|||
13423360|NCT00446030|26870103|FG001|FOLLOW-UP (up to 2-years)|Death|2|||
13423361|NCT00446030|26870102|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3|||
13423362|NCT00446030|26870103|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2|||
13423363|NCT00446030|26870102|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2|||
13423364|NCT00446030|26870103|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0|||
13423365|NCT00446030|26870102|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2|||
13423366|NCT00446030|26870103|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0|||
13423367|NCT00446030|26870102|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1|||
13423368|NCT00446030|26870103|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0|||
13423369|NCT00446030|26870102|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1|||
13423370|NCT00446030|26870103|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0|||
13423371|NCT00446030|26870102|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1|||
13423372|NCT00446030|26870103|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0|||
13423373|NCT00446030|26870102|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0|||
13423374|NCT00446030|26870103|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1|||
13423375|NCT00445978|26870119|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1|||
13423376|NCT00445978|26870119|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1|||
13423377|NCT00445978|26870119|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1|||
13423378|NCT00445978|26870119|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1|||
13423379|NCT00445978|26870119|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1|||
13423380|NCT00445978|26870119|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1|||
13423381|NCT00445978|26870119|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1|||
13423382|NCT00445978|26870119|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1|||
13423383|NCT00445978|26870119|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1|||
13423384|NCT00445939|26870153|FG000|Period A - Week 0 - Week 4|Adverse Event|1|||
13423385|NCT00445939|26870154|FG001|Period A - Week 0 - Week 4|Adverse Event|2|||
13423386|NCT00445939|26870155|FG002|Period A - Week 0 - Week 4|Adverse Event|0|||
13423387|NCT00445939|26870156|FG003|Period A - Week 0 - Week 4|Adverse Event|0|||
13423388|NCT00445939|26870153|FG000|Period B - Week 4 - Week 8|Adverse Event|2|||
13423389|NCT00445939|26870154|FG001|Period B - Week 4 - Week 8|Adverse Event|0|||
13423390|NCT00445939|26870155|FG002|Period B - Week 4 - Week 8|Adverse Event|0|||
13423391|NCT00445939|26870156|FG003|Period B - Week 4 - Week 8|Adverse Event|1|||
13423392|NCT00445848|26870165|FG000|Overall Study|Adverse Event|14|||
13423393|NCT00445848|26870165|FG000|Overall Study|Withdrawal by Subject|4|||
13423394|NCT00445848|26870165|FG000|Overall Study|Progression|62|||
13423395|NCT00445848|26870165|FG000|Overall Study|Other-Not protocol specified|5|||
13423396|NCT00445770|26870242|FG000|Overall Study|Adverse Event|9|||
13423397|NCT00445770|26870243|FG001|Overall Study|Adverse Event|15|||
13423398|NCT00445770|26870244|FG002|Overall Study|Adverse Event|19|||
13423399|NCT00445770|26870242|FG000|Overall Study|Lack of Efficacy|38|||
13423400|NCT00445770|26870243|FG001|Overall Study|Lack of Efficacy|13|||
13423401|NCT00445770|26870244|FG002|Overall Study|Lack of Efficacy|6|||
13423402|NCT00445770|26870242|FG000|Overall Study|Lost to Follow-up|0|||
13423403|NCT00445770|26870243|FG001|Overall Study|Lost to Follow-up|2|||
13423404|NCT00445770|26870244|FG002|Overall Study|Lost to Follow-up|0|||
13423405|NCT00445770|26870242|FG000|Overall Study|Other|6|||
13423406|NCT00445770|26870243|FG001|Overall Study|Other|5|||
13423407|NCT00445770|26870244|FG002|Overall Study|Other|6|||
13423408|NCT00445692|26870252|FG000|Overall Study|Adverse Event|11|||
13423409|NCT00445692|26870252|FG000|Overall Study|Lack of Efficacy|5|||
13423410|NCT00445679|26870299|FG000|Overall Study|Adverse Event|22|||
13423411|NCT00445679|26870300|FG001|Overall Study|Adverse Event|12|||
13423412|NCT00445679|26870301|FG002|Overall Study|Adverse Event|30|||
13423413|NCT00445679|26870302|FG003|Overall Study|Adverse Event|19|||
13423414|NCT00445679|26870299|FG000|Overall Study|Failed to return|1|||
13423415|NCT00445679|26870300|FG001|Overall Study|Failed to return|3|||
13423416|NCT00445679|26870301|FG002|Overall Study|Failed to return|2|||
13423417|NCT00445679|26870302|FG003|Overall Study|Failed to return|2|||
13423418|NCT00445679|26870299|FG000|Overall Study|Physician Decision|0|||
13423419|NCT00445679|26870300|FG001|Overall Study|Physician Decision|0|||
13423420|NCT00445679|26870301|FG002|Overall Study|Physician Decision|1|||
13423421|NCT00445679|26870302|FG003|Overall Study|Physician Decision|0|||
13423422|NCT00445679|26870299|FG000|Overall Study|Lost to Follow-up|10|||
13423423|NCT00445679|26870300|FG001|Overall Study|Lost to Follow-up|6|||
13423424|NCT00445679|26870301|FG002|Overall Study|Lost to Follow-up|6|||
13423425|NCT00445679|26870302|FG003|Overall Study|Lost to Follow-up|5|||
13423426|NCT00445679|26870299|FG000|Overall Study|Compliance|3|||
13423427|NCT00445679|26870300|FG001|Overall Study|Compliance|2|||
13423428|NCT00445679|26870301|FG002|Overall Study|Compliance|1|||
13423429|NCT00445679|26870302|FG003|Overall Study|Compliance|2|||
13423430|NCT00445679|26870299|FG000|Overall Study|Withdrawal of Informed Consent|0|||
13423431|NCT00445679|26870300|FG001|Overall Study|Withdrawal of Informed Consent|0|||
13423432|NCT00445679|26870301|FG002|Overall Study|Withdrawal of Informed Consent|1|||
13423433|NCT00445679|26870302|FG003|Overall Study|Withdrawal of Informed Consent|0|||
13423434|NCT00445679|26870299|FG000|Overall Study|Protocol Violation|2|||
13423435|NCT00445679|26870300|FG001|Overall Study|Protocol Violation|3|||
13423436|NCT00445679|26870301|FG002|Overall Study|Protocol Violation|3|||
13423437|NCT00445679|26870302|FG003|Overall Study|Protocol Violation|1|||
13423438|NCT00445679|26870299|FG000|Overall Study|Withdrawal by Subject|8|||
13423439|NCT00445679|26870300|FG001|Overall Study|Withdrawal by Subject|14|||
13423440|NCT00445679|26870301|FG002|Overall Study|Withdrawal by Subject|20|||
13423441|NCT00445679|26870302|FG003|Overall Study|Withdrawal by Subject|18|||
13423442|NCT00445679|26870299|FG000|Overall Study|Lack of Efficacy|2|||
13423443|NCT00445679|26870300|FG001|Overall Study|Lack of Efficacy|6|||
13423444|NCT00445679|26870301|FG002|Overall Study|Lack of Efficacy|2|||
13423445|NCT00445679|26870302|FG003|Overall Study|Lack of Efficacy|0|||
13423446|NCT00445601|26870321|FG000|Overall Study|Withdrawal by Subject|11|||
13423447|NCT00445601|26870322|FG001|Overall Study|Withdrawal by Subject|11|||
13423448|NCT00445601|26870321|FG000|Overall Study|TURBT Complication|12|||
13423449|NCT00445601|26870322|FG001|Overall Study|TURBT Complication|8|||
13423450|NCT00445601|26870321|FG000|Overall Study|Incorrect Disease Status|6|||
13423451|NCT00445601|26870322|FG001|Overall Study|Incorrect Disease Status|6|||
13423452|NCT00445601|26870321|FG000|Overall Study|Drug Delivery Issue|2|||
13423453|NCT00445601|26870322|FG001|Overall Study|Drug Delivery Issue|2|||
13423454|NCT00445601|26870321|FG000|Overall Study|Adverse Event|2|||
13423455|NCT00445601|26870322|FG001|Overall Study|Adverse Event|0|||
13423456|NCT00445601|26870321|FG000|Overall Study|Death prior to TURBT|0|||
13423457|NCT00445601|26870322|FG001|Overall Study|Death prior to TURBT|1|||
13423458|NCT00445549|26870329|FG000|Overall Study|progressive disease|12|||
13423459|NCT00445458|26870357|FG000|Overall Study|Disease Progression|3|||
13423460|NCT00445458|26870358|FG001|Overall Study|Disease Progression|4|||
13423461|NCT00445458|26870359|FG002|Overall Study|Disease Progression|54|||
13423462|NCT00445458|26870360|FG003|Overall Study|Disease Progression|27|||
13423463|NCT00445458|26870357|FG000|Overall Study|Withdrawal by Subject|0|||
13423464|NCT00445458|26870358|FG001|Overall Study|Withdrawal by Subject|0|||
13423465|NCT00445458|26870359|FG002|Overall Study|Withdrawal by Subject|7|||
13423466|NCT00445458|26870360|FG003|Overall Study|Withdrawal by Subject|0|||
13423467|NCT00445458|26870357|FG000|Overall Study|Adverse Event|0|||
13423468|NCT00445458|26870358|FG001|Overall Study|Adverse Event|0|||
13423469|NCT00445458|26870359|FG002|Overall Study|Adverse Event|3|||
13423470|NCT00445458|26870360|FG003|Overall Study|Adverse Event|0|||
13423471|NCT00445458|26870357|FG000|Overall Study|Death|0|||
13423472|NCT00445458|26870358|FG001|Overall Study|Death|1|||
13423473|NCT00445458|26870359|FG002|Overall Study|Death|2|||
13423474|NCT00445458|26870360|FG003|Overall Study|Death|0|||
13423475|NCT00445458|26870357|FG000|Overall Study|Physician Decision|0|||
13423476|NCT00445458|26870358|FG001|Overall Study|Physician Decision|0|||
13423477|NCT00445458|26870359|FG002|Overall Study|Physician Decision|1|||
13423478|NCT00445458|26870360|FG003|Overall Study|Physician Decision|1|||
13423479|NCT00445458|26870357|FG000|Overall Study|Surgery|0|||
13423480|NCT00445458|26870358|FG001|Overall Study|Surgery|0|||
13423481|NCT00445458|26870359|FG002|Overall Study|Surgery|1|||
13423482|NCT00445458|26870360|FG003|Overall Study|Surgery|0|||
13423483|NCT00445432|26870404|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1|||
13423484|NCT00445432|26870405|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2|||
13423485|NCT00445432|26870406|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7|||
13423486|NCT00445432|26870407|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0|||
13423487|NCT00445432|26870404|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
13423488|NCT00445432|26870405|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
13423489|NCT00445432|26870406|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2|||
13423490|NCT00445432|26870407|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
13423491|NCT00445432|26870404|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14|||
13423492|NCT00445432|26870405|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20|||
13423493|NCT00445432|26870406|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
13423494|NCT00445432|26870407|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
13423495|NCT00445432|26870404|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
13423496|NCT00445432|26870405|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1|||
13423497|NCT00445432|26870406|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2|||
13423498|NCT00445432|26870407|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
13423499|NCT00445432|26870404|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
13423500|NCT00445432|26870405|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
13423501|NCT00445432|26870406|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
13423502|NCT00445432|26870407|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32|||
13423503|NCT00445432|26870404|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
13423504|NCT00445432|26870405|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
13423505|NCT00445432|26870406|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
13423506|NCT00445432|26870407|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3|||
13423507|NCT00445432|26870404|FG000|148 Weeks of Adalimumab Treatment|Other|0|||
13423508|NCT00445432|26870405|FG001|148 Weeks of Adalimumab Treatment|Other|0|||
13423509|NCT00445432|26870406|FG002|148 Weeks of Adalimumab Treatment|Other|0|||
13423510|NCT00445432|26870407|FG003|148 Weeks of Adalimumab Treatment|Other|9|||
13423511|NCT00445341|26870414|FG000|Overall Study|refused further treatment|1|||
13423512|NCT00445341|26870414|FG000|Overall Study|taken off treatment too early|1|||
13423513|NCT00445328|26870439|FG000|Overall Study|Death|0|||
13423514|NCT00445328|26870440|FG001|Overall Study|Death|1|||
13423515|NCT00445328|26870439|FG000|Overall Study|Adverse Event|0|||
13423516|NCT00445328|26870440|FG001|Overall Study|Adverse Event|3|||
13423517|NCT00445328|26870439|FG000|Overall Study|Other|0|||
13423518|NCT00445328|26870440|FG001|Overall Study|Other|2|||
13423519|NCT00445328|26870439|FG000|Overall Study|Withdrawal by Subject|2|||
13423520|NCT00445328|26870440|FG001|Overall Study|Withdrawal by Subject|0|||
13423521|NCT00445328|26870439|FG000|Overall Study|Protocol Violation|1|||
13423522|NCT00445328|26870440|FG001|Overall Study|Protocol Violation|0|||
13423523|NCT00445224|26870457|FG000|Specific Exercises|Withdrawal by Subject|3|||
13423524|NCT00445224|26870458|FG001|Specific Exercises|Withdrawal by Subject|3|||
13423525|NCT00445224|26870457|FG000|Specific Exercises|Withdrawal by Subject|1|||
13423526|NCT00445224|26870458|FG001|Specific Exercises|Withdrawal by Subject|0|||
13423527|NCT00445146|26870479|FG000|Overall Study|Withdrew Consent|29|||
13423528|NCT00445146|26870479|FG000|Overall Study|Lack of Efficacy|28|||
13423529|NCT00445146|26870479|FG000|Overall Study|Investigator's Discretion|22|||
13423530|NCT00445146|26870479|FG000|Overall Study|Adverse Event|13|||
13423531|NCT00445146|26870479|FG000|Overall Study|Lost to Follow-up|13|||
13423532|NCT00445146|26870479|FG000|Overall Study|Death|9|||
13423533|NCT00445146|26870479|FG000|Overall Study|Protocol Violation|4|||
13423534|NCT00445146|26870479|FG000|Overall Study|Pregnancy|1|||
13423535|NCT00445068|26870496|FG000|Overall Study|Disease progression|26|||
13423536|NCT00445068|26870496|FG000|Overall Study|Adverse Event|5|||
13423537|NCT00445068|26870496|FG000|Overall Study|Abnormal laboratory value|2|||
13423538|NCT00445068|26870496|FG000|Overall Study|Withdrawal by Subject|2|||
13423539|NCT00445068|26870496|FG000|Overall Study|Death|1|||
13423540|NCT00445003|26870535|FG000|Overall Study|Death|1|||
13423541|NCT00445003|26870536|FG001|Overall Study|Death|2|||
13423542|NCT00445003|26870537|FG002|Overall Study|Death|1|||
13423543|NCT00445003|26870535|FG000|Overall Study|Missed Visit|3|||
13423544|NCT00445003|26870536|FG001|Overall Study|Missed Visit|5|||
13423545|NCT00445003|26870537|FG002|Overall Study|Missed Visit|1|||
13423546|NCT00445003|26870535|FG000|Overall Study|Dropped|1|||
13423547|NCT00445003|26870536|FG001|Overall Study|Dropped|3|||
13423548|NCT00445003|26870537|FG002|Overall Study|Dropped|2|||
13423549|NCT00444951|26870561|FG000|Overall Study|Lost to Follow-up|1|||
13423550|NCT00444951|26870562|FG001|Overall Study|Lost to Follow-up|1|||
13423551|NCT00444951|26870563|FG002|Overall Study|Lost to Follow-up|0|||
13423552|NCT00444951|26870561|FG000|Overall Study|Withdrawal by Subject|4|||
13423553|NCT00444951|26870562|FG001|Overall Study|Withdrawal by Subject|5|||
13423554|NCT00444951|26870563|FG002|Overall Study|Withdrawal by Subject|3|||
13423555|NCT00444925|26870635|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3|||
13423556|NCT00444925|26870636|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6|||
13423557|NCT00444925|26870637|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6|||
13423558|NCT00444925|26870635|FG000|Double-blind Treatment Period|Death|2|||
13423559|NCT00444925|26870636|FG001|Double-blind Treatment Period|Death|0|||
13423560|NCT00444925|26870637|FG002|Double-blind Treatment Period|Death|0|||
13423561|NCT00444925|26870635|FG000|Double-blind Treatment Period|Adverse Event|6|||
13423562|NCT00444925|26870636|FG001|Double-blind Treatment Period|Adverse Event|28|||
13423563|NCT00444925|26870637|FG002|Double-blind Treatment Period|Adverse Event|44|||
13423564|NCT00444925|26870635|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
13423565|NCT00444925|26870636|FG001|Double-blind Treatment Period|Lack of Efficacy|5|||
13423566|NCT00444925|26870637|FG002|Double-blind Treatment Period|Lack of Efficacy|13|||
13423567|NCT00444925|26870635|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
13423568|NCT00444925|26870636|FG001|Double-blind Treatment Period|Lost to Follow-up|8|||
13423569|NCT00444925|26870637|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
13423570|NCT00444925|26870635|FG000|Double-blind Treatment Period|Withdrawal by Subject|6|||
13423571|NCT00444925|26870636|FG001|Double-blind Treatment Period|Withdrawal by Subject|8|||
13423572|NCT00444925|26870637|FG002|Double-blind Treatment Period|Withdrawal by Subject|7|||
13423573|NCT00444925|26870635|FG000|Double-blind Treatment Period|Other|7|||
13423574|NCT00444925|26870636|FG001|Double-blind Treatment Period|Other|7|||
13423575|NCT00444925|26870637|FG002|Double-blind Treatment Period|Other|12|||
13423576|NCT00444912|26870672|FG000|Overall Study|Death|1|||
13423577|NCT00444912|26870673|FG001|Overall Study|Death|2|||
13423578|NCT00444912|26870672|FG000|Overall Study|Lost to Follow-up|1|||
13423579|NCT00444912|26870673|FG001|Overall Study|Lost to Follow-up|0|||
13423580|NCT00444912|26870672|FG000|Overall Study|Participant Failed Mobilization|1|||
13423581|NCT00444912|26870673|FG001|Overall Study|Participant Failed Mobilization|0|||
13423582|NCT00444795|26870680|FG000|Overall Study|Not Treated|1|||
13423583|NCT00444795|26870680|FG000|Overall Study|Treated Prior to the Contract Date|2|||
13423584|NCT00444678|26870689|FG000|Overall Study|Toxicity|11|||
13423585|NCT00444678|26870689|FG000|Overall Study|Disease Progression|12|||
13423586|NCT00444678|26870689|FG000|Overall Study|Death|3|||
13423587|NCT00444678|26870689|FG000|Overall Study|Physician Decision|3|||
13423588|NCT00444678|26870689|FG000|Overall Study|Withdrawal by Subject|2|||
13423589|NCT00444626|26870717|FG000|Initial Treatment Period|Withdrawal by Subject|2|||
13423590|NCT00444626|26870717|FG000|Initial Treatment Period|Adverse Event|1|||
13423591|NCT00444626|26870717|FG000|Initial Treatment Period|Lost to Follow-up|9|||
13423592|NCT00444600|26870820|FG000|Overall Study|Death|7|||
13423593|NCT00444600|26870821|FG001|Overall Study|Death|5|||
13423594|NCT00444600|26870822|FG002|Overall Study|Death|3|||
13423595|NCT00444600|26870823|FG003|Overall Study|Death|2|||
13423596|NCT00444600|26870820|FG000|Overall Study|Dropped|11|||
13423597|NCT00444600|26870821|FG001|Overall Study|Dropped|11|||
13423598|NCT00444600|26870822|FG002|Overall Study|Dropped|7|||
13423599|NCT00444600|26870823|FG003|Overall Study|Dropped|7|||
13423600|NCT00444600|26870820|FG000|Overall Study|Missed visit|1|||
13423601|NCT00444600|26870821|FG001|Overall Study|Missed visit|0|||
13423602|NCT00444600|26870822|FG002|Overall Study|Missed visit|0|||
13423603|NCT00444600|26870823|FG003|Overall Study|Missed visit|1|||
13423604|NCT00444587|26870851|FG000|Overall Study|Death|2|||
13423605|NCT00444587|26870852|FG001|Overall Study|Death|1|||
13423606|NCT00444587|26870851|FG000|Overall Study|Progression of the disease|73|||
13423607|NCT00444587|26870852|FG001|Overall Study|Progression of the disease|8|||
13423608|NCT00444587|26870851|FG000|Overall Study|Refused treatment/did not cooperate|4|||
13423609|NCT00444587|26870852|FG001|Overall Study|Refused treatment/did not cooperate|1|||
13423610|NCT00444587|26870851|FG000|Overall Study|Investigator decision|3|||
13423611|NCT00444587|26870852|FG001|Overall Study|Investigator decision|0|||
13423612|NCT00444587|26870851|FG000|Overall Study|Protocol Violation|1|||
13423613|NCT00444587|26870852|FG001|Overall Study|Protocol Violation|0|||
13423614|NCT00444587|26870851|FG000|Overall Study|Missing|0|||
13423615|NCT00444587|26870852|FG001|Overall Study|Missing|5|||
13423616|NCT00444535|26870864|FG000|Overall Study|Withdrawal by Subject|5|||
13423617|NCT00444535|26870864|FG000|Overall Study|Physician Decision|5|||
13423618|NCT00444535|26870864|FG000|Overall Study|progressive disease|1|||
13423619|NCT00444535|26870864|FG000|Overall Study|Adverse Event|2|||
13423620|NCT00444457|26870939|FG000|Infant Series|Other|0|||
13423621|NCT00444457|26870940|FG001|Infant Series|Other|1|||
13423622|NCT00444457|26870941|FG002|Infant Series|Other|0|||
13423623|NCT00444457|26870942|FG003|Infant Series|Other|0|||
13423624|NCT00444457|26870939|FG000|Infant Series|Parent or legal guardian request|18|||
13423625|NCT00444457|26870940|FG001|Infant Series|Parent or legal guardian request|29|||
13423626|NCT00444457|26870941|FG002|Infant Series|Parent or legal guardian request|34|||
13423627|NCT00444457|26870942|FG003|Infant Series|Parent or legal guardian request|14|||
13423628|NCT00444457|26870939|FG000|Infant Series|Lost to Follow-up|10|||
13423629|NCT00444457|26870940|FG001|Infant Series|Lost to Follow-up|11|||
13423630|NCT00444457|26870941|FG002|Infant Series|Lost to Follow-up|7|||
13423631|NCT00444457|26870942|FG003|Infant Series|Lost to Follow-up|6|||
13423632|NCT00444457|26870939|FG000|Infant Series|Protocol Violation|16|||
13423633|NCT00444457|26870940|FG001|Infant Series|Protocol Violation|8|||
13423634|NCT00444457|26870941|FG002|Infant Series|Protocol Violation|6|||
13423635|NCT00444457|26870942|FG003|Infant Series|Protocol Violation|3|||
13423636|NCT00444457|26870939|FG000|Infant Series|Failed to return|5|||
13423637|NCT00444457|26870940|FG001|Infant Series|Failed to return|4|||
13423638|NCT00444457|26870941|FG002|Infant Series|Failed to return|4|||
13423639|NCT00444457|26870942|FG003|Infant Series|Failed to return|2|||
13423640|NCT00444457|26870939|FG000|Infant Series|Investigator request|4|||
13423641|NCT00444457|26870940|FG001|Infant Series|Investigator request|3|||
13423642|NCT00444457|26870941|FG002|Infant Series|Investigator request|3|||
13423643|NCT00444457|26870942|FG003|Infant Series|Investigator request|2|||
13423644|NCT00444457|26870939|FG000|Infant Series|Other|0|||
13423645|NCT00444457|26870940|FG001|Infant Series|Other|2|||
13423646|NCT00444457|26870941|FG002|Infant Series|Other|4|||
13423647|NCT00444457|26870942|FG003|Infant Series|Other|0|||
13423648|NCT00444457|26870939|FG000|Infant Series|Adverse Event|1|||
13423649|NCT00444457|26870940|FG001|Infant Series|Adverse Event|2|||
13423650|NCT00444457|26870941|FG002|Infant Series|Adverse Event|2|||
13423651|NCT00444457|26870942|FG003|Infant Series|Adverse Event|0|||
13423652|NCT00444457|26870939|FG000|Infant Series|Death|0|||
13423653|NCT00444457|26870940|FG001|Infant Series|Death|1|||
13423654|NCT00444457|26870941|FG002|Infant Series|Death|1|||
13423655|NCT00444457|26870942|FG003|Infant Series|Death|1|||
13423656|NCT00444457|26870939|FG000|After Infant Series|Other|0|||
13423657|NCT00444457|26870940|FG001|After Infant Series|Other|1|||
13423658|NCT00444457|26870941|FG002|After Infant Series|Other|1|||
13423659|NCT00444457|26870942|FG003|After Infant Series|Other|1|||
13423660|NCT00444457|26870939|FG000|After Infant Series|Parent or legal guardian request|4|||
13423661|NCT00444457|26870940|FG001|After Infant Series|Parent or legal guardian request|11|||
13423662|NCT00444457|26870941|FG002|After Infant Series|Parent or legal guardian request|6|||
13423663|NCT00444457|26870942|FG003|After Infant Series|Parent or legal guardian request|3|||
13423664|NCT00444457|26870939|FG000|After Infant Series|Failed to return|7|||
13423665|NCT00444457|26870940|FG001|After Infant Series|Failed to return|6|||
13423666|NCT00444457|26870941|FG002|After Infant Series|Failed to return|5|||
13423667|NCT00444457|26870942|FG003|After Infant Series|Failed to return|1|||
13423668|NCT00444457|26870939|FG000|After Infant Series|Lost to Follow-up|5|||
13423669|NCT00444457|26870940|FG001|After Infant Series|Lost to Follow-up|5|||
13423670|NCT00444457|26870941|FG002|After Infant Series|Lost to Follow-up|5|||
13423671|NCT00444457|26870942|FG003|After Infant Series|Lost to Follow-up|2|||
13423672|NCT00444457|26870939|FG000|After Infant Series|Protocol Violation|2|||
13423673|NCT00444457|26870940|FG001|After Infant Series|Protocol Violation|4|||
13423674|NCT00444457|26870941|FG002|After Infant Series|Protocol Violation|2|||
13423675|NCT00444457|26870942|FG003|After Infant Series|Protocol Violation|2|||
13423676|NCT00444457|26870939|FG000|After Infant Series|Adverse Event|2|||
13423677|NCT00444457|26870940|FG001|After Infant Series|Adverse Event|2|||
13423678|NCT00444457|26870941|FG002|After Infant Series|Adverse Event|0|||
13423679|NCT00444457|26870942|FG003|After Infant Series|Adverse Event|0|||
13423680|NCT00444457|26870939|FG000|After Infant Series|Investigator request|0|||
13423681|NCT00444457|26870940|FG001|After Infant Series|Investigator request|0|||
13423682|NCT00444457|26870941|FG002|After Infant Series|Investigator request|0|||
13423683|NCT00444457|26870942|FG003|After Infant Series|Investigator request|1|||
13423684|NCT00444457|26870939|FG000|After Infant Series|Other|0|||
13423685|NCT00444457|26870940|FG001|After Infant Series|Other|1|||
13423686|NCT00444457|26870941|FG002|After Infant Series|Other|0|||
13423687|NCT00444457|26870942|FG003|After Infant Series|Other|0|||
13423688|NCT00444457|26870939|FG000|Toddler Dose|Lost to Follow-up|4|||
13423689|NCT00444457|26870940|FG001|Toddler Dose|Lost to Follow-up|1|||
13423690|NCT00444457|26870941|FG002|Toddler Dose|Lost to Follow-up|1|||
13423691|NCT00444457|26870942|FG003|Toddler Dose|Lost to Follow-up|3|||
13423692|NCT00444457|26870939|FG000|Toddler Dose|Failed to return|2|||
13423693|NCT00444457|26870940|FG001|Toddler Dose|Failed to return|2|||
13423694|NCT00444457|26870941|FG002|Toddler Dose|Failed to return|1|||
13423695|NCT00444457|26870942|FG003|Toddler Dose|Failed to return|3|||
13423696|NCT00444457|26870939|FG000|Toddler Dose|Parent or legal guardian request|0|||
13423697|NCT00444457|26870940|FG001|Toddler Dose|Parent or legal guardian request|3|||
13423698|NCT00444457|26870941|FG002|Toddler Dose|Parent or legal guardian request|2|||
13423699|NCT00444457|26870942|FG003|Toddler Dose|Parent or legal guardian request|1|||
13423700|NCT00444457|26870939|FG000|Toddler Dose|Protocol Violation|1|||
13423701|NCT00444457|26870940|FG001|Toddler Dose|Protocol Violation|0|||
13423702|NCT00444457|26870941|FG002|Toddler Dose|Protocol Violation|0|||
13423703|NCT00444457|26870942|FG003|Toddler Dose|Protocol Violation|1|||
13423704|NCT00444275|26871004|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
13423705|NCT00444275|26871005|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
13423706|NCT00444275|26871006|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22|||
13423707|NCT00444275|26871007|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17|||
13423708|NCT00444275|26871008|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29|||
13423709|NCT00444275|26871004|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
13423710|NCT00444275|26871005|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
13423711|NCT00444275|26871006|FG002|Maintenance Treatment Phase|Lost to Follow-up|8|||
13423712|NCT00444275|26871007|FG003|Maintenance Treatment Phase|Lost to Follow-up|14|||
13423713|NCT00444275|26871008|FG004|Maintenance Treatment Phase|Lost to Follow-up|10|||
13423714|NCT00444275|26871004|FG000|Maintenance Treatment Phase|Adverse Event|0|||
13423715|NCT00444275|26871005|FG001|Maintenance Treatment Phase|Adverse Event|0|||
13423716|NCT00444275|26871006|FG002|Maintenance Treatment Phase|Adverse Event|3|||
13423717|NCT00444275|26871007|FG003|Maintenance Treatment Phase|Adverse Event|2|||
13423718|NCT00444275|26871008|FG004|Maintenance Treatment Phase|Adverse Event|13|||
13423719|NCT00444275|26871004|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
13423720|NCT00444275|26871005|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
13423721|NCT00444275|26871006|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1|||
13423722|NCT00444275|26871007|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
13423723|NCT00444275|26871008|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6|||
13423724|NCT00444275|26871004|FG000|Maintenance Treatment Phase|Patient's wish|0|||
13423725|NCT00444275|26871005|FG001|Maintenance Treatment Phase|Patient's wish|0|||
13423726|NCT00444275|26871006|FG002|Maintenance Treatment Phase|Patient's wish|19|||
13423727|NCT00444275|26871007|FG003|Maintenance Treatment Phase|Patient's wish|9|||
13423728|NCT00444275|26871008|FG004|Maintenance Treatment Phase|Patient's wish|20|||
13423729|NCT00444275|26871004|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
13423730|NCT00444275|26871005|FG001|Maintenance Treatment Phase|Protocol Violation|0|||
13423731|NCT00444275|26871006|FG002|Maintenance Treatment Phase|Protocol Violation|103|||
13423732|NCT00444275|26871007|FG003|Maintenance Treatment Phase|Protocol Violation|88|||
13423733|NCT00444275|26871008|FG004|Maintenance Treatment Phase|Protocol Violation|87|||
13423734|NCT00444275|26871004|FG000|Maintenance Treatment Phase|Ineffectiveness|0|||
13423735|NCT00444275|26871005|FG001|Maintenance Treatment Phase|Ineffectiveness|0|||
13423736|NCT00444275|26871006|FG002|Maintenance Treatment Phase|Ineffectiveness|5|||
13423737|NCT00444275|26871007|FG003|Maintenance Treatment Phase|Ineffectiveness|3|||
13423738|NCT00444275|26871008|FG004|Maintenance Treatment Phase|Ineffectiveness|14|||
13423739|NCT00444145|26871014|FG000|Overall Study|Withdrawal by Subject|2|||
13423740|NCT00444145|26871014|FG000|Overall Study|Lost to Follow-up|1|||
13423741|NCT00444145|26871014|FG000|Overall Study|non-compliant|11|||
13423742|NCT00444145|26871014|FG000|Overall Study|Screen Failures|5|||
13423743|NCT00444106|26871039|FG000|Overall Study|Lost to Follow-up|2|||
13423744|NCT00444106|26871040|FG001|Overall Study|Lost to Follow-up|1|||
13423745|NCT00444106|26871041|FG002|Overall Study|Lost to Follow-up|0|||
13423746|NCT00444106|26871039|FG000|Overall Study|Abnormal Test Procedure Results|0|||
13423747|NCT00444106|26871040|FG001|Overall Study|Abnormal Test Procedure Results|0|||
13423748|NCT00444106|26871041|FG002|Overall Study|Abnormal Test Procedure Results|1|||
13423749|NCT00444067|26871058|FG000|Overall Study|Lost to Follow-up|0|||
13423750|NCT00444067|26871059|FG001|Overall Study|Lost to Follow-up|1|||
13423751|NCT00443898|26871094|FG000|Overall Study|Adverse Event|0|||
13423752|NCT00443898|26871095|FG001|Overall Study|Adverse Event|0|||
13423753|NCT00443898|26871096|FG002|Overall Study|Adverse Event|1|||
13423754|NCT00443898|26871097|FG003|Overall Study|Adverse Event|1|||
13423755|NCT00443898|26871094|FG000|Overall Study|Lack of Efficacy|2|||
13423756|NCT00443898|26871095|FG001|Overall Study|Lack of Efficacy|3|||
13423757|NCT00443898|26871096|FG002|Overall Study|Lack of Efficacy|3|||
13423758|NCT00443898|26871097|FG003|Overall Study|Lack of Efficacy|1|||
13423759|NCT00443898|26871094|FG000|Overall Study|Protocol Violation|1|||
13423760|NCT00443898|26871095|FG001|Overall Study|Protocol Violation|1|||
13423761|NCT00443898|26871096|FG002|Overall Study|Protocol Violation|1|||
13423762|NCT00443898|26871097|FG003|Overall Study|Protocol Violation|0|||
13423763|NCT00443898|26871094|FG000|Overall Study|Withdrawal by Subject|11|||
13423764|NCT00443898|26871095|FG001|Overall Study|Withdrawal by Subject|10|||
13423765|NCT00443898|26871096|FG002|Overall Study|Withdrawal by Subject|10|||
13423766|NCT00443898|26871097|FG003|Overall Study|Withdrawal by Subject|6|||
13423767|NCT00443898|26871094|FG000|Overall Study|Lost to Follow-up|10|||
13423768|NCT00443898|26871095|FG001|Overall Study|Lost to Follow-up|10|||
13423769|NCT00443898|26871096|FG002|Overall Study|Lost to Follow-up|14|||
13423770|NCT00443898|26871097|FG003|Overall Study|Lost to Follow-up|10|||
13423771|NCT00443898|26871094|FG000|Overall Study|Death|0|||
13423772|NCT00443898|26871095|FG001|Overall Study|Death|1|||
13423773|NCT00443898|26871096|FG002|Overall Study|Death|0|||
13423774|NCT00443898|26871097|FG003|Overall Study|Death|0|||
13423775|NCT00443872|26871112|FG000|Overall Study|Protocol Violation|7|||
13423776|NCT00443872|26871112|FG000|Overall Study|Lost to Follow-up|2|||
13423777|NCT00443872|26871112|FG000|Overall Study|Adverse Event|8|||
13423778|NCT00443846|26871125|FG000|Overall Study|Withdrawn due to intercurrent disease|1|||
13423779|NCT00443846|26871126|FG001|Overall Study|Withdrawn due to intercurrent disease|0|||
13423780|NCT00443846|26871125|FG000|Overall Study|Not vaccinated, no blood sample drawn|1|||
13423781|NCT00443846|26871126|FG001|Overall Study|Not vaccinated, no blood sample drawn|0|||
13423782|NCT00443846|26871125|FG000|Overall Study|Adverse Event|0|||
13423783|NCT00443846|26871126|FG001|Overall Study|Adverse Event|1|||
13423784|NCT00443846|26871125|FG000|Overall Study|Personal reason|8|||
13423785|NCT00443846|26871126|FG001|Overall Study|Personal reason|3|||
13423786|NCT00443846|26871125|FG000|Overall Study|Lost to Follow-up|1|||
13423787|NCT00443846|26871126|FG001|Overall Study|Lost to Follow-up|2|||
13423788|NCT00443820|26871161|FG000|Overall Study|Adverse Event|1|||
13423789|NCT00443820|26871162|FG001|Overall Study|Adverse Event|1|||
13423790|NCT00443820|26871163|FG002|Overall Study|Adverse Event|0|||
13423791|NCT00443820|26871164|FG003|Overall Study|Adverse Event|0|||
13423792|NCT00443820|26871161|FG000|Overall Study|Lack of Efficacy|3|||
13423793|NCT00443820|26871162|FG001|Overall Study|Lack of Efficacy|2|||
13423794|NCT00443820|26871163|FG002|Overall Study|Lack of Efficacy|1|||
13423795|NCT00443820|26871164|FG003|Overall Study|Lack of Efficacy|1|||
13423796|NCT00443820|26871161|FG000|Overall Study|Protocol Violation|2|||
13423797|NCT00443820|26871162|FG001|Overall Study|Protocol Violation|1|||
13423798|NCT00443820|26871163|FG002|Overall Study|Protocol Violation|2|||
13423799|NCT00443820|26871164|FG003|Overall Study|Protocol Violation|1|||
13423800|NCT00443820|26871161|FG000|Overall Study|Withdrawal by Subject|6|||
13423801|NCT00443820|26871162|FG001|Overall Study|Withdrawal by Subject|7|||
13423802|NCT00443820|26871163|FG002|Overall Study|Withdrawal by Subject|8|||
13423803|NCT00443820|26871164|FG003|Overall Study|Withdrawal by Subject|9|||
13423804|NCT00443820|26871161|FG000|Overall Study|Lost to Follow-up|9|||
13423805|NCT00443820|26871162|FG001|Overall Study|Lost to Follow-up|8|||
13423806|NCT00443820|26871163|FG002|Overall Study|Lost to Follow-up|6|||
13423807|NCT00443820|26871164|FG003|Overall Study|Lost to Follow-up|5|||
13423808|NCT00443820|26871161|FG000|Overall Study|Administrative problems|0|||
13423809|NCT00443820|26871162|FG001|Overall Study|Administrative problems|0|||
13423810|NCT00443820|26871163|FG002|Overall Study|Administrative problems|0|||
13423811|NCT00443820|26871164|FG003|Overall Study|Administrative problems|1|||
13423812|NCT00443820|26871161|FG000|Overall Study|Death|0|||
13423813|NCT00443820|26871162|FG001|Overall Study|Death|0|||
13423814|NCT00443820|26871163|FG002|Overall Study|Death|1|||
13423815|NCT00443820|26871164|FG003|Overall Study|Death|0|||
13423816|NCT00443781|26871170|FG000|Overall Study|Lost to Follow-up|10|||
13423817|NCT00443781|26871170|FG000|Overall Study|Physician Decision|2|||
13423818|NCT00443781|26871170|FG000|Overall Study|Protocol Violation|1|||
13423819|NCT00443781|26871170|FG000|Overall Study|Withdrawal by Subject|6|||
13423820|NCT00443781|26871170|FG000|Overall Study|Unable to comply with study follow up|2|||
13423821|NCT00443781|26871170|FG000|Overall Study|Investigator terminated participation|1|||
13423822|NCT00443781|26871170|FG000|Overall Study|Insurance not covered|2|||
13423823|NCT00443781|26871170|FG000|Overall Study|PD/FAD not done|1|||
13423824|NCT00443755|26871209|FG000|Overall Study|Withdrawal by Subject|2|||
13423825|NCT00443755|26871210|FG001|Overall Study|Withdrawal by Subject|1|||
13423826|NCT00443729|26871263|FG000|Overall Study|Never Treated|0|||
13423827|NCT00443729|26871264|FG001|Overall Study|Never Treated|1|||
13423828|NCT00443729|26871263|FG000|Overall Study|Lack of Efficacy|4|||
13423829|NCT00443729|26871264|FG001|Overall Study|Lack of Efficacy|2|||
13423830|NCT00443729|26871263|FG000|Overall Study|Lost to Follow-up|0|||
13423831|NCT00443729|26871264|FG001|Overall Study|Lost to Follow-up|1|||
13423832|NCT00443729|26871263|FG000|Overall Study|Physician Decision|2|||
13423833|NCT00443729|26871264|FG001|Overall Study|Physician Decision|1|||
13423834|NCT00443729|26871263|FG000|Overall Study|Protocol Violation|1|||
13423835|NCT00443729|26871264|FG001|Overall Study|Protocol Violation|1|||
13423836|NCT00443729|26871263|FG000|Overall Study|Withdrawal by Subject|3|||
13423837|NCT00443729|26871264|FG001|Overall Study|Withdrawal by Subject|1|||
13423838|NCT00443703|26871321|FG000|Overall Study|Never Treated|3|||
13423839|NCT00443703|26871322|FG001|Overall Study|Never Treated|1|||
13423840|NCT00443703|26871321|FG000|Overall Study|Adverse Event|7|||
13423841|NCT00443703|26871322|FG001|Overall Study|Adverse Event|3|||
13423842|NCT00443703|26871321|FG000|Overall Study|Lack of Efficacy|3|||
13423843|NCT00443703|26871322|FG001|Overall Study|Lack of Efficacy|1|||
13423844|NCT00443703|26871321|FG000|Overall Study|Lost to Follow-up|0|||
13423845|NCT00443703|26871322|FG001|Overall Study|Lost to Follow-up|4|||
13423846|NCT00443703|26871321|FG000|Overall Study|Physician Decision|4|||
13423847|NCT00443703|26871322|FG001|Overall Study|Physician Decision|2|||
13423848|NCT00443703|26871321|FG000|Overall Study|Protocol Violation|1|||
13423849|NCT00443703|26871322|FG001|Overall Study|Protocol Violation|1|||
13423850|NCT00443703|26871321|FG000|Overall Study|Withdrawal by Subject|9|||
13423851|NCT00443703|26871322|FG001|Overall Study|Withdrawal by Subject|6|||
13423852|NCT00443703|26871321|FG000|Overall Study|Progressive Disease|1|||
13423853|NCT00443703|26871322|FG001|Overall Study|Progressive Disease|0|||
13423854|NCT00443651|26871347|FG000|Overall Study|Death|1|||
13423855|NCT00443651|26871348|FG001|Overall Study|Death|5|||
13423856|NCT00443651|26871347|FG000|Overall Study|Adverse Event|5|||
13423857|NCT00443651|26871348|FG001|Overall Study|Adverse Event|6|||
13423858|NCT00443651|26871347|FG000|Overall Study|Lost to Follow-up|18|||
13423859|NCT00443651|26871348|FG001|Overall Study|Lost to Follow-up|12|||
13423860|NCT00443651|26871347|FG000|Overall Study|Patient's/Guardian's Decision|58|||
13423861|NCT00443651|26871348|FG001|Overall Study|Patient's/Guardian's Decision|30|||
13423862|NCT00443651|26871347|FG000|Overall Study|Physician Decision|13|||
13423863|NCT00443651|26871348|FG001|Overall Study|Physician Decision|4|||
13423864|NCT00443651|26871347|FG000|Overall Study|Pregnancy|0|||
13423865|NCT00443651|26871348|FG001|Overall Study|Pregnancy|1|||
13423866|NCT00443599|26871387|FG000|Overall Study|Physician Decision|2|||
13423867|NCT00443599|26871388|FG001|Overall Study|Physician Decision|1|||
13423868|NCT00443599|26871387|FG000|Overall Study|Death|1|||
13423869|NCT00443599|26871388|FG001|Overall Study|Death|1|||
13423870|NCT00443599|26871387|FG000|Overall Study|Cardiopulmonary bypass canceled|3|||
13423871|NCT00443599|26871388|FG001|Overall Study|Cardiopulmonary bypass canceled|1|||
13423872|NCT00443560|26871405|FG000|Overall Study|No intrathecal dose|58|||
13423873|NCT00443560|26871406|FG001|Overall Study|No intrathecal dose|26|||
13423874|NCT00443560|26871405|FG000|Overall Study|Multiple pregnancies or fetal demise|2|||
13423875|NCT00443560|26871406|FG001|Overall Study|Multiple pregnancies or fetal demise|4|||
13423876|NCT00443534|26871415|FG000|Overall Study|Lack of Efficacy|67|||
13423877|NCT00443534|26871415|FG000|Overall Study|Adverse Event|16|||
13423878|NCT00443534|26871415|FG000|Overall Study|Death|9|||
13423879|NCT00443534|26871415|FG000|Overall Study|Withdrawal by Subject|8|||
13423880|NCT00443534|26871415|FG000|Overall Study|Study Terminated by Sponsor|12|||
13423881|NCT00443534|26871415|FG000|Overall Study|Other|10|||
13423882|NCT00443534|26871415|FG000|Overall Study|Enrolled, Not Treated|1|||
13423883|NCT00443456|26871450|FG000|Overall Study|Adverse Event|16|||
13423884|NCT00443456|26871450|FG000|Overall Study|Move|1|||
13423885|NCT00443456|26871450|FG000|Overall Study|Withdrawal by Subject|1|||
13423886|NCT00443430|26871467|FG000|Overall Study|Lack of Efficacy|3|||
13423887|NCT00443430|26871468|FG001|Overall Study|Lack of Efficacy|3|||
13423888|NCT00443430|26871467|FG000|Overall Study|Adverse Event|1|||
13423889|NCT00443430|26871468|FG001|Overall Study|Adverse Event|1|||
13423890|NCT00443261|26871474|FG000|Overall Study|Death|1|||
13423891|NCT00443209|26871495|FG000|Months 1 to 12 Treatment Period|Adverse Event|22|||
13423892|NCT00443209|26871496|FG001|Months 1 to 12 Treatment Period|Adverse Event|11|||
13423893|NCT00443209|26871495|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14|||
13423894|NCT00443209|26871496|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7|||
13423895|NCT00443209|26871495|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50|||
13423896|NCT00443209|26871496|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11|||
13423897|NCT00443209|26871495|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
13423898|NCT00443209|26871496|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
13423899|NCT00443209|26871495|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36|||
13423900|NCT00443209|26871496|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15|||
13423901|NCT00443209|26871495|FG000|Months 1 to 12 Treatment Period|Physician Decision|8|||
13423902|NCT00443209|26871496|FG001|Months 1 to 12 Treatment Period|Physician Decision|4|||
13423903|NCT00443209|26871495|FG000|Months 1 to 12 Treatment Period|Pregnancy|3|||
13423904|NCT00443209|26871496|FG001|Months 1 to 12 Treatment Period|Pregnancy|4|||
13423905|NCT00443209|26871495|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43|||
13423906|NCT00443209|26871496|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23|||
13423907|NCT00443209|26871495|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95|||
13423908|NCT00443209|26871496|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34|||
13423909|NCT00443209|26871495|FG000|Months 1 to 12 Treatment Period|Missing|2|||
13423910|NCT00443209|26871496|FG001|Months 1 to 12 Treatment Period|Missing|1|||
13423911|NCT00443209|26871495|FG000|Months 1 to 12 Treatment Period|Not Treated|71|||
13423912|NCT00443209|26871496|FG001|Months 1 to 12 Treatment Period|Not Treated|43|||
13423913|NCT00443209|26871495|FG000|Months 13 to 18 Treatment Period|Adverse Event|1|||
13423914|NCT00443209|26871496|FG001|Months 13 to 18 Treatment Period|Adverse Event|0|||
13423915|NCT00443209|26871495|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1|||
13423916|NCT00443209|26871496|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0|||
13423917|NCT00443209|26871495|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1|||
13423918|NCT00443209|26871496|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0|||
13423919|NCT00443209|26871495|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
13423920|NCT00443209|26871496|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
13423921|NCT00443209|26871495|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87|||
13423922|NCT00443209|26871496|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43|||
13423923|NCT00443209|26871495|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7|||
13423924|NCT00443209|26871496|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2|||
13423925|NCT00443118|26871553|FG000|Overall Study|unknown primary outcome|3|||
13423926|NCT00443118|26871554|FG001|Overall Study|unknown primary outcome|1|||
13423927|NCT00443118|26871555|FG002|Overall Study|unknown primary outcome|0|||
13423928|NCT00443118|26871553|FG000|Overall Study|Withdrawal by Subject|1|||
13423929|NCT00443118|26871554|FG001|Overall Study|Withdrawal by Subject|0|||
13423930|NCT00443118|26871555|FG002|Overall Study|Withdrawal by Subject|0|||
13423931|NCT00443079|26871570|FG000|Overall Study|Lost to Follow-up|0|||
13423932|NCT00443079|26871571|FG001|Overall Study|Lost to Follow-up|1|||
13423933|NCT00443053|26871596|FG000|Overall Study|Adverse Event|2|||
13423934|NCT00443053|26871597|FG001|Overall Study|Adverse Event|1|||
13423935|NCT00443053|26871596|FG000|Overall Study|Withdrawal by Subject|9|||
13423936|NCT00443053|26871597|FG001|Overall Study|Withdrawal by Subject|18|||
13423937|NCT00443053|26871596|FG000|Overall Study|Lost to Follow-up|4|||
13423938|NCT00443053|26871597|FG001|Overall Study|Lost to Follow-up|5|||
13423939|NCT00443053|26871596|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
13423940|NCT00443053|26871597|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
13423941|NCT00443053|26871596|FG000|Overall Study|Noncompliance|2|||
13423942|NCT00443053|26871597|FG001|Overall Study|Noncompliance|1|||
13423943|NCT00443053|26871596|FG000|Overall Study|Other|3|||
13423944|NCT00443053|26871597|FG001|Overall Study|Other|4|||
13423945|NCT00443053|26871596|FG000|Overall Study|Physician Decision|0|||
13423946|NCT00443053|26871597|FG001|Overall Study|Physician Decision|4|||
13423947|NCT00443040|26871615|FG000|Overall Study|Withdrawal by Subject|1|||
13423948|NCT00443040|26871616|FG001|Overall Study|Withdrawal by Subject|0|||
13423949|NCT00443040|26871617|FG002|Overall Study|Withdrawal by Subject|0|||
13423950|NCT00443040|26871615|FG000|Overall Study|Converted to an open laparotomy|3|||
13423951|NCT00443040|26871616|FG001|Overall Study|Converted to an open laparotomy|0|||
13423952|NCT00443040|26871617|FG002|Overall Study|Converted to an open laparotomy|1|||
13423953|NCT00442962|26871633|FG000|Overall Study|Pregnancy|1|||
13423954|NCT00442962|26871633|FG000|Overall Study|Lost to Follow-up|7|||
13423955|NCT00442936|26871692|FG000|Overall Study|Protocol Violation|1|||
13423956|NCT00442936|26871693|FG001|Overall Study|Protocol Violation|0|||
13423957|NCT00442936|26871694|FG002|Overall Study|Protocol Violation|1|||
13423958|NCT00442936|26871695|FG003|Overall Study|Protocol Violation|1|||
13423959|NCT00442702|26871714|FG000|Titration Period|Adverse Event|2|||
13423960|NCT00442702|26871715|FG001|Titration Period|Adverse Event|0|||
13423961|NCT00442702|26871714|FG000|Titration Period|Death|3|||
13423962|NCT00442702|26871715|FG001|Titration Period|Death|2|||
13423963|NCT00442702|26871714|FG000|Titration Period|Insufficient Therapeutic Response|1|||
13423964|NCT00442702|26871715|FG001|Titration Period|Insufficient Therapeutic Response|0|||
13423965|NCT00442702|26871714|FG000|Titration Period|Refused Treatment|4|||
13423966|NCT00442702|26871715|FG001|Titration Period|Refused Treatment|1|||
13423967|NCT00442702|26871714|FG000|Titration Period|Failure to return|1|||
13423968|NCT00442702|26871715|FG001|Titration Period|Failure to return|0|||
13423969|NCT00442702|26871714|FG000|Titration Period|Hospitalized in another hospital|1|||
13423970|NCT00442702|26871715|FG001|Titration Period|Hospitalized in another hospital|0|||
13423971|NCT00442702|26871714|FG000|Evaluation Period|Adverse Event|1|||
13423972|NCT00442702|26871715|FG001|Evaluation Period|Adverse Event|0|||
13423973|NCT00442702|26871714|FG000|Evaluation Period|Death|1|||
13423974|NCT00442702|26871715|FG001|Evaluation Period|Death|1|||
13423975|NCT00442702|26871714|FG000|Evaluation Period|Insufficient Therapeutic Response|1|||
13423976|NCT00442702|26871715|FG001|Evaluation Period|Insufficient Therapeutic Response|0|||
13423977|NCT00442702|26871714|FG000|Evaluation Period|Refused treatment|1|||
13423978|NCT00442702|26871715|FG001|Evaluation Period|Refused treatment|1|||
13423979|NCT00442702|26871714|FG000|Evaluation Period|Renal transplant|0|||
13423980|NCT00442702|26871715|FG001|Evaluation Period|Renal transplant|1|||
13423981|NCT00442702|26871714|FG000|Evaluation Period|Failure to return|1|||
13423982|NCT00442702|26871715|FG001|Evaluation Period|Failure to return|0|||
13423983|NCT00442702|26871714|FG000|Evaluation Period|Site closure|0|||
13423984|NCT00442702|26871715|FG001|Evaluation Period|Site closure|1|||
13423985|NCT00442598|26871741|FG000|Overall Study|Adverse Event|1|||
13423986|NCT00442598|26871742|FG001|Overall Study|Adverse Event|0|||
13423987|NCT00442598|26871743|FG002|Overall Study|Adverse Event|0|||
13423988|NCT00442598|26871741|FG000|Overall Study|Tumor progression|3|||
13423989|NCT00442598|26871742|FG001|Overall Study|Tumor progression|4|||
13423990|NCT00442598|26871743|FG002|Overall Study|Tumor progression|0|||
13423991|NCT00442598|26871741|FG000|Overall Study|Clinical deterioration|1|||
13423992|NCT00442598|26871742|FG001|Overall Study|Clinical deterioration|2|||
13423993|NCT00442598|26871743|FG002|Overall Study|Clinical deterioration|0|||
13423994|NCT00442598|26871741|FG000|Overall Study|CA125 progression|0|||
13423995|NCT00442598|26871742|FG001|Overall Study|CA125 progression|1|||
13423996|NCT00442598|26871743|FG002|Overall Study|CA125 progression|0|||
13423997|NCT00442598|26871741|FG000|Overall Study|Reduced creatinine clearance|1|||
13423998|NCT00442598|26871742|FG001|Overall Study|Reduced creatinine clearance|0|||
13423999|NCT00442598|26871743|FG002|Overall Study|Reduced creatinine clearance|0|||
13424000|NCT00442598|26871741|FG000|Overall Study|Death|0|||
13424001|NCT00442598|26871742|FG001|Overall Study|Death|1|||
13424002|NCT00442598|26871743|FG002|Overall Study|Death|0|||
13424003|NCT00442572|26871788|FG000|Overall Study|Relapse|8|||
13424004|NCT00442572|26871789|FG001|Overall Study|Relapse|1|||
13424005|NCT00442572|26871788|FG000|Overall Study|Lost to Follow-up|0|||
13424006|NCT00442572|26871789|FG001|Overall Study|Lost to Follow-up|1|||
13424007|NCT00442572|26871788|FG000|Overall Study|Withdrawal by Subject|0|||
13424008|NCT00442572|26871789|FG001|Overall Study|Withdrawal by Subject|1|||
13424009|NCT00442559|26871808|FG000|Overall Study|Lost to Follow-up|32|||
13424010|NCT00442559|26871809|FG001|Overall Study|Lost to Follow-up|34|||
13424011|NCT00442559|26871808|FG000|Overall Study|Protocol Violation|1|||
13424012|NCT00442559|26871809|FG001|Overall Study|Protocol Violation|1|||
13424013|NCT00442559|26871808|FG000|Overall Study|Withdrawal by Subject|1|||
13424014|NCT00442559|26871809|FG001|Overall Study|Withdrawal by Subject|0|||
13424015|NCT00442546|26871941|FG000|Overall Study|Adverse Event|11|||
13424016|NCT00442546|26871942|FG001|Overall Study|Adverse Event|17|||
13424017|NCT00442546|26871943|FG002|Overall Study|Adverse Event|13|||
13424018|NCT00442546|26871941|FG000|Overall Study|Lost to Follow-up|1|||
13424019|NCT00442546|26871942|FG001|Overall Study|Lost to Follow-up|2|||
13424020|NCT00442546|26871943|FG002|Overall Study|Lost to Follow-up|1|||
13424021|NCT00442546|26871941|FG000|Overall Study|Other|4|||
13424022|NCT00442546|26871942|FG001|Overall Study|Other|9|||
13424023|NCT00442546|26871943|FG002|Overall Study|Other|6|||
13424024|NCT00442546|26871941|FG000|Overall Study|Withdrawal by Subject|5|||
13424025|NCT00442546|26871942|FG001|Overall Study|Withdrawal by Subject|5|||
13424026|NCT00442546|26871943|FG002|Overall Study|Withdrawal by Subject|7|||
13424027|NCT00442546|26871941|FG000|Overall Study|Randomized But Not Treated|5|||
13424028|NCT00442546|26871942|FG001|Overall Study|Randomized But Not Treated|4|||
13424029|NCT00442546|26871943|FG002|Overall Study|Randomized But Not Treated|6|||
13424030|NCT00442468|26871973|FG000|Overall Study|Adverse Event|4|||
13424031|NCT00442468|26871973|FG000|Overall Study|Withdrawal by Subject|91|||
13424032|NCT00442468|26871973|FG000|Overall Study|Did not complete all study procedures|88|||
13424033|NCT00442416|26872013|FG000|Overall Study|Adverse Event|4|||
13424034|NCT00442416|26872014|FG001|Overall Study|Adverse Event|1|||
13424035|NCT00442416|26872013|FG000|Overall Study|Death|1|||
13424036|NCT00442416|26872014|FG001|Overall Study|Death|0|||
13424037|NCT00442416|26872013|FG000|Overall Study|Lack of Efficacy|2|||
13424038|NCT00442416|26872014|FG001|Overall Study|Lack of Efficacy|0|||
13424039|NCT00442416|26872013|FG000|Overall Study|Protocol Violation|2|||
13424040|NCT00442416|26872014|FG001|Overall Study|Protocol Violation|3|||
13424041|NCT00442416|26872013|FG000|Overall Study|Withdrew consent|1|||
13424042|NCT00442416|26872014|FG001|Overall Study|Withdrew consent|2|||
13424043|NCT00442416|26872013|FG000|Overall Study|Administrative/Other|27|||
13424044|NCT00442416|26872014|FG001|Overall Study|Administrative/Other|33|||
13424045|NCT00442351|26872027|FG000|Overall Study|Administrative|6|||
13424046|NCT00442351|26872028|FG001|Overall Study|Administrative|5|||
13424047|NCT00442351|26872027|FG000|Overall Study|Did not meet protocol eligibility|1|||
13424048|NCT00442351|26872028|FG001|Overall Study|Did not meet protocol eligibility|0|||
13424049|NCT00442351|26872027|FG000|Overall Study|Other|0|||
13424050|NCT00442351|26872028|FG001|Overall Study|Other|1|||
13424051|NCT00442286|26872048|FG000|Overall Study|Death|2|||
13424052|NCT00442286|26872049|FG001|Overall Study|Death|2|||
13424053|NCT00442286|26872048|FG000|Overall Study|Lost to Follow-up|1|||
13424054|NCT00442286|26872049|FG001|Overall Study|Lost to Follow-up|0|||
13424055|NCT00442286|26872048|FG000|Overall Study|Withdrawal by Subject|2|||
13424056|NCT00442286|26872049|FG001|Overall Study|Withdrawal by Subject|0|||
13424057|NCT00442286|26872048|FG000|Overall Study|System explanted|1|||
13424058|NCT00442286|26872049|FG001|Overall Study|System explanted|0|||
13424059|NCT00442286|26872048|FG000|Overall Study|Patient Injury|1|||
13424060|NCT00442286|26872049|FG001|Overall Study|Patient Injury|0|||
13424061|NCT00442117|26872068|FG000|Overall Study|Adverse Event|3|||
13424062|NCT00442117|26872069|FG001|Overall Study|Adverse Event|2|||
13424063|NCT00442117|26872068|FG000|Overall Study|Lack of Efficacy|2|||
13424064|NCT00442117|26872069|FG001|Overall Study|Lack of Efficacy|6|||
13424065|NCT00442117|26872068|FG000|Overall Study|Lost to Follow-up|1|||
13424066|NCT00442117|26872069|FG001|Overall Study|Lost to Follow-up|2|||
13424067|NCT00442117|26872068|FG000|Overall Study|Withdrawal by Subject|2|||
13424068|NCT00442117|26872069|FG001|Overall Study|Withdrawal by Subject|2|||
13424069|NCT00442117|26872068|FG000|Overall Study|Major Deviation|25|||
13424070|NCT00442117|26872069|FG001|Overall Study|Major Deviation|20|||
13424071|NCT00442117|26872068|FG000|Overall Study|Non compliance with protocol|3|||
13424072|NCT00442117|26872069|FG001|Overall Study|Non compliance with protocol|5|||
13424073|NCT00442117|26872068|FG000|Overall Study|Met Withdrawal Criteria|2|||
13424074|NCT00442117|26872069|FG001|Overall Study|Met Withdrawal Criteria|1|||
13424075|NCT00441974|26872085|FG000|Overall Study|Adverse Event|6|||
13424076|NCT00441974|26872085|FG000|Overall Study|Consent Withdrawn|35|||
13424077|NCT00441974|26872085|FG000|Overall Study|Lost to Follow-up|80|||
13424078|NCT00441974|26872085|FG000|Overall Study|Protocol Violation|7|||
13424079|NCT00441792|26872100|FG000|Overall Study|Lost to Follow-up|0|||
13424080|NCT00441792|26872101|FG001|Overall Study|Lost to Follow-up|2|||
13424081|NCT00441727|26872134|FG000|Overall Study|Protocol Violation|19|||
13424082|NCT00441727|26872135|FG001|Overall Study|Protocol Violation|28|||
13424083|NCT00441727|26872136|FG002|Overall Study|Protocol Violation|32|||
13424084|NCT00441727|26872134|FG000|Overall Study|Adverse Event|26|||
13424085|NCT00441727|26872135|FG001|Overall Study|Adverse Event|33|||
13424086|NCT00441727|26872136|FG002|Overall Study|Adverse Event|28|||
13424087|NCT00441727|26872134|FG000|Overall Study|Lack of Efficacy|7|||
13424088|NCT00441727|26872135|FG001|Overall Study|Lack of Efficacy|8|||
13424089|NCT00441727|26872136|FG002|Overall Study|Lack of Efficacy|48|||
13424090|NCT00441727|26872134|FG000|Overall Study|Withdrawal by Subject|40|||
13424091|NCT00441727|26872135|FG001|Overall Study|Withdrawal by Subject|34|||
13424092|NCT00441727|26872136|FG002|Overall Study|Withdrawal by Subject|47|||
13424093|NCT00441727|26872134|FG000|Overall Study|Lost to Follow-up|5|||
13424094|NCT00441727|26872135|FG001|Overall Study|Lost to Follow-up|6|||
13424095|NCT00441727|26872136|FG002|Overall Study|Lost to Follow-up|5|||
13424096|NCT00441727|26872134|FG000|Overall Study|Safety Reasons|3|||
13424097|NCT00441727|26872135|FG001|Overall Study|Safety Reasons|1|||
13424098|NCT00441727|26872136|FG002|Overall Study|Safety Reasons|3|||
13424099|NCT00441727|26872134|FG000|Overall Study|Various reason specified|6|||
13424100|NCT00441727|26872135|FG001|Overall Study|Various reason specified|8|||
13424101|NCT00441727|26872136|FG002|Overall Study|Various reason specified|5|||
13476718|NCT01425008|27003746|FG017|Dose Escalation Phase|Withdrawal by Subject|0|||
13476719|NCT01425008|27003747|FG018|Dose Escalation Phase|Withdrawal by Subject|0|||
13476720|NCT01425008|27003729|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
13476721|NCT01425008|27003730|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
13476722|NCT01425008|27003731|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
13476723|NCT01425008|27003732|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
13476724|NCT01425008|27003733|FG004|Dose Escalation Phase|Symptomatic Deterioration|0|||
13476725|NCT01425008|27003734|FG005|Dose Escalation Phase|Symptomatic Deterioration|0|||
13476726|NCT01425008|27003735|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
13476727|NCT01425008|27003736|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
13476728|NCT01425008|27003737|FG008|Dose Escalation Phase|Symptomatic Deterioration|2|||
13476729|NCT01425008|27003738|FG009|Dose Escalation Phase|Symptomatic Deterioration|2|||
13476730|NCT01425008|27003739|FG010|Dose Escalation Phase|Symptomatic Deterioration|0|||
13476731|NCT01425008|27003740|FG011|Dose Escalation Phase|Symptomatic Deterioration|0|||
13476732|NCT01425008|27003741|FG012|Dose Escalation Phase|Symptomatic Deterioration|0|||
13476733|NCT01425008|27003742|FG013|Dose Escalation Phase|Symptomatic Deterioration|0|||
13476734|NCT01425008|27003743|FG014|Dose Escalation Phase|Symptomatic Deterioration|0|||
13476735|NCT01425008|27003744|FG015|Dose Escalation Phase|Symptomatic Deterioration|0|||
13476736|NCT01425008|27003745|FG016|Dose Escalation Phase|Symptomatic Deterioration|0|||
13476737|NCT01425008|27003746|FG017|Dose Escalation Phase|Symptomatic Deterioration|0|||
13476738|NCT01425008|27003747|FG018|Dose Escalation Phase|Symptomatic Deterioration|0|||
13476739|NCT01425008|27003729|FG000|Dose Escalation Phase|Other|0|||
13476740|NCT01425008|27003730|FG001|Dose Escalation Phase|Other|0|||
13476741|NCT01425008|27003731|FG002|Dose Escalation Phase|Other|0|||
13476742|NCT01425008|27003732|FG003|Dose Escalation Phase|Other|0|||
13476743|NCT01425008|27003733|FG004|Dose Escalation Phase|Other|0|||
13476744|NCT01425008|27003734|FG005|Dose Escalation Phase|Other|0|||
13476745|NCT01425008|27003735|FG006|Dose Escalation Phase|Other|0|||
13476746|NCT01425008|27003736|FG007|Dose Escalation Phase|Other|0|||
13476747|NCT01425008|27003737|FG008|Dose Escalation Phase|Other|1|||
13476748|NCT01425008|27003738|FG009|Dose Escalation Phase|Other|0|||
13476749|NCT01425008|27003739|FG010|Dose Escalation Phase|Other|0|||
13476750|NCT01425008|27003740|FG011|Dose Escalation Phase|Other|0|||
13476751|NCT01425008|27003741|FG012|Dose Escalation Phase|Other|0|||
13476752|NCT01425008|27003742|FG013|Dose Escalation Phase|Other|0|||
13476753|NCT01425008|27003743|FG014|Dose Escalation Phase|Other|0|||
13476754|NCT01425008|27003744|FG015|Dose Escalation Phase|Other|0|||
13476755|NCT01425008|27003745|FG016|Dose Escalation Phase|Other|0|||
13476756|NCT01425008|27003746|FG017|Dose Escalation Phase|Other|0|||
13476757|NCT01425008|27003747|FG018|Dose Escalation Phase|Other|0|||
13476758|NCT01425008|27003729|FG000|Dose Expansion Phase|Progressive Disease|0|||
13476759|NCT01425008|27003730|FG001|Dose Expansion Phase|Progressive Disease|0|||
13476760|NCT01425008|27003731|FG002|Dose Expansion Phase|Progressive Disease|0|||
13476761|NCT01425008|27003732|FG003|Dose Expansion Phase|Progressive Disease|0|||
13476762|NCT01425008|27003733|FG004|Dose Expansion Phase|Progressive Disease|0|||
13476763|NCT01425008|27003734|FG005|Dose Expansion Phase|Progressive Disease|0|||
13476764|NCT01425008|27003735|FG006|Dose Expansion Phase|Progressive Disease|0|||
13476765|NCT01425008|27003736|FG007|Dose Expansion Phase|Progressive Disease|0|||
13476766|NCT01425008|27003737|FG008|Dose Expansion Phase|Progressive Disease|0|||
13476767|NCT01425008|27003738|FG009|Dose Expansion Phase|Progressive Disease|0|||
13476768|NCT01425008|27003739|FG010|Dose Expansion Phase|Progressive Disease|10|||
13476769|NCT01425008|27003740|FG011|Dose Expansion Phase|Progressive Disease|4|||
13476770|NCT01425008|27003741|FG012|Dose Expansion Phase|Progressive Disease|12|||
13476771|NCT01425008|27003742|FG013|Dose Expansion Phase|Progressive Disease|1|||
13476772|NCT01425008|27003743|FG014|Dose Expansion Phase|Progressive Disease|5|||
13476773|NCT01425008|27003744|FG015|Dose Expansion Phase|Progressive Disease|8|||
13476774|NCT01425008|27003745|FG016|Dose Expansion Phase|Progressive Disease|9|||
13476775|NCT01425008|27003746|FG017|Dose Expansion Phase|Progressive Disease|2|||
13476776|NCT01425008|27003747|FG018|Dose Expansion Phase|Progressive Disease|10|||
13476777|NCT01425008|27003729|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
13476778|NCT01425008|27003730|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
13476779|NCT01425008|27003731|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
13476780|NCT01425008|27003732|FG003|Dose Expansion Phase|Withdrawal by Subject|0|||
13424102|NCT00441701|26872249|FG000|Overall Study|Adverse Event|3|||
13424103|NCT00441701|26872250|FG001|Overall Study|Adverse Event|2|||
13424104|NCT00441701|26872251|FG002|Overall Study|Adverse Event|1|||
13424105|NCT00441701|26872252|FG003|Overall Study|Adverse Event|0|||
13424106|NCT00441701|26872253|FG004|Overall Study|Adverse Event|2|||
13424107|NCT00441701|26872254|FG005|Overall Study|Adverse Event|2|||
13424108|NCT00441701|26872255|FG006|Overall Study|Adverse Event|0|||
13424109|NCT00441701|26872256|FG007|Overall Study|Adverse Event|0|||
13424110|NCT00441701|26872257|FG008|Overall Study|Adverse Event|0|||
13424111|NCT00441701|26872258|FG009|Overall Study|Adverse Event|0|||
13424112|NCT00441701|26872249|FG000|Overall Study|Lack of Efficacy|2|||
13424113|NCT00441701|26872250|FG001|Overall Study|Lack of Efficacy|0|||
13424114|NCT00441701|26872251|FG002|Overall Study|Lack of Efficacy|2|||
13424115|NCT00441701|26872252|FG003|Overall Study|Lack of Efficacy|2|||
13424116|NCT00441701|26872253|FG004|Overall Study|Lack of Efficacy|0|||
13424117|NCT00441701|26872254|FG005|Overall Study|Lack of Efficacy|1|||
13424118|NCT00441701|26872255|FG006|Overall Study|Lack of Efficacy|0|||
13424119|NCT00441701|26872256|FG007|Overall Study|Lack of Efficacy|0|||
13424120|NCT00441701|26872257|FG008|Overall Study|Lack of Efficacy|0|||
13424121|NCT00441701|26872258|FG009|Overall Study|Lack of Efficacy|0|||
13424122|NCT00441701|26872249|FG000|Overall Study|Withdrawal by Subject|0|||
13424123|NCT00441701|26872250|FG001|Overall Study|Withdrawal by Subject|2|||
13424124|NCT00441701|26872251|FG002|Overall Study|Withdrawal by Subject|1|||
13424125|NCT00441701|26872252|FG003|Overall Study|Withdrawal by Subject|1|||
13424126|NCT00441701|26872253|FG004|Overall Study|Withdrawal by Subject|0|||
13424127|NCT00441701|26872254|FG005|Overall Study|Withdrawal by Subject|0|||
13424128|NCT00441701|26872255|FG006|Overall Study|Withdrawal by Subject|0|||
13424129|NCT00441701|26872256|FG007|Overall Study|Withdrawal by Subject|0|||
13424130|NCT00441701|26872257|FG008|Overall Study|Withdrawal by Subject|0|||
13424131|NCT00441701|26872258|FG009|Overall Study|Withdrawal by Subject|0|||
13424132|NCT00441584|26872264|FG000|Overall Study|Lack of Efficacy|79|||
13424133|NCT00441584|26872264|FG000|Overall Study|Withdrawal by Subject|8|||
13424134|NCT00441584|26872264|FG000|Overall Study|Adverse Event|6|||
13424135|NCT00441584|26872264|FG000|Overall Study|Protocol Violation|5|||
13424136|NCT00441584|26872264|FG000|Overall Study|Lost to Follow-up|4|||
13424137|NCT00441584|26872264|FG000|Overall Study|Failure to meet eligibility criteria|3|||
13424138|NCT00441545|26872279|FG000|First Intervention|Adverse Event|6|||
13424139|NCT00441545|26872280|FG001|First Intervention|Adverse Event|5|||
13424140|NCT00441545|26872279|FG000|First Intervention|Protocol Violation|2|||
13424141|NCT00441545|26872280|FG001|First Intervention|Protocol Violation|2|||
13424142|NCT00441545|26872279|FG000|First Intervention|Withdrawal by Subject|3|||
13424143|NCT00441545|26872280|FG001|First Intervention|Withdrawal by Subject|3|||
13424144|NCT00441545|26872279|FG000|First Intervention|Kidney transplant|1|||
13424145|NCT00441545|26872280|FG001|First Intervention|Kidney transplant|1|||
13424146|NCT00441545|26872279|FG000|First Intervention|Lack of Efficacy|2|||
13424147|NCT00441545|26872280|FG001|First Intervention|Lack of Efficacy|0|||
13424148|NCT00441545|26872279|FG000|First Intervention|Subject exceeded safety criteria|0|||
13424149|NCT00441545|26872280|FG001|First Intervention|Subject exceeded safety criteria|1|||
13424150|NCT00441545|26872279|FG000|First Intervention|Subject met an exclusionary criteria|1|||
13424151|NCT00441545|26872280|FG001|First Intervention|Subject met an exclusionary criteria|0|||
13424152|NCT00441545|26872279|FG000|First Intervention|Extended hospitalization|1|||
13424153|NCT00441545|26872280|FG001|First Intervention|Extended hospitalization|0|||
13424154|NCT00441545|26872279|FG000|First Intervention|Site error|1|||
13424155|NCT00441545|26872280|FG001|First Intervention|Site error|0|||
13424156|NCT00441545|26872279|FG000|First Intervention|Sponsor's request|1|||
13424157|NCT00441545|26872280|FG001|First Intervention|Sponsor's request|0|||
13424158|NCT00441545|26872279|FG000|Second Intervention|Adverse Event|5|||
13424159|NCT00441545|26872280|FG001|Second Intervention|Adverse Event|2|||
13424160|NCT00441545|26872279|FG000|Second Intervention|Protocol Violation|4|||
13424161|NCT00441545|26872280|FG001|Second Intervention|Protocol Violation|1|||
13424162|NCT00441545|26872279|FG000|Second Intervention|Withdrawal by Subject|1|||
13424163|NCT00441545|26872280|FG001|Second Intervention|Withdrawal by Subject|1|||
13424164|NCT00441545|26872279|FG000|Second Intervention|Kidney Transplant|1|||
13424165|NCT00441545|26872280|FG001|Second Intervention|Kidney Transplant|1|||
13424166|NCT00441545|26872279|FG000|Second Intervention|Lack of Efficacy|0|||
13424167|NCT00441545|26872280|FG001|Second Intervention|Lack of Efficacy|1|||
13424168|NCT00441545|26872279|FG000|Second Intervention|Subject exceeded safety criteria|1|||
13424169|NCT00441545|26872280|FG001|Second Intervention|Subject exceeded safety criteria|0|||
13424170|NCT00441545|26872279|FG000|Second Intervention|Subject moved|0|||
13424171|NCT00441545|26872280|FG001|Second Intervention|Subject moved|1|||
13424172|NCT00441480|26872319|FG000|Overall Study|Protocol Violation|1|||
13424173|NCT00441480|26872320|FG001|Overall Study|Protocol Violation|1|||
13424174|NCT00441480|26872319|FG000|Overall Study|Withdrawal by Subject|2|||
13424175|NCT00441480|26872320|FG001|Overall Study|Withdrawal by Subject|3|||
13424176|NCT00441467|26872328|FG000|Overall Study|Adverse Event|6|||
13424177|NCT00441467|26872328|FG000|Overall Study|Withdrawal by Subject|3|||
13424178|NCT00441467|26872328|FG000|Overall Study|Progressive disease|9|||
13424179|NCT00441441|26872393|FG000|Overall Study|Adverse Event|2|||
13424180|NCT00441441|26872394|FG001|Overall Study|Adverse Event|1|||
13424181|NCT00441441|26872393|FG000|Overall Study|Protocol Violation|4|||
13424182|NCT00441441|26872394|FG001|Overall Study|Protocol Violation|6|||
13424183|NCT00441441|26872393|FG000|Overall Study|Exacerbation of asthma|1|||
13424184|NCT00441441|26872394|FG001|Overall Study|Exacerbation of asthma|2|||
13424185|NCT00441441|26872393|FG000|Overall Study|Withdrawal by Subject|1|||
13424186|NCT00441441|26872394|FG001|Overall Study|Withdrawal by Subject|2|||
13424187|NCT00441441|26872393|FG000|Overall Study|Other|3|||
13424188|NCT00441441|26872394|FG001|Overall Study|Other|3|||
13424189|NCT00441363|26872409|FG000|Overall Study|Adverse Event|4|||
13424190|NCT00441363|26872410|FG001|Overall Study|Adverse Event|2|||
13424191|NCT00441363|26872409|FG000|Overall Study|Withdrawal by Subject|3|||
13424192|NCT00441363|26872410|FG001|Overall Study|Withdrawal by Subject|4|||
13424193|NCT00441363|26872409|FG000|Overall Study|Physician Decision|6|||
13424194|NCT00441363|26872410|FG001|Overall Study|Physician Decision|7|||
13424195|NCT00441363|26872409|FG000|Overall Study|Lost to Follow-up|2|||
13424196|NCT00441363|26872410|FG001|Overall Study|Lost to Follow-up|2|||
13424197|NCT00441363|26872409|FG000|Overall Study|Other|2|||
13424198|NCT00441363|26872410|FG001|Overall Study|Other|0|||
13424199|NCT00441337|26872501|FG000|Overall Study|Disease Progression|6|||
13424200|NCT00441337|26872502|FG001|Overall Study|Disease Progression|6|||
13424201|NCT00441337|26872503|FG002|Overall Study|Disease Progression|4|||
13424202|NCT00441337|26872504|FG003|Overall Study|Disease Progression|18|||
13424203|NCT00441337|26872501|FG000|Overall Study|Lost to Follow-up|0|||
13424204|NCT00441337|26872502|FG001|Overall Study|Lost to Follow-up|0|||
13424205|NCT00441337|26872503|FG002|Overall Study|Lost to Follow-up|0|||
13424206|NCT00441337|26872504|FG003|Overall Study|Lost to Follow-up|1|||
13424207|NCT00441337|26872501|FG000|Overall Study|Sponsor Decision|0|||
13424208|NCT00441337|26872502|FG001|Overall Study|Sponsor Decision|0|||
13424209|NCT00441337|26872503|FG002|Overall Study|Sponsor Decision|1|||
13424210|NCT00441337|26872504|FG003|Overall Study|Sponsor Decision|2|||
13424211|NCT00441337|26872501|FG000|Overall Study|Did not meet inclusion criteria|0|||
13424212|NCT00441337|26872502|FG001|Overall Study|Did not meet inclusion criteria|0|||
13424213|NCT00441337|26872503|FG002|Overall Study|Did not meet inclusion criteria|1|||
13424214|NCT00441337|26872504|FG003|Overall Study|Did not meet inclusion criteria|0|||
13424215|NCT00441272|26872517|FG000|Overall Study|Study terminated prior to enrollment|25|||
13424216|NCT00441272|26872518|FG001|Overall Study|Study terminated prior to enrollment|25|||
13424217|NCT00441168|26872535|FG000|Treatment Period|Death|3|||
13424218|NCT00441168|26872536|FG001|Treatment Period|Death|0|||
13424219|NCT00441168|26872535|FG000|Treatment Period|Adverse Event|1|||
13424220|NCT00441168|26872536|FG001|Treatment Period|Adverse Event|2|||
13424221|NCT00441168|26872535|FG000|Treatment Period|Progressive Disease|0|||
13424222|NCT00441168|26872536|FG001|Treatment Period|Progressive Disease|2|||
13424223|NCT00441168|26872535|FG000|Treatment Period|Protocol Violation|0|||
13424224|NCT00441168|26872536|FG001|Treatment Period|Protocol Violation|1|||
13424225|NCT00441168|26872535|FG000|Treatment Period|Lost to Follow-up|0|||
13424226|NCT00441168|26872536|FG001|Treatment Period|Lost to Follow-up|1|||
13424227|NCT00441168|26872535|FG000|Treatment Period|Withdrawal by Subject|3|||
13424228|NCT00441168|26872536|FG001|Treatment Period|Withdrawal by Subject|0|||
13424229|NCT00441168|26872535|FG000|Treatment Period|qualified for stem-cell transplantation|3|||
13424230|NCT00441168|26872536|FG001|Treatment Period|qualified for stem-cell transplantation|0|||
13424231|NCT00441168|26872535|FG000|Treatment Period|refractory disease|1|||
13424232|NCT00441168|26872536|FG001|Treatment Period|refractory disease|0|||
13424233|NCT00441168|26872535|FG000|Follow-up Period|Death|3|||
13424234|NCT00441168|26872536|FG001|Follow-up Period|Death|0|||
13424235|NCT00441168|26872535|FG000|Follow-up Period|Lost to Follow-up|5|||
13424236|NCT00441168|26872536|FG001|Follow-up Period|Lost to Follow-up|6|||
13424237|NCT00441168|26872535|FG000|Follow-up Period|Withdrawal by Subject|3|||
13424238|NCT00441168|26872536|FG001|Follow-up Period|Withdrawal by Subject|0|||
13424239|NCT00441168|26872535|FG000|Follow-up Period|Other|1|||
13424240|NCT00441168|26872536|FG001|Follow-up Period|Other|3|||
13424241|NCT00441142|26872569|FG000|Overall Study|Adverse Event|2|||
13424242|NCT00441142|26872570|FG001|Overall Study|Adverse Event|3|||
13424243|NCT00441142|26872571|FG002|Overall Study|Adverse Event|3|||
13424244|NCT00441142|26872572|FG003|Overall Study|Adverse Event|22|||
13424245|NCT00441142|26872569|FG000|Overall Study|Lack of Efficacy|3|||
13424246|NCT00441142|26872570|FG001|Overall Study|Lack of Efficacy|3|||
13424247|NCT00441142|26872571|FG002|Overall Study|Lack of Efficacy|17|||
13424248|NCT00441142|26872572|FG003|Overall Study|Lack of Efficacy|32|||
13424249|NCT00441142|26872569|FG000|Overall Study|Withdrawal by Subject|0|||
13424250|NCT00441142|26872570|FG001|Overall Study|Withdrawal by Subject|0|||
13424251|NCT00441142|26872571|FG002|Overall Study|Withdrawal by Subject|2|||
13424252|NCT00441142|26872572|FG003|Overall Study|Withdrawal by Subject|10|||
13424253|NCT00441142|26872569|FG000|Overall Study|Patient still receiving active study tx|1|||
13424254|NCT00441142|26872570|FG001|Overall Study|Patient still receiving active study tx|0|||
13424255|NCT00441142|26872571|FG002|Overall Study|Patient still receiving active study tx|0|||
13424256|NCT00441142|26872572|FG003|Overall Study|Patient still receiving active study tx|2|||
13424257|NCT00441142|26872569|FG000|Overall Study|Physician Decision|0|||
13424258|NCT00441142|26872570|FG001|Overall Study|Physician Decision|1|||
13424259|NCT00441142|26872571|FG002|Overall Study|Physician Decision|0|||
13424260|NCT00441142|26872572|FG003|Overall Study|Physician Decision|1|||
13424261|NCT00441142|26872569|FG000|Overall Study|Death|0|||
13424262|NCT00441142|26872570|FG001|Overall Study|Death|0|||
13424263|NCT00441142|26872571|FG002|Overall Study|Death|0|||
13424264|NCT00441142|26872572|FG003|Overall Study|Death|1|||
13424265|NCT00441129|26872589|FG000|Overall Study|Withdrawal by Subject|6|||
13424266|NCT00441129|26872590|FG001|Overall Study|Withdrawal by Subject|14|||
13424267|NCT00441116|26872663|FG000|Overall Study|Adverse Event|1|||
13424268|NCT00441116|26872664|FG001|Overall Study|Adverse Event|1|||
13424269|NCT00441116|26872663|FG000|Overall Study|Withdrawal by Subject|1|||
13424270|NCT00441116|26872664|FG001|Overall Study|Withdrawal by Subject|0|||
13424271|NCT00441116|26872663|FG000|Overall Study|Did not meet Eligibility Criteria|1|||
13424272|NCT00441116|26872664|FG001|Overall Study|Did not meet Eligibility Criteria|1|||
13424273|NCT00441103|26872682|FG000|Overall Study|Adverse Event|2|||
13424274|NCT00441103|26872683|FG001|Overall Study|Adverse Event|1|||
13424275|NCT00441103|26872682|FG000|Overall Study|Death|1|||
13424276|NCT00441103|26872683|FG001|Overall Study|Death|0|||
13424277|NCT00441103|26872682|FG000|Overall Study|Disease Progression|2|||
13424278|NCT00441103|26872683|FG001|Overall Study|Disease Progression|0|||
13424279|NCT00441103|26872682|FG000|Overall Study|Lost to Follow-up|1|||
13424280|NCT00441103|26872683|FG001|Overall Study|Lost to Follow-up|0|||
13424281|NCT00441103|26872682|FG000|Overall Study|Protocol Violation|1|||
13424282|NCT00441103|26872683|FG001|Overall Study|Protocol Violation|0|||
13424283|NCT00441103|26872682|FG000|Overall Study|Participant unable to use Rebiject II|1|||
13424284|NCT00441103|26872683|FG001|Overall Study|Participant unable to use Rebiject II|0|||
13424285|NCT00441103|26872682|FG000|Overall Study|Participant refused MRI|1|||
13424286|NCT00441103|26872683|FG001|Overall Study|Participant refused MRI|0|||
13424287|NCT00441103|26872682|FG000|Overall Study|Inclusion criteria absent|1|||
13424288|NCT00441103|26872683|FG001|Overall Study|Inclusion criteria absent|0|||
13424289|NCT00441103|26872682|FG000|Overall Study|Non-compliant|0|||
13424290|NCT00441103|26872683|FG001|Overall Study|Non-compliant|1|||
13424291|NCT00441103|26872682|FG000|Overall Study|Participant decided to withdraw|1|||
13424292|NCT00441103|26872683|FG001|Overall Study|Participant decided to withdraw|0|||
13424293|NCT00441103|26872682|FG000|Overall Study|Participant's reason|0|||
13424294|NCT00441103|26872683|FG001|Overall Study|Participant's reason|1|||
13424295|NCT00441103|26872682|FG000|Overall Study|Participant decided to stop|0|||
13424296|NCT00441103|26872683|FG001|Overall Study|Participant decided to stop|1|||
13424297|NCT00441090|26872741|FG000|Overall Study|Adverse Event|0|||
13424298|NCT00441090|26872742|FG001|Overall Study|Adverse Event|1|||
13424299|NCT00441090|26872743|FG002|Overall Study|Adverse Event|1|||
13424300|NCT00441090|26872744|FG003|Overall Study|Adverse Event|0|||
13424301|NCT00441090|26872745|FG004|Overall Study|Adverse Event|0|||
13424302|NCT00441090|26872741|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
13424303|NCT00441090|26872742|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
13424304|NCT00441090|26872743|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
13424305|NCT00441090|26872744|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2|||
13424306|NCT00441090|26872745|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
13424307|NCT00441090|26872741|FG000|Overall Study|Withdrawal by Subject|1|||
13424308|NCT00441090|26872742|FG001|Overall Study|Withdrawal by Subject|0|||
13424309|NCT00441090|26872743|FG002|Overall Study|Withdrawal by Subject|1|||
13424310|NCT00441090|26872744|FG003|Overall Study|Withdrawal by Subject|0|||
13424311|NCT00441090|26872745|FG004|Overall Study|Withdrawal by Subject|0|||
13424312|NCT00441090|26872741|FG000|Overall Study|Lack of Efficacy|1|||
13424313|NCT00441090|26872742|FG001|Overall Study|Lack of Efficacy|0|||
13424314|NCT00441090|26872743|FG002|Overall Study|Lack of Efficacy|0|||
13424315|NCT00441090|26872744|FG003|Overall Study|Lack of Efficacy|0|||
13424316|NCT00441090|26872745|FG004|Overall Study|Lack of Efficacy|0|||
13424317|NCT00441064|26872762|FG000|Overall Study|Adverse Event|1|||
13424318|NCT00441064|26872763|FG001|Overall Study|Adverse Event|0|||
13424319|NCT00441064|26872762|FG000|Overall Study|Abnormal laboratory values|0|||
13424320|NCT00441064|26872763|FG001|Overall Study|Abnormal laboratory values|2|||
13424321|NCT00441064|26872762|FG000|Overall Study|Abnormal test procedure results|0|||
13424322|NCT00441064|26872763|FG001|Overall Study|Abnormal test procedure results|1|||
13424323|NCT00441064|26872762|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
13424324|NCT00441064|26872763|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
13424325|NCT00441064|26872762|FG000|Overall Study|Protocol Deviation|3|||
13424326|NCT00441064|26872763|FG001|Overall Study|Protocol Deviation|2|||
13424327|NCT00441064|26872762|FG000|Overall Study|Patient withdrew consent|5|||
13424328|NCT00441064|26872763|FG001|Overall Study|Patient withdrew consent|2|||
13424329|NCT00441012|26872784|FG000|Overall Study|Adverse Event|0|||
13424330|NCT00441012|26872785|FG001|Overall Study|Adverse Event|1|||
13424331|NCT00441012|26872784|FG000|Overall Study|Lost to Follow-up|3|||
13424332|NCT00441012|26872785|FG001|Overall Study|Lost to Follow-up|3|||
13424333|NCT00441012|26872784|FG000|Overall Study|Protocol Violation|10|||
13424334|NCT00441012|26872785|FG001|Overall Study|Protocol Violation|9|||
13424335|NCT00441012|26872784|FG000|Overall Study|Withdrawal by Subject|4|||
13424336|NCT00441012|26872785|FG001|Overall Study|Withdrawal by Subject|0|||
13424337|NCT00441012|26872784|FG000|Overall Study|Subject Randomized but Not Vaccinated|1|||
13424338|NCT00441012|26872785|FG001|Overall Study|Subject Randomized but Not Vaccinated|0|||
13424339|NCT00440999|26872814|FG000|Overall Study|Adverse Event|0|||
13424340|NCT00440999|26872815|FG001|Overall Study|Adverse Event|2|||
13424341|NCT00440999|26872814|FG000|Overall Study|Lack of Efficacy|6|||
13424342|NCT00440999|26872815|FG001|Overall Study|Lack of Efficacy|7|||
13424343|NCT00440999|26872814|FG000|Overall Study|Lost to Follow-up|19|||
13424344|NCT00440999|26872815|FG001|Overall Study|Lost to Follow-up|12|||
13424345|NCT00440999|26872814|FG000|Overall Study|Protocol Violation|1|||
13424346|NCT00440999|26872815|FG001|Overall Study|Protocol Violation|0|||
13424347|NCT00440999|26872814|FG000|Overall Study|Withdrawal by Subject|2|||
13424348|NCT00440999|26872815|FG001|Overall Study|Withdrawal by Subject|5|||
13424349|NCT00440999|26872814|FG000|Overall Study|Subjets missed the visit|1|||
13424350|NCT00440999|26872815|FG001|Overall Study|Subjets missed the visit|0|||
13424351|NCT00440999|26872814|FG000|Overall Study|Mixed infection at entry|1|||
13424352|NCT00440999|26872815|FG001|Overall Study|Mixed infection at entry|0|||
13424353|NCT00440999|26872814|FG000|Overall Study|P. falciparum malaria|5|||
13424354|NCT00440999|26872815|FG001|Overall Study|P. falciparum malaria|14|||
13424355|NCT00440999|26872814|FG000|Overall Study|Subj left hosp without inform staff|0|||
13424356|NCT00440999|26872815|FG001|Overall Study|Subj left hosp without inform staff|1|||
13424357|NCT00440947|26872872|FG000|36-Week Induction Phase|Adverse Event|16|||
13424358|NCT00440947|26872873|FG001|36-Week Induction Phase|Adverse Event|0|||
13424359|NCT00440947|26872874|FG002|36-Week Induction Phase|Adverse Event|0|||
13424360|NCT00440947|26872875|FG003|36-Week Induction Phase|Adverse Event|0|||
13424361|NCT00440947|26872876|FG004|36-Week Induction Phase|Adverse Event|0|||
13424362|NCT00440947|26872872|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11|||
13424363|NCT00440947|26872873|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0|||
13424364|NCT00440947|26872874|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0|||
13424365|NCT00440947|26872875|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0|||
13424366|NCT00440947|26872876|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0|||
13424367|NCT00440947|26872872|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5|||
13424368|NCT00440947|26872873|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
13424369|NCT00440947|26872874|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
13424370|NCT00440947|26872875|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
13424371|NCT00440947|26872876|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
13424372|NCT00440947|26872872|FG000|36-Week Induction Phase|Non-compliance|10|||
13424373|NCT00440947|26872873|FG001|36-Week Induction Phase|Non-compliance|0|||
13424374|NCT00440947|26872874|FG002|36-Week Induction Phase|Non-compliance|0|||
13424375|NCT00440947|26872875|FG003|36-Week Induction Phase|Non-compliance|0|||
13424376|NCT00440947|26872876|FG004|36-Week Induction Phase|Non-compliance|0|||
13424377|NCT00440947|26872872|FG000|36-Week Induction Phase|Lost to Follow-up|16|||
13424378|NCT00440947|26872873|FG001|36-Week Induction Phase|Lost to Follow-up|0|||
13424379|NCT00440947|26872874|FG002|36-Week Induction Phase|Lost to Follow-up|0|||
13424380|NCT00440947|26872875|FG003|36-Week Induction Phase|Lost to Follow-up|0|||
13424381|NCT00440947|26872876|FG004|36-Week Induction Phase|Lost to Follow-up|0|||
13424382|NCT00440947|26872872|FG000|36-Week Induction Phase|Withdrawal by Subject|7|||
13424383|NCT00440947|26872873|FG001|36-Week Induction Phase|Withdrawal by Subject|0|||
13424384|NCT00440947|26872874|FG002|36-Week Induction Phase|Withdrawal by Subject|0|||
13424385|NCT00440947|26872875|FG003|36-Week Induction Phase|Withdrawal by Subject|0|||
13424386|NCT00440947|26872876|FG004|36-Week Induction Phase|Withdrawal by Subject|0|||
13424387|NCT00440947|26872872|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1|||
13424388|NCT00440947|26872873|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
13424389|NCT00440947|26872874|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
13424390|NCT00440947|26872875|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
13424391|NCT00440947|26872876|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
13424392|NCT00440947|26872872|FG000|36-Week Induction Phase|Took Exclusionary Medications|1|||
13424393|NCT00440947|26872873|FG001|36-Week Induction Phase|Took Exclusionary Medications|0|||
13424394|NCT00440947|26872874|FG002|36-Week Induction Phase|Took Exclusionary Medications|0|||
13424395|NCT00440947|26872875|FG003|36-Week Induction Phase|Took Exclusionary Medications|0|||
13424396|NCT00440947|26872876|FG004|36-Week Induction Phase|Took Exclusionary Medications|0|||
13424397|NCT00440947|26872872|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1|||
13424398|NCT00440947|26872873|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
13424399|NCT00440947|26872874|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
13424400|NCT00440947|26872875|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
13424401|NCT00440947|26872876|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
13424402|NCT00440947|26872872|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1|||
13424403|NCT00440947|26872873|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
13424404|NCT00440947|26872874|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
13424405|NCT00440947|26872875|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
13424406|NCT00440947|26872876|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
13424407|NCT00440947|26872872|FG000|36-Week Induction Phase|Incarceration|3|||
13424408|NCT00440947|26872873|FG001|36-Week Induction Phase|Incarceration|0|||
13424409|NCT00440947|26872874|FG002|36-Week Induction Phase|Incarceration|0|||
13424410|NCT00440947|26872875|FG003|36-Week Induction Phase|Incarceration|0|||
13424411|NCT00440947|26872876|FG004|36-Week Induction Phase|Incarceration|0|||
13424412|NCT00440947|26872872|FG000|36-Week Induction Phase|Pregnancy|1|||
13424413|NCT00440947|26872873|FG001|36-Week Induction Phase|Pregnancy|0|||
13424414|NCT00440947|26872874|FG002|36-Week Induction Phase|Pregnancy|0|||
13424415|NCT00440947|26872875|FG003|36-Week Induction Phase|Pregnancy|0|||
13424416|NCT00440947|26872876|FG004|36-Week Induction Phase|Pregnancy|0|||
13424417|NCT00440947|26872872|FG000|48-Week Randomization Phase|Adverse Event|0|||
13424418|NCT00440947|26872873|FG001|48-Week Randomization Phase|Adverse Event|2|||
13424419|NCT00440947|26872874|FG002|48-Week Randomization Phase|Adverse Event|5|||
13424420|NCT00440947|26872875|FG003|48-Week Randomization Phase|Adverse Event|0|||
13424421|NCT00440947|26872876|FG004|48-Week Randomization Phase|Adverse Event|0|||
13424422|NCT00440947|26872872|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
13424423|NCT00440947|26872873|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
13424424|NCT00440947|26872874|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
13424425|NCT00440947|26872875|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
13424426|NCT00440947|26872876|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
13424427|NCT00440947|26872872|FG000|48-Week Randomization Phase|Non-compliance|0|||
13424428|NCT00440947|26872873|FG001|48-Week Randomization Phase|Non-compliance|3|||
13424429|NCT00440947|26872874|FG002|48-Week Randomization Phase|Non-compliance|4|||
13424430|NCT00440947|26872875|FG003|48-Week Randomization Phase|Non-compliance|0|||
13424431|NCT00440947|26872876|FG004|48-Week Randomization Phase|Non-compliance|0|||
13424432|NCT00440947|26872872|FG000|48-Week Randomization Phase|Lost to Follow-up|0|||
13424433|NCT00440947|26872873|FG001|48-Week Randomization Phase|Lost to Follow-up|2|||
13424434|NCT00440947|26872874|FG002|48-Week Randomization Phase|Lost to Follow-up|8|||
13424435|NCT00440947|26872875|FG003|48-Week Randomization Phase|Lost to Follow-up|0|||
13424436|NCT00440947|26872876|FG004|48-Week Randomization Phase|Lost to Follow-up|0|||
13424437|NCT00440947|26872872|FG000|48-Week Randomization Phase|Protocol Violation|0|||
13424438|NCT00440947|26872873|FG001|48-Week Randomization Phase|Protocol Violation|0|||
13424439|NCT00440947|26872874|FG002|48-Week Randomization Phase|Protocol Violation|1|||
13424440|NCT00440947|26872875|FG003|48-Week Randomization Phase|Protocol Violation|0|||
13424441|NCT00440947|26872876|FG004|48-Week Randomization Phase|Protocol Violation|0|||
13424442|NCT00440947|26872872|FG000|48-Week Randomization Phase|Withdrawal by Subject|0|||
13424443|NCT00440947|26872873|FG001|48-Week Randomization Phase|Withdrawal by Subject|2|||
13424444|NCT00440947|26872874|FG002|48-Week Randomization Phase|Withdrawal by Subject|4|||
13424445|NCT00440947|26872875|FG003|48-Week Randomization Phase|Withdrawal by Subject|0|||
13424446|NCT00440947|26872876|FG004|48-Week Randomization Phase|Withdrawal by Subject|0|||
13424447|NCT00440947|26872872|FG000|48-Week Randomization Phase|Pregnancy|0|||
13424448|NCT00440947|26872873|FG001|48-Week Randomization Phase|Pregnancy|0|||
13424449|NCT00440947|26872874|FG002|48-Week Randomization Phase|Pregnancy|1|||
13424450|NCT00440947|26872875|FG003|48-Week Randomization Phase|Pregnancy|0|||
13424451|NCT00440947|26872876|FG004|48-Week Randomization Phase|Pregnancy|0|||
13424452|NCT00440947|26872872|FG000|48-Week Randomization Phase|Incarceration|0|||
13424453|NCT00440947|26872873|FG001|48-Week Randomization Phase|Incarceration|3|||
13424454|NCT00440947|26872874|FG002|48-Week Randomization Phase|Incarceration|0|||
13424455|NCT00440947|26872875|FG003|48-Week Randomization Phase|Incarceration|0|||
13424456|NCT00440947|26872876|FG004|48-Week Randomization Phase|Incarceration|0|||
13424457|NCT00440947|26872872|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0|||
13424458|NCT00440947|26872873|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1|||
13424459|NCT00440947|26872874|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0|||
13424460|NCT00440947|26872875|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0|||
13424461|NCT00440947|26872876|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0|||
13424462|NCT00440947|26872872|FG000|48-Week Randomization Phase|Physician Decision|0|||
13424463|NCT00440947|26872873|FG001|48-Week Randomization Phase|Physician Decision|2|||
13424464|NCT00440947|26872874|FG002|48-Week Randomization Phase|Physician Decision|0|||
13424465|NCT00440947|26872875|FG003|48-Week Randomization Phase|Physician Decision|0|||
13424466|NCT00440947|26872876|FG004|48-Week Randomization Phase|Physician Decision|0|||
13424467|NCT00440947|26872872|FG000|Optional 60-Week Extension Phase|Adverse Event|0|||
13424468|NCT00440947|26872873|FG001|Optional 60-Week Extension Phase|Adverse Event|0|||
13424469|NCT00440947|26872874|FG002|Optional 60-Week Extension Phase|Adverse Event|0|||
13424470|NCT00440947|26872875|FG003|Optional 60-Week Extension Phase|Adverse Event|1|||
13424471|NCT00440947|26872876|FG004|Optional 60-Week Extension Phase|Adverse Event|3|||
13424472|NCT00440947|26872872|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
13424473|NCT00440947|26872873|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
13424474|NCT00440947|26872874|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
13424475|NCT00440947|26872875|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
13424476|NCT00440947|26872876|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
13424477|NCT00440947|26872872|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
13424478|NCT00440947|26872873|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
13424479|NCT00440947|26872874|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
13424480|NCT00440947|26872875|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3|||
13424481|NCT00440947|26872876|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2|||
13424482|NCT00440947|26872872|FG000|Optional 60-Week Extension Phase|Non-compliance|0|||
13424483|NCT00440947|26872873|FG001|Optional 60-Week Extension Phase|Non-compliance|0|||
13424484|NCT00440947|26872874|FG002|Optional 60-Week Extension Phase|Non-compliance|0|||
13424485|NCT00440947|26872875|FG003|Optional 60-Week Extension Phase|Non-compliance|1|||
13424486|NCT00440947|26872876|FG004|Optional 60-Week Extension Phase|Non-compliance|1|||
13424487|NCT00440947|26872872|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
13424488|NCT00440947|26872873|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
13424489|NCT00440947|26872874|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
13424490|NCT00440947|26872875|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
13424491|NCT00440947|26872876|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
13424492|NCT00440947|26872872|FG000|Optional 60-Week Extension Phase|Protocol Violation|0|||
13424493|NCT00440947|26872873|FG001|Optional 60-Week Extension Phase|Protocol Violation|0|||
13424494|NCT00440947|26872874|FG002|Optional 60-Week Extension Phase|Protocol Violation|0|||
13424495|NCT00440947|26872875|FG003|Optional 60-Week Extension Phase|Protocol Violation|1|||
13424496|NCT00440947|26872876|FG004|Optional 60-Week Extension Phase|Protocol Violation|0|||
13424497|NCT00440947|26872872|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
13424498|NCT00440947|26872873|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
13424499|NCT00440947|26872874|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
13424500|NCT00440947|26872875|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4|||
13424501|NCT00440947|26872876|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3|||
13424502|NCT00440947|26872872|FG000|Optional 60-Week Extension Phase|Pregnancy|0|||
13424503|NCT00440947|26872873|FG001|Optional 60-Week Extension Phase|Pregnancy|0|||
13424504|NCT00440947|26872874|FG002|Optional 60-Week Extension Phase|Pregnancy|0|||
13424505|NCT00440947|26872875|FG003|Optional 60-Week Extension Phase|Pregnancy|3|||
13424506|NCT00440947|26872876|FG004|Optional 60-Week Extension Phase|Pregnancy|0|||
13424507|NCT00440947|26872872|FG000|Optional 60-Week Extension Phase|Participant Moved|0|||
13424508|NCT00440947|26872873|FG001|Optional 60-Week Extension Phase|Participant Moved|0|||
13424509|NCT00440947|26872874|FG002|Optional 60-Week Extension Phase|Participant Moved|0|||
13424510|NCT00440947|26872875|FG003|Optional 60-Week Extension Phase|Participant Moved|1|||
13424511|NCT00440947|26872876|FG004|Optional 60-Week Extension Phase|Participant Moved|1|||
13424512|NCT00440947|26872872|FG000|Optional 60-Week Extension Phase|Sponsor Request|0|||
13424513|NCT00440947|26872873|FG001|Optional 60-Week Extension Phase|Sponsor Request|0|||
13424514|NCT00440947|26872874|FG002|Optional 60-Week Extension Phase|Sponsor Request|0|||
13424515|NCT00440947|26872875|FG003|Optional 60-Week Extension Phase|Sponsor Request|1|||
13424516|NCT00440947|26872876|FG004|Optional 60-Week Extension Phase|Sponsor Request|1|||
13424517|NCT00440947|26872872|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
13424518|NCT00440947|26872873|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
13424519|NCT00440947|26872874|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
13424520|NCT00440947|26872875|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
13424521|NCT00440947|26872876|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
13424522|NCT00440947|26872872|FG000|Optional 60-Week Extension Phase|Other|0|||
13424523|NCT00440947|26872873|FG001|Optional 60-Week Extension Phase|Other|0|||
13424524|NCT00440947|26872874|FG002|Optional 60-Week Extension Phase|Other|0|||
13424525|NCT00440947|26872875|FG003|Optional 60-Week Extension Phase|Other|1|||
13424526|NCT00440947|26872876|FG004|Optional 60-Week Extension Phase|Other|0|||
13424527|NCT00440947|26872872|FG000|Optional 60-Week Extension Phase|Physician Decision|0|||
13424528|NCT00440947|26872873|FG001|Optional 60-Week Extension Phase|Physician Decision|0|||
13424529|NCT00440947|26872874|FG002|Optional 60-Week Extension Phase|Physician Decision|0|||
13424530|NCT00440947|26872875|FG003|Optional 60-Week Extension Phase|Physician Decision|0|||
13424531|NCT00440947|26872876|FG004|Optional 60-Week Extension Phase|Physician Decision|1|||
13424532|NCT00440947|26872872|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
13424533|NCT00440947|26872873|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
13424534|NCT00440947|26872874|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
13424535|NCT00440947|26872875|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
13424536|NCT00440947|26872876|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1|||
13424537|NCT00440726|26872897|FG000|Phase 1|Dose-Limiting Toxicity|0|||
13424538|NCT00440726|26872898|FG001|Phase 1|Dose-Limiting Toxicity|1|||
13424539|NCT00440726|26872899|FG002|Phase 1|Dose-Limiting Toxicity|0|||
13424540|NCT00440726|26872897|FG000|Phase 1|Physician Decision|1|||
13424541|NCT00440726|26872898|FG001|Phase 1|Physician Decision|0|||
13424542|NCT00440726|26872899|FG002|Phase 1|Physician Decision|0|||
13424543|NCT00440726|26872897|FG000|Phase 2|Death|0|||
13424544|NCT00440726|26872898|FG001|Phase 2|Death|0|||
13424545|NCT00440726|26872899|FG002|Phase 2|Death|1|||
13424546|NCT00440726|26872897|FG000|Phase 2|Adverse Event|0|||
13424547|NCT00440726|26872898|FG001|Phase 2|Adverse Event|0|||
13424548|NCT00440726|26872899|FG002|Phase 2|Adverse Event|1|||
13424549|NCT00440700|26872929|FG000|Overall Study|Withdrawal by Subject|8|||
13424550|NCT00440700|26872930|FG001|Overall Study|Withdrawal by Subject|8|||
13424551|NCT00440700|26872931|FG002|Overall Study|Withdrawal by Subject|4|||
13424552|NCT00440557|26872970|FG000|Overall Study|Withdrawal by Subject|10|||
13424553|NCT00440557|26872971|FG001|Overall Study|Withdrawal by Subject|5|||
13424554|NCT00440557|26872972|FG002|Overall Study|Withdrawal by Subject|11|||
13424555|NCT00440557|26872970|FG000|Overall Study|Lost to Follow-up|1|||
13424556|NCT00440557|26872971|FG001|Overall Study|Lost to Follow-up|2|||
13424557|NCT00440557|26872972|FG002|Overall Study|Lost to Follow-up|6|||
13424558|NCT00440557|26872970|FG000|Overall Study|Adverse Event|3|||
13424559|NCT00440557|26872971|FG001|Overall Study|Adverse Event|3|||
13424560|NCT00440557|26872972|FG002|Overall Study|Adverse Event|5|||
13424561|NCT00440557|26872970|FG000|Overall Study|Death|2|||
13424562|NCT00440557|26872971|FG001|Overall Study|Death|6|||
13424563|NCT00440557|26872972|FG002|Overall Study|Death|3|||
13424564|NCT00440557|26872970|FG000|Overall Study|Began Dialysis|4|||
13424565|NCT00440557|26872971|FG001|Overall Study|Began Dialysis|1|||
13424566|NCT00440557|26872972|FG002|Overall Study|Began Dialysis|4|||
13424567|NCT00440557|26872970|FG000|Overall Study|Principal Investigator decision|0|||
13424568|NCT00440557|26872971|FG001|Overall Study|Principal Investigator decision|3|||
13424569|NCT00440557|26872972|FG002|Overall Study|Principal Investigator decision|1|||
13424570|NCT00440557|26872970|FG000|Overall Study|Patient moved|1|||
13424571|NCT00440557|26872971|FG001|Overall Study|Patient moved|2|||
13424572|NCT00440557|26872972|FG002|Overall Study|Patient moved|1|||
13424573|NCT00440557|26872970|FG000|Overall Study|Principal Investigator's office closed|3|||
13424574|NCT00440557|26872971|FG001|Overall Study|Principal Investigator's office closed|6|||
13424575|NCT00440557|26872972|FG002|Overall Study|Principal Investigator's office closed|4|||
13424576|NCT00440557|26872970|FG000|Overall Study|Patient transferred to nursing home|0|||
13424577|NCT00440557|26872971|FG001|Overall Study|Patient transferred to nursing home|1|||
13424578|NCT00440557|26872972|FG002|Overall Study|Patient transferred to nursing home|0|||
13424579|NCT00440557|26872970|FG000|Overall Study|Patient had surgery|1|||
13424580|NCT00440557|26872971|FG001|Overall Study|Patient had surgery|0|||
13424581|NCT00440557|26872972|FG002|Overall Study|Patient had surgery|0|||
13424582|NCT00440518|26873002|FG000|Randomized /Titration Period|Lack of Efficacy|1|||
13424583|NCT00440518|26873003|FG001|Randomized /Titration Period|Lack of Efficacy|0|||
13424584|NCT00440518|26873004|FG002|Randomized /Titration Period|Lack of Efficacy|1|||
13424585|NCT00440518|26873002|FG000|Randomized /Titration Period|Subject Withdrew Consent|4|||
13424586|NCT00440518|26873003|FG001|Randomized /Titration Period|Subject Withdrew Consent|1|||
13424587|NCT00440518|26873004|FG002|Randomized /Titration Period|Subject Withdrew Consent|0|||
13424588|NCT00440518|26873002|FG000|Randomized /Titration Period|Protocol Deviation|1|||
13424589|NCT00440518|26873003|FG001|Randomized /Titration Period|Protocol Deviation|0|||
13424590|NCT00440518|26873004|FG002|Randomized /Titration Period|Protocol Deviation|0|||
13424591|NCT00440518|26873002|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2|||
13424592|NCT00440518|26873003|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3|||
13424593|NCT00440518|26873004|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2|||
13424594|NCT00440518|26873002|FG000|Randomized /Titration Period|Other|1|||
13424595|NCT00440518|26873003|FG001|Randomized /Titration Period|Other|0|||
13424596|NCT00440518|26873004|FG002|Randomized /Titration Period|Other|0|||
13424597|NCT00440518|26873002|FG000|Randomized /Titration Period|Lost to Follow-up|2|||
13424598|NCT00440518|26873003|FG001|Randomized /Titration Period|Lost to Follow-up|2|||
13424599|NCT00440518|26873004|FG002|Randomized /Titration Period|Lost to Follow-up|1|||
13424600|NCT00440518|26873002|FG000|Randomized /Titration Period|Adverse Event|2|||
13424601|NCT00440518|26873003|FG001|Randomized /Titration Period|Adverse Event|3|||
13424602|NCT00440518|26873004|FG002|Randomized /Titration Period|Adverse Event|0|||
13424603|NCT00440518|26873002|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3|||
13424604|NCT00440518|26873003|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4|||
13424605|NCT00440518|26873004|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2|||
13424606|NCT00440518|26873002|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0|||
13424607|NCT00440518|26873003|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
13424608|NCT00440518|26873004|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
13424609|NCT00440518|26873002|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3|||
13424610|NCT00440518|26873003|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2|||
13424611|NCT00440518|26873004|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4|||
13424612|NCT00440518|26873002|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0|||
13424613|NCT00440518|26873003|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3|||
13424614|NCT00440518|26873004|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6|||
13424615|NCT00440518|26873002|FG000|Maintenance and Safety Follow-up Periods|Other|0|||
13424616|NCT00440518|26873003|FG001|Maintenance and Safety Follow-up Periods|Other|0|||
13424617|NCT00440518|26873004|FG002|Maintenance and Safety Follow-up Periods|Other|2|||
13424618|NCT00440518|26873002|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1|||
13424619|NCT00440518|26873003|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2|||
13424620|NCT00440518|26873004|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0|||
13424621|NCT00440466|26873046|FG000|Overall Study|Death|3|||
13424622|NCT00440466|26873047|FG001|Overall Study|Death|2|||
13424623|NCT00440466|26873048|FG002|Overall Study|Death|9|||
13424624|NCT00440466|26873046|FG000|Overall Study|Adverse Event|3|||
13424625|NCT00440466|26873047|FG001|Overall Study|Adverse Event|4|||
13424626|NCT00440466|26873048|FG002|Overall Study|Adverse Event|11|||
13424627|NCT00440466|26873046|FG000|Overall Study|Lost to Follow-up|1|||
13424628|NCT00440466|26873047|FG001|Overall Study|Lost to Follow-up|0|||
13424629|NCT00440466|26873048|FG002|Overall Study|Lost to Follow-up|2|||
13424630|NCT00440466|26873046|FG000|Overall Study|Physician Decision|2|||
13424631|NCT00440466|26873047|FG001|Overall Study|Physician Decision|0|||
13424632|NCT00440466|26873048|FG002|Overall Study|Physician Decision|1|||
13424633|NCT00440466|26873046|FG000|Overall Study|Protocol Violation|2|||
13424634|NCT00440466|26873047|FG001|Overall Study|Protocol Violation|0|||
13424635|NCT00440466|26873048|FG002|Overall Study|Protocol Violation|4|||
13424636|NCT00440466|26873046|FG000|Overall Study|Withdrawal by Subject|2|||
13424637|NCT00440466|26873047|FG001|Overall Study|Withdrawal by Subject|5|||
13424638|NCT00440466|26873048|FG002|Overall Study|Withdrawal by Subject|9|||
13424639|NCT00440466|26873046|FG000|Overall Study|Began Dialysis|0|||
13424640|NCT00440466|26873047|FG001|Overall Study|Began Dialysis|0|||
13424641|NCT00440466|26873048|FG002|Overall Study|Began Dialysis|1|||
13424642|NCT00440466|26873046|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0|||
13424643|NCT00440466|26873047|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
13424644|NCT00440466|26873048|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
13424645|NCT00440401|26873063|FG000|Overall Study|Adverse Event|2|||
13424646|NCT00440401|26873064|FG001|Overall Study|Adverse Event|1|||
13424647|NCT00440401|26873063|FG000|Overall Study|Other|2|||
13424648|NCT00440401|26873064|FG001|Overall Study|Other|5|||
13424649|NCT00440310|26873077|FG000|Overall Study|Lost to Follow-up|4|||
13424650|NCT00440310|26873078|FG001|Overall Study|Lost to Follow-up|5|||
13424651|NCT00440310|26873077|FG000|Overall Study|Protocol Violation|0|||
13424652|NCT00440310|26873078|FG001|Overall Study|Protocol Violation|1|||
13424653|NCT00440310|26873077|FG000|Overall Study|Withdrawal by Subject|15|||
13424654|NCT00440310|26873078|FG001|Overall Study|Withdrawal by Subject|14|||
13424655|NCT00440310|26873077|FG000|Overall Study|No Reply at EOS|7|||
13424656|NCT00440310|26873078|FG001|Overall Study|No Reply at EOS|7|||
13424657|NCT00440310|26873077|FG000|Overall Study|Other|1|||
13424658|NCT00440310|26873078|FG001|Overall Study|Other|0|||
13424659|NCT00440310|26873077|FG000|Overall Study|Status Unknown|1|||
13424660|NCT00440310|26873078|FG001|Overall Study|Status Unknown|3|||
13424661|NCT00440297|26873099|FG000|Overall Study|Adverse Event|8|||
13424662|NCT00440297|26873100|FG001|Overall Study|Adverse Event|5|||
13424663|NCT00440297|26873099|FG000|Overall Study|Lost to Follow-up|1|||
13424664|NCT00440297|26873100|FG001|Overall Study|Lost to Follow-up|0|||
13424665|NCT00440297|26873099|FG000|Overall Study|Physician Decision|1|||
13424666|NCT00440297|26873100|FG001|Overall Study|Physician Decision|0|||
13424667|NCT00440297|26873099|FG000|Overall Study|Protocol Violation|11|||
13424668|NCT00440297|26873100|FG001|Overall Study|Protocol Violation|7|||
13424669|NCT00440297|26873099|FG000|Overall Study|Withdrawal by Subject|1|||
13424670|NCT00440297|26873100|FG001|Overall Study|Withdrawal by Subject|6|||
13424671|NCT00440297|26873099|FG000|Overall Study|Randomized by mistake|1|||
13424672|NCT00440297|26873100|FG001|Overall Study|Randomized by mistake|0|||
13424673|NCT00440271|26873139|FG000|Overall Study|Protocol Violation|1|||
13424674|NCT00440271|26873140|FG001|Overall Study|Protocol Violation|1|||
13424675|NCT00440271|26873139|FG000|Overall Study|Adverse Event|0|||
13424676|NCT00440271|26873140|FG001|Overall Study|Adverse Event|1|||
13424677|NCT00440271|26873139|FG000|Overall Study|Lost to Follow-up|1|||
13424678|NCT00440271|26873140|FG001|Overall Study|Lost to Follow-up|0|||
13424679|NCT00440271|26873139|FG000|Overall Study|Withdrawal by Subject|0|||
13424680|NCT00440271|26873140|FG001|Overall Study|Withdrawal by Subject|2|||
13424681|NCT00440271|26873139|FG000|Overall Study|Lack of Efficacy|0|||
13424682|NCT00440271|26873140|FG001|Overall Study|Lack of Efficacy|1|||
13424683|NCT00440271|26873139|FG000|Overall Study|Due to closure of trial|8|||
13424684|NCT00440271|26873140|FG001|Overall Study|Due to closure of trial|10|||
13424685|NCT00440271|26873139|FG000|Overall Study|Other|2|||
13424686|NCT00440271|26873140|FG001|Overall Study|Other|0|||
13424687|NCT00440232|26873155|FG000|Overall Study|Lost to Follow-up|1|||
13424688|NCT00440232|26873156|FG001|Overall Study|Lost to Follow-up|1|||
13424689|NCT00440232|26873155|FG000|Overall Study|Unable to treat within allowed time|0|||
13424690|NCT00440232|26873156|FG001|Overall Study|Unable to treat within allowed time|1|||
13424691|NCT00440232|26873155|FG000|Overall Study|Onset of headache within 4 hours of fast|2|||
13424692|NCT00440232|26873156|FG001|Overall Study|Onset of headache within 4 hours of fast|2|||
13424693|NCT00440193|26873197|FG000|Treatment Period|Adverse Event|74|||
13424694|NCT00440193|26873198|FG001|Treatment Period|Adverse Event|67|||
13424695|NCT00440193|26873197|FG000|Treatment Period|Death|19|||
13424696|NCT00440193|26873198|FG001|Treatment Period|Death|22|||
13424697|NCT00440193|26873197|FG000|Treatment Period|Lack of Efficacy|0|||
13424698|NCT00440193|26873198|FG001|Treatment Period|Lack of Efficacy|1|||
13424699|NCT00440193|26873197|FG000|Treatment Period|Lost to Follow-up|12|||
13424700|NCT00440193|26873198|FG001|Treatment Period|Lost to Follow-up|18|||
13424701|NCT00440193|26873197|FG000|Treatment Period|Physician Decision|3|||
13424702|NCT00440193|26873198|FG001|Treatment Period|Physician Decision|6|||
13424703|NCT00440193|26873197|FG000|Treatment Period|Protocol Violation|16|||
13424704|NCT00440193|26873198|FG001|Treatment Period|Protocol Violation|19|||
13424705|NCT00440193|26873197|FG000|Treatment Period|Withdrawal by Subject|36|||
13424706|NCT00440193|26873198|FG001|Treatment Period|Withdrawal by Subject|77|||
13424707|NCT00440193|26873197|FG000|Treatment Period|Clinical endpoint reached|28|||
13424708|NCT00440193|26873198|FG001|Treatment Period|Clinical endpoint reached|25|||
13424709|NCT00440193|26873197|FG000|Treatment Period|Study terminated by sponsor|102|||
13424710|NCT00440193|26873198|FG001|Treatment Period|Study terminated by sponsor|94|||
13424711|NCT00440193|26873197|FG000|Treatment Period|Protocol driven decision point|2|||
13424712|NCT00440193|26873198|FG001|Treatment Period|Protocol driven decision point|2|||
13424713|NCT00440193|26873197|FG000|Treatment Period|Switch to commercial drug|0|||
13424714|NCT00440193|26873198|FG001|Treatment Period|Switch to commercial drug|2|||
13424715|NCT00440193|26873197|FG000|Treatment Period|Technical problems|1|||
13424716|NCT00440193|26873198|FG001|Treatment Period|Technical problems|1|||
13424717|NCT00440193|26873197|FG000|Treatment Period|Participant convenience|5|||
13424718|NCT00440193|26873198|FG001|Treatment Period|Participant convenience|2|||
13424719|NCT00440193|26873197|FG000|Treatment Period|Participant did not receive treatment|7|||
13424720|NCT00440193|26873198|FG001|Treatment Period|Participant did not receive treatment|13|||
13424721|NCT00440193|26873197|FG000|Treatment Period|Site closed by investigator|0|||
13424722|NCT00440193|26873198|FG001|Treatment Period|Site closed by investigator|2|||
13424723|NCT00440193|26873197|FG000|Observational Period|Adverse Event|2|||
13424724|NCT00440193|26873198|FG001|Observational Period|Adverse Event|2|||
13424725|NCT00440193|26873197|FG000|Observational Period|Death|15|||
13424726|NCT00440193|26873198|FG001|Observational Period|Death|20|||
13424727|NCT00440193|26873197|FG000|Observational Period|Lost to Follow-up|12|||
13424728|NCT00440193|26873198|FG001|Observational Period|Lost to Follow-up|8|||
13424729|NCT00440193|26873197|FG000|Observational Period|Protocol Violation|1|||
13424730|NCT00440193|26873198|FG001|Observational Period|Protocol Violation|0|||
13424731|NCT00440193|26873197|FG000|Observational Period|Withdrawal by Subject|11|||
13424732|NCT00440193|26873198|FG001|Observational Period|Withdrawal by Subject|8|||
13424733|NCT00440193|26873197|FG000|Observational Period|Physician Decision|1|||
13424734|NCT00440193|26873198|FG001|Observational Period|Physician Decision|0|||
13424735|NCT00440193|26873197|FG000|Observational Period|Clinical endpoint reached|1|||
13424736|NCT00440193|26873198|FG001|Observational Period|Clinical endpoint reached|0|||
13424737|NCT00440193|26873197|FG000|Observational Period|Participant convenience|2|||
13424738|NCT00440193|26873198|FG001|Observational Period|Participant convenience|0|||
13424739|NCT00440115|26873222|FG000|Overall Study|Death|7|||
13424740|NCT00440115|26873223|FG001|Overall Study|Death|9|||
13424741|NCT00440115|26873224|FG002|Overall Study|Death|5|||
13424742|NCT00440115|26873222|FG000|Overall Study|Incarceration|0|||
13424743|NCT00440115|26873223|FG001|Overall Study|Incarceration|2|||
13424744|NCT00440115|26873224|FG002|Overall Study|Incarceration|1|||
13424745|NCT00440037|26873234|FG000|Overall Study|Withdrawal by Subject|6|||
13424746|NCT00440037|26873234|FG000|Overall Study|Administrative decision|3|||
13424747|NCT00440011|26873249|FG000|Overall Study|Adverse Event|2|||
13424748|NCT00440011|26873250|FG001|Overall Study|Adverse Event|0|||
13424749|NCT00440011|26873249|FG000|Overall Study|Lost to Follow-up|0|||
13424750|NCT00440011|26873250|FG001|Overall Study|Lost to Follow-up|2|||
13424751|NCT00440011|26873249|FG000|Overall Study|Protocol Violation|1|||
13424752|NCT00440011|26873250|FG001|Overall Study|Protocol Violation|1|||
13424753|NCT00440011|26873249|FG000|Overall Study|Withdrawal by Subject|1|||
13424754|NCT00440011|26873250|FG001|Overall Study|Withdrawal by Subject|0|||
13424755|NCT00439777|26873293|FG000|Treatment Period|Death|29|||
13424756|NCT00439777|26873294|FG001|Treatment Period|Death|21|||
13424757|NCT00439777|26873293|FG000|Treatment Period|Study terminated by sponsor|125|||
13424758|NCT00439777|26873294|FG001|Treatment Period|Study terminated by sponsor|132|||
13424759|NCT00439777|26873293|FG000|Treatment Period|Site closed by investigator|0|||
13424760|NCT00439777|26873294|FG001|Treatment Period|Site closed by investigator|1|||
13424761|NCT00439777|26873293|FG000|Treatment Period|Did not take study treatment|7|||
13424762|NCT00439777|26873294|FG001|Treatment Period|Did not take study treatment|8|||
13424763|NCT00439777|26873293|FG000|Treatment Period|Adverse Event|111|||
13424764|NCT00439777|26873294|FG001|Treatment Period|Adverse Event|92|||
13424765|NCT00439777|26873293|FG000|Treatment Period|Protocol Violation|23|||
13424766|NCT00439777|26873294|FG001|Treatment Period|Protocol Violation|30|||
13424767|NCT00439777|26873293|FG000|Treatment Period|Withdrawal by Subject|66|||
13424768|NCT00439777|26873294|FG001|Treatment Period|Withdrawal by Subject|118|||
13424769|NCT00439777|26873293|FG000|Treatment Period|Lack of Efficacy|1|||
13424770|NCT00439777|26873294|FG001|Treatment Period|Lack of Efficacy|4|||
13424771|NCT00439777|26873293|FG000|Treatment Period|Lost to Follow-up|8|||
13424772|NCT00439777|26873294|FG001|Treatment Period|Lost to Follow-up|10|||
13424773|NCT00439777|26873293|FG000|Treatment Period|Protocol driven decision point|1|||
13424774|NCT00439777|26873294|FG001|Treatment Period|Protocol driven decision point|3|||
13424775|NCT00439777|26873293|FG000|Treatment Period|Physician Decision|7|||
13424776|NCT00439777|26873294|FG001|Treatment Period|Physician Decision|18|||
13424777|NCT00439777|26873293|FG000|Treatment Period|Clinical endpoint reached|26|||
13424778|NCT00439777|26873294|FG001|Treatment Period|Clinical endpoint reached|13|||
13424779|NCT00439777|26873293|FG000|Treatment Period|Technical problems|3|||
13424780|NCT00439777|26873294|FG001|Treatment Period|Technical problems|1|||
13424781|NCT00439777|26873293|FG000|Treatment Period|Participant convenience|12|||
13424782|NCT00439777|26873294|FG001|Treatment Period|Participant convenience|8|||
13424783|NCT00439777|26873293|FG000|Observational Period|Protocol Violation|0|||
13424784|NCT00439777|26873294|FG001|Observational Period|Protocol Violation|2|||
13424785|NCT00439777|26873293|FG000|Observational Period|Withdrawal by Subject|9|||
13424786|NCT00439777|26873294|FG001|Observational Period|Withdrawal by Subject|5|||
13424787|NCT00439777|26873293|FG000|Observational Period|Lost to Follow-up|1|||
13424788|NCT00439777|26873294|FG001|Observational Period|Lost to Follow-up|11|||
13424789|NCT00439777|26873293|FG000|Observational Period|Death|27|||
13424790|NCT00439777|26873294|FG001|Observational Period|Death|20|||
13424791|NCT00439777|26873293|FG000|Observational Period|Study terminated by sponsor|3|||
13424792|NCT00439777|26873294|FG001|Observational Period|Study terminated by sponsor|1|||
13424793|NCT00439777|26873293|FG000|Observational Period|Protocol driven decision point|0|||
13424794|NCT00439777|26873294|FG001|Observational Period|Protocol driven decision point|1|||
13424795|NCT00439777|26873293|FG000|Observational Period|Lack of Efficacy|1|||
13424796|NCT00439777|26873294|FG001|Observational Period|Lack of Efficacy|0|||
13424797|NCT00439777|26873293|FG000|Observational Period|Technical problems|0|||
13424798|NCT00439777|26873294|FG001|Observational Period|Technical problems|1|||
13424799|NCT00439725|26873345|FG000|Treatment Period|Withdrawal by Subject|22|||
13424800|NCT00439725|26873346|FG001|Treatment Period|Withdrawal by Subject|19|||
13424801|NCT00439725|26873345|FG000|Treatment Period|Study terminated by sponsor|156|||
13424802|NCT00439725|26873346|FG001|Treatment Period|Study terminated by sponsor|148|||
13424803|NCT00439725|26873345|FG000|Treatment Period|Site closed by investigator|1|||
13424804|NCT00439725|26873346|FG001|Treatment Period|Site closed by investigator|2|||
13424805|NCT00439725|26873345|FG000|Treatment Period|Adverse Event|39|||
13424806|NCT00439725|26873346|FG001|Treatment Period|Adverse Event|18|||
13424807|NCT00439725|26873345|FG000|Treatment Period|Physician Decision|1|||
13424808|NCT00439725|26873346|FG001|Treatment Period|Physician Decision|1|||
13424809|NCT00439725|26873345|FG000|Treatment Period|Protocol Violation|2|||
13424810|NCT00439725|26873346|FG001|Treatment Period|Protocol Violation|1|||
13424811|NCT00439725|26873345|FG000|Treatment Period|Clinical endpoint reached|6|||
13424812|NCT00439725|26873346|FG001|Treatment Period|Clinical endpoint reached|50|||
13424813|NCT00439725|26873345|FG000|Treatment Period|Technical problems|1|||
13424814|NCT00439725|26873346|FG001|Treatment Period|Technical problems|0|||
13424815|NCT00439725|26873345|FG000|Treatment Period|Lost to Follow-up|1|||
13424816|NCT00439725|26873346|FG001|Treatment Period|Lost to Follow-up|1|||
13424817|NCT00439725|26873345|FG000|Treatment Period|Participant convenience|1|||
13424818|NCT00439725|26873346|FG001|Treatment Period|Participant convenience|0|||
13424819|NCT00439725|26873345|FG000|Treatment Period|Protocol driven decision point|1|||
13424820|NCT00439725|26873346|FG001|Treatment Period|Protocol driven decision point|1|||
13424821|NCT00439725|26873345|FG000|Treatment Period|Death|1|||
13424822|NCT00439725|26873346|FG001|Treatment Period|Death|1|||
13424823|NCT00439725|26873345|FG000|Treatment Period|Participant did not receive treatment|4|||
13424824|NCT00439725|26873346|FG001|Treatment Period|Participant did not receive treatment|4|||
13424825|NCT00439725|26873345|FG000|Observational Period|Withdrawal by Subject|2|||
13424826|NCT00439725|26873346|FG001|Observational Period|Withdrawal by Subject|2|||
13424827|NCT00439725|26873345|FG000|Observational Period|Lost to Follow-up|0|||
13424828|NCT00439725|26873346|FG001|Observational Period|Lost to Follow-up|1|||
13424829|NCT00439725|26873345|FG000|Observational Period|Death|0|||
13424830|NCT00439725|26873346|FG001|Observational Period|Death|2|||
13424831|NCT00439725|26873345|FG000|Observational Period|Study termination by sponsor|1|||
13424832|NCT00439725|26873346|FG001|Observational Period|Study termination by sponsor|1|||
13424833|NCT00439725|26873345|FG000|Observational Period|Clinical endpoint reached|3|||
13424834|NCT00439725|26873346|FG001|Observational Period|Clinical endpoint reached|1|||
13424835|NCT00439725|26873345|FG000|Observational Period|Technical problems|1|||
13424836|NCT00439725|26873346|FG001|Observational Period|Technical problems|0|||
13424837|NCT00439725|26873345|FG000|Observational Period|Participant convenience|1|||
13424838|NCT00439725|26873346|FG001|Observational Period|Participant convenience|0|||
13424839|NCT00439647|26873385|FG000|Overall Study|Withdrawal by Subject|25|||
13424840|NCT00439647|26873386|FG001|Overall Study|Withdrawal by Subject|22|||
13424841|NCT00439647|26873385|FG000|Overall Study|Death|15|||
13424842|NCT00439647|26873386|FG001|Overall Study|Death|18|||
13424843|NCT00439647|26873385|FG000|Overall Study|Adverse Event|11|||
13424844|NCT00439647|26873386|FG001|Overall Study|Adverse Event|11|||
13424845|NCT00439647|26873385|FG000|Overall Study|Lost to Follow-up|4|||
13424846|NCT00439647|26873386|FG001|Overall Study|Lost to Follow-up|12|||
13424847|NCT00439647|26873385|FG000|Overall Study|Protocol Violation|3|||
13424848|NCT00439647|26873386|FG001|Overall Study|Protocol Violation|4|||
13424849|NCT00439647|26873385|FG000|Overall Study|Lack of Efficacy|0|||
13424850|NCT00439647|26873386|FG001|Overall Study|Lack of Efficacy|4|||
13424851|NCT00439569|26873399|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1|||
13424852|NCT00439569|26873399|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3|||
13424853|NCT00439569|26873399|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
13424854|NCT00439556|26873420|FG000|Overall Study|Patient was taken off study for non-comp|0|||
13424855|NCT00439556|26873421|FG001|Overall Study|Patient was taken off study for non-comp|1|||
13424856|NCT00439556|26873422|FG002|Overall Study|Patient was taken off study for non-comp|0|||
13424857|NCT00439517|26873451|FG000|Overall Study|Subject on treatment|1|||
13424858|NCT00439517|26873452|FG001|Overall Study|Subject on treatment|0|||
13424859|NCT00439517|26873451|FG000|Overall Study|Subject in survival follow-up|1|||
13424860|NCT00439517|26873452|FG001|Overall Study|Subject in survival follow-up|0|||
13424861|NCT00439309|26873473|FG000|Follow-Up|Death|1|||
13424862|NCT00439309|26873474|FG001|Follow-Up|Death|0|||
13424863|NCT00439309|26873473|FG000|Follow-Up|Lost to Follow-up|2|||
13424864|NCT00439309|26873474|FG001|Follow-Up|Lost to Follow-up|0|||
13424865|NCT00439309|26873473|FG000|Follow-Up|Withdrawal by Subject|0|||
13424866|NCT00439309|26873474|FG001|Follow-Up|Withdrawal by Subject|1|||
13424867|NCT00439309|26873473|FG000|Follow-Up|Late response by subject|0|||
13424868|NCT00439309|26873474|FG001|Follow-Up|Late response by subject|1|||
13424869|NCT00439270|26873529|FG000|Phase 1 (18.1 Months)|Disease progression|3|||
13424870|NCT00439270|26873530|FG001|Phase 1 (18.1 Months)|Disease progression|2|||
13424871|NCT00439270|26873531|FG002|Phase 1 (18.1 Months)|Disease progression|3|||
13424872|NCT00439270|26873532|FG003|Phase 1 (18.1 Months)|Disease progression|0|||
13424873|NCT00439270|26873533|FG004|Phase 1 (18.1 Months)|Disease progression|3|||
13424874|NCT00439270|26873529|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0|||
13424875|NCT00439270|26873530|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1|||
13424876|NCT00439270|26873531|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0|||
13424877|NCT00439270|26873532|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0|||
13424878|NCT00439270|26873533|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0|||
13424879|NCT00439270|26873529|FG000|Phase 2 (51.6 Months)|Disease progression|0|||
13424880|NCT00439270|26873530|FG001|Phase 2 (51.6 Months)|Disease progression|0|||
13424881|NCT00439270|26873531|FG002|Phase 2 (51.6 Months)|Disease progression|0|||
13424882|NCT00439270|26873532|FG003|Phase 2 (51.6 Months)|Disease progression|18|||
13424883|NCT00439270|26873533|FG004|Phase 2 (51.6 Months)|Disease progression|0|||
13424884|NCT00439270|26873529|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
13424885|NCT00439270|26873530|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
13424886|NCT00439270|26873531|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
13424887|NCT00439270|26873532|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1|||
13424888|NCT00439270|26873533|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
13424889|NCT00439270|26873529|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0|||
13424890|NCT00439270|26873530|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0|||
13424891|NCT00439270|26873531|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0|||
13424892|NCT00439270|26873532|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6|||
13424893|NCT00439270|26873533|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0|||
13424894|NCT00439270|26873529|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
13424895|NCT00439270|26873530|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
13424896|NCT00439270|26873531|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
13424897|NCT00439270|26873532|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3|||
13424898|NCT00439270|26873533|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
13424899|NCT00439270|26873529|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
13424900|NCT00439270|26873530|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
13424901|NCT00439270|26873531|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
13424902|NCT00439270|26873532|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1|||
13424903|NCT00439270|26873533|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
13424904|NCT00439270|26873529|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
13424905|NCT00439270|26873530|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
13424906|NCT00439270|26873531|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
13424907|NCT00439270|26873532|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2|||
13424908|NCT00439270|26873533|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
13424909|NCT00439270|26873529|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
13424910|NCT00439270|26873530|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
13424911|NCT00439270|26873531|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
13424912|NCT00439270|26873532|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2|||
13424913|NCT00439270|26873533|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
13424914|NCT00439270|26873529|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
13424915|NCT00439270|26873530|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
13424916|NCT00439270|26873531|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
13424917|NCT00439270|26873532|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1|||
13424918|NCT00439270|26873533|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
13424919|NCT00439244|26873563|FG000|Overall Study|Adverse Event|5|||
13424920|NCT00439244|26873564|FG001|Overall Study|Adverse Event|2|||
13424921|NCT00439244|26873565|FG002|Overall Study|Adverse Event|3|||
13424922|NCT00439244|26873563|FG000|Overall Study|Withdrawal by Subject|3|||
13424923|NCT00439244|26873564|FG001|Overall Study|Withdrawal by Subject|1|||
13424924|NCT00439244|26873565|FG002|Overall Study|Withdrawal by Subject|2|||
13424925|NCT00439244|26873563|FG000|Overall Study|Lost to Follow-up|2|||
13424926|NCT00439244|26873564|FG001|Overall Study|Lost to Follow-up|1|||
13424927|NCT00439244|26873565|FG002|Overall Study|Lost to Follow-up|2|||
13424928|NCT00439244|26873563|FG000|Overall Study|Death|0|||
13424929|NCT00439244|26873564|FG001|Overall Study|Death|1|||
13424930|NCT00439244|26873565|FG002|Overall Study|Death|0|||
13424931|NCT00439244|26873563|FG000|Overall Study|Protocol Violation|0|||
13424932|NCT00439244|26873564|FG001|Overall Study|Protocol Violation|1|||
13424933|NCT00439244|26873565|FG002|Overall Study|Protocol Violation|0|||
13424934|NCT00439244|26873563|FG000|Overall Study|Administrative problems|1|||
13424935|NCT00439244|26873564|FG001|Overall Study|Administrative problems|0|||
13424936|NCT00439244|26873565|FG002|Overall Study|Administrative problems|0|||
13424937|NCT00439231|26873571|FG000|Overall Study|Lack of Efficacy|28|||
13424938|NCT00439218|26873584|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
13424939|NCT00439179|26873611|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
13424940|NCT00439179|26873612|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2|||
13424941|NCT00439179|26873613|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
13424942|NCT00439179|26873614|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
13424943|NCT00439140|26873653|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
13424944|NCT00439140|26873654|FG001|Treatment Cycle 1|Lost to Follow-up|1|||
13424945|NCT00439140|26873655|FG002|Treatment Cycle 1|Lost to Follow-up|1|||
13424946|NCT00439140|26873653|FG000|Treatment Cycle 1|Personal reasons|0|||
13424947|NCT00439140|26873654|FG001|Treatment Cycle 1|Personal reasons|2|||
13424948|NCT00439140|26873655|FG002|Treatment Cycle 1|Personal reasons|0|||
13424949|NCT00439140|26873653|FG000|Treatment Cycle 1|Withdrawal by Subject|0|||
13424950|NCT00439140|26873654|FG001|Treatment Cycle 1|Withdrawal by Subject|1|||
13424951|NCT00439140|26873655|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
13424952|NCT00439140|26873653|FG000|Treatment Cycle 2|Withdrawal by Subject|1|||
13424953|NCT00439140|26873654|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
13424954|NCT00439140|26873655|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
13424955|NCT00439140|26873653|FG000|Treatment Cycle 2|Lost to Follow-up|1|||
13424956|NCT00439140|26873654|FG001|Treatment Cycle 2|Lost to Follow-up|1|||
13424957|NCT00439140|26873655|FG002|Treatment Cycle 2|Lost to Follow-up|0|||
13424958|NCT00438815|26873667|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30|||
13424959|NCT00438815|26873667|FG000|Overall Study|3-month follow-up no longer required|12|||
13424960|NCT00438815|26873667|FG000|Overall Study|Noncompliance with protocol requirements|9|||
13424961|NCT00438815|26873667|FG000|Overall Study|Transitioned to commercial C1INH-nf|6|||
13424962|NCT00438815|26873667|FG000|Overall Study|Lost to Follow-up|6|||
13424963|NCT00438815|26873667|FG000|Overall Study|Withdrawal by Subject|6|||
13424964|NCT00438815|26873667|FG000|Overall Study|Death|1|||
13424965|NCT00438672|26873682|FG000|Overall Study|Lost to Follow-up|7|||
13424966|NCT00438672|26873683|FG001|Overall Study|Lost to Follow-up|9|||
13424967|NCT00438659|26873712|FG000|Overall Study|Discontinued Mometasone/Placebo|1|||
13424968|NCT00438659|26873713|FG001|Overall Study|Discontinued Mometasone/Placebo|2|||
13424969|NCT00438659|26873712|FG000|Overall Study|Cancel|5|||
13424970|NCT00438659|26873713|FG001|Overall Study|Cancel|2|||
13424971|NCT00438633|26873734|FG000|Overall Study|Withdrawal by Subject|1|||
13424972|NCT00438633|26873735|FG001|Overall Study|Withdrawal by Subject|0|||
13424973|NCT00438633|26873734|FG000|Overall Study|Lost to Follow-up|15|||
13424974|NCT00438633|26873735|FG001|Overall Study|Lost to Follow-up|17|||
13424975|NCT00438464|26873794|FG000|Overall Study|Terminated Early|14|||
13424976|NCT00438464|26873795|FG001|Overall Study|Terminated Early|5|||
13424977|NCT00438464|26873794|FG000|Overall Study|Incomplete data submission|0|||
13424978|NCT00438464|26873795|FG001|Overall Study|Incomplete data submission|2|||
13424979|NCT00438399|26873817|FG000|Overall Study|Lost to Follow-up|2|||
13424980|NCT00438399|26873818|FG001|Overall Study|Lost to Follow-up|2|||
13424981|NCT00438399|26873819|FG002|Overall Study|Lost to Follow-up|1|||
13424982|NCT00438399|26873820|FG003|Overall Study|Lost to Follow-up|1|||
13424983|NCT00438399|26873821|FG004|Overall Study|Lost to Follow-up|1|||
13424984|NCT00438399|26873822|FG005|Overall Study|Lost to Follow-up|1|||
13424985|NCT00438399|26873817|FG000|Overall Study|Adverse Event|0|||
13424986|NCT00438399|26873818|FG001|Overall Study|Adverse Event|0|||
13424987|NCT00438399|26873819|FG002|Overall Study|Adverse Event|1|||
13424988|NCT00438399|26873820|FG003|Overall Study|Adverse Event|1|||
13424989|NCT00438399|26873821|FG004|Overall Study|Adverse Event|0|||
13424990|NCT00438399|26873822|FG005|Overall Study|Adverse Event|1|||
13424991|NCT00438399|26873817|FG000|Overall Study|Withdrawal by Subject|5|||
13424992|NCT00438399|26873818|FG001|Overall Study|Withdrawal by Subject|6|||
13424993|NCT00438399|26873819|FG002|Overall Study|Withdrawal by Subject|3|||
13424994|NCT00438399|26873820|FG003|Overall Study|Withdrawal by Subject|2|||
13424995|NCT00438399|26873821|FG004|Overall Study|Withdrawal by Subject|2|||
13424996|NCT00438399|26873822|FG005|Overall Study|Withdrawal by Subject|2|||
13424997|NCT00438399|26873817|FG000|Overall Study|Protocol Violation|0|||
13424998|NCT00438399|26873818|FG001|Overall Study|Protocol Violation|0|||
13424999|NCT00438399|26873819|FG002|Overall Study|Protocol Violation|1|||
13425000|NCT00438399|26873820|FG003|Overall Study|Protocol Violation|0|||
13425001|NCT00438399|26873821|FG004|Overall Study|Protocol Violation|0|||
13425002|NCT00438399|26873822|FG005|Overall Study|Protocol Violation|1|||
13425003|NCT00438399|26873817|FG000|Overall Study|Subje stopped study|0|||
13425004|NCT00438399|26873818|FG001|Overall Study|Subje stopped study|0|||
13425005|NCT00438399|26873819|FG002|Overall Study|Subje stopped study|1|||
13425006|NCT00438399|26873820|FG003|Overall Study|Subje stopped study|0|||
13425007|NCT00438399|26873821|FG004|Overall Study|Subje stopped study|0|||
13425008|NCT00438399|26873822|FG005|Overall Study|Subje stopped study|0|||
13425009|NCT00438399|26873817|FG000|Overall Study|Pregnancy|0|||
13425010|NCT00438399|26873818|FG001|Overall Study|Pregnancy|0|||
13425011|NCT00438399|26873819|FG002|Overall Study|Pregnancy|0|||
13425012|NCT00438399|26873820|FG003|Overall Study|Pregnancy|0|||
13425013|NCT00438399|26873821|FG004|Overall Study|Pregnancy|0|||
13425014|NCT00438399|26873822|FG005|Overall Study|Pregnancy|1|||
13425015|NCT00438399|26873817|FG000|Overall Study|Patien stopped study at visit 4 by error|1|||
13425016|NCT00438399|26873818|FG001|Overall Study|Patien stopped study at visit 4 by error|0|||
13425017|NCT00438399|26873819|FG002|Overall Study|Patien stopped study at visit 4 by error|0|||
13425018|NCT00438399|26873820|FG003|Overall Study|Patien stopped study at visit 4 by error|0|||
13425019|NCT00438399|26873821|FG004|Overall Study|Patien stopped study at visit 4 by error|0|||
13425020|NCT00438399|26873822|FG005|Overall Study|Patien stopped study at visit 4 by error|0|||
13425021|NCT00438360|26873843|FG000|Overall Study|Adverse Event|6|||
13425022|NCT00438360|26873844|FG001|Overall Study|Adverse Event|1|||
13425023|NCT00438360|26873843|FG000|Overall Study|Lack of Efficacy|42|||
13425024|NCT00438360|26873844|FG001|Overall Study|Lack of Efficacy|27|||
13425025|NCT00438360|26873843|FG000|Overall Study|Other|24|||
13425026|NCT00438360|26873844|FG001|Overall Study|Other|15|||
13425027|NCT00438256|26873865|FG000|Overall Study|Ineligible for Resection|2|||
13425028|NCT00438256|26873866|FG001|Overall Study|Ineligible for Resection|1|||
13425029|NCT00438256|26873867|FG002|Overall Study|Ineligible for Resection|1|||
13425030|NCT00438256|26873868|FG003|Overall Study|Ineligible for Resection|7|||
13425031|NCT00438256|26873865|FG000|Overall Study|Excluded final Diagnosis|0|||
13425032|NCT00438256|26873866|FG001|Overall Study|Excluded final Diagnosis|0|||
13425033|NCT00438256|26873867|FG002|Overall Study|Excluded final Diagnosis|0|||
13425034|NCT00438256|26873868|FG003|Overall Study|Excluded final Diagnosis|2|||
13425035|NCT00437983|26873885|FG000|Overall Study|Adverse Event|6|||
13425036|NCT00437983|26873886|FG001|Overall Study|Adverse Event|6|||
13425037|NCT00437983|26873885|FG000|Overall Study|Protocol Violation|2|||
13425038|NCT00437983|26873886|FG001|Overall Study|Protocol Violation|1|||
13425039|NCT00437983|26873885|FG000|Overall Study|Withdrawal by Subject|5|||
13425040|NCT00437983|26873886|FG001|Overall Study|Withdrawal by Subject|6|||
13425041|NCT00437658|26873988|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
13425042|NCT00437658|26873989|FG001|Treatment Period (24 Weeks)|Adverse Event|7|||
13425043|NCT00437658|26873990|FG002|Treatment Period (24 Weeks)|Adverse Event|14|||
13425044|NCT00437658|26873988|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
13425045|NCT00437658|26873989|FG001|Treatment Period (24 Weeks)|Non-compliance|1|||
13425046|NCT00437658|26873990|FG002|Treatment Period (24 Weeks)|Non-compliance|4|||
13425047|NCT00437658|26873988|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9|||
13425048|NCT00437658|26873989|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
13425049|NCT00437658|26873990|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
13425050|NCT00437658|26873988|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4|||
13425051|NCT00437658|26873989|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2|||
13425052|NCT00437658|26873990|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3|||
13425053|NCT00437658|26873988|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
13425054|NCT00437658|26873989|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4|||
13425055|NCT00437658|26873990|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
13425056|NCT00437658|26873988|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5|||
13425057|NCT00437658|26873989|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
13425058|NCT00437658|26873990|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
13425059|NCT00437658|26873988|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1|||
13425060|NCT00437658|26873989|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0|||
13425061|NCT00437658|26873990|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1|||
13425062|NCT00437658|26873988|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3|||
13425063|NCT00437658|26873989|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0|||
13425064|NCT00437658|26873990|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1|||
13425065|NCT00437658|26873988|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12|||
13425066|NCT00437658|26873989|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6|||
13425067|NCT00437658|26873990|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8|||
13425068|NCT00437658|26873988|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0|||
13425069|NCT00437658|26873989|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
13425070|NCT00437658|26873990|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
13425071|NCT00437658|26873988|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5|||
13425072|NCT00437658|26873989|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0|||
13425073|NCT00437658|26873990|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1|||
13425074|NCT00437658|26873988|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3|||
13425075|NCT00437658|26873989|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
13425076|NCT00437658|26873990|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
13425077|NCT00437645|26874011|FG000|Overall Study|Adverse Event|15|||
13425078|NCT00437645|26874012|FG001|Overall Study|Adverse Event|84|||
13425079|NCT00437645|26874011|FG000|Overall Study|Withdrawal by Subject|10|||
13425080|NCT00437645|26874012|FG001|Overall Study|Withdrawal by Subject|22|||
13425081|NCT00437645|26874011|FG000|Overall Study|Protocol Violation|3|||
13425082|NCT00437645|26874012|FG001|Overall Study|Protocol Violation|3|||
13425083|NCT00437645|26874011|FG000|Overall Study|Lost to Follow-up|2|||
13425084|NCT00437645|26874012|FG001|Overall Study|Lost to Follow-up|3|||
13425085|NCT00437645|26874011|FG000|Overall Study|Administrative problems|2|||
13425086|NCT00437645|26874012|FG001|Overall Study|Administrative problems|1|||
13425087|NCT00437645|26874011|FG000|Overall Study|Lack of Efficacy|2|||
13425088|NCT00437645|26874012|FG001|Overall Study|Lack of Efficacy|1|||
13425089|NCT00437645|26874011|FG000|Overall Study|Condition no longer requires study drug|1|||
13425090|NCT00437645|26874012|FG001|Overall Study|Condition no longer requires study drug|1|||
13425091|NCT00437489|26874031|FG000|Overall Study|Study terminated by sponsor|23|||
13425092|NCT00437489|26874032|FG001|Overall Study|Study terminated by sponsor|21|||
13425093|NCT00437489|26874031|FG000|Overall Study|Lost to Follow-up|0|||
13425094|NCT00437489|26874032|FG001|Overall Study|Lost to Follow-up|1|||
13425095|NCT00437294|26874060|FG000|Overall Study|Adverse Event|5|||
13425096|NCT00437294|26874061|FG001|Overall Study|Adverse Event|4|||
13425097|NCT00437294|26874060|FG000|Overall Study|Death|5|||
13425098|NCT00437294|26874061|FG001|Overall Study|Death|2|||
13425099|NCT00437294|26874060|FG000|Overall Study|Physician Decision|0|||
13425100|NCT00437294|26874061|FG001|Overall Study|Physician Decision|3|||
13425101|NCT00437294|26874060|FG000|Overall Study|Withdrawal by Subject|5|||
13425102|NCT00437294|26874061|FG001|Overall Study|Withdrawal by Subject|0|||
13425103|NCT00437294|26874060|FG000|Overall Study|Progressive Disease|19|||
13425104|NCT00437294|26874061|FG001|Overall Study|Progressive Disease|23|||
13425105|NCT00437294|26874060|FG000|Overall Study|Sponsor Decision|8|||
13425106|NCT00437294|26874061|FG001|Overall Study|Sponsor Decision|9|||
13425107|NCT00437294|26874060|FG000|Overall Study|Protocol Violation|0|||
13425108|NCT00437294|26874061|FG001|Overall Study|Protocol Violation|1|||
13425109|NCT00437294|26874060|FG000|Overall Study|Entry criteria not met|1|||
13425110|NCT00437294|26874061|FG001|Overall Study|Entry criteria not met|1|||
13425111|NCT00437281|26874416|FG000|Overall Study|Adverse Event|0|||
13425112|NCT00437281|26874417|FG001|Overall Study|Adverse Event|0|||
13425113|NCT00437281|26874418|FG002|Overall Study|Adverse Event|0|||
13425114|NCT00437281|26874419|FG003|Overall Study|Adverse Event|1|||
13425115|NCT00437281|26874420|FG004|Overall Study|Adverse Event|0|||
13425116|NCT00437281|26874421|FG005|Overall Study|Adverse Event|1|||
13425117|NCT00437281|26874422|FG006|Overall Study|Adverse Event|0|||
13425118|NCT00437281|26874423|FG007|Overall Study|Adverse Event|0|||
13425119|NCT00437281|26874424|FG008|Overall Study|Adverse Event|0|||
13425120|NCT00437281|26874425|FG009|Overall Study|Adverse Event|1|||
13425121|NCT00437281|26874426|FG010|Overall Study|Adverse Event|0|||
13425122|NCT00437281|26874427|FG011|Overall Study|Adverse Event|0|||
13425123|NCT00437281|26874428|FG012|Overall Study|Adverse Event|0|||
13425124|NCT00437281|26874429|FG013|Overall Study|Adverse Event|1|||
13425125|NCT00437281|26874430|FG014|Overall Study|Adverse Event|1|||
13425126|NCT00437281|26874431|FG015|Overall Study|Adverse Event|0|||
13425127|NCT00437281|26874432|FG016|Overall Study|Adverse Event|0|||
13425128|NCT00437281|26874433|FG017|Overall Study|Adverse Event|0|||
13425129|NCT00437281|26874434|FG018|Overall Study|Adverse Event|1|||
13425130|NCT00437281|26874435|FG019|Overall Study|Adverse Event|0|||
13425131|NCT00437281|26874416|FG000|Overall Study|Lost to Follow-up|0|||
13425132|NCT00437281|26874417|FG001|Overall Study|Lost to Follow-up|0|||
13425133|NCT00437281|26874418|FG002|Overall Study|Lost to Follow-up|0|||
13425134|NCT00437281|26874419|FG003|Overall Study|Lost to Follow-up|0|||
13425135|NCT00437281|26874420|FG004|Overall Study|Lost to Follow-up|0|||
13425136|NCT00437281|26874421|FG005|Overall Study|Lost to Follow-up|0|||
13425137|NCT00437281|26874422|FG006|Overall Study|Lost to Follow-up|0|||
13425138|NCT00437281|26874423|FG007|Overall Study|Lost to Follow-up|0|||
13425139|NCT00437281|26874424|FG008|Overall Study|Lost to Follow-up|0|||
13425140|NCT00437281|26874425|FG009|Overall Study|Lost to Follow-up|0|||
13425141|NCT00437281|26874426|FG010|Overall Study|Lost to Follow-up|0|||
13425142|NCT00437281|26874427|FG011|Overall Study|Lost to Follow-up|0|||
13425143|NCT00437281|26874428|FG012|Overall Study|Lost to Follow-up|0|||
13425144|NCT00437281|26874429|FG013|Overall Study|Lost to Follow-up|0|||
13425145|NCT00437281|26874430|FG014|Overall Study|Lost to Follow-up|0|||
13425146|NCT00437281|26874431|FG015|Overall Study|Lost to Follow-up|0|||
13425147|NCT00437281|26874432|FG016|Overall Study|Lost to Follow-up|0|||
13425148|NCT00437281|26874433|FG017|Overall Study|Lost to Follow-up|0|||
13425149|NCT00437281|26874434|FG018|Overall Study|Lost to Follow-up|0|||
13425150|NCT00437281|26874435|FG019|Overall Study|Lost to Follow-up|1|||
13425151|NCT00437268|26874458|FG000|Overall Study|Adverse Event|1|||
13425152|NCT00437268|26874459|FG001|Overall Study|Adverse Event|1|||
13425153|NCT00437268|26874458|FG000|Overall Study|Withdrawal by Subject|2|||
13425154|NCT00437268|26874459|FG001|Overall Study|Withdrawal by Subject|2|||
13425155|NCT00437268|26874458|FG000|Overall Study|Progressive disease|9|||
13425156|NCT00437268|26874459|FG001|Overall Study|Progressive disease|9|||
13425157|NCT00437268|26874458|FG000|Overall Study|Physician Decision|1|||
13425158|NCT00437268|26874459|FG001|Overall Study|Physician Decision|0|||
13425159|NCT00437268|26874458|FG000|Overall Study|Death|0|||
13425160|NCT00437268|26874459|FG001|Overall Study|Death|1|||
13425161|NCT00437203|26874594|FG000|Overall Study|Death|0|||
13425162|NCT00437203|26874595|FG001|Overall Study|Death|0|||
13425163|NCT00437203|26874596|FG002|Overall Study|Death|1|||
13425164|NCT00437203|26874597|FG003|Overall Study|Death|0|||
13425165|NCT00437203|26874598|FG004|Overall Study|Death|0|||
13425166|NCT00437203|26874599|FG005|Overall Study|Death|0|||
13425167|NCT00437203|26874600|FG006|Overall Study|Death|0|||
13425168|NCT00437203|26874601|FG007|Overall Study|Death|1|||
13425169|NCT00437203|26874602|FG008|Overall Study|Death|0|||
13425170|NCT00437203|26874603|FG009|Overall Study|Death|1|||
13425171|NCT00437203|26874594|FG000|Overall Study|Adverse Event|1|||
13425172|NCT00437203|26874595|FG001|Overall Study|Adverse Event|1|||
13425173|NCT00437203|26874596|FG002|Overall Study|Adverse Event|0|||
13425174|NCT00437203|26874597|FG003|Overall Study|Adverse Event|0|||
13425175|NCT00437203|26874598|FG004|Overall Study|Adverse Event|0|||
13425176|NCT00437203|26874599|FG005|Overall Study|Adverse Event|0|||
13425177|NCT00437203|26874600|FG006|Overall Study|Adverse Event|0|||
13425178|NCT00437203|26874601|FG007|Overall Study|Adverse Event|1|||
13425179|NCT00437203|26874602|FG008|Overall Study|Adverse Event|0|||
13425180|NCT00437203|26874603|FG009|Overall Study|Adverse Event|1|||
13425181|NCT00437203|26874594|FG000|Overall Study|Study terminated by sponsor|0|||
13425182|NCT00437203|26874595|FG001|Overall Study|Study terminated by sponsor|0|||
13425183|NCT00437203|26874596|FG002|Overall Study|Study terminated by sponsor|0|||
13425184|NCT00437203|26874597|FG003|Overall Study|Study terminated by sponsor|0|||
13425185|NCT00437203|26874598|FG004|Overall Study|Study terminated by sponsor|0|||
13425186|NCT00437203|26874599|FG005|Overall Study|Study terminated by sponsor|0|||
13425187|NCT00437203|26874600|FG006|Overall Study|Study terminated by sponsor|0|||
13425188|NCT00437203|26874601|FG007|Overall Study|Study terminated by sponsor|0|||
13425189|NCT00437203|26874602|FG008|Overall Study|Study terminated by sponsor|1|||
13425190|NCT00437203|26874603|FG009|Overall Study|Study terminated by sponsor|0|||
13425191|NCT00437203|26874594|FG000|Overall Study|Objective progression or relapse|5|||
13425192|NCT00437203|26874595|FG001|Overall Study|Objective progression or relapse|6|||
13425193|NCT00437203|26874596|FG002|Overall Study|Objective progression or relapse|2|||
13425194|NCT00437203|26874597|FG003|Overall Study|Objective progression or relapse|3|||
13425195|NCT00437203|26874598|FG004|Overall Study|Objective progression or relapse|3|||
13425196|NCT00437203|26874599|FG005|Overall Study|Objective progression or relapse|3|||
13425197|NCT00437203|26874600|FG006|Overall Study|Objective progression or relapse|6|||
13425198|NCT00437203|26874601|FG007|Overall Study|Objective progression or relapse|1|||
13425199|NCT00437203|26874602|FG008|Overall Study|Objective progression or relapse|2|||
13425200|NCT00437203|26874603|FG009|Overall Study|Objective progression or relapse|2|||
13425201|NCT00437203|26874594|FG000|Overall Study|Other|0|||
13425202|NCT00437203|26874595|FG001|Overall Study|Other|1|||
13425203|NCT00437203|26874596|FG002|Overall Study|Other|0|||
13425204|NCT00437203|26874597|FG003|Overall Study|Other|0|||
13425205|NCT00437203|26874598|FG004|Overall Study|Other|0|||
13425206|NCT00437203|26874599|FG005|Overall Study|Other|0|||
13425207|NCT00437203|26874600|FG006|Overall Study|Other|1|||
13425208|NCT00437203|26874601|FG007|Overall Study|Other|0|||
13425209|NCT00437203|26874602|FG008|Overall Study|Other|0|||
13425210|NCT00437203|26874603|FG009|Overall Study|Other|0|||
13425211|NCT00437125|26874624|FG000|Overall Study|Adverse Event|12|||
13425212|NCT00437125|26874624|FG000|Overall Study|Death|1|||
13425213|NCT00437125|26874624|FG000|Overall Study|Clinical Relapse|1|||
13425214|NCT00437125|26874624|FG000|Overall Study|Lack of Efficacy|1|||
13425215|NCT00437125|26874624|FG000|Overall Study|Lost to Follow-up|1|||
13425216|NCT00437125|26874624|FG000|Overall Study|Withdrawal by Subject|13|||
13425217|NCT00437125|26874624|FG000|Overall Study|Withdrawal by Caregiver|2|||
13425218|NCT00437125|26874624|FG000|Overall Study|Physician Decision|1|||
13425219|NCT00437073|26874659|FG000|Overall Study|Sponsor Terminated Study|1|||
13425220|NCT00437073|26874660|FG001|Overall Study|Sponsor Terminated Study|0|||
13425221|NCT00437073|26874659|FG000|Overall Study|Physician Decision|0|||
13425222|NCT00437073|26874660|FG001|Overall Study|Physician Decision|1|||
13425223|NCT00437034|26874673|FG000|Overall Study|Adverse Event|1|||
13425224|NCT00437034|26874673|FG000|Overall Study|Disease progression during treatment|5|||
13425225|NCT00436982|26874700|FG000|Overall Study|Withdrawal by Subject|3|||
13425226|NCT00436982|26874701|FG001|Overall Study|Withdrawal by Subject|1|||
13425227|NCT00436982|26874700|FG000|Overall Study|Did not receive allocated intervention|0|||
13425228|NCT00436982|26874701|FG001|Overall Study|Did not receive allocated intervention|1|||
13425229|NCT00436982|26874700|FG000|Overall Study|no RSA data|1|||
13425230|NCT00436982|26874701|FG001|Overall Study|no RSA data|2|||
13425231|NCT00436956|26874718|FG000|Overall Study|Not evaluable|1|||
13425232|NCT00436956|26874719|FG001|Overall Study|Not evaluable|0|||
13425233|NCT00436917|26874736|FG000|Overall Study|Withdrawal by Subject|13|||
13425234|NCT00436917|26874736|FG000|Overall Study|Adverse Event|2|||
13425235|NCT00436917|26874736|FG000|Overall Study|Physician Decision|1|||
13425236|NCT00436917|26874736|FG000|Overall Study|Death|1|||
13425237|NCT00436917|26874736|FG000|Overall Study|Lost to Follow-up|1|||
13425238|NCT00436917|26874736|FG000|Overall Study|Treatment for polymyalgia rheumatic|1|||
13425239|NCT00436917|26874736|FG000|Overall Study|Increased creatinine|1|||
13425240|NCT00436917|26874736|FG000|Overall Study|Personal conflicts of patient|1|||
13425241|NCT00436852|26874760|FG000|Overall Study|Death|23|||
13425242|NCT00436852|26874761|FG001|Overall Study|Death|34|||
13425243|NCT00436852|26874760|FG000|Overall Study|Lack of Efficacy|9|||
13425244|NCT00436852|26874761|FG001|Overall Study|Lack of Efficacy|7|||
13425245|NCT00436852|26874760|FG000|Overall Study|Withdrawal by Subject|2|||
13425246|NCT00436852|26874761|FG001|Overall Study|Withdrawal by Subject|4|||
13425247|NCT00436852|26874760|FG000|Overall Study|Ineligible|1|||
13425248|NCT00436852|26874761|FG001|Overall Study|Ineligible|0|||
13425249|NCT00436826|26874868|FG000|Double Blind Period (DBP)|Adverse Event|2|||
13425250|NCT00436826|26874869|FG001|Double Blind Period (DBP)|Adverse Event|0|||
13425251|NCT00436826|26874870|FG002|Double Blind Period (DBP)|Adverse Event|0|||
13425252|NCT00436826|26874871|FG003|Double Blind Period (DBP)|Adverse Event|0|||
13425253|NCT00436826|26874872|FG004|Double Blind Period (DBP)|Adverse Event|0|||
13425254|NCT00436826|26874873|FG005|Double Blind Period (DBP)|Adverse Event|0|||
13425255|NCT00436826|26874868|FG000|Double Blind Period (DBP)|Protocol Violation|1|||
13425256|NCT00436826|26874869|FG001|Double Blind Period (DBP)|Protocol Violation|0|||
13425257|NCT00436826|26874870|FG002|Double Blind Period (DBP)|Protocol Violation|0|||
13425258|NCT00436826|26874871|FG003|Double Blind Period (DBP)|Protocol Violation|0|||
13425259|NCT00436826|26874872|FG004|Double Blind Period (DBP)|Protocol Violation|0|||
13425260|NCT00436826|26874873|FG005|Double Blind Period (DBP)|Protocol Violation|0|||
13425261|NCT00436826|26874868|FG000|Double Blind Period (DBP)|Other|10|||
13425262|NCT00436826|26874869|FG001|Double Blind Period (DBP)|Other|11|||
13425263|NCT00436826|26874870|FG002|Double Blind Period (DBP)|Other|0|||
13425264|NCT00436826|26874871|FG003|Double Blind Period (DBP)|Other|0|||
13425265|NCT00436826|26874872|FG004|Double Blind Period (DBP)|Other|0|||
13425266|NCT00436826|26874873|FG005|Double Blind Period (DBP)|Other|0|||
13425267|NCT00436826|26874868|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
13425268|NCT00436826|26874869|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
13425269|NCT00436826|26874870|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
13425270|NCT00436826|26874871|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1|||
13425271|NCT00436826|26874872|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
13425272|NCT00436826|26874873|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
13425273|NCT00436826|26874868|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
13425274|NCT00436826|26874869|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
13425275|NCT00436826|26874870|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46|||
13425276|NCT00436826|26874871|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25|||
13425277|NCT00436826|26874872|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
13425278|NCT00436826|26874873|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
13425279|NCT00436826|26874868|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
13425280|NCT00436826|26874869|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
13425281|NCT00436826|26874870|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
13425282|NCT00436826|26874871|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
13425283|NCT00436826|26874872|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51|||
13425284|NCT00436826|26874873|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7|||
13425285|NCT00436644|26874882|FG000|Overall Study|Adverse Event|2|||
13425286|NCT00436644|26874882|FG000|Overall Study|Death|1|||
13425287|NCT00436618|26874909|FG000|Overall Study|Withdrawal by Subject|5|||
13425288|NCT00436618|26874910|FG001|Overall Study|Withdrawal by Subject|8|||
13425289|NCT00436618|26874911|FG002|Overall Study|Withdrawal by Subject|11|||
13425290|NCT00436618|26874909|FG000|Overall Study|Adverse Event|8|||
13425291|NCT00436618|26874910|FG001|Overall Study|Adverse Event|8|||
13425292|NCT00436618|26874911|FG002|Overall Study|Adverse Event|9|||
13425293|NCT00436618|26874909|FG000|Overall Study|Alternate Treatment|3|||
13425294|NCT00436618|26874910|FG001|Overall Study|Alternate Treatment|4|||
13425295|NCT00436618|26874911|FG002|Overall Study|Alternate Treatment|12|||
13425296|NCT00436618|26874909|FG000|Overall Study|Other Medical Problems|3|||
13425297|NCT00436618|26874910|FG001|Overall Study|Other Medical Problems|1|||
13425298|NCT00436618|26874911|FG002|Overall Study|Other Medical Problems|7|||
13425299|NCT00436618|26874909|FG000|Overall Study|Death|4|||
13425300|NCT00436618|26874910|FG001|Overall Study|Death|2|||
13425301|NCT00436618|26874911|FG002|Overall Study|Death|3|||
13425302|NCT00436618|26874909|FG000|Overall Study|New Primary or Other Reasons|6|||
13425303|NCT00436618|26874910|FG001|Overall Study|New Primary or Other Reasons|2|||
13425304|NCT00436618|26874911|FG002|Overall Study|New Primary or Other Reasons|12|||
13425305|NCT00436618|26874909|FG000|Overall Study|Still on treatment|1|||
13425306|NCT00436618|26874910|FG001|Overall Study|Still on treatment|2|||
13425307|NCT00436618|26874911|FG002|Overall Study|Still on treatment|7|||
13425308|NCT00436605|26874918|FG000|Overall Study|Protocol Violation|3|||
13425309|NCT00436566|26874932|FG000|Overall Study|Withdrawal by Subject|2|||
13425310|NCT00436566|26874932|FG000|Overall Study|Protocol Violation|1|||
13425311|NCT00436553|26874961|FG000|Overall Study|Adverse Event|4|||
13425312|NCT00436553|26874962|FG001|Overall Study|Adverse Event|3|||
13425313|NCT00436553|26874963|FG002|Overall Study|Adverse Event|4|||
13425314|NCT00436553|26874961|FG000|Overall Study|Death|3|||
13425315|NCT00436553|26874962|FG001|Overall Study|Death|1|||
13425316|NCT00436553|26874963|FG002|Overall Study|Death|3|||
13425317|NCT00436553|26874961|FG000|Overall Study|Lost to Follow-up|0|||
13425318|NCT00436553|26874962|FG001|Overall Study|Lost to Follow-up|2|||
13425319|NCT00436553|26874963|FG002|Overall Study|Lost to Follow-up|0|||
13425320|NCT00436553|26874961|FG000|Overall Study|Protocol Violation|1|||
13425321|NCT00436553|26874962|FG001|Overall Study|Protocol Violation|0|||
13425322|NCT00436553|26874963|FG002|Overall Study|Protocol Violation|0|||
13425323|NCT00436553|26874961|FG000|Overall Study|Withdrawal by Subject|5|||
13425324|NCT00436553|26874962|FG001|Overall Study|Withdrawal by Subject|6|||
13425325|NCT00436553|26874963|FG002|Overall Study|Withdrawal by Subject|3|||
13425326|NCT00436501|26874985|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0|||
13425327|NCT00436501|26874986|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2|||
13425328|NCT00436501|26874985|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0|||
13425329|NCT00436501|26874986|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1|||
13425330|NCT00436436|26874997|FG000|Overall Study|Progression|4|||
13425331|NCT00436436|26874997|FG000|Overall Study|Adverse Event|2|||
13425332|NCT00436436|26874997|FG000|Overall Study|Death|6|||
13425333|NCT00436345|26875057|FG000|Overall Study|ICU resident beyond follow-up period|3|||
13425334|NCT00436345|26875058|FG001|Overall Study|ICU resident beyond follow-up period|0|||
13425335|NCT00436332|26875067|FG000|Overall Study|Adverse Event|9|||
13425336|NCT00436332|26875067|FG000|Overall Study|Withdrawal by Subject|2|||
13425337|NCT00436332|26875067|FG000|Overall Study|Progression|59|||
13425338|NCT00436332|26875067|FG000|Overall Study|Death|2|||
13425339|NCT00436332|26875067|FG000|Overall Study|Not Protocol Specified|6|||
13425340|NCT00436332|26875067|FG000|Overall Study|Ineligible|2|||
13425341|NCT00436332|26875067|FG000|Overall Study|Never Received Treatment|3|||
13425342|NCT00436280|26875083|FG000|Period 1: Induction|Adverse Event|8|||
13425343|NCT00436280|26875083|FG000|Period 1: Induction|Progressive Disease|12|||
13425344|NCT00436280|26875083|FG000|Period 1: Induction|Stable Disease|6|||
13425345|NCT00436280|26875083|FG000|Period 1: Induction|Withdrawal by Subject|1|||
13425346|NCT00436280|26875083|FG000|Period 1: Induction|Death|1|||
13425347|NCT00436280|26875083|FG000|Period 2: Consolidation|Adverse Event|1|||
13425348|NCT00436280|26875083|FG000|Period 2: Consolidation|Progressive Disease|10|||
13425349|NCT00436280|26875083|FG000|Period 2: Consolidation|Stable Disease|1|||
13425350|NCT00436280|26875083|FG000|Period 2: Consolidation|Physician Decision|2|||
13425351|NCT00436280|26875083|FG000|Period 2: Consolidation|Withdrawal by Subject|2|||
13425352|NCT00436280|26875083|FG000|Period 2: Consolidation|Death|1|||
13425353|NCT00436280|26875083|FG000|Period 3: Maintenance|Adverse Event|6|||
13425354|NCT00436280|26875083|FG000|Period 3: Maintenance|Progressive Disease|12|||
13425355|NCT00436215|26875091|FG000|Overall Study|Refused further treatment|3|||
13425356|NCT00436215|26875091|FG000|Overall Study|Small bowel obstruction|1|||
13425357|NCT00436163|26875104|FG000|Overall Study|Lost to Follow-up|2|||
13425358|NCT00436163|26875104|FG000|Overall Study|Adverse Event|1|||
13425359|NCT00436007|26875159|FG000|Overall Study|Withdrawal by Subject|5|||
13425360|NCT00436007|26875160|FG001|Overall Study|Withdrawal by Subject|3|||
13425361|NCT00436007|26875161|FG002|Overall Study|Withdrawal by Subject|4|||
13425362|NCT00436007|26875159|FG000|Overall Study|Lost to Follow-up|14|||
13425363|NCT00436007|26875160|FG001|Overall Study|Lost to Follow-up|10|||
13425364|NCT00436007|26875161|FG002|Overall Study|Lost to Follow-up|13|||
13425365|NCT00436007|26875159|FG000|Overall Study|Physician Decision|0|||
13425366|NCT00436007|26875160|FG001|Overall Study|Physician Decision|0|||
13425367|NCT00436007|26875161|FG002|Overall Study|Physician Decision|2|||
13425368|NCT00436007|26875159|FG000|Overall Study|Death|0|||
13425369|NCT00436007|26875160|FG001|Overall Study|Death|1|||
13425370|NCT00436007|26875161|FG002|Overall Study|Death|3|||
13425371|NCT00436007|26875159|FG000|Overall Study|Other|0|||
13425372|NCT00436007|26875160|FG001|Overall Study|Other|0|||
13425373|NCT00436007|26875161|FG002|Overall Study|Other|1|||
13425374|NCT00435994|26875180|FG000|Overall Study|Lost to Follow-up|7|||
13425375|NCT00435994|26875181|FG001|Overall Study|Lost to Follow-up|0|||
13425376|NCT00435994|26875182|FG002|Overall Study|Lost to Follow-up|0|||
13425377|NCT00435942|26875196|FG000|Overall Study|Death|17|||
13425378|NCT00435942|26875197|FG001|Overall Study|Death|10|||
13425379|NCT00435942|26875196|FG000|Overall Study|Withdrawal by Subject|2|||
13425380|NCT00435942|26875197|FG001|Overall Study|Withdrawal by Subject|0|||
13425381|NCT00435942|26875196|FG000|Overall Study|Lost to Follow-up|0|||
13425382|NCT00435942|26875197|FG001|Overall Study|Lost to Follow-up|16|||
13425383|NCT00435942|26875196|FG000|Overall Study|Conversion to Open Repair|1|||
13425384|NCT00435942|26875197|FG001|Overall Study|Conversion to Open Repair|0|||
13425385|NCT00435942|26875196|FG000|Overall Study|Technical Failure|3|||
13425386|NCT00435942|26875197|FG001|Overall Study|Technical Failure|0|||
13425387|NCT00435942|26875196|FG000|Overall Study|Other|0|||
13425388|NCT00435942|26875197|FG001|Overall Study|Other|1|||
13425389|NCT00435825|26875264|FG000|Overall Study|Abnormality of Laboratory Test|0|||
13425390|NCT00435825|26875265|FG001|Overall Study|Abnormality of Laboratory Test|1|||
13425391|NCT00435825|26875266|FG002|Overall Study|Abnormality of Laboratory Test|0|||
13425392|NCT00435825|26875267|FG003|Overall Study|Abnormality of Laboratory Test|0|||
13425393|NCT00435825|26875264|FG000|Overall Study|Insufficient Therapeutic Response|3|||
13425394|NCT00435825|26875265|FG001|Overall Study|Insufficient Therapeutic Response|1|||
13425395|NCT00435825|26875266|FG002|Overall Study|Insufficient Therapeutic Response|0|||
13425396|NCT00435825|26875267|FG003|Overall Study|Insufficient Therapeutic Response|3|||
13425397|NCT00435825|26875264|FG000|Overall Study|Other Protocol Violation|1|||
13425398|NCT00435825|26875265|FG001|Overall Study|Other Protocol Violation|0|||
13425399|NCT00435825|26875266|FG002|Overall Study|Other Protocol Violation|0|||
13425400|NCT00435825|26875267|FG003|Overall Study|Other Protocol Violation|0|||
13425401|NCT00435825|26875264|FG000|Overall Study|Refused treatment|2|||
13425402|NCT00435825|26875265|FG001|Overall Study|Refused treatment|0|||
13425403|NCT00435825|26875266|FG002|Overall Study|Refused treatment|0|||
13425404|NCT00435825|26875267|FG003|Overall Study|Refused treatment|5|||
13425405|NCT00435825|26875264|FG000|Overall Study|Failure to return|5|||
13425406|NCT00435825|26875265|FG001|Overall Study|Failure to return|0|||
13425407|NCT00435825|26875266|FG002|Overall Study|Failure to return|4|||
13425408|NCT00435825|26875267|FG003|Overall Study|Failure to return|0|||
13425409|NCT00435825|26875264|FG000|Overall Study|Did not receive study drug|1|||
13425410|NCT00435825|26875265|FG001|Overall Study|Did not receive study drug|0|||
13425411|NCT00435825|26875266|FG002|Overall Study|Did not receive study drug|2|||
13425412|NCT00435825|26875267|FG003|Overall Study|Did not receive study drug|0|||
13425413|NCT00435825|26875264|FG000|Overall Study|Did not enter follow-up|0|||
13425414|NCT00435825|26875265|FG001|Overall Study|Did not enter follow-up|4|||
13425415|NCT00435825|26875266|FG002|Overall Study|Did not enter follow-up|1|||
13425416|NCT00435825|26875267|FG003|Overall Study|Did not enter follow-up|3|||
13425417|NCT00435825|26875264|FG000|Overall Study|Did not complete full follow-up period|6|||
13425418|NCT00435825|26875265|FG001|Overall Study|Did not complete full follow-up period|6|||
13425419|NCT00435825|26875266|FG002|Overall Study|Did not complete full follow-up period|4|||
13425420|NCT00435825|26875267|FG003|Overall Study|Did not complete full follow-up period|5|||
13425421|NCT00435487|26875290|FG000|Overall Study|Death|3|||
13425422|NCT00435487|26875291|FG001|Overall Study|Death|4|||
13425423|NCT00435487|26875290|FG000|Overall Study|Adverse Event|0|||
13425424|NCT00435487|26875291|FG001|Overall Study|Adverse Event|3|||
13425425|NCT00435487|26875290|FG000|Overall Study|Lost to Follow-up|2|||
13425426|NCT00435487|26875291|FG001|Overall Study|Lost to Follow-up|2|||
13425427|NCT00435487|26875290|FG000|Overall Study|Other|5|||
13425428|NCT00435487|26875291|FG001|Overall Study|Other|2|||
13425429|NCT00435487|26875290|FG000|Overall Study|Withdrawal by Subject|2|||
13425430|NCT00435487|26875291|FG001|Overall Study|Withdrawal by Subject|1|||
13425431|NCT00435487|26875290|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0|||
13425432|NCT00435487|26875291|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2|||
13425433|NCT00435487|26875290|FG000|Overall Study|Received Drug in Other Treatment Group|0|||
13425434|NCT00435487|26875291|FG001|Overall Study|Received Drug in Other Treatment Group|1|||
13425435|NCT00435461|26875336|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1|||
13425436|NCT00435461|26875337|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
13425437|NCT00435461|26875338|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
13425438|NCT00435461|26875336|FG000|Overall Study|Protocol Violation|6|||
13425439|NCT00435461|26875337|FG001|Overall Study|Protocol Violation|9|||
13425440|NCT00435461|26875338|FG002|Overall Study|Protocol Violation|10|||
13425441|NCT00435461|26875336|FG000|Overall Study|Participant randomized(inadequate score)|1|||
13425442|NCT00435461|26875337|FG001|Overall Study|Participant randomized(inadequate score)|0|||
13425443|NCT00435461|26875338|FG002|Overall Study|Participant randomized(inadequate score)|0|||
13425444|NCT00435461|26875336|FG000|Overall Study|Compliance less than 80 percent|1|||
13425445|NCT00435461|26875337|FG001|Overall Study|Compliance less than 80 percent|0|||
13425446|NCT00435461|26875338|FG002|Overall Study|Compliance less than 80 percent|0|||
13425447|NCT00435461|26875336|FG000|Overall Study|In error, two study medications switched|1|||
13425448|NCT00435461|26875337|FG001|Overall Study|In error, two study medications switched|0|||
13425449|NCT00435461|26875338|FG002|Overall Study|In error, two study medications switched|0|||
13425450|NCT00435461|26875336|FG000|Overall Study|Lack of Efficacy|2|||
13425451|NCT00435461|26875337|FG001|Overall Study|Lack of Efficacy|1|||
13425452|NCT00435461|26875338|FG002|Overall Study|Lack of Efficacy|0|||
13425453|NCT00435461|26875336|FG000|Overall Study|Withdrawal by Subject|1|||
13425454|NCT00435461|26875337|FG001|Overall Study|Withdrawal by Subject|0|||
13425455|NCT00435461|26875338|FG002|Overall Study|Withdrawal by Subject|2|||
13425456|NCT00435461|26875336|FG000|Overall Study|Randomized in error|1|||
13425457|NCT00435461|26875337|FG001|Overall Study|Randomized in error|0|||
13425458|NCT00435461|26875338|FG002|Overall Study|Randomized in error|0|||
13425459|NCT00435461|26875336|FG000|Overall Study|Participant could not tolerate symptoms|0|||
13425460|NCT00435461|26875337|FG001|Overall Study|Participant could not tolerate symptoms|0|||
13425461|NCT00435461|26875338|FG002|Overall Study|Participant could not tolerate symptoms|1|||
13425462|NCT00435461|26875336|FG000|Overall Study|Participant could not swallow capsule|0|||
13425463|NCT00435461|26875337|FG001|Overall Study|Participant could not swallow capsule|0|||
13425464|NCT00435461|26875338|FG002|Overall Study|Participant could not swallow capsule|1|||
13425465|NCT00435461|26875336|FG000|Overall Study|Pregnancy|2|||
13425466|NCT00435461|26875337|FG001|Overall Study|Pregnancy|0|||
13425467|NCT00435461|26875338|FG002|Overall Study|Pregnancy|0|||
13425468|NCT00435461|26875336|FG000|Overall Study|Participant moved eDiary,studymedication|1|||
13425469|NCT00435461|26875337|FG001|Overall Study|Participant moved eDiary,studymedication|0|||
13425470|NCT00435461|26875338|FG002|Overall Study|Participant moved eDiary,studymedication|0|||
13425471|NCT00435461|26875336|FG000|Overall Study|Participant ended study one day early|1|||
13425472|NCT00435461|26875337|FG001|Overall Study|Participant ended study one day early|0|||
13425473|NCT00435461|26875338|FG002|Overall Study|Participant ended study one day early|0|||
13425474|NCT00435461|26875336|FG000|Overall Study|Noncompliance with study requirements|1|||
13425475|NCT00435461|26875337|FG001|Overall Study|Noncompliance with study requirements|1|||
13425476|NCT00435461|26875338|FG002|Overall Study|Noncompliance with study requirements|1|||
13425477|NCT00435461|26875336|FG000|Overall Study|Adverse Event|1|||
13425478|NCT00435461|26875337|FG001|Overall Study|Adverse Event|2|||
13425479|NCT00435461|26875338|FG002|Overall Study|Adverse Event|6|||
13425480|NCT00435461|26875336|FG000|Overall Study|Non-Compliance of diary|2|||
13425481|NCT00435461|26875337|FG001|Overall Study|Non-Compliance of diary|0|||
13425482|NCT00435461|26875338|FG002|Overall Study|Non-Compliance of diary|1|||
13425483|NCT00435461|26875336|FG000|Overall Study|Lost to Follow-up|1|||
13425484|NCT00435461|26875337|FG001|Overall Study|Lost to Follow-up|1|||
13425485|NCT00435461|26875338|FG002|Overall Study|Lost to Follow-up|2|||
13425486|NCT00435409|26875366|FG000|Overall Study|Protocol Violation|1|||
13425487|NCT00435409|26875367|FG001|Overall Study|Protocol Violation|2|||
13425488|NCT00435409|26875368|FG002|Overall Study|Protocol Violation|0|||
13425489|NCT00435409|26875366|FG000|Overall Study|Lost to Follow-up|1|||
13425490|NCT00435409|26875367|FG001|Overall Study|Lost to Follow-up|2|||
13425491|NCT00435409|26875368|FG002|Overall Study|Lost to Follow-up|0|||
13425492|NCT00435409|26875366|FG000|Overall Study|Death|8|||
13425493|NCT00435409|26875367|FG001|Overall Study|Death|6|||
13425494|NCT00435409|26875368|FG002|Overall Study|Death|6|||
13425495|NCT00435409|26875366|FG000|Overall Study|Objective progression or relapse|158|||
13425496|NCT00435409|26875367|FG001|Overall Study|Objective progression or relapse|93|||
13425497|NCT00435409|26875368|FG002|Overall Study|Objective progression or relapse|58|||
13425498|NCT00435409|26875366|FG000|Overall Study|Global deterioration of health status|0|||
13425499|NCT00435409|26875367|FG001|Overall Study|Global deterioration of health status|0|||
13425500|NCT00435409|26875368|FG002|Overall Study|Global deterioration of health status|4|||
13425501|NCT00435409|26875366|FG000|Overall Study|Withdrawal by Subject|8|||
13425502|NCT00435409|26875367|FG001|Overall Study|Withdrawal by Subject|7|||
13425503|NCT00435409|26875368|FG002|Overall Study|Withdrawal by Subject|1|||
13425504|NCT00435409|26875366|FG000|Overall Study|Other|45|||
13425505|NCT00435409|26875367|FG001|Overall Study|Other|30|||
13425506|NCT00435409|26875368|FG002|Overall Study|Other|1|||
13425507|NCT00435409|26875366|FG000|Overall Study|Adverse Event|0|||
13425508|NCT00435409|26875367|FG001|Overall Study|Adverse Event|0|||
13425509|NCT00435409|26875368|FG002|Overall Study|Adverse Event|8|||
13425510|NCT00435409|26875366|FG000|Overall Study|Sponsor decision|0|||
13425511|NCT00435409|26875367|FG001|Overall Study|Sponsor decision|3|||
13425512|NCT00435409|26875368|FG002|Overall Study|Sponsor decision|0|||
13425513|NCT00435370|26875381|FG000|Overall Study|Adverse Event|8|||
13425514|NCT00435370|26875382|FG001|Overall Study|Adverse Event|8|||
13425515|NCT00435370|26875381|FG000|Overall Study|Withdrawal by Subject|10|||
13425516|NCT00435370|26875382|FG001|Overall Study|Withdrawal by Subject|10|||
13425517|NCT00435370|26875381|FG000|Overall Study|Antipsychotic medication changed|4|||
13425518|NCT00435370|26875382|FG001|Overall Study|Antipsychotic medication changed|2|||
13425519|NCT00435188|26875429|FG000|Overall Study|Death|1|||
13425520|NCT00435188|26875430|FG001|Overall Study|Death|6|||
13425521|NCT00435188|26875429|FG000|Overall Study|Withdrawal by Subject|16|||
13425522|NCT00435188|26875430|FG001|Overall Study|Withdrawal by Subject|11|||
13425523|NCT00435188|26875429|FG000|Overall Study|Lost to Follow-up|5|||
13425524|NCT00435188|26875430|FG001|Overall Study|Lost to Follow-up|6|||
13425525|NCT00435162|26875461|FG000|Period 2 (2 Weeks)|Adverse Event|0|||
13425526|NCT00435162|26875462|FG001|Period 2 (2 Weeks)|Adverse Event|1|||
13425527|NCT00435162|26875463|FG002|Period 2 (2 Weeks)|Adverse Event|0|||
13425528|NCT00435162|26875464|FG003|Period 2 (2 Weeks)|Adverse Event|0|||
13425529|NCT00435162|26875465|FG004|Period 2 (2 Weeks)|Adverse Event|0|||
13425530|NCT00435162|26875466|FG005|Period 2 (2 Weeks)|Adverse Event|0|||
13425531|NCT00435045|26875527|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
13425532|NCT00435045|26875528|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
13425533|NCT00435045|26875527|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
13425534|NCT00435045|26875528|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
13425535|NCT00435045|26875527|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2|||
13425536|NCT00435045|26875528|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1|||
13425537|NCT00435045|26875527|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1|||
13425538|NCT00435045|26875528|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0|||
13425539|NCT00435045|26875527|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0|||
13425540|NCT00435045|26875528|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1|||
13425541|NCT00435045|26875527|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4|||
13425542|NCT00435045|26875528|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3|||
13425543|NCT00435045|26875527|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
13425544|NCT00435045|26875528|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
13425545|NCT00435045|26875527|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0|||
13425546|NCT00435045|26875528|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1|||
13425547|NCT00435045|26875527|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3|||
13425548|NCT00435045|26875528|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2|||
13425549|NCT00435045|26875527|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1|||
13425550|NCT00435045|26875528|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0|||
13425551|NCT00435045|26875527|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1|||
13425552|NCT00435045|26875528|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0|||
13425553|NCT00435019|26875545|FG000|Overall Study|Adverse Event|1|||
13425554|NCT00435019|26875546|FG001|Overall Study|Adverse Event|0|||
13425555|NCT00435019|26875545|FG000|Overall Study|Lack of Efficacy|1|||
13425556|NCT00435019|26875546|FG001|Overall Study|Lack of Efficacy|2|||
13425557|NCT00435019|26875545|FG000|Overall Study|Protocol Violation|3|||
13425558|NCT00435019|26875546|FG001|Overall Study|Protocol Violation|1|||
13425559|NCT00435019|26875545|FG000|Overall Study|Personal reasons for withdrawal|8|||
13425560|NCT00435019|26875546|FG001|Overall Study|Personal reasons for withdrawal|7|||
13425561|NCT00434967|26875577|FG000|Overall Study|Adverse Event|2|||
13425562|NCT00434967|26875578|FG001|Overall Study|Adverse Event|4|||
13425563|NCT00434967|26875579|FG002|Overall Study|Adverse Event|3|||
13425564|NCT00434967|26875580|FG003|Overall Study|Adverse Event|3|||
13425565|NCT00434967|26875577|FG000|Overall Study|Lost to Follow-up|0|||
13425566|NCT00434967|26875578|FG001|Overall Study|Lost to Follow-up|0|||
13425567|NCT00434967|26875579|FG002|Overall Study|Lost to Follow-up|1|||
13425568|NCT00434967|26875580|FG003|Overall Study|Lost to Follow-up|0|||
13425569|NCT00434967|26875577|FG000|Overall Study|Withdrawal by Subject|2|||
13425570|NCT00434967|26875578|FG001|Overall Study|Withdrawal by Subject|2|||
13425571|NCT00434967|26875579|FG002|Overall Study|Withdrawal by Subject|4|||
13425572|NCT00434967|26875580|FG003|Overall Study|Withdrawal by Subject|6|||
13425573|NCT00434967|26875577|FG000|Overall Study|Randomized in error|0|||
13425574|NCT00434967|26875578|FG001|Overall Study|Randomized in error|0|||
13425575|NCT00434967|26875579|FG002|Overall Study|Randomized in error|0|||
13425576|NCT00434967|26875580|FG003|Overall Study|Randomized in error|1|||
13425577|NCT00434967|26875577|FG000|Overall Study|Protocol Violation|0|||
13425578|NCT00434967|26875578|FG001|Overall Study|Protocol Violation|1|||
13425579|NCT00434967|26875579|FG002|Overall Study|Protocol Violation|0|||
13425580|NCT00434967|26875580|FG003|Overall Study|Protocol Violation|1|||
13425581|NCT00434967|26875577|FG000|Overall Study|Physician Decision|1|||
13425582|NCT00434967|26875578|FG001|Overall Study|Physician Decision|1|||
13425583|NCT00434967|26875579|FG002|Overall Study|Physician Decision|1|||
13425584|NCT00434967|26875580|FG003|Overall Study|Physician Decision|0|||
13425585|NCT00434967|26875577|FG000|Overall Study|Patient Disposition Challenges|2|||
13425586|NCT00434967|26875578|FG001|Overall Study|Patient Disposition Challenges|0|||
13425587|NCT00434967|26875579|FG002|Overall Study|Patient Disposition Challenges|0|||
13425588|NCT00434967|26875580|FG003|Overall Study|Patient Disposition Challenges|3|||
13425589|NCT00434954|26875615|FG000|Overall Study|Adverse Event|17|||
13425590|NCT00434954|26875616|FG001|Overall Study|Adverse Event|2|||
13425591|NCT00434954|26875615|FG000|Overall Study|Entry criteria not met|14|||
13425592|NCT00434954|26875616|FG001|Overall Study|Entry criteria not met|16|||
13425593|NCT00434954|26875615|FG000|Overall Study|Lost to Follow-up|0|||
13425594|NCT00434954|26875616|FG001|Overall Study|Lost to Follow-up|1|||
13425595|NCT00434954|26875615|FG000|Overall Study|Physician Decision|6|||
13425596|NCT00434954|26875616|FG001|Overall Study|Physician Decision|3|||
13425597|NCT00434954|26875615|FG000|Overall Study|Protocol Violation|36|||
13425598|NCT00434954|26875616|FG001|Overall Study|Protocol Violation|27|||
13425599|NCT00434954|26875615|FG000|Overall Study|Sponsor decision|1|||
13425600|NCT00434954|26875616|FG001|Overall Study|Sponsor decision|0|||
13425601|NCT00434954|26875615|FG000|Overall Study|Subject decision|8|||
13425602|NCT00434954|26875616|FG001|Overall Study|Subject decision|22|||
13425603|NCT00434876|26875635|FG000|Overall Study|Lost to Follow-up|1|||
13425604|NCT00434876|26875636|FG001|Overall Study|Lost to Follow-up|1|||
13425605|NCT00434759|26875657|FG000|Overall Study|Lack of Efficacy|5|||
13425606|NCT00434759|26875658|FG001|Overall Study|Lack of Efficacy|4|||
13425607|NCT00434759|26875657|FG000|Overall Study|Withdrawal by Subject|17|||
13425608|NCT00434759|26875658|FG001|Overall Study|Withdrawal by Subject|1|||
13425609|NCT00434759|26875657|FG000|Overall Study|family affairs|2|||
13425610|NCT00434759|26875658|FG001|Overall Study|family affairs|0|||
13425611|NCT00434642|26875681|FG000|Blinded Treatment Phase|Adverse Event|12|||
13425612|NCT00434642|26875682|FG001|Blinded Treatment Phase|Adverse Event|58|||
13425613|NCT00434642|26875681|FG000|Blinded Treatment Phase|Clinical Disease Progression|4|||
13425614|NCT00434642|26875682|FG001|Blinded Treatment Phase|Clinical Disease Progression|5|||
13425615|NCT00434642|26875681|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168|||
13425616|NCT00434642|26875682|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109|||
13425617|NCT00434642|26875681|FG000|Blinded Treatment Phase|Physician Decision|19|||
13425618|NCT00434642|26875682|FG001|Blinded Treatment Phase|Physician Decision|27|||
13425619|NCT00434642|26875681|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3|||
13425620|NCT00434642|26875682|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0|||
13425621|NCT00434642|26875681|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32|||
13425622|NCT00434642|26875682|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29|||
13425623|NCT00434642|26875681|FG000|Blinded Treatment Phase|Did not Receive Treatment|4|||
13425624|NCT00434642|26875682|FG001|Blinded Treatment Phase|Did not Receive Treatment|1|||
13425625|NCT00434642|26875681|FG000|Open-label Treatment Phase|Adverse Event|0|||
13425626|NCT00434642|26875682|FG001|Open-label Treatment Phase|Adverse Event|5|||
13425627|NCT00434642|26875681|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0|||
13425628|NCT00434642|26875682|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6|||
13425629|NCT00434590|26875695|FG000|Overall Study|Administrative problems|5|||
13425630|NCT00434590|26875696|FG001|Overall Study|Administrative problems|5|||
13476781|NCT01425008|27003733|FG004|Dose Expansion Phase|Withdrawal by Subject|0|||
13476782|NCT01425008|27003734|FG005|Dose Expansion Phase|Withdrawal by Subject|0|||
13476783|NCT01425008|27003735|FG006|Dose Expansion Phase|Withdrawal by Subject|0|||
13476784|NCT01425008|27003736|FG007|Dose Expansion Phase|Withdrawal by Subject|0|||
13476785|NCT01425008|27003737|FG008|Dose Expansion Phase|Withdrawal by Subject|0|||
13476786|NCT01425008|27003738|FG009|Dose Expansion Phase|Withdrawal by Subject|0|||
13476787|NCT01425008|27003739|FG010|Dose Expansion Phase|Withdrawal by Subject|1|||
13476788|NCT01425008|27003740|FG011|Dose Expansion Phase|Withdrawal by Subject|0|||
13476789|NCT01425008|27003741|FG012|Dose Expansion Phase|Withdrawal by Subject|0|||
13476790|NCT01425008|27003742|FG013|Dose Expansion Phase|Withdrawal by Subject|0|||
13476791|NCT01425008|27003743|FG014|Dose Expansion Phase|Withdrawal by Subject|0|||
13476792|NCT01425008|27003744|FG015|Dose Expansion Phase|Withdrawal by Subject|1|||
13476793|NCT01425008|27003745|FG016|Dose Expansion Phase|Withdrawal by Subject|1|||
13476794|NCT01425008|27003746|FG017|Dose Expansion Phase|Withdrawal by Subject|0|||
13476795|NCT01425008|27003747|FG018|Dose Expansion Phase|Withdrawal by Subject|0|||
13476796|NCT01425008|27003729|FG000|Dose Expansion Phase|Other|0|||
13476797|NCT01425008|27003730|FG001|Dose Expansion Phase|Other|0|||
13476798|NCT01425008|27003731|FG002|Dose Expansion Phase|Other|0|||
13476799|NCT01425008|27003732|FG003|Dose Expansion Phase|Other|0|||
13476800|NCT01425008|27003733|FG004|Dose Expansion Phase|Other|0|||
13476801|NCT01425008|27003734|FG005|Dose Expansion Phase|Other|0|||
13476802|NCT01425008|27003735|FG006|Dose Expansion Phase|Other|0|||
13476803|NCT01425008|27003736|FG007|Dose Expansion Phase|Other|0|||
13476804|NCT01425008|27003737|FG008|Dose Expansion Phase|Other|0|||
13476805|NCT01425008|27003738|FG009|Dose Expansion Phase|Other|0|||
13476806|NCT01425008|27003739|FG010|Dose Expansion Phase|Other|0|||
13476807|NCT01425008|27003740|FG011|Dose Expansion Phase|Other|0|||
13476808|NCT01425008|27003741|FG012|Dose Expansion Phase|Other|1|||
13476809|NCT01425008|27003742|FG013|Dose Expansion Phase|Other|0|||
13476810|NCT01425008|27003743|FG014|Dose Expansion Phase|Other|0|||
13476811|NCT01425008|27003744|FG015|Dose Expansion Phase|Other|0|||
13476812|NCT01425008|27003745|FG016|Dose Expansion Phase|Other|2|||
13476813|NCT01425008|27003746|FG017|Dose Expansion Phase|Other|0|||
13476814|NCT01425008|27003747|FG018|Dose Expansion Phase|Other|4|||
13476815|NCT01425008|27003729|FG000|Dose Expansion Phase|Symptomatic Deterioration|0|||
13476816|NCT01425008|27003730|FG001|Dose Expansion Phase|Symptomatic Deterioration|0|||
13476817|NCT01425008|27003731|FG002|Dose Expansion Phase|Symptomatic Deterioration|0|||
13476818|NCT01425008|27003732|FG003|Dose Expansion Phase|Symptomatic Deterioration|0|||
13476819|NCT01425008|27003733|FG004|Dose Expansion Phase|Symptomatic Deterioration|0|||
13476820|NCT01425008|27003734|FG005|Dose Expansion Phase|Symptomatic Deterioration|0|||
13425631|NCT00434577|26875884|FG000|Months 0-3|Serious Adverse Event|0|||
13425632|NCT00434577|26875885|FG001|Months 0-3|Serious Adverse Event|0|||
13425633|NCT00434577|26875886|FG002|Months 0-3|Serious Adverse Event|1|||
13425634|NCT00434577|26875887|FG003|Months 0-3|Serious Adverse Event|0|||
13425635|NCT00434577|26875888|FG004|Months 0-3|Serious Adverse Event|0|||
13425636|NCT00434577|26875884|FG000|Months 0-3|Adverse Event|0|||
13425637|NCT00434577|26875885|FG001|Months 0-3|Adverse Event|1|||
13425638|NCT00434577|26875886|FG002|Months 0-3|Adverse Event|1|||
13425639|NCT00434577|26875887|FG003|Months 0-3|Adverse Event|0|||
13425640|NCT00434577|26875888|FG004|Months 0-3|Adverse Event|0|||
13425641|NCT00434577|26875884|FG000|Months 0-3|Lost to Follow-up|0|||
13425642|NCT00434577|26875885|FG001|Months 0-3|Lost to Follow-up|0|||
13425643|NCT00434577|26875886|FG002|Months 0-3|Lost to Follow-up|0|||
13425644|NCT00434577|26875887|FG003|Months 0-3|Lost to Follow-up|0|||
13425645|NCT00434577|26875888|FG004|Months 0-3|Lost to Follow-up|2|||
13425646|NCT00434577|26875884|FG000|Months 0-3|Protocol Violation|1|||
13425647|NCT00434577|26875885|FG001|Months 0-3|Protocol Violation|0|||
13425648|NCT00434577|26875886|FG002|Months 0-3|Protocol Violation|1|||
13425649|NCT00434577|26875887|FG003|Months 0-3|Protocol Violation|0|||
13425650|NCT00434577|26875888|FG004|Months 0-3|Protocol Violation|0|||
13425651|NCT00434577|26875884|FG000|Months 0-3|Withdrawal by Subject|2|||
13425652|NCT00434577|26875885|FG001|Months 0-3|Withdrawal by Subject|1|||
13425653|NCT00434577|26875886|FG002|Months 0-3|Withdrawal by Subject|1|||
13425654|NCT00434577|26875887|FG003|Months 0-3|Withdrawal by Subject|1|||
13425655|NCT00434577|26875888|FG004|Months 0-3|Withdrawal by Subject|1|||
13425656|NCT00434512|26876005|FG000|Overall Study|Migrated/moved from study area|0|||
13425657|NCT00434512|26876006|FG001|Overall Study|Migrated/moved from study area|0|||
13425658|NCT00434512|26876007|FG002|Overall Study|Migrated/moved from study area|0|||
13425659|NCT00434512|26876008|FG003|Overall Study|Migrated/moved from study area|1|||
13425660|NCT00434512|26876009|FG004|Overall Study|Migrated/moved from study area|1|||
13425661|NCT00434512|26876010|FG005|Overall Study|Migrated/moved from study area|1|||
13425662|NCT00434512|26876005|FG000|Overall Study|Other|0|||
13425663|NCT00434512|26876006|FG001|Overall Study|Other|1|||
13425664|NCT00434512|26876007|FG002|Overall Study|Other|0|||
13425665|NCT00434512|26876008|FG003|Overall Study|Other|0|||
13425666|NCT00434512|26876009|FG004|Overall Study|Other|0|||
13425667|NCT00434512|26876010|FG005|Overall Study|Other|0|||
13425668|NCT00434421|26876016|FG000|Overall Study|Withdrawal by Subject|1|||
13425669|NCT00434421|26876016|FG000|Overall Study|Non-compliance with study treatment|1|||
13425670|NCT00434330|26876067|FG000|Overall Study|Adverse Event|0|||
13425671|NCT00434330|26876068|FG001|Overall Study|Adverse Event|0|||
13425672|NCT00434330|26876069|FG002|Overall Study|Adverse Event|1|||
13425673|NCT00434330|26876070|FG003|Overall Study|Adverse Event|0|||
13425674|NCT00434330|26876071|FG004|Overall Study|Adverse Event|0|||
13425675|NCT00434330|26876072|FG005|Overall Study|Adverse Event|0|||
13425676|NCT00434330|26876067|FG000|Overall Study|Death|1|||
13425677|NCT00434330|26876068|FG001|Overall Study|Death|0|||
13425678|NCT00434330|26876069|FG002|Overall Study|Death|0|||
13425679|NCT00434330|26876070|FG003|Overall Study|Death|0|||
13425680|NCT00434330|26876071|FG004|Overall Study|Death|1|||
13425681|NCT00434330|26876072|FG005|Overall Study|Death|1|||
13425682|NCT00434330|26876067|FG000|Overall Study|Withdrawal by Subject|0|||
13425683|NCT00434330|26876068|FG001|Overall Study|Withdrawal by Subject|0|||
13425684|NCT00434330|26876069|FG002|Overall Study|Withdrawal by Subject|1|||
13425685|NCT00434330|26876070|FG003|Overall Study|Withdrawal by Subject|1|||
13425686|NCT00434330|26876071|FG004|Overall Study|Withdrawal by Subject|0|||
13425687|NCT00434330|26876072|FG005|Overall Study|Withdrawal by Subject|0|||
13425688|NCT00434330|26876067|FG000|Overall Study|Renal transplant|0|||
13425689|NCT00434330|26876068|FG001|Overall Study|Renal transplant|0|||
13425690|NCT00434330|26876069|FG002|Overall Study|Renal transplant|0|||
13425691|NCT00434330|26876070|FG003|Overall Study|Renal transplant|1|||
13425692|NCT00434330|26876071|FG004|Overall Study|Renal transplant|0|||
13425693|NCT00434330|26876072|FG005|Overall Study|Renal transplant|0|||
13425694|NCT00434330|26876067|FG000|Overall Study|Subject Not Compliant With Study|0|||
13425695|NCT00434330|26876068|FG001|Overall Study|Subject Not Compliant With Study|0|||
13425696|NCT00434330|26876069|FG002|Overall Study|Subject Not Compliant With Study|1|||
13425697|NCT00434330|26876070|FG003|Overall Study|Subject Not Compliant With Study|0|||
13425698|NCT00434330|26876071|FG004|Overall Study|Subject Not Compliant With Study|0|||
13425699|NCT00434330|26876072|FG005|Overall Study|Subject Not Compliant With Study|0|||
13425700|NCT00434304|26876110|FG000|Overall Study|Adverse Event|14|||
13425701|NCT00434304|26876110|FG000|Overall Study|Lack of Efficacy|2|||
13425702|NCT00434304|26876110|FG000|Overall Study|Withdrawal by Subject|4|||
13425703|NCT00434252|26876137|FG000|Overall Study|Lack of Efficacy|50|||
13425704|NCT00434252|26876138|FG001|Overall Study|Lack of Efficacy|100|||
13425705|NCT00434252|26876137|FG000|Overall Study|Adverse Event|6|||
13425706|NCT00434252|26876138|FG001|Overall Study|Adverse Event|13|||
13425707|NCT00434252|26876137|FG000|Overall Study|Death|1|||
13425708|NCT00434252|26876138|FG001|Overall Study|Death|2|||
13425709|NCT00434252|26876137|FG000|Overall Study|Lost to Follow-up|0|||
13425710|NCT00434252|26876138|FG001|Overall Study|Lost to Follow-up|1|||
13425711|NCT00434252|26876137|FG000|Overall Study|Physician Decision|4|||
13425712|NCT00434252|26876138|FG001|Overall Study|Physician Decision|8|||
13425713|NCT00434252|26876137|FG000|Overall Study|Withdrawal by Subject|3|||
13425714|NCT00434252|26876138|FG001|Overall Study|Withdrawal by Subject|7|||
13425715|NCT00434213|26876145|FG000|Overall Study|Adverse Event|12|||
13425716|NCT00434213|26876145|FG000|Overall Study|Lack of Efficacy|9|||
13425717|NCT00434213|26876145|FG000|Overall Study|Lost to Follow-up|14|||
13425718|NCT00434213|26876145|FG000|Overall Study|Withdrawal by Subject|7|||
13425719|NCT00434213|26876145|FG000|Overall Study|Protocol Violation|3|||
13425720|NCT00434213|26876145|FG000|Overall Study|Unable to comply with study visit window|2|||
13425721|NCT00434213|26876145|FG000|Overall Study|Application site reaction|1|||
13425722|NCT00434213|26876145|FG000|Overall Study|Non-compliant to study schedule|1|||
13425723|NCT00434161|26876197|FG000|Overall Study|Adverse Event|5|||
13425724|NCT00434161|26876198|FG001|Overall Study|Adverse Event|1|||
13425725|NCT00434161|26876199|FG002|Overall Study|Adverse Event|4|||
13425726|NCT00434161|26876197|FG000|Overall Study|Lost to Follow-up|0|||
13425727|NCT00434161|26876198|FG001|Overall Study|Lost to Follow-up|1|||
13425728|NCT00434161|26876199|FG002|Overall Study|Lost to Follow-up|0|||
13425729|NCT00434161|26876197|FG000|Overall Study|Death|1|||
13425730|NCT00434161|26876198|FG001|Overall Study|Death|0|||
13425731|NCT00434161|26876199|FG002|Overall Study|Death|1|||
13425732|NCT00434161|26876197|FG000|Overall Study|Non-Compliance|1|||
13425733|NCT00434161|26876198|FG001|Overall Study|Non-Compliance|1|||
13425734|NCT00434161|26876199|FG002|Overall Study|Non-Compliance|0|||
13425735|NCT00434161|26876197|FG000|Overall Study|Withdrawal by Subject|2|||
13425736|NCT00434161|26876198|FG001|Overall Study|Withdrawal by Subject|0|||
13425737|NCT00434161|26876199|FG002|Overall Study|Withdrawal by Subject|3|||
13425738|NCT00434161|26876197|FG000|Overall Study|Logistical error study assessments|1|||
13425739|NCT00434161|26876198|FG001|Overall Study|Logistical error study assessments|0|||
13425740|NCT00434161|26876199|FG002|Overall Study|Logistical error study assessments|3|||
13425741|NCT00434148|26876240|FG000|Overall Study|Adverse Event|18|||
13425742|NCT00434148|26876241|FG001|Overall Study|Adverse Event|18|||
13425743|NCT00434148|26876240|FG000|Overall Study|Lack of Efficacy|25|||
13425744|NCT00434148|26876241|FG001|Overall Study|Lack of Efficacy|28|||
13425745|NCT00434148|26876240|FG000|Overall Study|Withdrawal by Subject|15|||
13425746|NCT00434148|26876241|FG001|Overall Study|Withdrawal by Subject|15|||
13425747|NCT00434148|26876240|FG000|Overall Study|Protocol Violation|4|||
13425748|NCT00434148|26876241|FG001|Overall Study|Protocol Violation|0|||
13425749|NCT00434148|26876240|FG000|Overall Study|Administrative problems|6|||
13425750|NCT00434148|26876241|FG001|Overall Study|Administrative problems|10|||
13425751|NCT00434148|26876240|FG000|Overall Study|Lost to Follow-up|0|||
13425752|NCT00434148|26876241|FG001|Overall Study|Lost to Follow-up|1|||
13425753|NCT00434148|26876240|FG000|Overall Study|Condition no longer requires study drug|1|||
13425754|NCT00434148|26876241|FG001|Overall Study|Condition no longer requires study drug|0|||
13425755|NCT00434148|26876240|FG000|Overall Study|Abnormal test procedure result|0|||
13425756|NCT00434148|26876241|FG001|Overall Study|Abnormal test procedure result|1|||
13425757|NCT00434122|26876257|FG000|Overall Study|Non-compliance with protocol|0|||
13425758|NCT00434122|26876258|FG001|Overall Study|Non-compliance with protocol|1|||
13425759|NCT00434122|26876257|FG000|Overall Study|loss of subject contact|1|||
13425760|NCT00434122|26876258|FG001|Overall Study|loss of subject contact|1|||
13425761|NCT00434122|26876257|FG000|Overall Study|Personal reasons|1|||
13425762|NCT00434122|26876258|FG001|Overall Study|Personal reasons|1|||
13425763|NCT00434122|26876257|FG000|Overall Study|Large follicle size|2|||
13425764|NCT00434122|26876258|FG001|Overall Study|Large follicle size|2|||
13425765|NCT00434122|26876257|FG000|Overall Study|Low follicular response.|1|||
13425766|NCT00434122|26876258|FG001|Overall Study|Low follicular response.|2|||
13425767|NCT00434122|26876257|FG000|Overall Study|Travelling of subject.|1|||
13425768|NCT00434122|26876258|FG001|Overall Study|Travelling of subject.|0|||
13425769|NCT00434109|26876269|FG000|Overall Study|Physician Decision|9|||
13425770|NCT00434109|26876269|FG000|Overall Study|Adverse Event|5|||
13425771|NCT00434109|26876269|FG000|Overall Study|Protocol Violation|1|||
13425772|NCT00434109|26876269|FG000|Overall Study|had embolism, did not receive sunitinib|3|||
13425773|NCT00434057|26876275|FG000|Overall Study|Withdrawal by Subject|1|||
13425774|NCT00433966|26876304|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40|||
13425775|NCT00433966|26876305|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43|||
13425776|NCT00433966|26876306|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
13425777|NCT00433966|26876307|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
13425778|NCT00433966|26876304|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97|||
13425779|NCT00433966|26876305|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103|||
13425780|NCT00433966|26876306|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
13425781|NCT00433966|26876307|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
13425782|NCT00433966|26876304|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29|||
13425783|NCT00433966|26876305|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28|||
13425784|NCT00433966|26876306|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
13425785|NCT00433966|26876307|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
13425786|NCT00433966|26876304|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0|||
13425787|NCT00433966|26876305|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0|||
13425788|NCT00433966|26876306|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41|||
13425789|NCT00433966|26876307|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15|||
13425790|NCT00433966|26876304|FG000|Stent Intervention/Randomization|Lost to Follow-up|0|||
13425791|NCT00433966|26876305|FG001|Stent Intervention/Randomization|Lost to Follow-up|0|||
13425792|NCT00433966|26876306|FG002|Stent Intervention/Randomization|Lost to Follow-up|113|||
13425793|NCT00433966|26876307|FG003|Stent Intervention/Randomization|Lost to Follow-up|47|||
13425794|NCT00433914|26876332|FG000|Overall Study|Withdrawal by Subject|0|||
13425795|NCT00433914|26876333|FG001|Overall Study|Withdrawal by Subject|2|||
13425796|NCT00433914|26876332|FG000|Overall Study|Lost to Follow-up|0|||
13425797|NCT00433914|26876333|FG001|Overall Study|Lost to Follow-up|1|||
13425798|NCT00433836|26876352|FG000|Overall Study|Adverse Event|7|||
13425799|NCT00433836|26876353|FG001|Overall Study|Adverse Event|0|||
13425800|NCT00433836|26876352|FG000|Overall Study|Lost to Follow-up|3|||
13425801|NCT00433836|26876353|FG001|Overall Study|Lost to Follow-up|0|||
13425802|NCT00433836|26876352|FG000|Overall Study|Withdrawal by Subject|2|||
13425803|NCT00433836|26876353|FG001|Overall Study|Withdrawal by Subject|1|||
13425804|NCT00433836|26876352|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
13425805|NCT00433836|26876353|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
13425806|NCT00433836|26876352|FG000|Overall Study|Protocol Violation|0|||
13425807|NCT00433836|26876353|FG001|Overall Study|Protocol Violation|2|||
13425808|NCT00433836|26876352|FG000|Overall Study|Condition no longer requires study drug|0|||
13425809|NCT00433836|26876353|FG001|Overall Study|Condition no longer requires study drug|1|||
13425810|NCT00433836|26876352|FG000|Overall Study|Abnormal laboratory values|0|||
13425811|NCT00433836|26876353|FG001|Overall Study|Abnormal laboratory values|1|||
13425812|NCT00433771|26876371|FG000|Overall Study|screen fail|14|||
13425813|NCT00433771|26876371|FG000|Overall Study|Treated and later found to be ineligible|2|||
13425814|NCT00433771|26876371|FG000|Overall Study|Death|2|||
13425815|NCT00433771|26876371|FG000|Overall Study|Failure to deploy stent|1|||
13425816|NCT00433654|26876409|FG000|Overall Study|Death|4|||
13425817|NCT00433654|26876410|FG001|Overall Study|Death|0|||
13425818|NCT00433654|26876409|FG000|Overall Study|Missed visit|6|||
13425819|NCT00433654|26876410|FG001|Overall Study|Missed visit|3|||
13425820|NCT00433654|26876409|FG000|Overall Study|Subject not yet due for visit|4|||
13425821|NCT00433654|26876410|FG001|Overall Study|Subject not yet due for visit|0|||
13425822|NCT00433654|26876409|FG000|Overall Study|Withdrawal by Subject|1|||
13425823|NCT00433654|26876410|FG001|Overall Study|Withdrawal by Subject|2|||
13425824|NCT00433537|26876423|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
13425825|NCT00433537|26876424|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0|||
13425826|NCT00433537|26876425|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
13425827|NCT00433537|26876423|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
13425828|NCT00433537|26876424|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
13425829|NCT00433537|26876425|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2|||
13425830|NCT00433537|26876423|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
13425831|NCT00433537|26876424|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
13425832|NCT00433537|26876425|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4|||
13425833|NCT00433537|26876423|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
13425834|NCT00433537|26876424|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
13425835|NCT00433537|26876425|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2|||
13425836|NCT00433537|26876423|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1|||
13425837|NCT00433537|26876424|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
13425838|NCT00433537|26876425|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
13425839|NCT00433537|26876423|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8|||
13425840|NCT00433537|26876424|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
13425841|NCT00433537|26876425|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
13425842|NCT00433537|26876423|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2|||
13425843|NCT00433537|26876424|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
13425844|NCT00433537|26876425|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
13425845|NCT00433537|26876423|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4|||
13425846|NCT00433537|26876424|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
13425847|NCT00433537|26876425|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
13425848|NCT00433537|26876423|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1|||
13425849|NCT00433537|26876424|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
13425850|NCT00433537|26876425|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
13425851|NCT00433446|26876435|FG000|Overall Study|Adverse Event|4|||
13425852|NCT00433446|26876435|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
13425853|NCT00433446|26876435|FG000|Overall Study|Progression|44|||
13425854|NCT00433446|26876435|FG000|Overall Study|Other - Not Protocol specified|3|||
13425855|NCT00433446|26876435|FG000|Overall Study|Ineligible|9|||
13425856|NCT00433381|26876461|FG000|Overall Study|Ineligible / no protocol treatment|3|||
13425857|NCT00433381|26876462|FG001|Overall Study|Ineligible / no protocol treatment|3|||
13425858|NCT00433329|26876468|FG000|Overall Study|Adverse Event|9|||
13425859|NCT00433329|26876468|FG000|Overall Study|Death|4|||
13425860|NCT00433329|26876468|FG000|Overall Study|Withdrew consent|3|||
13425861|NCT00433329|26876468|FG000|Overall Study|Discontinued sildenafil|2|||
13425862|NCT00433329|26876468|FG000|Overall Study|Moved out of state|1|||
13425863|NCT00433329|26876468|FG000|Overall Study|Lost to Follow-up|1|||
13425864|NCT00433329|26876468|FG000|Overall Study|Physician Decision|1|||
13425865|NCT00433290|26876542|FG000|Overall Study|Adverse Event|24|||
13425866|NCT00433290|26876543|FG001|Overall Study|Adverse Event|7|||
13425867|NCT00433290|26876542|FG000|Overall Study|Lack of Efficacy|1|||
13425868|NCT00433290|26876543|FG001|Overall Study|Lack of Efficacy|5|||
13425869|NCT00433290|26876542|FG000|Overall Study|Withdrawal by Subject|4|||
13425870|NCT00433290|26876543|FG001|Overall Study|Withdrawal by Subject|2|||
13425871|NCT00433290|26876542|FG000|Overall Study|Protocol Violation|3|||
13425872|NCT00433290|26876543|FG001|Overall Study|Protocol Violation|2|||
13425873|NCT00433290|26876542|FG000|Overall Study|Physician Decision|2|||
13425874|NCT00433290|26876543|FG001|Overall Study|Physician Decision|0|||
13425875|NCT00433290|26876542|FG000|Overall Study|Entry Criteria Not Met|0|||
13425876|NCT00433290|26876543|FG001|Overall Study|Entry Criteria Not Met|1|||
13425877|NCT00433290|26876542|FG000|Overall Study|Lost to Follow-up|1|||
13425878|NCT00433290|26876543|FG001|Overall Study|Lost to Follow-up|0|||
13425879|NCT00433199|26876568|FG000|Double-Blind Period|Adverse Event|0|||
13425880|NCT00433199|26876569|FG001|Double-Blind Period|Adverse Event|25|||
13425881|NCT00433199|26876568|FG000|Double-Blind Period|Lack of Efficacy|0|||
13425882|NCT00433199|26876569|FG001|Double-Blind Period|Lack of Efficacy|2|||
13425883|NCT00433199|26876568|FG000|Double-Blind Period|Lost to Follow-up|2|||
13425884|NCT00433199|26876569|FG001|Double-Blind Period|Lost to Follow-up|5|||
13425885|NCT00433199|26876568|FG000|Double-Blind Period|Withdrawal by Subject|8|||
13425886|NCT00433199|26876569|FG001|Double-Blind Period|Withdrawal by Subject|19|||
13425887|NCT00433199|26876568|FG000|Double-Blind Period|Protocol Violation|1|||
13425888|NCT00433199|26876569|FG001|Double-Blind Period|Protocol Violation|10|||
13425889|NCT00433199|26876568|FG000|Double-Blind Period|Administrative|1|||
13425890|NCT00433199|26876569|FG001|Double-Blind Period|Administrative|5|||
13425891|NCT00433199|26876568|FG000|Open-Label Period|Adverse Event|0|||
13425892|NCT00433199|26876569|FG001|Open-Label Period|Adverse Event|19|||
13425893|NCT00433199|26876568|FG000|Open-Label Period|Lack of Efficacy|0|||
13425894|NCT00433199|26876569|FG001|Open-Label Period|Lack of Efficacy|2|||
13425895|NCT00433199|26876568|FG000|Open-Label Period|Lost to Follow-up|0|||
13425896|NCT00433199|26876569|FG001|Open-Label Period|Lost to Follow-up|3|||
13425897|NCT00433199|26876568|FG000|Open-Label Period|Withdrawal by Subject|0|||
13425898|NCT00433199|26876569|FG001|Open-Label Period|Withdrawal by Subject|7|||
13425899|NCT00433199|26876568|FG000|Open-Label Period|Protocol Violation|0|||
13425900|NCT00433199|26876569|FG001|Open-Label Period|Protocol Violation|2|||
13425901|NCT00433199|26876568|FG000|Open-Label Period|Administrative|0|||
13425902|NCT00433199|26876569|FG001|Open-Label Period|Administrative|1|||
13425903|NCT00433160|26876624|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6|||
13425904|NCT00433160|26876625|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2|||
13425905|NCT00433160|26876624|FG000|52-Week Double-Blind (DB) Period|Death|0|||
13425906|NCT00433160|26876625|FG001|52-Week Double-Blind (DB) Period|Death|0|||
13425907|NCT00433160|26876624|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
13425908|NCT00433160|26876625|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
13425909|NCT00433160|26876624|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0|||
13425910|NCT00433160|26876625|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1|||
13425911|NCT00433160|26876624|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
13425912|NCT00433160|26876625|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2|||
13425913|NCT00433160|26876624|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6|||
13425914|NCT00433160|26876625|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1|||
13425915|NCT00433160|26876624|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4|||
13425916|NCT00433160|26876625|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2|||
13425917|NCT00433160|26876624|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
13425918|NCT00433160|26876625|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
13425919|NCT00433160|26876624|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1|||
13425920|NCT00433160|26876625|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2|||
13425921|NCT00433160|26876624|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3|||
13425922|NCT00433160|26876625|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1|||
13425923|NCT00433160|26876624|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1|||
13425924|NCT00433160|26876625|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2|||
13425925|NCT00433160|26876624|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2|||
13425926|NCT00433160|26876625|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0|||
13425927|NCT00433160|26876624|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0|||
13425928|NCT00433160|26876625|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1|||
13425929|NCT00433160|26876624|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2|||
13425930|NCT00433160|26876625|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0|||
13425931|NCT00433160|26876624|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8|||
13425932|NCT00433160|26876625|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2|||
13425933|NCT00433160|26876624|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0|||
13425934|NCT00433160|26876625|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1|||
13425935|NCT00433147|26876652|FG000|Overall Study|Adverse Event|0|||
13425936|NCT00433147|26876653|FG001|Overall Study|Adverse Event|1|||
13425937|NCT00433147|26876654|FG002|Overall Study|Adverse Event|0|||
13425938|NCT00433147|26876655|FG003|Overall Study|Adverse Event|0|||
13425939|NCT00433017|26876676|FG000|Overall Study|Adverse Event|5|||
13425940|NCT00433017|26876677|FG001|Overall Study|Adverse Event|3|||
13425941|NCT00433017|26876676|FG000|Overall Study|Withdrawal by Subject|4|||
13425942|NCT00433017|26876677|FG001|Overall Study|Withdrawal by Subject|5|||
13425943|NCT00433017|26876676|FG000|Overall Study|Lost to Follow-up|3|||
13425944|NCT00433017|26876677|FG001|Overall Study|Lost to Follow-up|4|||
13425945|NCT00433017|26876676|FG000|Overall Study|Administrative problems|80|||
13425946|NCT00433017|26876677|FG001|Overall Study|Administrative problems|86|||
13425947|NCT00433017|26876676|FG000|Overall Study|Protocol Violation|1|||
13425948|NCT00433017|26876677|FG001|Overall Study|Protocol Violation|0|||
13425949|NCT00433017|26876676|FG000|Overall Study|Death|2|||
13425950|NCT00433017|26876677|FG001|Overall Study|Death|2|||
13425951|NCT00433017|26876676|FG000|Overall Study|Subject no longer requires study drug|1|||
13425952|NCT00433017|26876677|FG001|Overall Study|Subject no longer requires study drug|1|||
13425953|NCT00433004|26876694|FG000|Overall Study|Lost to Follow-up|5|||
13425954|NCT00433004|26876695|FG001|Overall Study|Lost to Follow-up|7|||
13425955|NCT00432991|26876712|FG000|Overall Study|Protocol Violation|7|||
13425956|NCT00432991|26876713|FG001|Overall Study|Protocol Violation|12|||
13425957|NCT00432965|26876726|FG000|Overall Study|Lost to Follow-up|22|||
13425958|NCT00432965|26876727|FG001|Overall Study|Lost to Follow-up|19|||
13425959|NCT00432965|26876726|FG000|Overall Study|Withdrawal by Subject|13|||
13425960|NCT00432965|26876727|FG001|Overall Study|Withdrawal by Subject|13|||
13425961|NCT00432965|26876726|FG000|Overall Study|Physician Decision|14|||
13425962|NCT00432965|26876727|FG001|Overall Study|Physician Decision|13|||
13425963|NCT00432965|26876726|FG000|Overall Study|Lack of Efficacy|8|||
13425964|NCT00432965|26876727|FG001|Overall Study|Lack of Efficacy|13|||
13425965|NCT00432965|26876726|FG000|Overall Study|Non-compliance|7|||
13425966|NCT00432965|26876727|FG001|Overall Study|Non-compliance|0|||
13425967|NCT00432965|26876726|FG000|Overall Study|Adverse Event|22|||
13425968|NCT00432965|26876727|FG001|Overall Study|Adverse Event|19|||
13425969|NCT00432965|26876726|FG000|Overall Study|Death|3|||
13425970|NCT00432965|26876727|FG001|Overall Study|Death|4|||
13425971|NCT00432965|26876726|FG000|Overall Study|Exclusionary Methods|1|||
13425972|NCT00432965|26876727|FG001|Overall Study|Exclusionary Methods|2|||
13425973|NCT00432965|26876726|FG000|Overall Study|Incomplete Data|4|||
13425974|NCT00432965|26876727|FG001|Overall Study|Incomplete Data|3|||
13425975|NCT00432835|26876744|FG000|Overall Study|Adverse event: lead dislodgement.|6|||
13425976|NCT00432835|26876745|FG001|Overall Study|Adverse event: lead dislodgement.|7|||
13425977|NCT00432809|26876826|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2|||
13425978|NCT00432809|26876827|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0|||
13425979|NCT00432809|26876828|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0|||
13425980|NCT00432809|26876826|FG000|1 Year Follow-up|Withdrawal by Subject|7|||
13425981|NCT00432809|26876827|FG001|1 Year Follow-up|Withdrawal by Subject|0|||
13425982|NCT00432809|26876828|FG002|1 Year Follow-up|Withdrawal by Subject|1|||
13425983|NCT00432744|26876845|FG000|Months 0-6|Withdrawal by Subject|4|||
13425984|NCT00432744|26876846|FG001|Months 0-6|Withdrawal by Subject|4|||
13425985|NCT00432744|26876845|FG000|Months 0-6|Too disabled to score|1|||
13425986|NCT00432744|26876846|FG001|Months 0-6|Too disabled to score|0|||
13425987|NCT00432744|26876845|FG000|Months 7 - 12|Withdrawal by Subject|1|||
13425988|NCT00432744|26876846|FG001|Months 7 - 12|Withdrawal by Subject|0|||
13425989|NCT00432744|26876845|FG000|Months 7 - 12|Too disabled to score|0|||
13425990|NCT00432744|26876846|FG001|Months 7 - 12|Too disabled to score|1|||
13425991|NCT00432666|26877015|FG000|Main Period|Adverse Event|1|||
13425992|NCT00432666|26877016|FG001|Main Period|Adverse Event|1|||
13425993|NCT00432666|26877015|FG000|Main Period|Consent Withdrawn|1|||
13425994|NCT00432666|26877016|FG001|Main Period|Consent Withdrawn|0|||
13425995|NCT00432666|26877015|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1|||
13425996|NCT00432666|26877016|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0|||
13425997|NCT00432666|26877015|FG000|Open-Label Extension Period|Lack of Efficacy|6|||
13425998|NCT00432666|26877016|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
13425999|NCT00432666|26877015|FG000|Open-Label Extension Period|Adverse Event|5|||
13426000|NCT00432666|26877016|FG001|Open-Label Extension Period|Adverse Event|0|||
13426001|NCT00432666|26877015|FG000|Open-Label Extension Period|Consent withdrawn|10|||
13426002|NCT00432666|26877016|FG001|Open-Label Extension Period|Consent withdrawn|0|||
13426003|NCT00432666|26877015|FG000|Open-Label Extension Period|Physician Decision|3|||
13426004|NCT00432666|26877016|FG001|Open-Label Extension Period|Physician Decision|0|||
13426005|NCT00432562|26877047|FG000|Overall Study|Death|3|||
13426006|NCT00432562|26877048|FG001|Overall Study|Death|0|||
13426007|NCT00432380|26877082|FG000|Overall Study|Migrated/moved from study area|3|||
13426008|NCT00432380|26877083|FG001|Overall Study|Migrated/moved from study area|4|||
13426009|NCT00432380|26877084|FG002|Overall Study|Migrated/moved from study area|1|||
13426010|NCT00432380|26877082|FG000|Overall Study|Adverse Event|1|||
13426011|NCT00432380|26877083|FG001|Overall Study|Adverse Event|0|||
13426012|NCT00432380|26877084|FG002|Overall Study|Adverse Event|0|||
13426013|NCT00432276|26877177|FG000|Overall Study|Hyperglycemic Rescue|44|||
13426014|NCT00432276|26877178|FG001|Overall Study|Hyperglycemic Rescue|87|||
13426015|NCT00432276|26877177|FG000|Overall Study|Adverse Event|13|||
13426016|NCT00432276|26877178|FG001|Overall Study|Adverse Event|16|||
13426017|NCT00432276|26877177|FG000|Overall Study|Protocol Violation|25|||
13426018|NCT00432276|26877178|FG001|Overall Study|Protocol Violation|20|||
13426019|NCT00432276|26877177|FG000|Overall Study|Lost to Follow-up|6|||
13426020|NCT00432276|26877178|FG001|Overall Study|Lost to Follow-up|2|||
13426021|NCT00432276|26877177|FG000|Overall Study|Withdrawal by Subject|25|||
13426022|NCT00432276|26877178|FG001|Overall Study|Withdrawal by Subject|20|||
13426023|NCT00432276|26877177|FG000|Overall Study|Physician Decision|6|||
13426024|NCT00432276|26877178|FG001|Overall Study|Physician Decision|8|||
13426025|NCT00432276|26877177|FG000|Overall Study|Other|2|||
13426026|NCT00432276|26877178|FG001|Overall Study|Other|3|||
13426027|NCT00432237|26877229|FG000|Overall Study|Adverse Event|0|||
13426028|NCT00432237|26877230|FG001|Overall Study|Adverse Event|0|||
13426029|NCT00432237|26877231|FG002|Overall Study|Adverse Event|0|||
13426030|NCT00432237|26877232|FG003|Overall Study|Adverse Event|1|||
13426031|NCT00432237|26877229|FG000|Overall Study|Lack of Efficacy|0|||
13426032|NCT00432237|26877230|FG001|Overall Study|Lack of Efficacy|0|||
13426033|NCT00432237|26877231|FG002|Overall Study|Lack of Efficacy|0|||
13426034|NCT00432237|26877232|FG003|Overall Study|Lack of Efficacy|1|||
13426035|NCT00432237|26877229|FG000|Overall Study|Lost to Follow-up|10|||
13426036|NCT00432237|26877230|FG001|Overall Study|Lost to Follow-up|10|||
13426037|NCT00432237|26877231|FG002|Overall Study|Lost to Follow-up|18|||
13426038|NCT00432237|26877232|FG003|Overall Study|Lost to Follow-up|18|||
13426039|NCT00432237|26877229|FG000|Overall Study|Physician Decision|1|||
13426040|NCT00432237|26877230|FG001|Overall Study|Physician Decision|3|||
13426041|NCT00432237|26877231|FG002|Overall Study|Physician Decision|2|||
13426042|NCT00432237|26877232|FG003|Overall Study|Physician Decision|1|||
13426043|NCT00432237|26877229|FG000|Overall Study|Pregnancy|0|||
13426044|NCT00432237|26877230|FG001|Overall Study|Pregnancy|1|||
13426045|NCT00432237|26877231|FG002|Overall Study|Pregnancy|0|||
13426046|NCT00432237|26877232|FG003|Overall Study|Pregnancy|0|||
13426047|NCT00432237|26877229|FG000|Overall Study|Protocol Violation|13|||
13426048|NCT00432237|26877230|FG001|Overall Study|Protocol Violation|10|||
13426049|NCT00432237|26877231|FG002|Overall Study|Protocol Violation|11|||
13426050|NCT00432237|26877232|FG003|Overall Study|Protocol Violation|8|||
13426051|NCT00432237|26877229|FG000|Overall Study|Withdrawal by Subject|5|||
13426052|NCT00432237|26877230|FG001|Overall Study|Withdrawal by Subject|6|||
13426053|NCT00432237|26877231|FG002|Overall Study|Withdrawal by Subject|9|||
13426054|NCT00432237|26877232|FG003|Overall Study|Withdrawal by Subject|11|||
13426055|NCT00432237|26877229|FG000|Overall Study|Lack of Qualifying Event|38|||
13426056|NCT00432237|26877230|FG001|Overall Study|Lack of Qualifying Event|71|||
13426057|NCT00432237|26877231|FG002|Overall Study|Lack of Qualifying Event|69|||
13426058|NCT00432237|26877232|FG003|Overall Study|Lack of Qualifying Event|84|||
13426059|NCT00432172|26877265|FG000|Overall Study|Physician Decision|0|||
13426060|NCT00432172|26877266|FG001|Overall Study|Physician Decision|0|||
13426061|NCT00432172|26877267|FG002|Overall Study|Physician Decision|2|||
13426062|NCT00432172|26877268|FG003|Overall Study|Physician Decision|0|||
13426063|NCT00432172|26877265|FG000|Overall Study|Adverse Event|4|||
13426064|NCT00432172|26877266|FG001|Overall Study|Adverse Event|2|||
13426065|NCT00432172|26877267|FG002|Overall Study|Adverse Event|4|||
13426066|NCT00432172|26877268|FG003|Overall Study|Adverse Event|3|||
13426067|NCT00432172|26877265|FG000|Overall Study|Disease progression|0|||
13426068|NCT00432172|26877266|FG001|Overall Study|Disease progression|2|||
13426069|NCT00432172|26877267|FG002|Overall Study|Disease progression|5|||
13426070|NCT00432172|26877268|FG003|Overall Study|Disease progression|1|||
13426071|NCT00432172|26877265|FG000|Overall Study|Withdrawal by Subject|0|||
13426072|NCT00432172|26877266|FG001|Overall Study|Withdrawal by Subject|1|||
13426073|NCT00432172|26877267|FG002|Overall Study|Withdrawal by Subject|0|||
13426074|NCT00432172|26877268|FG003|Overall Study|Withdrawal by Subject|2|||
13426075|NCT00432172|26877265|FG000|Overall Study|No treatment received|2|||
13426076|NCT00432172|26877266|FG001|Overall Study|No treatment received|2|||
13426077|NCT00432172|26877267|FG002|Overall Study|No treatment received|0|||
13426078|NCT00432172|26877268|FG003|Overall Study|No treatment received|1|||
13426079|NCT00432159|26877388|FG000|Overall Study|Death|0|||
13426080|NCT00432159|26877389|FG001|Overall Study|Death|1|||
13426081|NCT00432159|26877390|FG002|Overall Study|Death|0|||
13426082|NCT00432159|26877391|FG003|Overall Study|Death|0|||
13426083|NCT00432159|26877392|FG004|Overall Study|Death|0|||
13426084|NCT00432159|26877388|FG000|Overall Study|Failure|9|||
13426085|NCT00432159|26877389|FG001|Overall Study|Failure|5|||
13426086|NCT00432159|26877390|FG002|Overall Study|Failure|3|||
13426087|NCT00432159|26877391|FG003|Overall Study|Failure|2|||
13426088|NCT00432159|26877392|FG004|Overall Study|Failure|3|||
13426089|NCT00432159|26877388|FG000|Overall Study|Missing NDI and/or neuro. assessment|13|||
13426090|NCT00432159|26877389|FG001|Overall Study|Missing NDI and/or neuro. assessment|24|||
13426091|NCT00432159|26877390|FG002|Overall Study|Missing NDI and/or neuro. assessment|1|||
13426092|NCT00432159|26877391|FG003|Overall Study|Missing NDI and/or neuro. assessment|3|||
13426093|NCT00432159|26877392|FG004|Overall Study|Missing NDI and/or neuro. assessment|7|||
13426094|NCT00432042|26877413|FG000|Overall Study|Protocol Violation|2|||
13426095|NCT00432042|26877414|FG001|Overall Study|Protocol Violation|0|||
13426096|NCT00432042|26877415|FG002|Overall Study|Protocol Violation|0|||
13426097|NCT00432042|26877413|FG000|Overall Study|Withdrawal by Subject|0|||
13426098|NCT00432042|26877414|FG001|Overall Study|Withdrawal by Subject|0|||
13426099|NCT00432042|26877415|FG002|Overall Study|Withdrawal by Subject|2|||
13426100|NCT00432042|26877413|FG000|Overall Study|Lost to Follow-up|5|||
13426101|NCT00432042|26877414|FG001|Overall Study|Lost to Follow-up|1|||
13426102|NCT00432042|26877415|FG002|Overall Study|Lost to Follow-up|0|||
13426103|NCT00431964|26877428|FG000|Overall Study|Adverse Event|1|||
13426104|NCT00431964|26877429|FG001|Overall Study|Adverse Event|0|||
13426105|NCT00431964|26877428|FG000|Overall Study|Lost to Follow-up|1|||
13426106|NCT00431964|26877429|FG001|Overall Study|Lost to Follow-up|2|||
13426107|NCT00431964|26877428|FG000|Overall Study|Physician Decision|2|||
13426108|NCT00431964|26877429|FG001|Overall Study|Physician Decision|2|||
13426109|NCT00431964|26877428|FG000|Overall Study|Withdrawal by Subject|2|||
13426110|NCT00431964|26877429|FG001|Overall Study|Withdrawal by Subject|1|||
13426111|NCT00431964|26877428|FG000|Overall Study|Parental Consent Withdrawn|0|||
13426112|NCT00431964|26877429|FG001|Overall Study|Parental Consent Withdrawn|2|||
13426113|NCT00431964|26877428|FG000|Overall Study|Due to Unstable Health|0|||
13426114|NCT00431964|26877429|FG001|Overall Study|Due to Unstable Health|1|||
13426115|NCT00431951|26877500|FG000|Overall Study|Inability to follow study procedures|1|||
13426116|NCT00431951|26877501|FG001|Overall Study|Inability to follow study procedures|0|||
13426117|NCT00431951|26877502|FG002|Overall Study|Inability to follow study procedures|1|||
13426118|NCT00431951|26877503|FG003|Overall Study|Inability to follow study procedures|2|||
13426119|NCT00431951|26877500|FG000|Overall Study|Lost to Follow-up|0|||
13426120|NCT00431951|26877501|FG001|Overall Study|Lost to Follow-up|1|||
13426121|NCT00431951|26877502|FG002|Overall Study|Lost to Follow-up|0|||
13426122|NCT00431951|26877503|FG003|Overall Study|Lost to Follow-up|0|||
13426123|NCT00431951|26877500|FG000|Overall Study|Withdrawal by Subject|0|||
13426124|NCT00431951|26877501|FG001|Overall Study|Withdrawal by Subject|1|||
13426125|NCT00431951|26877502|FG002|Overall Study|Withdrawal by Subject|0|||
13426126|NCT00431951|26877503|FG003|Overall Study|Withdrawal by Subject|0|||
13426127|NCT00431951|26877500|FG000|Overall Study|Adverse Event|0|||
13426128|NCT00431951|26877501|FG001|Overall Study|Adverse Event|0|||
13426129|NCT00431951|26877502|FG002|Overall Study|Adverse Event|1|||
13426130|NCT00431951|26877503|FG003|Overall Study|Adverse Event|0|||
13426131|NCT00431847|26877591|FG000|Overall Study|completion of less than two study visits|6|||
13426132|NCT00431847|26877592|FG001|Overall Study|completion of less than two study visits|3|||
13426133|NCT00431847|26877593|FG002|Overall Study|completion of less than two study visits|4|||
13426134|NCT00431847|26877594|FG003|Overall Study|completion of less than two study visits|14|||
13426135|NCT00431847|26877595|FG004|Overall Study|completion of less than two study visits|0|||
13426136|NCT00431847|26877591|FG000|Overall Study|Protocol Violation|0|||
13426137|NCT00431847|26877592|FG001|Overall Study|Protocol Violation|0|||
13426138|NCT00431847|26877593|FG002|Overall Study|Protocol Violation|0|||
13426139|NCT00431847|26877594|FG003|Overall Study|Protocol Violation|0|||
13426140|NCT00431847|26877595|FG004|Overall Study|Protocol Violation|1|||
13426141|NCT00431834|26877604|FG000|Overall Study|Withdrawal by Subject|7|||
13426142|NCT00431834|26877604|FG000|Overall Study|Death|3|||
13426143|NCT00431834|26877604|FG000|Overall Study|Missed Endpoint Visit|2|||
13426144|NCT00431834|26877604|FG000|Overall Study|Lost to Follow-up|1|||
13426145|NCT00431496|26877615|FG000|Overall Study|Adverse Event|3|||
13426146|NCT00431496|26877615|FG000|Overall Study|Lost to Follow-up|1|||
13426147|NCT00431496|26877615|FG000|Overall Study|Withdrawal by Subject|2|||
13426148|NCT00431496|26877615|FG000|Overall Study|Protocol-specified criteria|5|||
13426149|NCT00431444|26877646|FG000|Overall Study|Protocol Violation|1|||
13426150|NCT00431444|26877647|FG001|Overall Study|Protocol Violation|4|||
13426151|NCT00431444|26877646|FG000|Overall Study|Adverse Event|2|||
13426152|NCT00431444|26877647|FG001|Overall Study|Adverse Event|1|||
13426153|NCT00431444|26877646|FG000|Overall Study|Withdrawal by Subject|1|||
13426154|NCT00431444|26877647|FG001|Overall Study|Withdrawal by Subject|1|||
13426155|NCT00431444|26877646|FG000|Overall Study|Lost to Follow-up|1|||
13426156|NCT00431444|26877647|FG001|Overall Study|Lost to Follow-up|0|||
13426157|NCT00431444|26877646|FG000|Overall Study|Administrative Problems|0|||
13426158|NCT00431444|26877647|FG001|Overall Study|Administrative Problems|1|||
13426159|NCT00431067|26877657|FG000|Overall Study|Other Adverse Event|9|||
13426160|NCT00431067|26877657|FG000|Overall Study|Progressive disease|30|||
13426161|NCT00431067|26877657|FG000|Overall Study|Non-compliance,lost to follow-up|2|||
13426162|NCT00430989|26877682|FG000|Overall Study|Lost to Follow-up|2|||
13426163|NCT00430989|26877683|FG001|Overall Study|Lost to Follow-up|3|||
13426164|NCT00430989|26877682|FG000|Overall Study|Withdrawal by Subject|15|||
13426165|NCT00430989|26877683|FG001|Overall Study|Withdrawal by Subject|14|||
13426166|NCT00430989|26877682|FG000|Overall Study|Protocol Violation|30|||
13426167|NCT00430989|26877683|FG001|Overall Study|Protocol Violation|37|||
13426168|NCT00430989|26877682|FG000|Overall Study|Not eligible|13|||
13426169|NCT00430989|26877683|FG001|Overall Study|Not eligible|6|||
13426170|NCT00430937|26877698|FG000|Overall Study|Adverse Event|3|||
13426171|NCT00430937|26877699|FG001|Overall Study|Adverse Event|8|||
13426172|NCT00430937|26877698|FG000|Overall Study|Death|0|||
13426173|NCT00430937|26877699|FG001|Overall Study|Death|1|||
13426174|NCT00430937|26877698|FG000|Overall Study|Lost to Follow-up|6|||
13426175|NCT00430937|26877699|FG001|Overall Study|Lost to Follow-up|6|||
13426176|NCT00430937|26877698|FG000|Overall Study|Withdrawal by Subject|5|||
13426177|NCT00430937|26877699|FG001|Overall Study|Withdrawal by Subject|2|||
13426178|NCT00430937|26877698|FG000|Overall Study|Protocol Violation|3|||
13426179|NCT00430937|26877699|FG001|Overall Study|Protocol Violation|2|||
13426180|NCT00430937|26877698|FG000|Overall Study|Lack of Efficacy|6|||
13426181|NCT00430937|26877699|FG001|Overall Study|Lack of Efficacy|5|||
13426182|NCT00430937|26877698|FG000|Overall Study|Inappropriate enrollment|2|||
13426183|NCT00430937|26877699|FG001|Overall Study|Inappropriate enrollment|1|||
13426184|NCT00430937|26877698|FG000|Overall Study|Administrative reasons|1|||
13426185|NCT00430937|26877699|FG001|Overall Study|Administrative reasons|0|||
13426186|NCT00430937|26877698|FG000|Overall Study|Protocol discontinuation criteria met|1|||
13426187|NCT00430937|26877699|FG001|Overall Study|Protocol discontinuation criteria met|2|||
13426188|NCT00430937|26877698|FG000|Overall Study|Unable to classify|0|||
13426189|NCT00430937|26877699|FG001|Overall Study|Unable to classify|1|||
13426190|NCT00430781|26877732|FG000|Interim Analysis; 11 February 2008|Adverse Event|10|||
13426191|NCT00430781|26877733|FG001|Interim Analysis; 11 February 2008|Adverse Event|3|||
13426192|NCT00430781|26877734|FG002|Interim Analysis; 11 February 2008|Adverse Event|7|||
13426193|NCT00430781|26877732|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
13426194|NCT00430781|26877733|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0|||
13426195|NCT00430781|26877734|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
13426196|NCT00430781|26877732|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0|||
13426197|NCT00430781|26877733|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1|||
13426198|NCT00430781|26877734|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0|||
13426199|NCT00430781|26877732|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4|||
13426200|NCT00430781|26877733|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0|||
13426201|NCT00430781|26877734|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2|||
13426202|NCT00430781|26877732|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1|||
13426203|NCT00430781|26877733|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
13426204|NCT00430781|26877734|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
13426205|NCT00430781|26877732|FG000|Interim Analysis; 11 February 2008|Disease Progression|16|||
13426206|NCT00430781|26877733|FG001|Interim Analysis; 11 February 2008|Disease Progression|30|||
13426207|NCT00430781|26877734|FG002|Interim Analysis; 11 February 2008|Disease Progression|22|||
13426208|NCT00430781|26877732|FG000|Interim Analysis; 11 February 2008|Death|0|||
13426209|NCT00430781|26877733|FG001|Interim Analysis; 11 February 2008|Death|1|||
13426210|NCT00430781|26877734|FG002|Interim Analysis; 11 February 2008|Death|0|||
13426211|NCT00430781|26877732|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2|||
13426212|NCT00430781|26877733|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
13426213|NCT00430781|26877734|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
13426214|NCT00430781|26877732|FG000|Interim Analysis; 11 February 2008|Physician Decision|2|||
13426215|NCT00430781|26877733|FG001|Interim Analysis; 11 February 2008|Physician Decision|3|||
13426216|NCT00430781|26877734|FG002|Interim Analysis; 11 February 2008|Physician Decision|3|||
13426217|NCT00430781|26877732|FG000|Interim Analysis; 11 February 2008|Ongoing|23|||
13426218|NCT00430781|26877733|FG001|Interim Analysis; 11 February 2008|Ongoing|20|||
13426219|NCT00430781|26877734|FG002|Interim Analysis; 11 February 2008|Ongoing|25|||
13426220|NCT00430781|26877732|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
13426221|NCT00430781|26877733|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
13426222|NCT00430781|26877734|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3|||
13426223|NCT00430781|26877732|FG000|Final Analysis; 31 July 2008|Protocol Violation|0|||
13426224|NCT00430781|26877733|FG001|Final Analysis; 31 July 2008|Protocol Violation|1|||
13426225|NCT00430781|26877734|FG002|Final Analysis; 31 July 2008|Protocol Violation|0|||
13426226|NCT00430781|26877732|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0|||
13426227|NCT00430781|26877733|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2|||
13426228|NCT00430781|26877734|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7|||
13426229|NCT00430781|26877732|FG000|Final Analysis; 31 July 2008|Physician Decision|0|||
13426230|NCT00430781|26877733|FG001|Final Analysis; 31 July 2008|Physician Decision|6|||
13426231|NCT00430781|26877734|FG002|Final Analysis; 31 July 2008|Physician Decision|6|||
13426232|NCT00430781|26877732|FG000|Final Analysis; 31 July 2008|Other|0|||
13426233|NCT00430781|26877733|FG001|Final Analysis; 31 July 2008|Other|1|||
13426234|NCT00430781|26877734|FG002|Final Analysis; 31 July 2008|Other|0|||
13426235|NCT00430781|26877732|FG000|Final Analysis; 31 July 2008|Ongoing|0|||
13426236|NCT00430781|26877733|FG001|Final Analysis; 31 July 2008|Ongoing|29|||
13426237|NCT00430781|26877734|FG002|Final Analysis; 31 July 2008|Ongoing|32|||
13426238|NCT00430781|26877732|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5|||
13426239|NCT00430781|26877733|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
13426240|NCT00430781|26877734|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
13426241|NCT00430781|26877732|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
13426242|NCT00430781|26877733|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1|||
13426243|NCT00430781|26877734|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
13426244|NCT00430781|26877732|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
13426245|NCT00430781|26877733|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2|||
13426246|NCT00430781|26877734|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
13426247|NCT00430781|26877732|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
13426248|NCT00430781|26877733|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5|||
13426249|NCT00430781|26877734|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
13426250|NCT00430781|26877732|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4|||
13426251|NCT00430781|26877733|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
13426252|NCT00430781|26877734|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
13426253|NCT00430781|26877732|FG000|End-of-Study Analysis; 28 July 2011|Other|4|||
13426254|NCT00430781|26877733|FG001|End-of-Study Analysis; 28 July 2011|Other|1|||
13426255|NCT00430781|26877734|FG002|End-of-Study Analysis; 28 July 2011|Other|0|||
13426256|NCT00430755|26877740|FG000|Overall Study|Withdrawal by Subject|53|||
13426257|NCT00430716|26877779|FG000|Double Blind Phase|Death|1|||
13426258|NCT00430716|26877780|FG001|Double Blind Phase|Death|0|||
13426259|NCT00430716|26877781|FG002|Double Blind Phase|Death|0|||
13426260|NCT00430716|26877779|FG000|Double Blind Phase|No longer willing to participate|2|||
13426261|NCT00430716|26877780|FG001|Double Blind Phase|No longer willing to participate|1|||
13426262|NCT00430716|26877781|FG002|Double Blind Phase|No longer willing to participate|1|||
13426263|NCT00430716|26877779|FG000|Double Blind Phase|Other|0|||
13426264|NCT00430716|26877780|FG001|Double Blind Phase|Other|2|||
13426265|NCT00430716|26877781|FG002|Double Blind Phase|Other|0|||
13426266|NCT00430716|26877779|FG000|Double Blind Phase|Study terminated by sponsor|1|||
13426267|NCT00430716|26877780|FG001|Double Blind Phase|Study terminated by sponsor|1|||
13426268|NCT00430716|26877781|FG002|Double Blind Phase|Study terminated by sponsor|2|||
13426269|NCT00430716|26877779|FG000|Double Blind Phase|Adverse Event|1|||
13426270|NCT00430716|26877780|FG001|Double Blind Phase|Adverse Event|1|||
13426271|NCT00430716|26877781|FG002|Double Blind Phase|Adverse Event|3|||
13426272|NCT00430716|26877779|FG000|Double Blind Phase|Not treated|1|||
13426273|NCT00430716|26877780|FG001|Double Blind Phase|Not treated|0|||
13426274|NCT00430716|26877781|FG002|Double Blind Phase|Not treated|0|||
13426275|NCT00430716|26877779|FG000|Open Label Phase|Lost to Follow-up|1|||
13426276|NCT00430716|26877780|FG001|Open Label Phase|Lost to Follow-up|0|||
13426277|NCT00430716|26877781|FG002|Open Label Phase|Lost to Follow-up|1|||
13426278|NCT00430716|26877779|FG000|Open Label Phase|No longer willing to participate|0|||
13426279|NCT00430716|26877780|FG001|Open Label Phase|No longer willing to participate|1|||
13426280|NCT00430716|26877781|FG002|Open Label Phase|No longer willing to participate|1|||
13426281|NCT00430716|26877779|FG000|Open Label Phase|Other|3|||
13426282|NCT00430716|26877780|FG001|Open Label Phase|Other|1|||
13426283|NCT00430716|26877781|FG002|Open Label Phase|Other|1|||
13426284|NCT00430716|26877779|FG000|Open Label Phase|Protocol Violation|1|||
13426285|NCT00430716|26877780|FG001|Open Label Phase|Protocol Violation|0|||
13426286|NCT00430716|26877781|FG002|Open Label Phase|Protocol Violation|0|||
13426287|NCT00430716|26877779|FG000|Open Label Phase|Study terminated by sponsor|4|||
13426288|NCT00430716|26877780|FG001|Open Label Phase|Study terminated by sponsor|5|||
13426289|NCT00430716|26877781|FG002|Open Label Phase|Study terminated by sponsor|4|||
13426290|NCT00430677|26877912|FG000|Short-term Period|Death|1|||
13426291|NCT00430677|26877913|FG001|Short-term Period|Death|1|||
13426292|NCT00430677|26877914|FG002|Short-term Period|Death|5|||
13426293|NCT00430677|26877912|FG000|Short-term Period|Adverse Event|15|||
13426294|NCT00430677|26877913|FG001|Short-term Period|Adverse Event|13|||
13426295|NCT00430677|26877914|FG002|Short-term Period|Adverse Event|9|||
13426296|NCT00430677|26877912|FG000|Short-term Period|Lack of Efficacy|5|||
13426297|NCT00430677|26877913|FG001|Short-term Period|Lack of Efficacy|6|||
13426298|NCT00430677|26877914|FG002|Short-term Period|Lack of Efficacy|4|||
13426299|NCT00430677|26877912|FG000|Short-term Period|Withdrawal by Subject|1|||
13426300|NCT00430677|26877913|FG001|Short-term Period|Withdrawal by Subject|1|||
13426301|NCT00430677|26877914|FG002|Short-term Period|Withdrawal by Subject|2|||
13426302|NCT00430677|26877912|FG000|Short-term Period|Participant no longer met study criteria|1|||
13426303|NCT00430677|26877913|FG001|Short-term Period|Participant no longer met study criteria|1|||
13426304|NCT00430677|26877914|FG002|Short-term Period|Participant no longer met study criteria|2|||
13426305|NCT00430677|26877912|FG000|Short-term Period|Poor compliance/ noncompliance|0|||
13426306|NCT00430677|26877913|FG001|Short-term Period|Poor compliance/ noncompliance|1|||
13426307|NCT00430677|26877914|FG002|Short-term Period|Poor compliance/ noncompliance|0|||
13426308|NCT00430677|26877912|FG000|Short-term Period|Pregnancy|0|||
13426309|NCT00430677|26877913|FG001|Short-term Period|Pregnancy|2|||
13426310|NCT00430677|26877914|FG002|Short-term Period|Pregnancy|0|||
13426311|NCT00430677|26877912|FG000|Long-term Extension Period|Death|1|||
13426312|NCT00430677|26877913|FG001|Long-term Extension Period|Death|0|||
13426313|NCT00430677|26877914|FG002|Long-term Extension Period|Death|0|||
13426314|NCT00430677|26877912|FG000|Long-term Extension Period|Adverse Event|3|||
13426315|NCT00430677|26877913|FG001|Long-term Extension Period|Adverse Event|2|||
13426316|NCT00430677|26877914|FG002|Long-term Extension Period|Adverse Event|5|||
13426317|NCT00430677|26877912|FG000|Long-term Extension Period|Lack of Efficacy|5|||
13426318|NCT00430677|26877913|FG001|Long-term Extension Period|Lack of Efficacy|3|||
13426319|NCT00430677|26877914|FG002|Long-term Extension Period|Lack of Efficacy|8|||
13426320|NCT00430677|26877912|FG000|Long-term Extension Period|Lost to Follow-up|1|||
13426321|NCT00430677|26877913|FG001|Long-term Extension Period|Lost to Follow-up|1|||
13426322|NCT00430677|26877914|FG002|Long-term Extension Period|Lost to Follow-up|1|||
13426323|NCT00430677|26877912|FG000|Long-term Extension Period|Withdrawal by Subject|5|||
13426324|NCT00430677|26877913|FG001|Long-term Extension Period|Withdrawal by Subject|1|||
13426325|NCT00430677|26877914|FG002|Long-term Extension Period|Withdrawal by Subject|2|||
13426326|NCT00430677|26877912|FG000|Long-term Extension Period|Pregnancy|1|||
13426327|NCT00430677|26877913|FG001|Long-term Extension Period|Pregnancy|1|||
13426328|NCT00430677|26877914|FG002|Long-term Extension Period|Pregnancy|0|||
13426329|NCT00430677|26877912|FG000|Long-term Extension Period|Administrative reason by sponsor|41|||
13426330|NCT00430677|26877913|FG001|Long-term Extension Period|Administrative reason by sponsor|49|||
13426331|NCT00430677|26877914|FG002|Long-term Extension Period|Administrative reason by sponsor|46|||
13426332|NCT00430677|26877912|FG000|Long-term Extension Period|Other|2|||
13426333|NCT00430677|26877913|FG001|Long-term Extension Period|Other|1|||
13426334|NCT00430677|26877914|FG002|Long-term Extension Period|Other|1|||
13426335|NCT00430677|26877912|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
13426336|NCT00430677|26877913|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
13426337|NCT00430677|26877914|FG002|Long-term Extension Period|Poor compliance/noncompliance|0|||
13426338|NCT00430638|26877937|FG000|Overall Study|Adverse Event|15|||
13426339|NCT00430638|26877938|FG001|Overall Study|Adverse Event|15|||
13426340|NCT00430638|26877937|FG000|Overall Study|Uncontrolled blood pressure|48|||
13426341|NCT00430638|26877938|FG001|Overall Study|Uncontrolled blood pressure|13|||
13426342|NCT00430638|26877937|FG000|Overall Study|Lost to Follow-up|1|||
13426343|NCT00430638|26877938|FG001|Overall Study|Lost to Follow-up|7|||
13426344|NCT00430638|26877937|FG000|Overall Study|Protocol Violation|6|||
13426345|NCT00430638|26877938|FG001|Overall Study|Protocol Violation|4|||
13426346|NCT00430638|26877937|FG000|Overall Study|Withdrawal by Subject|4|||
13426347|NCT00430638|26877938|FG001|Overall Study|Withdrawal by Subject|6|||
13426348|NCT00430638|26877937|FG000|Overall Study|Non-compliant|2|||
13426349|NCT00430638|26877938|FG001|Overall Study|Non-compliant|1|||
13426350|NCT00430638|26877937|FG000|Overall Study|Other|2|||
13426351|NCT00430638|26877938|FG001|Overall Study|Other|2|||
13426352|NCT00430573|26877945|FG000|Overall Study|Withdrawal by Subject|5|||
13426353|NCT00430521|26878208|FG000|Overall Study|Adverse Event|0|||
13426354|NCT00430521|26878209|FG001|Overall Study|Adverse Event|0|||
13426355|NCT00430521|26878210|FG002|Overall Study|Adverse Event|0|||
13426356|NCT00430521|26878211|FG003|Overall Study|Adverse Event|0|||
13426357|NCT00430521|26878212|FG004|Overall Study|Adverse Event|0|||
13426358|NCT00430521|26878213|FG005|Overall Study|Adverse Event|2|||
13426359|NCT00430521|26878214|FG006|Overall Study|Adverse Event|1|||
13426360|NCT00430521|26878215|FG007|Overall Study|Adverse Event|0|||
13426361|NCT00430521|26878208|FG000|Overall Study|Lost to Follow-up|7|||
13426362|NCT00430521|26878209|FG001|Overall Study|Lost to Follow-up|8|||
13426363|NCT00430521|26878210|FG002|Overall Study|Lost to Follow-up|3|||
13426364|NCT00430521|26878211|FG003|Overall Study|Lost to Follow-up|5|||
13426365|NCT00430521|26878212|FG004|Overall Study|Lost to Follow-up|5|||
13426366|NCT00430521|26878213|FG005|Overall Study|Lost to Follow-up|2|||
13426367|NCT00430521|26878214|FG006|Overall Study|Lost to Follow-up|8|||
13426368|NCT00430521|26878215|FG007|Overall Study|Lost to Follow-up|10|||
13426369|NCT00430521|26878208|FG000|Overall Study|Pregnancy|0|||
13426370|NCT00430521|26878209|FG001|Overall Study|Pregnancy|0|||
13426371|NCT00430521|26878210|FG002|Overall Study|Pregnancy|0|||
13426372|NCT00430521|26878211|FG003|Overall Study|Pregnancy|0|||
13426373|NCT00430521|26878212|FG004|Overall Study|Pregnancy|0|||
13426374|NCT00430521|26878213|FG005|Overall Study|Pregnancy|0|||
13426375|NCT00430521|26878214|FG006|Overall Study|Pregnancy|1|||
13426376|NCT00430521|26878215|FG007|Overall Study|Pregnancy|0|||
13426377|NCT00430521|26878208|FG000|Overall Study|Vaccine Expired|0|||
13426378|NCT00430521|26878209|FG001|Overall Study|Vaccine Expired|0|||
13426379|NCT00430521|26878210|FG002|Overall Study|Vaccine Expired|0|||
13426380|NCT00430521|26878211|FG003|Overall Study|Vaccine Expired|0|||
13426381|NCT00430521|26878212|FG004|Overall Study|Vaccine Expired|0|||
13426382|NCT00430521|26878213|FG005|Overall Study|Vaccine Expired|1|||
13426383|NCT00430521|26878214|FG006|Overall Study|Vaccine Expired|0|||
13426384|NCT00430521|26878215|FG007|Overall Study|Vaccine Expired|0|||
13426385|NCT00430521|26878208|FG000|Overall Study|Protocol Violation|1|||
13426386|NCT00430521|26878209|FG001|Overall Study|Protocol Violation|0|||
13426387|NCT00430521|26878210|FG002|Overall Study|Protocol Violation|0|||
13426388|NCT00430521|26878211|FG003|Overall Study|Protocol Violation|0|||
13426389|NCT00430521|26878212|FG004|Overall Study|Protocol Violation|0|||
13426390|NCT00430521|26878213|FG005|Overall Study|Protocol Violation|0|||
13426391|NCT00430521|26878214|FG006|Overall Study|Protocol Violation|0|||
13426392|NCT00430521|26878215|FG007|Overall Study|Protocol Violation|0|||
13426393|NCT00430521|26878208|FG000|Overall Study|Withdrawal by Subject|3|||
13426394|NCT00430521|26878209|FG001|Overall Study|Withdrawal by Subject|1|||
13426395|NCT00430521|26878210|FG002|Overall Study|Withdrawal by Subject|0|||
13426396|NCT00430521|26878211|FG003|Overall Study|Withdrawal by Subject|3|||
13426397|NCT00430521|26878212|FG004|Overall Study|Withdrawal by Subject|0|||
13426398|NCT00430521|26878213|FG005|Overall Study|Withdrawal by Subject|0|||
13426399|NCT00430521|26878214|FG006|Overall Study|Withdrawal by Subject|0|||
13426400|NCT00430521|26878215|FG007|Overall Study|Withdrawal by Subject|2|||
13426401|NCT00430495|26878266|FG000|Overall Study|Adverse Event|2|||
13426402|NCT00430495|26878267|FG001|Overall Study|Adverse Event|3|||
13426403|NCT00430495|26878268|FG002|Overall Study|Adverse Event|2|||
13426404|NCT00430495|26878269|FG003|Overall Study|Adverse Event|0|||
13426405|NCT00430495|26878266|FG000|Overall Study|Death|0|||
13426406|NCT00430495|26878267|FG001|Overall Study|Death|0|||
13426407|NCT00430495|26878268|FG002|Overall Study|Death|1|||
13426408|NCT00430495|26878269|FG003|Overall Study|Death|0|||
13426409|NCT00430495|26878266|FG000|Overall Study|Lost to Follow-up|0|||
13426410|NCT00430495|26878267|FG001|Overall Study|Lost to Follow-up|1|||
13426411|NCT00430495|26878268|FG002|Overall Study|Lost to Follow-up|4|||
13426412|NCT00430495|26878269|FG003|Overall Study|Lost to Follow-up|0|||
13426413|NCT00430495|26878266|FG000|Overall Study|Protocol Violation|1|||
13426414|NCT00430495|26878267|FG001|Overall Study|Protocol Violation|0|||
13426415|NCT00430495|26878268|FG002|Overall Study|Protocol Violation|1|||
13426416|NCT00430495|26878269|FG003|Overall Study|Protocol Violation|0|||
13426417|NCT00430495|26878266|FG000|Overall Study|Disease Progression|1|||
13426418|NCT00430495|26878267|FG001|Overall Study|Disease Progression|1|||
13426419|NCT00430495|26878268|FG002|Overall Study|Disease Progression|0|||
13426420|NCT00430495|26878269|FG003|Overall Study|Disease Progression|0|||
13426421|NCT00430495|26878266|FG000|Overall Study|Other|8|||
13426422|NCT00430495|26878267|FG001|Overall Study|Other|2|||
13426423|NCT00430495|26878268|FG002|Overall Study|Other|5|||
13426424|NCT00430495|26878269|FG003|Overall Study|Other|4|||
13426425|NCT00430495|26878266|FG000|Overall Study|Randomized but not Treated|2|||
13426426|NCT00430495|26878267|FG001|Overall Study|Randomized but not Treated|0|||
13426427|NCT00430495|26878268|FG002|Overall Study|Randomized but not Treated|0|||
13426428|NCT00430495|26878269|FG003|Overall Study|Randomized but not Treated|0|||
13426429|NCT00430482|26878284|FG000|Completed Treatment|Insufficient Treatment|7|||
13426430|NCT00430482|26878285|FG001|Completed Treatment|Insufficient Treatment|11|||
13426431|NCT00430352|26878301|FG000|Overall Study|Disease progression|58|||
13426432|NCT00430352|26878301|FG000|Overall Study|Withdrawal by Subject|11|||
13426433|NCT00430352|26878301|FG000|Overall Study|Adverse Event|16|||
13426434|NCT00430352|26878301|FG000|Overall Study|Death|5|||
13426435|NCT00430352|26878301|FG000|Overall Study|Other|48|||
13426436|NCT00430300|26878416|FG000|Overall Study|Adverse Event|0|||
13426437|NCT00430300|26878417|FG001|Overall Study|Adverse Event|2|||
13426438|NCT00430300|26878418|FG002|Overall Study|Adverse Event|1|||
13426439|NCT00430300|26878419|FG003|Overall Study|Adverse Event|1|||
13426440|NCT00430300|26878416|FG000|Overall Study|Withdrawal by Subject|1|||
13426441|NCT00430300|26878417|FG001|Overall Study|Withdrawal by Subject|0|||
13426442|NCT00430300|26878418|FG002|Overall Study|Withdrawal by Subject|5|||
13426443|NCT00430300|26878419|FG003|Overall Study|Withdrawal by Subject|0|||
13426444|NCT00430300|26878416|FG000|Overall Study|Laboratory abnormality|1|||
13426445|NCT00430300|26878417|FG001|Overall Study|Laboratory abnormality|0|||
13426446|NCT00430300|26878418|FG002|Overall Study|Laboratory abnormality|0|||
13426447|NCT00430300|26878419|FG003|Overall Study|Laboratory abnormality|0|||
13426448|NCT00430300|26878416|FG000|Overall Study|Other|0|||
13426449|NCT00430300|26878417|FG001|Overall Study|Other|0|||
13426450|NCT00430300|26878418|FG002|Overall Study|Other|0|||
13426451|NCT00430300|26878419|FG003|Overall Study|Other|1|||
13426452|NCT00430248|26878485|FG000|Overall Study|Adverse Event|49|||
13426453|NCT00430248|26878486|FG001|Overall Study|Adverse Event|61|||
13426454|NCT00430248|26878487|FG002|Overall Study|Adverse Event|64|||
13426455|NCT00430248|26878485|FG000|Overall Study|Protocol Violation|10|||
13426456|NCT00430248|26878486|FG001|Overall Study|Protocol Violation|2|||
13426457|NCT00430248|26878487|FG002|Overall Study|Protocol Violation|4|||
13426458|NCT00430248|26878485|FG000|Overall Study|Personal Reasons|12|||
13426459|NCT00430248|26878486|FG001|Overall Study|Personal Reasons|24|||
13426460|NCT00430248|26878487|FG002|Overall Study|Personal Reasons|9|||
13426461|NCT00430248|26878485|FG000|Overall Study|Lost to Follow-up|28|||
13426462|NCT00430248|26878486|FG001|Overall Study|Lost to Follow-up|33|||
13426463|NCT00430248|26878487|FG002|Overall Study|Lost to Follow-up|28|||
13426464|NCT00430248|26878485|FG000|Overall Study|Therapeutic Failure|1|||
13426465|NCT00430248|26878486|FG001|Overall Study|Therapeutic Failure|1|||
13426466|NCT00430248|26878487|FG002|Overall Study|Therapeutic Failure|1|||
13426467|NCT00430248|26878485|FG000|Overall Study|Withdrawal by Subject|14|||
13426468|NCT00430248|26878486|FG001|Overall Study|Withdrawal by Subject|20|||
13426469|NCT00430248|26878487|FG002|Overall Study|Withdrawal by Subject|16|||
13426470|NCT00430248|26878485|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
13426471|NCT00430248|26878486|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
13426472|NCT00430248|26878487|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
13426473|NCT00430248|26878485|FG000|Overall Study|Gout Flare|3|||
13426474|NCT00430248|26878486|FG001|Overall Study|Gout Flare|7|||
13426475|NCT00430248|26878487|FG002|Overall Study|Gout Flare|2|||
13426476|NCT00430248|26878485|FG000|Overall Study|Reason Not Specified|8|||
13426477|NCT00430248|26878486|FG001|Overall Study|Reason Not Specified|8|||
13426478|NCT00430248|26878487|FG002|Overall Study|Reason Not Specified|11|||
13426479|NCT00430027|26878493|FG000|Overall Study|Study terminated|8|||
13426480|NCT00429858|26878506|FG000|Overall Study|Withdrawal by Subject|1|||
13426481|NCT00429858|26878506|FG000|Overall Study|Study Termination|1|||
13426482|NCT00429793|26878522|FG000|Overall Study|Improper pre-protocol treatment|3|||
13426483|NCT00429793|26878522|FG000|Overall Study|Required test not done|1|||
13426484|NCT00429793|26878522|FG000|Overall Study|Never treated|1|||
13426485|NCT00429793|26878522|FG000|Overall Study|Non-measurable|1|||
13426486|NCT00429663|26878543|FG000|Overall Study|Lost to Follow-up|24|||
13426487|NCT00429663|26878544|FG001|Overall Study|Lost to Follow-up|31|||
13426488|NCT00429663|26878543|FG000|Overall Study|Physician Decision|6|||
13426489|NCT00429663|26878544|FG001|Overall Study|Physician Decision|3|||
13426490|NCT00429663|26878543|FG000|Overall Study|Withdrawal by Subject|2|||
13426491|NCT00429663|26878544|FG001|Overall Study|Withdrawal by Subject|5|||
13426492|NCT00429663|26878543|FG000|Overall Study|Death|4|||
13426493|NCT00429663|26878544|FG001|Overall Study|Death|0|||
13426494|NCT00429585|26878577|FG000|Overall Study|Death|1|||
13426495|NCT00429585|26878578|FG001|Overall Study|Death|0|||
13426496|NCT00429585|26878577|FG000|Overall Study|Lost to Follow-up|27|||
13426497|NCT00429585|26878578|FG001|Overall Study|Lost to Follow-up|20|||
13426498|NCT00429585|26878577|FG000|Overall Study|Physician Decision|2|||
13426499|NCT00429585|26878578|FG001|Overall Study|Physician Decision|0|||
13426500|NCT00429572|26878588|FG000|Overall Study|Disease progression|1|||
13426501|NCT00429494|26878594|FG000|Overall Study|Withdrawal by Subject|9|||
13426502|NCT00429494|26878594|FG000|Overall Study|Death|6|||
13426503|NCT00429416|26878604|FG000|Overall Study|Death|1|||
13426504|NCT00429364|26878667|FG000|Overall Study|Withdrawal by Subject|11|||
13426505|NCT00429364|26878668|FG001|Overall Study|Withdrawal by Subject|5|||
13426506|NCT00429364|26878667|FG000|Overall Study|Physician Decision|4|||
13426507|NCT00429364|26878668|FG001|Overall Study|Physician Decision|2|||
13426508|NCT00429364|26878667|FG000|Overall Study|Lost to Follow-up|7|||
13426509|NCT00429364|26878668|FG001|Overall Study|Lost to Follow-up|6|||
13426510|NCT00429364|26878667|FG000|Overall Study|Death|0|||
13426511|NCT00429364|26878668|FG001|Overall Study|Death|1|||
13426512|NCT00429364|26878667|FG000|Overall Study|Underwent aortic root surgery|10|||
13426513|NCT00429364|26878668|FG001|Overall Study|Underwent aortic root surgery|18|||
13426514|NCT00429364|26878667|FG000|Overall Study|Pregnancy|0|||
13426515|NCT00429364|26878668|FG001|Overall Study|Pregnancy|1|||
13426516|NCT00429299|26878707|FG000|Overall Study|Disease Progression|1|||
13426517|NCT00429299|26878708|FG001|Overall Study|Disease Progression|1|||
13426518|NCT00429299|26878709|FG002|Overall Study|Disease Progression|0|||
13426519|NCT00429299|26878707|FG000|Overall Study|Adverse Event|2|||
13426520|NCT00429299|26878708|FG001|Overall Study|Adverse Event|5|||
13426521|NCT00429299|26878709|FG002|Overall Study|Adverse Event|1|||
13426522|NCT00429299|26878707|FG000|Overall Study|Protocol Violation|1|||
13426523|NCT00429299|26878708|FG001|Overall Study|Protocol Violation|0|||
13426524|NCT00429299|26878709|FG002|Overall Study|Protocol Violation|0|||
13426525|NCT00429299|26878707|FG000|Overall Study|Withdrawal by Subject|0|||
13426526|NCT00429299|26878708|FG001|Overall Study|Withdrawal by Subject|1|||
13426527|NCT00429299|26878709|FG002|Overall Study|Withdrawal by Subject|3|||
13426528|NCT00429273|26878727|FG000|Overall Study|Lost to Follow-up|1|||
13426529|NCT00429273|26878728|FG001|Overall Study|Lost to Follow-up|2|||
13426530|NCT00429273|26878729|FG002|Overall Study|Lost to Follow-up|2|||
13426531|NCT00429273|26878727|FG000|Overall Study|Physician Decision|6|||
13426532|NCT00429273|26878728|FG001|Overall Study|Physician Decision|5|||
13426533|NCT00429273|26878729|FG002|Overall Study|Physician Decision|5|||
13426534|NCT00429273|26878727|FG000|Overall Study|Adverse Event|1|||
13426535|NCT00429273|26878728|FG001|Overall Study|Adverse Event|1|||
13426536|NCT00429273|26878729|FG002|Overall Study|Adverse Event|2|||
13426537|NCT00429182|26878736|FG000|Overall Study|Not evaluable, Disease Progression|2|||
13426538|NCT00429182|26878736|FG000|Overall Study|Not eligible|5|||
13426539|NCT00429169|26878755|FG000|Overall Study|Lost to Follow-up|0|||
13426540|NCT00429169|26878756|FG001|Overall Study|Lost to Follow-up|1|||
13426541|NCT00429169|26878755|FG000|Overall Study|Ineligibility discovered after entry|2|||
13426542|NCT00429169|26878756|FG001|Overall Study|Ineligibility discovered after entry|1|||
13426543|NCT00429104|26878763|FG000|Overall Study|Protocol Violation|1|||
13426544|NCT00429026|26878769|FG000|Overall Study|Inevaluable for response.|40|||
13426545|NCT00428948|26878794|FG000|Overall Study|Lost to Follow-up|15|||
13426546|NCT00428948|26878795|FG001|Overall Study|Lost to Follow-up|8|||
13426547|NCT00428948|26878794|FG000|Overall Study|Adverse Event|148|||
13426548|NCT00428948|26878795|FG001|Overall Study|Adverse Event|24|||
13426549|NCT00428948|26878794|FG000|Overall Study|Subject Met Withdrawal Criteria|4|||
13426550|NCT00428948|26878795|FG001|Overall Study|Subject Met Withdrawal Criteria|0|||
13426551|NCT00428948|26878794|FG000|Overall Study|Investigator Withdrew Subject|3|||
13426552|NCT00428948|26878795|FG001|Overall Study|Investigator Withdrew Subject|4|||
13426553|NCT00428948|26878794|FG000|Overall Study|Subject Withdrew Consent|50|||
13426554|NCT00428948|26878795|FG001|Overall Study|Subject Withdrew Consent|30|||
13426555|NCT00428948|26878794|FG000|Overall Study|Protocol Deviation|1|||
13426556|NCT00428948|26878795|FG001|Overall Study|Protocol Deviation|1|||
13426557|NCT00428844|26878826|FG000|Completed Study Drug Treatment|Adverse Event|2|||
13426558|NCT00428844|26878827|FG001|Completed Study Drug Treatment|Adverse Event|4|||
13426559|NCT00428844|26878828|FG002|Completed Study Drug Treatment|Adverse Event|4|||
13426560|NCT00428844|26878826|FG000|Completed Study Drug Treatment|Protocol Violation|0|||
13426561|NCT00428844|26878827|FG001|Completed Study Drug Treatment|Protocol Violation|1|||
13426562|NCT00428844|26878828|FG002|Completed Study Drug Treatment|Protocol Violation|1|||
13426563|NCT00428844|26878826|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0|||
13426564|NCT00428844|26878827|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1|||
13426565|NCT00428844|26878828|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1|||
13426566|NCT00428844|26878826|FG000|Completed Study Drug Treatment|Randomized Not Treated|0|||
13426567|NCT00428844|26878827|FG001|Completed Study Drug Treatment|Randomized Not Treated|0|||
13426568|NCT00428844|26878828|FG002|Completed Study Drug Treatment|Randomized Not Treated|1|||
13426569|NCT00428844|26878826|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0|||
13426570|NCT00428844|26878827|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
13426571|NCT00428844|26878828|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
13426572|NCT00428844|26878826|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
13426573|NCT00428844|26878827|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
13426574|NCT00428844|26878828|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1|||
13426575|NCT00428844|26878826|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1|||
13426576|NCT00428844|26878827|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
13426577|NCT00428844|26878828|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
13426578|NCT00428844|26878826|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2|||
13426579|NCT00428844|26878827|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
13426580|NCT00428844|26878828|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
13426581|NCT00428844|26878826|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
13426582|NCT00428844|26878827|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1|||
13426583|NCT00428844|26878828|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
13426584|NCT00428792|26878859|FG000|Overall Study|Lack of Efficacy|1|||
13426585|NCT00428792|26878860|FG001|Overall Study|Lack of Efficacy|3|||
13426586|NCT00428792|26878859|FG000|Overall Study|Lost to Follow-up|0|||
13426587|NCT00428792|26878860|FG001|Overall Study|Lost to Follow-up|1|||
13426588|NCT00428714|26878883|FG000|Overall Study|Progressive Disease|28|||
13426589|NCT00428714|26878884|FG001|Overall Study|Progressive Disease|36|||
13426590|NCT00428714|26878883|FG000|Overall Study|Withdrawal by Subject|0|||
13426591|NCT00428714|26878884|FG001|Overall Study|Withdrawal by Subject|3|||
13426592|NCT00428714|26878883|FG000|Overall Study|Adverse Event|0|||
13426593|NCT00428714|26878884|FG001|Overall Study|Adverse Event|2|||
13426594|NCT00428714|26878883|FG000|Overall Study|Physician Decision|1|||
13426595|NCT00428714|26878884|FG001|Overall Study|Physician Decision|1|||
13426596|NCT00428714|26878883|FG000|Overall Study|Death due to Progressive Disease (PD)|1|||
13426597|NCT00428714|26878884|FG001|Overall Study|Death due to Progressive Disease (PD)|0|||
13426598|NCT00428714|26878883|FG000|Overall Study|Death due to other then PD|1|||
13426599|NCT00428714|26878884|FG001|Overall Study|Death due to other then PD|0|||
13426600|NCT00428610|26878926|FG000|Overall Study|Death Due to Adverse Event|3|||
13426601|NCT00428610|26878927|FG001|Overall Study|Death Due to Adverse Event|0|||
13426602|NCT00428610|26878928|FG002|Overall Study|Death Due to Adverse Event|5|||
13426603|NCT00428610|26878926|FG000|Overall Study|Death Due to Progressive Disease|0|||
13426604|NCT00428610|26878927|FG001|Overall Study|Death Due to Progressive Disease|0|||
13426605|NCT00428610|26878928|FG002|Overall Study|Death Due to Progressive Disease|2|||
13426606|NCT00428610|26878926|FG000|Overall Study|Adverse Event|2|||
13426607|NCT00428610|26878927|FG001|Overall Study|Adverse Event|3|||
13426608|NCT00428610|26878928|FG002|Overall Study|Adverse Event|2|||
13426609|NCT00428610|26878926|FG000|Overall Study|Investigator Decision|2|||
13426610|NCT00428610|26878927|FG001|Overall Study|Investigator Decision|1|||
13426611|NCT00428610|26878928|FG002|Overall Study|Investigator Decision|1|||
13426612|NCT00428610|26878926|FG000|Overall Study|Progressive Disease|42|||
13219915|NCT01829230|26278637|FG000|Overall Study|Lost to Follow-up|1|||
13426613|NCT00428610|26878927|FG001|Overall Study|Progressive Disease|14|||
13426614|NCT00428610|26878928|FG002|Overall Study|Progressive Disease|22|||
13426615|NCT00428610|26878926|FG000|Overall Study|Withdrawal by Subject|4|||
13426616|NCT00428610|26878927|FG001|Overall Study|Withdrawal by Subject|0|||
13426617|NCT00428610|26878928|FG002|Overall Study|Withdrawal by Subject|0|||
13426618|NCT00428597|26878975|FG000|Overall Study|Randomized but not treated|3|||
13426619|NCT00428597|26878976|FG001|Overall Study|Randomized but not treated|3|||
13426620|NCT00428597|26878975|FG000|Overall Study|Objective Progression or Relapse|19|||
13426621|NCT00428597|26878976|FG001|Overall Study|Objective Progression or Relapse|47|||
13426622|NCT00428597|26878975|FG000|Overall Study|Study Terminated by Sponsor|41|||
13426623|NCT00428597|26878976|FG001|Overall Study|Study Terminated by Sponsor|16|||
13426624|NCT00428597|26878975|FG000|Overall Study|Adverse Event|15|||
13426625|NCT00428597|26878976|FG001|Overall Study|Adverse Event|7|||
13426626|NCT00428597|26878975|FG000|Overall Study|Global Deterioration of Health Status|1|||
13426627|NCT00428597|26878976|FG001|Overall Study|Global Deterioration of Health Status|5|||
13426628|NCT00428597|26878975|FG000|Overall Study|Protocol Violation|2|||
13426629|NCT00428597|26878976|FG001|Overall Study|Protocol Violation|1|||
13426630|NCT00428597|26878975|FG000|Overall Study|Withdrawal by Subject|2|||
13426631|NCT00428597|26878976|FG001|Overall Study|Withdrawal by Subject|1|||
13426632|NCT00428597|26878975|FG000|Overall Study|Other|1|||
13426633|NCT00428597|26878976|FG001|Overall Study|Other|1|||
13426634|NCT00428597|26878975|FG000|Overall Study|Lost to Follow-up|0|||
13426635|NCT00428597|26878976|FG001|Overall Study|Lost to Follow-up|1|||
13426636|NCT00428597|26878975|FG000|Overall Study|Pregnancy|1|||
13426637|NCT00428597|26878976|FG001|Overall Study|Pregnancy|0|||
13426638|NCT00428597|26878975|FG000|Overall Study|Death|1|||
13426639|NCT00428597|26878976|FG001|Overall Study|Death|3|||
13426640|NCT00428441|26878982|FG000|Overall Study|Lost to Follow-up|1|||
13426641|NCT00428389|26879007|FG000|Core Phase|Adverse Event|6|||
13426642|NCT00428389|26879008|FG001|Core Phase|Adverse Event|4|||
13426643|NCT00428389|26879007|FG000|Core Phase|Lack of Efficacy|2|||
13426644|NCT00428389|26879008|FG001|Core Phase|Lack of Efficacy|0|||
13426645|NCT00428389|26879007|FG000|Core Phase|Abnormal test procedure result(s)|0|||
13426646|NCT00428389|26879008|FG001|Core Phase|Abnormal test procedure result(s)|1|||
13426647|NCT00428389|26879007|FG000|Core Phase|Withdrawal by Subject|3|||
13426648|NCT00428389|26879008|FG001|Core Phase|Withdrawal by Subject|4|||
13426649|NCT00428389|26879007|FG000|Core Phase|Protocol deviation|0|||
13426650|NCT00428389|26879008|FG001|Core Phase|Protocol deviation|2|||
13426651|NCT00428389|26879007|FG000|Extension Phase|Adverse Event|17|||
13426652|NCT00428389|26879008|FG001|Extension Phase|Adverse Event|11|||
13426653|NCT00428389|26879007|FG000|Extension Phase|Lack of Efficacy|4|||
13426654|NCT00428389|26879008|FG001|Extension Phase|Lack of Efficacy|3|||
13426655|NCT00428389|26879007|FG000|Extension Phase|Withdrawal by Subject|6|||
13426656|NCT00428389|26879008|FG001|Extension Phase|Withdrawal by Subject|6|||
13426657|NCT00428389|26879007|FG000|Extension Phase|Lost to Follow-up|0|||
13426658|NCT00428389|26879008|FG001|Extension Phase|Lost to Follow-up|3|||
13426659|NCT00428389|26879007|FG000|Extension Phase|Death|1|||
13426660|NCT00428389|26879008|FG001|Extension Phase|Death|0|||
13426661|NCT00428389|26879007|FG000|Extension Phase|Protocol Violation|3|||
13426662|NCT00428389|26879008|FG001|Extension Phase|Protocol Violation|2|||
13426663|NCT00428389|26879007|FG000|Extension Phase|Administrative problems|1|||
13426664|NCT00428389|26879008|FG001|Extension Phase|Administrative problems|1|||
13426665|NCT00428246|26879026|FG000|Overall Study|Withdrawal by Subject|0|||
13426666|NCT00428246|26879027|FG001|Overall Study|Withdrawal by Subject|0|||
13426667|NCT00428246|26879028|FG002|Overall Study|Withdrawal by Subject|1|||
13426668|NCT00428246|26879026|FG000|Overall Study|Adverse Event|1|||
13426669|NCT00428246|26879027|FG001|Overall Study|Adverse Event|0|||
13426670|NCT00428246|26879028|FG002|Overall Study|Adverse Event|0|||
13426671|NCT00428220|26879046|FG000|Overall Study|Participant died|8|||
13426672|NCT00428220|26879046|FG000|Overall Study|Global deterioration of health status|7|||
13426673|NCT00428220|26879046|FG000|Overall Study|Lost to Follow-up|4|||
13426674|NCT00428220|26879046|FG000|Overall Study|Objective progression or relapse|123|||
13426675|NCT00428220|26879046|FG000|Overall Study|Participant refused continued treatment|7|||
13426676|NCT00428220|26879046|FG000|Overall Study|Adverse Event|51|||
13426677|NCT00428220|26879046|FG000|Overall Study|Other|23|||
13426678|NCT00428116|26879061|FG000|Overall Study|Death|1|||
13426679|NCT00428116|26879062|FG001|Overall Study|Death|0|||
13426680|NCT00428116|26879061|FG000|Overall Study|Withdrawal by Subject|1|||
13426681|NCT00428116|26879062|FG001|Overall Study|Withdrawal by Subject|0|||
13426682|NCT00428116|26879061|FG000|Overall Study|Lost to Follow-up|1|||
13426683|NCT00428116|26879062|FG001|Overall Study|Lost to Follow-up|0|||
13426684|NCT00428090|26879189|FG000|Overall Study|Adverse Event|10|||
13426685|NCT00428090|26879190|FG001|Overall Study|Adverse Event|8|||
13426686|NCT00428090|26879191|FG002|Overall Study|Adverse Event|10|||
13426687|NCT00428090|26879192|FG003|Overall Study|Adverse Event|11|||
13426688|NCT00428090|26879189|FG000|Overall Study|Lost to Follow-up|3|||
13426689|NCT00428090|26879190|FG001|Overall Study|Lost to Follow-up|6|||
13426690|NCT00428090|26879191|FG002|Overall Study|Lost to Follow-up|1|||
13426691|NCT00428090|26879192|FG003|Overall Study|Lost to Follow-up|4|||
13426692|NCT00428090|26879189|FG000|Overall Study|Protocol Violation|3|||
13426693|NCT00428090|26879190|FG001|Overall Study|Protocol Violation|1|||
13426694|NCT00428090|26879191|FG002|Overall Study|Protocol Violation|3|||
13426695|NCT00428090|26879192|FG003|Overall Study|Protocol Violation|3|||
13426696|NCT00428090|26879189|FG000|Overall Study|Withdrawal by Subject|10|||
13426697|NCT00428090|26879190|FG001|Overall Study|Withdrawal by Subject|12|||
13426698|NCT00428090|26879191|FG002|Overall Study|Withdrawal by Subject|15|||
13426699|NCT00428090|26879192|FG003|Overall Study|Withdrawal by Subject|5|||
13426700|NCT00428090|26879189|FG000|Overall Study|Sponsor terminated study|0|||
13426701|NCT00428090|26879190|FG001|Overall Study|Sponsor terminated study|1|||
13426702|NCT00428090|26879191|FG002|Overall Study|Sponsor terminated study|0|||
13426703|NCT00428090|26879192|FG003|Overall Study|Sponsor terminated study|0|||
13426704|NCT00428090|26879189|FG000|Overall Study|Non-compliance|4|||
13426705|NCT00428090|26879190|FG001|Overall Study|Non-compliance|0|||
13426706|NCT00428090|26879191|FG002|Overall Study|Non-compliance|1|||
13426707|NCT00428090|26879192|FG003|Overall Study|Non-compliance|3|||
13426708|NCT00428090|26879189|FG000|Overall Study|Par. did not returned to visit|1|||
13426709|NCT00428090|26879190|FG001|Overall Study|Par. did not returned to visit|0|||
13426710|NCT00428090|26879191|FG002|Overall Study|Par. did not returned to visit|0|||
13426711|NCT00428090|26879192|FG003|Overall Study|Par. did not returned to visit|1|||
13426712|NCT00428090|26879189|FG000|Overall Study|Follow-Up visit not possible|1|||
13426713|NCT00428090|26879190|FG001|Overall Study|Follow-Up visit not possible|0|||
13426714|NCT00428090|26879191|FG002|Overall Study|Follow-Up visit not possible|0|||
13426715|NCT00428090|26879192|FG003|Overall Study|Follow-Up visit not possible|0|||
13426716|NCT00428090|26879189|FG000|Overall Study|Prohibited medication used for SAE|1|||
13426717|NCT00428090|26879190|FG001|Overall Study|Prohibited medication used for SAE|0|||
13426718|NCT00428090|26879191|FG002|Overall Study|Prohibited medication used for SAE|0|||
13426719|NCT00428090|26879192|FG003|Overall Study|Prohibited medication used for SAE|0|||
13426720|NCT00428090|26879189|FG000|Overall Study|Death of par.|1|||
13426721|NCT00428090|26879190|FG001|Overall Study|Death of par.|0|||
13426722|NCT00428090|26879191|FG002|Overall Study|Death of par.|1|||
13426723|NCT00428090|26879192|FG003|Overall Study|Death of par.|0|||
13426724|NCT00428090|26879189|FG000|Overall Study|Visit 7 exceed the visit window|0|||
13426725|NCT00428090|26879190|FG001|Overall Study|Visit 7 exceed the visit window|1|||
13426726|NCT00428090|26879191|FG002|Overall Study|Visit 7 exceed the visit window|0|||
13426727|NCT00428090|26879192|FG003|Overall Study|Visit 7 exceed the visit window|0|||
13426728|NCT00428090|26879189|FG000|Overall Study|Medical monitor terminated par.|0|||
13426729|NCT00428090|26879190|FG001|Overall Study|Medical monitor terminated par.|1|||
13426730|NCT00428090|26879191|FG002|Overall Study|Medical monitor terminated par.|0|||
13426731|NCT00428090|26879192|FG003|Overall Study|Medical monitor terminated par.|0|||
13426732|NCT00428090|26879189|FG000|Overall Study|Mental status of par. was|0|||
13426733|NCT00428090|26879190|FG001|Overall Study|Mental status of par. was|1|||
13426734|NCT00428090|26879191|FG002|Overall Study|Mental status of par. was|0|||
13426735|NCT00428090|26879192|FG003|Overall Study|Mental status of par. was|0|||
13426736|NCT00428090|26879189|FG000|Overall Study|Worsening of AD|0|||
13426737|NCT00428090|26879190|FG001|Overall Study|Worsening of AD|0|||
13426738|NCT00428090|26879191|FG002|Overall Study|Worsening of AD|1|||
13426739|NCT00428090|26879192|FG003|Overall Study|Worsening of AD|0|||
13426740|NCT00428090|26879189|FG000|Overall Study|Excluded for concerning QTc value|0|||
13426741|NCT00428090|26879190|FG001|Overall Study|Excluded for concerning QTc value|0|||
13426742|NCT00428090|26879191|FG002|Overall Study|Excluded for concerning QTc value|1|||
13426743|NCT00428090|26879192|FG003|Overall Study|Excluded for concerning QTc value|0|||
13426744|NCT00428090|26879189|FG000|Overall Study|Insufficient AD documentation|0|||
13426745|NCT00428090|26879190|FG001|Overall Study|Insufficient AD documentation|0|||
13426746|NCT00428090|26879191|FG002|Overall Study|Insufficient AD documentation|1|||
13426747|NCT00428090|26879192|FG003|Overall Study|Insufficient AD documentation|0|||
13426748|NCT00428090|26879189|FG000|Overall Study|High MMSE scores|0|||
13426749|NCT00428090|26879190|FG001|Overall Study|High MMSE scores|0|||
13426750|NCT00428090|26879191|FG002|Overall Study|High MMSE scores|1|||
13426751|NCT00428090|26879192|FG003|Overall Study|High MMSE scores|0|||
13426752|NCT00428090|26879189|FG000|Overall Study|Deterioration of cognitive status|0|||
13426753|NCT00428090|26879190|FG001|Overall Study|Deterioration of cognitive status|0|||
13426754|NCT00428090|26879191|FG002|Overall Study|Deterioration of cognitive status|1|||
13426755|NCT00428090|26879192|FG003|Overall Study|Deterioration of cognitive status|0|||
13426756|NCT00428090|26879189|FG000|Overall Study|Serious adverse event|0|||
13426757|NCT00428090|26879190|FG001|Overall Study|Serious adverse event|0|||
13426758|NCT00428090|26879191|FG002|Overall Study|Serious adverse event|1|||
13426759|NCT00428090|26879192|FG003|Overall Study|Serious adverse event|0|||
13426760|NCT00428090|26879189|FG000|Overall Study|Excluded for heart insufficiency|0|||
13426761|NCT00428090|26879190|FG001|Overall Study|Excluded for heart insufficiency|0|||
13426762|NCT00428090|26879191|FG002|Overall Study|Excluded for heart insufficiency|1|||
13426763|NCT00428090|26879192|FG003|Overall Study|Excluded for heart insufficiency|0|||
13426764|NCT00428090|26879189|FG000|Overall Study|Raised Creatinine Value|0|||
13426765|NCT00428090|26879190|FG001|Overall Study|Raised Creatinine Value|0|||
13426766|NCT00428090|26879191|FG002|Overall Study|Raised Creatinine Value|0|||
13426767|NCT00428090|26879192|FG003|Overall Study|Raised Creatinine Value|1|||
13426768|NCT00427999|26879203|FG000|Overall Study|Adverse Event|6|||
13426769|NCT00427999|26879203|FG000|Overall Study|Abnormal laboratory values|1|||
13426770|NCT00427999|26879203|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
13426771|NCT00427999|26879203|FG000|Overall Study|Protocol Violation|2|||
13426772|NCT00427999|26879203|FG000|Overall Study|Withdrawal by Subject|9|||
13426773|NCT00427999|26879203|FG000|Overall Study|Death|1|||
13426774|NCT00427960|26879244|FG000|Overall Study|Adverse Event|2|||
13426775|NCT00427960|26879245|FG001|Overall Study|Adverse Event|0|||
13426776|NCT00427960|26879244|FG000|Overall Study|Withdrawal by Subject|0|||
13426777|NCT00427960|26879245|FG001|Overall Study|Withdrawal by Subject|3|||
13426778|NCT00427960|26879244|FG000|Overall Study|Other|0|||
13426779|NCT00427960|26879245|FG001|Overall Study|Other|1|||
13426780|NCT00427934|26879326|FG000|Overall Study|Adverse Event|1|||
13426781|NCT00427934|26879327|FG001|Overall Study|Adverse Event|0|||
13426782|NCT00427934|26879328|FG002|Overall Study|Adverse Event|5|||
13426783|NCT00427934|26879329|FG003|Overall Study|Adverse Event|4|||
13426784|NCT00427934|26879326|FG000|Overall Study|Lack of Efficacy|0|||
13426785|NCT00427934|26879327|FG001|Overall Study|Lack of Efficacy|0|||
13426786|NCT00427934|26879328|FG002|Overall Study|Lack of Efficacy|5|||
13426787|NCT00427934|26879329|FG003|Overall Study|Lack of Efficacy|2|||
13426788|NCT00427934|26879326|FG000|Overall Study|Randomized But Did Not Receive Treatment|0|||
13426789|NCT00427934|26879327|FG001|Overall Study|Randomized But Did Not Receive Treatment|0|||
13426790|NCT00427934|26879328|FG002|Overall Study|Randomized But Did Not Receive Treatment|1|||
13426791|NCT00427934|26879329|FG003|Overall Study|Randomized But Did Not Receive Treatment|1|||
13426792|NCT00427934|26879326|FG000|Overall Study|Other|0|||
13426793|NCT00427934|26879327|FG001|Overall Study|Other|0|||
13426794|NCT00427934|26879328|FG002|Overall Study|Other|11|||
13426795|NCT00427934|26879329|FG003|Overall Study|Other|5|||
13426796|NCT00427934|26879326|FG000|Overall Study|Withdrawal by Subject|0|||
13426797|NCT00427934|26879327|FG001|Overall Study|Withdrawal by Subject|0|||
13426798|NCT00427934|26879328|FG002|Overall Study|Withdrawal by Subject|1|||
13426799|NCT00427934|26879329|FG003|Overall Study|Withdrawal by Subject|3|||
13426800|NCT00427921|26879350|FG000|Overall Study|Adverse Event|26|||
13426801|NCT00427921|26879350|FG000|Overall Study|Withdrawal by Subject|4|||
13426802|NCT00427921|26879350|FG000|Overall Study|Lost to Follow-up|2|||
13426803|NCT00427921|26879350|FG000|Overall Study|Other reason not specified|10|||
13426804|NCT00427921|26879350|FG000|Overall Study|Adverse Event + Hospitalization|1|||
13426805|NCT00427921|26879350|FG000|Overall Study|Adverse Event + Withdrew Consent|1|||
13426806|NCT00427921|26879350|FG000|Overall Study|Adverse Event + No Response|1|||
13426807|NCT00427921|26879350|FG000|Overall Study|Adverse Event + Worsening of CD|1|||
13426808|NCT00427921|26879350|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1|||
13426809|NCT00427921|26879350|FG000|Overall Study|Adverse Event + Lost Response|1|||
13426810|NCT00427921|26879350|FG000|Overall Study|Adverse Event + Withdrawn from Study|1|||
13426811|NCT00427921|26879350|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1|||
13426812|NCT00427908|26879559|FG000|Primary Phase|Lost to Follow-up|4|||
13426813|NCT00427908|26879560|FG001|Primary Phase|Lost to Follow-up|0|||
13426814|NCT00427908|26879561|FG002|Primary Phase|Lost to Follow-up|2|||
13426815|NCT00427908|26879562|FG003|Primary Phase|Lost to Follow-up|0|||
13426816|NCT00427908|26879559|FG000|Primary Phase|Withdrawal by Subject|1|||
13426817|NCT00427908|26879560|FG001|Primary Phase|Withdrawal by Subject|2|||
13426818|NCT00427908|26879561|FG002|Primary Phase|Withdrawal by Subject|1|||
13426819|NCT00427908|26879562|FG003|Primary Phase|Withdrawal by Subject|0|||
13426820|NCT00427908|26879559|FG000|Primary Phase|Adverse Event|0|||
13426821|NCT00427908|26879560|FG001|Primary Phase|Adverse Event|1|||
13426822|NCT00427908|26879561|FG002|Primary Phase|Adverse Event|0|||
13426823|NCT00427908|26879562|FG003|Primary Phase|Adverse Event|0|||
13426824|NCT00427895|26879634|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
13426825|NCT00427895|26879635|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
13426826|NCT00427895|26879636|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
13426827|NCT00427895|26879637|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352|||
13426828|NCT00427895|26879638|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
13426829|NCT00427895|26879639|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
13426830|NCT00427895|26879640|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
13426831|NCT00427895|26879641|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
13426832|NCT00427895|26879634|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
13426833|NCT00427895|26879635|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
13426834|NCT00427895|26879636|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
13426835|NCT00427895|26879637|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
13426836|NCT00427895|26879638|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
13426837|NCT00427895|26879639|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
13426838|NCT00427895|26879640|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
13426839|NCT00427895|26879641|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1|||
13426840|NCT00427895|26879634|FG000|Vax 2/Year 3 to 4|Protocol Violation|0|||
13426841|NCT00427895|26879635|FG001|Vax 2/Year 3 to 4|Protocol Violation|0|||
13426842|NCT00427895|26879636|FG002|Vax 2/Year 3 to 4|Protocol Violation|0|||
13426843|NCT00427895|26879637|FG003|Vax 2/Year 3 to 4|Protocol Violation|0|||
13426844|NCT00427895|26879638|FG004|Vax 2/Year 3 to 4|Protocol Violation|0|||
13426845|NCT00427895|26879639|FG005|Vax 2/Year 3 to 4|Protocol Violation|0|||
13426846|NCT00427895|26879640|FG006|Vax 2/Year 3 to 4|Protocol Violation|0|||
13426847|NCT00427895|26879641|FG007|Vax 2/Year 3 to 4|Protocol Violation|1|||
13426848|NCT00427895|26879634|FG000|Vax 2/Year 3 to 4|Failed to Return|0|||
13426849|NCT00427895|26879635|FG001|Vax 2/Year 3 to 4|Failed to Return|0|||
13426850|NCT00427895|26879636|FG002|Vax 2/Year 3 to 4|Failed to Return|0|||
13426851|NCT00427895|26879637|FG003|Vax 2/Year 3 to 4|Failed to Return|0|||
13426852|NCT00427895|26879638|FG004|Vax 2/Year 3 to 4|Failed to Return|1|||
13426853|NCT00427895|26879639|FG005|Vax 2/Year 3 to 4|Failed to Return|0|||
13426854|NCT00427895|26879640|FG006|Vax 2/Year 3 to 4|Failed to Return|0|||
13426855|NCT00427895|26879641|FG007|Vax 2/Year 3 to 4|Failed to Return|0|||
13426856|NCT00427895|26879634|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
13426857|NCT00427895|26879635|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1|||
13426858|NCT00427895|26879636|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4|||
13426859|NCT00427895|26879637|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32|||
13426860|NCT00427895|26879638|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
13426861|NCT00427895|26879639|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
13426862|NCT00427895|26879640|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
13426863|NCT00427895|26879641|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
13426864|NCT00427895|26879634|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4|||
13426865|NCT00427895|26879635|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
13426866|NCT00427895|26879636|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3|||
13426867|NCT00427895|26879637|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2|||
13426868|NCT00427895|26879638|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
13426869|NCT00427895|26879639|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
13426870|NCT00427895|26879640|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
13426871|NCT00427895|26879641|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
13426872|NCT00427895|26879634|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
13426873|NCT00427895|26879635|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
13426874|NCT00427895|26879636|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
13426875|NCT00427895|26879637|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
13426876|NCT00427895|26879638|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
13426877|NCT00427895|26879639|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
13426878|NCT00427895|26879640|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
13426879|NCT00427895|26879641|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
13426880|NCT00427895|26879634|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
13426881|NCT00427895|26879635|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
13426882|NCT00427895|26879636|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4|||
13426883|NCT00427895|26879637|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7|||
13426884|NCT00427895|26879638|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
13426885|NCT00427895|26879639|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
13426886|NCT00427895|26879640|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
13426887|NCT00427895|26879641|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
13426888|NCT00427895|26879634|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
13426889|NCT00427895|26879635|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
13426890|NCT00427895|26879636|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
13426891|NCT00427895|26879637|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2|||
13426892|NCT00427895|26879638|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
13426893|NCT00427895|26879639|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
13426894|NCT00427895|26879640|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
13426895|NCT00427895|26879641|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
13426896|NCT00427895|26879634|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
13426897|NCT00427895|26879635|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3|||
13426898|NCT00427895|26879636|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2|||
13426899|NCT00427895|26879637|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
13426900|NCT00427895|26879638|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
13426901|NCT00427895|26879639|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
13426902|NCT00427895|26879640|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
13426903|NCT00427895|26879641|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
13426904|NCT00427895|26879634|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0|||
13426905|NCT00427895|26879635|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0|||
13426906|NCT00427895|26879636|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1|||
13426907|NCT00427895|26879637|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2|||
13426908|NCT00427895|26879638|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0|||
13426909|NCT00427895|26879639|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0|||
13426910|NCT00427895|26879640|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0|||
13426911|NCT00427895|26879641|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0|||
13426912|NCT00427895|26879634|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
13426913|NCT00427895|26879635|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5|||
13426914|NCT00427895|26879636|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2|||
13426915|NCT00427895|26879637|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21|||
13426916|NCT00427895|26879638|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
13426917|NCT00427895|26879639|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
13426918|NCT00427895|26879640|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
13426919|NCT00427895|26879641|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
13426920|NCT00427895|26879634|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
13426921|NCT00427895|26879635|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
13426922|NCT00427895|26879636|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
13426923|NCT00427895|26879637|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1|||
13426924|NCT00427895|26879638|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
13426925|NCT00427895|26879639|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
13426926|NCT00427895|26879640|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
13426927|NCT00427895|26879641|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
13426928|NCT00427895|26879634|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3|||
13426929|NCT00427895|26879635|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6|||
13426930|NCT00427895|26879636|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5|||
13426931|NCT00427895|26879637|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4|||
13426932|NCT00427895|26879638|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
13426933|NCT00427895|26879639|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
13426934|NCT00427895|26879640|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
13426935|NCT00427895|26879641|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
13426936|NCT00427895|26879634|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0|||
13426937|NCT00427895|26879635|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1|||
13426938|NCT00427895|26879636|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0|||
13426939|NCT00427895|26879637|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0|||
13426940|NCT00427895|26879638|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0|||
13426941|NCT00427895|26879639|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0|||
13426942|NCT00427895|26879640|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0|||
13426943|NCT00427895|26879641|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0|||
13426944|NCT00427895|26879634|FG000|Vax 1/Year 1 Follow-up|Death|1|||
13426945|NCT00427895|26879635|FG001|Vax 1/Year 1 Follow-up|Death|0|||
13426946|NCT00427895|26879636|FG002|Vax 1/Year 1 Follow-up|Death|0|||
13426947|NCT00427895|26879637|FG003|Vax 1/Year 1 Follow-up|Death|0|||
13426948|NCT00427895|26879638|FG004|Vax 1/Year 1 Follow-up|Death|0|||
13426949|NCT00427895|26879639|FG005|Vax 1/Year 1 Follow-up|Death|0|||
13426950|NCT00427895|26879640|FG006|Vax 1/Year 1 Follow-up|Death|0|||
13426951|NCT00427895|26879641|FG007|Vax 1/Year 1 Follow-up|Death|0|||
13426952|NCT00427895|26879634|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0|||
13426953|NCT00427895|26879635|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0|||
13426954|NCT00427895|26879636|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12|||
13426955|NCT00427895|26879637|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5|||
13426956|NCT00427895|26879638|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0|||
13426957|NCT00427895|26879639|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0|||
13426958|NCT00427895|26879640|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0|||
13426959|NCT00427895|26879641|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0|||
13426960|NCT00427895|26879634|FG000|Vax 1/Year 1 Follow-up|Other|0|||
13426961|NCT00427895|26879635|FG001|Vax 1/Year 1 Follow-up|Other|0|||
13426962|NCT00427895|26879636|FG002|Vax 1/Year 1 Follow-up|Other|0|||
13426963|NCT00427895|26879637|FG003|Vax 1/Year 1 Follow-up|Other|2|||
13426964|NCT00427895|26879638|FG004|Vax 1/Year 1 Follow-up|Other|0|||
13426965|NCT00427895|26879639|FG005|Vax 1/Year 1 Follow-up|Other|0|||
13426966|NCT00427895|26879640|FG006|Vax 1/Year 1 Follow-up|Other|0|||
13426967|NCT00427895|26879641|FG007|Vax 1/Year 1 Follow-up|Other|0|||
13426968|NCT00427895|26879634|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188|||
13426969|NCT00427895|26879635|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207|||
13426970|NCT00427895|26879636|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159|||
13426971|NCT00427895|26879637|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469|||
13426972|NCT00427895|26879638|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
13426973|NCT00427895|26879639|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
13426974|NCT00427895|26879640|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
13426975|NCT00427895|26879641|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
13426976|NCT00427778|26879663|FG000|First Intervention (4 Weeks)|no longer interested|1|||
13426977|NCT00427778|26879664|FG001|First Intervention (4 Weeks)|no longer interested|0|||
13426978|NCT00427778|26879663|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2|||
13426979|NCT00427778|26879664|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0|||
13426980|NCT00427778|26879663|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0|||
13426981|NCT00427778|26879664|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1|||
13426982|NCT00427778|26879663|FG000|First Intervention (4 Weeks)|anxious about using ring|1|||
13426983|NCT00427778|26879664|FG001|First Intervention (4 Weeks)|anxious about using ring|0|||
13426984|NCT00427700|26879679|FG000|Overall Study|Lost to Follow-up|2|||
13426985|NCT00427700|26879680|FG001|Overall Study|Lost to Follow-up|5|||
13426986|NCT00427700|26879679|FG000|Overall Study|no induction of menses|1|||
13426987|NCT00427700|26879680|FG001|Overall Study|no induction of menses|4|||
13426988|NCT00427700|26879679|FG000|Overall Study|Pregnancy|0|||
13426989|NCT00427700|26879680|FG001|Overall Study|Pregnancy|2|||
13426990|NCT00427648|26879705|FG000|Overall Study|Protocol Violation|1|||
13426991|NCT00427648|26879706|FG001|Overall Study|Protocol Violation|2|||
13426992|NCT00427648|26879705|FG000|Overall Study|Adverse Event|0|||
13426993|NCT00427648|26879706|FG001|Overall Study|Adverse Event|1|||
13426994|NCT00427635|26879741|FG000|Treatment Phase|Withdrawal by Subject|1|||
13426995|NCT00427635|26879742|FG001|Treatment Phase|Withdrawal by Subject|0|||
13426996|NCT00427635|26879741|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0|||
13426997|NCT00427635|26879742|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1|||
13426998|NCT00427349|26879750|FG000|Overall Study|Lack of Efficacy|23|||
13426999|NCT00427349|26879750|FG000|Overall Study|Adverse Event|14|||
13427000|NCT00427349|26879750|FG000|Overall Study|Death|1|||
13427001|NCT00427349|26879750|FG000|Overall Study|Withdrawal by Subject|3|||
13427002|NCT00427349|26879750|FG000|Overall Study|Alternative therapy|1|||
13427003|NCT00427349|26879750|FG000|Overall Study|Other|2|||
13427004|NCT00427349|26879750|FG000|Overall Study|Ineligible|1|||
13427005|NCT00427349|26879750|FG000|Overall Study|Never started therapy|1|||
13427006|NCT00427011|26879763|FG000|Overall Study|Adverse Event|10|||
13427007|NCT00427011|26879763|FG000|Overall Study|Withdrawal by Subject|1|||
13427008|NCT00427011|26879763|FG000|Overall Study|Lack of Efficacy|2|||
13427009|NCT00427011|26879763|FG000|Overall Study|Other|12|||
13476821|NCT01425008|27003735|FG006|Dose Expansion Phase|Symptomatic Deterioration|0|||
13476822|NCT01425008|27003736|FG007|Dose Expansion Phase|Symptomatic Deterioration|0|||
13476823|NCT01425008|27003737|FG008|Dose Expansion Phase|Symptomatic Deterioration|0|||
13476824|NCT01425008|27003738|FG009|Dose Expansion Phase|Symptomatic Deterioration|0|||
13476825|NCT01425008|27003739|FG010|Dose Expansion Phase|Symptomatic Deterioration|2|||
13476826|NCT01425008|27003740|FG011|Dose Expansion Phase|Symptomatic Deterioration|1|||
13476827|NCT01425008|27003741|FG012|Dose Expansion Phase|Symptomatic Deterioration|0|||
13476828|NCT01425008|27003742|FG013|Dose Expansion Phase|Symptomatic Deterioration|0|||
13476829|NCT01425008|27003743|FG014|Dose Expansion Phase|Symptomatic Deterioration|0|||
13476830|NCT01425008|27003744|FG015|Dose Expansion Phase|Symptomatic Deterioration|1|||
13476831|NCT01425008|27003745|FG016|Dose Expansion Phase|Symptomatic Deterioration|2|||
13476832|NCT01425008|27003746|FG017|Dose Expansion Phase|Symptomatic Deterioration|0|||
13476833|NCT01425008|27003747|FG018|Dose Expansion Phase|Symptomatic Deterioration|1|||
13476834|NCT01425008|27003729|FG000|Dose Expansion Phase|Adverse Event|0|||
13476835|NCT01425008|27003730|FG001|Dose Expansion Phase|Adverse Event|0|||
13476836|NCT01425008|27003731|FG002|Dose Expansion Phase|Adverse Event|0|||
13476837|NCT01425008|27003732|FG003|Dose Expansion Phase|Adverse Event|0|||
13476838|NCT01425008|27003733|FG004|Dose Expansion Phase|Adverse Event|0|||
13476839|NCT01425008|27003734|FG005|Dose Expansion Phase|Adverse Event|0|||
13476840|NCT01425008|27003735|FG006|Dose Expansion Phase|Adverse Event|0|||
13476841|NCT01425008|27003736|FG007|Dose Expansion Phase|Adverse Event|0|||
13476842|NCT01425008|27003737|FG008|Dose Expansion Phase|Adverse Event|0|||
13476843|NCT01425008|27003738|FG009|Dose Expansion Phase|Adverse Event|0|||
13476844|NCT01425008|27003739|FG010|Dose Expansion Phase|Adverse Event|2|||
13476845|NCT01425008|27003740|FG011|Dose Expansion Phase|Adverse Event|3|||
13476846|NCT01425008|27003741|FG012|Dose Expansion Phase|Adverse Event|3|||
13476847|NCT01425008|27003742|FG013|Dose Expansion Phase|Adverse Event|0|||
13476848|NCT01425008|27003743|FG014|Dose Expansion Phase|Adverse Event|1|||
13476849|NCT01425008|27003744|FG015|Dose Expansion Phase|Adverse Event|1|||
13476850|NCT01425008|27003745|FG016|Dose Expansion Phase|Adverse Event|5|||
13476851|NCT01425008|27003746|FG017|Dose Expansion Phase|Adverse Event|0|||
13476852|NCT01425008|27003747|FG018|Dose Expansion Phase|Adverse Event|3|||
13476853|NCT01425008|27003729|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
13476854|NCT01425008|27003730|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
13476855|NCT01425008|27003731|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
13476856|NCT01425008|27003732|FG003|Dose Expansion Phase|Lost to Follow-up|0|||
13476857|NCT01425008|27003733|FG004|Dose Expansion Phase|Lost to Follow-up|0|||
13476858|NCT01425008|27003734|FG005|Dose Expansion Phase|Lost to Follow-up|0|||
13476859|NCT01425008|27003735|FG006|Dose Expansion Phase|Lost to Follow-up|0|||
13476860|NCT01425008|27003736|FG007|Dose Expansion Phase|Lost to Follow-up|0|||
13476861|NCT01425008|27003737|FG008|Dose Expansion Phase|Lost to Follow-up|0|||
13476862|NCT01425008|27003738|FG009|Dose Expansion Phase|Lost to Follow-up|0|||
13476863|NCT01425008|27003739|FG010|Dose Expansion Phase|Lost to Follow-up|0|||
13476864|NCT01425008|27003740|FG011|Dose Expansion Phase|Lost to Follow-up|0|||
13476865|NCT01425008|27003741|FG012|Dose Expansion Phase|Lost to Follow-up|0|||
13476866|NCT01425008|27003742|FG013|Dose Expansion Phase|Lost to Follow-up|0|||
13427010|NCT00426842|26879771|FG000|Overall Study|Lost to Follow-up|1|||
13427011|NCT00426764|26879788|FG000|Overall Study|Protocol Violation|1|||
13427012|NCT00426764|26879788|FG000|Overall Study|Withdrawal by Subject|4|||
13427013|NCT00426764|26879788|FG000|Overall Study|Physician Decision|6|||
13427014|NCT00426764|26879788|FG000|Overall Study|Compassionate Use|1|||
13427015|NCT00426764|26879788|FG000|Overall Study|Progressive Disease|83|||
13427016|NCT00426764|26879788|FG000|Overall Study|Adverse Event|24|||
13427017|NCT00426764|26879788|FG000|Overall Study|Other|1|||
13427018|NCT00426764|26879788|FG000|Overall Study|Death|1|||
13427019|NCT00426764|26879788|FG000|Overall Study|Other Reasons (Miscellaneous)|10|||
13427020|NCT00426751|26879839|FG000|Overall Study|Adverse Event|8|||
13427021|NCT00426751|26879840|FG001|Overall Study|Adverse Event|1|||
13427022|NCT00426751|26879839|FG000|Overall Study|Lost to Follow-up|7|||
13427023|NCT00426751|26879840|FG001|Overall Study|Lost to Follow-up|6|||
13427024|NCT00426751|26879839|FG000|Overall Study|Consent Withdrawn|0|||
13427025|NCT00426751|26879840|FG001|Overall Study|Consent Withdrawn|1|||
13427026|NCT00426751|26879839|FG000|Overall Study|Other Reasons|7|||
13427027|NCT00426751|26879840|FG001|Overall Study|Other Reasons|12|||
13427028|NCT00426660|26879869|FG000|Overall Study|Death|14|||
13427029|NCT00426660|26879869|FG000|Overall Study|Adverse Event|23|||
13427030|NCT00426660|26879869|FG000|Overall Study|Insufficient Clinical Response|22|||
13427031|NCT00426660|26879869|FG000|Overall Study|Lost to Follow-up|15|||
13427032|NCT00426660|26879869|FG000|Overall Study|Other|23|||
13427033|NCT00426660|26879869|FG000|Overall Study|Withdrawal by Subject|18|||
13427034|NCT00426660|26879869|FG000|Overall Study|Protocol Violation|1|||
13427035|NCT00426660|26879869|FG000|Overall Study|Enrolled Not Treated|15|||
13427036|NCT00426556|26879904|FG000|Phase I - Core Phase|Disease Progression|0|||
13427037|NCT00426556|26879905|FG001|Phase I - Core Phase|Disease Progression|6|||
13427038|NCT00426556|26879906|FG002|Phase I - Core Phase|Disease Progression|2|||
13427039|NCT00426556|26879907|FG003|Phase I - Core Phase|Disease Progression|0|||
13427040|NCT00426556|26879904|FG000|Phase I - Core Phase|Adverse Event|1|||
13427041|NCT00426556|26879905|FG001|Phase I - Core Phase|Adverse Event|3|||
13427042|NCT00426556|26879906|FG002|Phase I - Core Phase|Adverse Event|1|||
13427043|NCT00426556|26879907|FG003|Phase I - Core Phase|Adverse Event|0|||
13427044|NCT00426556|26879904|FG000|Phase I - Core Phase|Death|0|||
13427045|NCT00426556|26879905|FG001|Phase I - Core Phase|Death|1|||
13427046|NCT00426556|26879906|FG002|Phase I - Core Phase|Death|0|||
13427047|NCT00426556|26879907|FG003|Phase I - Core Phase|Death|0|||
13427048|NCT00426556|26879904|FG000|Phase I - Extension Phase|Adverse Event|0|||
13427049|NCT00426556|26879905|FG001|Phase I - Extension Phase|Adverse Event|1|||
13427050|NCT00426556|26879906|FG002|Phase I - Extension Phase|Adverse Event|1|||
13427051|NCT00426556|26879907|FG003|Phase I - Extension Phase|Adverse Event|0|||
13427052|NCT00426556|26879904|FG000|Phase I - Extension Phase|Disease Progression|5|||
13427053|NCT00426556|26879905|FG001|Phase I - Extension Phase|Disease Progression|5|||
13427054|NCT00426556|26879906|FG002|Phase I - Extension Phase|Disease Progression|6|||
13427055|NCT00426556|26879907|FG003|Phase I - Extension Phase|Disease Progression|0|||
13427056|NCT00426556|26879904|FG000|Phase II - Core Phase|Withdrawal by Subject|0|||
13427057|NCT00426556|26879905|FG001|Phase II - Core Phase|Withdrawal by Subject|0|||
13427058|NCT00426556|26879906|FG002|Phase II - Core Phase|Withdrawal by Subject|0|||
13427059|NCT00426556|26879907|FG003|Phase II - Core Phase|Withdrawal by Subject|3|||
13427060|NCT00426556|26879904|FG000|Phase II - Core Phase|Disease Progression|0|||
13427061|NCT00426556|26879905|FG001|Phase II - Core Phase|Disease Progression|0|||
13427062|NCT00426556|26879906|FG002|Phase II - Core Phase|Disease Progression|0|||
13427063|NCT00426556|26879907|FG003|Phase II - Core Phase|Disease Progression|16|||
13427064|NCT00426556|26879904|FG000|Phase II - Core Phase|Adverse Event|0|||
13427065|NCT00426556|26879905|FG001|Phase II - Core Phase|Adverse Event|0|||
13427066|NCT00426556|26879906|FG002|Phase II - Core Phase|Adverse Event|0|||
13427067|NCT00426556|26879907|FG003|Phase II - Core Phase|Adverse Event|8|||
13427068|NCT00426556|26879904|FG000|Phase II - Extension Phase|Disease Progression|0|||
13427069|NCT00426556|26879905|FG001|Phase II - Extension Phase|Disease Progression|0|||
13427070|NCT00426556|26879906|FG002|Phase II - Extension Phase|Disease Progression|0|||
13427071|NCT00426556|26879907|FG003|Phase II - Extension Phase|Disease Progression|21|||
13427072|NCT00426556|26879904|FG000|Phase II - Extension Phase|Adverse Event|0|||
13427073|NCT00426556|26879905|FG001|Phase II - Extension Phase|Adverse Event|0|||
13427074|NCT00426556|26879906|FG002|Phase II - Extension Phase|Adverse Event|0|||
13427075|NCT00426556|26879907|FG003|Phase II - Extension Phase|Adverse Event|2|||
13427076|NCT00426361|26879967|FG000|Overall Study|Lost to Follow-up|3|||
13427077|NCT00426361|26879968|FG001|Overall Study|Lost to Follow-up|2|||
13427078|NCT00426361|26879969|FG002|Overall Study|Lost to Follow-up|5|||
13427079|NCT00426361|26879967|FG000|Overall Study|Withdrawal by Subject|1|||
13427080|NCT00426361|26879968|FG001|Overall Study|Withdrawal by Subject|3|||
13427081|NCT00426361|26879969|FG002|Overall Study|Withdrawal by Subject|0|||
13427082|NCT00426270|26879979|FG000|Overall Study|Incorrectly Enrolled in the Study|1|||
13427083|NCT00426270|26879979|FG000|Overall Study|Adverse Event|5|||
13427084|NCT00426231|26879994|FG000|Overall Study|Withdrawal by Subject|9|||
13427085|NCT00426231|26879995|FG001|Overall Study|Withdrawal by Subject|12|||
13427086|NCT00426127|26880003|FG000|Overall Study|Adverse Event|1|||
13427087|NCT00426127|26880003|FG000|Overall Study|Removed due to disease progression|1|||
13427088|NCT00425945|26880046|FG000|Overall Study|Concern about Supplement|2|||
13427089|NCT00425945|26880047|FG001|Overall Study|Concern about Supplement|0|||
13427090|NCT00425945|26880046|FG000|Overall Study|Inconvenience|0|||
13427091|NCT00425945|26880047|FG001|Overall Study|Inconvenience|2|||
13427092|NCT00425945|26880046|FG000|Overall Study|Lost to Follow-up|0|||
13427093|NCT00425945|26880047|FG001|Overall Study|Lost to Follow-up|2|||
13427094|NCT00425945|26880046|FG000|Overall Study|Began hypertension medication|1|||
13427095|NCT00425945|26880047|FG001|Overall Study|Began hypertension medication|0|||
13427096|NCT00425945|26880046|FG000|Overall Study|Began cancer treatments|1|||
13427097|NCT00425945|26880047|FG001|Overall Study|Began cancer treatments|0|||
13427098|NCT00425945|26880046|FG000|Overall Study|Moved from area|0|||
13427099|NCT00425945|26880047|FG001|Overall Study|Moved from area|1|||
13427100|NCT00425854|26880075|FG000|Overall Study|Progressive Disease|19|||
13427101|NCT00425854|26880076|FG001|Overall Study|Progressive Disease|12|||
13427102|NCT00425854|26880075|FG000|Overall Study|Dose reduction toxicity AE|8|||
13427103|NCT00425854|26880076|FG001|Overall Study|Dose reduction toxicity AE|7|||
13427104|NCT00425854|26880075|FG000|Overall Study|Other Adverse Event|2|||
13427105|NCT00425854|26880076|FG001|Overall Study|Other Adverse Event|2|||
13427106|NCT00425750|26880084|FG000|Overall Study|Death|1|||
13427107|NCT00425750|26880084|FG000|Overall Study|Withdrawal by Subject|3|||
13427108|NCT00425750|26880084|FG000|Overall Study|Adverse Event|3|||
13427109|NCT00425750|26880084|FG000|Overall Study|Progression of disease|18|||
13427110|NCT00425698|26880097|FG000|Overall Study|Adverse Event|3|||
13427111|NCT00425698|26880098|FG001|Overall Study|Adverse Event|1|||
13427112|NCT00425698|26880097|FG000|Overall Study|Withdrawal by Subject|0|||
13427113|NCT00425698|26880098|FG001|Overall Study|Withdrawal by Subject|1|||
13427114|NCT00425607|26880104|FG000|Overall Study|Death|1|||
13427115|NCT00425607|26880104|FG000|Overall Study|Withdrawal by Subject|1|||
13427116|NCT00425555|26880141|FG000|Overall Study|Withdrawal by Subject|11|||
13427117|NCT00425555|26880142|FG001|Overall Study|Withdrawal by Subject|8|||
13427118|NCT00425555|26880141|FG000|Overall Study|Lost to Follow-up|0|||
13427119|NCT00425555|26880142|FG001|Overall Study|Lost to Follow-up|1|||
13427120|NCT00425555|26880141|FG000|Overall Study|Administrative problems|3|||
13427121|NCT00425555|26880142|FG001|Overall Study|Administrative problems|0|||
13427122|NCT00425555|26880141|FG000|Overall Study|Death|1|||
13427123|NCT00425555|26880142|FG001|Overall Study|Death|2|||
13427124|NCT00425555|26880141|FG000|Overall Study|New cancer therapy|2|||
13427125|NCT00425555|26880142|FG001|Overall Study|New cancer therapy|1|||
13427126|NCT00425555|26880141|FG000|Overall Study|Disease progression|36|||
13427127|NCT00425555|26880142|FG001|Overall Study|Disease progression|33|||
13427128|NCT00425555|26880141|FG000|Overall Study|Adverse Event|25|||
13427129|NCT00425555|26880142|FG001|Overall Study|Adverse Event|15|||
13427130|NCT00425555|26880141|FG000|Overall Study|Protocol Violation|1|||
13427131|NCT00425555|26880142|FG001|Overall Study|Protocol Violation|0|||
13427132|NCT00425503|26880148|FG000|Overall Study|Adverse Event|2|||
13427133|NCT00425503|26880148|FG000|Overall Study|Protocol Violation|1|||
13427134|NCT00425438|26880171|FG000|Overall Study|Termination by Sponsor|25|||
13427135|NCT00425438|26880172|FG001|Overall Study|Termination by Sponsor|27|||
13427136|NCT00425373|26880256|FG000|Overall Study|Adverse Event|2|||
13427137|NCT00425373|26880257|FG001|Overall Study|Adverse Event|2|||
13427138|NCT00425373|26880258|FG002|Overall Study|Adverse Event|0|||
13427139|NCT00425373|26880259|FG003|Overall Study|Adverse Event|1|||
13427140|NCT00425373|26880260|FG004|Overall Study|Adverse Event|4|||
13427141|NCT00425373|26880261|FG005|Overall Study|Adverse Event|6|||
13427142|NCT00425373|26880262|FG006|Overall Study|Adverse Event|2|||
13427143|NCT00425373|26880263|FG007|Overall Study|Adverse Event|3|||
13427144|NCT00425373|26880264|FG008|Overall Study|Adverse Event|8|||
13427145|NCT00425373|26880256|FG000|Overall Study|Lost to Follow-up|0|||
13427146|NCT00425373|26880257|FG001|Overall Study|Lost to Follow-up|1|||
13427147|NCT00425373|26880258|FG002|Overall Study|Lost to Follow-up|0|||
13427148|NCT00425373|26880259|FG003|Overall Study|Lost to Follow-up|0|||
13427149|NCT00425373|26880260|FG004|Overall Study|Lost to Follow-up|1|||
13427150|NCT00425373|26880261|FG005|Overall Study|Lost to Follow-up|0|||
13427151|NCT00425373|26880262|FG006|Overall Study|Lost to Follow-up|0|||
13427152|NCT00425373|26880263|FG007|Overall Study|Lost to Follow-up|0|||
13427153|NCT00425373|26880264|FG008|Overall Study|Lost to Follow-up|0|||
13427154|NCT00425373|26880256|FG000|Overall Study|Protocol Violation|1|||
13427155|NCT00425373|26880257|FG001|Overall Study|Protocol Violation|0|||
13427156|NCT00425373|26880258|FG002|Overall Study|Protocol Violation|1|||
13427157|NCT00425373|26880259|FG003|Overall Study|Protocol Violation|0|||
13427158|NCT00425373|26880260|FG004|Overall Study|Protocol Violation|0|||
13427159|NCT00425373|26880261|FG005|Overall Study|Protocol Violation|0|||
13427160|NCT00425373|26880262|FG006|Overall Study|Protocol Violation|0|||
13427161|NCT00425373|26880263|FG007|Overall Study|Protocol Violation|5|||
13427162|NCT00425373|26880264|FG008|Overall Study|Protocol Violation|3|||
13427163|NCT00425373|26880256|FG000|Overall Study|Withdrawal by Subject|2|||
13427164|NCT00425373|26880257|FG001|Overall Study|Withdrawal by Subject|0|||
13427165|NCT00425373|26880258|FG002|Overall Study|Withdrawal by Subject|2|||
13427166|NCT00425373|26880259|FG003|Overall Study|Withdrawal by Subject|1|||
13427167|NCT00425373|26880260|FG004|Overall Study|Withdrawal by Subject|4|||
13427168|NCT00425373|26880261|FG005|Overall Study|Withdrawal by Subject|0|||
13427169|NCT00425373|26880262|FG006|Overall Study|Withdrawal by Subject|2|||
13427170|NCT00425373|26880263|FG007|Overall Study|Withdrawal by Subject|2|||
13427171|NCT00425373|26880264|FG008|Overall Study|Withdrawal by Subject|2|||
13427172|NCT00425373|26880256|FG000|Overall Study|Lack of Efficacy|0|||
13427173|NCT00425373|26880257|FG001|Overall Study|Lack of Efficacy|0|||
13427174|NCT00425373|26880258|FG002|Overall Study|Lack of Efficacy|0|||
13427175|NCT00425373|26880259|FG003|Overall Study|Lack of Efficacy|0|||
13427176|NCT00425373|26880260|FG004|Overall Study|Lack of Efficacy|1|||
13427177|NCT00425373|26880261|FG005|Overall Study|Lack of Efficacy|3|||
13427178|NCT00425373|26880262|FG006|Overall Study|Lack of Efficacy|3|||
13427179|NCT00425373|26880263|FG007|Overall Study|Lack of Efficacy|0|||
13427180|NCT00425373|26880264|FG008|Overall Study|Lack of Efficacy|5|||
13427181|NCT00425308|26880299|FG000|Overall Study|Adverse Event|2|||
13427182|NCT00425308|26880300|FG001|Overall Study|Adverse Event|1|||
13427183|NCT00425308|26880299|FG000|Overall Study|Withdrawal by Subject|1|||
13427184|NCT00425308|26880300|FG001|Overall Study|Withdrawal by Subject|0|||
13427185|NCT00425308|26880299|FG000|Overall Study|Death|1|||
13427186|NCT00425308|26880300|FG001|Overall Study|Death|0|||
13427187|NCT00425269|26880383|FG000|Overall Study|Pregnancy|5|||
13427188|NCT00425269|26880384|FG001|Overall Study|Pregnancy|7|||
13427189|NCT00425269|26880383|FG000|Overall Study|Lost to Follow-up|9|||
13427190|NCT00425269|26880384|FG001|Overall Study|Lost to Follow-up|9|||
13427191|NCT00425269|26880383|FG000|Overall Study|moved or medical reason|5|||
13427192|NCT00425269|26880384|FG001|Overall Study|moved or medical reason|4|||
13427193|NCT00425113|26880399|FG000|Overall Study|uncontrolled diabetes mellitus|1|||
13427194|NCT00425113|26880400|FG001|Overall Study|uncontrolled diabetes mellitus|0|||
13427195|NCT00425113|26880399|FG000|Overall Study|diagnosis of abdominal TB|0|||
13427196|NCT00425113|26880400|FG001|Overall Study|diagnosis of abdominal TB|1|||
13427197|NCT00425113|26880399|FG000|Overall Study|missing study drug more than 14 days|0|||
13427198|NCT00425113|26880400|FG001|Overall Study|missing study drug more than 14 days|1|||
13427199|NCT00425113|26880399|FG000|Overall Study|Withdrawal by Subject|1|||
13427200|NCT00425113|26880400|FG001|Overall Study|Withdrawal by Subject|0|||
13427201|NCT00425061|26880538|FG000|Overall Study|Adverse Event|1|||
13427202|NCT00425061|26880539|FG001|Overall Study|Adverse Event|0|||
13427203|NCT00425061|26880540|FG002|Overall Study|Adverse Event|0|||
13427204|NCT00425061|26880541|FG003|Overall Study|Adverse Event|2|||
13427205|NCT00425061|26880542|FG004|Overall Study|Adverse Event|2|||
13427206|NCT00425061|26880543|FG005|Overall Study|Adverse Event|0|||
13427207|NCT00425061|26880544|FG006|Overall Study|Adverse Event|0|||
13427208|NCT00425061|26880538|FG000|Overall Study|Lost to Follow-up|0|||
13427209|NCT00425061|26880539|FG001|Overall Study|Lost to Follow-up|1|||
13427210|NCT00425061|26880540|FG002|Overall Study|Lost to Follow-up|0|||
13427211|NCT00425061|26880541|FG003|Overall Study|Lost to Follow-up|0|||
13427212|NCT00425061|26880542|FG004|Overall Study|Lost to Follow-up|0|||
13427213|NCT00425061|26880543|FG005|Overall Study|Lost to Follow-up|0|||
13427214|NCT00425061|26880544|FG006|Overall Study|Lost to Follow-up|0|||
13427215|NCT00425061|26880538|FG000|Overall Study|Protocol Violation|1|||
13427216|NCT00425061|26880539|FG001|Overall Study|Protocol Violation|0|||
13427217|NCT00425061|26880540|FG002|Overall Study|Protocol Violation|0|||
13427218|NCT00425061|26880541|FG003|Overall Study|Protocol Violation|0|||
13427219|NCT00425061|26880542|FG004|Overall Study|Protocol Violation|0|||
13427220|NCT00425061|26880543|FG005|Overall Study|Protocol Violation|0|||
13427221|NCT00425061|26880544|FG006|Overall Study|Protocol Violation|0|||
13427222|NCT00425061|26880538|FG000|Overall Study|Withdrawal by Subject|0|||
13427223|NCT00425061|26880539|FG001|Overall Study|Withdrawal by Subject|1|||
13427224|NCT00425061|26880540|FG002|Overall Study|Withdrawal by Subject|0|||
13427225|NCT00425061|26880541|FG003|Overall Study|Withdrawal by Subject|0|||
13427226|NCT00425061|26880542|FG004|Overall Study|Withdrawal by Subject|1|||
13427227|NCT00425061|26880543|FG005|Overall Study|Withdrawal by Subject|0|||
13427228|NCT00425061|26880544|FG006|Overall Study|Withdrawal by Subject|3|||
13427229|NCT00425061|26880538|FG000|Overall Study|Sponsor's request|0|||
13427230|NCT00425061|26880539|FG001|Overall Study|Sponsor's request|0|||
13427231|NCT00425061|26880540|FG002|Overall Study|Sponsor's request|0|||
13427232|NCT00425061|26880541|FG003|Overall Study|Sponsor's request|0|||
13427233|NCT00425061|26880542|FG004|Overall Study|Sponsor's request|19|||
13427234|NCT00425061|26880543|FG005|Overall Study|Sponsor's request|4|||
13427235|NCT00425061|26880544|FG006|Overall Study|Sponsor's request|15|||
13427236|NCT00425061|26880538|FG000|Overall Study|Physician Decision|0|||
13427237|NCT00425061|26880539|FG001|Overall Study|Physician Decision|0|||
13427238|NCT00425061|26880540|FG002|Overall Study|Physician Decision|0|||
13427239|NCT00425061|26880541|FG003|Overall Study|Physician Decision|0|||
13427240|NCT00425061|26880542|FG004|Overall Study|Physician Decision|1|||
13427241|NCT00425061|26880543|FG005|Overall Study|Physician Decision|0|||
13427242|NCT00425061|26880544|FG006|Overall Study|Physician Decision|0|||
13427243|NCT00425061|26880538|FG000|Overall Study|Other|0|||
13427244|NCT00425061|26880539|FG001|Overall Study|Other|0|||
13427245|NCT00425061|26880540|FG002|Overall Study|Other|0|||
13427246|NCT00425061|26880541|FG003|Overall Study|Other|0|||
13427247|NCT00425061|26880542|FG004|Overall Study|Other|3|||
13427248|NCT00425061|26880543|FG005|Overall Study|Other|0|||
13427249|NCT00425061|26880544|FG006|Overall Study|Other|1|||
13427250|NCT00424827|26880554|FG000|Overall Study|Adverse Event|1|||
13427251|NCT00424775|26880565|FG000|Overall Study|Adverse Event|2|||
13427252|NCT00424775|26880566|FG001|Overall Study|Adverse Event|0|||
13427253|NCT00424775|26880565|FG000|Overall Study|Lack of Efficacy|1|||
13427254|NCT00424775|26880566|FG001|Overall Study|Lack of Efficacy|0|||
13427255|NCT00424762|26880583|FG000|Overall Study|Withdrawal by Subject|18|||
13427256|NCT00424762|26880584|FG001|Overall Study|Withdrawal by Subject|19|||
13427257|NCT00424762|26880583|FG000|Overall Study|Lost to Follow-up|2|||
13427258|NCT00424762|26880584|FG001|Overall Study|Lost to Follow-up|3|||
13427259|NCT00424749|26880591|FG000|Overall Study|Withdrawal by Subject|1|||
13427260|NCT00424645|26880604|FG000|Overall Study|Death|1|||
13427261|NCT00424645|26880605|FG001|Overall Study|Death|0|||
13427262|NCT00424632|26880751|FG000|Overall Study|Death|0|||
13427263|NCT00424632|26880752|FG001|Overall Study|Death|0|||
13427264|NCT00424632|26880753|FG002|Overall Study|Death|0|||
13427265|NCT00424632|26880754|FG003|Overall Study|Death|0|||
13427266|NCT00424632|26880755|FG004|Overall Study|Death|0|||
13427267|NCT00424632|26880756|FG005|Overall Study|Death|2|||
13427268|NCT00424632|26880757|FG006|Overall Study|Death|0|||
13427269|NCT00424632|26880758|FG007|Overall Study|Death|0|||
13427270|NCT00424632|26880759|FG008|Overall Study|Death|0|||
13427271|NCT00424632|26880760|FG009|Overall Study|Death|0|||
13427272|NCT00424632|26880751|FG000|Overall Study|Adverse Event|0|||
13427273|NCT00424632|26880752|FG001|Overall Study|Adverse Event|0|||
13427274|NCT00424632|26880753|FG002|Overall Study|Adverse Event|0|||
13427275|NCT00424632|26880754|FG003|Overall Study|Adverse Event|0|||
13427276|NCT00424632|26880755|FG004|Overall Study|Adverse Event|0|||
13427277|NCT00424632|26880756|FG005|Overall Study|Adverse Event|0|||
13427278|NCT00424632|26880757|FG006|Overall Study|Adverse Event|0|||
13427279|NCT00424632|26880758|FG007|Overall Study|Adverse Event|0|||
13427280|NCT00424632|26880759|FG008|Overall Study|Adverse Event|3|||
13427281|NCT00424632|26880760|FG009|Overall Study|Adverse Event|2|||
13427282|NCT00424632|26880751|FG000|Overall Study|Global deterioration of health status|0|||
13427283|NCT00424632|26880752|FG001|Overall Study|Global deterioration of health status|0|||
13427284|NCT00424632|26880753|FG002|Overall Study|Global deterioration of health status|0|||
13427285|NCT00424632|26880754|FG003|Overall Study|Global deterioration of health status|1|||
13427286|NCT00424632|26880755|FG004|Overall Study|Global deterioration of health status|1|||
13427287|NCT00424632|26880756|FG005|Overall Study|Global deterioration of health status|0|||
13427288|NCT00424632|26880757|FG006|Overall Study|Global deterioration of health status|0|||
13427289|NCT00424632|26880758|FG007|Overall Study|Global deterioration of health status|0|||
13427290|NCT00424632|26880759|FG008|Overall Study|Global deterioration of health status|0|||
13427291|NCT00424632|26880760|FG009|Overall Study|Global deterioration of health status|0|||
13427292|NCT00424632|26880751|FG000|Overall Study|Objective progression or relapse|1|||
13427293|NCT00424632|26880752|FG001|Overall Study|Objective progression or relapse|1|||
13427294|NCT00424632|26880753|FG002|Overall Study|Objective progression or relapse|1|||
13427295|NCT00424632|26880754|FG003|Overall Study|Objective progression or relapse|2|||
13427296|NCT00424632|26880755|FG004|Overall Study|Objective progression or relapse|2|||
13427297|NCT00424632|26880756|FG005|Overall Study|Objective progression or relapse|13|||
13427298|NCT00424632|26880757|FG006|Overall Study|Objective progression or relapse|7|||
13427299|NCT00424632|26880758|FG007|Overall Study|Objective progression or relapse|3|||
13427300|NCT00424632|26880759|FG008|Overall Study|Objective progression or relapse|12|||
13427301|NCT00424632|26880760|FG009|Overall Study|Objective progression or relapse|4|||
13427302|NCT00424632|26880751|FG000|Overall Study|Other|0|||
13427303|NCT00424632|26880752|FG001|Overall Study|Other|0|||
13427304|NCT00424632|26880753|FG002|Overall Study|Other|0|||
13427305|NCT00424632|26880754|FG003|Overall Study|Other|1|||
13427306|NCT00424632|26880755|FG004|Overall Study|Other|0|||
13427307|NCT00424632|26880756|FG005|Overall Study|Other|0|||
13427308|NCT00424632|26880757|FG006|Overall Study|Other|0|||
13427309|NCT00424632|26880758|FG007|Overall Study|Other|0|||
13427310|NCT00424632|26880759|FG008|Overall Study|Other|1|||
13427311|NCT00424632|26880760|FG009|Overall Study|Other|0|||
13427312|NCT00424593|26880811|FG000|Acute Double-Blind Period|Adverse Event|16|||
13427313|NCT00424593|26880812|FG001|Acute Double-Blind Period|Adverse Event|7|||
13427314|NCT00424593|26880811|FG000|Acute Double-Blind Period|Withdrawal by Subject|11|||
13427315|NCT00424593|26880812|FG001|Acute Double-Blind Period|Withdrawal by Subject|10|||
13427316|NCT00424593|26880811|FG000|Acute Double-Blind Period|Protocol Violation|2|||
13427317|NCT00424593|26880812|FG001|Acute Double-Blind Period|Protocol Violation|2|||
13427318|NCT00424593|26880811|FG000|Acute Double-Blind Period|Physician Decision|1|||
13427319|NCT00424593|26880812|FG001|Acute Double-Blind Period|Physician Decision|2|||
13427320|NCT00424593|26880811|FG000|Acute Double-Blind Period|Lost to Follow-up|1|||
13427321|NCT00424593|26880812|FG001|Acute Double-Blind Period|Lost to Follow-up|1|||
13427322|NCT00424593|26880811|FG000|Acute Double-Blind Period|Lack of Efficacy|0|||
13427323|NCT00424593|26880812|FG001|Acute Double-Blind Period|Lack of Efficacy|1|||
13427324|NCT00424593|26880811|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19|||
13427325|NCT00424593|26880812|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0|||
13427326|NCT00424593|26880811|FG000|Dose-Blind Extension Period|Adverse Event|18|||
13427327|NCT00424593|26880812|FG001|Dose-Blind Extension Period|Adverse Event|0|||
13427328|NCT00424593|26880811|FG000|Dose-Blind Extension Period|Lack of Efficacy|9|||
13427329|NCT00424593|26880812|FG001|Dose-Blind Extension Period|Lack of Efficacy|0|||
13427330|NCT00424593|26880811|FG000|Dose-Blind Extension Period|Protocol Violation|9|||
13427331|NCT00424593|26880812|FG001|Dose-Blind Extension Period|Protocol Violation|0|||
13427332|NCT00424593|26880811|FG000|Dose-Blind Extension Period|Lost to Follow-up|6|||
13427333|NCT00424593|26880812|FG001|Dose-Blind Extension Period|Lost to Follow-up|0|||
13427334|NCT00424593|26880811|FG000|Dose-Blind Extension Period|Physician Decision|3|||
13427335|NCT00424593|26880812|FG001|Dose-Blind Extension Period|Physician Decision|0|||
13427336|NCT00424528|26880875|FG000|Overall Study|Adverse Event|2|||
13427337|NCT00424528|26880876|FG001|Overall Study|Adverse Event|1|||
13427338|NCT00424528|26880877|FG002|Overall Study|Adverse Event|2|||
13427339|NCT00424528|26880875|FG000|Overall Study|Protocol Violation|1|||
13427340|NCT00424528|26880876|FG001|Overall Study|Protocol Violation|1|||
13427341|NCT00424528|26880877|FG002|Overall Study|Protocol Violation|0|||
13427342|NCT00424528|26880875|FG000|Overall Study|Lost to Follow-up|0|||
13427343|NCT00424528|26880876|FG001|Overall Study|Lost to Follow-up|1|||
13427344|NCT00424528|26880877|FG002|Overall Study|Lost to Follow-up|0|||
13427345|NCT00424528|26880875|FG000|Overall Study|noncompliance with study requirements|2|||
13427346|NCT00424528|26880876|FG001|Overall Study|noncompliance with study requirements|1|||
13427347|NCT00424528|26880877|FG002|Overall Study|noncompliance with study requirements|2|||
13427348|NCT00424515|26880894|FG000|Overall Study|Progressive Disease|10|||
13427349|NCT00424515|26880895|FG001|Overall Study|Progressive Disease|11|||
13427350|NCT00424515|26880894|FG000|Overall Study|Adverse Event|0|||
13427351|NCT00424515|26880895|FG001|Overall Study|Adverse Event|1|||
13427352|NCT00424515|26880894|FG000|Overall Study|Intercurrent Illness|0|||
13427353|NCT00424515|26880895|FG001|Overall Study|Intercurrent Illness|1|||
13427354|NCT00424515|26880894|FG000|Overall Study|Withdrawal by Subject|1|||
13427355|NCT00424515|26880895|FG001|Overall Study|Withdrawal by Subject|0|||
13427356|NCT00424489|26880901|FG000|Overall Study|Death|3|||
13427357|NCT00424476|26880934|FG000|Overall Study|Withdrawal by Subject|7|||
13427358|NCT00424476|26880935|FG001|Overall Study|Withdrawal by Subject|6|||
13427359|NCT00424476|26880936|FG002|Overall Study|Withdrawal by Subject|3|||
13427360|NCT00424476|26880934|FG000|Overall Study|Adverse Event|19|||
13427361|NCT00424476|26880935|FG001|Overall Study|Adverse Event|16|||
13427362|NCT00424476|26880936|FG002|Overall Study|Adverse Event|15|||
13427363|NCT00424476|26880934|FG000|Overall Study|Lack of Efficacy|16|||
13427364|NCT00424476|26880935|FG001|Overall Study|Lack of Efficacy|12|||
13427365|NCT00424476|26880936|FG002|Overall Study|Lack of Efficacy|12|||
13427366|NCT00424476|26880934|FG000|Overall Study|Lack of Compliance|1|||
13427367|NCT00424476|26880935|FG001|Overall Study|Lack of Compliance|1|||
13427368|NCT00424476|26880936|FG002|Overall Study|Lack of Compliance|1|||
13427369|NCT00424476|26880934|FG000|Overall Study|Lost to Follow-up|4|||
13427370|NCT00424476|26880935|FG001|Overall Study|Lost to Follow-up|6|||
13427371|NCT00424476|26880936|FG002|Overall Study|Lost to Follow-up|3|||
13427372|NCT00424476|26880934|FG000|Overall Study|Protocol Violation|7|||
13427373|NCT00424476|26880935|FG001|Overall Study|Protocol Violation|2|||
13427374|NCT00424476|26880936|FG002|Overall Study|Protocol Violation|3|||
13427375|NCT00424476|26880934|FG000|Overall Study|Physician Decision|3|||
13427376|NCT00424476|26880935|FG001|Overall Study|Physician Decision|2|||
13427377|NCT00424476|26880936|FG002|Overall Study|Physician Decision|3|||
13427378|NCT00424476|26880934|FG000|Overall Study|Other|4|||
13427379|NCT00424476|26880935|FG001|Overall Study|Other|3|||
13427380|NCT00424476|26880936|FG002|Overall Study|Other|9|||
13427381|NCT00424463|26880972|FG000|Overall Study|Adverse Event|2|||
13427382|NCT00424463|26880973|FG001|Overall Study|Adverse Event|3|||
13427383|NCT00424463|26880974|FG002|Overall Study|Adverse Event|2|||
13427384|NCT00424463|26880972|FG000|Overall Study|Physician Decision|0|||
13427385|NCT00424463|26880973|FG001|Overall Study|Physician Decision|2|||
13427386|NCT00424463|26880974|FG002|Overall Study|Physician Decision|2|||
13427387|NCT00424463|26880972|FG000|Overall Study|Withdrawal by Subject|4|||
13427388|NCT00424463|26880973|FG001|Overall Study|Withdrawal by Subject|2|||
13427389|NCT00424463|26880974|FG002|Overall Study|Withdrawal by Subject|5|||
13427390|NCT00424463|26880972|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
13427391|NCT00424463|26880973|FG001|Overall Study|Tracheotomy due to worsening of ALS|7|||
13427392|NCT00424463|26880974|FG002|Overall Study|Tracheotomy due to worsening of ALS|6|||
13427393|NCT00424463|26880972|FG000|Overall Study|Patient's convenience|0|||
13427394|NCT00424463|26880973|FG001|Overall Study|Patient's convenience|0|||
13427395|NCT00424463|26880974|FG002|Overall Study|Patient's convenience|1|||
13427396|NCT00424398|26881028|FG000|Overall Study|Withdrawal by Subject|2|||
13427397|NCT00424398|26881029|FG001|Overall Study|Withdrawal by Subject|1|||
13427398|NCT00424398|26881030|FG002|Overall Study|Withdrawal by Subject|0|||
13427399|NCT00424398|26881028|FG000|Overall Study|Subject met exclusion criteria|1|||
13427400|NCT00424398|26881029|FG001|Overall Study|Subject met exclusion criteria|0|||
13427401|NCT00424398|26881030|FG002|Overall Study|Subject met exclusion criteria|0|||
13427402|NCT00424385|26881039|FG000|Cohort 0|Withdrawal by Subject|5|||
13427403|NCT00424385|26881039|FG000|Cohort 0|Physician Decision|1|||
13427404|NCT00424385|26881039|FG000|Cohort 1|Withdrawal by Subject|1|||
13427405|NCT00424372|26881050|FG000|Overall Study|Death|1|||
13427406|NCT00424372|26881050|FG000|Overall Study|Adverse Event|18|||
13427407|NCT00424372|26881050|FG000|Overall Study|Lack of Efficacy|6|||
13427408|NCT00424372|26881050|FG000|Overall Study|Withdrawal by Subject|4|||
13427409|NCT00424372|26881050|FG000|Overall Study|Protocol Violation|1|||
13427410|NCT00424372|26881050|FG000|Overall Study|Health deterioration|1|||
13427411|NCT00424346|26881176|FG000|Core Study|Adverse Event|5|||
13427412|NCT00424346|26881177|FG001|Core Study|Adverse Event|3|||
13427413|NCT00424346|26881178|FG002|Core Study|Adverse Event|1|||
13427414|NCT00424346|26881179|FG003|Core Study|Adverse Event|1|||
13427415|NCT00424346|26881176|FG000|Core Study|Abnormal Laboratory Values|0|||
13427416|NCT00424346|26881177|FG001|Core Study|Abnormal Laboratory Values|1|||
13427417|NCT00424346|26881178|FG002|Core Study|Abnormal Laboratory Values|0|||
13427418|NCT00424346|26881179|FG003|Core Study|Abnormal Laboratory Values|0|||
13427419|NCT00424346|26881176|FG000|Core Study|Lack of Efficacy|1|||
13427420|NCT00424346|26881177|FG001|Core Study|Lack of Efficacy|3|||
13427421|NCT00424346|26881178|FG002|Core Study|Lack of Efficacy|0|||
13427422|NCT00424346|26881179|FG003|Core Study|Lack of Efficacy|4|||
13427423|NCT00424346|26881176|FG000|Core Study|Withdrawal by Subject|1|||
13427424|NCT00424346|26881177|FG001|Core Study|Withdrawal by Subject|0|||
13427425|NCT00424346|26881178|FG002|Core Study|Withdrawal by Subject|0|||
13427426|NCT00424346|26881179|FG003|Core Study|Withdrawal by Subject|2|||
13427427|NCT00424346|26881176|FG000|Core Study|Lost to Follow-up|1|||
13427428|NCT00424346|26881177|FG001|Core Study|Lost to Follow-up|1|||
13427429|NCT00424346|26881178|FG002|Core Study|Lost to Follow-up|0|||
13427430|NCT00424346|26881179|FG003|Core Study|Lost to Follow-up|0|||
13427431|NCT00424346|26881176|FG000|Core Study|Administrative Problems|1|||
13427432|NCT00424346|26881177|FG001|Core Study|Administrative Problems|0|||
13427433|NCT00424346|26881178|FG002|Core Study|Administrative Problems|1|||
13427434|NCT00424346|26881179|FG003|Core Study|Administrative Problems|0|||
13427435|NCT00424346|26881176|FG000|Core Study|Protocol Violation|0|||
13427436|NCT00424346|26881177|FG001|Core Study|Protocol Violation|0|||
13427437|NCT00424346|26881178|FG002|Core Study|Protocol Violation|2|||
13427438|NCT00424346|26881179|FG003|Core Study|Protocol Violation|0|||
13427439|NCT00424346|26881176|FG000|Extension Phase|Adverse Event|0|||
13427440|NCT00424346|26881177|FG001|Extension Phase|Adverse Event|9|||
13427441|NCT00424346|26881178|FG002|Extension Phase|Adverse Event|5|||
13427442|NCT00424346|26881179|FG003|Extension Phase|Adverse Event|4|||
13427443|NCT00424346|26881176|FG000|Extension Phase|Lack of Efficacy|0|||
13427444|NCT00424346|26881177|FG001|Extension Phase|Lack of Efficacy|16|||
13427445|NCT00424346|26881178|FG002|Extension Phase|Lack of Efficacy|14|||
13427446|NCT00424346|26881179|FG003|Extension Phase|Lack of Efficacy|11|||
13427447|NCT00424346|26881176|FG000|Extension Phase|Withdrawal by Subject|0|||
13427448|NCT00424346|26881177|FG001|Extension Phase|Withdrawal by Subject|5|||
13427449|NCT00424346|26881178|FG002|Extension Phase|Withdrawal by Subject|3|||
13427450|NCT00424346|26881179|FG003|Extension Phase|Withdrawal by Subject|4|||
13427451|NCT00424346|26881176|FG000|Extension Phase|Lost to Follow-up|0|||
13427452|NCT00424346|26881177|FG001|Extension Phase|Lost to Follow-up|2|||
13427453|NCT00424346|26881178|FG002|Extension Phase|Lost to Follow-up|0|||
13427454|NCT00424346|26881179|FG003|Extension Phase|Lost to Follow-up|0|||
13427455|NCT00424346|26881176|FG000|Extension Phase|Administrative Problems|0|||
13427456|NCT00424346|26881177|FG001|Extension Phase|Administrative Problems|69|||
13427457|NCT00424346|26881178|FG002|Extension Phase|Administrative Problems|32|||
13427458|NCT00424346|26881179|FG003|Extension Phase|Administrative Problems|35|||
13427459|NCT00424346|26881176|FG000|Extension Phase|Death|0|||
13427460|NCT00424346|26881177|FG001|Extension Phase|Death|0|||
13427461|NCT00424346|26881178|FG002|Extension Phase|Death|0|||
13427462|NCT00424346|26881179|FG003|Extension Phase|Death|1|||
13427463|NCT00424346|26881176|FG000|Extension Phase|Protocol Violation|0|||
13427464|NCT00424346|26881177|FG001|Extension Phase|Protocol Violation|1|||
13427465|NCT00424346|26881178|FG002|Extension Phase|Protocol Violation|1|||
13427466|NCT00424346|26881179|FG003|Extension Phase|Protocol Violation|0|||
13427467|NCT00424294|26881234|FG000|Overall Study|Adverse Event|4|||
13427468|NCT00424294|26881235|FG001|Overall Study|Adverse Event|10|||
13427469|NCT00424294|26881234|FG000|Overall Study|Lack of Efficacy|2|||
13427470|NCT00424294|26881235|FG001|Overall Study|Lack of Efficacy|1|||
13427471|NCT00424294|26881234|FG000|Overall Study|Withdrawal by Subject|1|||
13427472|NCT00424294|26881235|FG001|Overall Study|Withdrawal by Subject|2|||
13427473|NCT00424294|26881234|FG000|Overall Study|Other|0|||
13427474|NCT00424294|26881235|FG001|Overall Study|Other|2|||
13427475|NCT00424294|26881234|FG000|Overall Study|Randomized but not Treated|1|||
13427476|NCT00424294|26881235|FG001|Overall Study|Randomized but not Treated|0|||
13427477|NCT00424255|26881288|FG000|Overall Study|Death|115|||
13427478|NCT00424255|26881289|FG001|Overall Study|Death|111|||
13427479|NCT00424255|26881288|FG000|Overall Study|Lost to Follow-up|26|||
13427480|NCT00424255|26881289|FG001|Overall Study|Lost to Follow-up|20|||
13427481|NCT00424255|26881288|FG000|Overall Study|Protocol Violation|0|||
13427482|NCT00424255|26881289|FG001|Overall Study|Protocol Violation|1|||
13427483|NCT00424255|26881288|FG000|Overall Study|Withdrawal by Subject|34|||
13427484|NCT00424255|26881289|FG001|Overall Study|Withdrawal by Subject|38|||
13427485|NCT00424255|26881288|FG000|Overall Study|Physician Decision|3|||
13427486|NCT00424255|26881289|FG001|Overall Study|Physician Decision|7|||
13427487|NCT00424255|26881288|FG000|Overall Study|Cognitive Disturbance|1|||
13427488|NCT00424255|26881289|FG001|Overall Study|Cognitive Disturbance|0|||
13427489|NCT00424255|26881288|FG000|Overall Study|Non-compliance by Participants|1|||
13427490|NCT00424255|26881289|FG001|Overall Study|Non-compliance by Participants|0|||
13427491|NCT00424255|26881288|FG000|Overall Study|Fatigue|1|||
13427492|NCT00424255|26881289|FG001|Overall Study|Fatigue|0|||
13427493|NCT00424255|26881288|FG000|Overall Study|Disease Progression|0|||
13427494|NCT00424255|26881289|FG001|Overall Study|Disease Progression|2|||
13427495|NCT00424255|26881288|FG000|Overall Study|Sponsor Terminated Study|161|||
13427496|NCT00424255|26881289|FG001|Overall Study|Sponsor Terminated Study|167|||
13427497|NCT00424190|26881302|FG000|Overall Study|Withdrew consent|3|||
13427498|NCT00424190|26881303|FG001|Overall Study|Withdrew consent|4|||
13427499|NCT00424190|26881302|FG000|Overall Study|Death|3|||
13427500|NCT00424190|26881303|FG001|Overall Study|Death|0|||
13427501|NCT00424190|26881302|FG000|Overall Study|Noncompliance|1|||
13427502|NCT00424190|26881303|FG001|Overall Study|Noncompliance|2|||
13427503|NCT00424190|26881302|FG000|Overall Study|Request of sponsor or investigator|0|||
13427504|NCT00424190|26881303|FG001|Overall Study|Request of sponsor or investigator|2|||
13427505|NCT00424190|26881302|FG000|Overall Study|Diagnosis of osteomyelitis|0|||
13427506|NCT00424190|26881303|FG001|Overall Study|Diagnosis of osteomyelitis|1|||
13427507|NCT00424190|26881302|FG000|Overall Study|Other|15|||
13427508|NCT00424190|26881303|FG001|Overall Study|Other|21|||
13427509|NCT00424177|26881332|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8|||
13427510|NCT00424177|26881332|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1|||
13427511|NCT00424177|26881332|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1|||
13427512|NCT00424177|26881332|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1|||
13427513|NCT00424177|26881332|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2|||
13427514|NCT00424177|26881332|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1|||
13427515|NCT00424177|26881332|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
13427516|NCT00424177|26881332|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1|||
13427517|NCT00424177|26881332|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
13427518|NCT00424177|26881332|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1|||
13427519|NCT00424047|26881367|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18|||
13427520|NCT00424047|26881368|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12|||
13427521|NCT00424047|26881367|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67|||
13427522|NCT00424047|26881368|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122|||
13427523|NCT00424047|26881367|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1|||
13427524|NCT00424047|26881368|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3|||
13427525|NCT00424047|26881367|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23|||
13427526|NCT00424047|26881368|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8|||
13427527|NCT00424047|26881367|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11|||
13427528|NCT00424047|26881368|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10|||
13427529|NCT00424047|26881367|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2|||
13427530|NCT00424047|26881368|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1|||
13427531|NCT00424047|26881367|FG000|On Study at Time of Unblinding|Adverse Event|22|||
13427532|NCT00424047|26881368|FG001|On Study at Time of Unblinding|Adverse Event|12|||
13427533|NCT00424047|26881367|FG000|On Study at Time of Unblinding|Progression of disease|92|||
13427534|NCT00424047|26881368|FG001|On Study at Time of Unblinding|Progression of disease|128|||
13427535|NCT00424047|26881367|FG000|On Study at Time of Unblinding|Lack of Efficacy|1|||
13427536|NCT00424047|26881368|FG001|On Study at Time of Unblinding|Lack of Efficacy|3|||
13427537|NCT00424047|26881367|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24|||
13427538|NCT00424047|26881368|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9|||
13427539|NCT00424047|26881367|FG000|On Study at Time of Unblinding|Death|11|||
13427540|NCT00424047|26881368|FG001|On Study at Time of Unblinding|Death|11|||
13427541|NCT00424047|26881367|FG000|On Study at Time of Unblinding|Other|5|||
13427542|NCT00424047|26881368|FG001|On Study at Time of Unblinding|Other|4|||
13427543|NCT00424047|26881367|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1|||
13427544|NCT00424047|26881368|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0|||
13427545|NCT00424047|26881367|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0|||
13427546|NCT00424047|26881368|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1|||
13427547|NCT00424047|26881367|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12|||
13427548|NCT00424047|26881368|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4|||
13427549|NCT00424047|26881367|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7|||
13427550|NCT00424047|26881368|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3|||
13427551|NCT00424047|26881367|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1|||
13427552|NCT00424047|26881368|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0|||
13427553|NCT00424021|26881422|FG000|NCT00046319 Study Period|Adverse Event|1|||
13427554|NCT00424021|26881423|FG001|NCT00046319 Study Period|Adverse Event|0|||
13427555|NCT00424021|26881424|FG002|NCT00046319 Study Period|Adverse Event|1|||
13427556|NCT00424021|26881425|FG003|NCT00046319 Study Period|Adverse Event|1|||
13427557|NCT00424021|26881422|FG000|NCT00046319 Study Period|Withdrawal by Subject|0|||
13427558|NCT00424021|26881423|FG001|NCT00046319 Study Period|Withdrawal by Subject|1|||
13427559|NCT00424021|26881424|FG002|NCT00046319 Study Period|Withdrawal by Subject|0|||
13427560|NCT00424021|26881425|FG003|NCT00046319 Study Period|Withdrawal by Subject|0|||
13427561|NCT00424021|26881422|FG000|NCT00046319 Study Period|Sponsor discretion|0|||
13427562|NCT00424021|26881423|FG001|NCT00046319 Study Period|Sponsor discretion|1|||
13427563|NCT00424021|26881424|FG002|NCT00046319 Study Period|Sponsor discretion|0|||
13427564|NCT00424021|26881425|FG003|NCT00046319 Study Period|Sponsor discretion|0|||
13427565|NCT00424021|26881422|FG000|NCT00046319 Study Period|Lost to Follow-up|0|||
13427566|NCT00424021|26881423|FG001|NCT00046319 Study Period|Lost to Follow-up|1|||
13427567|NCT00424021|26881424|FG002|NCT00046319 Study Period|Lost to Follow-up|0|||
13427568|NCT00424021|26881425|FG003|NCT00046319 Study Period|Lost to Follow-up|0|||
13427569|NCT00424021|26881422|FG000|AMB-220-E Study Period|Adverse Event|1|||
13427570|NCT00424021|26881423|FG001|AMB-220-E Study Period|Adverse Event|1|||
13427571|NCT00424021|26881424|FG002|AMB-220-E Study Period|Adverse Event|3|||
13427572|NCT00424021|26881425|FG003|AMB-220-E Study Period|Adverse Event|7|||
13427573|NCT00424021|26881422|FG000|AMB-220-E Study Period|Death|0|||
13427574|NCT00424021|26881423|FG001|AMB-220-E Study Period|Death|0|||
13427575|NCT00424021|26881424|FG002|AMB-220-E Study Period|Death|1|||
13427576|NCT00424021|26881425|FG003|AMB-220-E Study Period|Death|1|||
13427577|NCT00424021|26881422|FG000|AMB-220-E Study Period|Lost to Follow-up|0|||
13427578|NCT00424021|26881423|FG001|AMB-220-E Study Period|Lost to Follow-up|1|||
13427579|NCT00424021|26881424|FG002|AMB-220-E Study Period|Lost to Follow-up|1|||
13427580|NCT00424021|26881425|FG003|AMB-220-E Study Period|Lost to Follow-up|1|||
13427581|NCT00424021|26881422|FG000|AMB-220-E Study Period|Physician Decision|0|||
13427582|NCT00424021|26881423|FG001|AMB-220-E Study Period|Physician Decision|0|||
13427583|NCT00424021|26881424|FG002|AMB-220-E Study Period|Physician Decision|0|||
13427584|NCT00424021|26881425|FG003|AMB-220-E Study Period|Physician Decision|1|||
13427585|NCT00424008|26881445|FG000|Overall Study|Adverse Event|8|||
13427586|NCT00424008|26881446|FG001|Overall Study|Adverse Event|6|||
13427587|NCT00424008|26881445|FG000|Overall Study|Lack of Efficacy|40|||
13427588|NCT00424008|26881446|FG001|Overall Study|Lack of Efficacy|34|||
13427589|NCT00424008|26881445|FG000|Overall Study|Lost to Follow-up|1|||
13427590|NCT00424008|26881446|FG001|Overall Study|Lost to Follow-up|2|||
13427591|NCT00424008|26881445|FG000|Overall Study|Withdrawal by Subject|5|||
13427592|NCT00424008|26881446|FG001|Overall Study|Withdrawal by Subject|8|||
13427593|NCT00424008|26881445|FG000|Overall Study|Noncompliance with protocol|13|||
13427594|NCT00424008|26881446|FG001|Overall Study|Noncompliance with protocol|7|||
13427595|NCT00424008|26881445|FG000|Overall Study|Did not meet protocol eligibility|16|||
13427596|NCT00424008|26881446|FG001|Overall Study|Did not meet protocol eligibility|21|||
13427597|NCT00424008|26881445|FG000|Overall Study|Administrative|266|||
13427598|NCT00424008|26881446|FG001|Overall Study|Administrative|257|||
13427599|NCT00423943|26881467|FG000|Overall Study|Withdrawal by Subject|3|||
13427600|NCT00423943|26881468|FG001|Overall Study|Withdrawal by Subject|1|||
13427601|NCT00423930|26881475|FG000|Overall Study|Withdrawal by Subject|2|||
13427602|NCT00423917|26881487|FG000|Overall Study|Cancel|2|||
13427603|NCT00423917|26881487|FG000|Overall Study|Ineligible|1|||
13427604|NCT00423891|26881564|FG000|Enrolled|Withdrawal by Subject|0|||
13427605|NCT00423891|26881565|FG001|Enrolled|Withdrawal by Subject|0|||
13427606|NCT00423891|26881566|FG002|Enrolled|Withdrawal by Subject|1|||
13427607|NCT00423891|26881564|FG000|Enrolled|Lost to Follow-up|0|||
13427608|NCT00423891|26881565|FG001|Enrolled|Lost to Follow-up|0|||
13427609|NCT00423891|26881566|FG002|Enrolled|Lost to Follow-up|1|||
13427610|NCT00423891|26881564|FG000|Enrolled|No longer met criteria|11|||
13427611|NCT00423891|26881565|FG001|Enrolled|No longer met criteria|2|||
13427612|NCT00423891|26881566|FG002|Enrolled|No longer met criteria|1|||
13427613|NCT00423891|26881564|FG000|Treatment|Withdrawal by Subject|1|||
13427614|NCT00423891|26881565|FG001|Treatment|Withdrawal by Subject|0|||
13427615|NCT00423891|26881566|FG002|Treatment|Withdrawal by Subject|0|||
13427616|NCT00423891|26881564|FG000|Treatment|Lost to Follow-up|1|||
13427617|NCT00423891|26881565|FG001|Treatment|Lost to Follow-up|0|||
13427618|NCT00423891|26881566|FG002|Treatment|Lost to Follow-up|0|||
13427619|NCT00423891|26881564|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0|||
13427620|NCT00423891|26881565|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3|||
13427621|NCT00423891|26881566|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2|||
13427622|NCT00423891|26881564|FG000|Post-Dosing Follow Up|Lost to Follow-up|2|||
13427623|NCT00423891|26881565|FG001|Post-Dosing Follow Up|Lost to Follow-up|0|||
13427624|NCT00423891|26881566|FG002|Post-Dosing Follow Up|Lost to Follow-up|0|||
13427625|NCT00423852|26881573|FG000|Overall Study|Removed pior to the high-dose portion|3|||
13427626|NCT00423813|26881591|FG000|Overall Study|Adverse Event|11|||
13427627|NCT00423813|26881592|FG001|Overall Study|Adverse Event|30|||
13427628|NCT00423813|26881593|FG002|Overall Study|Adverse Event|40|||
13427629|NCT00423813|26881591|FG000|Overall Study|Withdrawal by Subject|6|||
13427630|NCT00423813|26881592|FG001|Overall Study|Withdrawal by Subject|8|||
13427631|NCT00423813|26881593|FG002|Overall Study|Withdrawal by Subject|5|||
13427632|NCT00423813|26881591|FG000|Overall Study|Lost to Follow-up|5|||
13427633|NCT00423813|26881592|FG001|Overall Study|Lost to Follow-up|4|||
13427634|NCT00423813|26881593|FG002|Overall Study|Lost to Follow-up|4|||
13427635|NCT00423813|26881591|FG000|Overall Study|Lack of Efficacy|23|||
13427636|NCT00423813|26881592|FG001|Overall Study|Lack of Efficacy|18|||
13427637|NCT00423813|26881593|FG002|Overall Study|Lack of Efficacy|19|||
13427638|NCT00423813|26881591|FG000|Overall Study|Physician Decision|2|||
13427639|NCT00423813|26881592|FG001|Overall Study|Physician Decision|0|||
13427640|NCT00423813|26881593|FG002|Overall Study|Physician Decision|0|||
13427641|NCT00423813|26881591|FG000|Overall Study|Sponsor Decision|0|||
13427642|NCT00423813|26881592|FG001|Overall Study|Sponsor Decision|1|||
13427643|NCT00423813|26881593|FG002|Overall Study|Sponsor Decision|0|||
13427644|NCT00423813|26881591|FG000|Overall Study|Protocol Violation|9|||
13427645|NCT00423813|26881592|FG001|Overall Study|Protocol Violation|4|||
13427646|NCT00423813|26881593|FG002|Overall Study|Protocol Violation|4|||
13427647|NCT00423813|26881591|FG000|Overall Study|Pregnancy|0|||
13427648|NCT00423813|26881592|FG001|Overall Study|Pregnancy|0|||
13427649|NCT00423813|26881593|FG002|Overall Study|Pregnancy|1|||
13427650|NCT00423813|26881591|FG000|Overall Study|Subject started night shift work|1|||
13427651|NCT00423813|26881592|FG001|Overall Study|Subject started night shift work|0|||
13427652|NCT00423813|26881593|FG002|Overall Study|Subject started night shift work|0|||
13427653|NCT00423813|26881591|FG000|Overall Study|Will start exclusionary medications|0|||
13427654|NCT00423813|26881592|FG001|Overall Study|Will start exclusionary medications|1|||
13427655|NCT00423813|26881593|FG002|Overall Study|Will start exclusionary medications|0|||
13427656|NCT00423813|26881591|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0|||
13427657|NCT00423813|26881592|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0|||
13427658|NCT00423813|26881593|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1|||
13427659|NCT00423800|26881609|FG000|Overall Study|Protocol Violation|0|||
13427660|NCT00423800|26881610|FG001|Overall Study|Protocol Violation|1|||
13427661|NCT00423735|26881641|FG000|Overall Study|Ineligible / No protocol treatment|8|||
13427662|NCT00423735|26881642|FG001|Overall Study|Ineligible / No protocol treatment|6|||
13427663|NCT00423735|26881643|FG002|Overall Study|Ineligible / No protocol treatment|0|||
13427664|NCT00423722|26881670|FG000|Overall Study|Death|4|||
13427665|NCT00423722|26881671|FG001|Overall Study|Death|4|||
13427666|NCT00423722|26881670|FG000|Overall Study|Declined to participate|2|||
13427667|NCT00423722|26881671|FG001|Overall Study|Declined to participate|3|||
13427668|NCT00423722|26881670|FG000|Overall Study|Unable to complete questionnaires|4|||
13427669|NCT00423722|26881671|FG001|Overall Study|Unable to complete questionnaires|4|||
13427670|NCT00423722|26881670|FG000|Overall Study|Withdrawal by Subject|4|||
13427671|NCT00423722|26881671|FG001|Overall Study|Withdrawal by Subject|2|||
13427672|NCT00423670|26881750|FG000|Treatment Period|Switched to Arm 8 at TW 24|36|||
13427673|NCT00423670|26881751|FG001|Treatment Period|Switched to Arm 8 at TW 24|0|||
13427674|NCT00423670|26881752|FG002|Treatment Period|Switched to Arm 8 at TW 24|0|||
13427675|NCT00423670|26881753|FG003|Treatment Period|Switched to Arm 8 at TW 24|0|||
13427676|NCT00423670|26881754|FG004|Treatment Period|Switched to Arm 8 at TW 24|0|||
13427677|NCT00423670|26881755|FG005|Treatment Period|Switched to Arm 8 at TW 24|0|||
13427678|NCT00423670|26881756|FG006|Treatment Period|Switched to Arm 8 at TW 24|0|||
13427679|NCT00423670|26881757|FG007|Treatment Period|Switched to Arm 8 at TW 24|0|||
13427680|NCT00423670|26881750|FG000|Treatment Period|Adverse Event|8|||
13427681|NCT00423670|26881751|FG001|Treatment Period|Adverse Event|12|||
13427682|NCT00423670|26881752|FG002|Treatment Period|Adverse Event|15|||
13427683|NCT00423670|26881753|FG003|Treatment Period|Adverse Event|20|||
13427684|NCT00423670|26881754|FG004|Treatment Period|Adverse Event|9|||
13427685|NCT00423670|26881755|FG005|Treatment Period|Adverse Event|4|||
13427686|NCT00423670|26881756|FG006|Treatment Period|Adverse Event|7|||
13427687|NCT00423670|26881757|FG007|Treatment Period|Adverse Event|2|||
13427688|NCT00423670|26881750|FG000|Treatment Period|Protocol-defined clinical event|0|||
13427689|NCT00423670|26881751|FG001|Treatment Period|Protocol-defined clinical event|7|||
13427690|NCT00423670|26881752|FG002|Treatment Period|Protocol-defined clinical event|4|||
13427691|NCT00423670|26881753|FG003|Treatment Period|Protocol-defined clinical event|12|||
13427692|NCT00423670|26881754|FG004|Treatment Period|Protocol-defined clinical event|5|||
13427693|NCT00423670|26881755|FG005|Treatment Period|Protocol-defined clinical event|4|||
13427694|NCT00423670|26881756|FG006|Treatment Period|Protocol-defined clinical event|16|||
13427695|NCT00423670|26881757|FG007|Treatment Period|Protocol-defined clinical event|15|||
13427696|NCT00423670|26881750|FG000|Treatment Period|Lost to Follow-up|2|||
13427697|NCT00423670|26881751|FG001|Treatment Period|Lost to Follow-up|1|||
13427698|NCT00423670|26881752|FG002|Treatment Period|Lost to Follow-up|3|||
13427699|NCT00423670|26881753|FG003|Treatment Period|Lost to Follow-up|1|||
13427700|NCT00423670|26881754|FG004|Treatment Period|Lost to Follow-up|6|||
13427701|NCT00423670|26881755|FG005|Treatment Period|Lost to Follow-up|0|||
13427702|NCT00423670|26881756|FG006|Treatment Period|Lost to Follow-up|3|||
13427703|NCT00423670|26881757|FG007|Treatment Period|Lost to Follow-up|1|||
13427704|NCT00423670|26881750|FG000|Treatment Period|Subject withdrew (not treatment related)|3|||
13427705|NCT00423670|26881751|FG001|Treatment Period|Subject withdrew (not treatment related)|9|||
13427706|NCT00423670|26881752|FG002|Treatment Period|Subject withdrew (not treatment related)|4|||
13427707|NCT00423670|26881753|FG003|Treatment Period|Subject withdrew (not treatment related)|4|||
13427708|NCT00423670|26881754|FG004|Treatment Period|Subject withdrew (not treatment related)|5|||
13427709|NCT00423670|26881755|FG005|Treatment Period|Subject withdrew (not treatment related)|0|||
13427710|NCT00423670|26881756|FG006|Treatment Period|Subject withdrew (not treatment related)|3|||
13427711|NCT00423670|26881757|FG007|Treatment Period|Subject withdrew (not treatment related)|0|||
13427712|NCT00423670|26881750|FG000|Treatment Period|Investigator decision|0|||
13427713|NCT00423670|26881751|FG001|Treatment Period|Investigator decision|0|||
13427714|NCT00423670|26881752|FG002|Treatment Period|Investigator decision|0|||
13427715|NCT00423670|26881753|FG003|Treatment Period|Investigator decision|0|||
13427716|NCT00423670|26881754|FG004|Treatment Period|Investigator decision|0|||
13427717|NCT00423670|26881755|FG005|Treatment Period|Investigator decision|0|||
13427718|NCT00423670|26881756|FG006|Treatment Period|Investigator decision|0|||
13427719|NCT00423670|26881757|FG007|Treatment Period|Investigator decision|1|||
13427720|NCT00423670|26881750|FG000|Treatment Period|Non-compliance with protocol|3|||
13427721|NCT00423670|26881751|FG001|Treatment Period|Non-compliance with protocol|1|||
13427722|NCT00423670|26881752|FG002|Treatment Period|Non-compliance with protocol|1|||
13427723|NCT00423670|26881753|FG003|Treatment Period|Non-compliance with protocol|3|||
13427724|NCT00423670|26881754|FG004|Treatment Period|Non-compliance with protocol|2|||
13427725|NCT00423670|26881755|FG005|Treatment Period|Non-compliance with protocol|0|||
13427726|NCT00423670|26881756|FG006|Treatment Period|Non-compliance with protocol|2|||
13427727|NCT00423670|26881757|FG007|Treatment Period|Non-compliance with protocol|2|||
13427728|NCT00423670|26881750|FG000|Follow-up Period|Lost to Follow-up|0|||
13427729|NCT00423670|26881751|FG001|Follow-up Period|Lost to Follow-up|12|||
13427730|NCT00423670|26881752|FG002|Follow-up Period|Lost to Follow-up|8|||
13427731|NCT00423670|26881753|FG003|Follow-up Period|Lost to Follow-up|3|||
13427732|NCT00423670|26881754|FG004|Follow-up Period|Lost to Follow-up|1|||
13427733|NCT00423670|26881755|FG005|Follow-up Period|Lost to Follow-up|0|||
13427734|NCT00423670|26881756|FG006|Follow-up Period|Lost to Follow-up|5|||
13427735|NCT00423670|26881757|FG007|Follow-up Period|Lost to Follow-up|0|||
13427736|NCT00423670|26881750|FG000|Follow-up Period|Subject withdrew (not treatment related)|1|||
13427737|NCT00423670|26881751|FG001|Follow-up Period|Subject withdrew (not treatment related)|4|||
13427738|NCT00423670|26881752|FG002|Follow-up Period|Subject withdrew (not treatment related)|2|||
13427739|NCT00423670|26881753|FG003|Follow-up Period|Subject withdrew (not treatment related)|1|||
13427740|NCT00423670|26881754|FG004|Follow-up Period|Subject withdrew (not treatment related)|1|||
13427741|NCT00423670|26881755|FG005|Follow-up Period|Subject withdrew (not treatment related)|0|||
13427742|NCT00423670|26881756|FG006|Follow-up Period|Subject withdrew (not treatment related)|1|||
13427743|NCT00423670|26881757|FG007|Follow-up Period|Subject withdrew (not treatment related)|1|||
13427744|NCT00423670|26881750|FG000|Follow-up Period|Non-compliance with protocol|2|||
13427745|NCT00423670|26881751|FG001|Follow-up Period|Non-compliance with protocol|0|||
13427746|NCT00423670|26881752|FG002|Follow-up Period|Non-compliance with protocol|1|||
13427747|NCT00423670|26881753|FG003|Follow-up Period|Non-compliance with protocol|1|||
13427748|NCT00423670|26881754|FG004|Follow-up Period|Non-compliance with protocol|0|||
13427749|NCT00423670|26881755|FG005|Follow-up Period|Non-compliance with protocol|0|||
13427750|NCT00423670|26881756|FG006|Follow-up Period|Non-compliance with protocol|3|||
13427751|NCT00423670|26881757|FG007|Follow-up Period|Non-compliance with protocol|2|||
13427752|NCT00423657|26881770|FG000|Overall Study|Withdrew consent|10|||
13427753|NCT00423657|26881771|FG001|Overall Study|Withdrew consent|8|||
13427754|NCT00423657|26881770|FG000|Overall Study|Non-compliance|0|||
13427755|NCT00423657|26881771|FG001|Overall Study|Non-compliance|1|||
13427756|NCT00423657|26881770|FG000|Overall Study|Other|15|||
13427757|NCT00423657|26881771|FG001|Overall Study|Other|16|||
13427758|NCT00423657|26881770|FG000|Overall Study|Request of sponsor/investigator|1|||
13427759|NCT00423657|26881771|FG001|Overall Study|Request of sponsor/investigator|0|||
13427760|NCT00423605|26881777|FG000|Overall Study|Adverse Event|129|||
13427761|NCT00423605|26881777|FG000|Overall Study|Withdrawal by Subject|36|||
13427762|NCT00423605|26881777|FG000|Overall Study|Lost to Follow-up|15|||
13427763|NCT00423605|26881777|FG000|Overall Study|Lack of Efficacy|38|||
13427764|NCT00423605|26881777|FG000|Overall Study|Sponsor Decision|3|||
13427765|NCT00423605|26881777|FG000|Overall Study|Physician Decision|8|||
13427766|NCT00423605|26881777|FG000|Overall Study|Protocol Violation|7|||
13427767|NCT00423605|26881777|FG000|Overall Study|Not one of the pre-specified options|5|||
13427768|NCT00423592|26881798|FG000|Overall Study|Adverse Event (through Week 12)|2|||
13427769|NCT00423592|26881798|FG000|Overall Study|Adverse Event (post Week 12)|5|||
13427770|NCT00423488|26881811|FG000|Overall Study|No evidence of study drug intake|2|||
13427771|NCT00423488|26881812|FG001|Overall Study|No evidence of study drug intake|1|||
13427772|NCT00423488|26881811|FG000|Overall Study|No post baseline data|3|||
13427773|NCT00423488|26881812|FG001|Overall Study|No post baseline data|0|||
13427774|NCT00423449|26881841|FG000|Overall Study|Clinical Adverse Event|1|||
13427775|NCT00423449|26881842|FG001|Overall Study|Clinical Adverse Event|0|||
13427776|NCT00423449|26881843|FG002|Overall Study|Clinical Adverse Event|1|||
13427777|NCT00423449|26881844|FG003|Overall Study|Clinical Adverse Event|8|||
13427778|NCT00423449|26881845|FG004|Overall Study|Clinical Adverse Event|2|||
13427779|NCT00423449|26881841|FG000|Overall Study|Death|1|||
13427780|NCT00423449|26881842|FG001|Overall Study|Death|0|||
13427781|NCT00423449|26881843|FG002|Overall Study|Death|2|||
13427782|NCT00423449|26881844|FG003|Overall Study|Death|1|||
13427783|NCT00423449|26881845|FG004|Overall Study|Death|1|||
13427784|NCT00423449|26881841|FG000|Overall Study|Progressive Disease|1|||
13427785|NCT00423449|26881842|FG001|Overall Study|Progressive Disease|3|||
13427786|NCT00423449|26881843|FG002|Overall Study|Progressive Disease|8|||
13427787|NCT00423449|26881844|FG003|Overall Study|Progressive Disease|11|||
13427788|NCT00423449|26881845|FG004|Overall Study|Progressive Disease|4|||
13427789|NCT00423449|26881841|FG000|Overall Study|Laboratory Adverse Event|0|||
13427790|NCT00423449|26881842|FG001|Overall Study|Laboratory Adverse Event|1|||
13427791|NCT00423449|26881843|FG002|Overall Study|Laboratory Adverse Event|2|||
13427792|NCT00423449|26881844|FG003|Overall Study|Laboratory Adverse Event|0|||
13427793|NCT00423449|26881845|FG004|Overall Study|Laboratory Adverse Event|0|||
13427794|NCT00423449|26881841|FG000|Overall Study|Other|0|||
13427795|NCT00423449|26881842|FG001|Overall Study|Other|0|||
13427796|NCT00423449|26881843|FG002|Overall Study|Other|0|||
13427797|NCT00423449|26881844|FG003|Overall Study|Other|1|||
13427798|NCT00423449|26881845|FG004|Overall Study|Other|0|||
13427799|NCT00423449|26881841|FG000|Overall Study|Protocol Violation|0|||
13427800|NCT00423449|26881842|FG001|Overall Study|Protocol Violation|0|||
13427801|NCT00423449|26881843|FG002|Overall Study|Protocol Violation|2|||
13427802|NCT00423449|26881844|FG003|Overall Study|Protocol Violation|1|||
13427803|NCT00423449|26881845|FG004|Overall Study|Protocol Violation|0|||
13427804|NCT00423332|26881869|FG000|Overall Study|Adverse Event|6|||
13427805|NCT00423332|26881870|FG001|Overall Study|Adverse Event|2|||
13427806|NCT00423332|26881869|FG000|Overall Study|Withdrawal by Subject|1|||
13427807|NCT00423332|26881870|FG001|Overall Study|Withdrawal by Subject|0|||
13427808|NCT00423332|26881869|FG000|Overall Study|Condition under investigation worsened|1|||
13427809|NCT00423332|26881870|FG001|Overall Study|Condition under investigation worsened|1|||
13427810|NCT00423332|26881869|FG000|Overall Study|Progressive at Week 6|0|||
13427811|NCT00423332|26881870|FG001|Overall Study|Progressive at Week 6|1|||
13427812|NCT00423332|26881869|FG000|Overall Study|Unblinded before 12 weeks|1|||
13427813|NCT00423332|26881870|FG001|Overall Study|Unblinded before 12 weeks|3|||
13427814|NCT00423319|26881909|FG000|Overall Study|Death|2|||
13427815|NCT00423319|26881910|FG001|Overall Study|Death|0|||
13427816|NCT00423319|26881909|FG000|Overall Study|Adverse Event|93|||
13427817|NCT00423319|26881910|FG001|Overall Study|Adverse Event|112|||
13427818|NCT00423319|26881909|FG000|Overall Study|Withdrawal by Subject|86|||
13427819|NCT00423319|26881910|FG001|Overall Study|Withdrawal by Subject|99|||
13427820|NCT00423319|26881909|FG000|Overall Study|Lost to Follow-up|4|||
13427821|NCT00423319|26881910|FG001|Overall Study|Lost to Follow-up|3|||
13427822|NCT00423319|26881909|FG000|Overall Study|Poor compliance or noncompliance|1|||
13427823|NCT00423319|26881910|FG001|Overall Study|Poor compliance or noncompliance|1|||
13427824|NCT00423319|26881909|FG000|Overall Study|No longer meets study criteria|15|||
13427825|NCT00423319|26881910|FG001|Overall Study|No longer meets study criteria|15|||
13427826|NCT00423319|26881909|FG000|Overall Study|Other|23|||
13427827|NCT00423319|26881910|FG001|Overall Study|Other|22|||
13427828|NCT00423293|26881927|FG000|Overall Study|Ineligible / No protocol treatment|11|||
13427829|NCT00423267|26881951|FG000|Period A|Withdrawal by Subject|0|||
13427830|NCT00423267|26881952|FG001|Period A|Withdrawal by Subject|1|||
13427831|NCT00423267|26881951|FG000|Period A|Non-compliance with protocol|1|||
13427832|NCT00423267|26881952|FG001|Period A|Non-compliance with protocol|0|||
13427833|NCT00423267|26881951|FG000|Period A|Administrative|1|||
13427834|NCT00423267|26881952|FG001|Period A|Administrative|0|||
13427835|NCT00423189|26881982|FG000|Overall Study|Death|0|||
13427836|NCT00423189|26881983|FG001|Overall Study|Death|1|||
13427837|NCT00423189|26881984|FG002|Overall Study|Death|0|||
13427838|NCT00423176|26881999|FG000|Overall Study|Adverse Event|4|||
13427839|NCT00423176|26882000|FG001|Overall Study|Adverse Event|6|||
13427840|NCT00423176|26881999|FG000|Overall Study|Treatment Failure|1|||
13427841|NCT00423176|26882000|FG001|Overall Study|Treatment Failure|6|||
13427842|NCT00423176|26881999|FG000|Overall Study|Lost to Follow-up|4|||
13427843|NCT00423176|26882000|FG001|Overall Study|Lost to Follow-up|7|||
13427844|NCT00423176|26881999|FG000|Overall Study|Withdrawal by Subject|4|||
13427845|NCT00423176|26882000|FG001|Overall Study|Withdrawal by Subject|3|||
13427846|NCT00423176|26881999|FG000|Overall Study|Protocol Violation|1|||
13427847|NCT00423176|26882000|FG001|Overall Study|Protocol Violation|3|||
13427848|NCT00423176|26881999|FG000|Overall Study|Did not meet protocol eligibility|2|||
13427849|NCT00423176|26882000|FG001|Overall Study|Did not meet protocol eligibility|4|||
13427850|NCT00423150|26882006|FG000|Overall Study|Adverse Event|11|||
13427851|NCT00423150|26882006|FG000|Overall Study|Progression of disease being studied|69|||
13427852|NCT00423150|26882006|FG000|Overall Study|Withdrawal by Subject|1|||
13427853|NCT00423150|26882006|FG000|Overall Study|Non-compliance with protocol|1|||
13427854|NCT00423150|26882006|FG000|Overall Study|Administrative|4|||
13427855|NCT00423137|26882066|FG000|Overall Study|Lost to Follow-up|0|||
13427856|NCT00423137|26882067|FG001|Overall Study|Lost to Follow-up|0|||
13427857|NCT00423137|26882068|FG002|Overall Study|Lost to Follow-up|1|||
13427858|NCT00423137|26882069|FG003|Overall Study|Lost to Follow-up|0|||
13427859|NCT00423137|26882066|FG000|Overall Study|Protocol Violation|0|||
13427860|NCT00423137|26882067|FG001|Overall Study|Protocol Violation|0|||
13427861|NCT00423137|26882068|FG002|Overall Study|Protocol Violation|0|||
13427862|NCT00423137|26882069|FG003|Overall Study|Protocol Violation|1|||
13427863|NCT00423137|26882066|FG000|Overall Study|Adverse Event Study disease worse|1|||
13427864|NCT00423137|26882067|FG001|Overall Study|Adverse Event Study disease worse|0|||
13427865|NCT00423137|26882068|FG002|Overall Study|Adverse Event Study disease worse|3|||
13427866|NCT00423137|26882069|FG003|Overall Study|Adverse Event Study disease worse|1|||
13427867|NCT00423137|26882066|FG000|Overall Study|Adverse Event Other|0|||
13427868|NCT00423137|26882067|FG001|Overall Study|Adverse Event Other|0|||
13427869|NCT00423137|26882068|FG002|Overall Study|Adverse Event Other|2|||
13427870|NCT00423137|26882069|FG003|Overall Study|Adverse Event Other|0|||
13427871|NCT00423098|26882100|FG000|Overall Study|Adverse Event|1|||
13427872|NCT00423098|26882101|FG001|Overall Study|Adverse Event|2|||
13427873|NCT00423098|26882100|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
13427874|NCT00423098|26882101|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
13427875|NCT00423098|26882100|FG000|Overall Study|Administrative problems|0|||
13427876|NCT00423098|26882101|FG001|Overall Study|Administrative problems|1|||
13427877|NCT00423098|26882100|FG000|Overall Study|Death|2|||
13427878|NCT00423098|26882101|FG001|Overall Study|Death|0|||
13427879|NCT00423085|26882139|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21|||
13427880|NCT00423085|26882140|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38|||
13427881|NCT00423085|26882141|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34|||
13427882|NCT00423085|26882142|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0|||
13427883|NCT00423085|26882139|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8|||
13427884|NCT00423085|26882140|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16|||
13427885|NCT00423085|26882141|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11|||
13427886|NCT00423085|26882142|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0|||
13427887|NCT00423085|26882139|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
13427888|NCT00423085|26882140|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6|||
13427889|NCT00423085|26882141|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
13427890|NCT00423085|26882142|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
13427891|NCT00423085|26882139|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8|||
13427892|NCT00423085|26882140|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3|||
13427893|NCT00423085|26882141|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7|||
13427894|NCT00423085|26882142|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0|||
13427895|NCT00423085|26882139|FG000|24-Week Double-Blind Treatment Phase|Death|1|||
13427896|NCT00423085|26882140|FG001|24-Week Double-Blind Treatment Phase|Death|1|||
13427897|NCT00423085|26882141|FG002|24-Week Double-Blind Treatment Phase|Death|0|||
13427898|NCT00423085|26882142|FG003|24-Week Double-Blind Treatment Phase|Death|0|||
13427899|NCT00423085|26882139|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1|||
13427900|NCT00423085|26882140|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
13427901|NCT00423085|26882141|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
13427902|NCT00423085|26882142|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
13427903|NCT00423085|26882139|FG000|52-Week Open-Label Extension Phase|Adverse Event|0|||
13427904|NCT00423085|26882140|FG001|52-Week Open-Label Extension Phase|Adverse Event|0|||
13427905|NCT00423085|26882141|FG002|52-Week Open-Label Extension Phase|Adverse Event|0|||
13427906|NCT00423085|26882142|FG003|52-Week Open-Label Extension Phase|Adverse Event|97|||
13427907|NCT00423085|26882139|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
13427908|NCT00423085|26882140|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
13427909|NCT00423085|26882141|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
13427910|NCT00423085|26882142|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37|||
13427911|NCT00423085|26882139|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
13427912|NCT00423085|26882140|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
13427913|NCT00423085|26882141|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
13427914|NCT00423085|26882142|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18|||
13427915|NCT00423085|26882139|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0|||
13427916|NCT00423085|26882140|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0|||
13427917|NCT00423085|26882141|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0|||
13427918|NCT00423085|26882142|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9|||
13427919|NCT00423085|26882139|FG000|52-Week Open-Label Extension Phase|Death|0|||
13427920|NCT00423085|26882140|FG001|52-Week Open-Label Extension Phase|Death|0|||
13427921|NCT00423085|26882141|FG002|52-Week Open-Label Extension Phase|Death|0|||
13427922|NCT00423085|26882142|FG003|52-Week Open-Label Extension Phase|Death|2|||
13427923|NCT00423046|26882215|FG000|Overall Study|Other|340|||
13427924|NCT00423046|26882216|FG001|Overall Study|Other|345|||
13427925|NCT00422942|26882235|FG000|Overall Study|Study terminated by Sponsor|3|||
13427926|NCT00422903|26882266|FG000|Overall Study|Disease Progression|3|||
13427927|NCT00422903|26882267|FG001|Overall Study|Disease Progression|1|||
13427928|NCT00422903|26882266|FG000|Overall Study|Adverse Event|0|||
13427929|NCT00422903|26882267|FG001|Overall Study|Adverse Event|2|||
13427930|NCT00422903|26882266|FG000|Overall Study|Informed Consent Withdrawn|1|||
13427931|NCT00422903|26882267|FG001|Overall Study|Informed Consent Withdrawn|2|||
13427932|NCT00422799|26882276|FG000|Overall Study|Withdrawal by Subject|6|||
13427933|NCT00422799|26882276|FG000|Overall Study|Adverse Event|7|||
13427934|NCT00422734|26882315|FG000|Overall Study|Physician Decision|1|||
13427935|NCT00422734|26882316|FG001|Overall Study|Physician Decision|1|||
13427936|NCT00422734|26882315|FG000|Overall Study|Protocol Violation|1|||
13427937|NCT00422734|26882316|FG001|Overall Study|Protocol Violation|6|||
13427938|NCT00422734|26882315|FG000|Overall Study|Withdrawal by Subject|12|||
13427939|NCT00422734|26882316|FG001|Overall Study|Withdrawal by Subject|8|||
13427940|NCT00422734|26882315|FG000|Overall Study|Adverse Event|0|||
13427941|NCT00422734|26882316|FG001|Overall Study|Adverse Event|3|||
13427942|NCT00422734|26882315|FG000|Overall Study|Partner Decision|0|||
13427943|NCT00422734|26882316|FG001|Overall Study|Partner Decision|3|||
13427944|NCT00422669|26882347|FG000|Overall Study|The study was terminated early.|98|||
13427945|NCT00422669|26882348|FG001|Overall Study|The study was terminated early.|100|||
13427946|NCT00422669|26882349|FG002|Overall Study|The study was terminated early.|7|||
13427947|NCT00422591|26882357|FG000|Overall Study|Physician Decision|4|||
13427948|NCT00422591|26882357|FG000|Overall Study|Withdrawal by Subject|2|||
13427949|NCT00422513|26882376|FG000|Overall Study|Lack of Efficacy|4|||
13427950|NCT00422513|26882377|FG001|Overall Study|Lack of Efficacy|5|||
13427951|NCT00422513|26882376|FG000|Overall Study|Protocol Violation|23|||
13427952|NCT00422513|26882377|FG001|Overall Study|Protocol Violation|7|||
13427953|NCT00422513|26882376|FG000|Overall Study|Refused Treatment|4|||
13427954|NCT00422513|26882377|FG001|Overall Study|Refused Treatment|2|||
13427955|NCT00422513|26882376|FG000|Overall Study|Withdrawal by Subject|2|||
13427956|NCT00422513|26882377|FG001|Overall Study|Withdrawal by Subject|1|||
13427957|NCT00422513|26882376|FG000|Overall Study|early termination of the study|67|||
13427958|NCT00422513|26882377|FG001|Overall Study|early termination of the study|80|||
13427959|NCT00422513|26882376|FG000|Overall Study|Adverse Event|4|||
13427960|NCT00422513|26882377|FG001|Overall Study|Adverse Event|4|||
13427961|NCT00422513|26882376|FG000|Overall Study|Death|3|||
13427962|NCT00422513|26882377|FG001|Overall Study|Death|7|||
13427963|NCT00422461|26882440|FG000|Overall Study|Adverse Event|1|||
13427964|NCT00422461|26882441|FG001|Overall Study|Adverse Event|2|||
13427965|NCT00422461|26882442|FG002|Overall Study|Adverse Event|1|||
13427966|NCT00422461|26882443|FG003|Overall Study|Adverse Event|1|||
13427967|NCT00422461|26882440|FG000|Overall Study|Other|0|||
13427968|NCT00422461|26882441|FG001|Overall Study|Other|0|||
13427969|NCT00422461|26882442|FG002|Overall Study|Other|0|||
13427970|NCT00422461|26882443|FG003|Overall Study|Other|2|||
13427971|NCT00422461|26882440|FG000|Overall Study|Participants no longer willing to participate in study|1|||
13427972|NCT00422461|26882441|FG001|Overall Study|Participants no longer willing to participate in study|0|||
13427973|NCT00422461|26882442|FG002|Overall Study|Participants no longer willing to participate in study|0|||
13427974|NCT00422461|26882443|FG003|Overall Study|Participants no longer willing to participate in study|0|||
13427975|NCT00422461|26882440|FG000|Overall Study|Randomized but not treated|1|||
13427976|NCT00422461|26882441|FG001|Overall Study|Randomized but not treated|1|||
13427977|NCT00422461|26882442|FG002|Overall Study|Randomized but not treated|0|||
13427978|NCT00422461|26882443|FG003|Overall Study|Randomized but not treated|0|||
13427979|NCT00422422|26882457|FG000|Overall Study|Lack of Efficacy|1|||
13427980|NCT00422422|26882457|FG000|Overall Study|Protocol Violation|1|||
13427981|NCT00422422|26882457|FG000|Overall Study|Withdrawal by Subject|2|||
13427982|NCT00422422|26882457|FG000|Overall Study|SAE, non-fatal|1|||
13427983|NCT00422422|26882457|FG000|Overall Study|AE, non-serious non-fatal|5|||
13427984|NCT00422383|26882612|FG000|Overall Study|Adverse Event|5|||
13427985|NCT00422383|26882613|FG001|Overall Study|Adverse Event|3|||
13427986|NCT00422383|26882614|FG002|Overall Study|Adverse Event|1|||
13427987|NCT00422383|26882615|FG003|Overall Study|Adverse Event|1|||
13427988|NCT00422383|26882616|FG004|Overall Study|Adverse Event|0|||
13427989|NCT00422383|26882612|FG000|Overall Study|Lack of Efficacy|4|||
13427990|NCT00422383|26882613|FG001|Overall Study|Lack of Efficacy|4|||
13427991|NCT00422383|26882614|FG002|Overall Study|Lack of Efficacy|2|||
13427992|NCT00422383|26882615|FG003|Overall Study|Lack of Efficacy|1|||
13427993|NCT00422383|26882616|FG004|Overall Study|Lack of Efficacy|1|||
13427994|NCT00422383|26882612|FG000|Overall Study|Lost to Follow-up|0|||
13427995|NCT00422383|26882613|FG001|Overall Study|Lost to Follow-up|1|||
13427996|NCT00422383|26882614|FG002|Overall Study|Lost to Follow-up|0|||
13427997|NCT00422383|26882615|FG003|Overall Study|Lost to Follow-up|0|||
13427998|NCT00422383|26882616|FG004|Overall Study|Lost to Follow-up|1|||
13427999|NCT00422383|26882612|FG000|Overall Study|Protocol Violation|1|||
13428000|NCT00422383|26882613|FG001|Overall Study|Protocol Violation|1|||
13428001|NCT00422383|26882614|FG002|Overall Study|Protocol Violation|1|||
13428002|NCT00422383|26882615|FG003|Overall Study|Protocol Violation|0|||
13428003|NCT00422383|26882616|FG004|Overall Study|Protocol Violation|0|||
13428004|NCT00422383|26882612|FG000|Overall Study|Withdrawal by Subject|5|||
13428005|NCT00422383|26882613|FG001|Overall Study|Withdrawal by Subject|5|||
13428006|NCT00422383|26882614|FG002|Overall Study|Withdrawal by Subject|0|||
13428007|NCT00422383|26882615|FG003|Overall Study|Withdrawal by Subject|0|||
13428008|NCT00422383|26882616|FG004|Overall Study|Withdrawal by Subject|1|||
13428009|NCT00422292|26882655|FG000|Overall Study|Serious adverse events|1|||
13428010|NCT00422292|26882656|FG001|Overall Study|Serious adverse events|4|||
13428011|NCT00422292|26882657|FG002|Overall Study|Serious adverse events|0|||
13428012|NCT00422292|26882658|FG003|Overall Study|Serious adverse events|0|||
13428013|NCT00422292|26882655|FG000|Overall Study|Adverse Event|1|||
13428014|NCT00422292|26882656|FG001|Overall Study|Adverse Event|0|||
13428015|NCT00422292|26882657|FG002|Overall Study|Adverse Event|1|||
13428016|NCT00422292|26882658|FG003|Overall Study|Adverse Event|0|||
13428017|NCT00422292|26882655|FG000|Overall Study|Protocol Violation|4|||
13428018|NCT00422292|26882656|FG001|Overall Study|Protocol Violation|25|||
13428019|NCT00422292|26882657|FG002|Overall Study|Protocol Violation|8|||
13428020|NCT00422292|26882658|FG003|Overall Study|Protocol Violation|5|||
13428021|NCT00422292|26882655|FG000|Overall Study|Lost to Follow-up|6|||
13428022|NCT00422292|26882656|FG001|Overall Study|Lost to Follow-up|12|||
13428023|NCT00422292|26882657|FG002|Overall Study|Lost to Follow-up|6|||
13428024|NCT00422292|26882658|FG003|Overall Study|Lost to Follow-up|6|||
13428025|NCT00422292|26882655|FG000|Overall Study|Withdrawal by Subject|6|||
13428026|NCT00422292|26882656|FG001|Overall Study|Withdrawal by Subject|25|||
13428027|NCT00422292|26882657|FG002|Overall Study|Withdrawal by Subject|7|||
13428028|NCT00422292|26882658|FG003|Overall Study|Withdrawal by Subject|13|||
13428029|NCT00422227|26882689|FG000|Overall Study|Adverse Event|3|||
13428030|NCT00422227|26882690|FG001|Overall Study|Adverse Event|8|||
13428031|NCT00422227|26882689|FG000|Overall Study|Lost to Follow-up|1|||
13428032|NCT00422227|26882690|FG001|Overall Study|Lost to Follow-up|3|||
13428033|NCT00422227|26882689|FG000|Overall Study|Withdrawal by Subject|0|||
13428034|NCT00422227|26882690|FG001|Overall Study|Withdrawal by Subject|4|||
13428035|NCT00422162|26882751|FG000|Overall Study|Adverse Event|11|||
13428036|NCT00422162|26882752|FG001|Overall Study|Adverse Event|9|||
13428037|NCT00422162|26882751|FG000|Overall Study|Lack of Efficacy|4|||
13428038|NCT00422162|26882752|FG001|Overall Study|Lack of Efficacy|10|||
13428039|NCT00422162|26882751|FG000|Overall Study|Withdrawal by Subject|7|||
13428040|NCT00422162|26882752|FG001|Overall Study|Withdrawal by Subject|6|||
13428041|NCT00422162|26882751|FG000|Overall Study|Lost to Follow-up|1|||
13428042|NCT00422162|26882752|FG001|Overall Study|Lost to Follow-up|2|||
13428043|NCT00422162|26882751|FG000|Overall Study|Non-Compliant with Protocol|1|||
13428044|NCT00422162|26882752|FG001|Overall Study|Non-Compliant with Protocol|1|||
13428045|NCT00422162|26882751|FG000|Overall Study|Other|0|||
13428046|NCT00422162|26882752|FG001|Overall Study|Other|1|||
13428047|NCT00422162|26882751|FG000|Overall Study|Didn't Receive Treatment|0|||
13428048|NCT00422162|26882752|FG001|Overall Study|Didn't Receive Treatment|1|||
13428049|NCT00422097|26882832|FG000|Dose Level 2|Still on treatment|0|||
13428050|NCT00422097|26882833|FG001|Dose Level 2|Still on treatment|1|||
13428051|NCT00422097|26882834|FG002|Dose Level 2|Still on treatment|0|||
13428052|NCT00422097|26882835|FG003|Dose Level 2|Still on treatment|0|||
13428053|NCT00422097|26882836|FG004|Dose Level 2|Still on treatment|0|||
13428054|NCT00422097|26882837|FG005|Dose Level 2|Still on treatment|0|||
13428055|NCT00422097|26882838|FG006|Dose Level 2|Still on treatment|0|||
13428056|NCT00422097|26882839|FG007|Dose Level 2|Still on treatment|0|||
13428057|NCT00422084|26882866|FG000|Overall Study|Adverse Event|21|||
13428058|NCT00422084|26882867|FG001|Overall Study|Adverse Event|7|||
13428059|NCT00422084|26882866|FG000|Overall Study|Withdrawal by Subject|12|||
13428060|NCT00422084|26882867|FG001|Overall Study|Withdrawal by Subject|9|||
13428061|NCT00422084|26882866|FG000|Overall Study|Lost to Follow-up|14|||
13428062|NCT00422084|26882867|FG001|Overall Study|Lost to Follow-up|9|||
13428063|NCT00422084|26882866|FG000|Overall Study|Protocol Violation|4|||
13428064|NCT00422084|26882867|FG001|Overall Study|Protocol Violation|1|||
13428065|NCT00422084|26882866|FG000|Overall Study|Lack of Efficacy|40|||
13428066|NCT00422084|26882867|FG001|Overall Study|Lack of Efficacy|42|||
13428067|NCT00422084|26882866|FG000|Overall Study|P. vivax infection|3|||
13428068|NCT00422084|26882867|FG001|Overall Study|P. vivax infection|6|||
13428069|NCT00422084|26882866|FG000|Overall Study|Cyesis|1|||
13428070|NCT00422084|26882867|FG001|Overall Study|Cyesis|0|||
13428071|NCT00422084|26882866|FG000|Overall Study|Withdrawn from study accidentally|1|||
13428072|NCT00422084|26882867|FG001|Overall Study|Withdrawn from study accidentally|0|||
13428073|NCT00422084|26882866|FG000|Overall Study|Non-compliance|1|||
13428074|NCT00422084|26882867|FG001|Overall Study|Non-compliance|0|||
13428075|NCT00422084|26882866|FG000|Overall Study|Re-location|0|||
13428076|NCT00422084|26882867|FG001|Overall Study|Re-location|1|||
13428077|NCT00422084|26882866|FG000|Overall Study|Not defined|1|||
13428078|NCT00422084|26882867|FG001|Overall Study|Not defined|1|||
13428079|NCT00422058|26883014|FG000|Double-Blind, Week 0-20|Adverse Event|3|||
13428080|NCT00422058|26883015|FG001|Double-Blind, Week 0-20|Adverse Event|4|||
13428081|NCT00422058|26883016|FG002|Double-Blind, Week 0-20|Adverse Event|5|||
13428082|NCT00422058|26883017|FG003|Double-Blind, Week 0-20|Adverse Event|9|||
13428083|NCT00422058|26883018|FG004|Double-Blind, Week 0-20|Adverse Event|5|||
13428084|NCT00422058|26883019|FG005|Double-Blind, Week 0-20|Adverse Event|3|||
13428085|NCT00422058|26883014|FG000|Double-Blind, Week 0-20|Protocol Violation|3|||
13428086|NCT00422058|26883015|FG001|Double-Blind, Week 0-20|Protocol Violation|2|||
13428087|NCT00422058|26883016|FG002|Double-Blind, Week 0-20|Protocol Violation|2|||
13428088|NCT00422058|26883017|FG003|Double-Blind, Week 0-20|Protocol Violation|3|||
13428089|NCT00422058|26883018|FG004|Double-Blind, Week 0-20|Protocol Violation|2|||
13428090|NCT00422058|26883019|FG005|Double-Blind, Week 0-20|Protocol Violation|2|||
13428091|NCT00422058|26883014|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2|||
13428092|NCT00422058|26883015|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1|||
13428093|NCT00422058|26883016|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1|||
13428094|NCT00422058|26883017|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0|||
13428095|NCT00422058|26883018|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0|||
13428096|NCT00422058|26883019|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1|||
13428097|NCT00422058|26883014|FG000|Double-Blind, Week 0-20|Other|11|||
13428098|NCT00422058|26883015|FG001|Double-Blind, Week 0-20|Other|3|||
13428099|NCT00422058|26883016|FG002|Double-Blind, Week 0-20|Other|8|||
13428100|NCT00422058|26883017|FG003|Double-Blind, Week 0-20|Other|8|||
13428101|NCT00422058|26883018|FG004|Double-Blind, Week 0-20|Other|4|||
13428102|NCT00422058|26883019|FG005|Double-Blind, Week 0-20|Other|10|||
13428103|NCT00422058|26883014|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
13428104|NCT00422058|26883015|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17|||
13428105|NCT00422058|26883016|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15|||
13428106|NCT00422058|26883017|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8|||
13428107|NCT00422058|26883018|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10|||
13428108|NCT00422058|26883019|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
13428109|NCT00422058|26883014|FG000|Open-Label Extension, Week 20-104|Adverse Event|3|||
13428110|NCT00422058|26883015|FG001|Open-Label Extension, Week 20-104|Adverse Event|4|||
13428111|NCT00422058|26883016|FG002|Open-Label Extension, Week 20-104|Adverse Event|7|||
13428112|NCT00422058|26883017|FG003|Open-Label Extension, Week 20-104|Adverse Event|4|||
13428113|NCT00422058|26883018|FG004|Open-Label Extension, Week 20-104|Adverse Event|4|||
13428114|NCT00422058|26883019|FG005|Open-Label Extension, Week 20-104|Adverse Event|0|||
13428115|NCT00422058|26883014|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1|||
13428116|NCT00422058|26883015|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2|||
13428117|NCT00422058|26883016|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3|||
13428118|NCT00422058|26883017|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1|||
13428119|NCT00422058|26883018|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5|||
13428120|NCT00422058|26883019|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3|||
13428121|NCT00422058|26883014|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3|||
13428122|NCT00422058|26883015|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
13428123|NCT00422058|26883016|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5|||
13428124|NCT00422058|26883017|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
13428125|NCT00422058|26883018|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0|||
13428126|NCT00422058|26883019|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1|||
13428127|NCT00422058|26883014|FG000|Open-Label Extension, Week 20-104|Other|13|||
13428128|NCT00422058|26883015|FG001|Open-Label Extension, Week 20-104|Other|14|||
13428129|NCT00422058|26883016|FG002|Open-Label Extension, Week 20-104|Other|6|||
13428130|NCT00422058|26883017|FG003|Open-Label Extension, Week 20-104|Other|13|||
13428131|NCT00422058|26883018|FG004|Open-Label Extension, Week 20-104|Other|16|||
13428132|NCT00422058|26883019|FG005|Open-Label Extension, Week 20-104|Other|18|||
13428133|NCT00421993|26883062|FG000|Overall Study|Withdrawal by Subject|22|||
13428134|NCT00421993|26883063|FG001|Overall Study|Withdrawal by Subject|23|||
13428135|NCT00421993|26883064|FG002|Overall Study|Withdrawal by Subject|23|||
13428136|NCT00421993|26883065|FG003|Overall Study|Withdrawal by Subject|24|||
13428137|NCT00421993|26883062|FG000|Overall Study|Lost to Follow-up|18|||
13428138|NCT00421993|26883063|FG001|Overall Study|Lost to Follow-up|19|||
13428139|NCT00421993|26883064|FG002|Overall Study|Lost to Follow-up|22|||
13428140|NCT00421993|26883065|FG003|Overall Study|Lost to Follow-up|20|||
13428141|NCT00421993|26883062|FG000|Overall Study|Adverse Event|11|||
13428142|NCT00421993|26883063|FG001|Overall Study|Adverse Event|1|||
13428143|NCT00421993|26883064|FG002|Overall Study|Adverse Event|6|||
13428144|NCT00421993|26883065|FG003|Overall Study|Adverse Event|4|||
13428145|NCT00421993|26883062|FG000|Overall Study|Protocol Violation|2|||
13428146|NCT00421993|26883063|FG001|Overall Study|Protocol Violation|2|||
13428147|NCT00421993|26883064|FG002|Overall Study|Protocol Violation|0|||
13428148|NCT00421993|26883065|FG003|Overall Study|Protocol Violation|1|||
13428149|NCT00421993|26883062|FG000|Overall Study|Lack of Efficacy|0|||
13428150|NCT00421993|26883063|FG001|Overall Study|Lack of Efficacy|3|||
13428151|NCT00421993|26883064|FG002|Overall Study|Lack of Efficacy|0|||
13428152|NCT00421993|26883065|FG003|Overall Study|Lack of Efficacy|5|||
13428153|NCT00421993|26883062|FG000|Overall Study|Pregnancy|0|||
13428154|NCT00421993|26883063|FG001|Overall Study|Pregnancy|1|||
13428155|NCT00421993|26883064|FG002|Overall Study|Pregnancy|1|||
13428156|NCT00421993|26883065|FG003|Overall Study|Pregnancy|2|||
13428157|NCT00421993|26883062|FG000|Overall Study|Subject transportation issues|0|||
13428158|NCT00421993|26883063|FG001|Overall Study|Subject transportation issues|0|||
13428159|NCT00421993|26883064|FG002|Overall Study|Subject transportation issues|0|||
13428160|NCT00421993|26883065|FG003|Overall Study|Subject transportation issues|1|||
13428161|NCT00421928|26883101|FG000|Overall Study|Adverse Event|61|||
13428162|NCT00421928|26883102|FG001|Overall Study|Adverse Event|140|||
13428163|NCT00421928|26883103|FG002|Overall Study|Adverse Event|22|||
13428164|NCT00421928|26883101|FG000|Overall Study|Lost to Follow-up|5|||
13428165|NCT00421928|26883102|FG001|Overall Study|Lost to Follow-up|0|||
13428166|NCT00421928|26883103|FG002|Overall Study|Lost to Follow-up|3|||
13428167|NCT00421928|26883101|FG000|Overall Study|Withdrawal by Subject|50|||
13428168|NCT00421928|26883102|FG001|Overall Study|Withdrawal by Subject|48|||
13428169|NCT00421928|26883103|FG002|Overall Study|Withdrawal by Subject|43|||
13428170|NCT00421928|26883101|FG000|Overall Study|Lack of Efficacy|15|||
13428171|NCT00421928|26883102|FG001|Overall Study|Lack of Efficacy|7|||
13428172|NCT00421928|26883103|FG002|Overall Study|Lack of Efficacy|35|||
13428173|NCT00421928|26883101|FG000|Overall Study|Study drug non-compliant|6|||
13428174|NCT00421928|26883102|FG001|Overall Study|Study drug non-compliant|7|||
13428175|NCT00421928|26883103|FG002|Overall Study|Study drug non-compliant|4|||
13428176|NCT00421928|26883101|FG000|Overall Study|All other|26|||
13428177|NCT00421928|26883102|FG001|Overall Study|All other|21|||
13428178|NCT00421928|26883103|FG002|Overall Study|All other|27|||
13428179|NCT00421928|26883101|FG000|Overall Study|Death|0|||
13428180|NCT00421928|26883102|FG001|Overall Study|Death|1|||
13428181|NCT00421928|26883103|FG002|Overall Study|Death|0|||
13428182|NCT00421889|26883173|FG000|Overall Study|Adverse Event|1|||
13428183|NCT00421889|26883174|FG001|Overall Study|Adverse Event|0|||
13428184|NCT00421889|26883175|FG002|Overall Study|Adverse Event|1|||
13428185|NCT00421889|26883176|FG003|Overall Study|Adverse Event|1|||
13428186|NCT00421889|26883177|FG004|Overall Study|Adverse Event|1|||
13428187|NCT00421889|26883178|FG005|Overall Study|Adverse Event|4|||
13428188|NCT00421889|26883179|FG006|Overall Study|Adverse Event|1|||
13428189|NCT00421889|26883180|FG007|Overall Study|Adverse Event|0|||
13428190|NCT00421889|26883181|FG008|Overall Study|Adverse Event|2|||
13428191|NCT00421889|26883173|FG000|Overall Study|Withdrawal by Subject|1|||
13428192|NCT00421889|26883174|FG001|Overall Study|Withdrawal by Subject|3|||
13428193|NCT00421889|26883175|FG002|Overall Study|Withdrawal by Subject|0|||
13428194|NCT00421889|26883176|FG003|Overall Study|Withdrawal by Subject|0|||
13428195|NCT00421889|26883177|FG004|Overall Study|Withdrawal by Subject|2|||
13428196|NCT00421889|26883178|FG005|Overall Study|Withdrawal by Subject|0|||
13428197|NCT00421889|26883179|FG006|Overall Study|Withdrawal by Subject|0|||
13428198|NCT00421889|26883180|FG007|Overall Study|Withdrawal by Subject|0|||
13428199|NCT00421889|26883181|FG008|Overall Study|Withdrawal by Subject|0|||
13428200|NCT00421889|26883173|FG000|Overall Study|Death|0|||
13428201|NCT00421889|26883174|FG001|Overall Study|Death|0|||
13428202|NCT00421889|26883175|FG002|Overall Study|Death|0|||
13428203|NCT00421889|26883176|FG003|Overall Study|Death|0|||
13428204|NCT00421889|26883177|FG004|Overall Study|Death|1|||
13428205|NCT00421889|26883178|FG005|Overall Study|Death|1|||
13428206|NCT00421889|26883179|FG006|Overall Study|Death|0|||
13428207|NCT00421889|26883180|FG007|Overall Study|Death|0|||
13428208|NCT00421889|26883181|FG008|Overall Study|Death|0|||
13428209|NCT00421889|26883173|FG000|Overall Study|Progressive disease|3|||
13428210|NCT00421889|26883174|FG001|Overall Study|Progressive disease|2|||
13428211|NCT00421889|26883175|FG002|Overall Study|Progressive disease|2|||
13428212|NCT00421889|26883176|FG003|Overall Study|Progressive disease|3|||
13428213|NCT00421889|26883177|FG004|Overall Study|Progressive disease|2|||
13428214|NCT00421889|26883178|FG005|Overall Study|Progressive disease|21|||
13428215|NCT00421889|26883179|FG006|Overall Study|Progressive disease|3|||
13428216|NCT00421889|26883180|FG007|Overall Study|Progressive disease|1|||
13428217|NCT00421889|26883181|FG008|Overall Study|Progressive disease|5|||
13428218|NCT00421889|26883173|FG000|Overall Study|Patient/Investigator request|0|||
13428219|NCT00421889|26883174|FG001|Overall Study|Patient/Investigator request|0|||
13428220|NCT00421889|26883175|FG002|Overall Study|Patient/Investigator request|0|||
13428221|NCT00421889|26883176|FG003|Overall Study|Patient/Investigator request|0|||
13428222|NCT00421889|26883177|FG004|Overall Study|Patient/Investigator request|0|||
13428223|NCT00421889|26883178|FG005|Overall Study|Patient/Investigator request|9|||
13428224|NCT00421889|26883179|FG006|Overall Study|Patient/Investigator request|0|||
13428225|NCT00421889|26883180|FG007|Overall Study|Patient/Investigator request|1|||
13428226|NCT00421889|26883181|FG008|Overall Study|Patient/Investigator request|3|||
13428227|NCT00421889|26883173|FG000|Overall Study|Lost to Follow-up|0|||
13428228|NCT00421889|26883174|FG001|Overall Study|Lost to Follow-up|0|||
13428229|NCT00421889|26883175|FG002|Overall Study|Lost to Follow-up|0|||
13428230|NCT00421889|26883176|FG003|Overall Study|Lost to Follow-up|0|||
13428231|NCT00421889|26883177|FG004|Overall Study|Lost to Follow-up|0|||
13428232|NCT00421889|26883178|FG005|Overall Study|Lost to Follow-up|0|||
13428233|NCT00421889|26883179|FG006|Overall Study|Lost to Follow-up|0|||
13428234|NCT00421889|26883180|FG007|Overall Study|Lost to Follow-up|0|||
13428235|NCT00421889|26883181|FG008|Overall Study|Lost to Follow-up|1|||
13428236|NCT00421733|26883209|FG000|Overall Study|Adverse Event|4|||
13428237|NCT00421733|26883210|FG001|Overall Study|Adverse Event|9|||
13428238|NCT00421733|26883211|FG002|Overall Study|Adverse Event|2|||
13428239|NCT00421733|26883209|FG000|Overall Study|Lost to Follow-up|1|||
13428240|NCT00421733|26883210|FG001|Overall Study|Lost to Follow-up|2|||
13428241|NCT00421733|26883211|FG002|Overall Study|Lost to Follow-up|4|||
13428242|NCT00421733|26883209|FG000|Overall Study|Withdrawal by Subject|1|||
13428243|NCT00421733|26883210|FG001|Overall Study|Withdrawal by Subject|2|||
13428244|NCT00421733|26883211|FG002|Overall Study|Withdrawal by Subject|7|||
13428245|NCT00421733|26883209|FG000|Overall Study|Death|0|||
13428246|NCT00421733|26883210|FG001|Overall Study|Death|3|||
13428247|NCT00421733|26883211|FG002|Overall Study|Death|0|||
13428248|NCT00421733|26883209|FG000|Overall Study|Required dialysis|1|||
13428249|NCT00421733|26883210|FG001|Overall Study|Required dialysis|0|||
13428250|NCT00421733|26883211|FG002|Overall Study|Required dialysis|0|||
13428251|NCT00421733|26883209|FG000|Overall Study|Administrative|2|||
13428252|NCT00421733|26883210|FG001|Overall Study|Administrative|0|||
13428253|NCT00421733|26883211|FG002|Overall Study|Administrative|0|||
13428254|NCT00421733|26883209|FG000|Overall Study|Did not satisfy entry criteria|1|||
13428255|NCT00421733|26883210|FG001|Overall Study|Did not satisfy entry criteria|3|||
13428256|NCT00421733|26883211|FG002|Overall Study|Did not satisfy entry criteria|2|||
13428257|NCT00421733|26883209|FG000|Overall Study|Sponsor request|1|||
13428258|NCT00421733|26883210|FG001|Overall Study|Sponsor request|0|||
13428259|NCT00421733|26883211|FG002|Overall Study|Sponsor request|3|||
13428260|NCT00421733|26883209|FG000|Overall Study|Protocol deviation|4|||
13428261|NCT00421733|26883210|FG001|Overall Study|Protocol deviation|7|||
13428262|NCT00421733|26883211|FG002|Overall Study|Protocol deviation|2|||
13428263|NCT00421707|26883258|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1|||
13428264|NCT00421707|26883259|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5|||
13428265|NCT00421707|26883258|FG000|Period 1: Treatment Period 1|Adverse Event|7|||
13428266|NCT00421707|26883259|FG001|Period 1: Treatment Period 1|Adverse Event|2|||
13428267|NCT00421707|26883258|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2|||
13428268|NCT00421707|26883259|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2|||
13428269|NCT00421707|26883258|FG000|Period 1: Treatment Period 1|Protocol Violation|1|||
13428270|NCT00421707|26883259|FG001|Period 1: Treatment Period 1|Protocol Violation|0|||
13428271|NCT00421707|26883258|FG000|Period 2: Washout|Adverse Event|1|||
13428272|NCT00421707|26883259|FG001|Period 2: Washout|Adverse Event|1|||
13428273|NCT00421707|26883258|FG000|Period 2: Washout|Withdrawal by Subject|0|||
13428274|NCT00421707|26883259|FG001|Period 2: Washout|Withdrawal by Subject|1|||
13428275|NCT00421707|26883258|FG000|Period 2: Washout|Lost to Follow-up|0|||
13428276|NCT00421707|26883259|FG001|Period 2: Washout|Lost to Follow-up|1|||
13428277|NCT00421707|26883258|FG000|Period 2: Washout|Other: Pregnancy|0|||
13428278|NCT00421707|26883259|FG001|Period 2: Washout|Other: Pregnancy|1|||
13428279|NCT00421707|26883258|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
13428280|NCT00421707|26883259|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
13428281|NCT00421707|26883258|FG000|Period 3:Treatment Period 2|Protocol Violation|1|||
13428282|NCT00421707|26883259|FG001|Period 3:Treatment Period 2|Protocol Violation|0|||
13428283|NCT00421707|26883258|FG000|Period 3:Treatment Period 2|Adverse Event|0|||
13428284|NCT00421707|26883259|FG001|Period 3:Treatment Period 2|Adverse Event|2|||
13428285|NCT00421408|26883284|FG000|Overall Study|Lost to Follow-up|30|||
13428286|NCT00421408|26883285|FG001|Overall Study|Lost to Follow-up|20|||
13428287|NCT00421408|26883284|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12|||
13428288|NCT00421408|26883285|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25|||
13428289|NCT00421343|26883291|FG000|Overall Study|Death|1|||
13428290|NCT00421343|26883291|FG000|Overall Study|Withdrawal by Subject|2|||
13428291|NCT00421343|26883291|FG000|Overall Study|Lost to Follow-up|3|||
13428292|NCT00421304|26883401|FG000|Overall Study|Lost to Follow-up|5|||
13428293|NCT00421304|26883402|FG001|Overall Study|Lost to Follow-up|2|||
13428294|NCT00421304|26883403|FG002|Overall Study|Lost to Follow-up|5|||
13428295|NCT00421304|26883401|FG000|Overall Study|Withdrawal by Subject|2|||
13428296|NCT00421304|26883402|FG001|Overall Study|Withdrawal by Subject|2|||
13428297|NCT00421304|26883403|FG002|Overall Study|Withdrawal by Subject|2|||
13428298|NCT00421304|26883401|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1|||
13428299|NCT00421304|26883402|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
13428300|NCT00421304|26883403|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
13428301|NCT00421304|26883401|FG000|Overall Study|Did not attend Day 360 visit|0|||
13428302|NCT00421304|26883402|FG001|Overall Study|Did not attend Day 360 visit|0|||
13428303|NCT00421304|26883403|FG002|Overall Study|Did not attend Day 360 visit|1|||
13428304|NCT00421174|26883438|FG000|Overall Study|Withdrawal by Subject|0|||
13428305|NCT00421174|26883439|FG001|Overall Study|Withdrawal by Subject|1|||
13428306|NCT00421174|26883438|FG000|Overall Study|Ineligible due to infection|2|||
13428307|NCT00421174|26883439|FG001|Overall Study|Ineligible due to infection|0|||
13428308|NCT00421148|26883582|FG000|Overall Study|Lost to Follow-up|0|||
13428309|NCT00421148|26883583|FG001|Overall Study|Lost to Follow-up|0|||
13428310|NCT00421148|26883584|FG002|Overall Study|Lost to Follow-up|0|||
13428311|NCT00421148|26883585|FG003|Overall Study|Lost to Follow-up|0|||
13428312|NCT00421148|26883586|FG004|Overall Study|Lost to Follow-up|0|||
13428313|NCT00421148|26883587|FG005|Overall Study|Lost to Follow-up|0|||
13428314|NCT00421148|26883588|FG006|Overall Study|Lost to Follow-up|0|||
13428315|NCT00421148|26883589|FG007|Overall Study|Lost to Follow-up|0|||
13428316|NCT00421148|26883590|FG008|Overall Study|Lost to Follow-up|0|||
13428317|NCT00421148|26883591|FG009|Overall Study|Lost to Follow-up|0|||
13428318|NCT00421148|26883592|FG010|Overall Study|Lost to Follow-up|0|||
13428319|NCT00421148|26883593|FG011|Overall Study|Lost to Follow-up|0|||
13428320|NCT00421148|26883594|FG012|Overall Study|Lost to Follow-up|0|||
13428321|NCT00421148|26883595|FG013|Overall Study|Lost to Follow-up|0|||
13428322|NCT00421148|26883596|FG014|Overall Study|Lost to Follow-up|0|||
13428323|NCT00421148|26883597|FG015|Overall Study|Lost to Follow-up|0|||
13428324|NCT00421148|26883598|FG016|Overall Study|Lost to Follow-up|0|||
13428325|NCT00421148|26883599|FG017|Overall Study|Lost to Follow-up|1|||
13428326|NCT00421148|26883600|FG018|Overall Study|Lost to Follow-up|0|||
13428327|NCT00421148|26883601|FG019|Overall Study|Lost to Follow-up|0|||
13428328|NCT00421148|26883582|FG000|Overall Study|Withdrawal by Subject|0|||
13428329|NCT00421148|26883583|FG001|Overall Study|Withdrawal by Subject|0|||
13428330|NCT00421148|26883584|FG002|Overall Study|Withdrawal by Subject|0|||
13428331|NCT00421148|26883585|FG003|Overall Study|Withdrawal by Subject|0|||
13428332|NCT00421148|26883586|FG004|Overall Study|Withdrawal by Subject|0|||
13428333|NCT00421148|26883587|FG005|Overall Study|Withdrawal by Subject|0|||
13428334|NCT00421148|26883588|FG006|Overall Study|Withdrawal by Subject|0|||
13428335|NCT00421148|26883589|FG007|Overall Study|Withdrawal by Subject|0|||
13428336|NCT00421148|26883590|FG008|Overall Study|Withdrawal by Subject|0|||
13428337|NCT00421148|26883591|FG009|Overall Study|Withdrawal by Subject|0|||
13428338|NCT00421148|26883592|FG010|Overall Study|Withdrawal by Subject|0|||
13428339|NCT00421148|26883593|FG011|Overall Study|Withdrawal by Subject|0|||
13428340|NCT00421148|26883594|FG012|Overall Study|Withdrawal by Subject|0|||
13428341|NCT00421148|26883595|FG013|Overall Study|Withdrawal by Subject|0|||
13428342|NCT00421148|26883596|FG014|Overall Study|Withdrawal by Subject|0|||
13428343|NCT00421148|26883597|FG015|Overall Study|Withdrawal by Subject|0|||
13428344|NCT00421148|26883598|FG016|Overall Study|Withdrawal by Subject|0|||
13428345|NCT00421148|26883599|FG017|Overall Study|Withdrawal by Subject|1|||
13428346|NCT00421148|26883600|FG018|Overall Study|Withdrawal by Subject|0|||
13428347|NCT00421148|26883601|FG019|Overall Study|Withdrawal by Subject|0|||
13428348|NCT00421148|26883582|FG000|Overall Study|Protocol Violation|0|||
13428349|NCT00421148|26883583|FG001|Overall Study|Protocol Violation|0|||
13428350|NCT00421148|26883584|FG002|Overall Study|Protocol Violation|0|||
13428351|NCT00421148|26883585|FG003|Overall Study|Protocol Violation|0|||
13428352|NCT00421148|26883586|FG004|Overall Study|Protocol Violation|0|||
13428353|NCT00421148|26883587|FG005|Overall Study|Protocol Violation|1|||
13428354|NCT00421148|26883588|FG006|Overall Study|Protocol Violation|0|||
13428355|NCT00421148|26883589|FG007|Overall Study|Protocol Violation|0|||
13428356|NCT00421148|26883590|FG008|Overall Study|Protocol Violation|0|||
13428357|NCT00421148|26883591|FG009|Overall Study|Protocol Violation|0|||
13428358|NCT00421148|26883592|FG010|Overall Study|Protocol Violation|0|||
13428359|NCT00421148|26883593|FG011|Overall Study|Protocol Violation|0|||
13428360|NCT00421148|26883594|FG012|Overall Study|Protocol Violation|0|||
13428361|NCT00421148|26883595|FG013|Overall Study|Protocol Violation|0|||
13428362|NCT00421148|26883596|FG014|Overall Study|Protocol Violation|0|||
13428363|NCT00421148|26883597|FG015|Overall Study|Protocol Violation|0|||
13428364|NCT00421148|26883598|FG016|Overall Study|Protocol Violation|0|||
13428365|NCT00421148|26883599|FG017|Overall Study|Protocol Violation|0|||
13428366|NCT00421148|26883600|FG018|Overall Study|Protocol Violation|1|||
13428367|NCT00421148|26883601|FG019|Overall Study|Protocol Violation|0|||
13428368|NCT00420927|26883727|FG000|Period 1|Adverse Event|19|||
13428369|NCT00420927|26883728|FG001|Period 1|Adverse Event|15|||
13428370|NCT00420927|26883729|FG002|Period 1|Adverse Event|0|||
13428371|NCT00420927|26883730|FG003|Period 1|Adverse Event|0|||
13428372|NCT00420927|26883731|FG004|Period 1|Adverse Event|0|||
13428373|NCT00420927|26883732|FG005|Period 1|Adverse Event|0|||
13428374|NCT00420927|26883733|FG006|Period 1|Adverse Event|0|||
13428375|NCT00420927|26883727|FG000|Period 1|Withdrawal by Subject|7|||
13428376|NCT00420927|26883728|FG001|Period 1|Withdrawal by Subject|12|||
13428377|NCT00420927|26883729|FG002|Period 1|Withdrawal by Subject|0|||
13428378|NCT00420927|26883730|FG003|Period 1|Withdrawal by Subject|0|||
13428379|NCT00420927|26883731|FG004|Period 1|Withdrawal by Subject|0|||
13428380|NCT00420927|26883732|FG005|Period 1|Withdrawal by Subject|0|||
13428381|NCT00420927|26883733|FG006|Period 1|Withdrawal by Subject|0|||
13428382|NCT00420927|26883727|FG000|Period 1|Lost to Follow-up|8|||
13428383|NCT00420927|26883728|FG001|Period 1|Lost to Follow-up|6|||
13428384|NCT00420927|26883729|FG002|Period 1|Lost to Follow-up|0|||
13428385|NCT00420927|26883730|FG003|Period 1|Lost to Follow-up|0|||
13428386|NCT00420927|26883731|FG004|Period 1|Lost to Follow-up|0|||
13428387|NCT00420927|26883732|FG005|Period 1|Lost to Follow-up|0|||
13428388|NCT00420927|26883733|FG006|Period 1|Lost to Follow-up|0|||
13428389|NCT00420927|26883727|FG000|Period 1|Lack of efficacy/Loss of efficacy|1|||
13428390|NCT00420927|26883728|FG001|Period 1|Lack of efficacy/Loss of efficacy|6|||
13428391|NCT00420927|26883729|FG002|Period 1|Lack of efficacy/Loss of efficacy|0|||
13428392|NCT00420927|26883730|FG003|Period 1|Lack of efficacy/Loss of efficacy|0|||
13428393|NCT00420927|26883731|FG004|Period 1|Lack of efficacy/Loss of efficacy|0|||
13428394|NCT00420927|26883732|FG005|Period 1|Lack of efficacy/Loss of efficacy|0|||
13428395|NCT00420927|26883733|FG006|Period 1|Lack of efficacy/Loss of efficacy|0|||
13428396|NCT00420927|26883727|FG000|Period 1|Death|2|||
13428397|NCT00420927|26883728|FG001|Period 1|Death|0|||
13428398|NCT00420927|26883729|FG002|Period 1|Death|0|||
13428399|NCT00420927|26883730|FG003|Period 1|Death|0|||
13428400|NCT00420927|26883731|FG004|Period 1|Death|0|||
13428401|NCT00420927|26883732|FG005|Period 1|Death|0|||
13428402|NCT00420927|26883733|FG006|Period 1|Death|0|||
13428403|NCT00420927|26883727|FG000|Period 1|Subject moved/relocated|0|||
13428404|NCT00420927|26883728|FG001|Period 1|Subject moved/relocated|2|||
13428405|NCT00420927|26883729|FG002|Period 1|Subject moved/relocated|0|||
13428406|NCT00420927|26883730|FG003|Period 1|Subject moved/relocated|0|||
13428407|NCT00420927|26883731|FG004|Period 1|Subject moved/relocated|0|||
13428408|NCT00420927|26883732|FG005|Period 1|Subject moved/relocated|0|||
13428409|NCT00420927|26883733|FG006|Period 1|Subject moved/relocated|0|||
13428410|NCT00420927|26883727|FG000|Period 1|Noncompliant with study drug|1|||
13428411|NCT00420927|26883728|FG001|Period 1|Noncompliant with study drug|1|||
13428412|NCT00420927|26883729|FG002|Period 1|Noncompliant with study drug|0|||
13428413|NCT00420927|26883730|FG003|Period 1|Noncompliant with study drug|0|||
13428414|NCT00420927|26883731|FG004|Period 1|Noncompliant with study drug|0|||
13428415|NCT00420927|26883732|FG005|Period 1|Noncompliant with study drug|0|||
13428416|NCT00420927|26883733|FG006|Period 1|Noncompliant with study drug|0|||
13428417|NCT00420927|26883727|FG000|Period 1|Randomization error|1|||
13428418|NCT00420927|26883728|FG001|Period 1|Randomization error|0|||
13428419|NCT00420927|26883729|FG002|Period 1|Randomization error|0|||
13428420|NCT00420927|26883730|FG003|Period 1|Randomization error|0|||
13428421|NCT00420927|26883731|FG004|Period 1|Randomization error|0|||
13428422|NCT00420927|26883732|FG005|Period 1|Randomization error|0|||
13428423|NCT00420927|26883733|FG006|Period 1|Randomization error|0|||
13428424|NCT00420927|26883727|FG000|Period 1|Suspected tuberculosis/positive test|1|||
13428425|NCT00420927|26883728|FG001|Period 1|Suspected tuberculosis/positive test|1|||
13428426|NCT00420927|26883729|FG002|Period 1|Suspected tuberculosis/positive test|0|||
13428427|NCT00420927|26883730|FG003|Period 1|Suspected tuberculosis/positive test|0|||
13428428|NCT00420927|26883731|FG004|Period 1|Suspected tuberculosis/positive test|0|||
13428429|NCT00420927|26883732|FG005|Period 1|Suspected tuberculosis/positive test|0|||
13428430|NCT00420927|26883733|FG006|Period 1|Suspected tuberculosis/positive test|0|||
13428431|NCT00420927|26883727|FG000|Period 1|Study site closure|0|||
13428432|NCT00420927|26883728|FG001|Period 1|Study site closure|1|||
13428433|NCT00420927|26883729|FG002|Period 1|Study site closure|0|||
13428434|NCT00420927|26883730|FG003|Period 1|Study site closure|0|||
13428435|NCT00420927|26883731|FG004|Period 1|Study site closure|0|||
13428436|NCT00420927|26883732|FG005|Period 1|Study site closure|0|||
13428437|NCT00420927|26883733|FG006|Period 1|Study site closure|0|||
13428438|NCT00420927|26883727|FG000|Period 1|Subject received new diagnosis|0|||
13428439|NCT00420927|26883728|FG001|Period 1|Subject received new diagnosis|2|||
13428440|NCT00420927|26883729|FG002|Period 1|Subject received new diagnosis|0|||
13428441|NCT00420927|26883730|FG003|Period 1|Subject received new diagnosis|0|||
13428442|NCT00420927|26883731|FG004|Period 1|Subject received new diagnosis|0|||
13428443|NCT00420927|26883732|FG005|Period 1|Subject received new diagnosis|0|||
13428444|NCT00420927|26883733|FG006|Period 1|Subject received new diagnosis|0|||
13428445|NCT00420927|26883727|FG000|Period 1|Received wrong treatment/incorrect dose|0|||
13428446|NCT00420927|26883728|FG001|Period 1|Received wrong treatment/incorrect dose|1|||
13428447|NCT00420927|26883729|FG002|Period 1|Received wrong treatment/incorrect dose|0|||
13428448|NCT00420927|26883730|FG003|Period 1|Received wrong treatment/incorrect dose|0|||
13428449|NCT00420927|26883731|FG004|Period 1|Received wrong treatment/incorrect dose|0|||
13428450|NCT00420927|26883732|FG005|Period 1|Received wrong treatment/incorrect dose|0|||
13428451|NCT00420927|26883733|FG006|Period 1|Received wrong treatment/incorrect dose|0|||
13428452|NCT00420927|26883727|FG000|Period 1|Failed to meet entry criteria|8|||
13428453|NCT00420927|26883728|FG001|Period 1|Failed to meet entry criteria|7|||
13428454|NCT00420927|26883729|FG002|Period 1|Failed to meet entry criteria|0|||
13428455|NCT00420927|26883730|FG003|Period 1|Failed to meet entry criteria|0|||
13428456|NCT00420927|26883731|FG004|Period 1|Failed to meet entry criteria|0|||
13428457|NCT00420927|26883732|FG005|Period 1|Failed to meet entry criteria|0|||
13428458|NCT00420927|26883733|FG006|Period 1|Failed to meet entry criteria|0|||
13428459|NCT00420927|26883727|FG000|Period 1|Took prohibited medication|1|||
13428460|NCT00420927|26883728|FG001|Period 1|Took prohibited medication|3|||
13428461|NCT00420927|26883729|FG002|Period 1|Took prohibited medication|0|||
13428462|NCT00420927|26883730|FG003|Period 1|Took prohibited medication|0|||
13428463|NCT00420927|26883731|FG004|Period 1|Took prohibited medication|0|||
13428464|NCT00420927|26883732|FG005|Period 1|Took prohibited medication|0|||
13428465|NCT00420927|26883733|FG006|Period 1|Took prohibited medication|0|||
13428466|NCT00420927|26883727|FG000|Period 2|Adverse Event|0|||
13428467|NCT00420927|26883728|FG001|Period 2|Adverse Event|0|||
13428468|NCT00420927|26883729|FG002|Period 2|Adverse Event|7|||
13428469|NCT00420927|26883730|FG003|Period 2|Adverse Event|3|||
13428470|NCT00420927|26883731|FG004|Period 2|Adverse Event|17|||
13428471|NCT00420927|26883732|FG005|Period 2|Adverse Event|6|||
13428472|NCT00420927|26883733|FG006|Period 2|Adverse Event|20|||
13428473|NCT00420927|26883727|FG000|Period 2|Withdrawal by Subject|0|||
13428474|NCT00420927|26883728|FG001|Period 2|Withdrawal by Subject|0|||
13428475|NCT00420927|26883729|FG002|Period 2|Withdrawal by Subject|1|||
13428476|NCT00420927|26883730|FG003|Period 2|Withdrawal by Subject|3|||
13428477|NCT00420927|26883731|FG004|Period 2|Withdrawal by Subject|11|||
13428478|NCT00420927|26883732|FG005|Period 2|Withdrawal by Subject|2|||
13428479|NCT00420927|26883733|FG006|Period 2|Withdrawal by Subject|12|||
13428480|NCT00420927|26883727|FG000|Period 2|Lost to Follow-up|0|||
13428481|NCT00420927|26883728|FG001|Period 2|Lost to Follow-up|0|||
13428482|NCT00420927|26883729|FG002|Period 2|Lost to Follow-up|2|||
13428483|NCT00420927|26883730|FG003|Period 2|Lost to Follow-up|2|||
13428484|NCT00420927|26883731|FG004|Period 2|Lost to Follow-up|6|||
13428485|NCT00420927|26883732|FG005|Period 2|Lost to Follow-up|3|||
13428486|NCT00420927|26883733|FG006|Period 2|Lost to Follow-up|9|||
13428487|NCT00420927|26883727|FG000|Period 2|Lack of efficacy/Loss of efficacy|0|||
13428488|NCT00420927|26883728|FG001|Period 2|Lack of efficacy/Loss of efficacy|0|||
13428489|NCT00420927|26883729|FG002|Period 2|Lack of efficacy/Loss of efficacy|2|||
13428490|NCT00420927|26883730|FG003|Period 2|Lack of efficacy/Loss of efficacy|1|||
13428491|NCT00420927|26883731|FG004|Period 2|Lack of efficacy/Loss of efficacy|6|||
13428492|NCT00420927|26883732|FG005|Period 2|Lack of efficacy/Loss of efficacy|2|||
13428493|NCT00420927|26883733|FG006|Period 2|Lack of efficacy/Loss of efficacy|6|||
13428494|NCT00420927|26883727|FG000|Period 2|Received wrong treatment/incorrect dose|0|||
13428495|NCT00420927|26883728|FG001|Period 2|Received wrong treatment/incorrect dose|0|||
13428496|NCT00420927|26883729|FG002|Period 2|Received wrong treatment/incorrect dose|0|||
13428497|NCT00420927|26883730|FG003|Period 2|Received wrong treatment/incorrect dose|0|||
13428498|NCT00420927|26883731|FG004|Period 2|Received wrong treatment/incorrect dose|0|||
13428499|NCT00420927|26883732|FG005|Period 2|Received wrong treatment/incorrect dose|0|||
13428500|NCT00420927|26883733|FG006|Period 2|Received wrong treatment/incorrect dose|1|||
13428501|NCT00420927|26883727|FG000|Period 2|Subject unable to find transportation|0|||
13428502|NCT00420927|26883728|FG001|Period 2|Subject unable to find transportation|0|||
13428503|NCT00420927|26883729|FG002|Period 2|Subject unable to find transportation|0|||
13428504|NCT00420927|26883730|FG003|Period 2|Subject unable to find transportation|0|||
13428505|NCT00420927|26883731|FG004|Period 2|Subject unable to find transportation|0|||
13428506|NCT00420927|26883732|FG005|Period 2|Subject unable to find transportation|0|||
13428507|NCT00420927|26883733|FG006|Period 2|Subject unable to find transportation|1|||
13428508|NCT00420927|26883727|FG000|Period 2|Physician Decision|0|||
13428509|NCT00420927|26883728|FG001|Period 2|Physician Decision|0|||
13428510|NCT00420927|26883729|FG002|Period 2|Physician Decision|0|||
13428511|NCT00420927|26883730|FG003|Period 2|Physician Decision|0|||
13428512|NCT00420927|26883731|FG004|Period 2|Physician Decision|1|||
13428513|NCT00420927|26883732|FG005|Period 2|Physician Decision|1|||
13428514|NCT00420927|26883733|FG006|Period 2|Physician Decision|0|||
13428515|NCT00420927|26883727|FG000|Period 2|Sponsor decision|0|||
13428516|NCT00420927|26883728|FG001|Period 2|Sponsor decision|0|||
13428517|NCT00420927|26883729|FG002|Period 2|Sponsor decision|1|||
13428518|NCT00420927|26883730|FG003|Period 2|Sponsor decision|0|||
13428519|NCT00420927|26883731|FG004|Period 2|Sponsor decision|0|||
13428520|NCT00420927|26883732|FG005|Period 2|Sponsor decision|0|||
13428521|NCT00420927|26883733|FG006|Period 2|Sponsor decision|1|||
13428522|NCT00420927|26883727|FG000|Period 2|Randomization error|0|||
13428523|NCT00420927|26883728|FG001|Period 2|Randomization error|0|||
13428524|NCT00420927|26883729|FG002|Period 2|Randomization error|0|||
13428525|NCT00420927|26883730|FG003|Period 2|Randomization error|0|||
13428526|NCT00420927|26883731|FG004|Period 2|Randomization error|1|||
13428527|NCT00420927|26883732|FG005|Period 2|Randomization error|1|||
13428528|NCT00420927|26883733|FG006|Period 2|Randomization error|0|||
13428529|NCT00420927|26883727|FG000|Period 2|Noncompliant with study drug|0|||
13428530|NCT00420927|26883728|FG001|Period 2|Noncompliant with study drug|0|||
13428531|NCT00420927|26883729|FG002|Period 2|Noncompliant with study drug|0|||
13428532|NCT00420927|26883730|FG003|Period 2|Noncompliant with study drug|1|||
13428533|NCT00420927|26883731|FG004|Period 2|Noncompliant with study drug|0|||
13428534|NCT00420927|26883732|FG005|Period 2|Noncompliant with study drug|0|||
13428535|NCT00420927|26883733|FG006|Period 2|Noncompliant with study drug|2|||
13428536|NCT00420927|26883727|FG000|Period 2|Methotrexate intolerance|0|||
13428537|NCT00420927|26883728|FG001|Period 2|Methotrexate intolerance|0|||
13428538|NCT00420927|26883729|FG002|Period 2|Methotrexate intolerance|0|||
13428539|NCT00420927|26883730|FG003|Period 2|Methotrexate intolerance|0|||
13428540|NCT00420927|26883731|FG004|Period 2|Methotrexate intolerance|0|||
13428541|NCT00420927|26883732|FG005|Period 2|Methotrexate intolerance|0|||
13428542|NCT00420927|26883733|FG006|Period 2|Methotrexate intolerance|1|||
13428543|NCT00420927|26883727|FG000|Period 2|Took prohibited medication|0|||
13428544|NCT00420927|26883728|FG001|Period 2|Took prohibited medication|0|||
13428545|NCT00420927|26883729|FG002|Period 2|Took prohibited medication|0|||
13428546|NCT00420927|26883730|FG003|Period 2|Took prohibited medication|0|||
13428547|NCT00420927|26883731|FG004|Period 2|Took prohibited medication|1|||
13428548|NCT00420927|26883732|FG005|Period 2|Took prohibited medication|0|||
13428549|NCT00420927|26883733|FG006|Period 2|Took prohibited medication|0|||
13428550|NCT00420849|26883800|FG000|Overall Study|Lack of Efficacy|154|||
13428551|NCT00420849|26883800|FG000|Overall Study|Adverse Event|107|||
13428552|NCT00420849|26883800|FG000|Overall Study|Withdrawal by Subject|28|||
13428553|NCT00420849|26883800|FG000|Overall Study|Death|18|||
13428554|NCT00420849|26883800|FG000|Overall Study|Other|14|||
13428555|NCT00420849|26883800|FG000|Overall Study|Transplant|8|||
13428556|NCT00420849|26883800|FG000|Overall Study|Protocol Violation|1|||
13428557|NCT00420849|26883800|FG000|Overall Study|Lost to Follow-up|1|||
13428558|NCT00420784|26883840|FG000|Overall Study|Adverse Event|11|||
13428559|NCT00420784|26883841|FG001|Overall Study|Adverse Event|29|||
13428560|NCT00420784|26883842|FG002|Overall Study|Adverse Event|10|||
13428561|NCT00420784|26883843|FG003|Overall Study|Adverse Event|5|||
13428562|NCT00420784|26883840|FG000|Overall Study|Withdrawal by Subject|0|||
13428563|NCT00420784|26883841|FG001|Overall Study|Withdrawal by Subject|1|||
13428564|NCT00420784|26883842|FG002|Overall Study|Withdrawal by Subject|0|||
13428565|NCT00420784|26883843|FG003|Overall Study|Withdrawal by Subject|0|||
13428566|NCT00420784|26883840|FG000|Overall Study|Lost to Follow-up|0|||
13428567|NCT00420784|26883841|FG001|Overall Study|Lost to Follow-up|0|||
13428568|NCT00420784|26883842|FG002|Overall Study|Lost to Follow-up|2|||
13428569|NCT00420784|26883843|FG003|Overall Study|Lost to Follow-up|1|||
13428570|NCT00420784|26883840|FG000|Overall Study|Virologic Stopping Rule|17|||
13428571|NCT00420784|26883841|FG001|Overall Study|Virologic Stopping Rule|26|||
13428572|NCT00420784|26883842|FG002|Overall Study|Virologic Stopping Rule|41|||
13428573|NCT00420784|26883843|FG003|Overall Study|Virologic Stopping Rule|67|||
13428574|NCT00420784|26883840|FG000|Overall Study|Other|1|||
13428575|NCT00420784|26883841|FG001|Overall Study|Other|2|||
13428576|NCT00420784|26883842|FG002|Overall Study|Other|0|||
13428577|NCT00420784|26883843|FG003|Overall Study|Other|5|||
13476867|NCT01425008|27003743|FG014|Dose Expansion Phase|Lost to Follow-up|0|||
13476868|NCT01425008|27003744|FG015|Dose Expansion Phase|Lost to Follow-up|0|||
13476869|NCT01425008|27003745|FG016|Dose Expansion Phase|Lost to Follow-up|1|||
13476870|NCT01425008|27003746|FG017|Dose Expansion Phase|Lost to Follow-up|0|||
13476871|NCT01425008|27003747|FG018|Dose Expansion Phase|Lost to Follow-up|0|||
13476872|NCT01425008|27003729|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
13476873|NCT01425008|27003730|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
13476874|NCT01425008|27003731|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
13476875|NCT01425008|27003732|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
13476876|NCT01425008|27003733|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
13476877|NCT01425008|27003734|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
13476878|NCT01425008|27003735|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
13476879|NCT01425008|27003736|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
13476880|NCT01425008|27003737|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
13476881|NCT01425008|27003738|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
13476882|NCT01425008|27003739|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
13428578|NCT00420745|26883866|FG000|Overall Study|Adverse Event|2|||
13428579|NCT00420745|26883867|FG001|Overall Study|Adverse Event|2|||
13428580|NCT00420745|26883866|FG000|Overall Study|Lost to Follow-up|10|||
13428581|NCT00420745|26883867|FG001|Overall Study|Lost to Follow-up|2|||
13428582|NCT00420745|26883866|FG000|Overall Study|Protocol Violation|1|||
13428583|NCT00420745|26883867|FG001|Overall Study|Protocol Violation|0|||
13428584|NCT00420745|26883866|FG000|Overall Study|Physician Decision|1|||
13428585|NCT00420745|26883867|FG001|Overall Study|Physician Decision|1|||
13428586|NCT00420745|26883866|FG000|Overall Study|Recurrent pneumonia & bronchitis|0|||
13428587|NCT00420745|26883867|FG001|Overall Study|Recurrent pneumonia & bronchitis|1|||
13428588|NCT00420745|26883866|FG000|Overall Study|Age limit exceeded for Dose 2|1|||
13428589|NCT00420745|26883867|FG001|Overall Study|Age limit exceeded for Dose 2|0|||
13428590|NCT00420641|26883951|FG000|Overall Study|Adverse Event|3|||
13428591|NCT00420641|26883952|FG001|Overall Study|Adverse Event|25|||
13428592|NCT00420641|26883953|FG002|Overall Study|Adverse Event|10|||
13428593|NCT00420641|26883951|FG000|Overall Study|Lost to Follow-up|2|||
13428594|NCT00420641|26883952|FG001|Overall Study|Lost to Follow-up|4|||
13428595|NCT00420641|26883953|FG002|Overall Study|Lost to Follow-up|2|||
13428596|NCT00420641|26883951|FG000|Overall Study|Protocol Violation|8|||
13428597|NCT00420641|26883952|FG001|Overall Study|Protocol Violation|8|||
13428598|NCT00420641|26883953|FG002|Overall Study|Protocol Violation|7|||
13428599|NCT00420641|26883951|FG000|Overall Study|Withdrawal by Subject|15|||
13428600|NCT00420641|26883952|FG001|Overall Study|Withdrawal by Subject|21|||
13428601|NCT00420641|26883953|FG002|Overall Study|Withdrawal by Subject|14|||
13428602|NCT00420641|26883951|FG000|Overall Study|Lack of Efficacy|6|||
13428603|NCT00420641|26883952|FG001|Overall Study|Lack of Efficacy|5|||
13428604|NCT00420641|26883953|FG002|Overall Study|Lack of Efficacy|4|||
13428605|NCT00420641|26883951|FG000|Overall Study|Non-compliance|7|||
13428606|NCT00420641|26883952|FG001|Overall Study|Non-compliance|5|||
13428607|NCT00420641|26883953|FG002|Overall Study|Non-compliance|4|||
13428608|NCT00420641|26883951|FG000|Overall Study|Other|4|||
13428609|NCT00420641|26883952|FG001|Overall Study|Other|4|||
13428610|NCT00420641|26883953|FG002|Overall Study|Other|3|||
13428611|NCT00420628|26883974|FG000|Overall Study|Withdrawn by parent or gaurdian|5|||
13428612|NCT00420628|26883975|FG001|Overall Study|Withdrawn by parent or gaurdian|2|||
13428613|NCT00420628|26883974|FG000|Overall Study|Lost to Follow-up|3|||
13428614|NCT00420628|26883975|FG001|Overall Study|Lost to Follow-up|2|||
13428615|NCT00420628|26883974|FG000|Overall Study|Adverse Event|1|||
13428616|NCT00420628|26883975|FG001|Overall Study|Adverse Event|0|||
13428617|NCT00420511|26883992|FG000|Overall Study|Adverse Event|1|||
13428618|NCT00420511|26883993|FG001|Overall Study|Adverse Event|1|||
13428619|NCT00420511|26883992|FG000|Overall Study|Lost to Follow-up|1|||
13428620|NCT00420511|26883993|FG001|Overall Study|Lost to Follow-up|0|||
13428621|NCT00420420|26884016|FG000|Overall Study|Adverse Event|5|||
13428622|NCT00420420|26884017|FG001|Overall Study|Adverse Event|3|||
13428623|NCT00420420|26884016|FG000|Overall Study|Protocol Violation|1|||
13428624|NCT00420420|26884017|FG001|Overall Study|Protocol Violation|1|||
13428625|NCT00420420|26884016|FG000|Overall Study|Withdrawal by Subject|1|||
13428626|NCT00420420|26884017|FG001|Overall Study|Withdrawal by Subject|0|||
13428627|NCT00420420|26884016|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1|||
13428628|NCT00420420|26884017|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0|||
13428629|NCT00420407|26884031|FG000|Overall Study|Lost to Follow-up|0|||
13428630|NCT00420407|26884032|FG001|Overall Study|Lost to Follow-up|3|||
13428631|NCT00420407|26884031|FG000|Overall Study|Physician Decision|2|||
13428632|NCT00420407|26884032|FG001|Overall Study|Physician Decision|1|||
13428633|NCT00420407|26884031|FG000|Overall Study|subject identified as detainee|1|||
13428634|NCT00420407|26884032|FG001|Overall Study|subject identified as detainee|0|||
13428635|NCT00420407|26884031|FG000|Overall Study|subject identified as Jehovah's witness|1|||
13428636|NCT00420407|26884032|FG001|Overall Study|subject identified as Jehovah's witness|0|||
13428637|NCT00420407|26884031|FG000|Overall Study|Withdrawal by Subject|0|||
13428638|NCT00420407|26884032|FG001|Overall Study|Withdrawal by Subject|2|||
13428639|NCT00420381|26884043|FG000|Overall Study|Protocol Violation|1|||
13428640|NCT00420342|26884094|FG000|Overall Study|Lost to Follow-up|1|||
13428641|NCT00420342|26884095|FG001|Overall Study|Lost to Follow-up|0|||
13428642|NCT00420342|26884096|FG002|Overall Study|Lost to Follow-up|1|||
13428643|NCT00420342|26884094|FG000|Overall Study|Withdrawal by Subject|0|||
13428644|NCT00420342|26884095|FG001|Overall Study|Withdrawal by Subject|2|||
13428645|NCT00420342|26884096|FG002|Overall Study|Withdrawal by Subject|0|||
13428646|NCT00420316|26884125|FG000|Overall Study|Withdrawal by Subject|0|||
13428647|NCT00420316|26884126|FG001|Overall Study|Withdrawal by Subject|1|||
13428648|NCT00420316|26884125|FG000|Overall Study|Lost to Follow-up|12|||
13428649|NCT00420316|26884126|FG001|Overall Study|Lost to Follow-up|8|||
13428650|NCT00420303|26884143|FG000|Overall Study|Serious Adverse Event|1|||
13428651|NCT00420303|26884144|FG001|Overall Study|Serious Adverse Event|0|||
13428652|NCT00420303|26884143|FG000|Overall Study|Lack of Efficacy|0|||
13428653|NCT00420303|26884144|FG001|Overall Study|Lack of Efficacy|3|||
13428654|NCT00420303|26884143|FG000|Overall Study|Physician Decision|0|||
13428655|NCT00420303|26884144|FG001|Overall Study|Physician Decision|1|||
13428656|NCT00420290|26884165|FG000|Overall Study|Adverse Event|3|||
13428657|NCT00420290|26884166|FG001|Overall Study|Adverse Event|1|||
13428658|NCT00420290|26884165|FG000|Overall Study|Withdrawal by Subject|0|||
13428659|NCT00420290|26884166|FG001|Overall Study|Withdrawal by Subject|2|||
13428660|NCT00420290|26884165|FG000|Overall Study|did not meet inclusion/exclusion|1|||
13428661|NCT00420290|26884166|FG001|Overall Study|did not meet inclusion/exclusion|1|||
13428662|NCT00420238|26884309|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1|||
13428663|NCT00420238|26884310|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0|||
13428664|NCT00420238|26884309|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0|||
13428665|NCT00420238|26884310|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2|||
13428666|NCT00420238|26884309|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0|||
13428667|NCT00420238|26884310|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1|||
13428668|NCT00420238|26884309|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0|||
13428669|NCT00420238|26884310|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1|||
13428670|NCT00420238|26884309|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1|||
13428671|NCT00420238|26884310|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0|||
13428672|NCT00420238|26884309|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
13428673|NCT00420238|26884310|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
13428674|NCT00420212|26884344|FG000|Overall Study|Adverse Event|22|||
13428675|NCT00420212|26884345|FG001|Overall Study|Adverse Event|40|||
13428676|NCT00420212|26884346|FG002|Overall Study|Adverse Event|36|||
13428677|NCT00420212|26884344|FG000|Overall Study|Lost to Follow-up|9|||
13428678|NCT00420212|26884345|FG001|Overall Study|Lost to Follow-up|11|||
13428679|NCT00420212|26884346|FG002|Overall Study|Lost to Follow-up|11|||
13428680|NCT00420212|26884344|FG000|Overall Study|Withdrawal by Subject|31|||
13428681|NCT00420212|26884345|FG001|Overall Study|Withdrawal by Subject|22|||
13428682|NCT00420212|26884346|FG002|Overall Study|Withdrawal by Subject|19|||
13428683|NCT00420212|26884344|FG000|Overall Study|Physician Decision|4|||
13428684|NCT00420212|26884345|FG001|Overall Study|Physician Decision|4|||
13428685|NCT00420212|26884346|FG002|Overall Study|Physician Decision|3|||
13428686|NCT00420212|26884344|FG000|Overall Study|Protocol Violation|4|||
13428687|NCT00420212|26884345|FG001|Overall Study|Protocol Violation|4|||
13428688|NCT00420212|26884346|FG002|Overall Study|Protocol Violation|8|||
13428689|NCT00420212|26884344|FG000|Overall Study|Death|0|||
13428690|NCT00420212|26884345|FG001|Overall Study|Death|0|||
13428691|NCT00420212|26884346|FG002|Overall Study|Death|1|||
13428692|NCT00420212|26884344|FG000|Overall Study|Other-Unspecified|21|||
13428693|NCT00420212|26884345|FG001|Overall Study|Other-Unspecified|14|||
13428694|NCT00420212|26884346|FG002|Overall Study|Other-Unspecified|18|||
13428695|NCT00420199|26884406|FG000|Overall Study|Participant no longer met study criteria|1|||
13428696|NCT00420199|26884407|FG001|Overall Study|Participant no longer met study criteria|0|||
13428697|NCT00420095|26884432|FG000|Overall Study|Adverse Event|1|||
13428698|NCT00420095|26884433|FG001|Overall Study|Adverse Event|0|||
13428699|NCT00420095|26884432|FG000|Overall Study|Protocol Violation|1|||
13428700|NCT00420095|26884433|FG001|Overall Study|Protocol Violation|1|||
13428701|NCT00420095|26884432|FG000|Overall Study|Lost to Follow-up|1|||
13428702|NCT00420095|26884433|FG001|Overall Study|Lost to Follow-up|0|||
13428703|NCT00420056|26884457|FG000|Overall Study|Objective progression or relapse|17|||
13428704|NCT00420004|26884530|FG000|Overall Study|Adverse Event|4|||
13428705|NCT00420004|26884531|FG001|Overall Study|Adverse Event|1|||
13428706|NCT00420004|26884532|FG002|Overall Study|Adverse Event|1|||
13428707|NCT00420004|26884530|FG000|Overall Study|Lack of Efficacy|5|||
13428708|NCT00420004|26884531|FG001|Overall Study|Lack of Efficacy|4|||
13428709|NCT00420004|26884532|FG002|Overall Study|Lack of Efficacy|1|||
13428710|NCT00420004|26884530|FG000|Overall Study|Lost to Follow-up|31|||
13428711|NCT00420004|26884531|FG001|Overall Study|Lost to Follow-up|12|||
13428712|NCT00420004|26884532|FG002|Overall Study|Lost to Follow-up|10|||
13428713|NCT00420004|26884530|FG000|Overall Study|Entry Criteria Not Met|0|||
13428714|NCT00420004|26884531|FG001|Overall Study|Entry Criteria Not Met|1|||
13428715|NCT00420004|26884532|FG002|Overall Study|Entry Criteria Not Met|0|||
13428716|NCT00420004|26884530|FG000|Overall Study|Physician Decision|14|||
13428717|NCT00420004|26884531|FG001|Overall Study|Physician Decision|4|||
13428718|NCT00420004|26884532|FG002|Overall Study|Physician Decision|2|||
13428719|NCT00420004|26884530|FG000|Overall Study|Protocol Violation|5|||
13428720|NCT00420004|26884531|FG001|Overall Study|Protocol Violation|4|||
13428721|NCT00420004|26884532|FG002|Overall Study|Protocol Violation|3|||
13428722|NCT00420004|26884530|FG000|Overall Study|Withdrawal by Subject|67|||
13428723|NCT00420004|26884531|FG001|Overall Study|Withdrawal by Subject|42|||
13428724|NCT00420004|26884532|FG002|Overall Study|Withdrawal by Subject|14|||
13428725|NCT00420004|26884530|FG000|Overall Study|Sponsor Decision|3|||
13428726|NCT00420004|26884531|FG001|Overall Study|Sponsor Decision|3|||
13428727|NCT00420004|26884532|FG002|Overall Study|Sponsor Decision|1|||
13428728|NCT00419952|26884571|FG000|Overall Study|Adverse Event|8|||
13428729|NCT00419952|26884572|FG001|Overall Study|Adverse Event|10|||
13428730|NCT00419952|26884571|FG000|Overall Study|Withdrawal by Subject|44|||
13428731|NCT00419952|26884572|FG001|Overall Study|Withdrawal by Subject|43|||
13428732|NCT00419952|26884571|FG000|Overall Study|Lost to Follow-up|43|||
13428733|NCT00419952|26884572|FG001|Overall Study|Lost to Follow-up|34|||
13428734|NCT00419952|26884571|FG000|Overall Study|Protocol Violation|32|||
13428735|NCT00419952|26884572|FG001|Overall Study|Protocol Violation|24|||
13428736|NCT00419952|26884571|FG000|Overall Study|Pregnancy|4|||
13428737|NCT00419952|26884572|FG001|Overall Study|Pregnancy|2|||
13428738|NCT00419952|26884571|FG000|Overall Study|Physician Decision|1|||
13428739|NCT00419952|26884572|FG001|Overall Study|Physician Decision|3|||
13428740|NCT00419952|26884571|FG000|Overall Study|Incorrectly enrolled|10|||
13428741|NCT00419952|26884572|FG001|Overall Study|Incorrectly enrolled|3|||
13428742|NCT00419952|26884571|FG000|Overall Study|Intake of prohibited medication|2|||
13306247|NCT01292603|26525396|FG001|Part 1: Regular Follow-Up Period|Death|1|||
13306248|NCT01292603|26525397|FG002|Part 1: Regular Follow-Up Period|Death|3|||
13306249|NCT01292603|26525398|FG003|Part 1: Regular Follow-Up Period|Death|1|||
13306250|NCT01292603|26525399|FG004|Part 1: Regular Follow-Up Period|Death|0|||
13306251|NCT01292603|26525400|FG005|Part 1: Regular Follow-Up Period|Death|0|||
13306252|NCT01292603|26525395|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3|||
13306253|NCT01292603|26525396|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6|||
13306254|NCT01292603|26525397|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3|||
13306255|NCT01292603|26525398|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0|||
13306256|NCT01292603|26525399|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0|||
13306257|NCT01292603|26525400|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0|||
13428743|NCT00419952|26884572|FG001|Overall Study|Intake of prohibited medication|2|||
13428744|NCT00419952|26884571|FG000|Overall Study|Occurence of 2 or more exacerbations|2|||
13428745|NCT00419952|26884572|FG001|Overall Study|Occurence of 2 or more exacerbations|0|||
13428746|NCT00419952|26884571|FG000|Overall Study|Diary or medication non-compliance|2|||
13428747|NCT00419952|26884572|FG001|Overall Study|Diary or medication non-compliance|4|||
13428748|NCT00419952|26884571|FG000|Overall Study|Abnormal ECG|1|||
13428749|NCT00419952|26884572|FG001|Overall Study|Abnormal ECG|0|||
13428750|NCT00419926|26884593|FG000|Overall Study|Withdrawal by Subject|7|||
13428751|NCT00419926|26884594|FG001|Overall Study|Withdrawal by Subject|3|||
13428752|NCT00419926|26884593|FG000|Overall Study|Administrative Problem|4|||
13428753|NCT00419926|26884594|FG001|Overall Study|Administrative Problem|4|||
13428754|NCT00419926|26884593|FG000|Overall Study|Lost to Follow-up|1|||
13428755|NCT00419926|26884594|FG001|Overall Study|Lost to Follow-up|2|||
13428756|NCT00419926|26884593|FG000|Overall Study|Death|2|||
13428757|NCT00419926|26884594|FG001|Overall Study|Death|1|||
13428758|NCT00419770|26884607|FG000|Overall Study|Withdrawal by Subject|5|||
13428759|NCT00419770|26884608|FG001|Overall Study|Withdrawal by Subject|1|||
13428760|NCT00419757|26884651|FG000|Overall Study|Adverse Event|1|||
13428761|NCT00419757|26884652|FG001|Overall Study|Adverse Event|4|||
13428762|NCT00419757|26884651|FG000|Overall Study|Lost to Follow-up|1|||
13428763|NCT00419757|26884652|FG001|Overall Study|Lost to Follow-up|4|||
13428764|NCT00419757|26884651|FG000|Overall Study|Withdrawal by Subject|7|||
13428765|NCT00419757|26884652|FG001|Overall Study|Withdrawal by Subject|1|||
13428766|NCT00419757|26884651|FG000|Overall Study|Protocol Violation|2|||
13428767|NCT00419757|26884652|FG001|Overall Study|Protocol Violation|3|||
13428768|NCT00419757|26884651|FG000|Overall Study|Study specific discontinuation criteria|4|||
13428769|NCT00419757|26884652|FG001|Overall Study|Study specific discontinuation criteria|8|||
13428770|NCT00419757|26884651|FG000|Overall Study|Multiple reasons|3|||
13428771|NCT00419757|26884652|FG001|Overall Study|Multiple reasons|1|||
13428772|NCT00419744|26884691|FG000|Overall Study|Adverse Event|39|||
13428773|NCT00419744|26884692|FG001|Overall Study|Adverse Event|40|||
13428774|NCT00419744|26884693|FG002|Overall Study|Adverse Event|50|||
13428775|NCT00419744|26884691|FG000|Overall Study|Withdrawal by Subject|45|||
13428776|NCT00419744|26884692|FG001|Overall Study|Withdrawal by Subject|49|||
13428777|NCT00419744|26884693|FG002|Overall Study|Withdrawal by Subject|52|||
13428778|NCT00419744|26884691|FG000|Overall Study|Lost to Follow-up|8|||
13428779|NCT00419744|26884692|FG001|Overall Study|Lost to Follow-up|10|||
13428780|NCT00419744|26884693|FG002|Overall Study|Lost to Follow-up|6|||
13428781|NCT00419744|26884691|FG000|Overall Study|Protocol Violation|4|||
13428782|NCT00419744|26884692|FG001|Overall Study|Protocol Violation|7|||
13428783|NCT00419744|26884693|FG002|Overall Study|Protocol Violation|8|||
13428784|NCT00419744|26884691|FG000|Overall Study|Randomized in error|9|||
13428785|NCT00419744|26884692|FG001|Overall Study|Randomized in error|6|||
13428786|NCT00419744|26884693|FG002|Overall Study|Randomized in error|7|||
13428787|NCT00419744|26884691|FG000|Overall Study|Moving out of state|2|||
13428788|NCT00419744|26884692|FG001|Overall Study|Moving out of state|0|||
13428789|NCT00419744|26884693|FG002|Overall Study|Moving out of state|1|||
13428790|NCT00419744|26884691|FG000|Overall Study|Physician Decision|10|||
13428791|NCT00419744|26884692|FG001|Overall Study|Physician Decision|5|||
13428792|NCT00419744|26884693|FG002|Overall Study|Physician Decision|6|||
13428793|NCT00419744|26884691|FG000|Overall Study|Spirometry mouthpiece issues|0|||
13428794|NCT00419744|26884692|FG001|Overall Study|Spirometry mouthpiece issues|1|||
13428795|NCT00419744|26884693|FG002|Overall Study|Spirometry mouthpiece issues|2|||
13428796|NCT00419744|26884691|FG000|Overall Study|Incorrect medication kit dispensed|0|||
13428797|NCT00419744|26884692|FG001|Overall Study|Incorrect medication kit dispensed|0|||
13428798|NCT00419744|26884693|FG002|Overall Study|Incorrect medication kit dispensed|1|||
13428799|NCT00419562|26884710|FG000|Overall Study|Lost to Follow-up|12|||
13428800|NCT00419562|26884711|FG001|Overall Study|Lost to Follow-up|13|||
13428801|NCT00419562|26884710|FG000|Overall Study|Withdrawal by Subject|20|||
13428802|NCT00419562|26884711|FG001|Overall Study|Withdrawal by Subject|18|||
13428803|NCT00419562|26884710|FG000|Overall Study|Participant Institutionalized|1|||
13428804|NCT00419562|26884711|FG001|Overall Study|Participant Institutionalized|0|||
13428805|NCT00419393|26884721|FG000|Overall Study|Adverse Event|5|||
13428806|NCT00419393|26884721|FG000|Overall Study|Protocol Violation|5|||
13428807|NCT00419393|26884721|FG000|Overall Study|Withdrawal by Subject|7|||
13428808|NCT00419393|26884721|FG000|Overall Study|Other: Sponsor request|3|||
13428809|NCT00419393|26884721|FG000|Overall Study|Other: Subject had temporal lobectomy|1|||
13428810|NCT00419393|26884721|FG000|Overall Study|Other: Site closure|1|||
13428811|NCT00419393|26884721|FG000|Overall Study|Other: Other health problems|1|||
13428812|NCT00419393|26884721|FG000|Overall Study|Other: Investigator decision|1|||
13428813|NCT00419380|26884736|FG000|Overall Study|Lack of Efficacy|1|||
13428814|NCT00419380|26884737|FG001|Overall Study|Lack of Efficacy|7|||
13428815|NCT00419380|26884736|FG000|Overall Study|Physician Decision|0|||
13428816|NCT00419380|26884737|FG001|Overall Study|Physician Decision|1|||
13428817|NCT00419380|26884736|FG000|Overall Study|Lost to Follow-up|0|||
13428818|NCT00419380|26884737|FG001|Overall Study|Lost to Follow-up|1|||
13428819|NCT00419380|26884736|FG000|Overall Study|Withdrawal by Subject|0|||
13428820|NCT00419380|26884737|FG001|Overall Study|Withdrawal by Subject|1|||
13428821|NCT00419341|26884760|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8|||
13428822|NCT00419341|26884760|FG000|Wash in/Wash Out Period|Adverse Event|2|||
13428823|NCT00419341|26884760|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1|||
13428824|NCT00419341|26884760|FG000|Efficacy Period|Withdrawal by Subject|6|||
13428825|NCT00419341|26884760|FG000|Efficacy Period|Protocol Violation|1|||
13428826|NCT00419341|26884760|FG000|Efficacy Period|Lost to Follow-up|1|||
13428827|NCT00419341|26884760|FG000|Efficacy Period|Non-compliance|1|||
13428828|NCT00419341|26884760|FG000|Efficacy Period|Termination of study site|1|||
13428829|NCT00419263|26884797|FG000|Overall Study|Lost to Follow-up|2|||
13428830|NCT00419263|26884798|FG001|Overall Study|Lost to Follow-up|1|||
13428831|NCT00419263|26884799|FG002|Overall Study|Lost to Follow-up|1|||
13428832|NCT00419263|26884797|FG000|Overall Study|Randomized in Error, Not Treated|1|||
13428833|NCT00419263|26884798|FG001|Overall Study|Randomized in Error, Not Treated|1|||
13428834|NCT00419263|26884799|FG002|Overall Study|Randomized in Error, Not Treated|0|||
13428835|NCT00419263|26884797|FG000|Overall Study|Adverse Event|0|||
13428836|NCT00419263|26884798|FG001|Overall Study|Adverse Event|0|||
13428837|NCT00419263|26884799|FG002|Overall Study|Adverse Event|1|||
13428838|NCT00419263|26884797|FG000|Overall Study|Withdrawal by Subject|0|||
13428839|NCT00419263|26884798|FG001|Overall Study|Withdrawal by Subject|0|||
13428840|NCT00419263|26884799|FG002|Overall Study|Withdrawal by Subject|1|||
13428841|NCT00419159|26884836|FG000|Overall Study|Adverse Event|7|||
13428842|NCT00419159|26884837|FG001|Overall Study|Adverse Event|15|||
13428843|NCT00419159|26884836|FG000|Overall Study|Abnormal laboratory value(s)|0|||
13428844|NCT00419159|26884837|FG001|Overall Study|Abnormal laboratory value(s)|2|||
13428845|NCT00419159|26884836|FG000|Overall Study|Subject's no longer requires study drug|0|||
13428846|NCT00419159|26884837|FG001|Overall Study|Subject's no longer requires study drug|1|||
13428847|NCT00419159|26884836|FG000|Overall Study|Protocol Violation|1|||
13428848|NCT00419159|26884837|FG001|Overall Study|Protocol Violation|0|||
13428849|NCT00419159|26884836|FG000|Overall Study|Withdrawal by Subject|10|||
13428850|NCT00419159|26884837|FG001|Overall Study|Withdrawal by Subject|3|||
13428851|NCT00419159|26884836|FG000|Overall Study|Lost to Follow-up|0|||
13428852|NCT00419159|26884837|FG001|Overall Study|Lost to Follow-up|1|||
13428853|NCT00419159|26884836|FG000|Overall Study|Death|2|||
13428854|NCT00419159|26884837|FG001|Overall Study|Death|2|||
13428855|NCT00419159|26884836|FG000|Overall Study|Disease progression|79|||
13428856|NCT00419159|26884837|FG001|Overall Study|Disease progression|76|||
13428857|NCT00419120|26884844|FG000|Long Term Follow up Period|study ongoing|10|||
13428858|NCT00419094|26884863|FG000|Overall Study|Adverse Event|3|||
13428859|NCT00419094|26884864|FG001|Overall Study|Adverse Event|7|||
13428860|NCT00419094|26884863|FG000|Overall Study|Lack of Efficacy|1|||
13428861|NCT00419094|26884864|FG001|Overall Study|Lack of Efficacy|0|||
13428862|NCT00419094|26884863|FG000|Overall Study|Lost to Follow-up|0|||
13428863|NCT00419094|26884864|FG001|Overall Study|Lost to Follow-up|2|||
13428864|NCT00419094|26884863|FG000|Overall Study|Protocol Violation|1|||
13428865|NCT00419094|26884864|FG001|Overall Study|Protocol Violation|14|||
13428866|NCT00419094|26884863|FG000|Overall Study|Withdrawal of consent|1|||
13428867|NCT00419094|26884864|FG001|Overall Study|Withdrawal of consent|5|||
13428868|NCT00419094|26884863|FG000|Overall Study|Other: Error determining exit criteria|1|||
13428869|NCT00419094|26884864|FG001|Overall Study|Other: Error determining exit criteria|0|||
13428870|NCT00419094|26884863|FG000|Overall Study|Other: Patient non-compliant|0|||
13428871|NCT00419094|26884864|FG001|Overall Study|Other: Patient non-compliant|1|||
13428872|NCT00419094|26884863|FG000|Overall Study|Other: No contact for extended period|0|||
13428873|NCT00419094|26884864|FG001|Overall Study|Other: No contact for extended period|1|||
13428874|NCT00419003|26884880|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
13428875|NCT00419003|26884881|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
13428876|NCT00419003|26884880|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1|||
13428877|NCT00419003|26884881|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0|||
13428878|NCT00418938|26884906|FG000|Overall Study|Reimbursement|1|||
13428879|NCT00418938|26884907|FG001|Overall Study|Reimbursement|0|||
13428880|NCT00418938|26884906|FG000|Overall Study|Administrative decision|3|||
13428881|NCT00418938|26884907|FG001|Overall Study|Administrative decision|3|||
13428882|NCT00418938|26884906|FG000|Overall Study|Withdrawal by Subject|16|||
13428883|NCT00418938|26884907|FG001|Overall Study|Withdrawal by Subject|15|||
13428884|NCT00418938|26884906|FG000|Overall Study|Lost to Follow-up|1|||
13428885|NCT00418938|26884907|FG001|Overall Study|Lost to Follow-up|3|||
13428886|NCT00418938|26884906|FG000|Overall Study|Adverse Event|1|||
13428887|NCT00418938|26884907|FG001|Overall Study|Adverse Event|1|||
13428888|NCT00418938|26884906|FG000|Overall Study|On-going|1|||
13428889|NCT00418938|26884907|FG001|Overall Study|On-going|1|||
13428890|NCT00418938|26884906|FG000|Overall Study|Ineligibility Determined|1|||
13428891|NCT00418938|26884907|FG001|Overall Study|Ineligibility Determined|0|||
13428892|NCT00418886|26884938|FG000|Overall Study|discontinue treatment survival follow up|90|||
13428893|NCT00418886|26884939|FG001|Overall Study|discontinue treatment survival follow up|91|||
13428894|NCT00418886|26884938|FG000|Overall Study|Death|122|||
13428895|NCT00418886|26884939|FG001|Overall Study|Death|147|||
13428896|NCT00418886|26884938|FG000|Overall Study|Withdrawal by Subject|9|||
13428897|NCT00418886|26884939|FG001|Overall Study|Withdrawal by Subject|10|||
13428898|NCT00418886|26884938|FG000|Overall Study|Lost to Follow-up|4|||
13428899|NCT00418886|26884939|FG001|Overall Study|Lost to Follow-up|6|||
13428900|NCT00418886|26884938|FG000|Overall Study|withdrawn due to other reason|1|||
13428901|NCT00418886|26884939|FG001|Overall Study|withdrawn due to other reason|0|||
13428902|NCT00418886|26884938|FG000|Overall Study|randomised but no treatment received|0|||
13428903|NCT00418886|26884939|FG001|Overall Study|randomised but no treatment received|1|||
13428904|NCT00418717|26884946|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1|||
13428905|NCT00418717|26884946|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2|||
13428906|NCT00418691|26884964|FG000|Overall Study|Lost to Follow-up|1|||
13428907|NCT00418691|26884965|FG001|Overall Study|Lost to Follow-up|2|||
13428908|NCT00418691|26884966|FG002|Overall Study|Lost to Follow-up|3|||
13428909|NCT00418691|26884964|FG000|Overall Study|Started new medication voiding entry|0|||
13428910|NCT00418691|26884965|FG001|Overall Study|Started new medication voiding entry|0|||
13428911|NCT00418691|26884966|FG002|Overall Study|Started new medication voiding entry|1|||
13428912|NCT00418691|26884964|FG000|Overall Study|Progressive Disease|1|||
13428913|NCT00418691|26884965|FG001|Overall Study|Progressive Disease|0|||
13428914|NCT00418691|26884966|FG002|Overall Study|Progressive Disease|1|||
13428915|NCT00418665|26884993|FG000|Treatment Period|Ineligibility determined|1|||
13428916|NCT00418665|26884994|FG001|Treatment Period|Ineligibility determined|1|||
13428917|NCT00418665|26884995|FG002|Treatment Period|Ineligibility determined|0|||
13428918|NCT00418665|26884993|FG000|Treatment Period|Adverse Event|2|||
13428919|NCT00418665|26884994|FG001|Treatment Period|Adverse Event|2|||
13428920|NCT00418665|26884995|FG002|Treatment Period|Adverse Event|0|||
13428921|NCT00418665|26884993|FG000|Treatment Period|Withdrawal by Subject|0|||
13428922|NCT00418665|26884994|FG001|Treatment Period|Withdrawal by Subject|3|||
13428923|NCT00418665|26884995|FG002|Treatment Period|Withdrawal by Subject|1|||
13428924|NCT00418665|26884993|FG000|Treatment Period|Requirement for alternative therapy|1|||
13428925|NCT00418665|26884994|FG001|Treatment Period|Requirement for alternative therapy|0|||
13428926|NCT00418665|26884995|FG002|Treatment Period|Requirement for alternative therapy|0|||
13428927|NCT00418665|26884993|FG000|Treatment Period|Physician Decision|1|||
13428928|NCT00418665|26884994|FG001|Treatment Period|Physician Decision|0|||
13428929|NCT00418665|26884995|FG002|Treatment Period|Physician Decision|3|||
13428930|NCT00418665|26884993|FG000|Treatment Extension|Adverse Event|1|||
13428931|NCT00418665|26884994|FG001|Treatment Extension|Adverse Event|0|||
13428932|NCT00418665|26884995|FG002|Treatment Extension|Adverse Event|0|||
13428933|NCT00418665|26884993|FG000|Treatment Extension|Withdrawal by Subject|1|||
13428934|NCT00418665|26884994|FG001|Treatment Extension|Withdrawal by Subject|0|||
13428935|NCT00418665|26884995|FG002|Treatment Extension|Withdrawal by Subject|0|||
13428936|NCT00418665|26884993|FG000|Treatment Extension|Requirement for alternative therapy|2|||
13428937|NCT00418665|26884994|FG001|Treatment Extension|Requirement for alternative therapy|2|||
13428938|NCT00418665|26884995|FG002|Treatment Extension|Requirement for alternative therapy|0|||
13428939|NCT00418665|26884993|FG000|Treatment Extension|Physician Decision|2|||
13428940|NCT00418665|26884994|FG001|Treatment Extension|Physician Decision|2|||
13428941|NCT00418665|26884995|FG002|Treatment Extension|Physician Decision|1|||
13428942|NCT00418665|26884993|FG000|Treatment Extension|Death|0|||
13428943|NCT00418665|26884994|FG001|Treatment Extension|Death|0|||
13428944|NCT00418665|26884995|FG002|Treatment Extension|Death|1|||
13428945|NCT00418561|26885073|FG000|Overall Study|Participant's (guardian's) decision|0|||
13428946|NCT00418561|26885074|FG001|Overall Study|Participant's (guardian's) decision|1|||
13428947|NCT00418561|26885075|FG002|Overall Study|Participant's (guardian's) decision|0|||
13428948|NCT00418522|26885126|FG000|Overall Study|Adverse Event|7|||
13428949|NCT00418522|26885127|FG001|Overall Study|Adverse Event|1|||
13428950|NCT00418522|26885126|FG000|Overall Study|Lack of Efficacy|1|||
13428951|NCT00418522|26885127|FG001|Overall Study|Lack of Efficacy|3|||
13428952|NCT00418522|26885126|FG000|Overall Study|Lost to Follow-up|10|||
13428953|NCT00418522|26885127|FG001|Overall Study|Lost to Follow-up|4|||
13428954|NCT00418522|26885126|FG000|Overall Study|Withdrawal by Subject|31|||
13428955|NCT00418522|26885127|FG001|Overall Study|Withdrawal by Subject|7|||
13428956|NCT00418522|26885126|FG000|Overall Study|Other|27|||
13428957|NCT00418522|26885127|FG001|Overall Study|Other|23|||
13428958|NCT00418522|26885126|FG000|Overall Study|Randomized but did not receive treatment|7|||
13428959|NCT00418522|26885127|FG001|Overall Study|Randomized but did not receive treatment|4|||
13428960|NCT00418379|26885145|FG000|Year 1|Adverse Event|9|||
13428961|NCT00418379|26885146|FG001|Year 1|Adverse Event|15|||
13428962|NCT00418379|26885147|FG002|Year 1|Adverse Event|3|||
13428963|NCT00418379|26885145|FG000|Year 1|Withdrawal by Subject|7|||
13428964|NCT00418379|26885146|FG001|Year 1|Withdrawal by Subject|8|||
13428965|NCT00418379|26885147|FG002|Year 1|Withdrawal by Subject|5|||
13428966|NCT00418379|26885145|FG000|Year 1|Any other reason not above-mentioned|2|||
13428967|NCT00418379|26885146|FG001|Year 1|Any other reason not above-mentioned|5|||
13428968|NCT00418379|26885147|FG002|Year 1|Any other reason not above-mentioned|7|||
13428969|NCT00418379|26885145|FG000|Year 2|Adverse Event|5|||
13428970|NCT00418379|26885146|FG001|Year 2|Adverse Event|2|||
13428971|NCT00418379|26885147|FG002|Year 2|Adverse Event|1|||
13428972|NCT00418379|26885145|FG000|Year 2|Withdrawal by Subject|1|||
13428973|NCT00418379|26885146|FG001|Year 2|Withdrawal by Subject|1|||
13428974|NCT00418379|26885147|FG002|Year 2|Withdrawal by Subject|3|||
13428975|NCT00418379|26885145|FG000|Year 2|Any other reason not above-mentioned|2|||
13428976|NCT00418379|26885146|FG001|Year 2|Any other reason not above-mentioned|1|||
13428977|NCT00418379|26885147|FG002|Year 2|Any other reason not above-mentioned|6|||
13428978|NCT00418379|26885145|FG000|Year 3|Withdrawal by Subject|1|||
13428979|NCT00418379|26885146|FG001|Year 3|Withdrawal by Subject|1|||
13428980|NCT00418379|26885147|FG002|Year 3|Withdrawal by Subject|2|||
13428981|NCT00418379|26885145|FG000|Year 3|Any other reason not above-mentioned|2|||
13428982|NCT00418379|26885146|FG001|Year 3|Any other reason not above-mentioned|1|||
13428983|NCT00418379|26885147|FG002|Year 3|Any other reason not above-mentioned|1|||
13428984|NCT00418379|26885145|FG000|Year 4|Adverse Event|0|||
13428985|NCT00418379|26885146|FG001|Year 4|Adverse Event|1|||
13428986|NCT00418379|26885147|FG002|Year 4|Adverse Event|0|||
13428987|NCT00418379|26885145|FG000|Year 4|Withdrawal by Subject|2|||
13428988|NCT00418379|26885146|FG001|Year 4|Withdrawal by Subject|3|||
13428989|NCT00418379|26885147|FG002|Year 4|Withdrawal by Subject|2|||
13428990|NCT00418379|26885145|FG000|Year 4|Any other reason not above-mentioned|1|||
13428991|NCT00418379|26885146|FG001|Year 4|Any other reason not above-mentioned|1|||
13428992|NCT00418379|26885147|FG002|Year 4|Any other reason not above-mentioned|0|||
13428993|NCT00418379|26885145|FG000|Year 5|Adverse Event|0|||
13428994|NCT00418379|26885146|FG001|Year 5|Adverse Event|1|||
13428995|NCT00418379|26885147|FG002|Year 5|Adverse Event|0|||
13428996|NCT00418379|26885145|FG000|Year 5|Any other reason not above-mentioned|2|||
13428997|NCT00418379|26885146|FG001|Year 5|Any other reason not above-mentioned|4|||
13428998|NCT00418379|26885147|FG002|Year 5|Any other reason not above-mentioned|3|||
13428999|NCT00418314|26885164|FG000|Overall Study|Withdrawal by Subject|1|||
13429000|NCT00418314|26885165|FG001|Overall Study|Withdrawal by Subject|2|||
13429001|NCT00418184|26885180|FG000|Double-blind Phase|Withdrawal by Subject|22|||
13429002|NCT00418184|26885181|FG001|Double-blind Phase|Withdrawal by Subject|9|||
13429003|NCT00418184|26885180|FG000|Double-blind Phase|Adverse Event|2|||
13429004|NCT00418184|26885181|FG001|Double-blind Phase|Adverse Event|1|||
13429005|NCT00418184|26885180|FG000|Double-blind Phase|Poor compliance|3|||
13429006|NCT00418184|26885181|FG001|Double-blind Phase|Poor compliance|1|||
13429007|NCT00418145|26885195|FG000|Overall Study|study terminated|6|||
13429008|NCT00417989|26885224|FG000|Overall Study|Withdrawal by Subject|13|||
13429009|NCT00417989|26885225|FG001|Overall Study|Withdrawal by Subject|13|||
13429010|NCT00417989|26885224|FG000|Overall Study|Lost to Follow-up|1|||
13429011|NCT00417989|26885225|FG001|Overall Study|Lost to Follow-up|6|||
13429012|NCT00417989|26885224|FG000|Overall Study|Protocol Violation|1|||
13429013|NCT00417989|26885225|FG001|Overall Study|Protocol Violation|0|||
13429014|NCT00417989|26885224|FG000|Overall Study|Death|0|||
13429015|NCT00417989|26885225|FG001|Overall Study|Death|1|||
13429016|NCT00417989|26885224|FG000|Overall Study|Physician Decision|5|||
13429017|NCT00417989|26885225|FG001|Overall Study|Physician Decision|2|||
13429018|NCT00417976|26885232|FG000|Overall Study|Non compliance unrelated to toxicity|1|||
13429019|NCT00417976|26885232|FG000|Overall Study|Treatment -related toxicity|2|||
13429020|NCT00417963|26885251|FG000|Overall Study|Lost to Follow-up|3|||
13429021|NCT00417963|26885251|FG000|Overall Study|Withdrawal by Subject|18|||
13429022|NCT00417963|26885251|FG000|Overall Study|Death|17|||
13429023|NCT00417963|26885251|FG000|Overall Study|Study device could not be deployed|3|||
13429024|NCT00417885|26885262|FG000|Overall Study|Adverse Event|1|||
13429025|NCT00417885|26885262|FG000|Overall Study|Objective Progression or Relapse|3|||
13429026|NCT00417885|26885262|FG000|Overall Study|Transferred to Another Sunitinib Study|2|||
13429027|NCT00417612|26885292|FG000|Overall Study|Errant diagnosis|0|||
13429028|NCT00417612|26885293|FG001|Overall Study|Errant diagnosis|1|||
13429029|NCT00417612|26885292|FG000|Overall Study|Adverse Event|2|||
13429030|NCT00417612|26885293|FG001|Overall Study|Adverse Event|0|||
13429031|NCT00417612|26885292|FG000|Overall Study|Protocol Violation|0|||
13429032|NCT00417612|26885293|FG001|Overall Study|Protocol Violation|2|||
13429033|NCT00417612|26885292|FG000|Overall Study|Lost to Follow-up|1|||
13429034|NCT00417612|26885293|FG001|Overall Study|Lost to Follow-up|0|||
13429035|NCT00417482|26885327|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14|||
13429036|NCT00417482|26885328|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8|||
13429037|NCT00417482|26885329|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24|||
13429038|NCT00417482|26885327|FG000|Phase B 1st 16 Weeks|Adverse Event|2|||
13429039|NCT00417482|26885328|FG001|Phase B 1st 16 Weeks|Adverse Event|0|||
13429040|NCT00417482|26885329|FG002|Phase B 1st 16 Weeks|Adverse Event|1|||
13429041|NCT00417482|26885327|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
13429042|NCT00417482|26885328|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3|||
13429043|NCT00417482|26885329|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
13429044|NCT00417482|26885327|FG000|Phase B 1st 16 Weeks|Death|1|||
13429045|NCT00417482|26885328|FG001|Phase B 1st 16 Weeks|Death|0|||
13429046|NCT00417482|26885329|FG002|Phase B 1st 16 Weeks|Death|0|||
13429047|NCT00417482|26885327|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1|||
13429048|NCT00417482|26885328|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12|||
13429049|NCT00417482|26885329|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2|||
13429050|NCT00417482|26885327|FG000|Phase B 2nd 16 Weeks|Adverse Event|0|||
13429051|NCT00417482|26885328|FG001|Phase B 2nd 16 Weeks|Adverse Event|0|||
13429052|NCT00417482|26885329|FG002|Phase B 2nd 16 Weeks|Adverse Event|1|||
13429053|NCT00417482|26885327|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1|||
13429054|NCT00417482|26885328|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
13429055|NCT00417482|26885329|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
13429056|NCT00417482|26885327|FG000|Phase B 2nd 16 Weeks|Death|1|||
13429057|NCT00417482|26885328|FG001|Phase B 2nd 16 Weeks|Death|1|||
13429058|NCT00417482|26885329|FG002|Phase B 2nd 16 Weeks|Death|0|||
13429059|NCT00417248|26885336|FG000|Overall Study|Study Terminated|6|||
13429060|NCT00417248|26885336|FG000|Overall Study|Death|1|||
13429061|NCT00417248|26885336|FG000|Overall Study|Lack of Efficacy|1|||
13429062|NCT00417170|26885357|FG000|Overall Study|Adverse Event|1|||
13429063|NCT00417170|26885358|FG001|Overall Study|Adverse Event|1|||
13429064|NCT00417170|26885357|FG000|Overall Study|Withdrawal by Subject|1|||
13429065|NCT00417170|26885358|FG001|Overall Study|Withdrawal by Subject|1|||
13429066|NCT00417170|26885357|FG000|Overall Study|Lost to Follow-up|0|||
13429067|NCT00417170|26885358|FG001|Overall Study|Lost to Follow-up|1|||
13429068|NCT00417079|26885385|FG000|Overall Study|Disease progression|267|||
13429069|NCT00417079|26885386|FG001|Overall Study|Disease progression|180|||
13429070|NCT00417079|26885385|FG000|Overall Study|Adverse Event|32|||
13429071|NCT00417079|26885386|FG001|Overall Study|Adverse Event|67|||
13429072|NCT00417079|26885385|FG000|Overall Study|Non-compliance to protocol|0|||
13429073|NCT00417079|26885386|FG001|Overall Study|Non-compliance to protocol|1|||
13429074|NCT00417079|26885385|FG000|Overall Study|Lost to Follow-up|2|||
13429075|NCT00417079|26885386|FG001|Overall Study|Lost to Follow-up|0|||
13429076|NCT00417079|26885385|FG000|Overall Study|Withdrawal by Subject|17|||
13429077|NCT00417079|26885386|FG001|Overall Study|Withdrawal by Subject|8|||
13429078|NCT00417079|26885385|FG000|Overall Study|Not treated|6|||
13429079|NCT00417079|26885386|FG001|Overall Study|Not treated|7|||
13429080|NCT00417079|26885385|FG000|Overall Study|Screened failure|2|||
13429081|NCT00417079|26885386|FG001|Overall Study|Screened failure|1|||
13429082|NCT00417079|26885385|FG000|Overall Study|Investigator's decision|1|||
13429083|NCT00417079|26885386|FG001|Overall Study|Investigator's decision|4|||
13429084|NCT00417079|26885385|FG000|Overall Study|Non-confirmed Disease progression|1|||
13429085|NCT00417079|26885386|FG001|Overall Study|Non-confirmed Disease progression|1|||
13429086|NCT00417079|26885385|FG000|Overall Study|Clinical deterioration|1|||
13429087|NCT00417079|26885386|FG001|Overall Study|Clinical deterioration|0|||
13429088|NCT00417079|26885385|FG000|Overall Study|Screening error|2|||
13429089|NCT00417079|26885386|FG001|Overall Study|Screening error|1|||
13429090|NCT00417079|26885385|FG000|Overall Study|Withdrawal by subject's family|0|||
13429091|NCT00417079|26885386|FG001|Overall Study|Withdrawal by subject's family|1|||
13429092|NCT00417079|26885385|FG000|Overall Study|Patient unable to come to the clinic|0|||
13429093|NCT00417079|26885386|FG001|Overall Study|Patient unable to come to the clinic|1|||
13429094|NCT00417079|26885385|FG000|Overall Study|abnormal liver function tests|0|||
13429095|NCT00417079|26885386|FG001|Overall Study|abnormal liver function tests|1|||
13429096|NCT00417027|26885422|FG000|Overall Study|Protocol Violation|0|||
13429097|NCT00417027|26885423|FG001|Overall Study|Protocol Violation|5|||
13429098|NCT00417027|26885424|FG002|Overall Study|Protocol Violation|5|||
13429099|NCT00416949|26885430|FG000|Overall Study|Patients refused to participate|5|||
13429100|NCT00416884|26885436|FG000|Overall Study|Study terminated due to low accrual|1|||
13429101|NCT00416715|26885445|FG000|Overall Study|Not evaluable for joint aches|7|||
13429102|NCT00416715|26885445|FG000|Overall Study|Vitamin D levels not evaluable|8|||
13429103|NCT00416624|26885512|FG000|Overall Study|Withdrawal by Subject|1|||
13429104|NCT00416624|26885513|FG001|Overall Study|Withdrawal by Subject|6|||
13429105|NCT00416624|26885514|FG002|Overall Study|Withdrawal by Subject|4|||
13429106|NCT00416624|26885515|FG003|Overall Study|Withdrawal by Subject|9|||
13429107|NCT00416624|26885512|FG000|Overall Study|Death|4|||
13429108|NCT00416624|26885513|FG001|Overall Study|Death|7|||
13429109|NCT00416624|26885514|FG002|Overall Study|Death|7|||
13429110|NCT00416624|26885515|FG003|Overall Study|Death|1|||
13429111|NCT00416624|26885512|FG000|Overall Study|Adverse Event|8|||
13429112|NCT00416624|26885513|FG001|Overall Study|Adverse Event|3|||
13429113|NCT00416624|26885514|FG002|Overall Study|Adverse Event|2|||
13429114|NCT00416624|26885515|FG003|Overall Study|Adverse Event|2|||
13429115|NCT00416624|26885512|FG000|Overall Study|Other|8|||
13429116|NCT00416624|26885513|FG001|Overall Study|Other|11|||
13429117|NCT00416624|26885514|FG002|Overall Study|Other|5|||
13429118|NCT00416624|26885515|FG003|Overall Study|Other|5|||
13429119|NCT00416624|26885512|FG000|Overall Study|Cancel|1|||
13429120|NCT00416624|26885513|FG001|Overall Study|Cancel|0|||
13429121|NCT00416624|26885514|FG002|Overall Study|Cancel|0|||
13429122|NCT00416624|26885515|FG003|Overall Study|Cancel|0|||
13429123|NCT00416598|26885522|FG000|Induction & Intensification|Adverse Event|38|||
13429124|NCT00416598|26885522|FG000|Induction & Intensification|Death|32|||
13429125|NCT00416598|26885522|FG000|Induction & Intensification|Withdrawal by Subject|46|||
13429126|NCT00416598|26885522|FG000|Induction & Intensification|Alternative Treatment|135|||
13429127|NCT00416598|26885522|FG000|Induction & Intensification|Physician discretion/other medical issue|45|||
13429128|NCT00416598|26885522|FG000|Induction & Intensification|Relapse/progression|29|||
13429129|NCT00416598|26885522|FG000|Induction & Intensification|Failed induction|87|||
13429130|NCT00416598|26885522|FG000|Decitabine Maintenance|Adverse Event|5|||
13429131|NCT00416598|26885522|FG000|Decitabine Maintenance|Withdrawal by Subject|18|||
13429132|NCT00416598|26885522|FG000|Decitabine Maintenance|Progression/relapse|38|||
13429133|NCT00416598|26885522|FG000|Decitabine Maintenance|Alternative treatment|2|||
13429134|NCT00416598|26885522|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9|||
13429135|NCT00416520|26885541|FG000|Open-label Period|Adverse Event|28|||
13429136|NCT00416520|26885542|FG001|Open-label Period|Adverse Event|10|||
13429137|NCT00416520|26885543|FG002|Open-label Period|Adverse Event|0|||
13429138|NCT00416520|26885544|FG003|Open-label Period|Adverse Event|0|||
13429139|NCT00416520|26885541|FG000|Open-label Period|Death|2|||
13429140|NCT00416520|26885542|FG001|Open-label Period|Death|1|||
13429141|NCT00416520|26885543|FG002|Open-label Period|Death|0|||
13429142|NCT00416520|26885544|FG003|Open-label Period|Death|0|||
13429143|NCT00416520|26885541|FG000|Open-label Period|Lack of Efficacy|8|||
13429144|NCT00416520|26885542|FG001|Open-label Period|Lack of Efficacy|1|||
13429145|NCT00416520|26885543|FG002|Open-label Period|Lack of Efficacy|0|||
13429146|NCT00416520|26885544|FG003|Open-label Period|Lack of Efficacy|0|||
13429147|NCT00416520|26885541|FG000|Open-label Period|Protocol Violation|3|||
13429148|NCT00416520|26885542|FG001|Open-label Period|Protocol Violation|3|||
13429149|NCT00416520|26885543|FG002|Open-label Period|Protocol Violation|0|||
13429150|NCT00416520|26885544|FG003|Open-label Period|Protocol Violation|0|||
13429151|NCT00416520|26885541|FG000|Open-label Period|Withdrawal by Subject|16|||
13429152|NCT00416520|26885542|FG001|Open-label Period|Withdrawal by Subject|5|||
13429153|NCT00416520|26885543|FG002|Open-label Period|Withdrawal by Subject|0|||
13429154|NCT00416520|26885544|FG003|Open-label Period|Withdrawal by Subject|0|||
13429155|NCT00416520|26885541|FG000|Open-label Period|Other Reasons|3|||
13429156|NCT00416520|26885542|FG001|Open-label Period|Other Reasons|12|||
13429157|NCT00416520|26885543|FG002|Open-label Period|Other Reasons|0|||
13429158|NCT00416520|26885544|FG003|Open-label Period|Other Reasons|0|||
13429159|NCT00416520|26885541|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0|||
13429160|NCT00416520|26885542|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0|||
13429161|NCT00416520|26885543|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0|||
13429162|NCT00416520|26885544|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1|||
13429163|NCT00416520|26885541|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
13429164|NCT00416520|26885542|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
13429165|NCT00416520|26885543|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
13429166|NCT00416520|26885544|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3|||
13429167|NCT00416520|26885541|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
13429168|NCT00416520|26885542|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
13429169|NCT00416520|26885543|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
13429170|NCT00416520|26885544|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
13429171|NCT00416455|26885586|FG000|Overall Study|PET / CT not done|3|||
13429172|NCT00416455|26885587|FG001|Overall Study|PET / CT not done|5|||
13429173|NCT00416455|26885586|FG000|Overall Study|PET / CT poor quality|2|||
13429174|NCT00416455|26885587|FG001|Overall Study|PET / CT poor quality|1|||
13429175|NCT00416455|26885586|FG000|Overall Study|Inadequate pathology|11|||
13429176|NCT00416455|26885587|FG001|Overall Study|Inadequate pathology|2|||
13429177|NCT00416312|26885593|FG000|Overall Study|tumors not visible on imaging|2|||
13429178|NCT00416195|26885608|FG000|Overall Study|Adverse Event|1|||
13429179|NCT00416195|26885609|FG001|Overall Study|Adverse Event|2|||
13429180|NCT00416195|26885608|FG000|Overall Study|Protocol Violation|1|||
13429181|NCT00416195|26885609|FG001|Overall Study|Protocol Violation|1|||
13429182|NCT00416195|26885608|FG000|Overall Study|Other|0|||
13429183|NCT00416195|26885609|FG001|Overall Study|Other|1|||
13429184|NCT00416078|26885632|FG000|Overall Study|Death|3|||
13429185|NCT00416078|26885633|FG001|Overall Study|Death|4|||
13429186|NCT00416078|26885632|FG000|Overall Study|Withdrawal by Subject|3|||
13429187|NCT00416078|26885633|FG001|Overall Study|Withdrawal by Subject|2|||
13429188|NCT00416078|26885632|FG000|Overall Study|Physician Decision|1|||
13429189|NCT00416078|26885633|FG001|Overall Study|Physician Decision|0|||
13429190|NCT00416078|26885632|FG000|Overall Study|Lost to Follow-up|4|||
13429191|NCT00416078|26885633|FG001|Overall Study|Lost to Follow-up|2|||
13429192|NCT00415909|26885639|FG000|Overall Study|Withdrawal by Subject|2|||
13429193|NCT00415909|26885639|FG000|Overall Study|Death|1|||
13429194|NCT00415636|26885690|FG000|Overall Study|Symptomatic deterioration|1|||
13429195|NCT00415636|26885691|FG001|Overall Study|Symptomatic deterioration|0|||
13429196|NCT00415636|26885692|FG002|Overall Study|Symptomatic deterioration|1|||
13429197|NCT00415636|26885693|FG003|Overall Study|Symptomatic deterioration|2|||
13429198|NCT00415636|26885694|FG004|Overall Study|Symptomatic deterioration|0|||
13429199|NCT00415636|26885695|FG005|Overall Study|Symptomatic deterioration|1|||
13429200|NCT00415636|26885690|FG000|Overall Study|Adverse Event|0|||
13429201|NCT00415636|26885691|FG001|Overall Study|Adverse Event|0|||
13429202|NCT00415636|26885692|FG002|Overall Study|Adverse Event|0|||
13429203|NCT00415636|26885693|FG003|Overall Study|Adverse Event|1|||
13429204|NCT00415636|26885694|FG004|Overall Study|Adverse Event|1|||
13429205|NCT00415636|26885695|FG005|Overall Study|Adverse Event|0|||
13429206|NCT00415636|26885690|FG000|Overall Study|Withdrawal by Subject|0|||
13429207|NCT00415636|26885691|FG001|Overall Study|Withdrawal by Subject|0|||
13429208|NCT00415636|26885692|FG002|Overall Study|Withdrawal by Subject|0|||
13429209|NCT00415636|26885693|FG003|Overall Study|Withdrawal by Subject|0|||
13429210|NCT00415636|26885694|FG004|Overall Study|Withdrawal by Subject|1|||
13429211|NCT00415636|26885695|FG005|Overall Study|Withdrawal by Subject|0|||
13429212|NCT00415636|26885690|FG000|Overall Study|Disease progression|0|||
13429213|NCT00415636|26885691|FG001|Overall Study|Disease progression|0|||
13429214|NCT00415636|26885692|FG002|Overall Study|Disease progression|0|||
13429215|NCT00415636|26885693|FG003|Overall Study|Disease progression|3|||
13429216|NCT00415636|26885694|FG004|Overall Study|Disease progression|0|||
13429217|NCT00415636|26885695|FG005|Overall Study|Disease progression|1|||
13429218|NCT00415610|26885725|FG000|Overall Study|Death|3|||
13429219|NCT00415610|26885726|FG001|Overall Study|Death|2|||
13429220|NCT00415610|26885727|FG002|Overall Study|Death|5|||
13429221|NCT00415597|26885735|FG000|Enrollment|Withdrawal by Subject|1|||
13429222|NCT00415597|26885735|FG000|Enrollment|Protocol Violation|1|||
13429223|NCT00415597|26885735|FG000|Treatment|Adverse Event|110|||
13429224|NCT00415597|26885735|FG000|Treatment|Lack of Efficacy|39|||
13429225|NCT00415597|26885735|FG000|Treatment|Protocol Violation|67|||
13429226|NCT00415597|26885735|FG000|Treatment|Physician Decision|3|||
13429227|NCT00415597|26885735|FG000|Treatment|Withdrawal by Subject|51|||
13429228|NCT00415597|26885735|FG000|Treatment|Lost to Follow-up|28|||
13429229|NCT00415597|26885735|FG000|Treatment|Drug Screen|2|||
13429230|NCT00415597|26885735|FG000|Treatment|Administrative|3|||
13429231|NCT00415597|26885735|FG000|Treatment|Sponsor Decision|1|||
13429232|NCT00415597|26885735|FG000|Treatment|Multiple Reasons|1|||
13429233|NCT00415519|26885760|FG000|Overall Study|Adverse Event|1|||
13429234|NCT00415519|26885761|FG001|Overall Study|Adverse Event|0|||
13429235|NCT00415519|26885760|FG000|Overall Study|Withdrawal by Subject|2|||
13429236|NCT00415519|26885761|FG001|Overall Study|Withdrawal by Subject|0|||
13429237|NCT00415519|26885760|FG000|Overall Study|Patient's convenience|1|||
13429238|NCT00415519|26885761|FG001|Overall Study|Patient's convenience|0|||
13429239|NCT00415363|26885796|FG000|Overall Study|Withdrawal by Subject|4|||
13429240|NCT00415363|26885797|FG001|Overall Study|Withdrawal by Subject|4|||
13429241|NCT00415363|26885796|FG000|Overall Study|Adverse Event|4|||
13429242|NCT00415363|26885797|FG001|Overall Study|Adverse Event|4|||
13429243|NCT00415363|26885796|FG000|Overall Study|Lost to Follow-up|2|||
13429244|NCT00415363|26885797|FG001|Overall Study|Lost to Follow-up|1|||
13429245|NCT00415363|26885796|FG000|Overall Study|Physician Decision|3|||
13429246|NCT00415363|26885797|FG001|Overall Study|Physician Decision|1|||
13429247|NCT00415363|26885796|FG000|Overall Study|Death|16|||
13429248|NCT00415363|26885797|FG001|Overall Study|Death|12|||
13429249|NCT00415363|26885796|FG000|Overall Study|Progressive disease|26|||
13429250|NCT00415363|26885797|FG001|Overall Study|Progressive disease|32|||
13429251|NCT00415194|26885820|FG000|Overall Study|Adverse Event|37|||
13429252|NCT00415194|26885821|FG001|Overall Study|Adverse Event|32|||
13429253|NCT00415194|26885820|FG000|Overall Study|Entry Criteria Not Met|4|||
13429254|NCT00415194|26885821|FG001|Overall Study|Entry Criteria Not Met|8|||
13429255|NCT00415194|26885820|FG000|Overall Study|Lost to Follow-up|1|||
13429256|NCT00415194|26885821|FG001|Overall Study|Lost to Follow-up|0|||
13429257|NCT00415194|26885820|FG000|Overall Study|Physician Decision|10|||
13429258|NCT00415194|26885821|FG001|Overall Study|Physician Decision|16|||
13429259|NCT00415194|26885820|FG000|Overall Study|Progressive Disease|180|||
13429260|NCT00415194|26885821|FG001|Overall Study|Progressive Disease|217|||
13429261|NCT00415194|26885820|FG000|Overall Study|Protocol Violation|4|||
13429262|NCT00415194|26885821|FG001|Overall Study|Protocol Violation|2|||
13429263|NCT00415194|26885820|FG000|Overall Study|Withdrawal by Subject|28|||
13429264|NCT00415194|26885821|FG001|Overall Study|Withdrawal by Subject|21|||
13429265|NCT00415194|26885820|FG000|Overall Study|Death Due to Study Disease|26|||
13429266|NCT00415194|26885821|FG001|Overall Study|Death Due to Study Disease|29|||
13429267|NCT00415194|26885820|FG000|Overall Study|Death Due to Study Drug Related AE|11|||
13429268|NCT00415194|26885821|FG001|Overall Study|Death Due to Study Drug Related AE|1|||
13429269|NCT00415194|26885820|FG000|Overall Study|Death Due to Procedural Related AE|0|||
13429270|NCT00415194|26885821|FG001|Overall Study|Death Due to Procedural Related AE|1|||
13429271|NCT00415194|26885820|FG000|Overall Study|Death Due to AE (Other Causes)|27|||
13429272|NCT00415194|26885821|FG001|Overall Study|Death Due to AE (Other Causes)|15|||
13429273|NCT00415168|26885833|FG000|Overall Study|Death|26|||
13429274|NCT00415168|26885833|FG000|Overall Study|Lost to Follow-up|3|||
13429275|NCT00415168|26885833|FG000|Overall Study|Physician Decision|13|||
13429276|NCT00415168|26885833|FG000|Overall Study|Sponsor Decision|4|||
13429277|NCT00415168|26885833|FG000|Overall Study|Withdrawal by Subject|6|||
13429278|NCT00415051|26885842|FG000|Overall Study|Protocol Violation|1|||
13429279|NCT00414973|26885873|FG000|Overall Study|Withdrawal by Subject|14|||
13429280|NCT00414973|26885874|FG001|Overall Study|Withdrawal by Subject|4|||
13429281|NCT00414973|26885875|FG002|Overall Study|Withdrawal by Subject|1|||
13429282|NCT00414973|26885876|FG003|Overall Study|Withdrawal by Subject|0|||
13429283|NCT00414973|26885873|FG000|Overall Study|Adverse Event|10|||
13429284|NCT00414973|26885874|FG001|Overall Study|Adverse Event|0|||
13429285|NCT00414973|26885875|FG002|Overall Study|Adverse Event|1|||
13429286|NCT00414973|26885876|FG003|Overall Study|Adverse Event|0|||
13429287|NCT00414973|26885873|FG000|Overall Study|Protocol Violation|3|||
13429288|NCT00414973|26885874|FG001|Overall Study|Protocol Violation|4|||
13429289|NCT00414973|26885875|FG002|Overall Study|Protocol Violation|0|||
13429290|NCT00414973|26885876|FG003|Overall Study|Protocol Violation|0|||
13429291|NCT00414973|26885873|FG000|Overall Study|Lost to Follow-up|0|||
13429292|NCT00414973|26885874|FG001|Overall Study|Lost to Follow-up|2|||
13429293|NCT00414973|26885875|FG002|Overall Study|Lost to Follow-up|0|||
13429294|NCT00414973|26885876|FG003|Overall Study|Lost to Follow-up|0|||
13429295|NCT00414973|26885873|FG000|Overall Study|Sponsor Decision|1|||
13429296|NCT00414973|26885874|FG001|Overall Study|Sponsor Decision|0|||
13429297|NCT00414973|26885875|FG002|Overall Study|Sponsor Decision|0|||
13429298|NCT00414973|26885876|FG003|Overall Study|Sponsor Decision|0|||
13429299|NCT00414973|26885873|FG000|Overall Study|Death|0|||
13429300|NCT00414973|26885874|FG001|Overall Study|Death|0|||
13429301|NCT00414973|26885875|FG002|Overall Study|Death|1|||
13429302|NCT00414973|26885876|FG003|Overall Study|Death|0|||
13429303|NCT00414960|26885891|FG000|Overall Study|Adverse Event|4|||
13429304|NCT00414960|26885892|FG001|Overall Study|Adverse Event|0|||
13429305|NCT00414960|26885891|FG000|Overall Study|Withdrawal by Subject|3|||
13429306|NCT00414960|26885892|FG001|Overall Study|Withdrawal by Subject|0|||
13429307|NCT00414960|26885891|FG000|Overall Study|Physician Decision|0|||
13429308|NCT00414960|26885892|FG001|Overall Study|Physician Decision|1|||
13429309|NCT00414908|26885921|FG000|Overall Study|Protocol Violation|1|||
13429310|NCT00414908|26885922|FG001|Overall Study|Protocol Violation|1|||
13429311|NCT00414765|26885935|FG000|Overall Study|Adverse Event|5|||
13429312|NCT00414765|26885936|FG001|Overall Study|Adverse Event|9|||
13429313|NCT00414765|26885935|FG000|Overall Study|Withdrawal by Subject|1|||
13429314|NCT00414765|26885936|FG001|Overall Study|Withdrawal by Subject|1|||
13429315|NCT00414765|26885935|FG000|Overall Study|Disease Progression|0|||
13429316|NCT00414765|26885936|FG001|Overall Study|Disease Progression|1|||
13429317|NCT00414726|26885951|FG000|Overall Study|Withdrawal by Subject|0|||
13429318|NCT00414726|26885952|FG001|Overall Study|Withdrawal by Subject|1|||
13429319|NCT00414661|26885987|FG000|Overall Study|Death|2|||
13429320|NCT00414661|26885988|FG001|Overall Study|Death|5|||
13429321|NCT00414661|26885989|FG002|Overall Study|Death|0|||
13429322|NCT00414661|26885990|FG003|Overall Study|Death|0|||
13429323|NCT00414661|26885987|FG000|Overall Study|Lost to Follow-up|1|||
13429324|NCT00414661|26885988|FG001|Overall Study|Lost to Follow-up|4|||
13429325|NCT00414661|26885989|FG002|Overall Study|Lost to Follow-up|0|||
13429326|NCT00414661|26885990|FG003|Overall Study|Lost to Follow-up|1|||
13429327|NCT00414661|26885987|FG000|Overall Study|Withdrawal by Subject|5|||
13429328|NCT00414661|26885988|FG001|Overall Study|Withdrawal by Subject|2|||
13429329|NCT00414661|26885989|FG002|Overall Study|Withdrawal by Subject|2|||
13429330|NCT00414661|26885990|FG003|Overall Study|Withdrawal by Subject|2|||
13429331|NCT00414661|26885987|FG000|Overall Study|Other|6|||
13429332|NCT00414661|26885988|FG001|Overall Study|Other|3|||
13429333|NCT00414661|26885989|FG002|Overall Study|Other|0|||
13429334|NCT00414661|26885990|FG003|Overall Study|Other|0|||
13429335|NCT00414609|26886021|FG000|Core Study|Adverse Event|9|||
13429336|NCT00414609|26886022|FG001|Core Study|Adverse Event|11|||
13429337|NCT00414609|26886023|FG002|Core Study|Adverse Event|0|||
13429338|NCT00414609|26886021|FG000|Core Study|Abnormal laboratory values|0|||
13429339|NCT00414609|26886022|FG001|Core Study|Abnormal laboratory values|1|||
13429340|NCT00414609|26886023|FG002|Core Study|Abnormal laboratory values|0|||
13429341|NCT00414609|26886021|FG000|Core Study|Abnormal test procedure results|1|||
13429342|NCT00414609|26886022|FG001|Core Study|Abnormal test procedure results|1|||
13429343|NCT00414609|26886023|FG002|Core Study|Abnormal test procedure results|0|||
13429344|NCT00414609|26886021|FG000|Core Study|Protocol deviation|0|||
13429345|NCT00414609|26886022|FG001|Core Study|Protocol deviation|1|||
13429346|NCT00414609|26886023|FG002|Core Study|Protocol deviation|0|||
13429347|NCT00414609|26886021|FG000|Core Study|Patient withdrew consent|10|||
13429348|NCT00414609|26886022|FG001|Core Study|Patient withdrew consent|11|||
13429349|NCT00414609|26886023|FG002|Core Study|Patient withdrew consent|0|||
13429350|NCT00414609|26886021|FG000|Core Study|Lost to Follow-up|7|||
13429351|NCT00414609|26886022|FG001|Core Study|Lost to Follow-up|4|||
13429352|NCT00414609|26886023|FG002|Core Study|Lost to Follow-up|0|||
13429353|NCT00414609|26886021|FG000|Core Study|Administrative problems|0|||
13429354|NCT00414609|26886022|FG001|Core Study|Administrative problems|2|||
13429355|NCT00414609|26886023|FG002|Core Study|Administrative problems|0|||
13429356|NCT00414609|26886021|FG000|Core Study|Death|7|||
13429357|NCT00414609|26886022|FG001|Core Study|Death|14|||
13429358|NCT00414609|26886023|FG002|Core Study|Death|0|||
13429359|NCT00414609|26886021|FG000|Extension Study|Adverse Event|0|||
13429360|NCT00414609|26886022|FG001|Extension Study|Adverse Event|0|||
13429361|NCT00414609|26886023|FG002|Extension Study|Adverse Event|14|||
13429362|NCT00414609|26886021|FG000|Extension Study|Unsatisfactory therapeutic effect|0|||
13429363|NCT00414609|26886022|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
13429364|NCT00414609|26886023|FG002|Extension Study|Unsatisfactory therapeutic effect|2|||
13429365|NCT00414609|26886021|FG000|Extension Study|Withdrawal by Subject|0|||
13429366|NCT00414609|26886022|FG001|Extension Study|Withdrawal by Subject|0|||
13429367|NCT00414609|26886023|FG002|Extension Study|Withdrawal by Subject|13|||
13429368|NCT00414609|26886021|FG000|Extension Study|Lost to Follow-up|0|||
13429369|NCT00414609|26886022|FG001|Extension Study|Lost to Follow-up|0|||
13429370|NCT00414609|26886023|FG002|Extension Study|Lost to Follow-up|10|||
13429371|NCT00414609|26886021|FG000|Extension Study|Administrative problems|0|||
13429372|NCT00414609|26886022|FG001|Extension Study|Administrative problems|0|||
13429373|NCT00414609|26886023|FG002|Extension Study|Administrative problems|1|||
13429374|NCT00414609|26886021|FG000|Extension Study|Death|0|||
13429375|NCT00414609|26886022|FG001|Extension Study|Death|0|||
13429376|NCT00414609|26886023|FG002|Extension Study|Death|17|||
13429377|NCT00414596|26886034|FG000|Overall Study|Protocol Violation|2|||
13429378|NCT00414544|26886042|FG000|Overall Study|Lost to Follow-up|14|||
13429379|NCT00414466|26886073|FG000|Overall Study|Adverse Event|0|||
13429380|NCT00414466|26886074|FG001|Overall Study|Adverse Event|0|||
13429381|NCT00414466|26886075|FG002|Overall Study|Adverse Event|1|||
13429382|NCT00414466|26886076|FG003|Overall Study|Adverse Event|1|||
13429383|NCT00414466|26886073|FG000|Overall Study|Lack of Efficacy|1|||
13429384|NCT00414466|26886074|FG001|Overall Study|Lack of Efficacy|0|||
13429385|NCT00414466|26886075|FG002|Overall Study|Lack of Efficacy|0|||
13429386|NCT00414466|26886076|FG003|Overall Study|Lack of Efficacy|0|||
13429387|NCT00414466|26886073|FG000|Overall Study|Withdrawn by Sponsor|1|||
13429388|NCT00414466|26886074|FG001|Overall Study|Withdrawn by Sponsor|0|||
13429389|NCT00414466|26886075|FG002|Overall Study|Withdrawn by Sponsor|0|||
13429390|NCT00414466|26886076|FG003|Overall Study|Withdrawn by Sponsor|0|||
13429391|NCT00414453|26886124|FG000|Overall Study|Abnormal lab work|16|||
13429392|NCT00414440|26886145|FG000|Core Period|Withdrawal by Subject|70|||
13429393|NCT00414440|26886146|FG001|Core Period|Withdrawal by Subject|32|||
13429394|NCT00414440|26886145|FG000|Extension Period|Lost to Follow-up|44|||
13429395|NCT00414440|26886146|FG001|Extension Period|Lost to Follow-up|52|||
13429396|NCT00414440|26886145|FG000|Extension Period|Did not consent to continue follow up|61|||
13429397|NCT00414440|26886146|FG001|Extension Period|Did not consent to continue follow up|54|||
13429398|NCT00414440|26886145|FG000|Extension Period|Other|1|||
13429399|NCT00414440|26886146|FG001|Extension Period|Other|1|||
13429400|NCT00414440|26886145|FG000|Extension Period|Administrative|16|||
13429401|NCT00414440|26886146|FG001|Extension Period|Administrative|16|||
13429402|NCT00414440|26886145|FG000|Extension Period|Death|1|||
13429403|NCT00414440|26886146|FG001|Extension Period|Death|2|||
13429404|NCT00414440|26886145|FG000|Extension Period|Withdrawal by Subject|9|||
13429405|NCT00414440|26886146|FG001|Extension Period|Withdrawal by Subject|7|||
13429406|NCT00414440|26886145|FG000|Extension Period|Not included in follow up period|18|||
13429407|NCT00414440|26886146|FG001|Extension Period|Not included in follow up period|8|||
13429408|NCT00414388|26886154|FG000|Overall Study|Adverse Event|1|||
13429409|NCT00414310|26886171|FG000|Overall Study|Not treated|1|||
13429410|NCT00414310|26886172|FG001|Overall Study|Not treated|0|||
13429411|NCT00414076|26886185|FG000|Overall Study|Progression|1|||
13429412|NCT00414076|26886186|FG001|Overall Study|Progression|2|||
13429413|NCT00414076|26886185|FG000|Overall Study|Withdrawal by Subject|1|||
13429414|NCT00414076|26886186|FG001|Overall Study|Withdrawal by Subject|3|||
13429415|NCT00414076|26886185|FG000|Overall Study|Adverse Event|1|||
13429416|NCT00414076|26886186|FG001|Overall Study|Adverse Event|0|||
13429417|NCT00414050|26886213|FG000|Overall Study|Adverse Event|1|||
13429418|NCT00414050|26886214|FG001|Overall Study|Adverse Event|1|||
13429419|NCT00414050|26886215|FG002|Overall Study|Adverse Event|1|||
13429420|NCT00414050|26886216|FG003|Overall Study|Adverse Event|1|||
13429421|NCT00414050|26886213|FG000|Overall Study|Lost to Follow-up|2|||
13429422|NCT00414050|26886214|FG001|Overall Study|Lost to Follow-up|2|||
13429423|NCT00414050|26886215|FG002|Overall Study|Lost to Follow-up|1|||
13429424|NCT00414050|26886216|FG003|Overall Study|Lost to Follow-up|1|||
13429425|NCT00414050|26886213|FG000|Overall Study|Withdrawal by Subject|5|||
13429426|NCT00414050|26886214|FG001|Overall Study|Withdrawal by Subject|3|||
13429427|NCT00414050|26886215|FG002|Overall Study|Withdrawal by Subject|2|||
13429428|NCT00414050|26886216|FG003|Overall Study|Withdrawal by Subject|4|||
13429429|NCT00414050|26886213|FG000|Overall Study|Subject discontinued for other reason|1|||
13429430|NCT00414050|26886214|FG001|Overall Study|Subject discontinued for other reason|2|||
13429431|NCT00414050|26886215|FG002|Overall Study|Subject discontinued for other reason|2|||
13429432|NCT00414050|26886216|FG003|Overall Study|Subject discontinued for other reason|1|||
13429433|NCT00414050|26886213|FG000|Overall Study|Subject Moved|0|||
13429434|NCT00414050|26886214|FG001|Overall Study|Subject Moved|0|||
13429435|NCT00414050|26886215|FG002|Overall Study|Subject Moved|0|||
13429436|NCT00414050|26886216|FG003|Overall Study|Subject Moved|1|||
13429437|NCT00414011|26886223|FG000|Overall Study|Physician Decision|3|||
13429438|NCT00414011|26886223|FG000|Overall Study|Withdrawal by Subject|2|||
13429439|NCT00413972|26886246|FG000|Overall Study|Adverse Event|2|||
13429440|NCT00413972|26886247|FG001|Overall Study|Adverse Event|1|||
13429441|NCT00413972|26886248|FG002|Overall Study|Adverse Event|0|||
13429442|NCT00413972|26886249|FG003|Overall Study|Adverse Event|0|||
13429443|NCT00413972|26886246|FG000|Overall Study|Lost to Follow-up|1|||
13429444|NCT00413972|26886247|FG001|Overall Study|Lost to Follow-up|2|||
13429445|NCT00413972|26886248|FG002|Overall Study|Lost to Follow-up|1|||
13429446|NCT00413972|26886249|FG003|Overall Study|Lost to Follow-up|0|||
13429447|NCT00413972|26886246|FG000|Overall Study|Withdrawal by Subject|4|||
13429448|NCT00413972|26886247|FG001|Overall Study|Withdrawal by Subject|5|||
13429449|NCT00413972|26886248|FG002|Overall Study|Withdrawal by Subject|7|||
13429450|NCT00413972|26886249|FG003|Overall Study|Withdrawal by Subject|2|||
13429451|NCT00413972|26886246|FG000|Overall Study|Protocol Violation|0|||
13429452|NCT00413972|26886247|FG001|Overall Study|Protocol Violation|0|||
13429453|NCT00413972|26886248|FG002|Overall Study|Protocol Violation|2|||
13429454|NCT00413972|26886249|FG003|Overall Study|Protocol Violation|0|||
13429455|NCT00413972|26886246|FG000|Overall Study|Other|0|||
13429456|NCT00413972|26886247|FG001|Overall Study|Other|0|||
13429457|NCT00413972|26886248|FG002|Overall Study|Other|0|||
13429458|NCT00413972|26886249|FG003|Overall Study|Other|1|||
13429459|NCT00413959|26886256|FG000|Overall Study|Pt had only one cycle.|1|||
13429460|NCT00413920|26886278|FG000|Overall Study|Adverse Event|9|||
13429461|NCT00413920|26886279|FG001|Overall Study|Adverse Event|11|||
13429462|NCT00413920|26886278|FG000|Overall Study|Lack of Efficacy|11|||
13429463|NCT00413920|26886279|FG001|Overall Study|Lack of Efficacy|9|||
13429464|NCT00413920|26886278|FG000|Overall Study|Death|3|||
13429465|NCT00413920|26886279|FG001|Overall Study|Death|5|||
13429466|NCT00413920|26886278|FG000|Overall Study|Graft Loss|5|||
13429467|NCT00413920|26886279|FG001|Overall Study|Graft Loss|3|||
13429468|NCT00413894|26886296|FG000|Overall Study|Withdrawal by Subject|10|||
13429469|NCT00413894|26886296|FG000|Overall Study|Administrative Reasons|1|||
13429470|NCT00413894|26886296|FG000|Overall Study|Hb <10 grams/deciliter|12|||
13429471|NCT00413894|26886296|FG000|Overall Study|Adverse Event|28|||
13429472|NCT00413894|26886296|FG000|Overall Study|Protocol Violation|11|||
13429473|NCT00413894|26886296|FG000|Overall Study|Other|18|||
13429474|NCT00413777|26886349|FG000|Fixed-dose Period|Lost to Follow-up|1|||
13429475|NCT00413777|26886350|FG001|Fixed-dose Period|Lost to Follow-up|1|||
13429476|NCT00413777|26886349|FG000|Fixed-dose Period|Adverse Event|2|||
13429477|NCT00413777|26886350|FG001|Fixed-dose Period|Adverse Event|1|||
13429478|NCT00413777|26886349|FG000|Fixed-dose Period|Met Withdrawal Criteria|1|||
13429479|NCT00413777|26886350|FG001|Fixed-dose Period|Met Withdrawal Criteria|0|||
13429480|NCT00413777|26886349|FG000|Fixed-dose Period|Withdrew Consent|0|||
13429481|NCT00413777|26886350|FG001|Fixed-dose Period|Withdrew Consent|1|||
13429482|NCT00413699|26886433|FG000|Initial Period|Death|25|||
13429483|NCT00413699|26886434|FG001|Initial Period|Death|30|||
13429484|NCT00413699|26886435|FG002|Initial Period|Death|0|||
13429485|NCT00413699|26886433|FG000|Initial Period|Lack of Efficacy|59|||
13429486|NCT00413699|26886434|FG001|Initial Period|Lack of Efficacy|115|||
13429487|NCT00413699|26886435|FG002|Initial Period|Lack of Efficacy|0|||
13429488|NCT00413699|26886433|FG000|Initial Period|Lost to Follow-up|31|||
13429489|NCT00413699|26886434|FG001|Initial Period|Lost to Follow-up|101|||
13429490|NCT00413699|26886435|FG002|Initial Period|Lost to Follow-up|0|||
13429491|NCT00413699|26886433|FG000|Initial Period|Protocol Violation|38|||
13429492|NCT00413699|26886434|FG001|Initial Period|Protocol Violation|89|||
13429493|NCT00413699|26886435|FG002|Initial Period|Protocol Violation|0|||
13429494|NCT00413699|26886433|FG000|Initial Period|Pregnancy|10|||
13429495|NCT00413699|26886434|FG001|Initial Period|Pregnancy|8|||
13429496|NCT00413699|26886435|FG002|Initial Period|Pregnancy|0|||
13429497|NCT00413699|26886433|FG000|Initial Period|Did not meet entrance criteria|2|||
13429498|NCT00413699|26886434|FG001|Initial Period|Did not meet entrance criteria|2|||
13429499|NCT00413699|26886435|FG002|Initial Period|Did not meet entrance criteria|0|||
13429500|NCT00413699|26886433|FG000|Initial Period|Medication error without adverse event|0|||
13429501|NCT00413699|26886434|FG001|Initial Period|Medication error without adverse event|1|||
13429502|NCT00413699|26886435|FG002|Initial Period|Medication error without adverse event|0|||
13429503|NCT00413699|26886433|FG000|Initial Period|Study terminated by Sponsor|0|||
13429504|NCT00413699|26886434|FG001|Initial Period|Study terminated by Sponsor|1|||
13429505|NCT00413699|26886435|FG002|Initial Period|Study terminated by Sponsor|0|||
13429506|NCT00413699|26886433|FG000|Initial Period|Other|67|||
13429507|NCT00413699|26886434|FG001|Initial Period|Other|211|||
13429508|NCT00413699|26886435|FG002|Initial Period|Other|0|||
13429509|NCT00413699|26886433|FG000|Initial Period|Adverse event related to study drug|178|||
13429510|NCT00413699|26886434|FG001|Initial Period|Adverse event related to study drug|527|||
13429511|NCT00413699|26886435|FG002|Initial Period|Adverse event related to study drug|0|||
13429512|NCT00413699|26886433|FG000|Initial Period|Adverse event not related to study drug|113|||
13429513|NCT00413699|26886434|FG001|Initial Period|Adverse event not related to study drug|248|||
13429514|NCT00413699|26886435|FG002|Initial Period|Adverse event not related to study drug|0|||
13429515|NCT00413699|26886433|FG000|Initial Period|Missing end of study page|0|||
13429516|NCT00413699|26886434|FG001|Initial Period|Missing end of study page|4|||
13429517|NCT00413699|26886435|FG002|Initial Period|Missing end of study page|0|||
13429518|NCT00413699|26886433|FG000|Initial Period|No longer willing to participate|116|||
13429519|NCT00413699|26886434|FG001|Initial Period|No longer willing to participate|368|||
13429520|NCT00413699|26886435|FG002|Initial Period|No longer willing to participate|0|||
13429521|NCT00413699|26886433|FG000|Extension Period|No Longer Willing to Participate|0|||
13429522|NCT00413699|26886434|FG001|Extension Period|No Longer Willing to Participate|0|||
13429523|NCT00413699|26886435|FG002|Extension Period|No Longer Willing to Participate|2|||
13429524|NCT00413699|26886433|FG000|Extension Period|Protocol Violation|0|||
13429525|NCT00413699|26886434|FG001|Extension Period|Protocol Violation|0|||
13429526|NCT00413699|26886435|FG002|Extension Period|Protocol Violation|1|||
13429527|NCT00413699|26886433|FG000|Extension Period|Adverse Event|0|||
13429528|NCT00413699|26886434|FG001|Extension Period|Adverse Event|0|||
13429529|NCT00413699|26886435|FG002|Extension Period|Adverse Event|2|||
13429530|NCT00413660|26886807|FG000|Up To Week 12|Adverse Event|1|||
13429531|NCT00413660|26886808|FG001|Up To Week 12|Adverse Event|3|||
13429532|NCT00413660|26886809|FG002|Up To Week 12|Adverse Event|1|||
13429533|NCT00413660|26886810|FG003|Up To Week 12|Adverse Event|4|||
13429534|NCT00413660|26886811|FG004|Up To Week 12|Adverse Event|6|||
13429535|NCT00413660|26886812|FG005|Up To Week 12|Adverse Event|4|||
13429536|NCT00413660|26886813|FG006|Up To Week 12|Adverse Event|1|||
13429537|NCT00413660|26886814|FG007|Up To Week 12|Adverse Event|0|||
13429538|NCT00413660|26886815|FG008|Up To Week 12|Adverse Event|0|||
13429539|NCT00413660|26886816|FG009|Up To Week 12|Adverse Event|0|||
13429540|NCT00413660|26886817|FG010|Up To Week 12|Adverse Event|0|||
13429541|NCT00413660|26886807|FG000|Up To Week 12|Lack of Efficacy|2|||
13429542|NCT00413660|26886808|FG001|Up To Week 12|Lack of Efficacy|0|||
13429543|NCT00413660|26886809|FG002|Up To Week 12|Lack of Efficacy|0|||
13429544|NCT00413660|26886810|FG003|Up To Week 12|Lack of Efficacy|0|||
13429545|NCT00413660|26886811|FG004|Up To Week 12|Lack of Efficacy|0|||
13429546|NCT00413660|26886812|FG005|Up To Week 12|Lack of Efficacy|0|||
13429547|NCT00413660|26886813|FG006|Up To Week 12|Lack of Efficacy|5|||
13429548|NCT00413660|26886814|FG007|Up To Week 12|Lack of Efficacy|0|||
13429549|NCT00413660|26886815|FG008|Up To Week 12|Lack of Efficacy|0|||
13429550|NCT00413660|26886816|FG009|Up To Week 12|Lack of Efficacy|0|||
13429551|NCT00413660|26886817|FG010|Up To Week 12|Lack of Efficacy|0|||
13429552|NCT00413660|26886807|FG000|Up To Week 12|Lost to Follow-up|0|||
13429553|NCT00413660|26886808|FG001|Up To Week 12|Lost to Follow-up|1|||
13429554|NCT00413660|26886809|FG002|Up To Week 12|Lost to Follow-up|0|||
13429555|NCT00413660|26886810|FG003|Up To Week 12|Lost to Follow-up|0|||
13429556|NCT00413660|26886811|FG004|Up To Week 12|Lost to Follow-up|1|||
13429557|NCT00413660|26886812|FG005|Up To Week 12|Lost to Follow-up|0|||
13429558|NCT00413660|26886813|FG006|Up To Week 12|Lost to Follow-up|0|||
13429559|NCT00413660|26886814|FG007|Up To Week 12|Lost to Follow-up|0|||
13429560|NCT00413660|26886815|FG008|Up To Week 12|Lost to Follow-up|0|||
13429561|NCT00413660|26886816|FG009|Up To Week 12|Lost to Follow-up|0|||
13429562|NCT00413660|26886817|FG010|Up To Week 12|Lost to Follow-up|0|||
13429563|NCT00413660|26886807|FG000|Up To Week 12|Withdrawal by Subject|0|||
13429564|NCT00413660|26886808|FG001|Up To Week 12|Withdrawal by Subject|2|||
13429565|NCT00413660|26886809|FG002|Up To Week 12|Withdrawal by Subject|0|||
13429566|NCT00413660|26886810|FG003|Up To Week 12|Withdrawal by Subject|2|||
13429567|NCT00413660|26886811|FG004|Up To Week 12|Withdrawal by Subject|0|||
13429568|NCT00413660|26886812|FG005|Up To Week 12|Withdrawal by Subject|2|||
13429569|NCT00413660|26886813|FG006|Up To Week 12|Withdrawal by Subject|2|||
13429570|NCT00413660|26886814|FG007|Up To Week 12|Withdrawal by Subject|0|||
13429571|NCT00413660|26886815|FG008|Up To Week 12|Withdrawal by Subject|0|||
13429572|NCT00413660|26886816|FG009|Up To Week 12|Withdrawal by Subject|0|||
13429573|NCT00413660|26886817|FG010|Up To Week 12|Withdrawal by Subject|0|||
13429574|NCT00413660|26886807|FG000|Up To Week 12|Randomized, Not Treated|1|||
13429575|NCT00413660|26886808|FG001|Up To Week 12|Randomized, Not Treated|0|||
13429576|NCT00413660|26886809|FG002|Up To Week 12|Randomized, Not Treated|0|||
13429577|NCT00413660|26886810|FG003|Up To Week 12|Randomized, Not Treated|1|||
13429578|NCT00413660|26886811|FG004|Up To Week 12|Randomized, Not Treated|0|||
13429579|NCT00413660|26886812|FG005|Up To Week 12|Randomized, Not Treated|0|||
13429580|NCT00413660|26886813|FG006|Up To Week 12|Randomized, Not Treated|0|||
13429581|NCT00413660|26886814|FG007|Up To Week 12|Randomized, Not Treated|0|||
13429582|NCT00413660|26886815|FG008|Up To Week 12|Randomized, Not Treated|0|||
13429583|NCT00413660|26886816|FG009|Up To Week 12|Randomized, Not Treated|0|||
13429584|NCT00413660|26886817|FG010|Up To Week 12|Randomized, Not Treated|0|||
13429585|NCT00413660|26886807|FG000|Up To Week 12|Other|3|||
13429586|NCT00413660|26886808|FG001|Up To Week 12|Other|1|||
13429587|NCT00413660|26886809|FG002|Up To Week 12|Other|6|||
13429588|NCT00413660|26886810|FG003|Up To Week 12|Other|1|||
13429589|NCT00413660|26886811|FG004|Up To Week 12|Other|2|||
13429590|NCT00413660|26886812|FG005|Up To Week 12|Other|4|||
13429591|NCT00413660|26886813|FG006|Up To Week 12|Other|3|||
13429592|NCT00413660|26886814|FG007|Up To Week 12|Other|0|||
13429593|NCT00413660|26886815|FG008|Up To Week 12|Other|0|||
13429594|NCT00413660|26886816|FG009|Up To Week 12|Other|0|||
13429595|NCT00413660|26886817|FG010|Up To Week 12|Other|0|||
13429596|NCT00413660|26886807|FG000|Post Week 12|Adverse Event|2|||
13429597|NCT00413660|26886808|FG001|Post Week 12|Adverse Event|0|||
13429598|NCT00413660|26886809|FG002|Post Week 12|Adverse Event|2|||
13429599|NCT00413660|26886810|FG003|Post Week 12|Adverse Event|1|||
13429600|NCT00413660|26886811|FG004|Post Week 12|Adverse Event|4|||
13429601|NCT00413660|26886812|FG005|Post Week 12|Adverse Event|2|||
13429602|NCT00413660|26886813|FG006|Post Week 12|Adverse Event|2|||
13429603|NCT00413660|26886814|FG007|Post Week 12|Adverse Event|0|||
13429604|NCT00413660|26886815|FG008|Post Week 12|Adverse Event|0|||
13429605|NCT00413660|26886816|FG009|Post Week 12|Adverse Event|0|||
13429606|NCT00413660|26886817|FG010|Post Week 12|Adverse Event|0|||
13429607|NCT00413660|26886807|FG000|Post Week 12|Lack of Efficacy|0|||
13429608|NCT00413660|26886808|FG001|Post Week 12|Lack of Efficacy|0|||
13429609|NCT00413660|26886809|FG002|Post Week 12|Lack of Efficacy|1|||
13429610|NCT00413660|26886810|FG003|Post Week 12|Lack of Efficacy|0|||
13429611|NCT00413660|26886811|FG004|Post Week 12|Lack of Efficacy|0|||
13429612|NCT00413660|26886812|FG005|Post Week 12|Lack of Efficacy|0|||
13429613|NCT00413660|26886813|FG006|Post Week 12|Lack of Efficacy|0|||
13429614|NCT00413660|26886814|FG007|Post Week 12|Lack of Efficacy|0|||
13429615|NCT00413660|26886815|FG008|Post Week 12|Lack of Efficacy|0|||
13429616|NCT00413660|26886816|FG009|Post Week 12|Lack of Efficacy|1|||
13429617|NCT00413660|26886817|FG010|Post Week 12|Lack of Efficacy|0|||
13429618|NCT00413660|26886807|FG000|Post Week 12|Lost to Follow-up|0|||
13429619|NCT00413660|26886808|FG001|Post Week 12|Lost to Follow-up|1|||
13429620|NCT00413660|26886809|FG002|Post Week 12|Lost to Follow-up|1|||
13429621|NCT00413660|26886810|FG003|Post Week 12|Lost to Follow-up|0|||
13429622|NCT00413660|26886811|FG004|Post Week 12|Lost to Follow-up|0|||
13429623|NCT00413660|26886812|FG005|Post Week 12|Lost to Follow-up|0|||
13429624|NCT00413660|26886813|FG006|Post Week 12|Lost to Follow-up|0|||
13429625|NCT00413660|26886814|FG007|Post Week 12|Lost to Follow-up|0|||
13429626|NCT00413660|26886815|FG008|Post Week 12|Lost to Follow-up|0|||
13429627|NCT00413660|26886816|FG009|Post Week 12|Lost to Follow-up|0|||
13429628|NCT00413660|26886817|FG010|Post Week 12|Lost to Follow-up|0|||
13429629|NCT00413660|26886807|FG000|Post Week 12|Withdrawal by Subject|0|||
13429630|NCT00413660|26886808|FG001|Post Week 12|Withdrawal by Subject|1|||
13429631|NCT00413660|26886809|FG002|Post Week 12|Withdrawal by Subject|1|||
13429632|NCT00413660|26886810|FG003|Post Week 12|Withdrawal by Subject|0|||
13429633|NCT00413660|26886811|FG004|Post Week 12|Withdrawal by Subject|1|||
13429634|NCT00413660|26886812|FG005|Post Week 12|Withdrawal by Subject|0|||
13429635|NCT00413660|26886813|FG006|Post Week 12|Withdrawal by Subject|0|||
13429636|NCT00413660|26886814|FG007|Post Week 12|Withdrawal by Subject|0|||
13429637|NCT00413660|26886815|FG008|Post Week 12|Withdrawal by Subject|0|||
13429638|NCT00413660|26886816|FG009|Post Week 12|Withdrawal by Subject|0|||
13429639|NCT00413660|26886817|FG010|Post Week 12|Withdrawal by Subject|1|||
13429640|NCT00413660|26886807|FG000|Post Week 12|Other|1|||
13429641|NCT00413660|26886808|FG001|Post Week 12|Other|2|||
13429642|NCT00413660|26886809|FG002|Post Week 12|Other|3|||
13429643|NCT00413660|26886810|FG003|Post Week 12|Other|0|||
13429644|NCT00413660|26886811|FG004|Post Week 12|Other|1|||
13429645|NCT00413660|26886812|FG005|Post Week 12|Other|1|||
13429646|NCT00413660|26886813|FG006|Post Week 12|Other|1|||
13429647|NCT00413660|26886814|FG007|Post Week 12|Other|0|||
13429648|NCT00413660|26886815|FG008|Post Week 12|Other|0|||
13429649|NCT00413660|26886816|FG009|Post Week 12|Other|0|||
13429650|NCT00413660|26886817|FG010|Post Week 12|Other|0|||
13429651|NCT00413413|26886847|FG000|Single-Blind|Adverse Event|0|||
13429652|NCT00413413|26886848|FG001|Single-Blind|Adverse Event|9|||
13429653|NCT00413413|26886849|FG002|Single-Blind|Adverse Event|0|||
13429654|NCT00413413|26886847|FG000|Single-Blind|Lack of Efficacy|0|||
13429655|NCT00413413|26886848|FG001|Single-Blind|Lack of Efficacy|5|||
13429656|NCT00413413|26886849|FG002|Single-Blind|Lack of Efficacy|0|||
13429657|NCT00413413|26886847|FG000|Single-Blind|Subject no longer requires study drug|0|||
13429658|NCT00413413|26886848|FG001|Single-Blind|Subject no longer requires study drug|151|||
13429659|NCT00413413|26886849|FG002|Single-Blind|Subject no longer requires study drug|0|||
13429660|NCT00413413|26886847|FG000|Single-Blind|Protocol Violation|0|||
13429661|NCT00413413|26886848|FG001|Single-Blind|Protocol Violation|16|||
13429662|NCT00413413|26886849|FG002|Single-Blind|Protocol Violation|0|||
13429663|NCT00413413|26886847|FG000|Single-Blind|Withdrawal by Subject|0|||
13429664|NCT00413413|26886848|FG001|Single-Blind|Withdrawal by Subject|27|||
13429665|NCT00413413|26886849|FG002|Single-Blind|Withdrawal by Subject|0|||
13429666|NCT00413413|26886847|FG000|Single-Blind|Lost to Follow-up|0|||
13429667|NCT00413413|26886848|FG001|Single-Blind|Lost to Follow-up|8|||
13429668|NCT00413413|26886849|FG002|Single-Blind|Lost to Follow-up|0|||
13429669|NCT00413413|26886847|FG000|Double-Blind|Adverse Event|6|||
13429670|NCT00413413|26886848|FG001|Double-Blind|Adverse Event|0|||
13429671|NCT00413413|26886849|FG002|Double-Blind|Adverse Event|5|||
13429672|NCT00413413|26886847|FG000|Double-Blind|Unsatisfactory therapeutic effect|1|||
13429673|NCT00413413|26886848|FG001|Double-Blind|Unsatisfactory therapeutic effect|2|||
13429674|NCT00413413|26886849|FG002|Double-Blind|Unsatisfactory therapeutic effect|1|||
13429675|NCT00413413|26886847|FG000|Double-Blind|Protocol deviation|1|||
13429676|NCT00413413|26886848|FG001|Double-Blind|Protocol deviation|2|||
13429677|NCT00413413|26886849|FG002|Double-Blind|Protocol deviation|1|||
13429678|NCT00413413|26886847|FG000|Double-Blind|Subject withdrew consent|4|||
13429679|NCT00413413|26886848|FG001|Double-Blind|Subject withdrew consent|6|||
13429680|NCT00413413|26886849|FG002|Double-Blind|Subject withdrew consent|9|||
13429681|NCT00413413|26886847|FG000|Double-Blind|Lost to Follow-up|3|||
13429682|NCT00413413|26886848|FG001|Double-Blind|Lost to Follow-up|4|||
13429683|NCT00413413|26886849|FG002|Double-Blind|Lost to Follow-up|2|||
13429684|NCT00413374|26886866|FG000|Overall Study|Ineligible due to screening criteria.|3|||
13429685|NCT00413374|26886867|FG001|Overall Study|Ineligible due to screening criteria.|0|||
13429686|NCT00413374|26886866|FG000|Overall Study|Adverse Event|1|||
13429687|NCT00413374|26886867|FG001|Overall Study|Adverse Event|0|||
13429688|NCT00413374|26886866|FG000|Overall Study|Lost to Follow-up|1|||
13429689|NCT00413374|26886867|FG001|Overall Study|Lost to Follow-up|0|||
13429690|NCT00413374|26886866|FG000|Overall Study|Surgery|1|||
13429691|NCT00413374|26886867|FG001|Overall Study|Surgery|0|||
13429692|NCT00413283|26886910|FG000|Overall Study|Withdrawal by Subject|1|||
13429693|NCT00413283|26886911|FG001|Overall Study|Withdrawal by Subject|0|||
13429694|NCT00413283|26886912|FG002|Overall Study|Withdrawal by Subject|0|||
13429695|NCT00413283|26886913|FG003|Overall Study|Withdrawal by Subject|1|||
13429696|NCT00413283|26886910|FG000|Overall Study|Death|0|||
13429697|NCT00413283|26886911|FG001|Overall Study|Death|0|||
13429698|NCT00413283|26886912|FG002|Overall Study|Death|1|||
13429699|NCT00413283|26886913|FG003|Overall Study|Death|1|||
13429700|NCT00413283|26886910|FG000|Overall Study|Adverse Event|0|||
13429701|NCT00413283|26886911|FG001|Overall Study|Adverse Event|0|||
13429702|NCT00413283|26886912|FG002|Overall Study|Adverse Event|0|||
13429703|NCT00413283|26886913|FG003|Overall Study|Adverse Event|1|||
13429704|NCT00413283|26886910|FG000|Overall Study|Ineligibility determined|0|||
13429705|NCT00413283|26886911|FG001|Overall Study|Ineligibility determined|0|||
13429706|NCT00413283|26886912|FG002|Overall Study|Ineligibility determined|0|||
13429707|NCT00413283|26886913|FG003|Overall Study|Ineligibility determined|1|||
13429708|NCT00413283|26886910|FG000|Overall Study|Protocol deviation|0|||
13429709|NCT00413283|26886911|FG001|Overall Study|Protocol deviation|1|||
13429710|NCT00413283|26886912|FG002|Overall Study|Protocol deviation|0|||
13429711|NCT00413283|26886913|FG003|Overall Study|Protocol deviation|0|||
13429712|NCT00413283|26886910|FG000|Overall Study|Requirement for alternative therapy|0|||
13429713|NCT00413283|26886911|FG001|Overall Study|Requirement for alternative therapy|2|||
13429714|NCT00413283|26886912|FG002|Overall Study|Requirement for alternative therapy|0|||
13429715|NCT00413283|26886913|FG003|Overall Study|Requirement for alternative therapy|0|||
13429716|NCT00413283|26886910|FG000|Overall Study|Other|0|||
13429717|NCT00413283|26886911|FG001|Overall Study|Other|0|||
13429718|NCT00413283|26886912|FG002|Overall Study|Other|1|||
13429719|NCT00413283|26886913|FG003|Overall Study|Other|0|||
13429720|NCT00413244|26886948|FG000|Overall Study|Withdrawal by Subject|10|||
13429721|NCT00413244|26886949|FG001|Overall Study|Withdrawal by Subject|1|||
13429722|NCT00413231|26886981|FG000|0 to 30-day Post Treatment|Death|5|||
13429723|NCT00413231|26886981|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3|||
13429724|NCT00413231|26886981|FG000|30-day to 365-day Post Treatment|Death|13|||
13429725|NCT00413231|26886981|FG000|365-day to 60-month Post Treatment|Death|36|||
13429726|NCT00413231|26886981|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5|||
13306258|NCT01292603|26525395|FG000|Part 2: Dose Confirmation Period|Death|0|||
13429727|NCT00413231|26886981|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4|||
13429728|NCT00413231|26886981|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1|||
13476883|NCT01425008|27003740|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
13429729|NCT00413218|26887010|FG000|Overall Study|Randomized but didn't receive study drug|2|||
13429730|NCT00413218|26887011|FG001|Overall Study|Randomized but didn't receive study drug|8|||
13429731|NCT00413218|26887010|FG000|Overall Study|Death|57|||
13429732|NCT00413218|26887011|FG001|Overall Study|Death|56|||
13429733|NCT00413218|26887010|FG000|Overall Study|Lost to Follow-up|14|||
13429734|NCT00413218|26887011|FG001|Overall Study|Lost to Follow-up|17|||
13429735|NCT00413218|26887010|FG000|Overall Study|Admin|20|||
13429736|NCT00413218|26887011|FG001|Overall Study|Admin|14|||
13429737|NCT00413218|26887010|FG000|Overall Study|Missing|1|||
13429738|NCT00413218|26887011|FG001|Overall Study|Missing|0|||
13429739|NCT00413218|26887010|FG000|Overall Study|Withdrawal by Subject|9|||
13429740|NCT00413218|26887011|FG001|Overall Study|Withdrawal by Subject|1|||
13429741|NCT00413192|26887062|FG000|Overall Study|Disease progression|26|||
13429742|NCT00413192|26887063|FG001|Overall Study|Disease progression|31|||
13429743|NCT00413192|26887064|FG002|Overall Study|Disease progression|16|||
13429744|NCT00413192|26887065|FG003|Overall Study|Disease progression|25|||
13429745|NCT00413192|26887062|FG000|Overall Study|Toxicity|3|||
13429746|NCT00413192|26887063|FG001|Overall Study|Toxicity|2|||
13429747|NCT00413192|26887064|FG002|Overall Study|Toxicity|2|||
13429748|NCT00413192|26887065|FG003|Overall Study|Toxicity|2|||
13429749|NCT00413192|26887062|FG000|Overall Study|Withdrawal by Subject|3|||
13429750|NCT00413192|26887063|FG001|Overall Study|Withdrawal by Subject|5|||
13429751|NCT00413192|26887064|FG002|Overall Study|Withdrawal by Subject|0|||
13429752|NCT00413192|26887065|FG003|Overall Study|Withdrawal by Subject|1|||
13429753|NCT00413192|26887062|FG000|Overall Study|Intercurrent illness|0|||
13429754|NCT00413192|26887063|FG001|Overall Study|Intercurrent illness|0|||
13429755|NCT00413192|26887064|FG002|Overall Study|Intercurrent illness|0|||
13429756|NCT00413192|26887065|FG003|Overall Study|Intercurrent illness|1|||
13429757|NCT00413192|26887062|FG000|Overall Study|Intercurrent death|0|||
13429758|NCT00413192|26887063|FG001|Overall Study|Intercurrent death|1|||
13429759|NCT00413192|26887064|FG002|Overall Study|Intercurrent death|0|||
13429760|NCT00413192|26887065|FG003|Overall Study|Intercurrent death|0|||
13429761|NCT00413192|26887062|FG000|Overall Study|Other|5|||
13429762|NCT00413192|26887063|FG001|Overall Study|Other|1|||
13429763|NCT00413192|26887064|FG002|Overall Study|Other|1|||
13429764|NCT00413192|26887065|FG003|Overall Study|Other|2|||
13429765|NCT00413192|26887062|FG000|Overall Study|Not treated|0|||
13429766|NCT00413192|26887063|FG001|Overall Study|Not treated|0|||
13429767|NCT00413192|26887064|FG002|Overall Study|Not treated|0|||
13429768|NCT00413192|26887065|FG003|Overall Study|Not treated|1|||
13429769|NCT00413153|26887094|FG000|Overall Study|Withdrawal by Subject|1|||
13429770|NCT00413153|26887095|FG001|Overall Study|Withdrawal by Subject|1|||
13429771|NCT00413153|26887094|FG000|Overall Study|Adverse Event|1|||
13429772|NCT00413153|26887095|FG001|Overall Study|Adverse Event|0|||
13429773|NCT00413062|26887126|FG000|Overall Study|Adverse event/serious adverse event|289|||
13429774|NCT00413062|26887127|FG001|Overall Study|Adverse event/serious adverse event|56|||
13429775|NCT00413062|26887126|FG000|Overall Study|Pre-treatment (serious) adverse event|1|||
13429776|NCT00413062|26887127|FG001|Overall Study|Pre-treatment (serious) adverse event|0|||
13429777|NCT00413062|26887126|FG000|Overall Study|Withdrawal of informed consent|111|||
13429778|NCT00413062|26887127|FG001|Overall Study|Withdrawal of informed consent|36|||
13429779|NCT00413062|26887126|FG000|Overall Study|Pregnancy|15|||
13429780|NCT00413062|26887127|FG001|Overall Study|Pregnancy|5|||
13429781|NCT00413062|26887126|FG000|Overall Study|Pregnancy wish|17|||
13429782|NCT00413062|26887127|FG001|Overall Study|Pregnancy wish|6|||
13429783|NCT00413062|26887126|FG000|Overall Study|Lost to Follow-up|175|||
13429784|NCT00413062|26887127|FG001|Overall Study|Lost to Follow-up|73|||
13429785|NCT00413062|26887126|FG000|Overall Study|Other reason|70|||
13429786|NCT00413062|26887127|FG001|Overall Study|Other reason|34|||
13429787|NCT00413049|26887150|FG000|Overall Study|Adverse Event|10|||
13429788|NCT00413049|26887151|FG001|Overall Study|Adverse Event|8|||
13429789|NCT00413049|26887150|FG000|Overall Study|Withdrawal by Subject|7|||
13429790|NCT00413049|26887151|FG001|Overall Study|Withdrawal by Subject|5|||
13429791|NCT00413049|26887150|FG000|Overall Study|Lost to Follow-up|2|||
13429792|NCT00413049|26887151|FG001|Overall Study|Lost to Follow-up|3|||
13429793|NCT00413049|26887150|FG000|Overall Study|Protocol Violation|3|||
13429794|NCT00413049|26887151|FG001|Overall Study|Protocol Violation|1|||
13429795|NCT00413049|26887150|FG000|Overall Study|Subject no longer requires study drug|0|||
13429796|NCT00413049|26887151|FG001|Overall Study|Subject no longer requires study drug|1|||
13429797|NCT00413049|26887150|FG000|Overall Study|Abnormal laboratory value(s)|1|||
13429798|NCT00413049|26887151|FG001|Overall Study|Abnormal laboratory value(s)|0|||
13429799|NCT00413049|26887150|FG000|Overall Study|Lack of Efficacy|1|||
13429800|NCT00413049|26887151|FG001|Overall Study|Lack of Efficacy|0|||
13429801|NCT00413036|26887161|FG000|Overall Study|Adverse Event|44|||
13429802|NCT00413036|26887161|FG000|Overall Study|Lack of Efficacy|129|||
13429803|NCT00413036|26887161|FG000|Overall Study|Withdrawal by Subject|7|||
13429804|NCT00413036|26887161|FG000|Overall Study|Death|9|||
13429805|NCT00413036|26887161|FG000|Overall Study|Other|26|||
13429806|NCT00413036|26887161|FG000|Overall Study|Missing|2|||
13429807|NCT00413010|26887188|FG000|Overall Study|Adverse Event|8|||
13429808|NCT00413010|26887189|FG001|Overall Study|Adverse Event|4|||
13429809|NCT00413010|26887188|FG000|Overall Study|Laboratory abnormality|0|||
13429810|NCT00413010|26887189|FG001|Overall Study|Laboratory abnormality|2|||
13429811|NCT00413010|26887188|FG000|Overall Study|Lack of Efficacy|0|||
13429812|NCT00413010|26887189|FG001|Overall Study|Lack of Efficacy|3|||
13429813|NCT00413010|26887188|FG000|Overall Study|Lost to Follow-up|3|||
13429814|NCT00413010|26887189|FG001|Overall Study|Lost to Follow-up|0|||
13429815|NCT00413010|26887188|FG000|Overall Study|Withdrawal by Subject|7|||
13429816|NCT00413010|26887189|FG001|Overall Study|Withdrawal by Subject|2|||
13429817|NCT00413010|26887188|FG000|Overall Study|Due to termination of the study|54|||
13429818|NCT00413010|26887189|FG001|Overall Study|Due to termination of the study|52|||
13429819|NCT00412984|26887238|FG000|Overall Study|Death|331|||
13429820|NCT00412984|26887239|FG001|Overall Study|Death|349|||
13429821|NCT00412984|26887238|FG000|Overall Study|Adverse Event|679|||
13429822|NCT00412984|26887239|FG001|Overall Study|Adverse Event|738|||
13429823|NCT00412984|26887238|FG000|Overall Study|Withdrawal by Subject|921|||
13429824|NCT00412984|26887239|FG001|Overall Study|Withdrawal by Subject|989|||
13429825|NCT00412984|26887238|FG000|Overall Study|Lost to Follow-up|51|||
13429826|NCT00412984|26887239|FG001|Overall Study|Lost to Follow-up|39|||
13429827|NCT00412984|26887238|FG000|Overall Study|Poor/Noncompliance|57|||
13429828|NCT00412984|26887239|FG001|Overall Study|Poor/Noncompliance|77|||
13429829|NCT00412984|26887238|FG000|Overall Study|Pregnancy|1|||
13429830|NCT00412984|26887239|FG001|Overall Study|Pregnancy|0|||
13429831|NCT00412984|26887238|FG000|Overall Study|Subject No Longer Meets Study Criteria|87|||
13429832|NCT00412984|26887239|FG001|Overall Study|Subject No Longer Meets Study Criteria|100|||
13429833|NCT00412984|26887238|FG000|Overall Study|Administrative Reason by Sponsor|11|||
13429834|NCT00412984|26887239|FG001|Overall Study|Administrative Reason by Sponsor|8|||
13429835|NCT00412984|26887238|FG000|Overall Study|Physician Refused to Continue Treatment|81|||
13429836|NCT00412984|26887239|FG001|Overall Study|Physician Refused to Continue Treatment|89|||
13429837|NCT00412984|26887238|FG000|Overall Study|Other Reason|80|||
13429838|NCT00412984|26887239|FG001|Overall Study|Other Reason|92|||
13429839|NCT00412984|26887238|FG000|Overall Study|Not Reported|11|||
13429840|NCT00412984|26887239|FG001|Overall Study|Not Reported|12|||
13429841|NCT00412971|26887255|FG000|Overall Study|Lost to Follow-up|17|||
13429842|NCT00412971|26887256|FG001|Overall Study|Lost to Follow-up|9|||
13429843|NCT00412971|26887255|FG000|Overall Study|Protocol Violation|13|||
13429844|NCT00412971|26887256|FG001|Overall Study|Protocol Violation|1|||
13429845|NCT00412958|26887279|FG000|Overall Study|Withdrawal by Subject|3|||
13429846|NCT00412958|26887280|FG001|Overall Study|Withdrawal by Subject|0|||
13429847|NCT00412958|26887281|FG002|Overall Study|Withdrawal by Subject|0|||
13429848|NCT00412958|26887282|FG003|Overall Study|Withdrawal by Subject|1|||
13429849|NCT00412958|26887279|FG000|Overall Study|Adverse Event|0|||
13429850|NCT00412958|26887280|FG001|Overall Study|Adverse Event|1|||
13429851|NCT00412958|26887281|FG002|Overall Study|Adverse Event|0|||
13429852|NCT00412958|26887282|FG003|Overall Study|Adverse Event|0|||
13429853|NCT00412958|26887279|FG000|Overall Study|Lost to Follow-up|0|||
13429854|NCT00412958|26887280|FG001|Overall Study|Lost to Follow-up|1|||
13429855|NCT00412958|26887281|FG002|Overall Study|Lost to Follow-up|0|||
13429856|NCT00412958|26887282|FG003|Overall Study|Lost to Follow-up|0|||
13429857|NCT00412958|26887279|FG000|Overall Study|Death|0|||
13429858|NCT00412958|26887280|FG001|Overall Study|Death|1|||
13429859|NCT00412958|26887281|FG002|Overall Study|Death|0|||
13429860|NCT00412958|26887282|FG003|Overall Study|Death|0|||
13429861|NCT00412958|26887279|FG000|Overall Study|Transport issue|0|||
13429862|NCT00412958|26887280|FG001|Overall Study|Transport issue|1|||
13429863|NCT00412958|26887281|FG002|Overall Study|Transport issue|0|||
13429864|NCT00412958|26887282|FG003|Overall Study|Transport issue|0|||
13429865|NCT00412893|26887315|FG000|Overall Study|Adverse Event|31|||
13429866|NCT00412893|26887316|FG001|Overall Study|Adverse Event|53|||
13429867|NCT00412893|26887315|FG000|Overall Study|Death|17|||
13429868|NCT00412893|26887316|FG001|Overall Study|Death|21|||
13429869|NCT00412893|26887315|FG000|Overall Study|Insufficient Therapeutic Response|39|||
13429870|NCT00412893|26887316|FG001|Overall Study|Insufficient Therapeutic Response|23|||
13429871|NCT00412893|26887315|FG000|Overall Study|Lost to Follow-up|2|||
13429872|NCT00412893|26887316|FG001|Overall Study|Lost to Follow-up|1|||
13429873|NCT00412893|26887315|FG000|Overall Study|Violation of Selection at Entry|17|||
13429874|NCT00412893|26887316|FG001|Overall Study|Violation of Selection at Entry|10|||
13429875|NCT00412893|26887315|FG000|Overall Study|Other Protocol Violation|10|||
13429876|NCT00412893|26887316|FG001|Overall Study|Other Protocol Violation|6|||
13429877|NCT00412893|26887315|FG000|Overall Study|Did Not Cooperate|12|||
13429878|NCT00412893|26887316|FG001|Overall Study|Did Not Cooperate|9|||
13429879|NCT00412893|26887315|FG000|Overall Study|Administrative Reason|12|||
13429880|NCT00412893|26887316|FG001|Overall Study|Administrative Reason|15|||
13429881|NCT00412893|26887315|FG000|Overall Study|Randomized but Never Received Study Drug|5|||
13429882|NCT00412893|26887316|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
13429883|NCT00412880|26887328|FG000|Overall Study|Withdrew, overdose of study treatment|1|||
13219916|NCT01829230|26278638|FG001|Overall Study|Lost to Follow-up|1|||
13429884|NCT00412880|26887328|FG000|Overall Study|Consent withdrawn|1|||
13429885|NCT00412880|26887328|FG000|Overall Study|Adverse Event|1|||
13429886|NCT00412880|26887328|FG000|Overall Study|Progressive disease|20|||
13429887|NCT00412854|26887361|FG000|Overall Study|Withdrawn due to adverse events|1|||
13429888|NCT00412854|26887362|FG001|Overall Study|Withdrawn due to adverse events|5|||
13429889|NCT00412854|26887361|FG000|Overall Study|Withdrawn for other reasons|13|||
13429890|NCT00412854|26887362|FG001|Overall Study|Withdrawn for other reasons|11|||
13429891|NCT00412750|26887395|FG000|Overall Study|Abnormal laboratory value(s)|1|||
13429892|NCT00412750|26887396|FG001|Overall Study|Abnormal laboratory value(s)|0|||
13429893|NCT00412750|26887397|FG002|Overall Study|Abnormal laboratory value(s)|0|||
13429894|NCT00412750|26887395|FG000|Overall Study|Administrative problems|21|||
13429895|NCT00412750|26887396|FG001|Overall Study|Administrative problems|17|||
13429896|NCT00412750|26887397|FG002|Overall Study|Administrative problems|14|||
13429897|NCT00412750|26887395|FG000|Overall Study|Adverse Event|8|||
13429898|NCT00412750|26887396|FG001|Overall Study|Adverse Event|3|||
13429899|NCT00412750|26887397|FG002|Overall Study|Adverse Event|3|||
13429900|NCT00412750|26887395|FG000|Overall Study|Lost to Follow-up|1|||
13429901|NCT00412750|26887396|FG001|Overall Study|Lost to Follow-up|0|||
13429902|NCT00412750|26887397|FG002|Overall Study|Lost to Follow-up|1|||
13429903|NCT00412750|26887395|FG000|Overall Study|Withdrawal by Subject|0|||
13429904|NCT00412750|26887396|FG001|Overall Study|Withdrawal by Subject|1|||
13429905|NCT00412750|26887397|FG002|Overall Study|Withdrawal by Subject|2|||
13429906|NCT00412750|26887395|FG000|Overall Study|Lack of Efficacy|0|||
13429907|NCT00412750|26887396|FG001|Overall Study|Lack of Efficacy|0|||
13429908|NCT00412750|26887397|FG002|Overall Study|Lack of Efficacy|3|||
13429909|NCT00412737|26887422|FG000|Overall Study|Death|1|||
13429910|NCT00412737|26887423|FG001|Overall Study|Death|0|||
13429911|NCT00412737|26887422|FG000|Overall Study|Adverse Event|3|||
13429912|NCT00412737|26887423|FG001|Overall Study|Adverse Event|2|||
13429913|NCT00412737|26887422|FG000|Overall Study|Refused Treatment|6|||
13429914|NCT00412737|26887423|FG001|Overall Study|Refused Treatment|2|||
13429915|NCT00412737|26887422|FG000|Overall Study|Failure to Return|6|||
13429916|NCT00412737|26887423|FG001|Overall Study|Failure to Return|2|||
13429917|NCT00412607|26887436|FG000|Overall Study|Withdrawal by Subject|9|||
13429918|NCT00412607|26887436|FG000|Overall Study|Lost to Follow-up|19|||
13429919|NCT00412607|26887436|FG000|Overall Study|Death|61|||
13429920|NCT00412607|26887436|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15|||
13429921|NCT00412542|26887447|FG000|Overall Study|Withdrawal by Subject|0|||
13429922|NCT00412542|26887448|FG001|Overall Study|Withdrawal by Subject|2|||
13429923|NCT00412542|26887447|FG000|Overall Study|Not Eligible|0|||
13429924|NCT00412542|26887448|FG001|Overall Study|Not Eligible|1|||
13429925|NCT00412373|26887495|FG000|Overall Study|Adverse Event|8|||
13429926|NCT00412373|26887496|FG001|Overall Study|Adverse Event|13|||
13429927|NCT00412373|26887495|FG000|Overall Study|Lack of Efficacy|16|||
13429928|NCT00412373|26887496|FG001|Overall Study|Lack of Efficacy|22|||
13429929|NCT00412373|26887495|FG000|Overall Study|Lost to Follow-up|7|||
13429930|NCT00412373|26887496|FG001|Overall Study|Lost to Follow-up|13|||
13429931|NCT00412373|26887495|FG000|Overall Study|Withdrawal by Subject|8|||
13429932|NCT00412373|26887496|FG001|Overall Study|Withdrawal by Subject|27|||
13429933|NCT00412373|26887495|FG000|Overall Study|Other|2|||
13429934|NCT00412373|26887496|FG001|Overall Study|Other|2|||
13429935|NCT00412360|26887527|FG000|Overall Study|Lost to Follow-up|0|||
13429936|NCT00412360|26887528|FG001|Overall Study|Lost to Follow-up|1|||
13429937|NCT00412360|26887527|FG000|Overall Study|Not Transplanted|1|||
13429938|NCT00412360|26887528|FG001|Overall Study|Not Transplanted|2|||
13429939|NCT00412217|26887547|FG000|Overall Study|Insufficient Data Available|8|||
13429940|NCT00412217|26887548|FG001|Overall Study|Insufficient Data Available|3|||
13429941|NCT00412217|26887547|FG000|Overall Study|Death|5|||
13429942|NCT00412217|26887548|FG001|Overall Study|Death|4|||
13429943|NCT00412217|26887547|FG000|Overall Study|Disease Progression|2|||
13429944|NCT00412217|26887548|FG001|Overall Study|Disease Progression|3|||
13429945|NCT00412217|26887547|FG000|Overall Study|Investigator Decision|1|||
13429946|NCT00412217|26887548|FG001|Overall Study|Investigator Decision|0|||
13429947|NCT00412217|26887547|FG000|Overall Study|Withdrawal by Subject|2|||
13429948|NCT00412217|26887548|FG001|Overall Study|Withdrawal by Subject|0|||
13429949|NCT00412217|26887547|FG000|Overall Study|Lost to Follow-up|1|||
13429950|NCT00412217|26887548|FG001|Overall Study|Lost to Follow-up|4|||
13429951|NCT00412217|26887547|FG000|Overall Study|Study Terminated by Sponsor|26|||
13429952|NCT00412217|26887548|FG001|Overall Study|Study Terminated by Sponsor|33|||
13429953|NCT00412217|26887547|FG000|Overall Study|Other|1|||
13429954|NCT00412217|26887548|FG001|Overall Study|Other|1|||
13429955|NCT00412113|26887607|FG000|Overall Study|Adverse Event|11|||
13429956|NCT00412113|26887608|FG001|Overall Study|Adverse Event|15|||
13429957|NCT00412113|26887607|FG000|Overall Study|did not receive treatment|1|||
13429958|NCT00412113|26887608|FG001|Overall Study|did not receive treatment|0|||
13429959|NCT00412061|26887633|FG000|Double Blind Phase|Disease Progression|101|||
13429960|NCT00412061|26887634|FG001|Double Blind Phase|Disease Progression|154|||
13429961|NCT00412061|26887633|FG000|Double Blind Phase|Adverse Event|61|||
13429962|NCT00412061|26887634|FG001|Double Blind Phase|Adverse Event|16|||
13429963|NCT00412061|26887633|FG000|Double Blind Phase|Final Primary Analysis|26|||
13429964|NCT00412061|26887634|FG001|Double Blind Phase|Final Primary Analysis|14|||
13429965|NCT00412061|26887633|FG000|Double Blind Phase|Withdrawal by Subject|18|||
13429966|NCT00412061|26887634|FG001|Double Blind Phase|Withdrawal by Subject|20|||
13429967|NCT00412061|26887633|FG000|Double Blind Phase|Death|6|||
13429968|NCT00412061|26887634|FG001|Double Blind Phase|Death|3|||
13429969|NCT00412061|26887633|FG000|Double Blind Phase|Protocol Violation|3|||
13429970|NCT00412061|26887634|FG001|Double Blind Phase|Protocol Violation|4|||
13429971|NCT00412061|26887633|FG000|Double Blind Phase|New Cander Therapy|1|||
13429972|NCT00412061|26887634|FG001|Double Blind Phase|New Cander Therapy|1|||
13429973|NCT00412061|26887633|FG000|Double Blind Phase|Lost to Follow-up|0|||
13429974|NCT00412061|26887634|FG001|Double Blind Phase|Lost to Follow-up|1|||
13429975|NCT00412061|26887633|FG000|Open Label Phase|Disease Progression|0|||
13429976|NCT00412061|26887634|FG001|Open Label Phase|Disease Progression|86|||
13429977|NCT00412061|26887633|FG000|Open Label Phase|Adverse Event|0|||
13429978|NCT00412061|26887634|FG001|Open Label Phase|Adverse Event|46|||
13429979|NCT00412061|26887633|FG000|Open Label Phase|Withdrawal by Subject|0|||
13429980|NCT00412061|26887634|FG001|Open Label Phase|Withdrawal by Subject|15|||
13429981|NCT00412061|26887633|FG000|Open Label Phase|Administrative Problems|0|||
13429982|NCT00412061|26887634|FG001|Open Label Phase|Administrative Problems|13|||
13429983|NCT00412061|26887633|FG000|Open Label Phase|Death|0|||
13429984|NCT00412061|26887634|FG001|Open Label Phase|Death|7|||
13429985|NCT00412061|26887633|FG000|Open Label Phase|Lost to Follow-up|0|||
13429986|NCT00412061|26887634|FG001|Open Label Phase|Lost to Follow-up|2|||
13429987|NCT00412061|26887633|FG000|Open Label Phase|New Cancer Therapy|0|||
13429988|NCT00412061|26887634|FG001|Open Label Phase|New Cancer Therapy|1|||
13429989|NCT00411788|26887645|FG000|Overall Study|Protocol Violation|1|||
13429990|NCT00411788|26887645|FG000|Overall Study|Adverse Event|1|||
13429991|NCT00411762|26887652|FG000|Overall Study|Withdrawal by Subject|5|||
13429992|NCT00411671|26887660|FG000|Overall Study|Adverse Event|15|||
13429993|NCT00411671|26887660|FG000|Overall Study|Death|2|||
13429994|NCT00411671|26887660|FG000|Overall Study|Lost to Follow-up|3|||
13429995|NCT00411645|26887691|FG000|Overall Study|Consent Withdrawn|13|||
13429996|NCT00411645|26887692|FG001|Overall Study|Consent Withdrawn|22|||
13429997|NCT00411645|26887691|FG000|Overall Study|Death|56|||
13429998|NCT00411645|26887692|FG001|Overall Study|Death|135|||
13429999|NCT00411645|26887691|FG000|Overall Study|Investigator/Sponsor Decision|10|||
13430000|NCT00411645|26887692|FG001|Overall Study|Investigator/Sponsor Decision|7|||
13430001|NCT00411645|26887691|FG000|Overall Study|Lost to Follow-up|2|||
13430002|NCT00411645|26887692|FG001|Overall Study|Lost to Follow-up|0|||
13430003|NCT00411632|26887698|FG000|Overall Study|Death|1|||
13430004|NCT00411554|26887715|FG000|Overall Study|Adverse Event|2|||
13430005|NCT00411554|26887716|FG001|Overall Study|Adverse Event|4|||
13430006|NCT00411554|26887715|FG000|Overall Study|Lack of Efficacy|2|||
13430007|NCT00411554|26887716|FG001|Overall Study|Lack of Efficacy|5|||
13430008|NCT00411554|26887715|FG000|Overall Study|Withdrawal by Subject|3|||
13430009|NCT00411554|26887716|FG001|Overall Study|Withdrawal by Subject|0|||
13430010|NCT00411554|26887715|FG000|Overall Study|Patient Moved|1|||
13430011|NCT00411554|26887716|FG001|Overall Study|Patient Moved|0|||
13430012|NCT00411450|26887744|FG000|Overall Study|Ongoing at time of data cut-off.|3|||
13430013|NCT00411216|26887757|FG000|Overall Study|Ten participants were entered into the c|0|||
13430014|NCT00411216|26887758|FG001|Overall Study|Ten participants were entered into the c|2|||
13430015|NCT00411151|26887770|FG000|Overall Study|Death|38|||
13430016|NCT00411151|26887770|FG000|Overall Study|Withdrawal by Subject|2|||
13430017|NCT00411151|26887770|FG000|Overall Study|Lost to Follow-up|2|||
13430018|NCT00411151|26887770|FG000|Overall Study|Protocol Violation|1|||
13430019|NCT00411151|26887770|FG000|Overall Study|Trial prematurely closed|4|||
13430020|NCT00410813|26887812|FG000|Overall Study|Adverse Event|6|||
13430021|NCT00410813|26887813|FG001|Overall Study|Adverse Event|11|||
13430022|NCT00410813|26887812|FG000|Overall Study|Progression|32|||
13430023|NCT00410813|26887813|FG001|Overall Study|Progression|21|||
13430024|NCT00410813|26887812|FG000|Overall Study|Not protocol specified|3|||
13430025|NCT00410813|26887813|FG001|Overall Study|Not protocol specified|4|||
13430026|NCT00410813|26887812|FG000|Overall Study|Ineligible|2|||
13430027|NCT00410813|26887813|FG001|Overall Study|Ineligible|4|||
13430028|NCT00410813|26887812|FG000|Overall Study|Death|0|||
13430029|NCT00410813|26887813|FG001|Overall Study|Death|2|||
13430030|NCT00410761|26887840|FG000|Overall Study|Adverse Event|29|||
13430031|NCT00410761|26887841|FG001|Overall Study|Adverse Event|3|||
13430032|NCT00410761|26887840|FG000|Overall Study|objective disease progression|71|||
13430033|NCT00410761|26887841|FG001|Overall Study|objective disease progression|55|||
13430034|NCT00410761|26887840|FG000|Overall Study|Withdrawal by Subject|8|||
13430035|NCT00410761|26887841|FG001|Overall Study|Withdrawal by Subject|4|||
13430036|NCT00410761|26887840|FG000|Overall Study|Other|12|||
13430037|NCT00410761|26887841|FG001|Overall Study|Other|9|||
13430038|NCT00410761|26887840|FG000|Overall Study|Never received randomised treatment|0|||
13430039|NCT00410761|26887841|FG001|Overall Study|Never received randomised treatment|1|||
13430040|NCT00410605|26887852|FG000|Overall Study|Adverse Event|12|||
13430041|NCT00410605|26887852|FG000|Overall Study|Physician Decision|3|||
13430042|NCT00410605|26887852|FG000|Overall Study|Withdrawal by Subject|5|||
13430043|NCT00410605|26887852|FG000|Overall Study|Started Non-Protocol Therapy|3|||
13430044|NCT00410605|26887852|FG000|Overall Study|Stopped treatmen to collect stem cells|1|||
13430045|NCT00410605|26887852|FG000|Overall Study|Transferred to another Institution|1|||
13430046|NCT00410514|26887921|FG000|Overall Study|Adverse Event|2|||
13430047|NCT00410514|26887922|FG001|Overall Study|Adverse Event|2|||
13430048|NCT00410514|26887923|FG002|Overall Study|Adverse Event|2|||
13430049|NCT00410514|26887921|FG000|Overall Study|Protocol Violation|0|||
13430050|NCT00410514|26887922|FG001|Overall Study|Protocol Violation|1|||
13430051|NCT00410514|26887923|FG002|Overall Study|Protocol Violation|1|||
13430052|NCT00410514|26887921|FG000|Overall Study|Lost to Follow-up|0|||
13430053|NCT00410514|26887922|FG001|Overall Study|Lost to Follow-up|0|||
13430054|NCT00410514|26887923|FG002|Overall Study|Lost to Follow-up|2|||
13430055|NCT00410514|26887921|FG000|Overall Study|Non-compliant with study procedures|0|||
13430056|NCT00410514|26887922|FG001|Overall Study|Non-compliant with study procedures|0|||
13430057|NCT00410514|26887923|FG002|Overall Study|Non-compliant with study procedures|2|||
13430058|NCT00410410|26888103|FG000|Induction Period (IP)|Death|1|||
13430059|NCT00410410|26888104|FG001|Induction Period (IP)|Death|0|||
13430060|NCT00410410|26888105|FG002|Induction Period (IP)|Death|0|||
13430061|NCT00410410|26888106|FG003|Induction Period (IP)|Death|0|||
13430062|NCT00410410|26888107|FG004|Induction Period (IP)|Death|0|||
13430063|NCT00410410|26888108|FG005|Induction Period (IP)|Death|0|||
13430064|NCT00410410|26888109|FG006|Induction Period (IP)|Death|0|||
13430065|NCT00410410|26888110|FG007|Induction Period (IP)|Death|0|||
13430066|NCT00410410|26888111|FG008|Induction Period (IP)|Death|0|||
13430067|NCT00410410|26888103|FG000|Induction Period (IP)|Adverse Event|3|||
13430068|NCT00410410|26888104|FG001|Induction Period (IP)|Adverse Event|4|||
13430069|NCT00410410|26888105|FG002|Induction Period (IP)|Adverse Event|2|||
13430070|NCT00410410|26888106|FG003|Induction Period (IP)|Adverse Event|4|||
13430071|NCT00410410|26888107|FG004|Induction Period (IP)|Adverse Event|1|||
13430072|NCT00410410|26888108|FG005|Induction Period (IP)|Adverse Event|0|||
13430073|NCT00410410|26888109|FG006|Induction Period (IP)|Adverse Event|0|||
13430074|NCT00410410|26888110|FG007|Induction Period (IP)|Adverse Event|0|||
13430075|NCT00410410|26888111|FG008|Induction Period (IP)|Adverse Event|0|||
13430076|NCT00410410|26888103|FG000|Induction Period (IP)|Lack of Efficacy|26|||
13430077|NCT00410410|26888104|FG001|Induction Period (IP)|Lack of Efficacy|24|||
13430078|NCT00410410|26888105|FG002|Induction Period (IP)|Lack of Efficacy|8|||
13430079|NCT00410410|26888106|FG003|Induction Period (IP)|Lack of Efficacy|8|||
13430080|NCT00410410|26888107|FG004|Induction Period (IP)|Lack of Efficacy|7|||
13430081|NCT00410410|26888108|FG005|Induction Period (IP)|Lack of Efficacy|7|||
13430082|NCT00410410|26888109|FG006|Induction Period (IP)|Lack of Efficacy|0|||
13430083|NCT00410410|26888110|FG007|Induction Period (IP)|Lack of Efficacy|0|||
13430084|NCT00410410|26888111|FG008|Induction Period (IP)|Lack of Efficacy|0|||
13430085|NCT00410410|26888103|FG000|Induction Period (IP)|Lost to Follow-up|2|||
13430086|NCT00410410|26888104|FG001|Induction Period (IP)|Lost to Follow-up|2|||
13430087|NCT00410410|26888105|FG002|Induction Period (IP)|Lost to Follow-up|2|||
13430088|NCT00410410|26888106|FG003|Induction Period (IP)|Lost to Follow-up|3|||
13430089|NCT00410410|26888107|FG004|Induction Period (IP)|Lost to Follow-up|0|||
13430090|NCT00410410|26888108|FG005|Induction Period (IP)|Lost to Follow-up|1|||
13430091|NCT00410410|26888109|FG006|Induction Period (IP)|Lost to Follow-up|0|||
13430092|NCT00410410|26888110|FG007|Induction Period (IP)|Lost to Follow-up|0|||
13430093|NCT00410410|26888111|FG008|Induction Period (IP)|Lost to Follow-up|0|||
13430094|NCT00410410|26888103|FG000|Induction Period (IP)|Withdrawal by Subject|3|||
13430095|NCT00410410|26888104|FG001|Induction Period (IP)|Withdrawal by Subject|5|||
13430096|NCT00410410|26888105|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
13430097|NCT00410410|26888106|FG003|Induction Period (IP)|Withdrawal by Subject|5|||
13430098|NCT00410410|26888107|FG004|Induction Period (IP)|Withdrawal by Subject|2|||
13430099|NCT00410410|26888108|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
13430100|NCT00410410|26888109|FG006|Induction Period (IP)|Withdrawal by Subject|0|||
13430101|NCT00410410|26888110|FG007|Induction Period (IP)|Withdrawal by Subject|0|||
13430102|NCT00410410|26888111|FG008|Induction Period (IP)|Withdrawal by Subject|0|||
13430103|NCT00410410|26888103|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
13430104|NCT00410410|26888104|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
13430105|NCT00410410|26888105|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1|||
13430106|NCT00410410|26888106|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
13430107|NCT00410410|26888107|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
13430108|NCT00410410|26888108|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
13430109|NCT00410410|26888109|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
13430110|NCT00410410|26888110|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
13430111|NCT00410410|26888111|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
13430112|NCT00410410|26888103|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0|||
13430113|NCT00410410|26888104|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0|||
13430114|NCT00410410|26888105|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0|||
13430115|NCT00410410|26888106|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0|||
13430116|NCT00410410|26888107|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22|||
13430117|NCT00410410|26888108|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21|||
13430118|NCT00410410|26888109|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0|||
13430119|NCT00410410|26888110|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0|||
13430120|NCT00410410|26888111|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0|||
13430121|NCT00410410|26888103|FG000|Induction Period (IP)|Other|0|||
13430122|NCT00410410|26888104|FG001|Induction Period (IP)|Other|0|||
13430123|NCT00410410|26888105|FG002|Induction Period (IP)|Other|1|||
13430124|NCT00410410|26888106|FG003|Induction Period (IP)|Other|0|||
13430125|NCT00410410|26888107|FG004|Induction Period (IP)|Other|0|||
13430126|NCT00410410|26888108|FG005|Induction Period (IP)|Other|0|||
13430127|NCT00410410|26888109|FG006|Induction Period (IP)|Other|0|||
13430128|NCT00410410|26888110|FG007|Induction Period (IP)|Other|0|||
13430129|NCT00410410|26888111|FG008|Induction Period (IP)|Other|0|||
13430130|NCT00410410|26888103|FG000|Maintenance Period (MP)|Death|0|||
13430131|NCT00410410|26888104|FG001|Maintenance Period (MP)|Death|0|||
13430132|NCT00410410|26888105|FG002|Maintenance Period (MP)|Death|0|||
13430133|NCT00410410|26888106|FG003|Maintenance Period (MP)|Death|0|||
13430134|NCT00410410|26888107|FG004|Maintenance Period (MP)|Death|0|||
13430135|NCT00410410|26888108|FG005|Maintenance Period (MP)|Death|0|||
13430136|NCT00410410|26888109|FG006|Maintenance Period (MP)|Death|1|||
13430137|NCT00410410|26888110|FG007|Maintenance Period (MP)|Death|0|||
13430138|NCT00410410|26888111|FG008|Maintenance Period (MP)|Death|0|||
13430139|NCT00410410|26888103|FG000|Maintenance Period (MP)|Adverse Event|0|||
13430140|NCT00410410|26888104|FG001|Maintenance Period (MP)|Adverse Event|0|||
13430141|NCT00410410|26888105|FG002|Maintenance Period (MP)|Adverse Event|0|||
13430142|NCT00410410|26888106|FG003|Maintenance Period (MP)|Adverse Event|0|||
13430143|NCT00410410|26888107|FG004|Maintenance Period (MP)|Adverse Event|0|||
13430144|NCT00410410|26888108|FG005|Maintenance Period (MP)|Adverse Event|0|||
13430145|NCT00410410|26888109|FG006|Maintenance Period (MP)|Adverse Event|1|||
13430146|NCT00410410|26888110|FG007|Maintenance Period (MP)|Adverse Event|3|||
13430147|NCT00410410|26888111|FG008|Maintenance Period (MP)|Adverse Event|0|||
13430148|NCT00410410|26888103|FG000|Maintenance Period (MP)|Lack of Efficacy|0|||
13430149|NCT00410410|26888104|FG001|Maintenance Period (MP)|Lack of Efficacy|0|||
13430150|NCT00410410|26888105|FG002|Maintenance Period (MP)|Lack of Efficacy|0|||
13430151|NCT00410410|26888106|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
13430152|NCT00410410|26888107|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
13430153|NCT00410410|26888108|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
13430154|NCT00410410|26888109|FG006|Maintenance Period (MP)|Lack of Efficacy|25|||
13430155|NCT00410410|26888110|FG007|Maintenance Period (MP)|Lack of Efficacy|24|||
13430156|NCT00410410|26888111|FG008|Maintenance Period (MP)|Lack of Efficacy|0|||
13430157|NCT00410410|26888103|FG000|Maintenance Period (MP)|Lost to Follow-up|0|||
13430158|NCT00410410|26888104|FG001|Maintenance Period (MP)|Lost to Follow-up|0|||
13430159|NCT00410410|26888105|FG002|Maintenance Period (MP)|Lost to Follow-up|0|||
13430160|NCT00410410|26888106|FG003|Maintenance Period (MP)|Lost to Follow-up|0|||
13430161|NCT00410410|26888107|FG004|Maintenance Period (MP)|Lost to Follow-up|0|||
13430162|NCT00410410|26888108|FG005|Maintenance Period (MP)|Lost to Follow-up|0|||
13430163|NCT00410410|26888109|FG006|Maintenance Period (MP)|Lost to Follow-up|1|||
13430164|NCT00410410|26888110|FG007|Maintenance Period (MP)|Lost to Follow-up|2|||
13430165|NCT00410410|26888111|FG008|Maintenance Period (MP)|Lost to Follow-up|0|||
13430166|NCT00410410|26888103|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
13430167|NCT00410410|26888104|FG001|Maintenance Period (MP)|Withdrawal by Subject|0|||
13430168|NCT00410410|26888105|FG002|Maintenance Period (MP)|Withdrawal by Subject|0|||
13430169|NCT00410410|26888106|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
13430170|NCT00410410|26888107|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
13430171|NCT00410410|26888108|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
13430172|NCT00410410|26888109|FG006|Maintenance Period (MP)|Withdrawal by Subject|1|||
13430173|NCT00410410|26888110|FG007|Maintenance Period (MP)|Withdrawal by Subject|1|||
13430174|NCT00410410|26888111|FG008|Maintenance Period (MP)|Withdrawal by Subject|0|||
13430175|NCT00410410|26888103|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
13430176|NCT00410410|26888104|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
13430177|NCT00410410|26888105|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
13430178|NCT00410410|26888106|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
13430179|NCT00410410|26888107|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
13430180|NCT00410410|26888108|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
13430181|NCT00410410|26888109|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21|||
13430182|NCT00410410|26888110|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25|||
13430183|NCT00410410|26888111|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
13430184|NCT00410410|26888103|FG000|Open-Label Period (OL)|Death|0|||
13430185|NCT00410410|26888104|FG001|Open-Label Period (OL)|Death|0|||
13430186|NCT00410410|26888105|FG002|Open-Label Period (OL)|Death|0|||
13430187|NCT00410410|26888106|FG003|Open-Label Period (OL)|Death|0|||
13430188|NCT00410410|26888107|FG004|Open-Label Period (OL)|Death|0|||
13430189|NCT00410410|26888108|FG005|Open-Label Period (OL)|Death|0|||
13430190|NCT00410410|26888109|FG006|Open-Label Period (OL)|Death|0|||
13430191|NCT00410410|26888110|FG007|Open-Label Period (OL)|Death|0|||
13430192|NCT00410410|26888111|FG008|Open-Label Period (OL)|Death|1|||
13430193|NCT00410410|26888103|FG000|Open-Label Period (OL)|Adverse Event|0|||
13430194|NCT00410410|26888104|FG001|Open-Label Period (OL)|Adverse Event|0|||
13430195|NCT00410410|26888105|FG002|Open-Label Period (OL)|Adverse Event|0|||
13430196|NCT00410410|26888106|FG003|Open-Label Period (OL)|Adverse Event|0|||
13430197|NCT00410410|26888107|FG004|Open-Label Period (OL)|Adverse Event|0|||
13430198|NCT00410410|26888108|FG005|Open-Label Period (OL)|Adverse Event|0|||
13430199|NCT00410410|26888109|FG006|Open-Label Period (OL)|Adverse Event|0|||
13430200|NCT00410410|26888110|FG007|Open-Label Period (OL)|Adverse Event|0|||
13430201|NCT00410410|26888111|FG008|Open-Label Period (OL)|Adverse Event|10|||
13430202|NCT00410410|26888103|FG000|Open-Label Period (OL)|Lack of Efficacy|0|||
13430203|NCT00410410|26888104|FG001|Open-Label Period (OL)|Lack of Efficacy|0|||
13430204|NCT00410410|26888105|FG002|Open-Label Period (OL)|Lack of Efficacy|0|||
13430205|NCT00410410|26888106|FG003|Open-Label Period (OL)|Lack of Efficacy|0|||
13430206|NCT00410410|26888107|FG004|Open-Label Period (OL)|Lack of Efficacy|0|||
13430207|NCT00410410|26888108|FG005|Open-Label Period (OL)|Lack of Efficacy|0|||
13430208|NCT00410410|26888109|FG006|Open-Label Period (OL)|Lack of Efficacy|0|||
13430209|NCT00410410|26888110|FG007|Open-Label Period (OL)|Lack of Efficacy|0|||
13430210|NCT00410410|26888111|FG008|Open-Label Period (OL)|Lack of Efficacy|161|||
13430211|NCT00410410|26888103|FG000|Open-Label Period (OL)|Lost to Follow-up|0|||
13430212|NCT00410410|26888104|FG001|Open-Label Period (OL)|Lost to Follow-up|0|||
13430213|NCT00410410|26888105|FG002|Open-Label Period (OL)|Lost to Follow-up|0|||
13430214|NCT00410410|26888106|FG003|Open-Label Period (OL)|Lost to Follow-up|0|||
13430215|NCT00410410|26888107|FG004|Open-Label Period (OL)|Lost to Follow-up|0|||
13430216|NCT00410410|26888108|FG005|Open-Label Period (OL)|Lost to Follow-up|0|||
13430217|NCT00410410|26888109|FG006|Open-Label Period (OL)|Lost to Follow-up|0|||
13430218|NCT00410410|26888110|FG007|Open-Label Period (OL)|Lost to Follow-up|0|||
13430219|NCT00410410|26888111|FG008|Open-Label Period (OL)|Lost to Follow-up|4|||
13430220|NCT00410410|26888103|FG000|Open-Label Period (OL)|Withdrawal by Subject|0|||
13430221|NCT00410410|26888104|FG001|Open-Label Period (OL)|Withdrawal by Subject|0|||
13430222|NCT00410410|26888105|FG002|Open-Label Period (OL)|Withdrawal by Subject|0|||
13430223|NCT00410410|26888106|FG003|Open-Label Period (OL)|Withdrawal by Subject|0|||
13430224|NCT00410410|26888107|FG004|Open-Label Period (OL)|Withdrawal by Subject|0|||
13430225|NCT00410410|26888108|FG005|Open-Label Period (OL)|Withdrawal by Subject|0|||
13430226|NCT00410410|26888109|FG006|Open-Label Period (OL)|Withdrawal by Subject|0|||
13430227|NCT00410410|26888110|FG007|Open-Label Period (OL)|Withdrawal by Subject|0|||
13430228|NCT00410410|26888111|FG008|Open-Label Period (OL)|Withdrawal by Subject|20|||
13430229|NCT00410410|26888103|FG000|Open-Label Period (OL)|Pregnancy|0|||
13430230|NCT00410410|26888104|FG001|Open-Label Period (OL)|Pregnancy|0|||
13430231|NCT00410410|26888105|FG002|Open-Label Period (OL)|Pregnancy|0|||
13430232|NCT00410410|26888106|FG003|Open-Label Period (OL)|Pregnancy|0|||
13430233|NCT00410410|26888107|FG004|Open-Label Period (OL)|Pregnancy|0|||
13430234|NCT00410410|26888108|FG005|Open-Label Period (OL)|Pregnancy|0|||
13430235|NCT00410410|26888109|FG006|Open-Label Period (OL)|Pregnancy|0|||
13430236|NCT00410410|26888110|FG007|Open-Label Period (OL)|Pregnancy|0|||
13430237|NCT00410410|26888111|FG008|Open-Label Period (OL)|Pregnancy|1|||
13430238|NCT00410410|26888103|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
13430239|NCT00410410|26888104|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
13430240|NCT00410410|26888105|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
13430241|NCT00410410|26888106|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
13430242|NCT00410410|26888107|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
13430243|NCT00410410|26888108|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
13430244|NCT00410410|26888109|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
13430245|NCT00410410|26888110|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
13430246|NCT00410410|26888111|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145|||
13430247|NCT00410410|26888103|FG000|Open-Label Period (OL)|Other|0|||
13430248|NCT00410410|26888104|FG001|Open-Label Period (OL)|Other|0|||
13430249|NCT00410410|26888105|FG002|Open-Label Period (OL)|Other|0|||
13430250|NCT00410410|26888106|FG003|Open-Label Period (OL)|Other|0|||
13430251|NCT00410410|26888107|FG004|Open-Label Period (OL)|Other|0|||
13430252|NCT00410410|26888108|FG005|Open-Label Period (OL)|Other|0|||
13430253|NCT00410410|26888109|FG006|Open-Label Period (OL)|Other|0|||
13430254|NCT00410410|26888110|FG007|Open-Label Period (OL)|Other|0|||
13430255|NCT00410410|26888111|FG008|Open-Label Period (OL)|Other|7|||
13430256|NCT00410384|26888147|FG000|Overall Study|Withdrawal by Subject|28|||
13430257|NCT00410384|26888148|FG001|Overall Study|Withdrawal by Subject|17|||
13430258|NCT00410384|26888149|FG002|Overall Study|Withdrawal by Subject|20|||
13430259|NCT00410384|26888147|FG000|Overall Study|Adverse Event|23|||
13430260|NCT00410384|26888148|FG001|Overall Study|Adverse Event|18|||
13430261|NCT00410384|26888149|FG002|Overall Study|Adverse Event|23|||
13430262|NCT00410384|26888147|FG000|Overall Study|Lack of Efficacy|20|||
13430263|NCT00410384|26888148|FG001|Overall Study|Lack of Efficacy|12|||
13430264|NCT00410384|26888149|FG002|Overall Study|Lack of Efficacy|17|||
13430265|NCT00410384|26888147|FG000|Overall Study|Lack of Compliance|2|||
13430266|NCT00410384|26888148|FG001|Overall Study|Lack of Compliance|2|||
13430267|NCT00410384|26888149|FG002|Overall Study|Lack of Compliance|2|||
13430268|NCT00410384|26888147|FG000|Overall Study|Lost to Follow-up|4|||
13430269|NCT00410384|26888148|FG001|Overall Study|Lost to Follow-up|6|||
13430270|NCT00410384|26888149|FG002|Overall Study|Lost to Follow-up|6|||
13430271|NCT00410384|26888147|FG000|Overall Study|Protocol Violation|6|||
13430272|NCT00410384|26888148|FG001|Overall Study|Protocol Violation|6|||
13430273|NCT00410384|26888149|FG002|Overall Study|Protocol Violation|6|||
13430274|NCT00410384|26888147|FG000|Overall Study|Physician Decision|3|||
13430275|NCT00410384|26888148|FG001|Overall Study|Physician Decision|3|||
13430276|NCT00410384|26888149|FG002|Overall Study|Physician Decision|4|||
13430277|NCT00410384|26888147|FG000|Overall Study|Other|3|||
13430278|NCT00410384|26888148|FG001|Overall Study|Other|8|||
13430279|NCT00410384|26888149|FG002|Overall Study|Other|4|||
13430280|NCT00410202|26888239|FG000|On-Treatment|Continuing treatment|69|||
13430281|NCT00410202|26888240|FG001|On-Treatment|Continuing treatment|71|||
13430282|NCT00410202|26888241|FG002|On-Treatment|Continuing treatment|66|||
13430283|NCT00410202|26888239|FG000|On-Treatment|Adverse Event|1|||
13430284|NCT00410202|26888240|FG001|On-Treatment|Adverse Event|3|||
13430285|NCT00410202|26888241|FG002|On-Treatment|Adverse Event|2|||
13430286|NCT00410202|26888239|FG000|On-Treatment|Death|1|||
13430287|NCT00410202|26888240|FG001|On-Treatment|Death|0|||
13430288|NCT00410202|26888241|FG002|On-Treatment|Death|0|||
13430289|NCT00410202|26888239|FG000|On-Treatment|Lost to Follow-up|1|||
13430290|NCT00410202|26888240|FG001|On-Treatment|Lost to Follow-up|0|||
13430291|NCT00410202|26888241|FG002|On-Treatment|Lost to Follow-up|1|||
13430292|NCT00410202|26888239|FG000|On-Treatment|Lack of Efficacy|1|||
13430293|NCT00410202|26888240|FG001|On-Treatment|Lack of Efficacy|4|||
13430294|NCT00410202|26888241|FG002|On-Treatment|Lack of Efficacy|0|||
13430295|NCT00410202|26888239|FG000|On-Treatment|Withdrawal by Subject|2|||
13430296|NCT00410202|26888240|FG001|On-Treatment|Withdrawal by Subject|1|||
13430297|NCT00410202|26888241|FG002|On-Treatment|Withdrawal by Subject|1|||
13430298|NCT00410202|26888239|FG000|On-Treatment|Other Reason|0|||
13430299|NCT00410202|26888240|FG001|On-Treatment|Other Reason|0|||
13430300|NCT00410202|26888241|FG002|On-Treatment|Other Reason|1|||
13430301|NCT00410202|26888239|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10|||
13430302|NCT00410202|26888240|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8|||
13430303|NCT00410202|26888241|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11|||
13430304|NCT00410202|26888239|FG000|Off-treatment Follow up|Follow up not required per protocol|3|||
13430305|NCT00410202|26888240|FG001|Off-treatment Follow up|Follow up not required per protocol|0|||
13430306|NCT00410202|26888241|FG002|Off-treatment Follow up|Follow up not required per protocol|1|||
13430307|NCT00410202|26888239|FG000|Off-treatment Follow up|Lost to Follow-up|1|||
13430308|NCT00410202|26888240|FG001|Off-treatment Follow up|Lost to Follow-up|0|||
13430309|NCT00410202|26888241|FG002|Off-treatment Follow up|Lost to Follow-up|0|||
13430310|NCT00410163|26888290|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4|||
13430311|NCT00410163|26888291|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2|||
13430312|NCT00410163|26888290|FG000|Treatment and Follow-up Phase (2 Years)|Death|1|||
13430313|NCT00410163|26888291|FG001|Treatment and Follow-up Phase (2 Years)|Death|1|||
13430314|NCT00410163|26888290|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2|||
13430315|NCT00410163|26888291|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1|||
13430316|NCT00410163|26888290|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0|||
13430317|NCT00410163|26888291|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4|||
13430318|NCT00410163|26888290|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2|||
13430319|NCT00410163|26888291|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1|||
13430320|NCT00410163|26888290|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1|||
13430321|NCT00410163|26888291|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0|||
13430322|NCT00410163|26888290|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
13430323|NCT00410163|26888291|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
13430324|NCT00410163|26888290|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1|||
13430325|NCT00410163|26888291|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0|||
13430326|NCT00410163|26888290|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0|||
13430327|NCT00410163|26888291|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1|||
13430328|NCT00410163|26888290|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3|||
13430329|NCT00410163|26888291|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1|||
13430330|NCT00410163|26888290|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
13430331|NCT00410163|26888291|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
13430332|NCT00410163|26888290|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1|||
13430333|NCT00410163|26888291|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0|||
13430334|NCT00410163|26888290|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4|||
13430335|NCT00410163|26888291|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8|||
13430336|NCT00410163|26888290|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1|||
13430337|NCT00410163|26888291|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0|||
13430338|NCT00410124|26888327|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36|||
13430339|NCT00410124|26888328|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2|||
13430340|NCT00410124|26888327|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1|||
13430341|NCT00410124|26888328|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0|||
13430342|NCT00410124|26888327|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2|||
13430343|NCT00410124|26888328|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1|||
13430344|NCT00410124|26888327|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13|||
13430345|NCT00410124|26888328|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2|||
13430346|NCT00410124|26888327|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4|||
13430347|NCT00410124|26888328|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0|||
13430348|NCT00410124|26888327|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2|||
13430349|NCT00410124|26888328|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0|||
13430350|NCT00410124|26888327|FG000|Core Phase Double Blind (15 Months)|Death|7|||
13430351|NCT00410124|26888328|FG001|Core Phase Double Blind (15 Months)|Death|4|||
13430352|NCT00410124|26888327|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137|||
13430353|NCT00410124|26888328|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124|||
13430354|NCT00410124|26888327|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7|||
13430355|NCT00410124|26888328|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19|||
13430356|NCT00410124|26888327|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0|||
13430357|NCT00410124|26888328|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1|||
13430358|NCT00410124|26888327|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0|||
13430359|NCT00410124|26888328|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1|||
13430360|NCT00410124|26888327|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
13430361|NCT00410124|26888328|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
13430362|NCT00410124|26888327|FG000|Extension Phase - Open Label (45 Months)|Death|2|||
13430363|NCT00410124|26888328|FG001|Extension Phase - Open Label (45 Months)|Death|10|||
13430364|NCT00410124|26888327|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56|||
13430365|NCT00410124|26888328|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78|||
13430366|NCT00410124|26888327|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1|||
13430367|NCT00410124|26888328|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0|||
13430368|NCT00410124|26888327|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0|||
13430369|NCT00410124|26888328|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1|||
13430370|NCT00410072|26888371|FG000|Day 1 to Week 48|Adverse Event|1|||
13430371|NCT00410072|26888372|FG001|Day 1 to Week 48|Adverse Event|2|||
13430372|NCT00410072|26888371|FG000|Day 1 to Week 48|Lost to Follow-up|5|||
13430373|NCT00410072|26888372|FG001|Day 1 to Week 48|Lost to Follow-up|2|||
13430374|NCT00410072|26888371|FG000|Day 1 to Week 48|Other|0|||
13430375|NCT00410072|26888372|FG001|Day 1 to Week 48|Other|1|||
13430376|NCT00410072|26888371|FG000|Day 1 to Week 48|poor compliance/noncompliance|0|||
13430377|NCT00410072|26888372|FG001|Day 1 to Week 48|poor compliance/noncompliance|3|||
13430378|NCT00410072|26888371|FG000|Day 1 to Week 48|Pregnancy|0|||
13430379|NCT00410072|26888372|FG001|Day 1 to Week 48|Pregnancy|2|||
13430380|NCT00410072|26888371|FG000|Day 1 to Week 48|Withdrawal by Subject|0|||
13430381|NCT00410072|26888372|FG001|Day 1 to Week 48|Withdrawal by Subject|2|||
13430382|NCT00410072|26888371|FG000|After Week 48 to Week 96|Adverse Event|1|||
13430383|NCT00410072|26888372|FG001|After Week 48 to Week 96|Adverse Event|2|||
13430384|NCT00410072|26888371|FG000|After Week 48 to Week 96|Death|0|||
13430385|NCT00410072|26888372|FG001|After Week 48 to Week 96|Death|1|||
13430386|NCT00410072|26888371|FG000|After Week 48 to Week 96|Lack of Efficacy|1|||
13430387|NCT00410072|26888372|FG001|After Week 48 to Week 96|Lack of Efficacy|0|||
13430388|NCT00410072|26888371|FG000|After Week 48 to Week 96|Lost to Follow-up|2|||
13430389|NCT00410072|26888372|FG001|After Week 48 to Week 96|Lost to Follow-up|4|||
13430390|NCT00410072|26888371|FG000|After Week 48 to Week 96|Other|2|||
13430391|NCT00410072|26888372|FG001|After Week 48 to Week 96|Other|0|||
13430392|NCT00410072|26888371|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0|||
13430393|NCT00410072|26888372|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1|||
13430394|NCT00410072|26888371|FG000|After Week 48 to Week 96|Pregnancy|0|||
13430395|NCT00410072|26888372|FG001|After Week 48 to Week 96|Pregnancy|2|||
13430396|NCT00410072|26888371|FG000|After Week 48 to Week 96|Withdrawal by Subject|0|||
13430397|NCT00410072|26888372|FG001|After Week 48 to Week 96|Withdrawal by Subject|1|||
13430398|NCT00410046|26888403|FG000|Overall Study|Adverse Event|3|||
13430399|NCT00410046|26888403|FG000|Overall Study|Withdrawal by Subject|1|||
13430400|NCT00410046|26888403|FG000|Overall Study|Lost to Follow-up|1|||
13430401|NCT00409838|26888471|FG000|Short-term Period|Adverse Event|0|||
13430402|NCT00409838|26888472|FG001|Short-term Period|Adverse Event|1|||
13430403|NCT00409838|26888471|FG000|Short-term Period|Lost to Follow-up|0|||
13430404|NCT00409838|26888472|FG001|Short-term Period|Lost to Follow-up|1|||
13430405|NCT00409838|26888471|FG000|Short-term Period|Withdrawal by Subject|2|||
13430406|NCT00409838|26888472|FG001|Short-term Period|Withdrawal by Subject|3|||
13430407|NCT00409838|26888471|FG000|Short-term Period|Never Treated|1|||
13430408|NCT00409838|26888472|FG001|Short-term Period|Never Treated|0|||
13430409|NCT00409838|26888471|FG000|Long-term Extension Period|Adverse Event|10|||
13430410|NCT00409838|26888472|FG001|Long-term Extension Period|Adverse Event|0|||
13430411|NCT00409838|26888471|FG000|Long-term Extension Period|Death|1|||
13430412|NCT00409838|26888472|FG001|Long-term Extension Period|Death|0|||
13430413|NCT00409838|26888471|FG000|Long-term Extension Period|Lack of Efficacy|2|||
13430414|NCT00409838|26888472|FG001|Long-term Extension Period|Lack of Efficacy|0|||
13430415|NCT00409838|26888471|FG000|Long-term Extension Period|Withdrawal by Subject|3|||
13430416|NCT00409838|26888472|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
13430417|NCT00409838|26888471|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
13430418|NCT00409838|26888472|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
13430419|NCT00409838|26888471|FG000|Long-term Extension Period|Pregnancy|1|||
13430420|NCT00409838|26888472|FG001|Long-term Extension Period|Pregnancy|0|||
13430421|NCT00409786|26888478|FG000|Overall Study|Withdrawal by Subject|3|||
13430422|NCT00409747|26888485|FG000|Overall Study|Withdrawal by Subject|1|||
13430423|NCT00409708|26888510|FG000|Treatment|Abnormal test procedure result(s)|1|||
13430424|NCT00409708|26888511|FG001|Treatment|Abnormal test procedure result(s)|0|||
13430425|NCT00409708|26888510|FG000|Treatment|Lack of Efficacy|0|||
13430426|NCT00409708|26888511|FG001|Treatment|Lack of Efficacy|1|||
13430427|NCT00409708|26888510|FG000|Treatment|Protocol Violation|6|||
13430428|NCT00409708|26888511|FG001|Treatment|Protocol Violation|2|||
13430429|NCT00409708|26888510|FG000|Treatment|Withdrawal by Subject|3|||
13430430|NCT00409708|26888511|FG001|Treatment|Withdrawal by Subject|8|||
13430431|NCT00409708|26888510|FG000|Treatment|Lost to Follow-up|0|||
13430432|NCT00409708|26888511|FG001|Treatment|Lost to Follow-up|6|||
13430433|NCT00409708|26888510|FG000|Treatment|Administrative problems|5|||
13430434|NCT00409708|26888511|FG001|Treatment|Administrative problems|0|||
13430435|NCT00409708|26888510|FG000|Washout|Lack of Efficacy|9|||
13430436|NCT00409708|26888511|FG001|Washout|Lack of Efficacy|1|||
13430437|NCT00409708|26888510|FG000|Washout|Protocol Violation|0|||
13430438|NCT00409708|26888511|FG001|Washout|Protocol Violation|1|||
13430439|NCT00409708|26888510|FG000|Washout|Withdrawal by Subject|11|||
13430440|NCT00409708|26888511|FG001|Washout|Withdrawal by Subject|5|||
13430441|NCT00409708|26888510|FG000|Washout|Lost to Follow-up|1|||
13430442|NCT00409708|26888511|FG001|Washout|Lost to Follow-up|3|||
13430443|NCT00409682|26888538|FG000|Open-label Induction Period|Adverse Event|1|||
13430444|NCT00409682|26888539|FG001|Open-label Induction Period|Adverse Event|0|||
13430445|NCT00409682|26888540|FG002|Open-label Induction Period|Adverse Event|0|||
13430446|NCT00409682|26888538|FG000|Open-label Induction Period|Lack of Efficacy|1|||
13430447|NCT00409682|26888539|FG001|Open-label Induction Period|Lack of Efficacy|0|||
13430448|NCT00409682|26888540|FG002|Open-label Induction Period|Lack of Efficacy|0|||
13430449|NCT00409682|26888538|FG000|Open-label Induction Period|Protocol Violation|1|||
13430450|NCT00409682|26888539|FG001|Open-label Induction Period|Protocol Violation|0|||
13430451|NCT00409682|26888540|FG002|Open-label Induction Period|Protocol Violation|0|||
13430452|NCT00409682|26888538|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1|||
13430453|NCT00409682|26888539|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
13430454|NCT00409682|26888540|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
13430455|NCT00409682|26888538|FG000|EOW Double-blind Maintenance Period|Adverse Event|0|||
13430456|NCT00409682|26888539|FG001|EOW Double-blind Maintenance Period|Adverse Event|10|||
13430457|NCT00409682|26888540|FG002|EOW Double-blind Maintenance Period|Adverse Event|12|||
13430458|NCT00409682|26888538|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0|||
13430459|NCT00409682|26888539|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18|||
13430460|NCT00409682|26888540|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11|||
13430461|NCT00409682|26888538|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
13430462|NCT00409682|26888539|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1|||
13430463|NCT00409682|26888540|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
13430464|NCT00409682|26888538|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0|||
13430465|NCT00409682|26888539|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4|||
13430466|NCT00409682|26888540|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2|||
13430467|NCT00409682|26888538|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0|||
13430468|NCT00409682|26888539|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4|||
13430469|NCT00409682|26888540|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1|||
13430470|NCT00409682|26888538|FG000|EOW Double-blind Maintenance Period|Non-compliance|0|||
13430471|NCT00409682|26888539|FG001|EOW Double-blind Maintenance Period|Non-compliance|0|||
13430472|NCT00409682|26888540|FG002|EOW Double-blind Maintenance Period|Non-compliance|1|||
13430473|NCT00409617|26888554|FG000|Overall Study|Adverse Event|57|||
13430474|NCT00409617|26888554|FG000|Overall Study|Lack of Efficacy|54|||
13430475|NCT00409617|26888554|FG000|Overall Study|Lost to Follow-up|2|||
13430476|NCT00409617|26888554|FG000|Overall Study|Protocol Violation|24|||
13430477|NCT00409617|26888554|FG000|Overall Study|Withdrawal by Subject|8|||
13430478|NCT00409617|26888554|FG000|Overall Study|Administrative reasons|1|||
13430479|NCT00409617|26888554|FG000|Overall Study|Not described|14|||
13430480|NCT00409578|26888589|FG000|Overall Study|Adverse Event|27|||
13430481|NCT00409578|26888590|FG001|Overall Study|Adverse Event|37|||
13430482|NCT00409578|26888591|FG002|Overall Study|Adverse Event|25|||
13430483|NCT00409578|26888592|FG003|Overall Study|Adverse Event|33|||
13430484|NCT00409578|26888589|FG000|Overall Study|Abnormal laboratory value(s)|2|||
13430485|NCT00409578|26888590|FG001|Overall Study|Abnormal laboratory value(s)|2|||
13430486|NCT00409578|26888591|FG002|Overall Study|Abnormal laboratory value(s)|2|||
13430487|NCT00409578|26888592|FG003|Overall Study|Abnormal laboratory value(s)|4|||
13430488|NCT00409578|26888589|FG000|Overall Study|Lack of Efficacy|0|||
13430489|NCT00409578|26888590|FG001|Overall Study|Lack of Efficacy|0|||
13430490|NCT00409578|26888591|FG002|Overall Study|Lack of Efficacy|0|||
13430491|NCT00409578|26888592|FG003|Overall Study|Lack of Efficacy|2|||
13430492|NCT00409578|26888589|FG000|Overall Study|Subject no longer requires study drug|0|||
13430493|NCT00409578|26888590|FG001|Overall Study|Subject no longer requires study drug|0|||
13430494|NCT00409578|26888591|FG002|Overall Study|Subject no longer requires study drug|0|||
13430495|NCT00409578|26888592|FG003|Overall Study|Subject no longer requires study drug|1|||
13430496|NCT00409578|26888589|FG000|Overall Study|Withdrawal by Subject|8|||
13430497|NCT00409578|26888590|FG001|Overall Study|Withdrawal by Subject|15|||
13430498|NCT00409578|26888591|FG002|Overall Study|Withdrawal by Subject|16|||
13430499|NCT00409578|26888592|FG003|Overall Study|Withdrawal by Subject|17|||
13430500|NCT00409578|26888589|FG000|Overall Study|Lost to Follow-up|2|||
13430501|NCT00409578|26888590|FG001|Overall Study|Lost to Follow-up|0|||
13430502|NCT00409578|26888591|FG002|Overall Study|Lost to Follow-up|2|||
13430503|NCT00409578|26888592|FG003|Overall Study|Lost to Follow-up|2|||
13430504|NCT00409578|26888589|FG000|Overall Study|Administrative problems|8|||
13430505|NCT00409578|26888590|FG001|Overall Study|Administrative problems|9|||
13430506|NCT00409578|26888591|FG002|Overall Study|Administrative problems|2|||
13430507|NCT00409578|26888592|FG003|Overall Study|Administrative problems|4|||
13430508|NCT00409578|26888589|FG000|Overall Study|Death|2|||
13430509|NCT00409578|26888590|FG001|Overall Study|Death|4|||
13430510|NCT00409578|26888591|FG002|Overall Study|Death|4|||
13430511|NCT00409578|26888592|FG003|Overall Study|Death|2|||
13430512|NCT00409578|26888589|FG000|Overall Study|Protocol Violation|3|||
13430513|NCT00409578|26888590|FG001|Overall Study|Protocol Violation|2|||
13430514|NCT00409578|26888591|FG002|Overall Study|Protocol Violation|3|||
13430515|NCT00409578|26888592|FG003|Overall Study|Protocol Violation|1|||
13430516|NCT00409578|26888589|FG000|Overall Study|Missing|0|||
13430517|NCT00409578|26888590|FG001|Overall Study|Missing|1|||
13430518|NCT00409578|26888591|FG002|Overall Study|Missing|0|||
13430519|NCT00409578|26888592|FG003|Overall Study|Missing|1|||
13430520|NCT00409409|26888605|FG000|Overall Study|Adverse Event|7|||
13430521|NCT00409409|26888606|FG001|Overall Study|Adverse Event|2|||
13430522|NCT00409409|26888605|FG000|Overall Study|Withdrawal by Subject|1|||
13430523|NCT00409409|26888606|FG001|Overall Study|Withdrawal by Subject|1|||
13430524|NCT00409409|26888605|FG000|Overall Study|Any other reason not above-mentioned|0|||
13430525|NCT00409409|26888606|FG001|Overall Study|Any other reason not above-mentioned|1|||
13430526|NCT00409344|26888631|FG000|Overall Study|no enrollment|0|||
13430527|NCT00409344|26888632|FG001|Overall Study|no enrollment|0|||
13430528|NCT00409331|26888638|FG000|Overall Study|Physician Decision|1|||
13430529|NCT00409188|26888659|FG000|Overall Study|Ongoing at data cut-off|383|||
13430530|NCT00409188|26888660|FG001|Overall Study|Ongoing at data cut-off|175|||
13430531|NCT00409175|26888691|FG000|Overall Study|Adverse Event|4|||
13430532|NCT00409175|26888692|FG001|Overall Study|Adverse Event|3|||
13430533|NCT00409175|26888691|FG000|Overall Study|Withdrawal by Subject|1|||
13430534|NCT00409175|26888692|FG001|Overall Study|Withdrawal by Subject|2|||
13430535|NCT00409175|26888691|FG000|Overall Study|Negative genotype|0|||
13430536|NCT00409175|26888692|FG001|Overall Study|Negative genotype|1|||
13430537|NCT00409175|26888691|FG000|Overall Study|Liver transplantation|13|||
13430538|NCT00409175|26888692|FG001|Overall Study|Liver transplantation|13|||
13430539|NCT00409006|26888713|FG000|Overall Study|Death|15|||
13430540|NCT00409006|26888714|FG001|Overall Study|Death|6|||
13430541|NCT00409006|26888713|FG000|Overall Study|Lost to Follow-up|1|||
13430542|NCT00409006|26888714|FG001|Overall Study|Lost to Follow-up|2|||
13430543|NCT00409006|26888713|FG000|Overall Study|Withdrawal by Subject|3|||
13430544|NCT00409006|26888714|FG001|Overall Study|Withdrawal by Subject|2|||
13430545|NCT00409006|26888713|FG000|Overall Study|Physician Decision|1|||
13430546|NCT00409006|26888714|FG001|Overall Study|Physician Decision|2|||
13430547|NCT00408993|26888753|FG000|Overall Study|Adverse Event|15|||
13430548|NCT00408993|26888754|FG001|Overall Study|Adverse Event|4|||
13430549|NCT00408993|26888753|FG000|Overall Study|Protocol Violation|1|||
13430550|NCT00408993|26888754|FG001|Overall Study|Protocol Violation|6|||
13430551|NCT00408993|26888753|FG000|Overall Study|Lack of Efficacy|1|||
13430552|NCT00408993|26888754|FG001|Overall Study|Lack of Efficacy|4|||
13430553|NCT00408993|26888753|FG000|Overall Study|Withdrawal by Subject|2|||
13430554|NCT00408993|26888754|FG001|Overall Study|Withdrawal by Subject|3|||
13430555|NCT00408928|26888761|FG000|Overall Study|Withdrawal by Subject|1|||
13430556|NCT00408928|26888761|FG000|Overall Study|Death|1|||
13430557|NCT00408928|26888761|FG000|Overall Study|Infection indistinguishable from GVHD|1|||
13430558|NCT00408902|26888769|FG000|Overall Study|Lack of Efficacy|7|||
13430559|NCT00408902|26888769|FG000|Overall Study|Adverse Event|3|||
13430560|NCT00408876|26889032|FG000|Overall Study|Adverse Event|9|||
13430561|NCT00408876|26889033|FG001|Overall Study|Adverse Event|17|||
13430562|NCT00408876|26889034|FG002|Overall Study|Adverse Event|27|||
13430563|NCT00408876|26889035|FG003|Overall Study|Adverse Event|10|||
13430564|NCT00408876|26889032|FG000|Overall Study|Withdrawal by Subject|3|||
13430565|NCT00408876|26889033|FG001|Overall Study|Withdrawal by Subject|6|||
13430566|NCT00408876|26889034|FG002|Overall Study|Withdrawal by Subject|6|||
13430567|NCT00408876|26889035|FG003|Overall Study|Withdrawal by Subject|14|||
13430568|NCT00408876|26889032|FG000|Overall Study|Lack of Efficacy|2|||
13430569|NCT00408876|26889033|FG001|Overall Study|Lack of Efficacy|4|||
13430570|NCT00408876|26889034|FG002|Overall Study|Lack of Efficacy|5|||
13430571|NCT00408876|26889035|FG003|Overall Study|Lack of Efficacy|6|||
13430572|NCT00408876|26889032|FG000|Overall Study|Lost to Follow-up|1|||
13430573|NCT00408876|26889033|FG001|Overall Study|Lost to Follow-up|6|||
13430574|NCT00408876|26889034|FG002|Overall Study|Lost to Follow-up|5|||
13430575|NCT00408876|26889035|FG003|Overall Study|Lost to Follow-up|2|||
13430576|NCT00408876|26889032|FG000|Overall Study|Protocol Violation|0|||
13430577|NCT00408876|26889033|FG001|Overall Study|Protocol Violation|3|||
13430578|NCT00408876|26889034|FG002|Overall Study|Protocol Violation|4|||
13430579|NCT00408876|26889035|FG003|Overall Study|Protocol Violation|3|||
13430580|NCT00408876|26889032|FG000|Overall Study|Physician Decision|1|||
13430581|NCT00408876|26889033|FG001|Overall Study|Physician Decision|0|||
13430582|NCT00408876|26889034|FG002|Overall Study|Physician Decision|3|||
13430583|NCT00408876|26889035|FG003|Overall Study|Physician Decision|0|||
13430584|NCT00408694|26889049|FG000|Overall Study|Ineligible|1|||
13430585|NCT00408694|26889049|FG000|Overall Study|No protocol treatment|1|||
13430586|NCT00408681|26889068|FG000|Overall Study|Lack of Efficacy|2|||
13430587|NCT00408681|26889068|FG000|Overall Study|Adverse Event|7|||
13430588|NCT00408629|26889114|FG000|Overall Study|Adverse Event|13|||
13430589|NCT00408629|26889115|FG001|Overall Study|Adverse Event|27|||
13430590|NCT00408629|26889114|FG000|Overall Study|Withdrawal by Subject|8|||
13430591|NCT00408629|26889115|FG001|Overall Study|Withdrawal by Subject|4|||
13430592|NCT00408629|26889114|FG000|Overall Study|Lost to Follow-up|1|||
13430593|NCT00408629|26889115|FG001|Overall Study|Lost to Follow-up|1|||
13430594|NCT00408629|26889114|FG000|Overall Study|Lack of Efficacy|63|||
13430595|NCT00408629|26889115|FG001|Overall Study|Lack of Efficacy|73|||
13430596|NCT00408629|26889114|FG000|Overall Study|Protocol Violation|1|||
13430597|NCT00408629|26889115|FG001|Overall Study|Protocol Violation|5|||
13430598|NCT00408629|26889114|FG000|Overall Study|Miscellaneous|11|||
13430599|NCT00408629|26889115|FG001|Overall Study|Miscellaneous|15|||
13430600|NCT00408499|26889130|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0|||
13430601|NCT00408499|26889131|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0|||
13430602|NCT00408499|26889132|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1|||
13430603|NCT00408499|26889133|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0|||
13430604|NCT00408499|26889134|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0|||
13430605|NCT00408499|26889130|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
13430606|NCT00408499|26889131|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
13430607|NCT00408499|26889132|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
13430608|NCT00408499|26889133|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
13430609|NCT00408499|26889134|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
13430610|NCT00408499|26889130|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1|||
13430611|NCT00408499|26889131|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1|||
13430612|NCT00408499|26889132|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0|||
13430613|NCT00408499|26889133|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0|||
13430614|NCT00408499|26889134|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0|||
13430615|NCT00408499|26889130|FG000|Phase II- MTD Expansion|Adverse Event|0|||
13430616|NCT00408499|26889131|FG001|Phase II- MTD Expansion|Adverse Event|0|||
13430617|NCT00408499|26889132|FG002|Phase II- MTD Expansion|Adverse Event|0|||
13430618|NCT00408499|26889133|FG003|Phase II- MTD Expansion|Adverse Event|0|||
13430619|NCT00408499|26889134|FG004|Phase II- MTD Expansion|Adverse Event|9|||
13430620|NCT00408499|26889130|FG000|Phase II- MTD Expansion|Death|0|||
13430621|NCT00408499|26889131|FG001|Phase II- MTD Expansion|Death|0|||
13430622|NCT00408499|26889132|FG002|Phase II- MTD Expansion|Death|0|||
13430623|NCT00408499|26889133|FG003|Phase II- MTD Expansion|Death|0|||
13430624|NCT00408499|26889134|FG004|Phase II- MTD Expansion|Death|2|||
13430625|NCT00408499|26889130|FG000|Phase II- MTD Expansion|Physician Decision|0|||
13430626|NCT00408499|26889131|FG001|Phase II- MTD Expansion|Physician Decision|0|||
13430627|NCT00408499|26889132|FG002|Phase II- MTD Expansion|Physician Decision|0|||
13430628|NCT00408499|26889133|FG003|Phase II- MTD Expansion|Physician Decision|0|||
13430629|NCT00408499|26889134|FG004|Phase II- MTD Expansion|Physician Decision|1|||
13430630|NCT00408499|26889130|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0|||
13430631|NCT00408499|26889131|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0|||
13430632|NCT00408499|26889132|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0|||
13430633|NCT00408499|26889133|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0|||
13430634|NCT00408499|26889134|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5|||
13430635|NCT00408499|26889130|FG000|Phase II- MTD Expansion|treatment delay|0|||
13430636|NCT00408499|26889131|FG001|Phase II- MTD Expansion|treatment delay|0|||
13430637|NCT00408499|26889132|FG002|Phase II- MTD Expansion|treatment delay|0|||
13430638|NCT00408499|26889133|FG003|Phase II- MTD Expansion|treatment delay|0|||
13430639|NCT00408499|26889134|FG004|Phase II- MTD Expansion|treatment delay|3|||
13430640|NCT00408434|26889201|FG000|Overall Study|Adverse Event|0|||
13430641|NCT00408434|26889202|FG001|Overall Study|Adverse Event|0|||
13430642|NCT00408434|26889203|FG002|Overall Study|Adverse Event|1|||
13430643|NCT00408434|26889204|FG003|Overall Study|Adverse Event|0|||
13430644|NCT00408434|26889205|FG004|Overall Study|Adverse Event|0|||
13430645|NCT00408434|26889206|FG005|Overall Study|Adverse Event|0|||
13430646|NCT00408434|26889207|FG006|Overall Study|Adverse Event|0|||
13430647|NCT00408434|26889201|FG000|Overall Study|Progressive disease|6|||
13430648|NCT00408434|26889202|FG001|Overall Study|Progressive disease|3|||
13430649|NCT00408434|26889203|FG002|Overall Study|Progressive disease|4|||
13430650|NCT00408434|26889204|FG003|Overall Study|Progressive disease|3|||
13430651|NCT00408434|26889205|FG004|Overall Study|Progressive disease|3|||
13430652|NCT00408434|26889206|FG005|Overall Study|Progressive disease|1|||
13430653|NCT00408434|26889207|FG006|Overall Study|Progressive disease|4|||
13430654|NCT00408434|26889201|FG000|Overall Study|Other|0|||
13430655|NCT00408434|26889202|FG001|Overall Study|Other|0|||
13430656|NCT00408434|26889203|FG002|Overall Study|Other|1|||
13430657|NCT00408434|26889204|FG003|Overall Study|Other|0|||
13430658|NCT00408434|26889205|FG004|Overall Study|Other|2|||
13430659|NCT00408434|26889206|FG005|Overall Study|Other|1|||
13430660|NCT00408434|26889207|FG006|Overall Study|Other|0|||
13430661|NCT00408434|26889201|FG000|Overall Study|Terminated by Investigator|0|||
13430662|NCT00408434|26889202|FG001|Overall Study|Terminated by Investigator|0|||
13430663|NCT00408434|26889203|FG002|Overall Study|Terminated by Investigator|0|||
13430664|NCT00408434|26889204|FG003|Overall Study|Terminated by Investigator|0|||
13430665|NCT00408434|26889205|FG004|Overall Study|Terminated by Investigator|1|||
13430666|NCT00408434|26889206|FG005|Overall Study|Terminated by Investigator|1|||
13430667|NCT00408434|26889207|FG006|Overall Study|Terminated by Investigator|0|||
13430668|NCT00408421|26889289|FG000|Treatment Initial Randomization|Adverse Event|5|||
13430669|NCT00408421|26889290|FG001|Treatment Initial Randomization|Adverse Event|9|||
13430670|NCT00408421|26889291|FG002|Treatment Initial Randomization|Adverse Event|0|||
13430671|NCT00408421|26889289|FG000|Treatment Initial Randomization|Lack of Efficacy|2|||
13430672|NCT00408421|26889290|FG001|Treatment Initial Randomization|Lack of Efficacy|2|||
13430673|NCT00408421|26889291|FG002|Treatment Initial Randomization|Lack of Efficacy|0|||
13430674|NCT00408421|26889289|FG000|Treatment Initial Randomization|Lost to Follow-up|0|||
13430675|NCT00408421|26889290|FG001|Treatment Initial Randomization|Lost to Follow-up|3|||
13430676|NCT00408421|26889291|FG002|Treatment Initial Randomization|Lost to Follow-up|0|||
13430677|NCT00408421|26889289|FG000|Treatment Initial Randomization|Physician Decision|1|||
13430678|NCT00408421|26889290|FG001|Treatment Initial Randomization|Physician Decision|0|||
13430679|NCT00408421|26889291|FG002|Treatment Initial Randomization|Physician Decision|0|||
13430680|NCT00408421|26889289|FG000|Treatment Initial Randomization|Protocol Violation|0|||
13430681|NCT00408421|26889290|FG001|Treatment Initial Randomization|Protocol Violation|1|||
13430682|NCT00408421|26889291|FG002|Treatment Initial Randomization|Protocol Violation|0|||
13430683|NCT00408421|26889289|FG000|Treatment Initial Randomization|Withdrawal by Subject|7|||
13430684|NCT00408421|26889290|FG001|Treatment Initial Randomization|Withdrawal by Subject|7|||
13430685|NCT00408421|26889291|FG002|Treatment Initial Randomization|Withdrawal by Subject|0|||
13430686|NCT00408421|26889289|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1|||
13430687|NCT00408421|26889290|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0|||
13430688|NCT00408421|26889291|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0|||
13430689|NCT00408421|26889289|FG000|Treatment Initial Randomization|Sponsor Decision|1|||
13430690|NCT00408421|26889290|FG001|Treatment Initial Randomization|Sponsor Decision|0|||
13430691|NCT00408421|26889291|FG002|Treatment Initial Randomization|Sponsor Decision|0|||
13430692|NCT00408421|26889289|FG000|Treatment Re-Randomization|Adverse Event|2|||
13430693|NCT00408421|26889290|FG001|Treatment Re-Randomization|Adverse Event|2|||
13430694|NCT00408421|26889291|FG002|Treatment Re-Randomization|Adverse Event|4|||
13430695|NCT00408421|26889289|FG000|Treatment Re-Randomization|Lack of Efficacy|1|||
13430696|NCT00408421|26889290|FG001|Treatment Re-Randomization|Lack of Efficacy|0|||
13430697|NCT00408421|26889291|FG002|Treatment Re-Randomization|Lack of Efficacy|0|||
13430698|NCT00408421|26889289|FG000|Treatment Re-Randomization|Lost to Follow-up|0|||
13430699|NCT00408421|26889290|FG001|Treatment Re-Randomization|Lost to Follow-up|0|||
13430700|NCT00408421|26889291|FG002|Treatment Re-Randomization|Lost to Follow-up|1|||
13430701|NCT00408421|26889289|FG000|Treatment Re-Randomization|Physician Decision|1|||
13430702|NCT00408421|26889290|FG001|Treatment Re-Randomization|Physician Decision|3|||
13430703|NCT00408421|26889291|FG002|Treatment Re-Randomization|Physician Decision|0|||
13430704|NCT00408421|26889289|FG000|Treatment Re-Randomization|Protocol Violation|1|||
13430705|NCT00408421|26889290|FG001|Treatment Re-Randomization|Protocol Violation|1|||
13430706|NCT00408421|26889291|FG002|Treatment Re-Randomization|Protocol Violation|0|||
13430707|NCT00408421|26889289|FG000|Treatment Re-Randomization|Withdrawal by Subject|2|||
13430708|NCT00408421|26889290|FG001|Treatment Re-Randomization|Withdrawal by Subject|1|||
13430709|NCT00408421|26889291|FG002|Treatment Re-Randomization|Withdrawal by Subject|0|||
13430710|NCT00408408|26889372|FG000|Overall Study|No follow up data|2|||
13430711|NCT00408408|26889373|FG001|Overall Study|No follow up data|3|||
13430712|NCT00408408|26889374|FG002|Overall Study|No follow up data|0|||
13430713|NCT00408408|26889375|FG003|Overall Study|No follow up data|7|||
13430714|NCT00408408|26889376|FG004|Overall Study|No follow up data|5|||
13430715|NCT00408408|26889377|FG005|Overall Study|No follow up data|3|||
13430716|NCT00408317|26889392|FG000|First Intervention Period|Adverse Event|0|||
13430717|NCT00408317|26889393|FG001|First Intervention Period|Adverse Event|1|||
13430718|NCT00408317|26889392|FG000|Second Intervention Period|Adverse Event|2|||
13430719|NCT00408317|26889393|FG001|Second Intervention Period|Adverse Event|0|||
13430720|NCT00408317|26889392|FG000|Second Intervention Period|Protocol Violation|0|||
13430721|NCT00408317|26889393|FG001|Second Intervention Period|Protocol Violation|1|||
13430722|NCT00408317|26889392|FG000|Second Intervention Period|Withdrawal of consent|0|||
13430723|NCT00408317|26889393|FG001|Second Intervention Period|Withdrawal of consent|1|||
13430724|NCT00407797|26889410|FG000|Overall Study|Lost to Follow-up|2|||
13430725|NCT00407797|26889410|FG000|Overall Study|Adverse Event|6|||
13430726|NCT00407797|26889410|FG000|Overall Study|Other|7|||
13430727|NCT00407797|26889410|FG000|Overall Study|Withdrawal by Subject|3|||
13430728|NCT00407758|26889423|FG000|Overall Study|ineligible -improper prior treatment|1|||
13430729|NCT00407745|26889502|FG000|Overall Study|Lack of Efficacy|1|||
13430730|NCT00407745|26889503|FG001|Overall Study|Lack of Efficacy|2|||
13430731|NCT00407745|26889502|FG000|Overall Study|Withdrawal by Subject|3|||
13430732|NCT00407745|26889503|FG001|Overall Study|Withdrawal by Subject|3|||
13430733|NCT00407745|26889502|FG000|Overall Study|Protocol Violation|5|||
13430734|NCT00407745|26889503|FG001|Overall Study|Protocol Violation|3|||
13430735|NCT00407745|26889502|FG000|Overall Study|Adverse Event|8|||
13430736|NCT00407745|26889503|FG001|Overall Study|Adverse Event|8|||
13430737|NCT00407745|26889502|FG000|Overall Study|Other|2|||
13430738|NCT00407745|26889503|FG001|Overall Study|Other|0|||
13430739|NCT00407745|26889502|FG000|Overall Study|Randomized, unknown if treated|0|||
13430740|NCT00407745|26889503|FG001|Overall Study|Randomized, unknown if treated|1|||
13430741|NCT00407563|26889513|FG000|Overall Study|Patient continues on treatment|1|||
13430742|NCT00407550|26889532|FG000|Overall Study|Adverse Event|0|||
13430743|NCT00407550|26889533|FG001|Overall Study|Adverse Event|1|||
13430744|NCT00407550|26889532|FG000|Overall Study|Withdrawal by Subject|0|||
13430745|NCT00407550|26889533|FG001|Overall Study|Withdrawal by Subject|2|||
13430746|NCT00407550|26889532|FG000|Overall Study|Death|1|||
13430747|NCT00407550|26889533|FG001|Overall Study|Death|0|||
13430748|NCT00407550|26889532|FG000|Overall Study|Insurance or Other medical condition|2|||
13430749|NCT00407550|26889533|FG001|Overall Study|Insurance or Other medical condition|1|||
13430750|NCT00407537|26889588|FG000|Overall Study|Death|5|||
13430751|NCT00407537|26889589|FG001|Overall Study|Death|2|||
13430752|NCT00407537|26889588|FG000|Overall Study|Adverse Event|36|||
13430753|NCT00407537|26889589|FG001|Overall Study|Adverse Event|0|||
13430754|NCT00407537|26889588|FG000|Overall Study|Lost to Follow-up|12|||
13430755|NCT00407537|26889589|FG001|Overall Study|Lost to Follow-up|19|||
13430756|NCT00407537|26889588|FG000|Overall Study|Other|6|||
13430757|NCT00407537|26889589|FG001|Overall Study|Other|7|||
13430758|NCT00407537|26889588|FG000|Overall Study|Withdrawal by Subject|34|||
13430759|NCT00407537|26889589|FG001|Overall Study|Withdrawal by Subject|16|||
13430760|NCT00407511|26889605|FG000|Overall Study|Adverse Event|9|||
13430761|NCT00407511|26889605|FG000|Overall Study|Lost to Follow-up|4|||
13430762|NCT00407511|26889605|FG000|Overall Study|Other|5|||
13430763|NCT00407511|26889605|FG000|Overall Study|Withdrawal by Subject|4|||
13430764|NCT00407030|26889641|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2|||
13430765|NCT00407030|26889642|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1|||
13430766|NCT00407030|26889643|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0|||
13430767|NCT00407030|26889641|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
13430768|NCT00407030|26889642|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
13430769|NCT00407030|26889643|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3|||
13430770|NCT00407030|26889641|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
13430771|NCT00407030|26889642|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
13430772|NCT00407030|26889643|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
13430773|NCT00407030|26889641|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
13430774|NCT00407030|26889642|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
13430775|NCT00407030|26889643|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
13430776|NCT00407030|26889641|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
13430777|NCT00407030|26889642|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
13430778|NCT00407030|26889643|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1|||
13430779|NCT00407030|26889641|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1|||
13430780|NCT00407030|26889642|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0|||
13430781|NCT00407030|26889643|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0|||
13430782|NCT00407030|26889641|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
13430783|NCT00407030|26889642|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5|||
13430784|NCT00407030|26889643|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
13430785|NCT00407030|26889641|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
13430786|NCT00407030|26889642|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
13430787|NCT00407030|26889643|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0|||
13430788|NCT00407030|26889641|FG000|Extension Period - up to 68 Weeks|Adverse Event|1|||
13430789|NCT00407030|26889642|FG001|Extension Period - up to 68 Weeks|Adverse Event|0|||
13430790|NCT00407030|26889643|FG002|Extension Period - up to 68 Weeks|Adverse Event|0|||
13430791|NCT00407030|26889641|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
13430792|NCT00407030|26889642|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
13430793|NCT00407030|26889643|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0|||
13430794|NCT00407030|26889641|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
13430795|NCT00407030|26889642|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
13430796|NCT00407030|26889643|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0|||
13430797|NCT00407030|26889641|FG000|Extension Period - up to 68 Weeks|Patient Decision|1|||
13430798|NCT00407030|26889642|FG001|Extension Period - up to 68 Weeks|Patient Decision|2|||
13430799|NCT00407030|26889643|FG002|Extension Period - up to 68 Weeks|Patient Decision|0|||
13430800|NCT00407030|26889641|FG000|Extension Period - up to 68 Weeks|Physician Decision|1|||
13430801|NCT00407030|26889642|FG001|Extension Period - up to 68 Weeks|Physician Decision|2|||
13430802|NCT00407030|26889643|FG002|Extension Period - up to 68 Weeks|Physician Decision|0|||
13430803|NCT00406848|26889712|FG000|Overall Study|Withdrawal by Subject|27|||
13430804|NCT00406848|26889713|FG001|Overall Study|Withdrawal by Subject|22|||
13430805|NCT00406848|26889712|FG000|Overall Study|Adverse Event|38|||
13430806|NCT00406848|26889713|FG001|Overall Study|Adverse Event|7|||
13430807|NCT00406848|26889712|FG000|Overall Study|Lack of Efficacy|9|||
13430808|NCT00406848|26889713|FG001|Overall Study|Lack of Efficacy|14|||
13430809|NCT00406848|26889712|FG000|Overall Study|Protocol Violation|10|||
13430810|NCT00406848|26889713|FG001|Overall Study|Protocol Violation|6|||
13430811|NCT00406848|26889712|FG000|Overall Study|Lost to Follow-up|6|||
13430812|NCT00406848|26889713|FG001|Overall Study|Lost to Follow-up|2|||
13430813|NCT00406848|26889712|FG000|Overall Study|Physician Decision|2|||
13430814|NCT00406848|26889713|FG001|Overall Study|Physician Decision|2|||
13430815|NCT00406848|26889712|FG000|Overall Study|Sponsor Decision|1|||
13430816|NCT00406848|26889713|FG001|Overall Study|Sponsor Decision|1|||
13430817|NCT00406718|26889737|FG000|Overall Study|Withdrawal by Subject|2|||
13430818|NCT00406718|26889738|FG001|Overall Study|Withdrawal by Subject|9|||
13430819|NCT00406718|26889739|FG002|Overall Study|Withdrawal by Subject|4|||
13430820|NCT00406718|26889737|FG000|Overall Study|Lost to Follow-up|2|||
13430821|NCT00406718|26889738|FG001|Overall Study|Lost to Follow-up|5|||
13430822|NCT00406718|26889739|FG002|Overall Study|Lost to Follow-up|4|||
13430823|NCT00406692|26889747|FG000|Overall Study|Withdrawal by Subject|4|||
13430824|NCT00406692|26889747|FG000|Overall Study|Physician Decision|1|||
13430825|NCT00406692|26889747|FG000|Overall Study|Adverse Event|1|||
13430826|NCT00406692|26889747|FG000|Overall Study|Lack of Efficacy|1|||
13430827|NCT00406653|26889842|FG000|Induction Period|Adverse Event|1|||
13430828|NCT00406653|26889843|FG001|Induction Period|Adverse Event|10|||
13430829|NCT00406653|26889844|FG002|Induction Period|Adverse Event|4|||
13430830|NCT00406653|26889845|FG003|Induction Period|Adverse Event|11|||
13430831|NCT00406653|26889846|FG004|Induction Period|Adverse Event|0|||
13430832|NCT00406653|26889847|FG005|Induction Period|Adverse Event|0|||
13430833|NCT00406653|26889848|FG006|Induction Period|Adverse Event|0|||
13430834|NCT00406653|26889842|FG000|Induction Period|Lack of Efficacy|11|||
13430835|NCT00406653|26889843|FG001|Induction Period|Lack of Efficacy|14|||
13430836|NCT00406653|26889844|FG002|Induction Period|Lack of Efficacy|8|||
13430837|NCT00406653|26889845|FG003|Induction Period|Lack of Efficacy|10|||
13430838|NCT00406653|26889846|FG004|Induction Period|Lack of Efficacy|0|||
13430839|NCT00406653|26889847|FG005|Induction Period|Lack of Efficacy|0|||
13430840|NCT00406653|26889848|FG006|Induction Period|Lack of Efficacy|0|||
13430841|NCT00406653|26889842|FG000|Induction Period|Lost to Follow-up|0|||
13430842|NCT00406653|26889843|FG001|Induction Period|Lost to Follow-up|2|||
13430843|NCT00406653|26889844|FG002|Induction Period|Lost to Follow-up|0|||
13430844|NCT00406653|26889845|FG003|Induction Period|Lost to Follow-up|0|||
13430845|NCT00406653|26889846|FG004|Induction Period|Lost to Follow-up|0|||
13430846|NCT00406653|26889847|FG005|Induction Period|Lost to Follow-up|0|||
13430847|NCT00406653|26889848|FG006|Induction Period|Lost to Follow-up|0|||
13430848|NCT00406653|26889842|FG000|Induction Period|Withdrawal of Consent|2|||
13430849|NCT00406653|26889843|FG001|Induction Period|Withdrawal of Consent|5|||
13430850|NCT00406653|26889844|FG002|Induction Period|Withdrawal of Consent|1|||
13430851|NCT00406653|26889845|FG003|Induction Period|Withdrawal of Consent|2|||
13430852|NCT00406653|26889846|FG004|Induction Period|Withdrawal of Consent|0|||
13430853|NCT00406653|26889847|FG005|Induction Period|Withdrawal of Consent|0|||
13430854|NCT00406653|26889848|FG006|Induction Period|Withdrawal of Consent|0|||
13430855|NCT00406653|26889842|FG000|Induction Period|Subject No Longer Meets Study Criteria|0|||
13430856|NCT00406653|26889843|FG001|Induction Period|Subject No Longer Meets Study Criteria|0|||
13430857|NCT00406653|26889844|FG002|Induction Period|Subject No Longer Meets Study Criteria|0|||
13430858|NCT00406653|26889845|FG003|Induction Period|Subject No Longer Meets Study Criteria|2|||
13430859|NCT00406653|26889846|FG004|Induction Period|Subject No Longer Meets Study Criteria|0|||
13430860|NCT00406653|26889847|FG005|Induction Period|Subject No Longer Meets Study Criteria|0|||
13430861|NCT00406653|26889848|FG006|Induction Period|Subject No Longer Meets Study Criteria|0|||
13430862|NCT00406653|26889842|FG000|Induction Period|Pregnancy|1|||
13430863|NCT00406653|26889843|FG001|Induction Period|Pregnancy|0|||
13430864|NCT00406653|26889844|FG002|Induction Period|Pregnancy|0|||
13430865|NCT00406653|26889845|FG003|Induction Period|Pregnancy|0|||
13430866|NCT00406653|26889846|FG004|Induction Period|Pregnancy|0|||
13430867|NCT00406653|26889847|FG005|Induction Period|Pregnancy|0|||
13430868|NCT00406653|26889848|FG006|Induction Period|Pregnancy|0|||
13430869|NCT00406653|26889842|FG000|Induction Period|Declined participation but followup done|0|||
13430870|NCT00406653|26889843|FG001|Induction Period|Declined participation but followup done|2|||
13430871|NCT00406653|26889844|FG002|Induction Period|Declined participation but followup done|1|||
13430872|NCT00406653|26889845|FG003|Induction Period|Declined participation but followup done|1|||
13430873|NCT00406653|26889846|FG004|Induction Period|Declined participation but followup done|0|||
13430874|NCT00406653|26889847|FG005|Induction Period|Declined participation but followup done|0|||
13430875|NCT00406653|26889848|FG006|Induction Period|Declined participation but followup done|0|||
13430876|NCT00406653|26889842|FG000|Induction Period|Given prohibited drug|0|||
13430877|NCT00406653|26889843|FG001|Induction Period|Given prohibited drug|1|||
13430878|NCT00406653|26889844|FG002|Induction Period|Given prohibited drug|2|||
13430879|NCT00406653|26889845|FG003|Induction Period|Given prohibited drug|0|||
13430880|NCT00406653|26889846|FG004|Induction Period|Given prohibited drug|0|||
13430881|NCT00406653|26889847|FG005|Induction Period|Given prohibited drug|0|||
13430882|NCT00406653|26889848|FG006|Induction Period|Given prohibited drug|0|||
13430883|NCT00406653|26889842|FG000|Induction Period|Incarcerated|0|||
13430884|NCT00406653|26889843|FG001|Induction Period|Incarcerated|0|||
13430885|NCT00406653|26889844|FG002|Induction Period|Incarcerated|1|||
13430886|NCT00406653|26889845|FG003|Induction Period|Incarcerated|0|||
13430887|NCT00406653|26889846|FG004|Induction Period|Incarcerated|0|||
13430888|NCT00406653|26889847|FG005|Induction Period|Incarcerated|0|||
13430889|NCT00406653|26889848|FG006|Induction Period|Incarcerated|0|||
13430890|NCT00406653|26889842|FG000|Induction Period|Patient relocated|0|||
13430891|NCT00406653|26889843|FG001|Induction Period|Patient relocated|0|||
13430892|NCT00406653|26889844|FG002|Induction Period|Patient relocated|1|||
13430893|NCT00406653|26889845|FG003|Induction Period|Patient relocated|0|||
13430894|NCT00406653|26889846|FG004|Induction Period|Patient relocated|0|||
13430895|NCT00406653|26889847|FG005|Induction Period|Patient relocated|0|||
13430896|NCT00406653|26889848|FG006|Induction Period|Patient relocated|0|||
13430897|NCT00406653|26889842|FG000|Maintenance Period|Adverse Event|0|||
13430898|NCT00406653|26889843|FG001|Maintenance Period|Adverse Event|0|||
13430899|NCT00406653|26889844|FG002|Maintenance Period|Adverse Event|0|||
13430900|NCT00406653|26889845|FG003|Maintenance Period|Adverse Event|0|||
13430901|NCT00406653|26889846|FG004|Maintenance Period|Adverse Event|1|||
13430902|NCT00406653|26889847|FG005|Maintenance Period|Adverse Event|1|||
13430903|NCT00406653|26889848|FG006|Maintenance Period|Adverse Event|0|||
13430904|NCT00406653|26889842|FG000|Maintenance Period|Lack of Efficacy|0|||
13430905|NCT00406653|26889843|FG001|Maintenance Period|Lack of Efficacy|0|||
13430906|NCT00406653|26889844|FG002|Maintenance Period|Lack of Efficacy|0|||
13430907|NCT00406653|26889845|FG003|Maintenance Period|Lack of Efficacy|0|||
13430908|NCT00406653|26889846|FG004|Maintenance Period|Lack of Efficacy|20|||
13430909|NCT00406653|26889847|FG005|Maintenance Period|Lack of Efficacy|26|||
13430910|NCT00406653|26889848|FG006|Maintenance Period|Lack of Efficacy|0|||
13430911|NCT00406653|26889842|FG000|Maintenance Period|Lost to Follow-up|0|||
13430912|NCT00406653|26889843|FG001|Maintenance Period|Lost to Follow-up|0|||
13430913|NCT00406653|26889844|FG002|Maintenance Period|Lost to Follow-up|0|||
13430914|NCT00406653|26889845|FG003|Maintenance Period|Lost to Follow-up|0|||
13430915|NCT00406653|26889846|FG004|Maintenance Period|Lost to Follow-up|2|||
13430916|NCT00406653|26889847|FG005|Maintenance Period|Lost to Follow-up|1|||
13430917|NCT00406653|26889848|FG006|Maintenance Period|Lost to Follow-up|0|||
13430918|NCT00406653|26889842|FG000|Maintenance Period|Withdrawal of Consent|0|||
13430919|NCT00406653|26889843|FG001|Maintenance Period|Withdrawal of Consent|0|||
13430920|NCT00406653|26889844|FG002|Maintenance Period|Withdrawal of Consent|0|||
13430921|NCT00406653|26889845|FG003|Maintenance Period|Withdrawal of Consent|0|||
13430922|NCT00406653|26889846|FG004|Maintenance Period|Withdrawal of Consent|2|||
13430923|NCT00406653|26889847|FG005|Maintenance Period|Withdrawal of Consent|0|||
13430924|NCT00406653|26889848|FG006|Maintenance Period|Withdrawal of Consent|0|||
13430925|NCT00406653|26889842|FG000|Maintenance Period|Pregnancy|0|||
13430926|NCT00406653|26889843|FG001|Maintenance Period|Pregnancy|0|||
13430927|NCT00406653|26889844|FG002|Maintenance Period|Pregnancy|0|||
13430928|NCT00406653|26889845|FG003|Maintenance Period|Pregnancy|0|||
13430929|NCT00406653|26889846|FG004|Maintenance Period|Pregnancy|0|||
13430930|NCT00406653|26889847|FG005|Maintenance Period|Pregnancy|1|||
13430931|NCT00406653|26889848|FG006|Maintenance Period|Pregnancy|0|||
13430932|NCT00406653|26889842|FG000|Maintenance Period|Administrative Reason By Sponsor|0|||
13430933|NCT00406653|26889843|FG001|Maintenance Period|Administrative Reason By Sponsor|0|||
13430934|NCT00406653|26889844|FG002|Maintenance Period|Administrative Reason By Sponsor|0|||
13430935|NCT00406653|26889845|FG003|Maintenance Period|Administrative Reason By Sponsor|0|||
13430936|NCT00406653|26889846|FG004|Maintenance Period|Administrative Reason By Sponsor|4|||
13430937|NCT00406653|26889847|FG005|Maintenance Period|Administrative Reason By Sponsor|7|||
13430938|NCT00406653|26889848|FG006|Maintenance Period|Administrative Reason By Sponsor|0|||
13430939|NCT00406653|26889842|FG000|Maintenance Period|Error in disease score evaluation|0|||
13430940|NCT00406653|26889843|FG001|Maintenance Period|Error in disease score evaluation|0|||
13430941|NCT00406653|26889844|FG002|Maintenance Period|Error in disease score evaluation|0|||
13430942|NCT00406653|26889845|FG003|Maintenance Period|Error in disease score evaluation|0|||
13430943|NCT00406653|26889846|FG004|Maintenance Period|Error in disease score evaluation|1|||
13430944|NCT00406653|26889847|FG005|Maintenance Period|Error in disease score evaluation|0|||
13430945|NCT00406653|26889848|FG006|Maintenance Period|Error in disease score evaluation|0|||
13430946|NCT00406653|26889842|FG000|Open-Label Period|Death|0|||
13430947|NCT00406653|26889843|FG001|Open-Label Period|Death|0|||
13430948|NCT00406653|26889844|FG002|Open-Label Period|Death|0|||
13430949|NCT00406653|26889845|FG003|Open-Label Period|Death|0|||
13430950|NCT00406653|26889846|FG004|Open-Label Period|Death|0|||
13430951|NCT00406653|26889847|FG005|Open-Label Period|Death|0|||
13430952|NCT00406653|26889848|FG006|Open-Label Period|Death|1|||
13430953|NCT00406653|26889842|FG000|Open-Label Period|Adverse Event|0|||
13430954|NCT00406653|26889843|FG001|Open-Label Period|Adverse Event|0|||
13430955|NCT00406653|26889844|FG002|Open-Label Period|Adverse Event|0|||
13430956|NCT00406653|26889845|FG003|Open-Label Period|Adverse Event|0|||
13430957|NCT00406653|26889846|FG004|Open-Label Period|Adverse Event|0|||
13430958|NCT00406653|26889847|FG005|Open-Label Period|Adverse Event|0|||
13430959|NCT00406653|26889848|FG006|Open-Label Period|Adverse Event|18|||
13430960|NCT00406653|26889842|FG000|Open-Label Period|Lack of Efficacy|0|||
13430961|NCT00406653|26889843|FG001|Open-Label Period|Lack of Efficacy|0|||
13430962|NCT00406653|26889844|FG002|Open-Label Period|Lack of Efficacy|0|||
13430963|NCT00406653|26889845|FG003|Open-Label Period|Lack of Efficacy|0|||
13430964|NCT00406653|26889846|FG004|Open-Label Period|Lack of Efficacy|0|||
13430965|NCT00406653|26889847|FG005|Open-Label Period|Lack of Efficacy|0|||
13430966|NCT00406653|26889848|FG006|Open-Label Period|Lack of Efficacy|160|||
13430967|NCT00406653|26889842|FG000|Open-Label Period|Lost to Follow-up|0|||
13430968|NCT00406653|26889843|FG001|Open-Label Period|Lost to Follow-up|0|||
13430969|NCT00406653|26889844|FG002|Open-Label Period|Lost to Follow-up|0|||
13430970|NCT00406653|26889845|FG003|Open-Label Period|Lost to Follow-up|0|||
13430971|NCT00406653|26889846|FG004|Open-Label Period|Lost to Follow-up|0|||
13430972|NCT00406653|26889847|FG005|Open-Label Period|Lost to Follow-up|0|||
13430973|NCT00406653|26889848|FG006|Open-Label Period|Lost to Follow-up|6|||
13430974|NCT00406653|26889842|FG000|Open-Label Period|Withdrawal of Consent|0|||
13430975|NCT00406653|26889843|FG001|Open-Label Period|Withdrawal of Consent|0|||
13430976|NCT00406653|26889844|FG002|Open-Label Period|Withdrawal of Consent|0|||
13430977|NCT00406653|26889845|FG003|Open-Label Period|Withdrawal of Consent|0|||
13430978|NCT00406653|26889846|FG004|Open-Label Period|Withdrawal of Consent|0|||
13430979|NCT00406653|26889847|FG005|Open-Label Period|Withdrawal of Consent|0|||
13430980|NCT00406653|26889848|FG006|Open-Label Period|Withdrawal of Consent|11|||
13430981|NCT00406653|26889842|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
13430982|NCT00406653|26889843|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
13430983|NCT00406653|26889844|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
13430984|NCT00406653|26889845|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
13430985|NCT00406653|26889846|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
13430986|NCT00406653|26889847|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
13430987|NCT00406653|26889848|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1|||
13430988|NCT00406653|26889842|FG000|Open-Label Period|Pregnancy|0|||
13430989|NCT00406653|26889843|FG001|Open-Label Period|Pregnancy|0|||
13430990|NCT00406653|26889844|FG002|Open-Label Period|Pregnancy|0|||
13430991|NCT00406653|26889845|FG003|Open-Label Period|Pregnancy|0|||
13430992|NCT00406653|26889846|FG004|Open-Label Period|Pregnancy|0|||
13430993|NCT00406653|26889847|FG005|Open-Label Period|Pregnancy|0|||
13430994|NCT00406653|26889848|FG006|Open-Label Period|Pregnancy|2|||
13430995|NCT00406653|26889842|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
13430996|NCT00406653|26889843|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
13430997|NCT00406653|26889844|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
13430998|NCT00406653|26889845|FG003|Open-Label Period|Administrative Reason By Sponsor|0|||
13430999|NCT00406653|26889846|FG004|Open-Label Period|Administrative Reason By Sponsor|0|||
13431000|NCT00406653|26889847|FG005|Open-Label Period|Administrative Reason By Sponsor|0|||
13431001|NCT00406653|26889848|FG006|Open-Label Period|Administrative Reason By Sponsor|115|||
13431002|NCT00406653|26889842|FG000|Open-Label Period|Declined participation but followup done|0|||
13431003|NCT00406653|26889843|FG001|Open-Label Period|Declined participation but followup done|0|||
13431004|NCT00406653|26889844|FG002|Open-Label Period|Declined participation but followup done|0|||
13431005|NCT00406653|26889845|FG003|Open-Label Period|Declined participation but followup done|0|||
13431006|NCT00406653|26889846|FG004|Open-Label Period|Declined participation but followup done|0|||
13431007|NCT00406653|26889847|FG005|Open-Label Period|Declined participation but followup done|0|||
13431008|NCT00406653|26889848|FG006|Open-Label Period|Declined participation but followup done|8|||
13431009|NCT00406653|26889842|FG000|Open-Label Period|Discontinued by Sponsor|0|||
13431010|NCT00406653|26889843|FG001|Open-Label Period|Discontinued by Sponsor|0|||
13431011|NCT00406653|26889844|FG002|Open-Label Period|Discontinued by Sponsor|0|||
13431012|NCT00406653|26889845|FG003|Open-Label Period|Discontinued by Sponsor|0|||
13431013|NCT00406653|26889846|FG004|Open-Label Period|Discontinued by Sponsor|0|||
13431014|NCT00406653|26889847|FG005|Open-Label Period|Discontinued by Sponsor|0|||
13431015|NCT00406653|26889848|FG006|Open-Label Period|Discontinued by Sponsor|1|||
13431016|NCT00406653|26889842|FG000|Open-Label Period|Refused followup|0|||
13431017|NCT00406653|26889843|FG001|Open-Label Period|Refused followup|0|||
13431018|NCT00406653|26889844|FG002|Open-Label Period|Refused followup|0|||
13431019|NCT00406653|26889845|FG003|Open-Label Period|Refused followup|0|||
13431020|NCT00406653|26889846|FG004|Open-Label Period|Refused followup|0|||
13431021|NCT00406653|26889847|FG005|Open-Label Period|Refused followup|0|||
13431022|NCT00406653|26889848|FG006|Open-Label Period|Refused followup|1|||
13431023|NCT00406640|26889885|FG000|Acute Phase|Adverse Event|18|||
13431024|NCT00406640|26889886|FG001|Acute Phase|Adverse Event|13|||
13431025|NCT00406640|26889885|FG000|Acute Phase|Failed to Return|5|||
13431026|NCT00406640|26889886|FG001|Acute Phase|Failed to Return|1|||
13431027|NCT00406640|26889885|FG000|Acute Phase|Physician Decision|0|||
13431028|NCT00406640|26889886|FG001|Acute Phase|Physician Decision|1|||
13431029|NCT00406640|26889885|FG000|Acute Phase|Lost to Follow-up|7|||
13431030|NCT00406640|26889886|FG001|Acute Phase|Lost to Follow-up|4|||
13431031|NCT00406640|26889885|FG000|Acute Phase|Protocol deviation|4|||
13431032|NCT00406640|26889886|FG001|Acute Phase|Protocol deviation|10|||
13431033|NCT00406640|26889885|FG000|Acute Phase|Protocol Violation|3|||
13431034|NCT00406640|26889886|FG001|Acute Phase|Protocol Violation|2|||
13431035|NCT00406640|26889885|FG000|Acute Phase|Withdrawal by Subject|11|||
13431036|NCT00406640|26889886|FG001|Acute Phase|Withdrawal by Subject|9|||
13431037|NCT00406640|26889885|FG000|Acute Phase|Lack of Efficacy|3|||
13431038|NCT00406640|26889886|FG001|Acute Phase|Lack of Efficacy|3|||
13431039|NCT00406640|26889885|FG000|DB Continuation Phase for Responders|Adverse Event|11|||
13431040|NCT00406640|26889886|FG001|DB Continuation Phase for Responders|Adverse Event|11|||
13431041|NCT00406640|26889885|FG000|DB Continuation Phase for Responders|Death|1|||
13431042|NCT00406640|26889886|FG001|DB Continuation Phase for Responders|Death|0|||
13431043|NCT00406640|26889885|FG000|DB Continuation Phase for Responders|Failed to Return|0|||
13431044|NCT00406640|26889886|FG001|DB Continuation Phase for Responders|Failed to Return|2|||
13431045|NCT00406640|26889885|FG000|DB Continuation Phase for Responders|Physician Decision|2|||
13431046|NCT00406640|26889886|FG001|DB Continuation Phase for Responders|Physician Decision|3|||
13431047|NCT00406640|26889885|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1|||
13431048|NCT00406640|26889886|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7|||
13431049|NCT00406640|26889885|FG000|DB Continuation Phase for Responders|non-compliance|7|||
13431050|NCT00406640|26889886|FG001|DB Continuation Phase for Responders|non-compliance|5|||
13431051|NCT00406640|26889885|FG000|DB Continuation Phase for Responders|Protocol Violation|2|||
13431052|NCT00406640|26889886|FG001|DB Continuation Phase for Responders|Protocol Violation|2|||
13431053|NCT00406640|26889885|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8|||
13431054|NCT00406640|26889886|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6|||
13431055|NCT00406640|26889885|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1|||
13431056|NCT00406640|26889886|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1|||
13431057|NCT00406640|26889885|FG000|OL Extension Phase for Non-Responders|Adverse Event|6|||
13431058|NCT00406640|26889886|FG001|OL Extension Phase for Non-Responders|Adverse Event|6|||
13431059|NCT00406640|26889885|FG000|OL Extension Phase for Non-Responders|Failed to Return|1|||
13431060|NCT00406640|26889886|FG001|OL Extension Phase for Non-Responders|Failed to Return|0|||
13431061|NCT00406640|26889885|FG000|OL Extension Phase for Non-Responders|Physician Decision|1|||
13431062|NCT00406640|26889886|FG001|OL Extension Phase for Non-Responders|Physician Decision|0|||
13431063|NCT00406640|26889885|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2|||
13431064|NCT00406640|26889886|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3|||
13431065|NCT00406640|26889885|FG000|OL Extension Phase for Non-Responders|non-compliance|3|||
13431066|NCT00406640|26889886|FG001|OL Extension Phase for Non-Responders|non-compliance|2|||
13431067|NCT00406640|26889885|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3|||
13431068|NCT00406640|26889886|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6|||
13431069|NCT00406640|26889885|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6|||
13431070|NCT00406640|26889886|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7|||
13431071|NCT00406419|26889979|FG000|Overall Study|Death|3|||
13431072|NCT00406419|26889980|FG001|Overall Study|Death|1|||
13431073|NCT00406419|26889981|FG002|Overall Study|Death|4|||
13431074|NCT00406419|26889979|FG000|Overall Study|Protocol Violation|6|||
13431075|NCT00406419|26889980|FG001|Overall Study|Protocol Violation|2|||
13431076|NCT00406419|26889981|FG002|Overall Study|Protocol Violation|5|||
13431077|NCT00406419|26889979|FG000|Overall Study|Study Terminated by Sponsor|260|||
13431078|NCT00406419|26889980|FG001|Overall Study|Study Terminated by Sponsor|288|||
13431079|NCT00406419|26889981|FG002|Overall Study|Study Terminated by Sponsor|282|||
13431080|NCT00406419|26889979|FG000|Overall Study|Withdrawal by Subject|17|||
13431081|NCT00406419|26889980|FG001|Overall Study|Withdrawal by Subject|24|||
13431082|NCT00406419|26889981|FG002|Overall Study|Withdrawal by Subject|26|||
13431083|NCT00406419|26889979|FG000|Overall Study|Lack of Efficacy|12|||
13431084|NCT00406419|26889980|FG001|Overall Study|Lack of Efficacy|1|||
13431085|NCT00406419|26889981|FG002|Overall Study|Lack of Efficacy|6|||
13431086|NCT00406419|26889979|FG000|Overall Study|Non-Compliance with Study Drug|5|||
13431087|NCT00406419|26889980|FG001|Overall Study|Non-Compliance with Study Drug|6|||
13431088|NCT00406419|26889981|FG002|Overall Study|Non-Compliance with Study Drug|3|||
13431089|NCT00406419|26889979|FG000|Overall Study|Adverse Event|10|||
13431090|NCT00406419|26889980|FG001|Overall Study|Adverse Event|12|||
13431091|NCT00406419|26889981|FG002|Overall Study|Adverse Event|16|||
13431092|NCT00406419|26889979|FG000|Overall Study|Lost to Follow-up|11|||
13431093|NCT00406419|26889980|FG001|Overall Study|Lost to Follow-up|10|||
13431094|NCT00406419|26889981|FG002|Overall Study|Lost to Follow-up|5|||
13431095|NCT00406367|26890000|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4|||
13431096|NCT00406367|26890001|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0|||
13431097|NCT00406367|26890000|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1|||
13431098|NCT00406367|26890001|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0|||
13431099|NCT00406367|26890000|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0|||
13431100|NCT00406367|26890001|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1|||
13431101|NCT00406367|26890000|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0|||
13431102|NCT00406367|26890001|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1|||
13431103|NCT00406367|26890000|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2|||
13431104|NCT00406367|26890001|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0|||
13431105|NCT00406367|26890000|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6|||
13431106|NCT00406367|26890001|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0|||
13431107|NCT00406367|26890000|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
13431108|NCT00406367|26890001|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
13431109|NCT00406367|26890000|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4|||
13431110|NCT00406367|26890001|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0|||
13431111|NCT00406367|26890000|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1|||
13431112|NCT00406367|26890001|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0|||
13431113|NCT00406367|26890000|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1|||
13431114|NCT00406367|26890001|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0|||
13431115|NCT00406367|26890000|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1|||
13431116|NCT00406367|26890001|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0|||
13431117|NCT00406367|26890000|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1|||
13431118|NCT00406367|26890001|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0|||
13431119|NCT00406354|26890082|FG000|All Randomized Patients|Protocol Violation|0|||
13431120|NCT00406354|26890083|FG001|All Randomized Patients|Protocol Violation|0|||
13431121|NCT00406354|26890084|FG002|All Randomized Patients|Protocol Violation|1|||
13431122|NCT00406354|26890082|FG000|All Randomized and Treated Patients|Lack of Efficacy|7|||
13431123|NCT00406354|26890083|FG001|All Randomized and Treated Patients|Lack of Efficacy|4|||
13431124|NCT00406354|26890084|FG002|All Randomized and Treated Patients|Lack of Efficacy|17|||
13431125|NCT00406354|26890082|FG000|All Randomized and Treated Patients|Adverse Event|6|||
13431126|NCT00406354|26890083|FG001|All Randomized and Treated Patients|Adverse Event|2|||
13431127|NCT00406354|26890084|FG002|All Randomized and Treated Patients|Adverse Event|1|||
13431128|NCT00406354|26890082|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2|||
13431129|NCT00406354|26890083|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6|||
13431130|NCT00406354|26890084|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1|||
13431131|NCT00406354|26890082|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1|||
13431132|NCT00406354|26890083|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1|||
13431133|NCT00406354|26890084|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2|||
13431134|NCT00406354|26890082|FG000|All Randomized and Treated Patients|Physician Decision|0|||
13431135|NCT00406354|26890083|FG001|All Randomized and Treated Patients|Physician Decision|0|||
13431136|NCT00406354|26890084|FG002|All Randomized and Treated Patients|Physician Decision|1|||
13431137|NCT00406315|26890104|FG000|Overall Study|Death|1|||
13431138|NCT00406315|26890104|FG000|Overall Study|Adverse Event|39|||
13431139|NCT00406315|26890104|FG000|Overall Study|Laboratory Abnormality|4|||
13431140|NCT00406315|26890104|FG000|Overall Study|Lack of Efficacy|13|||
13431141|NCT00406315|26890104|FG000|Overall Study|Other|33|||
13431142|NCT00406315|26890104|FG000|Overall Study|Lost to Follow-up|21|||
13431143|NCT00406315|26890104|FG000|Overall Study|Withdrawal by Subject|30|||
13431144|NCT00406029|26890222|FG000|Overall Study|Adverse Event|12|||
13431145|NCT00406029|26890223|FG001|Overall Study|Adverse Event|2|||
13431146|NCT00406029|26890224|FG002|Overall Study|Adverse Event|5|||
13431147|NCT00406029|26890225|FG003|Overall Study|Adverse Event|10|||
13431148|NCT00406029|26890226|FG004|Overall Study|Adverse Event|7|||
13431149|NCT00406029|26890222|FG000|Overall Study|Withdrawal by Subject|3|||
13431150|NCT00406029|26890223|FG001|Overall Study|Withdrawal by Subject|4|||
13431151|NCT00406029|26890224|FG002|Overall Study|Withdrawal by Subject|2|||
13431152|NCT00406029|26890225|FG003|Overall Study|Withdrawal by Subject|2|||
13431153|NCT00406029|26890226|FG004|Overall Study|Withdrawal by Subject|0|||
13431154|NCT00406029|26890222|FG000|Overall Study|Protocol Violation|1|||
13431155|NCT00406029|26890223|FG001|Overall Study|Protocol Violation|2|||
13431156|NCT00406029|26890224|FG002|Overall Study|Protocol Violation|0|||
13431157|NCT00406029|26890225|FG003|Overall Study|Protocol Violation|2|||
13431158|NCT00406029|26890226|FG004|Overall Study|Protocol Violation|0|||
13431159|NCT00406029|26890222|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
13431160|NCT00406029|26890223|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
13431161|NCT00406029|26890224|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
13431162|NCT00406029|26890225|FG003|Overall Study|Did Not Meet Eligibility Criteria|0|||
13431163|NCT00406029|26890226|FG004|Overall Study|Did Not Meet Eligibility Criteria|0|||
13431164|NCT00406029|26890222|FG000|Overall Study|Randomized in Error|0|||
13431165|NCT00406029|26890223|FG001|Overall Study|Randomized in Error|0|||
13431166|NCT00406029|26890224|FG002|Overall Study|Randomized in Error|2|||
13431167|NCT00406029|26890225|FG003|Overall Study|Randomized in Error|3|||
13431168|NCT00406029|26890226|FG004|Overall Study|Randomized in Error|1|||
13431169|NCT00405912|26890247|FG000|Overall Study|Withdrawal by Subject|12|||
13431170|NCT00405912|26890248|FG001|Overall Study|Withdrawal by Subject|11|||
13431171|NCT00405912|26890249|FG002|Overall Study|Withdrawal by Subject|12|||
13431172|NCT00405912|26890247|FG000|Overall Study|Lost to Follow-up|4|||
13431173|NCT00405912|26890248|FG001|Overall Study|Lost to Follow-up|8|||
13431174|NCT00405912|26890249|FG002|Overall Study|Lost to Follow-up|4|||
13431175|NCT00405821|26890266|FG000|Overall Study|Death|5|||
13431176|NCT00405821|26890267|FG001|Overall Study|Death|7|||
13431177|NCT00405821|26890266|FG000|Overall Study|Lost to Follow-up|7|||
13431178|NCT00405821|26890267|FG001|Overall Study|Lost to Follow-up|7|||
13431179|NCT00405821|26890266|FG000|Overall Study|Protocol Violation|1|||
13431180|NCT00405821|26890267|FG001|Overall Study|Protocol Violation|0|||
13431181|NCT00405821|26890266|FG000|Overall Study|initiated ART|9|||
13431182|NCT00405821|26890267|FG001|Overall Study|initiated ART|8|||
13431183|NCT00405756|26890365|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45|||
13431184|NCT00405756|26890366|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24|||
13431185|NCT00405756|26890367|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18|||
13431186|NCT00405756|26890365|FG000|Double-blind Treatment|Adverse Event|31|||
13431187|NCT00405756|26890366|FG001|Double-blind Treatment|Adverse Event|27|||
13431188|NCT00405756|26890367|FG002|Double-blind Treatment|Adverse Event|12|||
13431189|NCT00405756|26890365|FG000|Double-blind Treatment|Disease Progression|47|||
13431190|NCT00405756|26890366|FG001|Double-blind Treatment|Disease Progression|81|||
13431191|NCT00405756|26890367|FG002|Double-blind Treatment|Disease Progression|102|||
13431192|NCT00405756|26890365|FG000|Double-blind Treatment|Lack of Efficacy|1|||
13431193|NCT00405756|26890366|FG001|Double-blind Treatment|Lack of Efficacy|4|||
13431194|NCT00405756|26890367|FG002|Double-blind Treatment|Lack of Efficacy|2|||
13431195|NCT00405756|26890365|FG000|Double-blind Treatment|Withdrawal by Subject|15|||
13431196|NCT00405756|26890366|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
13431197|NCT00405756|26890367|FG002|Double-blind Treatment|Withdrawal by Subject|10|||
13431198|NCT00405756|26890365|FG000|Double-blind Treatment|Lost to Follow-up|1|||
13431199|NCT00405756|26890366|FG001|Double-blind Treatment|Lost to Follow-up|0|||
13431200|NCT00405756|26890367|FG002|Double-blind Treatment|Lost to Follow-up|0|||
13431201|NCT00405756|26890365|FG000|Double-blind Treatment|Death|4|||
13431202|NCT00405756|26890366|FG001|Double-blind Treatment|Death|4|||
13431203|NCT00405756|26890367|FG002|Double-blind Treatment|Death|4|||
13431204|NCT00405756|26890365|FG000|Double-blind Treatment|Protocol Violation|1|||
13431205|NCT00405756|26890366|FG001|Double-blind Treatment|Protocol Violation|0|||
13431206|NCT00405756|26890367|FG002|Double-blind Treatment|Protocol Violation|2|||
13431207|NCT00405756|26890365|FG000|Double-blind Treatment|Other|7|||
13431208|NCT00405756|26890366|FG001|Double-blind Treatment|Other|4|||
13431209|NCT00405756|26890367|FG002|Double-blind Treatment|Other|4|||
13431210|NCT00405756|26890365|FG000|Open-label Extension|Ongoing in Open Label Period|7|||
13431211|NCT00405756|26890366|FG001|Open-label Extension|Ongoing in Open Label Period|15|||
13431212|NCT00405756|26890367|FG002|Open-label Extension|Ongoing in Open Label Period|25|||
13431213|NCT00405756|26890365|FG000|Open-label Extension|Adverse Event|1|||
13431214|NCT00405756|26890366|FG001|Open-label Extension|Adverse Event|3|||
13431215|NCT00405756|26890367|FG002|Open-label Extension|Adverse Event|7|||
13431216|NCT00405756|26890365|FG000|Open-label Extension|Disease Progression|8|||
13431217|NCT00405756|26890366|FG001|Open-label Extension|Disease Progression|23|||
13431218|NCT00405756|26890367|FG002|Open-label Extension|Disease Progression|26|||
13431219|NCT00405756|26890365|FG000|Open-label Extension|Withdrawal by Subject|2|||
13431220|NCT00405756|26890366|FG001|Open-label Extension|Withdrawal by Subject|3|||
13431221|NCT00405756|26890367|FG002|Open-label Extension|Withdrawal by Subject|3|||
13431222|NCT00405756|26890365|FG000|Open-label Extension|Death|1|||
13431223|NCT00405756|26890366|FG001|Open-label Extension|Death|2|||
13431224|NCT00405756|26890367|FG002|Open-label Extension|Death|4|||
13431225|NCT00405756|26890365|FG000|Open-label Extension|Other|0|||
13431226|NCT00405756|26890366|FG001|Open-label Extension|Other|1|||
13431227|NCT00405756|26890367|FG002|Open-label Extension|Other|7|||
13431228|NCT00405756|26890365|FG000|Follow-up|Ongoing in Follow-up Period|52|||
13431229|NCT00405756|26890366|FG001|Follow-up|Ongoing in Follow-up Period|51|||
13431230|NCT00405756|26890367|FG002|Follow-up|Ongoing in Follow-up Period|60|||
13431231|NCT00405756|26890365|FG000|Follow-up|Death|21|||
13431232|NCT00405756|26890366|FG001|Follow-up|Death|31|||
13431233|NCT00405756|26890367|FG002|Follow-up|Death|24|||
13431234|NCT00405756|26890365|FG000|Follow-up|Lost to Follow-up|2|||
13431235|NCT00405756|26890366|FG001|Follow-up|Lost to Follow-up|8|||
13431236|NCT00405756|26890367|FG002|Follow-up|Lost to Follow-up|4|||
13431237|NCT00405652|26890374|FG000|Overall Study|Adverse Event|4|||
13431238|NCT00405639|26890393|FG000|Overall Study|Withdrawal by Subject|1|||
13431239|NCT00405639|26890394|FG001|Overall Study|Withdrawal by Subject|0|||
13431240|NCT00405639|26890393|FG000|Overall Study|Adverse Event|1|||
13431241|NCT00405639|26890394|FG001|Overall Study|Adverse Event|0|||
13431242|NCT00405639|26890393|FG000|Overall Study|Seizure prior to receiving BNP|1|||
13431243|NCT00405639|26890394|FG001|Overall Study|Seizure prior to receiving BNP|0|||
13431244|NCT00405587|26890523|FG000|Overall Study|Death|0|||
13431245|NCT00405587|26890524|FG001|Overall Study|Death|0|||
13431246|NCT00405587|26890525|FG002|Overall Study|Death|0|||
13431247|NCT00405587|26890526|FG003|Overall Study|Death|1|||
13431248|NCT00405587|26890523|FG000|Overall Study|Disease Progression|22|||
13431249|NCT00405587|26890524|FG001|Overall Study|Disease Progression|23|||
13431250|NCT00405587|26890525|FG002|Overall Study|Disease Progression|21|||
13431251|NCT00405587|26890526|FG003|Overall Study|Disease Progression|17|||
13431252|NCT00405587|26890523|FG000|Overall Study|Physician Decision|3|||
13431253|NCT00405587|26890524|FG001|Overall Study|Physician Decision|2|||
13431254|NCT00405587|26890525|FG002|Overall Study|Physician Decision|0|||
13431255|NCT00405587|26890526|FG003|Overall Study|Physician Decision|0|||
13431256|NCT00405587|26890523|FG000|Overall Study|Adverse Event|1|||
13431257|NCT00405587|26890524|FG001|Overall Study|Adverse Event|0|||
13431258|NCT00405587|26890525|FG002|Overall Study|Adverse Event|0|||
13431259|NCT00405587|26890526|FG003|Overall Study|Adverse Event|0|||
13431260|NCT00405587|26890523|FG000|Overall Study|Lost to Follow-up|0|||
13431261|NCT00405587|26890524|FG001|Overall Study|Lost to Follow-up|1|||
13431262|NCT00405587|26890525|FG002|Overall Study|Lost to Follow-up|1|||
13431263|NCT00405587|26890526|FG003|Overall Study|Lost to Follow-up|0|||
13431264|NCT00405587|26890523|FG000|Overall Study|Radiation induced necrosis|0|||
13431265|NCT00405587|26890524|FG001|Overall Study|Radiation induced necrosis|1|||
13431266|NCT00405587|26890525|FG002|Overall Study|Radiation induced necrosis|0|||
13431267|NCT00405587|26890526|FG003|Overall Study|Radiation induced necrosis|0|||
13431268|NCT00405587|26890523|FG000|Overall Study|Withdrawal by Subject|0|||
13431269|NCT00405587|26890524|FG001|Overall Study|Withdrawal by Subject|0|||
13431270|NCT00405587|26890525|FG002|Overall Study|Withdrawal by Subject|0|||
13431271|NCT00405587|26890526|FG003|Overall Study|Withdrawal by Subject|2|||
13431272|NCT00405587|26890523|FG000|Overall Study|Participant not dosed|0|||
13431273|NCT00405587|26890524|FG001|Overall Study|Participant not dosed|1|||
13431274|NCT00405587|26890525|FG002|Overall Study|Participant not dosed|0|||
13431275|NCT00405587|26890526|FG003|Overall Study|Participant not dosed|0|||
13431276|NCT00405548|26890545|FG000|Overall Study|Cognitive Memory problems on study day|1|||
13431277|NCT00405548|26890546|FG001|Overall Study|Cognitive Memory problems on study day|0|||
13431278|NCT00405548|26890545|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0|||
13431279|NCT00405548|26890546|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1|||
13431280|NCT00405548|26890545|FG000|Overall Study|Unable to self-administer shots|1|||
13431281|NCT00405548|26890546|FG001|Overall Study|Unable to self-administer shots|0|||
13431282|NCT00405548|26890545|FG000|Overall Study|Venous access failed during study day|1|||
13431283|NCT00405548|26890546|FG001|Overall Study|Venous access failed during study day|0|||
13431284|NCT00405548|26890545|FG000|Overall Study|Withdrawal by Subject|1|||
13431285|NCT00405548|26890546|FG001|Overall Study|Withdrawal by Subject|0|||
13431286|NCT00405392|26890563|FG000|Overall Study|Adverse Event|15|||
13431287|NCT00405392|26890564|FG001|Overall Study|Adverse Event|14|||
13431288|NCT00405392|26890563|FG000|Overall Study|Did not meet Eligibility criteria|7|||
13431289|NCT00405392|26890564|FG001|Overall Study|Did not meet Eligibility criteria|2|||
13431290|NCT00405392|26890563|FG000|Overall Study|Withdrawal by Subject|4|||
13431291|NCT00405392|26890564|FG001|Overall Study|Withdrawal by Subject|3|||
13431292|NCT00405392|26890563|FG000|Overall Study|Lost to Follow-up|1|||
13431293|NCT00405392|26890564|FG001|Overall Study|Lost to Follow-up|2|||
13431294|NCT00405392|26890563|FG000|Overall Study|Data missing|2|||
13431295|NCT00405392|26890564|FG001|Overall Study|Data missing|0|||
13431296|NCT00405392|26890563|FG000|Overall Study|Non-compliance|0|||
13431297|NCT00405392|26890564|FG001|Overall Study|Non-compliance|1|||
13431298|NCT00405392|26890563|FG000|Overall Study|Other|1|||
13431299|NCT00405392|26890564|FG001|Overall Study|Other|5|||
13431300|NCT00405275|26890577|FG000|Overall Study|Death|1|||
13431301|NCT00405275|26890578|FG001|Overall Study|Death|0|||
13431302|NCT00405275|26890577|FG000|Overall Study|Lost to Follow-up|5|||
13431303|NCT00405275|26890578|FG001|Overall Study|Lost to Follow-up|1|||
13431304|NCT00405275|26890577|FG000|Overall Study|Withdrawal by Subject|7|||
13431305|NCT00405275|26890578|FG001|Overall Study|Withdrawal by Subject|9|||
13431306|NCT00405275|26890577|FG000|Overall Study|Unwilling to continue|10|||
13431307|NCT00405275|26890578|FG001|Overall Study|Unwilling to continue|9|||
13431308|NCT00405067|26890623|FG000|Overall Study|Adverse Event|4|||
13431309|NCT00405067|26890624|FG001|Overall Study|Adverse Event|9|||
13431310|NCT00405067|26890625|FG002|Overall Study|Adverse Event|4|||
13431311|NCT00405067|26890623|FG000|Overall Study|Lost to Follow-up|0|||
13431312|NCT00405067|26890624|FG001|Overall Study|Lost to Follow-up|0|||
13431313|NCT00405067|26890625|FG002|Overall Study|Lost to Follow-up|1|||
13431314|NCT00404924|26890648|FG000|Overall Study|Adverse Event|75|||
13431315|NCT00404924|26890649|FG001|Overall Study|Adverse Event|16|||
13431316|NCT00404924|26890648|FG000|Overall Study|Condition under investigation worsened|475|||
13431317|NCT00404924|26890649|FG001|Overall Study|Condition under investigation worsened|264|||
13431318|NCT00404924|26890648|FG000|Overall Study|Lost to Follow-up|1|||
13431319|NCT00404924|26890649|FG001|Overall Study|Lost to Follow-up|1|||
13431320|NCT00404924|26890648|FG000|Overall Study|Withdrawal by Subject|26|||
13431321|NCT00404924|26890649|FG001|Overall Study|Withdrawal by Subject|13|||
13431322|NCT00404924|26890648|FG000|Overall Study|Other|25|||
13431323|NCT00404924|26890649|FG001|Overall Study|Other|11|||
13431324|NCT00404924|26890648|FG000|Overall Study|Randomised but not received treatment|1|||
13431325|NCT00404924|26890649|FG001|Overall Study|Randomised but not received treatment|1|||
13431326|NCT00404820|26890674|FG000|Overall Study|Adverse Event|4|||
13431327|NCT00404820|26890675|FG001|Overall Study|Adverse Event|16|||
13431328|NCT00404820|26890674|FG000|Overall Study|Withdrawal by Subject|5|||
13431329|NCT00404820|26890675|FG001|Overall Study|Withdrawal by Subject|3|||
13431330|NCT00404820|26890674|FG000|Overall Study|Lost to Follow-up|7|||
13431331|NCT00404820|26890675|FG001|Overall Study|Lost to Follow-up|3|||
13431332|NCT00404820|26890674|FG000|Overall Study|Administrative problems|2|||
13431333|NCT00404820|26890675|FG001|Overall Study|Administrative problems|0|||
13431334|NCT00404820|26890674|FG000|Overall Study|Death|1|||
13431335|NCT00404820|26890675|FG001|Overall Study|Death|0|||
13431336|NCT00404820|26890674|FG000|Overall Study|Other|0|||
13431337|NCT00404820|26890675|FG001|Overall Study|Other|2|||
13431338|NCT00404768|26890749|FG000|Part A and B|Withdrawn due to labor progression|1|||
13431339|NCT00404768|26890750|FG001|Part A and B|Withdrawn due to labor progression|0|||
13431340|NCT00404768|26890751|FG002|Part A and B|Withdrawn due to labor progression|0|||
13431341|NCT00404768|26890752|FG003|Part A and B|Withdrawn due to labor progression|0|||
13431342|NCT00404768|26890749|FG000|Part A and B|Withdrawn as delivery imminemnt|0|||
13431343|NCT00404768|26890750|FG001|Part A and B|Withdrawn as delivery imminemnt|1|||
13431344|NCT00404768|26890751|FG002|Part A and B|Withdrawn as delivery imminemnt|0|||
13431345|NCT00404768|26890752|FG003|Part A and B|Withdrawn as delivery imminemnt|0|||
13431346|NCT00404768|26890749|FG000|Part C|Adverse Event|0|||
13431347|NCT00404768|26890750|FG001|Part C|Adverse Event|0|||
13431348|NCT00404768|26890751|FG002|Part C|Adverse Event|0|||
13431349|NCT00404768|26890752|FG003|Part C|Adverse Event|3|||
13431350|NCT00404768|26890749|FG000|Part C|Lost to Follow-up|0|||
13431351|NCT00404768|26890750|FG001|Part C|Lost to Follow-up|0|||
13431352|NCT00404768|26890751|FG002|Part C|Lost to Follow-up|3|||
13431353|NCT00404768|26890752|FG003|Part C|Lost to Follow-up|1|||
13431354|NCT00404768|26890749|FG000|Part C|Withdrawal by Subject|0|||
13431355|NCT00404768|26890750|FG001|Part C|Withdrawal by Subject|0|||
13431356|NCT00404768|26890751|FG002|Part C|Withdrawal by Subject|2|||
13431357|NCT00404768|26890752|FG003|Part C|Withdrawal by Subject|1|||
13431358|NCT00404768|26890749|FG000|Part C|Early withdrawal from study medication|0|||
13431359|NCT00404768|26890750|FG001|Part C|Early withdrawal from study medication|0|||
13431360|NCT00404768|26890751|FG002|Part C|Early withdrawal from study medication|1|||
13431361|NCT00404768|26890752|FG003|Part C|Early withdrawal from study medication|0|||
13431362|NCT00404768|26890749|FG000|Part C|Participant did not respond to therapy|0|||
13431363|NCT00404768|26890750|FG001|Part C|Participant did not respond to therapy|0|||
13431364|NCT00404768|26890751|FG002|Part C|Participant did not respond to therapy|1|||
13431365|NCT00404768|26890752|FG003|Part C|Participant did not respond to therapy|1|||
13431366|NCT00404768|26890749|FG000|Part C|Physician withdrew the study medication|0|||
13431367|NCT00404768|26890750|FG001|Part C|Physician withdrew the study medication|0|||
13431368|NCT00404768|26890751|FG002|Part C|Physician withdrew the study medication|1|||
13431369|NCT00404768|26890752|FG003|Part C|Physician withdrew the study medication|0|||
13431370|NCT00404768|26890749|FG000|Part C|Participant delivered baby|0|||
13431371|NCT00404768|26890750|FG001|Part C|Participant delivered baby|0|||
13431372|NCT00404768|26890751|FG002|Part C|Participant delivered baby|0|||
13431373|NCT00404768|26890752|FG003|Part C|Participant delivered baby|1|||
13431374|NCT00404768|26890749|FG000|Part C|Unsatisfactory uterine response to IP|0|||
13431375|NCT00404768|26890750|FG001|Part C|Unsatisfactory uterine response to IP|0|||
13431376|NCT00404768|26890751|FG002|Part C|Unsatisfactory uterine response to IP|0|||
13431377|NCT00404768|26890752|FG003|Part C|Unsatisfactory uterine response to IP|1|||
13431378|NCT00404768|26890749|FG000|Part C|Active labor|0|||
13431379|NCT00404768|26890750|FG001|Part C|Active labor|0|||
13431380|NCT00404768|26890751|FG002|Part C|Active labor|0|||
13431381|NCT00404768|26890752|FG003|Part C|Active labor|1|||
13431382|NCT00404768|26890749|FG000|Part C|Lack of Efficacy|0|||
13431383|NCT00404768|26890750|FG001|Part C|Lack of Efficacy|0|||
13431384|NCT00404768|26890751|FG002|Part C|Lack of Efficacy|0|||
13431385|NCT00404768|26890752|FG003|Part C|Lack of Efficacy|2|||
13431386|NCT00404768|26890749|FG000|Part C|Treatment failure|0|||
13431387|NCT00404768|26890750|FG001|Part C|Treatment failure|0|||
13431388|NCT00404768|26890751|FG002|Part C|Treatment failure|0|||
13431389|NCT00404768|26890752|FG003|Part C|Treatment failure|1|||
13431390|NCT00404768|26890749|FG000|Part C|Investigator discretion|0|||
13431391|NCT00404768|26890750|FG001|Part C|Investigator discretion|0|||
13431392|NCT00404768|26890751|FG002|Part C|Investigator discretion|0|||
13431393|NCT00404768|26890752|FG003|Part C|Investigator discretion|1|||
13431394|NCT00404768|26890749|FG000|Part C|Researcher suspended study medication|0|||
13431395|NCT00404768|26890750|FG001|Part C|Researcher suspended study medication|0|||
13431396|NCT00404768|26890751|FG002|Part C|Researcher suspended study medication|0|||
13431397|NCT00404768|26890752|FG003|Part C|Researcher suspended study medication|1|||
13431398|NCT00404755|26890765|FG000|Phase I (Bupropion)|Adverse Event|3|||
13431399|NCT00404755|26890765|FG000|Phase I (Bupropion)|Other|1|||
13431400|NCT00404755|26890765|FG000|Phase II (Escitalopram)|Lost to Follow-up|2|||
13431401|NCT00404651|26890804|FG000|Overall Study|Serious Adverse Event|0|||
13431402|NCT00404651|26890805|FG001|Overall Study|Serious Adverse Event|0|||
13431403|NCT00404651|26890806|FG002|Overall Study|Serious Adverse Event|2|||
13431404|NCT00404651|26890807|FG003|Overall Study|Serious Adverse Event|0|||
13431405|NCT00404651|26890804|FG000|Overall Study|Protocol Violation|10|||
13431406|NCT00404651|26890805|FG001|Overall Study|Protocol Violation|5|||
13431407|NCT00404651|26890806|FG002|Overall Study|Protocol Violation|14|||
13431408|NCT00404651|26890807|FG003|Overall Study|Protocol Violation|5|||
13431409|NCT00404651|26890804|FG000|Overall Study|Lost to Follow-up|15|||
13431410|NCT00404651|26890805|FG001|Overall Study|Lost to Follow-up|11|||
13431411|NCT00404651|26890806|FG002|Overall Study|Lost to Follow-up|13|||
13431412|NCT00404651|26890807|FG003|Overall Study|Lost to Follow-up|10|||
13431413|NCT00404651|26890804|FG000|Overall Study|Withdrawal by Subject|14|||
13431414|NCT00404651|26890805|FG001|Overall Study|Withdrawal by Subject|12|||
13431415|NCT00404651|26890806|FG002|Overall Study|Withdrawal by Subject|16|||
13431416|NCT00404651|26890807|FG003|Overall Study|Withdrawal by Subject|6|||
13476884|NCT01425008|27003741|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
13476885|NCT01425008|27003742|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
13476886|NCT01425008|27003743|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
13476887|NCT01425008|27003744|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
13476888|NCT01425008|27003745|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
13476889|NCT01425008|27003746|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
13476890|NCT01425008|27003747|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1|||
13431417|NCT00404547|26890822|FG000|Overall Study|Adverse Event|39|||
13431418|NCT00404547|26890823|FG001|Overall Study|Adverse Event|6|||
13431419|NCT00404547|26890822|FG000|Overall Study|Withdrawal by Subject|19|||
13431420|NCT00404547|26890823|FG001|Overall Study|Withdrawal by Subject|2|||
13431421|NCT00404547|26890822|FG000|Overall Study|Protocol Violation|0|||
13431422|NCT00404547|26890823|FG001|Overall Study|Protocol Violation|1|||
13431423|NCT00404547|26890822|FG000|Overall Study|Lost to Follow-up|20|||
13431424|NCT00404547|26890823|FG001|Overall Study|Lost to Follow-up|9|||
13431425|NCT00404547|26890822|FG000|Overall Study|Lack of compliance|5|||
13431426|NCT00404547|26890823|FG001|Overall Study|Lack of compliance|1|||
13431427|NCT00404547|26890822|FG000|Overall Study|Other|4|||
13431428|NCT00404547|26890823|FG001|Overall Study|Other|0|||
13431429|NCT00404547|26890822|FG000|Overall Study|Reason not stated|3|||
13431430|NCT00404547|26890823|FG001|Overall Study|Reason not stated|6|||
13431431|NCT00404495|26890846|FG000|Overall Study|Death|37|||
13431432|NCT00404495|26890847|FG001|Overall Study|Death|11|||
13431433|NCT00404495|26890846|FG000|Overall Study|Lost to Follow-up|5|||
13431434|NCT00404495|26890847|FG001|Overall Study|Lost to Follow-up|0|||
13431435|NCT00404495|26890846|FG000|Overall Study|Other|1|||
13431436|NCT00404495|26890847|FG001|Overall Study|Other|0|||
13431437|NCT00404495|26890846|FG000|Overall Study|Withdrawal by Subject|1|||
13431438|NCT00404495|26890847|FG001|Overall Study|Withdrawal by Subject|0|||
13431439|NCT00404352|26890895|FG000|Double Blind (up to 24 Month)|Adverse Event|5|||
13431440|NCT00404352|26890896|FG001|Double Blind (up to 24 Month)|Adverse Event|4|||
13431441|NCT00404352|26890897|FG002|Double Blind (up to 24 Month)|Adverse Event|6|||
13431442|NCT00404352|26890898|FG003|Double Blind (up to 24 Month)|Adverse Event|0|||
13431443|NCT00404352|26890899|FG004|Double Blind (up to 24 Month)|Adverse Event|0|||
13431444|NCT00404352|26890900|FG005|Double Blind (up to 24 Month)|Adverse Event|0|||
13431445|NCT00404352|26890901|FG006|Double Blind (up to 24 Month)|Adverse Event|0|||
13431446|NCT00404352|26890902|FG007|Double Blind (up to 24 Month)|Adverse Event|0|||
13431447|NCT00404352|26890903|FG008|Double Blind (up to 24 Month)|Adverse Event|0|||
13431448|NCT00404352|26890895|FG000|Double Blind (up to 24 Month)|Pregnancy|0|||
13431449|NCT00404352|26890896|FG001|Double Blind (up to 24 Month)|Pregnancy|0|||
13431450|NCT00404352|26890897|FG002|Double Blind (up to 24 Month)|Pregnancy|2|||
13431451|NCT00404352|26890898|FG003|Double Blind (up to 24 Month)|Pregnancy|0|||
13431452|NCT00404352|26890899|FG004|Double Blind (up to 24 Month)|Pregnancy|0|||
13431453|NCT00404352|26890900|FG005|Double Blind (up to 24 Month)|Pregnancy|0|||
13431454|NCT00404352|26890901|FG006|Double Blind (up to 24 Month)|Pregnancy|0|||
13431455|NCT00404352|26890902|FG007|Double Blind (up to 24 Month)|Pregnancy|0|||
13431456|NCT00404352|26890903|FG008|Double Blind (up to 24 Month)|Pregnancy|0|||
13431457|NCT00404352|26890895|FG000|Double Blind (up to 24 Month)|Death|0|||
13431458|NCT00404352|26890896|FG001|Double Blind (up to 24 Month)|Death|0|||
13431459|NCT00404352|26890897|FG002|Double Blind (up to 24 Month)|Death|1|||
13431460|NCT00404352|26890898|FG003|Double Blind (up to 24 Month)|Death|0|||
13431461|NCT00404352|26890899|FG004|Double Blind (up to 24 Month)|Death|0|||
13431462|NCT00404352|26890900|FG005|Double Blind (up to 24 Month)|Death|0|||
13431463|NCT00404352|26890901|FG006|Double Blind (up to 24 Month)|Death|0|||
13431464|NCT00404352|26890902|FG007|Double Blind (up to 24 Month)|Death|0|||
13431465|NCT00404352|26890903|FG008|Double Blind (up to 24 Month)|Death|0|||
13431466|NCT00404352|26890895|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
13431467|NCT00404352|26890896|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2|||
13431468|NCT00404352|26890897|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
13431469|NCT00404352|26890898|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
13431470|NCT00404352|26890899|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
13431471|NCT00404352|26890900|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
13431472|NCT00404352|26890901|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
13431473|NCT00404352|26890902|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
13431474|NCT00404352|26890903|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
13431475|NCT00404352|26890895|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11|||
13431476|NCT00404352|26890896|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8|||
13431477|NCT00404352|26890897|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7|||
13431478|NCT00404352|26890898|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
13431479|NCT00404352|26890899|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
13431480|NCT00404352|26890900|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
13431481|NCT00404352|26890901|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
13431482|NCT00404352|26890902|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
13431483|NCT00404352|26890903|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
13431484|NCT00404352|26890895|FG000|Double Blind (up to 24 Month)|Disease progression|3|||
13431485|NCT00404352|26890896|FG001|Double Blind (up to 24 Month)|Disease progression|0|||
13431486|NCT00404352|26890897|FG002|Double Blind (up to 24 Month)|Disease progression|2|||
13431487|NCT00404352|26890898|FG003|Double Blind (up to 24 Month)|Disease progression|0|||
13431488|NCT00404352|26890899|FG004|Double Blind (up to 24 Month)|Disease progression|0|||
13431489|NCT00404352|26890900|FG005|Double Blind (up to 24 Month)|Disease progression|0|||
13431490|NCT00404352|26890901|FG006|Double Blind (up to 24 Month)|Disease progression|0|||
13431491|NCT00404352|26890902|FG007|Double Blind (up to 24 Month)|Disease progression|0|||
13431492|NCT00404352|26890903|FG008|Double Blind (up to 24 Month)|Disease progression|0|||
13431493|NCT00404352|26890895|FG000|Double Blind (up to 24 Month)|Poor compliance|1|||
13431494|NCT00404352|26890896|FG001|Double Blind (up to 24 Month)|Poor compliance|0|||
13431495|NCT00404352|26890897|FG002|Double Blind (up to 24 Month)|Poor compliance|0|||
13431496|NCT00404352|26890898|FG003|Double Blind (up to 24 Month)|Poor compliance|0|||
13431497|NCT00404352|26890899|FG004|Double Blind (up to 24 Month)|Poor compliance|0|||
13431498|NCT00404352|26890900|FG005|Double Blind (up to 24 Month)|Poor compliance|0|||
13431499|NCT00404352|26890901|FG006|Double Blind (up to 24 Month)|Poor compliance|0|||
13431500|NCT00404352|26890902|FG007|Double Blind (up to 24 Month)|Poor compliance|0|||
13431501|NCT00404352|26890903|FG008|Double Blind (up to 24 Month)|Poor compliance|0|||
13431502|NCT00404352|26890895|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31|||
13431503|NCT00404352|26890896|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30|||
13431504|NCT00404352|26890897|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59|||
13431505|NCT00404352|26890898|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0|||
13431506|NCT00404352|26890899|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0|||
13431507|NCT00404352|26890900|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0|||
13431508|NCT00404352|26890901|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0|||
13431509|NCT00404352|26890902|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0|||
13431510|NCT00404352|26890903|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0|||
13431511|NCT00404352|26890895|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0|||
13431512|NCT00404352|26890896|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2|||
13431513|NCT00404352|26890897|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0|||
13431514|NCT00404352|26890898|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0|||
13431515|NCT00404352|26890899|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0|||
13431516|NCT00404352|26890900|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0|||
13431517|NCT00404352|26890901|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0|||
13431518|NCT00404352|26890902|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0|||
13431519|NCT00404352|26890903|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0|||
13431520|NCT00404352|26890895|FG000|Double Blind (up to 24 Month)|Physician Decision|0|||
13431521|NCT00404352|26890896|FG001|Double Blind (up to 24 Month)|Physician Decision|0|||
13431522|NCT00404352|26890897|FG002|Double Blind (up to 24 Month)|Physician Decision|1|||
13431523|NCT00404352|26890898|FG003|Double Blind (up to 24 Month)|Physician Decision|0|||
13431524|NCT00404352|26890899|FG004|Double Blind (up to 24 Month)|Physician Decision|0|||
13431525|NCT00404352|26890900|FG005|Double Blind (up to 24 Month)|Physician Decision|0|||
13431526|NCT00404352|26890901|FG006|Double Blind (up to 24 Month)|Physician Decision|0|||
13431527|NCT00404352|26890902|FG007|Double Blind (up to 24 Month)|Physician Decision|0|||
13431528|NCT00404352|26890903|FG008|Double Blind (up to 24 Month)|Physician Decision|0|||
13431529|NCT00404352|26890895|FG000|Double Blind (up to 24 Month)|Other|0|||
13431530|NCT00404352|26890896|FG001|Double Blind (up to 24 Month)|Other|1|||
13431531|NCT00404352|26890897|FG002|Double Blind (up to 24 Month)|Other|0|||
13431532|NCT00404352|26890898|FG003|Double Blind (up to 24 Month)|Other|0|||
13431533|NCT00404352|26890899|FG004|Double Blind (up to 24 Month)|Other|0|||
13431534|NCT00404352|26890900|FG005|Double Blind (up to 24 Month)|Other|0|||
13431535|NCT00404352|26890901|FG006|Double Blind (up to 24 Month)|Other|0|||
13431536|NCT00404352|26890902|FG007|Double Blind (up to 24 Month)|Other|0|||
13431537|NCT00404352|26890903|FG008|Double Blind (up to 24 Month)|Other|0|||
13431538|NCT00404352|26890895|FG000|Open Label (up to 24 Month)|Adverse Event|0|||
13431539|NCT00404352|26890896|FG001|Open Label (up to 24 Month)|Adverse Event|0|||
13431540|NCT00404352|26890897|FG002|Open Label (up to 24 Month)|Adverse Event|0|||
13431541|NCT00404352|26890898|FG003|Open Label (up to 24 Month)|Adverse Event|2|||
13431542|NCT00404352|26890899|FG004|Open Label (up to 24 Month)|Adverse Event|1|||
13431543|NCT00404352|26890900|FG005|Open Label (up to 24 Month)|Adverse Event|1|||
13431544|NCT00404352|26890901|FG006|Open Label (up to 24 Month)|Adverse Event|0|||
13431545|NCT00404352|26890902|FG007|Open Label (up to 24 Month)|Adverse Event|0|||
13431546|NCT00404352|26890903|FG008|Open Label (up to 24 Month)|Adverse Event|0|||
13431547|NCT00404352|26890895|FG000|Open Label (up to 24 Month)|Pregnancy|0|||
13431548|NCT00404352|26890896|FG001|Open Label (up to 24 Month)|Pregnancy|0|||
13431549|NCT00404352|26890897|FG002|Open Label (up to 24 Month)|Pregnancy|0|||
13431550|NCT00404352|26890898|FG003|Open Label (up to 24 Month)|Pregnancy|0|||
13431551|NCT00404352|26890899|FG004|Open Label (up to 24 Month)|Pregnancy|0|||
13431552|NCT00404352|26890900|FG005|Open Label (up to 24 Month)|Pregnancy|1|||
13431553|NCT00404352|26890901|FG006|Open Label (up to 24 Month)|Pregnancy|0|||
13431554|NCT00404352|26890902|FG007|Open Label (up to 24 Month)|Pregnancy|0|||
13431555|NCT00404352|26890903|FG008|Open Label (up to 24 Month)|Pregnancy|0|||
13431556|NCT00404352|26890895|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0|||
13431557|NCT00404352|26890896|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0|||
13431558|NCT00404352|26890897|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0|||
13431559|NCT00404352|26890898|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0|||
13431560|NCT00404352|26890899|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1|||
13431561|NCT00404352|26890900|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0|||
13431562|NCT00404352|26890901|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0|||
13431563|NCT00404352|26890902|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0|||
13431564|NCT00404352|26890903|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0|||
13431565|NCT00404352|26890895|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
13431566|NCT00404352|26890896|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
13431567|NCT00404352|26890897|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
13431568|NCT00404352|26890898|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
13431569|NCT00404352|26890899|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
13431570|NCT00404352|26890900|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5|||
13431571|NCT00404352|26890901|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
13431572|NCT00404352|26890902|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
13431573|NCT00404352|26890903|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
13431574|NCT00404352|26890895|FG000|Open Label (up to 24 Month)|Disease progression|0|||
13431575|NCT00404352|26890896|FG001|Open Label (up to 24 Month)|Disease progression|0|||
13431576|NCT00404352|26890897|FG002|Open Label (up to 24 Month)|Disease progression|0|||
13431577|NCT00404352|26890898|FG003|Open Label (up to 24 Month)|Disease progression|1|||
13431578|NCT00404352|26890899|FG004|Open Label (up to 24 Month)|Disease progression|0|||
13431579|NCT00404352|26890900|FG005|Open Label (up to 24 Month)|Disease progression|0|||
13431580|NCT00404352|26890901|FG006|Open Label (up to 24 Month)|Disease progression|0|||
13431581|NCT00404352|26890902|FG007|Open Label (up to 24 Month)|Disease progression|0|||
13431582|NCT00404352|26890903|FG008|Open Label (up to 24 Month)|Disease progression|0|||
13431583|NCT00404352|26890895|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0|||
13431584|NCT00404352|26890896|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0|||
13431585|NCT00404352|26890897|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0|||
13431586|NCT00404352|26890898|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0|||
13431587|NCT00404352|26890899|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0|||
13431588|NCT00404352|26890900|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0|||
13431589|NCT00404352|26890901|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1|||
13431590|NCT00404352|26890902|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1|||
13431591|NCT00404352|26890903|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0|||
13431592|NCT00404352|26890895|FG000|Open Label Extension (up to 36 Months)|Other|0|||
13431593|NCT00404352|26890896|FG001|Open Label Extension (up to 36 Months)|Other|0|||
13431594|NCT00404352|26890897|FG002|Open Label Extension (up to 36 Months)|Other|0|||
13431595|NCT00404352|26890898|FG003|Open Label Extension (up to 36 Months)|Other|0|||
13431596|NCT00404352|26890899|FG004|Open Label Extension (up to 36 Months)|Other|0|||
13431597|NCT00404352|26890900|FG005|Open Label Extension (up to 36 Months)|Other|0|||
13431598|NCT00404352|26890901|FG006|Open Label Extension (up to 36 Months)|Other|0|||
13431599|NCT00404352|26890902|FG007|Open Label Extension (up to 36 Months)|Other|0|||
13431600|NCT00404352|26890903|FG008|Open Label Extension (up to 36 Months)|Other|2|||
13431601|NCT00404248|26890950|FG000|Overall Study|pts declining status|0|||
13431602|NCT00404248|26890951|FG001|Overall Study|pts declining status|1|||
13431603|NCT00404248|26890952|FG002|Overall Study|pts declining status|0|||
13431604|NCT00404248|26890953|FG003|Overall Study|pts declining status|0|||
13431605|NCT00404248|26890954|FG004|Overall Study|pts declining status|0|||
13431606|NCT00404248|26890955|FG005|Overall Study|pts declining status|0|||
13431607|NCT00404248|26890956|FG006|Overall Study|pts declining status|0|||
13431608|NCT00404248|26890957|FG007|Overall Study|pts declining status|0|||
13431609|NCT00404248|26890958|FG008|Overall Study|pts declining status|0|||
13431610|NCT00404235|26890979|FG000|Overall Study|Withdrawal by Subject|1|||
13431611|NCT00404235|26890980|FG001|Overall Study|Withdrawal by Subject|2|||
13431612|NCT00404092|26891007|FG000|Overall Study|Death|1|||
13431613|NCT00404092|26891008|FG001|Overall Study|Death|0|||
13431614|NCT00404092|26891009|FG002|Overall Study|Death|0|||
13431615|NCT00404092|26891010|FG003|Overall Study|Death|0|||
13431616|NCT00404092|26891007|FG000|Overall Study|Adverse Event|0|||
13431617|NCT00404092|26891008|FG001|Overall Study|Adverse Event|0|||
13431618|NCT00404092|26891009|FG002|Overall Study|Adverse Event|1|||
13431619|NCT00404092|26891010|FG003|Overall Study|Adverse Event|0|||
13431620|NCT00404079|26891023|FG000|Overall Study|Lost to follow up, adverse event etc|22|||
13431621|NCT00404079|26891024|FG001|Overall Study|Lost to follow up, adverse event etc|20|||
13431622|NCT00404066|26891031|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1|||
13431623|NCT00404066|26891031|FG000|Overall Study|Withdrawal by Subject - Adverse event|2|||
13431624|NCT00403845|26891058|FG000|Treatment Period 1|Subject withdrew consent|1|||
13431625|NCT00403845|26891059|FG001|Treatment Period 1|Subject withdrew consent|0|||
13431626|NCT00403845|26891060|FG002|Treatment Period 1|Subject withdrew consent|0|||
13431627|NCT00403845|26891061|FG003|Treatment Period 1|Subject withdrew consent|0|||
13431628|NCT00403845|26891058|FG000|Treatment Period 1|Subject no longer needs study drug|0|||
13431629|NCT00403845|26891059|FG001|Treatment Period 1|Subject no longer needs study drug|0|||
13431630|NCT00403845|26891060|FG002|Treatment Period 1|Subject no longer needs study drug|0|||
13431631|NCT00403845|26891061|FG003|Treatment Period 1|Subject no longer needs study drug|1|||
13431632|NCT00403845|26891058|FG000|Treatment Period 2|Subject withdrew consent|1|||
13431633|NCT00403845|26891059|FG001|Treatment Period 2|Subject withdrew consent|0|||
13431634|NCT00403845|26891060|FG002|Treatment Period 2|Subject withdrew consent|0|||
13431635|NCT00403845|26891061|FG003|Treatment Period 2|Subject withdrew consent|0|||
13431636|NCT00403845|26891058|FG000|Treatment Period 3|Subject withdrew consent|0|||
13431637|NCT00403845|26891059|FG001|Treatment Period 3|Subject withdrew consent|0|||
13431638|NCT00403845|26891060|FG002|Treatment Period 3|Subject withdrew consent|0|||
13431639|NCT00403845|26891061|FG003|Treatment Period 3|Subject withdrew consent|1|||
13431640|NCT00403845|26891058|FG000|Treatment Period 3|Adverse Event|0|||
13431641|NCT00403845|26891059|FG001|Treatment Period 3|Adverse Event|0|||
13431642|NCT00403845|26891060|FG002|Treatment Period 3|Adverse Event|0|||
13431643|NCT00403845|26891061|FG003|Treatment Period 3|Adverse Event|1|||
13431644|NCT00403767|26891092|FG000|Overall Study|Adverse Event|993|||
13431645|NCT00403767|26891093|FG001|Overall Study|Adverse Event|919|||
13431646|NCT00403767|26891092|FG000|Overall Study|Non-compliant with study medication|134|||
13431647|NCT00403767|26891093|FG001|Overall Study|Non-compliant with study medication|164|||
13431648|NCT00403767|26891092|FG000|Overall Study|Consent withdrawn|671|||
13431649|NCT00403767|26891093|FG001|Overall Study|Consent withdrawn|673|||
13431650|NCT00403767|26891092|FG000|Overall Study|Investigator dec./not protocol-related|191|||
13431651|NCT00403767|26891093|FG001|Overall Study|Investigator dec./not protocol-related|178|||
13431652|NCT00403767|26891092|FG000|Overall Study|Lost to Follow-up|6|||
13431653|NCT00403767|26891093|FG001|Overall Study|Lost to Follow-up|8|||
13431654|NCT00403767|26891092|FG000|Overall Study|Protocol Violation|142|||
13431655|NCT00403767|26891093|FG001|Overall Study|Protocol Violation|124|||
13431656|NCT00403767|26891092|FG000|Overall Study|Clinical efficacy endpoint reached|300|||
13431657|NCT00403767|26891093|FG001|Overall Study|Clinical efficacy endpoint reached|332|||
13431658|NCT00403767|26891092|FG000|Overall Study|Study terminated by sponsor|82|||
13431659|NCT00403767|26891093|FG001|Overall Study|Study terminated by sponsor|69|||
13431660|NCT00403767|26891092|FG000|Overall Study|Missing/incomplete data|1|||
13431661|NCT00403767|26891093|FG001|Overall Study|Missing/incomplete data|1|||
13431662|NCT00403754|26891125|FG000|Core Treatment Period 1|Withdrawal by Subject|0|||
13431663|NCT00403754|26891126|FG001|Core Treatment Period 1|Withdrawal by Subject|1|||
13431664|NCT00403754|26891127|FG002|Core Treatment Period 1|Withdrawal by Subject|0|||
13431665|NCT00403754|26891128|FG003|Core Treatment Period 1|Withdrawal by Subject|0|||
13431666|NCT00403754|26891125|FG000|Core Treatment Period 2|Lack of Efficacy|0|||
13431667|NCT00403754|26891126|FG001|Core Treatment Period 2|Lack of Efficacy|0|||
13431668|NCT00403754|26891127|FG002|Core Treatment Period 2|Lack of Efficacy|1|||
13431669|NCT00403754|26891128|FG003|Core Treatment Period 2|Lack of Efficacy|0|||
13431670|NCT00403585|26891139|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
13431671|NCT00403585|26891139|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2|||
13431672|NCT00403585|26891139|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4|||
13431673|NCT00403559|26891154|FG000|Overall Study|Adverse Event|0|||
13431674|NCT00403559|26891155|FG001|Overall Study|Adverse Event|1|||
13431675|NCT00403559|26891154|FG000|Overall Study|Lost to Follow-up|3|||
13431676|NCT00403559|26891155|FG001|Overall Study|Lost to Follow-up|3|||
13431677|NCT00403559|26891154|FG000|Overall Study|Withdrawal by Subject|1|||
13431678|NCT00403559|26891155|FG001|Overall Study|Withdrawal by Subject|0|||
13431679|NCT00403546|26891203|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6|||
13431680|NCT00403546|26891204|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
13431681|NCT00403546|26891205|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
13431682|NCT00403546|26891203|FG000|Signed Informed Consent/Open-Label|Early Termination|8|||
13431683|NCT00403546|26891204|FG001|Signed Informed Consent/Open-Label|Early Termination|0|||
13431684|NCT00403546|26891205|FG002|Signed Informed Consent/Open-Label|Early Termination|0|||
13431685|NCT00403546|26891203|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9|||
13431686|NCT00403546|26891204|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
13431687|NCT00403546|26891205|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
13431688|NCT00403546|26891203|FG000|Signed Informed Consent/Open-Label|Adverse Event|5|||
13431689|NCT00403546|26891204|FG001|Signed Informed Consent/Open-Label|Adverse Event|0|||
13431690|NCT00403546|26891205|FG002|Signed Informed Consent/Open-Label|Adverse Event|0|||
13431691|NCT00403546|26891203|FG000|Screening Phase|Screening Failure|22|||
13431692|NCT00403546|26891204|FG001|Screening Phase|Screening Failure|0|||
13431693|NCT00403546|26891205|FG002|Screening Phase|Screening Failure|0|||
13431694|NCT00403546|26891203|FG000|Screening Phase|Adverse Event|1|||
13431695|NCT00403546|26891204|FG001|Screening Phase|Adverse Event|0|||
13431696|NCT00403546|26891205|FG002|Screening Phase|Adverse Event|0|||
13431697|NCT00403546|26891203|FG000|Screening Phase|Terminated Prior to Randomization|5|||
13431698|NCT00403546|26891204|FG001|Screening Phase|Terminated Prior to Randomization|0|||
13431699|NCT00403546|26891205|FG002|Screening Phase|Terminated Prior to Randomization|0|||
13431700|NCT00403546|26891203|FG000|Randomized Trial|Early Terminations|0|||
13431701|NCT00403546|26891204|FG001|Randomized Trial|Early Terminations|17|||
13431702|NCT00403546|26891205|FG002|Randomized Trial|Early Terminations|16|||
13431703|NCT00403494|26891224|FG000|Overall Study|Adverse Event|10|||
13431704|NCT00403494|26891225|FG001|Overall Study|Adverse Event|8|||
13431705|NCT00403494|26891224|FG000|Overall Study|Withdrew Consent|3|||
13431706|NCT00403494|26891225|FG001|Overall Study|Withdrew Consent|2|||
13431707|NCT00403494|26891224|FG000|Overall Study|Inappropriately enrolled|0|||
13431708|NCT00403494|26891225|FG001|Overall Study|Inappropriately enrolled|1|||
13431709|NCT00403494|26891224|FG000|Overall Study|Lost to Follow-up|0|||
13431710|NCT00403494|26891225|FG001|Overall Study|Lost to Follow-up|2|||
13431711|NCT00403494|26891224|FG000|Overall Study|Protocol noncompliance|0|||
13431712|NCT00403494|26891225|FG001|Overall Study|Protocol noncompliance|1|||
13431713|NCT00403494|26891224|FG000|Overall Study|Death|1|||
13431714|NCT00403494|26891225|FG001|Overall Study|Death|0|||
13431715|NCT00403494|26891224|FG000|Overall Study|Sponsor Request|1|||
13431716|NCT00403494|26891225|FG001|Overall Study|Sponsor Request|0|||
13431717|NCT00403481|26891242|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1|||
13431718|NCT00403481|26891242|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1|||
13431719|NCT00403481|26891242|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3|||
13431720|NCT00403481|26891242|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1|||
13431721|NCT00403481|26891242|FG000|Olm 40 mg|Adverse Event|2|||
13431722|NCT00403481|26891242|FG000|Olm 40 mg|Protocol Violation|1|||
13431723|NCT00403481|26891242|FG000|Olm 40 mg|Withdrawal by Subject|1|||
13431724|NCT00403481|26891242|FG000|Olm 40 mg|Other|1|||
13431725|NCT00403481|26891242|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2|||
13431726|NCT00403481|26891242|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1|||
13431727|NCT00403481|26891242|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1|||
13431728|NCT00403481|26891242|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1|||
13431729|NCT00403481|26891242|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1|||
13431730|NCT00403481|26891242|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
13431731|NCT00403455|26891248|FG000|Overall Study|Withdrawal by Subject|1|||
13431732|NCT00403390|26891261|FG000|Overall Study|Withdrawal by Subject|1|||
13431733|NCT00403390|26891262|FG001|Overall Study|Withdrawal by Subject|0|||
13431734|NCT00403390|26891261|FG000|Overall Study|samples lost|1|||
13431735|NCT00403390|26891262|FG001|Overall Study|samples lost|0|||
13431736|NCT00403390|26891261|FG000|Overall Study|non-compliant|1|||
13431737|NCT00403390|26891262|FG001|Overall Study|non-compliant|0|||
13431738|NCT00403273|26891307|FG000|Overall Study|Lost to Follow-up|3|||
13431739|NCT00403273|26891308|FG001|Overall Study|Lost to Follow-up|2|||
13431740|NCT00403273|26891307|FG000|Overall Study|Physician Decision|0|||
13431741|NCT00403273|26891308|FG001|Overall Study|Physician Decision|1|||
13431742|NCT00403273|26891307|FG000|Overall Study|pt. wanted to have a surgical procedure|0|||
13431743|NCT00403273|26891308|FG001|Overall Study|pt. wanted to have a surgical procedure|1|||
13431744|NCT00403260|26891335|FG000|Overall Study|Adverse Event|5|||
13431745|NCT00403260|26891336|FG001|Overall Study|Adverse Event|4|||
13431746|NCT00403260|26891335|FG000|Overall Study|Withdrawal by Subject|5|||
13431747|NCT00403260|26891336|FG001|Overall Study|Withdrawal by Subject|6|||
13431748|NCT00403260|26891335|FG000|Overall Study|Lost to Follow-up|49|||
13431749|NCT00403260|26891336|FG001|Overall Study|Lost to Follow-up|25|||
13431750|NCT00403260|26891335|FG000|Overall Study|Re-appearance of P. falciparum|34|||
13431751|NCT00403260|26891336|FG001|Overall Study|Re-appearance of P. falciparum|25|||
13431752|NCT00403260|26891335|FG000|Overall Study|P. vivax infection|26|||
13431753|NCT00403260|26891336|FG001|Overall Study|P. vivax infection|4|||
13431754|NCT00403260|26891335|FG000|Overall Study|Mixed infection with P. vivax|2|||
13431755|NCT00403260|26891336|FG001|Overall Study|Mixed infection with P. vivax|0|||
13431756|NCT00403260|26891335|FG000|Overall Study|Mixed infection with P. falciparum|1|||
13431757|NCT00403260|26891336|FG001|Overall Study|Mixed infection with P. falciparum|0|||
13431758|NCT00403260|26891335|FG000|Overall Study|P. vivax infection at screening|1|||
13431759|NCT00403260|26891336|FG001|Overall Study|P. vivax infection at screening|0|||
13431760|NCT00403260|26891335|FG000|Overall Study|P. ovale infection|1|||
13431761|NCT00403260|26891336|FG001|Overall Study|P. ovale infection|0|||
13431762|NCT00403260|26891335|FG000|Overall Study|Gametocyte re-appearance|1|||
13431763|NCT00403260|26891336|FG001|Overall Study|Gametocyte re-appearance|1|||
13431764|NCT00403260|26891335|FG000|Overall Study|Withdrawn from study accidentally|0|||
13431765|NCT00403260|26891336|FG001|Overall Study|Withdrawn from study accidentally|1|||
13431766|NCT00403234|26891359|FG000|Overall Study|Withdrawal by Subject|0|||
13431767|NCT00403234|26891360|FG001|Overall Study|Withdrawal by Subject|1|||
13431768|NCT00403234|26891361|FG002|Overall Study|Withdrawal by Subject|0|||
13431769|NCT00403234|26891362|FG003|Overall Study|Withdrawal by Subject|0|||
13431770|NCT00403234|26891359|FG000|Overall Study|Adverse Event|1|||
13431771|NCT00403234|26891360|FG001|Overall Study|Adverse Event|0|||
13431772|NCT00403234|26891361|FG002|Overall Study|Adverse Event|1|||
13431773|NCT00403234|26891362|FG003|Overall Study|Adverse Event|0|||
13431774|NCT00403130|26891371|FG000|2 Years From Start of Treatment|Not Eligible|3|||
13431775|NCT00403130|26891371|FG000|2 Years From Start of Treatment|Lost to Follow up|1|||
13431776|NCT00403130|26891371|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1|||
13431777|NCT00403130|26891371|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10|||
13431778|NCT00402987|26891546|FG000|Overall Study|Lack of Efficacy|0|||
13431779|NCT00402987|26891547|FG001|Overall Study|Lack of Efficacy|0|||
13431780|NCT00402987|26891548|FG002|Overall Study|Lack of Efficacy|1|||
13431781|NCT00402987|26891549|FG003|Overall Study|Lack of Efficacy|0|||
13431782|NCT00402831|26891588|FG000|Overall Study|Lost to Follow-up|1|||
13431783|NCT00402831|26891589|FG001|Overall Study|Lost to Follow-up|2|||
13431784|NCT00402831|26891588|FG000|Overall Study|Non-compliance with protocol|0|||
13431785|NCT00402831|26891589|FG001|Overall Study|Non-compliance with protocol|1|||
13431786|NCT00402779|26891602|FG000|Overall Study|Screen Failure|77|||
13431787|NCT00402779|26891603|FG001|Overall Study|Screen Failure|76|||
13431788|NCT00402740|26891615|FG000|Overall Study|Withdrawal by Subject|18|||
13431789|NCT00402740|26891615|FG000|Overall Study|Death|50|||
13431790|NCT00402740|26891615|FG000|Overall Study|Lost to Follow-up|6|||
13431791|NCT00402740|26891615|FG000|Overall Study|No stent. Completed FU at 30 days.|5|||
13431792|NCT00402740|26891615|FG000|Overall Study|Subject disposition unknown.|1|||
13431793|NCT00402727|26891650|FG000|Overall Study|Adverse Event|10|||
13431794|NCT00402727|26891651|FG001|Overall Study|Adverse Event|6|||
13431795|NCT00402727|26891650|FG000|Overall Study|Death|1|||
13431796|NCT00402727|26891651|FG001|Overall Study|Death|0|||
13431797|NCT00402727|26891650|FG000|Overall Study|Lack of Efficacy|1|||
13431798|NCT00402727|26891651|FG001|Overall Study|Lack of Efficacy|3|||
13431799|NCT00402727|26891650|FG000|Overall Study|Lost to Follow-up|24|||
13431800|NCT00402727|26891651|FG001|Overall Study|Lost to Follow-up|11|||
13431801|NCT00402727|26891650|FG000|Overall Study|Physician Decision|1|||
13431802|NCT00402727|26891651|FG001|Overall Study|Physician Decision|1|||
13431803|NCT00402727|26891650|FG000|Overall Study|Protocol Violation|0|||
13431804|NCT00402727|26891651|FG001|Overall Study|Protocol Violation|4|||
13431805|NCT00402727|26891650|FG000|Overall Study|Withdrawal by Subject|3|||
13431806|NCT00402727|26891651|FG001|Overall Study|Withdrawal by Subject|7|||
13431807|NCT00402727|26891650|FG000|Overall Study|supply problems|2|||
13431808|NCT00402727|26891651|FG001|Overall Study|supply problems|1|||
13431809|NCT00402727|26891650|FG000|Overall Study|non-compliance|0|||
13431810|NCT00402727|26891651|FG001|Overall Study|non-compliance|1|||
13431811|NCT00402688|26891684|FG000|Overall Study|Adverse Event|12|||
13431812|NCT00402688|26891685|FG001|Overall Study|Adverse Event|9|||
13431813|NCT00402688|26891686|FG002|Overall Study|Adverse Event|3|||
13431814|NCT00402688|26891684|FG000|Overall Study|Withdrawal by Subject|3|||
13431815|NCT00402688|26891685|FG001|Overall Study|Withdrawal by Subject|1|||
13431816|NCT00402688|26891686|FG002|Overall Study|Withdrawal by Subject|1|||
13431817|NCT00402688|26891684|FG000|Overall Study|Physician Decision|0|||
13431818|NCT00402688|26891685|FG001|Overall Study|Physician Decision|0|||
13431819|NCT00402688|26891686|FG002|Overall Study|Physician Decision|1|||
13431820|NCT00402688|26891684|FG000|Overall Study|Lack of Efficacy|4|||
13431821|NCT00402688|26891685|FG001|Overall Study|Lack of Efficacy|4|||
13431822|NCT00402688|26891686|FG002|Overall Study|Lack of Efficacy|5|||
13431823|NCT00402688|26891684|FG000|Overall Study|Protocol Violation|1|||
13431824|NCT00402688|26891685|FG001|Overall Study|Protocol Violation|1|||
13431825|NCT00402688|26891686|FG002|Overall Study|Protocol Violation|1|||
13431826|NCT00402688|26891684|FG000|Overall Study|Lost to Follow-up|1|||
13431827|NCT00402688|26891685|FG001|Overall Study|Lost to Follow-up|0|||
13431828|NCT00402688|26891686|FG002|Overall Study|Lost to Follow-up|2|||
13431829|NCT00402688|26891684|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
13431830|NCT00402688|26891685|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1|||
13431831|NCT00402688|26891686|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
13431832|NCT00402688|26891684|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
13431833|NCT00402688|26891685|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
13431834|NCT00402688|26891686|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1|||
13431835|NCT00402688|26891684|FG000|Overall Study|Patient Left Town and Forgot Medication|0|||
13431836|NCT00402688|26891685|FG001|Overall Study|Patient Left Town and Forgot Medication|0|||
13431837|NCT00402688|26891686|FG002|Overall Study|Patient Left Town and Forgot Medication|1|||
13431838|NCT00402649|26891698|FG000|Overall Study|Lost to Follow-up|1|||
13431839|NCT00402649|26891698|FG000|Overall Study|Withdrawal by Subject|1|||
13431840|NCT00402597|26891751|FG000|Overall Study|Death|15|||
13431841|NCT00402597|26891752|FG001|Overall Study|Death|7|||
13431842|NCT00402597|26891753|FG002|Overall Study|Death|6|||
13431843|NCT00402597|26891754|FG003|Overall Study|Death|4|||
13431844|NCT00402597|26891755|FG004|Overall Study|Death|6|||
13431845|NCT00402597|26891751|FG000|Overall Study|Adverse Event|81|||
13431846|NCT00402597|26891752|FG001|Overall Study|Adverse Event|18|||
13431847|NCT00402597|26891753|FG002|Overall Study|Adverse Event|106|||
13431848|NCT00402597|26891754|FG003|Overall Study|Adverse Event|39|||
13431849|NCT00402597|26891755|FG004|Overall Study|Adverse Event|71|||
13431850|NCT00402597|26891751|FG000|Overall Study|Lost to Follow-up|8|||
13431851|NCT00402597|26891752|FG001|Overall Study|Lost to Follow-up|1|||
13431852|NCT00402597|26891753|FG002|Overall Study|Lost to Follow-up|8|||
13431853|NCT00402597|26891754|FG003|Overall Study|Lost to Follow-up|2|||
13431854|NCT00402597|26891755|FG004|Overall Study|Lost to Follow-up|3|||
13431855|NCT00402597|26891751|FG000|Overall Study|Withdrawal by Subject|57|||
13431856|NCT00402597|26891752|FG001|Overall Study|Withdrawal by Subject|16|||
13431857|NCT00402597|26891753|FG002|Overall Study|Withdrawal by Subject|65|||
13431858|NCT00402597|26891754|FG003|Overall Study|Withdrawal by Subject|15|||
13431859|NCT00402597|26891755|FG004|Overall Study|Withdrawal by Subject|24|||
13431860|NCT00402597|26891751|FG000|Overall Study|reason not specified|30|||
13431861|NCT00402597|26891752|FG001|Overall Study|reason not specified|4|||
13431862|NCT00402597|26891753|FG002|Overall Study|reason not specified|27|||
13431863|NCT00402597|26891754|FG003|Overall Study|reason not specified|14|||
13431864|NCT00402597|26891755|FG004|Overall Study|reason not specified|20|||
13431865|NCT00402363|26891826|FG000|Overall Study|Adverse Event|9|||
13431866|NCT00402363|26891827|FG001|Overall Study|Adverse Event|14|||
13431867|NCT00402363|26891828|FG002|Overall Study|Adverse Event|2|||
13431868|NCT00402363|26891829|FG003|Overall Study|Adverse Event|2|||
13431869|NCT00402363|26891826|FG000|Overall Study|Withdrew Consent|10|||
13431870|NCT00402363|26891827|FG001|Overall Study|Withdrew Consent|5|||
13431871|NCT00402363|26891828|FG002|Overall Study|Withdrew Consent|2|||
13431872|NCT00402363|26891829|FG003|Overall Study|Withdrew Consent|1|||
13431873|NCT00402363|26891826|FG000|Overall Study|Protocol Violation|3|||
13431874|NCT00402363|26891827|FG001|Overall Study|Protocol Violation|5|||
13431875|NCT00402363|26891828|FG002|Overall Study|Protocol Violation|0|||
13431876|NCT00402363|26891829|FG003|Overall Study|Protocol Violation|3|||
13431877|NCT00402363|26891826|FG000|Overall Study|Lost to Follow-up|5|||
13431878|NCT00402363|26891827|FG001|Overall Study|Lost to Follow-up|4|||
13431879|NCT00402363|26891828|FG002|Overall Study|Lost to Follow-up|0|||
13431880|NCT00402363|26891829|FG003|Overall Study|Lost to Follow-up|2|||
13431881|NCT00402363|26891826|FG000|Overall Study|"Captured as Other"|6|||
13431882|NCT00402363|26891827|FG001|Overall Study|"Captured as Other"|2|||
13431883|NCT00402363|26891828|FG002|Overall Study|"Captured as Other"|2|||
13431884|NCT00402363|26891829|FG003|Overall Study|"Captured as Other"|2|||
13431885|NCT00402337|26891882|FG000|Overall Study|Adverse Event|0|||
13431886|NCT00402337|26891883|FG001|Overall Study|Adverse Event|2|||
13431887|NCT00402337|26891884|FG002|Overall Study|Adverse Event|2|||
13431888|NCT00402337|26891885|FG003|Overall Study|Adverse Event|3|||
13431889|NCT00402337|26891886|FG004|Overall Study|Adverse Event|2|||
13431890|NCT00402337|26891882|FG000|Overall Study|Noncompliance|0|||
13431891|NCT00402337|26891883|FG001|Overall Study|Noncompliance|0|||
13431892|NCT00402337|26891884|FG002|Overall Study|Noncompliance|0|||
13431893|NCT00402337|26891885|FG003|Overall Study|Noncompliance|0|||
13431894|NCT00402337|26891886|FG004|Overall Study|Noncompliance|2|||
13431895|NCT00402337|26891882|FG000|Overall Study|Withdrawal by Subject|5|||
13431896|NCT00402337|26891883|FG001|Overall Study|Withdrawal by Subject|3|||
13431897|NCT00402337|26891884|FG002|Overall Study|Withdrawal by Subject|1|||
13431898|NCT00402337|26891885|FG003|Overall Study|Withdrawal by Subject|6|||
13431899|NCT00402337|26891886|FG004|Overall Study|Withdrawal by Subject|4|||
13431900|NCT00402337|26891882|FG000|Overall Study|Lost to Follow-up|0|||
13431901|NCT00402337|26891883|FG001|Overall Study|Lost to Follow-up|0|||
13431902|NCT00402337|26891884|FG002|Overall Study|Lost to Follow-up|1|||
13431903|NCT00402337|26891885|FG003|Overall Study|Lost to Follow-up|2|||
13431904|NCT00402337|26891886|FG004|Overall Study|Lost to Follow-up|0|||
13431905|NCT00402337|26891882|FG000|Overall Study|Physician Decision|0|||
13431906|NCT00402337|26891883|FG001|Overall Study|Physician Decision|0|||
13431907|NCT00402337|26891884|FG002|Overall Study|Physician Decision|0|||
13431908|NCT00402337|26891885|FG003|Overall Study|Physician Decision|1|||
13431909|NCT00402337|26891886|FG004|Overall Study|Physician Decision|0|||
13431910|NCT00402337|26891882|FG000|Overall Study|Other Reason|0|||
13431911|NCT00402337|26891883|FG001|Overall Study|Other Reason|1|||
13431912|NCT00402337|26891884|FG002|Overall Study|Other Reason|0|||
13431913|NCT00402337|26891885|FG003|Overall Study|Other Reason|0|||
13431914|NCT00402337|26891886|FG004|Overall Study|Other Reason|0|||
13431915|NCT00402324|26891923|FG000|Overall Study|Lost to Follow-up|11|||
13431916|NCT00402324|26891924|FG001|Overall Study|Lost to Follow-up|11|||
13431917|NCT00402324|26891923|FG000|Overall Study|Protocol Entry Criteria Not Met|5|||
13431918|NCT00402324|26891924|FG001|Overall Study|Protocol Entry Criteria Not Met|4|||
13431919|NCT00402324|26891923|FG000|Overall Study|Protocol Violation|8|||
13431920|NCT00402324|26891924|FG001|Overall Study|Protocol Violation|7|||
13431921|NCT00402324|26891923|FG000|Overall Study|Withdrawal by Subject|5|||
13431922|NCT00402324|26891924|FG001|Overall Study|Withdrawal by Subject|2|||
13431923|NCT00402324|26891923|FG000|Overall Study|Physician Decision|2|||
13431924|NCT00402324|26891924|FG001|Overall Study|Physician Decision|4|||
13431925|NCT00402324|26891923|FG000|Overall Study|Sponsor Decision|4|||
13431926|NCT00402324|26891924|FG001|Overall Study|Sponsor Decision|5|||
13431927|NCT00402324|26891923|FG000|Overall Study|Lack of Efficacy|1|||
13431928|NCT00402324|26891924|FG001|Overall Study|Lack of Efficacy|4|||
13431929|NCT00402324|26891923|FG000|Overall Study|Adverse Event|6|||
13431930|NCT00402324|26891924|FG001|Overall Study|Adverse Event|4|||
13431931|NCT00402324|26891923|FG000|Overall Study|Death|1|||
13431932|NCT00402324|26891924|FG001|Overall Study|Death|0|||
13431933|NCT00402298|26891941|FG000|Overall Study|Withdrawal by Subject|1|||
13431934|NCT00402298|26891942|FG001|Overall Study|Withdrawal by Subject|0|||
13431935|NCT00402285|26891958|FG000|Overall Study|insufficient RNA quality|7|||
13431936|NCT00402285|26891959|FG001|Overall Study|insufficient RNA quality|6|||
13431937|NCT00402285|26891960|FG002|Overall Study|insufficient RNA quality|2|||
13431938|NCT00402246|26891997|FG000|Overall Study|Death|62|||
13431939|NCT00402246|26891998|FG001|Overall Study|Death|58|||
13431940|NCT00402246|26891997|FG000|Overall Study|Lost to Follow-up|20|||
13431941|NCT00402246|26891998|FG001|Overall Study|Lost to Follow-up|28|||
13431942|NCT00402246|26891997|FG000|Overall Study|Withdrawal by Subject|72|||
13431943|NCT00402246|26891998|FG001|Overall Study|Withdrawal by Subject|87|||
13431944|NCT00402246|26891997|FG000|Overall Study|Physician Decision|24|||
13431945|NCT00402246|26891998|FG001|Overall Study|Physician Decision|26|||
13431946|NCT00402246|26891997|FG000|Overall Study|Protocol Violation|25|||
13431947|NCT00402246|26891998|FG001|Overall Study|Protocol Violation|24|||
13431948|NCT00402246|26891997|FG000|Overall Study|Missed Final Visit|1|||
13431949|NCT00402246|26891998|FG001|Overall Study|Missed Final Visit|2|||
13431950|NCT00402246|26891997|FG000|Overall Study|Insurance Issues|2|||
13431951|NCT00402246|26891998|FG001|Overall Study|Insurance Issues|1|||
13431952|NCT00402246|26891997|FG000|Overall Study|Heart Transplant|0|||
13431953|NCT00402246|26891998|FG001|Overall Study|Heart Transplant|1|||
13431954|NCT00402246|26891997|FG000|Overall Study|Patient's device explanted|6|||
13431955|NCT00402246|26891998|FG001|Overall Study|Patient's device explanted|2|||
13431956|NCT00402246|26891997|FG000|Overall Study|Center Closure|5|||
13431957|NCT00402246|26891998|FG001|Overall Study|Center Closure|3|||
13431958|NCT00402246|26891997|FG000|Overall Study|Deterioriating Condition|3|||
13431959|NCT00402246|26891998|FG001|Overall Study|Deterioriating Condition|2|||
13431960|NCT00402233|26892033|FG000|Overall Study|Adverse Event|1|||
13431961|NCT00402233|26892034|FG001|Overall Study|Adverse Event|7|||
13431962|NCT00402233|26892035|FG002|Overall Study|Adverse Event|9|||
13431963|NCT00402233|26892036|FG003|Overall Study|Adverse Event|9|||
13431964|NCT00402233|26892033|FG000|Overall Study|Protocol Violation|0|||
13431965|NCT00402233|26892034|FG001|Overall Study|Protocol Violation|1|||
13431966|NCT00402233|26892035|FG002|Overall Study|Protocol Violation|0|||
13431967|NCT00402233|26892036|FG003|Overall Study|Protocol Violation|0|||
13431968|NCT00402233|26892033|FG000|Overall Study|Withdrawal by Subject|2|||
13431969|NCT00402233|26892034|FG001|Overall Study|Withdrawal by Subject|1|||
13431970|NCT00402233|26892035|FG002|Overall Study|Withdrawal by Subject|2|||
13431971|NCT00402233|26892036|FG003|Overall Study|Withdrawal by Subject|2|||
13431972|NCT00402233|26892033|FG000|Overall Study|Worsening of disease under study|2|||
13431973|NCT00402233|26892034|FG001|Overall Study|Worsening of disease under study|0|||
13431974|NCT00402233|26892035|FG002|Overall Study|Worsening of disease under study|0|||
13431975|NCT00402233|26892036|FG003|Overall Study|Worsening of disease under study|0|||
13431976|NCT00402233|26892033|FG000|Overall Study|Worsening of other pre-existing disease|0|||
13431977|NCT00402233|26892034|FG001|Overall Study|Worsening of other pre-existing disease|1|||
13431978|NCT00402233|26892035|FG002|Overall Study|Worsening of other pre-existing disease|0|||
13431979|NCT00402233|26892036|FG003|Overall Study|Worsening of other pre-existing disease|0|||
13431980|NCT00402168|26892098|FG000|Randomized|Lost to Follow-up|1|||
13431981|NCT00402168|26892099|FG001|Randomized|Lost to Follow-up|0|||
13431982|NCT00402168|26892098|FG000|Randomized|Withdrawal by Subject|0|||
13431983|NCT00402168|26892099|FG001|Randomized|Withdrawal by Subject|1|||
13431984|NCT00402168|26892098|FG000|Treatment (up to 12 Months)|Death|0|||
13431985|NCT00402168|26892099|FG001|Treatment (up to 12 Months)|Death|1|||
13431986|NCT00402168|26892098|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2|||
13431987|NCT00402168|26892099|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0|||
13431988|NCT00402168|26892098|FG000|Treatment (up to 12 Months)|non-specified|0|||
13431989|NCT00402168|26892099|FG001|Treatment (up to 12 Months)|non-specified|1|||
13431990|NCT00402168|26892098|FG000|Long Term (LT)|Adverse Event|1|||
13431991|NCT00402168|26892099|FG001|Long Term (LT)|Adverse Event|5|||
13431992|NCT00402168|26892098|FG000|Long Term (LT)|Withdrawal by Subject|4|||
13431993|NCT00402168|26892099|FG001|Long Term (LT)|Withdrawal by Subject|7|||
13431994|NCT00402168|26892098|FG000|Long Term (LT)|Pregnancy|0|||
13431995|NCT00402168|26892099|FG001|Long Term (LT)|Pregnancy|1|||
13431996|NCT00402168|26892098|FG000|Long Term (LT)|Lost to Follow-up|1|||
13431997|NCT00402168|26892099|FG001|Long Term (LT)|Lost to Follow-up|0|||
13431998|NCT00402168|26892098|FG000|Long Term (LT)|Death|4|||
13431999|NCT00402168|26892099|FG001|Long Term (LT)|Death|0|||
13432000|NCT00402168|26892098|FG000|Long Term (LT)|Lack of Efficacy|0|||
13432001|NCT00402168|26892099|FG001|Long Term (LT)|Lack of Efficacy|2|||
13432002|NCT00402168|26892098|FG000|Long Term (LT)|non-specified|1|||
13432003|NCT00402168|26892099|FG001|Long Term (LT)|non-specified|2|||
13432004|NCT00402168|26892098|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2|||
13432005|NCT00402168|26892099|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0|||
13432006|NCT00402168|26892098|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4|||
13432007|NCT00402168|26892099|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0|||
13432008|NCT00402116|26892137|FG000|Overall Study|Jaw infection after surgery-other|1|||
13432009|NCT00402116|26892138|FG001|Overall Study|Jaw infection after surgery-other|0|||
13432010|NCT00402116|26892139|FG002|Overall Study|Jaw infection after surgery-other|0|||
13432011|NCT00402116|26892137|FG000|Overall Study|Withdrawal by Subject|1|||
13432012|NCT00402116|26892138|FG001|Overall Study|Withdrawal by Subject|0|||
13432013|NCT00402116|26892139|FG002|Overall Study|Withdrawal by Subject|5|||
13432014|NCT00402116|26892137|FG000|Overall Study|Treatment completed per protocol|1|||
13432015|NCT00402116|26892138|FG001|Overall Study|Treatment completed per protocol|1|||
13432016|NCT00402116|26892139|FG002|Overall Study|Treatment completed per protocol|2|||
13432017|NCT00402116|26892137|FG000|Overall Study|other complicating disease|0|||
13432018|NCT00402116|26892138|FG001|Overall Study|other complicating disease|0|||
13432019|NCT00402116|26892139|FG002|Overall Study|other complicating disease|2|||
13432020|NCT00402116|26892137|FG000|Overall Study|Disease Progression|0|||
13432021|NCT00402116|26892138|FG001|Overall Study|Disease Progression|4|||
13432022|NCT00402116|26892139|FG002|Overall Study|Disease Progression|38|||
13432023|NCT00402116|26892137|FG000|Overall Study|mistaken thrombocytopenia|0|||
13432024|NCT00402116|26892138|FG001|Overall Study|mistaken thrombocytopenia|0|||
13432025|NCT00402116|26892139|FG002|Overall Study|mistaken thrombocytopenia|1|||
13432026|NCT00402116|26892137|FG000|Overall Study|decline related hyponatremia/tumor|0|||
13432027|NCT00402116|26892138|FG001|Overall Study|decline related hyponatremia/tumor|0|||
13432028|NCT00402116|26892139|FG002|Overall Study|decline related hyponatremia/tumor|1|||
13432029|NCT00402116|26892137|FG000|Overall Study|Adverse Event|0|||
13432030|NCT00402116|26892138|FG001|Overall Study|Adverse Event|1|||
13432031|NCT00402116|26892139|FG002|Overall Study|Adverse Event|6|||
13432032|NCT00402103|26892160|FG000|Overall Study|Adverse Event|60|||
13432033|NCT00402103|26892161|FG001|Overall Study|Adverse Event|7|||
13432034|NCT00402103|26892160|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
13432035|NCT00402103|26892161|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
13432036|NCT00402103|26892160|FG000|Overall Study|Condition no longer requires study drug|2|||
13432037|NCT00402103|26892161|FG001|Overall Study|Condition no longer requires study drug|0|||
13432038|NCT00402103|26892160|FG000|Overall Study|Protocol Deviation|8|||
13432039|NCT00402103|26892161|FG001|Overall Study|Protocol Deviation|0|||
13432040|NCT00402103|26892160|FG000|Overall Study|Patient withdrew consent|12|||
13432041|NCT00402103|26892161|FG001|Overall Study|Patient withdrew consent|1|||
13432042|NCT00402103|26892160|FG000|Overall Study|Lost to Follow-up|6|||
13432043|NCT00402103|26892161|FG001|Overall Study|Lost to Follow-up|3|||
13432044|NCT00402103|26892160|FG000|Overall Study|Administrative problems|2|||
13432045|NCT00402103|26892161|FG001|Overall Study|Administrative problems|0|||
13432046|NCT00402051|26892182|FG000|Overall Study|Progressive Disease|13|||
13432047|NCT00402051|26892183|FG001|Overall Study|Progressive Disease|20|||
13432048|NCT00402051|26892182|FG000|Overall Study|Adverse Event|11|||
13432049|NCT00402051|26892183|FG001|Overall Study|Adverse Event|4|||
13432050|NCT00402051|26892182|FG000|Overall Study|Physician Decision|7|||
13432051|NCT00402051|26892183|FG001|Overall Study|Physician Decision|3|||
13432052|NCT00402051|26892182|FG000|Overall Study|Withdrawal by Subject|3|||
13432053|NCT00402051|26892183|FG001|Overall Study|Withdrawal by Subject|3|||
13432054|NCT00402051|26892182|FG000|Overall Study|Death - Related to Study Drug|1|||
13432055|NCT00402051|26892183|FG001|Overall Study|Death - Related to Study Drug|2|||
13432056|NCT00402051|26892182|FG000|Overall Study|Death Due to Study Disease|2|||
13432057|NCT00402051|26892183|FG001|Overall Study|Death Due to Study Disease|1|||
13432058|NCT00402051|26892182|FG000|Overall Study|Death Due to Adverse Event|0|||
13432059|NCT00402051|26892183|FG001|Overall Study|Death Due to Adverse Event|2|||
13432060|NCT00402051|26892182|FG000|Overall Study|Lost to Follow-up|1|||
13432061|NCT00402051|26892183|FG001|Overall Study|Lost to Follow-up|0|||
13432062|NCT00402025|26892216|FG000|Overall Study|Adverse Event|0|||
13432063|NCT00402025|26892217|FG001|Overall Study|Adverse Event|0|||
13432064|NCT00402025|26892218|FG002|Overall Study|Adverse Event|2|||
13432065|NCT00402025|26892216|FG000|Overall Study|Death|0|||
13432066|NCT00402025|26892217|FG001|Overall Study|Death|1|||
13432067|NCT00402025|26892218|FG002|Overall Study|Death|5|||
13432068|NCT00402025|26892216|FG000|Overall Study|Disease Progression|1|||
13432069|NCT00402025|26892217|FG001|Overall Study|Disease Progression|1|||
13432070|NCT00402025|26892218|FG002|Overall Study|Disease Progression|2|||
13432071|NCT00402025|26892216|FG000|Overall Study|Physician Decision|1|||
13432072|NCT00402025|26892217|FG001|Overall Study|Physician Decision|1|||
13432073|NCT00402025|26892218|FG002|Overall Study|Physician Decision|0|||
13432074|NCT00402025|26892216|FG000|Overall Study|Participant Decision|0|||
13432075|NCT00402025|26892217|FG001|Overall Study|Participant Decision|0|||
13432076|NCT00402025|26892218|FG002|Overall Study|Participant Decision|1|||
13432077|NCT00401973|26892265|FG000|Overall Study|Adverse Event|2|||
13432078|NCT00401973|26892266|FG001|Overall Study|Adverse Event|8|||
13432079|NCT00401973|26892267|FG002|Overall Study|Adverse Event|4|||
13432080|NCT00401973|26892265|FG000|Overall Study|Clinical Relapse|0|||
13432081|NCT00401973|26892266|FG001|Overall Study|Clinical Relapse|1|||
13432082|NCT00401973|26892267|FG002|Overall Study|Clinical Relapse|1|||
13432083|NCT00401973|26892265|FG000|Overall Study|Lack of Efficacy|0|||
13432084|NCT00401973|26892266|FG001|Overall Study|Lack of Efficacy|0|||
13432085|NCT00401973|26892267|FG002|Overall Study|Lack of Efficacy|3|||
13432086|NCT00401973|26892265|FG000|Overall Study|Lost to Follow-up|2|||
13432087|NCT00401973|26892266|FG001|Overall Study|Lost to Follow-up|2|||
13432088|NCT00401973|26892267|FG002|Overall Study|Lost to Follow-up|2|||
13432089|NCT00401973|26892265|FG000|Overall Study|Physician Decision|2|||
13432090|NCT00401973|26892266|FG001|Overall Study|Physician Decision|0|||
13432091|NCT00401973|26892267|FG002|Overall Study|Physician Decision|1|||
13432092|NCT00401973|26892265|FG000|Overall Study|Protocol Violation|1|||
13432093|NCT00401973|26892266|FG001|Overall Study|Protocol Violation|2|||
13432094|NCT00401973|26892267|FG002|Overall Study|Protocol Violation|3|||
13432095|NCT00401973|26892265|FG000|Overall Study|Sponsor Decision|0|||
13432096|NCT00401973|26892266|FG001|Overall Study|Sponsor Decision|1|||
13432097|NCT00401973|26892267|FG002|Overall Study|Sponsor Decision|0|||
13432098|NCT00401973|26892265|FG000|Overall Study|Withdrawal by Subject|4|||
13432099|NCT00401973|26892266|FG001|Overall Study|Withdrawal by Subject|12|||
13432100|NCT00401973|26892267|FG002|Overall Study|Withdrawal by Subject|9|||
13432101|NCT00401960|26892282|FG000|Overall Study|Lost to Follow-up|3|||
13432102|NCT00401960|26892283|FG001|Overall Study|Lost to Follow-up|0|||
13432103|NCT00401960|26892282|FG000|Overall Study|Death|2|||
13432104|NCT00401960|26892283|FG001|Overall Study|Death|0|||
13432105|NCT00401843|26892309|FG000|Overall Study|Achieved Complete Response|1|||
13432106|NCT00401843|26892310|FG001|Overall Study|Achieved Complete Response|5|||
13432107|NCT00401843|26892311|FG002|Overall Study|Achieved Complete Response|11|||
13432108|NCT00401843|26892309|FG000|Overall Study|Adverse Event|7|||
13432109|NCT00401843|26892310|FG001|Overall Study|Adverse Event|26|||
13432110|NCT00401843|26892311|FG002|Overall Study|Adverse Event|27|||
13432111|NCT00401843|26892309|FG000|Overall Study|Death|0|||
13432112|NCT00401843|26892310|FG001|Overall Study|Death|8|||
13432113|NCT00401843|26892311|FG002|Overall Study|Death|10|||
13432114|NCT00401843|26892309|FG000|Overall Study|Disease progression|10|||
13432115|NCT00401843|26892310|FG001|Overall Study|Disease progression|60|||
13432116|NCT00401843|26892311|FG002|Overall Study|Disease progression|49|||
13432117|NCT00401843|26892309|FG000|Overall Study|End of Study|1|||
13432118|NCT00401843|26892310|FG001|Overall Study|End of Study|1|||
13432119|NCT00401843|26892311|FG002|Overall Study|End of Study|2|||
13432120|NCT00401843|26892309|FG000|Overall Study|Lost to Follow-up|0|||
13432121|NCT00401843|26892310|FG001|Overall Study|Lost to Follow-up|0|||
13432122|NCT00401843|26892311|FG002|Overall Study|Lost to Follow-up|2|||
13432123|NCT00401843|26892309|FG000|Overall Study|Other Unspecified|0|||
13432124|NCT00401843|26892310|FG001|Overall Study|Other Unspecified|3|||
13432125|NCT00401843|26892311|FG002|Overall Study|Other Unspecified|5|||
13432126|NCT00401843|26892309|FG000|Overall Study|Physician Decision|0|||
13432127|NCT00401843|26892310|FG001|Overall Study|Physician Decision|16|||
13432128|NCT00401843|26892311|FG002|Overall Study|Physician Decision|10|||
13432129|NCT00401843|26892309|FG000|Overall Study|Protocol Violation|0|||
13432130|NCT00401843|26892310|FG001|Overall Study|Protocol Violation|0|||
13432131|NCT00401843|26892311|FG002|Overall Study|Protocol Violation|1|||
13432132|NCT00401843|26892309|FG000|Overall Study|Withdrawal by Subject|1|||
13432133|NCT00401843|26892310|FG001|Overall Study|Withdrawal by Subject|5|||
13432134|NCT00401843|26892311|FG002|Overall Study|Withdrawal by Subject|5|||
13432135|NCT00401843|26892309|FG000|Overall Study|Withdrawal of consent to study agent|1|||
13432136|NCT00401843|26892310|FG001|Overall Study|Withdrawal of consent to study agent|15|||
13432137|NCT00401843|26892311|FG002|Overall Study|Withdrawal of consent to study agent|17|||
13432138|NCT00401843|26892309|FG000|Overall Study|Randomized but not Treated|0|||
13432139|NCT00401843|26892310|FG001|Overall Study|Randomized but not Treated|2|||
13432140|NCT00401843|26892311|FG002|Overall Study|Randomized but not Treated|3|||
13432141|NCT00401843|26892309|FG000|Overall Study|Received incorrect treatment|0|||
13432142|NCT00401843|26892310|FG001|Overall Study|Received incorrect treatment|3|||
13432143|NCT00401843|26892311|FG002|Overall Study|Received incorrect treatment|0|||
13432144|NCT00401830|26892350|FG000|Overall Study|Adverse Event|10|||
13432145|NCT00401830|26892351|FG001|Overall Study|Adverse Event|18|||
13432146|NCT00401830|26892350|FG000|Overall Study|Lack of Efficacy|11|||
13432147|NCT00401830|26892351|FG001|Overall Study|Lack of Efficacy|5|||
13432148|NCT00401830|26892350|FG000|Overall Study|Withdrawal by Subject|4|||
13432149|NCT00401830|26892351|FG001|Overall Study|Withdrawal by Subject|3|||
13432150|NCT00401830|26892350|FG000|Overall Study|Protocol Violation|3|||
13432151|NCT00401830|26892351|FG001|Overall Study|Protocol Violation|3|||
13432152|NCT00401830|26892350|FG000|Overall Study|Non-compliance with drug study|1|||
13432153|NCT00401830|26892351|FG001|Overall Study|Non-compliance with drug study|0|||
13432154|NCT00401830|26892350|FG000|Overall Study|Lost to Follow-up|1|||
13432155|NCT00401830|26892351|FG001|Overall Study|Lost to Follow-up|3|||
13432156|NCT00401830|26892350|FG000|Overall Study|Other: Personal / Family problems|1|||
13432157|NCT00401830|26892351|FG001|Overall Study|Other: Personal / Family problems|0|||
13432158|NCT00401752|26892374|FG000|Overall Study|Adverse Event|2|||
13432159|NCT00401752|26892375|FG001|Overall Study|Adverse Event|5|||
13432160|NCT00401752|26892374|FG000|Overall Study|Withdrawal by Subject|2|||
13432161|NCT00401752|26892375|FG001|Overall Study|Withdrawal by Subject|6|||
13432162|NCT00401752|26892374|FG000|Overall Study|Lost to Follow-up|1|||
13432163|NCT00401752|26892375|FG001|Overall Study|Lost to Follow-up|4|||
13432164|NCT00401752|26892374|FG000|Overall Study|Development of any exclusion criteria|4|||
13432165|NCT00401752|26892375|FG001|Overall Study|Development of any exclusion criteria|2|||
13432166|NCT00401752|26892374|FG000|Overall Study|Physician Decision|1|||
13432167|NCT00401752|26892375|FG001|Overall Study|Physician Decision|1|||
13432168|NCT00401726|26892402|FG000|Overall Study|Adverse Event|34|||
13432169|NCT00401726|26892403|FG001|Overall Study|Adverse Event|45|||
13432170|NCT00401726|26892402|FG000|Overall Study|Death|0|||
13432171|NCT00401726|26892403|FG001|Overall Study|Death|3|||
13432172|NCT00401726|26892402|FG000|Overall Study|Sponsor Request|0|||
13432173|NCT00401726|26892403|FG001|Overall Study|Sponsor Request|1|||
13432174|NCT00401726|26892402|FG000|Overall Study|Physician Decision|3|||
13432175|NCT00401726|26892403|FG001|Overall Study|Physician Decision|6|||
13432176|NCT00401726|26892402|FG000|Overall Study|Lost to Follow-up|23|||
13432177|NCT00401726|26892403|FG001|Overall Study|Lost to Follow-up|20|||
13432178|NCT00401726|26892402|FG000|Overall Study|Protocol Violation|6|||
13432179|NCT00401726|26892403|FG001|Overall Study|Protocol Violation|3|||
13432180|NCT00401726|26892402|FG000|Overall Study|Withdrawal by Subject|18|||
13432181|NCT00401726|26892403|FG001|Overall Study|Withdrawal by Subject|24|||
13432182|NCT00401726|26892402|FG000|Overall Study|Lack of Efficacy|4|||
13432183|NCT00401726|26892403|FG001|Overall Study|Lack of Efficacy|6|||
13432184|NCT00401726|26892402|FG000|Overall Study|Protocol Deviation|9|||
13432185|NCT00401726|26892403|FG001|Overall Study|Protocol Deviation|4|||
13432186|NCT00401544|26892454|FG000|Overall Study|Adverse Event|5|||
13432187|NCT00401544|26892455|FG001|Overall Study|Adverse Event|1|||
13432188|NCT00401544|26892456|FG002|Overall Study|Adverse Event|1|||
13432189|NCT00401544|26892457|FG003|Overall Study|Adverse Event|1|||
13432190|NCT00401544|26892454|FG000|Overall Study|Death|3|||
13432191|NCT00401544|26892455|FG001|Overall Study|Death|6|||
13432192|NCT00401544|26892456|FG002|Overall Study|Death|2|||
13432193|NCT00401544|26892457|FG003|Overall Study|Death|5|||
13432194|NCT00401544|26892454|FG000|Overall Study|Lost to Follow-up|2|||
13432195|NCT00401544|26892455|FG001|Overall Study|Lost to Follow-up|0|||
13432196|NCT00401544|26892456|FG002|Overall Study|Lost to Follow-up|1|||
13432197|NCT00401544|26892457|FG003|Overall Study|Lost to Follow-up|1|||
13432198|NCT00401544|26892454|FG000|Overall Study|Withdrawal by Subject|7|||
13432199|NCT00401544|26892455|FG001|Overall Study|Withdrawal by Subject|6|||
13432200|NCT00401544|26892456|FG002|Overall Study|Withdrawal by Subject|6|||
13432201|NCT00401544|26892457|FG003|Overall Study|Withdrawal by Subject|5|||
13432202|NCT00401544|26892454|FG000|Overall Study|Physician Decision|1|||
13432203|NCT00401544|26892455|FG001|Overall Study|Physician Decision|3|||
13432204|NCT00401544|26892456|FG002|Overall Study|Physician Decision|0|||
13432205|NCT00401544|26892457|FG003|Overall Study|Physician Decision|0|||
13432206|NCT00401544|26892454|FG000|Overall Study|Ineligibility determined|0|||
13432207|NCT00401544|26892455|FG001|Overall Study|Ineligibility determined|1|||
13432208|NCT00401544|26892456|FG002|Overall Study|Ineligibility determined|0|||
13432209|NCT00401544|26892457|FG003|Overall Study|Ineligibility determined|2|||
13432210|NCT00401544|26892454|FG000|Overall Study|Disease progression|0|||
13432211|NCT00401544|26892455|FG001|Overall Study|Disease progression|1|||
13432212|NCT00401544|26892456|FG002|Overall Study|Disease progression|0|||
13432213|NCT00401544|26892457|FG003|Overall Study|Disease progression|0|||
13432214|NCT00401544|26892454|FG000|Overall Study|Other|0|||
13432215|NCT00401544|26892455|FG001|Overall Study|Other|0|||
13432216|NCT00401544|26892456|FG002|Overall Study|Other|2|||
13432217|NCT00401544|26892457|FG003|Overall Study|Other|2|||
13432218|NCT00401531|26892480|FG000|Overall Study|Adverse Event|2|||
13432219|NCT00401531|26892481|FG001|Overall Study|Adverse Event|0|||
13432220|NCT00401531|26892480|FG000|Overall Study|Protocol Violation|3|||
13432221|NCT00401531|26892481|FG001|Overall Study|Protocol Violation|7|||
13432222|NCT00401531|26892480|FG000|Overall Study|Lost to Follow-up|1|||
13432223|NCT00401531|26892481|FG001|Overall Study|Lost to Follow-up|1|||
13432224|NCT00401531|26892480|FG000|Overall Study|Withdrawal by Subject|3|||
13432225|NCT00401531|26892481|FG001|Overall Study|Withdrawal by Subject|2|||
13432226|NCT00401375|26892508|FG000|Overall Study|Protocol Violation|2|||
13432227|NCT00401375|26892509|FG001|Overall Study|Protocol Violation|2|||
13432228|NCT00401375|26892510|FG002|Overall Study|Protocol Violation|1|||
13432229|NCT00401375|26892508|FG000|Overall Study|Adverse Event|6|||
13432230|NCT00401375|26892509|FG001|Overall Study|Adverse Event|11|||
13432231|NCT00401375|26892510|FG002|Overall Study|Adverse Event|10|||
13432232|NCT00401375|26892508|FG000|Overall Study|Withdrawal by Subject|9|||
13432233|NCT00401375|26892509|FG001|Overall Study|Withdrawal by Subject|7|||
13432234|NCT00401375|26892510|FG002|Overall Study|Withdrawal by Subject|7|||
13432235|NCT00401375|26892508|FG000|Overall Study|Lost to Follow-up|0|||
13432236|NCT00401375|26892509|FG001|Overall Study|Lost to Follow-up|1|||
13432237|NCT00401375|26892510|FG002|Overall Study|Lost to Follow-up|1|||
13432238|NCT00401375|26892508|FG000|Overall Study|Other than specified|2|||
13432239|NCT00401375|26892509|FG001|Overall Study|Other than specified|1|||
13432240|NCT00401375|26892510|FG002|Overall Study|Other than specified|3|||
13432241|NCT00401375|26892508|FG000|Overall Study|Randomized but not treated|3|||
13432242|NCT00401375|26892509|FG001|Overall Study|Randomized but not treated|3|||
13432243|NCT00401375|26892510|FG002|Overall Study|Randomized but not treated|3|||
13432244|NCT00401258|26892523|FG000|Overall Study|Adverse Event|7|||
13432245|NCT00401245|26892605|FG000|Double Blind Titration Phase|Adverse Event|3|||
13432246|NCT00401245|26892606|FG001|Double Blind Titration Phase|Adverse Event|2|||
13432247|NCT00401245|26892607|FG002|Double Blind Titration Phase|Adverse Event|5|||
13432248|NCT00401245|26892608|FG003|Double Blind Titration Phase|Adverse Event|12|||
13432249|NCT00401245|26892609|FG004|Double Blind Titration Phase|Adverse Event|0|||
13432250|NCT00401245|26892610|FG005|Double Blind Titration Phase|Adverse Event|0|||
13432251|NCT00401245|26892611|FG006|Double Blind Titration Phase|Adverse Event|0|||
13432252|NCT00401245|26892612|FG007|Double Blind Titration Phase|Adverse Event|0|||
13432253|NCT00401245|26892605|FG000|Double Blind Titration Phase|Other|0|||
13432254|NCT00401245|26892606|FG001|Double Blind Titration Phase|Other|0|||
13432255|NCT00401245|26892607|FG002|Double Blind Titration Phase|Other|1|||
13432256|NCT00401245|26892608|FG003|Double Blind Titration Phase|Other|0|||
13432257|NCT00401245|26892609|FG004|Double Blind Titration Phase|Other|0|||
13432258|NCT00401245|26892610|FG005|Double Blind Titration Phase|Other|0|||
13432259|NCT00401245|26892611|FG006|Double Blind Titration Phase|Other|0|||
13432260|NCT00401245|26892612|FG007|Double Blind Titration Phase|Other|0|||
13432261|NCT00401245|26892605|FG000|Double Blind Titration Phase|Protocol Violation|0|||
13432262|NCT00401245|26892606|FG001|Double Blind Titration Phase|Protocol Violation|0|||
13432263|NCT00401245|26892607|FG002|Double Blind Titration Phase|Protocol Violation|0|||
13432264|NCT00401245|26892608|FG003|Double Blind Titration Phase|Protocol Violation|1|||
13432265|NCT00401245|26892609|FG004|Double Blind Titration Phase|Protocol Violation|0|||
13432266|NCT00401245|26892610|FG005|Double Blind Titration Phase|Protocol Violation|0|||
13432267|NCT00401245|26892611|FG006|Double Blind Titration Phase|Protocol Violation|0|||
13432268|NCT00401245|26892612|FG007|Double Blind Titration Phase|Protocol Violation|0|||
13432269|NCT00401245|26892605|FG000|Double Blind Titration Phase|Withdrawal by Subject|1|||
13432270|NCT00401245|26892606|FG001|Double Blind Titration Phase|Withdrawal by Subject|1|||
13432271|NCT00401245|26892607|FG002|Double Blind Titration Phase|Withdrawal by Subject|0|||
13432272|NCT00401245|26892608|FG003|Double Blind Titration Phase|Withdrawal by Subject|2|||
13432273|NCT00401245|26892609|FG004|Double Blind Titration Phase|Withdrawal by Subject|0|||
13432274|NCT00401245|26892610|FG005|Double Blind Titration Phase|Withdrawal by Subject|0|||
13432275|NCT00401245|26892611|FG006|Double Blind Titration Phase|Withdrawal by Subject|0|||
13432276|NCT00401245|26892612|FG007|Double Blind Titration Phase|Withdrawal by Subject|0|||
13432277|NCT00401245|26892605|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
13432278|NCT00401245|26892606|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
13432279|NCT00401245|26892607|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
13432280|NCT00401245|26892608|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
13432281|NCT00401245|26892609|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
13432282|NCT00401245|26892610|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
13432283|NCT00401245|26892611|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
13432284|NCT00401245|26892612|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
13432285|NCT00401245|26892605|FG000|Open Label Phase|Adverse Event|5|||
13432286|NCT00401245|26892606|FG001|Open Label Phase|Adverse Event|14|||
13432287|NCT00401245|26892607|FG002|Open Label Phase|Adverse Event|6|||
13432288|NCT00401245|26892608|FG003|Open Label Phase|Adverse Event|7|||
13432289|NCT00401245|26892609|FG004|Open Label Phase|Adverse Event|0|||
13432290|NCT00401245|26892610|FG005|Open Label Phase|Adverse Event|0|||
13432291|NCT00401245|26892611|FG006|Open Label Phase|Adverse Event|0|||
13432292|NCT00401245|26892612|FG007|Open Label Phase|Adverse Event|0|||
13432293|NCT00401245|26892605|FG000|Open Label Phase|Lost to Follow-up|5|||
13432294|NCT00401245|26892606|FG001|Open Label Phase|Lost to Follow-up|7|||
13432295|NCT00401245|26892607|FG002|Open Label Phase|Lost to Follow-up|5|||
13432296|NCT00401245|26892608|FG003|Open Label Phase|Lost to Follow-up|4|||
13432297|NCT00401245|26892609|FG004|Open Label Phase|Lost to Follow-up|0|||
13432298|NCT00401245|26892610|FG005|Open Label Phase|Lost to Follow-up|0|||
13432299|NCT00401245|26892611|FG006|Open Label Phase|Lost to Follow-up|0|||
13432300|NCT00401245|26892612|FG007|Open Label Phase|Lost to Follow-up|0|||
13432301|NCT00401245|26892605|FG000|Open Label Phase|Other|4|||
13432302|NCT00401245|26892606|FG001|Open Label Phase|Other|8|||
13432303|NCT00401245|26892607|FG002|Open Label Phase|Other|7|||
13432304|NCT00401245|26892608|FG003|Open Label Phase|Other|8|||
13432305|NCT00401245|26892609|FG004|Open Label Phase|Other|0|||
13432306|NCT00401245|26892610|FG005|Open Label Phase|Other|0|||
13432307|NCT00401245|26892611|FG006|Open Label Phase|Other|0|||
13432308|NCT00401245|26892612|FG007|Open Label Phase|Other|0|||
13432309|NCT00401245|26892605|FG000|Open Label Phase|Protocol Violation|0|||
13432310|NCT00401245|26892606|FG001|Open Label Phase|Protocol Violation|1|||
13432311|NCT00401245|26892607|FG002|Open Label Phase|Protocol Violation|0|||
13432312|NCT00401245|26892608|FG003|Open Label Phase|Protocol Violation|1|||
13432313|NCT00401245|26892609|FG004|Open Label Phase|Protocol Violation|0|||
13432314|NCT00401245|26892610|FG005|Open Label Phase|Protocol Violation|0|||
13432315|NCT00401245|26892611|FG006|Open Label Phase|Protocol Violation|0|||
13432316|NCT00401245|26892612|FG007|Open Label Phase|Protocol Violation|0|||
13432317|NCT00401245|26892605|FG000|Open Label Phase|Withdrawal by Subject|3|||
13432318|NCT00401245|26892606|FG001|Open Label Phase|Withdrawal by Subject|3|||
13432319|NCT00401245|26892607|FG002|Open Label Phase|Withdrawal by Subject|2|||
13432320|NCT00401245|26892608|FG003|Open Label Phase|Withdrawal by Subject|1|||
13432321|NCT00401245|26892609|FG004|Open Label Phase|Withdrawal by Subject|0|||
13432322|NCT00401245|26892610|FG005|Open Label Phase|Withdrawal by Subject|0|||
13432323|NCT00401245|26892611|FG006|Open Label Phase|Withdrawal by Subject|0|||
13432324|NCT00401245|26892612|FG007|Open Label Phase|Withdrawal by Subject|0|||
13432325|NCT00401245|26892605|FG000|Open Label Phase|Lack of Efficacy|4|||
13432326|NCT00401245|26892606|FG001|Open Label Phase|Lack of Efficacy|2|||
13432327|NCT00401245|26892607|FG002|Open Label Phase|Lack of Efficacy|3|||
13432328|NCT00401245|26892608|FG003|Open Label Phase|Lack of Efficacy|0|||
13432329|NCT00401245|26892609|FG004|Open Label Phase|Lack of Efficacy|0|||
13432330|NCT00401245|26892610|FG005|Open Label Phase|Lack of Efficacy|0|||
13432331|NCT00401245|26892611|FG006|Open Label Phase|Lack of Efficacy|0|||
13432332|NCT00401245|26892612|FG007|Open Label Phase|Lack of Efficacy|0|||
13432333|NCT00401245|26892605|FG000|Double Blind Tapering Phase|Adverse Event|0|||
13432334|NCT00401245|26892606|FG001|Double Blind Tapering Phase|Adverse Event|0|||
13432335|NCT00401245|26892607|FG002|Double Blind Tapering Phase|Adverse Event|0|||
13432336|NCT00401245|26892608|FG003|Double Blind Tapering Phase|Adverse Event|0|||
13432337|NCT00401245|26892609|FG004|Double Blind Tapering Phase|Adverse Event|1|||
13432338|NCT00401245|26892610|FG005|Double Blind Tapering Phase|Adverse Event|1|||
13432339|NCT00401245|26892611|FG006|Double Blind Tapering Phase|Adverse Event|2|||
13432340|NCT00401245|26892612|FG007|Double Blind Tapering Phase|Adverse Event|4|||
13432341|NCT00401245|26892605|FG000|Double Blind Tapering Phase|Investigator request|0|||
13432342|NCT00401245|26892606|FG001|Double Blind Tapering Phase|Investigator request|0|||
13432343|NCT00401245|26892607|FG002|Double Blind Tapering Phase|Investigator request|0|||
13432344|NCT00401245|26892608|FG003|Double Blind Tapering Phase|Investigator request|0|||
13432345|NCT00401245|26892609|FG004|Double Blind Tapering Phase|Investigator request|0|||
13432346|NCT00401245|26892610|FG005|Double Blind Tapering Phase|Investigator request|0|||
13432347|NCT00401245|26892611|FG006|Double Blind Tapering Phase|Investigator request|0|||
13432348|NCT00401245|26892612|FG007|Double Blind Tapering Phase|Investigator request|1|||
13432349|NCT00401245|26892605|FG000|Double Blind Tapering Phase|Other|0|||
13432350|NCT00401245|26892606|FG001|Double Blind Tapering Phase|Other|0|||
13432351|NCT00401245|26892607|FG002|Double Blind Tapering Phase|Other|0|||
13432352|NCT00401245|26892608|FG003|Double Blind Tapering Phase|Other|0|||
13432353|NCT00401245|26892609|FG004|Double Blind Tapering Phase|Other|1|||
13432354|NCT00401245|26892610|FG005|Double Blind Tapering Phase|Other|0|||
13432355|NCT00401245|26892611|FG006|Double Blind Tapering Phase|Other|2|||
13432356|NCT00401245|26892612|FG007|Double Blind Tapering Phase|Other|2|||
13432357|NCT00401245|26892605|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0|||
13432358|NCT00401245|26892606|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0|||
13432359|NCT00401245|26892607|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0|||
13432360|NCT00401245|26892608|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0|||
13432361|NCT00401245|26892609|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2|||
13432362|NCT00401245|26892610|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2|||
13432363|NCT00401245|26892611|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3|||
13432364|NCT00401245|26892612|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0|||
13432365|NCT00401245|26892605|FG000|Double Blind Tapering Phase|Lack of Efficacy|0|||
13432366|NCT00401245|26892606|FG001|Double Blind Tapering Phase|Lack of Efficacy|0|||
13432367|NCT00401245|26892607|FG002|Double Blind Tapering Phase|Lack of Efficacy|0|||
13432368|NCT00401245|26892608|FG003|Double Blind Tapering Phase|Lack of Efficacy|0|||
13432369|NCT00401245|26892609|FG004|Double Blind Tapering Phase|Lack of Efficacy|0|||
13432370|NCT00401245|26892610|FG005|Double Blind Tapering Phase|Lack of Efficacy|1|||
13432371|NCT00401245|26892611|FG006|Double Blind Tapering Phase|Lack of Efficacy|0|||
13432372|NCT00401245|26892612|FG007|Double Blind Tapering Phase|Lack of Efficacy|0|||
13432373|NCT00401193|26892636|FG000|Overall Study|Adverse Event|1|||
13432374|NCT00401193|26892637|FG001|Overall Study|Adverse Event|3|||
13432375|NCT00401193|26892638|FG002|Overall Study|Adverse Event|1|||
13432376|NCT00401193|26892636|FG000|Overall Study|Protocol Violation|3|||
13432377|NCT00401193|26892637|FG001|Overall Study|Protocol Violation|1|||
13432378|NCT00401193|26892638|FG002|Overall Study|Protocol Violation|1|||
13432379|NCT00401193|26892636|FG000|Overall Study|Lost to Follow-up|6|||
13432380|NCT00401193|26892637|FG001|Overall Study|Lost to Follow-up|5|||
13432381|NCT00401193|26892638|FG002|Overall Study|Lost to Follow-up|1|||
13432382|NCT00401193|26892636|FG000|Overall Study|Withdrawal by Subject|2|||
13432383|NCT00401193|26892637|FG001|Overall Study|Withdrawal by Subject|0|||
13432384|NCT00401193|26892638|FG002|Overall Study|Withdrawal by Subject|1|||
13432385|NCT00401193|26892636|FG000|Overall Study|Other Event|3|||
13432386|NCT00401193|26892637|FG001|Overall Study|Other Event|2|||
13432387|NCT00401193|26892638|FG002|Overall Study|Other Event|2|||
13432388|NCT00400985|26892644|FG000|Overall Study|Withdrawal by Subject|5|||
13432389|NCT00400985|26892644|FG000|Overall Study|system modification|8|||
13432390|NCT00400985|26892644|FG000|Overall Study|Death|30|||
13432391|NCT00400985|26892644|FG000|Overall Study|Lost to Follow-up|9|||
13432392|NCT00400946|26892686|FG000|Overall Study|Ineligible|0|||
13432393|NCT00400946|26892687|FG001|Overall Study|Ineligible|0|||
13432394|NCT00400946|26892688|FG002|Overall Study|Ineligible|0|||
13432395|NCT00400946|26892689|FG003|Overall Study|Ineligible|5|||
13432396|NCT00400946|26892690|FG004|Overall Study|Ineligible|1|||
13432397|NCT00400946|26892686|FG000|Overall Study|Induction Failure|0|||
13432398|NCT00400946|26892687|FG001|Overall Study|Induction Failure|0|||
13432399|NCT00400946|26892688|FG002|Overall Study|Induction Failure|0|||
13432400|NCT00400946|26892689|FG003|Overall Study|Induction Failure|11|||
13432401|NCT00400946|26892690|FG004|Overall Study|Induction Failure|8|||
13432402|NCT00400946|26892686|FG000|Overall Study|Induction Death|0|||
13432403|NCT00400946|26892687|FG001|Overall Study|Induction Death|0|||
13432404|NCT00400946|26892688|FG002|Overall Study|Induction Death|0|||
13432405|NCT00400946|26892689|FG003|Overall Study|Induction Death|13|||
13432406|NCT00400946|26892690|FG004|Overall Study|Induction Death|3|||
13432407|NCT00400946|26892686|FG000|Overall Study|Lost to Follow-up|1|||
13432408|NCT00400946|26892687|FG001|Overall Study|Lost to Follow-up|1|||
13432409|NCT00400946|26892688|FG002|Overall Study|Lost to Follow-up|0|||
13432410|NCT00400946|26892689|FG003|Overall Study|Lost to Follow-up|0|||
13432411|NCT00400946|26892690|FG004|Overall Study|Lost to Follow-up|1|||
13432412|NCT00400946|26892686|FG000|Overall Study|Remission Death|1|||
13432413|NCT00400946|26892687|FG001|Overall Study|Remission Death|1|||
13432414|NCT00400946|26892688|FG002|Overall Study|Remission Death|0|||
13432415|NCT00400946|26892689|FG003|Overall Study|Remission Death|0|||
13432416|NCT00400946|26892690|FG004|Overall Study|Remission Death|1|||
13432417|NCT00400946|26892686|FG000|Overall Study|Relapse|9|||
13432418|NCT00400946|26892687|FG001|Overall Study|Relapse|2|||
13432419|NCT00400946|26892688|FG002|Overall Study|Relapse|1|||
13432420|NCT00400946|26892689|FG003|Overall Study|Relapse|1|||
13432421|NCT00400946|26892690|FG004|Overall Study|Relapse|5|||
13432422|NCT00400946|26892686|FG000|Overall Study|Transplant in CR1|0|||
13432423|NCT00400946|26892687|FG001|Overall Study|Transplant in CR1|0|||
13432424|NCT00400946|26892688|FG002|Overall Study|Transplant in CR1|0|||
13432425|NCT00400946|26892689|FG003|Overall Study|Transplant in CR1|10|||
13432426|NCT00400946|26892690|FG004|Overall Study|Transplant in CR1|1|||
13432427|NCT00400946|26892686|FG000|Overall Study|Withdrawal by Subject|2|||
13432428|NCT00400946|26892687|FG001|Overall Study|Withdrawal by Subject|5|||
13432429|NCT00400946|26892688|FG002|Overall Study|Withdrawal by Subject|1|||
13432430|NCT00400946|26892689|FG003|Overall Study|Withdrawal by Subject|5|||
13432431|NCT00400946|26892690|FG004|Overall Study|Withdrawal by Subject|8|||
13432432|NCT00400946|26892686|FG000|Overall Study|Clinical|1|||
13432433|NCT00400946|26892687|FG001|Overall Study|Clinical|2|||
13432434|NCT00400946|26892688|FG002|Overall Study|Clinical|0|||
13432435|NCT00400946|26892689|FG003|Overall Study|Clinical|2|||
13432436|NCT00400946|26892690|FG004|Overall Study|Clinical|9|||
13432437|NCT00400946|26892686|FG000|Overall Study|Other|0|||
13432438|NCT00400946|26892687|FG001|Overall Study|Other|0|||
13432439|NCT00400946|26892688|FG002|Overall Study|Other|0|||
13432440|NCT00400946|26892689|FG003|Overall Study|Other|0|||
13432441|NCT00400946|26892690|FG004|Overall Study|Other|1|||
13432442|NCT00400764|26892757|FG000|Phase Ib|Adverse Event|1|||
13432443|NCT00400764|26892758|FG001|Phase Ib|Adverse Event|0|||
13432444|NCT00400764|26892759|FG002|Phase Ib|Adverse Event|0|||
13432445|NCT00400764|26892760|FG003|Phase Ib|Adverse Event|0|||
13432446|NCT00400764|26892761|FG004|Phase Ib|Adverse Event|0|||
13432447|NCT00400764|26892757|FG000|Phase Ib|Death|1|||
13432448|NCT00400764|26892758|FG001|Phase Ib|Death|0|||
13432449|NCT00400764|26892759|FG002|Phase Ib|Death|0|||
13432450|NCT00400764|26892760|FG003|Phase Ib|Death|0|||
13432451|NCT00400764|26892761|FG004|Phase Ib|Death|0|||
13432452|NCT00400764|26892757|FG000|Phase Ib|Disease Progression|4|||
13432453|NCT00400764|26892758|FG001|Phase Ib|Disease Progression|4|||
13432454|NCT00400764|26892759|FG002|Phase Ib|Disease Progression|0|||
13432455|NCT00400764|26892760|FG003|Phase Ib|Disease Progression|0|||
13432456|NCT00400764|26892761|FG004|Phase Ib|Disease Progression|0|||
13432457|NCT00400764|26892757|FG000|Phase II|Death|0|||
13432458|NCT00400764|26892758|FG001|Phase II|Death|0|||
13432459|NCT00400764|26892759|FG002|Phase II|Death|1|||
13432460|NCT00400764|26892760|FG003|Phase II|Death|2|||
13432461|NCT00400764|26892761|FG004|Phase II|Death|0|||
13432462|NCT00400764|26892757|FG000|Phase II|Lost to Follow-up|0|||
13432463|NCT00400764|26892758|FG001|Phase II|Lost to Follow-up|0|||
13432464|NCT00400764|26892759|FG002|Phase II|Lost to Follow-up|1|||
13432465|NCT00400764|26892760|FG003|Phase II|Lost to Follow-up|0|||
13432466|NCT00400764|26892761|FG004|Phase II|Lost to Follow-up|0|||
13432467|NCT00400764|26892757|FG000|Phase II|Physician Decision|0|||
13432468|NCT00400764|26892758|FG001|Phase II|Physician Decision|0|||
13432469|NCT00400764|26892759|FG002|Phase II|Physician Decision|1|||
13432470|NCT00400764|26892760|FG003|Phase II|Physician Decision|1|||
13432471|NCT00400764|26892761|FG004|Phase II|Physician Decision|0|||
13432472|NCT00400764|26892757|FG000|Phase II|Sponsor's decision to terminate|0|||
13432473|NCT00400764|26892758|FG001|Phase II|Sponsor's decision to terminate|0|||
13432474|NCT00400764|26892759|FG002|Phase II|Sponsor's decision to terminate|18|||
13432475|NCT00400764|26892760|FG003|Phase II|Sponsor's decision to terminate|22|||
13432476|NCT00400764|26892761|FG004|Phase II|Sponsor's decision to terminate|11|||
13432477|NCT00400764|26892757|FG000|Phase II|Patient began new, non-protocol, therapy|0|||
13432478|NCT00400764|26892758|FG001|Phase II|Patient began new, non-protocol, therapy|0|||
13432479|NCT00400764|26892759|FG002|Phase II|Patient began new, non-protocol, therapy|1|||
13432480|NCT00400764|26892760|FG003|Phase II|Patient began new, non-protocol, therapy|0|||
13432481|NCT00400764|26892761|FG004|Phase II|Patient began new, non-protocol, therapy|0|||
13432482|NCT00400764|26892757|FG000|Phase II|Withdrawal by Subject|0|||
13432483|NCT00400764|26892758|FG001|Phase II|Withdrawal by Subject|0|||
13432484|NCT00400764|26892759|FG002|Phase II|Withdrawal by Subject|1|||
13432485|NCT00400764|26892760|FG003|Phase II|Withdrawal by Subject|1|||
13432486|NCT00400764|26892761|FG004|Phase II|Withdrawal by Subject|0|||
13432487|NCT00400712|26892786|FG000|Overall Study|Death|1|||
13432488|NCT00400712|26892787|FG001|Overall Study|Death|0|||
13432489|NCT00400712|26892786|FG000|Overall Study|Withdrawal by Subject|11|||
13432490|NCT00400712|26892787|FG001|Overall Study|Withdrawal by Subject|12|||
13432491|NCT00400712|26892786|FG000|Overall Study|Physician Decision|5|||
13432492|NCT00400712|26892787|FG001|Overall Study|Physician Decision|4|||
13432493|NCT00400569|26892800|FG000|Overall Study|Death|1|||
13432494|NCT00400517|26892809|FG000|Overall Study|Withdrawal by Subject|1|||
13432495|NCT00400517|26892809|FG000|Overall Study|Physician Decision|1|||
13432496|NCT00400400|26892834|FG000|Overall Study|Adverse Event|9|||
13432497|NCT00400400|26892835|FG001|Overall Study|Adverse Event|8|||
13432498|NCT00400400|26892834|FG000|Overall Study|Protocol Violation|2|||
13432499|NCT00400400|26892835|FG001|Overall Study|Protocol Violation|0|||
13432500|NCT00400400|26892834|FG000|Overall Study|Withdrawal by Subject|1|||
13432501|NCT00400400|26892835|FG001|Overall Study|Withdrawal by Subject|3|||
13432502|NCT00400400|26892834|FG000|Overall Study|Administrative Problem|1|||
13432503|NCT00400400|26892835|FG001|Overall Study|Administrative Problem|0|||
13432504|NCT00400400|26892834|FG000|Overall Study|Lost to Follow-up|0|||
13432505|NCT00400400|26892835|FG001|Overall Study|Lost to Follow-up|1|||
13432506|NCT00400400|26892834|FG000|Overall Study|Did not receive study drug|1|||
13432507|NCT00400400|26892835|FG001|Overall Study|Did not receive study drug|3|||
13432508|NCT00400179|26892856|FG000|Overall Study|Adverse Event|2|||
13432509|NCT00400179|26892857|FG001|Overall Study|Adverse Event|2|||
13432510|NCT00400179|26892856|FG000|Overall Study|Death|1|||
13432511|NCT00400179|26892857|FG001|Overall Study|Death|2|||
13432512|NCT00400179|26892856|FG000|Overall Study|Withdrew Consent|1|||
13432513|NCT00400179|26892857|FG001|Overall Study|Withdrew Consent|5|||
13432514|NCT00400179|26892856|FG000|Overall Study|Disease progression|1|||
13432515|NCT00400179|26892857|FG001|Overall Study|Disease progression|1|||
13432516|NCT00400179|26892856|FG000|Overall Study|Intercurrent illness|0|||
13432517|NCT00400179|26892857|FG001|Overall Study|Intercurrent illness|1|||
13432518|NCT00400179|26892856|FG000|Overall Study|Investigator judgment|0|||
13432519|NCT00400179|26892857|FG001|Overall Study|Investigator judgment|1|||
13432520|NCT00400179|26892856|FG000|Overall Study|Randomization error/patient ineligible|1|||
13432521|NCT00400179|26892857|FG001|Overall Study|Randomization error/patient ineligible|6|||
13432522|NCT00400153|26893112|FG000|Overall Study|AE due to study disease worsening|14|||
13432523|NCT00400153|26893113|FG001|Overall Study|AE due to study disease worsening|19|||
13432524|NCT00400153|26893114|FG002|Overall Study|AE due to study disease worsening|20|||
13432525|NCT00400153|26893112|FG000|Overall Study|AE due to other disease worsening|2|||
13432526|NCT00400153|26893113|FG001|Overall Study|AE due to other disease worsening|1|||
13432527|NCT00400153|26893114|FG002|Overall Study|AE due to other disease worsening|0|||
13432528|NCT00400153|26893112|FG000|Overall Study|AE due to other condition|3|||
13432529|NCT00400153|26893113|FG001|Overall Study|AE due to other condition|14|||
13432530|NCT00400153|26893114|FG002|Overall Study|AE due to other condition|15|||
13432531|NCT00400153|26893112|FG000|Overall Study|Protocol Violation|7|||
13432532|NCT00400153|26893113|FG001|Overall Study|Protocol Violation|4|||
13432533|NCT00400153|26893114|FG002|Overall Study|Protocol Violation|9|||
13432534|NCT00400153|26893112|FG000|Overall Study|Lost to Follow-up|2|||
13432535|NCT00400153|26893113|FG001|Overall Study|Lost to Follow-up|1|||
13432536|NCT00400153|26893114|FG002|Overall Study|Lost to Follow-up|4|||
13432537|NCT00400153|26893112|FG000|Overall Study|Withdrawal by Subject|12|||
13432538|NCT00400153|26893113|FG001|Overall Study|Withdrawal by Subject|11|||
13432539|NCT00400153|26893114|FG002|Overall Study|Withdrawal by Subject|10|||
13432540|NCT00400153|26893112|FG000|Overall Study|Other reasons - not mentioned above|8|||
13432541|NCT00400153|26893113|FG001|Overall Study|Other reasons - not mentioned above|5|||
13432542|NCT00400153|26893114|FG002|Overall Study|Other reasons - not mentioned above|3|||
13432543|NCT00399893|26893147|FG000|Overall Study|Withdrawal by Subject|1|||
13432544|NCT00399893|26893148|FG001|Overall Study|Withdrawal by Subject|0|||
13432545|NCT00399802|26893167|FG000|Overall Study|Adverse Event|0|||
13432546|NCT00399802|26893168|FG001|Overall Study|Adverse Event|2|||
13432547|NCT00399802|26893167|FG000|Overall Study|Participant discontinued by mistake|0|||
13432548|NCT00399802|26893168|FG001|Overall Study|Participant discontinued by mistake|1|||
13432549|NCT00399763|26893185|FG000|Overall Study|Lost to Follow-up|2|||
13432550|NCT00399763|26893186|FG001|Overall Study|Lost to Follow-up|3|||
13432551|NCT00399568|26893205|FG000|Overall Study|Adverse Event|1|||
13432552|NCT00399568|26893206|FG001|Overall Study|Adverse Event|2|||
13432553|NCT00399568|26893205|FG000|Overall Study|Withdrawal by Subject|7|||
13432554|NCT00399568|26893206|FG001|Overall Study|Withdrawal by Subject|3|||
13432555|NCT00399568|26893205|FG000|Overall Study|Protocol non-compliance|2|||
13432556|NCT00399568|26893206|FG001|Overall Study|Protocol non-compliance|2|||
13432557|NCT00399568|26893205|FG000|Overall Study|Lost to Follow-up|2|||
13432558|NCT00399568|26893206|FG001|Overall Study|Lost to Follow-up|2|||
13432559|NCT00399542|26893275|FG000|Overall Study|Adverse Event|18|||
13432560|NCT00399542|26893276|FG001|Overall Study|Adverse Event|15|||
13432561|NCT00399542|26893275|FG000|Overall Study|Protocol Violation|13|||
13432562|NCT00399542|26893276|FG001|Overall Study|Protocol Violation|3|||
13432563|NCT00399542|26893275|FG000|Overall Study|Withdrawal by Subject|28|||
13432564|NCT00399542|26893276|FG001|Overall Study|Withdrawal by Subject|10|||
13432565|NCT00399542|26893275|FG000|Overall Study|Lack of Efficacy|18|||
13432566|NCT00399542|26893276|FG001|Overall Study|Lack of Efficacy|8|||
13432567|NCT00399542|26893275|FG000|Overall Study|Lost to Follow-up|6|||
13432568|NCT00399542|26893276|FG001|Overall Study|Lost to Follow-up|6|||
13432569|NCT00399542|26893275|FG000|Overall Study|Other|1|||
13432570|NCT00399542|26893276|FG001|Overall Study|Other|0|||
13432571|NCT00399542|26893275|FG000|Overall Study|Physician Decision|0|||
13432572|NCT00399542|26893276|FG001|Overall Study|Physician Decision|1|||
13432573|NCT00399529|26893284|FG000|Overall Study|Off Study Prior to Treatment|2|||
13432574|NCT00399516|26893290|FG000|Overall Study|Lost to Follow-up|2|||
13432575|NCT00399490|26893311|FG000|Overall Study|Adverse Event|19|||
13432576|NCT00399490|26893311|FG000|Overall Study|Lack of Efficacy|31|||
13432577|NCT00399490|26893311|FG000|Overall Study|Lost to Follow-up|5|||
13432578|NCT00399490|26893311|FG000|Overall Study|Withdrawal by Subject|18|||
13432579|NCT00399490|26893311|FG000|Overall Study|Other|25|||
13432580|NCT00399360|26893370|FG000|Overall Study|Lost to Follow-up|2|||
13432581|NCT00399360|26893371|FG001|Overall Study|Lost to Follow-up|1|||
13432582|NCT00399360|26893372|FG002|Overall Study|Lost to Follow-up|2|||
13432583|NCT00399360|26893373|FG003|Overall Study|Lost to Follow-up|4|||
13432584|NCT00399360|26893370|FG000|Overall Study|Adverse Event|0|||
13432585|NCT00399360|26893371|FG001|Overall Study|Adverse Event|0|||
13432586|NCT00399360|26893372|FG002|Overall Study|Adverse Event|1|||
13432587|NCT00399360|26893373|FG003|Overall Study|Adverse Event|0|||
13432588|NCT00399360|26893370|FG000|Overall Study|Withdrawal by Subject|0|||
13432589|NCT00399360|26893371|FG001|Overall Study|Withdrawal by Subject|2|||
13432590|NCT00399360|26893372|FG002|Overall Study|Withdrawal by Subject|0|||
13432591|NCT00399360|26893373|FG003|Overall Study|Withdrawal by Subject|2|||
13432592|NCT00399035|26893402|FG000|Overall Study|Death|289|||
13432593|NCT00399035|26893403|FG001|Overall Study|Death|141|||
13432594|NCT00399035|26893404|FG002|Overall Study|Death|234|||
13432595|NCT00399035|26893402|FG000|Overall Study|Lost to Follow-up|2|||
13432596|NCT00399035|26893403|FG001|Overall Study|Lost to Follow-up|1|||
13432597|NCT00399035|26893404|FG002|Overall Study|Lost to Follow-up|5|||
13432598|NCT00399035|26893402|FG000|Overall Study|Withdrawal by Subject|19|||
13432599|NCT00399035|26893403|FG001|Overall Study|Withdrawal by Subject|15|||
13432600|NCT00399035|26893404|FG002|Overall Study|Withdrawal by Subject|12|||
13432601|NCT00399035|26893402|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
13432602|NCT00399035|26893403|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0|||
13432603|NCT00399035|26893404|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
13432604|NCT00399035|26893402|FG000|Overall Study|Severe non-compliance with protocol|2|||
13432605|NCT00399035|26893403|FG001|Overall Study|Severe non-compliance with protocol|1|||
13432606|NCT00399035|26893404|FG002|Overall Study|Severe non-compliance with protocol|0|||
13432607|NCT00398866|26893425|FG000|Overall Study|Adverse Event|1|||
13432608|NCT00398866|26893426|FG001|Overall Study|Adverse Event|0|||
13432609|NCT00398866|26893427|FG002|Overall Study|Adverse Event|0|||
13432610|NCT00398866|26893425|FG000|Overall Study|Lack of Efficacy|0|||
13432611|NCT00398866|26893426|FG001|Overall Study|Lack of Efficacy|0|||
13432612|NCT00398866|26893427|FG002|Overall Study|Lack of Efficacy|1|||
13432613|NCT00398866|26893425|FG000|Overall Study|Lost to Follow-up|7|||
13432614|NCT00398866|26893426|FG001|Overall Study|Lost to Follow-up|6|||
13432615|NCT00398866|26893427|FG002|Overall Study|Lost to Follow-up|4|||
13432616|NCT00398866|26893425|FG000|Overall Study|Withdrawal by Subject|5|||
13432617|NCT00398866|26893426|FG001|Overall Study|Withdrawal by Subject|1|||
13432618|NCT00398866|26893427|FG002|Overall Study|Withdrawal by Subject|2|||
13432619|NCT00398866|26893425|FG000|Overall Study|Unable to complete requirements of study|1|||
13432620|NCT00398866|26893426|FG001|Overall Study|Unable to complete requirements of study|1|||
13432621|NCT00398866|26893427|FG002|Overall Study|Unable to complete requirements of study|1|||
13432622|NCT00398632|26893434|FG000|Overall Study|Withdrawal by Subject|1|||
13432623|NCT00398632|26893434|FG000|Overall Study|Lack of Efficacy|1|||
13432624|NCT00398567|26893456|FG000|Overall Study|Disease Progression|3|||
13432625|NCT00398567|26893457|FG001|Overall Study|Disease Progression|4|||
13432626|NCT00398567|26893458|FG002|Overall Study|Disease Progression|27|||
13432627|NCT00398567|26893456|FG000|Overall Study|Withdrawal by Subject|1|||
13432628|NCT00398567|26893457|FG001|Overall Study|Withdrawal by Subject|0|||
13432629|NCT00398567|26893458|FG002|Overall Study|Withdrawal by Subject|4|||
13432630|NCT00398567|26893456|FG000|Overall Study|Adverse Event|0|||
13432631|NCT00398567|26893457|FG001|Overall Study|Adverse Event|0|||
13432632|NCT00398567|26893458|FG002|Overall Study|Adverse Event|2|||
13432633|NCT00398567|26893456|FG000|Overall Study|Protocol Violation|0|||
13432634|NCT00398567|26893457|FG001|Overall Study|Protocol Violation|0|||
13432635|NCT00398567|26893458|FG002|Overall Study|Protocol Violation|1|||
13432636|NCT00398411|26893481|FG000|Overall Study|Death|0|||
13432637|NCT00398411|26893482|FG001|Overall Study|Death|1|||
13432638|NCT00398320|26893492|FG000|Overall Study|Death|1|||
13432639|NCT00398320|26893492|FG000|Overall Study|Adverse Event|4|||
13432640|NCT00398320|26893492|FG000|Overall Study|Physician Decision|1|||
13432641|NCT00398216|26893535|FG000|Overall Study|Adverse Event|4|||
13432642|NCT00398216|26893536|FG001|Overall Study|Adverse Event|2|||
13432643|NCT00398216|26893537|FG002|Overall Study|Adverse Event|5|||
13432644|NCT00398216|26893538|FG003|Overall Study|Adverse Event|7|||
13432645|NCT00398216|26893539|FG004|Overall Study|Adverse Event|2|||
13432646|NCT00398216|26893535|FG000|Overall Study|Protocol Violation|2|||
13432647|NCT00398216|26893536|FG001|Overall Study|Protocol Violation|4|||
13432648|NCT00398216|26893537|FG002|Overall Study|Protocol Violation|5|||
13432649|NCT00398216|26893538|FG003|Overall Study|Protocol Violation|7|||
13432650|NCT00398216|26893539|FG004|Overall Study|Protocol Violation|5|||
13432651|NCT00398216|26893535|FG000|Overall Study|Lost to Follow-up|1|||
13432652|NCT00398216|26893536|FG001|Overall Study|Lost to Follow-up|6|||
13432653|NCT00398216|26893537|FG002|Overall Study|Lost to Follow-up|4|||
13432654|NCT00398216|26893538|FG003|Overall Study|Lost to Follow-up|4|||
13432655|NCT00398216|26893539|FG004|Overall Study|Lost to Follow-up|1|||
13432656|NCT00398216|26893535|FG000|Overall Study|Death|0|||
13432657|NCT00398216|26893536|FG001|Overall Study|Death|3|||
13432658|NCT00398216|26893537|FG002|Overall Study|Death|0|||
13432659|NCT00398216|26893538|FG003|Overall Study|Death|0|||
13432660|NCT00398216|26893539|FG004|Overall Study|Death|0|||
13432661|NCT00398216|26893535|FG000|Overall Study|Withdrawal by Subject|1|||
13432662|NCT00398216|26893536|FG001|Overall Study|Withdrawal by Subject|0|||
13432663|NCT00398216|26893537|FG002|Overall Study|Withdrawal by Subject|3|||
13432664|NCT00398216|26893538|FG003|Overall Study|Withdrawal by Subject|1|||
13432665|NCT00398216|26893539|FG004|Overall Study|Withdrawal by Subject|2|||
13432666|NCT00398216|26893535|FG000|Overall Study|administrative reasons|3|||
13432667|NCT00398216|26893536|FG001|Overall Study|administrative reasons|4|||
13432668|NCT00398216|26893537|FG002|Overall Study|administrative reasons|4|||
13432669|NCT00398216|26893538|FG003|Overall Study|administrative reasons|3|||
13432670|NCT00398216|26893539|FG004|Overall Study|administrative reasons|3|||
13432671|NCT00398216|26893535|FG000|Overall Study|entrance criteria|0|||
13432672|NCT00398216|26893536|FG001|Overall Study|entrance criteria|0|||
13432673|NCT00398216|26893537|FG002|Overall Study|entrance criteria|0|||
13432674|NCT00398216|26893538|FG003|Overall Study|entrance criteria|0|||
13432675|NCT00398216|26893539|FG004|Overall Study|entrance criteria|2|||
13432676|NCT00398138|26893546|FG000|Overall Study|Adverse Event|2|||
13432677|NCT00398112|26893556|FG000|Overall Study|Adverse Event|4|||
13432678|NCT00398112|26893556|FG000|Overall Study|Disease progression|9|||
13432679|NCT00398112|26893556|FG000|Overall Study|Alternative treatment|1|||
13432680|NCT00398112|26893556|FG000|Overall Study|Withdrawal by Subject|3|||
13432681|NCT00398112|26893556|FG000|Overall Study|Death|1|||
13432682|NCT00398086|26893598|FG000|Overall Study|Unacceptable Toxicity|2|||
13432683|NCT00398086|26893599|FG001|Overall Study|Unacceptable Toxicity|8|||
13432684|NCT00398086|26893600|FG002|Overall Study|Unacceptable Toxicity|2|||
13432685|NCT00398086|26893598|FG000|Overall Study|Adverse Event|1|||
13432686|NCT00398086|26893599|FG001|Overall Study|Adverse Event|4|||
13432687|NCT00398086|26893600|FG002|Overall Study|Adverse Event|0|||
13432688|NCT00398086|26893598|FG000|Overall Study|Physician Decision|1|||
13432689|NCT00398086|26893599|FG001|Overall Study|Physician Decision|4|||
13432690|NCT00398086|26893600|FG002|Overall Study|Physician Decision|0|||
13432691|NCT00398086|26893598|FG000|Overall Study|Withdrawal by Subject|5|||
13432692|NCT00398086|26893599|FG001|Overall Study|Withdrawal by Subject|7|||
13432693|NCT00398086|26893600|FG002|Overall Study|Withdrawal by Subject|0|||
13432694|NCT00398073|26893617|FG000|Overall Study|Withdrawal by Subject|1|||
13432695|NCT00398073|26893618|FG001|Overall Study|Withdrawal by Subject|0|||
13432696|NCT00398047|26893630|FG000|Overall Study|all patient progressed before completion|3|||
13432697|NCT00397982|26893641|FG000|Overall Study|Withdrawal by Subject|1|||
13432698|NCT00397982|26893641|FG000|Overall Study|Adverse Event|1|||
13432699|NCT00397982|26893641|FG000|Overall Study|noncompliance|1|||
13432700|NCT00397982|26893641|FG000|Overall Study|Unrelated health issues|1|||
13432701|NCT00397943|26893811|FG000|Overall Study|Unspecified reasons|12|||
13432702|NCT00397943|26893812|FG001|Overall Study|Unspecified reasons|9|||
13432703|NCT00397943|26893813|FG002|Overall Study|Unspecified reasons|0|||
13432704|NCT00397943|26893814|FG003|Overall Study|Unspecified reasons|0|||
13432705|NCT00397943|26893815|FG004|Overall Study|Unspecified reasons|0|||
13432706|NCT00397930|26893828|FG000|Overall Study|Personal reasons|14|||
13432707|NCT00397930|26893829|FG001|Overall Study|Personal reasons|8|||
13432708|NCT00397930|26893828|FG000|Overall Study|Other medical|9|||
13432709|NCT00397930|26893829|FG001|Overall Study|Other medical|4|||
13432710|NCT00397930|26893828|FG000|Overall Study|Unknown reasons|9|||
13432711|NCT00397930|26893829|FG001|Overall Study|Unknown reasons|14|||
13432712|NCT00397930|26893828|FG000|Overall Study|Noncompliant|3|||
13432713|NCT00397930|26893829|FG001|Overall Study|Noncompliant|2|||
13432714|NCT00397930|26893828|FG000|Overall Study|Too time-consuming|2|||
13432715|NCT00397930|26893829|FG001|Overall Study|Too time-consuming|9|||
13432716|NCT00397930|26893828|FG000|Overall Study|Started own yoga program|1|||
13432717|NCT00397930|26893829|FG001|Overall Study|Started own yoga program|1|||
13432718|NCT00397930|26893828|FG000|Overall Study|Did not want to be in control group|0|||
13432719|NCT00397930|26893829|FG001|Overall Study|Did not want to be in control group|1|||
13432720|NCT00397930|26893828|FG000|Overall Study|Withdrawal by Subject|0|||
13432721|NCT00397930|26893829|FG001|Overall Study|Withdrawal by Subject|8|||
13432722|NCT00397930|26893828|FG000|Overall Study|Missing data|0|||
13432723|NCT00397930|26893829|FG001|Overall Study|Missing data|4|||
13432724|NCT00397891|26893943|FG000|Overall Study|Withdrawal by Subject|1|||
13432725|NCT00397891|26893944|FG001|Overall Study|Withdrawal by Subject|0|||
13432726|NCT00397891|26893945|FG002|Overall Study|Withdrawal by Subject|0|||
13432727|NCT00397891|26893946|FG003|Overall Study|Withdrawal by Subject|0|||
13432728|NCT00397891|26893947|FG004|Overall Study|Withdrawal by Subject|1|||
13432729|NCT00397631|26893964|FG000|Overall Study|Adverse Event|5|||
13432730|NCT00397631|26893965|FG001|Overall Study|Adverse Event|6|||
13432731|NCT00397631|26893964|FG000|Overall Study|Lack of Efficacy|7|||
13432732|NCT00397631|26893965|FG001|Overall Study|Lack of Efficacy|10|||
13432733|NCT00397631|26893964|FG000|Overall Study|Lost to Follow-up|8|||
13432734|NCT00397631|26893965|FG001|Overall Study|Lost to Follow-up|9|||
13432735|NCT00397631|26893964|FG000|Overall Study|Physician Decision|2|||
13432736|NCT00397631|26893965|FG001|Overall Study|Physician Decision|0|||
13432737|NCT00397631|26893964|FG000|Overall Study|Protocol Violation|0|||
13432738|NCT00397631|26893965|FG001|Overall Study|Protocol Violation|1|||
13432739|NCT00397631|26893964|FG000|Overall Study|Withdrawal by Subject|7|||
13432740|NCT00397631|26893965|FG001|Overall Study|Withdrawal by Subject|14|||
13432741|NCT00397631|26893964|FG000|Overall Study|protocol discontinuation criteria|1|||
13432742|NCT00397631|26893965|FG001|Overall Study|protocol discontinuation criteria|4|||
13432743|NCT00397540|26893980|FG000|Overall Study|short follow-up duration < 12 months|1|||
13432744|NCT00397540|26893981|FG001|Overall Study|short follow-up duration < 12 months|0|||
13432745|NCT00397514|26893993|FG000|Overall Study|Withdrawal by Subject|1|||
13432746|NCT00397514|26893993|FG000|Overall Study|Pacing wire malfunction|1|||
13432747|NCT00397514|26893993|FG000|Overall Study|Not able to capture & pace LV intraoper.|4|||
13432748|NCT00397514|26893993|FG000|Overall Study|early extubation|2|||
13432749|NCT00397514|26893993|FG000|Overall Study|poor echocardiographic windows|1|||
13432750|NCT00397488|26893999|FG000|Overall Study|Withdrawal by Subject|3|||
13432751|NCT00397488|26893999|FG000|Overall Study|Adverse Event|3|||
13432752|NCT00397488|26893999|FG000|Overall Study|Death|1|||
13432753|NCT00397215|26894146|FG000|Month 0 (Day 0)|Adverse Event|0|||
13432754|NCT00397215|26894147|FG001|Month 0 (Day 0)|Adverse Event|1|||
13432755|NCT00397215|26894148|FG002|Month 0 (Day 0)|Adverse Event|0|||
13432756|NCT00397215|26894149|FG003|Month 0 (Day 0)|Adverse Event|0|||
13432757|NCT00397215|26894146|FG000|Month 0 (Day 0)|Withdrawal by Subject|3|||
13432758|NCT00397215|26894147|FG001|Month 0 (Day 0)|Withdrawal by Subject|3|||
13432759|NCT00397215|26894148|FG002|Month 0 (Day 0)|Withdrawal by Subject|3|||
13432760|NCT00397215|26894149|FG003|Month 0 (Day 0)|Withdrawal by Subject|1|||
13432761|NCT00397215|26894146|FG000|Month 0 (Day 0)|Other|4|||
13432762|NCT00397215|26894147|FG001|Month 0 (Day 0)|Other|1|||
13432763|NCT00397215|26894148|FG002|Month 0 (Day 0)|Other|3|||
13432764|NCT00397215|26894149|FG003|Month 0 (Day 0)|Other|3|||
13432765|NCT00397215|26894146|FG000|Month 6 (Day 180)|Adverse Event|0|||
13432766|NCT00397215|26894147|FG001|Month 6 (Day 180)|Adverse Event|3|||
13432767|NCT00397215|26894148|FG002|Month 6 (Day 180)|Adverse Event|2|||
13432768|NCT00397215|26894149|FG003|Month 6 (Day 180)|Adverse Event|0|||
13432769|NCT00397215|26894146|FG000|Month 6 (Day 180)|Other|2|||
13432770|NCT00397215|26894147|FG001|Month 6 (Day 180)|Other|0|||
13432771|NCT00397215|26894148|FG002|Month 6 (Day 180)|Other|3|||
13432772|NCT00397215|26894149|FG003|Month 6 (Day 180)|Other|0|||
13432773|NCT00397189|26894164|FG000|3 Weeks Period|Lost to Follow-up|5|||
13432774|NCT00397189|26894165|FG001|3 Weeks Period|Lost to Follow-up|4|||
13432775|NCT00397189|26894164|FG000|3 Weeks Period|Adverse Event|3|||
13432776|NCT00397189|26894165|FG001|3 Weeks Period|Adverse Event|2|||
13432777|NCT00397189|26894164|FG000|3 Weeks Period|Withdrawal by Subject|13|||
13432778|NCT00397189|26894165|FG001|3 Weeks Period|Withdrawal by Subject|9|||
13432779|NCT00397189|26894164|FG000|3 Weeks Period|Physician Decision|0|||
13432780|NCT00397189|26894165|FG001|3 Weeks Period|Physician Decision|2|||
13432781|NCT00397189|26894164|FG000|3 Weeks Period|Protocol Violation|0|||
13432782|NCT00397189|26894165|FG001|3 Weeks Period|Protocol Violation|3|||
13432783|NCT00397189|26894164|FG000|3 Weeks Period|Other|0|||
13432784|NCT00397189|26894165|FG001|3 Weeks Period|Other|2|||
13432785|NCT00397046|26894197|FG000|Overall Study|Disease Progression|3|||
13432786|NCT00397046|26894198|FG001|Overall Study|Disease Progression|3|||
13432787|NCT00397046|26894199|FG002|Overall Study|Disease Progression|10|||
13432788|NCT00397046|26894200|FG003|Overall Study|Disease Progression|5|||
13432789|NCT00397033|26894269|FG000|Overall Study|Adverse Event|7|||
13432790|NCT00397033|26894270|FG001|Overall Study|Adverse Event|10|||
13432791|NCT00397033|26894271|FG002|Overall Study|Adverse Event|4|||
13432792|NCT00397033|26894269|FG000|Overall Study|Lack of Efficacy|22|||
13432793|NCT00397033|26894270|FG001|Overall Study|Lack of Efficacy|12|||
13432794|NCT00397033|26894271|FG002|Overall Study|Lack of Efficacy|9|||
13219917|NCT01829191|26278652|FG000|Overall Study|Relocation|0|||
13432795|NCT00397033|26894269|FG000|Overall Study|Lost to Follow-up|3|||
13432796|NCT00397033|26894270|FG001|Overall Study|Lost to Follow-up|3|||
13432797|NCT00397033|26894271|FG002|Overall Study|Lost to Follow-up|3|||
13432798|NCT00397033|26894269|FG000|Overall Study|Withdrawal by Subject|12|||
13432799|NCT00397033|26894270|FG001|Overall Study|Withdrawal by Subject|7|||
13432800|NCT00397033|26894271|FG002|Overall Study|Withdrawal by Subject|5|||
13432801|NCT00397033|26894269|FG000|Overall Study|Other|0|||
13432802|NCT00397033|26894270|FG001|Overall Study|Other|5|||
13432803|NCT00397033|26894271|FG002|Overall Study|Other|2|||
13432804|NCT00396877|26894288|FG000|Overall Study|Lost to Follow-up|2|||
13432805|NCT00396877|26894289|FG001|Overall Study|Lost to Follow-up|1|||
13432806|NCT00396877|26894288|FG000|Overall Study|Parent(s)/guardian(s)'s request|4|||
13432807|NCT00396877|26894289|FG001|Overall Study|Parent(s)/guardian(s)'s request|7|||
13432808|NCT00396812|26894303|FG000|Overall Study|Physician Decision|1|||
13432809|NCT00396656|26894322|FG000|First Treatment Period|Withdrawal by Subject|0|||
13432810|NCT00396656|26894323|FG001|First Treatment Period|Withdrawal by Subject|2|||
13432811|NCT00396656|26894322|FG000|Second Treatment Period|Adverse Event|0|||
13432812|NCT00396656|26894323|FG001|Second Treatment Period|Adverse Event|1|||
13432813|NCT00396630|26894350|FG000|Overall Study|Lost to Follow-up|1|||
13432814|NCT00396630|26894351|FG001|Overall Study|Lost to Follow-up|1|||
13432815|NCT00396630|26894350|FG000|Overall Study|Withdrawal by Subject|1|||
13432816|NCT00396630|26894351|FG001|Overall Study|Withdrawal by Subject|1|||
13432817|NCT00396630|26894350|FG000|Overall Study|Not vaccinated at Visit 3|3|||
13432818|NCT00396630|26894351|FG001|Overall Study|Not vaccinated at Visit 3|3|||
13476891|NCT04425902|27003995|FG000|Treatment Period 2 (Days 11 to 20)|Adverse Event|1|||
13476892|NCT04072146|27004016|FG000|Overall Study|Adverse Event|0|||
13476893|NCT04072146|27004017|FG001|Overall Study|Adverse Event|1|||
13476894|NCT03861481|27004030|FG000|Overall Study|COVID-19 pandemic circumstances|0|||
13476895|NCT03861481|27004031|FG001|Overall Study|COVID-19 pandemic circumstances|1|||
13476896|NCT03861481|27004030|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1|||
13476897|NCT03861481|27004031|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0|||
13476898|NCT03861481|27004030|FG000|Overall Study|Relapse|1|||
13476899|NCT03861481|27004031|FG001|Overall Study|Relapse|0|||
13476900|NCT03861481|27004030|FG000|Overall Study|Withdrawal by Subject|0|||
13476901|NCT03861481|27004031|FG001|Overall Study|Withdrawal by Subject|1|||
13476902|NCT03861481|27004030|FG000|Overall Study|Lack of Efficacy|4|||
13476903|NCT03861481|27004031|FG001|Overall Study|Lack of Efficacy|5|||
13476904|NCT03648476|27004056|FG000|Overall Study|Withdrawal by Subject|2|||
13476905|NCT03648476|27004057|FG001|Overall Study|Withdrawal by Subject|1|||
13476906|NCT03375203|27004315|FG000|Overall Study|Protocol Violation|0|||
13476907|NCT03375203|27004316|FG001|Overall Study|Protocol Violation|0|||
13476908|NCT03375203|27004317|FG002|Overall Study|Protocol Violation|1|||
13476909|NCT03375203|27004318|FG003|Overall Study|Protocol Violation|0|||
13476910|NCT03375203|27004319|FG004|Overall Study|Protocol Violation|0|||
13476911|NCT03375203|27004315|FG000|Overall Study|Adverse Event|2|||
13476912|NCT03375203|27004316|FG001|Overall Study|Adverse Event|3|||
13476913|NCT03375203|27004317|FG002|Overall Study|Adverse Event|0|||
13476914|NCT03375203|27004318|FG003|Overall Study|Adverse Event|2|||
13476915|NCT03375203|27004319|FG004|Overall Study|Adverse Event|2|||
13476916|NCT03375203|27004315|FG000|Overall Study|Withdrawal by Subject|3|||
13476917|NCT03375203|27004316|FG001|Overall Study|Withdrawal by Subject|0|||
13476918|NCT03375203|27004317|FG002|Overall Study|Withdrawal by Subject|1|||
13476919|NCT03375203|27004318|FG003|Overall Study|Withdrawal by Subject|0|||
13476920|NCT03375203|27004319|FG004|Overall Study|Withdrawal by Subject|2|||
13476921|NCT03375203|27004315|FG000|Overall Study|Non-compliance with study drug|1|||
13476922|NCT03375203|27004316|FG001|Overall Study|Non-compliance with study drug|0|||
13476923|NCT03375203|27004317|FG002|Overall Study|Non-compliance with study drug|0|||
13476924|NCT03375203|27004318|FG003|Overall Study|Non-compliance with study drug|0|||
13476925|NCT03375203|27004319|FG004|Overall Study|Non-compliance with study drug|0|||
13476926|NCT03375203|27004315|FG000|Overall Study|Randomized, not treated.|0|||
13476927|NCT03375203|27004316|FG001|Overall Study|Randomized, not treated.|1|||
13476928|NCT03375203|27004317|FG002|Overall Study|Randomized, not treated.|0|||
13476929|NCT03375203|27004318|FG003|Overall Study|Randomized, not treated.|0|||
13476930|NCT03375203|27004319|FG004|Overall Study|Randomized, not treated.|0|||
13476931|NCT01231906|27004338|FG000|Overall Study|Lack of Efficacy|75|||
13476932|NCT01231906|27004339|FG001|Overall Study|Lack of Efficacy|68|||
13476933|NCT01231906|27004338|FG000|Overall Study|Lost to Follow-up|1|||
13476934|NCT01231906|27004339|FG001|Overall Study|Lost to Follow-up|0|||
13476935|NCT01231906|27004338|FG000|Overall Study|Physician Decision|34|||
13476936|NCT01231906|27004339|FG001|Overall Study|Physician Decision|24|||
13476937|NCT01231906|27004338|FG000|Overall Study|Withdrawal by Subject|0|||
13476938|NCT01231906|27004339|FG001|Overall Study|Withdrawal by Subject|4|||
13476939|NCT01231906|27004338|FG000|Overall Study|Ineligible|10|||
13476940|NCT01231906|27004339|FG001|Overall Study|Ineligible|3|||
13476941|NCT01231906|27004338|FG000|Overall Study|No treatment|1|||
13476942|NCT01231906|27004339|FG001|Overall Study|No treatment|2|||
13476943|NCT04545060|27004397|FG000|Overall Study|Adverse Event|0|||
13219918|NCT01829191|26278653|FG001|Overall Study|Relocation|1|||
13432819|NCT00396591|26894363|FG000|Overall Study|Disease Progression|13|||
13432820|NCT00396591|26894363|FG000|Overall Study|Adverse Event|2|||
13432821|NCT00396591|26894363|FG000|Overall Study|Participant request|1|||
13432822|NCT00396565|26894396|FG000|Overall Study|Physician Decision|3|||
13432823|NCT00396565|26894397|FG001|Overall Study|Physician Decision|1|||
13432824|NCT00396565|26894398|FG002|Overall Study|Physician Decision|2|||
13432825|NCT00396565|26894396|FG000|Overall Study|Adverse Event|5|||
13432826|NCT00396565|26894397|FG001|Overall Study|Adverse Event|13|||
13432827|NCT00396565|26894398|FG002|Overall Study|Adverse Event|3|||
13432828|NCT00396565|26894396|FG000|Overall Study|Withdrawal by Subject|8|||
13432829|NCT00396565|26894397|FG001|Overall Study|Withdrawal by Subject|13|||
13432830|NCT00396565|26894398|FG002|Overall Study|Withdrawal by Subject|1|||
13432831|NCT00396565|26894396|FG000|Overall Study|Lack of Efficacy|32|||
13432832|NCT00396565|26894397|FG001|Overall Study|Lack of Efficacy|64|||
13432833|NCT00396565|26894398|FG002|Overall Study|Lack of Efficacy|11|||
13432834|NCT00396409|26894435|FG000|Period 1 - 2007|Adverse Event|0|||
13432835|NCT00396409|26894436|FG001|Period 1 - 2007|Adverse Event|1|||
13432836|NCT00396409|26894435|FG000|Period 1 - 2007|Lack of Efficacy|0|||
13432837|NCT00396409|26894436|FG001|Period 1 - 2007|Lack of Efficacy|1|||
13432838|NCT00396409|26894435|FG000|Period 1 - 2007|Withdrawal by Subject|1|||
13432839|NCT00396409|26894436|FG001|Period 1 - 2007|Withdrawal by Subject|1|||
13432840|NCT00396409|26894435|FG000|Period 1 - 2007|Lost to Follow-up|2|||
13432841|NCT00396409|26894436|FG001|Period 1 - 2007|Lost to Follow-up|3|||
13432842|NCT00396409|26894435|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3|||
13432843|NCT00396409|26894436|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2|||
13432844|NCT00396409|26894435|FG000|Period 2 - 2008|Protocol Violation|1|||
13432845|NCT00396409|26894436|FG001|Period 2 - 2008|Protocol Violation|0|||
13432846|NCT00396409|26894435|FG000|Period 2 - 2008|Withdrawal by Subject|3|||
13432847|NCT00396409|26894436|FG001|Period 2 - 2008|Withdrawal by Subject|1|||
13432848|NCT00396409|26894435|FG000|Period 2 - 2008|Lost to Follow-up|3|||
13432849|NCT00396409|26894436|FG001|Period 2 - 2008|Lost to Follow-up|1|||
13432850|NCT00396383|26894447|FG000|Overall Study|Death|2|||
13432851|NCT00396383|26894447|FG000|Overall Study|Lost to Follow-up|1|||
13432852|NCT00396331|26894510|FG000|Overall Study|Failed to mobilize - no transplant|8|||
13432853|NCT00396331|26894510|FG000|Overall Study|Did not go on to transplant|5|||
13432854|NCT00396331|26894510|FG000|Overall Study|Lost to Follow-up|3|||
13432855|NCT00396331|26894510|FG000|Overall Study|Death|16|||
13432856|NCT00396318|26894523|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5|||
13432857|NCT00396253|26894537|FG000|Overall Study|Protocol Violation|1|||
13432858|NCT00396253|26894537|FG000|Overall Study|Withdrawal by Subject|7|||
13432859|NCT00396253|26894537|FG000|Overall Study|Death|3|||
13432860|NCT00396253|26894537|FG000|Overall Study|Physician Decision|1|||
13432861|NCT00396253|26894537|FG000|Overall Study|Change in eligibility status|1|||
13432862|NCT00396162|26894556|FG000|Overall Study|Withdrawal by Subject|2|||
13432863|NCT00396162|26894557|FG001|Overall Study|Withdrawal by Subject|3|||
13432864|NCT00396136|26894564|FG000|Overall Study|Death|43|||
13432865|NCT00396136|26894564|FG000|Overall Study|Withdrawal by Subject|59|||
13432866|NCT00396136|26894564|FG000|Overall Study|Lost to Follow-up|15|||
13432867|NCT00396136|26894564|FG000|Overall Study|Study device explanted|8|||
13432868|NCT00396097|26894593|FG000|Overall Study|Withdrawal by Subject|17|||
13432869|NCT00396097|26894594|FG001|Overall Study|Withdrawal by Subject|17|||
13432870|NCT00396097|26894593|FG000|Overall Study|Lost to Follow-up|4|||
13432871|NCT00396097|26894594|FG001|Overall Study|Lost to Follow-up|9|||
13432872|NCT00396097|26894593|FG000|Overall Study|Other|3|||
13432873|NCT00396097|26894594|FG001|Overall Study|Other|5|||
13432874|NCT00396097|26894593|FG000|Overall Study|Protocol Violation|0|||
13432875|NCT00396097|26894594|FG001|Overall Study|Protocol Violation|6|||
13432876|NCT00396097|26894593|FG000|Overall Study|Adverse Event|1|||
13432877|NCT00396097|26894594|FG001|Overall Study|Adverse Event|5|||
13432878|NCT00396097|26894593|FG000|Overall Study|Insufficient Clinical Response|1|||
13432879|NCT00396097|26894594|FG001|Overall Study|Insufficient Clinical Response|4|||
13432880|NCT00396084|26894686|FG000|Overall Study|Adverse Event|0|||
13432881|NCT00396084|26894687|FG001|Overall Study|Adverse Event|0|||
13432882|NCT00396084|26894688|FG002|Overall Study|Adverse Event|0|||
13432883|NCT00396084|26894689|FG003|Overall Study|Adverse Event|0|||
13432884|NCT00396084|26894690|FG004|Overall Study|Adverse Event|1|||
13432885|NCT00396084|26894691|FG005|Overall Study|Adverse Event|2|||
13432886|NCT00396084|26894686|FG000|Overall Study|Withdrawal by Subject|0|||
13432887|NCT00396084|26894687|FG001|Overall Study|Withdrawal by Subject|0|||
13432888|NCT00396084|26894688|FG002|Overall Study|Withdrawal by Subject|0|||
13432889|NCT00396084|26894689|FG003|Overall Study|Withdrawal by Subject|1|||
13432890|NCT00396084|26894690|FG004|Overall Study|Withdrawal by Subject|0|||
13432891|NCT00396084|26894691|FG005|Overall Study|Withdrawal by Subject|0|||
13432892|NCT00395967|26894702|FG000|Treatment Period|Failed Mobilization|1|||
13432893|NCT00395967|26894702|FG000|Follow-up Period|Death|1|||
13432894|NCT00395967|26894702|FG000|Follow-up Period|Lost to Follow-up|1|||
13432895|NCT00395863|26894740|FG000|Overall Study|Patients did not complete both exams|2|||
13432896|NCT00395863|26894741|FG001|Overall Study|Patients did not complete both exams|3|||
13432897|NCT00395850|26894768|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6|||
13432898|NCT00395850|26894769|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
13432899|NCT00395850|26894770|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
13432900|NCT00395850|26894771|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
13432901|NCT00395850|26894768|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4|||
13432902|NCT00395850|26894769|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
13432903|NCT00395850|26894770|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
13432904|NCT00395850|26894771|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
13432905|NCT00395850|26894768|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1|||
13432906|NCT00395850|26894769|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
13432907|NCT00395850|26894770|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
13432908|NCT00395850|26894771|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
13432909|NCT00395850|26894768|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
13432910|NCT00395850|26894769|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
13432911|NCT00395850|26894770|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6|||
13432912|NCT00395850|26894771|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4|||
13432913|NCT00395850|26894768|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1|||
13432914|NCT00395850|26894769|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
13432915|NCT00395850|26894770|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
13432916|NCT00395850|26894771|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
13432917|NCT00395850|26894768|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1|||
13432918|NCT00395850|26894769|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
13432919|NCT00395850|26894770|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
13432920|NCT00395850|26894771|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
13432921|NCT00395850|26894768|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1|||
13432922|NCT00395850|26894769|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
13432923|NCT00395850|26894770|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
13432924|NCT00395850|26894771|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
13432925|NCT00395746|26894825|FG000|Overall Study|Adverse Event|5|||
13432926|NCT00395746|26894826|FG001|Overall Study|Adverse Event|2|||
13432927|NCT00395746|26894827|FG002|Overall Study|Adverse Event|2|||
13432928|NCT00395746|26894825|FG000|Overall Study|Protocol Violation|0|||
13432929|NCT00395746|26894826|FG001|Overall Study|Protocol Violation|1|||
13432930|NCT00395746|26894827|FG002|Overall Study|Protocol Violation|0|||
13432931|NCT00395746|26894825|FG000|Overall Study|Lack of Efficacy|2|||
13432932|NCT00395746|26894826|FG001|Overall Study|Lack of Efficacy|0|||
13432933|NCT00395746|26894827|FG002|Overall Study|Lack of Efficacy|17|||
13432934|NCT00395746|26894825|FG000|Overall Study|Hypoglycaemia|2|||
13432935|NCT00395746|26894826|FG001|Overall Study|Hypoglycaemia|1|||
13432936|NCT00395746|26894827|FG002|Overall Study|Hypoglycaemia|0|||
13432937|NCT00395746|26894825|FG000|Overall Study|Subject decision|0|||
13432938|NCT00395746|26894826|FG001|Overall Study|Subject decision|0|||
13432939|NCT00395746|26894827|FG002|Overall Study|Subject decision|1|||
13432940|NCT00395746|26894825|FG000|Overall Study|Withdrawal of consent|0|||
13432941|NCT00395746|26894826|FG001|Overall Study|Withdrawal of consent|0|||
13432942|NCT00395746|26894827|FG002|Overall Study|Withdrawal of consent|1|||
13432943|NCT00395746|26894825|FG000|Overall Study|Difficultulty in use of device|0|||
13432944|NCT00395746|26894826|FG001|Overall Study|Difficultulty in use of device|0|||
13432945|NCT00395746|26894827|FG002|Overall Study|Difficultulty in use of device|1|||
13432946|NCT00395746|26894825|FG000|Overall Study|Unable to visit site on schedule|1|||
13432947|NCT00395746|26894826|FG001|Overall Study|Unable to visit site on schedule|0|||
13432948|NCT00395746|26894827|FG002|Overall Study|Unable to visit site on schedule|0|||
13432949|NCT00395733|26894856|FG000|Period 2|Withdrawal by Subject|1|||
13432950|NCT00395733|26894857|FG001|Period 2|Withdrawal by Subject|2|||
13432951|NCT00395733|26894856|FG000|Period 2|Protocol Violation|0|||
13432952|NCT00395733|26894857|FG001|Period 2|Protocol Violation|1|||
13432953|NCT00395733|26894856|FG000|Period 2|Adverse Event|0|||
13432954|NCT00395733|26894857|FG001|Period 2|Adverse Event|2|||
13432955|NCT00395733|26894856|FG000|Period 2|Technical problems|1|||
13432956|NCT00395733|26894857|FG001|Period 2|Technical problems|0|||
13432957|NCT00395694|26894895|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1|||
13432958|NCT00395694|26894896|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2|||
13432959|NCT00395694|26894895|FG000|Continuation Phase|Adverse Event|1|||
13432960|NCT00395694|26894896|FG001|Continuation Phase|Adverse Event|0|||
13432961|NCT00395694|26894895|FG000|Continuation Phase|Lack of Efficacy|12|||
13432962|NCT00395694|26894896|FG001|Continuation Phase|Lack of Efficacy|11|||
13432963|NCT00395694|26894895|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1|||
13432964|NCT00395694|26894896|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0|||
13219919|NCT01829191|26278652|FG000|Overall Study|Lens discomfort|0|||
13432965|NCT00395694|26894895|FG000|Continuation Phase|Poor Compliance|1|||
13432966|NCT00395694|26894896|FG001|Continuation Phase|Poor Compliance|0|||
13432967|NCT00395694|26894895|FG000|Continuation Phase|Withdrawal by Subject|0|||
13432968|NCT00395694|26894896|FG001|Continuation Phase|Withdrawal by Subject|2|||
13432969|NCT00395642|26894902|FG000|Overall Study|Death|4|||
13432970|NCT00395642|26894902|FG000|Overall Study|Lost to Follow-up|1|||
13432971|NCT00395642|26894902|FG000|Overall Study|Physician Decision|7|||
13432972|NCT00395642|26894902|FG000|Overall Study|Withdrawal by Subject|1|||
13432973|NCT00395629|26894926|FG000|Core Study|Adverse Event|0|||
13432974|NCT00395629|26894927|FG001|Core Study|Adverse Event|3|||
13432975|NCT00395629|26894928|FG002|Core Study|Adverse Event|4|||
13432976|NCT00395629|26894926|FG000|Core Study|Abnormal laboratory value(s)|0|||
13432977|NCT00395629|26894927|FG001|Core Study|Abnormal laboratory value(s)|0|||
13432978|NCT00395629|26894928|FG002|Core Study|Abnormal laboratory value(s)|1|||
13432979|NCT00395629|26894926|FG000|Core Study|Protocol Violation|1|||
13432980|NCT00395629|26894927|FG001|Core Study|Protocol Violation|0|||
13432981|NCT00395629|26894928|FG002|Core Study|Protocol Violation|0|||
13432982|NCT00395629|26894926|FG000|Core Study|Withdrawal by Subject|0|||
13432983|NCT00395629|26894927|FG001|Core Study|Withdrawal by Subject|1|||
13432984|NCT00395629|26894928|FG002|Core Study|Withdrawal by Subject|1|||
13432985|NCT00395629|26894926|FG000|Core Study|Lost to Follow-up|0|||
13432986|NCT00395629|26894927|FG001|Core Study|Lost to Follow-up|0|||
13432987|NCT00395629|26894928|FG002|Core Study|Lost to Follow-up|1|||
13432988|NCT00395629|26894926|FG000|Extension Study|Adverse Event|0|||
13432989|NCT00395629|26894927|FG001|Extension Study|Adverse Event|0|||
13432990|NCT00395629|26894928|FG002|Extension Study|Adverse Event|2|||
13432991|NCT00395629|26894926|FG000|Extension Study|Administrative problems|0|||
13432992|NCT00395629|26894927|FG001|Extension Study|Administrative problems|0|||
13432993|NCT00395629|26894928|FG002|Extension Study|Administrative problems|1|||
13432994|NCT00395538|26895007|FG000|Overall Study|Did not re-consent to revised protocol|1|||
13432995|NCT00395538|26895008|FG001|Overall Study|Did not re-consent to revised protocol|10|||
13432996|NCT00395538|26895009|FG002|Overall Study|Did not re-consent to revised protocol|0|||
13432997|NCT00395538|26895007|FG000|Overall Study|FDA partial hold on PTH|0|||
13432998|NCT00395538|26895008|FG001|Overall Study|FDA partial hold on PTH|0|||
13432999|NCT00395538|26895009|FG002|Overall Study|FDA partial hold on PTH|11|||
13433000|NCT00395538|26895007|FG000|Overall Study|Failed screening|0|||
13433001|NCT00395538|26895008|FG001|Overall Study|Failed screening|0|||
13433002|NCT00395538|26895009|FG002|Overall Study|Failed screening|4|||
13433003|NCT00395538|26895007|FG000|Overall Study|Switch to Natpara|0|||
13433004|NCT00395538|26895008|FG001|Overall Study|Switch to Natpara|0|||
13433005|NCT00395538|26895009|FG002|Overall Study|Switch to Natpara|3|||
13433006|NCT00395538|26895007|FG000|Overall Study|Adverse Event|1|||
13433007|NCT00395538|26895008|FG001|Overall Study|Adverse Event|0|||
13433008|NCT00395538|26895009|FG002|Overall Study|Adverse Event|2|||
13433009|NCT00395538|26895007|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0|||
13433010|NCT00395538|26895008|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2|||
13433011|NCT00395538|26895009|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0|||
13433012|NCT00395538|26895007|FG000|Overall Study|Non-compliance with study protocol|0|||
13433013|NCT00395538|26895008|FG001|Overall Study|Non-compliance with study protocol|1|||
13433014|NCT00395538|26895009|FG002|Overall Study|Non-compliance with study protocol|0|||
13433015|NCT00395538|26895007|FG000|Overall Study|PTH resistance|0|||
13433016|NCT00395538|26895008|FG001|Overall Study|PTH resistance|0|||
13433017|NCT00395538|26895009|FG002|Overall Study|PTH resistance|1|||
13433018|NCT00395538|26895007|FG000|Overall Study|Pregnancy|1|||
13433019|NCT00395538|26895008|FG001|Overall Study|Pregnancy|0|||
13433020|NCT00395538|26895009|FG002|Overall Study|Pregnancy|0|||
13433021|NCT00395538|26895007|FG000|Overall Study|Partial recovery of parathyroid function|0|||
13433022|NCT00395538|26895008|FG001|Overall Study|Partial recovery of parathyroid function|0|||
13433023|NCT00395538|26895009|FG002|Overall Study|Partial recovery of parathyroid function|1|||
13433024|NCT00395538|26895007|FG000|Overall Study|Participant elected to discontinue|0|||
13433025|NCT00395538|26895008|FG001|Overall Study|Participant elected to discontinue|0|||
13433026|NCT00395538|26895009|FG002|Overall Study|Participant elected to discontinue|1|||
13433027|NCT00395512|26895192|FG000|Overall Study|Adverse Event|3|||
13433028|NCT00395512|26895193|FG001|Overall Study|Adverse Event|8|||
13433029|NCT00395512|26895194|FG002|Overall Study|Adverse Event|6|||
13433030|NCT00395512|26895195|FG003|Overall Study|Adverse Event|6|||
13433031|NCT00395512|26895192|FG000|Overall Study|Protocol Violation|2|||
13433032|NCT00395512|26895193|FG001|Overall Study|Protocol Violation|3|||
13433033|NCT00395512|26895194|FG002|Overall Study|Protocol Violation|6|||
13433034|NCT00395512|26895195|FG003|Overall Study|Protocol Violation|7|||
13433035|NCT00395512|26895192|FG000|Overall Study|Lost to Follow-up|2|||
13433036|NCT00395512|26895193|FG001|Overall Study|Lost to Follow-up|6|||
13433037|NCT00395512|26895194|FG002|Overall Study|Lost to Follow-up|5|||
13433038|NCT00395512|26895195|FG003|Overall Study|Lost to Follow-up|5|||
13433039|NCT00395512|26895192|FG000|Overall Study|Withdrawal by Subject|6|||
13433040|NCT00395512|26895193|FG001|Overall Study|Withdrawal by Subject|5|||
13433041|NCT00395512|26895194|FG002|Overall Study|Withdrawal by Subject|5|||
13476944|NCT04545060|27004398|FG001|Overall Study|Adverse Event|1|||
13433042|NCT00395512|26895195|FG003|Overall Study|Withdrawal by Subject|12|||
13433043|NCT00395512|26895192|FG000|Overall Study|Physician Decision|6|||
13433044|NCT00395512|26895193|FG001|Overall Study|Physician Decision|4|||
13433045|NCT00395512|26895194|FG002|Overall Study|Physician Decision|2|||
13433046|NCT00395512|26895195|FG003|Overall Study|Physician Decision|2|||
13433047|NCT00395512|26895192|FG000|Overall Study|Other|1|||
13433048|NCT00395512|26895193|FG001|Overall Study|Other|1|||
13433049|NCT00395512|26895194|FG002|Overall Study|Other|0|||
13433050|NCT00395512|26895195|FG003|Overall Study|Other|0|||
13433051|NCT00395512|26895192|FG000|Overall Study|Hyperglycemic Rescue|18|||
13433052|NCT00395512|26895193|FG001|Overall Study|Hyperglycemic Rescue|10|||
13433053|NCT00395512|26895194|FG002|Overall Study|Hyperglycemic Rescue|4|||
13433054|NCT00395512|26895195|FG003|Overall Study|Hyperglycemic Rescue|6|||
13433055|NCT00395486|26895230|FG000|Overall Study|Adverse Event|1|||
13433056|NCT00395486|26895231|FG001|Overall Study|Adverse Event|2|||
13433057|NCT00395486|26895230|FG000|Overall Study|Withdrawal by Subject|5|||
13433058|NCT00395486|26895231|FG001|Overall Study|Withdrawal by Subject|2|||
13433059|NCT00395486|26895230|FG000|Overall Study|Lost to Follow-up|0|||
13433060|NCT00395486|26895231|FG001|Overall Study|Lost to Follow-up|1|||
13433061|NCT00395460|26895260|FG000|Overall Study|Withdrawal by Subject|1|||
13433062|NCT00395460|26895261|FG001|Overall Study|Withdrawal by Subject|0|||
13433063|NCT00395447|26895274|FG000|Overall Study|Death|37|||
13433064|NCT00395447|26895275|FG001|Overall Study|Death|32|||
13433065|NCT00395447|26895274|FG000|Overall Study|Lost to Follow-up|52|||
13433066|NCT00395447|26895275|FG001|Overall Study|Lost to Follow-up|43|||
13433067|NCT00395447|26895274|FG000|Overall Study|Withdrawal by Subject|24|||
13433068|NCT00395447|26895275|FG001|Overall Study|Withdrawal by Subject|19|||
13433069|NCT00395447|26895274|FG000|Overall Study|Withdrawl - Other (not subject)|8|||
13433070|NCT00395447|26895275|FG001|Overall Study|Withdrawl - Other (not subject)|17|||
13433071|NCT00395343|26895300|FG000|Overall Study|Adverse Event|13|||
13433072|NCT00395343|26895301|FG001|Overall Study|Adverse Event|5|||
13433073|NCT00395343|26895300|FG000|Overall Study|Lack of Efficacy|0|||
13433074|NCT00395343|26895301|FG001|Overall Study|Lack of Efficacy|1|||
13433075|NCT00395343|26895300|FG000|Overall Study|Lost to Follow-up|4|||
13433076|NCT00395343|26895301|FG001|Overall Study|Lost to Follow-up|4|||
13433077|NCT00395343|26895300|FG000|Overall Study|Physician Decision|2|||
13433078|NCT00395343|26895301|FG001|Overall Study|Physician Decision|4|||
13433079|NCT00395343|26895300|FG000|Overall Study|Protocol Violation|6|||
13433080|NCT00395343|26895301|FG001|Overall Study|Protocol Violation|8|||
13433081|NCT00395343|26895300|FG000|Overall Study|Withdrawal by Subject|11|||
13433082|NCT00395343|26895301|FG001|Overall Study|Withdrawal by Subject|12|||
13433083|NCT00395343|26895300|FG000|Overall Study|Other|5|||
13433084|NCT00395343|26895301|FG001|Overall Study|Other|2|||
13433085|NCT00395304|26895351|FG000|Treatment Period 1|Withdrawal by Subject|0|||
13433086|NCT00395304|26895352|FG001|Treatment Period 1|Withdrawal by Subject|3|||
13433087|NCT00395304|26895353|FG002|Treatment Period 1|Withdrawal by Subject|0|||
13433088|NCT00395304|26895354|FG003|Treatment Period 1|Withdrawal by Subject|2|||
13433089|NCT00395304|26895355|FG004|Treatment Period 1|Withdrawal by Subject|1|||
13433090|NCT00395304|26895356|FG005|Treatment Period 1|Withdrawal by Subject|1|||
13433091|NCT00395304|26895351|FG000|Treatment Period 1|Lost to Follow-up|1|||
13433092|NCT00395304|26895352|FG001|Treatment Period 1|Lost to Follow-up|0|||
13433093|NCT00395304|26895353|FG002|Treatment Period 1|Lost to Follow-up|0|||
13433094|NCT00395304|26895354|FG003|Treatment Period 1|Lost to Follow-up|1|||
13433095|NCT00395304|26895355|FG004|Treatment Period 1|Lost to Follow-up|0|||
13433096|NCT00395304|26895356|FG005|Treatment Period 1|Lost to Follow-up|1|||
13433097|NCT00395304|26895351|FG000|Treatment Period 1|Physician Decision|0|||
13433098|NCT00395304|26895352|FG001|Treatment Period 1|Physician Decision|1|||
13433099|NCT00395304|26895353|FG002|Treatment Period 1|Physician Decision|0|||
13433100|NCT00395304|26895354|FG003|Treatment Period 1|Physician Decision|0|||
13433101|NCT00395304|26895355|FG004|Treatment Period 1|Physician Decision|0|||
13433102|NCT00395304|26895356|FG005|Treatment Period 1|Physician Decision|0|||
13433103|NCT00395304|26895351|FG000|Treatment Period 2|Withdrawal by Subject|0|||
13433104|NCT00395304|26895352|FG001|Treatment Period 2|Withdrawal by Subject|0|||
13433105|NCT00395304|26895353|FG002|Treatment Period 2|Withdrawal by Subject|0|||
13433106|NCT00395304|26895354|FG003|Treatment Period 2|Withdrawal by Subject|1|||
13433107|NCT00395304|26895355|FG004|Treatment Period 2|Withdrawal by Subject|0|||
13433108|NCT00395304|26895356|FG005|Treatment Period 2|Withdrawal by Subject|2|||
13433109|NCT00395304|26895351|FG000|Treatment Period 2|Lost to Follow-up|0|||
13433110|NCT00395304|26895352|FG001|Treatment Period 2|Lost to Follow-up|3|||
13433111|NCT00395304|26895353|FG002|Treatment Period 2|Lost to Follow-up|0|||
13433112|NCT00395304|26895354|FG003|Treatment Period 2|Lost to Follow-up|0|||
13433113|NCT00395304|26895355|FG004|Treatment Period 2|Lost to Follow-up|0|||
13433114|NCT00395304|26895356|FG005|Treatment Period 2|Lost to Follow-up|0|||
13433115|NCT00395304|26895351|FG000|Treatment Period 2|Physician Decision|0|||
13433116|NCT00395304|26895352|FG001|Treatment Period 2|Physician Decision|0|||
13433117|NCT00395304|26895353|FG002|Treatment Period 2|Physician Decision|1|||
13433118|NCT00395304|26895354|FG003|Treatment Period 2|Physician Decision|0|||
13433119|NCT00395304|26895355|FG004|Treatment Period 2|Physician Decision|0|||
13433120|NCT00395304|26895356|FG005|Treatment Period 2|Physician Decision|0|||
13433121|NCT00395304|26895351|FG000|Treatment Period 2|Other|0|||
13433122|NCT00395304|26895352|FG001|Treatment Period 2|Other|1|||
13433123|NCT00395304|26895353|FG002|Treatment Period 2|Other|0|||
13433124|NCT00395304|26895354|FG003|Treatment Period 2|Other|0|||
13433125|NCT00395304|26895355|FG004|Treatment Period 2|Other|0|||
13433126|NCT00395304|26895356|FG005|Treatment Period 2|Other|0|||
13433127|NCT00395304|26895351|FG000|Treatment Period 3|Withdrawal by Subject|0|||
13433128|NCT00395304|26895352|FG001|Treatment Period 3|Withdrawal by Subject|0|||
13433129|NCT00395304|26895353|FG002|Treatment Period 3|Withdrawal by Subject|0|||
13433130|NCT00395304|26895354|FG003|Treatment Period 3|Withdrawal by Subject|1|||
13433131|NCT00395304|26895355|FG004|Treatment Period 3|Withdrawal by Subject|0|||
13433132|NCT00395304|26895356|FG005|Treatment Period 3|Withdrawal by Subject|1|||
13433133|NCT00395304|26895351|FG000|Treatment Period 3|Lost to Follow-up|1|||
13433134|NCT00395304|26895352|FG001|Treatment Period 3|Lost to Follow-up|1|||
13433135|NCT00395304|26895353|FG002|Treatment Period 3|Lost to Follow-up|0|||
13433136|NCT00395304|26895354|FG003|Treatment Period 3|Lost to Follow-up|0|||
13433137|NCT00395304|26895355|FG004|Treatment Period 3|Lost to Follow-up|0|||
13433138|NCT00395304|26895356|FG005|Treatment Period 3|Lost to Follow-up|0|||
13433139|NCT00395304|26895351|FG000|Treatment Period 3|Physician Decision|0|||
13433140|NCT00395304|26895352|FG001|Treatment Period 3|Physician Decision|1|||
13433141|NCT00395304|26895353|FG002|Treatment Period 3|Physician Decision|0|||
13433142|NCT00395304|26895354|FG003|Treatment Period 3|Physician Decision|0|||
13433143|NCT00395304|26895355|FG004|Treatment Period 3|Physician Decision|0|||
13433144|NCT00395304|26895356|FG005|Treatment Period 3|Physician Decision|0|||
13433145|NCT00395304|26895351|FG000|Treatment Period 3|Other|0|||
13433146|NCT00395304|26895352|FG001|Treatment Period 3|Other|0|||
13433147|NCT00395304|26895353|FG002|Treatment Period 3|Other|0|||
13433148|NCT00395304|26895354|FG003|Treatment Period 3|Other|1|||
13433149|NCT00395304|26895355|FG004|Treatment Period 3|Other|0|||
13433150|NCT00395304|26895356|FG005|Treatment Period 3|Other|0|||
13433151|NCT00395226|26895369|FG000|Overall Study|Adverse Event|4|||
13433152|NCT00395226|26895370|FG001|Overall Study|Adverse Event|3|||
13433153|NCT00395226|26895369|FG000|Overall Study|Withdrawal by Subject|0|||
13433154|NCT00395226|26895370|FG001|Overall Study|Withdrawal by Subject|1|||
13433155|NCT00395226|26895369|FG000|Overall Study|Lost to Follow-up|0|||
13433156|NCT00395226|26895370|FG001|Overall Study|Lost to Follow-up|1|||
13433157|NCT00395083|26895389|FG000|Overall Study|Withdrawal by Subject|6|||
13433158|NCT00395083|26895390|FG001|Overall Study|Withdrawal by Subject|5|||
13433159|NCT00395083|26895389|FG000|Overall Study|Developed another disease|4|||
13433160|NCT00395083|26895390|FG001|Overall Study|Developed another disease|3|||
13433161|NCT00395018|26895411|FG000|On-Treatment|Death|4|||
13433162|NCT00395018|26895411|FG000|On-Treatment|Other Reason|2|||
13433163|NCT00395018|26895411|FG000|On-Treatment|Poor/non-compliance|2|||
13433164|NCT00395018|26895411|FG000|On-Treatment|Subject no longer meets study criteria|2|||
13433165|NCT00395018|26895411|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1|||
13433166|NCT00395018|26895411|FG000|Off-Treatment Follow-up|Lost to Follow-up|2|||
13433167|NCT00395018|26895411|FG000|Off-Treatment Follow-up|Poor/non-compliance|1|||
13433168|NCT00394953|26895434|FG000|First Treatment Period|Adverse Event|1|||
13433169|NCT00394953|26895435|FG001|First Treatment Period|Adverse Event|2|||
13433170|NCT00394953|26895434|FG000|First Treatment Period|Death|6|||
13433171|NCT00394953|26895435|FG001|First Treatment Period|Death|7|||
13433172|NCT00394953|26895434|FG000|First Treatment Period|Lack of Efficacy|1|||
13433173|NCT00394953|26895435|FG001|First Treatment Period|Lack of Efficacy|1|||
13433174|NCT00394953|26895434|FG000|First Treatment Period|Withdrawal by Subject|6|||
13433175|NCT00394953|26895435|FG001|First Treatment Period|Withdrawal by Subject|3|||
13433176|NCT00394953|26895434|FG000|First Treatment Period|Lost to Follow-up|0|||
13433177|NCT00394953|26895435|FG001|First Treatment Period|Lost to Follow-up|1|||
13433178|NCT00394953|26895434|FG000|First Treatment Period|Renal transplant|11|||
13433179|NCT00394953|26895435|FG001|First Treatment Period|Renal transplant|7|||
13433180|NCT00394953|26895434|FG000|First Treatment Period|Not defined|4|||
13433181|NCT00394953|26895435|FG001|First Treatment Period|Not defined|1|||
13433182|NCT00394953|26895434|FG000|Second Treatment Period|Adverse Event|2|||
13433183|NCT00394953|26895435|FG001|Second Treatment Period|Adverse Event|5|||
13433184|NCT00394953|26895434|FG000|Second Treatment Period|Death|8|||
13433185|NCT00394953|26895435|FG001|Second Treatment Period|Death|4|||
13433186|NCT00394953|26895434|FG000|Second Treatment Period|Lack of Efficacy|9|||
13433187|NCT00394953|26895435|FG001|Second Treatment Period|Lack of Efficacy|47|||
13433188|NCT00394953|26895434|FG000|Second Treatment Period|Withdrawal by Subject|3|||
13433189|NCT00394953|26895435|FG001|Second Treatment Period|Withdrawal by Subject|3|||
13433190|NCT00394953|26895434|FG000|Second Treatment Period|Lost to Follow-up|0|||
13433191|NCT00394953|26895435|FG001|Second Treatment Period|Lost to Follow-up|1|||
13433192|NCT00394953|26895434|FG000|Second Treatment Period|Renal transplant|4|||
13433193|NCT00394953|26895435|FG001|Second Treatment Period|Renal transplant|6|||
13433194|NCT00394953|26895434|FG000|Second Treatment Period|Not defined|3|||
13433195|NCT00394953|26895435|FG001|Second Treatment Period|Not defined|8|||
13433196|NCT00394914|26895467|FG000|Treatment Period|Adverse Event|0|||
13433197|NCT00394914|26895468|FG001|Treatment Period|Adverse Event|3|||
13433198|NCT00394914|26895469|FG002|Treatment Period|Adverse Event|1|||
13433199|NCT00394914|26895467|FG000|Treatment Period|Lost to Follow-up|0|||
13433200|NCT00394914|26895468|FG001|Treatment Period|Lost to Follow-up|1|||
13433201|NCT00394914|26895469|FG002|Treatment Period|Lost to Follow-up|0|||
13433202|NCT00394914|26895467|FG000|Treatment Period|Withdrawal by Subject|0|||
13433203|NCT00394914|26895468|FG001|Treatment Period|Withdrawal by Subject|2|||
13433204|NCT00394914|26895469|FG002|Treatment Period|Withdrawal by Subject|2|||
13433205|NCT00394914|26895467|FG000|Treatment Period|Noncompliance with protocol|0|||
13433206|NCT00394914|26895468|FG001|Treatment Period|Noncompliance with protocol|3|||
13433207|NCT00394914|26895469|FG002|Treatment Period|Noncompliance with protocol|2|||
13433208|NCT00394914|26895467|FG000|Treatment Period|Did not meet protocol eligibility|0|||
13433209|NCT00394914|26895468|FG001|Treatment Period|Did not meet protocol eligibility|1|||
13433210|NCT00394914|26895469|FG002|Treatment Period|Did not meet protocol eligibility|1|||
13433211|NCT00394901|26895707|FG000|Baseline Phase|Protocol Violation|0|||
13433212|NCT00394901|26895708|FG001|Baseline Phase|Protocol Violation|0|||
13433213|NCT00394901|26895709|FG002|Baseline Phase|Protocol Violation|1|||
13433214|NCT00394901|26895710|FG003|Baseline Phase|Protocol Violation|0|||
13433215|NCT00394901|26895707|FG000|Double-blind Phase|Adverse Event|5|||
13433216|NCT00394901|26895708|FG001|Double-blind Phase|Adverse Event|7|||
13433217|NCT00394901|26895709|FG002|Double-blind Phase|Adverse Event|16|||
13433218|NCT00394901|26895710|FG003|Double-blind Phase|Adverse Event|20|||
13433219|NCT00394901|26895707|FG000|Double-blind Phase|Lack of Efficacy|6|||
13433220|NCT00394901|26895708|FG001|Double-blind Phase|Lack of Efficacy|4|||
13433221|NCT00394901|26895709|FG002|Double-blind Phase|Lack of Efficacy|1|||
13433222|NCT00394901|26895710|FG003|Double-blind Phase|Lack of Efficacy|3|||
13433223|NCT00394901|26895707|FG000|Double-blind Phase|Withdrawal by Subject|2|||
13433224|NCT00394901|26895708|FG001|Double-blind Phase|Withdrawal by Subject|0|||
13433225|NCT00394901|26895709|FG002|Double-blind Phase|Withdrawal by Subject|0|||
13433226|NCT00394901|26895710|FG003|Double-blind Phase|Withdrawal by Subject|0|||
13433227|NCT00394901|26895707|FG000|Double-blind Phase|Lost to Follow-up|0|||
13433228|NCT00394901|26895708|FG001|Double-blind Phase|Lost to Follow-up|0|||
13433229|NCT00394901|26895709|FG002|Double-blind Phase|Lost to Follow-up|0|||
13433230|NCT00394901|26895710|FG003|Double-blind Phase|Lost to Follow-up|1|||
13433231|NCT00394901|26895707|FG000|Double-blind Phase|Protocol Violation|0|||
13433232|NCT00394901|26895708|FG001|Double-blind Phase|Protocol Violation|0|||
13433233|NCT00394901|26895709|FG002|Double-blind Phase|Protocol Violation|0|||
13433234|NCT00394901|26895710|FG003|Double-blind Phase|Protocol Violation|1|||
13433235|NCT00394901|26895707|FG000|Double-blind Phase|Death|1|||
13433236|NCT00394901|26895708|FG001|Double-blind Phase|Death|0|||
13433237|NCT00394901|26895709|FG002|Double-blind Phase|Death|0|||
13433238|NCT00394901|26895710|FG003|Double-blind Phase|Death|0|||
13433239|NCT00394901|26895707|FG000|Double-blind Phase|Subject's Personal Reason|1|||
13433240|NCT00394901|26895708|FG001|Double-blind Phase|Subject's Personal Reason|0|||
13433241|NCT00394901|26895709|FG002|Double-blind Phase|Subject's Personal Reason|0|||
13433242|NCT00394901|26895710|FG003|Double-blind Phase|Subject's Personal Reason|1|||
13433243|NCT00394901|26895707|FG000|Double-blind Phase|Lack of Compliance|0|||
13433244|NCT00394901|26895708|FG001|Double-blind Phase|Lack of Compliance|3|||
13433245|NCT00394901|26895709|FG002|Double-blind Phase|Lack of Compliance|0|||
13433246|NCT00394901|26895710|FG003|Double-blind Phase|Lack of Compliance|0|||
13433247|NCT00394901|26895707|FG000|Double-blind Phase|Entry into another study was found|0|||
13433248|NCT00394901|26895708|FG001|Double-blind Phase|Entry into another study was found|0|||
13433249|NCT00394901|26895709|FG002|Double-blind Phase|Entry into another study was found|1|||
13433250|NCT00394901|26895710|FG003|Double-blind Phase|Entry into another study was found|0|||
13433251|NCT00394901|26895707|FG000|Double-blind Phase|Found not to meet entrance criteria|0|||
13433252|NCT00394901|26895708|FG001|Double-blind Phase|Found not to meet entrance criteria|0|||
13433253|NCT00394901|26895709|FG002|Double-blind Phase|Found not to meet entrance criteria|0|||
13433254|NCT00394901|26895710|FG003|Double-blind Phase|Found not to meet entrance criteria|1|||
13433255|NCT00394836|26895759|FG000|Teatment or Follow-up Phase|Adverse Event|0|||
13433256|NCT00394836|26895760|FG001|Teatment or Follow-up Phase|Adverse Event|2|||
13433257|NCT00394836|26895759|FG000|Teatment or Follow-up Phase|Protocol Violation|0|||
13433258|NCT00394836|26895760|FG001|Teatment or Follow-up Phase|Protocol Violation|2|||
13433259|NCT00394836|26895759|FG000|Teatment or Follow-up Phase|Disease Progression|27|||
13433260|NCT00394836|26895760|FG001|Teatment or Follow-up Phase|Disease Progression|60|||
13433261|NCT00394836|26895759|FG000|Teatment or Follow-up Phase|Patient Refusal|1|||
13433262|NCT00394836|26895760|FG001|Teatment or Follow-up Phase|Patient Refusal|2|||
13433263|NCT00394836|26895759|FG000|Teatment or Follow-up Phase|Death|0|||
13433264|NCT00394836|26895760|FG001|Teatment or Follow-up Phase|Death|1|||
13433265|NCT00394836|26895759|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0|||
13433266|NCT00394836|26895760|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1|||
13433267|NCT00394836|26895759|FG000|Teatment or Follow-up Phase|Started alternative treatment|0|||
13433268|NCT00394836|26895760|FG001|Teatment or Follow-up Phase|Started alternative treatment|6|||
13433269|NCT00394836|26895759|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0|||
13433270|NCT00394836|26895760|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1|||
13433271|NCT00394836|26895759|FG000|Teatment or Follow-up Phase|Physician Decision|0|||
13433272|NCT00394836|26895760|FG001|Teatment or Follow-up Phase|Physician Decision|1|||
13433273|NCT00394836|26895759|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0|||
13433274|NCT00394836|26895760|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1|||
13433275|NCT00394836|26895759|FG000|Teatment or Follow-up Phase|Non compliance|0|||
13433276|NCT00394836|26895760|FG001|Teatment or Follow-up Phase|Non compliance|1|||
13433277|NCT00394836|26895759|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0|||
13433278|NCT00394836|26895760|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1|||
13433279|NCT00394836|26895759|FG000|Extended Follow-up Phase (2-5 Years)|Death|0|||
13433280|NCT00394836|26895760|FG001|Extended Follow-up Phase (2-5 Years)|Death|1|||
13433281|NCT00394836|26895759|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13|||
13433282|NCT00394836|26895760|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41|||
13433283|NCT00394836|26895759|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7|||
13433284|NCT00394836|26895760|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10|||
13433285|NCT00394771|26895835|FG000|Overall Study|Did not meet protocol requirements|1|||
13433286|NCT00394771|26895836|FG001|Overall Study|Did not meet protocol requirements|0|||
13433287|NCT00394771|26895837|FG002|Overall Study|Did not meet protocol requirements|2|||
13433288|NCT00394771|26895838|FG003|Overall Study|Did not meet protocol requirements|0|||
13433289|NCT00394771|26895835|FG000|Overall Study|Protocol Violation|2|||
13433290|NCT00394771|26895836|FG001|Overall Study|Protocol Violation|4|||
13433291|NCT00394771|26895837|FG002|Overall Study|Protocol Violation|9|||
13433292|NCT00394771|26895838|FG003|Overall Study|Protocol Violation|7|||
13433293|NCT00394771|26895835|FG000|Overall Study|Withdrawal by Subject|10|||
13433294|NCT00394771|26895836|FG001|Overall Study|Withdrawal by Subject|6|||
13433295|NCT00394771|26895837|FG002|Overall Study|Withdrawal by Subject|8|||
13433296|NCT00394771|26895838|FG003|Overall Study|Withdrawal by Subject|12|||
13433297|NCT00394771|26895835|FG000|Overall Study|Adverse Event|10|||
13433298|NCT00394771|26895836|FG001|Overall Study|Adverse Event|5|||
13433299|NCT00394771|26895837|FG002|Overall Study|Adverse Event|12|||
13433300|NCT00394771|26895838|FG003|Overall Study|Adverse Event|8|||
13433301|NCT00394771|26895835|FG000|Overall Study|Participant pregnant|0|||
13433302|NCT00394771|26895836|FG001|Overall Study|Participant pregnant|1|||
13433303|NCT00394771|26895837|FG002|Overall Study|Participant pregnant|2|||
13433304|NCT00394771|26895838|FG003|Overall Study|Participant pregnant|2|||
13433305|NCT00394771|26895835|FG000|Overall Study|Lost to Follow-up|15|||
13433306|NCT00394771|26895836|FG001|Overall Study|Lost to Follow-up|15|||
13433307|NCT00394771|26895837|FG002|Overall Study|Lost to Follow-up|13|||
13433308|NCT00394771|26895838|FG003|Overall Study|Lost to Follow-up|10|||
13433309|NCT00394771|26895835|FG000|Overall Study|Other|3|||
13433310|NCT00394771|26895836|FG001|Overall Study|Other|3|||
13433311|NCT00394771|26895837|FG002|Overall Study|Other|1|||
13433312|NCT00394771|26895838|FG003|Overall Study|Other|0|||
13433313|NCT00394706|26895893|FG000|Overall Study|Withdrawal by Subject|2|||
13433314|NCT00394706|26895894|FG001|Overall Study|Withdrawal by Subject|0|||
13433315|NCT00394706|26895895|FG002|Overall Study|Withdrawal by Subject|1|||
13433316|NCT00394706|26895896|FG003|Overall Study|Withdrawal by Subject|0|||
13433317|NCT00394706|26895897|FG004|Overall Study|Withdrawal by Subject|0|||
13433318|NCT00394706|26895898|FG005|Overall Study|Withdrawal by Subject|2|||
13433319|NCT00394706|26895899|FG006|Overall Study|Withdrawal by Subject|1|||
13433320|NCT00394706|26895900|FG007|Overall Study|Withdrawal by Subject|0|||
13433321|NCT00394706|26895893|FG000|Overall Study|Lost to Follow-up|2|||
13433322|NCT00394706|26895894|FG001|Overall Study|Lost to Follow-up|2|||
13433323|NCT00394706|26895895|FG002|Overall Study|Lost to Follow-up|8|||
13433324|NCT00394706|26895896|FG003|Overall Study|Lost to Follow-up|1|||
13433325|NCT00394706|26895897|FG004|Overall Study|Lost to Follow-up|2|||
13433326|NCT00394706|26895898|FG005|Overall Study|Lost to Follow-up|5|||
13433327|NCT00394706|26895899|FG006|Overall Study|Lost to Follow-up|2|||
13433328|NCT00394706|26895900|FG007|Overall Study|Lost to Follow-up|0|||
13433329|NCT00394654|26895969|FG000|Overall Study|Lost to Follow-up|1|||
13433330|NCT00394654|26895970|FG001|Overall Study|Lost to Follow-up|0|||
13433331|NCT00394654|26895969|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1|||
13433332|NCT00394654|26895970|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0|||
13433333|NCT00394589|26895988|FG000|Overall Study|Adverse Event|2|||
13433334|NCT00394589|26895989|FG001|Overall Study|Adverse Event|1|||
13433335|NCT00394589|26895990|FG002|Overall Study|Adverse Event|2|||
13433336|NCT00394589|26895988|FG000|Overall Study|Lack of Efficacy|2|||
13433337|NCT00394589|26895989|FG001|Overall Study|Lack of Efficacy|2|||
13433338|NCT00394589|26895990|FG002|Overall Study|Lack of Efficacy|3|||
13433339|NCT00394589|26895988|FG000|Overall Study|Protocol Violation|4|||
13433340|NCT00394589|26895989|FG001|Overall Study|Protocol Violation|0|||
13433341|NCT00394589|26895990|FG002|Overall Study|Protocol Violation|2|||
13433342|NCT00394524|26896009|FG000|Overall Study|Protocol Violation|2|||
13433343|NCT00394524|26896010|FG001|Overall Study|Protocol Violation|3|||
13433344|NCT00394524|26896009|FG000|Overall Study|Death|1|||
13433345|NCT00394524|26896010|FG001|Overall Study|Death|0|||
13433346|NCT00394524|26896009|FG000|Overall Study|Withdrawal by Subject|0|||
13433347|NCT00394524|26896010|FG001|Overall Study|Withdrawal by Subject|1|||
13433348|NCT00394472|26896025|FG000|Overall Study|Protocol Violation|1|||
13433349|NCT00394472|26896026|FG001|Overall Study|Protocol Violation|3|||
13433350|NCT00394472|26896025|FG000|Overall Study|incorrect enrolment|4|||
13433351|NCT00394472|26896026|FG001|Overall Study|incorrect enrolment|2|||
13433352|NCT00394472|26896025|FG000|Overall Study|Adverse Event|4|||
13433353|NCT00394472|26896026|FG001|Overall Study|Adverse Event|2|||
13433354|NCT00394472|26896025|FG000|Overall Study|Withdrawal by Subject|0|||
13433355|NCT00394472|26896026|FG001|Overall Study|Withdrawal by Subject|2|||
13433356|NCT00394472|26896025|FG000|Overall Study|Physician Decision|0|||
13433357|NCT00394472|26896026|FG001|Overall Study|Physician Decision|1|||
13433358|NCT00394472|26896025|FG000|Overall Study|Lost to Follow-up|0|||
13433359|NCT00394472|26896026|FG001|Overall Study|Lost to Follow-up|1|||
13433360|NCT00394433|26896035|FG000|Overall Study|Adverse Event|2|||
13433361|NCT00394433|26896035|FG000|Overall Study|Alternative Therapy|1|||
13433362|NCT00394251|26896068|FG000|Overall Study|Adverse Event|7|||
13433363|NCT00394251|26896069|FG001|Overall Study|Adverse Event|5|||
13433364|NCT00394251|26896068|FG000|Overall Study|Unacceptable Toxicity|20|||
13433365|NCT00394251|26896069|FG001|Overall Study|Unacceptable Toxicity|18|||
13433366|NCT00394251|26896068|FG000|Overall Study|Physician Decision|1|||
13433367|NCT00394251|26896069|FG001|Overall Study|Physician Decision|1|||
13433368|NCT00394251|26896068|FG000|Overall Study|Protocol Violation|0|||
13433369|NCT00394251|26896069|FG001|Overall Study|Protocol Violation|1|||
13433370|NCT00394251|26896068|FG000|Overall Study|Withdrawal by Subject|7|||
13433371|NCT00394251|26896069|FG001|Overall Study|Withdrawal by Subject|11|||
13433372|NCT00394251|26896068|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
13433373|NCT00394251|26896069|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
13433374|NCT00394212|26896088|FG000|Overall Study|Lost to Follow-up|3|||
13433375|NCT00394212|26896089|FG001|Overall Study|Lost to Follow-up|0|||
13433376|NCT00394212|26896088|FG000|Overall Study|Withdrawal by Subject|4|||
13433377|NCT00394212|26896089|FG001|Overall Study|Withdrawal by Subject|1|||
13433378|NCT00394095|26896104|FG000|Overall Study|Adverse Event|1|||
13433379|NCT00394095|26896105|FG001|Overall Study|Adverse Event|0|||
13433380|NCT00394082|26896116|FG000|Overall Study|Unacceptable toxicity|15|||
13433381|NCT00394082|26896116|FG000|Overall Study|Adverse Event|4|||
13433382|NCT00394082|26896116|FG000|Overall Study|Physician Decision|4|||
13433383|NCT00394082|26896116|FG000|Overall Study|Withdrawal by Subject|2|||
13433384|NCT00394082|26896116|FG000|Overall Study|Other|1|||
13433385|NCT00393939|26896141|FG000|Overall Study|Protocol Violation|1|||
13433386|NCT00393939|26896142|FG001|Overall Study|Protocol Violation|1|||
13433387|NCT00393939|26896141|FG000|Overall Study|Lost to Follow-up|2|||
13433388|NCT00393939|26896142|FG001|Overall Study|Lost to Follow-up|4|||
13433389|NCT00393939|26896141|FG000|Overall Study|Death|10|||
13433390|NCT00393939|26896142|FG001|Overall Study|Death|4|||
13433391|NCT00393939|26896141|FG000|Overall Study|Sponsor|5|||
13433392|NCT00393939|26896142|FG001|Overall Study|Sponsor|13|||
13433393|NCT00393939|26896141|FG000|Overall Study|Objective progression or relapse|239|||
13433394|NCT00393939|26896142|FG001|Overall Study|Objective progression or relapse|223|||
13433395|NCT00393939|26896141|FG000|Overall Study|Withdrawal by Subject|2|||
13433396|NCT00393939|26896142|FG001|Overall Study|Withdrawal by Subject|7|||
13433397|NCT00393939|26896141|FG000|Overall Study|Other|37|||
13433398|NCT00393939|26896142|FG001|Overall Study|Other|45|||
13433399|NCT00393913|26896150|FG000|Initial Assessment|diagnosed with other sleep disorder|21|||
13433400|NCT00393913|26896150|FG000|Initial Assessment|Withdrawal by Subject|16|||
13433401|NCT00393913|26896150|FG000|CPAP|Withdrawal by Subject|3|||
13433402|NCT00393913|26896150|FG000|CPAP|Physician Decision|1|||
13433403|NCT00393913|26896150|FG000|CPAP|TEchnical problem with CPAP|3|||
13433404|NCT00393887|26896163|FG000|Overall Study|Physician Decision|5|||
13433405|NCT00393887|26896164|FG001|Overall Study|Physician Decision|0|||
13433406|NCT00393887|26896163|FG000|Overall Study|Lost to Follow-up|11|||
13433407|NCT00393887|26896164|FG001|Overall Study|Lost to Follow-up|9|||
13433408|NCT00393861|26896173|FG000|Overall Study|Adverse Event|2|||
13433409|NCT00393861|26896173|FG000|Overall Study|Disease Progression|24|||
13433410|NCT00393848|26896198|FG000|Overall Study|Surgical schedule|0|||
13433411|NCT00393848|26896199|FG001|Overall Study|Surgical schedule|0|||
13433412|NCT00393848|26896200|FG002|Overall Study|Surgical schedule|0|||
13433413|NCT00393848|26896201|FG003|Overall Study|Surgical schedule|1|||
13433414|NCT00393848|26896198|FG000|Overall Study|Personal reasons|0|||
13433415|NCT00393848|26896199|FG001|Overall Study|Personal reasons|0|||
13219920|NCT01829191|26278653|FG001|Overall Study|Lens discomfort|3|||
13433416|NCT00393848|26896200|FG002|Overall Study|Personal reasons|2|||
13433417|NCT00393848|26896201|FG003|Overall Study|Personal reasons|0|||
13433418|NCT00393718|26896238|FG000|Overall Study|Adverse Event|20|||
13433419|NCT00393718|26896239|FG001|Overall Study|Adverse Event|8|||
13433420|NCT00393718|26896238|FG000|Overall Study|Protocol Violation|1|||
13433421|NCT00393718|26896239|FG001|Overall Study|Protocol Violation|2|||
13433422|NCT00393718|26896238|FG000|Overall Study|Lack of Efficacy|10|||
13433423|NCT00393718|26896239|FG001|Overall Study|Lack of Efficacy|9|||
13433424|NCT00393718|26896238|FG000|Overall Study|Hypoglycaemia|3|||
13433425|NCT00393718|26896239|FG001|Overall Study|Hypoglycaemia|2|||
13433426|NCT00393718|26896238|FG000|Overall Study|Subject decision|5|||
13433427|NCT00393718|26896239|FG001|Overall Study|Subject decision|0|||
13433428|NCT00393718|26896238|FG000|Overall Study|Withdrawal of consent|2|||
13433429|NCT00393718|26896239|FG001|Overall Study|Withdrawal of consent|1|||
13433430|NCT00393718|26896238|FG000|Overall Study|Missed measurement|1|||
13433431|NCT00393718|26896239|FG001|Overall Study|Missed measurement|0|||
13433432|NCT00393718|26896238|FG000|Overall Study|Move|1|||
13433433|NCT00393718|26896239|FG001|Overall Study|Move|0|||
13433434|NCT00393705|26896270|FG000|Overall Study|Adverse Event|0|||
13433435|NCT00393705|26896271|FG001|Overall Study|Adverse Event|2|||
13433436|NCT00393705|26896270|FG000|Overall Study|Death|0|||
13433437|NCT00393705|26896271|FG001|Overall Study|Death|1|||
13433438|NCT00393705|26896270|FG000|Overall Study|Lost to Follow-up|2|||
13433439|NCT00393705|26896271|FG001|Overall Study|Lost to Follow-up|2|||
13433440|NCT00393705|26896270|FG000|Overall Study|Entry Criteria Not Met|10|||
13433441|NCT00393705|26896271|FG001|Overall Study|Entry Criteria Not Met|10|||
13433442|NCT00393705|26896270|FG000|Overall Study|Protocol Violation|4|||
13433443|NCT00393705|26896271|FG001|Overall Study|Protocol Violation|3|||
13433444|NCT00393705|26896270|FG000|Overall Study|Withdrawal by Subject|5|||
13433445|NCT00393705|26896271|FG001|Overall Study|Withdrawal by Subject|3|||
13433446|NCT00393705|26896270|FG000|Overall Study|Physician Decision|2|||
13433447|NCT00393705|26896271|FG001|Overall Study|Physician Decision|2|||
13433448|NCT00393523|26896302|FG000|Overall Study|Lost to Follow-up|0|||
13433449|NCT00393523|26896303|FG001|Overall Study|Lost to Follow-up|0|||
13433450|NCT00393523|26896304|FG002|Overall Study|Lost to Follow-up|0|||
13433451|NCT00393523|26896305|FG003|Overall Study|Lost to Follow-up|2|||
13433452|NCT00393523|26896306|FG004|Overall Study|Lost to Follow-up|1|||
13433453|NCT00393523|26896302|FG000|Overall Study|Protocol Violation|6|||
13433454|NCT00393523|26896303|FG001|Overall Study|Protocol Violation|2|||
13433455|NCT00393523|26896304|FG002|Overall Study|Protocol Violation|0|||
13433456|NCT00393523|26896305|FG003|Overall Study|Protocol Violation|1|||
13433457|NCT00393523|26896306|FG004|Overall Study|Protocol Violation|0|||
13433458|NCT00393523|26896302|FG000|Overall Study|Withdrawal by Subject|6|||
13433459|NCT00393523|26896303|FG001|Overall Study|Withdrawal by Subject|7|||
13433460|NCT00393523|26896304|FG002|Overall Study|Withdrawal by Subject|2|||
13433461|NCT00393523|26896305|FG003|Overall Study|Withdrawal by Subject|3|||
13433462|NCT00393523|26896306|FG004|Overall Study|Withdrawal by Subject|0|||
13433463|NCT00393523|26896302|FG000|Overall Study|Difficulties in specimen collection|0|||
13433464|NCT00393523|26896303|FG001|Overall Study|Difficulties in specimen collection|0|||
13433465|NCT00393523|26896304|FG002|Overall Study|Difficulties in specimen collection|1|||
13433466|NCT00393523|26896305|FG003|Overall Study|Difficulties in specimen collection|0|||
13433467|NCT00393523|26896306|FG004|Overall Study|Difficulties in specimen collection|0|||
13433468|NCT00393523|26896302|FG000|Overall Study|Vaccine supply issue|0|||
13433469|NCT00393523|26896303|FG001|Overall Study|Vaccine supply issue|0|||
13433470|NCT00393523|26896304|FG002|Overall Study|Vaccine supply issue|1|||
13433471|NCT00393523|26896305|FG003|Overall Study|Vaccine supply issue|0|||
13433472|NCT00393523|26896306|FG004|Overall Study|Vaccine supply issue|0|||
13433473|NCT00393510|26896323|FG000|Overall Study|Physician Decision|3|||
13433474|NCT00393510|26896324|FG001|Overall Study|Physician Decision|9|||
13433475|NCT00393484|26896363|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0|||
13433476|NCT00393484|26896364|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1|||
13433477|NCT00393484|26896363|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2|||
13433478|NCT00393484|26896364|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0|||
13433479|NCT00393484|26896363|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0|||
13433480|NCT00393484|26896364|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3|||
13433481|NCT00393484|26896363|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0|||
13433482|NCT00393484|26896364|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6|||
13433483|NCT00393484|26896363|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0|||
13433484|NCT00393484|26896364|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2|||
13433485|NCT00393484|26896363|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4|||
13433486|NCT00393484|26896364|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1|||
13433487|NCT00393484|26896363|FG000|Open-label Period (Weeks 96 to 240)|Death|1|||
13433488|NCT00393484|26896364|FG001|Open-label Period (Weeks 96 to 240)|Death|0|||
13433489|NCT00393484|26896363|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1|||
13433490|NCT00393484|26896364|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2|||
13433491|NCT00393484|26896363|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
13433492|NCT00393484|26896364|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
13433493|NCT00393484|26896363|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0|||
13433494|NCT00393484|26896364|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18|||
13433495|NCT00393458|26896391|FG000|Overall Study|Adverse Event|35|||
13433496|NCT00393458|26896392|FG001|Overall Study|Adverse Event|24|||
13433497|NCT00393458|26896393|FG002|Overall Study|Adverse Event|40|||
13433498|NCT00393458|26896394|FG003|Overall Study|Adverse Event|35|||
13433499|NCT00393458|26896391|FG000|Overall Study|Subject withdrew consent|27|||
13433500|NCT00393458|26896392|FG001|Overall Study|Subject withdrew consent|40|||
13433501|NCT00393458|26896393|FG002|Overall Study|Subject withdrew consent|33|||
13433502|NCT00393458|26896394|FG003|Overall Study|Subject withdrew consent|50|||
13433503|NCT00393458|26896391|FG000|Overall Study|Unsatisfactory therapeutic effect|12|||
13433504|NCT00393458|26896392|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
13433505|NCT00393458|26896393|FG002|Overall Study|Unsatisfactory therapeutic effect|12|||
13433506|NCT00393458|26896394|FG003|Overall Study|Unsatisfactory therapeutic effect|30|||
13433507|NCT00393458|26896391|FG000|Overall Study|Protocol deviation|11|||
13433508|NCT00393458|26896392|FG001|Overall Study|Protocol deviation|11|||
13433509|NCT00393458|26896393|FG002|Overall Study|Protocol deviation|11|||
13433510|NCT00393458|26896394|FG003|Overall Study|Protocol deviation|10|||
13433511|NCT00393458|26896391|FG000|Overall Study|Administrative problems|7|||
13433512|NCT00393458|26896392|FG001|Overall Study|Administrative problems|8|||
13433513|NCT00393458|26896393|FG002|Overall Study|Administrative problems|5|||
13433514|NCT00393458|26896394|FG003|Overall Study|Administrative problems|2|||
13433515|NCT00393458|26896391|FG000|Overall Study|Lost to Follow-up|5|||
13433516|NCT00393458|26896392|FG001|Overall Study|Lost to Follow-up|6|||
13433517|NCT00393458|26896393|FG002|Overall Study|Lost to Follow-up|5|||
13433518|NCT00393458|26896394|FG003|Overall Study|Lost to Follow-up|3|||
13433519|NCT00393458|26896391|FG000|Overall Study|Abnormal laboratory value(s)|1|||
13433520|NCT00393458|26896392|FG001|Overall Study|Abnormal laboratory value(s)|1|||
13433521|NCT00393458|26896393|FG002|Overall Study|Abnormal laboratory value(s)|0|||
13433522|NCT00393458|26896394|FG003|Overall Study|Abnormal laboratory value(s)|0|||
13433523|NCT00393458|26896391|FG000|Overall Study|Death|1|||
13433524|NCT00393458|26896392|FG001|Overall Study|Death|1|||
13433525|NCT00393458|26896393|FG002|Overall Study|Death|5|||
13433526|NCT00393458|26896394|FG003|Overall Study|Death|5|||
13433527|NCT00393458|26896391|FG000|Overall Study|Abnormal test procedure result(s)|0|||
13433528|NCT00393458|26896392|FG001|Overall Study|Abnormal test procedure result(s)|1|||
13433529|NCT00393458|26896393|FG002|Overall Study|Abnormal test procedure result(s)|1|||
13433530|NCT00393458|26896394|FG003|Overall Study|Abnormal test procedure result(s)|2|||
13433531|NCT00393458|26896391|FG000|Overall Study|Subject no longer requires study drug|0|||
13433532|NCT00393458|26896392|FG001|Overall Study|Subject no longer requires study drug|1|||
13433533|NCT00393458|26896393|FG002|Overall Study|Subject no longer requires study drug|0|||
13433534|NCT00393458|26896394|FG003|Overall Study|Subject no longer requires study drug|0|||
13433535|NCT00393367|26896429|FG000|Overall Study|Protocol Violation|2|||
13433536|NCT00393367|26896430|FG001|Overall Study|Protocol Violation|5|||
13433537|NCT00393367|26896429|FG000|Overall Study|Withdrawal by Subject|0|||
13433538|NCT00393367|26896430|FG001|Overall Study|Withdrawal by Subject|2|||
13433539|NCT00393094|26896439|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1|||
13433540|NCT00393094|26896439|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1|||
13433541|NCT00393042|26896512|FG000|First Intervention|Withdrawal by Subject|1|||
13433542|NCT00393042|26896513|FG001|First Intervention|Withdrawal by Subject|2|||
13433543|NCT00393042|26896512|FG000|First Intervention|Lost to Follow-up|3|||
13433544|NCT00393042|26896513|FG001|First Intervention|Lost to Follow-up|3|||
13433545|NCT00393042|26896512|FG000|First Intervention|Protocol Violation|1|||
13433546|NCT00393042|26896513|FG001|First Intervention|Protocol Violation|0|||
13433547|NCT00393042|26896512|FG000|First Intervention|Adverse Event|0|||
13433548|NCT00393042|26896513|FG001|First Intervention|Adverse Event|1|||
13433549|NCT00393042|26896512|FG000|Second Intervetion|Adverse Event|0|||
13433550|NCT00393042|26896513|FG001|Second Intervetion|Adverse Event|3|||
13433551|NCT00393042|26896512|FG000|Second Intervetion|Withdrawal by Subject|0|||
13433552|NCT00393042|26896513|FG001|Second Intervetion|Withdrawal by Subject|2|||
13433553|NCT00393042|26896512|FG000|Second Intervetion|Lack of Efficacy|1|||
13433554|NCT00393042|26896513|FG001|Second Intervetion|Lack of Efficacy|0|||
13433555|NCT00393042|26896512|FG000|Second Intervetion|Lost to Follow-up|0|||
13433556|NCT00393042|26896513|FG001|Second Intervetion|Lost to Follow-up|2|||
13433557|NCT00393042|26896512|FG000|Second Intervetion|Protocol Violation|1|||
13433558|NCT00393042|26896513|FG001|Second Intervetion|Protocol Violation|1|||
13433559|NCT00393029|26896529|FG000|Overall Study|Not treated|0|||
13433560|NCT00393029|26896530|FG001|Overall Study|Not treated|1|||
13433561|NCT00392990|26896549|FG000|Treatment on Study|Adverse Event|3|||
13433562|NCT00392990|26896550|FG001|Treatment on Study|Adverse Event|1|||
13433563|NCT00392990|26896549|FG000|Follow up for 2 Years|Death|4|||
13433564|NCT00392990|26896550|FG001|Follow up for 2 Years|Death|0|||
13433565|NCT00392925|26896649|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11|||
13433566|NCT00392925|26896650|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
13433567|NCT00392925|26896651|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
13433568|NCT00392925|26896652|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
13433569|NCT00392925|26896649|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5|||
13433570|NCT00392925|26896650|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
13433571|NCT00392925|26896651|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
13433572|NCT00392925|26896652|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
13433573|NCT00392925|26896649|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1|||
13433574|NCT00392925|26896650|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
13433575|NCT00392925|26896651|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
13433576|NCT00392925|26896652|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
13433577|NCT00392925|26896649|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5|||
13433578|NCT00392925|26896650|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
13433579|NCT00392925|26896651|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
13433580|NCT00392925|26896652|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
13433581|NCT00392925|26896649|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16|||
13433582|NCT00392925|26896650|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
13433583|NCT00392925|26896651|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
13433584|NCT00392925|26896652|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
13433585|NCT00392925|26896649|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0|||
13433586|NCT00392925|26896650|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2|||
13433587|NCT00392925|26896651|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6|||
13433588|NCT00392925|26896652|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8|||
13433589|NCT00392925|26896649|FG000|Randomization to Treatment Group Period|Adverse Event|0|||
13433590|NCT00392925|26896650|FG001|Randomization to Treatment Group Period|Adverse Event|3|||
13433591|NCT00392925|26896651|FG002|Randomization to Treatment Group Period|Adverse Event|3|||
13433592|NCT00392925|26896652|FG003|Randomization to Treatment Group Period|Adverse Event|5|||
13433593|NCT00392925|26896649|FG000|Randomization to Treatment Group Period|Protocol Violation|0|||
13433594|NCT00392925|26896650|FG001|Randomization to Treatment Group Period|Protocol Violation|0|||
13433595|NCT00392925|26896651|FG002|Randomization to Treatment Group Period|Protocol Violation|2|||
13433596|NCT00392925|26896652|FG003|Randomization to Treatment Group Period|Protocol Violation|1|||
13433597|NCT00392925|26896649|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0|||
13433598|NCT00392925|26896650|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3|||
13433599|NCT00392925|26896651|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8|||
13433600|NCT00392925|26896652|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4|||
13433601|NCT00392808|26896679|FG000|Overall Study|Lost to Follow-up|3|||
13433602|NCT00392808|26896680|FG001|Overall Study|Lost to Follow-up|2|||
13433603|NCT00392808|26896681|FG002|Overall Study|Lost to Follow-up|1|||
13433604|NCT00392808|26896682|FG003|Overall Study|Lost to Follow-up|2|||
13433605|NCT00392808|26896679|FG000|Overall Study|Unable to withdraw blood|3|||
13433606|NCT00392808|26896680|FG001|Overall Study|Unable to withdraw blood|1|||
13433607|NCT00392808|26896681|FG002|Overall Study|Unable to withdraw blood|1|||
13433608|NCT00392808|26896682|FG003|Overall Study|Unable to withdraw blood|2|||
13433609|NCT00392769|26896688|FG000|Overall Study|Clinical Deterioration|9|||
13433610|NCT00392769|26896688|FG000|Overall Study|Adverse Event|1|||
13433611|NCT00392665|26896707|FG000|Overall Study|Death|16|||
13433612|NCT00392665|26896708|FG001|Overall Study|Death|14|||
13433613|NCT00392665|26896707|FG000|Overall Study|Lost to Follow-up|1|||
13433614|NCT00392665|26896708|FG001|Overall Study|Lost to Follow-up|1|||
13433615|NCT00392379|26896725|FG000|Overall Study|Withdrawal by Subject|17|||
13433616|NCT00392379|26896726|FG001|Overall Study|Withdrawal by Subject|28|||
13433617|NCT00392379|26896725|FG000|Overall Study|Lost to Follow-up|4|||
13433618|NCT00392379|26896726|FG001|Overall Study|Lost to Follow-up|9|||
13433619|NCT00392379|26896725|FG000|Overall Study|Adverse Event|1|||
13433620|NCT00392379|26896726|FG001|Overall Study|Adverse Event|1|||
13433621|NCT00392288|26896750|FG000|Overall Study|Adverse Event|17|||
13433622|NCT00392288|26896751|FG001|Overall Study|Adverse Event|7|||
13433623|NCT00392288|26896752|FG002|Overall Study|Adverse Event|8|||
13433624|NCT00392288|26896750|FG000|Overall Study|Lack of Efficacy|8|||
13433625|NCT00392288|26896751|FG001|Overall Study|Lack of Efficacy|5|||
13433626|NCT00392288|26896752|FG002|Overall Study|Lack of Efficacy|3|||
13433627|NCT00392288|26896750|FG000|Overall Study|Protocol Violation|1|||
13433628|NCT00392288|26896751|FG001|Overall Study|Protocol Violation|3|||
13433629|NCT00392288|26896752|FG002|Overall Study|Protocol Violation|1|||
13433630|NCT00392288|26896750|FG000|Overall Study|Lost to Follow-up|1|||
13433631|NCT00392288|26896751|FG001|Overall Study|Lost to Follow-up|1|||
13433632|NCT00392288|26896752|FG002|Overall Study|Lost to Follow-up|1|||
13433633|NCT00392288|26896750|FG000|Overall Study|Withdrawal by Subject|1|||
13433634|NCT00392288|26896751|FG001|Overall Study|Withdrawal by Subject|0|||
13433635|NCT00392288|26896752|FG002|Overall Study|Withdrawal by Subject|2|||
13433636|NCT00392288|26896750|FG000|Overall Study|Parent/legal guardian withdrawal|1|||
13433637|NCT00392288|26896751|FG001|Overall Study|Parent/legal guardian withdrawal|2|||
13433638|NCT00392288|26896752|FG002|Overall Study|Parent/legal guardian withdrawal|1|||
13433639|NCT00392288|26896750|FG000|Overall Study|Other|3|||
13433640|NCT00392288|26896751|FG001|Overall Study|Other|4|||
13433641|NCT00392288|26896752|FG002|Overall Study|Other|1|||
13433642|NCT00392223|26896775|FG000|Overall Study|Adverse Event|5|||
13433643|NCT00392223|26896776|FG001|Overall Study|Adverse Event|4|||
13433644|NCT00392223|26896775|FG000|Overall Study|Lost to Follow-up|1|||
13433645|NCT00392223|26896776|FG001|Overall Study|Lost to Follow-up|4|||
13433646|NCT00392223|26896775|FG000|Overall Study|Protocol Violation|0|||
13433647|NCT00392223|26896776|FG001|Overall Study|Protocol Violation|3|||
13433648|NCT00392223|26896775|FG000|Overall Study|Withdrawal by Subject|3|||
13433649|NCT00392223|26896776|FG001|Overall Study|Withdrawal by Subject|2|||
13433650|NCT00392210|26896789|FG000|First Voiding Trial|Physician Decision|2|||
13433651|NCT00392210|26896790|FG001|First Voiding Trial|Physician Decision|2|||
13433652|NCT00392197|26896805|FG000|Overall Study|Adverse Event|4|||
13433653|NCT00392197|26896806|FG001|Overall Study|Adverse Event|12|||
13433654|NCT00392197|26896805|FG000|Overall Study|Lack of Efficacy|3|||
13433655|NCT00392197|26896806|FG001|Overall Study|Lack of Efficacy|4|||
13433656|NCT00392197|26896805|FG000|Overall Study|Lost to Follow-up|0|||
13433657|NCT00392197|26896806|FG001|Overall Study|Lost to Follow-up|1|||
13433658|NCT00392197|26896805|FG000|Overall Study|Physician Decision|3|||
13433659|NCT00392197|26896806|FG001|Overall Study|Physician Decision|2|||
13433660|NCT00392197|26896805|FG000|Overall Study|Protocol Violation|7|||
13433661|NCT00392197|26896806|FG001|Overall Study|Protocol Violation|5|||
13433662|NCT00392197|26896805|FG000|Overall Study|Withdrawal by Subject|4|||
13433663|NCT00392197|26896806|FG001|Overall Study|Withdrawal by Subject|6|||
13433664|NCT00392171|26896812|FG000|Overall Study|Did not meet inclusion criteria|4|||
13433665|NCT00392171|26896812|FG000|Overall Study|Disease progression|101|||
13433666|NCT00392015|26896857|FG000|Overall Study|Lost to Follow-up|2|||
13433667|NCT00392015|26896858|FG001|Overall Study|Lost to Follow-up|0|||
13433668|NCT00392015|26896859|FG002|Overall Study|Lost to Follow-up|2|||
13433669|NCT00392015|26896860|FG003|Overall Study|Lost to Follow-up|1|||
13433670|NCT00392015|26896861|FG004|Overall Study|Lost to Follow-up|1|||
13433671|NCT00392015|26896862|FG005|Overall Study|Lost to Follow-up|0|||
13433672|NCT00392015|26896857|FG000|Overall Study|Withdrawal by Subject|0|||
13433673|NCT00392015|26896858|FG001|Overall Study|Withdrawal by Subject|0|||
13433674|NCT00392015|26896859|FG002|Overall Study|Withdrawal by Subject|2|||
13433675|NCT00392015|26896860|FG003|Overall Study|Withdrawal by Subject|0|||
13433676|NCT00392015|26896861|FG004|Overall Study|Withdrawal by Subject|0|||
13433677|NCT00392015|26896862|FG005|Overall Study|Withdrawal by Subject|0|||
13433678|NCT00392015|26896857|FG000|Overall Study|Adverse Event|0|||
13433679|NCT00392015|26896858|FG001|Overall Study|Adverse Event|0|||
13433680|NCT00392015|26896859|FG002|Overall Study|Adverse Event|0|||
13433681|NCT00392015|26896860|FG003|Overall Study|Adverse Event|0|||
13433682|NCT00392015|26896861|FG004|Overall Study|Adverse Event|1|||
13433683|NCT00392015|26896862|FG005|Overall Study|Adverse Event|0|||
13433684|NCT00392015|26896857|FG000|Overall Study|Previous trial recipient|0|||
13433685|NCT00392015|26896858|FG001|Overall Study|Previous trial recipient|0|||
13433686|NCT00392015|26896859|FG002|Overall Study|Previous trial recipient|0|||
13433687|NCT00392015|26896860|FG003|Overall Study|Previous trial recipient|0|||
13433688|NCT00392015|26896861|FG004|Overall Study|Previous trial recipient|1|||
13433689|NCT00392015|26896862|FG005|Overall Study|Previous trial recipient|0|||
13433690|NCT00391976|26896894|FG000|Overall Study|Adverse Event|0|||
13433691|NCT00391976|26896895|FG001|Overall Study|Adverse Event|0|||
13433692|NCT00391976|26896896|FG002|Overall Study|Adverse Event|1|||
13433693|NCT00391976|26896894|FG000|Overall Study|Withdrawal of consent|0|||
13433694|NCT00391976|26896895|FG001|Overall Study|Withdrawal of consent|1|||
13433695|NCT00391976|26896896|FG002|Overall Study|Withdrawal of consent|1|||
13433696|NCT00391976|26896894|FG000|Overall Study|Lost to Follow-up|1|||
13433697|NCT00391976|26896895|FG001|Overall Study|Lost to Follow-up|2|||
13433698|NCT00391976|26896896|FG002|Overall Study|Lost to Follow-up|0|||
13433699|NCT00391976|26896894|FG000|Overall Study|Inappropriate enrollment|1|||
13433700|NCT00391976|26896895|FG001|Overall Study|Inappropriate enrollment|1|||
13433701|NCT00391976|26896896|FG002|Overall Study|Inappropriate enrollment|0|||
13433702|NCT00391976|26896894|FG000|Overall Study|Protocol deviation/violation|4|||
13433703|NCT00391976|26896895|FG001|Overall Study|Protocol deviation/violation|2|||
13433704|NCT00391976|26896896|FG002|Overall Study|Protocol deviation/violation|1|||
13433705|NCT00391976|26896894|FG000|Overall Study|Recurrence/no eradication of infection|21|||
13433706|NCT00391976|26896895|FG001|Overall Study|Recurrence/no eradication of infection|19|||
13433707|NCT00391976|26896896|FG002|Overall Study|Recurrence/no eradication of infection|0|||
13433708|NCT00391976|26896894|FG000|Overall Study|Unable to classify|0|||
13433709|NCT00391976|26896895|FG001|Overall Study|Unable to classify|0|||
13433710|NCT00391976|26896896|FG002|Overall Study|Unable to classify|1|||
13433711|NCT00391976|26896894|FG000|Overall Study|Positive P. aeruginosa antibody test|0|||
13433712|NCT00391976|26896895|FG001|Overall Study|Positive P. aeruginosa antibody test|0|||
13433713|NCT00391976|26896896|FG002|Overall Study|Positive P. aeruginosa antibody test|31|||
13433714|NCT00391898|26896921|FG000|Overall Study|Adverse Event|3|||
13433715|NCT00391898|26896922|FG001|Overall Study|Adverse Event|0|||
13433716|NCT00391898|26896921|FG000|Overall Study|Other|8|||
13433717|NCT00391898|26896922|FG001|Overall Study|Other|10|||
13433718|NCT00391872|26896965|FG000|Overall Study|Protocol Violation|7|||
13433719|NCT00391872|26896966|FG001|Overall Study|Protocol Violation|2|||
13433720|NCT00391872|26896965|FG000|Overall Study|Withdrawal by Subject|296|||
13433721|NCT00391872|26896966|FG001|Overall Study|Withdrawal by Subject|249|||
13433722|NCT00391872|26896965|FG000|Overall Study|Reason unknown|2|||
13433723|NCT00391872|26896966|FG001|Overall Study|Reason unknown|4|||
13433724|NCT00391872|26896965|FG000|Overall Study|Lost to Follow-up|2|||
13433725|NCT00391872|26896966|FG001|Overall Study|Lost to Follow-up|0|||
13433726|NCT00391846|26896993|FG000|Overall Study|Adverse Event|4|||
13433727|NCT00391846|26896994|FG001|Overall Study|Adverse Event|1|||
13433728|NCT00391846|26896993|FG000|Overall Study|Did not meet the required elig. crit|2|||
13433729|NCT00391846|26896994|FG001|Overall Study|Did not meet the required elig. crit|2|||
13433730|NCT00391846|26896993|FG000|Overall Study|Withdrawal by Subject|2|||
13433731|NCT00391846|26896994|FG001|Overall Study|Withdrawal by Subject|3|||
13433732|NCT00391846|26896993|FG000|Overall Study|Developed study specific DC criteria|0|||
13433733|NCT00391846|26896994|FG001|Overall Study|Developed study specific DC criteria|1|||
13433734|NCT00391807|26897016|FG000|Overall Study|Did not receive study medication|23|||
13433735|NCT00391807|26897016|FG000|Overall Study|Adverse Event|177|||
13433736|NCT00391807|26897016|FG000|Overall Study|Pregnancy|25|||
13433737|NCT00391807|26897016|FG000|Overall Study|Lost to Follow-up|227|||
13433738|NCT00391807|26897016|FG000|Overall Study|Withdrawal by Subject|147|||
13433739|NCT00391807|26897016|FG000|Overall Study|Protocol Violation|20|||
13433740|NCT00391807|26897016|FG000|Overall Study|Various|96|||
13433741|NCT00391768|26897103|FG000|Overall Study|Withdrawal by Subject|0|||
13433742|NCT00391768|26897104|FG001|Overall Study|Withdrawal by Subject|0|||
13433743|NCT00391768|26897105|FG002|Overall Study|Withdrawal by Subject|1|||
13433744|NCT00391768|26897106|FG003|Overall Study|Withdrawal by Subject|0|||
13433745|NCT00391768|26897107|FG004|Overall Study|Withdrawal by Subject|0|||
13433746|NCT00391768|26897108|FG005|Overall Study|Withdrawal by Subject|1|||
13433747|NCT00391768|26897109|FG006|Overall Study|Withdrawal by Subject|1|||
13433748|NCT00391768|26897103|FG000|Overall Study|Lost to Follow-up|0|||
13433749|NCT00391768|26897104|FG001|Overall Study|Lost to Follow-up|0|||
13433750|NCT00391768|26897105|FG002|Overall Study|Lost to Follow-up|0|||
13433751|NCT00391768|26897106|FG003|Overall Study|Lost to Follow-up|1|||
13433752|NCT00391768|26897107|FG004|Overall Study|Lost to Follow-up|2|||
13433753|NCT00391768|26897108|FG005|Overall Study|Lost to Follow-up|2|||
13433754|NCT00391768|26897109|FG006|Overall Study|Lost to Follow-up|3|||
13433755|NCT00391625|26897151|FG000|Month 14|Withdrawal by Subject|1|||
13433756|NCT00391625|26897151|FG000|Month 50|Physician Decision|1|||
13433757|NCT00391586|26897158|FG000|Overall Study|Progressive disease|13|||
13433758|NCT00391586|26897158|FG000|Overall Study|Adverse Event|5|||
13433759|NCT00391586|26897158|FG000|Overall Study|Physician Decision|2|||
13433760|NCT00391586|26897158|FG000|Overall Study|Death|4|||
13433761|NCT00391430|26897239|FG000|Overall Study|Withdrawal by Subject|3|||
13433762|NCT00391430|26897240|FG001|Overall Study|Withdrawal by Subject|0|||
13433763|NCT00391430|26897241|FG002|Overall Study|Withdrawal by Subject|12|||
13433764|NCT00391391|26897284|FG000|Overall Study|Adverse Event|0|||
13433765|NCT00391391|26897285|FG001|Overall Study|Adverse Event|0|||
13433766|NCT00391391|26897286|FG002|Overall Study|Adverse Event|0|||
13433767|NCT00391391|26897287|FG003|Overall Study|Adverse Event|1|||
13433768|NCT00391391|26897284|FG000|Overall Study|Lost to Follow-up|1|||
13433769|NCT00391391|26897285|FG001|Overall Study|Lost to Follow-up|3|||
13433770|NCT00391391|26897286|FG002|Overall Study|Lost to Follow-up|7|||
13433771|NCT00391391|26897287|FG003|Overall Study|Lost to Follow-up|4|||
13433772|NCT00391391|26897284|FG000|Overall Study|Protocol Violation|2|||
13433773|NCT00391391|26897285|FG001|Overall Study|Protocol Violation|3|||
13433774|NCT00391391|26897286|FG002|Overall Study|Protocol Violation|6|||
13433775|NCT00391391|26897287|FG003|Overall Study|Protocol Violation|7|||
13433776|NCT00391391|26897284|FG000|Overall Study|Withdrawal by Subject|6|||
13433777|NCT00391391|26897285|FG001|Overall Study|Withdrawal by Subject|4|||
13433778|NCT00391391|26897286|FG002|Overall Study|Withdrawal by Subject|10|||
13433779|NCT00391391|26897287|FG003|Overall Study|Withdrawal by Subject|7|||
13433780|NCT00391274|26897310|FG000|Overall Study|Death Due to Study Disease|55|||
13433781|NCT00391274|26897311|FG001|Overall Study|Death Due to Study Disease|45|||
13433782|NCT00391274|26897310|FG000|Overall Study|Lost to Follow-up|0|||
13433783|NCT00391274|26897311|FG001|Overall Study|Lost to Follow-up|3|||
13433784|NCT00391274|26897310|FG000|Overall Study|Physician Decision|4|||
13433785|NCT00391274|26897311|FG001|Overall Study|Physician Decision|2|||
13433786|NCT00391274|26897310|FG000|Overall Study|Withdrawal by Subject|0|||
13433787|NCT00391274|26897311|FG001|Overall Study|Withdrawal by Subject|3|||
13433788|NCT00391274|26897310|FG000|Overall Study|Death Due to Adverse Event|1|||
13433789|NCT00391274|26897311|FG001|Overall Study|Death Due to Adverse Event|3|||
13433790|NCT00391274|26897310|FG000|Overall Study|Death Due to Indeterminate Cause|1|||
13433791|NCT00391274|26897311|FG001|Overall Study|Death Due to Indeterminate Cause|0|||
13433792|NCT00391274|26897310|FG000|Overall Study|Death Not Study Related|0|||
13433793|NCT00391274|26897311|FG001|Overall Study|Death Not Study Related|1|||
13433794|NCT00391222|26897346|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
13433795|NCT00391222|26897347|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
13433796|NCT00391222|26897348|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
13433797|NCT00391222|26897349|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26|||
13433798|NCT00391222|26897346|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
13433799|NCT00391222|26897347|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
13433800|NCT00391222|26897348|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
13433801|NCT00391222|26897349|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5|||
13433802|NCT00391222|26897346|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
13433803|NCT00391222|26897347|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
13433804|NCT00391222|26897348|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
13433805|NCT00391222|26897349|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10|||
13433806|NCT00391222|26897346|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0|||
13433807|NCT00391222|26897347|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0|||
13433808|NCT00391222|26897348|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0|||
13433809|NCT00391222|26897349|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97|||
13433810|NCT00391222|26897346|FG000|Period II (Open-label Risperidone LAI)|Other|0|||
13433811|NCT00391222|26897347|FG001|Period II (Open-label Risperidone LAI)|Other|0|||
13433812|NCT00391222|26897348|FG002|Period II (Open-label Risperidone LAI)|Other|0|||
13433813|NCT00391222|26897349|FG003|Period II (Open-label Risperidone LAI)|Other|24|||
13433814|NCT00391222|26897346|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15|||
13433815|NCT00391222|26897347|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12|||
13433816|NCT00391222|26897348|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6|||
13433817|NCT00391222|26897349|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0|||
13433818|NCT00391222|26897346|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2|||
13433819|NCT00391222|26897347|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
13433820|NCT00391222|26897348|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
13433821|NCT00391222|26897349|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0|||
13433822|NCT00391222|26897346|FG000|Period III (Double-Blind Treatment)|Adverse Event|5|||
13433823|NCT00391222|26897347|FG001|Period III (Double-Blind Treatment)|Adverse Event|2|||
13433824|NCT00391222|26897348|FG002|Period III (Double-Blind Treatment)|Adverse Event|4|||
13433825|NCT00391222|26897349|FG003|Period III (Double-Blind Treatment)|Adverse Event|0|||
13433826|NCT00391222|26897346|FG000|Period III (Double-Blind Treatment)|Pregnancy|0|||
13433827|NCT00391222|26897347|FG001|Period III (Double-Blind Treatment)|Pregnancy|2|||
13433828|NCT00391222|26897348|FG002|Period III (Double-Blind Treatment)|Pregnancy|0|||
13433829|NCT00391222|26897349|FG003|Period III (Double-Blind Treatment)|Pregnancy|0|||
13433830|NCT00391222|26897346|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
13433831|NCT00391222|26897347|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1|||
13433832|NCT00391222|26897348|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3|||
13433833|NCT00391222|26897349|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
13433834|NCT00391222|26897346|FG000|Period III (Double-Blind Treatment)|Other|6|||
13433835|NCT00391222|26897347|FG001|Period III (Double-Blind Treatment)|Other|1|||
13433836|NCT00391222|26897348|FG002|Period III (Double-Blind Treatment)|Other|6|||
13433837|NCT00391222|26897349|FG003|Period III (Double-Blind Treatment)|Other|0|||
13433838|NCT00391170|26897368|FG000|Overall Study|Withdrawal by Subject|1|||
13433839|NCT00391170|26897369|FG001|Overall Study|Withdrawal by Subject|0|||
13433840|NCT00391170|26897368|FG000|Overall Study|Adverse Event|3|||
13433841|NCT00391170|26897369|FG001|Overall Study|Adverse Event|2|||
13433842|NCT00391170|26897368|FG000|Overall Study|Physician Decision|2|||
13433843|NCT00391170|26897369|FG001|Overall Study|Physician Decision|2|||
13433844|NCT00391118|26897403|FG000|Overall Study|Adverse Event|3|||
13433845|NCT00391118|26897404|FG001|Overall Study|Adverse Event|10|||
13433846|NCT00391118|26897405|FG002|Overall Study|Adverse Event|7|||
13433847|NCT00391118|26897403|FG000|Overall Study|Lost to Follow-up|0|||
13433848|NCT00391118|26897404|FG001|Overall Study|Lost to Follow-up|2|||
13433849|NCT00391118|26897405|FG002|Overall Study|Lost to Follow-up|3|||
13433850|NCT00391118|26897403|FG000|Overall Study|Withdrawal by Subject|0|||
13433851|NCT00391118|26897404|FG001|Overall Study|Withdrawal by Subject|9|||
13433852|NCT00391118|26897405|FG002|Overall Study|Withdrawal by Subject|1|||
13433853|NCT00391118|26897403|FG000|Overall Study|Death|0|||
13433854|NCT00391118|26897404|FG001|Overall Study|Death|1|||
13433855|NCT00391118|26897405|FG002|Overall Study|Death|0|||
13433856|NCT00391118|26897403|FG000|Overall Study|Physician Decision|0|||
13433857|NCT00391118|26897404|FG001|Overall Study|Physician Decision|3|||
13433858|NCT00391118|26897405|FG002|Overall Study|Physician Decision|0|||
13433859|NCT00391118|26897403|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
13433860|NCT00391118|26897404|FG001|Overall Study|Protocol Entry Criteria Not Met|3|||
13433861|NCT00391118|26897405|FG002|Overall Study|Protocol Entry Criteria Not Met|1|||
13433862|NCT00391118|26897403|FG000|Overall Study|Progressive Disease|7|||
13433863|NCT00391118|26897404|FG001|Overall Study|Progressive Disease|26|||
13433864|NCT00391118|26897405|FG002|Overall Study|Progressive Disease|43|||
13433865|NCT00391118|26897403|FG000|Overall Study|Sponsor Decision|0|||
13433866|NCT00391118|26897404|FG001|Overall Study|Sponsor Decision|1|||
13433867|NCT00391118|26897405|FG002|Overall Study|Sponsor Decision|3|||
13433868|NCT00391118|26897403|FG000|Overall Study|Protocol Violation|1|||
13433869|NCT00391118|26897404|FG001|Overall Study|Protocol Violation|0|||
13433870|NCT00391118|26897405|FG002|Overall Study|Protocol Violation|0|||
13433871|NCT00391092|26897430|FG000|Overall Study|Death|78|||
13433872|NCT00391092|26897431|FG001|Overall Study|Death|81|||
13433873|NCT00391092|26897430|FG000|Overall Study|Lost to Follow-up|13|||
13433874|NCT00391092|26897431|FG001|Overall Study|Lost to Follow-up|18|||
13433875|NCT00391092|26897430|FG000|Overall Study|Alive on treatment|29|||
13433876|NCT00391092|26897431|FG001|Overall Study|Alive on treatment|33|||
13433877|NCT00391092|26897430|FG000|Overall Study|Alive in follow-up|88|||
13433878|NCT00391092|26897431|FG001|Overall Study|Alive in follow-up|84|||
13433879|NCT00391053|26897466|FG000|Overall Study|Serious Adverse Events|1|||
13433880|NCT00391053|26897467|FG001|Overall Study|Serious Adverse Events|0|||
13433881|NCT00391053|26897468|FG002|Overall Study|Serious Adverse Events|1|||
13433882|NCT00391053|26897469|FG003|Overall Study|Serious Adverse Events|4|||
13433883|NCT00391053|26897466|FG000|Overall Study|Protocol Violation|2|||
13433884|NCT00391053|26897467|FG001|Overall Study|Protocol Violation|0|||
13433885|NCT00391053|26897468|FG002|Overall Study|Protocol Violation|0|||
13433886|NCT00391053|26897469|FG003|Overall Study|Protocol Violation|0|||
13433887|NCT00391053|26897466|FG000|Overall Study|Lost to Follow-up|1|||
13433888|NCT00391053|26897467|FG001|Overall Study|Lost to Follow-up|0|||
13433889|NCT00391053|26897468|FG002|Overall Study|Lost to Follow-up|0|||
13433890|NCT00391053|26897469|FG003|Overall Study|Lost to Follow-up|5|||
13433891|NCT00391053|26897466|FG000|Overall Study|Withdrawal by Subject|5|||
13433892|NCT00391053|26897467|FG001|Overall Study|Withdrawal by Subject|1|||
13433893|NCT00391053|26897468|FG002|Overall Study|Withdrawal by Subject|1|||
13433894|NCT00391053|26897469|FG003|Overall Study|Withdrawal by Subject|1|||
13433895|NCT00391027|26897514|FG000|Overall Study|Adverse Event|8|||
13433896|NCT00391027|26897515|FG001|Overall Study|Adverse Event|8|||
13433897|NCT00391027|26897514|FG000|Overall Study|Lack of Efficacy|3|||
13433898|NCT00391027|26897515|FG001|Overall Study|Lack of Efficacy|0|||
13433899|NCT00391027|26897514|FG000|Overall Study|Withdrawal by Subject|10|||
13433900|NCT00391027|26897515|FG001|Overall Study|Withdrawal by Subject|1|||
13433901|NCT00391027|26897514|FG000|Overall Study|Other|4|||
13433902|NCT00391027|26897515|FG001|Overall Study|Other|3|||
13433903|NCT00390910|26897611|FG000|Overall Study|Adverse Event|1|||
13433904|NCT00390910|26897612|FG001|Overall Study|Adverse Event|0|||
13433905|NCT00390910|26897613|FG002|Overall Study|Adverse Event|0|||
13433906|NCT00390910|26897611|FG000|Overall Study|Lost to Follow-up|0|||
13433907|NCT00390910|26897612|FG001|Overall Study|Lost to Follow-up|1|||
13433908|NCT00390910|26897613|FG002|Overall Study|Lost to Follow-up|5|||
13433909|NCT00390910|26897611|FG000|Overall Study|Withdrawal by Subject|1|||
13433910|NCT00390910|26897612|FG001|Overall Study|Withdrawal by Subject|3|||
13433911|NCT00390910|26897613|FG002|Overall Study|Withdrawal by Subject|2|||
13433912|NCT00390910|26897611|FG000|Overall Study|Migrated/moved from study area|0|||
13433913|NCT00390910|26897612|FG001|Overall Study|Migrated/moved from study area|0|||
13433914|NCT00390910|26897613|FG002|Overall Study|Migrated/moved from study area|3|||
13433915|NCT00390884|26897630|FG000|Overall Study|Withdrawal by Subject|2|||
13433916|NCT00390884|26897631|FG001|Overall Study|Withdrawal by Subject|2|||
13433917|NCT00390858|26897650|FG000|Overall Study|Adverse Event|6|||
13433918|NCT00390858|26897651|FG001|Overall Study|Adverse Event|2|||
13433919|NCT00390858|26897650|FG000|Overall Study|Lack of Efficacy|0|||
13433920|NCT00390858|26897651|FG001|Overall Study|Lack of Efficacy|1|||
13433921|NCT00390858|26897650|FG000|Overall Study|Withdrawal by Subject|3|||
13433922|NCT00390858|26897651|FG001|Overall Study|Withdrawal by Subject|4|||
13433923|NCT00390806|26897724|FG000|Overall Study|Lost to Follow-up|7|||
13433924|NCT00390806|26897725|FG001|Overall Study|Lost to Follow-up|6|||
13433925|NCT00390806|26897724|FG000|Overall Study|Protocol Violation|2|||
13433926|NCT00390806|26897725|FG001|Overall Study|Protocol Violation|2|||
13433927|NCT00390806|26897724|FG000|Overall Study|Withdrawal by Subject|12|||
13433928|NCT00390806|26897725|FG001|Overall Study|Withdrawal by Subject|15|||
13433929|NCT00390806|26897724|FG000|Overall Study|Investigator Decision|4|||
13433930|NCT00390806|26897725|FG001|Overall Study|Investigator Decision|6|||
13433931|NCT00390806|26897724|FG000|Overall Study|Death|1|||
13433932|NCT00390806|26897725|FG001|Overall Study|Death|0|||
13433933|NCT00390806|26897724|FG000|Overall Study|Physician Decision|0|||
13433934|NCT00390806|26897725|FG001|Overall Study|Physician Decision|1|||
13433935|NCT00390806|26897724|FG000|Overall Study|Ongoing|4|||
13433936|NCT00390806|26897725|FG001|Overall Study|Ongoing|2|||
13433937|NCT00390780|26897762|FG000|Overall Study|Not completed|10|||
13433938|NCT00390780|26897763|FG001|Overall Study|Not completed|4|||
13433939|NCT00390780|26897762|FG000|Overall Study|Protocol Violation|6|||
13433940|NCT00390780|26897763|FG001|Overall Study|Protocol Violation|4|||
13433941|NCT00390780|26897762|FG000|Overall Study|Lost to Follow-up|3|||
13433942|NCT00390780|26897763|FG001|Overall Study|Lost to Follow-up|6|||
13433943|NCT00390780|26897762|FG000|Overall Study|Adverse Event|2|||
13433944|NCT00390780|26897763|FG001|Overall Study|Adverse Event|3|||
13433945|NCT00390780|26897762|FG000|Overall Study|Death|1|||
13433946|NCT00390780|26897763|FG001|Overall Study|Death|3|||
13433947|NCT00390780|26897762|FG000|Overall Study|Withdrawal by Subject|1|||
13433948|NCT00390780|26897763|FG001|Overall Study|Withdrawal by Subject|2|||
13433949|NCT00390780|26897762|FG000|Overall Study|Inclusion criteria not satisfied|0|||
13433950|NCT00390780|26897763|FG001|Overall Study|Inclusion criteria not satisfied|2|||
13433951|NCT00390780|26897762|FG000|Overall Study|Lost to follow up and other reasons|0|||
13433952|NCT00390780|26897763|FG001|Overall Study|Lost to follow up and other reasons|1|||
13433953|NCT00390780|26897762|FG000|Overall Study|Investigator decision, SAE, other reason|0|||
13433954|NCT00390780|26897763|FG001|Overall Study|Investigator decision, SAE, other reason|1|||
13433955|NCT00390780|26897762|FG000|Overall Study|SAE, death|0|||
13433956|NCT00390780|26897763|FG001|Overall Study|SAE, death|1|||
13433957|NCT00390689|26897831|FG000|Overall Study|Adverse Event|2|||
13433958|NCT00390689|26897832|FG001|Overall Study|Adverse Event|5|||
13433959|NCT00390689|26897833|FG002|Overall Study|Adverse Event|2|||
13433960|NCT00390689|26897831|FG000|Overall Study|Lack of Efficacy|0|||
13433961|NCT00390689|26897832|FG001|Overall Study|Lack of Efficacy|0|||
13433962|NCT00390689|26897833|FG002|Overall Study|Lack of Efficacy|1|||
13433963|NCT00390689|26897831|FG000|Overall Study|Protocol Violation|1|||
13433964|NCT00390689|26897832|FG001|Overall Study|Protocol Violation|0|||
13433965|NCT00390689|26897833|FG002|Overall Study|Protocol Violation|0|||
13433966|NCT00390689|26897831|FG000|Overall Study|Investigator's judgement|2|||
13433967|NCT00390689|26897832|FG001|Overall Study|Investigator's judgement|0|||
13433968|NCT00390689|26897833|FG002|Overall Study|Investigator's judgement|0|||
13433969|NCT00390572|26897854|FG000|Overall Study|Lost to Follow-up|8|||
13433970|NCT00390572|26897855|FG001|Overall Study|Lost to Follow-up|4|||
13433971|NCT00390572|26897854|FG000|Overall Study|health condition|0|||
13433972|NCT00390572|26897855|FG001|Overall Study|health condition|1|||
13433973|NCT00390546|26897872|FG000|Overall Study|Renal impairment|1|||
13433974|NCT00390546|26897873|FG001|Overall Study|Renal impairment|0|||
13433975|NCT00390546|26897872|FG000|Overall Study|Physician Decision|5|||
13433976|NCT00390546|26897873|FG001|Overall Study|Physician Decision|5|||
13433977|NCT00390468|26897879|FG000|Overall Study|Protocol Violation|2|||
13433978|NCT00390468|26897879|FG000|Overall Study|Lack of Efficacy|1|||
13433979|NCT00390455|26897904|FG000|Overall Study|Adverse Event|17|||
13433980|NCT00390455|26897905|FG001|Overall Study|Adverse Event|3|||
13433981|NCT00390455|26897904|FG000|Overall Study|Withdrawal by Subject|8|||
13433982|NCT00390455|26897905|FG001|Overall Study|Withdrawal by Subject|8|||
13433983|NCT00390455|26897904|FG000|Overall Study|Alternate Treatment|0|||
13433984|NCT00390455|26897905|FG001|Overall Study|Alternate Treatment|1|||
13433985|NCT00390455|26897904|FG000|Overall Study|Other Medical Reasons|7|||
13433986|NCT00390455|26897905|FG001|Overall Study|Other Medical Reasons|11|||
13433987|NCT00390416|26897913|FG000|Overall Study|Withdrawal by Subject|1|||
13433988|NCT00390416|26897913|FG000|Overall Study|Not treated|3|||
13433989|NCT00390299|26897949|FG000|Overall Study|Cancellation|1|||
13433990|NCT00390299|26897950|FG001|Overall Study|Cancellation|0|||
13433991|NCT00390299|26897951|FG002|Overall Study|Cancellation|0|||
13433992|NCT00390299|26897952|FG003|Overall Study|Cancellation|0|||
13433993|NCT00390299|26897953|FG004|Overall Study|Cancellation|0|||
13476945|NCT04545060|27004397|FG000|Overall Study|Death|0|||
13476946|NCT04545060|27004398|FG001|Overall Study|Death|5|||
13476947|NCT04545060|27004397|FG000|Overall Study|Lost to Follow-up|10|||
13476948|NCT04545060|27004398|FG001|Overall Study|Lost to Follow-up|13|||
13476949|NCT04545060|27004397|FG000|Overall Study|Physician Decision|3|||
13476950|NCT04545060|27004398|FG001|Overall Study|Physician Decision|0|||
13476951|NCT04545060|27004397|FG000|Overall Study|Withdrawal by Subject|17|||
13476952|NCT04545060|27004398|FG001|Overall Study|Withdrawal by Subject|22|||
13306259|NCT01292603|26525396|FG001|Part 2: Dose Confirmation Period|Death|0|||
13433994|NCT00390221|26897984|FG000|Overall Study|Lost to Follow-up|0|||
13433995|NCT00390221|26897985|FG001|Overall Study|Lost to Follow-up|3|||
13433996|NCT00390221|26897986|FG002|Overall Study|Lost to Follow-up|0|||
13433997|NCT00390221|26897984|FG000|Overall Study|Adverse Event|1|||
13433998|NCT00390221|26897985|FG001|Overall Study|Adverse Event|4|||
13433999|NCT00390221|26897986|FG002|Overall Study|Adverse Event|3|||
13434000|NCT00390221|26897984|FG000|Overall Study|Investigator Decision|0|||
13434001|NCT00390221|26897985|FG001|Overall Study|Investigator Decision|0|||
13434002|NCT00390221|26897986|FG002|Overall Study|Investigator Decision|1|||
13434003|NCT00390221|26897984|FG000|Overall Study|Withdrawal by Subject|13|||
13434004|NCT00390221|26897985|FG001|Overall Study|Withdrawal by Subject|9|||
13434005|NCT00390221|26897986|FG002|Overall Study|Withdrawal by Subject|7|||
13434006|NCT00390221|26897984|FG000|Overall Study|Subject Non-compliance|1|||
13434007|NCT00390221|26897985|FG001|Overall Study|Subject Non-compliance|0|||
13434008|NCT00390221|26897986|FG002|Overall Study|Subject Non-compliance|2|||
13434009|NCT00390221|26897984|FG000|Overall Study|Other|3|||
13434010|NCT00390221|26897985|FG001|Overall Study|Other|4|||
13434011|NCT00390221|26897986|FG002|Overall Study|Other|2|||
13434012|NCT00390013|26898003|FG000|Phase 1|tired|0|||
13434013|NCT00390013|26898004|FG001|Phase 1|tired|0|||
13434014|NCT00390013|26898005|FG002|Phase 1|tired|0|||
13434015|NCT00390013|26898006|FG003|Phase 1|tired|1|||
13434016|NCT00390013|26898003|FG000|Phase 2 First Treatment|tired|1|||
13434017|NCT00390013|26898004|FG001|Phase 2 First Treatment|tired|0|||
13434018|NCT00390013|26898005|FG002|Phase 2 First Treatment|tired|0|||
13434019|NCT00390013|26898006|FG003|Phase 2 First Treatment|tired|0|||
13434020|NCT00390013|26898003|FG000|Phase 2 First Treatment|Withdrawal by Subject|0|||
13434021|NCT00390013|26898004|FG001|Phase 2 First Treatment|Withdrawal by Subject|1|||
13434022|NCT00390013|26898005|FG002|Phase 2 First Treatment|Withdrawal by Subject|0|||
13434023|NCT00390013|26898006|FG003|Phase 2 First Treatment|Withdrawal by Subject|0|||
13434024|NCT00389831|26898039|FG000|Overall Study|Lack of Efficacy|0|||
13434025|NCT00389831|26898040|FG001|Overall Study|Lack of Efficacy|2|||
13434026|NCT00389831|26898039|FG000|Overall Study|Did not receive treatment.|0|||
13434027|NCT00389831|26898040|FG001|Overall Study|Did not receive treatment.|2|||
13434028|NCT00389831|26898039|FG000|Overall Study|Other reasons|0|||
13434029|NCT00389831|26898040|FG001|Overall Study|Other reasons|2|||
13434030|NCT00389831|26898039|FG000|Overall Study|Lost to Follow-up|0|||
13434031|NCT00389831|26898040|FG001|Overall Study|Lost to Follow-up|1|||
13434032|NCT00389597|26898063|FG000|Overall Study|Lost to Follow-up|8|||
13434033|NCT00389597|26898064|FG001|Overall Study|Lost to Follow-up|6|||
13434034|NCT00389597|26898065|FG002|Overall Study|Lost to Follow-up|4|||
13434035|NCT00389597|26898066|FG003|Overall Study|Lost to Follow-up|6|||
13434036|NCT00389519|26898105|FG000|Placebo Run-In|Did not meet blood pressure criteria|119|||
13434037|NCT00389519|26898106|FG001|Placebo Run-In|Did not meet blood pressure criteria|0|||
13434038|NCT00389519|26898107|FG002|Placebo Run-In|Did not meet blood pressure criteria|0|||
13434039|NCT00389519|26898108|FG003|Placebo Run-In|Did not meet blood pressure criteria|0|||
13434040|NCT00389519|26898105|FG000|Placebo Run-In|Withdrawal by Subject|19|||
13434041|NCT00389519|26898106|FG001|Placebo Run-In|Withdrawal by Subject|0|||
13434042|NCT00389519|26898107|FG002|Placebo Run-In|Withdrawal by Subject|0|||
13434043|NCT00389519|26898108|FG003|Placebo Run-In|Withdrawal by Subject|0|||
13434044|NCT00389519|26898105|FG000|Placebo Run-In|Reason not specified|40|||
13434045|NCT00389519|26898106|FG001|Placebo Run-In|Reason not specified|0|||
13434046|NCT00389519|26898107|FG002|Placebo Run-In|Reason not specified|0|||
13434047|NCT00389519|26898108|FG003|Placebo Run-In|Reason not specified|0|||
13434048|NCT00389519|26898105|FG000|Randomized|Did not receive study drug|2|||
13434049|NCT00389519|26898106|FG001|Randomized|Did not receive study drug|0|||
13434050|NCT00389519|26898107|FG002|Randomized|Did not receive study drug|0|||
13434051|NCT00389519|26898108|FG003|Randomized|Did not receive study drug|0|||
13434052|NCT00389519|26898105|FG000|Treated|Adverse Event|1|||
13434053|NCT00389519|26898106|FG001|Treated|Adverse Event|0|||
13434054|NCT00389519|26898107|FG002|Treated|Adverse Event|0|||
13434055|NCT00389519|26898108|FG003|Treated|Adverse Event|2|||
13434056|NCT00389519|26898105|FG000|Treated|Reason not specified|1|||
13434057|NCT00389519|26898106|FG001|Treated|Reason not specified|1|||
13434058|NCT00389519|26898107|FG002|Treated|Reason not specified|0|||
13434059|NCT00389519|26898108|FG003|Treated|Reason not specified|2|||
13434060|NCT00389441|26898119|FG000|Overall Study|Adverse Event|7|||
13434061|NCT00389441|26898119|FG000|Overall Study|Death|4|||
13434062|NCT00389441|26898119|FG000|Overall Study|Lost to Follow-up|2|||
13434063|NCT00389441|26898119|FG000|Overall Study|Withdrawal by Subject|4|||
13434064|NCT00389441|26898119|FG000|Overall Study|Physician Decision|1|||
13434065|NCT00389441|26898119|FG000|Overall Study|Protocol Violation|1|||
13434066|NCT00389441|26898119|FG000|Overall Study|Global deterioration of health status|4|||
13434067|NCT00389441|26898119|FG000|Overall Study|Objective progression or relapse|26|||
13434068|NCT00389441|26898119|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2|||
13434069|NCT00389441|26898119|FG000|Overall Study|Clinical progression|1|||
13434070|NCT00389324|26898128|FG000|Run-In Phase|Adverse Event|1|||
13434071|NCT00389324|26898128|FG000|Run-In Phase|Lost to Follow-up|1|||
13434072|NCT00389324|26898128|FG000|Run-In Phase|Withdrawal by Subject|1|||
13434073|NCT00389324|26898128|FG000|Subcutaneous Phase|Adverse Event|2|||
13434074|NCT00389324|26898128|FG000|Subcutaneous Phase|Non-compliance with study medication|2|||
13434075|NCT00389324|26898128|FG000|Subcutaneous Phase|Withdrawal by Subject|2|||
13434076|NCT00389324|26898128|FG000|Subcutaneous Phase|Lost to Follow-up|1|||
13434077|NCT00389207|26898240|FG000|Overall Study|Adverse Event|26|||
13434078|NCT00389207|26898241|FG001|Overall Study|Adverse Event|32|||
13434079|NCT00389207|26898242|FG002|Overall Study|Adverse Event|10|||
13434080|NCT00389207|26898240|FG000|Overall Study|Protocol Violation|3|||
13434081|NCT00389207|26898241|FG001|Overall Study|Protocol Violation|1|||
13434082|NCT00389207|26898242|FG002|Overall Study|Protocol Violation|4|||
13434083|NCT00389207|26898240|FG000|Overall Study|Lost to Follow-up|12|||
13434084|NCT00389207|26898241|FG001|Overall Study|Lost to Follow-up|9|||
13434085|NCT00389207|26898242|FG002|Overall Study|Lost to Follow-up|7|||
13434086|NCT00389207|26898240|FG000|Overall Study|Withdrawal by Subject|5|||
13434087|NCT00389207|26898241|FG001|Overall Study|Withdrawal by Subject|7|||
13434088|NCT00389207|26898242|FG002|Overall Study|Withdrawal by Subject|11|||
13434089|NCT00389207|26898240|FG000|Overall Study|Other|17|||
13434090|NCT00389207|26898241|FG001|Overall Study|Other|23|||
13434091|NCT00389207|26898242|FG002|Overall Study|Other|9|||
13434092|NCT00389064|26898275|FG000|Overall Study|Adverse Event|11|||
13434093|NCT00389064|26898276|FG001|Overall Study|Adverse Event|3|||
13434094|NCT00389064|26898275|FG000|Overall Study|Lack of Efficacy|3|||
13434095|NCT00389064|26898276|FG001|Overall Study|Lack of Efficacy|14|||
13434096|NCT00389064|26898275|FG000|Overall Study|Withdrawal by Subject|17|||
13434097|NCT00389064|26898276|FG001|Overall Study|Withdrawal by Subject|27|||
13434098|NCT00389064|26898275|FG000|Overall Study|Physician Decision|2|||
13434099|NCT00389064|26898276|FG001|Overall Study|Physician Decision|2|||
13434100|NCT00389064|26898275|FG000|Overall Study|Lost to Follow-up|1|||
13434101|NCT00389064|26898276|FG001|Overall Study|Lost to Follow-up|2|||
13434102|NCT00389064|26898275|FG000|Overall Study|Protocol Violation|2|||
13434103|NCT00389064|26898276|FG001|Overall Study|Protocol Violation|0|||
13434104|NCT00389064|26898275|FG000|Overall Study|Multiple Reasons|9|||
13434105|NCT00389064|26898276|FG001|Overall Study|Multiple Reasons|11|||
13434106|NCT00388973|26898303|FG000|Overall Study|Adverse Event|16|||
13434107|NCT00388973|26898304|FG001|Overall Study|Adverse Event|6|||
13434108|NCT00388973|26898303|FG000|Overall Study|Lack of Efficacy|1|||
13434109|NCT00388973|26898304|FG001|Overall Study|Lack of Efficacy|12|||
13434110|NCT00388973|26898303|FG000|Overall Study|Protocol Violation|3|||
13434111|NCT00388973|26898304|FG001|Overall Study|Protocol Violation|0|||
13434112|NCT00388973|26898303|FG000|Overall Study|Withdrawal by Subject|14|||
13434113|NCT00388973|26898304|FG001|Overall Study|Withdrawal by Subject|17|||
13434114|NCT00388973|26898303|FG000|Overall Study|Study specific Discontinuation Criteria|0|||
13434115|NCT00388973|26898304|FG001|Overall Study|Study specific Discontinuation Criteria|1|||
13434116|NCT00388973|26898303|FG000|Overall Study|Did not complete 61 days of treatment|5|||
13434117|NCT00388973|26898304|FG001|Overall Study|Did not complete 61 days of treatment|4|||
13434118|NCT00388973|26898303|FG000|Overall Study|Left region|0|||
13434119|NCT00388973|26898304|FG001|Overall Study|Left region|1|||
13434120|NCT00388973|26898303|FG000|Overall Study|Did not complete 2-week follow-up visit|17|||
13434121|NCT00388973|26898304|FG001|Overall Study|Did not complete 2-week follow-up visit|17|||
13434122|NCT00388947|26898311|FG000|Overall Study|Protocol Violation|47|||
13434123|NCT00388726|26898332|FG000|Overall Study|Adverse Event|50|||
13434124|NCT00388726|26898333|FG001|Overall Study|Adverse Event|24|||
13434125|NCT00388726|26898332|FG000|Overall Study|Progressive Disease|336|||
13434126|NCT00388726|26898333|FG001|Overall Study|Progressive Disease|153|||
13434127|NCT00388726|26898332|FG000|Overall Study|Clinical Progression|61|||
13434128|NCT00388726|26898333|FG001|Overall Study|Clinical Progression|36|||
13434129|NCT00388726|26898332|FG000|Overall Study|Withdrawal by Subject|10|||
13434130|NCT00388726|26898333|FG001|Overall Study|Withdrawal by Subject|7|||
13434131|NCT00388726|26898332|FG000|Overall Study|Administrative|6|||
13434132|NCT00388726|26898333|FG001|Overall Study|Administrative|9|||
13434133|NCT00388726|26898332|FG000|Overall Study|Physician Decision|18|||
13434134|NCT00388726|26898333|FG001|Overall Study|Physician Decision|13|||
13434135|NCT00388726|26898332|FG000|Overall Study|Death|3|||
13434136|NCT00388726|26898333|FG001|Overall Study|Death|2|||
13434137|NCT00388674|26898356|FG000|Initial Treatment|Administrative Reason by Sponsor|241|||
13434138|NCT00388674|26898357|FG001|Initial Treatment|Administrative Reason by Sponsor|158|||
13434139|NCT00388674|26898356|FG000|Initial Treatment|Adverse Event|22|||
13434140|NCT00388674|26898357|FG001|Initial Treatment|Adverse Event|87|||
13434141|NCT00388674|26898356|FG000|Initial Treatment|Death|215|||
13434142|NCT00388674|26898357|FG001|Initial Treatment|Death|216|||
13434143|NCT00388674|26898356|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11|||
13434144|NCT00388674|26898357|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17|||
13434145|NCT00388674|26898356|FG000|Initial Treatment|HCC|12|||
13434146|NCT00388674|26898357|FG001|Initial Treatment|HCC|20|||
13434147|NCT00388674|26898356|FG000|Initial Treatment|Lost to Follow-up|526|||
13434148|NCT00388674|26898357|FG001|Initial Treatment|Lost to Follow-up|624|||
13434149|NCT00388674|26898356|FG000|Initial Treatment|Malignancy (Non-HCC)|7|||
13434150|NCT00388674|26898357|FG001|Initial Treatment|Malignancy (Non-HCC)|3|||
13434151|NCT00388674|26898356|FG000|Initial Treatment|Never Treated with Study Medication|1|||
13434152|NCT00388674|26898357|FG001|Initial Treatment|Never Treated with Study Medication|7|||
13434153|NCT00388674|26898356|FG000|Initial Treatment|Non-Study related Comorbidities|3|||
13434154|NCT00388674|26898357|FG001|Initial Treatment|Non-Study related Comorbidities|4|||
13434155|NCT00388674|26898356|FG000|Initial Treatment|Not Defined|125|||
13434156|NCT00388674|26898357|FG001|Initial Treatment|Not Defined|172|||
13434157|NCT00388674|26898356|FG000|Initial Treatment|Partial or inadequate Treatment|112|||
13434158|NCT00388674|26898357|FG001|Initial Treatment|Partial or inadequate Treatment|472|||
13434159|NCT00388674|26898356|FG000|Initial Treatment|Pregnancy|26|||
13434160|NCT00388674|26898357|FG001|Initial Treatment|Pregnancy|16|||
13434161|NCT00388674|26898356|FG000|Initial Treatment|Study Drug Toxicity|5|||
13434162|NCT00388674|26898357|FG001|Initial Treatment|Study Drug Toxicity|92|||
13434163|NCT00388674|26898356|FG000|Initial Treatment|Participant Request|501|||
13434164|NCT00388674|26898357|FG001|Initial Treatment|Participant Request|673|||
13434165|NCT00388674|26898356|FG000|Initial Treatment|No Off-Treatment Status Data|11|||
13434166|NCT00388674|26898357|FG001|Initial Treatment|No Off-Treatment Status Data|13|||
13434167|NCT00388674|26898356|FG000|Initial Treatment|Not Reported|10|||
13434168|NCT00388674|26898357|FG001|Initial Treatment|Not Reported|12|||
13434169|NCT00388674|26898356|FG000|End of Study|Administrative Reason By Sponsor|299|||
13434170|NCT00388674|26898357|FG001|End of Study|Administrative Reason By Sponsor|253|||
13434171|NCT00388674|26898356|FG000|End of Study|Death|239|||
13434172|NCT00388674|26898357|FG001|End of Study|Death|262|||
13434173|NCT00388674|26898356|FG000|End of Study|HBV Disease Progression (Non-HCC)|3|||
13434174|NCT00388674|26898357|FG001|End of Study|HBV Disease Progression (Non-HCC)|9|||
13434175|NCT00388674|26898356|FG000|End of Study|HCC|8|||
13434176|NCT00388674|26898357|FG001|End of Study|HCC|7|||
13434177|NCT00388674|26898356|FG000|End of Study|Lost to Follow-up|587|||
13434178|NCT00388674|26898357|FG001|End of Study|Lost to Follow-up|715|||
13434179|NCT00388674|26898356|FG000|End of Study|Malignancy (Non-HCC)|1|||
13434180|NCT00388674|26898357|FG001|End of Study|Malignancy (Non-HCC)|1|||
13434181|NCT00388674|26898356|FG000|End of Study|Non-Study Related Comorbidities|3|||
13434182|NCT00388674|26898357|FG001|End of Study|Non-Study Related Comorbidities|4|||
13434183|NCT00388674|26898356|FG000|End of Study|Not Defined|135|||
13434184|NCT00388674|26898357|FG001|End of Study|Not Defined|214|||
13434185|NCT00388674|26898356|FG000|End of Study|Participant Withdrew Consent|437|||
13434186|NCT00388674|26898357|FG001|End of Study|Participant Withdrew Consent|673|||
13434187|NCT00388674|26898356|FG000|End of Study|No Off-Treatment Status Data|22|||
13434188|NCT00388674|26898357|FG001|End of Study|No Off-Treatment Status Data|30|||
13434189|NCT00388674|26898356|FG000|End of Study|Not Reported|0|||
13434190|NCT00388674|26898357|FG001|End of Study|Not Reported|1|||
13434191|NCT00388583|26898376|FG000|Overall Study|Protocol Violation|1|||
13434192|NCT00388583|26898377|FG001|Overall Study|Protocol Violation|0|||
13434193|NCT00388583|26898376|FG000|Overall Study|Withdrawal by Subject|3|||
13434194|NCT00388583|26898377|FG001|Overall Study|Withdrawal by Subject|3|||
13434195|NCT00388583|26898376|FG000|Overall Study|Serious Adverse Event|2|||
13434196|NCT00388583|26898377|FG001|Overall Study|Serious Adverse Event|0|||
13434197|NCT00388583|26898376|FG000|Overall Study|Did not receive vaccine|0|||
13434198|NCT00388583|26898377|FG001|Overall Study|Did not receive vaccine|1|||
13434199|NCT00388505|26898406|FG000|Overall Study|Adverse Event or Death|43|||
13434200|NCT00388505|26898407|FG001|Overall Study|Adverse Event or Death|17|||
13434201|NCT00388505|26898406|FG000|Overall Study|Withdrawal by Subject|24|||
13434202|NCT00388505|26898407|FG001|Overall Study|Withdrawal by Subject|9|||
13434203|NCT00388505|26898406|FG000|Overall Study|Lost to Follow-up|5|||
13434204|NCT00388505|26898407|FG001|Overall Study|Lost to Follow-up|3|||
13434205|NCT00388505|26898406|FG000|Overall Study|Inappropriate Enrollment|0|||
13434206|NCT00388505|26898407|FG001|Overall Study|Inappropriate Enrollment|1|||
13434207|NCT00388505|26898406|FG000|Overall Study|Administrative Reason|1|||
13434208|NCT00388505|26898407|FG001|Overall Study|Administrative Reason|0|||
13434209|NCT00388505|26898406|FG000|Overall Study|Protocol Violation|6|||
13434210|NCT00388505|26898407|FG001|Overall Study|Protocol Violation|5|||
13434211|NCT00388505|26898406|FG000|Overall Study|Unable to classify|4|||
13434212|NCT00388505|26898407|FG001|Overall Study|Unable to classify|3|||
13434213|NCT00388362|26898414|FG000|Enrolled|Ineligible|1|||
13434214|NCT00388362|26898414|FG000|Enrolled|Adverse Event|9|||
13434215|NCT00388362|26898414|FG000|Enrolled|Death|1|||
13434216|NCT00388362|26898414|FG000|Enrolled|Loss insurance|1|||
13434217|NCT00388362|26898414|FG000|Enrolled|Withdrawal by Subject|1|||
13434218|NCT00388362|26898414|FG000|Remained on Study Median of 514 Days|Death|2|||
13434219|NCT00388349|26898426|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0|||
13434220|NCT00388349|26898427|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3|||
13434221|NCT00388297|26898550|FG000|Overall Study|Lost to Follow-up|16|||
13434222|NCT00388297|26898551|FG001|Overall Study|Lost to Follow-up|12|||
13434223|NCT00388297|26898552|FG002|Overall Study|Lost to Follow-up|11|||
13434224|NCT00388297|26898553|FG003|Overall Study|Lost to Follow-up|8|||
13434225|NCT00388154|26898560|FG000|Overall Study|Withdrawal by Subject|1|||
13434226|NCT00388037|26898566|FG000|Overall Study|Protocol Violation|1|||
13434227|NCT00387894|26898573|FG000|Overall Study|Withdrawal by Subject|1|||
13434228|NCT00387881|26898602|FG000|Overall Study|Lost to Follow-up|23|||
13434229|NCT00387881|26898603|FG001|Overall Study|Lost to Follow-up|23|||
13434230|NCT00387881|26898602|FG000|Overall Study|Protocol Violation|2|||
13434231|NCT00387881|26898603|FG001|Overall Study|Protocol Violation|12|||
13434232|NCT00387881|26898602|FG000|Overall Study|Withdrawal by Subject|15|||
13434233|NCT00387881|26898603|FG001|Overall Study|Withdrawal by Subject|18|||
13434234|NCT00387881|26898602|FG000|Overall Study|Sponsor terminated Study|0|||
13434235|NCT00387881|26898603|FG001|Overall Study|Sponsor terminated Study|1|||
13434236|NCT00387881|26898602|FG000|Overall Study|Not eligible|6|||
13434237|NCT00387881|26898603|FG001|Overall Study|Not eligible|7|||
13434238|NCT00387881|26898602|FG000|Overall Study|No opportunity to treat headache|32|||
13434239|NCT00387881|26898603|FG001|Overall Study|No opportunity to treat headache|34|||
13434240|NCT00387881|26898602|FG000|Overall Study|Not otherwise specified|11|||
13434241|NCT00387881|26898603|FG001|Overall Study|Not otherwise specified|7|||
13434242|NCT00387790|26898611|FG000|Overall Study|Adverse Event|5|||
13434243|NCT00387790|26898611|FG000|Overall Study|Lack of Efficacy|2|||
13434244|NCT00387790|26898611|FG000|Overall Study|Physician Decision|2|||
13434245|NCT00387790|26898611|FG000|Overall Study|Withdrawal by Subject|3|||
13434246|NCT00387790|26898611|FG000|Overall Study|Ineligible for study|2|||
13434247|NCT00387764|26898631|FG000|Overall Study|Adverse Event|12|||
13434248|NCT00387764|26898631|FG000|Overall Study|Withdrawal by Subject|8|||
13434249|NCT00387764|26898631|FG000|Overall Study|Sponsor Terminated Study|1|||
13434250|NCT00387764|26898631|FG000|Overall Study|Physician Decision|1|||
13434251|NCT00387764|26898631|FG000|Overall Study|Other|2|||
13434252|NCT00387764|26898631|FG000|Overall Study|Death|7|||
13434253|NCT00387725|26898662|FG000|Overall Study|Adverse Event|0|||
13434254|NCT00387725|26898663|FG001|Overall Study|Adverse Event|0|||
13434255|NCT00387725|26898664|FG002|Overall Study|Adverse Event|0|||
13434256|NCT00387725|26898665|FG003|Overall Study|Adverse Event|1|||
13434257|NCT00387725|26898662|FG000|Overall Study|Protocol Violation|0|||
13434258|NCT00387725|26898663|FG001|Overall Study|Protocol Violation|1|||
13434259|NCT00387725|26898664|FG002|Overall Study|Protocol Violation|0|||
13434260|NCT00387725|26898665|FG003|Overall Study|Protocol Violation|0|||
13434261|NCT00387725|26898662|FG000|Overall Study|Withdrawal by Subject|1|||
13434262|NCT00387725|26898663|FG001|Overall Study|Withdrawal by Subject|0|||
13434263|NCT00387725|26898664|FG002|Overall Study|Withdrawal by Subject|1|||
13434264|NCT00387725|26898665|FG003|Overall Study|Withdrawal by Subject|0|||
13434265|NCT00387725|26898662|FG000|Overall Study|Parent/legal guardian request|0|||
13434266|NCT00387725|26898663|FG001|Overall Study|Parent/legal guardian request|0|||
13434267|NCT00387725|26898664|FG002|Overall Study|Parent/legal guardian request|1|||
13434268|NCT00387725|26898665|FG003|Overall Study|Parent/legal guardian request|1|||
13434269|NCT00387712|26898682|FG000|Overall Study|Physician Decision|6|||
13434270|NCT00387712|26898683|FG001|Overall Study|Physician Decision|4|||
13434271|NCT00387712|26898682|FG000|Overall Study|Lost to Follow-up|17|||
13434272|NCT00387712|26898683|FG001|Overall Study|Lost to Follow-up|20|||
13434273|NCT00387712|26898682|FG000|Overall Study|Withdrawal by Subject|6|||
13434274|NCT00387712|26898683|FG001|Overall Study|Withdrawal by Subject|12|||
13434275|NCT00387647|26898691|FG000|Overall Study|Death|18|||
13434276|NCT00387465|26898718|FG000|Overall Study|Withdrawal by Subject|0|||
13434277|NCT00387465|26898719|FG001|Overall Study|Withdrawal by Subject|1|||
13434278|NCT00387465|26898720|FG002|Overall Study|Withdrawal by Subject|0|||
13434279|NCT00387426|26898726|FG000|Overall Study|Lack of Response|7|||
13434280|NCT00387426|26898726|FG000|Overall Study|Toxicities|4|||
13434281|NCT00387426|26898726|FG000|Overall Study|Disease Progression|3|||
13434282|NCT00387348|26898750|FG000|Overall Study|Death|1|||
13434283|NCT00387348|26898751|FG001|Overall Study|Death|1|||
13434284|NCT00387348|26898752|FG002|Overall Study|Death|0|||
13434285|NCT00387348|26898750|FG000|Overall Study|Physician Decision|1|||
13434286|NCT00387348|26898751|FG001|Overall Study|Physician Decision|0|||
13434287|NCT00387348|26898752|FG002|Overall Study|Physician Decision|1|||
13434288|NCT00387348|26898750|FG000|Overall Study|Withdrawal by Subject|0|||
13434289|NCT00387348|26898751|FG001|Overall Study|Withdrawal by Subject|2|||
13434290|NCT00387348|26898752|FG002|Overall Study|Withdrawal by Subject|2|||
13434291|NCT00387348|26898750|FG000|Overall Study|Adverse Event|1|||
13434292|NCT00387348|26898751|FG001|Overall Study|Adverse Event|0|||
13434293|NCT00387348|26898752|FG002|Overall Study|Adverse Event|1|||
13434294|NCT00387153|26898758|FG000|Overall Study|Adverse Event|1|||
13434295|NCT00387153|26898758|FG000|Overall Study|Disease Progression|3|||
13434296|NCT00387153|26898758|FG000|Overall Study|Lack of Response|4|||
13434297|NCT00387127|26898805|FG000|Overall Study|Lost to Follow-up|0|||
13434298|NCT00387127|26898806|FG001|Overall Study|Lost to Follow-up|4|||
13434299|NCT00387127|26898805|FG000|Overall Study|Death|16|||
13434300|NCT00387127|26898806|FG001|Overall Study|Death|16|||
13434301|NCT00387127|26898805|FG000|Overall Study|Physician Decision|0|||
13434302|NCT00387127|26898806|FG001|Overall Study|Physician Decision|1|||
13434303|NCT00387127|26898805|FG000|Overall Study|Withdrawal by Subject|3|||
13434304|NCT00387127|26898806|FG001|Overall Study|Withdrawal by Subject|2|||
13434305|NCT00387127|26898805|FG000|Overall Study|Required by Protocol Amendment #4|12|||
13434306|NCT00387127|26898806|FG001|Overall Study|Required by Protocol Amendment #4|10|||
13434307|NCT00387127|26898805|FG000|Overall Study|Serious Adverse Event|1|||
13434308|NCT00387127|26898806|FG001|Overall Study|Serious Adverse Event|1|||
13434309|NCT00387127|26898805|FG000|Overall Study|Sponsor Unblinded|1|||
13434310|NCT00387127|26898806|FG001|Overall Study|Sponsor Unblinded|0|||
13434311|NCT00387088|26898857|FG000|Overall Study|Adverse Event|143|||
13434312|NCT00387088|26898858|FG001|Overall Study|Adverse Event|156|||
13434313|NCT00387088|26898857|FG000|Overall Study|Protocol Violation|47|||
13434314|NCT00387088|26898858|FG001|Overall Study|Protocol Violation|35|||
13434315|NCT00387088|26898857|FG000|Overall Study|Withdrawal by Subject|20|||
13434316|NCT00387088|26898858|FG001|Overall Study|Withdrawal by Subject|35|||
13434317|NCT00387088|26898857|FG000|Overall Study|Lack of Efficacy|28|||
13434318|NCT00387088|26898858|FG001|Overall Study|Lack of Efficacy|67|||
13434319|NCT00387088|26898857|FG000|Overall Study|Lost to Follow-up|22|||
13434320|NCT00387088|26898858|FG001|Overall Study|Lost to Follow-up|28|||
13434321|NCT00387088|26898857|FG000|Overall Study|Other|58|||
13434322|NCT00387088|26898858|FG001|Overall Study|Other|52|||
13434323|NCT00387010|26898881|FG000|Dose Titration Period|Adverse Event|12|||
13434324|NCT00387010|26898881|FG000|Dose Titration Period|Lack of Efficacy|5|||
13434325|NCT00387010|26898881|FG000|Dose Titration Period|Withdrawal by Subject|3|||
13434326|NCT00387010|26898881|FG000|Dose Titration Period|Protocol Violation|1|||
13434327|NCT00387010|26898881|FG000|Dose Titration Period|Lost to Follow-up|2|||
13434328|NCT00387010|26898881|FG000|Dose Titration Period|Noncompliance with study medication|8|||
13434329|NCT00387010|26898881|FG000|Dose Titration Period|Noncompliance with study procedures|7|||
13434330|NCT00387010|26898881|FG000|Treatment Period|Adverse Event|4|||
13434331|NCT00387010|26898881|FG000|Treatment Period|Withdrawal by Subject|1|||
13434332|NCT00387010|26898881|FG000|Treatment Period|Noncompliance with study medication|2|||
13434333|NCT00387010|26898881|FG000|Treatment Period|Noncompliance with study procedures|3|||
13434334|NCT00387010|26898881|FG000|Treatment Period|Participant reported study drug stolen|1|||
13434335|NCT00386776|26898893|FG000|Overall Study|Withdrawal by Subject|8|||
13434336|NCT00386607|26898912|FG000|Core|Adverse Event|40|||
13434337|NCT00386607|26898913|FG001|Core|Adverse Event|0|||
13434338|NCT00386607|26898912|FG000|Core|Abnormal laboratory value(s)|3|||
13434339|NCT00386607|26898913|FG001|Core|Abnormal laboratory value(s)|0|||
13434340|NCT00386607|26898912|FG000|Core|Unsatisfactory therapeutic effect|23|||
13434341|NCT00386607|26898913|FG001|Core|Unsatisfactory therapeutic effect|0|||
13434342|NCT00386607|26898912|FG000|Core|Condition no longer requires study drug|4|||
13434343|NCT00386607|26898913|FG001|Core|Condition no longer requires study drug|0|||
13434344|NCT00386607|26898912|FG000|Core|Patient withdrew consent|15|||
13434345|NCT00386607|26898913|FG001|Core|Patient withdrew consent|0|||
13434346|NCT00386607|26898912|FG000|Core|Lost to Follow-up|23|||
13434347|NCT00386607|26898913|FG001|Core|Lost to Follow-up|0|||
13434348|NCT00386607|26898912|FG000|Core|Administrative problems|1|||
13434349|NCT00386607|26898913|FG001|Core|Administrative problems|0|||
13434350|NCT00386607|26898912|FG000|Core|Protocol Deviation|6|||
13434351|NCT00386607|26898913|FG001|Core|Protocol Deviation|0|||
13434352|NCT00386607|26898912|FG000|Extension|Adverse Event|0|||
13434353|NCT00386607|26898913|FG001|Extension|Adverse Event|6|||
13434354|NCT00386607|26898912|FG000|Extension|Abnormal laboratory value(s)|0|||
13434355|NCT00386607|26898913|FG001|Extension|Abnormal laboratory value(s)|1|||
13434356|NCT00386607|26898912|FG000|Extension|Administrative problems|0|||
13434357|NCT00386607|26898913|FG001|Extension|Administrative problems|1|||
13434358|NCT00386607|26898912|FG000|Extension|Lost to Follow-up|0|||
13434359|NCT00386607|26898913|FG001|Extension|Lost to Follow-up|3|||
13434360|NCT00386607|26898912|FG000|Extension|Patient withdrew consent|0|||
13434361|NCT00386607|26898913|FG001|Extension|Patient withdrew consent|5|||
13434362|NCT00386607|26898912|FG000|Extension|Unsatisfactory therapeutic effect|0|||
13434363|NCT00386607|26898913|FG001|Extension|Unsatisfactory therapeutic effect|1|||
13434364|NCT00386425|26898947|FG000|Overall Study|Physician Decision|3|||
13434365|NCT00386425|26898948|FG001|Overall Study|Physician Decision|0|||
13434366|NCT00386425|26898949|FG002|Overall Study|Physician Decision|0|||
13434367|NCT00386425|26898947|FG000|Overall Study|Withdrawal by Subject|0|||
13434368|NCT00386425|26898948|FG001|Overall Study|Withdrawal by Subject|1|||
13434369|NCT00386425|26898949|FG002|Overall Study|Withdrawal by Subject|0|||
13434370|NCT00386360|26898988|FG000|Overall Study|Adverse Event|4|||
13434371|NCT00386360|26898989|FG001|Overall Study|Adverse Event|2|||
13434372|NCT00386360|26898988|FG000|Overall Study|Physician Decision|2|||
13434373|NCT00386360|26898989|FG001|Overall Study|Physician Decision|2|||
13434374|NCT00386360|26898988|FG000|Overall Study|Lost to Follow-up|0|||
13434375|NCT00386360|26898989|FG001|Overall Study|Lost to Follow-up|2|||
13434376|NCT00386360|26898988|FG000|Overall Study|Protocol Violation|0|||
13434377|NCT00386360|26898989|FG001|Overall Study|Protocol Violation|3|||
13434378|NCT00386360|26898988|FG000|Overall Study|Withdrawal by Subject|3|||
13434379|NCT00386360|26898989|FG001|Overall Study|Withdrawal by Subject|6|||
13434380|NCT00386360|26898988|FG000|Overall Study|Did not take any study medication|0|||
13434381|NCT00386360|26898989|FG001|Overall Study|Did not take any study medication|2|||
13434382|NCT00386334|26899138|FG000|Double Blind Period|Adverse Event|9|||
13434383|NCT00386334|26899139|FG001|Double Blind Period|Adverse Event|14|||
13434384|NCT00386334|26899138|FG000|Double Blind Period|Protocol Violation|1|||
13434385|NCT00386334|26899139|FG001|Double Blind Period|Protocol Violation|1|||
13434386|NCT00386334|26899138|FG000|Double Blind Period|Withdrawal by Subject|9|||
13434387|NCT00386334|26899139|FG001|Double Blind Period|Withdrawal by Subject|13|||
13434388|NCT00386334|26899138|FG000|Double Blind Period|Lack of Efficacy|20|||
13434389|NCT00386334|26899139|FG001|Double Blind Period|Lack of Efficacy|11|||
13434390|NCT00386334|26899138|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4|||
13434391|NCT00386334|26899139|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5|||
13434392|NCT00386334|26899138|FG000|Double Blind Period|Other|3|||
13434393|NCT00386334|26899139|FG001|Double Blind Period|Other|3|||
13434394|NCT00386334|26899138|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3|||
13434395|NCT00386334|26899139|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1|||
13434396|NCT00386308|26899158|FG000|Overall Study|Adverse Event|3|||
13434397|NCT00386308|26899159|FG001|Overall Study|Adverse Event|3|||
13434398|NCT00386308|26899158|FG000|Overall Study|Protocol Violation|2|||
13434399|NCT00386308|26899159|FG001|Overall Study|Protocol Violation|5|||
13434400|NCT00386308|26899158|FG000|Overall Study|Lack of Efficacy|0|||
13434401|NCT00386308|26899159|FG001|Overall Study|Lack of Efficacy|2|||
13434402|NCT00386308|26899158|FG000|Overall Study|Lost to Follow-up|10|||
13434403|NCT00386308|26899159|FG001|Overall Study|Lost to Follow-up|6|||
13434404|NCT00386308|26899158|FG000|Overall Study|Withdrawal by Subject|6|||
13434405|NCT00386308|26899159|FG001|Overall Study|Withdrawal by Subject|2|||
13434406|NCT00386308|26899158|FG000|Overall Study|Other Event|8|||
13434407|NCT00386308|26899159|FG001|Overall Study|Other Event|1|||
13434408|NCT00386152|26899186|FG000|Overall Study|Adverse Event|6|||
13434409|NCT00386152|26899187|FG001|Overall Study|Adverse Event|5|||
13434410|NCT00386152|26899188|FG002|Overall Study|Adverse Event|4|||
13434411|NCT00386152|26899186|FG000|Overall Study|Chang from original chemo stratification|4|||
13434412|NCT00386152|26899187|FG001|Overall Study|Chang from original chemo stratification|5|||
13434413|NCT00386152|26899188|FG002|Overall Study|Chang from original chemo stratification|6|||
13434414|NCT00386152|26899186|FG000|Overall Study|Death|3|||
13434415|NCT00386152|26899187|FG001|Overall Study|Death|0|||
13434416|NCT00386152|26899188|FG002|Overall Study|Death|1|||
13434417|NCT00386152|26899186|FG000|Overall Study|Disease progression|7|||
13434418|NCT00386152|26899187|FG001|Overall Study|Disease progression|4|||
13434419|NCT00386152|26899188|FG002|Overall Study|Disease progression|5|||
13434420|NCT00386152|26899186|FG000|Overall Study|Physician Decision|13|||
13434421|NCT00386152|26899187|FG001|Overall Study|Physician Decision|10|||
13434422|NCT00386152|26899188|FG002|Overall Study|Physician Decision|4|||
13434423|NCT00386152|26899186|FG000|Overall Study|Lost to Follow-up|1|||
13434424|NCT00386152|26899187|FG001|Overall Study|Lost to Follow-up|0|||
13434425|NCT00386152|26899188|FG002|Overall Study|Lost to Follow-up|0|||
13434426|NCT00386152|26899186|FG000|Overall Study|Completed chemotherapy|4|||
13434427|NCT00386152|26899187|FG001|Overall Study|Completed chemotherapy|5|||
13434428|NCT00386152|26899188|FG002|Overall Study|Completed chemotherapy|1|||
13434429|NCT00386152|26899186|FG000|Overall Study|Protocol Violation|3|||
13434430|NCT00386152|26899187|FG001|Overall Study|Protocol Violation|5|||
13434431|NCT00386152|26899188|FG002|Overall Study|Protocol Violation|2|||
13434432|NCT00386152|26899186|FG000|Overall Study|Withdrawal by Subject|3|||
13434433|NCT00386152|26899187|FG001|Overall Study|Withdrawal by Subject|6|||
13434434|NCT00386152|26899188|FG002|Overall Study|Withdrawal by Subject|10|||
13434435|NCT00386100|26899257|FG000|Overall Study|Did not receive study medication|6|||
13434436|NCT00386100|26899258|FG001|Overall Study|Did not receive study medication|4|||
13434437|NCT00386100|26899257|FG000|Overall Study|Adverse Event|15|||
13434438|NCT00386100|26899258|FG001|Overall Study|Adverse Event|25|||
13434439|NCT00386100|26899257|FG000|Overall Study|Death|0|||
13434440|NCT00386100|26899258|FG001|Overall Study|Death|1|||
13434441|NCT00386100|26899257|FG000|Overall Study|Insufficient therapeutic effect|30|||
13434442|NCT00386100|26899258|FG001|Overall Study|Insufficient therapeutic effect|6|||
13434443|NCT00386100|26899257|FG000|Overall Study|Lost to Follow-up|29|||
13434444|NCT00386100|26899258|FG001|Overall Study|Lost to Follow-up|29|||
13434445|NCT00386100|26899257|FG000|Overall Study|Non-compliance|18|||
13434446|NCT00386100|26899258|FG001|Overall Study|Non-compliance|19|||
13434447|NCT00386100|26899257|FG000|Overall Study|Protocol Violation|5|||
13434448|NCT00386100|26899258|FG001|Overall Study|Protocol Violation|3|||
13434449|NCT00386100|26899257|FG000|Overall Study|Withdrawal by Subject|32|||
13434450|NCT00386100|26899258|FG001|Overall Study|Withdrawal by Subject|31|||
13434451|NCT00386100|26899257|FG000|Overall Study|Bone mass density (BMD) loss >6%|4|||
13434452|NCT00386100|26899258|FG001|Overall Study|Bone mass density (BMD) loss >6%|4|||
13434453|NCT00386100|26899257|FG000|Overall Study|BMD <2.5|1|||
13434454|NCT00386100|26899258|FG001|Overall Study|BMD <2.5|0|||
13434455|NCT00386100|26899257|FG000|Overall Study|Consecutive elevated Hba1C|1|||
13434456|NCT00386100|26899258|FG001|Overall Study|Consecutive elevated Hba1C|0|||
13434457|NCT00386100|26899257|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0|||
13434458|NCT00386100|26899258|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1|||
13434459|NCT00386100|26899257|FG000|Overall Study|Laboratory findings|1|||
13434460|NCT00386100|26899258|FG001|Overall Study|Laboratory findings|0|||
13434461|NCT00386100|26899257|FG000|Overall Study|Participant's concern due to CPK levels|1|||
13434462|NCT00386100|26899258|FG001|Overall Study|Participant's concern due to CPK levels|0|||
13434463|NCT00386100|26899257|FG000|Overall Study|Participant moving out of state|2|||
13434464|NCT00386100|26899258|FG001|Overall Study|Participant moving out of state|0|||
13434465|NCT00386100|26899257|FG000|Overall Study|Excessive bone loss vs. baseline value|0|||
13434466|NCT00386100|26899258|FG001|Overall Study|Excessive bone loss vs. baseline value|1|||
13434467|NCT00386100|26899257|FG000|Overall Study|Didn't meet entry criteria|1|||
13434468|NCT00386100|26899258|FG001|Overall Study|Didn't meet entry criteria|1|||
13434469|NCT00386100|26899257|FG000|Overall Study|Participant's PCP wanted to stop drug|1|||
13434470|NCT00386100|26899258|FG001|Overall Study|Participant's PCP wanted to stop drug|0|||
13434471|NCT00386100|26899257|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0|||
13434472|NCT00386100|26899258|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1|||
13434473|NCT00386100|26899257|FG000|Overall Study|Bad metabolic control & patient security|1|||
13434474|NCT00386100|26899258|FG001|Overall Study|Bad metabolic control & patient security|0|||
13434475|NCT00386100|26899257|FG000|Overall Study|Bone loss by DXA bone scan|1|||
13434476|NCT00386100|26899258|FG001|Overall Study|Bone loss by DXA bone scan|0|||
13434477|NCT00386100|26899257|FG000|Overall Study|DBP 93 mmHg at randomization|1|||
13434478|NCT00386100|26899258|FG001|Overall Study|DBP 93 mmHg at randomization|0|||
13434479|NCT00386100|26899257|FG000|Overall Study|7.6% bone loss|1|||
13434480|NCT00386100|26899258|FG001|Overall Study|7.6% bone loss|0|||
13434481|NCT00386100|26899257|FG000|Overall Study|Osteoporosis|0|||
13434482|NCT00386100|26899258|FG001|Overall Study|Osteoporosis|1|||
13434483|NCT00386100|26899257|FG000|Overall Study|Positive pregnancy test|1|||
13434484|NCT00386100|26899258|FG001|Overall Study|Positive pregnancy test|3|||
13434485|NCT00386100|26899257|FG000|Overall Study|Out of country for 5 months|1|||
13434486|NCT00386100|26899258|FG001|Overall Study|Out of country for 5 months|0|||
13434487|NCT00386100|26899257|FG000|Overall Study|Hb1Ac >8%|0|||
13434488|NCT00386100|26899258|FG001|Overall Study|Hb1Ac >8%|1|||
13434489|NCT00386100|26899257|FG000|Overall Study|Participant randomized in error|1|||
13434490|NCT00386100|26899258|FG001|Overall Study|Participant randomized in error|0|||
13434491|NCT00386022|26899273|FG000|Plus Estrogen|Lost to Follow-up|2|||
13434492|NCT00386022|26899274|FG001|Plus Estrogen|Lost to Follow-up|0|||
13434493|NCT00386022|26899273|FG000|Plus Estrogen|Adverse Event|0|||
13434494|NCT00386022|26899274|FG001|Plus Estrogen|Adverse Event|1|||
13434495|NCT00386009|26899319|FG000|Overall Study|Adverse Event|0|||
13434496|NCT00386009|26899320|FG001|Overall Study|Adverse Event|2|||
13434497|NCT00386009|26899319|FG000|Overall Study|Death|1|||
13434498|NCT00386009|26899320|FG001|Overall Study|Death|0|||
13434499|NCT00386009|26899319|FG000|Overall Study|Entry Criteria Not Met|0|||
13434500|NCT00386009|26899320|FG001|Overall Study|Entry Criteria Not Met|2|||
13434501|NCT00386009|26899319|FG000|Overall Study|Lost to Follow-up|1|||
13434502|NCT00386009|26899320|FG001|Overall Study|Lost to Follow-up|1|||
13434503|NCT00386009|26899319|FG000|Overall Study|Protocol Violation|1|||
13434504|NCT00386009|26899320|FG001|Overall Study|Protocol Violation|0|||
13434505|NCT00386009|26899319|FG000|Overall Study|Sponsor Decision|1|||
13434506|NCT00386009|26899320|FG001|Overall Study|Sponsor Decision|1|||
13434507|NCT00386009|26899319|FG000|Overall Study|Withdrawal by Subject|5|||
13434508|NCT00386009|26899320|FG001|Overall Study|Withdrawal by Subject|4|||
13434509|NCT00385944|26899369|FG000|1st Maintenance Dose Period|Physician Decision|1|||
13434510|NCT00385944|26899370|FG001|1st Maintenance Dose Period|Physician Decision|0|||
13434511|NCT00385944|26899371|FG002|1st Maintenance Dose Period|Physician Decision|0|||
13434512|NCT00385944|26899369|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
13434513|NCT00385944|26899370|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1|||
13434514|NCT00385944|26899371|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
13434515|NCT00385944|26899369|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3|||
13434516|NCT00385944|26899370|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
13434517|NCT00385944|26899371|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
13434518|NCT00385944|26899369|FG000|2nd Maintenance Dose Period|Invalid PD Data|2|||
13434519|NCT00385944|26899370|FG001|2nd Maintenance Dose Period|Invalid PD Data|3|||
13434520|NCT00385944|26899371|FG002|2nd Maintenance Dose Period|Invalid PD Data|0|||
13434521|NCT00385918|26899401|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
13434522|NCT00385918|26899402|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
13434523|NCT00385918|26899403|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8|||
13434524|NCT00385918|26899401|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
13434525|NCT00385918|26899402|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
13434526|NCT00385918|26899403|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5|||
13434527|NCT00385918|26899401|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
13434528|NCT00385918|26899402|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
13434529|NCT00385918|26899403|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1|||
13434530|NCT00385918|26899401|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1|||
13434531|NCT00385918|26899402|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0|||
13434532|NCT00385918|26899403|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0|||
13434533|NCT00385918|26899401|FG000|Intervention Phase After Randomization|Physician Decision|1|||
13434534|NCT00385918|26899402|FG001|Intervention Phase After Randomization|Physician Decision|0|||
13434535|NCT00385918|26899403|FG002|Intervention Phase After Randomization|Physician Decision|0|||
13434536|NCT00385918|26899401|FG000|Intervention Phase After Randomization|Lost to Follow-up|1|||
13434537|NCT00385918|26899402|FG001|Intervention Phase After Randomization|Lost to Follow-up|0|||
13434538|NCT00385918|26899403|FG002|Intervention Phase After Randomization|Lost to Follow-up|0|||
13434539|NCT00385840|26899430|FG000|Overall Study|Adverse Event|1|||
13434540|NCT00385840|26899431|FG001|Overall Study|Adverse Event|1|||
13434541|NCT00385840|26899430|FG000|Overall Study|Lost to Follow-up|3|||
13434542|NCT00385840|26899431|FG001|Overall Study|Lost to Follow-up|13|||
13434543|NCT00385827|26899461|FG000|Part 1|Adverse Event|1|||
13434544|NCT00385827|26899462|FG001|Part 1|Adverse Event|0|||
13434545|NCT00385827|26899463|FG002|Part 1|Adverse Event|0|||
13434546|NCT00385827|26899461|FG000|Part 1|Death|2|||
13434547|NCT00385827|26899462|FG001|Part 1|Death|0|||
13434548|NCT00385827|26899463|FG002|Part 1|Death|0|||
13434549|NCT00385827|26899461|FG000|Part 1|Lack of Efficacy|5|||
13434550|NCT00385827|26899462|FG001|Part 1|Lack of Efficacy|0|||
13434551|NCT00385827|26899463|FG002|Part 1|Lack of Efficacy|0|||
13434552|NCT00385827|26899461|FG000|Part 1|Other|1|||
13434553|NCT00385827|26899462|FG001|Part 1|Other|0|||
13434554|NCT00385827|26899463|FG002|Part 1|Other|0|||
13434555|NCT00385827|26899461|FG000|Part 2|Adverse Event|0|||
13434556|NCT00385827|26899462|FG001|Part 2|Adverse Event|6|||
13434557|NCT00385827|26899463|FG002|Part 2|Adverse Event|10|||
13434558|NCT00385827|26899461|FG000|Part 2|Death|0|||
13434559|NCT00385827|26899462|FG001|Part 2|Death|0|||
13434560|NCT00385827|26899463|FG002|Part 2|Death|2|||
13434561|NCT00385827|26899461|FG000|Part 2|Lack of Efficacy|0|||
13434562|NCT00385827|26899462|FG001|Part 2|Lack of Efficacy|14|||
13434563|NCT00385827|26899463|FG002|Part 2|Lack of Efficacy|13|||
13434564|NCT00385827|26899461|FG000|Part 2|Randomized but not treated|0|||
13434565|NCT00385827|26899462|FG001|Part 2|Randomized but not treated|2|||
13434566|NCT00385827|26899463|FG002|Part 2|Randomized but not treated|2|||
13434567|NCT00385827|26899461|FG000|Part 2|Other|0|||
13434568|NCT00385827|26899462|FG001|Part 2|Other|11|||
13434569|NCT00385827|26899463|FG002|Part 2|Other|21|||
13434570|NCT00385762|26899472|FG000|Overall Study|Adverse Event|1|||
13434571|NCT00385762|26899472|FG000|Overall Study|Lost to Follow-up|1|||
13434572|NCT00385736|26899524|FG000|Efficacy Analysis Set - Induction|Adverse Event|5|||
13434573|NCT00385736|26899525|FG001|Efficacy Analysis Set - Induction|Adverse Event|6|||
13434574|NCT00385736|26899526|FG002|Efficacy Analysis Set - Induction|Adverse Event|4|||
13434575|NCT00385736|26899524|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0|||
13434576|NCT00385736|26899525|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2|||
13434577|NCT00385736|26899526|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1|||
13434578|NCT00385736|26899524|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
13434579|NCT00385736|26899525|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2|||
13434580|NCT00385736|26899526|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
13434581|NCT00385736|26899524|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4|||
13434582|NCT00385736|26899525|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2|||
13434583|NCT00385736|26899526|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1|||
13434584|NCT00385736|26899524|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0|||
13434585|NCT00385736|26899525|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0|||
13434586|NCT00385736|26899526|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2|||
13434587|NCT00385736|26899524|FG000|Efficacy Analysis Set - Induction|Other|0|||
13434588|NCT00385736|26899525|FG001|Efficacy Analysis Set - Induction|Other|0|||
13434589|NCT00385736|26899526|FG002|Efficacy Analysis Set - Induction|Other|1|||
13434590|NCT00385736|26899524|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
13434591|NCT00385736|26899525|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15|||
13434592|NCT00385736|26899526|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
13434593|NCT00385736|26899524|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
13434594|NCT00385736|26899525|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
13434595|NCT00385736|26899526|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14|||
13434596|NCT00385736|26899524|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0|||
13434597|NCT00385736|26899525|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
13434598|NCT00385736|26899526|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
13434599|NCT00385736|26899524|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38|||
13434600|NCT00385736|26899525|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16|||
13434601|NCT00385736|26899526|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31|||
13434602|NCT00385736|26899524|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2|||
13434603|NCT00385736|26899525|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1|||
13434604|NCT00385736|26899526|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6|||
13434605|NCT00385736|26899524|FG000|Efficacy Analysis Set - Maintenance|Other|0|||
13434606|NCT00385736|26899525|FG001|Efficacy Analysis Set - Maintenance|Other|4|||
13434607|NCT00385736|26899526|FG002|Efficacy Analysis Set - Maintenance|Other|4|||
13434608|NCT00385736|26899524|FG000|Safety Analysis Set|Adverse Event|23|||
13434609|NCT00385736|26899525|FG001|Safety Analysis Set|Adverse Event|15|||
13434610|NCT00385736|26899526|FG002|Safety Analysis Set|Adverse Event|23|||
13434611|NCT00385736|26899524|FG000|Safety Analysis Set|Withdrawal by Subject|6|||
13434612|NCT00385736|26899525|FG001|Safety Analysis Set|Withdrawal by Subject|6|||
13434613|NCT00385736|26899526|FG002|Safety Analysis Set|Withdrawal by Subject|14|||
13434614|NCT00385736|26899524|FG000|Safety Analysis Set|Lost to Follow-up|0|||
13434615|NCT00385736|26899525|FG001|Safety Analysis Set|Lost to Follow-up|2|||
13434616|NCT00385736|26899526|FG002|Safety Analysis Set|Lost to Follow-up|2|||
13434617|NCT00385736|26899524|FG000|Safety Analysis Set|Lack of Efficacy|38|||
13434618|NCT00385736|26899525|FG001|Safety Analysis Set|Lack of Efficacy|16|||
13434619|NCT00385736|26899526|FG002|Safety Analysis Set|Lack of Efficacy|31|||
13434620|NCT00385736|26899524|FG000|Safety Analysis Set|Protocol Violation|2|||
13434621|NCT00385736|26899525|FG001|Safety Analysis Set|Protocol Violation|1|||
13434622|NCT00385736|26899526|FG002|Safety Analysis Set|Protocol Violation|6|||
13434623|NCT00385736|26899524|FG000|Safety Analysis Set|Other|1|||
13434624|NCT00385736|26899525|FG001|Safety Analysis Set|Other|4|||
13434625|NCT00385736|26899526|FG002|Safety Analysis Set|Other|4|||
13434626|NCT00385723|26899550|FG000|Overall Study|Lost to Follow-up|1|||
13434627|NCT00385723|26899551|FG001|Overall Study|Lost to Follow-up|1|||
13434628|NCT00385723|26899552|FG002|Overall Study|Lost to Follow-up|0|||
13434629|NCT00385723|26899550|FG000|Overall Study|Withdrawal by Subject|1|||
13434630|NCT00385723|26899551|FG001|Overall Study|Withdrawal by Subject|0|||
13434631|NCT00385723|26899552|FG002|Overall Study|Withdrawal by Subject|2|||
13434632|NCT00385684|26899561|FG000|FIRST INTERVENTION OF PHASE A|Death|1|||
13434633|NCT00385684|26899562|FG001|FIRST INTERVENTION OF PHASE A|Death|0|||
13434634|NCT00385684|26899561|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0|||
13434635|NCT00385684|26899562|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1|||
13434636|NCT00385684|26899561|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0|||
13434637|NCT00385684|26899562|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1|||
13434638|NCT00385671|26899726|FG000|Overall Study|Adverse Event|14|||
13434639|NCT00385671|26899727|FG001|Overall Study|Adverse Event|27|||
13434640|NCT00385671|26899728|FG002|Overall Study|Adverse Event|18|||
13434641|NCT00385671|26899726|FG000|Overall Study|Lack of Efficacy|5|||
13434642|NCT00385671|26899727|FG001|Overall Study|Lack of Efficacy|9|||
13434643|NCT00385671|26899728|FG002|Overall Study|Lack of Efficacy|5|||
13434644|NCT00385671|26899726|FG000|Overall Study|Lost to Follow-up|6|||
13434645|NCT00385671|26899727|FG001|Overall Study|Lost to Follow-up|6|||
13434646|NCT00385671|26899728|FG002|Overall Study|Lost to Follow-up|5|||
13434647|NCT00385671|26899726|FG000|Overall Study|Physician Decision|2|||
13434648|NCT00385671|26899727|FG001|Overall Study|Physician Decision|1|||
13434649|NCT00385671|26899728|FG002|Overall Study|Physician Decision|2|||
13434650|NCT00385671|26899726|FG000|Overall Study|Protocol Violation|5|||
13434651|NCT00385671|26899727|FG001|Overall Study|Protocol Violation|2|||
13434652|NCT00385671|26899728|FG002|Overall Study|Protocol Violation|1|||
13434653|NCT00385671|26899726|FG000|Overall Study|Sponsor Decision|2|||
13434654|NCT00385671|26899727|FG001|Overall Study|Sponsor Decision|2|||
13434655|NCT00385671|26899728|FG002|Overall Study|Sponsor Decision|1|||
13434656|NCT00385671|26899726|FG000|Overall Study|Withdrawal by Subject|4|||
13434657|NCT00385671|26899727|FG001|Overall Study|Withdrawal by Subject|4|||
13434658|NCT00385671|26899728|FG002|Overall Study|Withdrawal by Subject|4|||
13434659|NCT00385593|26899751|FG000|Overall Study|Adverse Event|3|||
13434660|NCT00385593|26899752|FG001|Overall Study|Adverse Event|2|||
13434661|NCT00385593|26899751|FG000|Overall Study|Withdrawal by Subject|17|||
13434662|NCT00385593|26899752|FG001|Overall Study|Withdrawal by Subject|7|||
13434663|NCT00385593|26899751|FG000|Overall Study|Lost to Follow-up|12|||
13434664|NCT00385593|26899752|FG001|Overall Study|Lost to Follow-up|8|||
13434665|NCT00385593|26899751|FG000|Overall Study|Protocol Violation|7|||
13434666|NCT00385593|26899752|FG001|Overall Study|Protocol Violation|4|||
13434667|NCT00385593|26899751|FG000|Overall Study|Several reasons|17|||
13434668|NCT00385593|26899752|FG001|Overall Study|Several reasons|15|||
13434669|NCT00385593|26899751|FG000|Overall Study|Incorrect inclusion|2|||
13434670|NCT00385593|26899752|FG001|Overall Study|Incorrect inclusion|0|||
13434671|NCT00385593|26899751|FG000|Overall Study|Incorrect randomization|0|||
13434672|NCT00385593|26899752|FG001|Overall Study|Incorrect randomization|1|||
13434673|NCT00385541|26899773|FG000|Overall Study|severe pain, clinician requested unblind|0|||
13434674|NCT00385541|26899774|FG001|Overall Study|severe pain, clinician requested unblind|1|||
13434675|NCT00385255|26899845|FG000|Overall Study|Serious Adverse Event|1|||
13434676|NCT00385255|26899846|FG001|Overall Study|Serious Adverse Event|2|||
13434677|NCT00385255|26899845|FG000|Overall Study|Protocol Violation|0|||
13434678|NCT00385255|26899846|FG001|Overall Study|Protocol Violation|4|||
13434679|NCT00385255|26899845|FG000|Overall Study|Withdrawal by Subject|0|||
13434680|NCT00385255|26899846|FG001|Overall Study|Withdrawal by Subject|8|||
13434681|NCT00385255|26899845|FG000|Overall Study|Migrated/moved from study area|0|||
13434682|NCT00385255|26899846|FG001|Overall Study|Migrated/moved from study area|1|||
13434683|NCT00385255|26899845|FG000|Overall Study|Lost to Follow-up|20|||
13434684|NCT00385255|26899846|FG001|Overall Study|Lost to Follow-up|58|||
13434685|NCT00385203|26899871|FG000|Overall Study|Adverse Event|5|||
13434686|NCT00385203|26899872|FG001|Overall Study|Adverse Event|4|||
13434687|NCT00385203|26899871|FG000|Overall Study|Death|1|||
13434688|NCT00385203|26899872|FG001|Overall Study|Death|0|||
13434689|NCT00385203|26899871|FG000|Overall Study|Condition under investigation worsened|18|||
13434690|NCT00385203|26899872|FG001|Overall Study|Condition under investigation worsened|3|||
13434691|NCT00385203|26899871|FG000|Overall Study|Incorrect enrollment|2|||
13434692|NCT00385203|26899872|FG001|Overall Study|Incorrect enrollment|0|||
13434693|NCT00384956|26899886|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3|||
13434694|NCT00384930|26899956|FG000|Overall Study|Adverse Event|5|||
13434695|NCT00384930|26899957|FG001|Overall Study|Adverse Event|4|||
13434696|NCT00384930|26899958|FG002|Overall Study|Adverse Event|12|||
13434697|NCT00384930|26899959|FG003|Overall Study|Adverse Event|11|||
13434698|NCT00384930|26899960|FG004|Overall Study|Adverse Event|14|||
13434699|NCT00384930|26899956|FG000|Overall Study|Entry Criteria Not Met|2|||
13434700|NCT00384930|26899957|FG001|Overall Study|Entry Criteria Not Met|6|||
13434701|NCT00384930|26899958|FG002|Overall Study|Entry Criteria Not Met|7|||
13434702|NCT00384930|26899959|FG003|Overall Study|Entry Criteria Not Met|8|||
13434703|NCT00384930|26899960|FG004|Overall Study|Entry Criteria Not Met|4|||
13434704|NCT00384930|26899956|FG000|Overall Study|Lack of Efficacy|1|||
13434705|NCT00384930|26899957|FG001|Overall Study|Lack of Efficacy|1|||
13434706|NCT00384930|26899958|FG002|Overall Study|Lack of Efficacy|2|||
13434707|NCT00384930|26899959|FG003|Overall Study|Lack of Efficacy|1|||
13434708|NCT00384930|26899960|FG004|Overall Study|Lack of Efficacy|2|||
13434709|NCT00384930|26899956|FG000|Overall Study|Lost to Follow-up|5|||
13434710|NCT00384930|26899957|FG001|Overall Study|Lost to Follow-up|3|||
13434711|NCT00384930|26899958|FG002|Overall Study|Lost to Follow-up|0|||
13434712|NCT00384930|26899959|FG003|Overall Study|Lost to Follow-up|4|||
13434713|NCT00384930|26899960|FG004|Overall Study|Lost to Follow-up|6|||
13434714|NCT00384930|26899956|FG000|Overall Study|Physician Decision|0|||
13434715|NCT00384930|26899957|FG001|Overall Study|Physician Decision|1|||
13434716|NCT00384930|26899958|FG002|Overall Study|Physician Decision|1|||
13434717|NCT00384930|26899959|FG003|Overall Study|Physician Decision|0|||
13434718|NCT00384930|26899960|FG004|Overall Study|Physician Decision|1|||
13434719|NCT00384930|26899956|FG000|Overall Study|Protocol Violation|1|||
13434720|NCT00384930|26899957|FG001|Overall Study|Protocol Violation|0|||
13434721|NCT00384930|26899958|FG002|Overall Study|Protocol Violation|1|||
13434722|NCT00384930|26899959|FG003|Overall Study|Protocol Violation|6|||
13434723|NCT00384930|26899960|FG004|Overall Study|Protocol Violation|4|||
13434724|NCT00384930|26899956|FG000|Overall Study|Sponsor Decision|3|||
13434725|NCT00384930|26899957|FG001|Overall Study|Sponsor Decision|4|||
13434726|NCT00384930|26899958|FG002|Overall Study|Sponsor Decision|0|||
13434727|NCT00384930|26899959|FG003|Overall Study|Sponsor Decision|5|||
13434728|NCT00384930|26899960|FG004|Overall Study|Sponsor Decision|0|||
13434729|NCT00384930|26899956|FG000|Overall Study|Withdrawal by Subject|9|||
13434730|NCT00384930|26899957|FG001|Overall Study|Withdrawal by Subject|7|||
13434731|NCT00384930|26899958|FG002|Overall Study|Withdrawal by Subject|7|||
13434732|NCT00384930|26899959|FG003|Overall Study|Withdrawal by Subject|6|||
13434733|NCT00384930|26899960|FG004|Overall Study|Withdrawal by Subject|16|||
13434734|NCT00384930|26899956|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
13434735|NCT00384930|26899957|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
13434736|NCT00384930|26899958|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
13434737|NCT00384930|26899959|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
13434738|NCT00384930|26899960|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
13434739|NCT00384839|26899971|FG000|Overall Study|Adverse Event|4|||
13434740|NCT00384839|26899971|FG000|Overall Study|Investigator Request|1|||
13434741|NCT00384839|26899971|FG000|Overall Study|Patient Request|1|||
13434742|NCT00384839|26899971|FG000|Overall Study|Ineligible|2|||
13434743|NCT00384397|26899998|FG000|Overall Study|Adverse Event|0|||
13434744|NCT00384397|26899999|FG001|Overall Study|Adverse Event|1|||
13434745|NCT00384397|26900000|FG002|Overall Study|Adverse Event|2|||
13434746|NCT00384397|26899998|FG000|Overall Study|Protocol Violation|7|||
13434747|NCT00384397|26899999|FG001|Overall Study|Protocol Violation|15|||
13434748|NCT00384397|26900000|FG002|Overall Study|Protocol Violation|13|||
13434749|NCT00384397|26899998|FG000|Overall Study|Lost to Follow-up|11|||
13434750|NCT00384397|26899999|FG001|Overall Study|Lost to Follow-up|13|||
13434751|NCT00384397|26900000|FG002|Overall Study|Lost to Follow-up|3|||
13434752|NCT00384397|26899998|FG000|Overall Study|Withdrawal by Subject|14|||
13434753|NCT00384397|26899999|FG001|Overall Study|Withdrawal by Subject|17|||
13434754|NCT00384397|26900000|FG002|Overall Study|Withdrawal by Subject|15|||
13434755|NCT00384332|26900015|FG000|Overall Study|Lost to Follow-up|4|||
13434756|NCT00384332|26900016|FG001|Overall Study|Lost to Follow-up|0|||
13434757|NCT00384293|26900035|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120|||
13434758|NCT00384293|26900036|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
13434759|NCT00384293|26900037|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
13434760|NCT00384293|26900035|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1|||
13434761|NCT00384293|26900036|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
13434762|NCT00384293|26900037|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
13434763|NCT00384293|26900035|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24|||
13434764|NCT00384293|26900036|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
13434765|NCT00384293|26900037|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
13434766|NCT00384293|26900035|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340|||
13434767|NCT00384293|26900036|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
13434768|NCT00384293|26900037|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
13434769|NCT00384293|26900035|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16|||
13434770|NCT00384293|26900036|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
13434771|NCT00384293|26900037|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
13434772|NCT00384293|26900035|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2|||
13434773|NCT00384293|26900036|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
13434774|NCT00384293|26900037|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
13434775|NCT00384293|26900035|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1|||
13434776|NCT00384293|26900036|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
13434777|NCT00384293|26900037|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
13434778|NCT00384293|26900035|FG000|Post-randomization Period|Adverse Event|0|||
13434779|NCT00384293|26900036|FG001|Post-randomization Period|Adverse Event|23|||
13434780|NCT00384293|26900037|FG002|Post-randomization Period|Adverse Event|7|||
13434781|NCT00384293|26900035|FG000|Post-randomization Period|Lost to Follow-up|0|||
13434782|NCT00384293|26900036|FG001|Post-randomization Period|Lost to Follow-up|2|||
13434783|NCT00384293|26900037|FG002|Post-randomization Period|Lost to Follow-up|1|||
13434784|NCT00384293|26900035|FG000|Post-randomization Period|Protocol Violation|0|||
13434785|NCT00384293|26900036|FG001|Post-randomization Period|Protocol Violation|1|||
13434786|NCT00384293|26900037|FG002|Post-randomization Period|Protocol Violation|0|||
13434787|NCT00384293|26900035|FG000|Post-randomization Period|Withdrawal by Subject|0|||
13434788|NCT00384293|26900036|FG001|Post-randomization Period|Withdrawal by Subject|8|||
13434789|NCT00384293|26900037|FG002|Post-randomization Period|Withdrawal by Subject|6|||
13434790|NCT00384293|26900035|FG000|Post-randomization Period|Trial Termination|0|||
13434791|NCT00384293|26900036|FG001|Post-randomization Period|Trial Termination|180|||
13434792|NCT00384293|26900037|FG002|Post-randomization Period|Trial Termination|204|||
13434793|NCT00384293|26900035|FG000|Post-randomization Period|Patient Randomized in Error|0|||
13434794|NCT00384293|26900036|FG001|Post-randomization Period|Patient Randomized in Error|0|||
13434795|NCT00384293|26900037|FG002|Post-randomization Period|Patient Randomized in Error|1|||
13434796|NCT00384189|26900108|FG000|Overall Study|Reason Not Specified|50|||
13434797|NCT00384189|26900109|FG001|Overall Study|Reason Not Specified|57|||
13434798|NCT00384189|26900110|FG002|Overall Study|Reason Not Specified|58|||
13434799|NCT00384189|26900111|FG003|Overall Study|Reason Not Specified|40|||
13434800|NCT00384176|26900144|FG000|Overall Study|Death|239|||
13434801|NCT00384176|26900145|FG001|Overall Study|Death|247|||
13434802|NCT00384176|26900146|FG002|Overall Study|Death|105|||
13434803|NCT00384176|26900144|FG000|Overall Study|Withdrawal by Subject|52|||
13434804|NCT00384176|26900145|FG001|Overall Study|Withdrawal by Subject|48|||
13434805|NCT00384176|26900146|FG002|Overall Study|Withdrawal by Subject|22|||
13434806|NCT00384176|26900144|FG000|Overall Study|Lost to Follow-up|16|||
13434807|NCT00384176|26900145|FG001|Overall Study|Lost to Follow-up|18|||
13434808|NCT00384176|26900146|FG002|Overall Study|Lost to Follow-up|4|||
13434809|NCT00384176|26900144|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2|||
13434810|NCT00384176|26900145|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3|||
13434811|NCT00384176|26900146|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0|||
13434812|NCT00384176|26900144|FG000|Overall Study|Longer QTC as Visit 1|1|||
13434813|NCT00384176|26900145|FG001|Overall Study|Longer QTC as Visit 1|0|||
13434814|NCT00384176|26900146|FG002|Overall Study|Longer QTC as Visit 1|0|||
13434815|NCT00384176|26900144|FG000|Overall Study|Toxicity of treatment|1|||
13434816|NCT00384176|26900145|FG001|Overall Study|Toxicity of treatment|0|||
13434817|NCT00384176|26900146|FG002|Overall Study|Toxicity of treatment|0|||
13434818|NCT00384176|26900144|FG000|Overall Study|Did not receive study treatment|0|||
13434819|NCT00384176|26900145|FG001|Overall Study|Did not receive study treatment|1|||
13434820|NCT00384176|26900146|FG002|Overall Study|Did not receive study treatment|1|||
13434821|NCT00384176|26900144|FG000|Overall Study|Physician Decision|0|||
13434822|NCT00384176|26900145|FG001|Overall Study|Physician Decision|2|||
13434823|NCT00384176|26900146|FG002|Overall Study|Physician Decision|0|||
13434824|NCT00384176|26900144|FG000|Overall Study|Liver metastases, colon resec. planned|1|||
13434825|NCT00384176|26900145|FG001|Overall Study|Liver metastases, colon resec. planned|0|||
13434826|NCT00384176|26900146|FG002|Overall Study|Liver metastases, colon resec. planned|0|||
13434827|NCT00384085|26900180|FG000|Overall Study|Adverse Event|5|||
13434828|NCT00384085|26900181|FG001|Overall Study|Adverse Event|5|||
13434829|NCT00384085|26900182|FG002|Overall Study|Adverse Event|4|||
13434830|NCT00384085|26900180|FG000|Overall Study|Lack of Efficacy|0|||
13434831|NCT00384085|26900181|FG001|Overall Study|Lack of Efficacy|3|||
13434832|NCT00384085|26900182|FG002|Overall Study|Lack of Efficacy|2|||
13434833|NCT00384085|26900180|FG000|Overall Study|No longer Requires Study Treatment|1|||
13434834|NCT00384085|26900181|FG001|Overall Study|No longer Requires Study Treatment|0|||
13434835|NCT00384085|26900182|FG002|Overall Study|No longer Requires Study Treatment|1|||
13434836|NCT00384085|26900180|FG000|Overall Study|Protocol Violation|2|||
13434837|NCT00384085|26900181|FG001|Overall Study|Protocol Violation|2|||
13434838|NCT00384085|26900182|FG002|Overall Study|Protocol Violation|2|||
13434839|NCT00384085|26900180|FG000|Overall Study|Lost to Follow-up|9|||
13434840|NCT00384085|26900181|FG001|Overall Study|Lost to Follow-up|9|||
13434841|NCT00384085|26900182|FG002|Overall Study|Lost to Follow-up|10|||
13434842|NCT00384085|26900180|FG000|Overall Study|Progressive Disease|0|||
13434843|NCT00384085|26900181|FG001|Overall Study|Progressive Disease|1|||
13434844|NCT00384085|26900182|FG002|Overall Study|Progressive Disease|0|||
13434845|NCT00384085|26900180|FG000|Overall Study|Withdrawal by Subject|14|||
13434846|NCT00384085|26900181|FG001|Overall Study|Withdrawal by Subject|19|||
13434847|NCT00384085|26900182|FG002|Overall Study|Withdrawal by Subject|29|||
13434848|NCT00384085|26900180|FG000|Overall Study|Patient non-compliant|4|||
13434849|NCT00384085|26900181|FG001|Overall Study|Patient non-compliant|4|||
13434850|NCT00384085|26900182|FG002|Overall Study|Patient non-compliant|5|||
13434851|NCT00384085|26900180|FG000|Overall Study|Physician Decision|1|||
13434852|NCT00384085|26900181|FG001|Overall Study|Physician Decision|0|||
13434853|NCT00384085|26900182|FG002|Overall Study|Physician Decision|0|||
13434854|NCT00384085|26900180|FG000|Overall Study|Loss of site personnel|1|||
13434855|NCT00384085|26900181|FG001|Overall Study|Loss of site personnel|0|||
13434856|NCT00384085|26900182|FG002|Overall Study|Loss of site personnel|1|||
13434857|NCT00384085|26900180|FG000|Overall Study|Sponsor decision|1|||
13434858|NCT00384085|26900181|FG001|Overall Study|Sponsor decision|2|||
13434859|NCT00384085|26900182|FG002|Overall Study|Sponsor decision|1|||
13434860|NCT00384085|26900180|FG000|Overall Study|Patient moved|1|||
13434861|NCT00384085|26900181|FG001|Overall Study|Patient moved|0|||
13434862|NCT00384085|26900182|FG002|Overall Study|Patient moved|1|||
13434863|NCT00384085|26900180|FG000|Overall Study|Patient required surgery|0|||
13434864|NCT00384085|26900181|FG001|Overall Study|Patient required surgery|1|||
13434865|NCT00384085|26900182|FG002|Overall Study|Patient required surgery|0|||
13434866|NCT00384059|26900235|FG000|Infant Series|Not consented|2|||
13434867|NCT00384059|26900236|FG001|Infant Series|Not consented|6|||
13434868|NCT00384059|26900235|FG000|Infant Series|Withdrawal by Subject|2|||
13434869|NCT00384059|26900236|FG001|Infant Series|Withdrawal by Subject|2|||
13434870|NCT00384059|26900235|FG000|Infant Series|Adverse Event|1|||
13434871|NCT00384059|26900236|FG001|Infant Series|Adverse Event|2|||
13434872|NCT00384059|26900235|FG000|Infant Series|Protocol Violation|1|||
13434873|NCT00384059|26900236|FG001|Infant Series|Protocol Violation|2|||
13434874|NCT00384059|26900235|FG000|Infant Series|Lost to Follow-up|0|||
13434875|NCT00384059|26900236|FG001|Infant Series|Lost to Follow-up|1|||
13434876|NCT00384059|26900235|FG000|After Infant Series|Protocol Violation|2|||
13434877|NCT00384059|26900236|FG001|After Infant Series|Protocol Violation|3|||
13434878|NCT00384059|26900235|FG000|After Infant Series|Withdrawal by Subject|2|||
13434879|NCT00384059|26900236|FG001|After Infant Series|Withdrawal by Subject|2|||
13434880|NCT00384059|26900235|FG000|After Infant Series|Failed to Return|0|||
13434881|NCT00384059|26900236|FG001|After Infant Series|Failed to Return|2|||
13434882|NCT00384059|26900235|FG000|After Infant Series|Adverse Event|0|||
13434883|NCT00384059|26900236|FG001|After Infant Series|Adverse Event|1|||
13434884|NCT00384059|26900235|FG000|After Infant Series|Physician Decision|0|||
13434885|NCT00384059|26900236|FG001|After Infant Series|Physician Decision|1|||
13434886|NCT00384059|26900235|FG000|After Infant Series|Lost to Follow-up|0|||
13434887|NCT00384059|26900236|FG001|After Infant Series|Lost to Follow-up|1|||
13434888|NCT00384059|26900235|FG000|Toddler Dose|Lost to Follow-up|1|||
13434889|NCT00384059|26900236|FG001|Toddler Dose|Lost to Follow-up|1|||
13434890|NCT00384059|26900235|FG000|Toddler Dose|Failed to return|0|||
13434891|NCT00384059|26900236|FG001|Toddler Dose|Failed to return|1|||
13434892|NCT00384033|26900291|FG000|Overall Study|Adverse Event|10|||
13434893|NCT00384033|26900292|FG001|Overall Study|Adverse Event|8|||
13434894|NCT00384033|26900293|FG002|Overall Study|Adverse Event|11|||
13434895|NCT00384033|26900294|FG003|Overall Study|Adverse Event|20|||
13434896|NCT00384033|26900291|FG000|Overall Study|Failed to return|1|||
13434897|NCT00384033|26900292|FG001|Overall Study|Failed to return|3|||
13434898|NCT00384033|26900293|FG002|Overall Study|Failed to return|2|||
13434899|NCT00384033|26900294|FG003|Overall Study|Failed to return|2|||
13434900|NCT00384033|26900291|FG000|Overall Study|Physician Decision|1|||
13434901|NCT00384033|26900292|FG001|Overall Study|Physician Decision|0|||
13434902|NCT00384033|26900293|FG002|Overall Study|Physician Decision|0|||
13434903|NCT00384033|26900294|FG003|Overall Study|Physician Decision|0|||
13434904|NCT00384033|26900291|FG000|Overall Study|Lost to Follow-up|6|||
13434905|NCT00384033|26900292|FG001|Overall Study|Lost to Follow-up|12|||
13434906|NCT00384033|26900293|FG002|Overall Study|Lost to Follow-up|7|||
13434907|NCT00384033|26900294|FG003|Overall Study|Lost to Follow-up|7|||
13434908|NCT00384033|26900291|FG000|Overall Study|Other|2|||
13434909|NCT00384033|26900292|FG001|Overall Study|Other|0|||
13434910|NCT00384033|26900293|FG002|Overall Study|Other|0|||
13434911|NCT00384033|26900294|FG003|Overall Study|Other|0|||
13434912|NCT00384033|26900291|FG000|Overall Study|Protocol Violation|5|||
13434913|NCT00384033|26900292|FG001|Overall Study|Protocol Violation|0|||
13434914|NCT00384033|26900293|FG002|Overall Study|Protocol Violation|5|||
13434915|NCT00384033|26900294|FG003|Overall Study|Protocol Violation|6|||
13434916|NCT00384033|26900291|FG000|Overall Study|Withdrawal by Subject|6|||
13434917|NCT00384033|26900292|FG001|Overall Study|Withdrawal by Subject|2|||
13434918|NCT00384033|26900293|FG002|Overall Study|Withdrawal by Subject|5|||
13434919|NCT00384033|26900294|FG003|Overall Study|Withdrawal by Subject|2|||
13434920|NCT00384033|26900291|FG000|Overall Study|Lack of Efficacy|7|||
13434921|NCT00384033|26900292|FG001|Overall Study|Lack of Efficacy|3|||
13434922|NCT00384033|26900293|FG002|Overall Study|Lack of Efficacy|3|||
13434923|NCT00384033|26900294|FG003|Overall Study|Lack of Efficacy|1|||
13434924|NCT00384033|26900291|FG000|Overall Study|Randomized but not treated|3|||
13434925|NCT00384033|26900292|FG001|Overall Study|Randomized but not treated|7|||
13434926|NCT00384033|26900293|FG002|Overall Study|Randomized but not treated|10|||
13434927|NCT00384033|26900294|FG003|Overall Study|Randomized but not treated|2|||
13434928|NCT00383786|26900307|FG000|Overall Study|Protocol Violation|2|||
13434929|NCT00383786|26900308|FG001|Overall Study|Protocol Violation|6|||
13434930|NCT00383786|26900307|FG000|Overall Study|Withdrawal by Subject|2|||
13434931|NCT00383786|26900308|FG001|Overall Study|Withdrawal by Subject|5|||
13434932|NCT00383786|26900307|FG000|Overall Study|Physician Decision|0|||
13434933|NCT00383786|26900308|FG001|Overall Study|Physician Decision|1|||
13434934|NCT00383708|26900344|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1|||
13434935|NCT00383708|26900344|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32|||
13434936|NCT00383708|26900344|FG000|Run-in Period|Protocol Violation|4|||
13434937|NCT00383708|26900344|FG000|Run-in Period|Adverse Event|2|||
13434938|NCT00383708|26900344|FG000|Run-in Period|Claustrophobia|1|||
13434939|NCT00383708|26900344|FG000|Co-administration Period|Adverse Event|5|||
13434940|NCT00383500|26900365|FG000|Overall Study|Withdrawal by Subject|8|||
13434941|NCT00383500|26900366|FG001|Overall Study|Withdrawal by Subject|3|||
13434942|NCT00383500|26900367|FG002|Overall Study|Withdrawal by Subject|0|||
13434943|NCT00383500|26900365|FG000|Overall Study|Lost to Follow-up|0|||
13434944|NCT00383500|26900366|FG001|Overall Study|Lost to Follow-up|0|||
13434945|NCT00383500|26900367|FG002|Overall Study|Lost to Follow-up|2|||
13434946|NCT00383331|26900390|FG000|Overall Study|Protocol Violation|0|||
13434947|NCT00383331|26900391|FG001|Overall Study|Protocol Violation|1|||
13434948|NCT00383292|26900429|FG000|Overall Study|Adverse Event|4|||
13434949|NCT00383292|26900430|FG001|Overall Study|Adverse Event|1|||
13434950|NCT00383292|26900431|FG002|Overall Study|Adverse Event|2|||
13434951|NCT00383292|26900429|FG000|Overall Study|Death|3|||
13434952|NCT00383292|26900430|FG001|Overall Study|Death|3|||
13434953|NCT00383292|26900431|FG002|Overall Study|Death|3|||
13434954|NCT00383292|26900429|FG000|Overall Study|Physician Decision|4|||
13434955|NCT00383292|26900430|FG001|Overall Study|Physician Decision|0|||
13434956|NCT00383292|26900431|FG002|Overall Study|Physician Decision|1|||
13434957|NCT00383292|26900429|FG000|Overall Study|Withdrawal by Subject|3|||
13434958|NCT00383292|26900430|FG001|Overall Study|Withdrawal by Subject|2|||
13434959|NCT00383292|26900431|FG002|Overall Study|Withdrawal by Subject|2|||
13434960|NCT00383292|26900429|FG000|Overall Study|Other|1|||
13434961|NCT00383292|26900430|FG001|Overall Study|Other|0|||
13434962|NCT00383292|26900431|FG002|Overall Study|Other|0|||
13434963|NCT00383240|26900475|FG000|Overall Study|Adverse Event|4|||
13434964|NCT00383240|26900476|FG001|Overall Study|Adverse Event|6|||
13434965|NCT00383240|26900477|FG002|Overall Study|Adverse Event|9|||
13434966|NCT00383240|26900478|FG003|Overall Study|Adverse Event|7|||
13434967|NCT00383240|26900475|FG000|Overall Study|Treatment Failure|8|||
13434968|NCT00383240|26900476|FG001|Overall Study|Treatment Failure|13|||
13434969|NCT00383240|26900477|FG002|Overall Study|Treatment Failure|47|||
13434970|NCT00383240|26900478|FG003|Overall Study|Treatment Failure|46|||
13434971|NCT00383240|26900475|FG000|Overall Study|Lost to Follow-up|3|||
13434972|NCT00383240|26900476|FG001|Overall Study|Lost to Follow-up|0|||
13434973|NCT00383240|26900477|FG002|Overall Study|Lost to Follow-up|0|||
13434974|NCT00383240|26900478|FG003|Overall Study|Lost to Follow-up|2|||
13434975|NCT00383240|26900475|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6|||
13434976|NCT00383240|26900476|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3|||
13434977|NCT00383240|26900477|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8|||
13434978|NCT00383240|26900478|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8|||
13434979|NCT00383240|26900475|FG000|Overall Study|Withdrawal by subjects, reasons related|0|||
13434980|NCT00383240|26900476|FG001|Overall Study|Withdrawal by subjects, reasons related|1|||
13434981|NCT00383240|26900477|FG002|Overall Study|Withdrawal by subjects, reasons related|3|||
13434982|NCT00383240|26900478|FG003|Overall Study|Withdrawal by subjects, reasons related|5|||
13434983|NCT00383240|26900475|FG000|Overall Study|Protocol Violation|4|||
13434984|NCT00383240|26900476|FG001|Overall Study|Protocol Violation|5|||
13434985|NCT00383240|26900477|FG002|Overall Study|Protocol Violation|9|||
13434986|NCT00383240|26900478|FG003|Overall Study|Protocol Violation|6|||
13434987|NCT00383240|26900475|FG000|Overall Study|Did not meet protocol eligibility|9|||
13434988|NCT00383240|26900476|FG001|Overall Study|Did not meet protocol eligibility|4|||
13434989|NCT00383240|26900477|FG002|Overall Study|Did not meet protocol eligibility|9|||
13434990|NCT00383240|26900478|FG003|Overall Study|Did not meet protocol eligibility|3|||
13434991|NCT00383240|26900475|FG000|Overall Study|Administrative|1|||
13434992|NCT00383240|26900476|FG001|Overall Study|Administrative|1|||
13434993|NCT00383240|26900477|FG002|Overall Study|Administrative|0|||
13434994|NCT00383240|26900478|FG003|Overall Study|Administrative|0|||
13434995|NCT00383188|26900615|FG000|Overall Study|Adverse Event|4|||
13434996|NCT00383188|26900616|FG001|Overall Study|Adverse Event|7|||
13434997|NCT00383188|26900617|FG002|Overall Study|Adverse Event|9|||
13434998|NCT00383188|26900618|FG003|Overall Study|Adverse Event|8|||
13434999|NCT00383188|26900619|FG004|Overall Study|Adverse Event|8|||
13435000|NCT00383188|26900615|FG000|Overall Study|Lack of Efficacy|9|||
13435001|NCT00383188|26900616|FG001|Overall Study|Lack of Efficacy|3|||
13435002|NCT00383188|26900617|FG002|Overall Study|Lack of Efficacy|3|||
13435003|NCT00383188|26900618|FG003|Overall Study|Lack of Efficacy|2|||
13435004|NCT00383188|26900619|FG004|Overall Study|Lack of Efficacy|6|||
13435005|NCT00383188|26900615|FG000|Overall Study|Other|3|||
13435006|NCT00383188|26900616|FG001|Overall Study|Other|1|||
13435007|NCT00383188|26900617|FG002|Overall Study|Other|0|||
13435008|NCT00383188|26900618|FG003|Overall Study|Other|2|||
13435009|NCT00383188|26900619|FG004|Overall Study|Other|6|||
13435010|NCT00383188|26900615|FG000|Overall Study|No longer willing to participate|1|||
13435011|NCT00383188|26900616|FG001|Overall Study|No longer willing to participate|0|||
13435012|NCT00383188|26900617|FG002|Overall Study|No longer willing to participate|1|||
13435013|NCT00383188|26900618|FG003|Overall Study|No longer willing to participate|0|||
13435014|NCT00383188|26900619|FG004|Overall Study|No longer willing to participate|2|||
13435015|NCT00383188|26900615|FG000|Overall Study|Lost to Follow-up|0|||
13435016|NCT00383188|26900616|FG001|Overall Study|Lost to Follow-up|0|||
13435017|NCT00383188|26900617|FG002|Overall Study|Lost to Follow-up|0|||
13435018|NCT00383188|26900618|FG003|Overall Study|Lost to Follow-up|0|||
13435019|NCT00383188|26900619|FG004|Overall Study|Lost to Follow-up|1|||
13435020|NCT00383162|26900664|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3|||
13435021|NCT00383162|26900665|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4|||
13435022|NCT00383162|26900664|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8|||
13435023|NCT00383162|26900665|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
13435024|NCT00383162|26900664|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4|||
13435025|NCT00383162|26900665|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2|||
13435026|NCT00383162|26900664|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2|||
13435027|NCT00383162|26900665|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0|||
13435028|NCT00383162|26900664|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3|||
13435029|NCT00383162|26900665|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0|||
13435030|NCT00383162|26900664|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1|||
13435031|NCT00383162|26900665|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3|||
13435032|NCT00383162|26900664|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
13435033|NCT00383162|26900665|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
13435034|NCT00383162|26900664|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1|||
13435035|NCT00383162|26900665|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0|||
13435036|NCT00383162|26900664|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0|||
13435037|NCT00383162|26900665|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3|||
13435038|NCT00383149|26900684|FG000|Overall Study|Adverse Event not Related to Study Drug|3|||
13435039|NCT00383149|26900684|FG000|Overall Study|Death|2|||
13435040|NCT00383149|26900684|FG000|Overall Study|Disease Progression|38|||
13435041|NCT00383149|26900684|FG000|Overall Study|Lost to Follow-up|1|||
13435042|NCT00383149|26900684|FG000|Overall Study|Other|1|||
13435043|NCT00383149|26900684|FG000|Overall Study|Study Drug Toxicity|4|||
13435044|NCT00383149|26900684|FG000|Overall Study|Request to Discontinue Treatment|4|||
13435045|NCT00383149|26900684|FG000|Overall Study|Participant Withdrew Consent|1|||
13435046|NCT00383123|26900711|FG000|Overall Study|Adverse Event|1|||
13435047|NCT00383123|26900712|FG001|Overall Study|Adverse Event|0|||
13435048|NCT00383123|26900711|FG000|Overall Study|Lost to Follow-up|68|||
13435049|NCT00383123|26900712|FG001|Overall Study|Lost to Follow-up|61|||
13435050|NCT00383123|26900711|FG000|Overall Study|Protocol Violation|5|||
13435051|NCT00383123|26900712|FG001|Overall Study|Protocol Violation|1|||
13435052|NCT00383123|26900711|FG000|Overall Study|Withdrawal by Subject|27|||
13435053|NCT00383123|26900712|FG001|Overall Study|Withdrawal by Subject|18|||
13435054|NCT00383123|26900711|FG000|Overall Study|Other reason|10|||
13435055|NCT00383123|26900712|FG001|Overall Study|Other reason|6|||
13435056|NCT00383084|26900731|FG000|Overall Study|Withdrawal by Subject|12|||
13435057|NCT00383084|26900732|FG001|Overall Study|Withdrawal by Subject|10|||
13435058|NCT00383019|26900761|FG000|Overall Study|Adverse Event|5|||
13435059|NCT00383019|26900762|FG001|Overall Study|Adverse Event|1|||
13435060|NCT00383019|26900761|FG000|Overall Study|Withdrawal by Subject|0|||
13435061|NCT00383019|26900762|FG001|Overall Study|Withdrawal by Subject|1|||
13435062|NCT00382993|26900807|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
13435063|NCT00382993|26900808|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2|||
13435064|NCT00382993|26900807|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1|||
13435065|NCT00382993|26900808|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3|||
13435066|NCT00382993|26900807|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0|||
13435067|NCT00382993|26900808|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5|||
13435068|NCT00382993|26900807|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
13435069|NCT00382993|26900808|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
13435070|NCT00382993|26900807|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3|||
13435071|NCT00382993|26900808|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5|||
13435072|NCT00382993|26900807|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
13435073|NCT00382993|26900808|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
13435074|NCT00382993|26900807|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0|||
13435075|NCT00382993|26900808|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1|||
13435076|NCT00382993|26900807|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0|||
13435077|NCT00382993|26900808|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1|||
13435078|NCT00382993|26900807|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0|||
13435079|NCT00382993|26900808|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1|||
13435080|NCT00382993|26900807|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
13435081|NCT00382993|26900808|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
13435082|NCT00382967|26900823|FG000|Overall Study|Protocol Violation|1|||
13435083|NCT00382967|26900824|FG001|Overall Study|Protocol Violation|1|||
13435084|NCT00382863|26900885|FG000|Overall Study|Death|9|||
13435085|NCT00382863|26900886|FG001|Overall Study|Death|9|||
13435086|NCT00382863|26900885|FG000|Overall Study|Lost to Follow-up|1|||
13435087|NCT00382863|26900886|FG001|Overall Study|Lost to Follow-up|2|||
13435088|NCT00382863|26900885|FG000|Overall Study|Withdrawal by Subject|5|||
13435089|NCT00382863|26900886|FG001|Overall Study|Withdrawal by Subject|25|||
13435090|NCT00382733|26900910|FG000|Overall Study|Withdrawal by Subject|0|||
13435091|NCT00382733|26900911|FG001|Overall Study|Withdrawal by Subject|1|||
13435092|NCT00382733|26900912|FG002|Overall Study|Withdrawal by Subject|0|||
13435093|NCT00382733|26900913|FG003|Overall Study|Withdrawal by Subject|0|||
13435094|NCT00382733|26900914|FG004|Overall Study|Withdrawal by Subject|0|||
13435095|NCT00382720|26900938|FG000|Overall Study|Adverse Event|21|||
13435096|NCT00382720|26900939|FG001|Overall Study|Adverse Event|23|||
13435097|NCT00382720|26900940|FG002|Overall Study|Adverse Event|15|||
13435098|NCT00382720|26900938|FG000|Overall Study|Protocol Violation|2|||
13435099|NCT00382720|26900939|FG001|Overall Study|Protocol Violation|5|||
13435100|NCT00382720|26900940|FG002|Overall Study|Protocol Violation|1|||
13435101|NCT00382720|26900938|FG000|Overall Study|Death|0|||
13435102|NCT00382720|26900939|FG001|Overall Study|Death|1|||
13435103|NCT00382720|26900940|FG002|Overall Study|Death|2|||
13435104|NCT00382720|26900938|FG000|Overall Study|Progressive disease|37|||
13435105|NCT00382720|26900939|FG001|Overall Study|Progressive disease|28|||
13435106|NCT00382720|26900940|FG002|Overall Study|Progressive disease|38|||
13435107|NCT00382720|26900938|FG000|Overall Study|Withdrew consent|1|||
13435108|NCT00382720|26900939|FG001|Overall Study|Withdrew consent|1|||
13435109|NCT00382720|26900940|FG002|Overall Study|Withdrew consent|2|||
13435110|NCT00382720|26900938|FG000|Overall Study|Withdrawal by Subject|11|||
13435111|NCT00382720|26900939|FG001|Overall Study|Withdrawal by Subject|20|||
13435112|NCT00382720|26900940|FG002|Overall Study|Withdrawal by Subject|12|||
13435113|NCT00382720|26900938|FG000|Overall Study|Surgery|1|||
13435114|NCT00382720|26900939|FG001|Overall Study|Surgery|1|||
13435115|NCT00382720|26900940|FG002|Overall Study|Surgery|4|||
13435116|NCT00382720|26900938|FG000|Overall Study|Patient did not receive study medication|1|||
13435117|NCT00382720|26900939|FG001|Overall Study|Patient did not receive study medication|1|||
13435118|NCT00382720|26900940|FG002|Overall Study|Patient did not receive study medication|4|||
13435119|NCT00382720|26900938|FG000|Overall Study|Clinically progressive disease|0|||
13435120|NCT00382720|26900939|FG001|Overall Study|Clinically progressive disease|1|||
13435121|NCT00382720|26900940|FG002|Overall Study|Clinically progressive disease|0|||
13435122|NCT00382720|26900938|FG000|Overall Study|Good prognosis|0|||
13435123|NCT00382720|26900939|FG001|Overall Study|Good prognosis|1|||
13435124|NCT00382720|26900940|FG002|Overall Study|Good prognosis|0|||
13435125|NCT00382720|26900938|FG000|Overall Study|Investigator/Clinical decision|5|||
13435126|NCT00382720|26900939|FG001|Overall Study|Investigator/Clinical decision|6|||
13435127|NCT00382720|26900940|FG002|Overall Study|Investigator/Clinical decision|6|||
13435128|NCT00382720|26900938|FG000|Overall Study|Discontinued at end of study|0|||
13435129|NCT00382720|26900939|FG001|Overall Study|Discontinued at end of study|1|||
13435130|NCT00382720|26900940|FG002|Overall Study|Discontinued at end of study|2|||
13435131|NCT00382408|26900971|FG000|Overall Study|Did not meet protocol requirement|3|||
13435132|NCT00382408|26900972|FG001|Overall Study|Did not meet protocol requirement|3|||
13435133|NCT00382408|26900971|FG000|Overall Study|Protocol Violation|2|||
13435134|NCT00382408|26900972|FG001|Overall Study|Protocol Violation|2|||
13435135|NCT00382408|26900971|FG000|Overall Study|Physician Decision|1|||
13435136|NCT00382408|26900972|FG001|Overall Study|Physician Decision|0|||
13435137|NCT00382408|26900971|FG000|Overall Study|Withdrawal by Subject|17|||
13435138|NCT00382408|26900972|FG001|Overall Study|Withdrawal by Subject|6|||
13435139|NCT00382408|26900971|FG000|Overall Study|Pregnancy|2|||
13435140|NCT00382408|26900972|FG001|Overall Study|Pregnancy|0|||
13435141|NCT00382408|26900971|FG000|Overall Study|Lost to Follow-up|19|||
13435142|NCT00382408|26900972|FG001|Overall Study|Lost to Follow-up|8|||
13435143|NCT00382408|26900971|FG000|Overall Study|Other|100|||
13435144|NCT00382408|26900972|FG001|Overall Study|Other|35|||
13435145|NCT00382291|26900993|FG000|Overall Study|Adverse Event|1|||
13435146|NCT00382291|26900994|FG001|Overall Study|Adverse Event|2|||
13435147|NCT00382291|26900995|FG002|Overall Study|Adverse Event|2|||
13435148|NCT00382291|26900993|FG000|Overall Study|Protocol Violation|1|||
13435149|NCT00382291|26900994|FG001|Overall Study|Protocol Violation|0|||
13435150|NCT00382291|26900995|FG002|Overall Study|Protocol Violation|0|||
13435151|NCT00382291|26900993|FG000|Overall Study|Temporary study suspension|2|||
13435152|NCT00382291|26900994|FG001|Overall Study|Temporary study suspension|2|||
13435153|NCT00382291|26900995|FG002|Overall Study|Temporary study suspension|5|||
13435154|NCT00382291|26900993|FG000|Overall Study|Withdrawal by Subject|0|||
13435155|NCT00382291|26900994|FG001|Overall Study|Withdrawal by Subject|2|||
13435156|NCT00382291|26900995|FG002|Overall Study|Withdrawal by Subject|0|||
13435157|NCT00382291|26900993|FG000|Overall Study|Physician Decision|0|||
13435158|NCT00382291|26900994|FG001|Overall Study|Physician Decision|1|||
13435159|NCT00382291|26900995|FG002|Overall Study|Physician Decision|0|||
13435160|NCT00382291|26900993|FG000|Overall Study|Lack of Efficacy|0|||
13435161|NCT00382291|26900994|FG001|Overall Study|Lack of Efficacy|0|||
13435162|NCT00382291|26900995|FG002|Overall Study|Lack of Efficacy|1|||
13435163|NCT00382174|26901014|FG000|Overall Study|Lost to Follow-up|1|||
13435164|NCT00382174|26901015|FG001|Overall Study|Lost to Follow-up|4|||
13435165|NCT00382174|26901016|FG002|Overall Study|Lost to Follow-up|5|||
13435166|NCT00382174|26901014|FG000|Overall Study|Adverse Event|1|||
13435167|NCT00382174|26901015|FG001|Overall Study|Adverse Event|4|||
13435168|NCT00382174|26901016|FG002|Overall Study|Adverse Event|5|||
13435169|NCT00382174|26901014|FG000|Overall Study|Withdrawal by Subject|1|||
13435170|NCT00382174|26901015|FG001|Overall Study|Withdrawal by Subject|4|||
13435171|NCT00382174|26901016|FG002|Overall Study|Withdrawal by Subject|5|||
13435172|NCT00382174|26901014|FG000|Overall Study|Non compliance|1|||
13435173|NCT00382174|26901015|FG001|Overall Study|Non compliance|0|||
13435174|NCT00382174|26901016|FG002|Overall Study|Non compliance|1|||
13435175|NCT00382174|26901014|FG000|Overall Study|Physician Decision|0|||
13435176|NCT00382174|26901015|FG001|Overall Study|Physician Decision|2|||
13435177|NCT00382174|26901016|FG002|Overall Study|Physician Decision|2|||
13435178|NCT00382174|26901014|FG000|Overall Study|Failed to meet criteria|0|||
13435179|NCT00382174|26901015|FG001|Overall Study|Failed to meet criteria|1|||
13435180|NCT00382174|26901016|FG002|Overall Study|Failed to meet criteria|1|||
13435181|NCT00382174|26901014|FG000|Overall Study|Wounds merged|0|||
13435182|NCT00382174|26901015|FG001|Overall Study|Wounds merged|2|||
13435183|NCT00382174|26901016|FG002|Overall Study|Wounds merged|2|||
13435184|NCT00382109|26901043|FG000|Overall Study|Adverse Event|3|||
13435185|NCT00382109|26901044|FG001|Overall Study|Adverse Event|0|||
13435186|NCT00382109|26901043|FG000|Overall Study|Physician Decision|6|||
13435187|NCT00382109|26901044|FG001|Overall Study|Physician Decision|1|||
13435188|NCT00382109|26901043|FG000|Overall Study|Withdrawal by Subject|1|||
13435189|NCT00382109|26901044|FG001|Overall Study|Withdrawal by Subject|0|||
13435190|NCT00382109|26901043|FG000|Overall Study|ineligible|2|||
13435191|NCT00382109|26901044|FG001|Overall Study|ineligible|0|||
13435192|NCT00382109|26901043|FG000|Overall Study|Other|0|||
13435193|NCT00382109|26901044|FG001|Overall Study|Other|2|||
13435194|NCT00382109|26901043|FG000|Overall Study|consent withdrawal|0|||
13435195|NCT00382109|26901044|FG001|Overall Study|consent withdrawal|1|||
13435196|NCT00382018|26901075|FG000|Overall Study|Progression|0|||
13435197|NCT00382018|26901076|FG001|Overall Study|Progression|136|||
13435198|NCT00382018|26901077|FG002|Overall Study|Progression|51|||
13435199|NCT00382018|26901078|FG003|Overall Study|Progression|43|||
13435200|NCT00382018|26901075|FG000|Overall Study|Death|0|||
13435201|NCT00382018|26901076|FG001|Overall Study|Death|9|||
13435202|NCT00382018|26901077|FG002|Overall Study|Death|7|||
13435203|NCT00382018|26901078|FG003|Overall Study|Death|11|||
13435204|NCT00382018|26901075|FG000|Overall Study|Withdrawal by Subject|0|||
13435205|NCT00382018|26901076|FG001|Overall Study|Withdrawal by Subject|4|||
13435206|NCT00382018|26901077|FG002|Overall Study|Withdrawal by Subject|3|||
13435207|NCT00382018|26901078|FG003|Overall Study|Withdrawal by Subject|4|||
13435208|NCT00382018|26901075|FG000|Overall Study|Other, not protocol specified|0|||
13435209|NCT00382018|26901076|FG001|Overall Study|Other, not protocol specified|16|||
13435210|NCT00382018|26901077|FG002|Overall Study|Other, not protocol specified|3|||
13435211|NCT00382018|26901078|FG003|Overall Study|Other, not protocol specified|1|||
13435212|NCT00381940|26901089|FG000|Overall Study|Lack of Efficacy|3|||
13435213|NCT00381940|26901089|FG000|Overall Study|Protocol Violation|1|||
13435214|NCT00381940|26901089|FG000|Overall Study|Ineligible|1|||
13435215|NCT00381888|26901096|FG000|Overall Study|Death|1|||
13435216|NCT00381888|26901096|FG000|Overall Study|Withdrawal by Subject|1|||
13435217|NCT00381888|26901096|FG000|Overall Study|Physician Decision|1|||
13435218|NCT00381888|26901096|FG000|Overall Study|Protocol Violation|9|||
13435219|NCT00381888|26901096|FG000|Overall Study|Had laparoscopic surgery|2|||
13435220|NCT00381888|26901096|FG000|Overall Study|Surgery was cancelled|2|||
13435221|NCT00381888|26901096|FG000|Overall Study|Adverse Event|1|||
13435222|NCT00381849|26901121|FG000|Wash Out|Withdrawal by Subject|0|||
13435223|NCT00381849|26901122|FG001|Wash Out|Withdrawal by Subject|1|||
13435224|NCT00381797|26901207|FG000|Overall Study|Withdrawal by Subject|1|||
13435225|NCT00381797|26901208|FG001|Overall Study|Withdrawal by Subject|1|||
13435226|NCT00381797|26901209|FG002|Overall Study|Withdrawal by Subject|0|||
13435227|NCT00381797|26901210|FG003|Overall Study|Withdrawal by Subject|0|||
13435228|NCT00381797|26901211|FG004|Overall Study|Withdrawal by Subject|2|||
13435229|NCT00381797|26901207|FG000|Overall Study|Ineligible|0|||
13435230|NCT00381797|26901208|FG001|Overall Study|Ineligible|0|||
13435231|NCT00381797|26901209|FG002|Overall Study|Ineligible|0|||
13435232|NCT00381797|26901210|FG003|Overall Study|Ineligible|1|||
13435233|NCT00381797|26901211|FG004|Overall Study|Ineligible|0|||
13435234|NCT00381706|26901250|FG000|Overall Study|Never treated|7|||
13435235|NCT00381706|26901251|FG001|Overall Study|Never treated|2|||
13435236|NCT00381706|26901252|FG002|Overall Study|Never treated|1|||
13435237|NCT00381693|26901261|FG000|Overall Study|Death|1|||
13435238|NCT00381693|26901261|FG000|Overall Study|Adverse Event|4|||
13435239|NCT00381693|26901261|FG000|Overall Study|Patient Choice|1|||
13435240|NCT00381693|26901261|FG000|Overall Study|Progression|2|||
13435241|NCT00381680|26901283|FG000|Overall Study|Adverse Event|9|||
13435242|NCT00381680|26901284|FG001|Overall Study|Adverse Event|3|||
13435243|NCT00381680|26901283|FG000|Overall Study|Death|10|||
13435244|NCT00381680|26901284|FG001|Overall Study|Death|7|||
13435245|NCT00381680|26901283|FG000|Overall Study|Lost to Follow-up|3|||
13435246|NCT00381680|26901284|FG001|Overall Study|Lost to Follow-up|2|||
13435247|NCT00381680|26901283|FG000|Overall Study|Physician Decision|25|||
13435248|NCT00381680|26901284|FG001|Overall Study|Physician Decision|6|||
13435249|NCT00381680|26901283|FG000|Overall Study|Withdrawal by Subject|3|||
13435250|NCT00381680|26901284|FG001|Overall Study|Withdrawal by Subject|1|||
13435251|NCT00381680|26901283|FG000|Overall Study|Entry onto another COG Trial|1|||
13435252|NCT00381680|26901284|FG001|Overall Study|Entry onto another COG Trial|2|||
13435253|NCT00381680|26901283|FG000|Overall Study|Alternative Therapy|11|||
13435254|NCT00381680|26901284|FG001|Overall Study|Alternative Therapy|5|||
13435255|NCT00381680|26901283|FG000|Overall Study|Secondary Malignancy|3|||
13435256|NCT00381680|26901284|FG001|Overall Study|Secondary Malignancy|0|||
13435257|NCT00381680|26901283|FG000|Overall Study|Delay initiation|1|||
13435258|NCT00381680|26901284|FG001|Overall Study|Delay initiation|0|||
13435259|NCT00381680|26901283|FG000|Overall Study|Stem Cell Transplant|26|||
13435260|NCT00381680|26901284|FG001|Overall Study|Stem Cell Transplant|10|||
13435261|NCT00381680|26901283|FG000|Overall Study|Relapse|18|||
13435262|NCT00381680|26901284|FG001|Overall Study|Relapse|9|||
13435263|NCT00381680|26901283|FG000|Overall Study|Induction Failure|4|||
13435264|NCT00381680|26901284|FG001|Overall Study|Induction Failure|1|||
13435265|NCT00381680|26901283|FG000|Overall Study|Progression|1|||
13435266|NCT00381680|26901284|FG001|Overall Study|Progression|1|||
13435267|NCT00381680|26901283|FG000|Overall Study|Other not otherwise specified|7|||
13435268|NCT00381680|26901284|FG001|Overall Study|Other not otherwise specified|2|||
13435269|NCT00381680|26901283|FG000|Overall Study|Ineligible|3|||
13435270|NCT00381680|26901284|FG001|Overall Study|Ineligible|1|||
13435271|NCT00381641|26901303|FG000|Overall Study|Withdrawal by Subject|0|||
13435272|NCT00381641|26901304|FG001|Overall Study|Withdrawal by Subject|2|||
13435273|NCT00381615|26901367|FG000|Overall Study|Withdrawal by Subject|1|||
13435274|NCT00381615|26901368|FG001|Overall Study|Withdrawal by Subject|3|||
13435275|NCT00381615|26901369|FG002|Overall Study|Withdrawal by Subject|0|||
13435276|NCT00381615|26901370|FG003|Overall Study|Withdrawal by Subject|1|||
13435277|NCT00381615|26901367|FG000|Overall Study|Lost to Follow-up|3|||
13435278|NCT00381615|26901368|FG001|Overall Study|Lost to Follow-up|2|||
13435279|NCT00381615|26901369|FG002|Overall Study|Lost to Follow-up|0|||
13435280|NCT00381615|26901370|FG003|Overall Study|Lost to Follow-up|1|||
13435281|NCT00381615|26901367|FG000|Overall Study|Protocol Violation|0|||
13435282|NCT00381615|26901368|FG001|Overall Study|Protocol Violation|0|||
13435283|NCT00381615|26901369|FG002|Overall Study|Protocol Violation|1|||
13435284|NCT00381615|26901370|FG003|Overall Study|Protocol Violation|0|||
13435285|NCT00381563|26901384|FG000|Overall Study|Withdrawal by Subject|5|||
13435286|NCT00381563|26901385|FG001|Overall Study|Withdrawal by Subject|5|||
13435287|NCT00381563|26901384|FG000|Overall Study|Lost to Follow-up|2|||
13435288|NCT00381563|26901385|FG001|Overall Study|Lost to Follow-up|0|||
13435289|NCT00381563|26901384|FG000|Overall Study|Protocol Violation|0|||
13435290|NCT00381563|26901385|FG001|Overall Study|Protocol Violation|1|||
13476953|NCT03533660|27004575|FG000|Overall Study|Withdrawal by Subject|2|||
13476954|NCT03533660|27004576|FG001|Overall Study|Withdrawal by Subject|2|||
13476955|NCT03533660|27004575|FG000|Overall Study|Death|2|||
13476956|NCT03533660|27004576|FG001|Overall Study|Death|4|||
13476957|NCT03533660|27004575|FG000|Overall Study|Adverse Event|0|||
13476958|NCT03533660|27004576|FG001|Overall Study|Adverse Event|2|||
13435291|NCT00381303|26901452|FG000|Overall Study|Lost to Follow-up|25|||
13435292|NCT00381303|26901453|FG001|Overall Study|Lost to Follow-up|9|||
13435293|NCT00381303|26901452|FG000|Overall Study|AE/HIV-related event|22|||
13435294|NCT00381303|26901453|FG001|Overall Study|AE/HIV-related event|6|||
13435295|NCT00381303|26901452|FG000|Overall Study|Non-Adherence|13|||
13435296|NCT00381303|26901453|FG001|Overall Study|Non-Adherence|6|||
13435297|NCT00381303|26901452|FG000|Overall Study|Withdrawal by Subject|13|||
13435298|NCT00381303|26901453|FG001|Overall Study|Withdrawal by Subject|6|||
13435299|NCT00381303|26901452|FG000|Overall Study|Virologic failure|6|||
13435300|NCT00381303|26901453|FG001|Overall Study|Virologic failure|4|||
13435301|NCT00381303|26901452|FG000|Overall Study|Ineligible to continue the trial|2|||
13435302|NCT00381303|26901453|FG001|Overall Study|Ineligible to continue the trial|1|||
13435303|NCT00381303|26901452|FG000|Overall Study|Pregnancy|2|||
13435304|NCT00381303|26901453|FG001|Overall Study|Pregnancy|0|||
13435305|NCT00381303|26901452|FG000|Overall Study|Physician Decision|1|||
13435306|NCT00381303|26901453|FG001|Overall Study|Physician Decision|0|||
13435307|NCT00381303|26901452|FG000|Overall Study|Physician's decision to close the site|3|||
13435308|NCT00381303|26901453|FG001|Overall Study|Physician's decision to close the site|1|||
13435309|NCT00381303|26901452|FG000|Overall Study|Subject moved out of state|2|||
13435310|NCT00381303|26901453|FG001|Overall Study|Subject moved out of state|0|||
13435311|NCT00381303|26901452|FG000|Overall Study|Subject taking too many different meds|1|||
13435312|NCT00381303|26901453|FG001|Overall Study|Subject taking too many different meds|0|||
13435313|NCT00381303|26901452|FG000|Overall Study|No virologic response by week 12|1|||
13435314|NCT00381303|26901453|FG001|Overall Study|No virologic response by week 12|0|||
13435315|NCT00381303|26901452|FG000|Overall Study|Subject was too busy for appointments|1|||
13435316|NCT00381303|26901453|FG001|Overall Study|Subject was too busy for appointments|0|||
13435317|NCT00381303|26901452|FG000|Overall Study|Subject did not continue visits|1|||
13435318|NCT00381303|26901453|FG001|Overall Study|Subject did not continue visits|0|||
13435319|NCT00381303|26901452|FG000|Overall Study|Subject primary physician's decision|1|||
13435320|NCT00381303|26901453|FG001|Overall Study|Subject primary physician's decision|0|||
13435321|NCT00381238|26901469|FG000|Overall Study|Adverse Event|3|||
13435322|NCT00381238|26901469|FG000|Overall Study|Protocol Violation|1|||
13435323|NCT00381238|26901469|FG000|Overall Study|Withdrawal by Subject|4|||
13435324|NCT00381238|26901469|FG000|Overall Study|Lack of Efficacy|2|||
13435325|NCT00381238|26901469|FG000|Overall Study|Withdrew by physician|1|||
13435326|NCT00381238|26901469|FG000|Overall Study|Disease progression|1|||
13435327|NCT00381095|26901506|FG000|Overall Study|Death|3|||
13435328|NCT00381095|26901507|FG001|Overall Study|Death|4|||
13435329|NCT00381095|26901506|FG000|Overall Study|Lack of Efficacy|2|||
13435330|NCT00381095|26901507|FG001|Overall Study|Lack of Efficacy|4|||
13435331|NCT00381095|26901506|FG000|Overall Study|Other|2|||
13435332|NCT00381095|26901507|FG001|Overall Study|Other|2|||
13435333|NCT00381095|26901506|FG000|Overall Study|Protocol Violation|1|||
13435334|NCT00381095|26901507|FG001|Overall Study|Protocol Violation|1|||
13435335|NCT00381095|26901506|FG000|Overall Study|Withdrawal by Subject|3|||
13435336|NCT00381095|26901507|FG001|Overall Study|Withdrawal by Subject|3|||
13435337|NCT00381095|26901506|FG000|Overall Study|Adverse Event|2|||
13435338|NCT00381095|26901507|FG001|Overall Study|Adverse Event|7|||
13435339|NCT00381043|26901532|FG000|Overall Study|Lost to Follow-up|8|||
13435340|NCT00381043|26901533|FG001|Overall Study|Lost to Follow-up|6|||
13435341|NCT00381043|26901532|FG000|Overall Study|Withdrawal by Subject|3|||
13435342|NCT00381043|26901533|FG001|Overall Study|Withdrawal by Subject|1|||
13435343|NCT00381043|26901532|FG000|Overall Study|wanted more care|0|||
13435344|NCT00381043|26901533|FG001|Overall Study|wanted more care|1|||
13435345|NCT00381043|26901532|FG000|Overall Study|incarcerated|1|||
13435346|NCT00381043|26901533|FG001|Overall Study|incarcerated|0|||
13435347|NCT00380978|26901560|FG000|Overall Study|Refused allocated intervention|0|||
13435348|NCT00380978|26901561|FG001|Overall Study|Refused allocated intervention|6|||
13435349|NCT00380978|26901560|FG000|Overall Study|Wrong study envelope|0|||
13435350|NCT00380978|26901561|FG001|Overall Study|Wrong study envelope|2|||
13435351|NCT00380978|26901560|FG000|Overall Study|Allocation prior to analgesia request|1|||
13435352|NCT00380978|26901561|FG001|Overall Study|Allocation prior to analgesia request|2|||
13435353|NCT00380978|26901560|FG000|Overall Study|Parous patient|1|||
13435354|NCT00380978|26901561|FG001|Overall Study|Parous patient|0|||
13435355|NCT00380874|26901584|FG000|Overall Study|Adverse Event|7|||
13435356|NCT00380874|26901585|FG001|Overall Study|Adverse Event|7|||
13435357|NCT00380874|26901584|FG000|Overall Study|Death|1|||
13435358|NCT00380874|26901585|FG001|Overall Study|Death|0|||
13435359|NCT00380874|26901584|FG000|Overall Study|Withdrawal by Subject|2|||
13435360|NCT00380874|26901585|FG001|Overall Study|Withdrawal by Subject|1|||
13435361|NCT00380874|26901584|FG000|Overall Study|Not related to study drug|3|||
13435362|NCT00380874|26901585|FG001|Overall Study|Not related to study drug|2|||
13435363|NCT00380744|26901657|FG000|Overall Study|Death|0|||
13435364|NCT00380744|26901658|FG001|Overall Study|Death|0|||
13435365|NCT00380744|26901659|FG002|Overall Study|Death|0|||
13435366|NCT00380744|26901660|FG003|Overall Study|Death|0|||
13435367|NCT00380744|26901661|FG004|Overall Study|Death|0|||
13435368|NCT00380744|26901662|FG005|Overall Study|Death|0|||
13435369|NCT00380744|26901663|FG006|Overall Study|Death|1|||
13435370|NCT00380744|26901657|FG000|Overall Study|Withdrawal by Subject|1|||
13435371|NCT00380744|26901658|FG001|Overall Study|Withdrawal by Subject|0|||
13435372|NCT00380744|26901659|FG002|Overall Study|Withdrawal by Subject|0|||
13435373|NCT00380744|26901660|FG003|Overall Study|Withdrawal by Subject|0|||
13435374|NCT00380744|26901661|FG004|Overall Study|Withdrawal by Subject|0|||
13435375|NCT00380744|26901662|FG005|Overall Study|Withdrawal by Subject|0|||
13435376|NCT00380744|26901663|FG006|Overall Study|Withdrawal by Subject|0|||
13435377|NCT00380718|26901675|FG000|Overall Study|Adverse Event|1|||
13435378|NCT00380718|26901675|FG000|Overall Study|Death after 30-day post-therapy followup|17|||
13435379|NCT00380692|26901728|FG000|Study Period II - Double Blind|Adverse Event|1|||
13435380|NCT00380692|26901729|FG001|Study Period II - Double Blind|Adverse Event|0|||
13435381|NCT00380692|26901728|FG000|Study Period II - Double Blind|Protocol Violation|2|||
13435382|NCT00380692|26901729|FG001|Study Period II - Double Blind|Protocol Violation|2|||
13435383|NCT00380692|26901728|FG000|Study Period II - Double Blind|Withdrawal by Subject|0|||
13435384|NCT00380692|26901729|FG001|Study Period II - Double Blind|Withdrawal by Subject|0|||
13435385|NCT00380692|26901728|FG000|Study Period II - Double Blind|Physician Decision|0|||
13435386|NCT00380692|26901729|FG001|Study Period II - Double Blind|Physician Decision|1|||
13435387|NCT00380692|26901728|FG000|Study Period II - Double Blind|Lack of Efficacy|1|||
13435388|NCT00380692|26901729|FG001|Study Period II - Double Blind|Lack of Efficacy|0|||
13435389|NCT00380692|26901728|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1|||
13435390|NCT00380692|26901729|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0|||
13435391|NCT00380692|26901728|FG000|Study Period III - Open Label|Adverse Event|5|||
13435392|NCT00380692|26901729|FG001|Study Period III - Open Label|Adverse Event|3|||
13435393|NCT00380692|26901728|FG000|Study Period III - Open Label|Protocol Violation|0|||
13435394|NCT00380692|26901729|FG001|Study Period III - Open Label|Protocol Violation|0|||
13435395|NCT00380692|26901728|FG000|Study Period III - Open Label|Withdrawal by Subject|0|||
13435396|NCT00380692|26901729|FG001|Study Period III - Open Label|Withdrawal by Subject|1|||
13435397|NCT00380692|26901728|FG000|Study Period III - Open Label|Physician Decision|0|||
13435398|NCT00380692|26901729|FG001|Study Period III - Open Label|Physician Decision|3|||
13435399|NCT00380692|26901728|FG000|Study Period III - Open Label|Lack of Efficacy|0|||
13435400|NCT00380692|26901729|FG001|Study Period III - Open Label|Lack of Efficacy|4|||
13435401|NCT00380692|26901728|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1|||
13435402|NCT00380692|26901729|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1|||
13435403|NCT00380588|26901748|FG000|Overall Study|Unequivocal Disease Progression|25|||
13435404|NCT00380588|26901749|FG001|Overall Study|Unequivocal Disease Progression|34|||
13435405|NCT00380588|26901748|FG000|Overall Study|Next Cycle Not Started|4|||
13435406|NCT00380588|26901749|FG001|Overall Study|Next Cycle Not Started|0|||
13435407|NCT00380588|26901748|FG000|Overall Study|Adverse Event|7|||
13435408|NCT00380588|26901749|FG001|Overall Study|Adverse Event|3|||
13435409|NCT00380588|26901748|FG000|Overall Study|Withdrawal by Subject|1|||
13435410|NCT00380588|26901749|FG001|Overall Study|Withdrawal by Subject|3|||
13435411|NCT00380588|26901748|FG000|Overall Study|Physician Decision|2|||
13435412|NCT00380588|26901749|FG001|Overall Study|Physician Decision|0|||
13435413|NCT00380393|26901804|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6|||
13435414|NCT00380393|26901805|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5|||
13435415|NCT00380393|26901804|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0|||
13435416|NCT00380393|26901805|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1|||
13435417|NCT00380393|26901804|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37|||
13435418|NCT00380393|26901805|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29|||
13435419|NCT00380393|26901804|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
13435420|NCT00380393|26901805|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
13435421|NCT00380393|26901804|FG000|Month 8 (Cross-sectional Visit)|Others|5|||
13435422|NCT00380393|26901805|FG001|Month 8 (Cross-sectional Visit)|Others|4|||
13435423|NCT00380393|26901804|FG000|Month 14|Withdrawal by Subject|9|||
13435424|NCT00380393|26901805|FG001|Month 14|Withdrawal by Subject|7|||
13435425|NCT00380393|26901804|FG000|Month 14|Death|1|||
13435426|NCT00380393|26901805|FG001|Month 14|Death|0|||
13435427|NCT00380393|26901804|FG000|Month 14|Lost to Follow-up|0|||
13435428|NCT00380393|26901805|FG001|Month 14|Lost to Follow-up|1|||
13435429|NCT00380393|26901804|FG000|Month 14|Migrated/moved from study area|39|||
13435430|NCT00380393|26901805|FG001|Month 14|Migrated/moved from study area|42|||
13435431|NCT00380393|26901804|FG000|Month 14|Protocol Violation|2|||
13435432|NCT00380393|26901805|FG001|Month 14|Protocol Violation|0|||
13435433|NCT00380393|26901804|FG000|Month 14|Others|6|||
13435434|NCT00380393|26901805|FG001|Month 14|Others|6|||
13435435|NCT00380367|26901812|FG000|Overall Study|Lost to Follow-up|1|||
13435436|NCT00380367|26901812|FG000|Overall Study|Withdrawal by Subject|1|||
13435437|NCT00380250|26901881|FG000|Overall Study|Withdrawal by Subject|39|||
13435438|NCT00380250|26901882|FG001|Overall Study|Withdrawal by Subject|28|||
13435439|NCT00380250|26901881|FG000|Overall Study|Adverse Event|20|||
13435440|NCT00380250|26901882|FG001|Overall Study|Adverse Event|9|||
13435441|NCT00380250|26901881|FG000|Overall Study|Lack of Efficacy|10|||
13435442|NCT00380250|26901882|FG001|Overall Study|Lack of Efficacy|8|||
13435443|NCT00380250|26901881|FG000|Overall Study|Protocol Violation|15|||
13435444|NCT00380250|26901882|FG001|Overall Study|Protocol Violation|5|||
13435445|NCT00380250|26901881|FG000|Overall Study|Lost to Follow-up|14|||
13435446|NCT00380250|26901882|FG001|Overall Study|Lost to Follow-up|5|||
13435447|NCT00380250|26901881|FG000|Overall Study|Physician Decision|1|||
13435448|NCT00380250|26901882|FG001|Overall Study|Physician Decision|0|||
13435449|NCT00380081|26901951|FG000|Overall Study|Withdrawal by Subject|0|||
13435450|NCT00380081|26901952|FG001|Overall Study|Withdrawal by Subject|0|||
13435451|NCT00380081|26901953|FG002|Overall Study|Withdrawal by Subject|0|||
13435452|NCT00380081|26901954|FG003|Overall Study|Withdrawal by Subject|0|||
13435453|NCT00380081|26901955|FG004|Overall Study|Withdrawal by Subject|1|||
13435454|NCT00380081|26901956|FG005|Overall Study|Withdrawal by Subject|0|||
13435455|NCT00380081|26901951|FG000|Overall Study|Family Emergency|0|||
13435456|NCT00380081|26901952|FG001|Overall Study|Family Emergency|0|||
13435457|NCT00380081|26901953|FG002|Overall Study|Family Emergency|0|||
13435458|NCT00380081|26901954|FG003|Overall Study|Family Emergency|0|||
13435459|NCT00380081|26901955|FG004|Overall Study|Family Emergency|0|||
13435460|NCT00380081|26901956|FG005|Overall Study|Family Emergency|1|||
13435461|NCT00380068|26901978|FG000|Overall Study|Adverse Event|40|||
13435462|NCT00380068|26901978|FG000|Overall Study|Withdrawal by Subject|10|||
13435463|NCT00380068|26901978|FG000|Overall Study|Not compliant|6|||
13435464|NCT00380068|26901978|FG000|Overall Study|Lost to Follow-up|1|||
13435465|NCT00380068|26901978|FG000|Overall Study|Addition of other PAH therapeutic agent|1|||
13435466|NCT00380068|26901978|FG000|Overall Study|Lung transplant|3|||
13435467|NCT00380068|26901978|FG000|Overall Study|Physician Decision|2|||
13435468|NCT00380068|26901978|FG000|Overall Study|Partipant moved away|1|||
13435469|NCT00380068|26901978|FG000|Overall Study|Lack of Efficacy|5|||
13435470|NCT00379912|26902005|FG000|Overall Study|Lack of Efficacy|1|||
13435471|NCT00379912|26902006|FG001|Overall Study|Lack of Efficacy|0|||
13435472|NCT00379899|26902041|FG000|Overall Study|Adverse Event|7|||
13435473|NCT00379899|26902042|FG001|Overall Study|Adverse Event|3|||
13435474|NCT00379899|26902041|FG000|Overall Study|Death|10|||
13435475|NCT00379899|26902042|FG001|Overall Study|Death|10|||
13435476|NCT00379899|26902041|FG000|Overall Study|Lost to Follow-up|2|||
13435477|NCT00379899|26902042|FG001|Overall Study|Lost to Follow-up|4|||
13435478|NCT00379899|26902041|FG000|Overall Study|Physician Decision|3|||
13435479|NCT00379899|26902042|FG001|Overall Study|Physician Decision|4|||
13435480|NCT00379899|26902041|FG000|Overall Study|Withdrawal by Subject|5|||
13435481|NCT00379899|26902042|FG001|Overall Study|Withdrawal by Subject|5|||
13435482|NCT00379899|26902041|FG000|Overall Study|Ineligibility determined|0|||
13435483|NCT00379899|26902042|FG001|Overall Study|Ineligibility determined|1|||
13435484|NCT00379899|26902041|FG000|Overall Study|Noncompliance|1|||
13435485|NCT00379899|26902042|FG001|Overall Study|Noncompliance|1|||
13435486|NCT00379899|26902041|FG000|Overall Study|Parathyroidectomy|0|||
13435487|NCT00379899|26902042|FG001|Overall Study|Parathyroidectomy|2|||
13435488|NCT00379899|26902041|FG000|Overall Study|Renal transplantation|5|||
13435489|NCT00379899|26902042|FG001|Overall Study|Renal transplantation|4|||
13435490|NCT00379899|26902041|FG000|Overall Study|Coronary artery bypass graft|1|||
13435491|NCT00379899|26902042|FG001|Overall Study|Coronary artery bypass graft|1|||
13435492|NCT00379899|26902041|FG000|Overall Study|Other protocol-specified criteria|3|||
13435493|NCT00379899|26902042|FG001|Overall Study|Other protocol-specified criteria|4|||
13435494|NCT00379899|26902041|FG000|Overall Study|Other|3|||
13435495|NCT00379899|26902042|FG001|Overall Study|Other|1|||
13435496|NCT00379834|26902048|FG000|Overall Study|Time constraints|2|||
13435497|NCT00379808|26902067|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0|||
13435498|NCT00379808|26902068|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1|||
13435499|NCT00379795|26902110|FG000|Overall Study|Death|31|||
13435500|NCT00379795|26902111|FG001|Overall Study|Death|8|||
13435501|NCT00379795|26902112|FG002|Overall Study|Death|6|||
13435502|NCT00379795|26902113|FG003|Overall Study|Death|4|||
13435503|NCT00379795|26902114|FG004|Overall Study|Death|7|||
13435504|NCT00379795|26902110|FG000|Overall Study|Adverse Event|17|||
13435505|NCT00379795|26902111|FG001|Overall Study|Adverse Event|3|||
13435506|NCT00379795|26902112|FG002|Overall Study|Adverse Event|3|||
13435507|NCT00379795|26902113|FG003|Overall Study|Adverse Event|1|||
13435508|NCT00379795|26902114|FG004|Overall Study|Adverse Event|4|||
13435509|NCT00379795|26902110|FG000|Overall Study|Lost to Follow-up|8|||
13435510|NCT00379795|26902111|FG001|Overall Study|Lost to Follow-up|1|||
13435511|NCT00379795|26902112|FG002|Overall Study|Lost to Follow-up|2|||
13435512|NCT00379795|26902113|FG003|Overall Study|Lost to Follow-up|1|||
13435513|NCT00379795|26902114|FG004|Overall Study|Lost to Follow-up|4|||
13435514|NCT00379795|26902110|FG000|Overall Study|Physician Decision|25|||
13435515|NCT00379795|26902111|FG001|Overall Study|Physician Decision|0|||
13435516|NCT00379795|26902112|FG002|Overall Study|Physician Decision|2|||
13435517|NCT00379795|26902113|FG003|Overall Study|Physician Decision|2|||
13435518|NCT00379795|26902114|FG004|Overall Study|Physician Decision|2|||
13435519|NCT00379795|26902110|FG000|Overall Study|Withdrawal by Subject|94|||
13435520|NCT00379795|26902111|FG001|Overall Study|Withdrawal by Subject|11|||
13435521|NCT00379795|26902112|FG002|Overall Study|Withdrawal by Subject|19|||
13435522|NCT00379795|26902113|FG003|Overall Study|Withdrawal by Subject|7|||
13435523|NCT00379795|26902114|FG004|Overall Study|Withdrawal by Subject|14|||
13435524|NCT00379795|26902110|FG000|Overall Study|Subject non-compliance|7|||
13435525|NCT00379795|26902111|FG001|Overall Study|Subject non-compliance|2|||
13435526|NCT00379795|26902112|FG002|Overall Study|Subject non-compliance|0|||
13435527|NCT00379795|26902113|FG003|Overall Study|Subject non-compliance|0|||
13435528|NCT00379795|26902114|FG004|Overall Study|Subject non-compliance|1|||
13435529|NCT00379795|26902110|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3|||
13435530|NCT00379795|26902111|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0|||
13435531|NCT00379795|26902112|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0|||
13435532|NCT00379795|26902113|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1|||
13435533|NCT00379795|26902114|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0|||
13435534|NCT00379795|26902110|FG000|Overall Study|Subjects condition mandated intervention|34|||
13435535|NCT00379795|26902111|FG001|Overall Study|Subjects condition mandated intervention|9|||
13435536|NCT00379795|26902112|FG002|Overall Study|Subjects condition mandated intervention|7|||
13435537|NCT00379795|26902113|FG003|Overall Study|Subjects condition mandated intervention|5|||
13435538|NCT00379795|26902114|FG004|Overall Study|Subjects condition mandated intervention|7|||
13435539|NCT00379795|26902110|FG000|Overall Study|Sponsor's decision|257|||
13435540|NCT00379795|26902111|FG001|Overall Study|Sponsor's decision|17|||
13435541|NCT00379795|26902112|FG002|Overall Study|Sponsor's decision|54|||
13435542|NCT00379795|26902113|FG003|Overall Study|Sponsor's decision|47|||
13435543|NCT00379795|26902114|FG004|Overall Study|Sponsor's decision|10|||
13435544|NCT00379769|26902283|FG000|Main Study|Death|57|||
13435545|NCT00379769|26902284|FG001|Main Study|Death|67|||
13435546|NCT00379769|26902285|FG002|Main Study|Death|54|||
13435547|NCT00379769|26902286|FG003|Main Study|Death|72|||
13435548|NCT00379769|26902287|FG004|Main Study|Death|0|||
13435549|NCT00379769|26902288|FG005|Main Study|Death|0|||
13435550|NCT00379769|26902283|FG000|Main Study|Adverse Event|5|||
13435551|NCT00379769|26902284|FG001|Main Study|Adverse Event|8|||
13435552|NCT00379769|26902285|FG002|Main Study|Adverse Event|10|||
13435553|NCT00379769|26902286|FG003|Main Study|Adverse Event|11|||
13435554|NCT00379769|26902287|FG004|Main Study|Adverse Event|0|||
13435555|NCT00379769|26902288|FG005|Main Study|Adverse Event|0|||
13435556|NCT00379769|26902283|FG000|Main Study|Lost to Follow-up|29|||
13435557|NCT00379769|26902284|FG001|Main Study|Lost to Follow-up|29|||
13435558|NCT00379769|26902285|FG002|Main Study|Lost to Follow-up|25|||
13435559|NCT00379769|26902286|FG003|Main Study|Lost to Follow-up|26|||
13435560|NCT00379769|26902287|FG004|Main Study|Lost to Follow-up|0|||
13435561|NCT00379769|26902288|FG005|Main Study|Lost to Follow-up|0|||
13435562|NCT00379769|26902283|FG000|Main Study|Withdrawal by Subject|46|||
13435563|NCT00379769|26902284|FG001|Main Study|Withdrawal by Subject|56|||
13435564|NCT00379769|26902285|FG002|Main Study|Withdrawal by Subject|72|||
13435565|NCT00379769|26902286|FG003|Main Study|Withdrawal by Subject|70|||
13435566|NCT00379769|26902287|FG004|Main Study|Withdrawal by Subject|0|||
13435567|NCT00379769|26902288|FG005|Main Study|Withdrawal by Subject|0|||
13435568|NCT00379769|26902283|FG000|Main Study|Moved to survival status follow-up only|27|||
13435569|NCT00379769|26902284|FG001|Main Study|Moved to survival status follow-up only|25|||
13435570|NCT00379769|26902285|FG002|Main Study|Moved to survival status follow-up only|32|||
13435571|NCT00379769|26902286|FG003|Main Study|Moved to survival status follow-up only|36|||
13435572|NCT00379769|26902287|FG004|Main Study|Moved to survival status follow-up only|0|||
13435573|NCT00379769|26902288|FG005|Main Study|Moved to survival status follow-up only|0|||
13435574|NCT00379769|26902283|FG000|Main Study|Participant moved|3|||
13435575|NCT00379769|26902284|FG001|Main Study|Participant moved|2|||
13435576|NCT00379769|26902285|FG002|Main Study|Participant moved|3|||
13435577|NCT00379769|26902286|FG003|Main Study|Participant moved|3|||
13435578|NCT00379769|26902287|FG004|Main Study|Participant moved|0|||
13435579|NCT00379769|26902288|FG005|Main Study|Participant moved|0|||
13435580|NCT00379769|26902283|FG000|Main Study|Poor compliance|3|||
13435581|NCT00379769|26902284|FG001|Main Study|Poor compliance|2|||
13435582|NCT00379769|26902285|FG002|Main Study|Poor compliance|2|||
13435583|NCT00379769|26902286|FG003|Main Study|Poor compliance|1|||
13435584|NCT00379769|26902287|FG004|Main Study|Poor compliance|0|||
13435585|NCT00379769|26902288|FG005|Main Study|Poor compliance|0|||
13435586|NCT00379769|26902283|FG000|Main Study|Prohibited glucose lowering medication|0|||
13435587|NCT00379769|26902284|FG001|Main Study|Prohibited glucose lowering medication|3|||
13435588|NCT00379769|26902285|FG002|Main Study|Prohibited glucose lowering medication|0|||
13435589|NCT00379769|26902286|FG003|Main Study|Prohibited glucose lowering medication|1|||
13435590|NCT00379769|26902287|FG004|Main Study|Prohibited glucose lowering medication|0|||
13435591|NCT00379769|26902288|FG005|Main Study|Prohibited glucose lowering medication|0|||
13435592|NCT00379769|26902283|FG000|Main Study|Site closed|4|||
13435593|NCT00379769|26902284|FG001|Main Study|Site closed|4|||
13435594|NCT00379769|26902285|FG002|Main Study|Site closed|4|||
13435595|NCT00379769|26902286|FG003|Main Study|Site closed|8|||
13435596|NCT00379769|26902287|FG004|Main Study|Site closed|0|||
13435597|NCT00379769|26902288|FG005|Main Study|Site closed|0|||
13435598|NCT00379769|26902283|FG000|Main Study|Entry criteria violation|0|||
13435599|NCT00379769|26902284|FG001|Main Study|Entry criteria violation|0|||
13435600|NCT00379769|26902285|FG002|Main Study|Entry criteria violation|1|||
13435601|NCT00379769|26902286|FG003|Main Study|Entry criteria violation|1|||
13435602|NCT00379769|26902287|FG004|Main Study|Entry criteria violation|0|||
13435603|NCT00379769|26902288|FG005|Main Study|Entry criteria violation|0|||
13435604|NCT00379769|26902283|FG000|Main Study|Participant did not take study drug|0|||
13435605|NCT00379769|26902284|FG001|Main Study|Participant did not take study drug|0|||
13435606|NCT00379769|26902285|FG002|Main Study|Participant did not take study drug|1|||
13435607|NCT00379769|26902286|FG003|Main Study|Participant did not take study drug|0|||
13435608|NCT00379769|26902287|FG004|Main Study|Participant did not take study drug|0|||
13435609|NCT00379769|26902288|FG005|Main Study|Participant did not take study drug|0|||
13435610|NCT00379769|26902283|FG000|Main Study|Physician Decision|2|||
13435611|NCT00379769|26902284|FG001|Main Study|Physician Decision|2|||
13435612|NCT00379769|26902285|FG002|Main Study|Physician Decision|1|||
13435613|NCT00379769|26902286|FG003|Main Study|Physician Decision|1|||
13435614|NCT00379769|26902287|FG004|Main Study|Physician Decision|0|||
13435615|NCT00379769|26902288|FG005|Main Study|Physician Decision|0|||
13435616|NCT00379769|26902283|FG000|Main Study|Participant completed study at visit 27|1|||
13435617|NCT00379769|26902284|FG001|Main Study|Participant completed study at visit 27|0|||
13435618|NCT00379769|26902285|FG002|Main Study|Participant completed study at visit 27|0|||
13435619|NCT00379769|26902286|FG003|Main Study|Participant completed study at visit 27|0|||
13435620|NCT00379769|26902287|FG004|Main Study|Participant completed study at visit 27|0|||
13435621|NCT00379769|26902288|FG005|Main Study|Participant completed study at visit 27|0|||
13435622|NCT00379769|26902283|FG000|Main Study|Personal reasons|1|||
13435623|NCT00379769|26902284|FG001|Main Study|Personal reasons|0|||
13435624|NCT00379769|26902285|FG002|Main Study|Personal reasons|0|||
13435625|NCT00379769|26902286|FG003|Main Study|Personal reasons|0|||
13435626|NCT00379769|26902287|FG004|Main Study|Personal reasons|0|||
13435627|NCT00379769|26902288|FG005|Main Study|Personal reasons|0|||
13435628|NCT00379769|26902283|FG000|Main Study|Risk of heart failure|0|||
13435629|NCT00379769|26902284|FG001|Main Study|Risk of heart failure|1|||
13435630|NCT00379769|26902285|FG002|Main Study|Risk of heart failure|0|||
13435631|NCT00379769|26902286|FG003|Main Study|Risk of heart failure|0|||
13435632|NCT00379769|26902287|FG004|Main Study|Risk of heart failure|0|||
13435633|NCT00379769|26902288|FG005|Main Study|Risk of heart failure|0|||
13435634|NCT00379769|26902283|FG000|Main Study|Investigator refused to log temperature|0|||
13435635|NCT00379769|26902284|FG001|Main Study|Investigator refused to log temperature|0|||
13435636|NCT00379769|26902285|FG002|Main Study|Investigator refused to log temperature|1|||
13435637|NCT00379769|26902286|FG003|Main Study|Investigator refused to log temperature|0|||
13435638|NCT00379769|26902287|FG004|Main Study|Investigator refused to log temperature|0|||
13435639|NCT00379769|26902288|FG005|Main Study|Investigator refused to log temperature|0|||
13435640|NCT00379769|26902283|FG000|Main Study|Reason unspecified|0|||
13435641|NCT00379769|26902284|FG001|Main Study|Reason unspecified|0|||
13435642|NCT00379769|26902285|FG002|Main Study|Reason unspecified|1|||
13435643|NCT00379769|26902286|FG003|Main Study|Reason unspecified|0|||
13435644|NCT00379769|26902287|FG004|Main Study|Reason unspecified|0|||
13435645|NCT00379769|26902288|FG005|Main Study|Reason unspecified|0|||
13435646|NCT00379769|26902283|FG000|Observational Follow-up|Death|0|||
13435647|NCT00379769|26902284|FG001|Observational Follow-up|Death|0|||
13435648|NCT00379769|26902285|FG002|Observational Follow-up|Death|0|||
13435649|NCT00379769|26902286|FG003|Observational Follow-up|Death|0|||
13435650|NCT00379769|26902287|FG004|Observational Follow-up|Death|78|||
13435651|NCT00379769|26902288|FG005|Observational Follow-up|Death|70|||
13435652|NCT00379769|26902283|FG000|Observational Follow-up|Adverse Event|0|||
13435653|NCT00379769|26902284|FG001|Observational Follow-up|Adverse Event|0|||
13435654|NCT00379769|26902285|FG002|Observational Follow-up|Adverse Event|0|||
13435655|NCT00379769|26902286|FG003|Observational Follow-up|Adverse Event|0|||
13435656|NCT00379769|26902287|FG004|Observational Follow-up|Adverse Event|1|||
13435657|NCT00379769|26902288|FG005|Observational Follow-up|Adverse Event|0|||
13435658|NCT00379769|26902283|FG000|Observational Follow-up|Lost to Follow-up|0|||
13435659|NCT00379769|26902284|FG001|Observational Follow-up|Lost to Follow-up|0|||
13435660|NCT00379769|26902285|FG002|Observational Follow-up|Lost to Follow-up|0|||
13435661|NCT00379769|26902286|FG003|Observational Follow-up|Lost to Follow-up|0|||
13435662|NCT00379769|26902287|FG004|Observational Follow-up|Lost to Follow-up|25|||
13435663|NCT00379769|26902288|FG005|Observational Follow-up|Lost to Follow-up|27|||
13435664|NCT00379769|26902283|FG000|Observational Follow-up|Withdrawal by Subject|0|||
13435665|NCT00379769|26902284|FG001|Observational Follow-up|Withdrawal by Subject|0|||
13435666|NCT00379769|26902285|FG002|Observational Follow-up|Withdrawal by Subject|0|||
13435667|NCT00379769|26902286|FG003|Observational Follow-up|Withdrawal by Subject|0|||
13435668|NCT00379769|26902287|FG004|Observational Follow-up|Withdrawal by Subject|12|||
13435669|NCT00379769|26902288|FG005|Observational Follow-up|Withdrawal by Subject|12|||
13435670|NCT00379769|26902283|FG000|Observational Follow-up|Entered into Another Clinical Trial|0|||
13435671|NCT00379769|26902284|FG001|Observational Follow-up|Entered into Another Clinical Trial|0|||
13435672|NCT00379769|26902285|FG002|Observational Follow-up|Entered into Another Clinical Trial|0|||
13435673|NCT00379769|26902286|FG003|Observational Follow-up|Entered into Another Clinical Trial|0|||
13435674|NCT00379769|26902287|FG004|Observational Follow-up|Entered into Another Clinical Trial|18|||
13435675|NCT00379769|26902288|FG005|Observational Follow-up|Entered into Another Clinical Trial|22|||
13435676|NCT00379769|26902283|FG000|Observational Follow-up|Physician Decision|0|||
13435677|NCT00379769|26902284|FG001|Observational Follow-up|Physician Decision|0|||
13435678|NCT00379769|26902285|FG002|Observational Follow-up|Physician Decision|0|||
13435679|NCT00379769|26902286|FG003|Observational Follow-up|Physician Decision|0|||
13435680|NCT00379769|26902287|FG004|Observational Follow-up|Physician Decision|8|||
13435681|NCT00379769|26902288|FG005|Observational Follow-up|Physician Decision|8|||
13435682|NCT00379769|26902283|FG000|Observational Follow-up|Site Closed Early|0|||
13435683|NCT00379769|26902284|FG001|Observational Follow-up|Site Closed Early|0|||
13435684|NCT00379769|26902285|FG002|Observational Follow-up|Site Closed Early|0|||
13435685|NCT00379769|26902286|FG003|Observational Follow-up|Site Closed Early|0|||
13435686|NCT00379769|26902287|FG004|Observational Follow-up|Site Closed Early|6|||
13435687|NCT00379769|26902288|FG005|Observational Follow-up|Site Closed Early|7|||
13435688|NCT00379769|26902283|FG000|Observational Follow-up|Participant Moved|0|||
13435689|NCT00379769|26902284|FG001|Observational Follow-up|Participant Moved|0|||
13435690|NCT00379769|26902285|FG002|Observational Follow-up|Participant Moved|0|||
13435691|NCT00379769|26902286|FG003|Observational Follow-up|Participant Moved|0|||
13435692|NCT00379769|26902287|FG004|Observational Follow-up|Participant Moved|0|||
13435693|NCT00379769|26902288|FG005|Observational Follow-up|Participant Moved|1|||
13435694|NCT00379769|26902283|FG000|Observational Follow-up|Unknown; Reason Not Provided|0|||
13435695|NCT00379769|26902284|FG001|Observational Follow-up|Unknown; Reason Not Provided|0|||
13435696|NCT00379769|26902285|FG002|Observational Follow-up|Unknown; Reason Not Provided|0|||
13435697|NCT00379769|26902286|FG003|Observational Follow-up|Unknown; Reason Not Provided|0|||
13435698|NCT00379769|26902287|FG004|Observational Follow-up|Unknown; Reason Not Provided|1|||
13435699|NCT00379769|26902288|FG005|Observational Follow-up|Unknown; Reason Not Provided|1|||
13435700|NCT00379639|26902326|FG000|Overall Study|Disease Progression|3|||
13435701|NCT00379639|26902327|FG001|Overall Study|Disease Progression|3|||
13435702|NCT00379639|26902328|FG002|Overall Study|Disease Progression|3|||
13435703|NCT00379639|26902329|FG003|Overall Study|Disease Progression|4|||
13435704|NCT00379639|26902330|FG004|Overall Study|Disease Progression|4|||
13435705|NCT00379639|26902326|FG000|Overall Study|Physician Decision|0|||
13435706|NCT00379639|26902327|FG001|Overall Study|Physician Decision|2|||
13435707|NCT00379639|26902328|FG002|Overall Study|Physician Decision|1|||
13435708|NCT00379639|26902329|FG003|Overall Study|Physician Decision|1|||
13435709|NCT00379639|26902330|FG004|Overall Study|Physician Decision|0|||
13435710|NCT00379639|26902326|FG000|Overall Study|Symptomatic Deterioration|0|||
13435711|NCT00379639|26902327|FG001|Overall Study|Symptomatic Deterioration|0|||
13435712|NCT00379639|26902328|FG002|Overall Study|Symptomatic Deterioration|1|||
13435713|NCT00379639|26902329|FG003|Overall Study|Symptomatic Deterioration|0|||
13435714|NCT00379639|26902330|FG004|Overall Study|Symptomatic Deterioration|1|||
13435715|NCT00379639|26902326|FG000|Overall Study|Adverse Event|0|||
13435716|NCT00379639|26902327|FG001|Overall Study|Adverse Event|0|||
13435717|NCT00379639|26902328|FG002|Overall Study|Adverse Event|1|||
13435718|NCT00379639|26902329|FG003|Overall Study|Adverse Event|0|||
13435719|NCT00379639|26902330|FG004|Overall Study|Adverse Event|1|||
13435720|NCT00379639|26902326|FG000|Overall Study|Lost to Follow-up|0|||
13435721|NCT00379639|26902327|FG001|Overall Study|Lost to Follow-up|0|||
13435722|NCT00379639|26902328|FG002|Overall Study|Lost to Follow-up|0|||
13435723|NCT00379639|26902329|FG003|Overall Study|Lost to Follow-up|1|||
13435724|NCT00379639|26902330|FG004|Overall Study|Lost to Follow-up|0|||
13435725|NCT00379639|26902326|FG000|Overall Study|Other|0|||
13435726|NCT00379639|26902327|FG001|Overall Study|Other|0|||
13435727|NCT00379639|26902328|FG002|Overall Study|Other|3|||
13435728|NCT00379639|26902329|FG003|Overall Study|Other|0|||
13435729|NCT00379639|26902330|FG004|Overall Study|Other|0|||
13435730|NCT00379587|26902339|FG000|Overall Study|Lost to Follow-up|2|||
13435731|NCT00379353|26902376|FG000|Overall Study|Hospitalization|3|||
13435732|NCT00379353|26902377|FG001|Overall Study|Hospitalization|3|||
13435733|NCT00379353|26902376|FG000|Overall Study|Withdrawal by Subject|5|||
13435734|NCT00379353|26902377|FG001|Overall Study|Withdrawal by Subject|2|||
13435735|NCT00379353|26902376|FG000|Overall Study|Death|1|||
13435736|NCT00379353|26902377|FG001|Overall Study|Death|0|||
13435737|NCT00379353|26902376|FG000|Overall Study|Cardiac Tamponade|1|||
13435738|NCT00379353|26902377|FG001|Overall Study|Cardiac Tamponade|0|||
13435739|NCT00379353|26902376|FG000|Overall Study|Non-compliance|1|||
13435740|NCT00379353|26902377|FG001|Overall Study|Non-compliance|0|||
13435741|NCT00379353|26902376|FG000|Overall Study|Conflicting drug treatment|0|||
13435742|NCT00379353|26902377|FG001|Overall Study|Conflicting drug treatment|1|||
13435743|NCT00379236|26902428|FG000|Double-blind|Adverse Event|11|||
13435744|NCT00379236|26902429|FG001|Double-blind|Adverse Event|6|||
13435745|NCT00379236|26902430|FG002|Double-blind|Adverse Event|0|||
13435746|NCT00379236|26902428|FG000|Double-blind|Protocol Violation|3|||
13435747|NCT00379236|26902429|FG001|Double-blind|Protocol Violation|3|||
13435748|NCT00379236|26902430|FG002|Double-blind|Protocol Violation|0|||
13435749|NCT00379236|26902428|FG000|Double-blind|Withdrawal by Subject|12|||
13435750|NCT00379236|26902429|FG001|Double-blind|Withdrawal by Subject|13|||
13435751|NCT00379236|26902430|FG002|Double-blind|Withdrawal by Subject|0|||
13435752|NCT00379236|26902428|FG000|Double-blind|Lost to Follow-up|4|||
13435753|NCT00379236|26902429|FG001|Double-blind|Lost to Follow-up|3|||
13435754|NCT00379236|26902430|FG002|Double-blind|Lost to Follow-up|0|||
13435755|NCT00379236|26902428|FG000|Double-blind|Use of exclusionary medication|1|||
13435756|NCT00379236|26902429|FG001|Double-blind|Use of exclusionary medication|2|||
13435757|NCT00379236|26902430|FG002|Double-blind|Use of exclusionary medication|0|||
13435758|NCT00379236|26902428|FG000|Double-blind|Other|3|||
13435759|NCT00379236|26902429|FG001|Double-blind|Other|7|||
13435760|NCT00379236|26902430|FG002|Double-blind|Other|0|||
13435761|NCT00379236|26902428|FG000|Double-blind|Data could not be retrieved|2|||
13435762|NCT00379236|26902429|FG001|Double-blind|Data could not be retrieved|2|||
13435763|NCT00379236|26902430|FG002|Double-blind|Data could not be retrieved|0|||
13435764|NCT00379236|26902428|FG000|Open-label Extension|Adverse Event|0|||
13435765|NCT00379236|26902429|FG001|Open-label Extension|Adverse Event|0|||
13435766|NCT00379236|26902430|FG002|Open-label Extension|Adverse Event|13|||
13435767|NCT00379236|26902428|FG000|Open-label Extension|Protocol Violation|0|||
13435768|NCT00379236|26902429|FG001|Open-label Extension|Protocol Violation|0|||
13435769|NCT00379236|26902430|FG002|Open-label Extension|Protocol Violation|7|||
13435770|NCT00379236|26902428|FG000|Open-label Extension|Withdrawal by Subject|0|||
13435771|NCT00379236|26902429|FG001|Open-label Extension|Withdrawal by Subject|0|||
13435772|NCT00379236|26902430|FG002|Open-label Extension|Withdrawal by Subject|13|||
13435773|NCT00379236|26902428|FG000|Open-label Extension|Lost to Follow-up|0|||
13435774|NCT00379236|26902429|FG001|Open-label Extension|Lost to Follow-up|0|||
13435775|NCT00379236|26902430|FG002|Open-label Extension|Lost to Follow-up|12|||
13435776|NCT00379236|26902428|FG000|Open-label Extension|Use of exclusionary medication|0|||
13435777|NCT00379236|26902429|FG001|Open-label Extension|Use of exclusionary medication|0|||
13435778|NCT00379236|26902430|FG002|Open-label Extension|Use of exclusionary medication|3|||
13435779|NCT00379236|26902428|FG000|Open-label Extension|Other|0|||
13435780|NCT00379236|26902429|FG001|Open-label Extension|Other|0|||
13435781|NCT00379236|26902430|FG002|Open-label Extension|Other|7|||
13435782|NCT00379210|26902443|FG000|Overall Study|Withdrawal by Subject|10|||
13435783|NCT00379210|26902444|FG001|Overall Study|Withdrawal by Subject|7|||
13435784|NCT00379080|26902497|FG000|Overall Study|Withdrawal by Subject|0|||
13435785|NCT00379080|26902498|FG001|Overall Study|Withdrawal by Subject|4|||
13435786|NCT00379080|26902499|FG002|Overall Study|Withdrawal by Subject|0|||
13435787|NCT00378898|26902514|FG000|Overall Study|Withdrawal by Subject|10|||
13435788|NCT00378898|26902515|FG001|Overall Study|Withdrawal by Subject|5|||
13435789|NCT00378898|26902514|FG000|Overall Study|Protocol Violation|1|||
13435790|NCT00378898|26902515|FG001|Overall Study|Protocol Violation|1|||
13435791|NCT00378703|26902550|FG000|Overall Study|Disease progression|59|||
13435792|NCT00378703|26902551|FG001|Overall Study|Disease progression|43|||
13435793|NCT00378703|26902552|FG002|Overall Study|Disease progression|48|||
13435794|NCT00378703|26902553|FG003|Overall Study|Disease progression|49|||
13435795|NCT00378703|26902550|FG000|Overall Study|Adverse Event|11|||
13435796|NCT00378703|26902551|FG001|Overall Study|Adverse Event|17|||
13435797|NCT00378703|26902552|FG002|Overall Study|Adverse Event|20|||
13435798|NCT00378703|26902553|FG003|Overall Study|Adverse Event|18|||
13435799|NCT00378703|26902550|FG000|Overall Study|Death|2|||
13435800|NCT00378703|26902551|FG001|Overall Study|Death|2|||
13435801|NCT00378703|26902552|FG002|Overall Study|Death|4|||
13435802|NCT00378703|26902553|FG003|Overall Study|Death|3|||
13435803|NCT00378703|26902550|FG000|Overall Study|Withdrawal by Subject|4|||
13435804|NCT00378703|26902551|FG001|Overall Study|Withdrawal by Subject|8|||
13435805|NCT00378703|26902552|FG002|Overall Study|Withdrawal by Subject|5|||
13435806|NCT00378703|26902553|FG003|Overall Study|Withdrawal by Subject|7|||
13435807|NCT00378703|26902550|FG000|Overall Study|Physician Decision|1|||
13435808|NCT00378703|26902551|FG001|Overall Study|Physician Decision|4|||
13435809|NCT00378703|26902552|FG002|Overall Study|Physician Decision|1|||
13435810|NCT00378703|26902553|FG003|Overall Study|Physician Decision|0|||
13435811|NCT00378703|26902550|FG000|Overall Study|Alternative therapy|4|||
13435812|NCT00378703|26902551|FG001|Overall Study|Alternative therapy|2|||
13435813|NCT00378703|26902552|FG002|Overall Study|Alternative therapy|0|||
13435814|NCT00378703|26902553|FG003|Overall Study|Alternative therapy|0|||
13435815|NCT00378703|26902550|FG000|Overall Study|Other complicated disease|0|||
13435816|NCT00378703|26902551|FG001|Overall Study|Other complicated disease|2|||
13435817|NCT00378703|26902552|FG002|Overall Study|Other complicated disease|2|||
13435818|NCT00378703|26902553|FG003|Overall Study|Other complicated disease|0|||
13435819|NCT00378703|26902550|FG000|Overall Study|Symptomatic deterioration|0|||
13435820|NCT00378703|26902551|FG001|Overall Study|Symptomatic deterioration|1|||
13435821|NCT00378703|26902552|FG002|Overall Study|Symptomatic deterioration|0|||
13435822|NCT00378703|26902553|FG003|Overall Study|Symptomatic deterioration|2|||
13435823|NCT00378703|26902550|FG000|Overall Study|Surgery|1|||
13435824|NCT00378703|26902551|FG001|Overall Study|Surgery|0|||
13435825|NCT00378703|26902552|FG002|Overall Study|Surgery|0|||
13435826|NCT00378703|26902553|FG003|Overall Study|Surgery|1|||
13435827|NCT00378703|26902550|FG000|Overall Study|Joint decision of physician and patient|1|||
13435828|NCT00378703|26902551|FG001|Overall Study|Joint decision of physician and patient|0|||
13435829|NCT00378703|26902552|FG002|Overall Study|Joint decision of physician and patient|0|||
13435830|NCT00378703|26902553|FG003|Overall Study|Joint decision of physician and patient|0|||
13435831|NCT00378703|26902550|FG000|Overall Study|Adverse events and progressive disease|0|||
13435832|NCT00378703|26902551|FG001|Overall Study|Adverse events and progressive disease|0|||
13435833|NCT00378703|26902552|FG002|Overall Study|Adverse events and progressive disease|0|||
13435834|NCT00378703|26902553|FG003|Overall Study|Adverse events and progressive disease|1|||
13435835|NCT00378703|26902550|FG000|Overall Study|Relocation|0|||
13435836|NCT00378703|26902551|FG001|Overall Study|Relocation|0|||
13435837|NCT00378703|26902552|FG002|Overall Study|Relocation|1|||
13435838|NCT00378703|26902553|FG003|Overall Study|Relocation|0|||
13435839|NCT00378703|26902550|FG000|Overall Study|Ineligible|4|||
13435840|NCT00378703|26902551|FG001|Overall Study|Ineligible|7|||
13435841|NCT00378703|26902552|FG002|Overall Study|Ineligible|7|||
13435842|NCT00378703|26902553|FG003|Overall Study|Ineligible|7|||
13435843|NCT00378703|26902550|FG000|Overall Study|Never started treatment|1|||
13435844|NCT00378703|26902551|FG001|Overall Study|Never started treatment|4|||
13435845|NCT00378703|26902552|FG002|Overall Study|Never started treatment|0|||
13435846|NCT00378703|26902553|FG003|Overall Study|Never started treatment|0|||
13435847|NCT00378703|26902550|FG000|Overall Study|Other|1|||
13435848|NCT00378703|26902551|FG001|Overall Study|Other|1|||
13435849|NCT00378703|26902552|FG002|Overall Study|Other|2|||
13435850|NCT00378703|26902553|FG003|Overall Study|Other|3|||
13435851|NCT00378599|26902559|FG000|Overall Study|Adverse Event|38|||
13435852|NCT00378599|26902559|FG000|Overall Study|Protocol Violation|2|||
13435853|NCT00378599|26902559|FG000|Overall Study|Treatment failure|7|||
13435854|NCT00378599|26902559|FG000|Overall Study|Withdrawal by Subject|5|||
13435855|NCT00378573|26902567|FG000|Treatment Period|Adverse Event|9|||
13435856|NCT00378573|26902567|FG000|Treatment Period|Physician Decision|1|||
13435857|NCT00378573|26902567|FG000|Treatment Period|Withdrawal by Subject|2|||
13435858|NCT00378573|26902567|FG000|Treatment Period|Disease Progression|4|||
13435859|NCT00378573|26902567|FG000|Treatment Period|Sponsor decision to close study|1|||
13435860|NCT00378573|26902567|FG000|Follow-up|Death|12|||
13435861|NCT00378573|26902567|FG000|Follow-up|Lost to Follow-up|1|||
13435862|NCT00378573|26902567|FG000|Follow-up|Withdrawal by Subject|1|||
13435863|NCT00378560|26902588|FG000|Overall Study|Adverse Event|1|||
13435864|NCT00378560|26902589|FG001|Overall Study|Adverse Event|0|||
13435865|NCT00378560|26902588|FG000|Overall Study|Lost to Follow-up|24|||
13435866|NCT00378560|26902589|FG001|Overall Study|Lost to Follow-up|29|||
13435867|NCT00378560|26902588|FG000|Overall Study|Protocol Violation|2|||
13435868|NCT00378560|26902589|FG001|Overall Study|Protocol Violation|0|||
13435869|NCT00378560|26902588|FG000|Overall Study|Withdrawal by Subject|17|||
13435870|NCT00378560|26902589|FG001|Overall Study|Withdrawal by Subject|21|||
13435871|NCT00378560|26902588|FG000|Overall Study|Moved|4|||
13435872|NCT00378560|26902589|FG001|Overall Study|Moved|3|||
13435873|NCT00378560|26902588|FG000|Overall Study|Pregnancy|7|||
13435874|NCT00378560|26902589|FG001|Overall Study|Pregnancy|5|||
13435875|NCT00378560|26902588|FG000|Overall Study|Laboratory test values abnormal|1|||
13435876|NCT00378560|26902589|FG001|Overall Study|Laboratory test values abnormal|0|||
13435877|NCT00378534|26902605|FG000|Overall Study|Participants did not receive transplant|3|||
13435878|NCT00378534|26902606|FG001|Overall Study|Participants did not receive transplant|0|||
13435879|NCT00378508|26902629|FG000|Overall Study|Withdrawal by Subject|1|||
13435880|NCT00378508|26902630|FG001|Overall Study|Withdrawal by Subject|3|||
13435881|NCT00378508|26902629|FG000|Overall Study|Lost to Follow-up|1|||
13435882|NCT00378508|26902630|FG001|Overall Study|Lost to Follow-up|0|||
13476959|NCT03416127|27004663|FG000|Overall Study|Withdrawal by Subject|0|||
13476960|NCT03416127|27004664|FG001|Overall Study|Withdrawal by Subject|1|||
13476961|NCT03416127|27004665|FG002|Overall Study|Withdrawal by Subject|1|||
13476962|NCT03260140|27004698|FG000|Overall Study|Death|4|||
13476963|NCT03260140|27004699|FG001|Overall Study|Death|1|||
13476964|NCT03260140|27004698|FG000|Overall Study|Withdrawal by Subject|1|||
13476965|NCT03260140|27004699|FG001|Overall Study|Withdrawal by Subject|4|||
13476966|NCT02986334|27004777|FG000|Overall Study|Withdrawal by Subject|0|||
13476967|NCT02986334|27004778|FG001|Overall Study|Withdrawal by Subject|1|||
13476968|NCT02986334|27004779|FG002|Overall Study|Withdrawal by Subject|2|||
13476969|NCT02986334|27004777|FG000|Overall Study|Lost to Follow-up|1|||
13476970|NCT02986334|27004778|FG001|Overall Study|Lost to Follow-up|2|||
13476971|NCT02986334|27004779|FG002|Overall Study|Lost to Follow-up|1|||
13476972|NCT02986334|27004777|FG000|Overall Study|Adverse Event|0|||
13476973|NCT02986334|27004778|FG001|Overall Study|Adverse Event|2|||
13476974|NCT02986334|27004779|FG002|Overall Study|Adverse Event|1|||
13476975|NCT02986334|27004777|FG000|Overall Study|non compliance in phone ratings|2|||
13476976|NCT02986334|27004778|FG001|Overall Study|non compliance in phone ratings|1|||
13476977|NCT02986334|27004779|FG002|Overall Study|non compliance in phone ratings|2|||
13476978|NCT02986334|27004777|FG000|Overall Study|undisclosed comorbidities|0|||
13476979|NCT02986334|27004778|FG001|Overall Study|undisclosed comorbidities|1|||
13476980|NCT02986334|27004779|FG002|Overall Study|undisclosed comorbidities|1|||
13476981|NCT02210221|27004908|FG000|Overall Study|Lack of Efficacy|7|||
13435883|NCT00378209|26902640|FG000|Overall Study|Progressive disease|11|||
13435884|NCT00378209|26902640|FG000|Overall Study|Adverse Event|3|||
13435885|NCT00378209|26902640|FG000|Overall Study|Initiation of non-protocol therapy|3|||
13435886|NCT00378209|26902640|FG000|Overall Study|Physician Decision|3|||
13435887|NCT00378209|26902640|FG000|Overall Study|Death|1|||
13435888|NCT00378209|26902640|FG000|Overall Study|Treatment delay|1|||
13435889|NCT00378105|26902656|FG000|Overall Study|Adverse Event|3|||
13435890|NCT00378105|26902657|FG001|Overall Study|Adverse Event|1|||
13435891|NCT00378105|26902656|FG000|Overall Study|Withdrawal by Subject|3|||
13435892|NCT00378105|26902657|FG001|Overall Study|Withdrawal by Subject|3|||
13435893|NCT00378105|26902656|FG000|Overall Study|Death|1|||
13435894|NCT00378105|26902657|FG001|Overall Study|Death|0|||
13435895|NCT00378105|26902656|FG000|Overall Study|Going to transplant|7|||
13435896|NCT00378105|26902657|FG001|Overall Study|Going to transplant|8|||
13435897|NCT00378105|26902656|FG000|Overall Study|Progressive disease|3|||
13435898|NCT00378105|26902657|FG001|Overall Study|Progressive disease|3|||
13435899|NCT00378105|26902656|FG000|Overall Study|remain on study|3|||
13435900|NCT00378105|26902657|FG001|Overall Study|remain on study|11|||
13435901|NCT00378105|26902656|FG000|Overall Study|Physician Decision|0|||
13435902|NCT00378105|26902657|FG001|Overall Study|Physician Decision|2|||
13435903|NCT00378105|26902656|FG000|Overall Study|Going non-protocol therapy|0|||
13435904|NCT00378105|26902657|FG001|Overall Study|Going non-protocol therapy|1|||
13435905|NCT00378105|26902656|FG000|Overall Study|necessity to increase lenalidomide dose|0|||
13435906|NCT00378105|26902657|FG001|Overall Study|necessity to increase lenalidomide dose|1|||
13435907|NCT00378079|26902687|FG000|Overall Study|Lost to Follow-up|6|||
13435908|NCT00378079|26902688|FG001|Overall Study|Lost to Follow-up|1|||
13435909|NCT00378079|26902689|FG002|Overall Study|Lost to Follow-up|0|||
13435910|NCT00378014|26902720|FG000|Core (Randomization to Month 11)|Adverse Event|1|||
13435911|NCT00378014|26902721|FG001|Core (Randomization to Month 11)|Adverse Event|0|||
13435912|NCT00378014|26902720|FG000|Core (Randomization to Month 11)|Graft loss|1|||
13435913|NCT00378014|26902721|FG001|Core (Randomization to Month 11)|Graft loss|2|||
13435914|NCT00378014|26902720|FG000|Core (Randomization to Month 11)|Death|5|||
13435915|NCT00378014|26902721|FG001|Core (Randomization to Month 11)|Death|3|||
13435916|NCT00378014|26902720|FG000|Core (Randomization to Month 11)|Administrative Problems|2|||
13435917|NCT00378014|26902721|FG001|Core (Randomization to Month 11)|Administrative Problems|2|||
13435918|NCT00378014|26902720|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0|||
13435919|NCT00378014|26902721|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1|||
13435920|NCT00378014|26902720|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5|||
13435921|NCT00378014|26902721|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2|||
13435922|NCT00378014|26902720|FG000|Core (Randomization to Month 11)|Protocol deviation|0|||
13435923|NCT00378014|26902721|FG001|Core (Randomization to Month 11)|Protocol deviation|1|||
13435924|NCT00378014|26902720|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0|||
13435925|NCT00378014|26902721|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1|||
13435926|NCT00378014|26902720|FG000|Extension (Month 12 to Month 59)|Adverse Event|8|||
13435927|NCT00378014|26902721|FG001|Extension (Month 12 to Month 59)|Adverse Event|7|||
13435928|NCT00378014|26902720|FG000|Extension (Month 12 to Month 59)|Death|1|||
13435929|NCT00378014|26902721|FG001|Extension (Month 12 to Month 59)|Death|2|||
13435930|NCT00378014|26902720|FG000|Extension (Month 12 to Month 59)|Administrative problems|1|||
13435931|NCT00378014|26902721|FG001|Extension (Month 12 to Month 59)|Administrative problems|0|||
13435932|NCT00378014|26902720|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
13435933|NCT00378014|26902721|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
13435934|NCT00378014|26902720|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0|||
13435935|NCT00378014|26902721|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3|||
13435936|NCT00378014|26902720|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3|||
13435937|NCT00378014|26902721|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1|||
13435938|NCT00377962|26902762|FG000|Core Study: 0-12 Months|Adverse Event|18|||
13435939|NCT00377962|26902763|FG001|Core Study: 0-12 Months|Adverse Event|2|||
13435940|NCT00377962|26902762|FG000|Core Study: 0-12 Months|Death|3|||
13435941|NCT00377962|26902763|FG001|Core Study: 0-12 Months|Death|0|||
13435942|NCT00377962|26902762|FG000|Core Study: 0-12 Months|Withdrew Consent|5|||
13435943|NCT00377962|26902763|FG001|Core Study: 0-12 Months|Withdrew Consent|2|||
13435944|NCT00377962|26902762|FG000|Core Study: 0-12 Months|Administrative Reason|1|||
13435945|NCT00377962|26902763|FG001|Core Study: 0-12 Months|Administrative Reason|1|||
13435946|NCT00377962|26902762|FG000|Core Study: 0-12 Months|Unspecified reasons|1|||
13435947|NCT00377962|26902763|FG001|Core Study: 0-12 Months|Unspecified reasons|4|||
13435948|NCT00377962|26902762|FG000|Extension Study: 12-24 Months|Death|1|||
13435949|NCT00377962|26902763|FG001|Extension Study: 12-24 Months|Death|1|||
13435950|NCT00377962|26902762|FG000|Extension Study: 12-24 Months|Adverse Event|8|||
13435951|NCT00377962|26902763|FG001|Extension Study: 12-24 Months|Adverse Event|0|||
13435952|NCT00377962|26902762|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1|||
13435953|NCT00377962|26902763|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0|||
13435954|NCT00377962|26902762|FG000|Extension Study: 12-24 Months|Unspecified reason|0|||
13435955|NCT00377962|26902763|FG001|Extension Study: 12-24 Months|Unspecified reason|3|||
13435956|NCT00377858|26902798|FG000|Overall Study|Withdrawal by Subject|12|||
13435957|NCT00377858|26902799|FG001|Overall Study|Withdrawal by Subject|11|||
13435958|NCT00377858|26902798|FG000|Overall Study|Lost to Follow-up|6|||
13435959|NCT00377858|26902799|FG001|Overall Study|Lost to Follow-up|1|||
13435960|NCT00377858|26902798|FG000|Overall Study|Physician Decision|5|||
13435961|NCT00377858|26902799|FG001|Overall Study|Physician Decision|5|||
13435962|NCT00377858|26902798|FG000|Overall Study|Protocol Violation|3|||
13435963|NCT00377858|26902799|FG001|Overall Study|Protocol Violation|4|||
13435964|NCT00377858|26902798|FG000|Overall Study|Adverse Event|2|||
13435965|NCT00377858|26902799|FG001|Overall Study|Adverse Event|1|||
13435966|NCT00377858|26902798|FG000|Overall Study|Entry Criteria Not Met|2|||
13435967|NCT00377858|26902799|FG001|Overall Study|Entry Criteria Not Met|0|||
13435968|NCT00377858|26902798|FG000|Overall Study|Sponsor Decision|1|||
13435969|NCT00377858|26902799|FG001|Overall Study|Sponsor Decision|2|||
13435970|NCT00377858|26902798|FG000|Overall Study|Death|0|||
13435971|NCT00377858|26902799|FG001|Overall Study|Death|3|||
13435972|NCT00377819|26902816|FG000|Overall Study|Adverse Event|2|||
13435973|NCT00377819|26902817|FG001|Overall Study|Adverse Event|3|||
13435974|NCT00377819|26902816|FG000|Overall Study|Withdrawal by Subject|10|||
13435975|NCT00377819|26902817|FG001|Overall Study|Withdrawal by Subject|4|||
13435976|NCT00377819|26902816|FG000|Overall Study|Death|0|||
13435977|NCT00377819|26902817|FG001|Overall Study|Death|1|||
13435978|NCT00377819|26902816|FG000|Overall Study|Lost to Follow-up|0|||
13435979|NCT00377819|26902817|FG001|Overall Study|Lost to Follow-up|1|||
13435980|NCT00377819|26902816|FG000|Overall Study|Protocol Violation|1|||
13435981|NCT00377819|26902817|FG001|Overall Study|Protocol Violation|1|||
13435982|NCT00377676|26902836|FG000|Overall Study|Adverse Event|498|||
13435983|NCT00377676|26902837|FG001|Overall Study|Adverse Event|107|||
13435984|NCT00377676|26902836|FG000|Overall Study|Protocol Violation|33|||
13435985|NCT00377676|26902837|FG001|Overall Study|Protocol Violation|27|||
13435986|NCT00377676|26902836|FG000|Overall Study|Death|5|||
13435987|NCT00377676|26902837|FG001|Overall Study|Death|2|||
13435988|NCT00377676|26902836|FG000|Overall Study|Withdrawal by Subject|187|||
13435989|NCT00377676|26902837|FG001|Overall Study|Withdrawal by Subject|72|||
13435990|NCT00377676|26902836|FG000|Overall Study|Lost to Follow-up|120|||
13435991|NCT00377676|26902837|FG001|Overall Study|Lost to Follow-up|56|||
13435992|NCT00377676|26902836|FG000|Overall Study|Other|118|||
13435993|NCT00377676|26902837|FG001|Overall Study|Other|58|||
13435994|NCT00377637|26902884|FG000|Induction Phase|Adverse Event|12|||
13435995|NCT00377637|26902885|FG001|Induction Phase|Adverse Event|21|||
13435996|NCT00377637|26902886|FG002|Induction Phase|Adverse Event|0|||
13435997|NCT00377637|26902887|FG003|Induction Phase|Adverse Event|0|||
13435998|NCT00377637|26902884|FG000|Induction Phase|Deterioration/serum creatinine|2|||
13435999|NCT00377637|26902885|FG001|Induction Phase|Deterioration/serum creatinine|0|||
13436000|NCT00377637|26902886|FG002|Induction Phase|Deterioration/serum creatinine|0|||
13436001|NCT00377637|26902887|FG003|Induction Phase|Deterioration/serum creatinine|0|||
13436002|NCT00377637|26902884|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
13436003|NCT00377637|26902885|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1|||
13436004|NCT00377637|26902886|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
13436005|NCT00377637|26902887|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
13436006|NCT00377637|26902884|FG000|Induction Phase|Lost to Follow-up|2|||
13436007|NCT00377637|26902885|FG001|Induction Phase|Lost to Follow-up|1|||
13436008|NCT00377637|26902886|FG002|Induction Phase|Lost to Follow-up|0|||
13436009|NCT00377637|26902887|FG003|Induction Phase|Lost to Follow-up|0|||
13436010|NCT00377637|26902884|FG000|Induction Phase|Death|1|||
13436011|NCT00377637|26902885|FG001|Induction Phase|Death|3|||
13436012|NCT00377637|26902886|FG002|Induction Phase|Death|0|||
13436013|NCT00377637|26902887|FG003|Induction Phase|Death|0|||
13436014|NCT00377637|26902884|FG000|Induction Phase|Withdrawal by Subject|5|||
13436015|NCT00377637|26902885|FG001|Induction Phase|Withdrawal by Subject|6|||
13436016|NCT00377637|26902886|FG002|Induction Phase|Withdrawal by Subject|0|||
13436017|NCT00377637|26902887|FG003|Induction Phase|Withdrawal by Subject|0|||
13436018|NCT00377637|26902884|FG000|Induction Phase|Physician Decision|3|||
13436019|NCT00377637|26902885|FG001|Induction Phase|Physician Decision|1|||
13436020|NCT00377637|26902886|FG002|Induction Phase|Physician Decision|0|||
13436021|NCT00377637|26902887|FG003|Induction Phase|Physician Decision|0|||
13436022|NCT00377637|26902884|FG000|Induction Phase|Sponsor decision|1|||
13436023|NCT00377637|26902885|FG001|Induction Phase|Sponsor decision|2|||
13436024|NCT00377637|26902886|FG002|Induction Phase|Sponsor decision|0|||
13436025|NCT00377637|26902887|FG003|Induction Phase|Sponsor decision|0|||
13436026|NCT00377637|26902884|FG000|Induction Phase|Non-Compliance|1|||
13436027|NCT00377637|26902885|FG001|Induction Phase|Non-Compliance|0|||
13436028|NCT00377637|26902886|FG002|Induction Phase|Non-Compliance|0|||
13436029|NCT00377637|26902887|FG003|Induction Phase|Non-Compliance|0|||
13436030|NCT00377637|26902884|FG000|Induction Phase|Reason for withdrawal is not noted|2|||
13436031|NCT00377637|26902885|FG001|Induction Phase|Reason for withdrawal is not noted|0|||
13436032|NCT00377637|26902886|FG002|Induction Phase|Reason for withdrawal is not noted|0|||
13436033|NCT00377637|26902887|FG003|Induction Phase|Reason for withdrawal is not noted|0|||
13436034|NCT00377637|26902884|FG000|Maintenance Phase|Adverse Event|0|||
13436035|NCT00377637|26902885|FG001|Maintenance Phase|Adverse Event|0|||
13436036|NCT00377637|26902886|FG002|Maintenance Phase|Adverse Event|29|||
13436037|NCT00377637|26902887|FG003|Maintenance Phase|Adverse Event|43|||
13436038|NCT00377637|26902884|FG000|Maintenance Phase|Physician Decision|0|||
13436039|NCT00377637|26902885|FG001|Maintenance Phase|Physician Decision|0|||
13436040|NCT00377637|26902886|FG002|Maintenance Phase|Physician Decision|5|||
13436041|NCT00377637|26902887|FG003|Maintenance Phase|Physician Decision|4|||
13436042|NCT00377637|26902884|FG000|Maintenance Phase|Lost to Follow-up|0|||
13436043|NCT00377637|26902885|FG001|Maintenance Phase|Lost to Follow-up|0|||
13436044|NCT00377637|26902886|FG002|Maintenance Phase|Lost to Follow-up|3|||
13436045|NCT00377637|26902887|FG003|Maintenance Phase|Lost to Follow-up|1|||
13436046|NCT00377637|26902884|FG000|Maintenance Phase|Withdrawal by Subject|0|||
13436047|NCT00377637|26902885|FG001|Maintenance Phase|Withdrawal by Subject|0|||
13436048|NCT00377637|26902886|FG002|Maintenance Phase|Withdrawal by Subject|3|||
13436049|NCT00377637|26902887|FG003|Maintenance Phase|Withdrawal by Subject|3|||
13436050|NCT00377637|26902884|FG000|Maintenance Phase|Sponsor decision|0|||
13436051|NCT00377637|26902885|FG001|Maintenance Phase|Sponsor decision|0|||
13436052|NCT00377637|26902886|FG002|Maintenance Phase|Sponsor decision|2|||
13436053|NCT00377637|26902887|FG003|Maintenance Phase|Sponsor decision|3|||
13436054|NCT00377637|26902884|FG000|Maintenance Phase|Non-compliance|0|||
13436055|NCT00377637|26902885|FG001|Maintenance Phase|Non-compliance|0|||
13436056|NCT00377637|26902886|FG002|Maintenance Phase|Non-compliance|1|||
13436057|NCT00377637|26902887|FG003|Maintenance Phase|Non-compliance|1|||
13436058|NCT00377637|26902884|FG000|Maintenance Phase|Study medication stopped > 14 days|0|||
13436059|NCT00377637|26902885|FG001|Maintenance Phase|Study medication stopped > 14 days|0|||
13436060|NCT00377637|26902886|FG002|Maintenance Phase|Study medication stopped > 14 days|0|||
13436061|NCT00377637|26902887|FG003|Maintenance Phase|Study medication stopped > 14 days|1|||
13436062|NCT00377637|26902884|FG000|Maintenance Phase|Death|0|||
13436063|NCT00377637|26902885|FG001|Maintenance Phase|Death|0|||
13436064|NCT00377637|26902886|FG002|Maintenance Phase|Death|0|||
13436065|NCT00377637|26902887|FG003|Maintenance Phase|Death|1|||
13436066|NCT00377611|26902955|FG000|Overall Study|Adverse Event|2|||
13436067|NCT00377611|26902956|FG001|Overall Study|Adverse Event|9|||
13436068|NCT00377611|26902955|FG000|Overall Study|Protocol Violation|2|||
13436069|NCT00377611|26902956|FG001|Overall Study|Protocol Violation|0|||
13436070|NCT00377611|26902955|FG000|Overall Study|Withdrawal by Subject|0|||
13436071|NCT00377611|26902956|FG001|Overall Study|Withdrawal by Subject|5|||
13436072|NCT00377611|26902955|FG000|Overall Study|Lost to Follow-up|18|||
13436073|NCT00377611|26902956|FG001|Overall Study|Lost to Follow-up|16|||
13436074|NCT00377611|26902955|FG000|Overall Study|Other|0|||
13436075|NCT00377611|26902956|FG001|Overall Study|Other|3|||
13436076|NCT00377520|26902963|FG000|Overall Study|Ineligible (Prior radiation)|1|||
13436077|NCT00377455|26902973|FG000|Overall Study|Withdrawal by Subject|1|||
13436078|NCT00377429|26902984|FG000|Overall Study|Withdrawal by Subject|5|||
13436079|NCT00377429|26902984|FG000|Overall Study|Adverse Event|8|||
13436080|NCT00377429|26902984|FG000|Overall Study|Physician Decision|1|||
13436081|NCT00377429|26902984|FG000|Overall Study|Patient non-compliance|1|||
13436082|NCT00377403|26902997|FG000|Overall Study|Unable to contact for telephone intervie|4|||
13436083|NCT00377403|26902998|FG001|Overall Study|Unable to contact for telephone intervie|7|||
13436084|NCT00377364|26903029|FG000|Overall Study|Lost to Follow-up|1|||
13436085|NCT00377364|26903030|FG001|Overall Study|Lost to Follow-up|0|||
13436086|NCT00377364|26903029|FG000|Overall Study|Withdrawal by Subject|1|||
13436087|NCT00377364|26903030|FG001|Overall Study|Withdrawal by Subject|0|||
13436088|NCT00377312|26903067|FG000|Overall Study|Adverse Event|1|||
13436089|NCT00377312|26903068|FG001|Overall Study|Adverse Event|1|||
13436090|NCT00377299|26903089|FG000|Overall Study|Lost to Follow-up|14|||
13436091|NCT00377299|26903090|FG001|Overall Study|Lost to Follow-up|19|||
13436092|NCT00377299|26903089|FG000|Overall Study|Adverse Event|0|||
13436093|NCT00377299|26903090|FG001|Overall Study|Adverse Event|1|||
13436094|NCT00377299|26903089|FG000|Overall Study|Withdrawal by Subject|5|||
13436095|NCT00377299|26903090|FG001|Overall Study|Withdrawal by Subject|4|||
13436096|NCT00377260|26903149|FG000|Overall Study|Lost to Follow-up|0|||
13436097|NCT00377260|26903150|FG001|Overall Study|Lost to Follow-up|1|||
13436098|NCT00377260|26903149|FG000|Overall Study|Withdrawal by Subject|2|||
13436099|NCT00377260|26903150|FG001|Overall Study|Withdrawal by Subject|4|||
13436100|NCT00377234|26903173|FG000|Overall Study|Adverse Event|14|||
13436101|NCT00377234|26903174|FG001|Overall Study|Adverse Event|17|||
13436102|NCT00377234|26903173|FG000|Overall Study|Withdrawal by Subject|11|||
13436103|NCT00377234|26903174|FG001|Overall Study|Withdrawal by Subject|9|||
13436104|NCT00377234|26903173|FG000|Overall Study|Lost to Follow-up|4|||
13436105|NCT00377234|26903174|FG001|Overall Study|Lost to Follow-up|2|||
13436106|NCT00377234|26903173|FG000|Overall Study|Administrative|2|||
13436107|NCT00377234|26903174|FG001|Overall Study|Administrative|1|||
13436108|NCT00377234|26903173|FG000|Overall Study|Not assigned|3|||
13436109|NCT00377234|26903174|FG001|Overall Study|Not assigned|2|||
13436110|NCT00377156|26903195|FG000|Overall Study|Death|23|||
13436111|NCT00377156|26903196|FG001|Overall Study|Death|19|||
13436112|NCT00377156|26903195|FG000|Overall Study|Withdrawal by Subject|16|||
13436113|NCT00377156|26903196|FG001|Overall Study|Withdrawal by Subject|24|||
13436114|NCT00377156|26903195|FG000|Overall Study|Had follow-up <90 d|3|||
13436115|NCT00377156|26903196|FG001|Overall Study|Had follow-up <90 d|6|||
13436116|NCT00377156|26903195|FG000|Overall Study|Cancellation|1|||
13436117|NCT00377156|26903196|FG001|Overall Study|Cancellation|0|||
13436118|NCT00377156|26903195|FG000|Overall Study|Refused testing|0|||
13436119|NCT00377156|26903196|FG001|Overall Study|Refused testing|1|||
13436120|NCT00377156|26903195|FG000|Overall Study|Ineligible|0|||
13436121|NCT00377156|26903196|FG001|Overall Study|Ineligible|1|||
13436122|NCT00377156|26903195|FG000|Overall Study|Disability or language problem|0|||
13436123|NCT00377156|26903196|FG001|Overall Study|Disability or language problem|1|||
13436124|NCT00377156|26903195|FG000|Overall Study|Other|5|||
13436125|NCT00377156|26903196|FG001|Overall Study|Other|2|||
13436126|NCT00376961|26903208|FG000|Initial Registration|Adverse Event|1|||
13436127|NCT00376961|26903209|FG001|Initial Registration|Adverse Event|0|||
13436128|NCT00376961|26903208|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2|||
13436129|NCT00376961|26903209|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
13436130|NCT00376961|26903208|FG000|Initial Registration|Progression/relapse|1|||
13436131|NCT00376961|26903209|FG001|Initial Registration|Progression/relapse|0|||
13436132|NCT00376961|26903208|FG000|Initial Registration|Ineligible|3|||
13436133|NCT00376961|26903209|FG001|Initial Registration|Ineligible|0|||
13436134|NCT00376961|26903208|FG000|Maintenance|Adverse Event|0|||
13436135|NCT00376961|26903209|FG001|Maintenance|Adverse Event|1|||
13436136|NCT00376961|26903208|FG000|Maintenance|Refusal Unrelated to Adverse Event|0|||
13436137|NCT00376961|26903209|FG001|Maintenance|Refusal Unrelated to Adverse Event|1|||
13436138|NCT00376961|26903208|FG000|Maintenance|Progression/relapse|0|||
13436139|NCT00376961|26903209|FG001|Maintenance|Progression/relapse|18|||
13436140|NCT00376961|26903208|FG000|Maintenance|Ineligible|0|||
13436141|NCT00376961|26903209|FG001|Maintenance|Ineligible|3|||
13436142|NCT00376688|26903215|FG000|Overall Study|Adverse Event|3|||
13436143|NCT00376688|26903215|FG000|Overall Study|Death|1|||
13436144|NCT00376675|26903244|FG000|Overall Study|Withdrawal by Subject|9|||
13436145|NCT00376675|26903245|FG001|Overall Study|Withdrawal by Subject|2|||
13436146|NCT00376675|26903244|FG000|Overall Study|Adverse Event|10|||
13436147|NCT00376675|26903245|FG001|Overall Study|Adverse Event|5|||
13436148|NCT00376675|26903244|FG000|Overall Study|Other Reason|1|||
13436149|NCT00376675|26903245|FG001|Overall Study|Other Reason|7|||
13436150|NCT00376623|26903320|FG000|Overall Study|Progressive disease|35|||
13436151|NCT00376623|26903321|FG001|Overall Study|Progressive disease|22|||
13436152|NCT00376623|26903322|FG002|Overall Study|Progressive disease|17|||
13436153|NCT00376623|26903320|FG000|Overall Study|Lost to Follow-up|0|||
13436154|NCT00376623|26903321|FG001|Overall Study|Lost to Follow-up|1|||
13436155|NCT00376623|26903322|FG002|Overall Study|Lost to Follow-up|0|||
13436156|NCT00376623|26903320|FG000|Overall Study|Adverse Event other than Dose Limiting Toxicity|6|||
13436157|NCT00376623|26903321|FG001|Overall Study|Adverse Event other than Dose Limiting Toxicity|1|||
13436158|NCT00376623|26903322|FG002|Overall Study|Adverse Event other than Dose Limiting Toxicity|2|||
13436159|NCT00376623|26903320|FG000|Overall Study|Not treated with BI 2536|1|||
13436160|NCT00376623|26903321|FG001|Overall Study|Not treated with BI 2536|0|||
13436161|NCT00376623|26903322|FG002|Overall Study|Not treated with BI 2536|0|||
13436162|NCT00376623|26903320|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
13436163|NCT00376623|26903321|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
13436164|NCT00376623|26903322|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
13436165|NCT00376623|26903320|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|1|||
13436166|NCT00376623|26903321|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
13436167|NCT00376623|26903322|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
13436168|NCT00376623|26903320|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|2|||
13436169|NCT00376623|26903321|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
13436170|NCT00376623|26903322|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
13436171|NCT00376623|26903320|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
13436172|NCT00376623|26903321|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536|1|||
13436173|NCT00376623|26903322|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
13436174|NCT00376623|26903320|FG000|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
13436175|NCT00376623|26903321|FG001|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
13436176|NCT00376623|26903322|FG002|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
13436177|NCT00376623|26903320|FG000|Overall Study|Participant's decision to stop treatment with BI 2536|2|||
13436178|NCT00376623|26903321|FG001|Overall Study|Participant's decision to stop treatment with BI 2536|0|||
13436179|NCT00376623|26903322|FG002|Overall Study|Participant's decision to stop treatment with BI 2536|1|||
13436180|NCT00376623|26903320|FG000|Overall Study|Increase of tumour markers|0|||
13436181|NCT00376623|26903321|FG001|Overall Study|Increase of tumour markers|1|||
13436182|NCT00376623|26903322|FG002|Overall Study|Increase of tumour markers|0|||
13436183|NCT00376623|26903320|FG000|Overall Study|Bone metastasis|1|||
13436184|NCT00376623|26903321|FG001|Overall Study|Bone metastasis|0|||
13436185|NCT00376623|26903322|FG002|Overall Study|Bone metastasis|0|||
13436186|NCT00376532|26903337|FG000|Overall Study|Lack sufficient blood sample|6|||
13436187|NCT00376532|26903338|FG001|Overall Study|Lack sufficient blood sample|6|||
13436188|NCT00376506|26903361|FG000|Overall Study|Death|0|||
13436189|NCT00376506|26903362|FG001|Overall Study|Death|2|||
13436190|NCT00376259|26903381|FG000|Overall Study|Sponsor request - study termination|21|||
13436191|NCT00376259|26903382|FG001|Overall Study|Sponsor request - study termination|21|||
13436192|NCT00376259|26903381|FG000|Overall Study|Patient request|1|||
13436193|NCT00376259|26903382|FG001|Overall Study|Patient request|0|||
13436194|NCT00376246|26903393|FG000|First Intervention (2 Weeks)|Adverse Event|2|||
13436195|NCT00376246|26903394|FG001|First Intervention (2 Weeks)|Adverse Event|0|||
13436196|NCT00376246|26903393|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
13436197|NCT00376246|26903394|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
13436198|NCT00376246|26903393|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1|||
13436199|NCT00376246|26903394|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
13436200|NCT00376220|26903407|FG000|Overall Study|Lost to Follow-up|7|||
13436201|NCT00376220|26903408|FG001|Overall Study|Lost to Follow-up|10|||
13436202|NCT00376220|26903407|FG000|Overall Study|Withdrawal by Subject|3|||
13436203|NCT00376220|26903408|FG001|Overall Study|Withdrawal by Subject|2|||
13436204|NCT00376168|26903429|FG000|Overall Study|Adverse Event|1|||
13436205|NCT00376168|26903430|FG001|Overall Study|Adverse Event|1|||
13436206|NCT00376168|26903429|FG000|Overall Study|Pregnancy|1|||
13436207|NCT00376168|26903430|FG001|Overall Study|Pregnancy|0|||
13436208|NCT00375934|26903463|FG000|Overall Study|Adverse Event|1|||
13436209|NCT00375934|26903464|FG001|Overall Study|Adverse Event|1|||
13436210|NCT00375934|26903463|FG000|Overall Study|Withdrawal by Subject|2|||
13436211|NCT00375934|26903464|FG001|Overall Study|Withdrawal by Subject|2|||
13436212|NCT00375934|26903463|FG000|Overall Study|Lack of Efficacy|0|||
13436213|NCT00375934|26903464|FG001|Overall Study|Lack of Efficacy|2|||
13436214|NCT00375934|26903463|FG000|Overall Study|Physician Decision|0|||
13436215|NCT00375934|26903464|FG001|Overall Study|Physician Decision|1|||
13436216|NCT00375752|26903485|FG000|Overall Study|Lack of Efficacy|4|||
13436217|NCT00375752|26903486|FG001|Overall Study|Lack of Efficacy|4|||
13436218|NCT00375752|26903485|FG000|Overall Study|Adverse Event|1|||
13436219|NCT00375752|26903486|FG001|Overall Study|Adverse Event|6|||
13436220|NCT00375752|26903485|FG000|Overall Study|Withdrawal by Subject|6|||
13436221|NCT00375752|26903486|FG001|Overall Study|Withdrawal by Subject|1|||
13436222|NCT00375752|26903485|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
13436223|NCT00375752|26903486|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
13436224|NCT00375752|26903485|FG000|Overall Study|Protocol Violation|0|||
13436225|NCT00375752|26903486|FG001|Overall Study|Protocol Violation|2|||
13436226|NCT00375752|26903485|FG000|Overall Study|Administrative Problems|0|||
13436227|NCT00375752|26903486|FG001|Overall Study|Administrative Problems|1|||
13436228|NCT00375674|26903519|FG000|Overall Study|Other|26|||
13436229|NCT00375674|26903520|FG001|Overall Study|Other|18|||
13436230|NCT00375674|26903519|FG000|Overall Study|Death|67|||
13436231|NCT00375674|26903520|FG001|Overall Study|Death|76|||
13436232|NCT00375674|26903519|FG000|Overall Study|Participants refused further follow-up|31|||
13436233|NCT00375674|26903520|FG001|Overall Study|Participants refused further follow-up|30|||
13436234|NCT00375674|26903519|FG000|Overall Study|Lost to Follow-up|17|||
13436235|NCT00375674|26903520|FG001|Overall Study|Lost to Follow-up|15|||
13436236|NCT00375674|26903519|FG000|Overall Study|Enrolled but not treated|3|||
13436237|NCT00375674|26903520|FG001|Overall Study|Enrolled but not treated|2|||
13436238|NCT00375609|26903544|FG000|Overall Study|Did not receive treatment|1|||
13436239|NCT00375609|26903545|FG001|Overall Study|Did not receive treatment|0|||
13436240|NCT00375609|26903546|FG002|Overall Study|Did not receive treatment|0|||
13436241|NCT00375609|26903544|FG000|Overall Study|Adverse Event|0|||
13436242|NCT00375609|26903545|FG001|Overall Study|Adverse Event|3|||
13436243|NCT00375609|26903546|FG002|Overall Study|Adverse Event|0|||
13436244|NCT00375609|26903544|FG000|Overall Study|Lost to Follow-up|1|||
13436245|NCT00375609|26903545|FG001|Overall Study|Lost to Follow-up|0|||
13436246|NCT00375609|26903546|FG002|Overall Study|Lost to Follow-up|0|||
13436247|NCT00375609|26903544|FG000|Overall Study|Physician Decision|0|||
13436248|NCT00375609|26903545|FG001|Overall Study|Physician Decision|0|||
13436249|NCT00375609|26903546|FG002|Overall Study|Physician Decision|1|||
13436250|NCT00375609|26903544|FG000|Overall Study|Withdrawal by Subject|1|||
13436251|NCT00375609|26903545|FG001|Overall Study|Withdrawal by Subject|4|||
13436252|NCT00375609|26903546|FG002|Overall Study|Withdrawal by Subject|0|||
13436253|NCT00375609|26903544|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1|||
13436254|NCT00375609|26903545|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
13436255|NCT00375609|26903546|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
13436256|NCT00375518|26903559|FG000|Overall Study|Withdrawal by Subject|2|||
13436257|NCT00375518|26903560|FG001|Overall Study|Withdrawal by Subject|10|||
13436258|NCT00375518|26903559|FG000|Overall Study|Patient Not Treated|6|||
13436259|NCT00375518|26903560|FG001|Overall Study|Patient Not Treated|6|||
13436260|NCT00375518|26903559|FG000|Overall Study|Death|0|||
13436261|NCT00375518|26903560|FG001|Overall Study|Death|1|||
13436262|NCT00375505|26903609|FG000|Overall Study|Adverse Event|1|||
13436263|NCT00375505|26903610|FG001|Overall Study|Adverse Event|2|||
13436264|NCT00375492|26903645|FG000|Overall Study|Adverse Event|4|||
13436265|NCT00375492|26903646|FG001|Overall Study|Adverse Event|5|||
13436266|NCT00375492|26903645|FG000|Overall Study|Entry Criteria Not Met|0|||
13436267|NCT00375492|26903646|FG001|Overall Study|Entry Criteria Not Met|1|||
13436268|NCT00375492|26903645|FG000|Overall Study|Loss of Glucose Control|0|||
13436269|NCT00375492|26903646|FG001|Overall Study|Loss of Glucose Control|1|||
13436270|NCT00375492|26903645|FG000|Overall Study|Lost to Follow-up|10|||
13436271|NCT00375492|26903646|FG001|Overall Study|Lost to Follow-up|5|||
13436272|NCT00375492|26903645|FG000|Overall Study|Physician Decision|0|||
13436273|NCT00375492|26903646|FG001|Overall Study|Physician Decision|4|||
13436274|NCT00375492|26903645|FG000|Overall Study|Protocol Violation|6|||
13436275|NCT00375492|26903646|FG001|Overall Study|Protocol Violation|3|||
13436276|NCT00375492|26903645|FG000|Overall Study|Sponsor Decision|0|||
13436277|NCT00375492|26903646|FG001|Overall Study|Sponsor Decision|1|||
13436278|NCT00375492|26903645|FG000|Overall Study|Withdrawal by Subject|6|||
13436279|NCT00375492|26903646|FG001|Overall Study|Withdrawal by Subject|6|||
13436280|NCT00375427|26903675|FG000|Overall Study|Adverse Event|21|||
13436281|NCT00375427|26903676|FG001|Overall Study|Adverse Event|27|||
13436282|NCT00375427|26903675|FG000|Overall Study|Abnormal test procedure result(s)|0|||
13436283|NCT00375427|26903676|FG001|Overall Study|Abnormal test procedure result(s)|1|||
13436284|NCT00375427|26903675|FG000|Overall Study|Abnormal laboratory value(s)|1|||
13436285|NCT00375427|26903676|FG001|Overall Study|Abnormal laboratory value(s)|2|||
13436286|NCT00375427|26903675|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
13436287|NCT00375427|26903676|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
13436288|NCT00375427|26903675|FG000|Overall Study|Patient no longer requires study drug|3|||
13436289|NCT00375427|26903676|FG001|Overall Study|Patient no longer requires study drug|7|||
13436290|NCT00375427|26903675|FG000|Overall Study|Protocol Violation|10|||
13436291|NCT00375427|26903676|FG001|Overall Study|Protocol Violation|8|||
13436292|NCT00375427|26903675|FG000|Overall Study|Withdrawal by Subject|9|||
13436293|NCT00375427|26903676|FG001|Overall Study|Withdrawal by Subject|13|||
13436294|NCT00375427|26903675|FG000|Overall Study|Lost to Follow-up|1|||
13436295|NCT00375427|26903676|FG001|Overall Study|Lost to Follow-up|1|||
13436296|NCT00375427|26903675|FG000|Overall Study|Administrative reasons|0|||
13436297|NCT00375427|26903676|FG001|Overall Study|Administrative reasons|1|||
13436298|NCT00375427|26903675|FG000|Overall Study|Death|11|||
13436299|NCT00375427|26903676|FG001|Overall Study|Death|10|||
13436300|NCT00375219|26903752|FG000|Overall Study|Failure to achieve a response|16|||
13436301|NCT00375219|26903753|FG001|Overall Study|Failure to achieve a response|2|||
13436302|NCT00375219|26903754|FG002|Overall Study|Failure to achieve a response|0|||
13436303|NCT00375219|26903752|FG000|Overall Study|Adverse Event|8|||
13436304|NCT00375219|26903753|FG001|Overall Study|Adverse Event|2|||
13436305|NCT00375219|26903754|FG002|Overall Study|Adverse Event|1|||
13436306|NCT00375219|26903752|FG000|Overall Study|Protocol Violation|1|||
13436307|NCT00375219|26903753|FG001|Overall Study|Protocol Violation|0|||
13436308|NCT00375219|26903754|FG002|Overall Study|Protocol Violation|1|||
13436309|NCT00375219|26903752|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5|||
13436310|NCT00375219|26903753|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3|||
13436311|NCT00375219|26903754|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0|||
13436312|NCT00375219|26903752|FG000|Overall Study|Lost to Follow-up|1|||
13436313|NCT00375219|26903753|FG001|Overall Study|Lost to Follow-up|1|||
13436314|NCT00375219|26903754|FG002|Overall Study|Lost to Follow-up|0|||
13436315|NCT00375219|26903752|FG000|Overall Study|Disease progression|18|||
13436316|NCT00375219|26903753|FG001|Overall Study|Disease progression|9|||
13436317|NCT00375219|26903754|FG002|Overall Study|Disease progression|12|||
13436318|NCT00375219|26903752|FG000|Overall Study|Death|4|||
13436319|NCT00375219|26903753|FG001|Overall Study|Death|3|||
13436320|NCT00375219|26903754|FG002|Overall Study|Death|7|||
13436321|NCT00375219|26903752|FG000|Overall Study|Hematologic resistance|1|||
13436322|NCT00375219|26903753|FG001|Overall Study|Hematologic resistance|0|||
13436323|NCT00375219|26903754|FG002|Overall Study|Hematologic resistance|0|||
13436324|NCT00375219|26903752|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1|||
13436325|NCT00375219|26903753|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
13436326|NCT00375219|26903754|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
13436327|NCT00375219|26903752|FG000|Overall Study|Allograft|2|||
13436328|NCT00375219|26903753|FG001|Overall Study|Allograft|0|||
13436329|NCT00375219|26903754|FG002|Overall Study|Allograft|0|||
13436330|NCT00375219|26903752|FG000|Overall Study|Cord blood transplantation|1|||
13436331|NCT00375219|26903753|FG001|Overall Study|Cord blood transplantation|0|||
13436332|NCT00375219|26903754|FG002|Overall Study|Cord blood transplantation|0|||
13436333|NCT00375219|26903752|FG000|Overall Study|Withdrawal by Subject|1|||
13436334|NCT00375219|26903753|FG001|Overall Study|Withdrawal by Subject|0|||
13436335|NCT00375219|26903754|FG002|Overall Study|Withdrawal by Subject|0|||
13436336|NCT00374907|26903773|FG000|12-Week Short-term Period|Subject Withdrew Consent|3|||
13436337|NCT00374907|26903774|FG001|12-Week Short-term Period|Subject Withdrew Consent|1|||
13436338|NCT00374907|26903773|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8|||
13436339|NCT00374907|26903774|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9|||
13436340|NCT00374907|26903773|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4|||
13436341|NCT00374907|26903774|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2|||
13436342|NCT00374907|26903773|FG000|116-Week Short-term + Long-term Period|Adverse Event|0|||
13436343|NCT00374907|26903774|FG001|116-Week Short-term + Long-term Period|Adverse Event|2|||
13436344|NCT00374907|26903773|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
13436345|NCT00374907|26903774|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
13436346|NCT00374868|26903787|FG000|Overall Study|Adverse Event|12|||
13436347|NCT00374868|26903787|FG000|Overall Study|Progressive Disease|7|||
13436348|NCT00374868|26903787|FG000|Overall Study|Physician Decision|13|||
13436349|NCT00374868|26903787|FG000|Overall Study|Lost to Follow-up|1|||
13436350|NCT00374868|26903787|FG000|Overall Study|Death|2|||
13436351|NCT00374868|26903787|FG000|Overall Study|Other - Not Specified|1|||
13436352|NCT00374556|26903844|FG000|Overall Study|Lost to Follow-up|1|||
13436353|NCT00374556|26903845|FG001|Overall Study|Lost to Follow-up|0|||
13436354|NCT00374556|26903844|FG000|Overall Study|Removed at baseline due to medical cond|0|||
13436355|NCT00374556|26903845|FG001|Overall Study|Removed at baseline due to medical cond|1|||
13436356|NCT00374452|26903858|FG000|Overall Study|Left clinic before intervention started|4|||
13436357|NCT00374452|26903859|FG001|Overall Study|Left clinic before intervention started|1|||
13436358|NCT00374452|26903858|FG000|Overall Study|Change in job role before intervention|0|||
13436359|NCT00374452|26903859|FG001|Overall Study|Change in job role before intervention|1|||
13436360|NCT00374452|26903858|FG000|Overall Study|Left clinic after intervention started|1|||
13436361|NCT00374452|26903859|FG001|Overall Study|Left clinic after intervention started|1|||
13436362|NCT00374452|26903858|FG000|Overall Study|Withdrawal by Subject|0|||
13436363|NCT00374452|26903859|FG001|Overall Study|Withdrawal by Subject|2|||
13436364|NCT00374322|26903902|FG000|Overall Study|Lost to Follow-up|92|||
13436365|NCT00374322|26903903|FG001|Overall Study|Lost to Follow-up|90|||
13436366|NCT00374322|26903902|FG000|Overall Study|Protocol Violation|8|||
13436367|NCT00374322|26903903|FG001|Overall Study|Protocol Violation|3|||
13436368|NCT00374322|26903902|FG000|Overall Study|Withdrawal by Subject|235|||
13436369|NCT00374322|26903903|FG001|Overall Study|Withdrawal by Subject|167|||
13436370|NCT00374322|26903902|FG000|Overall Study|Sponsor Terminated Study|866|||
13436371|NCT00374322|26903903|FG001|Overall Study|Sponsor Terminated Study|990|||
13436372|NCT00374322|26903902|FG000|Overall Study|Physician Decision|36|||
13436373|NCT00374322|26903903|FG001|Overall Study|Physician Decision|32|||
13436374|NCT00374322|26903902|FG000|Overall Study|Par. Consented to Survival FU Only|3|||
13436375|NCT00374322|26903903|FG001|Overall Study|Par. Consented to Survival FU Only|1|||
13436376|NCT00374322|26903902|FG000|Overall Study|Sponsor Decision|2|||
13436377|NCT00374322|26903903|FG001|Overall Study|Sponsor Decision|3|||
13436378|NCT00374322|26903902|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2|||
13436379|NCT00374322|26903903|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3|||
13436380|NCT00374322|26903902|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1|||
13436381|NCT00374322|26903903|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0|||
13436382|NCT00374322|26903902|FG000|Overall Study|Severe Toxicity|1|||
13436383|NCT00374322|26903903|FG001|Overall Study|Severe Toxicity|0|||
13436384|NCT00374322|26903902|FG000|Overall Study|Site Closed|2|||
13436385|NCT00374322|26903903|FG001|Overall Study|Site Closed|2|||
13436386|NCT00374322|26903902|FG000|Overall Study|Participant Changed Physician|1|||
13436387|NCT00374322|26903903|FG001|Overall Study|Participant Changed Physician|0|||
13436388|NCT00374322|26903902|FG000|Overall Study|Started Another Chemotherapy Regimen|0|||
13436389|NCT00374322|26903903|FG001|Overall Study|Started Another Chemotherapy Regimen|1|||
13436390|NCT00374322|26903902|FG000|Overall Study|Noncompliance with Study Requirements|0|||
13436391|NCT00374322|26903903|FG001|Overall Study|Noncompliance with Study Requirements|1|||
13436392|NCT00374322|26903902|FG000|Overall Study|Withdrew Consent During Follow-up|0|||
13436393|NCT00374322|26903903|FG001|Overall Study|Withdrew Consent During Follow-up|5|||
13436394|NCT00374322|26903902|FG000|Overall Study|Did Not Receive Study Medication|8|||
13436395|NCT00374322|26903903|FG001|Overall Study|Did Not Receive Study Medication|6|||
13436396|NCT00374140|26903912|FG000|Overall Study|Lost to Follow-up|1|||
13436397|NCT00374140|26903912|FG000|Overall Study|Protocol Violation|1|||
13436398|NCT00374127|26903948|FG000|Overall Study|Did not inhale during smoking procedure.|3|||
13436399|NCT00374127|26903948|FG000|Overall Study|Blood could not be drawn.|2|||
13436400|NCT00374127|26903948|FG000|Overall Study|Protocol Violation|5|||
13436401|NCT00374127|26903948|FG000|Overall Study|Pregnancy|1|||
13436402|NCT00373958|26904003|FG000|Infant Series|Withdrawal by Subject|13|||
13436403|NCT00373958|26904004|FG001|Infant Series|Withdrawal by Subject|15|||
13436404|NCT00373958|26904003|FG000|Infant Series|Failed to return|8|||
13436405|NCT00373958|26904004|FG001|Infant Series|Failed to return|13|||
13436406|NCT00373958|26904003|FG000|Infant Series|Lost to Follow-up|6|||
13436407|NCT00373958|26904004|FG001|Infant Series|Lost to Follow-up|5|||
13436408|NCT00373958|26904003|FG000|Infant Series|Protocol Violation|3|||
13436409|NCT00373958|26904004|FG001|Infant Series|Protocol Violation|7|||
13436410|NCT00373958|26904003|FG000|Infant Series|Lost Kaiser coverage|4|||
13436411|NCT00373958|26904004|FG001|Infant Series|Lost Kaiser coverage|0|||
13436412|NCT00373958|26904003|FG000|Infant Series|Child relocated|1|||
13436413|NCT00373958|26904004|FG001|Infant Series|Child relocated|0|||
13436414|NCT00373958|26904003|FG000|Infant Series|Consent was not received|1|||
13436415|NCT00373958|26904004|FG001|Infant Series|Consent was not received|0|||
13436416|NCT00373958|26904003|FG000|Infant Series|Adverse Event|3|||
13436417|NCT00373958|26904004|FG001|Infant Series|Adverse Event|1|||
13436418|NCT00373958|26904003|FG000|Infant Series|Physician Decision|1|||
13436419|NCT00373958|26904004|FG001|Infant Series|Physician Decision|1|||
13436420|NCT00373958|26904003|FG000|Toddler Dose|Lost to Follow-up|5|||
13436421|NCT00373958|26904004|FG001|Toddler Dose|Lost to Follow-up|8|||
13436422|NCT00373958|26904003|FG000|Toddler Dose|Withdrawal by Subject|2|||
13436423|NCT00373958|26904004|FG001|Toddler Dose|Withdrawal by Subject|2|||
13436424|NCT00373958|26904003|FG000|Toddler Dose|Failed to return|1|||
13436425|NCT00373958|26904004|FG001|Toddler Dose|Failed to return|2|||
13436426|NCT00373958|26904003|FG000|Toddler Dose|Protocol Violation|0|||
13436427|NCT00373958|26904004|FG001|Toddler Dose|Protocol Violation|1|||
13436428|NCT00373958|26904003|FG000|Toddler Dose|Withdrawn after infant series|22|||
13436429|NCT00373958|26904004|FG001|Toddler Dose|Withdrawn after infant series|25|||
13436430|NCT00373880|26904034|FG000|Overall Study|Physician Decision|3|||
13436431|NCT00373880|26904034|FG000|Overall Study|Arrested|1|||
13436432|NCT00373880|26904034|FG000|Overall Study|Protocol Violation|14|||
13436433|NCT00373685|26904075|FG000|Overall Study|Death|2|||
13436434|NCT00373685|26904076|FG001|Overall Study|Death|1|||
13436435|NCT00373685|26904075|FG000|Overall Study|Adverse Event|278|||
13436436|NCT00373685|26904076|FG001|Overall Study|Adverse Event|253|||
13436437|NCT00373685|26904075|FG000|Overall Study|Insufficient clinical response|169|||
13436438|NCT00373685|26904076|FG001|Overall Study|Insufficient clinical response|119|||
13436439|NCT00373685|26904075|FG000|Overall Study|Did not meet entrance criteria|167|||
13436440|NCT00373685|26904076|FG001|Overall Study|Did not meet entrance criteria|184|||
13436441|NCT00373685|26904075|FG000|Overall Study|Lost to follow up|83|||
13436442|NCT00373685|26904076|FG001|Overall Study|Lost to follow up|103|||
13436443|NCT00373685|26904075|FG000|Overall Study|No longer willing to participate|337|||
13436444|NCT00373685|26904076|FG001|Overall Study|No longer willing to participate|352|||
13436445|NCT00373685|26904075|FG000|Overall Study|Other|149|||
13436446|NCT00373685|26904076|FG001|Overall Study|Other|146|||
13436447|NCT00373685|26904075|FG000|Overall Study|Protocol Violation|191|||
13436448|NCT00373685|26904076|FG001|Overall Study|Protocol Violation|182|||
13436449|NCT00373685|26904075|FG000|Overall Study|Final Status Unknown|12|||
13436450|NCT00373685|26904076|FG001|Overall Study|Final Status Unknown|4|||
13436451|NCT00373685|26904075|FG000|Overall Study|Randomized, not treated|51|||
13436452|NCT00373685|26904076|FG001|Overall Study|Randomized, not treated|77|||
13436453|NCT00373529|26904088|FG000|Overall Study|Physician Decision|19|||
13436454|NCT00373529|26904088|FG000|Overall Study|Withdrawal by Subject|7|||
13436455|NCT00373529|26904088|FG000|Overall Study|Adverse Event|7|||
13436456|NCT00373529|26904088|FG000|Overall Study|Treatment failure|36|||
13436457|NCT00373529|26904088|FG000|Overall Study|Disease recurrence|10|||
13436458|NCT00373529|26904088|FG000|Overall Study|Death|16|||
13436459|NCT00373529|26904088|FG000|Overall Study|Need for treatment prohibited by study|1|||
13436460|NCT00373529|26904088|FG000|Overall Study|Other|8|||
13436461|NCT00373529|26904088|FG000|Overall Study|Failed independent confirmation of AML|3|||
13436462|NCT00373529|26904088|FG000|Overall Study|Consent violation|1|||
13436463|NCT00373490|26904113|FG000|Overall Study|Adverse Event|0|||
13436464|NCT00373490|26904114|FG001|Overall Study|Adverse Event|1|||
13436465|NCT00373490|26904113|FG000|Overall Study|Lack of Efficacy|9|||
13436466|NCT00373490|26904114|FG001|Overall Study|Lack of Efficacy|4|||
13436467|NCT00373490|26904113|FG000|Overall Study|Withdrawal by Subject|0|||
13436468|NCT00373490|26904114|FG001|Overall Study|Withdrawal by Subject|1|||
13436469|NCT00373425|26904155|FG000|Overall Study|Relapse of NSCLC|116|||
13436470|NCT00373425|26904156|FG001|Overall Study|Relapse of NSCLC|104|||
13436471|NCT00373425|26904157|FG002|Overall Study|Relapse of NSCLC|19|||
13436472|NCT00373425|26904158|FG003|Overall Study|Relapse of NSCLC|2|||
13436473|NCT00373425|26904159|FG004|Overall Study|Relapse of NSCLC|26|||
13436474|NCT00373425|26904155|FG000|Overall Study|Adverse Event|191|||
13436475|NCT00373425|26904156|FG001|Overall Study|Adverse Event|22|||
13436476|NCT00373425|26904157|FG002|Overall Study|Adverse Event|59|||
13436477|NCT00373425|26904158|FG003|Overall Study|Adverse Event|0|||
13436478|NCT00373425|26904159|FG004|Overall Study|Adverse Event|34|||
13436479|NCT00373425|26904155|FG000|Overall Study|Patient request|35|||
13436480|NCT00373425|26904156|FG001|Overall Study|Patient request|18|||
13436481|NCT00373425|26904157|FG002|Overall Study|Patient request|43|||
13436482|NCT00373425|26904158|FG003|Overall Study|Patient request|6|||
13436483|NCT00373425|26904159|FG004|Overall Study|Patient request|7|||
13436484|NCT00373425|26904155|FG000|Overall Study|Medical/ethical/noncompliance reason|21|||
13436485|NCT00373425|26904156|FG001|Overall Study|Medical/ethical/noncompliance reason|9|||
13436486|NCT00373425|26904157|FG002|Overall Study|Medical/ethical/noncompliance reason|10|||
13436487|NCT00373425|26904158|FG003|Overall Study|Medical/ethical/noncompliance reason|2|||
13436488|NCT00373425|26904159|FG004|Overall Study|Medical/ethical/noncompliance reason|5|||
13436489|NCT00373425|26904155|FG000|Overall Study|Death|7|||
13436490|NCT00373425|26904156|FG001|Overall Study|Death|0|||
13436491|NCT00373425|26904157|FG002|Overall Study|Death|3|||
13436492|NCT00373425|26904158|FG003|Overall Study|Death|1|||
13436493|NCT00373425|26904159|FG004|Overall Study|Death|0|||
13436494|NCT00373295|26904174|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
13436495|NCT00373295|26904175|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
13436496|NCT00373295|26904176|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
13436497|NCT00373295|26904177|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
13436498|NCT00373295|26904178|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
13436499|NCT00373295|26904179|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
13436500|NCT00373256|26904210|FG000|Overall Study|Adverse Event (AE)|1|||
13436501|NCT00373256|26904211|FG001|Overall Study|Adverse Event (AE)|5|||
13436502|NCT00373256|26904210|FG000|Overall Study|Lost to Follow-up|2|||
13436503|NCT00373256|26904211|FG001|Overall Study|Lost to Follow-up|1|||
13436504|NCT00373256|26904210|FG000|Overall Study|Death|9|||
13436505|NCT00373256|26904211|FG001|Overall Study|Death|8|||
13436506|NCT00373256|26904210|FG000|Overall Study|Objective Progression or Relapse|111|||
13436507|NCT00373256|26904211|FG001|Overall Study|Objective Progression or Relapse|104|||
13436508|NCT00373256|26904210|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4|||
13436509|NCT00373256|26904211|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7|||
13436510|NCT00373256|26904210|FG000|Overall Study|Other|73|||
13436511|NCT00373256|26904211|FG001|Overall Study|Other|107|||
13436512|NCT00373256|26904210|FG000|Overall Study|Protocol Violation|0|||
13436513|NCT00373256|26904211|FG001|Overall Study|Protocol Violation|2|||
13436514|NCT00373256|26904210|FG000|Overall Study|Study Terminated by Sponsor|41|||
13436515|NCT00373256|26904211|FG001|Overall Study|Study Terminated by Sponsor|13|||
13436516|NCT00373113|26904238|FG000|Overall Study|Death|1|||
13436517|NCT00373113|26904239|FG001|Overall Study|Death|7|||
13436518|NCT00373113|26904238|FG000|Overall Study|Adverse Event|38|||
13436519|NCT00373113|26904239|FG001|Overall Study|Adverse Event|24|||
13436520|NCT00373113|26904238|FG000|Overall Study|Study terminated by sponsor|9|||
13436521|NCT00373113|26904239|FG001|Overall Study|Study terminated by sponsor|1|||
13436522|NCT00373113|26904238|FG000|Overall Study|Global deterioration of health status|10|||
13436523|NCT00373113|26904239|FG001|Overall Study|Global deterioration of health status|7|||
13436524|NCT00373113|26904238|FG000|Overall Study|Lost to Follow-up|1|||
13436525|NCT00373113|26904239|FG001|Overall Study|Lost to Follow-up|3|||
13436526|NCT00373113|26904238|FG000|Overall Study|Objective progression or relapse|150|||
13436527|NCT00373113|26904239|FG001|Overall Study|Objective progression or relapse|169|||
13436528|NCT00373113|26904238|FG000|Overall Study|Other|14|||
13436529|NCT00373113|26904239|FG001|Overall Study|Other|17|||
13436530|NCT00373113|26904238|FG000|Overall Study|Protocol Violation|5|||
13436531|NCT00373113|26904239|FG001|Overall Study|Protocol Violation|1|||
13436532|NCT00373113|26904238|FG000|Overall Study|Withdrawal by Subject|10|||
13436533|NCT00373113|26904239|FG001|Overall Study|Withdrawal by Subject|15|||
13436534|NCT00372996|26904272|FG000|Overall Study|Death|11|||
13436535|NCT00372996|26904273|FG001|Overall Study|Death|4|||
13436536|NCT00372996|26904274|FG002|Overall Study|Death|8|||
13436537|NCT00372996|26904275|FG003|Overall Study|Death|7|||
13436538|NCT00372996|26904272|FG000|Overall Study|Lost to Follow-up|0|||
13436539|NCT00372996|26904273|FG001|Overall Study|Lost to Follow-up|2|||
13436540|NCT00372996|26904274|FG002|Overall Study|Lost to Follow-up|0|||
13436541|NCT00372996|26904275|FG003|Overall Study|Lost to Follow-up|1|||
13436542|NCT00372996|26904272|FG000|Overall Study|Withdrawal by Subject|12|||
13436543|NCT00372996|26904273|FG001|Overall Study|Withdrawal by Subject|6|||
13436544|NCT00372996|26904274|FG002|Overall Study|Withdrawal by Subject|9|||
13436545|NCT00372996|26904275|FG003|Overall Study|Withdrawal by Subject|5|||
13436546|NCT00372996|26904272|FG000|Overall Study|Study Terminated by Sponsor|4|||
13436547|NCT00372996|26904273|FG001|Overall Study|Study Terminated by Sponsor|0|||
13436548|NCT00372996|26904274|FG002|Overall Study|Study Terminated by Sponsor|4|||
13436549|NCT00372996|26904275|FG003|Overall Study|Study Terminated by Sponsor|0|||
13436550|NCT00372996|26904272|FG000|Overall Study|Other|10|||
13436551|NCT00372996|26904273|FG001|Overall Study|Other|2|||
13436552|NCT00372996|26904274|FG002|Overall Study|Other|7|||
13436553|NCT00372996|26904275|FG003|Overall Study|Other|7|||
13436554|NCT00372905|26904292|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2|||
13436555|NCT00372905|26904293|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
13436556|NCT00372905|26904294|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
13436557|NCT00372905|26904295|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
13436558|NCT00372905|26904292|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
13436559|NCT00372905|26904293|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
13436560|NCT00372905|26904294|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2|||
13436561|NCT00372905|26904295|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
13436562|NCT00372905|26904292|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
13436563|NCT00372905|26904293|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
13436564|NCT00372905|26904294|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1|||
13436565|NCT00372905|26904295|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
13436566|NCT00372905|26904292|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
13436567|NCT00372905|26904293|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
13436568|NCT00372905|26904294|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
13436569|NCT00372905|26904295|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2|||
13436570|NCT00372905|26904292|FG000|Follow up Until Relapse or Progression|Study closed|0|||
13436571|NCT00372905|26904293|FG001|Follow up Until Relapse or Progression|Study closed|0|||
13436572|NCT00372905|26904294|FG002|Follow up Until Relapse or Progression|Study closed|0|||
13436573|NCT00372905|26904295|FG003|Follow up Until Relapse or Progression|Study closed|3|||
13436574|NCT00372905|26904292|FG000|Follow up Until Relapse or Progression|Other|0|||
13436575|NCT00372905|26904293|FG001|Follow up Until Relapse or Progression|Other|1|||
13436576|NCT00372905|26904294|FG002|Follow up Until Relapse or Progression|Other|0|||
13436577|NCT00372905|26904295|FG003|Follow up Until Relapse or Progression|Other|0|||
13436578|NCT00372775|26904317|FG000|Overall Study|Adverse Event|8|||
13436579|NCT00372775|26904317|FG000|Overall Study|Death|15|||
13436580|NCT00372775|26904317|FG000|Overall Study|Objective progression or relapse|30|||
13436581|NCT00372775|26904317|FG000|Overall Study|Global deterioration of health status|6|||
13436582|NCT00372775|26904317|FG000|Overall Study|Withdrawal by Subject|1|||
13436583|NCT00372775|26904317|FG000|Overall Study|Other|1|||
13436584|NCT00372775|26904317|FG000|Overall Study|Not Treated|2|||
13436585|NCT00372697|26904342|FG000|Overall Study|Protocol Violation|1|||
13436586|NCT00372697|26904343|FG001|Overall Study|Protocol Violation|1|||
13436587|NCT00372619|26904395|FG000|Overall Study|Ineligible|0|||
13436588|NCT00372619|26904396|FG001|Overall Study|Ineligible|0|||
13436589|NCT00372619|26904397|FG002|Overall Study|Ineligible|0|||
13436590|NCT00372619|26904398|FG003|Overall Study|Ineligible|0|||
13436591|NCT00372619|26904399|FG004|Overall Study|Ineligible|0|||
13436592|NCT00372619|26904400|FG005|Overall Study|Ineligible|2|||
13436593|NCT00372619|26904401|FG006|Overall Study|Ineligible|0|||
13436594|NCT00372619|26904395|FG000|Overall Study|Inevaluable|0|||
13436595|NCT00372619|26904396|FG001|Overall Study|Inevaluable|0|||
13436596|NCT00372619|26904397|FG002|Overall Study|Inevaluable|0|||
13436597|NCT00372619|26904398|FG003|Overall Study|Inevaluable|0|||
13436598|NCT00372619|26904399|FG004|Overall Study|Inevaluable|0|||
13436599|NCT00372619|26904400|FG005|Overall Study|Inevaluable|1|||
13436600|NCT00372619|26904401|FG006|Overall Study|Inevaluable|0|||
13436601|NCT00372593|26904437|FG000|Overall Study|Adverse Event|43|||
13436602|NCT00372593|26904438|FG001|Overall Study|Adverse Event|45|||
13436603|NCT00372593|26904439|FG002|Overall Study|Adverse Event|0|||
13436604|NCT00372593|26904437|FG000|Overall Study|Death|16|||
13436605|NCT00372593|26904438|FG001|Overall Study|Death|20|||
13436606|NCT00372593|26904439|FG002|Overall Study|Death|1|||
13436607|NCT00372593|26904437|FG000|Overall Study|Lack of Efficacy|82|||
13436608|NCT00372593|26904438|FG001|Overall Study|Lack of Efficacy|71|||
13436609|NCT00372593|26904439|FG002|Overall Study|Lack of Efficacy|2|||
13436610|NCT00372593|26904437|FG000|Overall Study|Lost to Follow-up|1|||
13436611|NCT00372593|26904438|FG001|Overall Study|Lost to Follow-up|0|||
13436612|NCT00372593|26904439|FG002|Overall Study|Lost to Follow-up|0|||
13436613|NCT00372593|26904437|FG000|Overall Study|Physician Decision|42|||
13436614|NCT00372593|26904438|FG001|Overall Study|Physician Decision|41|||
13436615|NCT00372593|26904439|FG002|Overall Study|Physician Decision|0|||
13436616|NCT00372593|26904437|FG000|Overall Study|Ineligible|20|||
13436617|NCT00372593|26904438|FG001|Overall Study|Ineligible|21|||
13436618|NCT00372593|26904439|FG002|Overall Study|Ineligible|1|||
13436619|NCT00372567|26904477|FG000|Phase 3 Study|Adverse Event|5|||
13436620|NCT00372567|26904478|FG001|Phase 3 Study|Adverse Event|1|||
13436621|NCT00372567|26904479|FG002|Phase 3 Study|Adverse Event|1|||
13436622|NCT00372567|26904477|FG000|Phase 3 Study|Death|1|||
13436623|NCT00372567|26904478|FG001|Phase 3 Study|Death|1|||
13436624|NCT00372567|26904479|FG002|Phase 3 Study|Death|0|||
13436625|NCT00372567|26904477|FG000|Phase 3 Study|Protocol Violation|0|||
13436626|NCT00372567|26904478|FG001|Phase 3 Study|Protocol Violation|0|||
13436627|NCT00372567|26904479|FG002|Phase 3 Study|Protocol Violation|1|||
13436628|NCT00372567|26904477|FG000|Phase 3 Study|Objective progression or relapse|10|||
13436629|NCT00372567|26904478|FG001|Phase 3 Study|Objective progression or relapse|13|||
13436630|NCT00372567|26904479|FG002|Phase 3 Study|Objective progression or relapse|4|||
13436631|NCT00372567|26904477|FG000|Phase 3 Study|Global deterioration of health status|0|||
13436632|NCT00372567|26904478|FG001|Phase 3 Study|Global deterioration of health status|1|||
13436633|NCT00372567|26904479|FG002|Phase 3 Study|Global deterioration of health status|0|||
13436634|NCT00372567|26904477|FG000|Phase 3 Study|Other|2|||
13436635|NCT00372567|26904478|FG001|Phase 3 Study|Other|2|||
13436636|NCT00372567|26904479|FG002|Phase 3 Study|Other|1|||
13436637|NCT00372567|26904477|FG000|Phase 3 Study|study terminated by sponsor|13|||
13436638|NCT00372567|26904478|FG001|Phase 3 Study|study terminated by sponsor|8|||
13436639|NCT00372567|26904479|FG002|Phase 3 Study|study terminated by sponsor|5|||
13436640|NCT00372528|26904486|FG000|Overall Study|Lack of Efficacy|1|||
13436641|NCT00372528|26904486|FG000|Overall Study|Adverse Event|1|||
13436642|NCT00372528|26904486|FG000|Overall Study|Study Terminated by Sponsor|18|||
13436643|NCT00372528|26904486|FG000|Overall Study|Other|1|||
13436644|NCT00372489|26904492|FG000|Overall Study|Adverse Event|18|||
13436645|NCT00372489|26904492|FG000|Overall Study|Lack of Efficacy|1|||
13436646|NCT00372489|26904492|FG000|Overall Study|Lost to Follow-up|3|||
13436647|NCT00372489|26904492|FG000|Overall Study|Physician Decision|3|||
13436648|NCT00372489|26904492|FG000|Overall Study|Withdrawal by Subject|5|||
13436649|NCT00372489|26904492|FG000|Overall Study|Patient Relocation|2|||
13436650|NCT00372489|26904492|FG000|Overall Study|Renal transplant|6|||
13436651|NCT00372489|26904492|FG000|Overall Study|Sponsor Decision to Terminate Study|41|||
13436652|NCT00372424|26904505|FG000|Overall Study|Adverse Event|2|||
13436653|NCT00372424|26904505|FG000|Overall Study|Withdrawal by Subject|1|||
13436654|NCT00372424|26904505|FG000|Overall Study|Death|1|||
13436655|NCT00372424|26904505|FG000|Overall Study|Objective Progression or Relapse|14|||
13436656|NCT00372424|26904505|FG000|Overall Study|Other|7|||
13436657|NCT00372424|26904505|FG000|Overall Study|Enrolled, Not Treated|1|||
13436658|NCT00372411|26904535|FG000|Overall Study|Withdrawal by Subject|3|||
13436659|NCT00372411|26904536|FG001|Overall Study|Withdrawal by Subject|4|||
13436660|NCT00372411|26904537|FG002|Overall Study|Withdrawal by Subject|1|||
13436661|NCT00372411|26904535|FG000|Overall Study|Death|0|||
13436662|NCT00372411|26904536|FG001|Overall Study|Death|2|||
13436663|NCT00372411|26904537|FG002|Overall Study|Death|1|||
13436664|NCT00372411|26904535|FG000|Overall Study|Lost to Follow-up|1|||
13436665|NCT00372411|26904536|FG001|Overall Study|Lost to Follow-up|1|||
13436666|NCT00372411|26904537|FG002|Overall Study|Lost to Follow-up|1|||
13436667|NCT00372411|26904535|FG000|Overall Study|Adverse Event|1|||
13436668|NCT00372411|26904536|FG001|Overall Study|Adverse Event|1|||
13436669|NCT00372411|26904537|FG002|Overall Study|Adverse Event|0|||
13476982|NCT02210221|27004908|FG000|Overall Study|Withdrawal by Subject|43|||
13476983|NCT02124902|27004921|FG000|Overall Study|Adverse Event|7|||
13476984|NCT02124902|27004922|FG001|Overall Study|Adverse Event|2|||
13476985|NCT02124902|27004921|FG000|Overall Study|Went to alternative treatment|4|||
13476986|NCT02124902|27004922|FG001|Overall Study|Went to alternative treatment|0|||
13476987|NCT02124902|27004921|FG000|Overall Study|Withdrawal by Subject|2|||
13476988|NCT02124902|27004922|FG001|Overall Study|Withdrawal by Subject|1|||
13476989|NCT02124902|27004921|FG000|Overall Study|Physician Decision|2|||
13476990|NCT02124902|27004922|FG001|Overall Study|Physician Decision|0|||
13476991|NCT02124902|27004921|FG000|Overall Study|Not eligible|1|||
13476992|NCT02124902|27004922|FG001|Overall Study|Not eligible|0|||
13476993|NCT02124902|27004921|FG000|Overall Study|Did not receive carboplatin in cycle 6|1|||
13476994|NCT02124902|27004922|FG001|Overall Study|Did not receive carboplatin in cycle 6|3|||
13476995|NCT01940341|27004943|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
13476996|NCT01940341|27004944|FG001|Double-Blind Phase|Randomized but Never Treated|1|||
13476997|NCT01940341|27004943|FG000|Double-Blind Phase|Adverse Event|3|||
13476998|NCT01940341|27004944|FG001|Double-Blind Phase|Adverse Event|2|||
13476999|NCT01940341|27004943|FG000|Double-Blind Phase|Withdrew Consent|3|||
13477000|NCT01940341|27004944|FG001|Double-Blind Phase|Withdrew Consent|2|||
13477001|NCT01940341|27004943|FG000|Double-Blind Phase|Lost to Follow-up|4|||
13477002|NCT01940341|27004944|FG001|Double-Blind Phase|Lost to Follow-up|1|||
13477003|NCT01940341|27004943|FG000|Double-Blind Phase|Pregnancy|0|||
13477004|NCT01940341|27004944|FG001|Double-Blind Phase|Pregnancy|1|||
13477005|NCT01940341|27004943|FG000|Double-Blind Phase|Investigator's Discretion|1|||
13477006|NCT01940341|27004944|FG001|Double-Blind Phase|Investigator's Discretion|0|||
13477007|NCT01940341|27004943|FG000|Double-Blind Phase|Non-Compliance with Study Drug|0|||
13477008|NCT01940341|27004944|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
13477009|NCT01940341|27004943|FG000|Double-Blind Phase|Protocol Specified Criteria|1|||
13477010|NCT01940341|27004944|FG001|Double-Blind Phase|Protocol Specified Criteria|0|||
13477011|NCT01940341|27004943|FG000|Double-Blind Phase|Still on Double-Blind Treatment|269|||
13477012|NCT01940341|27004944|FG001|Double-Blind Phase|Still on Double-Blind Treatment|132|||
13477013|NCT01940341|27004943|FG000|Open-label Extension Phase|Still on Study|4|||
13477014|NCT01940341|27004944|FG001|Open-label Extension Phase|Still on Study|1|||
13477015|NCT01877837|27004951|FG000|Overall Study|Lost to Follow-up|1|||
13477016|NCT01877837|27004951|FG000|Overall Study|Ineligible|4|||
13436670|NCT00372385|26904577|FG000|Overall Study|Adverse Event|6|||
13436671|NCT00372385|26904578|FG001|Overall Study|Adverse Event|11|||
13436672|NCT00372385|26904579|FG002|Overall Study|Adverse Event|9|||
13436673|NCT00372385|26904580|FG003|Overall Study|Adverse Event|7|||
13436674|NCT00372385|26904577|FG000|Overall Study|Noncompliance|0|||
13436675|NCT00372385|26904578|FG001|Overall Study|Noncompliance|1|||
13436676|NCT00372385|26904579|FG002|Overall Study|Noncompliance|1|||
13436677|NCT00372385|26904580|FG003|Overall Study|Noncompliance|1|||
13436678|NCT00372385|26904577|FG000|Overall Study|Physician Decision|1|||
13436679|NCT00372385|26904578|FG001|Overall Study|Physician Decision|0|||
13436680|NCT00372385|26904579|FG002|Overall Study|Physician Decision|0|||
13436681|NCT00372385|26904580|FG003|Overall Study|Physician Decision|0|||
13436682|NCT00372385|26904577|FG000|Overall Study|Lost to Follow-up|2|||
13436683|NCT00372385|26904578|FG001|Overall Study|Lost to Follow-up|0|||
13436684|NCT00372385|26904579|FG002|Overall Study|Lost to Follow-up|0|||
13436685|NCT00372385|26904580|FG003|Overall Study|Lost to Follow-up|0|||
13436686|NCT00372385|26904577|FG000|Overall Study|Withdrawal by Subject|2|||
13436687|NCT00372385|26904578|FG001|Overall Study|Withdrawal by Subject|1|||
13436688|NCT00372385|26904579|FG002|Overall Study|Withdrawal by Subject|0|||
13436689|NCT00372385|26904580|FG003|Overall Study|Withdrawal by Subject|0|||
13436690|NCT00372385|26904577|FG000|Overall Study|Refusal of Treatment|3|||
13436691|NCT00372385|26904578|FG001|Overall Study|Refusal of Treatment|6|||
13436692|NCT00372385|26904579|FG002|Overall Study|Refusal of Treatment|0|||
13436693|NCT00372385|26904580|FG003|Overall Study|Refusal of Treatment|0|||
13436694|NCT00372385|26904577|FG000|Overall Study|No Response|1|||
13436695|NCT00372385|26904578|FG001|Overall Study|No Response|1|||
13436696|NCT00372385|26904579|FG002|Overall Study|No Response|0|||
13436697|NCT00372385|26904580|FG003|Overall Study|No Response|0|||
13436698|NCT00372385|26904577|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1|||
13436699|NCT00372385|26904578|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0|||
13436700|NCT00372385|26904579|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0|||
13436701|NCT00372385|26904580|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0|||
13436702|NCT00372385|26904577|FG000|Overall Study|Virologic Stopping Rule|17|||
13436703|NCT00372385|26904578|FG001|Overall Study|Virologic Stopping Rule|0|||
13436704|NCT00372385|26904579|FG002|Overall Study|Virologic Stopping Rule|0|||
13436705|NCT00372385|26904580|FG003|Overall Study|Virologic Stopping Rule|0|||
13436706|NCT00372255|26904607|FG000|Overall Study|Withdrawn for other reasons|2|||
13436707|NCT00372255|26904608|FG001|Overall Study|Withdrawn for other reasons|1|||
13436708|NCT00372229|26904703|FG000|Study Phase|Graft loss|0|||
13436709|NCT00372229|26904704|FG001|Study Phase|Graft loss|3|||
13436710|NCT00372229|26904703|FG000|Study Phase|Protocol Violation|3|||
13436711|NCT00372229|26904704|FG001|Study Phase|Protocol Violation|4|||
13436712|NCT00372229|26904703|FG000|Study Phase|Consent withdrawn|16|||
13436713|NCT00372229|26904704|FG001|Study Phase|Consent withdrawn|14|||
13436714|NCT00372229|26904703|FG000|Study Phase|Refused treatment/did not cooperate|3|||
13436715|NCT00372229|26904704|FG001|Study Phase|Refused treatment/did not cooperate|1|||
13436716|NCT00372229|26904703|FG000|Study Phase|Death|3|||
13436717|NCT00372229|26904704|FG001|Study Phase|Death|2|||
13436718|NCT00372229|26904703|FG000|Study Phase|Reason not specified|3|||
13436719|NCT00372229|26904704|FG001|Study Phase|Reason not specified|2|||
13436720|NCT00372229|26904703|FG000|Study Phase|Lost to Follow-up|3|||
13436721|NCT00372229|26904704|FG001|Study Phase|Lost to Follow-up|3|||
13436722|NCT00372229|26904703|FG000|Follow-Up Phase|Graft loss|8|||
13436723|NCT00372229|26904704|FG001|Follow-Up Phase|Graft loss|7|||
13436724|NCT00372229|26904703|FG000|Follow-Up Phase|Consent withdrawn|13|||
13436725|NCT00372229|26904704|FG001|Follow-Up Phase|Consent withdrawn|19|||
13436726|NCT00372229|26904703|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0|||
13436727|NCT00372229|26904704|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1|||
13436728|NCT00372229|26904703|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1|||
13436729|NCT00372229|26904704|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0|||
13436730|NCT00372229|26904703|FG000|Follow-Up Phase|Death|9|||
13436731|NCT00372229|26904704|FG001|Follow-Up Phase|Death|12|||
13436732|NCT00372229|26904703|FG000|Follow-Up Phase|Administrative|1|||
13436733|NCT00372229|26904704|FG001|Follow-Up Phase|Administrative|0|||
13436734|NCT00372229|26904703|FG000|Follow-Up Phase|Reason not specified|2|||
13436735|NCT00372229|26904704|FG001|Follow-Up Phase|Reason not specified|3|||
13436736|NCT00372229|26904703|FG000|Follow-Up Phase|Lost to Follow-up|12|||
13436737|NCT00372229|26904704|FG001|Follow-Up Phase|Lost to Follow-up|10|||
13436738|NCT00372190|26904723|FG000|Overall Study|Lost to Follow-up|3|||
13436739|NCT00372190|26904724|FG001|Overall Study|Lost to Follow-up|1|||
13436740|NCT00372112|26904866|FG000|Overall Study|Adverse Event|0|||
13436741|NCT00372112|26904867|FG001|Overall Study|Adverse Event|1|||
13436742|NCT00372112|26904868|FG002|Overall Study|Adverse Event|1|||
13436743|NCT00372112|26904869|FG003|Overall Study|Adverse Event|1|||
13436744|NCT00372112|26904866|FG000|Overall Study|Withdrawal by Subject|0|||
13436745|NCT00372112|26904867|FG001|Overall Study|Withdrawal by Subject|0|||
13436746|NCT00372112|26904868|FG002|Overall Study|Withdrawal by Subject|2|||
13436747|NCT00372112|26904869|FG003|Overall Study|Withdrawal by Subject|1|||
13436748|NCT00372112|26904866|FG000|Overall Study|Exacerbation|0|||
13436749|NCT00372112|26904867|FG001|Overall Study|Exacerbation|0|||
13436750|NCT00372112|26904868|FG002|Overall Study|Exacerbation|0|||
13436751|NCT00372112|26904869|FG003|Overall Study|Exacerbation|1|||
13436752|NCT00372112|26904866|FG000|Overall Study|PR >240 at Visit 3|0|||
13436753|NCT00372112|26904867|FG001|Overall Study|PR >240 at Visit 3|0|||
13436754|NCT00372112|26904868|FG002|Overall Study|PR >240 at Visit 3|0|||
13436755|NCT00372112|26904869|FG003|Overall Study|PR >240 at Visit 3|1|||
13436756|NCT00372112|26904866|FG000|Overall Study|Hepatitis B|1|||
13436757|NCT00372112|26904867|FG001|Overall Study|Hepatitis B|0|||
13436758|NCT00372112|26904868|FG002|Overall Study|Hepatitis B|0|||
13436759|NCT00372112|26904869|FG003|Overall Study|Hepatitis B|0|||
13436760|NCT00372112|26904866|FG000|Overall Study|Other-protocol violation|0|||
13436761|NCT00372112|26904867|FG001|Overall Study|Other-protocol violation|0|||
13436762|NCT00372112|26904868|FG002|Overall Study|Other-protocol violation|1|||
13436763|NCT00372112|26904869|FG003|Overall Study|Other-protocol violation|0|||
13436764|NCT00372060|26904889|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2|||
13436765|NCT00372060|26904890|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0|||
13436766|NCT00372060|26904889|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0|||
13436767|NCT00372060|26904890|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1|||
13436768|NCT00372060|26904889|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1|||
13436769|NCT00372060|26904890|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0|||
13436770|NCT00372060|26904889|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3|||
13436771|NCT00372060|26904890|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0|||
13436772|NCT00372060|26904889|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9|||
13436773|NCT00372060|26904890|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8|||
13436774|NCT00372060|26904889|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2|||
13436775|NCT00372060|26904890|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0|||
13436776|NCT00371865|26904911|FG000|Overall Study|Lack of Efficacy|0|||
13436777|NCT00371865|26904912|FG001|Overall Study|Lack of Efficacy|2|||
13436778|NCT00371865|26904911|FG000|Overall Study|Protocol Violation|3|||
13436779|NCT00371865|26904912|FG001|Overall Study|Protocol Violation|2|||
13436780|NCT00371865|26904911|FG000|Overall Study|Withdrawal by Subject|12|||
13436781|NCT00371865|26904912|FG001|Overall Study|Withdrawal by Subject|10|||
13436782|NCT00371839|26904928|FG000|Overall Study|Death|4|||
13436783|NCT00371839|26904929|FG001|Overall Study|Death|0|||
13436784|NCT00371839|26904930|FG002|Overall Study|Death|0|||
13436785|NCT00371839|26904928|FG000|Overall Study|Withdrawal by Subject|7|||
13436786|NCT00371839|26904929|FG001|Overall Study|Withdrawal by Subject|4|||
13436787|NCT00371839|26904930|FG002|Overall Study|Withdrawal by Subject|0|||
13436788|NCT00371839|26904928|FG000|Overall Study|Lost to Follow-up|6|||
13436789|NCT00371839|26904929|FG001|Overall Study|Lost to Follow-up|3|||
13436790|NCT00371839|26904930|FG002|Overall Study|Lost to Follow-up|2|||
13436791|NCT00371826|26905062|FG000|Core Phase (12 Months)|Adverse Event|15|||
13436792|NCT00371826|26905063|FG001|Core Phase (12 Months)|Adverse Event|4|||
13436793|NCT00371826|26905064|FG002|Core Phase (12 Months)|Adverse Event|9|||
13436794|NCT00371826|26905062|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
13436795|NCT00371826|26905063|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0|||
13436796|NCT00371826|26905064|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
13436797|NCT00371826|26905062|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6|||
13436798|NCT00371826|26905063|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3|||
13436799|NCT00371826|26905064|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2|||
13436800|NCT00371826|26905062|FG000|Core Phase (12 Months)|Protocol Violation|1|||
13436801|NCT00371826|26905063|FG001|Core Phase (12 Months)|Protocol Violation|0|||
13436802|NCT00371826|26905064|FG002|Core Phase (12 Months)|Protocol Violation|1|||
13436803|NCT00371826|26905062|FG000|Core Phase (12 Months)|Subject withdrew consent|0|||
13436804|NCT00371826|26905063|FG001|Core Phase (12 Months)|Subject withdrew consent|0|||
13436805|NCT00371826|26905064|FG002|Core Phase (12 Months)|Subject withdrew consent|3|||
13436806|NCT00371826|26905062|FG000|Core Phase (12 Months)|Administrative problems|1|||
13436807|NCT00371826|26905063|FG001|Core Phase (12 Months)|Administrative problems|0|||
13436808|NCT00371826|26905064|FG002|Core Phase (12 Months)|Administrative problems|8|||
13436809|NCT00371826|26905062|FG000|Core Phase (12 Months)|Graft Loss|0|||
13436810|NCT00371826|26905063|FG001|Core Phase (12 Months)|Graft Loss|1|||
13436811|NCT00371826|26905064|FG002|Core Phase (12 Months)|Graft Loss|0|||
13436812|NCT00371826|26905062|FG000|Extension Phase (24 Months)|Adverse Event|4|||
13436813|NCT00371826|26905063|FG001|Extension Phase (24 Months)|Adverse Event|5|||
13436814|NCT00371826|26905064|FG002|Extension Phase (24 Months)|Adverse Event|0|||
13436815|NCT00371826|26905062|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
13436816|NCT00371826|26905063|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1|||
13436817|NCT00371826|26905064|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
13436818|NCT00371826|26905062|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
13436819|NCT00371826|26905063|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2|||
13436820|NCT00371826|26905064|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
13436821|NCT00371826|26905062|FG000|Extension Phase (24 Months)|Subject withdrew consent|1|||
13436822|NCT00371826|26905063|FG001|Extension Phase (24 Months)|Subject withdrew consent|2|||
13436823|NCT00371826|26905064|FG002|Extension Phase (24 Months)|Subject withdrew consent|0|||
13436824|NCT00371826|26905062|FG000|Extension Phase (24 Months)|Administrative problems|0|||
13436825|NCT00371826|26905063|FG001|Extension Phase (24 Months)|Administrative problems|0|||
13436826|NCT00371826|26905064|FG002|Extension Phase (24 Months)|Administrative problems|2|||
13436827|NCT00371787|26905083|FG000|Overall Study|Withdrawal by Subject|3|||
13436828|NCT00371787|26905084|FG001|Overall Study|Withdrawal by Subject|1|||
13436829|NCT00371761|26905097|FG000|Overall Study|Adverse Event|1|||
13436830|NCT00371761|26905098|FG001|Overall Study|Adverse Event|1|||
13436831|NCT00371761|26905097|FG000|Overall Study|Withdrawal by Subject|1|||
13436832|NCT00371761|26905098|FG001|Overall Study|Withdrawal by Subject|3|||
13436833|NCT00371761|26905097|FG000|Overall Study|Investigator Judgment|2|||
13436834|NCT00371761|26905098|FG001|Overall Study|Investigator Judgment|3|||
13436835|NCT00371761|26905097|FG000|Overall Study|Study termination|4|||
13436836|NCT00371761|26905098|FG001|Overall Study|Study termination|3|||
13436837|NCT00371683|26905157|FG000|DB Treatment Period-Randomized Patients|Death|1|||
13436838|NCT00371683|26905158|FG001|DB Treatment Period-Randomized Patients|Death|1|||
13436839|NCT00371683|26905157|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60|||
13436840|NCT00371683|26905158|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58|||
13436841|NCT00371683|26905157|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18|||
13436842|NCT00371683|26905158|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37|||
13436843|NCT00371683|26905157|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0|||
13436844|NCT00371683|26905158|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1|||
13436845|NCT00371683|26905157|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1|||
13436846|NCT00371683|26905158|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2|||
13436847|NCT00371683|26905157|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1|||
13436848|NCT00371683|26905158|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0|||
13436849|NCT00371683|26905157|FG000|DB Treatment Period-Randomized Patients|non-specified|9|||
13436850|NCT00371683|26905158|FG001|DB Treatment Period-Randomized Patients|non-specified|8|||
13436851|NCT00371683|26905157|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17|||
13436852|NCT00371683|26905158|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19|||
13436853|NCT00371683|26905157|FG000|Follow-Up Period - Randomized Patients|Death|0|||
13436854|NCT00371683|26905158|FG001|Follow-Up Period - Randomized Patients|Death|2|||
13436855|NCT00371683|26905157|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38|||
13436856|NCT00371683|26905158|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39|||
13436857|NCT00371683|26905157|FG000|Follow-Up Period - Randomized Patients|non-specified|6|||
13436858|NCT00371683|26905158|FG001|Follow-Up Period - Randomized Patients|non-specified|12|||
13436859|NCT00371566|26905235|FG000|Treatment Phase|Withdrawal by Subject|0|||
13436860|NCT00371566|26905236|FG001|Treatment Phase|Withdrawal by Subject|1|||
13436861|NCT00371566|26905235|FG000|Treatment Phase|Adverse Event|0|||
13436862|NCT00371566|26905236|FG001|Treatment Phase|Adverse Event|1|||
13436863|NCT00371566|26905235|FG000|Treatment Phase|Protocol Violation|0|||
13436864|NCT00371566|26905236|FG001|Treatment Phase|Protocol Violation|1|||
13436865|NCT00371566|26905235|FG000|Chemoradiation Phase|Physician Decision|2|||
13436866|NCT00371566|26905236|FG001|Chemoradiation Phase|Physician Decision|0|||
13436867|NCT00371566|26905235|FG000|Chemoradiation Phase|Withdrawal by Subject|0|||
13436868|NCT00371566|26905236|FG001|Chemoradiation Phase|Withdrawal by Subject|1|||
13436869|NCT00371566|26905235|FG000|Chemoradiation Phase|Non compliant|0|||
13436870|NCT00371566|26905236|FG001|Chemoradiation Phase|Non compliant|1|||
13436871|NCT00371566|26905235|FG000|Chemoradiation Phase|Progressive Disease|1|||
13436872|NCT00371566|26905236|FG001|Chemoradiation Phase|Progressive Disease|1|||
13436873|NCT00371566|26905235|FG000|Chemoradiation Phase|Death|2|||
13436874|NCT00371566|26905236|FG001|Chemoradiation Phase|Death|0|||
13436875|NCT00371566|26905235|FG000|Follow Up Phase|Death|0|||
13436876|NCT00371566|26905236|FG001|Follow Up Phase|Death|5|||
13436877|NCT00371566|26905235|FG000|Follow Up Phase|Disease progression|1|||
13436878|NCT00371566|26905236|FG001|Follow Up Phase|Disease progression|0|||
13436879|NCT00371566|26905235|FG000|Follow Up Phase|Withdrawal by Subject|0|||
13436880|NCT00371566|26905236|FG001|Follow Up Phase|Withdrawal by Subject|1|||
13436881|NCT00371566|26905235|FG000|Follow Up Phase|Physician Decision|1|||
13436882|NCT00371566|26905236|FG001|Follow Up Phase|Physician Decision|1|||
13436883|NCT00371566|26905235|FG000|Follow Up Phase|Lost to Follow-up|1|||
13436884|NCT00371566|26905236|FG001|Follow Up Phase|Lost to Follow-up|0|||
13436885|NCT00371462|26905249|FG000|Overall Study|Withdrawal by Subject|1|||
13436886|NCT00371462|26905250|FG001|Overall Study|Withdrawal by Subject|0|||
13436887|NCT00371462|26905249|FG000|Overall Study|Other|7|||
13436888|NCT00371462|26905250|FG001|Overall Study|Other|8|||
13436889|NCT00371397|26905269|FG000|Session 1|Withdrawal by Subject|1|||
13436890|NCT00371397|26905270|FG001|Session 1|Withdrawal by Subject|0|||
13436891|NCT00371397|26905271|FG002|Session 1|Withdrawal by Subject|0|||
13436892|NCT00371397|26905272|FG003|Session 1|Withdrawal by Subject|0|||
13436893|NCT00371397|26905273|FG004|Session 1|Withdrawal by Subject|0|||
13436894|NCT00371397|26905274|FG005|Session 1|Withdrawal by Subject|0|||
13436895|NCT00371397|26905275|FG006|Session 1|Withdrawal by Subject|0|||
13436896|NCT00371397|26905276|FG007|Session 1|Withdrawal by Subject|1|||
13436897|NCT00371397|26905277|FG008|Session 1|Withdrawal by Subject|0|||
13436898|NCT00371397|26905278|FG009|Session 1|Withdrawal by Subject|0|||
13436899|NCT00371397|26905279|FG010|Session 1|Withdrawal by Subject|0|||
13436900|NCT00371397|26905280|FG011|Session 1|Withdrawal by Subject|0|||
13436901|NCT00371345|26905344|FG000|Overall Study|Disease Progression|21|||
13436902|NCT00371345|26905345|FG001|Overall Study|Disease Progression|35|||
13436903|NCT00371345|26905344|FG000|Overall Study|Study Drug Toxicity|1|||
13436904|NCT00371345|26905345|FG001|Overall Study|Study Drug Toxicity|7|||
13436905|NCT00371345|26905344|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1|||
13436906|NCT00371345|26905345|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2|||
13436907|NCT00371345|26905344|FG000|Overall Study|Participant Request|1|||
13436908|NCT00371345|26905345|FG001|Overall Study|Participant Request|1|||
13436909|NCT00371345|26905344|FG000|Overall Study|Participant Withdrew Consent|0|||
13436910|NCT00371345|26905345|FG001|Overall Study|Participant Withdrew Consent|1|||
13436911|NCT00371254|26905402|FG000|Overall Study|Disease progression|13|||
13436912|NCT00371254|26905403|FG001|Overall Study|Disease progression|13|||
13436913|NCT00371254|26905402|FG000|Overall Study|Study drug toxicity|3|||
13436914|NCT00371254|26905403|FG001|Overall Study|Study drug toxicity|5|||
13436915|NCT00371254|26905402|FG000|Overall Study|Subject request|5|||
13436916|NCT00371254|26905403|FG001|Overall Study|Subject request|0|||
13436917|NCT00371254|26905402|FG000|Overall Study|Investigator Decision|2|||
13436918|NCT00371254|26905403|FG001|Overall Study|Investigator Decision|0|||
13436919|NCT00371254|26905402|FG000|Overall Study|Adverse event unrelated to study drug|0|||
13436920|NCT00371254|26905403|FG001|Overall Study|Adverse event unrelated to study drug|1|||
13436921|NCT00371254|26905402|FG000|Overall Study|Lost to Follow-up|0|||
13436922|NCT00371254|26905403|FG001|Overall Study|Lost to Follow-up|1|||
13436923|NCT00371254|26905402|FG000|Overall Study|Withdrawal by Subject|0|||
13436924|NCT00371254|26905403|FG001|Overall Study|Withdrawal by Subject|1|||
13436925|NCT00371150|26905442|FG000|Overall Study|Lost to Follow-up|3|||
13436926|NCT00371150|26905443|FG001|Overall Study|Lost to Follow-up|2|||
13436927|NCT00371137|26905461|FG000|Overall Study|Adverse Event|20|||
13436928|NCT00371137|26905462|FG001|Overall Study|Adverse Event|35|||
13436929|NCT00371137|26905463|FG002|Overall Study|Adverse Event|42|||
13436930|NCT00371137|26905461|FG000|Overall Study|Withdrawal by Subject|11|||
13436931|NCT00371137|26905462|FG001|Overall Study|Withdrawal by Subject|10|||
13436932|NCT00371137|26905463|FG002|Overall Study|Withdrawal by Subject|15|||
13436933|NCT00371137|26905461|FG000|Overall Study|Lost to Follow-up|6|||
13436934|NCT00371137|26905462|FG001|Overall Study|Lost to Follow-up|3|||
13436935|NCT00371137|26905463|FG002|Overall Study|Lost to Follow-up|5|||
13436936|NCT00371137|26905461|FG000|Overall Study|Lack of Efficacy|30|||
13436937|NCT00371137|26905462|FG001|Overall Study|Lack of Efficacy|12|||
13436938|NCT00371137|26905463|FG002|Overall Study|Lack of Efficacy|13|||
13436939|NCT00371137|26905461|FG000|Overall Study|Sponsor Decision|2|||
13436940|NCT00371137|26905462|FG001|Overall Study|Sponsor Decision|1|||
13436941|NCT00371137|26905463|FG002|Overall Study|Sponsor Decision|2|||
13436942|NCT00371137|26905461|FG000|Overall Study|Physician Decision|1|||
13436943|NCT00371137|26905462|FG001|Overall Study|Physician Decision|1|||
13436944|NCT00371137|26905463|FG002|Overall Study|Physician Decision|1|||
13436945|NCT00371137|26905461|FG000|Overall Study|Protocol Violation|2|||
13436946|NCT00371137|26905462|FG001|Overall Study|Protocol Violation|1|||
13436947|NCT00371137|26905463|FG002|Overall Study|Protocol Violation|1|||
13436948|NCT00370682|26905512|FG000|Overall Study|Moved from area|0|||
13436949|NCT00370682|26905513|FG001|Overall Study|Moved from area|2|||
13436950|NCT00370682|26905514|FG002|Overall Study|Moved from area|0|||
13436951|NCT00370682|26905512|FG000|Overall Study|Lost to Follow-up|0|||
13436952|NCT00370682|26905513|FG001|Overall Study|Lost to Follow-up|1|||
13436953|NCT00370682|26905514|FG002|Overall Study|Lost to Follow-up|1|||
13436954|NCT00370552|26905562|FG000|Overall Study|Adverse Event|2|||
13436955|NCT00370552|26905563|FG001|Overall Study|Adverse Event|2|||
13436956|NCT00370552|26905564|FG002|Overall Study|Adverse Event|2|||
13436957|NCT00370552|26905562|FG000|Overall Study|Disease progression|23|||
13436958|NCT00370552|26905563|FG001|Overall Study|Disease progression|23|||
13436959|NCT00370552|26905564|FG002|Overall Study|Disease progression|15|||
13436960|NCT00370552|26905562|FG000|Overall Study|Maximum clinical benefit|3|||
13436961|NCT00370552|26905563|FG001|Overall Study|Maximum clinical benefit|5|||
13436962|NCT00370552|26905564|FG002|Overall Study|Maximum clinical benefit|5|||
13436963|NCT00370552|26905562|FG000|Overall Study|Poor or noncompliance|0|||
13436964|NCT00370552|26905563|FG001|Overall Study|Poor or noncompliance|0|||
13436965|NCT00370552|26905564|FG002|Overall Study|Poor or noncompliance|1|||
13436966|NCT00370552|26905562|FG000|Overall Study|Study drug toxicity|11|||
13436967|NCT00370552|26905563|FG001|Overall Study|Study drug toxicity|8|||
13436968|NCT00370552|26905564|FG002|Overall Study|Study drug toxicity|6|||
13436969|NCT00370552|26905562|FG000|Overall Study|Withdrawal by Subject|2|||
13436970|NCT00370552|26905563|FG001|Overall Study|Withdrawal by Subject|0|||
13436971|NCT00370552|26905564|FG002|Overall Study|Withdrawal by Subject|1|||
13436972|NCT00370552|26905562|FG000|Overall Study|Still on treatment|1|||
13436973|NCT00370552|26905563|FG001|Overall Study|Still on treatment|3|||
13436974|NCT00370552|26905564|FG002|Overall Study|Still on treatment|2|||
13436975|NCT00370552|26905562|FG000|Overall Study|Never treated|1|||
13436976|NCT00370552|26905563|FG001|Overall Study|Never treated|0|||
13436977|NCT00370552|26905564|FG002|Overall Study|Never treated|0|||
13436978|NCT00370552|26905562|FG000|Overall Study|Physician Decision|1|||
13436979|NCT00370552|26905563|FG001|Overall Study|Physician Decision|1|||
13436980|NCT00370552|26905564|FG002|Overall Study|Physician Decision|0|||
13436981|NCT00370552|26905562|FG000|Overall Study|Investigator decision|2|||
13436982|NCT00370552|26905563|FG001|Overall Study|Investigator decision|1|||
13436983|NCT00370552|26905564|FG002|Overall Study|Investigator decision|0|||
13436984|NCT00370552|26905562|FG000|Overall Study|High risk of allergic reaction|0|||
13436985|NCT00370552|26905563|FG001|Overall Study|High risk of allergic reaction|1|||
13436986|NCT00370552|26905564|FG002|Overall Study|High risk of allergic reaction|0|||
13436987|NCT00370552|26905562|FG000|Overall Study|Planned radiation for palliation|0|||
13436988|NCT00370552|26905563|FG001|Overall Study|Planned radiation for palliation|1|||
13436989|NCT00370552|26905564|FG002|Overall Study|Planned radiation for palliation|0|||
13436990|NCT00370396|26905626|FG000|Overall Study|Withdrawal by Subject|0|||
13436991|NCT00370396|26905627|FG001|Overall Study|Withdrawal by Subject|0|||
13436992|NCT00370396|26905628|FG002|Overall Study|Withdrawal by Subject|1|||
13436993|NCT00370396|26905626|FG000|Overall Study|Lost to Follow-up|11|||
13436994|NCT00370396|26905627|FG001|Overall Study|Lost to Follow-up|1|||
13436995|NCT00370396|26905628|FG002|Overall Study|Lost to Follow-up|0|||
13436996|NCT00370331|26905659|FG000|Overall Study|Adverse Event|4|||
13436997|NCT00370331|26905660|FG001|Overall Study|Adverse Event|13|||
13436998|NCT00370331|26905659|FG000|Overall Study|Withdrawal by Subject|2|||
13436999|NCT00370331|26905660|FG001|Overall Study|Withdrawal by Subject|4|||
13437000|NCT00370331|26905659|FG000|Overall Study|Lost to Follow-up|0|||
13437001|NCT00370331|26905660|FG001|Overall Study|Lost to Follow-up|3|||
13437002|NCT00370331|26905659|FG000|Overall Study|Lack of Efficacy|0|||
13437003|NCT00370331|26905660|FG001|Overall Study|Lack of Efficacy|1|||
13437004|NCT00370331|26905659|FG000|Overall Study|Non-compliance|0|||
13437005|NCT00370331|26905660|FG001|Overall Study|Non-compliance|1|||
13437006|NCT00370331|26905659|FG000|Overall Study|Protocol Violation|1|||
13437007|NCT00370331|26905660|FG001|Overall Study|Protocol Violation|1|||
13437008|NCT00370292|26905677|FG000|Overall Study|Disease Progression|4|||
13437009|NCT00370292|26905677|FG000|Overall Study|Adverse Event|7|||
13437010|NCT00370292|26905677|FG000|Overall Study|Physician Decision|2|||
13437011|NCT00370149|26905694|FG000|Overall Study|Physician Decision|16|||
13437012|NCT00370149|26905695|FG001|Overall Study|Physician Decision|16|||
13437013|NCT00370149|26905694|FG000|Overall Study|Protocol Violation|1|||
13437014|NCT00370149|26905695|FG001|Overall Study|Protocol Violation|0|||
13437015|NCT00370149|26905694|FG000|Overall Study|Catheter inserted in wrong vessel-|2|||
13437016|NCT00370149|26905695|FG001|Overall Study|Catheter inserted in wrong vessel-|1|||
13437017|NCT00370149|26905694|FG000|Overall Study|Pre-existing infection|0|||
13437018|NCT00370149|26905695|FG001|Overall Study|Pre-existing infection|1|||
13437019|NCT00370149|26905694|FG000|Overall Study|Antibiotic coated dressing placed|0|||
13437020|NCT00370149|26905695|FG001|Overall Study|Antibiotic coated dressing placed|1|||
13437021|NCT00370071|26905712|FG000|Overall Study|Withdrawal by Subject|2|||
13437022|NCT00370032|26905737|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0|||
13437023|NCT00370032|26905738|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1|||
13437024|NCT00370032|26905737|FG000|Washout Period|Withdrawal by Subject|0|||
13437025|NCT00370032|26905738|FG001|Washout Period|Withdrawal by Subject|1|||
13437026|NCT00370032|26905737|FG000|Washout Period|Lost to Follow-up|0|||
13437027|NCT00370032|26905738|FG001|Washout Period|Lost to Follow-up|1|||
13437028|NCT00370032|26905737|FG000|Washout Period|Adverse Event|1|||
13437029|NCT00370032|26905738|FG001|Washout Period|Adverse Event|0|||
13437030|NCT00370032|26905737|FG000|Follow-up Period|Withdrawal by Subject|1|||
13437031|NCT00370032|26905738|FG001|Follow-up Period|Withdrawal by Subject|0|||
13437032|NCT00369967|26905761|FG000|Overall Study|Lost to Follow-up|23|||
13437033|NCT00369967|26905762|FG001|Overall Study|Lost to Follow-up|12|||
13437034|NCT00369941|26905919|FG000|Overall Study|Never Treated|1|||
13437035|NCT00369941|26905920|FG001|Overall Study|Never Treated|2|||
13437036|NCT00369941|26905919|FG000|Overall Study|Adverse Event|14|||
13437037|NCT00369941|26905920|FG001|Overall Study|Adverse Event|28|||
13437038|NCT00369941|26905919|FG000|Overall Study|Lack of Efficacy|6|||
13437039|NCT00369941|26905920|FG001|Overall Study|Lack of Efficacy|10|||
13437040|NCT00369941|26905919|FG000|Overall Study|Lost to Follow-up|12|||
13437041|NCT00369941|26905920|FG001|Overall Study|Lost to Follow-up|22|||
13437042|NCT00369941|26905919|FG000|Overall Study|Protocol Violation|5|||
13437043|NCT00369941|26905920|FG001|Overall Study|Protocol Violation|3|||
13437044|NCT00369941|26905919|FG000|Overall Study|Withdrawal by Subject|5|||
13437045|NCT00369941|26905920|FG001|Overall Study|Withdrawal by Subject|18|||
13437046|NCT00369941|26905919|FG000|Overall Study|Pregnancy|4|||
13437047|NCT00369941|26905920|FG001|Overall Study|Pregnancy|2|||
13437048|NCT00369941|26905919|FG000|Overall Study|Completed, Did Not Enter Extension|5|||
13437049|NCT00369941|26905920|FG001|Overall Study|Completed, Did Not Enter Extension|6|||
13437050|NCT00369941|26905919|FG000|Overall Study|Moved|11|||
13437051|NCT00369941|26905920|FG001|Overall Study|Moved|5|||
13437052|NCT00369941|26905919|FG000|Overall Study|Treatment with Prohibited Medication|3|||
13437053|NCT00369941|26905920|FG001|Overall Study|Treatment with Prohibited Medication|1|||
13437054|NCT00369941|26905919|FG000|Overall Study|Employment Interfered with Study Visits|1|||
13437055|NCT00369941|26905920|FG001|Overall Study|Employment Interfered with Study Visits|0|||
13437056|NCT00369941|26905919|FG000|Overall Study|Study Site Terminated|2|||
13437057|NCT00369941|26905920|FG001|Overall Study|Study Site Terminated|0|||
13437058|NCT00369941|26905919|FG000|Overall Study|Miscellaneous|3|||
13437059|NCT00369941|26905920|FG001|Overall Study|Miscellaneous|3|||
13437060|NCT00369915|26905935|FG000|Overall Study|expected side effects|2|||
13437061|NCT00369915|26905936|FG001|Overall Study|expected side effects|1|||
13437062|NCT00369915|26905935|FG000|Overall Study|Withdrawal by Subject|4|||
13437063|NCT00369915|26905936|FG001|Overall Study|Withdrawal by Subject|1|||
13437064|NCT00369915|26905935|FG000|Overall Study|W/drawl by investigators|0|||
13437065|NCT00369915|26905936|FG001|Overall Study|W/drawl by investigators|1|||
13437066|NCT00369824|26906053|FG000|Overall Study|Adverse Event|0|||
13437067|NCT00369824|26906054|FG001|Overall Study|Adverse Event|2|||
13437068|NCT00369824|26906055|FG002|Overall Study|Adverse Event|0|||
13437069|NCT00369824|26906056|FG003|Overall Study|Adverse Event|0|||
13437070|NCT00369824|26906057|FG004|Overall Study|Adverse Event|1|||
13437071|NCT00369824|26906058|FG005|Overall Study|Adverse Event|0|||
13437072|NCT00369824|26906053|FG000|Overall Study|Protocol Violation|0|||
13437073|NCT00369824|26906054|FG001|Overall Study|Protocol Violation|1|||
13437074|NCT00369824|26906055|FG002|Overall Study|Protocol Violation|0|||
13437075|NCT00369824|26906056|FG003|Overall Study|Protocol Violation|1|||
13437076|NCT00369824|26906057|FG004|Overall Study|Protocol Violation|1|||
13437077|NCT00369824|26906058|FG005|Overall Study|Protocol Violation|0|||
13437078|NCT00369824|26906053|FG000|Overall Study|Withdrawal by Subject|9|||
13437079|NCT00369824|26906054|FG001|Overall Study|Withdrawal by Subject|5|||
13437080|NCT00369824|26906055|FG002|Overall Study|Withdrawal by Subject|5|||
13437081|NCT00369824|26906056|FG003|Overall Study|Withdrawal by Subject|4|||
13437082|NCT00369824|26906057|FG004|Overall Study|Withdrawal by Subject|6|||
13437083|NCT00369824|26906058|FG005|Overall Study|Withdrawal by Subject|2|||
13437084|NCT00369824|26906053|FG000|Overall Study|Lost to Follow-up|6|||
13437085|NCT00369824|26906054|FG001|Overall Study|Lost to Follow-up|11|||
13437086|NCT00369824|26906055|FG002|Overall Study|Lost to Follow-up|7|||
13437087|NCT00369824|26906056|FG003|Overall Study|Lost to Follow-up|8|||
13437088|NCT00369824|26906057|FG004|Overall Study|Lost to Follow-up|9|||
13437089|NCT00369824|26906058|FG005|Overall Study|Lost to Follow-up|6|||
13437090|NCT00369824|26906053|FG000|Overall Study|Other|0|||
13437091|NCT00369824|26906054|FG001|Overall Study|Other|0|||
13437092|NCT00369824|26906055|FG002|Overall Study|Other|0|||
13437093|NCT00369824|26906056|FG003|Overall Study|Other|2|||
13437094|NCT00369824|26906057|FG004|Overall Study|Other|1|||
13437095|NCT00369824|26906058|FG005|Overall Study|Other|3|||
13437096|NCT00369785|26906073|FG000|Overall Study|Physician Decision|3|||
13437097|NCT00369785|26906074|FG001|Overall Study|Physician Decision|2|||
13437098|NCT00369785|26906073|FG000|Overall Study|Death|1|||
13437099|NCT00369785|26906074|FG001|Overall Study|Death|2|||
13437100|NCT00369785|26906073|FG000|Overall Study|Withdrawal by Subject|7|||
13437101|NCT00369785|26906074|FG001|Overall Study|Withdrawal by Subject|6|||
13437102|NCT00369785|26906073|FG000|Overall Study|Toxicity|6|||
13437103|NCT00369785|26906074|FG001|Overall Study|Toxicity|4|||
13437104|NCT00369785|26906073|FG000|Overall Study|Never started|0|||
13437105|NCT00369785|26906074|FG001|Overall Study|Never started|2|||
13437106|NCT00369785|26906073|FG000|Overall Study|Progression|4|||
13437107|NCT00369785|26906074|FG001|Overall Study|Progression|4|||
13437108|NCT00369785|26906073|FG000|Overall Study|Multiple reasons|6|||
13437109|NCT00369785|26906074|FG001|Overall Study|Multiple reasons|5|||
13437110|NCT00369707|26906089|FG000|Induction Part B (2 Cycles)|Adverse Event|3|||
13437111|NCT00369707|26906089|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2|||
13437112|NCT00369707|26906089|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1|||
13437113|NCT00369707|26906089|FG000|Induction Part B (2 Cycles)|Progressive disease|1|||
13437114|NCT00369707|26906089|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2|||
13437115|NCT00369707|26906089|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2|||
13437116|NCT00369707|26906089|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4|||
13437117|NCT00369707|26906089|FG000|Follow up for 2 Years After Treatment|Death|1|||
13437118|NCT00369707|26906089|FG000|Follow up for 2 Years After Treatment|Other|2|||
13437119|NCT00369681|26906098|FG000|Overall Study|Death|1|||
13437120|NCT00369668|26906122|FG000|Overall Study|Lack of Efficacy|4|||
13437121|NCT00369668|26906123|FG001|Overall Study|Lack of Efficacy|5|||
13437122|NCT00369668|26906124|FG002|Overall Study|Lack of Efficacy|7|||
13437123|NCT00369655|26906135|FG000|Overall Study|Refusal of further treatment|2|||
13437124|NCT00369629|26906150|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
13437125|NCT00369629|26906151|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
13437126|NCT00369629|26906152|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
13437127|NCT00369629|26906153|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
13437128|NCT00369629|26906150|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
13437129|NCT00369629|26906151|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
13437130|NCT00369629|26906152|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1|||
13437131|NCT00369629|26906153|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
13437132|NCT00369629|26906150|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2|||
13437133|NCT00369629|26906151|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
13437134|NCT00369629|26906152|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
13437135|NCT00369629|26906153|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
13437136|NCT00369629|26906150|FG000|Moved on to 4 More Cycles|Progressive Disease|0|||
13437137|NCT00369629|26906151|FG001|Moved on to 4 More Cycles|Progressive Disease|0|||
13437138|NCT00369629|26906152|FG002|Moved on to 4 More Cycles|Progressive Disease|1|||
13437139|NCT00369629|26906153|FG003|Moved on to 4 More Cycles|Progressive Disease|0|||
13437140|NCT00369629|26906150|FG000|Completed 4 More Cycles|Withdrawal by Subject|2|||
13437141|NCT00369629|26906151|FG001|Completed 4 More Cycles|Withdrawal by Subject|1|||
13437142|NCT00369629|26906152|FG002|Completed 4 More Cycles|Withdrawal by Subject|0|||
13437143|NCT00369629|26906153|FG003|Completed 4 More Cycles|Withdrawal by Subject|0|||
13437144|NCT00369629|26906150|FG000|Completed 4 More Cycles|Progressive disease|2|||
13437145|NCT00369629|26906151|FG001|Completed 4 More Cycles|Progressive disease|1|||
13437146|NCT00369629|26906152|FG002|Completed 4 More Cycles|Progressive disease|2|||
13437147|NCT00369629|26906153|FG003|Completed 4 More Cycles|Progressive disease|0|||
13437148|NCT00369629|26906150|FG000|Follow up for 1 Year|Death|2|||
13437149|NCT00369629|26906151|FG001|Follow up for 1 Year|Death|1|||
13437150|NCT00369629|26906152|FG002|Follow up for 1 Year|Death|1|||
13437151|NCT00369629|26906153|FG003|Follow up for 1 Year|Death|0|||
13437152|NCT00369629|26906150|FG000|Follow up for 1 Year|Lost to Follow-up|0|||
13437153|NCT00369629|26906151|FG001|Follow up for 1 Year|Lost to Follow-up|1|||
13437154|NCT00369629|26906152|FG002|Follow up for 1 Year|Lost to Follow-up|0|||
13437155|NCT00369629|26906153|FG003|Follow up for 1 Year|Lost to Follow-up|0|||
13437156|NCT00369629|26906150|FG000|Follow up for 1 Year|stopped being followed as study closed|0|||
13437157|NCT00369629|26906151|FG001|Follow up for 1 Year|stopped being followed as study closed|0|||
13437158|NCT00369629|26906152|FG002|Follow up for 1 Year|stopped being followed as study closed|2|||
13437159|NCT00369629|26906153|FG003|Follow up for 1 Year|stopped being followed as study closed|0|||
13437160|NCT00369577|26906180|FG000|Overall Study|Withdrawal by Subject|0|||
13437161|NCT00369577|26906181|FG001|Overall Study|Withdrawal by Subject|0|||
13437162|NCT00369577|26906182|FG002|Overall Study|Withdrawal by Subject|1|||
13437163|NCT00369486|26906235|FG000|4-Week Visit|Missed visit|2|||
13437164|NCT00369486|26906236|FG001|4-Week Visit|Missed visit|2|||
13437165|NCT00369486|26906237|FG002|4-Week Visit|Missed visit|0|||
13437166|NCT00369486|26906238|FG003|4-Week Visit|Missed visit|2|||
13437167|NCT00369486|26906239|FG004|4-Week Visit|Missed visit|1|||
13437168|NCT00369486|26906235|FG000|4-Week Visit|Dropped|0|||
13437169|NCT00369486|26906236|FG001|4-Week Visit|Dropped|0|||
13437170|NCT00369486|26906237|FG002|4-Week Visit|Dropped|1|||
13437171|NCT00369486|26906238|FG003|4-Week Visit|Dropped|0|||
13437172|NCT00369486|26906239|FG004|4-Week Visit|Dropped|0|||
13437173|NCT00369486|26906235|FG000|8-Week Visit|Missed visit|0|||
13437174|NCT00369486|26906236|FG001|8-Week Visit|Missed visit|1|||
13437175|NCT00369486|26906237|FG002|8-Week Visit|Missed visit|0|||
13437176|NCT00369486|26906238|FG003|8-Week Visit|Missed visit|0|||
13437177|NCT00369486|26906239|FG004|8-Week Visit|Missed visit|1|||
13437178|NCT00369486|26906235|FG000|8-Week Visit|Dropped|0|||
13437179|NCT00369486|26906236|FG001|8-Week Visit|Dropped|0|||
13437180|NCT00369486|26906237|FG002|8-Week Visit|Dropped|0|||
13437181|NCT00369486|26906238|FG003|8-Week Visit|Dropped|1|||
13437182|NCT00369486|26906239|FG004|8-Week Visit|Dropped|0|||
13437183|NCT00369486|26906235|FG000|17-Week Visit|Missed visit|0|||
13437184|NCT00369486|26906236|FG001|17-Week Visit|Missed visit|0|||
13437185|NCT00369486|26906237|FG002|17-Week Visit|Missed visit|1|||
13437186|NCT00369486|26906238|FG003|17-Week Visit|Missed visit|1|||
13437187|NCT00369486|26906239|FG004|17-Week Visit|Missed visit|1|||
13437188|NCT00369486|26906235|FG000|34-Week Visit|Dropped|0|||
13437189|NCT00369486|26906236|FG001|34-Week Visit|Dropped|1|||
13437190|NCT00369486|26906237|FG002|34-Week Visit|Dropped|1|||
13437191|NCT00369486|26906238|FG003|34-Week Visit|Dropped|3|||
13437192|NCT00369486|26906239|FG004|34-Week Visit|Dropped|3|||
13437193|NCT00369382|26906277|FG000|Overall Study|Death|0|||
13437194|NCT00369382|26906278|FG001|Overall Study|Death|2|||
13437195|NCT00369382|26906277|FG000|Overall Study|Physician Decision|2|||
13437196|NCT00369382|26906278|FG001|Overall Study|Physician Decision|1|||
13437197|NCT00369382|26906277|FG000|Overall Study|Withdrawal by Subject|5|||
13437198|NCT00369382|26906278|FG001|Overall Study|Withdrawal by Subject|0|||
13437199|NCT00369382|26906277|FG000|Overall Study|Randomized, not treated|2|||
13437200|NCT00369382|26906278|FG001|Overall Study|Randomized, not treated|0|||
13437201|NCT00369382|26906277|FG000|Overall Study|Other|1|||
13437202|NCT00369382|26906278|FG001|Overall Study|Other|0|||
13437203|NCT00369343|26906318|FG000|Double-blind Phase|Adverse Event|19|||
13437204|NCT00369343|26906319|FG001|Double-blind Phase|Adverse Event|4|||
13437205|NCT00369343|26906318|FG000|Double-blind Phase|Failed to return|2|||
13437206|NCT00369343|26906319|FG001|Double-blind Phase|Failed to return|0|||
13437207|NCT00369343|26906318|FG000|Double-blind Phase|Lost to Follow-up|9|||
13437208|NCT00369343|26906319|FG001|Double-blind Phase|Lost to Follow-up|2|||
13437209|NCT00369343|26906318|FG000|Double-blind Phase|Protocol Violation|2|||
13437210|NCT00369343|26906319|FG001|Double-blind Phase|Protocol Violation|0|||
13437211|NCT00369343|26906318|FG000|Double-blind Phase|Withdrawal by Subject|8|||
13437212|NCT00369343|26906319|FG001|Double-blind Phase|Withdrawal by Subject|6|||
13437213|NCT00369343|26906318|FG000|Double-blind Phase|Lack of Efficacy|0|||
13437214|NCT00369343|26906319|FG001|Double-blind Phase|Lack of Efficacy|4|||
13437215|NCT00369343|26906318|FG000|Double-blind Phase|Protocol deviation|4|||
13437216|NCT00369343|26906319|FG001|Double-blind Phase|Protocol deviation|0|||
13437217|NCT00369343|26906318|FG000|Open-label Phase|Adverse Event|19|||
13437218|NCT00369343|26906319|FG001|Open-label Phase|Adverse Event|7|||
13437219|NCT00369343|26906318|FG000|Open-label Phase|Failed to return|4|||
13437220|NCT00369343|26906319|FG001|Open-label Phase|Failed to return|0|||
13437221|NCT00369343|26906318|FG000|Open-label Phase|Physician Decision|2|||
13437222|NCT00369343|26906319|FG001|Open-label Phase|Physician Decision|0|||
13437223|NCT00369343|26906318|FG000|Open-label Phase|Lost to Follow-up|5|||
13437224|NCT00369343|26906319|FG001|Open-label Phase|Lost to Follow-up|3|||
13437225|NCT00369343|26906318|FG000|Open-label Phase|inadvertently reported study completers|3|||
13437226|NCT00369343|26906319|FG001|Open-label Phase|inadvertently reported study completers|2|||
13437227|NCT00369343|26906318|FG000|Open-label Phase|Protocol Violation|1|||
13437228|NCT00369343|26906319|FG001|Open-label Phase|Protocol Violation|3|||
13437229|NCT00369343|26906318|FG000|Open-label Phase|Withdrawal by Subject|15|||
13437230|NCT00369343|26906319|FG001|Open-label Phase|Withdrawal by Subject|6|||
13437231|NCT00369343|26906318|FG000|Open-label Phase|Lack of Efficacy|4|||
13437232|NCT00369343|26906319|FG001|Open-label Phase|Lack of Efficacy|3|||
13437233|NCT00369343|26906318|FG000|Open-label Phase|Lack of continuance tolerability|3|||
13437234|NCT00369343|26906319|FG001|Open-label Phase|Lack of continuance tolerability|4|||
13437235|NCT00369343|26906318|FG000|Open-label Phase|did not take study drug|1|||
13437236|NCT00369343|26906319|FG001|Open-label Phase|did not take study drug|2|||
13437237|NCT00369278|26906340|FG000|Overall Study|Adverse Event|14|||
13437238|NCT00369278|26906341|FG001|Overall Study|Adverse Event|11|||
13437239|NCT00369278|26906340|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
13437240|NCT00369278|26906341|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
13437241|NCT00369278|26906340|FG000|Overall Study|Protocol Violation|2|||
13437242|NCT00369278|26906341|FG001|Overall Study|Protocol Violation|1|||
13437243|NCT00369278|26906340|FG000|Overall Study|Withdrawal by Subject|2|||
13437244|NCT00369278|26906341|FG001|Overall Study|Withdrawal by Subject|2|||
13437245|NCT00369278|26906340|FG000|Overall Study|Lost to Follow-up|1|||
13437246|NCT00369278|26906341|FG001|Overall Study|Lost to Follow-up|0|||
13437247|NCT00369278|26906340|FG000|Overall Study|Graft loss|1|||
13437248|NCT00369278|26906341|FG001|Overall Study|Graft loss|2|||
13437249|NCT00369265|26906354|FG000|Overall Study|Study terminated|4|||
13437250|NCT00369265|26906355|FG001|Overall Study|Study terminated|7|||
13437251|NCT00369161|26906372|FG000|Overall Study|Adverse Event|15|||
13437252|NCT00369161|26906373|FG001|Overall Study|Adverse Event|13|||
13437253|NCT00369161|26906372|FG000|Overall Study|Abnormal laboratory value|0|||
13437254|NCT00369161|26906373|FG001|Overall Study|Abnormal laboratory value|1|||
13437255|NCT00369161|26906372|FG000|Overall Study|Lack of Efficacy|3|||
13437256|NCT00369161|26906373|FG001|Overall Study|Lack of Efficacy|1|||
13437257|NCT00369161|26906372|FG000|Overall Study|Protocol Violation|0|||
13437258|NCT00369161|26906373|FG001|Overall Study|Protocol Violation|2|||
13437259|NCT00369161|26906372|FG000|Overall Study|Withdrawal by Subject|2|||
13437260|NCT00369161|26906373|FG001|Overall Study|Withdrawal by Subject|3|||
13437261|NCT00369161|26906372|FG000|Overall Study|Death|1|||
13437262|NCT00369161|26906373|FG001|Overall Study|Death|2|||
13437263|NCT00369161|26906372|FG000|Overall Study|Graft loss|4|||
13437264|NCT00369161|26906373|FG001|Overall Study|Graft loss|0|||
13437265|NCT00369161|26906372|FG000|Overall Study|Administrative Problem|2|||
13437266|NCT00369161|26906373|FG001|Overall Study|Administrative Problem|2|||
13437267|NCT00369122|26906382|FG000|Overall Study|Ineligible|10|||
13437268|NCT00369122|26906382|FG000|Overall Study|No protocol treatment|1|||
13437269|NCT00368992|26906391|FG000|Overall Study|Ineligible|5|||
13437270|NCT00368992|26906391|FG000|Overall Study|Refused treatment|3|||
13437271|NCT00368992|26906391|FG000|Overall Study|Lack of Efficacy|63|||
13437272|NCT00368992|26906391|FG000|Overall Study|Adverse Event|26|||
13437273|NCT00368992|26906391|FG000|Overall Study|Death|4|||
13437274|NCT00368992|26906391|FG000|Overall Study|Other|9|||
13437275|NCT00368979|26906412|FG000|Overall Study|Adverse Event|9|||
13437276|NCT00368979|26906413|FG001|Overall Study|Adverse Event|16|||
13437277|NCT00368979|26906412|FG000|Overall Study|Lack of Efficacy|5|||
13437278|NCT00368979|26906413|FG001|Overall Study|Lack of Efficacy|3|||
13437279|NCT00368979|26906412|FG000|Overall Study|Other|3|||
13437280|NCT00368979|26906413|FG001|Overall Study|Other|1|||
13437281|NCT00368979|26906412|FG000|Overall Study|Lost to Follow-up|1|||
13437282|NCT00368979|26906413|FG001|Overall Study|Lost to Follow-up|0|||
13437283|NCT00368979|26906412|FG000|Overall Study|Protocol Violation|2|||
13437284|NCT00368979|26906413|FG001|Overall Study|Protocol Violation|1|||
13437285|NCT00368979|26906412|FG000|Overall Study|Withdrawal by Subject|5|||
13437286|NCT00368979|26906413|FG001|Overall Study|Withdrawal by Subject|9|||
13437287|NCT00368966|26906474|FG000|Infant Series|Withdrawal by Subject|11|||
13437288|NCT00368966|26906475|FG001|Infant Series|Withdrawal by Subject|6|||
13437289|NCT00368966|26906474|FG000|Infant Series|Protocol Violation|2|||
13437290|NCT00368966|26906475|FG001|Infant Series|Protocol Violation|1|||
13437291|NCT00368966|26906474|FG000|Infant Series|Lost to Follow-up|2|||
13437292|NCT00368966|26906475|FG001|Infant Series|Lost to Follow-up|0|||
13437293|NCT00368966|26906474|FG000|Infant Series|Randomization error|0|||
13437294|NCT00368966|26906475|FG001|Infant Series|Randomization error|1|||
13437295|NCT00368966|26906474|FG000|Infant Series|Failed to meet eligibility criteria|0|||
13437296|NCT00368966|26906475|FG001|Infant Series|Failed to meet eligibility criteria|1|||
13437297|NCT00368966|26906474|FG000|Infant Series|Adverse Event|0|||
13437298|NCT00368966|26906475|FG001|Infant Series|Adverse Event|1|||
13437299|NCT00368966|26906474|FG000|Infant Series|Failed to return|1|||
13437300|NCT00368966|26906475|FG001|Infant Series|Failed to return|0|||
13437301|NCT00368966|26906474|FG000|After Infant|Failed to return|3|||
13437302|NCT00368966|26906475|FG001|After Infant|Failed to return|1|||
13437303|NCT00368966|26906474|FG000|After Infant|Adverse Event|1|||
13437304|NCT00368966|26906475|FG001|After Infant|Adverse Event|2|||
13437305|NCT00368966|26906474|FG000|After Infant|Withdrawal by Subject|1|||
13437306|NCT00368966|26906475|FG001|After Infant|Withdrawal by Subject|1|||
13437307|NCT00368966|26906474|FG000|After Infant|Death|1|||
13437308|NCT00368966|26906475|FG001|After Infant|Death|0|||
13437309|NCT00368966|26906474|FG000|After Infant|Lost to Follow-up|0|||
13437310|NCT00368966|26906475|FG001|After Infant|Lost to Follow-up|1|||
13437311|NCT00368966|26906474|FG000|Toddler Dose|Withdrawal by Subject|1|||
13437312|NCT00368966|26906475|FG001|Toddler Dose|Withdrawal by Subject|1|||
13437313|NCT00368966|26906474|FG000|Toddler Dose|Lost to Follow-up|0|||
13437314|NCT00368966|26906475|FG001|Toddler Dose|Lost to Follow-up|2|||
13437315|NCT00368927|26906490|FG000|Overall Study|Lost to Follow-up|2|||
13437316|NCT00368927|26906491|FG001|Overall Study|Lost to Follow-up|0|||
13437317|NCT00368927|26906490|FG000|Overall Study|Adverse Event|1|||
13437318|NCT00368927|26906491|FG001|Overall Study|Adverse Event|1|||
13437319|NCT00368927|26906490|FG000|Overall Study|Withdrawal by Subject|1|||
13437320|NCT00368927|26906491|FG001|Overall Study|Withdrawal by Subject|2|||
13437321|NCT00368927|26906490|FG000|Overall Study|Physician Decision|1|||
13437322|NCT00368927|26906491|FG001|Overall Study|Physician Decision|0|||
13437323|NCT00368875|26906502|FG000|Overall Study|Adverse Event|0|||
13437324|NCT00368875|26906503|FG001|Overall Study|Adverse Event|12|||
13437325|NCT00368875|26906502|FG000|Overall Study|Progressive disease|3|||
13437326|NCT00368875|26906503|FG001|Overall Study|Progressive disease|27|||
13437327|NCT00368875|26906502|FG000|Overall Study|Withdrawal by Subject|2|||
13437328|NCT00368875|26906503|FG001|Overall Study|Withdrawal by Subject|6|||
13437329|NCT00368875|26906502|FG000|Overall Study|Other Reason|0|||
13437330|NCT00368875|26906503|FG001|Overall Study|Other Reason|2|||
13437331|NCT00368875|26906502|FG000|Overall Study|Alternative Therapy|1|||
13437332|NCT00368875|26906503|FG001|Overall Study|Alternative Therapy|1|||
13437333|NCT00368849|26906520|FG000|Overall Study|Withdrawal by Subject|0|||
13437334|NCT00368849|26906521|FG001|Overall Study|Withdrawal by Subject|1|||
13437335|NCT00368849|26906520|FG000|Overall Study|Physician Decision|0|||
13437336|NCT00368849|26906521|FG001|Overall Study|Physician Decision|1|||
13437337|NCT00368836|26906534|FG000|Phase II|Screen Failure|1|||
13437338|NCT00368836|26906534|FG000|Phase II|Withdrawal by Subject|1|||
13437339|NCT00368836|26906534|FG000|Phase II|unable to collect blood and/or breath|17|||
13437340|NCT00368836|26906534|FG000|Phase II|Protocol Violation|2|||
13437341|NCT00368745|26906571|FG000|Double-blind Treatment Period|Adverse Event|6|||
13437342|NCT00368745|26906572|FG001|Double-blind Treatment Period|Adverse Event|6|||
13437343|NCT00368745|26906571|FG000|Double-blind Treatment Period|Lack of Efficacy|7|||
13437344|NCT00368745|26906572|FG001|Double-blind Treatment Period|Lack of Efficacy|16|||
13437345|NCT00368745|26906571|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
13437346|NCT00368745|26906572|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
13437347|NCT00368745|26906571|FG000|Double-blind Treatment Period|Withdrawal by Subject|5|||
13437348|NCT00368745|26906572|FG001|Double-blind Treatment Period|Withdrawal by Subject|3|||
13437349|NCT00368745|26906571|FG000|Double-blind Treatment Period|Other|7|||
13437350|NCT00368745|26906572|FG001|Double-blind Treatment Period|Other|6|||
13437351|NCT00368641|26906585|FG000|Overall Study|Adverse Event|2|||
13437352|NCT00368641|26906586|FG001|Overall Study|Adverse Event|1|||
13437353|NCT00368641|26906585|FG000|Overall Study|Death|1|||
13437354|NCT00368641|26906586|FG001|Overall Study|Death|0|||
13437355|NCT00368641|26906585|FG000|Overall Study|Withdrawal by Subject|1|||
13437356|NCT00368641|26906586|FG001|Overall Study|Withdrawal by Subject|0|||
13437357|NCT00368641|26906585|FG000|Overall Study|Sponsor decision to terminate study|2|||
13437358|NCT00368641|26906586|FG001|Overall Study|Sponsor decision to terminate study|5|||
13437359|NCT00368550|26906603|FG000|Overall Study|Adverse Event|7|||
13437360|NCT00368550|26906604|FG001|Overall Study|Adverse Event|4|||
13437361|NCT00368550|26906603|FG000|Overall Study|Lack of Efficacy|4|||
13437362|NCT00368550|26906604|FG001|Overall Study|Lack of Efficacy|9|||
13437363|NCT00368550|26906603|FG000|Overall Study|Withdrawal by Subject|17|||
13437364|NCT00368550|26906604|FG001|Overall Study|Withdrawal by Subject|10|||
13437365|NCT00368537|26906625|FG000|Randomization|No study drug dosed|13|||
13437366|NCT00368537|26906626|FG001|Randomization|No study drug dosed|6|||
13437367|NCT00368537|26906625|FG000|Baseline Participants|Lost to Follow-up|16|||
13437368|NCT00368537|26906626|FG001|Baseline Participants|Lost to Follow-up|17|||
13437369|NCT00368537|26906625|FG000|Baseline Participants|Withdrawal by Subject|6|||
13437370|NCT00368537|26906626|FG001|Baseline Participants|Withdrawal by Subject|4|||
13437371|NCT00368537|26906625|FG000|Baseline Participants|Death|1|||
13437372|NCT00368537|26906626|FG001|Baseline Participants|Death|2|||
13437373|NCT00368537|26906625|FG000|Baseline Participants|No susceptibility|1|||
13437374|NCT00368537|26906626|FG001|Baseline Participants|No susceptibility|0|||
13437375|NCT00368537|26906625|FG000|Baseline Participants|Patient uncompliant|0|||
13437376|NCT00368537|26906626|FG001|Baseline Participants|Patient uncompliant|1|||
13437377|NCT00368472|26906634|FG000|Overall Study|Adverse Event|22|||
13437378|NCT00368472|26906634|FG000|Overall Study|Medication non-compliance|4|||
13437379|NCT00368472|26906634|FG000|Overall Study|Protocol Violation|2|||
13437380|NCT00368472|26906634|FG000|Overall Study|Request of Investigator or Sponsor|3|||
13437381|NCT00368472|26906634|FG000|Overall Study|Withdrawal by Subject|40|||
13437382|NCT00368472|26906634|FG000|Overall Study|Diary non-compliance|1|||
13437383|NCT00368472|26906634|FG000|Overall Study|Other|32|||
13437384|NCT00368472|26906634|FG000|Overall Study|Missing Final Disposition Date|1|||
13437385|NCT00368355|26906655|FG000|Overall Study|Adverse Event|1|||
13437386|NCT00368355|26906656|FG001|Overall Study|Adverse Event|0|||
13437387|NCT00368355|26906655|FG000|Overall Study|Death|2|||
13437388|NCT00368355|26906656|FG001|Overall Study|Death|4|||
13437389|NCT00368355|26906655|FG000|Overall Study|Relapse|6|||
13437390|NCT00368355|26906656|FG001|Overall Study|Relapse|10|||
13437391|NCT00368355|26906655|FG000|Overall Study|Subsequent transplant|0|||
13437392|NCT00368355|26906656|FG001|Overall Study|Subsequent transplant|3|||
13437393|NCT00368355|26906655|FG000|Overall Study|Treatment - hematopoietic cell product|2|||
13437394|NCT00368355|26906656|FG001|Overall Study|Treatment - hematopoietic cell product|0|||
13437395|NCT00368277|26906675|FG000|Overall Study|Adverse Event|33|||
13437396|NCT00368277|26906676|FG001|Overall Study|Adverse Event|49|||
13437397|NCT00368277|26906675|FG000|Overall Study|Death|2|||
13437398|NCT00368277|26906676|FG001|Overall Study|Death|1|||
13437399|NCT00368277|26906675|FG000|Overall Study|Unsatisfactory therapeutic effect|31|||
13437400|NCT00368277|26906676|FG001|Overall Study|Unsatisfactory therapeutic effect|24|||
13437401|NCT00368277|26906675|FG000|Overall Study|Protocol deviation|7|||
13437402|NCT00368277|26906676|FG001|Overall Study|Protocol deviation|0|||
13437403|NCT00368277|26906675|FG000|Overall Study|Patient withdrew consent|32|||
13437404|NCT00368277|26906676|FG001|Overall Study|Patient withdrew consent|28|||
13437405|NCT00368277|26906675|FG000|Overall Study|Lost to Follow-up|8|||
13437406|NCT00368277|26906676|FG001|Overall Study|Lost to Follow-up|6|||
13437407|NCT00368251|26906706|FG000|Overall Study|SAE, non-fatal|1|||
13437408|NCT00368251|26906707|FG001|Overall Study|SAE, non-fatal|0|||
13437409|NCT00368251|26906708|FG002|Overall Study|SAE, non-fatal|0|||
13437410|NCT00368251|26906706|FG000|Overall Study|AE, non-serious non-fatal|0|||
13437411|NCT00368251|26906707|FG001|Overall Study|AE, non-serious non-fatal|0|||
13437412|NCT00368251|26906708|FG002|Overall Study|AE, non-serious non-fatal|1|||
13437413|NCT00368108|26906735|FG000|Overall Study|Adverse Event|38|||
13437414|NCT00368108|26906736|FG001|Overall Study|Adverse Event|26|||
13437415|NCT00368108|26906737|FG002|Overall Study|Adverse Event|44|||
13437416|NCT00368108|26906735|FG000|Overall Study|Abnormal Laboratory Value|0|||
13437417|NCT00368108|26906736|FG001|Overall Study|Abnormal Laboratory Value|0|||
13437418|NCT00368108|26906737|FG002|Overall Study|Abnormal Laboratory Value|3|||
13437419|NCT00368108|26906735|FG000|Overall Study|Protocol Violation|5|||
13437420|NCT00368108|26906736|FG001|Overall Study|Protocol Violation|9|||
13437421|NCT00368108|26906737|FG002|Overall Study|Protocol Violation|9|||
13437422|NCT00368108|26906735|FG000|Overall Study|Withdrawal by Subject|9|||
13437423|NCT00368108|26906736|FG001|Overall Study|Withdrawal by Subject|3|||
13437424|NCT00368108|26906737|FG002|Overall Study|Withdrawal by Subject|5|||
13437425|NCT00368108|26906735|FG000|Overall Study|Lack of Efficacy|7|||
13437426|NCT00368108|26906736|FG001|Overall Study|Lack of Efficacy|8|||
13437427|NCT00368108|26906737|FG002|Overall Study|Lack of Efficacy|5|||
13437428|NCT00368108|26906735|FG000|Overall Study|Physician Decision|2|||
13437429|NCT00368108|26906736|FG001|Overall Study|Physician Decision|0|||
13437430|NCT00368108|26906737|FG002|Overall Study|Physician Decision|1|||
13437431|NCT00368108|26906735|FG000|Overall Study|Other|3|||
13437432|NCT00368108|26906736|FG001|Overall Study|Other|7|||
13437433|NCT00368108|26906737|FG002|Overall Study|Other|1|||
13437434|NCT00368069|26906760|FG000|Overall Study|Adverse Event|5|||
13437435|NCT00368069|26906761|FG001|Overall Study|Adverse Event|2|||
13437436|NCT00368069|26906760|FG000|Overall Study|Lack of Efficacy|0|||
13437437|NCT00368069|26906761|FG001|Overall Study|Lack of Efficacy|1|||
13437438|NCT00368069|26906760|FG000|Overall Study|Lost to Follow-up|1|||
13437439|NCT00368069|26906761|FG001|Overall Study|Lost to Follow-up|0|||
13437440|NCT00368069|26906760|FG000|Overall Study|Protocol Violation|0|||
13437441|NCT00368069|26906761|FG001|Overall Study|Protocol Violation|2|||
13437442|NCT00368069|26906760|FG000|Overall Study|Withdrawal of Consent|2|||
13437443|NCT00368069|26906761|FG001|Overall Study|Withdrawal of Consent|1|||
13437444|NCT00368069|26906760|FG000|Overall Study|no blood sampling possible|0|||
13437445|NCT00368069|26906761|FG001|Overall Study|no blood sampling possible|1|||
13437446|NCT00367991|26906784|FG000|Overall Study|Withdrawal by Subject|1|||
13437447|NCT00367991|26906785|FG001|Overall Study|Withdrawal by Subject|1|||
13437448|NCT00367991|26906784|FG000|Overall Study|Adverse Event|1|||
13437449|NCT00367991|26906785|FG001|Overall Study|Adverse Event|1|||
13437450|NCT00367835|26906818|FG000|Overall Study|Adverse Event|14|||
13437451|NCT00367835|26906819|FG001|Overall Study|Adverse Event|1|||
13437452|NCT00367835|26906818|FG000|Overall Study|Protocol Violation|1|||
13437453|NCT00367835|26906819|FG001|Overall Study|Protocol Violation|7|||
13437454|NCT00367835|26906818|FG000|Overall Study|Withdrawal by Subject|7|||
13437455|NCT00367835|26906819|FG001|Overall Study|Withdrawal by Subject|6|||
13437456|NCT00367835|26906818|FG000|Overall Study|Lost to Follow-up|1|||
13437457|NCT00367835|26906819|FG001|Overall Study|Lost to Follow-up|4|||
13437458|NCT00367835|26906818|FG000|Overall Study|Lack of Efficacy|3|||
13437459|NCT00367835|26906819|FG001|Overall Study|Lack of Efficacy|12|||
13437460|NCT00367835|26906818|FG000|Overall Study|Subject in juvenile detention center|1|||
13437461|NCT00367835|26906819|FG001|Overall Study|Subject in juvenile detention center|0|||
13437462|NCT00367835|26906818|FG000|Overall Study|refused blood collection|1|||
13437463|NCT00367835|26906819|FG001|Overall Study|refused blood collection|0|||
13437464|NCT00367835|26906818|FG000|Overall Study|Did not respond to calls|1|||
13437465|NCT00367835|26906819|FG001|Overall Study|Did not respond to calls|0|||
13437466|NCT00367835|26906818|FG000|Overall Study|History of lead poisoning|0|||
13437467|NCT00367835|26906819|FG001|Overall Study|History of lead poisoning|1|||
13437468|NCT00367770|26906827|FG000|Overall Study|Adverse Event|1|||
13437469|NCT00367770|26906827|FG000|Overall Study|Withdrawal by Subject|1|||
13437470|NCT00367744|26906842|FG000|Overall Study|Lost to Follow-up|4|||
13437471|NCT00367744|26906843|FG001|Overall Study|Lost to Follow-up|5|||
13437472|NCT00367640|26906866|FG000|Overall Study|Adverse Event|3|||
13437473|NCT00367640|26906867|FG001|Overall Study|Adverse Event|6|||
13437474|NCT00367640|26906868|FG002|Overall Study|Adverse Event|8|||
13437475|NCT00367640|26906869|FG003|Overall Study|Adverse Event|0|||
13437476|NCT00367640|26906866|FG000|Overall Study|Withdrawal by Subject|8|||
13437477|NCT00367640|26906867|FG001|Overall Study|Withdrawal by Subject|11|||
13437478|NCT00367640|26906868|FG002|Overall Study|Withdrawal by Subject|8|||
13437479|NCT00367640|26906869|FG003|Overall Study|Withdrawal by Subject|6|||
13437480|NCT00367640|26906866|FG000|Overall Study|Any other reason not above-mentioned|7|||
13437481|NCT00367640|26906867|FG001|Overall Study|Any other reason not above-mentioned|5|||
13437482|NCT00367640|26906868|FG002|Overall Study|Any other reason not above-mentioned|3|||
13437483|NCT00367640|26906869|FG003|Overall Study|Any other reason not above-mentioned|4|||
13437484|NCT00367484|26906875|FG000|Overall Study|Adverse Event|7|||
13437485|NCT00367484|26906875|FG000|Overall Study|Withdrew informed consent|5|||
13437486|NCT00367484|26906875|FG000|Overall Study|Travel to USA|1|||
13437487|NCT00367484|26906875|FG000|Overall Study|Lost to Follow-up|1|||
13437488|NCT00367484|26906875|FG000|Overall Study|Protocol Violation|1|||
13437489|NCT00367484|26906875|FG000|Overall Study|The choice of the patient|1|||
13437490|NCT00367484|26906875|FG000|Overall Study|Lack of Efficacy|1|||
13437491|NCT00367458|26906896|FG000|First Intervention - 8 Weeks|Adverse Event|2|||
13437492|NCT00367458|26906897|FG001|First Intervention - 8 Weeks|Adverse Event|0|||
13437493|NCT00367432|26906912|FG000|First Period (16 Weeks)|Adverse Event|6|||
13437494|NCT00367432|26906913|FG001|First Period (16 Weeks)|Adverse Event|0|||
13437495|NCT00367432|26906912|FG000|First Period (16 Weeks)|Lack of Efficacy|24|||
13437496|NCT00367432|26906913|FG001|First Period (16 Weeks)|Lack of Efficacy|0|||
13437497|NCT00367432|26906912|FG000|First Period (16 Weeks)|Withdrawal by Subject|6|||
13437498|NCT00367432|26906913|FG001|First Period (16 Weeks)|Withdrawal by Subject|0|||
13437499|NCT00367432|26906912|FG000|First Period (16 Weeks)|Other Reason|2|||
13437500|NCT00367432|26906913|FG001|First Period (16 Weeks)|Other Reason|0|||
13437501|NCT00367432|26906912|FG000|Second Period (up to 54 Months)|Adverse Event|14|||
13437502|NCT00367432|26906913|FG001|Second Period (up to 54 Months)|Adverse Event|3|||
13437503|NCT00367432|26906912|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59|||
13437504|NCT00367432|26906913|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5|||
13437505|NCT00367432|26906912|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0|||
13437506|NCT00367432|26906913|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1|||
13437507|NCT00367432|26906912|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8|||
13437508|NCT00367432|26906913|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5|||
13437509|NCT00367432|26906912|FG000|Second Period (up to 54 Months)|Other Reason|6|||
13437510|NCT00367432|26906913|FG001|Second Period (up to 54 Months)|Other Reason|2|||
13437511|NCT00367341|26906928|FG000|Overall Study|Physician Decision|1|||
13437512|NCT00367341|26906929|FG001|Overall Study|Physician Decision|0|||
13437513|NCT00367341|26906928|FG000|Overall Study|Protocol Violation|1|||
13437514|NCT00367341|26906929|FG001|Overall Study|Protocol Violation|0|||
13437515|NCT00367237|26906942|FG000|Overall Study|Adverse Event|7|||
13437516|NCT00367237|26906943|FG001|Overall Study|Adverse Event|2|||
13437517|NCT00367237|26906942|FG000|Overall Study|Lost to Follow-up|1|||
13437518|NCT00367237|26906943|FG001|Overall Study|Lost to Follow-up|0|||
13437519|NCT00367237|26906942|FG000|Overall Study|Withdrawal by Subject|0|||
13437520|NCT00367237|26906943|FG001|Overall Study|Withdrawal by Subject|4|||
13437521|NCT00367237|26906942|FG000|Overall Study|Protocol Violation|2|||
13437522|NCT00367237|26906943|FG001|Overall Study|Protocol Violation|5|||
13437523|NCT00367133|26907003|FG000|2 Years|Death|20|||
13437524|NCT00367133|26907004|FG001|2 Years|Death|12|||
13437525|NCT00367133|26907005|FG002|2 Years|Death|12|||
13437526|NCT00367133|26907003|FG000|2 Years|Dropped|34|||
13437527|NCT00367133|26907004|FG001|2 Years|Dropped|19|||
13437528|NCT00367133|26907005|FG002|2 Years|Dropped|33|||
13437529|NCT00367133|26907003|FG000|2 Years|Missed visit|4|||
13437530|NCT00367133|26907004|FG001|2 Years|Missed visit|5|||
13437531|NCT00367133|26907005|FG002|2 Years|Missed visit|4|||
13437532|NCT00367055|26907026|FG000|Overall Study|Adverse Event|6|||
13437533|NCT00367055|26907027|FG001|Overall Study|Adverse Event|3|||
13437534|NCT00367055|26907026|FG000|Overall Study|Patient's Willing|3|||
13437535|NCT00367055|26907027|FG001|Overall Study|Patient's Willing|2|||
13437536|NCT00367055|26907026|FG000|Overall Study|Lack of Efficacy|1|||
13437537|NCT00367055|26907027|FG001|Overall Study|Lack of Efficacy|2|||
13437538|NCT00367055|26907026|FG000|Overall Study|Lost to Follow-up|1|||
13437539|NCT00367055|26907027|FG001|Overall Study|Lost to Follow-up|1|||
13437540|NCT00367055|26907026|FG000|Overall Study|Protocol Violation|0|||
13437541|NCT00367055|26907027|FG001|Overall Study|Protocol Violation|1|||
13437542|NCT00367055|26907026|FG000|Overall Study|Stopping Criterion Met|0|||
13437543|NCT00367055|26907027|FG001|Overall Study|Stopping Criterion Met|1|||
13437544|NCT00367055|26907026|FG000|Overall Study|Participant Living too Far from Hospital|0|||
13437545|NCT00367055|26907027|FG001|Overall Study|Participant Living too Far from Hospital|1|||
13437546|NCT00366899|26907092|FG000|Infant Series|Withdrawal by Subject|4|||
13437547|NCT00366899|26907093|FG001|Infant Series|Withdrawal by Subject|7|||
13437548|NCT00366899|26907092|FG000|Infant Series|Protocol Violation|2|||
13437549|NCT00366899|26907093|FG001|Infant Series|Protocol Violation|1|||
13437550|NCT00366899|26907092|FG000|Infant Series|Failed to return|1|||
13437551|NCT00366899|26907093|FG001|Infant Series|Failed to return|1|||
13437552|NCT00366899|26907092|FG000|Infant Series|Lost to Follow-up|0|||
13437553|NCT00366899|26907093|FG001|Infant Series|Lost to Follow-up|2|||
13437554|NCT00366899|26907092|FG000|Infant Series|Adverse Event|0|||
13437555|NCT00366899|26907093|FG001|Infant Series|Adverse Event|1|||
13437556|NCT00366899|26907092|FG000|Infant Series|Physician Decision|1|||
13437557|NCT00366899|26907093|FG001|Infant Series|Physician Decision|0|||
13437558|NCT00366899|26907092|FG000|Infant Series|Randomized but not consented|1|||
13437559|NCT00366899|26907093|FG001|Infant Series|Randomized but not consented|0|||
13437560|NCT00366899|26907092|FG000|After Infant Series|Lost to Follow-up|4|||
13437561|NCT00366899|26907093|FG001|After Infant Series|Lost to Follow-up|3|||
13437562|NCT00366899|26907092|FG000|After Infant Series|Withdrawal by Subject|1|||
13437563|NCT00366899|26907093|FG001|After Infant Series|Withdrawal by Subject|4|||
13437564|NCT00366899|26907092|FG000|After Infant Series|Adverse Event|1|||
13437565|NCT00366899|26907093|FG001|After Infant Series|Adverse Event|2|||
13437566|NCT00366899|26907092|FG000|After Infant Series|Protocol Violation|1|||
13437567|NCT00366899|26907093|FG001|After Infant Series|Protocol Violation|0|||
13437568|NCT00366899|26907092|FG000|Toddler Dose|Withdrawal by Subject|1|||
13437569|NCT00366899|26907093|FG001|Toddler Dose|Withdrawal by Subject|1|||
13437570|NCT00366899|26907092|FG000|Toddler Dose|Protocol Violation|1|||
13437571|NCT00366899|26907093|FG001|Toddler Dose|Protocol Violation|0|||
13437572|NCT00366678|26907166|FG000|Infant Series|Withdrawal by Subject|8|||
13437573|NCT00366678|26907167|FG001|Infant Series|Withdrawal by Subject|6|||
13437574|NCT00366678|26907168|FG002|Infant Series|Withdrawal by Subject|0|||
13437575|NCT00366678|26907166|FG000|Infant Series|Protocol Violation|4|||
13437576|NCT00366678|26907167|FG001|Infant Series|Protocol Violation|3|||
13437577|NCT00366678|26907168|FG002|Infant Series|Protocol Violation|0|||
13437578|NCT00366678|26907166|FG000|Infant Series|Failed to return|1|||
13437579|NCT00366678|26907167|FG001|Infant Series|Failed to return|1|||
13437580|NCT00366678|26907168|FG002|Infant Series|Failed to return|0|||
13437581|NCT00366678|26907166|FG000|Infant Series|Adverse Event|1|||
13437582|NCT00366678|26907167|FG001|Infant Series|Adverse Event|0|||
13437583|NCT00366678|26907168|FG002|Infant Series|Adverse Event|0|||
13437584|NCT00366678|26907166|FG000|After Infant|Withdrawal by Subject|8|||
13437585|NCT00366678|26907167|FG001|After Infant|Withdrawal by Subject|4|||
13437586|NCT00366678|26907168|FG002|After Infant|Withdrawal by Subject|0|||
13437587|NCT00366678|26907166|FG000|After Infant|Lost to Follow-up|2|||
13437588|NCT00366678|26907167|FG001|After Infant|Lost to Follow-up|1|||
13437589|NCT00366678|26907168|FG002|After Infant|Lost to Follow-up|0|||
13437590|NCT00366678|26907166|FG000|After Infant|Failed to return|5|||
13437591|NCT00366678|26907167|FG001|After Infant|Failed to return|5|||
13437592|NCT00366678|26907168|FG002|After Infant|Failed to return|0|||
13437593|NCT00366678|26907166|FG000|After Infant|Adverse Event|1|||
13437594|NCT00366678|26907167|FG001|After Infant|Adverse Event|0|||
13437595|NCT00366678|26907168|FG002|After Infant|Adverse Event|0|||
13437596|NCT00366678|26907166|FG000|After Infant|Protocol Violation|1|||
13437597|NCT00366678|26907167|FG001|After Infant|Protocol Violation|0|||
13437598|NCT00366678|26907168|FG002|After Infant|Protocol Violation|0|||
13437599|NCT00366678|26907166|FG000|Toddler Dose|Protocol Violation|2|||
13437600|NCT00366678|26907167|FG001|Toddler Dose|Protocol Violation|1|||
13437601|NCT00366678|26907168|FG002|Toddler Dose|Protocol Violation|0|||
13437602|NCT00366678|26907166|FG000|Toddler Dose|Failed to return|1|||
13437603|NCT00366678|26907167|FG001|Toddler Dose|Failed to return|0|||
13437604|NCT00366678|26907168|FG002|Toddler Dose|Failed to return|0|||
13437605|NCT00366678|26907166|FG000|Toddler Dose|Withdrawal by Subject|1|||
13437606|NCT00366678|26907167|FG001|Toddler Dose|Withdrawal by Subject|0|||
13437607|NCT00366678|26907168|FG002|Toddler Dose|Withdrawal by Subject|0|||
13437608|NCT00366678|26907166|FG000|Toddler Dose|protocol deviation|1|||
13437609|NCT00366678|26907167|FG001|Toddler Dose|protocol deviation|0|||
13437610|NCT00366678|26907168|FG002|Toddler Dose|protocol deviation|0|||
13437611|NCT00366548|26907209|FG000|Infant Series|Adverse Event|1|||
13437612|NCT00366548|26907210|FG001|Infant Series|Adverse Event|3|||
13437613|NCT00366548|26907209|FG000|Infant Series|Protocol Violation|0|||
13437614|NCT00366548|26907210|FG001|Infant Series|Protocol Violation|1|||
13437615|NCT00366548|26907209|FG000|Infant Series|Withdrawal by Subject|3|||
13437616|NCT00366548|26907210|FG001|Infant Series|Withdrawal by Subject|1|||
13437617|NCT00366548|26907209|FG000|After Infant Series|Withdrawal by Subject|3|||
13437618|NCT00366548|26907210|FG001|After Infant Series|Withdrawal by Subject|1|||
13437619|NCT00366548|26907209|FG000|After Infant Series|Adverse Event|2|||
13437620|NCT00366548|26907210|FG001|After Infant Series|Adverse Event|0|||
13437621|NCT00366548|26907209|FG000|After Infant Series|Lost to Follow-up|1|||
13437622|NCT00366548|26907210|FG001|After Infant Series|Lost to Follow-up|0|||
13437623|NCT00366535|26907231|FG000|First Phase: 12 Weeks|Adverse Event|1|||
13437624|NCT00366535|26907232|FG001|First Phase: 12 Weeks|Adverse Event|3|||
13437625|NCT00366535|26907231|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2|||
13437626|NCT00366535|26907232|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5|||
13437627|NCT00366535|26907231|FG000|Second Phase: 12 Weeks|Adverse Event|1|||
13437628|NCT00366535|26907232|FG001|Second Phase: 12 Weeks|Adverse Event|1|||
13437629|NCT00366535|26907231|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
13437630|NCT00366535|26907232|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
13437631|NCT00366457|26907241|FG000|Overall Study|never began study therapy|2|||
13437632|NCT00366444|26907274|FG000|Overall Study|Withdrawal by Subject|1|||
13437633|NCT00366444|26907275|FG001|Overall Study|Withdrawal by Subject|1|||
13437634|NCT00366444|26907274|FG000|Overall Study|Lack of Efficacy|0|||
13437635|NCT00366444|26907275|FG001|Overall Study|Lack of Efficacy|1|||
13437636|NCT00366340|26907336|FG000|Infant Series|Protocol Violation|3|||
13437637|NCT00366340|26907337|FG001|Infant Series|Protocol Violation|4|||
13437638|NCT00366340|26907336|FG000|Infant Series|Withdrawal by Subject|3|||
13437639|NCT00366340|26907337|FG001|Infant Series|Withdrawal by Subject|3|||
13437640|NCT00366340|26907336|FG000|Infant Series|Adverse Event|0|||
13437641|NCT00366340|26907337|FG001|Infant Series|Adverse Event|2|||
13437642|NCT00366340|26907336|FG000|Infant Series|Lost to Follow-up|1|||
13437643|NCT00366340|26907337|FG001|Infant Series|Lost to Follow-up|1|||
13437644|NCT00366340|26907336|FG000|Infant Series|Failure to return|1|||
13437645|NCT00366340|26907337|FG001|Infant Series|Failure to return|0|||
13437646|NCT00366340|26907336|FG000|After the Infant Series|Parent/legal guardian request|1|||
13437647|NCT00366340|26907337|FG001|After the Infant Series|Parent/legal guardian request|1|||
13437648|NCT00366340|26907336|FG000|After the Infant Series|Failed to return|0|||
13437649|NCT00366340|26907337|FG001|After the Infant Series|Failed to return|1|||
13437650|NCT00366340|26907336|FG000|After the Infant Series|Protocol Violation|2|||
13437651|NCT00366340|26907337|FG001|After the Infant Series|Protocol Violation|2|||
13437652|NCT00366340|26907336|FG000|After the Infant Series|Adverse Event|0|||
13437653|NCT00366340|26907337|FG001|After the Infant Series|Adverse Event|1|||
13437654|NCT00366340|26907336|FG000|After the Infant Series|Lost to Follow-up|0|||
13437655|NCT00366340|26907337|FG001|After the Infant Series|Lost to Follow-up|1|||
13437656|NCT00366340|26907336|FG000|Toddler Dose|Failed to return|1|||
13437657|NCT00366340|26907337|FG001|Toddler Dose|Failed to return|0|||
13437658|NCT00366340|26907336|FG000|Toddler Dose|Parent/legal guardian request|0|||
13437659|NCT00366340|26907337|FG001|Toddler Dose|Parent/legal guardian request|1|||
13437660|NCT00366301|26907360|FG000|Overall Study|Lost to Follow-up|4|||
13437661|NCT00366301|26907361|FG001|Overall Study|Lost to Follow-up|4|||
13437662|NCT00366301|26907362|FG002|Overall Study|Lost to Follow-up|3|||
13437663|NCT00366301|26907363|FG003|Overall Study|Lost to Follow-up|7|||
13437664|NCT00366301|26907360|FG000|Overall Study|Withdrawal by Subject|4|||
13437665|NCT00366301|26907361|FG001|Overall Study|Withdrawal by Subject|2|||
13437666|NCT00366301|26907362|FG002|Overall Study|Withdrawal by Subject|1|||
13437667|NCT00366301|26907363|FG003|Overall Study|Withdrawal by Subject|1|||
13437668|NCT00366249|26907384|FG000|Overall Study|Adverse Event|53|||
13437669|NCT00366249|26907385|FG001|Overall Study|Adverse Event|28|||
13437670|NCT00366249|26907384|FG000|Overall Study|Death|0|||
13437671|NCT00366249|26907385|FG001|Overall Study|Death|1|||
13437672|NCT00366249|26907384|FG000|Overall Study|Physician Decision|5|||
13437673|NCT00366249|26907385|FG001|Overall Study|Physician Decision|2|||
13437674|NCT00366249|26907384|FG000|Overall Study|Lost to Follow-up|2|||
13437675|NCT00366249|26907385|FG001|Overall Study|Lost to Follow-up|0|||
13437676|NCT00366249|26907384|FG000|Overall Study|Protocol Violation|1|||
13437677|NCT00366249|26907385|FG001|Overall Study|Protocol Violation|2|||
13437678|NCT00366249|26907384|FG000|Overall Study|Withdrawal by Subject|18|||
13437679|NCT00366249|26907385|FG001|Overall Study|Withdrawal by Subject|4|||
13437680|NCT00366249|26907384|FG000|Overall Study|Lack of Efficacy|21|||
13437681|NCT00366249|26907385|FG001|Overall Study|Lack of Efficacy|21|||
13437682|NCT00366249|26907384|FG000|Overall Study|Most due to osteomylitis status|31|||
13437683|NCT00366249|26907385|FG001|Overall Study|Most due to osteomylitis status|20|||
13437684|NCT00365989|26907393|FG000|Overall Study|Withdrawal by Subject|1|||
13437685|NCT00365989|26907393|FG000|Overall Study|Non-compliance|1|||
13437686|NCT00365976|26907428|FG000|Overall Study|Withdrawal by Subject|1|||
13437687|NCT00365976|26907429|FG001|Overall Study|Withdrawal by Subject|5|||
13437688|NCT00365846|26907440|FG000|Overall Study|Lost to Follow-up|1|||
13437689|NCT00365794|26907455|FG000|Overall Study|Withdrawal by Subject|2|||
13437690|NCT00365716|26907488|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1|||
13437691|NCT00365716|26907489|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2|||
13437692|NCT00365716|26907490|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
13437693|NCT00365716|26907491|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
13437694|NCT00365716|26907492|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
13437695|NCT00365716|26907493|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
13437696|NCT00365716|26907494|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
13437697|NCT00365716|26907488|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0|||
13437698|NCT00365716|26907489|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2|||
13437699|NCT00365716|26907490|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0|||
13437700|NCT00365716|26907491|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0|||
13437701|NCT00365716|26907492|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1|||
13437702|NCT00365716|26907493|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0|||
13437703|NCT00365716|26907494|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0|||
13437704|NCT00365716|26907488|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
13437705|NCT00365716|26907489|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
13437706|NCT00365716|26907490|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
13437707|NCT00365716|26907491|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
13437708|NCT00365716|26907492|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
13437709|NCT00365716|26907493|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
13437710|NCT00365716|26907494|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
13437711|NCT00365716|26907488|FG000|Base Study (Day 1 to Month 7)|Other|0|||
13437712|NCT00365716|26907489|FG001|Base Study (Day 1 to Month 7)|Other|1|||
13437713|NCT00365716|26907490|FG002|Base Study (Day 1 to Month 7)|Other|0|||
13437714|NCT00365716|26907491|FG003|Base Study (Day 1 to Month 7)|Other|0|||
13437715|NCT00365716|26907492|FG004|Base Study (Day 1 to Month 7)|Other|0|||
13437716|NCT00365716|26907493|FG005|Base Study (Day 1 to Month 7)|Other|0|||
13437717|NCT00365716|26907494|FG006|Base Study (Day 1 to Month 7)|Other|0|||
13437718|NCT00365716|26907488|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3|||
13437719|NCT00365716|26907489|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2|||
13437720|NCT00365716|26907490|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3|||
13437721|NCT00365716|26907491|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1|||
13437722|NCT00365716|26907492|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1|||
13437723|NCT00365716|26907493|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0|||
13437724|NCT00365716|26907494|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0|||
13437725|NCT00365716|26907488|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
13437726|NCT00365716|26907489|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
13437727|NCT00365716|26907490|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
13437728|NCT00365716|26907491|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
13437729|NCT00365716|26907492|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
13437730|NCT00365716|26907493|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
13437731|NCT00365716|26907494|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
13437732|NCT00365716|26907488|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
13437733|NCT00365716|26907489|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9|||
13437734|NCT00365716|26907490|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
13437735|NCT00365716|26907491|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4|||
13437736|NCT00365716|26907492|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3|||
13437737|NCT00365716|26907493|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
13437738|NCT00365716|26907494|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
13437739|NCT00365716|26907488|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114|||
13437740|NCT00365716|26907489|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
13437741|NCT00365716|26907490|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
13437742|NCT00365716|26907491|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69|||
13437743|NCT00365716|26907492|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75|||
13437744|NCT00365716|26907493|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
13437745|NCT00365716|26907494|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
13437746|NCT00365716|26907488|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6|||
13437747|NCT00365716|26907489|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8|||
13437748|NCT00365716|26907490|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5|||
13437749|NCT00365716|26907491|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4|||
13437750|NCT00365716|26907492|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3|||
13437751|NCT00365716|26907493|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
13437752|NCT00365716|26907494|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
13437753|NCT00365716|26907488|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3|||
13437754|NCT00365716|26907489|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
13437755|NCT00365716|26907490|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1|||
13437756|NCT00365716|26907491|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
13437757|NCT00365716|26907492|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
13437758|NCT00365716|26907493|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
13437759|NCT00365716|26907494|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
13437760|NCT00365716|26907488|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2|||
13437761|NCT00365716|26907489|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
13437762|NCT00365716|26907490|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
13437763|NCT00365716|26907491|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
13437764|NCT00365716|26907492|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1|||
13437765|NCT00365716|26907493|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
13437766|NCT00365716|26907494|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
13437767|NCT00365716|26907488|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
13437768|NCT00365716|26907489|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
13437769|NCT00365716|26907490|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
13437770|NCT00365716|26907491|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
13437771|NCT00365716|26907492|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
13437772|NCT00365716|26907493|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
13437773|NCT00365716|26907494|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
13437774|NCT00365716|26907488|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7|||
13437775|NCT00365716|26907489|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
13437776|NCT00365716|26907490|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13|||
13437777|NCT00365716|26907491|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
13437778|NCT00365716|26907492|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3|||
13437779|NCT00365716|26907493|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
13437780|NCT00365716|26907494|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
13437781|NCT00365716|26907488|FG000|Extension 1|Lost to Follow-up|0|||
13437782|NCT00365716|26907489|FG001|Extension 1|Lost to Follow-up|0|||
13437783|NCT00365716|26907490|FG002|Extension 1|Lost to Follow-up|0|||
13437784|NCT00365716|26907491|FG003|Extension 1|Lost to Follow-up|0|||
13437785|NCT00365716|26907492|FG004|Extension 1|Lost to Follow-up|0|||
13437786|NCT00365716|26907493|FG005|Extension 1|Lost to Follow-up|1|||
13437787|NCT00365716|26907494|FG006|Extension 1|Lost to Follow-up|0|||
13437788|NCT00365716|26907488|FG000|Extension 1|Other|0|||
13437789|NCT00365716|26907489|FG001|Extension 1|Other|0|||
13437790|NCT00365716|26907490|FG002|Extension 1|Other|0|||
13437791|NCT00365716|26907491|FG003|Extension 1|Other|0|||
13437792|NCT00365716|26907492|FG004|Extension 1|Other|0|||
13437793|NCT00365716|26907493|FG005|Extension 1|Other|9|||
13437794|NCT00365716|26907494|FG006|Extension 1|Other|0|||
13437795|NCT00365716|26907488|FG000|Extension 1|Moved|0|||
13437796|NCT00365716|26907489|FG001|Extension 1|Moved|0|||
13437797|NCT00365716|26907490|FG002|Extension 1|Moved|0|||
13437798|NCT00365716|26907491|FG003|Extension 1|Moved|0|||
13437799|NCT00365716|26907492|FG004|Extension 1|Moved|0|||
13437800|NCT00365716|26907493|FG005|Extension 1|Moved|4|||
13437801|NCT00365716|26907494|FG006|Extension 1|Moved|0|||
13437802|NCT00365716|26907488|FG000|Extension 1|Withdrawal by Subject|0|||
13437803|NCT00365716|26907489|FG001|Extension 1|Withdrawal by Subject|0|||
13437804|NCT00365716|26907490|FG002|Extension 1|Withdrawal by Subject|0|||
13437805|NCT00365716|26907491|FG003|Extension 1|Withdrawal by Subject|0|||
13437806|NCT00365716|26907492|FG004|Extension 1|Withdrawal by Subject|0|||
13437807|NCT00365716|26907493|FG005|Extension 1|Withdrawal by Subject|3|||
13437808|NCT00365716|26907494|FG006|Extension 1|Withdrawal by Subject|0|||
13437809|NCT00365716|26907488|FG000|Extension 1|Pregnancy|0|||
13437810|NCT00365716|26907489|FG001|Extension 1|Pregnancy|0|||
13437811|NCT00365716|26907490|FG002|Extension 1|Pregnancy|0|||
13437812|NCT00365716|26907491|FG003|Extension 1|Pregnancy|0|||
13437813|NCT00365716|26907492|FG004|Extension 1|Pregnancy|0|||
13437814|NCT00365716|26907493|FG005|Extension 1|Pregnancy|4|||
13437815|NCT00365716|26907494|FG006|Extension 1|Pregnancy|0|||
13437816|NCT00365716|26907488|FG000|Extension 1|Protocol Violation|0|||
13437817|NCT00365716|26907489|FG001|Extension 1|Protocol Violation|0|||
13437818|NCT00365716|26907490|FG002|Extension 1|Protocol Violation|0|||
13437819|NCT00365716|26907491|FG003|Extension 1|Protocol Violation|0|||
13437820|NCT00365716|26907492|FG004|Extension 1|Protocol Violation|0|||
13437821|NCT00365716|26907493|FG005|Extension 1|Protocol Violation|1|||
13437822|NCT00365716|26907494|FG006|Extension 1|Protocol Violation|0|||
13437823|NCT00365716|26907488|FG000|Extension 2|Lost to Follow-up|0|||
13437824|NCT00365716|26907489|FG001|Extension 2|Lost to Follow-up|0|||
13437825|NCT00365716|26907490|FG002|Extension 2|Lost to Follow-up|0|||
13437826|NCT00365716|26907491|FG003|Extension 2|Lost to Follow-up|0|||
13437827|NCT00365716|26907492|FG004|Extension 2|Lost to Follow-up|0|||
13437828|NCT00365716|26907493|FG005|Extension 2|Lost to Follow-up|0|||
13437829|NCT00365716|26907494|FG006|Extension 2|Lost to Follow-up|2|||
13437830|NCT00365716|26907488|FG000|Extension 2|Other|0|||
13437831|NCT00365716|26907489|FG001|Extension 2|Other|0|||
13437832|NCT00365716|26907490|FG002|Extension 2|Other|0|||
13437833|NCT00365716|26907491|FG003|Extension 2|Other|0|||
13437834|NCT00365716|26907492|FG004|Extension 2|Other|0|||
13437835|NCT00365716|26907493|FG005|Extension 2|Other|0|||
13437836|NCT00365716|26907494|FG006|Extension 2|Other|3|||
13437837|NCT00365716|26907488|FG000|Extension 2|Withdrawal by Subject|0|||
13437838|NCT00365716|26907489|FG001|Extension 2|Withdrawal by Subject|0|||
13437839|NCT00365716|26907490|FG002|Extension 2|Withdrawal by Subject|0|||
13437840|NCT00365716|26907491|FG003|Extension 2|Withdrawal by Subject|0|||
13437841|NCT00365716|26907492|FG004|Extension 2|Withdrawal by Subject|0|||
13437842|NCT00365716|26907493|FG005|Extension 2|Withdrawal by Subject|0|||
13437843|NCT00365716|26907494|FG006|Extension 2|Withdrawal by Subject|5|||
13437844|NCT00365547|26907504|FG000|Overall Study|Insurance did not cover Avastin|1|||
13437845|NCT00365547|26907504|FG000|Overall Study|Screen failure|1|||
13437846|NCT00365547|26907504|FG000|Overall Study|Withdrawal by Subject|1|||
13437847|NCT00365508|26907519|FG000|Overall Study|Lost to Follow-up|139|||
13437848|NCT00365508|26907520|FG001|Overall Study|Lost to Follow-up|154|||
13437849|NCT00365456|26907529|FG000|Trial Period I (12 Months)|Adverse Event|84|||
13437850|NCT00365456|26907530|FG001|Trial Period I (12 Months)|Adverse Event|0|||
13437851|NCT00365456|26907529|FG000|Trial Period I (12 Months)|Non-compliance|3|||
13437852|NCT00365456|26907530|FG001|Trial Period I (12 Months)|Non-compliance|0|||
13437853|NCT00365456|26907529|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27|||
13437854|NCT00365456|26907530|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0|||
13437855|NCT00365456|26907529|FG000|Trial Period I (12 Months)|Other|11|||
13437856|NCT00365456|26907530|FG001|Trial Period I (12 Months)|Other|0|||
13437857|NCT00365456|26907529|FG000|Trial Period II (12 Months)|Adverse Event|0|||
13437858|NCT00365456|26907530|FG001|Trial Period II (12 Months)|Adverse Event|6|||
13437859|NCT00365456|26907529|FG000|Trial Period II (12 Months)|Non-compliance|0|||
13437860|NCT00365456|26907530|FG001|Trial Period II (12 Months)|Non-compliance|2|||
13437861|NCT00365456|26907529|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0|||
13437862|NCT00365456|26907530|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5|||
13437863|NCT00365456|26907529|FG000|Trial Period II (12 Months)|Other|0|||
13437864|NCT00365456|26907530|FG001|Trial Period II (12 Months)|Other|1|||
13437865|NCT00365456|26907529|FG000|Trial Period III (12 Months)|Adverse Event|13|||
13437866|NCT00365456|26907530|FG001|Trial Period III (12 Months)|Adverse Event|3|||
13437867|NCT00365456|26907529|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4|||
13437868|NCT00365456|26907530|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1|||
13437869|NCT00365456|26907529|FG000|Trial Period III (12 Months)|Other|1|||
13437870|NCT00365456|26907530|FG001|Trial Period III (12 Months)|Other|1|||
13437871|NCT00365378|26907549|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11|||
13437872|NCT00365378|26907550|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7|||
13437873|NCT00365378|26907551|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
13437874|NCT00365378|26907549|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4|||
13437875|NCT00365378|26907550|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5|||
13437876|NCT00365378|26907551|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0|||
13437877|NCT00365378|26907549|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88|||
13437878|NCT00365378|26907550|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75|||
13437879|NCT00365378|26907551|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0|||
13437880|NCT00365378|26907549|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19|||
13437881|NCT00365378|26907550|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14|||
13437882|NCT00365378|26907551|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0|||
13437883|NCT00365378|26907549|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22|||
13437884|NCT00365378|26907550|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13|||
13437885|NCT00365378|26907551|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0|||
13437886|NCT00365378|26907549|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50|||
13437887|NCT00365378|26907550|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44|||
13437888|NCT00365378|26907551|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0|||
13437889|NCT00365378|26907549|FG000|Vaccination (Day 1 to Month 7)|Other|17|||
13437890|NCT00365378|26907550|FG001|Vaccination (Day 1 to Month 7)|Other|9|||
13437891|NCT00365378|26907551|FG002|Vaccination (Day 1 to Month 7)|Other|0|||
13437892|NCT00365378|26907549|FG000|Follow-up (Month 7 Though Month 48)|Moved|6|||
13437893|NCT00365378|26907550|FG001|Follow-up (Month 7 Though Month 48)|Moved|5|||
13437894|NCT00365378|26907551|FG002|Follow-up (Month 7 Though Month 48)|Moved|0|||
13437895|NCT00365378|26907549|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67|||
13437896|NCT00365378|26907550|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69|||
13437897|NCT00365378|26907551|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0|||
13437898|NCT00365378|26907549|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
13437899|NCT00365378|26907550|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1|||
13437900|NCT00365378|26907551|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
13437901|NCT00365378|26907549|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1|||
13437902|NCT00365378|26907550|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2|||
13437903|NCT00365378|26907551|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0|||
13437904|NCT00365378|26907549|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73|||
13437905|NCT00365378|26907550|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104|||
13437906|NCT00365378|26907551|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0|||
13437907|NCT00365378|26907549|FG000|Follow-up (Month 7 Though Month 48)|Other|11|||
13437908|NCT00365378|26907550|FG001|Follow-up (Month 7 Though Month 48)|Other|21|||
13437909|NCT00365378|26907551|FG002|Follow-up (Month 7 Though Month 48)|Other|0|||
13437910|NCT00365378|26907549|FG000|Extension|Adverse Event|0|||
13437911|NCT00365378|26907550|FG001|Extension|Adverse Event|0|||
13437912|NCT00365378|26907551|FG002|Extension|Adverse Event|1|||
13437913|NCT00365378|26907549|FG000|Extension|Moved|0|||
13437914|NCT00365378|26907550|FG001|Extension|Moved|0|||
13437915|NCT00365378|26907551|FG002|Extension|Moved|8|||
13437916|NCT00365378|26907549|FG000|Extension|Lost to Follow-up|0|||
13437917|NCT00365378|26907550|FG001|Extension|Lost to Follow-up|0|||
13437918|NCT00365378|26907551|FG002|Extension|Lost to Follow-up|57|||
13437919|NCT00365378|26907549|FG000|Extension|Protocol Violation|0|||
13437920|NCT00365378|26907550|FG001|Extension|Protocol Violation|0|||
13437921|NCT00365378|26907551|FG002|Extension|Protocol Violation|2|||
13437922|NCT00365378|26907549|FG000|Extension|Withdrawal by Subject|0|||
13437923|NCT00365378|26907550|FG001|Extension|Withdrawal by Subject|0|||
13437924|NCT00365378|26907551|FG002|Extension|Withdrawal by Subject|98|||
13437925|NCT00365378|26907549|FG000|Extension|Other|0|||
13437926|NCT00365378|26907550|FG001|Extension|Other|0|||
13437927|NCT00365378|26907551|FG002|Extension|Other|31|||
13437928|NCT00365365|26907575|FG000|Overall Study|Randomized but not treated|0|||
13437929|NCT00365365|26907576|FG001|Overall Study|Randomized but not treated|2|||
13437930|NCT00365365|26907577|FG002|Overall Study|Randomized but not treated|0|||
13437931|NCT00365365|26907575|FG000|Overall Study|Poor compliance to protocol|0|||
13437932|NCT00365365|26907576|FG001|Overall Study|Poor compliance to protocol|1|||
13437933|NCT00365365|26907577|FG002|Overall Study|Poor compliance to protocol|0|||
13437934|NCT00365365|26907575|FG000|Overall Study|Lost to Follow-up|3|||
13437935|NCT00365365|26907576|FG001|Overall Study|Lost to Follow-up|3|||
13437936|NCT00365365|26907577|FG002|Overall Study|Lost to Follow-up|3|||
13437937|NCT00365365|26907575|FG000|Overall Study|Death|1|||
13437938|NCT00365365|26907576|FG001|Overall Study|Death|3|||
13437939|NCT00365365|26907577|FG002|Overall Study|Death|0|||
13437940|NCT00365365|26907575|FG000|Overall Study|Subject's request|11|||
13437941|NCT00365365|26907576|FG001|Overall Study|Subject's request|13|||
13437942|NCT00365365|26907577|FG002|Overall Study|Subject's request|1|||
13437943|NCT00365365|26907575|FG000|Overall Study|Disease progression/relapse|9|||
13437944|NCT00365365|26907576|FG001|Overall Study|Disease progression/relapse|6|||
13437945|NCT00365365|26907577|FG002|Overall Study|Disease progression/relapse|7|||
13437946|NCT00365365|26907575|FG000|Overall Study|Adverse Event|6|||
13437947|NCT00365365|26907576|FG001|Overall Study|Adverse Event|6|||
13437948|NCT00365365|26907577|FG002|Overall Study|Adverse Event|3|||
13437949|NCT00365365|26907575|FG000|Overall Study|Moved|2|||
13437950|NCT00365365|26907576|FG001|Overall Study|Moved|0|||
13437951|NCT00365365|26907577|FG002|Overall Study|Moved|0|||
13437952|NCT00365365|26907575|FG000|Overall Study|New cancer|1|||
13437953|NCT00365365|26907576|FG001|Overall Study|New cancer|0|||
13437954|NCT00365365|26907577|FG002|Overall Study|New cancer|0|||
13437955|NCT00365365|26907575|FG000|Overall Study|Withdrew consent|1|||
13437956|NCT00365365|26907576|FG001|Overall Study|Withdrew consent|1|||
13437957|NCT00365365|26907577|FG002|Overall Study|Withdrew consent|0|||
13437958|NCT00365365|26907575|FG000|Overall Study|Second malignancy|0|||
13437959|NCT00365365|26907576|FG001|Overall Study|Second malignancy|1|||
13437960|NCT00365365|26907577|FG002|Overall Study|Second malignancy|0|||
13437961|NCT00365365|26907575|FG000|Overall Study|Patient/physician decision|0|||
13437962|NCT00365365|26907576|FG001|Overall Study|Patient/physician decision|0|||
13437963|NCT00365365|26907577|FG002|Overall Study|Patient/physician decision|1|||
13437964|NCT00365352|26907669|FG000|Overall Study|Adverse Event|6|||
13437965|NCT00365352|26907670|FG001|Overall Study|Adverse Event|7|||
13437966|NCT00365352|26907671|FG002|Overall Study|Adverse Event|8|||
13437967|NCT00365352|26907669|FG000|Overall Study|Participant Withdrew Consent|8|||
13437968|NCT00365352|26907670|FG001|Overall Study|Participant Withdrew Consent|3|||
13437969|NCT00365352|26907671|FG002|Overall Study|Participant Withdrew Consent|4|||
13437970|NCT00365352|26907669|FG000|Overall Study|Lack of Efficacy|3|||
13437971|NCT00365352|26907670|FG001|Overall Study|Lack of Efficacy|0|||
13437972|NCT00365352|26907671|FG002|Overall Study|Lack of Efficacy|0|||
13437973|NCT00365352|26907669|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
13437974|NCT00365352|26907670|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
13437975|NCT00365352|26907671|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2|||
13437976|NCT00365352|26907669|FG000|Overall Study|Non-Compliance (after Randomization)|1|||
13437977|NCT00365352|26907670|FG001|Overall Study|Non-Compliance (after Randomization)|0|||
13437978|NCT00365352|26907671|FG002|Overall Study|Non-Compliance (after Randomization)|1|||
13437979|NCT00365352|26907669|FG000|Overall Study|Lost to Follow-up|1|||
13437980|NCT00365352|26907670|FG001|Overall Study|Lost to Follow-up|1|||
13437981|NCT00365352|26907671|FG002|Overall Study|Lost to Follow-up|0|||
13437982|NCT00365352|26907669|FG000|Overall Study|Withdrawal of Participant by Sponsor|1|||
13437983|NCT00365352|26907670|FG001|Overall Study|Withdrawal of Participant by Sponsor|0|||
13437984|NCT00365352|26907671|FG002|Overall Study|Withdrawal of Participant by Sponsor|0|||
13437985|NCT00365300|26907687|FG000|Open-label Phase|Adverse Event|4|||
13437986|NCT00365300|26907688|FG001|Open-label Phase|Adverse Event|0|||
13437987|NCT00365300|26907687|FG000|Open-label Phase|Failed to Return|1|||
13437988|NCT00365300|26907688|FG001|Open-label Phase|Failed to Return|0|||
13437989|NCT00365300|26907687|FG000|Open-label Phase|Physician Decision|1|||
13437990|NCT00365300|26907688|FG001|Open-label Phase|Physician Decision|0|||
13437991|NCT00365300|26907687|FG000|Open-label Phase|Noncompliance|9|||
13437992|NCT00365300|26907688|FG001|Open-label Phase|Noncompliance|0|||
13437993|NCT00365300|26907687|FG000|Open-label Phase|Parent/Legal Guardian Request|4|||
13437994|NCT00365300|26907688|FG001|Open-label Phase|Parent/Legal Guardian Request|0|||
13437995|NCT00365300|26907687|FG000|Open-label Phase|Protocol Violation|1|||
13437996|NCT00365300|26907688|FG001|Open-label Phase|Protocol Violation|0|||
13437997|NCT00365300|26907687|FG000|Open-label Phase|Lack of Efficacy|1|||
13437998|NCT00365300|26907688|FG001|Open-label Phase|Lack of Efficacy|0|||
13437999|NCT00365300|26907687|FG000|Open-label Phase|Patient skipped open label phase|1|||
13438000|NCT00365300|26907688|FG001|Open-label Phase|Patient skipped open label phase|0|||
13438001|NCT00365300|26907687|FG000|Double-blind Phase|Failed to return|1|||
13438002|NCT00365300|26907688|FG001|Double-blind Phase|Failed to return|0|||
13438003|NCT00365300|26907687|FG000|Double-blind Phase|Noncompliance|1|||
13438004|NCT00365300|26907688|FG001|Double-blind Phase|Noncompliance|1|||
13438005|NCT00365300|26907687|FG000|Double-blind Phase|Withdrawal by Subject|0|||
13438006|NCT00365300|26907688|FG001|Double-blind Phase|Withdrawal by Subject|1|||
13438007|NCT00365300|26907687|FG000|Double-blind Phase|Protocol Violation|3|||
13438008|NCT00365300|26907688|FG001|Double-blind Phase|Protocol Violation|1|||
13438009|NCT00365300|26907687|FG000|Double-blind Phase|Lack of Efficacy|6|||
13438010|NCT00365300|26907688|FG001|Double-blind Phase|Lack of Efficacy|6|||
13438011|NCT00365105|26907711|FG000|Overall Study|Protocol Violation|5|||
13438012|NCT00365105|26907712|FG001|Overall Study|Protocol Violation|8|||
13438013|NCT00364923|26907721|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4|||
13438014|NCT00364923|26907721|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24|||
13438015|NCT00364858|26907741|FG000|Overall Study|Adverse Event|1|||
13438016|NCT00364858|26907742|FG001|Overall Study|Adverse Event|5|||
13438017|NCT00364858|26907741|FG000|Overall Study|Withdrawal by Subject|1|||
13438018|NCT00364858|26907742|FG001|Overall Study|Withdrawal by Subject|1|||
13438019|NCT00364858|26907741|FG000|Overall Study|Pregnancy|1|||
13438020|NCT00364858|26907742|FG001|Overall Study|Pregnancy|1|||
13438021|NCT00364858|26907741|FG000|Overall Study|Clinical failure|2|||
13438022|NCT00364858|26907742|FG001|Overall Study|Clinical failure|13|||
13438023|NCT00364858|26907741|FG000|Overall Study|Discontinuation at baseline|1|||
13438024|NCT00364858|26907742|FG001|Overall Study|Discontinuation at baseline|0|||
13438025|NCT00364858|26907741|FG000|Overall Study|Non-compliant|1|||
13438026|NCT00364858|26907742|FG001|Overall Study|Non-compliant|0|||
13438027|NCT00364858|26907741|FG000|Overall Study|Return to Q2 regimen|0|||
13438028|NCT00364858|26907742|FG001|Overall Study|Return to Q2 regimen|1|||
13438029|NCT00364858|26907741|FG000|Overall Study|Clinical baseline issue|0|||
13438030|NCT00364858|26907742|FG001|Overall Study|Clinical baseline issue|1|||
13438031|NCT00364845|26907761|FG000|Overall Study|Adverse Event|1|||
13438032|NCT00364845|26907762|FG001|Overall Study|Adverse Event|0|||
13438033|NCT00364845|26907761|FG000|Overall Study|Withdrawal by Subject|2|||
13438034|NCT00364845|26907762|FG001|Overall Study|Withdrawal by Subject|1|||
13438035|NCT00364845|26907761|FG000|Overall Study|Physician Decision|8|||
13438036|NCT00364845|26907762|FG001|Overall Study|Physician Decision|8|||
13438037|NCT00364845|26907761|FG000|Overall Study|Lost to Follow-up|0|||
13438038|NCT00364845|26907762|FG001|Overall Study|Lost to Follow-up|1|||
13438039|NCT00364845|26907761|FG000|Overall Study|Death|0|||
13438040|NCT00364845|26907762|FG001|Overall Study|Death|1|||
13438041|NCT00364832|26907846|FG000|Core Period|Early Withdrawals|2|||
13438042|NCT00364832|26907847|FG001|Core Period|Early Withdrawals|2|||
13438043|NCT00364832|26907848|FG002|Core Period|Early Withdrawals|1|||
13438044|NCT00364832|26907849|FG003|Core Period|Early Withdrawals|1|||
13438045|NCT00364832|26907850|FG004|Core Period|Early Withdrawals|0|||
13438046|NCT00364832|26907851|FG005|Core Period|Early Withdrawals|0|||
13438047|NCT00364832|26907852|FG006|Core Period|Early Withdrawals|4|||
13438048|NCT00364832|26907853|FG007|Core Period|Early Withdrawals|1|||
13438049|NCT00364832|26907854|FG008|Core Period|Early Withdrawals|0|||
13438050|NCT00364832|26907855|FG009|Core Period|Early Withdrawals|0|||
13438051|NCT00364832|26907856|FG010|Core Period|Early Withdrawals|0|||
13438052|NCT00364832|26907857|FG011|Core Period|Early Withdrawals|0|||
13438053|NCT00364832|26907846|FG000|Extension Year 1|Early Withdrawals|0|||
13438054|NCT00364832|26907847|FG001|Extension Year 1|Early Withdrawals|0|||
13438055|NCT00364832|26907848|FG002|Extension Year 1|Early Withdrawals|0|||
13438056|NCT00364832|26907849|FG003|Extension Year 1|Early Withdrawals|0|||
13438057|NCT00364832|26907850|FG004|Extension Year 1|Early Withdrawals|0|||
13438058|NCT00364832|26907851|FG005|Extension Year 1|Early Withdrawals|0|||
13438059|NCT00364832|26907852|FG006|Extension Year 1|Early Withdrawals|0|||
13438060|NCT00364832|26907853|FG007|Extension Year 1|Early Withdrawals|0|||
13438061|NCT00364832|26907854|FG008|Extension Year 1|Early Withdrawals|0|||
13438062|NCT00364832|26907855|FG009|Extension Year 1|Early Withdrawals|4|||
13438063|NCT00364832|26907856|FG010|Extension Year 1|Early Withdrawals|2|||
13438064|NCT00364832|26907857|FG011|Extension Year 1|Early Withdrawals|10|||
13438065|NCT00364832|26907846|FG000|Extension Year 2|Early Withdrawals|0|||
13438066|NCT00364832|26907847|FG001|Extension Year 2|Early Withdrawals|0|||
13438067|NCT00364832|26907848|FG002|Extension Year 2|Early Withdrawals|0|||
13438068|NCT00364832|26907849|FG003|Extension Year 2|Early Withdrawals|0|||
13438069|NCT00364832|26907850|FG004|Extension Year 2|Early Withdrawals|0|||
13438070|NCT00364832|26907851|FG005|Extension Year 2|Early Withdrawals|0|||
13438071|NCT00364832|26907852|FG006|Extension Year 2|Early Withdrawals|0|||
13438072|NCT00364832|26907853|FG007|Extension Year 2|Early Withdrawals|0|||
13438073|NCT00364832|26907854|FG008|Extension Year 2|Early Withdrawals|0|||
13438074|NCT00364832|26907855|FG009|Extension Year 2|Early Withdrawals|5|||
13438075|NCT00364832|26907856|FG010|Extension Year 2|Early Withdrawals|5|||
13438076|NCT00364832|26907857|FG011|Extension Year 2|Early Withdrawals|3|||
13477017|NCT01624142|27005011|FG000|Overall Study|Withdrawal by Subject|14|||
13477018|NCT01624142|27005012|FG001|Overall Study|Withdrawal by Subject|4|||
13477019|NCT01624142|27005011|FG000|Overall Study|Death|3|||
13477020|NCT01624142|27005012|FG001|Overall Study|Death|6|||
13477021|NCT01624142|27005011|FG000|Overall Study|Study Closure|12|||
13477022|NCT01624142|27005012|FG001|Overall Study|Study Closure|6|||
13477023|NCT01624142|27005011|FG000|Overall Study|Lost to Follow-up|2|||
13477024|NCT01624142|27005012|FG001|Overall Study|Lost to Follow-up|0|||
13477025|NCT01624142|27005011|FG000|Overall Study|Other|1|||
13477026|NCT01624142|27005012|FG001|Overall Study|Other|0|||
13477027|NCT01535807|27005027|FG000|Overall Study|Withdrawal by Subject|1|||
13477028|NCT01535807|27005028|FG001|Overall Study|Withdrawal by Subject|1|||
13477029|NCT01535807|27005027|FG000|Overall Study|Data collection error|1|||
13477030|NCT01535807|27005028|FG001|Overall Study|Data collection error|1|||
13477031|NCT01375764|27005087|FG000|Overall Study|Lost to Follow-up|0|||
13477032|NCT01375764|27005088|FG001|Overall Study|Lost to Follow-up|1|||
13477033|NCT01375764|27005089|FG002|Overall Study|Lost to Follow-up|0|||
13477034|NCT01375764|27005090|FG003|Overall Study|Lost to Follow-up|0|||
13477035|NCT01375764|27005091|FG004|Overall Study|Lost to Follow-up|0|||
13477036|NCT01375764|27005087|FG000|Overall Study|Withdrawal by Subject|2|||
13477037|NCT01375764|27005088|FG001|Overall Study|Withdrawal by Subject|0|||
13477038|NCT01375764|27005089|FG002|Overall Study|Withdrawal by Subject|0|||
13477039|NCT01375764|27005090|FG003|Overall Study|Withdrawal by Subject|0|||
13477040|NCT01375764|27005091|FG004|Overall Study|Withdrawal by Subject|1|||
13477041|NCT01375764|27005087|FG000|Overall Study|Other|0|||
13477042|NCT01375764|27005088|FG001|Overall Study|Other|0|||
13477043|NCT01375764|27005089|FG002|Overall Study|Other|0|||
13477044|NCT01375764|27005090|FG003|Overall Study|Other|1|||
13477045|NCT01375764|27005091|FG004|Overall Study|Other|0|||
13477056|NCT00722046|27005442|FG000|Overall Study|Adverse Event|0|||
13477057|NCT00722046|27005443|FG001|Overall Study|Adverse Event|1|||
13477058|NCT00722046|27005444|FG002|Overall Study|Adverse Event|2|||
13477059|NCT00722046|27005445|FG003|Overall Study|Adverse Event|1|||
13477060|NCT00722046|27005446|FG004|Overall Study|Adverse Event|2|||
13477061|NCT00722046|27005447|FG005|Overall Study|Adverse Event|1|||
13477062|NCT00722046|27005448|FG006|Overall Study|Adverse Event|0|||
13477063|NCT00722046|27005442|FG000|Overall Study|Death|0|||
13477064|NCT00722046|27005443|FG001|Overall Study|Death|1|||
13438077|NCT00364793|26908004|FG000|Overall Study|Adverse Event|2|||
13438078|NCT00364793|26908005|FG001|Overall Study|Adverse Event|0|||
13438079|NCT00364793|26908006|FG002|Overall Study|Adverse Event|0|||
13438080|NCT00364793|26908007|FG003|Overall Study|Adverse Event|0|||
13438081|NCT00364793|26908004|FG000|Overall Study|Death|1|||
13438082|NCT00364793|26908005|FG001|Overall Study|Death|0|||
13438083|NCT00364793|26908006|FG002|Overall Study|Death|1|||
13438084|NCT00364793|26908007|FG003|Overall Study|Death|0|||
13438085|NCT00364793|26908004|FG000|Overall Study|Lack of Efficacy|3|||
13438086|NCT00364793|26908005|FG001|Overall Study|Lack of Efficacy|3|||
13438087|NCT00364793|26908006|FG002|Overall Study|Lack of Efficacy|1|||
13438088|NCT00364793|26908007|FG003|Overall Study|Lack of Efficacy|1|||
13438089|NCT00364793|26908004|FG000|Overall Study|Lost to Follow-up|1|||
13438090|NCT00364793|26908005|FG001|Overall Study|Lost to Follow-up|0|||
13438091|NCT00364793|26908006|FG002|Overall Study|Lost to Follow-up|2|||
13438092|NCT00364793|26908007|FG003|Overall Study|Lost to Follow-up|0|||
13438093|NCT00364793|26908004|FG000|Overall Study|Poor or non-compliance|1|||
13438094|NCT00364793|26908005|FG001|Overall Study|Poor or non-compliance|1|||
13438095|NCT00364793|26908006|FG002|Overall Study|Poor or non-compliance|0|||
13438096|NCT00364793|26908007|FG003|Overall Study|Poor or non-compliance|1|||
13438097|NCT00364793|26908004|FG000|Overall Study|No longer meets criteria|0|||
13438098|NCT00364793|26908005|FG001|Overall Study|No longer meets criteria|0|||
13438099|NCT00364793|26908006|FG002|Overall Study|No longer meets criteria|0|||
13438100|NCT00364793|26908007|FG003|Overall Study|No longer meets criteria|1|||
13438101|NCT00364793|26908004|FG000|Overall Study|Withdrawal by Subject|0|||
13438102|NCT00364793|26908005|FG001|Overall Study|Withdrawal by Subject|1|||
13438103|NCT00364793|26908006|FG002|Overall Study|Withdrawal by Subject|0|||
13438104|NCT00364793|26908007|FG003|Overall Study|Withdrawal by Subject|0|||
13438105|NCT00364689|26908033|FG000|Overall Study|Lost to Follow-up|1|||
13438106|NCT00364611|26908058|FG000|Overall Study|Did not receive study medication|0|||
13438107|NCT00364611|26908059|FG001|Overall Study|Did not receive study medication|1|||
13438108|NCT00364611|26908058|FG000|Overall Study|Adverse Event|7|||
13438109|NCT00364611|26908059|FG001|Overall Study|Adverse Event|4|||
13438110|NCT00364611|26908058|FG000|Overall Study|Participant's Request|3|||
13438111|NCT00364611|26908059|FG001|Overall Study|Participant's Request|4|||
13438112|NCT00364611|26908058|FG000|Overall Study|Disease Progression|38|||
13438113|NCT00364611|26908059|FG001|Overall Study|Disease Progression|8|||
13438114|NCT00364611|26908058|FG000|Overall Study|Investigator decision|2|||
13438115|NCT00364611|26908059|FG001|Overall Study|Investigator decision|2|||
13438116|NCT00364611|26908058|FG000|Overall Study|Found Ineligible|1|||
13438117|NCT00364611|26908059|FG001|Overall Study|Found Ineligible|0|||
13438118|NCT00364611|26908058|FG000|Overall Study|Presumed CR on Study|0|||
13438119|NCT00364611|26908059|FG001|Overall Study|Presumed CR on Study|1|||
13438120|NCT00364611|26908058|FG000|Overall Study|Receiving Liver Ablation|0|||
13438121|NCT00364611|26908059|FG001|Overall Study|Receiving Liver Ablation|1|||
13438122|NCT00364533|26908097|FG000|Overall Study|Adverse Event|8|||
13438123|NCT00364533|26908098|FG001|Overall Study|Adverse Event|7|||
13438124|NCT00364533|26908099|FG002|Overall Study|Adverse Event|15|||
13438125|NCT00364533|26908100|FG003|Overall Study|Adverse Event|5|||
13438126|NCT00364533|26908101|FG004|Overall Study|Adverse Event|2|||
13438127|NCT00364533|26908097|FG000|Overall Study|Withdrawal by Subject|4|||
13438128|NCT00364533|26908098|FG001|Overall Study|Withdrawal by Subject|8|||
13438129|NCT00364533|26908099|FG002|Overall Study|Withdrawal by Subject|6|||
13438130|NCT00364533|26908100|FG003|Overall Study|Withdrawal by Subject|6|||
13438131|NCT00364533|26908101|FG004|Overall Study|Withdrawal by Subject|6|||
13438132|NCT00364533|26908097|FG000|Overall Study|Lack of Efficacy|22|||
13438133|NCT00364533|26908098|FG001|Overall Study|Lack of Efficacy|22|||
13438134|NCT00364533|26908099|FG002|Overall Study|Lack of Efficacy|21|||
13438135|NCT00364533|26908100|FG003|Overall Study|Lack of Efficacy|17|||
13438136|NCT00364533|26908101|FG004|Overall Study|Lack of Efficacy|42|||
13438137|NCT00364533|26908097|FG000|Overall Study|Subject discharged from hospital|4|||
13438138|NCT00364533|26908098|FG001|Overall Study|Subject discharged from hospital|1|||
13438139|NCT00364533|26908099|FG002|Overall Study|Subject discharged from hospital|2|||
13438140|NCT00364533|26908100|FG003|Overall Study|Subject discharged from hospital|3|||
13438141|NCT00364533|26908101|FG004|Overall Study|Subject discharged from hospital|1|||
13438142|NCT00364533|26908097|FG000|Overall Study|Variations in drug compliance|2|||
13438143|NCT00364533|26908098|FG001|Overall Study|Variations in drug compliance|1|||
13438144|NCT00364533|26908099|FG002|Overall Study|Variations in drug compliance|1|||
13438145|NCT00364533|26908100|FG003|Overall Study|Variations in drug compliance|0|||
13438146|NCT00364533|26908101|FG004|Overall Study|Variations in drug compliance|0|||
13438147|NCT00364533|26908097|FG000|Overall Study|Non-compliance|1|||
13438148|NCT00364533|26908098|FG001|Overall Study|Non-compliance|0|||
13438149|NCT00364533|26908099|FG002|Overall Study|Non-compliance|0|||
13438150|NCT00364533|26908100|FG003|Overall Study|Non-compliance|0|||
13438151|NCT00364533|26908101|FG004|Overall Study|Non-compliance|0|||
13438152|NCT00364533|26908097|FG000|Overall Study|Protocol Violation|1|||
13438153|NCT00364533|26908098|FG001|Overall Study|Protocol Violation|1|||
13438154|NCT00364533|26908099|FG002|Overall Study|Protocol Violation|0|||
13438155|NCT00364533|26908100|FG003|Overall Study|Protocol Violation|0|||
13438156|NCT00364533|26908101|FG004|Overall Study|Protocol Violation|0|||
13438157|NCT00364351|26908126|FG000|Overall Study|Adverse Event|90|||
13438158|NCT00364351|26908127|FG001|Overall Study|Adverse Event|44|||
13438159|NCT00364351|26908126|FG000|Overall Study|Condition under investigation worsened|469|||
13438160|NCT00364351|26908127|FG001|Overall Study|Condition under investigation worsened|497|||
13438161|NCT00364351|26908126|FG000|Overall Study|Prohibited concomitant medication|0|||
13438162|NCT00364351|26908127|FG001|Overall Study|Prohibited concomitant medication|2|||
13438163|NCT00364351|26908126|FG000|Overall Study|Lost to Follow-up|1|||
13438164|NCT00364351|26908127|FG001|Overall Study|Lost to Follow-up|1|||
13438165|NCT00364351|26908126|FG000|Overall Study|Withdrawal by Subject|30|||
13438166|NCT00364351|26908127|FG001|Overall Study|Withdrawal by Subject|29|||
13438167|NCT00364351|26908126|FG000|Overall Study|Incorrect enrollment|1|||
13438168|NCT00364351|26908127|FG001|Overall Study|Incorrect enrollment|1|||
13438169|NCT00364351|26908126|FG000|Overall Study|Sponsor decision|1|||
13438170|NCT00364351|26908127|FG001|Overall Study|Sponsor decision|0|||
13438171|NCT00364351|26908126|FG000|Overall Study|Poor treatment compliance|0|||
13438172|NCT00364351|26908127|FG001|Overall Study|Poor treatment compliance|3|||
13438173|NCT00364351|26908126|FG000|Overall Study|Investigator error|0|||
13438174|NCT00364351|26908127|FG001|Overall Study|Investigator error|2|||
13438175|NCT00364351|26908126|FG000|Overall Study|Patient could not travel to site|0|||
13438176|NCT00364351|26908127|FG001|Overall Study|Patient could not travel to site|1|||
13438177|NCT00364351|26908126|FG000|Overall Study|Randomised treatment not started|0|||
13438178|NCT00364351|26908127|FG001|Overall Study|Randomised treatment not started|3|||
13438179|NCT00364286|26908133|FG000|Overall Study|Withdrawal by Subject|1|||
13438180|NCT00364286|26908133|FG000|Overall Study|Adverse Event|2|||
13438181|NCT00364182|26908175|FG000|First Intervention|Secondary prophylaxis|1|||
13438182|NCT00364182|26908176|FG001|First Intervention|Secondary prophylaxis|0|||
13438183|NCT00364182|26908177|FG002|First Intervention|Secondary prophylaxis|0|||
13438184|NCT00364182|26908175|FG000|First Intervention|Withdrawal by Subject|2|||
13438185|NCT00364182|26908176|FG001|First Intervention|Withdrawal by Subject|0|||
13438186|NCT00364182|26908177|FG002|First Intervention|Withdrawal by Subject|0|||
13438187|NCT00364182|26908175|FG000|Second Intervention|non-compliance|0|||
13438188|NCT00364182|26908176|FG001|Second Intervention|non-compliance|1|||
13438189|NCT00364182|26908177|FG002|Second Intervention|non-compliance|1|||
13438190|NCT00364182|26908175|FG000|Second Intervention|Protocol Violation|0|||
13438191|NCT00364182|26908176|FG001|Second Intervention|Protocol Violation|1|||
13438192|NCT00364182|26908177|FG002|Second Intervention|Protocol Violation|0|||
13438193|NCT00364182|26908175|FG000|Second Intervention|Adverse Event|0|||
13438194|NCT00364182|26908176|FG001|Second Intervention|Adverse Event|0|||
13438195|NCT00364182|26908177|FG002|Second Intervention|Adverse Event|1|||
13438196|NCT00364182|26908175|FG000|Third Intervention|non-compliance|0|||
13438197|NCT00364182|26908176|FG001|Third Intervention|non-compliance|1|||
13438198|NCT00364182|26908177|FG002|Third Intervention|non-compliance|0|||
13438199|NCT00364182|26908175|FG000|Third Intervention|Lost to Follow-up|0|||
13438200|NCT00364182|26908176|FG001|Third Intervention|Lost to Follow-up|0|||
13438201|NCT00364182|26908177|FG002|Third Intervention|Lost to Follow-up|1|||
13438202|NCT00364156|26908190|FG000|Overall Study|Withdrawal by Subject|73|||
13438203|NCT00364156|26908191|FG001|Overall Study|Withdrawal by Subject|80|||
13438204|NCT00364156|26908190|FG000|Overall Study|Protocol Violation|6|||
13438205|NCT00364156|26908191|FG001|Overall Study|Protocol Violation|1|||
13438206|NCT00364130|26908218|FG000|Intervention Period|Lost to Follow-up|4|||
13438207|NCT00364130|26908219|FG001|Intervention Period|Lost to Follow-up|3|||
13438208|NCT00364130|26908218|FG000|Intervention Period|Pregnancy|1|||
13438209|NCT00364130|26908219|FG001|Intervention Period|Pregnancy|0|||
13438210|NCT00364130|26908218|FG000|Intervention Period|Withdrawal by Subject|4|||
13438211|NCT00364130|26908219|FG001|Intervention Period|Withdrawal by Subject|5|||
13438212|NCT00364130|26908218|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5|||
13438213|NCT00364130|26908219|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11|||
13438214|NCT00363896|26908238|FG000|Overall Study|Withdrawal by Subject|29|||
13438215|NCT00363896|26908239|FG001|Overall Study|Withdrawal by Subject|16|||
13438216|NCT00363896|26908238|FG000|Overall Study|Adverse Event|24|||
13438217|NCT00363896|26908239|FG001|Overall Study|Adverse Event|13|||
13438218|NCT00363896|26908238|FG000|Overall Study|COPD exacerbation|13|||
13438219|NCT00363896|26908239|FG001|Overall Study|COPD exacerbation|7|||
13438220|NCT00363896|26908238|FG000|Overall Study|Lack of Efficacy|12|||
13438221|NCT00363896|26908239|FG001|Overall Study|Lack of Efficacy|8|||
13438222|NCT00363896|26908238|FG000|Overall Study|Protocol Violation|6|||
13438223|NCT00363896|26908239|FG001|Overall Study|Protocol Violation|1|||
13438224|NCT00363896|26908238|FG000|Overall Study|Lost to Follow-up|3|||
13438225|NCT00363896|26908239|FG001|Overall Study|Lost to Follow-up|0|||
13438226|NCT00363896|26908238|FG000|Overall Study|Non-fulfilment of entry criteria|1|||
13438227|NCT00363896|26908239|FG001|Overall Study|Non-fulfilment of entry criteria|0|||
13438228|NCT00363896|26908238|FG000|Overall Study|Other|1|||
13438229|NCT00363896|26908239|FG001|Overall Study|Other|2|||
13438230|NCT00363766|26908266|FG000|Overall Study|Progressive Disease|15|||
13438231|NCT00363766|26908267|FG001|Overall Study|Progressive Disease|9|||
13438232|NCT00363766|26908266|FG000|Overall Study|Adverse Event|10|||
13438233|NCT00363766|26908267|FG001|Overall Study|Adverse Event|2|||
13438234|NCT00363766|26908266|FG000|Overall Study|Disease Related Death|1|||
13438235|NCT00363766|26908267|FG001|Overall Study|Disease Related Death|3|||
13438236|NCT00363766|26908266|FG000|Overall Study|Not Disease Related Death|3|||
13438237|NCT00363766|26908267|FG001|Overall Study|Not Disease Related Death|4|||
13438238|NCT00363766|26908266|FG000|Overall Study|Withdrawal by Subject|2|||
13438239|NCT00363766|26908267|FG001|Overall Study|Withdrawal by Subject|0|||
13438240|NCT00363766|26908266|FG000|Overall Study|Physician Decision|1|||
13438241|NCT00363766|26908267|FG001|Overall Study|Physician Decision|2|||
13438242|NCT00363649|26908288|FG000|Overall Study|Withdrawal by Subject|1|||
13438243|NCT00363649|26908289|FG001|Overall Study|Withdrawal by Subject|1|||
13438244|NCT00363649|26908288|FG000|Overall Study|Adverse Event|6|||
13438245|NCT00363649|26908289|FG001|Overall Study|Adverse Event|0|||
13438246|NCT00363545|26908314|FG000|Overall Study|Serious Adverse Event|0|||
13438247|NCT00363545|26908315|FG001|Overall Study|Serious Adverse Event|1|||
13438248|NCT00363545|26908314|FG000|Overall Study|Withdrawal by Subject|12|||
13438249|NCT00363545|26908315|FG001|Overall Study|Withdrawal by Subject|15|||
13438250|NCT00363545|26908314|FG000|Overall Study|Migrated/moved from study area|3|||
13438251|NCT00363545|26908315|FG001|Overall Study|Migrated/moved from study area|6|||
13438252|NCT00363545|26908314|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14|||
13438253|NCT00363545|26908315|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18|||
13438254|NCT00363545|26908314|FG000|Overall Study|Lost to follow-up (complete vaccination)|14|||
13438255|NCT00363545|26908315|FG001|Overall Study|Lost to follow-up (complete vaccination)|17|||
13438256|NCT00363545|26908314|FG000|Overall Study|Others|1|||
13438257|NCT00363545|26908315|FG001|Overall Study|Others|0|||
13438258|NCT00363480|26908337|FG000|Overall Study|Criteria for treatment period not fulfil|1|||
13438259|NCT00363480|26908337|FG000|Overall Study|Adverse Event|4|||
13438260|NCT00363480|26908337|FG000|Overall Study|Lost to Follow-up|5|||
13438261|NCT00363480|26908337|FG000|Overall Study|Withdrawal by Subject|5|||
13438262|NCT00363480|26908337|FG000|Overall Study|Non-compliance of subject|1|||
13438263|NCT00363480|26908337|FG000|Overall Study|Participant discontinued on its own|1|||
13438264|NCT00363467|26908347|FG000|Overall Study|Physician Decision|1|||
13438265|NCT00363415|26908370|FG000|Overall Study|Progressive Disease|196|||
13438266|NCT00363415|26908371|FG001|Overall Study|Progressive Disease|107|||
13438267|NCT00363415|26908370|FG000|Overall Study|Sponsor Decision|67|||
13438268|NCT00363415|26908371|FG001|Overall Study|Sponsor Decision|31|||
13438269|NCT00363415|26908370|FG000|Overall Study|Death|32|||
13438270|NCT00363415|26908371|FG001|Overall Study|Death|29|||
13438271|NCT00363415|26908370|FG000|Overall Study|Adverse Event|24|||
13438272|NCT00363415|26908371|FG001|Overall Study|Adverse Event|15|||
13438273|NCT00363415|26908370|FG000|Overall Study|Physician Decision|18|||
13438274|NCT00363415|26908371|FG001|Overall Study|Physician Decision|35|||
13438275|NCT00363415|26908370|FG000|Overall Study|Entry Criteria Not Met|11|||
13438276|NCT00363415|26908371|FG001|Overall Study|Entry Criteria Not Met|10|||
13438277|NCT00363415|26908370|FG000|Overall Study|Withdrawal by Subject|9|||
13438278|NCT00363415|26908371|FG001|Overall Study|Withdrawal by Subject|15|||
13438279|NCT00363415|26908370|FG000|Overall Study|Lost to Follow-up|3|||
13438280|NCT00363415|26908371|FG001|Overall Study|Lost to Follow-up|3|||
13438281|NCT00363415|26908370|FG000|Overall Study|Protocol Violation|1|||
13438282|NCT00363415|26908371|FG001|Overall Study|Protocol Violation|4|||
13438283|NCT00363311|26908442|FG000|Overall Study|Adverse Event|6|||
13438284|NCT00363311|26908443|FG001|Overall Study|Adverse Event|4|||
13438285|NCT00363311|26908442|FG000|Overall Study|Lost to Follow-up|3|||
13438286|NCT00363311|26908443|FG001|Overall Study|Lost to Follow-up|0|||
13438287|NCT00363311|26908442|FG000|Overall Study|Protocol Violation|1|||
13438288|NCT00363311|26908443|FG001|Overall Study|Protocol Violation|2|||
13438289|NCT00363311|26908442|FG000|Overall Study|Withdrawal by Subject|12|||
13438290|NCT00363311|26908443|FG001|Overall Study|Withdrawal by Subject|6|||
13438291|NCT00363311|26908442|FG000|Overall Study|Physician Decision|1|||
13438292|NCT00363311|26908443|FG001|Overall Study|Physician Decision|1|||
13438293|NCT00363311|26908442|FG000|Overall Study|Sponsor Terminated Study|2|||
13438294|NCT00363311|26908443|FG001|Overall Study|Sponsor Terminated Study|2|||
13438295|NCT00363311|26908442|FG000|Overall Study|Disease Progression|46|||
13438296|NCT00363311|26908443|FG001|Overall Study|Disease Progression|26|||
13438297|NCT00363311|26908442|FG000|Overall Study|Non-Compliance|1|||
13438298|NCT00363311|26908443|FG001|Overall Study|Non-Compliance|1|||
13438299|NCT00363311|26908442|FG000|Overall Study|Participant Refused Biopsy|1|||
13438300|NCT00363311|26908443|FG001|Overall Study|Participant Refused Biopsy|0|||
13438301|NCT00363311|26908442|FG000|Overall Study|Prostate Volume/PSA Doubled|1|||
13438302|NCT00363311|26908443|FG001|Overall Study|Prostate Volume/PSA Doubled|0|||
13438303|NCT00363311|26908442|FG000|Overall Study|Participant Opted for Treatment|1|||
13438304|NCT00363311|26908443|FG001|Overall Study|Participant Opted for Treatment|0|||
13438305|NCT00363311|26908442|FG000|Overall Study|Participant Moved to Another Country|1|||
13438306|NCT00363311|26908443|FG001|Overall Study|Participant Moved to Another Country|0|||
13438307|NCT00363311|26908442|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0|||
13477065|NCT00722046|27005444|FG002|Overall Study|Death|0|||
13438308|NCT00363311|26908443|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1|||
13438309|NCT00363311|26908442|FG000|Overall Study|Withdrawn per Instructions of Monitor|0|||
13438310|NCT00363311|26908443|FG001|Overall Study|Withdrawn per Instructions of Monitor|1|||
13438311|NCT00363311|26908442|FG000|Overall Study|Participant Moved to Louisiana|0|||
13438312|NCT00363311|26908443|FG001|Overall Study|Participant Moved to Louisiana|1|||
13438313|NCT00363298|26908458|FG000|First Study Week|Lack of Efficacy|6|||
13438314|NCT00363298|26908459|FG001|First Study Week|Lack of Efficacy|5|||
13438315|NCT00363298|26908458|FG000|4-week Study Continuation Phase|Lack of Efficacy|1|||
13438316|NCT00363298|26908459|FG001|4-week Study Continuation Phase|Lack of Efficacy|0|||
13438317|NCT00363246|26908466|FG000|Overall Study|Death|40|||
13438318|NCT00363246|26908466|FG000|Overall Study|Withdrawal by Subject|19|||
13438319|NCT00363246|26908466|FG000|Overall Study|Lost to Follow-up|14|||
13438320|NCT00363246|26908466|FG000|Overall Study|Bad health|6|||
13438321|NCT00363246|26908466|FG000|Overall Study|Stopped using wheelchair|11|||
13438322|NCT00363246|26908466|FG000|Overall Study|Subject expressed security concerns|2|||
13438323|NCT00363246|26908466|FG000|Overall Study|Eligibility changed due to Hospice move|5|||
13438324|NCT00363142|26908500|FG000|Overall Study|Adverse Event|2|||
13438325|NCT00363142|26908501|FG001|Overall Study|Adverse Event|0|||
13438326|NCT00363142|26908500|FG000|Overall Study|Lack of Efficacy|0|||
13438327|NCT00363142|26908501|FG001|Overall Study|Lack of Efficacy|1|||
13438328|NCT00363142|26908500|FG000|Overall Study|Lost to Follow-up|1|||
13438329|NCT00363142|26908501|FG001|Overall Study|Lost to Follow-up|0|||
13438330|NCT00363142|26908500|FG000|Overall Study|Non-compliance|1|||
13438331|NCT00363142|26908501|FG001|Overall Study|Non-compliance|1|||
13438332|NCT00363142|26908500|FG000|Overall Study|Withdrawal by Subject|3|||
13438333|NCT00363142|26908501|FG001|Overall Study|Withdrawal by Subject|1|||
13438334|NCT00363129|26908522|FG000|Overall Study|Withdrawal by Subject|11|||
13438335|NCT00363129|26908523|FG001|Overall Study|Withdrawal by Subject|18|||
13438336|NCT00363129|26908522|FG000|Overall Study|Adverse Event|8|||
13438337|NCT00363129|26908523|FG001|Overall Study|Adverse Event|3|||
13438338|NCT00363129|26908522|FG000|Overall Study|Alternate Treatment|2|||
13438339|NCT00363129|26908523|FG001|Overall Study|Alternate Treatment|4|||
13438340|NCT00363129|26908522|FG000|Overall Study|Other Medical Problems|2|||
13438341|NCT00363129|26908523|FG001|Overall Study|Other Medical Problems|4|||
13438342|NCT00363129|26908522|FG000|Overall Study|Death|0|||
13438343|NCT00363129|26908523|FG001|Overall Study|Death|1|||
13438344|NCT00363129|26908522|FG000|Overall Study|Other Reasons|6|||
13438345|NCT00363129|26908523|FG001|Overall Study|Other Reasons|3|||
13438346|NCT00363051|26908547|FG000|Overall Study|Adminstrative problems|1|||
13438347|NCT00363051|26908548|FG001|Overall Study|Adminstrative problems|1|||
13438348|NCT00363051|26908547|FG000|Overall Study|Adverse Event|21|||
13438349|NCT00363051|26908548|FG001|Overall Study|Adverse Event|12|||
13438350|NCT00363051|26908547|FG000|Overall Study|New Cancer Therapy|2|||
13438351|NCT00363051|26908548|FG001|Overall Study|New Cancer Therapy|1|||
13438352|NCT00363051|26908547|FG000|Overall Study|Withdrawal by Subject|11|||
13438353|NCT00363051|26908548|FG001|Overall Study|Withdrawal by Subject|3|||
13438354|NCT00363051|26908547|FG000|Overall Study|Lost to Follow-up|0|||
13438355|NCT00363051|26908548|FG001|Overall Study|Lost to Follow-up|1|||
13438356|NCT00363051|26908547|FG000|Overall Study|Protocol Violation|0|||
13438357|NCT00363051|26908548|FG001|Overall Study|Protocol Violation|2|||
13438358|NCT00363051|26908547|FG000|Overall Study|Death|3|||
13438359|NCT00363051|26908548|FG001|Overall Study|Death|2|||
13438360|NCT00362648|26908577|FG000|Overall Study|Adverse Event|12|||
13438361|NCT00362648|26908578|FG001|Overall Study|Adverse Event|21|||
13438362|NCT00362648|26908579|FG002|Overall Study|Adverse Event|1|||
13438363|NCT00362648|26908580|FG003|Overall Study|Adverse Event|0|||
13438364|NCT00362648|26908577|FG000|Overall Study|Lost to Follow-up|62|||
13438365|NCT00362648|26908578|FG001|Overall Study|Lost to Follow-up|69|||
13438366|NCT00362648|26908579|FG002|Overall Study|Lost to Follow-up|4|||
13438367|NCT00362648|26908580|FG003|Overall Study|Lost to Follow-up|3|||
13438368|NCT00362648|26908577|FG000|Overall Study|Protocol Violation|4|||
13438369|NCT00362648|26908578|FG001|Overall Study|Protocol Violation|2|||
13438370|NCT00362648|26908579|FG002|Overall Study|Protocol Violation|2|||
13438371|NCT00362648|26908580|FG003|Overall Study|Protocol Violation|2|||
13438372|NCT00362648|26908577|FG000|Overall Study|Withdrawal by Subject|48|||
13438373|NCT00362648|26908578|FG001|Overall Study|Withdrawal by Subject|42|||
13438374|NCT00362648|26908579|FG002|Overall Study|Withdrawal by Subject|2|||
13438375|NCT00362648|26908580|FG003|Overall Study|Withdrawal by Subject|6|||
13438376|NCT00362609|26908599|FG000|Overall Study|Withdrawal by Subject|0|||
13438377|NCT00362609|26908600|FG001|Overall Study|Withdrawal by Subject|1|||
13438378|NCT00362609|26908599|FG000|Overall Study|Protocol Violation|0|||
13438379|NCT00362609|26908600|FG001|Overall Study|Protocol Violation|1|||
13438380|NCT00362414|26908619|FG000|Overall Study|Death|2|||
13438381|NCT00362414|26908619|FG000|Overall Study|Adverse Event|1|||
13438382|NCT00362375|26908640|FG000|Overall Study|Lost to Follow-up|40|||
13438383|NCT00362375|26908641|FG001|Overall Study|Lost to Follow-up|35|||
13438384|NCT00362336|26908677|FG000|Overall Study|Serious Adverse Event|1|||
13438385|NCT00362336|26908678|FG001|Overall Study|Serious Adverse Event|0|||
13438386|NCT00362336|26908679|FG002|Overall Study|Serious Adverse Event|1|||
13438387|NCT00362336|26908677|FG000|Overall Study|Protocol Violation|0|||
13438388|NCT00362336|26908678|FG001|Overall Study|Protocol Violation|0|||
13438389|NCT00362336|26908679|FG002|Overall Study|Protocol Violation|1|||
13438390|NCT00362336|26908677|FG000|Overall Study|Lost to Follow-up|6|||
13438391|NCT00362336|26908678|FG001|Overall Study|Lost to Follow-up|4|||
13438392|NCT00362336|26908679|FG002|Overall Study|Lost to Follow-up|0|||
13438393|NCT00362336|26908677|FG000|Overall Study|Withdrawal by Subject|3|||
13438394|NCT00362336|26908678|FG001|Overall Study|Withdrawal by Subject|3|||
13438395|NCT00362336|26908679|FG002|Overall Study|Withdrawal by Subject|1|||
13438396|NCT00362297|26908692|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0|||
13438397|NCT00362297|26908693|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4|||
13438398|NCT00362232|26908736|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62|||
13438399|NCT00362232|26908737|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56|||
13438400|NCT00362232|26908736|FG000|Treatment (12 +/- 2 Days)|Death|1|||
13438401|NCT00362232|26908737|FG001|Treatment (12 +/- 2 Days)|Death|3|||
13438402|NCT00362232|26908736|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3|||
13438403|NCT00362232|26908737|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1|||
13438404|NCT00362232|26908736|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2|||
13438405|NCT00362232|26908737|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5|||
13438406|NCT00362232|26908736|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22|||
13438407|NCT00362232|26908737|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21|||
13438408|NCT00362232|26908736|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49|||
13438409|NCT00362232|26908737|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47|||
13438410|NCT00362232|26908736|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9|||
13438411|NCT00362232|26908737|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0|||
13438412|NCT00362232|26908736|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1|||
13438413|NCT00362232|26908737|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0|||
13438414|NCT00362232|26908736|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10|||
13438415|NCT00362232|26908737|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18|||
13438416|NCT00362232|26908736|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2|||
13438417|NCT00362232|26908737|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3|||
13438418|NCT00362232|26908736|FG000|Follow-up (30 (+ 5) Days)|Death|1|||
13438419|NCT00362232|26908737|FG001|Follow-up (30 (+ 5) Days)|Death|1|||
13438420|NCT00362232|26908736|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27|||
13438421|NCT00362232|26908737|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28|||
13438422|NCT00362232|26908736|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8|||
13438423|NCT00362232|26908737|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7|||
13438424|NCT00362180|26908826|FG000|Treated Period|Withdrawal by Subject|1|||
13438425|NCT00362180|26908827|FG001|Treated Period|Withdrawal by Subject|0|||
13438426|NCT00362180|26908828|FG002|Treated Period|Withdrawal by Subject|0|||
13438427|NCT00362180|26908829|FG003|Treated Period|Withdrawal by Subject|0|||
13438428|NCT00362180|26908830|FG004|Treated Period|Withdrawal by Subject|0|||
13438429|NCT00362180|26908831|FG005|Treated Period|Withdrawal by Subject|0|||
13438430|NCT00362180|26908832|FG006|Treated Period|Withdrawal by Subject|0|||
13438431|NCT00362180|26908833|FG007|Treated Period|Withdrawal by Subject|0|||
13438432|NCT00362180|26908834|FG008|Treated Period|Withdrawal by Subject|0|||
13438433|NCT00362180|26908826|FG000|Treated Period|Adverse Event|0|||
13438434|NCT00362180|26908827|FG001|Treated Period|Adverse Event|0|||
13438435|NCT00362180|26908828|FG002|Treated Period|Adverse Event|0|||
13438436|NCT00362180|26908829|FG003|Treated Period|Adverse Event|0|||
13438437|NCT00362180|26908830|FG004|Treated Period|Adverse Event|0|||
13438438|NCT00362180|26908831|FG005|Treated Period|Adverse Event|1|||
13438439|NCT00362180|26908832|FG006|Treated Period|Adverse Event|0|||
13438440|NCT00362180|26908833|FG007|Treated Period|Adverse Event|1|||
13438441|NCT00362180|26908834|FG008|Treated Period|Adverse Event|0|||
13438442|NCT00362115|26909005|FG000|Overall Study|Adverse Event|0|||
13438443|NCT00362115|26909006|FG001|Overall Study|Adverse Event|1|||
13438444|NCT00362115|26909007|FG002|Overall Study|Adverse Event|1|||
13438445|NCT00362115|26909008|FG003|Overall Study|Adverse Event|1|||
13438446|NCT00362115|26909009|FG004|Overall Study|Adverse Event|2|||
13438447|NCT00362115|26909010|FG005|Overall Study|Adverse Event|2|||
13438448|NCT00362115|26909011|FG006|Overall Study|Adverse Event|1|||
13438449|NCT00362115|26909005|FG000|Overall Study|Protocol Violation|0|||
13438450|NCT00362115|26909006|FG001|Overall Study|Protocol Violation|0|||
13438451|NCT00362115|26909007|FG002|Overall Study|Protocol Violation|0|||
13438452|NCT00362115|26909008|FG003|Overall Study|Protocol Violation|0|||
13438453|NCT00362115|26909009|FG004|Overall Study|Protocol Violation|0|||
13438454|NCT00362115|26909010|FG005|Overall Study|Protocol Violation|1|||
13438455|NCT00362115|26909011|FG006|Overall Study|Protocol Violation|0|||
13438456|NCT00362115|26909005|FG000|Overall Study|Lost to Follow-up|0|||
13438457|NCT00362115|26909006|FG001|Overall Study|Lost to Follow-up|1|||
13438458|NCT00362115|26909007|FG002|Overall Study|Lost to Follow-up|0|||
13438459|NCT00362115|26909008|FG003|Overall Study|Lost to Follow-up|0|||
13438460|NCT00362115|26909009|FG004|Overall Study|Lost to Follow-up|2|||
13438461|NCT00362115|26909010|FG005|Overall Study|Lost to Follow-up|0|||
13438462|NCT00362115|26909011|FG006|Overall Study|Lost to Follow-up|1|||
13438463|NCT00362115|26909005|FG000|Overall Study|Withdrawal by Subject|1|||
13438464|NCT00362115|26909006|FG001|Overall Study|Withdrawal by Subject|3|||
13438465|NCT00362115|26909007|FG002|Overall Study|Withdrawal by Subject|1|||
13438466|NCT00362115|26909008|FG003|Overall Study|Withdrawal by Subject|0|||
13438467|NCT00362115|26909009|FG004|Overall Study|Withdrawal by Subject|1|||
13438468|NCT00362115|26909010|FG005|Overall Study|Withdrawal by Subject|3|||
13438469|NCT00362115|26909011|FG006|Overall Study|Withdrawal by Subject|4|||
13438470|NCT00362115|26909005|FG000|Overall Study|Lack of Efficacy|1|||
13438471|NCT00362115|26909006|FG001|Overall Study|Lack of Efficacy|0|||
13438472|NCT00362115|26909007|FG002|Overall Study|Lack of Efficacy|5|||
13438473|NCT00362115|26909008|FG003|Overall Study|Lack of Efficacy|2|||
13438474|NCT00362115|26909009|FG004|Overall Study|Lack of Efficacy|2|||
13438475|NCT00362115|26909010|FG005|Overall Study|Lack of Efficacy|0|||
13438476|NCT00362115|26909011|FG006|Overall Study|Lack of Efficacy|3|||
13438477|NCT00362115|26909005|FG000|Overall Study|Physician Decision|0|||
13438478|NCT00362115|26909006|FG001|Overall Study|Physician Decision|0|||
13438479|NCT00362115|26909007|FG002|Overall Study|Physician Decision|0|||
13438480|NCT00362115|26909008|FG003|Overall Study|Physician Decision|0|||
13438481|NCT00362115|26909009|FG004|Overall Study|Physician Decision|0|||
13438482|NCT00362115|26909010|FG005|Overall Study|Physician Decision|0|||
13438483|NCT00362115|26909011|FG006|Overall Study|Physician Decision|3|||
13438484|NCT00362115|26909005|FG000|Overall Study|Other|0|||
13438485|NCT00362115|26909006|FG001|Overall Study|Other|1|||
13438486|NCT00362115|26909007|FG002|Overall Study|Other|0|||
13438487|NCT00362115|26909008|FG003|Overall Study|Other|1|||
13438488|NCT00362115|26909009|FG004|Overall Study|Other|0|||
13438489|NCT00362115|26909010|FG005|Overall Study|Other|1|||
13438490|NCT00362115|26909011|FG006|Overall Study|Other|0|||
13438491|NCT00361842|26909028|FG000|Overall Study|Withdrawal by Subject|2|||
13438492|NCT00361842|26909029|FG001|Overall Study|Withdrawal by Subject|3|||
13438493|NCT00361842|26909028|FG000|Overall Study|Death|2|||
13438494|NCT00361842|26909029|FG001|Overall Study|Death|1|||
13438495|NCT00361842|26909028|FG000|Overall Study|Disease progression|19|||
13438496|NCT00361842|26909029|FG001|Overall Study|Disease progression|20|||
13438497|NCT00361842|26909028|FG000|Overall Study|Adverse Event|2|||
13438498|NCT00361842|26909029|FG001|Overall Study|Adverse Event|3|||
13438499|NCT00361842|26909028|FG000|Overall Study|Occurrence of unacceptable toxicity|1|||
13438500|NCT00361842|26909029|FG001|Overall Study|Occurrence of unacceptable toxicity|5|||
13438501|NCT00361842|26909028|FG000|Overall Study|Other|1|||
13438502|NCT00361842|26909029|FG001|Overall Study|Other|0|||
13438503|NCT00361842|26909028|FG000|Overall Study|Other|0|||
13438504|NCT00361842|26909029|FG001|Overall Study|Other|2|||
13438505|NCT00361634|26909049|FG000|Overall Study|Lost to Follow-up|1|||
13438506|NCT00361634|26909049|FG000|Overall Study|Withdrawal by Subject|1|||
13438507|NCT00361569|26909084|FG000|Overall Study|Protocol Violation|3|||
13438508|NCT00361569|26909085|FG001|Overall Study|Protocol Violation|2|||
13438509|NCT00361569|26909086|FG002|Overall Study|Protocol Violation|4|||
13438510|NCT00361569|26909087|FG003|Overall Study|Protocol Violation|2|||
13438511|NCT00361569|26909084|FG000|Overall Study|Withdrawal by Subject|2|||
13438512|NCT00361569|26909085|FG001|Overall Study|Withdrawal by Subject|1|||
13438513|NCT00361569|26909086|FG002|Overall Study|Withdrawal by Subject|9|||
13438514|NCT00361569|26909087|FG003|Overall Study|Withdrawal by Subject|14|||
13438515|NCT00361569|26909084|FG000|Overall Study|Adverse Event|3|||
13438516|NCT00361569|26909085|FG001|Overall Study|Adverse Event|5|||
13438517|NCT00361569|26909086|FG002|Overall Study|Adverse Event|2|||
13438518|NCT00361569|26909087|FG003|Overall Study|Adverse Event|2|||
13438519|NCT00361569|26909084|FG000|Overall Study|Lost to Follow-up|2|||
13438520|NCT00361569|26909085|FG001|Overall Study|Lost to Follow-up|3|||
13438521|NCT00361569|26909086|FG002|Overall Study|Lost to Follow-up|3|||
13438522|NCT00361569|26909087|FG003|Overall Study|Lost to Follow-up|2|||
13438523|NCT00361569|26909084|FG000|Overall Study|Not specified by investigator|2|||
13438524|NCT00361569|26909085|FG001|Overall Study|Not specified by investigator|0|||
13438525|NCT00361569|26909086|FG002|Overall Study|Not specified by investigator|0|||
13438526|NCT00361569|26909087|FG003|Overall Study|Not specified by investigator|1|||
13438527|NCT00361504|26909102|FG000|Overall Study|Withdrawal by Subject|94|||
13438528|NCT00361504|26909103|FG001|Overall Study|Withdrawal by Subject|31|||
13438529|NCT00361504|26909102|FG000|Overall Study|Lost to Follow-up|40|||
13438530|NCT00361504|26909103|FG001|Overall Study|Lost to Follow-up|7|||
13438531|NCT00361504|26909102|FG000|Overall Study|Adverse Event|203|||
13438532|NCT00361504|26909103|FG001|Overall Study|Adverse Event|82|||
13438533|NCT00361504|26909102|FG000|Overall Study|Lack of Efficacy|72|||
13438534|NCT00361504|26909103|FG001|Overall Study|Lack of Efficacy|7|||
13438535|NCT00361504|26909102|FG000|Overall Study|Resolution of Pain|2|||
13438536|NCT00361504|26909103|FG001|Overall Study|Resolution of Pain|0|||
13438537|NCT00361504|26909102|FG000|Overall Study|Study medication non compliant|42|||
13438538|NCT00361504|26909103|FG001|Overall Study|Study medication non compliant|15|||
13438539|NCT00361504|26909102|FG000|Overall Study|All other|28|||
13438540|NCT00361504|26909103|FG001|Overall Study|All other|3|||
13438541|NCT00361335|26909165|FG000|IV Period: Baseline to E0|Adverse Event|9|||
13438542|NCT00361335|26909166|FG001|IV Period: Baseline to E0|Adverse Event|4|||
13438543|NCT00361335|26909167|FG002|IV Period: Baseline to E0|Adverse Event|5|||
13438544|NCT00361335|26909168|FG003|IV Period: Baseline to E0|Adverse Event|9|||
13438545|NCT00361335|26909169|FG004|IV Period: Baseline to E0|Adverse Event|8|||
13438546|NCT00361335|26909170|FG005|IV Period: Baseline to E0|Adverse Event|0|||
13438547|NCT00361335|26909171|FG006|IV Period: Baseline to E0|Adverse Event|0|||
13438548|NCT00361335|26909165|FG000|IV Period: Baseline to E0|Lost to Follow-up|1|||
13438549|NCT00361335|26909166|FG001|IV Period: Baseline to E0|Lost to Follow-up|0|||
13438550|NCT00361335|26909167|FG002|IV Period: Baseline to E0|Lost to Follow-up|0|||
13438551|NCT00361335|26909168|FG003|IV Period: Baseline to E0|Lost to Follow-up|2|||
13438552|NCT00361335|26909169|FG004|IV Period: Baseline to E0|Lost to Follow-up|2|||
13438553|NCT00361335|26909170|FG005|IV Period: Baseline to E0|Lost to Follow-up|0|||
13438554|NCT00361335|26909171|FG006|IV Period: Baseline to E0|Lost to Follow-up|0|||
13438555|NCT00361335|26909165|FG000|IV Period: Baseline to E0|Death|1|||
13438556|NCT00361335|26909166|FG001|IV Period: Baseline to E0|Death|1|||
13438557|NCT00361335|26909167|FG002|IV Period: Baseline to E0|Death|1|||
13438558|NCT00361335|26909168|FG003|IV Period: Baseline to E0|Death|1|||
13438559|NCT00361335|26909169|FG004|IV Period: Baseline to E0|Death|0|||
13438560|NCT00361335|26909170|FG005|IV Period: Baseline to E0|Death|0|||
13438561|NCT00361335|26909171|FG006|IV Period: Baseline to E0|Death|0|||
13438562|NCT00361335|26909165|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2|||
13438563|NCT00361335|26909166|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1|||
13438564|NCT00361335|26909167|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1|||
13438565|NCT00361335|26909168|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1|||
13438566|NCT00361335|26909169|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2|||
13438567|NCT00361335|26909170|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0|||
13438568|NCT00361335|26909171|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0|||
13438569|NCT00361335|26909165|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
13438570|NCT00361335|26909166|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
13438571|NCT00361335|26909167|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1|||
13438572|NCT00361335|26909168|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
13219921|NCT01829191|26278652|FG000|Overall Study|Lens handling difficulty|1|||
13219922|NCT01829191|26278653|FG001|Overall Study|Lens handling difficulty|4|||
13219923|NCT01829191|26278652|FG000|Overall Study|Protocol Violation|4|||
13219924|NCT01829191|26278653|FG001|Overall Study|Protocol Violation|1|||
13219925|NCT01829191|26278652|FG000|Overall Study|Withdrawal by Subject|2|||
13219926|NCT01829191|26278653|FG001|Overall Study|Withdrawal by Subject|3|||
13219927|NCT01829191|26278652|FG000|Overall Study|Lost to Follow-up|0|||
13219928|NCT01829191|26278653|FG001|Overall Study|Lost to Follow-up|1|||
13219929|NCT01829191|26278652|FG000|Overall Study|Subject was fit for ortho - k|0|||
13438573|NCT00361335|26909169|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
13438574|NCT00361335|26909170|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
13438575|NCT00361335|26909171|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
13438576|NCT00361335|26909165|FG000|IV Period: Baseline to E0|Worsening of RA|0|||
13438577|NCT00361335|26909166|FG001|IV Period: Baseline to E0|Worsening of RA|5|||
13438578|NCT00361335|26909167|FG002|IV Period: Baseline to E0|Worsening of RA|1|||
13438579|NCT00361335|26909168|FG003|IV Period: Baseline to E0|Worsening of RA|4|||
13438580|NCT00361335|26909169|FG004|IV Period: Baseline to E0|Worsening of RA|2|||
13438581|NCT00361335|26909170|FG005|IV Period: Baseline to E0|Worsening of RA|0|||
13438582|NCT00361335|26909171|FG006|IV Period: Baseline to E0|Worsening of RA|0|||
13438583|NCT00361335|26909165|FG000|IV Period: Baseline to E0|Other|2|||
13438584|NCT00361335|26909166|FG001|IV Period: Baseline to E0|Other|9|||
13438585|NCT00361335|26909167|FG002|IV Period: Baseline to E0|Other|9|||
13438586|NCT00361335|26909168|FG003|IV Period: Baseline to E0|Other|3|||
13438587|NCT00361335|26909169|FG004|IV Period: Baseline to E0|Other|2|||
13438588|NCT00361335|26909170|FG005|IV Period: Baseline to E0|Other|0|||
13438589|NCT00361335|26909171|FG006|IV Period: Baseline to E0|Other|0|||
13438590|NCT00361335|26909165|FG000|IV Period: Baseline to E0|Lack of Efficacy|5|||
13438591|NCT00361335|26909166|FG001|IV Period: Baseline to E0|Lack of Efficacy|9|||
13438592|NCT00361335|26909167|FG002|IV Period: Baseline to E0|Lack of Efficacy|3|||
13438593|NCT00361335|26909168|FG003|IV Period: Baseline to E0|Lack of Efficacy|7|||
13438594|NCT00361335|26909169|FG004|IV Period: Baseline to E0|Lack of Efficacy|8|||
13438595|NCT00361335|26909170|FG005|IV Period: Baseline to E0|Lack of Efficacy|0|||
13438596|NCT00361335|26909171|FG006|IV Period: Baseline to E0|Lack of Efficacy|0|||
13438597|NCT00361335|26909165|FG000|SC Period: Week E0 to Week E24|Adverse Event|0|||
13438598|NCT00361335|26909166|FG001|SC Period: Week E0 to Week E24|Adverse Event|2|||
13438599|NCT00361335|26909167|FG002|SC Period: Week E0 to Week E24|Adverse Event|1|||
13438600|NCT00361335|26909168|FG003|SC Period: Week E0 to Week E24|Adverse Event|2|||
13438601|NCT00361335|26909169|FG004|SC Period: Week E0 to Week E24|Adverse Event|0|||
13438602|NCT00361335|26909170|FG005|SC Period: Week E0 to Week E24|Adverse Event|0|||
13477066|NCT00722046|27005445|FG003|Overall Study|Death|0|||
13219930|NCT01829191|26278653|FG001|Overall Study|Subject was fit for ortho - k|1|||
13219931|NCT01829165|26278666|FG000|Overall Study|Did not complete intervention|2|||
13438603|NCT00361335|26909171|FG006|SC Period: Week E0 to Week E24|Adverse Event|2|||
13438604|NCT00361335|26909165|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
13438605|NCT00361335|26909166|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
13438606|NCT00361335|26909167|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
13438607|NCT00361335|26909168|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
13438608|NCT00361335|26909169|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
13438609|NCT00361335|26909170|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
13438610|NCT00361335|26909171|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
13438611|NCT00361335|26909165|FG000|SC Period: Week E0 to Week E24|Death|0|||
13438612|NCT00361335|26909166|FG001|SC Period: Week E0 to Week E24|Death|0|||
13438613|NCT00361335|26909167|FG002|SC Period: Week E0 to Week E24|Death|0|||
13438614|NCT00361335|26909168|FG003|SC Period: Week E0 to Week E24|Death|0|||
13438615|NCT00361335|26909169|FG004|SC Period: Week E0 to Week E24|Death|0|||
13438616|NCT00361335|26909170|FG005|SC Period: Week E0 to Week E24|Death|0|||
13438617|NCT00361335|26909171|FG006|SC Period: Week E0 to Week E24|Death|1|||
13438618|NCT00361335|26909165|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0|||
13438619|NCT00361335|26909166|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1|||
13438620|NCT00361335|26909167|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1|||
13438621|NCT00361335|26909168|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1|||
13438622|NCT00361335|26909169|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0|||
13438623|NCT00361335|26909170|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0|||
13438624|NCT00361335|26909171|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0|||
13438625|NCT00361335|26909165|FG000|SC Period: Week E0 to Week E24|Other|1|||
13438626|NCT00361335|26909166|FG001|SC Period: Week E0 to Week E24|Other|0|||
13438627|NCT00361335|26909167|FG002|SC Period: Week E0 to Week E24|Other|0|||
13438628|NCT00361335|26909168|FG003|SC Period: Week E0 to Week E24|Other|1|||
13438629|NCT00361335|26909169|FG004|SC Period: Week E0 to Week E24|Other|0|||
13438630|NCT00361335|26909170|FG005|SC Period: Week E0 to Week E24|Other|1|||
13438631|NCT00361335|26909171|FG006|SC Period: Week E0 to Week E24|Other|2|||
13438632|NCT00361335|26909165|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
13438633|NCT00361335|26909166|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
13438634|NCT00361335|26909167|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2|||
13438635|NCT00361335|26909168|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
13438636|NCT00361335|26909169|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
13438637|NCT00361335|26909170|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
13438638|NCT00361335|26909171|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3|||
13438639|NCT00361296|26909180|FG000|Overall Study|Physician Decision|1|||
13438640|NCT00361296|26909180|FG000|Overall Study|Lack of Efficacy|2|||
13438641|NCT00361283|26909186|FG000|Overall Study|Lost to Follow-up|27|||
13438642|NCT00361270|26909217|FG000|Overall Study|Death|0|||
13438643|NCT00361270|26909218|FG001|Overall Study|Death|0|||
13438644|NCT00361270|26909219|FG002|Overall Study|Death|0|||
13438645|NCT00361270|26909220|FG003|Overall Study|Death|2|||
13438646|NCT00361270|26909217|FG000|Overall Study|Lost to Follow-up|4|||
13438647|NCT00361270|26909218|FG001|Overall Study|Lost to Follow-up|1|||
13438648|NCT00361270|26909219|FG002|Overall Study|Lost to Follow-up|0|||
13438649|NCT00361270|26909220|FG003|Overall Study|Lost to Follow-up|0|||
13438650|NCT00361270|26909217|FG000|Overall Study|Physician Decision|0|||
13438651|NCT00361270|26909218|FG001|Overall Study|Physician Decision|0|||
13438652|NCT00361270|26909219|FG002|Overall Study|Physician Decision|1|||
13438653|NCT00361270|26909220|FG003|Overall Study|Physician Decision|0|||
13438654|NCT00361270|26909217|FG000|Overall Study|Protocol Violation|9|||
13438655|NCT00361270|26909218|FG001|Overall Study|Protocol Violation|4|||
13438656|NCT00361270|26909219|FG002|Overall Study|Protocol Violation|5|||
13438657|NCT00361270|26909220|FG003|Overall Study|Protocol Violation|4|||
13438658|NCT00361270|26909217|FG000|Overall Study|Withdrawal by Subject|6|||
13438659|NCT00361270|26909218|FG001|Overall Study|Withdrawal by Subject|6|||
13438660|NCT00361270|26909219|FG002|Overall Study|Withdrawal by Subject|3|||
13438661|NCT00361270|26909220|FG003|Overall Study|Withdrawal by Subject|7|||
13438662|NCT00361270|26909217|FG000|Overall Study|Afraid of Hypnosis|1|||
13438663|NCT00361270|26909218|FG001|Overall Study|Afraid of Hypnosis|2|||
13438664|NCT00361270|26909219|FG002|Overall Study|Afraid of Hypnosis|0|||
13438665|NCT00361270|26909220|FG003|Overall Study|Afraid of Hypnosis|0|||
13438666|NCT00361270|26909217|FG000|Overall Study|Problems with Transportation|4|||
13438667|NCT00361270|26909218|FG001|Overall Study|Problems with Transportation|0|||
13438668|NCT00361270|26909219|FG002|Overall Study|Problems with Transportation|0|||
13438669|NCT00361270|26909220|FG003|Overall Study|Problems with Transportation|0|||
13438670|NCT00361270|26909217|FG000|Overall Study|Adverse Event|0|||
13438671|NCT00361270|26909218|FG001|Overall Study|Adverse Event|1|||
13438672|NCT00361270|26909219|FG002|Overall Study|Adverse Event|1|||
13438673|NCT00361270|26909220|FG003|Overall Study|Adverse Event|0|||
13438674|NCT00361231|26909227|FG000|Overall Study|Physician Decision|3|||
13438675|NCT00361231|26909227|FG000|Overall Study|Symptomatic deterioration|5|||
13438676|NCT00361231|26909227|FG000|Overall Study|Radiographic disease progression|16|||
13438677|NCT00361231|26909227|FG000|Overall Study|Withdrawal by Subject|4|||
13438678|NCT00361231|26909227|FG000|Overall Study|Adverse Event|6|||
13438679|NCT00361218|26909234|FG000|Overall Study|Lost to Follow-up|11|||
13438680|NCT00361218|26909234|FG000|Overall Study|Personal Reasons|7|||
13438681|NCT00361218|26909234|FG000|Overall Study|terminated / withdrawn due to toxicity /|5|||
13438682|NCT00360698|26909267|FG000|Run-In|Physician Decision|0|||
13438683|NCT00360698|26909268|FG001|Run-In|Physician Decision|1|||
13438684|NCT00360698|26909267|FG000|Run-In|Withdrawal by Subject|0|||
13438685|NCT00360698|26909268|FG001|Run-In|Withdrawal by Subject|2|||
13438686|NCT00360698|26909267|FG000|Run-In|Non compliance with treatment procedure|0|||
13438687|NCT00360698|26909268|FG001|Run-In|Non compliance with treatment procedure|1|||
13438688|NCT00360698|26909267|FG000|Run-In|Sponsor request|0|||
13438689|NCT00360698|26909268|FG001|Run-In|Sponsor request|2|||
13438690|NCT00360698|26909267|FG000|Run-In|Patient did not meet inclusion criteria|0|||
13438691|NCT00360698|26909268|FG001|Run-In|Patient did not meet inclusion criteria|1|||
13438692|NCT00360698|26909267|FG000|Run-In|Patient personal reasons|0|||
13438693|NCT00360698|26909268|FG001|Run-In|Patient personal reasons|2|||
13438694|NCT00360698|26909267|FG000|Run-In|Need of insulin with meals|0|||
13438695|NCT00360698|26909268|FG001|Run-In|Need of insulin with meals|1|||
13438696|NCT00360698|26909267|FG000|Treatment Period|Non compliance with treatment procedure|1|||
13438697|NCT00360698|26909268|FG001|Treatment Period|Non compliance with treatment procedure|0|||
13438698|NCT00360698|26909267|FG000|Treatment Period|Early termination by error|0|||
13438699|NCT00360698|26909268|FG001|Treatment Period|Early termination by error|1|||
13438700|NCT00360568|26909382|FG000|Overall Study|Adverse Event|1|||
13438701|NCT00360568|26909383|FG001|Overall Study|Adverse Event|2|||
13438702|NCT00360568|26909382|FG000|Overall Study|Lack of Efficacy|1|||
13438703|NCT00360568|26909383|FG001|Overall Study|Lack of Efficacy|0|||
13438704|NCT00360568|26909382|FG000|Overall Study|Withdrawal by Subject|0|||
13438705|NCT00360568|26909383|FG001|Overall Study|Withdrawal by Subject|3|||
13438706|NCT00360529|26909419|FG000|Overall Study|Adverse Event|10|||
13438707|NCT00360529|26909420|FG001|Overall Study|Adverse Event|23|||
13438708|NCT00360529|26909421|FG002|Overall Study|Adverse Event|33|||
13438709|NCT00360529|26909419|FG000|Overall Study|Protocol Violation|3|||
13438710|NCT00360529|26909420|FG001|Overall Study|Protocol Violation|3|||
13438711|NCT00360529|26909421|FG002|Overall Study|Protocol Violation|11|||
13438712|NCT00360529|26909419|FG000|Overall Study|Lost to Follow-up|14|||
13438713|NCT00360529|26909420|FG001|Overall Study|Lost to Follow-up|10|||
13438714|NCT00360529|26909421|FG002|Overall Study|Lost to Follow-up|13|||
13438715|NCT00360529|26909419|FG000|Overall Study|Withdrawal by Subject|22|||
13438716|NCT00360529|26909420|FG001|Overall Study|Withdrawal by Subject|14|||
13438717|NCT00360529|26909421|FG002|Overall Study|Withdrawal by Subject|18|||
13438718|NCT00360529|26909419|FG000|Overall Study|Lack of Efficacy|8|||
13438719|NCT00360529|26909420|FG001|Overall Study|Lack of Efficacy|6|||
13438720|NCT00360529|26909421|FG002|Overall Study|Lack of Efficacy|5|||
13438721|NCT00360529|26909419|FG000|Overall Study|Reason discontinued not explained above|4|||
13438722|NCT00360529|26909420|FG001|Overall Study|Reason discontinued not explained above|9|||
13438723|NCT00360529|26909421|FG002|Overall Study|Reason discontinued not explained above|11|||
13438724|NCT00360490|26909461|FG000|Overall Study|Adverse Event|4|||
13438725|NCT00360490|26909462|FG001|Overall Study|Adverse Event|2|||
13438726|NCT00360490|26909461|FG000|Overall Study|Lost to Follow-up|2|||
13438727|NCT00360490|26909462|FG001|Overall Study|Lost to Follow-up|1|||
13438728|NCT00360490|26909461|FG000|Overall Study|Physician Decision|2|||
13438729|NCT00360490|26909462|FG001|Overall Study|Physician Decision|1|||
13438730|NCT00360490|26909461|FG000|Overall Study|Protocol Violation|0|||
13438731|NCT00360490|26909462|FG001|Overall Study|Protocol Violation|4|||
13438732|NCT00360490|26909461|FG000|Overall Study|Withdrawal by Subject|1|||
13438733|NCT00360490|26909462|FG001|Overall Study|Withdrawal by Subject|3|||
13438734|NCT00360412|26909481|FG000|Overall Study|Adverse Event|37|||
13438735|NCT00360412|26909482|FG001|Overall Study|Adverse Event|65|||
13438736|NCT00360412|26909481|FG000|Overall Study|Protocol Violation|2|||
13438737|NCT00360412|26909482|FG001|Overall Study|Protocol Violation|5|||
13438738|NCT00360412|26909481|FG000|Overall Study|Patient withdrew consent|27|||
13438739|NCT00360412|26909482|FG001|Overall Study|Patient withdrew consent|52|||
13438740|NCT00360412|26909481|FG000|Overall Study|Lack of therapeutic efficacy|46|||
13438741|NCT00360412|26909482|FG001|Overall Study|Lack of therapeutic efficacy|61|||
13438742|NCT00360412|26909481|FG000|Overall Study|Physician Decision|2|||
13438743|NCT00360412|26909482|FG001|Overall Study|Physician Decision|4|||
13438744|NCT00360412|26909481|FG000|Overall Study|Other|5|||
13438745|NCT00360412|26909482|FG001|Overall Study|Other|6|||
13438746|NCT00360412|26909481|FG000|Overall Study|Study termination by Sponsor|214|||
13438747|NCT00360412|26909482|FG001|Overall Study|Study termination by Sponsor|469|||
13438748|NCT00360334|26909549|FG000|Overall Study|Adverse Event|7|||
13438749|NCT00360334|26909550|FG001|Overall Study|Adverse Event|4|||
13438750|NCT00360334|26909549|FG000|Overall Study|Protocol Violation|1|||
13438751|NCT00360334|26909550|FG001|Overall Study|Protocol Violation|1|||
13438752|NCT00360334|26909549|FG000|Overall Study|Physician Decision|2|||
13438753|NCT00360334|26909550|FG001|Overall Study|Physician Decision|3|||
13438754|NCT00360334|26909549|FG000|Overall Study|Lack of Efficacy|0|||
13438755|NCT00360334|26909550|FG001|Overall Study|Lack of Efficacy|1|||
13438756|NCT00360334|26909549|FG000|Overall Study|Entry criterion not met|1|||
13438757|NCT00360334|26909550|FG001|Overall Study|Entry criterion not met|2|||
13438758|NCT00360334|26909549|FG000|Overall Study|Subject decision|8|||
13438759|NCT00360334|26909550|FG001|Overall Study|Subject decision|2|||
13438760|NCT00360308|26909577|FG000|Overall Study|Adverse Event|15|||
13438761|NCT00360308|26909578|FG001|Overall Study|Adverse Event|14|||
13438762|NCT00360308|26909579|FG002|Overall Study|Adverse Event|25|||
13438763|NCT00360308|26909577|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
13438764|NCT00360308|26909578|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
13438765|NCT00360308|26909579|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
13438766|NCT00360308|26909577|FG000|Overall Study|Protocol Violation|2|||
13438767|NCT00360308|26909578|FG001|Overall Study|Protocol Violation|1|||
13438768|NCT00360308|26909579|FG002|Overall Study|Protocol Violation|2|||
13438769|NCT00360308|26909577|FG000|Overall Study|Withdrawal by Subject|11|||
13438770|NCT00360308|26909578|FG001|Overall Study|Withdrawal by Subject|7|||
13438771|NCT00360308|26909579|FG002|Overall Study|Withdrawal by Subject|14|||
13438772|NCT00360308|26909577|FG000|Overall Study|Lack of Efficacy|3|||
13438773|NCT00360308|26909578|FG001|Overall Study|Lack of Efficacy|0|||
13438774|NCT00360308|26909579|FG002|Overall Study|Lack of Efficacy|2|||
13438775|NCT00360308|26909577|FG000|Overall Study|Other|2|||
13438776|NCT00360308|26909578|FG001|Overall Study|Other|1|||
13438777|NCT00360308|26909579|FG002|Overall Study|Other|1|||
13438778|NCT00360308|26909577|FG000|Overall Study|Study termination by sponsor|43|||
13438779|NCT00360308|26909578|FG001|Overall Study|Study termination by sponsor|55|||
13438780|NCT00360308|26909579|FG002|Overall Study|Study termination by sponsor|44|||
13438781|NCT00360282|26909594|FG000|Washout 1-3 Weeks|Lost to Follow-up|0|||
13438782|NCT00360282|26909595|FG001|Washout 1-3 Weeks|Lost to Follow-up|0|||
13438783|NCT00360282|26909596|FG002|Washout 1-3 Weeks|Lost to Follow-up|1|||
13438784|NCT00360282|26909597|FG003|Washout 1-3 Weeks|Lost to Follow-up|0|||
13438785|NCT00360282|26909594|FG000|Second Intervention|Adverse Event|0|||
13438786|NCT00360282|26909595|FG001|Second Intervention|Adverse Event|1|||
13438787|NCT00360282|26909596|FG002|Second Intervention|Adverse Event|0|||
13438788|NCT00360282|26909597|FG003|Second Intervention|Adverse Event|0|||
13438789|NCT00360269|26909618|FG000|Overall Study|Lost to Follow-up|7|||
13438790|NCT00360269|26909619|FG001|Overall Study|Lost to Follow-up|9|||
13438791|NCT00360269|26909618|FG000|Overall Study|Physician Decision|1|||
13438792|NCT00360269|26909619|FG001|Overall Study|Physician Decision|2|||
13438793|NCT00360269|26909618|FG000|Overall Study|Adverse Event|1|||
13438794|NCT00360269|26909619|FG001|Overall Study|Adverse Event|0|||
13438795|NCT00360269|26909618|FG000|Overall Study|Withdrawal by Subject|1|||
13438796|NCT00360269|26909619|FG001|Overall Study|Withdrawal by Subject|1|||
13438797|NCT00360230|26909692|FG000|Overall Study|Withdrawal by Subject|1|||
13438798|NCT00360230|26909693|FG001|Overall Study|Withdrawal by Subject|1|||
13438799|NCT00360230|26909694|FG002|Overall Study|Withdrawal by Subject|0|||
13438800|NCT00360230|26909695|FG003|Overall Study|Withdrawal by Subject|1|||
13438801|NCT00360230|26909696|FG004|Overall Study|Withdrawal by Subject|1|||
13438802|NCT00360230|26909697|FG005|Overall Study|Withdrawal by Subject|1|||
13438803|NCT00360230|26909698|FG006|Overall Study|Withdrawal by Subject|0|||
13438804|NCT00360230|26909692|FG000|Overall Study|Migrated|4|||
13438805|NCT00360230|26909693|FG001|Overall Study|Migrated|1|||
13438806|NCT00360230|26909694|FG002|Overall Study|Migrated|3|||
13438807|NCT00360230|26909695|FG003|Overall Study|Migrated|1|||
13438808|NCT00360230|26909696|FG004|Overall Study|Migrated|4|||
13438809|NCT00360230|26909697|FG005|Overall Study|Migrated|1|||
13438810|NCT00360230|26909698|FG006|Overall Study|Migrated|1|||
13438811|NCT00360230|26909692|FG000|Overall Study|Other|1|||
13438812|NCT00360230|26909693|FG001|Overall Study|Other|0|||
13438813|NCT00360230|26909694|FG002|Overall Study|Other|0|||
13438814|NCT00360230|26909695|FG003|Overall Study|Other|0|||
13438815|NCT00360230|26909696|FG004|Overall Study|Other|0|||
13438816|NCT00360230|26909697|FG005|Overall Study|Other|0|||
13438817|NCT00360230|26909698|FG006|Overall Study|Other|0|||
13438818|NCT00360230|26909692|FG000|Overall Study|Protocol Violation|0|||
13438819|NCT00360230|26909693|FG001|Overall Study|Protocol Violation|0|||
13438820|NCT00360230|26909694|FG002|Overall Study|Protocol Violation|0|||
13438821|NCT00360230|26909695|FG003|Overall Study|Protocol Violation|0|||
13438822|NCT00360230|26909696|FG004|Overall Study|Protocol Violation|0|||
13438823|NCT00360230|26909697|FG005|Overall Study|Protocol Violation|1|||
13438824|NCT00360230|26909698|FG006|Overall Study|Protocol Violation|0|||
13438825|NCT00360230|26909692|FG000|Overall Study|Death|0|||
13438826|NCT00360230|26909693|FG001|Overall Study|Death|1|||
13438827|NCT00360230|26909694|FG002|Overall Study|Death|0|||
13438828|NCT00360230|26909695|FG003|Overall Study|Death|0|||
13438829|NCT00360230|26909696|FG004|Overall Study|Death|0|||
13438830|NCT00360230|26909697|FG005|Overall Study|Death|1|||
13438831|NCT00360230|26909698|FG006|Overall Study|Death|1|||
13438832|NCT00359801|26909737|FG000|Overall Study|Lost to Follow-up|72|||
13438833|NCT00359801|26909738|FG001|Overall Study|Lost to Follow-up|58|||
13438834|NCT00359801|26909737|FG000|Overall Study|Withdrawal by Subject|143|||
13438835|NCT00359801|26909738|FG001|Overall Study|Withdrawal by Subject|96|||
13438836|NCT00359801|26909737|FG000|Overall Study|Other|66|||
13438837|NCT00359801|26909738|FG001|Overall Study|Other|46|||
13438838|NCT00359801|26909737|FG000|Overall Study|Final Status Unknown: missing data|7|||
13438839|NCT00359801|26909738|FG001|Overall Study|Final Status Unknown: missing data|4|||
13438840|NCT00359801|26909737|FG000|Overall Study|Sponsor Decision|17|||
13438841|NCT00359801|26909738|FG001|Overall Study|Sponsor Decision|16|||
13438842|NCT00359788|26909977|FG000|Overall Study|Adverse Event|11|||
13438843|NCT00359788|26909978|FG001|Overall Study|Adverse Event|10|||
13438844|NCT00359788|26909977|FG000|Overall Study|Lack of Efficacy|1|||
13438845|NCT00359788|26909978|FG001|Overall Study|Lack of Efficacy|2|||
13438846|NCT00359788|26909977|FG000|Overall Study|Lost to Follow-up|3|||
13438847|NCT00359788|26909978|FG001|Overall Study|Lost to Follow-up|2|||
13438848|NCT00359788|26909977|FG000|Overall Study|Withdrawal by Subject|4|||
13438849|NCT00359788|26909978|FG001|Overall Study|Withdrawal by Subject|1|||
13438850|NCT00359788|26909977|FG000|Overall Study|Protocol Violation|4|||
13438851|NCT00359788|26909978|FG001|Overall Study|Protocol Violation|2|||
13438852|NCT00359762|26910049|FG000|Period II|Adverse Event|17|||
13438853|NCT00359762|26910050|FG001|Period II|Adverse Event|0|||
13438854|NCT00359762|26910051|FG002|Period II|Adverse Event|0|||
13438855|NCT00359762|26910052|FG003|Period II|Adverse Event|0|||
13438856|NCT00359762|26910053|FG004|Period II|Adverse Event|49|||
13438857|NCT00359762|26910049|FG000|Period II|Protocol Violation|18|||
13438858|NCT00359762|26910050|FG001|Period II|Protocol Violation|0|||
13438859|NCT00359762|26910051|FG002|Period II|Protocol Violation|0|||
13438860|NCT00359762|26910052|FG003|Period II|Protocol Violation|0|||
13438861|NCT00359762|26910053|FG004|Period II|Protocol Violation|11|||
13438862|NCT00359762|26910049|FG000|Period II|Physician Decision|17|||
13438863|NCT00359762|26910050|FG001|Period II|Physician Decision|0|||
13438864|NCT00359762|26910051|FG002|Period II|Physician Decision|0|||
13438865|NCT00359762|26910052|FG003|Period II|Physician Decision|0|||
13438866|NCT00359762|26910053|FG004|Period II|Physician Decision|23|||
13438867|NCT00359762|26910049|FG000|Period II|Death|2|||
13438868|NCT00359762|26910050|FG001|Period II|Death|0|||
13438869|NCT00359762|26910051|FG002|Period II|Death|0|||
13438870|NCT00359762|26910052|FG003|Period II|Death|0|||
13438871|NCT00359762|26910053|FG004|Period II|Death|4|||
13438872|NCT00359762|26910049|FG000|Period II|Lack of Efficacy|11|||
13438873|NCT00359762|26910050|FG001|Period II|Lack of Efficacy|0|||
13438874|NCT00359762|26910051|FG002|Period II|Lack of Efficacy|0|||
13438875|NCT00359762|26910052|FG003|Period II|Lack of Efficacy|0|||
13438876|NCT00359762|26910053|FG004|Period II|Lack of Efficacy|8|||
13438877|NCT00359762|26910049|FG000|Period II|Lost to follow up|5|||
13438878|NCT00359762|26910050|FG001|Period II|Lost to follow up|0|||
13438879|NCT00359762|26910051|FG002|Period II|Lost to follow up|0|||
13438880|NCT00359762|26910052|FG003|Period II|Lost to follow up|0|||
13438881|NCT00359762|26910053|FG004|Period II|Lost to follow up|5|||
13438882|NCT00359762|26910049|FG000|Period II|Entry Criteria Not Met|8|||
13438883|NCT00359762|26910050|FG001|Period II|Entry Criteria Not Met|0|||
13438884|NCT00359762|26910051|FG002|Period II|Entry Criteria Not Met|0|||
13438885|NCT00359762|26910052|FG003|Period II|Entry Criteria Not Met|0|||
13438886|NCT00359762|26910053|FG004|Period II|Entry Criteria Not Met|4|||
13438887|NCT00359762|26910049|FG000|Period II|Subject Decision|50|||
13438888|NCT00359762|26910050|FG001|Period II|Subject Decision|0|||
13438889|NCT00359762|26910051|FG002|Period II|Subject Decision|0|||
13438890|NCT00359762|26910052|FG003|Period II|Subject Decision|0|||
13438891|NCT00359762|26910053|FG004|Period II|Subject Decision|70|||
13438892|NCT00359762|26910049|FG000|Period III|Protocol Violation|0|||
13438893|NCT00359762|26910050|FG001|Period III|Protocol Violation|5|||
13438894|NCT00359762|26910051|FG002|Period III|Protocol Violation|3|||
13438895|NCT00359762|26910052|FG003|Period III|Protocol Violation|8|||
13438896|NCT00359762|26910053|FG004|Period III|Protocol Violation|0|||
13438897|NCT00359762|26910049|FG000|Period III|Adverse Event|0|||
13438898|NCT00359762|26910050|FG001|Period III|Adverse Event|3|||
13438899|NCT00359762|26910051|FG002|Period III|Adverse Event|4|||
13438900|NCT00359762|26910052|FG003|Period III|Adverse Event|10|||
13438901|NCT00359762|26910053|FG004|Period III|Adverse Event|0|||
13438902|NCT00359762|26910049|FG000|Period III|Physician Decision|0|||
13438903|NCT00359762|26910050|FG001|Period III|Physician Decision|5|||
13438904|NCT00359762|26910051|FG002|Period III|Physician Decision|9|||
13438905|NCT00359762|26910052|FG003|Period III|Physician Decision|15|||
13438906|NCT00359762|26910053|FG004|Period III|Physician Decision|0|||
13438907|NCT00359762|26910049|FG000|Period III|Lack of Efficacy|0|||
13438908|NCT00359762|26910050|FG001|Period III|Lack of Efficacy|7|||
13438909|NCT00359762|26910051|FG002|Period III|Lack of Efficacy|5|||
13438910|NCT00359762|26910052|FG003|Period III|Lack of Efficacy|9|||
13438911|NCT00359762|26910053|FG004|Period III|Lack of Efficacy|0|||
13438912|NCT00359762|26910049|FG000|Period III|Lost to follow up|0|||
13438913|NCT00359762|26910050|FG001|Period III|Lost to follow up|1|||
13438914|NCT00359762|26910051|FG002|Period III|Lost to follow up|1|||
13438915|NCT00359762|26910052|FG003|Period III|Lost to follow up|2|||
13438916|NCT00359762|26910053|FG004|Period III|Lost to follow up|0|||
13438917|NCT00359762|26910049|FG000|Period III|Entry Criteria Not Met|0|||
13438918|NCT00359762|26910050|FG001|Period III|Entry Criteria Not Met|1|||
13438919|NCT00359762|26910051|FG002|Period III|Entry Criteria Not Met|0|||
13438920|NCT00359762|26910052|FG003|Period III|Entry Criteria Not Met|1|||
13438921|NCT00359762|26910053|FG004|Period III|Entry Criteria Not Met|0|||
13438922|NCT00359762|26910049|FG000|Period III|Subject Decision|0|||
13438923|NCT00359762|26910050|FG001|Period III|Subject Decision|7|||
13438924|NCT00359762|26910051|FG002|Period III|Subject Decision|8|||
13438925|NCT00359762|26910052|FG003|Period III|Subject Decision|20|||
13438926|NCT00359762|26910053|FG004|Period III|Subject Decision|0|||
13438927|NCT00359632|26910067|FG000|Overall Study|Death|2|||
13438928|NCT00359632|26910068|FG001|Overall Study|Death|0|||
13438929|NCT00359632|26910067|FG000|Overall Study|Adverse Event|1|||
13438930|NCT00359632|26910068|FG001|Overall Study|Adverse Event|0|||
13438931|NCT00359632|26910067|FG000|Overall Study|Non-compliance with visit schedule|1|||
13438932|NCT00359632|26910068|FG001|Overall Study|Non-compliance with visit schedule|0|||
13438933|NCT00359619|26910218|FG000|Overall Study|Adverse Event|0|||
13438934|NCT00359619|26910219|FG001|Overall Study|Adverse Event|0|||
13438935|NCT00359619|26910220|FG002|Overall Study|Adverse Event|1|||
13438936|NCT00359619|26910221|FG003|Overall Study|Adverse Event|0|||
13438937|NCT00359619|26910222|FG004|Overall Study|Adverse Event|0|||
13438938|NCT00359619|26910223|FG005|Overall Study|Adverse Event|0|||
13438939|NCT00359619|26910224|FG006|Overall Study|Adverse Event|1|||
13438940|NCT00359619|26910218|FG000|Overall Study|Withdrawal by Subject|3|||
13438941|NCT00359619|26910219|FG001|Overall Study|Withdrawal by Subject|1|||
13438942|NCT00359619|26910220|FG002|Overall Study|Withdrawal by Subject|4|||
13438943|NCT00359619|26910221|FG003|Overall Study|Withdrawal by Subject|2|||
13438944|NCT00359619|26910222|FG004|Overall Study|Withdrawal by Subject|2|||
13438945|NCT00359619|26910223|FG005|Overall Study|Withdrawal by Subject|0|||
13438946|NCT00359619|26910224|FG006|Overall Study|Withdrawal by Subject|3|||
13438947|NCT00359619|26910218|FG000|Overall Study|Other|1|||
13438948|NCT00359619|26910219|FG001|Overall Study|Other|0|||
13438949|NCT00359619|26910220|FG002|Overall Study|Other|0|||
13438950|NCT00359619|26910221|FG003|Overall Study|Other|0|||
13438951|NCT00359619|26910222|FG004|Overall Study|Other|0|||
13438952|NCT00359619|26910223|FG005|Overall Study|Other|0|||
13438953|NCT00359619|26910224|FG006|Overall Study|Other|0|||
13438954|NCT00359619|26910218|FG000|Overall Study|Lost to Follow-up|4|||
13438955|NCT00359619|26910219|FG001|Overall Study|Lost to Follow-up|4|||
13438956|NCT00359619|26910220|FG002|Overall Study|Lost to Follow-up|2|||
13438957|NCT00359619|26910221|FG003|Overall Study|Lost to Follow-up|1|||
13438958|NCT00359619|26910222|FG004|Overall Study|Lost to Follow-up|1|||
13438959|NCT00359619|26910223|FG005|Overall Study|Lost to Follow-up|5|||
13438960|NCT00359619|26910224|FG006|Overall Study|Lost to Follow-up|0|||
13438961|NCT00359424|26910261|FG000|Overall Study|Death|99|||
13438962|NCT00359424|26910262|FG001|Overall Study|Death|58|||
13438963|NCT00359424|26910261|FG000|Overall Study|Lost to Follow-up|19|||
13438964|NCT00359424|26910262|FG001|Overall Study|Lost to Follow-up|7|||
13438965|NCT00359424|26910261|FG000|Overall Study|Withdrawal by Subject|10|||
13438966|NCT00359424|26910262|FG001|Overall Study|Withdrawal by Subject|2|||
13438967|NCT00359424|26910261|FG000|Overall Study|follow up not conducted|2|||
13438968|NCT00359424|26910262|FG001|Overall Study|follow up not conducted|0|||
13438969|NCT00359294|26910291|FG000|Overall Study|Progressive disease|1|||
13438970|NCT00359294|26910292|FG001|Overall Study|Progressive disease|1|||
13438971|NCT00359294|26910293|FG002|Overall Study|Progressive disease|2|||
13438972|NCT00359294|26910294|FG003|Overall Study|Progressive disease|3|||
13438973|NCT00359294|26910295|FG004|Overall Study|Progressive disease|2|||
13438974|NCT00359294|26910291|FG000|Overall Study|Withdrawal by Subject|0|||
13438975|NCT00359294|26910292|FG001|Overall Study|Withdrawal by Subject|0|||
13438976|NCT00359294|26910293|FG002|Overall Study|Withdrawal by Subject|0|||
13438977|NCT00359294|26910294|FG003|Overall Study|Withdrawal by Subject|0|||
13438978|NCT00359294|26910295|FG004|Overall Study|Withdrawal by Subject|1|||
13438979|NCT00359294|26910291|FG000|Overall Study|Not treated|0|||
13438980|NCT00359294|26910292|FG001|Overall Study|Not treated|0|||
13438981|NCT00359294|26910293|FG002|Overall Study|Not treated|0|||
13438982|NCT00359294|26910294|FG003|Overall Study|Not treated|1|||
13438983|NCT00359294|26910295|FG004|Overall Study|Not treated|0|||
13438984|NCT00359294|26910291|FG000|Overall Study|Physician Decision|0|||
13438985|NCT00359294|26910292|FG001|Overall Study|Physician Decision|0|||
13438986|NCT00359294|26910293|FG002|Overall Study|Physician Decision|1|||
13438987|NCT00359294|26910294|FG003|Overall Study|Physician Decision|0|||
13438988|NCT00359294|26910295|FG004|Overall Study|Physician Decision|0|||
13438989|NCT00359281|26910353|FG000|Overall Study|Adverse Event|1|||
13438990|NCT00359281|26910354|FG001|Overall Study|Adverse Event|0|||
13438991|NCT00359281|26910355|FG002|Overall Study|Adverse Event|0|||
13438992|NCT00359281|26910356|FG003|Overall Study|Adverse Event|0|||
13438993|NCT00359281|26910357|FG004|Overall Study|Adverse Event|0|||
13438994|NCT00359281|26910358|FG005|Overall Study|Adverse Event|0|||
13438995|NCT00359281|26910359|FG006|Overall Study|Adverse Event|1|||
13438996|NCT00359281|26910360|FG007|Overall Study|Adverse Event|0|||
13438997|NCT00359281|26910361|FG008|Overall Study|Adverse Event|0|||
13438998|NCT00359281|26910353|FG000|Overall Study|Withdrawal by Subject|0|||
13438999|NCT00359281|26910354|FG001|Overall Study|Withdrawal by Subject|0|||
13439000|NCT00359281|26910355|FG002|Overall Study|Withdrawal by Subject|0|||
13439001|NCT00359281|26910356|FG003|Overall Study|Withdrawal by Subject|0|||
13439002|NCT00359281|26910357|FG004|Overall Study|Withdrawal by Subject|0|||
13439003|NCT00359281|26910358|FG005|Overall Study|Withdrawal by Subject|0|||
13439004|NCT00359281|26910359|FG006|Overall Study|Withdrawal by Subject|1|||
13439005|NCT00359281|26910360|FG007|Overall Study|Withdrawal by Subject|0|||
13439006|NCT00359281|26910361|FG008|Overall Study|Withdrawal by Subject|0|||
13439007|NCT00359073|26910378|FG000|Overall Study|Withdrawal by Subject|1|||
13439008|NCT00359073|26910379|FG001|Overall Study|Withdrawal by Subject|1|||
13439009|NCT00359073|26910378|FG000|Overall Study|Eligibility criteria no longer met|3|||
13439010|NCT00359073|26910379|FG001|Overall Study|Eligibility criteria no longer met|0|||
13439011|NCT00359073|26910378|FG000|Overall Study|developed RV16 antibody|0|||
13439012|NCT00359073|26910379|FG001|Overall Study|developed RV16 antibody|1|||
13439013|NCT00359021|26910398|FG000|Overall Study|Adverse Event|26|||
13439014|NCT00359021|26910399|FG001|Overall Study|Adverse Event|8|||
13439015|NCT00359021|26910398|FG000|Overall Study|Subject Non-Compliant|1|||
13439016|NCT00359021|26910399|FG001|Overall Study|Subject Non-Compliant|2|||
13439017|NCT00359021|26910398|FG000|Overall Study|Subject Ineligible To Continue The Trial|1|||
13439018|NCT00359021|26910399|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
13439019|NCT00359021|26910398|FG000|Overall Study|Subject Reached A Virologic Endpoint|45|||
13439020|NCT00359021|26910399|FG001|Overall Study|Subject Reached A Virologic Endpoint|32|||
13439021|NCT00359021|26910398|FG000|Overall Study|Withdrawal by Subject|2|||
13439022|NCT00359021|26910399|FG001|Overall Study|Withdrawal by Subject|9|||
13439023|NCT00359021|26910398|FG000|Overall Study|Lost to Follow-up|1|||
13439024|NCT00359021|26910399|FG001|Overall Study|Lost to Follow-up|0|||
13439025|NCT00359021|26910398|FG000|Overall Study|Other|4|||
13439026|NCT00359021|26910399|FG001|Overall Study|Other|1|||
13439027|NCT00359021|26910398|FG000|Overall Study|Pregnancy|1|||
13439028|NCT00359021|26910399|FG001|Overall Study|Pregnancy|0|||
13439029|NCT00358956|26910411|FG000|Overall Study|Adverse Event|3|||
13439030|NCT00358956|26910411|FG000|Overall Study|condition under investigation worsened|4|||
13439031|NCT00358956|26910411|FG000|Overall Study|Withdrawal by Subject|1|||
13439032|NCT00358917|26910432|FG000|Overall Study|Adverse Event|14|||
13439033|NCT00358917|26910433|FG001|Overall Study|Adverse Event|21|||
13439034|NCT00358917|26910432|FG000|Overall Study|Withdrawal by Subject|5|||
13439035|NCT00358917|26910433|FG001|Overall Study|Withdrawal by Subject|7|||
13439036|NCT00358917|26910432|FG000|Overall Study|Lost to Follow-up|20|||
13439037|NCT00358917|26910433|FG001|Overall Study|Lost to Follow-up|17|||
13439038|NCT00358917|26910432|FG000|Overall Study|Noncompliance|12|||
13439039|NCT00358917|26910433|FG001|Overall Study|Noncompliance|11|||
13439040|NCT00358917|26910432|FG000|Overall Study|Death|2|||
13439041|NCT00358917|26910433|FG001|Overall Study|Death|3|||
13439042|NCT00358917|26910432|FG000|Overall Study|Virologic failure|11|||
13439043|NCT00358917|26910433|FG001|Overall Study|Virologic failure|8|||
13439044|NCT00358917|26910432|FG000|Overall Study|Unable to Continue Participation|2|||
13439045|NCT00358917|26910433|FG001|Overall Study|Unable to Continue Participation|2|||
13439046|NCT00358826|26910484|FG000|Core Study|Adverse Event|1|||
13439047|NCT00358826|26910485|FG001|Core Study|Adverse Event|3|||
13439048|NCT00358826|26910486|FG002|Core Study|Adverse Event|1|||
13439049|NCT00358826|26910487|FG003|Core Study|Adverse Event|1|||
13439050|NCT00358826|26910488|FG004|Core Study|Adverse Event|0|||
13439051|NCT00358826|26910489|FG005|Core Study|Adverse Event|0|||
13439052|NCT00358826|26910490|FG006|Core Study|Adverse Event|0|||
13439053|NCT00358826|26910491|FG007|Core Study|Adverse Event|0|||
13439054|NCT00358826|26910484|FG000|Core Study|Withdrawal by Subject|2|||
13439055|NCT00358826|26910485|FG001|Core Study|Withdrawal by Subject|2|||
13439056|NCT00358826|26910486|FG002|Core Study|Withdrawal by Subject|0|||
13439057|NCT00358826|26910487|FG003|Core Study|Withdrawal by Subject|0|||
13439058|NCT00358826|26910488|FG004|Core Study|Withdrawal by Subject|0|||
13439059|NCT00358826|26910489|FG005|Core Study|Withdrawal by Subject|0|||
13439060|NCT00358826|26910490|FG006|Core Study|Withdrawal by Subject|0|||
13439061|NCT00358826|26910491|FG007|Core Study|Withdrawal by Subject|0|||
13439062|NCT00358826|26910484|FG000|Core Study|Lost to Follow-up|0|||
13439063|NCT00358826|26910485|FG001|Core Study|Lost to Follow-up|0|||
13439064|NCT00358826|26910486|FG002|Core Study|Lost to Follow-up|0|||
13439065|NCT00358826|26910487|FG003|Core Study|Lost to Follow-up|1|||
13439066|NCT00358826|26910488|FG004|Core Study|Lost to Follow-up|0|||
13439067|NCT00358826|26910489|FG005|Core Study|Lost to Follow-up|0|||
13439068|NCT00358826|26910490|FG006|Core Study|Lost to Follow-up|0|||
13439069|NCT00358826|26910491|FG007|Core Study|Lost to Follow-up|0|||
13439070|NCT00358826|26910484|FG000|Core Study|Physician Decision|0|||
13439071|NCT00358826|26910485|FG001|Core Study|Physician Decision|0|||
13439072|NCT00358826|26910486|FG002|Core Study|Physician Decision|1|||
13439073|NCT00358826|26910487|FG003|Core Study|Physician Decision|0|||
13439074|NCT00358826|26910488|FG004|Core Study|Physician Decision|0|||
13439075|NCT00358826|26910489|FG005|Core Study|Physician Decision|0|||
13439076|NCT00358826|26910490|FG006|Core Study|Physician Decision|0|||
13439077|NCT00358826|26910491|FG007|Core Study|Physician Decision|0|||
13439078|NCT00358826|26910484|FG000|MDCT Substudy|Adverse Event|0|||
13439079|NCT00358826|26910485|FG001|MDCT Substudy|Adverse Event|0|||
13439080|NCT00358826|26910486|FG002|MDCT Substudy|Adverse Event|0|||
13439081|NCT00358826|26910487|FG003|MDCT Substudy|Adverse Event|0|||
13439082|NCT00358826|26910488|FG004|MDCT Substudy|Adverse Event|1|||
13439083|NCT00358826|26910489|FG005|MDCT Substudy|Adverse Event|0|||
13439084|NCT00358826|26910490|FG006|MDCT Substudy|Adverse Event|0|||
13439085|NCT00358826|26910491|FG007|MDCT Substudy|Adverse Event|0|||
13439086|NCT00358826|26910484|FG000|MDCT Substudy|Lost to Follow-up|0|||
13439087|NCT00358826|26910485|FG001|MDCT Substudy|Lost to Follow-up|0|||
13439088|NCT00358826|26910486|FG002|MDCT Substudy|Lost to Follow-up|0|||
13439089|NCT00358826|26910487|FG003|MDCT Substudy|Lost to Follow-up|0|||
13439090|NCT00358826|26910488|FG004|MDCT Substudy|Lost to Follow-up|0|||
13439091|NCT00358826|26910489|FG005|MDCT Substudy|Lost to Follow-up|1|||
13439092|NCT00358826|26910490|FG006|MDCT Substudy|Lost to Follow-up|0|||
13439093|NCT00358826|26910491|FG007|MDCT Substudy|Lost to Follow-up|0|||
13439094|NCT00358826|26910484|FG000|MDCT Substudy|Withdrawal by Subject|0|||
13439095|NCT00358826|26910485|FG001|MDCT Substudy|Withdrawal by Subject|0|||
13439096|NCT00358826|26910486|FG002|MDCT Substudy|Withdrawal by Subject|0|||
13439097|NCT00358826|26910487|FG003|MDCT Substudy|Withdrawal by Subject|0|||
13439098|NCT00358826|26910488|FG004|MDCT Substudy|Withdrawal by Subject|0|||
13439099|NCT00358826|26910489|FG005|MDCT Substudy|Withdrawal by Subject|1|||
13439100|NCT00358826|26910490|FG006|MDCT Substudy|Withdrawal by Subject|0|||
13439101|NCT00358826|26910491|FG007|MDCT Substudy|Withdrawal by Subject|0|||
13439102|NCT00358670|26910512|FG000|Overall Study|Adverse Event|26|||
13439103|NCT00358670|26910513|FG001|Overall Study|Adverse Event|29|||
13439104|NCT00358670|26910512|FG000|Overall Study|Lack of Efficacy|20|||
13439105|NCT00358670|26910513|FG001|Overall Study|Lack of Efficacy|23|||
13439106|NCT00358670|26910512|FG000|Overall Study|Protocol Violation|6|||
13439107|NCT00358670|26910513|FG001|Overall Study|Protocol Violation|9|||
13439108|NCT00358670|26910512|FG000|Overall Study|Lost to Follow-up|4|||
13439109|NCT00358670|26910513|FG001|Overall Study|Lost to Follow-up|5|||
13439110|NCT00358670|26910512|FG000|Overall Study|Withdrawal by Subject|13|||
13439111|NCT00358670|26910513|FG001|Overall Study|Withdrawal by Subject|24|||
13439112|NCT00358670|26910512|FG000|Overall Study|Protocol Defined Clinical Event|0|||
13439113|NCT00358670|26910513|FG001|Overall Study|Protocol Defined Clinical Event|1|||
13439114|NCT00358670|26910512|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
13439115|NCT00358670|26910513|FG001|Overall Study|Did Not Meet Protocol Eligibility|3|||
13439116|NCT00358670|26910512|FG000|Overall Study|Administrative|153|||
13439117|NCT00358670|26910513|FG001|Overall Study|Administrative|125|||
13439118|NCT00358644|26910519|FG000|Overall Study|Progressive Disease|21|||
13439119|NCT00358644|26910519|FG000|Overall Study|Adverse Event|7|||
13439120|NCT00358644|26910519|FG000|Overall Study|Death|11|||
13439121|NCT00358644|26910519|FG000|Overall Study|Withdrawal by Subject|4|||
13439122|NCT00358644|26910519|FG000|Overall Study|Physician Decision|6|||
13439123|NCT00358644|26910519|FG000|Overall Study|Patient not eligible for study|1|||
13439124|NCT00358527|26910534|FG000|Overall Study|Adverse Event|4|||
13439125|NCT00358527|26910535|FG001|Overall Study|Adverse Event|0|||
13439126|NCT00358527|26910534|FG000|Overall Study|Withdrawal by Subject|1|||
13439127|NCT00358527|26910535|FG001|Overall Study|Withdrawal by Subject|1|||
13439128|NCT00358527|26910534|FG000|Overall Study|Non-compliance with protocol|6|||
13439129|NCT00358527|26910535|FG001|Overall Study|Non-compliance with protocol|1|||
13439130|NCT00358527|26910534|FG000|Overall Study|Administrative|2|||
13439131|NCT00358527|26910535|FG001|Overall Study|Administrative|1|||
13439132|NCT00358449|26910646|FG000|Overall Study|Adverse Event|1|||
13439133|NCT00358449|26910647|FG001|Overall Study|Adverse Event|0|||
13439134|NCT00358449|26910648|FG002|Overall Study|Adverse Event|1|||
13439135|NCT00358449|26910646|FG000|Overall Study|Lost to Follow-up|1|||
13439136|NCT00358449|26910647|FG001|Overall Study|Lost to Follow-up|0|||
13439137|NCT00358449|26910648|FG002|Overall Study|Lost to Follow-up|0|||
13439138|NCT00358449|26910646|FG000|Overall Study|Withdrawal by Subject|2|||
13439139|NCT00358449|26910647|FG001|Overall Study|Withdrawal by Subject|0|||
13439140|NCT00358449|26910648|FG002|Overall Study|Withdrawal by Subject|0|||
13439141|NCT00358449|26910646|FG000|Overall Study|Lack of Efficacy|0|||
13439142|NCT00358449|26910647|FG001|Overall Study|Lack of Efficacy|1|||
13439143|NCT00358449|26910648|FG002|Overall Study|Lack of Efficacy|0|||
13439144|NCT00358449|26910646|FG000|Overall Study|Steriod Inhaler was Increased|0|||
13439145|NCT00358449|26910647|FG001|Overall Study|Steriod Inhaler was Increased|0|||
13439146|NCT00358449|26910648|FG002|Overall Study|Steriod Inhaler was Increased|1|||
13439147|NCT00358436|26910667|FG000|Overall Study|Adverse Event|29|||
13439148|NCT00358436|26910668|FG001|Overall Study|Adverse Event|13|||
13439149|NCT00358436|26910667|FG000|Overall Study|Lack of Efficacy|34|||
13439150|NCT00358436|26910668|FG001|Overall Study|Lack of Efficacy|36|||
13439151|NCT00358436|26910667|FG000|Overall Study|Lost to Follow-up|11|||
13439152|NCT00358436|26910668|FG001|Overall Study|Lost to Follow-up|6|||
13439153|NCT00358436|26910667|FG000|Overall Study|Protocol Violation|8|||
13439154|NCT00358436|26910668|FG001|Overall Study|Protocol Violation|3|||
13439155|NCT00358436|26910667|FG000|Overall Study|Withdrawal by Subject|40|||
13439156|NCT00358436|26910668|FG001|Overall Study|Withdrawal by Subject|17|||
13439157|NCT00358436|26910667|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4|||
13439158|NCT00358436|26910668|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0|||
13439159|NCT00358436|26910667|FG000|Overall Study|COPD exacerbation|22|||
13439160|NCT00358436|26910668|FG001|Overall Study|COPD exacerbation|10|||
13439161|NCT00358436|26910667|FG000|Overall Study|Other|6|||
13439162|NCT00358436|26910668|FG001|Overall Study|Other|1|||
13439163|NCT00358150|26910692|FG000|Overall Study|Adverse Event|3|||
13439164|NCT00358150|26910692|FG000|Overall Study|Withdrawal by Subject|1|||
13439165|NCT00358150|26910692|FG000|Overall Study|Undefined|3|||
13439166|NCT00357994|26910751|FG000|Overall Study|Adverse Event|1|||
13439167|NCT00357994|26910752|FG001|Overall Study|Adverse Event|2|||
13439168|NCT00357994|26910751|FG000|Overall Study|Lack of Efficacy|0|||
13439169|NCT00357994|26910752|FG001|Overall Study|Lack of Efficacy|1|||
13439170|NCT00357994|26910751|FG000|Overall Study|Protocol Violation|1|||
13439171|NCT00357994|26910752|FG001|Overall Study|Protocol Violation|0|||
13439172|NCT00357968|26910801|FG000|First Maintenance Dose Phase|Not a PCI patient|47|||
13439173|NCT00357968|26910802|FG001|First Maintenance Dose Phase|Not a PCI patient|42|||
13439174|NCT00357968|26910801|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1|||
13439175|NCT00357968|26910802|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2|||
13439176|NCT00357903|26910847|FG000|Overall Study|Adverse Event|87|||
13439177|NCT00357903|26910848|FG001|Overall Study|Adverse Event|4|||
13439178|NCT00357903|26910847|FG000|Overall Study|Death|33|||
13439179|NCT00357903|26910848|FG001|Overall Study|Death|0|||
13439180|NCT00357903|26910847|FG000|Overall Study|Lost to Follow-up|23|||
13439181|NCT00357903|26910848|FG001|Overall Study|Lost to Follow-up|4|||
13439182|NCT00357903|26910847|FG000|Overall Study|Physician Decision|39|||
13439183|NCT00357903|26910848|FG001|Overall Study|Physician Decision|5|||
13439184|NCT00357903|26910847|FG000|Overall Study|Withdrawal by Subject|57|||
13439185|NCT00357903|26910848|FG001|Overall Study|Withdrawal by Subject|7|||
13439186|NCT00357903|26910847|FG000|Overall Study|Completed month 12 only|0|||
13439187|NCT00357903|26910848|FG001|Overall Study|Completed month 12 only|1|||
13439188|NCT00357903|26910847|FG000|Overall Study|Protocol issues|14|||
13439189|NCT00357903|26910848|FG001|Overall Study|Protocol issues|3|||
13439190|NCT00357903|26910847|FG000|Overall Study|Response status|61|||
13439191|NCT00357903|26910848|FG001|Overall Study|Response status|9|||
13439192|NCT00357903|26910847|FG000|Overall Study|Other|49|||
13439193|NCT00357903|26910848|FG001|Overall Study|Other|10|||
13439194|NCT00357877|26910867|FG000|Overall Study|Death|2|||
13439195|NCT00357877|26910868|FG001|Overall Study|Death|1|||
13439196|NCT00357877|26910867|FG000|Overall Study|Lost to Follow-up|20|||
13439197|NCT00357877|26910868|FG001|Overall Study|Lost to Follow-up|23|||
13439198|NCT00357877|26910867|FG000|Overall Study|Withdrawal by Subject|3|||
13439199|NCT00357877|26910868|FG001|Overall Study|Withdrawal by Subject|3|||
13439200|NCT00357877|26910867|FG000|Overall Study|Administrative withdrawal|1|||
13439201|NCT00357877|26910868|FG001|Overall Study|Administrative withdrawal|1|||
13439202|NCT00357877|26910867|FG000|Overall Study|Other|0|||
13439203|NCT00357877|26910868|FG001|Overall Study|Other|2|||
13439204|NCT00357760|26910885|FG000|Overall Study|Disease progression|44|||
13439205|NCT00357760|26910886|FG001|Overall Study|Disease progression|17|||
13439206|NCT00357760|26910885|FG000|Overall Study|Adverse Event|10|||
13439207|NCT00357760|26910886|FG001|Overall Study|Adverse Event|7|||
13439208|NCT00357760|26910885|FG000|Overall Study|Death|0|||
13439209|NCT00357760|26910886|FG001|Overall Study|Death|3|||
13439210|NCT00357760|26910885|FG000|Overall Study|Alternative therapy|1|||
13439211|NCT00357760|26910886|FG001|Overall Study|Alternative therapy|0|||
13439212|NCT00357760|26910885|FG000|Overall Study|Withdrawal by Subject|0|||
13439213|NCT00357760|26910886|FG001|Overall Study|Withdrawal by Subject|2|||
13439214|NCT00357760|26910885|FG000|Overall Study|Never started treatment|2|||
13439215|NCT00357760|26910886|FG001|Overall Study|Never started treatment|1|||
13439216|NCT00357760|26910885|FG000|Overall Study|Ineligible|0|||
13439217|NCT00357760|26910886|FG001|Overall Study|Ineligible|2|||
13439218|NCT00357760|26910885|FG000|Overall Study|Physician Decision|2|||
13439219|NCT00357760|26910886|FG001|Overall Study|Physician Decision|1|||
13439220|NCT00357760|26910885|FG000|Overall Study|Protocol Violation|0|||
13439221|NCT00357760|26910886|FG001|Overall Study|Protocol Violation|1|||
13439222|NCT00357760|26910885|FG000|Overall Study|To receive hospice care|0|||
13439223|NCT00357760|26910886|FG001|Overall Study|To receive hospice care|1|||
13219932|NCT01829165|26278667|FG001|Overall Study|Did not complete intervention|0|||
13306260|NCT01292603|26525397|FG002|Part 2: Dose Confirmation Period|Death|0|||
13306261|NCT01292603|26525398|FG003|Part 2: Dose Confirmation Period|Death|0|||
13306262|NCT01292603|26525399|FG004|Part 2: Dose Confirmation Period|Death|1|||
13306263|NCT01292603|26525400|FG005|Part 2: Dose Confirmation Period|Death|0|||
13306264|NCT01292603|26525395|FG000|Part 2: Dose Confirmation Period|Physician Decision|0|||
13306265|NCT01292603|26525396|FG001|Part 2: Dose Confirmation Period|Physician Decision|0|||
13306266|NCT01292603|26525397|FG002|Part 2: Dose Confirmation Period|Physician Decision|0|||
13306267|NCT01292603|26525398|FG003|Part 2: Dose Confirmation Period|Physician Decision|0|||
13306268|NCT01292603|26525399|FG004|Part 2: Dose Confirmation Period|Physician Decision|2|||
13306269|NCT01292603|26525400|FG005|Part 2: Dose Confirmation Period|Physician Decision|0|||
13306270|NCT01292603|26525395|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
13306271|NCT01292603|26525396|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
13306272|NCT01292603|26525397|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
13306273|NCT01292603|26525398|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
13306274|NCT01292603|26525399|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
13306275|NCT01292603|26525400|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
13306276|NCT01292603|26525395|FG000|Part 2: Dose Confirmation Period|Adverse Event|0|||
13306277|NCT01292603|26525396|FG001|Part 2: Dose Confirmation Period|Adverse Event|0|||
13306278|NCT01292603|26525397|FG002|Part 2: Dose Confirmation Period|Adverse Event|0|||
13306279|NCT01292603|26525398|FG003|Part 2: Dose Confirmation Period|Adverse Event|0|||
13306280|NCT01292603|26525399|FG004|Part 2: Dose Confirmation Period|Adverse Event|7|||
13306281|NCT01292603|26525400|FG005|Part 2: Dose Confirmation Period|Adverse Event|9|||
13306282|NCT01292603|26525395|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0|||
13306283|NCT01292603|26525396|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0|||
13306284|NCT01292603|26525397|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0|||
13306285|NCT01292603|26525398|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0|||
13306286|NCT01292603|26525399|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5|||
13306287|NCT01292603|26525400|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3|||
13439224|NCT00357656|26910944|FG000|Overall Study|Other, No surgery performed|0|||
13439225|NCT00357656|26910945|FG001|Overall Study|Other, No surgery performed|3|||
13439226|NCT00357552|26910962|FG000|Screening|Did not meet eligibility criteria|84|||
13439227|NCT00357552|26910962|FG000|Weeks 0 to 24|Death|1|||
13439228|NCT00357552|26910962|FG000|Weeks 24 to 104|Death|3|||
13439229|NCT00357552|26910962|FG000|Weeks 24 to 104|Not able to get to clinic|2|||
13439230|NCT00357500|26910971|FG000|Overall Study|Adverse Event|3|||
13439231|NCT00357500|26910971|FG000|Overall Study|Withdrawal by Subject|5|||
13439232|NCT00357500|26910971|FG000|Overall Study|Progressive Disease|65|||
13439233|NCT00357500|26910971|FG000|Overall Study|Not Started Protocol Therapy|4|||
13439234|NCT00357396|26910983|FG000|Overall Study|Adverse Event|1|||
13439235|NCT00357396|26910984|FG001|Overall Study|Adverse Event|0|||
13439236|NCT00357370|26911017|FG000|Cohort 2|Lack of Efficacy|0|||
13439237|NCT00357370|26911018|FG001|Cohort 2|Lack of Efficacy|2|||
13439238|NCT00357370|26911019|FG002|Cohort 2|Lack of Efficacy|1|||
13439239|NCT00357370|26911017|FG000|Cohort 2|Adverse Event|1|||
13439240|NCT00357370|26911018|FG001|Cohort 2|Adverse Event|1|||
13439241|NCT00357370|26911019|FG002|Cohort 2|Adverse Event|1|||
13439242|NCT00357370|26911017|FG000|Cohort 2|Lost to Follow-up|0|||
13439243|NCT00357370|26911018|FG001|Cohort 2|Lost to Follow-up|1|||
13439244|NCT00357370|26911019|FG002|Cohort 2|Lost to Follow-up|0|||
13439245|NCT00357370|26911017|FG000|Cohort 2|non-compliance, not met criteria, etc|1|||
13439246|NCT00357370|26911018|FG001|Cohort 2|non-compliance, not met criteria, etc|1|||
13439247|NCT00357370|26911019|FG002|Cohort 2|non-compliance, not met criteria, etc|0|||
13439248|NCT00357370|26911017|FG000|Cohort 2|Withdrawal by Subject|0|||
13439249|NCT00357370|26911018|FG001|Cohort 2|Withdrawal by Subject|2|||
13439250|NCT00357370|26911019|FG002|Cohort 2|Withdrawal by Subject|0|||
13439251|NCT00357110|26911032|FG000|Overall Study|Early study termination|5|||
13439252|NCT00357110|26911033|FG001|Overall Study|Early study termination|5|||
13439253|NCT00357097|26911084|FG000|Overall Study|Did not meet inclusion criteria|5|||
13439254|NCT00357097|26911085|FG001|Overall Study|Did not meet inclusion criteria|3|||
13439255|NCT00357097|26911084|FG000|Overall Study|Adverse Event|34|||
13439256|NCT00357097|26911085|FG001|Overall Study|Adverse Event|6|||
13439257|NCT00357097|26911084|FG000|Overall Study|Withdrawal by Subject|8|||
13439258|NCT00357097|26911085|FG001|Overall Study|Withdrawal by Subject|7|||
13439259|NCT00357097|26911084|FG000|Overall Study|Non-compliance|1|||
13439260|NCT00357097|26911085|FG001|Overall Study|Non-compliance|2|||
13439261|NCT00357097|26911084|FG000|Overall Study|Lack of Efficacy|2|||
13439262|NCT00357097|26911085|FG001|Overall Study|Lack of Efficacy|8|||
13439263|NCT00357097|26911084|FG000|Overall Study|Met Exclusion Criteria|3|||
13439264|NCT00357097|26911085|FG001|Overall Study|Met Exclusion Criteria|1|||
13439265|NCT00357097|26911084|FG000|Overall Study|Other|1|||
13439266|NCT00357097|26911085|FG001|Overall Study|Other|1|||
13439267|NCT00357097|26911084|FG000|Overall Study|Increase of RLS Symptoms|0|||
13439268|NCT00357097|26911085|FG001|Overall Study|Increase of RLS Symptoms|1|||
13439269|NCT00357006|26911103|FG000|Overall Study|Lost to Follow-up|1|||
13439270|NCT00357006|26911104|FG001|Overall Study|Lost to Follow-up|2|||
13439271|NCT00357006|26911105|FG002|Overall Study|Lost to Follow-up|1|||
13439272|NCT00357006|26911103|FG000|Overall Study|Withdrawal by Subject|1|||
13439273|NCT00357006|26911104|FG001|Overall Study|Withdrawal by Subject|3|||
13439274|NCT00357006|26911105|FG002|Overall Study|Withdrawal by Subject|2|||
13439275|NCT00356915|26911132|FG000|Overall Study|Non compliance|1|||
13439276|NCT00356915|26911133|FG001|Overall Study|Non compliance|2|||
13439277|NCT00356915|26911134|FG002|Overall Study|Non compliance|1|||
13439278|NCT00356915|26911132|FG000|Overall Study|Protocol Violation|2|||
13439279|NCT00356915|26911133|FG001|Overall Study|Protocol Violation|3|||
13439280|NCT00356915|26911134|FG002|Overall Study|Protocol Violation|2|||
13439281|NCT00356915|26911132|FG000|Overall Study|Withdrawal by Subject|14|||
13439282|NCT00356915|26911133|FG001|Overall Study|Withdrawal by Subject|14|||
13439283|NCT00356915|26911134|FG002|Overall Study|Withdrawal by Subject|10|||
13439284|NCT00356915|26911132|FG000|Overall Study|Lack of Efficacy|0|||
13439285|NCT00356915|26911133|FG001|Overall Study|Lack of Efficacy|0|||
13439286|NCT00356915|26911134|FG002|Overall Study|Lack of Efficacy|3|||
13439287|NCT00356915|26911132|FG000|Overall Study|Lost to Follow-up|27|||
13439288|NCT00356915|26911133|FG001|Overall Study|Lost to Follow-up|34|||
13439289|NCT00356915|26911134|FG002|Overall Study|Lost to Follow-up|14|||
13439290|NCT00356915|26911132|FG000|Overall Study|Administrative Decision|0|||
13439291|NCT00356915|26911133|FG001|Overall Study|Administrative Decision|0|||
13439292|NCT00356915|26911134|FG002|Overall Study|Administrative Decision|1|||
13439293|NCT00356915|26911132|FG000|Overall Study|Physician Decision|0|||
13439294|NCT00356915|26911133|FG001|Overall Study|Physician Decision|2|||
13439295|NCT00356915|26911134|FG002|Overall Study|Physician Decision|0|||
13439296|NCT00356915|26911132|FG000|Overall Study|Adverse Event|21|||
13439297|NCT00356915|26911133|FG001|Overall Study|Adverse Event|31|||
13439298|NCT00356915|26911134|FG002|Overall Study|Adverse Event|8|||
13439299|NCT00356915|26911132|FG000|Overall Study|Miscellaneous reasons|11|||
13439300|NCT00356915|26911133|FG001|Overall Study|Miscellaneous reasons|8|||
13439301|NCT00356915|26911134|FG002|Overall Study|Miscellaneous reasons|3|||
13439302|NCT00356889|26911143|FG000|Overall Study|Protocol Violation|2|||
13439303|NCT00356889|26911143|FG000|Overall Study|Adverse Event|1|||
13439304|NCT00356863|26911176|FG000|Overall Study|Death|16|||
13439305|NCT00356863|26911177|FG001|Overall Study|Death|32|||
13439306|NCT00356863|26911176|FG000|Overall Study|Lost to Follow-up|76|||
13439307|NCT00356863|26911177|FG001|Overall Study|Lost to Follow-up|43|||
13439308|NCT00356811|26911192|FG000|Overall Study|Death|35|||
13439309|NCT00356811|26911192|FG000|Overall Study|Lost to Follow-up|2|||
13439310|NCT00356811|26911192|FG000|Overall Study|Withdrawal by Subject|6|||
13439311|NCT00356811|26911192|FG000|Overall Study|Participant Could Not Make a Checkup|1|||
13439312|NCT00356811|26911192|FG000|Overall Study|Study Is Terminating|3|||
13439313|NCT00356811|26911192|FG000|Overall Study|Site Closed during Follow-up|2|||
13439314|NCT00356759|26911215|FG000|Overall Study|Death|5|||
13439315|NCT00356759|26911216|FG001|Overall Study|Death|2|||
13439316|NCT00356759|26911215|FG000|Overall Study|Withdrawal by Subject|2|||
13439317|NCT00356759|26911216|FG001|Overall Study|Withdrawal by Subject|2|||
13439318|NCT00356759|26911215|FG000|Overall Study|Adverse Event|1|||
13439319|NCT00356759|26911216|FG001|Overall Study|Adverse Event|3|||
13439320|NCT00356759|26911215|FG000|Overall Study|Lost to Follow-up|1|||
13439321|NCT00356759|26911216|FG001|Overall Study|Lost to Follow-up|1|||
13439322|NCT00356759|26911215|FG000|Overall Study|Intercurrent disease or persistent extre|5|||
13439323|NCT00356759|26911216|FG001|Overall Study|Intercurrent disease or persistent extre|2|||
13439324|NCT00356603|26911237|FG000|Overall Study|Other|6|||
13439325|NCT00356603|26911238|FG001|Overall Study|Other|3|||
13439326|NCT00356590|26911272|FG000|Overall Study|Adverse Event|54|||
13439327|NCT00356590|26911272|FG000|Overall Study|Death|10|||
13439328|NCT00356590|26911272|FG000|Overall Study|Lost to Follow-up|35|||
13439329|NCT00356590|26911272|FG000|Overall Study|Physician Decision|46|||
13439330|NCT00356590|26911272|FG000|Overall Study|Withdrawal by Subject|41|||
13439331|NCT00356590|26911272|FG000|Overall Study|Completed month 12 only|2|||
13439332|NCT00356590|26911272|FG000|Overall Study|Protocol issues|6|||
13439333|NCT00356590|26911272|FG000|Overall Study|Response status|28|||
13439334|NCT00356590|26911272|FG000|Overall Study|Other|52|||
13439335|NCT00356525|26911311|FG000|Overall Study|Progressive Disease|8|||
13439336|NCT00356525|26911312|FG001|Overall Study|Progressive Disease|5|||
13439337|NCT00356525|26911313|FG002|Overall Study|Progressive Disease|4|||
13439338|NCT00356525|26911314|FG003|Overall Study|Progressive Disease|2|||
13439339|NCT00356525|26911311|FG000|Overall Study|Adverse Event|1|||
13439340|NCT00356525|26911312|FG001|Overall Study|Adverse Event|3|||
13439341|NCT00356525|26911313|FG002|Overall Study|Adverse Event|1|||
13439342|NCT00356525|26911314|FG003|Overall Study|Adverse Event|1|||
13439343|NCT00356525|26911311|FG000|Overall Study|Lost to Follow-up|1|||
13439344|NCT00356525|26911312|FG001|Overall Study|Lost to Follow-up|0|||
13439345|NCT00356525|26911313|FG002|Overall Study|Lost to Follow-up|0|||
13439346|NCT00356525|26911314|FG003|Overall Study|Lost to Follow-up|0|||
13439347|NCT00356525|26911311|FG000|Overall Study|Physician Decision|2|||
13439348|NCT00356525|26911312|FG001|Overall Study|Physician Decision|2|||
13439349|NCT00356525|26911313|FG002|Overall Study|Physician Decision|2|||
13439350|NCT00356525|26911314|FG003|Overall Study|Physician Decision|1|||
13439351|NCT00356525|26911311|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
13439352|NCT00356525|26911312|FG001|Overall Study|Protocol Entry Criteria Not Met|0|||
13439353|NCT00356525|26911313|FG002|Overall Study|Protocol Entry Criteria Not Met|0|||
13439354|NCT00356525|26911314|FG003|Overall Study|Protocol Entry Criteria Not Met|0|||
13439355|NCT00356525|26911311|FG000|Overall Study|Withdrawal by Subject|1|||
13439356|NCT00356525|26911312|FG001|Overall Study|Withdrawal by Subject|1|||
13439357|NCT00356525|26911313|FG002|Overall Study|Withdrawal by Subject|0|||
13439358|NCT00356525|26911314|FG003|Overall Study|Withdrawal by Subject|3|||
13439359|NCT00356525|26911311|FG000|Overall Study|Death|0|||
13439360|NCT00356525|26911312|FG001|Overall Study|Death|0|||
13439361|NCT00356525|26911313|FG002|Overall Study|Death|0|||
13439362|NCT00356525|26911314|FG003|Overall Study|Death|1|||
13439363|NCT00356525|26911311|FG000|Overall Study|Sponsor Decision|0|||
13439364|NCT00356525|26911312|FG001|Overall Study|Sponsor Decision|0|||
13439365|NCT00356525|26911313|FG002|Overall Study|Sponsor Decision|0|||
13439366|NCT00356525|26911314|FG003|Overall Study|Sponsor Decision|1|||
13439367|NCT00356421|26911357|FG000|Overall Study|Lack of Efficacy|3|||
13439368|NCT00356421|26911358|FG001|Overall Study|Lack of Efficacy|0|||
13439369|NCT00356421|26911357|FG000|Overall Study|Withdrawal by Subject|9|||
13439370|NCT00356421|26911358|FG001|Overall Study|Withdrawal by Subject|2|||
13439371|NCT00356421|26911357|FG000|Overall Study|Related to study drug|15|||
13439372|NCT00356421|26911358|FG001|Overall Study|Related to study drug|12|||
13439373|NCT00356421|26911357|FG000|Overall Study|Not related to study drug|5|||
13439374|NCT00356421|26911358|FG001|Overall Study|Not related to study drug|3|||
13439375|NCT00356408|26911383|FG000|Overall Study|Adverse Event|9|||
13439376|NCT00356408|26911383|FG000|Overall Study|Lack of Efficacy|36|||
13439377|NCT00356408|26911383|FG000|Overall Study|Lost to Follow-up|2|||
13439378|NCT00356408|26911383|FG000|Overall Study|Withdrawal by Subject|6|||
13439379|NCT00356408|26911383|FG000|Overall Study|Other: Principal investigator discretion|3|||
13439380|NCT00356408|26911383|FG000|Overall Study|Other: Sponsor request|1|||
13439381|NCT00356408|26911383|FG000|Overall Study|Other: Azathioprine stopped|1|||
13439382|NCT00356408|26911383|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1|||
13439383|NCT00356408|26911383|FG000|Overall Study|Other: Subject chose commerical dosing|1|||
13439384|NCT00356369|26911458|FG000|Active Phase|Withdrawal by Subject|2|||
13439385|NCT00356369|26911459|FG001|Active Phase|Withdrawal by Subject|1|||
13439386|NCT00356278|26911504|FG000|Overall Study|Withdrawal by Subject|25|||
13439387|NCT00356278|26911505|FG001|Overall Study|Withdrawal by Subject|15|||
13439388|NCT00356278|26911506|FG002|Overall Study|Withdrawal by Subject|19|||
13439389|NCT00356265|26911526|FG000|Overall Study|Withdrawal by Subject|0|||
13439390|NCT00356265|26911527|FG001|Overall Study|Withdrawal by Subject|0|||
13439391|NCT00356265|26911528|FG002|Overall Study|Withdrawal by Subject|1|||
13439392|NCT00356200|26911547|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1|||
13439393|NCT00356200|26911548|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0|||
13439394|NCT00356200|26911547|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0|||
13439395|NCT00356200|26911548|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2|||
13439396|NCT00356148|26911563|FG000|Overall Study|Reoperation within 30 days|2|||
13439397|NCT00356148|26911564|FG001|Overall Study|Reoperation within 30 days|1|||
13439398|NCT00356135|26911596|FG000|Overall Study|Protocol Violation|1|||
13439399|NCT00356135|26911597|FG001|Overall Study|Protocol Violation|0|||
13439400|NCT00356135|26911598|FG002|Overall Study|Protocol Violation|0|||
13439401|NCT00356135|26911596|FG000|Overall Study|Adverse Event|1|||
13439402|NCT00356135|26911597|FG001|Overall Study|Adverse Event|0|||
13439403|NCT00356135|26911598|FG002|Overall Study|Adverse Event|0|||
13439404|NCT00356135|26911596|FG000|Overall Study|Lost to Follow-up|0|||
13439405|NCT00356135|26911597|FG001|Overall Study|Lost to Follow-up|0|||
13439406|NCT00356135|26911598|FG002|Overall Study|Lost to Follow-up|1|||
13439407|NCT00356135|26911596|FG000|Overall Study|Physician Decision|1|||
13439408|NCT00356135|26911597|FG001|Overall Study|Physician Decision|1|||
13439409|NCT00356135|26911598|FG002|Overall Study|Physician Decision|1|||
13439410|NCT00356135|26911596|FG000|Overall Study|Subject non-compliance|1|||
13439411|NCT00356135|26911597|FG001|Overall Study|Subject non-compliance|1|||
13439412|NCT00356135|26911598|FG002|Overall Study|Subject non-compliance|3|||
13439413|NCT00356122|26911608|FG000|TREATMENT|Lack of Efficacy|26|||
13439414|NCT00356122|26911608|FG000|TREATMENT|Adverse Event|10|||
13439415|NCT00356122|26911608|FG000|TREATMENT|Subject's request|4|||
13439416|NCT00356122|26911608|FG000|TREATMENT|Other|4|||
13439417|NCT00356122|26911608|FG000|TREATMENT|Did not receive study medication|1|||
13439418|NCT00356122|26911608|FG000|FOLLOW-UP|Death|37|||
13439419|NCT00356122|26911608|FG000|FOLLOW-UP|Lost to Follow-up|2|||
13439420|NCT00356122|26911608|FG000|FOLLOW-UP|Other|2|||
13477067|NCT00722046|27005446|FG004|Overall Study|Death|0|||
13477068|NCT00722046|27005447|FG005|Overall Study|Death|0|||
13477069|NCT00722046|27005448|FG006|Overall Study|Death|2|||
13477070|NCT00722046|27005442|FG000|Overall Study|Protocol Violation|1|||
13477071|NCT00722046|27005443|FG001|Overall Study|Protocol Violation|0|||
13477072|NCT00722046|27005444|FG002|Overall Study|Protocol Violation|0|||
13477073|NCT00722046|27005445|FG003|Overall Study|Protocol Violation|0|||
13477074|NCT00722046|27005446|FG004|Overall Study|Protocol Violation|0|||
13477075|NCT00722046|27005447|FG005|Overall Study|Protocol Violation|1|||
13477076|NCT00722046|27005448|FG006|Overall Study|Protocol Violation|0|||
13477077|NCT00722046|27005442|FG000|Overall Study|Withdrawal by Subject|3|||
13477078|NCT00722046|27005443|FG001|Overall Study|Withdrawal by Subject|3|||
13477079|NCT00722046|27005444|FG002|Overall Study|Withdrawal by Subject|4|||
13477080|NCT00722046|27005445|FG003|Overall Study|Withdrawal by Subject|4|||
13477081|NCT00722046|27005446|FG004|Overall Study|Withdrawal by Subject|4|||
13477082|NCT00722046|27005447|FG005|Overall Study|Withdrawal by Subject|7|||
13477083|NCT00722046|27005448|FG006|Overall Study|Withdrawal by Subject|3|||
13477084|NCT00722046|27005442|FG000|Overall Study|Randomized, but not treated|1|||
13477085|NCT00722046|27005443|FG001|Overall Study|Randomized, but not treated|1|||
13477086|NCT00722046|27005444|FG002|Overall Study|Randomized, but not treated|0|||
13477087|NCT00722046|27005445|FG003|Overall Study|Randomized, but not treated|2|||
13477088|NCT00722046|27005446|FG004|Overall Study|Randomized, but not treated|0|||
13477089|NCT00722046|27005447|FG005|Overall Study|Randomized, but not treated|0|||
13477090|NCT00722046|27005448|FG006|Overall Study|Randomized, but not treated|0|||
13477091|NCT00722046|27005442|FG000|Overall Study|Other|0|||
13477092|NCT00722046|27005443|FG001|Overall Study|Other|0|||
13477093|NCT00722046|27005444|FG002|Overall Study|Other|1|||
13477094|NCT00722046|27005445|FG003|Overall Study|Other|1|||
13477095|NCT00722046|27005446|FG004|Overall Study|Other|3|||
13477096|NCT00722046|27005447|FG005|Overall Study|Other|2|||
13477097|NCT00722046|27005448|FG006|Overall Study|Other|1|||
13477098|NCT00614523|27005479|FG000|Overall Study|Adverse Event|4|||
13477099|NCT00614523|27005480|FG001|Overall Study|Adverse Event|20|||
13477100|NCT00614523|27005479|FG000|Overall Study|Death|5|||
13477101|NCT00614523|27005480|FG001|Overall Study|Death|8|||
13477102|NCT00614523|27005479|FG000|Overall Study|Lack of Efficacy|9|||
13477103|NCT00614523|27005480|FG001|Overall Study|Lack of Efficacy|11|||
13477104|NCT00614523|27005479|FG000|Overall Study|Lost to Follow-up|0|||
13477105|NCT00614523|27005480|FG001|Overall Study|Lost to Follow-up|1|||
13477106|NCT00614523|27005479|FG000|Overall Study|Protocol Violation|3|||
13477107|NCT00614523|27005480|FG001|Overall Study|Protocol Violation|2|||
13477108|NCT00614523|27005479|FG000|Overall Study|Withdrawal by Subject|12|||
13477109|NCT00614523|27005480|FG001|Overall Study|Withdrawal by Subject|22|||
13477110|NCT00614523|27005479|FG000|Overall Study|Other|6|||
13477111|NCT00614523|27005480|FG001|Overall Study|Other|11|||
13439421|NCT00355784|26911650|FG000|Overall Study|Withdrawal by Subject|0|||
13439422|NCT00355784|26911651|FG001|Overall Study|Withdrawal by Subject|0|||
13439423|NCT00355784|26911652|FG002|Overall Study|Withdrawal by Subject|2|||
13439424|NCT00355615|26911725|FG000|Randomized Double Blind Period|Adverse Event|1|||
13439425|NCT00355615|26911726|FG001|Randomized Double Blind Period|Adverse Event|0|||
13439426|NCT00355615|26911727|FG002|Randomized Double Blind Period|Adverse Event|0|||
13439427|NCT00355615|26911728|FG003|Randomized Double Blind Period|Adverse Event|0|||
13439428|NCT00355615|26911729|FG004|Randomized Double Blind Period|Adverse Event|0|||
13439429|NCT00355615|26911725|FG000|Randomized Double Blind Period|Protocol Violation|0|||
13439430|NCT00355615|26911726|FG001|Randomized Double Blind Period|Protocol Violation|0|||
13439431|NCT00355615|26911727|FG002|Randomized Double Blind Period|Protocol Violation|1|||
13439432|NCT00355615|26911728|FG003|Randomized Double Blind Period|Protocol Violation|1|||
13439433|NCT00355615|26911729|FG004|Randomized Double Blind Period|Protocol Violation|0|||
13439434|NCT00355615|26911725|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
13439435|NCT00355615|26911726|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
13439436|NCT00355615|26911727|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
13439437|NCT00355615|26911728|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
13439438|NCT00355615|26911729|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4|||
13439439|NCT00355615|26911725|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
13439440|NCT00355615|26911726|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
13439441|NCT00355615|26911727|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
13439442|NCT00355615|26911728|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
13439443|NCT00355615|26911729|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1|||
13439444|NCT00355615|26911725|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
13439445|NCT00355615|26911726|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
13439446|NCT00355615|26911727|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
13439447|NCT00355615|26911728|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
13439448|NCT00355615|26911729|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3|||
13439449|NCT00355615|26911725|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
13439450|NCT00355615|26911726|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
13439451|NCT00355615|26911727|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
13439452|NCT00355615|26911728|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
13439453|NCT00355615|26911729|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1|||
13439454|NCT00355472|26911756|FG000|Overall Study|Physician Decision|1|||
13439455|NCT00355368|26911775|FG000|Overall Study|Protocol Violation|8|||
13439456|NCT00355368|26911776|FG001|Overall Study|Protocol Violation|7|||
13439457|NCT00355368|26911775|FG000|Overall Study|cardiac arrest prior to intubation|2|||
13439458|NCT00355368|26911776|FG001|Overall Study|cardiac arrest prior to intubation|2|||
13439459|NCT00355342|26911791|FG000|Overall Study|Adverse Event|13|||
13439460|NCT00355342|26911792|FG001|Overall Study|Adverse Event|15|||
13439461|NCT00355342|26911791|FG000|Overall Study|Lost to Follow-up|4|||
13439462|NCT00355342|26911792|FG001|Overall Study|Lost to Follow-up|2|||
13439463|NCT00355342|26911791|FG000|Overall Study|Withdrawal by Subject|14|||
13439464|NCT00355342|26911792|FG001|Overall Study|Withdrawal by Subject|11|||
13439465|NCT00355342|26911791|FG000|Overall Study|Sponsor terminated study|2|||
13439466|NCT00355342|26911792|FG001|Overall Study|Sponsor terminated study|2|||
13439467|NCT00355342|26911791|FG000|Overall Study|Overcompliant-PI discretion|1|||
13439468|NCT00355342|26911792|FG001|Overall Study|Overcompliant-PI discretion|0|||
13439469|NCT00355342|26911791|FG000|Overall Study|Use of prohibited medication|1|||
13439470|NCT00355342|26911792|FG001|Overall Study|Use of prohibited medication|0|||
13439471|NCT00355342|26911791|FG000|Overall Study|COPD exacerbation|1|||
13439472|NCT00355342|26911792|FG001|Overall Study|COPD exacerbation|1|||
13439473|NCT00355342|26911791|FG000|Overall Study|Dispensed wrong study drug kit|1|||
13439474|NCT00355342|26911792|FG001|Overall Study|Dispensed wrong study drug kit|0|||
13439475|NCT00355342|26911791|FG000|Overall Study|Non-compliance with Dexa scans|1|||
13439476|NCT00355342|26911792|FG001|Overall Study|Non-compliance with Dexa scans|0|||
13439477|NCT00355342|26911791|FG000|Overall Study|Withdrawal by participant and physician|1|||
13439478|NCT00355342|26911792|FG001|Overall Study|Withdrawal by participant and physician|0|||
13439479|NCT00355342|26911791|FG000|Overall Study|Participant relocated|0|||
13439480|NCT00355342|26911792|FG001|Overall Study|Participant relocated|1|||
13439481|NCT00355342|26911791|FG000|Overall Study|Participant discontinued study drug|0|||
13439482|NCT00355342|26911792|FG001|Overall Study|Participant discontinued study drug|1|||
13439483|NCT00355342|26911791|FG000|Overall Study|Study management|0|||
13439484|NCT00355342|26911792|FG001|Overall Study|Study management|1|||
13439485|NCT00355342|26911791|FG000|Overall Study|Protocol Violation|0|||
13439486|NCT00355342|26911792|FG001|Overall Study|Protocol Violation|1|||
13439487|NCT00355342|26911791|FG000|Overall Study|Use of protocol excluded medication|0|||
13439488|NCT00355342|26911792|FG001|Overall Study|Use of protocol excluded medication|1|||
13439489|NCT00355264|26911803|FG000|Extension (Variable Duration)|Adverse Event|1|||
13439490|NCT00355264|26911803|FG000|Extension (Variable Duration)|Withdrew Consent|1|||
13439491|NCT00355147|26911824|FG000|Overall Study|Lost to Follow-up|10|||
13439492|NCT00355147|26911825|FG001|Overall Study|Lost to Follow-up|8|||
13439493|NCT00355147|26911824|FG000|Overall Study|Withdrawal by Subject|8|||
13439494|NCT00355147|26911825|FG001|Overall Study|Withdrawal by Subject|12|||
13439495|NCT00355134|26911881|FG000|Core Phase|Withdrawal by Subject|35|||
13439496|NCT00355134|26911882|FG001|Core Phase|Withdrawal by Subject|24|||
13439497|NCT00355134|26911883|FG002|Core Phase|Withdrawal by Subject|35|||
13439498|NCT00355134|26911884|FG003|Core Phase|Withdrawal by Subject|0|||
13439499|NCT00355134|26911885|FG004|Core Phase|Withdrawal by Subject|0|||
13439500|NCT00355134|26911881|FG000|Core Phase|Adverse Event|28|||
13439501|NCT00355134|26911882|FG001|Core Phase|Adverse Event|22|||
13439502|NCT00355134|26911883|FG002|Core Phase|Adverse Event|16|||
13439503|NCT00355134|26911884|FG003|Core Phase|Adverse Event|0|||
13439504|NCT00355134|26911885|FG004|Core Phase|Adverse Event|0|||
13439505|NCT00355134|26911881|FG000|Core Phase|Lost to Follow-up|17|||
13439506|NCT00355134|26911882|FG001|Core Phase|Lost to Follow-up|13|||
13439507|NCT00355134|26911883|FG002|Core Phase|Lost to Follow-up|21|||
13439508|NCT00355134|26911884|FG003|Core Phase|Lost to Follow-up|0|||
13439509|NCT00355134|26911885|FG004|Core Phase|Lost to Follow-up|0|||
13439510|NCT00355134|26911881|FG000|Core Phase|Abnormal laboratory value(s)|19|||
13439511|NCT00355134|26911882|FG001|Core Phase|Abnormal laboratory value(s)|14|||
13439512|NCT00355134|26911883|FG002|Core Phase|Abnormal laboratory value(s)|2|||
13439513|NCT00355134|26911884|FG003|Core Phase|Abnormal laboratory value(s)|0|||
13439514|NCT00355134|26911885|FG004|Core Phase|Abnormal laboratory value(s)|0|||
13439515|NCT00355134|26911881|FG000|Core Phase|Unsatisfactory therapeutic effect|10|||
13439516|NCT00355134|26911882|FG001|Core Phase|Unsatisfactory therapeutic effect|6|||
13439517|NCT00355134|26911883|FG002|Core Phase|Unsatisfactory therapeutic effect|17|||
13439518|NCT00355134|26911884|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
13439519|NCT00355134|26911885|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
13439520|NCT00355134|26911881|FG000|Core Phase|Administrative problems|5|||
13439521|NCT00355134|26911882|FG001|Core Phase|Administrative problems|3|||
13439522|NCT00355134|26911883|FG002|Core Phase|Administrative problems|5|||
13439523|NCT00355134|26911884|FG003|Core Phase|Administrative problems|0|||
13439524|NCT00355134|26911885|FG004|Core Phase|Administrative problems|0|||
13439525|NCT00355134|26911881|FG000|Core Phase|Protocol Violation|3|||
13439526|NCT00355134|26911882|FG001|Core Phase|Protocol Violation|2|||
13439527|NCT00355134|26911883|FG002|Core Phase|Protocol Violation|2|||
13439528|NCT00355134|26911884|FG003|Core Phase|Protocol Violation|0|||
13439529|NCT00355134|26911885|FG004|Core Phase|Protocol Violation|0|||
13439530|NCT00355134|26911881|FG000|Core Phase|Abnormal test procedure result(s)|1|||
13439531|NCT00355134|26911882|FG001|Core Phase|Abnormal test procedure result(s)|2|||
13439532|NCT00355134|26911883|FG002|Core Phase|Abnormal test procedure result(s)|1|||
13439533|NCT00355134|26911884|FG003|Core Phase|Abnormal test procedure result(s)|0|||
13439534|NCT00355134|26911885|FG004|Core Phase|Abnormal test procedure result(s)|0|||
13439535|NCT00355134|26911881|FG000|Core Phase|Condition no longer requires study drug|1|||
13439536|NCT00355134|26911882|FG001|Core Phase|Condition no longer requires study drug|0|||
13439537|NCT00355134|26911883|FG002|Core Phase|Condition no longer requires study drug|1|||
13439538|NCT00355134|26911884|FG003|Core Phase|Condition no longer requires study drug|0|||
13439539|NCT00355134|26911885|FG004|Core Phase|Condition no longer requires study drug|0|||
13439540|NCT00355134|26911881|FG000|Extension Phase|Withdrawal by Subject|7|||
13439541|NCT00355134|26911882|FG001|Extension Phase|Withdrawal by Subject|11|||
13439542|NCT00355134|26911883|FG002|Extension Phase|Withdrawal by Subject|0|||
13439543|NCT00355134|26911884|FG003|Extension Phase|Withdrawal by Subject|7|||
13439544|NCT00355134|26911885|FG004|Extension Phase|Withdrawal by Subject|5|||
13439545|NCT00355134|26911881|FG000|Extension Phase|Adverse Event|13|||
13439546|NCT00355134|26911882|FG001|Extension Phase|Adverse Event|9|||
13439547|NCT00355134|26911883|FG002|Extension Phase|Adverse Event|0|||
13439548|NCT00355134|26911884|FG003|Extension Phase|Adverse Event|3|||
13439549|NCT00355134|26911885|FG004|Extension Phase|Adverse Event|5|||
13439550|NCT00355134|26911881|FG000|Extension Phase|Lost to Follow-up|2|||
13439551|NCT00355134|26911882|FG001|Extension Phase|Lost to Follow-up|6|||
13439552|NCT00355134|26911883|FG002|Extension Phase|Lost to Follow-up|0|||
13439553|NCT00355134|26911884|FG003|Extension Phase|Lost to Follow-up|2|||
13439554|NCT00355134|26911885|FG004|Extension Phase|Lost to Follow-up|4|||
13439555|NCT00355134|26911881|FG000|Extension Phase|Abnormal laboratory value(s)|4|||
13439556|NCT00355134|26911882|FG001|Extension Phase|Abnormal laboratory value(s)|2|||
13439557|NCT00355134|26911883|FG002|Extension Phase|Abnormal laboratory value(s)|0|||
13439558|NCT00355134|26911884|FG003|Extension Phase|Abnormal laboratory value(s)|2|||
13439559|NCT00355134|26911885|FG004|Extension Phase|Abnormal laboratory value(s)|2|||
13439560|NCT00355134|26911881|FG000|Extension Phase|Administrative problems|2|||
13439561|NCT00355134|26911882|FG001|Extension Phase|Administrative problems|4|||
13439562|NCT00355134|26911883|FG002|Extension Phase|Administrative problems|0|||
13439563|NCT00355134|26911884|FG003|Extension Phase|Administrative problems|1|||
13439564|NCT00355134|26911885|FG004|Extension Phase|Administrative problems|1|||
13439565|NCT00355134|26911881|FG000|Extension Phase|Unsatisfactory therapeutic effect|3|||
13439566|NCT00355134|26911882|FG001|Extension Phase|Unsatisfactory therapeutic effect|4|||
13439567|NCT00355134|26911883|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
13439568|NCT00355134|26911884|FG003|Extension Phase|Unsatisfactory therapeutic effect|0|||
13439569|NCT00355134|26911885|FG004|Extension Phase|Unsatisfactory therapeutic effect|1|||
13439570|NCT00355134|26911881|FG000|Extension Phase|Abnormal test procedure result(s)|0|||
13439571|NCT00355134|26911882|FG001|Extension Phase|Abnormal test procedure result(s)|1|||
13439572|NCT00355134|26911883|FG002|Extension Phase|Abnormal test procedure result(s)|0|||
13439573|NCT00355134|26911884|FG003|Extension Phase|Abnormal test procedure result(s)|0|||
13439574|NCT00355134|26911885|FG004|Extension Phase|Abnormal test procedure result(s)|1|||
13439575|NCT00355134|26911881|FG000|Extension Phase|Protocol Violation|0|||
13439576|NCT00355134|26911882|FG001|Extension Phase|Protocol Violation|0|||
13439577|NCT00355134|26911883|FG002|Extension Phase|Protocol Violation|0|||
13439578|NCT00355134|26911884|FG003|Extension Phase|Protocol Violation|1|||
13439579|NCT00355134|26911885|FG004|Extension Phase|Protocol Violation|0|||
13439580|NCT00355121|26911924|FG000|Overall Study|Did not receive study vaccine|1|||
13439581|NCT00355121|26911925|FG001|Overall Study|Did not receive study vaccine|0|||
13439582|NCT00355121|26911926|FG002|Overall Study|Did not receive study vaccine|1|||
13439583|NCT00355121|26911924|FG000|Overall Study|Adverse Event|0|||
13439584|NCT00355121|26911925|FG001|Overall Study|Adverse Event|1|||
13439585|NCT00355121|26911926|FG002|Overall Study|Adverse Event|0|||
13439586|NCT00355121|26911924|FG000|Overall Study|Protocol Violation|7|||
13439587|NCT00355121|26911925|FG001|Overall Study|Protocol Violation|9|||
13439588|NCT00355121|26911926|FG002|Overall Study|Protocol Violation|1|||
13439589|NCT00355121|26911924|FG000|Overall Study|Lost to Follow-up|4|||
13439590|NCT00355121|26911925|FG001|Overall Study|Lost to Follow-up|7|||
13439591|NCT00355121|26911926|FG002|Overall Study|Lost to Follow-up|1|||
13439592|NCT00355121|26911924|FG000|Overall Study|Withdrawal by Subject|9|||
13439593|NCT00355121|26911925|FG001|Overall Study|Withdrawal by Subject|10|||
13439594|NCT00355121|26911926|FG002|Overall Study|Withdrawal by Subject|2|||
13439595|NCT00355121|26911924|FG000|Overall Study|Serious adverse events|0|||
13439596|NCT00355121|26911925|FG001|Overall Study|Serious adverse events|2|||
13439597|NCT00355121|26911926|FG002|Overall Study|Serious adverse events|0|||
13439598|NCT00355082|26911954|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4|||
13439599|NCT00355082|26911955|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10|||
13439600|NCT00355082|26911956|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0|||
13439601|NCT00355082|26911954|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9|||
13439602|NCT00355082|26911955|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8|||
13439603|NCT00355082|26911956|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0|||
13439604|NCT00355082|26911954|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6|||
13439605|NCT00355082|26911955|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7|||
13439606|NCT00355082|26911956|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0|||
13439607|NCT00355082|26911954|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
13439608|NCT00355082|26911955|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4|||
13439609|NCT00355082|26911956|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
13439610|NCT00355082|26911954|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
13439611|NCT00355082|26911955|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4|||
13439612|NCT00355082|26911956|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
13439613|NCT00355082|26911954|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
13439614|NCT00355082|26911955|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1|||
13439615|NCT00355082|26911956|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
13439616|NCT00355082|26911954|FG000|Continuation Phase|Adverse Event|2|||
13439617|NCT00355082|26911955|FG001|Continuation Phase|Adverse Event|0|||
13439618|NCT00355082|26911956|FG002|Continuation Phase|Adverse Event|1|||
13439619|NCT00355082|26911954|FG000|Continuation Phase|Lost to Follow-up|2|||
13439620|NCT00355082|26911955|FG001|Continuation Phase|Lost to Follow-up|0|||
13439621|NCT00355082|26911956|FG002|Continuation Phase|Lost to Follow-up|1|||
13439622|NCT00355082|26911954|FG000|Continuation Phase|Protocol Violation|1|||
13439623|NCT00355082|26911955|FG001|Continuation Phase|Protocol Violation|0|||
13439624|NCT00355082|26911956|FG002|Continuation Phase|Protocol Violation|1|||
13439625|NCT00355082|26911954|FG000|Continuation Phase|Withdrawal by Subject|4|||
13439626|NCT00355082|26911955|FG001|Continuation Phase|Withdrawal by Subject|0|||
13439627|NCT00355082|26911956|FG002|Continuation Phase|Withdrawal by Subject|0|||
13439628|NCT00355082|26911954|FG000|Continuation Phase|Lack of Efficacy|5|||
13439629|NCT00355082|26911955|FG001|Continuation Phase|Lack of Efficacy|0|||
13439630|NCT00355082|26911956|FG002|Continuation Phase|Lack of Efficacy|0|||
13439631|NCT00355082|26911954|FG000|Continuation Phase|Site Closed by Sponsor|8|||
13439632|NCT00355082|26911955|FG001|Continuation Phase|Site Closed by Sponsor|0|||
13439633|NCT00355082|26911956|FG002|Continuation Phase|Site Closed by Sponsor|0|||
13439634|NCT00355082|26911954|FG000|Continuation Phase|Scheduling Error|1|||
13439635|NCT00355082|26911955|FG001|Continuation Phase|Scheduling Error|0|||
13439636|NCT00355082|26911956|FG002|Continuation Phase|Scheduling Error|0|||
13439637|NCT00355082|26911954|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1|||
13439638|NCT00355082|26911955|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0|||
13439639|NCT00355082|26911956|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0|||
13439640|NCT00355056|26911991|FG000|Randomization Period|Early Termination|4|||
13439641|NCT00355056|26911992|FG001|Randomization Period|Early Termination|6|||
13439642|NCT00355030|26912021|FG000|Study Period 1 Treatment|Adverse Event|1|||
13439643|NCT00355030|26912022|FG001|Study Period 1 Treatment|Adverse Event|1|||
13439644|NCT00355030|26912021|FG000|Study Period 1 Treatment|Lost to Follow-up|3|||
13439645|NCT00355030|26912022|FG001|Study Period 1 Treatment|Lost to Follow-up|0|||
13439646|NCT00355030|26912021|FG000|Study Period 1 Treatment|Withdrawal by Subject|4|||
13439647|NCT00355030|26912022|FG001|Study Period 1 Treatment|Withdrawal by Subject|1|||
13439648|NCT00355030|26912021|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1|||
13439649|NCT00355030|26912022|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2|||
13439650|NCT00355030|26912021|FG000|Study Period 1 Treatment|Physician Decision|0|||
13439651|NCT00355030|26912022|FG001|Study Period 1 Treatment|Physician Decision|1|||
13439652|NCT00355030|26912021|FG000|Study Period 1 Treatment|Sponsor Decision|34|||
13439653|NCT00355030|26912022|FG001|Study Period 1 Treatment|Sponsor Decision|32|||
13439654|NCT00355030|26912021|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0|||
13439655|NCT00355030|26912022|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1|||
13439656|NCT00355030|26912021|FG000|Study Period 1 Treatment|Other|2|||
13439657|NCT00355030|26912022|FG001|Study Period 1 Treatment|Other|6|||
13439658|NCT00355030|26912021|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0|||
13439659|NCT00355030|26912022|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1|||
13439660|NCT00355030|26912021|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
13439661|NCT00355030|26912022|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
13439662|NCT00354744|26912030|FG000|Overall Study|Adverse Event|2|||
13439663|NCT00354744|26912030|FG000|Overall Study|Death|2|||
13439664|NCT00354744|26912030|FG000|Overall Study|Lack of Efficacy|11|||
13439665|NCT00354744|26912030|FG000|Overall Study|Lost to Follow-up|2|||
13439666|NCT00354744|26912030|FG000|Overall Study|Physician Decision|11|||
13439667|NCT00354744|26912030|FG000|Overall Study|Withdrawal by Subject|14|||
13439668|NCT00354679|26912036|FG000|Overall Study|Patient Not Treated|1|||
13439669|NCT00354614|26912042|FG000|Overall Study|Lack of Efficacy|28|||
13439670|NCT00354601|26912051|FG000|Overall Study|Protocol Violation|1|||
13439671|NCT00354601|26912051|FG000|Overall Study|progression|1|||
13439672|NCT00354432|26912078|FG000|Overall Study|Adverse Event|3|||
13439673|NCT00354432|26912079|FG001|Overall Study|Adverse Event|1|||
13439674|NCT00354432|26912080|FG002|Overall Study|Adverse Event|5|||
13439675|NCT00354432|26912081|FG003|Overall Study|Adverse Event|5|||
13439676|NCT00354432|26912078|FG000|Overall Study|Off/Toxicity|3|||
13439677|NCT00354432|26912079|FG001|Overall Study|Off/Toxicity|7|||
13439678|NCT00354432|26912080|FG002|Overall Study|Off/Toxicity|5|||
13439679|NCT00354432|26912081|FG003|Overall Study|Off/Toxicity|5|||
13439680|NCT00354341|26912104|FG000|Overall Study|Adverse Event|1|||
13439681|NCT00354341|26912105|FG001|Overall Study|Adverse Event|0|||
13439682|NCT00354341|26912104|FG000|Overall Study|Death|0|||
13439683|NCT00354341|26912105|FG001|Overall Study|Death|2|||
13439684|NCT00354341|26912104|FG000|Overall Study|Refused treatment|1|||
13439685|NCT00354341|26912105|FG001|Overall Study|Refused treatment|2|||
13439686|NCT00354341|26912104|FG000|Overall Study|Failure to return|0|||
13439687|NCT00354341|26912105|FG001|Overall Study|Failure to return|1|||
13439688|NCT00354341|26912104|FG000|Overall Study|Other|1|||
13439689|NCT00354341|26912105|FG001|Overall Study|Other|2|||
13439690|NCT00354172|26912125|FG000|Overall Study|Did not receive transplant|1|||
13439691|NCT00354159|26912175|FG000|Randomized Study Period|Withdrawal by Subject|5|||
13439692|NCT00354159|26912176|FG001|Randomized Study Period|Withdrawal by Subject|3|||
13439693|NCT00354159|26912175|FG000|Randomized Study Period|Physician Decision|6|||
13439694|NCT00354159|26912176|FG001|Randomized Study Period|Physician Decision|10|||
13439695|NCT00354159|26912175|FG000|Randomized Study Period|Lost to Follow-up|4|||
13439696|NCT00354159|26912176|FG001|Randomized Study Period|Lost to Follow-up|0|||
13439697|NCT00354159|26912175|FG000|Randomized Study Period|Death|7|||
13439698|NCT00354159|26912176|FG001|Randomized Study Period|Death|9|||
13439699|NCT00354159|26912175|FG000|Long-term Follow-up|Withdrawal by Subject|9|||
13439700|NCT00354159|26912176|FG001|Long-term Follow-up|Withdrawal by Subject|9|||
13439701|NCT00354159|26912175|FG000|Long-term Follow-up|Physician Decision|127|||
13439702|NCT00354159|26912176|FG001|Long-term Follow-up|Physician Decision|122|||
13439703|NCT00354159|26912175|FG000|Long-term Follow-up|Lost to Follow-up|1|||
13439704|NCT00354159|26912176|FG001|Long-term Follow-up|Lost to Follow-up|0|||
13439705|NCT00354159|26912175|FG000|Long-term Follow-up|Death|14|||
13439706|NCT00354159|26912176|FG001|Long-term Follow-up|Death|11|||
13439707|NCT00354159|26912175|FG000|Long-term Follow-up|Study Closed|29|||
13439708|NCT00354159|26912176|FG001|Long-term Follow-up|Study Closed|34|||
13439709|NCT00354107|26912186|FG000|Overall Study|Adverse Event|2|||
13439710|NCT00354107|26912186|FG000|Overall Study|Physician Decision|2|||
13439711|NCT00354107|26912186|FG000|Overall Study|Withdrawal by Subject|1|||
13439712|NCT00354029|26912199|FG000|Overall Study|Protocol Violation|4|||
13439713|NCT00354029|26912200|FG001|Overall Study|Protocol Violation|2|||
13439714|NCT00353873|26912219|FG000|Overall Study|Protocol Violation|1|||
13439715|NCT00353873|26912220|FG001|Overall Study|Protocol Violation|2|||
13439716|NCT00353873|26912219|FG000|Overall Study|Exacerbation|1|||
13439717|NCT00353873|26912220|FG001|Overall Study|Exacerbation|0|||
13439718|NCT00353873|26912219|FG000|Overall Study|Adverse Event|1|||
13439719|NCT00353873|26912220|FG001|Overall Study|Adverse Event|0|||
13439720|NCT00353873|26912219|FG000|Overall Study|Physician Decision|2|||
13439721|NCT00353873|26912220|FG001|Overall Study|Physician Decision|0|||
13439722|NCT00353873|26912219|FG000|Overall Study|Withdrawal by Subject|1|||
13439723|NCT00353873|26912220|FG001|Overall Study|Withdrawal by Subject|1|||
13439724|NCT00353704|26912235|FG000|Overall Study|Protocol Violation|3|||
13439725|NCT00353704|26912236|FG001|Overall Study|Protocol Violation|1|||
13439726|NCT00353366|26912245|FG000|Overall Study|Adverse Event|8|||
13439727|NCT00353366|26912245|FG000|Overall Study|Protocol Violation|12|||
13439728|NCT00353366|26912245|FG000|Overall Study|Withdrawal by Subject|12|||
13439729|NCT00353366|26912245|FG000|Overall Study|Lost to Follow-up|92|||
13439730|NCT00353366|26912245|FG000|Overall Study|Other|19|||
13439731|NCT00353262|26912264|FG000|Overall Study|Adverse Event|8|||
13439732|NCT00353262|26912264|FG000|Overall Study|Withdrawal by Subject|2|||
13439733|NCT00353262|26912264|FG000|Overall Study|Insufficient Therapeutic Response|13|||
13439734|NCT00353262|26912264|FG000|Overall Study|Progression|1|||
13439735|NCT00353262|26912264|FG000|Overall Study|Surgery|4|||
13439736|NCT00353262|26912264|FG000|Overall Study|Break from Chemotherapy|1|||
13439737|NCT00352885|26912287|FG000|Overall Study|Withdrawal by Subject|0|||
13439738|NCT00352885|26912288|FG001|Overall Study|Withdrawal by Subject|3|||
13439739|NCT00352885|26912287|FG000|Overall Study|Development of major depression|0|||
13439740|NCT00352885|26912288|FG001|Overall Study|Development of major depression|1|||
13439741|NCT00352885|26912287|FG000|Overall Study|Progression of metastatic melanoma|5|||
13439742|NCT00352885|26912288|FG001|Overall Study|Progression of metastatic melanoma|3|||
13439743|NCT00352885|26912287|FG000|Overall Study|Side effects of IL-2 administration|1|||
13439744|NCT00352885|26912288|FG001|Overall Study|Side effects of IL-2 administration|0|||
13439745|NCT00352846|26912301|FG000|Overall Study|Disease progression|0|||
13439746|NCT00352846|26912302|FG001|Overall Study|Disease progression|2|||
13439747|NCT00352846|26912301|FG000|Overall Study|Withdrawal by Subject|3|||
13439748|NCT00352846|26912302|FG001|Overall Study|Withdrawal by Subject|8|||
13439749|NCT00352846|26912301|FG000|Overall Study|Ineligible|3|||
13439750|NCT00352846|26912302|FG001|Overall Study|Ineligible|2|||
13439751|NCT00352846|26912301|FG000|Overall Study|Non-compliance|2|||
13439752|NCT00352846|26912302|FG001|Overall Study|Non-compliance|0|||
13439753|NCT00352846|26912301|FG000|Overall Study|Death|0|||
13439754|NCT00352846|26912302|FG001|Overall Study|Death|1|||
13439755|NCT00352755|26912312|FG000|Overall Study|Physician Decision|1|||
13439756|NCT00352755|26912312|FG000|Overall Study|Adverse Event|1|||
13439757|NCT00352690|26912337|FG000|Overall Study|Determined to be ineligible|2|||
13439758|NCT00352690|26912338|FG001|Overall Study|Determined to be ineligible|0|||
13439759|NCT00352664|26912351|FG000|Overall Study|Withdrawal by Subject|7|||
13439760|NCT00352664|26912352|FG001|Overall Study|Withdrawal by Subject|0|||
13439761|NCT00352417|26912373|FG000|Overall Study|Adverse Event|1|||
13439762|NCT00352417|26912374|FG001|Overall Study|Adverse Event|0|||
13439763|NCT00352417|26912373|FG000|Overall Study|Protocol Violation|0|||
13439764|NCT00352417|26912374|FG001|Overall Study|Protocol Violation|2|||
13439765|NCT00352417|26912373|FG000|Overall Study|Withdrawal by Subject|1|||
13439766|NCT00352417|26912374|FG001|Overall Study|Withdrawal by Subject|2|||
13439767|NCT00352417|26912373|FG000|Overall Study|Lost to Follow-up|1|||
13439768|NCT00352417|26912374|FG001|Overall Study|Lost to Follow-up|0|||
13439769|NCT00352417|26912373|FG000|Overall Study|Schedule Change|2|||
13439770|NCT00352417|26912374|FG001|Overall Study|Schedule Change|1|||
13439771|NCT00352365|26912386|FG000|Induction Therapy|Adverse Event|7|||
13439772|NCT00352365|26912386|FG000|Induction Therapy|Progression/Relapse|8|||
13439773|NCT00352365|26912386|FG000|Induction Therapy|Death|7|||
13439774|NCT00352365|26912386|FG000|Induction Therapy|Not protocol specified|1|||
13439775|NCT00352365|26912386|FG000|Induction Therapy|Not eligible|3|||
13439776|NCT00352365|26912386|FG000|Induction Therapy|Death before starting protocol therapy|1|||
13439777|NCT00352365|26912386|FG000|Maintenance Therapy|Progression/Relapse|3|||
13439778|NCT00352365|26912386|FG000|Maintenance Therapy|Death|2|||
13439779|NCT00352365|26912386|FG000|Maintenance Therapy|Not protocol specified|3|||
13439780|NCT00352365|26912386|FG000|Maintenance Therapy|Not eligible|4|||
13439781|NCT00352118|26912398|FG000|Overall Study|Physician Decision|4|||
13439782|NCT00352105|26912409|FG000|Overall Study|Death|5|||
13439783|NCT00352105|26912409|FG000|Overall Study|Withdrawal by Subject|5|||
13439784|NCT00352105|26912409|FG000|Overall Study|Lack of Efficacy|9|||
13439785|NCT00352105|26912409|FG000|Overall Study|Adverse Event|19|||
13439786|NCT00352105|26912409|FG000|Overall Study|Protocol Violation|2|||
13439787|NCT00352053|26912583|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14|||
13439788|NCT00352053|26912584|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10|||
13439789|NCT00352053|26912583|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
13439790|NCT00352053|26912584|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
13439791|NCT00352053|26912583|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1|||
13439792|NCT00352053|26912584|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0|||
13439793|NCT00352053|26912583|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0|||
13439794|NCT00352053|26912584|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1|||
13439795|NCT00352053|26912583|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1|||
13439796|NCT00352053|26912584|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0|||
13439797|NCT00352053|26912583|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9|||
13439798|NCT00352053|26912584|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13|||
13439799|NCT00352053|26912583|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1|||
13439800|NCT00352053|26912584|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4|||
13439801|NCT00352053|26912583|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1|||
13439802|NCT00352053|26912584|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0|||
13439803|NCT00352053|26912583|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1|||
13439804|NCT00352053|26912584|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0|||
13439805|NCT00352053|26912583|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
13439806|NCT00352053|26912584|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
13439807|NCT00352053|26912583|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
13439808|NCT00352053|26912584|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
13439809|NCT00352053|26912583|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
13439810|NCT00352053|26912584|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
13439811|NCT00352053|26912583|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0|||
13439812|NCT00352053|26912584|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1|||
13439813|NCT00351819|26912639|FG000|Overall Study|Lost to Follow-up|4|||
13439814|NCT00351819|26912640|FG001|Overall Study|Lost to Follow-up|4|||
13439815|NCT00351819|26912639|FG000|Overall Study|Withdrawal by Subject|0|||
13439816|NCT00351819|26912640|FG001|Overall Study|Withdrawal by Subject|4|||
13439817|NCT00351819|26912639|FG000|Overall Study|Elevated PSA|1|||
13439818|NCT00351819|26912640|FG001|Overall Study|Elevated PSA|1|||
13439819|NCT00351819|26912639|FG000|Overall Study|Traumatic ankle fracture|1|||
13439820|NCT00351819|26912640|FG001|Overall Study|Traumatic ankle fracture|0|||
13439821|NCT00351819|26912639|FG000|Overall Study|Unprofessional behavior|1|||
13439822|NCT00351819|26912640|FG001|Overall Study|Unprofessional behavior|0|||
13439823|NCT00351819|26912639|FG000|Overall Study|Non-compliance|0|||
13439824|NCT00351819|26912640|FG001|Overall Study|Non-compliance|1|||
13439825|NCT00351819|26912639|FG000|Overall Study|Incarcerated|0|||
13439826|NCT00351819|26912640|FG001|Overall Study|Incarcerated|1|||
13439827|NCT00351819|26912639|FG000|Overall Study|Enrolled in another trial|0|||
13439828|NCT00351819|26912640|FG001|Overall Study|Enrolled in another trial|1|||
13439829|NCT00351611|26912657|FG000|Overall Study|Adverse Event|11|||
13439830|NCT00351611|26912658|FG001|Overall Study|Adverse Event|3|||
13439831|NCT00351611|26912657|FG000|Overall Study|Death|1|||
13439832|NCT00351611|26912658|FG001|Overall Study|Death|0|||
13439833|NCT00351611|26912657|FG000|Overall Study|Lost to Follow-up|1|||
13439834|NCT00351611|26912658|FG001|Overall Study|Lost to Follow-up|0|||
13439835|NCT00351611|26912657|FG000|Overall Study|No Longer Willing to Participate in Study|0|||
13439836|NCT00351611|26912658|FG001|Overall Study|No Longer Willing to Participate in Study|5|||
13439837|NCT00351611|26912657|FG000|Overall Study|Other|1|||
13439838|NCT00351611|26912658|FG001|Overall Study|Other|0|||
13439839|NCT00351611|26912657|FG000|Overall Study|Protocol Violation|0|||
13439840|NCT00351611|26912658|FG001|Overall Study|Protocol Violation|2|||
13439841|NCT00351533|26912725|FG000|Overall Study|Extubated before first BAL|1|||
13439842|NCT00351533|26912726|FG001|Overall Study|Extubated before first BAL|0|||
13439843|NCT00351533|26912725|FG000|Overall Study|Lost to Follow-up|1|||
13439844|NCT00351533|26912726|FG001|Overall Study|Lost to Follow-up|3|||
13439845|NCT00351533|26912725|FG000|Overall Study|Physician Decision|0|||
13439846|NCT00351533|26912726|FG001|Overall Study|Physician Decision|1|||
13439847|NCT00351533|26912725|FG000|Overall Study|Withdrawal by Subject|0|||
13439848|NCT00351533|26912726|FG001|Overall Study|Withdrawal by Subject|1|||
13439849|NCT00351468|26912743|FG000|Overall Study|Adverse Event|42|||
13439850|NCT00351468|26912743|FG000|Overall Study|Withdrawal by Subject|39|||
13439851|NCT00351468|26912743|FG000|Overall Study|Various -follow up w clinical team|39|||
13439852|NCT00351468|26912743|FG000|Overall Study|Lack of Efficacy|32|||
13439853|NCT00351468|26912743|FG000|Overall Study|Non-compliance|8|||
13439854|NCT00351468|26912743|FG000|Overall Study|Lost to Follow-up|4|||
13439855|NCT00351468|26912743|FG000|Overall Study|Protocol Violation|3|||
13439856|NCT00351377|26912757|FG000|Overall Study|Adverse Event|5|||
13439857|NCT00351377|26912757|FG000|Overall Study|Death|1|||
13439858|NCT00351377|26912757|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
13439859|NCT00351351|26912770|FG000|Overall Study|surgical access pbs; device issues|9|||
13439860|NCT00351351|26912771|FG001|Overall Study|surgical access pbs; device issues|4|||
13439861|NCT00351273|26912804|FG000|Overall Study|Lost to Follow-up|1|||
13439862|NCT00351273|26912805|FG001|Overall Study|Lost to Follow-up|2|||
13439863|NCT00351273|26912806|FG002|Overall Study|Lost to Follow-up|5|||
13439864|NCT00350870|26912833|FG000|Overall Study|Withdrawal by Subject|21|||
13439865|NCT00350870|26912834|FG001|Overall Study|Withdrawal by Subject|17|||
13439866|NCT00350870|26912835|FG002|Overall Study|Withdrawal by Subject|15|||
13439867|NCT00350870|26912836|FG003|Overall Study|Withdrawal by Subject|14|||
13439868|NCT00350870|26912833|FG000|Overall Study|Physician Decision|1|||
13439869|NCT00350870|26912834|FG001|Overall Study|Physician Decision|0|||
13439870|NCT00350870|26912835|FG002|Overall Study|Physician Decision|1|||
13439871|NCT00350870|26912836|FG003|Overall Study|Physician Decision|1|||
13439872|NCT00350844|26912842|FG000|Overall Study|Lost to Follow-up|1|||
13439873|NCT00350792|26912852|FG000|Overall Study|Adverse Event|11|||
13439874|NCT00350792|26912852|FG000|Overall Study|Death from Study Disease|1|||
13439875|NCT00350792|26912852|FG000|Overall Study|Death from Study Drug Toxicity|1|||
13439876|NCT00350792|26912852|FG000|Overall Study|Death Not Study Drug Related|2|||
13439877|NCT00350792|26912852|FG000|Overall Study|Protocol Violation|1|||
13439878|NCT00350792|26912852|FG000|Overall Study|Withdrawal by Subject|4|||
13439879|NCT00350792|26912852|FG000|Overall Study|Physician Decision|2|||
13439880|NCT00350792|26912852|FG000|Overall Study|Lack of Efficacy|11|||
13439881|NCT00350779|26912877|FG000|Overall Study|Adverse Event|4|||
13439882|NCT00350779|26912878|FG001|Overall Study|Adverse Event|2|||
13439883|NCT00350779|26912877|FG000|Overall Study|Lack of Efficacy|0|||
13439884|NCT00350779|26912878|FG001|Overall Study|Lack of Efficacy|4|||
13439885|NCT00350779|26912877|FG000|Overall Study|Lost to Follow-up|2|||
13439886|NCT00350779|26912878|FG001|Overall Study|Lost to Follow-up|0|||
13439887|NCT00350779|26912877|FG000|Overall Study|Physician Decision|2|||
13439888|NCT00350779|26912878|FG001|Overall Study|Physician Decision|4|||
13439889|NCT00350779|26912877|FG000|Overall Study|Protocol Violation|3|||
13439890|NCT00350779|26912878|FG001|Overall Study|Protocol Violation|1|||
13439891|NCT00350779|26912877|FG000|Overall Study|Withdrawal by Subject|9|||
13439892|NCT00350779|26912878|FG001|Overall Study|Withdrawal by Subject|8|||
13439893|NCT00350779|26912877|FG000|Overall Study|Patient Moved|2|||
13439894|NCT00350779|26912878|FG001|Overall Study|Patient Moved|1|||
13439895|NCT00350779|26912877|FG000|Overall Study|Non-compliance with study procedures|0|||
13439896|NCT00350779|26912878|FG001|Overall Study|Non-compliance with study procedures|1|||
13439897|NCT00350727|26913030|FG000|Phase I: Dose Escalation|Adverse Event|4|||
13439898|NCT00350727|26913031|FG001|Phase I: Dose Escalation|Adverse Event|0|||
13439899|NCT00350727|26913032|FG002|Phase I: Dose Escalation|Adverse Event|0|||
13439900|NCT00350727|26913030|FG000|Phase I: Dose Escalation|Lack of Efficacy|25|||
13439901|NCT00350727|26913031|FG001|Phase I: Dose Escalation|Lack of Efficacy|0|||
13439902|NCT00350727|26913032|FG002|Phase I: Dose Escalation|Lack of Efficacy|0|||
13439903|NCT00350727|26913030|FG000|Phase I: Dose Escalation|Death|1|||
13439904|NCT00350727|26913031|FG001|Phase I: Dose Escalation|Death|0|||
13439905|NCT00350727|26913032|FG002|Phase I: Dose Escalation|Death|0|||
13439906|NCT00350727|26913030|FG000|Phase I: Dose Escalation|Physician Decision|1|||
13439907|NCT00350727|26913031|FG001|Phase I: Dose Escalation|Physician Decision|0|||
13439908|NCT00350727|26913032|FG002|Phase I: Dose Escalation|Physician Decision|0|||
13439909|NCT00350727|26913030|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3|||
13439910|NCT00350727|26913031|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0|||
13439911|NCT00350727|26913032|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0|||
13439912|NCT00350727|26913030|FG000|Phase II|Disease Progression|0|||
13439913|NCT00350727|26913031|FG001|Phase II|Disease Progression|15|||
13439914|NCT00350727|26913032|FG002|Phase II|Disease Progression|16|||
13439915|NCT00350727|26913030|FG000|Phase II|Clinical Deterioration|0|||
13439916|NCT00350727|26913031|FG001|Phase II|Clinical Deterioration|1|||
13439917|NCT00350727|26913032|FG002|Phase II|Clinical Deterioration|0|||
13439918|NCT00350727|26913030|FG000|Phase II|Withdrawal by Subject|0|||
13439919|NCT00350727|26913031|FG001|Phase II|Withdrawal by Subject|2|||
13439920|NCT00350727|26913032|FG002|Phase II|Withdrawal by Subject|1|||
13439921|NCT00350727|26913030|FG000|Phase II|Adverse Event|0|||
13439922|NCT00350727|26913031|FG001|Phase II|Adverse Event|1|||
13439923|NCT00350727|26913032|FG002|Phase II|Adverse Event|1|||
13439924|NCT00350727|26913030|FG000|Phase II|Death|0|||
13439925|NCT00350727|26913031|FG001|Phase II|Death|0|||
13439926|NCT00350727|26913032|FG002|Phase II|Death|2|||
13439927|NCT00350727|26913030|FG000|Phase II|Sponsor Terminated Study|0|||
13439928|NCT00350727|26913031|FG001|Phase II|Sponsor Terminated Study|0|||
13439929|NCT00350727|26913032|FG002|Phase II|Sponsor Terminated Study|1|||
13439930|NCT00350727|26913030|FG000|Phase II|Enrolled in Rollover Study|0|||
13439931|NCT00350727|26913031|FG001|Phase II|Enrolled in Rollover Study|0|||
13439932|NCT00350727|26913032|FG002|Phase II|Enrolled in Rollover Study|1|||
13439933|NCT00350636|26913055|FG000|Overall Study|Adverse Event|19|||
13439934|NCT00350636|26913056|FG001|Overall Study|Adverse Event|13|||
13439935|NCT00350636|26913055|FG000|Overall Study|Protocol Violation|1|||
13439936|NCT00350636|26913056|FG001|Overall Study|Protocol Violation|3|||
13439937|NCT00350636|26913055|FG000|Overall Study|Withdrawal by Subject|13|||
13439938|NCT00350636|26913056|FG001|Overall Study|Withdrawal by Subject|17|||
13439939|NCT00350636|26913055|FG000|Overall Study|Lost to Follow-up|9|||
13439940|NCT00350636|26913056|FG001|Overall Study|Lost to Follow-up|8|||
13439941|NCT00350636|26913055|FG000|Overall Study|Physician Decision|0|||
13439942|NCT00350636|26913056|FG001|Overall Study|Physician Decision|2|||
13439943|NCT00350636|26913055|FG000|Overall Study|Other|1|||
13439944|NCT00350636|26913056|FG001|Overall Study|Other|2|||
13439945|NCT00350623|26913074|FG000|Overall Study|Lost to Follow-up|8|||
13439946|NCT00350623|26913075|FG001|Overall Study|Lost to Follow-up|3|||
13439947|NCT00350623|26913076|FG002|Overall Study|Lost to Follow-up|4|||
13439948|NCT00350623|26913074|FG000|Overall Study|Withdrawal by Subject|0|||
13439949|NCT00350623|26913075|FG001|Overall Study|Withdrawal by Subject|1|||
13439950|NCT00350623|26913076|FG002|Overall Study|Withdrawal by Subject|1|||
13439951|NCT00350623|26913074|FG000|Overall Study|patient traveling outside the country|0|||
13439952|NCT00350623|26913075|FG001|Overall Study|patient traveling outside the country|0|||
13439953|NCT00350623|26913076|FG002|Overall Study|patient traveling outside the country|1|||
13439954|NCT00350545|26913086|FG000|Overall Study|Withdrawal by Subject|2|||
13439955|NCT00350519|26913105|FG000|Overall Study|Death|0|||
13439956|NCT00350519|26913106|FG001|Overall Study|Death|1|||
13439957|NCT00350519|26913105|FG000|Overall Study|Physician Decision|0|||
13439958|NCT00350519|26913106|FG001|Overall Study|Physician Decision|1|||
13439959|NCT00350519|26913105|FG000|Overall Study|Protocol Violation|1|||
13439960|NCT00350519|26913106|FG001|Overall Study|Protocol Violation|2|||
13439961|NCT00350519|26913105|FG000|Overall Study|Withdrawal by Subject|3|||
13439962|NCT00350519|26913106|FG001|Overall Study|Withdrawal by Subject|2|||
13439963|NCT00350402|26913125|FG000|Overall Study|Lost to Follow-up|1|||
13439964|NCT00350402|26913126|FG001|Overall Study|Lost to Follow-up|1|||
13439965|NCT00350298|26913149|FG000|Overall Study|Death|7|||
13439966|NCT00350298|26913150|FG001|Overall Study|Death|8|||
13439967|NCT00350298|26913149|FG000|Overall Study|Lost to Follow-up|1|||
13439968|NCT00350298|26913150|FG001|Overall Study|Lost to Follow-up|2|||
13439969|NCT00350298|26913149|FG000|Overall Study|Withdrawal by Subject|1|||
13439970|NCT00350298|26913150|FG001|Overall Study|Withdrawal by Subject|3|||
13439971|NCT00350272|26913165|FG000|Blinded 12 Week Treatment|Adverse Event|1|||
13439972|NCT00350272|26913166|FG001|Blinded 12 Week Treatment|Adverse Event|0|||
13439973|NCT00350272|26913165|FG000|Blinded 12 Week Treatment|Death|1|||
13439974|NCT00350272|26913166|FG001|Blinded 12 Week Treatment|Death|0|||
13439975|NCT00350272|26913165|FG000|Blinded 12 Week Treatment|Lost to Follow-up|2|||
13439976|NCT00350272|26913166|FG001|Blinded 12 Week Treatment|Lost to Follow-up|0|||
13439977|NCT00350272|26913165|FG000|Blinded 12 Week Treatment|Withdrawal by Subject|3|||
13439978|NCT00350272|26913166|FG001|Blinded 12 Week Treatment|Withdrawal by Subject|0|||
13439979|NCT00350272|26913165|FG000|Blinded 12 Week Treatment|Physician Decision|2|||
13439980|NCT00350272|26913166|FG001|Blinded 12 Week Treatment|Physician Decision|1|||
13439981|NCT00350272|26913165|FG000|Blinded 12 Week Treatment|Sponsor decision|0|||
13439982|NCT00350272|26913166|FG001|Blinded 12 Week Treatment|Sponsor decision|1|||
13439983|NCT00350272|26913165|FG000|Open-Label 84 Week Treatment|Adverse Event|2|||
13439984|NCT00350272|26913166|FG001|Open-Label 84 Week Treatment|Adverse Event|1|||
13439985|NCT00350272|26913165|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3|||
13439986|NCT00350272|26913166|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2|||
13439987|NCT00350272|26913165|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1|||
13439988|NCT00350272|26913166|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2|||
13439989|NCT00350272|26913165|FG000|Open-Label 84 Week Treatment|Physician Decision|1|||
13439990|NCT00350272|26913166|FG001|Open-Label 84 Week Treatment|Physician Decision|2|||
13439991|NCT00350272|26913165|FG000|Open-Label 84 Week Treatment|Sponsor decision|2|||
13439992|NCT00350272|26913166|FG001|Open-Label 84 Week Treatment|Sponsor decision|1|||
13439993|NCT00350207|26913370|FG000|Overall Study|Adverse Event|5|||
13439994|NCT00350207|26913371|FG001|Overall Study|Adverse Event|2|||
13439995|NCT00350207|26913372|FG002|Overall Study|Adverse Event|2|||
13439996|NCT00350207|26913370|FG000|Overall Study|Lack of Efficacy|1|||
13439997|NCT00350207|26913371|FG001|Overall Study|Lack of Efficacy|0|||
13439998|NCT00350207|26913372|FG002|Overall Study|Lack of Efficacy|2|||
13439999|NCT00350207|26913370|FG000|Overall Study|Lost to Follow-up|1|||
13440000|NCT00350207|26913371|FG001|Overall Study|Lost to Follow-up|0|||
13440001|NCT00350207|26913372|FG002|Overall Study|Lost to Follow-up|1|||
13440002|NCT00350207|26913370|FG000|Overall Study|Withdrawal by Subject|0|||
13440003|NCT00350207|26913371|FG001|Overall Study|Withdrawal by Subject|1|||
13440004|NCT00350207|26913372|FG002|Overall Study|Withdrawal by Subject|1|||
13440005|NCT00350207|26913370|FG000|Overall Study|Other|1|||
13440006|NCT00350207|26913371|FG001|Overall Study|Other|3|||
13440007|NCT00350207|26913372|FG002|Overall Study|Other|1|||
13440008|NCT00349973|26913389|FG000|Overall Study|Adverse Event|3|||
13440009|NCT00349973|26913390|FG001|Overall Study|Adverse Event|3|||
13440010|NCT00349973|26913389|FG000|Overall Study|Withdrawal by Subject|1|||
13440011|NCT00349973|26913390|FG001|Overall Study|Withdrawal by Subject|0|||
13440012|NCT00349921|26913412|FG000|First Spinal Injection|Physician Decision|1|||
13440013|NCT00349921|26913413|FG001|First Spinal Injection|Physician Decision|0|||
13440014|NCT00349921|26913414|FG002|First Spinal Injection|Physician Decision|0|||
13440015|NCT00349921|26913415|FG003|First Spinal Injection|Physician Decision|0|||
13440016|NCT00349921|26913412|FG000|First Spinal Injection|Adverse Event|0|||
13440017|NCT00349921|26913413|FG001|First Spinal Injection|Adverse Event|0|||
13440018|NCT00349921|26913414|FG002|First Spinal Injection|Adverse Event|1|||
13440019|NCT00349921|26913415|FG003|First Spinal Injection|Adverse Event|0|||
13440020|NCT00349908|26913440|FG000|Overall Study|Withdrawal by Subject|0|||
13440021|NCT00349908|26913441|FG001|Overall Study|Withdrawal by Subject|4|||
13440022|NCT00349752|26913474|FG000|Overall Study|Adverse Event|8|||
13440023|NCT00349752|26913475|FG001|Overall Study|Adverse Event|12|||
13440024|NCT00349752|26913474|FG000|Overall Study|Lack of Efficacy|37|||
13440025|NCT00349752|26913475|FG001|Overall Study|Lack of Efficacy|42|||
13440026|NCT00349752|26913474|FG000|Overall Study|Lost to Follow-up|4|||
13440027|NCT00349752|26913475|FG001|Overall Study|Lost to Follow-up|2|||
13440028|NCT00349752|26913474|FG000|Overall Study|Personal reasons|6|||
13440029|NCT00349752|26913475|FG001|Overall Study|Personal reasons|5|||
13440030|NCT00349752|26913474|FG000|Overall Study|Other: Required exclusionary medication|0|||
13440031|NCT00349752|26913475|FG001|Overall Study|Other: Required exclusionary medication|1|||
13440032|NCT00349752|26913474|FG000|Overall Study|Other: Non compliance|0|||
13440033|NCT00349752|26913475|FG001|Overall Study|Other: Non compliance|1|||
13440034|NCT00349752|26913474|FG000|Overall Study|Other: Patient stopped steroids|0|||
13440035|NCT00349752|26913475|FG001|Overall Study|Other: Patient stopped steroids|1|||
13440036|NCT00349752|26913474|FG000|Overall Study|Other: Patient's steroid use|1|||
13440037|NCT00349752|26913475|FG001|Overall Study|Other: Patient's steroid use|0|||
13440038|NCT00349752|26913474|FG000|Overall Study|Other: Ineligible|1|||
13440039|NCT00349752|26913475|FG001|Overall Study|Other: Ineligible|0|||
13440040|NCT00349752|26913474|FG000|Overall Study|Other: Inadvertently unblinded|1|||
13440041|NCT00349752|26913475|FG001|Overall Study|Other: Inadvertently unblinded|0|||
13440042|NCT00349752|26913474|FG000|Overall Study|Other:History of squamous cell carcinoma|1|||
13440043|NCT00349752|26913475|FG001|Overall Study|Other:History of squamous cell carcinoma|0|||
13440044|NCT00349622|26913498|FG000|Overall Study|Death|168|||
13440045|NCT00349622|26913499|FG001|Overall Study|Death|86|||
13440046|NCT00349622|26913498|FG000|Overall Study|Lost to Follow-up|5|||
13440047|NCT00349622|26913499|FG001|Overall Study|Lost to Follow-up|1|||
13440048|NCT00349622|26913498|FG000|Overall Study|Withdrawal by Subject|5|||
13440049|NCT00349622|26913499|FG001|Overall Study|Withdrawal by Subject|9|||
13440050|NCT00349349|26913573|FG000|Overall Study|Adverse Event|5|||
13440051|NCT00349349|26913574|FG001|Overall Study|Adverse Event|6|||
13440052|NCT00349349|26913575|FG002|Overall Study|Adverse Event|2|||
13440053|NCT00349349|26913573|FG000|Overall Study|Withdrawal by Subject|5|||
13440054|NCT00349349|26913574|FG001|Overall Study|Withdrawal by Subject|2|||
13440055|NCT00349349|26913575|FG002|Overall Study|Withdrawal by Subject|1|||
13440056|NCT00349349|26913573|FG000|Overall Study|Withdrawn due to Disease Progression|27|||
13440057|NCT00349349|26913574|FG001|Overall Study|Withdrawn due to Disease Progression|37|||
13440058|NCT00349349|26913575|FG002|Overall Study|Withdrawn due to Disease Progression|1|||
13440059|NCT00349349|26913573|FG000|Overall Study|Death|13|||
13440060|NCT00349349|26913574|FG001|Overall Study|Death|10|||
13440061|NCT00349349|26913575|FG002|Overall Study|Death|1|||
13440062|NCT00349349|26913573|FG000|Overall Study|Other Treatment Selected|2|||
13440063|NCT00349349|26913574|FG001|Overall Study|Other Treatment Selected|0|||
13440064|NCT00349349|26913575|FG002|Overall Study|Other Treatment Selected|0|||
13440065|NCT00349349|26913573|FG000|Overall Study|Participant Reduced General Condition|0|||
13440066|NCT00349349|26913574|FG001|Overall Study|Participant Reduced General Condition|1|||
13440067|NCT00349349|26913575|FG002|Overall Study|Participant Reduced General Condition|0|||
13440068|NCT00349349|26913573|FG000|Overall Study|Physician Decision|1|||
13440069|NCT00349349|26913574|FG001|Overall Study|Physician Decision|2|||
13440070|NCT00349349|26913575|FG002|Overall Study|Physician Decision|1|||
13440071|NCT00349349|26913573|FG000|Overall Study|No Response|0|||
13440072|NCT00349349|26913574|FG001|Overall Study|No Response|3|||
13440073|NCT00349349|26913575|FG002|Overall Study|No Response|0|||
13440074|NCT00349349|26913573|FG000|Overall Study|New Malignancy (Bladder Cancer)|0|||
13440075|NCT00349349|26913574|FG001|Overall Study|New Malignancy (Bladder Cancer)|1|||
13440076|NCT00349349|26913575|FG002|Overall Study|New Malignancy (Bladder Cancer)|0|||
13440077|NCT00348933|26913583|FG000|Overall Study|Withdrawal by Subject|10|||
13440078|NCT00348933|26913583|FG000|Overall Study|Lost to Follow-up|6|||
13440079|NCT00348933|26913583|FG000|Overall Study|Protocol Violation|2|||
13440080|NCT00348933|26913583|FG000|Overall Study|Adverse Event|7|||
13440081|NCT00348881|26913602|FG000|Overall Study|Lost to Follow-up|12|||
13440082|NCT00348881|26913603|FG001|Overall Study|Lost to Follow-up|6|||
13440083|NCT00348881|26913602|FG000|Overall Study|Withdrawal by Subject|3|||
13440084|NCT00348881|26913603|FG001|Overall Study|Withdrawal by Subject|4|||
13440085|NCT00348881|26913602|FG000|Overall Study|Adverse Event|2|||
13440086|NCT00348881|26913603|FG001|Overall Study|Adverse Event|0|||
13440087|NCT00348881|26913602|FG000|Overall Study|Serious Adverse Event|0|||
13440088|NCT00348881|26913603|FG001|Overall Study|Serious Adverse Event|2|||
13440089|NCT00348816|26913612|FG000|Overall Study|Noncompliance with radiation treatment|1|||
13440090|NCT00348790|26913626|FG000|Completed Treatment|Withdrawal by Subject|4|||
13440091|NCT00348790|26913626|FG000|Completed Treatment|Disease progression|14|||
13440092|NCT00348790|26913626|FG000|Completed Treatment|Adverse Event|4|||
13440093|NCT00348790|26913626|FG000|Completed Treatment|Required surgery|2|||
13440094|NCT00348790|26913626|FG000|Completed Treatment|Unable to travel to study site|1|||
13440095|NCT00348686|26913637|FG000|Overall Study|Withdrawal by Subject|45|||
13440096|NCT00348686|26913637|FG000|Overall Study|Adverse Event|5|||
13440097|NCT00348686|26913637|FG000|Overall Study|Protocol Violation|6|||
13440098|NCT00348686|26913637|FG000|Overall Study|Lost to Follow-up|2|||
13440099|NCT00348686|26913637|FG000|Overall Study|Multiple Reasons|8|||
13440100|NCT00348673|26913710|FG000|Stage 1|Randomized but not Treated|0|||
13440101|NCT00348673|26913711|FG001|Stage 1|Randomized but not Treated|0|||
13440102|NCT00348673|26913712|FG002|Stage 1|Randomized but not Treated|1|||
13440103|NCT00348673|26913713|FG003|Stage 1|Randomized but not Treated|0|||
13440104|NCT00348673|26913714|FG004|Stage 1|Randomized but not Treated|0|||
13440105|NCT00348673|26913715|FG005|Stage 1|Randomized but not Treated|0|||
13440106|NCT00348673|26913716|FG006|Stage 1|Randomized but not Treated|0|||
13440107|NCT00348673|26913717|FG007|Stage 1|Randomized but not Treated|0|||
13440108|NCT00348673|26913718|FG008|Stage 1|Randomized but not Treated|0|||
13440109|NCT00348595|26913737|FG000|Overall Study|Adverse Event|5|||
13440110|NCT00348595|26913738|FG001|Overall Study|Adverse Event|8|||
13440111|NCT00348556|26913745|FG000|Overall Study|Adverse Event|1|||
13440112|NCT00348374|26913797|FG000|Overall Study|Adverse Event|1|||
13440113|NCT00348374|26913798|FG001|Overall Study|Adverse Event|4|||
13440114|NCT00348374|26913797|FG000|Overall Study|Lost to Follow-up|1|||
13440115|NCT00348374|26913798|FG001|Overall Study|Lost to Follow-up|3|||
13440116|NCT00348374|26913797|FG000|Overall Study|Withdrawal by Subject|5|||
13440117|NCT00348374|26913798|FG001|Overall Study|Withdrawal by Subject|5|||
13440118|NCT00348374|26913797|FG000|Overall Study|Other|11|||
13440119|NCT00348374|26913798|FG001|Overall Study|Other|12|||
13440120|NCT00348374|26913797|FG000|Overall Study|ongoing at date of cutoff|1|||
13440121|NCT00348374|26913798|FG001|Overall Study|ongoing at date of cutoff|1|||
13440122|NCT00348374|26913797|FG000|Overall Study|randomized but did not receive treatment|0|||
13440123|NCT00348374|26913798|FG001|Overall Study|randomized but did not receive treatment|7|||
13440124|NCT00348348|26913817|FG000|Overall Study|Adverse event - unrelated to study drug|0|||
13440125|NCT00348348|26913818|FG001|Overall Study|Adverse event - unrelated to study drug|1|||
13440126|NCT00348348|26913817|FG000|Overall Study|Lack of Efficacy|1|||
13440127|NCT00348348|26913818|FG001|Overall Study|Lack of Efficacy|1|||
13440128|NCT00348348|26913817|FG000|Overall Study|Lost to Follow-up|8|||
13440129|NCT00348348|26913818|FG001|Overall Study|Lost to Follow-up|10|||
13440130|NCT00348348|26913817|FG000|Overall Study|Withdrawal by Subject|4|||
13440131|NCT00348348|26913818|FG001|Overall Study|Withdrawal by Subject|1|||
13440132|NCT00348348|26913817|FG000|Overall Study|Other|7|||
13440133|NCT00348348|26913818|FG001|Overall Study|Other|4|||
13440134|NCT00348348|26913817|FG000|Overall Study|Dissallowed Meds - unrelated to study|1|||
13440135|NCT00348348|26913818|FG001|Overall Study|Dissallowed Meds - unrelated to study|3|||
13440136|NCT00348348|26913817|FG000|Overall Study|Dissallowed Meds - unlikley related|1|||
13440137|NCT00348348|26913818|FG001|Overall Study|Dissallowed Meds - unlikley related|1|||
13440138|NCT00348348|26913817|FG000|Overall Study|Dissallowed Meds - possibly releated|1|||
13440139|NCT00348348|26913818|FG001|Overall Study|Dissallowed Meds - possibly releated|1|||
13440140|NCT00348348|26913817|FG000|Overall Study|Worsening of BC - Unrelated to study|0|||
13440141|NCT00348348|26913818|FG001|Overall Study|Worsening of BC - Unrelated to study|3|||
13440142|NCT00348348|26913817|FG000|Overall Study|Worsening of BC - Unlikely related|1|||
13440143|NCT00348348|26913818|FG001|Overall Study|Worsening of BC - Unlikely related|2|||
13440144|NCT00348348|26913817|FG000|Overall Study|Adverse event probably related to study|1|||
13440145|NCT00348348|26913818|FG001|Overall Study|Adverse event probably related to study|0|||
13440146|NCT00348309|26913899|FG000|Overall Study|Adverse Event|56|||
13440147|NCT00348309|26913900|FG001|Overall Study|Adverse Event|28|||
13440148|NCT00348309|26913901|FG002|Overall Study|Adverse Event|63|||
13440149|NCT00348309|26913899|FG000|Overall Study|Lost to Follow-up|6|||
13440150|NCT00348309|26913900|FG001|Overall Study|Lost to Follow-up|7|||
13440151|NCT00348309|26913901|FG002|Overall Study|Lost to Follow-up|4|||
13440152|NCT00348309|26913899|FG000|Overall Study|Protocol Violation|7|||
13440153|NCT00348309|26913900|FG001|Overall Study|Protocol Violation|12|||
13440154|NCT00348309|26913901|FG002|Overall Study|Protocol Violation|7|||
13440155|NCT00348309|26913899|FG000|Overall Study|Withdrawal by Subject|33|||
13440156|NCT00348309|26913900|FG001|Overall Study|Withdrawal by Subject|37|||
13440157|NCT00348309|26913901|FG002|Overall Study|Withdrawal by Subject|40|||
13440158|NCT00348309|26913899|FG000|Overall Study|Non-compliance|8|||
13440159|NCT00348309|26913900|FG001|Overall Study|Non-compliance|6|||
13440160|NCT00348309|26913901|FG002|Overall Study|Non-compliance|8|||
13440161|NCT00348309|26913899|FG000|Overall Study|Death of caregiver|1|||
13440162|NCT00348309|26913900|FG001|Overall Study|Death of caregiver|0|||
13440163|NCT00348309|26913901|FG002|Overall Study|Death of caregiver|1|||
13440164|NCT00348309|26913899|FG000|Overall Study|Lack of insight, dementia|1|||
13440165|NCT00348309|26913900|FG001|Overall Study|Lack of insight, dementia|0|||
13440166|NCT00348309|26913901|FG002|Overall Study|Lack of insight, dementia|0|||
13440167|NCT00348309|26913899|FG000|Overall Study|Wrong bottle allocated|1|||
13440168|NCT00348309|26913900|FG001|Overall Study|Wrong bottle allocated|0|||
13440169|NCT00348309|26913901|FG002|Overall Study|Wrong bottle allocated|0|||
13440170|NCT00348309|26913899|FG000|Overall Study|Caregiver sick|1|||
13440171|NCT00348309|26913900|FG001|Overall Study|Caregiver sick|0|||
13440172|NCT00348309|26913901|FG002|Overall Study|Caregiver sick|0|||
13440173|NCT00348309|26913899|FG000|Overall Study|Use of prohibited medication|5|||
13440174|NCT00348309|26913900|FG001|Overall Study|Use of prohibited medication|2|||
13440175|NCT00348309|26913901|FG002|Overall Study|Use of prohibited medication|2|||
13440176|NCT00348309|26913899|FG000|Overall Study|Caregiver withdrawal|3|||
13440177|NCT00348309|26913900|FG001|Overall Study|Caregiver withdrawal|0|||
13440178|NCT00348309|26913901|FG002|Overall Study|Caregiver withdrawal|7|||
13440179|NCT00348309|26913899|FG000|Overall Study|Unable to complete ET visit|1|||
13440180|NCT00348309|26913900|FG001|Overall Study|Unable to complete ET visit|0|||
13440181|NCT00348309|26913901|FG002|Overall Study|Unable to complete ET visit|0|||
13440182|NCT00348309|26913899|FG000|Overall Study|PI closing medical practice|1|||
13440183|NCT00348309|26913900|FG001|Overall Study|PI closing medical practice|0|||
13440184|NCT00348309|26913901|FG002|Overall Study|PI closing medical practice|0|||
13440185|NCT00348309|26913899|FG000|Overall Study|Principal investigator's decision|1|||
13440186|NCT00348309|26913900|FG001|Overall Study|Principal investigator's decision|0|||
13440187|NCT00348309|26913901|FG002|Overall Study|Principal investigator's decision|0|||
13440188|NCT00348309|26913899|FG000|Overall Study|No disponibility of medication|1|||
13440189|NCT00348309|26913900|FG001|Overall Study|No disponibility of medication|0|||
13440190|NCT00348309|26913901|FG002|Overall Study|No disponibility of medication|0|||
13440191|NCT00348309|26913899|FG000|Overall Study|Worsened neurodegenerative disease|1|||
13440192|NCT00348309|26913900|FG001|Overall Study|Worsened neurodegenerative disease|0|||
13440193|NCT00348309|26913901|FG002|Overall Study|Worsened neurodegenerative disease|0|||
13440194|NCT00348309|26913899|FG000|Overall Study|Cognitive and behaviour worsening|2|||
13440195|NCT00348309|26913900|FG001|Overall Study|Cognitive and behaviour worsening|0|||
13440196|NCT00348309|26913901|FG002|Overall Study|Cognitive and behaviour worsening|0|||
13440197|NCT00348309|26913899|FG000|Overall Study|Worsening of alzheimer|1|||
13440198|NCT00348309|26913900|FG001|Overall Study|Worsening of alzheimer|0|||
13440199|NCT00348309|26913901|FG002|Overall Study|Worsening of alzheimer|1|||
13440200|NCT00348309|26913899|FG000|Overall Study|Did not appear in time for Visit 3|1|||
13440201|NCT00348309|26913900|FG001|Overall Study|Did not appear in time for Visit 3|0|||
13440202|NCT00348309|26913901|FG002|Overall Study|Did not appear in time for Visit 3|0|||
13440203|NCT00348309|26913899|FG000|Overall Study|Participant died|2|||
13440204|NCT00348309|26913900|FG001|Overall Study|Participant died|1|||
13440205|NCT00348309|26913901|FG002|Overall Study|Participant died|1|||
13440206|NCT00348309|26913899|FG000|Overall Study|Decision of sponsor|1|||
13440207|NCT00348309|26913900|FG001|Overall Study|Decision of sponsor|0|||
13440208|NCT00348309|26913901|FG002|Overall Study|Decision of sponsor|0|||
13440209|NCT00348309|26913899|FG000|Overall Study|Ineffectiveness of treatment|0|||
13440210|NCT00348309|26913900|FG001|Overall Study|Ineffectiveness of treatment|1|||
13440211|NCT00348309|26913901|FG002|Overall Study|Ineffectiveness of treatment|0|||
13440212|NCT00348309|26913899|FG000|Overall Study|A foul of exclusion criteria|0|||
13440213|NCT00348309|26913900|FG001|Overall Study|A foul of exclusion criteria|1|||
13440214|NCT00348309|26913901|FG002|Overall Study|A foul of exclusion criteria|0|||
13440215|NCT00348309|26913899|FG000|Overall Study|Participant was hospitalized|0|||
13440216|NCT00348309|26913900|FG001|Overall Study|Participant was hospitalized|1|||
13440217|NCT00348309|26913901|FG002|Overall Study|Participant was hospitalized|0|||
13440218|NCT00348309|26913899|FG000|Overall Study|Sponsor refuseal|0|||
13440219|NCT00348309|26913900|FG001|Overall Study|Sponsor refuseal|1|||
13440220|NCT00348309|26913901|FG002|Overall Study|Sponsor refuseal|1|||
13440221|NCT00348309|26913899|FG000|Overall Study|Forgot often medication|0|||
13440222|NCT00348309|26913900|FG001|Overall Study|Forgot often medication|1|||
13440223|NCT00348309|26913901|FG002|Overall Study|Forgot often medication|0|||
13440224|NCT00348309|26913899|FG000|Overall Study|Medical Monitor decision|0|||
13440225|NCT00348309|26913900|FG001|Overall Study|Medical Monitor decision|0|||
13440226|NCT00348309|26913901|FG002|Overall Study|Medical Monitor decision|1|||
13440227|NCT00348309|26913899|FG000|Overall Study|Increased dose of Aricept|0|||
13440228|NCT00348309|26913900|FG001|Overall Study|Increased dose of Aricept|0|||
13440229|NCT00348309|26913901|FG002|Overall Study|Increased dose of Aricept|1|||
13440230|NCT00348309|26913899|FG000|Overall Study|Site closure|0|||
13440231|NCT00348309|26913900|FG001|Overall Study|Site closure|0|||
13440232|NCT00348309|26913901|FG002|Overall Study|Site closure|1|||
13440233|NCT00348309|26913899|FG000|Overall Study|Adverse event not attended|0|||
13440234|NCT00348309|26913900|FG001|Overall Study|Adverse event not attended|0|||
13440235|NCT00348309|26913901|FG002|Overall Study|Adverse event not attended|1|||
13440236|NCT00348309|26913899|FG000|Overall Study|ECG abnormal|0|||
13440237|NCT00348309|26913900|FG001|Overall Study|ECG abnormal|0|||
13440238|NCT00348309|26913901|FG002|Overall Study|ECG abnormal|2|||
13440239|NCT00348309|26913899|FG000|Overall Study|Cardiologist recommendations|0|||
13440240|NCT00348309|26913900|FG001|Overall Study|Cardiologist recommendations|0|||
13440241|NCT00348309|26913901|FG002|Overall Study|Cardiologist recommendations|1|||
13440242|NCT00348309|26913899|FG000|Overall Study|HCV career|0|||
13440243|NCT00348309|26913900|FG001|Overall Study|HCV career|0|||
13440244|NCT00348309|26913901|FG002|Overall Study|HCV career|1|||
13440245|NCT00348283|26913924|FG000|Induction|Adverse Event|0|||
13440246|NCT00348283|26913925|FG001|Induction|Adverse Event|2|||
13440247|NCT00348283|26913924|FG000|Induction|Protocol Violation|0|||
13440248|NCT00348283|26913925|FG001|Induction|Protocol Violation|4|||
13440249|NCT00348283|26913924|FG000|Double Blind|Adverse Event|2|||
13440250|NCT00348283|26913925|FG001|Double Blind|Adverse Event|5|||
13440251|NCT00348283|26913924|FG000|Double Blind|Withdrawal by Subject|1|||
13440252|NCT00348283|26913925|FG001|Double Blind|Withdrawal by Subject|1|||
13440253|NCT00348283|26913924|FG000|Double Blind|Protocol Violation|0|||
13440254|NCT00348283|26913925|FG001|Double Blind|Protocol Violation|1|||
13440255|NCT00348283|26913924|FG000|Double Blind|Lack of Efficacy|2|||
13440256|NCT00348283|26913925|FG001|Double Blind|Lack of Efficacy|2|||
13440257|NCT00348283|26913924|FG000|Double Blind|Pregnancy|0|||
13440258|NCT00348283|26913925|FG001|Double Blind|Pregnancy|1|||
13440259|NCT00348283|26913924|FG000|Open Label|Adverse Event|0|||
13440260|NCT00348283|26913925|FG001|Open Label|Adverse Event|8|||
13440261|NCT00348283|26913924|FG000|Open Label|Withdrawal by Subject|0|||
13440262|NCT00348283|26913925|FG001|Open Label|Withdrawal by Subject|4|||
13440263|NCT00348283|26913924|FG000|Open Label|Lost to Follow-up|0|||
13440264|NCT00348283|26913925|FG001|Open Label|Lost to Follow-up|1|||
13440265|NCT00348283|26913924|FG000|Open Label|Lack of Efficacy|0|||
13440266|NCT00348283|26913925|FG001|Open Label|Lack of Efficacy|13|||
13440267|NCT00348283|26913924|FG000|Open Label|Administrative reasons|0|||
13440268|NCT00348283|26913925|FG001|Open Label|Administrative reasons|5|||
13440269|NCT00348283|26913924|FG000|Open Label|Subject moved to the United States|0|||
13440270|NCT00348283|26913925|FG001|Open Label|Subject moved to the United States|1|||
13440271|NCT00348283|26913924|FG000|Open Label|Pregnancy|0|||
13440272|NCT00348283|26913925|FG001|Open Label|Pregnancy|1|||
13440273|NCT00348283|26913924|FG000|Open Label|Sponsor decision|0|||
13440274|NCT00348283|26913925|FG001|Open Label|Sponsor decision|1|||
13440275|NCT00348140|26914033|FG000|Overall Study|Adverse Event|46|||
13440276|NCT00348140|26914034|FG001|Overall Study|Adverse Event|49|||
13440277|NCT00348140|26914035|FG002|Overall Study|Adverse Event|78|||
13440278|NCT00348140|26914033|FG000|Overall Study|Lost to Follow-up|4|||
13440279|NCT00348140|26914034|FG001|Overall Study|Lost to Follow-up|4|||
13440280|NCT00348140|26914035|FG002|Overall Study|Lost to Follow-up|4|||
13440281|NCT00348140|26914033|FG000|Overall Study|Protocol Violation|12|||
13440282|NCT00348140|26914034|FG001|Overall Study|Protocol Violation|13|||
13440283|NCT00348140|26914035|FG002|Overall Study|Protocol Violation|14|||
13440284|NCT00348140|26914033|FG000|Overall Study|Withdrawal by Subject|32|||
13440285|NCT00348140|26914034|FG001|Overall Study|Withdrawal by Subject|40|||
13440286|NCT00348140|26914035|FG002|Overall Study|Withdrawal by Subject|40|||
13440287|NCT00348140|26914033|FG000|Overall Study|Non-compliance|8|||
13440288|NCT00348140|26914034|FG001|Overall Study|Non-compliance|13|||
13440289|NCT00348140|26914035|FG002|Overall Study|Non-compliance|5|||
13440290|NCT00348140|26914033|FG000|Overall Study|Participant at risk due to study drug|2|||
13440291|NCT00348140|26914034|FG001|Overall Study|Participant at risk due to study drug|0|||
13440292|NCT00348140|26914035|FG002|Overall Study|Participant at risk due to study drug|0|||
13440293|NCT00348140|26914033|FG000|Overall Study|Conditional medication increased dose|1|||
13440294|NCT00348140|26914034|FG001|Overall Study|Conditional medication increased dose|0|||
13440295|NCT00348140|26914035|FG002|Overall Study|Conditional medication increased dose|0|||
13440296|NCT00348140|26914033|FG000|Overall Study|Caregiver related|4|||
13440297|NCT00348140|26914034|FG001|Overall Study|Caregiver related|7|||
13440298|NCT00348140|26914035|FG002|Overall Study|Caregiver related|3|||
13440299|NCT00348140|26914033|FG000|Overall Study|Participant hospitalised|3|||
13440300|NCT00348140|26914034|FG001|Overall Study|Participant hospitalised|0|||
13440301|NCT00348140|26914035|FG002|Overall Study|Participant hospitalised|0|||
13440302|NCT00348140|26914033|FG000|Overall Study|Efficacy related|1|||
13440303|NCT00348140|26914034|FG001|Overall Study|Efficacy related|1|||
13440304|NCT00348140|26914035|FG002|Overall Study|Efficacy related|0|||
13440305|NCT00348140|26914033|FG000|Overall Study|Administration related|3|||
13440306|NCT00348140|26914034|FG001|Overall Study|Administration related|1|||
13440307|NCT00348140|26914035|FG002|Overall Study|Administration related|1|||
13440308|NCT00348140|26914033|FG000|Overall Study|Unmet inclusion-exclusion criteria|1|||
13440309|NCT00348140|26914034|FG001|Overall Study|Unmet inclusion-exclusion criteria|0|||
13440310|NCT00348140|26914035|FG002|Overall Study|Unmet inclusion-exclusion criteria|1|||
13440311|NCT00348140|26914033|FG000|Overall Study|Participant unwell|1|||
13440312|NCT00348140|26914034|FG001|Overall Study|Participant unwell|0|||
13440313|NCT00348140|26914035|FG002|Overall Study|Participant unwell|0|||
13440314|NCT00348140|26914033|FG000|Overall Study|Screen failure|1|||
13440315|NCT00348140|26914034|FG001|Overall Study|Screen failure|0|||
13440316|NCT00348140|26914035|FG002|Overall Study|Screen failure|0|||
13440317|NCT00348140|26914033|FG000|Overall Study|Investigator decided to discontinue|4|||
13440318|NCT00348140|26914034|FG001|Overall Study|Investigator decided to discontinue|1|||
13440319|NCT00348140|26914035|FG002|Overall Study|Investigator decided to discontinue|4|||
13440320|NCT00348140|26914033|FG000|Overall Study|Decided to discontinue on their own|1|||
13440321|NCT00348140|26914034|FG001|Overall Study|Decided to discontinue on their own|4|||
13440322|NCT00348140|26914035|FG002|Overall Study|Decided to discontinue on their own|1|||
13440323|NCT00348140|26914033|FG000|Overall Study|Use of prohibited drug|1|||
13440324|NCT00348140|26914034|FG001|Overall Study|Use of prohibited drug|0|||
13440325|NCT00348140|26914035|FG002|Overall Study|Use of prohibited drug|2|||
13440326|NCT00348140|26914033|FG000|Overall Study|Disease progression|1|||
13440327|NCT00348140|26914034|FG001|Overall Study|Disease progression|2|||
13440328|NCT00348140|26914035|FG002|Overall Study|Disease progression|5|||
13440329|NCT00348140|26914033|FG000|Overall Study|Increased risk of cardiac infarction|0|||
13440330|NCT00348140|26914034|FG001|Overall Study|Increased risk of cardiac infarction|1|||
13440331|NCT00348140|26914035|FG002|Overall Study|Increased risk of cardiac infarction|0|||
13440332|NCT00348140|26914033|FG000|Overall Study|Serious adverse event|0|||
13440333|NCT00348140|26914034|FG001|Overall Study|Serious adverse event|1|||
13440334|NCT00348140|26914035|FG002|Overall Study|Serious adverse event|0|||
13440335|NCT00348140|26914033|FG000|Overall Study|Abnormal ECG|0|||
13440336|NCT00348140|26914034|FG001|Overall Study|Abnormal ECG|1|||
13440337|NCT00348140|26914035|FG002|Overall Study|Abnormal ECG|3|||
13440338|NCT00348140|26914033|FG000|Overall Study|Participant died|0|||
13440339|NCT00348140|26914034|FG001|Overall Study|Participant died|1|||
13440340|NCT00348140|26914035|FG002|Overall Study|Participant died|0|||
13440341|NCT00348140|26914033|FG000|Overall Study|Exclusion criteria met|0|||
13440342|NCT00348140|26914034|FG001|Overall Study|Exclusion criteria met|0|||
13440343|NCT00348140|26914035|FG002|Overall Study|Exclusion criteria met|1|||
13440344|NCT00348140|26914033|FG000|Overall Study|Memory declined|0|||
13440345|NCT00348140|26914034|FG001|Overall Study|Memory declined|0|||
13440346|NCT00348140|26914035|FG002|Overall Study|Memory declined|1|||
13440347|NCT00347958|26914044|FG000|Overall Study|Adverse Event|1|||
13440348|NCT00347958|26914044|FG000|Overall Study|Protocol Violation|2|||
13440349|NCT00347958|26914044|FG000|Overall Study|Withdrawal by Subject|1|||
13440350|NCT00347932|26914063|FG000|Overall Study|Adverse Event|4|||
13440351|NCT00347932|26914064|FG001|Overall Study|Adverse Event|5|||
13440352|NCT00347932|26914063|FG000|Overall Study|Lack of Efficacy|3|||
13440353|NCT00347932|26914064|FG001|Overall Study|Lack of Efficacy|14|||
13440354|NCT00347932|26914063|FG000|Overall Study|Lost to Follow-up|10|||
13440355|NCT00347932|26914064|FG001|Overall Study|Lost to Follow-up|9|||
13440356|NCT00347932|26914063|FG000|Overall Study|Withdrawal by Subject|10|||
13440357|NCT00347932|26914064|FG001|Overall Study|Withdrawal by Subject|16|||
13440358|NCT00347932|26914063|FG000|Overall Study|Did not meet inclusion criteria|4|||
13440359|NCT00347932|26914064|FG001|Overall Study|Did not meet inclusion criteria|8|||
13440360|NCT00347919|26914094|FG000|Overall Study|Lost to Follow-up|11|||
13440361|NCT00347919|26914095|FG001|Overall Study|Lost to Follow-up|13|||
13440362|NCT00347919|26914096|FG002|Overall Study|Lost to Follow-up|0|||
13440363|NCT00347919|26914094|FG000|Overall Study|Withdrawal by Subject|6|||
13440364|NCT00347919|26914095|FG001|Overall Study|Withdrawal by Subject|8|||
13440365|NCT00347919|26914096|FG002|Overall Study|Withdrawal by Subject|0|||
13440366|NCT00347919|26914094|FG000|Overall Study|Physician Decision|1|||
13440367|NCT00347919|26914095|FG001|Overall Study|Physician Decision|1|||
13440368|NCT00347919|26914096|FG002|Overall Study|Physician Decision|0|||
13440369|NCT00347919|26914094|FG000|Overall Study|Sponsor terminated study|15|||
13440370|NCT00347919|26914095|FG001|Overall Study|Sponsor terminated study|10|||
13440371|NCT00347919|26914096|FG002|Overall Study|Sponsor terminated study|16|||
13440372|NCT00347919|26914094|FG000|Overall Study|Death|35|||
13440373|NCT00347919|26914095|FG001|Overall Study|Death|42|||
13440374|NCT00347919|26914096|FG002|Overall Study|Death|19|||
13440375|NCT00347919|26914094|FG000|Overall Study|Par. Started Other Treatment|1|||
13440376|NCT00347919|26914095|FG001|Overall Study|Par. Started Other Treatment|1|||
13440377|NCT00347919|26914096|FG002|Overall Study|Par. Started Other Treatment|1|||
13440378|NCT00347919|26914094|FG000|Overall Study|Missing|2|||
13440379|NCT00347919|26914095|FG001|Overall Study|Missing|1|||
13440380|NCT00347919|26914096|FG002|Overall Study|Missing|2|||
13440381|NCT00347776|26914118|FG000|1.5 Month Follow-up|Death|2|||
13440382|NCT00347776|26914119|FG001|1.5 Month Follow-up|Death|0|||
13440383|NCT00347776|26914120|FG002|1.5 Month Follow-up|Death|0|||
13440384|NCT00347776|26914118|FG000|1.5 Month Follow-up|reached the endpoint|12|||
13440385|NCT00347776|26914119|FG001|1.5 Month Follow-up|reached the endpoint|8|||
13440386|NCT00347776|26914120|FG002|1.5 Month Follow-up|reached the endpoint|12|||
13440387|NCT00347776|26914118|FG000|6 Month Follow-up|Death|2|||
13440388|NCT00347776|26914119|FG001|6 Month Follow-up|Death|1|||
13440389|NCT00347776|26914120|FG002|6 Month Follow-up|Death|3|||
13440390|NCT00347776|26914118|FG000|6 Month Follow-up|reached endpont|20|||
13440391|NCT00347776|26914119|FG001|6 Month Follow-up|reached endpont|12|||
13440392|NCT00347776|26914120|FG002|6 Month Follow-up|reached endpont|15|||
13440393|NCT00347776|26914118|FG000|12 Month Follow-up|Lost to Follow-up|7|||
13440394|NCT00347776|26914119|FG001|12 Month Follow-up|Lost to Follow-up|6|||
13440395|NCT00347776|26914120|FG002|12 Month Follow-up|Lost to Follow-up|6|||
13440396|NCT00347776|26914118|FG000|12 Month Follow-up|Death|3|||
13440397|NCT00347776|26914119|FG001|12 Month Follow-up|Death|4|||
13440398|NCT00347776|26914120|FG002|12 Month Follow-up|Death|4|||
13440399|NCT00347776|26914118|FG000|12 Month Follow-up|Reached endpoint|13|||
13440400|NCT00347776|26914119|FG001|12 Month Follow-up|Reached endpoint|6|||
13440401|NCT00347776|26914120|FG002|12 Month Follow-up|Reached endpoint|9|||
13440402|NCT00347438|26914129|FG000|Overall Study|Withdrawal by Subject|1|||
13440403|NCT00347438|26914129|FG000|Overall Study|Physician Decision|1|||
13440404|NCT00347360|26914357|FG000|Overall Study|Adverse Event|1|||
13440405|NCT00347360|26914358|FG001|Overall Study|Adverse Event|2|||
13440406|NCT00347360|26914359|FG002|Overall Study|Adverse Event|0|||
13440407|NCT00347360|26914360|FG003|Overall Study|Adverse Event|4|||
13440408|NCT00347360|26914361|FG004|Overall Study|Adverse Event|1|||
13440409|NCT00347360|26914362|FG005|Overall Study|Adverse Event|2|||
13440410|NCT00347360|26914363|FG006|Overall Study|Adverse Event|2|||
13440411|NCT00347360|26914364|FG007|Overall Study|Adverse Event|0|||
13440412|NCT00347360|26914365|FG008|Overall Study|Adverse Event|2|||
13440413|NCT00347360|26914366|FG009|Overall Study|Adverse Event|3|||
13440414|NCT00347360|26914367|FG010|Overall Study|Adverse Event|3|||
13440415|NCT00347360|26914368|FG011|Overall Study|Adverse Event|1|||
13440416|NCT00347360|26914369|FG012|Overall Study|Adverse Event|3|||
13440417|NCT00347360|26914370|FG013|Overall Study|Adverse Event|2|||
13440418|NCT00347360|26914371|FG014|Overall Study|Adverse Event|2|||
13440419|NCT00347360|26914357|FG000|Overall Study|Lost to Follow-up|0|||
13440420|NCT00347360|26914358|FG001|Overall Study|Lost to Follow-up|0|||
13440421|NCT00347360|26914359|FG002|Overall Study|Lost to Follow-up|0|||
13440422|NCT00347360|26914360|FG003|Overall Study|Lost to Follow-up|2|||
13440423|NCT00347360|26914361|FG004|Overall Study|Lost to Follow-up|1|||
13440424|NCT00347360|26914362|FG005|Overall Study|Lost to Follow-up|1|||
13440425|NCT00347360|26914363|FG006|Overall Study|Lost to Follow-up|0|||
13440426|NCT00347360|26914364|FG007|Overall Study|Lost to Follow-up|1|||
13440427|NCT00347360|26914365|FG008|Overall Study|Lost to Follow-up|1|||
13440428|NCT00347360|26914366|FG009|Overall Study|Lost to Follow-up|2|||
13440429|NCT00347360|26914367|FG010|Overall Study|Lost to Follow-up|0|||
13440430|NCT00347360|26914368|FG011|Overall Study|Lost to Follow-up|0|||
13440431|NCT00347360|26914369|FG012|Overall Study|Lost to Follow-up|1|||
13440432|NCT00347360|26914370|FG013|Overall Study|Lost to Follow-up|0|||
13440433|NCT00347360|26914371|FG014|Overall Study|Lost to Follow-up|0|||
13440434|NCT00347360|26914357|FG000|Overall Study|Protocol Violation|2|||
13440435|NCT00347360|26914358|FG001|Overall Study|Protocol Violation|3|||
13440436|NCT00347360|26914359|FG002|Overall Study|Protocol Violation|1|||
13440437|NCT00347360|26914360|FG003|Overall Study|Protocol Violation|2|||
13440438|NCT00347360|26914361|FG004|Overall Study|Protocol Violation|1|||
13440439|NCT00347360|26914362|FG005|Overall Study|Protocol Violation|2|||
13440440|NCT00347360|26914363|FG006|Overall Study|Protocol Violation|0|||
13440441|NCT00347360|26914364|FG007|Overall Study|Protocol Violation|0|||
13440442|NCT00347360|26914365|FG008|Overall Study|Protocol Violation|1|||
13440443|NCT00347360|26914366|FG009|Overall Study|Protocol Violation|2|||
13440444|NCT00347360|26914367|FG010|Overall Study|Protocol Violation|0|||
13440445|NCT00347360|26914368|FG011|Overall Study|Protocol Violation|0|||
13440446|NCT00347360|26914369|FG012|Overall Study|Protocol Violation|0|||
13440447|NCT00347360|26914370|FG013|Overall Study|Protocol Violation|1|||
13440448|NCT00347360|26914371|FG014|Overall Study|Protocol Violation|0|||
13440449|NCT00347360|26914357|FG000|Overall Study|Withdrawal by Subject|0|||
13440450|NCT00347360|26914358|FG001|Overall Study|Withdrawal by Subject|1|||
13440451|NCT00347360|26914359|FG002|Overall Study|Withdrawal by Subject|2|||
13440452|NCT00347360|26914360|FG003|Overall Study|Withdrawal by Subject|4|||
13440453|NCT00347360|26914361|FG004|Overall Study|Withdrawal by Subject|1|||
13440454|NCT00347360|26914362|FG005|Overall Study|Withdrawal by Subject|2|||
13440455|NCT00347360|26914363|FG006|Overall Study|Withdrawal by Subject|1|||
13440456|NCT00347360|26914364|FG007|Overall Study|Withdrawal by Subject|1|||
13440457|NCT00347360|26914365|FG008|Overall Study|Withdrawal by Subject|1|||
13440458|NCT00347360|26914366|FG009|Overall Study|Withdrawal by Subject|1|||
13440459|NCT00347360|26914367|FG010|Overall Study|Withdrawal by Subject|0|||
13440460|NCT00347360|26914368|FG011|Overall Study|Withdrawal by Subject|3|||
13440461|NCT00347360|26914369|FG012|Overall Study|Withdrawal by Subject|4|||
13440462|NCT00347360|26914370|FG013|Overall Study|Withdrawal by Subject|2|||
13440463|NCT00347360|26914371|FG014|Overall Study|Withdrawal by Subject|1|||
13440464|NCT00347360|26914357|FG000|Overall Study|Lack of Efficacy|1|||
13440465|NCT00347360|26914358|FG001|Overall Study|Lack of Efficacy|1|||
13440466|NCT00347360|26914359|FG002|Overall Study|Lack of Efficacy|3|||
13440467|NCT00347360|26914360|FG003|Overall Study|Lack of Efficacy|1|||
13440468|NCT00347360|26914361|FG004|Overall Study|Lack of Efficacy|0|||
13440469|NCT00347360|26914362|FG005|Overall Study|Lack of Efficacy|1|||
13440470|NCT00347360|26914363|FG006|Overall Study|Lack of Efficacy|0|||
13440471|NCT00347360|26914364|FG007|Overall Study|Lack of Efficacy|1|||
13440472|NCT00347360|26914365|FG008|Overall Study|Lack of Efficacy|1|||
13440473|NCT00347360|26914366|FG009|Overall Study|Lack of Efficacy|0|||
13440474|NCT00347360|26914367|FG010|Overall Study|Lack of Efficacy|0|||
13440475|NCT00347360|26914368|FG011|Overall Study|Lack of Efficacy|0|||
13440476|NCT00347360|26914369|FG012|Overall Study|Lack of Efficacy|0|||
13440477|NCT00347360|26914370|FG013|Overall Study|Lack of Efficacy|0|||
13440478|NCT00347360|26914371|FG014|Overall Study|Lack of Efficacy|0|||
13219933|NCT01829113|26278686|FG000|Overall Study|Disease Progression|37|||
13440479|NCT00347360|26914357|FG000|Overall Study|Reason not listed/blank|1|||
13440480|NCT00347360|26914358|FG001|Overall Study|Reason not listed/blank|0|||
13440481|NCT00347360|26914359|FG002|Overall Study|Reason not listed/blank|0|||
13440482|NCT00347360|26914360|FG003|Overall Study|Reason not listed/blank|0|||
13440483|NCT00347360|26914361|FG004|Overall Study|Reason not listed/blank|0|||
13440484|NCT00347360|26914362|FG005|Overall Study|Reason not listed/blank|0|||
13440485|NCT00347360|26914363|FG006|Overall Study|Reason not listed/blank|1|||
13440486|NCT00347360|26914364|FG007|Overall Study|Reason not listed/blank|0|||
13440487|NCT00347360|26914365|FG008|Overall Study|Reason not listed/blank|0|||
13440488|NCT00347360|26914366|FG009|Overall Study|Reason not listed/blank|0|||
13440489|NCT00347360|26914367|FG010|Overall Study|Reason not listed/blank|0|||
13440490|NCT00347360|26914368|FG011|Overall Study|Reason not listed/blank|0|||
13440491|NCT00347360|26914369|FG012|Overall Study|Reason not listed/blank|0|||
13440492|NCT00347360|26914370|FG013|Overall Study|Reason not listed/blank|1|||
13440493|NCT00347360|26914371|FG014|Overall Study|Reason not listed/blank|0|||
13440494|NCT00347360|26914357|FG000|Overall Study|Per sponsors instruction|0|||
13440495|NCT00347360|26914358|FG001|Overall Study|Per sponsors instruction|1|||
13440496|NCT00347360|26914359|FG002|Overall Study|Per sponsors instruction|0|||
13440497|NCT00347360|26914360|FG003|Overall Study|Per sponsors instruction|0|||
13440498|NCT00347360|26914361|FG004|Overall Study|Per sponsors instruction|0|||
13440499|NCT00347360|26914362|FG005|Overall Study|Per sponsors instruction|0|||
13440500|NCT00347360|26914363|FG006|Overall Study|Per sponsors instruction|0|||
13440501|NCT00347360|26914364|FG007|Overall Study|Per sponsors instruction|0|||
13440502|NCT00347360|26914365|FG008|Overall Study|Per sponsors instruction|0|||
13440503|NCT00347360|26914366|FG009|Overall Study|Per sponsors instruction|0|||
13440504|NCT00347360|26914367|FG010|Overall Study|Per sponsors instruction|0|||
13440505|NCT00347360|26914368|FG011|Overall Study|Per sponsors instruction|0|||
13440506|NCT00347360|26914369|FG012|Overall Study|Per sponsors instruction|0|||
13440507|NCT00347360|26914370|FG013|Overall Study|Per sponsors instruction|0|||
13440508|NCT00347360|26914371|FG014|Overall Study|Per sponsors instruction|0|||
13440509|NCT00347360|26914357|FG000|Overall Study|P.I. recommended due to blood pressure|0|||
13440510|NCT00347360|26914358|FG001|Overall Study|P.I. recommended due to blood pressure|0|||
13440511|NCT00347360|26914359|FG002|Overall Study|P.I. recommended due to blood pressure|0|||
13440512|NCT00347360|26914360|FG003|Overall Study|P.I. recommended due to blood pressure|0|||
13440513|NCT00347360|26914361|FG004|Overall Study|P.I. recommended due to blood pressure|1|||
13440514|NCT00347360|26914362|FG005|Overall Study|P.I. recommended due to blood pressure|0|||
13440515|NCT00347360|26914363|FG006|Overall Study|P.I. recommended due to blood pressure|0|||
13440516|NCT00347360|26914364|FG007|Overall Study|P.I. recommended due to blood pressure|0|||
13440517|NCT00347360|26914365|FG008|Overall Study|P.I. recommended due to blood pressure|0|||
13440518|NCT00347360|26914366|FG009|Overall Study|P.I. recommended due to blood pressure|0|||
13440519|NCT00347360|26914367|FG010|Overall Study|P.I. recommended due to blood pressure|0|||
13440520|NCT00347360|26914368|FG011|Overall Study|P.I. recommended due to blood pressure|0|||
13440521|NCT00347360|26914369|FG012|Overall Study|P.I. recommended due to blood pressure|0|||
13440522|NCT00347360|26914370|FG013|Overall Study|P.I. recommended due to blood pressure|0|||
13440523|NCT00347360|26914371|FG014|Overall Study|P.I. recommended due to blood pressure|0|||
13440524|NCT00347360|26914357|FG000|Overall Study|Subject did not meet end of study ABPM|0|||
13440525|NCT00347360|26914358|FG001|Overall Study|Subject did not meet end of study ABPM|0|||
13440526|NCT00347360|26914359|FG002|Overall Study|Subject did not meet end of study ABPM|0|||
13440527|NCT00347360|26914360|FG003|Overall Study|Subject did not meet end of study ABPM|0|||
13440528|NCT00347360|26914361|FG004|Overall Study|Subject did not meet end of study ABPM|0|||
13440529|NCT00347360|26914362|FG005|Overall Study|Subject did not meet end of study ABPM|0|||
13440530|NCT00347360|26914363|FG006|Overall Study|Subject did not meet end of study ABPM|1|||
13440531|NCT00347360|26914364|FG007|Overall Study|Subject did not meet end of study ABPM|0|||
13440532|NCT00347360|26914365|FG008|Overall Study|Subject did not meet end of study ABPM|0|||
13440533|NCT00347360|26914366|FG009|Overall Study|Subject did not meet end of study ABPM|0|||
13440534|NCT00347360|26914367|FG010|Overall Study|Subject did not meet end of study ABPM|1|||
13440535|NCT00347360|26914368|FG011|Overall Study|Subject did not meet end of study ABPM|0|||
13440536|NCT00347360|26914369|FG012|Overall Study|Subject did not meet end of study ABPM|1|||
13440537|NCT00347360|26914370|FG013|Overall Study|Subject did not meet end of study ABPM|1|||
13440538|NCT00347360|26914371|FG014|Overall Study|Subject did not meet end of study ABPM|0|||
13440539|NCT00347360|26914357|FG000|Overall Study|Abnormal lab values|0|||
13440540|NCT00347360|26914358|FG001|Overall Study|Abnormal lab values|0|||
13440541|NCT00347360|26914359|FG002|Overall Study|Abnormal lab values|0|||
13440542|NCT00347360|26914360|FG003|Overall Study|Abnormal lab values|0|||
13440543|NCT00347360|26914361|FG004|Overall Study|Abnormal lab values|0|||
13440544|NCT00347360|26914362|FG005|Overall Study|Abnormal lab values|0|||
13440545|NCT00347360|26914363|FG006|Overall Study|Abnormal lab values|1|||
13440546|NCT00347360|26914364|FG007|Overall Study|Abnormal lab values|0|||
13440547|NCT00347360|26914365|FG008|Overall Study|Abnormal lab values|0|||
13440548|NCT00347360|26914366|FG009|Overall Study|Abnormal lab values|0|||
13440549|NCT00347360|26914367|FG010|Overall Study|Abnormal lab values|0|||
13440550|NCT00347360|26914368|FG011|Overall Study|Abnormal lab values|0|||
13440551|NCT00347360|26914369|FG012|Overall Study|Abnormal lab values|0|||
13440552|NCT00347360|26914370|FG013|Overall Study|Abnormal lab values|0|||
13440553|NCT00347360|26914371|FG014|Overall Study|Abnormal lab values|0|||
13440554|NCT00347360|26914357|FG000|Overall Study|PI recommended early withdrawal|0|||
13440555|NCT00347360|26914358|FG001|Overall Study|PI recommended early withdrawal|0|||
13440556|NCT00347360|26914359|FG002|Overall Study|PI recommended early withdrawal|0|||
13440557|NCT00347360|26914360|FG003|Overall Study|PI recommended early withdrawal|0|||
13440558|NCT00347360|26914361|FG004|Overall Study|PI recommended early withdrawal|0|||
13440559|NCT00347360|26914362|FG005|Overall Study|PI recommended early withdrawal|0|||
13440560|NCT00347360|26914363|FG006|Overall Study|PI recommended early withdrawal|0|||
13440561|NCT00347360|26914364|FG007|Overall Study|PI recommended early withdrawal|0|||
13440562|NCT00347360|26914365|FG008|Overall Study|PI recommended early withdrawal|0|||
13440563|NCT00347360|26914366|FG009|Overall Study|PI recommended early withdrawal|1|||
13440564|NCT00347360|26914367|FG010|Overall Study|PI recommended early withdrawal|0|||
13440565|NCT00347360|26914368|FG011|Overall Study|PI recommended early withdrawal|0|||
13440566|NCT00347360|26914369|FG012|Overall Study|PI recommended early withdrawal|0|||
13440567|NCT00347360|26914370|FG013|Overall Study|PI recommended early withdrawal|0|||
13440568|NCT00347360|26914371|FG014|Overall Study|PI recommended early withdrawal|0|||
13440569|NCT00347360|26914357|FG000|Overall Study|Did not meet criteria before ABPM|0|||
13440570|NCT00347360|26914358|FG001|Overall Study|Did not meet criteria before ABPM|0|||
13440571|NCT00347360|26914359|FG002|Overall Study|Did not meet criteria before ABPM|0|||
13440572|NCT00347360|26914360|FG003|Overall Study|Did not meet criteria before ABPM|0|||
13440573|NCT00347360|26914361|FG004|Overall Study|Did not meet criteria before ABPM|0|||
13440574|NCT00347360|26914362|FG005|Overall Study|Did not meet criteria before ABPM|0|||
13440575|NCT00347360|26914363|FG006|Overall Study|Did not meet criteria before ABPM|0|||
13440576|NCT00347360|26914364|FG007|Overall Study|Did not meet criteria before ABPM|0|||
13440577|NCT00347360|26914365|FG008|Overall Study|Did not meet criteria before ABPM|0|||
13440578|NCT00347360|26914366|FG009|Overall Study|Did not meet criteria before ABPM|0|||
13440579|NCT00347360|26914367|FG010|Overall Study|Did not meet criteria before ABPM|1|||
13440580|NCT00347360|26914368|FG011|Overall Study|Did not meet criteria before ABPM|0|||
13440581|NCT00347360|26914369|FG012|Overall Study|Did not meet criteria before ABPM|0|||
13440582|NCT00347360|26914370|FG013|Overall Study|Did not meet criteria before ABPM|0|||
13440583|NCT00347360|26914371|FG014|Overall Study|Did not meet criteria before ABPM|0|||
13440584|NCT00347360|26914357|FG000|Overall Study|Randomized in error|0|||
13440585|NCT00347360|26914358|FG001|Overall Study|Randomized in error|0|||
13440586|NCT00347360|26914359|FG002|Overall Study|Randomized in error|0|||
13440587|NCT00347360|26914360|FG003|Overall Study|Randomized in error|0|||
13440588|NCT00347360|26914361|FG004|Overall Study|Randomized in error|0|||
13440589|NCT00347360|26914362|FG005|Overall Study|Randomized in error|0|||
13440590|NCT00347360|26914363|FG006|Overall Study|Randomized in error|0|||
13440591|NCT00347360|26914364|FG007|Overall Study|Randomized in error|0|||
13440592|NCT00347360|26914365|FG008|Overall Study|Randomized in error|0|||
13440593|NCT00347360|26914366|FG009|Overall Study|Randomized in error|0|||
13440594|NCT00347360|26914367|FG010|Overall Study|Randomized in error|0|||
13440595|NCT00347360|26914368|FG011|Overall Study|Randomized in error|1|||
13440596|NCT00347360|26914369|FG012|Overall Study|Randomized in error|0|||
13440597|NCT00347360|26914370|FG013|Overall Study|Randomized in error|0|||
13440598|NCT00347360|26914371|FG014|Overall Study|Randomized in error|0|||
13440599|NCT00347360|26914357|FG000|Overall Study|Failed inclusion criteria #4|0|||
13440600|NCT00347360|26914358|FG001|Overall Study|Failed inclusion criteria #4|0|||
13440601|NCT00347360|26914359|FG002|Overall Study|Failed inclusion criteria #4|0|||
13440602|NCT00347360|26914360|FG003|Overall Study|Failed inclusion criteria #4|0|||
13440603|NCT00347360|26914361|FG004|Overall Study|Failed inclusion criteria #4|0|||
13440604|NCT00347360|26914362|FG005|Overall Study|Failed inclusion criteria #4|0|||
13440605|NCT00347360|26914363|FG006|Overall Study|Failed inclusion criteria #4|0|||
13440606|NCT00347360|26914364|FG007|Overall Study|Failed inclusion criteria #4|0|||
13440607|NCT00347360|26914365|FG008|Overall Study|Failed inclusion criteria #4|0|||
13440608|NCT00347360|26914366|FG009|Overall Study|Failed inclusion criteria #4|0|||
13440609|NCT00347360|26914367|FG010|Overall Study|Failed inclusion criteria #4|0|||
13440610|NCT00347360|26914368|FG011|Overall Study|Failed inclusion criteria #4|1|||
13440611|NCT00347360|26914369|FG012|Overall Study|Failed inclusion criteria #4|0|||
13440612|NCT00347360|26914370|FG013|Overall Study|Failed inclusion criteria #4|0|||
13440613|NCT00347360|26914371|FG014|Overall Study|Failed inclusion criteria #4|0|||
13440614|NCT00347360|26914357|FG000|Overall Study|Prolonged duration between visits|0|||
13440615|NCT00347360|26914358|FG001|Overall Study|Prolonged duration between visits|0|||
13440616|NCT00347360|26914359|FG002|Overall Study|Prolonged duration between visits|0|||
13440617|NCT00347360|26914360|FG003|Overall Study|Prolonged duration between visits|0|||
13440618|NCT00347360|26914361|FG004|Overall Study|Prolonged duration between visits|0|||
13440619|NCT00347360|26914362|FG005|Overall Study|Prolonged duration between visits|0|||
13440620|NCT00347360|26914363|FG006|Overall Study|Prolonged duration between visits|0|||
13440621|NCT00347360|26914364|FG007|Overall Study|Prolonged duration between visits|0|||
13440622|NCT00347360|26914365|FG008|Overall Study|Prolonged duration between visits|0|||
13440623|NCT00347360|26914366|FG009|Overall Study|Prolonged duration between visits|0|||
13440624|NCT00347360|26914367|FG010|Overall Study|Prolonged duration between visits|0|||
13440625|NCT00347360|26914368|FG011|Overall Study|Prolonged duration between visits|0|||
13440626|NCT00347360|26914369|FG012|Overall Study|Prolonged duration between visits|1|||
13440627|NCT00347360|26914370|FG013|Overall Study|Prolonged duration between visits|0|||
13440628|NCT00347360|26914371|FG014|Overall Study|Prolonged duration between visits|0|||
13440629|NCT00347360|26914357|FG000|Overall Study|Subject left town, ran out of study drug|0|||
13440630|NCT00347360|26914358|FG001|Overall Study|Subject left town, ran out of study drug|0|||
13440631|NCT00347360|26914359|FG002|Overall Study|Subject left town, ran out of study drug|0|||
13440632|NCT00347360|26914360|FG003|Overall Study|Subject left town, ran out of study drug|0|||
13440633|NCT00347360|26914361|FG004|Overall Study|Subject left town, ran out of study drug|0|||
13440634|NCT00347360|26914362|FG005|Overall Study|Subject left town, ran out of study drug|0|||
13440635|NCT00347360|26914363|FG006|Overall Study|Subject left town, ran out of study drug|0|||
13440636|NCT00347360|26914364|FG007|Overall Study|Subject left town, ran out of study drug|0|||
13440637|NCT00347360|26914365|FG008|Overall Study|Subject left town, ran out of study drug|0|||
13440638|NCT00347360|26914366|FG009|Overall Study|Subject left town, ran out of study drug|0|||
13440639|NCT00347360|26914367|FG010|Overall Study|Subject left town, ran out of study drug|0|||
13440640|NCT00347360|26914368|FG011|Overall Study|Subject left town, ran out of study drug|0|||
13440641|NCT00347360|26914369|FG012|Overall Study|Subject left town, ran out of study drug|0|||
13440642|NCT00347360|26914370|FG013|Overall Study|Subject left town, ran out of study drug|1|||
13440643|NCT00347360|26914371|FG014|Overall Study|Subject left town, ran out of study drug|0|||
13440644|NCT00347360|26914357|FG000|Overall Study|Subject refuse to sign updated consent|0|||
13440645|NCT00347360|26914358|FG001|Overall Study|Subject refuse to sign updated consent|0|||
13440646|NCT00347360|26914359|FG002|Overall Study|Subject refuse to sign updated consent|0|||
13440647|NCT00347360|26914360|FG003|Overall Study|Subject refuse to sign updated consent|0|||
13440648|NCT00347360|26914361|FG004|Overall Study|Subject refuse to sign updated consent|0|||
13440649|NCT00347360|26914362|FG005|Overall Study|Subject refuse to sign updated consent|0|||
13440650|NCT00347360|26914363|FG006|Overall Study|Subject refuse to sign updated consent|0|||
13440651|NCT00347360|26914364|FG007|Overall Study|Subject refuse to sign updated consent|0|||
13440652|NCT00347360|26914365|FG008|Overall Study|Subject refuse to sign updated consent|0|||
13440653|NCT00347360|26914366|FG009|Overall Study|Subject refuse to sign updated consent|0|||
13440654|NCT00347360|26914367|FG010|Overall Study|Subject refuse to sign updated consent|0|||
13440655|NCT00347360|26914368|FG011|Overall Study|Subject refuse to sign updated consent|0|||
13440656|NCT00347360|26914369|FG012|Overall Study|Subject refuse to sign updated consent|0|||
13440657|NCT00347360|26914370|FG013|Overall Study|Subject refuse to sign updated consent|0|||
13440658|NCT00347360|26914371|FG014|Overall Study|Subject refuse to sign updated consent|1|||
13440659|NCT00347360|26914357|FG000|Overall Study|Visits conflicted with new job|0|||
13440660|NCT00347360|26914358|FG001|Overall Study|Visits conflicted with new job|0|||
13440661|NCT00347360|26914359|FG002|Overall Study|Visits conflicted with new job|0|||
13440662|NCT00347360|26914360|FG003|Overall Study|Visits conflicted with new job|0|||
13440663|NCT00347360|26914361|FG004|Overall Study|Visits conflicted with new job|0|||
13440664|NCT00347360|26914362|FG005|Overall Study|Visits conflicted with new job|0|||
13440665|NCT00347360|26914363|FG006|Overall Study|Visits conflicted with new job|1|||
13440666|NCT00347360|26914364|FG007|Overall Study|Visits conflicted with new job|0|||
13440667|NCT00347360|26914365|FG008|Overall Study|Visits conflicted with new job|0|||
13440668|NCT00347360|26914366|FG009|Overall Study|Visits conflicted with new job|0|||
13440669|NCT00347360|26914367|FG010|Overall Study|Visits conflicted with new job|0|||
13440670|NCT00347360|26914368|FG011|Overall Study|Visits conflicted with new job|0|||
13440671|NCT00347360|26914369|FG012|Overall Study|Visits conflicted with new job|0|||
13440672|NCT00347360|26914370|FG013|Overall Study|Visits conflicted with new job|0|||
13440673|NCT00347360|26914371|FG014|Overall Study|Visits conflicted with new job|0|||
13440674|NCT00347269|26914384|FG000|Overall Study|Lost to Follow-up|74|||
13440675|NCT00347269|26914385|FG001|Overall Study|Lost to Follow-up|65|||
13440676|NCT00347269|26914384|FG000|Overall Study|Withdrawal by Subject|18|||
13440677|NCT00347269|26914385|FG001|Overall Study|Withdrawal by Subject|38|||
13440678|NCT00347269|26914384|FG000|Overall Study|Death|2|||
13440679|NCT00347269|26914385|FG001|Overall Study|Death|3|||
13440680|NCT00347009|26914404|FG000|Overall Study|Death|1|||
13440681|NCT00347009|26914404|FG000|Overall Study|Adverse Event|6|||
13440682|NCT00347009|26914404|FG000|Overall Study|Withdrawal by Subject|3|||
13440683|NCT00347009|26914404|FG000|Overall Study|Physician Decision|5|||
13440684|NCT00347009|26914404|FG000|Overall Study|Lost to Follow-up|4|||
13440685|NCT00347009|26914404|FG000|Overall Study|Protocol Violation|2|||
13440686|NCT00347009|26914404|FG000|Overall Study|Adverse Laboratory Experience|1|||
13440687|NCT00347009|26914404|FG000|Overall Study|Insufficient Viral Suppression|3|||
13440688|NCT00347009|26914404|FG000|Overall Study|Increased ALT/HBV DNA|1|||
13440689|NCT00347009|26914404|FG000|Overall Study|Serious Adverse Event|1|||
13440690|NCT00346775|26914417|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1|||
13440691|NCT00346775|26914418|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1|||
13440692|NCT00346775|26914417|FG000|Period 1: Intervention Period 1|Protocol Violation|3|||
13440693|NCT00346775|26914418|FG001|Period 1: Intervention Period 1|Protocol Violation|2|||
13440694|NCT00346775|26914417|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1|||
13440695|NCT00346775|26914418|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0|||
13440696|NCT00346697|26914459|FG000|Overall Study|Lost to Follow-up|0|||
13440697|NCT00346697|26914460|FG001|Overall Study|Lost to Follow-up|1|||
13440698|NCT00346632|26914618|FG000|Overall Study|Progressive Disease|2|||
13440699|NCT00346632|26914619|FG001|Overall Study|Progressive Disease|2|||
13440700|NCT00346632|26914620|FG002|Overall Study|Progressive Disease|4|||
13440701|NCT00346632|26914621|FG003|Overall Study|Progressive Disease|3|||
13440702|NCT00346632|26914622|FG004|Overall Study|Progressive Disease|3|||
13440703|NCT00346632|26914623|FG005|Overall Study|Progressive Disease|1|||
13440704|NCT00346632|26914624|FG006|Overall Study|Progressive Disease|2|||
13440705|NCT00346632|26914625|FG007|Overall Study|Progressive Disease|2|||
13440706|NCT00346632|26914626|FG008|Overall Study|Progressive Disease|2|||
13440707|NCT00346632|26914627|FG009|Overall Study|Progressive Disease|2|||
13440708|NCT00346632|26914618|FG000|Overall Study|Adverse Event|0|||
13440709|NCT00346632|26914619|FG001|Overall Study|Adverse Event|0|||
13440710|NCT00346632|26914620|FG002|Overall Study|Adverse Event|0|||
13440711|NCT00346632|26914621|FG003|Overall Study|Adverse Event|0|||
13440712|NCT00346632|26914622|FG004|Overall Study|Adverse Event|1|||
13440713|NCT00346632|26914623|FG005|Overall Study|Adverse Event|1|||
13440714|NCT00346632|26914624|FG006|Overall Study|Adverse Event|1|||
13440715|NCT00346632|26914625|FG007|Overall Study|Adverse Event|0|||
13440716|NCT00346632|26914626|FG008|Overall Study|Adverse Event|0|||
13440717|NCT00346632|26914627|FG009|Overall Study|Adverse Event|0|||
13440718|NCT00346632|26914618|FG000|Overall Study|Death|0|||
13440719|NCT00346632|26914619|FG001|Overall Study|Death|0|||
13440720|NCT00346632|26914620|FG002|Overall Study|Death|1|||
13440721|NCT00346632|26914621|FG003|Overall Study|Death|0|||
13440722|NCT00346632|26914622|FG004|Overall Study|Death|0|||
13440723|NCT00346632|26914623|FG005|Overall Study|Death|0|||
13440724|NCT00346632|26914624|FG006|Overall Study|Death|0|||
13440725|NCT00346632|26914625|FG007|Overall Study|Death|0|||
13440726|NCT00346632|26914626|FG008|Overall Study|Death|0|||
13440727|NCT00346632|26914627|FG009|Overall Study|Death|0|||
13440728|NCT00346632|26914618|FG000|Overall Study|Protocol Violation|0|||
13440729|NCT00346632|26914619|FG001|Overall Study|Protocol Violation|0|||
13440730|NCT00346632|26914620|FG002|Overall Study|Protocol Violation|0|||
13440731|NCT00346632|26914621|FG003|Overall Study|Protocol Violation|0|||
13440732|NCT00346632|26914622|FG004|Overall Study|Protocol Violation|0|||
13440733|NCT00346632|26914623|FG005|Overall Study|Protocol Violation|0|||
13440734|NCT00346632|26914624|FG006|Overall Study|Protocol Violation|1|||
13440735|NCT00346632|26914625|FG007|Overall Study|Protocol Violation|0|||
13440736|NCT00346632|26914626|FG008|Overall Study|Protocol Violation|0|||
13440737|NCT00346632|26914627|FG009|Overall Study|Protocol Violation|0|||
13440738|NCT00346632|26914618|FG000|Overall Study|Withdrawal by Subject|0|||
13440739|NCT00346632|26914619|FG001|Overall Study|Withdrawal by Subject|0|||
13440740|NCT00346632|26914620|FG002|Overall Study|Withdrawal by Subject|0|||
13440741|NCT00346632|26914621|FG003|Overall Study|Withdrawal by Subject|0|||
13440742|NCT00346632|26914622|FG004|Overall Study|Withdrawal by Subject|0|||
13440743|NCT00346632|26914623|FG005|Overall Study|Withdrawal by Subject|0|||
13440744|NCT00346632|26914624|FG006|Overall Study|Withdrawal by Subject|1|||
13440745|NCT00346632|26914625|FG007|Overall Study|Withdrawal by Subject|0|||
13440746|NCT00346632|26914626|FG008|Overall Study|Withdrawal by Subject|0|||
13440747|NCT00346632|26914627|FG009|Overall Study|Withdrawal by Subject|0|||
13440748|NCT00346632|26914618|FG000|Overall Study|Switched to alternative treatment|0|||
13440749|NCT00346632|26914619|FG001|Overall Study|Switched to alternative treatment|0|||
13440750|NCT00346632|26914620|FG002|Overall Study|Switched to alternative treatment|1|||
13440751|NCT00346632|26914621|FG003|Overall Study|Switched to alternative treatment|0|||
13440752|NCT00346632|26914622|FG004|Overall Study|Switched to alternative treatment|0|||
13440753|NCT00346632|26914623|FG005|Overall Study|Switched to alternative treatment|0|||
13440754|NCT00346632|26914624|FG006|Overall Study|Switched to alternative treatment|0|||
13440755|NCT00346632|26914625|FG007|Overall Study|Switched to alternative treatment|0|||
13440756|NCT00346632|26914626|FG008|Overall Study|Switched to alternative treatment|0|||
13440757|NCT00346632|26914627|FG009|Overall Study|Switched to alternative treatment|0|||
13440758|NCT00346632|26914618|FG000|Overall Study|Not Stated|1|||
13440759|NCT00346632|26914619|FG001|Overall Study|Not Stated|1|||
13440760|NCT00346632|26914620|FG002|Overall Study|Not Stated|0|||
13440761|NCT00346632|26914621|FG003|Overall Study|Not Stated|0|||
13440762|NCT00346632|26914622|FG004|Overall Study|Not Stated|0|||
13440763|NCT00346632|26914623|FG005|Overall Study|Not Stated|0|||
13440764|NCT00346632|26914624|FG006|Overall Study|Not Stated|0|||
13440765|NCT00346632|26914625|FG007|Overall Study|Not Stated|2|||
13440766|NCT00346632|26914626|FG008|Overall Study|Not Stated|2|||
13440767|NCT00346632|26914627|FG009|Overall Study|Not Stated|1|||
13440768|NCT00346398|26914644|FG000|Overall Study|Lost to Follow-up|3|||
13440769|NCT00346398|26914645|FG001|Overall Study|Lost to Follow-up|0|||
13440770|NCT00346398|26914644|FG000|Overall Study|Withdrawal by Subject|0|||
13440771|NCT00346398|26914645|FG001|Overall Study|Withdrawal by Subject|2|||
13440772|NCT00346333|26914666|FG000|Overall Study|Death|1|||
13440773|NCT00346333|26914667|FG001|Overall Study|Death|0|||
13440774|NCT00346333|26914666|FG000|Overall Study|unwilling or unable to continue|4|||
13440775|NCT00346333|26914667|FG001|Overall Study|unwilling or unable to continue|8|||
13440776|NCT00346268|26914706|FG000|Overall Study|Adverse Event|1|||
13440777|NCT00346268|26914707|FG001|Overall Study|Adverse Event|0|||
13440778|NCT00346268|26914706|FG000|Overall Study|Protocol Violation|1|||
13440779|NCT00346268|26914707|FG001|Overall Study|Protocol Violation|0|||
13440780|NCT00346268|26914706|FG000|Overall Study|Participant refused|0|||
13440781|NCT00346268|26914707|FG001|Overall Study|Participant refused|3|||
13440782|NCT00346216|26914734|FG000|Overall Study|Other|181|||
13440783|NCT00346216|26914735|FG001|Overall Study|Other|231|||
13440784|NCT00346216|26914736|FG002|Overall Study|Other|205|||
13440785|NCT00346216|26914734|FG000|Overall Study|No longer willing to participate|600|||
13440786|NCT00346216|26914735|FG001|Overall Study|No longer willing to participate|606|||
13440787|NCT00346216|26914736|FG002|Overall Study|No longer willing to participate|585|||
13440788|NCT00346216|26914734|FG000|Overall Study|Withdrawal by Subject|661|||
13440789|NCT00346216|26914735|FG001|Overall Study|Withdrawal by Subject|692|||
13440790|NCT00346216|26914736|FG002|Overall Study|Withdrawal by Subject|651|||
13440791|NCT00346216|26914734|FG000|Overall Study|Lost to Follow-up|611|||
13440792|NCT00346216|26914735|FG001|Overall Study|Lost to Follow-up|588|||
13440793|NCT00346216|26914736|FG002|Overall Study|Lost to Follow-up|542|||
13440794|NCT00346216|26914734|FG000|Overall Study|Physician Decision|80|||
13440795|NCT00346216|26914735|FG001|Overall Study|Physician Decision|76|||
13440796|NCT00346216|26914736|FG002|Overall Study|Physician Decision|59|||
13440797|NCT00346216|26914734|FG000|Overall Study|Does not meet entrance criteria|13|||
13440798|NCT00346216|26914735|FG001|Overall Study|Does not meet entrance criteria|10|||
13440799|NCT00346216|26914736|FG002|Overall Study|Does not meet entrance criteria|8|||
13440800|NCT00346216|26914734|FG000|Overall Study|Death|189|||
13440801|NCT00346216|26914735|FG001|Overall Study|Death|192|||
13440802|NCT00346216|26914736|FG002|Overall Study|Death|228|||
13440803|NCT00346216|26914734|FG000|Overall Study|Study terminated by sponsor|11|||
13440804|NCT00346216|26914735|FG001|Overall Study|Study terminated by sponsor|4|||
13440805|NCT00346216|26914736|FG002|Overall Study|Study terminated by sponsor|8|||
13440806|NCT00346216|26914734|FG000|Overall Study|Missing Subject Summary Status|62|||
13440807|NCT00346216|26914735|FG001|Overall Study|Missing Subject Summary Status|61|||
13440808|NCT00346216|26914736|FG002|Overall Study|Missing Subject Summary Status|62|||
13440809|NCT00346164|26914784|FG000|Overall Study|Adverse Event|0|||
13440810|NCT00346164|26914785|FG001|Overall Study|Adverse Event|0|||
13440811|NCT00346164|26914786|FG002|Overall Study|Adverse Event|0|||
13440812|NCT00346164|26914787|FG003|Overall Study|Adverse Event|1|||
13440813|NCT00346164|26914784|FG000|Overall Study|Lack of Efficacy|0|||
13440814|NCT00346164|26914785|FG001|Overall Study|Lack of Efficacy|1|||
13440815|NCT00346164|26914786|FG002|Overall Study|Lack of Efficacy|7|||
13440816|NCT00346164|26914787|FG003|Overall Study|Lack of Efficacy|25|||
13440817|NCT00346164|26914784|FG000|Overall Study|Physician Decision|0|||
13440818|NCT00346164|26914785|FG001|Overall Study|Physician Decision|1|||
13440819|NCT00346164|26914786|FG002|Overall Study|Physician Decision|2|||
13440820|NCT00346164|26914787|FG003|Overall Study|Physician Decision|27|||
13440821|NCT00346164|26914784|FG000|Overall Study|Protocol Violation|6|||
13440822|NCT00346164|26914785|FG001|Overall Study|Protocol Violation|2|||
13440823|NCT00346164|26914786|FG002|Overall Study|Protocol Violation|10|||
13440824|NCT00346164|26914787|FG003|Overall Study|Protocol Violation|4|||
13440825|NCT00346164|26914784|FG000|Overall Study|Withdrawal by Subject|0|||
13440826|NCT00346164|26914785|FG001|Overall Study|Withdrawal by Subject|0|||
13440827|NCT00346164|26914786|FG002|Overall Study|Withdrawal by Subject|2|||
13440828|NCT00346164|26914787|FG003|Overall Study|Withdrawal by Subject|0|||
13440829|NCT00346164|26914784|FG000|Overall Study|Ineligible|11|||
13440830|NCT00346164|26914785|FG001|Overall Study|Ineligible|2|||
13440831|NCT00346164|26914786|FG002|Overall Study|Ineligible|2|||
13440832|NCT00346164|26914787|FG003|Overall Study|Ineligible|23|||
13440833|NCT00346164|26914784|FG000|Overall Study|Refusal of further protocol therapy|0|||
13440834|NCT00346164|26914785|FG001|Overall Study|Refusal of further protocol therapy|1|||
13440835|NCT00346164|26914786|FG002|Overall Study|Refusal of further protocol therapy|3|||
13440836|NCT00346164|26914787|FG003|Overall Study|Refusal of further protocol therapy|15|||
13440837|NCT00346164|26914784|FG000|Overall Study|Inability to start week 16 tx on time|0|||
13440838|NCT00346164|26914785|FG001|Overall Study|Inability to start week 16 tx on time|0|||
13440839|NCT00346164|26914786|FG002|Overall Study|Inability to start week 16 tx on time|0|||
13440840|NCT00346164|26914787|FG003|Overall Study|Inability to start week 16 tx on time|11|||
13440841|NCT00346151|26914807|FG000|Overall Study|Withdrawal by Subject|3|||
13440842|NCT00346073|26914848|FG000|Overall Study|Serious Adverse Event|2|||
13440843|NCT00346073|26914849|FG001|Overall Study|Serious Adverse Event|0|||
13440844|NCT00346073|26914848|FG000|Overall Study|Lost to Follow-up|39|||
13440845|NCT00346073|26914849|FG001|Overall Study|Lost to Follow-up|24|||
13440846|NCT00346034|26914856|FG000|Overall Study|Adverse Event|34|||
13440847|NCT00346034|26914856|FG000|Overall Study|Lack of Efficacy|8|||
13440848|NCT00346034|26914856|FG000|Overall Study|Withdrawal by Subject|13|||
13440849|NCT00346034|26914856|FG000|Overall Study|Patient Stopped Taking Study Drug|1|||
13440850|NCT00346034|26914856|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1|||
13440851|NCT00345878|26914879|FG000|Overall Study|Adverse Event|1|||
13440852|NCT00345878|26914880|FG001|Overall Study|Adverse Event|0|||
13440853|NCT00345878|26914879|FG000|Overall Study|Lost to Follow-up|2|||
13440854|NCT00345878|26914880|FG001|Overall Study|Lost to Follow-up|1|||
13440855|NCT00345878|26914879|FG000|Overall Study|Other|1|||
13440856|NCT00345878|26914880|FG001|Overall Study|Other|0|||
13440857|NCT00345683|26914907|FG000|Overall Study|Lost to Follow-up|19|||
13440858|NCT00345683|26914908|FG001|Overall Study|Lost to Follow-up|7|||
13440859|NCT00345683|26914907|FG000|Overall Study|Other|6|||
13440860|NCT00345683|26914908|FG001|Overall Study|Other|2|||
13440861|NCT00345631|26914950|FG000|Overall Study|Withdrawal by Subject|1|||
13440862|NCT00345631|26914951|FG001|Overall Study|Withdrawal by Subject|0|||
13440863|NCT00345631|26914952|FG002|Overall Study|Withdrawal by Subject|1|||
13440864|NCT00345631|26914950|FG000|Overall Study|Adverse Event|0|||
13440865|NCT00345631|26914951|FG001|Overall Study|Adverse Event|1|||
13440866|NCT00345631|26914952|FG002|Overall Study|Adverse Event|0|||
13440867|NCT00345631|26914950|FG000|Overall Study|Lost to Follow-up|3|||
13440868|NCT00345631|26914951|FG001|Overall Study|Lost to Follow-up|7|||
13440869|NCT00345631|26914952|FG002|Overall Study|Lost to Follow-up|4|||
13440870|NCT00345631|26914950|FG000|Overall Study|Other reasons|0|||
13440871|NCT00345631|26914951|FG001|Overall Study|Other reasons|0|||
13440872|NCT00345631|26914952|FG002|Overall Study|Other reasons|1|||
13440873|NCT00345605|26914973|FG000|Arm 1|Adverse Event|0|||
13440874|NCT00345605|26914974|FG001|Arm 1|Adverse Event|1|||
13440875|NCT00345605|26914973|FG000|Arm 2, Opposite Treatment|Adverse Event|1|||
13440876|NCT00345605|26914974|FG001|Arm 2, Opposite Treatment|Adverse Event|0|||
13440877|NCT00345592|26914987|FG000|Overall Study|Death|14|||
13440878|NCT00345592|26914988|FG001|Overall Study|Death|16|||
13440879|NCT00345592|26914987|FG000|Overall Study|Withdrawal by Subject|11|||
13440880|NCT00345592|26914988|FG001|Overall Study|Withdrawal by Subject|8|||
13440881|NCT00345579|26915015|FG000|Overall Study|Adverse Event|9|||
13440882|NCT00345579|26915016|FG001|Overall Study|Adverse Event|6|||
13440883|NCT00345579|26915015|FG000|Overall Study|Protocol Violation|14|||
13440884|NCT00345579|26915016|FG001|Overall Study|Protocol Violation|5|||
13440885|NCT00345579|26915015|FG000|Overall Study|Withdrawal by Subject|50|||
13440886|NCT00345579|26915016|FG001|Overall Study|Withdrawal by Subject|17|||
13440887|NCT00345579|26915015|FG000|Overall Study|Lost to Follow-up|82|||
13440888|NCT00345579|26915016|FG001|Overall Study|Lost to Follow-up|36|||
13440889|NCT00345579|26915015|FG000|Overall Study|Other|9|||
13440890|NCT00345579|26915016|FG001|Overall Study|Other|1|||
13477112|NCT00614523|27005479|FG000|Overall Study|Ineligibility Determined|1|||
13477113|NCT00614523|27005480|FG001|Overall Study|Ineligibility Determined|2|||
13477114|NCT00614523|27005479|FG000|Overall Study|Disease Progression|0|||
13477115|NCT00614523|27005480|FG001|Overall Study|Disease Progression|8|||
13477116|NCT00614523|27005479|FG000|Overall Study|Administrative Decision|23|||
13477117|NCT00614523|27005480|FG001|Overall Study|Administrative Decision|46|||
13477118|NCT00523341|27005587|FG000|Overall Study|Withdrawal by Subject|399|||
13477119|NCT00523341|27005588|FG001|Overall Study|Withdrawal by Subject|427|||
13477120|NCT00523341|27005587|FG000|Overall Study|Other|181|||
13477121|NCT00523341|27005588|FG001|Overall Study|Other|198|||
13477122|NCT00523341|27005587|FG000|Overall Study|Adverse Event|122|||
13477123|NCT00523341|27005588|FG001|Overall Study|Adverse Event|155|||
13477124|NCT00523341|27005587|FG000|Overall Study|Death|101|||
13477125|NCT00523341|27005588|FG001|Overall Study|Death|110|||
13477126|NCT00523341|27005587|FG000|Overall Study|Lost to Follow-up|73|||
13477127|NCT00523341|27005588|FG001|Overall Study|Lost to Follow-up|61|||
13477128|NCT00523341|27005587|FG000|Overall Study|Non-compliance|20|||
13477129|NCT00523341|27005588|FG001|Overall Study|Non-compliance|13|||
13477130|NCT00523341|27005587|FG000|Overall Study|Physician Decision|14|||
13477131|NCT00523341|27005588|FG001|Overall Study|Physician Decision|13|||
13477132|NCT00523341|27005587|FG000|Overall Study|Requirement for Alternative Therapy|4|||
13477133|NCT00523341|27005588|FG001|Overall Study|Requirement for Alternative Therapy|14|||
13477134|NCT00523341|27005587|FG000|Overall Study|Protocol Deviation|6|||
13477135|NCT00523341|27005588|FG001|Overall Study|Protocol Deviation|5|||
13477136|NCT00523341|27005587|FG000|Overall Study|Ineligibility Determined|3|||
13477137|NCT00523341|27005588|FG001|Overall Study|Ineligibility Determined|4|||
13477138|NCT00523341|27005587|FG000|Overall Study|Disease Progression|1|||
13477139|NCT00523341|27005588|FG001|Overall Study|Disease Progression|0|||
13477140|NCT00364013|27005621|FG000|Overall Study|Ineligibility determined|4|||
13477141|NCT00364013|27005622|FG001|Overall Study|Ineligibility determined|2|||
13477142|NCT00364013|27005621|FG000|Overall Study|Adverse Event|4|||
13477143|NCT00364013|27005622|FG001|Overall Study|Adverse Event|3|||
13477144|NCT00364013|27005621|FG000|Overall Study|Withdrawal by Subject|13|||
13477145|NCT00364013|27005622|FG001|Overall Study|Withdrawal by Subject|18|||
13477146|NCT00364013|27005621|FG000|Overall Study|Physician Decision|3|||
13477147|NCT00364013|27005622|FG001|Overall Study|Physician Decision|3|||
13477148|NCT00364013|27005621|FG000|Overall Study|Lost to Follow-up|10|||
13477149|NCT00364013|27005622|FG001|Overall Study|Lost to Follow-up|3|||
13477150|NCT00364013|27005621|FG000|Overall Study|Protocol-specified criteria|6|||
13477151|NCT00364013|27005622|FG001|Overall Study|Protocol-specified criteria|6|||
13477152|NCT00364013|27005621|FG000|Overall Study|Other|41|||
13477153|NCT00364013|27005622|FG001|Overall Study|Other|47|||
13477154|NCT00364013|27005621|FG000|Overall Study|Ongoing|20|||
13477155|NCT00364013|27005622|FG001|Overall Study|Ongoing|13|||
13477156|NCT00345839|27005653|FG000|Overall Study|Withdrawal by Subject|91|||
13477157|NCT00345839|27005654|FG001|Overall Study|Withdrawal by Subject|98|||
13440891|NCT00345540|26915024|FG000|Overall Study|Withdrawal by Subject|1|||
13440892|NCT00345397|26915031|FG000|Overall Study|Death|1|||
13440893|NCT00345358|26915119|FG000|Primary Vaccination Phase|Other|0|||
13440894|NCT00345358|26915120|FG001|Primary Vaccination Phase|Other|1|||
13440895|NCT00345358|26915121|FG002|Primary Vaccination Phase|Other|1|||
13440896|NCT00345358|26915122|FG003|Primary Vaccination Phase|Other|0|||
13440897|NCT00345358|26915119|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3|||
13440898|NCT00345358|26915120|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1|||
13440899|NCT00345358|26915121|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1|||
13440900|NCT00345358|26915122|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0|||
13440901|NCT00345358|26915119|FG000|Primary Vaccination Phase|Withdrawal by Subject|1|||
13440902|NCT00345358|26915120|FG001|Primary Vaccination Phase|Withdrawal by Subject|2|||
13440903|NCT00345358|26915121|FG002|Primary Vaccination Phase|Withdrawal by Subject|4|||
13440904|NCT00345358|26915122|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
13440905|NCT00345358|26915119|FG000|Primary Vaccination Phase|Lost to Follow-up|1|||
13440906|NCT00345358|26915120|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
13440907|NCT00345358|26915121|FG002|Primary Vaccination Phase|Lost to Follow-up|2|||
13440908|NCT00345358|26915122|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
13440909|NCT00345358|26915119|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
13440910|NCT00345358|26915120|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
13440911|NCT00345358|26915121|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
13440912|NCT00345358|26915122|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
13440913|NCT00345358|26915119|FG000|Booster Vaccination Phase|Lost to Follow-up|3|||
13440914|NCT00345358|26915120|FG001|Booster Vaccination Phase|Lost to Follow-up|0|||
13440915|NCT00345358|26915121|FG002|Booster Vaccination Phase|Lost to Follow-up|0|||
13440916|NCT00345358|26915122|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
13440917|NCT00345293|26915132|FG000|Overall Study|Unable to access line for sample|1|||
13440918|NCT00345293|26915133|FG001|Overall Study|Unable to access line for sample|0|||
13440919|NCT00345293|26915132|FG000|Overall Study|Withdrawal by Subject|1|||
13440920|NCT00345293|26915133|FG001|Overall Study|Withdrawal by Subject|0|||
13440921|NCT00345046|26915151|FG000|Overall Study|Protocol Violation|1|||
13440922|NCT00345046|26915152|FG001|Overall Study|Protocol Violation|1|||
13440923|NCT00345046|26915153|FG002|Overall Study|Protocol Violation|2|||
13440924|NCT00344968|26915174|FG000|Overall Study|Adverse Event|5|||
13440925|NCT00344968|26915175|FG001|Overall Study|Adverse Event|4|||
13440926|NCT00344968|26915176|FG002|Overall Study|Adverse Event|15|||
13440927|NCT00344968|26915174|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
13440928|NCT00344968|26915175|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
13440929|NCT00344968|26915176|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
13440930|NCT00344968|26915174|FG000|Overall Study|Protocol Violation|2|||
13440931|NCT00344968|26915175|FG001|Overall Study|Protocol Violation|2|||
13440932|NCT00344968|26915176|FG002|Overall Study|Protocol Violation|5|||
13440933|NCT00344968|26915174|FG000|Overall Study|Withdrawal by Subject|14|||
13440934|NCT00344968|26915175|FG001|Overall Study|Withdrawal by Subject|31|||
13440935|NCT00344968|26915176|FG002|Overall Study|Withdrawal by Subject|27|||
13440936|NCT00344968|26915174|FG000|Overall Study|Lost to Follow-up|24|||
13440937|NCT00344968|26915175|FG001|Overall Study|Lost to Follow-up|37|||
13440938|NCT00344968|26915176|FG002|Overall Study|Lost to Follow-up|37|||
13440939|NCT00344968|26915174|FG000|Overall Study|Death|11|||
13440940|NCT00344968|26915175|FG001|Overall Study|Death|27|||
13440941|NCT00344968|26915176|FG002|Overall Study|Death|31|||
13440942|NCT00344968|26915174|FG000|Overall Study|Other|0|||
13440943|NCT00344968|26915175|FG001|Overall Study|Other|1|||
13440944|NCT00344968|26915176|FG002|Overall Study|Other|0|||
13440945|NCT00344773|26915184|FG000|Overall Study|Adverse Event|2|||
13440946|NCT00344773|26915184|FG000|Overall Study|Objective Disease Progression|16|||
13440947|NCT00344773|26915184|FG000|Overall Study|Withdrawal by Subject|1|||
13440948|NCT00344773|26915184|FG000|Overall Study|Not Eligible for the study|2|||
13440949|NCT00344500|26915203|FG000|Overall Study|Adverse Event|6|||
13440950|NCT00344500|26915204|FG001|Overall Study|Adverse Event|2|||
13440951|NCT00344500|26915205|FG002|Overall Study|Adverse Event|0|||
13440952|NCT00344500|26915203|FG000|Overall Study|Lost to Follow-up|5|||
13440953|NCT00344500|26915204|FG001|Overall Study|Lost to Follow-up|13|||
13440954|NCT00344500|26915205|FG002|Overall Study|Lost to Follow-up|1|||
13440955|NCT00344500|26915203|FG000|Overall Study|Withdrawal by Subject|7|||
13440956|NCT00344500|26915204|FG001|Overall Study|Withdrawal by Subject|10|||
13440957|NCT00344500|26915205|FG002|Overall Study|Withdrawal by Subject|0|||
13440958|NCT00344500|26915203|FG000|Overall Study|Protocol Violation|4|||
13440959|NCT00344500|26915204|FG001|Overall Study|Protocol Violation|7|||
13440960|NCT00344500|26915205|FG002|Overall Study|Protocol Violation|1|||
13440961|NCT00344500|26915203|FG000|Overall Study|Not Noted|1|||
13440962|NCT00344500|26915204|FG001|Overall Study|Not Noted|3|||
13440963|NCT00344500|26915205|FG002|Overall Study|Not Noted|0|||
13440964|NCT00344461|26915216|FG000|Overall Study|Adverse Event|6|||
13440965|NCT00344461|26915216|FG000|Overall Study|Death|1|||
13440966|NCT00344461|26915216|FG000|Overall Study|Lack of Efficacy|2|||
13440967|NCT00344461|26915216|FG000|Overall Study|Lost to Follow-up|2|||
13440968|NCT00344461|26915216|FG000|Overall Study|Physician Decision|2|||
13440969|NCT00344461|26915216|FG000|Overall Study|Protocol Violation|6|||
13440970|NCT00344461|26915216|FG000|Overall Study|Withdrawal by Subject|2|||
13440971|NCT00344448|26915229|FG000|Screening|Withdrawal by Subject|0|||
13440972|NCT00344448|26915230|FG001|Screening|Withdrawal by Subject|1|||
13440973|NCT00344448|26915229|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1|||
13440974|NCT00344448|26915230|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0|||
13440975|NCT00344448|26915229|FG000|Double Blind, Placebo Controlled|Study terminated|1|||
13440976|NCT00344448|26915230|FG001|Double Blind, Placebo Controlled|Study terminated|0|||
13440977|NCT00344448|26915229|FG000|Open Label|Withdrawal by Subject|1|||
13440978|NCT00344448|26915230|FG001|Open Label|Withdrawal by Subject|1|||
13440979|NCT00344448|26915229|FG000|Open Label|Study terminated|1|||
13440980|NCT00344448|26915230|FG001|Open Label|Study terminated|0|||
13440981|NCT00344318|26915363|FG000|Overall Study|Adverse Event|0|||
13440982|NCT00344318|26915364|FG001|Overall Study|Adverse Event|3|||
13440983|NCT00344318|26915365|FG002|Overall Study|Adverse Event|0|||
13440984|NCT00344318|26915366|FG003|Overall Study|Adverse Event|1|||
13440985|NCT00344318|26915363|FG000|Overall Study|Withdrawal by Subject|2|||
13440986|NCT00344318|26915364|FG001|Overall Study|Withdrawal by Subject|2|||
13440987|NCT00344318|26915365|FG002|Overall Study|Withdrawal by Subject|0|||
13440988|NCT00344318|26915366|FG003|Overall Study|Withdrawal by Subject|2|||
13440989|NCT00344318|26915363|FG000|Overall Study|Lost to Follow-up|2|||
13440990|NCT00344318|26915364|FG001|Overall Study|Lost to Follow-up|0|||
13440991|NCT00344318|26915365|FG002|Overall Study|Lost to Follow-up|1|||
13440992|NCT00344318|26915366|FG003|Overall Study|Lost to Follow-up|0|||
13440993|NCT00344305|26915408|FG000|Overall Study|Lost to Follow-up|2|||
13440994|NCT00344305|26915409|FG001|Overall Study|Lost to Follow-up|0|||
13440995|NCT00344305|26915408|FG000|Overall Study|Participant was not contacted in window|0|||
13440996|NCT00344305|26915409|FG001|Overall Study|Participant was not contacted in window|1|||
13440997|NCT00344032|26915432|FG000|Overall Study|Adverse Event|0|||
13440998|NCT00344032|26915433|FG001|Overall Study|Adverse Event|1|||
13440999|NCT00344032|26915432|FG000|Overall Study|Withdrawal by Subject|6|||
13441000|NCT00344032|26915433|FG001|Overall Study|Withdrawal by Subject|2|||
13441001|NCT00344032|26915432|FG000|Overall Study|Lost to Follow-up|4|||
13441002|NCT00344032|26915433|FG001|Overall Study|Lost to Follow-up|6|||
13441003|NCT00344032|26915432|FG000|Overall Study|Physician Decision|4|||
13441004|NCT00344032|26915433|FG001|Overall Study|Physician Decision|1|||
13441005|NCT00344019|26915459|FG000|Overall Study|did not meet final inclusion criteria|0|||
13441006|NCT00344019|26915460|FG001|Overall Study|did not meet final inclusion criteria|0|||
13441007|NCT00344019|26915461|FG002|Overall Study|did not meet final inclusion criteria|74|||
13441008|NCT00343915|26915492|FG000|Primary Study|Withdrawal by Subject|1|||
13441009|NCT00343915|26915493|FG001|Primary Study|Withdrawal by Subject|0|||
13441010|NCT00343915|26915492|FG000|Primary Study|Lost to Follow-up|2|||
13441011|NCT00343915|26915493|FG001|Primary Study|Lost to Follow-up|3|||
13441012|NCT00343915|26915492|FG000|Primary Study|Other|1|||
13441013|NCT00343915|26915493|FG001|Primary Study|Other|0|||
13441014|NCT00343889|26915516|FG000|Overall Study|Lost to Follow-up|2|||
13441015|NCT00343889|26915517|FG001|Overall Study|Lost to Follow-up|0|||
13441016|NCT00343889|26915516|FG000|Overall Study|Withdrawal by Subject|0|||
13441017|NCT00343889|26915517|FG001|Overall Study|Withdrawal by Subject|1|||
13441018|NCT00343889|26915516|FG000|Overall Study|Protocol Violation|1|||
13441019|NCT00343889|26915517|FG001|Overall Study|Protocol Violation|0|||
13441020|NCT00343642|26915544|FG000|Overall Study|Lost to Follow-up|0|||
13441021|NCT00343642|26915545|FG001|Overall Study|Lost to Follow-up|1|||
13441022|NCT00343642|26915546|FG002|Overall Study|Lost to Follow-up|0|||
13441023|NCT00343642|26915544|FG000|Overall Study|Pregnancy|1|||
13441024|NCT00343642|26915545|FG001|Overall Study|Pregnancy|0|||
13441025|NCT00343642|26915546|FG002|Overall Study|Pregnancy|2|||
13441026|NCT00343642|26915544|FG000|Overall Study|Withdrawal by Subject|2|||
13441027|NCT00343642|26915545|FG001|Overall Study|Withdrawal by Subject|3|||
13441028|NCT00343642|26915546|FG002|Overall Study|Withdrawal by Subject|4|||
13441029|NCT00343642|26915544|FG000|Overall Study|Adverse Event|0|||
13441030|NCT00343642|26915545|FG001|Overall Study|Adverse Event|0|||
13441031|NCT00343642|26915546|FG002|Overall Study|Adverse Event|1|||
13441032|NCT00343642|26915544|FG000|Overall Study|Flare up|6|||
13306288|NCT01292603|26525395|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
13441033|NCT00343642|26915545|FG001|Overall Study|Flare up|4|||
13441034|NCT00343642|26915546|FG002|Overall Study|Flare up|0|||
13441035|NCT00343512|26915554|FG000|Overall Study|Withdrawal by Subject|2|||
13441036|NCT00343382|26915581|FG000|Overall Study|Adverse Event|2|||
13441037|NCT00343382|26915582|FG001|Overall Study|Adverse Event|10|||
13441038|NCT00343382|26915583|FG002|Overall Study|Adverse Event|7|||
13441039|NCT00343382|26915581|FG000|Overall Study|Withdrawal by Subject|1|||
13441040|NCT00343382|26915582|FG001|Overall Study|Withdrawal by Subject|2|||
13441041|NCT00343382|26915583|FG002|Overall Study|Withdrawal by Subject|6|||
13441042|NCT00343382|26915581|FG000|Overall Study|Other Reason Not Specified|1|||
13441043|NCT00343382|26915582|FG001|Overall Study|Other Reason Not Specified|2|||
13441044|NCT00343382|26915583|FG002|Overall Study|Other Reason Not Specified|4|||
13441045|NCT00343291|26915604|FG000|Overall Study|Adverse Event|13|||
13441046|NCT00343291|26915605|FG001|Overall Study|Adverse Event|13|||
13441047|NCT00343291|26915604|FG000|Overall Study|Death|3|||
13441048|NCT00343291|26915605|FG001|Overall Study|Death|2|||
13441049|NCT00343291|26915604|FG000|Overall Study|Progressive disease|33|||
13441050|NCT00343291|26915605|FG001|Overall Study|Progressive disease|34|||
13441051|NCT00343291|26915604|FG000|Overall Study|Withdrawal by Subject|0|||
13441052|NCT00343291|26915605|FG001|Overall Study|Withdrawal by Subject|2|||
13441053|NCT00343291|26915604|FG000|Overall Study|Other|8|||
13441054|NCT00343291|26915605|FG001|Overall Study|Other|5|||
13441055|NCT00343252|26915658|FG000|6 Months (All Treated Participants)|Adverse Event|17|||
13441056|NCT00343252|26915659|FG001|6 Months (All Treated Participants)|Adverse Event|11|||
13441057|NCT00343252|26915658|FG000|6 Months (All Treated Participants)|Death|0|||
13441058|NCT00343252|26915659|FG001|6 Months (All Treated Participants)|Death|2|||
13441059|NCT00343252|26915658|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10|||
13441060|NCT00343252|26915659|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8|||
13441061|NCT00343252|26915658|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0|||
13441062|NCT00343252|26915659|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1|||
13441063|NCT00343252|26915658|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0|||
13441064|NCT00343252|26915659|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4|||
13441065|NCT00343252|26915658|FG000|6 Months (All Treated Participants)|Physician Decision|1|||
13441066|NCT00343252|26915659|FG001|6 Months (All Treated Participants)|Physician Decision|3|||
13441067|NCT00343252|26915658|FG000|6 Months (All Treated Participants)|Protocol Violation|2|||
13441068|NCT00343252|26915659|FG001|6 Months (All Treated Participants)|Protocol Violation|2|||
13441069|NCT00343252|26915658|FG000|6 Months (All Treated Participants)|Sponsor Decision|7|||
13441070|NCT00343252|26915659|FG001|6 Months (All Treated Participants)|Sponsor Decision|4|||
13441071|NCT00343252|26915658|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19|||
13441072|NCT00343252|26915659|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9|||
13441073|NCT00343252|26915658|FG000|12 Months (All Treated Participants)|Adverse Event|22|||
13441074|NCT00343252|26915659|FG001|12 Months (All Treated Participants)|Adverse Event|20|||
13441075|NCT00343252|26915658|FG000|12 Months (All Treated Participants)|Death|3|||
13441076|NCT00343252|26915659|FG001|12 Months (All Treated Participants)|Death|3|||
13441077|NCT00343252|26915658|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
13441078|NCT00343252|26915659|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
13441079|NCT00343252|26915658|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1|||
13441080|NCT00343252|26915659|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1|||
13441081|NCT00343252|26915658|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1|||
13441082|NCT00343252|26915659|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5|||
13441083|NCT00343252|26915658|FG000|12 Months (All Treated Participants)|Physician Decision|4|||
13441084|NCT00343252|26915659|FG001|12 Months (All Treated Participants)|Physician Decision|5|||
13441085|NCT00343252|26915658|FG000|12 Months (All Treated Participants)|Protocol Violation|3|||
13441086|NCT00343252|26915659|FG001|12 Months (All Treated Participants)|Protocol Violation|2|||
13441087|NCT00343252|26915658|FG000|12 Months (All Treated Participants)|Sponsor Decision|9|||
13441088|NCT00343252|26915659|FG001|12 Months (All Treated Participants)|Sponsor Decision|6|||
13441089|NCT00343252|26915658|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33|||
13441090|NCT00343252|26915659|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17|||
13441091|NCT00343252|26915658|FG000|18 Months (All Treated Participants)|Adverse Event|31|||
13441092|NCT00343252|26915659|FG001|18 Months (All Treated Participants)|Adverse Event|23|||
13441093|NCT00343252|26915658|FG000|18 Months (All Treated Participants)|Death|4|||
13441094|NCT00343252|26915659|FG001|18 Months (All Treated Participants)|Death|5|||
13441095|NCT00343252|26915658|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11|||
13441096|NCT00343252|26915659|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10|||
13441097|NCT00343252|26915658|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1|||
13441098|NCT00343252|26915659|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1|||
13441099|NCT00343252|26915658|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3|||
13441100|NCT00343252|26915659|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7|||
13441101|NCT00343252|26915658|FG000|18 Months (All Treated Participants)|Physician Decision|4|||
13441102|NCT00343252|26915659|FG001|18 Months (All Treated Participants)|Physician Decision|7|||
13441103|NCT00343252|26915658|FG000|18 Months (All Treated Participants)|Protocol Violation|3|||
13441104|NCT00343252|26915659|FG001|18 Months (All Treated Participants)|Protocol Violation|3|||
13441105|NCT00343252|26915658|FG000|18 Months (All Treated Participants)|Sponsor Decision|8|||
13441106|NCT00343252|26915659|FG001|18 Months (All Treated Participants)|Sponsor Decision|5|||
13441107|NCT00343252|26915658|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36|||
13441108|NCT00343252|26915659|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20|||
13441109|NCT00342628|26915686|FG000|Overall Study|Withdrawal by Subject|19|||
13441110|NCT00342628|26915687|FG001|Overall Study|Withdrawal by Subject|19|||
13441111|NCT00342628|26915688|FG002|Overall Study|Withdrawal by Subject|18|||
13441112|NCT00342628|26915686|FG000|Overall Study|Death|1|||
13441113|NCT00342628|26915687|FG001|Overall Study|Death|1|||
13441114|NCT00342628|26915688|FG002|Overall Study|Death|0|||
13441115|NCT00342628|26915686|FG000|Overall Study|moved residence|0|||
13441116|NCT00342628|26915687|FG001|Overall Study|moved residence|1|||
13441117|NCT00342628|26915688|FG002|Overall Study|moved residence|1|||
13441118|NCT00340834|26915729|FG000|Core Phase of Study|Adverse Event|26|||
13441119|NCT00340834|26915730|FG001|Core Phase of Study|Adverse Event|9|||
13441120|NCT00340834|26915731|FG002|Core Phase of Study|Adverse Event|9|||
13441121|NCT00340834|26915732|FG003|Core Phase of Study|Adverse Event|0|||
13441122|NCT00340834|26915733|FG004|Core Phase of Study|Adverse Event|0|||
13441123|NCT00340834|26915729|FG000|Core Phase of Study|Withdrawal by Subject|11|||
13441124|NCT00340834|26915730|FG001|Core Phase of Study|Withdrawal by Subject|9|||
13441125|NCT00340834|26915731|FG002|Core Phase of Study|Withdrawal by Subject|16|||
13441126|NCT00340834|26915732|FG003|Core Phase of Study|Withdrawal by Subject|0|||
13441127|NCT00340834|26915733|FG004|Core Phase of Study|Withdrawal by Subject|0|||
13441128|NCT00340834|26915729|FG000|Core Phase of Study|Administrative Problems|6|||
13441129|NCT00340834|26915730|FG001|Core Phase of Study|Administrative Problems|2|||
13441130|NCT00340834|26915731|FG002|Core Phase of Study|Administrative Problems|7|||
13441131|NCT00340834|26915732|FG003|Core Phase of Study|Administrative Problems|0|||
13441132|NCT00340834|26915733|FG004|Core Phase of Study|Administrative Problems|0|||
13441133|NCT00340834|26915729|FG000|Core Phase of Study|Lack of Efficacy|3|||
13441134|NCT00340834|26915730|FG001|Core Phase of Study|Lack of Efficacy|3|||
13441135|NCT00340834|26915731|FG002|Core Phase of Study|Lack of Efficacy|7|||
13441136|NCT00340834|26915732|FG003|Core Phase of Study|Lack of Efficacy|0|||
13441137|NCT00340834|26915733|FG004|Core Phase of Study|Lack of Efficacy|0|||
13441138|NCT00340834|26915729|FG000|Core Phase of Study|Abnormal laboratory value(s)|4|||
13441139|NCT00340834|26915730|FG001|Core Phase of Study|Abnormal laboratory value(s)|6|||
13441140|NCT00340834|26915731|FG002|Core Phase of Study|Abnormal laboratory value(s)|1|||
13441141|NCT00340834|26915732|FG003|Core Phase of Study|Abnormal laboratory value(s)|0|||
13441142|NCT00340834|26915733|FG004|Core Phase of Study|Abnormal laboratory value(s)|0|||
13441143|NCT00340834|26915729|FG000|Core Phase of Study|Abnormal test procedure result(s)|4|||
13441144|NCT00340834|26915730|FG001|Core Phase of Study|Abnormal test procedure result(s)|3|||
13441145|NCT00340834|26915731|FG002|Core Phase of Study|Abnormal test procedure result(s)|3|||
13441146|NCT00340834|26915732|FG003|Core Phase of Study|Abnormal test procedure result(s)|0|||
13441147|NCT00340834|26915733|FG004|Core Phase of Study|Abnormal test procedure result(s)|0|||
13441148|NCT00340834|26915729|FG000|Core Phase of Study|Lost to Follow-up|1|||
13441149|NCT00340834|26915730|FG001|Core Phase of Study|Lost to Follow-up|1|||
13441150|NCT00340834|26915731|FG002|Core Phase of Study|Lost to Follow-up|4|||
13441151|NCT00340834|26915732|FG003|Core Phase of Study|Lost to Follow-up|0|||
13441152|NCT00340834|26915733|FG004|Core Phase of Study|Lost to Follow-up|0|||
13441153|NCT00340834|26915729|FG000|Core Phase of Study|Death|2|||
13441154|NCT00340834|26915730|FG001|Core Phase of Study|Death|0|||
13441155|NCT00340834|26915731|FG002|Core Phase of Study|Death|0|||
13441156|NCT00340834|26915732|FG003|Core Phase of Study|Death|0|||
13441157|NCT00340834|26915733|FG004|Core Phase of Study|Death|0|||
13441158|NCT00340834|26915729|FG000|Core Phase of Study|Protocol Violation|0|||
13441159|NCT00340834|26915730|FG001|Core Phase of Study|Protocol Violation|0|||
13441160|NCT00340834|26915731|FG002|Core Phase of Study|Protocol Violation|2|||
13441161|NCT00340834|26915732|FG003|Core Phase of Study|Protocol Violation|0|||
13441162|NCT00340834|26915733|FG004|Core Phase of Study|Protocol Violation|0|||
13441163|NCT00340834|26915729|FG000|Extension Phase of Study|Subject did not receive study drug|0|||
13441164|NCT00340834|26915730|FG001|Extension Phase of Study|Subject did not receive study drug|1|||
13441165|NCT00340834|26915731|FG002|Extension Phase of Study|Subject did not receive study drug|0|||
13441166|NCT00340834|26915732|FG003|Extension Phase of Study|Subject did not receive study drug|2|||
13441167|NCT00340834|26915733|FG004|Extension Phase of Study|Subject did not receive study drug|0|||
13441168|NCT00340834|26915729|FG000|Extension Phase of Study|Subject withdrew consent|26|||
13441169|NCT00340834|26915730|FG001|Extension Phase of Study|Subject withdrew consent|31|||
13441170|NCT00340834|26915731|FG002|Extension Phase of Study|Subject withdrew consent|0|||
13441171|NCT00340834|26915732|FG003|Extension Phase of Study|Subject withdrew consent|12|||
13441172|NCT00340834|26915733|FG004|Extension Phase of Study|Subject withdrew consent|15|||
13441173|NCT00340834|26915729|FG000|Extension Phase of Study|Adverse Event|21|||
13441174|NCT00340834|26915730|FG001|Extension Phase of Study|Adverse Event|22|||
13441175|NCT00340834|26915731|FG002|Extension Phase of Study|Adverse Event|0|||
13441176|NCT00340834|26915732|FG003|Extension Phase of Study|Adverse Event|19|||
13441177|NCT00340834|26915733|FG004|Extension Phase of Study|Adverse Event|7|||
13441178|NCT00340834|26915729|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14|||
13441179|NCT00340834|26915730|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13|||
13441180|NCT00340834|26915731|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0|||
13441181|NCT00340834|26915732|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13|||
13441182|NCT00340834|26915733|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4|||
13441183|NCT00340834|26915729|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13|||
13441184|NCT00340834|26915730|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7|||
13477158|NCT00345839|27005653|FG000|Overall Study|Lost to Follow-up|58|||
13441185|NCT00340834|26915731|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0|||
13441186|NCT00340834|26915732|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4|||
13441187|NCT00340834|26915733|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9|||
13441188|NCT00340834|26915729|FG000|Extension Phase of Study|Lost to Follow-up|1|||
13441189|NCT00340834|26915730|FG001|Extension Phase of Study|Lost to Follow-up|1|||
13441190|NCT00340834|26915731|FG002|Extension Phase of Study|Lost to Follow-up|0|||
13441191|NCT00340834|26915732|FG003|Extension Phase of Study|Lost to Follow-up|2|||
13441192|NCT00340834|26915733|FG004|Extension Phase of Study|Lost to Follow-up|3|||
13441193|NCT00340834|26915729|FG000|Extension Phase of Study|Subject no longer requires study drug|4|||
13441194|NCT00340834|26915730|FG001|Extension Phase of Study|Subject no longer requires study drug|0|||
13441195|NCT00340834|26915731|FG002|Extension Phase of Study|Subject no longer requires study drug|0|||
13441196|NCT00340834|26915732|FG003|Extension Phase of Study|Subject no longer requires study drug|0|||
13441197|NCT00340834|26915733|FG004|Extension Phase of Study|Subject no longer requires study drug|2|||
13441198|NCT00340834|26915729|FG000|Extension Phase of Study|Administrative problems|3|||
13441199|NCT00340834|26915730|FG001|Extension Phase of Study|Administrative problems|0|||
13441200|NCT00340834|26915731|FG002|Extension Phase of Study|Administrative problems|0|||
13441201|NCT00340834|26915732|FG003|Extension Phase of Study|Administrative problems|1|||
13441202|NCT00340834|26915733|FG004|Extension Phase of Study|Administrative problems|1|||
13441203|NCT00340834|26915729|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0|||
13441204|NCT00340834|26915730|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1|||
13441205|NCT00340834|26915731|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0|||
13441206|NCT00340834|26915732|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0|||
13441207|NCT00340834|26915733|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2|||
13441208|NCT00340834|26915729|FG000|Extension Phase of Study|Protocol Violation|3|||
13441209|NCT00340834|26915730|FG001|Extension Phase of Study|Protocol Violation|0|||
13441210|NCT00340834|26915731|FG002|Extension Phase of Study|Protocol Violation|0|||
13441211|NCT00340834|26915732|FG003|Extension Phase of Study|Protocol Violation|0|||
13441212|NCT00340834|26915733|FG004|Extension Phase of Study|Protocol Violation|0|||
13441213|NCT00340834|26915729|FG000|Extension Phase of Study|Death|0|||
13441214|NCT00340834|26915730|FG001|Extension Phase of Study|Death|0|||
13441215|NCT00340834|26915731|FG002|Extension Phase of Study|Death|0|||
13441216|NCT00340834|26915732|FG003|Extension Phase of Study|Death|0|||
13441217|NCT00340834|26915733|FG004|Extension Phase of Study|Death|1|||
13441218|NCT00340704|26915863|FG000|PK Study|Adverse Event|0|||
13441219|NCT00340704|26915864|FG001|PK Study|Adverse Event|1|||
13441220|NCT00340704|26915865|FG002|PK Study|Adverse Event|0|||
13441221|NCT00340704|26915866|FG003|PK Study|Adverse Event|0|||
13441222|NCT00340704|26915867|FG004|PK Study|Adverse Event|0|||
13441223|NCT00340704|26915868|FG005|PK Study|Adverse Event|0|||
13441224|NCT00340704|26915869|FG006|PK Study|Adverse Event|0|||
13441225|NCT00340704|26915870|FG007|PK Study|Adverse Event|0|||
13441226|NCT00340704|26915871|FG008|PK Study|Adverse Event|0|||
13441227|NCT00340704|26915863|FG000|PK Study|Not treated|0|||
13441228|NCT00340704|26915864|FG001|PK Study|Not treated|0|||
13441229|NCT00340704|26915865|FG002|PK Study|Not treated|1|||
13441230|NCT00340704|26915866|FG003|PK Study|Not treated|0|||
13441231|NCT00340704|26915867|FG004|PK Study|Not treated|0|||
13441232|NCT00340704|26915868|FG005|PK Study|Not treated|0|||
13441233|NCT00340704|26915869|FG006|PK Study|Not treated|0|||
13441234|NCT00340704|26915870|FG007|PK Study|Not treated|0|||
13441235|NCT00340704|26915871|FG008|PK Study|Not treated|0|||
13441236|NCT00340704|26915863|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
13441237|NCT00340704|26915864|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
13441238|NCT00340704|26915865|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
13441239|NCT00340704|26915866|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2|||
13441240|NCT00340704|26915867|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4|||
13441241|NCT00340704|26915868|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
13441242|NCT00340704|26915869|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
13441243|NCT00340704|26915870|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
13441244|NCT00340704|26915871|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
13441245|NCT00340704|26915863|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
13441246|NCT00340704|26915864|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
13441247|NCT00340704|26915865|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
13441248|NCT00340704|26915866|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
13441249|NCT00340704|26915867|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
13441250|NCT00340704|26915868|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1|||
13441251|NCT00340704|26915869|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
13441252|NCT00340704|26915870|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
13441253|NCT00340704|26915871|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
13441254|NCT00340704|26915863|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
13477159|NCT00345839|27005654|FG001|Overall Study|Lost to Follow-up|61|||
13441255|NCT00340704|26915864|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
13441256|NCT00340704|26915865|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
13441257|NCT00340704|26915866|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
13441258|NCT00340704|26915867|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1|||
13441259|NCT00340704|26915868|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3|||
13441260|NCT00340704|26915869|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
13441261|NCT00340704|26915870|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
13441262|NCT00340704|26915871|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
13441263|NCT00340704|26915863|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
13441264|NCT00340704|26915864|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
13441265|NCT00340704|26915865|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
13441266|NCT00340704|26915866|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
13441267|NCT00340704|26915867|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
13441268|NCT00340704|26915868|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3|||
13441269|NCT00340704|26915869|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53|||
13441270|NCT00340704|26915870|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11|||
13441271|NCT00340704|26915871|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28|||
13441272|NCT00340678|26915896|FG000|Overall Study|Lost to Follow-up|1|||
13441273|NCT00340678|26915897|FG001|Overall Study|Lost to Follow-up|0|||
13441274|NCT00340678|26915898|FG002|Overall Study|Lost to Follow-up|0|||
13441275|NCT00340678|26915899|FG003|Overall Study|Lost to Follow-up|0|||
13441276|NCT00339833|26915914|FG000|Overall Study|Withdrawal by Subject|1|||
13441277|NCT00339833|26915915|FG001|Overall Study|Withdrawal by Subject|2|||
13441278|NCT00339833|26915914|FG000|Overall Study|toothache|0|||
13441279|NCT00339833|26915915|FG001|Overall Study|toothache|1|||
13441280|NCT00339833|26915914|FG000|Overall Study|indigestion|0|||
13441281|NCT00339833|26915915|FG001|Overall Study|indigestion|1|||
13441282|NCT00339833|26915914|FG000|Overall Study|Chest pain|0|||
13441283|NCT00339833|26915915|FG001|Overall Study|Chest pain|1|||
13441284|NCT00339833|26915914|FG000|Overall Study|minor infection|0|||
13441285|NCT00339833|26915915|FG001|Overall Study|minor infection|1|||
13441286|NCT00339833|26915914|FG000|Overall Study|Poor venous access|2|||
13441287|NCT00339833|26915915|FG001|Overall Study|Poor venous access|2|||
13441288|NCT00339833|26915914|FG000|Overall Study|anaemia or excess drop in glycaemia|2|||
13441289|NCT00339833|26915915|FG001|Overall Study|anaemia or excess drop in glycaemia|0|||
13441290|NCT00339833|26915914|FG000|Overall Study|Error in data records|1|||
13441291|NCT00339833|26915915|FG001|Overall Study|Error in data records|0|||
13441292|NCT00339183|26915948|FG000|Overall Study|Adverse Event|5|||
13441293|NCT00339183|26915949|FG001|Overall Study|Adverse Event|3|||
13441294|NCT00339183|26915948|FG000|Overall Study|Withdrawal by Subject|16|||
13441295|NCT00339183|26915949|FG001|Overall Study|Withdrawal by Subject|19|||
13441296|NCT00339183|26915948|FG000|Overall Study|Physician Decision|2|||
13441297|NCT00339183|26915949|FG001|Overall Study|Physician Decision|4|||
13441298|NCT00339183|26915948|FG000|Overall Study|Lost to Follow-up|17|||
13441299|NCT00339183|26915949|FG001|Overall Study|Lost to Follow-up|17|||
13441300|NCT00339183|26915948|FG000|Overall Study|Protocol-specified criteria|12|||
13441301|NCT00339183|26915949|FG001|Overall Study|Protocol-specified criteria|8|||
13441302|NCT00339183|26915948|FG000|Overall Study|Missing reason|3|||
13441303|NCT00339183|26915949|FG001|Overall Study|Missing reason|1|||
13441304|NCT00339183|26915948|FG000|Overall Study|Other|46|||
13441305|NCT00339183|26915949|FG001|Overall Study|Other|40|||
13441306|NCT00339183|26915948|FG000|Overall Study|Ongoing|20|||
13441307|NCT00339183|26915949|FG001|Overall Study|Ongoing|13|||
13441308|NCT00339144|26916041|FG000|Overall Study|Disease progression|5|||
13441309|NCT00339144|26916042|FG001|Overall Study|Disease progression|2|||
13441310|NCT00339144|26916043|FG002|Overall Study|Disease progression|2|||
13441311|NCT00339144|26916041|FG000|Overall Study|Study drug toxicity|3|||
13441312|NCT00339144|26916042|FG001|Overall Study|Study drug toxicity|1|||
13441313|NCT00339144|26916043|FG002|Overall Study|Study drug toxicity|1|||
13441314|NCT00339144|26916041|FG000|Overall Study|Participant's request to discontinuation|1|||
13441315|NCT00339144|26916042|FG001|Overall Study|Participant's request to discontinuation|0|||
13441316|NCT00339144|26916043|FG002|Overall Study|Participant's request to discontinuation|1|||
13441317|NCT00339040|26916068|FG000|Stage I|Not able to attend clinic|1|||
13441318|NCT00339040|26916069|FG001|Stage I|Not able to attend clinic|0|||
13441319|NCT00339040|26916068|FG000|Stage I|Protocol Violation|1|||
13441320|NCT00339040|26916069|FG001|Stage I|Protocol Violation|1|||
13441321|NCT00339040|26916068|FG000|Stage II|Lost to Follow-up|3|||
13441322|NCT00339040|26916069|FG001|Stage II|Lost to Follow-up|0|||
13441323|NCT00339040|26916068|FG000|Stage II|Withdrawal by Subject|1|||
13441324|NCT00339040|26916069|FG001|Stage II|Withdrawal by Subject|2|||
13441325|NCT00339040|26916068|FG000|Stage II|Protocol Violation|3|||
13441326|NCT00339040|26916069|FG001|Stage II|Protocol Violation|0|||
13441327|NCT00339040|26916068|FG000|Stage II|Not able to attend clinic|1|||
13441328|NCT00339040|26916069|FG001|Stage II|Not able to attend clinic|0|||
13441329|NCT00339040|26916068|FG000|Stage II|Site closing|2|||
13441330|NCT00339040|26916069|FG001|Stage II|Site closing|0|||
13441331|NCT00338962|26916104|FG000|Overall Study|Lost to Follow-up|3|||
13441332|NCT00338962|26916105|FG001|Overall Study|Lost to Follow-up|3|||
13441333|NCT00338962|26916106|FG002|Overall Study|Lost to Follow-up|2|||
13441334|NCT00338962|26916107|FG003|Overall Study|Lost to Follow-up|3|||
13441335|NCT00338962|26916104|FG000|Overall Study|Withdrawal by Subject|1|||
13441336|NCT00338962|26916105|FG001|Overall Study|Withdrawal by Subject|0|||
13441337|NCT00338962|26916106|FG002|Overall Study|Withdrawal by Subject|0|||
13441338|NCT00338962|26916107|FG003|Overall Study|Withdrawal by Subject|0|||
13441339|NCT00338962|26916104|FG000|Overall Study|No Transportation|2|||
13441340|NCT00338962|26916105|FG001|Overall Study|No Transportation|0|||
13441341|NCT00338962|26916106|FG002|Overall Study|No Transportation|0|||
13441342|NCT00338962|26916107|FG003|Overall Study|No Transportation|0|||
13441343|NCT00338962|26916104|FG000|Overall Study|Time Constraint|2|||
13441344|NCT00338962|26916105|FG001|Overall Study|Time Constraint|0|||
13441345|NCT00338962|26916106|FG002|Overall Study|Time Constraint|0|||
13441346|NCT00338962|26916107|FG003|Overall Study|Time Constraint|0|||
13441347|NCT00338962|26916104|FG000|Overall Study|Moved|0|||
13441348|NCT00338962|26916105|FG001|Overall Study|Moved|1|||
13441349|NCT00338962|26916106|FG002|Overall Study|Moved|0|||
13441350|NCT00338962|26916107|FG003|Overall Study|Moved|0|||
13441351|NCT00338962|26916104|FG000|Overall Study|Adverse Event|0|||
13441352|NCT00338962|26916105|FG001|Overall Study|Adverse Event|0|||
13441353|NCT00338962|26916106|FG002|Overall Study|Adverse Event|2|||
13441354|NCT00338962|26916107|FG003|Overall Study|Adverse Event|0|||
13441355|NCT00338962|26916104|FG000|Overall Study|Poor Compliance|0|||
13441356|NCT00338962|26916105|FG001|Overall Study|Poor Compliance|0|||
13441357|NCT00338962|26916106|FG002|Overall Study|Poor Compliance|2|||
13441358|NCT00338962|26916107|FG003|Overall Study|Poor Compliance|0|||
13441359|NCT00338949|26916122|FG000|Subject Screening|Screen failures|11|||
13441360|NCT00338949|26916123|FG001|Subject Screening|Screen failures|11|||
13441361|NCT00338949|26916122|FG000|Randomization|Withdrawal by Subject|1|||
13441362|NCT00338949|26916123|FG001|Randomization|Withdrawal by Subject|0|||
13441363|NCT00338949|26916122|FG000|Randomization|Adverse Event|0|||
13441364|NCT00338949|26916123|FG001|Randomization|Adverse Event|5|||
13441365|NCT00338884|26916157|FG000|Overall Study|Objective Disease Progression or Relapse|44|||
13441366|NCT00338884|26916157|FG000|Overall Study|Adverse Event|14|||
13441367|NCT00338884|26916157|FG000|Overall Study|Death|8|||
13441368|NCT00338884|26916157|FG000|Overall Study|Other|4|||
13441369|NCT00338884|26916157|FG000|Overall Study|Global Deterioration of Health Status|3|||
13441370|NCT00338884|26916157|FG000|Overall Study|Withdrawal by Subject|3|||
13441371|NCT00338884|26916157|FG000|Overall Study|Lost to Follow-up|1|||
13441372|NCT00338884|26916157|FG000|Overall Study|Randomized But Did Not Receive Treatment|1|||
13441373|NCT00338806|26916224|FG000|Acute Phase|Withdrawal by Subject|0|||
13441374|NCT00338806|26916225|FG001|Acute Phase|Withdrawal by Subject|1|||
13441375|NCT00338806|26916224|FG000|Follow-up|Lost to Follow-up|1|||
13441376|NCT00338806|26916225|FG001|Follow-up|Lost to Follow-up|3|||
13441377|NCT00338741|26916240|FG000|Overall Study|Lost to Follow-up|2|||
13441378|NCT00338741|26916241|FG001|Overall Study|Lost to Follow-up|0|||
13441379|NCT00338728|26916248|FG000|Overall Study|Screen Failure|14|||
13441380|NCT00338455|26916267|FG000|Overall Study|Death|2|||
13441381|NCT00338455|26916268|FG001|Overall Study|Death|1|||
13441382|NCT00338455|26916267|FG000|Overall Study|Physician Decision|1|||
13441383|NCT00338455|26916268|FG001|Overall Study|Physician Decision|0|||
13441384|NCT00338286|26916289|FG000|Overall Study|Withdrawal by Subject|50|||
13441385|NCT00338286|26916290|FG001|Overall Study|Withdrawal by Subject|54|||
13441386|NCT00338286|26916289|FG000|Overall Study|Lost to Follow-up|80|||
13441387|NCT00338286|26916290|FG001|Overall Study|Lost to Follow-up|66|||
13441388|NCT00338286|26916289|FG000|Overall Study|Other|103|||
13441389|NCT00338286|26916290|FG001|Overall Study|Other|93|||
13441390|NCT00337935|26916307|FG000|Overall Study|Adverse Event|2|||
13441391|NCT00337935|26916308|FG001|Overall Study|Adverse Event|5|||
13441392|NCT00337935|26916307|FG000|Overall Study|Death|2|||
13441393|NCT00337935|26916308|FG001|Overall Study|Death|8|||
13441394|NCT00337935|26916307|FG000|Overall Study|Physician Decision|1|||
13441395|NCT00337935|26916308|FG001|Overall Study|Physician Decision|1|||
13441396|NCT00337935|26916307|FG000|Overall Study|Lost to Follow-up|0|||
13441397|NCT00337935|26916308|FG001|Overall Study|Lost to Follow-up|1|||
13441398|NCT00337935|26916307|FG000|Overall Study|Protocol Violation|4|||
13441399|NCT00337935|26916308|FG001|Overall Study|Protocol Violation|3|||
13441400|NCT00337935|26916307|FG000|Overall Study|Withdrawal by Subject|1|||
13441401|NCT00337935|26916308|FG001|Overall Study|Withdrawal by Subject|7|||
13441402|NCT00337935|26916307|FG000|Overall Study|Other|0|||
13441403|NCT00337935|26916308|FG001|Overall Study|Other|1|||
13441404|NCT00337935|26916307|FG000|Overall Study|Lack of Efficacy|0|||
13441405|NCT00337935|26916308|FG001|Overall Study|Lack of Efficacy|1|||
13441406|NCT00337818|26916338|FG000|Overall Study|Lost to Follow-up|289|||
13441407|NCT00337818|26916339|FG001|Overall Study|Lost to Follow-up|91|||
13441408|NCT00337818|26916340|FG002|Overall Study|Lost to Follow-up|107|||
13441409|NCT00337779|26916357|FG000|Overall Study|Withdrawal by Subject|10|||
13441410|NCT00337779|26916358|FG001|Overall Study|Withdrawal by Subject|12|||
13441411|NCT00337779|26916357|FG000|Overall Study|Sponsor decision|1|||
13441412|NCT00337779|26916358|FG001|Overall Study|Sponsor decision|1|||
13441413|NCT00337779|26916357|FG000|Overall Study|Physician Decision|3|||
13441414|NCT00337779|26916358|FG001|Overall Study|Physician Decision|6|||
13441415|NCT00337779|26916357|FG000|Overall Study|Protocol Violation|1|||
13441416|NCT00337779|26916358|FG001|Overall Study|Protocol Violation|1|||
13441417|NCT00337779|26916357|FG000|Overall Study|Lost to Follow-up|6|||
13441418|NCT00337779|26916358|FG001|Overall Study|Lost to Follow-up|5|||
13441419|NCT00337779|26916357|FG000|Overall Study|Adverse Event|28|||
13441420|NCT00337779|26916358|FG001|Overall Study|Adverse Event|51|||
13441421|NCT00337779|26916357|FG000|Overall Study|Pregnancy|3|||
13441422|NCT00337779|26916358|FG001|Overall Study|Pregnancy|2|||
13441423|NCT00337779|26916357|FG000|Overall Study|Death|0|||
13441424|NCT00337779|26916358|FG001|Overall Study|Death|1|||
13441425|NCT00337727|26916373|FG000|Overall Study|Adverse Event|5|||
13441426|NCT00337727|26916374|FG001|Overall Study|Adverse Event|3|||
13441427|NCT00337727|26916373|FG000|Overall Study|Lost to Follow-up|5|||
13441428|NCT00337727|26916374|FG001|Overall Study|Lost to Follow-up|4|||
13441429|NCT00337727|26916373|FG000|Overall Study|Physician Decision|1|||
13441430|NCT00337727|26916374|FG001|Overall Study|Physician Decision|0|||
13441431|NCT00337727|26916373|FG000|Overall Study|Protocol Violation|4|||
13441432|NCT00337727|26916374|FG001|Overall Study|Protocol Violation|0|||
13441433|NCT00337727|26916373|FG000|Overall Study|Withdrawal by Subject|3|||
13441434|NCT00337727|26916374|FG001|Overall Study|Withdrawal by Subject|5|||
13441435|NCT00337675|26916398|FG000|Overall Study|Adverse Event|10|||
13441436|NCT00337675|26916399|FG001|Overall Study|Adverse Event|9|||
13441437|NCT00337675|26916400|FG002|Overall Study|Adverse Event|19|||
13441438|NCT00337675|26916398|FG000|Overall Study|Lack of Efficacy|10|||
13441439|NCT00337675|26916399|FG001|Overall Study|Lack of Efficacy|7|||
13441440|NCT00337675|26916400|FG002|Overall Study|Lack of Efficacy|9|||
13441441|NCT00337675|26916398|FG000|Overall Study|Lost to Follow-up|22|||
13441442|NCT00337675|26916399|FG001|Overall Study|Lost to Follow-up|19|||
13441443|NCT00337675|26916400|FG002|Overall Study|Lost to Follow-up|17|||
13441444|NCT00337675|26916398|FG000|Overall Study|Physician Decision|9|||
13441445|NCT00337675|26916399|FG001|Overall Study|Physician Decision|17|||
13441446|NCT00337675|26916400|FG002|Overall Study|Physician Decision|14|||
13441447|NCT00337675|26916398|FG000|Overall Study|Protocol Violation|21|||
13441448|NCT00337675|26916399|FG001|Overall Study|Protocol Violation|24|||
13441449|NCT00337675|26916400|FG002|Overall Study|Protocol Violation|19|||
13441450|NCT00337675|26916398|FG000|Overall Study|Withdrawal by Subject|25|||
13441451|NCT00337675|26916399|FG001|Overall Study|Withdrawal by Subject|25|||
13441452|NCT00337675|26916400|FG002|Overall Study|Withdrawal by Subject|19|||
13441453|NCT00337675|26916398|FG000|Overall Study|Progressive Disease|0|||
13441454|NCT00337675|26916399|FG001|Overall Study|Progressive Disease|2|||
13441455|NCT00337675|26916400|FG002|Overall Study|Progressive Disease|0|||
13441456|NCT00337675|26916398|FG000|Overall Study|Trial Terminated|0|||
13441457|NCT00337675|26916399|FG001|Overall Study|Trial Terminated|0|||
13441458|NCT00337675|26916400|FG002|Overall Study|Trial Terminated|2|||
13441459|NCT00337662|26916463|FG000|Study Period II|Lost to Follow-up|0|||
13441460|NCT00337662|26916464|FG001|Study Period II|Lost to Follow-up|0|||
13441461|NCT00337662|26916465|FG002|Study Period II|Lost to Follow-up|0|||
13441462|NCT00337662|26916466|FG003|Study Period II|Lost to Follow-up|35|||
13441463|NCT00337662|26916463|FG000|Study Period II|Withdrawal by Subject|0|||
13441464|NCT00337662|26916464|FG001|Study Period II|Withdrawal by Subject|0|||
13441465|NCT00337662|26916465|FG002|Study Period II|Withdrawal by Subject|0|||
13441466|NCT00337662|26916466|FG003|Study Period II|Withdrawal by Subject|20|||
13441467|NCT00337662|26916463|FG000|Study Period II|Adverse Event|0|||
13441468|NCT00337662|26916464|FG001|Study Period II|Adverse Event|0|||
13441469|NCT00337662|26916465|FG002|Study Period II|Adverse Event|0|||
13441470|NCT00337662|26916466|FG003|Study Period II|Adverse Event|16|||
13441471|NCT00337662|26916463|FG000|Study Period II|Physician Decision|0|||
13441472|NCT00337662|26916464|FG001|Study Period II|Physician Decision|0|||
13441473|NCT00337662|26916465|FG002|Study Period II|Physician Decision|0|||
13441474|NCT00337662|26916466|FG003|Study Period II|Physician Decision|13|||
13441475|NCT00337662|26916463|FG000|Study Period II|Entry Criteria Not Met|0|||
13441476|NCT00337662|26916464|FG001|Study Period II|Entry Criteria Not Met|0|||
13441477|NCT00337662|26916465|FG002|Study Period II|Entry Criteria Not Met|0|||
13441478|NCT00337662|26916466|FG003|Study Period II|Entry Criteria Not Met|6|||
13441479|NCT00337662|26916463|FG000|Study Period II|Protocol Violation|0|||
13441480|NCT00337662|26916464|FG001|Study Period II|Protocol Violation|0|||
13441481|NCT00337662|26916465|FG002|Study Period II|Protocol Violation|0|||
13441482|NCT00337662|26916466|FG003|Study Period II|Protocol Violation|6|||
13441483|NCT00337662|26916463|FG000|Study Period II|Lack of Efficacy|0|||
13219934|NCT01829113|26278687|FG001|Overall Study|Disease Progression|48|||
13441484|NCT00337662|26916464|FG001|Study Period II|Lack of Efficacy|0|||
13441485|NCT00337662|26916465|FG002|Study Period II|Lack of Efficacy|0|||
13441486|NCT00337662|26916466|FG003|Study Period II|Lack of Efficacy|7|||
13441487|NCT00337662|26916463|FG000|Study Period II|Sponsor Decision|0|||
13441488|NCT00337662|26916464|FG001|Study Period II|Sponsor Decision|0|||
13441489|NCT00337662|26916465|FG002|Study Period II|Sponsor Decision|0|||
13441490|NCT00337662|26916466|FG003|Study Period II|Sponsor Decision|2|||
13441491|NCT00337662|26916463|FG000|Study Period II|Parent/Caregiver Decision|0|||
13441492|NCT00337662|26916464|FG001|Study Period II|Parent/Caregiver Decision|0|||
13441493|NCT00337662|26916465|FG002|Study Period II|Parent/Caregiver Decision|0|||
13441494|NCT00337662|26916466|FG003|Study Period II|Parent/Caregiver Decision|1|||
13441495|NCT00337662|26916463|FG000|Study Period III|Lost to Follow-up|14|||
13441496|NCT00337662|26916464|FG001|Study Period III|Lost to Follow-up|16|||
13441497|NCT00337662|26916465|FG002|Study Period III|Lost to Follow-up|14|||
13441498|NCT00337662|26916466|FG003|Study Period III|Lost to Follow-up|0|||
13441499|NCT00337662|26916463|FG000|Study Period III|Withdrawal by Subject|18|||
13441500|NCT00337662|26916464|FG001|Study Period III|Withdrawal by Subject|14|||
13441501|NCT00337662|26916465|FG002|Study Period III|Withdrawal by Subject|12|||
13441502|NCT00337662|26916466|FG003|Study Period III|Withdrawal by Subject|0|||
13441503|NCT00337662|26916463|FG000|Study Period III|Adverse Event|9|||
13441504|NCT00337662|26916464|FG001|Study Period III|Adverse Event|10|||
13441505|NCT00337662|26916465|FG002|Study Period III|Adverse Event|8|||
13441506|NCT00337662|26916466|FG003|Study Period III|Adverse Event|0|||
13441507|NCT00337662|26916463|FG000|Study Period III|Protocol Violation|3|||
13441508|NCT00337662|26916464|FG001|Study Period III|Protocol Violation|8|||
13441509|NCT00337662|26916465|FG002|Study Period III|Protocol Violation|2|||
13441510|NCT00337662|26916466|FG003|Study Period III|Protocol Violation|0|||
13441511|NCT00337662|26916463|FG000|Study Period III|Physician Decision|6|||
13441512|NCT00337662|26916464|FG001|Study Period III|Physician Decision|5|||
13441513|NCT00337662|26916465|FG002|Study Period III|Physician Decision|0|||
13441514|NCT00337662|26916466|FG003|Study Period III|Physician Decision|0|||
13441515|NCT00337662|26916463|FG000|Study Period III|Entry Criteria Not Met|4|||
13441516|NCT00337662|26916464|FG001|Study Period III|Entry Criteria Not Met|1|||
13441517|NCT00337662|26916465|FG002|Study Period III|Entry Criteria Not Met|3|||
13441518|NCT00337662|26916466|FG003|Study Period III|Entry Criteria Not Met|0|||
13441519|NCT00337662|26916463|FG000|Study Period III|Lack of Efficacy|4|||
13441520|NCT00337662|26916464|FG001|Study Period III|Lack of Efficacy|4|||
13441521|NCT00337662|26916465|FG002|Study Period III|Lack of Efficacy|2|||
13441522|NCT00337662|26916466|FG003|Study Period III|Lack of Efficacy|0|||
13441523|NCT00337662|26916463|FG000|Study Period III|Parent/Caregiver Decision|0|||
13441524|NCT00337662|26916464|FG001|Study Period III|Parent/Caregiver Decision|0|||
13441525|NCT00337662|26916465|FG002|Study Period III|Parent/Caregiver Decision|2|||
13441526|NCT00337662|26916466|FG003|Study Period III|Parent/Caregiver Decision|0|||
13441527|NCT00337662|26916463|FG000|Study Period III|Sponsor Decision|1|||
13441528|NCT00337662|26916464|FG001|Study Period III|Sponsor Decision|0|||
13441529|NCT00337662|26916465|FG002|Study Period III|Sponsor Decision|1|||
13441530|NCT00337662|26916466|FG003|Study Period III|Sponsor Decision|0|||
13441531|NCT00337662|26916463|FG000|Study Period III|Clinical Relapse|1|||
13441532|NCT00337662|26916464|FG001|Study Period III|Clinical Relapse|0|||
13441533|NCT00337662|26916465|FG002|Study Period III|Clinical Relapse|0|||
13441534|NCT00337662|26916466|FG003|Study Period III|Clinical Relapse|0|||
13441535|NCT00337610|26916485|FG000|Overall Study|Adverse Event|2|||
13441536|NCT00337610|26916486|FG001|Overall Study|Adverse Event|2|||
13441537|NCT00337610|26916485|FG000|Overall Study|Death|0|||
13441538|NCT00337610|26916486|FG001|Overall Study|Death|1|||
13441539|NCT00337610|26916485|FG000|Overall Study|Lack of Efficacy|6|||
13441540|NCT00337610|26916486|FG001|Overall Study|Lack of Efficacy|3|||
13441541|NCT00337610|26916485|FG000|Overall Study|Lost to Follow-up|3|||
13441542|NCT00337610|26916486|FG001|Overall Study|Lost to Follow-up|3|||
13441543|NCT00337610|26916485|FG000|Overall Study|Withdrawal by Subject|6|||
13441544|NCT00337610|26916486|FG001|Overall Study|Withdrawal by Subject|5|||
13441545|NCT00337571|26916537|FG000|Overall Study|Lack of Efficacy|3|||
13441546|NCT00337571|26916538|FG001|Overall Study|Lack of Efficacy|0|||
13441547|NCT00337571|26916539|FG002|Overall Study|Lack of Efficacy|0|||
13441548|NCT00337571|26916540|FG003|Overall Study|Lack of Efficacy|0|||
13441549|NCT00337571|26916537|FG000|Overall Study|Adverse Event|4|||
13441550|NCT00337571|26916538|FG001|Overall Study|Adverse Event|5|||
13441551|NCT00337571|26916539|FG002|Overall Study|Adverse Event|8|||
13441552|NCT00337571|26916540|FG003|Overall Study|Adverse Event|4|||
13441553|NCT00337571|26916537|FG000|Overall Study|Withdrawal by Subject|2|||
13441554|NCT00337571|26916538|FG001|Overall Study|Withdrawal by Subject|2|||
13441555|NCT00337571|26916539|FG002|Overall Study|Withdrawal by Subject|1|||
13441556|NCT00337571|26916540|FG003|Overall Study|Withdrawal by Subject|0|||
13441557|NCT00337571|26916537|FG000|Overall Study|Lost to Follow-up|3|||
13441558|NCT00337571|26916538|FG001|Overall Study|Lost to Follow-up|1|||
13441559|NCT00337571|26916539|FG002|Overall Study|Lost to Follow-up|0|||
13441560|NCT00337571|26916540|FG003|Overall Study|Lost to Follow-up|1|||
13441561|NCT00337571|26916537|FG000|Overall Study|Poor/noncompliance|1|||
13441562|NCT00337571|26916538|FG001|Overall Study|Poor/noncompliance|1|||
13441563|NCT00337571|26916539|FG002|Overall Study|Poor/noncompliance|1|||
13441564|NCT00337571|26916540|FG003|Overall Study|Poor/noncompliance|1|||
13441565|NCT00337571|26916537|FG000|Overall Study|No longer met study criteria|1|||
13441566|NCT00337571|26916538|FG001|Overall Study|No longer met study criteria|0|||
13441567|NCT00337571|26916539|FG002|Overall Study|No longer met study criteria|0|||
13441568|NCT00337571|26916540|FG003|Overall Study|No longer met study criteria|0|||
13441569|NCT00337571|26916537|FG000|Overall Study|High Potassium level|0|||
13441570|NCT00337571|26916538|FG001|Overall Study|High Potassium level|0|||
13441571|NCT00337571|26916539|FG002|Overall Study|High Potassium level|0|||
13441572|NCT00337571|26916540|FG003|Overall Study|High Potassium level|1|||
13441573|NCT00337467|26916559|FG000|Overall Study|Adverse Event|3|||
13441574|NCT00337467|26916559|FG000|Overall Study|Subject Withdrew Consent|2|||
13441575|NCT00337467|26916559|FG000|Overall Study|Pregnancy|1|||
13441576|NCT00337467|26916559|FG000|Overall Study|Lost to Follow-up|2|||
13441577|NCT00337467|26916559|FG000|Overall Study|Subject No Longer Met Study Criteria|2|||
13441578|NCT00337428|26916604|FG000|Overall Study|Withdrawal by Subject|1|||
13441579|NCT00337428|26916605|FG001|Overall Study|Withdrawal by Subject|2|||
13441580|NCT00337428|26916604|FG000|Overall Study|Lack of Time|1|||
13441581|NCT00337428|26916605|FG001|Overall Study|Lack of Time|1|||
13441582|NCT00337428|26916604|FG000|Overall Study|Unwilling to Continue|1|||
13441583|NCT00337428|26916605|FG001|Overall Study|Unwilling to Continue|0|||
13441584|NCT00337428|26916604|FG000|Overall Study|Anorexia|1|||
13441585|NCT00337428|26916605|FG001|Overall Study|Anorexia|0|||
13441586|NCT00337285|26916613|FG000|Overall Study|Withdrawal by Subject|42|||
13441587|NCT00337285|26916613|FG000|Overall Study|Lost to Follow-up|41|||
13441588|NCT00337285|26916613|FG000|Overall Study|Adverse Event|28|||
13441589|NCT00337285|26916613|FG000|Overall Study|Protocol Violation|27|||
13441590|NCT00337285|26916613|FG000|Overall Study|Lack of Efficacy|11|||
13441591|NCT00337285|26916613|FG000|Overall Study|Death|1|||
13441592|NCT00337285|26916613|FG000|Overall Study|Physician Decision|1|||
13441593|NCT00337285|26916613|FG000|Overall Study|Lack of protocol compliance|7|||
13441594|NCT00337272|26916640|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2|||
13441595|NCT00337272|26916641|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0|||
13441596|NCT00337272|26916640|FG000|Screening Period (Pre-randomization)|Non-compliance|1|||
13441597|NCT00337272|26916641|FG001|Screening Period (Pre-randomization)|Non-compliance|0|||
13441598|NCT00337272|26916640|FG000|Screening Period (Pre-randomization)|Screen failure|3|||
13441599|NCT00337272|26916641|FG001|Screening Period (Pre-randomization)|Screen failure|0|||
13441600|NCT00337272|26916640|FG000|Treatment Period|Non-compliance|1|||
13441601|NCT00337272|26916641|FG001|Treatment Period|Non-compliance|1|||
13441602|NCT00337272|26916640|FG000|Treatment Period|Withdrawal by Subject|0|||
13441603|NCT00337272|26916641|FG001|Treatment Period|Withdrawal by Subject|1|||
13441604|NCT00337272|26916640|FG000|Withdrawal Period|Non-compliance|0|||
13441605|NCT00337272|26916641|FG001|Withdrawal Period|Non-compliance|1|||
13441606|NCT00337207|26916649|FG000|Overall Study|Withdrawal by Subject|3|||
13441607|NCT00337194|26916671|FG000|Overall Study|Adverse Event|5|||
13441608|NCT00337194|26916672|FG001|Overall Study|Adverse Event|1|||
13441609|NCT00337194|26916671|FG000|Overall Study|Death|2|||
13441610|NCT00337194|26916672|FG001|Overall Study|Death|0|||
13441611|NCT00337194|26916671|FG000|Overall Study|Withdrawal by Subject|1|||
13441612|NCT00337194|26916672|FG001|Overall Study|Withdrawal by Subject|0|||
13441613|NCT00337194|26916671|FG000|Overall Study|Disease progression|1|||
13441614|NCT00337194|26916672|FG001|Overall Study|Disease progression|2|||
13441615|NCT00337194|26916671|FG000|Overall Study|Subsequent non-protocol therapy|3|||
13441616|NCT00337194|26916672|FG001|Overall Study|Subsequent non-protocol therapy|1|||
13441617|NCT00337168|26916681|FG000|Overall Study|Death|5|||
13441618|NCT00337168|26916681|FG000|Overall Study|Not protocol specified|2|||
13441619|NCT00337168|26916681|FG000|Overall Study|Did not start therapy|1|||
13441620|NCT00337129|26916690|FG000|Overall Study|Adverse Event|4|||
13441621|NCT00337129|26916690|FG000|Overall Study|Withdrawal by Subject|1|||
13441622|NCT00337129|26916690|FG000|Overall Study|Lack of Efficacy|32|||
13441623|NCT00337129|26916690|FG000|Overall Study|Death|2|||
13441624|NCT00337129|26916690|FG000|Overall Study|not protocol specified|1|||
13441625|NCT00337103|26916728|FG000|Overall Study|Progressive Disease|414|||
13441626|NCT00337103|26916729|FG001|Overall Study|Progressive Disease|410|||
13441627|NCT00337103|26916728|FG000|Overall Study|Adverse Event|45|||
13441628|NCT00337103|26916729|FG001|Overall Study|Adverse Event|59|||
13441629|NCT00337103|26916728|FG000|Overall Study|Subject Choice|34|||
13441630|NCT00337103|26916729|FG001|Overall Study|Subject Choice|27|||
13441631|NCT00337103|26916728|FG000|Overall Study|Clinical Progression|27|||
13441632|NCT00337103|26916729|FG001|Overall Study|Clinical Progression|24|||
13441633|NCT00337103|26916728|FG000|Overall Study|Physician Decision|15|||
13441634|NCT00337103|26916729|FG001|Overall Study|Physician Decision|14|||
13441635|NCT00337103|26916728|FG000|Overall Study|Withdrawal by Subject|8|||
13441636|NCT00337103|26916729|FG001|Overall Study|Withdrawal by Subject|5|||
13441637|NCT00337103|26916728|FG000|Overall Study|Other|5|||
13441638|NCT00337103|26916729|FG001|Overall Study|Other|6|||
13441639|NCT00337103|26916728|FG000|Overall Study|Entry Criteria Not Met|4|||
13441640|NCT00337103|26916729|FG001|Overall Study|Entry Criteria Not Met|1|||
13441641|NCT00337103|26916728|FG000|Overall Study|Lost to Follow-up|1|||
13441642|NCT00337103|26916729|FG001|Overall Study|Lost to Follow-up|2|||
13441643|NCT00337103|26916728|FG000|Overall Study|Death|1|||
13441644|NCT00337103|26916729|FG001|Overall Study|Death|0|||
13441645|NCT00337077|26916748|FG000|Overall Study|Progressive disease|25|||
13441646|NCT00337077|26916749|FG001|Overall Study|Progressive disease|37|||
13441647|NCT00337077|26916750|FG002|Overall Study|Progressive disease|19|||
13441648|NCT00337077|26916748|FG000|Overall Study|Adverse Event|7|||
13441649|NCT00337077|26916749|FG001|Overall Study|Adverse Event|7|||
13441650|NCT00337077|26916750|FG002|Overall Study|Adverse Event|1|||
13441651|NCT00337077|26916748|FG000|Overall Study|Death|0|||
13441652|NCT00337077|26916749|FG001|Overall Study|Death|1|||
13441653|NCT00337077|26916750|FG002|Overall Study|Death|0|||
13441654|NCT00337077|26916748|FG000|Overall Study|Withdrawal by Subject|7|||
13441655|NCT00337077|26916749|FG001|Overall Study|Withdrawal by Subject|2|||
13441656|NCT00337077|26916750|FG002|Overall Study|Withdrawal by Subject|2|||
13441657|NCT00337077|26916748|FG000|Overall Study|Alternative therapy|1|||
13441658|NCT00337077|26916749|FG001|Overall Study|Alternative therapy|0|||
13441659|NCT00337077|26916750|FG002|Overall Study|Alternative therapy|0|||
13441660|NCT00337077|26916748|FG000|Overall Study|Physician Decision|1|||
13441661|NCT00337077|26916749|FG001|Overall Study|Physician Decision|4|||
13441662|NCT00337077|26916750|FG002|Overall Study|Physician Decision|2|||
13441663|NCT00337077|26916748|FG000|Overall Study|Never started treatment|1|||
13441664|NCT00337077|26916749|FG001|Overall Study|Never started treatment|1|||
13441665|NCT00337077|26916750|FG002|Overall Study|Never started treatment|0|||
13441666|NCT00337077|26916748|FG000|Overall Study|Ineligible|1|||
13441667|NCT00337077|26916749|FG001|Overall Study|Ineligible|1|||
13441668|NCT00337077|26916750|FG002|Overall Study|Ineligible|1|||
13441669|NCT00336895|26916758|FG000|Overall Study|diarrhea|1|||
13441670|NCT00336895|26916758|FG000|Overall Study|nausea and upset stomach|1|||
13441671|NCT00336895|26916758|FG000|Overall Study|Physician Decision|1|||
13441672|NCT00336895|26916758|FG000|Overall Study|screen failed|1|||
13441673|NCT00336856|26916766|FG000|Overall Study|Withdrawal by Subject|3|||
13441674|NCT00336856|26916766|FG000|Overall Study|Found ineligible at time of analysis|1|||
13441675|NCT00336583|26916773|FG000|Overall Study|Lost to Follow-up|1|||
13441676|NCT00336583|26916773|FG000|Overall Study|Death|1|||
13441677|NCT00336544|26916792|FG000|Overall Study|Lack of Efficacy|8|||
13441678|NCT00336544|26916793|FG001|Overall Study|Lack of Efficacy|5|||
13441679|NCT00336544|26916792|FG000|Overall Study|Adverse Event|4|||
13441680|NCT00336544|26916793|FG001|Overall Study|Adverse Event|9|||
13441681|NCT00336544|26916792|FG000|Overall Study|Withdrawal by Subject|4|||
13441682|NCT00336544|26916793|FG001|Overall Study|Withdrawal by Subject|3|||
13441683|NCT00336544|26916792|FG000|Overall Study|Other|3|||
13441684|NCT00336544|26916793|FG001|Overall Study|Other|5|||
13441685|NCT00336505|26916812|FG000|Overall Study|Adverse Event|10|||
13441686|NCT00336505|26916813|FG001|Overall Study|Adverse Event|9|||
13441687|NCT00336505|26916812|FG000|Overall Study|Lack of Efficacy|8|||
13441688|NCT00336505|26916813|FG001|Overall Study|Lack of Efficacy|4|||
13441689|NCT00336505|26916812|FG000|Overall Study|Lost to Follow-up|7|||
13441690|NCT00336505|26916813|FG001|Overall Study|Lost to Follow-up|4|||
13441691|NCT00336505|26916812|FG000|Overall Study|Withdrawal by Subject|5|||
13441692|NCT00336505|26916813|FG001|Overall Study|Withdrawal by Subject|3|||
13441693|NCT00336505|26916812|FG000|Overall Study|Other|7|||
13441694|NCT00336505|26916813|FG001|Overall Study|Other|7|||
13441695|NCT00336492|26916831|FG000|Overall Study|Adverse Event|4|||
13441696|NCT00336492|26916832|FG001|Overall Study|Adverse Event|3|||
13441697|NCT00336492|26916833|FG002|Overall Study|Adverse Event|6|||
13441698|NCT00336492|26916831|FG000|Overall Study|Lack of Efficacy|6|||
13441699|NCT00336492|26916832|FG001|Overall Study|Lack of Efficacy|1|||
13441700|NCT00336492|26916833|FG002|Overall Study|Lack of Efficacy|4|||
13441701|NCT00336492|26916831|FG000|Overall Study|Other|5|||
13441702|NCT00336492|26916832|FG001|Overall Study|Other|0|||
13441703|NCT00336492|26916833|FG002|Overall Study|Other|1|||
13441704|NCT00336479|26916869|FG000|Overall Study|Adverse Event|8|||
13441705|NCT00336479|26916870|FG001|Overall Study|Adverse Event|11|||
13441706|NCT00336479|26916871|FG002|Overall Study|Adverse Event|18|||
13441707|NCT00336479|26916872|FG003|Overall Study|Adverse Event|4|||
13441708|NCT00336479|26916869|FG000|Overall Study|Noncompliant|1|||
13441709|NCT00336479|26916870|FG001|Overall Study|Noncompliant|7|||
13441710|NCT00336479|26916871|FG002|Overall Study|Noncompliant|3|||
13441711|NCT00336479|26916872|FG003|Overall Study|Noncompliant|0|||
13441712|NCT00336479|26916869|FG000|Overall Study|Physician Decision|2|||
13441713|NCT00336479|26916870|FG001|Overall Study|Physician Decision|3|||
13441714|NCT00336479|26916871|FG002|Overall Study|Physician Decision|1|||
13441715|NCT00336479|26916872|FG003|Overall Study|Physician Decision|0|||
13441716|NCT00336479|26916869|FG000|Overall Study|Lost to Follow-up|3|||
13441717|NCT00336479|26916870|FG001|Overall Study|Lost to Follow-up|2|||
13441718|NCT00336479|26916871|FG002|Overall Study|Lost to Follow-up|0|||
13441719|NCT00336479|26916872|FG003|Overall Study|Lost to Follow-up|0|||
13441720|NCT00336479|26916869|FG000|Overall Study|Withdrawal by Subject|3|||
13441721|NCT00336479|26916870|FG001|Overall Study|Withdrawal by Subject|2|||
13441722|NCT00336479|26916871|FG002|Overall Study|Withdrawal by Subject|3|||
13441723|NCT00336479|26916872|FG003|Overall Study|Withdrawal by Subject|0|||
13441724|NCT00336479|26916869|FG000|Overall Study|Other|0|||
13441725|NCT00336479|26916870|FG001|Overall Study|Other|0|||
13441726|NCT00336479|26916871|FG002|Overall Study|Other|1|||
13441727|NCT00336479|26916872|FG003|Overall Study|Other|0|||
13441728|NCT00336479|26916869|FG000|Overall Study|Virologic Stopping Rule|20|||
13441729|NCT00336479|26916870|FG001|Overall Study|Virologic Stopping Rule|0|||
13441730|NCT00336479|26916871|FG002|Overall Study|Virologic Stopping Rule|0|||
13441731|NCT00336479|26916872|FG003|Overall Study|Virologic Stopping Rule|0|||
13441732|NCT00336284|26916891|FG000|Overall Study|Death|52|||
13441733|NCT00336284|26916892|FG001|Overall Study|Death|26|||
13441734|NCT00336284|26916891|FG000|Overall Study|Lost to Follow-up|82|||
13441735|NCT00336284|26916892|FG001|Overall Study|Lost to Follow-up|61|||
13441736|NCT00336284|26916891|FG000|Overall Study|Withdrawal by Physician or Subject|102|||
13441737|NCT00336284|26916892|FG001|Overall Study|Withdrawal by Physician or Subject|64|||
13441738|NCT00336024|26916933|FG000|Overall Study|Death|2|||
13441739|NCT00336024|26916934|FG001|Overall Study|Death|1|||
13441740|NCT00336024|26916933|FG000|Overall Study|Physician Decision|4|||
13441741|NCT00336024|26916934|FG001|Overall Study|Physician Decision|1|||
13441742|NCT00336024|26916933|FG000|Overall Study|Protocol Violation|1|||
13441743|NCT00336024|26916934|FG001|Overall Study|Protocol Violation|0|||
13441744|NCT00336024|26916933|FG000|Overall Study|Withdrawal by Subject|1|||
13441745|NCT00336024|26916934|FG001|Overall Study|Withdrawal by Subject|2|||
13441746|NCT00336024|26916933|FG000|Overall Study|Failure to fulfill consolidation|1|||
13441747|NCT00336024|26916934|FG001|Overall Study|Failure to fulfill consolidation|1|||
13441748|NCT00336024|26916933|FG000|Overall Study|Progressive Disease|4|||
13441749|NCT00336024|26916934|FG001|Overall Study|Progressive Disease|7|||
13441750|NCT00336024|26916933|FG000|Overall Study|Ineligible|7|||
13441751|NCT00336024|26916934|FG001|Overall Study|Ineligible|7|||
13441752|NCT00335972|26916951|FG000|Overall Study|not given treatments|0|||
13441753|NCT00335972|26916952|FG001|Overall Study|not given treatments|3|||
13441754|NCT00335959|26916959|FG000|Overall Study|Adverse Event|2|||
13441755|NCT00335959|26916959|FG000|Overall Study|Ineligible|1|||
13441756|NCT00335829|26916975|FG000|Overall Study|Withdrawal by Subject|1|||
13441757|NCT00335829|26916975|FG000|Overall Study|Lost to Follow-up|1|||
13441758|NCT00335829|26916975|FG000|Overall Study|Adverse Event|1|||
13441759|NCT00335764|26917038|FG000|Overall Study|wrong histology|1|||
13441760|NCT00335764|26917039|FG001|Overall Study|wrong histology|0|||
13441761|NCT00335764|26917040|FG002|Overall Study|wrong histology|0|||
13441762|NCT00335764|26917041|FG003|Overall Study|wrong histology|0|||
13441763|NCT00335764|26917042|FG004|Overall Study|wrong histology|1|||
13441764|NCT00335738|26917064|FG000|Overall Study|Physician Decision|6|||
13441765|NCT00335738|26917065|FG001|Overall Study|Physician Decision|0|||
13441766|NCT00335738|26917064|FG000|Overall Study|Withdrawal by Subject|2|||
13441767|NCT00335738|26917065|FG001|Overall Study|Withdrawal by Subject|0|||
13441768|NCT00335738|26917064|FG000|Overall Study|Ineligible|3|||
13441769|NCT00335738|26917065|FG001|Overall Study|Ineligible|4|||
13441770|NCT00335556|26917105|FG000|Overall Study|Death|0|||
13441771|NCT00335556|26917106|FG001|Overall Study|Death|5|||
13441772|NCT00335556|26917107|FG002|Overall Study|Death|0|||
13441773|NCT00335556|26917108|FG003|Overall Study|Death|0|||
13441774|NCT00335556|26917109|FG004|Overall Study|Death|1|||
13441775|NCT00335556|26917110|FG005|Overall Study|Death|0|||
13441776|NCT00335556|26917105|FG000|Overall Study|Lack of Efficacy|0|||
13441777|NCT00335556|26917106|FG001|Overall Study|Lack of Efficacy|19|||
13441778|NCT00335556|26917107|FG002|Overall Study|Lack of Efficacy|3|||
13441779|NCT00335556|26917108|FG003|Overall Study|Lack of Efficacy|3|||
13441780|NCT00335556|26917109|FG004|Overall Study|Lack of Efficacy|0|||
13441781|NCT00335556|26917110|FG005|Overall Study|Lack of Efficacy|1|||
13441782|NCT00335556|26917105|FG000|Overall Study|Physician Decision|0|||
13441783|NCT00335556|26917106|FG001|Overall Study|Physician Decision|6|||
13441784|NCT00335556|26917107|FG002|Overall Study|Physician Decision|2|||
13441785|NCT00335556|26917108|FG003|Overall Study|Physician Decision|1|||
13441786|NCT00335556|26917109|FG004|Overall Study|Physician Decision|0|||
13441787|NCT00335556|26917110|FG005|Overall Study|Physician Decision|0|||
13441788|NCT00335556|26917105|FG000|Overall Study|Ineligible|2|||
13441789|NCT00335556|26917106|FG001|Overall Study|Ineligible|0|||
13441790|NCT00335556|26917107|FG002|Overall Study|Ineligible|0|||
13441791|NCT00335556|26917108|FG003|Overall Study|Ineligible|0|||
13441792|NCT00335556|26917109|FG004|Overall Study|Ineligible|0|||
13441793|NCT00335556|26917110|FG005|Overall Study|Ineligible|0|||
13441794|NCT00335556|26917105|FG000|Overall Study|Refusal of further protocol therapy|0|||
13441795|NCT00335556|26917106|FG001|Overall Study|Refusal of further protocol therapy|4|||
13441796|NCT00335556|26917107|FG002|Overall Study|Refusal of further protocol therapy|0|||
13441797|NCT00335556|26917108|FG003|Overall Study|Refusal of further protocol therapy|1|||
13441798|NCT00335556|26917109|FG004|Overall Study|Refusal of further protocol therapy|0|||
13441799|NCT00335556|26917110|FG005|Overall Study|Refusal of further protocol therapy|0|||
13441800|NCT00335452|26917145|FG000|Overall Study|Death|156|||
13441801|NCT00335452|26917146|FG001|Overall Study|Death|144|||
13441802|NCT00335452|26917147|FG002|Overall Study|Death|158|||
13441803|NCT00335452|26917148|FG003|Overall Study|Death|129|||
13441804|NCT00335452|26917145|FG000|Overall Study|Lost to Follow-up|2|||
13441805|NCT00335452|26917146|FG001|Overall Study|Lost to Follow-up|3|||
13441806|NCT00335452|26917147|FG002|Overall Study|Lost to Follow-up|1|||
13441807|NCT00335452|26917148|FG003|Overall Study|Lost to Follow-up|2|||
13441808|NCT00335322|26917169|FG000|Overall Study|Randomised but withdrew prior to ART sta|1|||
13441809|NCT00335322|26917170|FG001|Overall Study|Randomised but withdrew prior to ART sta|2|||
13441810|NCT00335322|26917171|FG002|Overall Study|Randomised but withdrew prior to ART sta|2|||
13441811|NCT00335153|26917210|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5|||
13441812|NCT00335153|26917210|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5|||
13441813|NCT00335153|26917210|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12|||
13441814|NCT00335153|26917210|FG000|Nasojejunal (NJ) Test Period|Administrative|1|||
13441815|NCT00335153|26917210|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7|||
13441816|NCT00335153|26917210|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22|||
13441817|NCT00335153|26917210|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2|||
13441818|NCT00335153|26917210|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13|||
13441819|NCT00335153|26917210|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13|||
13441820|NCT00335153|26917210|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2|||
13441821|NCT00335140|26917216|FG000|Overall Study|Ineligible|1|||
13441822|NCT00334958|26917235|FG000|Overall Study|Medication Noncompliance|0|||
13441823|NCT00334958|26917236|FG001|Overall Study|Medication Noncompliance|3|||
13441824|NCT00334958|26917235|FG000|Overall Study|Protocol Violation|2|||
13441825|NCT00334958|26917236|FG001|Overall Study|Protocol Violation|2|||
13441826|NCT00334958|26917235|FG000|Overall Study|Request of the investigator or sponsor|0|||
13441827|NCT00334958|26917236|FG001|Overall Study|Request of the investigator or sponsor|1|||
13441828|NCT00334958|26917235|FG000|Overall Study|Withdrawal by Subject|7|||
13441829|NCT00334958|26917236|FG001|Overall Study|Withdrawal by Subject|4|||
13441830|NCT00334958|26917235|FG000|Overall Study|Adverse Event|27|||
13441831|NCT00334958|26917236|FG001|Overall Study|Adverse Event|12|||
13441832|NCT00334958|26917235|FG000|Overall Study|Other|1|||
13441833|NCT00334958|26917236|FG001|Overall Study|Other|2|||
13441834|NCT00334893|26917251|FG000|Overall Study|Not Treated|1|||
13441835|NCT00334893|26917252|FG001|Overall Study|Not Treated|0|||
13441836|NCT00334815|26917271|FG000|Overall Study|Adverse Event|3|||
13441837|NCT00334815|26917272|FG001|Overall Study|Adverse Event|2|||
13441838|NCT00334815|26917271|FG000|Overall Study|Death|0|||
13441839|NCT00334815|26917272|FG001|Overall Study|Death|2|||
13441840|NCT00334815|26917271|FG000|Overall Study|Progression|1|||
13441841|NCT00334815|26917272|FG001|Overall Study|Progression|0|||
13441842|NCT00334815|26917271|FG000|Overall Study|ineligible|1|||
13441843|NCT00334815|26917272|FG001|Overall Study|ineligible|1|||
13441844|NCT00334815|26917271|FG000|Overall Study|patient refused treatment|0|||
13441845|NCT00334815|26917272|FG001|Overall Study|patient refused treatment|1|||
13441846|NCT00334815|26917271|FG000|Overall Study|Physician Decision|2|||
13441847|NCT00334815|26917272|FG001|Overall Study|Physician Decision|4|||
13441848|NCT00334802|26917296|FG000|Overall Study|Progressive Disease|2|||
13441849|NCT00334802|26917297|FG001|Overall Study|Progressive Disease|24|||
13441850|NCT00334802|26917296|FG000|Overall Study|Toxicity|1|||
13441851|NCT00334802|26917297|FG001|Overall Study|Toxicity|5|||
13441852|NCT00334802|26917296|FG000|Overall Study|Lack of Efficacy|1|||
13441853|NCT00334802|26917297|FG001|Overall Study|Lack of Efficacy|3|||
13441854|NCT00334802|26917296|FG000|Overall Study|Patient Condition Aggrevated|1|||
13441855|NCT00334802|26917297|FG001|Overall Study|Patient Condition Aggrevated|0|||
13441856|NCT00334802|26917296|FG000|Overall Study|Physician Decision|1|||
13441857|NCT00334802|26917297|FG001|Overall Study|Physician Decision|0|||
13441858|NCT00334802|26917296|FG000|Overall Study|Withdrawal by Subject|0|||
13441859|NCT00334802|26917297|FG001|Overall Study|Withdrawal by Subject|4|||
13441860|NCT00334802|26917296|FG000|Overall Study|Adverse Event|0|||
13441861|NCT00334802|26917297|FG001|Overall Study|Adverse Event|3|||
13441862|NCT00334802|26917296|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0|||
13441863|NCT00334802|26917297|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1|||
13441864|NCT00334737|26917339|FG000|Hospital Phase|Death|1|||
13441865|NCT00334737|26917340|FG001|Hospital Phase|Death|2|||
13441866|NCT00334737|26917341|FG002|Hospital Phase|Death|3|||
13441867|NCT00334737|26917339|FG000|Hospital Phase|Withdrawal by Subject|0|||
13441868|NCT00334737|26917340|FG001|Hospital Phase|Withdrawal by Subject|0|||
13441869|NCT00334737|26917341|FG002|Hospital Phase|Withdrawal by Subject|1|||
13441870|NCT00334737|26917339|FG000|Hospital Phase|Did not receive study drug|1|||
13441871|NCT00334737|26917340|FG001|Hospital Phase|Did not receive study drug|0|||
13441872|NCT00334737|26917341|FG002|Hospital Phase|Did not receive study drug|0|||
13441873|NCT00334737|26917339|FG000|Follow up Phase|Lost to Follow-up|5|||
13441874|NCT00334737|26917340|FG001|Follow up Phase|Lost to Follow-up|3|||
13441875|NCT00334737|26917341|FG002|Follow up Phase|Lost to Follow-up|6|||
13441876|NCT00334542|26917350|FG000|Overall Study|Adverse Event|3|||
13441877|NCT00334542|26917350|FG000|Overall Study|Withdrawal by Subject|1|||
13441878|NCT00334542|26917350|FG000|Overall Study|New cancer diagnosis|1|||
13441879|NCT00334295|26917360|FG000|Overall Study|Patients received fewer than 3 injection|5|||
13441880|NCT00334282|26917390|FG000|Overall Study|Lost to Follow-up|11|||
13441881|NCT00334282|26917391|FG001|Overall Study|Lost to Follow-up|5|||
13441882|NCT00334282|26917390|FG000|Overall Study|Withdrawal by Subject|17|||
13441883|NCT00334282|26917391|FG001|Overall Study|Withdrawal by Subject|3|||
13441884|NCT00334282|26917390|FG000|Overall Study|Death|194|||
13441885|NCT00334282|26917391|FG001|Overall Study|Death|100|||
13441886|NCT00334113|26917404|FG000|Overall Study|Lost to Follow-up|2|||
13441887|NCT00334113|26917405|FG001|Overall Study|Lost to Follow-up|2|||
13441888|NCT00334113|26917404|FG000|Overall Study|Withdrawal by Subject|0|||
13441889|NCT00334113|26917405|FG001|Overall Study|Withdrawal by Subject|1|||
13441890|NCT00333983|26917423|FG000|Overall Study|Lost to Follow-up|2|||
13441891|NCT00333983|26917424|FG001|Overall Study|Lost to Follow-up|1|||
13441892|NCT00333983|26917425|FG002|Overall Study|Lost to Follow-up|0|||
13441893|NCT00333983|26917423|FG000|Overall Study|Adverse Event|1|||
13441894|NCT00333983|26917424|FG001|Overall Study|Adverse Event|1|||
13441895|NCT00333983|26917425|FG002|Overall Study|Adverse Event|1|||
13441896|NCT00333983|26917423|FG000|Overall Study|Withdrawal by Subject|0|||
13441897|NCT00333983|26917424|FG001|Overall Study|Withdrawal by Subject|3|||
13441898|NCT00333983|26917425|FG002|Overall Study|Withdrawal by Subject|1|||
13441899|NCT00333970|26917438|FG000|Overall Study|Withdrawal by Subject|13|||
13441900|NCT00333970|26917439|FG001|Overall Study|Withdrawal by Subject|7|||
13441901|NCT00333866|26917510|FG000|Overall Study|Adverse Event|23|||
13441902|NCT00333866|26917511|FG001|Overall Study|Adverse Event|37|||
13441903|NCT00333866|26917512|FG002|Overall Study|Adverse Event|38|||
13441904|NCT00333866|26917513|FG003|Overall Study|Adverse Event|47|||
13441905|NCT00333866|26917510|FG000|Overall Study|Other|3|||
13441906|NCT00333866|26917511|FG001|Overall Study|Other|2|||
13441907|NCT00333866|26917512|FG002|Overall Study|Other|2|||
13441908|NCT00333866|26917513|FG003|Overall Study|Other|2|||
13441909|NCT00333866|26917510|FG000|Overall Study|Lack of Efficacy|8|||
13441910|NCT00333866|26917511|FG001|Overall Study|Lack of Efficacy|6|||
13441911|NCT00333866|26917512|FG002|Overall Study|Lack of Efficacy|3|||
13441912|NCT00333866|26917513|FG003|Overall Study|Lack of Efficacy|5|||
13441913|NCT00333866|26917510|FG000|Overall Study|Lost to Follow-up|1|||
13441914|NCT00333866|26917511|FG001|Overall Study|Lost to Follow-up|2|||
13441915|NCT00333866|26917512|FG002|Overall Study|Lost to Follow-up|2|||
13441916|NCT00333866|26917513|FG003|Overall Study|Lost to Follow-up|2|||
13441917|NCT00333866|26917510|FG000|Overall Study|Withdrawal by Subject|8|||
13441918|NCT00333866|26917511|FG001|Overall Study|Withdrawal by Subject|14|||
13441919|NCT00333866|26917512|FG002|Overall Study|Withdrawal by Subject|4|||
13441920|NCT00333866|26917513|FG003|Overall Study|Withdrawal by Subject|9|||
13441921|NCT00333866|26917510|FG000|Overall Study|Randomized but not Treated|5|||
13441922|NCT00333866|26917511|FG001|Overall Study|Randomized but not Treated|3|||
13441923|NCT00333866|26917512|FG002|Overall Study|Randomized but not Treated|2|||
13441924|NCT00333866|26917513|FG003|Overall Study|Randomized but not Treated|1|||
13441925|NCT00333840|26917547|FG000|First-line Treatment Period|Adverse Event|38|||
13441926|NCT00333840|26917548|FG001|First-line Treatment Period|Adverse Event|37|||
13441927|NCT00333840|26917549|FG002|First-line Treatment Period|Adverse Event|0|||
13441928|NCT00333840|26917550|FG003|First-line Treatment Period|Adverse Event|0|||
13441929|NCT00333840|26917547|FG000|First-line Treatment Period|Abnormal laboratory values|3|||
13441930|NCT00333840|26917548|FG001|First-line Treatment Period|Abnormal laboratory values|1|||
13441931|NCT00333840|26917549|FG002|First-line Treatment Period|Abnormal laboratory values|0|||
13441932|NCT00333840|26917550|FG003|First-line Treatment Period|Abnormal laboratory values|0|||
13441933|NCT00333840|26917547|FG000|First-line Treatment Period|Abnormal procedure|2|||
13441934|NCT00333840|26917548|FG001|First-line Treatment Period|Abnormal procedure|0|||
13441935|NCT00333840|26917549|FG002|First-line Treatment Period|Abnormal procedure|0|||
13441936|NCT00333840|26917550|FG003|First-line Treatment Period|Abnormal procedure|0|||
13441937|NCT00333840|26917547|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88|||
13441938|NCT00333840|26917548|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29|||
13441939|NCT00333840|26917549|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
13441940|NCT00333840|26917550|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
13441941|NCT00333840|26917547|FG000|First-line Treatment Period|No longer required study drug|21|||
13441942|NCT00333840|26917548|FG001|First-line Treatment Period|No longer required study drug|8|||
13441943|NCT00333840|26917549|FG002|First-line Treatment Period|No longer required study drug|0|||
13441944|NCT00333840|26917550|FG003|First-line Treatment Period|No longer required study drug|0|||
13441945|NCT00333840|26917547|FG000|First-line Treatment Period|Protocol Violation|17|||
13441946|NCT00333840|26917548|FG001|First-line Treatment Period|Protocol Violation|17|||
13441947|NCT00333840|26917549|FG002|First-line Treatment Period|Protocol Violation|0|||
13441948|NCT00333840|26917550|FG003|First-line Treatment Period|Protocol Violation|0|||
13441949|NCT00333840|26917547|FG000|First-line Treatment Period|Subject withdrew consent|57|||
13441950|NCT00333840|26917548|FG001|First-line Treatment Period|Subject withdrew consent|77|||
13441951|NCT00333840|26917549|FG002|First-line Treatment Period|Subject withdrew consent|0|||
13441952|NCT00333840|26917550|FG003|First-line Treatment Period|Subject withdrew consent|0|||
13441953|NCT00333840|26917547|FG000|First-line Treatment Period|Lost to Follow-up|15|||
13441954|NCT00333840|26917548|FG001|First-line Treatment Period|Lost to Follow-up|6|||
13441955|NCT00333840|26917549|FG002|First-line Treatment Period|Lost to Follow-up|0|||
13441956|NCT00333840|26917550|FG003|First-line Treatment Period|Lost to Follow-up|0|||
13441957|NCT00333840|26917547|FG000|First-line Treatment Period|Administrative problems|12|||
13441958|NCT00333840|26917548|FG001|First-line Treatment Period|Administrative problems|6|||
13441959|NCT00333840|26917549|FG002|First-line Treatment Period|Administrative problems|0|||
13441960|NCT00333840|26917550|FG003|First-line Treatment Period|Administrative problems|0|||
13441961|NCT00333840|26917547|FG000|First-line Treatment Period|Death|19|||
13441962|NCT00333840|26917548|FG001|First-line Treatment Period|Death|2|||
13441963|NCT00333840|26917549|FG002|First-line Treatment Period|Death|0|||
13441964|NCT00333840|26917550|FG003|First-line Treatment Period|Death|0|||
13441965|NCT00333840|26917547|FG000|First-line Treatment Period|Crossed over to other treatment arm|14|||
13441966|NCT00333840|26917548|FG001|First-line Treatment Period|Crossed over to other treatment arm|363|||
13441967|NCT00333840|26917549|FG002|First-line Treatment Period|Crossed over to other treatment arm|0|||
13441968|NCT00333840|26917550|FG003|First-line Treatment Period|Crossed over to other treatment arm|0|||
13441969|NCT00333840|26917547|FG000|Second-line Treatment Period|Adverse Event|0|||
13441970|NCT00333840|26917548|FG001|Second-line Treatment Period|Adverse Event|0|||
13441971|NCT00333840|26917549|FG002|Second-line Treatment Period|Adverse Event|3|||
13441972|NCT00333840|26917550|FG003|Second-line Treatment Period|Adverse Event|34|||
13441973|NCT00333840|26917547|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0|||
13441974|NCT00333840|26917548|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0|||
13441975|NCT00333840|26917549|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0|||
13441976|NCT00333840|26917550|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3|||
13441977|NCT00333840|26917547|FG000|Second-line Treatment Period|Abnormal procedure|0|||
13441978|NCT00333840|26917548|FG001|Second-line Treatment Period|Abnormal procedure|0|||
13441979|NCT00333840|26917549|FG002|Second-line Treatment Period|Abnormal procedure|0|||
13441980|NCT00333840|26917550|FG003|Second-line Treatment Period|Abnormal procedure|1|||
13441981|NCT00333840|26917547|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
13441982|NCT00333840|26917548|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
13441983|NCT00333840|26917549|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9|||
13441984|NCT00333840|26917550|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70|||
13441985|NCT00333840|26917547|FG000|Second-line Treatment Period|No longer required study drug|0|||
13441986|NCT00333840|26917548|FG001|Second-line Treatment Period|No longer required study drug|0|||
13441987|NCT00333840|26917549|FG002|Second-line Treatment Period|No longer required study drug|1|||
13441988|NCT00333840|26917550|FG003|Second-line Treatment Period|No longer required study drug|14|||
13441989|NCT00333840|26917547|FG000|Second-line Treatment Period|Protocol Violation|0|||
13441990|NCT00333840|26917548|FG001|Second-line Treatment Period|Protocol Violation|0|||
13441991|NCT00333840|26917549|FG002|Second-line Treatment Period|Protocol Violation|1|||
13441992|NCT00333840|26917550|FG003|Second-line Treatment Period|Protocol Violation|10|||
13441993|NCT00333840|26917547|FG000|Second-line Treatment Period|Subject withdrew consent|0|||
13441994|NCT00333840|26917548|FG001|Second-line Treatment Period|Subject withdrew consent|0|||
13441995|NCT00333840|26917549|FG002|Second-line Treatment Period|Subject withdrew consent|0|||
13441996|NCT00333840|26917550|FG003|Second-line Treatment Period|Subject withdrew consent|34|||
13441997|NCT00333840|26917547|FG000|Second-line Treatment Period|Lost to Follow-up|0|||
13441998|NCT00333840|26917548|FG001|Second-line Treatment Period|Lost to Follow-up|0|||
13441999|NCT00333840|26917549|FG002|Second-line Treatment Period|Lost to Follow-up|0|||
13442000|NCT00333840|26917550|FG003|Second-line Treatment Period|Lost to Follow-up|6|||
13442001|NCT00333840|26917547|FG000|Second-line Treatment Period|Administrative problems|0|||
13442002|NCT00333840|26917548|FG001|Second-line Treatment Period|Administrative problems|0|||
13442003|NCT00333840|26917549|FG002|Second-line Treatment Period|Administrative problems|0|||
13442004|NCT00333840|26917550|FG003|Second-line Treatment Period|Administrative problems|7|||
13442005|NCT00333840|26917547|FG000|Second-line Treatment Period|Death|0|||
13442006|NCT00333840|26917548|FG001|Second-line Treatment Period|Death|0|||
13442007|NCT00333840|26917549|FG002|Second-line Treatment Period|Death|0|||
13442008|NCT00333840|26917550|FG003|Second-line Treatment Period|Death|9|||
13442009|NCT00333801|26917575|FG000|Overall Study|Moved to another state|5|||
13442010|NCT00333801|26917576|FG001|Overall Study|Moved to another state|3|||
13442011|NCT00333801|26917575|FG000|Overall Study|Lost to Follow-up|2|||
13442012|NCT00333801|26917576|FG001|Overall Study|Lost to Follow-up|0|||
13442013|NCT00333801|26917575|FG000|Overall Study|Incarcerated|1|||
13442014|NCT00333801|26917576|FG001|Overall Study|Incarcerated|2|||
13442015|NCT00333801|26917575|FG000|Overall Study|Withdrawal by Subject|0|||
13442016|NCT00333801|26917576|FG001|Overall Study|Withdrawal by Subject|1|||
13442017|NCT00333788|26917605|FG000|Overall Study|Adverse Event|44|||
13442018|NCT00333788|26917605|FG000|Overall Study|Lack of Efficacy|80|||
13442019|NCT00333788|26917605|FG000|Overall Study|Lost to Follow-up|2|||
13442020|NCT00333788|26917605|FG000|Overall Study|Withdrawal by Subject|24|||
13442021|NCT00333788|26917605|FG000|Overall Study|Other: Non-compliance|2|||
13442022|NCT00333788|26917605|FG000|Overall Study|Other: Moved|2|||
13442023|NCT00333788|26917605|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1|||
13442024|NCT00333788|26917605|FG000|Overall Study|Other: Investigator decision|1|||
13442025|NCT00333788|26917605|FG000|Overall Study|Other: Quality of life concern|1|||
13442026|NCT00333788|26917605|FG000|Overall Study|Other: Sponsor decision|1|||
13442027|NCT00333788|26917605|FG000|Overall Study|Other: Subject in need of an Entocort|1|||
13442028|NCT00333788|26917605|FG000|Overall Study|Other: Medical monitor decision|1|||
13442029|NCT00333788|26917605|FG000|Overall Study|Other: Physician decision|1|||
13442030|NCT00333788|26917605|FG000|Overall Study|Other: Signed consent for another study|1|||
13442031|NCT00333775|26917635|FG000|Overall Study|Death|144|||
13442032|NCT00333775|26917636|FG001|Overall Study|Death|149|||
13442033|NCT00333775|26917637|FG002|Overall Study|Death|143|||
13442034|NCT00333775|26917635|FG000|Overall Study|In Follow-up When Study Stopped|87|||
13442035|NCT00333775|26917636|FG001|Overall Study|In Follow-up When Study Stopped|92|||
13442036|NCT00333775|26917637|FG002|Overall Study|In Follow-up When Study Stopped|96|||
13442037|NCT00333775|26917635|FG000|Overall Study|Lost to Follow-up|10|||
13442038|NCT00333775|26917636|FG001|Overall Study|Lost to Follow-up|7|||
13442039|NCT00333775|26917637|FG002|Overall Study|Lost to Follow-up|8|||
13442040|NCT00333619|26917652|FG000|Overall Study|Death|12|||
13442041|NCT00333619|26917653|FG001|Overall Study|Death|6|||
13442042|NCT00333619|26917652|FG000|Overall Study|Withdrawal by Subject|6|||
13442043|NCT00333619|26917653|FG001|Overall Study|Withdrawal by Subject|1|||
13442044|NCT00333619|26917652|FG000|Overall Study|Lost to Follow-up|3|||
13442045|NCT00333619|26917653|FG001|Overall Study|Lost to Follow-up|3|||
13442046|NCT00333359|26917701|FG000|Overall Study|Adverse Event|29|||
13442047|NCT00333359|26917702|FG001|Overall Study|Adverse Event|35|||
13442048|NCT00333359|26917701|FG000|Overall Study|Withdrawal by Subject|19|||
13442049|NCT00333359|26917702|FG001|Overall Study|Withdrawal by Subject|37|||
13442050|NCT00333359|26917701|FG000|Overall Study|Physician Decision|2|||
13442051|NCT00333359|26917702|FG001|Overall Study|Physician Decision|2|||
13442052|NCT00333359|26917701|FG000|Overall Study|Protocol Non-compliance|2|||
13442053|NCT00333359|26917702|FG001|Overall Study|Protocol Non-compliance|8|||
13442054|NCT00333359|26917701|FG000|Overall Study|Lost to Follow-up|15|||
13442055|NCT00333359|26917702|FG001|Overall Study|Lost to Follow-up|25|||
13442056|NCT00333359|26917701|FG000|Overall Study|Termination or Withdrawal by Sponsor|1|||
13442057|NCT00333359|26917702|FG001|Overall Study|Termination or Withdrawal by Sponsor|1|||
13442058|NCT00333359|26917701|FG000|Overall Study|Treatment Failure|3|||
13442059|NCT00333359|26917702|FG001|Overall Study|Treatment Failure|8|||
13442060|NCT00333359|26917701|FG000|Overall Study|Withdrew before Receiving One Dose|2|||
13442061|NCT00333359|26917702|FG001|Overall Study|Withdrew before Receiving One Dose|6|||
13442062|NCT00333229|26917723|FG000|Overall Study|Lack of Efficacy|0|||
13442063|NCT00333229|26917724|FG001|Overall Study|Lack of Efficacy|1|||
13442064|NCT00333138|26917771|FG000|Core Study (6 Months)|Adverse Event|4|||
13442065|NCT00333138|26917772|FG001|Core Study (6 Months)|Adverse Event|5|||
13442066|NCT00333138|26917773|FG002|Core Study (6 Months)|Adverse Event|8|||
13442067|NCT00333138|26917771|FG000|Core Study (6 Months)|Withdrawal by Subject|1|||
13442068|NCT00333138|26917772|FG001|Core Study (6 Months)|Withdrawal by Subject|1|||
13442069|NCT00333138|26917773|FG002|Core Study (6 Months)|Withdrawal by Subject|2|||
13442070|NCT00333138|26917771|FG000|Core Study (6 Months)|Lack of Efficacy|1|||
13442071|NCT00333138|26917772|FG001|Core Study (6 Months)|Lack of Efficacy|0|||
13442072|NCT00333138|26917773|FG002|Core Study (6 Months)|Lack of Efficacy|0|||
13442073|NCT00333138|26917771|FG000|Core Study (6 Months)|Protocol Violation|1|||
13442074|NCT00333138|26917772|FG001|Core Study (6 Months)|Protocol Violation|0|||
13442075|NCT00333138|26917773|FG002|Core Study (6 Months)|Protocol Violation|1|||
13442076|NCT00333138|26917771|FG000|Core Study (6 Months)|Laboratory abnormality|0|||
13442077|NCT00333138|26917772|FG001|Core Study (6 Months)|Laboratory abnormality|0|||
13442078|NCT00333138|26917773|FG002|Core Study (6 Months)|Laboratory abnormality|1|||
13442079|NCT00333138|26917771|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3|||
13442080|NCT00333138|26917772|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
13442081|NCT00333138|26917773|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
13442082|NCT00333138|26917771|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1|||
13442083|NCT00333138|26917772|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1|||
13442084|NCT00333138|26917773|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2|||
13442085|NCT00333138|26917771|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15|||
13442086|NCT00333138|26917772|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19|||
13442087|NCT00333138|26917773|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15|||
13442088|NCT00333138|26917771|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
13442089|NCT00333138|26917772|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
13442090|NCT00333138|26917773|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3|||
13442091|NCT00333138|26917771|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
13442092|NCT00333138|26917772|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13|||
13442093|NCT00333138|26917773|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
13442094|NCT00333138|26917771|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
13442095|NCT00333138|26917772|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4|||
13442096|NCT00333138|26917773|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
13442097|NCT00333138|26917771|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2|||
13442098|NCT00333138|26917772|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1|||
13442099|NCT00333138|26917773|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0|||
13442100|NCT00333138|26917771|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
13442101|NCT00333138|26917772|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
13442102|NCT00333138|26917773|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0|||
13442103|NCT00333138|26917771|FG000|Extension Study (Month6 to End of Study)|Death|0|||
13442104|NCT00333138|26917772|FG001|Extension Study (Month6 to End of Study)|Death|1|||
13442105|NCT00333138|26917773|FG002|Extension Study (Month6 to End of Study)|Death|0|||
13442106|NCT00332839|26917798|FG000|Core (Months 0 - 12)|Administrative problems|1|||
13442107|NCT00332839|26917799|FG001|Core (Months 0 - 12)|Administrative problems|1|||
13442108|NCT00332839|26917798|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3|||
13442109|NCT00332839|26917799|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1|||
13442110|NCT00332839|26917798|FG000|Core (Months 0 - 12)|Protocol deviation|1|||
13442111|NCT00332839|26917799|FG001|Core (Months 0 - 12)|Protocol deviation|1|||
13442112|NCT00332839|26917798|FG000|Core (Months 0 - 12)|Adverse Event|5|||
13442113|NCT00332839|26917799|FG001|Core (Months 0 - 12)|Adverse Event|15|||
13442114|NCT00332839|26917798|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
13442115|NCT00332839|26917799|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
13442116|NCT00332839|26917798|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2|||
13442117|NCT00332839|26917799|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1|||
13442118|NCT00332839|26917798|FG000|Follow-up (Months 12 - 60)|Death|1|||
13442119|NCT00332839|26917799|FG001|Follow-up (Months 12 - 60)|Death|1|||
13442120|NCT00332709|26917828|FG000|Overall Study|Adverse Event|11|||
13442121|NCT00332709|26917829|FG001|Overall Study|Adverse Event|14|||
13442122|NCT00332709|26917828|FG000|Overall Study|Withdrawal by Subject|2|||
13442123|NCT00332709|26917829|FG001|Overall Study|Withdrawal by Subject|3|||
13442124|NCT00332709|26917828|FG000|Overall Study|Lost to Follow-up|2|||
13442125|NCT00332709|26917829|FG001|Overall Study|Lost to Follow-up|0|||
13442126|NCT00332709|26917828|FG000|Overall Study|Administrative Problems|0|||
13442127|NCT00332709|26917829|FG001|Overall Study|Administrative Problems|3|||
13442128|NCT00332709|26917828|FG000|Overall Study|Abnormal test procedure result|1|||
13442129|NCT00332709|26917829|FG001|Overall Study|Abnormal test procedure result|0|||
13442130|NCT00332696|26917862|FG000|Overall Study|Death|24|||
13442131|NCT00332696|26917863|FG001|Overall Study|Death|14|||
13442132|NCT00332696|26917862|FG000|Overall Study|Insufficient therapeutic effect|4|||
13442133|NCT00332696|26917863|FG001|Overall Study|Insufficient therapeutic effect|11|||
13442134|NCT00332696|26917862|FG000|Overall Study|Adverse Event|1|||
13442135|NCT00332696|26917863|FG001|Overall Study|Adverse Event|2|||
13442136|NCT00332696|26917862|FG000|Overall Study|Condition does not justify treatment|0|||
13442137|NCT00332696|26917863|FG001|Overall Study|Condition does not justify treatment|2|||
13442138|NCT00332696|26917862|FG000|Overall Study|Lost to Follow-up|0|||
13442139|NCT00332696|26917863|FG001|Overall Study|Lost to Follow-up|1|||
13442140|NCT00332696|26917862|FG000|Overall Study|Withdrawal by Subject|1|||
13442141|NCT00332696|26917863|FG001|Overall Study|Withdrawal by Subject|0|||
13442142|NCT00332488|26917885|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8|||
13442143|NCT00332488|26917886|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2|||
13442144|NCT00332488|26917887|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6|||
13442145|NCT00332488|26917885|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13|||
13442146|NCT00332488|26917886|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2|||
13442147|NCT00332488|26917887|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10|||
13442148|NCT00332488|26917885|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21|||
13442149|NCT00332488|26917886|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10|||
13442150|NCT00332488|26917887|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20|||
13442151|NCT00332488|26917885|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4|||
13442152|NCT00332488|26917886|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0|||
13442153|NCT00332488|26917887|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20|||
13442154|NCT00332488|26917885|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1|||
13442155|NCT00332488|26917886|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3|||
13442156|NCT00332488|26917887|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0|||
13442157|NCT00332488|26917885|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3|||
13442158|NCT00332488|26917886|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1|||
13442159|NCT00332488|26917887|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0|||
13442160|NCT00332488|26917885|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
13442161|NCT00332488|26917886|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
13442162|NCT00332488|26917887|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3|||
13442163|NCT00332488|26917885|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
13442164|NCT00332488|26917886|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
13442165|NCT00332488|26917887|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1|||
13442166|NCT00332488|26917885|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
13442167|NCT00332488|26917886|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
13442168|NCT00332488|26917887|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3|||
13442169|NCT00332488|26917885|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
13442170|NCT00332488|26917886|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
13442171|NCT00332488|26917887|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1|||
13442172|NCT00332488|26917885|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
13442173|NCT00332488|26917886|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
13442174|NCT00332488|26917887|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8|||
13442175|NCT00332488|26917885|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
13442176|NCT00332488|26917886|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
13442177|NCT00332488|26917887|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5|||
13442178|NCT00332462|26917896|FG000|Overall Study|Adverse Event|5|||
13442179|NCT00332462|26917896|FG000|Overall Study|Abnormal Lab Value|1|||
13442180|NCT00332462|26917896|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
13442181|NCT00332462|26917896|FG000|Overall Study|no longer requires study drug|1|||
13442182|NCT00332462|26917896|FG000|Overall Study|Death|3|||
13442183|NCT00332462|26917896|FG000|Overall Study|Graft Loss|2|||
13477160|NCT00330759|27005671|FG000|Overall Study|Death|316|||
13477161|NCT00330759|27005672|FG001|Overall Study|Death|310|||
13477162|NCT00330759|27005671|FG000|Overall Study|Disease progression|104|||
13477163|NCT00330759|27005672|FG001|Overall Study|Disease progression|126|||
13477164|NCT00330759|27005671|FG000|Overall Study|Withdrawal by Subject|143|||
13477165|NCT00330759|27005672|FG001|Overall Study|Withdrawal by Subject|124|||
13477166|NCT00330759|27005671|FG000|Overall Study|Adverse Event|48|||
13477167|NCT00330759|27005672|FG001|Overall Study|Adverse Event|36|||
13477168|NCT00330759|27005671|FG000|Overall Study|Participant request|31|||
13477169|NCT00330759|27005672|FG001|Overall Study|Participant request|22|||
13477170|NCT00330759|27005671|FG000|Overall Study|Lost to Follow-up|16|||
13477171|NCT00330759|27005672|FG001|Overall Study|Lost to Follow-up|22|||
13477172|NCT00330759|27005671|FG000|Overall Study|Noncompliance|15|||
13477173|NCT00330759|27005672|FG001|Overall Study|Noncompliance|17|||
13477174|NCT00330759|27005671|FG000|Overall Study|Physician Decision|1|||
13477175|NCT00330759|27005672|FG001|Overall Study|Physician Decision|2|||
13442184|NCT00332332|26917905|FG000|Overall Study|Adverse Event|13|||
13442185|NCT00332332|26917905|FG000|Overall Study|Death|1|||
13442186|NCT00332332|26917905|FG000|Overall Study|Withdrawal by Subject|8|||
13442187|NCT00332332|26917905|FG000|Overall Study|Physician Decision|1|||
13442188|NCT00332332|26917905|FG000|Overall Study|Lost to Follow-up|3|||
13442189|NCT00332332|26917905|FG000|Overall Study|Protocol deviation|4|||
13442190|NCT00332332|26917905|FG000|Overall Study|Noncompliance|2|||
13442191|NCT00332332|26917905|FG000|Overall Study|Disease progression|2|||
13442192|NCT00332332|26917905|FG000|Overall Study|Other|18|||
13442193|NCT00332332|26917905|FG000|Overall Study|Did not receive study treatment|16|||
13442194|NCT00332241|26917932|FG000|Overall Study|Lack of Efficacy|6|||
13442195|NCT00332241|26917933|FG001|Overall Study|Lack of Efficacy|1|||
13442196|NCT00332241|26917932|FG000|Overall Study|Adverse Event|3|||
13442197|NCT00332241|26917933|FG001|Overall Study|Adverse Event|5|||
13442198|NCT00332241|26917932|FG000|Overall Study|Withdrawal by Subject|2|||
13442199|NCT00332241|26917933|FG001|Overall Study|Withdrawal by Subject|1|||
13442200|NCT00332241|26917932|FG000|Overall Study|Lost to Follow-up|4|||
13442201|NCT00332241|26917933|FG001|Overall Study|Lost to Follow-up|1|||
13442202|NCT00332202|26917969|FG000|Overall Study|Adverse Event|72|||
13442203|NCT00332202|26917970|FG001|Overall Study|Adverse Event|28|||
13442204|NCT00332202|26917969|FG000|Overall Study|Lost to Follow-up|2|||
13442205|NCT00332202|26917970|FG001|Overall Study|Lost to Follow-up|1|||
13442206|NCT00332202|26917969|FG000|Overall Study|Physician Decision|6|||
13442207|NCT00332202|26917970|FG001|Overall Study|Physician Decision|8|||
13442208|NCT00332202|26917969|FG000|Overall Study|Protocol Entry Criteria Not Met|6|||
13442209|NCT00332202|26917970|FG001|Overall Study|Protocol Entry Criteria Not Met|5|||
13442210|NCT00332202|26917969|FG000|Overall Study|Protocol Violation|7|||
13442211|NCT00332202|26917970|FG001|Overall Study|Protocol Violation|2|||
13442212|NCT00332202|26917969|FG000|Overall Study|Sponsor Decision|1|||
13442213|NCT00332202|26917970|FG001|Overall Study|Sponsor Decision|2|||
13442214|NCT00332202|26917969|FG000|Overall Study|Withdrawal by Subject|36|||
13442215|NCT00332202|26917970|FG001|Overall Study|Withdrawal by Subject|17|||
13442216|NCT00332202|26917969|FG000|Overall Study|Progressive Disease|106|||
13442217|NCT00332202|26917970|FG001|Overall Study|Progressive Disease|60|||
13442218|NCT00332202|26917969|FG000|Overall Study|Death|5|||
13442219|NCT00332202|26917970|FG001|Overall Study|Death|2|||
13442220|NCT00332189|26917977|FG000|Overall Study|Adverse Event|3|||
13442221|NCT00332189|26917977|FG000|Overall Study|Uncooperative/Noncompliant|3|||
13442222|NCT00332189|26917977|FG000|Overall Study|Withdrawal by Subject|9|||
13442223|NCT00332189|26917977|FG000|Overall Study|Lack of Efficacy|4|||
13442224|NCT00332189|26917977|FG000|Overall Study|Moved out of country|2|||
13442225|NCT00331864|26918003|FG000|Overall Study|Adverse Event|30|||
13442226|NCT00331864|26918004|FG001|Overall Study|Adverse Event|1|||
13442227|NCT00331864|26918003|FG000|Overall Study|Lack of Efficacy|4|||
13442228|NCT00331864|26918004|FG001|Overall Study|Lack of Efficacy|0|||
13442229|NCT00331864|26918003|FG000|Overall Study|Protocol Violation|3|||
13442230|NCT00331864|26918004|FG001|Overall Study|Protocol Violation|0|||
13442231|NCT00331864|26918003|FG000|Overall Study|Withdrawal by Subject|10|||
13442232|NCT00331864|26918004|FG001|Overall Study|Withdrawal by Subject|0|||
13442233|NCT00331864|26918003|FG000|Overall Study|Lost to Follow-up|4|||
13442234|NCT00331864|26918004|FG001|Overall Study|Lost to Follow-up|3|||
13442235|NCT00331864|26918003|FG000|Overall Study|Administrative Problems|1|||
13442236|NCT00331864|26918004|FG001|Overall Study|Administrative Problems|0|||
13442237|NCT00331864|26918003|FG000|Overall Study|Death|6|||
13442238|NCT00331864|26918004|FG001|Overall Study|Death|0|||
13442239|NCT00331799|26918010|FG000|Overall Study|Withdrawal by Subject|2|||
13442240|NCT00331799|26918010|FG000|Overall Study|Sedation|1|||
13442241|NCT00331760|26918038|FG000|Overall Study|Ineligible / no protocol treatment|15|||
13442242|NCT00331760|26918039|FG001|Overall Study|Ineligible / no protocol treatment|8|||
13442243|NCT00331682|26918047|FG000|Overall Study|Adverse Event|1|||
13442244|NCT00331630|26918059|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1|||
13442245|NCT00331630|26918059|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1|||
13442246|NCT00331630|26918059|FG000|Follow up for 5 Years|Death|5|||
13442247|NCT00331630|26918059|FG000|Follow up for 5 Years|Data collection was stopped|24|||
13442248|NCT00331552|26918080|FG000|Period 3: Phase II|Neurological Symptoms|1|||
13442249|NCT00331552|26918081|FG001|Period 3: Phase II|Neurological Symptoms|0|||
13442250|NCT00331552|26918080|FG000|Period 3: Phase II|Severe Nausea|1|||
13442251|NCT00331552|26918081|FG001|Period 3: Phase II|Severe Nausea|0|||
13442252|NCT00331422|26918092|FG000|Overall Study|Did not receive entire study regimen|5|||
13442253|NCT00331409|26918102|FG000|Overall Study|Lack of Efficacy|4|||
13442254|NCT00331344|26918126|FG000|Phase I|Adverse Event|0|||
13442255|NCT00331344|26918127|FG001|Phase I|Adverse Event|0|||
13442256|NCT00331344|26918128|FG002|Phase I|Adverse Event|0|||
13442257|NCT00331344|26918129|FG003|Phase I|Adverse Event|1|||
13442258|NCT00331344|26918130|FG004|Phase I|Adverse Event|2|||
13442259|NCT00331344|26918131|FG005|Phase I|Adverse Event|2|||
13442260|NCT00331344|26918132|FG006|Phase I|Adverse Event|0|||
13442261|NCT00331344|26918133|FG007|Phase I|Adverse Event|1|||
13442262|NCT00331344|26918134|FG008|Phase I|Adverse Event|0|||
13442263|NCT00331344|26918126|FG000|Phase II|Death|0|||
13442264|NCT00331344|26918127|FG001|Phase II|Death|0|||
13442265|NCT00331344|26918128|FG002|Phase II|Death|0|||
13442266|NCT00331344|26918129|FG003|Phase II|Death|0|||
13442267|NCT00331344|26918130|FG004|Phase II|Death|0|||
13442268|NCT00331344|26918131|FG005|Phase II|Death|0|||
13442269|NCT00331344|26918132|FG006|Phase II|Death|0|||
13442270|NCT00331344|26918133|FG007|Phase II|Death|0|||
13442271|NCT00331344|26918134|FG008|Phase II|Death|4|||
13442272|NCT00331136|26918193|FG000|Overall Study|Adverse Event|3|||
13442273|NCT00331136|26918194|FG001|Overall Study|Adverse Event|5|||
13442274|NCT00331136|26918195|FG002|Overall Study|Adverse Event|0|||
13442275|NCT00331136|26918196|FG003|Overall Study|Adverse Event|1|||
13442276|NCT00331136|26918193|FG000|Overall Study|Withdrawal by Subject|0|||
13442277|NCT00331136|26918194|FG001|Overall Study|Withdrawal by Subject|1|||
13442278|NCT00331136|26918195|FG002|Overall Study|Withdrawal by Subject|0|||
13442279|NCT00331136|26918196|FG003|Overall Study|Withdrawal by Subject|0|||
13442280|NCT00331136|26918193|FG000|Overall Study|Lost to Follow-up|0|||
13442281|NCT00331136|26918194|FG001|Overall Study|Lost to Follow-up|1|||
13442282|NCT00331136|26918195|FG002|Overall Study|Lost to Follow-up|0|||
13442283|NCT00331136|26918196|FG003|Overall Study|Lost to Follow-up|0|||
13442284|NCT00331136|26918193|FG000|Overall Study|Protocol Violation|1|||
13442285|NCT00331136|26918194|FG001|Overall Study|Protocol Violation|0|||
13442286|NCT00331136|26918195|FG002|Overall Study|Protocol Violation|0|||
13442287|NCT00331136|26918196|FG003|Overall Study|Protocol Violation|0|||
13442288|NCT00331136|26918193|FG000|Overall Study|Not treated|1|||
13442289|NCT00331136|26918194|FG001|Overall Study|Not treated|0|||
13442290|NCT00331136|26918195|FG002|Overall Study|Not treated|0|||
13442291|NCT00331136|26918196|FG003|Overall Study|Not treated|0|||
13442292|NCT00331006|26918209|FG000|Screening Phase|Withdrawal by Subject|1|||
13442293|NCT00331006|26918209|FG000|Screening Phase|enrollment halted|1|||
13442294|NCT00331006|26918209|FG000|Screening Phase|Lost to Follow-up|1|||
13442295|NCT00331006|26918209|FG000|Screening Phase|Ineligible for treatment phase|4|||
13442296|NCT00331006|26918209|FG000|Treatment Phase|Withdrawal by Subject|1|||
13442297|NCT00331006|26918209|FG000|Follow-Up Phase I|Lost to Follow-up|1|||
13442298|NCT00331006|26918209|FG000|Follow-Up Phase II|Lost to Follow-up|3|||
13442299|NCT00330967|26918227|FG000|Overall Study|Withdrawal by Subject|0|||
13442300|NCT00330967|26918228|FG001|Overall Study|Withdrawal by Subject|5|||
13442301|NCT00330967|26918227|FG000|Overall Study|Physician Decision|0|||
13442302|NCT00330967|26918228|FG001|Overall Study|Physician Decision|9|||
13442303|NCT00330928|26918235|FG000|Overall Study|Lost to Follow-up|6|||
13442304|NCT00330928|26918235|FG000|Overall Study|Physician Decision|9|||
13442305|NCT00330928|26918235|FG000|Overall Study|Death|1|||
13442306|NCT00330928|26918235|FG000|Overall Study|IVUS could not be performed.|1|||
13442307|NCT00330681|26918264|FG000|Overall Study|Adverse Event|3|||
13442308|NCT00330681|26918265|FG001|Overall Study|Adverse Event|6|||
13442309|NCT00330681|26918264|FG000|Overall Study|Protocol Violation|0|||
13442310|NCT00330681|26918265|FG001|Overall Study|Protocol Violation|1|||
13442311|NCT00330681|26918264|FG000|Overall Study|Withdrawal by Subject|5|||
13442312|NCT00330681|26918265|FG001|Overall Study|Withdrawal by Subject|5|||
13442313|NCT00330681|26918264|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
13442314|NCT00330681|26918265|FG001|Overall Study|Tracheotomy due to worsening of ALS|2|||
13442315|NCT00330668|26918275|FG000|BID Dosing Period|Adverse Event|1|||
13442316|NCT00330668|26918275|FG000|BID Dosing Period|Lost to Follow-up|7|||
13442317|NCT00330668|26918275|FG000|BID Dosing Period|Non-Compliance|5|||
13442318|NCT00330668|26918275|FG000|BID Dosing Period|Withdrawal by Subject|19|||
13442319|NCT00330668|26918275|FG000|BID Dosing Period|Sponsor's decision|1|||
13442320|NCT00330668|26918275|FG000|BID Dosing Period|Other|3|||
13442321|NCT00330668|26918275|FG000|QD Dosing Period|Sponsor decision to terminate study|74|||
13442322|NCT00330668|26918275|FG000|QD Dosing Period|Other|1|||
13442323|NCT00330668|26918275|FG000|QD Dosing Period|Withdrawal by Subject|1|||
13442324|NCT00330668|26918275|FG000|QD Dosing Period|Lost to Follow-up|2|||
13442325|NCT00330616|26918296|FG000|Overall Study|Adverse Event|13|||
13442326|NCT00330616|26918296|FG000|Overall Study|Lack of Efficacy|1|||
13442327|NCT00330616|26918296|FG000|Overall Study|Lost to Follow-up|2|||
13442328|NCT00330616|26918296|FG000|Overall Study|Withdrawal by Subject|4|||
13442329|NCT00330616|26918296|FG000|Overall Study|Other|1|||
13442330|NCT00330460|26918317|FG000|Overall Study|Physician Decision|1|||
13442331|NCT00330460|26918318|FG001|Overall Study|Physician Decision|0|||
13442332|NCT00330460|26918317|FG000|Overall Study|Adverse Event|10|||
13442333|NCT00330460|26918318|FG001|Overall Study|Adverse Event|8|||
13442334|NCT00330460|26918317|FG000|Overall Study|Withdrawal by Subject|18|||
13442335|NCT00330460|26918318|FG001|Overall Study|Withdrawal by Subject|17|||
13442336|NCT00330460|26918317|FG000|Overall Study|Death|1|||
13442337|NCT00330460|26918318|FG001|Overall Study|Death|1|||
13442338|NCT00330460|26918317|FG000|Overall Study|Ineligibility determined|1|||
13442339|NCT00330460|26918318|FG001|Overall Study|Ineligibility determined|3|||
13442340|NCT00330460|26918317|FG000|Overall Study|Lost to Follow-up|8|||
13442341|NCT00330460|26918318|FG001|Overall Study|Lost to Follow-up|3|||
13442342|NCT00330460|26918317|FG000|Overall Study|Noncompliance|2|||
13442343|NCT00330460|26918318|FG001|Overall Study|Noncompliance|1|||
13442344|NCT00330460|26918317|FG000|Overall Study|Other|1|||
13442345|NCT00330460|26918318|FG001|Overall Study|Other|0|||
13442346|NCT00330343|26918324|FG000|Overall Study|Lost to Follow-up|5|||
13442347|NCT00330187|26918347|FG000|Overall Study|Lost to Follow-up|12|||
13442348|NCT00330187|26918348|FG001|Overall Study|Lost to Follow-up|13|||
13442349|NCT00330187|26918349|FG002|Overall Study|Lost to Follow-up|14|||
13442350|NCT00330187|26918350|FG003|Overall Study|Lost to Follow-up|10|||
13442351|NCT00330187|26918347|FG000|Overall Study|Withdrawal by Subject|8|||
13442352|NCT00330187|26918348|FG001|Overall Study|Withdrawal by Subject|5|||
13442353|NCT00330187|26918349|FG002|Overall Study|Withdrawal by Subject|4|||
13442354|NCT00330187|26918350|FG003|Overall Study|Withdrawal by Subject|4|||
13442355|NCT00330174|26918369|FG000|Overall Study|Withdrawal by Subject|7|||
13442356|NCT00330174|26918370|FG001|Overall Study|Withdrawal by Subject|7|||
13442357|NCT00330174|26918369|FG000|Overall Study|Lost to Follow-up|4|||
13442358|NCT00330174|26918370|FG001|Overall Study|Lost to Follow-up|1|||
13442359|NCT00330174|26918369|FG000|Overall Study|Clinical deterioration|1|||
13442360|NCT00330174|26918370|FG001|Overall Study|Clinical deterioration|2|||
13442361|NCT00330174|26918369|FG000|Overall Study|Excessive missed visits|3|||
13442362|NCT00330174|26918370|FG001|Overall Study|Excessive missed visits|8|||
13442363|NCT00330174|26918369|FG000|Overall Study|Miscellaneous reasons|7|||
13442364|NCT00330174|26918370|FG001|Overall Study|Miscellaneous reasons|1|||
13442365|NCT00329901|26918408|FG000|Overall Study|Withdrawal by Subject|4|||
13442366|NCT00329901|26918409|FG001|Overall Study|Withdrawal by Subject|3|||
13442367|NCT00329901|26918410|FG002|Overall Study|Withdrawal by Subject|2|||
13442368|NCT00329901|26918408|FG000|Overall Study|Lost to Follow-up|2|||
13442369|NCT00329901|26918409|FG001|Overall Study|Lost to Follow-up|0|||
13442370|NCT00329901|26918410|FG002|Overall Study|Lost to Follow-up|1|||
13442371|NCT00329901|26918408|FG000|Overall Study|Protocol Violation|1|||
13442372|NCT00329901|26918409|FG001|Overall Study|Protocol Violation|0|||
13442373|NCT00329901|26918410|FG002|Overall Study|Protocol Violation|1|||
13442374|NCT00329901|26918408|FG000|Overall Study|Unable to classify|2|||
13442375|NCT00329901|26918409|FG001|Overall Study|Unable to classify|2|||
13442376|NCT00329901|26918410|FG002|Overall Study|Unable to classify|0|||
13442377|NCT00329849|26918437|FG000|Overall Study|Withdrawal by Subject|6|||
13442378|NCT00329849|26918438|FG001|Overall Study|Withdrawal by Subject|4|||
13442379|NCT00329797|26918457|FG000|Overall Study|Protocol Violation|1|||
13442380|NCT00329797|26918458|FG001|Overall Study|Protocol Violation|0|||
13442381|NCT00329797|26918457|FG000|Overall Study|Withdrawal by Subject|6|||
13442382|NCT00329797|26918458|FG001|Overall Study|Withdrawal by Subject|6|||
13442383|NCT00329784|26918493|FG000|Overall Study|Lost to Follow-up|0|||
13442384|NCT00329784|26918494|FG001|Overall Study|Lost to Follow-up|1|||
13442385|NCT00329784|26918495|FG002|Overall Study|Lost to Follow-up|0|||
13442386|NCT00329784|26918496|FG003|Overall Study|Lost to Follow-up|0|||
13442387|NCT00329784|26918493|FG000|Overall Study|Withdrawal by Subject|4|||
13442388|NCT00329784|26918494|FG001|Overall Study|Withdrawal by Subject|2|||
13442389|NCT00329784|26918495|FG002|Overall Study|Withdrawal by Subject|0|||
13442390|NCT00329784|26918496|FG003|Overall Study|Withdrawal by Subject|0|||
13442391|NCT00329784|26918493|FG000|Overall Study|Other|1|||
13442392|NCT00329784|26918494|FG001|Overall Study|Other|2|||
13442393|NCT00329784|26918495|FG002|Overall Study|Other|0|||
13442394|NCT00329784|26918496|FG003|Overall Study|Other|0|||
13442395|NCT00329745|26918511|FG000|Overall Study|Protocol Violation|1|||
13442396|NCT00329745|26918512|FG001|Overall Study|Protocol Violation|0|||
13442397|NCT00329745|26918511|FG000|Overall Study|Withdrawal by Subject|0|||
13442398|NCT00329745|26918512|FG001|Overall Study|Withdrawal by Subject|1|||
13442399|NCT00329745|26918511|FG000|Overall Study|Lost to Follow-up|86|||
13442400|NCT00329745|26918512|FG001|Overall Study|Lost to Follow-up|101|||
13442401|NCT00329719|26918547|FG000|Overall Study|Lost to Follow-up|0|||
13442402|NCT00329719|26918548|FG001|Overall Study|Lost to Follow-up|0|||
13442403|NCT00329719|26918549|FG002|Overall Study|Lost to Follow-up|0|||
13442404|NCT00329719|26918550|FG003|Overall Study|Lost to Follow-up|1|||
13442405|NCT00329641|26918559|FG000|Overall Study|Did not start treatment|1|||
13442406|NCT00329641|26918559|FG000|Overall Study|Not eligible|1|||
13442407|NCT00329641|26918559|FG000|Overall Study|Adverse Event|3|||
13442408|NCT00329641|26918559|FG000|Overall Study|Other reason, not protocol specified|1|||
13442409|NCT00329602|26918602|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119|||
13442410|NCT00329602|26918603|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99|||
13442411|NCT00329602|26918604|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0|||
13442412|NCT00329602|26918602|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0|||
13442413|NCT00329602|26918603|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0|||
13442414|NCT00329602|26918604|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20|||
13442415|NCT00329602|26918602|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
13442416|NCT00329602|26918603|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
13442417|NCT00329602|26918604|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1|||
13442418|NCT00329602|26918602|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
13442419|NCT00329602|26918603|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
13442420|NCT00329602|26918604|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2|||
13442421|NCT00329602|26918602|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
13442422|NCT00329602|26918603|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
13442423|NCT00329602|26918604|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9|||
13442424|NCT00329602|26918602|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0|||
13442425|NCT00329602|26918603|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0|||
13442426|NCT00329602|26918604|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4|||
13442427|NCT00329550|26918861|FG000|Overall Study|Adverse Event|3|||
13442428|NCT00329550|26918862|FG001|Overall Study|Adverse Event|4|||
13442429|NCT00329550|26918863|FG002|Overall Study|Adverse Event|2|||
13442430|NCT00329550|26918861|FG000|Overall Study|Withdrawal of Consent|1|||
13442431|NCT00329550|26918862|FG001|Overall Study|Withdrawal of Consent|0|||
13442432|NCT00329550|26918863|FG002|Overall Study|Withdrawal of Consent|1|||
13442433|NCT00329550|26918861|FG000|Overall Study|Due to Relocation|0|||
13442434|NCT00329550|26918862|FG001|Overall Study|Due to Relocation|0|||
13442435|NCT00329550|26918863|FG002|Overall Study|Due to Relocation|1|||
13442436|NCT00329420|26919252|FG000|Re-induction Phase|Lack of Efficacy|0|||
13442437|NCT00329420|26919253|FG001|Re-induction Phase|Lack of Efficacy|1|||
13442438|NCT00329420|26919254|FG002|Re-induction Phase|Lack of Efficacy|0|||
13442439|NCT00329420|26919252|FG000|Re-induction Phase|Withdrawal of Consent|0|||
13442440|NCT00329420|26919253|FG001|Re-induction Phase|Withdrawal of Consent|0|||
13442441|NCT00329420|26919254|FG002|Re-induction Phase|Withdrawal of Consent|1|||
13442442|NCT00329420|26919252|FG000|Re-induction Phase|Did not respond to re-induction|6|||
13442443|NCT00329420|26919253|FG001|Re-induction Phase|Did not respond to re-induction|5|||
13442444|NCT00329420|26919254|FG002|Re-induction Phase|Did not respond to re-induction|7|||
13442445|NCT00329420|26919252|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2|||
13442446|NCT00329420|26919253|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
13442447|NCT00329420|26919254|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
13442448|NCT00329420|26919252|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
13442449|NCT00329420|26919253|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
13442450|NCT00329420|26919254|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0|||
13442451|NCT00329420|26919252|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1|||
13442452|NCT00329420|26919253|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
13442453|NCT00329420|26919254|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
13442454|NCT00329407|26919261|FG000|Overall Study|Withdrawal by Subject|1|||
13442455|NCT00329303|26919428|FG000|Overall Study|Lack of Efficacy|1|||
13442456|NCT00329303|26919429|FG001|Overall Study|Lack of Efficacy|0|||
13442457|NCT00329303|26919428|FG000|Overall Study|Decision of the sponsor|0|||
13442458|NCT00329303|26919429|FG001|Overall Study|Decision of the sponsor|1|||
13442459|NCT00329303|26919428|FG000|Overall Study|Patient no longer available|1|||
13442460|NCT00329303|26919429|FG001|Overall Study|Patient no longer available|0|||
13442461|NCT00329303|26919428|FG000|Overall Study|Patient relocated|0|||
13442462|NCT00329303|26919429|FG001|Overall Study|Patient relocated|1|||
13442463|NCT00329238|26919472|FG000|Overall Study|Adverse Event|147|||
13442464|NCT00329238|26919473|FG001|Overall Study|Adverse Event|129|||
13442465|NCT00329238|26919472|FG000|Overall Study|Protocol Violation|23|||
13442466|NCT00329238|26919473|FG001|Overall Study|Protocol Violation|34|||
13442467|NCT00329238|26919472|FG000|Overall Study|Lost to Follow-up|2|||
13442468|NCT00329238|26919473|FG001|Overall Study|Lost to Follow-up|6|||
13442469|NCT00329238|26919472|FG000|Overall Study|Withdrawal by Subject|64|||
13442470|NCT00329238|26919473|FG001|Overall Study|Withdrawal by Subject|58|||
13442471|NCT00329238|26919472|FG000|Overall Study|Other reason (not specified)|40|||
13442472|NCT00329238|26919473|FG001|Overall Study|Other reason (not specified)|54|||
13442473|NCT00329160|26919482|FG000|Overall Study|Adverse Event|27|||
13442474|NCT00329160|26919482|FG000|Overall Study|Withdrawal by Subject|13|||
13442475|NCT00329160|26919482|FG000|Overall Study|Protocol Violation|2|||
13442476|NCT00329160|26919482|FG000|Overall Study|Did not Receive Study Drug|1|||
13442477|NCT00329160|26919482|FG000|Overall Study|Incomplete IVUS|45|||
13442478|NCT00329108|26919495|FG000|Overall Study|Adverse Event|2|||
13442479|NCT00329108|26919496|FG001|Overall Study|Adverse Event|2|||
13442480|NCT00329108|26919495|FG000|Overall Study|Lack of Efficacy|3|||
13442481|NCT00329108|26919496|FG001|Overall Study|Lack of Efficacy|3|||
13442482|NCT00329108|26919495|FG000|Overall Study|Withdrawal by Subject|0|||
13442483|NCT00329108|26919496|FG001|Overall Study|Withdrawal by Subject|2|||
13442484|NCT00329108|26919495|FG000|Overall Study|symptomatic deterioration|1|||
13442485|NCT00329108|26919496|FG001|Overall Study|symptomatic deterioration|1|||
13442486|NCT00329108|26919495|FG000|Overall Study|Subject no longer willing to participate|2|||
13442487|NCT00329108|26919496|FG001|Overall Study|Subject no longer willing to participate|2|||
13442488|NCT00329108|26919495|FG000|Overall Study|study terminated by sponsor|1|||
13442489|NCT00329108|26919496|FG001|Overall Study|study terminated by sponsor|0|||
13442490|NCT00329108|26919495|FG000|Overall Study|withdrew patient after SAE resolved|1|||
13442491|NCT00329108|26919496|FG001|Overall Study|withdrew patient after SAE resolved|0|||
13442492|NCT00329108|26919495|FG000|Overall Study|Protocol Violation|0|||
13442493|NCT00329108|26919496|FG001|Overall Study|Protocol Violation|2|||
13442494|NCT00329030|26919531|FG000|Overall Study|Withdrawal by Subject|1|||
13442495|NCT00329030|26919532|FG001|Overall Study|Withdrawal by Subject|3|||
13442496|NCT00329030|26919531|FG000|Overall Study|Progressive Disease|6|||
13442497|NCT00329030|26919532|FG001|Overall Study|Progressive Disease|2|||
13442498|NCT00329030|26919531|FG000|Overall Study|Ineligible Pathology|1|||
13442499|NCT00329030|26919532|FG001|Overall Study|Ineligible Pathology|1|||
13442500|NCT00328926|26919556|FG000|Overall Study|Pregnancy|2|||
13442501|NCT00328926|26919557|FG001|Overall Study|Pregnancy|1|||
13442502|NCT00328926|26919558|FG002|Overall Study|Pregnancy|0|||
13442503|NCT00328926|26919556|FG000|Overall Study|Lost to Follow-up|0|||
13442504|NCT00328926|26919557|FG001|Overall Study|Lost to Follow-up|1|||
13442505|NCT00328926|26919558|FG002|Overall Study|Lost to Follow-up|0|||
13442506|NCT00328926|26919556|FG000|Overall Study|Death|0|||
13442507|NCT00328926|26919557|FG001|Overall Study|Death|0|||
13442508|NCT00328926|26919558|FG002|Overall Study|Death|1|||
13442509|NCT00328926|26919556|FG000|Overall Study|In vitro fertilization treatment|0|||
13442510|NCT00328926|26919557|FG001|Overall Study|In vitro fertilization treatment|0|||
13442511|NCT00328926|26919558|FG002|Overall Study|In vitro fertilization treatment|1|||
13442512|NCT00328926|26919556|FG000|Overall Study|Lack of ovarian response|0|||
13442513|NCT00328926|26919557|FG001|Overall Study|Lack of ovarian response|1|||
13442514|NCT00328926|26919558|FG002|Overall Study|Lack of ovarian response|0|||
13442515|NCT00328783|26919568|FG000|Overall Study|Could not tolerate ABC|21|||
13442516|NCT00328783|26919568|FG000|Overall Study|No heart in RT field|4|||
13442517|NCT00328783|26919568|FG000|Overall Study|Withdrawal by Subject|1|||
13442518|NCT00328627|26921122|FG000|Overall Study|Hyperglycemic Rescue|41|||
13442519|NCT00328627|26921123|FG001|Overall Study|Hyperglycemic Rescue|18|||
13442520|NCT00328627|26921124|FG002|Overall Study|Hyperglycemic Rescue|16|||
13442521|NCT00328627|26921125|FG003|Overall Study|Hyperglycemic Rescue|13|||
13442522|NCT00328627|26921126|FG004|Overall Study|Hyperglycemic Rescue|6|||
13442523|NCT00328627|26921127|FG005|Overall Study|Hyperglycemic Rescue|5|||
13442524|NCT00328627|26921128|FG006|Overall Study|Hyperglycemic Rescue|19|||
13442525|NCT00328627|26921129|FG007|Overall Study|Hyperglycemic Rescue|6|||
13442526|NCT00328627|26921130|FG008|Overall Study|Hyperglycemic Rescue|6|||
13442527|NCT00328627|26921131|FG009|Overall Study|Hyperglycemic Rescue|11|||
13442528|NCT00328627|26921132|FG010|Overall Study|Hyperglycemic Rescue|3|||
13442529|NCT00328627|26921133|FG011|Overall Study|Hyperglycemic Rescue|2|||
13442530|NCT00328627|26921122|FG000|Overall Study|Adverse Event|3|||
13442531|NCT00328627|26921123|FG001|Overall Study|Adverse Event|1|||
13442532|NCT00328627|26921124|FG002|Overall Study|Adverse Event|2|||
13442533|NCT00328627|26921125|FG003|Overall Study|Adverse Event|3|||
13442534|NCT00328627|26921126|FG004|Overall Study|Adverse Event|1|||
13442535|NCT00328627|26921127|FG005|Overall Study|Adverse Event|2|||
13442536|NCT00328627|26921128|FG006|Overall Study|Adverse Event|1|||
13442537|NCT00328627|26921129|FG007|Overall Study|Adverse Event|2|||
13442538|NCT00328627|26921130|FG008|Overall Study|Adverse Event|0|||
13442539|NCT00328627|26921131|FG009|Overall Study|Adverse Event|7|||
13442540|NCT00328627|26921132|FG010|Overall Study|Adverse Event|5|||
13442541|NCT00328627|26921133|FG011|Overall Study|Adverse Event|4|||
13442542|NCT00328627|26921122|FG000|Overall Study|Protocol Violation|2|||
13442543|NCT00328627|26921123|FG001|Overall Study|Protocol Violation|2|||
13442544|NCT00328627|26921124|FG002|Overall Study|Protocol Violation|2|||
13442545|NCT00328627|26921125|FG003|Overall Study|Protocol Violation|8|||
13442546|NCT00328627|26921126|FG004|Overall Study|Protocol Violation|5|||
13442547|NCT00328627|26921127|FG005|Overall Study|Protocol Violation|5|||
13442548|NCT00328627|26921128|FG006|Overall Study|Protocol Violation|6|||
13442549|NCT00328627|26921129|FG007|Overall Study|Protocol Violation|2|||
13442550|NCT00328627|26921130|FG008|Overall Study|Protocol Violation|1|||
13442551|NCT00328627|26921131|FG009|Overall Study|Protocol Violation|4|||
13442552|NCT00328627|26921132|FG010|Overall Study|Protocol Violation|6|||
13442553|NCT00328627|26921133|FG011|Overall Study|Protocol Violation|2|||
13442554|NCT00328627|26921122|FG000|Overall Study|Lost to Follow-up|4|||
13442555|NCT00328627|26921123|FG001|Overall Study|Lost to Follow-up|2|||
13442556|NCT00328627|26921124|FG002|Overall Study|Lost to Follow-up|2|||
13442557|NCT00328627|26921125|FG003|Overall Study|Lost to Follow-up|4|||
13442558|NCT00328627|26921126|FG004|Overall Study|Lost to Follow-up|0|||
13442559|NCT00328627|26921127|FG005|Overall Study|Lost to Follow-up|2|||
13442560|NCT00328627|26921128|FG006|Overall Study|Lost to Follow-up|3|||
13442561|NCT00328627|26921129|FG007|Overall Study|Lost to Follow-up|0|||
13442562|NCT00328627|26921130|FG008|Overall Study|Lost to Follow-up|3|||
13442563|NCT00328627|26921131|FG009|Overall Study|Lost to Follow-up|2|||
13442564|NCT00328627|26921132|FG010|Overall Study|Lost to Follow-up|0|||
13442565|NCT00328627|26921133|FG011|Overall Study|Lost to Follow-up|1|||
13442566|NCT00328627|26921122|FG000|Overall Study|Withdrawal by Subject|5|||
13442567|NCT00328627|26921123|FG001|Overall Study|Withdrawal by Subject|4|||
13442568|NCT00328627|26921124|FG002|Overall Study|Withdrawal by Subject|5|||
13442569|NCT00328627|26921125|FG003|Overall Study|Withdrawal by Subject|6|||
13442570|NCT00328627|26921126|FG004|Overall Study|Withdrawal by Subject|2|||
13442571|NCT00328627|26921127|FG005|Overall Study|Withdrawal by Subject|5|||
13442572|NCT00328627|26921128|FG006|Overall Study|Withdrawal by Subject|4|||
13442573|NCT00328627|26921129|FG007|Overall Study|Withdrawal by Subject|4|||
13442574|NCT00328627|26921130|FG008|Overall Study|Withdrawal by Subject|4|||
13442575|NCT00328627|26921131|FG009|Overall Study|Withdrawal by Subject|5|||
13442576|NCT00328627|26921132|FG010|Overall Study|Withdrawal by Subject|2|||
13442577|NCT00328627|26921133|FG011|Overall Study|Withdrawal by Subject|7|||
13442578|NCT00328627|26921122|FG000|Overall Study|Pregnancy|0|||
13442579|NCT00328627|26921123|FG001|Overall Study|Pregnancy|1|||
13442580|NCT00328627|26921124|FG002|Overall Study|Pregnancy|0|||
13442581|NCT00328627|26921125|FG003|Overall Study|Pregnancy|0|||
13442582|NCT00328627|26921126|FG004|Overall Study|Pregnancy|0|||
13442583|NCT00328627|26921127|FG005|Overall Study|Pregnancy|0|||
13442584|NCT00328627|26921128|FG006|Overall Study|Pregnancy|0|||
13442585|NCT00328627|26921129|FG007|Overall Study|Pregnancy|0|||
13442586|NCT00328627|26921130|FG008|Overall Study|Pregnancy|0|||
13442587|NCT00328627|26921131|FG009|Overall Study|Pregnancy|0|||
13442588|NCT00328627|26921132|FG010|Overall Study|Pregnancy|0|||
13442589|NCT00328627|26921133|FG011|Overall Study|Pregnancy|0|||
13442590|NCT00328627|26921122|FG000|Overall Study|Physician Decision|4|||
13442591|NCT00328627|26921123|FG001|Overall Study|Physician Decision|3|||
13442592|NCT00328627|26921124|FG002|Overall Study|Physician Decision|1|||
13442593|NCT00328627|26921125|FG003|Overall Study|Physician Decision|2|||
13442594|NCT00328627|26921126|FG004|Overall Study|Physician Decision|1|||
13442595|NCT00328627|26921127|FG005|Overall Study|Physician Decision|1|||
13442596|NCT00328627|26921128|FG006|Overall Study|Physician Decision|1|||
13442597|NCT00328627|26921129|FG007|Overall Study|Physician Decision|0|||
13442598|NCT00328627|26921130|FG008|Overall Study|Physician Decision|3|||
13442599|NCT00328627|26921131|FG009|Overall Study|Physician Decision|2|||
13442600|NCT00328627|26921132|FG010|Overall Study|Physician Decision|1|||
13442601|NCT00328627|26921133|FG011|Overall Study|Physician Decision|0|||
13442602|NCT00328627|26921122|FG000|Overall Study|Other|0|||
13442603|NCT00328627|26921123|FG001|Overall Study|Other|0|||
13442604|NCT00328627|26921124|FG002|Overall Study|Other|0|||
13442605|NCT00328627|26921125|FG003|Overall Study|Other|1|||
13442606|NCT00328627|26921126|FG004|Overall Study|Other|0|||
13442607|NCT00328627|26921127|FG005|Overall Study|Other|0|||
13442608|NCT00328627|26921128|FG006|Overall Study|Other|1|||
13442609|NCT00328627|26921129|FG007|Overall Study|Other|0|||
13442610|NCT00328627|26921130|FG008|Overall Study|Other|0|||
13442611|NCT00328627|26921131|FG009|Overall Study|Other|1|||
13442612|NCT00328627|26921132|FG010|Overall Study|Other|1|||
13442613|NCT00328627|26921133|FG011|Overall Study|Other|0|||
13442614|NCT00328562|26921142|FG000|Overall Study|Disease progression|1|||
13442615|NCT00328510|26921155|FG000|Overall Study|Gag disorder, could not use frame|4|||
13442616|NCT00328510|26921156|FG001|Overall Study|Gag disorder, could not use frame|0|||
13442617|NCT00328510|26921155|FG000|Overall Study|Dentition problems, could not use frame|1|||
13442618|NCT00328510|26921156|FG001|Overall Study|Dentition problems, could not use frame|0|||
13442619|NCT00328510|26921155|FG000|Overall Study|Withdrawal by Subject|4|||
13442620|NCT00328510|26921156|FG001|Overall Study|Withdrawal by Subject|2|||
13442621|NCT00328510|26921155|FG000|Overall Study|Severe kyphosis, could not use mask|0|||
13442622|NCT00328510|26921156|FG001|Overall Study|Severe kyphosis, could not use mask|1|||
13442623|NCT00328510|26921155|FG000|Overall Study|Treatment changed to a single fraction|1|||
13442624|NCT00328510|26921156|FG001|Overall Study|Treatment changed to a single fraction|1|||
13442625|NCT00328198|26921168|FG000|Treatment|Adverse Event|21|||
13442626|NCT00328198|26921168|FG000|Treatment|Death|1|||
13442627|NCT00328198|26921168|FG000|Treatment|Physician Decision|5|||
13442628|NCT00328198|26921168|FG000|Treatment|Withdrawal by Subject|5|||
13442629|NCT00328198|26921168|FG000|Treatment|Evidence of disease progression|2|||
13442630|NCT00328198|26921168|FG000|Treatment|Non-compliance|1|||
13442631|NCT00328198|26921168|FG000|Treatment|Confirmed complete response, MRD -|3|||
13442632|NCT00328198|26921168|FG000|Follow-up|Lost to Follow-up|4|||
13442633|NCT00328198|26921168|FG000|Follow-up|Death|31|||
13442634|NCT00328172|26921206|FG000|Overall Study|Adverse Event|3|||
13442635|NCT00328172|26921207|FG001|Overall Study|Adverse Event|2|||
13442636|NCT00328172|26921208|FG002|Overall Study|Adverse Event|1|||
13442637|NCT00328172|26921209|FG003|Overall Study|Adverse Event|2|||
13442638|NCT00328172|26921210|FG004|Overall Study|Adverse Event|1|||
13442639|NCT00328172|26921206|FG000|Overall Study|Protocol Violation|0|||
13442640|NCT00328172|26921207|FG001|Overall Study|Protocol Violation|1|||
13442641|NCT00328172|26921208|FG002|Overall Study|Protocol Violation|1|||
13442642|NCT00328172|26921209|FG003|Overall Study|Protocol Violation|0|||
13442643|NCT00328172|26921210|FG004|Overall Study|Protocol Violation|0|||
13442644|NCT00328172|26921206|FG000|Overall Study|Lost to Follow-up|1|||
13442645|NCT00328172|26921207|FG001|Overall Study|Lost to Follow-up|1|||
13442646|NCT00328172|26921208|FG002|Overall Study|Lost to Follow-up|2|||
13442647|NCT00328172|26921209|FG003|Overall Study|Lost to Follow-up|1|||
13442648|NCT00328172|26921210|FG004|Overall Study|Lost to Follow-up|1|||
13442649|NCT00328172|26921206|FG000|Overall Study|Withdrawal by Subject|1|||
13442650|NCT00328172|26921207|FG001|Overall Study|Withdrawal by Subject|1|||
13442651|NCT00328172|26921208|FG002|Overall Study|Withdrawal by Subject|1|||
13442652|NCT00328172|26921209|FG003|Overall Study|Withdrawal by Subject|6|||
13442653|NCT00328172|26921210|FG004|Overall Study|Withdrawal by Subject|0|||
13442654|NCT00328172|26921206|FG000|Overall Study|Lack of Efficacy|14|||
13442655|NCT00328172|26921207|FG001|Overall Study|Lack of Efficacy|9|||
13442656|NCT00328172|26921208|FG002|Overall Study|Lack of Efficacy|4|||
13442657|NCT00328172|26921209|FG003|Overall Study|Lack of Efficacy|4|||
13442658|NCT00328172|26921210|FG004|Overall Study|Lack of Efficacy|3|||
13442659|NCT00328172|26921206|FG000|Overall Study|Other reason (not specified)|3|||
13442660|NCT00328172|26921207|FG001|Overall Study|Other reason (not specified)|0|||
13442661|NCT00328172|26921208|FG002|Overall Study|Other reason (not specified)|1|||
13442662|NCT00328172|26921209|FG003|Overall Study|Other reason (not specified)|0|||
13442663|NCT00328172|26921210|FG004|Overall Study|Other reason (not specified)|0|||
13442664|NCT00328094|26921225|FG000|Overall Study|Physician Decision|3|||
13442665|NCT00328094|26921226|FG001|Overall Study|Physician Decision|3|||
13442666|NCT00327717|26921257|FG000|Overall Study|Adverse Event|6|||
13442667|NCT00327717|26921258|FG001|Overall Study|Adverse Event|6|||
13442668|NCT00327717|26921257|FG000|Overall Study|Lack of Efficacy|0|||
13442669|NCT00327717|26921258|FG001|Overall Study|Lack of Efficacy|1|||
13442670|NCT00327717|26921257|FG000|Overall Study|Withdrawal by Subject|3|||
13442671|NCT00327717|26921258|FG001|Overall Study|Withdrawal by Subject|7|||
13442672|NCT00327470|26921283|FG000|Overall Study|Randomized, but not treated|0|||
13442673|NCT00327470|26921284|FG001|Overall Study|Randomized, but not treated|2|||
13442674|NCT00327470|26921283|FG000|Overall Study|Adverse Event|9|||
13442675|NCT00327470|26921284|FG001|Overall Study|Adverse Event|14|||
13442676|NCT00327470|26921283|FG000|Overall Study|Lack of Efficacy|7|||
13442677|NCT00327470|26921284|FG001|Overall Study|Lack of Efficacy|19|||
13442678|NCT00327470|26921283|FG000|Overall Study|Other|5|||
13442679|NCT00327470|26921284|FG001|Overall Study|Other|9|||
13442680|NCT00327470|26921283|FG000|Overall Study|Lost to Follow-up|1|||
13442681|NCT00327470|26921284|FG001|Overall Study|Lost to Follow-up|3|||
13442682|NCT00327470|26921283|FG000|Overall Study|Withdrawal by Subject|6|||
13442683|NCT00327470|26921284|FG001|Overall Study|Withdrawal by Subject|12|||
13442684|NCT00327470|26921283|FG000|Overall Study|Death|1|||
13442685|NCT00327470|26921284|FG001|Overall Study|Death|4|||
13442686|NCT00327444|26921303|FG000|Double Blind Treatment (DB) Period|Disease progression|10|||
13442687|NCT00327444|26921304|FG001|Double Blind Treatment (DB) Period|Disease progression|13|||
13442688|NCT00327444|26921303|FG000|Double Blind Treatment (DB) Period|Adverse Event|5|||
13442689|NCT00327444|26921304|FG001|Double Blind Treatment (DB) Period|Adverse Event|5|||
13442690|NCT00327444|26921303|FG000|Double Blind Treatment (DB) Period|Subject request|0|||
13442691|NCT00327444|26921304|FG001|Double Blind Treatment (DB) Period|Subject request|1|||
13442692|NCT00327444|26921303|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11|||
13442693|NCT00327444|26921304|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10|||
13442694|NCT00327444|26921303|FG000|Open Label Treatment (OL) Period|Disease progression|8|||
13442695|NCT00327444|26921304|FG001|Open Label Treatment (OL) Period|Disease progression|7|||
13442696|NCT00327444|26921303|FG000|Open Label Treatment (OL) Period|Adverse Event|2|||
13442697|NCT00327444|26921304|FG001|Open Label Treatment (OL) Period|Adverse Event|2|||
13442698|NCT00327444|26921303|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0|||
13442699|NCT00327444|26921304|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1|||
13442700|NCT00327444|26921303|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1|||
13442701|NCT00327444|26921304|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0|||
13442702|NCT00327340|26921323|FG000|Overall Study|Withdrawal by Subject|1|||
13442703|NCT00327340|26921324|FG001|Overall Study|Withdrawal by Subject|5|||
13442704|NCT00327340|26921323|FG000|Overall Study|Physician Decision|1|||
13442705|NCT00327340|26921324|FG001|Overall Study|Physician Decision|1|||
13442706|NCT00327340|26921323|FG000|Overall Study|Disease Progression|10|||
13442707|NCT00327340|26921324|FG001|Overall Study|Disease Progression|19|||
13442708|NCT00327340|26921323|FG000|Overall Study|Symptomatic Disease|0|||
13442709|NCT00327340|26921324|FG001|Overall Study|Symptomatic Disease|2|||
13442710|NCT00327340|26921323|FG000|Overall Study|Adverse Event|3|||
13442711|NCT00327340|26921324|FG001|Overall Study|Adverse Event|3|||
13442712|NCT00327171|26921359|FG000|Overall Study|Did not receive study medication|3|||
13442713|NCT00327171|26921360|FG001|Overall Study|Did not receive study medication|0|||
13442714|NCT00327171|26921359|FG000|Overall Study|Adverse Event|23|||
13442715|NCT00327171|26921360|FG001|Overall Study|Adverse Event|23|||
13442716|NCT00327171|26921359|FG000|Overall Study|Disease progression/lack of efficacy|68|||
13442717|NCT00327171|26921360|FG001|Overall Study|Disease progression/lack of efficacy|69|||
13442718|NCT00327171|26921359|FG000|Overall Study|Investigator/participant request|1|||
13442719|NCT00327171|26921360|FG001|Overall Study|Investigator/participant request|8|||
13442720|NCT00327171|26921359|FG000|Overall Study|Clinical progression|12|||
13442721|NCT00327171|26921360|FG001|Overall Study|Clinical progression|8|||
13442722|NCT00327171|26921359|FG000|Overall Study|Undisclosed history of ischemia|0|||
13442723|NCT00327171|26921360|FG001|Overall Study|Undisclosed history of ischemia|1|||
13442724|NCT00327171|26921359|FG000|Overall Study|Other|1|||
13442725|NCT00327171|26921360|FG001|Overall Study|Other|0|||
13442726|NCT00327015|26921415|FG000|Overall Study|Lack of Efficacy|18|||
13442727|NCT00327015|26921416|FG001|Overall Study|Lack of Efficacy|18|||
13442728|NCT00327015|26921417|FG002|Overall Study|Lack of Efficacy|35|||
13442729|NCT00327015|26921418|FG003|Overall Study|Lack of Efficacy|29|||
13442730|NCT00327015|26921415|FG000|Overall Study|Withdrawal of Consent by Subject|20|||
13442731|NCT00327015|26921416|FG001|Overall Study|Withdrawal of Consent by Subject|24|||
13442732|NCT00327015|26921417|FG002|Overall Study|Withdrawal of Consent by Subject|28|||
13442733|NCT00327015|26921418|FG003|Overall Study|Withdrawal of Consent by Subject|25|||
13442734|NCT00327015|26921415|FG000|Overall Study|Lost to Follow-up|22|||
13442735|NCT00327015|26921416|FG001|Overall Study|Lost to Follow-up|23|||
13442736|NCT00327015|26921417|FG002|Overall Study|Lost to Follow-up|29|||
13442737|NCT00327015|26921418|FG003|Overall Study|Lost to Follow-up|22|||
13442738|NCT00327015|26921415|FG000|Overall Study|Adverse Event|14|||
13442739|NCT00327015|26921416|FG001|Overall Study|Adverse Event|10|||
13442740|NCT00327015|26921417|FG002|Overall Study|Adverse Event|14|||
13442741|NCT00327015|26921418|FG003|Overall Study|Adverse Event|14|||
13442742|NCT00327015|26921415|FG000|Overall Study|Subject no longer meets study criteria|4|||
13442743|NCT00327015|26921416|FG001|Overall Study|Subject no longer meets study criteria|2|||
13442744|NCT00327015|26921417|FG002|Overall Study|Subject no longer meets study criteria|8|||
13442745|NCT00327015|26921418|FG003|Overall Study|Subject no longer meets study criteria|7|||
13442746|NCT00327015|26921415|FG000|Overall Study|Poor/Noncompliance|11|||
13442747|NCT00327015|26921416|FG001|Overall Study|Poor/Noncompliance|8|||
13442748|NCT00327015|26921417|FG002|Overall Study|Poor/Noncompliance|4|||
13442749|NCT00327015|26921418|FG003|Overall Study|Poor/Noncompliance|5|||
13442750|NCT00327015|26921415|FG000|Overall Study|Physician Decision|0|||
13442751|NCT00327015|26921416|FG001|Overall Study|Physician Decision|1|||
13442752|NCT00327015|26921417|FG002|Overall Study|Physician Decision|3|||
13442753|NCT00327015|26921418|FG003|Overall Study|Physician Decision|2|||
13442754|NCT00327015|26921415|FG000|Overall Study|Death|1|||
13442755|NCT00327015|26921416|FG001|Overall Study|Death|2|||
13442756|NCT00327015|26921417|FG002|Overall Study|Death|2|||
13442757|NCT00327015|26921418|FG003|Overall Study|Death|3|||
13442758|NCT00327015|26921415|FG000|Overall Study|Pregnancy|0|||
13442759|NCT00327015|26921416|FG001|Overall Study|Pregnancy|2|||
13442760|NCT00327015|26921417|FG002|Overall Study|Pregnancy|1|||
13442761|NCT00327015|26921418|FG003|Overall Study|Pregnancy|1|||
13442762|NCT00327015|26921415|FG000|Overall Study|Administrative Reason by Sponsor|1|||
13442763|NCT00327015|26921416|FG001|Overall Study|Administrative Reason by Sponsor|2|||
13442764|NCT00327015|26921417|FG002|Overall Study|Administrative Reason by Sponsor|2|||
13442765|NCT00327015|26921418|FG003|Overall Study|Administrative Reason by Sponsor|1|||
13442766|NCT00326963|26921440|FG000|Overall Study|Adverse Event|2|||
13442767|NCT00326963|26921440|FG000|Overall Study|Injection site reaction|1|||
13442768|NCT00326963|26921440|FG000|Overall Study|Death|1|||
13442769|NCT00326963|26921440|FG000|Overall Study|Failure to return|10|||
13442770|NCT00326963|26921440|FG000|Overall Study|Withdrawal by Subject|10|||
13442771|NCT00326963|26921440|FG000|Overall Study|Refused treatment / did not cooperate|5|||
13442772|NCT00326963|26921440|FG000|Overall Study|Violation of selection criteria at entry|2|||
13442773|NCT00326963|26921440|FG000|Overall Study|Other protocol violation|1|||
13442774|NCT00326963|26921440|FG000|Overall Study|Administrative / other|1|||
13442775|NCT00326950|26921447|FG000|Overall Study|Progressive Disease|1|||
13442776|NCT00326911|26921504|FG000|Overall Study|Hospitalization prior to treatment|0|||
13442777|NCT00326911|26921505|FG001|Overall Study|Hospitalization prior to treatment|1|||
13442778|NCT00326911|26921504|FG000|Overall Study|Physician decision prior to treatment|1|||
13442779|NCT00326911|26921505|FG001|Overall Study|Physician decision prior to treatment|0|||
13442780|NCT00326911|26921504|FG000|Overall Study|Withdrawal by subject prior to treatment|0|||
13442781|NCT00326911|26921505|FG001|Overall Study|Withdrawal by subject prior to treatment|1|||
13442782|NCT00326898|26921532|FG000|Overall Study|Disease progression|52|||
13442783|NCT00326898|26921533|FG001|Overall Study|Disease progression|54|||
13442784|NCT00326898|26921534|FG002|Overall Study|Disease progression|102|||
13442785|NCT00326898|26921532|FG000|Overall Study|Adverse Event|124|||
13442786|NCT00326898|26921533|FG001|Overall Study|Adverse Event|128|||
13442787|NCT00326898|26921534|FG002|Overall Study|Adverse Event|33|||
13442788|NCT00326898|26921532|FG000|Overall Study|Death|2|||
13442789|NCT00326898|26921533|FG001|Overall Study|Death|0|||
13442790|NCT00326898|26921534|FG002|Overall Study|Death|0|||
13442791|NCT00326898|26921532|FG000|Overall Study|Withdrawal by Subject|134|||
13442792|NCT00326898|26921533|FG001|Overall Study|Withdrawal by Subject|128|||
13442793|NCT00326898|26921534|FG002|Overall Study|Withdrawal by Subject|32|||
13442794|NCT00326898|26921532|FG000|Overall Study|Alternative therapy|1|||
13442795|NCT00326898|26921533|FG001|Overall Study|Alternative therapy|0|||
13442796|NCT00326898|26921534|FG002|Overall Study|Alternative therapy|0|||
13442797|NCT00326898|26921532|FG000|Overall Study|Other complicating disease|5|||
13442798|NCT00326898|26921533|FG001|Overall Study|Other complicating disease|5|||
13442799|NCT00326898|26921534|FG002|Overall Study|Other complicating disease|4|||
13442800|NCT00326898|26921532|FG000|Overall Study|Other/Missing/Unknown|33|||
13442801|NCT00326898|26921533|FG001|Overall Study|Other/Missing/Unknown|28|||
13442802|NCT00326898|26921534|FG002|Overall Study|Other/Missing/Unknown|32|||
13442803|NCT00326885|26921545|FG000|Overall Study|Adverse Event|1|||
13442804|NCT00326885|26921545|FG000|Overall Study|Withdrawal by Subject|3|||
13442805|NCT00326885|26921545|FG000|Overall Study|Physician Decision|1|||
13442806|NCT00326885|26921545|FG000|Overall Study|Hospice withdrew consent|2|||
13442807|NCT00326716|26921624|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1|||
13442808|NCT00326716|26921625|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2|||
13442809|NCT00326716|26921626|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
13442810|NCT00326716|26921627|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
13442811|NCT00326625|26921642|FG000|Overall Study|Adverse Event|20|||
13442812|NCT00326625|26921643|FG001|Overall Study|Adverse Event|9|||
13442813|NCT00326625|26921642|FG000|Overall Study|Withdrawal by Subject|15|||
13442814|NCT00326625|26921643|FG001|Overall Study|Withdrawal by Subject|12|||
13442815|NCT00326625|26921642|FG000|Overall Study|Death|18|||
13442816|NCT00326625|26921643|FG001|Overall Study|Death|16|||
13442817|NCT00326625|26921642|FG000|Overall Study|Lost to Follow-up|1|||
13442818|NCT00326625|26921643|FG001|Overall Study|Lost to Follow-up|0|||
13442819|NCT00326625|26921642|FG000|Overall Study|prescheduled medical intervention|0|||
13442820|NCT00326625|26921643|FG001|Overall Study|prescheduled medical intervention|1|||
13442821|NCT00326612|26921668|FG000|Overall Study|They did not have a seizure requiring tx|129|||
13442822|NCT00326612|26921669|FG001|Overall Study|They did not have a seizure requiring tx|137|||
13442823|NCT00326599|26921701|FG000|Overall Study|Withdrawal by Subject|1|||
13442824|NCT00326599|26921702|FG001|Overall Study|Withdrawal by Subject|0|||
13442825|NCT00326599|26921703|FG002|Overall Study|Withdrawal by Subject|5|||
13442826|NCT00326599|26921704|FG003|Overall Study|Withdrawal by Subject|2|||
13442827|NCT00326599|26921701|FG000|Overall Study|Adverse Event|1|||
13442828|NCT00326599|26921702|FG001|Overall Study|Adverse Event|0|||
13442829|NCT00326599|26921703|FG002|Overall Study|Adverse Event|32|||
13442830|NCT00326599|26921704|FG003|Overall Study|Adverse Event|3|||
13442831|NCT00326599|26921701|FG000|Overall Study|Disease Progression|3|||
13442832|NCT00326599|26921702|FG001|Overall Study|Disease Progression|1|||
13442833|NCT00326599|26921703|FG002|Overall Study|Disease Progression|13|||
13442834|NCT00326599|26921704|FG003|Overall Study|Disease Progression|11|||
13442835|NCT00326599|26921701|FG000|Overall Study|Alternate Treatment|1|||
13442836|NCT00326599|26921702|FG001|Overall Study|Alternate Treatment|0|||
13442837|NCT00326599|26921703|FG002|Overall Study|Alternate Treatment|0|||
13442838|NCT00326599|26921704|FG003|Overall Study|Alternate Treatment|0|||
13442839|NCT00326599|26921701|FG000|Overall Study|Death|0|||
13442840|NCT00326599|26921702|FG001|Overall Study|Death|0|||
13442841|NCT00326599|26921703|FG002|Overall Study|Death|1|||
13442842|NCT00326599|26921704|FG003|Overall Study|Death|2|||
13442843|NCT00326599|26921701|FG000|Overall Study|Other Unspecified Reason|0|||
13442844|NCT00326599|26921702|FG001|Overall Study|Other Unspecified Reason|0|||
13442845|NCT00326599|26921703|FG002|Overall Study|Other Unspecified Reason|2|||
13442846|NCT00326599|26921704|FG003|Overall Study|Other Unspecified Reason|1|||
13442847|NCT00326495|26921711|FG000|Overall Study|Switched to alternative treatment|1|||
13442848|NCT00326495|26921711|FG000|Overall Study|Disease progression before treatment|1|||
13442849|NCT00326495|26921711|FG000|Overall Study|Refused further treatment|2|||
13442850|NCT00326495|26921711|FG000|Overall Study|Subject off study before assessment|1|||
13442851|NCT00326417|26921736|FG000|Overall Study|Withdrawal by Subject|0|||
13442852|NCT00326417|26921737|FG001|Overall Study|Withdrawal by Subject|0|||
13442853|NCT00326417|26921738|FG002|Overall Study|Withdrawal by Subject|1|||
13442854|NCT00326417|26921739|FG003|Overall Study|Withdrawal by Subject|0|||
13442855|NCT00326417|26921736|FG000|Overall Study|Arm Closed|7|||
13442856|NCT00326417|26921737|FG001|Overall Study|Arm Closed|0|||
13442857|NCT00326417|26921738|FG002|Overall Study|Arm Closed|0|||
13442858|NCT00326417|26921739|FG003|Overall Study|Arm Closed|3|||
13442859|NCT00326417|26921736|FG000|Overall Study|Death|7|||
13442860|NCT00326417|26921737|FG001|Overall Study|Death|0|||
13442861|NCT00326417|26921738|FG002|Overall Study|Death|0|||
13442862|NCT00326417|26921739|FG003|Overall Study|Death|0|||
13442863|NCT00326209|26921748|FG000|Overall Study|Adverse Event|28|||
13442864|NCT00326209|26921748|FG000|Overall Study|Withdrawal by Subject|22|||
13442865|NCT00326209|26921748|FG000|Overall Study|Lack of Efficacy|31|||
13442866|NCT00326209|26921748|FG000|Overall Study|Lost to Follow-up|18|||
13442867|NCT00326209|26921748|FG000|Overall Study|Participant non-compliant|6|||
13442868|NCT00326209|26921748|FG000|Overall Study|Sponsor closed study|173|||
13442869|NCT00326209|26921748|FG000|Overall Study|Prohibited medication use|1|||
13442870|NCT00326209|26921748|FG000|Overall Study|Violation of entry criteria|1|||
13442871|NCT00326209|26921748|FG000|Overall Study|Withdrawn in error|1|||
13442872|NCT00326209|26921748|FG000|Overall Study|Pregnancy|1|||
13442873|NCT00326118|26921789|FG000|Active Phase|Withdrawal by Subject|4|||
13442874|NCT00326118|26921790|FG001|Active Phase|Withdrawal by Subject|1|||
13442875|NCT00326001|26921809|FG000|Overall Study|Adverse Event|4|||
13442876|NCT00326001|26921810|FG001|Overall Study|Adverse Event|5|||
13442877|NCT00326001|26921809|FG000|Overall Study|Physician Decision|3|||
13442878|NCT00326001|26921810|FG001|Overall Study|Physician Decision|3|||
13442879|NCT00325897|26921835|FG000|Overall Study|Lost to Follow-up|12|||
13442880|NCT00325897|26921836|FG001|Overall Study|Lost to Follow-up|13|||
13442881|NCT00325819|26921863|FG000|Overall Study|Study product lost in mail|2|||
13442882|NCT00325819|26921864|FG001|Overall Study|Study product lost in mail|1|||
13442883|NCT00325819|26921863|FG000|Overall Study|Did not take a dose of study product|4|||
13442884|NCT00325819|26921864|FG001|Overall Study|Did not take a dose of study product|9|||
13442885|NCT00325819|26921863|FG000|Overall Study|Lost to Follow-up|3|||
13442886|NCT00325819|26921864|FG001|Overall Study|Lost to Follow-up|3|||
13442887|NCT00325754|26921885|FG000|Overall Study|Adverse Event|4|||
13442888|NCT00325754|26921886|FG001|Overall Study|Adverse Event|1|||
13442889|NCT00325468|26921935|FG000|Overall Study|Adverse Event|1|||
13442890|NCT00325468|26921936|FG001|Overall Study|Adverse Event|1|||
13442891|NCT00325468|26921937|FG002|Overall Study|Adverse Event|0|||
13442892|NCT00325468|26921938|FG003|Overall Study|Adverse Event|5|||
13442893|NCT00325468|26921939|FG004|Overall Study|Adverse Event|1|||
13442894|NCT00325468|26921935|FG000|Overall Study|Death|2|||
13442895|NCT00325468|26921936|FG001|Overall Study|Death|0|||
13442896|NCT00325468|26921937|FG002|Overall Study|Death|2|||
13442897|NCT00325468|26921938|FG003|Overall Study|Death|4|||
13442898|NCT00325468|26921939|FG004|Overall Study|Death|0|||
13442899|NCT00325468|26921935|FG000|Overall Study|Lost to Follow-up|0|||
13442900|NCT00325468|26921936|FG001|Overall Study|Lost to Follow-up|0|||
13442901|NCT00325468|26921937|FG002|Overall Study|Lost to Follow-up|1|||
13442902|NCT00325468|26921938|FG003|Overall Study|Lost to Follow-up|2|||
13442903|NCT00325468|26921939|FG004|Overall Study|Lost to Follow-up|2|||
13442904|NCT00325468|26921935|FG000|Overall Study|Physician Decision|1|||
13442905|NCT00325468|26921936|FG001|Overall Study|Physician Decision|1|||
13442906|NCT00325468|26921937|FG002|Overall Study|Physician Decision|0|||
13442907|NCT00325468|26921938|FG003|Overall Study|Physician Decision|1|||
13442908|NCT00325468|26921939|FG004|Overall Study|Physician Decision|0|||
13442909|NCT00325468|26921935|FG000|Overall Study|Withdrawal by Subject|3|||
13442910|NCT00325468|26921936|FG001|Overall Study|Withdrawal by Subject|1|||
13442911|NCT00325468|26921937|FG002|Overall Study|Withdrawal by Subject|0|||
13442912|NCT00325468|26921938|FG003|Overall Study|Withdrawal by Subject|14|||
13442913|NCT00325468|26921939|FG004|Overall Study|Withdrawal by Subject|4|||
13442914|NCT00325468|26921935|FG000|Overall Study|site closure etc|4|||
13442915|NCT00325468|26921936|FG001|Overall Study|site closure etc|2|||
13442916|NCT00325468|26921937|FG002|Overall Study|site closure etc|1|||
13442917|NCT00325468|26921938|FG003|Overall Study|site closure etc|8|||
13442918|NCT00325468|26921939|FG004|Overall Study|site closure etc|1|||
13442919|NCT00325416|26921958|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8|||
13442920|NCT00325416|26921959|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9|||
13442921|NCT00325416|26921958|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7|||
13442922|NCT00325416|26921959|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4|||
13442923|NCT00325416|26921958|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7|||
13442924|NCT00325416|26921959|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2|||
13442925|NCT00325416|26921958|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0|||
13442926|NCT00325416|26921959|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1|||
13442927|NCT00325416|26921958|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0|||
13442928|NCT00325416|26921959|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1|||
13442929|NCT00325416|26921958|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0|||
13442930|NCT00325416|26921959|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1|||
13442931|NCT00325234|26921982|FG000|Overall Study|Adverse Event|10|||
13442932|NCT00325234|26921983|FG001|Overall Study|Adverse Event|7|||
13442933|NCT00325234|26921982|FG000|Overall Study|Death due to Study Disease|1|||
13442934|NCT00325234|26921983|FG001|Overall Study|Death due to Study Disease|0|||
13442935|NCT00325234|26921982|FG000|Overall Study|Entry Criteria Not Met|1|||
13442936|NCT00325234|26921983|FG001|Overall Study|Entry Criteria Not Met|2|||
13442937|NCT00325234|26921982|FG000|Overall Study|Subject Decision|6|||
13442938|NCT00325234|26921983|FG001|Overall Study|Subject Decision|8|||
13442939|NCT00325234|26921982|FG000|Overall Study|Physician Decision|17|||
13442940|NCT00325234|26921983|FG001|Overall Study|Physician Decision|12|||
13442941|NCT00325234|26921982|FG000|Overall Study|Progressive Disease|34|||
13442942|NCT00325234|26921983|FG001|Overall Study|Progressive Disease|37|||
13442943|NCT00325195|26922016|FG000|Randomized|Not dosed|5|||
13442944|NCT00325195|26922017|FG001|Randomized|Not dosed|5|||
13442945|NCT00325195|26922018|FG002|Randomized|Not dosed|3|||
13442946|NCT00325195|26922016|FG000|Received Intervention: ITT Population|Adverse Event|15|||
13442947|NCT00325195|26922017|FG001|Received Intervention: ITT Population|Adverse Event|17|||
13442948|NCT00325195|26922018|FG002|Received Intervention: ITT Population|Adverse Event|1|||
13442949|NCT00325195|26922016|FG000|Received Intervention: ITT Population|Death|3|||
13442950|NCT00325195|26922017|FG001|Received Intervention: ITT Population|Death|1|||
13442951|NCT00325195|26922018|FG002|Received Intervention: ITT Population|Death|0|||
13442952|NCT00325195|26922016|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7|||
13442953|NCT00325195|26922017|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6|||
13442954|NCT00325195|26922018|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1|||
13442955|NCT00325195|26922016|FG000|Received Intervention: ITT Population|Lost to Follow-up|0|||
13442956|NCT00325195|26922017|FG001|Received Intervention: ITT Population|Lost to Follow-up|0|||
13442957|NCT00325195|26922018|FG002|Received Intervention: ITT Population|Lost to Follow-up|2|||
13442958|NCT00325195|26922016|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
13306289|NCT01292603|26525396|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
13442959|NCT00325195|26922017|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
13442960|NCT00325195|26922018|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0|||
13442961|NCT00325156|26922027|FG000|Overall Study|Protocol Violation|8|||
13442962|NCT00325156|26922027|FG000|Overall Study|Lost to follow-up (complete vaccination)|41|||
13442963|NCT00325156|26922027|FG000|Overall Study|Migrated/moved from study area|12|||
13442964|NCT00325156|26922027|FG000|Overall Study|Adverse event, non-fatal|3|||
13442965|NCT00325156|26922027|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16|||
13442966|NCT00325156|26922027|FG000|Overall Study|Other|1|||
13442967|NCT00325156|26922027|FG000|Overall Study|Withdrawal by Subject|31|||
13442968|NCT00325143|26922037|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13|||
13442969|NCT00325143|26922037|FG000|Overall Study|Migrated/moved from study area|1|||
13442970|NCT00325143|26922037|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4|||
13442971|NCT00325143|26922037|FG000|Overall Study|Withdrawal by Subject|8|||
13442972|NCT00325130|26922084|FG000|Overall Study|Lost to Follow-up|6|||
13442973|NCT00325130|26922085|FG001|Overall Study|Lost to Follow-up|14|||
13442974|NCT00325130|26922084|FG000|Overall Study|Withdrawal by Subject|12|||
13442975|NCT00325130|26922085|FG001|Overall Study|Withdrawal by Subject|14|||
13442976|NCT00325130|26922084|FG000|Overall Study|Protocol Deviation|0|||
13442977|NCT00325130|26922085|FG001|Overall Study|Protocol Deviation|1|||
13442978|NCT00325130|26922084|FG000|Overall Study|Moved|0|||
13442979|NCT00325130|26922085|FG001|Overall Study|Moved|1|||
13442980|NCT00325130|26922084|FG000|Overall Study|Patient Discontinued for Other|1|||
13442981|NCT00325130|26922085|FG001|Overall Study|Patient Discontinued for Other|0|||
13442982|NCT00325039|26922106|FG000|Overall Study|Lost to Follow-up|18|||
13442983|NCT00325039|26922107|FG001|Overall Study|Lost to Follow-up|14|||
13442984|NCT00324987|26922128|FG000|Overall Study|Adverse Event|2|||
13442985|NCT00324987|26922129|FG001|Overall Study|Adverse Event|1|||
13442986|NCT00324987|26922128|FG000|Overall Study|Withdrawal by Subject|1|||
13442987|NCT00324987|26922129|FG001|Overall Study|Withdrawal by Subject|1|||
13442988|NCT00324987|26922128|FG000|Overall Study|Progression|1|||
13442989|NCT00324987|26922129|FG001|Overall Study|Progression|1|||
13442990|NCT00324987|26922128|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2|||
13442991|NCT00324987|26922129|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3|||
13442992|NCT00324961|26922144|FG000|Overall Study|Adverse Event|5|||
13442993|NCT00324961|26922144|FG000|Overall Study|Consent Withdrawn|11|||
13442994|NCT00324961|26922144|FG000|Overall Study|Lost to Follow-up|22|||
13442995|NCT00324961|26922144|FG000|Overall Study|Protocol Violation|3|||
13442996|NCT00324961|26922144|FG000|Overall Study|Other|2|||
13442997|NCT00324740|26922158|FG000|Overall Study|Withdrawal by Subject|1|||
13442998|NCT00324740|26922159|FG001|Overall Study|Withdrawal by Subject|0|||
13442999|NCT00324740|26922160|FG002|Overall Study|Withdrawal by Subject|1|||
13443000|NCT00324675|26922173|FG000|Overall Study|Adverse Event|1|||
13443001|NCT00324675|26922174|FG001|Overall Study|Adverse Event|0|||
13443002|NCT00324649|26922221|FG000|Overall Study|Adverse Event|1|||
13443003|NCT00324649|26922222|FG001|Overall Study|Adverse Event|4|||
13443004|NCT00324649|26922221|FG000|Overall Study|Withdrawal by Subject|0|||
13443005|NCT00324649|26922222|FG001|Overall Study|Withdrawal by Subject|1|||
13443006|NCT00324649|26922221|FG000|Overall Study|Noncompliance|1|||
13443007|NCT00324649|26922222|FG001|Overall Study|Noncompliance|0|||
13443008|NCT00324233|26922235|FG000|First Period|unable to insert catheter|1|||
13443009|NCT00324233|26922236|FG001|First Period|unable to insert catheter|0|||
13443010|NCT00324233|26922235|FG000|Second Period|unable to insert catheter|1|||
13443011|NCT00324233|26922236|FG001|Second Period|unable to insert catheter|1|||
13443012|NCT00324233|26922235|FG000|Second Period|Protocol Violation|4|||
13443013|NCT00324233|26922236|FG001|Second Period|Protocol Violation|6|||
13443014|NCT00324168|26922269|FG000|Overall Study|Lost to Follow-up|19|||
13443015|NCT00324168|26922270|FG001|Overall Study|Lost to Follow-up|18|||
13443016|NCT00324168|26922269|FG000|Overall Study|Death|3|||
13443017|NCT00324168|26922270|FG001|Overall Study|Death|3|||
13443018|NCT00324168|26922269|FG000|Overall Study|Patient did not visit in f/u window|6|||
13443019|NCT00324168|26922270|FG001|Overall Study|Patient did not visit in f/u window|9|||
13443020|NCT00324155|26922307|FG000|Enrolled and Randomized|No longer met study criteria|3|||
13443021|NCT00324155|26922308|FG001|Enrolled and Randomized|No longer met study criteria|0|||
13443022|NCT00324155|26922307|FG000|Enrolled and Randomized|Lost to Follow-up|0|||
13443023|NCT00324155|26922308|FG001|Enrolled and Randomized|Lost to Follow-up|1|||
13443024|NCT00324155|26922307|FG000|Received Treatment in Induction Phase|Disease Progression|88|||
13443025|NCT00324155|26922308|FG001|Received Treatment in Induction Phase|Disease Progression|152|||
13443026|NCT00324155|26922307|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83|||
13443027|NCT00324155|26922308|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10|||
13443028|NCT00324155|26922307|FG000|Received Treatment in Induction Phase|Death|8|||
13443029|NCT00324155|26922308|FG001|Received Treatment in Induction Phase|Death|15|||
13443030|NCT00324155|26922307|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9|||
13443031|NCT00324155|26922308|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8|||
13443032|NCT00324155|26922307|FG000|Received Treatment in Induction Phase|Adverse Event|6|||
13443033|NCT00324155|26922308|FG001|Received Treatment in Induction Phase|Adverse Event|7|||
13443034|NCT00324155|26922307|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6|||
13443035|NCT00324155|26922308|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5|||
13443036|NCT00324155|26922307|FG000|Received Treatment in Induction Phase|Physician Decision|2|||
13443037|NCT00324155|26922308|FG001|Received Treatment in Induction Phase|Physician Decision|0|||
13443038|NCT00324155|26922307|FG000|Received Treatment in Maintenance Phase|Disease Progression|26|||
13443039|NCT00324155|26922308|FG001|Received Treatment in Maintenance Phase|Disease Progression|41|||
13443040|NCT00324155|26922307|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4|||
13443041|NCT00324155|26922308|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0|||
13443042|NCT00324155|26922307|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1|||
13443043|NCT00324155|26922308|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3|||
13443044|NCT00324155|26922307|FG000|Received Treatment in Maintenance Phase|Adverse Event|0|||
13443045|NCT00324155|26922308|FG001|Received Treatment in Maintenance Phase|Adverse Event|3|||
13443046|NCT00324155|26922307|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1|||
13443047|NCT00324155|26922308|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0|||
13443048|NCT00324155|26922307|FG000|Follow-up Phase|On-going participants still on drug|11|||
13443049|NCT00324155|26922308|FG001|Follow-up Phase|On-going participants still on drug|6|||
13443050|NCT00324116|26922320|FG000|Overall Study|Adverse Event|5|||
13443051|NCT00324116|26922320|FG000|Overall Study|Lack of Efficacy|17|||
13443052|NCT00324116|26922320|FG000|Overall Study|Withdrawal by Subject|5|||
13443053|NCT00324116|26922320|FG000|Overall Study|Other|5|||
13443054|NCT00324038|26922333|FG000|Overall Study|Adverse Event|38|||
13443055|NCT00324038|26922334|FG001|Overall Study|Adverse Event|23|||
13443056|NCT00324038|26922333|FG000|Overall Study|Lack of Efficacy|5|||
13443057|NCT00324038|26922334|FG001|Overall Study|Lack of Efficacy|13|||
13443058|NCT00324038|26922333|FG000|Overall Study|Lost to Follow-up|0|||
13443059|NCT00324038|26922334|FG001|Overall Study|Lost to Follow-up|2|||
13443060|NCT00324038|26922333|FG000|Overall Study|Other|6|||
13443061|NCT00324038|26922334|FG001|Overall Study|Other|13|||
13443062|NCT00323882|26922421|FG000|Overall Study|Adverse Event|2|||
13443063|NCT00323882|26922422|FG001|Overall Study|Adverse Event|1|||
13443064|NCT00323882|26922423|FG002|Overall Study|Adverse Event|1|||
13443065|NCT00323882|26922424|FG003|Overall Study|Adverse Event|1|||
13443066|NCT00323882|26922425|FG004|Overall Study|Adverse Event|3|||
13443067|NCT00323882|26922421|FG000|Overall Study|Disease Progression|6|||
13443068|NCT00323882|26922422|FG001|Overall Study|Disease Progression|4|||
13443069|NCT00323882|26922423|FG002|Overall Study|Disease Progression|10|||
13443070|NCT00323882|26922424|FG003|Overall Study|Disease Progression|5|||
13443071|NCT00323882|26922425|FG004|Overall Study|Disease Progression|22|||
13443072|NCT00323882|26922421|FG000|Overall Study|Death|0|||
13443073|NCT00323882|26922422|FG001|Overall Study|Death|1|||
13443074|NCT00323882|26922423|FG002|Overall Study|Death|1|||
13443075|NCT00323882|26922424|FG003|Overall Study|Death|0|||
13443076|NCT00323882|26922425|FG004|Overall Study|Death|5|||
13443077|NCT00323882|26922421|FG000|Overall Study|Lost to Follow-up|0|||
13443078|NCT00323882|26922422|FG001|Overall Study|Lost to Follow-up|0|||
13443079|NCT00323882|26922423|FG002|Overall Study|Lost to Follow-up|1|||
13443080|NCT00323882|26922424|FG003|Overall Study|Lost to Follow-up|0|||
13443081|NCT00323882|26922425|FG004|Overall Study|Lost to Follow-up|1|||
13443082|NCT00323882|26922421|FG000|Overall Study|Other|0|||
13443083|NCT00323882|26922422|FG001|Overall Study|Other|0|||
13443084|NCT00323882|26922423|FG002|Overall Study|Other|0|||
13443085|NCT00323882|26922424|FG003|Overall Study|Other|1|||
13443086|NCT00323882|26922425|FG004|Overall Study|Other|1|||
13443087|NCT00323869|26922439|FG000|Overall Study|Death|1|||
13443088|NCT00323622|26922504|FG000|Overall Study|Other|30|||
13443089|NCT00323622|26922505|FG001|Overall Study|Other|91|||
13443090|NCT00323622|26922506|FG002|Overall Study|Other|4|||
13443091|NCT00323622|26922507|FG003|Overall Study|Other|12|||
13443092|NCT00323622|26922508|FG004|Overall Study|Other|32|||
13443093|NCT00323622|26922509|FG005|Overall Study|Other|74|||
13443094|NCT00323622|26922510|FG006|Overall Study|Other|5|||
13443095|NCT00323622|26922511|FG007|Overall Study|Other|13|||
13443096|NCT00323622|26922504|FG000|Overall Study|Death|1|||
13443097|NCT00323622|26922505|FG001|Overall Study|Death|1|||
13443098|NCT00323622|26922506|FG002|Overall Study|Death|0|||
13443099|NCT00323622|26922507|FG003|Overall Study|Death|0|||
13443100|NCT00323622|26922508|FG004|Overall Study|Death|7|||
13443101|NCT00323622|26922509|FG005|Overall Study|Death|0|||
13306290|NCT01292603|26525397|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
13443102|NCT00323622|26922510|FG006|Overall Study|Death|0|||
13443103|NCT00323622|26922511|FG007|Overall Study|Death|2|||
13443104|NCT00323609|26922554|FG000|Overall Study|Death|16|||
13443105|NCT00323609|26922555|FG001|Overall Study|Death|21|||
13443106|NCT00323609|26922556|FG002|Overall Study|Death|0|||
13443107|NCT00323609|26922557|FG003|Overall Study|Death|0|||
13443108|NCT00323609|26922554|FG000|Overall Study|Lost to Follow-up|9|||
13443109|NCT00323609|26922555|FG001|Overall Study|Lost to Follow-up|10|||
13443110|NCT00323609|26922556|FG002|Overall Study|Lost to Follow-up|0|||
13443111|NCT00323609|26922557|FG003|Overall Study|Lost to Follow-up|0|||
13443112|NCT00323609|26922554|FG000|Overall Study|Physician Decision|2|||
13443113|NCT00323609|26922555|FG001|Overall Study|Physician Decision|0|||
13443114|NCT00323609|26922556|FG002|Overall Study|Physician Decision|0|||
13443115|NCT00323609|26922557|FG003|Overall Study|Physician Decision|1|||
13443116|NCT00323609|26922554|FG000|Overall Study|Withdrawal by Subject|11|||
13443117|NCT00323609|26922555|FG001|Overall Study|Withdrawal by Subject|23|||
13443118|NCT00323609|26922556|FG002|Overall Study|Withdrawal by Subject|4|||
13443119|NCT00323609|26922557|FG003|Overall Study|Withdrawal by Subject|4|||
13443120|NCT00323609|26922554|FG000|Overall Study|Other non-VCF-related medical condition|3|||
13443121|NCT00323609|26922555|FG001|Overall Study|Other non-VCF-related medical condition|2|||
13443122|NCT00323609|26922556|FG002|Overall Study|Other non-VCF-related medical condition|0|||
13443123|NCT00323609|26922557|FG003|Overall Study|Other non-VCF-related medical condition|0|||
13443124|NCT00323609|26922554|FG000|Overall Study|Sponsor discontinued trial|29|||
13443125|NCT00323609|26922555|FG001|Overall Study|Sponsor discontinued trial|29|||
13443126|NCT00323609|26922556|FG002|Overall Study|Sponsor discontinued trial|0|||
13443127|NCT00323609|26922557|FG003|Overall Study|Sponsor discontinued trial|0|||
13443128|NCT00323609|26922554|FG000|Overall Study|Unrelenting or severe back pain|1|||
13443129|NCT00323609|26922555|FG001|Overall Study|Unrelenting or severe back pain|1|||
13443130|NCT00323609|26922556|FG002|Overall Study|Unrelenting or severe back pain|0|||
13443131|NCT00323609|26922557|FG003|Overall Study|Unrelenting or severe back pain|0|||
13443132|NCT00323609|26922554|FG000|Overall Study|Logistical withdrawal|9|||
13443133|NCT00323609|26922555|FG001|Overall Study|Logistical withdrawal|5|||
13443134|NCT00323609|26922556|FG002|Overall Study|Logistical withdrawal|0|||
13443135|NCT00323609|26922557|FG003|Overall Study|Logistical withdrawal|1|||
13443136|NCT00323609|26922554|FG000|Overall Study|Other reason|11|||
13443137|NCT00323609|26922555|FG001|Overall Study|Other reason|8|||
13443138|NCT00323609|26922556|FG002|Overall Study|Other reason|4|||
13443139|NCT00323609|26922557|FG003|Overall Study|Other reason|9|||
13443140|NCT00323557|26922571|FG000|Overall Study|Physician Decision|1|||
13443141|NCT00323557|26922572|FG001|Overall Study|Physician Decision|0|||
13443142|NCT00323492|26922611|FG000|Study Phase 1|Adverse Event|2|||
13443143|NCT00323492|26922612|FG001|Study Phase 1|Adverse Event|0|||
13443144|NCT00323492|26922613|FG002|Study Phase 1|Adverse Event|0|||
13443145|NCT00323492|26922611|FG000|Study Phase 2|Adverse Event|1|||
13443146|NCT00323492|26922612|FG001|Study Phase 2|Adverse Event|0|||
13443147|NCT00323492|26922613|FG002|Study Phase 2|Adverse Event|0|||
13443148|NCT00323492|26922611|FG000|Study Phase 2|Physician Decision|1|||
13443149|NCT00323492|26922612|FG001|Study Phase 2|Physician Decision|0|||
13443150|NCT00323492|26922613|FG002|Study Phase 2|Physician Decision|0|||
13443151|NCT00323492|26922611|FG000|Study Phase 2|Lost to Follow-up|1|||
13443152|NCT00323492|26922612|FG001|Study Phase 2|Lost to Follow-up|0|||
13443153|NCT00323492|26922613|FG002|Study Phase 2|Lost to Follow-up|0|||
13443154|NCT00323492|26922611|FG000|Study Phase 2|Withdrawal by Subject|0|||
13443155|NCT00323492|26922612|FG001|Study Phase 2|Withdrawal by Subject|1|||
13443156|NCT00323492|26922613|FG002|Study Phase 2|Withdrawal by Subject|0|||
13443157|NCT00323492|26922611|FG000|Study Phase 2|Noncompliance with study schedule|0|||
13443158|NCT00323492|26922612|FG001|Study Phase 2|Noncompliance with study schedule|0|||
13443159|NCT00323492|26922613|FG002|Study Phase 2|Noncompliance with study schedule|1|||
13443160|NCT00323492|26922611|FG000|Study Phase 2|Protocol Violation|1|||
13443161|NCT00323492|26922612|FG001|Study Phase 2|Protocol Violation|0|||
13443162|NCT00323492|26922613|FG002|Study Phase 2|Protocol Violation|0|||
13443163|NCT00323479|26922624|FG000|Overall Study|Adverse Event|2|||
13443164|NCT00323479|26922624|FG000|Overall Study|Withdrawal by Subject|2|||
13443165|NCT00323479|26922624|FG000|Overall Study|Protocol Violation|3|||
13443166|NCT00323479|26922624|FG000|Overall Study|house moving|1|||
13443167|NCT00323414|26922647|FG000|Overall Study|Withdrawal by Subject|0|||
13443168|NCT00323414|26922648|FG001|Overall Study|Withdrawal by Subject|1|||
13443169|NCT00323310|26922663|FG000|Overall Study|Withdrawal by Subject|1|||
13443170|NCT00323310|26922663|FG000|Overall Study|a parent refused blood draw|1|||
13443171|NCT00323310|26922663|FG000|Overall Study|did not complete the 24-hr f-up visit|1|||
13443172|NCT00323297|26922686|FG000|Part A (Double Blind Randomized)|Reason unspecified|0|||
13443173|NCT00323297|26922687|FG001|Part A (Double Blind Randomized)|Reason unspecified|1|||
13443174|NCT00323297|26922686|FG000|Part A (Double Blind Randomized)|Death|0|||
13443175|NCT00323297|26922687|FG001|Part A (Double Blind Randomized)|Death|1|||
13443176|NCT00323297|26922686|FG000|Part A (Double Blind Randomized)|Protocol Violation|1|||
13443177|NCT00323297|26922687|FG001|Part A (Double Blind Randomized)|Protocol Violation|3|||
13443178|NCT00323297|26922686|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1|||
13443179|NCT00323297|26922687|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0|||
13443180|NCT00323297|26922686|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1|||
13443181|NCT00323297|26922687|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0|||
13443182|NCT00323297|26922686|FG000|Part A (Double Blind Randomized)|Related adverse event|2|||
13443183|NCT00323297|26922687|FG001|Part A (Double Blind Randomized)|Related adverse event|2|||
13443184|NCT00323297|26922686|FG000|Part B (Open-label)|Death|0|||
13443185|NCT00323297|26922687|FG001|Part B (Open-label)|Death|1|||
13443186|NCT00323297|26922686|FG000|Part B (Open-label)|Reason unspecified|0|||
13443187|NCT00323297|26922687|FG001|Part B (Open-label)|Reason unspecified|1|||
13443188|NCT00323297|26922686|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
13443189|NCT00323297|26922687|FG001|Part B (Open-label)|Withdrawal by Subject|3|||
13443190|NCT00323297|26922686|FG000|Part B (Open-label)|Lack of Efficacy|3|||
13443191|NCT00323297|26922687|FG001|Part B (Open-label)|Lack of Efficacy|1|||
13443192|NCT00323297|26922686|FG000|Part B (Open-label)|Adverse Event|5|||
13443193|NCT00323297|26922687|FG001|Part B (Open-label)|Adverse Event|5|||
13443194|NCT00323297|26922686|FG000|Part B (Open-label)|Protocol Violation|0|||
13443195|NCT00323297|26922687|FG001|Part B (Open-label)|Protocol Violation|1|||
13443196|NCT00323258|26922708|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1|||
13443197|NCT00323258|26922709|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2|||
13443198|NCT00323258|26922708|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12|||
13443199|NCT00323258|26922709|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11|||
13443200|NCT00323258|26922708|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1|||
13443201|NCT00323258|26922709|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5|||
13443202|NCT00323258|26922708|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2|||
13443203|NCT00323258|26922709|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1|||
13443204|NCT00323258|26922708|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1|||
13443205|NCT00323258|26922709|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2|||
13443206|NCT00323258|26922708|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12|||
13443207|NCT00323258|26922709|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10|||
13443208|NCT00323258|26922708|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1|||
13443209|NCT00323258|26922709|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2|||
13477176|NCT00330759|27005671|FG000|Overall Study|Protocol deviation|0|||
13477177|NCT00330759|27005672|FG001|Overall Study|Protocol deviation|2|||
13477178|NCT00330759|27005671|FG000|Overall Study|Ineligibility determined|2|||
13477179|NCT00330759|27005672|FG001|Overall Study|Ineligibility determined|1|||
13477180|NCT00330759|27005671|FG000|Overall Study|Other|36|||
13477181|NCT00330759|27005672|FG001|Overall Study|Other|44|||
13477182|NCT00113763|27005703|FG000|Overall Study|Adverse Event|5|||
13477183|NCT00113763|27005704|FG001|Overall Study|Adverse Event|2|||
13477184|NCT00113763|27005703|FG000|Overall Study|Disease Progression|28|||
13477185|NCT00113763|27005704|FG001|Overall Study|Disease Progression|14|||
13477186|NCT00113763|27005703|FG000|Overall Study|Lost to Follow-up|10|||
13477187|NCT00113763|27005704|FG001|Overall Study|Lost to Follow-up|0|||
13477188|NCT00113763|27005703|FG000|Overall Study|Withdrawal by Subject|1|||
13477189|NCT00113763|27005704|FG001|Overall Study|Withdrawal by Subject|4|||
13477190|NCT00113763|27005703|FG000|Overall Study|Other|27|||
13477191|NCT00113763|27005704|FG001|Overall Study|Other|6|||
13477192|NCT00113763|27005703|FG000|Overall Study|Non-compliance|1|||
13477193|NCT00113763|27005704|FG001|Overall Study|Non-compliance|0|||
13477194|NCT00113763|27005703|FG000|Overall Study|Ongoing|1|||
13477195|NCT00113763|27005704|FG001|Overall Study|Ongoing|0|||
13443210|NCT00323115|26922736|FG000|Vaccine Administration|Adverse Event|1|||
13443211|NCT00323115|26922736|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8|||
13443212|NCT00323063|26922753|FG000|Overall Study|Adverse Event|1|||
13443213|NCT00323063|26922754|FG001|Overall Study|Adverse Event|0|||
13443214|NCT00323063|26922753|FG000|Overall Study|brain mets discovered prior to treatment|1|||
13443215|NCT00323063|26922754|FG001|Overall Study|brain mets discovered prior to treatment|0|||
13443216|NCT00322881|26922760|FG000|Overall Study|Death|2|||
13443217|NCT00322881|26922760|FG000|Overall Study|Adverse Event|1|||
13443218|NCT00322881|26922760|FG000|Overall Study|Disease Progression|2|||
13443219|NCT00322868|26922781|FG000|Overall Study|disease progression|1|||
13443220|NCT00322842|26922813|FG000|Overall Study|Withdrawal by Subject|0|||
13443221|NCT00322842|26922814|FG001|Overall Study|Withdrawal by Subject|1|||
13443222|NCT00322842|26922813|FG000|Overall Study|Lost to Follow-up|0|||
13443223|NCT00322842|26922814|FG001|Overall Study|Lost to Follow-up|1|||
13443224|NCT00322842|26922813|FG000|Overall Study|Refused transplant|1|||
13443225|NCT00322842|26922814|FG001|Overall Study|Refused transplant|0|||
13443226|NCT00322842|26922813|FG000|Overall Study|Death|1|||
13443227|NCT00322842|26922814|FG001|Overall Study|Death|0|||
13443228|NCT00322712|26922820|FG000|Overall Study|treated with bevacizumab not cetuximab|1|||
13443229|NCT00322621|26922876|FG000|Period II - Acute Therapy Phase|Adverse Event|20|||
13443230|NCT00322621|26922877|FG001|Period II - Acute Therapy Phase|Adverse Event|0|||
13443231|NCT00322621|26922878|FG002|Period II - Acute Therapy Phase|Adverse Event|0|||
13443232|NCT00322621|26922876|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1|||
13443233|NCT00322621|26922877|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
13443234|NCT00322621|26922878|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
13443235|NCT00322621|26922876|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8|||
13443236|NCT00322621|26922877|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
13443237|NCT00322621|26922878|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
13443238|NCT00322621|26922876|FG000|Period II - Acute Therapy Phase|Protocol Violation|2|||
13443239|NCT00322621|26922877|FG001|Period II - Acute Therapy Phase|Protocol Violation|0|||
13443240|NCT00322621|26922878|FG002|Period II - Acute Therapy Phase|Protocol Violation|0|||
13443241|NCT00322621|26922876|FG000|Period II - Acute Therapy Phase|Physician Decision|1|||
13443242|NCT00322621|26922877|FG001|Period II - Acute Therapy Phase|Physician Decision|0|||
13443243|NCT00322621|26922878|FG002|Period II - Acute Therapy Phase|Physician Decision|0|||
13443244|NCT00322621|26922876|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0|||
13443245|NCT00322621|26922877|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14|||
13443246|NCT00322621|26922878|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5|||
13443247|NCT00322621|26922876|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0|||
13443248|NCT00322621|26922877|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4|||
13443249|NCT00322621|26922878|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24|||
13443250|NCT00322621|26922876|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0|||
13443251|NCT00322621|26922877|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7|||
13443252|NCT00322621|26922878|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1|||
13443253|NCT00322621|26922876|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0|||
13443254|NCT00322621|26922877|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2|||
13443255|NCT00322621|26922878|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5|||
13443256|NCT00322621|26922876|FG000|Period III - Maintenance / Rescue Phase|Death|0|||
13443257|NCT00322621|26922877|FG001|Period III - Maintenance / Rescue Phase|Death|1|||
13443258|NCT00322621|26922878|FG002|Period III - Maintenance / Rescue Phase|Death|0|||
13443259|NCT00322621|26922876|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0|||
13443260|NCT00322621|26922877|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
13443261|NCT00322621|26922878|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
13443262|NCT00322556|26922894|FG000|Overall Study|Adverse Event|1|||
13443263|NCT00322556|26922894|FG000|Overall Study|Withdrawal by Subject|1|||
13443264|NCT00322556|26922894|FG000|Overall Study|Lost to Follow-up|3|||
13443265|NCT00322556|26922894|FG000|Overall Study|Other Reason|7|||
13443266|NCT00322491|26922923|FG000|Overall Study|Adverse Event|1|||
13443267|NCT00322491|26922924|FG001|Overall Study|Adverse Event|0|||
13443268|NCT00322491|26922923|FG000|Overall Study|Death|1|||
13443269|NCT00322491|26922924|FG001|Overall Study|Death|2|||
13443270|NCT00322452|26922967|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
13443271|NCT00322452|26922968|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
13443272|NCT00322452|26922967|FG000|Overall Study|Lost to Follow-up|5|||
13443273|NCT00322452|26922968|FG001|Overall Study|Lost to Follow-up|2|||
13443274|NCT00322452|26922967|FG000|Overall Study|Withdrawal by Subject|19|||
13443275|NCT00322452|26922968|FG001|Overall Study|Withdrawal by Subject|46|||
13443276|NCT00322452|26922967|FG000|Overall Study|Death|223|||
13443277|NCT00322452|26922968|FG001|Overall Study|Death|227|||
13443278|NCT00322387|26923006|FG000|Treatment Period|Adverse Event|0|||
13443279|NCT00322387|26923007|FG001|Treatment Period|Adverse Event|1|||
13443280|NCT00322387|26923006|FG000|Follow-up Period|Final assessment not done|1|||
13443281|NCT00322387|26923007|FG001|Follow-up Period|Final assessment not done|3|||
13443282|NCT00322387|26923006|FG000|Follow-up Period|Death|1|||
13443283|NCT00322387|26923007|FG001|Follow-up Period|Death|0|||
13443284|NCT00322374|26923066|FG000|Starting Dose|Physician Decision|2|||
13443285|NCT00322374|26923067|FG001|Starting Dose|Physician Decision|0|||
13443286|NCT00322374|26923068|FG002|Starting Dose|Physician Decision|0|||
13443287|NCT00322374|26923069|FG003|Starting Dose|Physician Decision|0|||
13443288|NCT00322374|26923066|FG000|Starting Dose|Study Drug Toxicity|4|||
13443289|NCT00322374|26923067|FG001|Starting Dose|Study Drug Toxicity|0|||
13443290|NCT00322374|26923068|FG002|Starting Dose|Study Drug Toxicity|0|||
13443291|NCT00322374|26923069|FG003|Starting Dose|Study Drug Toxicity|0|||
13443292|NCT00322374|26923066|FG000|First Escalation|Documented Disease Progression|0|||
13443293|NCT00322374|26923067|FG001|First Escalation|Documented Disease Progression|6|||
13443294|NCT00322374|26923068|FG002|First Escalation|Documented Disease Progression|0|||
13443295|NCT00322374|26923069|FG003|First Escalation|Documented Disease Progression|0|||
13443296|NCT00322374|26923066|FG000|First Escalation|Physician Decision|0|||
13443297|NCT00322374|26923067|FG001|First Escalation|Physician Decision|12|||
13443298|NCT00322374|26923068|FG002|First Escalation|Physician Decision|0|||
13443299|NCT00322374|26923069|FG003|First Escalation|Physician Decision|0|||
13443300|NCT00322374|26923066|FG000|First Escalation|Study Drug Toxicity|0|||
13443301|NCT00322374|26923067|FG001|First Escalation|Study Drug Toxicity|11|||
13443302|NCT00322374|26923068|FG002|First Escalation|Study Drug Toxicity|0|||
13443303|NCT00322374|26923069|FG003|First Escalation|Study Drug Toxicity|0|||
13443304|NCT00322374|26923066|FG000|First Escalation|Participant Request|0|||
13443305|NCT00322374|26923067|FG001|First Escalation|Participant Request|1|||
13443306|NCT00322374|26923068|FG002|First Escalation|Participant Request|0|||
13443307|NCT00322374|26923069|FG003|First Escalation|Participant Request|0|||
13443308|NCT00322374|26923066|FG000|Second Escalation|Physician Decision|0|||
13443309|NCT00322374|26923067|FG001|Second Escalation|Physician Decision|0|||
13443310|NCT00322374|26923068|FG002|Second Escalation|Physician Decision|5|||
13443311|NCT00322374|26923069|FG003|Second Escalation|Physician Decision|0|||
13443312|NCT00322374|26923066|FG000|Second Escalation|Study Drug Toxicity|0|||
13443313|NCT00322374|26923067|FG001|Second Escalation|Study Drug Toxicity|0|||
13443314|NCT00322374|26923068|FG002|Second Escalation|Study Drug Toxicity|1|||
13443315|NCT00322374|26923069|FG003|Second Escalation|Study Drug Toxicity|0|||
13443316|NCT00322348|26923092|FG000|Overall Study|Adverse Event|0|||
13443317|NCT00322348|26923093|FG001|Overall Study|Adverse Event|1|||
13443318|NCT00322348|26923092|FG000|Overall Study|Withdrawal by Subject|1|||
13443319|NCT00322348|26923093|FG001|Overall Study|Withdrawal by Subject|4|||
13443320|NCT00322348|26923092|FG000|Overall Study|Lost to Follow-up|1|||
13443321|NCT00322348|26923093|FG001|Overall Study|Lost to Follow-up|0|||
13443322|NCT00322348|26923092|FG000|Overall Study|Death|0|||
13443323|NCT00322348|26923093|FG001|Overall Study|Death|2|||
13443324|NCT00322348|26923092|FG000|Overall Study|Disease Progression|30|||
13443325|NCT00322348|26923093|FG001|Overall Study|Disease Progression|25|||
13443326|NCT00322348|26923092|FG000|Overall Study|Reasons not specified|5|||
13443327|NCT00322348|26923093|FG001|Overall Study|Reasons not specified|1|||
13443328|NCT00322153|26923110|FG000|Overall Study|Adverse Event|21|||
13443329|NCT00322153|26923111|FG001|Overall Study|Adverse Event|34|||
13443330|NCT00322153|26923110|FG000|Overall Study|Protocol Violation|6|||
13443331|NCT00322153|26923111|FG001|Overall Study|Protocol Violation|14|||
13443332|NCT00322153|26923110|FG000|Overall Study|Withdrawal by Subject|18|||
13443333|NCT00322153|26923111|FG001|Overall Study|Withdrawal by Subject|10|||
13443334|NCT00322153|26923110|FG000|Overall Study|Lack of Efficacy|8|||
13443335|NCT00322153|26923111|FG001|Overall Study|Lack of Efficacy|3|||
13443336|NCT00322153|26923110|FG000|Overall Study|Lost to Follow-up|5|||
13443337|NCT00322153|26923111|FG001|Overall Study|Lost to Follow-up|4|||
13443338|NCT00322153|26923110|FG000|Overall Study|Withdrawn for other reasons|5|||
13443339|NCT00322153|26923111|FG001|Overall Study|Withdrawn for other reasons|4|||
13443340|NCT00322049|26923154|FG000|Overall Study|Moved out of area|0|||
13443341|NCT00322049|26923155|FG001|Overall Study|Moved out of area|0|||
13443342|NCT00322049|26923156|FG002|Overall Study|Moved out of area|0|||
13443343|NCT00322049|26923157|FG003|Overall Study|Moved out of area|1|||
13443344|NCT00322049|26923154|FG000|Overall Study|Infected with Dengue during study|0|||
13443345|NCT00322049|26923155|FG001|Overall Study|Infected with Dengue during study|1|||
13443346|NCT00322049|26923156|FG002|Overall Study|Infected with Dengue during study|0|||
13443347|NCT00322049|26923157|FG003|Overall Study|Infected with Dengue during study|0|||
13443348|NCT00322023|26923181|FG000|Overall Study|various|0|||
13443349|NCT00322023|26923182|FG001|Overall Study|various|2|||
13443350|NCT00322023|26923183|FG002|Overall Study|various|6|||
13443351|NCT00321984|26923210|FG000|Overall Study|Adverse Event|9|||
13443352|NCT00321984|26923211|FG001|Overall Study|Adverse Event|6|||
13443353|NCT00321984|26923212|FG002|Overall Study|Adverse Event|8|||
13443354|NCT00321984|26923210|FG000|Overall Study|Protocol Violation|0|||
13443355|NCT00321984|26923211|FG001|Overall Study|Protocol Violation|1|||
13443356|NCT00321984|26923212|FG002|Overall Study|Protocol Violation|1|||
13443357|NCT00321984|26923210|FG000|Overall Study|Lost to Follow-up|2|||
13443358|NCT00321984|26923211|FG001|Overall Study|Lost to Follow-up|4|||
13443359|NCT00321984|26923212|FG002|Overall Study|Lost to Follow-up|2|||
13443360|NCT00321984|26923210|FG000|Overall Study|Withdrawal by Subject|8|||
13443361|NCT00321984|26923211|FG001|Overall Study|Withdrawal by Subject|6|||
13443362|NCT00321984|26923212|FG002|Overall Study|Withdrawal by Subject|5|||
13443363|NCT00321984|26923210|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3|||
13443364|NCT00321984|26923211|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
13443365|NCT00321984|26923212|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
13443366|NCT00321984|26923210|FG000|Overall Study|Lack of Efficacy|3|||
13443367|NCT00321984|26923211|FG001|Overall Study|Lack of Efficacy|1|||
13443368|NCT00321984|26923212|FG002|Overall Study|Lack of Efficacy|3|||
13443369|NCT00321984|26923210|FG000|Overall Study|Noncompliant|0|||
13443370|NCT00321984|26923211|FG001|Overall Study|Noncompliant|0|||
13443371|NCT00321984|26923212|FG002|Overall Study|Noncompliant|2|||
13443372|NCT00321984|26923210|FG000|Overall Study|Pregnancy|0|||
13443373|NCT00321984|26923211|FG001|Overall Study|Pregnancy|1|||
13443374|NCT00321984|26923212|FG002|Overall Study|Pregnancy|0|||
13443375|NCT00321984|26923210|FG000|Overall Study|Per Subject Request|1|||
13443376|NCT00321984|26923211|FG001|Overall Study|Per Subject Request|0|||
13443377|NCT00321984|26923212|FG002|Overall Study|Per Subject Request|0|||
13443378|NCT00321984|26923210|FG000|Overall Study|Per Investigator Request|1|||
13443379|NCT00321984|26923211|FG001|Overall Study|Per Investigator Request|0|||
13443380|NCT00321984|26923212|FG002|Overall Study|Per Investigator Request|0|||
13443381|NCT00321984|26923210|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
13443382|NCT00321984|26923211|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1|||
13443383|NCT00321984|26923212|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
13443384|NCT00321932|26923241|FG000|Overall Study|Death|3|||
13443385|NCT00321932|26923242|FG001|Overall Study|Death|6|||
13443386|NCT00321932|26923241|FG000|Overall Study|Withdrawal by Subject|3|||
13443387|NCT00321932|26923242|FG001|Overall Study|Withdrawal by Subject|6|||
13443388|NCT00321932|26923241|FG000|Overall Study|Early relapse|2|||
13443389|NCT00321932|26923242|FG001|Overall Study|Early relapse|8|||
13443390|NCT00321932|26923241|FG000|Overall Study|Missing data|2|||
13443391|NCT00321932|26923242|FG001|Overall Study|Missing data|1|||
13443392|NCT00321919|26923289|FG000|Overall Study|Adverse Event|17|||
13443393|NCT00321919|26923290|FG001|Overall Study|Adverse Event|10|||
13443394|NCT00321919|26923289|FG000|Overall Study|Death|21|||
13443395|NCT00321919|26923290|FG001|Overall Study|Death|17|||
13443396|NCT00321919|26923289|FG000|Overall Study|Insufficient Therapeutic Response|1|||
13443397|NCT00321919|26923290|FG001|Overall Study|Insufficient Therapeutic Response|0|||
13443398|NCT00321919|26923289|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
13443399|NCT00321919|26923290|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
13443400|NCT00321919|26923289|FG000|Overall Study|Refused Treatment|23|||
13443401|NCT00321919|26923290|FG001|Overall Study|Refused Treatment|14|||
13443402|NCT00321919|26923289|FG000|Overall Study|Other Protocol Violation|2|||
13443403|NCT00321919|26923290|FG001|Overall Study|Other Protocol Violation|3|||
13443404|NCT00321919|26923289|FG000|Overall Study|Failure to Return|3|||
13443405|NCT00321919|26923290|FG001|Overall Study|Failure to Return|1|||
13443406|NCT00321919|26923289|FG000|Overall Study|Other withdrawal reason|7|||
13443407|NCT00321919|26923290|FG001|Overall Study|Other withdrawal reason|6|||
13443408|NCT00321906|26923317|FG000|Overall Study|Adverse Event|36|||
13443409|NCT00321906|26923318|FG001|Overall Study|Adverse Event|44|||
13443410|NCT00321906|26923317|FG000|Overall Study|Death|9|||
13443411|NCT00321906|26923318|FG001|Overall Study|Death|6|||
13443412|NCT00321906|26923317|FG000|Overall Study|Lost to Follow-up|1|||
13443413|NCT00321906|26923318|FG001|Overall Study|Lost to Follow-up|2|||
13443414|NCT00321906|26923317|FG000|Overall Study|Withdrawal by Subject|0|||
13443415|NCT00321906|26923318|FG001|Overall Study|Withdrawal by Subject|4|||
13443416|NCT00321893|26923337|FG000|Overall Study|Non-Compliance/Refusal|16|||
13443417|NCT00321893|26923338|FG001|Overall Study|Non-Compliance/Refusal|10|||
13443418|NCT00321893|26923337|FG000|Overall Study|Lost to Follow-up|2|||
13443419|NCT00321893|26923338|FG001|Overall Study|Lost to Follow-up|1|||
13443420|NCT00321893|26923337|FG000|Overall Study|Adverse Event|6|||
13443421|NCT00321893|26923338|FG001|Overall Study|Adverse Event|3|||
13443422|NCT00321854|26923463|FG000|Overall Study|Adverse Event|41|||
13443423|NCT00321854|26923464|FG001|Overall Study|Adverse Event|43|||
13443424|NCT00321854|26923463|FG000|Overall Study|Lack of Efficacy|9|||
13443425|NCT00321854|26923464|FG001|Overall Study|Lack of Efficacy|14|||
13443426|NCT00321854|26923463|FG000|Overall Study|Protocol Violation|6|||
13443427|NCT00321854|26923464|FG001|Overall Study|Protocol Violation|5|||
13443428|NCT00321854|26923463|FG000|Overall Study|Lost to Follow-up|0|||
13443429|NCT00321854|26923464|FG001|Overall Study|Lost to Follow-up|2|||
13443430|NCT00321854|26923463|FG000|Overall Study|Withdrawal by Subject|6|||
13443431|NCT00321854|26923464|FG001|Overall Study|Withdrawal by Subject|17|||
13443432|NCT00321854|26923463|FG000|Overall Study|Other|1|||
13443433|NCT00321854|26923464|FG001|Overall Study|Other|1|||
13443434|NCT00321828|26923470|FG000|Overall Study|Ineligible|3|||
13443435|NCT00321828|26923470|FG000|Overall Study|No follow up data|1|||
13443436|NCT00321789|26923505|FG000|Overall Study|Lost to Follow-up|4|||
13443437|NCT00321789|26923506|FG001|Overall Study|Lost to Follow-up|7|||
13443438|NCT00321789|26923505|FG000|Overall Study|Withdrawal by Subject|6|||
13443439|NCT00321789|26923506|FG001|Overall Study|Withdrawal by Subject|6|||
13443440|NCT00321789|26923505|FG000|Overall Study|Protocol Violation|5|||
13443441|NCT00321789|26923506|FG001|Overall Study|Protocol Violation|3|||
13443442|NCT00321763|26923576|FG000|Overall Study|Adverse Event|1|||
13443443|NCT00321763|26923577|FG001|Overall Study|Adverse Event|1|||
13443444|NCT00321763|26923578|FG002|Overall Study|Adverse Event|0|||
13443445|NCT00321763|26923579|FG003|Overall Study|Adverse Event|1|||
13443446|NCT00321763|26923576|FG000|Overall Study|Withdrawal by Subject|2|||
13443447|NCT00321763|26923577|FG001|Overall Study|Withdrawal by Subject|0|||
13443448|NCT00321763|26923578|FG002|Overall Study|Withdrawal by Subject|1|||
13443449|NCT00321763|26923579|FG003|Overall Study|Withdrawal by Subject|0|||
13443450|NCT00321763|26923576|FG000|Overall Study|Lost to Follow-up|3|||
13443451|NCT00321763|26923577|FG001|Overall Study|Lost to Follow-up|1|||
13443452|NCT00321763|26923578|FG002|Overall Study|Lost to Follow-up|5|||
13443453|NCT00321763|26923579|FG003|Overall Study|Lost to Follow-up|4|||
13443454|NCT00321737|26923612|FG000|Overall Study|Relapse of Erosive Esophagitis|76|||
13443455|NCT00321737|26923613|FG001|Overall Study|Relapse of Erosive Esophagitis|25|||
13443456|NCT00321737|26923614|FG002|Overall Study|Relapse of Erosive Esophagitis|19|||
13443457|NCT00321737|26923612|FG000|Overall Study|Adverse Event|11|||
13443458|NCT00321737|26923613|FG001|Overall Study|Adverse Event|3|||
13443459|NCT00321737|26923614|FG002|Overall Study|Adverse Event|6|||
13443460|NCT00321737|26923612|FG000|Overall Study|Lost to Follow-up|5|||
13443461|NCT00321737|26923613|FG001|Overall Study|Lost to Follow-up|5|||
13443462|NCT00321737|26923614|FG002|Overall Study|Lost to Follow-up|6|||
13443463|NCT00321737|26923612|FG000|Overall Study|Withdrawal by Subject|19|||
13443464|NCT00321737|26923613|FG001|Overall Study|Withdrawal by Subject|12|||
13443465|NCT00321737|26923614|FG002|Overall Study|Withdrawal by Subject|17|||
13443466|NCT00321737|26923612|FG000|Overall Study|Protocol Violation|0|||
13443467|NCT00321737|26923613|FG001|Overall Study|Protocol Violation|0|||
13443468|NCT00321737|26923614|FG002|Overall Study|Protocol Violation|1|||
13443469|NCT00321737|26923612|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
13443470|NCT00321737|26923613|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
13443471|NCT00321737|26923614|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
13443472|NCT00321737|26923612|FG000|Overall Study|Possible Barrett's Esophagus|2|||
13443473|NCT00321737|26923613|FG001|Overall Study|Possible Barrett's Esophagus|1|||
13443474|NCT00321737|26923614|FG002|Overall Study|Possible Barrett's Esophagus|1|||
13443475|NCT00321737|26923612|FG000|Overall Study|Therapeutic Failure|6|||
13443476|NCT00321737|26923613|FG001|Overall Study|Therapeutic Failure|0|||
13443477|NCT00321737|26923614|FG002|Overall Study|Therapeutic Failure|2|||
13443478|NCT00321737|26923612|FG000|Overall Study|Pregnancy|0|||
13443479|NCT00321737|26923613|FG001|Overall Study|Pregnancy|2|||
13443480|NCT00321737|26923614|FG002|Overall Study|Pregnancy|0|||
13443481|NCT00321737|26923612|FG000|Overall Study|Noncompliance|2|||
13443482|NCT00321737|26923613|FG001|Overall Study|Noncompliance|0|||
13443483|NCT00321737|26923614|FG002|Overall Study|Noncompliance|0|||
13443484|NCT00321737|26923612|FG000|Overall Study|Subject Request/ Subject Unavailable|0|||
13443485|NCT00321737|26923613|FG001|Overall Study|Subject Request/ Subject Unavailable|0|||
13443486|NCT00321737|26923614|FG002|Overall Study|Subject Request/ Subject Unavailable|2|||
13443487|NCT00321711|26923657|FG000|Part A|Adverse Event|3|||
13443488|NCT00321711|26923658|FG001|Part A|Adverse Event|3|||
13443489|NCT00321711|26923659|FG002|Part A|Adverse Event|2|||
13443490|NCT00321711|26923660|FG003|Part A|Adverse Event|0|||
13443491|NCT00321711|26923661|FG004|Part A|Adverse Event|0|||
13443492|NCT00321711|26923657|FG000|Part A|Withdrawal by Subject|1|||
13443493|NCT00321711|26923658|FG001|Part A|Withdrawal by Subject|1|||
13443494|NCT00321711|26923659|FG002|Part A|Withdrawal by Subject|1|||
13443495|NCT00321711|26923660|FG003|Part A|Withdrawal by Subject|0|||
13443496|NCT00321711|26923661|FG004|Part A|Withdrawal by Subject|0|||
13443497|NCT00321711|26923657|FG000|Part A|Disease progression|0|||
13443498|NCT00321711|26923658|FG001|Part A|Disease progression|1|||
13443499|NCT00321711|26923659|FG002|Part A|Disease progression|0|||
13443500|NCT00321711|26923660|FG003|Part A|Disease progression|0|||
13443501|NCT00321711|26923661|FG004|Part A|Disease progression|0|||
13443502|NCT00321711|26923657|FG000|Part A|Requirement for alternative therapy|0|||
13443503|NCT00321711|26923658|FG001|Part A|Requirement for alternative therapy|2|||
13443504|NCT00321711|26923659|FG002|Part A|Requirement for alternative therapy|1|||
13443505|NCT00321711|26923660|FG003|Part A|Requirement for alternative therapy|0|||
13443506|NCT00321711|26923661|FG004|Part A|Requirement for alternative therapy|0|||
13443507|NCT00321711|26923657|FG000|Part A|Physician Decision|0|||
13443508|NCT00321711|26923658|FG001|Part A|Physician Decision|1|||
13443509|NCT00321711|26923659|FG002|Part A|Physician Decision|3|||
13443510|NCT00321711|26923660|FG003|Part A|Physician Decision|0|||
13443511|NCT00321711|26923661|FG004|Part A|Physician Decision|0|||
13443512|NCT00321711|26923657|FG000|Part A|Other|1|||
13443513|NCT00321711|26923658|FG001|Part A|Other|2|||
13443514|NCT00321711|26923659|FG002|Part A|Other|3|||
13443515|NCT00321711|26923660|FG003|Part A|Other|0|||
13443516|NCT00321711|26923661|FG004|Part A|Other|0|||
13443517|NCT00321711|26923657|FG000|Part A|Protocol deviation|0|||
13443518|NCT00321711|26923658|FG001|Part A|Protocol deviation|0|||
13443519|NCT00321711|26923659|FG002|Part A|Protocol deviation|1|||
13443520|NCT00321711|26923660|FG003|Part A|Protocol deviation|0|||
13443521|NCT00321711|26923661|FG004|Part A|Protocol deviation|0|||
13443522|NCT00321711|26923657|FG000|Part B|Noncompliance|0|||
13443523|NCT00321711|26923658|FG001|Part B|Noncompliance|0|||
13443524|NCT00321711|26923659|FG002|Part B|Noncompliance|0|||
13443525|NCT00321711|26923660|FG003|Part B|Noncompliance|0|||
13443526|NCT00321711|26923661|FG004|Part B|Noncompliance|1|||
13443527|NCT00321711|26923657|FG000|Part B|Adverse Event|0|||
13443528|NCT00321711|26923658|FG001|Part B|Adverse Event|0|||
13443529|NCT00321711|26923659|FG002|Part B|Adverse Event|0|||
13443530|NCT00321711|26923660|FG003|Part B|Adverse Event|2|||
13443531|NCT00321711|26923661|FG004|Part B|Adverse Event|1|||
13443532|NCT00321711|26923657|FG000|Part B|Disease progression|0|||
13443533|NCT00321711|26923658|FG001|Part B|Disease progression|0|||
13443534|NCT00321711|26923659|FG002|Part B|Disease progression|0|||
13443535|NCT00321711|26923660|FG003|Part B|Disease progression|1|||
13443536|NCT00321711|26923661|FG004|Part B|Disease progression|0|||
13443537|NCT00321711|26923657|FG000|Part B|Physician Decision|0|||
13443538|NCT00321711|26923658|FG001|Part B|Physician Decision|0|||
13443539|NCT00321711|26923659|FG002|Part B|Physician Decision|0|||
13443540|NCT00321711|26923660|FG003|Part B|Physician Decision|1|||
13443541|NCT00321711|26923661|FG004|Part B|Physician Decision|2|||
13443542|NCT00321711|26923657|FG000|Part B|Death|0|||
13443543|NCT00321711|26923658|FG001|Part B|Death|0|||
13443544|NCT00321711|26923659|FG002|Part B|Death|0|||
13443545|NCT00321711|26923660|FG003|Part B|Death|2|||
13443546|NCT00321711|26923661|FG004|Part B|Death|1|||
13443547|NCT00321685|26923671|FG000|Overall Study|Adverse Event|18|||
13443548|NCT00321685|26923671|FG000|Overall Study|Death|2|||
13443549|NCT00321685|26923671|FG000|Overall Study|Withdrawal by Subject|8|||
13443550|NCT00321685|26923671|FG000|Overall Study|Alternative therapy|1|||
13443551|NCT00321685|26923671|FG000|Overall Study|Complicating disese|1|||
13443552|NCT00321685|26923671|FG000|Overall Study|Other|5|||
13443553|NCT00321685|26923671|FG000|Overall Study|Not start protocol therapy|2|||
13443554|NCT00321685|26923671|FG000|Overall Study|Ineligible|2|||
13443555|NCT00321672|26923710|FG000|Overall Study|Withdrawal by Subject|5|||
13443556|NCT00321672|26923711|FG001|Overall Study|Withdrawal by Subject|1|||
13443557|NCT00321672|26923712|FG002|Overall Study|Withdrawal by Subject|2|||
13443558|NCT00321672|26923713|FG003|Overall Study|Withdrawal by Subject|0|||
13443559|NCT00321672|26923710|FG000|Overall Study|Noncompliance|1|||
13443560|NCT00321672|26923711|FG001|Overall Study|Noncompliance|2|||
13443561|NCT00321672|26923712|FG002|Overall Study|Noncompliance|1|||
13443562|NCT00321672|26923713|FG003|Overall Study|Noncompliance|0|||
13443563|NCT00321672|26923710|FG000|Overall Study|Adverse Event|1|||
13443564|NCT00321672|26923711|FG001|Overall Study|Adverse Event|1|||
13443565|NCT00321672|26923712|FG002|Overall Study|Adverse Event|0|||
13443566|NCT00321672|26923713|FG003|Overall Study|Adverse Event|0|||
13443567|NCT00321672|26923710|FG000|Overall Study|Lack of Efficacy|1|||
13443568|NCT00321672|26923711|FG001|Overall Study|Lack of Efficacy|1|||
13443569|NCT00321672|26923712|FG002|Overall Study|Lack of Efficacy|0|||
13443570|NCT00321672|26923713|FG003|Overall Study|Lack of Efficacy|0|||
13443571|NCT00321672|26923710|FG000|Overall Study|Lost to Follow-up|2|||
13443572|NCT00321672|26923711|FG001|Overall Study|Lost to Follow-up|0|||
13443573|NCT00321672|26923712|FG002|Overall Study|Lost to Follow-up|4|||
13443574|NCT00321672|26923713|FG003|Overall Study|Lost to Follow-up|2|||
13443575|NCT00321672|26923710|FG000|Overall Study|Death|1|||
13443576|NCT00321672|26923711|FG001|Overall Study|Death|0|||
13443577|NCT00321672|26923712|FG002|Overall Study|Death|0|||
13443578|NCT00321672|26923713|FG003|Overall Study|Death|0|||
13443579|NCT00321672|26923710|FG000|Overall Study|Too far to travel for visits|1|||
13443580|NCT00321672|26923711|FG001|Overall Study|Too far to travel for visits|0|||
13443581|NCT00321672|26923712|FG002|Overall Study|Too far to travel for visits|0|||
13443582|NCT00321672|26923713|FG003|Overall Study|Too far to travel for visits|0|||
13443583|NCT00321672|26923710|FG000|Overall Study|Incarcerated|0|||
13443584|NCT00321672|26923711|FG001|Overall Study|Incarcerated|0|||
13443585|NCT00321672|26923712|FG002|Overall Study|Incarcerated|2|||
13443586|NCT00321672|26923713|FG003|Overall Study|Incarcerated|0|||
13443587|NCT00321672|26923710|FG000|Overall Study|Moved out of state|0|||
13443588|NCT00321672|26923711|FG001|Overall Study|Moved out of state|1|||
13443589|NCT00321672|26923712|FG002|Overall Study|Moved out of state|1|||
13443590|NCT00321672|26923713|FG003|Overall Study|Moved out of state|0|||
13443591|NCT00321672|26923710|FG000|Overall Study|Protocol Violation|0|||
13443592|NCT00321672|26923711|FG001|Overall Study|Protocol Violation|0|||
13443593|NCT00321672|26923712|FG002|Overall Study|Protocol Violation|1|||
13443594|NCT00321672|26923713|FG003|Overall Study|Protocol Violation|0|||
13443595|NCT00321672|26923710|FG000|Overall Study|Diagnosis of testicular cancer|0|||
13443596|NCT00321672|26923711|FG001|Overall Study|Diagnosis of testicular cancer|1|||
13443597|NCT00321672|26923712|FG002|Overall Study|Diagnosis of testicular cancer|0|||
13443598|NCT00321672|26923713|FG003|Overall Study|Diagnosis of testicular cancer|0|||
13443599|NCT00321672|26923710|FG000|Overall Study|Extensive travel required for new job|0|||
13443600|NCT00321672|26923711|FG001|Overall Study|Extensive travel required for new job|1|||
13443601|NCT00321672|26923712|FG002|Overall Study|Extensive travel required for new job|0|||
13443602|NCT00321672|26923713|FG003|Overall Study|Extensive travel required for new job|0|||
13443603|NCT00321646|26923720|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
13443604|NCT00321646|26923720|FG000|Neoadjuvant Chemotherapy|Adverse Event|2|||
13443605|NCT00321646|26923720|FG000|Neoadjuvant Chemotherapy|Disease progression|1|||
13443606|NCT00321620|26923737|FG000|Overall Study|Death|269|||
13443607|NCT00321620|26923738|FG001|Overall Study|Death|294|||
13443608|NCT00321620|26923737|FG000|Overall Study|Withdrawal by Subject|164|||
13443609|NCT00321620|26923738|FG001|Overall Study|Withdrawal by Subject|147|||
13443610|NCT00321620|26923737|FG000|Overall Study|Disease progression|113|||
13443611|NCT00321620|26923738|FG001|Overall Study|Disease progression|117|||
13443612|NCT00321620|26923737|FG000|Overall Study|Adverse Event|43|||
13443613|NCT00321620|26923738|FG001|Overall Study|Adverse Event|56|||
13443614|NCT00321620|26923737|FG000|Overall Study|Lost to Follow-up|13|||
13443615|NCT00321620|26923738|FG001|Overall Study|Lost to Follow-up|9|||
13443616|NCT00321620|26923737|FG000|Overall Study|Physician Decision|4|||
13443617|NCT00321620|26923738|FG001|Overall Study|Physician Decision|1|||
13443618|NCT00321620|26923737|FG000|Overall Study|Noncompliance|14|||
13443619|NCT00321620|26923738|FG001|Overall Study|Noncompliance|7|||
13443620|NCT00321620|26923737|FG000|Overall Study|Protocol deviation|4|||
13443621|NCT00321620|26923738|FG001|Overall Study|Protocol deviation|3|||
13443622|NCT00321620|26923737|FG000|Overall Study|Ineligibility determined|2|||
13443623|NCT00321620|26923738|FG001|Overall Study|Ineligibility determined|3|||
13443624|NCT00321620|26923737|FG000|Overall Study|Participant request|75|||
13443625|NCT00321620|26923738|FG001|Overall Study|Participant request|52|||
13443626|NCT00321620|26923737|FG000|Overall Study|Other|42|||
13443627|NCT00321620|26923738|FG001|Overall Study|Other|33|||
13443628|NCT00321555|26923746|FG000|Overall Study|Developed antibodies|1|||
13443629|NCT00321555|26923746|FG000|Overall Study|Switched to alternative treatment|3|||
13443630|NCT00321555|26923746|FG000|Overall Study|Physician Decision|1|||
13443631|NCT00321555|26923746|FG000|Overall Study|Disease progression on study|1|||
13443632|NCT00321373|26923779|FG000|Overall Study|Adverse Event|0|||
13443633|NCT00321373|26923780|FG001|Overall Study|Adverse Event|0|||
13443634|NCT00321373|26923781|FG002|Overall Study|Adverse Event|1|||
13443635|NCT00321373|26923779|FG000|Overall Study|Lost to Follow-up|1|||
13443636|NCT00321373|26923780|FG001|Overall Study|Lost to Follow-up|0|||
13443637|NCT00321373|26923781|FG002|Overall Study|Lost to Follow-up|1|||
13443638|NCT00321373|26923779|FG000|Overall Study|Withdrawal by Subject|1|||
13443639|NCT00321373|26923780|FG001|Overall Study|Withdrawal by Subject|0|||
13443640|NCT00321373|26923781|FG002|Overall Study|Withdrawal by Subject|0|||
13443641|NCT00321373|26923779|FG000|Overall Study|Other|0|||
13443642|NCT00321373|26923780|FG001|Overall Study|Other|0|||
13443643|NCT00321373|26923781|FG002|Overall Study|Other|1|||
13443644|NCT00321048|26923794|FG000|Overall Study|Withdrawal by Subject|6|||
13443645|NCT00321048|26923795|FG001|Overall Study|Withdrawal by Subject|8|||
13443646|NCT00320801|26923814|FG000|Open-label Run-in Period|Withdrawal by Subject|2|||
13443647|NCT00320801|26923815|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
13443648|NCT00320801|26923816|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
13443649|NCT00320801|26923817|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
13443650|NCT00320801|26923814|FG000|Open-label Run-in Period|Adverse Event|33|||
13443651|NCT00320801|26923815|FG001|Open-label Run-in Period|Adverse Event|0|||
13443652|NCT00320801|26923816|FG002|Open-label Run-in Period|Adverse Event|0|||
13443653|NCT00320801|26923817|FG003|Open-label Run-in Period|Adverse Event|0|||
13443654|NCT00320801|26923814|FG000|Open-label Run-in Period|Administrative|10|||
13443655|NCT00320801|26923815|FG001|Open-label Run-in Period|Administrative|0|||
13443656|NCT00320801|26923816|FG002|Open-label Run-in Period|Administrative|0|||
13443657|NCT00320801|26923817|FG003|Open-label Run-in Period|Administrative|0|||
13443658|NCT00320801|26923814|FG000|Open-label Run-in Period|Lack of Efficacy|44|||
13443659|NCT00320801|26923815|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
13443660|NCT00320801|26923816|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
13443661|NCT00320801|26923817|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
13443662|NCT00320801|26923814|FG000|Open-label Run-in Period|Lost to Follow-up|2|||
13443663|NCT00320801|26923815|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
13443664|NCT00320801|26923816|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
13443665|NCT00320801|26923817|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
13443666|NCT00320801|26923814|FG000|Open-label Run-in Period|Did not qualify|1|||
13443667|NCT00320801|26923815|FG001|Open-label Run-in Period|Did not qualify|0|||
13443668|NCT00320801|26923816|FG002|Open-label Run-in Period|Did not qualify|0|||
13443669|NCT00320801|26923817|FG003|Open-label Run-in Period|Did not qualify|0|||
13443670|NCT00320801|26923814|FG000|Double-blind Phase|Withdrawal by Subject|0|||
13443671|NCT00320801|26923815|FG001|Double-blind Phase|Withdrawal by Subject|0|||
13443672|NCT00320801|26923816|FG002|Double-blind Phase|Withdrawal by Subject|1|||
13443673|NCT00320801|26923817|FG003|Double-blind Phase|Withdrawal by Subject|0|||
13443674|NCT00320801|26923814|FG000|Double-blind Phase|Adverse Event|0|||
13443675|NCT00320801|26923815|FG001|Double-blind Phase|Adverse Event|2|||
13443676|NCT00320801|26923816|FG002|Double-blind Phase|Adverse Event|8|||
13443677|NCT00320801|26923817|FG003|Double-blind Phase|Adverse Event|0|||
13443678|NCT00320801|26923814|FG000|Double-blind Phase|Administrative|0|||
13443679|NCT00320801|26923815|FG001|Double-blind Phase|Administrative|0|||
13443680|NCT00320801|26923816|FG002|Double-blind Phase|Administrative|4|||
13443681|NCT00320801|26923817|FG003|Double-blind Phase|Administrative|0|||
13443682|NCT00320801|26923814|FG000|Double-blind Phase|Lack of Efficacy|0|||
13443683|NCT00320801|26923815|FG001|Double-blind Phase|Lack of Efficacy|9|||
13443684|NCT00320801|26923816|FG002|Double-blind Phase|Lack of Efficacy|1|||
13443685|NCT00320801|26923817|FG003|Double-blind Phase|Lack of Efficacy|0|||
13443686|NCT00320801|26923814|FG000|Extension Phase|Withdrawal by Subject|0|||
13443687|NCT00320801|26923815|FG001|Extension Phase|Withdrawal by Subject|0|||
13443688|NCT00320801|26923816|FG002|Extension Phase|Withdrawal by Subject|0|||
13443689|NCT00320801|26923817|FG003|Extension Phase|Withdrawal by Subject|6|||
13443690|NCT00320801|26923814|FG000|Extension Phase|Adverse Event|0|||
13443691|NCT00320801|26923815|FG001|Extension Phase|Adverse Event|0|||
13443692|NCT00320801|26923816|FG002|Extension Phase|Adverse Event|0|||
13443693|NCT00320801|26923817|FG003|Extension Phase|Adverse Event|8|||
13443694|NCT00320801|26923814|FG000|Extension Phase|Administrative|0|||
13443695|NCT00320801|26923815|FG001|Extension Phase|Administrative|0|||
13443696|NCT00320801|26923816|FG002|Extension Phase|Administrative|0|||
13443697|NCT00320801|26923817|FG003|Extension Phase|Administrative|29|||
13443698|NCT00320801|26923814|FG000|Extension Phase|Lack of Efficacy|0|||
13443699|NCT00320801|26923815|FG001|Extension Phase|Lack of Efficacy|0|||
13443700|NCT00320801|26923816|FG002|Extension Phase|Lack of Efficacy|0|||
13443701|NCT00320801|26923817|FG003|Extension Phase|Lack of Efficacy|2|||
13443702|NCT00320801|26923814|FG000|Extension Phase|Lost to Follow-up|0|||
13443703|NCT00320801|26923815|FG001|Extension Phase|Lost to Follow-up|0|||
13443704|NCT00320801|26923816|FG002|Extension Phase|Lost to Follow-up|0|||
13443705|NCT00320801|26923817|FG003|Extension Phase|Lost to Follow-up|3|||
13443706|NCT00320788|26923876|FG000|Overall Study|Adverse Event|0|||
13443707|NCT00320788|26923877|FG001|Overall Study|Adverse Event|0|||
13443708|NCT00320788|26923878|FG002|Overall Study|Adverse Event|0|||
13443709|NCT00320788|26923879|FG003|Overall Study|Adverse Event|1|||
13443710|NCT00320788|26923880|FG004|Overall Study|Adverse Event|0|||
13443711|NCT00320788|26923876|FG000|Overall Study|Death|0|||
13443712|NCT00320788|26923877|FG001|Overall Study|Death|0|||
13443713|NCT00320788|26923878|FG002|Overall Study|Death|1|||
13443714|NCT00320788|26923879|FG003|Overall Study|Death|0|||
13443715|NCT00320788|26923880|FG004|Overall Study|Death|1|||
13443716|NCT00320788|26923876|FG000|Overall Study|Lost to Follow-up|0|||
13443717|NCT00320788|26923877|FG001|Overall Study|Lost to Follow-up|2|||
13443718|NCT00320788|26923878|FG002|Overall Study|Lost to Follow-up|1|||
13443719|NCT00320788|26923879|FG003|Overall Study|Lost to Follow-up|0|||
13443720|NCT00320788|26923880|FG004|Overall Study|Lost to Follow-up|0|||
13443721|NCT00320788|26923876|FG000|Overall Study|Decision by the Sponsor|1|||
13443722|NCT00320788|26923877|FG001|Overall Study|Decision by the Sponsor|1|||
13443723|NCT00320788|26923878|FG002|Overall Study|Decision by the Sponsor|0|||
13443724|NCT00320788|26923879|FG003|Overall Study|Decision by the Sponsor|0|||
13443725|NCT00320788|26923880|FG004|Overall Study|Decision by the Sponsor|1|||
13443726|NCT00320788|26923876|FG000|Overall Study|Other|1|||
13443727|NCT00320788|26923877|FG001|Overall Study|Other|2|||
13443728|NCT00320788|26923878|FG002|Overall Study|Other|1|||
13443729|NCT00320788|26923879|FG003|Overall Study|Other|1|||
13443730|NCT00320788|26923880|FG004|Overall Study|Other|1|||
13443731|NCT00320788|26923876|FG000|Overall Study|Physician Decision|1|||
13443732|NCT00320788|26923877|FG001|Overall Study|Physician Decision|1|||
13443733|NCT00320788|26923878|FG002|Overall Study|Physician Decision|0|||
13443734|NCT00320788|26923879|FG003|Overall Study|Physician Decision|0|||
13443735|NCT00320788|26923880|FG004|Overall Study|Physician Decision|0|||
13443736|NCT00320788|26923876|FG000|Overall Study|Protocol Violation|0|||
13443737|NCT00320788|26923877|FG001|Overall Study|Protocol Violation|0|||
13443738|NCT00320788|26923878|FG002|Overall Study|Protocol Violation|0|||
13443739|NCT00320788|26923879|FG003|Overall Study|Protocol Violation|0|||
13443740|NCT00320788|26923880|FG004|Overall Study|Protocol Violation|1|||
13443741|NCT00320788|26923876|FG000|Overall Study|Withdrawal by Subject|3|||
13443742|NCT00320788|26923877|FG001|Overall Study|Withdrawal by Subject|0|||
13443743|NCT00320788|26923878|FG002|Overall Study|Withdrawal by Subject|0|||
13443744|NCT00320788|26923879|FG003|Overall Study|Withdrawal by Subject|3|||
13443745|NCT00320788|26923880|FG004|Overall Study|Withdrawal by Subject|1|||
13443746|NCT00320710|26923911|FG000|Overall Study|Disease progression|24|||
13443747|NCT00320710|26923912|FG001|Overall Study|Disease progression|19|||
13443748|NCT00320710|26923913|FG002|Overall Study|Disease progression|2|||
13443749|NCT00320710|26923911|FG000|Overall Study|Death|10|||
13443750|NCT00320710|26923912|FG001|Overall Study|Death|7|||
13443751|NCT00320710|26923913|FG002|Overall Study|Death|1|||
13443752|NCT00320710|26923911|FG000|Overall Study|Administrative problems|1|||
13443753|NCT00320710|26923912|FG001|Overall Study|Administrative problems|2|||
13443754|NCT00320710|26923913|FG002|Overall Study|Administrative problems|0|||
13443755|NCT00320710|26923911|FG000|Overall Study|Withdrawal by Subject|20|||
13443756|NCT00320710|26923912|FG001|Overall Study|Withdrawal by Subject|26|||
13443757|NCT00320710|26923913|FG002|Overall Study|Withdrawal by Subject|1|||
13443758|NCT00320710|26923911|FG000|Overall Study|Protocol Violation|6|||
13443759|NCT00320710|26923912|FG001|Overall Study|Protocol Violation|5|||
13443760|NCT00320710|26923913|FG002|Overall Study|Protocol Violation|0|||
13443761|NCT00320710|26923911|FG000|Overall Study|Abnormal test procedure result(s)|2|||
13443762|NCT00320710|26923912|FG001|Overall Study|Abnormal test procedure result(s)|0|||
13443763|NCT00320710|26923913|FG002|Overall Study|Abnormal test procedure result(s)|0|||
13443764|NCT00320710|26923911|FG000|Overall Study|Abnormal laboratory value(s)|12|||
13443765|NCT00320710|26923912|FG001|Overall Study|Abnormal laboratory value(s)|3|||
13443766|NCT00320710|26923913|FG002|Overall Study|Abnormal laboratory value(s)|0|||
13443767|NCT00320710|26923911|FG000|Overall Study|Adverse Event|18|||
13443768|NCT00320710|26923912|FG001|Overall Study|Adverse Event|14|||
13443769|NCT00320710|26923913|FG002|Overall Study|Adverse Event|1|||
13443770|NCT00320710|26923911|FG000|Overall Study|Lost to Follow-up|1|||
13443771|NCT00320710|26923912|FG001|Overall Study|Lost to Follow-up|0|||
13443772|NCT00320710|26923913|FG002|Overall Study|Lost to Follow-up|0|||
13443773|NCT00320606|26923929|FG000|Overall Study|Adverse Event|1|||
13443774|NCT00320606|26923929|FG000|Overall Study|Protocol Violation|1|||
13443775|NCT00320606|26923929|FG000|Overall Study|Withdrawal by Subject|1|||
13443776|NCT00320593|26923958|FG000|Overall Study|Lost to Follow-up|3|||
13390514|NCT00685750|26773929|FG004|Overall Study|Tumor sampling failure|0|||
13390515|NCT00685750|26773930|FG005|Overall Study|Tumor sampling failure|0|||
13390516|NCT00685750|26773931|FG006|Overall Study|Tumor sampling failure|0|||
13390517|NCT00685750|26773925|FG000|Overall Study|Patient didn't receive the treatment|0|||
13390518|NCT00685750|26773926|FG001|Overall Study|Patient didn't receive the treatment|0|||
13390519|NCT00685750|26773927|FG002|Overall Study|Patient didn't receive the treatment|0|||
13390520|NCT00685750|26773928|FG003|Overall Study|Patient didn't receive the treatment|0|||
13443777|NCT00320593|26923959|FG001|Overall Study|Lost to Follow-up|0|||
13443778|NCT00320593|26923958|FG000|Overall Study|Moved to another state|1|||
13443779|NCT00320593|26923959|FG001|Overall Study|Moved to another state|0|||
13443780|NCT00320593|26923958|FG000|Overall Study|Withdrawal by Subject|2|||
13443781|NCT00320593|26923959|FG001|Overall Study|Withdrawal by Subject|1|||
13443782|NCT00320593|26923958|FG000|Overall Study|Withdrawal by clinical center|1|||
13443783|NCT00320593|26923959|FG001|Overall Study|Withdrawal by clinical center|0|||
13443784|NCT00320541|26923990|FG000|Overall Study|Adverse Event|21|||
13443785|NCT00320541|26923991|FG001|Overall Study|Adverse Event|19|||
13443786|NCT00320541|26923990|FG000|Overall Study|Protocol Violation|0|||
13443787|NCT00320541|26923991|FG001|Overall Study|Protocol Violation|1|||
13443788|NCT00320541|26923990|FG000|Overall Study|Withdrawal by Subject|12|||
13443789|NCT00320541|26923991|FG001|Overall Study|Withdrawal by Subject|16|||
13443790|NCT00320541|26923990|FG000|Overall Study|Physician Decision|9|||
13443791|NCT00320541|26923991|FG001|Overall Study|Physician Decision|13|||
13443792|NCT00320541|26923990|FG000|Overall Study|Other|3|||
13443793|NCT00320541|26923991|FG001|Overall Study|Other|4|||
13443794|NCT00320541|26923990|FG000|Overall Study|Sponsor Decision|2|||
13443795|NCT00320541|26923991|FG001|Overall Study|Sponsor Decision|1|||
13443796|NCT00320541|26923990|FG000|Overall Study|Death due to Study Disease|1|||
13443797|NCT00320541|26923991|FG001|Overall Study|Death due to Study Disease|3|||
13443798|NCT00320541|26923990|FG000|Overall Study|Death due to Adverse Event(s)|1|||
13443799|NCT00320541|26923991|FG001|Overall Study|Death due to Adverse Event(s)|0|||
13443800|NCT00320541|26923990|FG000|Overall Study|Protocol Entry Criterion Not Met|1|||
13443801|NCT00320541|26923991|FG001|Overall Study|Protocol Entry Criterion Not Met|0|||
13443802|NCT00320528|26924036|FG000|Study Period II|Adverse Event|3|||
13443803|NCT00320528|26924037|FG001|Study Period II|Adverse Event|4|||
13443804|NCT00320528|26924038|FG002|Study Period II|Adverse Event|8|||
13443805|NCT00320528|26924036|FG000|Study Period II|Parent/Caregiver Decision|8|||
13443806|NCT00320528|26924037|FG001|Study Period II|Parent/Caregiver Decision|3|||
13443807|NCT00320528|26924038|FG002|Study Period II|Parent/Caregiver Decision|11|||
13443808|NCT00320528|26924036|FG000|Study Period II|Withdrawal by Subject|0|||
13443809|NCT00320528|26924037|FG001|Study Period II|Withdrawal by Subject|1|||
13443810|NCT00320528|26924038|FG002|Study Period II|Withdrawal by Subject|1|||
13443811|NCT00320528|26924036|FG000|Study Period II|Entry Criteria Exclusion|0|||
13443812|NCT00320528|26924037|FG001|Study Period II|Entry Criteria Exclusion|2|||
13443813|NCT00320528|26924038|FG002|Study Period II|Entry Criteria Exclusion|2|||
13443814|NCT00320528|26924036|FG000|Study Period III|Adverse Event|1|||
13443815|NCT00320528|26924037|FG001|Study Period III|Adverse Event|0|||
13443816|NCT00320528|26924038|FG002|Study Period III|Adverse Event|0|||
13443817|NCT00320528|26924036|FG000|Study Period III|Lost to Follow-up|1|||
13443818|NCT00320528|26924037|FG001|Study Period III|Lost to Follow-up|0|||
13443819|NCT00320528|26924038|FG002|Study Period III|Lost to Follow-up|0|||
13390521|NCT00685750|26773929|FG004|Overall Study|Patient didn't receive the treatment|0|||
13443820|NCT00320528|26924036|FG000|Study Period III|Withdrawal by Subject|1|||
13443821|NCT00320528|26924037|FG001|Study Period III|Withdrawal by Subject|1|||
13443822|NCT00320528|26924038|FG002|Study Period III|Withdrawal by Subject|2|||
13443823|NCT00320528|26924036|FG000|Study Period III|Lack of Efficacy|2|||
13443824|NCT00320528|26924037|FG001|Study Period III|Lack of Efficacy|0|||
13443825|NCT00320528|26924038|FG002|Study Period III|Lack of Efficacy|0|||
13443826|NCT00320528|26924036|FG000|Study Period III|Parent/Caregiver Decision|14|||
13443827|NCT00320528|26924037|FG001|Study Period III|Parent/Caregiver Decision|3|||
13443828|NCT00320528|26924038|FG002|Study Period III|Parent/Caregiver Decision|11|||
13443829|NCT00320528|26924036|FG000|Study Period III|Protocol Violation|0|||
13443830|NCT00320528|26924037|FG001|Study Period III|Protocol Violation|1|||
13443831|NCT00320528|26924038|FG002|Study Period III|Protocol Violation|0|||
13443832|NCT00320528|26924036|FG000|Study Period III|Physician Decision|0|||
13443833|NCT00320528|26924037|FG001|Study Period III|Physician Decision|1|||
13443834|NCT00320528|26924038|FG002|Study Period III|Physician Decision|2|||
13443835|NCT00320528|26924036|FG000|Study Period III|Sponsor Decision|0|||
13443836|NCT00320528|26924037|FG001|Study Period III|Sponsor Decision|0|||
13443837|NCT00320528|26924038|FG002|Study Period III|Sponsor Decision|1|||
13443838|NCT00320528|26924036|FG000|Study Period III|Atomoxetine Commercially Available|68|||
13443839|NCT00320528|26924037|FG001|Study Period III|Atomoxetine Commercially Available|25|||
13443840|NCT00320528|26924038|FG002|Study Period III|Atomoxetine Commercially Available|90|||
13443841|NCT00320515|26924047|FG000|Overall Study|Death|33|||
13443842|NCT00320515|26924047|FG000|Overall Study|Lost to Follow-up|6|||
13443843|NCT00320515|26924047|FG000|Overall Study|Physician Decision|2|||
13443844|NCT00320515|26924047|FG000|Overall Study|Withdrawal by Subject|8|||
13443845|NCT00320489|26924110|FG000|Overall Study|Adverse Event|26|||
13443846|NCT00320489|26924111|FG001|Overall Study|Adverse Event|25|||
13443847|NCT00320489|26924110|FG000|Overall Study|Clinical Relapse|26|||
13443848|NCT00320489|26924111|FG001|Overall Study|Clinical Relapse|20|||
13443849|NCT00320489|26924110|FG000|Overall Study|Death|0|||
13443850|NCT00320489|26924111|FG001|Overall Study|Death|2|||
13443851|NCT00320489|26924110|FG000|Overall Study|Entry Criteria Exclusion|2|||
13443852|NCT00320489|26924111|FG001|Overall Study|Entry Criteria Exclusion|4|||
13443853|NCT00320489|26924110|FG000|Overall Study|Lack of Efficacy|16|||
13443854|NCT00320489|26924111|FG001|Overall Study|Lack of Efficacy|7|||
13443855|NCT00320489|26924110|FG000|Overall Study|Lost to Follow-up|21|||
13443856|NCT00320489|26924111|FG001|Overall Study|Lost to Follow-up|22|||
13443857|NCT00320489|26924110|FG000|Overall Study|Physician Decision|8|||
13443858|NCT00320489|26924111|FG001|Overall Study|Physician Decision|8|||
13443859|NCT00320489|26924110|FG000|Overall Study|Protocol Violation|4|||
13443860|NCT00320489|26924111|FG001|Overall Study|Protocol Violation|4|||
13443861|NCT00320489|26924110|FG000|Overall Study|Sponsor Decision|3|||
13443862|NCT00320489|26924111|FG001|Overall Study|Sponsor Decision|3|||
13443863|NCT00320489|26924110|FG000|Overall Study|Withdrawal by Subject|39|||
13443864|NCT00320489|26924111|FG001|Overall Study|Withdrawal by Subject|41|||
13443865|NCT00320424|26924127|FG000|Overall Study|Adverse Event|3|||
13443866|NCT00320424|26924127|FG000|Overall Study|Other|3|||
13443867|NCT00320411|26924150|FG000|Overall Study|No investigational product admin.|4|||
13443868|NCT00320398|26924183|FG000|Overall Study|Adverse Event|1|||
13443869|NCT00320398|26924184|FG001|Overall Study|Adverse Event|4|||
13443870|NCT00320398|26924183|FG000|Overall Study|Other|1|||
13443871|NCT00320398|26924184|FG001|Overall Study|Other|0|||
13443872|NCT00320385|26924211|FG000|Overall Study|Lost to Follow-up|7|||
13443873|NCT00320385|26924212|FG001|Overall Study|Lost to Follow-up|10|||
13443874|NCT00320385|26924211|FG000|Overall Study|Withdrawal by Subject|6|||
13443875|NCT00320385|26924212|FG001|Overall Study|Withdrawal by Subject|7|||
13443876|NCT00320385|26924211|FG000|Overall Study|Sponsor Terminated Study|2|||
13443877|NCT00320385|26924212|FG001|Overall Study|Sponsor Terminated Study|1|||
13443878|NCT00320385|26924211|FG000|Overall Study|Investigator Decision|0|||
13443879|NCT00320385|26924212|FG001|Overall Study|Investigator Decision|1|||
13443880|NCT00320385|26924211|FG000|Overall Study|Death|1|||
13443881|NCT00320385|26924212|FG001|Overall Study|Death|2|||
13443882|NCT00320385|26924211|FG000|Overall Study|Serious Adverse Event|1|||
13443883|NCT00320385|26924212|FG001|Overall Study|Serious Adverse Event|0|||
13443884|NCT00320385|26924211|FG000|Overall Study|Withdrew Consent|1|||
13443885|NCT00320385|26924212|FG001|Overall Study|Withdrew Consent|0|||
13443886|NCT00320385|26924211|FG000|Overall Study|Adverse Event|0|||
13443887|NCT00320385|26924212|FG001|Overall Study|Adverse Event|1|||
13443888|NCT00320372|26924246|FG000|Overall Study|Physician Decision|4|||
13443889|NCT00320372|26924247|FG001|Overall Study|Physician Decision|7|||
13443890|NCT00320372|26924246|FG000|Overall Study|Death|7|||
13443891|NCT00320372|26924247|FG001|Overall Study|Death|8|||
13443892|NCT00320372|26924246|FG000|Overall Study|Withdrawal by Subject|55|||
13443893|NCT00320372|26924247|FG001|Overall Study|Withdrawal by Subject|37|||
13443894|NCT00320372|26924246|FG000|Overall Study|Non-Compliance|40|||
13443895|NCT00320372|26924247|FG001|Overall Study|Non-Compliance|39|||
13443896|NCT00320372|26924246|FG000|Overall Study|Did not Meet (I/E)|3|||
13443897|NCT00320372|26924247|FG001|Overall Study|Did not Meet (I/E)|1|||
13443898|NCT00320372|26924246|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86|||
13443899|NCT00320372|26924247|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71|||
13443900|NCT00320255|26924346|FG000|Overall Study|Lack of Efficacy|1|||
13443901|NCT00320255|26924347|FG001|Overall Study|Lack of Efficacy|0|||
13443902|NCT00320255|26924348|FG002|Overall Study|Lack of Efficacy|0|||
13443903|NCT00320255|26924349|FG003|Overall Study|Lack of Efficacy|0|||
13443904|NCT00320255|26924350|FG004|Overall Study|Lack of Efficacy|0|||
13443905|NCT00320255|26924351|FG005|Overall Study|Lack of Efficacy|0|||
13443906|NCT00320255|26924346|FG000|Overall Study|Adverse Event|5|||
13443907|NCT00320255|26924347|FG001|Overall Study|Adverse Event|2|||
13443908|NCT00320255|26924348|FG002|Overall Study|Adverse Event|3|||
13443909|NCT00320255|26924349|FG003|Overall Study|Adverse Event|2|||
13443910|NCT00320255|26924350|FG004|Overall Study|Adverse Event|0|||
13443911|NCT00320255|26924351|FG005|Overall Study|Adverse Event|0|||
13443912|NCT00320255|26924346|FG000|Overall Study|Withdrawal by Subject|1|||
13443913|NCT00320255|26924347|FG001|Overall Study|Withdrawal by Subject|2|||
13443914|NCT00320255|26924348|FG002|Overall Study|Withdrawal by Subject|2|||
13443915|NCT00320255|26924349|FG003|Overall Study|Withdrawal by Subject|4|||
13443916|NCT00320255|26924350|FG004|Overall Study|Withdrawal by Subject|0|||
13443917|NCT00320255|26924351|FG005|Overall Study|Withdrawal by Subject|0|||
13443918|NCT00320255|26924346|FG000|Overall Study|Poor compliance/noncompliance|1|||
13443919|NCT00320255|26924347|FG001|Overall Study|Poor compliance/noncompliance|1|||
13443920|NCT00320255|26924348|FG002|Overall Study|Poor compliance/noncompliance|0|||
13443921|NCT00320255|26924349|FG003|Overall Study|Poor compliance/noncompliance|1|||
13443922|NCT00320255|26924350|FG004|Overall Study|Poor compliance/noncompliance|0|||
13443923|NCT00320255|26924351|FG005|Overall Study|Poor compliance/noncompliance|0|||
13443924|NCT00320255|26924346|FG000|Overall Study|No longer meets study criteria|0|||
13443925|NCT00320255|26924347|FG001|Overall Study|No longer meets study criteria|0|||
13443926|NCT00320255|26924348|FG002|Overall Study|No longer meets study criteria|0|||
13443927|NCT00320255|26924349|FG003|Overall Study|No longer meets study criteria|1|||
13443928|NCT00320255|26924350|FG004|Overall Study|No longer meets study criteria|0|||
13443929|NCT00320255|26924351|FG005|Overall Study|No longer meets study criteria|0|||
13443930|NCT00320255|26924346|FG000|Overall Study|Other|3|||
13443931|NCT00320255|26924347|FG001|Overall Study|Other|2|||
13443932|NCT00320255|26924348|FG002|Overall Study|Other|1|||
13443933|NCT00320255|26924349|FG003|Overall Study|Other|0|||
13443934|NCT00320255|26924350|FG004|Overall Study|Other|0|||
13443935|NCT00320255|26924351|FG005|Overall Study|Other|0|||
13443936|NCT00320216|26924399|FG000|Overall Study|Adverse Event|0|||
13443937|NCT00320216|26924400|FG001|Overall Study|Adverse Event|6|||
13443938|NCT00320216|26924401|FG002|Overall Study|Adverse Event|0|||
13443939|NCT00320216|26924402|FG003|Overall Study|Adverse Event|2|||
13443940|NCT00320216|26924403|FG004|Overall Study|Adverse Event|2|||
13443941|NCT00320216|26924399|FG000|Overall Study|Lack of Efficacy|6|||
13443942|NCT00320216|26924400|FG001|Overall Study|Lack of Efficacy|2|||
13443943|NCT00320216|26924401|FG002|Overall Study|Lack of Efficacy|1|||
13443944|NCT00320216|26924402|FG003|Overall Study|Lack of Efficacy|0|||
13443945|NCT00320216|26924403|FG004|Overall Study|Lack of Efficacy|1|||
13443946|NCT00320216|26924399|FG000|Overall Study|Lost to Follow-up|3|||
13443947|NCT00320216|26924400|FG001|Overall Study|Lost to Follow-up|0|||
13443948|NCT00320216|26924401|FG002|Overall Study|Lost to Follow-up|0|||
13443949|NCT00320216|26924402|FG003|Overall Study|Lost to Follow-up|0|||
13443950|NCT00320216|26924403|FG004|Overall Study|Lost to Follow-up|0|||
13443951|NCT00320216|26924399|FG000|Overall Study|Other|7|||
13443952|NCT00320216|26924400|FG001|Overall Study|Other|2|||
13443953|NCT00320216|26924401|FG002|Overall Study|Other|5|||
13443954|NCT00320216|26924402|FG003|Overall Study|Other|1|||
13443955|NCT00320216|26924403|FG004|Overall Study|Other|3|||
13443956|NCT00320190|26924428|FG000|First 12 Months|Completed but did not enter extension|5|||
13443957|NCT00320190|26924429|FG001|First 12 Months|Completed but did not enter extension|3|||
13443958|NCT00320190|26924428|FG000|First 12 Months|Sponsor terminated study|2|||
13443959|NCT00320190|26924429|FG001|First 12 Months|Sponsor terminated study|2|||
13443960|NCT00320190|26924428|FG000|First 12 Months|Lost to Follow-up|0|||
13443961|NCT00320190|26924429|FG001|First 12 Months|Lost to Follow-up|1|||
13443962|NCT00320190|26924428|FG000|First 12 Months|Enrollment failure|0|||
13443963|NCT00320190|26924429|FG001|First 12 Months|Enrollment failure|1|||
13443964|NCT00320190|26924428|FG000|First 12 Months|Adverse event unrelated to study drug|1|||
13443965|NCT00320190|26924429|FG001|First 12 Months|Adverse event unrelated to study drug|0|||
13443966|NCT00320190|26924428|FG000|First 12 Months|Investigator request|0|||
13443967|NCT00320190|26924429|FG001|First 12 Months|Investigator request|1|||
13443968|NCT00320190|26924428|FG000|First 12 Months|Study drug toxicity|0|||
13443969|NCT00320190|26924429|FG001|First 12 Months|Study drug toxicity|1|||
13443970|NCT00320190|26924428|FG000|First 12 Months|Withdrawal by Subject|0|||
13443971|NCT00320190|26924429|FG001|First 12 Months|Withdrawal by Subject|1|||
13443972|NCT00320190|26924428|FG000|Long-term (12-month) Extension|Sponsor terminated study|7|||
13443973|NCT00320190|26924429|FG001|Long-term (12-month) Extension|Sponsor terminated study|0|||
13443974|NCT00320190|26924428|FG000|Long-term (12-month) Extension|Lack of major molecular response|1|||
13443975|NCT00320190|26924429|FG001|Long-term (12-month) Extension|Lack of major molecular response|2|||
13443976|NCT00320190|26924428|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1|||
13443977|NCT00320190|26924429|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0|||
13443978|NCT00320112|26924448|FG000|Overall Study|Lost to Follow-up|3|||
13443979|NCT00320112|26924449|FG001|Overall Study|Lost to Follow-up|4|||
13443980|NCT00320112|26924448|FG000|Overall Study|Withdrawal by Subject|3|||
13443981|NCT00320112|26924449|FG001|Overall Study|Withdrawal by Subject|0|||
13443982|NCT00320112|26924448|FG000|Overall Study|Death|2|||
13443983|NCT00320112|26924449|FG001|Overall Study|Death|1|||
13443984|NCT00319982|26924474|FG000|Overall Study|Withdrawal by Subject|1|||
13443985|NCT00319982|26924475|FG001|Overall Study|Withdrawal by Subject|0|||
13443986|NCT00319956|26924494|FG000|Overall Study|Death|20|||
13443987|NCT00319956|26924495|FG001|Overall Study|Death|24|||
13443988|NCT00319839|26924503|FG000|Overall Study|Adverse Event|5|||
13443989|NCT00319839|26924503|FG000|Overall Study|Withdrawal by Subject|1|||
13443990|NCT00319735|26924518|FG000|Overall Study|Death|2|||
13443991|NCT00319696|26924544|FG000|Overall Study|Adverse Event|36|||
13443992|NCT00319696|26924544|FG000|Overall Study|withdrawal of consent|14|||
13443993|NCT00319696|26924544|FG000|Overall Study|administrative|7|||
13443994|NCT00319696|26924544|FG000|Overall Study|Lost to Follow-up|3|||
13443995|NCT00319592|26924565|FG000|Overall Study|Protocol Violation|1|||
13443996|NCT00319592|26924566|FG001|Overall Study|Protocol Violation|0|||
13443997|NCT00319592|26924565|FG000|Overall Study|Physician Decision|0|||
13443998|NCT00319592|26924566|FG001|Overall Study|Physician Decision|1|||
13443999|NCT00319553|26924585|FG000|Overall Study|Protocol Violation|1|||
13444000|NCT00319553|26924586|FG001|Overall Study|Protocol Violation|2|||
13444001|NCT00319553|26924585|FG000|Overall Study|Lost to Follow-up|2|||
13444002|NCT00319553|26924586|FG001|Overall Study|Lost to Follow-up|1|||
13444003|NCT00319553|26924585|FG000|Overall Study|Withdrawal by Subject|1|||
13444004|NCT00319553|26924586|FG001|Overall Study|Withdrawal by Subject|1|||
13444005|NCT00319501|26924617|FG000|Double-blind Period|Withdrawal by Subject|0|||
13444006|NCT00319501|26924618|FG001|Double-blind Period|Withdrawal by Subject|3|||
13444007|NCT00319501|26924617|FG000|Double-blind Period|Sponsor Request|1|||
13444008|NCT00319501|26924618|FG001|Double-blind Period|Sponsor Request|0|||
13444009|NCT00319501|26924617|FG000|Double-blind Period|Did not receive treatment|42|||
13444010|NCT00319501|26924618|FG001|Double-blind Period|Did not receive treatment|29|||
13444011|NCT00319501|26924617|FG000|Open-label Period|Adverse Event|5|||
13444012|NCT00319501|26924618|FG001|Open-label Period|Adverse Event|0|||
13444013|NCT00319501|26924617|FG000|Open-label Period|Protocol Violation|6|||
13444014|NCT00319501|26924618|FG001|Open-label Period|Protocol Violation|0|||
13444015|NCT00319501|26924617|FG000|Open-label Period|Withdrawal by Subject|38|||
13444016|NCT00319501|26924618|FG001|Open-label Period|Withdrawal by Subject|0|||
13444017|NCT00319501|26924617|FG000|Open-label Period|Principal Investigator decision|6|||
13444018|NCT00319501|26924618|FG001|Open-label Period|Principal Investigator decision|0|||
13444019|NCT00319501|26924617|FG000|Open-label Period|Sponsor request|12|||
13444020|NCT00319501|26924618|FG001|Open-label Period|Sponsor request|0|||
13444021|NCT00319501|26924617|FG000|Open-label Period|Lost to Follow-up|5|||
13444022|NCT00319501|26924618|FG001|Open-label Period|Lost to Follow-up|0|||
13444023|NCT00319501|26924617|FG000|Open-label Period|Did not receive treatment|33|||
13444024|NCT00319501|26924618|FG001|Open-label Period|Did not receive treatment|0|||
13444025|NCT00319501|26924617|FG000|Open-label Period|Other|11|||
13444026|NCT00319501|26924618|FG001|Open-label Period|Other|0|||
13444027|NCT00319501|26924617|FG000|Open-label Extension Period|Adverse Event|2|||
13444028|NCT00319501|26924618|FG001|Open-label Extension Period|Adverse Event|0|||
13444029|NCT00319501|26924617|FG000|Open-label Extension Period|Did not receive treatment|18|||
13444030|NCT00319501|26924618|FG001|Open-label Extension Period|Did not receive treatment|0|||
13444031|NCT00319501|26924617|FG000|Open-label Extension Period|Other|1|||
13444032|NCT00319501|26924618|FG001|Open-label Extension Period|Other|0|||
13444033|NCT00319501|26924617|FG000|Open-label Extension Period|Principal investigator decision|2|||
13444034|NCT00319501|26924618|FG001|Open-label Extension Period|Principal investigator decision|0|||
13444035|NCT00319501|26924617|FG000|Open-label Extension Period|Sponsor request|26|||
13444036|NCT00319501|26924618|FG001|Open-label Extension Period|Sponsor request|0|||
13444037|NCT00319501|26924617|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
13444038|NCT00319501|26924618|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
13444039|NCT00319449|26924635|FG000|Overall Study|Subject did not wish to continue|1|||
13444040|NCT00319449|26924636|FG001|Overall Study|Subject did not wish to continue|0|||
13444041|NCT00319449|26924635|FG000|Overall Study|Noncompliance with the protocol|1|||
13444042|NCT00319449|26924636|FG001|Overall Study|Noncompliance with the protocol|0|||
13444043|NCT00319436|26924661|FG000|Overall Study|Withdrawal by Subject|6|||
13444044|NCT00319436|26924662|FG001|Overall Study|Withdrawal by Subject|7|||
13444045|NCT00319254|26924677|FG000|Overall Study|Withdrawal by Subject|4|||
13444046|NCT00319254|26924677|FG000|Overall Study|Death|46|||
13444047|NCT00319254|26924677|FG000|Overall Study|Lost to Follow-up|2|||
13444048|NCT00319254|26924677|FG000|Overall Study|Enrolled, Not Treated|2|||
13444049|NCT00319111|26924689|FG000|Overall Study|Adverse Event|20|||
13444050|NCT00319111|26924689|FG000|Overall Study|Withdrawal of consent|11|||
13444051|NCT00319111|26924689|FG000|Overall Study|Death|9|||
13444052|NCT00319111|26924689|FG000|Overall Study|Lack of clinical improvement|4|||
13444053|NCT00319111|26924689|FG000|Overall Study|Administrative|2|||
13444054|NCT00319111|26924689|FG000|Overall Study|Treatment failure|1|||
13444055|NCT00319098|26924758|FG000|Overall Study|Serious adverse event|3|||
13444056|NCT00319098|26924759|FG001|Overall Study|Serious adverse event|0|||
13444057|NCT00319098|26924758|FG000|Overall Study|Adverse Event|20|||
13444058|NCT00319098|26924759|FG001|Overall Study|Adverse Event|1|||
13444059|NCT00319098|26924758|FG000|Overall Study|Withdrawal by Subject|37|||
13444060|NCT00319098|26924759|FG001|Overall Study|Withdrawal by Subject|8|||
13444061|NCT00319098|26924758|FG000|Overall Study|Migrated/moved from study area|2|||
13444062|NCT00319098|26924759|FG001|Overall Study|Migrated/moved from study area|1|||
13444063|NCT00319098|26924758|FG000|Overall Study|Lost to Follow-up|37|||
13444064|NCT00319098|26924759|FG001|Overall Study|Lost to Follow-up|13|||
13444065|NCT00319098|26924758|FG000|Overall Study|Others|33|||
13444066|NCT00319098|26924759|FG001|Overall Study|Others|8|||
13444067|NCT00319098|26924758|FG000|Overall Study|Protocol Violation|3|||
13444068|NCT00319098|26924759|FG001|Overall Study|Protocol Violation|1|||
13444069|NCT00319046|26924768|FG000|Overall Study|withdrawal of subject's consent|7|||
13444070|NCT00319046|26924768|FG000|Overall Study|administrative reason|1|||
13444071|NCT00319020|26924804|FG000|Overall Study|Death|2|||
13444072|NCT00319020|26924805|FG001|Overall Study|Death|2|||
13444073|NCT00319020|26924804|FG000|Overall Study|Withdrawal by Subject|4|||
13444074|NCT00319020|26924805|FG001|Overall Study|Withdrawal by Subject|1|||
13444075|NCT00319020|26924804|FG000|Overall Study|F-1 completed but not enrolled in F-2|1|||
13444076|NCT00319020|26924805|FG001|Overall Study|F-1 completed but not enrolled in F-2|0|||
13444077|NCT00319020|26924804|FG000|Overall Study|Administrative reason|0|||
13444078|NCT00319020|26924805|FG001|Overall Study|Administrative reason|5|||
13444079|NCT00319020|26924804|FG000|Overall Study|Disease progression|0|||
13444080|NCT00319020|26924805|FG001|Overall Study|Disease progression|2|||
13444081|NCT00319020|26924804|FG000|Overall Study|Transplant|0|||
13444082|NCT00319020|26924805|FG001|Overall Study|Transplant|1|||
13444083|NCT00319020|26924804|FG000|Overall Study|Treatment failure|0|||
13444084|NCT00319020|26924805|FG001|Overall Study|Treatment failure|1|||
13444085|NCT00319020|26924804|FG000|Overall Study|Adverse Event|0|||
13444086|NCT00319020|26924805|FG001|Overall Study|Adverse Event|1|||
13444087|NCT00318643|26924850|FG000|Overall Study|Adverse Event|0|||
13444088|NCT00318643|26924851|FG001|Overall Study|Adverse Event|0|||
13444089|NCT00318643|26924852|FG002|Overall Study|Adverse Event|0|||
13444090|NCT00318643|26924853|FG003|Overall Study|Adverse Event|0|||
13444091|NCT00318643|26924854|FG004|Overall Study|Adverse Event|1|||
13444092|NCT00318643|26924850|FG000|Overall Study|Participant's Decision|0|||
13444093|NCT00318643|26924851|FG001|Overall Study|Participant's Decision|0|||
13444094|NCT00318643|26924852|FG002|Overall Study|Participant's Decision|0|||
13444095|NCT00318643|26924853|FG003|Overall Study|Participant's Decision|0|||
13444096|NCT00318643|26924854|FG004|Overall Study|Participant's Decision|1|||
13444097|NCT00318643|26924850|FG000|Overall Study|Investigator's Decision|0|||
13444098|NCT00318643|26924851|FG001|Overall Study|Investigator's Decision|0|||
13444099|NCT00318643|26924852|FG002|Overall Study|Investigator's Decision|0|||
13444100|NCT00318643|26924853|FG003|Overall Study|Investigator's Decision|0|||
13444101|NCT00318643|26924854|FG004|Overall Study|Investigator's Decision|1|||
13444102|NCT00318565|26924861|FG000|Overall Study|Excluded per protocol|24|||
13444103|NCT00318474|26924874|FG000|Overall Study|Adverse Event|1|||
13444104|NCT00318474|26924875|FG001|Overall Study|Adverse Event|1|||
13444105|NCT00318474|26924874|FG000|Overall Study|Lost to Follow-up|0|||
13444106|NCT00318474|26924875|FG001|Overall Study|Lost to Follow-up|1|||
13444107|NCT00318474|26924874|FG000|Overall Study|Pregnancy|0|||
13444108|NCT00318474|26924875|FG001|Overall Study|Pregnancy|2|||
13444109|NCT00318474|26924874|FG000|Overall Study|Protocol Violation|1|||
13444110|NCT00318474|26924875|FG001|Overall Study|Protocol Violation|0|||
13444111|NCT00318474|26924874|FG000|Overall Study|Withdrawal by Subject|3|||
13444112|NCT00318474|26924875|FG001|Overall Study|Withdrawal by Subject|2|||
13444113|NCT00318474|26924874|FG000|Overall Study|Fall in GFR|3|||
13444114|NCT00318474|26924875|FG001|Overall Study|Fall in GFR|3|||
13444115|NCT00318474|26924874|FG000|Overall Study|Post-therapy hyperflycemia|0|||
13444116|NCT00318474|26924875|FG001|Overall Study|Post-therapy hyperflycemia|1|||
13444117|NCT00318474|26924874|FG000|Overall Study|Trial terminated|10|||
13444118|NCT00318474|26924875|FG001|Overall Study|Trial terminated|7|||
13444119|NCT00318461|26924968|FG000|Double-Blind, 6 Months|Adverse Event|11|||
13444120|NCT00318461|26924969|FG001|Double-Blind, 6 Months|Adverse Event|23|||
13444121|NCT00318461|26924970|FG002|Double-Blind, 6 Months|Adverse Event|29|||
13444122|NCT00318461|26924971|FG003|Double-Blind, 6 Months|Adverse Event|2|||
13444123|NCT00318461|26924972|FG004|Double-Blind, 6 Months|Adverse Event|8|||
13444124|NCT00318461|26924968|FG000|Double-Blind, 6 Months|Lack of Efficacy|19|||
13444125|NCT00318461|26924969|FG001|Double-Blind, 6 Months|Lack of Efficacy|8|||
13444126|NCT00318461|26924970|FG002|Double-Blind, 6 Months|Lack of Efficacy|13|||
13444127|NCT00318461|26924971|FG003|Double-Blind, 6 Months|Lack of Efficacy|29|||
13444128|NCT00318461|26924972|FG004|Double-Blind, 6 Months|Lack of Efficacy|9|||
13444129|NCT00318461|26924968|FG000|Double-Blind, 6 Months|Protocol Violation|2|||
13444130|NCT00318461|26924969|FG001|Double-Blind, 6 Months|Protocol Violation|4|||
13444131|NCT00318461|26924970|FG002|Double-Blind, 6 Months|Protocol Violation|4|||
13444132|NCT00318461|26924971|FG003|Double-Blind, 6 Months|Protocol Violation|4|||
13444133|NCT00318461|26924972|FG004|Double-Blind, 6 Months|Protocol Violation|5|||
13444134|NCT00318461|26924968|FG000|Double-Blind, 6 Months|Lost to follow up|0|||
13444135|NCT00318461|26924969|FG001|Double-Blind, 6 Months|Lost to follow up|1|||
13444136|NCT00318461|26924970|FG002|Double-Blind, 6 Months|Lost to follow up|0|||
13444137|NCT00318461|26924971|FG003|Double-Blind, 6 Months|Lost to follow up|0|||
13444138|NCT00318461|26924972|FG004|Double-Blind, 6 Months|Lost to follow up|0|||
13444139|NCT00318461|26924968|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
13444140|NCT00318461|26924969|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1|||
13444141|NCT00318461|26924970|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
13444142|NCT00318461|26924971|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
13444143|NCT00318461|26924972|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
13444144|NCT00318461|26924968|FG000|Double-Blind, 6 Months|Consent withdrawn|0|||
13444145|NCT00318461|26924969|FG001|Double-Blind, 6 Months|Consent withdrawn|3|||
13444146|NCT00318461|26924970|FG002|Double-Blind, 6 Months|Consent withdrawn|4|||
13444147|NCT00318461|26924971|FG003|Double-Blind, 6 Months|Consent withdrawn|10|||
13444148|NCT00318461|26924972|FG004|Double-Blind, 6 Months|Consent withdrawn|4|||
13444149|NCT00318461|26924968|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
13444150|NCT00318461|26924969|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
13444151|NCT00318461|26924970|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1|||
13444152|NCT00318461|26924971|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
13444153|NCT00318461|26924972|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
13444154|NCT00318461|26924968|FG000|Double-Blind, 6 Months|Move|0|||
13444155|NCT00318461|26924969|FG001|Double-Blind, 6 Months|Move|1|||
13444156|NCT00318461|26924970|FG002|Double-Blind, 6 Months|Move|0|||
13444157|NCT00318461|26924971|FG003|Double-Blind, 6 Months|Move|0|||
13444158|NCT00318461|26924972|FG004|Double-Blind, 6 Months|Move|0|||
13444159|NCT00318461|26924968|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
13444160|NCT00318461|26924969|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
13444161|NCT00318461|26924970|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
13444162|NCT00318461|26924971|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
13444163|NCT00318461|26924972|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1|||
13444164|NCT00318461|26924968|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1|||
13444165|NCT00318461|26924969|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
13444166|NCT00318461|26924970|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
13444167|NCT00318461|26924971|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2|||
13444168|NCT00318461|26924972|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
13444169|NCT00318461|26924968|FG000|Double-Blind, 6 Months|Work commitment|0|||
13444170|NCT00318461|26924969|FG001|Double-Blind, 6 Months|Work commitment|0|||
13444171|NCT00318461|26924970|FG002|Double-Blind, 6 Months|Work commitment|0|||
13444172|NCT00318461|26924971|FG003|Double-Blind, 6 Months|Work commitment|0|||
13444173|NCT00318461|26924972|FG004|Double-Blind, 6 Months|Work commitment|1|||
13444174|NCT00318461|26924968|FG000|Double-Blind, 6 Months|Investigator decision|0|||
13444175|NCT00318461|26924969|FG001|Double-Blind, 6 Months|Investigator decision|0|||
13444176|NCT00318461|26924970|FG002|Double-Blind, 6 Months|Investigator decision|0|||
13444177|NCT00318461|26924971|FG003|Double-Blind, 6 Months|Investigator decision|0|||
13444178|NCT00318461|26924972|FG004|Double-Blind, 6 Months|Investigator decision|1|||
13444179|NCT00318461|26924968|FG000|Double-Blind, 6 Months|Lack of time|1|||
13444180|NCT00318461|26924969|FG001|Double-Blind, 6 Months|Lack of time|0|||
13444181|NCT00318461|26924970|FG002|Double-Blind, 6 Months|Lack of time|0|||
13444182|NCT00318461|26924971|FG003|Double-Blind, 6 Months|Lack of time|0|||
13444183|NCT00318461|26924972|FG004|Double-Blind, 6 Months|Lack of time|0|||
13444184|NCT00318461|26924968|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
13444185|NCT00318461|26924969|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
13444186|NCT00318461|26924970|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
13444187|NCT00318461|26924971|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
13444188|NCT00318461|26924972|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2|||
13444189|NCT00318461|26924968|FG000|Double-Blind, 6 Months|Hyperglicaemia|0|||
13444190|NCT00318461|26924969|FG001|Double-Blind, 6 Months|Hyperglicaemia|0|||
13444191|NCT00318461|26924970|FG002|Double-Blind, 6 Months|Hyperglicaemia|0|||
13444192|NCT00318461|26924971|FG003|Double-Blind, 6 Months|Hyperglicaemia|1|||
13444193|NCT00318461|26924972|FG004|Double-Blind, 6 Months|Hyperglicaemia|0|||
13444194|NCT00318461|26924968|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
13444195|NCT00318461|26924969|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
13444196|NCT00318461|26924970|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
13444197|NCT00318461|26924971|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
13444198|NCT00318461|26924972|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1|||
13444199|NCT00318461|26924968|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
13444200|NCT00318461|26924969|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1|||
13444201|NCT00318461|26924970|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
13444202|NCT00318461|26924971|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
13444203|NCT00318461|26924972|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
13444204|NCT00318461|26924968|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19|||
13444205|NCT00318461|26924969|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14|||
13444206|NCT00318461|26924970|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27|||
13444207|NCT00318461|26924971|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11|||
13444208|NCT00318461|26924972|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22|||
13444209|NCT00318461|26924968|FG000|Open-Label Extension, 18 Months|Adverse Event|11|||
13444210|NCT00318461|26924969|FG001|Open-Label Extension, 18 Months|Adverse Event|8|||
13444211|NCT00318461|26924970|FG002|Open-Label Extension, 18 Months|Adverse Event|6|||
13444212|NCT00318461|26924971|FG003|Open-Label Extension, 18 Months|Adverse Event|1|||
13444213|NCT00318461|26924972|FG004|Open-Label Extension, 18 Months|Adverse Event|6|||
13444214|NCT00318461|26924968|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41|||
13444215|NCT00318461|26924969|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33|||
13444216|NCT00318461|26924970|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37|||
13444217|NCT00318461|26924971|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27|||
13444218|NCT00318461|26924972|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63|||
13444219|NCT00318461|26924968|FG000|Open-Label Extension, 18 Months|Protocol Violation|7|||
13444220|NCT00318461|26924969|FG001|Open-Label Extension, 18 Months|Protocol Violation|5|||
13444221|NCT00318461|26924970|FG002|Open-Label Extension, 18 Months|Protocol Violation|3|||
13444222|NCT00318461|26924971|FG003|Open-Label Extension, 18 Months|Protocol Violation|4|||
13444223|NCT00318461|26924972|FG004|Open-Label Extension, 18 Months|Protocol Violation|6|||
13444224|NCT00318370|26924986|FG000|Period 1|Lack of Efficacy|5|||
13444225|NCT00318370|26924987|FG001|Period 1|Lack of Efficacy|0|||
13444226|NCT00318370|26924988|FG002|Period 1|Lack of Efficacy|0|||
13444227|NCT00318370|26924986|FG000|Period 1|Physician Decision|1|||
13444228|NCT00318370|26924987|FG001|Period 1|Physician Decision|0|||
13444229|NCT00318370|26924988|FG002|Period 1|Physician Decision|0|||
13444230|NCT00318370|26924986|FG000|Period 1|Withdrawal by Subject|1|||
13444231|NCT00318370|26924987|FG001|Period 1|Withdrawal by Subject|0|||
13444232|NCT00318370|26924988|FG002|Period 1|Withdrawal by Subject|0|||
13444233|NCT00318370|26924986|FG000|Period 2|Adverse Event|0|||
13444234|NCT00318370|26924987|FG001|Period 2|Adverse Event|3|||
13444235|NCT00318370|26924988|FG002|Period 2|Adverse Event|0|||
13444236|NCT00318370|26924986|FG000|Period 2|Lack of Efficacy|0|||
13444237|NCT00318370|26924987|FG001|Period 2|Lack of Efficacy|5|||
13444238|NCT00318370|26924988|FG002|Period 2|Lack of Efficacy|0|||
13444239|NCT00318370|26924986|FG000|Period 2|Physician Decision|0|||
13444240|NCT00318370|26924987|FG001|Period 2|Physician Decision|1|||
13444241|NCT00318370|26924988|FG002|Period 2|Physician Decision|0|||
13444242|NCT00318370|26924986|FG000|Period 2|Withdrawal by Subject|0|||
13444243|NCT00318370|26924987|FG001|Period 2|Withdrawal by Subject|1|||
13444244|NCT00318370|26924988|FG002|Period 2|Withdrawal by Subject|0|||
13444245|NCT00318370|26924986|FG000|Period 2|Other|0|||
13444246|NCT00318370|26924987|FG001|Period 2|Other|1|||
13444247|NCT00318370|26924988|FG002|Period 2|Other|0|||
13444248|NCT00318370|26924986|FG000|Period 3|Adverse Event|0|||
13444249|NCT00318370|26924987|FG001|Period 3|Adverse Event|0|||
13444250|NCT00318370|26924988|FG002|Period 3|Adverse Event|1|||
13444251|NCT00318370|26924986|FG000|Period 3|Lack of Efficacy|0|||
13444252|NCT00318370|26924987|FG001|Period 3|Lack of Efficacy|0|||
13444253|NCT00318370|26924988|FG002|Period 3|Lack of Efficacy|24|||
13444254|NCT00318370|26924986|FG000|Period 3|Death|0|||
13444255|NCT00318370|26924987|FG001|Period 3|Death|0|||
13444256|NCT00318370|26924988|FG002|Period 3|Death|1|||
13444257|NCT00318370|26924986|FG000|Period 3|Physician Decision|0|||
13444258|NCT00318370|26924987|FG001|Period 3|Physician Decision|0|||
13444259|NCT00318370|26924988|FG002|Period 3|Physician Decision|1|||
13444260|NCT00318370|26924986|FG000|Period 3|Withdrawal by Subject|0|||
13444261|NCT00318370|26924987|FG001|Period 3|Withdrawal by Subject|0|||
13444262|NCT00318370|26924988|FG002|Period 3|Withdrawal by Subject|3|||
13444263|NCT00318370|26924986|FG000|Period 3|Other|0|||
13444264|NCT00318370|26924987|FG001|Period 3|Other|0|||
13444265|NCT00318370|26924988|FG002|Period 3|Other|3|||
13444266|NCT00318149|26925093|FG000|Overall Study|Adverse Event|0|||
13444267|NCT00318149|26925094|FG001|Overall Study|Adverse Event|0|||
13444268|NCT00318149|26925095|FG002|Overall Study|Adverse Event|0|||
13444269|NCT00318149|26925096|FG003|Overall Study|Adverse Event|0|||
13444270|NCT00318149|26925097|FG004|Overall Study|Adverse Event|0|||
13444271|NCT00318149|26925098|FG005|Overall Study|Adverse Event|2|||
13444272|NCT00317772|26925125|FG000|Overall Study|Adverse Event|0|||
13444273|NCT00317772|26925126|FG001|Overall Study|Adverse Event|0|||
13444274|NCT00317772|26925127|FG002|Overall Study|Adverse Event|0|||
13444275|NCT00317772|26925128|FG003|Overall Study|Adverse Event|2|||
13444276|NCT00317772|26925125|FG000|Overall Study|Disease Progression|2|||
13444277|NCT00317772|26925126|FG001|Overall Study|Disease Progression|2|||
13444278|NCT00317772|26925127|FG002|Overall Study|Disease Progression|1|||
13444279|NCT00317772|26925128|FG003|Overall Study|Disease Progression|7|||
13444280|NCT00317642|26925208|FG000|Overall Study|Not Received Either Study Drug|1|||
13477196|NCT01470326|27005717|FG000|Overall Study|Protocol Violation|32|||
13444281|NCT00317642|26925209|FG001|Overall Study|Not Received Either Study Drug|3|||
13444282|NCT00317642|26925208|FG000|Overall Study|Physician Decision|15|||
13444283|NCT00317642|26925209|FG001|Overall Study|Physician Decision|7|||
13444284|NCT00317642|26925208|FG000|Overall Study|Participant declined treatment|14|||
13444285|NCT00317642|26925209|FG001|Overall Study|Participant declined treatment|3|||
13444286|NCT00317642|26925208|FG000|Overall Study|Adverse Event|17|||
13444287|NCT00317642|26925209|FG001|Overall Study|Adverse Event|5|||
13444288|NCT00317642|26925208|FG000|Overall Study|Treatment Failure|56|||
13444289|NCT00317642|26925209|FG001|Overall Study|Treatment Failure|102|||
13444290|NCT00317642|26925208|FG000|Overall Study|Disease Recurrence|1|||
13444291|NCT00317642|26925209|FG001|Overall Study|Disease Recurrence|2|||
13444292|NCT00317642|26925208|FG000|Overall Study|Death|14|||
13444293|NCT00317642|26925209|FG001|Overall Study|Death|7|||
13444294|NCT00317642|26925208|FG000|Overall Study|Not Continue to Consolidation|2|||
13444295|NCT00317642|26925209|FG001|Overall Study|Not Continue to Consolidation|0|||
13444296|NCT00317642|26925208|FG000|Overall Study|Withdrawal by Subject|0|||
13444297|NCT00317642|26925209|FG001|Overall Study|Withdrawal by Subject|1|||
13444298|NCT00317642|26925208|FG000|Overall Study|Referred For Transplantation|1|||
13444299|NCT00317642|26925209|FG001|Overall Study|Referred For Transplantation|0|||
13444300|NCT00317642|26925208|FG000|Overall Study|AML Not Centrally Confirmed|1|||
13444301|NCT00317642|26925209|FG001|Overall Study|AML Not Centrally Confirmed|5|||
13444302|NCT00317603|26925217|FG000|Overall Study|Progressive Disease|3|||
13444303|NCT00317473|26925260|FG000|Overall Study|Withdrawal by Subject|2|||
13444304|NCT00317473|26925261|FG001|Overall Study|Withdrawal by Subject|1|||
13444305|NCT00317473|26925262|FG002|Overall Study|Withdrawal by Subject|2|||
13444306|NCT00317473|26925263|FG003|Overall Study|Withdrawal by Subject|1|||
13444307|NCT00317473|26925264|FG004|Overall Study|Withdrawal by Subject|3|||
13444308|NCT00317473|26925265|FG005|Overall Study|Withdrawal by Subject|1|||
13444309|NCT00317473|26925260|FG000|Overall Study|Relocation|1|||
13444310|NCT00317473|26925261|FG001|Overall Study|Relocation|0|||
13444311|NCT00317473|26925262|FG002|Overall Study|Relocation|1|||
13444312|NCT00317473|26925263|FG003|Overall Study|Relocation|1|||
13444313|NCT00317473|26925264|FG004|Overall Study|Relocation|5|||
13444314|NCT00317473|26925265|FG005|Overall Study|Relocation|2|||
13444315|NCT00317473|26925260|FG000|Overall Study|Death|1|||
13444316|NCT00317473|26925261|FG001|Overall Study|Death|0|||
13444317|NCT00317473|26925262|FG002|Overall Study|Death|0|||
13444318|NCT00317473|26925263|FG003|Overall Study|Death|0|||
13444319|NCT00317473|26925264|FG004|Overall Study|Death|0|||
13444320|NCT00317473|26925265|FG005|Overall Study|Death|0|||
13444321|NCT00317473|26925260|FG000|Overall Study|Other|0|||
13444322|NCT00317473|26925261|FG001|Overall Study|Other|2|||
13444323|NCT00317473|26925262|FG002|Overall Study|Other|0|||
13444324|NCT00317473|26925263|FG003|Overall Study|Other|0|||
13444325|NCT00317473|26925264|FG004|Overall Study|Other|0|||
13444326|NCT00317473|26925265|FG005|Overall Study|Other|0|||
13444327|NCT00317369|26925304|FG000|Overall Study|Adverse Event|2|||
13444328|NCT00317369|26925305|FG001|Overall Study|Adverse Event|1|||
13444329|NCT00317369|26925306|FG002|Overall Study|Adverse Event|0|||
13444330|NCT00317369|26925304|FG000|Overall Study|Lack of Efficacy|0|||
13444331|NCT00317369|26925305|FG001|Overall Study|Lack of Efficacy|1|||
13444332|NCT00317369|26925306|FG002|Overall Study|Lack of Efficacy|1|||
13444333|NCT00317369|26925304|FG000|Overall Study|Withdrawal by Subject|0|||
13444334|NCT00317369|26925305|FG001|Overall Study|Withdrawal by Subject|0|||
13444335|NCT00317369|26925306|FG002|Overall Study|Withdrawal by Subject|1|||
13444336|NCT00317356|26925357|FG000|Overall Study|Adverse Event|0|||
13444337|NCT00317356|26925358|FG001|Overall Study|Adverse Event|0|||
13444338|NCT00317356|26925359|FG002|Overall Study|Adverse Event|1|||
13444339|NCT00317356|26925360|FG003|Overall Study|Adverse Event|0|||
13444340|NCT00317356|26925357|FG000|Overall Study|Lack of Efficacy|1|||
13444341|NCT00317356|26925358|FG001|Overall Study|Lack of Efficacy|1|||
13444342|NCT00317356|26925359|FG002|Overall Study|Lack of Efficacy|0|||
13444343|NCT00317356|26925360|FG003|Overall Study|Lack of Efficacy|3|||
13444344|NCT00317356|26925357|FG000|Overall Study|Physician Decision|0|||
13444345|NCT00317356|26925358|FG001|Overall Study|Physician Decision|1|||
13444346|NCT00317356|26925359|FG002|Overall Study|Physician Decision|0|||
13444347|NCT00317356|26925360|FG003|Overall Study|Physician Decision|0|||
13444348|NCT00317109|26925401|FG000|Overall Study|Withdrawal by Subject|2|||
13444349|NCT00317109|26925402|FG001|Overall Study|Withdrawal by Subject|0|||
13444350|NCT00317109|26925401|FG000|Overall Study|Migated/moved from study area|1|||
13444351|NCT00317109|26925402|FG001|Overall Study|Migated/moved from study area|0|||
13444352|NCT00317044|26925456|FG000|Overall Study|Protocol Violation|28|||
13444353|NCT00317044|26925457|FG001|Overall Study|Protocol Violation|22|||
13444354|NCT00317044|26925458|FG002|Overall Study|Protocol Violation|20|||
13444355|NCT00317044|26925456|FG000|Overall Study|Adverse Event|4|||
13444356|NCT00317044|26925457|FG001|Overall Study|Adverse Event|7|||
13444357|NCT00317044|26925458|FG002|Overall Study|Adverse Event|4|||
13444358|NCT00317044|26925456|FG000|Overall Study|Withdrawal by Subject|10|||
13444359|NCT00317044|26925457|FG001|Overall Study|Withdrawal by Subject|7|||
13444360|NCT00317044|26925458|FG002|Overall Study|Withdrawal by Subject|12|||
13444361|NCT00317044|26925456|FG000|Overall Study|Lost to Follow-up|0|||
13444362|NCT00317044|26925457|FG001|Overall Study|Lost to Follow-up|2|||
13444363|NCT00317044|26925458|FG002|Overall Study|Lost to Follow-up|3|||
13444364|NCT00317044|26925456|FG000|Overall Study|Multiple Reasons|6|||
13444365|NCT00317044|26925457|FG001|Overall Study|Multiple Reasons|2|||
13444366|NCT00317044|26925458|FG002|Overall Study|Multiple Reasons|6|||
13444367|NCT00316914|26925493|FG000|Overall Study|Withdrawal by Subject|5|||
13444368|NCT00316914|26925494|FG001|Overall Study|Withdrawal by Subject|3|||
13444369|NCT00316914|26925493|FG000|Overall Study|Adverse Event|8|||
13444370|NCT00316914|26925494|FG001|Overall Study|Adverse Event|7|||
13444371|NCT00316914|26925493|FG000|Overall Study|Other Problems|6|||
13444372|NCT00316914|26925494|FG001|Overall Study|Other Problems|11|||
13444373|NCT00316914|26925493|FG000|Overall Study|Missing end of treatment documentation|14|||
13444374|NCT00316914|26925494|FG001|Overall Study|Missing end of treatment documentation|15|||
13444375|NCT00316719|26925525|FG000|Overall Study|Adverse Event|0|||
13444376|NCT00316719|26925526|FG001|Overall Study|Adverse Event|6|||
13444377|NCT00316719|26925525|FG000|Overall Study|Consent withdrawn|2|||
13444378|NCT00316719|26925526|FG001|Overall Study|Consent withdrawn|0|||
13444379|NCT00316706|26925547|FG000|Overall Study|Lost to Follow-up|38|||
13444380|NCT00316706|26925548|FG001|Overall Study|Lost to Follow-up|48|||
13444381|NCT00316693|26925595|FG000|Overall Study|Adverse Event|6|||
13444382|NCT00316693|26925596|FG001|Overall Study|Adverse Event|1|||
13444383|NCT00316693|26925595|FG000|Overall Study|Protocol Violation|1|||
13444384|NCT00316693|26925596|FG001|Overall Study|Protocol Violation|0|||
13444385|NCT00316693|26925595|FG000|Overall Study|Withdrawal by Subject|6|||
13444386|NCT00316693|26925596|FG001|Overall Study|Withdrawal by Subject|6|||
13444387|NCT00316693|26925595|FG000|Overall Study|Lost to Follow-up|26|||
13444388|NCT00316693|26925596|FG001|Overall Study|Lost to Follow-up|34|||
13444389|NCT00316693|26925595|FG000|Overall Study|Other|38|||
13444390|NCT00316693|26925596|FG001|Overall Study|Other|44|||
13444391|NCT00316602|26925631|FG000|Overall Study|Withdrawal by Subject|3|||
13444392|NCT00316602|26925632|FG001|Overall Study|Withdrawal by Subject|2|||
13444393|NCT00316602|26925631|FG000|Overall Study|Subject unwilling/unable to comply with|3|||
13444394|NCT00316602|26925632|FG001|Overall Study|Subject unwilling/unable to comply with|17|||
13444395|NCT00316602|26925631|FG000|Overall Study|Adverse Event|1|||
13444396|NCT00316602|26925632|FG001|Overall Study|Adverse Event|0|||
13444397|NCT00316602|26925631|FG000|Overall Study|Other|3|||
13444398|NCT00316602|26925632|FG001|Overall Study|Other|6|||
13444399|NCT00316589|26925709|FG000|Overall Study|Withdrawal by Subject|0|||
13444400|NCT00316589|26925710|FG001|Overall Study|Withdrawal by Subject|5|||
13444401|NCT00316589|26925711|FG002|Overall Study|Withdrawal by Subject|0|||
13444402|NCT00316589|26925712|FG003|Overall Study|Withdrawal by Subject|1|||
13444403|NCT00316589|26925709|FG000|Overall Study|Subject unwilling/unable to comply|0|||
13444404|NCT00316589|26925710|FG001|Overall Study|Subject unwilling/unable to comply|6|||
13444405|NCT00316589|26925711|FG002|Overall Study|Subject unwilling/unable to comply|0|||
13444406|NCT00316589|26925712|FG003|Overall Study|Subject unwilling/unable to comply|2|||
13444407|NCT00316589|26925709|FG000|Overall Study|Adverse Event|1|||
13444408|NCT00316589|26925710|FG001|Overall Study|Adverse Event|0|||
13444409|NCT00316589|26925711|FG002|Overall Study|Adverse Event|0|||
13444410|NCT00316589|26925712|FG003|Overall Study|Adverse Event|1|||
13444411|NCT00316589|26925709|FG000|Overall Study|Physician Decision|0|||
13444412|NCT00316589|26925710|FG001|Overall Study|Physician Decision|1|||
13444413|NCT00316589|26925711|FG002|Overall Study|Physician Decision|0|||
13444414|NCT00316589|26925712|FG003|Overall Study|Physician Decision|0|||
13444415|NCT00316589|26925709|FG000|Overall Study|Other reason|0|||
13444416|NCT00316589|26925710|FG001|Overall Study|Other reason|12|||
13444417|NCT00316589|26925711|FG002|Overall Study|Other reason|1|||
13444418|NCT00316589|26925712|FG003|Overall Study|Other reason|1|||
13444419|NCT00316303|26925733|FG000|Overall Study|Lost to Follow-up|11|||
13444420|NCT00316303|26925734|FG001|Overall Study|Lost to Follow-up|16|||
13444421|NCT00316277|26925759|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88|||
13444422|NCT00316277|26925760|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75|||
13444423|NCT00316277|26925759|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2|||
13444424|NCT00316277|26925760|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0|||
13444425|NCT00316277|26925759|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220|||
13444426|NCT00316277|26925760|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225|||
13444427|NCT00316277|26925759|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19|||
13444428|NCT00316277|26925760|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18|||
13444429|NCT00316277|26925759|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0|||
13444430|NCT00316277|26925760|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1|||
13444431|NCT00316264|26925838|FG000|Overall Study|Lost to Follow-up|0|||
13444432|NCT00316264|26925839|FG001|Overall Study|Lost to Follow-up|1|||
13444433|NCT00316264|26925840|FG002|Overall Study|Lost to Follow-up|0|||
13444434|NCT00316264|26925838|FG000|Overall Study|Withdrawal of Consent|3|||
13444435|NCT00316264|26925839|FG001|Overall Study|Withdrawal of Consent|5|||
13444436|NCT00316264|26925840|FG002|Overall Study|Withdrawal of Consent|6|||
13444437|NCT00316264|26925838|FG000|Overall Study|Death|2|||
13444438|NCT00316264|26925839|FG001|Overall Study|Death|0|||
13444439|NCT00316264|26925840|FG002|Overall Study|Death|0|||
13444440|NCT00316264|26925838|FG000|Overall Study|Other|1|||
13444441|NCT00316264|26925839|FG001|Overall Study|Other|1|||
13444442|NCT00316264|26925840|FG002|Overall Study|Other|0|||
13444443|NCT00316225|26925851|FG000|Overall Study|Adverse Event|2|||
13444444|NCT00316225|26925851|FG000|Overall Study|Physician Decision|3|||
13444445|NCT00316225|26925851|FG000|Overall Study|Progressive Disease|15|||
13444446|NCT00316225|26925851|FG000|Overall Study|Withdrawal by Subject|3|||
13444447|NCT00316225|26925851|FG000|Overall Study|Death|2|||
13444448|NCT00316199|26925861|FG000|Overall Study|Adverse Event|2|||
13444449|NCT00316199|26925861|FG000|Overall Study|Death|8|||
13444450|NCT00316199|26925861|FG000|Overall Study|Lost to Follow-up|2|||
13444451|NCT00316186|26925875|FG000|Overall Study|Adverse Event|6|||
13444452|NCT00316186|26925875|FG000|Overall Study|Disease Progression|4|||
13444453|NCT00316186|26925875|FG000|Overall Study|Lost to Follow-up|1|||
13444454|NCT00316186|26925875|FG000|Overall Study|Other|1|||
13444455|NCT00316173|26925893|FG000|Run-in Phase|Adverse Event|1|||
13444456|NCT00316173|26925894|FG001|Run-in Phase|Adverse Event|0|||
13444457|NCT00316173|26925893|FG000|Run-in Phase|Protocol Violation|1|||
13444458|NCT00316173|26925894|FG001|Run-in Phase|Protocol Violation|0|||
13444459|NCT00316173|26925893|FG000|Run-in Phase|Study Follow-up Stopped|5|||
13444460|NCT00316173|26925894|FG001|Run-in Phase|Study Follow-up Stopped|0|||
13444461|NCT00316173|26925893|FG000|Treatment Phase|Adverse Event|0|||
13444462|NCT00316173|26925894|FG001|Treatment Phase|Adverse Event|1|||
13444463|NCT00316173|26925893|FG000|Treatment Phase|Lack of Efficacy|0|||
13444464|NCT00316173|26925894|FG001|Treatment Phase|Lack of Efficacy|3|||
13444465|NCT00316173|26925893|FG000|Treatment Phase|Lost to Follow-up|0|||
13444466|NCT00316173|26925894|FG001|Treatment Phase|Lost to Follow-up|3|||
13444467|NCT00316173|26925893|FG000|Treatment Phase|Withdrawal by Subject|0|||
13444468|NCT00316173|26925894|FG001|Treatment Phase|Withdrawal by Subject|1|||
13444469|NCT00316173|26925893|FG000|Treatment Phase|Study Follow-up Stopped|0|||
13444470|NCT00316173|26925894|FG001|Treatment Phase|Study Follow-up Stopped|34|||
13444471|NCT00316121|26925907|FG000|Overall Study|Death|1|||
13444472|NCT00316121|26925908|FG001|Overall Study|Death|0|||
13444473|NCT00316121|26925907|FG000|Overall Study|Lost to Follow-up|14|||
13444474|NCT00316121|26925908|FG001|Overall Study|Lost to Follow-up|8|||
13444475|NCT00316121|26925907|FG000|Overall Study|Withdrawal by Subject|2|||
13444476|NCT00316121|26925908|FG001|Overall Study|Withdrawal by Subject|0|||
13444477|NCT00316121|26925907|FG000|Overall Study|Reason is missing|1|||
13444478|NCT00316121|26925908|FG001|Overall Study|Reason is missing|0|||
13444479|NCT00316121|26925907|FG000|Overall Study|Subject relocated|1|||
13444480|NCT00316121|26925908|FG001|Overall Study|Subject relocated|1|||
13444481|NCT00316121|26925907|FG000|Overall Study|Subject refused to return|1|||
13444482|NCT00316121|26925908|FG001|Overall Study|Subject refused to return|0|||
13444483|NCT00316121|26925907|FG000|Overall Study|Subject no show for visit x 3|1|||
13444484|NCT00316121|26925908|FG001|Overall Study|Subject no show for visit x 3|0|||
13444485|NCT00316121|26925907|FG000|Overall Study|Subject did not have 24 month visit|1|||
13444486|NCT00316121|26925908|FG001|Overall Study|Subject did not have 24 month visit|0|||
13444487|NCT00316082|26925952|FG000|Overall Study|Lack of Efficacy|2|||
13444488|NCT00316082|26925953|FG001|Overall Study|Lack of Efficacy|3|||
13444489|NCT00316082|26925954|FG002|Overall Study|Lack of Efficacy|3|||
13444490|NCT00316082|26925955|FG003|Overall Study|Lack of Efficacy|4|||
13444491|NCT00316082|26925956|FG004|Overall Study|Lack of Efficacy|6|||
13444492|NCT00316082|26925952|FG000|Overall Study|Withdrawal of Consent by Subject|10|||
13444493|NCT00316082|26925953|FG001|Overall Study|Withdrawal of Consent by Subject|8|||
13444494|NCT00316082|26925954|FG002|Overall Study|Withdrawal of Consent by Subject|2|||
13444495|NCT00316082|26925955|FG003|Overall Study|Withdrawal of Consent by Subject|9|||
13444496|NCT00316082|26925956|FG004|Overall Study|Withdrawal of Consent by Subject|5|||
13444497|NCT00316082|26925952|FG000|Overall Study|Lost to Follow-up|7|||
13444498|NCT00316082|26925953|FG001|Overall Study|Lost to Follow-up|6|||
13444499|NCT00316082|26925954|FG002|Overall Study|Lost to Follow-up|7|||
13444500|NCT00316082|26925955|FG003|Overall Study|Lost to Follow-up|8|||
13444501|NCT00316082|26925956|FG004|Overall Study|Lost to Follow-up|6|||
13444502|NCT00316082|26925952|FG000|Overall Study|Poor/noncompliance|6|||
13444503|NCT00316082|26925953|FG001|Overall Study|Poor/noncompliance|1|||
13444504|NCT00316082|26925954|FG002|Overall Study|Poor/noncompliance|4|||
13444505|NCT00316082|26925955|FG003|Overall Study|Poor/noncompliance|1|||
13444506|NCT00316082|26925956|FG004|Overall Study|Poor/noncompliance|4|||
13444507|NCT00316082|26925952|FG000|Overall Study|Adverse Event|4|||
13444508|NCT00316082|26925953|FG001|Overall Study|Adverse Event|2|||
13444509|NCT00316082|26925954|FG002|Overall Study|Adverse Event|5|||
13444510|NCT00316082|26925955|FG003|Overall Study|Adverse Event|1|||
13444511|NCT00316082|26925956|FG004|Overall Study|Adverse Event|3|||
13444512|NCT00316082|26925952|FG000|Overall Study|Subject no longer meets study criteria|3|||
13444513|NCT00316082|26925953|FG001|Overall Study|Subject no longer meets study criteria|1|||
13444514|NCT00316082|26925954|FG002|Overall Study|Subject no longer meets study criteria|2|||
13444515|NCT00316082|26925955|FG003|Overall Study|Subject no longer meets study criteria|2|||
13444516|NCT00316082|26925956|FG004|Overall Study|Subject no longer meets study criteria|1|||
13444517|NCT00316082|26925952|FG000|Overall Study|Physician Decision|1|||
13444518|NCT00316082|26925953|FG001|Overall Study|Physician Decision|1|||
13444519|NCT00316082|26925954|FG002|Overall Study|Physician Decision|2|||
13444520|NCT00316082|26925955|FG003|Overall Study|Physician Decision|1|||
13444521|NCT00316082|26925956|FG004|Overall Study|Physician Decision|1|||
13444522|NCT00316082|26925952|FG000|Overall Study|Death|0|||
13444523|NCT00316082|26925953|FG001|Overall Study|Death|0|||
13444524|NCT00316082|26925954|FG002|Overall Study|Death|1|||
13444525|NCT00316082|26925955|FG003|Overall Study|Death|0|||
13444526|NCT00316082|26925956|FG004|Overall Study|Death|0|||
13444527|NCT00316082|26925952|FG000|Overall Study|Administrative reason by sponsor|0|||
13444528|NCT00316082|26925953|FG001|Overall Study|Administrative reason by sponsor|0|||
13444529|NCT00316082|26925954|FG002|Overall Study|Administrative reason by sponsor|1|||
13444530|NCT00316082|26925955|FG003|Overall Study|Administrative reason by sponsor|0|||
13444531|NCT00316082|26925956|FG004|Overall Study|Administrative reason by sponsor|0|||
13444532|NCT00316017|26926037|FG000|Overall Study|Protocol Violation|11|||
13444533|NCT00316017|26926038|FG001|Overall Study|Protocol Violation|13|||
13444534|NCT00316017|26926039|FG002|Overall Study|Protocol Violation|19|||
13444535|NCT00316004|26926102|FG000|Overall Study|Subject was not given study fluid.|14|||
13444536|NCT00316004|26926103|FG001|Overall Study|Subject was not given study fluid.|14|||
13444537|NCT00316004|26926104|FG002|Overall Study|Subject was not given study fluid.|21|||
13444538|NCT00315731|26926132|FG000|Overall Study|Lost to Follow-up|1|||
13444539|NCT00315731|26926132|FG000|Overall Study|Death|5|||
13444540|NCT00315705|26926175|FG000|Phase 1|Refused further treatment|1|||
13444541|NCT00315705|26926175|FG000|Phase 1|Failure to achieve response|8|||
13444542|NCT00315705|26926175|FG000|Phase 1|Disease relapse|4|||
13444543|NCT00315705|26926175|FG000|Phase 1|Scheduled for transplant|9|||
13444544|NCT00315705|26926175|FG000|Phase 1|Death|3|||
13444545|NCT00315705|26926175|FG000|Phase 2|Physician Decision|4|||
13444546|NCT00315705|26926175|FG000|Phase 2|Adverse Event|1|||
13444547|NCT00315705|26926175|FG000|Phase 2|Failure to achieve response|3|||
13444548|NCT00315705|26926175|FG000|Phase 2|Disease relapse|1|||
13444549|NCT00315705|26926175|FG000|Phase 2|Scheduled for transplant|8|||
13444550|NCT00315705|26926175|FG000|Phase 2|Other|1|||
13444551|NCT00315705|26926175|FG000|Phase 2|Death|7|||
13477197|NCT01470326|27005717|FG000|Overall Study|No Drug Administration Information|2|||
13477198|NCT01470326|27005717|FG000|Overall Study|No Visit After 1st Day of Treatment|119|||
13444552|NCT00315458|26926194|FG000|Overall Study|Administrative|0|||
13444553|NCT00315458|26926195|FG001|Overall Study|Administrative|3|||
13444554|NCT00315458|26926196|FG002|Overall Study|Administrative|8|||
13444555|NCT00315458|26926197|FG003|Overall Study|Administrative|21|||
13444556|NCT00315458|26926194|FG000|Overall Study|Adverse Event|2|||
13444557|NCT00315458|26926195|FG001|Overall Study|Adverse Event|4|||
13444558|NCT00315458|26926196|FG002|Overall Study|Adverse Event|23|||
13444559|NCT00315458|26926197|FG003|Overall Study|Adverse Event|3|||
13444560|NCT00315458|26926194|FG000|Overall Study|Lost to Follow-up|1|||
13444561|NCT00315458|26926195|FG001|Overall Study|Lost to Follow-up|2|||
13444562|NCT00315458|26926196|FG002|Overall Study|Lost to Follow-up|0|||
13444563|NCT00315458|26926197|FG003|Overall Study|Lost to Follow-up|2|||
13444564|NCT00315458|26926194|FG000|Overall Study|Withdrawal by Subject|0|||
13444565|NCT00315458|26926195|FG001|Overall Study|Withdrawal by Subject|3|||
13444566|NCT00315458|26926196|FG002|Overall Study|Withdrawal by Subject|0|||
13444567|NCT00315458|26926197|FG003|Overall Study|Withdrawal by Subject|2|||
13444568|NCT00315458|26926194|FG000|Overall Study|Lack of Efficacy|0|||
13444569|NCT00315458|26926195|FG001|Overall Study|Lack of Efficacy|0|||
13444570|NCT00315458|26926196|FG002|Overall Study|Lack of Efficacy|20|||
13444571|NCT00315458|26926197|FG003|Overall Study|Lack of Efficacy|1|||
13444572|NCT00315458|26926194|FG000|Overall Study|Did not qualify|0|||
13444573|NCT00315458|26926195|FG001|Overall Study|Did not qualify|0|||
13444574|NCT00315458|26926196|FG002|Overall Study|Did not qualify|1|||
13444575|NCT00315458|26926197|FG003|Overall Study|Did not qualify|0|||
13444576|NCT00315445|26926278|FG000|Overall Study|Adverse Event|7|||
13444577|NCT00315445|26926279|FG001|Overall Study|Adverse Event|12|||
13444578|NCT00315445|26926280|FG002|Overall Study|Adverse Event|15|||
13444579|NCT00315445|26926278|FG000|Overall Study|Lack of Efficacy|16|||
13444580|NCT00315445|26926279|FG001|Overall Study|Lack of Efficacy|1|||
13444581|NCT00315445|26926280|FG002|Overall Study|Lack of Efficacy|7|||
13444582|NCT00315445|26926278|FG000|Overall Study|Lost to Follow-up|1|||
13444583|NCT00315445|26926279|FG001|Overall Study|Lost to Follow-up|0|||
13444584|NCT00315445|26926280|FG002|Overall Study|Lost to Follow-up|1|||
13444585|NCT00315445|26926278|FG000|Overall Study|Protocol Violation|2|||
13444586|NCT00315445|26926279|FG001|Overall Study|Protocol Violation|0|||
13444587|NCT00315445|26926280|FG002|Overall Study|Protocol Violation|1|||
13444588|NCT00315445|26926278|FG000|Overall Study|Other|1|||
13444589|NCT00315445|26926279|FG001|Overall Study|Other|3|||
13444590|NCT00315445|26926280|FG002|Overall Study|Other|0|||
13444591|NCT00315055|26926303|FG000|Overall Study|Protocol Violation|2|||
13444592|NCT00315055|26926304|FG001|Overall Study|Protocol Violation|4|||
13444593|NCT00315055|26926303|FG000|Overall Study|Lost to Follow-up|1|||
13444594|NCT00315055|26926304|FG001|Overall Study|Lost to Follow-up|1|||
13444595|NCT00314951|26926321|FG000|Treatment|Didn't meet criteria for mITT population|16|||
13444596|NCT00314951|26926322|FG001|Treatment|Didn't meet criteria for mITT population|11|||
13444597|NCT00314951|26926321|FG000|Follow-up|mITT failure|44|||
13444598|NCT00314951|26926322|FG001|Follow-up|mITT failure|34|||
13444599|NCT00314808|26926332|FG000|Overall Study|Disease Progression without AE|4|||
13444600|NCT00314808|26926332|FG000|Overall Study|Withdrawal by Subject/PI without AE|4|||
13444601|NCT00314795|26926342|FG000|Overall Study|Adverse Event|8|||
13444602|NCT00314795|26926342|FG000|Overall Study|Death|4|||
13444603|NCT00314795|26926342|FG000|Overall Study|Reason not Specified|3|||
13444604|NCT00314795|26926342|FG000|Overall Study|Renal Transplant|3|||
13444605|NCT00314795|26926342|FG000|Overall Study|Participants Withdrew Consent|2|||
13444606|NCT00314574|26926363|FG000|Overall Study|Death|3|||
13444607|NCT00314574|26926364|FG001|Overall Study|Death|0|||
13444608|NCT00314574|26926363|FG000|Overall Study|Adverse Event|11|||
13444609|NCT00314574|26926364|FG001|Overall Study|Adverse Event|16|||
13444610|NCT00314574|26926363|FG000|Overall Study|Lost to Follow-up|19|||
13444611|NCT00314574|26926364|FG001|Overall Study|Lost to Follow-up|25|||
13444612|NCT00314574|26926363|FG000|Overall Study|Withdrawal by Subject|33|||
13444613|NCT00314574|26926364|FG001|Overall Study|Withdrawal by Subject|22|||
13444614|NCT00314574|26926363|FG000|Overall Study|Physician Decision|22|||
13444615|NCT00314574|26926364|FG001|Overall Study|Physician Decision|15|||
13444616|NCT00314574|26926363|FG000|Overall Study|Pregnancy|6|||
13444617|NCT00314574|26926364|FG001|Overall Study|Pregnancy|4|||
13444618|NCT00314574|26926363|FG000|Overall Study|Data unknown at database lock|0|||
13444619|NCT00314574|26926364|FG001|Overall Study|Data unknown at database lock|1|||
13444620|NCT00314366|26926399|FG000|Overall Study|not treated due to patient medical condi|1|||
13444621|NCT00314366|26926400|FG001|Overall Study|not treated due to patient medical condi|0|||
13444622|NCT00314340|26926408|FG000|Overall Study|lost interest|1|||
13444623|NCT00314327|26926415|FG000|Overall Study|Withdrawal by Subject|1|||
13444624|NCT00314262|26926423|FG000|Overall Study|Adverse Event|2|||
13444625|NCT00314262|26926423|FG000|Overall Study|Withdrawal by Subject|2|||
13444626|NCT00314262|26926423|FG000|Overall Study|Physician Decision|1|||
13444627|NCT00314249|26926446|FG000|Overall Study|Adverse Event|73|||
13444628|NCT00314249|26926447|FG001|Overall Study|Adverse Event|94|||
13444629|NCT00314249|26926446|FG000|Overall Study|Lack of Efficacy|33|||
13444630|NCT00314249|26926447|FG001|Overall Study|Lack of Efficacy|24|||
13477199|NCT01480180|27005883|FG000|Main Phase|Withdrawal criteria|12|||
13444631|NCT00314249|26926446|FG000|Overall Study|Withdrawal by Subject|21|||
13444632|NCT00314249|26926447|FG001|Overall Study|Withdrawal by Subject|28|||
13444633|NCT00314249|26926446|FG000|Overall Study|Lost to Follow-up|15|||
13444634|NCT00314249|26926447|FG001|Overall Study|Lost to Follow-up|9|||
13444635|NCT00314249|26926446|FG000|Overall Study|Physician Decision|1|||
13444636|NCT00314249|26926447|FG001|Overall Study|Physician Decision|1|||
13444637|NCT00314249|26926446|FG000|Overall Study|Withdrawn for other reasons|4|||
13444638|NCT00314249|26926447|FG001|Overall Study|Withdrawn for other reasons|1|||
13444639|NCT00314249|26926446|FG000|Overall Study|Non-Compliant|5|||
13444640|NCT00314249|26926447|FG001|Overall Study|Non-Compliant|6|||
13444641|NCT00314145|26926466|FG000|Overall Study|Withdrawal by Subject|8|||
13444642|NCT00314145|26926467|FG001|Overall Study|Withdrawal by Subject|10|||
13444643|NCT00314145|26926466|FG000|Overall Study|Lost to Follow-up|5|||
13444644|NCT00314145|26926467|FG001|Overall Study|Lost to Follow-up|12|||
13444645|NCT00314145|26926466|FG000|Overall Study|Physician Decision|3|||
13444646|NCT00314145|26926467|FG001|Overall Study|Physician Decision|4|||
13444647|NCT00314145|26926466|FG000|Overall Study|Adverse Event|0|||
13444648|NCT00314145|26926467|FG001|Overall Study|Adverse Event|3|||
13444649|NCT00314145|26926466|FG000|Overall Study|Protocol Violation|3|||
13444650|NCT00314145|26926467|FG001|Overall Study|Protocol Violation|0|||
13444651|NCT00314145|26926466|FG000|Overall Study|Sponsor Decision|2|||
13444652|NCT00314145|26926467|FG001|Overall Study|Sponsor Decision|0|||
13444653|NCT00314132|26926482|FG000|Overall Study|Lost to Follow-up|3|||
13444654|NCT00314132|26926483|FG001|Overall Study|Lost to Follow-up|13|||
13444655|NCT00314132|26926482|FG000|Overall Study|Withdrawal by Subject|3|||
13444656|NCT00314132|26926483|FG001|Overall Study|Withdrawal by Subject|5|||
13444657|NCT00314132|26926482|FG000|Overall Study|Adverse Event|1|||
13444658|NCT00314132|26926483|FG001|Overall Study|Adverse Event|0|||
13444659|NCT00314132|26926482|FG000|Overall Study|Physician Decision|1|||
13444660|NCT00314132|26926483|FG001|Overall Study|Physician Decision|0|||
13444661|NCT00313911|26926502|FG000|Overall Study|Serious adverse event|6|||
13444662|NCT00313911|26926503|FG001|Overall Study|Serious adverse event|1|||
13444663|NCT00313911|26926502|FG000|Overall Study|Adverse Event|2|||
13444664|NCT00313911|26926503|FG001|Overall Study|Adverse Event|3|||
13444665|NCT00313911|26926502|FG000|Overall Study|Protocol Violation|19|||
13444666|NCT00313911|26926503|FG001|Overall Study|Protocol Violation|10|||
13444667|NCT00313911|26926502|FG000|Overall Study|Lost to Follow-up|27|||
13444668|NCT00313911|26926503|FG001|Overall Study|Lost to Follow-up|14|||
13444669|NCT00313911|26926502|FG000|Overall Study|Withdrawal by Subject|39|||
13444670|NCT00313911|26926503|FG001|Overall Study|Withdrawal by Subject|12|||
13444671|NCT00313911|26926502|FG000|Overall Study|Did not meet age criteria|1|||
13444672|NCT00313911|26926503|FG001|Overall Study|Did not meet age criteria|1|||
13444673|NCT00313846|26926519|FG000|Overall Study|Withdrawal by Subject|2|||
13444674|NCT00313846|26926520|FG001|Overall Study|Withdrawal by Subject|0|||
13444675|NCT00313846|26926519|FG000|Overall Study|Adverse Event|1|||
13444676|NCT00313846|26926520|FG001|Overall Study|Adverse Event|8|||
13444677|NCT00313846|26926519|FG000|Overall Study|Administrative|2|||
13444678|NCT00313846|26926520|FG001|Overall Study|Administrative|3|||
13444679|NCT00313820|26926563|FG000|Assigned to Treatment|Other|1|||
13444680|NCT00313820|26926564|FG001|Assigned to Treatment|Other|0|||
13444681|NCT00313820|26926563|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9|||
13444682|NCT00313820|26926564|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4|||
13444683|NCT00313820|26926563|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0|||
13444684|NCT00313820|26926564|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1|||
13444685|NCT00313820|26926563|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0|||
13444686|NCT00313820|26926564|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7|||
13444687|NCT00313820|26926563|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6|||
13444688|NCT00313820|26926564|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4|||
13444689|NCT00313820|26926563|FG000|Pregabalin or Placebo Treatment Period|Other|2|||
13444690|NCT00313820|26926564|FG001|Pregabalin or Placebo Treatment Period|Other|3|||
13444691|NCT00313781|26926606|FG000|Before Crossover|Death|22|||
13444692|NCT00313781|26926607|FG001|Before Crossover|Death|8|||
13444693|NCT00313781|26926608|FG002|Before Crossover|Death|0|||
13444694|NCT00313781|26926606|FG000|Before Crossover|Lost to Follow-up|0|||
13444695|NCT00313781|26926607|FG001|Before Crossover|Lost to Follow-up|3|||
13444696|NCT00313781|26926608|FG002|Before Crossover|Lost to Follow-up|0|||
13444697|NCT00313781|26926606|FG000|Before Crossover|Withdrawal by Subject|3|||
13444698|NCT00313781|26926607|FG001|Before Crossover|Withdrawal by Subject|1|||
13444699|NCT00313781|26926608|FG002|Before Crossover|Withdrawal by Subject|0|||
13444700|NCT00313781|26926606|FG000|Before Crossover|Other|45|||
13444701|NCT00313781|26926607|FG001|Before Crossover|Other|30|||
13444702|NCT00313781|26926608|FG002|Before Crossover|Other|0|||
13444703|NCT00313781|26926606|FG000|Before Crossover|Crossover|0|||
13444704|NCT00313781|26926607|FG001|Before Crossover|Crossover|37|||
13444705|NCT00313781|26926608|FG002|Before Crossover|Crossover|0|||
13444706|NCT00313781|26926606|FG000|Before Crossover|Randomized, not treated|5|||
13444707|NCT00313781|26926607|FG001|Before Crossover|Randomized, not treated|0|||
13444708|NCT00313781|26926608|FG002|Before Crossover|Randomized, not treated|0|||
13444709|NCT00313781|26926606|FG000|After Crossover|Death|0|||
13444710|NCT00313781|26926607|FG001|After Crossover|Death|0|||
13444711|NCT00313781|26926608|FG002|After Crossover|Death|6|||
13444712|NCT00313781|26926606|FG000|After Crossover|Withdrawal by Subject|0|||
13444713|NCT00313781|26926607|FG001|After Crossover|Withdrawal by Subject|0|||
13444714|NCT00313781|26926608|FG002|After Crossover|Withdrawal by Subject|3|||
13444715|NCT00313781|26926606|FG000|After Crossover|Other|0|||
13444716|NCT00313781|26926607|FG001|After Crossover|Other|0|||
13444717|NCT00313781|26926608|FG002|After Crossover|Other|18|||
13444718|NCT00313716|26926650|FG000|Overall Study|Death|3|||
13444719|NCT00313716|26926651|FG001|Overall Study|Death|2|||
13444720|NCT00313716|26926652|FG002|Overall Study|Death|9|||
13444721|NCT00313716|26926653|FG003|Overall Study|Death|3|||
13444722|NCT00313716|26926654|FG004|Overall Study|Death|5|||
13444723|NCT00313716|26926655|FG005|Overall Study|Death|9|||
13444724|NCT00313716|26926650|FG000|Overall Study|Lost to Follow-up|2|||
13444725|NCT00313716|26926651|FG001|Overall Study|Lost to Follow-up|5|||
13444726|NCT00313716|26926652|FG002|Overall Study|Lost to Follow-up|2|||
13444727|NCT00313716|26926653|FG003|Overall Study|Lost to Follow-up|1|||
13444728|NCT00313716|26926654|FG004|Overall Study|Lost to Follow-up|0|||
13444729|NCT00313716|26926655|FG005|Overall Study|Lost to Follow-up|4|||
13444730|NCT00313716|26926650|FG000|Overall Study|Withdrawal by Subject|0|||
13444731|NCT00313716|26926651|FG001|Overall Study|Withdrawal by Subject|1|||
13444732|NCT00313716|26926652|FG002|Overall Study|Withdrawal by Subject|1|||
13444733|NCT00313716|26926653|FG003|Overall Study|Withdrawal by Subject|0|||
13444734|NCT00313716|26926654|FG004|Overall Study|Withdrawal by Subject|1|||
13444735|NCT00313716|26926655|FG005|Overall Study|Withdrawal by Subject|0|||
13444736|NCT00313703|26926682|FG000|Overall Study|Lost to Follow-up|11|||
13444737|NCT00313703|26926683|FG001|Overall Study|Lost to Follow-up|2|||
13444738|NCT00313703|26926684|FG002|Overall Study|Lost to Follow-up|5|||
13444739|NCT00313703|26926685|FG003|Overall Study|Lost to Follow-up|12|||
13444740|NCT00313612|26926700|FG000|Overall Study|Patient never received treatment|0|||
13444741|NCT00313612|26926701|FG001|Overall Study|Patient never received treatment|1|||
13444742|NCT00313586|26926722|FG000|Overall Study|Disease progression|14|||
13444743|NCT00313586|26926723|FG001|Overall Study|Disease progression|19|||
13444744|NCT00313586|26926724|FG002|Overall Study|Disease progression|10|||
13444745|NCT00313586|26926725|FG003|Overall Study|Disease progression|3|||
13444746|NCT00313586|26926722|FG000|Overall Study|Adverse Event|12|||
13444747|NCT00313586|26926723|FG001|Overall Study|Adverse Event|18|||
13444748|NCT00313586|26926724|FG002|Overall Study|Adverse Event|3|||
13444749|NCT00313586|26926725|FG003|Overall Study|Adverse Event|10|||
13444750|NCT00313586|26926722|FG000|Overall Study|Death|11|||
13444751|NCT00313586|26926723|FG001|Overall Study|Death|8|||
13444752|NCT00313586|26926724|FG002|Overall Study|Death|1|||
13444753|NCT00313586|26926725|FG003|Overall Study|Death|7|||
13444754|NCT00313586|26926722|FG000|Overall Study|Withdrawal by Subject|13|||
13444755|NCT00313586|26926723|FG001|Overall Study|Withdrawal by Subject|6|||
13444756|NCT00313586|26926724|FG002|Overall Study|Withdrawal by Subject|6|||
13444757|NCT00313586|26926725|FG003|Overall Study|Withdrawal by Subject|2|||
13444758|NCT00313586|26926722|FG000|Overall Study|Alternative therapy|3|||
13444759|NCT00313586|26926723|FG001|Overall Study|Alternative therapy|6|||
13444760|NCT00313586|26926724|FG002|Overall Study|Alternative therapy|2|||
13444761|NCT00313586|26926725|FG003|Overall Study|Alternative therapy|0|||
13444762|NCT00313586|26926722|FG000|Overall Study|Other complicating disease|2|||
13444763|NCT00313586|26926723|FG001|Overall Study|Other complicating disease|2|||
13444764|NCT00313586|26926724|FG002|Overall Study|Other complicating disease|0|||
13444765|NCT00313586|26926725|FG003|Overall Study|Other complicating disease|0|||
13444766|NCT00313586|26926722|FG000|Overall Study|Did not achieve HI-major/better response|10|||
13444767|NCT00313586|26926723|FG001|Overall Study|Did not achieve HI-major/better response|7|||
13444768|NCT00313586|26926724|FG002|Overall Study|Did not achieve HI-major/better response|2|||
13444769|NCT00313586|26926725|FG003|Overall Study|Did not achieve HI-major/better response|1|||
13444770|NCT00313586|26926722|FG000|Overall Study|Physician Decision|2|||
13444771|NCT00313586|26926723|FG001|Overall Study|Physician Decision|1|||
13444772|NCT00313586|26926724|FG002|Overall Study|Physician Decision|0|||
13444773|NCT00313586|26926725|FG003|Overall Study|Physician Decision|0|||
13444774|NCT00313586|26926722|FG000|Overall Study|Absolute neutrophil count not recovered|2|||
13444775|NCT00313586|26926723|FG001|Overall Study|Absolute neutrophil count not recovered|1|||
13444776|NCT00313586|26926724|FG002|Overall Study|Absolute neutrophil count not recovered|0|||
13444777|NCT00313586|26926725|FG003|Overall Study|Absolute neutrophil count not recovered|0|||
13444778|NCT00313586|26926722|FG000|Overall Study|Lost insurance|0|||
13444779|NCT00313586|26926723|FG001|Overall Study|Lost insurance|1|||
13444780|NCT00313586|26926724|FG002|Overall Study|Lost insurance|0|||
13444781|NCT00313586|26926725|FG003|Overall Study|Lost insurance|0|||
13444782|NCT00313586|26926722|FG000|Overall Study|Moved|0|||
13444783|NCT00313586|26926723|FG001|Overall Study|Moved|1|||
13444784|NCT00313586|26926724|FG002|Overall Study|Moved|0|||
13444785|NCT00313586|26926725|FG003|Overall Study|Moved|0|||
13444786|NCT00313586|26926722|FG000|Overall Study|Death before starting treatment|1|||
13444787|NCT00313586|26926723|FG001|Overall Study|Death before starting treatment|0|||
13444788|NCT00313586|26926724|FG002|Overall Study|Death before starting treatment|0|||
13444789|NCT00313586|26926725|FG003|Overall Study|Death before starting treatment|0|||
13444790|NCT00313313|26926752|FG000|Overall Study|Lack of Efficacy|14|||
13444791|NCT00313313|26926753|FG001|Overall Study|Lack of Efficacy|9|||
13444792|NCT00313313|26926754|FG002|Overall Study|Lack of Efficacy|20|||
13444793|NCT00313313|26926752|FG000|Overall Study|Withdrawal of consent by subject|18|||
13444794|NCT00313313|26926753|FG001|Overall Study|Withdrawal of consent by subject|17|||
13444795|NCT00313313|26926754|FG002|Overall Study|Withdrawal of consent by subject|31|||
13444796|NCT00313313|26926752|FG000|Overall Study|Lost to Follow-up|10|||
13444797|NCT00313313|26926753|FG001|Overall Study|Lost to Follow-up|7|||
13444798|NCT00313313|26926754|FG002|Overall Study|Lost to Follow-up|9|||
13444799|NCT00313313|26926752|FG000|Overall Study|Adverse Event|15|||
13444800|NCT00313313|26926753|FG001|Overall Study|Adverse Event|16|||
13444801|NCT00313313|26926754|FG002|Overall Study|Adverse Event|12|||
13444802|NCT00313313|26926752|FG000|Overall Study|Physician Decision|2|||
13444803|NCT00313313|26926753|FG001|Overall Study|Physician Decision|6|||
13444804|NCT00313313|26926754|FG002|Overall Study|Physician Decision|4|||
13444805|NCT00313313|26926752|FG000|Overall Study|Poor/Noncompliance|3|||
13444806|NCT00313313|26926753|FG001|Overall Study|Poor/Noncompliance|6|||
13444807|NCT00313313|26926754|FG002|Overall Study|Poor/Noncompliance|2|||
13444808|NCT00313313|26926752|FG000|Overall Study|Pregnancy|1|||
13444809|NCT00313313|26926753|FG001|Overall Study|Pregnancy|2|||
13444810|NCT00313313|26926754|FG002|Overall Study|Pregnancy|0|||
13444811|NCT00313313|26926752|FG000|Overall Study|Death|0|||
13444812|NCT00313313|26926753|FG001|Overall Study|Death|0|||
13444813|NCT00313313|26926754|FG002|Overall Study|Death|2|||
13444814|NCT00313313|26926752|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
13444815|NCT00313313|26926753|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
13444816|NCT00313313|26926754|FG002|Overall Study|Subject No Longer Meets Study Criteria|2|||
13444817|NCT00313300|26926820|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19|||
13444818|NCT00313300|26926821|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14|||
13444819|NCT00313300|26926822|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17|||
13444820|NCT00313300|26926823|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
13444821|NCT00313300|26926824|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
13444822|NCT00313300|26926820|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20|||
13444823|NCT00313300|26926821|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12|||
13444824|NCT00313300|26926822|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13|||
13444825|NCT00313300|26926823|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
13444826|NCT00313300|26926824|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
13444827|NCT00313300|26926820|FG000|Randomized in Phase A (26 Weeks)|Death|3|||
13444828|NCT00313300|26926821|FG001|Randomized in Phase A (26 Weeks)|Death|4|||
13444829|NCT00313300|26926822|FG002|Randomized in Phase A (26 Weeks)|Death|0|||
13444830|NCT00313300|26926823|FG003|Randomized in Phase A (26 Weeks)|Death|0|||
13444831|NCT00313300|26926824|FG004|Randomized in Phase A (26 Weeks)|Death|0|||
13444832|NCT00313300|26926820|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
13444833|NCT00313300|26926821|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
13444834|NCT00313300|26926822|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2|||
13444835|NCT00313300|26926823|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
13444836|NCT00313300|26926824|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
13444837|NCT00313300|26926820|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3|||
13444838|NCT00313300|26926821|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2|||
13444839|NCT00313300|26926822|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1|||
13444840|NCT00313300|26926823|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
13444841|NCT00313300|26926824|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
13444842|NCT00313300|26926820|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4|||
13444843|NCT00313300|26926821|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3|||
13444844|NCT00313300|26926822|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2|||
13444845|NCT00313300|26926823|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
13444846|NCT00313300|26926824|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
13444847|NCT00313300|26926820|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1|||
13444848|NCT00313300|26926821|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
13444849|NCT00313300|26926822|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
13444850|NCT00313300|26926823|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
13219935|NCT01829113|26278686|FG000|Overall Study|Adverse Event|14|||
13444851|NCT00313300|26926824|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
13444852|NCT00313300|26926820|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34|||
13444853|NCT00313300|26926821|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9|||
13444854|NCT00313300|26926822|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12|||
13444855|NCT00313300|26926823|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23|||
13444856|NCT00313300|26926824|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19|||
13444857|NCT00313300|26926820|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35|||
13444858|NCT00313300|26926821|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14|||
13444859|NCT00313300|26926822|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
13444860|NCT00313300|26926823|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15|||
13444861|NCT00313300|26926824|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
13444862|NCT00313300|26926820|FG000|Randomized in Phase B (26 Weeks)|Death|5|||
13444863|NCT00313300|26926821|FG001|Randomized in Phase B (26 Weeks)|Death|3|||
13444864|NCT00313300|26926822|FG002|Randomized in Phase B (26 Weeks)|Death|1|||
13444865|NCT00313300|26926823|FG003|Randomized in Phase B (26 Weeks)|Death|0|||
13444866|NCT00313300|26926824|FG004|Randomized in Phase B (26 Weeks)|Death|1|||
13444867|NCT00313300|26926820|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5|||
13444868|NCT00313300|26926821|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
13444869|NCT00313300|26926822|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
13444870|NCT00313300|26926823|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
13444871|NCT00313300|26926824|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
13444872|NCT00313300|26926820|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
13444873|NCT00313300|26926821|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1|||
13444874|NCT00313300|26926822|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
13444875|NCT00313300|26926823|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
13444876|NCT00313300|26926824|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
13444877|NCT00313300|26926820|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9|||
13444878|NCT00313300|26926821|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3|||
13444879|NCT00313300|26926822|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
13444880|NCT00313300|26926823|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0|||
13444881|NCT00313300|26926824|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
13444882|NCT00313300|26926820|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2|||
13444883|NCT00313300|26926821|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1|||
13444884|NCT00313300|26926822|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0|||
13444885|NCT00313300|26926823|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193|||
13444886|NCT00313300|26926824|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164|||
13444887|NCT00313300|26926820|FG000|Randomized in Phase B (26 Weeks)|non-specified|1|||
13444888|NCT00313300|26926821|FG001|Randomized in Phase B (26 Weeks)|non-specified|0|||
13444889|NCT00313300|26926822|FG002|Randomized in Phase B (26 Weeks)|non-specified|0|||
13444890|NCT00313300|26926823|FG003|Randomized in Phase B (26 Weeks)|non-specified|0|||
13444891|NCT00313300|26926824|FG004|Randomized in Phase B (26 Weeks)|non-specified|0|||
13444892|NCT00313300|26926820|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
13444893|NCT00313300|26926821|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
13444894|NCT00313300|26926822|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2|||
13444895|NCT00313300|26926823|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
13444896|NCT00313300|26926824|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
13444897|NCT00313300|26926820|FG000|Follow-Up(30days)-Randomized Phase A|Death|0|||
13444898|NCT00313300|26926821|FG001|Follow-Up(30days)-Randomized Phase A|Death|1|||
13444899|NCT00313300|26926822|FG002|Follow-Up(30days)-Randomized Phase A|Death|0|||
13444900|NCT00313300|26926823|FG003|Follow-Up(30days)-Randomized Phase A|Death|0|||
13444901|NCT00313300|26926824|FG004|Follow-Up(30days)-Randomized Phase A|Death|0|||
13444902|NCT00313300|26926820|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
13444903|NCT00313300|26926821|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0|||
13444904|NCT00313300|26926822|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2|||
13444905|NCT00313300|26926823|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
13444906|NCT00313300|26926824|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
13444907|NCT00313300|26926820|FG000|Follow-Up(30days)-Randomized Phase B|Death|1|||
13444908|NCT00313300|26926821|FG001|Follow-Up(30days)-Randomized Phase B|Death|0|||
13444909|NCT00313300|26926822|FG002|Follow-Up(30days)-Randomized Phase B|Death|0|||
13444910|NCT00313300|26926823|FG003|Follow-Up(30days)-Randomized Phase B|Death|0|||
13444911|NCT00313300|26926824|FG004|Follow-Up(30days)-Randomized Phase B|Death|0|||
13444912|NCT00313300|26926820|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
13444913|NCT00313300|26926821|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
13444914|NCT00313300|26926822|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
13444915|NCT00313300|26926823|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2|||
13444916|NCT00313300|26926824|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1|||
13444917|NCT00313300|26926820|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1|||
13444918|NCT00313300|26926821|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
13444919|NCT00313300|26926822|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
13444920|NCT00313300|26926823|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2|||
13444921|NCT00313300|26926824|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
13444922|NCT00313170|26926853|FG000|Overall Study|Death|2|||
13444923|NCT00313170|26926854|FG001|Overall Study|Death|4|||
13444924|NCT00313170|26926855|FG002|Overall Study|Death|2|||
13444925|NCT00313170|26926853|FG000|Overall Study|Adverse Event|1|||
13444926|NCT00313170|26926854|FG001|Overall Study|Adverse Event|2|||
13444927|NCT00313170|26926855|FG002|Overall Study|Adverse Event|0|||
13444928|NCT00313170|26926853|FG000|Overall Study|Disease progression|31|||
13444929|NCT00313170|26926854|FG001|Overall Study|Disease progression|26|||
13444930|NCT00313170|26926855|FG002|Overall Study|Disease progression|27|||
13444931|NCT00313170|26926853|FG000|Overall Study|Withdrawal by Subject|1|||
13444932|NCT00313170|26926854|FG001|Overall Study|Withdrawal by Subject|0|||
13444933|NCT00313170|26926855|FG002|Overall Study|Withdrawal by Subject|1|||
13444934|NCT00313170|26926853|FG000|Overall Study|Incorrect enrollment|0|||
13444935|NCT00313170|26926854|FG001|Overall Study|Incorrect enrollment|2|||
13444936|NCT00313170|26926855|FG002|Overall Study|Incorrect enrollment|1|||
13444937|NCT00313170|26926853|FG000|Overall Study|Lost to Follow-up|0|||
13444938|NCT00313170|26926854|FG001|Overall Study|Lost to Follow-up|0|||
13444939|NCT00313170|26926855|FG002|Overall Study|Lost to Follow-up|1|||
13444940|NCT00313170|26926853|FG000|Overall Study|Progression (investigators opinion)|1|||
13444941|NCT00313170|26926854|FG001|Overall Study|Progression (investigators opinion)|0|||
13444942|NCT00313170|26926855|FG002|Overall Study|Progression (investigators opinion)|0|||
13444943|NCT00313144|26926941|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12|||
13444944|NCT00313144|26926941|FG000|Overall Study|Death|7|||
13444945|NCT00313144|26926941|FG000|Overall Study|Lost to Follow-up|5|||
13444946|NCT00313144|26926941|FG000|Overall Study|Withdrawal by Subject|4|||
13444947|NCT00313144|26926941|FG000|Overall Study|Terminated by sponsor/ homecare provider|4|||
13444948|NCT00313144|26926941|FG000|Overall Study|Physician Decision|4|||
13444949|NCT00313144|26926941|FG000|Overall Study|Adverse event - transient|5|||
13444950|NCT00313144|26926941|FG000|Overall Study|Liver transplant|1|||
13444951|NCT00313144|26926941|FG000|Overall Study|Insurance (homecare provider) change|1|||
13444952|NCT00313144|26926941|FG000|Overall Study|Change to different product|1|||
13444953|NCT00313144|26926941|FG000|Overall Study|Due to termination of the study|66|||
13444954|NCT00313014|26926969|FG000|Overall Study|Withdrawal by Subject|11|||
13444955|NCT00313014|26926970|FG001|Overall Study|Withdrawal by Subject|7|||
13444956|NCT00313014|26926971|FG002|Overall Study|Withdrawal by Subject|5|||
13444957|NCT00313014|26926969|FG000|Overall Study|Adverse Event|14|||
13444958|NCT00313014|26926970|FG001|Overall Study|Adverse Event|29|||
13444959|NCT00313014|26926971|FG002|Overall Study|Adverse Event|16|||
13444960|NCT00313014|26926969|FG000|Overall Study|Lost to Follow-up|7|||
13444961|NCT00313014|26926970|FG001|Overall Study|Lost to Follow-up|6|||
13444962|NCT00313014|26926971|FG002|Overall Study|Lost to Follow-up|10|||
13444963|NCT00313014|26926969|FG000|Overall Study|Administrative|9|||
13444964|NCT00313014|26926970|FG001|Overall Study|Administrative|6|||
13444965|NCT00313014|26926971|FG002|Overall Study|Administrative|14|||
13444966|NCT00313014|26926969|FG000|Overall Study|Lack of Efficacy|52|||
13444967|NCT00313014|26926970|FG001|Overall Study|Lack of Efficacy|25|||
13444968|NCT00313014|26926971|FG002|Overall Study|Lack of Efficacy|16|||
13444969|NCT00312897|26926986|FG000|Overall Study|Adverse Event|1|||
13444970|NCT00312897|26926987|FG001|Overall Study|Adverse Event|0|||
13444971|NCT00312897|26926986|FG000|Overall Study|Lost to Follow-up|2|||
13444972|NCT00312897|26926987|FG001|Overall Study|Lost to Follow-up|0|||
13444973|NCT00312897|26926986|FG000|Overall Study|Physician Decision|1|||
13444974|NCT00312897|26926987|FG001|Overall Study|Physician Decision|0|||
13444975|NCT00312897|26926986|FG000|Overall Study|Withdrawal by Subject|1|||
13444976|NCT00312897|26926987|FG001|Overall Study|Withdrawal by Subject|3|||
13444977|NCT00312897|26926986|FG000|Overall Study|Pregnancy|1|||
13444978|NCT00312897|26926987|FG001|Overall Study|Pregnancy|0|||
13444979|NCT00312897|26926986|FG000|Overall Study|discontinued prior to getting treatment|0|||
13444980|NCT00312897|26926987|FG001|Overall Study|discontinued prior to getting treatment|3|||
13444981|NCT00312858|26927046|FG000|Overall Study|Adverse Event|0|||
13444982|NCT00312858|26927047|FG001|Overall Study|Adverse Event|1|||
13444983|NCT00312858|26927046|FG000|Overall Study|Lost to Follow-up|25|||
13444984|NCT00312858|26927047|FG001|Overall Study|Lost to Follow-up|42|||
13444985|NCT00312858|26927046|FG000|Overall Study|Protocol Violation|3|||
13444986|NCT00312858|26927047|FG001|Overall Study|Protocol Violation|8|||
13444987|NCT00312858|26927046|FG000|Overall Study|Withdraw by Participant|20|||
13444988|NCT00312858|26927047|FG001|Overall Study|Withdraw by Participant|20|||
13444989|NCT00312858|26927046|FG000|Overall Study|Participant Moved|11|||
13444990|NCT00312858|26927047|FG001|Overall Study|Participant Moved|10|||
13444991|NCT00312858|26927046|FG000|Overall Study|Other|9|||
13444992|NCT00312858|26927047|FG001|Overall Study|Other|12|||
13444993|NCT00312845|26927062|FG000|Overall Study|Adverse Event|19|||
13444994|NCT00312845|26927063|FG001|Overall Study|Adverse Event|5|||
13444995|NCT00312845|26927062|FG000|Overall Study|Death|2|||
13444996|NCT00312845|26927063|FG001|Overall Study|Death|2|||
13444997|NCT00312845|26927062|FG000|Overall Study|Withdrawal by Subject|14|||
13444998|NCT00312845|26927063|FG001|Overall Study|Withdrawal by Subject|6|||
13444999|NCT00312845|26927062|FG000|Overall Study|Disease Progression|56|||
13445000|NCT00312845|26927063|FG001|Overall Study|Disease Progression|77|||
13445001|NCT00312845|26927062|FG000|Overall Study|Lost to Follow-up|2|||
13445002|NCT00312845|26927063|FG001|Overall Study|Lost to Follow-up|0|||
13445003|NCT00312845|26927062|FG000|Overall Study|Other|6|||
13445004|NCT00312845|26927063|FG001|Overall Study|Other|5|||
13445005|NCT00312702|26927083|FG000|Immunization Phase|Lost to Follow-up|0|||
13445006|NCT00312702|26927084|FG001|Immunization Phase|Lost to Follow-up|1|||
13445007|NCT00312702|26927085|FG002|Immunization Phase|Lost to Follow-up|0|||
13445008|NCT00312663|26927106|FG000|Immunization Phase|Adverse Event|0|||
13445009|NCT00312663|26927107|FG001|Immunization Phase|Adverse Event|1|||
13445010|NCT00312663|26927108|FG002|Immunization Phase|Adverse Event|0|||
13445011|NCT00312572|26927123|FG000|Overall Study|Adverse Event|10|||
13445012|NCT00312572|26927124|FG001|Overall Study|Adverse Event|16|||
13445013|NCT00312572|26927123|FG000|Overall Study|Lost to Follow-up|1|||
13445014|NCT00312572|26927124|FG001|Overall Study|Lost to Follow-up|1|||
13445015|NCT00312572|26927123|FG000|Overall Study|Administrative|4|||
13445016|NCT00312572|26927124|FG001|Overall Study|Administrative|2|||
13445017|NCT00312572|26927123|FG000|Overall Study|Lack of Efficacy|1|||
13445018|NCT00312572|26927124|FG001|Overall Study|Lack of Efficacy|2|||
13445019|NCT00312494|26927166|FG000|Overall Study|Randomized; not treated with study drug|9|||
13445020|NCT00312494|26927167|FG001|Overall Study|Randomized; not treated with study drug|10|||
13445021|NCT00312494|26927168|FG002|Overall Study|Randomized; not treated with study drug|5|||
13445022|NCT00312494|26927166|FG000|Overall Study|Adverse Event|33|||
13445023|NCT00312494|26927167|FG001|Overall Study|Adverse Event|15|||
13445024|NCT00312494|26927168|FG002|Overall Study|Adverse Event|11|||
13445025|NCT00312494|26927166|FG000|Overall Study|Lack of Efficacy|4|||
13445026|NCT00312494|26927167|FG001|Overall Study|Lack of Efficacy|6|||
13445027|NCT00312494|26927168|FG002|Overall Study|Lack of Efficacy|8|||
13445028|NCT00312494|26927166|FG000|Overall Study|Laboratory abnormality|1|||
13445029|NCT00312494|26927167|FG001|Overall Study|Laboratory abnormality|0|||
13445030|NCT00312494|26927168|FG002|Overall Study|Laboratory abnormality|0|||
13445031|NCT00312494|26927166|FG000|Overall Study|Lost to Follow-up|8|||
13445032|NCT00312494|26927167|FG001|Overall Study|Lost to Follow-up|8|||
13445033|NCT00312494|26927168|FG002|Overall Study|Lost to Follow-up|8|||
13445034|NCT00312494|26927166|FG000|Overall Study|Withdrawal by Subject|6|||
13445035|NCT00312494|26927167|FG001|Overall Study|Withdrawal by Subject|9|||
13445036|NCT00312494|26927168|FG002|Overall Study|Withdrawal by Subject|10|||
13445037|NCT00312494|26927166|FG000|Overall Study|Other|10|||
13445038|NCT00312494|26927167|FG001|Overall Study|Other|10|||
13445039|NCT00312494|26927168|FG002|Overall Study|Other|1|||
13445040|NCT00312377|26927197|FG000|Overall Study|Death|403|||
13445041|NCT00312377|26927198|FG001|Overall Study|Death|418|||
13445042|NCT00312377|26927197|FG000|Overall Study|Withdrawal by Subject|23|||
13445043|NCT00312377|26927198|FG001|Overall Study|Withdrawal by Subject|30|||
13445044|NCT00312377|26927197|FG000|Overall Study|Lost to Follow-up|9|||
13445045|NCT00312377|26927198|FG001|Overall Study|Lost to Follow-up|12|||
13445046|NCT00312377|26927197|FG000|Overall Study|Non-compliance|0|||
13445047|NCT00312377|26927198|FG001|Overall Study|Non-compliance|2|||
13445048|NCT00312377|26927197|FG000|Overall Study|Randomised but never received treatment|6|||
13445049|NCT00312377|26927198|FG001|Overall Study|Randomised but never received treatment|6|||
13445050|NCT00312377|26927197|FG000|Overall Study|Discontinue treatment survival follow up|202|||
13445051|NCT00312377|26927198|FG001|Overall Study|Discontinue treatment survival follow up|200|||
13445052|NCT00312377|26927197|FG000|Overall Study|Site ended participation in study|1|||
13445053|NCT00312377|26927198|FG001|Overall Study|Site ended participation in study|0|||
13445054|NCT00312338|26927215|FG000|Overall Study|Adverse Event|7|||
13445055|NCT00312338|26927216|FG001|Overall Study|Adverse Event|2|||
13445056|NCT00312338|26927215|FG000|Overall Study|Lost to Follow-up|9|||
13445057|NCT00312338|26927216|FG001|Overall Study|Lost to Follow-up|1|||
13445058|NCT00312338|26927215|FG000|Overall Study|Withdrawal by Subject|4|||
13445059|NCT00312338|26927216|FG001|Overall Study|Withdrawal by Subject|0|||
13445060|NCT00312338|26927215|FG000|Overall Study|Subsequent infection|2|||
13445061|NCT00312338|26927216|FG001|Overall Study|Subsequent infection|0|||
13445062|NCT00312221|26927245|FG000|Open-label Run-in Period|Withdrawal by Subject|6|||
13445063|NCT00312221|26927246|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
13445064|NCT00312221|26927247|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
13445065|NCT00312221|26927248|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
13219936|NCT01829113|26278687|FG001|Overall Study|Adverse Event|10|||
13445066|NCT00312221|26927245|FG000|Open-label Run-in Period|Adverse Event|74|||
13445067|NCT00312221|26927246|FG001|Open-label Run-in Period|Adverse Event|0|||
13445068|NCT00312221|26927247|FG002|Open-label Run-in Period|Adverse Event|0|||
13445069|NCT00312221|26927248|FG003|Open-label Run-in Period|Adverse Event|0|||
13445070|NCT00312221|26927245|FG000|Open-label Run-in Period|Lost to Follow-up|5|||
13445071|NCT00312221|26927246|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
13445072|NCT00312221|26927247|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
13445073|NCT00312221|26927248|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
13445074|NCT00312221|26927245|FG000|Open-label Run-in Period|Administrative|42|||
13445075|NCT00312221|26927246|FG001|Open-label Run-in Period|Administrative|0|||
13445076|NCT00312221|26927247|FG002|Open-label Run-in Period|Administrative|0|||
13445077|NCT00312221|26927248|FG003|Open-label Run-in Period|Administrative|0|||
13445078|NCT00312221|26927245|FG000|Open-label Run-in Period|Lack of Efficacy|102|||
13445079|NCT00312221|26927246|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
13445080|NCT00312221|26927247|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
13445081|NCT00312221|26927248|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
13445082|NCT00312221|26927245|FG000|Open-label Run-in Period|Did not qualify|5|||
13445083|NCT00312221|26927246|FG001|Open-label Run-in Period|Did not qualify|0|||
13445084|NCT00312221|26927247|FG002|Open-label Run-in Period|Did not qualify|0|||
13445085|NCT00312221|26927248|FG003|Open-label Run-in Period|Did not qualify|0|||
13445086|NCT00312221|26927245|FG000|Double-blind Phase|Withdrawal by Subject|0|||
13445087|NCT00312221|26927246|FG001|Double-blind Phase|Withdrawal by Subject|6|||
13445088|NCT00312221|26927247|FG002|Double-blind Phase|Withdrawal by Subject|8|||
13445089|NCT00312221|26927248|FG003|Double-blind Phase|Withdrawal by Subject|7|||
13445090|NCT00312221|26927245|FG000|Double-blind Phase|Adverse Event|0|||
13445091|NCT00312221|26927246|FG001|Double-blind Phase|Adverse Event|10|||
13445092|NCT00312221|26927247|FG002|Double-blind Phase|Adverse Event|19|||
13445093|NCT00312221|26927248|FG003|Double-blind Phase|Adverse Event|18|||
13445094|NCT00312221|26927245|FG000|Double-blind Phase|Lost to Follow-up|0|||
13445095|NCT00312221|26927246|FG001|Double-blind Phase|Lost to Follow-up|0|||
13445096|NCT00312221|26927247|FG002|Double-blind Phase|Lost to Follow-up|2|||
13445097|NCT00312221|26927248|FG003|Double-blind Phase|Lost to Follow-up|2|||
13445098|NCT00312221|26927245|FG000|Double-blind Phase|Administrative|0|||
13445099|NCT00312221|26927246|FG001|Double-blind Phase|Administrative|26|||
13445100|NCT00312221|26927247|FG002|Double-blind Phase|Administrative|37|||
13445101|NCT00312221|26927248|FG003|Double-blind Phase|Administrative|33|||
13445102|NCT00312221|26927245|FG000|Double-blind Phase|Lack of Efficacy|0|||
13445103|NCT00312221|26927246|FG001|Double-blind Phase|Lack of Efficacy|17|||
13445104|NCT00312221|26927247|FG002|Double-blind Phase|Lack of Efficacy|6|||
13445105|NCT00312221|26927248|FG003|Double-blind Phase|Lack of Efficacy|10|||
13445106|NCT00312208|26927263|FG000|Overall Study|Adverse Event|97|||
13445107|NCT00312208|26927264|FG001|Overall Study|Adverse Event|61|||
13445108|NCT00312208|26927263|FG000|Overall Study|Protocol Violation|5|||
13445109|NCT00312208|26927264|FG001|Overall Study|Protocol Violation|3|||
13445110|NCT00312208|26927263|FG000|Overall Study|Death|2|||
13445111|NCT00312208|26927264|FG001|Overall Study|Death|1|||
13445112|NCT00312208|26927263|FG000|Overall Study|Lack of Efficacy|7|||
13445113|NCT00312208|26927264|FG001|Overall Study|Lack of Efficacy|4|||
13445114|NCT00312208|26927263|FG000|Overall Study|Lost to Follow-up|3|||
13445115|NCT00312208|26927264|FG001|Overall Study|Lost to Follow-up|5|||
13445116|NCT00312208|26927263|FG000|Overall Study|Withdrawal by Subject|53|||
13445117|NCT00312208|26927264|FG001|Overall Study|Withdrawal by Subject|42|||
13445118|NCT00312208|26927263|FG000|Overall Study|Other|5|||
13445119|NCT00312208|26927264|FG001|Overall Study|Other|7|||
13445120|NCT00312195|26927285|FG000|Overall Study|Adverse Event|4|||
13445121|NCT00312195|26927286|FG001|Overall Study|Adverse Event|6|||
13445122|NCT00312195|26927285|FG000|Overall Study|Lost to Follow-up|1|||
13445123|NCT00312195|26927286|FG001|Overall Study|Lost to Follow-up|0|||
13445124|NCT00312195|26927285|FG000|Overall Study|Protocol Violation|1|||
13445125|NCT00312195|26927286|FG001|Overall Study|Protocol Violation|0|||
13445126|NCT00311623|26927336|FG000|Overall Study|Physician Decision|0|||
13445127|NCT00311623|26927337|FG001|Overall Study|Physician Decision|0|||
13445128|NCT00311623|26927338|FG002|Overall Study|Physician Decision|2|||
13445129|NCT00311584|26927351|FG000|Overall Study|Death|1|||
13445130|NCT00311584|26927352|FG001|Overall Study|Death|0|||
13445131|NCT00311584|26927351|FG000|Overall Study|Lack of Efficacy|12|||
13445132|NCT00311584|26927352|FG001|Overall Study|Lack of Efficacy|15|||
13445133|NCT00311584|26927351|FG000|Overall Study|Physician Decision|4|||
13445134|NCT00311584|26927352|FG001|Overall Study|Physician Decision|5|||
13445135|NCT00311584|26927351|FG000|Overall Study|Withdrawal by Subject|1|||
13445136|NCT00311584|26927352|FG001|Overall Study|Withdrawal by Subject|1|||
13445137|NCT00311584|26927351|FG000|Overall Study|ineligible|2|||
13445138|NCT00311584|26927352|FG001|Overall Study|ineligible|2|||
13445139|NCT00311402|26927383|FG000|Overall Study|Adverse Event|118|||
13445140|NCT00311402|26927384|FG001|Overall Study|Adverse Event|105|||
13445141|NCT00311402|26927383|FG000|Overall Study|Lost to Follow-up|0|||
13445142|NCT00311402|26927384|FG001|Overall Study|Lost to Follow-up|3|||
13445143|NCT00311402|26927383|FG000|Overall Study|Withdrawal by Subject|17|||
13445144|NCT00311402|26927384|FG001|Overall Study|Withdrawal by Subject|18|||
13445145|NCT00311402|26927383|FG000|Overall Study|Lack of Efficacy|58|||
13445146|NCT00311402|26927384|FG001|Overall Study|Lack of Efficacy|42|||
13445147|NCT00311402|26927383|FG000|Overall Study|Protocol Violation|7|||
13445148|NCT00311402|26927384|FG001|Overall Study|Protocol Violation|6|||
13445149|NCT00311402|26927383|FG000|Overall Study|IRB's rejection etc.|10|||
13445150|NCT00311402|26927384|FG001|Overall Study|IRB's rejection etc.|3|||
13445151|NCT00311363|26927452|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42|||
13445152|NCT00311363|26927453|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0|||
13445153|NCT00311363|26927454|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0|||
13445154|NCT00311363|26927452|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13|||
13445155|NCT00311363|26927453|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
13445156|NCT00311363|26927454|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
13445157|NCT00311363|26927452|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27|||
13445158|NCT00311363|26927453|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
13445159|NCT00311363|26927454|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
13445160|NCT00311363|26927452|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12|||
13445161|NCT00311363|26927453|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
13445162|NCT00311363|26927454|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
13445163|NCT00311363|26927452|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8|||
13445164|NCT00311363|26927453|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
13445165|NCT00311363|26927454|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
13445166|NCT00311363|26927452|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1|||
13445167|NCT00311363|26927453|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
13445168|NCT00311363|26927454|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
13445169|NCT00311363|26927452|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1|||
13445170|NCT00311363|26927453|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
13445171|NCT00311363|26927454|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
13445172|NCT00311363|26927452|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1|||
13445173|NCT00311363|26927453|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0|||
13445174|NCT00311363|26927454|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0|||
13445175|NCT00311363|26927452|FG000|24-Week Single-Blind Treatment Period|Death|1|||
13445176|NCT00311363|26927453|FG001|24-Week Single-Blind Treatment Period|Death|0|||
13445177|NCT00311363|26927454|FG002|24-Week Single-Blind Treatment Period|Death|0|||
13445178|NCT00311363|26927452|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0|||
13445179|NCT00311363|26927453|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3|||
13445180|NCT00311363|26927454|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0|||
13445181|NCT00311363|26927452|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
13445182|NCT00311363|26927453|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
13445183|NCT00311363|26927454|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
13445184|NCT00311363|26927452|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0|||
13445185|NCT00311363|26927453|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6|||
13445186|NCT00311363|26927454|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
13445187|NCT00311363|26927452|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0|||
13445188|NCT00311363|26927453|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2|||
13445189|NCT00311363|26927454|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4|||
13445190|NCT00311363|26927452|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0|||
13445191|NCT00311363|26927453|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1|||
13445192|NCT00311363|26927454|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2|||
13445193|NCT00311363|26927452|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
13445194|NCT00311363|26927453|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1|||
13445195|NCT00311363|26927454|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
13445196|NCT00311311|26927511|FG000|Overall Study|Adverse Event|3|||
13445197|NCT00311311|26927512|FG001|Overall Study|Adverse Event|2|||
13445198|NCT00311311|26927511|FG000|Overall Study|Withdrawal by Subject|1|||
13445199|NCT00311311|26927512|FG001|Overall Study|Withdrawal by Subject|1|||
13445200|NCT00311311|26927511|FG000|Overall Study|Noncompliance|0|||
13445201|NCT00311311|26927512|FG001|Overall Study|Noncompliance|1|||
13445202|NCT00311311|26927511|FG000|Overall Study|Study Termination by Sponsor|3|||
13445203|NCT00311311|26927512|FG001|Overall Study|Study Termination by Sponsor|4|||
13445204|NCT00311311|26927511|FG000|Overall Study|Death|1|||
13445205|NCT00311311|26927512|FG001|Overall Study|Death|0|||
13445206|NCT00311311|26927511|FG000|Overall Study|Lack of ancillary assistance|0|||
13445207|NCT00311311|26927512|FG001|Overall Study|Lack of ancillary assistance|1|||
13445208|NCT00311181|26927520|FG000|Overall Study|Final DFTs were not obtained|96|||
13445209|NCT00311168|26927547|FG000|First Intervention|Withdrawal by Subject|2|||
13445210|NCT00311168|26927548|FG001|First Intervention|Withdrawal by Subject|2|||
13445211|NCT00311168|26927547|FG000|First Intervention|Lost to Follow-up|1|||
13445212|NCT00311168|26927548|FG001|First Intervention|Lost to Follow-up|1|||
13445213|NCT00311168|26927547|FG000|First Intervention|Protocol Violation|1|||
13445214|NCT00311168|26927548|FG001|First Intervention|Protocol Violation|1|||
13445215|NCT00311168|26927547|FG000|First Intervention|Adverse Event|1|||
13445216|NCT00311168|26927548|FG001|First Intervention|Adverse Event|0|||
13445217|NCT00311168|26927547|FG000|First Intervention|Other|2|||
13445218|NCT00311168|26927548|FG001|First Intervention|Other|2|||
13445219|NCT00311168|26927547|FG000|Second Intervention|Lost to Follow-up|9|||
13445220|NCT00311168|26927548|FG001|Second Intervention|Lost to Follow-up|2|||
13445221|NCT00311168|26927547|FG000|Second Intervention|Withdrawal by Subject|0|||
13445222|NCT00311168|26927548|FG001|Second Intervention|Withdrawal by Subject|1|||
13445223|NCT00311168|26927547|FG000|Second Intervention|Other|1|||
13445224|NCT00311168|26927548|FG001|Second Intervention|Other|1|||
13445225|NCT00311155|26927559|FG000|Overall Study|Adverse Event|21|||
13445226|NCT00311155|26927559|FG000|Overall Study|Withdrawal by Subject|17|||
13445227|NCT00311155|26927559|FG000|Overall Study|Did not meet entry criteria|55|||
13445228|NCT00310856|26927589|FG000|Overall Study|Withdrawal by Subject|2|||
13445229|NCT00310856|26927590|FG001|Overall Study|Withdrawal by Subject|2|||
13445230|NCT00310856|26927591|FG002|Overall Study|Withdrawal by Subject|2|||
13445231|NCT00310856|26927589|FG000|Overall Study|Lost to Follow-up|1|||
13445232|NCT00310856|26927590|FG001|Overall Study|Lost to Follow-up|2|||
13445233|NCT00310856|26927591|FG002|Overall Study|Lost to Follow-up|6|||
13445234|NCT00310856|26927589|FG000|Overall Study|Inappropriate enrollment|1|||
13445235|NCT00310856|26927590|FG001|Overall Study|Inappropriate enrollment|1|||
13445236|NCT00310856|26927591|FG002|Overall Study|Inappropriate enrollment|0|||
13445237|NCT00310856|26927589|FG000|Overall Study|Unable to classify|1|||
13445238|NCT00310856|26927590|FG001|Overall Study|Unable to classify|0|||
13445239|NCT00310856|26927591|FG002|Overall Study|Unable to classify|0|||
13445240|NCT00310817|26927690|FG000|Overall Study|AE or Death|3|||
13445241|NCT00310817|26927691|FG001|Overall Study|AE or Death|1|||
13445242|NCT00310817|26927692|FG002|Overall Study|AE or Death|0|||
13445243|NCT00310817|26927693|FG003|Overall Study|AE or Death|0|||
13445244|NCT00310817|26927690|FG000|Overall Study|Withdrawal by Subject|1|||
13445245|NCT00310817|26927691|FG001|Overall Study|Withdrawal by Subject|4|||
13445246|NCT00310817|26927692|FG002|Overall Study|Withdrawal by Subject|6|||
13445247|NCT00310817|26927693|FG003|Overall Study|Withdrawal by Subject|7|||
13445248|NCT00310817|26927690|FG000|Overall Study|Lost to Follow-up|2|||
13445249|NCT00310817|26927691|FG001|Overall Study|Lost to Follow-up|1|||
13445250|NCT00310817|26927692|FG002|Overall Study|Lost to Follow-up|0|||
13445251|NCT00310817|26927693|FG003|Overall Study|Lost to Follow-up|0|||
13445252|NCT00310817|26927690|FG000|Overall Study|Inappropriate Enrollment|1|||
13445253|NCT00310817|26927691|FG001|Overall Study|Inappropriate Enrollment|0|||
13445254|NCT00310817|26927692|FG002|Overall Study|Inappropriate Enrollment|1|||
13445255|NCT00310817|26927693|FG003|Overall Study|Inappropriate Enrollment|0|||
13445256|NCT00310817|26927690|FG000|Overall Study|Protocol Violation|1|||
13445257|NCT00310817|26927691|FG001|Overall Study|Protocol Violation|1|||
13445258|NCT00310817|26927692|FG002|Overall Study|Protocol Violation|1|||
13445259|NCT00310817|26927693|FG003|Overall Study|Protocol Violation|1|||
13445260|NCT00310817|26927690|FG000|Overall Study|Unable to classify|3|||
13445261|NCT00310817|26927691|FG001|Overall Study|Unable to classify|1|||
13445262|NCT00310817|26927692|FG002|Overall Study|Unable to classify|0|||
13445263|NCT00310817|26927693|FG003|Overall Study|Unable to classify|0|||
13445264|NCT00310804|26927733|FG000|Overall Study|Lost to Follow-up|2|||
13445265|NCT00310804|26927734|FG001|Overall Study|Lost to Follow-up|0|||
13445266|NCT00310804|26927733|FG000|Overall Study|Withdrawal by Subject|3|||
13445267|NCT00310804|26927734|FG001|Overall Study|Withdrawal by Subject|0|||
13445268|NCT00310440|26927765|FG000|Overall Study|Lost to Follow-up|17|||
13445269|NCT00310440|26927766|FG001|Overall Study|Lost to Follow-up|8|||
13445270|NCT00310440|26927765|FG000|Overall Study|Withdrawal by Subject|2|||
13445271|NCT00310440|26927766|FG001|Overall Study|Withdrawal by Subject|1|||
13445272|NCT00310440|26927765|FG000|Overall Study|Missed 12 Month Visit|7|||
13445273|NCT00310440|26927766|FG001|Overall Study|Missed 12 Month Visit|4|||
13445274|NCT00310388|26927809|FG000|Primary Reporting Phase|Adverse Event|101|||
13445275|NCT00310388|26927810|FG001|Primary Reporting Phase|Adverse Event|0|||
13445276|NCT00310388|26927809|FG000|Primary Reporting Phase|Lack of Efficacy|56|||
13445277|NCT00310388|26927810|FG001|Primary Reporting Phase|Lack of Efficacy|0|||
13445278|NCT00310388|26927809|FG000|Primary Reporting Phase|Withdrawal by Subject|97|||
13445279|NCT00310388|26927810|FG001|Primary Reporting Phase|Withdrawal by Subject|0|||
13445280|NCT00310388|26927809|FG000|Primary Reporting Phase|Protocol Violation|10|||
13445281|NCT00310388|26927810|FG001|Primary Reporting Phase|Protocol Violation|0|||
13445282|NCT00310388|26927809|FG000|Primary Reporting Phase|Pregnancy|3|||
13445283|NCT00310388|26927810|FG001|Primary Reporting Phase|Pregnancy|0|||
13445284|NCT00310388|26927809|FG000|Primary Reporting Phase|Change in participant medical condition|3|||
13445285|NCT00310388|26927810|FG001|Primary Reporting Phase|Change in participant medical condition|0|||
13445286|NCT00310388|26927809|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3|||
13445287|NCT00310388|26927810|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0|||
13445288|NCT00310388|26927809|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3|||
13445289|NCT00310388|26927810|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0|||
13445290|NCT00310388|26927809|FG000|Primary Reporting Phase|Physician Decision|2|||
13445291|NCT00310388|26927810|FG001|Primary Reporting Phase|Physician Decision|0|||
13445292|NCT00310388|26927809|FG000|Primary Reporting Phase|Request of the sponsor|19|||
13445293|NCT00310388|26927810|FG001|Primary Reporting Phase|Request of the sponsor|0|||
13445294|NCT00310388|26927809|FG000|Primary Reporting Phase|Failed to return|8|||
13445295|NCT00310388|26927810|FG001|Primary Reporting Phase|Failed to return|0|||
13445296|NCT00310388|26927809|FG000|Primary Reporting Phase|Participant request unrelated to study|2|||
13445297|NCT00310388|26927810|FG001|Primary Reporting Phase|Participant request unrelated to study|0|||
13445298|NCT00310388|26927809|FG000|Primary Reporting Phase|Participant request|2|||
13445299|NCT00310388|26927810|FG001|Primary Reporting Phase|Participant request|0|||
13445300|NCT00310388|26927809|FG000|Primary Reporting Phase|Ministry of Health decision|25|||
13445301|NCT00310388|26927810|FG001|Primary Reporting Phase|Ministry of Health decision|0|||
13445302|NCT00310388|26927809|FG000|Primary Reporting Phase|Discontinuation of study|1|||
13445303|NCT00310388|26927810|FG001|Primary Reporting Phase|Discontinuation of study|0|||
13445304|NCT00310388|26927809|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1|||
13445305|NCT00310388|26927810|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0|||
13445306|NCT00310388|26927809|FG000|Primary Reporting Phase|Termination of study at sponsor request|3|||
13445307|NCT00310388|26927810|FG001|Primary Reporting Phase|Termination of study at sponsor request|0|||
13445308|NCT00310388|26927809|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1|||
13445309|NCT00310388|26927810|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0|||
13445310|NCT00310388|26927809|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2|||
13445311|NCT00310388|26927810|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0|||
13445312|NCT00310388|26927809|FG000|Primary Reporting Phase|Participant passed away|1|||
13445313|NCT00310388|26927810|FG001|Primary Reporting Phase|Participant passed away|0|||
13445314|NCT00310388|26927809|FG000|Primary Reporting Phase|Participant retired the informed consent|1|||
13445315|NCT00310388|26927810|FG001|Primary Reporting Phase|Participant retired the informed consent|0|||
13445316|NCT00310388|26927809|FG000|Primary Reporting Phase|Missing|1|||
13445317|NCT00310388|26927810|FG001|Primary Reporting Phase|Missing|0|||
13445318|NCT00310388|26927809|FG000|Primary Reporting Phase|Other|1|||
13445319|NCT00310388|26927810|FG001|Primary Reporting Phase|Other|0|||
13445320|NCT00310388|26927809|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0|||
13445321|NCT00310388|26927810|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5|||
13445322|NCT00310388|26927809|FG000|Safety Follow-up Continuation Phase|Adverse Event|0|||
13445323|NCT00310388|26927810|FG001|Safety Follow-up Continuation Phase|Adverse Event|1|||
13445324|NCT00310388|26927809|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0|||
13445325|NCT00310388|26927810|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5|||
13445326|NCT00310388|26927809|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0|||
13445327|NCT00310388|26927810|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2|||
13445328|NCT00310375|26927860|FG000|Primary Reporting Phase|Adverse Event|28|||
13445329|NCT00310375|26927861|FG001|Primary Reporting Phase|Adverse Event|22|||
13445330|NCT00310375|26927862|FG002|Primary Reporting Phase|Adverse Event|0|||
13445331|NCT00310375|26927860|FG000|Primary Reporting Phase|Lack of Efficacy|24|||
13445332|NCT00310375|26927861|FG001|Primary Reporting Phase|Lack of Efficacy|19|||
13445333|NCT00310375|26927862|FG002|Primary Reporting Phase|Lack of Efficacy|0|||
13445334|NCT00310375|26927860|FG000|Primary Reporting Phase|Pregnancy|2|||
13445335|NCT00310375|26927861|FG001|Primary Reporting Phase|Pregnancy|2|||
13445336|NCT00310375|26927862|FG002|Primary Reporting Phase|Pregnancy|0|||
13445337|NCT00310375|26927860|FG000|Primary Reporting Phase|Withdrawal by Subject|10|||
13445338|NCT00310375|26927861|FG001|Primary Reporting Phase|Withdrawal by Subject|7|||
13445339|NCT00310375|26927862|FG002|Primary Reporting Phase|Withdrawal by Subject|0|||
13445340|NCT00310375|26927860|FG000|Primary Reporting Phase|Protocol Violation|8|||
13445341|NCT00310375|26927861|FG001|Primary Reporting Phase|Protocol Violation|5|||
13445342|NCT00310375|26927862|FG002|Primary Reporting Phase|Protocol Violation|0|||
13445343|NCT00310375|26927860|FG000|Primary Reporting Phase|Change in Par medical condition|2|||
13445344|NCT00310375|26927861|FG001|Primary Reporting Phase|Change in Par medical condition|0|||
13445345|NCT00310375|26927862|FG002|Primary Reporting Phase|Change in Par medical condition|0|||
13445346|NCT00310375|26927860|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2|||
13445347|NCT00310375|26927861|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1|||
13445348|NCT00310375|26927862|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0|||
13445349|NCT00310375|26927860|FG000|Primary Reporting Phase|Physician Decision|5|||
13445350|NCT00310375|26927861|FG001|Primary Reporting Phase|Physician Decision|3|||
13445351|NCT00310375|26927862|FG002|Primary Reporting Phase|Physician Decision|0|||
13445352|NCT00310375|26927860|FG000|Primary Reporting Phase|Request of the sponsor|2|||
13445353|NCT00310375|26927861|FG001|Primary Reporting Phase|Request of the sponsor|2|||
13445354|NCT00310375|26927862|FG002|Primary Reporting Phase|Request of the sponsor|0|||
13445355|NCT00310375|26927860|FG000|Primary Reporting Phase|Failed to return|1|||
13445356|NCT00310375|26927861|FG001|Primary Reporting Phase|Failed to return|3|||
13445357|NCT00310375|26927862|FG002|Primary Reporting Phase|Failed to return|0|||
13445358|NCT00310375|26927860|FG000|Primary Reporting Phase|Participant request unrelated to study|1|||
13445359|NCT00310375|26927861|FG001|Primary Reporting Phase|Participant request unrelated to study|2|||
13445360|NCT00310375|26927862|FG002|Primary Reporting Phase|Participant request unrelated to study|0|||
13445361|NCT00310375|26927860|FG000|Primary Reporting Phase|Going for temporal lobectomy|1|||
13445362|NCT00310375|26927861|FG001|Primary Reporting Phase|Going for temporal lobectomy|0|||
13445363|NCT00310375|26927862|FG002|Primary Reporting Phase|Going for temporal lobectomy|0|||
13445364|NCT00310375|26927860|FG000|Primary Reporting Phase|Missed study drug >5 days|1|||
13445365|NCT00310375|26927861|FG001|Primary Reporting Phase|Missed study drug >5 days|0|||
13445366|NCT00310375|26927862|FG002|Primary Reporting Phase|Missed study drug >5 days|0|||
13445367|NCT00310375|26927860|FG000|Primary Reporting Phase|Site closure|3|||
13306291|NCT01292603|26525398|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
13445368|NCT00310375|26927861|FG001|Primary Reporting Phase|Site closure|0|||
13445369|NCT00310375|26927862|FG002|Primary Reporting Phase|Site closure|0|||
13445370|NCT00310375|26927860|FG000|Primary Reporting Phase|Missed study drug for 2 months|1|||
13445371|NCT00310375|26927861|FG001|Primary Reporting Phase|Missed study drug for 2 months|0|||
13445372|NCT00310375|26927862|FG002|Primary Reporting Phase|Missed study drug for 2 months|0|||
13445373|NCT00310375|26927860|FG000|Primary Reporting Phase|Par. switched to commercial product|0|||
13445374|NCT00310375|26927861|FG001|Primary Reporting Phase|Par. switched to commercial product|1|||
13445375|NCT00310375|26927862|FG002|Primary Reporting Phase|Par. switched to commercial product|0|||
13445376|NCT00310375|26927860|FG000|Primary Reporting Phase|Request of Ethics Committee|0|||
13445377|NCT00310375|26927861|FG001|Primary Reporting Phase|Request of Ethics Committee|1|||
13445378|NCT00310375|26927862|FG002|Primary Reporting Phase|Request of Ethics Committee|0|||
13445379|NCT00310375|26927860|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
13445380|NCT00310375|26927861|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
13445381|NCT00310375|26927862|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1|||
13445382|NCT00310037|26927881|FG000|Overall Study|Adverse Event|7|||
13445383|NCT00310037|26927882|FG001|Overall Study|Adverse Event|14|||
13445384|NCT00310037|26927881|FG000|Overall Study|Withdrawal by Subject|4|||
13445385|NCT00310037|26927882|FG001|Overall Study|Withdrawal by Subject|3|||
13445386|NCT00310037|26927881|FG000|Overall Study|Progression|6|||
13445387|NCT00310037|26927882|FG001|Overall Study|Progression|0|||
13445388|NCT00310037|26927881|FG000|Overall Study|Non-protocol treatment|1|||
13445389|NCT00310037|26927882|FG001|Overall Study|Non-protocol treatment|0|||
13445390|NCT00309959|26927893|FG000|Overall Study|Ineligible - no prior chemotherapy|2|||
13445391|NCT00309946|26927901|FG000|Overall Study|Withdrawal by Subject|1|||
13445392|NCT00309907|26927912|FG000|Overall Study|Death|4|||
13445393|NCT00309907|26927912|FG000|Overall Study|Physician Decision|1|||
13445394|NCT00309907|26927912|FG000|Overall Study|Ineligible|11|||
13445395|NCT00309907|26927912|FG000|Overall Study|Major infectious event|4|||
13445396|NCT00309842|26927928|FG000|Overall Study|Lost to Follow-up|1|||
13445397|NCT00309777|26927955|FG000|Overall Study|Adverse Event|13|||
13445398|NCT00309777|26927956|FG001|Overall Study|Adverse Event|2|||
13445399|NCT00309777|26927957|FG002|Overall Study|Adverse Event|8|||
13445400|NCT00309777|26927958|FG003|Overall Study|Adverse Event|1|||
13445401|NCT00309777|26927955|FG000|Overall Study|Protocol Violation|4|||
13445402|NCT00309777|26927956|FG001|Overall Study|Protocol Violation|1|||
13445403|NCT00309777|26927957|FG002|Overall Study|Protocol Violation|3|||
13445404|NCT00309777|26927958|FG003|Overall Study|Protocol Violation|1|||
13445405|NCT00309777|26927955|FG000|Overall Study|Withdrawal by Subject|6|||
13445406|NCT00309777|26927956|FG001|Overall Study|Withdrawal by Subject|5|||
13445407|NCT00309777|26927957|FG002|Overall Study|Withdrawal by Subject|7|||
13445408|NCT00309777|26927958|FG003|Overall Study|Withdrawal by Subject|2|||
13445409|NCT00309777|26927955|FG000|Overall Study|Lost to Follow-up|0|||
13445410|NCT00309777|26927956|FG001|Overall Study|Lost to Follow-up|0|||
13445411|NCT00309777|26927957|FG002|Overall Study|Lost to Follow-up|1|||
13445412|NCT00309777|26927958|FG003|Overall Study|Lost to Follow-up|0|||
13445413|NCT00309777|26927955|FG000|Overall Study|Death|0|||
13445414|NCT00309777|26927956|FG001|Overall Study|Death|1|||
13445415|NCT00309777|26927957|FG002|Overall Study|Death|0|||
13445416|NCT00309777|26927958|FG003|Overall Study|Death|0|||
13445417|NCT00309608|26927995|FG000|Overall Study|Adverse Event|1|||
13445418|NCT00309608|26927996|FG001|Overall Study|Adverse Event|5|||
13445419|NCT00309608|26927997|FG002|Overall Study|Adverse Event|3|||
13445420|NCT00309608|26927998|FG003|Overall Study|Adverse Event|2|||
13445421|NCT00309608|26927999|FG004|Overall Study|Adverse Event|3|||
13445422|NCT00309608|26927995|FG000|Overall Study|Protocol Violation|2|||
13445423|NCT00309608|26927996|FG001|Overall Study|Protocol Violation|0|||
13445424|NCT00309608|26927997|FG002|Overall Study|Protocol Violation|0|||
13445425|NCT00309608|26927998|FG003|Overall Study|Protocol Violation|0|||
13445426|NCT00309608|26927999|FG004|Overall Study|Protocol Violation|0|||
13445427|NCT00309608|26927995|FG000|Overall Study|Lost to Follow-up|0|||
13445428|NCT00309608|26927996|FG001|Overall Study|Lost to Follow-up|0|||
13445429|NCT00309608|26927997|FG002|Overall Study|Lost to Follow-up|2|||
13445430|NCT00309608|26927998|FG003|Overall Study|Lost to Follow-up|0|||
13445431|NCT00309608|26927999|FG004|Overall Study|Lost to Follow-up|1|||
13445432|NCT00309608|26927995|FG000|Overall Study|Withdrawal by Subject|1|||
13445433|NCT00309608|26927996|FG001|Overall Study|Withdrawal by Subject|4|||
13445434|NCT00309608|26927997|FG002|Overall Study|Withdrawal by Subject|2|||
13445435|NCT00309608|26927998|FG003|Overall Study|Withdrawal by Subject|0|||
13445436|NCT00309608|26927999|FG004|Overall Study|Withdrawal by Subject|0|||
13445437|NCT00309608|26927995|FG000|Overall Study|Other incl. Lack of efficacy|10|||
13445438|NCT00309608|26927996|FG001|Overall Study|Other incl. Lack of efficacy|4|||
13445439|NCT00309608|26927997|FG002|Overall Study|Other incl. Lack of efficacy|3|||
13445440|NCT00309608|26927998|FG003|Overall Study|Other incl. Lack of efficacy|4|||
13445441|NCT00309608|26927999|FG004|Overall Study|Other incl. Lack of efficacy|0|||
13445442|NCT00309452|26928032|FG000|Overall Study|Withdrawal by Subject|3|||
13445443|NCT00309452|26928033|FG001|Overall Study|Withdrawal by Subject|0|||
13445444|NCT00309387|26928056|FG000|Overall Study|Death|72|||
13445445|NCT00309387|26928057|FG001|Overall Study|Death|73|||
13445446|NCT00309387|26928056|FG000|Overall Study|Lost to Follow-up|70|||
13445447|NCT00309387|26928057|FG001|Overall Study|Lost to Follow-up|86|||
13445448|NCT00309244|26928084|FG000|Overall Study|Adverse Event|29|||
13445449|NCT00309244|26928085|FG001|Overall Study|Adverse Event|12|||
13445450|NCT00309244|26928084|FG000|Overall Study|Lost to Follow-up|6|||
13445451|NCT00309244|26928085|FG001|Overall Study|Lost to Follow-up|22|||
13445452|NCT00309244|26928084|FG000|Overall Study|Physician Decision|5|||
13445453|NCT00309244|26928085|FG001|Overall Study|Physician Decision|8|||
13445454|NCT00309244|26928084|FG000|Overall Study|Protocol Violation|6|||
13445455|NCT00309244|26928085|FG001|Overall Study|Protocol Violation|3|||
13445456|NCT00309244|26928084|FG000|Overall Study|Withdrawal by Subject|50|||
13445457|NCT00309244|26928085|FG001|Overall Study|Withdrawal by Subject|32|||
13445458|NCT00309244|26928084|FG000|Overall Study|Various|7|||
13445459|NCT00309244|26928085|FG001|Overall Study|Various|7|||
13445460|NCT00309244|26928084|FG000|Overall Study|Randomized but not dosed|11|||
13445461|NCT00309244|26928085|FG001|Overall Study|Randomized but not dosed|12|||
13445462|NCT00309244|26928084|FG000|Overall Study|Death|4|||
13445463|NCT00309244|26928085|FG001|Overall Study|Death|1|||
13445464|NCT00309166|26928118|FG000|Overall Study|Adverse event, non-fatal|1|||
13445465|NCT00309166|26928119|FG001|Overall Study|Adverse event, non-fatal|0|||
13445466|NCT00309166|26928118|FG000|Overall Study|Withdrawal by Subject|4|||
13445467|NCT00309166|26928119|FG001|Overall Study|Withdrawal by Subject|3|||
13445468|NCT00308997|26928142|FG000|Overall Study|Subject feigned clinical data|0|||
13445469|NCT00308997|26928143|FG001|Overall Study|Subject feigned clinical data|1|||
13445470|NCT00308997|26928142|FG000|Overall Study|Unable to tolerate intervention|1|||
13445471|NCT00308997|26928143|FG001|Overall Study|Unable to tolerate intervention|0|||
13445472|NCT00308750|26928188|FG000|Overall Study|Adverse Event|9|||
13445473|NCT00308750|26928189|FG001|Overall Study|Adverse Event|9|||
13445474|NCT00308750|26928190|FG002|Overall Study|Adverse Event|13|||
13445475|NCT00308750|26928188|FG000|Overall Study|Withdrawal by Subject|6|||
13445476|NCT00308750|26928189|FG001|Overall Study|Withdrawal by Subject|2|||
13445477|NCT00308750|26928190|FG002|Overall Study|Withdrawal by Subject|3|||
13445478|NCT00308750|26928188|FG000|Overall Study|Physician Decision|3|||
13445479|NCT00308750|26928189|FG001|Overall Study|Physician Decision|4|||
13445480|NCT00308750|26928190|FG002|Overall Study|Physician Decision|3|||
13445481|NCT00308750|26928188|FG000|Overall Study|Sponsor Decision|1|||
13445482|NCT00308750|26928189|FG001|Overall Study|Sponsor Decision|0|||
13445483|NCT00308750|26928190|FG002|Overall Study|Sponsor Decision|0|||
13445484|NCT00308750|26928188|FG000|Overall Study|Disease Progression|47|||
13445485|NCT00308750|26928189|FG001|Overall Study|Disease Progression|24|||
13445486|NCT00308750|26928190|FG002|Overall Study|Disease Progression|28|||
13445487|NCT00308750|26928188|FG000|Overall Study|Unrelated Complication|3|||
13445488|NCT00308750|26928189|FG001|Overall Study|Unrelated Complication|0|||
13445489|NCT00308750|26928190|FG002|Overall Study|Unrelated Complication|1|||
13445490|NCT00308750|26928188|FG000|Overall Study|Death|1|||
13445491|NCT00308750|26928189|FG001|Overall Study|Death|0|||
13445492|NCT00308750|26928190|FG002|Overall Study|Death|1|||
13445493|NCT00308750|26928188|FG000|Overall Study|Protocol Violation|1|||
13445494|NCT00308750|26928189|FG001|Overall Study|Protocol Violation|0|||
13445495|NCT00308750|26928190|FG002|Overall Study|Protocol Violation|0|||
13445496|NCT00308750|26928188|FG000|Overall Study|New Primary Disease Identified|1|||
13445497|NCT00308750|26928189|FG001|Overall Study|New Primary Disease Identified|1|||
13445498|NCT00308750|26928190|FG002|Overall Study|New Primary Disease Identified|0|||
13445499|NCT00308737|26928237|FG000|Overall Study|Adverse Event|104|||
13445500|NCT00308737|26928238|FG001|Overall Study|Adverse Event|9|||
13445501|NCT00308737|26928239|FG002|Overall Study|Adverse Event|0|||
13445502|NCT00308737|26928237|FG000|Overall Study|Death|4|||
13445503|NCT00308737|26928238|FG001|Overall Study|Death|3|||
13445504|NCT00308737|26928239|FG002|Overall Study|Death|0|||
13445505|NCT00308737|26928237|FG000|Overall Study|Lost to Follow-up|56|||
13445506|NCT00308737|26928238|FG001|Overall Study|Lost to Follow-up|80|||
13445507|NCT00308737|26928239|FG002|Overall Study|Lost to Follow-up|5|||
13445508|NCT00308737|26928237|FG000|Overall Study|Physician Decision|15|||
13445509|NCT00308737|26928238|FG001|Overall Study|Physician Decision|2|||
13445510|NCT00308737|26928239|FG002|Overall Study|Physician Decision|1|||
13445511|NCT00308737|26928237|FG000|Overall Study|Protocol Violation|34|||
13445512|NCT00308737|26928238|FG001|Overall Study|Protocol Violation|9|||
13445513|NCT00308737|26928239|FG002|Overall Study|Protocol Violation|5|||
13445514|NCT00308737|26928237|FG000|Overall Study|Withdrawal by Subject|218|||
13445515|NCT00308737|26928238|FG001|Overall Study|Withdrawal by Subject|166|||
13445516|NCT00308737|26928239|FG002|Overall Study|Withdrawal by Subject|18|||
13445517|NCT00308737|26928237|FG000|Overall Study|Various|32|||
13445518|NCT00308737|26928238|FG001|Overall Study|Various|20|||
13445519|NCT00308737|26928239|FG002|Overall Study|Various|8|||
13445520|NCT00308711|26928281|FG000|Overall Study|Withdrawal by Subject|1|||
13445521|NCT00308711|26928282|FG001|Overall Study|Withdrawal by Subject|0|||
13445522|NCT00308711|26928283|FG002|Overall Study|Withdrawal by Subject|1|||
13445523|NCT00308711|26928281|FG000|Overall Study|Protocol Violation|0|||
13445524|NCT00308711|26928282|FG001|Overall Study|Protocol Violation|1|||
13445525|NCT00308711|26928283|FG002|Overall Study|Protocol Violation|1|||
13445526|NCT00308711|26928281|FG000|Overall Study|Lost to Follow-up|0|||
13445527|NCT00308711|26928282|FG001|Overall Study|Lost to Follow-up|1|||
13445528|NCT00308711|26928283|FG002|Overall Study|Lost to Follow-up|0|||
13445529|NCT00308711|26928281|FG000|Overall Study|Baby not born within 7 days of treatment|1|||
13445530|NCT00308711|26928282|FG001|Overall Study|Baby not born within 7 days of treatment|2|||
13445531|NCT00308711|26928283|FG002|Overall Study|Baby not born within 7 days of treatment|2|||
13445532|NCT00308711|26928281|FG000|Overall Study|Subject incarcerated, data not allowed|0|||
13445533|NCT00308711|26928282|FG001|Overall Study|Subject incarcerated, data not allowed|0|||
13445534|NCT00308711|26928283|FG002|Overall Study|Subject incarcerated, data not allowed|1|||
13445535|NCT00308685|26928298|FG000|Overall Study|Lost to Follow-up|1|||
13445536|NCT00308685|26928299|FG001|Overall Study|Lost to Follow-up|0|||
13445537|NCT00308685|26928298|FG000|Overall Study|Need to administer prohibited medication|1|||
13445538|NCT00308685|26928299|FG001|Overall Study|Need to administer prohibited medication|2|||
13445539|NCT00308685|26928298|FG000|Overall Study|Other than specified|1|||
13445540|NCT00308685|26928299|FG001|Overall Study|Other than specified|3|||
13445541|NCT00308620|26928318|FG000|Overall Study|Death|1|||
13445542|NCT00308620|26928319|FG001|Overall Study|Death|1|||
13445543|NCT00308620|26928320|FG002|Overall Study|Death|0|||
13445544|NCT00308620|26928318|FG000|Overall Study|Lost to Follow-up|0|||
13445545|NCT00308620|26928319|FG001|Overall Study|Lost to Follow-up|0|||
13445546|NCT00308620|26928320|FG002|Overall Study|Lost to Follow-up|1|||
13445547|NCT00308581|26928448|FG000|Induction Phase|Adverse Event|0|||
13445548|NCT00308581|26928449|FG001|Induction Phase|Adverse Event|0|||
13445549|NCT00308581|26928450|FG002|Induction Phase|Adverse Event|37|||
13445550|NCT00308581|26928448|FG000|Induction Phase|Lack of Efficacy|0|||
13445551|NCT00308581|26928449|FG001|Induction Phase|Lack of Efficacy|0|||
13445552|NCT00308581|26928450|FG002|Induction Phase|Lack of Efficacy|121|||
13445553|NCT00308581|26928448|FG000|Induction Phase|Withdrawal by Subject|0|||
13445554|NCT00308581|26928449|FG001|Induction Phase|Withdrawal by Subject|0|||
13445555|NCT00308581|26928450|FG002|Induction Phase|Withdrawal by Subject|5|||
13445556|NCT00308581|26928448|FG000|Induction Phase|Unknown reason|0|||
13445557|NCT00308581|26928449|FG001|Induction Phase|Unknown reason|0|||
13445558|NCT00308581|26928450|FG002|Induction Phase|Unknown reason|3|||
13445559|NCT00308581|26928448|FG000|Randomized Maintenance Phase|Adverse Event|10|||
13445560|NCT00308581|26928449|FG001|Randomized Maintenance Phase|Adverse Event|17|||
13445561|NCT00308581|26928450|FG002|Randomized Maintenance Phase|Adverse Event|0|||
13445562|NCT00308581|26928448|FG000|Randomized Maintenance Phase|Lack of Efficacy|9|||
13445563|NCT00308581|26928449|FG001|Randomized Maintenance Phase|Lack of Efficacy|21|||
13445564|NCT00308581|26928450|FG002|Randomized Maintenance Phase|Lack of Efficacy|0|||
13445565|NCT00308581|26928448|FG000|Randomized Maintenance Phase|Lost to Follow-up|0|||
13445566|NCT00308581|26928449|FG001|Randomized Maintenance Phase|Lost to Follow-up|2|||
13445567|NCT00308581|26928450|FG002|Randomized Maintenance Phase|Lost to Follow-up|0|||
13445568|NCT00308581|26928448|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1|||
13445569|NCT00308581|26928449|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4|||
13445570|NCT00308581|26928450|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0|||
13445571|NCT00308581|26928448|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82|||
13445572|NCT00308581|26928449|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59|||
13445573|NCT00308581|26928450|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0|||
13445574|NCT00308581|26928448|FG000|Randomized Maintenance Phase|Unknown reason|3|||
13445575|NCT00308581|26928449|FG001|Randomized Maintenance Phase|Unknown reason|0|||
13445576|NCT00308581|26928450|FG002|Randomized Maintenance Phase|Unknown reason|0|||
13445577|NCT00308555|26928463|FG000|Overall Study|Withdrawal by Subject|1|||
13445578|NCT00308555|26928464|FG001|Overall Study|Withdrawal by Subject|0|||
13445579|NCT00308555|26928463|FG000|Overall Study|Physician Decision|2|||
13445580|NCT00308555|26928464|FG001|Overall Study|Physician Decision|0|||
13445581|NCT00308308|26928491|FG000|Overall Study|Adverse Event|17|||
13445582|NCT00308308|26928492|FG001|Overall Study|Adverse Event|2|||
13445583|NCT00308308|26928491|FG000|Overall Study|Lost to Follow-up|5|||
13445584|NCT00308308|26928492|FG001|Overall Study|Lost to Follow-up|5|||
13445585|NCT00308308|26928491|FG000|Overall Study|Physician Decision|15|||
13445586|NCT00308308|26928492|FG001|Overall Study|Physician Decision|7|||
13445587|NCT00308308|26928491|FG000|Overall Study|Protocol Violation|3|||
13445588|NCT00308308|26928492|FG001|Overall Study|Protocol Violation|14|||
13445589|NCT00308308|26928491|FG000|Overall Study|Withdrawal by Subject|47|||
13445590|NCT00308308|26928492|FG001|Overall Study|Withdrawal by Subject|19|||
13445591|NCT00308308|26928491|FG000|Overall Study|Various|7|||
13445592|NCT00308308|26928492|FG001|Overall Study|Various|5|||
13445593|NCT00308308|26928491|FG000|Overall Study|Randomized but not dosed|8|||
13445594|NCT00308308|26928492|FG001|Overall Study|Randomized but not dosed|16|||
13445595|NCT00308308|26928491|FG000|Overall Study|Other|1|||
13445596|NCT00308308|26928492|FG001|Overall Study|Other|0|||
13445597|NCT00308139|26928569|FG000|Overall Study|Adverse Event|20|||
13445598|NCT00308139|26928570|FG001|Overall Study|Adverse Event|14|||
13445599|NCT00308139|26928569|FG000|Overall Study|Lost to Follow-up|13|||
13445600|NCT00308139|26928570|FG001|Overall Study|Lost to Follow-up|8|||
13445601|NCT00308139|26928569|FG000|Overall Study|Protocol Violation|3|||
13445602|NCT00308139|26928570|FG001|Overall Study|Protocol Violation|2|||
13445603|NCT00308139|26928569|FG000|Overall Study|Withdrawal of Consent|40|||
13445604|NCT00308139|26928570|FG001|Overall Study|Withdrawal of Consent|42|||
13445605|NCT00308139|26928569|FG000|Overall Study|Investigator Decision|11|||
13445606|NCT00308139|26928570|FG001|Overall Study|Investigator Decision|10|||
13445607|NCT00308139|26928569|FG000|Overall Study|Loss of Glucose Control|5|||
13445608|NCT00308139|26928570|FG001|Overall Study|Loss of Glucose Control|7|||
13445609|NCT00308139|26928569|FG000|Overall Study|Administrative|1|||
13445610|NCT00308139|26928570|FG001|Overall Study|Administrative|4|||
13445611|NCT00308139|26928569|FG000|Overall Study|Other|1|||
13445612|NCT00308139|26928570|FG001|Overall Study|Other|0|||
13445613|NCT00308113|26928601|FG000|Overall Study|Protocol closure|0|||
13445614|NCT00308113|26928602|FG001|Overall Study|Protocol closure|0|||
13445615|NCT00308113|26928603|FG002|Overall Study|Protocol closure|0|||
13445616|NCT00308113|26928604|FG003|Overall Study|Protocol closure|1|||
13445617|NCT00308087|26928627|FG000|Overall Study|Progressive Disease|19|||
13445618|NCT00308087|26928628|FG001|Overall Study|Progressive Disease|21|||
13445619|NCT00308087|26928627|FG000|Overall Study|Study Closure|11|||
13445620|NCT00308087|26928628|FG001|Overall Study|Study Closure|12|||
13445621|NCT00308087|26928627|FG000|Overall Study|Withdrawal by Subject|2|||
13445622|NCT00308087|26928628|FG001|Overall Study|Withdrawal by Subject|1|||
13445623|NCT00308087|26928627|FG000|Overall Study|Other|4|||
13445624|NCT00308087|26928628|FG001|Overall Study|Other|3|||
13445625|NCT00308074|26928637|FG000|Overall Study|Withdrawal by Subject|1|||
13445626|NCT00307931|26928654|FG000|Overall Study|Adverse Event|1|||
13445627|NCT00307801|26928773|FG000|Overall Study|Adverse Event|12|||
13445628|NCT00307801|26928774|FG001|Overall Study|Adverse Event|4|||
13445629|NCT00307801|26928773|FG000|Overall Study|Withdrawal by Subject|9|||
13445630|NCT00307801|26928774|FG001|Overall Study|Withdrawal by Subject|4|||
13445631|NCT00307801|26928773|FG000|Overall Study|Non-compliance, not taken all tablets|1|||
13445632|NCT00307801|26928774|FG001|Overall Study|Non-compliance, not taken all tablets|2|||
13445633|NCT00307801|26928773|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2|||
13445634|NCT00307801|26928774|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0|||
13445635|NCT00307801|26928773|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0|||
13445636|NCT00307801|26928774|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1|||
13445637|NCT00307801|26928773|FG000|Overall Study|Wrong Randomization|1|||
13445638|NCT00307801|26928774|FG001|Overall Study|Wrong Randomization|0|||
13445639|NCT00307801|26928773|FG000|Overall Study|Lack of Efficacy|0|||
13445640|NCT00307801|26928774|FG001|Overall Study|Lack of Efficacy|2|||
13445641|NCT00307801|26928773|FG000|Overall Study|Lost to Follow-up, moved abroad|1|||
13445642|NCT00307801|26928774|FG001|Overall Study|Lost to Follow-up, moved abroad|1|||
13445643|NCT00307801|26928773|FG000|Overall Study|Frustration with e-diary|1|||
13445644|NCT00307801|26928774|FG001|Overall Study|Frustration with e-diary|0|||
13445645|NCT00307801|26928773|FG000|Overall Study|Protocol Violation|3|||
13445646|NCT00307801|26928774|FG001|Overall Study|Protocol Violation|2|||
13445647|NCT00307801|26928773|FG000|Overall Study|No reason specified|2|||
13445648|NCT00307801|26928774|FG001|Overall Study|No reason specified|0|||
13445649|NCT00307801|26928773|FG000|Overall Study|Pregnancy|0|||
13445650|NCT00307801|26928774|FG001|Overall Study|Pregnancy|1|||
13445651|NCT00307736|26928790|FG000|Overall Study|Adverse Event|0|||
13445652|NCT00307736|26928791|FG001|Overall Study|Adverse Event|0|||
13445653|NCT00307736|26928792|FG002|Overall Study|Adverse Event|1|||
13445654|NCT00307736|26928793|FG003|Overall Study|Adverse Event|3|||
13445655|NCT00307736|26928790|FG000|Overall Study|Withdrawal by Subject|0|||
13445656|NCT00307736|26928791|FG001|Overall Study|Withdrawal by Subject|0|||
13445657|NCT00307736|26928792|FG002|Overall Study|Withdrawal by Subject|2|||
13445658|NCT00307736|26928793|FG003|Overall Study|Withdrawal by Subject|0|||
13445659|NCT00307684|26928823|FG000|Open Label Phase|Lack of Efficacy|0|||
13445660|NCT00307684|26928824|FG001|Open Label Phase|Lack of Efficacy|0|||
13445661|NCT00307684|26928825|FG002|Open Label Phase|Lack of Efficacy|3|||
13445662|NCT00307684|26928823|FG000|Open Label Phase|Adverse Event|0|||
13445663|NCT00307684|26928824|FG001|Open Label Phase|Adverse Event|0|||
13445664|NCT00307684|26928825|FG002|Open Label Phase|Adverse Event|16|||
13445665|NCT00307684|26928823|FG000|Open Label Phase|Withdrawal by Subject|0|||
13445666|NCT00307684|26928824|FG001|Open Label Phase|Withdrawal by Subject|0|||
13445667|NCT00307684|26928825|FG002|Open Label Phase|Withdrawal by Subject|15|||
13445668|NCT00307684|26928823|FG000|Open Label Phase|Lost to Follow-up|0|||
13445669|NCT00307684|26928824|FG001|Open Label Phase|Lost to Follow-up|0|||
13445670|NCT00307684|26928825|FG002|Open Label Phase|Lost to Follow-up|11|||
13445671|NCT00307684|26928823|FG000|Open Label Phase|non compliance|0|||
13445672|NCT00307684|26928824|FG001|Open Label Phase|non compliance|0|||
13445673|NCT00307684|26928825|FG002|Open Label Phase|non compliance|5|||
13445674|NCT00307684|26928823|FG000|Open Label Phase|other|0|||
13445675|NCT00307684|26928824|FG001|Open Label Phase|other|0|||
13445676|NCT00307684|26928825|FG002|Open Label Phase|other|6|||
13445677|NCT00307684|26928823|FG000|Double Blind Phase|Lack of Efficacy|2|||
13445678|NCT00307684|26928824|FG001|Double Blind Phase|Lack of Efficacy|5|||
13445679|NCT00307684|26928825|FG002|Double Blind Phase|Lack of Efficacy|0|||
13445680|NCT00307489|26928874|FG000|Baseline Through Week 48|Lost to Follow-up|0|||
13445681|NCT00307489|26928875|FG001|Baseline Through Week 48|Lost to Follow-up|1|||
13445682|NCT00307489|26928874|FG000|Baseline Through Week 48|Physician Decision|1|||
13445683|NCT00307489|26928875|FG001|Baseline Through Week 48|Physician Decision|0|||
13445684|NCT00307489|26928874|FG000|Baseline Through Week 48|Withdrawal by Subject|0|||
13445685|NCT00307489|26928875|FG001|Baseline Through Week 48|Withdrawal by Subject|1|||
13445686|NCT00307489|26928874|FG000|Week 48 Through Week 168|Adverse Event|1|||
13445687|NCT00307489|26928875|FG001|Week 48 Through Week 168|Adverse Event|0|||
13445688|NCT00307489|26928874|FG000|Week 48 Through Week 168|Physician Decision|1|||
13445689|NCT00307489|26928875|FG001|Week 48 Through Week 168|Physician Decision|0|||
13445690|NCT00307489|26928874|FG000|Week 48 Through Week 168|Withdrawal by Subject|1|||
13445691|NCT00307489|26928875|FG001|Week 48 Through Week 168|Withdrawal by Subject|2|||
13445692|NCT00307489|26928874|FG000|Week 48 Through Week 168|Lack of Efficacy|2|||
13445693|NCT00307489|26928875|FG001|Week 48 Through Week 168|Lack of Efficacy|2|||
13445694|NCT00307489|26928874|FG000|Week 48 Through Week 168|Death|0|||
13445695|NCT00307489|26928875|FG001|Week 48 Through Week 168|Death|1|||
13445696|NCT00307489|26928874|FG000|Week 48 Through Week 168|Lost to Follow-up|0|||
13445697|NCT00307489|26928875|FG001|Week 48 Through Week 168|Lost to Follow-up|1|||
13445698|NCT00307489|26928874|FG000|Week 48 Through Week 168|Seroconversion|1|||
13445699|NCT00307489|26928875|FG001|Week 48 Through Week 168|Seroconversion|0|||
13445700|NCT00307437|26928913|FG000|Controlled Period|Adverse Event|7|||
13445701|NCT00307437|26928914|FG001|Controlled Period|Adverse Event|2|||
13445702|NCT00307437|26928915|FG002|Controlled Period|Adverse Event|5|||
13445703|NCT00307437|26928916|FG003|Controlled Period|Adverse Event|0|||
13445704|NCT00307437|26928917|FG004|Controlled Period|Adverse Event|0|||
13445705|NCT00307437|26928918|FG005|Controlled Period|Adverse Event|0|||
13445706|NCT00307437|26928919|FG006|Controlled Period|Adverse Event|0|||
13445707|NCT00307437|26928913|FG000|Controlled Period|Death|0|||
13445708|NCT00307437|26928914|FG001|Controlled Period|Death|0|||
13445709|NCT00307437|26928915|FG002|Controlled Period|Death|1|||
13445710|NCT00307437|26928916|FG003|Controlled Period|Death|0|||
13445711|NCT00307437|26928917|FG004|Controlled Period|Death|0|||
13445712|NCT00307437|26928918|FG005|Controlled Period|Death|0|||
13445713|NCT00307437|26928919|FG006|Controlled Period|Death|0|||
13445714|NCT00307437|26928913|FG000|Controlled Period|Lack of Efficacy|2|||
13445715|NCT00307437|26928914|FG001|Controlled Period|Lack of Efficacy|0|||
13445716|NCT00307437|26928915|FG002|Controlled Period|Lack of Efficacy|0|||
13445717|NCT00307437|26928916|FG003|Controlled Period|Lack of Efficacy|0|||
13445718|NCT00307437|26928917|FG004|Controlled Period|Lack of Efficacy|0|||
13445719|NCT00307437|26928918|FG005|Controlled Period|Lack of Efficacy|0|||
13445720|NCT00307437|26928919|FG006|Controlled Period|Lack of Efficacy|0|||
13445721|NCT00307437|26928913|FG000|Controlled Period|Lost to Follow-up|2|||
13445722|NCT00307437|26928914|FG001|Controlled Period|Lost to Follow-up|3|||
13445723|NCT00307437|26928915|FG002|Controlled Period|Lost to Follow-up|0|||
13445724|NCT00307437|26928916|FG003|Controlled Period|Lost to Follow-up|0|||
13445725|NCT00307437|26928917|FG004|Controlled Period|Lost to Follow-up|0|||
13445726|NCT00307437|26928918|FG005|Controlled Period|Lost to Follow-up|0|||
13445727|NCT00307437|26928919|FG006|Controlled Period|Lost to Follow-up|0|||
13445728|NCT00307437|26928913|FG000|Controlled Period|Other|5|||
13445729|NCT00307437|26928914|FG001|Controlled Period|Other|1|||
13445730|NCT00307437|26928915|FG002|Controlled Period|Other|3|||
13445731|NCT00307437|26928916|FG003|Controlled Period|Other|0|||
13445732|NCT00307437|26928917|FG004|Controlled Period|Other|0|||
13445733|NCT00307437|26928918|FG005|Controlled Period|Other|0|||
13445734|NCT00307437|26928919|FG006|Controlled Period|Other|0|||
13445735|NCT00307437|26928913|FG000|After Controlled Period|Adverse Event|0|||
13445736|NCT00307437|26928914|FG001|After Controlled Period|Adverse Event|0|||
13445737|NCT00307437|26928915|FG002|After Controlled Period|Adverse Event|0|||
13445738|NCT00307437|26928916|FG003|After Controlled Period|Adverse Event|18|||
13445739|NCT00307437|26928917|FG004|After Controlled Period|Adverse Event|16|||
13445740|NCT00307437|26928918|FG005|After Controlled Period|Adverse Event|31|||
13445741|NCT00307437|26928919|FG006|After Controlled Period|Adverse Event|40|||
13445742|NCT00307437|26928913|FG000|After Controlled Period|Death|0|||
13445743|NCT00307437|26928914|FG001|After Controlled Period|Death|0|||
13445744|NCT00307437|26928915|FG002|After Controlled Period|Death|0|||
13445745|NCT00307437|26928916|FG003|After Controlled Period|Death|3|||
13445746|NCT00307437|26928917|FG004|After Controlled Period|Death|1|||
13445747|NCT00307437|26928918|FG005|After Controlled Period|Death|1|||
13445748|NCT00307437|26928919|FG006|After Controlled Period|Death|3|||
13445749|NCT00307437|26928913|FG000|After Controlled Period|Lack of Efficacy|0|||
13445750|NCT00307437|26928914|FG001|After Controlled Period|Lack of Efficacy|0|||
13445751|NCT00307437|26928915|FG002|After Controlled Period|Lack of Efficacy|0|||
13445752|NCT00307437|26928916|FG003|After Controlled Period|Lack of Efficacy|15|||
13445753|NCT00307437|26928917|FG004|After Controlled Period|Lack of Efficacy|17|||
13445754|NCT00307437|26928918|FG005|After Controlled Period|Lack of Efficacy|37|||
13445755|NCT00307437|26928919|FG006|After Controlled Period|Lack of Efficacy|24|||
13445756|NCT00307437|26928913|FG000|After Controlled Period|Lost to Follow-up|0|||
13445757|NCT00307437|26928914|FG001|After Controlled Period|Lost to Follow-up|0|||
13445758|NCT00307437|26928915|FG002|After Controlled Period|Lost to Follow-up|0|||
13445759|NCT00307437|26928916|FG003|After Controlled Period|Lost to Follow-up|7|||
13445760|NCT00307437|26928917|FG004|After Controlled Period|Lost to Follow-up|12|||
13445761|NCT00307437|26928918|FG005|After Controlled Period|Lost to Follow-up|13|||
13445762|NCT00307437|26928919|FG006|After Controlled Period|Lost to Follow-up|18|||
13445763|NCT00307437|26928913|FG000|After Controlled Period|Other|0|||
13445764|NCT00307437|26928914|FG001|After Controlled Period|Other|0|||
13445765|NCT00307437|26928915|FG002|After Controlled Period|Other|0|||
13445766|NCT00307437|26928916|FG003|After Controlled Period|Other|15|||
13445767|NCT00307437|26928917|FG004|After Controlled Period|Other|9|||
13445768|NCT00307437|26928918|FG005|After Controlled Period|Other|40|||
13445769|NCT00307437|26928919|FG006|After Controlled Period|Other|28|||
13445770|NCT00307333|26928938|FG000|Overall Study|Lost to Follow-up|11|||
13445771|NCT00307333|26928939|FG001|Overall Study|Lost to Follow-up|3|||
13445772|NCT00307294|26928948|FG000|Overall Study|Withdrawal by Subject|1|||
13445773|NCT00307164|26928991|FG000|Overall Study|Death|1|||
13445774|NCT00307164|26928992|FG001|Overall Study|Death|0|||
13445775|NCT00307164|26928991|FG000|Overall Study|Severe debilitation, unable to continue|1|||
13445776|NCT00307164|26928992|FG001|Overall Study|Severe debilitation, unable to continue|0|||
13445777|NCT00307164|26928991|FG000|Overall Study|Subject/parent not able to get to clinic|2|||
13445778|NCT00307164|26928992|FG001|Overall Study|Subject/parent not able to get to clinic|1|||
13445779|NCT00307164|26928991|FG000|Overall Study|Withdrawal by Subject|1|||
13445780|NCT00307164|26928992|FG001|Overall Study|Withdrawal by Subject|8|||
13445781|NCT00307164|26928991|FG000|Overall Study|Not compliant with requirements|4|||
13445782|NCT00307164|26928992|FG001|Overall Study|Not compliant with requirements|4|||
13445783|NCT00307164|26928991|FG000|Overall Study|Lost to Follow-up|6|||
13445784|NCT00307164|26928992|FG001|Overall Study|Lost to Follow-up|1|||
13445785|NCT00307151|26929047|FG000|Overall Study|Death|4|||
13445786|NCT00307151|26929048|FG001|Overall Study|Death|3|||
13445787|NCT00307151|26929049|FG002|Overall Study|Death|10|||
13445788|NCT00307151|26929050|FG003|Overall Study|Death|3|||
13445789|NCT00307151|26929047|FG000|Overall Study|Severe debilitation, unable to continue|1|||
13445790|NCT00307151|26929048|FG001|Overall Study|Severe debilitation, unable to continue|0|||
13445791|NCT00307151|26929049|FG002|Overall Study|Severe debilitation, unable to continue|0|||
13445792|NCT00307151|26929050|FG003|Overall Study|Severe debilitation, unable to continue|0|||
13445793|NCT00307151|26929047|FG000|Overall Study|Subject unable to get to clinic|1|||
13445794|NCT00307151|26929048|FG001|Overall Study|Subject unable to get to clinic|0|||
13445795|NCT00307151|26929049|FG002|Overall Study|Subject unable to get to clinic|6|||
13445796|NCT00307151|26929050|FG003|Overall Study|Subject unable to get to clinic|2|||
13445797|NCT00307151|26929047|FG000|Overall Study|Withdrew consent|0|||
13445798|NCT00307151|26929048|FG001|Overall Study|Withdrew consent|1|||
13445799|NCT00307151|26929049|FG002|Overall Study|Withdrew consent|1|||
13445800|NCT00307151|26929050|FG003|Overall Study|Withdrew consent|3|||
13445801|NCT00307151|26929047|FG000|Overall Study|Not willing to adhere to study reqs|2|||
13445802|NCT00307151|26929048|FG001|Overall Study|Not willing to adhere to study reqs|0|||
13445803|NCT00307151|26929049|FG002|Overall Study|Not willing to adhere to study reqs|2|||
13445804|NCT00307151|26929050|FG003|Overall Study|Not willing to adhere to study reqs|2|||
13445805|NCT00307151|26929047|FG000|Overall Study|Clinic unable to contact subject|3|||
13445806|NCT00307151|26929048|FG001|Overall Study|Clinic unable to contact subject|3|||
13445807|NCT00307151|26929049|FG002|Overall Study|Clinic unable to contact subject|1|||
13445808|NCT00307151|26929050|FG003|Overall Study|Clinic unable to contact subject|1|||
13445809|NCT00307125|26929080|FG000|Screening Phase|Adverse Event|1|||
13445810|NCT00307125|26929081|FG001|Screening Phase|Adverse Event|0|||
13445811|NCT00307125|26929082|FG002|Screening Phase|Adverse Event|0|||
13445812|NCT00307125|26929080|FG000|Screening Phase|Protocol Violation|27|||
13445813|NCT00307125|26929081|FG001|Screening Phase|Protocol Violation|0|||
13445814|NCT00307125|26929082|FG002|Screening Phase|Protocol Violation|0|||
13445815|NCT00307125|26929080|FG000|Screening Phase|Lost to Follow-up|87|||
13445816|NCT00307125|26929081|FG001|Screening Phase|Lost to Follow-up|0|||
13445817|NCT00307125|26929082|FG002|Screening Phase|Lost to Follow-up|0|||
13445818|NCT00307125|26929080|FG000|Screening Phase|Death|10|||
13445819|NCT00307125|26929081|FG001|Screening Phase|Death|0|||
13445820|NCT00307125|26929082|FG002|Screening Phase|Death|0|||
13445821|NCT00307125|26929080|FG000|Screening Phase|Withdrawal by Subject|77|||
13445822|NCT00307125|26929081|FG001|Screening Phase|Withdrawal by Subject|0|||
13445823|NCT00307125|26929082|FG002|Screening Phase|Withdrawal by Subject|0|||
13445824|NCT00307125|26929080|FG000|Screening Phase|Physician Decision|26|||
13445825|NCT00307125|26929081|FG001|Screening Phase|Physician Decision|0|||
13445826|NCT00307125|26929082|FG002|Screening Phase|Physician Decision|0|||
13445827|NCT00307125|26929080|FG000|Screening Phase|Sponsor Decision|4|||
13445828|NCT00307125|26929081|FG001|Screening Phase|Sponsor Decision|0|||
13445829|NCT00307125|26929082|FG002|Screening Phase|Sponsor Decision|0|||
13445830|NCT00307125|26929080|FG000|Screening Phase|Study Terminated|17|||
13445831|NCT00307125|26929081|FG001|Screening Phase|Study Terminated|0|||
13445832|NCT00307125|26929082|FG002|Screening Phase|Study Terminated|0|||
13445833|NCT00307125|26929080|FG000|Screening Phase|Graft Loss|3|||
13445834|NCT00307125|26929081|FG001|Screening Phase|Graft Loss|0|||
13445835|NCT00307125|26929082|FG002|Screening Phase|Graft Loss|0|||
13445836|NCT00307125|26929080|FG000|Screening Phase|Graft Failure|8|||
13445837|NCT00307125|26929081|FG001|Screening Phase|Graft Failure|0|||
13445838|NCT00307125|26929082|FG002|Screening Phase|Graft Failure|0|||
13445839|NCT00307125|26929080|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83|||
13445840|NCT00307125|26929081|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
13445841|NCT00307125|26929082|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
13445842|NCT00307125|26929080|FG000|Screening Phase|Scheduling issues/Non-compliance|55|||
13445843|NCT00307125|26929081|FG001|Screening Phase|Scheduling issues/Non-compliance|0|||
13445844|NCT00307125|26929082|FG002|Screening Phase|Scheduling issues/Non-compliance|0|||
13445845|NCT00307125|26929080|FG000|Screening Phase|Moved or transferred facilities|34|||
13445846|NCT00307125|26929081|FG001|Screening Phase|Moved or transferred facilities|0|||
13445847|NCT00307125|26929082|FG002|Screening Phase|Moved or transferred facilities|0|||
13445848|NCT00307125|26929080|FG000|Screening Phase|Received Pancreas Transplant|8|||
13445849|NCT00307125|26929081|FG001|Screening Phase|Received Pancreas Transplant|0|||
13445850|NCT00307125|26929082|FG002|Screening Phase|Received Pancreas Transplant|0|||
13445851|NCT00307125|26929080|FG000|Screening Phase|Ineligible for pilot|4|||
13445852|NCT00307125|26929081|FG001|Screening Phase|Ineligible for pilot|0|||
13445853|NCT00307125|26929082|FG002|Screening Phase|Ineligible for pilot|0|||
13445854|NCT00307125|26929080|FG000|Screening Phase|Try to get pregnant|1|||
13445855|NCT00307125|26929081|FG001|Screening Phase|Try to get pregnant|0|||
13445856|NCT00307125|26929082|FG002|Screening Phase|Try to get pregnant|0|||
13445857|NCT00307125|26929080|FG000|Screening Phase|Developed acute leukemia|1|||
13445858|NCT00307125|26929081|FG001|Screening Phase|Developed acute leukemia|0|||
13445859|NCT00307125|26929082|FG002|Screening Phase|Developed acute leukemia|0|||
13445860|NCT00307125|26929080|FG000|Screening Phase|Metastatic colon cancer|1|||
13445861|NCT00307125|26929081|FG001|Screening Phase|Metastatic colon cancer|0|||
13445862|NCT00307125|26929082|FG002|Screening Phase|Metastatic colon cancer|0|||
13445863|NCT00307125|26929080|FG000|Screening Phase|Malignancy|1|||
13445864|NCT00307125|26929081|FG001|Screening Phase|Malignancy|0|||
13445865|NCT00307125|26929082|FG002|Screening Phase|Malignancy|0|||
13445866|NCT00307125|26929080|FG000|Screening Phase|PAK|1|||
13445867|NCT00307125|26929081|FG001|Screening Phase|PAK|0|||
13445868|NCT00307125|26929082|FG002|Screening Phase|PAK|0|||
13445869|NCT00307125|26929080|FG000|Screening Phase|Ineligible|1|||
13445870|NCT00307125|26929081|FG001|Screening Phase|Ineligible|0|||
13445871|NCT00307125|26929082|FG002|Screening Phase|Ineligible|0|||
13445872|NCT00307125|26929080|FG000|Screening Phase|Screen Error|1|||
13445873|NCT00307125|26929081|FG001|Screening Phase|Screen Error|0|||
13445874|NCT00307125|26929082|FG002|Screening Phase|Screen Error|0|||
13445875|NCT00307125|26929080|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1|||
13445876|NCT00307125|26929081|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
13445877|NCT00307125|26929082|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
13445878|NCT00307125|26929080|FG000|Screening Phase|AMR and treated with rituximab|1|||
13445879|NCT00307125|26929081|FG001|Screening Phase|AMR and treated with rituximab|0|||
13445880|NCT00307125|26929082|FG002|Screening Phase|AMR and treated with rituximab|0|||
13445881|NCT00307125|26929080|FG000|Screening Phase|Coronary artery bypass|1|||
13445882|NCT00307125|26929081|FG001|Screening Phase|Coronary artery bypass|0|||
13445883|NCT00307125|26929082|FG002|Screening Phase|Coronary artery bypass|0|||
13445884|NCT00307125|26929080|FG000|Pilot Phase|Lost to Follow-up|0|||
13445885|NCT00307125|26929081|FG001|Pilot Phase|Lost to Follow-up|1|||
13445886|NCT00307125|26929082|FG002|Pilot Phase|Lost to Follow-up|0|||
13445887|NCT00307125|26929080|FG000|Pilot Phase|Withdrawal by Subject|0|||
13445888|NCT00307125|26929081|FG001|Pilot Phase|Withdrawal by Subject|1|||
13445889|NCT00307125|26929082|FG002|Pilot Phase|Withdrawal by Subject|1|||
13445890|NCT00307086|26929088|FG000|Overall Study|ineligible|5|||
13445891|NCT00307047|26929231|FG000|Overall Study|Lost to Follow-up|35|||
13445892|NCT00307047|26929232|FG001|Overall Study|Lost to Follow-up|24|||
13445893|NCT00307047|26929231|FG000|Overall Study|Withdrawal by Subject|6|||
13445894|NCT00307047|26929232|FG001|Overall Study|Withdrawal by Subject|6|||
13445895|NCT00307047|26929231|FG000|Overall Study|Physician Decision|1|||
13445896|NCT00307047|26929232|FG001|Overall Study|Physician Decision|2|||
13445897|NCT00307047|26929231|FG000|Overall Study|Lost to follow-up for other reasons|0|||
13445898|NCT00307047|26929232|FG001|Overall Study|Lost to follow-up for other reasons|1|||
13445899|NCT00307047|26929231|FG000|Overall Study|All death, all MI, all Revascularization|27|||
13445900|NCT00307047|26929232|FG001|Overall Study|All death, all MI, all Revascularization|16|||
13445901|NCT00307034|26929277|FG000|Overall Study|Adverse Event|1|||
13445902|NCT00307034|26929278|FG001|Overall Study|Adverse Event|2|||
13445903|NCT00307034|26929277|FG000|Overall Study|Withdrawal by Subject|1|||
13445904|NCT00307034|26929278|FG001|Overall Study|Withdrawal by Subject|2|||
13445905|NCT00307034|26929277|FG000|Overall Study|Lost to Follow-up|0|||
13445906|NCT00307034|26929278|FG001|Overall Study|Lost to Follow-up|3|||
13445907|NCT00306995|26929680|FG000|Study Part I|Withdrawal by Subject|0|||
13445908|NCT00306995|26929681|FG001|Study Part I|Withdrawal by Subject|0|||
13445909|NCT00306995|26929682|FG002|Study Part I|Withdrawal by Subject|0|||
13445910|NCT00306995|26929683|FG003|Study Part I|Withdrawal by Subject|0|||
13445911|NCT00306995|26929684|FG004|Study Part I|Withdrawal by Subject|0|||
13445912|NCT00306995|26929685|FG005|Study Part I|Withdrawal by Subject|0|||
13445913|NCT00306995|26929686|FG006|Study Part I|Withdrawal by Subject|1|||
13445914|NCT00306995|26929680|FG000|Study Part II for Subset 2|Serious Adverse Event|0|||
13445915|NCT00306995|26929681|FG001|Study Part II for Subset 2|Serious Adverse Event|1|||
13445916|NCT00306995|26929682|FG002|Study Part II for Subset 2|Serious Adverse Event|0|||
13445917|NCT00306995|26929683|FG003|Study Part II for Subset 2|Serious Adverse Event|0|||
13445918|NCT00306995|26929684|FG004|Study Part II for Subset 2|Serious Adverse Event|0|||
13445919|NCT00306995|26929685|FG005|Study Part II for Subset 2|Serious Adverse Event|0|||
13445920|NCT00306995|26929686|FG006|Study Part II for Subset 2|Serious Adverse Event|0|||
13445921|NCT00306891|26929720|FG000|Part A|Withdrawal by Subject|1|||
13445922|NCT00306891|26929721|FG001|Part A|Withdrawal by Subject|1|||
13445923|NCT00306891|26929722|FG002|Part A|Withdrawal by Subject|0|||
13445924|NCT00306891|26929723|FG003|Part A|Withdrawal by Subject|0|||
13445925|NCT00306891|26929720|FG000|Part A|Condition under investigation worsened|2|||
13445926|NCT00306891|26929721|FG001|Part A|Condition under investigation worsened|2|||
13445927|NCT00306891|26929722|FG002|Part A|Condition under investigation worsened|0|||
13445928|NCT00306891|26929723|FG003|Part A|Condition under investigation worsened|0|||
13445929|NCT00306891|26929720|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0|||
13445930|NCT00306891|26929721|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1|||
13445931|NCT00306891|26929722|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0|||
13445932|NCT00306891|26929723|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0|||
13445933|NCT00306891|26929720|FG000|Part A|Partial bowel obstruction|1|||
13445934|NCT00306891|26929721|FG001|Part A|Partial bowel obstruction|0|||
13445935|NCT00306891|26929722|FG002|Part A|Partial bowel obstruction|0|||
13445936|NCT00306891|26929723|FG003|Part A|Partial bowel obstruction|0|||
13445937|NCT00306891|26929720|FG000|Part A|Reaccumul. of ascites following drainage|0|||
13445938|NCT00306891|26929721|FG001|Part A|Reaccumul. of ascites following drainage|1|||
13445939|NCT00306891|26929722|FG002|Part A|Reaccumul. of ascites following drainage|0|||
13445940|NCT00306891|26929723|FG003|Part A|Reaccumul. of ascites following drainage|0|||
13445941|NCT00306891|26929720|FG000|Part A|Suspicion of second malignancy|0|||
13445942|NCT00306891|26929721|FG001|Part A|Suspicion of second malignancy|1|||
13445943|NCT00306891|26929722|FG002|Part A|Suspicion of second malignancy|0|||
13445944|NCT00306891|26929723|FG003|Part A|Suspicion of second malignancy|0|||
13445945|NCT00306891|26929720|FG000|Part A|QTC interval outwith elig. criteria|1|||
13445946|NCT00306891|26929721|FG001|Part A|QTC interval outwith elig. criteria|0|||
13445947|NCT00306891|26929722|FG002|Part A|QTC interval outwith elig. criteria|0|||
13445948|NCT00306891|26929723|FG003|Part A|QTC interval outwith elig. criteria|0|||
13445949|NCT00306891|26929720|FG000|Part B|Death|0|||
13445950|NCT00306891|26929721|FG001|Part B|Death|0|||
13445951|NCT00306891|26929722|FG002|Part B|Death|1|||
13445952|NCT00306891|26929723|FG003|Part B|Death|2|||
13445953|NCT00306891|26929720|FG000|Part B|Adverse Event|0|||
13445954|NCT00306891|26929721|FG001|Part B|Adverse Event|0|||
13445955|NCT00306891|26929722|FG002|Part B|Adverse Event|5|||
13445956|NCT00306891|26929723|FG003|Part B|Adverse Event|5|||
13445957|NCT00306891|26929720|FG000|Part B|Withdrawal by Subject|0|||
13445958|NCT00306891|26929721|FG001|Part B|Withdrawal by Subject|0|||
13445959|NCT00306891|26929722|FG002|Part B|Withdrawal by Subject|3|||
13445960|NCT00306891|26929723|FG003|Part B|Withdrawal by Subject|1|||
13445961|NCT00306891|26929720|FG000|Part B|Condition under investigation worsened|0|||
13445962|NCT00306891|26929721|FG001|Part B|Condition under investigation worsened|0|||
13445963|NCT00306891|26929722|FG002|Part B|Condition under investigation worsened|2|||
13445964|NCT00306891|26929723|FG003|Part B|Condition under investigation worsened|8|||
13445965|NCT00306891|26929720|FG000|Part B|Development of study specific disc crit.|0|||
13445966|NCT00306891|26929721|FG001|Part B|Development of study specific disc crit.|0|||
13445967|NCT00306891|26929722|FG002|Part B|Development of study specific disc crit.|0|||
13445968|NCT00306891|26929723|FG003|Part B|Development of study specific disc crit.|1|||
13445969|NCT00306852|26929746|FG000|Overall Study|Death|14|||
13445970|NCT00306852|26929747|FG001|Overall Study|Death|14|||
13445971|NCT00306852|26929746|FG000|Overall Study|Lost to Follow-up|15|||
13445972|NCT00306852|26929747|FG001|Overall Study|Lost to Follow-up|24|||
13445973|NCT00306787|26929770|FG000|Overall Study|Discontinued without taking study drug|208|||
13445974|NCT00306787|26929771|FG001|Overall Study|Discontinued without taking study drug|215|||
13445975|NCT00306787|26929770|FG000|Overall Study|Adverse Event|1|||
13445976|NCT00306787|26929771|FG001|Overall Study|Adverse Event|1|||
13445977|NCT00306787|26929770|FG000|Overall Study|Lack of Efficacy|1|||
13445978|NCT00306787|26929771|FG001|Overall Study|Lack of Efficacy|0|||
13445979|NCT00306787|26929770|FG000|Overall Study|Protocol Violation|8|||
13445980|NCT00306787|26929771|FG001|Overall Study|Protocol Violation|10|||
13445981|NCT00306787|26929770|FG000|Overall Study|Withdrawal by Subject|2|||
13445982|NCT00306787|26929771|FG001|Overall Study|Withdrawal by Subject|9|||
13445983|NCT00306787|26929770|FG000|Overall Study|Lost to Follow-up|9|||
13445984|NCT00306787|26929771|FG001|Overall Study|Lost to Follow-up|6|||
13445985|NCT00306787|26929770|FG000|Overall Study|Administrative problems|4|||
13445986|NCT00306787|26929771|FG001|Overall Study|Administrative problems|0|||
13445987|NCT00306787|26929770|FG000|Overall Study|Abnormal laboratory value(s)|1|||
13445988|NCT00306787|26929771|FG001|Overall Study|Abnormal laboratory value(s)|0|||
13445989|NCT00306670|26929784|FG000|Overall Study|patients recruited; Genentech, the st|0|||
13445990|NCT00306670|26929785|FG001|Overall Study|patients recruited; Genentech, the st|2|||
13445991|NCT00306592|26929794|FG000|Overall Study|Adverse Event|8|||
13445992|NCT00306592|26929795|FG001|Overall Study|Adverse Event|15|||
13445993|NCT00306592|26929794|FG000|Overall Study|Lost to Follow-up|1|||
13445994|NCT00306592|26929795|FG001|Overall Study|Lost to Follow-up|0|||
13445995|NCT00306592|26929794|FG000|Overall Study|Noncompliance|0|||
13445996|NCT00306592|26929795|FG001|Overall Study|Noncompliance|2|||
13445997|NCT00306592|26929794|FG000|Overall Study|Persistent Antibodies|6|||
13445998|NCT00306592|26929795|FG001|Overall Study|Persistent Antibodies|3|||
13445999|NCT00306592|26929794|FG000|Overall Study|Voluntary|10|||
13446000|NCT00306592|26929795|FG001|Overall Study|Voluntary|6|||
13446001|NCT00306592|26929794|FG000|Overall Study|Other|5|||
13446002|NCT00306592|26929795|FG001|Overall Study|Other|10|||
13446003|NCT00306592|26929794|FG000|Overall Study|Other|1|||
13446004|NCT00306592|26929795|FG001|Overall Study|Other|2|||
13446005|NCT00306592|26929794|FG000|Overall Study|48-week Treatment Period Ongoing|0|||
13446006|NCT00306592|26929795|FG001|Overall Study|48-week Treatment Period Ongoing|20|||
13446007|NCT00306527|26929862|FG000|Overall Study|Lost to Follow-up|3|||
13446008|NCT00306527|26929863|FG001|Overall Study|Lost to Follow-up|4|||
13446009|NCT00306527|26929864|FG002|Overall Study|Lost to Follow-up|3|||
13446010|NCT00306527|26929865|FG003|Overall Study|Lost to Follow-up|0|||
13446011|NCT00306527|26929862|FG000|Overall Study|Withdrawal by Subject|2|||
13446012|NCT00306527|26929863|FG001|Overall Study|Withdrawal by Subject|3|||
13446013|NCT00306527|26929864|FG002|Overall Study|Withdrawal by Subject|0|||
13446014|NCT00306527|26929865|FG003|Overall Study|Withdrawal by Subject|3|||
13446015|NCT00306527|26929862|FG000|Overall Study|Adverse Event|0|||
13446016|NCT00306527|26929863|FG001|Overall Study|Adverse Event|0|||
13446017|NCT00306527|26929864|FG002|Overall Study|Adverse Event|1|||
13446018|NCT00306527|26929865|FG003|Overall Study|Adverse Event|1|||
13446019|NCT00306527|26929862|FG000|Overall Study|Death|1|||
13446020|NCT00306527|26929863|FG001|Overall Study|Death|0|||
13446021|NCT00306527|26929864|FG002|Overall Study|Death|1|||
13446022|NCT00306527|26929865|FG003|Overall Study|Death|2|||
13446023|NCT00306384|26929907|FG000|Overall Study|Adverse Event|103|||
13446024|NCT00306384|26929908|FG001|Overall Study|Adverse Event|87|||
13446025|NCT00306384|26929909|FG002|Overall Study|Adverse Event|40|||
13446026|NCT00306384|26929907|FG000|Overall Study|Major protocol deviation|43|||
13446027|NCT00306384|26929908|FG001|Overall Study|Major protocol deviation|51|||
13446028|NCT00306384|26929909|FG002|Overall Study|Major protocol deviation|18|||
13446029|NCT00306384|26929907|FG000|Overall Study|Lost to Follow-up|57|||
13446030|NCT00306384|26929908|FG001|Overall Study|Lost to Follow-up|41|||
13446031|NCT00306384|26929909|FG002|Overall Study|Lost to Follow-up|35|||
13446032|NCT00306384|26929907|FG000|Overall Study|Voluntary withdrawal|199|||
13446033|NCT00306384|26929908|FG001|Overall Study|Voluntary withdrawal|187|||
13446034|NCT00306384|26929909|FG002|Overall Study|Voluntary withdrawal|91|||
13446035|NCT00306384|26929907|FG000|Overall Study|Study termination|1|||
13446036|NCT00306384|26929908|FG001|Overall Study|Study termination|0|||
13446037|NCT00306384|26929909|FG002|Overall Study|Study termination|1|||
13446038|NCT00306384|26929907|FG000|Overall Study|Pregnancy|3|||
13446039|NCT00306384|26929908|FG001|Overall Study|Pregnancy|1|||
13446040|NCT00306384|26929909|FG002|Overall Study|Pregnancy|1|||
13446041|NCT00306384|26929907|FG000|Overall Study|Lack of Efficacy|26|||
13446042|NCT00306384|26929908|FG001|Overall Study|Lack of Efficacy|40|||
13446043|NCT00306384|26929909|FG002|Overall Study|Lack of Efficacy|38|||
13446044|NCT00306384|26929907|FG000|Overall Study|Investigator discretion|28|||
13446045|NCT00306384|26929908|FG001|Overall Study|Investigator discretion|31|||
13446046|NCT00306384|26929909|FG002|Overall Study|Investigator discretion|21|||
13446047|NCT00306384|26929907|FG000|Overall Study|Other|80|||
13446048|NCT00306384|26929908|FG001|Overall Study|Other|70|||
13446049|NCT00306384|26929909|FG002|Overall Study|Other|32|||
13446050|NCT00306384|26929907|FG000|Overall Study|Site closure|2|||
13446051|NCT00306384|26929908|FG001|Overall Study|Site closure|0|||
13446052|NCT00306384|26929909|FG002|Overall Study|Site closure|0|||
13446053|NCT00306293|26929930|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1|||
13446054|NCT00306293|26929931|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0|||
13446055|NCT00306293|26929930|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3|||
13446056|NCT00306293|26929931|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4|||
13446057|NCT00306293|26929930|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
13446058|NCT00306293|26929931|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
13446059|NCT00306293|26929930|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
13446060|NCT00306293|26929931|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
13446061|NCT00306293|26929930|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1|||
13446062|NCT00306293|26929931|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0|||
13446063|NCT00306293|26929930|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1|||
13446064|NCT00306293|26929931|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0|||
13446065|NCT00306293|26929930|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0|||
13446066|NCT00306293|26929931|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1|||
13446067|NCT00306293|26929930|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1|||
13446068|NCT00306293|26929931|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0|||
13477200|NCT01480180|27005884|FG001|Main Phase|Withdrawal criteria|1|||
13477201|NCT01480180|27005885|FG002|Main Phase|Withdrawal criteria|0|||
13477202|NCT01480180|27005886|FG003|Main Phase|Withdrawal criteria|0|||
13477203|NCT01480180|27005887|FG004|Main Phase|Withdrawal criteria|0|||
13477204|NCT01480180|27005888|FG005|Main Phase|Withdrawal criteria|0|||
13477205|NCT01480180|27005883|FG000|Main Phase|Lack of Efficacy|1|||
13477206|NCT01480180|27005884|FG001|Main Phase|Lack of Efficacy|0|||
13477207|NCT01480180|27005885|FG002|Main Phase|Lack of Efficacy|0|||
13477208|NCT01480180|27005886|FG003|Main Phase|Lack of Efficacy|0|||
13477209|NCT01480180|27005887|FG004|Main Phase|Lack of Efficacy|0|||
13477210|NCT01480180|27005888|FG005|Main Phase|Lack of Efficacy|0|||
13477211|NCT01480180|27005883|FG000|Main Phase|Non-compliance|3|||
13477212|NCT01480180|27005884|FG001|Main Phase|Non-compliance|0|||
13477213|NCT01480180|27005885|FG002|Main Phase|Non-compliance|0|||
13477214|NCT01480180|27005886|FG003|Main Phase|Non-compliance|0|||
13477215|NCT01480180|27005887|FG004|Main Phase|Non-compliance|0|||
13477216|NCT01480180|27005888|FG005|Main Phase|Non-compliance|0|||
13477217|NCT01480180|27005883|FG000|Main Phase|Unclassified|3|||
13477218|NCT01480180|27005884|FG001|Main Phase|Unclassified|0|||
13477219|NCT01480180|27005885|FG002|Main Phase|Unclassified|0|||
13477220|NCT01480180|27005886|FG003|Main Phase|Unclassified|0|||
13477221|NCT01480180|27005887|FG004|Main Phase|Unclassified|0|||
13477222|NCT01480180|27005888|FG005|Main Phase|Unclassified|0|||
13477223|NCT01480180|27005883|FG000|Extension Phase, Part 1|Withdrawal criteria|0|||
13477224|NCT01480180|27005884|FG001|Extension Phase, Part 1|Withdrawal criteria|0|||
13477225|NCT01480180|27005885|FG002|Extension Phase, Part 1|Withdrawal criteria|5|||
13477226|NCT01480180|27005886|FG003|Extension Phase, Part 1|Withdrawal criteria|0|||
13477227|NCT01480180|27005887|FG004|Extension Phase, Part 1|Withdrawal criteria|0|||
13477228|NCT01480180|27005888|FG005|Extension Phase, Part 1|Withdrawal criteria|0|||
13477229|NCT01480180|27005883|FG000|Extension Phase, Part 1|Unclassified|0|||
13477230|NCT01480180|27005884|FG001|Extension Phase, Part 1|Unclassified|0|||
13477231|NCT01480180|27005885|FG002|Extension Phase, Part 1|Unclassified|1|||
13477232|NCT01480180|27005886|FG003|Extension Phase, Part 1|Unclassified|0|||
13477233|NCT01480180|27005887|FG004|Extension Phase, Part 1|Unclassified|0|||
13477234|NCT01480180|27005888|FG005|Extension Phase, Part 1|Unclassified|0|||
13477235|NCT01480180|27005883|FG000|Extension Phase, Part 1|Adverse Event|0|||
13477236|NCT01480180|27005884|FG001|Extension Phase, Part 1|Adverse Event|0|||
13477237|NCT01480180|27005885|FG002|Extension Phase, Part 1|Adverse Event|4|||
13477238|NCT01480180|27005886|FG003|Extension Phase, Part 1|Adverse Event|1|||
13477239|NCT01480180|27005887|FG004|Extension Phase, Part 1|Adverse Event|0|||
13477240|NCT01480180|27005888|FG005|Extension Phase, Part 1|Adverse Event|0|||
13477241|NCT01480180|27005883|FG000|Extension Phase, Part 1|Change of treatment|0|||
13477242|NCT01480180|27005884|FG001|Extension Phase, Part 1|Change of treatment|0|||
13477243|NCT01480180|27005885|FG002|Extension Phase, Part 1|Change of treatment|0|||
13477244|NCT01480180|27005886|FG003|Extension Phase, Part 1|Change of treatment|9|||
13477245|NCT01480180|27005887|FG004|Extension Phase, Part 1|Change of treatment|0|||
13477246|NCT01480180|27005888|FG005|Extension Phase, Part 1|Change of treatment|0|||
13477247|NCT01480180|27005883|FG000|Extension Phase, Part 2|Withdrawal criteria|0|||
13477248|NCT01480180|27005884|FG001|Extension Phase, Part 2|Withdrawal criteria|0|||
13477249|NCT01480180|27005885|FG002|Extension Phase, Part 2|Withdrawal criteria|10|||
13477250|NCT01480180|27005886|FG003|Extension Phase, Part 2|Withdrawal criteria|6|||
13477251|NCT01480180|27005887|FG004|Extension Phase, Part 2|Withdrawal criteria|1|||
13477252|NCT01480180|27005888|FG005|Extension Phase, Part 2|Withdrawal criteria|0|||
13477253|NCT01480180|27005883|FG000|Extension Phase, Part 2|Lack of Efficacy|0|||
13477254|NCT01480180|27005884|FG001|Extension Phase, Part 2|Lack of Efficacy|0|||
13477255|NCT01480180|27005885|FG002|Extension Phase, Part 2|Lack of Efficacy|4|||
13477256|NCT01480180|27005886|FG003|Extension Phase, Part 2|Lack of Efficacy|0|||
13477257|NCT01480180|27005887|FG004|Extension Phase, Part 2|Lack of Efficacy|0|||
13477258|NCT01480180|27005888|FG005|Extension Phase, Part 2|Lack of Efficacy|0|||
13477259|NCT01480180|27005883|FG000|Extension Phase, Part 2|Unclassified|0|||
13477260|NCT01480180|27005884|FG001|Extension Phase, Part 2|Unclassified|0|||
13477261|NCT01480180|27005885|FG002|Extension Phase, Part 2|Unclassified|3|||
13477262|NCT01480180|27005886|FG003|Extension Phase, Part 2|Unclassified|1|||
13477263|NCT01480180|27005887|FG004|Extension Phase, Part 2|Unclassified|1|||
13477264|NCT01480180|27005888|FG005|Extension Phase, Part 2|Unclassified|0|||
13446069|NCT00306189|26929954|FG000|Overall Study|Physician Decision|0|||
13446070|NCT00306189|26929955|FG001|Overall Study|Physician Decision|0|||
13446071|NCT00306189|26929956|FG002|Overall Study|Physician Decision|0|||
13446072|NCT00306189|26929957|FG003|Overall Study|Physician Decision|1|||
13446073|NCT00306189|26929954|FG000|Overall Study|Adverse Event|3|||
13446074|NCT00306189|26929955|FG001|Overall Study|Adverse Event|3|||
13446075|NCT00306189|26929956|FG002|Overall Study|Adverse Event|2|||
13446076|NCT00306189|26929957|FG003|Overall Study|Adverse Event|2|||
13446077|NCT00306189|26929954|FG000|Overall Study|Withdrawal by Subject|4|||
13446078|NCT00306189|26929955|FG001|Overall Study|Withdrawal by Subject|2|||
13446079|NCT00306189|26929956|FG002|Overall Study|Withdrawal by Subject|8|||
13446080|NCT00306189|26929957|FG003|Overall Study|Withdrawal by Subject|1|||
13446081|NCT00306189|26929954|FG000|Overall Study|Ineligibility determined|1|||
13446082|NCT00306189|26929955|FG001|Overall Study|Ineligibility determined|1|||
13446083|NCT00306189|26929956|FG002|Overall Study|Ineligibility determined|1|||
13446084|NCT00306189|26929957|FG003|Overall Study|Ineligibility determined|1|||
13446085|NCT00306189|26929954|FG000|Overall Study|Other|1|||
13446086|NCT00306189|26929955|FG001|Overall Study|Other|0|||
13446087|NCT00306189|26929956|FG002|Overall Study|Other|0|||
13446088|NCT00306189|26929957|FG003|Overall Study|Other|0|||
13446089|NCT00305877|26929974|FG000|Overall Study|Lack of Efficacy|6|||
13446090|NCT00305877|26929975|FG001|Overall Study|Lack of Efficacy|9|||
13446091|NCT00305877|26929974|FG000|Overall Study|Adverse Event|9|||
13446092|NCT00305877|26929975|FG001|Overall Study|Adverse Event|14|||
13446093|NCT00305877|26929974|FG000|Overall Study|Death|0|||
13446094|NCT00305877|26929975|FG001|Overall Study|Death|1|||
13446095|NCT00305877|26929974|FG000|Overall Study|Withdrawal by Subject|4|||
13446096|NCT00305877|26929975|FG001|Overall Study|Withdrawal by Subject|2|||
13446097|NCT00305877|26929974|FG000|Overall Study|Physician Decision|1|||
13446098|NCT00305877|26929975|FG001|Overall Study|Physician Decision|1|||
13446099|NCT00305877|26929974|FG000|Overall Study|Never start treatment|2|||
13446100|NCT00305877|26929975|FG001|Overall Study|Never start treatment|5|||
13446101|NCT00305877|26929974|FG000|Overall Study|Ineligible|2|||
13446102|NCT00305877|26929975|FG001|Overall Study|Ineligible|1|||
13446103|NCT00305877|26929974|FG000|Overall Study|Transportation issue with daily RT|0|||
13446104|NCT00305877|26929975|FG001|Overall Study|Transportation issue with daily RT|1|||
13446105|NCT00305864|26929999|FG000|Overall Study|Ineligible / No protocol treatment|0|||
13446106|NCT00305864|26930000|FG001|Overall Study|Ineligible / No protocol treatment|1|||
13446107|NCT00305864|26930001|FG002|Overall Study|Ineligible / No protocol treatment|1|||
13446108|NCT00305864|26930002|FG003|Overall Study|Ineligible / No protocol treatment|13|||
13446109|NCT00305773|26930023|FG000|Overall Study|Death|3|||
13446110|NCT00305773|26930024|FG001|Overall Study|Death|2|||
13446111|NCT00305773|26930023|FG000|Overall Study|Adverse Event|1|||
13446112|NCT00305773|26930024|FG001|Overall Study|Adverse Event|2|||
13446113|NCT00305773|26930023|FG000|Overall Study|Alternative Treatment|4|||
13446114|NCT00305773|26930024|FG001|Overall Study|Alternative Treatment|4|||
13446115|NCT00305773|26930023|FG000|Overall Study|Physician Decision|1|||
13446116|NCT00305773|26930024|FG001|Overall Study|Physician Decision|1|||
13446117|NCT00305773|26930023|FG000|Overall Study|Withdrawal by Subject|1|||
13446118|NCT00305773|26930024|FG001|Overall Study|Withdrawal by Subject|4|||
13446119|NCT00305773|26930023|FG000|Overall Study|Disease Progression|1|||
13446120|NCT00305773|26930024|FG001|Overall Study|Disease Progression|3|||
13446121|NCT00305773|26930023|FG000|Overall Study|All other reasons|3|||
13446122|NCT00305773|26930024|FG001|Overall Study|All other reasons|2|||
13446123|NCT00305695|26930043|FG000|Overall Study|Withdrawal by subject prior to 18 month|40|||
13446124|NCT00305695|26930044|FG001|Overall Study|Withdrawal by subject prior to 18 month|26|||
13446125|NCT00305695|26930043|FG000|Overall Study|Did not have baseline scan|1|||
13446126|NCT00305695|26930044|FG001|Overall Study|Did not have baseline scan|1|||
13446127|NCT00305604|26930063|FG000|Overall Study|Adverse Event|6|||
13446128|NCT00305604|26930064|FG001|Overall Study|Adverse Event|3|||
13446129|NCT00305604|26930063|FG000|Overall Study|Lack of Efficacy|11|||
13446130|NCT00305604|26930064|FG001|Overall Study|Lack of Efficacy|18|||
13446131|NCT00305604|26930063|FG000|Overall Study|Lost to Follow-up|0|||
13446132|NCT00305604|26930064|FG001|Overall Study|Lost to Follow-up|4|||
13446133|NCT00305604|26930063|FG000|Overall Study|Protocol Violation|2|||
13446134|NCT00305604|26930064|FG001|Overall Study|Protocol Violation|1|||
13446135|NCT00305604|26930063|FG000|Overall Study|Withdrawal by Subject|12|||
13446136|NCT00305604|26930064|FG001|Overall Study|Withdrawal by Subject|21|||
13446137|NCT00305604|26930063|FG000|Overall Study|Patient moved|1|||
13446138|NCT00305604|26930064|FG001|Overall Study|Patient moved|0|||
13446139|NCT00305448|26930090|FG000|Overall Study|Protocol Violation|0|||
13446140|NCT00305448|26930091|FG001|Overall Study|Protocol Violation|1|||
13446141|NCT00305448|26930092|FG002|Overall Study|Protocol Violation|0|||
13446142|NCT00305448|26930090|FG000|Overall Study|Withdrawal by Subject|2|||
13446143|NCT00305448|26930091|FG001|Overall Study|Withdrawal by Subject|0|||
13446144|NCT00305448|26930092|FG002|Overall Study|Withdrawal by Subject|1|||
13446145|NCT00305448|26930090|FG000|Overall Study|Adverse Event|1|||
13446146|NCT00305448|26930091|FG001|Overall Study|Adverse Event|0|||
13446147|NCT00305448|26930092|FG002|Overall Study|Adverse Event|1|||
13446148|NCT00305448|26930090|FG000|Overall Study|Disease Progression|27|||
13446149|NCT00305448|26930091|FG001|Overall Study|Disease Progression|31|||
13446150|NCT00305448|26930092|FG002|Overall Study|Disease Progression|28|||
13446151|NCT00305448|26930090|FG000|Overall Study|Subjective Disease Progression|1|||
13446152|NCT00305448|26930091|FG001|Overall Study|Subjective Disease Progression|2|||
13446153|NCT00305448|26930092|FG002|Overall Study|Subjective Disease Progression|2|||
13446154|NCT00305448|26930090|FG000|Overall Study|Tumor Marker Elevation|0|||
13446155|NCT00305448|26930091|FG001|Overall Study|Tumor Marker Elevation|0|||
13446156|NCT00305448|26930092|FG002|Overall Study|Tumor Marker Elevation|1|||
13446157|NCT00305253|26930109|FG000|Overall Study|Withdrawal by Subject|0|||
13446158|NCT00305253|26930110|FG001|Overall Study|Withdrawal by Subject|1|||
13446159|NCT00305227|26930123|FG000|Overall Study|Lost to Follow-up|7|||
13446160|NCT00305227|26930124|FG001|Overall Study|Lost to Follow-up|6|||
13446161|NCT00305110|26930135|FG000|Overall Study|Missing data|29|||
13446162|NCT00305058|26930154|FG000|Overall Study|Participant too young|1|||
13446163|NCT00305058|26930155|FG001|Overall Study|Participant too young|0|||
13446164|NCT00305058|26930154|FG000|Overall Study|Missing data collection instrument|3|||
13446165|NCT00305058|26930155|FG001|Overall Study|Missing data collection instrument|2|||
13446166|NCT00305058|26930154|FG000|Overall Study|Missing outcome data|3|||
13446167|NCT00305058|26930155|FG001|Overall Study|Missing outcome data|2|||
13446168|NCT00305006|26930170|FG000|Overall Study|Withdrawal by Subject|1|||
13446169|NCT00305006|26930171|FG001|Overall Study|Withdrawal by Subject|0|||
13446170|NCT00305006|26930170|FG000|Overall Study|Failure to complete pretest|0|||
13446171|NCT00305006|26930171|FG001|Overall Study|Failure to complete pretest|1|||
13446172|NCT00304954|26930202|FG000|Overall Study|Withdrawal by Subject|0|||
13446173|NCT00304954|26930203|FG001|Overall Study|Withdrawal by Subject|0|||
13446174|NCT00304954|26930204|FG002|Overall Study|Withdrawal by Subject|1|||
13446175|NCT00304954|26930205|FG003|Overall Study|Withdrawal by Subject|0|||
13446176|NCT00304954|26930202|FG000|Overall Study|Adverse Event|1|||
13446177|NCT00304954|26930203|FG001|Overall Study|Adverse Event|0|||
13446178|NCT00304954|26930204|FG002|Overall Study|Adverse Event|0|||
13446179|NCT00304954|26930205|FG003|Overall Study|Adverse Event|0|||
13446180|NCT00304915|26930218|FG000|Overall Study|Lost to Follow-up|11|||
13446181|NCT00304915|26930219|FG001|Overall Study|Lost to Follow-up|11|||
13446182|NCT00304915|26930218|FG000|Overall Study|Death|4|||
13446183|NCT00304915|26930219|FG001|Overall Study|Death|5|||
13446184|NCT00304915|26930218|FG000|Overall Study|Withdrawal by Subject|3|||
13446185|NCT00304915|26930219|FG001|Overall Study|Withdrawal by Subject|0|||
13446186|NCT00304356|26930225|FG000|Nitazoxanide|Physician Decision|5|||
13446187|NCT00304356|26930225|FG000|Nitazoxanide|Physician Decision|1|||
13446188|NCT00304356|26930225|FG000|Nitazoxanide|number is 0|1|||
13446189|NCT00304356|26930225|FG000|Nitazoxanide|Physician Decision|1|||
13446190|NCT00304356|26930225|FG000|Nitazoxanide|Physician Decision|1|||
13446191|NCT00304356|26930225|FG000|Nitazoxanide|Physician Decision|1|||
13446192|NCT00304278|26930232|FG000|Overall Study|lack of insurance coverage for chemoRT|1|||
13446193|NCT00304278|26930232|FG000|Overall Study|PT had medical condition preventing TX|1|||
13446194|NCT00304083|26930255|FG000|Overall Study|Withdrawal by Subject|4|||
13446195|NCT00304083|26930256|FG001|Overall Study|Withdrawal by Subject|2|||
13446196|NCT00304083|26930255|FG000|Overall Study|Physician Decision|8|||
13446197|NCT00304083|26930256|FG001|Overall Study|Physician Decision|3|||
13446198|NCT00304083|26930255|FG000|Overall Study|Disease Progression|5|||
13446199|NCT00304083|26930256|FG001|Overall Study|Disease Progression|1|||
13446200|NCT00304083|26930255|FG000|Overall Study|Other|5|||
13446201|NCT00304083|26930256|FG001|Overall Study|Other|2|||
13446202|NCT00304031|26930316|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144|||
13446203|NCT00304031|26930317|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
13446204|NCT00304031|26930318|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
13446205|NCT00304031|26930316|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48|||
13446206|NCT00304031|26930317|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
13446207|NCT00304031|26930318|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
13446208|NCT00304031|26930316|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19|||
13446209|NCT00304031|26930317|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
13446210|NCT00304031|26930318|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
13446211|NCT00304031|26930316|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18|||
13446212|NCT00304031|26930317|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
13446213|NCT00304031|26930318|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
13446214|NCT00304031|26930316|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15|||
13446215|NCT00304031|26930317|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
13446216|NCT00304031|26930318|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
13446217|NCT00304031|26930316|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10|||
13446218|NCT00304031|26930317|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
13446219|NCT00304031|26930318|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
13446220|NCT00304031|26930316|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1|||
13446221|NCT00304031|26930317|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
13446222|NCT00304031|26930318|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
13446223|NCT00304031|26930316|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37|||
13446224|NCT00304031|26930317|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
13446225|NCT00304031|26930318|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
13446226|NCT00304031|26930316|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
13446227|NCT00304031|26930317|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
13446228|NCT00304031|26930318|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2|||
13446229|NCT00303953|26930326|FG000|Overall Study|Ineligible|1|||
13446230|NCT00303953|26930326|FG000|Overall Study|Death|1|||
13446231|NCT00303953|26930326|FG000|Overall Study|Adverse Event|4|||
13446232|NCT00303953|26930326|FG000|Overall Study|Lack of Efficacy|12|||
13446233|NCT00303953|26930326|FG000|Overall Study|Physician Decision|1|||
13446234|NCT00303719|26930347|FG000|Overall Study|Not evaluable, prior therapies|0|||
13446235|NCT00303719|26930348|FG001|Overall Study|Not evaluable, prior therapies|30|||
13446236|NCT00303719|26930347|FG000|Overall Study|Lost to Follow-up|0|||
13446237|NCT00303719|26930348|FG001|Overall Study|Lost to Follow-up|7|||
13446238|NCT00303667|26930377|FG000|Overall Study|Death|0|||
13446239|NCT00303667|26930378|FG001|Overall Study|Death|4|||
13446240|NCT00303628|26930401|FG000|Overall Study|Disease progression|0|||
13446241|NCT00303628|26930402|FG001|Overall Study|Disease progression|1|||
13446242|NCT00303628|26930401|FG000|Overall Study|Adverse Event|26|||
13446243|NCT00303628|26930402|FG001|Overall Study|Adverse Event|36|||
13446244|NCT00303628|26930401|FG000|Overall Study|Death|0|||
13446245|NCT00303628|26930402|FG001|Overall Study|Death|1|||
13446246|NCT00303628|26930401|FG000|Overall Study|Withdrawal by Subject|11|||
13446247|NCT00303628|26930402|FG001|Overall Study|Withdrawal by Subject|20|||
13446248|NCT00303628|26930401|FG000|Overall Study|Alternative therapy|2|||
13446249|NCT00303628|26930402|FG001|Overall Study|Alternative therapy|0|||
13446250|NCT00303628|26930401|FG000|Overall Study|Other complicating disease|0|||
13446251|NCT00303628|26930402|FG001|Overall Study|Other complicating disease|1|||
13446252|NCT00303628|26930401|FG000|Overall Study|Not start protocol therapy|3|||
13446253|NCT00303628|26930402|FG001|Overall Study|Not start protocol therapy|5|||
13446254|NCT00303628|26930401|FG000|Overall Study|Other|8|||
13446255|NCT00303628|26930402|FG001|Overall Study|Other|9|||
13446256|NCT00303602|26930449|FG000|Overall Study|Adverse Event|2|||
13446257|NCT00303602|26930450|FG001|Overall Study|Adverse Event|2|||
13446258|NCT00303602|26930449|FG000|Overall Study|Withdrawal by Subject|5|||
13446259|NCT00303602|26930450|FG001|Overall Study|Withdrawal by Subject|6|||
13446260|NCT00303602|26930449|FG000|Overall Study|Lost to Follow-up|5|||
13446261|NCT00303602|26930450|FG001|Overall Study|Lost to Follow-up|2|||
13446262|NCT00303602|26930449|FG000|Overall Study|Protocol entry criteria not met|2|||
13446263|NCT00303602|26930450|FG001|Overall Study|Protocol entry criteria not met|2|||
13446264|NCT00303602|26930449|FG000|Overall Study|Physician Decision|2|||
13446265|NCT00303602|26930450|FG001|Overall Study|Physician Decision|1|||
13446266|NCT00303602|26930449|FG000|Overall Study|Noncompliance|2|||
13446267|NCT00303602|26930450|FG001|Overall Study|Noncompliance|2|||
13446268|NCT00303602|26930449|FG000|Overall Study|Protocol Violation|1|||
13446269|NCT00303602|26930450|FG001|Overall Study|Protocol Violation|0|||
13446270|NCT00303485|26930481|FG000|Overall Study|Adverse Event/Intercurrent Illness|0|||
13446271|NCT00303485|26930482|FG001|Overall Study|Adverse Event/Intercurrent Illness|1|||
13446272|NCT00303485|26930481|FG000|Overall Study|Failure to return|0|||
13446273|NCT00303485|26930482|FG001|Overall Study|Failure to return|1|||
13446274|NCT00303485|26930481|FG000|Overall Study|Withdrawal by Subject|1|||
13446275|NCT00303485|26930482|FG001|Overall Study|Withdrawal by Subject|0|||
13446276|NCT00303472|26930562|FG000|Treatment Period|Adverse Event|0|||
13446277|NCT00303472|26930563|FG001|Treatment Period|Adverse Event|0|||
13446278|NCT00303472|26930564|FG002|Treatment Period|Adverse Event|0|||
13446279|NCT00303472|26930565|FG003|Treatment Period|Adverse Event|0|||
13446280|NCT00303472|26930566|FG004|Treatment Period|Adverse Event|1|||
13446281|NCT00303472|26930567|FG005|Treatment Period|Adverse Event|0|||
13446282|NCT00303472|26930568|FG006|Treatment Period|Adverse Event|0|||
13446283|NCT00303472|26930562|FG000|Treatment Period|Death|0|||
13446284|NCT00303472|26930563|FG001|Treatment Period|Death|0|||
13446285|NCT00303472|26930564|FG002|Treatment Period|Death|0|||
13446286|NCT00303472|26930565|FG003|Treatment Period|Death|1|||
13446287|NCT00303472|26930566|FG004|Treatment Period|Death|0|||
13446288|NCT00303472|26930567|FG005|Treatment Period|Death|0|||
13446289|NCT00303472|26930568|FG006|Treatment Period|Death|1|||
13446290|NCT00303472|26930562|FG000|Treatment Period|Withdrawal by Subject|0|||
13446291|NCT00303472|26930563|FG001|Treatment Period|Withdrawal by Subject|0|||
13446292|NCT00303472|26930564|FG002|Treatment Period|Withdrawal by Subject|0|||
13446293|NCT00303472|26930565|FG003|Treatment Period|Withdrawal by Subject|1|||
13446294|NCT00303472|26930566|FG004|Treatment Period|Withdrawal by Subject|0|||
13446295|NCT00303472|26930567|FG005|Treatment Period|Withdrawal by Subject|1|||
13446296|NCT00303472|26930568|FG006|Treatment Period|Withdrawal by Subject|0|||
13446297|NCT00303472|26930562|FG000|Treatment Period|Other|0|||
13446298|NCT00303472|26930563|FG001|Treatment Period|Other|0|||
13446299|NCT00303472|26930564|FG002|Treatment Period|Other|0|||
13446300|NCT00303472|26930565|FG003|Treatment Period|Other|0|||
13446301|NCT00303472|26930566|FG004|Treatment Period|Other|1|||
13446302|NCT00303472|26930567|FG005|Treatment Period|Other|0|||
13446303|NCT00303472|26930568|FG006|Treatment Period|Other|1|||
13446304|NCT00303472|26930562|FG000|Treatment Period|Disease Progression (to AML)|0|||
13446305|NCT00303472|26930563|FG001|Treatment Period|Disease Progression (to AML)|0|||
13446306|NCT00303472|26930564|FG002|Treatment Period|Disease Progression (to AML)|0|||
13446307|NCT00303472|26930565|FG003|Treatment Period|Disease Progression (to AML)|0|||
13446308|NCT00303472|26930566|FG004|Treatment Period|Disease Progression (to AML)|1|||
13446309|NCT00303472|26930567|FG005|Treatment Period|Disease Progression (to AML)|0|||
13446310|NCT00303472|26930568|FG006|Treatment Period|Disease Progression (to AML)|0|||
13446311|NCT00303472|26930562|FG000|Treatment Extension (Optional)|Adverse Event|1|||
13446312|NCT00303472|26930563|FG001|Treatment Extension (Optional)|Adverse Event|0|||
13446313|NCT00303472|26930564|FG002|Treatment Extension (Optional)|Adverse Event|1|||
13446314|NCT00303472|26930565|FG003|Treatment Extension (Optional)|Adverse Event|0|||
13446315|NCT00303472|26930566|FG004|Treatment Extension (Optional)|Adverse Event|0|||
13446316|NCT00303472|26930567|FG005|Treatment Extension (Optional)|Adverse Event|0|||
13446317|NCT00303472|26930568|FG006|Treatment Extension (Optional)|Adverse Event|0|||
13446318|NCT00303472|26930562|FG000|Treatment Extension (Optional)|Death|2|||
13446319|NCT00303472|26930563|FG001|Treatment Extension (Optional)|Death|0|||
13446320|NCT00303472|26930564|FG002|Treatment Extension (Optional)|Death|1|||
13446321|NCT00303472|26930565|FG003|Treatment Extension (Optional)|Death|0|||
13446322|NCT00303472|26930566|FG004|Treatment Extension (Optional)|Death|0|||
13446323|NCT00303472|26930567|FG005|Treatment Extension (Optional)|Death|0|||
13446324|NCT00303472|26930568|FG006|Treatment Extension (Optional)|Death|0|||
13446325|NCT00303472|26930562|FG000|Treatment Extension (Optional)|Lost to Follow-up|0|||
13446326|NCT00303472|26930563|FG001|Treatment Extension (Optional)|Lost to Follow-up|0|||
13446327|NCT00303472|26930564|FG002|Treatment Extension (Optional)|Lost to Follow-up|0|||
13446328|NCT00303472|26930565|FG003|Treatment Extension (Optional)|Lost to Follow-up|1|||
13446329|NCT00303472|26930566|FG004|Treatment Extension (Optional)|Lost to Follow-up|0|||
13446330|NCT00303472|26930567|FG005|Treatment Extension (Optional)|Lost to Follow-up|0|||
13446331|NCT00303472|26930568|FG006|Treatment Extension (Optional)|Lost to Follow-up|0|||
13390522|NCT00685750|26773930|FG005|Overall Study|Patient didn't receive the treatment|0|||
13390523|NCT00685750|26773931|FG006|Overall Study|Patient didn't receive the treatment|1|||
13390524|NCT00685750|26773925|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
13390525|NCT00685750|26773926|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
13390526|NCT00685750|26773927|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
13390527|NCT00685750|26773928|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
13446332|NCT00303472|26930562|FG000|Treatment Extension (Optional)|Physician Decision|0|||
13446333|NCT00303472|26930563|FG001|Treatment Extension (Optional)|Physician Decision|4|||
13446334|NCT00303472|26930564|FG002|Treatment Extension (Optional)|Physician Decision|2|||
13446335|NCT00303472|26930565|FG003|Treatment Extension (Optional)|Physician Decision|3|||
13446336|NCT00303472|26930566|FG004|Treatment Extension (Optional)|Physician Decision|2|||
13446337|NCT00303472|26930567|FG005|Treatment Extension (Optional)|Physician Decision|0|||
13446338|NCT00303472|26930568|FG006|Treatment Extension (Optional)|Physician Decision|0|||
13446339|NCT00303472|26930562|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1|||
13446340|NCT00303472|26930563|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0|||
13446341|NCT00303472|26930564|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1|||
13446342|NCT00303472|26930565|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2|||
13446343|NCT00303472|26930566|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1|||
13446344|NCT00303472|26930567|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0|||
13446345|NCT00303472|26930568|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0|||
13446346|NCT00303472|26930562|FG000|Treatment Extension (Optional)|Other|0|||
13446347|NCT00303472|26930563|FG001|Treatment Extension (Optional)|Other|2|||
13446348|NCT00303472|26930564|FG002|Treatment Extension (Optional)|Other|4|||
13446349|NCT00303472|26930565|FG003|Treatment Extension (Optional)|Other|2|||
13446350|NCT00303472|26930566|FG004|Treatment Extension (Optional)|Other|1|||
13446351|NCT00303472|26930567|FG005|Treatment Extension (Optional)|Other|0|||
13446352|NCT00303472|26930568|FG006|Treatment Extension (Optional)|Other|0|||
13446353|NCT00303472|26930562|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
13446354|NCT00303472|26930563|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
13446355|NCT00303472|26930564|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
13446356|NCT00303472|26930565|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
13446357|NCT00303472|26930566|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
13446358|NCT00303472|26930567|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
13446359|NCT00303472|26930568|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
13390528|NCT00685750|26773929|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
13390529|NCT00685750|26773930|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
13390530|NCT00685750|26773931|FG006|Overall Study|Eligibility criteria not fulfilled|0|||
13446360|NCT00303459|26930599|FG000|Overall Study|Death|33|||
13446361|NCT00303459|26930600|FG001|Overall Study|Death|44|||
13446362|NCT00303459|26930599|FG000|Overall Study|Withdrawal of consent|32|||
13446363|NCT00303459|26930600|FG001|Overall Study|Withdrawal of consent|26|||
13446364|NCT00303459|26930599|FG000|Overall Study|Lost to Follow-up|5|||
13446365|NCT00303459|26930600|FG001|Overall Study|Lost to Follow-up|4|||
13446366|NCT00303459|26930599|FG000|Overall Study|Administrative reason|7|||
13446367|NCT00303459|26930600|FG001|Overall Study|Administrative reason|7|||
13446368|NCT00303459|26930599|FG000|Overall Study|Decision by the investigator|5|||
13446369|NCT00303459|26930600|FG001|Overall Study|Decision by the investigator|7|||
13446370|NCT00303459|26930599|FG000|Overall Study|Lung transplantation|1|||
13446371|NCT00303459|26930600|FG001|Overall Study|Lung transplantation|1|||
13446372|NCT00303446|26930641|FG000|Overall Study|Withdrawal by Subject|2|||
13446373|NCT00303446|26930642|FG001|Overall Study|Withdrawal by Subject|2|||
13446374|NCT00303446|26930641|FG000|Overall Study|Death|0|||
13446375|NCT00303446|26930642|FG001|Overall Study|Death|1|||
13446376|NCT00303446|26930641|FG000|Overall Study|Physician Decision|0|||
13446377|NCT00303446|26930642|FG001|Overall Study|Physician Decision|1|||
13446378|NCT00303329|26930661|FG000|Overall Study|Adverse Event|7|||
13446379|NCT00303329|26930662|FG001|Overall Study|Adverse Event|14|||
13446380|NCT00303329|26930661|FG000|Overall Study|Abnormal Laboratory Values|0|||
13446381|NCT00303329|26930662|FG001|Overall Study|Abnormal Laboratory Values|1|||
13446382|NCT00303329|26930661|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
13446383|NCT00303329|26930662|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
13446384|NCT00303329|26930661|FG000|Overall Study|Condition no longer requires study drug|0|||
13446385|NCT00303329|26930662|FG001|Overall Study|Condition no longer requires study drug|8|||
13446386|NCT00303329|26930661|FG000|Overall Study|Protocol Violation|3|||
13446387|NCT00303329|26930662|FG001|Overall Study|Protocol Violation|0|||
13446388|NCT00303329|26930661|FG000|Overall Study|Withdrawal by Subject|9|||
13446389|NCT00303329|26930662|FG001|Overall Study|Withdrawal by Subject|15|||
13446390|NCT00303329|26930661|FG000|Overall Study|Lost to Follow-up|0|||
13446391|NCT00303329|26930662|FG001|Overall Study|Lost to Follow-up|1|||
13446392|NCT00303329|26930661|FG000|Overall Study|Administrative problems|1|||
13446393|NCT00303329|26930662|FG001|Overall Study|Administrative problems|0|||
13446394|NCT00303329|26930661|FG000|Overall Study|Death|2|||
13446395|NCT00303329|26930662|FG001|Overall Study|Death|12|||
13446396|NCT00303329|26930661|FG000|Overall Study|Stopped at end of core|3|||
13446397|NCT00303329|26930662|FG001|Overall Study|Stopped at end of core|9|||
13446398|NCT00303329|26930661|FG000|Overall Study|Stopped at end of extension 1|1|||
13446399|NCT00303329|26930662|FG001|Overall Study|Stopped at end of extension 1|0|||
13446400|NCT00303316|26930681|FG000|Overall Study|Protocol Violation|1|||
13446401|NCT00303316|26930682|FG001|Overall Study|Protocol Violation|0|||
13446402|NCT00303316|26930681|FG000|Overall Study|Lost to Follow-up|0|||
13446403|NCT00303316|26930682|FG001|Overall Study|Lost to Follow-up|1|||
13446404|NCT00303316|26930681|FG000|Overall Study|Withdrawal by Subject|1|||
13446405|NCT00303316|26930682|FG001|Overall Study|Withdrawal by Subject|2|||
13446406|NCT00303186|26930715|FG000|Overall Study|Other|52|||
13446407|NCT00303108|26930741|FG000|Overall Study|Adverse Event|5|||
13446408|NCT00303108|26930742|FG001|Overall Study|Adverse Event|6|||
13446409|NCT00303108|26930743|FG002|Overall Study|Adverse Event|7|||
13446410|NCT00303108|26930741|FG000|Overall Study|Patient Request|4|||
13446411|NCT00303108|26930742|FG001|Overall Study|Patient Request|2|||
13446412|NCT00303108|26930743|FG002|Overall Study|Patient Request|8|||
13446413|NCT00303108|26930741|FG000|Overall Study|Failed Entry|1|||
13446414|NCT00303108|26930742|FG001|Overall Study|Failed Entry|0|||
13446415|NCT00303108|26930743|FG002|Overall Study|Failed Entry|1|||
13446416|NCT00303108|26930741|FG000|Overall Study|ineligible|2|||
13446417|NCT00303108|26930742|FG001|Overall Study|ineligible|1|||
13446418|NCT00303108|26930743|FG002|Overall Study|ineligible|0|||
13446419|NCT00303069|26930774|FG000|Overall Study|Lost to Follow-up|1|||
13446420|NCT00303069|26930775|FG001|Overall Study|Lost to Follow-up|0|||
13446421|NCT00303069|26930776|FG002|Overall Study|Lost to Follow-up|0|||
13446422|NCT00303069|26930777|FG003|Overall Study|Lost to Follow-up|2|||
13446423|NCT00303069|26930774|FG000|Overall Study|subject moved|1|||
13446424|NCT00303069|26930775|FG001|Overall Study|subject moved|0|||
13446425|NCT00303069|26930776|FG002|Overall Study|subject moved|0|||
13446426|NCT00303069|26930777|FG003|Overall Study|subject moved|0|||
13446427|NCT00303069|26930774|FG000|Overall Study|Recruitment into Army Reserves|0|||
13446428|NCT00303069|26930775|FG001|Overall Study|Recruitment into Army Reserves|0|||
13446429|NCT00303069|26930776|FG002|Overall Study|Recruitment into Army Reserves|1|||
13446430|NCT00303069|26930777|FG003|Overall Study|Recruitment into Army Reserves|0|||
13446431|NCT00302952|26930818|FG000|Overall Study|Physician Decision|1|||
13446432|NCT00302952|26930819|FG001|Overall Study|Physician Decision|1|||
13446433|NCT00302952|26930818|FG000|Overall Study|Withdrawal by Subject|2|||
13446434|NCT00302952|26930819|FG001|Overall Study|Withdrawal by Subject|3|||
13446435|NCT00302952|26930818|FG000|Overall Study|Elevated SGOT (AST) lab value|0|||
13446436|NCT00302952|26930819|FG001|Overall Study|Elevated SGOT (AST) lab value|1|||
13446437|NCT00302731|26930854|FG000|Overall Study|Lost to Follow-up|1|||
13446438|NCT00302731|26930855|FG001|Overall Study|Lost to Follow-up|2|||
13446439|NCT00302731|26930856|FG002|Overall Study|Lost to Follow-up|0|||
13446440|NCT00302731|26930857|FG003|Overall Study|Lost to Follow-up|0|||
13446441|NCT00302731|26930854|FG000|Overall Study|Adverse Event|0|||
13446442|NCT00302731|26930855|FG001|Overall Study|Adverse Event|2|||
13446443|NCT00302731|26930856|FG002|Overall Study|Adverse Event|2|||
13446444|NCT00302731|26930857|FG003|Overall Study|Adverse Event|0|||
13446445|NCT00302731|26930854|FG000|Overall Study|Withdrawal by Subject|1|||
13446446|NCT00302731|26930855|FG001|Overall Study|Withdrawal by Subject|1|||
13446447|NCT00302731|26930856|FG002|Overall Study|Withdrawal by Subject|0|||
13446448|NCT00302731|26930857|FG003|Overall Study|Withdrawal by Subject|0|||
13446449|NCT00302731|26930854|FG000|Overall Study|Protocol Violation|1|||
13446450|NCT00302731|26930855|FG001|Overall Study|Protocol Violation|0|||
13446451|NCT00302731|26930856|FG002|Overall Study|Protocol Violation|0|||
13446452|NCT00302731|26930857|FG003|Overall Study|Protocol Violation|0|||
13446453|NCT00302731|26930854|FG000|Overall Study|cancer unrelated to study discovered|1|||
13446454|NCT00302731|26930855|FG001|Overall Study|cancer unrelated to study discovered|0|||
13446455|NCT00302731|26930856|FG002|Overall Study|cancer unrelated to study discovered|1|||
13446456|NCT00302731|26930857|FG003|Overall Study|cancer unrelated to study discovered|0|||
13446457|NCT00302718|26930936|FG000|Overall Study|Participant left the hospital|1|||
13446458|NCT00302718|26930937|FG001|Overall Study|Participant left the hospital|0|||
13446459|NCT00302718|26930938|FG002|Overall Study|Participant left the hospital|0|||
13446460|NCT00302718|26930939|FG003|Overall Study|Participant left the hospital|1|||
13446461|NCT00302718|26930936|FG000|Overall Study|Withdrawal by Subject|0|||
13446462|NCT00302718|26930937|FG001|Overall Study|Withdrawal by Subject|1|||
13446463|NCT00302718|26930938|FG002|Overall Study|Withdrawal by Subject|0|||
13446464|NCT00302718|26930939|FG003|Overall Study|Withdrawal by Subject|0|||
13446465|NCT00302718|26930936|FG000|Overall Study|Participant left primary care setting|0|||
13446466|NCT00302718|26930937|FG001|Overall Study|Participant left primary care setting|0|||
13446467|NCT00302718|26930938|FG002|Overall Study|Participant left primary care setting|2|||
13446468|NCT00302718|26930939|FG003|Overall Study|Participant left primary care setting|1|||
13446469|NCT00302458|26930949|FG000|Overall Study|Lost to Follow-up|1|||
13446470|NCT00302458|26930949|FG000|Overall Study|Ineligible after screening|1|||
13446471|NCT00302458|26930949|FG000|Overall Study|Withdrawal by Subject|1|||
13446472|NCT00302328|26930973|FG000|Overall Study|Physician Decision|0|||
13446473|NCT00302328|26930974|FG001|Overall Study|Physician Decision|1|||
13446474|NCT00302328|26930975|FG002|Overall Study|Physician Decision|0|||
13446475|NCT00302211|26931013|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2|||
13446476|NCT00302211|26931014|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1|||
13446477|NCT00302211|26931015|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
13446478|NCT00302211|26931016|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
13446479|NCT00302211|26931017|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
13446480|NCT00302211|26931013|FG000|Double Blind Period (New Patients)|Adverse Event|0|||
13446481|NCT00302211|26931014|FG001|Double Blind Period (New Patients)|Adverse Event|0|||
13446482|NCT00302211|26931015|FG002|Double Blind Period (New Patients)|Adverse Event|3|||
13446483|NCT00302211|26931016|FG003|Double Blind Period (New Patients)|Adverse Event|0|||
13446484|NCT00302211|26931017|FG004|Double Blind Period (New Patients)|Adverse Event|0|||
13446485|NCT00302211|26931013|FG000|Double Blind Period (New Patients)|Investigator's judgement|1|||
13446486|NCT00302211|26931014|FG001|Double Blind Period (New Patients)|Investigator's judgement|0|||
13446487|NCT00302211|26931015|FG002|Double Blind Period (New Patients)|Investigator's judgement|0|||
13446488|NCT00302211|26931016|FG003|Double Blind Period (New Patients)|Investigator's judgement|0|||
13446489|NCT00302211|26931017|FG004|Double Blind Period (New Patients)|Investigator's judgement|0|||
13446490|NCT00302211|26931013|FG000|Double Blind Period (New Patients)|Disease progression|0|||
13446491|NCT00302211|26931014|FG001|Double Blind Period (New Patients)|Disease progression|1|||
13446492|NCT00302211|26931015|FG002|Double Blind Period (New Patients)|Disease progression|1|||
13446493|NCT00302211|26931016|FG003|Double Blind Period (New Patients)|Disease progression|0|||
13446494|NCT00302211|26931017|FG004|Double Blind Period (New Patients)|Disease progression|0|||
13446495|NCT00302211|26931013|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
13446496|NCT00302211|26931014|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
13446497|NCT00302211|26931015|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
13446498|NCT00302211|26931016|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
13446499|NCT00302211|26931017|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
13446500|NCT00302211|26931013|FG000|Open Label-Patients From Double-Blind|Adverse Event|0|||
13446501|NCT00302211|26931014|FG001|Open Label-Patients From Double-Blind|Adverse Event|0|||
13446502|NCT00302211|26931015|FG002|Open Label-Patients From Double-Blind|Adverse Event|0|||
13446503|NCT00302211|26931016|FG003|Open Label-Patients From Double-Blind|Adverse Event|1|||
13446504|NCT00302211|26931017|FG004|Open Label-Patients From Double-Blind|Adverse Event|0|||
13446505|NCT00302211|26931013|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
13446506|NCT00302211|26931014|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
13477265|NCT01545050|27005967|FG000|Overall Study|Lack of Efficacy|0|||
13446507|NCT00302211|26931015|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
13446508|NCT00302211|26931016|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1|||
13446509|NCT00302211|26931017|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
13446510|NCT00302211|26931013|FG000|Open Label-Patients From Double-Blind|Disease progression|0|||
13446511|NCT00302211|26931014|FG001|Open Label-Patients From Double-Blind|Disease progression|0|||
13446512|NCT00302211|26931015|FG002|Open Label-Patients From Double-Blind|Disease progression|0|||
13446513|NCT00302211|26931016|FG003|Open Label-Patients From Double-Blind|Disease progression|1|||
13446514|NCT00302211|26931017|FG004|Open Label-Patients From Double-Blind|Disease progression|2|||
13446515|NCT00302211|26931013|FG000|Open Label-Patients From Double-Blind|Death|0|||
13446516|NCT00302211|26931014|FG001|Open Label-Patients From Double-Blind|Death|0|||
13446517|NCT00302211|26931015|FG002|Open Label-Patients From Double-Blind|Death|0|||
13446518|NCT00302211|26931016|FG003|Open Label-Patients From Double-Blind|Death|1|||
13446519|NCT00302211|26931017|FG004|Open Label-Patients From Double-Blind|Death|1|||
13446520|NCT00302211|26931013|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
13446521|NCT00302211|26931014|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
13446522|NCT00302211|26931015|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
13446523|NCT00302211|26931016|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
13446524|NCT00302211|26931017|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1|||
13446525|NCT00302211|26931013|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
13446526|NCT00302211|26931014|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
13446527|NCT00302211|26931015|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
13446528|NCT00302211|26931016|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
13446529|NCT00302211|26931017|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1|||
13446530|NCT00302211|26931013|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
13446531|NCT00302211|26931014|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
13446532|NCT00302211|26931015|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
13446533|NCT00302211|26931016|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1|||
13446534|NCT00302211|26931017|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
13446535|NCT00302159|26931028|FG000|Overall Study|pt declined before treatment started|1|||
13446536|NCT00302159|26931028|FG000|Overall Study|pt started Avastin|1|||
13446537|NCT00302107|26931041|FG000|Overall Study|Lost to Follow-up|6|||
13446538|NCT00302107|26931042|FG001|Overall Study|Lost to Follow-up|5|||
13446539|NCT00302107|26931041|FG000|Overall Study|Protocol Violation|1|||
13446540|NCT00302107|26931042|FG001|Overall Study|Protocol Violation|0|||
13446541|NCT00302107|26931041|FG000|Overall Study|Relocation|0|||
13446542|NCT00302107|26931042|FG001|Overall Study|Relocation|1|||
13446543|NCT00302107|26931041|FG000|Overall Study|Withdrawal by Subject|0|||
13446544|NCT00302107|26931042|FG001|Overall Study|Withdrawal by Subject|3|||
13446545|NCT00302107|26931041|FG000|Overall Study|Adverse Event|1|||
13446546|NCT00302107|26931042|FG001|Overall Study|Adverse Event|0|||
13446547|NCT00302081|26931060|FG000|Overall Study|Adverse Event|6|||
13446548|NCT00302081|26931061|FG001|Overall Study|Adverse Event|5|||
13446549|NCT00302081|26931062|FG002|Overall Study|Adverse Event|4|||
13446550|NCT00302081|26931060|FG000|Overall Study|Lost to Follow-up|21|||
13446551|NCT00302081|26931061|FG001|Overall Study|Lost to Follow-up|18|||
13446552|NCT00302081|26931062|FG002|Overall Study|Lost to Follow-up|28|||
13446553|NCT00302081|26931060|FG000|Overall Study|Withdrawal by Subject|8|||
13446554|NCT00302081|26931061|FG001|Overall Study|Withdrawal by Subject|12|||
13446555|NCT00302081|26931062|FG002|Overall Study|Withdrawal by Subject|8|||
13446556|NCT00302081|26931060|FG000|Overall Study|Protocol Violation|5|||
13446557|NCT00302081|26931061|FG001|Overall Study|Protocol Violation|1|||
13446558|NCT00302081|26931062|FG002|Overall Study|Protocol Violation|2|||
13446559|NCT00302081|26931060|FG000|Overall Study|Lack of Efficacy|1|||
13446560|NCT00302081|26931061|FG001|Overall Study|Lack of Efficacy|0|||
13446561|NCT00302081|26931062|FG002|Overall Study|Lack of Efficacy|5|||
13446562|NCT00302081|26931060|FG000|Overall Study|Death|2|||
13446563|NCT00302081|26931061|FG001|Overall Study|Death|1|||
13446564|NCT00302081|26931062|FG002|Overall Study|Death|0|||
13446565|NCT00302081|26931060|FG000|Overall Study|Other|13|||
13446566|NCT00302081|26931061|FG001|Overall Study|Other|6|||
13446567|NCT00302081|26931062|FG002|Overall Study|Other|5|||
13446568|NCT00302003|26931071|FG000|Overall Study|Lack of Efficacy|62|||
13446569|NCT00302003|26931071|FG000|Overall Study|Lost to Follow-up|1|||
13446570|NCT00302003|26931071|FG000|Overall Study|Physician Decision|2|||
13446571|NCT00302003|26931071|FG000|Overall Study|Withdrawal by Subject|5|||
13446572|NCT00302003|26931071|FG000|Overall Study|Ineligible|9|||
13446573|NCT00302003|26931071|FG000|Overall Study|Protocol Violation|1|||
13446574|NCT00301964|26931088|FG000|Overall Study|Second primary|2|||
13446575|NCT00301964|26931088|FG000|Overall Study|Wrong primary|1|||
13446576|NCT00301964|26931088|FG000|Overall Study|Inadequate pathology|1|||
13446577|NCT00301834|26931099|FG000|Overall Study|Death|1|||
13446578|NCT00301821|26931108|FG000|Overall Study|Ineligible|25|||
13446579|NCT00301821|26931108|FG000|Overall Study|Cancel|1|||
13446580|NCT00301808|26931117|FG000|Overall Study|Adverse Event|5|||
13446581|NCT00301808|26931117|FG000|Overall Study|Death|3|||
13446582|NCT00301808|26931117|FG000|Overall Study|Lack of Efficacy|4|||
13446583|NCT00301366|26931123|FG000|Overall Study|Adverse Event|1|||
13446584|NCT00301080|26931158|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1|||
13446585|NCT00301080|26931159|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
13446586|NCT00301080|26931160|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
13446587|NCT00301080|26931161|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
13446588|NCT00301080|26931162|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
13446589|NCT00301067|26931186|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1|||
13446590|NCT00301067|26931187|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0|||
13446591|NCT00301067|26931188|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0|||
13446592|NCT00301067|26931189|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1|||
13446593|NCT00301067|26931186|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2|||
13446594|NCT00301067|26931187|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1|||
13446595|NCT00301067|26931188|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1|||
13446596|NCT00301067|26931189|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2|||
13446597|NCT00301067|26931186|FG000|Completed 4 Cycles of Treatment|Progressive disease|1|||
13446598|NCT00301067|26931187|FG001|Completed 4 Cycles of Treatment|Progressive disease|1|||
13446599|NCT00301067|26931188|FG002|Completed 4 Cycles of Treatment|Progressive disease|2|||
13446600|NCT00301067|26931189|FG003|Completed 4 Cycles of Treatment|Progressive disease|5|||
13446601|NCT00301067|26931186|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0|||
13446602|NCT00301067|26931187|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1|||
13446603|NCT00301067|26931188|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0|||
13446604|NCT00301067|26931189|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1|||
13446605|NCT00301067|26931186|FG000|Completed 12 Cycles of Treatment|Adverse Event|0|||
13446606|NCT00301067|26931187|FG001|Completed 12 Cycles of Treatment|Adverse Event|0|||
13446607|NCT00301067|26931188|FG002|Completed 12 Cycles of Treatment|Adverse Event|0|||
13446608|NCT00301067|26931189|FG003|Completed 12 Cycles of Treatment|Adverse Event|1|||
13446609|NCT00301067|26931186|FG000|Follow up Until Death|Alive at last data cut point|1|||
13446610|NCT00301067|26931187|FG001|Follow up Until Death|Alive at last data cut point|0|||
13446611|NCT00301067|26931188|FG002|Follow up Until Death|Alive at last data cut point|0|||
13446612|NCT00301067|26931189|FG003|Follow up Until Death|Alive at last data cut point|1|||
13446613|NCT00300885|26931212|FG000|Treatment|Adverse Event|134|||
13446614|NCT00300885|26931213|FG001|Treatment|Adverse Event|82|||
13446615|NCT00300885|26931212|FG000|Treatment|Death|20|||
13446616|NCT00300885|26931213|FG001|Treatment|Death|7|||
13446617|NCT00300885|26931212|FG000|Treatment|Lack of Efficacy|1|||
13446618|NCT00300885|26931213|FG001|Treatment|Lack of Efficacy|1|||
13446619|NCT00300885|26931212|FG000|Treatment|Lost to Follow-up|3|||
13446620|NCT00300885|26931213|FG001|Treatment|Lost to Follow-up|2|||
13446621|NCT00300885|26931212|FG000|Treatment|Physician Decision|4|||
13446622|NCT00300885|26931213|FG001|Treatment|Physician Decision|5|||
13446623|NCT00300885|26931212|FG000|Treatment|Protocol Violation|11|||
13446624|NCT00300885|26931213|FG001|Treatment|Protocol Violation|11|||
13446625|NCT00300885|26931212|FG000|Treatment|Withdrawal by Subject|26|||
13446626|NCT00300885|26931213|FG001|Treatment|Withdrawal by Subject|23|||
13446627|NCT00300885|26931212|FG000|Treatment|Disease progression|171|||
13446628|NCT00300885|26931213|FG001|Treatment|Disease progression|238|||
13446629|NCT00300885|26931212|FG000|Treatment|Random code broken (subject died)|0|||
13446630|NCT00300885|26931213|FG001|Treatment|Random code broken (subject died)|1|||
13446631|NCT00300885|26931212|FG000|Treatment|Non-compliant with study medication|3|||
13446632|NCT00300885|26931213|FG001|Treatment|Non-compliant with study medication|4|||
13446633|NCT00300885|26931212|FG000|Follow-up|Death|141|||
13446634|NCT00300885|26931213|FG001|Follow-up|Death|163|||
13446635|NCT00300885|26931212|FG000|Follow-up|Lost to Follow-up|11|||
13446636|NCT00300885|26931213|FG001|Follow-up|Lost to Follow-up|7|||
13446637|NCT00300885|26931212|FG000|Follow-up|Withdrawal by Subject|26|||
13446638|NCT00300885|26931213|FG001|Follow-up|Withdrawal by Subject|25|||
13446639|NCT00300781|26931232|FG000|Overall Study|Disease Progression|55|||
13446640|NCT00300781|26931233|FG001|Overall Study|Disease Progression|52|||
13446641|NCT00300781|26931232|FG000|Overall Study|Adverse Event|5|||
13446642|NCT00300781|26931233|FG001|Overall Study|Adverse Event|6|||
13446643|NCT00300781|26931232|FG000|Overall Study|Withdrawal by Subject|1|||
13446644|NCT00300781|26931233|FG001|Overall Study|Withdrawal by Subject|2|||
13446645|NCT00300781|26931232|FG000|Overall Study|Physician Decision|1|||
13446646|NCT00300781|26931233|FG001|Overall Study|Physician Decision|0|||
13446647|NCT00300781|26931232|FG000|Overall Study|Not Recorded|0|||
13446648|NCT00300781|26931233|FG001|Overall Study|Not Recorded|1|||
13446649|NCT00300781|26931232|FG000|Overall Study|Symptomatic Deterioration|1|||
13446650|NCT00300781|26931233|FG001|Overall Study|Symptomatic Deterioration|0|||
13446651|NCT00300781|26931232|FG000|Overall Study|Lost to Follow-up|0|||
13446652|NCT00300781|26931233|FG001|Overall Study|Lost to Follow-up|1|||
13446653|NCT00300755|26931260|FG000|Overall Study|Adverse Event|1|||
13446654|NCT00300755|26931261|FG001|Overall Study|Adverse Event|2|||
13446655|NCT00300755|26931262|FG002|Overall Study|Adverse Event|1|||
13446656|NCT00300755|26931260|FG000|Overall Study|Withdrawal by Subject|0|||
13446657|NCT00300755|26931261|FG001|Overall Study|Withdrawal by Subject|2|||
13446658|NCT00300755|26931262|FG002|Overall Study|Withdrawal by Subject|0|||
13446659|NCT00300755|26931260|FG000|Overall Study|Protocol Violation|0|||
13446660|NCT00300755|26931261|FG001|Overall Study|Protocol Violation|0|||
13446661|NCT00300755|26931262|FG002|Overall Study|Protocol Violation|1|||
13446662|NCT00300495|26931277|FG000|Overall Study|Protocol Violation|4|||
13446663|NCT00300495|26931278|FG001|Overall Study|Protocol Violation|1|||
13446664|NCT00300365|26931291|FG000|Overall Study|Lost to Follow-up|1|||
13446665|NCT00300365|26931292|FG001|Overall Study|Lost to Follow-up|0|||
13446666|NCT00300365|26931291|FG000|Overall Study|Physician Decision|2|||
13446667|NCT00300365|26931292|FG001|Overall Study|Physician Decision|0|||
13446668|NCT00300365|26931291|FG000|Overall Study|Withdrawal by Subject|1|||
13446669|NCT00300365|26931292|FG001|Overall Study|Withdrawal by Subject|0|||
13446670|NCT00300365|26931291|FG000|Overall Study|Adverse Event|0|||
13446671|NCT00300365|26931292|FG001|Overall Study|Adverse Event|2|||
13446672|NCT00300274|26931337|FG000|Overall Study|Withdrawal by Subject|12|||
13446673|NCT00300274|26931338|FG001|Overall Study|Withdrawal by Subject|3|||
13446674|NCT00300274|26931339|FG002|Overall Study|Withdrawal by Subject|14|||
13446675|NCT00300274|26931337|FG000|Overall Study|Lost to Follow-up|3|||
13446676|NCT00300274|26931338|FG001|Overall Study|Lost to Follow-up|4|||
13446677|NCT00300274|26931339|FG002|Overall Study|Lost to Follow-up|5|||
13446678|NCT00300274|26931337|FG000|Overall Study|Death|31|||
13446679|NCT00300274|26931338|FG001|Overall Study|Death|20|||
13446680|NCT00300274|26931339|FG002|Overall Study|Death|25|||
13446681|NCT00300274|26931337|FG000|Overall Study|Re-transplant|0|||
13446682|NCT00300274|26931338|FG001|Overall Study|Re-transplant|0|||
13446683|NCT00300274|26931339|FG002|Overall Study|Re-transplant|1|||
13446684|NCT00300053|26931373|FG000|Overall Study|Patient/Caregiver Preference|2|||
13446685|NCT00300053|26931374|FG001|Overall Study|Patient/Caregiver Preference|2|||
13446686|NCT00300053|26931375|FG002|Overall Study|Patient/Caregiver Preference|3|||
13446687|NCT00300053|26931373|FG000|Overall Study|Death|0|||
13446688|NCT00300053|26931374|FG001|Overall Study|Death|0|||
13446689|NCT00300053|26931375|FG002|Overall Study|Death|3|||
13446690|NCT00300053|26931373|FG000|Overall Study|Lost to Follow-up|0|||
13446691|NCT00300053|26931374|FG001|Overall Study|Lost to Follow-up|1|||
13446692|NCT00300053|26931375|FG002|Overall Study|Lost to Follow-up|0|||
13446693|NCT00299975|26931435|FG000|Overall Study|Adverse Event|1|||
13446694|NCT00299975|26931436|FG001|Overall Study|Adverse Event|0|||
13446695|NCT00299975|26931437|FG002|Overall Study|Adverse Event|2|||
13446696|NCT00299975|26931435|FG000|Overall Study|Pregnancy|0|||
13446697|NCT00299975|26931436|FG001|Overall Study|Pregnancy|0|||
13446698|NCT00299975|26931437|FG002|Overall Study|Pregnancy|1|||
13446699|NCT00299975|26931435|FG000|Overall Study|Lack of Efficacy|1|||
13446700|NCT00299975|26931436|FG001|Overall Study|Lack of Efficacy|0|||
13446701|NCT00299975|26931437|FG002|Overall Study|Lack of Efficacy|1|||
13446702|NCT00299975|26931435|FG000|Overall Study|Lost to Follow-up|1|||
13446703|NCT00299975|26931436|FG001|Overall Study|Lost to Follow-up|0|||
13446704|NCT00299975|26931437|FG002|Overall Study|Lost to Follow-up|0|||
13446705|NCT00299975|26931435|FG000|Overall Study|Withdrawal by Subject|0|||
13446706|NCT00299975|26931436|FG001|Overall Study|Withdrawal by Subject|1|||
13446707|NCT00299975|26931437|FG002|Overall Study|Withdrawal by Subject|3|||
13446708|NCT00299975|26931435|FG000|Overall Study|Physician Decision|0|||
13446709|NCT00299975|26931436|FG001|Overall Study|Physician Decision|0|||
13446710|NCT00299975|26931437|FG002|Overall Study|Physician Decision|1|||
13446711|NCT00299728|26931458|FG000|Overall Study|Lost to Follow-up|0|||
13446712|NCT00299728|26931459|FG001|Overall Study|Lost to Follow-up|1|||
13446713|NCT00299728|26931458|FG000|Overall Study|Withdrawal by Subject|0|||
13446714|NCT00299728|26931459|FG001|Overall Study|Withdrawal by Subject|1|||
13446715|NCT00299728|26931458|FG000|Overall Study|Progressive disease|0|||
13446716|NCT00299728|26931459|FG001|Overall Study|Progressive disease|1|||
13446717|NCT00299702|26931474|FG000|Overall Study|Death|1|||
13446718|NCT00299702|26931475|FG001|Overall Study|Death|0|||
13446719|NCT00299702|26931474|FG000|Overall Study|Adverse Event|0|||
13446720|NCT00299702|26931475|FG001|Overall Study|Adverse Event|4|||
13446721|NCT00299702|26931474|FG000|Overall Study|Lost to Follow-up|18|||
13446722|NCT00299702|26931475|FG001|Overall Study|Lost to Follow-up|10|||
13446723|NCT00299702|26931474|FG000|Overall Study|Withdrawal by Subject|25|||
13446724|NCT00299702|26931475|FG001|Overall Study|Withdrawal by Subject|23|||
13446725|NCT00299702|26931474|FG000|Overall Study|Pregnancy|0|||
13446726|NCT00299702|26931475|FG001|Overall Study|Pregnancy|1|||
13446727|NCT00299702|26931474|FG000|Overall Study|Insufficient Response|4|||
13446728|NCT00299702|26931475|FG001|Overall Study|Insufficient Response|3|||
13446729|NCT00299702|26931474|FG000|Overall Study|Admin issues, sponsor decision, etc.|5|||
13446730|NCT00299702|26931475|FG001|Overall Study|Admin issues, sponsor decision, etc.|9|||
13446731|NCT00299546|26931510|FG000|Overall Study|Death|3|||
13446732|NCT00299546|26931511|FG001|Overall Study|Death|2|||
13446733|NCT00299546|26931512|FG002|Overall Study|Death|0|||
13446734|NCT00299546|26931510|FG000|Overall Study|Lost to Follow-up|2|||
13446735|NCT00299546|26931511|FG001|Overall Study|Lost to Follow-up|2|||
13446736|NCT00299546|26931512|FG002|Overall Study|Lost to Follow-up|5|||
13446737|NCT00299546|26931510|FG000|Overall Study|Adverse Event|37|||
13446738|NCT00299546|26931511|FG001|Overall Study|Adverse Event|22|||
13446739|NCT00299546|26931512|FG002|Overall Study|Adverse Event|27|||
13446740|NCT00299546|26931510|FG000|Overall Study|Unsatisfactory therapeutic effect|34|||
13446741|NCT00299546|26931511|FG001|Overall Study|Unsatisfactory therapeutic effect|39|||
13446742|NCT00299546|26931512|FG002|Overall Study|Unsatisfactory therapeutic effect|34|||
13446743|NCT00299546|26931510|FG000|Overall Study|Other|24|||
13446744|NCT00299546|26931511|FG001|Overall Study|Other|26|||
13446745|NCT00299546|26931512|FG002|Overall Study|Other|19|||
13446746|NCT00299546|26931510|FG000|Overall Study|Not treated|0|||
13446747|NCT00299546|26931511|FG001|Overall Study|Not treated|1|||
13446748|NCT00299546|26931512|FG002|Overall Study|Not treated|1|||
13446749|NCT00299494|26931634|FG000|Overall Study|Withdrawal by Subject|0|||
13446750|NCT00299494|26931635|FG001|Overall Study|Withdrawal by Subject|0|||
13446751|NCT00299494|26931636|FG002|Overall Study|Withdrawal by Subject|0|||
13446752|NCT00299494|26931637|FG003|Overall Study|Withdrawal by Subject|3|||
13446753|NCT00299494|26931638|FG004|Overall Study|Withdrawal by Subject|1|||
13446754|NCT00299494|26931639|FG005|Overall Study|Withdrawal by Subject|4|||
13446755|NCT00299494|26931634|FG000|Overall Study|Physician Decision|0|||
13446756|NCT00299494|26931635|FG001|Overall Study|Physician Decision|0|||
13446757|NCT00299494|26931636|FG002|Overall Study|Physician Decision|0|||
13446758|NCT00299494|26931637|FG003|Overall Study|Physician Decision|0|||
13446759|NCT00299494|26931638|FG004|Overall Study|Physician Decision|1|||
13446760|NCT00299494|26931639|FG005|Overall Study|Physician Decision|0|||
13446761|NCT00299494|26931634|FG000|Overall Study|Death|3|||
13446762|NCT00299494|26931635|FG001|Overall Study|Death|1|||
13446763|NCT00299494|26931636|FG002|Overall Study|Death|4|||
13446764|NCT00299494|26931637|FG003|Overall Study|Death|6|||
13446765|NCT00299494|26931638|FG004|Overall Study|Death|18|||
13446766|NCT00299494|26931639|FG005|Overall Study|Death|19|||
13446767|NCT00299494|26931634|FG000|Overall Study|Lost to Follow-up|0|||
13446768|NCT00299494|26931635|FG001|Overall Study|Lost to Follow-up|0|||
13446769|NCT00299494|26931636|FG002|Overall Study|Lost to Follow-up|0|||
13446770|NCT00299494|26931637|FG003|Overall Study|Lost to Follow-up|0|||
13446771|NCT00299494|26931638|FG004|Overall Study|Lost to Follow-up|3|||
13446772|NCT00299494|26931639|FG005|Overall Study|Lost to Follow-up|1|||
13446773|NCT00299494|26931634|FG000|Overall Study|Other - Unspecified|0|||
13446774|NCT00299494|26931635|FG001|Overall Study|Other - Unspecified|0|||
13446775|NCT00299494|26931636|FG002|Overall Study|Other - Unspecified|0|||
13446776|NCT00299494|26931637|FG003|Overall Study|Other - Unspecified|0|||
13446777|NCT00299494|26931638|FG004|Overall Study|Other - Unspecified|3|||
13446778|NCT00299494|26931639|FG005|Overall Study|Other - Unspecified|1|||
13446779|NCT00299494|26931634|FG000|Overall Study|Other - site closure|0|||
13446780|NCT00299494|26931635|FG001|Overall Study|Other - site closure|0|||
13446781|NCT00299494|26931636|FG002|Overall Study|Other - site closure|0|||
13446782|NCT00299494|26931637|FG003|Overall Study|Other - site closure|1|||
13446783|NCT00299494|26931638|FG004|Overall Study|Other - site closure|1|||
13446784|NCT00299494|26931639|FG005|Overall Study|Other - site closure|1|||
13446785|NCT00299182|26931684|FG000|Overall Study|Withdrawal by Subject|0|||
13446786|NCT00299182|26931685|FG001|Overall Study|Withdrawal by Subject|0|||
13446787|NCT00299182|26931686|FG002|Overall Study|Withdrawal by Subject|1|||
13446788|NCT00299182|26931687|FG003|Overall Study|Withdrawal by Subject|0|||
13446789|NCT00299182|26931688|FG004|Overall Study|Withdrawal by Subject|1|||
13446790|NCT00299182|26931689|FG005|Overall Study|Withdrawal by Subject|2|||
13446791|NCT00299182|26931690|FG006|Overall Study|Withdrawal by Subject|0|||
13446792|NCT00299182|26931684|FG000|Overall Study|Chemotherapy Changed|0|||
13446793|NCT00299182|26931685|FG001|Overall Study|Chemotherapy Changed|0|||
13446794|NCT00299182|26931686|FG002|Overall Study|Chemotherapy Changed|1|||
13446795|NCT00299182|26931687|FG003|Overall Study|Chemotherapy Changed|0|||
13446796|NCT00299182|26931688|FG004|Overall Study|Chemotherapy Changed|1|||
13446797|NCT00299182|26931689|FG005|Overall Study|Chemotherapy Changed|0|||
13446798|NCT00299182|26931690|FG006|Overall Study|Chemotherapy Changed|1|||
13446799|NCT00299182|26931684|FG000|Overall Study|Adverse Event|0|||
13446800|NCT00299182|26931685|FG001|Overall Study|Adverse Event|0|||
13446801|NCT00299182|26931686|FG002|Overall Study|Adverse Event|0|||
13446802|NCT00299182|26931687|FG003|Overall Study|Adverse Event|0|||
13446803|NCT00299182|26931688|FG004|Overall Study|Adverse Event|0|||
13446804|NCT00299182|26931689|FG005|Overall Study|Adverse Event|1|||
13446805|NCT00299182|26931690|FG006|Overall Study|Adverse Event|0|||
13446806|NCT00299182|26931684|FG000|Overall Study|Not Eligible|0|||
13446807|NCT00299182|26931685|FG001|Overall Study|Not Eligible|0|||
13446808|NCT00299182|26931686|FG002|Overall Study|Not Eligible|0|||
13446809|NCT00299182|26931687|FG003|Overall Study|Not Eligible|0|||
13446810|NCT00299182|26931688|FG004|Overall Study|Not Eligible|1|||
13446811|NCT00299182|26931689|FG005|Overall Study|Not Eligible|0|||
13446812|NCT00299182|26931690|FG006|Overall Study|Not Eligible|0|||
13446813|NCT00299156|26931708|FG000|Period 2 (Randomized)|Screen Failure|0|||
13477266|NCT01545050|27005968|FG001|Overall Study|Lack of Efficacy|0|||
13446814|NCT00299156|26931709|FG001|Period 2 (Randomized)|Screen Failure|1|||
13446815|NCT00299156|26931710|FG002|Period 2 (Randomized)|Screen Failure|0|||
13446816|NCT00299130|26931822|FG000|Treatment Period (up to 5 Years)|Adverse Event|13|||
13446817|NCT00299130|26931823|FG001|Treatment Period (up to 5 Years)|Adverse Event|8|||
13446818|NCT00299130|26931824|FG002|Treatment Period (up to 5 Years)|Adverse Event|13|||
13446819|NCT00299130|26931822|FG000|Treatment Period (up to 5 Years)|Death|1|||
13446820|NCT00299130|26931823|FG001|Treatment Period (up to 5 Years)|Death|3|||
13446821|NCT00299130|26931824|FG002|Treatment Period (up to 5 Years)|Death|1|||
13446822|NCT00299130|26931822|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19|||
13446823|NCT00299130|26931823|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
13446824|NCT00299130|26931824|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
13446825|NCT00299130|26931822|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0|||
13446826|NCT00299130|26931823|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1|||
13446827|NCT00299130|26931824|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0|||
13446828|NCT00299130|26931822|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12|||
13446829|NCT00299130|26931823|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12|||
13446830|NCT00299130|26931824|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19|||
13446831|NCT00299130|26931822|FG000|Treatment Period (up to 5 Years)|Failure to Return|4|||
13446832|NCT00299130|26931823|FG001|Treatment Period (up to 5 Years)|Failure to Return|6|||
13446833|NCT00299130|26931824|FG002|Treatment Period (up to 5 Years)|Failure to Return|6|||
13446834|NCT00299130|26931822|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4|||
13446835|NCT00299130|26931823|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6|||
13446836|NCT00299130|26931824|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4|||
13446837|NCT00299130|26931822|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0|||
13446838|NCT00299130|26931823|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
13446839|NCT00299130|26931824|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
13446840|NCT00299130|26931822|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
13446841|NCT00299130|26931823|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9|||
13446842|NCT00299130|26931824|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
13446843|NCT00299130|26931822|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4|||
13446844|NCT00299130|26931823|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5|||
13446845|NCT00299130|26931824|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3|||
13446846|NCT00299130|26931822|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
13446847|NCT00299130|26931823|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
13446848|NCT00299130|26931824|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2|||
13446849|NCT00299130|26931822|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14|||
13446850|NCT00299130|26931823|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7|||
13446851|NCT00299130|26931824|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15|||
13446852|NCT00299130|26931822|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
13446853|NCT00299130|26931823|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1|||
13446854|NCT00299130|26931824|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
13446855|NCT00299130|26931822|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
13446856|NCT00299130|26931823|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
13446857|NCT00299130|26931824|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21|||
13446858|NCT00299130|26931822|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
13446859|NCT00299130|26931823|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3|||
13446860|NCT00299130|26931824|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
13446861|NCT00299130|26931822|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0|||
13446862|NCT00299130|26931823|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
13446863|NCT00299130|26931824|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
13446864|NCT00299130|26931822|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0|||
13446865|NCT00299130|26931823|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3|||
13446866|NCT00299130|26931824|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4|||
13446867|NCT00299104|26931929|FG000|Treatment Period|Adverse Event|14|||
13446868|NCT00299104|26931930|FG001|Treatment Period|Adverse Event|9|||
13446869|NCT00299104|26931931|FG002|Treatment Period|Adverse Event|7|||
13446870|NCT00299104|26931929|FG000|Treatment Period|Death|1|||
13446871|NCT00299104|26931930|FG001|Treatment Period|Death|1|||
13446872|NCT00299104|26931931|FG002|Treatment Period|Death|1|||
13446873|NCT00299104|26931929|FG000|Treatment Period|Insufficient therapeutic response|34|||
13446874|NCT00299104|26931930|FG001|Treatment Period|Insufficient therapeutic response|13|||
13446875|NCT00299104|26931931|FG002|Treatment Period|Insufficient therapeutic response|8|||
13446876|NCT00299104|26931929|FG000|Treatment Period|Failure to return|9|||
13446877|NCT00299104|26931930|FG001|Treatment Period|Failure to return|8|||
13446878|NCT00299104|26931931|FG002|Treatment Period|Failure to return|8|||
13446879|NCT00299104|26931929|FG000|Treatment Period|Violation of selection criteria|1|||
13446880|NCT00299104|26931930|FG001|Treatment Period|Violation of selection criteria|2|||
13446881|NCT00299104|26931931|FG002|Treatment Period|Violation of selection criteria|0|||
13446882|NCT00299104|26931929|FG000|Treatment Period|Protocol Violation|1|||
13446883|NCT00299104|26931930|FG001|Treatment Period|Protocol Violation|1|||
13446884|NCT00299104|26931931|FG002|Treatment Period|Protocol Violation|0|||
13446885|NCT00299104|26931929|FG000|Treatment Period|Refused treatment|9|||
13446886|NCT00299104|26931930|FG001|Treatment Period|Refused treatment|2|||
13446887|NCT00299104|26931931|FG002|Treatment Period|Refused treatment|2|||
13446888|NCT00299104|26931929|FG000|Treatment Period|Withdrew consent|14|||
13446889|NCT00299104|26931930|FG001|Treatment Period|Withdrew consent|19|||
13446890|NCT00299104|26931931|FG002|Treatment Period|Withdrew consent|9|||
13446891|NCT00299104|26931929|FG000|Treatment Period|Administrative reasons|106|||
13446892|NCT00299104|26931930|FG001|Treatment Period|Administrative reasons|120|||
13446893|NCT00299104|26931931|FG002|Treatment Period|Administrative reasons|137|||
13446894|NCT00299104|26931929|FG000|Safety Follow-Up (SFU) Period|Death|3|||
13446895|NCT00299104|26931930|FG001|Safety Follow-Up (SFU) Period|Death|2|||
13446896|NCT00299104|26931931|FG002|Safety Follow-Up (SFU) Period|Death|1|||
13446897|NCT00299104|26931929|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9|||
13446898|NCT00299104|26931930|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11|||
13446899|NCT00299104|26931931|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20|||
13446900|NCT00299104|26931929|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16|||
13446901|NCT00299104|26931930|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21|||
13446902|NCT00299104|26931931|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11|||
13446903|NCT00299104|26931929|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27|||
13446904|NCT00299104|26931930|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7|||
13446905|NCT00299104|26931931|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5|||
13446906|NCT00299104|26931929|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0|||
13446907|NCT00299104|26931930|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1|||
13446908|NCT00299104|26931931|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0|||
13446909|NCT00299104|26931929|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
13446910|NCT00299104|26931930|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
13446911|NCT00299104|26931931|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
13446912|NCT00299104|26931929|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2|||
13446913|NCT00299104|26931930|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4|||
13446914|NCT00299104|26931931|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8|||
13446915|NCT00299104|26931929|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1|||
13446916|NCT00299104|26931930|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
13446917|NCT00299104|26931931|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
13446918|NCT00298896|26931938|FG000|Overall Study|Death|3|||
13446919|NCT00298896|26931938|FG000|Overall Study|Physician Decision|2|||
13446920|NCT00298896|26931938|FG000|Overall Study|Intercurrent Illness|1|||
13446921|NCT00298896|26931938|FG000|Overall Study|Disease Progression|41|||
13446922|NCT00298896|26931938|FG000|Overall Study|Withdrawal by Subject|2|||
13446923|NCT00298896|26931938|FG000|Overall Study|Assigned to treatment in error|1|||
13446924|NCT00298831|26931949|FG000|Overall Study|Adverse Event|1|||
13446925|NCT00298831|26931949|FG000|Overall Study|Lost to Follow-up|3|||
13446926|NCT00298831|26931949|FG000|Overall Study|Withdrawal by Subject|1|||
13446927|NCT00298831|26931949|FG000|Overall Study|Participants did not receive treatment|27|||
13446928|NCT00298766|26931960|FG000|Overall Study|Adverse Event|18|||
13446929|NCT00298766|26931960|FG000|Overall Study|Death|2|||
13446930|NCT00298766|26931960|FG000|Overall Study|Withdrawal by Subject|9|||
13446931|NCT00298766|26931960|FG000|Overall Study|Treatment ongoing|4|||
13446932|NCT00298766|26931960|FG000|Overall Study|Progression of amyloid markers|4|||
13446933|NCT00298766|26931960|FG000|Overall Study|Deterioration in KPS and organ function|1|||
13446934|NCT00298766|26931960|FG000|Overall Study|Subjects overall condition deterioration|4|||
13446935|NCT00298766|26931960|FG000|Overall Study|Other|4|||
13446936|NCT00298740|26931966|FG000|Overall Study|Lack of Efficacy|6|||
13446937|NCT00298740|26931966|FG000|Overall Study|Withdrawal by Subject|3|||
13446938|NCT00298363|26932132|FG000|Overall Study|Lost to Follow-up|0|||
13446939|NCT00298363|26932133|FG001|Overall Study|Lost to Follow-up|0|||
13446940|NCT00298363|26932134|FG002|Overall Study|Lost to Follow-up|1|||
13446941|NCT00298363|26932132|FG000|Overall Study|Physician Decision|4|||
13446942|NCT00298363|26932133|FG001|Overall Study|Physician Decision|1|||
13446943|NCT00298363|26932134|FG002|Overall Study|Physician Decision|0|||
13446944|NCT00298363|26932132|FG000|Overall Study|Protocol Violation|1|||
13446945|NCT00298363|26932133|FG001|Overall Study|Protocol Violation|1|||
13446946|NCT00298363|26932134|FG002|Overall Study|Protocol Violation|0|||
13446947|NCT00298363|26932132|FG000|Overall Study|Withdrawal by Subject|5|||
13446948|NCT00298363|26932133|FG001|Overall Study|Withdrawal by Subject|1|||
13446949|NCT00298363|26932134|FG002|Overall Study|Withdrawal by Subject|3|||
13446950|NCT00298363|26932132|FG000|Overall Study|Adverse Event|5|||
13446951|NCT00298363|26932133|FG001|Overall Study|Adverse Event|2|||
13446952|NCT00298363|26932134|FG002|Overall Study|Adverse Event|2|||
13446953|NCT00298363|26932132|FG000|Overall Study|Lack of Efficacy|2|||
13446954|NCT00298363|26932133|FG001|Overall Study|Lack of Efficacy|3|||
13446955|NCT00298363|26932134|FG002|Overall Study|Lack of Efficacy|0|||
13446956|NCT00298272|26932162|FG000|Double-blind Phase|Adverse Event|2|||
13390531|NCT00685698|26773968|FG000|Overall Study|Withdrawal by Subject|1|||
13390532|NCT00685698|26773968|FG000|Overall Study|Protocol Violation|6|||
13390533|NCT00685698|26773968|FG000|Overall Study|Adverse Event|3|||
13390534|NCT00685698|26773968|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1|||
13390535|NCT00685698|26773968|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1|||
13390536|NCT00685698|26773968|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1|||
13390537|NCT00685685|26773981|FG000|Washout Period of 7 Days|Adverse Event|2|||
13390538|NCT00685685|26773982|FG001|Washout Period of 7 Days|Adverse Event|0|||
13390539|NCT00685685|26773981|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
13390540|NCT00685685|26773982|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
13390541|NCT00685399|26774038|FG000|Treatment Period 1|Withdrawal by Subject|2|||
13390542|NCT00685399|26774039|FG001|Treatment Period 1|Withdrawal by Subject|0|||
13390543|NCT00685399|26774040|FG002|Treatment Period 1|Withdrawal by Subject|0|||
13390544|NCT00685399|26774041|FG003|Treatment Period 1|Withdrawal by Subject|0|||
13390545|NCT00685399|26774042|FG004|Treatment Period 1|Withdrawal by Subject|0|||
13390546|NCT00685399|26774043|FG005|Treatment Period 1|Withdrawal by Subject|0|||
13390547|NCT00685399|26774044|FG006|Treatment Period 1|Withdrawal by Subject|0|||
13390548|NCT00685399|26774045|FG007|Treatment Period 1|Withdrawal by Subject|0|||
13390549|NCT00685399|26774038|FG000|Treatment Period 1|Protocol Violation|1|||
13390550|NCT00685399|26774039|FG001|Treatment Period 1|Protocol Violation|0|||
13390551|NCT00685399|26774040|FG002|Treatment Period 1|Protocol Violation|0|||
13390552|NCT00685399|26774041|FG003|Treatment Period 1|Protocol Violation|0|||
13390553|NCT00685399|26774042|FG004|Treatment Period 1|Protocol Violation|0|||
13390554|NCT00685399|26774043|FG005|Treatment Period 1|Protocol Violation|0|||
13390555|NCT00685399|26774044|FG006|Treatment Period 1|Protocol Violation|0|||
13390556|NCT00685399|26774045|FG007|Treatment Period 1|Protocol Violation|0|||
13390557|NCT00685399|26774038|FG000|Treatment Period 1|Administrative|2|||
13390558|NCT00685399|26774039|FG001|Treatment Period 1|Administrative|0|||
13390559|NCT00685399|26774040|FG002|Treatment Period 1|Administrative|0|||
13390560|NCT00685399|26774041|FG003|Treatment Period 1|Administrative|0|||
13390561|NCT00685399|26774042|FG004|Treatment Period 1|Administrative|0|||
13390562|NCT00685399|26774043|FG005|Treatment Period 1|Administrative|0|||
13390563|NCT00685399|26774044|FG006|Treatment Period 1|Administrative|0|||
13390564|NCT00685399|26774045|FG007|Treatment Period 1|Administrative|0|||
13390565|NCT00685399|26774038|FG000|Treatment Period 1|Lack of Efficacy|1|||
13390566|NCT00685399|26774039|FG001|Treatment Period 1|Lack of Efficacy|0|||
13390567|NCT00685399|26774040|FG002|Treatment Period 1|Lack of Efficacy|0|||
13390568|NCT00685399|26774041|FG003|Treatment Period 1|Lack of Efficacy|0|||
13390569|NCT00685399|26774042|FG004|Treatment Period 1|Lack of Efficacy|0|||
13390570|NCT00685399|26774043|FG005|Treatment Period 1|Lack of Efficacy|0|||
13390571|NCT00685399|26774044|FG006|Treatment Period 1|Lack of Efficacy|0|||
13390572|NCT00685399|26774045|FG007|Treatment Period 1|Lack of Efficacy|0|||
13390573|NCT00685399|26774038|FG000|Treatment Period 2|Administrative Problems|0|||
13390574|NCT00685399|26774039|FG001|Treatment Period 2|Administrative Problems|2|||
13390575|NCT00685399|26774040|FG002|Treatment Period 2|Administrative Problems|1|||
13390576|NCT00685399|26774041|FG003|Treatment Period 2|Administrative Problems|0|||
13390577|NCT00685399|26774042|FG004|Treatment Period 2|Administrative Problems|0|||
13390578|NCT00685399|26774043|FG005|Treatment Period 2|Administrative Problems|0|||
13390579|NCT00685399|26774044|FG006|Treatment Period 2|Administrative Problems|0|||
13390580|NCT00685399|26774045|FG007|Treatment Period 2|Administrative Problems|0|||
13390581|NCT00685399|26774038|FG000|Treatment Period 2|Withdrawal by Subject|0|||
13390582|NCT00685399|26774039|FG001|Treatment Period 2|Withdrawal by Subject|0|||
13390583|NCT00685399|26774040|FG002|Treatment Period 2|Withdrawal by Subject|0|||
13390584|NCT00685399|26774041|FG003|Treatment Period 2|Withdrawal by Subject|0|||
13390585|NCT00685399|26774042|FG004|Treatment Period 2|Withdrawal by Subject|0|||
13390586|NCT00685399|26774043|FG005|Treatment Period 2|Withdrawal by Subject|0|||
13390587|NCT00685399|26774044|FG006|Treatment Period 2|Withdrawal by Subject|0|||
13390588|NCT00685399|26774045|FG007|Treatment Period 2|Withdrawal by Subject|2|||
13390589|NCT00685399|26774038|FG000|Treatment Period 2|Adverse Event|0|||
13390590|NCT00685399|26774039|FG001|Treatment Period 2|Adverse Event|0|||
13390591|NCT00685399|26774040|FG002|Treatment Period 2|Adverse Event|0|||
13390592|NCT00685399|26774041|FG003|Treatment Period 2|Adverse Event|0|||
13390593|NCT00685399|26774042|FG004|Treatment Period 2|Adverse Event|0|||
13390594|NCT00685399|26774043|FG005|Treatment Period 2|Adverse Event|1|||
13390595|NCT00685399|26774044|FG006|Treatment Period 2|Adverse Event|0|||
13390596|NCT00685399|26774045|FG007|Treatment Period 2|Adverse Event|0|||
13390597|NCT00685399|26774038|FG000|Treatment Period 2|Lack of Efficacy|0|||
13390598|NCT00685399|26774039|FG001|Treatment Period 2|Lack of Efficacy|10|||
13390599|NCT00685399|26774040|FG002|Treatment Period 2|Lack of Efficacy|2|||
13390600|NCT00685399|26774041|FG003|Treatment Period 2|Lack of Efficacy|0|||
13390601|NCT00685399|26774042|FG004|Treatment Period 2|Lack of Efficacy|0|||
13390602|NCT00685399|26774043|FG005|Treatment Period 2|Lack of Efficacy|1|||
13390603|NCT00685399|26774044|FG006|Treatment Period 2|Lack of Efficacy|0|||
13390604|NCT00685399|26774045|FG007|Treatment Period 2|Lack of Efficacy|0|||
13390605|NCT00685399|26774038|FG000|Extension|Administrative Issues|0|||
13446957|NCT00298272|26932163|FG001|Double-blind Phase|Adverse Event|0|||
13446958|NCT00298272|26932162|FG000|Double-blind Phase|Failure to Return|2|||
13446959|NCT00298272|26932163|FG001|Double-blind Phase|Failure to Return|0|||
13446960|NCT00298272|26932162|FG000|Double-blind Phase|Protocol Violation|2|||
13446961|NCT00298272|26932163|FG001|Double-blind Phase|Protocol Violation|0|||
13446962|NCT00298272|26932162|FG000|Double-blind Phase|Withdrawal by Subject|2|||
13446963|NCT00298272|26932163|FG001|Double-blind Phase|Withdrawal by Subject|0|||
13446964|NCT00298272|26932162|FG000|Open Label Retreatment Phase|Adverse Event|1|||
13446965|NCT00298272|26932163|FG001|Open Label Retreatment Phase|Adverse Event|2|||
13446966|NCT00298272|26932162|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2|||
13446967|NCT00298272|26932163|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1|||
13446968|NCT00298272|26932162|FG000|Open Label Retreatment Phase|Failure to Return|1|||
13446969|NCT00298272|26932163|FG001|Open Label Retreatment Phase|Failure to Return|0|||
13446970|NCT00298272|26932162|FG000|Open Label Retreatment Phase|Protocol Violation|2|||
13446971|NCT00298272|26932163|FG001|Open Label Retreatment Phase|Protocol Violation|1|||
13446972|NCT00298272|26932162|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1|||
13446973|NCT00298272|26932163|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0|||
13446974|NCT00298272|26932162|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2|||
13446975|NCT00298272|26932163|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0|||
13446976|NCT00298272|26932162|FG000|Safety Follow-up Phase|Failure to Return|1|||
13446977|NCT00298272|26932163|FG001|Safety Follow-up Phase|Failure to Return|1|||
13446978|NCT00298272|26932162|FG000|Safety Follow-up Phase|Withdrawal by Subject|2|||
13446979|NCT00298272|26932163|FG001|Safety Follow-up Phase|Withdrawal by Subject|2|||
13446980|NCT00298272|26932162|FG000|Safety Follow-up Phase|Administrative/Other Reason|1|||
13446981|NCT00298272|26932163|FG001|Safety Follow-up Phase|Administrative/Other Reason|1|||
13446982|NCT00298038|26932186|FG000|Overall Study|Lost to Follow-up|0|||
13446983|NCT00298038|26932187|FG001|Overall Study|Lost to Follow-up|1|||
13446984|NCT00298038|26932186|FG000|Overall Study|Liver Transplant|0|||
13446985|NCT00298038|26932187|FG001|Overall Study|Liver Transplant|1|||
13446986|NCT00298038|26932186|FG000|Overall Study|Protocol Violation|1|||
13446987|NCT00298038|26932187|FG001|Overall Study|Protocol Violation|3|||
13446988|NCT00298038|26932186|FG000|Overall Study|Death|6|||
13446989|NCT00298038|26932187|FG001|Overall Study|Death|3|||
13446990|NCT00298038|26932186|FG000|Overall Study|Withdrawal by Subject|6|||
13446991|NCT00298038|26932187|FG001|Overall Study|Withdrawal by Subject|9|||
13446992|NCT00298038|26932186|FG000|Overall Study|Adverse Event|8|||
13446993|NCT00298038|26932187|FG001|Overall Study|Adverse Event|7|||
13446994|NCT00298038|26932186|FG000|Overall Study|Breakthrough overt HE episode|28|||
13446995|NCT00298038|26932187|FG001|Overall Study|Breakthrough overt HE episode|69|||
13446996|NCT00298038|26932186|FG000|Overall Study|Noncompliance|1|||
13446997|NCT00298038|26932187|FG001|Overall Study|Noncompliance|0|||
13446998|NCT00298038|26932186|FG000|Overall Study|Cocaine Abuse|1|||
13446999|NCT00298038|26932187|FG001|Overall Study|Cocaine Abuse|0|||
13447000|NCT00298038|26932186|FG000|Overall Study|Severe Gastrointestinal Bleed|1|||
13447001|NCT00298038|26932187|FG001|Overall Study|Severe Gastrointestinal Bleed|0|||
13447002|NCT00297882|26932202|FG000|Day 14|Lack of Efficacy|12|||
13447003|NCT00297882|26932203|FG001|Day 14|Lack of Efficacy|49|||
13447004|NCT00297882|26932202|FG000|Day 28|Lost to Follow-up|13|||
13447005|NCT00297882|26932203|FG001|Day 28|Lost to Follow-up|23|||
13447006|NCT00297882|26932202|FG000|Day 28|Lack of Efficacy|3|||
13447007|NCT00297882|26932203|FG001|Day 28|Lack of Efficacy|0|||
13447008|NCT00297830|26932230|FG000|6 Month Visit|Death|1|||
13447009|NCT00297830|26932231|FG001|6 Month Visit|Death|0|||
13447010|NCT00297830|26932232|FG002|6 Month Visit|Death|2|||
13447011|NCT00297830|26932230|FG000|6 Month Visit|Withdrawal by Subject|2|||
13447012|NCT00297830|26932231|FG001|6 Month Visit|Withdrawal by Subject|1|||
13447013|NCT00297830|26932232|FG002|6 Month Visit|Withdrawal by Subject|1|||
13447014|NCT00297830|26932230|FG000|6 Month Visit|Adverse Event|0|||
13447015|NCT00297830|26932231|FG001|6 Month Visit|Adverse Event|1|||
13447016|NCT00297830|26932232|FG002|6 Month Visit|Adverse Event|0|||
13447017|NCT00297830|26932230|FG000|12 Month Visit|Lost to Follow-up|1|||
13447018|NCT00297830|26932231|FG001|12 Month Visit|Lost to Follow-up|0|||
13447019|NCT00297830|26932232|FG002|12 Month Visit|Lost to Follow-up|0|||
13447020|NCT00297830|26932230|FG000|12 Month Visit|Adverse Event|0|||
13447021|NCT00297830|26932231|FG001|12 Month Visit|Adverse Event|3|||
13447022|NCT00297830|26932232|FG002|12 Month Visit|Adverse Event|0|||
13447023|NCT00297830|26932230|FG000|12 Month Visit|Withdrawal by Subject|0|||
13447024|NCT00297830|26932231|FG001|12 Month Visit|Withdrawal by Subject|3|||
13447025|NCT00297830|26932232|FG002|12 Month Visit|Withdrawal by Subject|0|||
13447026|NCT00297778|26932273|FG000|Overall Study|Adverse Event|16|||
13447027|NCT00297778|26932274|FG001|Overall Study|Adverse Event|10|||
13447028|NCT00297778|26932273|FG000|Overall Study|Withdrawal by Subject|1|||
13447029|NCT00297778|26932274|FG001|Overall Study|Withdrawal by Subject|5|||
13447030|NCT00297778|26932273|FG000|Overall Study|Lack of Efficacy|2|||
13447031|NCT00297778|26932274|FG001|Overall Study|Lack of Efficacy|1|||
13447032|NCT00297778|26932273|FG000|Overall Study|Non-compliant with trial protocol|0|||
13447033|NCT00297778|26932274|FG001|Overall Study|Non-compliant with trial protocol|3|||
13447034|NCT00297778|26932273|FG000|Overall Study|Other|0|||
13447035|NCT00297778|26932274|FG001|Overall Study|Other|1|||
13447036|NCT00297648|26932315|FG000|Overall Study|Adverse Event|13|||
13447037|NCT00297648|26932315|FG000|Overall Study|Lack of Efficacy|18|||
13447038|NCT00297648|26932315|FG000|Overall Study|Lost to Follow-up|1|||
13447039|NCT00297648|26932315|FG000|Overall Study|Withdrawal by Subject|3|||
13447040|NCT00297648|26932315|FG000|Overall Study|Other: Incompliance|1|||
13447041|NCT00297492|26932333|FG000|Set Quit Date|Lost to Follow-up|7|||
13447042|NCT00297492|26932334|FG001|Set Quit Date|Lost to Follow-up|13|||
13447043|NCT00297492|26932335|FG002|Set Quit Date|Lost to Follow-up|5|||
13447044|NCT00297492|26932333|FG000|6 Month Follow-up|Lost to Follow-up|63|||
13447045|NCT00297492|26932334|FG001|6 Month Follow-up|Lost to Follow-up|49|||
13447046|NCT00297492|26932335|FG002|6 Month Follow-up|Lost to Follow-up|27|||
13447047|NCT00297479|26932362|FG000|Overall Study|Lost to Follow-up|37|||
13447048|NCT00297479|26932363|FG001|Overall Study|Lost to Follow-up|54|||
13447049|NCT00297479|26932364|FG002|Overall Study|Lost to Follow-up|51|||
13447050|NCT00297427|26932412|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8|||
13447051|NCT00297427|26932413|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5|||
13447052|NCT00297427|26932412|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0|||
13447053|NCT00297427|26932413|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3|||
13447054|NCT00297427|26932412|FG000|Phase 1: Initial Intervention|Death|0|||
13447055|NCT00297427|26932413|FG001|Phase 1: Initial Intervention|Death|1|||
13447056|NCT00297427|26932412|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15|||
13447057|NCT00297427|26932413|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0|||
13447058|NCT00297427|26932412|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1|||
13447059|NCT00297427|26932413|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0|||
13447060|NCT00297427|26932412|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29|||
13447061|NCT00297427|26932413|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0|||
13447062|NCT00297427|26932412|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3|||
13447063|NCT00297427|26932413|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0|||
13447064|NCT00297427|26932412|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2|||
13447065|NCT00297427|26932413|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0|||
13447066|NCT00297258|26932434|FG000|Overall Study|Disease Progression, Relapse, Death|120|||
13447067|NCT00297258|26932434|FG000|Overall Study|Toxicity (or Toxic Death)|10|||
13447068|NCT00297258|26932434|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2|||
13447069|NCT00297258|26932434|FG000|Overall Study|Intercurrent Illness|3|||
13447070|NCT00297258|26932434|FG000|Overall Study|Intercurrent Death|2|||
13447071|NCT00297258|26932434|FG000|Overall Study|Deteriorization of General Condition|1|||
13447072|NCT00297258|26932434|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1|||
13447073|NCT00297258|26932434|FG000|Overall Study|Surgery Performed on Target Lesion|1|||
13447074|NCT00297258|26932434|FG000|Overall Study|Switch to Commercial Treatment|1|||
13447075|NCT00297258|26932434|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1|||
13447076|NCT00297232|26932442|FG000|Overall Study|Lack of Efficacy|7|||
13447077|NCT00297232|26932442|FG000|Overall Study|Lost to Follow-up|10|||
13447078|NCT00297232|26932442|FG000|Overall Study|Adverse Event|63|||
13447079|NCT00297232|26932442|FG000|Overall Study|Voluntary Withdrawal|120|||
13447080|NCT00297232|26932442|FG000|Overall Study|Subject was Noncompliant|9|||
13447081|NCT00297232|26932442|FG000|Overall Study|Death|9|||
13447082|NCT00297232|26932442|FG000|Overall Study|Anti-natalizumab Positive|8|||
13447083|NCT00297232|26932442|FG000|Overall Study|Switched to Commercial Tysabri|22|||
13447084|NCT00297232|26932442|FG000|Overall Study|Disease Progression|8|||
13447085|NCT00297232|26932442|FG000|Overall Study|Fear of PML|10|||
13447086|NCT00297232|26932442|FG000|Overall Study|Anti-JCV Antibody Positive|13|||
13447087|NCT00297232|26932442|FG000|Overall Study|Miscellaneous|5|||
13447088|NCT00297232|26932442|FG000|Overall Study|Sponsor Decision|34|||
13447089|NCT00297232|26932442|FG000|Overall Study|Subject Relocated|7|||
13447090|NCT00297232|26932442|FG000|Overall Study|Subject Withdrew Consent|37|||
13447091|NCT00297232|26932442|FG000|Overall Study|Persistently Positive Antibodies|11|||
13447092|NCT00297232|26932442|FG000|Overall Study|Investigator Withdrew From Program|19|||
13447093|NCT00297232|26932442|FG000|Overall Study|Did Not Enroll to Week 264|34|||
13447094|NCT00297232|26932442|FG000|Overall Study|Did Not Enroll to Week 480|17|||
13447095|NCT00297232|26932442|FG000|Overall Study|No data available after Week 264|161|||
13447096|NCT00297232|26932442|FG000|Overall Study|Other|1|||
13447097|NCT00297167|26932470|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
13447098|NCT00297167|26932471|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
13447099|NCT00297167|26932472|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1|||
13447100|NCT00297167|26932470|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
13447101|NCT00297167|26932471|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
13447102|NCT00297167|26932472|FG002|Second Double-blind Intervention Period|Protocol Violation|0|||
13447103|NCT00297037|26932489|FG000|Overall Study|Withdrawal by Subject|2|||
13447104|NCT00297037|26932490|FG001|Overall Study|Withdrawal by Subject|0|||
13447105|NCT00296816|26932508|FG000|Overall Study|Disease Progression|37|||
13447106|NCT00296816|26932508|FG000|Overall Study|Adverse Event|18|||
13447107|NCT00296816|26932508|FG000|Overall Study|Investigator/Participant request|5|||
13447108|NCT00296816|26932508|FG000|Overall Study|Non-compliance|1|||
13447109|NCT00296816|26932508|FG000|Overall Study|Missing for end of treatment|4|||
13447110|NCT00296816|26932508|FG000|Overall Study|Progression based on CA-125 (biomarker)|2|||
13447111|NCT00296816|26932508|FG000|Overall Study|Poor performance status|1|||
13447112|NCT00296816|26932508|FG000|Overall Study|Relocation to Florida|1|||
13447113|NCT00296816|26932508|FG000|Overall Study|Noncompliance/decision to discontinue|1|||
13447114|NCT00296816|26932508|FG000|Overall Study|Urine protein/creatinine ratio delay|1|||
13447115|NCT00296816|26932508|FG000|Overall Study|Neuropathy/patient preference|1|||
13447116|NCT00296816|26932508|FG000|Overall Study|Proteinuria|1|||
13447117|NCT00296816|26932508|FG000|Overall Study|ineligibility due to radiation treatment|1|||
13447118|NCT00296725|26932518|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1|||
13447119|NCT00296725|26932518|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4|||
13447120|NCT00296725|26932518|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1|||
13447121|NCT00296647|26932546|FG000|Overall Study|Death|4|||
13447122|NCT00296647|26932547|FG001|Overall Study|Death|1|||
13447123|NCT00296647|26932548|FG002|Overall Study|Death|2|||
13447124|NCT00296647|26932549|FG003|Overall Study|Death|1|||
13447125|NCT00296647|26932550|FG004|Overall Study|Death|1|||
13447126|NCT00296647|26932546|FG000|Overall Study|Withdrawal by Subject|28|||
13447127|NCT00296647|26932547|FG001|Overall Study|Withdrawal by Subject|27|||
13447128|NCT00296647|26932548|FG002|Overall Study|Withdrawal by Subject|32|||
13447129|NCT00296647|26932549|FG003|Overall Study|Withdrawal by Subject|16|||
13447130|NCT00296647|26932550|FG004|Overall Study|Withdrawal by Subject|19|||
13447131|NCT00296517|26932585|FG000|Dose Level 2 - Week 2|Adverse Event|1|||
13447132|NCT00296517|26932586|FG001|Dose Level 2 - Week 2|Adverse Event|5|||
13447133|NCT00296517|26932585|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1|||
13447134|NCT00296517|26932586|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0|||
13447135|NCT00296517|26932585|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30|||
13447136|NCT00296517|26932586|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34|||
13447137|NCT00296517|26932585|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3|||
13447138|NCT00296517|26932586|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6|||
13447139|NCT00296517|26932585|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3|||
13447140|NCT00296517|26932586|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2|||
13447141|NCT00296517|26932585|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1|||
13447142|NCT00296517|26932586|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0|||
13447143|NCT00296517|26932585|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7|||
13447144|NCT00296517|26932586|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18|||
13447145|NCT00296517|26932585|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1|||
13447146|NCT00296517|26932586|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0|||
13447147|NCT00296517|26932585|FG000|Dose Level 3 - Weeks 3-12|Other|0|||
13447148|NCT00296517|26932586|FG001|Dose Level 3 - Weeks 3-12|Other|2|||
13447149|NCT00296504|26932701|FG000|Interim Analysis|Withdrawal by Subject|8|||
13447150|NCT00296504|26932702|FG001|Interim Analysis|Withdrawal by Subject|0|||
13447151|NCT00296504|26932703|FG002|Interim Analysis|Withdrawal by Subject|12|||
13447152|NCT00296504|26932704|FG003|Interim Analysis|Withdrawal by Subject|0|||
13447153|NCT00296504|26932705|FG004|Interim Analysis|Withdrawal by Subject|5|||
13447154|NCT00296504|26932706|FG005|Interim Analysis|Withdrawal by Subject|5|||
13447155|NCT00296504|26932707|FG006|Interim Analysis|Withdrawal by Subject|9|||
13447156|NCT00296504|26932708|FG007|Interim Analysis|Withdrawal by Subject|3|||
13447157|NCT00296504|26932709|FG008|Interim Analysis|Withdrawal by Subject|0|||
13447158|NCT00296504|26932701|FG000|Interim Analysis|Lost to Follow-up|13|||
13447159|NCT00296504|26932702|FG001|Interim Analysis|Lost to Follow-up|3|||
13447160|NCT00296504|26932703|FG002|Interim Analysis|Lost to Follow-up|26|||
13447161|NCT00296504|26932704|FG003|Interim Analysis|Lost to Follow-up|8|||
13447162|NCT00296504|26932705|FG004|Interim Analysis|Lost to Follow-up|14|||
13447163|NCT00296504|26932706|FG005|Interim Analysis|Lost to Follow-up|4|||
13447164|NCT00296504|26932707|FG006|Interim Analysis|Lost to Follow-up|11|||
13447165|NCT00296504|26932708|FG007|Interim Analysis|Lost to Follow-up|4|||
13447166|NCT00296504|26932709|FG008|Interim Analysis|Lost to Follow-up|0|||
13447167|NCT00296504|26932701|FG000|Interim Analysis|Clinical Progression|1|||
13447168|NCT00296504|26932702|FG001|Interim Analysis|Clinical Progression|0|||
13447169|NCT00296504|26932703|FG002|Interim Analysis|Clinical Progression|1|||
13447170|NCT00296504|26932704|FG003|Interim Analysis|Clinical Progression|1|||
13447171|NCT00296504|26932705|FG004|Interim Analysis|Clinical Progression|0|||
13447172|NCT00296504|26932706|FG005|Interim Analysis|Clinical Progression|2|||
13447173|NCT00296504|26932707|FG006|Interim Analysis|Clinical Progression|1|||
13447174|NCT00296504|26932708|FG007|Interim Analysis|Clinical Progression|2|||
13447175|NCT00296504|26932709|FG008|Interim Analysis|Clinical Progression|0|||
13447176|NCT00296504|26932701|FG000|Interim Analysis|Insufficient Viral Load Response|5|||
13447177|NCT00296504|26932702|FG001|Interim Analysis|Insufficient Viral Load Response|1|||
13447178|NCT00296504|26932703|FG002|Interim Analysis|Insufficient Viral Load Response|12|||
13447179|NCT00296504|26932704|FG003|Interim Analysis|Insufficient Viral Load Response|2|||
13447180|NCT00296504|26932705|FG004|Interim Analysis|Insufficient Viral Load Response|7|||
13447181|NCT00296504|26932706|FG005|Interim Analysis|Insufficient Viral Load Response|9|||
13447182|NCT00296504|26932707|FG006|Interim Analysis|Insufficient Viral Load Response|2|||
13447183|NCT00296504|26932708|FG007|Interim Analysis|Insufficient Viral Load Response|24|||
13447184|NCT00296504|26932709|FG008|Interim Analysis|Insufficient Viral Load Response|0|||
13447185|NCT00296504|26932701|FG000|Interim Analysis|Adverse Event|0|||
13447186|NCT00296504|26932702|FG001|Interim Analysis|Adverse Event|0|||
13447187|NCT00296504|26932703|FG002|Interim Analysis|Adverse Event|13|||
13447188|NCT00296504|26932704|FG003|Interim Analysis|Adverse Event|4|||
13447189|NCT00296504|26932705|FG004|Interim Analysis|Adverse Event|6|||
13447190|NCT00296504|26932706|FG005|Interim Analysis|Adverse Event|3|||
13447191|NCT00296504|26932707|FG006|Interim Analysis|Adverse Event|4|||
13447192|NCT00296504|26932708|FG007|Interim Analysis|Adverse Event|5|||
13447193|NCT00296504|26932709|FG008|Interim Analysis|Adverse Event|0|||
13447194|NCT00296504|26932701|FG000|Interim Analysis|Protocol Violation|0|||
13447195|NCT00296504|26932702|FG001|Interim Analysis|Protocol Violation|0|||
13447196|NCT00296504|26932703|FG002|Interim Analysis|Protocol Violation|2|||
13447197|NCT00296504|26932704|FG003|Interim Analysis|Protocol Violation|0|||
13447198|NCT00296504|26932705|FG004|Interim Analysis|Protocol Violation|1|||
13447199|NCT00296504|26932706|FG005|Interim Analysis|Protocol Violation|0|||
13447200|NCT00296504|26932707|FG006|Interim Analysis|Protocol Violation|0|||
13447201|NCT00296504|26932708|FG007|Interim Analysis|Protocol Violation|1|||
13447202|NCT00296504|26932709|FG008|Interim Analysis|Protocol Violation|0|||
13447203|NCT00296504|26932701|FG000|Interim Analysis|Insufficient CD4 Response|0|||
13447204|NCT00296504|26932702|FG001|Interim Analysis|Insufficient CD4 Response|0|||
13447205|NCT00296504|26932703|FG002|Interim Analysis|Insufficient CD4 Response|0|||
13447206|NCT00296504|26932704|FG003|Interim Analysis|Insufficient CD4 Response|0|||
13447207|NCT00296504|26932705|FG004|Interim Analysis|Insufficient CD4 Response|1|||
13447208|NCT00296504|26932706|FG005|Interim Analysis|Insufficient CD4 Response|1|||
13447209|NCT00296504|26932707|FG006|Interim Analysis|Insufficient CD4 Response|0|||
13447210|NCT00296504|26932708|FG007|Interim Analysis|Insufficient CD4 Response|0|||
13447211|NCT00296504|26932709|FG008|Interim Analysis|Insufficient CD4 Response|0|||
13447212|NCT00296504|26932701|FG000|Interim Analysis|Switched to Commercially Available Drug|2|||
13447213|NCT00296504|26932702|FG001|Interim Analysis|Switched to Commercially Available Drug|0|||
13447214|NCT00296504|26932703|FG002|Interim Analysis|Switched to Commercially Available Drug|4|||
13447215|NCT00296504|26932704|FG003|Interim Analysis|Switched to Commercially Available Drug|1|||
13447216|NCT00296504|26932705|FG004|Interim Analysis|Switched to Commercially Available Drug|0|||
13447217|NCT00296504|26932706|FG005|Interim Analysis|Switched to Commercially Available Drug|5|||
13447218|NCT00296504|26932707|FG006|Interim Analysis|Switched to Commercially Available Drug|3|||
13447219|NCT00296504|26932708|FG007|Interim Analysis|Switched to Commercially Available Drug|4|||
13447220|NCT00296504|26932709|FG008|Interim Analysis|Switched to Commercially Available Drug|0|||
13447221|NCT00296504|26932701|FG000|Interim Analysis|Pregnancy|4|||
13447222|NCT00296504|26932702|FG001|Interim Analysis|Pregnancy|1|||
13447223|NCT00296504|26932703|FG002|Interim Analysis|Pregnancy|4|||
13447224|NCT00296504|26932704|FG003|Interim Analysis|Pregnancy|2|||
13447225|NCT00296504|26932705|FG004|Interim Analysis|Pregnancy|0|||
13447226|NCT00296504|26932706|FG005|Interim Analysis|Pregnancy|1|||
13447227|NCT00296504|26932707|FG006|Interim Analysis|Pregnancy|1|||
13447228|NCT00296504|26932708|FG007|Interim Analysis|Pregnancy|1|||
13447229|NCT00296504|26932709|FG008|Interim Analysis|Pregnancy|0|||
13447230|NCT00296504|26932701|FG000|Interim Analysis|Death|1|||
13447231|NCT00296504|26932702|FG001|Interim Analysis|Death|0|||
13447232|NCT00296504|26932703|FG002|Interim Analysis|Death|3|||
13447233|NCT00296504|26932704|FG003|Interim Analysis|Death|0|||
13447234|NCT00296504|26932705|FG004|Interim Analysis|Death|0|||
13447235|NCT00296504|26932706|FG005|Interim Analysis|Death|0|||
13447236|NCT00296504|26932707|FG006|Interim Analysis|Death|0|||
13447237|NCT00296504|26932708|FG007|Interim Analysis|Death|0|||
13447238|NCT00296504|26932709|FG008|Interim Analysis|Death|0|||
13447239|NCT00296504|26932701|FG000|Interim Analysis|Participant Non-compliant|0|||
13447240|NCT00296504|26932702|FG001|Interim Analysis|Participant Non-compliant|1|||
13447241|NCT00296504|26932703|FG002|Interim Analysis|Participant Non-compliant|2|||
13447242|NCT00296504|26932704|FG003|Interim Analysis|Participant Non-compliant|1|||
13447243|NCT00296504|26932705|FG004|Interim Analysis|Participant Non-compliant|1|||
13447244|NCT00296504|26932706|FG005|Interim Analysis|Participant Non-compliant|3|||
13447245|NCT00296504|26932707|FG006|Interim Analysis|Participant Non-compliant|6|||
13447246|NCT00296504|26932708|FG007|Interim Analysis|Participant Non-compliant|2|||
13447247|NCT00296504|26932709|FG008|Interim Analysis|Participant Non-compliant|0|||
13447248|NCT00296504|26932701|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0|||
13447249|NCT00296504|26932702|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0|||
13447250|NCT00296504|26932703|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2|||
13447251|NCT00296504|26932704|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0|||
13447252|NCT00296504|26932705|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0|||
13447253|NCT00296504|26932706|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1|||
13447254|NCT00296504|26932707|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0|||
13447255|NCT00296504|26932708|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0|||
13447256|NCT00296504|26932709|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0|||
13447257|NCT00296504|26932701|FG000|Interim Analysis|To Simplify Treatment|0|||
13447258|NCT00296504|26932702|FG001|Interim Analysis|To Simplify Treatment|0|||
13447259|NCT00296504|26932703|FG002|Interim Analysis|To Simplify Treatment|1|||
13447260|NCT00296504|26932704|FG003|Interim Analysis|To Simplify Treatment|0|||
13447261|NCT00296504|26932705|FG004|Interim Analysis|To Simplify Treatment|0|||
13447262|NCT00296504|26932706|FG005|Interim Analysis|To Simplify Treatment|0|||
13447263|NCT00296504|26932707|FG006|Interim Analysis|To Simplify Treatment|2|||
13447264|NCT00296504|26932708|FG007|Interim Analysis|To Simplify Treatment|0|||
13447265|NCT00296504|26932709|FG008|Interim Analysis|To Simplify Treatment|0|||
13447266|NCT00296504|26932701|FG000|Interim Analysis|Participant Had Problems with Alcohol|0|||
13447267|NCT00296504|26932702|FG001|Interim Analysis|Participant Had Problems with Alcohol|0|||
13447268|NCT00296504|26932703|FG002|Interim Analysis|Participant Had Problems with Alcohol|1|||
13447269|NCT00296504|26932704|FG003|Interim Analysis|Participant Had Problems with Alcohol|0|||
13447270|NCT00296504|26932705|FG004|Interim Analysis|Participant Had Problems with Alcohol|0|||
13447271|NCT00296504|26932706|FG005|Interim Analysis|Participant Had Problems with Alcohol|0|||
13447272|NCT00296504|26932707|FG006|Interim Analysis|Participant Had Problems with Alcohol|0|||
13447273|NCT00296504|26932708|FG007|Interim Analysis|Participant Had Problems with Alcohol|0|||
13447274|NCT00296504|26932709|FG008|Interim Analysis|Participant Had Problems with Alcohol|0|||
13447275|NCT00296504|26932701|FG000|Interim Analysis|Participant Moved|1|||
13447276|NCT00296504|26932702|FG001|Interim Analysis|Participant Moved|0|||
13447277|NCT00296504|26932703|FG002|Interim Analysis|Participant Moved|1|||
13447278|NCT00296504|26932704|FG003|Interim Analysis|Participant Moved|0|||
13447279|NCT00296504|26932705|FG004|Interim Analysis|Participant Moved|0|||
13447280|NCT00296504|26932706|FG005|Interim Analysis|Participant Moved|1|||
13447281|NCT00296504|26932707|FG006|Interim Analysis|Participant Moved|1|||
13447282|NCT00296504|26932708|FG007|Interim Analysis|Participant Moved|0|||
13447283|NCT00296504|26932709|FG008|Interim Analysis|Participant Moved|0|||
13447284|NCT00296504|26932701|FG000|Interim Analysis|Participant Was Incarcerated|2|||
13447285|NCT00296504|26932702|FG001|Interim Analysis|Participant Was Incarcerated|0|||
13447286|NCT00296504|26932703|FG002|Interim Analysis|Participant Was Incarcerated|1|||
13447287|NCT00296504|26932704|FG003|Interim Analysis|Participant Was Incarcerated|0|||
13447288|NCT00296504|26932705|FG004|Interim Analysis|Participant Was Incarcerated|0|||
13447289|NCT00296504|26932706|FG005|Interim Analysis|Participant Was Incarcerated|0|||
13447290|NCT00296504|26932707|FG006|Interim Analysis|Participant Was Incarcerated|0|||
13447291|NCT00296504|26932708|FG007|Interim Analysis|Participant Was Incarcerated|0|||
13447292|NCT00296504|26932709|FG008|Interim Analysis|Participant Was Incarcerated|0|||
13447293|NCT00296504|26932701|FG000|Interim Analysis|Resistance to FPV|0|||
13447294|NCT00296504|26932702|FG001|Interim Analysis|Resistance to FPV|0|||
13447295|NCT00296504|26932703|FG002|Interim Analysis|Resistance to FPV|1|||
13447296|NCT00296504|26932704|FG003|Interim Analysis|Resistance to FPV|0|||
13447297|NCT00296504|26932705|FG004|Interim Analysis|Resistance to FPV|0|||
13447298|NCT00296504|26932706|FG005|Interim Analysis|Resistance to FPV|0|||
13447299|NCT00296504|26932707|FG006|Interim Analysis|Resistance to FPV|0|||
13447300|NCT00296504|26932708|FG007|Interim Analysis|Resistance to FPV|0|||
13447301|NCT00296504|26932709|FG008|Interim Analysis|Resistance to FPV|0|||
13447302|NCT00296504|26932701|FG000|Interim Analysis|Physician Decision|0|||
13447303|NCT00296504|26932702|FG001|Interim Analysis|Physician Decision|0|||
13447304|NCT00296504|26932703|FG002|Interim Analysis|Physician Decision|1|||
13447305|NCT00296504|26932704|FG003|Interim Analysis|Physician Decision|0|||
13447306|NCT00296504|26932705|FG004|Interim Analysis|Physician Decision|0|||
13447307|NCT00296504|26932706|FG005|Interim Analysis|Physician Decision|0|||
13447308|NCT00296504|26932707|FG006|Interim Analysis|Physician Decision|0|||
13447309|NCT00296504|26932708|FG007|Interim Analysis|Physician Decision|0|||
13447310|NCT00296504|26932709|FG008|Interim Analysis|Physician Decision|0|||
13447311|NCT00296504|26932701|FG000|Interim Analysis|Principle Investigator Discretion|2|||
13447312|NCT00296504|26932702|FG001|Interim Analysis|Principle Investigator Discretion|0|||
13447313|NCT00296504|26932703|FG002|Interim Analysis|Principle Investigator Discretion|1|||
13447314|NCT00296504|26932704|FG003|Interim Analysis|Principle Investigator Discretion|1|||
13447315|NCT00296504|26932705|FG004|Interim Analysis|Principle Investigator Discretion|0|||
13447316|NCT00296504|26932706|FG005|Interim Analysis|Principle Investigator Discretion|0|||
13447317|NCT00296504|26932707|FG006|Interim Analysis|Principle Investigator Discretion|0|||
13447318|NCT00296504|26932708|FG007|Interim Analysis|Principle Investigator Discretion|0|||
13447319|NCT00296504|26932709|FG008|Interim Analysis|Principle Investigator Discretion|0|||
13447320|NCT00296504|26932701|FG000|Interim Analysis|Principle Investigator Terminated Study|0|||
13447321|NCT00296504|26932702|FG001|Interim Analysis|Principle Investigator Terminated Study|0|||
13447322|NCT00296504|26932703|FG002|Interim Analysis|Principle Investigator Terminated Study|1|||
13447323|NCT00296504|26932704|FG003|Interim Analysis|Principle Investigator Terminated Study|0|||
13447324|NCT00296504|26932705|FG004|Interim Analysis|Principle Investigator Terminated Study|0|||
13447325|NCT00296504|26932706|FG005|Interim Analysis|Principle Investigator Terminated Study|0|||
13447326|NCT00296504|26932707|FG006|Interim Analysis|Principle Investigator Terminated Study|0|||
13447327|NCT00296504|26932708|FG007|Interim Analysis|Principle Investigator Terminated Study|0|||
13447328|NCT00296504|26932709|FG008|Interim Analysis|Principle Investigator Terminated Study|0|||
13447329|NCT00296504|26932701|FG000|Interim Analysis|Non-adherence|2|||
13447330|NCT00296504|26932702|FG001|Interim Analysis|Non-adherence|0|||
13447331|NCT00296504|26932703|FG002|Interim Analysis|Non-adherence|0|||
13447332|NCT00296504|26932704|FG003|Interim Analysis|Non-adherence|0|||
13447333|NCT00296504|26932705|FG004|Interim Analysis|Non-adherence|1|||
13447334|NCT00296504|26932706|FG005|Interim Analysis|Non-adherence|0|||
13447335|NCT00296504|26932707|FG006|Interim Analysis|Non-adherence|0|||
13447336|NCT00296504|26932708|FG007|Interim Analysis|Non-adherence|1|||
13447337|NCT00296504|26932709|FG008|Interim Analysis|Non-adherence|0|||
13447338|NCT00296504|26932701|FG000|Interim Analysis|Site Closing|1|||
13447339|NCT00296504|26932702|FG001|Interim Analysis|Site Closing|0|||
13447340|NCT00296504|26932703|FG002|Interim Analysis|Site Closing|0|||
13447341|NCT00296504|26932704|FG003|Interim Analysis|Site Closing|0|||
13447342|NCT00296504|26932705|FG004|Interim Analysis|Site Closing|0|||
13447343|NCT00296504|26932706|FG005|Interim Analysis|Site Closing|1|||
13447344|NCT00296504|26932707|FG006|Interim Analysis|Site Closing|2|||
13447345|NCT00296504|26932708|FG007|Interim Analysis|Site Closing|0|||
13447346|NCT00296504|26932709|FG008|Interim Analysis|Site Closing|0|||
13447347|NCT00296504|26932701|FG000|Interim Analysis|Lack of Personnel at Site|1|||
13447348|NCT00296504|26932702|FG001|Interim Analysis|Lack of Personnel at Site|0|||
13447349|NCT00296504|26932703|FG002|Interim Analysis|Lack of Personnel at Site|0|||
13447350|NCT00296504|26932704|FG003|Interim Analysis|Lack of Personnel at Site|0|||
13447351|NCT00296504|26932705|FG004|Interim Analysis|Lack of Personnel at Site|0|||
13447352|NCT00296504|26932706|FG005|Interim Analysis|Lack of Personnel at Site|0|||
13447353|NCT00296504|26932707|FG006|Interim Analysis|Lack of Personnel at Site|0|||
13447354|NCT00296504|26932708|FG007|Interim Analysis|Lack of Personnel at Site|0|||
13447355|NCT00296504|26932709|FG008|Interim Analysis|Lack of Personnel at Site|0|||
13447356|NCT00296504|26932701|FG000|Interim Analysis|Missed Schedule Date|1|||
13447357|NCT00296504|26932702|FG001|Interim Analysis|Missed Schedule Date|0|||
13447358|NCT00296504|26932703|FG002|Interim Analysis|Missed Schedule Date|0|||
13447359|NCT00296504|26932704|FG003|Interim Analysis|Missed Schedule Date|0|||
13447360|NCT00296504|26932705|FG004|Interim Analysis|Missed Schedule Date|0|||
13447361|NCT00296504|26932706|FG005|Interim Analysis|Missed Schedule Date|0|||
13447362|NCT00296504|26932707|FG006|Interim Analysis|Missed Schedule Date|0|||
13447363|NCT00296504|26932708|FG007|Interim Analysis|Missed Schedule Date|0|||
13447364|NCT00296504|26932709|FG008|Interim Analysis|Missed Schedule Date|0|||
13447365|NCT00296504|26932701|FG000|Interim Analysis|Inclusion in Other Protocol|0|||
13447366|NCT00296504|26932702|FG001|Interim Analysis|Inclusion in Other Protocol|0|||
13447367|NCT00296504|26932703|FG002|Interim Analysis|Inclusion in Other Protocol|0|||
13447368|NCT00296504|26932704|FG003|Interim Analysis|Inclusion in Other Protocol|1|||
13447369|NCT00296504|26932705|FG004|Interim Analysis|Inclusion in Other Protocol|0|||
13447370|NCT00296504|26932706|FG005|Interim Analysis|Inclusion in Other Protocol|0|||
13447371|NCT00296504|26932707|FG006|Interim Analysis|Inclusion in Other Protocol|0|||
13447372|NCT00296504|26932708|FG007|Interim Analysis|Inclusion in Other Protocol|0|||
13447373|NCT00296504|26932709|FG008|Interim Analysis|Inclusion in Other Protocol|0|||
13447374|NCT00296504|26932701|FG000|Interim Analysis|Participant Stopped|0|||
13447375|NCT00296504|26932702|FG001|Interim Analysis|Participant Stopped|0|||
13447376|NCT00296504|26932703|FG002|Interim Analysis|Participant Stopped|0|||
13447377|NCT00296504|26932704|FG003|Interim Analysis|Participant Stopped|0|||
13447378|NCT00296504|26932705|FG004|Interim Analysis|Participant Stopped|1|||
13447379|NCT00296504|26932706|FG005|Interim Analysis|Participant Stopped|0|||
13447380|NCT00296504|26932707|FG006|Interim Analysis|Participant Stopped|0|||
13447381|NCT00296504|26932708|FG007|Interim Analysis|Participant Stopped|0|||
13447382|NCT00296504|26932709|FG008|Interim Analysis|Participant Stopped|0|||
13447383|NCT00296504|26932701|FG000|Interim Analysis|Physician and Participant Decision|0|||
13447384|NCT00296504|26932702|FG001|Interim Analysis|Physician and Participant Decision|0|||
13447385|NCT00296504|26932703|FG002|Interim Analysis|Physician and Participant Decision|0|||
13447386|NCT00296504|26932704|FG003|Interim Analysis|Physician and Participant Decision|0|||
13447387|NCT00296504|26932705|FG004|Interim Analysis|Physician and Participant Decision|0|||
13447388|NCT00296504|26932706|FG005|Interim Analysis|Physician and Participant Decision|1|||
13447389|NCT00296504|26932707|FG006|Interim Analysis|Physician and Participant Decision|0|||
13447390|NCT00296504|26932708|FG007|Interim Analysis|Physician and Participant Decision|0|||
13447391|NCT00296504|26932709|FG008|Interim Analysis|Physician and Participant Decision|0|||
13447392|NCT00296504|26932701|FG000|Interim Analysis|Participant Stopped HIV Medications|0|||
13447393|NCT00296504|26932702|FG001|Interim Analysis|Participant Stopped HIV Medications|0|||
13447394|NCT00296504|26932703|FG002|Interim Analysis|Participant Stopped HIV Medications|0|||
13447395|NCT00296504|26932704|FG003|Interim Analysis|Participant Stopped HIV Medications|0|||
13477267|NCT01545050|27005969|FG002|Overall Study|Lack of Efficacy|0|||
13447396|NCT00296504|26932705|FG004|Interim Analysis|Participant Stopped HIV Medications|0|||
13447397|NCT00296504|26932706|FG005|Interim Analysis|Participant Stopped HIV Medications|0|||
13447398|NCT00296504|26932707|FG006|Interim Analysis|Participant Stopped HIV Medications|1|||
13447399|NCT00296504|26932708|FG007|Interim Analysis|Participant Stopped HIV Medications|0|||
13447400|NCT00296504|26932709|FG008|Interim Analysis|Participant Stopped HIV Medications|0|||
13447401|NCT00296504|26932701|FG000|Interim Analysis|Study Ended|0|||
13447402|NCT00296504|26932702|FG001|Interim Analysis|Study Ended|0|||
13447403|NCT00296504|26932703|FG002|Interim Analysis|Study Ended|0|||
13447404|NCT00296504|26932704|FG003|Interim Analysis|Study Ended|0|||
13447405|NCT00296504|26932705|FG004|Interim Analysis|Study Ended|0|||
13447406|NCT00296504|26932706|FG005|Interim Analysis|Study Ended|0|||
13447407|NCT00296504|26932707|FG006|Interim Analysis|Study Ended|1|||
13447408|NCT00296504|26932708|FG007|Interim Analysis|Study Ended|0|||
13447409|NCT00296504|26932709|FG008|Interim Analysis|Study Ended|0|||
13447410|NCT00296504|26932701|FG000|Interim Analysis|Participant Needed Interferon|0|||
13447411|NCT00296504|26932702|FG001|Interim Analysis|Participant Needed Interferon|0|||
13447412|NCT00296504|26932703|FG002|Interim Analysis|Participant Needed Interferon|0|||
13447413|NCT00296504|26932704|FG003|Interim Analysis|Participant Needed Interferon|0|||
13447414|NCT00296504|26932705|FG004|Interim Analysis|Participant Needed Interferon|0|||
13447415|NCT00296504|26932706|FG005|Interim Analysis|Participant Needed Interferon|0|||
13447416|NCT00296504|26932707|FG006|Interim Analysis|Participant Needed Interferon|0|||
13447417|NCT00296504|26932708|FG007|Interim Analysis|Participant Needed Interferon|1|||
13447418|NCT00296504|26932709|FG008|Interim Analysis|Participant Needed Interferon|0|||
13447419|NCT00296504|26932701|FG000|Interim Analysis|Ongoing|32|||
13447420|NCT00296504|26932702|FG001|Interim Analysis|Ongoing|12|||
13447421|NCT00296504|26932703|FG002|Interim Analysis|Ongoing|16|||
13447422|NCT00296504|26932704|FG003|Interim Analysis|Ongoing|22|||
13447423|NCT00296504|26932705|FG004|Interim Analysis|Ongoing|0|||
13447424|NCT00296504|26932706|FG005|Interim Analysis|Ongoing|0|||
13447425|NCT00296504|26932707|FG006|Interim Analysis|Ongoing|30|||
13447426|NCT00296504|26932708|FG007|Interim Analysis|Ongoing|1|||
13447427|NCT00296504|26932709|FG008|Interim Analysis|Ongoing|0|||
13447428|NCT00296504|26932701|FG000|Final Analysis|Withdrawal by Subject|0|||
13447429|NCT00296504|26932702|FG001|Final Analysis|Withdrawal by Subject|0|||
13447430|NCT00296504|26932703|FG002|Final Analysis|Withdrawal by Subject|0|||
13447431|NCT00296504|26932704|FG003|Final Analysis|Withdrawal by Subject|0|||
13447432|NCT00296504|26932705|FG004|Final Analysis|Withdrawal by Subject|0|||
13447433|NCT00296504|26932706|FG005|Final Analysis|Withdrawal by Subject|0|||
13447434|NCT00296504|26932707|FG006|Final Analysis|Withdrawal by Subject|0|||
13447435|NCT00296504|26932708|FG007|Final Analysis|Withdrawal by Subject|0|||
13447436|NCT00296504|26932709|FG008|Final Analysis|Withdrawal by Subject|1|||
13447437|NCT00296504|26932701|FG000|Final Analysis|Lost to Follow-up|0|||
13447438|NCT00296504|26932702|FG001|Final Analysis|Lost to Follow-up|0|||
13447439|NCT00296504|26932703|FG002|Final Analysis|Lost to Follow-up|0|||
13447440|NCT00296504|26932704|FG003|Final Analysis|Lost to Follow-up|0|||
13447441|NCT00296504|26932705|FG004|Final Analysis|Lost to Follow-up|0|||
13447442|NCT00296504|26932706|FG005|Final Analysis|Lost to Follow-up|0|||
13447443|NCT00296504|26932707|FG006|Final Analysis|Lost to Follow-up|0|||
13447444|NCT00296504|26932708|FG007|Final Analysis|Lost to Follow-up|0|||
13447445|NCT00296504|26932709|FG008|Final Analysis|Lost to Follow-up|5|||
13447446|NCT00296504|26932701|FG000|Final Analysis|Insufficient Viral Load Response|0|||
13447447|NCT00296504|26932702|FG001|Final Analysis|Insufficient Viral Load Response|0|||
13447448|NCT00296504|26932703|FG002|Final Analysis|Insufficient Viral Load Response|0|||
13447449|NCT00296504|26932704|FG003|Final Analysis|Insufficient Viral Load Response|0|||
13447450|NCT00296504|26932705|FG004|Final Analysis|Insufficient Viral Load Response|0|||
13447451|NCT00296504|26932706|FG005|Final Analysis|Insufficient Viral Load Response|0|||
13447452|NCT00296504|26932707|FG006|Final Analysis|Insufficient Viral Load Response|0|||
13447453|NCT00296504|26932708|FG007|Final Analysis|Insufficient Viral Load Response|0|||
13447454|NCT00296504|26932709|FG008|Final Analysis|Insufficient Viral Load Response|6|||
13447455|NCT00296504|26932701|FG000|Final Analysis|Adverse Event|0|||
13447456|NCT00296504|26932702|FG001|Final Analysis|Adverse Event|0|||
13447457|NCT00296504|26932703|FG002|Final Analysis|Adverse Event|0|||
13447458|NCT00296504|26932704|FG003|Final Analysis|Adverse Event|0|||
13447459|NCT00296504|26932705|FG004|Final Analysis|Adverse Event|0|||
13447460|NCT00296504|26932706|FG005|Final Analysis|Adverse Event|0|||
13447461|NCT00296504|26932707|FG006|Final Analysis|Adverse Event|0|||
13447462|NCT00296504|26932708|FG007|Final Analysis|Adverse Event|0|||
13447463|NCT00296504|26932709|FG008|Final Analysis|Adverse Event|2|||
13447464|NCT00296504|26932701|FG000|Final Analysis|Pregnancy|0|||
13447465|NCT00296504|26932702|FG001|Final Analysis|Pregnancy|0|||
13447466|NCT00296504|26932703|FG002|Final Analysis|Pregnancy|0|||
13447467|NCT00296504|26932704|FG003|Final Analysis|Pregnancy|0|||
13447468|NCT00296504|26932705|FG004|Final Analysis|Pregnancy|0|||
13447469|NCT00296504|26932706|FG005|Final Analysis|Pregnancy|0|||
13447470|NCT00296504|26932707|FG006|Final Analysis|Pregnancy|0|||
13447471|NCT00296504|26932708|FG007|Final Analysis|Pregnancy|0|||
13447472|NCT00296504|26932709|FG008|Final Analysis|Pregnancy|4|||
13447473|NCT00296504|26932701|FG000|Final Analysis|Tuberculosis|0|||
13447474|NCT00296504|26932702|FG001|Final Analysis|Tuberculosis|0|||
13447475|NCT00296504|26932703|FG002|Final Analysis|Tuberculosis|0|||
13447476|NCT00296504|26932704|FG003|Final Analysis|Tuberculosis|0|||
13447477|NCT00296504|26932705|FG004|Final Analysis|Tuberculosis|0|||
13447478|NCT00296504|26932706|FG005|Final Analysis|Tuberculosis|0|||
13447479|NCT00296504|26932707|FG006|Final Analysis|Tuberculosis|0|||
13447480|NCT00296504|26932708|FG007|Final Analysis|Tuberculosis|0|||
13447481|NCT00296504|26932709|FG008|Final Analysis|Tuberculosis|1|||
13447482|NCT00296504|26932701|FG000|Final Analysis|Participant Moved to Another Country|0|||
13447483|NCT00296504|26932702|FG001|Final Analysis|Participant Moved to Another Country|0|||
13447484|NCT00296504|26932703|FG002|Final Analysis|Participant Moved to Another Country|0|||
13447485|NCT00296504|26932704|FG003|Final Analysis|Participant Moved to Another Country|0|||
13447486|NCT00296504|26932705|FG004|Final Analysis|Participant Moved to Another Country|0|||
13447487|NCT00296504|26932706|FG005|Final Analysis|Participant Moved to Another Country|0|||
13447488|NCT00296504|26932707|FG006|Final Analysis|Participant Moved to Another Country|0|||
13447489|NCT00296504|26932708|FG007|Final Analysis|Participant Moved to Another Country|0|||
13447490|NCT00296504|26932709|FG008|Final Analysis|Participant Moved to Another Country|1|||
13447491|NCT00296504|26932701|FG000|Final Analysis|Poor Adherence|0|||
13447492|NCT00296504|26932702|FG001|Final Analysis|Poor Adherence|0|||
13447493|NCT00296504|26932703|FG002|Final Analysis|Poor Adherence|0|||
13447494|NCT00296504|26932704|FG003|Final Analysis|Poor Adherence|0|||
13447495|NCT00296504|26932705|FG004|Final Analysis|Poor Adherence|0|||
13447496|NCT00296504|26932706|FG005|Final Analysis|Poor Adherence|0|||
13447497|NCT00296504|26932707|FG006|Final Analysis|Poor Adherence|0|||
13447498|NCT00296504|26932708|FG007|Final Analysis|Poor Adherence|0|||
13447499|NCT00296504|26932709|FG008|Final Analysis|Poor Adherence|1|||
13447500|NCT00296491|26932748|FG000|Overall Study|Low Pollen Counts|18|||
13447501|NCT00296491|26932749|FG001|Overall Study|Low Pollen Counts|26|||
13447502|NCT00296491|26932750|FG002|Overall Study|Low Pollen Counts|25|||
13447503|NCT00296491|26932751|FG003|Overall Study|Low Pollen Counts|16|||
13447504|NCT00296491|26932748|FG000|Overall Study|Protocol Violation|4|||
13447505|NCT00296491|26932749|FG001|Overall Study|Protocol Violation|6|||
13447506|NCT00296491|26932750|FG002|Overall Study|Protocol Violation|2|||
13447507|NCT00296491|26932751|FG003|Overall Study|Protocol Violation|3|||
13447508|NCT00296491|26932748|FG000|Overall Study|Adverse Event|1|||
13447509|NCT00296491|26932749|FG001|Overall Study|Adverse Event|3|||
13447510|NCT00296491|26932750|FG002|Overall Study|Adverse Event|1|||
13447511|NCT00296491|26932751|FG003|Overall Study|Adverse Event|4|||
13447512|NCT00296491|26932748|FG000|Overall Study|Withdrawn due to Asthma|0|||
13447513|NCT00296491|26932749|FG001|Overall Study|Withdrawn due to Asthma|0|||
13447514|NCT00296491|26932750|FG002|Overall Study|Withdrawn due to Asthma|0|||
13447515|NCT00296491|26932751|FG003|Overall Study|Withdrawn due to Asthma|4|||
13447516|NCT00296491|26932748|FG000|Overall Study|Withdrawal by Subject|7|||
13447517|NCT00296491|26932749|FG001|Overall Study|Withdrawal by Subject|3|||
13447518|NCT00296491|26932750|FG002|Overall Study|Withdrawal by Subject|3|||
13447519|NCT00296491|26932751|FG003|Overall Study|Withdrawal by Subject|2|||
13447520|NCT00296491|26932748|FG000|Overall Study|Non-Compliance|12|||
13447521|NCT00296491|26932749|FG001|Overall Study|Non-Compliance|13|||
13447522|NCT00296491|26932750|FG002|Overall Study|Non-Compliance|10|||
13447523|NCT00296491|26932751|FG003|Overall Study|Non-Compliance|14|||
13447524|NCT00296491|26932748|FG000|Overall Study|Lost to Follow-up|0|||
13447525|NCT00296491|26932749|FG001|Overall Study|Lost to Follow-up|2|||
13447526|NCT00296491|26932750|FG002|Overall Study|Lost to Follow-up|2|||
13447527|NCT00296491|26932751|FG003|Overall Study|Lost to Follow-up|0|||
13447528|NCT00296400|26932982|FG000|Overall Study|Adverse Event|7|||
13447529|NCT00296400|26932983|FG001|Overall Study|Adverse Event|7|||
13447530|NCT00296400|26932984|FG002|Overall Study|Adverse Event|7|||
13447531|NCT00296400|26932982|FG000|Overall Study|Withdrawal by Subject|5|||
13447532|NCT00296400|26932983|FG001|Overall Study|Withdrawal by Subject|6|||
13447533|NCT00296400|26932984|FG002|Overall Study|Withdrawal by Subject|2|||
13447534|NCT00296400|26932982|FG000|Overall Study|Incorrect enrollment|2|||
13447535|NCT00296400|26932983|FG001|Overall Study|Incorrect enrollment|0|||
13447536|NCT00296400|26932984|FG002|Overall Study|Incorrect enrollment|0|||
13447537|NCT00296400|26932982|FG000|Overall Study|Protocol Violation|1|||
13447538|NCT00296400|26932983|FG001|Overall Study|Protocol Violation|1|||
13447539|NCT00296400|26932984|FG002|Overall Study|Protocol Violation|1|||
13447540|NCT00296400|26932982|FG000|Overall Study|Lost to Follow-up|1|||
13447541|NCT00296400|26932983|FG001|Overall Study|Lost to Follow-up|1|||
13447542|NCT00296400|26932984|FG002|Overall Study|Lost to Follow-up|2|||
13447543|NCT00296400|26932982|FG000|Overall Study|Study specific discontinuation criteria|0|||
13447544|NCT00296400|26932983|FG001|Overall Study|Study specific discontinuation criteria|0|||
13447545|NCT00296400|26932984|FG002|Overall Study|Study specific discontinuation criteria|1|||
13447546|NCT00296400|26932982|FG000|Overall Study|Visit 10 was performed earlier|0|||
13447547|NCT00296400|26932983|FG001|Overall Study|Visit 10 was performed earlier|1|||
13447548|NCT00296400|26932984|FG002|Overall Study|Visit 10 was performed earlier|0|||
13447549|NCT00296400|26932982|FG000|Overall Study|Pregnancy|1|||
13447550|NCT00296400|26932983|FG001|Overall Study|Pregnancy|2|||
13447551|NCT00296400|26932984|FG002|Overall Study|Pregnancy|0|||
13447552|NCT00296374|26933215|FG000|Overall Study|Adverse Event|14|||
13447553|NCT00296374|26933216|FG001|Overall Study|Adverse Event|10|||
13447554|NCT00296374|26933217|FG002|Overall Study|Adverse Event|7|||
13447555|NCT00296374|26933215|FG000|Overall Study|Withdrawal by Subject|3|||
13447556|NCT00296374|26933216|FG001|Overall Study|Withdrawal by Subject|5|||
13447557|NCT00296374|26933217|FG002|Overall Study|Withdrawal by Subject|11|||
13447558|NCT00296374|26933215|FG000|Overall Study|Incorrect enrollment|3|||
13447559|NCT00296374|26933216|FG001|Overall Study|Incorrect enrollment|3|||
13447560|NCT00296374|26933217|FG002|Overall Study|Incorrect enrollment|4|||
13447561|NCT00296374|26933215|FG000|Overall Study|Protocol Violation|1|||
13447562|NCT00296374|26933216|FG001|Overall Study|Protocol Violation|2|||
13447563|NCT00296374|26933217|FG002|Overall Study|Protocol Violation|3|||
13447564|NCT00296374|26933215|FG000|Overall Study|Lost to Follow-up|3|||
13447565|NCT00296374|26933216|FG001|Overall Study|Lost to Follow-up|1|||
13447566|NCT00296374|26933217|FG002|Overall Study|Lost to Follow-up|1|||
13447567|NCT00296374|26933215|FG000|Overall Study|Relocated to another state|1|||
13447568|NCT00296374|26933216|FG001|Overall Study|Relocated to another state|0|||
13447569|NCT00296374|26933217|FG002|Overall Study|Relocated to another state|0|||
13447570|NCT00296374|26933215|FG000|Overall Study|Stopped drug before end of study visit|0|||
13447571|NCT00296374|26933216|FG001|Overall Study|Stopped drug before end of study visit|1|||
13447572|NCT00296374|26933217|FG002|Overall Study|Stopped drug before end of study visit|0|||
13447573|NCT00296374|26933215|FG000|Overall Study|Nephrologist introduced ACE|0|||
13447574|NCT00296374|26933216|FG001|Overall Study|Nephrologist introduced ACE|1|||
13447575|NCT00296374|26933217|FG002|Overall Study|Nephrologist introduced ACE|0|||
13447576|NCT00296374|26933215|FG000|Overall Study|Pregnancy|0|||
13447577|NCT00296374|26933216|FG001|Overall Study|Pregnancy|0|||
13447578|NCT00296374|26933217|FG002|Overall Study|Pregnancy|2|||
13447579|NCT00296374|26933215|FG000|Overall Study|Other|0|||
13447580|NCT00296374|26933216|FG001|Overall Study|Other|0|||
13447581|NCT00296374|26933217|FG002|Overall Study|Other|1|||
13447582|NCT00296335|26933234|FG000|Overall Study|Recurrence|3|||
13447583|NCT00296335|26933235|FG001|Overall Study|Recurrence|51|||
13447584|NCT00296335|26933234|FG000|Overall Study|Adverse Event|17|||
13447585|NCT00296335|26933235|FG001|Overall Study|Adverse Event|27|||
13447586|NCT00296335|26933234|FG000|Overall Study|Lost to Follow-up|7|||
13447587|NCT00296335|26933235|FG001|Overall Study|Lost to Follow-up|33|||
13447588|NCT00296335|26933234|FG000|Overall Study|Physician Decision|3|||
13447589|NCT00296335|26933235|FG001|Overall Study|Physician Decision|11|||
13447590|NCT00296244|26933258|FG000|Overall Study|Underwent retransplant|0|||
13447591|NCT00296244|26933259|FG001|Overall Study|Underwent retransplant|1|||
13447592|NCT00296140|26933276|FG000|Overall Study|Lost to Follow-up|1|||
13447593|NCT00296140|26933277|FG001|Overall Study|Lost to Follow-up|0|||
13447594|NCT00296140|26933276|FG000|Overall Study|Withdrawal by Subject|1|||
13447595|NCT00296140|26933277|FG001|Overall Study|Withdrawal by Subject|0|||
13447596|NCT00296140|26933276|FG000|Overall Study|Discharge to Nursing Home|1|||
13447597|NCT00296140|26933277|FG001|Overall Study|Discharge to Nursing Home|0|||
13447598|NCT00296036|26933314|FG000|Overall Study|Withdrawal by Subject|1|||
13447599|NCT00296036|26933315|FG001|Overall Study|Withdrawal by Subject|0|||
13447600|NCT00296036|26933316|FG002|Overall Study|Withdrawal by Subject|2|||
13447601|NCT00296036|26933317|FG003|Overall Study|Withdrawal by Subject|1|||
13447602|NCT00296036|26933318|FG004|Overall Study|Withdrawal by Subject|2|||
13447603|NCT00296036|26933319|FG005|Overall Study|Withdrawal by Subject|1|||
13447604|NCT00296036|26933314|FG000|Overall Study|Protocol Violation|0|||
13447605|NCT00296036|26933315|FG001|Overall Study|Protocol Violation|0|||
13447606|NCT00296036|26933316|FG002|Overall Study|Protocol Violation|0|||
13447607|NCT00296036|26933317|FG003|Overall Study|Protocol Violation|0|||
13447608|NCT00296036|26933318|FG004|Overall Study|Protocol Violation|0|||
13447609|NCT00296036|26933319|FG005|Overall Study|Protocol Violation|3|||
13447610|NCT00295932|26933387|FG000|Overall Study|Not Treated|0|||
13447611|NCT00295932|26933388|FG001|Overall Study|Not Treated|0|||
13447612|NCT00295932|26933389|FG002|Overall Study|Not Treated|0|||
13447613|NCT00295932|26933390|FG003|Overall Study|Not Treated|0|||
13447614|NCT00295932|26933391|FG004|Overall Study|Not Treated|0|||
13447615|NCT00295932|26933392|FG005|Overall Study|Not Treated|0|||
13447616|NCT00295932|26933393|FG006|Overall Study|Not Treated|0|||
13447617|NCT00295932|26933394|FG007|Overall Study|Not Treated|0|||
13447618|NCT00295932|26933395|FG008|Overall Study|Not Treated|0|||
13447619|NCT00295932|26933396|FG009|Overall Study|Not Treated|0|||
13447620|NCT00295932|26933397|FG010|Overall Study|Not Treated|1|||
13447621|NCT00295880|26933410|FG000|Overall Study|IBMI unit could not be volume reduced|1|||
13447622|NCT00295880|26933410|FG000|Overall Study|Unit randomization did not occur|1|||
13447623|NCT00295854|26933431|FG000|Overall Study|Adverse Event|7|||
13447624|NCT00295854|26933432|FG001|Overall Study|Adverse Event|7|||
13447625|NCT00295854|26933433|FG002|Overall Study|Adverse Event|6|||
13447626|NCT00295854|26933431|FG000|Overall Study|Protocol Violation|1|||
13447627|NCT00295854|26933432|FG001|Overall Study|Protocol Violation|1|||
13447628|NCT00295854|26933433|FG002|Overall Study|Protocol Violation|1|||
13447629|NCT00295854|26933431|FG000|Overall Study|Lost to Follow-up|2|||
13447630|NCT00295854|26933432|FG001|Overall Study|Lost to Follow-up|0|||
13447631|NCT00295854|26933433|FG002|Overall Study|Lost to Follow-up|1|||
13447632|NCT00295854|26933431|FG000|Overall Study|Withdrawal by Subject|3|||
13447633|NCT00295854|26933432|FG001|Overall Study|Withdrawal by Subject|7|||
13447634|NCT00295854|26933433|FG002|Overall Study|Withdrawal by Subject|4|||
13447635|NCT00295854|26933431|FG000|Overall Study|did not continue to meet criteria|1|||
13447636|NCT00295854|26933432|FG001|Overall Study|did not continue to meet criteria|1|||
13447637|NCT00295854|26933433|FG002|Overall Study|did not continue to meet criteria|2|||
13447638|NCT00295854|26933431|FG000|Overall Study|required a prohibited medication|1|||
13447639|NCT00295854|26933432|FG001|Overall Study|required a prohibited medication|0|||
13447640|NCT00295854|26933433|FG002|Overall Study|required a prohibited medication|0|||
13447641|NCT00295854|26933431|FG000|Overall Study|Other|3|||
13447642|NCT00295854|26933432|FG001|Overall Study|Other|5|||
13447643|NCT00295854|26933433|FG002|Overall Study|Other|1|||
13447644|NCT00295750|26933475|FG000|Overall Study|Adverse Event|19|||
13447645|NCT00295750|26933476|FG001|Overall Study|Adverse Event|15|||
13447646|NCT00295750|26933477|FG002|Overall Study|Adverse Event|12|||
13390606|NCT00685399|26774039|FG001|Extension|Administrative Issues|0|||
13390607|NCT00685399|26774040|FG002|Extension|Administrative Issues|0|||
13390608|NCT00685399|26774041|FG003|Extension|Administrative Issues|1|||
13390609|NCT00685399|26774042|FG004|Extension|Administrative Issues|0|||
13390610|NCT00685399|26774043|FG005|Extension|Administrative Issues|0|||
13390611|NCT00685399|26774044|FG006|Extension|Administrative Issues|0|||
13390612|NCT00685399|26774045|FG007|Extension|Administrative Issues|0|||
13390613|NCT00685399|26774038|FG000|Extension|Withdrawal by Subject|0|||
13390614|NCT00685399|26774039|FG001|Extension|Withdrawal by Subject|0|||
13390615|NCT00685399|26774040|FG002|Extension|Withdrawal by Subject|0|||
13390616|NCT00685399|26774041|FG003|Extension|Withdrawal by Subject|1|||
13390617|NCT00685399|26774042|FG004|Extension|Withdrawal by Subject|0|||
13390618|NCT00685399|26774043|FG005|Extension|Withdrawal by Subject|0|||
13390619|NCT00685399|26774044|FG006|Extension|Withdrawal by Subject|0|||
13390620|NCT00685399|26774045|FG007|Extension|Withdrawal by Subject|0|||
13390621|NCT00685399|26774038|FG000|Extension|Protocol Violation|0|||
13390622|NCT00685399|26774039|FG001|Extension|Protocol Violation|0|||
13390623|NCT00685399|26774040|FG002|Extension|Protocol Violation|0|||
13390624|NCT00685399|26774041|FG003|Extension|Protocol Violation|1|||
13390625|NCT00685399|26774042|FG004|Extension|Protocol Violation|0|||
13390626|NCT00685399|26774043|FG005|Extension|Protocol Violation|0|||
13390627|NCT00685399|26774044|FG006|Extension|Protocol Violation|0|||
13390628|NCT00685399|26774045|FG007|Extension|Protocol Violation|0|||
13390629|NCT00685399|26774038|FG000|Extension|Lack of Efficacy|0|||
13390630|NCT00685399|26774039|FG001|Extension|Lack of Efficacy|0|||
13390631|NCT00685399|26774040|FG002|Extension|Lack of Efficacy|0|||
13390632|NCT00685399|26774041|FG003|Extension|Lack of Efficacy|2|||
13390633|NCT00685399|26774042|FG004|Extension|Lack of Efficacy|0|||
13390634|NCT00685399|26774043|FG005|Extension|Lack of Efficacy|0|||
13390635|NCT00685399|26774044|FG006|Extension|Lack of Efficacy|0|||
13390636|NCT00685399|26774045|FG007|Extension|Lack of Efficacy|0|||
13390637|NCT00685399|26774038|FG000|Extension|Adverse Event|0|||
13390638|NCT00685399|26774039|FG001|Extension|Adverse Event|0|||
13390639|NCT00685399|26774040|FG002|Extension|Adverse Event|0|||
13390640|NCT00685399|26774041|FG003|Extension|Adverse Event|2|||
13390641|NCT00685399|26774042|FG004|Extension|Adverse Event|0|||
13390642|NCT00685399|26774043|FG005|Extension|Adverse Event|0|||
13390643|NCT00685399|26774044|FG006|Extension|Adverse Event|0|||
13390644|NCT00685399|26774045|FG007|Extension|Adverse Event|0|||
13390645|NCT00685373|26774054|FG000|Overall Study|Adverse Event|3|||
13390646|NCT00685373|26774054|FG000|Overall Study|Withdrawal by Subject|5|||
13390647|NCT00685373|26774054|FG000|Overall Study|Lack of Efficacy|3|||
13390648|NCT00685373|26774054|FG000|Overall Study|Condition no longer requires study drug|1|||
13390649|NCT00685373|26774054|FG000|Overall Study|Lost to Follow-up|2|||
13390650|NCT00685373|26774054|FG000|Overall Study|Protocol Violation|1|||
13390651|NCT00685360|26774175|FG000|Overall Study|Lost to Follow-up|0|||
13390652|NCT00685360|26774176|FG001|Overall Study|Lost to Follow-up|1|||
13390653|NCT00685360|26774177|FG002|Overall Study|Lost to Follow-up|2|||
13390654|NCT00685360|26774175|FG000|Overall Study|Adverse Event|4|||
13390655|NCT00685360|26774176|FG001|Overall Study|Adverse Event|6|||
13390656|NCT00685360|26774177|FG002|Overall Study|Adverse Event|4|||
13390657|NCT00685360|26774175|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1|||
13390658|NCT00685360|26774176|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0|||
13390659|NCT00685360|26774177|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2|||
13390660|NCT00685360|26774175|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0|||
13390661|NCT00685360|26774176|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4|||
13390662|NCT00685360|26774177|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1|||
13390663|NCT00685360|26774175|FG000|Overall Study|Subject Withdrew Consent to Participate|13|||
13390664|NCT00685360|26774176|FG001|Overall Study|Subject Withdrew Consent to Participate|2|||
13447647|NCT00295750|26933475|FG000|Overall Study|Lack of Efficacy|1|||
13447648|NCT00295750|26933476|FG001|Overall Study|Lack of Efficacy|1|||
13447649|NCT00295750|26933477|FG002|Overall Study|Lack of Efficacy|0|||
13447650|NCT00295750|26933475|FG000|Overall Study|Lost to Follow-up|1|||
13447651|NCT00295750|26933476|FG001|Overall Study|Lost to Follow-up|4|||
13447652|NCT00295750|26933477|FG002|Overall Study|Lost to Follow-up|1|||
13447653|NCT00295750|26933475|FG000|Overall Study|Taking prohibited therapy|2|||
13447654|NCT00295750|26933476|FG001|Overall Study|Taking prohibited therapy|3|||
13447655|NCT00295750|26933477|FG002|Overall Study|Taking prohibited therapy|2|||
13447656|NCT00295750|26933475|FG000|Overall Study|Administrative errors|2|||
13447657|NCT00295750|26933476|FG001|Overall Study|Administrative errors|4|||
13447658|NCT00295750|26933477|FG002|Overall Study|Administrative errors|5|||
13447659|NCT00295750|26933475|FG000|Overall Study|Trial drug errors|1|||
13447660|NCT00295750|26933476|FG001|Overall Study|Trial drug errors|1|||
13447661|NCT00295750|26933477|FG002|Overall Study|Trial drug errors|0|||
13447662|NCT00295750|26933475|FG000|Overall Study|Disease progression|2|||
13447663|NCT00295750|26933476|FG001|Overall Study|Disease progression|1|||
13447664|NCT00295750|26933477|FG002|Overall Study|Disease progression|0|||
13447665|NCT00295750|26933475|FG000|Overall Study|Personal reasons|0|||
13447666|NCT00295750|26933476|FG001|Overall Study|Personal reasons|1|||
13447667|NCT00295750|26933477|FG002|Overall Study|Personal reasons|0|||
13447668|NCT00295750|26933475|FG000|Overall Study|Randomized but never received trial drug|4|||
13447669|NCT00295750|26933476|FG001|Overall Study|Randomized but never received trial drug|3|||
13447670|NCT00295750|26933477|FG002|Overall Study|Randomized but never received trial drug|3|||
13447671|NCT00295750|26933475|FG000|Overall Study|Withdrawal by Subject|9|||
13447672|NCT00295750|26933476|FG001|Overall Study|Withdrawal by Subject|4|||
13447673|NCT00295750|26933477|FG002|Overall Study|Withdrawal by Subject|7|||
13447674|NCT00295750|26933475|FG000|Overall Study|Protocol Violation|2|||
13447675|NCT00295750|26933476|FG001|Overall Study|Protocol Violation|4|||
13447676|NCT00295750|26933477|FG002|Overall Study|Protocol Violation|2|||
13447677|NCT00295633|26933504|FG000|Overall Study|Lack of Efficacy|19|||
13447678|NCT00295633|26933505|FG001|Overall Study|Lack of Efficacy|7|||
13447679|NCT00295633|26933506|FG002|Overall Study|Lack of Efficacy|16|||
13447680|NCT00295633|26933504|FG000|Overall Study|Withdrawal of consent by subject|16|||
13447681|NCT00295633|26933505|FG001|Overall Study|Withdrawal of consent by subject|16|||
13447682|NCT00295633|26933506|FG002|Overall Study|Withdrawal of consent by subject|26|||
13447683|NCT00295633|26933504|FG000|Overall Study|Adverse Event|9|||
13447684|NCT00295633|26933505|FG001|Overall Study|Adverse Event|17|||
13447685|NCT00295633|26933506|FG002|Overall Study|Adverse Event|9|||
13447686|NCT00295633|26933504|FG000|Overall Study|Lost to Follow-up|6|||
13447687|NCT00295633|26933505|FG001|Overall Study|Lost to Follow-up|11|||
13447688|NCT00295633|26933506|FG002|Overall Study|Lost to Follow-up|7|||
13447689|NCT00295633|26933504|FG000|Overall Study|Physician Decision|9|||
13447690|NCT00295633|26933505|FG001|Overall Study|Physician Decision|10|||
13447691|NCT00295633|26933506|FG002|Overall Study|Physician Decision|8|||
13447692|NCT00295633|26933504|FG000|Overall Study|Poor/Noncompliance|2|||
13447693|NCT00295633|26933505|FG001|Overall Study|Poor/Noncompliance|2|||
13447694|NCT00295633|26933506|FG002|Overall Study|Poor/Noncompliance|6|||
13447695|NCT00295633|26933504|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
13447696|NCT00295633|26933505|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
13447697|NCT00295633|26933506|FG002|Overall Study|Subject No Longer Meets Study Criteria|3|||
13447698|NCT00295633|26933504|FG000|Overall Study|Death|1|||
13447699|NCT00295633|26933505|FG001|Overall Study|Death|1|||
13447700|NCT00295633|26933506|FG002|Overall Study|Death|0|||
13447701|NCT00295633|26933504|FG000|Overall Study|Administrative reason by sponsor|0|||
13447702|NCT00295633|26933505|FG001|Overall Study|Administrative reason by sponsor|0|||
13447703|NCT00295633|26933506|FG002|Overall Study|Administrative reason by sponsor|1|||
13477268|NCT01545050|27005970|FG003|Overall Study|Lack of Efficacy|3|||
13477269|NCT01545050|27005971|FG004|Overall Study|Lack of Efficacy|2|||
13477270|NCT01545050|27005967|FG000|Overall Study|Adverse Event|1|||
13477271|NCT01545050|27005968|FG001|Overall Study|Adverse Event|1|||
13477272|NCT01545050|27005969|FG002|Overall Study|Adverse Event|2|||
13477273|NCT01545050|27005970|FG003|Overall Study|Adverse Event|2|||
13477274|NCT01545050|27005971|FG004|Overall Study|Adverse Event|0|||
13477275|NCT01545050|27005967|FG000|Overall Study|Discontinued study treatment|1|||
13477276|NCT01545050|27005968|FG001|Overall Study|Discontinued study treatment|0|||
13477277|NCT01545050|27005969|FG002|Overall Study|Discontinued study treatment|0|||
13477278|NCT01545050|27005970|FG003|Overall Study|Discontinued study treatment|0|||
13477279|NCT01545050|27005971|FG004|Overall Study|Discontinued study treatment|0|||
13477280|NCT01545050|27005967|FG000|Overall Study|Withdrawal by Subject|1|||
13477281|NCT01545050|27005968|FG001|Overall Study|Withdrawal by Subject|0|||
13477282|NCT01545050|27005969|FG002|Overall Study|Withdrawal by Subject|0|||
13477283|NCT01545050|27005970|FG003|Overall Study|Withdrawal by Subject|2|||
13477284|NCT01545050|27005971|FG004|Overall Study|Withdrawal by Subject|1|||
13477285|NCT01545050|27005967|FG000|Overall Study|Participant no longer meets study criteria|0|||
13477286|NCT01545050|27005968|FG001|Overall Study|Participant no longer meets study criteria|2|||
13447704|NCT00295620|26933527|FG000|Overall Study|Lost to Follow-up|9|||
13447705|NCT00295620|26933528|FG001|Overall Study|Lost to Follow-up|5|||
13447706|NCT00295620|26933527|FG000|Overall Study|Withdrawal by Subject|37|||
13447707|NCT00295620|26933528|FG001|Overall Study|Withdrawal by Subject|50|||
13447708|NCT00295620|26933527|FG000|Overall Study|Death|206|||
13447709|NCT00295620|26933528|FG001|Overall Study|Death|207|||
13447710|NCT00295620|26933527|FG000|Overall Study|Other reasons|10|||
13447711|NCT00295620|26933528|FG001|Overall Study|Other reasons|9|||
13447712|NCT00295620|26933527|FG000|Overall Study|Discontinuation by sponsor|580|||
13447713|NCT00295620|26933528|FG001|Overall Study|Discontinuation by sponsor|593|||
13447714|NCT00295620|26933527|FG000|Overall Study|Protocol Violation|30|||
13447715|NCT00295620|26933528|FG001|Overall Study|Protocol Violation|32|||
13447716|NCT00295490|26933579|FG000|Overall Study|Protocol Violation|0|||
13447717|NCT00295490|26933580|FG001|Overall Study|Protocol Violation|0|||
13447718|NCT00295490|26933581|FG002|Overall Study|Protocol Violation|3|||
13447719|NCT00295490|26933582|FG003|Overall Study|Protocol Violation|3|||
13447720|NCT00295490|26933579|FG000|Overall Study|Withdrawal by Subject|0|||
13447721|NCT00295490|26933580|FG001|Overall Study|Withdrawal by Subject|2|||
13447722|NCT00295490|26933581|FG002|Overall Study|Withdrawal by Subject|0|||
13447723|NCT00295490|26933582|FG003|Overall Study|Withdrawal by Subject|1|||
13447724|NCT00295490|26933579|FG000|Overall Study|Lost to Follow-up|0|||
13447725|NCT00295490|26933580|FG001|Overall Study|Lost to Follow-up|0|||
13447726|NCT00295490|26933581|FG002|Overall Study|Lost to Follow-up|1|||
13447727|NCT00295490|26933582|FG003|Overall Study|Lost to Follow-up|0|||
13447728|NCT00295490|26933579|FG000|Overall Study|Adverse Event|1|||
13447729|NCT00295490|26933580|FG001|Overall Study|Adverse Event|0|||
13447730|NCT00295490|26933581|FG002|Overall Study|Adverse Event|0|||
13447731|NCT00295490|26933582|FG003|Overall Study|Adverse Event|0|||
13447732|NCT00295490|26933579|FG000|Overall Study|Other|0|||
13447733|NCT00295490|26933580|FG001|Overall Study|Other|2|||
13447734|NCT00295490|26933581|FG002|Overall Study|Other|0|||
13447735|NCT00295490|26933582|FG003|Overall Study|Other|1|||
13447736|NCT00295022|26933675|FG000|Overall Study|Adverse Event|1|||
13447737|NCT00295022|26933676|FG001|Overall Study|Adverse Event|1|||
13447738|NCT00295022|26933677|FG002|Overall Study|Adverse Event|2|||
13447739|NCT00295022|26933675|FG000|Overall Study|Lost to Follow-up|0|||
13447740|NCT00295022|26933676|FG001|Overall Study|Lost to Follow-up|0|||
13447741|NCT00295022|26933677|FG002|Overall Study|Lost to Follow-up|1|||
13447742|NCT00295022|26933675|FG000|Overall Study|Withdrawal by Subject|0|||
13447743|NCT00295022|26933676|FG001|Overall Study|Withdrawal by Subject|0|||
13447744|NCT00295022|26933677|FG002|Overall Study|Withdrawal by Subject|2|||
13447745|NCT00294762|26933700|FG000|Overall Study|Did not receive study treatment|3|||
13447746|NCT00294762|26933701|FG001|Overall Study|Did not receive study treatment|3|||
13447747|NCT00294723|26933770|FG000|Double-Blind Period 52 Weeks|Adverse Event|18|||
13447748|NCT00294723|26933771|FG001|Double-Blind Period 52 Weeks|Adverse Event|25|||
13447749|NCT00294723|26933772|FG002|Double-Blind Period 52 Weeks|Adverse Event|15|||
13447750|NCT00294723|26933770|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9|||
13447751|NCT00294723|26933771|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15|||
13447752|NCT00294723|26933772|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25|||
13447753|NCT00294723|26933770|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11|||
13447754|NCT00294723|26933771|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11|||
13447755|NCT00294723|26933772|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5|||
13447756|NCT00294723|26933770|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36|||
13447757|NCT00294723|26933771|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38|||
13447758|NCT00294723|26933772|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51|||
13447759|NCT00294723|26933770|FG000|Open-Label Extension 52 Weeks|Adverse Event|5|||
13447760|NCT00294723|26933771|FG001|Open-Label Extension 52 Weeks|Adverse Event|5|||
13447761|NCT00294723|26933772|FG002|Open-Label Extension 52 Weeks|Adverse Event|2|||
13447762|NCT00294723|26933770|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12|||
13447763|NCT00294723|26933771|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15|||
13447764|NCT00294723|26933772|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21|||
13447765|NCT00294723|26933770|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4|||
13447766|NCT00294723|26933771|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3|||
13447767|NCT00294723|26933772|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3|||
13447768|NCT00294723|26933770|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19|||
13447769|NCT00294723|26933771|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16|||
13447770|NCT00294723|26933772|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14|||
13447771|NCT00294723|26933770|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
13447772|NCT00294723|26933771|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
13447773|NCT00294723|26933772|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0|||
13447774|NCT00294723|26933770|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24|||
13447775|NCT00294723|26933771|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14|||
13447776|NCT00294723|26933772|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16|||
13447777|NCT00294723|26933770|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
13447778|NCT00294723|26933771|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
13447779|NCT00294723|26933772|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
13447780|NCT00294723|26933770|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2|||
13447781|NCT00294723|26933771|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5|||
13447782|NCT00294723|26933772|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3|||
13447783|NCT00294684|26933817|FG000|Overall Study|Lost to Follow-up|5|||
13447784|NCT00294684|26933818|FG001|Overall Study|Lost to Follow-up|8|||
13447785|NCT00294671|26933839|FG000|Overall Study|Lack of Efficacy|11|||
13447786|NCT00294671|26933840|FG001|Overall Study|Lack of Efficacy|23|||
13447787|NCT00294671|26933839|FG000|Overall Study|Liver transplant|7|||
13447788|NCT00294671|26933840|FG001|Overall Study|Liver transplant|9|||
13447789|NCT00294671|26933839|FG000|Overall Study|Drug related adverse event (AE)|4|||
13447790|NCT00294671|26933840|FG001|Overall Study|Drug related adverse event (AE)|2|||
13447791|NCT00294671|26933839|FG000|Overall Study|Non-drug related AE|3|||
13447792|NCT00294671|26933840|FG001|Overall Study|Non-drug related AE|2|||
13447793|NCT00294671|26933839|FG000|Overall Study|Lost to Follow-up|1|||
13447794|NCT00294671|26933840|FG001|Overall Study|Lost to Follow-up|3|||
13447795|NCT00294671|26933839|FG000|Overall Study|Non-compliance|1|||
13447796|NCT00294671|26933840|FG001|Overall Study|Non-compliance|0|||
13447797|NCT00294671|26933839|FG000|Overall Study|Death|0|||
13447798|NCT00294671|26933840|FG001|Overall Study|Death|1|||
13447799|NCT00294658|26933909|FG000|Overall Study|Death|0|||
13447800|NCT00294658|26933910|FG001|Overall Study|Death|1|||
13447801|NCT00294658|26933909|FG000|Overall Study|Lost to Follow-up|4|||
13447802|NCT00294658|26933910|FG001|Overall Study|Lost to Follow-up|0|||
13447803|NCT00294658|26933909|FG000|Overall Study|Physician Decision|1|||
13447804|NCT00294658|26933910|FG001|Overall Study|Physician Decision|2|||
13447805|NCT00294658|26933909|FG000|Overall Study|Pregnancy|0|||
13447806|NCT00294658|26933910|FG001|Overall Study|Pregnancy|1|||
13447807|NCT00294658|26933909|FG000|Overall Study|Withdrawal by Subject|0|||
13447808|NCT00294658|26933910|FG001|Overall Study|Withdrawal by Subject|4|||
13447809|NCT00294658|26933909|FG000|Overall Study|Found to have invasive thymoma|1|||
13447810|NCT00294658|26933910|FG001|Overall Study|Found to have invasive thymoma|0|||
13447811|NCT00294658|26933909|FG000|Overall Study|Patient and family were not satisfied|0|||
13447812|NCT00294658|26933910|FG001|Overall Study|Patient and family were not satisfied|1|||
13447813|NCT00294645|26933949|FG000|Overall Study|Death|10|||
13447814|NCT00294645|26933950|FG001|Overall Study|Death|18|||
13447815|NCT00294645|26933949|FG000|Overall Study|Lost to Follow-up|1|||
13447816|NCT00294645|26933950|FG001|Overall Study|Lost to Follow-up|10|||
13447817|NCT00294645|26933949|FG000|Overall Study|Withdrawal by Subject|18|||
13447818|NCT00294645|26933950|FG001|Overall Study|Withdrawal by Subject|34|||
13447819|NCT00294645|26933949|FG000|Overall Study|Physician Decision|15|||
13447820|NCT00294645|26933950|FG001|Overall Study|Physician Decision|20|||
13447821|NCT00294645|26933949|FG000|Overall Study|Other|4|||
13447822|NCT00294645|26933950|FG001|Overall Study|Other|10|||
13447823|NCT00294554|26933965|FG000|Overall Study|Lack of Efficacy|0|||
13447824|NCT00294554|26933966|FG001|Overall Study|Lack of Efficacy|1|||
13447825|NCT00294554|26933965|FG000|Overall Study|Physician Decision|0|||
13447826|NCT00294554|26933966|FG001|Overall Study|Physician Decision|1|||
13447827|NCT00294398|26933981|FG000|Overall Study|Lost to Follow-up|21|||
13447828|NCT00294398|26933982|FG001|Overall Study|Lost to Follow-up|26|||
13447829|NCT00294060|26933990|FG000|Overall Study|Death|225|||
13447830|NCT00294060|26933990|FG000|Overall Study|Other|59|||
13447831|NCT00294060|26933990|FG000|Overall Study|Lost to Follow-up|55|||
13447832|NCT00294060|26933990|FG000|Overall Study|Withdrawal by Subject|11|||
13447833|NCT00294060|26933990|FG000|Overall Study|Physician Decision|797|||
13447834|NCT00294060|26933990|FG000|Overall Study|Medical condition|3|||
13447835|NCT00294060|26933990|FG000|Overall Study|Device explanted/not replaced|23|||
13447836|NCT00294047|26934099|FG000|Month 48|Adverse Event|28|||
13447837|NCT00294047|26934100|FG001|Month 48|Adverse Event|13|||
13447838|NCT00294047|26934099|FG000|Month 48|Protocol Violation|4|||
13447839|NCT00294047|26934100|FG001|Month 48|Protocol Violation|4|||
13447840|NCT00294047|26934099|FG000|Month 48|Withdrawal by Subject|111|||
13447841|NCT00294047|26934100|FG001|Month 48|Withdrawal by Subject|115|||
13447842|NCT00294047|26934099|FG000|Month 48|Lost to Follow-up|272|||
13447843|NCT00294047|26934100|FG001|Month 48|Lost to Follow-up|287|||
13447844|NCT00294047|26934099|FG000|Month 48|Other|10|||
13447845|NCT00294047|26934100|FG001|Month 48|Other|14|||
13447846|NCT00294047|26934099|FG000|Month 84|Adverse Event|4|||
13447847|NCT00294047|26934100|FG001|Month 84|Adverse Event|2|||
13447848|NCT00294047|26934099|FG000|Month 84|Protocol Violation|1|||
13447849|NCT00294047|26934100|FG001|Month 84|Protocol Violation|1|||
13447850|NCT00294047|26934099|FG000|Month 84|Withdrawal by Subject|33|||
13447851|NCT00294047|26934100|FG001|Month 84|Withdrawal by Subject|31|||
13447852|NCT00294047|26934099|FG000|Month 84|Lost to Follow-up|187|||
13447853|NCT00294047|26934100|FG001|Month 84|Lost to Follow-up|190|||
13447854|NCT00294047|26934099|FG000|Month 84|Absent Cervix|2|||
13447855|NCT00294047|26934100|FG001|Month 84|Absent Cervix|0|||
13447856|NCT00294047|26934099|FG000|Month 84|Work related reasons|4|||
13447857|NCT00294047|26934100|FG001|Month 84|Work related reasons|2|||
13447858|NCT00294047|26934099|FG000|Month 84|Center closed, subject did not transfer|1|||
13447859|NCT00294047|26934100|FG001|Month 84|Center closed, subject did not transfer|0|||
13447860|NCT00294047|26934099|FG000|Month 84|Family problems|2|||
13447861|NCT00294047|26934100|FG001|Month 84|Family problems|2|||
13447862|NCT00294047|26934099|FG000|Month 84|Lack of time|3|||
13447863|NCT00294047|26934100|FG001|Month 84|Lack of time|1|||
13447864|NCT00294047|26934099|FG000|Month 84|Personal reason|2|||
13447865|NCT00294047|26934100|FG001|Month 84|Personal reason|4|||
13447866|NCT00294047|26934099|FG000|Month 84|Subject does not want male physician|1|||
13447867|NCT00294047|26934100|FG001|Month 84|Subject does not want male physician|0|||
13447868|NCT00294047|26934099|FG000|Month 84|Transport reimbursement delayed|0|||
13447869|NCT00294047|26934100|FG001|Month 84|Transport reimbursement delayed|1|||
13447870|NCT00294047|26934099|FG000|Month 84|Unable to reach study site|1|||
13447871|NCT00294047|26934100|FG001|Month 84|Unable to reach study site|0|||
13447872|NCT00294047|26934099|FG000|Month 84|Under investigation locally|1|||
13447873|NCT00294047|26934100|FG001|Month 84|Under investigation locally|0|||
13447874|NCT00294047|26934099|FG000|Month 84|Visit missed|0|||
13447875|NCT00294047|26934100|FG001|Month 84|Visit missed|1|||
13447876|NCT00294047|26934099|FG000|Month 84|No consent for Month 84 Follow-up|731|||
13447877|NCT00294047|26934100|FG001|Month 84|No consent for Month 84 Follow-up|754|||
13447878|NCT00293813|26934121|FG000|Overall Study|Physician Decision|0|||
13447879|NCT00293813|26934122|FG001|Overall Study|Physician Decision|1|||
13447880|NCT00293813|26934123|FG002|Overall Study|Physician Decision|0|||
13447881|NCT00293813|26934121|FG000|Overall Study|Adverse Event|3|||
13447882|NCT00293813|26934122|FG001|Overall Study|Adverse Event|1|||
13447883|NCT00293813|26934123|FG002|Overall Study|Adverse Event|1|||
13447884|NCT00293813|26934121|FG000|Overall Study|Withdrawal by Subject|7|||
13447885|NCT00293813|26934122|FG001|Overall Study|Withdrawal by Subject|4|||
13447886|NCT00293813|26934123|FG002|Overall Study|Withdrawal by Subject|4|||
13447887|NCT00293813|26934121|FG000|Overall Study|Lost to Follow-up|3|||
13447888|NCT00293813|26934122|FG001|Overall Study|Lost to Follow-up|2|||
13447889|NCT00293813|26934123|FG002|Overall Study|Lost to Follow-up|3|||
13447890|NCT00293813|26934121|FG000|Overall Study|Noncompliance|0|||
13447891|NCT00293813|26934122|FG001|Overall Study|Noncompliance|1|||
13447892|NCT00293813|26934123|FG002|Overall Study|Noncompliance|0|||
13447893|NCT00293722|26934139|FG000|Overall Study|Other|427|||
13447894|NCT00293709|26934155|FG000|Overall Study|Other|47|||
13447895|NCT00293579|26934164|FG000|Overall Study|Withdrawal by Subject|1|||
13447896|NCT00293462|26934193|FG000|Overall Study|Withdrawal by Subject|4|||
13447897|NCT00293462|26934194|FG001|Overall Study|Withdrawal by Subject|3|||
13447898|NCT00293462|26934195|FG002|Overall Study|Withdrawal by Subject|8|||
13447899|NCT00293462|26934193|FG000|Overall Study|Death|1|||
13447900|NCT00293462|26934194|FG001|Overall Study|Death|0|||
13447901|NCT00293462|26934195|FG002|Overall Study|Death|0|||
13447902|NCT00293462|26934193|FG000|Overall Study|Lost to Follow-up|0|||
13447903|NCT00293462|26934194|FG001|Overall Study|Lost to Follow-up|1|||
13447904|NCT00293462|26934195|FG002|Overall Study|Lost to Follow-up|0|||
13447905|NCT00293462|26934193|FG000|Overall Study|Change Treatment Regimen (ineligible)|1|||
13447906|NCT00293462|26934194|FG001|Overall Study|Change Treatment Regimen (ineligible)|0|||
13447907|NCT00293462|26934195|FG002|Overall Study|Change Treatment Regimen (ineligible)|0|||
13447908|NCT00293462|26934193|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
13447909|NCT00293462|26934194|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1|||
13447910|NCT00293462|26934195|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
13447911|NCT00293462|26934193|FG000|Overall Study|Refuse Radiation Treatment|1|||
13447912|NCT00293462|26934194|FG001|Overall Study|Refuse Radiation Treatment|0|||
13447913|NCT00293462|26934195|FG002|Overall Study|Refuse Radiation Treatment|0|||
13447914|NCT00293462|26934193|FG000|Overall Study|No Show|0|||
13447915|NCT00293462|26934194|FG001|Overall Study|No Show|0|||
13447916|NCT00293462|26934195|FG002|Overall Study|No Show|1|||
13447917|NCT00293462|26934193|FG000|Overall Study|Went back to his home country|0|||
13447918|NCT00293462|26934194|FG001|Overall Study|Went back to his home country|0|||
13447919|NCT00293462|26934195|FG002|Overall Study|Went back to his home country|1|||
13447920|NCT00293462|26934193|FG000|Overall Study|Blood clot after chemotherapy|0|||
13447921|NCT00293462|26934194|FG001|Overall Study|Blood clot after chemotherapy|0|||
13447922|NCT00293462|26934195|FG002|Overall Study|Blood clot after chemotherapy|1|||
13447923|NCT00293462|26934193|FG000|Overall Study|Ischemic stroke after chemotherapy|0|||
13447924|NCT00293462|26934194|FG001|Overall Study|Ischemic stroke after chemotherapy|0|||
13447925|NCT00293462|26934195|FG002|Overall Study|Ischemic stroke after chemotherapy|1|||
13447926|NCT00293462|26934193|FG000|Overall Study|Possible Tracheostomy leakage|0|||
13447927|NCT00293462|26934194|FG001|Overall Study|Possible Tracheostomy leakage|1|||
13447928|NCT00293462|26934195|FG002|Overall Study|Possible Tracheostomy leakage|0|||
13447929|NCT00293462|26934193|FG000|Overall Study|Low radiation dose in oral cavity|0|||
13447930|NCT00293462|26934194|FG001|Overall Study|Low radiation dose in oral cavity|1|||
13447931|NCT00293462|26934195|FG002|Overall Study|Low radiation dose in oral cavity|0|||
13447932|NCT00293462|26934193|FG000|Overall Study|Physician Decision|0|||
13447933|NCT00293462|26934194|FG001|Overall Study|Physician Decision|1|||
13447934|NCT00293462|26934195|FG002|Overall Study|Physician Decision|0|||
13447935|NCT00293423|26934217|FG000|Surgical Resection|Less than a 90% extent of resection|0|||
13447936|NCT00293423|26934218|FG001|Surgical Resection|Less than a 90% extent of resection|1|||
13447937|NCT00293423|26934217|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0|||
13447938|NCT00293423|26934218|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4|||
13447939|NCT00293423|26934217|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9|||
13447940|NCT00293423|26934218|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13|||
13447941|NCT00293423|26934217|FG000|Surgical Resection|disease progression prior to initial vaccination|2|||
13447942|NCT00293423|26934218|FG001|Surgical Resection|disease progression prior to initial vaccination|9|||
13447943|NCT00293423|26934217|FG000|Surgical Resection|processing error during surgical resection|1|||
13447944|NCT00293423|26934218|FG001|Surgical Resection|processing error during surgical resection|0|||
13447945|NCT00293423|26934217|FG000|Surgical Resection|Withdrawal by Subject|4|||
13447946|NCT00293423|26934218|FG001|Surgical Resection|Withdrawal by Subject|0|||
13447947|NCT00293423|26934217|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0|||
13447948|NCT00293423|26934218|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3|||
13447949|NCT00293397|26934230|FG000|Overall Study|Death|2|||
13447950|NCT00293384|26934239|FG000|Overall Study|Non-compliance|2|||
13447951|NCT00293384|26934239|FG000|Overall Study|Missed dosage/study drug|1|||
13447952|NCT00293384|26934239|FG000|Overall Study|Ineligible|2|||
13447953|NCT00293293|26934272|FG000|Overall Study|Withdrawal by Subject|1|||
13447954|NCT00293293|26934273|FG001|Overall Study|Withdrawal by Subject|1|||
13447955|NCT00293293|26934272|FG000|Overall Study|"Patient too anxious to complete trial"|1|||
13447956|NCT00293293|26934273|FG001|Overall Study|"Patient too anxious to complete trial"|0|||
13447957|NCT00293293|26934272|FG000|Overall Study|Patient discontinued chemotherapy|0|||
13447958|NCT00293293|26934273|FG001|Overall Study|Patient discontinued chemotherapy|1|||
13447959|NCT00293267|26934318|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
13447960|NCT00293267|26934319|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
13447961|NCT00293267|26934318|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
13447962|NCT00293267|26934319|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
13447963|NCT00293267|26934318|FG000|Primary Study - Double-Blind Week 0-48|Death|3|||
13447964|NCT00293267|26934319|FG001|Primary Study - Double-Blind Week 0-48|Death|3|||
13447965|NCT00293267|26934318|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0|||
13447966|NCT00293267|26934319|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
13447967|NCT00293267|26934318|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
13447968|NCT00293267|26934319|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
13447969|NCT00293267|26934318|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
13447970|NCT00293267|26934319|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
13447971|NCT00293267|26934318|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33|||
13447972|NCT00293267|26934319|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60|||
13447973|NCT00293267|26934318|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1|||
13447974|NCT00293267|26934319|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4|||
13447975|NCT00293267|26934318|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7|||
13447976|NCT00293267|26934319|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1|||
13447977|NCT00293267|26934318|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4|||
13447978|NCT00293267|26934319|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0|||
13447979|NCT00293267|26934318|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13|||
13447980|NCT00293267|26934319|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4|||
13447981|NCT00293267|26934318|FG000|Extension - Double-Blind Week 49-156|Death|3|||
13447982|NCT00293267|26934319|FG001|Extension - Double-Blind Week 49-156|Death|0|||
13447983|NCT00293267|26934318|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2|||
13447984|NCT00293267|26934319|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0|||
13447985|NCT00293267|26934318|FG000|Extension - Double-Blind Week 49-156|Other Reason|7|||
13447986|NCT00293267|26934319|FG001|Extension - Double-Blind Week 49-156|Other Reason|0|||
13447987|NCT00293267|26934318|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
13447988|NCT00293267|26934319|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6|||
13447989|NCT00293267|26934318|FG000|Extension - Open-Label Week 157-240|Adverse Event|5|||
13447990|NCT00293267|26934319|FG001|Extension - Open-Label Week 157-240|Adverse Event|0|||
13447991|NCT00293267|26934318|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7|||
13447992|NCT00293267|26934319|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
13447993|NCT00293267|26934318|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1|||
13447994|NCT00293267|26934319|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
13447995|NCT00293267|26934318|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2|||
13447996|NCT00293267|26934319|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
13447997|NCT00293267|26934318|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2|||
13447998|NCT00293267|26934319|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0|||
13447999|NCT00293267|26934318|FG000|Extension - Open-Label Week 157-240|Other Reason|3|||
13448000|NCT00293267|26934319|FG001|Extension - Open-Label Week 157-240|Other Reason|1|||
13448001|NCT00293267|26934318|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2|||
13448002|NCT00293267|26934319|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3|||
13448003|NCT00293267|26934318|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23|||
13448004|NCT00293267|26934319|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19|||
13448005|NCT00293267|26934318|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2|||
13448006|NCT00293267|26934319|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4|||
13448007|NCT00293267|26934318|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
13448008|NCT00293267|26934319|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
13448009|NCT00293267|26934318|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0|||
13448010|NCT00293267|26934319|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2|||
13448011|NCT00293267|26934318|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0|||
13448012|NCT00293267|26934319|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2|||
13448013|NCT00293267|26934318|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4|||
13448014|NCT00293267|26934319|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5|||
13448015|NCT00293254|26934364|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
13448016|NCT00293254|26934365|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
13448017|NCT00293254|26934364|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2|||
13448018|NCT00293254|26934365|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
13448019|NCT00293254|26934364|FG000|Primary Study - Double-Blind Week 0-48|Death|5|||
13448020|NCT00293254|26934365|FG001|Primary Study - Double-Blind Week 0-48|Death|2|||
13448021|NCT00293254|26934364|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
13448022|NCT00293254|26934365|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
13448023|NCT00293254|26934364|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3|||
13448024|NCT00293254|26934365|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
13448025|NCT00293254|26934364|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5|||
13448026|NCT00293254|26934365|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
13448027|NCT00293254|26934364|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1|||
13448028|NCT00293254|26934365|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0|||
13448029|NCT00293254|26934364|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35|||
13448030|NCT00293254|26934365|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57|||
13448031|NCT00293254|26934364|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4|||
13448032|NCT00293254|26934365|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1|||
13448033|NCT00293254|26934364|FG000|Extension - Double-Blind Week 49-156|Death|4|||
13448034|NCT00293254|26934365|FG001|Extension - Double-Blind Week 49-156|Death|1|||
13448035|NCT00293254|26934364|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3|||
13448036|NCT00293254|26934365|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4|||
13448037|NCT00293254|26934364|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
13448038|NCT00293254|26934365|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
13448039|NCT00293254|26934364|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12|||
13448040|NCT00293254|26934365|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8|||
13448041|NCT00293254|26934364|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6|||
13448042|NCT00293254|26934365|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3|||
13448043|NCT00293254|26934364|FG000|Extension - Double-Blind Week 49-156|Other Reason|10|||
13448044|NCT00293254|26934365|FG001|Extension - Double-Blind Week 49-156|Other Reason|2|||
13448045|NCT00293254|26934364|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
13448046|NCT00293254|26934365|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7|||
13448047|NCT00293254|26934364|FG000|Extension - Open-Label Week 157-240|Adverse Event|2|||
13448048|NCT00293254|26934365|FG001|Extension - Open-Label Week 157-240|Adverse Event|1|||
13448049|NCT00293254|26934364|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1|||
13448050|NCT00293254|26934365|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
13448051|NCT00293254|26934364|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
13448052|NCT00293254|26934365|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0|||
13448053|NCT00293254|26934364|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2|||
13448054|NCT00293254|26934365|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
13448055|NCT00293254|26934364|FG000|Extension - Open-Label Week 157-240|Other Reason|4|||
13448056|NCT00293254|26934365|FG001|Extension - Open-Label Week 157-240|Other Reason|0|||
13448057|NCT00293254|26934364|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4|||
13448058|NCT00293254|26934365|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7|||
13448059|NCT00293254|26934364|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16|||
13448060|NCT00293254|26934365|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14|||
13448061|NCT00293254|26934364|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6|||
13448062|NCT00293254|26934365|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3|||
13448063|NCT00293254|26934364|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3|||
13448064|NCT00293254|26934365|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0|||
13448065|NCT00293254|26934364|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
13448066|NCT00293254|26934365|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
13448067|NCT00293254|26934364|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1|||
13448068|NCT00293254|26934365|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2|||
13448069|NCT00293241|26934414|FG000|Overall Study|Lost to Follow-up|9|||
13448070|NCT00293241|26934415|FG001|Overall Study|Lost to Follow-up|16|||
13448071|NCT00293241|26934414|FG000|Overall Study|Physician Decision|23|||
13448072|NCT00293241|26934415|FG001|Overall Study|Physician Decision|17|||
13448073|NCT00293241|26934414|FG000|Overall Study|Withdrawal by Subject|4|||
13448074|NCT00293241|26934415|FG001|Overall Study|Withdrawal by Subject|8|||
13448075|NCT00293215|26934442|FG000|Overall Study|Progressive disease|3|||
13448076|NCT00293215|26934443|FG001|Overall Study|Progressive disease|1|||
13448077|NCT00293215|26934442|FG000|Overall Study|Adverse Event|2|||
13448078|NCT00293215|26934443|FG001|Overall Study|Adverse Event|2|||
13448079|NCT00293202|26934460|FG000|Overall Study|Withdrawal by Subject|1|||
13448080|NCT00293202|26934461|FG001|Overall Study|Withdrawal by Subject|2|||
13448081|NCT00293202|26934460|FG000|Overall Study|positive ANA (antinuclear antibody)|1|||
13448082|NCT00293202|26934461|FG001|Overall Study|positive ANA (antinuclear antibody)|0|||
13448083|NCT00293202|26934460|FG000|Overall Study|on-hold due to fistula maturation time|1|||
13448084|NCT00293202|26934461|FG001|Overall Study|on-hold due to fistula maturation time|0|||
13448085|NCT00293059|26934580|FG000|Overall Study|Adverse Event|12|||
13448086|NCT00293059|26934581|FG001|Overall Study|Adverse Event|4|||
13448087|NCT00293059|26934580|FG000|Overall Study|Lack of Efficacy|2|||
13448088|NCT00293059|26934581|FG001|Overall Study|Lack of Efficacy|0|||
13448089|NCT00293059|26934580|FG000|Overall Study|Lost to Follow-up|2|||
13448090|NCT00293059|26934581|FG001|Overall Study|Lost to Follow-up|3|||
13448091|NCT00293059|26934580|FG000|Overall Study|Pregnancy|1|||
13448092|NCT00293059|26934581|FG001|Overall Study|Pregnancy|1|||
13448093|NCT00293059|26934580|FG000|Overall Study|Protocol Violation|2|||
13448094|NCT00293059|26934581|FG001|Overall Study|Protocol Violation|0|||
13448095|NCT00293059|26934580|FG000|Overall Study|Withdrawal by Subject|11|||
13448096|NCT00293059|26934581|FG001|Overall Study|Withdrawal by Subject|5|||
13448097|NCT00293059|26934580|FG000|Overall Study|Participant moved out of state|1|||
13448098|NCT00293059|26934581|FG001|Overall Study|Participant moved out of state|0|||
13448099|NCT00293059|26934580|FG000|Overall Study|Participant stopped study drug|1|||
13448100|NCT00293059|26934581|FG001|Overall Study|Participant stopped study drug|0|||
13448101|NCT00293059|26934580|FG000|Overall Study|Noncompliant - sanitary pads collection|0|||
13448102|NCT00293059|26934581|FG001|Overall Study|Noncompliant - sanitary pads collection|1|||
13448103|NCT00293059|26934580|FG000|Overall Study|missing|3|||
13448104|NCT00293059|26934581|FG001|Overall Study|missing|5|||
13448105|NCT00293033|26934686|FG000|Open-label Titration Period|Adverse Event|10|||
13448106|NCT00293033|26934686|FG000|Open-label Titration Period|Death|3|||
13448107|NCT00293033|26934686|FG000|Open-label Titration Period|Lack of Efficacy|5|||
13448108|NCT00293033|26934686|FG000|Open-label Titration Period|Protocol Violation|2|||
13448109|NCT00293033|26934686|FG000|Open-label Titration Period|Withdrawal by Subject|22|||
13448110|NCT00293033|26934686|FG000|Open-label Titration Period|Noncompliance and other|27|||
13448111|NCT00293033|26934686|FG000|Double-blind Treatment Period|Adverse Event|3|||
13448112|NCT00293033|26934686|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
13448113|NCT00293033|26934686|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
13448114|NCT00293033|26934686|FG000|Double-blind Treatment Period|Noncompliance|4|||
13448115|NCT00293020|26934692|FG000|Overall Study|Withdrawal by Subject|34|||
13448116|NCT00293020|26934692|FG000|Overall Study|Adverse Event|30|||
13448117|NCT00293020|26934692|FG000|Overall Study|Death|32|||
13448118|NCT00293020|26934692|FG000|Overall Study|Lack of Efficacy|12|||
13448119|NCT00293020|26934692|FG000|Overall Study|Lost to Follow-up|4|||
13448120|NCT00293020|26934692|FG000|Overall Study|Protocol Violation|6|||
13448121|NCT00293020|26934692|FG000|Overall Study|Physician Decision|21|||
13448122|NCT00293020|26934692|FG000|Overall Study|Other Reason|22|||
13448123|NCT00293020|26934692|FG000|Overall Study|No dose taken|1|||
13448124|NCT00292981|26934701|FG000|Overall Study|Adverse Event|1|||
13448125|NCT00292981|26934701|FG000|Overall Study|Lost to Follow-up|13|||
13448126|NCT00292981|26934701|FG000|Overall Study|Withdrawal by Subject|22|||
13448127|NCT00292981|26934701|FG000|Overall Study|Other|3|||
13448128|NCT00292942|26934745|FG000|Overall Study|Withdrawal by Subject|0|||
13448129|NCT00292942|26934746|FG001|Overall Study|Withdrawal by Subject|0|||
13448130|NCT00292942|26934747|FG002|Overall Study|Withdrawal by Subject|1|||
13448131|NCT00292942|26934748|FG003|Overall Study|Withdrawal by Subject|0|||
13448132|NCT00292942|26934745|FG000|Overall Study|Adverse Event|0|||
13448133|NCT00292942|26934746|FG001|Overall Study|Adverse Event|0|||
13448134|NCT00292942|26934747|FG002|Overall Study|Adverse Event|0|||
13448135|NCT00292942|26934748|FG003|Overall Study|Adverse Event|1|||
13448136|NCT00292461|26934767|FG000|Overall Study|Adverse Event|4|||
13448137|NCT00292461|26934768|FG001|Overall Study|Adverse Event|2|||
13448138|NCT00292461|26934767|FG000|Overall Study|Lack of Efficacy|1|||
13448139|NCT00292461|26934768|FG001|Overall Study|Lack of Efficacy|0|||
13448140|NCT00292461|26934767|FG000|Overall Study|Withdrawal by Subject|0|||
13448141|NCT00292461|26934768|FG001|Overall Study|Withdrawal by Subject|1|||
13448142|NCT00292461|26934767|FG000|Overall Study|Protocol Violation|4|||
13448143|NCT00292461|26934768|FG001|Overall Study|Protocol Violation|3|||
13448144|NCT00292461|26934767|FG000|Overall Study|Lost to Follow-up|1|||
13448145|NCT00292461|26934768|FG001|Overall Study|Lost to Follow-up|0|||
13448146|NCT00292370|26934801|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12|||
13448147|NCT00292370|26934802|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
13448148|NCT00292370|26934803|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
13448149|NCT00292370|26934801|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22|||
13448150|NCT00292370|26934802|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
13448151|NCT00292370|26934803|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
13448152|NCT00292370|26934801|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8|||
13448153|NCT00292370|26934802|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
13448154|NCT00292370|26934803|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
13448155|NCT00292370|26934801|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4|||
13448156|NCT00292370|26934802|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
13448157|NCT00292370|26934803|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
13448158|NCT00292370|26934801|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0|||
13448159|NCT00292370|26934802|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3|||
13448160|NCT00292370|26934803|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2|||
13448161|NCT00292370|26934801|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0|||
13448162|NCT00292370|26934802|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1|||
13448163|NCT00292370|26934803|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5|||
13448164|NCT00292318|26934818|FG000|Overall Study|Study terminated by officials|2|||
13448165|NCT00292318|26934819|FG001|Overall Study|Study terminated by officials|1|||
13448166|NCT00292227|26934907|FG000|Patch Period|Adverse Event|1|||
13448167|NCT00292227|26934908|FG001|Patch Period|Adverse Event|0|||
13448168|NCT00292227|26934909|FG002|Patch Period|Adverse Event|2|||
13448169|NCT00292227|26934907|FG000|Patch Period|Withdrawal by Subject|0|||
13448170|NCT00292227|26934908|FG001|Patch Period|Withdrawal by Subject|0|||
13448171|NCT00292227|26934909|FG002|Patch Period|Withdrawal by Subject|1|||
13448172|NCT00292188|26934976|FG000|Single-Blind|Adverse Event|14|||
13448173|NCT00292188|26934977|FG001|Single-Blind|Adverse Event|0|||
13448174|NCT00292188|26934978|FG002|Single-Blind|Adverse Event|0|||
13448175|NCT00292188|26934976|FG000|Single-Blind|Lack of Efficacy|2|||
13448176|NCT00292188|26934977|FG001|Single-Blind|Lack of Efficacy|0|||
13448177|NCT00292188|26934978|FG002|Single-Blind|Lack of Efficacy|0|||
13448178|NCT00292188|26934976|FG000|Single-Blind|Laboratory Abnormality|5|||
13448179|NCT00292188|26934977|FG001|Single-Blind|Laboratory Abnormality|0|||
13448180|NCT00292188|26934978|FG002|Single-Blind|Laboratory Abnormality|0|||
13448181|NCT00292188|26934976|FG000|Single-Blind|Lost to Follow-up|3|||
13448182|NCT00292188|26934977|FG001|Single-Blind|Lost to Follow-up|0|||
13448183|NCT00292188|26934978|FG002|Single-Blind|Lost to Follow-up|0|||
13448184|NCT00292188|26934976|FG000|Single-Blind|Other|77|||
13448185|NCT00292188|26934977|FG001|Single-Blind|Other|0|||
13448186|NCT00292188|26934978|FG002|Single-Blind|Other|0|||
13448187|NCT00292188|26934976|FG000|Single-Blind|Withdrawal by Subject|12|||
13448188|NCT00292188|26934977|FG001|Single-Blind|Withdrawal by Subject|0|||
13448189|NCT00292188|26934978|FG002|Single-Blind|Withdrawal by Subject|0|||
13448190|NCT00292188|26934976|FG000|Single-Blind|Did not receive treatment|1|||
13448191|NCT00292188|26934977|FG001|Single-Blind|Did not receive treatment|0|||
13448192|NCT00292188|26934978|FG002|Single-Blind|Did not receive treatment|0|||
13448193|NCT00292188|26934976|FG000|Double-Blind|Adverse Event|0|||
13448194|NCT00292188|26934977|FG001|Double-Blind|Adverse Event|25|||
13448195|NCT00292188|26934978|FG002|Double-Blind|Adverse Event|9|||
13448196|NCT00292188|26934976|FG000|Double-Blind|Lack of Efficacy|0|||
13448197|NCT00292188|26934977|FG001|Double-Blind|Lack of Efficacy|2|||
13448198|NCT00292188|26934978|FG002|Double-Blind|Lack of Efficacy|12|||
13448199|NCT00292188|26934976|FG000|Double-Blind|Lost to Follow-up|0|||
13448200|NCT00292188|26934977|FG001|Double-Blind|Lost to Follow-up|1|||
13448201|NCT00292188|26934978|FG002|Double-Blind|Lost to Follow-up|0|||
13448202|NCT00292188|26934976|FG000|Double-Blind|Other|0|||
13448203|NCT00292188|26934977|FG001|Double-Blind|Other|3|||
13448204|NCT00292188|26934978|FG002|Double-Blind|Other|4|||
13448205|NCT00292188|26934976|FG000|Double-Blind|Withdrawal by Subject|0|||
13448206|NCT00292188|26934977|FG001|Double-Blind|Withdrawal by Subject|0|||
13448207|NCT00292188|26934978|FG002|Double-Blind|Withdrawal by Subject|3|||
13448208|NCT00292188|26934976|FG000|Double-Blind|Laboratory Abnormality|0|||
13448209|NCT00292188|26934977|FG001|Double-Blind|Laboratory Abnormality|0|||
13448210|NCT00292188|26934978|FG002|Double-Blind|Laboratory Abnormality|1|||
13448211|NCT00292045|26934987|FG000|Core Study (Through Week 13)|Adverse Event|1|||
13448212|NCT00292045|26934987|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1|||
13448213|NCT00291668|26935083|FG000|Overall Study|Lack of Efficacy|1|||
13448214|NCT00291668|26935084|FG001|Overall Study|Lack of Efficacy|0|||
13448215|NCT00291668|26935085|FG002|Overall Study|Lack of Efficacy|0|||
13448216|NCT00291668|26935083|FG000|Overall Study|SAE, non-fatal|1|||
13448217|NCT00291668|26935084|FG001|Overall Study|SAE, non-fatal|1|||
13448218|NCT00291668|26935085|FG002|Overall Study|SAE, non-fatal|1|||
13448219|NCT00291668|26935083|FG000|Overall Study|AE, non-serious non-fatal|1|||
13448220|NCT00291668|26935084|FG001|Overall Study|AE, non-serious non-fatal|0|||
13448221|NCT00291668|26935085|FG002|Overall Study|AE, non-serious non-fatal|0|||
13448222|NCT00291668|26935083|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
13448223|NCT00291668|26935084|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
13448224|NCT00291668|26935085|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
13448225|NCT00291642|26935153|FG000|Overall Study|Adverse Event|1|||
13448226|NCT00291642|26935154|FG001|Overall Study|Adverse Event|0|||
13448227|NCT00291642|26935155|FG002|Overall Study|Adverse Event|1|||
13448228|NCT00291642|26935156|FG003|Overall Study|Adverse Event|0|||
13448229|NCT00291642|26935157|FG004|Overall Study|Adverse Event|1|||
13448230|NCT00291642|26935153|FG000|Overall Study|Patient missed visit|0|||
13448231|NCT00291642|26935154|FG001|Overall Study|Patient missed visit|0|||
13448232|NCT00291642|26935155|FG002|Overall Study|Patient missed visit|1|||
13448233|NCT00291642|26935156|FG003|Overall Study|Patient missed visit|0|||
13448234|NCT00291642|26935157|FG004|Overall Study|Patient missed visit|0|||
13448235|NCT00291642|26935153|FG000|Overall Study|Intake of prohibited medication|1|||
13448236|NCT00291642|26935154|FG001|Overall Study|Intake of prohibited medication|0|||
13448237|NCT00291642|26935155|FG002|Overall Study|Intake of prohibited medication|0|||
13448238|NCT00291642|26935156|FG003|Overall Study|Intake of prohibited medication|0|||
13448239|NCT00291642|26935157|FG004|Overall Study|Intake of prohibited medication|0|||
13448240|NCT00291577|26935178|FG000|Overall Study|Adverse Event|1|||
13448241|NCT00291577|26935178|FG000|Overall Study|Other|4|||
13448242|NCT00291577|26935178|FG000|Overall Study|Withdrawal by Subject|2|||
13448243|NCT00291577|26935178|FG000|Overall Study|Lack of Efficacy|14|||
13448244|NCT00291551|26935195|FG000|Overall Study|Death|7|||
13448245|NCT00291551|26935195|FG000|Overall Study|Withdrawal by Subject|6|||
13448246|NCT00291499|26935218|FG000|Overall Study|Adverse Event|3|||
13448247|NCT00291499|26935219|FG001|Overall Study|Adverse Event|8|||
13448248|NCT00291499|26935218|FG000|Overall Study|Change to other therapy|2|||
13448249|NCT00291499|26935219|FG001|Overall Study|Change to other therapy|1|||
13448250|NCT00291499|26935218|FG000|Overall Study|Intercurrent illness|1|||
13448251|NCT00291499|26935219|FG001|Overall Study|Intercurrent illness|0|||
13448252|NCT00291499|26935218|FG000|Overall Study|Protocol Violation|2|||
13448253|NCT00291499|26935219|FG001|Overall Study|Protocol Violation|2|||
13448254|NCT00291499|26935218|FG000|Overall Study|Other reasons|1|||
13448255|NCT00291499|26935219|FG001|Overall Study|Other reasons|4|||
13448256|NCT00291486|26935271|FG000|Overall Study|Adverse Event|0|||
13448257|NCT00291486|26935272|FG001|Overall Study|Adverse Event|3|||
13448258|NCT00291486|26935273|FG002|Overall Study|Adverse Event|0|||
13448259|NCT00291486|26935274|FG003|Overall Study|Adverse Event|1|||
13448260|NCT00291486|26935275|FG004|Overall Study|Adverse Event|0|||
13448261|NCT00291486|26935271|FG000|Overall Study|Withdrawal by Subject|0|||
13448262|NCT00291486|26935272|FG001|Overall Study|Withdrawal by Subject|0|||
13448263|NCT00291486|26935273|FG002|Overall Study|Withdrawal by Subject|0|||
13448264|NCT00291486|26935274|FG003|Overall Study|Withdrawal by Subject|0|||
13448265|NCT00291486|26935275|FG004|Overall Study|Withdrawal by Subject|1|||
13448266|NCT00291486|26935271|FG000|Overall Study|Disease progression|1|||
13448267|NCT00291486|26935272|FG001|Overall Study|Disease progression|0|||
13448268|NCT00291486|26935273|FG002|Overall Study|Disease progression|1|||
13448269|NCT00291486|26935274|FG003|Overall Study|Disease progression|0|||
13448270|NCT00291486|26935275|FG004|Overall Study|Disease progression|0|||
13448271|NCT00291330|26935304|FG000|Overall Study|Adverse Event|47|||
13448272|NCT00291330|26935305|FG001|Overall Study|Adverse Event|40|||
13448273|NCT00291330|26935304|FG000|Overall Study|Protocol Violation|13|||
13448274|NCT00291330|26935305|FG001|Overall Study|Protocol Violation|20|||
13448275|NCT00291330|26935304|FG000|Overall Study|Lost to Follow-up|16|||
13448276|NCT00291330|26935305|FG001|Overall Study|Lost to Follow-up|11|||
13448277|NCT00291330|26935304|FG000|Overall Study|Withdrawal by Subject|22|||
13448278|NCT00291330|26935305|FG001|Overall Study|Withdrawal by Subject|25|||
13448279|NCT00291330|26935304|FG000|Overall Study|Other|3|||
13448280|NCT00291330|26935305|FG001|Overall Study|Other|1|||
13448281|NCT00291187|26935340|FG000|Overall Study|Protocol Violation- No Drug Administered|0|||
13448282|NCT00291187|26935341|FG001|Overall Study|Protocol Violation- No Drug Administered|0|||
13448283|NCT00291187|26935342|FG002|Overall Study|Protocol Violation- No Drug Administered|1|||
13448284|NCT00291187|26935343|FG003|Overall Study|Protocol Violation- No Drug Administered|0|||
13448285|NCT00291018|26935391|FG000|Overall Study|Not Consented or Declined PAS|12|||
13448286|NCT00291018|26935392|FG001|Overall Study|Not Consented or Declined PAS|15|||
13448287|NCT00291018|26935393|FG002|Overall Study|Not Consented or Declined PAS|15|||
13448288|NCT00291018|26935391|FG000|Overall Study|Death|3|||
13448289|NCT00291018|26935392|FG001|Overall Study|Death|3|||
13448290|NCT00291018|26935393|FG002|Overall Study|Death|4|||
13448291|NCT00291018|26935391|FG000|Overall Study|Withdrawal by Subject|2|||
13448292|NCT00291018|26935392|FG001|Overall Study|Withdrawal by Subject|8|||
13448293|NCT00291018|26935393|FG002|Overall Study|Withdrawal by Subject|1|||
13448294|NCT00291018|26935391|FG000|Overall Study|Failures|5|||
13448295|NCT00291018|26935392|FG001|Overall Study|Failures|12|||
13448296|NCT00291018|26935393|FG002|Overall Study|Failures|5|||
13448297|NCT00291018|26935391|FG000|Overall Study|Lost to Follow-up|3|||
13448298|NCT00291018|26935392|FG001|Overall Study|Lost to Follow-up|4|||
13448299|NCT00291018|26935393|FG002|Overall Study|Lost to Follow-up|18|||
13448300|NCT00290888|26935408|FG000|Overall Study|Physician Decision|3|||
13448301|NCT00290888|26935409|FG001|Overall Study|Physician Decision|1|||
13448302|NCT00290771|26935438|FG000|Overall Study|Disease progression|95|||
13448303|NCT00290771|26935439|FG001|Overall Study|Disease progression|73|||
13448304|NCT00290771|26935438|FG000|Overall Study|Death|11|||
13448305|NCT00290771|26935439|FG001|Overall Study|Death|10|||
13448306|NCT00290771|26935438|FG000|Overall Study|Adverse Event|12|||
13448307|NCT00290771|26935439|FG001|Overall Study|Adverse Event|6|||
13448308|NCT00290771|26935438|FG000|Overall Study|Withdrawal by Subject|5|||
13448309|NCT00290771|26935439|FG001|Overall Study|Withdrawal by Subject|6|||
13448310|NCT00290771|26935438|FG000|Overall Study|Administrative problems|2|||
13448311|NCT00290771|26935439|FG001|Overall Study|Administrative problems|1|||
13448312|NCT00290771|26935438|FG000|Overall Study|Protocol Violation|2|||
13448313|NCT00290771|26935439|FG001|Overall Study|Protocol Violation|0|||
13448314|NCT00290771|26935438|FG000|Overall Study|Lost to Follow-up|0|||
13448315|NCT00290771|26935439|FG001|Overall Study|Lost to Follow-up|1|||
13448316|NCT00290758|26935466|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1|||
13448317|NCT00290758|26935467|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2|||
13448318|NCT00290758|26935466|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1|||
13448319|NCT00290758|26935467|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0|||
13448320|NCT00290758|26935466|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3|||
13448321|NCT00290758|26935467|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1|||
13448322|NCT00290758|26935466|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
13448323|NCT00290758|26935467|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
13448324|NCT00290758|26935466|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0|||
13448325|NCT00290758|26935467|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5|||
13448326|NCT00290758|26935466|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1|||
13448327|NCT00290758|26935467|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0|||
13448328|NCT00290758|26935466|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0|||
13448329|NCT00290758|26935467|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1|||
13448330|NCT00290758|26935466|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6|||
13448331|NCT00290758|26935467|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5|||
13448332|NCT00290745|26935481|FG000|Overall Study|Withdrawal by Subject|4|||
13448333|NCT00290745|26935481|FG000|Overall Study|Physician Decision|2|||
13448334|NCT00290745|26935481|FG000|Overall Study|Surgery after 3 months for progression|3|||
13448335|NCT00290745|26935481|FG000|Overall Study|Baseline MRI not available|3|||
13448336|NCT00290732|26935509|FG000|Overall Study|Inability to instill drug intraductally.|0|||
13448337|NCT00290732|26935510|FG001|Overall Study|Inability to instill drug intraductally.|1|||
13448338|NCT00290732|26935511|FG002|Overall Study|Inability to instill drug intraductally.|1|||
13448339|NCT00290732|26935512|FG003|Overall Study|Inability to instill drug intraductally.|0|||
13448340|NCT00290732|26935513|FG004|Overall Study|Inability to instill drug intraductally.|0|||
13448341|NCT00290706|26935545|FG000|Overall Study|Withdrawal by Subject|2|||
13448342|NCT00290706|26935546|FG001|Overall Study|Withdrawal by Subject|0|||
13448343|NCT00290706|26935547|FG002|Overall Study|Withdrawal by Subject|0|||
13448344|NCT00290706|26935548|FG003|Overall Study|Withdrawal by Subject|0|||
13448345|NCT00290706|26935545|FG000|Overall Study|Progressive Disease|3|||
13448346|NCT00290706|26935546|FG001|Overall Study|Progressive Disease|5|||
13448347|NCT00290706|26935547|FG002|Overall Study|Progressive Disease|4|||
13448348|NCT00290706|26935548|FG003|Overall Study|Progressive Disease|10|||
13448349|NCT00290706|26935545|FG000|Overall Study|Adverse Event|0|||
13448350|NCT00290706|26935546|FG001|Overall Study|Adverse Event|1|||
13448351|NCT00290706|26935547|FG002|Overall Study|Adverse Event|2|||
13448352|NCT00290706|26935548|FG003|Overall Study|Adverse Event|0|||
13448353|NCT00290706|26935545|FG000|Overall Study|Receive auto transplant or radiation|0|||
13448354|NCT00290706|26935546|FG001|Overall Study|Receive auto transplant or radiation|0|||
13448355|NCT00290706|26935547|FG002|Overall Study|Receive auto transplant or radiation|0|||
13448356|NCT00290706|26935548|FG003|Overall Study|Receive auto transplant or radiation|1|||
13448357|NCT00290706|26935545|FG000|Overall Study|Physician Decision|0|||
13448358|NCT00290706|26935546|FG001|Overall Study|Physician Decision|0|||
13448359|NCT00290706|26935547|FG002|Overall Study|Physician Decision|0|||
13448360|NCT00290706|26935548|FG003|Overall Study|Physician Decision|1|||
13448361|NCT00290693|26935558|FG000|Overall Study|Withdrawal by Subject|2|||
13448362|NCT00290589|26935575|FG000|Overall Study|Lost to Follow-up|2|||
13448363|NCT00290589|26935576|FG001|Overall Study|Lost to Follow-up|2|||
13448364|NCT00290511|26935588|FG000|Overall Study|Adverse Event|1|||
13448365|NCT00290511|26935588|FG000|Overall Study|Death|1|||
13448366|NCT00290511|26935588|FG000|Overall Study|Physician Decision|1|||
13448367|NCT00290511|26935588|FG000|Overall Study|Withdrawal by Subject|1|||
13448368|NCT00290498|26935603|FG000|Overall Study|Death|2|||
13448369|NCT00290498|26935604|FG001|Overall Study|Death|0|||
13448370|NCT00290498|26935603|FG000|Overall Study|Physician Decision|1|||
13448371|NCT00290498|26935604|FG001|Overall Study|Physician Decision|0|||
13448372|NCT00290498|26935603|FG000|Overall Study|Withdrawal by Subject|1|||
13448373|NCT00290498|26935604|FG001|Overall Study|Withdrawal by Subject|0|||
13448374|NCT00290498|26935603|FG000|Overall Study|Ineligible|3|||
13448375|NCT00290498|26935604|FG001|Overall Study|Ineligible|0|||
13448376|NCT00290498|26935603|FG000|Overall Study|Non-Compliance|1|||
13448377|NCT00290498|26935604|FG001|Overall Study|Non-Compliance|0|||
13448378|NCT00290433|26935610|FG000|Overall Study|Disease Progression|13|||
13448379|NCT00290433|26935610|FG000|Overall Study|Adverse Event|14|||
13448380|NCT00290433|26935610|FG000|Overall Study|Withdrawal by Subject|1|||
13448381|NCT00290433|26935610|FG000|Overall Study|Non-Compliance|1|||
13448382|NCT00290433|26935610|FG000|Overall Study|Congestive Heart Failure|1|||
13448383|NCT00290433|26935610|FG000|Overall Study|Transplant in CR|5|||
13448384|NCT00290433|26935610|FG000|Overall Study|Unrelated Infection/Death|1|||
13448385|NCT00290407|26935617|FG000|Overall Study|Physician Decision|2|||
13448386|NCT00290355|26935666|FG000|Overall Study|Serious adverse event|7|||
13448387|NCT00290355|26935667|FG001|Overall Study|Serious adverse event|4|||
13448388|NCT00290355|26935666|FG000|Overall Study|Study product reactogenicity|1|||
13448389|NCT00290355|26935667|FG001|Overall Study|Study product reactogenicity|0|||
13448390|NCT00290355|26935666|FG000|Overall Study|Protocol Violation|1|||
13448391|NCT00290355|26935667|FG001|Overall Study|Protocol Violation|0|||
13448392|NCT00290355|26935666|FG000|Overall Study|Withdrawal by Subject|2|||
13448393|NCT00290355|26935667|FG001|Overall Study|Withdrawal by Subject|0|||
13448394|NCT00290355|26935666|FG000|Overall Study|Migrated / moved from the study area|1|||
13448395|NCT00290355|26935667|FG001|Overall Study|Migrated / moved from the study area|0|||
13448396|NCT00290355|26935666|FG000|Overall Study|Lost to Follow-up|3|||
13448397|NCT00290355|26935667|FG001|Overall Study|Lost to Follow-up|1|||
13448398|NCT00290355|26935666|FG000|Overall Study|Other|2|||
13448399|NCT00290355|26935667|FG001|Overall Study|Other|0|||
13448400|NCT00290342|26935702|FG000|Overall Study|Other|0|||
13448401|NCT00290342|26935703|FG001|Overall Study|Other|1|||
13448402|NCT00290342|26935702|FG000|Overall Study|Withdrawal by Subject|6|||
13448403|NCT00290342|26935703|FG001|Overall Study|Withdrawal by Subject|4|||
13448404|NCT00290342|26935702|FG000|Overall Study|Lost to Follow-up|1|||
13448405|NCT00290342|26935703|FG001|Overall Study|Lost to Follow-up|0|||
13448406|NCT00290290|26935716|FG000|Overall Study|Death|3|||
13448407|NCT00290290|26935717|FG001|Overall Study|Death|4|||
13448408|NCT00290290|26935716|FG000|Overall Study|Withdrawal by Subject|2|||
13448409|NCT00290290|26935717|FG001|Overall Study|Withdrawal by Subject|2|||
13448410|NCT00290290|26935716|FG000|Overall Study|Underwent clean surgical procedure|13|||
13448411|NCT00290290|26935717|FG001|Overall Study|Underwent clean surgical procedure|12|||
13448412|NCT00290238|26935732|FG000|Overall Study|Study terminated|27|||
13448413|NCT00290238|26935733|FG001|Overall Study|Study terminated|27|||
13448414|NCT00290238|26935732|FG000|Overall Study|Lost to Follow-up|0|||
13448415|NCT00290238|26935733|FG001|Overall Study|Lost to Follow-up|1|||
13448416|NCT00290238|26935732|FG000|Overall Study|Withdrawal by Subject|15|||
13448417|NCT00290238|26935733|FG001|Overall Study|Withdrawal by Subject|13|||
13448418|NCT00290186|26935778|FG000|Overall Study|Adverse Event|1|||
13448419|NCT00290186|26935779|FG001|Overall Study|Adverse Event|1|||
13448420|NCT00290186|26935778|FG000|Overall Study|Lost to Follow-up|3|||
13448421|NCT00290186|26935779|FG001|Overall Study|Lost to Follow-up|2|||
13448422|NCT00290186|26935778|FG000|Overall Study|Study was terminated prior to 3-month te|1|||
13448423|NCT00290186|26935779|FG001|Overall Study|Study was terminated prior to 3-month te|1|||
13448424|NCT00290186|26935778|FG000|Overall Study|Withdrawal by Subject|0|||
13448425|NCT00290186|26935779|FG001|Overall Study|Withdrawal by Subject|1|||
13448426|NCT00289991|26935808|FG000|Overall Study|Death|35|||
13448427|NCT00289991|26935809|FG001|Overall Study|Death|38|||
13448428|NCT00289991|26935808|FG000|Overall Study|Adverse Event|15|||
13448429|NCT00289991|26935809|FG001|Overall Study|Adverse Event|13|||
13448430|NCT00289991|26935808|FG000|Overall Study|Failure of prophylaxis|1|||
13448431|NCT00289991|26935809|FG001|Overall Study|Failure of prophylaxis|1|||
13448432|NCT00289991|26935808|FG000|Overall Study|Fungal breakthrough infection|0|||
13448433|NCT00289991|26935809|FG001|Overall Study|Fungal breakthrough infection|1|||
13448434|NCT00289991|26935808|FG000|Overall Study|Lost to Follow-up|0|||
13448435|NCT00289991|26935809|FG001|Overall Study|Lost to Follow-up|1|||
13448436|NCT00289991|26935808|FG000|Overall Study|Withdrawal by Subject|2|||
13448437|NCT00289991|26935809|FG001|Overall Study|Withdrawal by Subject|12|||
13448438|NCT00289991|26935808|FG000|Overall Study|Other|5|||
13448439|NCT00289991|26935809|FG001|Overall Study|Other|14|||
13448440|NCT00289978|26935833|FG000|Overall Study|Withdrawal by Subject|31|||
13448441|NCT00289978|26935834|FG001|Overall Study|Withdrawal by Subject|17|||
13448442|NCT00289978|26935835|FG002|Overall Study|Withdrawal by Subject|28|||
13448443|NCT00289978|26935833|FG000|Overall Study|Adverse Event|22|||
13448444|NCT00289978|26935834|FG001|Overall Study|Adverse Event|13|||
13448445|NCT00289978|26935835|FG002|Overall Study|Adverse Event|18|||
13448446|NCT00289978|26935833|FG000|Overall Study|Lack of Efficacy|13|||
13448447|NCT00289978|26935834|FG001|Overall Study|Lack of Efficacy|6|||
13448448|NCT00289978|26935835|FG002|Overall Study|Lack of Efficacy|25|||
13448449|NCT00289978|26935833|FG000|Overall Study|Abnormal laboratory value(s)|20|||
13448450|NCT00289978|26935834|FG001|Overall Study|Abnormal laboratory value(s)|9|||
13448451|NCT00289978|26935835|FG002|Overall Study|Abnormal laboratory value(s)|1|||
13448452|NCT00289978|26935833|FG000|Overall Study|Lost to Follow-up|3|||
13219937|NCT01829113|26278686|FG000|Overall Study|Withdrawal by Subject|17|||
13448453|NCT00289978|26935834|FG001|Overall Study|Lost to Follow-up|5|||
13448454|NCT00289978|26935835|FG002|Overall Study|Lost to Follow-up|7|||
13448455|NCT00289978|26935833|FG000|Overall Study|Protocol Violation|5|||
13448456|NCT00289978|26935834|FG001|Overall Study|Protocol Violation|5|||
13448457|NCT00289978|26935835|FG002|Overall Study|Protocol Violation|4|||
13448458|NCT00289978|26935833|FG000|Overall Study|Abnormal test procedure result(s)|2|||
13448459|NCT00289978|26935834|FG001|Overall Study|Abnormal test procedure result(s)|1|||
13448460|NCT00289978|26935835|FG002|Overall Study|Abnormal test procedure result(s)|1|||
13448461|NCT00289978|26935833|FG000|Overall Study|Death|1|||
13448462|NCT00289978|26935834|FG001|Overall Study|Death|0|||
13448463|NCT00289978|26935835|FG002|Overall Study|Death|2|||
13448464|NCT00289913|26935876|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
13448465|NCT00289913|26935877|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
13448466|NCT00289913|26935878|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
13448467|NCT00289913|26935879|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
13448468|NCT00289913|26935880|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
13448469|NCT00289913|26935876|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3|||
13448470|NCT00289913|26935877|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
13448471|NCT00289913|26935878|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
13448472|NCT00289913|26935879|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
13448473|NCT00289913|26935880|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1|||
13448474|NCT00289913|26935876|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
13448475|NCT00289913|26935877|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
13448476|NCT00289913|26935878|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
13448477|NCT00289913|26935879|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
13448478|NCT00289913|26935880|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
13448479|NCT00289913|26935876|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
13448480|NCT00289913|26935877|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
13448481|NCT00289913|26935878|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
13448482|NCT00289913|26935879|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
13448483|NCT00289913|26935880|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1|||
13448484|NCT00289913|26935876|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
13448485|NCT00289913|26935877|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
13448486|NCT00289913|26935878|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
13448487|NCT00289913|26935879|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1|||
13448488|NCT00289913|26935880|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
13448489|NCT00289913|26935876|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
13448490|NCT00289913|26935877|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2|||
13448491|NCT00289913|26935878|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
13448492|NCT00289913|26935879|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
13448493|NCT00289913|26935880|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
13448494|NCT00289913|26935876|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2|||
13448495|NCT00289913|26935877|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1|||
13448496|NCT00289913|26935878|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
13448497|NCT00289913|26935879|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
13448498|NCT00289913|26935880|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5|||
13448499|NCT00289913|26935876|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
13448500|NCT00289913|26935877|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8|||
13448501|NCT00289913|26935878|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5|||
13448502|NCT00289913|26935879|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6|||
13448503|NCT00289913|26935880|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
13448504|NCT00289913|26935876|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1|||
13448505|NCT00289913|26935877|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
13448506|NCT00289913|26935878|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2|||
13448507|NCT00289913|26935879|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
13448508|NCT00289913|26935880|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
13448509|NCT00289913|26935876|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
13448510|NCT00289913|26935877|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
13448511|NCT00289913|26935878|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
13448512|NCT00289913|26935879|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
13448513|NCT00289913|26935880|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
13390665|NCT00685360|26774177|FG002|Overall Study|Subject Withdrew Consent to Participate|5|||
13390666|NCT00685360|26774175|FG000|Overall Study|Protocol Deviation|0|||
13390667|NCT00685360|26774176|FG001|Overall Study|Protocol Deviation|1|||
13390668|NCT00685360|26774177|FG002|Overall Study|Protocol Deviation|1|||
13390669|NCT00685334|26774192|FG000|Overall Study|Withdrawal by Subject|5|||
13390670|NCT00685334|26774193|FG001|Overall Study|Withdrawal by Subject|6|||
13390671|NCT00685334|26774192|FG000|Overall Study|Lost to Follow-up|4|||
13390672|NCT00685334|26774193|FG001|Overall Study|Lost to Follow-up|0|||
13390673|NCT00685334|26774192|FG000|Overall Study|Chose to enter hospital|1|||
13390674|NCT00685334|26774193|FG001|Overall Study|Chose to enter hospital|1|||
13448514|NCT00289913|26935876|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8|||
13448515|NCT00289913|26935877|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11|||
13448516|NCT00289913|26935878|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
13448517|NCT00289913|26935879|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
13448518|NCT00289913|26935880|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0|||
13448519|NCT00289913|26935876|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
13448520|NCT00289913|26935877|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1|||
13448521|NCT00289913|26935878|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
13448522|NCT00289913|26935879|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
13448523|NCT00289913|26935880|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
13448524|NCT00289913|26935876|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3|||
13448525|NCT00289913|26935877|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
13448526|NCT00289913|26935878|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
13448527|NCT00289913|26935879|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
13448528|NCT00289913|26935880|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
13448529|NCT00289913|26935876|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
13448530|NCT00289913|26935877|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
13448531|NCT00289913|26935878|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
13448532|NCT00289913|26935879|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
13448533|NCT00289913|26935880|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
13448534|NCT00289913|26935876|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
13448535|NCT00289913|26935877|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
13448536|NCT00289913|26935878|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3|||
13448537|NCT00289913|26935879|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
13448538|NCT00289913|26935880|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
13448539|NCT00289913|26935876|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2|||
13448540|NCT00289913|26935877|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5|||
13448541|NCT00289913|26935878|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
13448542|NCT00289913|26935879|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3|||
13448543|NCT00289913|26935880|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
13448544|NCT00289913|26935876|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
13448545|NCT00289913|26935877|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1|||
13448546|NCT00289913|26935878|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2|||
13448547|NCT00289913|26935879|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
13448548|NCT00289913|26935880|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
13448549|NCT00289913|26935876|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1|||
13448550|NCT00289913|26935877|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
13448551|NCT00289913|26935878|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
13448552|NCT00289913|26935879|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
13448553|NCT00289913|26935880|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
13448554|NCT00289913|26935876|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
13448555|NCT00289913|26935877|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
13448556|NCT00289913|26935878|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
13448557|NCT00289913|26935879|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
13448558|NCT00289913|26935880|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7|||
13448559|NCT00289913|26935876|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
13448560|NCT00289913|26935877|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
13448561|NCT00289913|26935878|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
13448562|NCT00289913|26935879|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
13448563|NCT00289913|26935880|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11|||
13448564|NCT00289913|26935876|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
13448565|NCT00289913|26935877|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
13448566|NCT00289913|26935878|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
13448567|NCT00289913|26935879|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
13448568|NCT00289913|26935880|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6|||
13448569|NCT00289913|26935876|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
13448570|NCT00289913|26935877|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
13448571|NCT00289913|26935878|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
13448572|NCT00289913|26935879|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
13448573|NCT00289913|26935880|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7|||
13448574|NCT00289913|26935876|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
13448575|NCT00289913|26935877|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
13448576|NCT00289913|26935878|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
13448577|NCT00289913|26935879|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
13448578|NCT00289913|26935880|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9|||
13448579|NCT00289913|26935876|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
13448580|NCT00289913|26935877|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
13448581|NCT00289913|26935878|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
13448582|NCT00289913|26935879|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
13448583|NCT00289913|26935880|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
13448584|NCT00289913|26935876|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8|||
13448585|NCT00289913|26935877|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3|||
13448586|NCT00289913|26935878|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1|||
13448587|NCT00289913|26935879|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
13448588|NCT00289913|26935880|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
13448589|NCT00289913|26935876|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
13448590|NCT00289913|26935877|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
13448591|NCT00289913|26935878|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
13448592|NCT00289913|26935879|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
13448593|NCT00289913|26935880|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
13448594|NCT00289913|26935876|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
13448595|NCT00289913|26935877|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
13448596|NCT00289913|26935878|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
13448597|NCT00289913|26935879|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
13448598|NCT00289913|26935880|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1|||
13448599|NCT00289913|26935876|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
13448600|NCT00289913|26935877|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2|||
13448601|NCT00289913|26935878|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0|||
13448602|NCT00289913|26935879|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
13448603|NCT00289913|26935880|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4|||
13448604|NCT00289913|26935876|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
13448605|NCT00289913|26935877|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
13448606|NCT00289913|26935878|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
13448607|NCT00289913|26935879|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
13448608|NCT00289913|26935880|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
13448609|NCT00289913|26935876|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
13448610|NCT00289913|26935877|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
13448611|NCT00289913|26935878|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
13448612|NCT00289913|26935879|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
13448613|NCT00289913|26935880|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1|||
13448614|NCT00289913|26935876|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
13448615|NCT00289913|26935877|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1|||
13448616|NCT00289913|26935878|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
13219938|NCT01829113|26278687|FG001|Overall Study|Withdrawal by Subject|10|||
13219939|NCT01829113|26278686|FG000|Overall Study|Death|4|||
13219940|NCT01829113|26278687|FG001|Overall Study|Death|6|||
13219941|NCT01829113|26278686|FG000|Overall Study|Sponsor Decision|1|||
13219942|NCT01829113|26278687|FG001|Overall Study|Sponsor Decision|1|||
13219943|NCT01829113|26278686|FG000|Overall Study|No Study Treatment Received|3|||
13219944|NCT01829113|26278687|FG001|Overall Study|No Study Treatment Received|2|||
13219945|NCT01829113|26278686|FG000|Overall Study|Physician Decision|1|||
13219946|NCT01829113|26278687|FG001|Overall Study|Physician Decision|1|||
13219947|NCT01829048|26278775|FG000|Overall Study|Withdrawal by Subject|0|||
13219948|NCT01829048|26278776|FG001|Overall Study|Withdrawal by Subject|0|||
13219949|NCT01829048|26278777|FG002|Overall Study|Withdrawal by Subject|0|||
13219950|NCT01829048|26278778|FG003|Overall Study|Withdrawal by Subject|2|||
13219951|NCT01829048|26278779|FG004|Overall Study|Withdrawal by Subject|0|||
13219952|NCT01828567|26278802|FG000|Overall Study|Lost to Follow-up|27|||
13219953|NCT01828567|26278803|FG001|Overall Study|Lost to Follow-up|9|||
13219954|NCT01828567|26278802|FG000|Overall Study|Excluded - did not meet criteria|4|||
13219955|NCT01828567|26278803|FG001|Overall Study|Excluded - did not meet criteria|1|||
13219956|NCT01828281|26278820|FG000|Overall Study|Withdrawal by Subject|1|||
13448617|NCT00289913|26935879|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
13448618|NCT00289913|26935880|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
13448619|NCT00289900|26936001|FG000|Overall Study|Adverse Event|28|||
13448620|NCT00289900|26936002|FG001|Overall Study|Adverse Event|40|||
13448621|NCT00289900|26936003|FG002|Overall Study|Adverse Event|13|||
13448622|NCT00289900|26936004|FG003|Overall Study|Adverse Event|19|||
13448623|NCT00289900|26936005|FG004|Overall Study|Adverse Event|20|||
13448624|NCT00289900|26936006|FG005|Overall Study|Adverse Event|33|||
13448625|NCT00289900|26936001|FG000|Overall Study|Lost to Follow-up|7|||
13448626|NCT00289900|26936002|FG001|Overall Study|Lost to Follow-up|7|||
13448627|NCT00289900|26936003|FG002|Overall Study|Lost to Follow-up|8|||
13448628|NCT00289900|26936004|FG003|Overall Study|Lost to Follow-up|8|||
13448629|NCT00289900|26936005|FG004|Overall Study|Lost to Follow-up|4|||
13448630|NCT00289900|26936006|FG005|Overall Study|Lost to Follow-up|8|||
13448631|NCT00289900|26936001|FG000|Overall Study|Participant had flushing|18|||
13448632|NCT00289900|26936002|FG001|Overall Study|Participant had flushing|42|||
13448633|NCT00289900|26936003|FG002|Overall Study|Participant had flushing|1|||
13448634|NCT00289900|26936004|FG003|Overall Study|Participant had flushing|2|||
13448635|NCT00289900|26936005|FG004|Overall Study|Participant had flushing|0|||
13448636|NCT00289900|26936006|FG005|Overall Study|Participant had flushing|4|||
13448637|NCT00289900|26936001|FG000|Overall Study|Other|0|||
13448638|NCT00289900|26936002|FG001|Overall Study|Other|0|||
13448639|NCT00289900|26936003|FG002|Overall Study|Other|0|||
13448640|NCT00289900|26936004|FG003|Overall Study|Other|5|||
13448641|NCT00289900|26936005|FG004|Overall Study|Other|1|||
13448642|NCT00289900|26936006|FG005|Overall Study|Other|0|||
13448643|NCT00289900|26936001|FG000|Overall Study|Participant moved|1|||
13448644|NCT00289900|26936002|FG001|Overall Study|Participant moved|0|||
13448645|NCT00289900|26936003|FG002|Overall Study|Participant moved|0|||
13448646|NCT00289900|26936004|FG003|Overall Study|Participant moved|1|||
13448647|NCT00289900|26936005|FG004|Overall Study|Participant moved|1|||
13448648|NCT00289900|26936006|FG005|Overall Study|Participant moved|1|||
13448649|NCT00289900|26936001|FG000|Overall Study|Withdrawal by Subject|10|||
13448650|NCT00289900|26936002|FG001|Overall Study|Withdrawal by Subject|21|||
13448651|NCT00289900|26936003|FG002|Overall Study|Withdrawal by Subject|8|||
13448652|NCT00289900|26936004|FG003|Overall Study|Withdrawal by Subject|18|||
13448653|NCT00289900|26936005|FG004|Overall Study|Withdrawal by Subject|12|||
13448654|NCT00289900|26936006|FG005|Overall Study|Withdrawal by Subject|11|||
13448655|NCT00289900|26936001|FG000|Overall Study|Protocol Violation|3|||
13448656|NCT00289900|26936002|FG001|Overall Study|Protocol Violation|9|||
13448657|NCT00289900|26936003|FG002|Overall Study|Protocol Violation|2|||
13448658|NCT00289900|26936004|FG003|Overall Study|Protocol Violation|6|||
13448659|NCT00289900|26936005|FG004|Overall Study|Protocol Violation|7|||
13448660|NCT00289900|26936006|FG005|Overall Study|Protocol Violation|4|||
13448661|NCT00289900|26936001|FG000|Overall Study|site terminated|1|||
13448662|NCT00289900|26936002|FG001|Overall Study|site terminated|0|||
13448663|NCT00289900|26936003|FG002|Overall Study|site terminated|1|||
13448664|NCT00289900|26936004|FG003|Overall Study|site terminated|0|||
13448665|NCT00289900|26936005|FG004|Overall Study|site terminated|0|||
13448666|NCT00289900|26936006|FG005|Overall Study|site terminated|0|||
13448667|NCT00289900|26936001|FG000|Overall Study|Not treated|0|||
13448668|NCT00289900|26936002|FG001|Overall Study|Not treated|1|||
13448669|NCT00289900|26936003|FG002|Overall Study|Not treated|0|||
13448670|NCT00289900|26936004|FG003|Overall Study|Not treated|0|||
13448671|NCT00289900|26936005|FG004|Overall Study|Not treated|0|||
13448672|NCT00289900|26936006|FG005|Overall Study|Not treated|0|||
13448673|NCT00289887|26936029|FG000|Overall Study|Adverse Event|3|||
13448674|NCT00289887|26936030|FG001|Overall Study|Adverse Event|3|||
13448675|NCT00289887|26936029|FG000|Overall Study|Lack of Efficacy|3|||
13448676|NCT00289887|26936030|FG001|Overall Study|Lack of Efficacy|11|||
13448677|NCT00289887|26936029|FG000|Overall Study|Lost to Follow-up|3|||
13448678|NCT00289887|26936030|FG001|Overall Study|Lost to Follow-up|3|||
13448679|NCT00289887|26936029|FG000|Overall Study|Protocol Violation|3|||
13448680|NCT00289887|26936030|FG001|Overall Study|Protocol Violation|1|||
13448681|NCT00289887|26936029|FG000|Overall Study|Withdrawal by Subject|3|||
13448682|NCT00289887|26936030|FG001|Overall Study|Withdrawal by Subject|8|||
13448683|NCT00289887|26936029|FG000|Overall Study|Other|7|||
13448684|NCT00289887|26936030|FG001|Overall Study|Other|3|||
13448685|NCT00289848|26936047|FG000|Overall Study|Adverse Event|6|||
13448686|NCT00289848|26936048|FG001|Overall Study|Adverse Event|4|||
13448687|NCT00289848|26936047|FG000|Overall Study|Death|1|||
13448688|NCT00289848|26936048|FG001|Overall Study|Death|0|||
13448689|NCT00289848|26936047|FG000|Overall Study|Lack of Efficacy|20|||
13448690|NCT00289848|26936048|FG001|Overall Study|Lack of Efficacy|24|||
13448691|NCT00289848|26936047|FG000|Overall Study|Lost to Follow-up|3|||
13448692|NCT00289848|26936048|FG001|Overall Study|Lost to Follow-up|1|||
13448693|NCT00289848|26936047|FG000|Overall Study|Protocol Violation|5|||
13448694|NCT00289848|26936048|FG001|Overall Study|Protocol Violation|2|||
13448695|NCT00289848|26936047|FG000|Overall Study|Withdrawal by Subject|5|||
13448696|NCT00289848|26936048|FG001|Overall Study|Withdrawal by Subject|11|||
13448697|NCT00289848|26936047|FG000|Overall Study|Patient Moved|6|||
13448698|NCT00289848|26936048|FG001|Overall Study|Patient Moved|2|||
13448699|NCT00289848|26936047|FG000|Overall Study|Open-Label AHA Treatment Requested|0|||
13448700|NCT00289848|26936048|FG001|Overall Study|Open-Label AHA Treatment Requested|1|||
13448701|NCT00289783|26936233|FG000|Primary Phase|Adverse Event|10|||
13448702|NCT00289783|26936234|FG001|Primary Phase|Adverse Event|1|||
13448703|NCT00289783|26936233|FG000|Primary Phase|Protocol Violation|27|||
13448704|NCT00289783|26936234|FG001|Primary Phase|Protocol Violation|6|||
13448705|NCT00289783|26936233|FG000|Primary Phase|Withdrawal by Subject|93|||
13448706|NCT00289783|26936234|FG001|Primary Phase|Withdrawal by Subject|40|||
13448707|NCT00289783|26936233|FG000|Primary Phase|Lost to Follow-up|60|||
13448708|NCT00289783|26936234|FG001|Primary Phase|Lost to Follow-up|14|||
13448709|NCT00289783|26936233|FG000|Primary Phase|Migration from the study area|26|||
13448710|NCT00289783|26936234|FG001|Primary Phase|Migration from the study area|10|||
13448711|NCT00289783|26936233|FG000|Primary Phase|Other|32|||
13448712|NCT00289783|26936234|FG001|Primary Phase|Other|12|||
13448713|NCT00289783|26936233|FG000|Fourth Dose Phase|Adverse Event|1|||
13448714|NCT00289783|26936234|FG001|Fourth Dose Phase|Adverse Event|0|||
13448715|NCT00289783|26936233|FG000|Fourth Dose Phase|Withdrawal by Subject|10|||
13448716|NCT00289783|26936234|FG001|Fourth Dose Phase|Withdrawal by Subject|1|||
13448717|NCT00289783|26936233|FG000|Fourth Dose Phase|Lost to Follow-up|53|||
13448718|NCT00289783|26936234|FG001|Fourth Dose Phase|Lost to Follow-up|12|||
13448719|NCT00289783|26936233|FG000|Fourth Dose Phase|Migration from the study area|1|||
13448720|NCT00289783|26936234|FG001|Fourth Dose Phase|Migration from the study area|1|||
13448721|NCT00289783|26936233|FG000|Fourth Dose Phase|Other|22|||
13448722|NCT00289783|26936234|FG001|Fourth Dose Phase|Other|10|||
13448723|NCT00289770|26936248|FG000|Year 15|Withdrawal by Subject|1|||
13448724|NCT00289731|26936350|FG000|Overall Study|Adverse Event|1|||
13448725|NCT00289731|26936351|FG001|Overall Study|Adverse Event|2|||
13448726|NCT00289731|26936352|FG002|Overall Study|Adverse Event|2|||
13448727|NCT00289731|26936350|FG000|Overall Study|Other|1|||
13448728|NCT00289731|26936351|FG001|Overall Study|Other|0|||
13448729|NCT00289731|26936352|FG002|Overall Study|Other|0|||
13448730|NCT00289536|26936395|FG000|Period 3|Lost to Follow-up|0|||
13448731|NCT00289536|26936396|FG001|Period 3|Lost to Follow-up|0|||
13448732|NCT00289536|26936397|FG002|Period 3|Lost to Follow-up|1|||
13448733|NCT00289458|26936430|FG000|Overall Study|Death|1|||
13448734|NCT00289458|26936431|FG001|Overall Study|Death|0|||
13448735|NCT00289458|26936432|FG002|Overall Study|Death|0|||
13448736|NCT00289458|26936430|FG000|Overall Study|Physician Decision|3|||
13448737|NCT00289458|26936431|FG001|Overall Study|Physician Decision|4|||
13448738|NCT00289458|26936432|FG002|Overall Study|Physician Decision|2|||
13448739|NCT00289458|26936430|FG000|Overall Study|Withdrawal by Subject|2|||
13448740|NCT00289458|26936431|FG001|Overall Study|Withdrawal by Subject|2|||
13448741|NCT00289458|26936432|FG002|Overall Study|Withdrawal by Subject|4|||
13448742|NCT00289289|26936455|FG000|Overall Study|Withdrawal by Subject|5|||
13448743|NCT00289289|26936456|FG001|Overall Study|Withdrawal by Subject|3|||
13448744|NCT00289289|26936457|FG002|Overall Study|Withdrawal by Subject|15|||
13448745|NCT00289289|26936455|FG000|Overall Study|Lost to Follow-up|1|||
13448746|NCT00289289|26936456|FG001|Overall Study|Lost to Follow-up|0|||
13448747|NCT00289289|26936457|FG002|Overall Study|Lost to Follow-up|1|||
13448748|NCT00289289|26936455|FG000|Overall Study|Death|4|||
13448749|NCT00289289|26936456|FG001|Overall Study|Death|2|||
13448750|NCT00289289|26936457|FG002|Overall Study|Death|5|||
13448751|NCT00289289|26936455|FG000|Overall Study|No implant attempted|0|||
13448752|NCT00289289|26936456|FG001|Overall Study|No implant attempted|0|||
13448753|NCT00289289|26936457|FG002|Overall Study|No implant attempted|1|||
13448754|NCT00289289|26936455|FG000|Overall Study|Physician Decision|1|||
13448755|NCT00289289|26936456|FG001|Overall Study|Physician Decision|0|||
13448756|NCT00289289|26936457|FG002|Overall Study|Physician Decision|6|||
13448757|NCT00289289|26936455|FG000|Overall Study|Non-study device implanted|2|||
13448758|NCT00289289|26936456|FG001|Overall Study|Non-study device implanted|1|||
13448759|NCT00289289|26936457|FG002|Overall Study|Non-study device implanted|3|||
13448760|NCT00289289|26936455|FG000|Overall Study|Did not meet inclusion/exclusion|0|||
13448761|NCT00289289|26936456|FG001|Overall Study|Did not meet inclusion/exclusion|0|||
13448762|NCT00289289|26936457|FG002|Overall Study|Did not meet inclusion/exclusion|6|||
13448763|NCT00289289|26936455|FG000|Overall Study|Other Exit Reason|6|||
13448764|NCT00289289|26936456|FG001|Overall Study|Other Exit Reason|4|||
13448765|NCT00289289|26936457|FG002|Overall Study|Other Exit Reason|12|||
13448766|NCT00289276|26936476|FG000|Second Part of FAST Study (Expansion)|Death|0|||
13448767|NCT00289276|26936477|FG001|Second Part of FAST Study (Expansion)|Death|2|||
13448768|NCT00289276|26936476|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0|||
13448769|NCT00289276|26936477|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1|||
13448770|NCT00289198|26936532|FG000|Overall Study|Adverse Event|0|||
13448771|NCT00289198|26936533|FG001|Overall Study|Adverse Event|2|||
13448772|NCT00289198|26936532|FG000|Overall Study|Protocol Violation|2|||
13448773|NCT00289198|26936533|FG001|Overall Study|Protocol Violation|1|||
13448774|NCT00289198|26936532|FG000|Overall Study|Withdrawal by Subject|4|||
13448775|NCT00289198|26936533|FG001|Overall Study|Withdrawal by Subject|1|||
13448776|NCT00289198|26936532|FG000|Overall Study|Lack of Efficacy|2|||
13448777|NCT00289198|26936533|FG001|Overall Study|Lack of Efficacy|0|||
13448778|NCT00289198|26936532|FG000|Overall Study|Other: Low compliance|0|||
13448779|NCT00289198|26936533|FG001|Overall Study|Other: Low compliance|1|||
13448780|NCT00289198|26936532|FG000|Overall Study|Other: Physician's decision|0|||
13448781|NCT00289198|26936533|FG001|Overall Study|Other: Physician's decision|1|||
13448782|NCT00289198|26936532|FG000|Overall Study|Other: Unable to attend on schedule|2|||
13448783|NCT00289198|26936533|FG001|Overall Study|Other: Unable to attend on schedule|1|||
13448784|NCT00289198|26936532|FG000|Overall Study|Other: Miscalculation of the visit date|21|||
13448785|NCT00289198|26936533|FG001|Overall Study|Other: Miscalculation of the visit date|22|||
13448786|NCT00289198|26936532|FG000|Overall Study|Other: Impossible to come on visit|0|||
13448787|NCT00289198|26936533|FG001|Overall Study|Other: Impossible to come on visit|1|||
13448788|NCT00289185|26936585|FG000|Overall Study|Withdrawal by Subject|4|||
13448789|NCT00289185|26936586|FG001|Overall Study|Withdrawal by Subject|8|||
13448790|NCT00289185|26936585|FG000|Overall Study|Lost to Follow-up|23|||
13448791|NCT00289185|26936586|FG001|Overall Study|Lost to Follow-up|17|||
13448792|NCT00289185|26936585|FG000|Overall Study|Death|1|||
13448793|NCT00289185|26936586|FG001|Overall Study|Death|1|||
13448794|NCT00289133|26936615|FG000|Overall Study|Non-study device implanted|12|||
13448795|NCT00289133|26936616|FG001|Overall Study|Non-study device implanted|0|||
13448796|NCT00289133|26936615|FG000|Overall Study|Protocol Violation|32|||
13448797|NCT00289133|26936616|FG001|Overall Study|Protocol Violation|38|||
13448798|NCT00289133|26936615|FG000|Overall Study|Withdrawal by Subject|9|||
13448799|NCT00289133|26936616|FG001|Overall Study|Withdrawal by Subject|10|||
13448800|NCT00289133|26936615|FG000|Overall Study|Death|5|||
13448801|NCT00289133|26936616|FG001|Overall Study|Death|10|||
13448802|NCT00289133|26936615|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73|||
13448803|NCT00289133|26936616|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74|||
13448804|NCT00289133|26936615|FG000|Overall Study|Physician Decision|41|||
13448805|NCT00289133|26936616|FG001|Overall Study|Physician Decision|45|||
13448806|NCT00289133|26936615|FG000|Overall Study|Revision|8|||
13448807|NCT00289133|26936616|FG001|Overall Study|Revision|6|||
13448808|NCT00289133|26936615|FG000|Overall Study|Lost to Follow-up|92|||
13448809|NCT00289133|26936616|FG001|Overall Study|Lost to Follow-up|115|||
13448810|NCT00289016|26936627|FG000|Overall Study|Disease Progression|29|||
13448811|NCT00289016|26936627|FG000|Overall Study|Death|2|||
13448812|NCT00289016|26936627|FG000|Overall Study|Unrelated Medical Condition or Accident|2|||
13448813|NCT00289016|26936627|FG000|Overall Study|Withdrawal by Subject|2|||
13448814|NCT00289016|26936627|FG000|Overall Study|Adverse Event|1|||
13448815|NCT00289016|26936627|FG000|Overall Study|Other|1|||
13448816|NCT00288912|26936654|FG000|Overall Study|Developed exclusion criterion|4|||
13448817|NCT00288912|26936655|FG001|Overall Study|Developed exclusion criterion|6|||
13448818|NCT00288912|26936656|FG002|Overall Study|Developed exclusion criterion|7|||
13448819|NCT00288912|26936654|FG000|Overall Study|Lost to Follow-up|9|||
13448820|NCT00288912|26936655|FG001|Overall Study|Lost to Follow-up|6|||
13448821|NCT00288912|26936656|FG002|Overall Study|Lost to Follow-up|9|||
13448822|NCT00288912|26936654|FG000|Overall Study|Withdrawal by Subject|4|||
13448823|NCT00288912|26936655|FG001|Overall Study|Withdrawal by Subject|5|||
13448824|NCT00288912|26936656|FG002|Overall Study|Withdrawal by Subject|12|||
13448825|NCT00288860|26936673|FG000|Overall Study|Did not complete intake|4|||
13448826|NCT00288860|26936674|FG001|Overall Study|Did not complete intake|8|||
13448827|NCT00288860|26936673|FG000|Overall Study|Death|4|||
13448828|NCT00288860|26936674|FG001|Overall Study|Death|3|||
13448829|NCT00288860|26936673|FG000|Overall Study|Withdrawal by Subject|20|||
13448830|NCT00288860|26936674|FG001|Overall Study|Withdrawal by Subject|15|||
13448831|NCT00288860|26936673|FG000|Overall Study|Lost to Follow-up|74|||
13448832|NCT00288860|26936674|FG001|Overall Study|Lost to Follow-up|71|||
13448833|NCT00288704|26936711|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
13448834|NCT00288704|26936712|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1|||
13448835|NCT00288704|26936713|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
13448836|NCT00288704|26936711|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
13448837|NCT00288704|26936712|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1|||
13448838|NCT00288704|26936713|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
13448839|NCT00288704|26936711|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
13448840|NCT00288704|26936712|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
13448841|NCT00288704|26936713|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1|||
13448842|NCT00288704|26936711|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
13448843|NCT00288704|26936712|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
13448844|NCT00288704|26936713|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1|||
13448845|NCT00288704|26936711|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
13448846|NCT00288704|26936712|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
13448847|NCT00288704|26936713|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2|||
13448848|NCT00288704|26936711|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
13448849|NCT00288704|26936712|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
13448850|NCT00288704|26936713|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15|||
13448851|NCT00288704|26936711|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
13448852|NCT00288704|26936712|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
13448853|NCT00288704|26936713|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1|||
13448854|NCT00288639|26936732|FG000|Overall Study|Adverse Event|5|||
13448855|NCT00288639|26936732|FG000|Overall Study|Lack of Efficacy|4|||
13448856|NCT00288639|26936732|FG000|Overall Study|Withdrawal by Subject|2|||
13448857|NCT00288639|26936732|FG000|Overall Study|Other|1|||
13448858|NCT00288626|26936757|FG000|Overall Study|Death|3|||
13448859|NCT00288626|26936757|FG000|Overall Study|Withdrawal by Subject|4|||
13448860|NCT00288587|26936778|FG000|Overall Study|Death|4|||
13448861|NCT00288587|26936779|FG001|Overall Study|Death|4|||
13448862|NCT00288587|26936778|FG000|Overall Study|Transplant|0|||
13448863|NCT00288587|26936779|FG001|Overall Study|Transplant|3|||
13448864|NCT00288587|26936778|FG000|Overall Study|Adverse Event|0|||
13448865|NCT00288587|26936779|FG001|Overall Study|Adverse Event|1|||
13448866|NCT00288587|26936778|FG000|Overall Study|Physician Decision|0|||
13448867|NCT00288587|26936779|FG001|Overall Study|Physician Decision|2|||
13448868|NCT00288587|26936778|FG000|Overall Study|Severe Aortic Stenosis|1|||
13448869|NCT00288587|26936779|FG001|Overall Study|Severe Aortic Stenosis|0|||
13448870|NCT00288509|26936788|FG000|Treatment Cycle 1|Adverse Event|1|||
13448871|NCT00288509|26936788|FG000|Treatment Cycle 1|Lack of Efficacy|1|||
13448872|NCT00288509|26936788|FG000|Treatment Cycle 1|Withdrawal by Subject|1|||
13448873|NCT00288509|26936788|FG000|Treatment Cycle 1|Lost to Follow-up|2|||
13448874|NCT00288509|26936788|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1|||
13448875|NCT00288509|26936788|FG000|Treatment Cycle 2|Lack of Efficacy|1|||
13448876|NCT00288509|26936788|FG000|Treatment Cycle 2|Withdrawal by Subject|2|||
13448877|NCT00288509|26936788|FG000|Treatment Cycle 3|Lack of Efficacy|1|||
13448878|NCT00288509|26936788|FG000|Treatment Cycle 3|Withdrawal by Subject|1|||
13448879|NCT00288509|26936788|FG000|Treatment Cycle 3|Lost to Follow-up|2|||
13448880|NCT00288509|26936788|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1|||
13448881|NCT00288509|26936788|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
13448882|NCT00288509|26936788|FG000|Treatment Cycle 4|Physician Decision|4|||
13448883|NCT00288509|26936788|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1|||
13448884|NCT00288080|26936815|FG000|Overall Study|Withdrawal by Subject|1|||
13448885|NCT00288080|26936816|FG001|Overall Study|Withdrawal by Subject|3|||
13448886|NCT00288080|26936815|FG000|Overall Study|Protocol Violation|25|||
13448887|NCT00288080|26936816|FG001|Overall Study|Protocol Violation|20|||
13448888|NCT00288054|26936826|FG000|Overall Study|Protocol Violation|2|||
13448889|NCT00288054|26936826|FG000|Overall Study|Lack of Efficacy|16|||
13448890|NCT00288054|26936826|FG000|Overall Study|Adverse Event|3|||
13448891|NCT00288054|26936826|FG000|Overall Study|Withdrawal by Subject|1|||
13448892|NCT00288054|26936826|FG000|Overall Study|Not protocol specified|2|||
13448893|NCT00288015|26936837|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1|||
13448894|NCT00288015|26936837|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1|||
13448895|NCT00288015|26936837|FG000|First Response Assessment|Withdrawal by Subject|1|||
13448896|NCT00288015|26936837|FG000|First Response Assessment|Death|1|||
13448897|NCT00288015|26936837|FG000|First Response Assessment|Physician Decision|2|||
13448898|NCT00288015|26936837|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7|||
13448899|NCT00288015|26936837|FG000|Follow up for Survival x 2 Years|Death|13|||
13448900|NCT00288015|26936837|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4|||
13448901|NCT00288015|26936837|FG000|Follow up for Survival x 2 Years|Other|9|||
13448902|NCT00287690|26936854|FG000|Overall Study|Protocol Violation|20|||
13448903|NCT00287690|26936855|FG001|Overall Study|Protocol Violation|26|||
13448904|NCT00287586|26936898|FG000|Overall Study|Withdrew Consent|19|||
13448905|NCT00287586|26936899|FG001|Overall Study|Withdrew Consent|30|||
13448906|NCT00287586|26936898|FG000|Overall Study|Lost to Follow-up|5|||
13448907|NCT00287586|26936899|FG001|Overall Study|Lost to Follow-up|4|||
13448908|NCT00287586|26936898|FG000|Overall Study|Death|2|||
13448909|NCT00287586|26936899|FG001|Overall Study|Death|3|||
13448910|NCT00287586|26936898|FG000|Overall Study|Elevated Hematocrit|3|||
13448911|NCT00287586|26936899|FG001|Overall Study|Elevated Hematocrit|0|||
13448912|NCT00287586|26936898|FG000|Overall Study|Rash|3|||
13448913|NCT00287586|26936899|FG001|Overall Study|Rash|0|||
13448914|NCT00287586|26936898|FG000|Overall Study|Elevated Prostate Specific Antigen|2|||
13448915|NCT00287586|26936899|FG001|Overall Study|Elevated Prostate Specific Antigen|0|||
13448916|NCT00287586|26936898|FG000|Overall Study|Stroke|2|||
13448917|NCT00287586|26936899|FG001|Overall Study|Stroke|0|||
13448918|NCT00287586|26936898|FG000|Overall Study|Myocardial Infarction|1|||
13448919|NCT00287586|26936899|FG001|Overall Study|Myocardial Infarction|0|||
13448920|NCT00287586|26936898|FG000|Overall Study|Lower Urinary Tract Symptoms|1|||
13448921|NCT00287586|26936899|FG001|Overall Study|Lower Urinary Tract Symptoms|0|||
13448922|NCT00287586|26936898|FG000|Overall Study|Cognitive Impairment|1|||
13448923|NCT00287586|26936899|FG001|Overall Study|Cognitive Impairment|0|||
13448924|NCT00287586|26936898|FG000|Overall Study|Pancreatic Cancer|1|||
13448925|NCT00287586|26936899|FG001|Overall Study|Pancreatic Cancer|3|||
13448926|NCT00287586|26936898|FG000|Overall Study|Sleep Apnea|1|||
13448927|NCT00287586|26936899|FG001|Overall Study|Sleep Apnea|0|||
13448928|NCT00287586|26936898|FG000|Overall Study|Shoulder Pain|1|||
13448929|NCT00287586|26936899|FG001|Overall Study|Shoulder Pain|0|||
13448930|NCT00287586|26936898|FG000|Overall Study|Inappropriate Behaviour with Staff|1|||
13448931|NCT00287586|26936899|FG001|Overall Study|Inappropriate Behaviour with Staff|0|||
13448932|NCT00287586|26936898|FG000|Overall Study|Nonadherence|1|||
13448933|NCT00287586|26936899|FG001|Overall Study|Nonadherence|1|||
13448934|NCT00287586|26936898|FG000|Overall Study|Enrolled in Another Study|1|||
13448935|NCT00287586|26936899|FG001|Overall Study|Enrolled in Another Study|0|||
13448936|NCT00287586|26936898|FG000|Overall Study|Major Depression|0|||
13448937|NCT00287586|26936899|FG001|Overall Study|Major Depression|2|||
13448938|NCT00287586|26936898|FG000|Overall Study|Lung Cancer|0|||
13448939|NCT00287586|26936899|FG001|Overall Study|Lung Cancer|2|||
13448940|NCT00287586|26936898|FG000|Overall Study|Elevated IPSS Score|0|||
13448941|NCT00287586|26936899|FG001|Overall Study|Elevated IPSS Score|1|||
13448942|NCT00287586|26936898|FG000|Overall Study|Retroperitoneal Cancer|0|||
13448943|NCT00287586|26936899|FG001|Overall Study|Retroperitoneal Cancer|1|||
13448944|NCT00287586|26936898|FG000|Overall Study|Mastodynia and Gynecomastia|0|||
13448945|NCT00287586|26936899|FG001|Overall Study|Mastodynia and Gynecomastia|1|||
13448946|NCT00287586|26936898|FG000|Overall Study|Mood Swings and Irritability|0|||
13448947|NCT00287586|26936899|FG001|Overall Study|Mood Swings and Irritability|1|||
13448948|NCT00287586|26936898|FG000|Overall Study|Bradycardia|0|||
13448949|NCT00287586|26936899|FG001|Overall Study|Bradycardia|1|||
13448950|NCT00287586|26936898|FG000|Overall Study|Itchy Swollen Eyes|0|||
13448951|NCT00287586|26936899|FG001|Overall Study|Itchy Swollen Eyes|1|||
13448952|NCT00287586|26936898|FG000|Overall Study|Recurrent Melanoma|0|||
13448953|NCT00287586|26936899|FG001|Overall Study|Recurrent Melanoma|1|||
13448954|NCT00287469|26936916|FG000|Overall Study|serious adverse event|1|||
13448955|NCT00287469|26936917|FG001|Overall Study|serious adverse event|6|||
13448956|NCT00287469|26936916|FG000|Overall Study|Adverse Event|1|||
13448957|NCT00287469|26936917|FG001|Overall Study|Adverse Event|1|||
13448958|NCT00287469|26936916|FG000|Overall Study|moved from area|144|||
13448959|NCT00287469|26936917|FG001|Overall Study|moved from area|138|||
13448960|NCT00287469|26936916|FG000|Overall Study|Lost to Follow-up|74|||
13448961|NCT00287469|26936917|FG001|Overall Study|Lost to Follow-up|69|||
13448962|NCT00287365|26936928|FG000|Overall Study|sample not acquired|13|||
13448963|NCT00287118|26936934|FG000|Overall Study|Adverse Event|30|||
13448964|NCT00287118|26936934|FG000|Overall Study|Death|1|||
13448965|NCT00287118|26936934|FG000|Overall Study|Lack of Efficacy|11|||
13448966|NCT00287118|26936934|FG000|Overall Study|Lost to Follow-up|1|||
13448967|NCT00287118|26936934|FG000|Overall Study|Protocol Violation|2|||
13448968|NCT00287118|26936934|FG000|Overall Study|Other|7|||
13448969|NCT00287079|26936951|FG000|Overall Study|Qualifying relapse|12|||
13448970|NCT00287079|26936952|FG001|Overall Study|Qualifying relapse|1|||
13448971|NCT00287079|26936951|FG000|Overall Study|Non-qualifying relapse|1|||
13448972|NCT00287079|26936952|FG001|Overall Study|Non-qualifying relapse|0|||
13448973|NCT00287079|26936951|FG000|Overall Study|Adverse Event|5|||
13448974|NCT00287079|26936952|FG001|Overall Study|Adverse Event|0|||
13448975|NCT00287079|26936951|FG000|Overall Study|Protocol Violation|1|||
13448976|NCT00287079|26936952|FG001|Overall Study|Protocol Violation|0|||
13448977|NCT00287079|26936951|FG000|Overall Study|Other|3|||
13448978|NCT00287079|26936952|FG001|Overall Study|Other|0|||
13448979|NCT00286754|26936994|FG000|Overall Study|Adverse Event|2|||
13448980|NCT00286754|26936995|FG001|Overall Study|Adverse Event|2|||
13448981|NCT00286754|26936996|FG002|Overall Study|Adverse Event|3|||
13448982|NCT00286754|26936994|FG000|Overall Study|Withdrawal by Subject|6|||
13448983|NCT00286754|26936995|FG001|Overall Study|Withdrawal by Subject|2|||
13448984|NCT00286754|26936996|FG002|Overall Study|Withdrawal by Subject|0|||
13448985|NCT00286754|26936994|FG000|Overall Study|Lost to Follow-up|12|||
13448986|NCT00286754|26936995|FG001|Overall Study|Lost to Follow-up|14|||
13448987|NCT00286754|26936996|FG002|Overall Study|Lost to Follow-up|6|||
13448988|NCT00286754|26936994|FG000|Overall Study|Moved out of state|0|||
13448989|NCT00286754|26936995|FG001|Overall Study|Moved out of state|0|||
13448990|NCT00286754|26936996|FG002|Overall Study|Moved out of state|1|||
13448991|NCT00286494|26937164|FG000|Overall Study|Hyperglycemic rescue|12|||
13448992|NCT00286494|26937165|FG001|Overall Study|Hyperglycemic rescue|19|||
13448993|NCT00286494|26937166|FG002|Overall Study|Hyperglycemic rescue|18|||
13448994|NCT00286494|26937164|FG000|Overall Study|Withdrawal by Subject|2|||
13448995|NCT00286494|26937165|FG001|Overall Study|Withdrawal by Subject|10|||
13448996|NCT00286494|26937166|FG002|Overall Study|Withdrawal by Subject|9|||
13448997|NCT00286494|26937164|FG000|Overall Study|Adverse Event|3|||
13448998|NCT00286494|26937165|FG001|Overall Study|Adverse Event|8|||
13448999|NCT00286494|26937166|FG002|Overall Study|Adverse Event|6|||
13449000|NCT00286494|26937164|FG000|Overall Study|Physician Decision|5|||
13449001|NCT00286494|26937165|FG001|Overall Study|Physician Decision|5|||
13449002|NCT00286494|26937166|FG002|Overall Study|Physician Decision|1|||
13449003|NCT00286494|26937164|FG000|Overall Study|Lost to Follow-up|3|||
13449004|NCT00286494|26937165|FG001|Overall Study|Lost to Follow-up|1|||
13449005|NCT00286494|26937166|FG002|Overall Study|Lost to Follow-up|3|||
13449006|NCT00286494|26937164|FG000|Overall Study|Protocol Violation|1|||
13449007|NCT00286494|26937165|FG001|Overall Study|Protocol Violation|1|||
13449008|NCT00286494|26937166|FG002|Overall Study|Protocol Violation|2|||
13449009|NCT00286468|26937334|FG000|Overall Study|Hyperglycemic Rescue|28|||
13449010|NCT00286468|26937335|FG001|Overall Study|Hyperglycemic Rescue|30|||
13449011|NCT00286468|26937336|FG002|Overall Study|Hyperglycemic Rescue|31|||
13449012|NCT00286468|26937334|FG000|Overall Study|Adverse Event|2|||
13449013|NCT00286468|26937335|FG001|Overall Study|Adverse Event|6|||
13449014|NCT00286468|26937336|FG002|Overall Study|Adverse Event|4|||
13449015|NCT00286468|26937334|FG000|Overall Study|Protocol Violation|0|||
13449016|NCT00286468|26937335|FG001|Overall Study|Protocol Violation|3|||
13449017|NCT00286468|26937336|FG002|Overall Study|Protocol Violation|1|||
13449018|NCT00286468|26937334|FG000|Overall Study|Lost to Follow-up|1|||
13449019|NCT00286468|26937335|FG001|Overall Study|Lost to Follow-up|1|||
13449020|NCT00286468|26937336|FG002|Overall Study|Lost to Follow-up|2|||
13449021|NCT00286468|26937334|FG000|Overall Study|Withdrawal by Subject|3|||
13449022|NCT00286468|26937335|FG001|Overall Study|Withdrawal by Subject|8|||
13449023|NCT00286468|26937336|FG002|Overall Study|Withdrawal by Subject|11|||
13449024|NCT00286468|26937334|FG000|Overall Study|Physician Decision|3|||
13449025|NCT00286468|26937335|FG001|Overall Study|Physician Decision|2|||
13449026|NCT00286468|26937336|FG002|Overall Study|Physician Decision|1|||
13477287|NCT01545050|27005969|FG002|Overall Study|Participant no longer meets study criteria|0|||
13477288|NCT01545050|27005970|FG003|Overall Study|Participant no longer meets study criteria|0|||
13477289|NCT01545050|27005971|FG004|Overall Study|Participant no longer meets study criteria|1|||
13477290|NCT01545050|27005967|FG000|Overall Study|Administrative reason by sponsor|4|||
13477291|NCT01545050|27005968|FG001|Overall Study|Administrative reason by sponsor|2|||
13477292|NCT01545050|27005969|FG002|Overall Study|Administrative reason by sponsor|3|||
13477293|NCT01545050|27005970|FG003|Overall Study|Administrative reason by sponsor|5|||
13477294|NCT01545050|27005971|FG004|Overall Study|Administrative reason by sponsor|5|||
13449027|NCT00286455|26937522|FG000|Overall Study|Hyperglycemia rescue|19|||
13449028|NCT00286455|26937523|FG001|Overall Study|Hyperglycemia rescue|13|||
13449029|NCT00286455|26937524|FG002|Overall Study|Hyperglycemia rescue|10|||
13449030|NCT00286455|26937522|FG000|Overall Study|Adverse Event|1|||
13449031|NCT00286455|26937523|FG001|Overall Study|Adverse Event|3|||
13449032|NCT00286455|26937524|FG002|Overall Study|Adverse Event|2|||
13449033|NCT00286455|26937522|FG000|Overall Study|Lost to Follow-up|0|||
13449034|NCT00286455|26937523|FG001|Overall Study|Lost to Follow-up|3|||
13449035|NCT00286455|26937524|FG002|Overall Study|Lost to Follow-up|3|||
13449036|NCT00286455|26937522|FG000|Overall Study|Physician Decision|3|||
13449037|NCT00286455|26937523|FG001|Overall Study|Physician Decision|0|||
13449038|NCT00286455|26937524|FG002|Overall Study|Physician Decision|2|||
13449039|NCT00286455|26937522|FG000|Overall Study|Protocol Violation|1|||
13449040|NCT00286455|26937523|FG001|Overall Study|Protocol Violation|1|||
13449041|NCT00286455|26937524|FG002|Overall Study|Protocol Violation|0|||
13449042|NCT00286455|26937522|FG000|Overall Study|Participant Non-compliance|1|||
13449043|NCT00286455|26937523|FG001|Overall Study|Participant Non-compliance|0|||
13449044|NCT00286455|26937524|FG002|Overall Study|Participant Non-compliance|0|||
13449045|NCT00286455|26937522|FG000|Overall Study|Withdrawal by Subject|0|||
13449046|NCT00286455|26937523|FG001|Overall Study|Withdrawal by Subject|8|||
13449047|NCT00286455|26937524|FG002|Overall Study|Withdrawal by Subject|7|||
13449048|NCT00286442|26937692|FG000|Overall Study|Hyperglycemic Rescue|19|||
13449049|NCT00286442|26937693|FG001|Overall Study|Hyperglycemic Rescue|17|||
13449050|NCT00286442|26937694|FG002|Overall Study|Hyperglycemic Rescue|25|||
13449051|NCT00286442|26937692|FG000|Overall Study|Adverse Event|7|||
13449052|NCT00286442|26937693|FG001|Overall Study|Adverse Event|6|||
13449053|NCT00286442|26937694|FG002|Overall Study|Adverse Event|1|||
13449054|NCT00286442|26937692|FG000|Overall Study|Protocol Violation|2|||
13449055|NCT00286442|26937693|FG001|Overall Study|Protocol Violation|4|||
13449056|NCT00286442|26937694|FG002|Overall Study|Protocol Violation|2|||
13449057|NCT00286442|26937692|FG000|Overall Study|Lost to Follow-up|5|||
13449058|NCT00286442|26937693|FG001|Overall Study|Lost to Follow-up|2|||
13449059|NCT00286442|26937694|FG002|Overall Study|Lost to Follow-up|1|||
13449060|NCT00286442|26937692|FG000|Overall Study|Physician Decision|1|||
13449061|NCT00286442|26937693|FG001|Overall Study|Physician Decision|1|||
13449062|NCT00286442|26937694|FG002|Overall Study|Physician Decision|1|||
13449063|NCT00286442|26937692|FG000|Overall Study|Administrative Error|1|||
13449064|NCT00286442|26937693|FG001|Overall Study|Administrative Error|1|||
13449065|NCT00286442|26937694|FG002|Overall Study|Administrative Error|0|||
13449066|NCT00286442|26937692|FG000|Overall Study|Withdrawal by Subject|2|||
13449067|NCT00286442|26937693|FG001|Overall Study|Withdrawal by Subject|14|||
13449068|NCT00286442|26937694|FG002|Overall Study|Withdrawal by Subject|2|||
13449069|NCT00286429|26937808|FG000|Overall Study|Adverse Event|4|||
13449070|NCT00286429|26937809|FG001|Overall Study|Adverse Event|1|||
13449071|NCT00286429|26937810|FG002|Overall Study|Adverse Event|6|||
13449072|NCT00286429|26937808|FG000|Overall Study|Lack of Efficacy|52|||
13449073|NCT00286429|26937809|FG001|Overall Study|Lack of Efficacy|27|||
13449074|NCT00286429|26937810|FG002|Overall Study|Lack of Efficacy|25|||
13449075|NCT00286429|26937808|FG000|Overall Study|Lost to Follow-up|2|||
13449076|NCT00286429|26937809|FG001|Overall Study|Lost to Follow-up|4|||
13449077|NCT00286429|26937810|FG002|Overall Study|Lost to Follow-up|3|||
13449078|NCT00286429|26937808|FG000|Overall Study|Physician Decision|10|||
13449079|NCT00286429|26937809|FG001|Overall Study|Physician Decision|7|||
13449080|NCT00286429|26937810|FG002|Overall Study|Physician Decision|7|||
13449081|NCT00286429|26937808|FG000|Overall Study|Protocol Violation|3|||
13449082|NCT00286429|26937809|FG001|Overall Study|Protocol Violation|5|||
13449083|NCT00286429|26937810|FG002|Overall Study|Protocol Violation|4|||
13449084|NCT00286429|26937808|FG000|Overall Study|Withdrawal by Subject|3|||
13449085|NCT00286429|26937809|FG001|Overall Study|Withdrawal by Subject|2|||
13449086|NCT00286429|26937810|FG002|Overall Study|Withdrawal by Subject|6|||
13449087|NCT00286429|26937808|FG000|Overall Study|Administrative Error|1|||
13449088|NCT00286429|26937809|FG001|Overall Study|Administrative Error|1|||
13449089|NCT00286429|26937810|FG002|Overall Study|Administrative Error|1|||
13449090|NCT00286429|26937808|FG000|Overall Study|Administrative Decision|0|||
13449091|NCT00286429|26937809|FG001|Overall Study|Administrative Decision|1|||
13449092|NCT00286429|26937810|FG002|Overall Study|Administrative Decision|0|||
13449093|NCT00286234|26937837|FG000|Overall Study|Protocol Violation|1|||
13449094|NCT00286234|26937838|FG001|Overall Study|Protocol Violation|2|||
13449095|NCT00286234|26937839|FG002|Overall Study|Protocol Violation|0|||
13449096|NCT00286234|26937840|FG003|Overall Study|Protocol Violation|1|||
13449097|NCT00286234|26937837|FG000|Overall Study|Physician Decision|1|||
13449098|NCT00286234|26937838|FG001|Overall Study|Physician Decision|0|||
13449099|NCT00286234|26937839|FG002|Overall Study|Physician Decision|0|||
13449100|NCT00286234|26937840|FG003|Overall Study|Physician Decision|1|||
13449101|NCT00286234|26937837|FG000|Overall Study|Adverse Event|0|||
13449102|NCT00286234|26937838|FG001|Overall Study|Adverse Event|0|||
13449103|NCT00286234|26937839|FG002|Overall Study|Adverse Event|0|||
13449104|NCT00286234|26937840|FG003|Overall Study|Adverse Event|1|||
13449105|NCT00286234|26937837|FG000|Overall Study|Adverse Event|0|||
13449106|NCT00286234|26937838|FG001|Overall Study|Adverse Event|0|||
13449107|NCT00286234|26937839|FG002|Overall Study|Adverse Event|0|||
13449108|NCT00286234|26937840|FG003|Overall Study|Adverse Event|1|||
13449109|NCT00286221|26937867|FG000|Overall Study|Protocol Violation|2|||
13449110|NCT00286221|26937868|FG001|Overall Study|Protocol Violation|1|||
13449111|NCT00286221|26937869|FG002|Overall Study|Protocol Violation|6|||
13449112|NCT00286221|26937870|FG003|Overall Study|Protocol Violation|4|||
13449113|NCT00286221|26937867|FG000|Overall Study|Unanticipated Neurosurgical Complication|6|||
13449114|NCT00286221|26937868|FG001|Overall Study|Unanticipated Neurosurgical Complication|3|||
13449115|NCT00286221|26937869|FG002|Overall Study|Unanticipated Neurosurgical Complication|3|||
13449116|NCT00286221|26937870|FG003|Overall Study|Unanticipated Neurosurgical Complication|2|||
13449117|NCT00286221|26937867|FG000|Overall Study|Inability to trigger PCA|2|||
13449118|NCT00286221|26937868|FG001|Overall Study|Inability to trigger PCA|0|||
13449119|NCT00286221|26937869|FG002|Overall Study|Inability to trigger PCA|0|||
13449120|NCT00286221|26937870|FG003|Overall Study|Inability to trigger PCA|0|||
13449121|NCT00286221|26937867|FG000|Overall Study|Unrecognized exclusion criteria met|0|||
13449122|NCT00286221|26937868|FG001|Overall Study|Unrecognized exclusion criteria met|1|||
13449123|NCT00286221|26937869|FG002|Overall Study|Unrecognized exclusion criteria met|0|||
13449124|NCT00286221|26937870|FG003|Overall Study|Unrecognized exclusion criteria met|0|||
13449125|NCT00286156|26937891|FG000|Overall Study|Missed 12 month visit|0|||
13449126|NCT00286156|26937892|FG001|Overall Study|Missed 12 month visit|0|||
13449127|NCT00286156|26937893|FG002|Overall Study|Missed 12 month visit|1|||
13449128|NCT00286156|26937891|FG000|Overall Study|AE: pulmonary embolus|0|||
13449129|NCT00286156|26937892|FG001|Overall Study|AE: pulmonary embolus|1|||
13449130|NCT00286156|26937893|FG002|Overall Study|AE: pulmonary embolus|0|||
13449131|NCT00286156|26937891|FG000|Overall Study|AE: nephrotic-range proteinuruia|1|||
13449132|NCT00286156|26937892|FG001|Overall Study|AE: nephrotic-range proteinuruia|0|||
13449133|NCT00286156|26937893|FG002|Overall Study|AE: nephrotic-range proteinuruia|0|||
13449134|NCT00286156|26937891|FG000|Overall Study|AE: pneumonia|1|||
13449135|NCT00286156|26937892|FG001|Overall Study|AE: pneumonia|0|||
13449136|NCT00286156|26937893|FG002|Overall Study|AE: pneumonia|0|||
13449137|NCT00286091|26937912|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103|||
13449138|NCT00286091|26937913|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113|||
13449139|NCT00286091|26937912|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307|||
13449140|NCT00286091|26937913|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269|||
13449141|NCT00286091|26937912|FG000|Double-blind Treatment Phase|Death|58|||
13449142|NCT00286091|26937913|FG001|Double-blind Treatment Phase|Death|65|||
13449143|NCT00286091|26937912|FG000|Double-blind Treatment Phase|Adverse Event|28|||
13449144|NCT00286091|26937913|FG001|Double-blind Treatment Phase|Adverse Event|40|||
13449145|NCT00286091|26937912|FG000|Double-blind Treatment Phase|Disease Progression|22|||
13449146|NCT00286091|26937913|FG001|Double-blind Treatment Phase|Disease Progression|35|||
13449147|NCT00286091|26937912|FG000|Double-blind Treatment Phase|Other|25|||
13449148|NCT00286091|26937913|FG001|Double-blind Treatment Phase|Other|33|||
13449149|NCT00286091|26937912|FG000|Double-blind Treatment Phase|Administrative Decision|20|||
13449150|NCT00286091|26937913|FG001|Double-blind Treatment Phase|Administrative Decision|21|||
13449151|NCT00286091|26937912|FG000|Double-blind Treatment Phase|Noncompliance|8|||
13449152|NCT00286091|26937913|FG001|Double-blind Treatment Phase|Noncompliance|8|||
13449153|NCT00286091|26937912|FG000|Double-blind Treatment Phase|Lost to Follow-up|11|||
13449154|NCT00286091|26937913|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
13449155|NCT00286091|26937912|FG000|Double-blind Treatment Phase|Protocol Deviation|1|||
13449156|NCT00286091|26937913|FG001|Double-blind Treatment Phase|Protocol Deviation|3|||
13449157|NCT00286091|26937912|FG000|Double-blind Treatment Phase|Ineligibility Determined|1|||
13449158|NCT00286091|26937913|FG001|Double-blind Treatment Phase|Ineligibility Determined|2|||
13449159|NCT00286091|26937912|FG000|Open-label Treatment Phase|Physician Decision|24|||
13449160|NCT00286091|26937913|FG001|Open-label Treatment Phase|Physician Decision|21|||
13449161|NCT00286091|26937912|FG000|Open-label Treatment Phase|Adverse Event|5|||
13449162|NCT00286091|26937913|FG001|Open-label Treatment Phase|Adverse Event|16|||
13449163|NCT00286091|26937912|FG000|Open-label Treatment Phase|Other|11|||
13449164|NCT00286091|26937913|FG001|Open-label Treatment Phase|Other|11|||
13449165|NCT00286091|26937912|FG000|Open-label Treatment Phase|Withdrawal by Subject|14|||
13449166|NCT00286091|26937913|FG001|Open-label Treatment Phase|Withdrawal by Subject|10|||
13449167|NCT00286091|26937912|FG000|Open-label Treatment Phase|Death|10|||
13449168|NCT00286091|26937913|FG001|Open-label Treatment Phase|Death|7|||
13449169|NCT00286091|26937912|FG000|Open-label Treatment Phase|Disease Progression|9|||
13449170|NCT00286091|26937913|FG001|Open-label Treatment Phase|Disease Progression|3|||
13449171|NCT00286091|26937912|FG000|Open-label Treatment Phase|Noncompliance|3|||
13449172|NCT00286091|26937913|FG001|Open-label Treatment Phase|Noncompliance|1|||
13449173|NCT00286091|26937912|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
13449174|NCT00286091|26937913|FG001|Open-label Treatment Phase|Lost to Follow-up|1|||
13449175|NCT00286091|26937912|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1|||
13449176|NCT00286091|26937913|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0|||
13449177|NCT00286091|26937912|FG000|Open-label Treatment Phase|Missing End of Study Information|0|||
13449178|NCT00286091|26937913|FG001|Open-label Treatment Phase|Missing End of Study Information|1|||
13449179|NCT00285857|26937926|FG000|Overall Study|Withdrawal by Subject|2|||
13449180|NCT00285857|26937926|FG000|Overall Study|Inadequate initial breast cytology|1|||
13449181|NCT00285857|26937926|FG000|Overall Study|Adverse Event|1|||
13449182|NCT00285818|26937939|FG000|Overall Study|Withdrawal by Subject|3|||
13449183|NCT00285818|26937940|FG001|Overall Study|Withdrawal by Subject|2|||
13449184|NCT00285818|26937939|FG000|Overall Study|Lost to Follow-up|1|||
13449185|NCT00285818|26937940|FG001|Overall Study|Lost to Follow-up|0|||
13449186|NCT00285649|26937958|FG000|Overall Study|Lost to Follow-up|6|||
13449187|NCT00285649|26937959|FG001|Overall Study|Lost to Follow-up|4|||
13449188|NCT00285649|26937960|FG002|Overall Study|Lost to Follow-up|4|||
13449189|NCT00285649|26937958|FG000|Overall Study|Withdrawal by Subject|3|||
13449190|NCT00285649|26937959|FG001|Overall Study|Withdrawal by Subject|2|||
13449191|NCT00285649|26937960|FG002|Overall Study|Withdrawal by Subject|2|||
13449192|NCT00285584|26937979|FG000|Month 3|Lost to Follow-up|3|||
13449193|NCT00285584|26937980|FG001|Month 3|Lost to Follow-up|3|||
13449194|NCT00285584|26937979|FG000|Month 3|Withdrawal by Subject|1|||
13449195|NCT00285584|26937980|FG001|Month 3|Withdrawal by Subject|0|||
13449196|NCT00285584|26937979|FG000|Month 6|Lost to Follow-up|0|||
13449197|NCT00285584|26937980|FG001|Month 6|Lost to Follow-up|1|||
13449198|NCT00285207|26937993|FG000|Overall Study|Lost to Follow-up|3|||
13449199|NCT00285207|26937994|FG001|Overall Study|Lost to Follow-up|2|||
13449200|NCT00285207|26937993|FG000|Overall Study|Withdrawal by Subject|5|||
13449201|NCT00285207|26937994|FG001|Overall Study|Withdrawal by Subject|2|||
13449202|NCT00285207|26937993|FG000|Overall Study|Pregnancy|1|||
13449203|NCT00285207|26937994|FG001|Overall Study|Pregnancy|1|||
13449204|NCT00285207|26937993|FG000|Overall Study|non-compliance|0|||
13449205|NCT00285207|26937994|FG001|Overall Study|non-compliance|1|||
13449206|NCT00285012|26938025|FG000|Assigned to Study Treatment (Tx)|Other|2|||
13449207|NCT00285012|26938026|FG001|Assigned to Study Treatment (Tx)|Other|3|||
13449208|NCT00285012|26938025|FG000|Received Study Tx|Death|2|||
13449209|NCT00285012|26938026|FG001|Received Study Tx|Death|1|||
13449210|NCT00285012|26938025|FG000|Received Study Tx|Adverse Event|5|||
13449211|NCT00285012|26938026|FG001|Received Study Tx|Adverse Event|11|||
13449212|NCT00285012|26938025|FG000|Received Study Tx|Lack of Efficacy|0|||
13449213|NCT00285012|26938026|FG001|Received Study Tx|Lack of Efficacy|3|||
13449214|NCT00285012|26938025|FG000|Received Study Tx|Lost to Follow-up|29|||
13449215|NCT00285012|26938026|FG001|Received Study Tx|Lost to Follow-up|31|||
13449216|NCT00285012|26938025|FG000|Received Study Tx|Withdrawal by Subject|31|||
13449217|NCT00285012|26938026|FG001|Received Study Tx|Withdrawal by Subject|43|||
13449218|NCT00285012|26938025|FG000|Received Study Tx|Other|5|||
13449219|NCT00285012|26938026|FG001|Received Study Tx|Other|5|||
13449220|NCT00284934|26938045|FG000|Overall Study|Adverse Event|1|||
13449221|NCT00284934|26938046|FG001|Overall Study|Adverse Event|2|||
13449222|NCT00284934|26938045|FG000|Overall Study|Other reasons|3|||
13449223|NCT00284934|26938046|FG001|Overall Study|Other reasons|1|||
13449224|NCT00284856|26938070|FG000|Overall Study|Adverse Event|3|||
13449225|NCT00284856|26938071|FG001|Overall Study|Adverse Event|3|||
13449226|NCT00284856|26938072|FG002|Overall Study|Adverse Event|3|||
13449227|NCT00284856|26938070|FG000|Overall Study|Lack of Efficacy|2|||
13449228|NCT00284856|26938071|FG001|Overall Study|Lack of Efficacy|1|||
13449229|NCT00284856|26938072|FG002|Overall Study|Lack of Efficacy|8|||
13449230|NCT00284856|26938070|FG000|Overall Study|Lost to Follow-up|25|||
13449231|NCT00284856|26938071|FG001|Overall Study|Lost to Follow-up|21|||
13449232|NCT00284856|26938072|FG002|Overall Study|Lost to Follow-up|22|||
13449233|NCT00284856|26938070|FG000|Overall Study|Protocol Violation|5|||
13449234|NCT00284856|26938071|FG001|Overall Study|Protocol Violation|4|||
13449235|NCT00284856|26938072|FG002|Overall Study|Protocol Violation|5|||
13449236|NCT00284856|26938070|FG000|Overall Study|Withdrawal by Subject|12|||
13449237|NCT00284856|26938071|FG001|Overall Study|Withdrawal by Subject|16|||
13449238|NCT00284856|26938072|FG002|Overall Study|Withdrawal by Subject|18|||
13449239|NCT00284856|26938070|FG000|Overall Study|Other|4|||
13449240|NCT00284856|26938071|FG001|Overall Study|Other|5|||
13449241|NCT00284856|26938072|FG002|Overall Study|Other|4|||
13449242|NCT00284141|26938093|FG000|Overall Study|Disease Progression / Lack of efficacy|51|||
13449243|NCT00284141|26938093|FG000|Overall Study|Adverse Event|19|||
13449244|NCT00284141|26938093|FG000|Overall Study|Participant's request|9|||
13449245|NCT00284141|26938093|FG000|Overall Study|Symptomatic / Clinical Progression|11|||
13449246|NCT00284141|26938093|FG000|Overall Study|Clinical deterioration / death|2|||
13449247|NCT00284141|26938093|FG000|Overall Study|General decline|1|||
13449248|NCT00284141|26938093|FG000|Overall Study|Pneumonia|1|||
13449249|NCT00284141|26938093|FG000|Overall Study|Did not take study medication|2|||
13449250|NCT00284141|26938093|FG000|Overall Study|Ongoing treatment|2|||
13449251|NCT00284089|26938132|FG000|Multiple Dose Phase|Adverse Event|1|||
13449252|NCT00284089|26938133|FG001|Multiple Dose Phase|Adverse Event|0|||
13449253|NCT00284089|26938134|FG002|Multiple Dose Phase|Adverse Event|1|||
13449254|NCT00284089|26938135|FG003|Multiple Dose Phase|Adverse Event|1|||
13449255|NCT00284089|26938132|FG000|Multiple Dose Phase|Protocol Violation|0|||
13449256|NCT00284089|26938133|FG001|Multiple Dose Phase|Protocol Violation|0|||
13449257|NCT00284089|26938134|FG002|Multiple Dose Phase|Protocol Violation|1|||
13449258|NCT00284089|26938135|FG003|Multiple Dose Phase|Protocol Violation|0|||
13449259|NCT00284089|26938132|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
13449260|NCT00284089|26938133|FG001|Multiple Dose Phase|Withdrawal by Subject|0|||
13449261|NCT00284089|26938134|FG002|Multiple Dose Phase|Withdrawal by Subject|1|||
13449262|NCT00284089|26938135|FG003|Multiple Dose Phase|Withdrawal by Subject|2|||
13449263|NCT00284089|26938132|FG000|Multiple Dose Phase|Death|0|||
13449264|NCT00284089|26938133|FG001|Multiple Dose Phase|Death|0|||
13449265|NCT00284089|26938134|FG002|Multiple Dose Phase|Death|1|||
13449266|NCT00284089|26938135|FG003|Multiple Dose Phase|Death|1|||
13449267|NCT00284089|26938132|FG000|Extension Phase|Adverse Event|0|||
13449268|NCT00284089|26938133|FG001|Extension Phase|Adverse Event|0|||
13449269|NCT00284089|26938134|FG002|Extension Phase|Adverse Event|2|||
13449270|NCT00284089|26938135|FG003|Extension Phase|Adverse Event|2|||
13449271|NCT00284089|26938132|FG000|Extension Phase|condition no longer requires study drug|2|||
13449272|NCT00284089|26938133|FG001|Extension Phase|condition no longer requires study drug|0|||
13449273|NCT00284089|26938134|FG002|Extension Phase|condition no longer requires study drug|2|||
13449274|NCT00284089|26938135|FG003|Extension Phase|condition no longer requires study drug|7|||
13449275|NCT00284089|26938132|FG000|Extension Phase|Protocol Violation|0|||
13449276|NCT00284089|26938133|FG001|Extension Phase|Protocol Violation|0|||
13449277|NCT00284089|26938134|FG002|Extension Phase|Protocol Violation|1|||
13449278|NCT00284089|26938135|FG003|Extension Phase|Protocol Violation|0|||
13449279|NCT00284089|26938132|FG000|Extension Phase|Withdrawal by Subject|0|||
13449280|NCT00284089|26938133|FG001|Extension Phase|Withdrawal by Subject|0|||
13449281|NCT00284089|26938134|FG002|Extension Phase|Withdrawal by Subject|1|||
13449282|NCT00284089|26938135|FG003|Extension Phase|Withdrawal by Subject|3|||
13449283|NCT00284050|26938159|FG000|Overall Study|Adverse Event|1|||
13449284|NCT00284050|26938160|FG001|Overall Study|Adverse Event|1|||
13449285|NCT00284050|26938161|FG002|Overall Study|Adverse Event|1|||
13449286|NCT00284050|26938159|FG000|Overall Study|Lack of Efficacy|0|||
13449287|NCT00284050|26938160|FG001|Overall Study|Lack of Efficacy|1|||
13449288|NCT00284050|26938161|FG002|Overall Study|Lack of Efficacy|3|||
13449289|NCT00284050|26938159|FG000|Overall Study|Protocol Violation|0|||
13449290|NCT00284050|26938160|FG001|Overall Study|Protocol Violation|1|||
13449291|NCT00284050|26938161|FG002|Overall Study|Protocol Violation|2|||
13449292|NCT00284050|26938159|FG000|Overall Study|Withdrawal by Subject|2|||
13449293|NCT00284050|26938160|FG001|Overall Study|Withdrawal by Subject|2|||
13449294|NCT00284050|26938161|FG002|Overall Study|Withdrawal by Subject|2|||
13449295|NCT00284050|26938159|FG000|Overall Study|Lost to Follow-up|1|||
13449296|NCT00284050|26938160|FG001|Overall Study|Lost to Follow-up|0|||
13449297|NCT00284050|26938161|FG002|Overall Study|Lost to Follow-up|1|||
13449298|NCT00284050|26938159|FG000|Overall Study|Death|1|||
13449299|NCT00284050|26938160|FG001|Overall Study|Death|0|||
13449300|NCT00284050|26938161|FG002|Overall Study|Death|0|||
13449301|NCT00283959|26938168|FG000|Extension Period|Low Compliance|1|||
13449302|NCT00283842|26938201|FG000|Overall Study|Adverse Event|8|||
13449303|NCT00283842|26938202|FG001|Overall Study|Adverse Event|7|||
13449304|NCT00283842|26938203|FG002|Overall Study|Adverse Event|21|||
13449305|NCT00283842|26938204|FG003|Overall Study|Adverse Event|21|||
13449306|NCT00283842|26938205|FG004|Overall Study|Adverse Event|5|||
13449307|NCT00283842|26938201|FG000|Overall Study|Protocol Violation|1|||
13449308|NCT00283842|26938202|FG001|Overall Study|Protocol Violation|5|||
13449309|NCT00283842|26938203|FG002|Overall Study|Protocol Violation|4|||
13449310|NCT00283842|26938204|FG003|Overall Study|Protocol Violation|0|||
13449311|NCT00283842|26938205|FG004|Overall Study|Protocol Violation|0|||
13449312|NCT00283842|26938201|FG000|Overall Study|Protocol deviation|0|||
13449313|NCT00283842|26938202|FG001|Overall Study|Protocol deviation|0|||
13449314|NCT00283842|26938203|FG002|Overall Study|Protocol deviation|0|||
13449315|NCT00283842|26938204|FG003|Overall Study|Protocol deviation|0|||
13449316|NCT00283842|26938205|FG004|Overall Study|Protocol deviation|2|||
13449317|NCT00283842|26938201|FG000|Overall Study|Withdrawal by Subject|2|||
13449318|NCT00283842|26938202|FG001|Overall Study|Withdrawal by Subject|1|||
13449319|NCT00283842|26938203|FG002|Overall Study|Withdrawal by Subject|1|||
13449320|NCT00283842|26938204|FG003|Overall Study|Withdrawal by Subject|5|||
13449321|NCT00283842|26938205|FG004|Overall Study|Withdrawal by Subject|4|||
13449322|NCT00283842|26938201|FG000|Overall Study|Lack of Efficacy|1|||
13449323|NCT00283842|26938202|FG001|Overall Study|Lack of Efficacy|3|||
13449324|NCT00283842|26938203|FG002|Overall Study|Lack of Efficacy|1|||
13449325|NCT00283842|26938204|FG003|Overall Study|Lack of Efficacy|0|||
13449326|NCT00283842|26938205|FG004|Overall Study|Lack of Efficacy|3|||
13449327|NCT00283842|26938201|FG000|Overall Study|Lost to Follow-up|0|||
13449328|NCT00283842|26938202|FG001|Overall Study|Lost to Follow-up|2|||
13449329|NCT00283842|26938203|FG002|Overall Study|Lost to Follow-up|4|||
13449330|NCT00283842|26938204|FG003|Overall Study|Lost to Follow-up|1|||
13449331|NCT00283842|26938205|FG004|Overall Study|Lost to Follow-up|1|||
13449332|NCT00283803|26938213|FG000|Overall Study|Physician Decision|9|||
13449333|NCT00283803|26938213|FG000|Overall Study|Withdrawal by Subject|4|||
13449334|NCT00283712|26938254|FG000|Overall Study|Death|0|||
13449335|NCT00283712|26938255|FG001|Overall Study|Death|1|||
13449336|NCT00283686|26938310|FG000|Overall Study|Death|1|||
13449337|NCT00283686|26938311|FG001|Overall Study|Death|1|||
13449338|NCT00283686|26938312|FG002|Overall Study|Death|1|||
13449339|NCT00283686|26938313|FG003|Overall Study|Death|0|||
13449340|NCT00283686|26938310|FG000|Overall Study|Lost to Follow-up|21|||
13449341|NCT00283686|26938311|FG001|Overall Study|Lost to Follow-up|31|||
13449342|NCT00283686|26938312|FG002|Overall Study|Lost to Follow-up|26|||
13449343|NCT00283686|26938313|FG003|Overall Study|Lost to Follow-up|20|||
13449344|NCT00283686|26938310|FG000|Overall Study|Less than full participation|7|||
13449345|NCT00283686|26938311|FG001|Overall Study|Less than full participation|9|||
13449346|NCT00283686|26938312|FG002|Overall Study|Less than full participation|6|||
13449347|NCT00283686|26938313|FG003|Overall Study|Less than full participation|12|||
13449348|NCT00283595|26938328|FG000|Overall Study|Withdrawal by Subject|1|||
13449349|NCT00283595|26938329|FG001|Overall Study|Withdrawal by Subject|2|||
13449350|NCT00283439|26938364|FG000|Overall Study|Adverse Event|0|||
13449351|NCT00283439|26938365|FG001|Overall Study|Adverse Event|0|||
13449352|NCT00283439|26938366|FG002|Overall Study|Adverse Event|0|||
13449353|NCT00283439|26938367|FG003|Overall Study|Adverse Event|1|||
13449354|NCT00283439|26938364|FG000|Overall Study|Death|0|||
13449355|NCT00283439|26938365|FG001|Overall Study|Death|0|||
13449356|NCT00283439|26938366|FG002|Overall Study|Death|1|||
13449357|NCT00283439|26938367|FG003|Overall Study|Death|0|||
13449358|NCT00283439|26938364|FG000|Overall Study|Disease progression|0|||
13449359|NCT00283439|26938365|FG001|Overall Study|Disease progression|1|||
13449360|NCT00283439|26938366|FG002|Overall Study|Disease progression|0|||
13449361|NCT00283439|26938367|FG003|Overall Study|Disease progression|0|||
13449362|NCT00283439|26938364|FG000|Overall Study|Requirement for alternative therapy|1|||
13449363|NCT00283439|26938365|FG001|Overall Study|Requirement for alternative therapy|2|||
13449364|NCT00283439|26938366|FG002|Overall Study|Requirement for alternative therapy|5|||
13449365|NCT00283439|26938367|FG003|Overall Study|Requirement for alternative therapy|2|||
13449366|NCT00283439|26938364|FG000|Overall Study|Stem cell transplant|6|||
13449367|NCT00283439|26938365|FG001|Overall Study|Stem cell transplant|6|||
13449368|NCT00283439|26938366|FG002|Overall Study|Stem cell transplant|4|||
13449369|NCT00283439|26938367|FG003|Overall Study|Stem cell transplant|3|||
13449370|NCT00283439|26938364|FG000|Overall Study|Treatment discontinued|0|||
13449371|NCT00283439|26938365|FG001|Overall Study|Treatment discontinued|2|||
13449372|NCT00283439|26938366|FG002|Overall Study|Treatment discontinued|1|||
13449373|NCT00283439|26938367|FG003|Overall Study|Treatment discontinued|3|||
13449374|NCT00283439|26938364|FG000|Overall Study|Other|1|||
13449375|NCT00283439|26938365|FG001|Overall Study|Other|0|||
13449376|NCT00283439|26938366|FG002|Overall Study|Other|0|||
13449377|NCT00283439|26938367|FG003|Overall Study|Other|0|||
13449378|NCT00283400|26938398|FG000|Overall Study|Withdrawal by Subject|1|||
13449379|NCT00283400|26938399|FG001|Overall Study|Withdrawal by Subject|1|||
13449380|NCT00283400|26938400|FG002|Overall Study|Withdrawal by Subject|0|||
13449381|NCT00283400|26938401|FG003|Overall Study|Withdrawal by Subject|0|||
13449382|NCT00283400|26938398|FG000|Overall Study|Death|1|||
13449383|NCT00283400|26938399|FG001|Overall Study|Death|0|||
13449384|NCT00283400|26938400|FG002|Overall Study|Death|1|||
13449385|NCT00283400|26938401|FG003|Overall Study|Death|0|||
13449386|NCT00283387|26938410|FG000|First Intervention|Subject non-compliant|1|||
13449387|NCT00283387|26938411|FG001|First Intervention|Subject non-compliant|1|||
13449388|NCT00283387|26938410|FG000|First Intervention|Withdrawal by Subject|0|||
13449389|NCT00283387|26938411|FG001|First Intervention|Withdrawal by Subject|1|||
13449390|NCT00283296|26938419|FG000|Overall Study|in-home trial not completed|5|||
13449391|NCT00283244|26938449|FG000|Overall Study|Adverse Event|0|||
13449392|NCT00283244|26938450|FG001|Overall Study|Adverse Event|8|||
13449393|NCT00283244|26938451|FG002|Overall Study|Adverse Event|11|||
13449394|NCT00283244|26938449|FG000|Overall Study|Death|4|||
13449395|NCT00283244|26938450|FG001|Overall Study|Death|3|||
13449396|NCT00283244|26938451|FG002|Overall Study|Death|2|||
13449397|NCT00283244|26938449|FG000|Overall Study|Lack of Efficacy|8|||
13449398|NCT00283244|26938450|FG001|Overall Study|Lack of Efficacy|32|||
13449399|NCT00283244|26938451|FG002|Overall Study|Lack of Efficacy|26|||
13449400|NCT00283244|26938449|FG000|Overall Study|Withdrawal by Subject|1|||
13449401|NCT00283244|26938450|FG001|Overall Study|Withdrawal by Subject|2|||
13449402|NCT00283244|26938451|FG002|Overall Study|Withdrawal by Subject|2|||
13449403|NCT00283244|26938449|FG000|Overall Study|Physician Decision|0|||
13449404|NCT00283244|26938450|FG001|Overall Study|Physician Decision|0|||
13449405|NCT00283244|26938451|FG002|Overall Study|Physician Decision|1|||
13449406|NCT00283244|26938449|FG000|Overall Study|Medical illness (other complicating dz)|4|||
13449407|NCT00283244|26938450|FG001|Overall Study|Medical illness (other complicating dz)|3|||
13449408|NCT00283244|26938451|FG002|Overall Study|Medical illness (other complicating dz)|6|||
13449409|NCT00283244|26938449|FG000|Overall Study|Clinical deterioration|1|||
13449410|NCT00283244|26938450|FG001|Overall Study|Clinical deterioration|3|||
13449411|NCT00283244|26938451|FG002|Overall Study|Clinical deterioration|3|||
13449412|NCT00283062|26938494|FG000|Overall Study|Did not receive any study medication|5|||
13449413|NCT00283062|26938495|FG001|Overall Study|Did not receive any study medication|4|||
13449414|NCT00283062|26938496|FG002|Overall Study|Did not receive any study medication|36|||
13449415|NCT00283062|26938497|FG003|Overall Study|Did not receive any study medication|45|||
13449416|NCT00283062|26938494|FG000|Overall Study|Adverse Event|2|||
13449417|NCT00283062|26938495|FG001|Overall Study|Adverse Event|0|||
13449418|NCT00283062|26938496|FG002|Overall Study|Adverse Event|1|||
13449419|NCT00283062|26938497|FG003|Overall Study|Adverse Event|0|||
13449420|NCT00283062|26938494|FG000|Overall Study|Lost to Follow-up|1|||
13449421|NCT00283062|26938495|FG001|Overall Study|Lost to Follow-up|0|||
13449422|NCT00283062|26938496|FG002|Overall Study|Lost to Follow-up|1|||
13449423|NCT00283062|26938497|FG003|Overall Study|Lost to Follow-up|0|||
13449424|NCT00283062|26938494|FG000|Overall Study|Progressive disease|0|||
13449425|NCT00283062|26938495|FG001|Overall Study|Progressive disease|0|||
13449426|NCT00283062|26938496|FG002|Overall Study|Progressive disease|1|||
13449427|NCT00283062|26938497|FG003|Overall Study|Progressive disease|0|||
13449428|NCT00283062|26938494|FG000|Overall Study|Participant did not wish to continue|3|||
13449429|NCT00283062|26938495|FG001|Overall Study|Participant did not wish to continue|2|||
13449430|NCT00283062|26938496|FG002|Overall Study|Participant did not wish to continue|1|||
13449431|NCT00283062|26938497|FG003|Overall Study|Participant did not wish to continue|0|||
13449432|NCT00283062|26938494|FG000|Overall Study|Undefined|0|||
13449433|NCT00283062|26938495|FG001|Overall Study|Undefined|1|||
13449434|NCT00283062|26938496|FG002|Overall Study|Undefined|1|||
13449435|NCT00283062|26938497|FG003|Overall Study|Undefined|4|||
13449436|NCT00283062|26938494|FG000|Overall Study|chemotherapy not completed (cycle 6)|1|||
13449437|NCT00283062|26938495|FG001|Overall Study|chemotherapy not completed (cycle 6)|0|||
13449438|NCT00283062|26938496|FG002|Overall Study|chemotherapy not completed (cycle 6)|0|||
13449439|NCT00283062|26938497|FG003|Overall Study|chemotherapy not completed (cycle 6)|0|||
13449440|NCT00283049|26938533|FG000|Overall Study|Adverse Event|6|||
13449441|NCT00283049|26938534|FG001|Overall Study|Adverse Event|1|||
13449442|NCT00283049|26938535|FG002|Overall Study|Adverse Event|4|||
13449443|NCT00283049|26938533|FG000|Overall Study|Protocol Violation|3|||
13449444|NCT00283049|26938534|FG001|Overall Study|Protocol Violation|0|||
13449445|NCT00283049|26938535|FG002|Overall Study|Protocol Violation|3|||
13449446|NCT00283049|26938533|FG000|Overall Study|Death|1|||
13449447|NCT00283049|26938534|FG001|Overall Study|Death|1|||
13449448|NCT00283049|26938535|FG002|Overall Study|Death|1|||
13449449|NCT00283049|26938533|FG000|Overall Study|Lack of Efficacy|0|||
13449450|NCT00283049|26938534|FG001|Overall Study|Lack of Efficacy|1|||
13449451|NCT00283049|26938535|FG002|Overall Study|Lack of Efficacy|1|||
13449452|NCT00283049|26938533|FG000|Overall Study|Lost to Follow-up|4|||
13449453|NCT00283049|26938534|FG001|Overall Study|Lost to Follow-up|2|||
13449454|NCT00283049|26938535|FG002|Overall Study|Lost to Follow-up|5|||
13449455|NCT00283049|26938533|FG000|Overall Study|Withdrawal by Subject|26|||
13449456|NCT00283049|26938534|FG001|Overall Study|Withdrawal by Subject|24|||
13449457|NCT00283049|26938535|FG002|Overall Study|Withdrawal by Subject|19|||
13449458|NCT00283049|26938533|FG000|Overall Study|Discontinuation of Study|18|||
13449459|NCT00283049|26938534|FG001|Overall Study|Discontinuation of Study|16|||
13449460|NCT00283049|26938535|FG002|Overall Study|Discontinuation of Study|20|||
13449461|NCT00283049|26938533|FG000|Overall Study|No longer requires study treatment|0|||
13449462|NCT00283049|26938534|FG001|Overall Study|No longer requires study treatment|0|||
13449463|NCT00283049|26938535|FG002|Overall Study|No longer requires study treatment|1|||
13449464|NCT00282984|26938566|FG000|Overall Study|Death|2|||
13449465|NCT00282984|26938567|FG001|Overall Study|Death|5|||
13449466|NCT00282984|26938566|FG000|Overall Study|Adverse Event|8|||
13449467|NCT00282984|26938567|FG001|Overall Study|Adverse Event|5|||
13449468|NCT00282984|26938566|FG000|Overall Study|Lack of Efficacy|0|||
13449469|NCT00282984|26938567|FG001|Overall Study|Lack of Efficacy|2|||
13449470|NCT00282984|26938566|FG000|Overall Study|Lost to Follow-up|14|||
13449471|NCT00282984|26938567|FG001|Overall Study|Lost to Follow-up|10|||
13449472|NCT00282984|26938566|FG000|Overall Study|Withdrawal by Participant|22|||
13449473|NCT00282984|26938567|FG001|Overall Study|Withdrawal by Participant|34|||
13449474|NCT00282984|26938566|FG000|Overall Study|Participant stopped study medication|2|||
13449475|NCT00282984|26938567|FG001|Overall Study|Participant stopped study medication|2|||
13449476|NCT00282984|26938566|FG000|Overall Study|Participant only allowed phone follow-up|0|||
13449477|NCT00282984|26938567|FG001|Overall Study|Participant only allowed phone follow-up|1|||
13449478|NCT00282984|26938566|FG000|Overall Study|Participant used antipsychosis meds|0|||
13449479|NCT00282984|26938567|FG001|Overall Study|Participant used antipsychosis meds|1|||
13449480|NCT00282984|26938566|FG000|Overall Study|lack of motivation|1|||
13449481|NCT00282984|26938567|FG001|Overall Study|lack of motivation|0|||
13449482|NCT00282984|26938566|FG000|Overall Study|in prison|0|||
13449483|NCT00282984|26938567|FG001|Overall Study|in prison|1|||
13449484|NCT00282984|26938566|FG000|Overall Study|Protocol Violation|2|||
13449485|NCT00282984|26938567|FG001|Overall Study|Protocol Violation|0|||
13449486|NCT00282919|26938581|FG000|Overall Study|Lack of Efficacy|4|||
13449487|NCT00282919|26938581|FG000|Overall Study|Withdrawal by Subject|1|||
13449488|NCT00282919|26938581|FG000|Overall Study|Asymptomatic Parasitemia|2|||
13449489|NCT00282568|26938607|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2|||
13449490|NCT00282568|26938607|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1|||
13449491|NCT00282568|26938607|FG000|Extended Treatment Period|Adverse Event|17|||
13449492|NCT00282568|26938607|FG000|Extended Treatment Period|Non-compliance|4|||
13449493|NCT00282568|26938607|FG000|Extended Treatment Period|Physician Decision|1|||
13449494|NCT00282568|26938607|FG000|Extended Treatment Period|Lost to Follow-up|2|||
13449495|NCT00282464|26938662|FG000|Overall Study|Adverse Event|26|||
13449496|NCT00282464|26938663|FG001|Overall Study|Adverse Event|20|||
13449497|NCT00282464|26938662|FG000|Overall Study|Lack of Efficacy|8|||
13449498|NCT00282464|26938663|FG001|Overall Study|Lack of Efficacy|8|||
13449499|NCT00282464|26938662|FG000|Overall Study|Lost to Follow-up|10|||
13449500|NCT00282464|26938663|FG001|Overall Study|Lost to Follow-up|10|||
13449501|NCT00282464|26938662|FG000|Overall Study|Withdrawal by Subject|24|||
13449502|NCT00282464|26938663|FG001|Overall Study|Withdrawal by Subject|10|||
13449503|NCT00282464|26938662|FG000|Overall Study|laboratory abnormality|1|||
13449504|NCT00282464|26938663|FG001|Overall Study|laboratory abnormality|2|||
13449505|NCT00282464|26938662|FG000|Overall Study|Protocol Violation|0|||
13449506|NCT00282464|26938663|FG001|Overall Study|Protocol Violation|7|||
13449507|NCT00282464|26938662|FG000|Overall Study|Patient moved|1|||
13449508|NCT00282464|26938663|FG001|Overall Study|Patient moved|0|||
13449509|NCT00282464|26938662|FG000|Overall Study|patient non-compliant|3|||
13449510|NCT00282464|26938663|FG001|Overall Study|patient non-compliant|0|||
13449511|NCT00282464|26938662|FG000|Overall Study|patient no show|0|||
13449512|NCT00282464|26938663|FG001|Overall Study|patient no show|1|||
13449513|NCT00282464|26938662|FG000|Overall Study|patient incarcerated|0|||
13449514|NCT00282464|26938663|FG001|Overall Study|patient incarcerated|1|||
13449515|NCT00282464|26938662|FG000|Overall Study|family crisis|0|||
13449516|NCT00282464|26938663|FG001|Overall Study|family crisis|1|||
13449517|NCT00282464|26938662|FG000|Overall Study|dispensed wrong kit|0|||
13449518|NCT00282464|26938663|FG001|Overall Study|dispensed wrong kit|1|||
13449519|NCT00282464|26938662|FG000|Overall Study|dropped due to missed visits|0|||
13449520|NCT00282464|26938663|FG001|Overall Study|dropped due to missed visits|1|||
13449521|NCT00282438|26938680|FG000|Overall Study|Lack of Efficacy|1|||
13449522|NCT00282438|26938681|FG001|Overall Study|Lack of Efficacy|0|||
13449523|NCT00282438|26938680|FG000|Overall Study|Death|0|||
13449524|NCT00282438|26938681|FG001|Overall Study|Death|1|||
13449525|NCT00282412|26938687|FG000|Overall Study|Death|2|||
13449526|NCT00282347|26938718|FG000|Treatment Period|Death|2|||
13449527|NCT00282347|26938719|FG001|Treatment Period|Death|0|||
13449528|NCT00282347|26938718|FG000|Treatment Period|Lost to Follow-up|2|||
13449529|NCT00282347|26938719|FG001|Treatment Period|Lost to Follow-up|5|||
13449530|NCT00282347|26938718|FG000|Treatment Period|Withdrawal by Subject|1|||
13449531|NCT00282347|26938719|FG001|Treatment Period|Withdrawal by Subject|3|||
13449532|NCT00282347|26938718|FG000|Treatment Period|Physician Decision|0|||
13449533|NCT00282347|26938719|FG001|Treatment Period|Physician Decision|1|||
13449534|NCT00282347|26938718|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
13449535|NCT00282347|26938719|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
13449536|NCT00282347|26938718|FG000|Safety Follow-up Period|Withdrawal by Subject|2|||
13449537|NCT00282347|26938719|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
13449538|NCT00282347|26938718|FG000|Safety Follow-up Period|Physician Decision|1|||
13449539|NCT00282347|26938719|FG001|Safety Follow-up Period|Physician Decision|1|||
13449540|NCT00282347|26938718|FG000|Safety Follow-up Period|Protocol Deviation|0|||
13449541|NCT00282347|26938719|FG001|Safety Follow-up Period|Protocol Deviation|2|||
13449542|NCT00282347|26938718|FG000|B Cell Follow-up Period|Withdrawal by Subject|2|||
13449543|NCT00282347|26938719|FG001|B Cell Follow-up Period|Withdrawal by Subject|0|||
13449544|NCT00282347|26938718|FG000|B Cell Follow-up Period|Physician Decision|1|||
13449545|NCT00282347|26938719|FG001|B Cell Follow-up Period|Physician Decision|0|||
13449546|NCT00282347|26938718|FG000|B Cell Follow-up Period|Reason Not Specified|2|||
13449547|NCT00282347|26938719|FG001|B Cell Follow-up Period|Reason Not Specified|0|||
13449548|NCT00282334|26938732|FG000|Overall Study|Withdrawal by Subject|8|||
13449549|NCT00282334|26938733|FG001|Overall Study|Withdrawal by Subject|5|||
13449550|NCT00282308|26938768|FG000|Treatment Period|Lost to Follow-up|1|||
13449551|NCT00282308|26938769|FG001|Treatment Period|Lost to Follow-up|0|||
13449552|NCT00282308|26938770|FG002|Treatment Period|Lost to Follow-up|0|||
13449553|NCT00282308|26938768|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2|||
13449554|NCT00282308|26938769|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4|||
13449555|NCT00282308|26938770|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0|||
13449556|NCT00282308|26938768|FG000|Treatment Period|Adverse Event|0|||
13449557|NCT00282308|26938769|FG001|Treatment Period|Adverse Event|2|||
13449558|NCT00282308|26938770|FG002|Treatment Period|Adverse Event|0|||
13449559|NCT00282308|26938768|FG000|Treatment Period|Not Treated with Study Drug|1|||
13449560|NCT00282308|26938769|FG001|Treatment Period|Not Treated with Study Drug|0|||
13449561|NCT00282308|26938770|FG002|Treatment Period|Not Treated with Study Drug|0|||
13449562|NCT00282308|26938768|FG000|Optional Extension Re-treatment Period|Adverse Event|0|||
13449563|NCT00282308|26938769|FG001|Optional Extension Re-treatment Period|Adverse Event|0|||
13449564|NCT00282308|26938770|FG002|Optional Extension Re-treatment Period|Adverse Event|4|||
13449565|NCT00282308|26938768|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
13449566|NCT00282308|26938769|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
13449567|NCT00282308|26938770|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1|||
13449568|NCT00282308|26938768|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
13449569|NCT00282308|26938769|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
13449570|NCT00282308|26938770|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1|||
13449571|NCT00282308|26938768|FG000|Safety Follow-up Period|Adverse Event|0|||
13449572|NCT00282308|26938769|FG001|Safety Follow-up Period|Adverse Event|0|||
13449573|NCT00282308|26938770|FG002|Safety Follow-up Period|Adverse Event|1|||
13449574|NCT00282308|26938768|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
13449575|NCT00282308|26938769|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
13449576|NCT00282308|26938770|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
13449577|NCT00282308|26938768|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0|||
13449578|NCT00282308|26938769|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0|||
13449579|NCT00282308|26938770|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1|||
13449580|NCT00282308|26938768|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
13449581|NCT00282308|26938769|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
13449582|NCT00282308|26938770|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12|||
13449583|NCT00282295|26938829|FG000|Overall Study|Adverse Event|0|||
13449584|NCT00282295|26938830|FG001|Overall Study|Adverse Event|1|||
13449585|NCT00282295|26938831|FG002|Overall Study|Adverse Event|0|||
13449586|NCT00282295|26938829|FG000|Overall Study|Serious Adverse Events|0|||
13449587|NCT00282295|26938830|FG001|Overall Study|Serious Adverse Events|0|||
13449588|NCT00282295|26938831|FG002|Overall Study|Serious Adverse Events|1|||
13449589|NCT00282295|26938829|FG000|Overall Study|Protocol Violation|0|||
13449590|NCT00282295|26938830|FG001|Overall Study|Protocol Violation|2|||
13449591|NCT00282295|26938831|FG002|Overall Study|Protocol Violation|1|||
13449592|NCT00282295|26938829|FG000|Overall Study|Withdrawal by Subject|2|||
13449593|NCT00282295|26938830|FG001|Overall Study|Withdrawal by Subject|6|||
13449594|NCT00282295|26938831|FG002|Overall Study|Withdrawal by Subject|4|||
13449595|NCT00282295|26938829|FG000|Overall Study|Lost to Follow-up|1|||
13449596|NCT00282295|26938830|FG001|Overall Study|Lost to Follow-up|7|||
13449597|NCT00282295|26938831|FG002|Overall Study|Lost to Follow-up|2|||
13449598|NCT00282295|26938829|FG000|Overall Study|Other|0|||
13449599|NCT00282295|26938830|FG001|Overall Study|Other|1|||
13449600|NCT00282295|26938831|FG002|Overall Study|Other|0|||
13449601|NCT00282256|26938854|FG000|Pharmacokinetic Treatment Period|Poor venous access|1|||
13449602|NCT00282256|26938854|FG000|Extension Treatment Period|Adverse Event|2|||
13449603|NCT00282243|26938880|FG000|Pharmacokinetic Treatment Period|Adverse Event|3|||
13449604|NCT00282243|26938880|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2|||
13449605|NCT00282243|26938880|FG000|Extension Treatment Period|Adverse Event|15|||
13449606|NCT00282243|26938880|FG000|Extension Treatment Period|Withdrawal by Subject|4|||
13449607|NCT00282243|26938880|FG000|Extension Treatment Period|Non-compliance|2|||
13449608|NCT00282243|26938880|FG000|Extension Treatment Period|Physician Decision|1|||
13449609|NCT00282152|26938905|FG000|Overall Study|Withdrawal by Subject|1|||
13449610|NCT00282152|26938906|FG001|Overall Study|Withdrawal by Subject|0|||
13449611|NCT00282113|26938930|FG000|Overall Study|Removed at parents request|1|||
13449612|NCT00282113|26938931|FG001|Overall Study|Removed at parents request|0|||
13449613|NCT00282113|26938932|FG002|Overall Study|Removed at parents request|0|||
13449614|NCT00282087|26938947|FG000|Overall Study|Death|1|||
13449615|NCT00282048|26938961|FG000|Overall Study|Lack of Efficacy|30|||
13449616|NCT00282048|26938961|FG000|Overall Study|Adverse Event|22|||
13449617|NCT00282048|26938961|FG000|Overall Study|Withdrawal by Subject|1|||
13449618|NCT00282048|26938961|FG000|Overall Study|Other|8|||
13449619|NCT00282048|26938961|FG000|Overall Study|Ongoing|1|||
13449620|NCT00281957|26938980|FG000|Overall Study|Adverse Event|7|||
13449621|NCT00281957|26938981|FG001|Overall Study|Adverse Event|2|||
13449622|NCT00281957|26938980|FG000|Overall Study|Death|1|||
13449623|NCT00281957|26938981|FG001|Overall Study|Death|0|||
13449624|NCT00281957|26938980|FG000|Overall Study|Progression/relapse|47|||
13449625|NCT00281957|26938981|FG001|Overall Study|Progression/relapse|35|||
13449626|NCT00281957|26938980|FG000|Overall Study|Not protocol specified|8|||
13449627|NCT00281957|26938981|FG001|Overall Study|Not protocol specified|1|||
13449628|NCT00281957|26938980|FG000|Overall Study|Not eligible|1|||
13449629|NCT00281957|26938981|FG001|Overall Study|Not eligible|2|||
13449630|NCT00281957|26938980|FG000|Overall Study|Did not start treatment|3|||
13449631|NCT00281957|26938981|FG001|Overall Study|Did not start treatment|1|||
13449632|NCT00281957|26938980|FG000|Overall Study|Refusal unrelated to adverse events|0|||
13449633|NCT00281957|26938981|FG001|Overall Study|Refusal unrelated to adverse events|1|||
13449634|NCT00281840|26938988|FG000|Overall Study|Adverse Event|12|||
13449635|NCT00281840|26938988|FG000|Overall Study|Physician Decision|6|||
13449636|NCT00281840|26938988|FG000|Overall Study|Withdrawal by Subject|3|||
13449637|NCT00281840|26938988|FG000|Overall Study|Disease Progression|2|||
13449638|NCT00281840|26938988|FG000|Overall Study|exceed maximum delay in treatment|1|||
13449639|NCT00281840|26938988|FG000|Overall Study|Complicating Disease|1|||
13449640|NCT00281697|26939011|FG000|Overall Study|> 60 days since last dose of study drug|4|||
13449641|NCT00281697|26939012|FG001|Overall Study|> 60 days since last dose of study drug|4|||
13449642|NCT00281697|26939011|FG000|Overall Study|Adverse Event|54|||
13449643|NCT00281697|26939012|FG001|Overall Study|Adverse Event|15|||
13449644|NCT00281697|26939011|FG000|Overall Study|Death|8|||
13449645|NCT00281697|26939012|FG001|Overall Study|Death|3|||
13449646|NCT00281697|26939011|FG000|Overall Study|Disease progression|279|||
13449647|NCT00281697|26939012|FG001|Overall Study|Disease progression|149|||
13449648|NCT00281697|26939011|FG000|Overall Study|Other|5|||
13449649|NCT00281697|26939012|FG001|Overall Study|Other|6|||
13449650|NCT00281697|26939011|FG000|Overall Study|Physician's decision to withdraw|15|||
13449651|NCT00281697|26939012|FG001|Overall Study|Physician's decision to withdraw|12|||
13449652|NCT00281697|26939011|FG000|Overall Study|Subject/guardian's decision to withdraw|33|||
13449653|NCT00281697|26939012|FG001|Overall Study|Subject/guardian's decision to withdraw|6|||
13449654|NCT00281697|26939011|FG000|Overall Study|Did not receive study drug|3|||
13449655|NCT00281697|26939012|FG001|Overall Study|Did not receive study drug|2|||
13449656|NCT00281684|26939097|FG000|Overall Study|Lost to Follow-up|0|||
13449657|NCT00281684|26939098|FG001|Overall Study|Lost to Follow-up|0|||
13449658|NCT00281684|26939099|FG002|Overall Study|Lost to Follow-up|1|||
13449659|NCT00281684|26939100|FG003|Overall Study|Lost to Follow-up|0|||
13449660|NCT00281684|26939097|FG000|Overall Study|Withdrawal by Subject|1|||
13449661|NCT00281684|26939098|FG001|Overall Study|Withdrawal by Subject|0|||
13449662|NCT00281684|26939099|FG002|Overall Study|Withdrawal by Subject|0|||
13449663|NCT00281684|26939100|FG003|Overall Study|Withdrawal by Subject|0|||
13449664|NCT00281632|26939128|FG000|Overall Study|Adverse Event|7|||
13449665|NCT00281632|26939128|FG000|Overall Study|Withdrawal by Subject|2|||
13449666|NCT00281632|26939128|FG000|Overall Study|Disease Progression|22|||
13449667|NCT00281632|26939128|FG000|Overall Study|Death|1|||
13449668|NCT00281632|26939128|FG000|Overall Study|Physician Decision|1|||
13449669|NCT00281632|26939128|FG000|Overall Study|Ongoing|3|||
13449670|NCT00281580|26939521|FG000|Overall Study|Adverse Event|2|||
13449671|NCT00281580|26939522|FG001|Overall Study|Adverse Event|0|||
13449672|NCT00281580|26939523|FG002|Overall Study|Adverse Event|2|||
13449673|NCT00281580|26939524|FG003|Overall Study|Adverse Event|4|||
13449674|NCT00281580|26939525|FG004|Overall Study|Adverse Event|1|||
13449675|NCT00281580|26939526|FG005|Overall Study|Adverse Event|0|||
13449676|NCT00281580|26939527|FG006|Overall Study|Adverse Event|1|||
13449677|NCT00281580|26939528|FG007|Overall Study|Adverse Event|0|||
13449678|NCT00281580|26939529|FG008|Overall Study|Adverse Event|1|||
13449679|NCT00281580|26939530|FG009|Overall Study|Adverse Event|6|||
13449680|NCT00281580|26939531|FG010|Overall Study|Adverse Event|0|||
13449681|NCT00281580|26939532|FG011|Overall Study|Adverse Event|5|||
13449682|NCT00281580|26939533|FG012|Overall Study|Adverse Event|8|||
13449683|NCT00281580|26939534|FG013|Overall Study|Adverse Event|2|||
13449684|NCT00281580|26939535|FG014|Overall Study|Adverse Event|3|||
13449685|NCT00281580|26939536|FG015|Overall Study|Adverse Event|3|||
13449686|NCT00281580|26939521|FG000|Overall Study|Protocol Violation|0|||
13449687|NCT00281580|26939522|FG001|Overall Study|Protocol Violation|0|||
13449688|NCT00281580|26939523|FG002|Overall Study|Protocol Violation|1|||
13449689|NCT00281580|26939524|FG003|Overall Study|Protocol Violation|1|||
13449690|NCT00281580|26939525|FG004|Overall Study|Protocol Violation|0|||
13449691|NCT00281580|26939526|FG005|Overall Study|Protocol Violation|0|||
13449692|NCT00281580|26939527|FG006|Overall Study|Protocol Violation|1|||
13449693|NCT00281580|26939528|FG007|Overall Study|Protocol Violation|0|||
13449694|NCT00281580|26939529|FG008|Overall Study|Protocol Violation|2|||
13449695|NCT00281580|26939530|FG009|Overall Study|Protocol Violation|0|||
13449696|NCT00281580|26939531|FG010|Overall Study|Protocol Violation|1|||
13449697|NCT00281580|26939532|FG011|Overall Study|Protocol Violation|2|||
13449698|NCT00281580|26939533|FG012|Overall Study|Protocol Violation|0|||
13449699|NCT00281580|26939534|FG013|Overall Study|Protocol Violation|1|||
13449700|NCT00281580|26939535|FG014|Overall Study|Protocol Violation|1|||
13449701|NCT00281580|26939536|FG015|Overall Study|Protocol Violation|3|||
13449702|NCT00281580|26939521|FG000|Overall Study|Withdrawal by Subject|3|||
13449703|NCT00281580|26939522|FG001|Overall Study|Withdrawal by Subject|0|||
13449704|NCT00281580|26939523|FG002|Overall Study|Withdrawal by Subject|1|||
13449705|NCT00281580|26939524|FG003|Overall Study|Withdrawal by Subject|1|||
13449706|NCT00281580|26939525|FG004|Overall Study|Withdrawal by Subject|1|||
13449707|NCT00281580|26939526|FG005|Overall Study|Withdrawal by Subject|2|||
13449708|NCT00281580|26939527|FG006|Overall Study|Withdrawal by Subject|2|||
13449709|NCT00281580|26939528|FG007|Overall Study|Withdrawal by Subject|0|||
13449710|NCT00281580|26939529|FG008|Overall Study|Withdrawal by Subject|1|||
13449711|NCT00281580|26939530|FG009|Overall Study|Withdrawal by Subject|4|||
13449712|NCT00281580|26939531|FG010|Overall Study|Withdrawal by Subject|1|||
13449713|NCT00281580|26939532|FG011|Overall Study|Withdrawal by Subject|1|||
13449714|NCT00281580|26939533|FG012|Overall Study|Withdrawal by Subject|2|||
13449715|NCT00281580|26939534|FG013|Overall Study|Withdrawal by Subject|2|||
13449716|NCT00281580|26939535|FG014|Overall Study|Withdrawal by Subject|1|||
13477295|NCT01555021|27006016|FG000|Overall Study|Lost to Follow-up|1|||
13449717|NCT00281580|26939536|FG015|Overall Study|Withdrawal by Subject|5|||
13449718|NCT00281580|26939521|FG000|Overall Study|Lack of Efficacy|2|||
13449719|NCT00281580|26939522|FG001|Overall Study|Lack of Efficacy|1|||
13449720|NCT00281580|26939523|FG002|Overall Study|Lack of Efficacy|1|||
13449721|NCT00281580|26939524|FG003|Overall Study|Lack of Efficacy|6|||
13449722|NCT00281580|26939525|FG004|Overall Study|Lack of Efficacy|2|||
13449723|NCT00281580|26939526|FG005|Overall Study|Lack of Efficacy|0|||
13449724|NCT00281580|26939527|FG006|Overall Study|Lack of Efficacy|0|||
13449725|NCT00281580|26939528|FG007|Overall Study|Lack of Efficacy|0|||
13449726|NCT00281580|26939529|FG008|Overall Study|Lack of Efficacy|0|||
13449727|NCT00281580|26939530|FG009|Overall Study|Lack of Efficacy|0|||
13449728|NCT00281580|26939531|FG010|Overall Study|Lack of Efficacy|0|||
13449729|NCT00281580|26939532|FG011|Overall Study|Lack of Efficacy|1|||
13449730|NCT00281580|26939533|FG012|Overall Study|Lack of Efficacy|0|||
13449731|NCT00281580|26939534|FG013|Overall Study|Lack of Efficacy|2|||
13449732|NCT00281580|26939535|FG014|Overall Study|Lack of Efficacy|1|||
13449733|NCT00281580|26939536|FG015|Overall Study|Lack of Efficacy|0|||
13449734|NCT00281580|26939521|FG000|Overall Study|Lost to Follow-up|0|||
13449735|NCT00281580|26939522|FG001|Overall Study|Lost to Follow-up|0|||
13449736|NCT00281580|26939523|FG002|Overall Study|Lost to Follow-up|0|||
13449737|NCT00281580|26939524|FG003|Overall Study|Lost to Follow-up|3|||
13449738|NCT00281580|26939525|FG004|Overall Study|Lost to Follow-up|0|||
13449739|NCT00281580|26939526|FG005|Overall Study|Lost to Follow-up|1|||
13449740|NCT00281580|26939527|FG006|Overall Study|Lost to Follow-up|0|||
13449741|NCT00281580|26939528|FG007|Overall Study|Lost to Follow-up|1|||
13449742|NCT00281580|26939529|FG008|Overall Study|Lost to Follow-up|2|||
13449743|NCT00281580|26939530|FG009|Overall Study|Lost to Follow-up|1|||
13449744|NCT00281580|26939531|FG010|Overall Study|Lost to Follow-up|1|||
13449745|NCT00281580|26939532|FG011|Overall Study|Lost to Follow-up|0|||
13449746|NCT00281580|26939533|FG012|Overall Study|Lost to Follow-up|1|||
13449747|NCT00281580|26939534|FG013|Overall Study|Lost to Follow-up|0|||
13449748|NCT00281580|26939535|FG014|Overall Study|Lost to Follow-up|0|||
13449749|NCT00281580|26939536|FG015|Overall Study|Lost to Follow-up|0|||
13449750|NCT00281580|26939521|FG000|Overall Study|Randomised in error; pregnancy; moving|0|||
13449751|NCT00281580|26939522|FG001|Overall Study|Randomised in error; pregnancy; moving|0|||
13449752|NCT00281580|26939523|FG002|Overall Study|Randomised in error; pregnancy; moving|0|||
13449753|NCT00281580|26939524|FG003|Overall Study|Randomised in error; pregnancy; moving|2|||
13449754|NCT00281580|26939525|FG004|Overall Study|Randomised in error; pregnancy; moving|0|||
13449755|NCT00281580|26939526|FG005|Overall Study|Randomised in error; pregnancy; moving|0|||
13449756|NCT00281580|26939527|FG006|Overall Study|Randomised in error; pregnancy; moving|1|||
13449757|NCT00281580|26939528|FG007|Overall Study|Randomised in error; pregnancy; moving|0|||
13449758|NCT00281580|26939529|FG008|Overall Study|Randomised in error; pregnancy; moving|2|||
13449759|NCT00281580|26939530|FG009|Overall Study|Randomised in error; pregnancy; moving|1|||
13449760|NCT00281580|26939531|FG010|Overall Study|Randomised in error; pregnancy; moving|1|||
13449761|NCT00281580|26939532|FG011|Overall Study|Randomised in error; pregnancy; moving|1|||
13449762|NCT00281580|26939533|FG012|Overall Study|Randomised in error; pregnancy; moving|2|||
13449763|NCT00281580|26939534|FG013|Overall Study|Randomised in error; pregnancy; moving|0|||
13449764|NCT00281580|26939535|FG014|Overall Study|Randomised in error; pregnancy; moving|1|||
13449765|NCT00281580|26939536|FG015|Overall Study|Randomised in error; pregnancy; moving|2|||
13449766|NCT00281528|26939590|FG000|Overall Study|Progressive Disease|28|||
13449767|NCT00281528|26939591|FG001|Overall Study|Progressive Disease|18|||
13449768|NCT00281528|26939592|FG002|Overall Study|Progressive Disease|27|||
13449769|NCT00281528|26939590|FG000|Overall Study|Unacceptable Toxicity-related to trt|21|||
13449770|NCT00281528|26939591|FG001|Overall Study|Unacceptable Toxicity-related to trt|24|||
13449771|NCT00281528|26939592|FG002|Overall Study|Unacceptable Toxicity-related to trt|32|||
13449772|NCT00281528|26939590|FG000|Overall Study|Adverse Event-unrelated to treatment|3|||
13449773|NCT00281528|26939591|FG001|Overall Study|Adverse Event-unrelated to treatment|0|||
13449774|NCT00281528|26939592|FG002|Overall Study|Adverse Event-unrelated to treatment|2|||
13449775|NCT00281528|26939590|FG000|Overall Study|Physician Decision|11|||
13449776|NCT00281528|26939591|FG001|Overall Study|Physician Decision|4|||
13449777|NCT00281528|26939592|FG002|Overall Study|Physician Decision|5|||
13449778|NCT00281528|26939590|FG000|Overall Study|Protocol Violation|1|||
13449779|NCT00281528|26939591|FG001|Overall Study|Protocol Violation|0|||
13449780|NCT00281528|26939592|FG002|Overall Study|Protocol Violation|1|||
13449781|NCT00281528|26939590|FG000|Overall Study|Withdrawal by Subject|5|||
13449782|NCT00281528|26939591|FG001|Overall Study|Withdrawal by Subject|5|||
13449783|NCT00281528|26939592|FG002|Overall Study|Withdrawal by Subject|7|||
13449784|NCT00281528|26939590|FG000|Overall Study|Other|6|||
13449785|NCT00281528|26939591|FG001|Overall Study|Other|3|||
13449786|NCT00281528|26939592|FG002|Overall Study|Other|5|||
13449787|NCT00281320|26939619|FG000|Overall Study|Adverse Event|12|||
13449788|NCT00281320|26939620|FG001|Overall Study|Adverse Event|9|||
13449789|NCT00281320|26939619|FG000|Overall Study|Lack of Efficacy|4|||
13449790|NCT00281320|26939620|FG001|Overall Study|Lack of Efficacy|3|||
13449791|NCT00281320|26939619|FG000|Overall Study|Withdrawal by Subject|5|||
13449792|NCT00281320|26939620|FG001|Overall Study|Withdrawal by Subject|6|||
13449793|NCT00281320|26939619|FG000|Overall Study|Lost to Follow-up|1|||
13449794|NCT00281320|26939620|FG001|Overall Study|Lost to Follow-up|2|||
13449795|NCT00281320|26939619|FG000|Overall Study|Other|3|||
13449796|NCT00281320|26939620|FG001|Overall Study|Other|1|||
13449797|NCT00281099|26939668|FG000|Overall Study|Death|46|||
13449798|NCT00281099|26939669|FG001|Overall Study|Death|57|||
13449799|NCT00281099|26939668|FG000|Overall Study|Lost to Follow-up|10|||
13449800|NCT00281099|26939669|FG001|Overall Study|Lost to Follow-up|19|||
13449801|NCT00281099|26939668|FG000|Overall Study|Withdrawal by Subject|65|||
13449802|NCT00281099|26939669|FG001|Overall Study|Withdrawal by Subject|70|||
13449803|NCT00281099|26939668|FG000|Overall Study|Physician Decision|79|||
13449804|NCT00281099|26939669|FG001|Overall Study|Physician Decision|72|||
13449805|NCT00281099|26939668|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5|||
13449806|NCT00281099|26939669|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4|||
13449807|NCT00280917|26939692|FG000|Overall Study|Adverse Event|1|||
13449808|NCT00280917|26939693|FG001|Overall Study|Adverse Event|1|||
13449809|NCT00280917|26939694|FG002|Overall Study|Adverse Event|4|||
13449810|NCT00280917|26939695|FG003|Overall Study|Adverse Event|1|||
13449811|NCT00280917|26939692|FG000|Overall Study|Change Therapy|1|||
13449812|NCT00280917|26939693|FG001|Overall Study|Change Therapy|2|||
13449813|NCT00280917|26939694|FG002|Overall Study|Change Therapy|0|||
13449814|NCT00280917|26939695|FG003|Overall Study|Change Therapy|0|||
13449815|NCT00280917|26939692|FG000|Overall Study|Withdrawal by Subject|0|||
13449816|NCT00280917|26939693|FG001|Overall Study|Withdrawal by Subject|2|||
13449817|NCT00280917|26939694|FG002|Overall Study|Withdrawal by Subject|0|||
13449818|NCT00280917|26939695|FG003|Overall Study|Withdrawal by Subject|1|||
13449819|NCT00280917|26939692|FG000|Overall Study|Noncompliance|0|||
13449820|NCT00280917|26939693|FG001|Overall Study|Noncompliance|1|||
13449821|NCT00280917|26939694|FG002|Overall Study|Noncompliance|2|||
13449822|NCT00280917|26939695|FG003|Overall Study|Noncompliance|0|||
13449823|NCT00280748|26939707|FG000|Overall Study|Decline in performance|3|||
13449824|NCT00280748|26939707|FG000|Overall Study|Extra-cranial disease progression|1|||
13449825|NCT00280735|26939719|FG000|Overall Study|Adverse Event|5|||
13449826|NCT00280735|26939719|FG000|Overall Study|Lack of Efficacy|3|||
13449827|NCT00280735|26939719|FG000|Overall Study|Withdrawal by Subject|8|||
13449828|NCT00280735|26939719|FG000|Overall Study|Intercurrent Illness|2|||
13449829|NCT00280683|26939734|FG000|Overall Study|Withdrawal by Subject|1|||
13449830|NCT00280683|26939735|FG001|Overall Study|Withdrawal by Subject|2|||
13449831|NCT00280683|26939734|FG000|Overall Study|Adverse Event|1|||
13449832|NCT00280683|26939735|FG001|Overall Study|Adverse Event|1|||
13449833|NCT00280566|26939768|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31|||
13449834|NCT00280566|26939769|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
13449835|NCT00280566|26939770|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
13449836|NCT00280566|26939768|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3|||
13449837|NCT00280566|26939769|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
13449838|NCT00280566|26939770|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
13449839|NCT00280566|26939768|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148|||
13449840|NCT00280566|26939769|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0|||
13449841|NCT00280566|26939770|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0|||
13449842|NCT00280566|26939768|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35|||
13449843|NCT00280566|26939769|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
13449844|NCT00280566|26939770|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
13449845|NCT00280566|26939768|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76|||
13449846|NCT00280566|26939769|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
13449847|NCT00280566|26939770|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
13449848|NCT00280566|26939768|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50|||
13449849|NCT00280566|26939769|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
13449850|NCT00280566|26939770|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
13449851|NCT00280566|26939768|FG000|Period 2 Double Blind|Lack of Efficacy|0|||
13449852|NCT00280566|26939769|FG001|Period 2 Double Blind|Lack of Efficacy|9|||
13449853|NCT00280566|26939770|FG002|Period 2 Double Blind|Lack of Efficacy|22|||
13449854|NCT00280566|26939768|FG000|Period 2 Double Blind|Laboratory Abnormality|0|||
13449855|NCT00280566|26939769|FG001|Period 2 Double Blind|Laboratory Abnormality|1|||
13449856|NCT00280566|26939770|FG002|Period 2 Double Blind|Laboratory Abnormality|0|||
13449857|NCT00280566|26939768|FG000|Period 2 Double Blind|Adverse Event|0|||
13449858|NCT00280566|26939769|FG001|Period 2 Double Blind|Adverse Event|11|||
13449859|NCT00280566|26939770|FG002|Period 2 Double Blind|Adverse Event|15|||
13449860|NCT00280566|26939768|FG000|Period 2 Double Blind|Lost to Follow-up|0|||
13449861|NCT00280566|26939769|FG001|Period 2 Double Blind|Lost to Follow-up|3|||
13449862|NCT00280566|26939770|FG002|Period 2 Double Blind|Lost to Follow-up|6|||
13449863|NCT00280566|26939768|FG000|Period 2 Double Blind|Withdrawal by Subject|0|||
13449864|NCT00280566|26939769|FG001|Period 2 Double Blind|Withdrawal by Subject|9|||
13449865|NCT00280566|26939770|FG002|Period 2 Double Blind|Withdrawal by Subject|9|||
13449866|NCT00280566|26939768|FG000|Period 2 Double Blind|miscellaneous|0|||
13449867|NCT00280566|26939769|FG001|Period 2 Double Blind|miscellaneous|10|||
13449868|NCT00280566|26939770|FG002|Period 2 Double Blind|miscellaneous|5|||
13449869|NCT00280397|26939779|FG000|Overall Study|Adverse Event|1|||
13449870|NCT00280293|26939798|FG000|Overall Study|Protocol Violation|3|||
13449871|NCT00280293|26939799|FG001|Overall Study|Protocol Violation|0|||
13449872|NCT00280293|26939798|FG000|Overall Study|Physician Decision|5|||
13449873|NCT00280293|26939799|FG001|Overall Study|Physician Decision|4|||
13449874|NCT00280293|26939798|FG000|Overall Study|Lost to Follow-up|14|||
13449875|NCT00280293|26939799|FG001|Overall Study|Lost to Follow-up|12|||
13449876|NCT00280293|26939798|FG000|Overall Study|Withdrawal by Subject|3|||
13449877|NCT00280293|26939799|FG001|Overall Study|Withdrawal by Subject|5|||
13449878|NCT00280293|26939798|FG000|Overall Study|Incarceration/Legal Reasons|1|||
13449879|NCT00280293|26939799|FG001|Overall Study|Incarceration/Legal Reasons|1|||
13449880|NCT00280293|26939798|FG000|Overall Study|Adverse Event|0|||
13449881|NCT00280293|26939799|FG001|Overall Study|Adverse Event|1|||
13449882|NCT00280150|26939825|FG000|Overall Study|Adverse Event|0|||
13449883|NCT00280150|26939826|FG001|Overall Study|Adverse Event|1|||
13449884|NCT00280150|26939827|FG002|Overall Study|Adverse Event|2|||
13449885|NCT00280150|26939828|FG003|Overall Study|Adverse Event|3|||
13449886|NCT00280150|26939825|FG000|Overall Study|Lack of Efficacy|0|||
13449887|NCT00280150|26939826|FG001|Overall Study|Lack of Efficacy|0|||
13449888|NCT00280150|26939827|FG002|Overall Study|Lack of Efficacy|0|||
13449889|NCT00280150|26939828|FG003|Overall Study|Lack of Efficacy|3|||
13449890|NCT00280150|26939825|FG000|Overall Study|Physician Decision|0|||
13449891|NCT00280150|26939826|FG001|Overall Study|Physician Decision|0|||
13449892|NCT00280150|26939827|FG002|Overall Study|Physician Decision|0|||
13449893|NCT00280150|26939828|FG003|Overall Study|Physician Decision|1|||
13449894|NCT00280150|26939825|FG000|Overall Study|Protocol Violation|0|||
13449895|NCT00280150|26939826|FG001|Overall Study|Protocol Violation|0|||
13449896|NCT00280150|26939827|FG002|Overall Study|Protocol Violation|0|||
13449897|NCT00280150|26939828|FG003|Overall Study|Protocol Violation|1|||
13449898|NCT00280150|26939825|FG000|Overall Study|Withdrawal by Subject|0|||
13449899|NCT00280150|26939826|FG001|Overall Study|Withdrawal by Subject|0|||
13449900|NCT00280150|26939827|FG002|Overall Study|Withdrawal by Subject|0|||
13449901|NCT00280150|26939828|FG003|Overall Study|Withdrawal by Subject|1|||
13449902|NCT00280150|26939825|FG000|Overall Study|Did not get consolidation therapy|3|||
13449903|NCT00280150|26939826|FG001|Overall Study|Did not get consolidation therapy|0|||
13449904|NCT00280150|26939827|FG002|Overall Study|Did not get consolidation therapy|3|||
13449905|NCT00280150|26939828|FG003|Overall Study|Did not get consolidation therapy|0|||
13449906|NCT00280150|26939825|FG000|Overall Study|Declining Performance Status|0|||
13449907|NCT00280150|26939826|FG001|Overall Study|Declining Performance Status|0|||
13449908|NCT00280150|26939827|FG002|Overall Study|Declining Performance Status|0|||
13449909|NCT00280150|26939828|FG003|Overall Study|Declining Performance Status|1|||
13449910|NCT00280059|26939881|FG000|Efficacy Assessment Phase|Death|2|||
13449911|NCT00280059|26939882|FG001|Efficacy Assessment Phase|Death|0|||
13449912|NCT00280059|26939881|FG000|Efficacy Assessment Phase|Adverse Event|33|||
13449913|NCT00280059|26939882|FG001|Efficacy Assessment Phase|Adverse Event|31|||
13449914|NCT00280059|26939881|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1|||
13449915|NCT00280059|26939882|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0|||
13449916|NCT00280059|26939881|FG000|Efficacy Assessment Phase|Lack of Efficacy|19|||
13449917|NCT00280059|26939882|FG001|Efficacy Assessment Phase|Lack of Efficacy|3|||
13449918|NCT00280059|26939881|FG000|Efficacy Assessment Phase|Lost to Follow-up|6|||
13449919|NCT00280059|26939882|FG001|Efficacy Assessment Phase|Lost to Follow-up|13|||
13449920|NCT00280059|26939881|FG000|Efficacy Assessment Phase|Other|7|||
13449921|NCT00280059|26939882|FG001|Efficacy Assessment Phase|Other|8|||
13449922|NCT00280059|26939881|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26|||
13449923|NCT00280059|26939882|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25|||
13449924|NCT00279916|26939909|FG000|Overall Study|Withdrawal by Subject|4|||
13449925|NCT00279916|26939910|FG001|Overall Study|Withdrawal by Subject|3|||
13449926|NCT00279916|26939909|FG000|Overall Study|Lost to Follow-up|3|||
13449927|NCT00279916|26939910|FG001|Overall Study|Lost to Follow-up|2|||
13449928|NCT00279812|26939955|FG000|Overall Study|Protocol Violation|1|||
13449929|NCT00279812|26939956|FG001|Overall Study|Protocol Violation|1|||
13449930|NCT00279812|26939957|FG002|Overall Study|Protocol Violation|0|||
13449931|NCT00279812|26939958|FG003|Overall Study|Protocol Violation|0|||
13449932|NCT00279812|26939959|FG004|Overall Study|Protocol Violation|1|||
13449933|NCT00279812|26939960|FG005|Overall Study|Protocol Violation|0|||
13449934|NCT00279812|26939955|FG000|Overall Study|Withdrawal by Subject|0|||
13449935|NCT00279812|26939956|FG001|Overall Study|Withdrawal by Subject|4|||
13449936|NCT00279812|26939957|FG002|Overall Study|Withdrawal by Subject|2|||
13449937|NCT00279812|26939958|FG003|Overall Study|Withdrawal by Subject|0|||
13449938|NCT00279812|26939959|FG004|Overall Study|Withdrawal by Subject|0|||
13449939|NCT00279812|26939960|FG005|Overall Study|Withdrawal by Subject|0|||
13449940|NCT00279812|26939955|FG000|Overall Study|Adverse Event|0|||
13449941|NCT00279812|26939956|FG001|Overall Study|Adverse Event|1|||
13449942|NCT00279812|26939957|FG002|Overall Study|Adverse Event|1|||
13449943|NCT00279812|26939958|FG003|Overall Study|Adverse Event|0|||
13449944|NCT00279812|26939959|FG004|Overall Study|Adverse Event|2|||
13449945|NCT00279812|26939960|FG005|Overall Study|Adverse Event|1|||
13449946|NCT00279708|26939973|FG000|Overall Study|Withdrawal by Subject|2|||
13449947|NCT00279708|26939974|FG001|Overall Study|Withdrawal by Subject|3|||
13449948|NCT00279708|26939973|FG000|Overall Study|Adverse Event|1|||
13449949|NCT00279708|26939974|FG001|Overall Study|Adverse Event|1|||
13449950|NCT00279305|26939987|FG000|Overall Study|Pregnancy|1|||
13449951|NCT00279305|26939988|FG001|Overall Study|Pregnancy|0|||
13449952|NCT00279305|26939987|FG000|Overall Study|Withdrawal by Subject|2|||
13449953|NCT00279305|26939988|FG001|Overall Study|Withdrawal by Subject|0|||
13449954|NCT00279305|26939987|FG000|Overall Study|Dificulting establishing IV|1|||
13449955|NCT00279305|26939988|FG001|Overall Study|Dificulting establishing IV|0|||
13449956|NCT00279305|26939987|FG000|Overall Study|FDA Safety Alert|4|||
13449957|NCT00279305|26939988|FG001|Overall Study|FDA Safety Alert|1|||
13449958|NCT00279214|26940023|FG000|Overall Study|Physician Decision|3|||
13449959|NCT00279214|26940024|FG001|Overall Study|Physician Decision|2|||
13449960|NCT00279201|26940179|FG000|Initiation|Death|1|||
13449961|NCT00279201|26940180|FG001|Initiation|Death|5|||
13449962|NCT00279201|26940181|FG002|Initiation|Death|0|||
13449963|NCT00279201|26940182|FG003|Initiation|Death|0|||
13449964|NCT00279201|26940183|FG004|Initiation|Death|0|||
13449965|NCT00279201|26940184|FG005|Initiation|Death|0|||
13449966|NCT00279201|26940179|FG000|Initiation|Adverse Event|6|||
13449967|NCT00279201|26940180|FG001|Initiation|Adverse Event|15|||
13449968|NCT00279201|26940181|FG002|Initiation|Adverse Event|0|||
13449969|NCT00279201|26940182|FG003|Initiation|Adverse Event|0|||
13449970|NCT00279201|26940183|FG004|Initiation|Adverse Event|0|||
13449971|NCT00279201|26940184|FG005|Initiation|Adverse Event|0|||
13449972|NCT00279201|26940179|FG000|Initiation|Lost to Follow-up|42|||
13449973|NCT00279201|26940180|FG001|Initiation|Lost to Follow-up|41|||
13449974|NCT00279201|26940181|FG002|Initiation|Lost to Follow-up|0|||
13449975|NCT00279201|26940182|FG003|Initiation|Lost to Follow-up|0|||
13449976|NCT00279201|26940183|FG004|Initiation|Lost to Follow-up|0|||
13449977|NCT00279201|26940184|FG005|Initiation|Lost to Follow-up|0|||
13449978|NCT00279201|26940179|FG000|Initiation|Entry Criteria Exclusion|7|||
13449979|NCT00279201|26940180|FG001|Initiation|Entry Criteria Exclusion|9|||
13449980|NCT00279201|26940181|FG002|Initiation|Entry Criteria Exclusion|0|||
13449981|NCT00279201|26940182|FG003|Initiation|Entry Criteria Exclusion|0|||
13449982|NCT00279201|26940183|FG004|Initiation|Entry Criteria Exclusion|0|||
13449983|NCT00279201|26940184|FG005|Initiation|Entry Criteria Exclusion|0|||
13449984|NCT00279201|26940179|FG000|Initiation|Protocol Violation|9|||
13449985|NCT00279201|26940180|FG001|Initiation|Protocol Violation|10|||
13449986|NCT00279201|26940181|FG002|Initiation|Protocol Violation|0|||
13449987|NCT00279201|26940182|FG003|Initiation|Protocol Violation|0|||
13449988|NCT00279201|26940183|FG004|Initiation|Protocol Violation|0|||
13449989|NCT00279201|26940184|FG005|Initiation|Protocol Violation|0|||
13449990|NCT00279201|26940179|FG000|Initiation|Withdrawal by Subject|35|||
13449991|NCT00279201|26940180|FG001|Initiation|Withdrawal by Subject|41|||
13449992|NCT00279201|26940181|FG002|Initiation|Withdrawal by Subject|0|||
13449993|NCT00279201|26940182|FG003|Initiation|Withdrawal by Subject|0|||
13449994|NCT00279201|26940183|FG004|Initiation|Withdrawal by Subject|0|||
13449995|NCT00279201|26940184|FG005|Initiation|Withdrawal by Subject|0|||
13449996|NCT00279201|26940179|FG000|Initiation|Physician Decision|15|||
13449997|NCT00279201|26940180|FG001|Initiation|Physician Decision|18|||
13449998|NCT00279201|26940181|FG002|Initiation|Physician Decision|0|||
13449999|NCT00279201|26940182|FG003|Initiation|Physician Decision|0|||
13450000|NCT00279201|26940183|FG004|Initiation|Physician Decision|0|||
13450001|NCT00279201|26940184|FG005|Initiation|Physician Decision|0|||
13450002|NCT00279201|26940179|FG000|Initiation|Sponsor Decision|13|||
13450003|NCT00279201|26940180|FG001|Initiation|Sponsor Decision|5|||
13450004|NCT00279201|26940181|FG002|Initiation|Sponsor Decision|0|||
13450005|NCT00279201|26940182|FG003|Initiation|Sponsor Decision|0|||
13450006|NCT00279201|26940183|FG004|Initiation|Sponsor Decision|0|||
13450007|NCT00279201|26940184|FG005|Initiation|Sponsor Decision|0|||
13450008|NCT00279201|26940179|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0|||
13450009|NCT00279201|26940180|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1|||
13450010|NCT00279201|26940181|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0|||
13450011|NCT00279201|26940182|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0|||
13450012|NCT00279201|26940183|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0|||
13450013|NCT00279201|26940184|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0|||
13450014|NCT00279201|26940179|FG000|Maintenance|Lack of Efficacy|32|||
13450015|NCT00279201|26940180|FG001|Maintenance|Lack of Efficacy|30|||
13450016|NCT00279201|26940181|FG002|Maintenance|Lack of Efficacy|0|||
13450017|NCT00279201|26940182|FG003|Maintenance|Lack of Efficacy|0|||
13450018|NCT00279201|26940183|FG004|Maintenance|Lack of Efficacy|0|||
13450019|NCT00279201|26940184|FG005|Maintenance|Lack of Efficacy|0|||
13450020|NCT00279201|26940179|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3|||
13450021|NCT00279201|26940180|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2|||
13450022|NCT00279201|26940181|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
13450023|NCT00279201|26940182|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
13450024|NCT00279201|26940183|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
13450025|NCT00279201|26940184|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
13450026|NCT00279201|26940179|FG000|Maintenance|Adverse Event|4|||
13450027|NCT00279201|26940180|FG001|Maintenance|Adverse Event|4|||
13450028|NCT00279201|26940181|FG002|Maintenance|Adverse Event|0|||
13450029|NCT00279201|26940182|FG003|Maintenance|Adverse Event|0|||
13450030|NCT00279201|26940183|FG004|Maintenance|Adverse Event|0|||
13450031|NCT00279201|26940184|FG005|Maintenance|Adverse Event|0|||
13450032|NCT00279201|26940179|FG000|Maintenance|Death|4|||
13450033|NCT00279201|26940180|FG001|Maintenance|Death|4|||
13450034|NCT00279201|26940181|FG002|Maintenance|Death|0|||
13450035|NCT00279201|26940182|FG003|Maintenance|Death|0|||
13450036|NCT00279201|26940183|FG004|Maintenance|Death|0|||
13450037|NCT00279201|26940184|FG005|Maintenance|Death|0|||
13450038|NCT00279201|26940179|FG000|Maintenance|Lost to Follow-up|17|||
13450039|NCT00279201|26940180|FG001|Maintenance|Lost to Follow-up|13|||
13450040|NCT00279201|26940181|FG002|Maintenance|Lost to Follow-up|0|||
13450041|NCT00279201|26940182|FG003|Maintenance|Lost to Follow-up|0|||
13450042|NCT00279201|26940183|FG004|Maintenance|Lost to Follow-up|0|||
13450043|NCT00279201|26940184|FG005|Maintenance|Lost to Follow-up|0|||
13450044|NCT00279201|26940179|FG000|Maintenance|Entry Criteria Exclusion|1|||
13450045|NCT00279201|26940180|FG001|Maintenance|Entry Criteria Exclusion|4|||
13450046|NCT00279201|26940181|FG002|Maintenance|Entry Criteria Exclusion|0|||
13450047|NCT00279201|26940182|FG003|Maintenance|Entry Criteria Exclusion|0|||
13450048|NCT00279201|26940183|FG004|Maintenance|Entry Criteria Exclusion|0|||
13450049|NCT00279201|26940184|FG005|Maintenance|Entry Criteria Exclusion|0|||
13450050|NCT00279201|26940179|FG000|Maintenance|Protocol Violation|16|||
13450051|NCT00279201|26940180|FG001|Maintenance|Protocol Violation|24|||
13450052|NCT00279201|26940181|FG002|Maintenance|Protocol Violation|0|||
13450053|NCT00279201|26940182|FG003|Maintenance|Protocol Violation|0|||
13450054|NCT00279201|26940183|FG004|Maintenance|Protocol Violation|0|||
13450055|NCT00279201|26940184|FG005|Maintenance|Protocol Violation|0|||
13450056|NCT00279201|26940179|FG000|Maintenance|Withdrawal by Subject|18|||
13450057|NCT00279201|26940180|FG001|Maintenance|Withdrawal by Subject|18|||
13450058|NCT00279201|26940181|FG002|Maintenance|Withdrawal by Subject|0|||
13450059|NCT00279201|26940182|FG003|Maintenance|Withdrawal by Subject|0|||
13450060|NCT00279201|26940183|FG004|Maintenance|Withdrawal by Subject|0|||
13450061|NCT00279201|26940184|FG005|Maintenance|Withdrawal by Subject|0|||
13450062|NCT00279201|26940179|FG000|Maintenance|Physician Decision|9|||
13450063|NCT00279201|26940180|FG001|Maintenance|Physician Decision|9|||
13450064|NCT00279201|26940181|FG002|Maintenance|Physician Decision|0|||
13450065|NCT00279201|26940182|FG003|Maintenance|Physician Decision|0|||
13450066|NCT00279201|26940183|FG004|Maintenance|Physician Decision|0|||
13450067|NCT00279201|26940184|FG005|Maintenance|Physician Decision|0|||
13450068|NCT00279201|26940179|FG000|Maintenance|Sponsor Decision|4|||
13450069|NCT00279201|26940180|FG001|Maintenance|Sponsor Decision|0|||
13450070|NCT00279201|26940181|FG002|Maintenance|Sponsor Decision|0|||
13450071|NCT00279201|26940182|FG003|Maintenance|Sponsor Decision|0|||
13450072|NCT00279201|26940183|FG004|Maintenance|Sponsor Decision|0|||
13450073|NCT00279201|26940184|FG005|Maintenance|Sponsor Decision|0|||
13450074|NCT00279201|26940179|FG000|Maintenance|HbA1c>7.5%|123|||
13450075|NCT00279201|26940180|FG001|Maintenance|HbA1c>7.5%|126|||
13450076|NCT00279201|26940181|FG002|Maintenance|HbA1c>7.5%|0|||
13450077|NCT00279201|26940182|FG003|Maintenance|HbA1c>7.5%|0|||
13450078|NCT00279201|26940183|FG004|Maintenance|HbA1c>7.5%|0|||
13450079|NCT00279201|26940184|FG005|Maintenance|HbA1c>7.5%|0|||
13450080|NCT00279201|26940179|FG000|Intensification Addendum|Withdrawal by Subject|0|||
13450081|NCT00279201|26940180|FG001|Intensification Addendum|Withdrawal by Subject|0|||
13450082|NCT00279201|26940181|FG002|Intensification Addendum|Withdrawal by Subject|12|||
13450083|NCT00279201|26940182|FG003|Intensification Addendum|Withdrawal by Subject|14|||
13450084|NCT00279201|26940183|FG004|Intensification Addendum|Withdrawal by Subject|9|||
13450085|NCT00279201|26940184|FG005|Intensification Addendum|Withdrawal by Subject|18|||
13450086|NCT00279201|26940179|FG000|Intensification Addendum|Lost to Follow-up|0|||
13450087|NCT00279201|26940180|FG001|Intensification Addendum|Lost to Follow-up|0|||
13450088|NCT00279201|26940181|FG002|Intensification Addendum|Lost to Follow-up|4|||
13450089|NCT00279201|26940182|FG003|Intensification Addendum|Lost to Follow-up|6|||
13450090|NCT00279201|26940183|FG004|Intensification Addendum|Lost to Follow-up|7|||
13450091|NCT00279201|26940184|FG005|Intensification Addendum|Lost to Follow-up|7|||
13450092|NCT00279201|26940179|FG000|Intensification Addendum|Protocol Violation|0|||
13450093|NCT00279201|26940180|FG001|Intensification Addendum|Protocol Violation|0|||
13450094|NCT00279201|26940181|FG002|Intensification Addendum|Protocol Violation|2|||
13450095|NCT00279201|26940182|FG003|Intensification Addendum|Protocol Violation|2|||
13450096|NCT00279201|26940183|FG004|Intensification Addendum|Protocol Violation|6|||
13450097|NCT00279201|26940184|FG005|Intensification Addendum|Protocol Violation|6|||
13450098|NCT00279201|26940179|FG000|Intensification Addendum|Adverse Event|0|||
13450099|NCT00279201|26940180|FG001|Intensification Addendum|Adverse Event|0|||
13450100|NCT00279201|26940181|FG002|Intensification Addendum|Adverse Event|0|||
13450101|NCT00279201|26940182|FG003|Intensification Addendum|Adverse Event|4|||
13450102|NCT00279201|26940183|FG004|Intensification Addendum|Adverse Event|1|||
13450103|NCT00279201|26940184|FG005|Intensification Addendum|Adverse Event|3|||
13450104|NCT00279201|26940179|FG000|Intensification Addendum|Physician Decision|0|||
13450105|NCT00279201|26940180|FG001|Intensification Addendum|Physician Decision|0|||
13450106|NCT00279201|26940181|FG002|Intensification Addendum|Physician Decision|4|||
13450107|NCT00279201|26940182|FG003|Intensification Addendum|Physician Decision|1|||
13450108|NCT00279201|26940183|FG004|Intensification Addendum|Physician Decision|3|||
13450109|NCT00279201|26940184|FG005|Intensification Addendum|Physician Decision|2|||
13450110|NCT00279201|26940179|FG000|Intensification Addendum|Sponsor Decision|0|||
13450111|NCT00279201|26940180|FG001|Intensification Addendum|Sponsor Decision|0|||
13450112|NCT00279201|26940181|FG002|Intensification Addendum|Sponsor Decision|0|||
13450113|NCT00279201|26940182|FG003|Intensification Addendum|Sponsor Decision|0|||
13450114|NCT00279201|26940183|FG004|Intensification Addendum|Sponsor Decision|1|||
13450115|NCT00279201|26940184|FG005|Intensification Addendum|Sponsor Decision|1|||
13450116|NCT00279201|26940179|FG000|Intensification Addendum|Entry Criteria Exclusion|0|||
13450117|NCT00279201|26940180|FG001|Intensification Addendum|Entry Criteria Exclusion|0|||
13450118|NCT00279201|26940181|FG002|Intensification Addendum|Entry Criteria Exclusion|1|||
13450119|NCT00279201|26940182|FG003|Intensification Addendum|Entry Criteria Exclusion|0|||
13450120|NCT00279201|26940183|FG004|Intensification Addendum|Entry Criteria Exclusion|0|||
13450121|NCT00279201|26940184|FG005|Intensification Addendum|Entry Criteria Exclusion|0|||
13450122|NCT00279201|26940179|FG000|Intensification Addendum|Lack of Efficacy|0|||
13450123|NCT00279201|26940180|FG001|Intensification Addendum|Lack of Efficacy|0|||
13450124|NCT00279201|26940181|FG002|Intensification Addendum|Lack of Efficacy|0|||
13450125|NCT00279201|26940182|FG003|Intensification Addendum|Lack of Efficacy|1|||
13450126|NCT00279201|26940183|FG004|Intensification Addendum|Lack of Efficacy|1|||
13450127|NCT00279201|26940184|FG005|Intensification Addendum|Lack of Efficacy|0|||
13450128|NCT00279201|26940179|FG000|Intensification Addendum|Death|0|||
13450129|NCT00279201|26940180|FG001|Intensification Addendum|Death|0|||
13450130|NCT00279201|26940181|FG002|Intensification Addendum|Death|0|||
13450131|NCT00279201|26940182|FG003|Intensification Addendum|Death|0|||
13450132|NCT00279201|26940183|FG004|Intensification Addendum|Death|1|||
13450133|NCT00279201|26940184|FG005|Intensification Addendum|Death|0|||
13450134|NCT00278993|26940194|FG000|Overall Study|Adverse Event|24|||
13450135|NCT00278993|26940194|FG000|Overall Study|Withdrawal by Subject|5|||
13450136|NCT00278993|26940194|FG000|Overall Study|Progressive Disease|65|||
13450137|NCT00278993|26940194|FG000|Overall Study|Physician Decision|9|||
13450138|NCT00278993|26940194|FG000|Overall Study|Not Otherwise Specified|4|||
13450139|NCT00278954|26940204|FG000|Overall Study|Adverse Event|3|||
13450140|NCT00278954|26940204|FG000|Overall Study|Lost to Follow-up|1|||
13450141|NCT00278954|26940204|FG000|Overall Study|Withdrawal by Subject|1|||
13450142|NCT00278889|26940240|FG000|Overall Study|Withdrawal by Subject|0|||
13450143|NCT00278889|26940241|FG001|Overall Study|Withdrawal by Subject|5|||
13450144|NCT00278889|26940242|FG002|Overall Study|Withdrawal by Subject|3|||
13450145|NCT00278889|26940240|FG000|Overall Study|Lost to Follow-up|1|||
13450146|NCT00278889|26940241|FG001|Overall Study|Lost to Follow-up|1|||
13450147|NCT00278889|26940242|FG002|Overall Study|Lost to Follow-up|0|||
13450148|NCT00278889|26940240|FG000|Overall Study|Death|24|||
13450149|NCT00278889|26940241|FG001|Overall Study|Death|21|||
13450150|NCT00278889|26940242|FG002|Overall Study|Death|17|||
13450151|NCT00278629|26940251|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14|||
13450152|NCT00278564|26940257|FG000|Overall Study|Lack of Efficacy|4|||
13450153|NCT00278512|26940270|FG000|Overall Study|Death|1|||
13450154|NCT00278512|26940271|FG001|Overall Study|Death|0|||
13450155|NCT00278473|26940294|FG000|Overall Study|drop out|4|||
13450156|NCT00278473|26940295|FG001|Overall Study|drop out|3|||
13450157|NCT00278395|26940304|FG000|Overall Study|Adverse Event|2|||
13450158|NCT00278395|26940304|FG000|Overall Study|Nonevaluable|1|||
13450159|NCT00278200|26940320|FG000|Overall Study|Death|1|||
13450160|NCT00278200|26940321|FG001|Overall Study|Death|3|||
13450161|NCT00278200|26940320|FG000|Overall Study|Physician Decision|0|||
13450162|NCT00278200|26940321|FG001|Overall Study|Physician Decision|1|||
13450163|NCT00278161|26940329|FG000|Overall Study|Death|11|||
13450164|NCT00278148|26940345|FG000|Phase II - Expansion Phase|Disease progression|0|||
13450165|NCT00278148|26940346|FG001|Phase II - Expansion Phase|Disease progression|0|||
13450166|NCT00278148|26940347|FG002|Phase II - Expansion Phase|Disease progression|4|||
13450167|NCT00278148|26940345|FG000|Phase II - Expansion Phase|Adverse Event|0|||
13450168|NCT00278148|26940346|FG001|Phase II - Expansion Phase|Adverse Event|0|||
13450169|NCT00278148|26940347|FG002|Phase II - Expansion Phase|Adverse Event|2|||
13450170|NCT00278109|26940353|FG000|Overall Study|Adverse Event|3|||
13450171|NCT00278109|26940353|FG000|Overall Study|social circumstances|1|||
13450172|NCT00277355|26940368|FG000|Overall Study|Withdrawal by Subject|3|||
13450173|NCT00277355|26940369|FG001|Overall Study|Withdrawal by Subject|3|||
13450174|NCT00277355|26940368|FG000|Overall Study|Lost to Follow-up|2|||
13450175|NCT00277355|26940369|FG001|Overall Study|Lost to Follow-up|2|||
13450176|NCT00277355|26940368|FG000|Overall Study|Adverse Event|5|||
13450177|NCT00277355|26940369|FG001|Overall Study|Adverse Event|0|||
13450178|NCT00277355|26940368|FG000|Overall Study|Death|3|||
13450179|NCT00277355|26940369|FG001|Overall Study|Death|0|||
13450180|NCT00277355|26940368|FG000|Overall Study|Physician Decision|1|||
13450181|NCT00277355|26940369|FG001|Overall Study|Physician Decision|0|||
13450182|NCT00277212|26940411|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61|||
13450183|NCT00277212|26940412|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
13450184|NCT00277212|26940413|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
13450185|NCT00277212|26940411|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93|||
13450186|NCT00277212|26940412|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
13450187|NCT00277212|26940413|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
13450188|NCT00277212|26940411|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96|||
13450189|NCT00277212|26940412|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
13450190|NCT00277212|26940413|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
13450191|NCT00277212|26940411|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87|||
13450192|NCT00277212|26940412|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
13450193|NCT00277212|26940413|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
13450194|NCT00277212|26940411|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35|||
13450195|NCT00277212|26940412|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
13450196|NCT00277212|26940413|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
13450197|NCT00277212|26940411|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6|||
13450198|NCT00277212|26940412|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
13450199|NCT00277212|26940413|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
13450200|NCT00277212|26940411|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44|||
13450201|NCT00277212|26940412|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
13450202|NCT00277212|26940413|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
13450203|NCT00277212|26940411|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1|||
13450204|NCT00277212|26940412|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
13450205|NCT00277212|26940413|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
13450206|NCT00277212|26940411|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12|||
13450207|NCT00277212|26940412|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
13450208|NCT00277212|26940413|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
13450209|NCT00277212|26940411|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0|||
13450210|NCT00277212|26940412|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54|||
13450211|NCT00277212|26940413|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39|||
13450212|NCT00277212|26940411|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0|||
13450213|NCT00277212|26940412|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10|||
13450214|NCT00277212|26940413|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16|||
13450215|NCT00277212|26940411|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0|||
13450216|NCT00277212|26940412|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17|||
13450217|NCT00277212|26940413|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16|||
13450218|NCT00277212|26940411|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0|||
13450219|NCT00277212|26940412|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
13450220|NCT00277212|26940413|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
13450221|NCT00277212|26940411|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0|||
13450222|NCT00277212|26940412|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7|||
13450223|NCT00277212|26940413|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8|||
13450224|NCT00277212|26940411|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0|||
13450225|NCT00277212|26940412|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
13450226|NCT00277212|26940413|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
13450227|NCT00277212|26940411|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0|||
13450228|NCT00277212|26940412|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4|||
13450229|NCT00277212|26940413|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6|||
13450230|NCT00277212|26940411|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0|||
13450231|NCT00277212|26940412|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1|||
13450232|NCT00277212|26940413|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3|||
13450233|NCT00277212|26940411|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0|||
13450234|NCT00277212|26940412|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7|||
13450235|NCT00277212|26940413|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5|||
13450236|NCT00277095|26940419|FG000|Overall Study|Death|2|||
13450237|NCT00277095|26940419|FG000|Overall Study|Explanted|7|||
13450238|NCT00277095|26940419|FG000|Overall Study|Lost to Follow-up|2|||
13450239|NCT00277095|26940419|FG000|Overall Study|Missed Follow-up|9|||
13450240|NCT00277095|26940419|FG000|Overall Study|Physician Decision|1|||
13450241|NCT00276744|26940425|FG000|PART A|Reason unknown|98|||
13450242|NCT00276614|26940431|FG000|Overall Study|Progression of disease under study|3|||
13450243|NCT00276484|26940468|FG000|Overall Study|Adverse Event|4|||
13450244|NCT00276484|26940469|FG001|Overall Study|Adverse Event|7|||
13450245|NCT00276484|26940468|FG000|Overall Study|Lost to Follow-up|1|||
13450246|NCT00276484|26940469|FG001|Overall Study|Lost to Follow-up|1|||
13450247|NCT00276484|26940468|FG000|Overall Study|Protocol Violation|0|||
13450248|NCT00276484|26940469|FG001|Overall Study|Protocol Violation|1|||
13450249|NCT00276484|26940468|FG000|Overall Study|Withdrawal by Subject|4|||
13450250|NCT00276484|26940469|FG001|Overall Study|Withdrawal by Subject|3|||
13450251|NCT00276484|26940468|FG000|Overall Study|Could not take time off work|0|||
13450252|NCT00276484|26940469|FG001|Overall Study|Could not take time off work|1|||
13450253|NCT00276458|26940508|FG000|Overall Study|Adverse Event|0|||
13450254|NCT00276458|26940509|FG001|Overall Study|Adverse Event|2|||
13450255|NCT00276458|26940508|FG000|Overall Study|Lost to Follow-up|2|||
13450256|NCT00276458|26940509|FG001|Overall Study|Lost to Follow-up|2|||
13450257|NCT00276458|26940508|FG000|Overall Study|Protocol Violation|4|||
13450258|NCT00276458|26940509|FG001|Overall Study|Protocol Violation|3|||
13450259|NCT00276419|26940526|FG000|First Intervention|Adverse Event|1|||
13450260|NCT00276419|26940527|FG001|First Intervention|Adverse Event|0|||
13450261|NCT00276419|26940526|FG000|First Intervention|Withdrawal by Subject|0|||
13450262|NCT00276419|26940527|FG001|First Intervention|Withdrawal by Subject|2|||
13450263|NCT00276380|26940552|FG000|Overall Study|Adverse Event|5|||
13450264|NCT00276380|26940553|FG001|Overall Study|Adverse Event|3|||
13450265|NCT00276380|26940552|FG000|Overall Study|Lost to Follow-up|1|||
13450266|NCT00276380|26940553|FG001|Overall Study|Lost to Follow-up|1|||
13450267|NCT00276380|26940552|FG000|Overall Study|Withdrawal by Subject|3|||
13450268|NCT00276380|26940553|FG001|Overall Study|Withdrawal by Subject|6|||
13450269|NCT00276380|26940552|FG000|Overall Study|Death|5|||
13450270|NCT00276380|26940553|FG001|Overall Study|Death|3|||
13450271|NCT00276380|26940552|FG000|Overall Study|Abnormal aPPT Levels|0|||
13450272|NCT00276380|26940553|FG001|Overall Study|Abnormal aPPT Levels|1|||
13450273|NCT00276159|26940562|FG000|Overall Study|Did not receive all 24 doses of 852A|6|||
13450274|NCT00276094|26940619|FG000|Overall Study|Adverse Event|15|||
13450275|NCT00276094|26940620|FG001|Overall Study|Adverse Event|13|||
13450276|NCT00276094|26940621|FG002|Overall Study|Adverse Event|11|||
13450277|NCT00276094|26940619|FG000|Overall Study|Withdrawal by Subject|14|||
13450278|NCT00276094|26940620|FG001|Overall Study|Withdrawal by Subject|14|||
13450279|NCT00276094|26940621|FG002|Overall Study|Withdrawal by Subject|12|||
13450280|NCT00276094|26940619|FG000|Overall Study|Protocol Violation|16|||
13450281|NCT00276094|26940620|FG001|Overall Study|Protocol Violation|7|||
13450282|NCT00276094|26940621|FG002|Overall Study|Protocol Violation|10|||
13450283|NCT00276094|26940619|FG000|Overall Study|Lost to Follow-up|8|||
13450284|NCT00276094|26940620|FG001|Overall Study|Lost to Follow-up|6|||
13450285|NCT00276094|26940621|FG002|Overall Study|Lost to Follow-up|4|||
13450286|NCT00276094|26940619|FG000|Overall Study|Other-Subject moved out of country|1|||
13450287|NCT00276094|26940620|FG001|Overall Study|Other-Subject moved out of country|0|||
13450288|NCT00276094|26940621|FG002|Overall Study|Other-Subject moved out of country|0|||
13450289|NCT00276094|26940619|FG000|Overall Study|Other-Scheduled gastroplasty|1|||
13450290|NCT00276094|26940620|FG001|Overall Study|Other-Scheduled gastroplasty|0|||
13450291|NCT00276094|26940621|FG002|Overall Study|Other-Scheduled gastroplasty|0|||
13450292|NCT00276094|26940619|FG000|Overall Study|Other-Lack of efficacy|1|||
13450293|NCT00276094|26940620|FG001|Overall Study|Other-Lack of efficacy|0|||
13450294|NCT00276094|26940621|FG002|Overall Study|Other-Lack of efficacy|0|||
13450295|NCT00276094|26940619|FG000|Overall Study|Other-Refused follow-up visit|1|||
13450296|NCT00276094|26940620|FG001|Overall Study|Other-Refused follow-up visit|0|||
13450297|NCT00276094|26940621|FG002|Overall Study|Other-Refused follow-up visit|0|||
13450298|NCT00276094|26940619|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0|||
13450299|NCT00276094|26940620|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1|||
13450300|NCT00276094|26940621|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0|||
13450301|NCT00276094|26940619|FG000|Overall Study|Other-Relocation|0|||
13450302|NCT00276094|26940620|FG001|Overall Study|Other-Relocation|1|||
13450303|NCT00276094|26940621|FG002|Overall Study|Other-Relocation|0|||
13450304|NCT00276094|26940619|FG000|Overall Study|Other-Study medication lost|0|||
13450305|NCT00276094|26940620|FG001|Overall Study|Other-Study medication lost|0|||
13450306|NCT00276094|26940621|FG002|Overall Study|Other-Study medication lost|1|||
13450307|NCT00276016|26940649|FG000|Intervention 1|Withdrawal by Subject|0|||
13450308|NCT00276016|26940650|FG001|Intervention 1|Withdrawal by Subject|1|||
13450309|NCT00276016|26940651|FG002|Intervention 1|Withdrawal by Subject|0|||
13450310|NCT00276016|26940652|FG003|Intervention 1|Withdrawal by Subject|0|||
13450311|NCT00276016|26940653|FG004|Intervention 1|Withdrawal by Subject|0|||
13450312|NCT00276016|26940654|FG005|Intervention 1|Withdrawal by Subject|0|||
13450313|NCT00275821|26940681|FG000|Overall Study|Adverse Event|4|||
13450314|NCT00275821|26940682|FG001|Overall Study|Adverse Event|12|||
13450315|NCT00275821|26940683|FG002|Overall Study|Adverse Event|5|||
13450316|NCT00275821|26940681|FG000|Overall Study|Administrative problems|3|||
13450317|NCT00275821|26940682|FG001|Overall Study|Administrative problems|4|||
13450318|NCT00275821|26940683|FG002|Overall Study|Administrative problems|4|||
13450319|NCT00275821|26940681|FG000|Overall Study|Withdrawal by Subject|0|||
13450320|NCT00275821|26940682|FG001|Overall Study|Withdrawal by Subject|2|||
13450321|NCT00275821|26940683|FG002|Overall Study|Withdrawal by Subject|1|||
13390675|NCT00685178|26774220|FG000|Overall Study|Adverse Event|1|||
13390676|NCT00685178|26774221|FG001|Overall Study|Adverse Event|5|||
13390677|NCT00685178|26774222|FG002|Overall Study|Adverse Event|2|||
13390678|NCT00685178|26774223|FG003|Overall Study|Adverse Event|4|||
13390679|NCT00685178|26774220|FG000|Overall Study|missed 3 consecutive methadone clin days|7|||
13390680|NCT00685178|26774221|FG001|Overall Study|missed 3 consecutive methadone clin days|5|||
13390681|NCT00685178|26774222|FG002|Overall Study|missed 3 consecutive methadone clin days|2|||
13390682|NCT00685178|26774223|FG003|Overall Study|missed 3 consecutive methadone clin days|6|||
13450322|NCT00275821|26940681|FG000|Overall Study|Lost to Follow-up|0|||
13450323|NCT00275821|26940682|FG001|Overall Study|Lost to Follow-up|1|||
13450324|NCT00275821|26940683|FG002|Overall Study|Lost to Follow-up|1|||
13450325|NCT00275821|26940681|FG000|Overall Study|Death|0|||
13450326|NCT00275821|26940682|FG001|Overall Study|Death|2|||
13450327|NCT00275821|26940683|FG002|Overall Study|Death|1|||
13450328|NCT00275821|26940681|FG000|Overall Study|Lack of Efficacy|2|||
13450329|NCT00275821|26940682|FG001|Overall Study|Lack of Efficacy|1|||
13450330|NCT00275821|26940683|FG002|Overall Study|Lack of Efficacy|0|||
13450331|NCT00275821|26940681|FG000|Overall Study|Protocol Violation|5|||
13450332|NCT00275821|26940682|FG001|Overall Study|Protocol Violation|1|||
13450333|NCT00275821|26940683|FG002|Overall Study|Protocol Violation|0|||
13450334|NCT00275561|26940700|FG000|Overall Study|Withdrawal by Subject|0|||
13450335|NCT00275561|26940701|FG001|Overall Study|Withdrawal by Subject|1|||
13450336|NCT00275561|26940700|FG000|Overall Study|Travel|1|||
13450337|NCT00275561|26940701|FG001|Overall Study|Travel|1|||
13450338|NCT00275561|26940700|FG000|Overall Study|Scheduling|1|||
13450339|NCT00275561|26940701|FG001|Overall Study|Scheduling|2|||
13450340|NCT00275561|26940700|FG000|Overall Study|Family Issues|0|||
13450341|NCT00275561|26940701|FG001|Overall Study|Family Issues|2|||
13450342|NCT00275509|26940718|FG000|Overall Study|graft thrombosis, post-operative day #8|0|||
13450343|NCT00275509|26940719|FG001|Overall Study|graft thrombosis, post-operative day #8|1|||
13450344|NCT00275340|26940730|FG000|Overall Study|Lost to Follow-up|2|||
13450345|NCT00275340|26940731|FG001|Overall Study|Lost to Follow-up|4|||
13450346|NCT00275301|26940737|FG000|Overall Study|Adverse Event|5|||
13477296|NCT01555021|27006017|FG001|Overall Study|Lost to Follow-up|2|||
13450347|NCT00275262|26940758|FG000|Overall Study|Adverse Event|2|||
13450348|NCT00275262|26940759|FG001|Overall Study|Adverse Event|0|||
13450349|NCT00275262|26940758|FG000|Overall Study|Disease progression|2|||
13450350|NCT00275262|26940759|FG001|Overall Study|Disease progression|5|||
13450351|NCT00275262|26940758|FG000|Overall Study|Lost to Follow-up|0|||
13450352|NCT00275262|26940759|FG001|Overall Study|Lost to Follow-up|2|||
13450353|NCT00275262|26940758|FG000|Overall Study|Protocol Violation|0|||
13450354|NCT00275262|26940759|FG001|Overall Study|Protocol Violation|2|||
13450355|NCT00275262|26940758|FG000|Overall Study|Death|1|||
13450356|NCT00275262|26940759|FG001|Overall Study|Death|0|||
13450357|NCT00275262|26940758|FG000|Overall Study|Started Chemotherapy|1|||
13450358|NCT00275262|26940759|FG001|Overall Study|Started Chemotherapy|0|||
13450359|NCT00275028|26940766|FG000|Overall Study|Withdrew consent before treatment began|1|||
13450360|NCT00275028|26940766|FG000|Overall Study|Withdrawal by Subject|5|||
13450361|NCT00275028|26940766|FG000|Overall Study|Adverse Event|9|||
13450362|NCT00275028|26940766|FG000|Overall Study|Progressive Disease|30|||
13450363|NCT00275028|26940766|FG000|Overall Study|Physician Decision|2|||
13450364|NCT00275002|26940781|FG000|Overall Study|Death|1|||
13450365|NCT00275002|26940782|FG001|Overall Study|Death|0|||
13450366|NCT00275002|26940781|FG000|Overall Study|Disease progression|21|||
13450367|NCT00275002|26940782|FG001|Overall Study|Disease progression|15|||
13450368|NCT00275002|26940781|FG000|Overall Study|Adverse Event|0|||
13450369|NCT00275002|26940782|FG001|Overall Study|Adverse Event|1|||
13450370|NCT00274937|26940793|FG000|Overall Study|Physician Decision|10|||
13450371|NCT00274937|26940793|FG000|Overall Study|Withdrawal by Subject|6|||
13450372|NCT00274937|26940793|FG000|Overall Study|Progressive Disease|4|||
13450373|NCT00274924|26940812|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4|||
13450374|NCT00274924|26940813|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14|||
13450375|NCT00274924|26940814|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1|||
13450376|NCT00274924|26940812|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
13450377|NCT00274924|26940813|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
13450378|NCT00274924|26940814|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1|||
13450379|NCT00274924|26940812|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
13450380|NCT00274924|26940813|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
13450381|NCT00274924|26940814|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1|||
13450382|NCT00274924|26940812|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
13450383|NCT00274924|26940813|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
13450384|NCT00274924|26940814|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1|||
13450385|NCT00274924|26940812|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
13450386|NCT00274924|26940813|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
13450387|NCT00274924|26940814|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1|||
13450388|NCT00274924|26940812|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
13450389|NCT00274924|26940813|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
13450390|NCT00274924|26940814|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1|||
13450391|NCT00274924|26940812|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4|||
13450392|NCT00274924|26940813|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15|||
13450393|NCT00274924|26940814|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0|||
13450394|NCT00274924|26940812|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1|||
13450395|NCT00274924|26940813|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
13450396|NCT00274924|26940814|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
13450397|NCT00274924|26940812|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1|||
13450398|NCT00274924|26940813|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
13450399|NCT00274924|26940814|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
13450400|NCT00274924|26940812|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1|||
13450401|NCT00274924|26940813|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
13450402|NCT00274924|26940814|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
13450403|NCT00274924|26940812|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
13450404|NCT00274924|26940813|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1|||
13450405|NCT00274924|26940814|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
13450406|NCT00274924|26940812|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
13450407|NCT00274924|26940813|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1|||
13450408|NCT00274924|26940814|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
13450409|NCT00274924|26940812|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
13450410|NCT00274924|26940813|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1|||
13450411|NCT00274924|26940814|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
13450412|NCT00274846|26940824|FG000|Overall Study|Did not receive adequate NK cells|1|||
13450413|NCT00274742|26940875|FG000|Overall Study|Adverse Event|0|||
13450414|NCT00274742|26940876|FG001|Overall Study|Adverse Event|4|||
13450415|NCT00274742|26940877|FG002|Overall Study|Adverse Event|1|||
13450416|NCT00274742|26940878|FG003|Overall Study|Adverse Event|4|||
13450417|NCT00274742|26940879|FG004|Overall Study|Adverse Event|12|||
13450418|NCT00274742|26940880|FG005|Overall Study|Adverse Event|3|||
13450419|NCT00274742|26940875|FG000|Overall Study|Lost to Follow-up|0|||
13450420|NCT00274742|26940876|FG001|Overall Study|Lost to Follow-up|0|||
13450421|NCT00274742|26940877|FG002|Overall Study|Lost to Follow-up|0|||
13450422|NCT00274742|26940878|FG003|Overall Study|Lost to Follow-up|0|||
13450423|NCT00274742|26940879|FG004|Overall Study|Lost to Follow-up|1|||
13450424|NCT00274742|26940880|FG005|Overall Study|Lost to Follow-up|0|||
13450425|NCT00274742|26940875|FG000|Overall Study|End of Study|0|||
13450426|NCT00274742|26940876|FG001|Overall Study|End of Study|0|||
13450427|NCT00274742|26940877|FG002|Overall Study|End of Study|0|||
13450428|NCT00274742|26940878|FG003|Overall Study|End of Study|1|||
13450429|NCT00274742|26940879|FG004|Overall Study|End of Study|0|||
13450430|NCT00274742|26940880|FG005|Overall Study|End of Study|0|||
13450431|NCT00274742|26940875|FG000|Overall Study|Disease Progression|0|||
13450432|NCT00274742|26940876|FG001|Overall Study|Disease Progression|1|||
13450433|NCT00274742|26940877|FG002|Overall Study|Disease Progression|1|||
13450434|NCT00274742|26940878|FG003|Overall Study|Disease Progression|0|||
13450435|NCT00274742|26940879|FG004|Overall Study|Disease Progression|1|||
13450436|NCT00274742|26940880|FG005|Overall Study|Disease Progression|0|||
13450437|NCT00274742|26940875|FG000|Overall Study|Other|0|||
13450438|NCT00274742|26940876|FG001|Overall Study|Other|3|||
13450439|NCT00274742|26940877|FG002|Overall Study|Other|0|||
13450440|NCT00274742|26940878|FG003|Overall Study|Other|0|||
13450441|NCT00274742|26940879|FG004|Overall Study|Other|2|||
13450442|NCT00274742|26940880|FG005|Overall Study|Other|0|||
13450443|NCT00274716|26940959|FG000|Phase A|Other non-reported reason|4|||
13450444|NCT00274716|26940960|FG001|Phase A|Other non-reported reason|2|||
13450445|NCT00274716|26940961|FG002|Phase A|Other non-reported reason|1|||
13450446|NCT00274716|26940962|FG003|Phase A|Other non-reported reason|2|||
13450447|NCT00274716|26940963|FG004|Phase A|Other non-reported reason|0|||
13450448|NCT00274716|26940964|FG005|Phase A|Other non-reported reason|1|||
13450449|NCT00274716|26940959|FG000|Phase A|Participant moved|0|||
13450450|NCT00274716|26940960|FG001|Phase A|Participant moved|0|||
13450451|NCT00274716|26940961|FG002|Phase A|Participant moved|1|||
13450452|NCT00274716|26940962|FG003|Phase A|Participant moved|0|||
13450453|NCT00274716|26940963|FG004|Phase A|Participant moved|0|||
13450454|NCT00274716|26940964|FG005|Phase A|Participant moved|1|||
13450455|NCT00274716|26940959|FG000|Phase A|Site Terminated|0|||
13450456|NCT00274716|26940960|FG001|Phase A|Site Terminated|0|||
13450457|NCT00274716|26940961|FG002|Phase A|Site Terminated|0|||
13450458|NCT00274716|26940962|FG003|Phase A|Site Terminated|1|||
13450459|NCT00274716|26940963|FG004|Phase A|Site Terminated|0|||
13450460|NCT00274716|26940964|FG005|Phase A|Site Terminated|0|||
13450461|NCT00274716|26940959|FG000|Phase A|Protocol Violation|1|||
13450462|NCT00274716|26940960|FG001|Phase A|Protocol Violation|0|||
13450463|NCT00274716|26940961|FG002|Phase A|Protocol Violation|0|||
13450464|NCT00274716|26940962|FG003|Phase A|Protocol Violation|1|||
13450465|NCT00274716|26940963|FG004|Phase A|Protocol Violation|0|||
13450466|NCT00274716|26940964|FG005|Phase A|Protocol Violation|0|||
13450467|NCT00274716|26940959|FG000|Phase A|Met criteria for discontinuation|1|||
13450468|NCT00274716|26940960|FG001|Phase A|Met criteria for discontinuation|1|||
13450469|NCT00274716|26940961|FG002|Phase A|Met criteria for discontinuation|0|||
13450470|NCT00274716|26940962|FG003|Phase A|Met criteria for discontinuation|0|||
13450471|NCT00274716|26940963|FG004|Phase A|Met criteria for discontinuation|0|||
13450472|NCT00274716|26940964|FG005|Phase A|Met criteria for discontinuation|0|||
13450473|NCT00274716|26940959|FG000|Phase A|Withdrawal by Subject|2|||
13450474|NCT00274716|26940960|FG001|Phase A|Withdrawal by Subject|2|||
13450475|NCT00274716|26940961|FG002|Phase A|Withdrawal by Subject|1|||
13450476|NCT00274716|26940962|FG003|Phase A|Withdrawal by Subject|3|||
13450477|NCT00274716|26940963|FG004|Phase A|Withdrawal by Subject|0|||
13450478|NCT00274716|26940964|FG005|Phase A|Withdrawal by Subject|1|||
13450479|NCT00274716|26940959|FG000|Phase A|Adverse Event|2|||
13450480|NCT00274716|26940960|FG001|Phase A|Adverse Event|3|||
13450481|NCT00274716|26940961|FG002|Phase A|Adverse Event|3|||
13450482|NCT00274716|26940962|FG003|Phase A|Adverse Event|0|||
13450483|NCT00274716|26940963|FG004|Phase A|Adverse Event|2|||
13450484|NCT00274716|26940964|FG005|Phase A|Adverse Event|0|||
13450485|NCT00274716|26940959|FG000|Phase A|Completed but did not enter Phase B|1|||
13450486|NCT00274716|26940960|FG001|Phase A|Completed but did not enter Phase B|2|||
13450487|NCT00274716|26940961|FG002|Phase A|Completed but did not enter Phase B|2|||
13450488|NCT00274716|26940962|FG003|Phase A|Completed but did not enter Phase B|2|||
13450489|NCT00274716|26940963|FG004|Phase A|Completed but did not enter Phase B|1|||
13450490|NCT00274716|26940964|FG005|Phase A|Completed but did not enter Phase B|1|||
13450491|NCT00274716|26940959|FG000|Phase B|Adverse Event|0|||
13450492|NCT00274716|26940960|FG001|Phase B|Adverse Event|0|||
13450493|NCT00274716|26940961|FG002|Phase B|Adverse Event|2|||
13450494|NCT00274716|26940962|FG003|Phase B|Adverse Event|0|||
13450495|NCT00274716|26940963|FG004|Phase B|Adverse Event|0|||
13450496|NCT00274716|26940964|FG005|Phase B|Adverse Event|1|||
13450497|NCT00274716|26940959|FG000|Phase B|Protocol Violation|0|||
13450498|NCT00274716|26940960|FG001|Phase B|Protocol Violation|2|||
13450499|NCT00274716|26940961|FG002|Phase B|Protocol Violation|0|||
13450500|NCT00274716|26940962|FG003|Phase B|Protocol Violation|0|||
13450501|NCT00274716|26940963|FG004|Phase B|Protocol Violation|0|||
13450502|NCT00274716|26940964|FG005|Phase B|Protocol Violation|0|||
13450503|NCT00274716|26940959|FG000|Phase B|Withdrawal by Subject|0|||
13450504|NCT00274716|26940960|FG001|Phase B|Withdrawal by Subject|1|||
13450505|NCT00274716|26940961|FG002|Phase B|Withdrawal by Subject|0|||
13450506|NCT00274716|26940962|FG003|Phase B|Withdrawal by Subject|0|||
13450507|NCT00274716|26940963|FG004|Phase B|Withdrawal by Subject|0|||
13450508|NCT00274716|26940964|FG005|Phase B|Withdrawal by Subject|0|||
13450509|NCT00274716|26940959|FG000|Phase B|Participant moved|1|||
13450510|NCT00274716|26940960|FG001|Phase B|Participant moved|0|||
13450511|NCT00274716|26940961|FG002|Phase B|Participant moved|0|||
13450512|NCT00274716|26940962|FG003|Phase B|Participant moved|0|||
13450513|NCT00274716|26940963|FG004|Phase B|Participant moved|0|||
13450514|NCT00274716|26940964|FG005|Phase B|Participant moved|0|||
13450515|NCT00274716|26940959|FG000|Phase B|Other non-reported reason|0|||
13450516|NCT00274716|26940960|FG001|Phase B|Other non-reported reason|0|||
13450517|NCT00274716|26940961|FG002|Phase B|Other non-reported reason|1|||
13450518|NCT00274716|26940962|FG003|Phase B|Other non-reported reason|1|||
13450519|NCT00274716|26940963|FG004|Phase B|Other non-reported reason|0|||
13450520|NCT00274716|26940964|FG005|Phase B|Other non-reported reason|0|||
13450521|NCT00274716|26940959|FG000|Phase B|Lost to Follow-up|0|||
13450522|NCT00274716|26940960|FG001|Phase B|Lost to Follow-up|1|||
13450523|NCT00274716|26940961|FG002|Phase B|Lost to Follow-up|0|||
13450524|NCT00274716|26940962|FG003|Phase B|Lost to Follow-up|0|||
13450525|NCT00274716|26940963|FG004|Phase B|Lost to Follow-up|0|||
13450526|NCT00274716|26940964|FG005|Phase B|Lost to Follow-up|0|||
13450527|NCT00274651|26940984|FG000|Overall Study|Adverse Event|6|||
13450528|NCT00274651|26940985|FG001|Overall Study|Adverse Event|3|||
13450529|NCT00274651|26940984|FG000|Overall Study|Lack of Efficacy|13|||
13450530|NCT00274651|26940985|FG001|Overall Study|Lack of Efficacy|6|||
13450531|NCT00274651|26940984|FG000|Overall Study|Death|1|||
13450532|NCT00274651|26940985|FG001|Overall Study|Death|3|||
13450533|NCT00274651|26940984|FG000|Overall Study|Withdrawal by Subject|0|||
13450534|NCT00274651|26940985|FG001|Overall Study|Withdrawal by Subject|1|||
13450535|NCT00274651|26940984|FG000|Overall Study|Physician Decision|8|||
13450536|NCT00274651|26940985|FG001|Overall Study|Physician Decision|7|||
13450537|NCT00274625|26940998|FG000|Overall Study|Lost to Follow-up|46|||
13450538|NCT00274625|26940999|FG001|Overall Study|Lost to Follow-up|54|||
13450539|NCT00274625|26940998|FG000|Overall Study|Excluded from analysis|14|||
13450540|NCT00274625|26940999|FG001|Overall Study|Excluded from analysis|8|||
13450541|NCT00274469|26941022|FG000|Overall Study|Death|63|||
13450542|NCT00274469|26941023|FG001|Overall Study|Death|74|||
13450543|NCT00274469|26941022|FG000|Overall Study|Did not consent to OS follow-up|16|||
13450544|NCT00274469|26941023|FG001|Overall Study|Did not consent to OS follow-up|19|||
13450545|NCT00274456|26941078|FG000|Overall Study|Still on treatment|2|||
13450546|NCT00274456|26941079|FG001|Overall Study|Still on treatment|3|||
13450547|NCT00274456|26941080|FG002|Overall Study|Still on treatment|5|||
13450548|NCT00274456|26941081|FG003|Overall Study|Still on treatment|1|||
13450549|NCT00274456|26941078|FG000|Overall Study|Unacceptable toxicity|10|||
13450550|NCT00274456|26941079|FG001|Overall Study|Unacceptable toxicity|5|||
13450551|NCT00274456|26941080|FG002|Overall Study|Unacceptable toxicity|12|||
13450552|NCT00274456|26941081|FG003|Overall Study|Unacceptable toxicity|16|||
13450553|NCT00274456|26941078|FG000|Overall Study|Adverse Event|0|||
13450554|NCT00274456|26941079|FG001|Overall Study|Adverse Event|1|||
13450555|NCT00274456|26941080|FG002|Overall Study|Adverse Event|2|||
13450556|NCT00274456|26941081|FG003|Overall Study|Adverse Event|2|||
13450557|NCT00274456|26941078|FG000|Overall Study|Physician Decision|7|||
13450558|NCT00274456|26941079|FG001|Overall Study|Physician Decision|5|||
13450559|NCT00274456|26941080|FG002|Overall Study|Physician Decision|6|||
13450560|NCT00274456|26941081|FG003|Overall Study|Physician Decision|13|||
13450561|NCT00274456|26941078|FG000|Overall Study|Lost to Follow-up|0|||
13450562|NCT00274456|26941079|FG001|Overall Study|Lost to Follow-up|0|||
13450563|NCT00274456|26941080|FG002|Overall Study|Lost to Follow-up|1|||
13450564|NCT00274456|26941081|FG003|Overall Study|Lost to Follow-up|0|||
13450565|NCT00274456|26941078|FG000|Overall Study|Withdrawal by Subject|18|||
13450566|NCT00274456|26941079|FG001|Overall Study|Withdrawal by Subject|13|||
13450567|NCT00274456|26941080|FG002|Overall Study|Withdrawal by Subject|9|||
13450568|NCT00274456|26941081|FG003|Overall Study|Withdrawal by Subject|13|||
13450569|NCT00274287|26941091|FG000|Overall Study|Withdrawal by Subject|1|||
13450570|NCT00274287|26941091|FG000|Overall Study|subject non-compliance|1|||
13450571|NCT00274261|26941106|FG000|Overall Study|Adverse Event|19|||
13450572|NCT00274261|26941107|FG001|Overall Study|Adverse Event|11|||
13450573|NCT00274261|26941106|FG000|Overall Study|Pregnancy|114|||
13450574|NCT00274261|26941107|FG001|Overall Study|Pregnancy|83|||
13450575|NCT00274261|26941106|FG000|Overall Study|Withdrawal by Subject|179|||
13450576|NCT00274261|26941107|FG001|Overall Study|Withdrawal by Subject|126|||
13450577|NCT00274261|26941106|FG000|Overall Study|Protocol Violation|71|||
13450578|NCT00274261|26941107|FG001|Overall Study|Protocol Violation|42|||
13450579|NCT00274261|26941106|FG000|Overall Study|Lost to Follow-up|106|||
13450580|NCT00274261|26941107|FG001|Overall Study|Lost to Follow-up|75|||
13450581|NCT00273858|26941118|FG000|Overall Study|Not completed 24 month observation time|334|||
13450582|NCT00273858|26941118|FG000|Overall Study|Lost to Follow-up|101|||
13450583|NCT00273858|26941118|FG000|Overall Study|Withdrawal by Subject|21|||
13450584|NCT00273858|26941118|FG000|Overall Study|Adverse Event|81|||
13450585|NCT00273182|26941128|FG000|Overall Study|Death|450|||
13450586|NCT00273182|26941128|FG000|Overall Study|Lost to Follow-up|88|||
13450587|NCT00273182|26941128|FG000|Overall Study|Withdrawal by Subject|257|||
13450588|NCT00273182|26941128|FG000|Overall Study|Device/System Explant|154|||
13450589|NCT00273182|26941128|FG000|Overall Study|Site exit, system change, 36 m FU missed|36|||
13450590|NCT00273052|26941167|FG000|Overall Study|Withdrawal by Subject|16|||
13450591|NCT00273052|26941168|FG001|Overall Study|Withdrawal by Subject|19|||
13450592|NCT00273052|26941167|FG000|Overall Study|Adverse Event|21|||
13450593|NCT00273052|26941168|FG001|Overall Study|Adverse Event|19|||
13450594|NCT00273052|26941167|FG000|Overall Study|Protocol Violation|14|||
13450595|NCT00273052|26941168|FG001|Overall Study|Protocol Violation|18|||
13450596|NCT00273052|26941167|FG000|Overall Study|Lost to Follow-up|7|||
13450597|NCT00273052|26941168|FG001|Overall Study|Lost to Follow-up|25|||
13450598|NCT00273052|26941167|FG000|Overall Study|Lack of Efficacy|6|||
13450599|NCT00273052|26941168|FG001|Overall Study|Lack of Efficacy|4|||
13450600|NCT00273052|26941167|FG000|Overall Study|Non-Compliance|3|||
13450601|NCT00273052|26941168|FG001|Overall Study|Non-Compliance|1|||
13450602|NCT00273052|26941167|FG000|Overall Study|Other|2|||
13450603|NCT00273052|26941168|FG001|Overall Study|Other|0|||
13450604|NCT00273052|26941167|FG000|Overall Study|Worsening serum lipid levels|0|||
13450605|NCT00273052|26941168|FG001|Overall Study|Worsening serum lipid levels|2|||
13450606|NCT00272987|26941243|FG000|Overall Study|Adverse Event|1|||
13450607|NCT00272987|26941244|FG001|Overall Study|Adverse Event|0|||
13450608|NCT00272987|26941245|FG002|Overall Study|Adverse Event|0|||
13450609|NCT00272987|26941243|FG000|Overall Study|Lost to Follow-up|3|||
13450610|NCT00272987|26941244|FG001|Overall Study|Lost to Follow-up|1|||
13450611|NCT00272987|26941245|FG002|Overall Study|Lost to Follow-up|1|||
13450612|NCT00272987|26941243|FG000|Overall Study|Withdrawal by Subject|1|||
13450613|NCT00272987|26941244|FG001|Overall Study|Withdrawal by Subject|0|||
13450614|NCT00272987|26941245|FG002|Overall Study|Withdrawal by Subject|3|||
13450615|NCT00272987|26941243|FG000|Overall Study|Sponsor Terminated study|0|||
13450616|NCT00272987|26941244|FG001|Overall Study|Sponsor Terminated study|1|||
13450617|NCT00272987|26941245|FG002|Overall Study|Sponsor Terminated study|1|||
13450618|NCT00272987|26941243|FG000|Overall Study|Disease progression|1|||
13450619|NCT00272987|26941244|FG001|Overall Study|Disease progression|1|||
13450620|NCT00272987|26941245|FG002|Overall Study|Disease progression|2|||
13450621|NCT00272987|26941243|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2|||
13450622|NCT00272987|26941244|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1|||
13450623|NCT00272987|26941245|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4|||
13450624|NCT00272987|26941243|FG000|Overall Study|Death|1|||
13450625|NCT00272987|26941244|FG001|Overall Study|Death|0|||
13450626|NCT00272987|26941245|FG002|Overall Study|Death|0|||
13450627|NCT00272961|26941318|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1|||
13450628|NCT00272961|26941319|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
13450629|NCT00272961|26941320|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
13450630|NCT00272961|26941321|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
13450631|NCT00272961|26941322|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
13450632|NCT00272961|26941318|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1|||
13450633|NCT00272961|26941319|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
13450634|NCT00272961|26941320|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
13450635|NCT00272961|26941321|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
13450636|NCT00272961|26941322|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
13450637|NCT00272961|26941318|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5|||
13450638|NCT00272961|26941319|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
13450639|NCT00272961|26941320|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
13450640|NCT00272961|26941321|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
13450641|NCT00272961|26941322|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
13450642|NCT00272961|26941318|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2|||
13450643|NCT00272961|26941319|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
13450644|NCT00272961|26941320|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
13450645|NCT00272961|26941321|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
13450646|NCT00272961|26941322|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
13450647|NCT00272961|26941318|FG000|Placebo Run-in Phase: Up to Week 2|Other|2|||
13450648|NCT00272961|26941319|FG001|Placebo Run-in Phase: Up to Week 2|Other|0|||
13450649|NCT00272961|26941320|FG002|Placebo Run-in Phase: Up to Week 2|Other|0|||
13450650|NCT00272961|26941321|FG003|Placebo Run-in Phase: Up to Week 2|Other|0|||
13450651|NCT00272961|26941322|FG004|Placebo Run-in Phase: Up to Week 2|Other|0|||
13450652|NCT00272961|26941318|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
13450653|NCT00272961|26941319|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
13450654|NCT00272961|26941320|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
13450655|NCT00272961|26941321|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
13450656|NCT00272961|26941322|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2|||
13450657|NCT00272961|26941318|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
13450658|NCT00272961|26941319|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
13450659|NCT00272961|26941320|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
13450660|NCT00272961|26941321|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
13450661|NCT00272961|26941322|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
13450662|NCT00272961|26941318|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1|||
13450663|NCT00272961|26941319|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3|||
13450664|NCT00272961|26941320|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3|||
13450665|NCT00272961|26941321|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2|||
13450666|NCT00272961|26941322|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2|||
13450667|NCT00272844|26941330|FG000|Overall Study|Withdrawal by Subject|5|||
13450668|NCT00272792|26941345|FG000|Part 1: Responsiveness|Lost to Follow-up|1|||
13450669|NCT00272792|26941346|FG001|Part 1: Responsiveness|Lost to Follow-up|0|||
13450670|NCT00272792|26941345|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0|||
13450671|NCT00272792|26941346|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2|||
13450672|NCT00272792|26941345|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1|||
13450673|NCT00272792|26941346|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0|||
13450674|NCT00272792|26941345|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0|||
13450675|NCT00272792|26941346|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1|||
13450676|NCT00272779|26941532|FG000|Baseline Through Week 48|Adverse event before Week 48|10|||
13450677|NCT00272779|26941533|FG001|Baseline Through Week 48|Adverse event before Week 48|14|||
13450678|NCT00272779|26941532|FG000|Baseline Through Week 48|Death before Week 48|4|||
13450679|NCT00272779|26941533|FG001|Baseline Through Week 48|Death before Week 48|4|||
13450680|NCT00272779|26941532|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5|||
13450681|NCT00272779|26941533|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8|||
13450682|NCT00272779|26941532|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
13450683|NCT00272779|26941533|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
13450684|NCT00272779|26941532|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1|||
13450685|NCT00272779|26941533|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0|||
13450686|NCT00272779|26941532|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6|||
13450687|NCT00272779|26941533|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9|||
13450688|NCT00272779|26941532|FG000|Baseline Through Week 48|Pregnancy before Week 48|2|||
13450689|NCT00272779|26941533|FG001|Baseline Through Week 48|Pregnancy before Week 48|2|||
13450690|NCT00272779|26941532|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1|||
13450691|NCT00272779|26941533|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0|||
13450692|NCT00272779|26941532|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4|||
13450693|NCT00272779|26941533|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13|||
13450694|NCT00272779|26941532|FG000|Baseline Through Week 48|Participant's decision before wk 48|0|||
13450695|NCT00272779|26941533|FG001|Baseline Through Week 48|Participant's decision before wk 48|1|||
13450696|NCT00272779|26941532|FG000|Baseline Through Week 48|Chose different site before wk 48|0|||
13450697|NCT00272779|26941533|FG001|Baseline Through Week 48|Chose different site before wk 48|1|||
13450698|NCT00272779|26941532|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1|||
13450699|NCT00272779|26941533|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1|||
13450700|NCT00272779|26941532|FG000|Baseline Through Week 48|Death on/after Week 48|1|||
13450701|NCT00272779|26941533|FG001|Baseline Through Week 48|Death on/after Week 48|1|||
13450702|NCT00272779|26941532|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7|||
13450703|NCT00272779|26941533|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1|||
13450704|NCT00272779|26941532|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
13450705|NCT00272779|26941533|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
13450706|NCT00272779|26941532|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
13450707|NCT00272779|26941533|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
13450708|NCT00272779|26941532|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1|||
13450709|NCT00272779|26941533|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2|||
13450710|NCT00272779|26941532|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0|||
13450711|NCT00272779|26941533|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2|||
13450712|NCT00272779|26941532|FG000|Baseline Through Week 48|Continuing treatment|385|||
13450713|NCT00272779|26941533|FG001|Baseline Through Week 48|Continuing treatment|368|||
13450714|NCT00272779|26941532|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0|||
13450715|NCT00272779|26941533|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3|||
13450716|NCT00272779|26941532|FG000|Baseline Through Week 48|Never treated|2|||
13450717|NCT00272779|26941533|FG001|Baseline Through Week 48|Never treated|3|||
13450718|NCT00272779|26941532|FG000|Baseline Through Week 96|Adverse event before Week 96|13|||
13450719|NCT00272779|26941533|FG001|Baseline Through Week 96|Adverse event before Week 96|22|||
13450720|NCT00272779|26941532|FG000|Baseline Through Week 96|Death before Week 96|6|||
13450721|NCT00272779|26941533|FG001|Baseline Through Week 96|Death before Week 96|5|||
13450722|NCT00272779|26941532|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16|||
13450723|NCT00272779|26941533|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10|||
13450724|NCT00272779|26941532|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10|||
13450725|NCT00272779|26941533|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13|||
13450726|NCT00272779|26941532|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1|||
13450727|NCT00272779|26941533|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0|||
13450728|NCT00272779|26941532|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12|||
13450729|NCT00272779|26941533|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16|||
13450730|NCT00272779|26941532|FG000|Baseline Through Week 96|Pregnancy before Week 96|5|||
13450731|NCT00272779|26941533|FG001|Baseline Through Week 96|Pregnancy before Week 96|7|||
13450732|NCT00272779|26941532|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4|||
13450733|NCT00272779|26941533|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3|||
13450734|NCT00272779|26941532|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5|||
13450735|NCT00272779|26941533|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18|||
13450736|NCT00272779|26941532|FG000|Baseline Through Week 96|Changed address before Week 96|0|||
13450737|NCT00272779|26941533|FG001|Baseline Through Week 96|Changed address before Week 96|1|||
13450738|NCT00272779|26941532|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1|||
13450739|NCT00272779|26941533|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0|||
13450740|NCT00272779|26941532|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2|||
13450741|NCT00272779|26941533|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0|||
13450742|NCT00272779|26941532|FG000|Baseline Through Week 96|Pregnancy at Week 96|1|||
13450743|NCT00272779|26941533|FG001|Baseline Through Week 96|Pregnancy at Week 96|0|||
13450744|NCT00272779|26941532|FG000|Baseline Through Week 96|Never treated|2|||
13450745|NCT00272779|26941533|FG001|Baseline Through Week 96|Never treated|3|||
13450746|NCT00272779|26941532|FG000|Baseline Through Week 96|Continuing on treatment|61|||
13450747|NCT00272779|26941533|FG001|Baseline Through Week 96|Continuing on treatment|38|||
13450748|NCT00272038|26941541|FG000|Overall Study|withdrew before they received 2 cycles|7|||
13450749|NCT00271947|26941547|FG000|Overall Study|Lost to Follow-up|1|||
13450750|NCT00271856|26941570|FG000|Overall Study|Withdrawal by Subject|1|||
13450751|NCT00271856|26941571|FG001|Overall Study|Withdrawal by Subject|7|||
13450752|NCT00271856|26941570|FG000|Overall Study|Lost to Follow-up|10|||
13450753|NCT00271856|26941571|FG001|Overall Study|Lost to Follow-up|11|||
13450754|NCT00271609|26941586|FG000|Overall Study|Adverse Event|11|||
13450755|NCT00271609|26941587|FG001|Overall Study|Adverse Event|3|||
13450756|NCT00271609|26941586|FG000|Overall Study|Withdrawal by Subject|2|||
13450757|NCT00271609|26941587|FG001|Overall Study|Withdrawal by Subject|0|||
13450758|NCT00271596|26941618|FG000|Overall Study|Protocol Violation|1|||
13450759|NCT00271596|26941619|FG001|Overall Study|Protocol Violation|0|||
13450760|NCT00271596|26941618|FG000|Overall Study|Withdrawal by Subject|0|||
13450761|NCT00271596|26941619|FG001|Overall Study|Withdrawal by Subject|1|||
13450762|NCT00271505|26941627|FG000|Overall Study|Screen Failure|3|||
13450763|NCT00271505|26941627|FG000|Overall Study|Adverse Event|1|||
13450764|NCT00271505|26941627|FG000|Overall Study|Death|1|||
13450765|NCT00271024|26941682|FG000|Overall Study|Lost Interest|3|||
13450766|NCT00271024|26941683|FG001|Overall Study|Lost Interest|4|||
13450767|NCT00271024|26941684|FG002|Overall Study|Lost Interest|2|||
13450768|NCT00271024|26941685|FG003|Overall Study|Lost Interest|3|||
13450769|NCT00271024|26941682|FG000|Overall Study|Unknown/Unspecified|11|||
13450770|NCT00271024|26941683|FG001|Overall Study|Unknown/Unspecified|11|||
13450771|NCT00271024|26941684|FG002|Overall Study|Unknown/Unspecified|8|||
13450772|NCT00271024|26941685|FG003|Overall Study|Unknown/Unspecified|4|||
13450773|NCT00271024|26941682|FG000|Overall Study|Protocol Violation|1|||
13450774|NCT00271024|26941683|FG001|Overall Study|Protocol Violation|6|||
13450775|NCT00271024|26941684|FG002|Overall Study|Protocol Violation|5|||
13450776|NCT00271024|26941685|FG003|Overall Study|Protocol Violation|11|||
13450777|NCT00271024|26941682|FG000|Overall Study|Unpleasant Reaction To Tablet|1|||
13450778|NCT00271024|26941683|FG001|Overall Study|Unpleasant Reaction To Tablet|3|||
13450779|NCT00271024|26941684|FG002|Overall Study|Unpleasant Reaction To Tablet|4|||
13450780|NCT00271024|26941685|FG003|Overall Study|Unpleasant Reaction To Tablet|2|||
13450781|NCT00271024|26941682|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6|||
13450782|NCT00271024|26941683|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2|||
13450783|NCT00271024|26941684|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4|||
13450784|NCT00271024|26941685|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4|||
13450785|NCT00270998|26941724|FG000|3 Month Follow-up|Adverse Event|1|||
13450786|NCT00270998|26941725|FG001|3 Month Follow-up|Adverse Event|0|||
13450787|NCT00270998|26941726|FG002|3 Month Follow-up|Adverse Event|0|||
13450788|NCT00270998|26941724|FG000|3 Month Follow-up|Lack of Efficacy|1|||
13450789|NCT00270998|26941725|FG001|3 Month Follow-up|Lack of Efficacy|2|||
13450790|NCT00270998|26941726|FG002|3 Month Follow-up|Lack of Efficacy|1|||
13450791|NCT00270998|26941724|FG000|3 Month Follow-up|Withdrawal by Subject|11|||
13450792|NCT00270998|26941725|FG001|3 Month Follow-up|Withdrawal by Subject|14|||
13450793|NCT00270998|26941726|FG002|3 Month Follow-up|Withdrawal by Subject|15|||
13450794|NCT00270998|26941724|FG000|3 Month Follow-up|Pessary did not fit|12|||
13450795|NCT00270998|26941725|FG001|3 Month Follow-up|Pessary did not fit|0|||
13450796|NCT00270998|26941726|FG002|3 Month Follow-up|Pessary did not fit|0|||
13450797|NCT00270998|26941724|FG000|3 Month Follow-up|Personal/family health|1|||
13450798|NCT00270998|26941725|FG001|3 Month Follow-up|Personal/family health|1|||
13450799|NCT00270998|26941726|FG002|3 Month Follow-up|Personal/family health|0|||
13450800|NCT00270998|26941724|FG000|3 Month Follow-up|Received/desired alternate treatment|13|||
13450801|NCT00270998|26941725|FG001|3 Month Follow-up|Received/desired alternate treatment|5|||
13450802|NCT00270998|26941726|FG002|3 Month Follow-up|Received/desired alternate treatment|2|||
13450803|NCT00270998|26941724|FG000|12 Month Follow-up|Lack of Efficacy|5|||
13450804|NCT00270998|26941725|FG001|12 Month Follow-up|Lack of Efficacy|4|||
13450805|NCT00270998|26941726|FG002|12 Month Follow-up|Lack of Efficacy|3|||
13450806|NCT00270998|26941724|FG000|12 Month Follow-up|Withdrawal by Subject|7|||
13450807|NCT00270998|26941725|FG001|12 Month Follow-up|Withdrawal by Subject|12|||
13450808|NCT00270998|26941726|FG002|12 Month Follow-up|Withdrawal by Subject|16|||
13450809|NCT00270998|26941724|FG000|12 Month Follow-up|Pessary did not fit|1|||
13450810|NCT00270998|26941725|FG001|12 Month Follow-up|Pessary did not fit|0|||
13450811|NCT00270998|26941726|FG002|12 Month Follow-up|Pessary did not fit|0|||
13450812|NCT00270998|26941724|FG000|12 Month Follow-up|Personal/family health|0|||
13450813|NCT00270998|26941725|FG001|12 Month Follow-up|Personal/family health|5|||
13450814|NCT00270998|26941726|FG002|12 Month Follow-up|Personal/family health|1|||
13450815|NCT00270998|26941724|FG000|12 Month Follow-up|Received/desired alternate treatment|1|||
13450816|NCT00270998|26941725|FG001|12 Month Follow-up|Received/desired alternate treatment|4|||
13450817|NCT00270998|26941726|FG002|12 Month Follow-up|Received/desired alternate treatment|1|||
13450818|NCT00270894|26941738|FG000|Overall Study|Adverse Event|1|||
13450819|NCT00270894|26941738|FG000|Overall Study|Withdrawal by Subject|1|||
13450820|NCT00270855|26941801|FG000|Overall Study|Withdrawal by Subject|8|||
13450821|NCT00270855|26941802|FG001|Overall Study|Withdrawal by Subject|8|||
13450822|NCT00270257|26941827|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412|||
13450823|NCT00270257|26941828|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424|||
13450824|NCT00270231|26941837|FG000|First Intervention|Lost to Follow-up|1|||
13450825|NCT00270231|26941838|FG001|First Intervention|Lost to Follow-up|1|||
13450826|NCT00270231|26941837|FG000|Washout Period|Lost to Follow-up|1|||
13450827|NCT00270231|26941838|FG001|Washout Period|Lost to Follow-up|0|||
13450828|NCT00270231|26941837|FG000|Second Intervention|Lost to Follow-up|0|||
13450829|NCT00270231|26941838|FG001|Second Intervention|Lost to Follow-up|1|||
13450830|NCT00270205|26941969|FG000|Overall Study|Lost to Follow-up|1|||
13450831|NCT00270205|26941970|FG001|Overall Study|Lost to Follow-up|0|||
13450832|NCT00270205|26941971|FG002|Overall Study|Lost to Follow-up|0|||
13450833|NCT00270205|26941972|FG003|Overall Study|Lost to Follow-up|1|||
13450834|NCT00269919|26941991|FG000|Overall Study|Other|26|||
13450835|NCT00269919|26941991|FG000|Overall Study|Started but not treated|1|||
13450836|NCT00269633|26942004|FG000|Overall Study|Withdrawal by Subject|1|||
13450837|NCT00269633|26942005|FG001|Overall Study|Withdrawal by Subject|0|||
13450838|NCT00269477|26942032|FG000|Overall Study|Protocol Violation|5|||
13450839|NCT00269477|26942033|FG001|Overall Study|Protocol Violation|5|||
13450840|NCT00269477|26942034|FG002|Overall Study|Protocol Violation|1|||
13450841|NCT00269477|26942035|FG003|Overall Study|Protocol Violation|0|||
13450842|NCT00269477|26942032|FG000|Overall Study|Missed post-vaccination blood draw|0|||
13450843|NCT00269477|26942033|FG001|Overall Study|Missed post-vaccination blood draw|1|||
13450844|NCT00269477|26942034|FG002|Overall Study|Missed post-vaccination blood draw|0|||
13450845|NCT00269477|26942035|FG003|Overall Study|Missed post-vaccination blood draw|0|||
13450846|NCT00269399|26942050|FG000|Overall Study|Lack of Efficacy|27|||
13450847|NCT00269399|26942051|FG001|Overall Study|Lack of Efficacy|10|||
13450848|NCT00269399|26942050|FG000|Overall Study|Adverse Event|10|||
13450849|NCT00269399|26942051|FG001|Overall Study|Adverse Event|4|||
13450850|NCT00269399|26942050|FG000|Overall Study|Withdrawal by Subject|2|||
13450851|NCT00269399|26942051|FG001|Overall Study|Withdrawal by Subject|5|||
13450852|NCT00269399|26942050|FG000|Overall Study|Negative Lab Result for C. difficile|2|||
13450853|NCT00269399|26942051|FG001|Overall Study|Negative Lab Result for C. difficile|3|||
13450854|NCT00269399|26942050|FG000|Overall Study|Other|0|||
13450855|NCT00269399|26942051|FG001|Overall Study|Other|4|||
13450856|NCT00269399|26942050|FG000|Overall Study|Development of exclusion criteria|0|||
13450857|NCT00269399|26942051|FG001|Overall Study|Development of exclusion criteria|1|||
13450858|NCT00269152|26942072|FG000|Overall Study|Adverse Event|9|||
13450859|NCT00269152|26942073|FG001|Overall Study|Adverse Event|3|||
13450860|NCT00269152|26942072|FG000|Overall Study|Withdrawal by Subject|7|||
13450861|NCT00269152|26942073|FG001|Overall Study|Withdrawal by Subject|3|||
13450862|NCT00269152|26942072|FG000|Overall Study|Physician Decision|2|||
13450863|NCT00269152|26942073|FG001|Overall Study|Physician Decision|3|||
13450864|NCT00269152|26942072|FG000|Overall Study|Protocol Violation|0|||
13450865|NCT00269152|26942073|FG001|Overall Study|Protocol Violation|1|||
13450866|NCT00269113|26942098|FG000|Overall Study|Adverse Event|14|||
13450867|NCT00269113|26942099|FG001|Overall Study|Adverse Event|7|||
13450868|NCT00269113|26942098|FG000|Overall Study|Lack of Efficacy|35|||
13450869|NCT00269113|26942099|FG001|Overall Study|Lack of Efficacy|18|||
13450870|NCT00269113|26942098|FG000|Overall Study|Early Improvement|2|||
13450871|NCT00269113|26942099|FG001|Overall Study|Early Improvement|0|||
13450872|NCT00269113|26942098|FG000|Overall Study|Withdrawal by Subject|0|||
13450873|NCT00269113|26942099|FG001|Overall Study|Withdrawal by Subject|2|||
13450874|NCT00269113|26942098|FG000|Overall Study|Death|6|||
13450875|NCT00269113|26942099|FG001|Overall Study|Death|2|||
13450876|NCT00269113|26942098|FG000|Overall Study|Lost to Follow-up|2|||
13450877|NCT00269113|26942099|FG001|Overall Study|Lost to Follow-up|1|||
13450878|NCT00269113|26942098|FG000|Overall Study|Protocol Violation|15|||
13450879|NCT00269113|26942099|FG001|Overall Study|Protocol Violation|5|||
13450880|NCT00269113|26942098|FG000|Overall Study|Other|0|||
13450881|NCT00269113|26942099|FG001|Overall Study|Other|2|||
13450882|NCT00269087|26942129|FG000|Overall Study|Adverse Event|20|||
13450883|NCT00269087|26942129|FG000|Overall Study|Withdrawal by Subject|1|||
13450884|NCT00269087|26942129|FG000|Overall Study|Exacerbation of COPD|13|||
13450885|NCT00268996|26942178|FG000|Overall Study|Adverse Event|11|||
13450886|NCT00268996|26942179|FG001|Overall Study|Adverse Event|7|||
13450887|NCT00268996|26942178|FG000|Overall Study|Lost to Follow-up|3|||
13450888|NCT00268996|26942179|FG001|Overall Study|Lost to Follow-up|1|||
13450889|NCT00268996|26942178|FG000|Overall Study|Withdrawal by Subject|5|||
13450890|NCT00268996|26942179|FG001|Overall Study|Withdrawal by Subject|11|||
13450891|NCT00268996|26942178|FG000|Overall Study|Non-compliance|1|||
13450892|NCT00268996|26942179|FG001|Overall Study|Non-compliance|0|||
13450893|NCT00268996|26942178|FG000|Overall Study|Other|1|||
13450894|NCT00268996|26942179|FG001|Overall Study|Other|1|||
13450895|NCT00268983|26942226|FG000|Overall Study|Death|3|||
13450896|NCT00268983|26942227|FG001|Overall Study|Death|0|||
13450897|NCT00268905|26942251|FG000|Overall Study|Adverse Event|3|||
13450898|NCT00268905|26942252|FG001|Overall Study|Adverse Event|0|||
13450899|NCT00268905|26942253|FG002|Overall Study|Adverse Event|4|||
13450900|NCT00268905|26942251|FG000|Overall Study|Lost to Follow-up|0|||
13450901|NCT00268905|26942252|FG001|Overall Study|Lost to Follow-up|1|||
13450902|NCT00268905|26942253|FG002|Overall Study|Lost to Follow-up|0|||
13450903|NCT00268905|26942251|FG000|Overall Study|Withdrawal by Subject|0|||
13450904|NCT00268905|26942252|FG001|Overall Study|Withdrawal by Subject|0|||
13450905|NCT00268905|26942253|FG002|Overall Study|Withdrawal by Subject|3|||
13450906|NCT00268905|26942251|FG000|Overall Study|Progressive Disease|28|||
13450907|NCT00268905|26942252|FG001|Overall Study|Progressive Disease|4|||
13450908|NCT00268905|26942253|FG002|Overall Study|Progressive Disease|3|||
13450909|NCT00268905|26942251|FG000|Overall Study|Physician Decision|3|||
13450910|NCT00268905|26942252|FG001|Overall Study|Physician Decision|0|||
13450911|NCT00268905|26942253|FG002|Overall Study|Physician Decision|1|||
13450912|NCT00268905|26942251|FG000|Overall Study|Clinical Progression|9|||
13450913|NCT00268905|26942252|FG001|Overall Study|Clinical Progression|4|||
13450914|NCT00268905|26942253|FG002|Overall Study|Clinical Progression|1|||
13450915|NCT00268892|26942274|FG000|Overall Study|Adverse Event|14|||
13450916|NCT00268892|26942275|FG001|Overall Study|Adverse Event|17|||
13450917|NCT00268892|26942276|FG002|Overall Study|Adverse Event|20|||
13450918|NCT00268892|26942274|FG000|Overall Study|Lack of Efficacy|1|||
13450919|NCT00268892|26942275|FG001|Overall Study|Lack of Efficacy|3|||
13450920|NCT00268892|26942276|FG002|Overall Study|Lack of Efficacy|0|||
13450921|NCT00268892|26942274|FG000|Overall Study|Withdrawal by Subject|14|||
13450922|NCT00268892|26942275|FG001|Overall Study|Withdrawal by Subject|15|||
13450923|NCT00268892|26942276|FG002|Overall Study|Withdrawal by Subject|13|||
13450924|NCT00268892|26942274|FG000|Overall Study|Physician Decision|0|||
13450925|NCT00268892|26942275|FG001|Overall Study|Physician Decision|1|||
13450926|NCT00268892|26942276|FG002|Overall Study|Physician Decision|0|||
13450927|NCT00268892|26942274|FG000|Overall Study|Lost to Follow-up|5|||
13450928|NCT00268892|26942275|FG001|Overall Study|Lost to Follow-up|2|||
13450929|NCT00268892|26942276|FG002|Overall Study|Lost to Follow-up|4|||
13450930|NCT00268892|26942274|FG000|Overall Study|Protocol Violation|0|||
13450931|NCT00268892|26942275|FG001|Overall Study|Protocol Violation|1|||
13450932|NCT00268892|26942276|FG002|Overall Study|Protocol Violation|0|||
13450933|NCT00268892|26942274|FG000|Overall Study|Disease Progression|1|||
13450934|NCT00268892|26942275|FG001|Overall Study|Disease Progression|1|||
13450935|NCT00268892|26942276|FG002|Overall Study|Disease Progression|0|||
13450936|NCT00268892|26942274|FG000|Overall Study|Trial Site Closed|4|||
13450937|NCT00268892|26942275|FG001|Overall Study|Trial Site Closed|2|||
13450938|NCT00268892|26942276|FG002|Overall Study|Trial Site Closed|2|||
13450939|NCT00268463|26942289|FG000|Overall Study|study terminated due to low accrual|10|||
13450940|NCT00268463|26942290|FG001|Overall Study|study terminated due to low accrual|12|||
13450941|NCT00268437|26942297|FG000|Overall Study|Ineligible|1|||
13450942|NCT00268346|26942310|FG000|Overall Study|Adverse Event|0|||
13450943|NCT00268346|26942311|FG001|Overall Study|Adverse Event|1|||
13450944|NCT00268346|26942310|FG000|Overall Study|Death|0|||
13450945|NCT00268346|26942311|FG001|Overall Study|Death|1|||
13450946|NCT00268346|26942310|FG000|Overall Study|Withdrawal by Subject|0|||
13450947|NCT00268346|26942311|FG001|Overall Study|Withdrawal by Subject|1|||
13450948|NCT00268242|26942322|FG000|Overall Study|Death|1|||
13450949|NCT00268203|26942335|FG000|Overall Study|Lost to Follow-up|92|||
13450950|NCT00268203|26942335|FG000|Overall Study|Withdrawal by Subject|9|||
13450951|NCT00268203|26942335|FG000|Overall Study|Received Other NHL Therapy|7|||
13450952|NCT00268203|26942335|FG000|Overall Study|Progressive Disease|359|||
13450953|NCT00268203|26942335|FG000|Overall Study|Death|84|||
13450954|NCT00268203|26942335|FG000|Overall Study|Reason Not Specified|34|||
13450955|NCT00268203|26942335|FG000|Overall Study|Completed 2 Years of Follow-up|62|||
13450956|NCT00267969|26942373|FG000|Controlled Period|Adverse Event|6|||
13450957|NCT00267969|26942374|FG001|Controlled Period|Adverse Event|0|||
13450958|NCT00267969|26942375|FG002|Controlled Period|Adverse Event|2|||
13450959|NCT00267969|26942376|FG003|Controlled Period|Adverse Event|0|||
13450960|NCT00267969|26942377|FG004|Controlled Period|Adverse Event|0|||
13450961|NCT00267969|26942378|FG005|Controlled Period|Adverse Event|0|||
13450962|NCT00267969|26942379|FG006|Controlled Period|Adverse Event|0|||
13450963|NCT00267969|26942373|FG000|Controlled Period|Lack of Efficacy|3|||
13450964|NCT00267969|26942374|FG001|Controlled Period|Lack of Efficacy|0|||
13450965|NCT00267969|26942375|FG002|Controlled Period|Lack of Efficacy|1|||
13450966|NCT00267969|26942376|FG003|Controlled Period|Lack of Efficacy|0|||
13450967|NCT00267969|26942377|FG004|Controlled Period|Lack of Efficacy|0|||
13450968|NCT00267969|26942378|FG005|Controlled Period|Lack of Efficacy|0|||
13450969|NCT00267969|26942379|FG006|Controlled Period|Lack of Efficacy|0|||
13450970|NCT00267969|26942373|FG000|Controlled Period|Lost to Follow-up|1|||
13450971|NCT00267969|26942374|FG001|Controlled Period|Lost to Follow-up|0|||
13450972|NCT00267969|26942375|FG002|Controlled Period|Lost to Follow-up|1|||
13450973|NCT00267969|26942376|FG003|Controlled Period|Lost to Follow-up|0|||
13450974|NCT00267969|26942377|FG004|Controlled Period|Lost to Follow-up|0|||
13450975|NCT00267969|26942378|FG005|Controlled Period|Lost to Follow-up|0|||
13450976|NCT00267969|26942379|FG006|Controlled Period|Lost to Follow-up|0|||
13450977|NCT00267969|26942373|FG000|Controlled Period|Randomized but not treated|0|||
13450978|NCT00267969|26942374|FG001|Controlled Period|Randomized but not treated|0|||
13450979|NCT00267969|26942375|FG002|Controlled Period|Randomized but not treated|1|||
13450980|NCT00267969|26942376|FG003|Controlled Period|Randomized but not treated|0|||
13450981|NCT00267969|26942377|FG004|Controlled Period|Randomized but not treated|0|||
13450982|NCT00267969|26942378|FG005|Controlled Period|Randomized but not treated|0|||
13450983|NCT00267969|26942379|FG006|Controlled Period|Randomized but not treated|0|||
13450984|NCT00267969|26942373|FG000|Controlled Period|Other|2|||
13450985|NCT00267969|26942374|FG001|Controlled Period|Other|1|||
13450986|NCT00267969|26942375|FG002|Controlled Period|Other|6|||
13450987|NCT00267969|26942376|FG003|Controlled Period|Other|0|||
13450988|NCT00267969|26942377|FG004|Controlled Period|Other|0|||
13450989|NCT00267969|26942378|FG005|Controlled Period|Other|0|||
13450990|NCT00267969|26942379|FG006|Controlled Period|Other|0|||
13450991|NCT00267969|26942373|FG000|After Controlled Period|Adverse Event|0|||
13450992|NCT00267969|26942374|FG001|After Controlled Period|Adverse Event|0|||
13450993|NCT00267969|26942375|FG002|After Controlled Period|Adverse Event|0|||
13450994|NCT00267969|26942376|FG003|After Controlled Period|Adverse Event|7|||
13450995|NCT00267969|26942377|FG004|After Controlled Period|Adverse Event|8|||
13450996|NCT00267969|26942378|FG005|After Controlled Period|Adverse Event|23|||
13450997|NCT00267969|26942379|FG006|After Controlled Period|Adverse Event|21|||
13450998|NCT00267969|26942373|FG000|After Controlled Period|Death|0|||
13450999|NCT00267969|26942374|FG001|After Controlled Period|Death|0|||
13451000|NCT00267969|26942375|FG002|After Controlled Period|Death|0|||
13451001|NCT00267969|26942376|FG003|After Controlled Period|Death|1|||
13451002|NCT00267969|26942377|FG004|After Controlled Period|Death|2|||
13451003|NCT00267969|26942378|FG005|After Controlled Period|Death|0|||
13451004|NCT00267969|26942379|FG006|After Controlled Period|Death|1|||
13451005|NCT00267969|26942373|FG000|After Controlled Period|Lack of Efficacy|0|||
13451006|NCT00267969|26942374|FG001|After Controlled Period|Lack of Efficacy|0|||
13451007|NCT00267969|26942375|FG002|After Controlled Period|Lack of Efficacy|0|||
13451008|NCT00267969|26942376|FG003|After Controlled Period|Lack of Efficacy|10|||
13451009|NCT00267969|26942377|FG004|After Controlled Period|Lack of Efficacy|6|||
13451010|NCT00267969|26942378|FG005|After Controlled Period|Lack of Efficacy|28|||
13451011|NCT00267969|26942379|FG006|After Controlled Period|Lack of Efficacy|15|||
13451012|NCT00267969|26942373|FG000|After Controlled Period|Lost to Follow-up|0|||
13451013|NCT00267969|26942374|FG001|After Controlled Period|Lost to Follow-up|0|||
13451014|NCT00267969|26942375|FG002|After Controlled Period|Lost to Follow-up|0|||
13451015|NCT00267969|26942376|FG003|After Controlled Period|Lost to Follow-up|5|||
13451016|NCT00267969|26942377|FG004|After Controlled Period|Lost to Follow-up|8|||
13451017|NCT00267969|26942378|FG005|After Controlled Period|Lost to Follow-up|9|||
13451018|NCT00267969|26942379|FG006|After Controlled Period|Lost to Follow-up|10|||
13451019|NCT00267969|26942373|FG000|After Controlled Period|Other|0|||
13451020|NCT00267969|26942374|FG001|After Controlled Period|Other|0|||
13451021|NCT00267969|26942375|FG002|After Controlled Period|Other|0|||
13451022|NCT00267969|26942376|FG003|After Controlled Period|Other|13|||
13451023|NCT00267969|26942377|FG004|After Controlled Period|Other|11|||
13451024|NCT00267969|26942378|FG005|After Controlled Period|Other|22|||
13451025|NCT00267969|26942379|FG006|After Controlled Period|Other|25|||
13451026|NCT00267956|26942406|FG000|Controlled Period|Adverse Event|4|||
13451027|NCT00267956|26942407|FG001|Controlled Period|Adverse Event|1|||
13451028|NCT00267956|26942408|FG002|Controlled Period|Adverse Event|0|||
13451029|NCT00267956|26942409|FG003|Controlled Period|Adverse Event|0|||
13451030|NCT00267956|26942406|FG000|Controlled Period|Lack of Efficacy|4|||
13451031|NCT00267956|26942407|FG001|Controlled Period|Lack of Efficacy|2|||
13451032|NCT00267956|26942408|FG002|Controlled Period|Lack of Efficacy|0|||
13451033|NCT00267956|26942409|FG003|Controlled Period|Lack of Efficacy|0|||
13451034|NCT00267956|26942406|FG000|Controlled Period|Lost to Follow-up|2|||
13451035|NCT00267956|26942407|FG001|Controlled Period|Lost to Follow-up|0|||
13451036|NCT00267956|26942408|FG002|Controlled Period|Lost to Follow-up|0|||
13451037|NCT00267956|26942409|FG003|Controlled Period|Lost to Follow-up|0|||
13451038|NCT00267956|26942406|FG000|Controlled Period|Withdrew consent|3|||
13451039|NCT00267956|26942407|FG001|Controlled Period|Withdrew consent|1|||
13451040|NCT00267956|26942408|FG002|Controlled Period|Withdrew consent|0|||
13451041|NCT00267956|26942409|FG003|Controlled Period|Withdrew consent|0|||
13451042|NCT00267956|26942406|FG000|After Controlled Period|Adverse Event|0|||
13451043|NCT00267956|26942407|FG001|After Controlled Period|Adverse Event|0|||
13451044|NCT00267956|26942408|FG002|After Controlled Period|Adverse Event|2|||
13451045|NCT00267956|26942409|FG003|After Controlled Period|Adverse Event|1|||
13451046|NCT00267956|26942406|FG000|After Controlled Period|Lack of Efficacy|0|||
13451047|NCT00267956|26942407|FG001|After Controlled Period|Lack of Efficacy|0|||
13451048|NCT00267956|26942408|FG002|After Controlled Period|Lack of Efficacy|1|||
13451049|NCT00267956|26942409|FG003|After Controlled Period|Lack of Efficacy|1|||
13451050|NCT00267956|26942406|FG000|After Controlled Period|Lost to Follow-up|0|||
13451051|NCT00267956|26942407|FG001|After Controlled Period|Lost to Follow-up|0|||
13451052|NCT00267956|26942408|FG002|After Controlled Period|Lost to Follow-up|1|||
13451053|NCT00267956|26942409|FG003|After Controlled Period|Lost to Follow-up|0|||
13451054|NCT00267956|26942406|FG000|After Controlled Period|Withdrew consent|0|||
13451055|NCT00267956|26942407|FG001|After Controlled Period|Withdrew consent|0|||
13451056|NCT00267956|26942408|FG002|After Controlled Period|Withdrew consent|1|||
13451057|NCT00267956|26942409|FG003|After Controlled Period|Withdrew consent|0|||
13451058|NCT00267865|26942420|FG000|Induction Treatment|Died before completing.|2|||
13451059|NCT00267865|26942420|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1|||
13451060|NCT00267748|26942447|FG000|Non-randomized Period|Progressive disease|10|||
13451061|NCT00267748|26942448|FG001|Non-randomized Period|Progressive disease|0|||
13451062|NCT00267748|26942449|FG002|Non-randomized Period|Progressive disease|0|||
13451063|NCT00267748|26942447|FG000|Non-randomized Period|Adverse Event|8|||
13451064|NCT00267748|26942448|FG001|Non-randomized Period|Adverse Event|0|||
13451065|NCT00267748|26942449|FG002|Non-randomized Period|Adverse Event|0|||
13451066|NCT00267748|26942447|FG000|Non-randomized Period|Death|1|||
13451067|NCT00267748|26942448|FG001|Non-randomized Period|Death|0|||
13451068|NCT00267748|26942449|FG002|Non-randomized Period|Death|0|||
13451069|NCT00267748|26942447|FG000|Non-randomized Period|Participant not willing to participate|1|||
13451070|NCT00267748|26942448|FG001|Non-randomized Period|Participant not willing to participate|0|||
13451071|NCT00267748|26942449|FG002|Non-randomized Period|Participant not willing to participate|0|||
13451072|NCT00267748|26942447|FG000|Non-randomized Period|Other|3|||
13451073|NCT00267748|26942448|FG001|Non-randomized Period|Other|0|||
13451074|NCT00267748|26942449|FG002|Non-randomized Period|Other|0|||
13451075|NCT00267748|26942447|FG000|Randomized Period|Death|0|||
13451076|NCT00267748|26942448|FG001|Randomized Period|Death|2|||
13451077|NCT00267748|26942449|FG002|Randomized Period|Death|3|||
13451078|NCT00267748|26942447|FG000|Randomized Period|Adverse Event|0|||
13451079|NCT00267748|26942448|FG001|Randomized Period|Adverse Event|23|||
13451080|NCT00267748|26942449|FG002|Randomized Period|Adverse Event|25|||
13451081|NCT00267748|26942447|FG000|Randomized Period|Global deterioration of health status|0|||
13451082|NCT00267748|26942448|FG001|Randomized Period|Global deterioration of health status|6|||
13451083|NCT00267748|26942449|FG002|Randomized Period|Global deterioration of health status|7|||
13451084|NCT00267748|26942447|FG000|Randomized Period|Lost to Follow-up|0|||
13451085|NCT00267748|26942448|FG001|Randomized Period|Lost to Follow-up|1|||
13451086|NCT00267748|26942449|FG002|Randomized Period|Lost to Follow-up|0|||
13451087|NCT00267748|26942447|FG000|Randomized Period|Objective progression or relapse|0|||
13451088|NCT00267748|26942448|FG001|Randomized Period|Objective progression or relapse|77|||
13451089|NCT00267748|26942449|FG002|Randomized Period|Objective progression or relapse|86|||
13451090|NCT00267748|26942447|FG000|Randomized Period|Withdrawal by Subject|0|||
13451091|NCT00267748|26942448|FG001|Randomized Period|Withdrawal by Subject|9|||
13451092|NCT00267748|26942449|FG002|Randomized Period|Withdrawal by Subject|2|||
13451093|NCT00267748|26942447|FG000|Randomized Period|Other|0|||
13451094|NCT00267748|26942448|FG001|Randomized Period|Other|9|||
13451095|NCT00267748|26942449|FG002|Randomized Period|Other|6|||
13451096|NCT00267748|26942447|FG000|Randomized Period|randomized but not treated|0|||
13451097|NCT00267748|26942448|FG001|Randomized Period|randomized but not treated|0|||
13451098|NCT00267748|26942449|FG002|Randomized Period|randomized but not treated|3|||
13451099|NCT00267488|26942460|FG000|Overall Study|Sponsor Terminated Study|9|||
13451100|NCT00267488|26942460|FG000|Overall Study|Protocol Violation|1|||
13451101|NCT00267488|26942460|FG000|Overall Study|Other (Disease Progression)|1|||
13451102|NCT00267202|26942486|FG000|Overall Study|Unsatisfactory therapeutic effect|21|||
13451103|NCT00267202|26942487|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
13451104|NCT00267202|26942486|FG000|Overall Study|Withdrawal by Subject|12|||
13451105|NCT00267202|26942487|FG001|Overall Study|Withdrawal by Subject|15|||
13451106|NCT00267202|26942486|FG000|Overall Study|Adverse Event|13|||
13451107|NCT00267202|26942487|FG001|Overall Study|Adverse Event|7|||
13451108|NCT00267202|26942486|FG000|Overall Study|Protocol Violation|2|||
13451109|NCT00267202|26942487|FG001|Overall Study|Protocol Violation|3|||
13451110|NCT00267202|26942486|FG000|Overall Study|Administrative problems|2|||
13451111|NCT00267202|26942487|FG001|Overall Study|Administrative problems|1|||
13451112|NCT00267202|26942486|FG000|Overall Study|Lost to Follow-up|3|||
13451113|NCT00267202|26942487|FG001|Overall Study|Lost to Follow-up|0|||
13451114|NCT00267189|26942504|FG000|Overall Study|Patient withdrew consent|1|||
13451115|NCT00267189|26942505|FG001|Overall Study|Patient withdrew consent|1|||
13451116|NCT00267189|26942504|FG000|Overall Study|Death|1|||
13451117|NCT00267189|26942505|FG001|Overall Study|Death|0|||
13451118|NCT00267189|26942504|FG000|Overall Study|Missing|3|||
13451119|NCT00267189|26942505|FG001|Overall Study|Missing|0|||
13451120|NCT00267150|26942512|FG000|Overall Study|Adverse Event|1|||
13451121|NCT00267098|26942670|FG000|Overall Study|Death|0|||
13451122|NCT00267098|26942671|FG001|Overall Study|Death|0|||
13451123|NCT00267098|26942672|FG002|Overall Study|Death|57|||
13451124|NCT00267098|26942673|FG003|Overall Study|Death|66|||
13451125|NCT00267098|26942674|FG004|Overall Study|Death|14|||
13451126|NCT00267098|26942675|FG005|Overall Study|Death|23|||
13451127|NCT00267098|26942676|FG006|Overall Study|Death|28|||
13451128|NCT00267098|26942677|FG007|Overall Study|Death|9|||
13451129|NCT00267098|26942670|FG000|Overall Study|Lost to Follow-up|0|||
13451130|NCT00267098|26942671|FG001|Overall Study|Lost to Follow-up|0|||
13451131|NCT00267098|26942672|FG002|Overall Study|Lost to Follow-up|6|||
13451132|NCT00267098|26942673|FG003|Overall Study|Lost to Follow-up|5|||
13451133|NCT00267098|26942674|FG004|Overall Study|Lost to Follow-up|2|||
13451134|NCT00267098|26942675|FG005|Overall Study|Lost to Follow-up|3|||
13451135|NCT00267098|26942676|FG006|Overall Study|Lost to Follow-up|1|||
13451136|NCT00267098|26942677|FG007|Overall Study|Lost to Follow-up|1|||
13451137|NCT00267098|26942670|FG000|Overall Study|Withdrawal by Subject|8|||
13451138|NCT00267098|26942671|FG001|Overall Study|Withdrawal by Subject|0|||
13451139|NCT00267098|26942672|FG002|Overall Study|Withdrawal by Subject|24|||
13451140|NCT00267098|26942673|FG003|Overall Study|Withdrawal by Subject|21|||
13451141|NCT00267098|26942674|FG004|Overall Study|Withdrawal by Subject|12|||
13451142|NCT00267098|26942675|FG005|Overall Study|Withdrawal by Subject|9|||
13451143|NCT00267098|26942676|FG006|Overall Study|Withdrawal by Subject|12|||
13451144|NCT00267098|26942677|FG007|Overall Study|Withdrawal by Subject|5|||
13451145|NCT00267098|26942670|FG000|Overall Study|Physician Decision|5|||
13451146|NCT00267098|26942671|FG001|Overall Study|Physician Decision|0|||
13451147|NCT00267098|26942672|FG002|Overall Study|Physician Decision|7|||
13451148|NCT00267098|26942673|FG003|Overall Study|Physician Decision|11|||
13451149|NCT00267098|26942674|FG004|Overall Study|Physician Decision|5|||
13451150|NCT00267098|26942675|FG005|Overall Study|Physician Decision|4|||
13451151|NCT00267098|26942676|FG006|Overall Study|Physician Decision|3|||
13451152|NCT00267098|26942677|FG007|Overall Study|Physician Decision|0|||
13451153|NCT00267098|26942670|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96|||
13451154|NCT00267098|26942671|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
13451155|NCT00267098|26942672|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
13451156|NCT00267098|26942673|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
13451157|NCT00267098|26942674|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
13451158|NCT00267098|26942675|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
13451159|NCT00267098|26942676|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
13451160|NCT00267098|26942677|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
13451161|NCT00267098|26942670|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
13451162|NCT00267098|26942671|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51|||
13451163|NCT00267098|26942672|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
13451164|NCT00267098|26942673|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
13451165|NCT00267098|26942674|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
13451166|NCT00267098|26942675|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
13451167|NCT00267098|26942676|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
13451168|NCT00267098|26942677|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
13451169|NCT00267098|26942670|FG000|Overall Study|Site closure|0|||
13451170|NCT00267098|26942671|FG001|Overall Study|Site closure|0|||
13451171|NCT00267098|26942672|FG002|Overall Study|Site closure|0|||
13451172|NCT00267098|26942673|FG003|Overall Study|Site closure|1|||
13451173|NCT00267098|26942674|FG004|Overall Study|Site closure|0|||
13451174|NCT00267098|26942675|FG005|Overall Study|Site closure|1|||
13451175|NCT00267098|26942676|FG006|Overall Study|Site closure|1|||
13451176|NCT00267098|26942677|FG007|Overall Study|Site closure|0|||
13451177|NCT00267098|26942670|FG000|Overall Study|Explanted Medtronic device|0|||
13451178|NCT00267098|26942671|FG001|Overall Study|Explanted Medtronic device|0|||
13451179|NCT00267098|26942672|FG002|Overall Study|Explanted Medtronic device|0|||
13451180|NCT00267098|26942673|FG003|Overall Study|Explanted Medtronic device|1|||
13451181|NCT00267098|26942674|FG004|Overall Study|Explanted Medtronic device|0|||
13451182|NCT00267098|26942675|FG005|Overall Study|Explanted Medtronic device|0|||
13451183|NCT00267098|26942676|FG006|Overall Study|Explanted Medtronic device|0|||
13451184|NCT00267098|26942677|FG007|Overall Study|Explanted Medtronic device|0|||
13451185|NCT00267098|26942670|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0|||
13451186|NCT00267098|26942671|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0|||
13451187|NCT00267098|26942672|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0|||
13451188|NCT00267098|26942673|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0|||
13451189|NCT00267098|26942674|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2|||
13451190|NCT00267098|26942675|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0|||
13451191|NCT00267098|26942676|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0|||
13451192|NCT00267098|26942677|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0|||
13451193|NCT00267098|26942670|FG000|Overall Study|Subject listed for heart transplant|0|||
13451194|NCT00267098|26942671|FG001|Overall Study|Subject listed for heart transplant|0|||
13451195|NCT00267098|26942672|FG002|Overall Study|Subject listed for heart transplant|0|||
13451196|NCT00267098|26942673|FG003|Overall Study|Subject listed for heart transplant|0|||
13451197|NCT00267098|26942674|FG004|Overall Study|Subject listed for heart transplant|0|||
13451198|NCT00267098|26942675|FG005|Overall Study|Subject listed for heart transplant|0|||
13451199|NCT00267098|26942676|FG006|Overall Study|Subject listed for heart transplant|1|||
13451200|NCT00267098|26942677|FG007|Overall Study|Subject listed for heart transplant|0|||
13451201|NCT00267098|26942670|FG000|Overall Study|Sponsor withdrew subject|0|||
13451202|NCT00267098|26942671|FG001|Overall Study|Sponsor withdrew subject|0|||
13451203|NCT00267098|26942672|FG002|Overall Study|Sponsor withdrew subject|0|||
13451204|NCT00267098|26942673|FG003|Overall Study|Sponsor withdrew subject|1|||
13451205|NCT00267098|26942674|FG004|Overall Study|Sponsor withdrew subject|0|||
13451206|NCT00267098|26942675|FG005|Overall Study|Sponsor withdrew subject|0|||
13451207|NCT00267098|26942676|FG006|Overall Study|Sponsor withdrew subject|0|||
13451208|NCT00267098|26942677|FG007|Overall Study|Sponsor withdrew subject|0|||
13451209|NCT00267046|26942692|FG000|Overall Study|Disease progression|4|||
13451210|NCT00267046|26942693|FG001|Overall Study|Disease progression|2|||
13451211|NCT00267046|26942692|FG000|Overall Study|Chemotoxicity|2|||
13451212|NCT00267046|26942693|FG001|Overall Study|Chemotoxicity|0|||
13451213|NCT00267046|26942692|FG000|Overall Study|Open-label palifermin|2|||
13451214|NCT00267046|26942693|FG001|Overall Study|Open-label palifermin|7|||
13451215|NCT00267046|26942692|FG000|Overall Study|Surgery|3|||
13451216|NCT00267046|26942693|FG001|Overall Study|Surgery|1|||
13451217|NCT00267046|26942692|FG000|Overall Study|Withdrawal by Subject|1|||
13451218|NCT00267046|26942693|FG001|Overall Study|Withdrawal by Subject|0|||
13451219|NCT00267046|26942692|FG000|Overall Study|Radiation|0|||
13451220|NCT00267046|26942693|FG001|Overall Study|Radiation|1|||
13451221|NCT00267020|26942720|FG000|Overall Study|Adverse Event|22|||
13451222|NCT00267020|26942721|FG001|Overall Study|Adverse Event|5|||
13451223|NCT00267020|26942720|FG000|Overall Study|Death|2|||
13451224|NCT00267020|26942721|FG001|Overall Study|Death|1|||
13451225|NCT00267020|26942720|FG000|Overall Study|Withdrawal by Subject|17|||
13451226|NCT00267020|26942721|FG001|Overall Study|Withdrawal by Subject|7|||
13451227|NCT00267020|26942720|FG000|Overall Study|Physician Decision|3|||
13451228|NCT00267020|26942721|FG001|Overall Study|Physician Decision|2|||
13451229|NCT00267020|26942720|FG000|Overall Study|Disease Progression|39|||
13451230|NCT00267020|26942721|FG001|Overall Study|Disease Progression|25|||
13451231|NCT00267020|26942720|FG000|Overall Study|Unrelated Complication|1|||
13451232|NCT00267020|26942721|FG001|Overall Study|Unrelated Complication|1|||
13451233|NCT00267020|26942720|FG000|Overall Study|Sponsor Request|1|||
13451234|NCT00267020|26942721|FG001|Overall Study|Sponsor Request|0|||
13451235|NCT00267020|26942720|FG000|Overall Study|Other|1|||
13451236|NCT00267020|26942721|FG001|Overall Study|Other|2|||
13451237|NCT00267007|26942736|FG000|Overall Study|Withdrawal by Subject|6|||
13451238|NCT00267007|26942737|FG001|Overall Study|Withdrawal by Subject|0|||
13451239|NCT00267007|26942736|FG000|Overall Study|Lost to Follow-up|1|||
13451240|NCT00267007|26942737|FG001|Overall Study|Lost to Follow-up|0|||
13451241|NCT00267007|26942736|FG000|Overall Study|Non-compliance|0|||
13451242|NCT00267007|26942737|FG001|Overall Study|Non-compliance|1|||
13451243|NCT00267007|26942736|FG000|Overall Study|Adverse Event|1|||
13451244|NCT00267007|26942737|FG001|Overall Study|Adverse Event|0|||
13451245|NCT00266877|26942764|FG000|Overall Study|Death|1|||
13451246|NCT00266877|26942765|FG001|Overall Study|Death|1|||
13451247|NCT00266877|26942766|FG002|Overall Study|Death|1|||
13451248|NCT00266877|26942764|FG000|Overall Study|Adverse Event|6|||
13451249|NCT00266877|26942765|FG001|Overall Study|Adverse Event|4|||
13451250|NCT00266877|26942766|FG002|Overall Study|Adverse Event|1|||
13451251|NCT00266877|26942764|FG000|Overall Study|Physician Decision|2|||
13451252|NCT00266877|26942765|FG001|Overall Study|Physician Decision|1|||
13451253|NCT00266877|26942766|FG002|Overall Study|Physician Decision|1|||
13451254|NCT00266877|26942764|FG000|Overall Study|Withdrawal by Subject|3|||
13451255|NCT00266877|26942765|FG001|Overall Study|Withdrawal by Subject|1|||
13451256|NCT00266877|26942766|FG002|Overall Study|Withdrawal by Subject|1|||
13451257|NCT00266877|26942764|FG000|Overall Study|Disease Progression|72|||
13451258|NCT00266877|26942765|FG001|Overall Study|Disease Progression|37|||
13451259|NCT00266877|26942766|FG002|Overall Study|Disease Progression|23|||
13451260|NCT00266877|26942764|FG000|Overall Study|Symptomatic Deterioration|6|||
13451261|NCT00266877|26942765|FG001|Overall Study|Symptomatic Deterioration|3|||
13451262|NCT00266877|26942766|FG002|Overall Study|Symptomatic Deterioration|1|||
13451263|NCT00266877|26942764|FG000|Overall Study|Hospitalization|1|||
13451264|NCT00266877|26942765|FG001|Overall Study|Hospitalization|0|||
13451265|NCT00266877|26942766|FG002|Overall Study|Hospitalization|0|||
13451266|NCT00266877|26942764|FG000|Overall Study|Concomitant Radiotherapy|0|||
13451267|NCT00266877|26942765|FG001|Overall Study|Concomitant Radiotherapy|1|||
13451268|NCT00266877|26942766|FG002|Overall Study|Concomitant Radiotherapy|0|||
13451269|NCT00266864|26942780|FG000|Overall Study|Lost to Follow-up|4|||
13451270|NCT00266864|26942781|FG001|Overall Study|Lost to Follow-up|1|||
13451271|NCT00266864|26942780|FG000|Overall Study|Withdrawal by Subject|1|||
13451272|NCT00266864|26942781|FG001|Overall Study|Withdrawal by Subject|1|||
13451273|NCT00266825|26942812|FG000|Completed Follow-Up|Lost to Follow-up|14|||
13451274|NCT00266825|26942813|FG001|Completed Follow-Up|Lost to Follow-up|19|||
13451275|NCT00266825|26942812|FG000|Completed Follow-Up|Withdrawal by Subject|11|||
13451276|NCT00266825|26942813|FG001|Completed Follow-Up|Withdrawal by Subject|5|||
13451277|NCT00266812|26942826|FG000|Overall Study|Disease Progression|9|||
13451278|NCT00266812|26942827|FG001|Overall Study|Disease Progression|3|||
13451279|NCT00266812|26942826|FG000|Overall Study|Death|5|||
13451280|NCT00266812|26942827|FG001|Overall Study|Death|4|||
13451281|NCT00266812|26942826|FG000|Overall Study|Adverse Event|3|||
13451282|NCT00266812|26942827|FG001|Overall Study|Adverse Event|1|||
13451283|NCT00266812|26942826|FG000|Overall Study|Protocol Violation|0|||
13451284|NCT00266812|26942827|FG001|Overall Study|Protocol Violation|1|||
13451285|NCT00266812|26942826|FG000|Overall Study|Withdrawal by Subject|0|||
13451286|NCT00266812|26942827|FG001|Overall Study|Withdrawal by Subject|2|||
13451287|NCT00266812|26942826|FG000|Overall Study|Discontinued before starting study drug|4|||
13451288|NCT00266812|26942827|FG001|Overall Study|Discontinued before starting study drug|0|||
13451289|NCT00266708|26942874|FG000|Overall Study|No renal function|1|||
13451290|NCT00266708|26942875|FG001|Overall Study|No renal function|1|||
13451291|NCT00266708|26942874|FG000|Overall Study|Refused biopsy|3|||
13451292|NCT00266708|26942875|FG001|Overall Study|Refused biopsy|6|||
13451293|NCT00266708|26942874|FG000|Overall Study|Asthma|0|||
13451294|NCT00266708|26942875|FG001|Overall Study|Asthma|2|||
13451295|NCT00266695|26942887|FG000|Overall Study|Adverse Event|1|||
13451296|NCT00266695|26942887|FG000|Overall Study|Death|9|||
13451297|NCT00266695|26942887|FG000|Overall Study|Physician Decision|1|||
13451298|NCT00266695|26942887|FG000|Overall Study|Lost to Follow-up|3|||
13451299|NCT00266695|26942887|FG000|Overall Study|Withdrawal by Subject|15|||
13451300|NCT00266656|26942916|FG000|Overall Study|Death|1|||
13451301|NCT00266656|26942917|FG001|Overall Study|Death|0|||
13451302|NCT00266656|26942916|FG000|Overall Study|Lost to Follow-up|4|||
13451303|NCT00266656|26942917|FG001|Overall Study|Lost to Follow-up|1|||
13451304|NCT00266656|26942916|FG000|Overall Study|Withdrawal by Subject|4|||
13451305|NCT00266656|26942917|FG001|Overall Study|Withdrawal by Subject|2|||
13451306|NCT00266656|26942916|FG000|Overall Study|Did Not Reach Final Height|4|||
13451307|NCT00266656|26942917|FG001|Overall Study|Did Not Reach Final Height|8|||
13451308|NCT00266656|26942916|FG000|Overall Study|Parent/Caregiver Decision|1|||
13451309|NCT00266656|26942917|FG001|Overall Study|Parent/Caregiver Decision|2|||
13451310|NCT00266630|26942962|FG000|Overall Study|Adverse Event|8|||
13451311|NCT00266630|26942963|FG001|Overall Study|Adverse Event|6|||
13451312|NCT00266630|26942962|FG000|Overall Study|Lack of Efficacy|1|||
13451313|NCT00266630|26942963|FG001|Overall Study|Lack of Efficacy|4|||
13451314|NCT00266630|26942962|FG000|Overall Study|Entry Criteria not met|1|||
13451315|NCT00266630|26942963|FG001|Overall Study|Entry Criteria not met|0|||
13451316|NCT00266630|26942962|FG000|Overall Study|Protocol Violation|1|||
13451317|NCT00266630|26942963|FG001|Overall Study|Protocol Violation|3|||
13451318|NCT00266630|26942962|FG000|Overall Study|Physician Decision|1|||
13451319|NCT00266630|26942963|FG001|Overall Study|Physician Decision|2|||
13451320|NCT00266630|26942962|FG000|Overall Study|Withdrawal by Subject|10|||
13451321|NCT00266630|26942963|FG001|Overall Study|Withdrawal by Subject|2|||
13451322|NCT00266630|26942962|FG000|Overall Study|Lost to Follow-up|1|||
13451323|NCT00266630|26942963|FG001|Overall Study|Lost to Follow-up|0|||
13451324|NCT00266630|26942962|FG000|Overall Study|Other|19|||
13451325|NCT00266630|26942963|FG001|Overall Study|Other|11|||
13451326|NCT00266409|26943258|FG000|Overall Study|Lack of Efficacy|2|||
13451327|NCT00266409|26943259|FG001|Overall Study|Lack of Efficacy|6|||
13451328|NCT00266409|26943260|FG002|Overall Study|Lack of Efficacy|1|||
13451329|NCT00266409|26943261|FG003|Overall Study|Lack of Efficacy|2|||
13451330|NCT00266409|26943258|FG000|Overall Study|Adverse Event|7|||
13451331|NCT00266409|26943259|FG001|Overall Study|Adverse Event|2|||
13451332|NCT00266409|26943260|FG002|Overall Study|Adverse Event|1|||
13451333|NCT00266409|26943261|FG003|Overall Study|Adverse Event|1|||
13451334|NCT00266409|26943258|FG000|Overall Study|Lost to Follow-up|18|||
13451335|NCT00266409|26943259|FG001|Overall Study|Lost to Follow-up|21|||
13451336|NCT00266409|26943260|FG002|Overall Study|Lost to Follow-up|6|||
13451337|NCT00266409|26943261|FG003|Overall Study|Lost to Follow-up|8|||
13451338|NCT00266409|26943258|FG000|Overall Study|Withdrawal by Subject|6|||
13451339|NCT00266409|26943259|FG001|Overall Study|Withdrawal by Subject|10|||
13451340|NCT00266409|26943260|FG002|Overall Study|Withdrawal by Subject|3|||
13451341|NCT00266409|26943261|FG003|Overall Study|Withdrawal by Subject|9|||
13451342|NCT00266409|26943258|FG000|Overall Study|Protocol Violation|5|||
13451343|NCT00266409|26943259|FG001|Overall Study|Protocol Violation|3|||
13451344|NCT00266409|26943260|FG002|Overall Study|Protocol Violation|4|||
13451345|NCT00266409|26943261|FG003|Overall Study|Protocol Violation|2|||
13451346|NCT00266409|26943258|FG000|Overall Study|Other|7|||
13451347|NCT00266409|26943259|FG001|Overall Study|Other|4|||
13451348|NCT00266409|26943260|FG002|Overall Study|Other|2|||
13451349|NCT00266409|26943261|FG003|Overall Study|Other|0|||
13451350|NCT00266227|26943314|FG000|Initial Treatment|Adverse Event|0|||
13451351|NCT00266227|26943315|FG001|Initial Treatment|Adverse Event|0|||
13451352|NCT00266227|26943316|FG002|Initial Treatment|Adverse Event|13|||
13451353|NCT00266227|26943314|FG000|Initial Treatment|Lost to Follow-up|0|||
13451354|NCT00266227|26943315|FG001|Initial Treatment|Lost to Follow-up|0|||
13451355|NCT00266227|26943316|FG002|Initial Treatment|Lost to Follow-up|6|||
13451356|NCT00266227|26943314|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0|||
13451357|NCT00266227|26943315|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0|||
13451358|NCT00266227|26943316|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45|||
13451359|NCT00266227|26943314|FG000|Initial Treatment|Physician decision to withdraw|0|||
13451360|NCT00266227|26943315|FG001|Initial Treatment|Physician decision to withdraw|0|||
13451361|NCT00266227|26943316|FG002|Initial Treatment|Physician decision to withdraw|12|||
13451362|NCT00266227|26943314|FG000|Initial Treatment|Pregnancy|0|||
13451363|NCT00266227|26943315|FG001|Initial Treatment|Pregnancy|0|||
13451364|NCT00266227|26943316|FG002|Initial Treatment|Pregnancy|1|||
13451365|NCT00266227|26943314|FG000|Retreatment: Up to Week 48|Death|1|||
13451366|NCT00266227|26943315|FG001|Retreatment: Up to Week 48|Death|0|||
13451367|NCT00266227|26943316|FG002|Retreatment: Up to Week 48|Death|0|||
13451368|NCT00266227|26943314|FG000|Retreatment: Up to Week 48|Adverse Event|7|||
13451369|NCT00266227|26943315|FG001|Retreatment: Up to Week 48|Adverse Event|7|||
13451370|NCT00266227|26943316|FG002|Retreatment: Up to Week 48|Adverse Event|0|||
13451371|NCT00266227|26943314|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3|||
13451372|NCT00266227|26943315|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0|||
13451373|NCT00266227|26943316|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0|||
13451374|NCT00266227|26943314|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11|||
13451375|NCT00266227|26943315|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14|||
13451376|NCT00266227|26943316|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0|||
13451377|NCT00266227|26943314|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4|||
13451378|NCT00266227|26943315|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2|||
13451379|NCT00266227|26943316|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0|||
13451380|NCT00266227|26943314|FG000|Retreatment: Up to Week 48|Pregnancy|1|||
13451381|NCT00266227|26943315|FG001|Retreatment: Up to Week 48|Pregnancy|0|||
13451382|NCT00266227|26943316|FG002|Retreatment: Up to Week 48|Pregnancy|0|||
13451383|NCT00266227|26943314|FG000|Retreatment: Week 48 to Week 72|Death|1|||
13451384|NCT00266227|26943315|FG001|Retreatment: Week 48 to Week 72|Death|1|||
13451385|NCT00266227|26943316|FG002|Retreatment: Week 48 to Week 72|Death|0|||
13451386|NCT00266227|26943314|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6|||
13451387|NCT00266227|26943315|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2|||
13451388|NCT00266227|26943316|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0|||
13451389|NCT00266227|26943314|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1|||
13451390|NCT00266227|26943315|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
13451391|NCT00266227|26943316|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
13451392|NCT00266227|26943314|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41|||
13451393|NCT00266227|26943315|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29|||
13451394|NCT00266227|26943316|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0|||
13451395|NCT00266227|26943314|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15|||
13451396|NCT00266227|26943315|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10|||
13451397|NCT00266227|26943316|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0|||
13451398|NCT00266032|26943354|FG000|Treatment|Adverse Event|42|||
13451399|NCT00266032|26943355|FG001|Treatment|Adverse Event|26|||
13451400|NCT00266032|26943356|FG002|Treatment|Adverse Event|10|||
13451401|NCT00266032|26943354|FG000|Treatment|Lost to Follow-up|19|||
13451402|NCT00266032|26943355|FG001|Treatment|Lost to Follow-up|4|||
13451403|NCT00266032|26943356|FG002|Treatment|Lost to Follow-up|2|||
13451404|NCT00266032|26943354|FG000|Treatment|Pregnancy|3|||
13451405|NCT00266032|26943355|FG001|Treatment|Pregnancy|2|||
13451406|NCT00266032|26943356|FG002|Treatment|Pregnancy|2|||
13451407|NCT00266032|26943354|FG000|Treatment|Protocol Violation|6|||
13451408|NCT00266032|26943355|FG001|Treatment|Protocol Violation|14|||
13451409|NCT00266032|26943356|FG002|Treatment|Protocol Violation|13|||
13451410|NCT00266032|26943354|FG000|Treatment|Withdrawal by Subject|28|||
13451411|NCT00266032|26943355|FG001|Treatment|Withdrawal by Subject|13|||
13451412|NCT00266032|26943356|FG002|Treatment|Withdrawal by Subject|12|||
13451413|NCT00266032|26943354|FG000|Treatment|patient moved/wish for pregnancy/no need|13|||
13451414|NCT00266032|26943355|FG001|Treatment|patient moved/wish for pregnancy/no need|5|||
13451415|NCT00266032|26943356|FG002|Treatment|patient moved/wish for pregnancy/no need|8|||
13451416|NCT00266032|26943354|FG000|Open-label Safety Extension|Adverse Event|5|||
13451417|NCT00266032|26943355|FG001|Open-label Safety Extension|Adverse Event|0|||
13451418|NCT00266032|26943356|FG002|Open-label Safety Extension|Adverse Event|4|||
13451419|NCT00266032|26943354|FG000|Open-label Safety Extension|Lost to Follow-up|2|||
13451420|NCT00266032|26943355|FG001|Open-label Safety Extension|Lost to Follow-up|5|||
13451421|NCT00266032|26943356|FG002|Open-label Safety Extension|Lost to Follow-up|4|||
13451422|NCT00266032|26943354|FG000|Open-label Safety Extension|Pregnancy|4|||
13451423|NCT00266032|26943355|FG001|Open-label Safety Extension|Pregnancy|1|||
13451424|NCT00266032|26943356|FG002|Open-label Safety Extension|Pregnancy|2|||
13451425|NCT00266032|26943354|FG000|Open-label Safety Extension|Protocol Violation|1|||
13451426|NCT00266032|26943355|FG001|Open-label Safety Extension|Protocol Violation|3|||
13451427|NCT00266032|26943356|FG002|Open-label Safety Extension|Protocol Violation|2|||
13451428|NCT00266032|26943354|FG000|Open-label Safety Extension|Withdrawal by Subject|19|||
13451429|NCT00266032|26943355|FG001|Open-label Safety Extension|Withdrawal by Subject|3|||
13451430|NCT00266032|26943356|FG002|Open-label Safety Extension|Withdrawal by Subject|12|||
13451431|NCT00266032|26943354|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10|||
13451432|NCT00266032|26943355|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2|||
13451433|NCT00266032|26943356|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1|||
13451434|NCT00265889|26943364|FG000|Overall Study|Physician Decision|1|||
13451435|NCT00265889|26943364|FG000|Overall Study|Protocol Violation|1|||
13451436|NCT00265889|26943364|FG000|Overall Study|Insurance denied the request|3|||
13451437|NCT00265785|26943373|FG000|Overall Study|Adverse Event|4|||
13451438|NCT00265785|26943373|FG000|Overall Study|Withdrawal by Subject|3|||
13451439|NCT00265785|26943373|FG000|Overall Study|Progression/Relapse|15|||
13451440|NCT00265785|26943373|FG000|Overall Study|Not protocol specified|2|||
13451441|NCT00265785|26943373|FG000|Overall Study|Ineligible|1|||
13451442|NCT00265785|26943373|FG000|Overall Study|Did not receive protocol treatment|2|||
13451443|NCT00265759|26943419|FG000|Overall Study|Withdrawal by Subject|0|||
13451444|NCT00265759|26943420|FG001|Overall Study|Withdrawal by Subject|1|||
13451445|NCT00265759|26943421|FG002|Overall Study|Withdrawal by Subject|2|||
13451446|NCT00265759|26943422|FG003|Overall Study|Withdrawal by Subject|2|||
13451447|NCT00265759|26943419|FG000|Overall Study|Cancel|0|||
13451448|NCT00265759|26943420|FG001|Overall Study|Cancel|0|||
13451449|NCT00265759|26943421|FG002|Overall Study|Cancel|0|||
13451450|NCT00265759|26943422|FG003|Overall Study|Cancel|3|||
13451451|NCT00265759|26943419|FG000|Overall Study|Ineligible|0|||
13451452|NCT00265759|26943420|FG001|Overall Study|Ineligible|0|||
13451453|NCT00265759|26943421|FG002|Overall Study|Ineligible|0|||
13451454|NCT00265759|26943422|FG003|Overall Study|Ineligible|1|||
13451455|NCT00265759|26943419|FG000|Overall Study|Bilateral disease|0|||
13451456|NCT00265759|26943420|FG001|Overall Study|Bilateral disease|0|||
13451457|NCT00265759|26943421|FG002|Overall Study|Bilateral disease|0|||
13451458|NCT00265759|26943422|FG003|Overall Study|Bilateral disease|2|||
13451459|NCT00265759|26943419|FG000|Overall Study|Discontinued due to intolerability|0|||
13451460|NCT00265759|26943420|FG001|Overall Study|Discontinued due to intolerability|0|||
13451461|NCT00265759|26943421|FG002|Overall Study|Discontinued due to intolerability|0|||
13451462|NCT00265759|26943422|FG003|Overall Study|Discontinued due to intolerability|1|||
13451463|NCT00265564|26943439|FG000|Overall Study|Lost to Follow-up|5|||
13451464|NCT00265564|26943440|FG001|Overall Study|Lost to Follow-up|7|||
13451465|NCT00265564|26943439|FG000|Overall Study|met exclusion criteria|5|||
13451466|NCT00265564|26943440|FG001|Overall Study|met exclusion criteria|2|||
13451467|NCT00265395|26943452|FG000|Overall Study|Adverse Event|3|||
13451468|NCT00265395|26943453|FG001|Overall Study|Adverse Event|6|||
13451469|NCT00265395|26943452|FG000|Overall Study|Lost to Follow-up|2|||
13451470|NCT00265395|26943453|FG001|Overall Study|Lost to Follow-up|1|||
13451471|NCT00265395|26943452|FG000|Overall Study|Withdrawal by Subject|1|||
13451472|NCT00265395|26943453|FG001|Overall Study|Withdrawal by Subject|6|||
13451473|NCT00265395|26943452|FG000|Overall Study|Protocol Violation|2|||
13451474|NCT00265395|26943453|FG001|Overall Study|Protocol Violation|2|||
13451475|NCT00265395|26943452|FG000|Overall Study|Lack of Efficacy|0|||
13451476|NCT00265395|26943453|FG001|Overall Study|Lack of Efficacy|1|||
13451477|NCT00265395|26943452|FG000|Overall Study|Administrative|0|||
13451478|NCT00265395|26943453|FG001|Overall Study|Administrative|1|||
13451479|NCT00265382|26943473|FG000|Overall Study|Adverse Event|21|||
13451480|NCT00265382|26943473|FG000|Overall Study|Laboratory Abnormality|1|||
13451481|NCT00265382|26943473|FG000|Overall Study|Lost to Follow-up|3|||
13451482|NCT00265382|26943473|FG000|Overall Study|Lack of Efficacy|6|||
13451483|NCT00265382|26943473|FG000|Overall Study|Miscellaneous|6|||
13451484|NCT00265382|26943473|FG000|Overall Study|Withdrawal by Subject|13|||
13451485|NCT00265382|26943473|FG000|Overall Study|Study terminated by sponsor|94|||
13451486|NCT00265382|26943473|FG000|Overall Study|Death|1|||
13451487|NCT00265343|26943488|FG000|Overall Study|Adverse Event|10|||
13451488|NCT00265343|26943489|FG001|Overall Study|Adverse Event|7|||
13451489|NCT00265343|26943488|FG000|Overall Study|Withdrawal by Subject|3|||
13451490|NCT00265343|26943489|FG001|Overall Study|Withdrawal by Subject|9|||
13451491|NCT00265343|26943488|FG000|Overall Study|Other|8|||
13451492|NCT00265343|26943489|FG001|Overall Study|Other|3|||
13451493|NCT00265330|26943513|FG000|Overall Study|Adverse Event|41|||
13451494|NCT00265330|26943513|FG000|Overall Study|Lost to Follow-up|8|||
13451495|NCT00265330|26943513|FG000|Overall Study|Withdrawal by Subject|34|||
13451496|NCT00265330|26943513|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1|||
13451497|NCT00265330|26943513|FG000|Overall Study|Lack of Efficacy|4|||
13451498|NCT00265330|26943513|FG000|Overall Study|Family Scheduling Conflicts|1|||
13451499|NCT00265330|26943513|FG000|Overall Study|Began Taking Formulary Geodon|1|||
13451500|NCT00265330|26943513|FG000|Overall Study|Discharged from Unit for Long Term Care|1|||
13451501|NCT00265330|26943513|FG000|Overall Study|Site Closed by Sponsor|1|||
13451502|NCT00265330|26943513|FG000|Overall Study|Principal Investigators Request|1|||
13451503|NCT00265330|26943513|FG000|Overall Study|Withdrew Consent|1|||
13451504|NCT00265330|26943513|FG000|Overall Study|Protocol Violation|1|||
13451505|NCT00265317|26943639|FG000|Lead-In|Objective progression or relapse|6|||
13451506|NCT00265317|26943640|FG001|Lead-In|Objective progression or relapse|11|||
13451507|NCT00265317|26943641|FG002|Lead-In|Objective progression or relapse|0|||
13451508|NCT00265317|26943642|FG003|Lead-In|Objective progression or relapse|0|||
13451509|NCT00265317|26943639|FG000|Lead-In|Adverse Event|2|||
13451510|NCT00265317|26943640|FG001|Lead-In|Adverse Event|1|||
13451511|NCT00265317|26943641|FG002|Lead-In|Adverse Event|0|||
13451512|NCT00265317|26943642|FG003|Lead-In|Adverse Event|0|||
13451513|NCT00265317|26943639|FG000|Lead-In|Death|3|||
13451514|NCT00265317|26943640|FG001|Lead-In|Death|5|||
13451515|NCT00265317|26943641|FG002|Lead-In|Death|0|||
13451516|NCT00265317|26943642|FG003|Lead-In|Death|0|||
13451517|NCT00265317|26943639|FG000|Lead-In|Withdrawal/other than adverse event|1|||
13451518|NCT00265317|26943640|FG001|Lead-In|Withdrawal/other than adverse event|0|||
13451519|NCT00265317|26943641|FG002|Lead-In|Withdrawal/other than adverse event|0|||
13451520|NCT00265317|26943642|FG003|Lead-In|Withdrawal/other than adverse event|0|||
13451521|NCT00265317|26943639|FG000|Phase 2|Objective progression or relapse|0|||
13451522|NCT00265317|26943640|FG001|Phase 2|Objective progression or relapse|0|||
13451523|NCT00265317|26943641|FG002|Phase 2|Objective progression or relapse|37|||
13451524|NCT00265317|26943642|FG003|Phase 2|Objective progression or relapse|38|||
13451525|NCT00265317|26943639|FG000|Phase 2|Global deterioration of health status|0|||
13451526|NCT00265317|26943640|FG001|Phase 2|Global deterioration of health status|0|||
13451527|NCT00265317|26943641|FG002|Phase 2|Global deterioration of health status|3|||
13451528|NCT00265317|26943642|FG003|Phase 2|Global deterioration of health status|0|||
13451529|NCT00265317|26943639|FG000|Phase 2|Adverse Event|0|||
13451530|NCT00265317|26943640|FG001|Phase 2|Adverse Event|0|||
13451531|NCT00265317|26943641|FG002|Phase 2|Adverse Event|7|||
13451532|NCT00265317|26943642|FG003|Phase 2|Adverse Event|5|||
13451533|NCT00265317|26943639|FG000|Phase 2|Death|0|||
13451534|NCT00265317|26943640|FG001|Phase 2|Death|0|||
13451535|NCT00265317|26943641|FG002|Phase 2|Death|12|||
13451536|NCT00265317|26943642|FG003|Phase 2|Death|15|||
13451537|NCT00265317|26943639|FG000|Phase 2|Protocol Violation|0|||
13451538|NCT00265317|26943640|FG001|Phase 2|Protocol Violation|0|||
13451539|NCT00265317|26943641|FG002|Phase 2|Protocol Violation|1|||
13451540|NCT00265317|26943642|FG003|Phase 2|Protocol Violation|4|||
13451541|NCT00265317|26943639|FG000|Phase 2|Lost to Follow-up|0|||
13451542|NCT00265317|26943640|FG001|Phase 2|Lost to Follow-up|0|||
13451543|NCT00265317|26943641|FG002|Phase 2|Lost to Follow-up|0|||
13451544|NCT00265317|26943642|FG003|Phase 2|Lost to Follow-up|1|||
13451545|NCT00265317|26943639|FG000|Phase 2|Withdrawal/other than adverse event|0|||
13451546|NCT00265317|26943640|FG001|Phase 2|Withdrawal/other than adverse event|0|||
13451547|NCT00265317|26943641|FG002|Phase 2|Withdrawal/other than adverse event|2|||
13451548|NCT00265317|26943642|FG003|Phase 2|Withdrawal/other than adverse event|1|||
13451549|NCT00265317|26943639|FG000|Phase 2|Study terminated by sponsor|0|||
13451550|NCT00265317|26943640|FG001|Phase 2|Study terminated by sponsor|0|||
13451551|NCT00265317|26943641|FG002|Phase 2|Study terminated by sponsor|1|||
13451552|NCT00265317|26943642|FG003|Phase 2|Study terminated by sponsor|0|||
13451553|NCT00265317|26943639|FG000|Phase 2|Other|0|||
13451554|NCT00265317|26943640|FG001|Phase 2|Other|0|||
13451555|NCT00265317|26943641|FG002|Phase 2|Other|1|||
13451556|NCT00265317|26943642|FG003|Phase 2|Other|1|||
13451557|NCT00265239|26943661|FG000|Overall Study|Adverse Event|2|||
13451558|NCT00265239|26943662|FG001|Overall Study|Adverse Event|1|||
13451559|NCT00265148|26943727|FG000|Overall Study|Adverse Event|2|||
13451560|NCT00265148|26943728|FG001|Overall Study|Adverse Event|2|||
13451561|NCT00265148|26943727|FG000|Overall Study|Lack of Efficacy|0|||
13451562|NCT00265148|26943728|FG001|Overall Study|Lack of Efficacy|2|||
13451563|NCT00265148|26943727|FG000|Overall Study|Protocol Violation|3|||
13451564|NCT00265148|26943728|FG001|Overall Study|Protocol Violation|2|||
13451565|NCT00265148|26943727|FG000|Overall Study|Lost to Follow-up|0|||
13451566|NCT00265148|26943728|FG001|Overall Study|Lost to Follow-up|1|||
13451567|NCT00265148|26943727|FG000|Overall Study|Withdrawal by Subject|2|||
13451568|NCT00265148|26943728|FG001|Overall Study|Withdrawal by Subject|1|||
13451569|NCT00265148|26943727|FG000|Overall Study|Physician Decision|1|||
13451570|NCT00265148|26943728|FG001|Overall Study|Physician Decision|0|||
13451571|NCT00265148|26943727|FG000|Overall Study|Increasing frailty|0|||
13451572|NCT00265148|26943728|FG001|Overall Study|Increasing frailty|1|||
13451573|NCT00265148|26943727|FG000|Overall Study|Subject chose to change of the dose|1|||
13451574|NCT00265148|26943728|FG001|Overall Study|Subject chose to change of the dose|0|||
13451575|NCT00265122|26943769|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
13451576|NCT00265122|26943770|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
13451577|NCT00265122|26943771|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3|||
13451578|NCT00265122|26943772|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
13451579|NCT00265122|26943773|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
13451580|NCT00265122|26943774|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
13451581|NCT00265122|26943769|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
13451582|NCT00265122|26943770|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
13451583|NCT00265122|26943771|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
13451584|NCT00265122|26943772|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
13451585|NCT00265122|26943773|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
13451586|NCT00265122|26943774|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
13451587|NCT00265122|26943769|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
13451588|NCT00265122|26943770|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
13451589|NCT00265122|26943771|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2|||
13451590|NCT00265122|26943772|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
13451591|NCT00265122|26943773|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
13451592|NCT00265122|26943774|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
13451593|NCT00265122|26943769|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2|||
13451594|NCT00265122|26943770|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
13451595|NCT00265122|26943771|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
13451596|NCT00265122|26943772|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
13451597|NCT00265122|26943773|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
13451598|NCT00265122|26943774|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0|||
13451599|NCT00265122|26943769|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
13451600|NCT00265122|26943770|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
13451601|NCT00265122|26943771|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
13451602|NCT00265122|26943772|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
13451603|NCT00265122|26943773|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
13451604|NCT00265122|26943774|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
13451605|NCT00265122|26943769|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4|||
13451606|NCT00265122|26943770|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
13451607|NCT00265122|26943771|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
13451608|NCT00265122|26943772|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
13451609|NCT00265122|26943773|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
13451610|NCT00265122|26943774|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
13451611|NCT00265109|26943792|FG000|Overall Study|Withdrawal by Subject|5|||
13451612|NCT00265109|26943792|FG000|Overall Study|Adverse Event|1|||
13451613|NCT00265096|26943831|FG000|Overall Study|Adverse Event|14|||
13451614|NCT00265096|26943832|FG001|Overall Study|Adverse Event|18|||
13451615|NCT00265096|26943833|FG002|Overall Study|Adverse Event|18|||
13451616|NCT00265096|26943831|FG000|Overall Study|Lost to Follow-up|2|||
13451617|NCT00265096|26943832|FG001|Overall Study|Lost to Follow-up|5|||
13451618|NCT00265096|26943833|FG002|Overall Study|Lost to Follow-up|3|||
13451619|NCT00265096|26943831|FG000|Overall Study|Death|0|||
13451620|NCT00265096|26943832|FG001|Overall Study|Death|1|||
13451621|NCT00265096|26943833|FG002|Overall Study|Death|2|||
13451622|NCT00265096|26943831|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
13451623|NCT00265096|26943832|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
13451624|NCT00265096|26943833|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
13451625|NCT00265096|26943831|FG000|Overall Study|Other|11|||
13451626|NCT00265096|26943832|FG001|Overall Study|Other|19|||
13451627|NCT00265096|26943833|FG002|Overall Study|Other|10|||
13451628|NCT00265083|26943864|FG000|Overall Study|Adverse Event|5|||
13451629|NCT00265083|26943865|FG001|Overall Study|Adverse Event|13|||
13451630|NCT00265083|26943866|FG002|Overall Study|Adverse Event|15|||
13451631|NCT00265083|26943864|FG000|Overall Study|Lost to Follow-up|3|||
13451632|NCT00265083|26943865|FG001|Overall Study|Lost to Follow-up|4|||
13451633|NCT00265083|26943866|FG002|Overall Study|Lost to Follow-up|4|||
13451634|NCT00265083|26943864|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
13451635|NCT00265083|26943865|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
13451636|NCT00265083|26943866|FG002|Overall Study|Unsatisfactory therapeutic effect|14|||
13451637|NCT00265083|26943864|FG000|Overall Study|Other|1|||
13451638|NCT00265083|26943865|FG001|Overall Study|Other|12|||
13451639|NCT00265083|26943866|FG002|Overall Study|Other|9|||
13451640|NCT00264875|26943872|FG000|Overall Study|Adverse Event|6|||
13451641|NCT00264875|26943872|FG000|Overall Study|Lost to Follow-up|6|||
13451642|NCT00264875|26943872|FG000|Overall Study|Protocol Violation|11|||
13451643|NCT00264875|26943872|FG000|Overall Study|Withdrawal by Subject|7|||
13451644|NCT00264849|26943911|FG000|Overall Study|Adverse Event|7|||
13451645|NCT00264849|26943912|FG001|Overall Study|Adverse Event|2|||
13451646|NCT00264849|26943911|FG000|Overall Study|Withdrawal by Subject|7|||
13451647|NCT00264849|26943912|FG001|Overall Study|Withdrawal by Subject|11|||
13451648|NCT00264849|26943911|FG000|Overall Study|Protocol Violation|5|||
13451649|NCT00264849|26943912|FG001|Overall Study|Protocol Violation|3|||
13451650|NCT00264849|26943911|FG000|Overall Study|Lack of Efficacy|1|||
13451651|NCT00264849|26943912|FG001|Overall Study|Lack of Efficacy|6|||
13451652|NCT00264849|26943911|FG000|Overall Study|Lost to Follow-up|0|||
13451653|NCT00264849|26943912|FG001|Overall Study|Lost to Follow-up|2|||
13451654|NCT00264849|26943911|FG000|Overall Study|Death|0|||
13451655|NCT00264849|26943912|FG001|Overall Study|Death|1|||
13451656|NCT00264849|26943911|FG000|Overall Study|Administrative Problems|2|||
13451657|NCT00264849|26943912|FG001|Overall Study|Administrative Problems|0|||
13451658|NCT00264810|26943927|FG000|Baseline|Withdrawal by Subject|10|||
13451659|NCT00264810|26943928|FG001|Baseline|Withdrawal by Subject|10|||
13451660|NCT00264810|26943927|FG000|Baseline|Physician Decision|7|||
13451661|NCT00264810|26943928|FG001|Baseline|Physician Decision|8|||
13451662|NCT00264810|26943927|FG000|Baseline|Subject Compliance Failure|3|||
13451663|NCT00264810|26943928|FG001|Baseline|Subject Compliance Failure|3|||
13451664|NCT00264810|26943927|FG000|Baseline|Insufficient Seizure Frequency|2|||
13451665|NCT00264810|26943928|FG001|Baseline|Insufficient Seizure Frequency|2|||
13451666|NCT00264810|26943927|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1|||
13451667|NCT00264810|26943928|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2|||
13451668|NCT00264810|26943927|FG000|Baseline|Other|0|||
13451669|NCT00264810|26943928|FG001|Baseline|Other|1|||
13451670|NCT00264810|26943927|FG000|Stimulation Optimization Period|Withdrawal by Subject|1|||
13451671|NCT00264810|26943928|FG001|Stimulation Optimization Period|Withdrawal by Subject|0|||
13451672|NCT00264810|26943927|FG000|Stimulation Optimization Period|Death|0|||
13451673|NCT00264810|26943928|FG001|Stimulation Optimization Period|Death|1|||
13451674|NCT00264810|26943927|FG000|Blinded Evaluation Period|Explant due to infection|1|||
13451675|NCT00264810|26943928|FG001|Blinded Evaluation Period|Explant due to infection|1|||
13451676|NCT00264810|26943927|FG000|Open Label Evaluation Period|Explant due to infection|1|||
13451677|NCT00264810|26943928|FG001|Open Label Evaluation Period|Explant due to infection|1|||
13451678|NCT00264810|26943927|FG000|Open Label Evaluation Period|Death|3|||
13451679|NCT00264810|26943928|FG001|Open Label Evaluation Period|Death|2|||
13451680|NCT00264810|26943927|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2|||
13451681|NCT00264810|26943928|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3|||
13451682|NCT00264797|26943947|FG000|Overall Study|Withdrawal by Subject|11|||
13451683|NCT00264797|26943948|FG001|Overall Study|Withdrawal by Subject|11|||
13451684|NCT00264797|26943947|FG000|Overall Study|Lost to Follow-up|9|||
13451685|NCT00264797|26943948|FG001|Overall Study|Lost to Follow-up|17|||
13451686|NCT00264797|26943947|FG000|Overall Study|Moved from area|3|||
13451687|NCT00264797|26943948|FG001|Overall Study|Moved from area|1|||
13451688|NCT00264797|26943947|FG000|Overall Study|Practical Problems|2|||
13451689|NCT00264797|26943948|FG001|Overall Study|Practical Problems|3|||
13451690|NCT00264797|26943947|FG000|Overall Study|Incarceration|4|||
13451691|NCT00264797|26943948|FG001|Overall Study|Incarceration|5|||
13451692|NCT00264797|26943947|FG000|Overall Study|Pressure/advice from Outsiders|1|||
13451693|NCT00264797|26943948|FG001|Overall Study|Pressure/advice from Outsiders|1|||
13451694|NCT00264797|26943947|FG000|Overall Study|Feels treatment not necessary, not worki|0|||
13451695|NCT00264797|26943948|FG001|Overall Study|Feels treatment not necessary, not worki|1|||
13451696|NCT00264797|26943947|FG000|Overall Study|Other|3|||
13451697|NCT00264797|26943948|FG001|Overall Study|Other|4|||
13451698|NCT00264576|26943975|FG000|Overall Study|Lost to Follow-up|1|||
13451699|NCT00264576|26943976|FG001|Overall Study|Lost to Follow-up|1|||
13451700|NCT00264550|26944024|FG000|Overall Study|Death|0|||
13451701|NCT00264550|26944025|FG001|Overall Study|Death|3|||
13451702|NCT00264550|26944026|FG002|Overall Study|Death|0|||
13451703|NCT00264550|26944027|FG003|Overall Study|Death|0|||
13451704|NCT00264550|26944024|FG000|Overall Study|Lost to Follow-up|3|||
13451705|NCT00264550|26944025|FG001|Overall Study|Lost to Follow-up|1|||
13451706|NCT00264550|26944026|FG002|Overall Study|Lost to Follow-up|1|||
13451707|NCT00264550|26944027|FG003|Overall Study|Lost to Follow-up|1|||
13451708|NCT00264550|26944024|FG000|Overall Study|Adverse Event|23|||
13451709|NCT00264550|26944025|FG001|Overall Study|Adverse Event|18|||
13451710|NCT00264550|26944026|FG002|Overall Study|Adverse Event|9|||
13451711|NCT00264550|26944027|FG003|Overall Study|Adverse Event|14|||
13451712|NCT00264550|26944024|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
13451713|NCT00264550|26944025|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
13451714|NCT00264550|26944026|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
13451715|NCT00264550|26944027|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
13451716|NCT00264550|26944024|FG000|Overall Study|Discontinued oral study agent|0|||
13451717|NCT00264550|26944025|FG001|Overall Study|Discontinued oral study agent|1|||
13451718|NCT00264550|26944026|FG002|Overall Study|Discontinued oral study agent|0|||
13451719|NCT00264550|26944027|FG003|Overall Study|Discontinued oral study agent|0|||
13451720|NCT00264550|26944024|FG000|Overall Study|Other|13|||
13451721|NCT00264550|26944025|FG001|Overall Study|Other|7|||
13451722|NCT00264550|26944026|FG002|Overall Study|Other|3|||
13451723|NCT00264550|26944027|FG003|Overall Study|Other|9|||
13451724|NCT00264537|26944070|FG000|Overall Study|Death|0|||
13451725|NCT00264537|26944071|FG001|Overall Study|Death|3|||
13451726|NCT00264537|26944072|FG002|Overall Study|Death|3|||
13451727|NCT00264537|26944073|FG003|Overall Study|Death|2|||
13451728|NCT00264537|26944070|FG000|Overall Study|Lost to Follow-up|3|||
13451729|NCT00264537|26944071|FG001|Overall Study|Lost to Follow-up|4|||
13451730|NCT00264537|26944072|FG002|Overall Study|Lost to Follow-up|7|||
13451731|NCT00264537|26944073|FG003|Overall Study|Lost to Follow-up|6|||
13451732|NCT00264537|26944070|FG000|Overall Study|Adverse Event|21|||
13451733|NCT00264537|26944071|FG001|Overall Study|Adverse Event|32|||
13451734|NCT00264537|26944072|FG002|Overall Study|Adverse Event|24|||
13451735|NCT00264537|26944073|FG003|Overall Study|Adverse Event|34|||
13451736|NCT00264537|26944070|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
13451737|NCT00264537|26944071|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
13451738|NCT00264537|26944072|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
13451739|NCT00264537|26944073|FG003|Overall Study|Unsatisfactory therapeutic effect|7|||
13451740|NCT00264537|26944070|FG000|Overall Study|Other|21|||
13451741|NCT00264537|26944071|FG001|Overall Study|Other|11|||
13451742|NCT00264537|26944072|FG002|Overall Study|Other|10|||
13451743|NCT00264537|26944073|FG003|Overall Study|Other|11|||
13451744|NCT00264537|26944070|FG000|Overall Study|Not treated|0|||
13451745|NCT00264537|26944071|FG001|Overall Study|Not treated|2|||
13451746|NCT00264537|26944072|FG002|Overall Study|Not treated|1|||
13451747|NCT00264537|26944073|FG003|Overall Study|Not treated|0|||
13451748|NCT00264498|26944086|FG000|Randomized Treatment|Death|0|||
13451749|NCT00264498|26944087|FG001|Randomized Treatment|Death|3|||
13451750|NCT00264498|26944086|FG000|Randomized Treatment|Withdrawal by Subject|0|||
13451751|NCT00264498|26944087|FG001|Randomized Treatment|Withdrawal by Subject|1|||
13451752|NCT00264498|26944086|FG000|Randomized Treatment|Objective disease Progression|13|||
13451753|NCT00264498|26944087|FG001|Randomized Treatment|Objective disease Progression|14|||
13451754|NCT00264498|26944086|FG000|Randomized Treatment|Physician Decision|1|||
13451755|NCT00264498|26944087|FG001|Randomized Treatment|Physician Decision|0|||
13451756|NCT00264498|26944086|FG000|Randomized Treatment|Incorrectly randomized|1|||
13451757|NCT00264498|26944087|FG001|Randomized Treatment|Incorrectly randomized|0|||
13451758|NCT00264498|26944086|FG000|Randomized Treatment|Study Closure|1|||
13451759|NCT00264498|26944087|FG001|Randomized Treatment|Study Closure|0|||
13451760|NCT00264498|26944086|FG000|Randomized Treatment|Protocol Violation|1|||
13451761|NCT00264498|26944087|FG001|Randomized Treatment|Protocol Violation|0|||
13451762|NCT00264498|26944086|FG000|Crossover Treatment|Death|1|||
13451763|NCT00264498|26944087|FG001|Crossover Treatment|Death|3|||
13451764|NCT00264498|26944086|FG000|Crossover Treatment|Objective disease progression|4|||
13451765|NCT00264498|26944087|FG001|Crossover Treatment|Objective disease progression|5|||
13451766|NCT00264498|26944086|FG000|Crossover Treatment|Study closure|0|||
13451767|NCT00264498|26944087|FG001|Crossover Treatment|Study closure|1|||
13451768|NCT00264498|26944086|FG000|Crossover Treatment|Withdrawal by Subject|1|||
13451769|NCT00264498|26944087|FG001|Crossover Treatment|Withdrawal by Subject|0|||
13451770|NCT00264303|26944110|FG000|Overall Study|Adverse Event|4|||
13451771|NCT00264303|26944111|FG001|Overall Study|Adverse Event|3|||
13451772|NCT00264303|26944110|FG000|Overall Study|Lack of Efficacy|10|||
13451773|NCT00264303|26944111|FG001|Overall Study|Lack of Efficacy|13|||
13451774|NCT00264303|26944110|FG000|Overall Study|Lost to Follow-up|3|||
13451775|NCT00264303|26944111|FG001|Overall Study|Lost to Follow-up|3|||
13451776|NCT00264303|26944110|FG000|Overall Study|Withdrawal by Subject|2|||
13451777|NCT00264303|26944111|FG001|Overall Study|Withdrawal by Subject|3|||
13451778|NCT00264303|26944110|FG000|Overall Study|Various reasons listed in study report|6|||
13451779|NCT00264303|26944111|FG001|Overall Study|Various reasons listed in study report|7|||
13451780|NCT00264290|26944134|FG000|Intervention (8 Weeks)|Adverse Event|1|||
13451781|NCT00264290|26944135|FG001|Intervention (8 Weeks)|Adverse Event|0|||
13477297|NCT04705051|27006027|FG000|Overall Study|Enrolled but not treated|1|||
13477298|NCT04705051|27006027|FG000|Overall Study|Study terminated by sponsor|23|||
13477299|NCT04464421|27006040|FG000|Overall Study|Lost to Follow-up|2|||
13477300|NCT04464421|27006041|FG001|Overall Study|Lost to Follow-up|2|||
13477301|NCT04112784|27006070|FG000|Overall Study|Did Not Proceed Due to Time Constraints|9|||
13477302|NCT04112784|27006070|FG000|Overall Study|Screen Failures|4|||
13477303|NCT04049617|27006121|FG000|Overall Study|Adverse Event|0|||
13477304|NCT04049617|27006122|FG001|Overall Study|Adverse Event|0|||
13477305|NCT04049617|27006123|FG002|Overall Study|Adverse Event|0|||
13477306|NCT04049617|27006124|FG003|Overall Study|Adverse Event|1|||
13477307|NCT04049617|27006125|FG004|Overall Study|Adverse Event|0|||
13477308|NCT04049617|27006126|FG005|Overall Study|Adverse Event|0|||
13477309|NCT04049617|27006121|FG000|Overall Study|Death|0|||
13477310|NCT04049617|27006122|FG001|Overall Study|Death|0|||
13477311|NCT04049617|27006123|FG002|Overall Study|Death|0|||
13477312|NCT04049617|27006124|FG003|Overall Study|Death|0|||
13477313|NCT04049617|27006125|FG004|Overall Study|Death|0|||
13477314|NCT04049617|27006126|FG005|Overall Study|Death|1|||
13477315|NCT04049617|27006121|FG000|Overall Study|Lost to Follow-up|0|||
13477316|NCT04049617|27006122|FG001|Overall Study|Lost to Follow-up|0|||
13477317|NCT04049617|27006123|FG002|Overall Study|Lost to Follow-up|0|||
13477318|NCT04049617|27006124|FG003|Overall Study|Lost to Follow-up|1|||
13477319|NCT04049617|27006125|FG004|Overall Study|Lost to Follow-up|0|||
13477320|NCT04049617|27006126|FG005|Overall Study|Lost to Follow-up|0|||
13477321|NCT04049617|27006121|FG000|Overall Study|Withdrew consent|0|||
13477322|NCT04049617|27006122|FG001|Overall Study|Withdrew consent|0|||
13477323|NCT04049617|27006123|FG002|Overall Study|Withdrew consent|1|||
13477324|NCT04049617|27006124|FG003|Overall Study|Withdrew consent|0|||
13477325|NCT04049617|27006125|FG004|Overall Study|Withdrew consent|0|||
13477326|NCT04049617|27006126|FG005|Overall Study|Withdrew consent|0|||
13477327|NCT03911154|27006139|FG000|Overall Study|Withdrawal by Subject|1|||
13477328|NCT03782064|27006162|FG000|Overall Study|Lack of Efficacy|2|||
13477329|NCT03782064|27006162|FG000|Overall Study|Progression Prior to Starting Treatment|3|||
13477330|NCT03781778|27006187|FG000|Overall Study|Withdrawal by Subject|2|||
13477331|NCT03781778|27006188|FG001|Overall Study|Withdrawal by Subject|2|||
13477332|NCT03710590|27006207|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10|||
13477333|NCT03710590|27006208|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8|||
13477334|NCT03470922|27006346|FG000|Overall Study|Death|107|||
13477335|NCT03470922|27006347|FG001|Overall Study|Death|118|||
13477336|NCT03470922|27006346|FG000|Overall Study|Lost to Follow-up|5|||
13477337|NCT03470922|27006347|FG001|Overall Study|Lost to Follow-up|5|||
13477338|NCT03470922|27006346|FG000|Overall Study|Participant Withdrew Consent|4|||
13477339|NCT03470922|27006347|FG001|Overall Study|Participant Withdrew Consent|9|||
13451782|NCT00264238|26944144|FG000|Overall Study|Protocol Violation|1|||
13451783|NCT00264147|26944200|FG000|Treatment I Period|Adverse Event|3|||
13451784|NCT00264147|26944201|FG001|Treatment I Period|Adverse Event|6|||
13451785|NCT00264147|26944202|FG002|Treatment I Period|Adverse Event|3|||
13451786|NCT00264147|26944203|FG003|Treatment I Period|Adverse Event|5|||
13451787|NCT00264147|26944204|FG004|Treatment I Period|Adverse Event|7|||
13451788|NCT00264147|26944205|FG005|Treatment I Period|Adverse Event|0|||
13451789|NCT00264147|26944200|FG000|Treatment I Period|Laboratory Adverse Event|0|||
13451790|NCT00264147|26944201|FG001|Treatment I Period|Laboratory Adverse Event|0|||
13451791|NCT00264147|26944202|FG002|Treatment I Period|Laboratory Adverse Event|0|||
13451792|NCT00264147|26944203|FG003|Treatment I Period|Laboratory Adverse Event|1|||
13451793|NCT00264147|26944204|FG004|Treatment I Period|Laboratory Adverse Event|0|||
13451794|NCT00264147|26944205|FG005|Treatment I Period|Laboratory Adverse Event|0|||
13451795|NCT00264147|26944200|FG000|Treatment I Period|Lack of Efficacy|6|||
13451796|NCT00264147|26944201|FG001|Treatment I Period|Lack of Efficacy|2|||
13451797|NCT00264147|26944202|FG002|Treatment I Period|Lack of Efficacy|8|||
13451798|NCT00264147|26944203|FG003|Treatment I Period|Lack of Efficacy|0|||
13451799|NCT00264147|26944204|FG004|Treatment I Period|Lack of Efficacy|1|||
13451800|NCT00264147|26944205|FG005|Treatment I Period|Lack of Efficacy|0|||
13451801|NCT00264147|26944200|FG000|Treatment I Period|Lost to Follow-up|1|||
13451802|NCT00264147|26944201|FG001|Treatment I Period|Lost to Follow-up|0|||
13451803|NCT00264147|26944202|FG002|Treatment I Period|Lost to Follow-up|0|||
13451804|NCT00264147|26944203|FG003|Treatment I Period|Lost to Follow-up|1|||
13451805|NCT00264147|26944204|FG004|Treatment I Period|Lost to Follow-up|1|||
13451806|NCT00264147|26944205|FG005|Treatment I Period|Lost to Follow-up|0|||
13451807|NCT00264147|26944200|FG000|Treatment I Period|Protocol Violation|2|||
13451808|NCT00264147|26944201|FG001|Treatment I Period|Protocol Violation|2|||
13451809|NCT00264147|26944202|FG002|Treatment I Period|Protocol Violation|0|||
13451810|NCT00264147|26944203|FG003|Treatment I Period|Protocol Violation|0|||
13451811|NCT00264147|26944204|FG004|Treatment I Period|Protocol Violation|0|||
13451812|NCT00264147|26944205|FG005|Treatment I Period|Protocol Violation|0|||
13451813|NCT00264147|26944200|FG000|Treatment I Period|Withdrawal by Subject|2|||
13451814|NCT00264147|26944201|FG001|Treatment I Period|Withdrawal by Subject|0|||
13451815|NCT00264147|26944202|FG002|Treatment I Period|Withdrawal by Subject|0|||
13451816|NCT00264147|26944203|FG003|Treatment I Period|Withdrawal by Subject|2|||
13451817|NCT00264147|26944204|FG004|Treatment I Period|Withdrawal by Subject|2|||
13451818|NCT00264147|26944205|FG005|Treatment I Period|Withdrawal by Subject|0|||
13451819|NCT00264147|26944200|FG000|Treatment I Period|Patient out of town for an extended time|0|||
13451820|NCT00264147|26944201|FG001|Treatment I Period|Patient out of town for an extended time|1|||
13451821|NCT00264147|26944202|FG002|Treatment I Period|Patient out of town for an extended time|0|||
13451822|NCT00264147|26944203|FG003|Treatment I Period|Patient out of town for an extended time|0|||
13451823|NCT00264147|26944204|FG004|Treatment I Period|Patient out of town for an extended time|0|||
13451824|NCT00264147|26944205|FG005|Treatment I Period|Patient out of town for an extended time|0|||
13451825|NCT00264147|26944200|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
13451826|NCT00264147|26944201|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
13451827|NCT00264147|26944202|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1|||
13451828|NCT00264147|26944203|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
13451829|NCT00264147|26944204|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
13451830|NCT00264147|26944205|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
13451831|NCT00264147|26944200|FG000|Treatment I Period|Reassigned to Treatment II Period|84|||
13451832|NCT00264147|26944201|FG001|Treatment I Period|Reassigned to Treatment II Period|72|||
13451833|NCT00264147|26944202|FG002|Treatment I Period|Reassigned to Treatment II Period|65|||
13451834|NCT00264147|26944203|FG003|Treatment I Period|Reassigned to Treatment II Period|63|||
13451835|NCT00264147|26944204|FG004|Treatment I Period|Reassigned to Treatment II Period|45|||
13451836|NCT00264147|26944205|FG005|Treatment I Period|Reassigned to Treatment II Period|0|||
13451837|NCT00264147|26944200|FG000|Treatment II Period|Adverse Event|0|||
13451838|NCT00264147|26944201|FG001|Treatment II Period|Adverse Event|0|||
13451839|NCT00264147|26944202|FG002|Treatment II Period|Adverse Event|0|||
13451840|NCT00264147|26944203|FG003|Treatment II Period|Adverse Event|0|||
13451841|NCT00264147|26944204|FG004|Treatment II Period|Adverse Event|9|||
13451842|NCT00264147|26944205|FG005|Treatment II Period|Adverse Event|9|||
13451843|NCT00264147|26944200|FG000|Treatment II Period|Laboratory Adverse Event|0|||
13451844|NCT00264147|26944201|FG001|Treatment II Period|Laboratory Adverse Event|0|||
13451845|NCT00264147|26944202|FG002|Treatment II Period|Laboratory Adverse Event|0|||
13451846|NCT00264147|26944203|FG003|Treatment II Period|Laboratory Adverse Event|0|||
13451847|NCT00264147|26944204|FG004|Treatment II Period|Laboratory Adverse Event|0|||
13451848|NCT00264147|26944205|FG005|Treatment II Period|Laboratory Adverse Event|1|||
13451849|NCT00264147|26944200|FG000|Treatment II Period|Lack of Efficacy|0|||
13451850|NCT00264147|26944201|FG001|Treatment II Period|Lack of Efficacy|0|||
13451851|NCT00264147|26944202|FG002|Treatment II Period|Lack of Efficacy|0|||
13451852|NCT00264147|26944203|FG003|Treatment II Period|Lack of Efficacy|0|||
13451853|NCT00264147|26944204|FG004|Treatment II Period|Lack of Efficacy|20|||
13451854|NCT00264147|26944205|FG005|Treatment II Period|Lack of Efficacy|19|||
13451855|NCT00264147|26944200|FG000|Treatment II Period|Lost to Follow-up|0|||
13451856|NCT00264147|26944201|FG001|Treatment II Period|Lost to Follow-up|0|||
13451857|NCT00264147|26944202|FG002|Treatment II Period|Lost to Follow-up|0|||
13451858|NCT00264147|26944203|FG003|Treatment II Period|Lost to Follow-up|0|||
13451859|NCT00264147|26944204|FG004|Treatment II Period|Lost to Follow-up|1|||
13451860|NCT00264147|26944205|FG005|Treatment II Period|Lost to Follow-up|1|||
13451861|NCT00264147|26944200|FG000|Treatment II Period|Withdrawal by Subject|0|||
13451862|NCT00264147|26944201|FG001|Treatment II Period|Withdrawal by Subject|0|||
13451863|NCT00264147|26944202|FG002|Treatment II Period|Withdrawal by Subject|0|||
13451864|NCT00264147|26944203|FG003|Treatment II Period|Withdrawal by Subject|0|||
13451865|NCT00264147|26944204|FG004|Treatment II Period|Withdrawal by Subject|3|||
13451866|NCT00264147|26944205|FG005|Treatment II Period|Withdrawal by Subject|2|||
13451867|NCT00264147|26944200|FG000|Treatment II Period|Pre-scheduled total hip replacement|0|||
13451868|NCT00264147|26944201|FG001|Treatment II Period|Pre-scheduled total hip replacement|0|||
13451869|NCT00264147|26944202|FG002|Treatment II Period|Pre-scheduled total hip replacement|0|||
13451870|NCT00264147|26944203|FG003|Treatment II Period|Pre-scheduled total hip replacement|0|||
13451871|NCT00264147|26944204|FG004|Treatment II Period|Pre-scheduled total hip replacement|0|||
13451872|NCT00264147|26944205|FG005|Treatment II Period|Pre-scheduled total hip replacement|1|||
13451873|NCT00264004|26944244|FG000|Overall Study|Adverse Event|2|||
13451874|NCT00264004|26944245|FG001|Overall Study|Adverse Event|3|||
13451875|NCT00264004|26944246|FG002|Overall Study|Adverse Event|6|||
13451876|NCT00264004|26944247|FG003|Overall Study|Adverse Event|4|||
13451877|NCT00264004|26944244|FG000|Overall Study|Withdrawal by Subject|0|||
13451878|NCT00264004|26944245|FG001|Overall Study|Withdrawal by Subject|1|||
13451879|NCT00264004|26944246|FG002|Overall Study|Withdrawal by Subject|2|||
13451880|NCT00264004|26944247|FG003|Overall Study|Withdrawal by Subject|2|||
13451881|NCT00264004|26944244|FG000|Overall Study|Other|2|||
13451882|NCT00264004|26944245|FG001|Overall Study|Other|2|||
13451883|NCT00264004|26944246|FG002|Overall Study|Other|0|||
13451884|NCT00264004|26944247|FG003|Overall Study|Other|3|||
13451885|NCT00264004|26944244|FG000|Overall Study|Development study specific disc. crit.|1|||
13451886|NCT00264004|26944245|FG001|Overall Study|Development study specific disc. crit.|0|||
13451887|NCT00264004|26944246|FG002|Overall Study|Development study specific disc. crit.|1|||
13451888|NCT00264004|26944247|FG003|Overall Study|Development study specific disc. crit.|0|||
13451889|NCT00264004|26944244|FG000|Overall Study|Cond. under inv. worsened|9|||
13451890|NCT00264004|26944245|FG001|Overall Study|Cond. under inv. worsened|5|||
13451891|NCT00264004|26944246|FG002|Overall Study|Cond. under inv. worsened|3|||
13451892|NCT00264004|26944247|FG003|Overall Study|Cond. under inv. worsened|4|||
13451893|NCT00264004|26944244|FG000|Overall Study|Not treated|3|||
13451894|NCT00264004|26944245|FG001|Overall Study|Not treated|0|||
13451895|NCT00264004|26944246|FG002|Overall Study|Not treated|2|||
13451896|NCT00264004|26944247|FG003|Overall Study|Not treated|2|||
13451897|NCT00263887|26944260|FG000|Overall Study|Withdrawal by Subject|1|||
13451898|NCT00263887|26944261|FG001|Overall Study|Withdrawal by Subject|1|||
13451899|NCT00263887|26944260|FG000|Overall Study|Lung transplantation|1|||
13451900|NCT00263887|26944261|FG001|Overall Study|Lung transplantation|2|||
13451901|NCT00263887|26944260|FG000|Overall Study|Too ill to attend visit|1|||
13451902|NCT00263887|26944261|FG001|Overall Study|Too ill to attend visit|0|||
13451903|NCT00263887|26944260|FG000|Overall Study|Adverse Event|0|||
13451904|NCT00263887|26944261|FG001|Overall Study|Adverse Event|2|||
13451905|NCT00263887|26944260|FG000|Overall Study|Disease progression|0|||
13451906|NCT00263887|26944261|FG001|Overall Study|Disease progression|1|||
13451907|NCT00263887|26944260|FG000|Overall Study|Lack of Efficacy|0|||
13451908|NCT00263887|26944261|FG001|Overall Study|Lack of Efficacy|1|||
13451909|NCT00263757|26944278|FG000|Overall Study|Withdrawal by Subject|5|||
13451910|NCT00263757|26944279|FG001|Overall Study|Withdrawal by Subject|4|||
13451911|NCT00263757|26944278|FG000|Overall Study|Screen failure|0|||
13451912|NCT00263757|26944279|FG001|Overall Study|Screen failure|1|||
13451913|NCT00263757|26944278|FG000|Overall Study|Adverse Event|3|||
13451914|NCT00263757|26944279|FG001|Overall Study|Adverse Event|3|||
13451915|NCT00263666|26944337|FG000|Overall Study|Adverse Event|6|||
13451916|NCT00263666|26944338|FG001|Overall Study|Adverse Event|8|||
13451917|NCT00263666|26944337|FG000|Overall Study|Lost to Follow-up|1|||
13451918|NCT00263666|26944338|FG001|Overall Study|Lost to Follow-up|2|||
13451919|NCT00263666|26944337|FG000|Overall Study|Withdrawal by Subject|0|||
13451920|NCT00263666|26944338|FG001|Overall Study|Withdrawal by Subject|1|||
13451921|NCT00263588|26944368|FG000|Overall Study|Death|54|||
13451922|NCT00263588|26944369|FG001|Overall Study|Death|90|||
13451923|NCT00263588|26944368|FG000|Overall Study|disease progression, coma, 1 unknown|10|||
13451924|NCT00263588|26944369|FG001|Overall Study|disease progression, coma, 1 unknown|11|||
13451925|NCT00263588|26944368|FG000|Overall Study|Lost to Follow-up|7|||
13451926|NCT00263588|26944369|FG001|Overall Study|Lost to Follow-up|10|||
13451927|NCT00263588|26944368|FG000|Overall Study|Withdrawal by Subject|3|||
13451928|NCT00263588|26944369|FG001|Overall Study|Withdrawal by Subject|4|||
13451929|NCT00263588|26944368|FG000|Overall Study|Protocol Violation|0|||
13451930|NCT00263588|26944369|FG001|Overall Study|Protocol Violation|1|||
13451931|NCT00263588|26944368|FG000|Overall Study|Investigator decision|7|||
13451932|NCT00263588|26944369|FG001|Overall Study|Investigator decision|15|||
13451933|NCT00263588|26944368|FG000|Overall Study|Sponsor terminated study|0|||
13451934|NCT00263588|26944369|FG001|Overall Study|Sponsor terminated study|1|||
13451935|NCT00263575|26944377|FG000|Titration Period|Adverse Event|14|||
13451936|NCT00263575|26944377|FG000|Titration Period|Withdrawal by Subject|10|||
13451937|NCT00263575|26944377|FG000|Titration Period|Protocol Violation|9|||
13451938|NCT00263575|26944377|FG000|Titration Period|Sponsor Decision|2|||
13451939|NCT00263575|26944377|FG000|Titration Period|Other|2|||
13451940|NCT00263575|26944377|FG000|Titration Period|Lack of Efficacy|6|||
13451941|NCT00263575|26944377|FG000|Maintence Period|Adverse Event|23|||
13451942|NCT00263575|26944377|FG000|Maintence Period|Withdrawal by Subject|8|||
13451943|NCT00263575|26944377|FG000|Maintence Period|Protocol Violation|4|||
13451944|NCT00263575|26944377|FG000|Maintence Period|Lack of Efficacy|4|||
13451945|NCT00263575|26944377|FG000|Maintence Period|Physician Decision|6|||
13451946|NCT00263575|26944377|FG000|Maintence Period|Lost to Follow-up|1|||
13451947|NCT00263575|26944377|FG000|Maintence Period|Sponsor Decision|24|||
13451948|NCT00263575|26944377|FG000|Maintence Period|Other|7|||
13451949|NCT00263562|26944398|FG000|Overall Study|Protocol Violation|3|||
13451950|NCT00263562|26944399|FG001|Overall Study|Protocol Violation|0|||
13451951|NCT00263328|26944565|FG000|Overall Study|Death|0|||
13451952|NCT00263328|26944566|FG001|Overall Study|Death|0|||
13451953|NCT00263328|26944567|FG002|Overall Study|Death|1|||
13451954|NCT00263328|26944565|FG000|Overall Study|Lost to Follow-up|1|||
13451955|NCT00263328|26944566|FG001|Overall Study|Lost to Follow-up|1|||
13451956|NCT00263328|26944567|FG002|Overall Study|Lost to Follow-up|0|||
13451957|NCT00263328|26944565|FG000|Overall Study|Withdrawal by Subject|3|||
13451958|NCT00263328|26944566|FG001|Overall Study|Withdrawal by Subject|0|||
13451959|NCT00263328|26944567|FG002|Overall Study|Withdrawal by Subject|1|||
13451960|NCT00263328|26944565|FG000|Overall Study|Other|3|||
13451961|NCT00263328|26944566|FG001|Overall Study|Other|0|||
13451962|NCT00263328|26944567|FG002|Overall Study|Other|1|||
13451963|NCT00263328|26944565|FG000|Overall Study|Adverse Event|1|||
13451964|NCT00263328|26944566|FG001|Overall Study|Adverse Event|1|||
13451965|NCT00263328|26944567|FG002|Overall Study|Adverse Event|4|||
13451966|NCT00263211|26944590|FG000|Overall Study|Death|1|||
13451967|NCT00263211|26944591|FG001|Overall Study|Death|0|||
13451968|NCT00263211|26944590|FG000|Overall Study|Withdrawal by Subject|3|||
13451969|NCT00263211|26944591|FG001|Overall Study|Withdrawal by Subject|0|||
13451970|NCT00263211|26944590|FG000|Overall Study|Protocol Violation|1|||
13451971|NCT00263211|26944591|FG001|Overall Study|Protocol Violation|0|||
13451972|NCT00263211|26944590|FG000|Overall Study|Disease Progression|0|||
13451973|NCT00263211|26944591|FG001|Overall Study|Disease Progression|1|||
13451974|NCT00262951|26944598|FG000|Overall Study|Progressive disease/relapse|3|||
13451975|NCT00262951|26944598|FG000|Overall Study|Adverse Event|7|||
13451976|NCT00262951|26944598|FG000|Overall Study|Death|1|||
13451977|NCT00262951|26944598|FG000|Overall Study|Withdrawal by Subject|1|||
13451978|NCT00262951|26944598|FG000|Overall Study|Alternative treatment|3|||
13451979|NCT00262951|26944598|FG000|Overall Study|Off treatment for other disease|1|||
13451980|NCT00262925|26944606|FG000|Overall Study|Lack of Efficacy|3|||
13451981|NCT00262925|26944606|FG000|Overall Study|Adverse Event|4|||
13451982|NCT00262925|26944606|FG000|Overall Study|Death|2|||
13451983|NCT00262925|26944606|FG000|Overall Study|alternative therapy|1|||
13451984|NCT00262925|26944606|FG000|Overall Study|Other|1|||
13451985|NCT00262873|26944619|FG000|Overall Study|Adverse Event|3|||
13451986|NCT00262873|26944619|FG000|Overall Study|Withdrawal by Subject|5|||
13451987|NCT00262860|26944627|FG000|Overall Study|Adverse Event|2|||
13451988|NCT00262847|26944654|FG000|Overall Study|Disease Progression|309|||
13451989|NCT00262847|26944655|FG001|Overall Study|Disease Progression|274|||
13451990|NCT00262847|26944656|FG002|Overall Study|Disease Progression|195|||
13451991|NCT00262847|26944654|FG000|Overall Study|Patient Refusal|41|||
13451992|NCT00262847|26944655|FG001|Overall Study|Patient Refusal|52|||
13451993|NCT00262847|26944656|FG002|Overall Study|Patient Refusal|47|||
13451994|NCT00262847|26944654|FG000|Overall Study|Adverse Event|74|||
13451995|NCT00262847|26944655|FG001|Overall Study|Adverse Event|88|||
13451996|NCT00262847|26944656|FG002|Overall Study|Adverse Event|108|||
13451997|NCT00262847|26944654|FG000|Overall Study|Death|8|||
13451998|NCT00262847|26944655|FG001|Overall Study|Death|8|||
13451999|NCT00262847|26944656|FG002|Overall Study|Death|11|||
13452000|NCT00262847|26944654|FG000|Overall Study|Concomitant disease|3|||
13452001|NCT00262847|26944655|FG001|Overall Study|Concomitant disease|2|||
13452002|NCT00262847|26944656|FG002|Overall Study|Concomitant disease|4|||
13452003|NCT00262847|26944654|FG000|Overall Study|Other Reasons|79|||
13452004|NCT00262847|26944655|FG001|Overall Study|Other Reasons|88|||
13452005|NCT00262847|26944656|FG002|Overall Study|Other Reasons|27|||
13452006|NCT00262847|26944654|FG000|Overall Study|Did not receive study treatment|4|||
13452007|NCT00262847|26944655|FG001|Overall Study|Did not receive study treatment|1|||
13452008|NCT00262847|26944656|FG002|Overall Study|Did not receive study treatment|4|||
13452009|NCT00262834|26944674|FG000|Overall Study|Surgery delayed/tissue not collected|1|||
13452010|NCT00262834|26944675|FG001|Overall Study|Surgery delayed/tissue not collected|4|||
13452011|NCT00262821|26944692|FG000|Overall Study|Ineligible - wrong stage|0|||
13452012|NCT00262821|26944693|FG001|Overall Study|Ineligible - wrong stage|3|||
13452013|NCT00262821|26944692|FG000|Overall Study|Ineligible - wrong cell type|2|||
13452014|NCT00262821|26944693|FG001|Overall Study|Ineligible - wrong cell type|2|||
13452015|NCT00262821|26944692|FG000|Overall Study|Ineligible - wrong primary|0|||
13452016|NCT00262821|26944693|FG001|Overall Study|Ineligible - wrong primary|1|||
13452017|NCT00262821|26944692|FG000|Overall Study|Ineligible - inadequate pathology|1|||
13452018|NCT00262821|26944693|FG001|Overall Study|Ineligible - inadequate pathology|3|||
13452019|NCT00262821|26944692|FG000|Overall Study|Ineligible - elevated creatinine|0|||
13452020|NCT00262821|26944693|FG001|Overall Study|Ineligible - elevated creatinine|2|||
13452021|NCT00262821|26944692|FG000|Overall Study|Ineligible - required test not done|1|||
13452022|NCT00262821|26944693|FG001|Overall Study|Ineligible - required test not done|4|||
13452023|NCT00262821|26944692|FG000|Overall Study|Inevaluable - inadequate data|0|||
13452024|NCT00262821|26944693|FG001|Overall Study|Inevaluable - inadequate data|4|||
13452025|NCT00262743|26944707|FG000|Overall Study|Adverse Event|0|||
13452026|NCT00262743|26944708|FG001|Overall Study|Adverse Event|9|||
13452027|NCT00262743|26944707|FG000|Overall Study|Disease progression|0|||
13452028|NCT00262743|26944708|FG001|Overall Study|Disease progression|3|||
13452029|NCT00262600|26944741|FG000|Overall Study|Lost to Follow-up|17|||
13452030|NCT00262600|26944742|FG001|Overall Study|Lost to Follow-up|31|||
13452031|NCT00262600|26944743|FG002|Overall Study|Lost to Follow-up|41|||
13452032|NCT00262600|26944741|FG000|Overall Study|Withdrawal by Subject|128|||
13452033|NCT00262600|26944742|FG001|Overall Study|Withdrawal by Subject|145|||
13452034|NCT00262600|26944743|FG002|Overall Study|Withdrawal by Subject|139|||
13452035|NCT00262600|26944741|FG000|Overall Study|Not Treated|32|||
13452036|NCT00262600|26944742|FG001|Overall Study|Not Treated|17|||
13452037|NCT00262600|26944743|FG002|Overall Study|Not Treated|24|||
13452038|NCT00262600|26944741|FG000|Overall Study|Other|58|||
13452039|NCT00262600|26944742|FG001|Overall Study|Other|59|||
13452040|NCT00262600|26944743|FG002|Overall Study|Other|62|||
13452041|NCT00262522|26944776|FG000|Study Start Through 8 Weeks|Adverse Event|1|||
13452042|NCT00262522|26944777|FG001|Study Start Through 8 Weeks|Adverse Event|2|||
13452043|NCT00262522|26944778|FG002|Study Start Through 8 Weeks|Adverse Event|3|||
13452044|NCT00262522|26944779|FG003|Study Start Through 8 Weeks|Adverse Event|1|||
13452045|NCT00262522|26944776|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
13452046|NCT00262522|26944777|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
13452047|NCT00262522|26944778|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3|||
13452048|NCT00262522|26944779|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0|||
13452049|NCT00262522|26944776|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1|||
13452050|NCT00262522|26944777|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2|||
13452051|NCT00262522|26944778|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3|||
13452052|NCT00262522|26944779|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2|||
13452053|NCT00262522|26944776|FG000|Study Start Through 8 Weeks|Noncompliance|0|||
13452054|NCT00262522|26944777|FG001|Study Start Through 8 Weeks|Noncompliance|0|||
13452055|NCT00262522|26944778|FG002|Study Start Through 8 Weeks|Noncompliance|2|||
13452056|NCT00262522|26944779|FG003|Study Start Through 8 Weeks|Noncompliance|2|||
13452057|NCT00262522|26944776|FG000|Study Start Through 8 Weeks|Death|1|||
13452058|NCT00262522|26944777|FG001|Study Start Through 8 Weeks|Death|0|||
13452059|NCT00262522|26944778|FG002|Study Start Through 8 Weeks|Death|0|||
13452060|NCT00262522|26944779|FG003|Study Start Through 8 Weeks|Death|0|||
13452061|NCT00262522|26944776|FG000|Study Start Through 48 Weeks|Adverse Event|16|||
13452062|NCT00262522|26944777|FG001|Study Start Through 48 Weeks|Adverse Event|0|||
13452063|NCT00262522|26944778|FG002|Study Start Through 48 Weeks|Adverse Event|10|||
13452064|NCT00262522|26944779|FG003|Study Start Through 48 Weeks|Adverse Event|0|||
13452065|NCT00262522|26944776|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10|||
13452066|NCT00262522|26944777|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
13452067|NCT00262522|26944778|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11|||
13452068|NCT00262522|26944779|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
13452069|NCT00262522|26944776|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8|||
13452070|NCT00262522|26944777|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0|||
13452071|NCT00262522|26944778|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14|||
13452072|NCT00262522|26944779|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0|||
13452073|NCT00262522|26944776|FG000|Study Start Through 48 Weeks|Noncompliance|3|||
13452074|NCT00262522|26944777|FG001|Study Start Through 48 Weeks|Noncompliance|0|||
13452075|NCT00262522|26944778|FG002|Study Start Through 48 Weeks|Noncompliance|8|||
13452076|NCT00262522|26944779|FG003|Study Start Through 48 Weeks|Noncompliance|0|||
13452077|NCT00262522|26944776|FG000|Study Start Through 48 Weeks|Death|2|||
13452078|NCT00262522|26944777|FG001|Study Start Through 48 Weeks|Death|0|||
13452079|NCT00262522|26944778|FG002|Study Start Through 48 Weeks|Death|1|||
13452080|NCT00262522|26944779|FG003|Study Start Through 48 Weeks|Death|0|||
13452081|NCT00262522|26944776|FG000|Study Start Through 48 Weeks|Virologic failure|2|||
13452082|NCT00262522|26944777|FG001|Study Start Through 48 Weeks|Virologic failure|0|||
13452083|NCT00262522|26944778|FG002|Study Start Through 48 Weeks|Virologic failure|4|||
13452084|NCT00262522|26944779|FG003|Study Start Through 48 Weeks|Virologic failure|0|||
13452085|NCT00262522|26944776|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8|||
13452086|NCT00262522|26944777|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
13452087|NCT00262522|26944778|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7|||
13452088|NCT00262522|26944779|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
13452089|NCT00262522|26944776|FG000|Study Start Through 96 Weeks|Adverse Event|20|||
13452090|NCT00262522|26944777|FG001|Study Start Through 96 Weeks|Adverse Event|0|||
13452091|NCT00262522|26944778|FG002|Study Start Through 96 Weeks|Adverse Event|16|||
13452092|NCT00262522|26944779|FG003|Study Start Through 96 Weeks|Adverse Event|0|||
13452093|NCT00262522|26944776|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15|||
13452094|NCT00262522|26944777|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
13452095|NCT00262522|26944778|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13|||
13477340|NCT03470922|27006346|FG000|Overall Study|Other reasons|1|||
13452096|NCT00262522|26944779|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
13452097|NCT00262522|26944776|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19|||
13452098|NCT00262522|26944777|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0|||
13452099|NCT00262522|26944778|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18|||
13452100|NCT00262522|26944779|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0|||
13452101|NCT00262522|26944776|FG000|Study Start Through 96 Weeks|Noncompliance|6|||
13452102|NCT00262522|26944777|FG001|Study Start Through 96 Weeks|Noncompliance|0|||
13452103|NCT00262522|26944778|FG002|Study Start Through 96 Weeks|Noncompliance|11|||
13452104|NCT00262522|26944779|FG003|Study Start Through 96 Weeks|Noncompliance|0|||
13452105|NCT00262522|26944776|FG000|Study Start Through 96 Weeks|Death|2|||
13452106|NCT00262522|26944777|FG001|Study Start Through 96 Weeks|Death|0|||
13452107|NCT00262522|26944778|FG002|Study Start Through 96 Weeks|Death|2|||
13452108|NCT00262522|26944779|FG003|Study Start Through 96 Weeks|Death|0|||
13452109|NCT00262522|26944776|FG000|Study Start Through 96 Weeks|Virologic failure|5|||
13452110|NCT00262522|26944777|FG001|Study Start Through 96 Weeks|Virologic failure|0|||
13452111|NCT00262522|26944778|FG002|Study Start Through 96 Weeks|Virologic failure|8|||
13452112|NCT00262522|26944779|FG003|Study Start Through 96 Weeks|Virologic failure|0|||
13452113|NCT00262522|26944776|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10|||
13452114|NCT00262522|26944777|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
13452115|NCT00262522|26944778|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9|||
13452116|NCT00262522|26944779|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
13452117|NCT00262314|26944796|FG000|Overall Study|Changing physicians|38|||
13452118|NCT00262314|26944796|FG000|Overall Study|Death|12|||
13452119|NCT00262314|26944796|FG000|Overall Study|Patient's decision|92|||
13452120|NCT00262314|26944796|FG000|Overall Study|Other|95|||
13452121|NCT00262314|26944796|FG000|Overall Study|Lost to Follow-up|70|||
13452122|NCT00262314|26944796|FG000|Overall Study|Administrative withdrawal|30|||
13452123|NCT00262301|26944817|FG000|Double-blind Phase|Lost to Follow-up|1|||
13452124|NCT00262301|26944818|FG001|Double-blind Phase|Lost to Follow-up|0|||
13452125|NCT00262301|26944819|FG002|Double-blind Phase|Lost to Follow-up|0|||
13452126|NCT00262301|26944817|FG000|Double-blind Phase|"worsening of HAE symptoms"|0|||
13452127|NCT00262301|26944818|FG001|Double-blind Phase|"worsening of HAE symptoms"|1|||
13452128|NCT00262301|26944819|FG002|Double-blind Phase|"worsening of HAE symptoms"|0|||
13452129|NCT00262223|26944834|FG000|Treatment Phase|Withdrawal by Subject|3|||
13452130|NCT00262223|26944835|FG001|Treatment Phase|Withdrawal by Subject|6|||
13452131|NCT00262223|26944834|FG000|Treatment Phase|Adverse Event|1|||
13452132|NCT00262223|26944835|FG001|Treatment Phase|Adverse Event|2|||
13452133|NCT00262223|26944834|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
13452134|NCT00262223|26944835|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
13452135|NCT00262223|26944834|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6|||
13452136|NCT00262223|26944835|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1|||
13452137|NCT00262223|26944834|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
13452138|NCT00262223|26944835|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
13452139|NCT00262119|26944862|FG000|Overall Study|Lost to Follow-up|38|||
13452140|NCT00262119|26944863|FG001|Overall Study|Lost to Follow-up|51|||
13452141|NCT00262119|26944864|FG002|Overall Study|Lost to Follow-up|42|||
13452142|NCT00262119|26944862|FG000|Overall Study|Death|20|||
13452143|NCT00262119|26944863|FG001|Overall Study|Death|19|||
13452144|NCT00262119|26944864|FG002|Overall Study|Death|16|||
13452145|NCT00262080|26944890|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
13452146|NCT00262080|26944891|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
13452147|NCT00262080|26944892|FG002|Double Blind Treatment Period|Lost to Follow-up|0|||
13452148|NCT00262080|26944890|FG000|Repeat Dose Treatment Period|Adverse Event|1|||
13452149|NCT00262080|26944891|FG001|Repeat Dose Treatment Period|Adverse Event|0|||
13452150|NCT00262080|26944892|FG002|Repeat Dose Treatment Period|Adverse Event|0|||
13452151|NCT00262080|26944890|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0|||
13452152|NCT00262080|26944891|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
13452153|NCT00262080|26944892|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
13452154|NCT00262080|26944890|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2|||
13452155|NCT00262080|26944891|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0|||
13452156|NCT00262080|26944892|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2|||
13452157|NCT00262080|26944890|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
13452158|NCT00262080|26944891|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
13452159|NCT00262080|26944892|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2|||
13452160|NCT00262080|26944890|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1|||
13452161|NCT00262080|26944891|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
13452162|NCT00262080|26944892|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
13452163|NCT00262067|26944935|FG000|Overall Study|Death|190|||
13452164|NCT00262067|26944936|FG001|Overall Study|Death|89|||
13452165|NCT00262067|26944937|FG002|Overall Study|Death|186|||
13452166|NCT00262067|26944938|FG003|Overall Study|Death|99|||
13452167|NCT00262067|26944935|FG000|Overall Study|Lost to Follow-up|5|||
13452168|NCT00262067|26944936|FG001|Overall Study|Lost to Follow-up|4|||
13452169|NCT00262067|26944937|FG002|Overall Study|Lost to Follow-up|7|||
13452170|NCT00262067|26944938|FG003|Overall Study|Lost to Follow-up|5|||
13452171|NCT00262067|26944935|FG000|Overall Study|Sponsor's Decision to Terminate Study|1|||
13452172|NCT00262067|26944936|FG001|Overall Study|Sponsor's Decision to Terminate Study|0|||
13452173|NCT00262067|26944937|FG002|Overall Study|Sponsor's Decision to Terminate Study|0|||
13452174|NCT00262067|26944938|FG003|Overall Study|Sponsor's Decision to Terminate Study|0|||
13452175|NCT00262067|26944935|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23|||
13452176|NCT00262067|26944936|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7|||
13452177|NCT00262067|26944937|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23|||
13452178|NCT00262067|26944938|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9|||
13452179|NCT00262041|26944970|FG000|Overall Study|Withdrawal by Subject|0|||
13452180|NCT00262041|26944971|FG001|Overall Study|Withdrawal by Subject|3|||
13452181|NCT00262041|26944972|FG002|Overall Study|Withdrawal by Subject|1|||
13452182|NCT00262041|26944970|FG000|Overall Study|Lost to Follow-up|1|||
13452183|NCT00262041|26944971|FG001|Overall Study|Lost to Follow-up|1|||
13452184|NCT00262041|26944972|FG002|Overall Study|Lost to Follow-up|5|||
13452185|NCT00262041|26944970|FG000|Overall Study|Unable to classify|1|||
13452186|NCT00262041|26944971|FG001|Overall Study|Unable to classify|0|||
13452187|NCT00262041|26944972|FG002|Overall Study|Unable to classify|0|||
13452188|NCT00262028|26945055|FG000|Overall Study|Withdrawal by Subject|6|||
13452189|NCT00262028|26945056|FG001|Overall Study|Withdrawal by Subject|3|||
13452190|NCT00262028|26945057|FG002|Overall Study|Withdrawal by Subject|6|||
13452191|NCT00262028|26945058|FG003|Overall Study|Withdrawal by Subject|5|||
13452192|NCT00262028|26945059|FG004|Overall Study|Withdrawal by Subject|2|||
13452193|NCT00262028|26945060|FG005|Overall Study|Withdrawal by Subject|3|||
13452194|NCT00262028|26945061|FG006|Overall Study|Withdrawal by Subject|5|||
13452195|NCT00262028|26945062|FG007|Overall Study|Withdrawal by Subject|7|||
13452196|NCT00262028|26945063|FG008|Overall Study|Withdrawal by Subject|2|||
13452197|NCT00262028|26945055|FG000|Overall Study|Lost to Follow-up|7|||
13452198|NCT00262028|26945056|FG001|Overall Study|Lost to Follow-up|7|||
13452199|NCT00262028|26945057|FG002|Overall Study|Lost to Follow-up|5|||
13452200|NCT00262028|26945058|FG003|Overall Study|Lost to Follow-up|5|||
13452201|NCT00262028|26945059|FG004|Overall Study|Lost to Follow-up|4|||
13452202|NCT00262028|26945060|FG005|Overall Study|Lost to Follow-up|3|||
13452203|NCT00262028|26945061|FG006|Overall Study|Lost to Follow-up|3|||
13452204|NCT00262028|26945062|FG007|Overall Study|Lost to Follow-up|5|||
13452205|NCT00262028|26945063|FG008|Overall Study|Lost to Follow-up|6|||
13452206|NCT00262028|26945055|FG000|Overall Study|Administrative Reason|11|||
13452207|NCT00262028|26945056|FG001|Overall Study|Administrative Reason|14|||
13452208|NCT00262028|26945057|FG002|Overall Study|Administrative Reason|9|||
13452209|NCT00262028|26945058|FG003|Overall Study|Administrative Reason|12|||
13452210|NCT00262028|26945059|FG004|Overall Study|Administrative Reason|6|||
13452211|NCT00262028|26945060|FG005|Overall Study|Administrative Reason|7|||
13452212|NCT00262028|26945061|FG006|Overall Study|Administrative Reason|4|||
13452213|NCT00262028|26945062|FG007|Overall Study|Administrative Reason|6|||
13452214|NCT00262028|26945063|FG008|Overall Study|Administrative Reason|10|||
13452215|NCT00262028|26945055|FG000|Overall Study|Protocol Violation|0|||
13452216|NCT00262028|26945056|FG001|Overall Study|Protocol Violation|0|||
13452217|NCT00262028|26945057|FG002|Overall Study|Protocol Violation|0|||
13452218|NCT00262028|26945058|FG003|Overall Study|Protocol Violation|1|||
13452219|NCT00262028|26945059|FG004|Overall Study|Protocol Violation|0|||
13452220|NCT00262028|26945060|FG005|Overall Study|Protocol Violation|0|||
13452221|NCT00262028|26945061|FG006|Overall Study|Protocol Violation|0|||
13452222|NCT00262028|26945062|FG007|Overall Study|Protocol Violation|0|||
13452223|NCT00262028|26945063|FG008|Overall Study|Protocol Violation|0|||
13452224|NCT00262028|26945055|FG000|Overall Study|Unable to classify|0|||
13452225|NCT00262028|26945056|FG001|Overall Study|Unable to classify|3|||
13452226|NCT00262028|26945057|FG002|Overall Study|Unable to classify|0|||
13452227|NCT00262028|26945058|FG003|Overall Study|Unable to classify|0|||
13452228|NCT00262028|26945059|FG004|Overall Study|Unable to classify|0|||
13452229|NCT00262028|26945060|FG005|Overall Study|Unable to classify|0|||
13452230|NCT00262028|26945061|FG006|Overall Study|Unable to classify|0|||
13452231|NCT00262028|26945062|FG007|Overall Study|Unable to classify|0|||
13452232|NCT00262028|26945063|FG008|Overall Study|Unable to classify|1|||
13452233|NCT00262002|26945178|FG000|Overall Study|Adverse Event|2|||
13452234|NCT00262002|26945179|FG001|Overall Study|Adverse Event|1|||
13452235|NCT00262002|26945180|FG002|Overall Study|Adverse Event|0|||
13452236|NCT00262002|26945181|FG003|Overall Study|Adverse Event|0|||
13452237|NCT00262002|26945182|FG004|Overall Study|Adverse Event|0|||
13452238|NCT00262002|26945183|FG005|Overall Study|Adverse Event|1|||
13452239|NCT00262002|26945184|FG006|Overall Study|Adverse Event|0|||
13452240|NCT00262002|26945178|FG000|Overall Study|Withdrawal by Subject|4|||
13452241|NCT00262002|26945179|FG001|Overall Study|Withdrawal by Subject|2|||
13452242|NCT00262002|26945180|FG002|Overall Study|Withdrawal by Subject|0|||
13452243|NCT00262002|26945181|FG003|Overall Study|Withdrawal by Subject|1|||
13452244|NCT00262002|26945182|FG004|Overall Study|Withdrawal by Subject|2|||
13452245|NCT00262002|26945183|FG005|Overall Study|Withdrawal by Subject|2|||
13452246|NCT00262002|26945184|FG006|Overall Study|Withdrawal by Subject|2|||
13452247|NCT00262002|26945178|FG000|Overall Study|Lost to Follow-up|2|||
13452248|NCT00262002|26945179|FG001|Overall Study|Lost to Follow-up|0|||
13452249|NCT00262002|26945180|FG002|Overall Study|Lost to Follow-up|0|||
13452250|NCT00262002|26945181|FG003|Overall Study|Lost to Follow-up|2|||
13452251|NCT00262002|26945182|FG004|Overall Study|Lost to Follow-up|0|||
13452252|NCT00262002|26945183|FG005|Overall Study|Lost to Follow-up|1|||
13452253|NCT00262002|26945184|FG006|Overall Study|Lost to Follow-up|0|||
13452254|NCT00262002|26945178|FG000|Overall Study|Inapropriate enrollment|0|||
13452255|NCT00262002|26945179|FG001|Overall Study|Inapropriate enrollment|1|||
13452256|NCT00262002|26945180|FG002|Overall Study|Inapropriate enrollment|0|||
13452257|NCT00262002|26945181|FG003|Overall Study|Inapropriate enrollment|0|||
13452258|NCT00262002|26945182|FG004|Overall Study|Inapropriate enrollment|0|||
13452259|NCT00262002|26945183|FG005|Overall Study|Inapropriate enrollment|0|||
13452260|NCT00262002|26945184|FG006|Overall Study|Inapropriate enrollment|0|||
13452261|NCT00262002|26945178|FG000|Overall Study|Protocol Violation|3|||
13452262|NCT00262002|26945179|FG001|Overall Study|Protocol Violation|2|||
13452263|NCT00262002|26945180|FG002|Overall Study|Protocol Violation|0|||
13452264|NCT00262002|26945181|FG003|Overall Study|Protocol Violation|2|||
13452265|NCT00262002|26945182|FG004|Overall Study|Protocol Violation|5|||
13452266|NCT00262002|26945183|FG005|Overall Study|Protocol Violation|3|||
13452267|NCT00262002|26945184|FG006|Overall Study|Protocol Violation|2|||
13452268|NCT00262002|26945178|FG000|Overall Study|Unable to classify|0|||
13452269|NCT00262002|26945179|FG001|Overall Study|Unable to classify|0|||
13452270|NCT00262002|26945180|FG002|Overall Study|Unable to classify|0|||
13452271|NCT00262002|26945181|FG003|Overall Study|Unable to classify|0|||
13452272|NCT00262002|26945182|FG004|Overall Study|Unable to classify|0|||
13452273|NCT00262002|26945183|FG005|Overall Study|Unable to classify|0|||
13452274|NCT00262002|26945184|FG006|Overall Study|Unable to classify|2|||
13452275|NCT00261950|26945202|FG000|Overall Study|Lost to Follow-up|2|||
13452276|NCT00261950|26945202|FG000|Overall Study|Death|6|||
13452277|NCT00261950|26945202|FG000|Overall Study|Withdrawal by Subject|5|||
13452278|NCT00261950|26945202|FG000|Overall Study|Other|1|||
13452279|NCT00261950|26945202|FG000|Overall Study|Physician Decision|1|||
13452280|NCT00261950|26945202|FG000|Overall Study|Protocol specified Criteria|11|||
13452281|NCT00261846|26945490|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
13452282|NCT00261846|26945491|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
13452283|NCT00261846|26945492|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12|||
13452284|NCT00261846|26945493|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
13452285|NCT00261846|26945494|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
13452286|NCT00261846|26945495|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
13452287|NCT00261846|26945496|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
13452288|NCT00261846|26945497|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
13452289|NCT00261846|26945498|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
13452290|NCT00261846|26945499|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
13452291|NCT00261846|26945500|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
13452292|NCT00261846|26945501|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
13452293|NCT00261846|26945490|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
13452294|NCT00261846|26945491|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
13452295|NCT00261846|26945492|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
13452296|NCT00261846|26945493|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
13452297|NCT00261846|26945494|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
13452298|NCT00261846|26945495|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
13452299|NCT00261846|26945496|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
13452300|NCT00261846|26945497|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
13452301|NCT00261846|26945498|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
13452302|NCT00261846|26945499|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
13452303|NCT00261846|26945500|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
13452304|NCT00261846|26945501|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
13452305|NCT00261846|26945490|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
13452306|NCT00261846|26945491|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
13452307|NCT00261846|26945492|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
13452308|NCT00261846|26945493|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9|||
13452309|NCT00261846|26945494|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8|||
13452310|NCT00261846|26945495|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1|||
13452311|NCT00261846|26945496|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
13452312|NCT00261846|26945497|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
13452313|NCT00261846|26945498|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
13452314|NCT00261846|26945499|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2|||
13452315|NCT00261846|26945500|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
13452316|NCT00261846|26945501|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
13452317|NCT00261846|26945490|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
13452318|NCT00261846|26945491|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
13452319|NCT00261846|26945492|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
13452320|NCT00261846|26945493|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12|||
13452321|NCT00261846|26945494|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
13452322|NCT00261846|26945495|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
13452323|NCT00261846|26945496|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
13452324|NCT00261846|26945497|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
13452325|NCT00261846|26945498|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1|||
13452326|NCT00261846|26945499|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
13452327|NCT00261846|26945500|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
13452328|NCT00261846|26945501|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
13452329|NCT00261846|26945490|FG000|Period 2: Part 2 (Efficacy)|Other|0|||
13452330|NCT00261846|26945491|FG001|Period 2: Part 2 (Efficacy)|Other|0|||
13452331|NCT00261846|26945492|FG002|Period 2: Part 2 (Efficacy)|Other|0|||
13452332|NCT00261846|26945493|FG003|Period 2: Part 2 (Efficacy)|Other|15|||
13452333|NCT00261846|26945494|FG004|Period 2: Part 2 (Efficacy)|Other|4|||
13452334|NCT00261846|26945495|FG005|Period 2: Part 2 (Efficacy)|Other|0|||
13452335|NCT00261846|26945496|FG006|Period 2: Part 2 (Efficacy)|Other|1|||
13452336|NCT00261846|26945497|FG007|Period 2: Part 2 (Efficacy)|Other|5|||
13452337|NCT00261846|26945498|FG008|Period 2: Part 2 (Efficacy)|Other|4|||
13452338|NCT00261846|26945499|FG009|Period 2: Part 2 (Efficacy)|Other|4|||
13452339|NCT00261846|26945500|FG010|Period 2: Part 2 (Efficacy)|Other|0|||
13452340|NCT00261846|26945501|FG011|Period 2: Part 2 (Efficacy)|Other|0|||
13452341|NCT00261846|26945490|FG000|Period 2: Part 2 (Efficacy)|Death|0|||
13452342|NCT00261846|26945491|FG001|Period 2: Part 2 (Efficacy)|Death|0|||
13452343|NCT00261846|26945492|FG002|Period 2: Part 2 (Efficacy)|Death|0|||
13452344|NCT00261846|26945493|FG003|Period 2: Part 2 (Efficacy)|Death|37|||
13452345|NCT00261846|26945494|FG004|Period 2: Part 2 (Efficacy)|Death|7|||
13452346|NCT00261846|26945495|FG005|Period 2: Part 2 (Efficacy)|Death|1|||
13452347|NCT00261846|26945496|FG006|Period 2: Part 2 (Efficacy)|Death|10|||
13452348|NCT00261846|26945497|FG007|Period 2: Part 2 (Efficacy)|Death|12|||
13452349|NCT00261846|26945498|FG008|Period 2: Part 2 (Efficacy)|Death|3|||
13452350|NCT00261846|26945499|FG009|Period 2: Part 2 (Efficacy)|Death|30|||
13452351|NCT00261846|26945500|FG010|Period 2: Part 2 (Efficacy)|Death|44|||
13452352|NCT00261846|26945501|FG011|Period 2: Part 2 (Efficacy)|Death|22|||
13452353|NCT00261846|26945490|FG000|Period 2: Part 2 (Efficacy)|Extension study|0|||
13452354|NCT00261846|26945491|FG001|Period 2: Part 2 (Efficacy)|Extension study|0|||
13452355|NCT00261846|26945492|FG002|Period 2: Part 2 (Efficacy)|Extension study|0|||
13452356|NCT00261846|26945493|FG003|Period 2: Part 2 (Efficacy)|Extension study|61|||
13452357|NCT00261846|26945494|FG004|Period 2: Part 2 (Efficacy)|Extension study|27|||
13452358|NCT00261846|26945495|FG005|Period 2: Part 2 (Efficacy)|Extension study|0|||
13452359|NCT00261846|26945496|FG006|Period 2: Part 2 (Efficacy)|Extension study|4|||
13452360|NCT00261846|26945497|FG007|Period 2: Part 2 (Efficacy)|Extension study|9|||
13452361|NCT00261846|26945498|FG008|Period 2: Part 2 (Efficacy)|Extension study|5|||
13452362|NCT00261846|26945499|FG009|Period 2: Part 2 (Efficacy)|Extension study|9|||
13452363|NCT00261846|26945500|FG010|Period 2: Part 2 (Efficacy)|Extension study|1|||
13452364|NCT00261846|26945501|FG011|Period 2: Part 2 (Efficacy)|Extension study|1|||
13452365|NCT00261833|26945540|FG000|Overall Study|Death|1|||
13452366|NCT00261833|26945541|FG001|Overall Study|Death|3|||
13452367|NCT00261833|26945540|FG000|Overall Study|Adverse Event|1|||
13452368|NCT00261833|26945541|FG001|Overall Study|Adverse Event|4|||
13452369|NCT00261833|26945540|FG000|Overall Study|Withdrawal by Subject|5|||
13452370|NCT00261833|26945541|FG001|Overall Study|Withdrawal by Subject|7|||
13452371|NCT00261833|26945540|FG000|Overall Study|Protocol Violation|0|||
13452372|NCT00261833|26945541|FG001|Overall Study|Protocol Violation|1|||
13452373|NCT00261833|26945540|FG000|Overall Study|Suspicion of pulmonary cancer|0|||
13452374|NCT00261833|26945541|FG001|Overall Study|Suspicion of pulmonary cancer|1|||
13452375|NCT00261833|26945540|FG000|Overall Study|Lung transplantation|1|||
13452376|NCT00261833|26945541|FG001|Overall Study|Lung transplantation|1|||
13452377|NCT00261833|26945540|FG000|Overall Study|Missing reason|1|||
13452378|NCT00261833|26945541|FG001|Overall Study|Missing reason|0|||
13452379|NCT00261833|26945540|FG000|Overall Study|Not interested in being participant|0|||
13452380|NCT00261833|26945541|FG001|Overall Study|Not interested in being participant|1|||
13452381|NCT00261716|26945566|FG000|Overall Study|Withdrawal by Subject|6|||
13452382|NCT00261716|26945567|FG001|Overall Study|Withdrawal by Subject|8|||
13452383|NCT00261716|26945566|FG000|Overall Study|Lost to Follow-up|0|||
13452384|NCT00261716|26945567|FG001|Overall Study|Lost to Follow-up|2|||
13452385|NCT00261495|26945736|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28|||
13452386|NCT00261495|26945737|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36|||
13452387|NCT00261495|26945736|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6|||
13452388|NCT00261495|26945737|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11|||
13452389|NCT00261495|26945736|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
13452390|NCT00261495|26945737|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
13452391|NCT00261495|26945736|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3|||
13452392|NCT00261495|26945737|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1|||
13452393|NCT00261495|26945736|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2|||
13452394|NCT00261495|26945737|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5|||
13452395|NCT00261495|26945736|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1|||
13452396|NCT00261495|26945737|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4|||
13452397|NCT00261495|26945736|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29|||
13452398|NCT00261495|26945737|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20|||
13452399|NCT00261495|26945736|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14|||
13452400|NCT00261495|26945737|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10|||
13452401|NCT00261495|26945736|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6|||
13452402|NCT00261495|26945737|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5|||
13452403|NCT00261495|26945736|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1|||
13452404|NCT00261495|26945737|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5|||
13452405|NCT00261495|26945736|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5|||
13452406|NCT00261495|26945737|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2|||
13452407|NCT00261495|26945736|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6|||
13452408|NCT00261495|26945737|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5|||
13452409|NCT00261495|26945736|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
13452410|NCT00261495|26945737|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
13452411|NCT00261495|26945736|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2|||
13452412|NCT00261495|26945737|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0|||
13452413|NCT00261495|26945736|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2|||
13452414|NCT00261495|26945737|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0|||
13452415|NCT00261495|26945736|FG000|Extension Phase (Weeks 24 to 52)|Other|4|||
13452416|NCT00261495|26945737|FG001|Extension Phase (Weeks 24 to 52)|Other|2|||
13452417|NCT00261495|26945736|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4|||
13452418|NCT00261495|26945737|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
13452419|NCT00261495|26945736|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
13452420|NCT00261495|26945737|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
13452421|NCT00261495|26945736|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
13452422|NCT00261495|26945737|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
13452423|NCT00261495|26945736|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1|||
13452424|NCT00261495|26945737|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0|||
13452425|NCT00261495|26945736|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
13452426|NCT00261495|26945737|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
13452427|NCT00261443|26946000|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33|||
13452428|NCT00261443|26946001|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
13452429|NCT00261443|26946002|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
13452430|NCT00261443|26946000|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93|||
13452431|NCT00261443|26946001|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
13452432|NCT00261443|26946002|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
13452433|NCT00261443|26946000|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111|||
13452434|NCT00261443|26946001|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
13452435|NCT00261443|26946002|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
13452436|NCT00261443|26946000|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23|||
13452437|NCT00261443|26946001|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
13452438|NCT00261443|26946002|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
13452439|NCT00261443|26946000|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1|||
13452440|NCT00261443|26946001|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
13452441|NCT00261443|26946002|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
13452442|NCT00261443|26946000|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307|||
13452443|NCT00261443|26946001|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
13452444|NCT00261443|26946002|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
13452445|NCT00261443|26946000|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16|||
13452446|NCT00261443|26946001|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
13452447|NCT00261443|26946002|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
13452448|NCT00261443|26946000|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43|||
13452449|NCT00261443|26946001|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
13452450|NCT00261443|26946002|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
13452451|NCT00261443|26946000|FG000|2: Stability & Maintenance of Stability|Adverse Event|93|||
13452452|NCT00261443|26946001|FG001|2: Stability & Maintenance of Stability|Adverse Event|0|||
13452453|NCT00261443|26946002|FG002|2: Stability & Maintenance of Stability|Adverse Event|0|||
13452454|NCT00261443|26946000|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65|||
13452455|NCT00261443|26946001|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
13452456|NCT00261443|26946002|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
13452457|NCT00261443|26946000|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59|||
13452458|NCT00261443|26946001|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
13452459|NCT00261443|26946002|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
13452460|NCT00261443|26946000|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33|||
13452461|NCT00261443|26946001|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
13452462|NCT00261443|26946002|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
13452463|NCT00261443|26946000|FG000|2: Stability & Maintenance of Stability|Pregnancy|1|||
13452464|NCT00261443|26946001|FG001|2: Stability & Maintenance of Stability|Pregnancy|0|||
13477341|NCT03470922|27006347|FG001|Overall Study|Other reasons|0|||
13452465|NCT00261443|26946002|FG002|2: Stability & Maintenance of Stability|Pregnancy|0|||
13452466|NCT00261443|26946000|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32|||
13452467|NCT00261443|26946001|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
13452468|NCT00261443|26946002|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
13452469|NCT00261443|26946000|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1|||
13452470|NCT00261443|26946001|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
13452471|NCT00261443|26946002|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
13452472|NCT00261443|26946000|FG000|2: Stability & Maintenance of Stability|Other Reasons|13|||
13452473|NCT00261443|26946001|FG001|2: Stability & Maintenance of Stability|Other Reasons|0|||
13452474|NCT00261443|26946002|FG002|2: Stability & Maintenance of Stability|Other Reasons|0|||
13452475|NCT00261443|26946000|FG000|3: Assessment of Relapse|Lack of Efficacy|0|||
13452476|NCT00261443|26946001|FG001|3: Assessment of Relapse|Lack of Efficacy|31|||
13452477|NCT00261443|26946002|FG002|3: Assessment of Relapse|Lack of Efficacy|14|||
13452478|NCT00261443|26946000|FG000|3: Assessment of Relapse|Adverse Event|0|||
13452479|NCT00261443|26946001|FG001|3: Assessment of Relapse|Adverse Event|15|||
13452480|NCT00261443|26946002|FG002|3: Assessment of Relapse|Adverse Event|19|||
13452481|NCT00261443|26946000|FG000|3: Assessment of Relapse|Withdrawal by Subject|0|||
13452482|NCT00261443|26946001|FG001|3: Assessment of Relapse|Withdrawal by Subject|14|||
13452483|NCT00261443|26946002|FG002|3: Assessment of Relapse|Withdrawal by Subject|15|||
13452484|NCT00261443|26946000|FG000|3: Assessment of Relapse|Death|0|||
13452485|NCT00261443|26946001|FG001|3: Assessment of Relapse|Death|0|||
13452486|NCT00261443|26946002|FG002|3: Assessment of Relapse|Death|1|||
13452487|NCT00261443|26946000|FG000|3: Assessment of Relapse|Lost to Follow-up|0|||
13452488|NCT00261443|26946001|FG001|3: Assessment of Relapse|Lost to Follow-up|7|||
13452489|NCT00261443|26946002|FG002|3: Assessment of Relapse|Lost to Follow-up|6|||
13452490|NCT00261443|26946000|FG000|3: Assessment of Relapse|Poor/Noncompliance|0|||
13452491|NCT00261443|26946001|FG001|3: Assessment of Relapse|Poor/Noncompliance|5|||
13452492|NCT00261443|26946002|FG002|3: Assessment of Relapse|Poor/Noncompliance|3|||
13452493|NCT00261443|26946000|FG000|3: Assessment of Relapse|Pregnancy|0|||
13452494|NCT00261443|26946001|FG001|3: Assessment of Relapse|Pregnancy|2|||
13452495|NCT00261443|26946002|FG002|3: Assessment of Relapse|Pregnancy|1|||
13452496|NCT00261443|26946000|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0|||
13452497|NCT00261443|26946001|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2|||
13452498|NCT00261443|26946002|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1|||
13452499|NCT00261443|26946000|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
13452500|NCT00261443|26946001|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
13452501|NCT00261443|26946002|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2|||
13452502|NCT00261443|26946000|FG000|3: Assessment of Relapse|Other Reasons|0|||
13452503|NCT00261443|26946001|FG001|3: Assessment of Relapse|Other Reasons|4|||
13452504|NCT00261443|26946002|FG002|3: Assessment of Relapse|Other Reasons|3|||
13452505|NCT00261443|26946000|FG000|4: Extension Phase|Adverse Event|0|||
13452506|NCT00261443|26946001|FG001|4: Extension Phase|Adverse Event|1|||
13452507|NCT00261443|26946002|FG002|4: Extension Phase|Adverse Event|0|||
13452508|NCT00261443|26946000|FG000|4: Extension Phase|Withdrawal by Subject|0|||
13452509|NCT00261443|26946001|FG001|4: Extension Phase|Withdrawal by Subject|1|||
13452510|NCT00261443|26946002|FG002|4: Extension Phase|Withdrawal by Subject|2|||
13452511|NCT00261443|26946000|FG000|4: Extension Phase|Lost to Follow-up|0|||
13452512|NCT00261443|26946001|FG001|4: Extension Phase|Lost to Follow-up|1|||
13452513|NCT00261443|26946002|FG002|4: Extension Phase|Lost to Follow-up|0|||
13452514|NCT00260832|26946017|FG000|Overall Study|Adverse Event|26|||
13452515|NCT00260832|26946018|FG001|Overall Study|Adverse Event|19|||
13452516|NCT00260832|26946017|FG000|Overall Study|Progression|116|||
13452517|NCT00260832|26946018|FG001|Overall Study|Progression|96|||
13452518|NCT00260832|26946017|FG000|Overall Study|Withdrawal by Subject|15|||
13452519|NCT00260832|26946018|FG001|Overall Study|Withdrawal by Subject|17|||
13452520|NCT00260832|26946017|FG000|Overall Study|Physician Decision|15|||
13452521|NCT00260832|26946018|FG001|Overall Study|Physician Decision|9|||
13452522|NCT00260832|26946017|FG000|Overall Study|Death|43|||
13452523|NCT00260832|26946018|FG001|Overall Study|Death|62|||
13452524|NCT00260832|26946017|FG000|Overall Study|Other|10|||
13452525|NCT00260832|26946018|FG001|Overall Study|Other|7|||
13452526|NCT00260832|26946017|FG000|Overall Study|Protocol Violation|3|||
13452527|NCT00260832|26946018|FG001|Overall Study|Protocol Violation|1|||
13452528|NCT00260533|26946031|FG000|Overall Study|Other|3|||
13452529|NCT00260533|26946032|FG001|Overall Study|Other|3|||
13452530|NCT00260429|26946045|FG000|Overall Study|failure to follow appointments|1|||
13452531|NCT00260429|26946046|FG001|Overall Study|failure to follow appointments|0|||
13452532|NCT00260429|26946045|FG000|Overall Study|scheduled hand surgery|1|||
13452533|NCT00260429|26946046|FG001|Overall Study|scheduled hand surgery|0|||
13452534|NCT00260208|26946081|FG000|Overall Study|Subject withdrew consent|11|||
13452535|NCT00260208|26946082|FG001|Overall Study|Subject withdrew consent|7|||
13452536|NCT00260208|26946081|FG000|Overall Study|Lost to Follow-up|6|||
13452537|NCT00260208|26946082|FG001|Overall Study|Lost to Follow-up|1|||
13452538|NCT00260208|26946081|FG000|Overall Study|Death|12|||
13452539|NCT00260208|26946082|FG001|Overall Study|Death|10|||
13452540|NCT00260208|26946081|FG000|Overall Study|Missing|18|||
13452541|NCT00260208|26946082|FG001|Overall Study|Missing|16|||
13452542|NCT00260065|26946089|FG000|Overall Study|Progressive Disease|22|||
13452543|NCT00260065|26946089|FG000|Overall Study|Adverse Event|17|||
13452544|NCT00260065|26946089|FG000|Overall Study|Death|13|||
13452545|NCT00260065|26946089|FG000|Overall Study|Withdrawal by Subject|13|||
13452546|NCT00260065|26946089|FG000|Overall Study|Physician Decision|19|||
13452547|NCT00260065|26946089|FG000|Overall Study|Not otherwise specified|8|||
13452548|NCT00260065|26946089|FG000|Overall Study|Medication Noncompliance|1|||
13452549|NCT00259857|26946112|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1|||
13452550|NCT00259857|26946113|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2|||
13452551|NCT00259857|26946112|FG000|24 Months Treatment|Lost to Follow-up|0|||
13452552|NCT00259857|26946113|FG001|24 Months Treatment|Lost to Follow-up|3|||
13452553|NCT00259740|26946130|FG000|Overall Study|Physician Decision|1|||
13452554|NCT00259740|26946131|FG001|Overall Study|Physician Decision|1|||
13452555|NCT00259740|26946130|FG000|Overall Study|Adverse Event|0|||
13452556|NCT00259740|26946131|FG001|Overall Study|Adverse Event|2|||
13452557|NCT00259740|26946130|FG000|Overall Study|Withdrawal by Subject|2|||
13452558|NCT00259740|26946131|FG001|Overall Study|Withdrawal by Subject|6|||
13452559|NCT00259740|26946130|FG000|Overall Study|Death|1|||
13452560|NCT00259740|26946131|FG001|Overall Study|Death|1|||
13452561|NCT00259740|26946130|FG000|Overall Study|Disease progression|19|||
13452562|NCT00259740|26946131|FG001|Overall Study|Disease progression|36|||
13452563|NCT00259740|26946130|FG000|Overall Study|Ongoing|17|||
13452564|NCT00259740|26946131|FG001|Overall Study|Ongoing|3|||
13452565|NCT00259740|26946130|FG000|Overall Study|Other|3|||
13452566|NCT00259740|26946131|FG001|Overall Study|Other|0|||
13452567|NCT00259740|26946130|FG000|Overall Study|Requirement for alternative therapy|0|||
13452568|NCT00259740|26946131|FG001|Overall Study|Requirement for alternative therapy|4|||
13452569|NCT00259649|26946137|FG000|Overall Study|Lost to Follow-up|7|||
13452570|NCT00259649|26946137|FG000|Overall Study|irregular menses|3|||
13452571|NCT00259610|26946164|FG000|Overall Study|Withdrawal by Subject|33|||
13452572|NCT00259610|26946165|FG001|Overall Study|Withdrawal by Subject|25|||
13452573|NCT00259610|26946166|FG002|Overall Study|Withdrawal by Subject|29|||
13452574|NCT00259610|26946167|FG003|Overall Study|Withdrawal by Subject|19|||
13452575|NCT00259610|26946164|FG000|Overall Study|Lost to Follow-up|19|||
13452576|NCT00259610|26946165|FG001|Overall Study|Lost to Follow-up|8|||
13452577|NCT00259610|26946166|FG002|Overall Study|Lost to Follow-up|18|||
13452578|NCT00259610|26946167|FG003|Overall Study|Lost to Follow-up|15|||
13452579|NCT00259610|26946164|FG000|Overall Study|Physician Decision|6|||
13452580|NCT00259610|26946165|FG001|Overall Study|Physician Decision|4|||
13452581|NCT00259610|26946166|FG002|Overall Study|Physician Decision|7|||
13452582|NCT00259610|26946167|FG003|Overall Study|Physician Decision|2|||
13452583|NCT00259610|26946164|FG000|Overall Study|Death|1|||
13452584|NCT00259610|26946165|FG001|Overall Study|Death|1|||
13452585|NCT00259610|26946166|FG002|Overall Study|Death|2|||
13452586|NCT00259610|26946167|FG003|Overall Study|Death|0|||
13452587|NCT00259610|26946164|FG000|Overall Study|non medical reason|6|||
13452588|NCT00259610|26946165|FG001|Overall Study|non medical reason|2|||
13452589|NCT00259610|26946166|FG002|Overall Study|non medical reason|10|||
13452590|NCT00259610|26946167|FG003|Overall Study|non medical reason|3|||
13452591|NCT00259610|26946164|FG000|Overall Study|Adverse Event|3|||
13452592|NCT00259610|26946165|FG001|Overall Study|Adverse Event|4|||
13452593|NCT00259610|26946166|FG002|Overall Study|Adverse Event|5|||
13452594|NCT00259610|26946167|FG003|Overall Study|Adverse Event|2|||
13452595|NCT00259610|26946164|FG000|Overall Study|Serious Adverse Event|8|||
13452596|NCT00259610|26946165|FG001|Overall Study|Serious Adverse Event|2|||
13452597|NCT00259610|26946166|FG002|Overall Study|Serious Adverse Event|2|||
13452598|NCT00259610|26946167|FG003|Overall Study|Serious Adverse Event|2|||
13452599|NCT00259298|26946177|FG000|Overall Study|Withdrawal by Subject|1|||
13452600|NCT00259298|26946177|FG000|Overall Study|Physician Decision|2|||
13452601|NCT00259272|26946265|FG000|Overall Study|Adverse Event|2|||
13452602|NCT00259272|26946266|FG001|Overall Study|Adverse Event|1|||
13452603|NCT00259272|26946267|FG002|Overall Study|Adverse Event|0|||
13452604|NCT00259272|26946268|FG003|Overall Study|Adverse Event|3|||
13452605|NCT00259272|26946265|FG000|Overall Study|Lack of Efficacy|5|||
13452606|NCT00259272|26946266|FG001|Overall Study|Lack of Efficacy|1|||
13452607|NCT00259272|26946267|FG002|Overall Study|Lack of Efficacy|2|||
13452608|NCT00259272|26946268|FG003|Overall Study|Lack of Efficacy|6|||
13452609|NCT00259272|26946265|FG000|Overall Study|Physician Decision|1|||
13452610|NCT00259272|26946266|FG001|Overall Study|Physician Decision|2|||
13452611|NCT00259272|26946267|FG002|Overall Study|Physician Decision|1|||
13452612|NCT00259272|26946268|FG003|Overall Study|Physician Decision|3|||
13452613|NCT00259272|26946265|FG000|Overall Study|Protocol Violation|2|||
13452614|NCT00259272|26946266|FG001|Overall Study|Protocol Violation|0|||
13452615|NCT00259272|26946267|FG002|Overall Study|Protocol Violation|0|||
13452616|NCT00259272|26946268|FG003|Overall Study|Protocol Violation|1|||
13452617|NCT00259272|26946265|FG000|Overall Study|Sponsor Decision|0|||
13452618|NCT00259272|26946266|FG001|Overall Study|Sponsor Decision|1|||
13452619|NCT00259272|26946267|FG002|Overall Study|Sponsor Decision|0|||
13452620|NCT00259272|26946268|FG003|Overall Study|Sponsor Decision|0|||
13452621|NCT00259272|26946265|FG000|Overall Study|Withdrawal by Subject|4|||
13452622|NCT00259272|26946266|FG001|Overall Study|Withdrawal by Subject|2|||
13452623|NCT00259272|26946267|FG002|Overall Study|Withdrawal by Subject|2|||
13452624|NCT00259272|26946268|FG003|Overall Study|Withdrawal by Subject|7|||
13452625|NCT00259272|26946265|FG000|Overall Study|Lost to Follow-up|1|||
13452626|NCT00259272|26946266|FG001|Overall Study|Lost to Follow-up|0|||
13452627|NCT00259272|26946267|FG002|Overall Study|Lost to Follow-up|0|||
13452628|NCT00259272|26946268|FG003|Overall Study|Lost to Follow-up|1|||
13452629|NCT00259012|26946307|FG000|Overall Study|Adverse Event|0|||
13452630|NCT00259012|26946308|FG001|Overall Study|Adverse Event|1|||
13452631|NCT00259012|26946307|FG000|Overall Study|Withdrawal by Subject|1|||
13452632|NCT00259012|26946308|FG001|Overall Study|Withdrawal by Subject|0|||
13452633|NCT00259012|26946307|FG000|Overall Study|Physician Decision|0|||
13452634|NCT00259012|26946308|FG001|Overall Study|Physician Decision|1|||
13452635|NCT00259012|26946307|FG000|Overall Study|Lost to Follow-up|0|||
13452636|NCT00259012|26946308|FG001|Overall Study|Lost to Follow-up|1|||
13452637|NCT00259012|26946307|FG000|Overall Study|Protocol Violation|1|||
13452638|NCT00259012|26946308|FG001|Overall Study|Protocol Violation|1|||
13452639|NCT00258960|26946318|FG000|Overall Study|Death|2|||
13452640|NCT00258960|26946318|FG000|Overall Study|Disease Progression|7|||
13452641|NCT00258960|26946318|FG000|Overall Study|Adverse Event|4|||
13452642|NCT00258960|26946318|FG000|Overall Study|Physician Decision|1|||
13452643|NCT00258960|26946318|FG000|Overall Study|Withdrawal by Subject|1|||
13452644|NCT00258960|26946318|FG000|Overall Study|Mistake|2|||
13452645|NCT00258895|26946339|FG000|Overall Study|Lost to Follow-up|3|||
13452646|NCT00258895|26946340|FG001|Overall Study|Lost to Follow-up|1|||
13452647|NCT00258895|26946339|FG000|Overall Study|Protocol Violation|6|||
13452648|NCT00258895|26946340|FG001|Overall Study|Protocol Violation|2|||
13452649|NCT00258895|26946339|FG000|Overall Study|Withdrawal by Subject|1|||
13452650|NCT00258895|26946340|FG001|Overall Study|Withdrawal by Subject|0|||
13452651|NCT00258856|26946363|FG000|Overall Study|Lost to Follow-up|1|||
13452652|NCT00258856|26946364|FG001|Overall Study|Lost to Follow-up|0|||
13452653|NCT00258856|26946365|FG002|Overall Study|Lost to Follow-up|2|||
13452654|NCT00258856|26946366|FG003|Overall Study|Lost to Follow-up|0|||
13452655|NCT00258856|26946363|FG000|Overall Study|Non-compliance|2|||
13452656|NCT00258856|26946364|FG001|Overall Study|Non-compliance|0|||
13452657|NCT00258856|26946365|FG002|Overall Study|Non-compliance|0|||
13452658|NCT00258856|26946366|FG003|Overall Study|Non-compliance|1|||
13452659|NCT00258674|26946432|FG000|Overall Study|Death|32|||
13452660|NCT00258674|26946433|FG001|Overall Study|Death|53|||
13452661|NCT00258674|26946434|FG002|Overall Study|Death|34|||
13452662|NCT00258440|26946455|FG000|Overall Study|Withdrawal by Subject|0|||
13452663|NCT00258440|26946456|FG001|Overall Study|Withdrawal by Subject|0|||
13452664|NCT00258440|26946457|FG002|Overall Study|Withdrawal by Subject|1|||
13452665|NCT00258154|26946532|FG000|Overall Study|Adverse Event|1|||
13452666|NCT00258154|26946533|FG001|Overall Study|Adverse Event|0|||
13452667|NCT00258154|26946532|FG000|Overall Study|Lost to Follow-up|0|||
13452668|NCT00258154|26946533|FG001|Overall Study|Lost to Follow-up|1|||
13452669|NCT00258154|26946532|FG000|Overall Study|Protocol Violation|2|||
13452670|NCT00258154|26946533|FG001|Overall Study|Protocol Violation|1|||
13452671|NCT00258154|26946532|FG000|Overall Study|Withdrawal by Subject|3|||
13452672|NCT00258154|26946533|FG001|Overall Study|Withdrawal by Subject|4|||
13452673|NCT00258154|26946532|FG000|Overall Study|Patient Moved|3|||
13452674|NCT00258154|26946533|FG001|Overall Study|Patient Moved|1|||
13452675|NCT00257920|26946548|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0|||
13452676|NCT00257920|26946549|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1|||
13452677|NCT00257920|26946548|FG000|Period: Second Intervention|Other|2|||
13452678|NCT00257920|26946549|FG001|Period: Second Intervention|Other|1|||
13452679|NCT00257725|26946557|FG000|Overall Study|Adverse Event|3|||
13452680|NCT00257660|26946592|FG000|Overall Study|Lack of Efficacy|5|||
13452681|NCT00257660|26946593|FG001|Overall Study|Lack of Efficacy|23|||
13452682|NCT00257660|26946592|FG000|Overall Study|Withdrawal by Subject|2|||
13452683|NCT00257660|26946593|FG001|Overall Study|Withdrawal by Subject|0|||
13452684|NCT00257660|26946592|FG000|Overall Study|Lost to Follow-up|1|||
13452685|NCT00257660|26946593|FG001|Overall Study|Lost to Follow-up|0|||
13452686|NCT00257660|26946592|FG000|Overall Study|PI & Subject Schedule Conflicts|1|||
13452687|NCT00257660|26946593|FG001|Overall Study|PI & Subject Schedule Conflicts|0|||
13452688|NCT00257660|26946592|FG000|Overall Study|No longer wanted to do blood draws|1|||
13452689|NCT00257660|26946593|FG001|Overall Study|No longer wanted to do blood draws|0|||
13452690|NCT00257608|26946625|FG000|Chemotherapy Phase|Adverse Event|138|||
13452691|NCT00257608|26946626|FG001|Chemotherapy Phase|Adverse Event|0|||
13452692|NCT00257608|26946627|FG002|Chemotherapy Phase|Adverse Event|0|||
13452693|NCT00257608|26946625|FG000|Chemotherapy Phase|Disease progression|139|||
13452694|NCT00257608|26946626|FG001|Chemotherapy Phase|Disease progression|0|||
13452695|NCT00257608|26946627|FG002|Chemotherapy Phase|Disease progression|0|||
13452696|NCT00257608|26946625|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6|||
13452697|NCT00257608|26946626|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0|||
13452698|NCT00257608|26946627|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0|||
13452699|NCT00257608|26946625|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27|||
13452700|NCT00257608|26946626|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
13452701|NCT00257608|26946627|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
13452702|NCT00257608|26946625|FG000|Chemotherapy Phase|Patient's decision to discontinue|35|||
13452703|NCT00257608|26946626|FG001|Chemotherapy Phase|Patient's decision to discontinue|0|||
13452704|NCT00257608|26946627|FG002|Chemotherapy Phase|Patient's decision to discontinue|0|||
13452705|NCT00257608|26946625|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3|||
13452706|NCT00257608|26946626|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0|||
13452707|NCT00257608|26946627|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0|||
13452708|NCT00257608|26946625|FG000|Chemotherapy Phase|Physician Decision|28|||
13452709|NCT00257608|26946626|FG001|Chemotherapy Phase|Physician Decision|0|||
13452710|NCT00257608|26946627|FG002|Chemotherapy Phase|Physician Decision|0|||
13452711|NCT00257608|26946625|FG000|Post Chemotherapy Phase|Adverse Event|0|||
13452712|NCT00257608|26946626|FG001|Post Chemotherapy Phase|Adverse Event|34|||
13452713|NCT00257608|26946627|FG002|Post Chemotherapy Phase|Adverse Event|38|||
13452714|NCT00257608|26946625|FG000|Post Chemotherapy Phase|Disease progression|0|||
13452715|NCT00257608|26946626|FG001|Post Chemotherapy Phase|Disease progression|204|||
13452716|NCT00257608|26946627|FG002|Post Chemotherapy Phase|Disease progression|168|||
13452717|NCT00257608|26946625|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0|||
13452718|NCT00257608|26946626|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4|||
13452719|NCT00257608|26946627|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5|||
13452720|NCT00257608|26946625|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
13452721|NCT00257608|26946626|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
13452722|NCT00257608|26946627|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
13452723|NCT00257608|26946625|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0|||
13452724|NCT00257608|26946626|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4|||
13452725|NCT00257608|26946627|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8|||
13452726|NCT00257608|26946625|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
13452727|NCT00257608|26946626|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
13452728|NCT00257608|26946627|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1|||
13452729|NCT00257608|26946625|FG000|Post Chemotherapy Phase|Lost to Follow-up|0|||
13452730|NCT00257608|26946626|FG001|Post Chemotherapy Phase|Lost to Follow-up|0|||
13452731|NCT00257608|26946627|FG002|Post Chemotherapy Phase|Lost to Follow-up|1|||
13452732|NCT00257608|26946625|FG000|Post Chemotherapy Phase|Physician Decision|0|||
13452733|NCT00257608|26946626|FG001|Post Chemotherapy Phase|Physician Decision|8|||
13452734|NCT00257608|26946627|FG002|Post Chemotherapy Phase|Physician Decision|11|||
13452735|NCT00257608|26946625|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
13452736|NCT00257608|26946626|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1|||
13452737|NCT00257608|26946627|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
13452738|NCT00257608|26946625|FG000|Post Chemotherapy Phase|Not treated|0|||
13452739|NCT00257608|26946626|FG001|Post Chemotherapy Phase|Not treated|4|||
13452740|NCT00257608|26946627|FG002|Post Chemotherapy Phase|Not treated|7|||
13452741|NCT00257556|26946660|FG000|Overall Study|Adverse Event|1|||
13452742|NCT00257556|26946661|FG001|Overall Study|Adverse Event|4|||
13452743|NCT00257556|26946660|FG000|Overall Study|Physician Decision|6|||
13452744|NCT00257556|26946661|FG001|Overall Study|Physician Decision|0|||
13452745|NCT00257556|26946660|FG000|Overall Study|Did not meet hCG criterion|3|||
13452746|NCT00257556|26946661|FG001|Overall Study|Did not meet hCG criterion|0|||
13452747|NCT00257556|26946660|FG000|Overall Study|other reason|4|||
13452748|NCT00257556|26946661|FG001|Overall Study|other reason|6|||
13452749|NCT00257192|26946710|FG000|Overall Study|Adverse Event|21|||
13452750|NCT00257192|26946711|FG001|Overall Study|Adverse Event|10|||
13452751|NCT00257192|26946710|FG000|Overall Study|Laboratory abnormality|1|||
13452752|NCT00257192|26946711|FG001|Overall Study|Laboratory abnormality|1|||
13452753|NCT00257192|26946710|FG000|Overall Study|Lost to Follow-up|3|||
13452754|NCT00257192|26946711|FG001|Overall Study|Lost to Follow-up|3|||
13452755|NCT00257192|26946710|FG000|Overall Study|Insufficient clinical response|18|||
13452756|NCT00257192|26946711|FG001|Overall Study|Insufficient clinical response|18|||
13452757|NCT00257192|26946710|FG000|Overall Study|Withdrawal by Subject|14|||
13452758|NCT00257192|26946711|FG001|Overall Study|Withdrawal by Subject|2|||
13452759|NCT00257192|26946710|FG000|Overall Study|Randomized but not treated|0|||
13452760|NCT00257192|26946711|FG001|Overall Study|Randomized but not treated|1|||
13452761|NCT00257192|26946710|FG000|Overall Study|Study terminated by sponsor|1|||
13452762|NCT00257192|26946711|FG001|Overall Study|Study terminated by sponsor|0|||
13452763|NCT00257192|26946710|FG000|Overall Study|Miscellaneous|0|||
13452764|NCT00257192|26946711|FG001|Overall Study|Miscellaneous|4|||
13452765|NCT00257166|26946730|FG000|Overall Study|Adverse Event|18|||
13452766|NCT00257166|26946731|FG001|Overall Study|Adverse Event|13|||
13452767|NCT00257166|26946730|FG000|Overall Study|Laboratory abnormality|1|||
13452768|NCT00257166|26946731|FG001|Overall Study|Laboratory abnormality|0|||
13452769|NCT00257166|26946730|FG000|Overall Study|Lost to Follow-up|8|||
13452770|NCT00257166|26946731|FG001|Overall Study|Lost to Follow-up|1|||
13452771|NCT00257166|26946730|FG000|Overall Study|Withdrawal by Subject|9|||
13452772|NCT00257166|26946731|FG001|Overall Study|Withdrawal by Subject|2|||
13452773|NCT00257166|26946730|FG000|Overall Study|Other|16|||
13452774|NCT00257166|26946731|FG001|Overall Study|Other|21|||
13452775|NCT00257166|26946730|FG000|Overall Study|Randomized, but not treated|1|||
13452776|NCT00257166|26946731|FG001|Overall Study|Randomized, but not treated|0|||
13452777|NCT00257010|26946742|FG000|Overall Study|Lack of Efficacy|11|||
13452778|NCT00257010|26946742|FG000|Overall Study|Lost to Follow-up|53|||
13452779|NCT00257010|26946742|FG000|Overall Study|Withdrawal by Subject|34|||
13452780|NCT00257010|26946742|FG000|Overall Study|Adverse Event|10|||
13452781|NCT00257010|26946742|FG000|Overall Study|various|11|||
13452782|NCT00257010|26946742|FG000|Overall Study|no headache reported|9|||
13452783|NCT00256997|26946773|FG000|Overall Study|Protocol Violation|1|||
13452784|NCT00256997|26946774|FG001|Overall Study|Protocol Violation|4|||
13452785|NCT00256997|26946773|FG000|Overall Study|Lack of Efficacy|1|||
13452786|NCT00256997|26946774|FG001|Overall Study|Lack of Efficacy|4|||
13452787|NCT00256997|26946773|FG000|Overall Study|Death|2|||
13452788|NCT00256997|26946774|FG001|Overall Study|Death|0|||
13452789|NCT00256997|26946773|FG000|Overall Study|Adverse Event|4|||
13452790|NCT00256997|26946774|FG001|Overall Study|Adverse Event|0|||
13452791|NCT00256997|26946773|FG000|Overall Study|Lost to Follow-up|3|||
13452792|NCT00256997|26946774|FG001|Overall Study|Lost to Follow-up|5|||
13452793|NCT00256997|26946773|FG000|Overall Study|Withdrawal by Subject|13|||
13452794|NCT00256997|26946774|FG001|Overall Study|Withdrawal by Subject|3|||
13452795|NCT00256997|26946773|FG000|Overall Study|Started but not treated|2|||
13452796|NCT00256997|26946774|FG001|Overall Study|Started but not treated|0|||
13452797|NCT00256997|26946773|FG000|Overall Study|Other|5|||
13452798|NCT00256997|26946774|FG001|Overall Study|Other|8|||
13452799|NCT00256997|26946773|FG000|Overall Study|End of Study (As Per Sponsor)|12|||
13452800|NCT00256997|26946774|FG001|Overall Study|End of Study (As Per Sponsor)|24|||
13452801|NCT00256997|26946773|FG000|Overall Study|Participant Non-compliant|3|||
13452802|NCT00256997|26946774|FG001|Overall Study|Participant Non-compliant|6|||
13452803|NCT00256997|26946773|FG000|Overall Study|Investigator Withdrew Participant|2|||
13452804|NCT00256997|26946774|FG001|Overall Study|Investigator Withdrew Participant|1|||
13452805|NCT00256867|26946883|FG000|Overall Study|Adverse Event|0|||
13452806|NCT00256867|26946884|FG001|Overall Study|Adverse Event|1|||
13452807|NCT00256867|26946885|FG002|Overall Study|Adverse Event|1|||
13452808|NCT00256867|26946886|FG003|Overall Study|Adverse Event|1|||
13452809|NCT00256867|26946887|FG004|Overall Study|Adverse Event|2|||
13452810|NCT00256867|26946888|FG005|Overall Study|Adverse Event|2|||
13452811|NCT00256867|26946889|FG006|Overall Study|Adverse Event|1|||
13452812|NCT00256867|26946890|FG007|Overall Study|Adverse Event|4|||
13452813|NCT00256867|26946883|FG000|Overall Study|Lost to Follow-up|2|||
13452814|NCT00256867|26946884|FG001|Overall Study|Lost to Follow-up|2|||
13452815|NCT00256867|26946885|FG002|Overall Study|Lost to Follow-up|2|||
13452816|NCT00256867|26946886|FG003|Overall Study|Lost to Follow-up|3|||
13452817|NCT00256867|26946887|FG004|Overall Study|Lost to Follow-up|2|||
13452818|NCT00256867|26946888|FG005|Overall Study|Lost to Follow-up|0|||
13452819|NCT00256867|26946889|FG006|Overall Study|Lost to Follow-up|1|||
13452820|NCT00256867|26946890|FG007|Overall Study|Lost to Follow-up|2|||
13452821|NCT00256867|26946883|FG000|Overall Study|Protocol Violation|0|||
13452822|NCT00256867|26946884|FG001|Overall Study|Protocol Violation|0|||
13452823|NCT00256867|26946885|FG002|Overall Study|Protocol Violation|0|||
13452824|NCT00256867|26946886|FG003|Overall Study|Protocol Violation|1|||
13452825|NCT00256867|26946887|FG004|Overall Study|Protocol Violation|0|||
13452826|NCT00256867|26946888|FG005|Overall Study|Protocol Violation|1|||
13452827|NCT00256867|26946889|FG006|Overall Study|Protocol Violation|0|||
13452828|NCT00256867|26946890|FG007|Overall Study|Protocol Violation|1|||
13452829|NCT00256867|26946883|FG000|Overall Study|Withdrawal by Subject|0|||
13452830|NCT00256867|26946884|FG001|Overall Study|Withdrawal by Subject|0|||
13452831|NCT00256867|26946885|FG002|Overall Study|Withdrawal by Subject|1|||
13452832|NCT00256867|26946886|FG003|Overall Study|Withdrawal by Subject|1|||
13452833|NCT00256867|26946887|FG004|Overall Study|Withdrawal by Subject|2|||
13452834|NCT00256867|26946888|FG005|Overall Study|Withdrawal by Subject|2|||
13452835|NCT00256867|26946889|FG006|Overall Study|Withdrawal by Subject|3|||
13452836|NCT00256867|26946890|FG007|Overall Study|Withdrawal by Subject|2|||
13452837|NCT00256867|26946883|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
13452838|NCT00256867|26946884|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1|||
13452839|NCT00256867|26946885|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
13452840|NCT00256867|26946886|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
13452841|NCT00256867|26946887|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
13452842|NCT00256867|26946888|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
13452843|NCT00256867|26946889|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
13452844|NCT00256867|26946890|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
13452845|NCT00256867|26946883|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0|||
13452846|NCT00256867|26946884|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0|||
13452847|NCT00256867|26946885|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0|||
13452848|NCT00256867|26946886|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0|||
13452849|NCT00256867|26946887|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0|||
13452850|NCT00256867|26946888|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0|||
13452851|NCT00256867|26946889|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0|||
13452852|NCT00256867|26946890|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1|||
13452853|NCT00256867|26946883|FG000|Overall Study|Investigator's Decision|0|||
13452854|NCT00256867|26946884|FG001|Overall Study|Investigator's Decision|0|||
13452855|NCT00256867|26946885|FG002|Overall Study|Investigator's Decision|0|||
13452856|NCT00256867|26946886|FG003|Overall Study|Investigator's Decision|0|||
13452857|NCT00256867|26946887|FG004|Overall Study|Investigator's Decision|1|||
13452858|NCT00256867|26946888|FG005|Overall Study|Investigator's Decision|0|||
13452859|NCT00256867|26946889|FG006|Overall Study|Investigator's Decision|0|||
13452860|NCT00256867|26946890|FG007|Overall Study|Investigator's Decision|0|||
13452861|NCT00256867|26946883|FG000|Overall Study|Non-compliance with study medication|0|||
13452862|NCT00256867|26946884|FG001|Overall Study|Non-compliance with study medication|0|||
13452863|NCT00256867|26946885|FG002|Overall Study|Non-compliance with study medication|0|||
13452864|NCT00256867|26946886|FG003|Overall Study|Non-compliance with study medication|0|||
13452865|NCT00256867|26946887|FG004|Overall Study|Non-compliance with study medication|0|||
13452866|NCT00256867|26946888|FG005|Overall Study|Non-compliance with study medication|0|||
13452867|NCT00256867|26946889|FG006|Overall Study|Non-compliance with study medication|0|||
13452868|NCT00256867|26946890|FG007|Overall Study|Non-compliance with study medication|1|||
13452869|NCT00256867|26946883|FG000|Overall Study|Participant travelled Overseas|0|||
13452870|NCT00256867|26946884|FG001|Overall Study|Participant travelled Overseas|1|||
13452871|NCT00256867|26946885|FG002|Overall Study|Participant travelled Overseas|0|||
13452872|NCT00256867|26946886|FG003|Overall Study|Participant travelled Overseas|0|||
13452873|NCT00256867|26946887|FG004|Overall Study|Participant travelled Overseas|0|||
13452874|NCT00256867|26946888|FG005|Overall Study|Participant travelled Overseas|0|||
13452875|NCT00256867|26946889|FG006|Overall Study|Participant travelled Overseas|0|||
13452876|NCT00256867|26946890|FG007|Overall Study|Participant travelled Overseas|0|||
13452877|NCT00256867|26946883|FG000|Overall Study|Participant out of assessment window|0|||
13452878|NCT00256867|26946884|FG001|Overall Study|Participant out of assessment window|0|||
13452879|NCT00256867|26946885|FG002|Overall Study|Participant out of assessment window|1|||
13452880|NCT00256867|26946886|FG003|Overall Study|Participant out of assessment window|0|||
13452881|NCT00256867|26946887|FG004|Overall Study|Participant out of assessment window|0|||
13452882|NCT00256867|26946888|FG005|Overall Study|Participant out of assessment window|0|||
13452883|NCT00256867|26946889|FG006|Overall Study|Participant out of assessment window|0|||
13452884|NCT00256867|26946890|FG007|Overall Study|Participant out of assessment window|0|||
13452885|NCT00256867|26946883|FG000|Overall Study|Withdrawal by participant|0|||
13452886|NCT00256867|26946884|FG001|Overall Study|Withdrawal by participant|0|||
13452887|NCT00256867|26946885|FG002|Overall Study|Withdrawal by participant|0|||
13452888|NCT00256867|26946886|FG003|Overall Study|Withdrawal by participant|0|||
13452889|NCT00256867|26946887|FG004|Overall Study|Withdrawal by participant|0|||
13452890|NCT00256867|26946888|FG005|Overall Study|Withdrawal by participant|1|||
13452891|NCT00256867|26946889|FG006|Overall Study|Withdrawal by participant|0|||
13452892|NCT00256867|26946890|FG007|Overall Study|Withdrawal by participant|0|||
13452893|NCT00256854|26946965|FG000|Overall Study|Withdrawal by Subject|2|||
13452894|NCT00256854|26946966|FG001|Overall Study|Withdrawal by Subject|3|||
13452895|NCT00256854|26946967|FG002|Overall Study|Withdrawal by Subject|0|||
13452896|NCT00256854|26946968|FG003|Overall Study|Withdrawal by Subject|0|||
13452897|NCT00256854|26946969|FG004|Overall Study|Withdrawal by Subject|0|||
13452898|NCT00256854|26946970|FG005|Overall Study|Withdrawal by Subject|0|||
13452899|NCT00256854|26946965|FG000|Overall Study|Lack of Efficacy|1|||
13452900|NCT00256854|26946966|FG001|Overall Study|Lack of Efficacy|0|||
13452901|NCT00256854|26946967|FG002|Overall Study|Lack of Efficacy|0|||
13452902|NCT00256854|26946968|FG003|Overall Study|Lack of Efficacy|0|||
13452903|NCT00256854|26946969|FG004|Overall Study|Lack of Efficacy|0|||
13452904|NCT00256854|26946970|FG005|Overall Study|Lack of Efficacy|0|||
13452905|NCT00256854|26946965|FG000|Overall Study|Protocol Violation|0|||
13452906|NCT00256854|26946966|FG001|Overall Study|Protocol Violation|1|||
13452907|NCT00256854|26946967|FG002|Overall Study|Protocol Violation|1|||
13452908|NCT00256854|26946968|FG003|Overall Study|Protocol Violation|1|||
13452909|NCT00256854|26946969|FG004|Overall Study|Protocol Violation|0|||
13452910|NCT00256854|26946970|FG005|Overall Study|Protocol Violation|0|||
13452911|NCT00256854|26946965|FG000|Overall Study|Adverse Event|0|||
13452912|NCT00256854|26946966|FG001|Overall Study|Adverse Event|0|||
13452913|NCT00256854|26946967|FG002|Overall Study|Adverse Event|2|||
13452914|NCT00256854|26946968|FG003|Overall Study|Adverse Event|2|||
13452915|NCT00256854|26946969|FG004|Overall Study|Adverse Event|0|||
13452916|NCT00256854|26946970|FG005|Overall Study|Adverse Event|1|||
13452917|NCT00256854|26946965|FG000|Overall Study|Not compliant with the study drug|0|||
13452918|NCT00256854|26946966|FG001|Overall Study|Not compliant with the study drug|0|||
13452919|NCT00256854|26946967|FG002|Overall Study|Not compliant with the study drug|0|||
13452920|NCT00256854|26946968|FG003|Overall Study|Not compliant with the study drug|0|||
13452921|NCT00256854|26946969|FG004|Overall Study|Not compliant with the study drug|1|||
13452922|NCT00256854|26946970|FG005|Overall Study|Not compliant with the study drug|0|||
13452923|NCT00256750|26947114|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3|||
13452924|NCT00256750|26947115|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
13452925|NCT00256750|26947116|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
13452926|NCT00256750|26947114|FG000|Transplanted Pre-Treatment|Other|2|||
13452927|NCT00256750|26947115|FG001|Transplanted Pre-Treatment|Other|0|||
13452928|NCT00256750|26947116|FG002|Transplanted Pre-Treatment|Other|0|||
13452929|NCT00256750|26947114|FG000|Transplanted Pre-Treatment|Death|1|||
13452930|NCT00256750|26947115|FG001|Transplanted Pre-Treatment|Death|0|||
13452931|NCT00256750|26947116|FG002|Transplanted Pre-Treatment|Death|0|||
13452932|NCT00256750|26947114|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20|||
13452933|NCT00256750|26947115|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12|||
13452934|NCT00256750|26947116|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8|||
13452935|NCT00256750|26947114|FG000|Post-Transplant Treated (12 Months)|Death|3|||
13452936|NCT00256750|26947115|FG001|Post-Transplant Treated (12 Months)|Death|2|||
13452937|NCT00256750|26947116|FG002|Post-Transplant Treated (12 Months)|Death|4|||
13452938|NCT00256750|26947114|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10|||
13452939|NCT00256750|26947115|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22|||
13452940|NCT00256750|26947116|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27|||
13452941|NCT00256750|26947114|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1|||
13452942|NCT00256750|26947115|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
13452943|NCT00256750|26947116|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
13452944|NCT00256750|26947114|FG000|Post-Transplant Treated (12 Months)|Other|5|||
13452945|NCT00256750|26947115|FG001|Post-Transplant Treated (12 Months)|Other|4|||
13452946|NCT00256750|26947116|FG002|Post-Transplant Treated (12 Months)|Other|2|||
13452947|NCT00256750|26947114|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0|||
13452948|NCT00256750|26947115|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3|||
13452949|NCT00256750|26947116|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5|||
13452950|NCT00256750|26947114|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2|||
13452951|NCT00256750|26947115|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
13452952|NCT00256750|26947116|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
13452953|NCT00256750|26947114|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7|||
13452954|NCT00256750|26947115|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3|||
13452955|NCT00256750|26947116|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6|||
13452956|NCT00256750|26947114|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5|||
13452957|NCT00256750|26947115|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1|||
13452958|NCT00256750|26947116|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0|||
13452959|NCT00256750|26947114|FG000|Post-Transplant Treated (24 Months)|Death|3|||
13452960|NCT00256750|26947115|FG001|Post-Transplant Treated (24 Months)|Death|0|||
13452961|NCT00256750|26947116|FG002|Post-Transplant Treated (24 Months)|Death|0|||
13452962|NCT00256750|26947114|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4|||
13452963|NCT00256750|26947115|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3|||
13452964|NCT00256750|26947116|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2|||
13452965|NCT00256750|26947114|FG000|Post-Transplant Treated (24 Months)|Other|2|||
13452966|NCT00256750|26947115|FG001|Post-Transplant Treated (24 Months)|Other|0|||
13452967|NCT00256750|26947116|FG002|Post-Transplant Treated (24 Months)|Other|1|||
13452968|NCT00256750|26947114|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5|||
13452969|NCT00256750|26947115|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1|||
13452970|NCT00256750|26947116|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2|||
13452971|NCT00256750|26947114|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
13452972|NCT00256750|26947115|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0|||
13452973|NCT00256750|26947116|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
13452974|NCT00256750|26947114|FG000|Post-Transplant Treated (36 Months)|Death|0|||
13452975|NCT00256750|26947115|FG001|Post-Transplant Treated (36 Months)|Death|2|||
13452976|NCT00256750|26947116|FG002|Post-Transplant Treated (36 Months)|Death|1|||
13452977|NCT00256750|26947114|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
13452978|NCT00256750|26947115|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
13452979|NCT00256750|26947116|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1|||
13452980|NCT00256750|26947114|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4|||
13452981|NCT00256750|26947115|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1|||
13452982|NCT00256750|26947116|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0|||
13452983|NCT00256750|26947114|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
13452984|NCT00256750|26947115|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1|||
13452985|NCT00256750|26947116|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
13452986|NCT00256750|26947114|FG000|Post-Transplant Treated (36 Months)|Other|0|||
13452987|NCT00256750|26947115|FG001|Post-Transplant Treated (36 Months)|Other|1|||
13452988|NCT00256750|26947116|FG002|Post-Transplant Treated (36 Months)|Other|1|||
13452989|NCT00256750|26947114|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13|||
13452990|NCT00256750|26947115|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11|||
13452991|NCT00256750|26947116|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14|||
13452992|NCT00256750|26947114|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5|||
13452993|NCT00256750|26947115|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4|||
13452994|NCT00256750|26947116|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1|||
13452995|NCT00256750|26947114|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4|||
13452996|NCT00256750|26947115|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
13452997|NCT00256750|26947116|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
13452998|NCT00256750|26947114|FG000|Long Term Extension (LTE; 84 Months)|Death|9|||
13452999|NCT00256750|26947115|FG001|Long Term Extension (LTE; 84 Months)|Death|4|||
13453000|NCT00256750|26947116|FG002|Long Term Extension (LTE; 84 Months)|Death|4|||
13453001|NCT00256750|26947114|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6|||
13453002|NCT00256750|26947115|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3|||
13453003|NCT00256750|26947116|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0|||
13453004|NCT00256750|26947114|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4|||
13453005|NCT00256750|26947115|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
13453006|NCT00256750|26947116|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
13453007|NCT00256750|26947114|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0|||
13453008|NCT00256750|26947115|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1|||
13453009|NCT00256750|26947116|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2|||
13453010|NCT00256750|26947114|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
13453011|NCT00256750|26947115|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
13453012|NCT00256750|26947116|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0|||
13453013|NCT00256750|26947114|FG000|Long Term Extension (LTE; 84 Months)|Other|5|||
13453014|NCT00256750|26947115|FG001|Long Term Extension (LTE; 84 Months)|Other|4|||
13453015|NCT00256750|26947116|FG002|Long Term Extension (LTE; 84 Months)|Other|5|||
13453016|NCT00256724|26947131|FG000|Overall Study|Physician Decision|2|||
13453017|NCT00256724|26947132|FG001|Overall Study|Physician Decision|5|||
13453018|NCT00256724|26947131|FG000|Overall Study|Protocol Violation|3|||
13453019|NCT00256724|26947132|FG001|Overall Study|Protocol Violation|3|||
13453020|NCT00256698|26947157|FG000|Overall Study|Withdrawal by Subject|7|||
13453021|NCT00256698|26947158|FG001|Overall Study|Withdrawal by Subject|7|||
13453022|NCT00256698|26947157|FG000|Overall Study|Adverse Event|13|||
13453023|NCT00256698|26947158|FG001|Overall Study|Adverse Event|6|||
13453024|NCT00256698|26947157|FG000|Overall Study|Protocol Violation|6|||
13453025|NCT00256698|26947158|FG001|Overall Study|Protocol Violation|5|||
13453026|NCT00256698|26947157|FG000|Overall Study|Lost to Follow-up|1|||
13453027|NCT00256698|26947158|FG001|Overall Study|Lost to Follow-up|3|||
13453028|NCT00256698|26947157|FG000|Overall Study|disease progression|97|||
13453029|NCT00256698|26947158|FG001|Overall Study|disease progression|105|||
13453030|NCT00256698|26947157|FG000|Overall Study|still ongoing at data cut-off|41|||
13453031|NCT00256698|26947158|FG001|Overall Study|still ongoing at data cut-off|46|||
13453032|NCT00256698|26947157|FG000|Overall Study|withdrawn due to osteoporosis|1|||
13453033|NCT00256698|26947158|FG001|Overall Study|withdrawn due to osteoporosis|0|||
13453034|NCT00256698|26947157|FG000|Overall Study|Prematurely Discontinued|1|||
13453035|NCT00256698|26947158|FG001|Overall Study|Prematurely Discontinued|0|||
13453036|NCT00256308|26947168|FG000|Overall Study|Death|2|||
13453037|NCT00256295|26947176|FG000|Overall Study|Withdrawal by Subject|3|||
13453038|NCT00256295|26947176|FG000|Overall Study|Death|1|||
13453039|NCT00256282|26947183|FG000|Overall Study|Disease progression, relapse during acti|12|||
13453040|NCT00256282|26947183|FG000|Overall Study|Adverse Event|3|||
13453041|NCT00256282|26947183|FG000|Overall Study|Physician Decision|1|||
13453042|NCT00256243|26947190|FG000|Overall Study|Lost to Follow-up|2|||
13453043|NCT00256243|26947190|FG000|Overall Study|Death|7|||
13453044|NCT00256243|26947190|FG000|Overall Study|Not treated|1|||
13453045|NCT00256204|26947216|FG000|Overall Study|Adverse Event|10|||
13453046|NCT00256204|26947217|FG001|Overall Study|Adverse Event|14|||
13453047|NCT00256204|26947218|FG002|Overall Study|Adverse Event|16|||
13453048|NCT00256204|26947219|FG003|Overall Study|Adverse Event|14|||
13453049|NCT00256204|26947216|FG000|Overall Study|Death|0|||
13453050|NCT00256204|26947217|FG001|Overall Study|Death|1|||
13453051|NCT00256204|26947218|FG002|Overall Study|Death|0|||
13453052|NCT00256204|26947219|FG003|Overall Study|Death|0|||
13453053|NCT00256204|26947216|FG000|Overall Study|Lost to Follow-up|1|||
13453054|NCT00256204|26947217|FG001|Overall Study|Lost to Follow-up|1|||
13453055|NCT00256204|26947218|FG002|Overall Study|Lost to Follow-up|1|||
13453056|NCT00256204|26947219|FG003|Overall Study|Lost to Follow-up|2|||
13453057|NCT00256204|26947216|FG000|Overall Study|Protocol Violation|1|||
13453058|NCT00256204|26947217|FG001|Overall Study|Protocol Violation|0|||
13453059|NCT00256204|26947218|FG002|Overall Study|Protocol Violation|2|||
13453060|NCT00256204|26947219|FG003|Overall Study|Protocol Violation|1|||
13453061|NCT00256204|26947216|FG000|Overall Study|Physician Decision|0|||
13453062|NCT00256204|26947217|FG001|Overall Study|Physician Decision|0|||
13453063|NCT00256204|26947218|FG002|Overall Study|Physician Decision|1|||
13453064|NCT00256204|26947219|FG003|Overall Study|Physician Decision|2|||
13453065|NCT00256204|26947216|FG000|Overall Study|Withdrawal by Subject|17|||
13453066|NCT00256204|26947217|FG001|Overall Study|Withdrawal by Subject|6|||
13453067|NCT00256204|26947218|FG002|Overall Study|Withdrawal by Subject|7|||
13453068|NCT00256204|26947219|FG003|Overall Study|Withdrawal by Subject|5|||
13453069|NCT00256204|26947216|FG000|Overall Study|Need for additional prohibited treatment|38|||
13453070|NCT00256204|26947217|FG001|Overall Study|Need for additional prohibited treatment|28|||
13453071|NCT00256204|26947218|FG002|Overall Study|Need for additional prohibited treatment|27|||
13453072|NCT00256204|26947219|FG003|Overall Study|Need for additional prohibited treatment|25|||
13453073|NCT00256126|26947242|FG000|Overall Study|Adverse Event|1|||
13453074|NCT00256126|26947243|FG001|Overall Study|Adverse Event|0|||
13453075|NCT00256126|26947242|FG000|Overall Study|Other|1|||
13453076|NCT00256126|26947243|FG001|Overall Study|Other|2|||
13453077|NCT00255944|26947256|FG000|Overall Study|Lost to Follow-up|797|||
13453078|NCT00255944|26947257|FG001|Overall Study|Lost to Follow-up|834|||
13453079|NCT00255840|26947270|FG000|Overall Study|Lost to Follow-up|10|||
13453080|NCT00255840|26947271|FG001|Overall Study|Lost to Follow-up|14|||
13453081|NCT00255840|26947270|FG000|Overall Study|Discontinued intervention|53|||
13453082|NCT00255840|26947271|FG001|Overall Study|Discontinued intervention|56|||
13453083|NCT00255723|26947284|FG000|Overall Study|Adverse Event|1|||
13453084|NCT00255723|26947285|FG001|Overall Study|Adverse Event|1|||
13453085|NCT00255723|26947284|FG000|Overall Study|Death|0|||
13453086|NCT00255723|26947285|FG001|Overall Study|Death|1|||
13453087|NCT00255723|26947284|FG000|Overall Study|Response Data Not Available|1|||
13453088|NCT00255723|26947285|FG001|Overall Study|Response Data Not Available|0|||
13453089|NCT00255346|26947314|FG000|Overall Study|Adverse Event|1|||
13453090|NCT00255346|26947315|FG001|Overall Study|Adverse Event|0|||
13453091|NCT00255346|26947316|FG002|Overall Study|Adverse Event|0|||
13453092|NCT00255346|26947317|FG003|Overall Study|Adverse Event|0|||
13453093|NCT00255346|26947318|FG004|Overall Study|Adverse Event|0|||
13453094|NCT00255190|26947389|FG000|Overall Study|Adverse Event|17|||
13453095|NCT00255190|26947390|FG001|Overall Study|Adverse Event|36|||
13453096|NCT00255190|26947389|FG000|Overall Study|Protocol Violation|2|||
13453097|NCT00255190|26947390|FG001|Overall Study|Protocol Violation|2|||
13453098|NCT00255190|26947389|FG000|Overall Study|Lost to Follow-up|10|||
13453099|NCT00255190|26947390|FG001|Overall Study|Lost to Follow-up|27|||
13453100|NCT00255190|26947389|FG000|Overall Study|Withdrew Consent|17|||
13453101|NCT00255190|26947390|FG001|Overall Study|Withdrew Consent|48|||
13453102|NCT00255190|26947389|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
13453103|NCT00255190|26947390|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
13453104|NCT00255190|26947389|FG000|Overall Study|Erosive esophagitis not healed|0|||
13453105|NCT00255190|26947390|FG001|Overall Study|Erosive esophagitis not healed|20|||
13453106|NCT00255190|26947389|FG000|Overall Study|Various|4|||
13453107|NCT00255190|26947390|FG001|Overall Study|Various|23|||
13453108|NCT00255164|26947423|FG000|Overall Study|Adverse Event|10|||
13453109|NCT00255164|26947424|FG001|Overall Study|Adverse Event|6|||
13453110|NCT00255164|26947425|FG002|Overall Study|Adverse Event|9|||
13453111|NCT00255164|26947423|FG000|Overall Study|Lost to Follow-up|4|||
13453112|NCT00255164|26947424|FG001|Overall Study|Lost to Follow-up|3|||
13453113|NCT00255164|26947425|FG002|Overall Study|Lost to Follow-up|4|||
13453114|NCT00255164|26947423|FG000|Overall Study|Withdrawal by Subject|18|||
13453115|NCT00255164|26947424|FG001|Overall Study|Withdrawal by Subject|17|||
13453116|NCT00255164|26947425|FG002|Overall Study|Withdrawal by Subject|8|||
13453117|NCT00255164|26947423|FG000|Overall Study|Noncompliance|0|||
13453118|NCT00255164|26947424|FG001|Overall Study|Noncompliance|1|||
13453119|NCT00255164|26947425|FG002|Overall Study|Noncompliance|2|||
13453120|NCT00255164|26947423|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
13453121|NCT00255164|26947424|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
13453122|NCT00255164|26947425|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
13453123|NCT00255164|26947423|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
13453124|NCT00255164|26947424|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
13453125|NCT00255164|26947425|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
13453126|NCT00255164|26947423|FG000|Overall Study|Possible Barrett's Esophagus|1|||
13453127|NCT00255164|26947424|FG001|Overall Study|Possible Barrett's Esophagus|3|||
13453128|NCT00255164|26947425|FG002|Overall Study|Possible Barrett's Esophagus|8|||
13453129|NCT00255164|26947423|FG000|Overall Study|Esophageal Stricture|0|||
13453130|NCT00255164|26947424|FG001|Overall Study|Esophageal Stricture|0|||
13453131|NCT00255164|26947425|FG002|Overall Study|Esophageal Stricture|1|||
13453132|NCT00255164|26947423|FG000|Overall Study|Therapeutic Failure|11|||
13453133|NCT00255164|26947424|FG001|Overall Study|Therapeutic Failure|2|||
13453134|NCT00255164|26947425|FG002|Overall Study|Therapeutic Failure|3|||
13453135|NCT00255151|26947458|FG000|Overall Study|Adverse Event|10|||
13453136|NCT00255151|26947459|FG001|Overall Study|Adverse Event|6|||
13453137|NCT00255151|26947460|FG002|Overall Study|Adverse Event|9|||
13453138|NCT00255151|26947458|FG000|Overall Study|Lost to Follow-up|4|||
13453139|NCT00255151|26947459|FG001|Overall Study|Lost to Follow-up|3|||
13453140|NCT00255151|26947460|FG002|Overall Study|Lost to Follow-up|4|||
13453141|NCT00255151|26947458|FG000|Overall Study|Withdrawal by Subject|18|||
13453142|NCT00255151|26947459|FG001|Overall Study|Withdrawal by Subject|17|||
13453143|NCT00255151|26947460|FG002|Overall Study|Withdrawal by Subject|8|||
13453144|NCT00255151|26947458|FG000|Overall Study|Noncompliance|0|||
13453145|NCT00255151|26947459|FG001|Overall Study|Noncompliance|1|||
13453146|NCT00255151|26947460|FG002|Overall Study|Noncompliance|2|||
13453147|NCT00255151|26947458|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
13453148|NCT00255151|26947459|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
13453149|NCT00255151|26947460|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
13453150|NCT00255151|26947458|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
13453151|NCT00255151|26947459|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
13453152|NCT00255151|26947460|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
13453153|NCT00255151|26947458|FG000|Overall Study|Possible Barrett's Esophagus|1|||
13453154|NCT00255151|26947459|FG001|Overall Study|Possible Barrett's Esophagus|3|||
13453155|NCT00255151|26947460|FG002|Overall Study|Possible Barrett's Esophagus|8|||
13453156|NCT00255151|26947458|FG000|Overall Study|Esophageal Stricture|0|||
13453157|NCT00255151|26947459|FG001|Overall Study|Esophageal Stricture|0|||
13453158|NCT00255151|26947460|FG002|Overall Study|Esophageal Stricture|1|||
13453159|NCT00255151|26947458|FG000|Overall Study|Therapeutic Failure|11|||
13453160|NCT00255151|26947459|FG001|Overall Study|Therapeutic Failure|2|||
13453161|NCT00255151|26947460|FG002|Overall Study|Therapeutic Failure|3|||
13453162|NCT00255086|26947475|FG000|Overall Study|Adverse Event|1|||
13453163|NCT00255086|26947476|FG001|Overall Study|Adverse Event|1|||
13453164|NCT00255086|26947475|FG000|Overall Study|Protocol Violation|1|||
13453165|NCT00255086|26947476|FG001|Overall Study|Protocol Violation|1|||
13453166|NCT00255047|26947511|FG000|Overall Study|Serious Adverse Events|2|||
13453167|NCT00255047|26947512|FG001|Overall Study|Serious Adverse Events|1|||
13453168|NCT00255047|26947513|FG002|Overall Study|Serious Adverse Events|2|||
13453169|NCT00255047|26947514|FG003|Overall Study|Serious Adverse Events|1|||
13453170|NCT00255047|26947511|FG000|Overall Study|Adverse Event|0|||
13453171|NCT00255047|26947512|FG001|Overall Study|Adverse Event|3|||
13453172|NCT00255047|26947513|FG002|Overall Study|Adverse Event|2|||
13453173|NCT00255047|26947514|FG003|Overall Study|Adverse Event|1|||
13453174|NCT00255047|26947511|FG000|Overall Study|Protocol Violation|13|||
13453175|NCT00255047|26947512|FG001|Overall Study|Protocol Violation|13|||
13453176|NCT00255047|26947513|FG002|Overall Study|Protocol Violation|16|||
13453177|NCT00255047|26947514|FG003|Overall Study|Protocol Violation|20|||
13453178|NCT00255047|26947511|FG000|Overall Study|Lost to Follow-up|9|||
13453179|NCT00255047|26947512|FG001|Overall Study|Lost to Follow-up|8|||
13453180|NCT00255047|26947513|FG002|Overall Study|Lost to Follow-up|5|||
13453181|NCT00255047|26947514|FG003|Overall Study|Lost to Follow-up|6|||
13453182|NCT00255047|26947511|FG000|Overall Study|Withdrawal by Subject|24|||
13453183|NCT00255047|26947512|FG001|Overall Study|Withdrawal by Subject|23|||
13453184|NCT00255047|26947513|FG002|Overall Study|Withdrawal by Subject|25|||
13453185|NCT00255047|26947514|FG003|Overall Study|Withdrawal by Subject|18|||
13453186|NCT00255034|26947527|FG000|Overall Study|Withdrawal by Subject|15|||
13453187|NCT00255034|26947528|FG001|Overall Study|Withdrawal by Subject|38|||
13453188|NCT00255008|26947551|FG000|Overall Study|Adverse Event|1|||
13453189|NCT00255008|26947552|FG001|Overall Study|Adverse Event|1|||
13453190|NCT00255008|26947553|FG002|Overall Study|Adverse Event|2|||
13453191|NCT00255008|26947554|FG003|Overall Study|Adverse Event|0|||
13453192|NCT00255008|26947551|FG000|Overall Study|Lost to Follow-up|1|||
13453193|NCT00255008|26947552|FG001|Overall Study|Lost to Follow-up|0|||
13453194|NCT00255008|26947553|FG002|Overall Study|Lost to Follow-up|1|||
13453195|NCT00255008|26947554|FG003|Overall Study|Lost to Follow-up|2|||
13453196|NCT00255008|26947551|FG000|Overall Study|Did not meet viral reduction criteria|4|||
13453197|NCT00255008|26947552|FG001|Overall Study|Did not meet viral reduction criteria|5|||
13453198|NCT00255008|26947553|FG002|Overall Study|Did not meet viral reduction criteria|0|||
13453199|NCT00255008|26947554|FG003|Overall Study|Did not meet viral reduction criteria|1|||
13453200|NCT00255008|26947551|FG000|Overall Study|Withdrew consent|0|||
13453201|NCT00255008|26947552|FG001|Overall Study|Withdrew consent|0|||
13453202|NCT00255008|26947553|FG002|Overall Study|Withdrew consent|2|||
13453203|NCT00255008|26947554|FG003|Overall Study|Withdrew consent|0|||
13453204|NCT00255008|26947551|FG000|Overall Study|Sponsor request|18|||
13453205|NCT00255008|26947552|FG001|Overall Study|Sponsor request|3|||
13453206|NCT00255008|26947553|FG002|Overall Study|Sponsor request|8|||
13453207|NCT00255008|26947554|FG003|Overall Study|Sponsor request|17|||
13453208|NCT00255008|26947551|FG000|Overall Study|Adverse lab experience|1|||
13453209|NCT00255008|26947552|FG001|Overall Study|Adverse lab experience|0|||
13453210|NCT00255008|26947553|FG002|Overall Study|Adverse lab experience|0|||
13453211|NCT00255008|26947554|FG003|Overall Study|Adverse lab experience|0|||
13453212|NCT00255008|26947551|FG000|Overall Study|Other|7|||
13453213|NCT00255008|26947552|FG001|Overall Study|Other|0|||
13453214|NCT00255008|26947553|FG002|Overall Study|Other|3|||
13453215|NCT00255008|26947554|FG003|Overall Study|Other|2|||
13453216|NCT00254982|26947567|FG000|Overall Study|Other|2|||
13453217|NCT00254982|26947568|FG001|Overall Study|Other|1|||
13453218|NCT00254982|26947567|FG000|Overall Study|Lack of Efficacy|5|||
13453219|NCT00254982|26947568|FG001|Overall Study|Lack of Efficacy|3|||
13453220|NCT00254982|26947567|FG000|Overall Study|Lost to Follow-up|5|||
13453221|NCT00254982|26947568|FG001|Overall Study|Lost to Follow-up|3|||
13453222|NCT00254982|26947567|FG000|Overall Study|Adverse Event|18|||
13453223|NCT00254982|26947568|FG001|Overall Study|Adverse Event|16|||
13453224|NCT00254982|26947567|FG000|Overall Study|Withdrawal by Subject|1|||
13453225|NCT00254982|26947568|FG001|Overall Study|Withdrawal by Subject|1|||
13453226|NCT00254982|26947567|FG000|Overall Study|Inclusion/exclusion criteria violation|0|||
13453227|NCT00254982|26947568|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
13453228|NCT00254982|26947567|FG000|Overall Study|Protocol deviation|1|||
13453229|NCT00254982|26947568|FG001|Overall Study|Protocol deviation|1|||
13453230|NCT00254982|26947567|FG000|Overall Study|Diagnosis of Tuberculosis|1|||
13453231|NCT00254982|26947568|FG001|Overall Study|Diagnosis of Tuberculosis|1|||
13453232|NCT00254982|26947567|FG000|Overall Study|Malignancy|0|||
13453233|NCT00254982|26947568|FG001|Overall Study|Malignancy|2|||
13453234|NCT00254982|26947567|FG000|Overall Study|Opportunistic infection|1|||
13453235|NCT00254982|26947568|FG001|Overall Study|Opportunistic infection|0|||
13453236|NCT00254982|26947567|FG000|Overall Study|Abnormal liver function tests|2|||
13453237|NCT00254982|26947568|FG001|Overall Study|Abnormal liver function tests|1|||
13453238|NCT00254566|26947597|FG000|Overall Study|Death|1|||
13453239|NCT00254566|26947598|FG001|Overall Study|Death|0|||
13453240|NCT00254566|26947597|FG000|Overall Study|Adverse Event|5|||
13453241|NCT00254566|26947598|FG001|Overall Study|Adverse Event|4|||
13453242|NCT00254566|26947597|FG000|Overall Study|Lack of Efficacy|12|||
13453243|NCT00254566|26947598|FG001|Overall Study|Lack of Efficacy|9|||
13453244|NCT00254566|26947597|FG000|Overall Study|Other|1|||
13453245|NCT00254566|26947598|FG001|Overall Study|Other|5|||
13453246|NCT00254566|26947597|FG000|Overall Study|Withdrawal by Subject|5|||
13453247|NCT00254566|26947598|FG001|Overall Study|Withdrawal by Subject|6|||
13453248|NCT00254566|26947597|FG000|Overall Study|Lost to Follow-up|7|||
13453249|NCT00254566|26947598|FG001|Overall Study|Lost to Follow-up|2|||
13453250|NCT00254540|26947632|FG000|Overall Study|Adverse Event|6|||
13453251|NCT00254540|26947633|FG001|Overall Study|Adverse Event|7|||
13453252|NCT00254540|26947632|FG000|Overall Study|Lack of Efficacy|13|||
13453253|NCT00254540|26947633|FG001|Overall Study|Lack of Efficacy|13|||
13453254|NCT00254540|26947632|FG000|Overall Study|Death|0|||
13453255|NCT00254540|26947633|FG001|Overall Study|Death|1|||
13453256|NCT00254540|26947632|FG000|Overall Study|Laboratory Test Abnormality|0|||
13453257|NCT00254540|26947633|FG001|Overall Study|Laboratory Test Abnormality|1|||
13453258|NCT00254501|26947652|FG000|Overall Study|Lost to Follow-up|1|||
13453259|NCT00254501|26947653|FG001|Overall Study|Lost to Follow-up|1|||
13453260|NCT00254397|26947684|FG000|Overall Study|Disease Progression|4|||
13453261|NCT00254397|26947685|FG001|Overall Study|Disease Progression|1|||
13453262|NCT00254397|26947686|FG002|Overall Study|Disease Progression|16|||
13453263|NCT00254397|26947687|FG003|Overall Study|Disease Progression|23|||
13453264|NCT00254397|26947684|FG000|Overall Study|Non-Compliant|0|||
13453265|NCT00254397|26947685|FG001|Overall Study|Non-Compliant|0|||
13453266|NCT00254397|26947686|FG002|Overall Study|Non-Compliant|0|||
13453267|NCT00254397|26947687|FG003|Overall Study|Non-Compliant|1|||
13453268|NCT00254397|26947684|FG000|Overall Study|Adverse Event|2|||
13453269|NCT00254397|26947685|FG001|Overall Study|Adverse Event|0|||
13453270|NCT00254397|26947686|FG002|Overall Study|Adverse Event|3|||
13453271|NCT00254397|26947687|FG003|Overall Study|Adverse Event|1|||
13453272|NCT00254293|26947788|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
13453273|NCT00254293|26947789|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
13453274|NCT00254293|26947790|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
13453275|NCT00254293|26947791|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
13453276|NCT00254293|26947792|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
13453277|NCT00254293|26947793|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
13453278|NCT00254293|26947794|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
13453279|NCT00254293|26947788|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
13453280|NCT00254293|26947789|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
13453281|NCT00254293|26947790|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1|||
13453282|NCT00254293|26947791|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
13453283|NCT00254293|26947792|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
13453284|NCT00254293|26947793|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
13453285|NCT00254293|26947794|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
13453286|NCT00254293|26947788|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
13453287|NCT00254293|26947789|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
13453288|NCT00254293|26947790|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2|||
13453289|NCT00254293|26947791|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
13453290|NCT00254293|26947792|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
13453291|NCT00254293|26947793|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
13453292|NCT00254293|26947794|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
13453293|NCT00254293|26947788|FG000|LTE Open Label Variable SC Dosing|Death|0|||
13453294|NCT00254293|26947789|FG001|LTE Open Label Variable SC Dosing|Death|0|||
13453295|NCT00254293|26947790|FG002|LTE Open Label Variable SC Dosing|Death|1|||
13453296|NCT00254293|26947791|FG003|LTE Open Label Variable SC Dosing|Death|0|||
13453297|NCT00254293|26947792|FG004|LTE Open Label Variable SC Dosing|Death|0|||
13453298|NCT00254293|26947793|FG005|LTE Open Label Variable SC Dosing|Death|0|||
13453299|NCT00254293|26947794|FG006|LTE Open Label Variable SC Dosing|Death|0|||
13453300|NCT00254293|26947788|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1|||
13453301|NCT00254293|26947789|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0|||
13453302|NCT00254293|26947790|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2|||
13453303|NCT00254293|26947791|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0|||
13453304|NCT00254293|26947792|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1|||
13453305|NCT00254293|26947793|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0|||
13453306|NCT00254293|26947794|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0|||
13453307|NCT00254293|26947788|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
13453308|NCT00254293|26947789|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
13453309|NCT00254293|26947790|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
13453310|NCT00254293|26947791|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
13453311|NCT00254293|26947792|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1|||
13453312|NCT00254293|26947793|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
13453313|NCT00254293|26947794|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
13453314|NCT00254293|26947788|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
13453315|NCT00254293|26947789|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
13453316|NCT00254293|26947790|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1|||
13453317|NCT00254293|26947791|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
13453318|NCT00254293|26947792|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
13453319|NCT00254293|26947793|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
13453320|NCT00254293|26947794|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
13453321|NCT00254293|26947788|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
13453322|NCT00254293|26947789|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
13453323|NCT00254293|26947790|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1|||
13453324|NCT00254293|26947791|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
13453325|NCT00254293|26947792|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
13453326|NCT00254293|26947793|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
13453327|NCT00254293|26947794|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
13453328|NCT00254293|26947788|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
13453329|NCT00254293|26947789|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
13453330|NCT00254293|26947790|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1|||
13453331|NCT00254293|26947791|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
13453332|NCT00254293|26947792|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
13453333|NCT00254293|26947793|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
13453334|NCT00254293|26947794|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
13453335|NCT00254293|26947788|FG000|LTE Open Label Variable SC Dosing|Other|0|||
13453336|NCT00254293|26947789|FG001|LTE Open Label Variable SC Dosing|Other|0|||
13453337|NCT00254293|26947790|FG002|LTE Open Label Variable SC Dosing|Other|2|||
13453338|NCT00254293|26947791|FG003|LTE Open Label Variable SC Dosing|Other|0|||
13453339|NCT00254293|26947792|FG004|LTE Open Label Variable SC Dosing|Other|0|||
13453340|NCT00254293|26947793|FG005|LTE Open Label Variable SC Dosing|Other|0|||
13453341|NCT00254293|26947794|FG006|LTE Open Label Variable SC Dosing|Other|0|||
13453342|NCT00254293|26947788|FG000|LTE Open Label Fixed Dosing|Death|0|||
13453343|NCT00254293|26947789|FG001|LTE Open Label Fixed Dosing|Death|0|||
13453344|NCT00254293|26947790|FG002|LTE Open Label Fixed Dosing|Death|0|||
13453345|NCT00254293|26947791|FG003|LTE Open Label Fixed Dosing|Death|0|||
13453346|NCT00254293|26947792|FG004|LTE Open Label Fixed Dosing|Death|0|||
13453347|NCT00254293|26947793|FG005|LTE Open Label Fixed Dosing|Death|0|||
13453348|NCT00254293|26947794|FG006|LTE Open Label Fixed Dosing|Death|3|||
13453349|NCT00254293|26947788|FG000|LTE Open Label Fixed Dosing|Adverse Event|0|||
13453350|NCT00254293|26947789|FG001|LTE Open Label Fixed Dosing|Adverse Event|0|||
13453351|NCT00254293|26947790|FG002|LTE Open Label Fixed Dosing|Adverse Event|0|||
13453352|NCT00254293|26947791|FG003|LTE Open Label Fixed Dosing|Adverse Event|0|||
13453353|NCT00254293|26947792|FG004|LTE Open Label Fixed Dosing|Adverse Event|0|||
13453354|NCT00254293|26947793|FG005|LTE Open Label Fixed Dosing|Adverse Event|0|||
13453355|NCT00254293|26947794|FG006|LTE Open Label Fixed Dosing|Adverse Event|1|||
13453356|NCT00254293|26947788|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
13453357|NCT00254293|26947789|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
13453358|NCT00254293|26947790|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
13453359|NCT00254293|26947791|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
13453360|NCT00254293|26947792|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
13453361|NCT00254293|26947793|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
13453362|NCT00254293|26947794|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3|||
13453363|NCT00254293|26947788|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
13453364|NCT00254293|26947789|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
13453365|NCT00254293|26947790|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
13453366|NCT00254293|26947791|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
13453367|NCT00254293|26947792|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
13453368|NCT00254293|26947793|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
13453369|NCT00254293|26947794|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1|||
13453370|NCT00254293|26947788|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
13453371|NCT00254293|26947789|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
13453372|NCT00254293|26947790|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
13453373|NCT00254293|26947791|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
13453374|NCT00254293|26947792|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
13453375|NCT00254293|26947793|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
13453376|NCT00254293|26947794|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3|||
13453377|NCT00254293|26947788|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
13453378|NCT00254293|26947789|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
13453379|NCT00254293|26947790|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
13453380|NCT00254293|26947791|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
13453381|NCT00254293|26947792|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
13453382|NCT00254293|26947793|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
13453383|NCT00254293|26947794|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1|||
13453384|NCT00254293|26947788|FG000|LTE Open Label Fixed Dosing|Other|0|||
13453385|NCT00254293|26947789|FG001|LTE Open Label Fixed Dosing|Other|0|||
13453386|NCT00254293|26947790|FG002|LTE Open Label Fixed Dosing|Other|0|||
13453387|NCT00254293|26947791|FG003|LTE Open Label Fixed Dosing|Other|0|||
13453388|NCT00254293|26947792|FG004|LTE Open Label Fixed Dosing|Other|0|||
13453389|NCT00254293|26947793|FG005|LTE Open Label Fixed Dosing|Other|0|||
13453390|NCT00254293|26947794|FG006|LTE Open Label Fixed Dosing|Other|1|||
13453391|NCT00254163|26947823|FG000|Overall Study|Adverse Event|29|||
13453392|NCT00254163|26947824|FG001|Overall Study|Adverse Event|26|||
13453393|NCT00254163|26947823|FG000|Overall Study|Patient request/withdrew consent|6|||
13453394|NCT00254163|26947824|FG001|Overall Study|Patient request/withdrew consent|4|||
13453395|NCT00254163|26947823|FG000|Overall Study|Investigator request|1|||
13453396|NCT00254163|26947824|FG001|Overall Study|Investigator request|3|||
13453397|NCT00254163|26947823|FG000|Overall Study|Failed entry|1|||
13453398|NCT00254163|26947824|FG001|Overall Study|Failed entry|3|||
13453399|NCT00254163|26947823|FG000|Overall Study|Progressive disease|0|||
13453400|NCT00254163|26947824|FG001|Overall Study|Progressive disease|1|||
13453401|NCT00254163|26947823|FG000|Overall Study|Death|0|||
13453402|NCT00254163|26947824|FG001|Overall Study|Death|1|||
13453403|NCT00254163|26947823|FG000|Overall Study|Other|8|||
13453404|NCT00254163|26947824|FG001|Overall Study|Other|8|||
13453405|NCT00253747|26947849|FG000|Overall Study|Lost to Follow-up|13|||
13453406|NCT00253747|26947850|FG001|Overall Study|Lost to Follow-up|14|||
13453407|NCT00253747|26947849|FG000|Overall Study|Withdrawal by Subject|10|||
13453408|NCT00253747|26947850|FG001|Overall Study|Withdrawal by Subject|11|||
13453409|NCT00253747|26947849|FG000|Overall Study|Administrative Discharge (1), Other (2)|1|||
13453410|NCT00253747|26947850|FG001|Overall Study|Administrative Discharge (1), Other (2)|2|||
13453411|NCT00253643|26947877|FG000|Overall Study|Withdrawal by Subject|0|||
13453412|NCT00253643|26947878|FG001|Overall Study|Withdrawal by Subject|0|||
13453413|NCT00253643|26947879|FG002|Overall Study|Withdrawal by Subject|1|||
13453414|NCT00253643|26947880|FG003|Overall Study|Withdrawal by Subject|1|||
13453415|NCT00253643|26947877|FG000|Overall Study|Non-Compliance|0|||
13453416|NCT00253643|26947878|FG001|Overall Study|Non-Compliance|0|||
13453417|NCT00253643|26947879|FG002|Overall Study|Non-Compliance|0|||
13453418|NCT00253643|26947880|FG003|Overall Study|Non-Compliance|2|||
13453419|NCT00253630|26947891|FG000|Overall Study|ineligible|2|||
13453420|NCT00253448|26947897|FG000|Overall Study|Withdrawal by Subject|1|||
13453421|NCT00253370|26947905|FG000|Overall Study|Adverse Event|18|||
13453422|NCT00253370|26947905|FG000|Overall Study|Disease progression|13|||
13453423|NCT00253370|26947905|FG000|Overall Study|Death|2|||
13453424|NCT00253370|26947905|FG000|Overall Study|Withdrawal by Subject|6|||
13453425|NCT00253370|26947905|FG000|Overall Study|Non-protocol therapy|1|||
13453426|NCT00253370|26947905|FG000|Overall Study|Physician Decision|1|||
13453427|NCT00253370|26947905|FG000|Overall Study|Protocol Violation|1|||
13453428|NCT00253370|26947905|FG000|Overall Study|Abdominal pain due to disease|1|||
13453429|NCT00252733|26947920|FG000|Overall Study|Withdrawal by Subject|73|||
13453430|NCT00252733|26947921|FG001|Overall Study|Withdrawal by Subject|67|||
13453431|NCT00252733|26947920|FG000|Overall Study|Death|7|||
13453432|NCT00252733|26947921|FG001|Overall Study|Death|5|||
13453433|NCT00252733|26947920|FG000|Overall Study|Lost to Follow-up|12|||
13453434|NCT00252733|26947921|FG001|Overall Study|Lost to Follow-up|6|||
13453435|NCT00252733|26947920|FG000|Overall Study|Multiple Reasons|14|||
13453436|NCT00252733|26947921|FG001|Overall Study|Multiple Reasons|14|||
13453437|NCT00252720|26947940|FG000|Overall Study|Withdrawal by Subject|95|||
13453438|NCT00252720|26947941|FG001|Overall Study|Withdrawal by Subject|97|||
13453439|NCT00252720|26947940|FG000|Overall Study|Death|7|||
13453440|NCT00252720|26947941|FG001|Overall Study|Death|8|||
13453441|NCT00252720|26947940|FG000|Overall Study|Moving|23|||
13453442|NCT00252720|26947941|FG001|Overall Study|Moving|42|||
13453443|NCT00252720|26947940|FG000|Overall Study|Mainly patients lost to follow-up|7|||
13453444|NCT00252720|26947941|FG001|Overall Study|Mainly patients lost to follow-up|18|||
13453445|NCT00252694|26947960|FG000|Overall Study|Withdrawal by Subject|83|||
13453446|NCT00252694|26947961|FG001|Overall Study|Withdrawal by Subject|91|||
13453447|NCT00252694|26947960|FG000|Overall Study|Death|36|||
13453448|NCT00252694|26947961|FG001|Overall Study|Death|34|||
13453449|NCT00252694|26947960|FG000|Overall Study|Mostly Lost to Follow Up|8|||
13453450|NCT00252694|26947961|FG001|Overall Study|Mostly Lost to Follow Up|13|||
13453451|NCT00252694|26947960|FG000|Overall Study|Patient Moving|17|||
13453452|NCT00252694|26947961|FG001|Overall Study|Patient Moving|16|||
13477342|NCT03470922|27006346|FG000|Overall Study|Not reported|1|||
13477343|NCT03470922|27006347|FG001|Overall Study|Not reported|0|||
13477344|NCT03465722|27006366|FG000|Overall Study|Withdrawal by Subject|21|||
13477345|NCT03465722|27006367|FG001|Overall Study|Withdrawal by Subject|14|||
13477346|NCT03465722|27006366|FG000|Overall Study|Death|89|||
13477347|NCT03465722|27006367|FG001|Overall Study|Death|87|||
13477348|NCT03465722|27006366|FG000|Overall Study|Lost to Follow-up|5|||
13477349|NCT03465722|27006367|FG001|Overall Study|Lost to Follow-up|3|||
13477350|NCT03465722|27006366|FG000|Overall Study|Administrative/Other|33|||
13477351|NCT03465722|27006367|FG001|Overall Study|Administrative/Other|32|||
13477352|NCT03465722|27006366|FG000|Overall Study|Not treated|1|||
13477353|NCT03465722|27006367|FG001|Overall Study|Not treated|2|||
13477354|NCT03465722|27006366|FG000|Overall Study|Sponsor decision|91|||
13477355|NCT03465722|27006367|FG001|Overall Study|Sponsor decision|98|||
13477356|NCT03205423|27006392|FG000|Overall Study|Personal|1|||
13477357|NCT03205423|27006393|FG001|Overall Study|Personal|1|||
13477358|NCT03205423|27006392|FG000|Overall Study|Physician Decision|0|||
13477359|NCT03205423|27006393|FG001|Overall Study|Physician Decision|2|||
13477360|NCT03104400|27006488|FG000|Overall Study|Adverse Event|5|||
13477361|NCT03104400|27006489|FG001|Overall Study|Adverse Event|7|||
13477362|NCT03104400|27006490|FG002|Overall Study|Adverse Event|11|||
13477363|NCT03104400|27006491|FG003|Overall Study|Adverse Event|9|||
13477364|NCT03104400|27006492|FG004|Overall Study|Adverse Event|21|||
13477365|NCT03104400|27006488|FG000|Overall Study|Withdrawal by Subject|17|||
13477366|NCT03104400|27006489|FG001|Overall Study|Withdrawal by Subject|19|||
13477367|NCT03104400|27006490|FG002|Overall Study|Withdrawal by Subject|29|||
13477368|NCT03104400|27006491|FG003|Overall Study|Withdrawal by Subject|25|||
13477369|NCT03104400|27006492|FG004|Overall Study|Withdrawal by Subject|24|||
13477370|NCT03104400|27006488|FG000|Overall Study|Lost to Follow-up|4|||
13477371|NCT03104400|27006489|FG001|Overall Study|Lost to Follow-up|1|||
13477372|NCT03104400|27006490|FG002|Overall Study|Lost to Follow-up|4|||
13477373|NCT03104400|27006491|FG003|Overall Study|Lost to Follow-up|8|||
13477374|NCT03104400|27006492|FG004|Overall Study|Lost to Follow-up|7|||
13477375|NCT03104400|27006488|FG000|Overall Study|Lack of Efficacy|6|||
13477376|NCT03104400|27006489|FG001|Overall Study|Lack of Efficacy|3|||
13477377|NCT03104400|27006490|FG002|Overall Study|Lack of Efficacy|8|||
13477378|NCT03104400|27006491|FG003|Overall Study|Lack of Efficacy|2|||
13477379|NCT03104400|27006492|FG004|Overall Study|Lack of Efficacy|1|||
13477380|NCT03104400|27006488|FG000|Overall Study|COVID Logistical Restrictions|0|||
13477381|NCT03104400|27006489|FG001|Overall Study|COVID Logistical Restrictions|0|||
13477382|NCT03104400|27006490|FG002|Overall Study|COVID Logistical Restrictions|0|||
13477383|NCT03104400|27006491|FG003|Overall Study|COVID Logistical Restrictions|1|||
13477384|NCT03104400|27006492|FG004|Overall Study|COVID Logistical Restrictions|0|||
13477385|NCT03104400|27006488|FG000|Overall Study|Other|2|||
13477386|NCT03104400|27006489|FG001|Overall Study|Other|3|||
13477387|NCT03104400|27006490|FG002|Overall Study|Other|7|||
13477388|NCT03104400|27006491|FG003|Overall Study|Other|6|||
13477389|NCT03104400|27006492|FG004|Overall Study|Other|4|||
13477390|NCT03104400|27006488|FG000|Overall Study|Other|0|||
13477391|NCT03104400|27006489|FG001|Overall Study|Other|1|||
13477392|NCT03104400|27006490|FG002|Overall Study|Other|0|||
13477393|NCT03104400|27006491|FG003|Overall Study|Other|0|||
13477394|NCT03104400|27006492|FG004|Overall Study|Other|0|||
13477395|NCT03104374|27006543|FG000|Overall Study|Adverse Event|7|||
13477396|NCT03104374|27006544|FG001|Overall Study|Adverse Event|6|||
13477397|NCT03104374|27006545|FG002|Overall Study|Adverse Event|12|||
13477398|NCT03104374|27006546|FG003|Overall Study|Adverse Event|15|||
13477399|NCT03104374|27006543|FG000|Overall Study|Withdrawal by Subject|18|||
13477400|NCT03104374|27006544|FG001|Overall Study|Withdrawal by Subject|10|||
13477401|NCT03104374|27006545|FG002|Overall Study|Withdrawal by Subject|10|||
13477402|NCT03104374|27006546|FG003|Overall Study|Withdrawal by Subject|17|||
13477403|NCT03104374|27006543|FG000|Overall Study|Lost to Follow-up|4|||
13477404|NCT03104374|27006544|FG001|Overall Study|Lost to Follow-up|4|||
13477405|NCT03104374|27006545|FG002|Overall Study|Lost to Follow-up|6|||
13477406|NCT03104374|27006546|FG003|Overall Study|Lost to Follow-up|8|||
13453453|NCT00252577|26947967|FG000|Overall Study|Lost to Follow-up|20|||
13453454|NCT00252564|26947986|FG000|Overall Study|Adverse Event|17|||
13453455|NCT00252564|26947987|FG001|Overall Study|Adverse Event|13|||
13453456|NCT00252564|26947986|FG000|Overall Study|Unrelated Complication|2|||
13453457|NCT00252564|26947987|FG001|Overall Study|Unrelated Complication|1|||
13453458|NCT00252564|26947986|FG000|Overall Study|Disease Progression|14|||
13453459|NCT00252564|26947987|FG001|Overall Study|Disease Progression|20|||
13453460|NCT00252564|26947986|FG000|Overall Study|Death|0|||
13453461|NCT00252564|26947987|FG001|Overall Study|Death|3|||
13453462|NCT00252564|26947986|FG000|Overall Study|Physician Decision|1|||
13453463|NCT00252564|26947987|FG001|Overall Study|Physician Decision|0|||
13453464|NCT00252564|26947986|FG000|Overall Study|Lost to Follow-up|1|||
13453465|NCT00252564|26947987|FG001|Overall Study|Lost to Follow-up|0|||
13453466|NCT00252564|26947986|FG000|Overall Study|Patient Request|4|||
13453467|NCT00252564|26947987|FG001|Overall Study|Patient Request|5|||
13453468|NCT00252564|26947986|FG000|Overall Study|Withdrawal by Subject|0|||
13453469|NCT00252564|26947987|FG001|Overall Study|Withdrawal by Subject|2|||
13453470|NCT00252499|26948020|FG000|Overall Study|Lost to Follow-up|1|||
13453471|NCT00252499|26948021|FG001|Overall Study|Lost to Follow-up|0|||
13453472|NCT00252499|26948022|FG002|Overall Study|Lost to Follow-up|0|||
13453473|NCT00252239|26948045|FG000|Overall Study|Withdrawal by Subject|1|||
13453474|NCT00252239|26948046|FG001|Overall Study|Withdrawal by Subject|0|||
13453475|NCT00252239|26948047|FG002|Overall Study|Withdrawal by Subject|0|||
13453476|NCT00252239|26948048|FG003|Overall Study|Withdrawal by Subject|1|||
13453477|NCT00252239|26948045|FG000|Overall Study|Lost to Follow-up|0|||
13453478|NCT00252239|26948046|FG001|Overall Study|Lost to Follow-up|0|||
13453479|NCT00252239|26948047|FG002|Overall Study|Lost to Follow-up|2|||
13453480|NCT00252239|26948048|FG003|Overall Study|Lost to Follow-up|0|||
13453481|NCT00252187|26948075|FG000|Overall Study|Adverse Event|3|||
13453482|NCT00252187|26948076|FG001|Overall Study|Adverse Event|1|||
13453483|NCT00252187|26948075|FG000|Overall Study|Withdrawal by Subject|1|||
13453484|NCT00252187|26948076|FG001|Overall Study|Withdrawal by Subject|0|||
13453485|NCT00252174|26948124|FG000|Overall Study|Withdrawal by Subject|0|||
13453486|NCT00252174|26948125|FG001|Overall Study|Withdrawal by Subject|1|||
13453487|NCT00252174|26948126|FG002|Overall Study|Withdrawal by Subject|0|||
13453488|NCT00252057|26948139|FG000|Overall Study|Withdrawal by Subject|2|||
13453489|NCT00252057|26948140|FG001|Overall Study|Withdrawal by Subject|5|||
13453490|NCT00252057|26948139|FG000|Overall Study|Death|1|||
13453491|NCT00252057|26948140|FG001|Overall Study|Death|2|||
13453492|NCT00252057|26948139|FG000|Overall Study|Participant previously enrolled|0|||
13453493|NCT00252057|26948140|FG001|Overall Study|Participant previously enrolled|1|||
13453494|NCT00251979|26948177|FG000|Overall Study|Protocol Violation|3|||
13453495|NCT00251979|26948178|FG001|Overall Study|Protocol Violation|5|||
13453496|NCT00251979|26948177|FG000|Overall Study|Adverse Event|11|||
13453497|NCT00251979|26948178|FG001|Overall Study|Adverse Event|17|||
13453498|NCT00251979|26948177|FG000|Overall Study|Withdrawal by Subject|13|||
13453499|NCT00251979|26948178|FG001|Overall Study|Withdrawal by Subject|7|||
13453500|NCT00251979|26948177|FG000|Overall Study|Lost to Follow-up|8|||
13453501|NCT00251979|26948178|FG001|Overall Study|Lost to Follow-up|6|||
13453502|NCT00251979|26948177|FG000|Overall Study|Death|3|||
13453503|NCT00251979|26948178|FG001|Overall Study|Death|5|||
13453504|NCT00251927|26948212|FG000|Overall Study|Adverse Event|3|||
13453505|NCT00251927|26948213|FG001|Overall Study|Adverse Event|15|||
13453506|NCT00251927|26948212|FG000|Overall Study|Lack of Efficacy|22|||
13453507|NCT00251927|26948213|FG001|Overall Study|Lack of Efficacy|16|||
13453508|NCT00251927|26948212|FG000|Overall Study|Lost to Follow-up|22|||
13453509|NCT00251927|26948213|FG001|Overall Study|Lost to Follow-up|8|||
13453510|NCT00251927|26948212|FG000|Overall Study|Protocol Violation|1|||
13453511|NCT00251927|26948213|FG001|Overall Study|Protocol Violation|2|||
13453512|NCT00251927|26948212|FG000|Overall Study|Pregnancy|2|||
13453513|NCT00251927|26948213|FG001|Overall Study|Pregnancy|0|||
13453514|NCT00251927|26948212|FG000|Overall Study|Withdrawal by Subject|40|||
13453515|NCT00251927|26948213|FG001|Overall Study|Withdrawal by Subject|25|||
13453516|NCT00251927|26948212|FG000|Overall Study|Study-specific discont. achieved|13|||
13453517|NCT00251927|26948213|FG001|Overall Study|Study-specific discont. achieved|2|||
13453518|NCT00251927|26948212|FG000|Overall Study|Study procedure non-compliance|5|||
13453519|NCT00251927|26948213|FG001|Overall Study|Study procedure non-compliance|6|||
13453520|NCT00251758|26948240|FG000|Overall Study|Adverse Event|7|||
13453521|NCT00251758|26948241|FG001|Overall Study|Adverse Event|9|||
13453522|NCT00251758|26948242|FG002|Overall Study|Adverse Event|11|||
13453523|NCT00251758|26948240|FG000|Overall Study|Lost to Follow-up|4|||
13453524|NCT00251758|26948241|FG001|Overall Study|Lost to Follow-up|2|||
13453525|NCT00251758|26948242|FG002|Overall Study|Lost to Follow-up|5|||
13453526|NCT00251758|26948240|FG000|Overall Study|Withdrawal by Subject|13|||
13453527|NCT00251758|26948241|FG001|Overall Study|Withdrawal by Subject|7|||
13453528|NCT00251758|26948242|FG002|Overall Study|Withdrawal by Subject|3|||
13453529|NCT00251758|26948240|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
13453530|NCT00251758|26948241|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
13453531|NCT00251758|26948242|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
13453532|NCT00251758|26948240|FG000|Overall Study|Lack of Efficacy|3|||
13453533|NCT00251758|26948241|FG001|Overall Study|Lack of Efficacy|0|||
13453534|NCT00251758|26948242|FG002|Overall Study|Lack of Efficacy|0|||
13453535|NCT00251758|26948240|FG000|Overall Study|Noncompliant|0|||
13453536|NCT00251758|26948241|FG001|Overall Study|Noncompliant|2|||
13453537|NCT00251758|26948242|FG002|Overall Study|Noncompliant|2|||
13453538|NCT00251758|26948240|FG000|Overall Study|Pregnancy|0|||
13453539|NCT00251758|26948241|FG001|Overall Study|Pregnancy|1|||
13453540|NCT00251758|26948242|FG002|Overall Study|Pregnancy|0|||
13453541|NCT00251758|26948240|FG000|Overall Study|Per Subject Request|0|||
13453542|NCT00251758|26948241|FG001|Overall Study|Per Subject Request|0|||
13453543|NCT00251758|26948242|FG002|Overall Study|Per Subject Request|1|||
13453544|NCT00251758|26948240|FG000|Overall Study|Per Investigator Request|1|||
13453545|NCT00251758|26948241|FG001|Overall Study|Per Investigator Request|0|||
13453546|NCT00251758|26948242|FG002|Overall Study|Per Investigator Request|0|||
13453547|NCT00251745|26948269|FG000|Overall Study|Adverse Event|7|||
13453548|NCT00251745|26948270|FG001|Overall Study|Adverse Event|9|||
13453549|NCT00251745|26948271|FG002|Overall Study|Adverse Event|11|||
13453550|NCT00251745|26948269|FG000|Overall Study|Lost to Follow-up|4|||
13453551|NCT00251745|26948270|FG001|Overall Study|Lost to Follow-up|2|||
13453552|NCT00251745|26948271|FG002|Overall Study|Lost to Follow-up|5|||
13453553|NCT00251745|26948269|FG000|Overall Study|Withdrawal by Subject|13|||
13453554|NCT00251745|26948270|FG001|Overall Study|Withdrawal by Subject|7|||
13453555|NCT00251745|26948271|FG002|Overall Study|Withdrawal by Subject|3|||
13453556|NCT00251745|26948269|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
13453557|NCT00251745|26948270|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
13453558|NCT00251745|26948271|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
13453559|NCT00251745|26948269|FG000|Overall Study|Lack of Efficacy|3|||
13453560|NCT00251745|26948270|FG001|Overall Study|Lack of Efficacy|0|||
13453561|NCT00251745|26948271|FG002|Overall Study|Lack of Efficacy|0|||
13453562|NCT00251745|26948269|FG000|Overall Study|Noncompliant|0|||
13453563|NCT00251745|26948270|FG001|Overall Study|Noncompliant|2|||
13453564|NCT00251745|26948271|FG002|Overall Study|Noncompliant|2|||
13453565|NCT00251745|26948269|FG000|Overall Study|Pregnancy|0|||
13453566|NCT00251745|26948270|FG001|Overall Study|Pregnancy|1|||
13453567|NCT00251745|26948271|FG002|Overall Study|Pregnancy|0|||
13453568|NCT00251745|26948269|FG000|Overall Study|Per Subject Request|0|||
13453569|NCT00251745|26948270|FG001|Overall Study|Per Subject Request|0|||
13453570|NCT00251745|26948271|FG002|Overall Study|Per Subject Request|1|||
13453571|NCT00251745|26948269|FG000|Overall Study|Per Investigator Request|1|||
13453572|NCT00251745|26948270|FG001|Overall Study|Per Investigator Request|0|||
13453573|NCT00251745|26948271|FG002|Overall Study|Per Investigator Request|0|||
13453574|NCT00251719|26948304|FG000|Overall Study|Adverse Event|14|||
13453575|NCT00251719|26948305|FG001|Overall Study|Adverse Event|8|||
13453576|NCT00251719|26948306|FG002|Overall Study|Adverse Event|7|||
13453577|NCT00251719|26948304|FG000|Overall Study|Protocol Violation|1|||
13453578|NCT00251719|26948305|FG001|Overall Study|Protocol Violation|1|||
13453579|NCT00251719|26948306|FG002|Overall Study|Protocol Violation|1|||
13453580|NCT00251719|26948304|FG000|Overall Study|Lost to Follow-up|5|||
13453581|NCT00251719|26948305|FG001|Overall Study|Lost to Follow-up|11|||
13453582|NCT00251719|26948306|FG002|Overall Study|Lost to Follow-up|8|||
13453583|NCT00251719|26948304|FG000|Overall Study|Withdrawal by Subject|14|||
13453584|NCT00251719|26948305|FG001|Overall Study|Withdrawal by Subject|12|||
13453585|NCT00251719|26948306|FG002|Overall Study|Withdrawal by Subject|11|||
13453586|NCT00251719|26948304|FG000|Overall Study|Lack of Efficacy|2|||
13453587|NCT00251719|26948305|FG001|Overall Study|Lack of Efficacy|1|||
13453588|NCT00251719|26948306|FG002|Overall Study|Lack of Efficacy|0|||
13453589|NCT00251719|26948304|FG000|Overall Study|Inclusion/exclusion criteria not met|12|||
13453590|NCT00251719|26948305|FG001|Overall Study|Inclusion/exclusion criteria not met|6|||
13453591|NCT00251719|26948306|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
13453592|NCT00251719|26948304|FG000|Overall Study|Investigator decision|1|||
13453593|NCT00251719|26948305|FG001|Overall Study|Investigator decision|1|||
13453594|NCT00251719|26948306|FG002|Overall Study|Investigator decision|0|||
13453595|NCT00251719|26948304|FG000|Overall Study|Noncompliance|2|||
13453596|NCT00251719|26948305|FG001|Overall Study|Noncompliance|3|||
13453597|NCT00251719|26948306|FG002|Overall Study|Noncompliance|1|||
13453598|NCT00251719|26948304|FG000|Overall Study|Barrett's esophagus|2|||
13453599|NCT00251719|26948305|FG001|Overall Study|Barrett's esophagus|2|||
13453600|NCT00251719|26948306|FG002|Overall Study|Barrett's esophagus|0|||
13453601|NCT00251693|26948339|FG000|Overall Study|Adverse Event|17|||
13453602|NCT00251693|26948340|FG001|Overall Study|Adverse Event|9|||
13453603|NCT00251693|26948341|FG002|Overall Study|Adverse Event|9|||
13453604|NCT00251693|26948339|FG000|Overall Study|Protocol Violation|2|||
13453605|NCT00251693|26948340|FG001|Overall Study|Protocol Violation|0|||
13453606|NCT00251693|26948341|FG002|Overall Study|Protocol Violation|2|||
13453607|NCT00251693|26948339|FG000|Overall Study|Lost to Follow-up|12|||
13453608|NCT00251693|26948340|FG001|Overall Study|Lost to Follow-up|7|||
13453609|NCT00251693|26948341|FG002|Overall Study|Lost to Follow-up|8|||
13453610|NCT00251693|26948339|FG000|Overall Study|Withdrawal by Subject|11|||
13453611|NCT00251693|26948340|FG001|Overall Study|Withdrawal by Subject|17|||
13453612|NCT00251693|26948341|FG002|Overall Study|Withdrawal by Subject|14|||
13453613|NCT00251693|26948339|FG000|Overall Study|Lack of Efficacy|0|||
13453614|NCT00251693|26948340|FG001|Overall Study|Lack of Efficacy|1|||
13453615|NCT00251693|26948341|FG002|Overall Study|Lack of Efficacy|0|||
13453616|NCT00251693|26948339|FG000|Overall Study|Inclusion/exclusion criteria not met|5|||
13453617|NCT00251693|26948340|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
13453618|NCT00251693|26948341|FG002|Overall Study|Inclusion/exclusion criteria not met|8|||
13453619|NCT00251693|26948339|FG000|Overall Study|Noncompliant|0|||
13453620|NCT00251693|26948340|FG001|Overall Study|Noncompliant|0|||
13453621|NCT00251693|26948341|FG002|Overall Study|Noncompliant|2|||
13453622|NCT00251693|26948339|FG000|Overall Study|Possible Barrett's esophagus|3|||
13453623|NCT00251693|26948340|FG001|Overall Study|Possible Barrett's esophagus|5|||
13453624|NCT00251693|26948341|FG002|Overall Study|Possible Barrett's esophagus|2|||
13453625|NCT00251693|26948339|FG000|Overall Study|Subject request/subject unavailable|1|||
13453626|NCT00251693|26948340|FG001|Overall Study|Subject request/subject unavailable|2|||
13453627|NCT00251693|26948341|FG002|Overall Study|Subject request/subject unavailable|0|||
13453628|NCT00251693|26948339|FG000|Overall Study|Abnormal laboratory findings|0|||
13453629|NCT00251693|26948340|FG001|Overall Study|Abnormal laboratory findings|0|||
13453630|NCT00251693|26948341|FG002|Overall Study|Abnormal laboratory findings|1|||
13453631|NCT00251641|26948362|FG000|Overall Study|Adverse Event|80|||
13453632|NCT00251641|26948363|FG001|Overall Study|Adverse Event|8|||
13453633|NCT00251641|26948362|FG000|Overall Study|Lack of Efficacy|2|||
13453634|NCT00251641|26948363|FG001|Overall Study|Lack of Efficacy|1|||
13453635|NCT00251641|26948362|FG000|Overall Study|Progression of Disease|0|||
13453636|NCT00251641|26948363|FG001|Overall Study|Progression of Disease|2|||
13453637|NCT00251641|26948362|FG000|Overall Study|Lost to Follow-up|3|||
13453638|NCT00251641|26948363|FG001|Overall Study|Lost to Follow-up|3|||
13453639|NCT00251641|26948362|FG000|Overall Study|Withdrawal by Subject|6|||
13453640|NCT00251641|26948363|FG001|Overall Study|Withdrawal by Subject|8|||
13453641|NCT00251641|26948362|FG000|Overall Study|Protocol Violation|10|||
13453642|NCT00251641|26948363|FG001|Overall Study|Protocol Violation|2|||
13453643|NCT00251641|26948362|FG000|Overall Study|Did not Meet protocol Eligibility|2|||
13453644|NCT00251641|26948363|FG001|Overall Study|Did not Meet protocol Eligibility|1|||
13453645|NCT00251641|26948362|FG000|Overall Study|Switched Treatment|9|||
13453646|NCT00251641|26948363|FG001|Overall Study|Switched Treatment|63|||
13453647|NCT00251589|26948411|FG000|Overall Study|Adverse Event|5|||
13453648|NCT00251589|26948412|FG001|Overall Study|Adverse Event|1|||
13453649|NCT00251589|26948413|FG002|Overall Study|Adverse Event|2|||
13453650|NCT00251589|26948414|FG003|Overall Study|Adverse Event|1|||
13453651|NCT00251589|26948411|FG000|Overall Study|Withdrawal by Subject|1|||
13453652|NCT00251589|26948412|FG001|Overall Study|Withdrawal by Subject|1|||
13453653|NCT00251589|26948413|FG002|Overall Study|Withdrawal by Subject|0|||
13453654|NCT00251589|26948414|FG003|Overall Study|Withdrawal by Subject|0|||
13453655|NCT00251589|26948411|FG000|Overall Study|Discontinued due to progressive disease|9|||
13453656|NCT00251589|26948412|FG001|Overall Study|Discontinued due to progressive disease|1|||
13453657|NCT00251589|26948413|FG002|Overall Study|Discontinued due to progressive disease|0|||
13453658|NCT00251589|26948414|FG003|Overall Study|Discontinued due to progressive disease|1|||
13453659|NCT00251316|26948427|FG000|Overall Study|Physician Decision|2|||
13453660|NCT00251316|26948428|FG001|Overall Study|Physician Decision|3|||
13453661|NCT00251004|26948455|FG000|Overall Study|Withdrawal by Subject|23|||
13453662|NCT00251004|26948456|FG001|Overall Study|Withdrawal by Subject|16|||
13453663|NCT00251004|26948457|FG002|Overall Study|Withdrawal by Subject|14|||
13453664|NCT00251004|26948455|FG000|Overall Study|Death|9|||
13453665|NCT00251004|26948456|FG001|Overall Study|Death|10|||
13453666|NCT00251004|26948457|FG002|Overall Study|Death|8|||
13453667|NCT00251004|26948455|FG000|Overall Study|Lost to Follow-up|1|||
13453668|NCT00251004|26948456|FG001|Overall Study|Lost to Follow-up|2|||
13453669|NCT00251004|26948457|FG002|Overall Study|Lost to Follow-up|1|||
13453670|NCT00251004|26948455|FG000|Overall Study|Graft Loss|12|||
13453671|NCT00251004|26948456|FG001|Overall Study|Graft Loss|13|||
13453672|NCT00251004|26948457|FG002|Overall Study|Graft Loss|8|||
13453673|NCT00250835|26948468|FG000|Overall Study|Withdrawal by Subject|1|||
13453674|NCT00250718|26948475|FG000|Overall Study|Death|1|||
13453675|NCT00250718|26948475|FG000|Overall Study|Adverse Event|1|||
13453676|NCT00250718|26948475|FG000|Overall Study|Withdrawal by Subject|1|||
13453677|NCT00250705|26948485|FG000|Overall Study|Lack of Efficacy|2|||
13453678|NCT00250679|26948593|FG000|Overall Study|Adverse Event|12|||
13453679|NCT00250679|26948594|FG001|Overall Study|Adverse Event|15|||
13453680|NCT00250679|26948595|FG002|Overall Study|Adverse Event|16|||
13453681|NCT00250679|26948593|FG000|Overall Study|Protocol Violation|2|||
13453682|NCT00250679|26948594|FG001|Overall Study|Protocol Violation|4|||
13453683|NCT00250679|26948595|FG002|Overall Study|Protocol Violation|3|||
13453684|NCT00250679|26948593|FG000|Overall Study|Withdrawal by Subject|15|||
13453685|NCT00250679|26948594|FG001|Overall Study|Withdrawal by Subject|18|||
13453686|NCT00250679|26948595|FG002|Overall Study|Withdrawal by Subject|15|||
13453687|NCT00250679|26948593|FG000|Overall Study|Lost to Follow-up|3|||
13453688|NCT00250679|26948594|FG001|Overall Study|Lost to Follow-up|4|||
13453689|NCT00250679|26948595|FG002|Overall Study|Lost to Follow-up|2|||
13453690|NCT00250679|26948593|FG000|Overall Study|Does Not Meet Entry Criteria|1|||
13453691|NCT00250679|26948594|FG001|Overall Study|Does Not Meet Entry Criteria|4|||
13453692|NCT00250679|26948595|FG002|Overall Study|Does Not Meet Entry Criteria|2|||
13453693|NCT00250679|26948593|FG000|Overall Study|Lack of Efficacy|0|||
13453694|NCT00250679|26948594|FG001|Overall Study|Lack of Efficacy|1|||
13453695|NCT00250679|26948595|FG002|Overall Study|Lack of Efficacy|3|||
13453696|NCT00250679|26948593|FG000|Overall Study|Technical Holter issues|1|||
13453697|NCT00250679|26948594|FG001|Overall Study|Technical Holter issues|0|||
13453698|NCT00250679|26948595|FG002|Overall Study|Technical Holter issues|2|||
13453699|NCT00250679|26948593|FG000|Overall Study|Moved|1|||
13453700|NCT00250679|26948594|FG001|Overall Study|Moved|1|||
13453701|NCT00250679|26948595|FG002|Overall Study|Moved|0|||
13453702|NCT00250679|26948593|FG000|Overall Study|Non-compliance|1|||
13453703|NCT00250679|26948594|FG001|Overall Study|Non-compliance|1|||
13453704|NCT00250679|26948595|FG002|Overall Study|Non-compliance|0|||
13453705|NCT00250679|26948593|FG000|Overall Study|various single events: hip surgery,diary|3|||
13453706|NCT00250679|26948594|FG001|Overall Study|various single events: hip surgery,diary|1|||
13453707|NCT00250679|26948595|FG002|Overall Study|various single events: hip surgery,diary|1|||
13453708|NCT00250588|26948619|FG000|Overall Study|Withdrawal by Subject|3|||
13453709|NCT00250588|26948620|FG001|Overall Study|Withdrawal by Subject|6|||
13453710|NCT00250588|26948621|FG002|Overall Study|Withdrawal by Subject|0|||
13453711|NCT00250588|26948619|FG000|Overall Study|Lost to Follow-up|6|||
13453712|NCT00250588|26948620|FG001|Overall Study|Lost to Follow-up|13|||
13453713|NCT00250588|26948621|FG002|Overall Study|Lost to Follow-up|13|||
13453714|NCT00250432|26948636|FG000|Overall Study|Adverse Event|25|||
13453715|NCT00250432|26948637|FG001|Overall Study|Adverse Event|29|||
13453716|NCT00250432|26948636|FG000|Overall Study|Lack of Efficacy|2|||
13453717|NCT00250432|26948637|FG001|Overall Study|Lack of Efficacy|1|||
13453718|NCT00250432|26948636|FG000|Overall Study|Lost to Follow-up|6|||
13453719|NCT00250432|26948637|FG001|Overall Study|Lost to Follow-up|5|||
13453720|NCT00250432|26948636|FG000|Overall Study|Patient Moved|0|||
13453721|NCT00250432|26948637|FG001|Overall Study|Patient Moved|1|||
13453722|NCT00250432|26948636|FG000|Overall Study|Protocol Violation|0|||
13453723|NCT00250432|26948637|FG001|Overall Study|Protocol Violation|3|||
13453724|NCT00250432|26948636|FG000|Overall Study|Withdrawal by Subject|6|||
13453725|NCT00250432|26948637|FG001|Overall Study|Withdrawal by Subject|2|||
13453726|NCT00250432|26948636|FG000|Overall Study|Pt died out of posttherapy report period|6|||
13453727|NCT00250432|26948637|FG001|Overall Study|Pt died out of posttherapy report period|5|||
13453728|NCT00250432|26948636|FG000|Overall Study|Pt was considered untreatable|0|||
13453729|NCT00250432|26948637|FG001|Overall Study|Pt was considered untreatable|1|||
13453730|NCT00250276|26948728|FG000|Overall Study|Serious Adverse Event|0|||
13453731|NCT00250276|26948729|FG001|Overall Study|Serious Adverse Event|0|||
13453732|NCT00250276|26948730|FG002|Overall Study|Serious Adverse Event|1|||
13453733|NCT00250276|26948731|FG003|Overall Study|Serious Adverse Event|0|||
13453734|NCT00250276|26948728|FG000|Overall Study|Non-serious Adverse Event|2|||
13453735|NCT00250276|26948729|FG001|Overall Study|Non-serious Adverse Event|0|||
13453736|NCT00250276|26948730|FG002|Overall Study|Non-serious Adverse Event|0|||
13453737|NCT00250276|26948731|FG003|Overall Study|Non-serious Adverse Event|2|||
13453738|NCT00250276|26948728|FG000|Overall Study|Protocol Violation|0|||
13453739|NCT00250276|26948729|FG001|Overall Study|Protocol Violation|1|||
13453740|NCT00250276|26948730|FG002|Overall Study|Protocol Violation|0|||
13453741|NCT00250276|26948731|FG003|Overall Study|Protocol Violation|0|||
13453742|NCT00250276|26948728|FG000|Overall Study|Withdrawal by Subject|1|||
13453743|NCT00250276|26948729|FG001|Overall Study|Withdrawal by Subject|2|||
13453744|NCT00250276|26948730|FG002|Overall Study|Withdrawal by Subject|3|||
13453745|NCT00250276|26948731|FG003|Overall Study|Withdrawal by Subject|2|||
13453746|NCT00250276|26948728|FG000|Overall Study|Migrated/moved from study area|3|||
13453747|NCT00250276|26948729|FG001|Overall Study|Migrated/moved from study area|0|||
13453748|NCT00250276|26948730|FG002|Overall Study|Migrated/moved from study area|2|||
13453749|NCT00250276|26948731|FG003|Overall Study|Migrated/moved from study area|7|||
13453750|NCT00250276|26948728|FG000|Overall Study|Lost to Follow-up|11|||
13453751|NCT00250276|26948729|FG001|Overall Study|Lost to Follow-up|18|||
13453752|NCT00250276|26948730|FG002|Overall Study|Lost to Follow-up|13|||
13453753|NCT00250276|26948731|FG003|Overall Study|Lost to Follow-up|8|||
13453754|NCT00249873|26948750|FG000|Overall Study|Not treated|7|||
13453755|NCT00249873|26948751|FG001|Overall Study|Not treated|8|||
13453756|NCT00249873|26948750|FG000|Overall Study|Significant thrombocytopenia|9|||
13453757|NCT00249873|26948751|FG001|Overall Study|Significant thrombocytopenia|8|||
13453758|NCT00249873|26948750|FG000|Overall Study|Severe allergic reaction|8|||
13453759|NCT00249873|26948751|FG001|Overall Study|Severe allergic reaction|1|||
13453760|NCT00249873|26948750|FG000|Overall Study|Serious haemorrhagic Adverse Event|74|||
13453761|NCT00249873|26948751|FG001|Overall Study|Serious haemorrhagic Adverse Event|30|||
13453762|NCT00249873|26948750|FG000|Overall Study|Other Serious Adverse Event|86|||
13453763|NCT00249873|26948751|FG001|Overall Study|Other Serious Adverse Event|97|||
13453764|NCT00249873|26948750|FG000|Overall Study|Qualifying condition not present|20|||
13453765|NCT00249873|26948751|FG001|Overall Study|Qualifying condition not present|23|||
13453766|NCT00249873|26948750|FG000|Overall Study|Contraindication to oral anticoagulant|4|||
13453767|NCT00249873|26948751|FG001|Overall Study|Contraindication to oral anticoagulant|8|||
13453768|NCT00249873|26948750|FG000|Overall Study|Withdrawal by Subject|504|||
13453769|NCT00249873|26948751|FG001|Overall Study|Withdrawal by Subject|466|||
13453770|NCT00249873|26948750|FG000|Overall Study|Lost to Follow-up|4|||
13453771|NCT00249873|26948751|FG001|Overall Study|Lost to Follow-up|7|||
13453772|NCT00249873|26948750|FG000|Overall Study|Minor bleeding|99|||
13453773|NCT00249873|26948751|FG001|Overall Study|Minor bleeding|37|||
13453774|NCT00249873|26948750|FG000|Overall Study|Non-compliance|41|||
13453775|NCT00249873|26948751|FG001|Overall Study|Non-compliance|46|||
13453776|NCT00249873|26948750|FG000|Overall Study|Other non serious Adverse Event|112|||
13453777|NCT00249873|26948751|FG001|Overall Study|Other non serious Adverse Event|108|||
13453778|NCT00249873|26948750|FG000|Overall Study|Other contraindicated medication|1|||
13453779|NCT00249873|26948751|FG001|Overall Study|Other contraindicated medication|0|||
13453780|NCT00249873|26948750|FG000|Overall Study|Patient not wish to continue after May08|3|||
13453781|NCT00249873|26948751|FG001|Overall Study|Patient not wish to continue after May08|4|||
13453782|NCT00249873|26948750|FG000|Overall Study|Physician withdrew consent|59|||
13453783|NCT00249873|26948751|FG001|Overall Study|Physician withdrew consent|60|||
13453784|NCT00249873|26948750|FG000|Overall Study|Open label clopidogrel required|31|||
13453785|NCT00249873|26948751|FG001|Overall Study|Open label clopidogrel required|42|||
13453786|NCT00249873|26948750|FG000|Overall Study|Angiotensin II receptor blocker required|1|||
13453787|NCT00249873|26948751|FG001|Overall Study|Angiotensin II receptor blocker required|0|||
13453788|NCT00249873|26948750|FG000|Overall Study|Oral anticoagulant required|159|||
13453789|NCT00249873|26948751|FG001|Overall Study|Oral anticoagulant required|157|||
13453790|NCT00249873|26948750|FG000|Overall Study|Study drug intolerance|5|||
13453791|NCT00249873|26948751|FG001|Overall Study|Study drug intolerance|0|||
13453792|NCT00249873|26948750|FG000|Overall Study|Surgery/ procedure|9|||
13453793|NCT00249873|26948751|FG001|Overall Study|Surgery/ procedure|9|||
13453794|NCT00249873|26948750|FG000|Overall Study|Event related to cardiac condition|12|||
13453795|NCT00249873|26948751|FG001|Overall Study|Event related to cardiac condition|21|||
13453796|NCT00249873|26948750|FG000|Overall Study|Thromboembolic/outcome event|82|||
13453797|NCT00249873|26948751|FG001|Overall Study|Thromboembolic/outcome event|122|||
13453798|NCT00249808|26948759|FG000|Overall Study|Other|27|||
13453799|NCT00249808|26948759|FG000|Overall Study|Protocol Violation|3|||
13453800|NCT00249808|26948759|FG000|Overall Study|Lost to Follow-up|8|||
13453801|NCT00249808|26948759|FG000|Overall Study|Adverse Event|81|||
13453802|NCT00249808|26948759|FG000|Overall Study|Lack of Efficacy|52|||
13453803|NCT00249808|26948759|FG000|Overall Study|Did Not Provide Post-Baseline Data|11|||
13453804|NCT00248625|26948786|FG000|Overall Study|Withdrawal by Subject|0|||
13453805|NCT00248625|26948787|FG001|Overall Study|Withdrawal by Subject|2|||
13453806|NCT00247676|26948817|FG000|Overall Study|Death|5|||
13453807|NCT00247676|26948817|FG000|Overall Study|Adverse Event|11|||
13453808|NCT00247676|26948817|FG000|Overall Study|Lack of Efficacy|15|||
13453809|NCT00247676|26948817|FG000|Overall Study|Other|3|||
13453810|NCT00247676|26948817|FG000|Overall Study|Withdrawal by Subject|2|||
13453811|NCT00246805|26948830|FG000|Phase 1|Lost to Follow-up|1|||
13453812|NCT00246805|26948831|FG001|Phase 1|Lost to Follow-up|0|||
13453813|NCT00246571|26948876|FG000|Overall Study|Adverse Event|7|||
13453814|NCT00246571|26948877|FG001|Overall Study|Adverse Event|0|||
13453815|NCT00246571|26948876|FG000|Overall Study|Protocol Violation|0|||
13453816|NCT00246571|26948877|FG001|Overall Study|Protocol Violation|1|||
13453817|NCT00246571|26948876|FG000|Overall Study|Withdrawal by Subject|2|||
13453818|NCT00246571|26948877|FG001|Overall Study|Withdrawal by Subject|3|||
13453819|NCT00246571|26948876|FG000|Overall Study|Lack of Efficacy|84|||
13453820|NCT00246571|26948877|FG001|Overall Study|Lack of Efficacy|21|||
13453821|NCT00246571|26948876|FG000|Overall Study|Death|17|||
13453822|NCT00246571|26948877|FG001|Overall Study|Death|3|||
13453823|NCT00246571|26948876|FG000|Overall Study|Sponsor|0|||
13453824|NCT00246571|26948877|FG001|Overall Study|Sponsor|1|||
13453825|NCT00246571|26948876|FG000|Overall Study|Did not meet entrance criteria|2|||
13453826|NCT00246571|26948877|FG001|Overall Study|Did not meet entrance criteria|1|||
13453827|NCT00246571|26948876|FG000|Overall Study|Laboratory abnormalities|1|||
13453828|NCT00246571|26948877|FG001|Overall Study|Laboratory abnormalities|0|||
13453829|NCT00246571|26948876|FG000|Overall Study|Crossover participants|0|||
13453830|NCT00246571|26948877|FG001|Overall Study|Crossover participants|74|||
13453831|NCT00246337|26948952|FG000|Overall Study|Lost to Follow-up|3|||
13453832|NCT00246337|26948953|FG001|Overall Study|Lost to Follow-up|0|||
13453833|NCT00246337|26948954|FG002|Overall Study|Lost to Follow-up|0|||
13453834|NCT00246337|26948955|FG003|Overall Study|Lost to Follow-up|0|||
13453835|NCT00246337|26948956|FG004|Overall Study|Lost to Follow-up|2|||
13453836|NCT00246337|26948957|FG005|Overall Study|Lost to Follow-up|2|||
13453837|NCT00246337|26948958|FG006|Overall Study|Lost to Follow-up|1|||
13453838|NCT00246337|26948959|FG007|Overall Study|Lost to Follow-up|2|||
13453839|NCT00246337|26948960|FG008|Overall Study|Lost to Follow-up|0|||
13453840|NCT00246337|26948952|FG000|Overall Study|Protocol Violation|1|||
13453841|NCT00246337|26948953|FG001|Overall Study|Protocol Violation|0|||
13453842|NCT00246337|26948954|FG002|Overall Study|Protocol Violation|0|||
13453843|NCT00246337|26948955|FG003|Overall Study|Protocol Violation|0|||
13453844|NCT00246337|26948956|FG004|Overall Study|Protocol Violation|1|||
13453845|NCT00246337|26948957|FG005|Overall Study|Protocol Violation|0|||
13453846|NCT00246337|26948958|FG006|Overall Study|Protocol Violation|1|||
13453847|NCT00246337|26948959|FG007|Overall Study|Protocol Violation|1|||
13453848|NCT00246337|26948960|FG008|Overall Study|Protocol Violation|0|||
13453849|NCT00246337|26948952|FG000|Overall Study|Withdrawal by Subject|2|||
13453850|NCT00246337|26948953|FG001|Overall Study|Withdrawal by Subject|0|||
13453851|NCT00246337|26948954|FG002|Overall Study|Withdrawal by Subject|0|||
13453852|NCT00246337|26948955|FG003|Overall Study|Withdrawal by Subject|0|||
13453853|NCT00246337|26948956|FG004|Overall Study|Withdrawal by Subject|0|||
13453854|NCT00246337|26948957|FG005|Overall Study|Withdrawal by Subject|0|||
13453855|NCT00246337|26948958|FG006|Overall Study|Withdrawal by Subject|1|||
13453856|NCT00246337|26948959|FG007|Overall Study|Withdrawal by Subject|1|||
13453857|NCT00246337|26948960|FG008|Overall Study|Withdrawal by Subject|0|||
13453858|NCT00246337|26948952|FG000|Overall Study|Lack of Qualifying Event|8|||
13453859|NCT00246337|26948953|FG001|Overall Study|Lack of Qualifying Event|2|||
13453860|NCT00246337|26948954|FG002|Overall Study|Lack of Qualifying Event|1|||
13453861|NCT00246337|26948955|FG003|Overall Study|Lack of Qualifying Event|1|||
13453862|NCT00246337|26948956|FG004|Overall Study|Lack of Qualifying Event|1|||
13453863|NCT00246337|26948957|FG005|Overall Study|Lack of Qualifying Event|3|||
13453864|NCT00246337|26948958|FG006|Overall Study|Lack of Qualifying Event|3|||
13453865|NCT00246337|26948959|FG007|Overall Study|Lack of Qualifying Event|2|||
13453866|NCT00246337|26948960|FG008|Overall Study|Lack of Qualifying Event|5|||
13453867|NCT00246337|26948952|FG000|Overall Study|Site Terminated|10|||
13453868|NCT00246337|26948953|FG001|Overall Study|Site Terminated|0|||
13453869|NCT00246337|26948954|FG002|Overall Study|Site Terminated|0|||
13453870|NCT00246337|26948955|FG003|Overall Study|Site Terminated|0|||
13453871|NCT00246337|26948956|FG004|Overall Study|Site Terminated|0|||
13453872|NCT00246337|26948957|FG005|Overall Study|Site Terminated|7|||
13453873|NCT00246337|26948958|FG006|Overall Study|Site Terminated|1|||
13453874|NCT00246337|26948959|FG007|Overall Study|Site Terminated|6|||
13453875|NCT00246337|26948960|FG008|Overall Study|Site Terminated|2|||
13453876|NCT00246337|26948952|FG000|Overall Study|Abnormal baseline lab values|7|||
13453877|NCT00246337|26948953|FG001|Overall Study|Abnormal baseline lab values|0|||
13453878|NCT00246337|26948954|FG002|Overall Study|Abnormal baseline lab values|2|||
13453879|NCT00246337|26948955|FG003|Overall Study|Abnormal baseline lab values|0|||
13453880|NCT00246337|26948956|FG004|Overall Study|Abnormal baseline lab values|0|||
13453881|NCT00246337|26948957|FG005|Overall Study|Abnormal baseline lab values|2|||
13453882|NCT00246337|26948958|FG006|Overall Study|Abnormal baseline lab values|2|||
13453883|NCT00246337|26948959|FG007|Overall Study|Abnormal baseline lab values|0|||
13453884|NCT00246337|26948960|FG008|Overall Study|Abnormal baseline lab values|4|||
13453885|NCT00246337|26948952|FG000|Overall Study|Overwhelmed|0|||
13453886|NCT00246337|26948953|FG001|Overall Study|Overwhelmed|0|||
13453887|NCT00246337|26948954|FG002|Overall Study|Overwhelmed|0|||
13453888|NCT00246337|26948955|FG003|Overall Study|Overwhelmed|0|||
13453889|NCT00246337|26948956|FG004|Overall Study|Overwhelmed|0|||
13453890|NCT00246337|26948957|FG005|Overall Study|Overwhelmed|1|||
13453891|NCT00246337|26948958|FG006|Overall Study|Overwhelmed|0|||
13453892|NCT00246337|26948959|FG007|Overall Study|Overwhelmed|0|||
13453893|NCT00246337|26948960|FG008|Overall Study|Overwhelmed|0|||
13453894|NCT00246337|26948952|FG000|Overall Study|Protocol Violator|1|||
13453895|NCT00246337|26948953|FG001|Overall Study|Protocol Violator|0|||
13453896|NCT00246337|26948954|FG002|Overall Study|Protocol Violator|0|||
13453897|NCT00246337|26948955|FG003|Overall Study|Protocol Violator|0|||
13453898|NCT00246337|26948956|FG004|Overall Study|Protocol Violator|0|||
13453899|NCT00246337|26948957|FG005|Overall Study|Protocol Violator|0|||
13453900|NCT00246337|26948958|FG006|Overall Study|Protocol Violator|0|||
13453901|NCT00246337|26948959|FG007|Overall Study|Protocol Violator|0|||
13453902|NCT00246337|26948960|FG008|Overall Study|Protocol Violator|0|||
13453903|NCT00246337|26948952|FG000|Overall Study|Reported as completing trial in error|0|||
13453904|NCT00246337|26948953|FG001|Overall Study|Reported as completing trial in error|0|||
13453905|NCT00246337|26948954|FG002|Overall Study|Reported as completing trial in error|0|||
13453906|NCT00246337|26948955|FG003|Overall Study|Reported as completing trial in error|0|||
13453907|NCT00246337|26948956|FG004|Overall Study|Reported as completing trial in error|0|||
13453908|NCT00246337|26948957|FG005|Overall Study|Reported as completing trial in error|0|||
13453909|NCT00246337|26948958|FG006|Overall Study|Reported as completing trial in error|0|||
13453910|NCT00246337|26948959|FG007|Overall Study|Reported as completing trial in error|1|||
13453911|NCT00246337|26948960|FG008|Overall Study|Reported as completing trial in error|0|||
13453912|NCT00243919|26949011|FG000|Overall Study|Death|3|||
13453913|NCT00243919|26949012|FG001|Overall Study|Death|4|||
13453914|NCT00243919|26949013|FG002|Overall Study|Death|6|||
13453915|NCT00243919|26949011|FG000|Overall Study|Withdrawal by Subject|6|||
13453916|NCT00243919|26949012|FG001|Overall Study|Withdrawal by Subject|6|||
13453917|NCT00243919|26949013|FG002|Overall Study|Withdrawal by Subject|2|||
13453918|NCT00243919|26949011|FG000|Overall Study|Lost to Follow-up|6|||
13453919|NCT00243919|26949012|FG001|Overall Study|Lost to Follow-up|7|||
13453920|NCT00243919|26949013|FG002|Overall Study|Lost to Follow-up|3|||
13453921|NCT00243919|26949011|FG000|Overall Study|Administrative Error|1|||
13453922|NCT00243919|26949012|FG001|Overall Study|Administrative Error|0|||
13453923|NCT00243919|26949013|FG002|Overall Study|Administrative Error|0|||
13453924|NCT00243919|26949011|FG000|Overall Study|Physician Decision|1|||
13453925|NCT00243919|26949012|FG001|Overall Study|Physician Decision|1|||
13453926|NCT00243919|26949013|FG002|Overall Study|Physician Decision|0|||
13453927|NCT00243503|26949030|FG000|Overall Study|Adverse Event|11|||
13453928|NCT00243503|26949030|FG000|Overall Study|Withdrawal by Subject|1|||
13453929|NCT00243503|26949030|FG000|Overall Study|Lack of Efficacy|44|||
13453930|NCT00243503|26949030|FG000|Overall Study|Death|1|||
13453931|NCT00243503|26949030|FG000|Overall Study|Other|1|||
13453932|NCT00242710|26949093|FG000|Core Study (up to Year 1)|Adverse Event|30|||
13453933|NCT00242710|26949094|FG001|Core Study (up to Year 1)|Adverse Event|25|||
13453934|NCT00242710|26949095|FG002|Core Study (up to Year 1)|Adverse Event|23|||
13453935|NCT00242710|26949096|FG003|Core Study (up to Year 1)|Adverse Event|14|||
13453936|NCT00242710|26949093|FG000|Core Study (up to Year 1)|Death|0|||
13453937|NCT00242710|26949094|FG001|Core Study (up to Year 1)|Death|0|||
13453938|NCT00242710|26949095|FG002|Core Study (up to Year 1)|Death|1|||
13453939|NCT00242710|26949096|FG003|Core Study (up to Year 1)|Death|0|||
13453940|NCT00242710|26949093|FG000|Core Study (up to Year 1)|Physician Decision|0|||
13453941|NCT00242710|26949094|FG001|Core Study (up to Year 1)|Physician Decision|1|||
13453942|NCT00242710|26949095|FG002|Core Study (up to Year 1)|Physician Decision|0|||
13453943|NCT00242710|26949096|FG003|Core Study (up to Year 1)|Physician Decision|1|||
13453944|NCT00242710|26949093|FG000|Core Study (up to Year 1)|Lost to Follow-up|8|||
13453945|NCT00242710|26949094|FG001|Core Study (up to Year 1)|Lost to Follow-up|8|||
13453946|NCT00242710|26949095|FG002|Core Study (up to Year 1)|Lost to Follow-up|7|||
13453947|NCT00242710|26949096|FG003|Core Study (up to Year 1)|Lost to Follow-up|3|||
13453948|NCT00242710|26949093|FG000|Core Study (up to Year 1)|Other|6|||
13453949|NCT00242710|26949094|FG001|Core Study (up to Year 1)|Other|1|||
13453950|NCT00242710|26949095|FG002|Core Study (up to Year 1)|Other|0|||
13453951|NCT00242710|26949096|FG003|Core Study (up to Year 1)|Other|2|||
13453952|NCT00242710|26949093|FG000|Core Study (up to Year 1)|Protocol Violation|2|||
13453953|NCT00242710|26949094|FG001|Core Study (up to Year 1)|Protocol Violation|9|||
13453954|NCT00242710|26949095|FG002|Core Study (up to Year 1)|Protocol Violation|1|||
13453955|NCT00242710|26949096|FG003|Core Study (up to Year 1)|Protocol Violation|3|||
13453956|NCT00242710|26949093|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27|||
13453957|NCT00242710|26949094|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16|||
13453958|NCT00242710|26949095|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15|||
13453959|NCT00242710|26949096|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6|||
13453960|NCT00242710|26949093|FG000|Core Study (up to Year 1)|Lack of Efficacy|1|||
13453961|NCT00242710|26949094|FG001|Core Study (up to Year 1)|Lack of Efficacy|0|||
13453962|NCT00242710|26949095|FG002|Core Study (up to Year 1)|Lack of Efficacy|0|||
13453963|NCT00242710|26949096|FG003|Core Study (up to Year 1)|Lack of Efficacy|0|||
13453964|NCT00242710|26949093|FG000|Core Study (up to Year 1)|Randomized but not Treated|12|||
13453965|NCT00242710|26949094|FG001|Core Study (up to Year 1)|Randomized but not Treated|4|||
13453966|NCT00242710|26949095|FG002|Core Study (up to Year 1)|Randomized but not Treated|4|||
13453967|NCT00242710|26949096|FG003|Core Study (up to Year 1)|Randomized but not Treated|2|||
13453968|NCT00242710|26949093|FG000|Period Between Core Study and Extension|Adverse Event|2|||
13453969|NCT00242710|26949094|FG001|Period Between Core Study and Extension|Adverse Event|3|||
13453970|NCT00242710|26949095|FG002|Period Between Core Study and Extension|Adverse Event|5|||
13453971|NCT00242710|26949096|FG003|Period Between Core Study and Extension|Adverse Event|2|||
13453972|NCT00242710|26949093|FG000|Period Between Core Study and Extension|Physician Decision|1|||
13453973|NCT00242710|26949094|FG001|Period Between Core Study and Extension|Physician Decision|1|||
13453974|NCT00242710|26949095|FG002|Period Between Core Study and Extension|Physician Decision|0|||
13453975|NCT00242710|26949096|FG003|Period Between Core Study and Extension|Physician Decision|0|||
13453976|NCT00242710|26949093|FG000|Period Between Core Study and Extension|Other|24|||
13453977|NCT00242710|26949094|FG001|Period Between Core Study and Extension|Other|24|||
13453978|NCT00242710|26949095|FG002|Period Between Core Study and Extension|Other|9|||
13453979|NCT00242710|26949096|FG003|Period Between Core Study and Extension|Other|11|||
13453980|NCT00242710|26949093|FG000|Period Between Core Study and Extension|Extension not Available|17|||
13453981|NCT00242710|26949094|FG001|Period Between Core Study and Extension|Extension not Available|21|||
13453982|NCT00242710|26949095|FG002|Period Between Core Study and Extension|Extension not Available|8|||
13453983|NCT00242710|26949096|FG003|Period Between Core Study and Extension|Extension not Available|7|||
13453984|NCT00242710|26949093|FG000|Period Between Core Study and Extension|Protocol Violation|0|||
13453985|NCT00242710|26949094|FG001|Period Between Core Study and Extension|Protocol Violation|0|||
13453986|NCT00242710|26949095|FG002|Period Between Core Study and Extension|Protocol Violation|2|||
13453987|NCT00242710|26949096|FG003|Period Between Core Study and Extension|Protocol Violation|1|||
13453988|NCT00242710|26949093|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75|||
13453989|NCT00242710|26949094|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63|||
13453990|NCT00242710|26949095|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24|||
13453991|NCT00242710|26949096|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28|||
13453992|NCT00242710|26949093|FG000|Study Extension (up to Year 2)|Adverse Event|7|||
13453993|NCT00242710|26949094|FG001|Study Extension (up to Year 2)|Adverse Event|9|||
13453994|NCT00242710|26949095|FG002|Study Extension (up to Year 2)|Adverse Event|2|||
13453995|NCT00242710|26949096|FG003|Study Extension (up to Year 2)|Adverse Event|4|||
13453996|NCT00242710|26949093|FG000|Study Extension (up to Year 2)|Death|0|||
13453997|NCT00242710|26949094|FG001|Study Extension (up to Year 2)|Death|0|||
13453998|NCT00242710|26949095|FG002|Study Extension (up to Year 2)|Death|0|||
13453999|NCT00242710|26949096|FG003|Study Extension (up to Year 2)|Death|1|||
13454000|NCT00242710|26949093|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7|||
13454001|NCT00242710|26949094|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7|||
13454002|NCT00242710|26949095|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5|||
13454003|NCT00242710|26949096|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0|||
13454004|NCT00242710|26949093|FG000|Study Extension (up to Year 2)|Other|3|||
13454005|NCT00242710|26949094|FG001|Study Extension (up to Year 2)|Other|5|||
13454006|NCT00242710|26949095|FG002|Study Extension (up to Year 2)|Other|4|||
13454007|NCT00242710|26949096|FG003|Study Extension (up to Year 2)|Other|3|||
13454008|NCT00242710|26949093|FG000|Study Extension (up to Year 2)|Protocol Violation|0|||
13454009|NCT00242710|26949094|FG001|Study Extension (up to Year 2)|Protocol Violation|2|||
13454010|NCT00242710|26949095|FG002|Study Extension (up to Year 2)|Protocol Violation|0|||
13454011|NCT00242710|26949096|FG003|Study Extension (up to Year 2)|Protocol Violation|1|||
13454012|NCT00242710|26949093|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10|||
13454013|NCT00242710|26949094|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6|||
13454014|NCT00242710|26949095|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4|||
13454015|NCT00242710|26949096|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1|||
13454016|NCT00242216|26949111|FG000|Overall Study|Lost to Follow-up|12|||
13454017|NCT00242216|26949112|FG001|Overall Study|Lost to Follow-up|17|||
13454018|NCT00242216|26949111|FG000|Overall Study|Death|4|||
13454019|NCT00242216|26949112|FG001|Overall Study|Death|2|||
13454020|NCT00242216|26949111|FG000|Overall Study|Lack of Efficacy|1|||
13454021|NCT00242216|26949112|FG001|Overall Study|Lack of Efficacy|2|||
13454022|NCT00242216|26949111|FG000|Overall Study|no medicaiton dispensed|1|||
13454023|NCT00242216|26949112|FG001|Overall Study|no medicaiton dispensed|1|||
13454024|NCT00240994|26949118|FG000|Overall Study|Lost to Follow-up|1|||
13454025|NCT00240994|26949118|FG000|Overall Study|Protocol Violation|1|||
13454026|NCT00240994|26949118|FG000|Overall Study|Graft failure|1|||
13454027|NCT00240110|26949133|FG000|Overall Study|Lost to Follow-up|6|||
13454028|NCT00240110|26949134|FG001|Overall Study|Lost to Follow-up|7|||
13454029|NCT00239928|26949146|FG000|Overall Study|Lack of Efficacy|1|||
13454030|NCT00239928|26949146|FG000|Overall Study|Adverse Event|4|||
13454031|NCT00239928|26949146|FG000|Overall Study|Not need to continue study|3|||
13454032|NCT00239928|26949146|FG000|Overall Study|Withdrawal by Subject|2|||
13454033|NCT00239837|26949173|FG000|Overall Study|Lost to Follow-up|3|||
13454034|NCT00239837|26949174|FG001|Overall Study|Lost to Follow-up|7|||
13454035|NCT00239720|26949187|FG000|Overall Study|Adverse Event|1|||
13454036|NCT00239720|26949188|FG001|Overall Study|Adverse Event|0|||
13454037|NCT00239720|26949187|FG000|Overall Study|Lost to Follow-up|0|||
13454038|NCT00239720|26949188|FG001|Overall Study|Lost to Follow-up|1|||
13454039|NCT00239681|26949211|FG000|Overall Study|Adverse Event|100|||
13454040|NCT00239681|26949212|FG001|Overall Study|Adverse Event|99|||
13454041|NCT00239681|26949211|FG000|Overall Study|Withdrawal by Subject|458|||
13454042|NCT00239681|26949212|FG001|Overall Study|Withdrawal by Subject|489|||
13454043|NCT00239681|26949211|FG000|Overall Study|Lost to Follow-up|28|||
13454044|NCT00239681|26949212|FG001|Overall Study|Lost to Follow-up|22|||
13454045|NCT00239681|26949211|FG000|Overall Study|Protocol Violation|4|||
13454046|NCT00239681|26949212|FG001|Overall Study|Protocol Violation|4|||
13454047|NCT00239681|26949211|FG000|Overall Study|Physician Decision|13|||
13454048|NCT00239681|26949212|FG001|Overall Study|Physician Decision|17|||
13454049|NCT00239681|26949211|FG000|Overall Study|No information chacked on CaseReportForm|90|||
13454050|NCT00239681|26949212|FG001|Overall Study|No information chacked on CaseReportForm|84|||
13454051|NCT00239590|26949223|FG000|Randomized|Lost to Follow-up|0|||
13454052|NCT00239590|26949224|FG001|Randomized|Lost to Follow-up|1|||
13454053|NCT00239590|26949223|FG000|Randomized|Withdrawal by Subject|0|||
13454054|NCT00239590|26949224|FG001|Randomized|Withdrawal by Subject|1|||
13454055|NCT00239590|26949223|FG000|Completed Study Protocol|Adverse Event|1|||
13454056|NCT00239590|26949224|FG001|Completed Study Protocol|Adverse Event|1|||
13454057|NCT00239590|26949223|FG000|Completed Study Protocol|Withdrawal by Subject|0|||
13454058|NCT00239590|26949224|FG001|Completed Study Protocol|Withdrawal by Subject|1|||
13454059|NCT00239577|26949339|FG000|Primary Phase|Adverse Event|0|||
13454060|NCT00239577|26949340|FG001|Primary Phase|Adverse Event|0|||
13454061|NCT00239577|26949341|FG002|Primary Phase|Adverse Event|1|||
13454062|NCT00239577|26949342|FG003|Primary Phase|Adverse Event|0|||
13454063|NCT00239577|26949339|FG000|Primary Phase|Other|5|||
13454064|NCT00239577|26949340|FG001|Primary Phase|Other|3|||
13454065|NCT00239577|26949341|FG002|Primary Phase|Other|2|||
13454066|NCT00239577|26949342|FG003|Primary Phase|Other|0|||
13454067|NCT00239356|26949367|FG000|Overall Study|Lack of Efficacy|1|||
13454068|NCT00239356|26949368|FG001|Overall Study|Lack of Efficacy|0|||
13454069|NCT00239356|26949367|FG000|Overall Study|Adverse Event|6|||
13454070|NCT00239356|26949368|FG001|Overall Study|Adverse Event|0|||
13454071|NCT00239356|26949367|FG000|Overall Study|Withdrawal by Subject|15|||
13454072|NCT00239356|26949368|FG001|Overall Study|Withdrawal by Subject|6|||
13454073|NCT00239356|26949367|FG000|Overall Study|Lost to Follow-up|3|||
13454074|NCT00239356|26949368|FG001|Overall Study|Lost to Follow-up|0|||
13454075|NCT00239356|26949367|FG000|Overall Study|poor/non-compliance|2|||
13454076|NCT00239356|26949368|FG001|Overall Study|poor/non-compliance|0|||
13454077|NCT00239356|26949367|FG000|Overall Study|Pregnancy|1|||
13454078|NCT00239356|26949368|FG001|Overall Study|Pregnancy|0|||
13454079|NCT00239356|26949367|FG000|Overall Study|Administrative reason|0|||
13454080|NCT00239356|26949368|FG001|Overall Study|Administrative reason|1|||
13454081|NCT00239356|26949367|FG000|Overall Study|Drug available on market|11|||
13454082|NCT00239356|26949368|FG001|Overall Study|Drug available on market|2|||
13454083|NCT00239226|26949391|FG000|Overall Study|permAF during stabilization period|0|||
13454084|NCT00239226|26949392|FG001|Overall Study|permAF during stabilization period|0|||
13454085|NCT00239226|26949393|FG002|Overall Study|permAF during stabilization period|0|||
13454086|NCT00239226|26949394|FG003|Overall Study|permAF during stabilization period|3|||
13454087|NCT00239226|26949391|FG000|Overall Study|Lost to Follow-up|1|||
13454088|NCT00239226|26949392|FG001|Overall Study|Lost to Follow-up|0|||
13454089|NCT00239226|26949393|FG002|Overall Study|Lost to Follow-up|1|||
13454090|NCT00239226|26949394|FG003|Overall Study|Lost to Follow-up|0|||
13454091|NCT00239005|26949411|FG000|Overall Study|Adverse Event|6|||
13454092|NCT00239005|26949412|FG001|Overall Study|Adverse Event|6|||
13454093|NCT00239005|26949411|FG000|Overall Study|Withdrawal by Subject|3|||
13454094|NCT00239005|26949412|FG001|Overall Study|Withdrawal by Subject|4|||
13454095|NCT00239005|26949411|FG000|Overall Study|Unsatisfactory Therapeutic effect|2|||
13454096|NCT00239005|26949412|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
13454097|NCT00239005|26949411|FG000|Overall Study|Protocol Violation|1|||
13454098|NCT00239005|26949412|FG001|Overall Study|Protocol Violation|0|||
13454099|NCT00239005|26949411|FG000|Overall Study|Subj. cond. no longer needs study drug|0|||
13454100|NCT00239005|26949412|FG001|Overall Study|Subj. cond. no longer needs study drug|1|||
13454101|NCT00239005|26949411|FG000|Overall Study|Lost to Follow-up|0|||
13454102|NCT00239005|26949412|FG001|Overall Study|Lost to Follow-up|1|||
13454103|NCT00238433|26949419|FG000|Overall Study|Screen failure|1|||
13454104|NCT00238433|26949419|FG000|Overall Study|Lost to Follow-up|1|||
13454105|NCT00238433|26949419|FG000|Overall Study|Death|1|||
13454106|NCT00238303|26949446|FG000|Overall Study|Withdrawal by Subject|11|||
13454107|NCT00238303|26949447|FG001|Overall Study|Withdrawal by Subject|1|||
13454108|NCT00238303|26949448|FG002|Overall Study|Withdrawal by Subject|2|||
13454109|NCT00238303|26949446|FG000|Overall Study|Death|1|||
13454110|NCT00238303|26949447|FG001|Overall Study|Death|0|||
13454111|NCT00238303|26949448|FG002|Overall Study|Death|1|||
13454112|NCT00238303|26949446|FG000|Overall Study|Other Medical Problems|2|||
13454113|NCT00238303|26949447|FG001|Overall Study|Other Medical Problems|0|||
13454114|NCT00238303|26949448|FG002|Overall Study|Other Medical Problems|2|||
13454115|NCT00238303|26949446|FG000|Overall Study|Poor tolerance of study treatment|1|||
13454116|NCT00238303|26949447|FG001|Overall Study|Poor tolerance of study treatment|0|||
13454117|NCT00238303|26949448|FG002|Overall Study|Poor tolerance of study treatment|1|||
13454118|NCT00238303|26949446|FG000|Overall Study|Adverse Event|0|||
13454119|NCT00238303|26949447|FG001|Overall Study|Adverse Event|1|||
13454120|NCT00238303|26949448|FG002|Overall Study|Adverse Event|3|||
13454121|NCT00238264|26949460|FG000|Overall Study|Death|7|||
13454122|NCT00238264|26949460|FG000|Overall Study|Lost to Follow-up|18|||
13454123|NCT00238264|26949460|FG000|Overall Study|Withdrawal by Subject|4|||
13454124|NCT00238264|26949460|FG000|Overall Study|Ineligible|7|||
13454125|NCT00238238|26949481|FG000|Overall Study|Withdrawal by Subject|0|||
13454126|NCT00238238|26949482|FG001|Overall Study|Withdrawal by Subject|3|||
13454127|NCT00238238|26949483|FG002|Overall Study|Withdrawal by Subject|0|||
13454128|NCT00238121|26949501|FG000|Overall Study|Withdrawal by Subject|1|||
13454129|NCT00238121|26949502|FG001|Overall Study|Withdrawal by Subject|1|||
13454130|NCT00238121|26949501|FG000|Overall Study|Adverse Event|2|||
13454131|NCT00238121|26949502|FG001|Overall Study|Adverse Event|1|||
13454132|NCT00237809|26949549|FG000|Overall Study|Lost to Follow-up|11|||
13454133|NCT00237809|26949550|FG001|Overall Study|Lost to Follow-up|10|||
13454134|NCT00237809|26949551|FG002|Overall Study|Lost to Follow-up|9|||
13454135|NCT00237809|26949552|FG003|Overall Study|Lost to Follow-up|9|||
13454136|NCT00237796|26949577|FG000|Overall Study|Baseline and one other ILSS required|10|||
13454137|NCT00237796|26949578|FG001|Overall Study|Baseline and one other ILSS required|5|||
13454138|NCT00237744|26949599|FG000|Overall Study|Withdrawal by Subject|3|||
13454139|NCT00237744|26949600|FG001|Overall Study|Withdrawal by Subject|1|||
13454140|NCT00237744|26949601|FG002|Overall Study|Withdrawal by Subject|0|||
13454141|NCT00237692|26949644|FG000|Overall Study|Lost to Follow-up|9|||
13454142|NCT00237692|26949645|FG001|Overall Study|Lost to Follow-up|3|||
13454143|NCT00237692|26949646|FG002|Overall Study|Lost to Follow-up|5|||
13454144|NCT00237692|26949647|FG003|Overall Study|Lost to Follow-up|3|||
13454145|NCT00237692|26949644|FG000|Overall Study|Death|1|||
13454146|NCT00237692|26949645|FG001|Overall Study|Death|2|||
13454147|NCT00237692|26949646|FG002|Overall Study|Death|2|||
13454148|NCT00237692|26949647|FG003|Overall Study|Death|3|||
13454149|NCT00237692|26949644|FG000|Overall Study|Excluded - did not meet criteria|4|||
13454150|NCT00237692|26949645|FG001|Overall Study|Excluded - did not meet criteria|3|||
13454151|NCT00237692|26949646|FG002|Overall Study|Excluded - did not meet criteria|5|||
13454152|NCT00237692|26949647|FG003|Overall Study|Excluded - did not meet criteria|9|||
13454153|NCT00237692|26949644|FG000|Overall Study|Withdrawal by Subject|4|||
13454154|NCT00237692|26949645|FG001|Overall Study|Withdrawal by Subject|6|||
13454155|NCT00237692|26949646|FG002|Overall Study|Withdrawal by Subject|10|||
13454156|NCT00237692|26949647|FG003|Overall Study|Withdrawal by Subject|4|||
13454157|NCT00237458|26949665|FG000|Overall Study|Lack of Efficacy|1|||
13454158|NCT00237458|26949665|FG000|Overall Study|Adverse Event|1|||
13454159|NCT00237458|26949665|FG000|Overall Study|Withdrawal by Subject|1|||
13454160|NCT00237185|26949700|FG000|Core|Adverse Event|3|||
13454161|NCT00237185|26949701|FG001|Core|Adverse Event|4|||
13454162|NCT00237185|26949700|FG000|Core|Abnormal laboratory value|0|||
13454163|NCT00237185|26949701|FG001|Core|Abnormal laboratory value|4|||
13454164|NCT00237185|26949700|FG000|Core|Abnormal test procedure results|1|||
13454165|NCT00237185|26949701|FG001|Core|Abnormal test procedure results|0|||
13454166|NCT00237185|26949700|FG000|Core|Lack of Efficacy|30|||
13454167|NCT00237185|26949701|FG001|Core|Lack of Efficacy|23|||
13454168|NCT00237185|26949700|FG000|Core|Protocol Violation|1|||
13454169|NCT00237185|26949701|FG001|Core|Protocol Violation|1|||
13454170|NCT00237185|26949700|FG000|Core|Withdrawal by Subject|4|||
13454171|NCT00237185|26949701|FG001|Core|Withdrawal by Subject|4|||
13454172|NCT00237185|26949700|FG000|Core|Administrative problems|0|||
13454173|NCT00237185|26949701|FG001|Core|Administrative problems|1|||
13454174|NCT00237185|26949700|FG000|Core|Death|4|||
13454175|NCT00237185|26949701|FG001|Core|Death|0|||
13454176|NCT00237185|26949700|FG000|Core|Determined ineligible post randomization|1|||
13454177|NCT00237185|26949701|FG001|Core|Determined ineligible post randomization|0|||
13454178|NCT00237185|26949700|FG000|Extension|Adverse Event|1|||
13454179|NCT00237185|26949701|FG001|Extension|Adverse Event|0|||
13454180|NCT00237185|26949700|FG000|Extension|Abnormal laboratory value|0|||
13454181|NCT00237185|26949701|FG001|Extension|Abnormal laboratory value|1|||
13454182|NCT00237185|26949700|FG000|Extension|Lack of Efficacy|9|||
13454183|NCT00237185|26949701|FG001|Extension|Lack of Efficacy|14|||
13454184|NCT00237185|26949700|FG000|Extension|Condition no longer required study drug|0|||
13454185|NCT00237185|26949701|FG001|Extension|Condition no longer required study drug|1|||
13454186|NCT00237185|26949700|FG000|Extension|Withdrawal by Subject|3|||
13454187|NCT00237185|26949701|FG001|Extension|Withdrawal by Subject|2|||
13454188|NCT00237185|26949700|FG000|Extension|Lost to Follow-up|1|||
13454189|NCT00237185|26949701|FG001|Extension|Lost to Follow-up|0|||
13454190|NCT00237185|26949700|FG000|Extension|Administrative problems|1|||
13454191|NCT00237185|26949701|FG001|Extension|Administrative problems|0|||
13454192|NCT00237185|26949700|FG000|Extension|Death|1|||
13454193|NCT00237185|26949701|FG001|Extension|Death|1|||
13454194|NCT00237042|26949728|FG000|Treatment|Became ineligible post-randomization|0|||
13454195|NCT00237042|26949729|FG001|Treatment|Became ineligible post-randomization|1|||
13454196|NCT00237042|26949730|FG002|Treatment|Became ineligible post-randomization|16|||
13454197|NCT00237042|26949728|FG000|Treatment|Moved out of state|1|||
13454198|NCT00237042|26949729|FG001|Treatment|Moved out of state|1|||
13454199|NCT00237042|26949730|FG002|Treatment|Moved out of state|1|||
13454200|NCT00237042|26949728|FG000|Treatment|Completed no treatment|5|||
13454201|NCT00237042|26949729|FG001|Treatment|Completed no treatment|5|||
13454202|NCT00237042|26949730|FG002|Treatment|Completed no treatment|21|||
13454203|NCT00237042|26949728|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9|||
13454204|NCT00237042|26949729|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8|||
13454205|NCT00237042|26949730|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11|||
13454206|NCT00237042|26949728|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11|||
13454207|NCT00237042|26949729|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
13454208|NCT00237042|26949730|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
13454209|NCT00236899|26949773|FG000|Overall Study|Adverse Event (Study Related)|1|||
13454210|NCT00236899|26949774|FG001|Overall Study|Adverse Event (Study Related)|1|||
13454211|NCT00236899|26949775|FG002|Overall Study|Adverse Event (Study Related)|2|||
13454212|NCT00236899|26949776|FG003|Overall Study|Adverse Event (Study Related)|1|||
13454213|NCT00236899|26949773|FG000|Overall Study|Adverse Event (Not Study Related)|3|||
13454214|NCT00236899|26949774|FG001|Overall Study|Adverse Event (Not Study Related)|3|||
13454215|NCT00236899|26949775|FG002|Overall Study|Adverse Event (Not Study Related)|4|||
13454216|NCT00236899|26949776|FG003|Overall Study|Adverse Event (Not Study Related)|7|||
13454217|NCT00236899|26949773|FG000|Overall Study|Death (Study Disease)|1|||
13454218|NCT00236899|26949774|FG001|Overall Study|Death (Study Disease)|4|||
13454219|NCT00236899|26949775|FG002|Overall Study|Death (Study Disease)|0|||
13454220|NCT00236899|26949776|FG003|Overall Study|Death (Study Disease)|0|||
13454221|NCT00236899|26949773|FG000|Overall Study|Death (Not Study Related)|2|||
13454222|NCT00236899|26949774|FG001|Overall Study|Death (Not Study Related)|0|||
13454223|NCT00236899|26949775|FG002|Overall Study|Death (Not Study Related)|0|||
13454224|NCT00236899|26949776|FG003|Overall Study|Death (Not Study Related)|0|||
13454225|NCT00236899|26949773|FG000|Overall Study|Death (Study Drug Toxicity)|1|||
13454226|NCT00236899|26949774|FG001|Overall Study|Death (Study Drug Toxicity)|0|||
13454227|NCT00236899|26949775|FG002|Overall Study|Death (Study Drug Toxicity)|0|||
13454228|NCT00236899|26949776|FG003|Overall Study|Death (Study Drug Toxicity)|0|||
13454229|NCT00236899|26949773|FG000|Overall Study|Lost to Follow-up|0|||
13454230|NCT00236899|26949774|FG001|Overall Study|Lost to Follow-up|1|||
13454231|NCT00236899|26949775|FG002|Overall Study|Lost to Follow-up|0|||
13454232|NCT00236899|26949776|FG003|Overall Study|Lost to Follow-up|0|||
13454233|NCT00236899|26949773|FG000|Overall Study|Entry Criteria Exclusion|0|||
13454234|NCT00236899|26949774|FG001|Overall Study|Entry Criteria Exclusion|1|||
13454235|NCT00236899|26949775|FG002|Overall Study|Entry Criteria Exclusion|1|||
13454236|NCT00236899|26949776|FG003|Overall Study|Entry Criteria Exclusion|0|||
13454237|NCT00236899|26949773|FG000|Overall Study|Protocol Violation|1|||
13454238|NCT00236899|26949774|FG001|Overall Study|Protocol Violation|0|||
13454239|NCT00236899|26949775|FG002|Overall Study|Protocol Violation|0|||
13454240|NCT00236899|26949776|FG003|Overall Study|Protocol Violation|0|||
13454241|NCT00236899|26949773|FG000|Overall Study|Withdrawal by Subject|6|||
13454242|NCT00236899|26949774|FG001|Overall Study|Withdrawal by Subject|4|||
13454243|NCT00236899|26949775|FG002|Overall Study|Withdrawal by Subject|5|||
13454244|NCT00236899|26949776|FG003|Overall Study|Withdrawal by Subject|2|||
13454245|NCT00236899|26949773|FG000|Overall Study|Physician Decision|7|||
13454246|NCT00236899|26949774|FG001|Overall Study|Physician Decision|8|||
13454247|NCT00236899|26949775|FG002|Overall Study|Physician Decision|7|||
13454248|NCT00236899|26949776|FG003|Overall Study|Physician Decision|6|||
13454249|NCT00236899|26949773|FG000|Overall Study|Satisfactory Response|2|||
13454250|NCT00236899|26949774|FG001|Overall Study|Satisfactory Response|0|||
13454251|NCT00236899|26949775|FG002|Overall Study|Satisfactory Response|0|||
13454252|NCT00236899|26949776|FG003|Overall Study|Satisfactory Response|1|||
13454253|NCT00236899|26949773|FG000|Overall Study|Lack of Efficacy|18|||
13454254|NCT00236899|26949774|FG001|Overall Study|Lack of Efficacy|18|||
13454255|NCT00236899|26949775|FG002|Overall Study|Lack of Efficacy|25|||
13454256|NCT00236899|26949776|FG003|Overall Study|Lack of Efficacy|23|||
13454257|NCT00236197|26949789|FG000|Overall Study|Withdrawal by Subject|3|||
13454258|NCT00236197|26949790|FG001|Overall Study|Withdrawal by Subject|2|||
13454259|NCT00236197|26949789|FG000|Overall Study|Lost to Follow-up|1|||
13454260|NCT00236197|26949790|FG001|Overall Study|Lost to Follow-up|5|||
13454261|NCT00236197|26949789|FG000|Overall Study|Protocol Violation|0|||
13454262|NCT00236197|26949790|FG001|Overall Study|Protocol Violation|3|||
13454263|NCT00236197|26949789|FG000|Overall Study|Medication non-compliance|1|||
13454264|NCT00236197|26949790|FG001|Overall Study|Medication non-compliance|2|||
13454265|NCT00236197|26949789|FG000|Overall Study|Other|0|||
13454266|NCT00236197|26949790|FG001|Overall Study|Other|2|||
13454267|NCT00236184|26949803|FG000|Overall Study|Adverse Event|5|||
13454268|NCT00236184|26949804|FG001|Overall Study|Adverse Event|2|||
13454269|NCT00236184|26949803|FG000|Overall Study|Lack of Efficacy|0|||
13454270|NCT00236184|26949804|FG001|Overall Study|Lack of Efficacy|1|||
13454271|NCT00236184|26949803|FG000|Overall Study|Lost to Follow-up|3|||
13454272|NCT00236184|26949804|FG001|Overall Study|Lost to Follow-up|4|||
13454273|NCT00236184|26949803|FG000|Overall Study|Physician Decision|1|||
13454274|NCT00236184|26949804|FG001|Overall Study|Physician Decision|1|||
13454275|NCT00236184|26949803|FG000|Overall Study|Withdrawal by Subject|3|||
13454276|NCT00236184|26949804|FG001|Overall Study|Withdrawal by Subject|0|||
13454277|NCT00236184|26949803|FG000|Overall Study|Protocol Violation|3|||
13454278|NCT00236184|26949804|FG001|Overall Study|Protocol Violation|0|||
13454279|NCT00236184|26949803|FG000|Overall Study|non-compliance with study drug|2|||
13454280|NCT00236184|26949804|FG001|Overall Study|non-compliance with study drug|1|||
13454281|NCT00236184|26949803|FG000|Overall Study|other|1|||
13454282|NCT00236184|26949804|FG001|Overall Study|other|2|||
13454283|NCT00236080|26949837|FG000|Overall Study|Adverse Event|0|||
13454284|NCT00236080|26949838|FG001|Overall Study|Adverse Event|0|||
13454285|NCT00236080|26949839|FG002|Overall Study|Adverse Event|3|||
13454286|NCT00236080|26949840|FG003|Overall Study|Adverse Event|1|||
13454287|NCT00236080|26949841|FG004|Overall Study|Adverse Event|0|||
13454288|NCT00236080|26949837|FG000|Overall Study|Lost to Follow-up|0|||
13454289|NCT00236080|26949838|FG001|Overall Study|Lost to Follow-up|1|||
13454290|NCT00236080|26949839|FG002|Overall Study|Lost to Follow-up|0|||
13454291|NCT00236080|26949840|FG003|Overall Study|Lost to Follow-up|0|||
13454292|NCT00236080|26949841|FG004|Overall Study|Lost to Follow-up|0|||
13454293|NCT00236080|26949837|FG000|Overall Study|Physician Decision|1|||
13454294|NCT00236080|26949838|FG001|Overall Study|Physician Decision|0|||
13454295|NCT00236080|26949839|FG002|Overall Study|Physician Decision|1|||
13454296|NCT00236080|26949840|FG003|Overall Study|Physician Decision|1|||
13454297|NCT00236080|26949841|FG004|Overall Study|Physician Decision|1|||
13454298|NCT00236080|26949837|FG000|Overall Study|Withdrawal by Subject|1|||
13454299|NCT00236080|26949838|FG001|Overall Study|Withdrawal by Subject|0|||
13454300|NCT00236080|26949839|FG002|Overall Study|Withdrawal by Subject|0|||
13454301|NCT00236080|26949840|FG003|Overall Study|Withdrawal by Subject|0|||
13454302|NCT00236080|26949841|FG004|Overall Study|Withdrawal by Subject|0|||
13454303|NCT00236080|26949837|FG000|Overall Study|Miscellaneous|0|||
13454304|NCT00236080|26949838|FG001|Overall Study|Miscellaneous|0|||
13454305|NCT00236080|26949839|FG002|Overall Study|Miscellaneous|1|||
13454306|NCT00236080|26949840|FG003|Overall Study|Miscellaneous|0|||
13454307|NCT00236080|26949841|FG004|Overall Study|Miscellaneous|0|||
13454308|NCT00235989|26949870|FG000|Core Treatment Period (CT)|Lost to Follow-up|0|||
13454309|NCT00235989|26949871|FG001|Core Treatment Period (CT)|Lost to Follow-up|0|||
13454310|NCT00235989|26949872|FG002|Core Treatment Period (CT)|Lost to Follow-up|0|||
13454311|NCT00235989|26949873|FG003|Core Treatment Period (CT)|Lost to Follow-up|0|||
13454312|NCT00235989|26949874|FG004|Core Treatment Period (CT)|Lost to Follow-up|0|||
13454313|NCT00235989|26949875|FG005|Core Treatment Period (CT)|Lost to Follow-up|2|||
13454314|NCT00235989|26949870|FG000|Extension Treatment Period (ET)|Adverse Event|3|||
13454315|NCT00235989|26949871|FG001|Extension Treatment Period (ET)|Adverse Event|0|||
13454316|NCT00235989|26949872|FG002|Extension Treatment Period (ET)|Adverse Event|2|||
13454317|NCT00235989|26949873|FG003|Extension Treatment Period (ET)|Adverse Event|0|||
13454318|NCT00235989|26949874|FG004|Extension Treatment Period (ET)|Adverse Event|0|||
13454319|NCT00235989|26949875|FG005|Extension Treatment Period (ET)|Adverse Event|0|||
13454320|NCT00235989|26949870|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2|||
13454321|NCT00235989|26949871|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0|||
13454322|NCT00235989|26949872|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1|||
13454323|NCT00235989|26949873|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0|||
13454324|NCT00235989|26949874|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0|||
13454325|NCT00235989|26949875|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0|||
13454326|NCT00235989|26949870|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
13454327|NCT00235989|26949871|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
13454328|NCT00235989|26949872|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
13454329|NCT00235989|26949873|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4|||
13454330|NCT00235989|26949874|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
13454331|NCT00235989|26949875|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
13454332|NCT00235989|26949870|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
13454333|NCT00235989|26949871|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3|||
13454334|NCT00235989|26949872|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1|||
13454335|NCT00235989|26949873|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
13454336|NCT00235989|26949874|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
13454337|NCT00235989|26949875|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
13454338|NCT00235872|26949892|FG000|Overall Study|Adverse Event|34|||
13454339|NCT00235872|26949892|FG000|Overall Study|Death|1|||
13454340|NCT00235872|26949892|FG000|Overall Study|Lost to Follow-up|1|||
13454341|NCT00235872|26949892|FG000|Overall Study|Withdrawal by Subject|50|||
13454342|NCT00235872|26949892|FG000|Overall Study|Administrative reason|61|||
13454343|NCT00235755|26949976|FG000|4-Week Titration Phase|Adverse Event|6|||
13454344|NCT00235755|26949977|FG001|4-Week Titration Phase|Adverse Event|14|||
13454345|NCT00235755|26949978|FG002|4-Week Titration Phase|Adverse Event|20|||
13454346|NCT00235755|26949976|FG000|4-Week Titration Phase|Lost to Follow-up|0|||
13454347|NCT00235755|26949977|FG001|4-Week Titration Phase|Lost to Follow-up|1|||
13454348|NCT00235755|26949978|FG002|4-Week Titration Phase|Lost to Follow-up|1|||
13454349|NCT00235755|26949976|FG000|4-Week Titration Phase|Protocol Violation|2|||
13454350|NCT00235755|26949977|FG001|4-Week Titration Phase|Protocol Violation|2|||
13454351|NCT00235755|26949978|FG002|4-Week Titration Phase|Protocol Violation|1|||
13454352|NCT00235755|26949976|FG000|4-Week Titration Phase|Withdrawal by Subject|1|||
13454353|NCT00235755|26949977|FG001|4-Week Titration Phase|Withdrawal by Subject|2|||
13454354|NCT00235755|26949978|FG002|4-Week Titration Phase|Withdrawal by Subject|3|||
13454355|NCT00235755|26949976|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
13454356|NCT00235755|26949977|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
13454357|NCT00235755|26949978|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
13454358|NCT00235755|26949976|FG000|4-Week Titration Phase|Randomization Occurred in Error|1|||
13454359|NCT00235755|26949977|FG001|4-Week Titration Phase|Randomization Occurred in Error|0|||
13454360|NCT00235755|26949978|FG002|4-Week Titration Phase|Randomization Occurred in Error|0|||
13454361|NCT00235755|26949976|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1|||
13454362|NCT00235755|26949977|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
13454363|NCT00235755|26949978|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
13454364|NCT00235755|26949976|FG000|12-Week Maintenance Phase|Adverse Event|8|||
13454365|NCT00235755|26949977|FG001|12-Week Maintenance Phase|Adverse Event|12|||
13454366|NCT00235755|26949978|FG002|12-Week Maintenance Phase|Adverse Event|26|||
13454367|NCT00235755|26949976|FG000|12-Week Maintenance Phase|Lost to Follow-up|2|||
13454368|NCT00235755|26949977|FG001|12-Week Maintenance Phase|Lost to Follow-up|3|||
13454369|NCT00235755|26949978|FG002|12-Week Maintenance Phase|Lost to Follow-up|0|||
13454370|NCT00235755|26949976|FG000|12-Week Maintenance Phase|Lack of Efficacy|5|||
13454371|NCT00235755|26949977|FG001|12-Week Maintenance Phase|Lack of Efficacy|0|||
13454372|NCT00235755|26949978|FG002|12-Week Maintenance Phase|Lack of Efficacy|0|||
13454373|NCT00235755|26949976|FG000|12-Week Maintenance Phase|Protocol Violation|0|||
13454374|NCT00235755|26949977|FG001|12-Week Maintenance Phase|Protocol Violation|4|||
13454375|NCT00235755|26949978|FG002|12-Week Maintenance Phase|Protocol Violation|2|||
13454376|NCT00235755|26949976|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0|||
13454377|NCT00235755|26949977|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8|||
13454378|NCT00235755|26949978|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3|||
13454379|NCT00235755|26949976|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1|||
13454380|NCT00235755|26949977|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
13454381|NCT00235755|26949978|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
13454382|NCT00235716|26950025|FG000|Overall Study|Death|26|||
13454383|NCT00235716|26950026|FG001|Overall Study|Death|39|||
13454384|NCT00235716|26950027|FG002|Overall Study|Death|32|||
13454385|NCT00235716|26950028|FG003|Overall Study|Death|31|||
13454386|NCT00235716|26950025|FG000|Overall Study|Withdrawal by Subject|23|||
13454387|NCT00235716|26950026|FG001|Overall Study|Withdrawal by Subject|19|||
13454388|NCT00235716|26950027|FG002|Overall Study|Withdrawal by Subject|17|||
13454389|NCT00235716|26950028|FG003|Overall Study|Withdrawal by Subject|18|||
13454390|NCT00235716|26950025|FG000|Overall Study|Lost to Follow-up|12|||
13454391|NCT00235716|26950026|FG001|Overall Study|Lost to Follow-up|7|||
13454392|NCT00235716|26950027|FG002|Overall Study|Lost to Follow-up|14|||
13454393|NCT00235716|26950028|FG003|Overall Study|Lost to Follow-up|10|||
13454394|NCT00235716|26950025|FG000|Overall Study|Adverse Event|1|||
13454395|NCT00235716|26950026|FG001|Overall Study|Adverse Event|1|||
13454396|NCT00235716|26950027|FG002|Overall Study|Adverse Event|1|||
13454397|NCT00235716|26950028|FG003|Overall Study|Adverse Event|0|||
13454398|NCT00235716|26950025|FG000|Overall Study|Physician Decision|0|||
13454399|NCT00235716|26950026|FG001|Overall Study|Physician Decision|1|||
13454400|NCT00235716|26950027|FG002|Overall Study|Physician Decision|1|||
13454401|NCT00235716|26950028|FG003|Overall Study|Physician Decision|3|||
13454402|NCT00235495|26950083|FG000|Overall Study|Death|52|||
13454403|NCT00235495|26950084|FG001|Overall Study|Death|42|||
13454404|NCT00235495|26950083|FG000|Overall Study|Withdrawal by Subject|5|||
13454405|NCT00235495|26950084|FG001|Overall Study|Withdrawal by Subject|3|||
13454406|NCT00235495|26950083|FG000|Overall Study|Lost to Follow-up|11|||
13454407|NCT00235495|26950084|FG001|Overall Study|Lost to Follow-up|13|||
13454408|NCT00235495|26950083|FG000|Overall Study|Visit/assessmen outside window/missing|0|||
13454409|NCT00235495|26950084|FG001|Overall Study|Visit/assessmen outside window/missing|10|||
13454410|NCT00235443|26950238|FG000|Overall Study|Adverse Event|4|||
13454411|NCT00235443|26950239|FG001|Overall Study|Adverse Event|12|||
13454412|NCT00235443|26950240|FG002|Overall Study|Adverse Event|17|||
13454413|NCT00235443|26950241|FG003|Overall Study|Adverse Event|44|||
13454414|NCT00235443|26950242|FG004|Overall Study|Adverse Event|10|||
13454415|NCT00235443|26950243|FG005|Overall Study|Adverse Event|15|||
13454416|NCT00235443|26950238|FG000|Overall Study|Lack of Efficacy|0|||
13454417|NCT00235443|26950239|FG001|Overall Study|Lack of Efficacy|1|||
13454418|NCT00235443|26950240|FG002|Overall Study|Lack of Efficacy|5|||
13454419|NCT00235443|26950241|FG003|Overall Study|Lack of Efficacy|12|||
13454420|NCT00235443|26950242|FG004|Overall Study|Lack of Efficacy|2|||
13454421|NCT00235443|26950243|FG005|Overall Study|Lack of Efficacy|9|||
13454422|NCT00235443|26950238|FG000|Overall Study|Withdrawal by Subject|3|||
13454423|NCT00235443|26950239|FG001|Overall Study|Withdrawal by Subject|9|||
13454424|NCT00235443|26950240|FG002|Overall Study|Withdrawal by Subject|25|||
13454425|NCT00235443|26950241|FG003|Overall Study|Withdrawal by Subject|24|||
13454426|NCT00235443|26950242|FG004|Overall Study|Withdrawal by Subject|10|||
13454427|NCT00235443|26950243|FG005|Overall Study|Withdrawal by Subject|12|||
13454428|NCT00235443|26950238|FG000|Overall Study|Lost to Follow-up|0|||
13454429|NCT00235443|26950239|FG001|Overall Study|Lost to Follow-up|8|||
13454430|NCT00235443|26950240|FG002|Overall Study|Lost to Follow-up|6|||
13454431|NCT00235443|26950241|FG003|Overall Study|Lost to Follow-up|6|||
13454432|NCT00235443|26950242|FG004|Overall Study|Lost to Follow-up|4|||
13454433|NCT00235443|26950243|FG005|Overall Study|Lost to Follow-up|3|||
13454434|NCT00235443|26950238|FG000|Overall Study|Unsatisfactory compliance|0|||
13454435|NCT00235443|26950239|FG001|Overall Study|Unsatisfactory compliance|2|||
13454436|NCT00235443|26950240|FG002|Overall Study|Unsatisfactory compliance|3|||
13454437|NCT00235443|26950241|FG003|Overall Study|Unsatisfactory compliance|4|||
13454438|NCT00235443|26950242|FG004|Overall Study|Unsatisfactory compliance|1|||
13454439|NCT00235443|26950243|FG005|Overall Study|Unsatisfactory compliance|0|||
13454440|NCT00235443|26950238|FG000|Overall Study|Other reasons for premature termination|1|||
13454441|NCT00235443|26950239|FG001|Overall Study|Other reasons for premature termination|6|||
13454442|NCT00235443|26950240|FG002|Overall Study|Other reasons for premature termination|6|||
13454443|NCT00235443|26950241|FG003|Overall Study|Other reasons for premature termination|7|||
13454444|NCT00235443|26950242|FG004|Overall Study|Other reasons for premature termination|3|||
13454445|NCT00235443|26950243|FG005|Overall Study|Other reasons for premature termination|6|||
13454446|NCT00235391|26950277|FG000|Overall Study|Adverse Event|4|||
13454447|NCT00235391|26950278|FG001|Overall Study|Adverse Event|5|||
13454448|NCT00235391|26950279|FG002|Overall Study|Adverse Event|10|||
13454449|NCT00235391|26950280|FG003|Overall Study|Adverse Event|72|||
13454450|NCT00235391|26950281|FG004|Overall Study|Adverse Event|5|||
13454451|NCT00235391|26950282|FG005|Overall Study|Adverse Event|2|||
13454452|NCT00235391|26950277|FG000|Overall Study|Abnormal laboratory value(s)|3|||
13454453|NCT00235391|26950278|FG001|Overall Study|Abnormal laboratory value(s)|5|||
13454454|NCT00235391|26950279|FG002|Overall Study|Abnormal laboratory value(s)|4|||
13454455|NCT00235391|26950280|FG003|Overall Study|Abnormal laboratory value(s)|27|||
13454456|NCT00235391|26950281|FG004|Overall Study|Abnormal laboratory value(s)|1|||
13454457|NCT00235391|26950282|FG005|Overall Study|Abnormal laboratory value(s)|2|||
13454458|NCT00235391|26950277|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
13454459|NCT00235391|26950278|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
13454460|NCT00235391|26950279|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
13454461|NCT00235391|26950280|FG003|Overall Study|Unsatisfactory therapeutic effect|17|||
13454462|NCT00235391|26950281|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
13454463|NCT00235391|26950282|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
13454464|NCT00235391|26950277|FG000|Overall Study|Condition no longer requires treatment|3|||
13454465|NCT00235391|26950278|FG001|Overall Study|Condition no longer requires treatment|0|||
13454466|NCT00235391|26950279|FG002|Overall Study|Condition no longer requires treatment|0|||
13454467|NCT00235391|26950280|FG003|Overall Study|Condition no longer requires treatment|11|||
13454468|NCT00235391|26950281|FG004|Overall Study|Condition no longer requires treatment|1|||
13454469|NCT00235391|26950282|FG005|Overall Study|Condition no longer requires treatment|0|||
13454470|NCT00235391|26950277|FG000|Overall Study|Protocol deviation|0|||
13454471|NCT00235391|26950278|FG001|Overall Study|Protocol deviation|0|||
13454472|NCT00235391|26950279|FG002|Overall Study|Protocol deviation|1|||
13454473|NCT00235391|26950280|FG003|Overall Study|Protocol deviation|11|||
13454474|NCT00235391|26950281|FG004|Overall Study|Protocol deviation|0|||
13454475|NCT00235391|26950282|FG005|Overall Study|Protocol deviation|0|||
13454476|NCT00235391|26950277|FG000|Overall Study|Withdrawal by Subject|2|||
13454477|NCT00235391|26950278|FG001|Overall Study|Withdrawal by Subject|3|||
13454478|NCT00235391|26950279|FG002|Overall Study|Withdrawal by Subject|3|||
13454479|NCT00235391|26950280|FG003|Overall Study|Withdrawal by Subject|61|||
13454480|NCT00235391|26950281|FG004|Overall Study|Withdrawal by Subject|5|||
13454481|NCT00235391|26950282|FG005|Overall Study|Withdrawal by Subject|0|||
13454482|NCT00235391|26950277|FG000|Overall Study|Lost to Follow-up|0|||
13454483|NCT00235391|26950278|FG001|Overall Study|Lost to Follow-up|3|||
13454484|NCT00235391|26950279|FG002|Overall Study|Lost to Follow-up|3|||
13454485|NCT00235391|26950280|FG003|Overall Study|Lost to Follow-up|16|||
13454486|NCT00235391|26950281|FG004|Overall Study|Lost to Follow-up|0|||
13454487|NCT00235391|26950282|FG005|Overall Study|Lost to Follow-up|0|||
13454488|NCT00235391|26950277|FG000|Overall Study|Administrative problems|0|||
13454489|NCT00235391|26950278|FG001|Overall Study|Administrative problems|0|||
13454490|NCT00235391|26950279|FG002|Overall Study|Administrative problems|0|||
13454491|NCT00235391|26950280|FG003|Overall Study|Administrative problems|1|||
13454492|NCT00235391|26950281|FG004|Overall Study|Administrative problems|0|||
13454493|NCT00235391|26950282|FG005|Overall Study|Administrative problems|0|||
13454494|NCT00235391|26950277|FG000|Overall Study|Death|0|||
13454495|NCT00235391|26950278|FG001|Overall Study|Death|0|||
13454496|NCT00235391|26950279|FG002|Overall Study|Death|1|||
13454497|NCT00235391|26950280|FG003|Overall Study|Death|4|||
13454498|NCT00235391|26950281|FG004|Overall Study|Death|0|||
13454499|NCT00235391|26950282|FG005|Overall Study|Death|0|||
13454500|NCT00234533|26950303|FG000|Overall Study|Withdrawal by Subject|6|||
13454501|NCT00234533|26950303|FG000|Overall Study|Adverse Event|2|||
13454502|NCT00234533|26950303|FG000|Overall Study|Enrolled but not treated|3|||
13454503|NCT00234494|26950312|FG000|Overall Study|Protocol Violation|2|||
13454504|NCT00234104|26950335|FG000|Overall Study|Adverse Event|4|||
13454505|NCT00234104|26950336|FG001|Overall Study|Adverse Event|0|||
13454506|NCT00234104|26950337|FG002|Overall Study|Adverse Event|3|||
13454507|NCT00234104|26950338|FG003|Overall Study|Adverse Event|5|||
13454508|NCT00234104|26950335|FG000|Overall Study|Protocol Violation|0|||
13454509|NCT00234104|26950336|FG001|Overall Study|Protocol Violation|0|||
13454510|NCT00234104|26950337|FG002|Overall Study|Protocol Violation|0|||
13454511|NCT00234104|26950338|FG003|Overall Study|Protocol Violation|1|||
13454512|NCT00234104|26950335|FG000|Overall Study|Physician Decision|0|||
13454513|NCT00234104|26950336|FG001|Overall Study|Physician Decision|1|||
13454514|NCT00234104|26950337|FG002|Overall Study|Physician Decision|2|||
13454515|NCT00234104|26950338|FG003|Overall Study|Physician Decision|2|||
13454516|NCT00234065|26950361|FG000|Overall Study|Adverse Event|268|||
13454517|NCT00234065|26950362|FG001|Overall Study|Adverse Event|166|||
13454518|NCT00234065|26950361|FG000|Overall Study|Withdrawal by Subject|73|||
13454519|NCT00234065|26950362|FG001|Overall Study|Withdrawal by Subject|56|||
13454520|NCT00234065|26950361|FG000|Overall Study|Physician Decision|23|||
13454521|NCT00234065|26950362|FG001|Overall Study|Physician Decision|22|||
13454522|NCT00234065|26950361|FG000|Overall Study|Not Classified|111|||
13454523|NCT00234065|26950362|FG001|Overall Study|Not Classified|112|||
13454524|NCT00234052|26950374|FG000|Treatment|Withdrawal by Subject|3|||
13454525|NCT00234052|26950374|FG000|Treatment|Adverse Event|5|||
13454526|NCT00234052|26950374|FG000|Treatment|Death|2|||
13454527|NCT00234052|26950374|FG000|Treatment|Progressive Disease|11|||
13454528|NCT00234052|26950374|FG000|Follow-up for 5 Years|Death|41|||
13454529|NCT00234052|26950374|FG000|Follow-up for 5 Years|Lost to Follow-up|1|||
13454530|NCT00234052|26950374|FG000|Follow-up for 5 Years|Other|7|||
13454531|NCT00234039|26950383|FG000|Overall Study|Adverse Event|2|||
13454532|NCT00234039|26950383|FG000|Overall Study|Progression/relapse|34|||
13454533|NCT00234039|26950383|FG000|Overall Study|Other - Not Protocol Specified|3|||
13454534|NCT00234039|26950383|FG000|Overall Study|Ineligible|9|||
13454535|NCT00234039|26950383|FG000|Overall Study|No Protocol Treatment Received|2|||
13454536|NCT00233987|26950392|FG000|Overall Study|Withdrawal by Subject|1|||
13454537|NCT00233987|26950392|FG000|Overall Study|Lack of Efficacy|2|||
13454538|NCT00233987|26950392|FG000|Overall Study|Reason Under Review|1|||
13454539|NCT00233987|26950392|FG000|Overall Study|Other - Not Protocol Specified|5|||
13454540|NCT00233987|26950392|FG000|Overall Study|Eligible but No Treatment Received|2|||
13454541|NCT00233987|26950392|FG000|Overall Study|Ineligible|4|||
13454542|NCT00233948|26950418|FG000|Overall Study|Adverse Event|1|||
13454543|NCT00233948|26950419|FG001|Overall Study|Adverse Event|0|||
13454544|NCT00233948|26950420|FG002|Overall Study|Adverse Event|0|||
13454545|NCT00233948|26950421|FG003|Overall Study|Adverse Event|0|||
13454546|NCT00233948|26950422|FG004|Overall Study|Adverse Event|0|||
13454547|NCT00233948|26950423|FG005|Overall Study|Adverse Event|0|||
13454548|NCT00233480|26950446|FG000|Overall Study|Underwent status II heart transplant|0|||
13454549|NCT00233480|26950447|FG001|Overall Study|Underwent status II heart transplant|1|||
13454550|NCT00233454|26950455|FG000|Overall Study|Death|6|||
13454551|NCT00233402|26950473|FG000|Overall Study|No pathology data|12|||
13454552|NCT00233402|26950474|FG001|Overall Study|No pathology data|9|||
13454553|NCT00233402|26950473|FG000|Overall Study|No Ta/T1|89|||
13454554|NCT00233402|26950474|FG001|Overall Study|No Ta/T1|94|||
13454555|NCT00233402|26950473|FG000|Overall Study|Lost to follow up etc|3|||
13454556|NCT00233402|26950474|FG001|Overall Study|Lost to follow up etc|21|||
13454557|NCT00233389|26950487|FG000|Overall Study|Adverse Event|5|||
13454558|NCT00233389|26950488|FG001|Overall Study|Adverse Event|5|||
13454559|NCT00233389|26950487|FG000|Overall Study|Lack of Efficacy|11|||
13454560|NCT00233389|26950488|FG001|Overall Study|Lack of Efficacy|8|||
13454561|NCT00233389|26950487|FG000|Overall Study|Lost to Follow-up|1|||
13454562|NCT00233389|26950488|FG001|Overall Study|Lost to Follow-up|1|||
13454563|NCT00233389|26950487|FG000|Overall Study|Physician Decision|1|||
13454564|NCT00233389|26950488|FG001|Overall Study|Physician Decision|0|||
13454565|NCT00233389|26950487|FG000|Overall Study|Protocol Violation|0|||
13454566|NCT00233389|26950488|FG001|Overall Study|Protocol Violation|1|||
13454567|NCT00233389|26950487|FG000|Overall Study|Withdrawal by Subject|0|||
13454568|NCT00233389|26950488|FG001|Overall Study|Withdrawal by Subject|1|||
13454569|NCT00233363|26950501|FG000|Overall Study|Adverse Event|1|||
13454570|NCT00233363|26950502|FG001|Overall Study|Adverse Event|2|||
13454571|NCT00233363|26950501|FG000|Overall Study|Lack of Efficacy|0|||
13454572|NCT00233363|26950502|FG001|Overall Study|Lack of Efficacy|2|||
13454573|NCT00233363|26950501|FG000|Overall Study|Withdrawal by Subject|1|||
13454574|NCT00233363|26950502|FG001|Overall Study|Withdrawal by Subject|1|||
13454575|NCT00233363|26950501|FG000|Overall Study|Aggravation of complication|1|||
13454576|NCT00233363|26950502|FG001|Overall Study|Aggravation of complication|0|||
13454577|NCT00233324|26950597|FG000|Main Study|Death|68|||
13454578|NCT00233324|26950598|FG001|Main Study|Death|60|||
13454579|NCT00233324|26950599|FG002|Main Study|Death|62|||
13454580|NCT00233324|26950600|FG003|Main Study|Death|47|||
13454581|NCT00233324|26950597|FG000|Follow up at 18-22 Months Corrected Age|Death|5|||
13454582|NCT00233324|26950598|FG001|Follow up at 18-22 Months Corrected Age|Death|7|||
13454583|NCT00233324|26950599|FG002|Follow up at 18-22 Months Corrected Age|Death|5|||
13454584|NCT00233324|26950600|FG003|Follow up at 18-22 Months Corrected Age|Death|4|||
13454585|NCT00233324|26950597|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8|||
13454586|NCT00233324|26950598|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
13454587|NCT00233324|26950599|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13|||
13454588|NCT00233324|26950600|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
13454589|NCT00233064|26950614|FG000|Overall Study|Lost to Follow-up|7|||
13454590|NCT00233064|26950615|FG001|Overall Study|Lost to Follow-up|7|||
13454591|NCT00233064|26950614|FG000|Overall Study|Withdrawal by Subject|5|||
13454592|NCT00233064|26950615|FG001|Overall Study|Withdrawal by Subject|3|||
13454593|NCT00233064|26950614|FG000|Overall Study|Death|0|||
13454594|NCT00233064|26950615|FG001|Overall Study|Death|1|||
13454595|NCT00233064|26950614|FG000|Overall Study|Relocation|0|||
13454596|NCT00233064|26950615|FG001|Overall Study|Relocation|1|||
13454597|NCT00233064|26950614|FG000|Overall Study|Protocol Violation|1|||
13454598|NCT00233064|26950615|FG001|Overall Study|Protocol Violation|0|||
13454599|NCT00233064|26950614|FG000|Overall Study|Moved to Dom. Republic|1|||
13454600|NCT00233064|26950615|FG001|Overall Study|Moved to Dom. Republic|0|||
13454601|NCT00232596|26950672|FG000|6-Week Titration Phase|Adverse Event|6|||
13454602|NCT00232596|26950673|FG001|6-Week Titration Phase|Adverse Event|19|||
13454603|NCT00232596|26950672|FG000|6-Week Titration Phase|Failed to Return|2|||
13454604|NCT00232596|26950673|FG001|6-Week Titration Phase|Failed to Return|1|||
13454605|NCT00232596|26950672|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1|||
13454606|NCT00232596|26950673|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2|||
13454607|NCT00232596|26950672|FG000|6-Week Titration Phase|Protocol Violation|1|||
13454608|NCT00232596|26950673|FG001|6-Week Titration Phase|Protocol Violation|3|||
13454609|NCT00232596|26950672|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1|||
13454610|NCT00232596|26950673|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0|||
13454611|NCT00232596|26950672|FG000|6-Week Titration Phase|Other|3|||
13454612|NCT00232596|26950673|FG001|6-Week Titration Phase|Other|3|||
13454613|NCT00232596|26950672|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
13454614|NCT00232596|26950673|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
13454615|NCT00232596|26950672|FG000|12-Week Maintenance Phase|Adverse Event|7|||
13454616|NCT00232596|26950673|FG001|12-Week Maintenance Phase|Adverse Event|22|||
13454617|NCT00232596|26950672|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1|||
13454618|NCT00232596|26950673|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2|||
13454619|NCT00232596|26950672|FG000|12-Week Maintenance Phase|Protocol Violation|3|||
13454620|NCT00232596|26950673|FG001|12-Week Maintenance Phase|Protocol Violation|1|||
13454621|NCT00232596|26950672|FG000|12-Week Maintenance Phase|Other|1|||
13454622|NCT00232596|26950673|FG001|12-Week Maintenance Phase|Other|3|||
13454623|NCT00232557|26950688|FG000|Overall Study|Lost to Follow-up|3|||
13454624|NCT00232557|26950689|FG001|Overall Study|Lost to Follow-up|5|||
13454625|NCT00232544|26950704|FG000|Overall Study|Lost to Follow-up|20|||
13454626|NCT00232544|26950705|FG001|Overall Study|Lost to Follow-up|15|||
13454627|NCT00232180|26950756|FG000|Double-blind (DB) Phase|Death|186|||
13454628|NCT00232180|26950757|FG001|Double-blind (DB) Phase|Death|222|||
13454629|NCT00232180|26950758|FG002|Double-blind (DB) Phase|Death|0|||
13454630|NCT00232180|26950756|FG000|Double-blind (DB) Phase|Lost to Follow-up|34|||
13454631|NCT00232180|26950757|FG001|Double-blind (DB) Phase|Lost to Follow-up|28|||
13454632|NCT00232180|26950758|FG002|Double-blind (DB) Phase|Lost to Follow-up|0|||
13454633|NCT00232180|26950756|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131|||
13454634|NCT00232180|26950757|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148|||
13454635|NCT00232180|26950758|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0|||
13454636|NCT00232180|26950756|FG000|Double-blind (DB) Phase|Protocol Violation|28|||
13454637|NCT00232180|26950757|FG001|Double-blind (DB) Phase|Protocol Violation|21|||
13454638|NCT00232180|26950758|FG002|Double-blind (DB) Phase|Protocol Violation|0|||
13454639|NCT00232180|26950756|FG000|Double-blind (DB) Phase|Adverse Event|83|||
13454640|NCT00232180|26950757|FG001|Double-blind (DB) Phase|Adverse Event|100|||
13454641|NCT00232180|26950758|FG002|Double-blind (DB) Phase|Adverse Event|0|||
13454642|NCT00232180|26950756|FG000|Double-blind (DB) Phase|Other|70|||
13454643|NCT00232180|26950757|FG001|Double-blind (DB) Phase|Other|75|||
13454644|NCT00232180|26950758|FG002|Double-blind (DB) Phase|Other|0|||
13454645|NCT00232180|26950756|FG000|Double-blind (DB) Phase|Randomized but not treated|3|||
13454646|NCT00232180|26950757|FG001|Double-blind (DB) Phase|Randomized but not treated|4|||
13454647|NCT00232180|26950758|FG002|Double-blind (DB) Phase|Randomized but not treated|0|||
13454648|NCT00232180|26950756|FG000|Double-blind (DB) Phase|Laboratory abnormality|6|||
13454649|NCT00232180|26950757|FG001|Double-blind (DB) Phase|Laboratory abnormality|7|||
13454650|NCT00232180|26950758|FG002|Double-blind (DB) Phase|Laboratory abnormality|0|||
13454651|NCT00232180|26950756|FG000|Open Label Phase|Death|0|||
13454652|NCT00232180|26950757|FG001|Open Label Phase|Death|0|||
13454653|NCT00232180|26950758|FG002|Open Label Phase|Death|48|||
13454654|NCT00232180|26950756|FG000|Open Label Phase|Lost to Follow-up|0|||
13454655|NCT00232180|26950757|FG001|Open Label Phase|Lost to Follow-up|0|||
13454656|NCT00232180|26950758|FG002|Open Label Phase|Lost to Follow-up|5|||
13454657|NCT00232180|26950756|FG000|Open Label Phase|Protocol Violation|0|||
13454658|NCT00232180|26950757|FG001|Open Label Phase|Protocol Violation|0|||
13454659|NCT00232180|26950758|FG002|Open Label Phase|Protocol Violation|3|||
13454660|NCT00232180|26950756|FG000|Open Label Phase|Study terminated by sponsor|0|||
13454661|NCT00232180|26950757|FG001|Open Label Phase|Study terminated by sponsor|0|||
13454662|NCT00232180|26950758|FG002|Open Label Phase|Study terminated by sponsor|3|||
13454663|NCT00232180|26950756|FG000|Open Label Phase|Withdrawal by Subject|0|||
13454664|NCT00232180|26950757|FG001|Open Label Phase|Withdrawal by Subject|0|||
13454665|NCT00232180|26950758|FG002|Open Label Phase|Withdrawal by Subject|37|||
13454666|NCT00232180|26950756|FG000|Open Label Phase|Other|0|||
13454667|NCT00232180|26950757|FG001|Open Label Phase|Other|0|||
13454668|NCT00232180|26950758|FG002|Open Label Phase|Other|16|||
13454669|NCT00232180|26950756|FG000|Open Label Phase|Adverse Event|0|||
13454670|NCT00232180|26950757|FG001|Open Label Phase|Adverse Event|0|||
13454671|NCT00232180|26950758|FG002|Open Label Phase|Adverse Event|25|||
13454672|NCT00232180|26950756|FG000|Open Label Phase|Laboratory abnormality|0|||
13454673|NCT00232180|26950757|FG001|Open Label Phase|Laboratory abnormality|0|||
13454674|NCT00232180|26950758|FG002|Open Label Phase|Laboratory abnormality|10|||
13454675|NCT00232180|26950756|FG000|Open Label Phase|Randomized but not treated|0|||
13454676|NCT00232180|26950757|FG001|Open Label Phase|Randomized but not treated|0|||
13454677|NCT00232180|26950758|FG002|Open Label Phase|Randomized but not treated|1|||
13454678|NCT00231894|26950787|FG000|Overall Study|Withdrawal by Subject|1|||
13454679|NCT00231894|26950788|FG001|Overall Study|Withdrawal by Subject|1|||
13454680|NCT00231842|26950795|FG000|Overall Study|Withdrawal by Subject|3|||
13454681|NCT00231842|26950795|FG000|Overall Study|Did not complete the last 3 cycle|8|||
13454682|NCT00231816|26950815|FG000|Overall Study|Adverse Event|1|||
13454683|NCT00231816|26950816|FG001|Overall Study|Adverse Event|0|||
13454684|NCT00231816|26950815|FG000|Overall Study|Lost to Follow-up|8|||
13454685|NCT00231816|26950816|FG001|Overall Study|Lost to Follow-up|5|||
13454686|NCT00231816|26950815|FG000|Overall Study|Protocol Violation|2|||
13454687|NCT00231816|26950816|FG001|Overall Study|Protocol Violation|3|||
13454688|NCT00231816|26950815|FG000|Overall Study|Withdrawal by Subject|3|||
13454689|NCT00231816|26950816|FG001|Overall Study|Withdrawal by Subject|3|||
13454690|NCT00231816|26950815|FG000|Overall Study|Other|2|||
13454691|NCT00231816|26950816|FG001|Overall Study|Other|1|||
13454692|NCT00231777|26950835|FG000|Overall Study|Lost to Follow-up|3|||
13454693|NCT00231777|26950836|FG001|Overall Study|Lost to Follow-up|0|||
13454694|NCT00231777|26950835|FG000|Overall Study|Other|3|||
13454695|NCT00231777|26950836|FG001|Overall Study|Other|2|||
13454696|NCT00231478|26950855|FG000|Overall Study|Protocol Violation|3|||
13454697|NCT00231478|26950856|FG001|Overall Study|Protocol Violation|2|||
13454698|NCT00231478|26950855|FG000|Overall Study|Refused Treatment|1|||
13454699|NCT00231478|26950856|FG001|Overall Study|Refused Treatment|1|||
13454700|NCT00231478|26950855|FG000|Overall Study|Withdrawal by Subject|1|||
13454701|NCT00231478|26950856|FG001|Overall Study|Withdrawal by Subject|0|||
13454702|NCT00231478|26950855|FG000|Overall Study|Adverse Event|0|||
13454703|NCT00231478|26950856|FG001|Overall Study|Adverse Event|1|||
13454704|NCT00231478|26950855|FG000|Overall Study|Administrative|3|||
13454705|NCT00231478|26950856|FG001|Overall Study|Administrative|2|||
13454706|NCT00231465|26950864|FG000|Overall Study|Completed only one cycle|1|||
13454707|NCT00231465|26950864|FG000|Overall Study|Did not have follow up CT scans|1|||
13454708|NCT00231413|26951042|FG000|Overall Study|Non-serious AE|0|||
13454709|NCT00231413|26951043|FG001|Overall Study|Non-serious AE|0|||
13454710|NCT00231413|26951044|FG002|Overall Study|Non-serious AE|1|||
13454711|NCT00231413|26951045|FG003|Overall Study|Non-serious AE|0|||
13454712|NCT00231413|26951046|FG004|Overall Study|Non-serious AE|0|||
13454713|NCT00231413|26951047|FG005|Overall Study|Non-serious AE|0|||
13454714|NCT00231413|26951048|FG006|Overall Study|Non-serious AE|1|||
13454715|NCT00231413|26951042|FG000|Overall Study|Withdrawal by Subject|3|||
13454716|NCT00231413|26951043|FG001|Overall Study|Withdrawal by Subject|1|||
13454717|NCT00231413|26951044|FG002|Overall Study|Withdrawal by Subject|4|||
13454718|NCT00231413|26951045|FG003|Overall Study|Withdrawal by Subject|2|||
13454719|NCT00231413|26951046|FG004|Overall Study|Withdrawal by Subject|2|||
13454720|NCT00231413|26951047|FG005|Overall Study|Withdrawal by Subject|0|||
13454721|NCT00231413|26951048|FG006|Overall Study|Withdrawal by Subject|3|||
13454722|NCT00231413|26951042|FG000|Overall Study|Migrated/moved from study area|0|||
13454723|NCT00231413|26951043|FG001|Overall Study|Migrated/moved from study area|0|||
13454724|NCT00231413|26951044|FG002|Overall Study|Migrated/moved from study area|1|||
13454725|NCT00231413|26951045|FG003|Overall Study|Migrated/moved from study area|0|||
13454726|NCT00231413|26951046|FG004|Overall Study|Migrated/moved from study area|0|||
13454727|NCT00231413|26951047|FG005|Overall Study|Migrated/moved from study area|1|||
13454728|NCT00231413|26951048|FG006|Overall Study|Migrated/moved from study area|0|||
13454729|NCT00231413|26951042|FG000|Overall Study|Lost to Follow-up|4|||
13454730|NCT00231413|26951043|FG001|Overall Study|Lost to Follow-up|4|||
13454731|NCT00231413|26951044|FG002|Overall Study|Lost to Follow-up|1|||
13454732|NCT00231413|26951045|FG003|Overall Study|Lost to Follow-up|1|||
13454733|NCT00231413|26951046|FG004|Overall Study|Lost to Follow-up|1|||
13454734|NCT00231413|26951047|FG005|Overall Study|Lost to Follow-up|4|||
13454735|NCT00231413|26951048|FG006|Overall Study|Lost to Follow-up|0|||
13454736|NCT00231413|26951042|FG000|Overall Study|Pregnancy|1|||
13454737|NCT00231413|26951043|FG001|Overall Study|Pregnancy|0|||
13454738|NCT00231413|26951044|FG002|Overall Study|Pregnancy|0|||
13454739|NCT00231413|26951045|FG003|Overall Study|Pregnancy|0|||
13454740|NCT00231413|26951046|FG004|Overall Study|Pregnancy|0|||
13454741|NCT00231413|26951047|FG005|Overall Study|Pregnancy|0|||
13454742|NCT00231413|26951048|FG006|Overall Study|Pregnancy|0|||
13454743|NCT00231179|26951069|FG000|Overall Study|Lost to Follow-up|21|||
13454744|NCT00231179|26951070|FG001|Overall Study|Lost to Follow-up|21|||
13454745|NCT00231179|26951069|FG000|Overall Study|Withdrawal by Subject|3|||
13454746|NCT00231179|26951070|FG001|Overall Study|Withdrawal by Subject|3|||
13454747|NCT00231114|26951113|FG000|Randomized|Withdrawal by Subject|6|||
13454748|NCT00231114|26951114|FG001|Randomized|Withdrawal by Subject|3|||
13454749|NCT00231114|26951113|FG000|Treatment Period|Death: Motor Vehicle Accident|1|||
13454750|NCT00231114|26951114|FG001|Treatment Period|Death: Motor Vehicle Accident|0|||
13454751|NCT00231114|26951113|FG000|Post-Treatment Period|Lost to Follow-up|6|||
13454752|NCT00231114|26951114|FG001|Post-Treatment Period|Lost to Follow-up|1|||
13454753|NCT00231114|26951113|FG000|Post-Treatment Period|Physician Decision|1|||
13454754|NCT00231114|26951114|FG001|Post-Treatment Period|Physician Decision|0|||
13454755|NCT00231114|26951113|FG000|Post-Treatment Period|Withdrawal by Subject|1|||
13454756|NCT00231114|26951114|FG001|Post-Treatment Period|Withdrawal by Subject|0|||
13454757|NCT00231062|26951122|FG000|Overall Study|Physician Decision|6|||
13454758|NCT00230971|26951141|FG000|Randomization|No study drug administered|3|||
13454759|NCT00230971|26951142|FG001|Randomization|No study drug administered|3|||
13454760|NCT00230971|26951141|FG000|Baseline Participants|Lost to Follow-up|5|||
13454761|NCT00230971|26951142|FG001|Baseline Participants|Lost to Follow-up|12|||
13454762|NCT00230971|26951141|FG000|Baseline Participants|Death|6|||
13454763|NCT00230971|26951142|FG001|Baseline Participants|Death|5|||
13454764|NCT00230971|26951141|FG000|Baseline Participants|Withdrawal by Subject|7|||
13454765|NCT00230971|26951142|FG001|Baseline Participants|Withdrawal by Subject|1|||
13454766|NCT00230971|26951141|FG000|Baseline Participants|Adverse Event|1|||
13454767|NCT00230971|26951142|FG001|Baseline Participants|Adverse Event|0|||
13454768|NCT00230971|26951141|FG000|Baseline Participants|No bacteria observed|1|||
13454769|NCT00230971|26951142|FG001|Baseline Participants|No bacteria observed|0|||
13454770|NCT00230971|26951141|FG000|Baseline Participants|Failure to return|1|||
13454771|NCT00230971|26951142|FG001|Baseline Participants|Failure to return|1|||
13454772|NCT00230971|26951141|FG000|Baseline Participants|Reintervention|1|||
13454773|NCT00230971|26951142|FG001|Baseline Participants|Reintervention|0|||
13454774|NCT00230282|26951149|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4|||
13454775|NCT00230282|26951149|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1|||
13454776|NCT00230282|26951149|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1|||
13454777|NCT00230282|26951149|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2|||
13477407|NCT03104374|27006543|FG000|Overall Study|Lack of Efficacy|6|||
13477408|NCT03104374|27006544|FG001|Overall Study|Lack of Efficacy|7|||
13477409|NCT03104374|27006545|FG002|Overall Study|Lack of Efficacy|12|||
13477410|NCT03104374|27006546|FG003|Overall Study|Lack of Efficacy|6|||
13477411|NCT03104374|27006543|FG000|Overall Study|Other|2|||
13477412|NCT03104374|27006544|FG001|Overall Study|Other|2|||
13477413|NCT03104374|27006545|FG002|Overall Study|Other|4|||
13477414|NCT03104374|27006546|FG003|Overall Study|Other|7|||
13477415|NCT03073603|27006599|FG000|Overall Study|Noncompliance|3|||
13477416|NCT03073603|27006600|FG001|Overall Study|Noncompliance|1|||
13477417|NCT03073603|27006599|FG000|Overall Study|Adverse Event|5|||
13477418|NCT03073603|27006600|FG001|Overall Study|Adverse Event|3|||
13477419|NCT03073603|27006599|FG000|Overall Study|Physician Decision|1|||
13477420|NCT03073603|27006600|FG001|Overall Study|Physician Decision|2|||
13477421|NCT03073603|27006599|FG000|Overall Study|Required treatment not allowed by protocol|1|||
13477422|NCT03073603|27006600|FG001|Overall Study|Required treatment not allowed by protocol|0|||
13477423|NCT03073603|27006599|FG000|Overall Study|Financial or insurance-related|8|||
13477424|NCT03073603|27006600|FG001|Overall Study|Financial or insurance-related|0|||
13477425|NCT03073603|27006599|FG000|Overall Study|Withdrawal by Subject|0|||
13477426|NCT03073603|27006600|FG001|Overall Study|Withdrawal by Subject|1|||
13477427|NCT03073603|27006599|FG000|Overall Study|Discontinued DMT|4|||
13477428|NCT03073603|27006600|FG001|Overall Study|Discontinued DMT|0|||
13477429|NCT03073603|27006599|FG000|Overall Study|Restarted DMT|0|||
13477430|NCT03073603|27006600|FG001|Overall Study|Restarted DMT|1|||
13477431|NCT03002155|27006638|FG000|Overall Study|Lost to Follow-up|1|||
13477432|NCT03002155|27006639|FG001|Overall Study|Lost to Follow-up|2|||
13477433|NCT03002155|27006638|FG000|Overall Study|Withdrawal by Subject|1|||
13477434|NCT03002155|27006639|FG001|Overall Study|Withdrawal by Subject|0|||
13477435|NCT03002155|27006638|FG000|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
13477436|NCT03002155|27006639|FG001|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
13477437|NCT02918006|27006686|FG000|Allocation and Follow-Up|Lost to Follow-up|1|||
13477438|NCT02918006|27006687|FG001|Allocation and Follow-Up|Lost to Follow-up|2|||
13477439|NCT02918006|27006688|FG002|Allocation and Follow-Up|Lost to Follow-up|1|||
13477440|NCT02918006|27006686|FG000|Allocation and Follow-Up|Withdrawal by Subject|1|||
13477441|NCT02918006|27006687|FG001|Allocation and Follow-Up|Withdrawal by Subject|0|||
13477442|NCT02918006|27006688|FG002|Allocation and Follow-Up|Withdrawal by Subject|0|||
13477443|NCT02918006|27006686|FG000|Vaccination Phase Analysis|Withdrawal by Subject|3|||
13477444|NCT02918006|27006687|FG001|Vaccination Phase Analysis|Withdrawal by Subject|7|||
13477445|NCT02918006|27006688|FG002|Vaccination Phase Analysis|Withdrawal by Subject|2|||
13477446|NCT02918006|27006686|FG000|Vaccination Phase Analysis|Biofire Positive|5|||
13477447|NCT02918006|27006687|FG001|Vaccination Phase Analysis|Biofire Positive|5|||
13477448|NCT02918006|27006688|FG002|Vaccination Phase Analysis|Biofire Positive|0|||
13477449|NCT02918006|27006686|FG000|Vaccination Phase Analysis|Symptoms of Sinusitis|1|||
13477450|NCT02918006|27006687|FG001|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
13477451|NCT02918006|27006688|FG002|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
13477452|NCT02918006|27006686|FG000|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
13477453|NCT02918006|27006687|FG001|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|3|||
13477454|NCT02918006|27006688|FG002|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
13477455|NCT02918006|27006686|FG000|Vaccination Phase Analysis|Seasonal allergies|0|||
13477456|NCT02918006|27006687|FG001|Vaccination Phase Analysis|Seasonal allergies|1|||
13477457|NCT02918006|27006688|FG002|Vaccination Phase Analysis|Seasonal allergies|0|||
13477458|NCT02918006|27006686|FG000|Challenge Phase Analysis|Withdrawal by Subject|0|||
13477459|NCT02918006|27006687|FG001|Challenge Phase Analysis|Withdrawal by Subject|0|||
13477460|NCT02918006|27006688|FG002|Challenge Phase Analysis|Withdrawal by Subject|1|||
13477461|NCT02918006|27006686|FG000|Challenge Phase Analysis|Lost to Follow-up|0|||
13477462|NCT02918006|27006687|FG001|Challenge Phase Analysis|Lost to Follow-up|0|||
13477463|NCT02918006|27006688|FG002|Challenge Phase Analysis|Lost to Follow-up|1|||
13477464|NCT02658487|27006743|FG000|Overall Study|Death|2|||
13477465|NCT02658487|27006743|FG000|Overall Study|Disease progression|10|||
13477466|NCT02658487|27006743|FG000|Overall Study|Alternative therapy|1|||
13477467|NCT02658487|27006743|FG000|Overall Study|Adverse Event|1|||
13477468|NCT02658487|27006743|FG000|Overall Study|Treatment Failure, circulating blasts|1|||
13477469|NCT02658487|27006743|FG000|Overall Study|Refractory AML|1|||
13454778|NCT00230178|26951173|FG000|Overall Study|Adverse Event|1|||
13454779|NCT00230178|26951174|FG001|Overall Study|Adverse Event|5|||
13454780|NCT00230178|26951175|FG002|Overall Study|Adverse Event|2|||
13454781|NCT00230178|26951173|FG000|Overall Study|Withdrawal by Subject|0|||
13454782|NCT00230178|26951174|FG001|Overall Study|Withdrawal by Subject|0|||
13454783|NCT00230178|26951175|FG002|Overall Study|Withdrawal by Subject|1|||
13454784|NCT00230178|26951173|FG000|Overall Study|Various other reasons|3|||
13454785|NCT00230178|26951174|FG001|Overall Study|Various other reasons|2|||
13454786|NCT00230178|26951175|FG002|Overall Study|Various other reasons|4|||
13454787|NCT00230048|26951190|FG000|Overall Study|Lost to Follow-up|13|||
13454788|NCT00230048|26951191|FG001|Overall Study|Lost to Follow-up|18|||
13454789|NCT00229931|26951206|FG000|Overall Study|Death|1|||
13454790|NCT00229931|26951207|FG001|Overall Study|Death|0|||
13454791|NCT00229931|26951206|FG000|Overall Study|Lost to Follow-up|3|||
13454792|NCT00229931|26951207|FG001|Overall Study|Lost to Follow-up|2|||
13454793|NCT00229723|26951280|FG000|Concomitant Phase|Adverse Event|4|||
13454794|NCT00229723|26951281|FG001|Concomitant Phase|Adverse Event|2|||
13454795|NCT00229723|26951282|FG002|Concomitant Phase|Adverse Event|5|||
13454796|NCT00229723|26951283|FG003|Concomitant Phase|Adverse Event|2|||
13454797|NCT00229723|26951284|FG004|Concomitant Phase|Adverse Event|0|||
13454798|NCT00229723|26951285|FG005|Concomitant Phase|Adverse Event|1|||
13454799|NCT00229723|26951286|FG006|Concomitant Phase|Adverse Event|2|||
13454800|NCT00229723|26951280|FG000|Concomitant Phase|Objective disease progression|0|||
13454801|NCT00229723|26951281|FG001|Concomitant Phase|Objective disease progression|0|||
13454802|NCT00229723|26951282|FG002|Concomitant Phase|Objective disease progression|0|||
13454803|NCT00229723|26951283|FG003|Concomitant Phase|Objective disease progression|0|||
13454804|NCT00229723|26951284|FG004|Concomitant Phase|Objective disease progression|0|||
13454805|NCT00229723|26951285|FG005|Concomitant Phase|Objective disease progression|0|||
13454806|NCT00229723|26951286|FG006|Concomitant Phase|Objective disease progression|0|||
13454807|NCT00229723|26951280|FG000|Concomitant Phase|Clinical progression|0|||
13454808|NCT00229723|26951281|FG001|Concomitant Phase|Clinical progression|0|||
13454809|NCT00229723|26951282|FG002|Concomitant Phase|Clinical progression|0|||
13454810|NCT00229723|26951283|FG003|Concomitant Phase|Clinical progression|0|||
13454811|NCT00229723|26951284|FG004|Concomitant Phase|Clinical progression|0|||
13454812|NCT00229723|26951285|FG005|Concomitant Phase|Clinical progression|0|||
13454813|NCT00229723|26951286|FG006|Concomitant Phase|Clinical progression|1|||
13454814|NCT00229723|26951280|FG000|Concomitant Phase|Lost to Follow-up|0|||
13454815|NCT00229723|26951281|FG001|Concomitant Phase|Lost to Follow-up|0|||
13454816|NCT00229723|26951282|FG002|Concomitant Phase|Lost to Follow-up|0|||
13454817|NCT00229723|26951283|FG003|Concomitant Phase|Lost to Follow-up|0|||
13454818|NCT00229723|26951284|FG004|Concomitant Phase|Lost to Follow-up|1|||
13454819|NCT00229723|26951285|FG005|Concomitant Phase|Lost to Follow-up|0|||
13454820|NCT00229723|26951286|FG006|Concomitant Phase|Lost to Follow-up|0|||
13454821|NCT00229723|26951280|FG000|Concomitant Phase|Informed consent withdrawn|3|||
13454822|NCT00229723|26951281|FG001|Concomitant Phase|Informed consent withdrawn|2|||
13454823|NCT00229723|26951282|FG002|Concomitant Phase|Informed consent withdrawn|0|||
13454824|NCT00229723|26951283|FG003|Concomitant Phase|Informed consent withdrawn|2|||
13454825|NCT00229723|26951284|FG004|Concomitant Phase|Informed consent withdrawn|0|||
13454826|NCT00229723|26951285|FG005|Concomitant Phase|Informed consent withdrawn|0|||
13454827|NCT00229723|26951286|FG006|Concomitant Phase|Informed consent withdrawn|0|||
13454828|NCT00229723|26951280|FG000|Concomitant Phase|Severe non-compliance|0|||
13454829|NCT00229723|26951281|FG001|Concomitant Phase|Severe non-compliance|1|||
13454830|NCT00229723|26951282|FG002|Concomitant Phase|Severe non-compliance|0|||
13454831|NCT00229723|26951283|FG003|Concomitant Phase|Severe non-compliance|0|||
13454832|NCT00229723|26951284|FG004|Concomitant Phase|Severe non-compliance|1|||
13454833|NCT00229723|26951285|FG005|Concomitant Phase|Severe non-compliance|0|||
13454834|NCT00229723|26951286|FG006|Concomitant Phase|Severe non-compliance|0|||
13454835|NCT00229723|26951280|FG000|Concomitant Phase|Other|3|||
13454836|NCT00229723|26951281|FG001|Concomitant Phase|Other|0|||
13454837|NCT00229723|26951282|FG002|Concomitant Phase|Other|1|||
13454838|NCT00229723|26951283|FG003|Concomitant Phase|Other|1|||
13454839|NCT00229723|26951284|FG004|Concomitant Phase|Other|0|||
13454840|NCT00229723|26951285|FG005|Concomitant Phase|Other|2|||
13454841|NCT00229723|26951286|FG006|Concomitant Phase|Other|0|||
13454842|NCT00229723|26951280|FG000|Maintenance Phase|Adverse Event|7|||
13454843|NCT00229723|26951281|FG001|Maintenance Phase|Adverse Event|2|||
13454844|NCT00229723|26951282|FG002|Maintenance Phase|Adverse Event|1|||
13454845|NCT00229723|26951283|FG003|Maintenance Phase|Adverse Event|4|||
13454846|NCT00229723|26951284|FG004|Maintenance Phase|Adverse Event|7|||
13454847|NCT00229723|26951285|FG005|Maintenance Phase|Adverse Event|5|||
13454848|NCT00229723|26951286|FG006|Maintenance Phase|Adverse Event|2|||
13454849|NCT00229723|26951280|FG000|Maintenance Phase|Objective disease progression|5|||
13454850|NCT00229723|26951281|FG001|Maintenance Phase|Objective disease progression|5|||
13454851|NCT00229723|26951282|FG002|Maintenance Phase|Objective disease progression|3|||
13454852|NCT00229723|26951283|FG003|Maintenance Phase|Objective disease progression|6|||
13454853|NCT00229723|26951284|FG004|Maintenance Phase|Objective disease progression|2|||
13454854|NCT00229723|26951285|FG005|Maintenance Phase|Objective disease progression|9|||
13454855|NCT00229723|26951286|FG006|Maintenance Phase|Objective disease progression|5|||
13454856|NCT00229723|26951280|FG000|Maintenance Phase|Clinical progression|4|||
13454857|NCT00229723|26951281|FG001|Maintenance Phase|Clinical progression|1|||
13454858|NCT00229723|26951282|FG002|Maintenance Phase|Clinical progression|2|||
13454859|NCT00229723|26951283|FG003|Maintenance Phase|Clinical progression|2|||
13454860|NCT00229723|26951284|FG004|Maintenance Phase|Clinical progression|1|||
13454861|NCT00229723|26951285|FG005|Maintenance Phase|Clinical progression|1|||
13454862|NCT00229723|26951286|FG006|Maintenance Phase|Clinical progression|1|||
13454863|NCT00229723|26951280|FG000|Maintenance Phase|Lost to Follow-up|0|||
13454864|NCT00229723|26951281|FG001|Maintenance Phase|Lost to Follow-up|1|||
13454865|NCT00229723|26951282|FG002|Maintenance Phase|Lost to Follow-up|2|||
13454866|NCT00229723|26951283|FG003|Maintenance Phase|Lost to Follow-up|2|||
13454867|NCT00229723|26951284|FG004|Maintenance Phase|Lost to Follow-up|0|||
13454868|NCT00229723|26951285|FG005|Maintenance Phase|Lost to Follow-up|0|||
13454869|NCT00229723|26951286|FG006|Maintenance Phase|Lost to Follow-up|1|||
13454870|NCT00229723|26951280|FG000|Maintenance Phase|Informed consent withdrawn|1|||
13454871|NCT00229723|26951281|FG001|Maintenance Phase|Informed consent withdrawn|0|||
13454872|NCT00229723|26951282|FG002|Maintenance Phase|Informed consent withdrawn|0|||
13454873|NCT00229723|26951283|FG003|Maintenance Phase|Informed consent withdrawn|1|||
13454874|NCT00229723|26951284|FG004|Maintenance Phase|Informed consent withdrawn|1|||
13454875|NCT00229723|26951285|FG005|Maintenance Phase|Informed consent withdrawn|1|||
13454876|NCT00229723|26951286|FG006|Maintenance Phase|Informed consent withdrawn|0|||
13454877|NCT00229723|26951280|FG000|Maintenance Phase|Severe non-compliance|3|||
13454878|NCT00229723|26951281|FG001|Maintenance Phase|Severe non-compliance|1|||
13454879|NCT00229723|26951282|FG002|Maintenance Phase|Severe non-compliance|0|||
13454880|NCT00229723|26951283|FG003|Maintenance Phase|Severe non-compliance|0|||
13454881|NCT00229723|26951284|FG004|Maintenance Phase|Severe non-compliance|1|||
13454882|NCT00229723|26951285|FG005|Maintenance Phase|Severe non-compliance|0|||
13454883|NCT00229723|26951286|FG006|Maintenance Phase|Severe non-compliance|0|||
13454884|NCT00229723|26951280|FG000|Maintenance Phase|Other|5|||
13454885|NCT00229723|26951281|FG001|Maintenance Phase|Other|4|||
13454886|NCT00229723|26951282|FG002|Maintenance Phase|Other|1|||
13454887|NCT00229723|26951283|FG003|Maintenance Phase|Other|2|||
13454888|NCT00229723|26951284|FG004|Maintenance Phase|Other|3|||
13454889|NCT00229723|26951285|FG005|Maintenance Phase|Other|3|||
13454890|NCT00229723|26951286|FG006|Maintenance Phase|Other|1|||
13454891|NCT00229658|26951321|FG000|Overall Study|Administrative|2|||
13454892|NCT00229658|26951322|FG001|Overall Study|Administrative|1|||
13454893|NCT00229658|26951321|FG000|Overall Study|Investigator decision|13|||
13454894|NCT00229658|26951322|FG001|Overall Study|Investigator decision|10|||
13454895|NCT00229658|26951321|FG000|Overall Study|Other|80|||
13454896|NCT00229658|26951322|FG001|Overall Study|Other|60|||
13454897|NCT00229658|26951321|FG000|Overall Study|Lost to Follow-up|82|||
13454898|NCT00229658|26951322|FG001|Overall Study|Lost to Follow-up|55|||
13454899|NCT00229658|26951321|FG000|Overall Study|Serious Adverse Event|2|||
13454900|NCT00229658|26951322|FG001|Overall Study|Serious Adverse Event|2|||
13454901|NCT00229658|26951321|FG000|Overall Study|Withdrawal of consent|46|||
13454902|NCT00229658|26951322|FG001|Overall Study|Withdrawal of consent|39|||
13454903|NCT00229203|26951341|FG000|Overall Study|Progressive disease|18|||
13454904|NCT00229203|26951342|FG001|Overall Study|Progressive disease|9|||
13454905|NCT00229203|26951341|FG000|Overall Study|Toxicity|6|||
13454906|NCT00229203|26951342|FG001|Overall Study|Toxicity|1|||
13454907|NCT00229203|26951341|FG000|Overall Study|Death|4|||
13454908|NCT00229203|26951342|FG001|Overall Study|Death|2|||
13454909|NCT00229203|26951341|FG000|Overall Study|Other|3|||
13454910|NCT00229203|26951342|FG001|Overall Study|Other|3|||
13454911|NCT00229203|26951341|FG000|Overall Study|Withdrawal by Subject|1|||
13454912|NCT00229203|26951342|FG001|Overall Study|Withdrawal by Subject|4|||
13454913|NCT00228917|26951413|FG000|Overall Study|Migrated/moved from study area|0|||
13454914|NCT00228917|26951414|FG001|Overall Study|Migrated/moved from study area|0|||
13454915|NCT00228917|26951415|FG002|Overall Study|Migrated/moved from study area|0|||
13454916|NCT00228917|26951416|FG003|Overall Study|Migrated/moved from study area|0|||
13454917|NCT00228917|26951417|FG004|Overall Study|Migrated/moved from study area|0|||
13454918|NCT00228917|26951418|FG005|Overall Study|Migrated/moved from study area|2|||
13454919|NCT00228917|26951419|FG006|Overall Study|Migrated/moved from study area|0|||
13454920|NCT00228917|26951420|FG007|Overall Study|Migrated/moved from study area|0|||
13454921|NCT00228813|26951428|FG000|Overall Study|Death|4|||
13454922|NCT00228566|26951434|FG000|Overall Study|Adverse Event|31|||
13454923|NCT00228566|26951434|FG000|Overall Study|Lack of Efficacy|14|||
13454924|NCT00228566|26951434|FG000|Overall Study|Lost to Follow-up|16|||
13454925|NCT00228566|26951434|FG000|Overall Study|Physician Decision|5|||
13454926|NCT00228566|26951434|FG000|Overall Study|Withdrawal by Subject|4|||
13454927|NCT00228566|26951434|FG000|Overall Study|Miscellaneous|1|||
13454928|NCT00228553|26951440|FG000|Overall Study|Adverse Event|112|||
13454929|NCT00228553|26951440|FG000|Overall Study|Lack of Efficacy|34|||
13454930|NCT00228553|26951440|FG000|Overall Study|Lost to Follow-up|67|||
13454931|NCT00228553|26951440|FG000|Overall Study|Physician Decision|48|||
13454932|NCT00228553|26951440|FG000|Overall Study|Protocol Violation|6|||
13454933|NCT00228553|26951440|FG000|Overall Study|Withdrawal by Subject|115|||
13454934|NCT00228553|26951440|FG000|Overall Study|Pregnancy|2|||
13454935|NCT00228553|26951440|FG000|Overall Study|Miscellaneous|46|||
13454936|NCT00228423|26951459|FG000|Overall Study|Adverse Event|2|||
13454937|NCT00228423|26951460|FG001|Overall Study|Adverse Event|5|||
13454938|NCT00228423|26951459|FG000|Overall Study|Withdrawal by Subject|7|||
13454939|NCT00228423|26951460|FG001|Overall Study|Withdrawal by Subject|3|||
13454940|NCT00228423|26951459|FG000|Overall Study|Protocol Violation|1|||
13454941|NCT00228423|26951460|FG001|Overall Study|Protocol Violation|3|||
13454942|NCT00228423|26951459|FG000|Overall Study|Physician Decision|0|||
13454943|NCT00228423|26951460|FG001|Overall Study|Physician Decision|1|||
13454944|NCT00228384|26951505|FG000|Overall Study|Death|9|||
13454945|NCT00228384|26951506|FG001|Overall Study|Death|3|||
13454946|NCT00228384|26951505|FG000|Overall Study|Lost to Follow-up|6|||
13454947|NCT00228384|26951506|FG001|Overall Study|Lost to Follow-up|10|||
13454948|NCT00228384|26951505|FG000|Overall Study|Surgical Intervention (bypass)|5|||
13454949|NCT00228384|26951506|FG001|Overall Study|Surgical Intervention (bypass)|5|||
13454950|NCT00228384|26951505|FG000|Overall Study|Withdrawal by Subject|9|||
13454951|NCT00228384|26951506|FG001|Overall Study|Withdrawal by Subject|10|||
13454952|NCT00228384|26951505|FG000|Overall Study|Physician Decision|0|||
13454953|NCT00228384|26951506|FG001|Overall Study|Physician Decision|1|||
13454954|NCT00227903|26951573|FG000|Overall Study|Withdrawal by Subject|2|||
13454955|NCT00227903|26951574|FG001|Overall Study|Withdrawal by Subject|5|||
13454956|NCT00227903|26951573|FG000|Overall Study|Subject moved out of area|1|||
13454957|NCT00227903|26951574|FG001|Overall Study|Subject moved out of area|2|||
13454958|NCT00227903|26951573|FG000|Overall Study|Lost to Follow-up|1|||
13454959|NCT00227903|26951574|FG001|Overall Study|Lost to Follow-up|3|||
13454960|NCT00227903|26951573|FG000|Overall Study|Miscarriage|1|||
13454961|NCT00227903|26951574|FG001|Overall Study|Miscarriage|0|||
13454962|NCT00227877|26951617|FG000|Pre-visit Assessment|Technical difficulties|7|||
13454963|NCT00227877|26951618|FG001|Pre-visit Assessment|Technical difficulties|3|||
13454964|NCT00227877|26951619|FG002|Pre-visit Assessment|Technical difficulties|0|||
13454965|NCT00227877|26951620|FG003|Pre-visit Assessment|Technical difficulties|0|||
13454966|NCT00227877|26951617|FG000|Post-visit Checklist|Lost to Follow-up|24|||
13454967|NCT00227877|26951618|FG001|Post-visit Checklist|Lost to Follow-up|13|||
13454968|NCT00227877|26951619|FG002|Post-visit Checklist|Lost to Follow-up|1|||
13454969|NCT00227877|26951620|FG003|Post-visit Checklist|Lost to Follow-up|0|||
13454970|NCT00227877|26951617|FG000|3-months Follow-up|Completed late|135|||
13454971|NCT00227877|26951618|FG001|3-months Follow-up|Completed late|128|||
13454972|NCT00227877|26951619|FG002|3-months Follow-up|Completed late|34|||
13454973|NCT00227877|26951620|FG003|3-months Follow-up|Completed late|8|||
13454974|NCT00227877|26951617|FG000|3-months Follow-up|Lost to Follow-up|178|||
13454975|NCT00227877|26951618|FG001|3-months Follow-up|Lost to Follow-up|139|||
13454976|NCT00227877|26951619|FG002|3-months Follow-up|Lost to Follow-up|18|||
13454977|NCT00227877|26951620|FG003|3-months Follow-up|Lost to Follow-up|13|||
13454978|NCT00227877|26951617|FG000|12-months Follow-up|Completed late|78|||
13454979|NCT00227877|26951618|FG001|12-months Follow-up|Completed late|74|||
13454980|NCT00227877|26951619|FG002|12-months Follow-up|Completed late|1|||
13454981|NCT00227877|26951620|FG003|12-months Follow-up|Completed late|0|||
13454982|NCT00227877|26951617|FG000|12-months Follow-up|Lost to Follow-up|232|||
13454983|NCT00227877|26951618|FG001|12-months Follow-up|Lost to Follow-up|189|||
13454984|NCT00227877|26951619|FG002|12-months Follow-up|Lost to Follow-up|30|||
13454985|NCT00227877|26951620|FG003|12-months Follow-up|Lost to Follow-up|26|||
13454986|NCT00227721|26951627|FG000|Overall Study|On study, but never treated.|1|||
13454987|NCT00227591|26951633|FG000|Overall Study|Withdrawal by Subject|1|||
13454988|NCT00227539|26951641|FG000|Overall Study|Protocol Violation|1|||
13454989|NCT00227370|26951666|FG000|Overall Study|Withdrawal by Subject|1|||
13454990|NCT00227370|26951667|FG001|Overall Study|Withdrawal by Subject|2|||
13454991|NCT00227370|26951666|FG000|Overall Study|Death|3|||
13454992|NCT00227370|26951667|FG001|Overall Study|Death|4|||
13454993|NCT00227370|26951666|FG000|Overall Study|Adverse Event|6|||
13454994|NCT00227370|26951667|FG001|Overall Study|Adverse Event|11|||
13454995|NCT00227370|26951666|FG000|Overall Study|Physician Decision|9|||
13454996|NCT00227370|26951667|FG001|Overall Study|Physician Decision|6|||
13454997|NCT00227370|26951666|FG000|Overall Study|Other reasons|2|||
13454998|NCT00227370|26951667|FG001|Overall Study|Other reasons|1|||
13454999|NCT00227344|26951694|FG000|Overall Study|study terminated early|12|||
13455000|NCT00227344|26951695|FG001|Overall Study|study terminated early|5|||
13455001|NCT00227305|26951711|FG000|Overall Study|Adverse Event|40|||
13455002|NCT00227305|26951711|FG000|Overall Study|Withdrawal by Subject|42|||
13455003|NCT00227305|26951711|FG000|Overall Study|Lost to Follow-up|33|||
13455004|NCT00227305|26951711|FG000|Overall Study|Study specific discontinuation|13|||
13455005|NCT00227305|26951711|FG000|Overall Study|MOVED OUT OF AREA|3|||
13455006|NCT00227305|26951711|FG000|Overall Study|Lack of Efficacy|7|||
13455007|NCT00227305|26951711|FG000|Overall Study|Physician Decision|3|||
13455008|NCT00227305|26951711|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1|||
13455009|NCT00227305|26951711|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1|||
13455010|NCT00227305|26951711|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1|||
13455011|NCT00227266|26951741|FG000|Overall Study|Withdrawal by Subject|0|||
13455012|NCT00227266|26951742|FG001|Overall Study|Withdrawal by Subject|0|||
13455013|NCT00227266|26951743|FG002|Overall Study|Withdrawal by Subject|1|||
13455014|NCT00227266|26951741|FG000|Overall Study|Protocol Violation|1|||
13455015|NCT00227266|26951742|FG001|Overall Study|Protocol Violation|0|||
13455016|NCT00227266|26951743|FG002|Overall Study|Protocol Violation|1|||
13455017|NCT00227266|26951741|FG000|Overall Study|Excessive weight gain|0|||
13455018|NCT00227266|26951742|FG001|Overall Study|Excessive weight gain|0|||
13455019|NCT00227266|26951743|FG002|Overall Study|Excessive weight gain|2|||
13455020|NCT00226941|26951790|FG000|Overall Study|Withdrawal by subject - toxicity|0|||
13455021|NCT00226941|26951791|FG001|Overall Study|Withdrawal by subject - toxicity|0|||
13455022|NCT00226941|26951792|FG002|Overall Study|Withdrawal by subject - toxicity|0|||
13455023|NCT00226941|26951793|FG003|Overall Study|Withdrawal by subject - toxicity|1|||
13455024|NCT00226941|26951790|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0|||
13455025|NCT00226941|26951791|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0|||
13455026|NCT00226941|26951792|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0|||
13455027|NCT00226941|26951793|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1|||
13455028|NCT00226811|26951805|FG000|Overall Study|Death|8|||
13455029|NCT00226811|26951805|FG000|Overall Study|Adverse Event|11|||
13455030|NCT00226811|26951805|FG000|Overall Study|Lack of Efficacy|55|||
13455031|NCT00226811|26951805|FG000|Overall Study|Withdrawal by Subject|2|||
13455032|NCT00226655|26951811|FG000|Overall Study|Death|13|||
13455033|NCT00226655|26951811|FG000|Overall Study|Withdrawal by Subject|15|||
13455034|NCT00226655|26951811|FG000|Overall Study|Adverse Event|35|||
13455035|NCT00226655|26951811|FG000|Overall Study|Physician Decision|6|||
13455036|NCT00226655|26951811|FG000|Overall Study|Clinical deterioration|10|||
13455037|NCT00226499|26951936|FG000|Overall Study|Adverse Event|10|||
13455038|NCT00226499|26951937|FG001|Overall Study|Adverse Event|6|||
13455039|NCT00226499|26951938|FG002|Overall Study|Adverse Event|3|||
13455040|NCT00226499|26951936|FG000|Overall Study|Others|1064|||
13455041|NCT00226499|26951937|FG001|Overall Study|Others|1066|||
13455042|NCT00226499|26951938|FG002|Overall Study|Others|356|||
13455043|NCT00225758|26951948|FG000|Overall Study|Adverse Event|4|||
13455044|NCT00225277|26951971|FG000|Overall Study|Adverse Event|30|||
13455045|NCT00225277|26951972|FG001|Overall Study|Adverse Event|34|||
13455046|NCT00225277|26951971|FG000|Overall Study|Lack of Efficacy|4|||
13455047|NCT00225277|26951972|FG001|Overall Study|Lack of Efficacy|1|||
13455048|NCT00225277|26951971|FG000|Overall Study|Lost to Follow-up|4|||
13455049|NCT00225277|26951972|FG001|Overall Study|Lost to Follow-up|6|||
13455050|NCT00225277|26951971|FG000|Overall Study|Physician Decision|6|||
13455051|NCT00225277|26951972|FG001|Overall Study|Physician Decision|8|||
13455052|NCT00225277|26951971|FG000|Overall Study|Protocol Violation|6|||
13455053|NCT00225277|26951972|FG001|Overall Study|Protocol Violation|3|||
13455054|NCT00225277|26951971|FG000|Overall Study|Withdrawal by Subject|40|||
13455055|NCT00225277|26951972|FG001|Overall Study|Withdrawal by Subject|34|||
13455056|NCT00225277|26951971|FG000|Overall Study|Other|7|||
13455057|NCT00225277|26951972|FG001|Overall Study|Other|9|||
13455058|NCT00225251|26951993|FG000|Overall Study|Withdrawal by Subject|1|||
13455059|NCT00225251|26951994|FG001|Overall Study|Withdrawal by Subject|1|||
13455060|NCT00225212|26952001|FG000|Overall Study|Disease progression|2|||
13455061|NCT00225212|26952001|FG000|Overall Study|Death|1|||
13455062|NCT00225212|26952001|FG000|Overall Study|Adverse Event|2|||
13455063|NCT00225212|26952001|FG000|Overall Study|Intercurrent illness|1|||
13455064|NCT00225147|26952028|FG000|Open-label Phase|Lost to Follow-up|0|||
13455065|NCT00225147|26952029|FG001|Open-label Phase|Lost to Follow-up|0|||
13455066|NCT00225147|26952030|FG002|Open-label Phase|Lost to Follow-up|0|||
13455067|NCT00225147|26952031|FG003|Open-label Phase|Lost to Follow-up|4|||
13455068|NCT00225147|26952028|FG000|Open-label Phase|Withdrawal by Subject|0|||
13455069|NCT00225147|26952029|FG001|Open-label Phase|Withdrawal by Subject|0|||
13455070|NCT00225147|26952030|FG002|Open-label Phase|Withdrawal by Subject|0|||
13455071|NCT00225147|26952031|FG003|Open-label Phase|Withdrawal by Subject|6|||
13455072|NCT00224887|26952044|FG000|Overall Study|Pregnancy|6|||
13455073|NCT00224887|26952045|FG001|Overall Study|Pregnancy|6|||
13455074|NCT00224874|26952100|FG000|Overall Study|Withdrawal by Subject|0|||
13455075|NCT00224874|26952101|FG001|Overall Study|Withdrawal by Subject|0|||
13455076|NCT00224874|26952102|FG002|Overall Study|Withdrawal by Subject|1|||
13455077|NCT00224874|26952103|FG003|Overall Study|Withdrawal by Subject|0|||
13455078|NCT00224770|26952145|FG000|Overall Study|Lost to Follow-up|4|||
13455079|NCT00224770|26952146|FG001|Overall Study|Lost to Follow-up|2|||
13455080|NCT00224770|26952147|FG002|Overall Study|Lost to Follow-up|0|||
13455081|NCT00224484|26952216|FG000|Overall Study|Serious Adverse Event|1|||
13455082|NCT00224484|26952217|FG001|Overall Study|Serious Adverse Event|1|||
13455083|NCT00224484|26952218|FG002|Overall Study|Serious Adverse Event|0|||
13455084|NCT00224484|26952216|FG000|Overall Study|Non-Serious Adverse Event|5|||
13455085|NCT00224484|26952217|FG001|Overall Study|Non-Serious Adverse Event|7|||
13455086|NCT00224484|26952218|FG002|Overall Study|Non-Serious Adverse Event|3|||
13455087|NCT00224484|26952216|FG000|Overall Study|Protocol Violation|2|||
13455088|NCT00224484|26952217|FG001|Overall Study|Protocol Violation|2|||
13455089|NCT00224484|26952218|FG002|Overall Study|Protocol Violation|0|||
13455090|NCT00224484|26952216|FG000|Overall Study|Withdrawal by Subject|49|||
13455091|NCT00224484|26952217|FG001|Overall Study|Withdrawal by Subject|18|||
13455092|NCT00224484|26952218|FG002|Overall Study|Withdrawal by Subject|16|||
13455093|NCT00224484|26952216|FG000|Overall Study|Migrated/moved from study area|18|||
13455094|NCT00224484|26952217|FG001|Overall Study|Migrated/moved from study area|5|||
13455095|NCT00224484|26952218|FG002|Overall Study|Migrated/moved from study area|5|||
13455096|NCT00224484|26952216|FG000|Overall Study|Lost to Follow-up|66|||
13455097|NCT00224484|26952217|FG001|Overall Study|Lost to Follow-up|28|||
13455098|NCT00224484|26952218|FG002|Overall Study|Lost to Follow-up|36|||
13455099|NCT00224484|26952216|FG000|Overall Study|Reason not specified|5|||
13455100|NCT00224484|26952217|FG001|Overall Study|Reason not specified|4|||
13455101|NCT00224484|26952218|FG002|Overall Study|Reason not specified|2|||
13455102|NCT00224133|26952224|FG000|Overall Study|Adverse Event|93|||
13455103|NCT00224133|26952224|FG000|Overall Study|Protocol Violation|6|||
13455104|NCT00224133|26952224|FG000|Overall Study|Withdrawal by Subject|33|||
13455105|NCT00224133|26952224|FG000|Overall Study|Lack of Efficacy|58|||
13455106|NCT00224133|26952224|FG000|Overall Study|Lost to Follow-up|21|||
13455107|NCT00224133|26952224|FG000|Overall Study|Physician Decision|1|||
13455108|NCT00224133|26952224|FG000|Overall Study|Other|14|||
13455109|NCT00224120|26952239|FG000|Overall Study|Adverse Event|10|||
13455110|NCT00224120|26952240|FG001|Overall Study|Adverse Event|4|||
13455111|NCT00224120|26952239|FG000|Overall Study|Protocol Violation|1|||
13455112|NCT00224120|26952240|FG001|Overall Study|Protocol Violation|0|||
13455113|NCT00224120|26952239|FG000|Overall Study|Withdrawal by Subject|5|||
13455114|NCT00224120|26952240|FG001|Overall Study|Withdrawal by Subject|10|||
13455115|NCT00224120|26952239|FG000|Overall Study|Lack of Efficacy|0|||
13455116|NCT00224120|26952240|FG001|Overall Study|Lack of Efficacy|2|||
13455117|NCT00224120|26952239|FG000|Overall Study|Lost to Follow-up|2|||
13455118|NCT00224120|26952240|FG001|Overall Study|Lost to Follow-up|3|||
13455119|NCT00224120|26952239|FG000|Overall Study|Other|4|||
13455120|NCT00224120|26952240|FG001|Overall Study|Other|5|||
13455121|NCT00224107|26952255|FG000|Overall Study|Adverse Event|20|||
13455122|NCT00224107|26952256|FG001|Overall Study|Adverse Event|6|||
13455123|NCT00224107|26952255|FG000|Overall Study|Protocol Violation|2|||
13455124|NCT00224107|26952256|FG001|Overall Study|Protocol Violation|3|||
13455125|NCT00224107|26952255|FG000|Overall Study|Withdrawal by Subject|1|||
13455126|NCT00224107|26952256|FG001|Overall Study|Withdrawal by Subject|4|||
13455127|NCT00224107|26952255|FG000|Overall Study|Lack of Efficacy|2|||
13455128|NCT00224107|26952256|FG001|Overall Study|Lack of Efficacy|0|||
13455129|NCT00224107|26952255|FG000|Overall Study|Lost to Follow-up|4|||
13455130|NCT00224107|26952256|FG001|Overall Study|Lost to Follow-up|0|||
13455131|NCT00224107|26952255|FG000|Overall Study|Physician Decision|1|||
13455132|NCT00224107|26952256|FG001|Overall Study|Physician Decision|0|||
13455133|NCT00224107|26952255|FG000|Overall Study|Other|1|||
13455134|NCT00224107|26952256|FG001|Overall Study|Other|1|||
13455135|NCT00224055|26952271|FG000|Overall Study|Adverse Event|9|||
13455136|NCT00224055|26952272|FG001|Overall Study|Adverse Event|3|||
13455137|NCT00224055|26952271|FG000|Overall Study|Lost to Follow-up|1|||
13455138|NCT00224055|26952272|FG001|Overall Study|Lost to Follow-up|2|||
13455139|NCT00224055|26952271|FG000|Overall Study|Protocol Violation|1|||
13455140|NCT00224055|26952272|FG001|Overall Study|Protocol Violation|1|||
13455141|NCT00224055|26952271|FG000|Overall Study|Inclusion Violation|3|||
13455142|NCT00224055|26952272|FG001|Overall Study|Inclusion Violation|6|||
13455143|NCT00224055|26952271|FG000|Overall Study|Withdrawal by Subject|0|||
13455144|NCT00224055|26952272|FG001|Overall Study|Withdrawal by Subject|2|||
13455145|NCT00224055|26952271|FG000|Overall Study|Other|1|||
13455146|NCT00224055|26952272|FG001|Overall Study|Other|0|||
13455147|NCT00224042|26952291|FG000|Overall Study|Adverse Event|2|||
13455148|NCT00224042|26952292|FG001|Overall Study|Adverse Event|1|||
13455149|NCT00224042|26952291|FG000|Overall Study|Protocol Violation|0|||
13455150|NCT00224042|26952292|FG001|Overall Study|Protocol Violation|1|||
13455151|NCT00224042|26952291|FG000|Overall Study|Physician Decision|0|||
13455152|NCT00224042|26952292|FG001|Overall Study|Physician Decision|1|||
13455153|NCT00224042|26952291|FG000|Overall Study|Did not meet lab incusion criteria|2|||
13455154|NCT00224042|26952292|FG001|Overall Study|Did not meet lab incusion criteria|3|||
13455155|NCT00224042|26952291|FG000|Overall Study|Other|2|||
13455156|NCT00224042|26952292|FG001|Overall Study|Other|0|||
13455157|NCT00224029|26952298|FG000|Overall Study|Lost to Follow-up|1|||
13455158|NCT00224029|26952298|FG000|Overall Study|Withdrawal by Subject|4|||
13455159|NCT00224029|26952298|FG000|Overall Study|Other|1|||
13455160|NCT00224016|26952313|FG000|Titration Period|Withdrawal by Subject|0|||
13455161|NCT00224016|26952314|FG001|Titration Period|Withdrawal by Subject|1|||
13455162|NCT00224016|26952313|FG000|Titration Period|Lost to Follow-up|1|||
13455163|NCT00224016|26952314|FG001|Titration Period|Lost to Follow-up|0|||
13455164|NCT00224016|26952313|FG000|Maintenance Period|Withdrawal by Subject|2|||
13455165|NCT00224016|26952314|FG001|Maintenance Period|Withdrawal by Subject|0|||
13455166|NCT00224016|26952313|FG000|Maintenance Period|Lost to Follow-up|0|||
13455167|NCT00224016|26952314|FG001|Maintenance Period|Lost to Follow-up|1|||
13455168|NCT00223990|26952343|FG000|Overall Study|Moved from area|2|||
13455169|NCT00223990|26952344|FG001|Overall Study|Moved from area|1|||
13455170|NCT00223990|26952343|FG000|Overall Study|Withdrawal by Subject|4|||
13455171|NCT00223990|26952344|FG001|Overall Study|Withdrawal by Subject|8|||
13455172|NCT00223990|26952343|FG000|Overall Study|Lost to Follow-up|1|||
13455173|NCT00223990|26952344|FG001|Overall Study|Lost to Follow-up|0|||
13455174|NCT00223977|26952374|FG000|Overall Study|Adverse Event|7|||
13455175|NCT00223977|26952375|FG001|Overall Study|Adverse Event|10|||
13455176|NCT00223977|26952376|FG002|Overall Study|Adverse Event|0|||
13455177|NCT00223977|26952374|FG000|Overall Study|Protocol Violation|0|||
13455178|NCT00223977|26952375|FG001|Overall Study|Protocol Violation|0|||
13455179|NCT00223977|26952376|FG002|Overall Study|Protocol Violation|1|||
13455180|NCT00223977|26952374|FG000|Overall Study|Withdrawal by Subject|1|||
13455181|NCT00223977|26952375|FG001|Overall Study|Withdrawal by Subject|1|||
13455182|NCT00223977|26952376|FG002|Overall Study|Withdrawal by Subject|2|||
13455183|NCT00223977|26952374|FG000|Overall Study|Other|1|||
13455184|NCT00223977|26952375|FG001|Overall Study|Other|0|||
13455185|NCT00223977|26952376|FG002|Overall Study|Other|0|||
13455186|NCT00223808|26952403|FG000|Overall Study|<5 hrs therapy before discharge|3|||
13455187|NCT00223808|26952404|FG001|Overall Study|<5 hrs therapy before discharge|5|||
13455188|NCT00223808|26952405|FG002|Overall Study|<5 hrs therapy before discharge|5|||
13455189|NCT00223795|26952415|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7|||
13455190|NCT00223795|26952416|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9|||
13455191|NCT00223795|26952415|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
13455192|NCT00223795|26952416|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
13455193|NCT00223496|26952422|FG000|Overall Study|screen failure|9|||
13455194|NCT00223496|26952422|FG000|Overall Study|Lost to Follow-up|4|||
13455195|NCT00223496|26952422|FG000|Overall Study|Lack of Efficacy|6|||
13455196|NCT00223496|26952422|FG000|Overall Study|Withdrawal by Subject|1|||
13455197|NCT00223496|26952422|FG000|Overall Study|Physician Decision|2|||
13455198|NCT00223080|26952447|FG000|Overall Study|Withdrawal by Subject|253|||
13455199|NCT00223080|26952448|FG001|Overall Study|Withdrawal by Subject|232|||
13455200|NCT00223080|26952447|FG000|Overall Study|Required contraindicated med|0|||
13455201|NCT00223080|26952448|FG001|Overall Study|Required contraindicated med|1|||
13455202|NCT00223080|26952447|FG000|Overall Study|Non-compliant|7|||
13455203|NCT00223080|26952448|FG001|Overall Study|Non-compliant|7|||
13455204|NCT00223080|26952447|FG000|Overall Study|Moved from study area|37|||
13455205|NCT00223080|26952448|FG001|Overall Study|Moved from study area|47|||
13455206|NCT00223080|26952447|FG000|Overall Study|Lost to Follow-up|259|||
13455207|NCT00223080|26952448|FG001|Overall Study|Lost to Follow-up|284|||
13455208|NCT00223080|26952447|FG000|Overall Study|Death|85|||
13455209|NCT00223080|26952448|FG001|Overall Study|Death|74|||
13455210|NCT00223080|26952447|FG000|Overall Study|Other|14|||
13455211|NCT00223080|26952448|FG001|Overall Study|Other|11|||
13455212|NCT00223080|26952447|FG000|Overall Study|Reason not provided|141|||
13455213|NCT00223080|26952448|FG001|Overall Study|Reason not provided|140|||
13455214|NCT00223080|26952447|FG000|Overall Study|Adverse Event|0|||
13455215|NCT00223080|26952448|FG001|Overall Study|Adverse Event|1|||
13455216|NCT00222729|26952457|FG000|Overall Study|Adverse Event|3|||
13455217|NCT00222105|26952464|FG000|Overall Study|Removed due to wrong diagnosis|1|||
13455218|NCT00222105|26952464|FG000|Overall Study|Withdrawal by Subject|1|||
13455219|NCT00222105|26952464|FG000|Overall Study|Adverse Event|8|||
13455220|NCT00222105|26952464|FG000|Overall Study|Treatment delays|2|||
13455221|NCT00222105|26952464|FG000|Overall Study|Death|2|||
13455222|NCT00221403|26952482|FG000|Overall Study|Protocol Violation|1|||
13455223|NCT00221403|26952483|FG001|Overall Study|Protocol Violation|0|||
13455224|NCT00221403|26952484|FG002|Overall Study|Protocol Violation|0|||
13455225|NCT00221403|26952482|FG000|Overall Study|Physician Decision|1|||
13455226|NCT00221403|26952483|FG001|Overall Study|Physician Decision|0|||
13455227|NCT00221403|26952484|FG002|Overall Study|Physician Decision|0|||
13455228|NCT00221403|26952482|FG000|Overall Study|Withdrawal by Subject|0|||
13455229|NCT00221403|26952483|FG001|Overall Study|Withdrawal by Subject|3|||
13455230|NCT00221403|26952484|FG002|Overall Study|Withdrawal by Subject|0|||
13455231|NCT00221403|26952482|FG000|Overall Study|Lack of Efficacy|0|||
13455232|NCT00221403|26952483|FG001|Overall Study|Lack of Efficacy|1|||
13455233|NCT00221403|26952484|FG002|Overall Study|Lack of Efficacy|0|||
13455234|NCT00221403|26952482|FG000|Overall Study|Adverse Event|0|||
13455235|NCT00221403|26952483|FG001|Overall Study|Adverse Event|1|||
13455236|NCT00221403|26952484|FG002|Overall Study|Adverse Event|0|||
13455237|NCT00221195|26952498|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3|||
13455238|NCT00221195|26952499|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1|||
13455239|NCT00221195|26952498|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0|||
13455240|NCT00221195|26952499|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1|||
13455241|NCT00221195|26952498|FG000|Washout Period (Months 7-9)|Death|0|||
13455242|NCT00221195|26952499|FG001|Washout Period (Months 7-9)|Death|1|||
13455243|NCT00221195|26952498|FG000|Therapy 2 (Months 10-15)|Death|1|||
13455244|NCT00221195|26952499|FG001|Therapy 2 (Months 10-15)|Death|0|||
13455245|NCT00221195|26952498|FG000|Therapy 2 (Months 10-15)|Adverse Event|1|||
13455246|NCT00221195|26952499|FG001|Therapy 2 (Months 10-15)|Adverse Event|0|||
13455247|NCT00221104|26952520|FG000|Overall Study|Adverse Event|1|||
13455248|NCT00221104|26952521|FG001|Overall Study|Adverse Event|0|||
13455249|NCT00221104|26952520|FG000|Overall Study|Physician Decision|1|||
13455250|NCT00221104|26952521|FG001|Overall Study|Physician Decision|0|||
13455251|NCT00221104|26952520|FG000|Overall Study|Protocol Violation|2|||
13455252|NCT00221104|26952521|FG001|Overall Study|Protocol Violation|0|||
13455253|NCT00221104|26952520|FG000|Overall Study|Withdrawal by Subject|42|||
13455254|NCT00221104|26952521|FG001|Overall Study|Withdrawal by Subject|29|||
13455255|NCT00221104|26952520|FG000|Overall Study|Others|37|||
13455256|NCT00221104|26952521|FG001|Overall Study|Others|47|||
13455257|NCT00220805|26952546|FG000|Overall Study|Adverse Event|1|||
13455258|NCT00220805|26952547|FG001|Overall Study|Adverse Event|3|||
13455259|NCT00220805|26952546|FG000|Overall Study|Withdrawal by Subject|3|||
13455260|NCT00220805|26952547|FG001|Overall Study|Withdrawal by Subject|0|||
13455261|NCT00220805|26952546|FG000|Overall Study|Lack of Efficacy|1|||
13455262|NCT00220805|26952547|FG001|Overall Study|Lack of Efficacy|0|||
13455263|NCT00220805|26952546|FG000|Overall Study|Develop. of choroidal neovascularization|3|||
13455264|NCT00220805|26952547|FG001|Overall Study|Develop. of choroidal neovascularization|8|||
13455265|NCT00220779|26952565|FG000|Overall Study|Adverse Event|1|||
13455266|NCT00220779|26952566|FG001|Overall Study|Adverse Event|0|||
13455267|NCT00220779|26952567|FG002|Overall Study|Adverse Event|0|||
13455268|NCT00220779|26952565|FG000|Overall Study|Withdrawal by Subject|1|||
13455269|NCT00220779|26952566|FG001|Overall Study|Withdrawal by Subject|4|||
13455270|NCT00220779|26952567|FG002|Overall Study|Withdrawal by Subject|1|||
13455271|NCT00220779|26952565|FG000|Overall Study|Non-compliance|1|||
13455272|NCT00220779|26952566|FG001|Overall Study|Non-compliance|0|||
13455273|NCT00220779|26952567|FG002|Overall Study|Non-compliance|0|||
13455274|NCT00220779|26952565|FG000|Overall Study|Too time consuming|1|||
13455275|NCT00220779|26952566|FG001|Overall Study|Too time consuming|0|||
13455276|NCT00220779|26952567|FG002|Overall Study|Too time consuming|0|||
13455277|NCT00220779|26952565|FG000|Overall Study|Pregnancy|0|||
13455278|NCT00220779|26952566|FG001|Overall Study|Pregnancy|0|||
13455279|NCT00220779|26952567|FG002|Overall Study|Pregnancy|2|||
13455280|NCT00220779|26952565|FG000|Overall Study|Lack of Efficacy|3|||
13455281|NCT00220779|26952566|FG001|Overall Study|Lack of Efficacy|0|||
13455282|NCT00220779|26952567|FG002|Overall Study|Lack of Efficacy|1|||
13455283|NCT00220740|26952586|FG000|Efficacy Period|Entered rescue treatment with placebo|23|||
13455284|NCT00220740|26952587|FG001|Efficacy Period|Entered rescue treatment with placebo|0|||
13455285|NCT00220740|26952586|FG000|Efficacy Period|Adverse Event|1|||
13455286|NCT00220740|26952587|FG001|Efficacy Period|Adverse Event|1|||
13455287|NCT00220740|26952586|FG000|Efficacy Period|Withdrawal by Subject|1|||
13455288|NCT00220740|26952587|FG001|Efficacy Period|Withdrawal by Subject|0|||
13455289|NCT00220740|26952586|FG000|Efficacy Period|Protocol Violation|1|||
13455290|NCT00220740|26952587|FG001|Efficacy Period|Protocol Violation|0|||
13455291|NCT00220740|26952586|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0|||
13455292|NCT00220740|26952587|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45|||
13455293|NCT00220727|26952608|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1|||
13455294|NCT00220727|26952609|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0|||
13455295|NCT00220701|26952632|FG000|Overall Study|Lost to Follow-up|5|||
13455296|NCT00220701|26952633|FG001|Overall Study|Lost to Follow-up|4|||
13455297|NCT00220636|26952642|FG000|Overall Study|Withdrawal by Subject|4|||
13455298|NCT00219557|26952680|FG000|Phase 1|Lack of Efficacy|3|||
13455299|NCT00219557|26952681|FG001|Phase 1|Lack of Efficacy|0|||
13455300|NCT00219557|26952682|FG002|Phase 1|Lack of Efficacy|0|||
13455301|NCT00219557|26952680|FG000|Phase 1|Adverse Event|2|||
13455302|NCT00219557|26952681|FG001|Phase 1|Adverse Event|0|||
13455303|NCT00219557|26952682|FG002|Phase 1|Adverse Event|0|||
13455304|NCT00219557|26952680|FG000|Phase 1|Withdrawal by Subject|1|||
13455305|NCT00219557|26952681|FG001|Phase 1|Withdrawal by Subject|0|||
13455306|NCT00219557|26952682|FG002|Phase 1|Withdrawal by Subject|0|||
13455307|NCT00219557|26952680|FG000|Phase 1|Started chemotherapy at other institute|1|||
13455308|NCT00219557|26952681|FG001|Phase 1|Started chemotherapy at other institute|0|||
13455309|NCT00219557|26952682|FG002|Phase 1|Started chemotherapy at other institute|0|||
13455310|NCT00219557|26952680|FG000|Phase 2|Lack of Efficacy|0|||
13455311|NCT00219557|26952681|FG001|Phase 2|Lack of Efficacy|21|||
13455312|NCT00219557|26952682|FG002|Phase 2|Lack of Efficacy|15|||
13455313|NCT00219557|26952680|FG000|Phase 2|Adverse Event|0|||
13455314|NCT00219557|26952681|FG001|Phase 2|Adverse Event|22|||
13455315|NCT00219557|26952682|FG002|Phase 2|Adverse Event|2|||
13455316|NCT00219557|26952680|FG000|Phase 2|Death|0|||
13455317|NCT00219557|26952681|FG001|Phase 2|Death|8|||
13455318|NCT00219557|26952682|FG002|Phase 2|Death|2|||
13455319|NCT00219557|26952680|FG000|Phase 2|Other|0|||
13455320|NCT00219557|26952681|FG001|Phase 2|Other|8|||
13455321|NCT00219557|26952682|FG002|Phase 2|Other|6|||
13455322|NCT00219557|26952680|FG000|Phase 2|Withdrawal by Subject|0|||
13455323|NCT00219557|26952681|FG001|Phase 2|Withdrawal by Subject|9|||
13455324|NCT00219557|26952682|FG002|Phase 2|Withdrawal by Subject|5|||
13455325|NCT00219557|26952680|FG000|Phase 2|Treatment not received|0|||
13455326|NCT00219557|26952681|FG001|Phase 2|Treatment not received|1|||
13455327|NCT00219557|26952682|FG002|Phase 2|Treatment not received|3|||
13455328|NCT00219544|26952723|FG000|Single Blind Treatment Period|Lack of Efficacy|5|||
13455329|NCT00219544|26952724|FG001|Single Blind Treatment Period|Lack of Efficacy|0|||
13455330|NCT00219544|26952723|FG000|Single Blind Treatment Period|Adverse Event|9|||
13455331|NCT00219544|26952724|FG001|Single Blind Treatment Period|Adverse Event|0|||
13455332|NCT00219544|26952723|FG000|Single Blind Treatment Period|Protocol Violation|4|||
13455333|NCT00219544|26952724|FG001|Single Blind Treatment Period|Protocol Violation|0|||
13455334|NCT00219544|26952723|FG000|Single Blind Treatment Period|Lost to Follow-up|2|||
13455335|NCT00219544|26952724|FG001|Single Blind Treatment Period|Lost to Follow-up|0|||
13455336|NCT00219544|26952723|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1|||
13455337|NCT00219544|26952724|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0|||
13455338|NCT00219544|26952723|FG000|Single Blind Treatment Period|Withdrawal by Subject|1|||
13455339|NCT00219544|26952724|FG001|Single Blind Treatment Period|Withdrawal by Subject|0|||
13455340|NCT00219141|26952778|FG000|Overall Study|Adverse Event|4|||
13455341|NCT00219141|26952779|FG001|Overall Study|Adverse Event|10|||
13455342|NCT00219141|26952780|FG002|Overall Study|Adverse Event|5|||
13455343|NCT00219141|26952778|FG000|Overall Study|Lack of Efficacy|3|||
13455344|NCT00219141|26952779|FG001|Overall Study|Lack of Efficacy|2|||
13455345|NCT00219141|26952780|FG002|Overall Study|Lack of Efficacy|0|||
13455346|NCT00219141|26952778|FG000|Overall Study|Administrative problems|0|||
13455347|NCT00219141|26952779|FG001|Overall Study|Administrative problems|1|||
13455348|NCT00219141|26952780|FG002|Overall Study|Administrative problems|0|||
13455349|NCT00219141|26952778|FG000|Overall Study|Lost to Follow-up|2|||
13455350|NCT00219141|26952779|FG001|Overall Study|Lost to Follow-up|4|||
13455351|NCT00219141|26952780|FG002|Overall Study|Lost to Follow-up|1|||
13455352|NCT00219141|26952778|FG000|Overall Study|Protocol Violation|3|||
13455353|NCT00219141|26952779|FG001|Overall Study|Protocol Violation|1|||
13455354|NCT00219141|26952780|FG002|Overall Study|Protocol Violation|1|||
13455355|NCT00219141|26952778|FG000|Overall Study|Withdrawal by Subject|1|||
13455356|NCT00219141|26952779|FG001|Overall Study|Withdrawal by Subject|3|||
13455357|NCT00219141|26952780|FG002|Overall Study|Withdrawal by Subject|5|||
13455358|NCT00219141|26952778|FG000|Overall Study|Condition no longer requires study drug|1|||
13455359|NCT00219141|26952779|FG001|Overall Study|Condition no longer requires study drug|0|||
13455360|NCT00219141|26952780|FG002|Overall Study|Condition no longer requires study drug|0|||
13455361|NCT00215540|26952825|FG000|Overall Study|Withdrew from study medication|1|||
13455362|NCT00215540|26952826|FG001|Overall Study|Withdrew from study medication|0|||
13455363|NCT00215540|26952827|FG002|Overall Study|Withdrew from study medication|0|||
13455364|NCT00213135|26952854|FG000|Overall Study|Adverse Event|9|||
13455365|NCT00213135|26952855|FG001|Overall Study|Adverse Event|5|||
13455366|NCT00213135|26952856|FG002|Overall Study|Adverse Event|5|||
13455367|NCT00213135|26952854|FG000|Overall Study|Lost to Follow-up|11|||
13455368|NCT00213135|26952855|FG001|Overall Study|Lost to Follow-up|8|||
13455369|NCT00213135|26952856|FG002|Overall Study|Lost to Follow-up|4|||
13455370|NCT00213135|26952854|FG000|Overall Study|Protocol Violation|4|||
13455371|NCT00213135|26952855|FG001|Overall Study|Protocol Violation|4|||
13455372|NCT00213135|26952856|FG002|Overall Study|Protocol Violation|10|||
13455373|NCT00213135|26952854|FG000|Overall Study|Death|1|||
13455374|NCT00213135|26952855|FG001|Overall Study|Death|1|||
13455375|NCT00213135|26952856|FG002|Overall Study|Death|2|||
13455376|NCT00213135|26952854|FG000|Overall Study|Disease progression|4|||
13455377|NCT00213135|26952855|FG001|Overall Study|Disease progression|5|||
13455378|NCT00213135|26952856|FG002|Overall Study|Disease progression|21|||
13455379|NCT00213135|26952854|FG000|Overall Study|Other|21|||
13455380|NCT00213135|26952855|FG001|Overall Study|Other|12|||
13455381|NCT00213135|26952856|FG002|Overall Study|Other|15|||
13455382|NCT00211809|26952872|FG000|Overall Study|Lack of Efficacy|1|||
13455383|NCT00211809|26952872|FG000|Overall Study|Lost to Follow-up|2|||
13455384|NCT00211809|26952872|FG000|Overall Study|Pregnancy|1|||
13455385|NCT00211809|26952872|FG000|Overall Study|side effects|2|||
13455386|NCT00211081|26952884|FG000|Overall Study|Withdrawal by Subject|2|||
13455387|NCT00209560|26952899|FG000|Overall Study|Lack of Efficacy|1|||
13455388|NCT00209560|26952900|FG001|Overall Study|Lack of Efficacy|0|||
13455389|NCT00209339|26952984|FG000|At 12 Months Follow-up|Withdrawal by Subject|8|||
13455390|NCT00209339|26952984|FG000|At 12 Months Follow-up|Death|1|||
13455391|NCT00209339|26952984|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6|||
13455392|NCT00209339|26952984|FG000|At 24 Months Follow-up|Withdrawal by Subject|4|||
13455393|NCT00209339|26952984|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6|||
13455394|NCT00209339|26952984|FG000|At 24 Months Follow-up|Death|1|||
13455395|NCT00209339|26952984|FG000|At 3 Years Follow-up|Withdrawal by Subject|1|||
13455396|NCT00209339|26952984|FG000|At 4 Years Follow-up|Withdrawal by Subject|4|||
13455397|NCT00209339|26952984|FG000|At 4 Years Follow-up|Death|1|||
13455398|NCT00209339|26952984|FG000|At 5 Years Follow-up|Withdrawal by Subject|2|||
13455399|NCT00209339|26952984|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5|||
13455400|NCT00209339|26952984|FG000|At 5 Years Follow-up|Death|1|||
13455401|NCT00209274|26953309|FG000|Overall Study|Missed visit|3|||
13455402|NCT00209274|26953310|FG001|Overall Study|Missed visit|2|||
13455403|NCT00209274|26953309|FG000|Overall Study|Death|32|||
13455404|NCT00209274|26953310|FG001|Overall Study|Death|15|||
13455405|NCT00209274|26953309|FG000|Overall Study|Withdrawal by Subject|30|||
13455406|NCT00209274|26953310|FG001|Overall Study|Withdrawal by Subject|15|||
13455407|NCT00209274|26953309|FG000|Overall Study|Randomized not treated (RNT)|6|||
13455408|NCT00209274|26953310|FG001|Overall Study|Randomized not treated (RNT)|15|||
13455409|NCT00209170|26953323|FG000|Overall Study|Adverse Event|0|||
13455410|NCT00209170|26953324|FG001|Overall Study|Adverse Event|1|||
13455411|NCT00209170|26953323|FG000|Overall Study|Withdrawal by Subject|2|||
13455412|NCT00209170|26953324|FG001|Overall Study|Withdrawal by Subject|1|||
13455413|NCT00209170|26953323|FG000|Overall Study|Lack of Efficacy|0|||
13455414|NCT00209170|26953324|FG001|Overall Study|Lack of Efficacy|1|||
13455415|NCT00209131|26953339|FG000|Overall Study|Lack of personnel due to turnovers.|15|||
13455416|NCT00209131|26953340|FG001|Overall Study|Lack of personnel due to turnovers.|11|||
13455417|NCT00209092|26953355|FG000|Overall Study|Progression of disease|7|||
13455418|NCT00209092|26953356|FG001|Overall Study|Progression of disease|1|||
13455419|NCT00209092|26953355|FG000|Overall Study|Adverse Event|0|||
13455420|NCT00209092|26953356|FG001|Overall Study|Adverse Event|1|||
13455421|NCT00209092|26953355|FG000|Overall Study|Withdrawal by Subject|1|||
13455422|NCT00209092|26953356|FG001|Overall Study|Withdrawal by Subject|0|||
13455423|NCT00209027|26953369|FG000|Overall Study|study terminated|10|||
13455424|NCT00209027|26953370|FG001|Overall Study|study terminated|0|||
13455425|NCT00208767|26953383|FG000|Overall Study|Adverse Event|9|||
13455426|NCT00208767|26953384|FG001|Overall Study|Adverse Event|1|||
13455427|NCT00208767|26953383|FG000|Overall Study|Withdrawal by Subject|14|||
13455428|NCT00208767|26953384|FG001|Overall Study|Withdrawal by Subject|3|||
13455429|NCT00208767|26953383|FG000|Overall Study|Death|1|||
13455430|NCT00208767|26953384|FG001|Overall Study|Death|0|||
13455431|NCT00208767|26953383|FG000|Overall Study|Lost to Follow-up|3|||
13455432|NCT00208767|26953384|FG001|Overall Study|Lost to Follow-up|3|||
13455433|NCT00208325|26953505|FG000|Overall Study|Death|18|||
13455434|NCT00208325|26953506|FG001|Overall Study|Death|19|||
13455435|NCT00208325|26953507|FG002|Overall Study|Death|7|||
13455436|NCT00208325|26953508|FG003|Overall Study|Death|5|||
13455437|NCT00208325|26953505|FG000|Overall Study|Withdrawal by Subject|0|||
13455438|NCT00208325|26953506|FG001|Overall Study|Withdrawal by Subject|1|||
13455439|NCT00208325|26953507|FG002|Overall Study|Withdrawal by Subject|0|||
13455440|NCT00208325|26953508|FG003|Overall Study|Withdrawal by Subject|0|||
13455441|NCT00208325|26953505|FG000|Overall Study|Revision|4|||
13455442|NCT00208325|26953506|FG001|Overall Study|Revision|1|||
13455443|NCT00208325|26953507|FG002|Overall Study|Revision|0|||
13455444|NCT00208325|26953508|FG003|Overall Study|Revision|4|||
13455445|NCT00208325|26953505|FG000|Overall Study|Lost to Follow-up|1|||
13455446|NCT00208325|26953506|FG001|Overall Study|Lost to Follow-up|0|||
13455447|NCT00208325|26953507|FG002|Overall Study|Lost to Follow-up|2|||
13455448|NCT00208325|26953508|FG003|Overall Study|Lost to Follow-up|0|||
13455449|NCT00208325|26953505|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4|||
13455450|NCT00208325|26953506|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4|||
13455451|NCT00208325|26953507|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1|||
13455452|NCT00208325|26953508|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3|||
13455453|NCT00208325|26953505|FG000|Overall Study|Does not wish to Continue in Study|5|||
13455454|NCT00208325|26953506|FG001|Overall Study|Does not wish to Continue in Study|8|||
13455455|NCT00208325|26953507|FG002|Overall Study|Does not wish to Continue in Study|3|||
13455456|NCT00208325|26953508|FG003|Overall Study|Does not wish to Continue in Study|2|||
13455457|NCT00208325|26953505|FG000|Overall Study|Other|2|||
13455458|NCT00208325|26953506|FG001|Overall Study|Other|1|||
13455459|NCT00208325|26953507|FG002|Overall Study|Other|1|||
13455460|NCT00208325|26953508|FG003|Overall Study|Other|0|||
13455461|NCT00208325|26953505|FG000|Overall Study|Mis-Randomized|17|||
13455462|NCT00208325|26953506|FG001|Overall Study|Mis-Randomized|20|||
13455463|NCT00208325|26953507|FG002|Overall Study|Mis-Randomized|0|||
13455464|NCT00208325|26953508|FG003|Overall Study|Mis-Randomized|0|||
13455465|NCT00207740|26953562|FG000|Overall Study|Adverse Event|4|||
13455466|NCT00207740|26953563|FG001|Overall Study|Adverse Event|14|||
13455467|NCT00207740|26953564|FG002|Overall Study|Adverse Event|14|||
13455468|NCT00207740|26953565|FG003|Overall Study|Adverse Event|11|||
13455469|NCT00207740|26953562|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
13455470|NCT00207740|26953563|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
13455471|NCT00207740|26953564|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
13455472|NCT00207740|26953565|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
13455473|NCT00207740|26953562|FG000|Overall Study|Lost to Follow-up|0|||
13455474|NCT00207740|26953563|FG001|Overall Study|Lost to Follow-up|2|||
13455475|NCT00207740|26953564|FG002|Overall Study|Lost to Follow-up|1|||
13455476|NCT00207740|26953565|FG003|Overall Study|Lost to Follow-up|1|||
13455477|NCT00207740|26953562|FG000|Overall Study|Death|0|||
13455478|NCT00207740|26953563|FG001|Overall Study|Death|0|||
13455479|NCT00207740|26953564|FG002|Overall Study|Death|0|||
13455480|NCT00207740|26953565|FG003|Overall Study|Death|1|||
13455481|NCT00207740|26953562|FG000|Overall Study|Sponsor Directive|22|||
13455482|NCT00207740|26953563|FG001|Overall Study|Sponsor Directive|15|||
13455483|NCT00207740|26953564|FG002|Overall Study|Sponsor Directive|16|||
13455484|NCT00207740|26953565|FG003|Overall Study|Sponsor Directive|21|||
13455485|NCT00207740|26953562|FG000|Overall Study|Other|2|||
13455486|NCT00207740|26953563|FG001|Overall Study|Other|10|||
13455487|NCT00207740|26953564|FG002|Overall Study|Other|7|||
13455488|NCT00207740|26953565|FG003|Overall Study|Other|5|||
13455489|NCT00207727|26953603|FG000|Overall Study|Withdrawal by Subject|0|||
13455490|NCT00207727|26953604|FG001|Overall Study|Withdrawal by Subject|0|||
13455491|NCT00207727|26953605|FG002|Overall Study|Withdrawal by Subject|0|||
13455492|NCT00207727|26953606|FG003|Overall Study|Withdrawal by Subject|0|||
13455493|NCT00207727|26953607|FG004|Overall Study|Withdrawal by Subject|1|||
13455494|NCT00207727|26953603|FG000|Overall Study|Lost to Follow-up|0|||
13455495|NCT00207727|26953604|FG001|Overall Study|Lost to Follow-up|1|||
13455496|NCT00207727|26953605|FG002|Overall Study|Lost to Follow-up|0|||
13455497|NCT00207727|26953606|FG003|Overall Study|Lost to Follow-up|0|||
13455498|NCT00207727|26953607|FG004|Overall Study|Lost to Follow-up|0|||
13455499|NCT00207727|26953603|FG000|Overall Study|Other|38|||
13455500|NCT00207727|26953604|FG001|Overall Study|Other|41|||
13455501|NCT00207727|26953605|FG002|Overall Study|Other|41|||
13455502|NCT00207727|26953606|FG003|Overall Study|Other|37|||
13455503|NCT00207727|26953607|FG004|Overall Study|Other|33|||
13455504|NCT00207714|26953642|FG000|Overall Study|Adverse Event|6|||
13455505|NCT00207714|26953643|FG001|Overall Study|Adverse Event|2|||
13455506|NCT00207714|26953644|FG002|Overall Study|Adverse Event|4|||
13455507|NCT00207714|26953645|FG003|Overall Study|Adverse Event|3|||
13455508|NCT00207714|26953646|FG004|Overall Study|Adverse Event|1|||
13455509|NCT00207714|26953642|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
13455510|NCT00207714|26953643|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
13455511|NCT00207714|26953644|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
13455512|NCT00207714|26953645|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
13455513|NCT00207714|26953646|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
13455514|NCT00207714|26953642|FG000|Overall Study|Other|3|||
13455515|NCT00207714|26953643|FG001|Overall Study|Other|2|||
13455516|NCT00207714|26953644|FG002|Overall Study|Other|5|||
13455517|NCT00207714|26953645|FG003|Overall Study|Other|1|||
13455518|NCT00207714|26953646|FG004|Overall Study|Other|0|||
13455519|NCT00207142|26953694|FG000|Induction Phase|Adverse Event|9|||
13455520|NCT00207142|26953695|FG001|Induction Phase|Adverse Event|0|||
13455521|NCT00207142|26953696|FG002|Induction Phase|Adverse Event|0|||
13455522|NCT00207142|26953697|FG003|Induction Phase|Adverse Event|0|||
13455523|NCT00207142|26953694|FG000|Induction Phase|Death|1|||
13455524|NCT00207142|26953695|FG001|Induction Phase|Death|0|||
13455525|NCT00207142|26953696|FG002|Induction Phase|Death|0|||
13455526|NCT00207142|26953697|FG003|Induction Phase|Death|0|||
13455527|NCT00207142|26953694|FG000|Induction Phase|Lack of Efficacy|1|||
13455528|NCT00207142|26953695|FG001|Induction Phase|Lack of Efficacy|0|||
13455529|NCT00207142|26953696|FG002|Induction Phase|Lack of Efficacy|0|||
13455530|NCT00207142|26953697|FG003|Induction Phase|Lack of Efficacy|0|||
13455531|NCT00207142|26953694|FG000|Induction Phase|Lost to Follow-up|5|||
13455532|NCT00207142|26953695|FG001|Induction Phase|Lost to Follow-up|0|||
13455533|NCT00207142|26953696|FG002|Induction Phase|Lost to Follow-up|0|||
13455534|NCT00207142|26953697|FG003|Induction Phase|Lost to Follow-up|0|||
13455535|NCT00207142|26953694|FG000|Induction Phase|Physician Decision|2|||
13455536|NCT00207142|26953695|FG001|Induction Phase|Physician Decision|0|||
13455537|NCT00207142|26953696|FG002|Induction Phase|Physician Decision|0|||
13455538|NCT00207142|26953697|FG003|Induction Phase|Physician Decision|0|||
13455539|NCT00207142|26953694|FG000|Induction Phase|Poor/noncompliance|2|||
13455540|NCT00207142|26953695|FG001|Induction Phase|Poor/noncompliance|0|||
13455541|NCT00207142|26953696|FG002|Induction Phase|Poor/noncompliance|0|||
13455542|NCT00207142|26953697|FG003|Induction Phase|Poor/noncompliance|0|||
13455543|NCT00207142|26953694|FG000|Induction Phase|Pregnancy|1|||
13455544|NCT00207142|26953695|FG001|Induction Phase|Pregnancy|0|||
13455545|NCT00207142|26953696|FG002|Induction Phase|Pregnancy|0|||
13455546|NCT00207142|26953697|FG003|Induction Phase|Pregnancy|0|||
13455547|NCT00207142|26953694|FG000|Induction Phase|Subject no longer meets study criteria|3|||
13455548|NCT00207142|26953695|FG001|Induction Phase|Subject no longer meets study criteria|0|||
13455549|NCT00207142|26953696|FG002|Induction Phase|Subject no longer meets study criteria|0|||
13455550|NCT00207142|26953697|FG003|Induction Phase|Subject no longer meets study criteria|0|||
13455551|NCT00207142|26953694|FG000|Induction Phase|Withdrawal by Subject|4|||
13455552|NCT00207142|26953695|FG001|Induction Phase|Withdrawal by Subject|0|||
13455553|NCT00207142|26953696|FG002|Induction Phase|Withdrawal by Subject|0|||
13455554|NCT00207142|26953697|FG003|Induction Phase|Withdrawal by Subject|0|||
13455555|NCT00207142|26953694|FG000|Induction Phase|Incarceration|1|||
13455556|NCT00207142|26953695|FG001|Induction Phase|Incarceration|0|||
13455557|NCT00207142|26953696|FG002|Induction Phase|Incarceration|0|||
13455558|NCT00207142|26953697|FG003|Induction Phase|Incarceration|0|||
13455559|NCT00207142|26953694|FG000|Induction Phase|Missing lab data|1|||
13455560|NCT00207142|26953695|FG001|Induction Phase|Missing lab data|0|||
13455561|NCT00207142|26953696|FG002|Induction Phase|Missing lab data|0|||
13455562|NCT00207142|26953697|FG003|Induction Phase|Missing lab data|0|||
13455563|NCT00207142|26953694|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0|||
13455564|NCT00207142|26953695|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1|||
13455565|NCT00207142|26953696|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4|||
13455566|NCT00207142|26953697|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1|||
13455567|NCT00207142|26953694|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0|||
13455568|NCT00207142|26953695|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
13455569|NCT00207142|26953696|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
13455570|NCT00207142|26953697|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2|||
13455571|NCT00207142|26953694|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
13455572|NCT00207142|26953695|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
13455573|NCT00207142|26953696|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1|||
13455574|NCT00207142|26953697|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
13455575|NCT00207142|26953694|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0|||
13455576|NCT00207142|26953695|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
13455577|NCT00207142|26953696|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2|||
13455578|NCT00207142|26953697|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
13455579|NCT00207142|26953694|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0|||
13455580|NCT00207142|26953695|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2|||
13455581|NCT00207142|26953696|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2|||
13455582|NCT00207142|26953697|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0|||
13455583|NCT00207142|26953694|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
13455584|NCT00207142|26953695|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
13455585|NCT00207142|26953696|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1|||
13455586|NCT00207142|26953697|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
13455587|NCT00207142|26953694|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0|||
13455588|NCT00207142|26953695|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
13455589|NCT00207142|26953696|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
13455590|NCT00207142|26953697|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1|||
13455591|NCT00207142|26953694|FG000|Maintenance Phase/Rescue Phase|Death|0|||
13455592|NCT00207142|26953695|FG001|Maintenance Phase/Rescue Phase|Death|0|||
13455593|NCT00207142|26953696|FG002|Maintenance Phase/Rescue Phase|Death|0|||
13455594|NCT00207142|26953697|FG003|Maintenance Phase/Rescue Phase|Death|1|||
13455595|NCT00207142|26953694|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
13455596|NCT00207142|26953695|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
13455597|NCT00207142|26953696|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
13455598|NCT00207142|26953697|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1|||
13455599|NCT00207090|26953728|FG000|Overall Study|Study drug toxicity|3|||
13455600|NCT00207090|26953728|FG000|Overall Study|Chest wall mass larger|1|||
13455601|NCT00207090|26953728|FG000|Overall Study|Disease progression/relapse|2|||
13455602|NCT00207090|26953728|FG000|Overall Study|Physician Decision|1|||
13455603|NCT00206726|26953739|FG000|Overall Study|Delayed recovery of blood counts|1|||
13455604|NCT00206726|26953739|FG000|Overall Study|Progressive disease or relapsed disease|18|||
13455605|NCT00206726|26953739|FG000|Overall Study|Placed on new protocol|1|||
13455606|NCT00206726|26953739|FG000|Overall Study|Bone marrow transplant|1|||
13455607|NCT00206726|26953739|FG000|Overall Study|Adverse Event|17|||
13455608|NCT00206726|26953739|FG000|Overall Study|Death|4|||
13455609|NCT00206726|26953739|FG000|Overall Study|Protocol Violation|1|||
13455610|NCT00206726|26953739|FG000|Overall Study|Withdrawal by Subject|8|||
13455611|NCT00206518|26953756|FG000|Overall Study|Lack of Efficacy|6|||
13455612|NCT00206518|26953757|FG001|Overall Study|Lack of Efficacy|4|||
13455613|NCT00206518|26953756|FG000|Overall Study|Adverse Event|2|||
13455614|NCT00206518|26953757|FG001|Overall Study|Adverse Event|1|||
13455615|NCT00206518|26953756|FG000|Overall Study|Physician Decision|1|||
13455616|NCT00206518|26953757|FG001|Overall Study|Physician Decision|0|||
13455617|NCT00206518|26953756|FG000|Overall Study|Protocol Violation|1|||
13455618|NCT00206518|26953757|FG001|Overall Study|Protocol Violation|1|||
13455619|NCT00206440|26953770|FG000|Overall Study|Protocol Violation|1|||
13455620|NCT00206440|26953771|FG001|Overall Study|Protocol Violation|2|||
13455621|NCT00206440|26953770|FG000|Overall Study|Adverse Event|4|||
13455622|NCT00206440|26953771|FG001|Overall Study|Adverse Event|2|||
13455623|NCT00206427|26953779|FG000|Overall Study|Adverse Event|2|||
13455624|NCT00206375|26953803|FG000|Overall Study|Lost to Follow-up|1|||
13455625|NCT00206375|26953804|FG001|Overall Study|Lost to Follow-up|0|||
13455626|NCT00206375|26953805|FG002|Overall Study|Lost to Follow-up|0|||
13455627|NCT00206375|26953803|FG000|Overall Study|Withdrawal by Subject|2|||
13455628|NCT00206375|26953804|FG001|Overall Study|Withdrawal by Subject|1|||
13455629|NCT00206375|26953805|FG002|Overall Study|Withdrawal by Subject|3|||
13455630|NCT00206375|26953803|FG000|Overall Study|Study terminated due to lack of funds|0|||
13455631|NCT00206375|26953804|FG001|Overall Study|Study terminated due to lack of funds|1|||
13455632|NCT00206375|26953805|FG002|Overall Study|Study terminated due to lack of funds|1|||
13455633|NCT00206323|26953818|FG000|Overall Study|Lack of Efficacy|4|||
13455634|NCT00206323|26953819|FG001|Overall Study|Lack of Efficacy|1|||
13455635|NCT00206323|26953818|FG000|Overall Study|Adverse Event|1|||
13455636|NCT00206323|26953819|FG001|Overall Study|Adverse Event|1|||
13455637|NCT00206323|26953818|FG000|Overall Study|Lost to Follow-up|1|||
13455638|NCT00206323|26953819|FG001|Overall Study|Lost to Follow-up|1|||
13455639|NCT00206102|26953860|FG000|Overall Study|Adverse Event|119|||
13455640|NCT00206102|26953861|FG001|Overall Study|Adverse Event|82|||
13455641|NCT00206102|26953860|FG000|Overall Study|Protocol Violation|0|||
13455642|NCT00206102|26953861|FG001|Overall Study|Protocol Violation|2|||
13455643|NCT00206102|26953860|FG000|Overall Study|Lack of therapeutic response|16|||
13455644|NCT00206102|26953861|FG001|Overall Study|Lack of therapeutic response|11|||
13455645|NCT00206102|26953860|FG000|Overall Study|Lost to Follow-up|95|||
13455646|NCT00206102|26953861|FG001|Overall Study|Lost to Follow-up|66|||
13455647|NCT00206102|26953860|FG000|Overall Study|Withdrawal by Subject|118|||
13455648|NCT00206102|26953861|FG001|Overall Study|Withdrawal by Subject|101|||
13455649|NCT00206102|26953860|FG000|Overall Study|Study-specific discontinuation criteria|18|||
13455650|NCT00206102|26953861|FG001|Overall Study|Study-specific discontinuation criteria|17|||
13455651|NCT00206102|26953860|FG000|Overall Study|None of those categories|42|||
13455652|NCT00206102|26953861|FG001|Overall Study|None of those categories|36|||
13455653|NCT00206076|26953878|FG000|Overall Study|Physician Decision|2|||
13455654|NCT00206076|26953879|FG001|Overall Study|Physician Decision|0|||
13455655|NCT00206076|26953878|FG000|Overall Study|Withdrawal by Subject|1|||
13455656|NCT00206076|26953879|FG001|Overall Study|Withdrawal by Subject|1|||
13455657|NCT00205881|26953886|FG000|Overall Study|Withdrawal by Subject|16|||
13455658|NCT00205855|26953892|FG000|Overall Study|Only received temporary implants|16|||
13455659|NCT00205855|26953892|FG000|Overall Study|Withdrawal by Subject|5|||
13455660|NCT00205803|26953951|FG000|Infant Series|Lost to Follow-up|10|||
13455661|NCT00205803|26953952|FG001|Infant Series|Lost to Follow-up|4|||
13455662|NCT00205803|26953951|FG000|Infant Series|Withdrawal by Subject|2|||
13455663|NCT00205803|26953952|FG001|Infant Series|Withdrawal by Subject|5|||
13455664|NCT00205803|26953951|FG000|Infant Series|Physician Decision|3|||
13455665|NCT00205803|26953952|FG001|Infant Series|Physician Decision|1|||
13455666|NCT00205803|26953951|FG000|Infant Series|Protocol Violation|1|||
13455667|NCT00205803|26953952|FG001|Infant Series|Protocol Violation|0|||
13455668|NCT00205803|26953951|FG000|Infant Series|Lost Kaiser coverage|0|||
13455669|NCT00205803|26953952|FG001|Infant Series|Lost Kaiser coverage|1|||
13455670|NCT00205803|26953951|FG000|Infant Series|Non-compliant|1|||
13455671|NCT00205803|26953952|FG001|Infant Series|Non-compliant|0|||
13455672|NCT00205803|26953951|FG000|Infant Series|Sponsor request|1|||
13455673|NCT00205803|26953952|FG001|Infant Series|Sponsor request|0|||
13455674|NCT00205803|26953951|FG000|After Infant Series|Adverse Event|1|||
13455675|NCT00205803|26953952|FG001|After Infant Series|Adverse Event|1|||
13455676|NCT00205803|26953951|FG000|After Infant Series|Protocol Violation|1|||
13455677|NCT00205803|26953952|FG001|After Infant Series|Protocol Violation|1|||
13455678|NCT00205803|26953951|FG000|After Infant Series|Lost to Follow-up|2|||
13455679|NCT00205803|26953952|FG001|After Infant Series|Lost to Follow-up|1|||
13455680|NCT00205803|26953951|FG000|After Infant Series|Physician Decision|3|||
13455681|NCT00205803|26953952|FG001|After Infant Series|Physician Decision|2|||
13455682|NCT00205803|26953951|FG000|After Infant Series|Withdrawal by Subject|1|||
13455683|NCT00205803|26953952|FG001|After Infant Series|Withdrawal by Subject|4|||
13455684|NCT00205803|26953951|FG000|After Infant Series|Other|10|||
13455685|NCT00205803|26953952|FG001|After Infant Series|Other|4|||
13455686|NCT00205803|26953951|FG000|Toddler Dose|Lost to Follow-up|2|||
13455687|NCT00205803|26953952|FG001|Toddler Dose|Lost to Follow-up|3|||
13455688|NCT00205777|26954174|FG000|Core Study (Up to 3 Years)|Adverse Event|260|||
13455689|NCT00205777|26954175|FG001|Core Study (Up to 3 Years)|Adverse Event|267|||
13455690|NCT00205777|26954176|FG002|Core Study (Up to 3 Years)|Adverse Event|252|||
13455691|NCT00205777|26954177|FG003|Core Study (Up to 3 Years)|Adverse Event|232|||
13455692|NCT00205777|26954178|FG004|Core Study (Up to 3 Years)|Adverse Event|0|||
13455693|NCT00205777|26954179|FG005|Core Study (Up to 3 Years)|Adverse Event|0|||
13455694|NCT00205777|26954174|FG000|Core Study (Up to 3 Years)|Death|9|||
13455695|NCT00205777|26954175|FG001|Core Study (Up to 3 Years)|Death|7|||
13455696|NCT00205777|26954176|FG002|Core Study (Up to 3 Years)|Death|14|||
13455697|NCT00205777|26954177|FG003|Core Study (Up to 3 Years)|Death|7|||
13455698|NCT00205777|26954178|FG004|Core Study (Up to 3 Years)|Death|0|||
13455699|NCT00205777|26954179|FG005|Core Study (Up to 3 Years)|Death|0|||
13455700|NCT00205777|26954174|FG000|Core Study (Up to 3 Years)|Failed to return|40|||
13455701|NCT00205777|26954175|FG001|Core Study (Up to 3 Years)|Failed to return|25|||
13455702|NCT00205777|26954176|FG002|Core Study (Up to 3 Years)|Failed to return|27|||
13455703|NCT00205777|26954177|FG003|Core Study (Up to 3 Years)|Failed to return|27|||
13455704|NCT00205777|26954178|FG004|Core Study (Up to 3 Years)|Failed to return|0|||
13455705|NCT00205777|26954179|FG005|Core Study (Up to 3 Years)|Failed to return|0|||
13455706|NCT00205777|26954174|FG000|Core Study (Up to 3 Years)|Other Event|49|||
13455707|NCT00205777|26954175|FG001|Core Study (Up to 3 Years)|Other Event|52|||
13455708|NCT00205777|26954176|FG002|Core Study (Up to 3 Years)|Other Event|41|||
13455709|NCT00205777|26954177|FG003|Core Study (Up to 3 Years)|Other Event|58|||
13455710|NCT00205777|26954178|FG004|Core Study (Up to 3 Years)|Other Event|0|||
13455711|NCT00205777|26954179|FG005|Core Study (Up to 3 Years)|Other Event|0|||
13455712|NCT00205777|26954174|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144|||
13455713|NCT00205777|26954175|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169|||
13455714|NCT00205777|26954176|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149|||
13455715|NCT00205777|26954177|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162|||
13455716|NCT00205777|26954178|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
13455717|NCT00205777|26954179|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
13455718|NCT00205777|26954174|FG000|Core Study (Up to 3 Years)|Protocol Violation|53|||
13455719|NCT00205777|26954175|FG001|Core Study (Up to 3 Years)|Protocol Violation|55|||
13455720|NCT00205777|26954176|FG002|Core Study (Up to 3 Years)|Protocol Violation|50|||
13455721|NCT00205777|26954177|FG003|Core Study (Up to 3 Years)|Protocol Violation|42|||
13455722|NCT00205777|26954178|FG004|Core Study (Up to 3 Years)|Protocol Violation|0|||
13455723|NCT00205777|26954179|FG005|Core Study (Up to 3 Years)|Protocol Violation|0|||
13455724|NCT00205777|26954174|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
13455725|NCT00205777|26954175|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
13455726|NCT00205777|26954176|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39|||
13455727|NCT00205777|26954177|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75|||
13455728|NCT00205777|26954178|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
13455729|NCT00205777|26954179|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
13455730|NCT00205777|26954174|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21|||
13455731|NCT00205777|26954175|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32|||
13455732|NCT00205777|26954176|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35|||
13455733|NCT00205777|26954177|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29|||
13455734|NCT00205777|26954178|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0|||
13455735|NCT00205777|26954179|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0|||
13455736|NCT00205777|26954174|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180|||
13455737|NCT00205777|26954175|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158|||
13455738|NCT00205777|26954176|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160|||
13455739|NCT00205777|26954177|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174|||
13455740|NCT00205777|26954178|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
13455741|NCT00205777|26954179|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
13455742|NCT00205777|26954174|FG000|Completed Core Study, Entered SE I|Other Event|52|||
13455743|NCT00205777|26954175|FG001|Completed Core Study, Entered SE I|Other Event|46|||
13455744|NCT00205777|26954176|FG002|Completed Core Study, Entered SE I|Other Event|47|||
13455745|NCT00205777|26954177|FG003|Completed Core Study, Entered SE I|Other Event|50|||
13455746|NCT00205777|26954178|FG004|Completed Core Study, Entered SE I|Other Event|0|||
13455747|NCT00205777|26954179|FG005|Completed Core Study, Entered SE I|Other Event|0|||
13455748|NCT00205777|26954174|FG000|Study Extension I|Adverse Event|57|||
13455749|NCT00205777|26954175|FG001|Study Extension I|Adverse Event|0|||
13455750|NCT00205777|26954176|FG002|Study Extension I|Adverse Event|0|||
13455751|NCT00205777|26954177|FG003|Study Extension I|Adverse Event|61|||
13455752|NCT00205777|26954178|FG004|Study Extension I|Adverse Event|58|||
13455753|NCT00205777|26954179|FG005|Study Extension I|Adverse Event|0|||
13455754|NCT00205777|26954174|FG000|Study Extension I|Death|5|||
13455755|NCT00205777|26954175|FG001|Study Extension I|Death|0|||
13455756|NCT00205777|26954176|FG002|Study Extension I|Death|0|||
13455757|NCT00205777|26954177|FG003|Study Extension I|Death|1|||
13455758|NCT00205777|26954178|FG004|Study Extension I|Death|2|||
13455759|NCT00205777|26954179|FG005|Study Extension I|Death|0|||
13455760|NCT00205777|26954174|FG000|Study Extension I|Withdrawal by Subject|99|||
13455761|NCT00205777|26954175|FG001|Study Extension I|Withdrawal by Subject|0|||
13455762|NCT00205777|26954176|FG002|Study Extension I|Withdrawal by Subject|0|||
13455763|NCT00205777|26954177|FG003|Study Extension I|Withdrawal by Subject|106|||
13455764|NCT00205777|26954178|FG004|Study Extension I|Withdrawal by Subject|89|||
13455765|NCT00205777|26954179|FG005|Study Extension I|Withdrawal by Subject|0|||
13455766|NCT00205777|26954174|FG000|Study Extension I|Protocol Violation|4|||
13455767|NCT00205777|26954175|FG001|Study Extension I|Protocol Violation|0|||
13455768|NCT00205777|26954176|FG002|Study Extension I|Protocol Violation|0|||
13455769|NCT00205777|26954177|FG003|Study Extension I|Protocol Violation|8|||
13455770|NCT00205777|26954178|FG004|Study Extension I|Protocol Violation|8|||
13455771|NCT00205777|26954179|FG005|Study Extension I|Protocol Violation|0|||
13455772|NCT00205777|26954174|FG000|Study Extension I|Lack of Efficacy|0|||
13455773|NCT00205777|26954175|FG001|Study Extension I|Lack of Efficacy|0|||
13455774|NCT00205777|26954176|FG002|Study Extension I|Lack of Efficacy|0|||
13455775|NCT00205777|26954177|FG003|Study Extension I|Lack of Efficacy|1|||
13455776|NCT00205777|26954178|FG004|Study Extension I|Lack of Efficacy|2|||
13455777|NCT00205777|26954179|FG005|Study Extension I|Lack of Efficacy|0|||
13455778|NCT00205777|26954174|FG000|Study Extension I|Failed to return|15|||
13455779|NCT00205777|26954175|FG001|Study Extension I|Failed to return|0|||
13455780|NCT00205777|26954176|FG002|Study Extension I|Failed to return|0|||
13455781|NCT00205777|26954177|FG003|Study Extension I|Failed to return|17|||
13455782|NCT00205777|26954178|FG004|Study Extension I|Failed to return|13|||
13455783|NCT00205777|26954179|FG005|Study Extension I|Failed to return|0|||
13455784|NCT00205777|26954174|FG000|Study Extension I|Other Event|34|||
13455785|NCT00205777|26954175|FG001|Study Extension I|Other Event|0|||
13455786|NCT00205777|26954176|FG002|Study Extension I|Other Event|0|||
13455787|NCT00205777|26954177|FG003|Study Extension I|Other Event|34|||
13455788|NCT00205777|26954178|FG004|Study Extension I|Other Event|29|||
13455789|NCT00205777|26954179|FG005|Study Extension I|Other Event|0|||
13455790|NCT00205777|26954174|FG000|Study Extension I|Withdrawn as per protocol|0|||
13455791|NCT00205777|26954175|FG001|Study Extension I|Withdrawn as per protocol|0|||
13455792|NCT00205777|26954176|FG002|Study Extension I|Withdrawn as per protocol|1070|||
13455793|NCT00205777|26954177|FG003|Study Extension I|Withdrawn as per protocol|0|||
13455794|NCT00205777|26954178|FG004|Study Extension I|Withdrawn as per protocol|0|||
13455795|NCT00205777|26954179|FG005|Study Extension I|Withdrawn as per protocol|0|||
13455796|NCT00205777|26954174|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273|||
13455797|NCT00205777|26954175|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
13455798|NCT00205777|26954176|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
13455799|NCT00205777|26954177|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240|||
13455800|NCT00205777|26954178|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258|||
13455801|NCT00205777|26954179|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
13455802|NCT00205777|26954174|FG000|Study Extension II|Adverse Event|0|||
13455803|NCT00205777|26954175|FG001|Study Extension II|Adverse Event|0|||
13455804|NCT00205777|26954176|FG002|Study Extension II|Adverse Event|0|||
13455805|NCT00205777|26954177|FG003|Study Extension II|Adverse Event|14|||
13455806|NCT00205777|26954178|FG004|Study Extension II|Adverse Event|0|||
13455807|NCT00205777|26954179|FG005|Study Extension II|Adverse Event|30|||
13455808|NCT00205777|26954174|FG000|Study Extension II|Death|0|||
13455809|NCT00205777|26954175|FG001|Study Extension II|Death|0|||
13455810|NCT00205777|26954176|FG002|Study Extension II|Death|0|||
13455811|NCT00205777|26954177|FG003|Study Extension II|Death|2|||
13455812|NCT00205777|26954178|FG004|Study Extension II|Death|0|||
13455813|NCT00205777|26954179|FG005|Study Extension II|Death|5|||
13455814|NCT00205777|26954174|FG000|Study Extension II|Withdrawal by Subject|0|||
13455815|NCT00205777|26954175|FG001|Study Extension II|Withdrawal by Subject|0|||
13455816|NCT00205777|26954176|FG002|Study Extension II|Withdrawal by Subject|0|||
13455817|NCT00205777|26954177|FG003|Study Extension II|Withdrawal by Subject|35|||
13455818|NCT00205777|26954178|FG004|Study Extension II|Withdrawal by Subject|0|||
13455819|NCT00205777|26954179|FG005|Study Extension II|Withdrawal by Subject|59|||
13455820|NCT00205777|26954174|FG000|Study Extension II|Protocol Violation|0|||
13455821|NCT00205777|26954175|FG001|Study Extension II|Protocol Violation|0|||
13455822|NCT00205777|26954176|FG002|Study Extension II|Protocol Violation|0|||
13455823|NCT00205777|26954177|FG003|Study Extension II|Protocol Violation|1|||
13455824|NCT00205777|26954178|FG004|Study Extension II|Protocol Violation|0|||
13455825|NCT00205777|26954179|FG005|Study Extension II|Protocol Violation|10|||
13455826|NCT00205777|26954174|FG000|Study Extension II|Lack of Efficacy|0|||
13455827|NCT00205777|26954175|FG001|Study Extension II|Lack of Efficacy|0|||
13455828|NCT00205777|26954176|FG002|Study Extension II|Lack of Efficacy|0|||
13455829|NCT00205777|26954177|FG003|Study Extension II|Lack of Efficacy|0|||
13455830|NCT00205777|26954178|FG004|Study Extension II|Lack of Efficacy|0|||
13455831|NCT00205777|26954179|FG005|Study Extension II|Lack of Efficacy|1|||
13455832|NCT00205777|26954174|FG000|Study Extension II|Failed to return|0|||
13455833|NCT00205777|26954175|FG001|Study Extension II|Failed to return|0|||
13455834|NCT00205777|26954176|FG002|Study Extension II|Failed to return|0|||
13455835|NCT00205777|26954177|FG003|Study Extension II|Failed to return|14|||
13455836|NCT00205777|26954178|FG004|Study Extension II|Failed to return|0|||
13455837|NCT00205777|26954179|FG005|Study Extension II|Failed to return|26|||
13455838|NCT00205777|26954174|FG000|Study Extension II|Other Event|0|||
13455839|NCT00205777|26954175|FG001|Study Extension II|Other Event|0|||
13455840|NCT00205777|26954176|FG002|Study Extension II|Other Event|0|||
13455841|NCT00205777|26954177|FG003|Study Extension II|Other Event|12|||
13455842|NCT00205777|26954178|FG004|Study Extension II|Other Event|0|||
13455843|NCT00205777|26954179|FG005|Study Extension II|Other Event|20|||
13455844|NCT00205777|26954174|FG000|Study Extension II|Enrolled but not treated|0|||
13455845|NCT00205777|26954175|FG001|Study Extension II|Enrolled but not treated|0|||
13455846|NCT00205777|26954176|FG002|Study Extension II|Enrolled but not treated|0|||
13455847|NCT00205777|26954177|FG003|Study Extension II|Enrolled but not treated|71|||
13455848|NCT00205777|26954178|FG004|Study Extension II|Enrolled but not treated|0|||
13455849|NCT00205777|26954179|FG005|Study Extension II|Enrolled but not treated|131|||
13455850|NCT00205712|26954196|FG000|Overall Study|Lost to Follow-up|0|||
13455851|NCT00205712|26954197|FG001|Overall Study|Lost to Follow-up|1|||
13455852|NCT00205699|26954230|FG000|Overall Study|Lost to Follow-up|1|||
13455853|NCT00205699|26954231|FG001|Overall Study|Lost to Follow-up|3|||
13455854|NCT00205699|26954232|FG002|Overall Study|Lost to Follow-up|5|||
13455855|NCT00205699|26954230|FG000|Overall Study|Adverse Event|1|||
13455856|NCT00205699|26954231|FG001|Overall Study|Adverse Event|0|||
13455857|NCT00205699|26954232|FG002|Overall Study|Adverse Event|0|||
13455858|NCT00205699|26954230|FG000|Overall Study|Withdrawal by Subject|1|||
13455859|NCT00205699|26954231|FG001|Overall Study|Withdrawal by Subject|2|||
13455860|NCT00205699|26954232|FG002|Overall Study|Withdrawal by Subject|1|||
13455861|NCT00205699|26954230|FG000|Overall Study|Lack of Efficacy|0|||
13455862|NCT00205699|26954231|FG001|Overall Study|Lack of Efficacy|1|||
13455863|NCT00205699|26954232|FG002|Overall Study|Lack of Efficacy|0|||
13455864|NCT00205179|26954301|FG000|Overall Study|Death|0|||
13455865|NCT00205179|26954302|FG001|Overall Study|Death|2|||
13455866|NCT00205179|26954301|FG000|Overall Study|Physician Decision|1|||
13455867|NCT00205179|26954302|FG001|Overall Study|Physician Decision|1|||
13455868|NCT00205179|26954301|FG000|Overall Study|Adverse Event|1|||
13455869|NCT00205179|26954302|FG001|Overall Study|Adverse Event|1|||
13455870|NCT00203996|26954372|FG000|Overall Study|Lost to Follow-up|0|||
13455871|NCT00203996|26954373|FG001|Overall Study|Lost to Follow-up|0|||
13455872|NCT00203996|26954374|FG002|Overall Study|Lost to Follow-up|0|||
13455873|NCT00203996|26954375|FG003|Overall Study|Lost to Follow-up|1|||
13455874|NCT00203996|26954376|FG004|Overall Study|Lost to Follow-up|0|||
13455875|NCT00203996|26954377|FG005|Overall Study|Lost to Follow-up|0|||
13455876|NCT00203996|26954378|FG006|Overall Study|Lost to Follow-up|0|||
13455877|NCT00203996|26954379|FG007|Overall Study|Lost to Follow-up|0|||
13455878|NCT00203996|26954380|FG008|Overall Study|Lost to Follow-up|0|||
13455879|NCT00203996|26954381|FG009|Overall Study|Lost to Follow-up|0|||
13455880|NCT00203996|26954372|FG000|Overall Study|Protocol Violation|0|||
13455881|NCT00203996|26954373|FG001|Overall Study|Protocol Violation|0|||
13455882|NCT00203996|26954374|FG002|Overall Study|Protocol Violation|0|||
13455883|NCT00203996|26954375|FG003|Overall Study|Protocol Violation|6|||
13455884|NCT00203996|26954376|FG004|Overall Study|Protocol Violation|1|||
13455885|NCT00203996|26954377|FG005|Overall Study|Protocol Violation|0|||
13455886|NCT00203996|26954378|FG006|Overall Study|Protocol Violation|0|||
13455887|NCT00203996|26954379|FG007|Overall Study|Protocol Violation|0|||
13455888|NCT00203996|26954380|FG008|Overall Study|Protocol Violation|0|||
13455889|NCT00203996|26954381|FG009|Overall Study|Protocol Violation|0|||
13455890|NCT00203996|26954372|FG000|Overall Study|Physician Decision|0|||
13455891|NCT00203996|26954373|FG001|Overall Study|Physician Decision|0|||
13455892|NCT00203996|26954374|FG002|Overall Study|Physician Decision|0|||
13455893|NCT00203996|26954375|FG003|Overall Study|Physician Decision|2|||
13455894|NCT00203996|26954376|FG004|Overall Study|Physician Decision|0|||
13455895|NCT00203996|26954377|FG005|Overall Study|Physician Decision|0|||
13455896|NCT00203996|26954378|FG006|Overall Study|Physician Decision|0|||
13455897|NCT00203996|26954379|FG007|Overall Study|Physician Decision|0|||
13455898|NCT00203996|26954380|FG008|Overall Study|Physician Decision|0|||
13455899|NCT00203996|26954381|FG009|Overall Study|Physician Decision|1|||
13455900|NCT00203996|26954372|FG000|Overall Study|CPAP machine malfunction|0|||
13455901|NCT00203996|26954373|FG001|Overall Study|CPAP machine malfunction|0|||
13455902|NCT00203996|26954374|FG002|Overall Study|CPAP machine malfunction|0|||
13455903|NCT00203996|26954375|FG003|Overall Study|CPAP machine malfunction|1|||
13455904|NCT00203996|26954376|FG004|Overall Study|CPAP machine malfunction|0|||
13455905|NCT00203996|26954377|FG005|Overall Study|CPAP machine malfunction|0|||
13455906|NCT00203996|26954378|FG006|Overall Study|CPAP machine malfunction|0|||
13455907|NCT00203996|26954379|FG007|Overall Study|CPAP machine malfunction|0|||
13455908|NCT00203996|26954380|FG008|Overall Study|CPAP machine malfunction|0|||
13455909|NCT00203996|26954381|FG009|Overall Study|CPAP machine malfunction|0|||
13455910|NCT00203996|26954372|FG000|Overall Study|Scheduling issue|0|||
13455911|NCT00203996|26954373|FG001|Overall Study|Scheduling issue|0|||
13455912|NCT00203996|26954374|FG002|Overall Study|Scheduling issue|0|||
13455913|NCT00203996|26954375|FG003|Overall Study|Scheduling issue|0|||
13455914|NCT00203996|26954376|FG004|Overall Study|Scheduling issue|0|||
13455915|NCT00203996|26954377|FG005|Overall Study|Scheduling issue|0|||
13455916|NCT00203996|26954378|FG006|Overall Study|Scheduling issue|0|||
13455917|NCT00203996|26954379|FG007|Overall Study|Scheduling issue|2|||
13455918|NCT00203996|26954380|FG008|Overall Study|Scheduling issue|0|||
13455919|NCT00203996|26954381|FG009|Overall Study|Scheduling issue|0|||
13455920|NCT00203892|26954402|FG000|Overall Study|Physician Decision|1|||
13455921|NCT00203892|26954403|FG001|Overall Study|Physician Decision|2|||
13455922|NCT00203892|26954404|FG002|Overall Study|Physician Decision|0|||
13455923|NCT00203892|26954402|FG000|Overall Study|Death|1|||
13455924|NCT00203892|26954403|FG001|Overall Study|Death|0|||
13455925|NCT00203892|26954404|FG002|Overall Study|Death|0|||
13455926|NCT00203502|26954414|FG000|Overall Study|Death|1|||
13455927|NCT00203476|26954441|FG000|Overall Study|Lost to Follow-up|1|||
13455928|NCT00203476|26954442|FG001|Overall Study|Lost to Follow-up|0|||
13455929|NCT00203476|26954443|FG002|Overall Study|Lost to Follow-up|0|||
13455930|NCT00203476|26954441|FG000|Overall Study|Withdrawal by Subject|0|||
13455931|NCT00203476|26954442|FG001|Overall Study|Withdrawal by Subject|1|||
13455932|NCT00203476|26954443|FG002|Overall Study|Withdrawal by Subject|0|||
13455933|NCT00203424|26954452|FG000|Treatment Period|Withdrawal by Subject|4|||
13455934|NCT00203424|26954452|FG000|Treatment Period|Adverse Event|5|||
13455935|NCT00203424|26954452|FG000|Treatment Period|progressive disease|2|||
13455936|NCT00203424|26954452|FG000|Follow-up Period|Withdrawal by Subject|1|||
13455937|NCT00203424|26954452|FG000|Follow-up Period|progressive disease|4|||
13455938|NCT00203424|26954452|FG000|Follow-up Period|Lost to Follow-up|1|||
13455939|NCT00203411|26954461|FG000|Follow-up|Progressive Disease|4|||
13477470|NCT02184195|27006808|FG000|Overall Study|Patients ongoing Study Treatment|19|||
13477471|NCT02184195|27006809|FG001|Overall Study|Patients ongoing Study Treatment|7|||
13477472|NCT02179749|27006830|FG000|Overall Study|Adverse Event|0|||
13477473|NCT02179749|27006831|FG001|Overall Study|Adverse Event|0|||
13477474|NCT02179749|27006832|FG002|Overall Study|Adverse Event|1|||
13477475|NCT02179749|27006830|FG000|Overall Study|Withdrawal by Subject|0|||
13477476|NCT02179749|27006831|FG001|Overall Study|Withdrawal by Subject|0|||
13477477|NCT02179749|27006832|FG002|Overall Study|Withdrawal by Subject|1|||
13477478|NCT02075593|27006872|FG000|Overall Study|Withdrawal by Subject|1|||
13477479|NCT00700882|27006946|FG000|Overall Study|Never received treatment|6|||
13477480|NCT00700882|27006946|FG000|Overall Study|Ineligible|2|||
13477481|NCT00700882|27006946|FG000|Overall Study|No KIT mutation|51|||
13477482|NCT00641186|27006953|FG000|Overall Study|Adverse Event|3|||
13455940|NCT00203307|26954474|FG000|First Intervention|Adverse Event|2|||
13455941|NCT00203307|26954475|FG001|First Intervention|Adverse Event|0|||
13455942|NCT00203294|26954488|FG000|Overall Study|Withdrawal by Subject|8|||
13455943|NCT00203294|26954489|FG001|Overall Study|Withdrawal by Subject|13|||
13455944|NCT00203268|26954497|FG000|Early Treatment|only treated one headache|2|||
13455945|NCT00203268|26954497|FG000|Early Treatment|Lost to Follow-up|1|||
13455946|NCT00203268|26954497|FG000|Early Treatment|Withdrawal by Subject|1|||
13455947|NCT00203242|26954503|FG000|Overall Study|Lost to Follow-up|1|||
13455948|NCT00203047|26954522|FG000|Overall Study|Ongoing: in database - January 29, 2009|131|||
13455949|NCT00203047|26954523|FG001|Overall Study|Ongoing: in database - January 29, 2009|109|||
13455950|NCT00203047|26954522|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5|||
13455951|NCT00203047|26954523|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1|||
13455952|NCT00203047|26954522|FG000|Overall Study|Withdrawal by Subject|13|||
13455953|NCT00203047|26954523|FG001|Overall Study|Withdrawal by Subject|47|||
13455954|NCT00203047|26954522|FG000|Overall Study|Teva requested participant withdrawal|1|||
13455955|NCT00203047|26954523|FG001|Overall Study|Teva requested participant withdrawal|1|||
13455956|NCT00203047|26954522|FG000|Overall Study|Physician Decision|8|||
13455957|NCT00203047|26954523|FG001|Overall Study|Physician Decision|7|||
13455958|NCT00203047|26954522|FG000|Overall Study|Non-compliance|4|||
13455959|NCT00203047|26954523|FG001|Overall Study|Non-compliance|8|||
13455960|NCT00203047|26954522|FG000|Overall Study|Protocol Violation|1|||
13455961|NCT00203047|26954523|FG001|Overall Study|Protocol Violation|0|||
13455962|NCT00203047|26954522|FG000|Overall Study|Lost to Follow-up|11|||
13455963|NCT00203047|26954523|FG001|Overall Study|Lost to Follow-up|5|||
13455964|NCT00203047|26954522|FG000|Overall Study|Adverse Event|8|||
13455965|NCT00203047|26954523|FG001|Overall Study|Adverse Event|18|||
13455966|NCT00203047|26954522|FG000|Overall Study|Death|1|||
13455967|NCT00203047|26954523|FG001|Overall Study|Death|2|||
13455968|NCT00203047|26954522|FG000|Overall Study|Pregnancy|3|||
13455969|NCT00203047|26954523|FG001|Overall Study|Pregnancy|0|||
13455970|NCT00203047|26954522|FG000|Overall Study|Other|5|||
13455971|NCT00203047|26954523|FG001|Overall Study|Other|5|||
13455972|NCT00203021|26954538|FG000|Overall Study|Death|4|||
13455973|NCT00203021|26954539|FG001|Overall Study|Death|1|||
13455974|NCT00203021|26954538|FG000|Overall Study|Adverse Event|10|||
13455975|NCT00203021|26954539|FG001|Overall Study|Adverse Event|5|||
13455976|NCT00203021|26954538|FG000|Overall Study|Withdrawal by Subject|45|||
13455977|NCT00203021|26954539|FG001|Overall Study|Withdrawal by Subject|48|||
13455978|NCT00203021|26954538|FG000|Overall Study|Lost to Follow-up|9|||
13455979|NCT00203021|26954539|FG001|Overall Study|Lost to Follow-up|7|||
13455980|NCT00203021|26954538|FG000|Overall Study|Other than specified|11|||
13455981|NCT00203021|26954539|FG001|Overall Study|Other than specified|16|||
13455982|NCT00202878|26954558|FG000|Overall Study|Death|964|||
13455983|NCT00202878|26954559|FG001|Overall Study|Death|968|||
13455984|NCT00202878|26954558|FG000|Overall Study|Only Vital Status Known|357|||
13455985|NCT00202878|26954559|FG001|Overall Study|Only Vital Status Known|356|||
13455986|NCT00202878|26954558|FG000|Overall Study|Lost to Follow-up|44|||
13455987|NCT00202878|26954559|FG001|Overall Study|Lost to Follow-up|49|||
13455988|NCT00202878|26954558|FG000|Overall Study|Site Closure|39|||
13455989|NCT00202878|26954559|FG001|Overall Study|Site Closure|36|||
13455990|NCT00202878|26954558|FG000|Overall Study|Withdrawal by Subject|795|||
13455991|NCT00202878|26954559|FG001|Overall Study|Withdrawal by Subject|808|||
13455992|NCT00202839|26954574|FG000|Overall Study|Adverse Event|1|||
13455993|NCT00202839|26954575|FG001|Overall Study|Adverse Event|5|||
13455994|NCT00202839|26954574|FG000|Overall Study|Physician Decision|12|||
13455995|NCT00202839|26954575|FG001|Overall Study|Physician Decision|0|||
13455996|NCT00202839|26954574|FG000|Overall Study|Withdrawal by Subject|6|||
13455997|NCT00202839|26954575|FG001|Overall Study|Withdrawal by Subject|2|||
13455998|NCT00202839|26954574|FG000|Overall Study|Protocol Violation|2|||
13455999|NCT00202839|26954575|FG001|Overall Study|Protocol Violation|1|||
13456000|NCT00202839|26954574|FG000|Overall Study|Lost to Follow-up|3|||
13456001|NCT00202839|26954575|FG001|Overall Study|Lost to Follow-up|2|||
13456002|NCT00202644|26954606|FG000|Overall Study|Adverse Event|12|||
13456003|NCT00202644|26954607|FG001|Overall Study|Adverse Event|13|||
13456004|NCT00202644|26954606|FG000|Overall Study|Withdrawal by Subject|8|||
13456005|NCT00202644|26954607|FG001|Overall Study|Withdrawal by Subject|6|||
13456006|NCT00202644|26954606|FG000|Overall Study|Lack of Efficacy|6|||
13456007|NCT00202644|26954607|FG001|Overall Study|Lack of Efficacy|6|||
13456008|NCT00202644|26954606|FG000|Overall Study|Lost to Follow-up|0|||
13456009|NCT00202644|26954607|FG001|Overall Study|Lost to Follow-up|1|||
13456010|NCT00202644|26954606|FG000|Overall Study|Other|9|||
13456011|NCT00202644|26954607|FG001|Overall Study|Other|1|||
13456012|NCT00201851|26954625|FG000|Overall Study|Lost to Follow-up|2|||
13456013|NCT00201851|26954626|FG001|Overall Study|Lost to Follow-up|1|||
13456014|NCT00201851|26954627|FG002|Overall Study|Lost to Follow-up|0|||
13456015|NCT00201851|26954625|FG000|Overall Study|Ineligible post enrollment|6|||
13456016|NCT00201851|26954626|FG001|Overall Study|Ineligible post enrollment|1|||
13456017|NCT00201851|26954627|FG002|Overall Study|Ineligible post enrollment|1|||
13456018|NCT00201643|26954656|FG000|Overall Study|Withdrawal by Subject|5|||
13456019|NCT00201643|26954657|FG001|Overall Study|Withdrawal by Subject|4|||
13456020|NCT00201201|26954680|FG000|Overall Study|Death|0|||
13456021|NCT00201201|26954681|FG001|Overall Study|Death|2|||
13456022|NCT00201201|26954680|FG000|Overall Study|Withdrawal by Subject|5|||
13456023|NCT00201201|26954681|FG001|Overall Study|Withdrawal by Subject|5|||
13456024|NCT00201006|26954699|FG000|Overall Study|Withdrawal by Subject|7|||
13456025|NCT00201006|26954700|FG001|Overall Study|Withdrawal by Subject|2|||
13456026|NCT00201006|26954701|FG002|Overall Study|Withdrawal by Subject|3|||
13456027|NCT00201006|26954699|FG000|Overall Study|Adverse Event|1|||
13456028|NCT00201006|26954700|FG001|Overall Study|Adverse Event|0|||
13456029|NCT00201006|26954701|FG002|Overall Study|Adverse Event|1|||
13456030|NCT00200967|26954736|FG000|First Treatment Period|Withdrawal by Subject|5|||
13456031|NCT00200967|26954737|FG001|First Treatment Period|Withdrawal by Subject|1|||
13456032|NCT00200967|26954736|FG000|First Treatment Period|Pregnancy|1|||
13456033|NCT00200967|26954737|FG001|First Treatment Period|Pregnancy|0|||
13456034|NCT00200967|26954736|FG000|Wash-out Period|Lost to Follow-up|0|||
13456035|NCT00200967|26954737|FG001|Wash-out Period|Lost to Follow-up|1|||
13456036|NCT00200967|26954736|FG000|Second Treatment Period|Withdrawal by Subject|1|||
13456037|NCT00200967|26954737|FG001|Second Treatment Period|Withdrawal by Subject|2|||
13456038|NCT00200967|26954736|FG000|Run-out Period|Lost to Follow-up|1|||
13456039|NCT00200967|26954737|FG001|Run-out Period|Lost to Follow-up|0|||
13456040|NCT00200850|26954755|FG000|Overall Study|relocation|1|||
13456041|NCT00200850|26954756|FG001|Overall Study|relocation|0|||
13456042|NCT00200850|26954757|FG002|Overall Study|relocation|1|||
13456043|NCT00200850|26954755|FG000|Overall Study|too busy|1|||
13456044|NCT00200850|26954756|FG001|Overall Study|too busy|0|||
13456045|NCT00200850|26954757|FG002|Overall Study|too busy|0|||
13456046|NCT00200850|26954755|FG000|Overall Study|Pregnancy|0|||
13456047|NCT00200850|26954756|FG001|Overall Study|Pregnancy|0|||
13456048|NCT00200850|26954757|FG002|Overall Study|Pregnancy|1|||
13456049|NCT00200850|26954755|FG000|Overall Study|Poor adherence|0|||
13456050|NCT00200850|26954756|FG001|Overall Study|Poor adherence|0|||
13456051|NCT00200850|26954757|FG002|Overall Study|Poor adherence|1|||
13456052|NCT00200850|26954755|FG000|Overall Study|optic neuritis|0|||
13456053|NCT00200850|26954756|FG001|Overall Study|optic neuritis|0|||
13456054|NCT00200850|26954757|FG002|Overall Study|optic neuritis|1|||
13456055|NCT00200850|26954755|FG000|Overall Study|Adverse Event|1|||
13456056|NCT00200850|26954756|FG001|Overall Study|Adverse Event|1|||
13456057|NCT00200850|26954757|FG002|Overall Study|Adverse Event|2|||
13456058|NCT00200356|26954788|FG000|Overall Study|Lack of Efficacy|3|||
13456059|NCT00200356|26954789|FG001|Overall Study|Lack of Efficacy|3|||
13456060|NCT00200356|26954788|FG000|Overall Study|Protocol Violation|4|||
13456061|NCT00200356|26954789|FG001|Overall Study|Protocol Violation|4|||
13456062|NCT00200356|26954788|FG000|Overall Study|Nontreatment|1|||
13456063|NCT00200356|26954789|FG001|Overall Study|Nontreatment|0|||
13456064|NCT00200057|26954801|FG000|Overall Study|Lack of Efficacy|3|||
13456065|NCT00200057|26954801|FG000|Overall Study|Exited due to terminal illness of PI|2|||
13456066|NCT00200057|26954801|FG000|Overall Study|Withdrawal by Subject|1|||
13456067|NCT00200057|26954801|FG000|Overall Study|Change in medical condition|1|||
13456068|NCT00200057|26954801|FG000|Overall Study|Infection|1|||
13456069|NCT00200057|26954801|FG000|Overall Study|Death|1|||
13456070|NCT00197028|26954848|FG000|Overall Study|Adverse Event|2|||
13456071|NCT00197028|26954849|FG001|Overall Study|Adverse Event|2|||
13456072|NCT00197028|26954848|FG000|Overall Study|Protocol Violation|2|||
13456073|NCT00197028|26954849|FG001|Overall Study|Protocol Violation|1|||
13456074|NCT00197028|26954848|FG000|Overall Study|Withdrawal by Subject|8|||
13456075|NCT00197028|26954849|FG001|Overall Study|Withdrawal by Subject|12|||
13456076|NCT00197028|26954848|FG000|Overall Study|Lost to Follow-up|1|||
13456077|NCT00197028|26954849|FG001|Overall Study|Lost to Follow-up|0|||
13456078|NCT00197028|26954848|FG000|Overall Study|Other|3|||
13456079|NCT00197028|26954849|FG001|Overall Study|Other|6|||
13456080|NCT00196937|26954903|FG000|Overall Study|Serious Adverse Event|1|||
13456081|NCT00196937|26954904|FG001|Overall Study|Serious Adverse Event|0|||
13456082|NCT00196937|26954905|FG002|Overall Study|Serious Adverse Event|0|||
13456083|NCT00196937|26954903|FG000|Overall Study|Non-serious adverse event|1|||
13456084|NCT00196937|26954904|FG001|Overall Study|Non-serious adverse event|1|||
13456085|NCT00196937|26954905|FG002|Overall Study|Non-serious adverse event|1|||
13456086|NCT00196937|26954903|FG000|Overall Study|Withdrawal by Subject|0|||
13456087|NCT00196937|26954904|FG001|Overall Study|Withdrawal by Subject|0|||
13456088|NCT00196937|26954905|FG002|Overall Study|Withdrawal by Subject|2|||
13456089|NCT00196937|26954903|FG000|Overall Study|Lost to Follow-up|4|||
13456090|NCT00196937|26954904|FG001|Overall Study|Lost to Follow-up|3|||
13456091|NCT00196937|26954905|FG002|Overall Study|Lost to Follow-up|3|||
13456092|NCT00196937|26954903|FG000|Overall Study|Other|3|||
13456093|NCT00196937|26954904|FG001|Overall Study|Other|1|||
13456094|NCT00196937|26954905|FG002|Overall Study|Other|1|||
13456095|NCT00195819|26954958|FG000|Double-Blind|Withdrawal by Subject|1|||
13456096|NCT00195819|26954959|FG001|Double-Blind|Withdrawal by Subject|0|||
13456097|NCT00195819|26954958|FG000|Double-Blind|Moved|1|||
13456098|NCT00195819|26954959|FG001|Double-Blind|Moved|0|||
13456099|NCT00195819|26954958|FG000|Open-label|Adverse Event|0|||
13456100|NCT00195819|26954959|FG001|Open-label|Adverse Event|9|||
13456101|NCT00195819|26954958|FG000|Open-label|Lack of Efficacy|0|||
13456102|NCT00195819|26954959|FG001|Open-label|Lack of Efficacy|2|||
13456103|NCT00195819|26954958|FG000|Open-label|Pregnancy|0|||
13456104|NCT00195819|26954959|FG001|Open-label|Pregnancy|1|||
13456105|NCT00195819|26954958|FG000|Open-label|Protocol Violation|0|||
13456106|NCT00195819|26954959|FG001|Open-label|Protocol Violation|2|||
13456107|NCT00195819|26954958|FG000|Open-label|Moved|0|||
13456108|NCT00195819|26954959|FG001|Open-label|Moved|1|||
13456109|NCT00195819|26954958|FG000|Open-label|Withdrawal by Subject|0|||
13456110|NCT00195819|26954959|FG001|Open-label|Withdrawal by Subject|5|||
13456111|NCT00195442|26954978|FG000|Overall Study|Less than expected therapeutic effect|38|||
13456112|NCT00195442|26954978|FG000|Overall Study|Lost to Follow-up|27|||
13456113|NCT00195442|26954978|FG000|Overall Study|Switch to other Factor VIII preparation|23|||
13456114|NCT00195442|26954978|FG000|Overall Study|Intermittent product shortage|21|||
13456115|NCT00195442|26954978|FG000|Overall Study|Death|7|||
13456116|NCT00195442|26954978|FG000|Overall Study|No reason specified|4|||
13456117|NCT00195442|26954978|FG000|Overall Study|Poor cooperation|2|||
13456118|NCT00195442|26954978|FG000|Overall Study|Other|14|||
13456119|NCT00195338|26954988|FG000|Overall Study|Lost to Follow-up|2|||
13456120|NCT00195338|26954988|FG000|Overall Study|Adverse Event|5|||
13456121|NCT00195338|26954988|FG000|Overall Study|Lack of Efficacy|1|||
13456122|NCT00195338|26954988|FG000|Overall Study|Early closure of the site|4|||
13456123|NCT00195260|26955150|FG000|Part 1: Dose Escalation|Adverse Event|0|||
13456124|NCT00195260|26955151|FG001|Part 1: Dose Escalation|Adverse Event|1|||
13456125|NCT00195260|26955152|FG002|Part 1: Dose Escalation|Adverse Event|0|||
13456126|NCT00195260|26955153|FG003|Part 1: Dose Escalation|Adverse Event|1|||
13456127|NCT00195260|26955154|FG004|Part 1: Dose Escalation|Adverse Event|1|||
13456128|NCT00195260|26955155|FG005|Part 1: Dose Escalation|Adverse Event|0|||
13456129|NCT00195260|26955156|FG006|Part 1: Dose Escalation|Adverse Event|3|||
13456130|NCT00195260|26955157|FG007|Part 1: Dose Escalation|Adverse Event|0|||
13456131|NCT00195260|26955158|FG008|Part 1: Dose Escalation|Adverse Event|0|||
13456132|NCT00195260|26955159|FG009|Part 1: Dose Escalation|Adverse Event|0|||
13456133|NCT00195260|26955160|FG010|Part 1: Dose Escalation|Adverse Event|0|||
13456134|NCT00195260|26955150|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
13456135|NCT00195260|26955151|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
13456136|NCT00195260|26955152|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
13456137|NCT00195260|26955153|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
13456138|NCT00195260|26955154|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2|||
13456139|NCT00195260|26955155|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
13456140|NCT00195260|26955156|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
13456141|NCT00195260|26955157|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1|||
13456142|NCT00195260|26955158|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
13456143|NCT00195260|26955159|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
13456144|NCT00195260|26955160|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
13456145|NCT00195260|26955150|FG000|Part 1: Dose Escalation|Death|0|||
13456146|NCT00195260|26955151|FG001|Part 1: Dose Escalation|Death|0|||
13456147|NCT00195260|26955152|FG002|Part 1: Dose Escalation|Death|0|||
13456148|NCT00195260|26955153|FG003|Part 1: Dose Escalation|Death|0|||
13456149|NCT00195260|26955154|FG004|Part 1: Dose Escalation|Death|0|||
13456150|NCT00195260|26955155|FG005|Part 1: Dose Escalation|Death|0|||
13456151|NCT00195260|26955156|FG006|Part 1: Dose Escalation|Death|0|||
13456152|NCT00195260|26955157|FG007|Part 1: Dose Escalation|Death|1|||
13456153|NCT00195260|26955158|FG008|Part 1: Dose Escalation|Death|0|||
13456154|NCT00195260|26955159|FG009|Part 1: Dose Escalation|Death|0|||
13456155|NCT00195260|26955160|FG010|Part 1: Dose Escalation|Death|0|||
13456156|NCT00195260|26955150|FG000|Part 1: Dose Escalation|Disease Progression|3|||
13456157|NCT00195260|26955151|FG001|Part 1: Dose Escalation|Disease Progression|2|||
13456158|NCT00195260|26955152|FG002|Part 1: Dose Escalation|Disease Progression|5|||
13456159|NCT00195260|26955153|FG003|Part 1: Dose Escalation|Disease Progression|6|||
13456160|NCT00195260|26955154|FG004|Part 1: Dose Escalation|Disease Progression|4|||
13456161|NCT00195260|26955155|FG005|Part 1: Dose Escalation|Disease Progression|6|||
13456162|NCT00195260|26955156|FG006|Part 1: Dose Escalation|Disease Progression|7|||
13456163|NCT00195260|26955157|FG007|Part 1: Dose Escalation|Disease Progression|4|||
13456164|NCT00195260|26955158|FG008|Part 1: Dose Escalation|Disease Progression|0|||
13456165|NCT00195260|26955159|FG009|Part 1: Dose Escalation|Disease Progression|0|||
13456166|NCT00195260|26955160|FG010|Part 1: Dose Escalation|Disease Progression|0|||
13456167|NCT00195260|26955150|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
13456168|NCT00195260|26955151|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
13456169|NCT00195260|26955152|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
13456170|NCT00195260|26955153|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
13456171|NCT00195260|26955154|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
13456172|NCT00195260|26955155|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
13456173|NCT00195260|26955156|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
13456174|NCT00195260|26955157|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
13456175|NCT00195260|26955158|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
13456176|NCT00195260|26955159|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
13456177|NCT00195260|26955160|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
13456178|NCT00195260|26955150|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
13456179|NCT00195260|26955151|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
13456180|NCT00195260|26955152|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
13456181|NCT00195260|26955153|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
13456182|NCT00195260|26955154|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
13456183|NCT00195260|26955155|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
13456184|NCT00195260|26955156|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
13456185|NCT00195260|26955157|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
13456186|NCT00195260|26955158|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21|||
13456187|NCT00195260|26955159|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29|||
13456188|NCT00195260|26955160|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15|||
13456189|NCT00195260|26955150|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
13456190|NCT00195260|26955151|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
13456191|NCT00195260|26955152|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
13456192|NCT00195260|26955153|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
13456193|NCT00195260|26955154|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
13456194|NCT00195260|26955155|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
13456195|NCT00195260|26955156|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
13456196|NCT00195260|26955157|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
13456197|NCT00195260|26955158|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5|||
13456198|NCT00195260|26955159|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3|||
13456199|NCT00195260|26955160|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2|||
13456200|NCT00195260|26955150|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
13456201|NCT00195260|26955151|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
13456202|NCT00195260|26955152|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
13456203|NCT00195260|26955153|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
13456204|NCT00195260|26955154|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
13456205|NCT00195260|26955155|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
13456206|NCT00195260|26955156|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
13456207|NCT00195260|26955157|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
13456208|NCT00195260|26955158|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1|||
13456209|NCT00195260|26955159|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2|||
13456210|NCT00195260|26955160|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3|||
13456211|NCT00195260|26955150|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
13456212|NCT00195260|26955151|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
13456213|NCT00195260|26955152|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
13456214|NCT00195260|26955153|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
13456215|NCT00195260|26955154|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
13456216|NCT00195260|26955155|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
13456217|NCT00195260|26955156|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
13456218|NCT00195260|26955157|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
13456219|NCT00195260|26955158|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6|||
13456220|NCT00195260|26955159|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4|||
13456221|NCT00195260|26955160|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3|||
13456222|NCT00194025|26955175|FG000|Overall Study|Adverse Event|1|||
13456223|NCT00194025|26955175|FG000|Overall Study|non-adherence with study medication|4|||
13456224|NCT00191945|26955214|FG000|Double-Blind Acute Treatment|Parent's Decision|3|||
13456225|NCT00191945|26955215|FG001|Double-Blind Acute Treatment|Parent's Decision|0|||
13456226|NCT00191945|26955214|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0|||
13456227|NCT00191945|26955215|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1|||
13456228|NCT00191945|26955214|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3|||
13456229|NCT00191945|26955215|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0|||
13456230|NCT00191945|26955214|FG000|Double-Blind Acute Treatment|Physician Decision|0|||
13456231|NCT00191945|26955215|FG001|Double-Blind Acute Treatment|Physician Decision|2|||
13456232|NCT00191477|26955238|FG000|Overall Study|Tumor Recurrence|49|||
13456233|NCT00191477|26955239|FG001|Overall Study|Tumor Recurrence|48|||
13456234|NCT00191477|26955238|FG000|Overall Study|Death, Study Disease|1|||
13456235|NCT00191477|26955239|FG001|Overall Study|Death, Study Disease|1|||
13456236|NCT00191477|26955238|FG000|Overall Study|Death, Other Cause|3|||
13456237|NCT00191477|26955239|FG001|Overall Study|Death, Other Cause|6|||
13456238|NCT00191477|26955238|FG000|Overall Study|Lost to Follow-up|23|||
13456239|NCT00191477|26955239|FG001|Overall Study|Lost to Follow-up|21|||
13456240|NCT00191477|26955238|FG000|Overall Study|Protocol Violation|1|||
13456241|NCT00191477|26955239|FG001|Overall Study|Protocol Violation|1|||
13456242|NCT00191477|26955238|FG000|Overall Study|Treatment Change|2|||
13456243|NCT00191477|26955239|FG001|Overall Study|Treatment Change|0|||
13456244|NCT00191477|26955238|FG000|Overall Study|Withdrawal by Subject|2|||
13456245|NCT00191477|26955239|FG001|Overall Study|Withdrawal by Subject|0|||
13456246|NCT00191477|26955238|FG000|Overall Study|Other|2|||
13456247|NCT00191477|26955239|FG001|Overall Study|Other|0|||
13456248|NCT00191477|26955238|FG000|Overall Study|Not Eligible|41|||
13456249|NCT00191477|26955239|FG001|Overall Study|Not Eligible|38|||
13456250|NCT00191477|26955238|FG000|Overall Study|Pathological Specimen Lost|1|||
13456251|NCT00191477|26955239|FG001|Overall Study|Pathological Specimen Lost|0|||
13456252|NCT00191477|26955238|FG000|Overall Study|Discontinued Prior to Instillation|13|||
13456253|NCT00191477|26955239|FG001|Overall Study|Discontinued Prior to Instillation|14|||
13456254|NCT00191113|26955286|FG000|Core Study|Withdrawal by Subject|25|||
13456255|NCT00191113|26955287|FG001|Core Study|Withdrawal by Subject|9|||
13456256|NCT00191113|26955286|FG000|Core Study|Protocol Violation|6|||
13456257|NCT00191113|26955287|FG001|Core Study|Protocol Violation|2|||
13456258|NCT00191113|26955286|FG000|Core Study|Lost to Follow-up|3|||
13456259|NCT00191113|26955287|FG001|Core Study|Lost to Follow-up|0|||
13456260|NCT00191113|26955286|FG000|Core Study|Adverse Event|0|||
13456261|NCT00191113|26955287|FG001|Core Study|Adverse Event|2|||
13456262|NCT00191113|26955286|FG000|Core Study|Lack of Efficacy|0|||
13456263|NCT00191113|26955287|FG001|Core Study|Lack of Efficacy|2|||
13456264|NCT00191113|26955286|FG000|Core Study|Death|1|||
13456265|NCT00191113|26955287|FG001|Core Study|Death|0|||
13456266|NCT00191100|26955310|FG000|Overall Study|Adverse Event|18|||
13456267|NCT00191100|26955311|FG001|Overall Study|Adverse Event|1|||
13456268|NCT00191100|26955310|FG000|Overall Study|Lost to Follow-up|2|||
13456269|NCT00191100|26955311|FG001|Overall Study|Lost to Follow-up|0|||
13456270|NCT00191100|26955310|FG000|Overall Study|Patient Moved|0|||
13456271|NCT00191100|26955311|FG001|Overall Study|Patient Moved|1|||
13456272|NCT00191100|26955310|FG000|Overall Study|Withdrawal by Subject|9|||
13456273|NCT00191100|26955311|FG001|Overall Study|Withdrawal by Subject|3|||
13456274|NCT00191100|26955310|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
13456275|NCT00191100|26955311|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
13456276|NCT00191100|26955310|FG000|Overall Study|Clinical Relapse|2|||
13456277|NCT00191100|26955311|FG001|Overall Study|Clinical Relapse|1|||
13456278|NCT00191100|26955310|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1|||
13456279|NCT00191100|26955311|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2|||
13456280|NCT00191100|26955310|FG000|Overall Study|Lack of Efficacy, Stable Disease|1|||
13456281|NCT00191100|26955311|FG001|Overall Study|Lack of Efficacy, Stable Disease|0|||
13456282|NCT00191100|26955310|FG000|Overall Study|Physician Decision|3|||
13456283|NCT00191100|26955311|FG001|Overall Study|Physician Decision|1|||
13456284|NCT00191100|26955310|FG000|Overall Study|Death from Study Drug Toxicity|2|||
13456285|NCT00191100|26955311|FG001|Overall Study|Death from Study Drug Toxicity|0|||
13456286|NCT00191100|26955310|FG000|Overall Study|Protocol Violation|1|||
13456287|NCT00191100|26955311|FG001|Overall Study|Protocol Violation|1|||
13456288|NCT00191100|26955310|FG000|Overall Study|Death from Other Cause|1|||
13456289|NCT00191100|26955311|FG001|Overall Study|Death from Other Cause|0|||
13456290|NCT00191100|26955310|FG000|Overall Study|Reason Not Specified|0|||
13456291|NCT00191100|26955311|FG001|Overall Study|Reason Not Specified|1|||
13456292|NCT00189540|26955334|FG000|Overall Study|Withdrawal by Subject|3|||
13456293|NCT00189540|26955335|FG001|Overall Study|Withdrawal by Subject|0|||
13456294|NCT00189540|26955334|FG000|Overall Study|Death|4|||
13456295|NCT00189540|26955335|FG001|Overall Study|Death|1|||
13456296|NCT00189488|26955362|FG000|Overall Study|Ineligibility determined|1|||
13456297|NCT00189488|26955363|FG001|Overall Study|Ineligibility determined|0|||
13456298|NCT00189488|26955362|FG000|Overall Study|Protocol deviation|2|||
13456299|NCT00189488|26955363|FG001|Overall Study|Protocol deviation|1|||
13456300|NCT00189488|26955362|FG000|Overall Study|Adverse Event|2|||
13456301|NCT00189488|26955363|FG001|Overall Study|Adverse Event|1|||
13456302|NCT00189488|26955362|FG000|Overall Study|Withdrawal by Subject|2|||
13456303|NCT00189488|26955363|FG001|Overall Study|Withdrawal by Subject|6|||
13456304|NCT00189488|26955362|FG000|Overall Study|Disease progression|2|||
13456305|NCT00189488|26955363|FG001|Overall Study|Disease progression|4|||
13456306|NCT00189488|26955362|FG000|Overall Study|Administrative Decision|0|||
13456307|NCT00189488|26955363|FG001|Overall Study|Administrative Decision|2|||
13456308|NCT00189488|26955362|FG000|Overall Study|Death|5|||
13456309|NCT00189488|26955363|FG001|Overall Study|Death|8|||
13456310|NCT00189488|26955362|FG000|Overall Study|Other|1|||
13456311|NCT00189488|26955363|FG001|Overall Study|Other|0|||
13456312|NCT00189462|26955376|FG000|Overall Study|Lack of Efficacy|5|||
13456313|NCT00189462|26955377|FG001|Overall Study|Lack of Efficacy|1|||
13456314|NCT00189462|26955376|FG000|Overall Study|Lost to Follow-up|18|||
13456315|NCT00189462|26955377|FG001|Overall Study|Lost to Follow-up|20|||
13456316|NCT00189423|26955406|FG000|Overall Study|Death|746|||
13456317|NCT00189423|26955407|FG001|Overall Study|Death|747|||
13456318|NCT00189423|26955406|FG000|Overall Study|Withdrawal by Subject|9|||
13456319|NCT00189423|26955407|FG001|Overall Study|Withdrawal by Subject|9|||
13456320|NCT00189423|26955406|FG000|Overall Study|Lost to Follow-up|10|||
13456321|NCT00189423|26955407|FG001|Overall Study|Lost to Follow-up|10|||
13456322|NCT00189306|26955414|FG000|Treatment Period|Withdrawal by Subject|2|||
13456323|NCT00189306|26955414|FG000|Treatment Period|Adverse Event|2|||
13456324|NCT00189306|26955414|FG000|Treatment Period|Protocol Violation|1|||
13456325|NCT00189306|26955414|FG000|Posttreatment Period|Death|1|||
13456326|NCT00189306|26955414|FG000|Posttreatment Period|Withdrawal by Subject|2|||
13456327|NCT00189306|26955414|FG000|Posttreatment Period|Noncompliance|1|||
13456328|NCT00189306|26955414|FG000|Posttreatment Period|Target lesion excised|1|||
13456329|NCT00189306|26955414|FG000|Posttreatment Period|Protocol Violation|1|||
13456330|NCT00189306|26955414|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5|||
13456331|NCT00189306|26955414|FG000|Posttreatment Period|Local skin reaction/sign|1|||
13456332|NCT00189306|26955414|FG000|Long-Term Follow-up|Adverse Event|2|||
13456333|NCT00189306|26955414|FG000|Long-Term Follow-up|Death|4|||
13456334|NCT00189306|26955414|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
13456335|NCT00189306|26955414|FG000|Long-Term Follow-up|Intercurrent disease|2|||
13456336|NCT00189306|26955414|FG000|Long-Term Follow-up|Lost to Follow-up|9|||
13456337|NCT00189306|26955414|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20|||
13456338|NCT00189202|26955425|FG000|Overall Study|Physician Decision|5|||
13456339|NCT00187889|26955440|FG000|Overall Study|Withdrawal by Subject|6|||
13456340|NCT00187889|26955441|FG001|Overall Study|Withdrawal by Subject|4|||
13456341|NCT00187486|26955448|FG000|Overall Study|Protocol Violation|1|||
13456342|NCT00187278|26955493|FG000|Overall Study|Protocol Violation|10|||
13456343|NCT00187278|26955494|FG001|Overall Study|Protocol Violation|13|||
13456344|NCT00187135|26955533|FG000|Visit One|Withdrawal by Subject|1|||
13456345|NCT00187135|26955534|FG001|Visit One|Withdrawal by Subject|0|||
13456346|NCT00187135|26955535|FG002|Visit One|Withdrawal by Subject|0|||
13456347|NCT00187135|26955536|FG003|Visit One|Withdrawal by Subject|0|||
13456348|NCT00187135|26955537|FG004|Visit One|Withdrawal by Subject|0|||
13456349|NCT00187135|26955538|FG005|Visit One|Withdrawal by Subject|1|||
13456350|NCT00187135|26955533|FG000|Visit One|Physician Decision|3|||
13456351|NCT00187135|26955534|FG001|Visit One|Physician Decision|1|||
13456352|NCT00187135|26955535|FG002|Visit One|Physician Decision|0|||
13456353|NCT00187135|26955536|FG003|Visit One|Physician Decision|0|||
13456354|NCT00187135|26955537|FG004|Visit One|Physician Decision|0|||
13456355|NCT00187135|26955538|FG005|Visit One|Physician Decision|1|||
13456356|NCT00187135|26955533|FG000|Visit Two|Death|0|||
13456357|NCT00187135|26955534|FG001|Visit Two|Death|0|||
13456358|NCT00187135|26955535|FG002|Visit Two|Death|0|||
13456359|NCT00187135|26955536|FG003|Visit Two|Death|1|||
13456360|NCT00187135|26955537|FG004|Visit Two|Death|0|||
13456361|NCT00187135|26955538|FG005|Visit Two|Death|1|||
13456362|NCT00187135|26955533|FG000|Visit Two|Physician Decision|1|||
13456363|NCT00187135|26955534|FG001|Visit Two|Physician Decision|0|||
13456364|NCT00187135|26955535|FG002|Visit Two|Physician Decision|0|||
13456365|NCT00187135|26955536|FG003|Visit Two|Physician Decision|0|||
13456366|NCT00187135|26955537|FG004|Visit Two|Physician Decision|0|||
13456367|NCT00187135|26955538|FG005|Visit Two|Physician Decision|0|||
13456368|NCT00187135|26955533|FG000|Visit Two|Withdrawal by Subject|1|||
13456369|NCT00187135|26955534|FG001|Visit Two|Withdrawal by Subject|1|||
13456370|NCT00187135|26955535|FG002|Visit Two|Withdrawal by Subject|1|||
13456371|NCT00187135|26955536|FG003|Visit Two|Withdrawal by Subject|0|||
13456372|NCT00187135|26955537|FG004|Visit Two|Withdrawal by Subject|1|||
13456373|NCT00187135|26955538|FG005|Visit Two|Withdrawal by Subject|1|||
13456374|NCT00187135|26955533|FG000|Visit Two|Study Discontinued|3|||
13456375|NCT00187135|26955534|FG001|Visit Two|Study Discontinued|2|||
13456376|NCT00187135|26955535|FG002|Visit Two|Study Discontinued|1|||
13456377|NCT00187135|26955536|FG003|Visit Two|Study Discontinued|7|||
13456378|NCT00187135|26955537|FG004|Visit Two|Study Discontinued|5|||
13456379|NCT00187135|26955538|FG005|Visit Two|Study Discontinued|6|||
13456380|NCT00187135|26955533|FG000|Visit Three|Death|0|||
13456381|NCT00187135|26955534|FG001|Visit Three|Death|0|||
13456382|NCT00187135|26955535|FG002|Visit Three|Death|1|||
13456383|NCT00187135|26955536|FG003|Visit Three|Death|0|||
13456384|NCT00187135|26955537|FG004|Visit Three|Death|1|||
13456385|NCT00187135|26955538|FG005|Visit Three|Death|0|||
13456386|NCT00187135|26955533|FG000|Visit Three|Withdrawal by Subject|0|||
13456387|NCT00187135|26955534|FG001|Visit Three|Withdrawal by Subject|1|||
13456388|NCT00187135|26955535|FG002|Visit Three|Withdrawal by Subject|1|||
13456389|NCT00187135|26955536|FG003|Visit Three|Withdrawal by Subject|2|||
13456390|NCT00187135|26955537|FG004|Visit Three|Withdrawal by Subject|0|||
13456391|NCT00187135|26955538|FG005|Visit Three|Withdrawal by Subject|0|||
13456392|NCT00187135|26955533|FG000|Visit Three|Study Discontinued|7|||
13456393|NCT00187135|26955534|FG001|Visit Three|Study Discontinued|6|||
13456394|NCT00187135|26955535|FG002|Visit Three|Study Discontinued|7|||
13456395|NCT00187135|26955536|FG003|Visit Three|Study Discontinued|7|||
13456396|NCT00187135|26955537|FG004|Visit Three|Study Discontinued|7|||
13456397|NCT00187135|26955538|FG005|Visit Three|Study Discontinued|6|||
13456398|NCT00187096|26955583|FG000|Overall Study|unacceptable toxicity|0|||
13456399|NCT00187096|26955584|FG001|Overall Study|unacceptable toxicity|0|||
13456400|NCT00187096|26955585|FG002|Overall Study|unacceptable toxicity|1|||
13456401|NCT00186901|26955632|FG000|Overall Study|Pregnancy|6|||
13456402|NCT00186901|26955633|FG001|Overall Study|Pregnancy|3|||
13456403|NCT00186901|26955634|FG002|Overall Study|Pregnancy|0|||
13456404|NCT00186901|26955632|FG000|Overall Study|Lost to Follow-up|6|||
13456405|NCT00186901|26955633|FG001|Overall Study|Lost to Follow-up|3|||
13456406|NCT00186901|26955634|FG002|Overall Study|Lost to Follow-up|0|||
13456407|NCT00186901|26955632|FG000|Overall Study|Bone Mineral Density dropped > 5%|9|||
13456408|NCT00186901|26955633|FG001|Overall Study|Bone Mineral Density dropped > 5%|7|||
13456409|NCT00186901|26955634|FG002|Overall Study|Bone Mineral Density dropped > 5%|0|||
13456410|NCT00186901|26955632|FG000|Overall Study|ALL relapse or second malignancy|1|||
13456411|NCT00186901|26955633|FG001|Overall Study|ALL relapse or second malignancy|2|||
13456412|NCT00186901|26955634|FG002|Overall Study|ALL relapse or second malignancy|0|||
13456413|NCT00186901|26955632|FG000|Overall Study|Withdrawal by Subject|4|||
13456414|NCT00186901|26955633|FG001|Overall Study|Withdrawal by Subject|5|||
13456415|NCT00186901|26955634|FG002|Overall Study|Withdrawal by Subject|0|||
13456416|NCT00186901|26955632|FG000|Overall Study|Open label|3|||
13456417|NCT00186901|26955633|FG001|Overall Study|Open label|2|||
13456418|NCT00186901|26955634|FG002|Overall Study|Open label|0|||
13456419|NCT00186901|26955632|FG000|Overall Study|Limited adherence to study requirements|20|||
13456420|NCT00186901|26955633|FG001|Overall Study|Limited adherence to study requirements|23|||
13456421|NCT00186901|26955634|FG002|Overall Study|Limited adherence to study requirements|0|||
13456422|NCT00186901|26955632|FG000|Overall Study|Bone Mineral Density > 0|0|||
13456423|NCT00186901|26955633|FG001|Overall Study|Bone Mineral Density > 0|0|||
13456424|NCT00186901|26955634|FG002|Overall Study|Bone Mineral Density > 0|149|||
13456425|NCT00186628|26955644|FG000|Overall Study|Death|2|||
13456426|NCT00186628|26955644|FG000|Overall Study|Withdrawal by subject (before treatment)|1|||
13456427|NCT00186537|26955668|FG000|Overall Study|Withdrawal by Subject|4|||
13456428|NCT00186537|26955669|FG001|Overall Study|Withdrawal by Subject|0|||
13456429|NCT00186537|26955670|FG002|Overall Study|Withdrawal by Subject|3|||
13456430|NCT00186537|26955668|FG000|Overall Study|ALT > 1.5 x ULN|3|||
13456431|NCT00186537|26955669|FG001|Overall Study|ALT > 1.5 x ULN|0|||
13456432|NCT00186537|26955670|FG002|Overall Study|ALT > 1.5 x ULN|0|||
13456433|NCT00186485|26955678|FG000|Overall Study|Lost to Follow-up|3|||
13456434|NCT00186186|26955685|FG000|Overall Study|Lack of Efficacy|3|||
13456435|NCT00186186|26955685|FG000|Overall Study|Withdrawal by Subject|3|||
13456436|NCT00186186|26955685|FG000|Overall Study|Not reported as to reason|2|||
13456437|NCT00186121|26955697|FG000|Overall Study|Subject withdrawal (no treatment)|1|||
13456438|NCT00186121|26955697|FG000|Overall Study|Underwent oophorectomy (no treatment)|1|||
13456439|NCT00186121|26955697|FG000|Overall Study|Not eligible (no treatment)|1|||
13456440|NCT00186043|26955714|FG000|Overall Study|Lack of Efficacy|1|||
13456441|NCT00186043|26955715|FG001|Overall Study|Lack of Efficacy|3|||
13456442|NCT00186043|26955714|FG000|Overall Study|Lost to Follow-up|4|||
13456443|NCT00186043|26955715|FG001|Overall Study|Lost to Follow-up|6|||
13456444|NCT00186043|26955714|FG000|Overall Study|Withdrawal by Subject|1|||
13456445|NCT00186043|26955715|FG001|Overall Study|Withdrawal by Subject|0|||
13456446|NCT00186043|26955714|FG000|Overall Study|Adverse Event|7|||
13456447|NCT00186043|26955715|FG001|Overall Study|Adverse Event|3|||
13456448|NCT00186043|26955714|FG000|Overall Study|Protocol Violation|2|||
13456449|NCT00186043|26955715|FG001|Overall Study|Protocol Violation|1|||
13456450|NCT00185965|26955728|FG000|Overall Study|Adverse Event|0|||
13456451|NCT00185965|26955729|FG001|Overall Study|Adverse Event|1|||
13456452|NCT00185731|26955737|FG000|Overall Study|Withdrawal by Subject|1|||
13456453|NCT00185731|26955737|FG000|Overall Study|Not Eligible|1|||
13456454|NCT00185640|26955748|FG000|Overall Study|Not Eligible|4|||
13456455|NCT00185640|26955748|FG000|Overall Study|Withdrawal by Subject|3|||
13456456|NCT00185640|26955748|FG000|Overall Study|Death|138|||
13456457|NCT00185614|26955758|FG000|Inter-treatment Period|Physician Decision|1|||
13456458|NCT00185614|26955758|FG000|Inter-treatment Period|Relapse|2|||
13456459|NCT00185614|26955758|FG000|Inter-treatment Period|Lack of allogenic donor|1|||
13456460|NCT00185588|26955785|FG000|Overall Study|Adverse Event|3|||
13456461|NCT00185588|26955786|FG001|Overall Study|Adverse Event|1|||
13456462|NCT00185588|26955787|FG002|Overall Study|Adverse Event|4|||
13456463|NCT00185588|26955788|FG003|Overall Study|Adverse Event|2|||
13456464|NCT00185588|26955785|FG000|Overall Study|Lost to Follow-up|0|||
13456465|NCT00185588|26955786|FG001|Overall Study|Lost to Follow-up|0|||
13456466|NCT00185588|26955787|FG002|Overall Study|Lost to Follow-up|1|||
13456467|NCT00185588|26955788|FG003|Overall Study|Lost to Follow-up|2|||
13456468|NCT00185588|26955785|FG000|Overall Study|Withdrawal by Subject|0|||
13456469|NCT00185588|26955786|FG001|Overall Study|Withdrawal by Subject|1|||
13456470|NCT00185588|26955787|FG002|Overall Study|Withdrawal by Subject|0|||
13456471|NCT00185588|26955788|FG003|Overall Study|Withdrawal by Subject|0|||
13456472|NCT00185588|26955785|FG000|Overall Study|Physician Decision|0|||
13456473|NCT00185588|26955786|FG001|Overall Study|Physician Decision|0|||
13456474|NCT00185588|26955787|FG002|Overall Study|Physician Decision|1|||
13456475|NCT00185588|26955788|FG003|Overall Study|Physician Decision|0|||
13456476|NCT00185458|26955850|FG000|Contraception Phase|Adverse Event|37|||
13456477|NCT00185458|26955850|FG000|Contraception Phase|Lost to Follow-up|10|||
13456478|NCT00185458|26955850|FG000|Contraception Phase|Protocol Violation|2|||
13456479|NCT00185458|26955850|FG000|Contraception Phase|Physician Decision|2|||
13456480|NCT00185458|26955850|FG000|Contraception Phase|Withdrawal by Subject|7|||
13456481|NCT00185458|26955850|FG000|HRT Phase|Adverse Event|18|||
13456482|NCT00185458|26955850|FG000|HRT Phase|Lost to Follow-up|4|||
13456483|NCT00185458|26955850|FG000|HRT Phase|Protocol Violation|2|||
13456484|NCT00185458|26955850|FG000|HRT Phase|Withdrawal by Subject|3|||
13456485|NCT00185380|26955886|FG000|Overall Study|Adverse Event|41|||
13456486|NCT00185380|26955887|FG001|Overall Study|Adverse Event|43|||
13456487|NCT00185380|26955888|FG002|Overall Study|Adverse Event|48|||
13456488|NCT00185380|26955886|FG000|Overall Study|Lost to Follow-up|0|||
13456489|NCT00185380|26955887|FG001|Overall Study|Lost to Follow-up|4|||
13456490|NCT00185380|26955888|FG002|Overall Study|Lost to Follow-up|3|||
13456491|NCT00185380|26955886|FG000|Overall Study|Pregnancy|1|||
13456492|NCT00185380|26955887|FG001|Overall Study|Pregnancy|4|||
13456493|NCT00185380|26955888|FG002|Overall Study|Pregnancy|0|||
13456494|NCT00185380|26955886|FG000|Overall Study|Protocol Violation|2|||
13456495|NCT00185380|26955887|FG001|Overall Study|Protocol Violation|2|||
13456496|NCT00185380|26955888|FG002|Overall Study|Protocol Violation|1|||
13456497|NCT00185380|26955886|FG000|Overall Study|Withdrawal by Subject|1|||
13456498|NCT00185380|26955887|FG001|Overall Study|Withdrawal by Subject|2|||
13456499|NCT00185380|26955888|FG002|Overall Study|Withdrawal by Subject|0|||
13456500|NCT00185380|26955886|FG000|Overall Study|Failed insertion|1|||
13456501|NCT00185380|26955887|FG001|Overall Study|Failed insertion|1|||
13456502|NCT00185380|26955888|FG002|Overall Study|Failed insertion|2|||
13456503|NCT00185380|26955886|FG000|Overall Study|Planned pregnancy|9|||
13456504|NCT00185380|26955887|FG001|Overall Study|Planned pregnancy|12|||
13456505|NCT00185380|26955888|FG002|Overall Study|Planned pregnancy|12|||
13456506|NCT00185380|26955886|FG000|Overall Study|No need for contraception|3|||
13456507|NCT00185380|26955887|FG001|Overall Study|No need for contraception|3|||
13456508|NCT00185380|26955888|FG002|Overall Study|No need for contraception|3|||
13456509|NCT00185380|26955886|FG000|Overall Study|Could not attend visits|2|||
13456510|NCT00185380|26955887|FG001|Overall Study|Could not attend visits|0|||
13456511|NCT00185380|26955888|FG002|Overall Study|Could not attend visits|4|||
13456512|NCT00185380|26955886|FG000|Overall Study|personal reason|6|||
13456513|NCT00185380|26955887|FG001|Overall Study|personal reason|1|||
13456514|NCT00185380|26955888|FG002|Overall Study|personal reason|1|||
13456515|NCT00185211|26955920|FG000|Placebo-controlled Study (92012)|Adverse Event|8|||
13456516|NCT00185211|26955921|FG001|Placebo-controlled Study (92012)|Adverse Event|0|||
13456517|NCT00185211|26955920|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3|||
13456518|NCT00185211|26955921|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2|||
13456519|NCT00185211|26955920|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9|||
13456520|NCT00185211|26955921|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7|||
13456521|NCT00185211|26955920|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0|||
13456522|NCT00185211|26955921|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1|||
13456523|NCT00185211|26955920|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1|||
13456524|NCT00185211|26955921|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0|||
13456525|NCT00185211|26955920|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5|||
13456526|NCT00185211|26955921|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6|||
13456527|NCT00185211|26955920|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1|||
13456528|NCT00185211|26955921|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0|||
13456529|NCT00185211|26955920|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6|||
13456530|NCT00185211|26955921|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4|||
13456531|NCT00185211|26955920|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1|||
13456532|NCT00185211|26955921|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0|||
13456533|NCT00185211|26955920|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0|||
13456534|NCT00185211|26955921|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1|||
13456535|NCT00185211|26955920|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13|||
13456536|NCT00185211|26955921|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21|||
13456537|NCT00185211|26955920|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0|||
13456538|NCT00185211|26955921|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2|||
13456539|NCT00184600|26955981|FG000|Overall Study|Adverse Event|9|||
13456540|NCT00184600|26955982|FG001|Overall Study|Adverse Event|0|||
13456541|NCT00184600|26955983|FG002|Overall Study|Adverse Event|5|||
13456542|NCT00184600|26955981|FG000|Overall Study|Death|3|||
13456543|NCT00184600|26955982|FG001|Overall Study|Death|9|||
13456544|NCT00184600|26955983|FG002|Overall Study|Death|7|||
13456545|NCT00184600|26955981|FG000|Overall Study|Lack of Efficacy|3|||
13456546|NCT00184600|26955982|FG001|Overall Study|Lack of Efficacy|1|||
13456547|NCT00184600|26955983|FG002|Overall Study|Lack of Efficacy|3|||
13456548|NCT00184600|26955981|FG000|Overall Study|Lost to Follow-up|4|||
13456549|NCT00184600|26955982|FG001|Overall Study|Lost to Follow-up|6|||
13456550|NCT00184600|26955983|FG002|Overall Study|Lost to Follow-up|1|||
13456551|NCT00184600|26955981|FG000|Overall Study|Protocol Violation|2|||
13456552|NCT00184600|26955982|FG001|Overall Study|Protocol Violation|2|||
13456553|NCT00184600|26955983|FG002|Overall Study|Protocol Violation|3|||
13456554|NCT00184600|26955981|FG000|Overall Study|Withdrawal by Subject|20|||
13456555|NCT00184600|26955982|FG001|Overall Study|Withdrawal by Subject|28|||
13456556|NCT00184600|26955983|FG002|Overall Study|Withdrawal by Subject|12|||
13456557|NCT00184600|26955981|FG000|Overall Study|Unclassified|4|||
13456558|NCT00184600|26955982|FG001|Overall Study|Unclassified|5|||
13456559|NCT00184600|26955983|FG002|Overall Study|Unclassified|3|||
13456560|NCT00184093|26955990|FG000|Overall Study|Adverse Event|3|||
13456561|NCT00184093|26955990|FG000|Overall Study|Lost to Follow-up|3|||
13456562|NCT00184093|26955990|FG000|Overall Study|Physician Decision|1|||
13456563|NCT00184093|26955990|FG000|Overall Study|Withdrawal by Subject|2|||
13456564|NCT00184054|26955997|FG000|Overall Study|Adverse Event|1|||
13456565|NCT00184028|26956004|FG000|Overall Study|Death|1|||
13456566|NCT00184028|26956004|FG000|Overall Study|Lack of Efficacy|4|||
13456567|NCT00184028|26956004|FG000|Overall Study|Adverse Event|2|||
13456568|NCT00184028|26956004|FG000|Overall Study|Withdrawal by Subject|1|||
13456569|NCT00184028|26956004|FG000|Overall Study|Non-compliance|2|||
13456570|NCT00184002|26956011|FG000|Overall Study|Adverse Event|9|||
13456571|NCT00184002|26956011|FG000|Overall Study|Death|3|||
13456572|NCT00184002|26956011|FG000|Overall Study|Physician Decision|1|||
13456573|NCT00184002|26956011|FG000|Overall Study|Withdrawal by Subject|4|||
13456574|NCT00183872|26956018|FG000|Overall Study|Death|3|||
13456575|NCT00183872|26956018|FG000|Overall Study|Adverse Event|9|||
13456576|NCT00183872|26956018|FG000|Overall Study|Withdrawal by Subject|2|||
13456577|NCT00183872|26956018|FG000|Overall Study|Drug delayed more than 28 days|2|||
13456578|NCT00183625|26956035|FG000|Overall Study|Withdrawal by Subject|18|||
13456579|NCT00183625|26956036|FG001|Overall Study|Withdrawal by Subject|18|||
13456580|NCT00183625|26956037|FG002|Overall Study|Withdrawal by Subject|19|||
13456581|NCT00183625|26956038|FG003|Overall Study|Withdrawal by Subject|14|||
13456582|NCT00183430|26956055|FG000|Overall Study|Adverse Event|1|||
13456583|NCT00183430|26956056|FG001|Overall Study|Adverse Event|0|||
13456584|NCT00183430|26956055|FG000|Overall Study|Lost to Follow-up|3|||
13456585|NCT00183430|26956056|FG001|Overall Study|Lost to Follow-up|0|||
13456586|NCT00183430|26956055|FG000|Overall Study|did not meet inclusion criteria|1|||
13456587|NCT00183430|26956056|FG001|Overall Study|did not meet inclusion criteria|0|||
13456588|NCT00183430|26956055|FG000|Overall Study|Withdrawal by Subject|1|||
13456589|NCT00183430|26956056|FG001|Overall Study|Withdrawal by Subject|0|||
13456590|NCT00183391|26956121|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13|||
13456591|NCT00183391|26956122|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14|||
13456592|NCT00183391|26956121|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4|||
13456593|NCT00183391|26956122|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2|||
13456594|NCT00183274|26956144|FG000|Phase 1: Open-Label|Adverse Event|31|||
13456595|NCT00183274|26956145|FG001|Phase 1: Open-Label|Adverse Event|0|||
13456596|NCT00183274|26956146|FG002|Phase 1: Open-Label|Adverse Event|0|||
13456597|NCT00183274|26956147|FG003|Phase 1: Open-Label|Adverse Event|0|||
13456598|NCT00183274|26956148|FG004|Phase 1: Open-Label|Adverse Event|0|||
13456599|NCT00183274|26956149|FG005|Phase 1: Open-Label|Adverse Event|0|||
13456600|NCT00183274|26956144|FG000|Phase 1: Open-Label|Lack of Efficacy|13|||
13456601|NCT00183274|26956145|FG001|Phase 1: Open-Label|Lack of Efficacy|0|||
13456602|NCT00183274|26956146|FG002|Phase 1: Open-Label|Lack of Efficacy|0|||
13456603|NCT00183274|26956147|FG003|Phase 1: Open-Label|Lack of Efficacy|0|||
13456604|NCT00183274|26956148|FG004|Phase 1: Open-Label|Lack of Efficacy|0|||
13456605|NCT00183274|26956149|FG005|Phase 1: Open-Label|Lack of Efficacy|0|||
13456606|NCT00183274|26956144|FG000|Phase 1: Open-Label|Protocol Violation|11|||
13456607|NCT00183274|26956145|FG001|Phase 1: Open-Label|Protocol Violation|0|||
13456608|NCT00183274|26956146|FG002|Phase 1: Open-Label|Protocol Violation|0|||
13456609|NCT00183274|26956147|FG003|Phase 1: Open-Label|Protocol Violation|0|||
13456610|NCT00183274|26956148|FG004|Phase 1: Open-Label|Protocol Violation|0|||
13456611|NCT00183274|26956149|FG005|Phase 1: Open-Label|Protocol Violation|0|||
13456612|NCT00183274|26956144|FG000|Phase 1: Open-Label|Withdrawal by Subject|13|||
13456613|NCT00183274|26956145|FG001|Phase 1: Open-Label|Withdrawal by Subject|0|||
13456614|NCT00183274|26956146|FG002|Phase 1: Open-Label|Withdrawal by Subject|0|||
13456615|NCT00183274|26956147|FG003|Phase 1: Open-Label|Withdrawal by Subject|0|||
13456616|NCT00183274|26956148|FG004|Phase 1: Open-Label|Withdrawal by Subject|0|||
13456617|NCT00183274|26956149|FG005|Phase 1: Open-Label|Withdrawal by Subject|0|||
13456618|NCT00183274|26956144|FG000|Phase 1: Open-Label|Lost to Follow-up|33|||
13456619|NCT00183274|26956145|FG001|Phase 1: Open-Label|Lost to Follow-up|0|||
13456620|NCT00183274|26956146|FG002|Phase 1: Open-Label|Lost to Follow-up|0|||
13456621|NCT00183274|26956147|FG003|Phase 1: Open-Label|Lost to Follow-up|0|||
13456622|NCT00183274|26956148|FG004|Phase 1: Open-Label|Lost to Follow-up|0|||
13456623|NCT00183274|26956149|FG005|Phase 1: Open-Label|Lost to Follow-up|0|||
13456624|NCT00183274|26956144|FG000|Phase 1: Open-Label|Other|9|||
13456625|NCT00183274|26956145|FG001|Phase 1: Open-Label|Other|0|||
13456626|NCT00183274|26956146|FG002|Phase 1: Open-Label|Other|0|||
13456627|NCT00183274|26956147|FG003|Phase 1: Open-Label|Other|0|||
13456628|NCT00183274|26956148|FG004|Phase 1: Open-Label|Other|0|||
13456629|NCT00183274|26956149|FG005|Phase 1: Open-Label|Other|0|||
13456630|NCT00183274|26956144|FG000|Phase 2: Double-Blind|Relapsed|0|||
13456631|NCT00183274|26956145|FG001|Phase 2: Double-Blind|Relapsed|8|||
13456632|NCT00183274|26956146|FG002|Phase 2: Double-Blind|Relapsed|29|||
13456633|NCT00183274|26956147|FG003|Phase 2: Double-Blind|Relapsed|0|||
13456634|NCT00183274|26956148|FG004|Phase 2: Double-Blind|Relapsed|0|||
13456635|NCT00183274|26956149|FG005|Phase 2: Double-Blind|Relapsed|0|||
13456636|NCT00183274|26956144|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0|||
13456637|NCT00183274|26956145|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18|||
13456638|NCT00183274|26956146|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14|||
13456639|NCT00183274|26956147|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0|||
13456640|NCT00183274|26956148|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0|||
13456641|NCT00183274|26956149|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0|||
13456642|NCT00183274|26956144|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0|||
13456643|NCT00183274|26956145|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0|||
13456644|NCT00183274|26956146|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0|||
13456645|NCT00183274|26956147|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1|||
13456646|NCT00183274|26956148|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9|||
13456647|NCT00183274|26956149|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2|||
13456648|NCT00183274|26956144|FG000|Phase 3: Double-Blind|Relapsed|0|||
13456649|NCT00183274|26956145|FG001|Phase 3: Double-Blind|Relapsed|0|||
13456650|NCT00183274|26956146|FG002|Phase 3: Double-Blind|Relapsed|0|||
13456651|NCT00183274|26956147|FG003|Phase 3: Double-Blind|Relapsed|1|||
13456652|NCT00183274|26956148|FG004|Phase 3: Double-Blind|Relapsed|11|||
13456653|NCT00183274|26956149|FG005|Phase 3: Double-Blind|Relapsed|2|||
13456654|NCT00183248|26956174|FG000|Overall Study|Lost to Follow-up|0|||
13456655|NCT00183248|26956175|FG001|Overall Study|Lost to Follow-up|1|||
13456656|NCT00183248|26956174|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1|||
13456657|NCT00183248|26956175|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0|||
13456658|NCT00183196|26956193|FG000|Overall Study|Withdrawal by Subject|18|||
13456659|NCT00183196|26956194|FG001|Overall Study|Withdrawal by Subject|11|||
13456660|NCT00183196|26956195|FG002|Overall Study|Withdrawal by Subject|13|||
13456661|NCT00183196|26956193|FG000|Overall Study|Adverse Event|1|||
13456662|NCT00183196|26956194|FG001|Overall Study|Adverse Event|2|||
13456663|NCT00183196|26956195|FG002|Overall Study|Adverse Event|2|||
13456664|NCT00183196|26956193|FG000|Overall Study|Legal event|1|||
13456665|NCT00183196|26956194|FG001|Overall Study|Legal event|1|||
13456666|NCT00183196|26956195|FG002|Overall Study|Legal event|1|||
13456667|NCT00183196|26956193|FG000|Overall Study|Required more intensive care|0|||
13456668|NCT00183196|26956194|FG001|Overall Study|Required more intensive care|1|||
13456669|NCT00183196|26956195|FG002|Overall Study|Required more intensive care|2|||
13456670|NCT00183170|26956216|FG000|First Intervention|Did not complete study|1|||
13456671|NCT00183170|26956217|FG001|First Intervention|Did not complete study|0|||
13456672|NCT00183170|26956216|FG000|First Intervention|Did not meet targeted BrAC|1|||
13456673|NCT00183170|26956217|FG001|First Intervention|Did not meet targeted BrAC|0|||
13456674|NCT00183170|26956216|FG000|Washout 1 Week|Did not complete study|6|||
13456675|NCT00183170|26956217|FG001|Washout 1 Week|Did not complete study|8|||
13456676|NCT00183170|26956216|FG000|Second Intervention|Did not complete study|1|||
13456677|NCT00183170|26956217|FG001|Second Intervention|Did not complete study|0|||
13456678|NCT00183170|26956216|FG000|Second Intervention|Did not meet targeted BrAC|0|||
13456679|NCT00183170|26956217|FG001|Second Intervention|Did not meet targeted BrAC|2|||
13456680|NCT00182689|26956234|FG000|Overall Study|Adverse Event|8|||
13456681|NCT00182689|26956235|FG001|Overall Study|Adverse Event|11|||
13456682|NCT00182689|26956234|FG000|Overall Study|Withdrawal by Subject|2|||
13456683|NCT00182689|26956235|FG001|Overall Study|Withdrawal by Subject|2|||
13456684|NCT00182689|26956234|FG000|Overall Study|Progression|27|||
13456685|NCT00182689|26956235|FG001|Overall Study|Progression|29|||
13456686|NCT00182689|26956234|FG000|Overall Study|Death|1|||
13456687|NCT00182689|26956235|FG001|Overall Study|Death|0|||
13456688|NCT00182689|26956234|FG000|Overall Study|not protocol specified|0|||
13456689|NCT00182689|26956235|FG001|Overall Study|not protocol specified|3|||
13456690|NCT00182689|26956234|FG000|Overall Study|Ineligible|1|||
13456691|NCT00182689|26956235|FG001|Overall Study|Ineligible|4|||
13456692|NCT00182689|26956234|FG000|Overall Study|Never received treatment|1|||
13456693|NCT00182689|26956235|FG001|Overall Study|Never received treatment|0|||
13456694|NCT00182637|26956243|FG000|Overall Study|Adverse Event|2|||
13456695|NCT00182637|26956243|FG000|Overall Study|Disease Progression|1|||
13456696|NCT00182325|26956274|FG000|Overall Study|Lost to Follow-up|7|||
13456697|NCT00182325|26956275|FG001|Overall Study|Lost to Follow-up|7|||
13456698|NCT00182325|26956274|FG000|Overall Study|Miscarriage|5|||
13456699|NCT00182325|26956275|FG001|Overall Study|Miscarriage|3|||
13456700|NCT00182325|26956274|FG000|Overall Study|Did not complete survey|22|||
13456701|NCT00182325|26956275|FG001|Overall Study|Did not complete survey|43|||
13456702|NCT00182091|26956302|FG000|Overall Study|Withdrawal by Subject|1|||
13456703|NCT00182091|26956303|FG001|Overall Study|Withdrawal by Subject|0|||
13456704|NCT00182091|26956304|FG002|Overall Study|Withdrawal by Subject|0|||
13456705|NCT00182091|26956305|FG003|Overall Study|Withdrawal by Subject|0|||
13456706|NCT00182078|26956322|FG000|Overall Study|Withdrawal by Subject|1|||
13456707|NCT00182078|26956323|FG001|Overall Study|Withdrawal by Subject|0|||
13456708|NCT00181883|26956329|FG000|Overall Study|Lack of Efficacy|2|||
13456709|NCT00181883|26956329|FG000|Overall Study|Treatment Limiting AEs|3|||
13456710|NCT00181883|26956329|FG000|Overall Study|Withdrawal by Subject|4|||
13456711|NCT00181883|26956329|FG000|Overall Study|Lost to Follow-up|1|||
13456712|NCT00181844|26956335|FG000|Signed Consent|Withdrawal by Subject|5|||
13456713|NCT00181844|26956335|FG000|Signed Consent|Did not meet entrance criteria|7|||
13456714|NCT00181844|26956335|FG000|Exposed to Study Medication|Adverse Event|10|||
13456715|NCT00181844|26956335|FG000|Exposed to Study Medication|Lack of Efficacy|2|||
13456716|NCT00181844|26956335|FG000|Exposed to Study Medication|Non-compliance|2|||
13456717|NCT00181844|26956335|FG000|Exposed to Study Medication|Withdrawal by Subject|1|||
13456718|NCT00181844|26956335|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2|||
13456719|NCT00181766|26956342|FG000|Overall Study|Lost to Follow-up|6|||
13456720|NCT00181766|26956342|FG000|Overall Study|Adverse Event|4|||
13456721|NCT00181766|26956342|FG000|Overall Study|non-compliance|2|||
13456722|NCT00181155|26956353|FG000|Overall Study|Physician Decision|1|||
13456723|NCT00181155|26956354|FG001|Overall Study|Physician Decision|0|||
13456724|NCT00181155|26956353|FG000|Overall Study|Withdrawal by Subject|1|||
13456725|NCT00181155|26956354|FG001|Overall Study|Withdrawal by Subject|0|||
13456726|NCT00180713|26956375|FG000|Overall Study|Withdrawal by Subject|2|||
13456727|NCT00180713|26956376|FG001|Overall Study|Withdrawal by Subject|0|||
13456728|NCT00180713|26956375|FG000|Overall Study|Adverse Event|3|||
13456729|NCT00180713|26956376|FG001|Overall Study|Adverse Event|3|||
13456730|NCT00180674|26956386|FG000|Phase 1, Observation Period|Withdrawal by Subject|4|||
13456731|NCT00180674|26956386|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1|||
13456732|NCT00180479|26956485|FG000|Overall Study|Death|4|||
13456733|NCT00180479|26956486|FG001|Overall Study|Death|2|||
13456734|NCT00180479|26956485|FG000|Overall Study|Lost to Follow-up|9|||
13456735|NCT00180479|26956486|FG001|Overall Study|Lost to Follow-up|7|||
13456736|NCT00180479|26956485|FG000|Overall Study|Withdrawal by Subject|3|||
13456737|NCT00180479|26956486|FG001|Overall Study|Withdrawal by Subject|3|||
13456738|NCT00180479|26956485|FG000|Overall Study|Informed consent not signed|0|||
13456739|NCT00180479|26956486|FG001|Overall Study|Informed consent not signed|1|||
13456740|NCT00180414|26956505|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4|||
13456741|NCT00180414|26956506|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4|||
13456742|NCT00179621|26956568|FG000|Double-Blind Period|Lack of Therapeutic Effect|59|||
13456743|NCT00179621|26956569|FG001|Double-Blind Period|Lack of Therapeutic Effect|35|||
13456744|NCT00179621|26956570|FG002|Double-Blind Period|Lack of Therapeutic Effect|19|||
13456745|NCT00179621|26956571|FG003|Double-Blind Period|Lack of Therapeutic Effect|0|||
13456746|NCT00179621|26956568|FG000|Double-Blind Period|Adverse Event|2|||
13456747|NCT00179621|26956569|FG001|Double-Blind Period|Adverse Event|7|||
13456748|NCT00179621|26956570|FG002|Double-Blind Period|Adverse Event|4|||
13456749|NCT00179621|26956571|FG003|Double-Blind Period|Adverse Event|0|||
13456750|NCT00179621|26956568|FG000|Double-Blind Period|Withdrawal by Subject|2|||
13456751|NCT00179621|26956569|FG001|Double-Blind Period|Withdrawal by Subject|1|||
13456752|NCT00179621|26956570|FG002|Double-Blind Period|Withdrawal by Subject|3|||
13456753|NCT00179621|26956571|FG003|Double-Blind Period|Withdrawal by Subject|0|||
13456754|NCT00179621|26956568|FG000|Double-Blind Period|Death|0|||
13456755|NCT00179621|26956569|FG001|Double-Blind Period|Death|1|||
13456756|NCT00179621|26956570|FG002|Double-Blind Period|Death|2|||
13456757|NCT00179621|26956571|FG003|Double-Blind Period|Death|0|||
13456758|NCT00179621|26956568|FG000|Double-Blind Period|Protocol Violation|1|||
13456759|NCT00179621|26956569|FG001|Double-Blind Period|Protocol Violation|0|||
13456760|NCT00179621|26956570|FG002|Double-Blind Period|Protocol Violation|0|||
13456761|NCT00179621|26956571|FG003|Double-Blind Period|Protocol Violation|0|||
13456762|NCT00179621|26956568|FG000|Double-Blind Period|Other|0|||
13456763|NCT00179621|26956569|FG001|Double-Blind Period|Other|2|||
13456764|NCT00179621|26956570|FG002|Double-Blind Period|Other|2|||
13456765|NCT00179621|26956571|FG003|Double-Blind Period|Other|0|||
13456766|NCT00179621|26956568|FG000|Open-Label Period|Lack of Therapeutic Effect|0|||
13456767|NCT00179621|26956569|FG001|Open-Label Period|Lack of Therapeutic Effect|19|||
13456768|NCT00179621|26956570|FG002|Open-Label Period|Lack of Therapeutic Effect|19|||
13456769|NCT00179621|26956571|FG003|Open-Label Period|Lack of Therapeutic Effect|31|||
13456770|NCT00179621|26956568|FG000|Open-Label Period|Adverse Event|0|||
13456771|NCT00179621|26956569|FG001|Open-Label Period|Adverse Event|6|||
13456772|NCT00179621|26956570|FG002|Open-Label Period|Adverse Event|5|||
13456773|NCT00179621|26956571|FG003|Open-Label Period|Adverse Event|6|||
13456774|NCT00179621|26956568|FG000|Open-Label Period|Withdrawal by Subject|0|||
13456775|NCT00179621|26956569|FG001|Open-Label Period|Withdrawal by Subject|2|||
13456776|NCT00179621|26956570|FG002|Open-Label Period|Withdrawal by Subject|2|||
13456777|NCT00179621|26956571|FG003|Open-Label Period|Withdrawal by Subject|2|||
13456778|NCT00179621|26956568|FG000|Open-Label Period|Death|0|||
13456779|NCT00179621|26956569|FG001|Open-Label Period|Death|0|||
13456780|NCT00179621|26956570|FG002|Open-Label Period|Death|1|||
13456781|NCT00179621|26956571|FG003|Open-Label Period|Death|2|||
13456782|NCT00179621|26956568|FG000|Open-Label Period|Other|0|||
13456783|NCT00179621|26956569|FG001|Open-Label Period|Other|1|||
13456784|NCT00179621|26956570|FG002|Open-Label Period|Other|1|||
13456785|NCT00179621|26956571|FG003|Open-Label Period|Other|2|||
13456786|NCT00179309|26956586|FG000|Treatment|Toxicity|2|||
13456787|NCT00179309|26956587|FG001|Treatment|Toxicity|3|||
13456788|NCT00179309|26956586|FG000|Treatment|Withdrawal by Subject|1|||
13456789|NCT00179309|26956587|FG001|Treatment|Withdrawal by Subject|2|||
13456790|NCT00179309|26956586|FG000|Treatment|Allergy|1|||
13456791|NCT00179309|26956587|FG001|Treatment|Allergy|0|||
13456792|NCT00178685|26956608|FG000|Overall Study|Death|3|||
13456793|NCT00178685|26956609|FG001|Overall Study|Death|3|||
13456794|NCT00178685|26956610|FG002|Overall Study|Death|6|||
13456795|NCT00178685|26956608|FG000|Overall Study|Lost to Follow-up|100|||
13456796|NCT00178685|26956609|FG001|Overall Study|Lost to Follow-up|187|||
13456797|NCT00178685|26956610|FG002|Overall Study|Lost to Follow-up|183|||
13456798|NCT00178685|26956608|FG000|Overall Study|Withdrawal by Subject|8|||
13456799|NCT00178685|26956609|FG001|Overall Study|Withdrawal by Subject|14|||
13456800|NCT00178685|26956610|FG002|Overall Study|Withdrawal by Subject|7|||
13456801|NCT00177671|26956629|FG000|Overall Study|Withdrawal by Subject|5|||
13456802|NCT00177671|26956630|FG001|Overall Study|Withdrawal by Subject|6|||
13456803|NCT00177671|26956629|FG000|Overall Study|medical complications|2|||
13456804|NCT00177671|26956630|FG001|Overall Study|medical complications|0|||
13456805|NCT00177671|26956629|FG000|Overall Study|Adverse Event|6|||
13456806|NCT00177671|26956630|FG001|Overall Study|Adverse Event|0|||
13456807|NCT00177671|26956629|FG000|Overall Study|Physician Decision|12|||
13456808|NCT00177671|26956630|FG001|Overall Study|Physician Decision|8|||
13456809|NCT00175916|26956641|FG000|Overall Study|Death|19|||
13456810|NCT00175916|26956641|FG000|Overall Study|Adverse Event|81|||
13456811|NCT00175916|26956641|FG000|Overall Study|Lack of Efficacy|354|||
13456812|NCT00175916|26956641|FG000|Overall Study|Lost to Follow-up|17|||
13456813|NCT00175916|26956641|FG000|Overall Study|Subject Choice|98|||
13456814|NCT00175916|26956641|FG000|Overall Study|Lack of compliance|8|||
13456815|NCT00175916|26956641|FG000|Overall Study|Patient cannot record seizures|1|||
13456816|NCT00175916|26956641|FG000|Overall Study|Sponsor decision|17|||
13456817|NCT00175916|26956641|FG000|Overall Study|Vigabatrin intake|1|||
13456818|NCT00175916|26956641|FG000|Overall Study|Suicidal behaviour|1|||
13456819|NCT00175916|26956641|FG000|Overall Study|Withdrawal by Subject|1|||
13456820|NCT00175916|26956641|FG000|Overall Study|Seizure - free|4|||
13456821|NCT00175916|26956641|FG000|Overall Study|Administrative reason|1|||
13456822|NCT00175916|26956641|FG000|Overall Study|Pregnancy|1|||
13456823|NCT00175916|26956641|FG000|Overall Study|Patient's request|2|||
13456824|NCT00175916|26956641|FG000|Overall Study|Treating physiciant's choice|1|||
13456825|NCT00175916|26956641|FG000|Overall Study|Moved overseas|1|||
13456826|NCT00175916|26956641|FG000|Overall Study|Loss of job and economic burden|1|||
13456827|NCT00175916|26956641|FG000|Overall Study|Site was closed|9|||
13456828|NCT00175916|26956641|FG000|Overall Study|Patient went to prison|1|||
13456829|NCT00175877|26956674|FG000|Overall Study|Adverse Event|136|||
13456830|NCT00175877|26956674|FG000|Overall Study|Withdrawal by Subject|141|||
13456831|NCT00175877|26956674|FG000|Overall Study|Lost to Follow-up|9|||
13456832|NCT00175877|26956674|FG000|Overall Study|Lack of Efficacy|26|||
13456833|NCT00175877|26956674|FG000|Overall Study|Protocol Violation|15|||
13456834|NCT00175877|26956674|FG000|Overall Study|Other Reason|20|||
13456835|NCT00175877|26956674|FG000|Overall Study|AE & Other|1|||
13456836|NCT00175877|26956674|FG000|Overall Study|Withdrawal by subject & Other|1|||
13456837|NCT00174785|26956695|FG000|Overall Study|Adverse Event|293|||
13456838|NCT00174785|26956696|FG001|Overall Study|Adverse Event|191|||
13456839|NCT00174785|26956695|FG000|Overall Study|Protocol Violation|14|||
13456840|NCT00174785|26956696|FG001|Overall Study|Protocol Violation|14|||
13456841|NCT00174785|26956695|FG000|Overall Study|Withdrawal by Subject|173|||
13456842|NCT00174785|26956696|FG001|Overall Study|Withdrawal by Subject|175|||
13456843|NCT00174785|26956695|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110|||
13456844|NCT00174785|26956696|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167|||
13456845|NCT00174785|26956695|FG000|Overall Study|Prohibited antiarrhythmic medication|39|||
13456846|NCT00174785|26956696|FG001|Overall Study|Prohibited antiarrhythmic medication|88|||
13456847|NCT00174785|26956695|FG000|Overall Study|Other prohibited medication|5|||
13456848|NCT00174785|26956696|FG001|Overall Study|Other prohibited medication|3|||
13456849|NCT00174785|26956695|FG000|Overall Study|Family request|6|||
13456850|NCT00174785|26956696|FG001|Overall Study|Family request|8|||
13456851|NCT00174785|26956695|FG000|Overall Study|Not pre-specified/Not coded|56|||
13456852|NCT00174785|26956696|FG001|Overall Study|Not pre-specified/Not coded|70|||
13456853|NCT00174460|26956749|FG000|Overall Study|Withdrawal by Subject|0|||
13456854|NCT00174460|26956750|FG001|Overall Study|Withdrawal by Subject|1|||
13456855|NCT00174447|26956761|FG000|Overall Study|Adverse Event|19|||
13456856|NCT00174447|26956761|FG000|Overall Study|Withdrawal by Subject|15|||
13456857|NCT00174447|26956761|FG000|Overall Study|Protocol Violation|1|||
13456858|NCT00174447|26956761|FG000|Overall Study|Lack of Efficacy|1|||
13456859|NCT00174447|26956761|FG000|Overall Study|Administrative reason/Other|2|||
13456860|NCT00174382|26956780|FG000|Overall Study|Death|2|||
13456861|NCT00174382|26956780|FG000|Overall Study|Adverse Event|19|||
13456862|NCT00174382|26956780|FG000|Overall Study|Withdrawal by Subject|6|||
13456863|NCT00174382|26956780|FG000|Overall Study|Protocol Violation|3|||
13456864|NCT00174382|26956780|FG000|Overall Study|Arrived early for last visit in error|1|||
13456865|NCT00174382|26956780|FG000|Overall Study|Subject felt pill not effective enough|1|||
13456866|NCT00174382|26956780|FG000|Overall Study|Lost to Follow-up|1|||
13456867|NCT00174291|26956815|FG000|Overall Study|Lost to Follow-up|1|||
13456868|NCT00174291|26956816|FG001|Overall Study|Lost to Follow-up|1|||
13456869|NCT00174291|26956815|FG000|Overall Study|Protocol Violation|0|||
13456870|NCT00174291|26956816|FG001|Overall Study|Protocol Violation|2|||
13456871|NCT00174291|26956815|FG000|Overall Study|Study terminated by sponsor|1|||
13456872|NCT00174291|26956816|FG001|Overall Study|Study terminated by sponsor|0|||
13456873|NCT00174291|26956815|FG000|Overall Study|Withdrawal by Subject|3|||
13456874|NCT00174291|26956816|FG001|Overall Study|Withdrawal by Subject|3|||
13456875|NCT00174252|26956851|FG000|Overall Study|Protocol Violation|2|||
13456876|NCT00174187|26956920|FG000|Period 1 (up to 3 Years)|Serious adverse event|0|||
13456877|NCT00174187|26956921|FG001|Period 1 (up to 3 Years)|Serious adverse event|1|||
13456878|NCT00174187|26956922|FG002|Period 1 (up to 3 Years)|Serious adverse event|0|||
13456879|NCT00174187|26956920|FG000|Period 1 (up to 3 Years)|Non compliance|0|||
13456880|NCT00174187|26956921|FG001|Period 1 (up to 3 Years)|Non compliance|1|||
13456881|NCT00174187|26956922|FG002|Period 1 (up to 3 Years)|Non compliance|0|||
13456882|NCT00174187|26956920|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
13456883|NCT00174187|26956921|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1|||
13456884|NCT00174187|26956922|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
13456885|NCT00174187|26956920|FG000|Period 1 (up to 3 Years)|Other|0|||
13456886|NCT00174187|26956921|FG001|Period 1 (up to 3 Years)|Other|1|||
13456887|NCT00174187|26956922|FG002|Period 1 (up to 3 Years)|Other|0|||
13456888|NCT00174187|26956920|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
13456889|NCT00174187|26956921|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
13456890|NCT00174187|26956922|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2|||
13456891|NCT00174187|26956920|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
13456892|NCT00174187|26956921|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
13456893|NCT00174187|26956922|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3|||
13456894|NCT00174187|26956920|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0|||
13456895|NCT00174187|26956921|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0|||
13456896|NCT00174187|26956922|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2|||
13456897|NCT00174187|26956920|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
13456898|NCT00174187|26956921|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
13456899|NCT00174187|26956922|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1|||
13456900|NCT00174187|26956920|FG000|Period 2 (After 3 Years)|Other|0|||
13456901|NCT00174187|26956921|FG001|Period 2 (After 3 Years)|Other|0|||
13456902|NCT00174187|26956922|FG002|Period 2 (After 3 Years)|Other|5|||
13456903|NCT00171730|26956940|FG000|Overall Study|Adverse Event|3|||
13456904|NCT00171730|26956940|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
13456905|NCT00171730|26956940|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8|||
13456906|NCT00171730|26956940|FG000|Overall Study|Withdrawal by Subject|3|||
13456907|NCT00170950|26956957|FG000|Overall Study|Death|236|||
13456908|NCT00170950|26956958|FG001|Overall Study|Death|274|||
13456909|NCT00170950|26956957|FG000|Overall Study|Withdrawal by Subject|496|||
13456910|NCT00170950|26956958|FG001|Overall Study|Withdrawal by Subject|498|||
13456911|NCT00170950|26956957|FG000|Overall Study|Lost to Follow-up|134|||
13456912|NCT00170950|26956958|FG001|Overall Study|Lost to Follow-up|115|||
13456913|NCT00170950|26956957|FG000|Overall Study|Missing|2|||
13456914|NCT00170950|26956958|FG001|Overall Study|Missing|1|||
13456915|NCT00170950|26956957|FG000|Overall Study|Termination Data Not Recorded|17|||
13456916|NCT00170950|26956958|FG001|Overall Study|Termination Data Not Recorded|22|||
13456917|NCT00169442|26957084|FG000|Overall Study|Withdrawal by Subject|0|||
13456918|NCT00169442|26957085|FG001|Overall Study|Withdrawal by Subject|0|||
13456919|NCT00169442|26957086|FG002|Overall Study|Withdrawal by Subject|1|||
13456920|NCT00169442|26957087|FG003|Overall Study|Withdrawal by Subject|0|||
13456921|NCT00169442|26957088|FG004|Overall Study|Withdrawal by Subject|0|||
13456922|NCT00169442|26957089|FG005|Overall Study|Withdrawal by Subject|0|||
13456923|NCT00169442|26957084|FG000|Overall Study|Migrated/moved from study area|0|||
13456924|NCT00169442|26957085|FG001|Overall Study|Migrated/moved from study area|0|||
13456925|NCT00169442|26957086|FG002|Overall Study|Migrated/moved from study area|0|||
13456926|NCT00169442|26957087|FG003|Overall Study|Migrated/moved from study area|0|||
13456927|NCT00169442|26957088|FG004|Overall Study|Migrated/moved from study area|0|||
13456928|NCT00169442|26957089|FG005|Overall Study|Migrated/moved from study area|2|||
13456929|NCT00169442|26957084|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
13456930|NCT00169442|26957085|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
13456931|NCT00169442|26957086|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
13456932|NCT00169442|26957087|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
13456933|NCT00169442|26957088|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
13456934|NCT00169442|26957089|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
13456935|NCT00169442|26957084|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0|||
13456936|NCT00169442|26957085|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1|||
13456937|NCT00169442|26957086|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0|||
13456938|NCT00169442|26957087|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0|||
13456939|NCT00169442|26957088|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0|||
13456940|NCT00169442|26957089|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0|||
13456941|NCT00169104|26957107|FG000|Overall Study|Withdrawal by Subject|2|||
13456942|NCT00169104|26957108|FG001|Overall Study|Withdrawal by Subject|0|||
13456943|NCT00169104|26957107|FG000|Overall Study|Protocol Violation|0|||
13456944|NCT00169104|26957108|FG001|Overall Study|Protocol Violation|1|||
13456945|NCT00169104|26957107|FG000|Overall Study|Physician Decision|0|||
13456946|NCT00169104|26957108|FG001|Overall Study|Physician Decision|1|||
13456947|NCT00168844|26957297|FG000|Overall Study|Adverse Event|31|||
13456948|NCT00168844|26957298|FG001|Overall Study|Adverse Event|32|||
13456949|NCT00168844|26957299|FG002|Overall Study|Adverse Event|48|||
13456950|NCT00168844|26957297|FG000|Overall Study|Lost to Follow-up|4|||
13456951|NCT00168844|26957298|FG001|Overall Study|Lost to Follow-up|5|||
13456952|NCT00168844|26957299|FG002|Overall Study|Lost to Follow-up|11|||
13456953|NCT00168844|26957297|FG000|Overall Study|Withdrawal by Subject|12|||
13456954|NCT00168844|26957298|FG001|Overall Study|Withdrawal by Subject|9|||
13456955|NCT00168844|26957299|FG002|Overall Study|Withdrawal by Subject|19|||
13456956|NCT00168844|26957297|FG000|Overall Study|Protocol Violation|2|||
13456957|NCT00168844|26957298|FG001|Overall Study|Protocol Violation|2|||
13456958|NCT00168844|26957299|FG002|Overall Study|Protocol Violation|4|||
13456959|NCT00168844|26957297|FG000|Overall Study|Other|6|||
13456960|NCT00168844|26957298|FG001|Overall Study|Other|7|||
13456961|NCT00168844|26957299|FG002|Overall Study|Other|9|||
13456962|NCT00168831|26957488|FG000|Overall Study|Adverse Event|36|||
13456963|NCT00168831|26957489|FG001|Overall Study|Adverse Event|47|||
13456964|NCT00168831|26957490|FG002|Overall Study|Adverse Event|74|||
13456965|NCT00168831|26957488|FG000|Overall Study|Lost to Follow-up|5|||
13456966|NCT00168831|26957489|FG001|Overall Study|Lost to Follow-up|6|||
13456967|NCT00168831|26957490|FG002|Overall Study|Lost to Follow-up|4|||
13456968|NCT00168831|26957488|FG000|Overall Study|Withdrawal by Subject|7|||
13456969|NCT00168831|26957489|FG001|Overall Study|Withdrawal by Subject|14|||
13456970|NCT00168831|26957490|FG002|Overall Study|Withdrawal by Subject|19|||
13456971|NCT00168831|26957488|FG000|Overall Study|Protocol Violation|6|||
13456972|NCT00168831|26957489|FG001|Overall Study|Protocol Violation|11|||
13456973|NCT00168831|26957490|FG002|Overall Study|Protocol Violation|11|||
13456974|NCT00168831|26957488|FG000|Overall Study|Other|6|||
13456975|NCT00168831|26957489|FG001|Overall Study|Other|3|||
13456976|NCT00168831|26957490|FG002|Overall Study|Other|6|||
13456977|NCT00168818|26957541|FG000|Overall Study|Adverse Event|23|||
13456978|NCT00168818|26957542|FG001|Overall Study|Adverse Event|29|||
13456979|NCT00168818|26957543|FG002|Overall Study|Adverse Event|31|||
13456980|NCT00168818|26957541|FG000|Overall Study|Protocol Violation|16|||
13456981|NCT00168818|26957542|FG001|Overall Study|Protocol Violation|11|||
13456982|NCT00168818|26957543|FG002|Overall Study|Protocol Violation|11|||
13456983|NCT00168818|26957541|FG000|Overall Study|Lost to Follow-up|13|||
13456984|NCT00168818|26957542|FG001|Overall Study|Lost to Follow-up|4|||
13456985|NCT00168818|26957543|FG002|Overall Study|Lost to Follow-up|15|||
13456986|NCT00168818|26957541|FG000|Overall Study|Withdrawal by Subject|43|||
13456987|NCT00168818|26957542|FG001|Overall Study|Withdrawal by Subject|41|||
13456988|NCT00168818|26957543|FG002|Overall Study|Withdrawal by Subject|37|||
13456989|NCT00168818|26957541|FG000|Overall Study|Other|22|||
13456990|NCT00168818|26957542|FG001|Overall Study|Other|24|||
13456991|NCT00168818|26957543|FG002|Overall Study|Other|30|||
13456992|NCT00168818|26957541|FG000|Treatment|Adverse Event|77|||
13456993|NCT00168818|26957542|FG001|Treatment|Adverse Event|89|||
13456994|NCT00168818|26957543|FG002|Treatment|Adverse Event|68|||
13456995|NCT00168818|26957541|FG000|Treatment|Protocol Violation|8|||
13456996|NCT00168818|26957542|FG001|Treatment|Protocol Violation|11|||
13456997|NCT00168818|26957543|FG002|Treatment|Protocol Violation|11|||
13456998|NCT00168818|26957541|FG000|Treatment|Lost to Follow-up|0|||
13456999|NCT00168818|26957542|FG001|Treatment|Lost to Follow-up|2|||
13457000|NCT00168818|26957543|FG002|Treatment|Lost to Follow-up|1|||
13457001|NCT00168818|26957541|FG000|Treatment|Withdrawal by Subject|25|||
13457002|NCT00168818|26957542|FG001|Treatment|Withdrawal by Subject|20|||
13457003|NCT00168818|26957543|FG002|Treatment|Withdrawal by Subject|22|||
13457004|NCT00168818|26957541|FG000|Treatment|Other|23|||
13457005|NCT00168818|26957542|FG001|Treatment|Other|29|||
13457006|NCT00168818|26957543|FG002|Treatment|Other|31|||
13457007|NCT00168805|26957594|FG000|Overall Study|Adverse Event|7|||
13457008|NCT00168805|26957595|FG001|Overall Study|Adverse Event|11|||
13457009|NCT00168805|26957596|FG002|Overall Study|Adverse Event|16|||
13457010|NCT00168805|26957594|FG000|Overall Study|Protocol Violation|12|||
13457011|NCT00168805|26957595|FG001|Overall Study|Protocol Violation|11|||
13457012|NCT00168805|26957596|FG002|Overall Study|Protocol Violation|8|||
13457013|NCT00168805|26957594|FG000|Overall Study|Lost to Follow-up|12|||
13457014|NCT00168805|26957595|FG001|Overall Study|Lost to Follow-up|17|||
13457015|NCT00168805|26957596|FG002|Overall Study|Lost to Follow-up|11|||
13457016|NCT00168805|26957594|FG000|Overall Study|Withdrawal by Subject|16|||
13457017|NCT00168805|26957595|FG001|Overall Study|Withdrawal by Subject|18|||
13457018|NCT00168805|26957596|FG002|Overall Study|Withdrawal by Subject|21|||
13457019|NCT00168805|26957594|FG000|Overall Study|Other|24|||
13457020|NCT00168805|26957595|FG001|Overall Study|Other|21|||
13457021|NCT00168805|26957596|FG002|Overall Study|Other|22|||
13457022|NCT00168805|26957594|FG000|Treatment|Adverse Event|25|||
13457023|NCT00168805|26957595|FG001|Treatment|Adverse Event|26|||
13457024|NCT00168805|26957596|FG002|Treatment|Adverse Event|32|||
13457025|NCT00168805|26957594|FG000|Treatment|Protocol Violation|3|||
13457026|NCT00168805|26957595|FG001|Treatment|Protocol Violation|5|||
13457027|NCT00168805|26957596|FG002|Treatment|Protocol Violation|5|||
13457028|NCT00168805|26957594|FG000|Treatment|Withdrawal by Subject|3|||
13457029|NCT00168805|26957595|FG001|Treatment|Withdrawal by Subject|7|||
13457030|NCT00168805|26957596|FG002|Treatment|Withdrawal by Subject|8|||
13457031|NCT00168805|26957594|FG000|Treatment|Other|18|||
13457032|NCT00168805|26957595|FG001|Treatment|Other|18|||
13457033|NCT00168805|26957596|FG002|Treatment|Other|17|||
13457034|NCT00168103|26957627|FG000|Overall Study|Withdrawal by Subject|1|||
13457035|NCT00168103|26957628|FG001|Overall Study|Withdrawal by Subject|2|||
13457036|NCT00168103|26957629|FG002|Overall Study|Withdrawal by Subject|1|||
13457037|NCT00168103|26957630|FG003|Overall Study|Withdrawal by Subject|0|||
13457038|NCT00168103|26957627|FG000|Overall Study|Lost to Follow-up|1|||
13457039|NCT00168103|26957628|FG001|Overall Study|Lost to Follow-up|3|||
13457040|NCT00168103|26957629|FG002|Overall Study|Lost to Follow-up|0|||
13457041|NCT00168103|26957630|FG003|Overall Study|Lost to Follow-up|0|||
13457042|NCT00168064|26957645|FG000|Overall Study|Adverse Event|26|||
13457043|NCT00168064|26957646|FG001|Overall Study|Adverse Event|22|||
13457044|NCT00168064|26957645|FG000|Overall Study|Withdrawal by Subject|3|||
13457045|NCT00168064|26957646|FG001|Overall Study|Withdrawal by Subject|4|||
13457046|NCT00168064|26957645|FG000|Overall Study|Lack of Efficacy|4|||
13457047|NCT00168064|26957646|FG001|Overall Study|Lack of Efficacy|4|||
13457048|NCT00168064|26957645|FG000|Overall Study|Lost to Follow-up|4|||
13457049|NCT00168064|26957646|FG001|Overall Study|Lost to Follow-up|3|||
13457050|NCT00168064|26957645|FG000|Overall Study|Non-compliance|2|||
13457051|NCT00168064|26957646|FG001|Overall Study|Non-compliance|3|||
13457052|NCT00168064|26957645|FG000|Overall Study|Concurrent Illness|4|||
13457053|NCT00168064|26957646|FG001|Overall Study|Concurrent Illness|3|||
13457054|NCT00168064|26957645|FG000|Overall Study|Subject's Best interest|2|||
13457055|NCT00168064|26957646|FG001|Overall Study|Subject's Best interest|2|||
13457056|NCT00168064|26957645|FG000|Overall Study|Various|4|||
13457057|NCT00168064|26957646|FG001|Overall Study|Various|3|||
13457058|NCT00168038|26957660|FG000|Overall Study|Adverse Event|1|||
13457059|NCT00168038|26957660|FG000|Overall Study|Therapy failure|1|||
13457060|NCT00167778|26957711|FG000|Overall Study|Withdrawal by Subject|1|||
13457061|NCT00167414|26957721|FG000|Overall Study|Death|10|||
13457062|NCT00167310|26957736|FG000|Overall Study|Protocol Violation|5|||
13457063|NCT00167310|26957737|FG001|Overall Study|Protocol Violation|3|||
13457064|NCT00167310|26957736|FG000|Overall Study|Withdrawal by Subject|3|||
13457065|NCT00167310|26957737|FG001|Overall Study|Withdrawal by Subject|7|||
13457066|NCT00167245|26957756|FG000|Overall Study|Lost to Follow-up|20|||
13457067|NCT00167245|26957757|FG001|Overall Study|Lost to Follow-up|31|||
13457068|NCT00167245|26957756|FG000|Overall Study|Withdrawal by Subject|5|||
13457069|NCT00167245|26957757|FG001|Overall Study|Withdrawal by Subject|8|||
13457070|NCT00167245|26957756|FG000|Overall Study|Incarcerated|3|||
13457071|NCT00167245|26957757|FG001|Overall Study|Incarcerated|2|||
13457072|NCT00167245|26957756|FG000|Overall Study|Drowsy|1|||
13457073|NCT00167245|26957757|FG001|Overall Study|Drowsy|0|||
13457074|NCT00166712|26957779|FG000|Overall Study|Death|0|||
13457075|NCT00166712|26957780|FG001|Overall Study|Death|1|||
13457076|NCT00166712|26957779|FG000|Overall Study|Adverse Event|1|||
13457077|NCT00166712|26957780|FG001|Overall Study|Adverse Event|0|||
13457078|NCT00166712|26957779|FG000|Overall Study|Withdrawal by Subject|1|||
13457079|NCT00166712|26957780|FG001|Overall Study|Withdrawal by Subject|2|||
13457080|NCT00166712|26957779|FG000|Overall Study|Physician Decision|0|||
13457081|NCT00166712|26957780|FG001|Overall Study|Physician Decision|2|||
13457082|NCT00166517|26957795|FG000|Overall Study|Lost to Follow-up|1|||
13457083|NCT00166517|26957796|FG001|Overall Study|Lost to Follow-up|0|||
13457084|NCT00166517|26957795|FG000|Overall Study|Protocol Violation|4|||
13457085|NCT00166517|26957796|FG001|Overall Study|Protocol Violation|1|||
13457086|NCT00166517|26957795|FG000|Overall Study|Withdrawal by Subject|0|||
13457087|NCT00166517|26957796|FG001|Overall Study|Withdrawal by Subject|1|||
13457088|NCT00166439|26957804|FG000|Overall Study|Ineligible|5|||
13457089|NCT00166296|26957823|FG000|Overall Study|Withdrawal by Subject|1|||
13457090|NCT00166296|26957824|FG001|Overall Study|Withdrawal by Subject|3|||
13457091|NCT00166296|26957823|FG000|Overall Study|Adverse Event|2|||
13457092|NCT00166296|26957824|FG001|Overall Study|Adverse Event|4|||
13457093|NCT00166296|26957823|FG000|Overall Study|Lost to Follow-up|4|||
13457094|NCT00166296|26957824|FG001|Overall Study|Lost to Follow-up|2|||
13457095|NCT00166114|26957837|FG000|Overall Study|Protocol Violation|2|||
13457096|NCT00166114|26957838|FG001|Overall Study|Protocol Violation|1|||
13457097|NCT00166114|26957837|FG000|Overall Study|Withdrawal by Subject|10|||
13457098|NCT00166114|26957838|FG001|Overall Study|Withdrawal by Subject|4|||
13457099|NCT00166114|26957837|FG000|Overall Study|Adverse Event|2|||
13457100|NCT00166114|26957838|FG001|Overall Study|Adverse Event|1|||
13457101|NCT00165984|26957847|FG000|Overall Study|Death|15|||
13457102|NCT00165841|26957860|FG000|Overall Study|Adverse Event|2|||
13457103|NCT00165841|26957861|FG001|Overall Study|Adverse Event|3|||
13457104|NCT00165841|26957860|FG000|Overall Study|Lack of Efficacy|6|||
13457105|NCT00165841|26957861|FG001|Overall Study|Lack of Efficacy|33|||
13457106|NCT00165841|26957860|FG000|Overall Study|Lost to Follow-up|4|||
13457107|NCT00165841|26957861|FG001|Overall Study|Lost to Follow-up|4|||
13457108|NCT00165841|26957860|FG000|Overall Study|Withdrawal by Subject|7|||
13457109|NCT00165841|26957861|FG001|Overall Study|Withdrawal by Subject|8|||
13457110|NCT00165841|26957860|FG000|Overall Study|Physician Decision|1|||
13457111|NCT00165841|26957861|FG001|Overall Study|Physician Decision|0|||
13457112|NCT00165841|26957860|FG000|Overall Study|Protocol Violation|6|||
13457113|NCT00165841|26957861|FG001|Overall Study|Protocol Violation|8|||
13457114|NCT00165841|26957860|FG000|Overall Study|Other|3|||
13457115|NCT00165841|26957861|FG001|Overall Study|Other|5|||
13457116|NCT00165841|26957860|FG000|Overall Study|Medication Noncompliance|1|||
13457117|NCT00165841|26957861|FG001|Overall Study|Medication Noncompliance|1|||
13457118|NCT00165789|26957924|FG000|Overall Study|Adverse Event|0|||
13457119|NCT00165789|26957925|FG001|Overall Study|Adverse Event|3|||
13457120|NCT00165789|26957926|FG002|Overall Study|Adverse Event|0|||
13457121|NCT00165789|26957927|FG003|Overall Study|Adverse Event|12|||
13457122|NCT00165789|26957924|FG000|Overall Study|Withdrawal by Subject|0|||
13457123|NCT00165789|26957925|FG001|Overall Study|Withdrawal by Subject|1|||
13457124|NCT00165789|26957926|FG002|Overall Study|Withdrawal by Subject|1|||
13457125|NCT00165789|26957927|FG003|Overall Study|Withdrawal by Subject|2|||
13457126|NCT00165776|26957974|FG000|Overall Study|Lack of Efficacy|0|||
13457127|NCT00165776|26957975|FG001|Overall Study|Lack of Efficacy|0|||
13457128|NCT00165776|26957976|FG002|Overall Study|Lack of Efficacy|0|||
13457129|NCT00165776|26957977|FG003|Overall Study|Lack of Efficacy|1|||
13457130|NCT00165776|26957974|FG000|Overall Study|Withdrawal by Subject|4|||
13457131|NCT00165776|26957975|FG001|Overall Study|Withdrawal by Subject|1|||
13457132|NCT00165776|26957976|FG002|Overall Study|Withdrawal by Subject|2|||
13457133|NCT00165776|26957977|FG003|Overall Study|Withdrawal by Subject|0|||
13457134|NCT00165776|26957974|FG000|Overall Study|Worsening of Cervical Dystonia|0|||
13457135|NCT00165776|26957975|FG001|Overall Study|Worsening of Cervical Dystonia|0|||
13457136|NCT00165776|26957976|FG002|Overall Study|Worsening of Cervical Dystonia|0|||
13457137|NCT00165776|26957977|FG003|Overall Study|Worsening of Cervical Dystonia|1|||
13457138|NCT00165698|26958008|FG000|Overall Study|Adverse Event|2|||
13457139|NCT00165698|26958009|FG001|Overall Study|Adverse Event|10|||
13457140|NCT00165698|26958008|FG000|Overall Study|Lost to Follow-up|2|||
13457141|NCT00165698|26958009|FG001|Overall Study|Lost to Follow-up|2|||
13457142|NCT00165698|26958008|FG000|Overall Study|Withdrawal by Subject|2|||
13457143|NCT00165698|26958009|FG001|Overall Study|Withdrawal by Subject|1|||
13457144|NCT00165698|26958008|FG000|Overall Study|Protocol Violation|1|||
13457145|NCT00165698|26958009|FG001|Overall Study|Protocol Violation|0|||
13457146|NCT00165698|26958008|FG000|Overall Study|Not Taken/Lost the medicine|1|||
13457147|NCT00165698|26958009|FG001|Overall Study|Not Taken/Lost the medicine|2|||
13457148|NCT00165672|26958022|FG000|Overall Study|Adverse Event|0|||
13457149|NCT00165672|26958023|FG001|Overall Study|Adverse Event|1|||
13457150|NCT00165646|26958041|FG000|Overall Study|Adverse Event|1|||
13457151|NCT00165646|26958042|FG001|Overall Study|Adverse Event|1|||
13457152|NCT00165646|26958043|FG002|Overall Study|Adverse Event|1|||
13457153|NCT00165646|26958041|FG000|Overall Study|Lack of Efficacy|1|||
13457154|NCT00165646|26958042|FG001|Overall Study|Lack of Efficacy|2|||
13457155|NCT00165646|26958043|FG002|Overall Study|Lack of Efficacy|0|||
13457156|NCT00165646|26958041|FG000|Overall Study|Withdrawal by Subject|0|||
13457157|NCT00165646|26958042|FG001|Overall Study|Withdrawal by Subject|2|||
13457158|NCT00165646|26958043|FG002|Overall Study|Withdrawal by Subject|1|||
13457159|NCT00165646|26958041|FG000|Overall Study|Physician Decision|2|||
13457160|NCT00165646|26958042|FG001|Overall Study|Physician Decision|0|||
13457161|NCT00165646|26958043|FG002|Overall Study|Physician Decision|2|||
13457162|NCT00165646|26958041|FG000|Overall Study|Protocol Violation|1|||
13457163|NCT00165646|26958042|FG001|Overall Study|Protocol Violation|0|||
13457164|NCT00165646|26958043|FG002|Overall Study|Protocol Violation|0|||
13457165|NCT00165503|26958049|FG000|Overall Study|Death|1|||
13457166|NCT00165503|26958049|FG000|Overall Study|Lost to Follow-up|12|||
13457167|NCT00165503|26958049|FG000|Overall Study|Unresectable|3|||
13457168|NCT00163657|26958070|FG000|Overall Study|Death|12|||
13457169|NCT00163657|26958071|FG001|Overall Study|Death|14|||
13457170|NCT00163657|26958072|FG002|Overall Study|Death|19|||
13457171|NCT00163657|26958070|FG000|Overall Study|graft loss|4|||
13457172|NCT00163657|26958071|FG001|Overall Study|graft loss|1|||
13457173|NCT00163657|26958072|FG002|Overall Study|graft loss|2|||
13457174|NCT00163657|26958070|FG000|Overall Study|Withdrawal by Subject|2|||
13457175|NCT00163657|26958071|FG001|Overall Study|Withdrawal by Subject|3|||
13457176|NCT00163657|26958072|FG002|Overall Study|Withdrawal by Subject|2|||
13457177|NCT00163657|26958070|FG000|Overall Study|Physician Decision|0|||
13457178|NCT00163657|26958071|FG001|Overall Study|Physician Decision|1|||
13457179|NCT00163657|26958072|FG002|Overall Study|Physician Decision|1|||
13457180|NCT00163657|26958070|FG000|Overall Study|Non Compliance|1|||
13457181|NCT00163657|26958071|FG001|Overall Study|Non Compliance|0|||
13457182|NCT00163657|26958072|FG002|Overall Study|Non Compliance|0|||
13457183|NCT00163657|26958070|FG000|Overall Study|Lost to Follow-up|1|||
13457184|NCT00163657|26958071|FG001|Overall Study|Lost to Follow-up|3|||
13457185|NCT00163657|26958072|FG002|Overall Study|Lost to Follow-up|10|||
13457186|NCT00163657|26958070|FG000|Overall Study|Other reason|0|||
13457187|NCT00163657|26958071|FG001|Overall Study|Other reason|1|||
13457188|NCT00163657|26958072|FG002|Overall Study|Other reason|3|||
13457189|NCT00163215|26958094|FG000|Overall Study|Lack of Efficacy|3|||
13457190|NCT00163215|26958094|FG000|Overall Study|Withdrawal by Subject|5|||
13457191|NCT00163215|26958094|FG000|Overall Study|Other|7|||
13457192|NCT00163189|26958118|FG000|Overall Study|Other|6|||
13457193|NCT00163189|26958118|FG000|Overall Study|Lost to Follow-up|1|||
13457194|NCT00163189|26958118|FG000|Overall Study|Protocol Violation|2|||
13457195|NCT00163189|26958118|FG000|Overall Study|Death|3|||
13457196|NCT00163189|26958118|FG000|Overall Study|Adverse Event|6|||
13457197|NCT00163189|26958118|FG000|Overall Study|Lack of Efficacy|7|||
13457198|NCT00163189|26958118|FG000|Overall Study|Study terminated by sponsor|11|||
13457199|NCT00163189|26958118|FG000|Overall Study|Withdrawal by Subject|11|||
13457200|NCT00163189|26958118|FG000|Overall Study|Did not meet continuation criterion|16|||
13457201|NCT00163020|26958163|FG000|Overall Study|Lost to Follow-up|0|||
13457202|NCT00163020|26958164|FG001|Overall Study|Lost to Follow-up|2|||
13457203|NCT00162981|26958185|FG000|Overall Study|Adverse Event|2|||
13457204|NCT00162981|26958186|FG001|Overall Study|Adverse Event|5|||
13457205|NCT00162981|26958185|FG000|Overall Study|Withdrawal by Subject|1|||
13457206|NCT00162981|26958186|FG001|Overall Study|Withdrawal by Subject|1|||
13457207|NCT00162981|26958185|FG000|Overall Study|Physician Decision|1|||
13457208|NCT00162981|26958186|FG001|Overall Study|Physician Decision|0|||
13457209|NCT00162773|26958192|FG000|Overall Study|P.I, Left institution. Study terminated|22|||
13457210|NCT00162370|26958209|FG000|Efficacy Population|Lost to Follow-up|51|||
13457211|NCT00162266|26958415|FG000|Double-Blind Period|Adverse Event|5|||
13457212|NCT00162266|26958416|FG001|Double-Blind Period|Adverse Event|9|||
13457213|NCT00162266|26958417|FG002|Double-Blind Period|Adverse Event|11|||
13457214|NCT00162266|26958418|FG003|Double-Blind Period|Adverse Event|0|||
13457215|NCT00162266|26958415|FG000|Double-Blind Period|Death|0|||
13457216|NCT00162266|26958416|FG001|Double-Blind Period|Death|1|||
13457217|NCT00162266|26958417|FG002|Double-Blind Period|Death|0|||
13457218|NCT00162266|26958418|FG003|Double-Blind Period|Death|0|||
13457219|NCT00162266|26958415|FG000|Double-Blind Period|Lost to Follow-up|1|||
13457220|NCT00162266|26958416|FG001|Double-Blind Period|Lost to Follow-up|2|||
13457221|NCT00162266|26958417|FG002|Double-Blind Period|Lost to Follow-up|0|||
13457222|NCT00162266|26958418|FG003|Double-Blind Period|Lost to Follow-up|0|||
13457223|NCT00162266|26958415|FG000|Double-Blind Period|Other Reason|1|||
13457224|NCT00162266|26958416|FG001|Double-Blind Period|Other Reason|0|||
13457225|NCT00162266|26958417|FG002|Double-Blind Period|Other Reason|1|||
13457226|NCT00162266|26958418|FG003|Double-Blind Period|Other Reason|0|||
13457227|NCT00162266|26958415|FG000|Double-Blind Period|Lack of Efficacy|13|||
13457228|NCT00162266|26958416|FG001|Double-Blind Period|Lack of Efficacy|17|||
13457229|NCT00162266|26958417|FG002|Double-Blind Period|Lack of Efficacy|30|||
13457230|NCT00162266|26958418|FG003|Double-Blind Period|Lack of Efficacy|0|||
13457231|NCT00162266|26958415|FG000|Double-Blind Period|Withdrawal by Subject|5|||
13457232|NCT00162266|26958416|FG001|Double-Blind Period|Withdrawal by Subject|2|||
13457233|NCT00162266|26958417|FG002|Double-Blind Period|Withdrawal by Subject|6|||
13457234|NCT00162266|26958418|FG003|Double-Blind Period|Withdrawal by Subject|0|||
13457235|NCT00162266|26958415|FG000|Open-Label Period|Death|0|||
13457236|NCT00162266|26958416|FG001|Open-Label Period|Death|0|||
13457237|NCT00162266|26958417|FG002|Open-Label Period|Death|0|||
13457238|NCT00162266|26958418|FG003|Open-Label Period|Death|7|||
13457239|NCT00162266|26958415|FG000|Open-Label Period|Adverse Event|0|||
13457240|NCT00162266|26958416|FG001|Open-Label Period|Adverse Event|0|||
13457241|NCT00162266|26958417|FG002|Open-Label Period|Adverse Event|0|||
13457242|NCT00162266|26958418|FG003|Open-Label Period|Adverse Event|46|||
13457243|NCT00162266|26958415|FG000|Open-Label Period|Lack of Efficacy|0|||
13457244|NCT00162266|26958416|FG001|Open-Label Period|Lack of Efficacy|0|||
13457245|NCT00162266|26958417|FG002|Open-Label Period|Lack of Efficacy|0|||
13457246|NCT00162266|26958418|FG003|Open-Label Period|Lack of Efficacy|26|||
13457247|NCT00162266|26958415|FG000|Open-Label Period|Lost to Follow-up|0|||
13457248|NCT00162266|26958416|FG001|Open-Label Period|Lost to Follow-up|0|||
13457249|NCT00162266|26958417|FG002|Open-Label Period|Lost to Follow-up|0|||
13457250|NCT00162266|26958418|FG003|Open-Label Period|Lost to Follow-up|3|||
13457251|NCT00162266|26958415|FG000|Open-Label Period|Withdrawal by Subject|0|||
13457252|NCT00162266|26958416|FG001|Open-Label Period|Withdrawal by Subject|0|||
13457253|NCT00162266|26958417|FG002|Open-Label Period|Withdrawal by Subject|0|||
13457254|NCT00162266|26958418|FG003|Open-Label Period|Withdrawal by Subject|31|||
13457255|NCT00162266|26958415|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
13457256|NCT00162266|26958416|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
13457257|NCT00162266|26958417|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
13457258|NCT00162266|26958418|FG003|Open-Label Period|Administrative Reason By Sponsor|9|||
13457259|NCT00162266|26958415|FG000|Open-Label Period|Other Reasons|0|||
13457260|NCT00162266|26958416|FG001|Open-Label Period|Other Reasons|0|||
13457261|NCT00162266|26958417|FG002|Open-Label Period|Other Reasons|0|||
13457262|NCT00162266|26958418|FG003|Open-Label Period|Other Reasons|15|||
13457263|NCT00162136|26958456|FG000|Overall Study|Adverse Event|1|||
13457264|NCT00162136|26958456|FG000|Overall Study|Death|1|||
13457265|NCT00162136|26958456|FG000|Overall Study|Disease Progression/Relapse|23|||
13457266|NCT00162136|26958456|FG000|Overall Study|Investigator Request|5|||
13457267|NCT00162136|26958456|FG000|Overall Study|Study Drug Toxicity|4|||
13457268|NCT00162136|26958456|FG000|Overall Study|Withdrawal by Subject|1|||
13457269|NCT00162123|26958510|FG000|Overall Study|Disease progression|27|||
13457270|NCT00162123|26958511|FG001|Overall Study|Disease progression|19|||
13457271|NCT00162123|26958512|FG002|Overall Study|Disease progression|10|||
13457272|NCT00162123|26958513|FG003|Overall Study|Disease progression|4|||
13457273|NCT00162123|26958514|FG004|Overall Study|Disease progression|8|||
13457274|NCT00162123|26958515|FG005|Overall Study|Disease progression|3|||
13457275|NCT00162123|26958516|FG006|Overall Study|Disease progression|1|||
13457276|NCT00162123|26958517|FG007|Overall Study|Disease progression|0|||
13457277|NCT00162123|26958510|FG000|Overall Study|Study drug toxicity|6|||
13457278|NCT00162123|26958511|FG001|Overall Study|Study drug toxicity|1|||
13457279|NCT00162123|26958512|FG002|Overall Study|Study drug toxicity|5|||
13457280|NCT00162123|26958513|FG003|Overall Study|Study drug toxicity|0|||
13457281|NCT00162123|26958514|FG004|Overall Study|Study drug toxicity|4|||
13457282|NCT00162123|26958515|FG005|Overall Study|Study drug toxicity|1|||
13457283|NCT00162123|26958516|FG006|Overall Study|Study drug toxicity|1|||
13457284|NCT00162123|26958517|FG007|Overall Study|Study drug toxicity|0|||
13457285|NCT00162123|26958510|FG000|Overall Study|Death|3|||
13457286|NCT00162123|26958511|FG001|Overall Study|Death|3|||
13457287|NCT00162123|26958512|FG002|Overall Study|Death|1|||
13457288|NCT00162123|26958513|FG003|Overall Study|Death|1|||
13457289|NCT00162123|26958514|FG004|Overall Study|Death|1|||
13457290|NCT00162123|26958515|FG005|Overall Study|Death|1|||
13457291|NCT00162123|26958516|FG006|Overall Study|Death|0|||
13457292|NCT00162123|26958517|FG007|Overall Study|Death|0|||
13457293|NCT00162123|26958510|FG000|Overall Study|Withdrawal by Subject|2|||
13457294|NCT00162123|26958511|FG001|Overall Study|Withdrawal by Subject|0|||
13457295|NCT00162123|26958512|FG002|Overall Study|Withdrawal by Subject|2|||
13457296|NCT00162123|26958513|FG003|Overall Study|Withdrawal by Subject|1|||
13457297|NCT00162123|26958514|FG004|Overall Study|Withdrawal by Subject|1|||
13457298|NCT00162123|26958515|FG005|Overall Study|Withdrawal by Subject|2|||
13457299|NCT00162123|26958516|FG006|Overall Study|Withdrawal by Subject|1|||
13457300|NCT00162123|26958517|FG007|Overall Study|Withdrawal by Subject|0|||
13457301|NCT00162123|26958510|FG000|Overall Study|Deterioration without progression|2|||
13457302|NCT00162123|26958511|FG001|Overall Study|Deterioration without progression|2|||
13457303|NCT00162123|26958512|FG002|Overall Study|Deterioration without progression|3|||
13457304|NCT00162123|26958513|FG003|Overall Study|Deterioration without progression|0|||
13457305|NCT00162123|26958514|FG004|Overall Study|Deterioration without progression|1|||
13457306|NCT00162123|26958515|FG005|Overall Study|Deterioration without progression|0|||
13457307|NCT00162123|26958516|FG006|Overall Study|Deterioration without progression|0|||
13457308|NCT00162123|26958517|FG007|Overall Study|Deterioration without progression|0|||
13457309|NCT00162123|26958510|FG000|Overall Study|Adverse Event|1|||
13457310|NCT00162123|26958511|FG001|Overall Study|Adverse Event|2|||
13457311|NCT00162123|26958512|FG002|Overall Study|Adverse Event|0|||
13457312|NCT00162123|26958513|FG003|Overall Study|Adverse Event|2|||
13457313|NCT00162123|26958514|FG004|Overall Study|Adverse Event|1|||
13457314|NCT00162123|26958515|FG005|Overall Study|Adverse Event|0|||
13457315|NCT00162123|26958516|FG006|Overall Study|Adverse Event|0|||
13457316|NCT00162123|26958517|FG007|Overall Study|Adverse Event|0|||
13457317|NCT00162123|26958510|FG000|Overall Study|Not specified (before treatment)|2|||
13457318|NCT00162123|26958511|FG001|Overall Study|Not specified (before treatment)|0|||
13457319|NCT00162123|26958512|FG002|Overall Study|Not specified (before treatment)|0|||
13457320|NCT00162123|26958513|FG003|Overall Study|Not specified (before treatment)|0|||
13457321|NCT00162123|26958514|FG004|Overall Study|Not specified (before treatment)|12|||
13457322|NCT00162123|26958515|FG005|Overall Study|Not specified (before treatment)|1|||
13457323|NCT00162123|26958516|FG006|Overall Study|Not specified (before treatment)|0|||
13457324|NCT00162123|26958517|FG007|Overall Study|Not specified (before treatment)|0|||
13457325|NCT00162123|26958510|FG000|Overall Study|Not specified (after start of treatment)|0|||
13457326|NCT00162123|26958511|FG001|Overall Study|Not specified (after start of treatment)|0|||
13457327|NCT00162123|26958512|FG002|Overall Study|Not specified (after start of treatment)|0|||
13457328|NCT00162123|26958513|FG003|Overall Study|Not specified (after start of treatment)|0|||
13457329|NCT00162123|26958514|FG004|Overall Study|Not specified (after start of treatment)|3|||
13457330|NCT00162123|26958515|FG005|Overall Study|Not specified (after start of treatment)|0|||
13457331|NCT00162123|26958516|FG006|Overall Study|Not specified (after start of treatment)|0|||
13457332|NCT00162123|26958517|FG007|Overall Study|Not specified (after start of treatment)|0|||
13457333|NCT00162123|26958510|FG000|Overall Study|Physician Decision|1|||
13457334|NCT00162123|26958511|FG001|Overall Study|Physician Decision|2|||
13457335|NCT00162123|26958512|FG002|Overall Study|Physician Decision|0|||
13457336|NCT00162123|26958513|FG003|Overall Study|Physician Decision|0|||
13457337|NCT00162123|26958514|FG004|Overall Study|Physician Decision|0|||
13457338|NCT00162123|26958515|FG005|Overall Study|Physician Decision|1|||
13457339|NCT00162123|26958516|FG006|Overall Study|Physician Decision|1|||
13457340|NCT00162123|26958517|FG007|Overall Study|Physician Decision|0|||
13457341|NCT00162123|26958510|FG000|Overall Study|Tumor assessment only (not treated)|0|||
13457342|NCT00162123|26958511|FG001|Overall Study|Tumor assessment only (not treated)|0|||
13457343|NCT00162123|26958512|FG002|Overall Study|Tumor assessment only (not treated)|0|||
13457344|NCT00162123|26958513|FG003|Overall Study|Tumor assessment only (not treated)|0|||
13457345|NCT00162123|26958514|FG004|Overall Study|Tumor assessment only (not treated)|0|||
13457346|NCT00162123|26958515|FG005|Overall Study|Tumor assessment only (not treated)|0|||
13457347|NCT00162123|26958516|FG006|Overall Study|Tumor assessment only (not treated)|0|||
13457348|NCT00162123|26958517|FG007|Overall Study|Tumor assessment only (not treated)|1|||
13457349|NCT00162123|26958510|FG000|Overall Study|Follow-up only (not treated or assessed)|0|||
13457350|NCT00162123|26958511|FG001|Overall Study|Follow-up only (not treated or assessed)|0|||
13457351|NCT00162123|26958512|FG002|Overall Study|Follow-up only (not treated or assessed)|0|||
13457352|NCT00162123|26958513|FG003|Overall Study|Follow-up only (not treated or assessed)|0|||
13457353|NCT00162123|26958514|FG004|Overall Study|Follow-up only (not treated or assessed)|0|||
13457354|NCT00162123|26958515|FG005|Overall Study|Follow-up only (not treated or assessed)|0|||
13457355|NCT00162123|26958516|FG006|Overall Study|Follow-up only (not treated or assessed)|0|||
13457356|NCT00162123|26958517|FG007|Overall Study|Follow-up only (not treated or assessed)|57|||
13457357|NCT00162097|26958590|FG000|Overall Study|Participant no longer met study criteria|0|||
13457358|NCT00162097|26958591|FG001|Overall Study|Participant no longer met study criteria|0|||
13457359|NCT00162097|26958592|FG002|Overall Study|Participant no longer met study criteria|0|||
13457360|NCT00162097|26958593|FG003|Overall Study|Participant no longer met study criteria|1|||
13457361|NCT00162032|26958619|FG000|Overall Study|Lost to Follow-up|4|||
13457362|NCT00162032|26958620|FG001|Overall Study|Lost to Follow-up|2|||
13457363|NCT00162032|26958619|FG000|Overall Study|Reason not specified|1|||
13457364|NCT00162032|26958620|FG001|Overall Study|Reason not specified|0|||
13457365|NCT00161616|26958635|FG000|Overall Study|Withdrawal by Subject|6|||
13457366|NCT00161616|26958636|FG001|Overall Study|Withdrawal by Subject|5|||
13457367|NCT00161616|26958635|FG000|Overall Study|Physician Decision|1|||
13457368|NCT00161616|26958636|FG001|Overall Study|Physician Decision|0|||
13457369|NCT00161616|26958635|FG000|Overall Study|Death|1|||
13457370|NCT00161616|26958636|FG001|Overall Study|Death|1|||
13457371|NCT00161616|26958635|FG000|Overall Study|Lost to Follow-up|17|||
13457372|NCT00161616|26958636|FG001|Overall Study|Lost to Follow-up|13|||
13457373|NCT00161616|26958635|FG000|Overall Study|Protocol deviation|1|||
13457374|NCT00161616|26958636|FG001|Overall Study|Protocol deviation|0|||
13457375|NCT00161213|26958645|FG000|Overall Study|Withdrawal by Subject|1|||
13457376|NCT00161213|26958645|FG000|Overall Study|Evaluable for toxicity but not response|1|||
13457377|NCT00160706|26958659|FG000|Overall Study|Adverse Event|53|||
13457378|NCT00160706|26958659|FG000|Overall Study|Adverse Event and Other Reason|105|||
13457379|NCT00160706|26958659|FG000|Overall Study|Protocol Violation|3|||
13457380|NCT00160706|26958659|FG000|Overall Study|Withdrawal by Subject|41|||
13457381|NCT00160706|26958659|FG000|Overall Study|Withdrawal by Subject and Other|12|||
13457382|NCT00160706|26958659|FG000|Overall Study|Physician Decision|10|||
13457383|NCT00160706|26958659|FG000|Overall Study|Physician Decision and Other|3|||
13457384|NCT00160706|26958659|FG000|Overall Study|Lost to Follow-up|4|||
13457385|NCT00160706|26958659|FG000|Overall Study|Lost to Follow-up and Other|1|||
13457386|NCT00160706|26958659|FG000|Overall Study|Lack of Efficacy|42|||
13457387|NCT00160706|26958659|FG000|Overall Study|Lack of Efficacy and Other|1|||
13457388|NCT00160706|26958659|FG000|Overall Study|Other Reason|11|||
13457389|NCT00160693|26958678|FG000|Overall Study|Adverse Event|97|||
13457390|NCT00160693|26958678|FG000|Overall Study|Lack of Efficacy|30|||
13457391|NCT00160693|26958678|FG000|Overall Study|Protocol Violation|24|||
13457392|NCT00160693|26958678|FG000|Overall Study|Lost to Follow-up|15|||
13457393|NCT00160693|26958678|FG000|Overall Study|Withdrawal by Subject|54|||
13457394|NCT00160693|26958678|FG000|Overall Study|Study terminated by sponsor|15|||
13457395|NCT00160680|26958717|FG000|Overall Study|Adverse Event|0|||
13457396|NCT00160680|26958718|FG001|Overall Study|Adverse Event|1|||
13457397|NCT00160680|26958717|FG000|Overall Study|Lack of Efficacy|2|||
13457398|NCT00160680|26958718|FG001|Overall Study|Lack of Efficacy|1|||
13457399|NCT00160680|26958717|FG000|Overall Study|Lost to Follow-up|3|||
13457400|NCT00160680|26958718|FG001|Overall Study|Lost to Follow-up|2|||
13457401|NCT00160680|26958717|FG000|Overall Study|Withdrawal by Subject|4|||
13457402|NCT00160680|26958718|FG001|Overall Study|Withdrawal by Subject|9|||
13457403|NCT00160667|26958775|FG000|Overall Study|Adverse Event|3|||
13457404|NCT00160667|26958776|FG001|Overall Study|Adverse Event|1|||
13457405|NCT00160667|26958777|FG002|Overall Study|Adverse Event|4|||
13457406|NCT00160667|26958775|FG000|Overall Study|Withdrawal by Subject|2|||
13457407|NCT00160667|26958776|FG001|Overall Study|Withdrawal by Subject|0|||
13457408|NCT00160667|26958777|FG002|Overall Study|Withdrawal by Subject|1|||
13457409|NCT00160667|26958775|FG000|Overall Study|Lack of Efficacy|0|||
13457410|NCT00160667|26958776|FG001|Overall Study|Lack of Efficacy|1|||
13457411|NCT00160667|26958777|FG002|Overall Study|Lack of Efficacy|0|||
13457412|NCT00160667|26958775|FG000|Overall Study|Protocol Violation|0|||
13457413|NCT00160667|26958776|FG001|Overall Study|Protocol Violation|1|||
13457414|NCT00160667|26958777|FG002|Overall Study|Protocol Violation|0|||
13457415|NCT00160667|26958775|FG000|Overall Study|Patient decision|0|||
13457416|NCT00160667|26958776|FG001|Overall Study|Patient decision|0|||
13457417|NCT00160667|26958777|FG002|Overall Study|Patient decision|1|||
13457418|NCT00160654|26958789|FG000|Overall Study|Adverse Event|14|||
13457419|NCT00160654|26958789|FG000|Overall Study|Lack of Efficacy|4|||
13457420|NCT00160654|26958789|FG000|Overall Study|Lost to Follow-up|2|||
13457421|NCT00160654|26958789|FG000|Overall Study|Intake of expired drug|7|||
13457422|NCT00160654|26958789|FG000|Overall Study|Psychological trauma|1|||
13457423|NCT00160654|26958789|FG000|Overall Study|Sponsor decision|1|||
13457424|NCT00160654|26958789|FG000|Overall Study|Patient met exclusion criteria|1|||
13457425|NCT00160654|26958789|FG000|Overall Study|Patient decision|1|||
13457426|NCT00160654|26958789|FG000|Overall Study|Poor compliance, dilantin toxicity|1|||
13457427|NCT00160654|26958789|FG000|Overall Study|Met exclusion criteria|1|||
13457428|NCT00160641|26958822|FG000|Overall Study|Adverse Event|102|||
13457429|NCT00160641|26958822|FG000|Overall Study|Withdrawal by Subject|87|||
13457430|NCT00160641|26958822|FG000|Overall Study|Lost to Follow-up|8|||
13457431|NCT00160641|26958822|FG000|Overall Study|Lack of Efficacy|12|||
13457432|NCT00160641|26958822|FG000|Overall Study|Protocol Violation|3|||
13457433|NCT00160641|26958822|FG000|Overall Study|Other|9|||
13457434|NCT00160615|26958849|FG000|Overall Study|Adverse Event|5|||
13457435|NCT00160615|26958850|FG001|Overall Study|Adverse Event|12|||
13457436|NCT00160615|26958849|FG000|Overall Study|Withdrawal by Subject|0|||
13457437|NCT00160615|26958850|FG001|Overall Study|Withdrawal by Subject|2|||
13457438|NCT00160615|26958849|FG000|Overall Study|Lack of Efficacy|11|||
13457439|NCT00160615|26958850|FG001|Overall Study|Lack of Efficacy|23|||
13457440|NCT00160615|26958849|FG000|Overall Study|Patient decision|1|||
13457441|NCT00160615|26958850|FG001|Overall Study|Patient decision|2|||
13457442|NCT00160615|26958849|FG000|Overall Study|Investigator decision|1|||
13457443|NCT00160615|26958850|FG001|Overall Study|Investigator decision|1|||
13457444|NCT00160615|26958849|FG000|Overall Study|AE agents had to be discontinued (exam.)|0|||
13457445|NCT00160615|26958850|FG001|Overall Study|AE agents had to be discontinued (exam.)|1|||
13457446|NCT00160615|26958849|FG000|Overall Study|Switch to surgical treatment|0|||
13457447|NCT00160615|26958850|FG001|Overall Study|Switch to surgical treatment|2|||
13457448|NCT00160615|26958849|FG000|Overall Study|Non-compliance was suspected|0|||
13457449|NCT00160615|26958850|FG001|Overall Study|Non-compliance was suspected|1|||
13457450|NCT00160615|26958849|FG000|Overall Study|Poor compliance|0|||
13457451|NCT00160615|26958850|FG001|Overall Study|Poor compliance|1|||
13457452|NCT00160563|26958872|FG000|Overall Study|Adverse Event|1|||
13457453|NCT00160563|26958873|FG001|Overall Study|Adverse Event|1|||
13457454|NCT00160563|26958874|FG002|Overall Study|Adverse Event|1|||
13457455|NCT00160563|26958872|FG000|Overall Study|Lost to Follow-up|1|||
13457456|NCT00160563|26958873|FG001|Overall Study|Lost to Follow-up|1|||
13457457|NCT00160563|26958874|FG002|Overall Study|Lost to Follow-up|2|||
13457458|NCT00160563|26958872|FG000|Overall Study|Protocol Violation|0|||
13457459|NCT00160563|26958873|FG001|Overall Study|Protocol Violation|0|||
13457460|NCT00160563|26958874|FG002|Overall Study|Protocol Violation|3|||
13457461|NCT00160563|26958872|FG000|Overall Study|Withdrawal by Subject|1|||
13457462|NCT00160563|26958873|FG001|Overall Study|Withdrawal by Subject|2|||
13457463|NCT00160563|26958874|FG002|Overall Study|Withdrawal by Subject|3|||
13457464|NCT00160563|26958872|FG000|Overall Study|Other (listed in the study report)|48|||
13457465|NCT00160563|26958873|FG001|Overall Study|Other (listed in the study report)|40|||
13457466|NCT00160563|26958874|FG002|Overall Study|Other (listed in the study report)|81|||
13457467|NCT00160563|26958872|FG000|Overall Study|Missing reason|0|||
13457468|NCT00160563|26958873|FG001|Overall Study|Missing reason|1|||
13457469|NCT00160563|26958874|FG002|Overall Study|Missing reason|0|||
13457470|NCT00160524|26958887|FG000|Overall Study|Adverse Event|119|||
13457471|NCT00160524|26958887|FG000|Overall Study|Adverse Event and Other|94|||
13457472|NCT00160524|26958887|FG000|Overall Study|Protocol Violation|16|||
13457473|NCT00160524|26958887|FG000|Overall Study|Protocol Violation and Other|2|||
13457474|NCT00160524|26958887|FG000|Overall Study|Withdrawal by Subject|141|||
13457475|NCT00160524|26958887|FG000|Overall Study|Withdrawal by Subject and Other|17|||
13457476|NCT00160524|26958887|FG000|Overall Study|Physician Decision|27|||
13457477|NCT00160524|26958887|FG000|Overall Study|Physician Decision and Other|6|||
13457478|NCT00160524|26958887|FG000|Overall Study|Lost to Follow-up|13|||
13457479|NCT00160524|26958887|FG000|Overall Study|Lost to Follow-up and Other|1|||
13457480|NCT00160524|26958887|FG000|Overall Study|Lack of Efficacy|21|||
13457481|NCT00160524|26958887|FG000|Overall Study|Lack of Efficacy and Other|1|||
13457482|NCT00160524|26958887|FG000|Overall Study|Other|20|||
13457483|NCT00160251|26958982|FG000|Prior to Amendment 2|Adverse Event|2|||
13457484|NCT00160251|26958983|FG001|Prior to Amendment 2|Adverse Event|1|||
13457485|NCT00160251|26958984|FG002|Prior to Amendment 2|Adverse Event|3|||
13457486|NCT00160251|26958985|FG003|Prior to Amendment 2|Adverse Event|1|||
13457487|NCT00160251|26958986|FG004|Prior to Amendment 2|Adverse Event|1|||
13457488|NCT00160251|26958987|FG005|Prior to Amendment 2|Adverse Event|1|||
13457489|NCT00160251|26958988|FG006|Prior to Amendment 2|Adverse Event|1|||
13457490|NCT00160251|26958989|FG007|Prior to Amendment 2|Adverse Event|0|||
13457491|NCT00160251|26958982|FG000|Prior to Amendment 2|Lack of Efficacy|0|||
13457492|NCT00160251|26958983|FG001|Prior to Amendment 2|Lack of Efficacy|4|||
13457493|NCT00160251|26958984|FG002|Prior to Amendment 2|Lack of Efficacy|37|||
13457494|NCT00160251|26958985|FG003|Prior to Amendment 2|Lack of Efficacy|35|||
13457495|NCT00160251|26958986|FG004|Prior to Amendment 2|Lack of Efficacy|24|||
13457496|NCT00160251|26958987|FG005|Prior to Amendment 2|Lack of Efficacy|55|||
13457497|NCT00160251|26958988|FG006|Prior to Amendment 2|Lack of Efficacy|0|||
13457498|NCT00160251|26958989|FG007|Prior to Amendment 2|Lack of Efficacy|0|||
13457499|NCT00160251|26958982|FG000|Prior to Amendment 2|Lost to Follow-up|0|||
13457500|NCT00160251|26958983|FG001|Prior to Amendment 2|Lost to Follow-up|0|||
13457501|NCT00160251|26958984|FG002|Prior to Amendment 2|Lost to Follow-up|1|||
13457502|NCT00160251|26958985|FG003|Prior to Amendment 2|Lost to Follow-up|0|||
13457503|NCT00160251|26958986|FG004|Prior to Amendment 2|Lost to Follow-up|1|||
13457504|NCT00160251|26958987|FG005|Prior to Amendment 2|Lost to Follow-up|1|||
13457505|NCT00160251|26958988|FG006|Prior to Amendment 2|Lost to Follow-up|0|||
13457506|NCT00160251|26958989|FG007|Prior to Amendment 2|Lost to Follow-up|0|||
13457507|NCT00160251|26958982|FG000|Prior to Amendment 2|Withdrawal by Subject|3|||
13457508|NCT00160251|26958983|FG001|Prior to Amendment 2|Withdrawal by Subject|1|||
13457509|NCT00160251|26958984|FG002|Prior to Amendment 2|Withdrawal by Subject|3|||
13457510|NCT00160251|26958985|FG003|Prior to Amendment 2|Withdrawal by Subject|4|||
13457511|NCT00160251|26958986|FG004|Prior to Amendment 2|Withdrawal by Subject|2|||
13457512|NCT00160251|26958987|FG005|Prior to Amendment 2|Withdrawal by Subject|3|||
13457513|NCT00160251|26958988|FG006|Prior to Amendment 2|Withdrawal by Subject|3|||
13457514|NCT00160251|26958989|FG007|Prior to Amendment 2|Withdrawal by Subject|0|||
13457515|NCT00160251|26958982|FG000|Prior to Amendment 2|Noncompliance with protocol|1|||
13457516|NCT00160251|26958983|FG001|Prior to Amendment 2|Noncompliance with protocol|0|||
13457517|NCT00160251|26958984|FG002|Prior to Amendment 2|Noncompliance with protocol|0|||
13457518|NCT00160251|26958985|FG003|Prior to Amendment 2|Noncompliance with protocol|0|||
13457519|NCT00160251|26958986|FG004|Prior to Amendment 2|Noncompliance with protocol|0|||
13457520|NCT00160251|26958987|FG005|Prior to Amendment 2|Noncompliance with protocol|0|||
13457521|NCT00160251|26958988|FG006|Prior to Amendment 2|Noncompliance with protocol|0|||
13457522|NCT00160251|26958989|FG007|Prior to Amendment 2|Noncompliance with protocol|0|||
13457523|NCT00160251|26958982|FG000|Prior to Amendment 2|Completed Treatment Phase|3|||
13457524|NCT00160251|26958983|FG001|Prior to Amendment 2|Completed Treatment Phase|0|||
13457525|NCT00160251|26958984|FG002|Prior to Amendment 2|Completed Treatment Phase|0|||
13457526|NCT00160251|26958985|FG003|Prior to Amendment 2|Completed Treatment Phase|0|||
13457527|NCT00160251|26958986|FG004|Prior to Amendment 2|Completed Treatment Phase|0|||
13457528|NCT00160251|26958987|FG005|Prior to Amendment 2|Completed Treatment Phase|23|||
13457529|NCT00160251|26958988|FG006|Prior to Amendment 2|Completed Treatment Phase|0|||
13457530|NCT00160251|26958989|FG007|Prior to Amendment 2|Completed Treatment Phase|0|||
13457531|NCT00160251|26958982|FG000|Post-amendment 2|Adverse Event|0|||
13457532|NCT00160251|26958983|FG001|Post-amendment 2|Adverse Event|0|||
13457533|NCT00160251|26958984|FG002|Post-amendment 2|Adverse Event|0|||
13457534|NCT00160251|26958985|FG003|Post-amendment 2|Adverse Event|0|||
13457535|NCT00160251|26958986|FG004|Post-amendment 2|Adverse Event|0|||
13457536|NCT00160251|26958987|FG005|Post-amendment 2|Adverse Event|0|||
13457537|NCT00160251|26958988|FG006|Post-amendment 2|Adverse Event|0|||
13457538|NCT00160251|26958989|FG007|Post-amendment 2|Adverse Event|20|||
13457539|NCT00160251|26958982|FG000|Post-amendment 2|Lack of Efficacy|0|||
13457540|NCT00160251|26958983|FG001|Post-amendment 2|Lack of Efficacy|0|||
13457541|NCT00160251|26958984|FG002|Post-amendment 2|Lack of Efficacy|0|||
13457542|NCT00160251|26958985|FG003|Post-amendment 2|Lack of Efficacy|0|||
13457543|NCT00160251|26958986|FG004|Post-amendment 2|Lack of Efficacy|0|||
13457544|NCT00160251|26958987|FG005|Post-amendment 2|Lack of Efficacy|0|||
13457545|NCT00160251|26958988|FG006|Post-amendment 2|Lack of Efficacy|0|||
13457546|NCT00160251|26958989|FG007|Post-amendment 2|Lack of Efficacy|24|||
13457547|NCT00160251|26958982|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
13457548|NCT00160251|26958983|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
13457549|NCT00160251|26958984|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
13457550|NCT00160251|26958985|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
13457551|NCT00160251|26958986|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
13457552|NCT00160251|26958987|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
13457553|NCT00160251|26958988|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
13457554|NCT00160251|26958989|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11|||
13457555|NCT00160199|26959014|FG000|Overall Study|Adverse Event|5|||
13457556|NCT00160199|26959015|FG001|Overall Study|Adverse Event|14|||
13457557|NCT00160199|26959014|FG000|Overall Study|Lack of Efficacy|0|||
13457558|NCT00160199|26959015|FG001|Overall Study|Lack of Efficacy|1|||
13457559|NCT00160199|26959014|FG000|Overall Study|Lost to Follow-up|7|||
13457560|NCT00160199|26959015|FG001|Overall Study|Lost to Follow-up|7|||
13457561|NCT00160199|26959014|FG000|Overall Study|Withdrawal by Subject|4|||
13457562|NCT00160199|26959015|FG001|Overall Study|Withdrawal by Subject|6|||
13457563|NCT00160199|26959014|FG000|Overall Study|Administrative|0|||
13457564|NCT00160199|26959015|FG001|Overall Study|Administrative|1|||
13457565|NCT00160199|26959014|FG000|Overall Study|Protocol Violation|8|||
13457566|NCT00160199|26959015|FG001|Overall Study|Protocol Violation|8|||
13457567|NCT00159913|26959095|FG000|Overall Study|Adverse Event|1|||
13457568|NCT00159913|26959096|FG001|Overall Study|Adverse Event|0|||
13457569|NCT00159913|26959097|FG002|Overall Study|Adverse Event|1|||
13457570|NCT00159913|26959098|FG003|Overall Study|Adverse Event|0|||
13457571|NCT00159913|26959095|FG000|Overall Study|Withdrawal by Subject|0|||
13457572|NCT00159913|26959096|FG001|Overall Study|Withdrawal by Subject|0|||
13457573|NCT00159913|26959097|FG002|Overall Study|Withdrawal by Subject|0|||
13457574|NCT00159913|26959098|FG003|Overall Study|Withdrawal by Subject|1|||
13457575|NCT00159913|26959095|FG000|Overall Study|Lost to Follow-up|0|||
13457576|NCT00159913|26959096|FG001|Overall Study|Lost to Follow-up|0|||
13457577|NCT00159913|26959097|FG002|Overall Study|Lost to Follow-up|0|||
13457578|NCT00159913|26959098|FG003|Overall Study|Lost to Follow-up|1|||
13457579|NCT00159913|26959095|FG000|Overall Study|Protocol Violation|1|||
13457580|NCT00159913|26959096|FG001|Overall Study|Protocol Violation|0|||
13457581|NCT00159913|26959097|FG002|Overall Study|Protocol Violation|1|||
13457582|NCT00159913|26959098|FG003|Overall Study|Protocol Violation|0|||
13457583|NCT00159874|26959288|FG000|Overall Study|Adverse Event|2|||
13457584|NCT00159874|26959289|FG001|Overall Study|Adverse Event|2|||
13457585|NCT00159874|26959290|FG002|Overall Study|Adverse Event|5|||
13457586|NCT00159874|26959291|FG003|Overall Study|Adverse Event|1|||
13457587|NCT00159874|26959292|FG004|Overall Study|Adverse Event|1|||
13457588|NCT00159874|26959293|FG005|Overall Study|Adverse Event|2|||
13457589|NCT00159874|26959294|FG006|Overall Study|Adverse Event|0|||
13457590|NCT00159874|26959288|FG000|Overall Study|Does Not Meet Entrance Criteria|1|||
13457591|NCT00159874|26959289|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
13457592|NCT00159874|26959290|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
13457593|NCT00159874|26959291|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
13457594|NCT00159874|26959292|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
13457595|NCT00159874|26959293|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
13457596|NCT00159874|26959294|FG006|Overall Study|Does Not Meet Entrance Criteria|0|||
13457597|NCT00159874|26959288|FG000|Overall Study|Lack of Efficacy|2|||
13457598|NCT00159874|26959289|FG001|Overall Study|Lack of Efficacy|0|||
13457599|NCT00159874|26959290|FG002|Overall Study|Lack of Efficacy|1|||
13457600|NCT00159874|26959291|FG003|Overall Study|Lack of Efficacy|1|||
13457601|NCT00159874|26959292|FG004|Overall Study|Lack of Efficacy|0|||
13457602|NCT00159874|26959293|FG005|Overall Study|Lack of Efficacy|3|||
13457603|NCT00159874|26959294|FG006|Overall Study|Lack of Efficacy|0|||
13457604|NCT00159874|26959288|FG000|Overall Study|Lost to Follow-up|1|||
13457605|NCT00159874|26959289|FG001|Overall Study|Lost to Follow-up|0|||
13457606|NCT00159874|26959290|FG002|Overall Study|Lost to Follow-up|3|||
13457607|NCT00159874|26959291|FG003|Overall Study|Lost to Follow-up|0|||
13457608|NCT00159874|26959292|FG004|Overall Study|Lost to Follow-up|1|||
13457609|NCT00159874|26959293|FG005|Overall Study|Lost to Follow-up|2|||
13457610|NCT00159874|26959294|FG006|Overall Study|Lost to Follow-up|1|||
13457611|NCT00159874|26959288|FG000|Overall Study|Other|8|||
13457612|NCT00159874|26959289|FG001|Overall Study|Other|8|||
13457613|NCT00159874|26959290|FG002|Overall Study|Other|8|||
13457614|NCT00159874|26959291|FG003|Overall Study|Other|0|||
13457615|NCT00159874|26959292|FG004|Overall Study|Other|2|||
13457616|NCT00159874|26959293|FG005|Overall Study|Other|1|||
13457617|NCT00159874|26959294|FG006|Overall Study|Other|3|||
13457618|NCT00159874|26959288|FG000|Overall Study|Protocol Violation|0|||
13457619|NCT00159874|26959289|FG001|Overall Study|Protocol Violation|5|||
13457620|NCT00159874|26959290|FG002|Overall Study|Protocol Violation|2|||
13457621|NCT00159874|26959291|FG003|Overall Study|Protocol Violation|0|||
13457622|NCT00159874|26959292|FG004|Overall Study|Protocol Violation|0|||
13457623|NCT00159874|26959293|FG005|Overall Study|Protocol Violation|0|||
13457624|NCT00159874|26959294|FG006|Overall Study|Protocol Violation|0|||
13457625|NCT00159874|26959288|FG000|Overall Study|Death|3|||
13457626|NCT00159874|26959289|FG001|Overall Study|Death|8|||
13457627|NCT00159874|26959290|FG002|Overall Study|Death|15|||
13457628|NCT00159874|26959291|FG003|Overall Study|Death|0|||
13457629|NCT00159874|26959292|FG004|Overall Study|Death|1|||
13457630|NCT00159874|26959293|FG005|Overall Study|Death|2|||
13457631|NCT00159874|26959294|FG006|Overall Study|Death|0|||
13457632|NCT00159874|26959288|FG000|Overall Study|Withdrawal by Subject|2|||
13457633|NCT00159874|26959289|FG001|Overall Study|Withdrawal by Subject|6|||
13457634|NCT00159874|26959290|FG002|Overall Study|Withdrawal by Subject|8|||
13457635|NCT00159874|26959291|FG003|Overall Study|Withdrawal by Subject|4|||
13457636|NCT00159874|26959292|FG004|Overall Study|Withdrawal by Subject|3|||
13457637|NCT00159874|26959293|FG005|Overall Study|Withdrawal by Subject|2|||
13457638|NCT00159874|26959294|FG006|Overall Study|Withdrawal by Subject|1|||
13457639|NCT00159874|26959288|FG000|Overall Study|Pregnancy|1|||
13457640|NCT00159874|26959289|FG001|Overall Study|Pregnancy|1|||
13457641|NCT00159874|26959290|FG002|Overall Study|Pregnancy|0|||
13457642|NCT00159874|26959291|FG003|Overall Study|Pregnancy|0|||
13457643|NCT00159874|26959292|FG004|Overall Study|Pregnancy|0|||
13457644|NCT00159874|26959293|FG005|Overall Study|Pregnancy|0|||
13457645|NCT00159874|26959294|FG006|Overall Study|Pregnancy|0|||
13457646|NCT00159861|26959322|FG000|Core Study - 16 Weeks|Death|3|||
13457647|NCT00159861|26959323|FG001|Core Study - 16 Weeks|Death|0|||
13457648|NCT00159861|26959322|FG000|Core Study - 16 Weeks|Adverse Event|12|||
13457649|NCT00159861|26959323|FG001|Core Study - 16 Weeks|Adverse Event|6|||
13457650|NCT00159861|26959322|FG000|Core Study - 16 Weeks|Lack of Efficacy|2|||
13457651|NCT00159861|26959323|FG001|Core Study - 16 Weeks|Lack of Efficacy|3|||
13457652|NCT00159861|26959322|FG000|Core Study - 16 Weeks|Reason Unspecified|5|||
13457653|NCT00159861|26959323|FG001|Core Study - 16 Weeks|Reason Unspecified|3|||
13457654|NCT00159861|26959322|FG000|Core Study - 16 Weeks|Subject Defaulted|1|||
13457655|NCT00159861|26959323|FG001|Core Study - 16 Weeks|Subject Defaulted|0|||
13457656|NCT00159861|26959322|FG000|Core Study - 16 Weeks|Randomized but not Treated|2|||
13457657|NCT00159861|26959323|FG001|Core Study - 16 Weeks|Randomized but not Treated|0|||
13457658|NCT00159861|26959322|FG000|Extension Study - up to 3 Years|Death|24|||
13457659|NCT00159861|26959323|FG001|Extension Study - up to 3 Years|Death|28|||
13457660|NCT00159861|26959322|FG000|Extension Study - up to 3 Years|Adverse Event|14|||
13457661|NCT00159861|26959323|FG001|Extension Study - up to 3 Years|Adverse Event|14|||
13457662|NCT00159861|26959322|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5|||
13457663|NCT00159861|26959323|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1|||
13457664|NCT00159861|26959322|FG000|Extension Study - up to 3 Years|Reason Unspecified|12|||
13457665|NCT00159861|26959323|FG001|Extension Study - up to 3 Years|Reason Unspecified|19|||
13457666|NCT00159861|26959322|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7|||
13457667|NCT00159861|26959323|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9|||
13457668|NCT00159822|26959340|FG000|Voriconazole Treatment Period|Lack of Efficacy|3|||
13457669|NCT00159822|26959340|FG000|Voriconazole Treatment Period|Adverse Event|9|||
13457670|NCT00159822|26959340|FG000|Voriconazole Treatment Period|Death|4|||
13457671|NCT00159822|26959340|FG000|Voriconazole Treatment Period|Protocol Violation|2|||
13457672|NCT00159822|26959340|FG000|Voriconazole Treatment Period|Lost to Follow-up|2|||
13457673|NCT00159822|26959340|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2|||
13457674|NCT00159822|26959340|FG000|Post-treatment Follow-up Period|Death|1|||
13457675|NCT00159822|26959340|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1|||
13457676|NCT00159822|26959340|FG000|Post-treatment Follow-up Period|Reason unspecified|1|||
13457677|NCT00158262|26959357|FG000|Overall Study|Lost to Follow-up|1|||
13457678|NCT00158262|26959358|FG001|Overall Study|Lost to Follow-up|1|||
13457679|NCT00157950|26959379|FG000|Overall Study|Death|1|||
13457680|NCT00157950|26959380|FG001|Overall Study|Death|0|||
13457681|NCT00157820|26959401|FG000|Randomized|Physician Decision|4|||
13457682|NCT00157820|26959402|FG001|Randomized|Physician Decision|2|||
13457683|NCT00157820|26959403|FG002|Randomized|Physician Decision|3|||
13457684|NCT00157820|26959401|FG000|Randomized|Withdrawal by Subject|1|||
13457685|NCT00157820|26959402|FG001|Randomized|Withdrawal by Subject|2|||
13457686|NCT00157820|26959403|FG002|Randomized|Withdrawal by Subject|3|||
13457687|NCT00157820|26959401|FG000|Randomized|Protocol Violation|2|||
13457688|NCT00157820|26959402|FG001|Randomized|Protocol Violation|1|||
13457689|NCT00157820|26959403|FG002|Randomized|Protocol Violation|2|||
13457690|NCT00157820|26959401|FG000|1st 8 Month|Death|7|||
13457691|NCT00157820|26959402|FG001|1st 8 Month|Death|8|||
13457692|NCT00157820|26959403|FG002|1st 8 Month|Death|3|||
13457693|NCT00157820|26959401|FG000|1st 8 Month|Lost to Follow-up|1|||
13457694|NCT00157820|26959402|FG001|1st 8 Month|Lost to Follow-up|2|||
13457695|NCT00157820|26959403|FG002|1st 8 Month|Lost to Follow-up|1|||
13457696|NCT00157820|26959401|FG000|1st 8 Month|Premature cross-over|0|||
13457697|NCT00157820|26959402|FG001|1st 8 Month|Premature cross-over|2|||
13457698|NCT00157820|26959403|FG002|1st 8 Month|Premature cross-over|2|||
13457699|NCT00157820|26959401|FG000|2nd 8 Months|Death|3|||
13457700|NCT00157820|26959402|FG001|2nd 8 Months|Death|1|||
13457701|NCT00157820|26959403|FG002|2nd 8 Months|Death|3|||
13457702|NCT00157820|26959401|FG000|2nd 8 Months|Lost to Follow-up|1|||
13457703|NCT00157820|26959402|FG001|2nd 8 Months|Lost to Follow-up|5|||
13457704|NCT00157820|26959403|FG002|2nd 8 Months|Lost to Follow-up|2|||
13457705|NCT00157820|26959401|FG000|2nd 8 Months|Premature cross-over|1|||
13457706|NCT00157820|26959402|FG001|2nd 8 Months|Premature cross-over|7|||
13457707|NCT00157820|26959403|FG002|2nd 8 Months|Premature cross-over|9|||
13457708|NCT00157209|26959424|FG000|Overall Study|Ongoing at data cut-off|10|||
13457709|NCT00157209|26959425|FG001|Overall Study|Ongoing at data cut-off|0|||
13457710|NCT00157157|26959450|FG000|Overall Study|Withdrawal by Subject|6|||
13457711|NCT00157157|26959450|FG000|Overall Study|Physician Decision|1|||
13457712|NCT00157157|26959450|FG000|Overall Study|Lost to Follow-up|1|||
13457713|NCT00157157|26959450|FG000|Overall Study|Enrolled in another study|1|||
13457714|NCT00157157|26959450|FG000|Overall Study|Met exclusion criteria|1|||
13457715|NCT00157157|26959450|FG000|Overall Study|Inclusion not met- baseline FVIII value|1|||
13457716|NCT00156819|26959468|FG000|Overall Study|Lost to Follow-up|1|||
13457717|NCT00156819|26959469|FG001|Overall Study|Lost to Follow-up|1|||
13457718|NCT00156819|26959470|FG002|Overall Study|Lost to Follow-up|3|||
13457719|NCT00154310|26959491|FG000|Overall Study|Adverse Event|19|||
13457720|NCT00154310|26959492|FG001|Overall Study|Adverse Event|9|||
13457721|NCT00154310|26959491|FG000|Overall Study|Lack of Efficacy|5|||
13457722|NCT00154310|26959492|FG001|Overall Study|Lack of Efficacy|4|||
13457723|NCT00154310|26959491|FG000|Overall Study|Protocol Violation|4|||
13457724|NCT00154310|26959492|FG001|Overall Study|Protocol Violation|2|||
13457725|NCT00154310|26959491|FG000|Overall Study|Withdrawal by Subject|9|||
13457726|NCT00154310|26959492|FG001|Overall Study|Withdrawal by Subject|3|||
13457727|NCT00154310|26959491|FG000|Overall Study|Lost to Follow-up|0|||
13457728|NCT00154310|26959492|FG001|Overall Study|Lost to Follow-up|8|||
13457729|NCT00154310|26959491|FG000|Overall Study|Administrative problems|0|||
13457730|NCT00154310|26959492|FG001|Overall Study|Administrative problems|1|||
13457731|NCT00154310|26959491|FG000|Overall Study|Death|0|||
13457732|NCT00154310|26959492|FG001|Overall Study|Death|1|||
13457733|NCT00153816|26959531|FG000|Overall Study|Death|6|||
13457734|NCT00153816|26959532|FG001|Overall Study|Death|5|||
13457735|NCT00153816|26959533|FG002|Overall Study|Death|4|||
13457736|NCT00153816|26959534|FG003|Overall Study|Death|6|||
13457737|NCT00153816|26959535|FG004|Overall Study|Death|0|||
13457738|NCT00153816|26959536|FG005|Overall Study|Death|2|||
13457739|NCT00153816|26959531|FG000|Overall Study|Lost to Follow-up|7|||
13457740|NCT00153816|26959532|FG001|Overall Study|Lost to Follow-up|8|||
13457741|NCT00153816|26959533|FG002|Overall Study|Lost to Follow-up|5|||
13457742|NCT00153816|26959534|FG003|Overall Study|Lost to Follow-up|8|||
13457743|NCT00153816|26959535|FG004|Overall Study|Lost to Follow-up|7|||
13457744|NCT00153816|26959536|FG005|Overall Study|Lost to Follow-up|9|||
13457745|NCT00153816|26959531|FG000|Overall Study|Withdrawal by Subject|9|||
13457746|NCT00153816|26959532|FG001|Overall Study|Withdrawal by Subject|9|||
13457747|NCT00153816|26959533|FG002|Overall Study|Withdrawal by Subject|9|||
13457748|NCT00153816|26959534|FG003|Overall Study|Withdrawal by Subject|4|||
13457749|NCT00153816|26959535|FG004|Overall Study|Withdrawal by Subject|1|||
13457750|NCT00153816|26959536|FG005|Overall Study|Withdrawal by Subject|5|||
13457751|NCT00153816|26959531|FG000|Overall Study|Follow-up exam not done|8|||
13457752|NCT00153816|26959532|FG001|Overall Study|Follow-up exam not done|7|||
13457753|NCT00153816|26959533|FG002|Overall Study|Follow-up exam not done|11|||
13457754|NCT00153816|26959534|FG003|Overall Study|Follow-up exam not done|10|||
13457755|NCT00153816|26959535|FG004|Overall Study|Follow-up exam not done|8|||
13457756|NCT00153816|26959536|FG005|Overall Study|Follow-up exam not done|9|||
13457757|NCT00153816|26959531|FG000|Overall Study|Follow-up exam done, histology missing|2|||
13457758|NCT00153816|26959532|FG001|Overall Study|Follow-up exam done, histology missing|3|||
13457759|NCT00153816|26959533|FG002|Overall Study|Follow-up exam done, histology missing|3|||
13457760|NCT00153816|26959534|FG003|Overall Study|Follow-up exam done, histology missing|3|||
13457761|NCT00153816|26959535|FG004|Overall Study|Follow-up exam done, histology missing|1|||
13457762|NCT00153816|26959536|FG005|Overall Study|Follow-up exam done, histology missing|2|||
13457763|NCT00153101|26959656|FG000|Overall Study|Lost to Follow-up|14|||
13457764|NCT00153101|26959657|FG001|Overall Study|Lost to Follow-up|14|||
13457765|NCT00153101|26959658|FG002|Overall Study|Lost to Follow-up|12|||
13457766|NCT00153101|26959659|FG003|Overall Study|Lost to Follow-up|5|||
13457767|NCT00153101|26959660|FG004|Overall Study|Lost to Follow-up|5|||
13457768|NCT00153101|26959656|FG000|Overall Study|Withdrawal by Subject|3|||
13457769|NCT00153101|26959657|FG001|Overall Study|Withdrawal by Subject|4|||
13457770|NCT00153101|26959658|FG002|Overall Study|Withdrawal by Subject|3|||
13457771|NCT00153101|26959659|FG003|Overall Study|Withdrawal by Subject|3|||
13457772|NCT00153101|26959660|FG004|Overall Study|Withdrawal by Subject|5|||
13457773|NCT00153062|26959689|FG000|Overall Study|Death|360|||
13457774|NCT00153062|26959690|FG001|Overall Study|Death|352|||
13457775|NCT00153062|26959691|FG002|Overall Study|Death|369|||
13457776|NCT00153062|26959692|FG003|Overall Study|Death|365|||
13457777|NCT00153062|26959689|FG000|Overall Study|Withdrawal by Subject|14|||
13457778|NCT00153062|26959690|FG001|Overall Study|Withdrawal by Subject|30|||
13457779|NCT00153062|26959691|FG002|Overall Study|Withdrawal by Subject|27|||
13457780|NCT00153062|26959692|FG003|Overall Study|Withdrawal by Subject|28|||
13457781|NCT00153062|26959689|FG000|Overall Study|Lost to Follow-up|12|||
13457782|NCT00153062|26959690|FG001|Overall Study|Lost to Follow-up|20|||
13457783|NCT00153062|26959691|FG002|Overall Study|Lost to Follow-up|15|||
13457784|NCT00153062|26959692|FG003|Overall Study|Lost to Follow-up|16|||
13457785|NCT00153062|26959689|FG000|Overall Study|Adverse Event|0|||
13457786|NCT00153062|26959690|FG001|Overall Study|Adverse Event|1|||
13457787|NCT00153062|26959691|FG002|Overall Study|Adverse Event|1|||
13457788|NCT00153062|26959692|FG003|Overall Study|Adverse Event|0|||
13457789|NCT00153062|26959689|FG000|Overall Study|Protocol Violation|0|||
13457790|NCT00153062|26959690|FG001|Overall Study|Protocol Violation|2|||
13457791|NCT00153062|26959691|FG002|Overall Study|Protocol Violation|1|||
13457792|NCT00153062|26959692|FG003|Overall Study|Protocol Violation|1|||
13457793|NCT00153062|26959689|FG000|Overall Study|No disposition data available|1|||
13457794|NCT00153062|26959690|FG001|Overall Study|No disposition data available|1|||
13457795|NCT00153062|26959691|FG002|Overall Study|No disposition data available|1|||
13457796|NCT00153062|26959692|FG003|Overall Study|No disposition data available|1|||
13457797|NCT00153062|26959689|FG000|Overall Study|Other|0|||
13457798|NCT00153062|26959690|FG001|Overall Study|Other|0|||
13457799|NCT00153062|26959691|FG002|Overall Study|Other|1|||
13457800|NCT00153062|26959692|FG003|Overall Study|Other|0|||
13457801|NCT00152516|26959718|FG000|Overall Study|Adverse Event|18|||
13457802|NCT00152516|26959718|FG000|Overall Study|Lack and Loss of Efficacy|30|||
13457803|NCT00152516|26959718|FG000|Overall Study|Lost to Follow-up|5|||
13457804|NCT00152516|26959718|FG000|Overall Study|Withdrawal by Subject|8|||
13457805|NCT00152516|26959718|FG000|Overall Study|Protocol Violation|3|||
13457806|NCT00152516|26959718|FG000|Overall Study|Other: Mother Refused To Cooperate|1|||
13457807|NCT00152516|26959718|FG000|Overall Study|Other: Given Commercial Drug in Error|2|||
13457808|NCT00152516|26959718|FG000|Overall Study|Other: Parents Withdrew Consent|2|||
13457809|NCT00152516|26959718|FG000|Overall Study|Other: Non-Compliance|2|||
13457810|NCT00152516|26959718|FG000|Overall Study|Other: Primary Care Physician's Decision|1|||
13457811|NCT00152516|26959718|FG000|Overall Study|Other: Moved Out Of State|1|||
13457812|NCT00152516|26959718|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1|||
13457813|NCT00152516|26959718|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1|||
13457814|NCT00151476|26959782|FG000|FAP Identified Subjects|Protocol Violation|0|||
13457815|NCT00151476|26959783|FG001|FAP Identified Subjects|Protocol Violation|1|||
13457816|NCT00151476|26959782|FG000|FAP Analyzed Subjects|Lost to Follow-up|0|||
13457817|NCT00151476|26959783|FG001|FAP Analyzed Subjects|Lost to Follow-up|2|||
13457818|NCT00151476|26959782|FG000|FAP Analyzed Subjects|Other study participation|0|||
13457819|NCT00151476|26959783|FG001|FAP Analyzed Subjects|Other study participation|1|||
13457820|NCT00150969|26959822|FG000|24 Month Main Study|Adverse Event|3|||
13457821|NCT00150969|26959823|FG001|24 Month Main Study|Adverse Event|4|||
13457822|NCT00150969|26959822|FG000|24 Month Main Study|Death|1|||
13457823|NCT00150969|26959823|FG001|24 Month Main Study|Death|1|||
13457824|NCT00150969|26959822|FG000|24 Month Main Study|Lack of Efficacy|1|||
13457825|NCT00150969|26959823|FG001|24 Month Main Study|Lack of Efficacy|8|||
13457826|NCT00150969|26959822|FG000|24 Month Main Study|Lost to Follow-up|3|||
13457827|NCT00150969|26959823|FG001|24 Month Main Study|Lost to Follow-up|2|||
13457828|NCT00150969|26959822|FG000|24 Month Main Study|Protocol Violation|4|||
13457829|NCT00150969|26959823|FG001|24 Month Main Study|Protocol Violation|2|||
13457830|NCT00150969|26959822|FG000|24 Month Main Study|Withdrawal by Subject|7|||
13457831|NCT00150969|26959823|FG001|24 Month Main Study|Withdrawal by Subject|4|||
13457832|NCT00150969|26959822|FG000|24-48 Month Extension|Withdrawal by Subject|6|||
13457833|NCT00150969|26959823|FG001|24-48 Month Extension|Withdrawal by Subject|5|||
13457834|NCT00150969|26959822|FG000|24-48 Month Extension|Lack of Efficacy|0|||
13457835|NCT00150969|26959823|FG001|24-48 Month Extension|Lack of Efficacy|1|||
13457836|NCT00150969|26959822|FG000|24-48 Month Extension|Adverse Event|1|||
13457837|NCT00150969|26959823|FG001|24-48 Month Extension|Adverse Event|3|||
13457838|NCT00150969|26959822|FG000|24-48 Month Extension|Other Reason|81|||
13457839|NCT00150969|26959823|FG001|24-48 Month Extension|Other Reason|91|||
13457840|NCT00150800|26959834|FG000|Overall Study|Adverse Event|89|||
13457841|NCT00150800|26959834|FG000|Overall Study|Death|18|||
13457842|NCT00150800|26959834|FG000|Overall Study|Lack of Efficacy|166|||
13457843|NCT00150800|26959834|FG000|Overall Study|Lost to Follow-up|58|||
13457844|NCT00150800|26959834|FG000|Overall Study|Subject's choice|90|||
13457845|NCT00150800|26959834|FG000|Overall Study|No compliance|18|||
13457846|NCT00150800|26959834|FG000|Overall Study|IP misshandling|1|||
13457847|NCT00150800|26959834|FG000|Overall Study|Site closure|24|||
13457848|NCT00150800|26959834|FG000|Overall Study|Protocol non-adherence|2|||
13457849|NCT00150800|26959834|FG000|Overall Study|Nobody to accompany patient|1|||
13457850|NCT00150800|26959834|FG000|Overall Study|Distance too long for patient|1|||
13457851|NCT00150800|26959834|FG000|Overall Study|Neurosurgery|2|||
13457852|NCT00150800|26959834|FG000|Overall Study|BRV monotherapy|1|||
13457853|NCT00150800|26959834|FG000|Overall Study|Visit refusal|3|||
13457854|NCT00150800|26959834|FG000|Overall Study|Sponsor's request|2|||
13457855|NCT00150800|26959834|FG000|Overall Study|Generalized Epilepsy|1|||
13457856|NCT00150800|26959834|FG000|Overall Study|Moved from area/country|8|||
13457857|NCT00150800|26959834|FG000|Overall Study|PI retiring|2|||
13457858|NCT00150800|26959834|FG000|Overall Study|PI leaving site|2|||
13457859|NCT00150800|26959834|FG000|Overall Study|Patient insurance|1|||
13457860|NCT00150800|26959834|FG000|Overall Study|Surgical intervention|4|||
13457861|NCT00150800|26959834|FG000|Overall Study|Pregnancy planned|1|||
13457862|NCT00150800|26959834|FG000|Overall Study|PI discontinuation request|1|||
13457863|NCT00150592|26959861|FG000|Overall Study|Adverse Event|4|||
13457864|NCT00150592|26959862|FG001|Overall Study|Adverse Event|1|||
13457865|NCT00150592|26959861|FG000|Overall Study|Protocol Violation|1|||
13457866|NCT00150592|26959862|FG001|Overall Study|Protocol Violation|0|||
13457867|NCT00150592|26959861|FG000|Overall Study|Withdrawal by Subject|1|||
13457868|NCT00150592|26959862|FG001|Overall Study|Withdrawal by Subject|2|||
13457869|NCT00150592|26959861|FG000|Overall Study|Non-compliance|1|||
13457870|NCT00150592|26959862|FG001|Overall Study|Non-compliance|0|||
13457871|NCT00150345|26959931|FG000|Overall Study|Death|5|||
13457872|NCT00150345|26959932|FG001|Overall Study|Death|2|||
13457873|NCT00150345|26959931|FG000|Overall Study|Adverse Event|8|||
13457874|NCT00150345|26959932|FG001|Overall Study|Adverse Event|6|||
13457875|NCT00150345|26959931|FG000|Overall Study|Lack of Efficacy|5|||
13457876|NCT00150345|26959932|FG001|Overall Study|Lack of Efficacy|4|||
13457877|NCT00150345|26959931|FG000|Overall Study|Withdrawal by Subject|3|||
13457878|NCT00150345|26959932|FG001|Overall Study|Withdrawal by Subject|4|||
13457879|NCT00150345|26959931|FG000|Overall Study|Laboratory abnormality|1|||
13457880|NCT00150345|26959932|FG001|Overall Study|Laboratory abnormality|2|||
13457881|NCT00150345|26959931|FG000|Overall Study|Other|12|||
13457882|NCT00150345|26959932|FG001|Overall Study|Other|14|||
13457883|NCT00149994|26959945|FG000|Overall Study|Administrative problems:|1|||
13457884|NCT00149994|26959946|FG001|Overall Study|Administrative problems:|0|||
13457885|NCT00149994|26959945|FG000|Overall Study|Protocol Violation|0|||
13457886|NCT00149994|26959946|FG001|Overall Study|Protocol Violation|1|||
13457887|NCT00149890|26959971|FG000|Overall Study|Adverse Event|1|||
13457888|NCT00149890|26959972|FG001|Overall Study|Adverse Event|8|||
13457889|NCT00149890|26959971|FG000|Overall Study|Lack of Efficacy|8|||
13457890|NCT00149890|26959972|FG001|Overall Study|Lack of Efficacy|9|||
13457891|NCT00149890|26959971|FG000|Overall Study|Protocol Violation|1|||
13457892|NCT00149890|26959972|FG001|Overall Study|Protocol Violation|0|||
13457893|NCT00149890|26959971|FG000|Overall Study|Lost to Follow-up|1|||
13457894|NCT00149890|26959972|FG001|Overall Study|Lost to Follow-up|0|||
13457895|NCT00149890|26959971|FG000|Overall Study|Graft Loss|2|||
13457896|NCT00149890|26959972|FG001|Overall Study|Graft Loss|1|||
13457897|NCT00149825|26959987|FG000|Overall Study|Intolerance to medication side effects|1|||
13457898|NCT00149825|26959988|FG001|Overall Study|Intolerance to medication side effects|2|||
13457899|NCT00149825|26959987|FG000|Overall Study|Time commitments|2|||
13457900|NCT00149825|26959988|FG001|Overall Study|Time commitments|1|||
13457901|NCT00149825|26959987|FG000|Overall Study|Not liking insomnia therapy|1|||
13457902|NCT00149825|26959988|FG001|Overall Study|Not liking insomnia therapy|0|||
13457903|NCT00149825|26959987|FG000|Overall Study|Other|1|||
13457904|NCT00149825|26959988|FG001|Overall Study|Other|0|||
13457905|NCT00149747|26960005|FG000|Overall Study|Death|1|||
13457906|NCT00149747|26960006|FG001|Overall Study|Death|0|||
13457907|NCT00149747|26960005|FG000|Overall Study|Withdrawal by Subject|3|||
13457908|NCT00149747|26960006|FG001|Overall Study|Withdrawal by Subject|3|||
13457909|NCT00149630|26960023|FG000|Overall Study|Incarceration|2|||
13457910|NCT00149630|26960024|FG001|Overall Study|Incarceration|0|||
13457911|NCT00149630|26960023|FG000|Overall Study|Treatment Programs|4|||
13457912|NCT00149630|26960024|FG001|Overall Study|Treatment Programs|5|||
13457913|NCT00149630|26960023|FG000|Overall Study|Adverse Event|2|||
13457914|NCT00149630|26960024|FG001|Overall Study|Adverse Event|0|||
13457915|NCT00149396|26960067|FG000|Overall Study|Death|15|||
13457916|NCT00149396|26960067|FG000|Overall Study|Withdrawal by Subject|1|||
13457917|NCT00149396|26960067|FG000|Overall Study|Subject noncompliance|2|||
13457918|NCT00149396|26960067|FG000|Overall Study|other treatment|5|||
13457919|NCT00149214|26960088|FG000|Overall Study|Adverse Event|12|||
13457920|NCT00149214|26960089|FG001|Overall Study|Adverse Event|9|||
13457921|NCT00149214|26960088|FG000|Overall Study|Withdrawal by Subject|4|||
13457922|NCT00149214|26960089|FG001|Overall Study|Withdrawal by Subject|1|||
13457923|NCT00149214|26960088|FG000|Overall Study|Physician Decision|3|||
13457924|NCT00149214|26960089|FG001|Overall Study|Physician Decision|3|||
13457925|NCT00149214|26960088|FG000|Overall Study|Sponsor Decision|0|||
13457926|NCT00149214|26960089|FG001|Overall Study|Sponsor Decision|1|||
13457927|NCT00149214|26960088|FG000|Overall Study|Progressive Disease|7|||
13457928|NCT00149214|26960089|FG001|Overall Study|Progressive Disease|3|||
13457929|NCT00148941|26960192|FG000|Overall Study|Lost to Follow-up|17|||
13457930|NCT00148941|26960193|FG001|Overall Study|Lost to Follow-up|24|||
13457931|NCT00148941|26960194|FG002|Overall Study|Lost to Follow-up|18|||
13457932|NCT00148941|26960195|FG003|Overall Study|Lost to Follow-up|22|||
13457933|NCT00148941|26960192|FG000|Overall Study|Withdrawal by Subject|1|||
13457934|NCT00148941|26960193|FG001|Overall Study|Withdrawal by Subject|0|||
13457935|NCT00148941|26960194|FG002|Overall Study|Withdrawal by Subject|1|||
13457936|NCT00148941|26960195|FG003|Overall Study|Withdrawal by Subject|0|||
13457937|NCT00148941|26960192|FG000|Overall Study|Other|0|||
13457938|NCT00148941|26960193|FG001|Overall Study|Other|0|||
13457939|NCT00148941|26960194|FG002|Overall Study|Other|1|||
13457940|NCT00148941|26960195|FG003|Overall Study|Other|2|||
13457941|NCT00148759|26960210|FG000|Overall Study|Withdrawal by Subject|1|||
13457942|NCT00148759|26960211|FG001|Overall Study|Withdrawal by Subject|1|||
13457943|NCT00148759|26960210|FG000|Overall Study|Lost to Follow-up|1|||
13457944|NCT00148759|26960211|FG001|Overall Study|Lost to Follow-up|0|||
13457945|NCT00148343|26960232|FG000|Overall Study|Withdrawal by Subject|12|||
13457946|NCT00148343|26960233|FG001|Overall Study|Withdrawal by Subject|7|||
13457947|NCT00148343|26960232|FG000|Overall Study|Physician Decision|3|||
13457948|NCT00148343|26960233|FG001|Overall Study|Physician Decision|4|||
13457949|NCT00148317|26960242|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8|||
13457950|NCT00148317|26960242|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2|||
13457951|NCT00148317|26960242|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1|||
13457952|NCT00148122|26960250|FG000|Overall Study|Withdrawal by Subject|2|||
13457953|NCT00148109|26960267|FG000|Overall Study|Lack of Efficacy|10|||
13457954|NCT00148109|26960268|FG001|Overall Study|Lack of Efficacy|18|||
13457955|NCT00148109|26960267|FG000|Overall Study|Adverse Event|0|||
13457956|NCT00148109|26960268|FG001|Overall Study|Adverse Event|2|||
13457957|NCT00148109|26960267|FG000|Overall Study|Withdrawal by Subject|2|||
13457958|NCT00148109|26960268|FG001|Overall Study|Withdrawal by Subject|0|||
13457959|NCT00147823|26960303|FG000|Overall Study|Lost to Follow-up|6|||
13457960|NCT00147823|26960304|FG001|Overall Study|Lost to Follow-up|12|||
13457961|NCT00147823|26960303|FG000|Overall Study|Physician Decision|1|||
13457962|NCT00147823|26960304|FG001|Overall Study|Physician Decision|0|||
13457963|NCT00147823|26960303|FG000|Overall Study|Withdrawal by Subject|0|||
13457964|NCT00147823|26960304|FG001|Overall Study|Withdrawal by Subject|1|||
13457965|NCT00147823|26960303|FG000|Overall Study|Did not receive vitoss due to infection|6|||
13457966|NCT00147823|26960304|FG001|Overall Study|Did not receive vitoss due to infection|2|||
13457967|NCT00147745|26960332|FG000|Overall Study|Withdrawal by Subject|1|||
13457968|NCT00147745|26960333|FG001|Overall Study|Withdrawal by Subject|0|||
13457969|NCT00147745|26960334|FG002|Overall Study|Withdrawal by Subject|0|||
13457970|NCT00147537|26960533|FG000|Phase 1b|Death|0|||
13457971|NCT00147537|26960534|FG001|Phase 1b|Death|1|||
13457972|NCT00147537|26960535|FG002|Phase 1b|Death|2|||
13457973|NCT00147537|26960536|FG003|Phase 1b|Death|1|||
13457974|NCT00147537|26960537|FG004|Phase 1b|Death|2|||
13457975|NCT00147537|26960538|FG005|Phase 1b|Death|2|||
13457976|NCT00147537|26960539|FG006|Phase 1b|Death|1|||
13457977|NCT00147537|26960540|FG007|Phase 1b|Death|3|||
13457978|NCT00147537|26960541|FG008|Phase 1b|Death|9|||
13457979|NCT00147537|26960542|FG009|Phase 1b|Death|0|||
13457980|NCT00147537|26960543|FG010|Phase 1b|Death|0|||
13457981|NCT00147537|26960533|FG000|Phase 1b|Lost to Follow-up|2|||
13457982|NCT00147537|26960534|FG001|Phase 1b|Lost to Follow-up|1|||
13133956|NCT02761629|25989881|FG000|Overall Study|Adverse Event/Intercurrent Illness|7|||
13133957|NCT02761629|25989882|FG001|Overall Study|Adverse Event/Intercurrent Illness|5|||
13457983|NCT00147537|26960535|FG002|Phase 1b|Lost to Follow-up|0|||
13457984|NCT00147537|26960536|FG003|Phase 1b|Lost to Follow-up|0|||
13457985|NCT00147537|26960537|FG004|Phase 1b|Lost to Follow-up|0|||
13457986|NCT00147537|26960538|FG005|Phase 1b|Lost to Follow-up|0|||
13457987|NCT00147537|26960539|FG006|Phase 1b|Lost to Follow-up|2|||
13457988|NCT00147537|26960540|FG007|Phase 1b|Lost to Follow-up|0|||
13457989|NCT00147537|26960541|FG008|Phase 1b|Lost to Follow-up|1|||
13457990|NCT00147537|26960542|FG009|Phase 1b|Lost to Follow-up|0|||
13457991|NCT00147537|26960543|FG010|Phase 1b|Lost to Follow-up|0|||
13457992|NCT00147537|26960533|FG000|Phase 1b|Other|0|||
13457993|NCT00147537|26960534|FG001|Phase 1b|Other|0|||
13457994|NCT00147537|26960535|FG002|Phase 1b|Other|2|||
13457995|NCT00147537|26960536|FG003|Phase 1b|Other|1|||
13457996|NCT00147537|26960537|FG004|Phase 1b|Other|1|||
13457997|NCT00147537|26960538|FG005|Phase 1b|Other|1|||
13457998|NCT00147537|26960539|FG006|Phase 1b|Other|14|||
13457999|NCT00147537|26960540|FG007|Phase 1b|Other|4|||
13458000|NCT00147537|26960541|FG008|Phase 1b|Other|4|||
13458001|NCT00147537|26960542|FG009|Phase 1b|Other|0|||
13458002|NCT00147537|26960543|FG010|Phase 1b|Other|0|||
13458003|NCT00147537|26960533|FG000|Phase 1b|Withdrawal by Subject|0|||
13458004|NCT00147537|26960534|FG001|Phase 1b|Withdrawal by Subject|0|||
13458005|NCT00147537|26960535|FG002|Phase 1b|Withdrawal by Subject|0|||
13458006|NCT00147537|26960536|FG003|Phase 1b|Withdrawal by Subject|0|||
13458007|NCT00147537|26960537|FG004|Phase 1b|Withdrawal by Subject|0|||
13458008|NCT00147537|26960538|FG005|Phase 1b|Withdrawal by Subject|0|||
13458009|NCT00147537|26960539|FG006|Phase 1b|Withdrawal by Subject|0|||
13458010|NCT00147537|26960540|FG007|Phase 1b|Withdrawal by Subject|0|||
13458011|NCT00147537|26960541|FG008|Phase 1b|Withdrawal by Subject|2|||
13458012|NCT00147537|26960542|FG009|Phase 1b|Withdrawal by Subject|0|||
13458013|NCT00147537|26960543|FG010|Phase 1b|Withdrawal by Subject|0|||
13458014|NCT00147537|26960533|FG000|Phase 1b|Randomized but not treated|0|||
13458015|NCT00147537|26960534|FG001|Phase 1b|Randomized but not treated|0|||
13458016|NCT00147537|26960535|FG002|Phase 1b|Randomized but not treated|0|||
13458017|NCT00147537|26960536|FG003|Phase 1b|Randomized but not treated|0|||
13458018|NCT00147537|26960537|FG004|Phase 1b|Randomized but not treated|0|||
13458019|NCT00147537|26960538|FG005|Phase 1b|Randomized but not treated|0|||
13458020|NCT00147537|26960539|FG006|Phase 1b|Randomized but not treated|1|||
13458021|NCT00147537|26960540|FG007|Phase 1b|Randomized but not treated|0|||
13458022|NCT00147537|26960541|FG008|Phase 1b|Randomized but not treated|1|||
13458023|NCT00147537|26960542|FG009|Phase 1b|Randomized but not treated|0|||
13458024|NCT00147537|26960543|FG010|Phase 1b|Randomized but not treated|0|||
13458025|NCT00147537|26960533|FG000|Phase 2|Death|0|||
13458026|NCT00147537|26960534|FG001|Phase 2|Death|0|||
13458027|NCT00147537|26960535|FG002|Phase 2|Death|0|||
13458028|NCT00147537|26960536|FG003|Phase 2|Death|0|||
13458029|NCT00147537|26960537|FG004|Phase 2|Death|0|||
13458030|NCT00147537|26960538|FG005|Phase 2|Death|0|||
13458031|NCT00147537|26960539|FG006|Phase 2|Death|0|||
13458032|NCT00147537|26960540|FG007|Phase 2|Death|0|||
13458033|NCT00147537|26960541|FG008|Phase 2|Death|0|||
13458034|NCT00147537|26960542|FG009|Phase 2|Death|85|||
13458035|NCT00147537|26960543|FG010|Phase 2|Death|31|||
13458036|NCT00147537|26960533|FG000|Phase 2|Lost to Follow-up|0|||
13458037|NCT00147537|26960534|FG001|Phase 2|Lost to Follow-up|0|||
13458038|NCT00147537|26960535|FG002|Phase 2|Lost to Follow-up|0|||
13458039|NCT00147537|26960536|FG003|Phase 2|Lost to Follow-up|0|||
13458040|NCT00147537|26960537|FG004|Phase 2|Lost to Follow-up|0|||
13458041|NCT00147537|26960538|FG005|Phase 2|Lost to Follow-up|0|||
13458042|NCT00147537|26960539|FG006|Phase 2|Lost to Follow-up|0|||
13458043|NCT00147537|26960540|FG007|Phase 2|Lost to Follow-up|0|||
13458044|NCT00147537|26960541|FG008|Phase 2|Lost to Follow-up|0|||
13458045|NCT00147537|26960542|FG009|Phase 2|Lost to Follow-up|12|||
13458046|NCT00147537|26960543|FG010|Phase 2|Lost to Follow-up|4|||
13458047|NCT00147537|26960533|FG000|Phase 2|Other|0|||
13458048|NCT00147537|26960534|FG001|Phase 2|Other|0|||
13458049|NCT00147537|26960535|FG002|Phase 2|Other|0|||
13458050|NCT00147537|26960536|FG003|Phase 2|Other|0|||
13458051|NCT00147537|26960537|FG004|Phase 2|Other|0|||
13458052|NCT00147537|26960538|FG005|Phase 2|Other|0|||
13458053|NCT00147537|26960539|FG006|Phase 2|Other|0|||
13458054|NCT00147537|26960540|FG007|Phase 2|Other|0|||
13458055|NCT00147537|26960541|FG008|Phase 2|Other|0|||
13458056|NCT00147537|26960542|FG009|Phase 2|Other|47|||
13458057|NCT00147537|26960543|FG010|Phase 2|Other|12|||
13458058|NCT00147537|26960533|FG000|Phase 2|Withdrawal by Subject|0|||
13458059|NCT00147537|26960534|FG001|Phase 2|Withdrawal by Subject|0|||
13458060|NCT00147537|26960535|FG002|Phase 2|Withdrawal by Subject|0|||
13458061|NCT00147537|26960536|FG003|Phase 2|Withdrawal by Subject|0|||
13458062|NCT00147537|26960537|FG004|Phase 2|Withdrawal by Subject|0|||
13458063|NCT00147537|26960538|FG005|Phase 2|Withdrawal by Subject|0|||
13458064|NCT00147537|26960539|FG006|Phase 2|Withdrawal by Subject|0|||
13458065|NCT00147537|26960540|FG007|Phase 2|Withdrawal by Subject|0|||
13458066|NCT00147537|26960541|FG008|Phase 2|Withdrawal by Subject|0|||
13458067|NCT00147537|26960542|FG009|Phase 2|Withdrawal by Subject|16|||
13458068|NCT00147537|26960543|FG010|Phase 2|Withdrawal by Subject|4|||
13458069|NCT00147537|26960533|FG000|Phase 2|Randomized but not treated|0|||
13458070|NCT00147537|26960534|FG001|Phase 2|Randomized but not treated|0|||
13458071|NCT00147537|26960535|FG002|Phase 2|Randomized but not treated|0|||
13458072|NCT00147537|26960536|FG003|Phase 2|Randomized but not treated|0|||
13458073|NCT00147537|26960537|FG004|Phase 2|Randomized but not treated|0|||
13458074|NCT00147537|26960538|FG005|Phase 2|Randomized but not treated|0|||
13458075|NCT00147537|26960539|FG006|Phase 2|Randomized but not treated|0|||
13458076|NCT00147537|26960540|FG007|Phase 2|Randomized but not treated|0|||
13458077|NCT00147537|26960541|FG008|Phase 2|Randomized but not treated|0|||
13458078|NCT00147537|26960542|FG009|Phase 2|Randomized but not treated|1|||
13458079|NCT00147537|26960543|FG010|Phase 2|Randomized but not treated|1|||
13458080|NCT00147498|26960650|FG000|Overall Study|Adverse Event|1|||
13458081|NCT00147498|26960651|FG001|Overall Study|Adverse Event|6|||
13458082|NCT00147498|26960652|FG002|Overall Study|Adverse Event|7|||
13458083|NCT00147498|26960653|FG003|Overall Study|Adverse Event|3|||
13458084|NCT00147498|26960650|FG000|Overall Study|Lack of Efficacy|1|||
13458085|NCT00147498|26960651|FG001|Overall Study|Lack of Efficacy|1|||
13458086|NCT00147498|26960652|FG002|Overall Study|Lack of Efficacy|1|||
13458087|NCT00147498|26960653|FG003|Overall Study|Lack of Efficacy|8|||
13458088|NCT00147498|26960650|FG000|Overall Study|Laboratory abnormality|0|||
13458089|NCT00147498|26960651|FG001|Overall Study|Laboratory abnormality|0|||
13458090|NCT00147498|26960652|FG002|Overall Study|Laboratory abnormality|2|||
13458091|NCT00147498|26960653|FG003|Overall Study|Laboratory abnormality|0|||
13458092|NCT00147498|26960650|FG000|Overall Study|Participant defaulted|0|||
13458093|NCT00147498|26960651|FG001|Overall Study|Participant defaulted|1|||
13458094|NCT00147498|26960652|FG002|Overall Study|Participant defaulted|4|||
13458095|NCT00147498|26960653|FG003|Overall Study|Participant defaulted|3|||
13458096|NCT00147498|26960650|FG000|Overall Study|Other|1|||
13458097|NCT00147498|26960651|FG001|Overall Study|Other|1|||
13458098|NCT00147498|26960652|FG002|Overall Study|Other|3|||
13458099|NCT00147498|26960653|FG003|Overall Study|Other|3|||
13458100|NCT00147251|26960668|FG000|Recruitment and Enrollment|change in treatment guidelines|24|||
13458101|NCT00147251|26960669|FG001|Recruitment and Enrollment|change in treatment guidelines|25|||
13458102|NCT00147238|26960675|FG000|Overall Study|Inevaluable|8|||
13458103|NCT00147225|26960714|FG000|Overall Study|Withdrawal by Subject|1|||
13458104|NCT00147225|26960715|FG001|Overall Study|Withdrawal by Subject|0|||
13458105|NCT00147225|26960716|FG002|Overall Study|Withdrawal by Subject|1|||
13458106|NCT00147225|26960717|FG003|Overall Study|Withdrawal by Subject|0|||
13458107|NCT00147225|26960718|FG004|Overall Study|Withdrawal by Subject|0|||
13458108|NCT00147225|26960719|FG005|Overall Study|Withdrawal by Subject|1|||
13458109|NCT00147225|26960714|FG000|Overall Study|Adverse Event|0|||
13458110|NCT00147225|26960715|FG001|Overall Study|Adverse Event|0|||
13458111|NCT00147225|26960716|FG002|Overall Study|Adverse Event|1|||
13458112|NCT00147225|26960717|FG003|Overall Study|Adverse Event|1|||
13458113|NCT00147225|26960718|FG004|Overall Study|Adverse Event|0|||
13458114|NCT00147225|26960719|FG005|Overall Study|Adverse Event|0|||
13458115|NCT00147225|26960714|FG000|Overall Study|Screen Failure|0|||
13458116|NCT00147225|26960715|FG001|Overall Study|Screen Failure|0|||
13458117|NCT00147225|26960716|FG002|Overall Study|Screen Failure|0|||
13458118|NCT00147225|26960717|FG003|Overall Study|Screen Failure|0|||
13458119|NCT00147225|26960718|FG004|Overall Study|Screen Failure|1|||
13458120|NCT00147225|26960719|FG005|Overall Study|Screen Failure|0|||
13458121|NCT00147225|26960714|FG000|Overall Study|Chemotherapy Changed|0|||
13458122|NCT00147225|26960715|FG001|Overall Study|Chemotherapy Changed|0|||
13458123|NCT00147225|26960716|FG002|Overall Study|Chemotherapy Changed|0|||
13458124|NCT00147225|26960717|FG003|Overall Study|Chemotherapy Changed|0|||
13458125|NCT00147225|26960718|FG004|Overall Study|Chemotherapy Changed|0|||
13458126|NCT00147225|26960719|FG005|Overall Study|Chemotherapy Changed|1|||
13458127|NCT00146848|26960743|FG000|Pre-randomization|Death|19|||
13458128|NCT00146848|26960744|FG001|Pre-randomization|Death|0|||
13458129|NCT00146848|26960745|FG002|Pre-randomization|Death|0|||
13458130|NCT00146848|26960743|FG000|Pre-randomization|Lost to Follow-up|70|||
13458131|NCT00146848|26960744|FG001|Pre-randomization|Lost to Follow-up|0|||
13458132|NCT00146848|26960745|FG002|Pre-randomization|Lost to Follow-up|0|||
13458133|NCT00146848|26960743|FG000|Pre-randomization|Physician Decision|8|||
13458134|NCT00146848|26960744|FG001|Pre-randomization|Physician Decision|0|||
13458135|NCT00146848|26960745|FG002|Pre-randomization|Physician Decision|0|||
13458136|NCT00146848|26960743|FG000|Pre-randomization|Protocol Violation|172|||
13458137|NCT00146848|26960744|FG001|Pre-randomization|Protocol Violation|0|||
13458138|NCT00146848|26960745|FG002|Pre-randomization|Protocol Violation|0|||
13458139|NCT00146848|26960743|FG000|Pre-randomization|Withdrawal by Subject|40|||
13458140|NCT00146848|26960744|FG001|Pre-randomization|Withdrawal by Subject|0|||
13458141|NCT00146848|26960745|FG002|Pre-randomization|Withdrawal by Subject|0|||
13458142|NCT00146848|26960743|FG000|Post-randomization|Lost to Follow-up|12|||
13458143|NCT00146848|26960744|FG001|Post-randomization|Lost to Follow-up|15|||
13458144|NCT00146848|26960745|FG002|Post-randomization|Lost to Follow-up|12|||
13458145|NCT00146848|26960743|FG000|Post-randomization|Withdrawn|26|||
13458146|NCT00146848|26960744|FG001|Post-randomization|Withdrawn|32|||
13458147|NCT00146848|26960745|FG002|Post-randomization|Withdrawn|27|||
13458148|NCT00146770|26960770|FG000|Overall Study|Adverse Event|2|||
13458149|NCT00146770|26960771|FG001|Overall Study|Adverse Event|0|||
13458150|NCT00146770|26960770|FG000|Overall Study|Pregnancy|1|||
13458151|NCT00146770|26960771|FG001|Overall Study|Pregnancy|0|||
13458152|NCT00146770|26960770|FG000|Overall Study|Withdrawal by Subject|2|||
13458153|NCT00146770|26960771|FG001|Overall Study|Withdrawal by Subject|0|||
13458154|NCT00146757|26960791|FG000|Overall Study|Death|1|||
13458155|NCT00146757|26960792|FG001|Overall Study|Death|0|||
13458156|NCT00146757|26960791|FG000|Overall Study|Adverse Event|1|||
13458157|NCT00146757|26960792|FG001|Overall Study|Adverse Event|0|||
13458158|NCT00146640|26960819|FG000|Overall Study|Adverse Event|12|||
13458159|NCT00146640|26960820|FG001|Overall Study|Adverse Event|10|||
13458160|NCT00146640|26960819|FG000|Overall Study|Medical Reasons|3|||
13458161|NCT00146640|26960820|FG001|Overall Study|Medical Reasons|0|||
13458162|NCT00146640|26960819|FG000|Overall Study|Non-Medical Reasons|8|||
13458163|NCT00146640|26960820|FG001|Overall Study|Non-Medical Reasons|4|||
13458164|NCT00146328|26960913|FG000|Overall Study|Adverse Event|39|||
13458165|NCT00146328|26960914|FG001|Overall Study|Adverse Event|48|||
13458166|NCT00146328|26960915|FG002|Overall Study|Adverse Event|79|||
13458167|NCT00146328|26960913|FG000|Overall Study|Protocol Violation|11|||
13458168|NCT00146328|26960914|FG001|Overall Study|Protocol Violation|6|||
13458169|NCT00146328|26960915|FG002|Overall Study|Protocol Violation|12|||
13458170|NCT00146328|26960913|FG000|Overall Study|Lost to Follow-up|7|||
13458171|NCT00146328|26960914|FG001|Overall Study|Lost to Follow-up|4|||
13458172|NCT00146328|26960915|FG002|Overall Study|Lost to Follow-up|7|||
13458173|NCT00146328|26960913|FG000|Overall Study|Withdrawal by Subject|16|||
13458174|NCT00146328|26960914|FG001|Overall Study|Withdrawal by Subject|16|||
13458175|NCT00146328|26960915|FG002|Overall Study|Withdrawal by Subject|22|||
13458176|NCT00146328|26960913|FG000|Overall Study|Virologic Failure/lack of efficacy|54|||
13458177|NCT00146328|26960914|FG001|Overall Study|Virologic Failure/lack of efficacy|72|||
13458178|NCT00146328|26960915|FG002|Overall Study|Virologic Failure/lack of efficacy|142|||
13458179|NCT00146328|26960913|FG000|Overall Study|Trial ended/site closed|8|||
13458180|NCT00146328|26960914|FG001|Overall Study|Trial ended/site closed|2|||
13458181|NCT00146328|26960915|FG002|Overall Study|Trial ended/site closed|19|||
13458182|NCT00146328|26960913|FG000|Overall Study|Patient decision to end|0|||
13458183|NCT00146328|26960914|FG001|Overall Study|Patient decision to end|1|||
13458184|NCT00146328|26960915|FG002|Overall Study|Patient decision to end|6|||
13458185|NCT00146328|26960913|FG000|Overall Study|Enroll into other trial|2|||
13458186|NCT00146328|26960914|FG001|Overall Study|Enroll into other trial|4|||
13458187|NCT00146328|26960915|FG002|Overall Study|Enroll into other trial|2|||
13458188|NCT00146328|26960913|FG000|Overall Study|Death|0|||
13458189|NCT00146328|26960914|FG001|Overall Study|Death|1|||
13458190|NCT00146328|26960915|FG002|Overall Study|Death|1|||
13458191|NCT00146328|26960913|FG000|Overall Study|Moved|2|||
13458192|NCT00146328|26960914|FG001|Overall Study|Moved|0|||
13458193|NCT00146328|26960915|FG002|Overall Study|Moved|0|||
13458194|NCT00146328|26960913|FG000|Overall Study|Interaction with other medication|2|||
13458195|NCT00146328|26960914|FG001|Overall Study|Interaction with other medication|0|||
13458196|NCT00146328|26960915|FG002|Overall Study|Interaction with other medication|1|||
13458197|NCT00146172|26960973|FG000|Overall Study|Adverse Event|0|||
13458198|NCT00146172|26960974|FG001|Overall Study|Adverse Event|0|||
13458199|NCT00146172|26960975|FG002|Overall Study|Adverse Event|1|||
13458200|NCT00146172|26960976|FG003|Overall Study|Adverse Event|1|||
13458201|NCT00146172|26960977|FG004|Overall Study|Adverse Event|0|||
13458202|NCT00146172|26960978|FG005|Overall Study|Adverse Event|2|||
13458203|NCT00146172|26960979|FG006|Overall Study|Adverse Event|3|||
13458204|NCT00146172|26960980|FG007|Overall Study|Adverse Event|10|||
13458205|NCT00146172|26960973|FG000|Overall Study|Lost to Follow-up|0|||
13458206|NCT00146172|26960974|FG001|Overall Study|Lost to Follow-up|0|||
13458207|NCT00146172|26960975|FG002|Overall Study|Lost to Follow-up|0|||
13458208|NCT00146172|26960976|FG003|Overall Study|Lost to Follow-up|0|||
13458209|NCT00146172|26960977|FG004|Overall Study|Lost to Follow-up|0|||
13458210|NCT00146172|26960978|FG005|Overall Study|Lost to Follow-up|0|||
13458211|NCT00146172|26960979|FG006|Overall Study|Lost to Follow-up|0|||
13458212|NCT00146172|26960980|FG007|Overall Study|Lost to Follow-up|1|||
13458213|NCT00146172|26960973|FG000|Overall Study|Disease Progression|2|||
13458214|NCT00146172|26960974|FG001|Overall Study|Disease Progression|4|||
13458215|NCT00146172|26960975|FG002|Overall Study|Disease Progression|2|||
13458216|NCT00146172|26960976|FG003|Overall Study|Disease Progression|5|||
13458217|NCT00146172|26960977|FG004|Overall Study|Disease Progression|2|||
13458218|NCT00146172|26960978|FG005|Overall Study|Disease Progression|2|||
13458219|NCT00146172|26960979|FG006|Overall Study|Disease Progression|1|||
13458220|NCT00146172|26960980|FG007|Overall Study|Disease Progression|22|||
13458221|NCT00146172|26960973|FG000|Overall Study|Death|0|||
13458222|NCT00146172|26960974|FG001|Overall Study|Death|0|||
13458223|NCT00146172|26960975|FG002|Overall Study|Death|0|||
13458224|NCT00146172|26960976|FG003|Overall Study|Death|0|||
13458225|NCT00146172|26960977|FG004|Overall Study|Death|0|||
13458226|NCT00146172|26960978|FG005|Overall Study|Death|0|||
13458227|NCT00146172|26960979|FG006|Overall Study|Death|1|||
13458228|NCT00146172|26960980|FG007|Overall Study|Death|0|||
13458229|NCT00146172|26960973|FG000|Overall Study|Physician Decision|0|||
13458230|NCT00146172|26960974|FG001|Overall Study|Physician Decision|0|||
13458231|NCT00146172|26960975|FG002|Overall Study|Physician Decision|0|||
13458232|NCT00146172|26960976|FG003|Overall Study|Physician Decision|0|||
13458233|NCT00146172|26960977|FG004|Overall Study|Physician Decision|0|||
13458234|NCT00146172|26960978|FG005|Overall Study|Physician Decision|0|||
13458235|NCT00146172|26960979|FG006|Overall Study|Physician Decision|0|||
13458236|NCT00146172|26960980|FG007|Overall Study|Physician Decision|1|||
13458237|NCT00146172|26960973|FG000|Overall Study|Withdrawal by Subject|0|||
13458238|NCT00146172|26960974|FG001|Overall Study|Withdrawal by Subject|0|||
13458239|NCT00146172|26960975|FG002|Overall Study|Withdrawal by Subject|0|||
13458240|NCT00146172|26960976|FG003|Overall Study|Withdrawal by Subject|0|||
13458241|NCT00146172|26960977|FG004|Overall Study|Withdrawal by Subject|0|||
13458242|NCT00146172|26960978|FG005|Overall Study|Withdrawal by Subject|1|||
13458243|NCT00146172|26960979|FG006|Overall Study|Withdrawal by Subject|1|||
13458244|NCT00146172|26960980|FG007|Overall Study|Withdrawal by Subject|4|||
13458245|NCT00146172|26960973|FG000|Overall Study|Symptomatic Deterioration|1|||
13458246|NCT00146172|26960974|FG001|Overall Study|Symptomatic Deterioration|0|||
13458247|NCT00146172|26960975|FG002|Overall Study|Symptomatic Deterioration|1|||
13458248|NCT00146172|26960976|FG003|Overall Study|Symptomatic Deterioration|0|||
13458249|NCT00146172|26960977|FG004|Overall Study|Symptomatic Deterioration|1|||
13458250|NCT00146172|26960978|FG005|Overall Study|Symptomatic Deterioration|2|||
13458251|NCT00146172|26960979|FG006|Overall Study|Symptomatic Deterioration|0|||
13458252|NCT00146172|26960980|FG007|Overall Study|Symptomatic Deterioration|2|||
13458253|NCT00145977|26961011|FG000|Overall Study|Lack of Efficacy|0|||
13458254|NCT00145977|26961012|FG001|Overall Study|Lack of Efficacy|4|||
13458255|NCT00145977|26961011|FG000|Overall Study|Lost to Follow-up|1|||
13458256|NCT00145977|26961012|FG001|Overall Study|Lost to Follow-up|0|||
13458257|NCT00145977|26961011|FG000|Overall Study|Withdrawal by Subject|1|||
13458258|NCT00145977|26961012|FG001|Overall Study|Withdrawal by Subject|0|||
13458259|NCT00145626|26961060|FG000|Overall Study|Did not have NK infusions|2|||
13458260|NCT00145626|26961060|FG000|Overall Study|Turned 2 years old before treatment|1|||
13458261|NCT00145626|26961060|FG000|Overall Study|Death|1|||
13458262|NCT00145626|26961060|FG000|Overall Study|Withdrawal by Subject|1|||
13458263|NCT00145600|26961189|FG000|Overall Study|Death|1|||
13458264|NCT00145600|26961190|FG001|Overall Study|Death|2|||
13458265|NCT00145600|26961191|FG002|Overall Study|Death|2|||
13458266|NCT00145600|26961192|FG003|Overall Study|Death|6|||
13458267|NCT00145600|26961189|FG000|Overall Study|Ineligible|3|||
13458268|NCT00145600|26961190|FG001|Overall Study|Ineligible|0|||
13458269|NCT00145600|26961191|FG002|Overall Study|Ineligible|1|||
13458270|NCT00145600|26961192|FG003|Overall Study|Ineligible|5|||
13458271|NCT00145600|26961189|FG000|Overall Study|Lost to Follow-up|2|||
13458272|NCT00145600|26961190|FG001|Overall Study|Lost to Follow-up|6|||
13458273|NCT00145600|26961191|FG002|Overall Study|Lost to Follow-up|2|||
13458274|NCT00145600|26961192|FG003|Overall Study|Lost to Follow-up|4|||
13458275|NCT00145600|26961189|FG000|Overall Study|Noncompliance|1|||
13458276|NCT00145600|26961190|FG001|Overall Study|Noncompliance|0|||
13458277|NCT00145600|26961191|FG002|Overall Study|Noncompliance|0|||
13458278|NCT00145600|26961192|FG003|Overall Study|Noncompliance|0|||
13458279|NCT00145600|26961189|FG000|Overall Study|Withdrawal by Subject|1|||
13458280|NCT00145600|26961190|FG001|Overall Study|Withdrawal by Subject|2|||
13458281|NCT00145600|26961191|FG002|Overall Study|Withdrawal by Subject|0|||
13458282|NCT00145600|26961192|FG003|Overall Study|Withdrawal by Subject|1|||
13458283|NCT00145574|26961257|FG000|Double Blind|Adverse Event|0|||
13458284|NCT00145574|26961258|FG001|Double Blind|Adverse Event|3|||
13458285|NCT00145574|26961259|FG002|Double Blind|Adverse Event|1|||
13458286|NCT00145574|26961257|FG000|Double Blind|Withdrawal by Subject|1|||
13458287|NCT00145574|26961258|FG001|Double Blind|Withdrawal by Subject|1|||
13458288|NCT00145574|26961259|FG002|Double Blind|Withdrawal by Subject|1|||
13458289|NCT00145574|26961257|FG000|Double Blind|required restricted medicine|0|||
13458290|NCT00145574|26961258|FG001|Double Blind|required restricted medicine|1|||
13458291|NCT00145574|26961259|FG002|Double Blind|required restricted medicine|0|||
13458292|NCT00145574|26961257|FG000|Open Label Long-term Extension|Adverse Event|0|||
13458293|NCT00145574|26961258|FG001|Open Label Long-term Extension|Adverse Event|0|||
13458294|NCT00145574|26961259|FG002|Open Label Long-term Extension|Adverse Event|5|||
13458295|NCT00145574|26961257|FG000|Open Label Long-term Extension|Lost to Follow-up|0|||
13458296|NCT00145574|26961258|FG001|Open Label Long-term Extension|Lost to Follow-up|0|||
13458297|NCT00145574|26961259|FG002|Open Label Long-term Extension|Lost to Follow-up|1|||
13458298|NCT00145574|26961257|FG000|Open Label Long-term Extension|Withdrawal by Subject|0|||
13458299|NCT00145574|26961258|FG001|Open Label Long-term Extension|Withdrawal by Subject|0|||
13458300|NCT00145574|26961259|FG002|Open Label Long-term Extension|Withdrawal by Subject|4|||
13458301|NCT00145574|26961257|FG000|Open Label Long-term Extension|required restricted medicine|0|||
13458302|NCT00145574|26961258|FG001|Open Label Long-term Extension|required restricted medicine|0|||
13458303|NCT00145574|26961259|FG002|Open Label Long-term Extension|required restricted medicine|1|||
13458304|NCT00145509|26961278|FG000|Overall Study|Adverse Event|10|||
13458305|NCT00145509|26961279|FG001|Overall Study|Adverse Event|3|||
13458306|NCT00145509|26961278|FG000|Overall Study|Lack of Efficacy|3|||
13458307|NCT00145509|26961279|FG001|Overall Study|Lack of Efficacy|1|||
13458308|NCT00145509|26961278|FG000|Overall Study|Lost to Follow-up|5|||
13458309|NCT00145509|26961279|FG001|Overall Study|Lost to Follow-up|9|||
13458310|NCT00145509|26961278|FG000|Overall Study|Withdrew Consent|2|||
13458311|NCT00145509|26961279|FG001|Overall Study|Withdrew Consent|7|||
13458312|NCT00145509|26961278|FG000|Overall Study|Reason not provided|2|||
13458313|NCT00145509|26961279|FG001|Overall Study|Reason not provided|1|||
13458314|NCT00145496|26961296|FG000|Overall Study|Adverse Event|42|||
13458315|NCT00145496|26961297|FG001|Overall Study|Adverse Event|30|||
13458316|NCT00145496|26961296|FG000|Overall Study|Lack of Efficacy|12|||
13458317|NCT00145496|26961297|FG001|Overall Study|Lack of Efficacy|7|||
13458318|NCT00145496|26961296|FG000|Overall Study|Withdrawal by Subject|32|||
13458319|NCT00145496|26961297|FG001|Overall Study|Withdrawal by Subject|26|||
13458320|NCT00145496|26961296|FG000|Overall Study|Lost to Follow-up|12|||
13458321|NCT00145496|26961297|FG001|Overall Study|Lost to Follow-up|5|||
13458322|NCT00145496|26961296|FG000|Overall Study|Other|25|||
13458323|NCT00145496|26961297|FG001|Overall Study|Other|13|||
13458324|NCT00145470|26961364|FG000|Overall Study|Adverse Event|19|||
13458325|NCT00145470|26961365|FG001|Overall Study|Adverse Event|25|||
13458326|NCT00145470|26961364|FG000|Overall Study|Lack of Efficacy|27|||
13458327|NCT00145470|26961365|FG001|Overall Study|Lack of Efficacy|13|||
13458328|NCT00145470|26961364|FG000|Overall Study|Withdrawal by Subject|36|||
13458329|NCT00145470|26961365|FG001|Overall Study|Withdrawal by Subject|34|||
13458330|NCT00145470|26961364|FG000|Overall Study|Lost to Follow-up|21|||
13458331|NCT00145470|26961365|FG001|Overall Study|Lost to Follow-up|17|||
13458332|NCT00145470|26961364|FG000|Overall Study|Reason Not Reported|9|||
13458333|NCT00145470|26961365|FG001|Overall Study|Reason Not Reported|9|||
13458334|NCT00145327|26961428|FG000|Overall Study|Withdrawal by Subject|77|||
13458335|NCT00145327|26961429|FG001|Overall Study|Withdrawal by Subject|72|||
13458336|NCT00145327|26961430|FG002|Overall Study|Withdrawal by Subject|164|||
13458337|NCT00145327|26961428|FG000|Overall Study|Death|26|||
13458338|NCT00145327|26961429|FG001|Overall Study|Death|18|||
13458339|NCT00145327|26961430|FG002|Overall Study|Death|30|||
13458340|NCT00145327|26961428|FG000|Overall Study|Adverse Event|14|||
13458341|NCT00145327|26961429|FG001|Overall Study|Adverse Event|11|||
13458342|NCT00145327|26961430|FG002|Overall Study|Adverse Event|22|||
13458343|NCT00145327|26961428|FG000|Overall Study|Lost to Follow-up|9|||
13458344|NCT00145327|26961429|FG001|Overall Study|Lost to Follow-up|14|||
13458345|NCT00145327|26961430|FG002|Overall Study|Lost to Follow-up|14|||
13458346|NCT00145327|26961428|FG000|Overall Study|Administrative problems|12|||
13458347|NCT00145327|26961429|FG001|Overall Study|Administrative problems|9|||
13458348|NCT00145327|26961430|FG002|Overall Study|Administrative problems|13|||
13458349|NCT00145327|26961428|FG000|Overall Study|Protocol Violation|2|||
13458350|NCT00145327|26961429|FG001|Overall Study|Protocol Violation|0|||
13458351|NCT00145327|26961430|FG002|Overall Study|Protocol Violation|2|||
13458352|NCT00145327|26961428|FG000|Overall Study|Abnormal laboratory value(s)|1|||
13458353|NCT00145327|26961429|FG001|Overall Study|Abnormal laboratory value(s)|0|||
13458354|NCT00145327|26961430|FG002|Overall Study|Abnormal laboratory value(s)|2|||
13458355|NCT00145327|26961428|FG000|Overall Study|Missing - not stated|1|||
13458356|NCT00145327|26961429|FG001|Overall Study|Missing - not stated|0|||
13458357|NCT00145327|26961430|FG002|Overall Study|Missing - not stated|1|||
13458358|NCT00145158|26961449|FG000|Overall Study|premature withdrawal|2|||
13458359|NCT00145158|26961450|FG001|Overall Study|premature withdrawal|3|||
13458360|NCT00145119|26961456|FG000|Overall Study|Death|45|||
13458361|NCT00144781|26961487|FG000|Overall Study|Adverse Event|0|||
13458362|NCT00144781|26961488|FG001|Overall Study|Adverse Event|1|||
13458363|NCT00144781|26961489|FG002|Overall Study|Adverse Event|0|||
13458364|NCT00144781|26961490|FG003|Overall Study|Adverse Event|0|||
13458365|NCT00144781|26961487|FG000|Overall Study|Non-compliant|0|||
13458366|NCT00144781|26961488|FG001|Overall Study|Non-compliant|1|||
13458367|NCT00144781|26961489|FG002|Overall Study|Non-compliant|0|||
13458368|NCT00144781|26961490|FG003|Overall Study|Non-compliant|0|||
13458369|NCT00144339|26961703|FG000|Overall Study|Adverse Event|746|||
13458370|NCT00144339|26961704|FG001|Overall Study|Adverse Event|627|||
13458371|NCT00144339|26961703|FG000|Overall Study|Protocol Violation|75|||
13458372|NCT00144339|26961704|FG001|Overall Study|Protocol Violation|48|||
13458373|NCT00144339|26961703|FG000|Overall Study|Withdrawal by Subject|403|||
13458374|NCT00144339|26961704|FG001|Overall Study|Withdrawal by Subject|300|||
13458375|NCT00144339|26961703|FG000|Overall Study|Lost to Follow-up|76|||
13458376|NCT00144339|26961704|FG001|Overall Study|Lost to Follow-up|64|||
13458377|NCT00144339|26961703|FG000|Overall Study|Other|58|||
13458378|NCT00144339|26961704|FG001|Overall Study|Other|60|||
13458379|NCT00144300|26961757|FG000|Overall Study|Adverse Event|18|||
13458380|NCT00144300|26961758|FG001|Overall Study|Adverse Event|16|||
13458381|NCT00144300|26961757|FG000|Overall Study|Protocol Violation|1|||
13458382|NCT00144300|26961758|FG001|Overall Study|Protocol Violation|3|||
13458383|NCT00144300|26961757|FG000|Overall Study|Lost to Follow-up|3|||
13458384|NCT00144300|26961758|FG001|Overall Study|Lost to Follow-up|0|||
13458385|NCT00144300|26961757|FG000|Overall Study|Withdrawal by Subject|6|||
13458386|NCT00144300|26961758|FG001|Overall Study|Withdrawal by Subject|6|||
13458387|NCT00144300|26961757|FG000|Overall Study|Other reason (not specified)|1|||
13458388|NCT00144300|26961758|FG001|Overall Study|Other reason (not specified)|3|||
13458389|NCT00144170|26961953|FG000|Overall Study|Adverse Event|84|||
13458390|NCT00144170|26961954|FG001|Overall Study|Adverse Event|41|||
13458391|NCT00144170|26961953|FG000|Overall Study|Protocol Violation|23|||
13458392|NCT00144170|26961954|FG001|Overall Study|Protocol Violation|16|||
13458393|NCT00144170|26961953|FG000|Overall Study|Lost to Follow-up|5|||
13458394|NCT00144170|26961954|FG001|Overall Study|Lost to Follow-up|10|||
13458395|NCT00144170|26961953|FG000|Overall Study|Withdrawal by Subject|29|||
13458396|NCT00144170|26961954|FG001|Overall Study|Withdrawal by Subject|13|||
13458397|NCT00144170|26961953|FG000|Overall Study|Other reason not defined above|211|||
13458398|NCT00144170|26961954|FG001|Overall Study|Other reason not defined above|316|||
13458399|NCT00144027|26961967|FG000|Overall Study|Lost to Follow-up|1|||
13458400|NCT00144027|26961968|FG001|Overall Study|Lost to Follow-up|3|||
13458401|NCT00144027|26961967|FG000|Overall Study|Withdrawal by Subject|2|||
13458402|NCT00144027|26961968|FG001|Overall Study|Withdrawal by Subject|2|||
13458403|NCT00144027|26961967|FG000|Overall Study|did not complete baseline assessment|0|||
13458404|NCT00144027|26961968|FG001|Overall Study|did not complete baseline assessment|6|||
13458405|NCT00143598|26961987|FG000|Overall Study|Lost to Follow-up|23|||
13458406|NCT00143598|26961988|FG001|Overall Study|Lost to Follow-up|21|||
13458407|NCT00143598|26961987|FG000|Overall Study|Withdrawal by Subject|33|||
13458408|NCT00143598|26961988|FG001|Overall Study|Withdrawal by Subject|37|||
13458409|NCT00143598|26961987|FG000|Overall Study|Death|36|||
13458410|NCT00143598|26961988|FG001|Overall Study|Death|36|||
13458411|NCT00143507|26962025|FG000|Overall Study|Death|572|||
13458412|NCT00143507|26962026|FG001|Overall Study|Death|547|||
13458413|NCT00143507|26962025|FG000|Overall Study|Withdrawal by Subject|114|||
13458414|NCT00143507|26962026|FG001|Overall Study|Withdrawal by Subject|102|||
13458415|NCT00143507|26962025|FG000|Overall Study|Lost to Follow-up|1|||
13458416|NCT00143507|26962026|FG001|Overall Study|Lost to Follow-up|0|||
13458417|NCT00143507|26962025|FG000|Overall Study|Withdrawn by sponsor's decision|0|||
13458418|NCT00143507|26962026|FG001|Overall Study|Withdrawn by sponsor's decision|3|||
13458419|NCT00143455|26962071|FG000|Cohort 1|Adverse Event|8|||
13458420|NCT00143455|26962072|FG001|Cohort 1|Adverse Event|4|||
13458421|NCT00143455|26962073|FG002|Cohort 1|Adverse Event|0|||
13458422|NCT00143455|26962074|FG003|Cohort 1|Adverse Event|0|||
13458423|NCT00143455|26962071|FG000|Cohort 1|Death|5|||
13458424|NCT00143455|26962072|FG001|Cohort 1|Death|2|||
13458425|NCT00143455|26962073|FG002|Cohort 1|Death|0|||
13458426|NCT00143455|26962074|FG003|Cohort 1|Death|0|||
13458427|NCT00143455|26962071|FG000|Cohort 1|Progressive Disease|0|||
13458428|NCT00143455|26962072|FG001|Cohort 1|Progressive Disease|6|||
13458429|NCT00143455|26962073|FG002|Cohort 1|Progressive Disease|0|||
13458430|NCT00143455|26962074|FG003|Cohort 1|Progressive Disease|0|||
13458431|NCT00143455|26962071|FG000|Cohort 1|Withdrawal by Subject|1|||
13458432|NCT00143455|26962072|FG001|Cohort 1|Withdrawal by Subject|4|||
13458433|NCT00143455|26962073|FG002|Cohort 1|Withdrawal by Subject|0|||
13458434|NCT00143455|26962074|FG003|Cohort 1|Withdrawal by Subject|0|||
13458435|NCT00143455|26962071|FG000|Cohort 1|Randomized But Not Treated|0|||
13458436|NCT00143455|26962072|FG001|Cohort 1|Randomized But Not Treated|1|||
13458437|NCT00143455|26962073|FG002|Cohort 1|Randomized But Not Treated|0|||
13458438|NCT00143455|26962074|FG003|Cohort 1|Randomized But Not Treated|0|||
13458439|NCT00143455|26962071|FG000|Cohort 2|Adverse Event|0|||
13458440|NCT00143455|26962072|FG001|Cohort 2|Adverse Event|0|||
13458441|NCT00143455|26962073|FG002|Cohort 2|Adverse Event|42|||
13458442|NCT00143455|26962074|FG003|Cohort 2|Adverse Event|30|||
13458443|NCT00143455|26962071|FG000|Cohort 2|No Longer Required Study Treatment|0|||
13458444|NCT00143455|26962072|FG001|Cohort 2|No Longer Required Study Treatment|0|||
13458445|NCT00143455|26962073|FG002|Cohort 2|No Longer Required Study Treatment|1|||
13458446|NCT00143455|26962074|FG003|Cohort 2|No Longer Required Study Treatment|0|||
13458447|NCT00143455|26962071|FG000|Cohort 2|Protocol Violation|0|||
13458448|NCT00143455|26962072|FG001|Cohort 2|Protocol Violation|0|||
13458449|NCT00143455|26962073|FG002|Cohort 2|Protocol Violation|1|||
13458450|NCT00143455|26962074|FG003|Cohort 2|Protocol Violation|1|||
13458451|NCT00143455|26962071|FG000|Cohort 2|Lost to Follow-up|0|||
13458452|NCT00143455|26962072|FG001|Cohort 2|Lost to Follow-up|0|||
13458453|NCT00143455|26962073|FG002|Cohort 2|Lost to Follow-up|1|||
13458454|NCT00143455|26962074|FG003|Cohort 2|Lost to Follow-up|4|||
13458455|NCT00143455|26962071|FG000|Cohort 2|Death|0|||
13458456|NCT00143455|26962072|FG001|Cohort 2|Death|0|||
13458457|NCT00143455|26962073|FG002|Cohort 2|Death|20|||
13458458|NCT00143455|26962074|FG003|Cohort 2|Death|12|||
13458459|NCT00143455|26962071|FG000|Cohort 2|Progressive Disease|0|||
13458460|NCT00143455|26962072|FG001|Cohort 2|Progressive Disease|0|||
13458461|NCT00143455|26962073|FG002|Cohort 2|Progressive Disease|20|||
13458462|NCT00143455|26962074|FG003|Cohort 2|Progressive Disease|27|||
13458463|NCT00143455|26962071|FG000|Cohort 2|Withdrawal by Subject|0|||
13458464|NCT00143455|26962072|FG001|Cohort 2|Withdrawal by Subject|0|||
13458465|NCT00143455|26962073|FG002|Cohort 2|Withdrawal by Subject|13|||
13458466|NCT00143455|26962074|FG003|Cohort 2|Withdrawal by Subject|12|||
13458467|NCT00143455|26962071|FG000|Cohort 2|Other|0|||
13458468|NCT00143455|26962072|FG001|Cohort 2|Other|0|||
13458469|NCT00143455|26962073|FG002|Cohort 2|Other|7|||
13458470|NCT00143455|26962074|FG003|Cohort 2|Other|6|||
13458471|NCT00143455|26962071|FG000|Cohort 2|Randomized But Not Treated|0|||
13458472|NCT00143455|26962072|FG001|Cohort 2|Randomized But Not Treated|0|||
13458473|NCT00143455|26962073|FG002|Cohort 2|Randomized But Not Treated|1|||
13458474|NCT00143455|26962074|FG003|Cohort 2|Randomized But Not Treated|1|||
13458475|NCT00143403|26962089|FG000|Overall Study|Adverse Event|3|||
13458476|NCT00143403|26962090|FG001|Overall Study|Adverse Event|8|||
13458477|NCT00143403|26962089|FG000|Overall Study|Death|1|||
13458478|NCT00143403|26962090|FG001|Overall Study|Death|0|||
13458479|NCT00143403|26962089|FG000|Overall Study|Withdrawal by Subject|3|||
13458480|NCT00143403|26962090|FG001|Overall Study|Withdrawal by Subject|12|||
13458481|NCT00143403|26962089|FG000|Overall Study|Relapse|15|||
13458482|NCT00143403|26962090|FG001|Overall Study|Relapse|7|||
13458483|NCT00143403|26962089|FG000|Overall Study|Protocol Violation|2|||
13458484|NCT00143403|26962090|FG001|Overall Study|Protocol Violation|2|||
13458485|NCT00143403|26962089|FG000|Overall Study|specified by site|4|||
13458486|NCT00143403|26962090|FG001|Overall Study|specified by site|9|||
13458487|NCT00143403|26962089|FG000|Overall Study|Randomized Not Treated|7|||
13458488|NCT00143403|26962090|FG001|Overall Study|Randomized Not Treated|8|||
13458489|NCT00143390|26962113|FG000|Overall Study|Death|2|||
13458490|NCT00143390|26962114|FG001|Overall Study|Death|0|||
13458491|NCT00143390|26962113|FG000|Overall Study|Not meeting entry criteria|2|||
13458492|NCT00143390|26962114|FG001|Overall Study|Not meeting entry criteria|5|||
13458493|NCT00143390|26962113|FG000|Overall Study|Withdrawal by Subject|4|||
13458494|NCT00143390|26962114|FG001|Overall Study|Withdrawal by Subject|4|||
13458495|NCT00143390|26962113|FG000|Overall Study|Progressive disease|119|||
13458496|NCT00143390|26962114|FG001|Overall Study|Progressive disease|115|||
13458497|NCT00143390|26962113|FG000|Overall Study|Protocol Violation|2|||
13458498|NCT00143390|26962114|FG001|Overall Study|Protocol Violation|0|||
13458499|NCT00143390|26962113|FG000|Overall Study|Study termination|10|||
13458500|NCT00143390|26962114|FG001|Overall Study|Study termination|15|||
13458501|NCT00143390|26962113|FG000|Overall Study|Adverse Event|9|||
13458502|NCT00143390|26962114|FG001|Overall Study|Adverse Event|8|||
13458503|NCT00143390|26962113|FG000|Overall Study|Other|1|||
13458504|NCT00143390|26962114|FG001|Overall Study|Other|2|||
13458505|NCT00143312|26962126|FG000|Overall Study|Death|11|||
13458506|NCT00143312|26962126|FG000|Overall Study|Adverse Event|2|||
13458507|NCT00143312|26962126|FG000|Overall Study|Lost to Follow-up|1|||
13458508|NCT00143312|26962126|FG000|Overall Study|Other|1|||
13458509|NCT00143312|26962126|FG000|Overall Study|Withdrawal by Subject|1|||
13458510|NCT00143247|26962142|FG000|Overall Study|Death|8|||
13458511|NCT00143247|26962142|FG000|Overall Study|Adverse Event|19|||
13458512|NCT00143247|26962142|FG000|Overall Study|Lack of Efficacy|3|||
13458513|NCT00143247|26962142|FG000|Overall Study|Withdrawal by Subject|55|||
13458514|NCT00143247|26962142|FG000|Overall Study|Study terminated by sponsor|31|||
13458515|NCT00143247|26962142|FG000|Overall Study|Protocol Violation|15|||
13458516|NCT00143247|26962142|FG000|Overall Study|Lost to Follow-up|12|||
13458517|NCT00143247|26962142|FG000|Overall Study|following inaccurate lab adverse event|1|||
13458518|NCT00143247|26962142|FG000|Overall Study|Other|12|||
13458519|NCT00142935|26962175|FG000|Overall Study|Other reason|1|||
13458520|NCT00142935|26962176|FG001|Overall Study|Other reason|1|||
13458521|NCT00142935|26962177|FG002|Overall Study|Other reason|1|||
13458522|NCT00142935|26962175|FG000|Overall Study|Lost to Follow-up|2|||
13458523|NCT00142935|26962176|FG001|Overall Study|Lost to Follow-up|5|||
13458524|NCT00142935|26962177|FG002|Overall Study|Lost to Follow-up|5|||
13458525|NCT00142935|26962175|FG000|Overall Study|Death|0|||
13458526|NCT00142935|26962176|FG001|Overall Study|Death|2|||
13458527|NCT00142935|26962177|FG002|Overall Study|Death|1|||
13458528|NCT00142909|26962200|FG000|Randomization|Various Reasons|7|||
13458529|NCT00142909|26962201|FG001|Randomization|Various Reasons|10|||
13458530|NCT00142909|26962200|FG000|Medications Begin|Protocol Violation|2|||
13458531|NCT00142909|26962201|FG001|Medications Begin|Protocol Violation|0|||
13458532|NCT00142909|26962200|FG000|Medications Begin|Withdrawal by Subject|5|||
13458533|NCT00142909|26962201|FG001|Medications Begin|Withdrawal by Subject|3|||
13458534|NCT00142909|26962200|FG000|Medications Begin|Withdrawal by Subject|2|||
13458535|NCT00142909|26962201|FG001|Medications Begin|Withdrawal by Subject|0|||
13458536|NCT00142792|26962222|FG000|Overall Study|Death|0|||
13458537|NCT00142792|26962223|FG001|Overall Study|Death|0|||
13458538|NCT00142792|26962224|FG002|Overall Study|Death|1|||
13458539|NCT00142792|26962222|FG000|Overall Study|Withdrawal by Subject|3|||
13458540|NCT00142792|26962223|FG001|Overall Study|Withdrawal by Subject|2|||
13458541|NCT00142792|26962224|FG002|Overall Study|Withdrawal by Subject|3|||
13458542|NCT00142792|26962222|FG000|Overall Study|Lost to Follow-up|8|||
13458543|NCT00142792|26962223|FG001|Overall Study|Lost to Follow-up|11|||
13458544|NCT00142792|26962224|FG002|Overall Study|Lost to Follow-up|7|||
13458545|NCT00142792|26962222|FG000|Overall Study|No category|1|||
13458546|NCT00142792|26962223|FG001|Overall Study|No category|2|||
13458547|NCT00142792|26962224|FG002|Overall Study|No category|1|||
13458548|NCT00142584|26962241|FG000|Overall Study|Sponsor Termination of Study, etc.|72|||
13458549|NCT00142584|26962242|FG001|Overall Study|Sponsor Termination of Study, etc.|16|||
13458550|NCT00142584|26962241|FG000|Overall Study|Withdrawal by Subject|30|||
13458551|NCT00142584|26962242|FG001|Overall Study|Withdrawal by Subject|16|||
13458552|NCT00142584|26962241|FG000|Overall Study|Lost to Follow-up|22|||
13458553|NCT00142584|26962242|FG001|Overall Study|Lost to Follow-up|12|||
13458554|NCT00142584|26962241|FG000|Overall Study|Adverse Event|14|||
13458555|NCT00142584|26962242|FG001|Overall Study|Adverse Event|5|||
13458556|NCT00142584|26962241|FG000|Overall Study|Protocol Violation|4|||
13458557|NCT00142584|26962242|FG001|Overall Study|Protocol Violation|7|||
13458558|NCT00142584|26962241|FG000|Overall Study|Treatment Failure|2|||
13458559|NCT00142584|26962242|FG001|Overall Study|Treatment Failure|0|||
13458560|NCT00142519|26962257|FG000|Overall Study|Not Treated|7|||
13458561|NCT00142519|26962258|FG001|Overall Study|Not Treated|9|||
13458562|NCT00142519|26962257|FG000|Overall Study|Protocol Violation|1|||
13458563|NCT00142519|26962258|FG001|Overall Study|Protocol Violation|0|||
13458564|NCT00142519|26962257|FG000|Overall Study|Withdrawal by Subject|10|||
13458565|NCT00142519|26962258|FG001|Overall Study|Withdrawal by Subject|7|||
13458566|NCT00142298|26962311|FG000|Overall Study|Adverse Event|10|||
13458567|NCT00142298|26962312|FG001|Overall Study|Adverse Event|10|||
13458568|NCT00142298|26962313|FG002|Overall Study|Adverse Event|1|||
13458569|NCT00142298|26962314|FG003|Overall Study|Adverse Event|5|||
13458570|NCT00142298|26962315|FG004|Overall Study|Adverse Event|2|||
13458571|NCT00142298|26962316|FG005|Overall Study|Adverse Event|2|||
13458572|NCT00142298|26962317|FG006|Overall Study|Adverse Event|0|||
13458573|NCT00142298|26962318|FG007|Overall Study|Adverse Event|0|||
13458574|NCT00142298|26962319|FG008|Overall Study|Adverse Event|0|||
13458575|NCT00142298|26962320|FG009|Overall Study|Adverse Event|0|||
13458576|NCT00142298|26962311|FG000|Overall Study|Clinical disease progression|1|||
13458577|NCT00142298|26962312|FG001|Overall Study|Clinical disease progression|0|||
13458578|NCT00142298|26962313|FG002|Overall Study|Clinical disease progression|0|||
13458579|NCT00142298|26962314|FG003|Overall Study|Clinical disease progression|0|||
13458580|NCT00142298|26962315|FG004|Overall Study|Clinical disease progression|0|||
13458581|NCT00142298|26962316|FG005|Overall Study|Clinical disease progression|0|||
13458582|NCT00142298|26962317|FG006|Overall Study|Clinical disease progression|0|||
13458583|NCT00142298|26962318|FG007|Overall Study|Clinical disease progression|0|||
13458584|NCT00142298|26962319|FG008|Overall Study|Clinical disease progression|0|||
13458585|NCT00142298|26962320|FG009|Overall Study|Clinical disease progression|0|||
13458586|NCT00142298|26962311|FG000|Overall Study|Death|1|||
13458587|NCT00142298|26962312|FG001|Overall Study|Death|1|||
13458588|NCT00142298|26962313|FG002|Overall Study|Death|1|||
13458589|NCT00142298|26962314|FG003|Overall Study|Death|0|||
13458590|NCT00142298|26962315|FG004|Overall Study|Death|0|||
13458591|NCT00142298|26962316|FG005|Overall Study|Death|6|||
13458592|NCT00142298|26962317|FG006|Overall Study|Death|0|||
13458593|NCT00142298|26962318|FG007|Overall Study|Death|0|||
13458594|NCT00142298|26962319|FG008|Overall Study|Death|0|||
13458595|NCT00142298|26962320|FG009|Overall Study|Death|0|||
13458596|NCT00142298|26962311|FG000|Overall Study|Lack of Efficacy|44|||
13458597|NCT00142298|26962312|FG001|Overall Study|Lack of Efficacy|62|||
13458598|NCT00142298|26962313|FG002|Overall Study|Lack of Efficacy|9|||
13458599|NCT00142298|26962314|FG003|Overall Study|Lack of Efficacy|12|||
13458600|NCT00142298|26962315|FG004|Overall Study|Lack of Efficacy|1|||
13458601|NCT00142298|26962316|FG005|Overall Study|Lack of Efficacy|0|||
13458602|NCT00142298|26962317|FG006|Overall Study|Lack of Efficacy|0|||
13458603|NCT00142298|26962318|FG007|Overall Study|Lack of Efficacy|1|||
13458604|NCT00142298|26962319|FG008|Overall Study|Lack of Efficacy|0|||
13458605|NCT00142298|26962320|FG009|Overall Study|Lack of Efficacy|0|||
13458606|NCT00142298|26962311|FG000|Overall Study|Non-compliance|15|||
13458607|NCT00142298|26962312|FG001|Overall Study|Non-compliance|13|||
13458608|NCT00142298|26962313|FG002|Overall Study|Non-compliance|0|||
13458609|NCT00142298|26962314|FG003|Overall Study|Non-compliance|6|||
13458610|NCT00142298|26962315|FG004|Overall Study|Non-compliance|1|||
13458611|NCT00142298|26962316|FG005|Overall Study|Non-compliance|0|||
13458612|NCT00142298|26962317|FG006|Overall Study|Non-compliance|0|||
13458613|NCT00142298|26962318|FG007|Overall Study|Non-compliance|3|||
13458614|NCT00142298|26962319|FG008|Overall Study|Non-compliance|3|||
13458615|NCT00142298|26962320|FG009|Overall Study|Non-compliance|0|||
13458616|NCT00142298|26962311|FG000|Overall Study|Patient, Investigator,or Sponsor request|66|||
13458617|NCT00142298|26962312|FG001|Overall Study|Patient, Investigator,or Sponsor request|60|||
13458618|NCT00142298|26962313|FG002|Overall Study|Patient, Investigator,or Sponsor request|11|||
13458619|NCT00142298|26962314|FG003|Overall Study|Patient, Investigator,or Sponsor request|51|||
13458620|NCT00142298|26962315|FG004|Overall Study|Patient, Investigator,or Sponsor request|4|||
13458621|NCT00142298|26962316|FG005|Overall Study|Patient, Investigator,or Sponsor request|3|||
13458622|NCT00142298|26962317|FG006|Overall Study|Patient, Investigator,or Sponsor request|1|||
13458623|NCT00142298|26962318|FG007|Overall Study|Patient, Investigator,or Sponsor request|4|||
13458624|NCT00142298|26962319|FG008|Overall Study|Patient, Investigator,or Sponsor request|1|||
13458625|NCT00142298|26962320|FG009|Overall Study|Patient, Investigator,or Sponsor request|0|||
13458626|NCT00142298|26962311|FG000|Overall Study|Pregnancy|4|||
13458627|NCT00142298|26962312|FG001|Overall Study|Pregnancy|4|||
13458628|NCT00142298|26962313|FG002|Overall Study|Pregnancy|2|||
13458629|NCT00142298|26962314|FG003|Overall Study|Pregnancy|3|||
13458630|NCT00142298|26962315|FG004|Overall Study|Pregnancy|0|||
13458631|NCT00142298|26962316|FG005|Overall Study|Pregnancy|0|||
13458632|NCT00142298|26962317|FG006|Overall Study|Pregnancy|0|||
13458633|NCT00142298|26962318|FG007|Overall Study|Pregnancy|0|||
13458634|NCT00142298|26962319|FG008|Overall Study|Pregnancy|1|||
13458635|NCT00142298|26962320|FG009|Overall Study|Pregnancy|0|||
13458636|NCT00142298|26962311|FG000|Overall Study|Virologic breakthrough|19|||
13458637|NCT00142298|26962312|FG001|Overall Study|Virologic breakthrough|23|||
13458638|NCT00142298|26962313|FG002|Overall Study|Virologic breakthrough|9|||
13458639|NCT00142298|26962314|FG003|Overall Study|Virologic breakthrough|7|||
13458640|NCT00142298|26962315|FG004|Overall Study|Virologic breakthrough|2|||
13458641|NCT00142298|26962316|FG005|Overall Study|Virologic breakthrough|3|||
13458642|NCT00142298|26962317|FG006|Overall Study|Virologic breakthrough|3|||
13458643|NCT00142298|26962318|FG007|Overall Study|Virologic breakthrough|0|||
13458644|NCT00142298|26962319|FG008|Overall Study|Virologic breakthrough|0|||
13458645|NCT00142298|26962320|FG009|Overall Study|Virologic breakthrough|0|||
13458646|NCT00142298|26962311|FG000|Overall Study|Other- not specified|0|||
13458647|NCT00142298|26962312|FG001|Overall Study|Other- not specified|3|||
13458648|NCT00142298|26962313|FG002|Overall Study|Other- not specified|0|||
13458649|NCT00142298|26962314|FG003|Overall Study|Other- not specified|1|||
13458650|NCT00142298|26962315|FG004|Overall Study|Other- not specified|0|||
13458651|NCT00142298|26962316|FG005|Overall Study|Other- not specified|0|||
13458652|NCT00142298|26962317|FG006|Overall Study|Other- not specified|0|||
13458653|NCT00142298|26962318|FG007|Overall Study|Other- not specified|0|||
13458654|NCT00142298|26962319|FG008|Overall Study|Other- not specified|0|||
13458655|NCT00142298|26962320|FG009|Overall Study|Other- not specified|0|||
13458656|NCT00142298|26962311|FG000|Overall Study|Lost to Follow-up|0|||
13458657|NCT00142298|26962312|FG001|Overall Study|Lost to Follow-up|0|||
13458658|NCT00142298|26962313|FG002|Overall Study|Lost to Follow-up|0|||
13458659|NCT00142298|26962314|FG003|Overall Study|Lost to Follow-up|0|||
13458660|NCT00142298|26962315|FG004|Overall Study|Lost to Follow-up|0|||
13458661|NCT00142298|26962316|FG005|Overall Study|Lost to Follow-up|0|||
13458662|NCT00142298|26962317|FG006|Overall Study|Lost to Follow-up|2|||
13458663|NCT00142298|26962318|FG007|Overall Study|Lost to Follow-up|0|||
13458664|NCT00142298|26962319|FG008|Overall Study|Lost to Follow-up|0|||
13458665|NCT00142298|26962320|FG009|Overall Study|Lost to Follow-up|0|||
13458666|NCT00142298|26962311|FG000|Overall Study|Treatment Failure|0|||
13458667|NCT00142298|26962312|FG001|Overall Study|Treatment Failure|0|||
13458668|NCT00142298|26962313|FG002|Overall Study|Treatment Failure|0|||
13458669|NCT00142298|26962314|FG003|Overall Study|Treatment Failure|0|||
13458670|NCT00142298|26962315|FG004|Overall Study|Treatment Failure|0|||
13458671|NCT00142298|26962316|FG005|Overall Study|Treatment Failure|2|||
13458672|NCT00142298|26962317|FG006|Overall Study|Treatment Failure|2|||
13458673|NCT00142298|26962318|FG007|Overall Study|Treatment Failure|0|||
13458674|NCT00142298|26962319|FG008|Overall Study|Treatment Failure|0|||
13458675|NCT00142298|26962320|FG009|Overall Study|Treatment Failure|0|||
13458676|NCT00141921|26962344|FG000|Overall Study|Remain on Study|28|||
13458677|NCT00141921|26962344|FG000|Overall Study|Withdrawal by Subject|42|||
13458678|NCT00141921|26962344|FG000|Overall Study|Lost to Follow-up|19|||
13458679|NCT00141921|26962344|FG000|Overall Study|Noncompliance|17|||
13458680|NCT00141921|26962344|FG000|Overall Study|Disease Progression|7|||
13458681|NCT00141921|26962344|FG000|Overall Study|Protocol Deviation|7|||
13458682|NCT00141921|26962344|FG000|Overall Study|Adverse Event|5|||
13458683|NCT00141921|26962344|FG000|Overall Study|Administrative Decision|2|||
13458684|NCT00141921|26962344|FG000|Overall Study|Pregnancy|4|||
13458685|NCT00141921|26962344|FG000|Overall Study|Ineligibility Determined|2|||
13458686|NCT00141921|26962344|FG000|Overall Study|Other|8|||
13458687|NCT00141817|26962395|FG000|Overall Study|Protocol Violation|0|||
13458688|NCT00141817|26962396|FG001|Overall Study|Protocol Violation|0|||
13458689|NCT00141817|26962397|FG002|Overall Study|Protocol Violation|1|||
13458690|NCT00141817|26962398|FG003|Overall Study|Protocol Violation|0|||
13458691|NCT00141817|26962395|FG000|Overall Study|Parent request|1|||
13458692|NCT00141817|26962396|FG001|Overall Study|Parent request|0|||
13458693|NCT00141817|26962397|FG002|Overall Study|Parent request|0|||
13458694|NCT00141817|26962398|FG003|Overall Study|Parent request|0|||
13458695|NCT00141778|26962446|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5|||
13458696|NCT00141778|26962447|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2|||
13458697|NCT00141778|26962448|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6|||
13458698|NCT00141778|26962446|FG000|Started Study Medication|Met safety criteria for discontinuation|2|||
13458699|NCT00141778|26962447|FG001|Started Study Medication|Met safety criteria for discontinuation|4|||
13458700|NCT00141778|26962448|FG002|Started Study Medication|Met safety criteria for discontinuation|3|||
13458701|NCT00141778|26962446|FG000|Started Study Medication|Withdrawal by Subject|0|||
13458702|NCT00141778|26962447|FG001|Started Study Medication|Withdrawal by Subject|2|||
13458703|NCT00141778|26962448|FG002|Started Study Medication|Withdrawal by Subject|0|||
13458704|NCT00141778|26962446|FG000|Started Study Medication|Difficulty Swallowing|0|||
13458705|NCT00141778|26962447|FG001|Started Study Medication|Difficulty Swallowing|1|||
13458706|NCT00141778|26962448|FG002|Started Study Medication|Difficulty Swallowing|0|||
13458707|NCT00141778|26962446|FG000|Started Study Medication|Chest Discomfort|0|||
13458708|NCT00141778|26962447|FG001|Started Study Medication|Chest Discomfort|0|||
13458709|NCT00141778|26962448|FG002|Started Study Medication|Chest Discomfort|1|||
13458710|NCT00141726|26962455|FG000|Overall Study|Completed <50% Scheduled Dosing|3|||
13458711|NCT00141518|26962652|FG000|Overall Study|Withdrew Consent Prior to Treatment|1|||
13458712|NCT00141518|26962653|FG001|Overall Study|Withdrew Consent Prior to Treatment|0|||
13458713|NCT00141518|26962654|FG002|Overall Study|Withdrew Consent Prior to Treatment|0|||
13458714|NCT00141518|26962652|FG000|Overall Study|Adverse Event|7|||
13458715|NCT00141518|26962653|FG001|Overall Study|Adverse Event|5|||
13458716|NCT00141518|26962654|FG002|Overall Study|Adverse Event|2|||
13458717|NCT00141518|26962652|FG000|Overall Study|Withdrawal by Subject|2|||
13458718|NCT00141518|26962653|FG001|Overall Study|Withdrawal by Subject|0|||
13458719|NCT00141518|26962654|FG002|Overall Study|Withdrawal by Subject|2|||
13458720|NCT00141518|26962652|FG000|Overall Study|Protocol Violation|1|||
13458721|NCT00141518|26962653|FG001|Overall Study|Protocol Violation|1|||
13458722|NCT00141518|26962654|FG002|Overall Study|Protocol Violation|2|||
13458723|NCT00141518|26962652|FG000|Overall Study|Lack of Efficacy|5|||
13458724|NCT00141518|26962653|FG001|Overall Study|Lack of Efficacy|0|||
13458725|NCT00141518|26962654|FG002|Overall Study|Lack of Efficacy|0|||
13458726|NCT00141453|26962673|FG000|Overall Study|Protocol Violation|6|||
13458727|NCT00141453|26962674|FG001|Overall Study|Protocol Violation|5|||
13458728|NCT00141297|26962964|FG000|Overall Study|Adverse Event|0|||
13458729|NCT00141297|26962965|FG001|Overall Study|Adverse Event|0|||
13458730|NCT00141297|26962966|FG002|Overall Study|Adverse Event|1|||
13458731|NCT00141297|26962967|FG003|Overall Study|Adverse Event|0|||
13458732|NCT00141297|26962968|FG004|Overall Study|Adverse Event|1|||
13458733|NCT00141297|26962969|FG005|Overall Study|Adverse Event|1|||
13458734|NCT00141297|26962970|FG006|Overall Study|Adverse Event|0|||
13458735|NCT00141297|26962971|FG007|Overall Study|Adverse Event|1|||
13458736|NCT00141297|26962972|FG008|Overall Study|Adverse Event|1|||
13458737|NCT00141297|26962973|FG009|Overall Study|Adverse Event|0|||
13458738|NCT00141297|26962964|FG000|Overall Study|Death|1|||
13458739|NCT00141297|26962965|FG001|Overall Study|Death|0|||
13458740|NCT00141297|26962966|FG002|Overall Study|Death|0|||
13458741|NCT00141297|26962967|FG003|Overall Study|Death|0|||
13458742|NCT00141297|26962968|FG004|Overall Study|Death|0|||
13458743|NCT00141297|26962969|FG005|Overall Study|Death|0|||
13458744|NCT00141297|26962970|FG006|Overall Study|Death|0|||
13458745|NCT00141297|26962971|FG007|Overall Study|Death|0|||
13458746|NCT00141297|26962972|FG008|Overall Study|Death|1|||
13458747|NCT00141297|26962973|FG009|Overall Study|Death|0|||
13458748|NCT00141297|26962964|FG000|Overall Study|Withdrawal by Subject|0|||
13458749|NCT00141297|26962965|FG001|Overall Study|Withdrawal by Subject|0|||
13458750|NCT00141297|26962966|FG002|Overall Study|Withdrawal by Subject|0|||
13458751|NCT00141297|26962967|FG003|Overall Study|Withdrawal by Subject|0|||
13458752|NCT00141297|26962968|FG004|Overall Study|Withdrawal by Subject|0|||
13458753|NCT00141297|26962969|FG005|Overall Study|Withdrawal by Subject|0|||
13458754|NCT00141297|26962970|FG006|Overall Study|Withdrawal by Subject|0|||
13458755|NCT00141297|26962971|FG007|Overall Study|Withdrawal by Subject|0|||
13458756|NCT00141297|26962972|FG008|Overall Study|Withdrawal by Subject|1|||
13458757|NCT00141297|26962973|FG009|Overall Study|Withdrawal by Subject|0|||
13458758|NCT00141297|26962964|FG000|Overall Study|Other|0|||
13458759|NCT00141297|26962965|FG001|Overall Study|Other|0|||
13458760|NCT00141297|26962966|FG002|Overall Study|Other|0|||
13458761|NCT00141297|26962967|FG003|Overall Study|Other|1|||
13458762|NCT00141297|26962968|FG004|Overall Study|Other|5|||
13458763|NCT00141297|26962969|FG005|Overall Study|Other|0|||
13458764|NCT00141297|26962970|FG006|Overall Study|Other|0|||
13458765|NCT00141297|26962971|FG007|Overall Study|Other|0|||
13458766|NCT00141297|26962972|FG008|Overall Study|Other|2|||
13458767|NCT00141297|26962973|FG009|Overall Study|Other|0|||
13458768|NCT00141297|26962964|FG000|Overall Study|Progressive Disease|2|||
13458769|NCT00141297|26962965|FG001|Overall Study|Progressive Disease|3|||
13458770|NCT00141297|26962966|FG002|Overall Study|Progressive Disease|6|||
13458771|NCT00141297|26962967|FG003|Overall Study|Progressive Disease|2|||
13458772|NCT00141297|26962968|FG004|Overall Study|Progressive Disease|15|||
13458773|NCT00141297|26962969|FG005|Overall Study|Progressive Disease|2|||
13458774|NCT00141297|26962970|FG006|Overall Study|Progressive Disease|3|||
13458775|NCT00141297|26962971|FG007|Overall Study|Progressive Disease|3|||
13458776|NCT00141297|26962972|FG008|Overall Study|Progressive Disease|15|||
13458777|NCT00141297|26962973|FG009|Overall Study|Progressive Disease|6|||
13458778|NCT00141297|26962964|FG000|Overall Study|Transitioned|0|||
13458779|NCT00141297|26962965|FG001|Overall Study|Transitioned|0|||
13458780|NCT00141297|26962966|FG002|Overall Study|Transitioned|0|||
13458781|NCT00141297|26962967|FG003|Overall Study|Transitioned|0|||
13458782|NCT00141297|26962968|FG004|Overall Study|Transitioned|1|||
13458783|NCT00141297|26962969|FG005|Overall Study|Transitioned|0|||
13458784|NCT00141297|26962970|FG006|Overall Study|Transitioned|0|||
13458785|NCT00141297|26962971|FG007|Overall Study|Transitioned|0|||
13458786|NCT00141297|26962972|FG008|Overall Study|Transitioned|0|||
13458787|NCT00141297|26962973|FG009|Overall Study|Transitioned|0|||
13458788|NCT00141271|26963102|FG000|Overall Study|Adverse Event|31|||
13458789|NCT00141271|26963103|FG001|Overall Study|Adverse Event|19|||
13458790|NCT00141271|26963104|FG002|Overall Study|Adverse Event|17|||
13458791|NCT00141271|26963102|FG000|Overall Study|Laboratory Abnormality|2|||
13458792|NCT00141271|26963103|FG001|Overall Study|Laboratory Abnormality|1|||
13458793|NCT00141271|26963104|FG002|Overall Study|Laboratory Abnormality|1|||
13458794|NCT00141271|26963102|FG000|Overall Study|Lack of Efficacy|7|||
13458795|NCT00141271|26963103|FG001|Overall Study|Lack of Efficacy|7|||
13458796|NCT00141271|26963104|FG002|Overall Study|Lack of Efficacy|3|||
13458797|NCT00141271|26963102|FG000|Overall Study|Lost to Follow-up|15|||
13458798|NCT00141271|26963103|FG001|Overall Study|Lost to Follow-up|15|||
13458799|NCT00141271|26963104|FG002|Overall Study|Lost to Follow-up|21|||
13458800|NCT00141271|26963102|FG000|Overall Study|Withdrawal by Subject|14|||
13458801|NCT00141271|26963103|FG001|Overall Study|Withdrawal by Subject|9|||
13458802|NCT00141271|26963104|FG002|Overall Study|Withdrawal by Subject|10|||
13458803|NCT00141271|26963102|FG000|Overall Study|Other|11|||
13458804|NCT00141271|26963103|FG001|Overall Study|Other|12|||
13458805|NCT00141271|26963104|FG002|Overall Study|Other|5|||
13458806|NCT00141219|26963161|FG000|Overall Study|Protocol violations|5|||
13458807|NCT00141219|26963162|FG001|Overall Study|Protocol violations|4|||
13458808|NCT00141219|26963161|FG000|Overall Study|Adverse Event|8|||
13458809|NCT00141219|26963162|FG001|Overall Study|Adverse Event|6|||
13458810|NCT00141219|26963161|FG000|Overall Study|Lack of Efficacy|5|||
13458811|NCT00141219|26963162|FG001|Overall Study|Lack of Efficacy|4|||
13458812|NCT00141219|26963161|FG000|Overall Study|Withdrawal by Subject|6|||
13458813|NCT00141219|26963162|FG001|Overall Study|Withdrawal by Subject|2|||
13458814|NCT00141102|26963207|FG000|Overall Study|Adverse Event|233|||
13458815|NCT00141102|26963208|FG001|Overall Study|Adverse Event|305|||
13458816|NCT00141102|26963207|FG000|Overall Study|Laboratory Abnormality|9|||
13458817|NCT00141102|26963208|FG001|Overall Study|Laboratory Abnormality|33|||
13458818|NCT00141102|26963207|FG000|Overall Study|Lack of Efficacy|21|||
13458819|NCT00141102|26963208|FG001|Overall Study|Lack of Efficacy|26|||
13458820|NCT00141102|26963207|FG000|Overall Study|Lost to Follow-up|29|||
13458821|NCT00141102|26963208|FG001|Overall Study|Lost to Follow-up|32|||
13458822|NCT00141102|26963207|FG000|Overall Study|Other|87|||
13458823|NCT00141102|26963208|FG001|Overall Study|Other|76|||
13458824|NCT00141102|26963207|FG000|Overall Study|Withdrawal by Subject|112|||
13458825|NCT00141102|26963208|FG001|Overall Study|Withdrawal by Subject|142|||
13458826|NCT00141102|26963207|FG000|Overall Study|Randomized But Did Not Receive Treatment|15|||
13458827|NCT00141102|26963208|FG001|Overall Study|Randomized But Did Not Receive Treatment|9|||
13458828|NCT00141102|26963207|FG000|Overall Study|Death|2|||
13458829|NCT00141102|26963208|FG001|Overall Study|Death|2|||
13458830|NCT00141037|26963223|FG000|Overall Study|Physician Decision|1|||
13458831|NCT00141037|26963224|FG001|Overall Study|Physician Decision|2|||
13458832|NCT00141037|26963223|FG000|Overall Study|Lost to Follow-up|3|||
13458833|NCT00141037|26963224|FG001|Overall Study|Lost to Follow-up|1|||
13458834|NCT00141037|26963223|FG000|Overall Study|Protocol Violation|0|||
13458835|NCT00141037|26963224|FG001|Overall Study|Protocol Violation|2|||
13458836|NCT00141037|26963223|FG000|Overall Study|Withdrawal by Subject|2|||
13458837|NCT00141037|26963224|FG001|Overall Study|Withdrawal by Subject|1|||
13458838|NCT00141037|26963223|FG000|Overall Study|Other|0|||
13458839|NCT00141037|26963224|FG001|Overall Study|Other|1|||
13458840|NCT00141037|26963223|FG000|Overall Study|Moved from area|1|||
13458841|NCT00141037|26963224|FG001|Overall Study|Moved from area|7|||
13458842|NCT00141037|26963223|FG000|Overall Study|Graft Failure|3|||
13458843|NCT00141037|26963224|FG001|Overall Study|Graft Failure|4|||
13458844|NCT00140426|26963261|FG000|Overall Study|Withdrawal by Subject|0|||
13458845|NCT00140426|26963262|FG001|Overall Study|Withdrawal by Subject|3|||
13458846|NCT00140413|26963278|FG000|Overall Study|Lost to Follow-up|1|||
13458847|NCT00140413|26963279|FG001|Overall Study|Lost to Follow-up|0|||
13458848|NCT00140413|26963278|FG000|Overall Study|Withdrawal by Subject|2|||
13458849|NCT00140413|26963279|FG001|Overall Study|Withdrawal by Subject|0|||
13458850|NCT00140140|26963326|FG000|Overall Study|Unacceptable toxicity|1|||
13458851|NCT00140140|26963327|FG001|Overall Study|Unacceptable toxicity|1|||
13458852|NCT00140140|26963328|FG002|Overall Study|Unacceptable toxicity|2|||
13458853|NCT00140140|26963326|FG000|Overall Study|Physician Decision|1|||
13458854|NCT00140140|26963327|FG001|Overall Study|Physician Decision|1|||
13458855|NCT00140140|26963328|FG002|Overall Study|Physician Decision|0|||
13458856|NCT00139776|26963372|FG000|Period I|Did not enter Period II|575|||
13458857|NCT00139776|26963373|FG001|Period I|Did not enter Period II|0|||
13458858|NCT00139776|26963374|FG002|Period I|Did not enter Period II|0|||
13458859|NCT00139776|26963375|FG003|Period I|Did not enter Period II|0|||
13458860|NCT00139776|26963372|FG000|Period II|Not Randomized into Period III|0|||
13458861|NCT00139776|26963373|FG001|Period II|Not Randomized into Period III|322|||
13458862|NCT00139776|26963374|FG002|Period II|Not Randomized into Period III|0|||
13458863|NCT00139776|26963375|FG003|Period II|Not Randomized into Period III|0|||
13458864|NCT00139776|26963372|FG000|Period III|Adverse Event|0|||
13458865|NCT00139776|26963373|FG001|Period III|Adverse Event|0|||
13458866|NCT00139776|26963374|FG002|Period III|Adverse Event|22|||
13458867|NCT00139776|26963375|FG003|Period III|Adverse Event|23|||
13458868|NCT00139776|26963372|FG000|Period III|Other|0|||
13458869|NCT00139776|26963373|FG001|Period III|Other|0|||
13458870|NCT00139776|26963374|FG002|Period III|Other|23|||
13458871|NCT00139776|26963375|FG003|Period III|Other|34|||
13458872|NCT00139776|26963372|FG000|Period III|Lack of Efficacy|0|||
13458873|NCT00139776|26963373|FG001|Period III|Lack of Efficacy|0|||
13458874|NCT00139776|26963374|FG002|Period III|Lack of Efficacy|10|||
13458875|NCT00139776|26963375|FG003|Period III|Lack of Efficacy|24|||
13458876|NCT00139776|26963372|FG000|Period III|Lost to Follow-up|0|||
13458877|NCT00139776|26963373|FG001|Period III|Lost to Follow-up|0|||
13458878|NCT00139776|26963374|FG002|Period III|Lost to Follow-up|5|||
13458879|NCT00139776|26963375|FG003|Period III|Lost to Follow-up|4|||
13458880|NCT00139776|26963372|FG000|Period III|Withdrawal by Subject|0|||
13458881|NCT00139776|26963373|FG001|Period III|Withdrawal by Subject|0|||
13458882|NCT00139776|26963374|FG002|Period III|Withdrawal by Subject|16|||
13458883|NCT00139776|26963375|FG003|Period III|Withdrawal by Subject|21|||
13458884|NCT00139737|26963381|FG000|Overall Study|Withdrawal by Subject|190|||
13458885|NCT00139737|26963381|FG000|Overall Study|Adverse Event|58|||
13458886|NCT00139737|26963381|FG000|Overall Study|Lack of Efficacy|40|||
13458887|NCT00139737|26963381|FG000|Overall Study|Lost to Follow-up|8|||
13458888|NCT00139737|26963381|FG000|Overall Study|Death|3|||
13458889|NCT00139737|26963381|FG000|Overall Study|Laboratory Abnormality|2|||
13458890|NCT00139737|26963381|FG000|Overall Study|Protocol Violation|18|||
13458891|NCT00139737|26963381|FG000|Overall Study|Withdrew During Screening Phase|8|||
13458892|NCT00139737|26963381|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
13458893|NCT00139737|26963381|FG000|Overall Study|Screened, Not Treated|13|||
13458894|NCT00139659|26963464|FG000|Overall Study|Adverse Event|12|||
13458895|NCT00139659|26963465|FG001|Overall Study|Adverse Event|1|||
13458896|NCT00139659|26963464|FG000|Overall Study|Lack of Efficacy|1|||
13458897|NCT00139659|26963465|FG001|Overall Study|Lack of Efficacy|1|||
13458898|NCT00139659|26963464|FG000|Overall Study|Lost to Follow-up|7|||
13458899|NCT00139659|26963465|FG001|Overall Study|Lost to Follow-up|3|||
13458900|NCT00139659|26963464|FG000|Overall Study|Reason not Specified|6|||
13458901|NCT00139659|26963465|FG001|Overall Study|Reason not Specified|3|||
13458902|NCT00139659|26963464|FG000|Overall Study|Withdrawal by Subject|14|||
13458903|NCT00139659|26963465|FG001|Overall Study|Withdrawal by Subject|10|||
13458904|NCT00139477|26963492|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6|||
13458905|NCT00139477|26963493|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7|||
13458906|NCT00139477|26963492|FG000|First Intervention -Baseline to 6Months|Relocation|1|||
13458907|NCT00139477|26963493|FG001|First Intervention -Baseline to 6Months|Relocation|2|||
13458908|NCT00139477|26963492|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
13458909|NCT00139477|26963493|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
13458910|NCT00139477|26963492|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2|||
13458911|NCT00139477|26963493|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0|||
13458912|NCT00139477|26963492|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0|||
13458913|NCT00139477|26963493|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2|||
13458914|NCT00139477|26963492|FG000|Second Intervention -6Months to 12Months|Relocation|1|||
13458915|NCT00139477|26963493|FG001|Second Intervention -6Months to 12Months|Relocation|0|||
13458916|NCT00139477|26963492|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4|||
13458917|NCT00139477|26963493|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3|||
13458918|NCT00138671|26963550|FG000|Overall Study|Death|0|||
13458919|NCT00138671|26963551|FG001|Overall Study|Death|3|||
13458920|NCT00138671|26963550|FG000|Overall Study|Adverse Event|6|||
13458921|NCT00138671|26963551|FG001|Overall Study|Adverse Event|3|||
13458922|NCT00138671|26963550|FG000|Overall Study|Lost to Follow-up|1|||
13458923|NCT00138671|26963551|FG001|Overall Study|Lost to Follow-up|2|||
13458924|NCT00138671|26963550|FG000|Overall Study|Withdrawal by Subject|3|||
13458925|NCT00138671|26963551|FG001|Overall Study|Withdrawal by Subject|5|||
13458926|NCT00138671|26963550|FG000|Overall Study|Other|3|||
13458927|NCT00138671|26963551|FG001|Overall Study|Other|3|||
13458928|NCT00138658|26963563|FG000|Overall Study|Adverse Event|23|||
13458929|NCT00138658|26963563|FG000|Overall Study|Death|1|||
13458930|NCT00138658|26963563|FG000|Overall Study|Disease Progression|21|||
13458931|NCT00138658|26963563|FG000|Overall Study|Physician Decision|11|||
13458932|NCT00138658|26963563|FG000|Overall Study|Withdrawal by Subject|5|||
13458933|NCT00138424|26963642|FG000|Overall Study|Physician Decision|0|||
13458934|NCT00138424|26963643|FG001|Overall Study|Physician Decision|1|||
13458935|NCT00138424|26963644|FG002|Overall Study|Physician Decision|0|||
13458936|NCT00138424|26963645|FG003|Overall Study|Physician Decision|0|||
13458937|NCT00138151|26963653|FG000|Overall Study|Withdrawal by Subject|3|||
13458938|NCT00138151|26963653|FG000|Overall Study|Physician Decision|1|||
13458939|NCT00138073|26963660|FG000|Overall Study|lack of resources|55|||
13458940|NCT00137839|26963673|FG000|Overall Study|Adverse Event|7|||
13458941|NCT00137839|26963673|FG000|Overall Study|Physician Decision|7|||
13458942|NCT00137839|26963673|FG000|Overall Study|Death|8|||
13458943|NCT00137839|26963673|FG000|Overall Study|Disease Progression|60|||
13458944|NCT00137839|26963673|FG000|Overall Study|Not Start Treatment|1|||
13458945|NCT00137839|26963673|FG000|Overall Study|Prolonged Treatment Delay|1|||
13458946|NCT00137631|26963694|FG000|Overall Study|Lost to Follow-up|37|||
13458947|NCT00137631|26963695|FG001|Overall Study|Lost to Follow-up|41|||
13458948|NCT00137449|26963739|FG000|Overall Study|Disease Progression|8|||
13458949|NCT00137449|26963740|FG001|Overall Study|Disease Progression|13|||
13458950|NCT00137449|26963739|FG000|Overall Study|Death|4|||
13458951|NCT00137449|26963740|FG001|Overall Study|Death|3|||
13458952|NCT00137449|26963739|FG000|Overall Study|Adverse Event|3|||
13458953|NCT00137449|26963740|FG001|Overall Study|Adverse Event|1|||
13458954|NCT00137449|26963739|FG000|Overall Study|Withdrawal by Subject|1|||
13458955|NCT00137449|26963740|FG001|Overall Study|Withdrawal by Subject|1|||
13458956|NCT00137436|26963759|FG000|Overall Study|Adverse Event|13|||
13458957|NCT00137436|26963759|FG000|Overall Study|Death|2|||
13458958|NCT00137436|26963759|FG000|Overall Study|Lack of Efficacy|17|||
13458959|NCT00137436|26963759|FG000|Overall Study|Withdrawal by Subject|6|||
13458960|NCT00137436|26963759|FG000|Overall Study|Other|5|||
13458961|NCT00137423|26963786|FG000|Overall Study|Adverse Event|7|||
13458962|NCT00137423|26963787|FG001|Overall Study|Adverse Event|9|||
13458963|NCT00137423|26963786|FG000|Overall Study|consent withdrawn|1|||
13458964|NCT00137423|26963787|FG001|Overall Study|consent withdrawn|1|||
13458965|NCT00137423|26963786|FG000|Overall Study|Lack of Efficacy|31|||
13458966|NCT00137423|26963787|FG001|Overall Study|Lack of Efficacy|33|||
13458967|NCT00137423|26963786|FG000|Overall Study|Death|0|||
13458968|NCT00137423|26963787|FG001|Overall Study|Death|1|||
13458969|NCT00137267|26963802|FG000|Overall Study|Lost to Follow-up|15|||
13458970|NCT00137267|26963803|FG001|Overall Study|Lost to Follow-up|21|||
13458971|NCT00137111|26963828|FG000|Total Therapy|Death|35|||
13458972|NCT00137111|26963829|FG001|Total Therapy|Death|0|||
13458973|NCT00137111|26963830|FG002|Total Therapy|Death|0|||
13458974|NCT00137111|26963831|FG003|Total Therapy|Death|0|||
13458975|NCT00137111|26963828|FG000|Total Therapy|Non Compliance|5|||
13458976|NCT00137111|26963829|FG001|Total Therapy|Non Compliance|0|||
13458977|NCT00137111|26963830|FG002|Total Therapy|Non Compliance|0|||
13458978|NCT00137111|26963831|FG003|Total Therapy|Non Compliance|0|||
13458979|NCT00137046|26963886|FG000|Overall Study|Death|2|||
13458980|NCT00137046|26963887|FG001|Overall Study|Death|1|||
13458981|NCT00137046|26963886|FG000|Overall Study|Adverse Event|16|||
13458982|NCT00137046|26963887|FG001|Overall Study|Adverse Event|5|||
13458983|NCT00137046|26963886|FG000|Overall Study|Laboratory Abnormality|2|||
13458984|NCT00137046|26963887|FG001|Overall Study|Laboratory Abnormality|0|||
13458985|NCT00137046|26963886|FG000|Overall Study|Lack of Efficacy|13|||
13458986|NCT00137046|26963887|FG001|Overall Study|Lack of Efficacy|1|||
13458987|NCT00137046|26963886|FG000|Overall Study|Lost to Follow-up|8|||
13458988|NCT00137046|26963887|FG001|Overall Study|Lost to Follow-up|24|||
13458989|NCT00137046|26963886|FG000|Overall Study|Other|23|||
13458990|NCT00137046|26963887|FG001|Overall Study|Other|19|||
13458991|NCT00137046|26963886|FG000|Overall Study|Withdrawal by Subject|33|||
13458992|NCT00137046|26963887|FG001|Overall Study|Withdrawal by Subject|42|||
13458993|NCT00137046|26963886|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1|||
13458994|NCT00137046|26963887|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0|||
13458995|NCT00137046|26963886|FG000|Overall Study|Withdrew prior to study treatment|1|||
13458996|NCT00137046|26963887|FG001|Overall Study|Withdrew prior to study treatment|1|||
13458997|NCT00136955|26963896|FG000|Overall Study|Adverse Event|8|||
13458998|NCT00136955|26963896|FG000|Overall Study|Lost to Follow-up|1|||
13458999|NCT00136955|26963896|FG000|Overall Study|Withdrawal by Subject|2|||
13459000|NCT00136955|26963896|FG000|Overall Study|Incl. prog. disease, protocol violation|12|||
13459001|NCT00136916|26963957|FG000|Overall Study|Never received study treatment|3|||
13459002|NCT00136916|26963958|FG001|Overall Study|Never received study treatment|5|||
13459003|NCT00136916|26963957|FG000|Overall Study|Death|1|||
13459004|NCT00136916|26963958|FG001|Overall Study|Death|3|||
13459005|NCT00136916|26963957|FG000|Overall Study|Adverse Event|27|||
13459006|NCT00136916|26963958|FG001|Overall Study|Adverse Event|8|||
13459007|NCT00136916|26963957|FG000|Overall Study|Laboratory abnormality|0|||
13459008|NCT00136916|26963958|FG001|Overall Study|Laboratory abnormality|1|||
13459009|NCT00136916|26963957|FG000|Overall Study|Lack of Efficacy|13|||
13459010|NCT00136916|26963958|FG001|Overall Study|Lack of Efficacy|3|||
13459011|NCT00136916|26963957|FG000|Overall Study|Lost to Follow-up|12|||
13459012|NCT00136916|26963958|FG001|Overall Study|Lost to Follow-up|14|||
13459013|NCT00136916|26963957|FG000|Overall Study|Withdrawal by Subject|44|||
13459014|NCT00136916|26963958|FG001|Overall Study|Withdrawal by Subject|46|||
13459015|NCT00136916|26963957|FG000|Overall Study|Other|22|||
13459016|NCT00136916|26963958|FG001|Overall Study|Other|24|||
13459017|NCT00136916|26963957|FG000|Overall Study|Discontinued in follow up period|3|||
13459018|NCT00136916|26963958|FG001|Overall Study|Discontinued in follow up period|0|||
13459019|NCT00136604|26964080|FG000|Overall Study|Lost to Follow-up|1|||
13459020|NCT00136604|26964081|FG001|Overall Study|Lost to Follow-up|0|||
13459021|NCT00136604|26964082|FG002|Overall Study|Lost to Follow-up|0|||
13459022|NCT00136604|26964083|FG003|Overall Study|Lost to Follow-up|0|||
13459023|NCT00136604|26964084|FG004|Overall Study|Lost to Follow-up|1|||
13459024|NCT00136604|26964080|FG000|Overall Study|Migrated/moved from study area|0|||
13459025|NCT00136604|26964081|FG001|Overall Study|Migrated/moved from study area|1|||
13459026|NCT00136604|26964082|FG002|Overall Study|Migrated/moved from study area|0|||
13459027|NCT00136604|26964083|FG003|Overall Study|Migrated/moved from study area|0|||
13459028|NCT00136604|26964084|FG004|Overall Study|Migrated/moved from study area|0|||
13459029|NCT00136357|26964097|FG000|Overall Study|Withdrawal by Subject|3|||
13459030|NCT00136357|26964098|FG001|Overall Study|Withdrawal by Subject|2|||
13459031|NCT00136318|26964119|FG000|Overall Study|Adverse Event|5|||
13459032|NCT00136318|26964120|FG001|Overall Study|Adverse Event|5|||
13459033|NCT00136318|26964119|FG000|Overall Study|Withdrawal by Subject|2|||
13459034|NCT00136318|26964120|FG001|Overall Study|Withdrawal by Subject|2|||
13459035|NCT00136084|26964140|FG000|Overall Study|Death|12|||
13459036|NCT00136084|26964141|FG001|Overall Study|Death|5|||
13459037|NCT00136084|26964140|FG000|Overall Study|Unacceptable toxicity|8|||
13459038|NCT00136084|26964141|FG001|Overall Study|Unacceptable toxicity|11|||
13459039|NCT00136084|26964140|FG000|Overall Study|Relapse|20|||
13459040|NCT00136084|26964141|FG001|Overall Study|Relapse|23|||
13459041|NCT00136084|26964140|FG000|Overall Study|Lost to Follow-up|2|||
13459042|NCT00136084|26964141|FG001|Overall Study|Lost to Follow-up|0|||
13459043|NCT00136084|26964140|FG000|Overall Study|No Response|1|||
13459044|NCT00136084|26964141|FG001|Overall Study|No Response|2|||
13459045|NCT00136084|26964140|FG000|Overall Study|Withdrawal by Subject|5|||
13459046|NCT00136084|26964141|FG001|Overall Study|Withdrawal by Subject|1|||
13459047|NCT00135707|26964228|FG000|Overall Study|Lost to Follow-up|94|||
13459048|NCT00135707|26964229|FG001|Overall Study|Lost to Follow-up|89|||
13459049|NCT00135707|26964228|FG000|Overall Study|Withdrawal by Subject|0|||
13459050|NCT00135707|26964229|FG001|Overall Study|Withdrawal by Subject|1|||
13459051|NCT00135707|26964228|FG000|Overall Study|Institutional review board request|1|||
13459052|NCT00135707|26964229|FG001|Overall Study|Institutional review board request|0|||
13459053|NCT00135694|26964257|FG000|Overall Study|Adverse Event|17|||
13459054|NCT00135694|26964258|FG001|Overall Study|Adverse Event|4|||
13459055|NCT00135694|26964259|FG002|Overall Study|Adverse Event|0|||
13459056|NCT00135694|26964257|FG000|Overall Study|Death|14|||
13459057|NCT00135694|26964258|FG001|Overall Study|Death|1|||
13459058|NCT00135694|26964259|FG002|Overall Study|Death|2|||
13459059|NCT00135694|26964257|FG000|Overall Study|Lost to Follow-up|8|||
13459060|NCT00135694|26964258|FG001|Overall Study|Lost to Follow-up|7|||
13459061|NCT00135694|26964259|FG002|Overall Study|Lost to Follow-up|1|||
13459062|NCT00135694|26964257|FG000|Overall Study|Withdrawal by Subject|41|||
13459063|NCT00135694|26964258|FG001|Overall Study|Withdrawal by Subject|7|||
13459064|NCT00135694|26964259|FG002|Overall Study|Withdrawal by Subject|4|||
13459065|NCT00135694|26964257|FG000|Overall Study|Protocol Violation|19|||
13459066|NCT00135694|26964258|FG001|Overall Study|Protocol Violation|1|||
13459067|NCT00135694|26964259|FG002|Overall Study|Protocol Violation|0|||
13459068|NCT00135694|26964257|FG000|Overall Study|Hepatitis C related reasons|39|||
13459069|NCT00135694|26964258|FG001|Overall Study|Hepatitis C related reasons|1|||
13459070|NCT00135694|26964259|FG002|Overall Study|Hepatitis C related reasons|0|||
13459071|NCT00135694|26964257|FG000|Overall Study|Ineligible for Random assignment|42|||
13459072|NCT00135694|26964258|FG001|Overall Study|Ineligible for Random assignment|0|||
13459073|NCT00135694|26964259|FG002|Overall Study|Ineligible for Random assignment|0|||
13459074|NCT00135512|26964271|FG000|Overall Study|Adverse Event|56|||
13459075|NCT00135512|26964271|FG000|Overall Study|Lack of Efficacy|25|||
13459076|NCT00135512|26964271|FG000|Overall Study|Other|42|||
13459077|NCT00135356|26964318|FG000|Overall Study|Adverse Event|6|||
13459078|NCT00135356|26964319|FG001|Overall Study|Adverse Event|2|||
13459079|NCT00135356|26964318|FG000|Overall Study|Lack of Efficacy|2|||
13459080|NCT00135356|26964319|FG001|Overall Study|Lack of Efficacy|0|||
13459081|NCT00135356|26964318|FG000|Overall Study|Lost to Follow-up|3|||
13459082|NCT00135356|26964319|FG001|Overall Study|Lost to Follow-up|1|||
13459083|NCT00135356|26964318|FG000|Overall Study|Surgery for abdominal fat|1|||
13459084|NCT00135356|26964319|FG001|Overall Study|Surgery for abdominal fat|0|||
13459085|NCT00135356|26964318|FG000|Overall Study|Change in antiviral regimen|0|||
13459086|NCT00135356|26964319|FG001|Overall Study|Change in antiviral regimen|1|||
13459087|NCT00135356|26964318|FG000|Overall Study|Poor/noncompliance|1|||
13459088|NCT00135356|26964319|FG001|Overall Study|Poor/noncompliance|1|||
13459089|NCT00135356|26964318|FG000|Overall Study|No longer meets study criteria|2|||
13459090|NCT00135356|26964319|FG001|Overall Study|No longer meets study criteria|0|||
13459091|NCT00135356|26964318|FG000|Overall Study|Withdrawal by Subject|2|||
13459092|NCT00135356|26964319|FG001|Overall Study|Withdrawal by Subject|4|||
13459093|NCT00135330|26964421|FG000|Overall Study|Adverse Event|2|||
13459094|NCT00135330|26964422|FG001|Overall Study|Adverse Event|5|||
13459095|NCT00135330|26964423|FG002|Overall Study|Adverse Event|1|||
13459096|NCT00135330|26964421|FG000|Overall Study|Lost to Follow-up|0|||
13459097|NCT00135330|26964422|FG001|Overall Study|Lost to Follow-up|2|||
13459098|NCT00135330|26964423|FG002|Overall Study|Lost to Follow-up|3|||
13459099|NCT00135330|26964421|FG000|Overall Study|Physician Decision|1|||
13459100|NCT00135330|26964422|FG001|Overall Study|Physician Decision|1|||
13459101|NCT00135330|26964423|FG002|Overall Study|Physician Decision|0|||
13459102|NCT00135330|26964421|FG000|Overall Study|Protocol Violation|4|||
13459103|NCT00135330|26964422|FG001|Overall Study|Protocol Violation|3|||
13459104|NCT00135330|26964423|FG002|Overall Study|Protocol Violation|3|||
13459105|NCT00135330|26964421|FG000|Overall Study|Patient Decision|5|||
13459106|NCT00135330|26964422|FG001|Overall Study|Patient Decision|1|||
13459107|NCT00135330|26964423|FG002|Overall Study|Patient Decision|4|||
13459108|NCT00135330|26964421|FG000|Overall Study|Sponsor Decision|0|||
13459109|NCT00135330|26964422|FG001|Overall Study|Sponsor Decision|1|||
13459110|NCT00135330|26964423|FG002|Overall Study|Sponsor Decision|0|||
13459111|NCT00134901|26964438|FG000|Overall Study|Lost to Follow-up|5|||
13459112|NCT00134901|26964439|FG001|Overall Study|Lost to Follow-up|5|||
13459113|NCT00134901|26964438|FG000|Overall Study|discontinued intervention|12|||
13459114|NCT00134901|26964439|FG001|Overall Study|discontinued intervention|10|||
13459115|NCT00134784|26964459|FG000|Overall Study|Withdrawal by Subject|2|||
13459116|NCT00134784|26964460|FG001|Overall Study|Withdrawal by Subject|2|||
13459117|NCT00134784|26964461|FG002|Overall Study|Withdrawal by Subject|2|||
13459118|NCT00134784|26964462|FG003|Overall Study|Withdrawal by Subject|1|||
13459119|NCT00134719|26964600|FG000|Primary Vaccination Phase|Adverse Event|4|||
13459120|NCT00134719|26964601|FG001|Primary Vaccination Phase|Adverse Event|0|||
13459121|NCT00134719|26964602|FG002|Primary Vaccination Phase|Adverse Event|0|||
13459122|NCT00134719|26964600|FG000|Primary Vaccination Phase|Protocol Violation|1|||
13459123|NCT00134719|26964601|FG001|Primary Vaccination Phase|Protocol Violation|0|||
13459124|NCT00134719|26964602|FG002|Primary Vaccination Phase|Protocol Violation|0|||
13459125|NCT00134719|26964600|FG000|Primary Vaccination Phase|Withdrawal by Subject|2|||
13459126|NCT00134719|26964601|FG001|Primary Vaccination Phase|Withdrawal by Subject|3|||
13459127|NCT00134719|26964602|FG002|Primary Vaccination Phase|Withdrawal by Subject|2|||
13459128|NCT00134719|26964600|FG000|Primary Vaccination Phase|Lost to Follow-up|7|||
13459129|NCT00134719|26964601|FG001|Primary Vaccination Phase|Lost to Follow-up|3|||
13459130|NCT00134719|26964602|FG002|Primary Vaccination Phase|Lost to Follow-up|3|||
13459131|NCT00134719|26964600|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
13459132|NCT00134719|26964601|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3|||
13459133|NCT00134719|26964602|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
13459134|NCT00134719|26964600|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1|||
13459135|NCT00134719|26964601|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
13459136|NCT00134719|26964602|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
13459137|NCT00134563|26964635|FG000|Overall Study|Not treated due to protocol violation|0|||
13459138|NCT00134563|26964636|FG001|Overall Study|Not treated due to protocol violation|1|||
13459139|NCT00134563|26964637|FG002|Overall Study|Not treated due to protocol violation|1|||
13459140|NCT00134563|26964635|FG000|Overall Study|Adverse Event|29|||
13459141|NCT00134563|26964636|FG001|Overall Study|Adverse Event|37|||
13459142|NCT00134563|26964637|FG002|Overall Study|Adverse Event|38|||
13459143|NCT00134563|26964635|FG000|Overall Study|Lack of Efficacy|24|||
13459144|NCT00134563|26964636|FG001|Overall Study|Lack of Efficacy|14|||
13459145|NCT00134563|26964637|FG002|Overall Study|Lack of Efficacy|17|||
13459146|NCT00134563|26964635|FG000|Overall Study|Protocol Violation|3|||
13459147|NCT00134563|26964636|FG001|Overall Study|Protocol Violation|2|||
13459148|NCT00134563|26964637|FG002|Overall Study|Protocol Violation|5|||
13459149|NCT00134563|26964635|FG000|Overall Study|Lost to Follow-up|4|||
13459150|NCT00134563|26964636|FG001|Overall Study|Lost to Follow-up|0|||
13459151|NCT00134563|26964637|FG002|Overall Study|Lost to Follow-up|2|||
13459152|NCT00134563|26964635|FG000|Overall Study|progressive disease|11|||
13459153|NCT00134563|26964636|FG001|Overall Study|progressive disease|4|||
13459154|NCT00134563|26964637|FG002|Overall Study|progressive disease|2|||
13459155|NCT00134563|26964635|FG000|Overall Study|did not wish to continue|33|||
13459156|NCT00134563|26964636|FG001|Overall Study|did not wish to continue|32|||
13459157|NCT00134563|26964637|FG002|Overall Study|did not wish to continue|26|||
13459158|NCT00134563|26964635|FG000|Overall Study|Reason other than above|0|||
13459159|NCT00134563|26964636|FG001|Overall Study|Reason other than above|2|||
13459160|NCT00134563|26964637|FG002|Overall Study|Reason other than above|5|||
13459161|NCT00134082|26964646|FG000|Overall Study|Adverse Event|2|||
13459162|NCT00134082|26964646|FG000|Overall Study|Death|1|||
13459163|NCT00134056|26964673|FG000|Randomization|Not eligible for assigned treatment|22|||
13459164|NCT00134056|26964674|FG001|Randomization|Not eligible for assigned treatment|20|||
13459165|NCT00134056|26964673|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
13459166|NCT00134056|26964674|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
13459167|NCT00134056|26964673|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81|||
13459168|NCT00134056|26964674|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67|||
13459169|NCT00134056|26964673|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20|||
13459170|NCT00134056|26964674|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21|||
13459171|NCT00134056|26964673|FG000|Eligible for Protocol Assigned Treatment|Other|55|||
13459172|NCT00134056|26964674|FG001|Eligible for Protocol Assigned Treatment|Other|56|||
13459173|NCT00133991|26964684|FG000|Overall Study|Death|4|||
13459174|NCT00133952|26964713|FG000|Overall Study|Adverse Event|1|||
13459175|NCT00133952|26964714|FG001|Overall Study|Adverse Event|2|||
13459176|NCT00133952|26964713|FG000|Overall Study|Death|3|||
13459177|NCT00133952|26964714|FG001|Overall Study|Death|2|||
13459178|NCT00133952|26964713|FG000|Overall Study|Lost to Follow-up|9|||
13459179|NCT00133952|26964714|FG001|Overall Study|Lost to Follow-up|14|||
13459180|NCT00133952|26964713|FG000|Overall Study|Protocol Entry Criteria Exclusion|4|||
13459181|NCT00133952|26964714|FG001|Overall Study|Protocol Entry Criteria Exclusion|1|||
13459182|NCT00133952|26964713|FG000|Overall Study|Protocol Violation|1|||
13459183|NCT00133952|26964714|FG001|Overall Study|Protocol Violation|1|||
13459184|NCT00133952|26964713|FG000|Overall Study|Withdrawal by Subject|20|||
13459185|NCT00133952|26964714|FG001|Overall Study|Withdrawal by Subject|4|||
13459186|NCT00133952|26964713|FG000|Overall Study|Physician Decision|4|||
13459187|NCT00133952|26964714|FG001|Overall Study|Physician Decision|3|||
13459188|NCT00133952|26964713|FG000|Overall Study|Sponsor Decision|0|||
13459189|NCT00133952|26964714|FG001|Overall Study|Sponsor Decision|1|||
13459190|NCT00133705|26964727|FG000|Overall Study|Withdrawal by Subject|2|||
13459191|NCT00133705|26964728|FG001|Overall Study|Withdrawal by Subject|3|||
13459192|NCT00132873|26964735|FG000|Overall Study|Adverse Event|3|||
13459193|NCT00132873|26964735|FG000|Overall Study|Lost to Follow-up|1|||
13459194|NCT00132873|26964735|FG000|Overall Study|Lack of Efficacy|1|||
13459195|NCT00132873|26964735|FG000|Overall Study|Withdrawal by Subject|3|||
13459196|NCT00132873|26964735|FG000|Overall Study|Planned Pregnancy|1|||
13459197|NCT00132808|26964768|FG000|Stratum I|Adverse Event|2|||
13459198|NCT00132808|26964769|FG001|Stratum I|Adverse Event|1|||
13459199|NCT00132808|26964770|FG002|Stratum I|Adverse Event|0|||
13459200|NCT00132808|26964768|FG000|Stratum I|Lost to Follow-up|3|||
13459201|NCT00132808|26964769|FG001|Stratum I|Lost to Follow-up|4|||
13459202|NCT00132808|26964770|FG002|Stratum I|Lost to Follow-up|1|||
13459203|NCT00132808|26964768|FG000|Stratum I|Withdrawal by Subject|4|||
13459204|NCT00132808|26964769|FG001|Stratum I|Withdrawal by Subject|7|||
13459205|NCT00132808|26964770|FG002|Stratum I|Withdrawal by Subject|3|||
13459206|NCT00132808|26964768|FG000|Stratum I|Abnormal test procedure result (s)|0|||
13459207|NCT00132808|26964769|FG001|Stratum I|Abnormal test procedure result (s)|0|||
13459208|NCT00132808|26964770|FG002|Stratum I|Abnormal test procedure result (s)|1|||
13459209|NCT00132808|26964768|FG000|Stratum II|Adverse Event|1|||
13459210|NCT00132808|26964769|FG001|Stratum II|Adverse Event|2|||
13459211|NCT00132808|26964770|FG002|Stratum II|Adverse Event|1|||
13459212|NCT00132808|26964768|FG000|Stratum II|Death|1|||
13459213|NCT00132808|26964769|FG001|Stratum II|Death|0|||
13459214|NCT00132808|26964770|FG002|Stratum II|Death|0|||
13459215|NCT00132808|26964768|FG000|Stratum II|Lost to Follow-up|2|||
13459216|NCT00132808|26964769|FG001|Stratum II|Lost to Follow-up|2|||
13459217|NCT00132808|26964770|FG002|Stratum II|Lost to Follow-up|1|||
13459218|NCT00132808|26964768|FG000|Stratum II|Protocol Violation|0|||
13459219|NCT00132808|26964769|FG001|Stratum II|Protocol Violation|2|||
13459220|NCT00132808|26964770|FG002|Stratum II|Protocol Violation|1|||
13459221|NCT00132808|26964768|FG000|Stratum II|Withdrawal by Subject|4|||
13459222|NCT00132808|26964769|FG001|Stratum II|Withdrawal by Subject|9|||
13459223|NCT00132808|26964770|FG002|Stratum II|Withdrawal by Subject|6|||
13459224|NCT00132769|26964799|FG000|Overall Study|Withdrawal by Subject|1|||
13459225|NCT00132769|26964800|FG001|Overall Study|Withdrawal by Subject|3|||
13459226|NCT00132769|26964799|FG000|Overall Study|Lack of Efficacy|7|||
13459227|NCT00132769|26964800|FG001|Overall Study|Lack of Efficacy|6|||
13459228|NCT00132769|26964799|FG000|Overall Study|Adverse Event|2|||
13459229|NCT00132769|26964800|FG001|Overall Study|Adverse Event|1|||
13459230|NCT00132769|26964799|FG000|Overall Study|Protocol Violation|1|||
13459231|NCT00132769|26964800|FG001|Overall Study|Protocol Violation|1|||
13459232|NCT00132730|26964857|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11|||
13459233|NCT00132730|26964858|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4|||
13459234|NCT00132730|26964859|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
13459235|NCT00132730|26964860|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
13459236|NCT00132730|26964861|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
13459237|NCT00132730|26964862|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
13459238|NCT00132730|26964857|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
13459239|NCT00132730|26964858|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
13459240|NCT00132730|26964859|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
13459241|NCT00132730|26964860|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
13459242|NCT00132730|26964861|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
13459243|NCT00132730|26964862|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
13459244|NCT00132730|26964857|FG000|Period II - 12-week Treatment (Base)|Other reasons|11|||
13459245|NCT00132730|26964858|FG001|Period II - 12-week Treatment (Base)|Other reasons|10|||
13459246|NCT00132730|26964859|FG002|Period II - 12-week Treatment (Base)|Other reasons|9|||
13459247|NCT00132730|26964860|FG003|Period II - 12-week Treatment (Base)|Other reasons|13|||
13459248|NCT00132730|26964861|FG004|Period II - 12-week Treatment (Base)|Other reasons|0|||
13459249|NCT00132730|26964862|FG005|Period II - 12-week Treatment (Base)|Other reasons|0|||
13459250|NCT00132730|26964857|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0|||
13459251|NCT00132730|26964858|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0|||
13459252|NCT00132730|26964859|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57|||
13459253|NCT00132730|26964860|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20|||
13459254|NCT00132730|26964861|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0|||
13459255|NCT00132730|26964862|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0|||
13459256|NCT00132730|26964857|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
13459257|NCT00132730|26964858|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
13459258|NCT00132730|26964859|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11|||
13459259|NCT00132730|26964860|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1|||
13459260|NCT00132730|26964861|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
13459261|NCT00132730|26964862|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
13459262|NCT00132730|26964857|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
13459263|NCT00132730|26964858|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
13459264|NCT00132730|26964859|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
13459265|NCT00132730|26964860|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1|||
13459266|NCT00132730|26964861|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
13459267|NCT00132730|26964862|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
13459268|NCT00132730|26964857|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0|||
13459269|NCT00132730|26964858|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0|||
13459270|NCT00132730|26964859|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14|||
13459271|NCT00132730|26964860|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3|||
13459272|NCT00132730|26964861|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0|||
13459273|NCT00132730|26964862|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0|||
13459274|NCT00132730|26964857|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
13459275|NCT00132730|26964858|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
13459276|NCT00132730|26964859|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
13459277|NCT00132730|26964860|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
13459278|NCT00132730|26964861|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169|||
13459279|NCT00132730|26964862|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68|||
13459280|NCT00132730|26964857|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
13459281|NCT00132730|26964858|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
13459282|NCT00132730|26964859|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
13459283|NCT00132730|26964860|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
13459284|NCT00132730|26964861|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3|||
13459285|NCT00132730|26964862|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
13459286|NCT00132730|26964857|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
13459287|NCT00132730|26964858|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
13459288|NCT00132730|26964859|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
13459289|NCT00132730|26964860|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
13459290|NCT00132730|26964861|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1|||
13459291|NCT00132730|26964862|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
13459292|NCT00132730|26964857|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
13459293|NCT00132730|26964858|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
13459294|NCT00132730|26964859|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
13459295|NCT00132730|26964860|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
13459296|NCT00132730|26964861|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6|||
13459297|NCT00132730|26964862|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
13459298|NCT00132730|26964857|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0|||
13459299|NCT00132730|26964858|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0|||
13459300|NCT00132730|26964859|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0|||
13459301|NCT00132730|26964860|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0|||
13459302|NCT00132730|26964861|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7|||
13459303|NCT00132730|26964862|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2|||
13459304|NCT00132691|26964907|FG000|Overall Study|Lost to Follow-up|5|||
13459305|NCT00132691|26964908|FG001|Overall Study|Lost to Follow-up|8|||
13459306|NCT00132691|26964907|FG000|Overall Study|Missed 2-year visit|4|||
13459307|NCT00132691|26964908|FG001|Overall Study|Missed 2-year visit|4|||
13459308|NCT00132691|26964907|FG000|Overall Study|Death|2|||
13459309|NCT00132691|26964908|FG001|Overall Study|Death|0|||
13459310|NCT00132678|26964928|FG000|Period II (Open-Label Oral Risperidone)|Death|0|||
13459311|NCT00132678|26964929|FG001|Period II (Open-Label Oral Risperidone)|Death|0|||
13459312|NCT00132678|26964930|FG002|Period II (Open-Label Oral Risperidone)|Death|1|||
13459313|NCT00132678|26964928|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
13459314|NCT00132678|26964929|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
13459315|NCT00132678|26964930|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13|||
13459316|NCT00132678|26964928|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0|||
13459317|NCT00132678|26964929|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0|||
13459318|NCT00132678|26964930|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6|||
13459319|NCT00132678|26964928|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
13459320|NCT00132678|26964929|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
13459321|NCT00132678|26964930|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7|||
13459322|NCT00132678|26964928|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
13459323|NCT00132678|26964929|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
13459324|NCT00132678|26964930|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14|||
13459325|NCT00132678|26964928|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
13459326|NCT00132678|26964929|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
13459327|NCT00132678|26964930|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16|||
13459328|NCT00132678|26964928|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
13459329|NCT00132678|26964929|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
13459330|NCT00132678|26964930|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1|||
13459331|NCT00132678|26964928|FG000|Period III (Open-Label Stabilization)|Death|2|||
13459332|NCT00132678|26964929|FG001|Period III (Open-Label Stabilization)|Death|0|||
13459333|NCT00132678|26964930|FG002|Period III (Open-Label Stabilization)|Death|0|||
13459334|NCT00132678|26964928|FG000|Period III (Open-Label Stabilization)|Adverse Event|12|||
13459335|NCT00132678|26964929|FG001|Period III (Open-Label Stabilization)|Adverse Event|0|||
13459336|NCT00132678|26964930|FG002|Period III (Open-Label Stabilization)|Adverse Event|0|||
13459337|NCT00132678|26964928|FG000|Period III (Open-Label Stabilization)|Non responder|107|||
13459338|NCT00132678|26964929|FG001|Period III (Open-Label Stabilization)|Non responder|0|||
13459339|NCT00132678|26964930|FG002|Period III (Open-Label Stabilization)|Non responder|0|||
13459340|NCT00132678|26964928|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5|||
13459341|NCT00132678|26964929|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
13459342|NCT00132678|26964930|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
13459343|NCT00132678|26964928|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19|||
13459344|NCT00132678|26964929|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
13459345|NCT00132678|26964930|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
13459346|NCT00132678|26964928|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49|||
13459347|NCT00132678|26964929|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
13459348|NCT00132678|26964930|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
13459349|NCT00132678|26964928|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1|||
13459350|NCT00132678|26964929|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
13459351|NCT00132678|26964930|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
13459352|NCT00132678|26964928|FG000|Period III (Open-Label Stabilization)|Physician Decision|1|||
13459353|NCT00132678|26964929|FG001|Period III (Open-Label Stabilization)|Physician Decision|0|||
13459354|NCT00132678|26964930|FG002|Period III (Open-Label Stabilization)|Physician Decision|0|||
13459355|NCT00132678|26964928|FG000|Period III (Open-Label Stabilization)|Pregnancy|2|||
13459356|NCT00132678|26964929|FG001|Period III (Open-Label Stabilization)|Pregnancy|0|||
13459357|NCT00132678|26964930|FG002|Period III (Open-Label Stabilization)|Pregnancy|0|||
13459358|NCT00132678|26964928|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1|||
13459359|NCT00132678|26964929|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1|||
13459360|NCT00132678|26964930|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0|||
13459361|NCT00132678|26964928|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
13459362|NCT00132678|26964929|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
13459363|NCT00132678|26964930|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0|||
13459364|NCT00132678|26964928|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6|||
13459365|NCT00132678|26964929|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3|||
13459366|NCT00132678|26964930|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0|||
13459367|NCT00132678|26964928|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14|||
13459368|NCT00132678|26964929|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15|||
13459369|NCT00132678|26964930|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0|||
13459370|NCT00132678|26964928|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10|||
13459371|NCT00132678|26964929|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14|||
13459372|NCT00132678|26964930|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0|||
13459373|NCT00132678|26964928|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2|||
13459374|NCT00132678|26964929|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1|||
13459375|NCT00132678|26964930|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0|||
13459376|NCT00132678|26964928|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0|||
13459377|NCT00132678|26964929|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2|||
13459378|NCT00132678|26964930|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0|||
13459379|NCT00132496|26964943|FG000|Overall Study|Withdrawal by Subject|1|||
13459380|NCT00132496|26964944|FG001|Overall Study|Withdrawal by Subject|2|||
13459381|NCT00132496|26964943|FG000|Overall Study|Physician Decision|1|||
13459382|NCT00132496|26964944|FG001|Overall Study|Physician Decision|0|||
13459383|NCT00132314|26964959|FG000|Overall Study|Lost to Follow-up|70|||
13459384|NCT00132314|26964960|FG001|Overall Study|Lost to Follow-up|62|||
13459385|NCT00132314|26964959|FG000|Overall Study|Lacked SSN|1|||
13459386|NCT00132314|26964960|FG001|Overall Study|Lacked SSN|3|||
13459387|NCT00132314|26964959|FG000|Overall Study|Refused intervention at baseline|2|||
13459388|NCT00132314|26964960|FG001|Overall Study|Refused intervention at baseline|7|||
13459389|NCT00132301|26964973|FG000|Overall Study|Death|7|||
13459390|NCT00132301|26964974|FG001|Overall Study|Death|6|||
13459391|NCT00132301|26964973|FG000|Overall Study|Withdrawal by Subject|5|||
13459392|NCT00132301|26964974|FG001|Overall Study|Withdrawal by Subject|2|||
13459393|NCT00132301|26964973|FG000|Overall Study|Physician Decision|1|||
13459394|NCT00132301|26964974|FG001|Overall Study|Physician Decision|1|||
13459395|NCT00132301|26964973|FG000|Overall Study|Lost to Follow-up|5|||
13459396|NCT00132301|26964974|FG001|Overall Study|Lost to Follow-up|3|||
13459397|NCT00132301|26964973|FG000|Overall Study|Other|1|||
13459398|NCT00132301|26964974|FG001|Overall Study|Other|1|||
13459399|NCT00132301|26964973|FG000|Overall Study|Excluded by Data Monitoring Committee|1|||
13459400|NCT00132301|26964974|FG001|Overall Study|Excluded by Data Monitoring Committee|0|||
13459401|NCT00132132|26964989|FG000|Overall Study|Lost to Follow-up|7|||
13459402|NCT00132132|26964990|FG001|Overall Study|Lost to Follow-up|2|||
13459403|NCT00132041|26965007|FG000|Baseline|Ineligible|6|||
13459404|NCT00132041|26965007|FG000|3 Months Post Ablation|Transplant|1|||
13459405|NCT00132041|26965007|FG000|3 Months Post Ablation|Non-Protocol Treatment|2|||
13459406|NCT00132041|26965007|FG000|6 Months Post Ablation|Withdrawal by Subject|2|||
13459407|NCT00132041|26965007|FG000|6 Months Post Ablation|Death|2|||
13459408|NCT00132041|26965007|FG000|6 Months Post Ablation|Transplant|6|||
13459409|NCT00132041|26965007|FG000|9 Months Post Ablation|Death|1|||
13459410|NCT00132041|26965007|FG000|9 Months Post Ablation|Transplant|1|||
13459411|NCT00132041|26965007|FG000|12 Months Post Ablation|Withdrawal by Subject|1|||
13459412|NCT00132041|26965007|FG000|12 Months Post Ablation|Death|1|||
13459413|NCT00132041|26965007|FG000|12 Months Post Ablation|Transplant|1|||
13459414|NCT00132041|26965007|FG000|12 Months Post Ablation|non-protocol Treatment|1|||
13459415|NCT00132041|26965007|FG000|15 Months Post Ablation|Withdrawal by Subject|1|||
13459416|NCT00132041|26965007|FG000|15 Months Post Ablation|Death|1|||
13459417|NCT00132041|26965007|FG000|15 Months Post Ablation|Transplant|5|||
13459418|NCT00132041|26965007|FG000|15 Months Post Ablation|Non-Protocol Treatment|1|||
13459419|NCT00132041|26965007|FG000|18 Months Post Ablation|Withdrawal by Subject|1|||
13459420|NCT00132041|26965007|FG000|18 Months Post Ablation|Transplant|1|||
13459421|NCT00132041|26965007|FG000|18 Months Post Ablation|Non-Protocol Treatment|3|||
13459422|NCT00132041|26965007|FG000|18 Months Post Ablation|ExtraHepatic tumor|1|||
13459423|NCT00132028|26965015|FG000|Overall Study|Adverse Event|7|||
13459424|NCT00132028|26965015|FG000|Overall Study|Death|2|||
13459425|NCT00132028|26965015|FG000|Overall Study|Lack of Efficacy|11|||
13459426|NCT00132028|26965015|FG000|Overall Study|Withdrawal by Subject|2|||
13459427|NCT00132028|26965015|FG000|Overall Study|not eligible|2|||
13459428|NCT00132028|26965015|FG000|Overall Study|Physician Decision|3|||
13459429|NCT00131937|26965023|FG000|Overall Study|Adverse Event|3|||
13459430|NCT00131937|26965023|FG000|Overall Study|Withdrawal by Subject|2|||
13459431|NCT00131937|26965023|FG000|Overall Study|Physician Decision|1|||
13459432|NCT00131937|26965023|FG000|Overall Study|Disease Progression|7|||
13459433|NCT00131937|26965023|FG000|Overall Study|Alternative therapy|1|||
13459434|NCT00131911|26965043|FG000|Overall Study|Withdrawal by Subject|1|||
13459435|NCT00131911|26965044|FG001|Overall Study|Withdrawal by Subject|0|||
13459436|NCT00131664|26965116|FG000|First Period (First 6 Months)|Lost to Follow-up|7|||
13459437|NCT00131664|26965117|FG001|First Period (First 6 Months)|Lost to Follow-up|3|||
13459438|NCT00131664|26965118|FG002|First Period (First 6 Months)|Lost to Follow-up|3|||
13459439|NCT00131664|26965119|FG003|First Period (First 6 Months)|Lost to Follow-up|0|||
13459440|NCT00131664|26965120|FG004|First Period (First 6 Months)|Lost to Follow-up|0|||
13459441|NCT00131664|26965121|FG005|First Period (First 6 Months)|Lost to Follow-up|0|||
13459442|NCT00131664|26965116|FG000|First Period (First 6 Months)|Death|0|||
13459443|NCT00131664|26965117|FG001|First Period (First 6 Months)|Death|1|||
13459444|NCT00131664|26965118|FG002|First Period (First 6 Months)|Death|0|||
13459445|NCT00131664|26965119|FG003|First Period (First 6 Months)|Death|0|||
13459446|NCT00131664|26965120|FG004|First Period (First 6 Months)|Death|0|||
13459447|NCT00131664|26965121|FG005|First Period (First 6 Months)|Death|0|||
13459448|NCT00131664|26965116|FG000|First Period (First 6 Months)|Protocol Violation|2|||
13459449|NCT00131664|26965117|FG001|First Period (First 6 Months)|Protocol Violation|2|||
13459450|NCT00131664|26965118|FG002|First Period (First 6 Months)|Protocol Violation|1|||
13459451|NCT00131664|26965119|FG003|First Period (First 6 Months)|Protocol Violation|0|||
13459452|NCT00131664|26965120|FG004|First Period (First 6 Months)|Protocol Violation|0|||
13459453|NCT00131664|26965121|FG005|First Period (First 6 Months)|Protocol Violation|0|||
13459454|NCT00131664|26965116|FG000|First Period (First 6 Months)|Withdrawal by Subject|4|||
13459455|NCT00131664|26965117|FG001|First Period (First 6 Months)|Withdrawal by Subject|6|||
13459456|NCT00131664|26965118|FG002|First Period (First 6 Months)|Withdrawal by Subject|2|||
13459457|NCT00131664|26965119|FG003|First Period (First 6 Months)|Withdrawal by Subject|0|||
13459458|NCT00131664|26965120|FG004|First Period (First 6 Months)|Withdrawal by Subject|0|||
13459459|NCT00131664|26965121|FG005|First Period (First 6 Months)|Withdrawal by Subject|0|||
13459460|NCT00131664|26965116|FG000|First Period (First 6 Months)|Adverse Event|9|||
13459461|NCT00131664|26965117|FG001|First Period (First 6 Months)|Adverse Event|4|||
13459462|NCT00131664|26965118|FG002|First Period (First 6 Months)|Adverse Event|5|||
13459463|NCT00131664|26965119|FG003|First Period (First 6 Months)|Adverse Event|0|||
13459464|NCT00131664|26965120|FG004|First Period (First 6 Months)|Adverse Event|0|||
13459465|NCT00131664|26965121|FG005|First Period (First 6 Months)|Adverse Event|0|||
13459466|NCT00131664|26965116|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1|||
13459467|NCT00131664|26965117|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2|||
13459468|NCT00131664|26965118|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
13459469|NCT00131664|26965119|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
13459470|NCT00131664|26965120|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
13459471|NCT00131664|26965121|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
13459472|NCT00131664|26965116|FG000|First Period (First 6 Months)|Administrative reasons|2|||
13459473|NCT00131664|26965117|FG001|First Period (First 6 Months)|Administrative reasons|0|||
13459474|NCT00131664|26965118|FG002|First Period (First 6 Months)|Administrative reasons|5|||
13459475|NCT00131664|26965119|FG003|First Period (First 6 Months)|Administrative reasons|0|||
13459476|NCT00131664|26965120|FG004|First Period (First 6 Months)|Administrative reasons|0|||
13459477|NCT00131664|26965121|FG005|First Period (First 6 Months)|Administrative reasons|0|||
13459478|NCT00131664|26965116|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3|||
13459479|NCT00131664|26965117|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
13459480|NCT00131664|26965118|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
13459481|NCT00131664|26965119|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1|||
13459482|NCT00131664|26965120|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
13459483|NCT00131664|26965121|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
13459484|NCT00131664|26965116|FG000|Second Period (Additional Drug Added)|Protocol Violation|0|||
13459485|NCT00131664|26965117|FG001|Second Period (Additional Drug Added)|Protocol Violation|1|||
13459486|NCT00131664|26965118|FG002|Second Period (Additional Drug Added)|Protocol Violation|1|||
13459487|NCT00131664|26965119|FG003|Second Period (Additional Drug Added)|Protocol Violation|0|||
13459488|NCT00131664|26965120|FG004|Second Period (Additional Drug Added)|Protocol Violation|0|||
13459489|NCT00131664|26965121|FG005|Second Period (Additional Drug Added)|Protocol Violation|0|||
13459490|NCT00131664|26965116|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2|||
13459491|NCT00131664|26965117|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
13459492|NCT00131664|26965118|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
13459493|NCT00131664|26965119|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
13459494|NCT00131664|26965120|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
13459495|NCT00131664|26965121|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
13459496|NCT00131664|26965116|FG000|Second Period (Additional Drug Added)|Adverse Event|0|||
13459497|NCT00131664|26965117|FG001|Second Period (Additional Drug Added)|Adverse Event|1|||
13459498|NCT00131664|26965118|FG002|Second Period (Additional Drug Added)|Adverse Event|0|||
13459499|NCT00131664|26965119|FG003|Second Period (Additional Drug Added)|Adverse Event|0|||
13459500|NCT00131664|26965120|FG004|Second Period (Additional Drug Added)|Adverse Event|0|||
13459501|NCT00131664|26965121|FG005|Second Period (Additional Drug Added)|Adverse Event|1|||
13459502|NCT00131664|26965116|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
13459503|NCT00131664|26965117|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
13459504|NCT00131664|26965118|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
13459505|NCT00131664|26965119|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1|||
13459506|NCT00131664|26965120|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
13459507|NCT00131664|26965121|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
13459508|NCT00131664|26965116|FG000|Second Period (Additional Drug Added)|Administrative reasons|4|||
13459509|NCT00131664|26965117|FG001|Second Period (Additional Drug Added)|Administrative reasons|2|||
13459510|NCT00131664|26965118|FG002|Second Period (Additional Drug Added)|Administrative reasons|0|||
13459511|NCT00131664|26965119|FG003|Second Period (Additional Drug Added)|Administrative reasons|0|||
13459512|NCT00131664|26965120|FG004|Second Period (Additional Drug Added)|Administrative reasons|1|||
13459513|NCT00131664|26965121|FG005|Second Period (Additional Drug Added)|Administrative reasons|0|||
13459514|NCT00131508|26965150|FG000|Overall Study|Disease progression|0|||
13459515|NCT00131508|26965151|FG001|Overall Study|Disease progression|2|||
13459516|NCT00131508|26965150|FG000|Overall Study|Non-Compliance|2|||
13459517|NCT00131508|26965151|FG001|Overall Study|Non-Compliance|4|||
13459518|NCT00131508|26965150|FG000|Overall Study|Withdrawal by Subject|1|||
13459519|NCT00131508|26965151|FG001|Overall Study|Withdrawal by Subject|2|||
13459520|NCT00131469|26965166|FG000|Overall Study|Withdrawal by Subject|3|||
13459521|NCT00131469|26965167|FG001|Overall Study|Withdrawal by Subject|4|||
13459522|NCT00131469|26965166|FG000|Overall Study|Protocol Violation|3|||
13459523|NCT00131469|26965167|FG001|Overall Study|Protocol Violation|1|||
13459524|NCT00131469|26965166|FG000|Overall Study|Death|0|||
13459525|NCT00131469|26965167|FG001|Overall Study|Death|1|||
13459526|NCT00131469|26965166|FG000|Overall Study|Lost to Follow-up|0|||
13459527|NCT00131469|26965167|FG001|Overall Study|Lost to Follow-up|1|||
13459528|NCT00131469|26965166|FG000|Overall Study|scan not analyzable|3|||
13459529|NCT00131469|26965167|FG001|Overall Study|scan not analyzable|6|||
13459530|NCT00131365|26965174|FG000|Overall Study|Withdrawal by Subject|1|||
13459531|NCT00131365|26965174|FG000|Overall Study|Alternative treatment|3|||
13459532|NCT00131352|26965203|FG000|Initial Treatment Period|Adverse Event|1|||
13459533|NCT00131352|26965204|FG001|Initial Treatment Period|Adverse Event|3|||
13459534|NCT00131352|26965203|FG000|Initial Treatment Period|Non-compliant|1|||
13459535|NCT00131352|26965204|FG001|Initial Treatment Period|Non-compliant|2|||
13459536|NCT00131352|26965203|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
13459537|NCT00131352|26965204|FG001|Initial Treatment Period|Withdrawal by Subject|1|||
13459538|NCT00131352|26965203|FG000|Initial Treatment Period|Lack of Efficacy|6|||
13459539|NCT00131352|26965204|FG001|Initial Treatment Period|Lack of Efficacy|4|||
13459540|NCT00131352|26965203|FG000|Initial Treatment Period|Other|0|||
13459541|NCT00131352|26965204|FG001|Initial Treatment Period|Other|2|||
13459542|NCT00131352|26965203|FG000|Repeat Treatment Period|Adverse Event|1|||
13459543|NCT00131352|26965204|FG001|Repeat Treatment Period|Adverse Event|0|||
13459544|NCT00131352|26965203|FG000|Repeat Treatment Period|Other|1|||
13459545|NCT00131352|26965204|FG001|Repeat Treatment Period|Other|0|||
13459546|NCT00131248|26965213|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1|||
13459547|NCT00131248|26965214|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0|||
13459548|NCT00130832|26965231|FG000|Overall Study|Adverse Event|1|||
13459549|NCT00130832|26965232|FG001|Overall Study|Adverse Event|1|||
13459550|NCT00130832|26965231|FG000|Overall Study|Lost to Follow-up|1|||
13459551|NCT00130832|26965232|FG001|Overall Study|Lost to Follow-up|2|||
13459552|NCT00130832|26965231|FG000|Overall Study|Protocol Violation|6|||
13459553|NCT00130832|26965232|FG001|Overall Study|Protocol Violation|8|||
13459554|NCT00130832|26965231|FG000|Overall Study|Withdrawal by Subject|6|||
13459555|NCT00130832|26965232|FG001|Overall Study|Withdrawal by Subject|1|||
13459556|NCT00130832|26965231|FG000|Overall Study|Moved|2|||
13459557|NCT00130832|26965232|FG001|Overall Study|Moved|2|||
13459558|NCT00130832|26965231|FG000|Overall Study|Other|0|||
13459559|NCT00130832|26965232|FG001|Overall Study|Other|3|||
13459560|NCT00130793|26965249|FG000|Overall Study|Lost to Follow-up|1|||
13459561|NCT00130793|26965250|FG001|Overall Study|Lost to Follow-up|4|||
13459562|NCT00130793|26965249|FG000|Overall Study|Withdrew consent|2|||
13459563|NCT00130793|26965250|FG001|Overall Study|Withdrew consent|0|||
13459564|NCT00130728|26965269|FG000|Overall Study|Death|258|||
13459565|NCT00130728|26965270|FG001|Overall Study|Death|258|||
13459566|NCT00130728|26965269|FG000|Overall Study|Lost to Follow-up|4|||
13459567|NCT00130728|26965270|FG001|Overall Study|Lost to Follow-up|0|||
13459568|NCT00130728|26965269|FG000|Overall Study|Withdrawal by Subject|0|||
13459569|NCT00130728|26965270|FG001|Overall Study|Withdrawal by Subject|2|||
13459570|NCT00130689|26965276|FG000|Overall Study|Progressive Disease|29|||
13459571|NCT00130689|26965276|FG000|Overall Study|Death|1|||
13459572|NCT00130689|26965276|FG000|Overall Study|Clinical Deterioration|4|||
13459573|NCT00130689|26965276|FG000|Overall Study|Withdrawal by Subject|3|||
13459574|NCT00130689|26965276|FG000|Overall Study|Ineligible|6|||
13459575|NCT00130637|26965283|FG000|Overall Study|Adverse Event|2|||
13459576|NCT00130637|26965283|FG000|Overall Study|Withdrawal by Subject|1|||
13459577|NCT00130533|26965302|FG000|Overall Study|Withdrawal by Subject|33|||
13459578|NCT00130533|26965303|FG001|Overall Study|Withdrawal by Subject|6|||
13459579|NCT00130533|26965302|FG000|Overall Study|Adverse Event|34|||
13459580|NCT00130533|26965303|FG001|Overall Study|Adverse Event|1|||
13459581|NCT00130533|26965302|FG000|Overall Study|Disease relapse|9|||
13459582|NCT00130533|26965303|FG001|Overall Study|Disease relapse|13|||
13459583|NCT00130533|26965302|FG000|Overall Study|Interruption of treatment > 3 weeks|11|||
13459584|NCT00130533|26965303|FG001|Overall Study|Interruption of treatment > 3 weeks|0|||
13459585|NCT00130533|26965302|FG000|Overall Study|Death|4|||
13459586|NCT00130533|26965303|FG001|Overall Study|Death|2|||
13459587|NCT00130533|26965302|FG000|Overall Study|Protocol Violation|5|||
13459588|NCT00130533|26965303|FG001|Overall Study|Protocol Violation|1|||
13459589|NCT00130533|26965302|FG000|Overall Study|Lost to Follow-up|1|||
13459590|NCT00130533|26965303|FG001|Overall Study|Lost to Follow-up|1|||
13459591|NCT00130533|26965302|FG000|Overall Study|Sponsor´s decision|2|||
13459592|NCT00130533|26965303|FG001|Overall Study|Sponsor´s decision|0|||
13459593|NCT00130533|26965302|FG000|Overall Study|Second Primary Malignancy|0|||
13459594|NCT00130533|26965303|FG001|Overall Study|Second Primary Malignancy|1|||
13459595|NCT00130533|26965302|FG000|Overall Study|Other|12|||
13459596|NCT00130533|26965303|FG001|Overall Study|Other|5|||
13459597|NCT00130520|26965311|FG000|Overall Study|Adverse Event|11|||
13459598|NCT00130520|26965311|FG000|Overall Study|Death|1|||
13459599|NCT00130520|26965311|FG000|Overall Study|Physician Decision|1|||
13459600|NCT00130520|26965311|FG000|Overall Study|Withdrawal by Subject|1|||
13459601|NCT00130520|26965311|FG000|Overall Study|Disease Progression|23|||
13459602|NCT00130520|26965311|FG000|Overall Study|Protocol non-compliance|1|||
13459603|NCT00130520|26965311|FG000|Overall Study|Did not meet re-treatment criteria|1|||
13459604|NCT00130442|26965332|FG000|Overall Study|Withdrawal by Subject|0|||
13459605|NCT00130442|26965333|FG001|Overall Study|Withdrawal by Subject|1|||
13459606|NCT00130442|26965332|FG000|Overall Study|did not meet criteria|1|||
13459607|NCT00130442|26965333|FG001|Overall Study|did not meet criteria|1|||
13459608|NCT00130247|26965356|FG000|Overall Study|Pregnancy|1|||
13459609|NCT00130247|26965357|FG001|Overall Study|Pregnancy|0|||
13459610|NCT00130247|26965356|FG000|Overall Study|Post-randomization exclusion|1|||
13459611|NCT00130247|26965357|FG001|Overall Study|Post-randomization exclusion|2|||
13459612|NCT00130247|26965356|FG000|Overall Study|Not compliant with DOT|0|||
13459613|NCT00130247|26965357|FG001|Overall Study|Not compliant with DOT|2|||
13459614|NCT00130208|26965374|FG000|Maintenance Period (26 Weeks)|Adverse Event|10|||
13459615|NCT00130208|26965375|FG001|Maintenance Period (26 Weeks)|Adverse Event|12|||
13459616|NCT00130208|26965374|FG000|Maintenance Period (26 Weeks)|Physician Decision|0|||
13459617|NCT00130208|26965375|FG001|Maintenance Period (26 Weeks)|Physician Decision|2|||
13459618|NCT00130208|26965374|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8|||
13459619|NCT00130208|26965375|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11|||
13459620|NCT00130208|26965374|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5|||
13459621|NCT00130208|26965375|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4|||
13459622|NCT00130208|26965374|FG000|Maintenance Period (26 Weeks)|Other|1|||
13459623|NCT00130208|26965375|FG001|Maintenance Period (26 Weeks)|Other|1|||
13459624|NCT00130208|26965374|FG000|Washout Period (8 Weeks)|Adverse Event|3|||
13459625|NCT00130208|26965375|FG001|Washout Period (8 Weeks)|Adverse Event|6|||
13459626|NCT00130208|26965374|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2|||
13459627|NCT00130208|26965375|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4|||
13459628|NCT00130208|26965374|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0|||
13459629|NCT00130208|26965375|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1|||
13459630|NCT00130208|26965374|FG000|Washout Period (8 Weeks)|Other|1|||
13459631|NCT00130208|26965375|FG001|Washout Period (8 Weeks)|Other|1|||
13459632|NCT00130039|26965398|FG000|Overall Study|Withdrawal by Subject|15|||
13459633|NCT00130039|26965399|FG001|Overall Study|Withdrawal by Subject|11|||
13459634|NCT00130039|26965398|FG000|Overall Study|Lost to Follow-up|3|||
13459635|NCT00130039|26965399|FG001|Overall Study|Lost to Follow-up|1|||
13459636|NCT00130039|26965398|FG000|Overall Study|Adverse Event|4|||
13459637|NCT00130039|26965399|FG001|Overall Study|Adverse Event|2|||
13459638|NCT00130039|26965398|FG000|Overall Study|Physician Decision|3|||
13459639|NCT00130039|26965399|FG001|Overall Study|Physician Decision|0|||
13459640|NCT00130039|26965398|FG000|Overall Study|clinical events without follow up MRI|5|||
13459641|NCT00130039|26965399|FG001|Overall Study|clinical events without follow up MRI|4|||
13459642|NCT00129987|26965418|FG000|1st Educational Session|Withdrawal by Subject|141|||
13459643|NCT00129987|26965419|FG001|1st Educational Session|Withdrawal by Subject|109|||
13459644|NCT00129987|26965418|FG000|1 Year|Withdrawal by Subject|32|||
13459645|NCT00129987|26965419|FG001|1 Year|Withdrawal by Subject|21|||
13459646|NCT00129974|26965426|FG000|Overall Study|Other|1|||
13459647|NCT00129961|26965467|FG000|Overall Study|Adverse Event|1|||
13459648|NCT00129961|26965468|FG001|Overall Study|Adverse Event|0|||
13459649|NCT00129961|26965467|FG000|Overall Study|Death|1|||
13459650|NCT00129961|26965468|FG001|Overall Study|Death|1|||
13459651|NCT00129961|26965467|FG000|Overall Study|Withdrawal by Sponsor|14|||
13459652|NCT00129961|26965468|FG001|Overall Study|Withdrawal by Sponsor|20|||
13459653|NCT00129961|26965467|FG000|Overall Study|Physician Decision|1|||
13459654|NCT00129961|26965468|FG001|Overall Study|Physician Decision|0|||
13459655|NCT00129961|26965467|FG000|Overall Study|Withdrawal by Subject|2|||
13459656|NCT00129961|26965468|FG001|Overall Study|Withdrawal by Subject|1|||
13459657|NCT00129961|26965467|FG000|Overall Study|Missing Record|0|||
13459658|NCT00129961|26965468|FG001|Overall Study|Missing Record|1|||
13459659|NCT00129935|26965491|FG000|Overall Study|Adverse Event|18|||
13459660|NCT00129935|26965492|FG001|Overall Study|Adverse Event|56|||
13459661|NCT00129935|26965491|FG000|Overall Study|Death|1|||
13459662|NCT00129935|26965492|FG001|Overall Study|Death|1|||
13459663|NCT00129935|26965491|FG000|Overall Study|Withdrawal by Subject|7|||
13459664|NCT00129935|26965492|FG001|Overall Study|Withdrawal by Subject|20|||
13459665|NCT00129935|26965491|FG000|Overall Study|Protocol Violation|0|||
13459666|NCT00129935|26965492|FG001|Overall Study|Protocol Violation|4|||
13459667|NCT00129935|26965491|FG000|Overall Study|Physician Decision|3|||
13459668|NCT00129935|26965492|FG001|Overall Study|Physician Decision|4|||
13459669|NCT00129935|26965491|FG000|Overall Study|Recurrence|1|||
13459670|NCT00129935|26965492|FG001|Overall Study|Recurrence|3|||
13459671|NCT00129935|26965491|FG000|Overall Study|Second primary|0|||
13459672|NCT00129935|26965492|FG001|Overall Study|Second primary|1|||
13459673|NCT00129935|26965491|FG000|Overall Study|Other|3|||
13459674|NCT00129935|26965492|FG001|Overall Study|Other|2|||
13459675|NCT00129935|26965491|FG000|Overall Study|Crossed to the other arm|2|||
13459676|NCT00129935|26965492|FG001|Overall Study|Crossed to the other arm|1|||
13459677|NCT00129935|26965491|FG000|Overall Study|Incorrect study treatment|1|||
13459678|NCT00129935|26965492|FG001|Overall Study|Incorrect study treatment|0|||
13459679|NCT00129766|26965537|FG000|Overall Study|Death|3|||
13459680|NCT00129766|26965538|FG001|Overall Study|Death|8|||
13459681|NCT00129766|26965537|FG000|Overall Study|Withdrawal of consent|31|||
13459682|NCT00129766|26965538|FG001|Overall Study|Withdrawal of consent|30|||
13459683|NCT00129766|26965537|FG000|Overall Study|Lost to Follow-up|26|||
13459684|NCT00129766|26965538|FG001|Overall Study|Lost to Follow-up|21|||
13459685|NCT00129701|26965547|FG000|Overall Study|Withdrawal by Subject|33|||
13459686|NCT00129649|26965560|FG000|Overall Study|Withdrawal by Subject|76|||
13459687|NCT00129649|26965561|FG001|Overall Study|Withdrawal by Subject|65|||
13459688|NCT00129623|26965590|FG000|Overall Study|Adverse Event|3|||
13459689|NCT00129623|26965591|FG001|Overall Study|Adverse Event|7|||
13459690|NCT00129623|26965590|FG000|Overall Study|Refused Treatment|5|||
13459691|NCT00129623|26965591|FG001|Overall Study|Refused Treatment|3|||
13459692|NCT00129623|26965590|FG000|Overall Study|Failure to Return|1|||
13459693|NCT00129623|26965591|FG001|Overall Study|Failure to Return|1|||
13459694|NCT00129623|26965590|FG000|Overall Study|Relocated job out of state|1|||
13459695|NCT00129623|26965591|FG001|Overall Study|Relocated job out of state|0|||
13459696|NCT00129623|26965590|FG000|Overall Study|Uncertainty to return|0|||
13459697|NCT00129623|26965591|FG001|Overall Study|Uncertainty to return|1|||
13459698|NCT00129545|26965611|FG000|Overall Study|Death|5|||
13459699|NCT00129545|26965612|FG001|Overall Study|Death|60|||
13459700|NCT00129545|26965613|FG002|Overall Study|Death|44|||
13459701|NCT00129545|26965611|FG000|Overall Study|Withdrawal by Subject|3|||
13459702|NCT00129545|26965612|FG001|Overall Study|Withdrawal by Subject|18|||
13459703|NCT00129545|26965613|FG002|Overall Study|Withdrawal by Subject|44|||
13459704|NCT00129545|26965611|FG000|Overall Study|Lost to Follow-up|2|||
13459705|NCT00129545|26965612|FG001|Overall Study|Lost to Follow-up|22|||
13459706|NCT00129545|26965613|FG002|Overall Study|Lost to Follow-up|13|||
13459707|NCT00129545|26965611|FG000|Overall Study|Physician Decision|0|||
13459708|NCT00129545|26965612|FG001|Overall Study|Physician Decision|3|||
13459709|NCT00129545|26965613|FG002|Overall Study|Physician Decision|10|||
13459710|NCT00129545|26965611|FG000|Overall Study|Device not implanted|16|||
13459711|NCT00129545|26965612|FG001|Overall Study|Device not implanted|61|||
13459712|NCT00129545|26965613|FG002|Overall Study|Device not implanted|0|||
13459713|NCT00129467|26965626|FG000|Received Intervention|Death|1|||
13459714|NCT00129467|26965627|FG001|Received Intervention|Death|1|||
13459715|NCT00129467|26965626|FG000|Received Intervention|Cardiac SAE (hypertension)|1|||
13459716|NCT00129467|26965627|FG001|Received Intervention|Cardiac SAE (hypertension)|1|||
13459717|NCT00129467|26965626|FG000|Received Intervention|Delirium|2|||
13459718|NCT00129467|26965627|FG001|Received Intervention|Delirium|0|||
13459719|NCT00129467|26965626|FG000|Received Intervention|Withdrawal by Subject|1|||
13459720|NCT00129467|26965627|FG001|Received Intervention|Withdrawal by Subject|0|||
13459721|NCT00129467|26965626|FG000|Received Intervention|Nausea|1|||
13459722|NCT00129467|26965627|FG001|Received Intervention|Nausea|0|||
13459723|NCT00129467|26965626|FG000|Received Intervention|Intolerance to citalopram|0|||
13459724|NCT00129467|26965627|FG001|Received Intervention|Intolerance to citalopram|1|||
13459725|NCT00129467|26965626|FG000|Received Intervention|Dizzyness, fatigue|0|||
13459726|NCT00129467|26965627|FG001|Received Intervention|Dizzyness, fatigue|1|||
13459727|NCT00129467|26965626|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1|||
13459728|NCT00129467|26965627|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0|||
13459729|NCT00129467|26965626|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1|||
13459730|NCT00129467|26965627|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0|||
13459731|NCT00129402|26965656|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
13459732|NCT00129402|26965657|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
13459733|NCT00129402|26965658|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
13459734|NCT00129402|26965659|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
13459735|NCT00129402|26965660|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
13459736|NCT00129402|26965661|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
13459737|NCT00129402|26965662|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
13459738|NCT00129402|26965656|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
13459739|NCT00129402|26965657|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
13459740|NCT00129402|26965658|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
13459741|NCT00129402|26965659|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
13459742|NCT00129402|26965660|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
13459743|NCT00129402|26965661|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1|||
13459744|NCT00129402|26965662|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
13459745|NCT00129402|26965656|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
13459746|NCT00129402|26965657|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
13459747|NCT00129402|26965658|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
13459748|NCT00129402|26965659|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1|||
13459749|NCT00129402|26965660|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
13459750|NCT00129402|26965661|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
13459751|NCT00129402|26965662|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
13459752|NCT00129402|26965656|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
13459753|NCT00129402|26965657|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
13459754|NCT00129402|26965658|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
13459755|NCT00129402|26965659|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
13459756|NCT00129402|26965660|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
13459757|NCT00129402|26965661|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
13459758|NCT00129402|26965662|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
13459759|NCT00129402|26965656|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
13459760|NCT00129402|26965657|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
13459761|NCT00129402|26965658|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2|||
13459762|NCT00129402|26965659|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
13459763|NCT00129402|26965660|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
13459764|NCT00129402|26965661|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
13459765|NCT00129402|26965662|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
13459766|NCT00129402|26965656|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
13459767|NCT00129402|26965657|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
13459768|NCT00129402|26965658|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3|||
13459769|NCT00129402|26965659|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
13459770|NCT00129402|26965660|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
13459771|NCT00129402|26965661|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1|||
13459772|NCT00129402|26965662|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
13459773|NCT00129402|26965656|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
13459774|NCT00129402|26965657|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
13459775|NCT00129402|26965658|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1|||
13459776|NCT00129402|26965659|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
13459777|NCT00129402|26965660|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
13459778|NCT00129402|26965661|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
13459779|NCT00129402|26965662|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
13459780|NCT00129402|26965656|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
13459781|NCT00129402|26965657|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
13459782|NCT00129402|26965658|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1|||
13459783|NCT00129402|26965659|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
13459784|NCT00129402|26965660|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
13459785|NCT00129402|26965661|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3|||
13459786|NCT00129402|26965662|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
13459787|NCT00129402|26965656|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
13459788|NCT00129402|26965657|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
13459789|NCT00129402|26965658|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
13459790|NCT00129402|26965659|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
13459791|NCT00129402|26965660|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
13459792|NCT00129402|26965661|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
13459793|NCT00129402|26965662|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
13459794|NCT00129402|26965656|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
13459795|NCT00129402|26965657|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
13459796|NCT00129402|26965658|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
13459797|NCT00129402|26965659|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
13459798|NCT00129402|26965660|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
13459799|NCT00129402|26965661|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
13459800|NCT00129402|26965662|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1|||
13459801|NCT00129402|26965656|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
13459802|NCT00129402|26965657|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
13459803|NCT00129402|26965658|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
13459804|NCT00129402|26965659|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
13459805|NCT00129402|26965660|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
13459806|NCT00129402|26965661|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
13459807|NCT00129402|26965662|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3|||
13459808|NCT00129402|26965656|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
13459809|NCT00129402|26965657|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
13459810|NCT00129402|26965658|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
13459811|NCT00129402|26965659|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
13459812|NCT00129402|26965660|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
13459813|NCT00129402|26965661|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
13459814|NCT00129402|26965662|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1|||
13459815|NCT00129402|26965656|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
13459816|NCT00129402|26965657|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
13459817|NCT00129402|26965658|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
13459818|NCT00129402|26965659|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
13459819|NCT00129402|26965660|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
13459820|NCT00129402|26965661|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
13459821|NCT00129402|26965662|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1|||
13459822|NCT00129389|26965677|FG000|Overall Study|Adverse Event|19|||
13459823|NCT00129389|26965678|FG001|Overall Study|Adverse Event|87|||
13459824|NCT00129389|26965677|FG000|Overall Study|Death|0|||
13459825|NCT00129389|26965678|FG001|Overall Study|Death|1|||
13459826|NCT00129389|26965677|FG000|Overall Study|Lost to Follow-up|2|||
13459827|NCT00129389|26965678|FG001|Overall Study|Lost to Follow-up|1|||
13459828|NCT00129389|26965677|FG000|Overall Study|Physician Decision|0|||
13459829|NCT00129389|26965678|FG001|Overall Study|Physician Decision|4|||
13459830|NCT00129389|26965677|FG000|Overall Study|Protocol Violation|0|||
13459831|NCT00129389|26965678|FG001|Overall Study|Protocol Violation|6|||
13459832|NCT00129389|26965677|FG000|Overall Study|Withdrawal by Subject|9|||
13459833|NCT00129389|26965678|FG001|Overall Study|Withdrawal by Subject|23|||
13459834|NCT00129389|26965677|FG000|Overall Study|Relapse|1|||
13459835|NCT00129389|26965678|FG001|Overall Study|Relapse|0|||
13459836|NCT00129389|26965677|FG000|Overall Study|Not eligible|1|||
13459837|NCT00129389|26965678|FG001|Overall Study|Not eligible|2|||
13459838|NCT00129389|26965677|FG000|Overall Study|Crossed to the other arm|1|||
13459839|NCT00129389|26965678|FG001|Overall Study|Crossed to the other arm|16|||
13459840|NCT00129376|26965688|FG000|Overall Study|Adverse Event|1|||
13459841|NCT00129376|26965688|FG000|Overall Study|Lack of Efficacy|1|||
13459842|NCT00129311|26965703|FG000|Overall Study|Withdrawal by Subject|12|||
13459843|NCT00129311|26965704|FG001|Overall Study|Withdrawal by Subject|19|||
13459844|NCT00129272|26965719|FG000|Overall Study|Lost to Follow-up|12|||
13459845|NCT00129272|26965720|FG001|Overall Study|Lost to Follow-up|11|||
13459846|NCT00129272|26965719|FG000|Overall Study|Withdrawal by Subject|5|||
13459847|NCT00129272|26965720|FG001|Overall Study|Withdrawal by Subject|11|||
13459848|NCT00129259|26965737|FG000|Overall Study|Lost to Follow-up|1|||
13459849|NCT00129259|26965738|FG001|Overall Study|Lost to Follow-up|1|||
13459850|NCT00129259|26965737|FG000|Overall Study|Withdrawal by Subject|2|||
13459851|NCT00129259|26965738|FG001|Overall Study|Withdrawal by Subject|1|||
13459852|NCT00129259|26965737|FG000|Overall Study|Only available minimal phone assessments|0|||
13459853|NCT00129259|26965738|FG001|Overall Study|Only available minimal phone assessments|1|||
13459854|NCT00129220|26965785|FG000|Study Period II|Adverse Event|9|||
13459855|NCT00129220|26965786|FG001|Study Period II|Adverse Event|5|||
13459856|NCT00129220|26965787|FG002|Study Period II|Adverse Event|7|||
13459857|NCT00129220|26965785|FG000|Study Period II|Lack of Efficacy|15|||
13459858|NCT00129220|26965786|FG001|Study Period II|Lack of Efficacy|1|||
13459859|NCT00129220|26965787|FG002|Study Period II|Lack of Efficacy|28|||
13459860|NCT00129220|26965785|FG000|Study Period II|Entry Criteria Not Met|2|||
13459861|NCT00129220|26965786|FG001|Study Period II|Entry Criteria Not Met|0|||
13459862|NCT00129220|26965787|FG002|Study Period II|Entry Criteria Not Met|2|||
13459863|NCT00129220|26965785|FG000|Study Period II|Protocol Violation|4|||
13459864|NCT00129220|26965786|FG001|Study Period II|Protocol Violation|2|||
13459865|NCT00129220|26965787|FG002|Study Period II|Protocol Violation|1|||
13459866|NCT00129220|26965785|FG000|Study Period II|Physician Decision|0|||
13459867|NCT00129220|26965786|FG001|Study Period II|Physician Decision|1|||
13459868|NCT00129220|26965787|FG002|Study Period II|Physician Decision|0|||
13459869|NCT00129220|26965785|FG000|Study Period II|Withdrawal by Subject|1|||
13459870|NCT00129220|26965786|FG001|Study Period II|Withdrawal by Subject|3|||
13459871|NCT00129220|26965787|FG002|Study Period II|Withdrawal by Subject|4|||
13459872|NCT00129220|26965785|FG000|Study Period II|Reason Not Specified|2|||
13459873|NCT00129220|26965786|FG001|Study Period II|Reason Not Specified|0|||
13459874|NCT00129220|26965787|FG002|Study Period II|Reason Not Specified|5|||
13459875|NCT00129220|26965785|FG000|Study Period III|Adverse Event|1|||
13459876|NCT00129220|26965786|FG001|Study Period III|Adverse Event|0|||
13459877|NCT00129220|26965787|FG002|Study Period III|Adverse Event|3|||
13459878|NCT00129220|26965785|FG000|Study Period III|Protocol Violation|1|||
13459879|NCT00129220|26965786|FG001|Study Period III|Protocol Violation|1|||
13459880|NCT00129220|26965787|FG002|Study Period III|Protocol Violation|2|||
13459881|NCT00129220|26965785|FG000|Study Period III|Withdrawal by Subject|1|||
13459882|NCT00129220|26965786|FG001|Study Period III|Withdrawal by Subject|0|||
13459883|NCT00129220|26965787|FG002|Study Period III|Withdrawal by Subject|3|||
13459884|NCT00129220|26965785|FG000|Study Period III|Sponsor Decision|1|||
13459885|NCT00129220|26965786|FG001|Study Period III|Sponsor Decision|0|||
13459886|NCT00129220|26965787|FG002|Study Period III|Sponsor Decision|0|||
13459887|NCT00129220|26965785|FG000|Study Period III|Reason Not Specified|9|||
13459888|NCT00129220|26965786|FG001|Study Period III|Reason Not Specified|0|||
13459889|NCT00129220|26965787|FG002|Study Period III|Reason Not Specified|2|||
13459890|NCT00129129|26966001|FG000|Primary Phase|Adverse Event|2|||
13459891|NCT00129129|26966002|FG001|Primary Phase|Adverse Event|1|||
13459892|NCT00129129|26966003|FG002|Primary Phase|Adverse Event|0|||
13459893|NCT00129129|26966004|FG003|Primary Phase|Adverse Event|0|||
13459894|NCT00129129|26966005|FG004|Primary Phase|Adverse Event|0|||
13459895|NCT00129129|26966001|FG000|Primary Phase|Withdrawal by Subject|12|||
13459896|NCT00129129|26966002|FG001|Primary Phase|Withdrawal by Subject|10|||
13459897|NCT00129129|26966003|FG002|Primary Phase|Withdrawal by Subject|0|||
13459898|NCT00129129|26966004|FG003|Primary Phase|Withdrawal by Subject|0|||
13459899|NCT00129129|26966005|FG004|Primary Phase|Withdrawal by Subject|0|||
13459900|NCT00129129|26966001|FG000|Primary Phase|Migration from study area|1|||
13459901|NCT00129129|26966002|FG001|Primary Phase|Migration from study area|3|||
13459902|NCT00129129|26966003|FG002|Primary Phase|Migration from study area|0|||
13459903|NCT00129129|26966004|FG003|Primary Phase|Migration from study area|0|||
13459904|NCT00129129|26966005|FG004|Primary Phase|Migration from study area|0|||
13459905|NCT00129129|26966001|FG000|Primary Phase|Lost to Follow-up|8|||
13459906|NCT00129129|26966002|FG001|Primary Phase|Lost to Follow-up|6|||
13459907|NCT00129129|26966003|FG002|Primary Phase|Lost to Follow-up|0|||
13459908|NCT00129129|26966004|FG003|Primary Phase|Lost to Follow-up|0|||
13459909|NCT00129129|26966005|FG004|Primary Phase|Lost to Follow-up|0|||
13459910|NCT00129129|26966001|FG000|Primary Phase|Other|2|||
13459911|NCT00129129|26966002|FG001|Primary Phase|Other|5|||
13459912|NCT00129129|26966003|FG002|Primary Phase|Other|0|||
13459913|NCT00129129|26966004|FG003|Primary Phase|Other|0|||
13459914|NCT00129129|26966005|FG004|Primary Phase|Other|0|||
13459915|NCT00129129|26966001|FG000|Fourth Dose Phase|Lost to Follow-up|4|||
13459916|NCT00129129|26966002|FG001|Fourth Dose Phase|Lost to Follow-up|0|||
13459917|NCT00129129|26966003|FG002|Fourth Dose Phase|Lost to Follow-up|0|||
13459918|NCT00129129|26966004|FG003|Fourth Dose Phase|Lost to Follow-up|2|||
13459919|NCT00129129|26966005|FG004|Fourth Dose Phase|Lost to Follow-up|2|||
13459920|NCT00129129|26966001|FG000|Fourth Dose Phase|Withdrawal by Subject|0|||
13459921|NCT00129129|26966002|FG001|Fourth Dose Phase|Withdrawal by Subject|0|||
13459922|NCT00129129|26966003|FG002|Fourth Dose Phase|Withdrawal by Subject|0|||
13459923|NCT00129129|26966004|FG003|Fourth Dose Phase|Withdrawal by Subject|0|||
13459924|NCT00129129|26966005|FG004|Fourth Dose Phase|Withdrawal by Subject|1|||
13459925|NCT00129129|26966001|FG000|Fourth Dose Phase|Migration from study area|0|||
13459926|NCT00129129|26966002|FG001|Fourth Dose Phase|Migration from study area|0|||
13459927|NCT00129129|26966003|FG002|Fourth Dose Phase|Migration from study area|0|||
13459928|NCT00129129|26966004|FG003|Fourth Dose Phase|Migration from study area|0|||
13459929|NCT00129129|26966005|FG004|Fourth Dose Phase|Migration from study area|2|||
13459930|NCT00129129|26966001|FG000|Fourth Dose Phase|Other|0|||
13459931|NCT00129129|26966002|FG001|Fourth Dose Phase|Other|0|||
13459932|NCT00129129|26966003|FG002|Fourth Dose Phase|Other|0|||
13459933|NCT00129129|26966004|FG003|Fourth Dose Phase|Other|1|||
13459934|NCT00129129|26966005|FG004|Fourth Dose Phase|Other|1|||
13459935|NCT00129129|26966001|FG000|Fourth Dose Phase|Protocol Violation|0|||
13459936|NCT00129129|26966002|FG001|Fourth Dose Phase|Protocol Violation|0|||
13459937|NCT00129129|26966003|FG002|Fourth Dose Phase|Protocol Violation|0|||
13459938|NCT00129129|26966004|FG003|Fourth Dose Phase|Protocol Violation|1|||
13459939|NCT00129129|26966005|FG004|Fourth Dose Phase|Protocol Violation|0|||
13459940|NCT00129116|26966283|FG000|Primary Phase|Lost to Follow-up|1|||
13459941|NCT00129116|26966284|FG001|Primary Phase|Lost to Follow-up|1|||
13459942|NCT00129116|26966285|FG002|Primary Phase|Lost to Follow-up|0|||
13459943|NCT00129116|26966286|FG003|Primary Phase|Lost to Follow-up|1|||
13459944|NCT00129116|26966287|FG004|Primary Phase|Lost to Follow-up|1|||
13459945|NCT00129116|26966283|FG000|Primary Phase|Protocol Violation|0|||
13459946|NCT00129116|26966284|FG001|Primary Phase|Protocol Violation|1|||
13459947|NCT00129116|26966285|FG002|Primary Phase|Protocol Violation|0|||
13459948|NCT00129116|26966286|FG003|Primary Phase|Protocol Violation|0|||
13459949|NCT00129116|26966287|FG004|Primary Phase|Protocol Violation|0|||
13459950|NCT00129116|26966283|FG000|Primary Phase|Adverse Event|1|||
13459951|NCT00129116|26966284|FG001|Primary Phase|Adverse Event|1|||
13459952|NCT00129116|26966285|FG002|Primary Phase|Adverse Event|0|||
13459953|NCT00129116|26966286|FG003|Primary Phase|Adverse Event|0|||
13459954|NCT00129116|26966287|FG004|Primary Phase|Adverse Event|0|||
13459955|NCT00129116|26966283|FG000|Primary Phase|Withdrawal by Subject|0|||
13459956|NCT00129116|26966284|FG001|Primary Phase|Withdrawal by Subject|1|||
13459957|NCT00129116|26966285|FG002|Primary Phase|Withdrawal by Subject|0|||
13459958|NCT00129116|26966286|FG003|Primary Phase|Withdrawal by Subject|0|||
13459959|NCT00129116|26966287|FG004|Primary Phase|Withdrawal by Subject|0|||
13459960|NCT00129116|26966283|FG000|Primary Phase|Other|0|||
13459961|NCT00129116|26966284|FG001|Primary Phase|Other|0|||
13459962|NCT00129116|26966285|FG002|Primary Phase|Other|1|||
13459963|NCT00129116|26966286|FG003|Primary Phase|Other|0|||
13459964|NCT00129116|26966287|FG004|Primary Phase|Other|0|||
13459965|NCT00129116|26966283|FG000|Booster Phase|Lost to Follow-up|2|||
13459966|NCT00129116|26966284|FG001|Booster Phase|Lost to Follow-up|0|||
13459967|NCT00129116|26966285|FG002|Booster Phase|Lost to Follow-up|0|||
13459968|NCT00129116|26966286|FG003|Booster Phase|Lost to Follow-up|0|||
13459969|NCT00129116|26966287|FG004|Booster Phase|Lost to Follow-up|1|||
13459970|NCT00128830|26966304|FG000|Overall Study|Adverse Event|10|||
13459971|NCT00128830|26966304|FG000|Overall Study|Withdrawal by Subject|14|||
13459972|NCT00128830|26966304|FG000|Overall Study|Lost to Follow-up|4|||
13459973|NCT00128830|26966304|FG000|Overall Study|Reached a virologic endpoint|29|||
13459974|NCT00128830|26966304|FG000|Overall Study|Non-compliant|4|||
13459975|NCT00128830|26966304|FG000|Overall Study|Discontinued or ineligible for study|2|||
13459976|NCT00128830|26966304|FG000|Overall Study|Other|9|||
13459977|NCT00128661|26966355|FG000|Overall Study|Adverse Event|14|||
13459978|NCT00128661|26966356|FG001|Overall Study|Adverse Event|11|||
13459979|NCT00128661|26966355|FG000|Overall Study|Lost to Follow-up|10|||
13459980|NCT00128661|26966356|FG001|Overall Study|Lost to Follow-up|7|||
13459981|NCT00128661|26966355|FG000|Overall Study|Withdrawal by Subject|243|||
13459982|NCT00128661|26966356|FG001|Overall Study|Withdrawal by Subject|232|||
13459983|NCT00128661|26966355|FG000|Overall Study|Other|7|||
13459984|NCT00128661|26966356|FG001|Overall Study|Other|8|||
13459985|NCT00128492|26966421|FG000|Overall Study|AE unrelated to study|2|||
13459986|NCT00128492|26966422|FG001|Overall Study|AE unrelated to study|9|||
13459987|NCT00128492|26966421|FG000|Overall Study|Study drug intolerance (AE)|2|||
13459988|NCT00128492|26966422|FG001|Overall Study|Study drug intolerance (AE)|8|||
13459989|NCT00128492|26966421|FG000|Overall Study|AE related to study|1|||
13459990|NCT00128492|26966422|FG001|Overall Study|AE related to study|4|||
13459991|NCT00128492|26966421|FG000|Overall Study|Death|1|||
13459992|NCT00128492|26966422|FG001|Overall Study|Death|0|||
13459993|NCT00128492|26966421|FG000|Overall Study|Lost to Follow-up|1|||
13459994|NCT00128492|26966422|FG001|Overall Study|Lost to Follow-up|5|||
13459995|NCT00128492|26966421|FG000|Overall Study|Noncompliance|0|||
13459996|NCT00128492|26966422|FG001|Overall Study|Noncompliance|5|||
13459997|NCT00128492|26966421|FG000|Overall Study|Personal or administrative|10|||
13459998|NCT00128492|26966422|FG001|Overall Study|Personal or administrative|22|||
13459999|NCT00128492|26966421|FG000|Overall Study|Withdrawal by Subject|3|||
13460000|NCT00128492|26966422|FG001|Overall Study|Withdrawal by Subject|5|||
13460001|NCT00128492|26966421|FG000|Overall Study|Pregnancy|0|||
13460002|NCT00128492|26966422|FG001|Overall Study|Pregnancy|1|||
13460003|NCT00128206|26966439|FG000|Overall Study|Lost to Follow-up|137|||
13460004|NCT00128206|26966440|FG001|Overall Study|Lost to Follow-up|118|||
13460005|NCT00128206|26966439|FG000|Overall Study|Adverse Event|0|||
13460006|NCT00128206|26966440|FG001|Overall Study|Adverse Event|2|||
13460007|NCT00128102|26966471|FG000|Overall Study|Site Discontinued|3|||
13460008|NCT00128102|26966472|FG001|Overall Study|Site Discontinued|6|||
13460009|NCT00128102|26966471|FG000|Overall Study|Other|0|||
13460010|NCT00128102|26966472|FG001|Overall Study|Other|1|||
13460011|NCT00128102|26966471|FG000|Overall Study|Progressive Disease|255|||
13460012|NCT00128102|26966472|FG001|Overall Study|Progressive Disease|285|||
13460013|NCT00128102|26966471|FG000|Overall Study|Adverse Event|34|||
13460014|NCT00128102|26966472|FG001|Overall Study|Adverse Event|11|||
13460015|NCT00128102|26966471|FG000|Overall Study|Death|12|||
13460016|NCT00128102|26966472|FG001|Overall Study|Death|13|||
13460017|NCT00128102|26966471|FG000|Overall Study|Physician Decision|3|||
13460018|NCT00128102|26966472|FG001|Overall Study|Physician Decision|3|||
13460019|NCT00128102|26966471|FG000|Overall Study|Withdrawal by Subject|19|||
13460020|NCT00128102|26966472|FG001|Overall Study|Withdrawal by Subject|11|||
13460021|NCT00128102|26966471|FG000|Overall Study|Protocol Violation|2|||
13460022|NCT00128102|26966472|FG001|Overall Study|Protocol Violation|2|||
13460023|NCT00127933|26966495|FG000|Overall Study|Randomized but not dosed|1|||
13460024|NCT00127933|26966496|FG001|Overall Study|Randomized but not dosed|0|||
13460025|NCT00127855|26966694|FG000|Primary Vaccination Course|Adverse Event|0|||
13460026|NCT00127855|26966695|FG001|Primary Vaccination Course|Adverse Event|0|||
13460027|NCT00127855|26966696|FG002|Primary Vaccination Course|Adverse Event|1|||
13460028|NCT00127855|26966697|FG003|Primary Vaccination Course|Adverse Event|0|||
13460029|NCT00127855|26966698|FG004|Primary Vaccination Course|Adverse Event|0|||
13460030|NCT00127855|26966694|FG000|Primary Vaccination Course|Withdrawal by Subject|1|||
13460031|NCT00127855|26966695|FG001|Primary Vaccination Course|Withdrawal by Subject|0|||
13460032|NCT00127855|26966696|FG002|Primary Vaccination Course|Withdrawal by Subject|0|||
13460033|NCT00127855|26966697|FG003|Primary Vaccination Course|Withdrawal by Subject|0|||
13460034|NCT00127855|26966698|FG004|Primary Vaccination Course|Withdrawal by Subject|1|||
13460035|NCT00127855|26966694|FG000|Primary Vaccination Course|Lost to Follow-up|1|||
13460036|NCT00127855|26966695|FG001|Primary Vaccination Course|Lost to Follow-up|1|||
13460037|NCT00127855|26966696|FG002|Primary Vaccination Course|Lost to Follow-up|1|||
13460038|NCT00127855|26966697|FG003|Primary Vaccination Course|Lost to Follow-up|0|||
13460039|NCT00127855|26966698|FG004|Primary Vaccination Course|Lost to Follow-up|2|||
13460040|NCT00127855|26966694|FG000|Primary Vaccination Course|Other|0|||
13460041|NCT00127855|26966695|FG001|Primary Vaccination Course|Other|0|||
13460042|NCT00127855|26966696|FG002|Primary Vaccination Course|Other|0|||
13460043|NCT00127855|26966697|FG003|Primary Vaccination Course|Other|0|||
13460044|NCT00127855|26966698|FG004|Primary Vaccination Course|Other|1|||
13460045|NCT00127842|26966714|FG000|Overall Study|Adverse Event|15|||
13460046|NCT00127842|26966714|FG000|Overall Study|Withdrawal by Subject|3|||
13460047|NCT00127842|26966714|FG000|Overall Study|Lost to Follow-up|1|||
13460048|NCT00127842|26966714|FG000|Overall Study|Lack of Efficacy|12|||
13460049|NCT00127842|26966714|FG000|Overall Study|Noncompliance|2|||
13460050|NCT00127842|26966714|FG000|Overall Study|Protocol Violation|1|||
13460051|NCT00127842|26966714|FG000|Overall Study|Other|5|||
13460052|NCT00127803|26966745|FG000|Overall Study|Adverse Event|2|||
13460053|NCT00127803|26966746|FG001|Overall Study|Adverse Event|0|||
13460054|NCT00127803|26966747|FG002|Overall Study|Adverse Event|0|||
13460055|NCT00127803|26966748|FG003|Overall Study|Adverse Event|0|||
13460056|NCT00127803|26966745|FG000|Overall Study|Withdrawal by Subject|1|||
13460057|NCT00127803|26966746|FG001|Overall Study|Withdrawal by Subject|0|||
13460058|NCT00127803|26966747|FG002|Overall Study|Withdrawal by Subject|0|||
13460059|NCT00127803|26966748|FG003|Overall Study|Withdrawal by Subject|0|||
13460060|NCT00127803|26966745|FG000|Overall Study|Lost to Follow-up|0|||
13460061|NCT00127803|26966746|FG001|Overall Study|Lost to Follow-up|0|||
13460062|NCT00127803|26966747|FG002|Overall Study|Lost to Follow-up|0|||
13460063|NCT00127803|26966748|FG003|Overall Study|Lost to Follow-up|1|||
13460064|NCT00127712|26966767|FG000|Overall Study|Adverse Event|3|||
13460065|NCT00127712|26966768|FG001|Overall Study|Adverse Event|0|||
13460066|NCT00127712|26966767|FG000|Overall Study|Lack of GI access to continue|2|||
13460067|NCT00127712|26966768|FG001|Overall Study|Lack of GI access to continue|0|||
13460068|NCT00127660|26966791|FG000|Overall Study|Protocol Violation|3|||
13460069|NCT00127660|26966792|FG001|Overall Study|Protocol Violation|3|||
13460070|NCT00127660|26966793|FG002|Overall Study|Protocol Violation|5|||
13460071|NCT00127660|26966794|FG003|Overall Study|Protocol Violation|0|||
13460072|NCT00127608|26966802|FG000|Overall Study|VZV DNA negative|1|||
13460073|NCT00127413|26966825|FG000|Overall Study|Lost to Follow-up|6|||
13460074|NCT00127413|26966826|FG001|Overall Study|Lost to Follow-up|4|||
13460075|NCT00127413|26966827|FG002|Overall Study|Lost to Follow-up|8|||
13460076|NCT00127413|26966828|FG003|Overall Study|Lost to Follow-up|2|||
13460077|NCT00127205|26966855|FG000|Overall Study|Adverse Event|228|||
13460078|NCT00127205|26966856|FG001|Overall Study|Adverse Event|387|||
13460079|NCT00127205|26966857|FG002|Overall Study|Adverse Event|273|||
13460080|NCT00127205|26966855|FG000|Overall Study|Death|8|||
13460081|NCT00127205|26966856|FG001|Overall Study|Death|6|||
13460082|NCT00127205|26966857|FG002|Overall Study|Death|5|||
13460083|NCT00127205|26966855|FG000|Overall Study|Withdrawal by Subject|318|||
13460084|NCT00127205|26966856|FG001|Overall Study|Withdrawal by Subject|310|||
13460085|NCT00127205|26966857|FG002|Overall Study|Withdrawal by Subject|172|||
13460086|NCT00127205|26966855|FG000|Overall Study|Other-non protocol specified|142|||
13460087|NCT00127205|26966856|FG001|Overall Study|Other-non protocol specified|129|||
13460088|NCT00127205|26966857|FG002|Overall Study|Other-non protocol specified|77|||
13460089|NCT00127205|26966855|FG000|Overall Study|Data not reported|6|||
13460090|NCT00127205|26966856|FG001|Overall Study|Data not reported|10|||
13460091|NCT00127205|26966857|FG002|Overall Study|Data not reported|1|||
13460092|NCT00127205|26966855|FG000|Overall Study|Progression|127|||
13460093|NCT00127205|26966856|FG001|Overall Study|Progression|131|||
13460094|NCT00127205|26966857|FG002|Overall Study|Progression|84|||
13460095|NCT00127192|26966895|FG000|Overall Study|Adverse Event|0|||
13460096|NCT00127192|26966896|FG001|Overall Study|Adverse Event|1|||
13460097|NCT00127192|26966897|FG002|Overall Study|Adverse Event|1|||
13460098|NCT00127192|26966898|FG003|Overall Study|Adverse Event|1|||
13460099|NCT00127192|26966899|FG004|Overall Study|Adverse Event|0|||
13460100|NCT00127192|26966895|FG000|Overall Study|Lack of Efficacy|2|||
13460101|NCT00127192|26966896|FG001|Overall Study|Lack of Efficacy|0|||
13460102|NCT00127192|26966897|FG002|Overall Study|Lack of Efficacy|0|||
13460103|NCT00127192|26966898|FG003|Overall Study|Lack of Efficacy|0|||
13460104|NCT00127192|26966899|FG004|Overall Study|Lack of Efficacy|2|||
13460105|NCT00127192|26966895|FG000|Overall Study|Withdrawal by Subject|0|||
13460106|NCT00127192|26966896|FG001|Overall Study|Withdrawal by Subject|0|||
13460107|NCT00127192|26966897|FG002|Overall Study|Withdrawal by Subject|1|||
13460108|NCT00127192|26966898|FG003|Overall Study|Withdrawal by Subject|0|||
13460109|NCT00127192|26966899|FG004|Overall Study|Withdrawal by Subject|3|||
13460110|NCT00127192|26966895|FG000|Overall Study|Adverse event in pre-treatment period|1|||
13460111|NCT00127192|26966896|FG001|Overall Study|Adverse event in pre-treatment period|0|||
13460112|NCT00127192|26966897|FG002|Overall Study|Adverse event in pre-treatment period|0|||
13460113|NCT00127192|26966898|FG003|Overall Study|Adverse event in pre-treatment period|0|||
13460114|NCT00127192|26966899|FG004|Overall Study|Adverse event in pre-treatment period|0|||
13460115|NCT00127166|26966920|FG000|Period I|Protocol Violation|0|||
13460116|NCT00127166|26966921|FG001|Period I|Protocol Violation|2|||
13460117|NCT00127166|26966920|FG000|Period I|Withdrawal by Subject|2|||
13460118|NCT00127166|26966921|FG001|Period I|Withdrawal by Subject|0|||
13460119|NCT00127166|26966920|FG000|Period I|Patient did not meet inclusion criteria|1|||
13460120|NCT00127166|26966921|FG001|Period I|Patient did not meet inclusion criteria|0|||
13460121|NCT00127166|26966920|FG000|Washout Period|Patient did not meet inclusion criteria|0|||
13460122|NCT00127166|26966921|FG001|Washout Period|Patient did not meet inclusion criteria|1|||
13460123|NCT00127166|26966920|FG000|Period II|Withdrawal by Subject|2|||
13460124|NCT00127166|26966921|FG001|Period II|Withdrawal by Subject|0|||
13460125|NCT00127166|26966920|FG000|Period II|Patient did not perform Visit 6 exercise|1|||
13460126|NCT00127166|26966921|FG001|Period II|Patient did not perform Visit 6 exercise|0|||
13460127|NCT00127127|26967000|FG000|Overall Study|Adverse Event|0|||
13460128|NCT00127127|26967001|FG001|Overall Study|Adverse Event|2|||
13460129|NCT00127127|26967002|FG002|Overall Study|Adverse Event|0|||
13460130|NCT00127127|26967003|FG003|Overall Study|Adverse Event|1|||
13460131|NCT00127127|26967000|FG000|Overall Study|Lack of Efficacy|1|||
13460132|NCT00127127|26967001|FG001|Overall Study|Lack of Efficacy|3|||
13460133|NCT00127127|26967002|FG002|Overall Study|Lack of Efficacy|0|||
13460134|NCT00127127|26967003|FG003|Overall Study|Lack of Efficacy|2|||
13460135|NCT00127101|26967042|FG000|Base Protocol|Adverse Event|0|||
13460136|NCT00127101|26967043|FG001|Base Protocol|Adverse Event|2|||
13460137|NCT00127101|26967044|FG002|Base Protocol|Adverse Event|1|||
13460138|NCT00127101|26967045|FG003|Base Protocol|Adverse Event|0|||
13460139|NCT00127101|26967046|FG004|Base Protocol|Adverse Event|0|||
13460140|NCT00127101|26967047|FG005|Base Protocol|Adverse Event|0|||
13460141|NCT00127101|26967042|FG000|Base Protocol|Lack of Efficacy|1|||
13460142|NCT00127101|26967043|FG001|Base Protocol|Lack of Efficacy|0|||
13460143|NCT00127101|26967044|FG002|Base Protocol|Lack of Efficacy|0|||
13460144|NCT00127101|26967045|FG003|Base Protocol|Lack of Efficacy|0|||
13460145|NCT00127101|26967046|FG004|Base Protocol|Lack of Efficacy|2|||
13460146|NCT00127101|26967047|FG005|Base Protocol|Lack of Efficacy|0|||
13460147|NCT00127101|26967042|FG000|Base Protocol|Withdrawal by Subject|1|||
13460148|NCT00127101|26967043|FG001|Base Protocol|Withdrawal by Subject|2|||
13460149|NCT00127101|26967044|FG002|Base Protocol|Withdrawal by Subject|1|||
13460150|NCT00127101|26967045|FG003|Base Protocol|Withdrawal by Subject|0|||
13460151|NCT00127101|26967046|FG004|Base Protocol|Withdrawal by Subject|0|||
13460152|NCT00127101|26967047|FG005|Base Protocol|Withdrawal by Subject|1|||
13460153|NCT00127101|26967042|FG000|Continuation Phase|Adverse Event|0|||
13460154|NCT00127101|26967043|FG001|Continuation Phase|Adverse Event|0|||
13460155|NCT00127101|26967044|FG002|Continuation Phase|Adverse Event|0|||
13460156|NCT00127101|26967045|FG003|Continuation Phase|Adverse Event|0|||
13460157|NCT00127101|26967046|FG004|Continuation Phase|Adverse Event|1|||
13460158|NCT00127101|26967047|FG005|Continuation Phase|Adverse Event|1|||
13460159|NCT00127101|26967042|FG000|Continuation Phase|Lack of Efficacy|0|||
13460160|NCT00127101|26967043|FG001|Continuation Phase|Lack of Efficacy|0|||
13460161|NCT00127101|26967044|FG002|Continuation Phase|Lack of Efficacy|0|||
13460162|NCT00127101|26967045|FG003|Continuation Phase|Lack of Efficacy|0|||
13460163|NCT00127101|26967046|FG004|Continuation Phase|Lack of Efficacy|0|||
13460164|NCT00127101|26967047|FG005|Continuation Phase|Lack of Efficacy|1|||
13460165|NCT00127101|26967042|FG000|Continuation Phase|Withdrawal by Subject|0|||
13460166|NCT00127101|26967043|FG001|Continuation Phase|Withdrawal by Subject|0|||
13460167|NCT00127101|26967044|FG002|Continuation Phase|Withdrawal by Subject|1|||
13460168|NCT00127101|26967045|FG003|Continuation Phase|Withdrawal by Subject|0|||
13460169|NCT00127101|26967046|FG004|Continuation Phase|Withdrawal by Subject|2|||
13460170|NCT00127101|26967047|FG005|Continuation Phase|Withdrawal by Subject|1|||
13460171|NCT00127036|26967064|FG000|Overall Study|Insufficient Data for Analysis|6|||
13460172|NCT00127036|26967065|FG001|Overall Study|Insufficient Data for Analysis|11|||
13460173|NCT00127036|26967064|FG000|Overall Study|Screen Failure|2|||
13460174|NCT00127036|26967065|FG001|Overall Study|Screen Failure|0|||
13460175|NCT00126672|26967073|FG000|Overall Study|Adverse Event|4|||
13460176|NCT00126672|26967073|FG000|Overall Study|Lost to Follow-up|4|||
13460177|NCT00126659|26967089|FG000|Overall Study|Adverse Event|0|||
13460178|NCT00126659|26967090|FG001|Overall Study|Adverse Event|0|||
13460179|NCT00126659|26967091|FG002|Overall Study|Adverse Event|2|||
13460180|NCT00126594|26967113|FG000|Overall Study|Ineligible|2|||
13460181|NCT00126594|26967114|FG001|Overall Study|Ineligible|0|||
13460182|NCT00126594|26967113|FG000|Overall Study|Withdrawal by Subject|0|||
13460183|NCT00126594|26967114|FG001|Overall Study|Withdrawal by Subject|4|||
13460184|NCT00126594|26967113|FG000|Overall Study|Physician Decision|1|||
13460185|NCT00126594|26967114|FG001|Overall Study|Physician Decision|3|||
13460186|NCT00126594|26967113|FG000|Overall Study|Adverse Event|7|||
13460187|NCT00126594|26967114|FG001|Overall Study|Adverse Event|5|||
13460188|NCT00126594|26967113|FG000|Overall Study|Non-compliance|0|||
13460189|NCT00126594|26967114|FG001|Overall Study|Non-compliance|1|||
13460190|NCT00126594|26967113|FG000|Overall Study|Disease Progression|29|||
13460191|NCT00126594|26967114|FG001|Overall Study|Disease Progression|24|||
13460192|NCT00126581|26967141|FG000|Overall Study|Adverse Event|3|||
13460193|NCT00126581|26967142|FG001|Overall Study|Adverse Event|7|||
13460194|NCT00126581|26967141|FG000|Overall Study|Death|3|||
13460195|NCT00126581|26967142|FG001|Overall Study|Death|2|||
13460196|NCT00126581|26967141|FG000|Overall Study|Withdrawal by Subject|1|||
13460197|NCT00126581|26967142|FG001|Overall Study|Withdrawal by Subject|4|||
13460198|NCT00126581|26967141|FG000|Overall Study|Alternative therapy|3|||
13460199|NCT00126581|26967142|FG001|Overall Study|Alternative therapy|3|||
13460200|NCT00126581|26967141|FG000|Overall Study|Other illness/MD discretion|3|||
13460201|NCT00126581|26967142|FG001|Overall Study|Other illness/MD discretion|4|||
13460202|NCT00126568|26967151|FG000|Overall Study|Death|2|||
13460203|NCT00126555|26967173|FG000|Overall Study|Withdrawal by Subject|1|||
13460204|NCT00126555|26967173|FG000|Overall Study|Adverse Event|2|||
13460205|NCT00126555|26967173|FG000|Overall Study|Progressive Disease|3|||
13460206|NCT00126503|26967192|FG000|Overall Study|disease progression|23|||
13460207|NCT00126503|26967193|FG001|Overall Study|disease progression|14|||
13460208|NCT00126503|26967192|FG000|Overall Study|Withdrawal by Subject|0|||
13460209|NCT00126503|26967193|FG001|Overall Study|Withdrawal by Subject|1|||
13460210|NCT00126503|26967192|FG000|Overall Study|alternative therapy|1|||
13460211|NCT00126503|26967193|FG001|Overall Study|alternative therapy|1|||
13460212|NCT00126503|26967192|FG000|Overall Study|other complicating disease|4|||
13460213|NCT00126503|26967193|FG001|Overall Study|other complicating disease|1|||
13460214|NCT00126503|26967192|FG000|Overall Study|Death|3|||
13460215|NCT00126503|26967193|FG001|Overall Study|Death|0|||
13460216|NCT00126503|26967192|FG000|Overall Study|Adverse Event|13|||
13460217|NCT00126503|26967193|FG001|Overall Study|Adverse Event|3|||
13460218|NCT00126503|26967192|FG000|Overall Study|non-compliant|1|||
13460219|NCT00126503|26967193|FG001|Overall Study|non-compliant|0|||
13460220|NCT00126503|26967192|FG000|Overall Study|Physician Decision|2|||
13460221|NCT00126503|26967193|FG001|Overall Study|Physician Decision|1|||
13460222|NCT00126490|26967203|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1|||
13460223|NCT00126438|26967216|FG000|Overall Study|Withdrawal due to adverse event|1|||
13460224|NCT00126438|26967217|FG001|Overall Study|Withdrawal due to adverse event|0|||
13460225|NCT00126438|26967216|FG000|Overall Study|Lost to Follow-up|22|||
13460226|NCT00126438|26967217|FG001|Overall Study|Lost to Follow-up|0|||
13460227|NCT00126438|26967216|FG000|Overall Study|Protocol Violation|8|||
13460228|NCT00126438|26967217|FG001|Overall Study|Protocol Violation|8|||
13460229|NCT00126438|26967216|FG000|Overall Study|Withdrawal by Subject|3|||
13460230|NCT00126438|26967217|FG001|Overall Study|Withdrawal by Subject|2|||
13460231|NCT00126425|26967230|FG000|Overall Study|Withdrawal by Subject|17|||
13460232|NCT00126425|26967231|FG001|Overall Study|Withdrawal by Subject|1|||
13460233|NCT00126425|26967230|FG000|Overall Study|Lost to Follow-up|8|||
13460234|NCT00126425|26967231|FG001|Overall Study|Lost to Follow-up|4|||
13460235|NCT00126425|26967230|FG000|Overall Study|Protocol Violation|9|||
13460236|NCT00126425|26967231|FG001|Overall Study|Protocol Violation|6|||
13460237|NCT00126425|26967230|FG000|Overall Study|Adverse Event|1|||
13460238|NCT00126425|26967231|FG001|Overall Study|Adverse Event|0|||
13460239|NCT00126425|26967230|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1|||
13460240|NCT00126425|26967231|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0|||
13460241|NCT00126425|26967230|FG000|Overall Study|Other|5|||
13460242|NCT00126425|26967231|FG001|Overall Study|Other|0|||
13460243|NCT00126191|26967246|FG000|Overall Study|Physician Decision|0|||
13460244|NCT00126191|26967247|FG001|Overall Study|Physician Decision|1|||
13460245|NCT00126191|26967246|FG000|Overall Study|Death|0|||
13460246|NCT00126191|26967247|FG001|Overall Study|Death|1|||
13460247|NCT00126126|26967262|FG000|Overall Study|Lost to Follow-up|0|||
13460248|NCT00126126|26967263|FG001|Overall Study|Lost to Follow-up|2|||
13460249|NCT00125853|26967280|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3|||
13460250|NCT00125853|26967281|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7|||
13460251|NCT00125359|26967290|FG000|Overall Study|Death|4|||
13460252|NCT00125359|26967290|FG000|Overall Study|Adverse Event|5|||
13460253|NCT00125359|26967290|FG000|Overall Study|Physician Decision|14|||
13460254|NCT00125268|26967307|FG000|Overall Study|Withdrawal by Subject|1|||
13460255|NCT00125268|26967308|FG001|Overall Study|Withdrawal by Subject|1|||
13460256|NCT00125242|26967320|FG000|Overall Study|did not qualify|7|||
13460257|NCT00125242|26967321|FG001|Overall Study|did not qualify|2|||
13460258|NCT00125190|26967335|FG000|Overall Study|Subject/Parent Decision|7|||
13460259|NCT00125190|26967335|FG000|Overall Study|Non-compliance|2|||
13460260|NCT00125190|26967335|FG000|Overall Study|Adverse Event|1|||
13460261|NCT00125190|26967335|FG000|Overall Study|Other|1|||
13460262|NCT00125190|26967335|FG000|Overall Study|Lost to Follow-up|4|||
13460263|NCT00125164|26967398|FG000|Overall Study|Adverse Event|0|||
13460264|NCT00125164|26967399|FG001|Overall Study|Adverse Event|0|||
13460265|NCT00125164|26967400|FG002|Overall Study|Adverse Event|2|||
13460266|NCT00125164|26967401|FG003|Overall Study|Adverse Event|4|||
13460267|NCT00125164|26967398|FG000|Overall Study|Lost to Follow-up|0|||
13460268|NCT00125164|26967399|FG001|Overall Study|Lost to Follow-up|0|||
13460269|NCT00125164|26967400|FG002|Overall Study|Lost to Follow-up|1|||
13460270|NCT00125164|26967401|FG003|Overall Study|Lost to Follow-up|1|||
13460271|NCT00125164|26967398|FG000|Overall Study|Withdrawal by Subject|2|||
13460272|NCT00125164|26967399|FG001|Overall Study|Withdrawal by Subject|0|||
13460273|NCT00125164|26967400|FG002|Overall Study|Withdrawal by Subject|1|||
13460274|NCT00125164|26967401|FG003|Overall Study|Withdrawal by Subject|1|||
13460275|NCT00125138|26967428|FG000|Overall Study|Adverse Event|1|||
13460276|NCT00125138|26967429|FG001|Overall Study|Adverse Event|0|||
13460277|NCT00125138|26967430|FG002|Overall Study|Adverse Event|3|||
13460278|NCT00125138|26967431|FG003|Overall Study|Adverse Event|2|||
13460279|NCT00125138|26967428|FG000|Overall Study|Withdrawal by Subject|2|||
13460280|NCT00125138|26967429|FG001|Overall Study|Withdrawal by Subject|3|||
13460281|NCT00125138|26967430|FG002|Overall Study|Withdrawal by Subject|1|||
13460282|NCT00125138|26967431|FG003|Overall Study|Withdrawal by Subject|1|||
13460283|NCT00125138|26967428|FG000|Overall Study|Lack of Efficacy|0|||
13460284|NCT00125138|26967429|FG001|Overall Study|Lack of Efficacy|0|||
13460285|NCT00125138|26967430|FG002|Overall Study|Lack of Efficacy|0|||
13460286|NCT00125138|26967431|FG003|Overall Study|Lack of Efficacy|1|||
13460287|NCT00125138|26967428|FG000|Overall Study|Sponsor decision-pt moved to assist care|0|||
13460288|NCT00125138|26967429|FG001|Overall Study|Sponsor decision-pt moved to assist care|0|||
13460289|NCT00125138|26967430|FG002|Overall Study|Sponsor decision-pt moved to assist care|0|||
13460290|NCT00125138|26967431|FG003|Overall Study|Sponsor decision-pt moved to assist care|1|||
13460291|NCT00124982|26967517|FG000|Short-term Period|Death|1|||
13460292|NCT00124982|26967518|FG001|Short-term Period|Death|1|||
13460293|NCT00124982|26967519|FG002|Short-term Period|Death|0|||
13460294|NCT00124982|26967517|FG000|Short-term Period|Adverse Event|17|||
13460295|NCT00124982|26967518|FG001|Short-term Period|Adverse Event|22|||
13460296|NCT00124982|26967519|FG002|Short-term Period|Adverse Event|0|||
13460297|NCT00124982|26967517|FG000|Short-term Period|Lack of Efficacy|32|||
13460298|NCT00124982|26967518|FG001|Short-term Period|Lack of Efficacy|73|||
13460299|NCT00124982|26967519|FG002|Short-term Period|Lack of Efficacy|0|||
13460300|NCT00124982|26967517|FG000|Short-term Period|Lost to Follow-up|8|||
13460301|NCT00124982|26967518|FG001|Short-term Period|Lost to Follow-up|5|||
13460302|NCT00124982|26967519|FG002|Short-term Period|Lost to Follow-up|0|||
13460303|NCT00124982|26967517|FG000|Short-term Period|Withdrawal of Consent|7|||
13460304|NCT00124982|26967518|FG001|Short-term Period|Withdrawal of Consent|9|||
13460305|NCT00124982|26967519|FG002|Short-term Period|Withdrawal of Consent|0|||
13460306|NCT00124982|26967517|FG000|Short-term Period|Poor/Non-compliance|3|||
13460307|NCT00124982|26967518|FG001|Short-term Period|Poor/Non-compliance|1|||
13460308|NCT00124982|26967519|FG002|Short-term Period|Poor/Non-compliance|0|||
13460309|NCT00124982|26967517|FG000|Short-term Period|No Longer Meets Study Criteria|1|||
13460310|NCT00124982|26967518|FG001|Short-term Period|No Longer Meets Study Criteria|2|||
13460311|NCT00124982|26967519|FG002|Short-term Period|No Longer Meets Study Criteria|0|||
13460312|NCT00124982|26967517|FG000|Short-term Period|Participant Decision|1|||
13460313|NCT00124982|26967518|FG001|Short-term Period|Participant Decision|0|||
13460314|NCT00124982|26967519|FG002|Short-term Period|Participant Decision|0|||
13460315|NCT00124982|26967517|FG000|Short-term Period|Participant Chose Own Doctor|0|||
13460316|NCT00124982|26967518|FG001|Short-term Period|Participant Chose Own Doctor|1|||
13460317|NCT00124982|26967519|FG002|Short-term Period|Participant Chose Own Doctor|0|||
13460318|NCT00124982|26967517|FG000|Short-term Period|Investigator Decision-No Specific AE|1|||
13460319|NCT00124982|26967518|FG001|Short-term Period|Investigator Decision-No Specific AE|0|||
13460320|NCT00124982|26967519|FG002|Short-term Period|Investigator Decision-No Specific AE|0|||
13460321|NCT00124982|26967517|FG000|Short-term Period|Participant Had Lymphopenia|1|||
13460322|NCT00124982|26967518|FG001|Short-term Period|Participant Had Lymphopenia|0|||
13460323|NCT00124982|26967519|FG002|Short-term Period|Participant Had Lymphopenia|0|||
13460324|NCT00124982|26967517|FG000|Long-term Period|Death|0|||
13460325|NCT00124982|26967518|FG001|Long-term Period|Death|0|||
13460326|NCT00124982|26967519|FG002|Long-term Period|Death|1|||
13460327|NCT00124982|26967517|FG000|Long-term Period|Adverse Event|0|||
13460328|NCT00124982|26967518|FG001|Long-term Period|Adverse Event|0|||
13460329|NCT00124982|26967519|FG002|Long-term Period|Adverse Event|17|||
13460330|NCT00124982|26967517|FG000|Long-term Period|Lack of Efficacy|0|||
13460331|NCT00124982|26967518|FG001|Long-term Period|Lack of Efficacy|0|||
13460332|NCT00124982|26967519|FG002|Long-term Period|Lack of Efficacy|46|||
13460333|NCT00124982|26967517|FG000|Long-term Period|Lost to Follow-up|0|||
13460334|NCT00124982|26967518|FG001|Long-term Period|Lost to Follow-up|0|||
13460335|NCT00124982|26967519|FG002|Long-term Period|Lost to Follow-up|4|||
13460336|NCT00124982|26967517|FG000|Long-term Period|Withdrawal by Subject|0|||
13460337|NCT00124982|26967518|FG001|Long-term Period|Withdrawal by Subject|0|||
13460338|NCT00124982|26967519|FG002|Long-term Period|Withdrawal by Subject|16|||
13460339|NCT00124982|26967517|FG000|Long-term Period|Pregnancy|0|||
13460340|NCT00124982|26967518|FG001|Long-term Period|Pregnancy|0|||
13460341|NCT00124982|26967519|FG002|Long-term Period|Pregnancy|1|||
13460342|NCT00124982|26967517|FG000|Long-term Period|Poor/Non-compliance|0|||
13460343|NCT00124982|26967518|FG001|Long-term Period|Poor/Non-compliance|0|||
13460344|NCT00124982|26967519|FG002|Long-term Period|Poor/Non-compliance|2|||
13460345|NCT00124982|26967517|FG000|Long-term Period|Administrative Reason by Sponsor|0|||
13460346|NCT00124982|26967518|FG001|Long-term Period|Administrative Reason by Sponsor|0|||
13460347|NCT00124982|26967519|FG002|Long-term Period|Administrative Reason by Sponsor|1|||
13460348|NCT00124982|26967517|FG000|Long-term Period|Neurologist Recommendation|0|||
13460349|NCT00124982|26967518|FG001|Long-term Period|Neurologist Recommendation|0|||
13460350|NCT00124982|26967519|FG002|Long-term Period|Neurologist Recommendation|1|||
13460351|NCT00124943|26967570|FG000|Phase II|Adverse Event|0|||
13460352|NCT00124943|26967571|FG001|Phase II|Adverse Event|2|||
13460353|NCT00124943|26967572|FG002|Phase II|Adverse Event|0|||
13460354|NCT00124943|26967573|FG003|Phase II|Adverse Event|1|||
13460355|NCT00124943|26967570|FG000|Phase II|Protocol Violation|0|||
13460356|NCT00124943|26967571|FG001|Phase II|Protocol Violation|0|||
13460357|NCT00124943|26967572|FG002|Phase II|Protocol Violation|0|||
13460358|NCT00124943|26967573|FG003|Phase II|Protocol Violation|1|||
13460359|NCT00124943|26967570|FG000|Phase II|Lost to Follow-up|0|||
13460360|NCT00124943|26967571|FG001|Phase II|Lost to Follow-up|0|||
13460361|NCT00124943|26967572|FG002|Phase II|Lost to Follow-up|0|||
13460362|NCT00124943|26967573|FG003|Phase II|Lost to Follow-up|1|||
13460363|NCT00124943|26967570|FG000|Phase II|Withdrawal by Subject|0|||
13460364|NCT00124943|26967571|FG001|Phase II|Withdrawal by Subject|0|||
13460365|NCT00124943|26967572|FG002|Phase II|Withdrawal by Subject|0|||
13460366|NCT00124943|26967573|FG003|Phase II|Withdrawal by Subject|2|||
13460367|NCT00124917|26967583|FG000|Overall Study|Physician Decision|3|||
13460368|NCT00124748|26967632|FG000|Overall Study|Adverse Event|8|||
13460369|NCT00124748|26967633|FG001|Overall Study|Adverse Event|39|||
13460370|NCT00124748|26967632|FG000|Overall Study|Abnormal laboratory Value|2|||
13460371|NCT00124748|26967633|FG001|Overall Study|Abnormal laboratory Value|2|||
13460372|NCT00124748|26967632|FG000|Overall Study|Abnormal Procedure|0|||
13460373|NCT00124748|26967633|FG001|Overall Study|Abnormal Procedure|1|||
13460374|NCT00124748|26967632|FG000|Overall Study|Lack of Efficacy|20|||
13460375|NCT00124748|26967633|FG001|Overall Study|Lack of Efficacy|41|||
13460376|NCT00124748|26967632|FG000|Overall Study|No longer requires study drug|1|||
13460377|NCT00124748|26967633|FG001|Overall Study|No longer requires study drug|1|||
13460378|NCT00124748|26967632|FG000|Overall Study|Protocol Violation|3|||
13460379|NCT00124748|26967633|FG001|Overall Study|Protocol Violation|1|||
13460380|NCT00124748|26967632|FG000|Overall Study|Withdrawal by Subject|5|||
13460381|NCT00124748|26967633|FG001|Overall Study|Withdrawal by Subject|15|||
13460382|NCT00124748|26967632|FG000|Overall Study|Lost to Follow-up|2|||
13460383|NCT00124748|26967633|FG001|Overall Study|Lost to Follow-up|7|||
13460384|NCT00124748|26967632|FG000|Overall Study|Administrative Problem(Study Terminated)|101|||
13460385|NCT00124748|26967633|FG001|Overall Study|Administrative Problem(Study Terminated)|174|||
13460386|NCT00124748|26967632|FG000|Overall Study|Death|1|||
13460387|NCT00124748|26967633|FG001|Overall Study|Death|3|||
13460388|NCT00124709|26967654|FG000|Overall Study|Randomized but did not take medication|3|||
13460389|NCT00124709|26967655|FG001|Overall Study|Randomized but did not take medication|1|||
13460390|NCT00124709|26967654|FG000|Overall Study|Adverse Event|3|||
13460391|NCT00124709|26967655|FG001|Overall Study|Adverse Event|0|||
13460392|NCT00124709|26967654|FG000|Overall Study|Lack of Efficacy|5|||
13460393|NCT00124709|26967655|FG001|Overall Study|Lack of Efficacy|10|||
13460394|NCT00124709|26967654|FG000|Overall Study|Protocol Violation|3|||
13460395|NCT00124709|26967655|FG001|Overall Study|Protocol Violation|5|||
13460396|NCT00124709|26967654|FG000|Overall Study|Withdrawal by Subject|127|||
13460397|NCT00124709|26967655|FG001|Overall Study|Withdrawal by Subject|136|||
13460398|NCT00124709|26967654|FG000|Overall Study|Lost to Follow-up|114|||
13460399|NCT00124709|26967655|FG001|Overall Study|Lost to Follow-up|120|||
13460400|NCT00124657|26967700|FG000|Overall Study|Toxicity|0|||
13460401|NCT00124657|26967701|FG001|Overall Study|Toxicity|0|||
13460402|NCT00124657|26967702|FG002|Overall Study|Toxicity|1|||
13460403|NCT00124657|26967700|FG000|Overall Study|Non-compliance|1|||
13460404|NCT00124657|26967701|FG001|Overall Study|Non-compliance|0|||
13460405|NCT00124657|26967702|FG002|Overall Study|Non-compliance|4|||
13460406|NCT00124657|26967700|FG000|Overall Study|Progressive disease|14|||
13460407|NCT00124657|26967701|FG001|Overall Study|Progressive disease|5|||
13460408|NCT00124657|26967702|FG002|Overall Study|Progressive disease|27|||
13460409|NCT00124657|26967700|FG000|Overall Study|Intercurrent illness|1|||
13460410|NCT00124657|26967701|FG001|Overall Study|Intercurrent illness|0|||
13460411|NCT00124657|26967702|FG002|Overall Study|Intercurrent illness|0|||
13460412|NCT00124618|26967711|FG000|Overall Study|Ineligible|1|||
13460413|NCT00124462|26967726|FG000|Overall Study|Lost to Follow-up|3|||
13460414|NCT00124462|26967727|FG001|Overall Study|Lost to Follow-up|3|||
13460415|NCT00124462|26967726|FG000|Overall Study|Physician Decision|3|||
13460416|NCT00124462|26967727|FG001|Overall Study|Physician Decision|4|||
13460417|NCT00124462|26967726|FG000|Overall Study|Withdrawal by Subject|4|||
13460418|NCT00124462|26967727|FG001|Overall Study|Withdrawal by Subject|5|||
13460419|NCT00124462|26967726|FG000|Overall Study|Device fitting, n=2, other hlth issues|1|||
13460420|NCT00124462|26967727|FG001|Overall Study|Device fitting, n=2, other hlth issues|1|||
13460421|NCT00124449|26967767|FG000|6-month Double-Blind Treatment Period|Adverse Event|1|||
13460422|NCT00124449|26967768|FG001|6-month Double-Blind Treatment Period|Adverse Event|0|||
13460423|NCT00124449|26967767|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3|||
13460424|NCT00124449|26967768|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8|||
13460425|NCT00124449|26967767|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
13460426|NCT00124449|26967768|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
13460427|NCT00124449|26967767|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1|||
13460428|NCT00124449|26967768|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0|||
13460429|NCT00124449|26967767|FG000|6-month Double-Blind Treatment Period|Sponsor request|0|||
13460430|NCT00124449|26967768|FG001|6-month Double-Blind Treatment Period|Sponsor request|1|||
13460431|NCT00124449|26967767|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0|||
13460432|NCT00124449|26967768|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1|||
13460433|NCT00124449|26967767|FG000|18-Month Untreated Observation Period|Adverse Event|0|||
13460434|NCT00124449|26967768|FG001|18-Month Untreated Observation Period|Adverse Event|1|||
13460435|NCT00124449|26967767|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11|||
13460436|NCT00124449|26967768|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12|||
13460437|NCT00124449|26967767|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1|||
13460438|NCT00124449|26967768|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0|||
13460439|NCT00124449|26967767|FG000|18-Month Untreated Observation Period|Pregnancy|1|||
13460440|NCT00124449|26967768|FG001|18-Month Untreated Observation Period|Pregnancy|0|||
13460441|NCT00124449|26967767|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1|||
13460442|NCT00124449|26967768|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0|||
13460443|NCT00124449|26967767|FG000|18-Month Untreated Observation Period|Relocated|1|||
13460444|NCT00124449|26967768|FG001|18-Month Untreated Observation Period|Relocated|0|||
13460445|NCT00124072|26967791|FG000|Overall Study|Lost to Follow-up for Mortality|0|||
13460446|NCT00124072|26967792|FG001|Overall Study|Lost to Follow-up for Mortality|3|||
13460447|NCT00124072|26967793|FG002|Overall Study|Lost to Follow-up for Mortality|2|||
13460448|NCT00124072|26967794|FG003|Overall Study|Lost to Follow-up for Mortality|2|||
13460449|NCT00124072|26967791|FG000|Overall Study|Lost to Follow-up for Morbidity|15|||
13460450|NCT00124072|26967792|FG001|Overall Study|Lost to Follow-up for Morbidity|25|||
13460451|NCT00124072|26967793|FG002|Overall Study|Lost to Follow-up for Morbidity|19|||
13460452|NCT00124072|26967794|FG003|Overall Study|Lost to Follow-up for Morbidity|18|||
13460453|NCT00124072|26967791|FG000|Overall Study|Death|499|||
13460454|NCT00124072|26967792|FG001|Overall Study|Death|484|||
13460455|NCT00124072|26967793|FG002|Overall Study|Death|471|||
13460456|NCT00124072|26967794|FG003|Overall Study|Death|480|||
13460457|NCT00124020|26967807|FG000|Overall Study|Death|67|||
13460458|NCT00124020|26967808|FG001|Overall Study|Death|71|||
13460459|NCT00124020|26967807|FG000|Overall Study|Withdrawal by Subject|13|||
13460460|NCT00124020|26967808|FG001|Overall Study|Withdrawal by Subject|11|||
13460461|NCT00124020|26967807|FG000|Overall Study|Lost to Follow-up|5|||
13460462|NCT00124020|26967808|FG001|Overall Study|Lost to Follow-up|8|||
13460463|NCT00124020|26967807|FG000|Overall Study|Other|1|||
13460464|NCT00124020|26967808|FG001|Overall Study|Other|1|||
13460465|NCT00124020|26967807|FG000|Overall Study|Transfer to another hospital|2|||
13460466|NCT00124020|26967808|FG001|Overall Study|Transfer to another hospital|0|||
13460467|NCT00123955|26967827|FG000|Overall Study|Adverse Event|1|||
13460468|NCT00123955|26967828|FG001|Overall Study|Adverse Event|0|||
13460469|NCT00123955|26967827|FG000|Overall Study|Withdrawal by Subject|4|||
13460470|NCT00123955|26967828|FG001|Overall Study|Withdrawal by Subject|3|||
13460471|NCT00123955|26967827|FG000|Overall Study|Death|0|||
13460472|NCT00123955|26967828|FG001|Overall Study|Death|1|||
13460473|NCT00123734|26967861|FG000|Overall Study|Death|3|||
13460474|NCT00123734|26967861|FG000|Overall Study|Lost to Follow-up|3|||
13460475|NCT00123734|26967861|FG000|Overall Study|Dropout|1|||
13460476|NCT00123734|26967861|FG000|Overall Study|Withdrawal by Subject|1|||
13460477|NCT00123487|26967908|FG000|Randomized|Death prior to starting treatment|0|||
13460478|NCT00123487|26967909|FG001|Randomized|Death prior to starting treatment|1|||
13460479|NCT00123487|26967908|FG000|Randomized|SAE prior to starting treatment|1|||
13460480|NCT00123487|26967909|FG001|Randomized|SAE prior to starting treatment|0|||
13460481|NCT00123487|26967908|FG000|Treated With Study Drug|Adverse Event|23|||
13460482|NCT00123487|26967909|FG001|Treated With Study Drug|Adverse Event|22|||
13460483|NCT00123487|26967908|FG000|Treated With Study Drug|Disease Progression|141|||
13460484|NCT00123487|26967909|FG001|Treated With Study Drug|Disease Progression|122|||
13460485|NCT00123487|26967908|FG000|Treated With Study Drug|Physician Decision|8|||
13460486|NCT00123487|26967909|FG001|Treated With Study Drug|Physician Decision|9|||
13460487|NCT00123487|26967908|FG000|Treated With Study Drug|Other|59|||
13460488|NCT00123487|26967909|FG001|Treated With Study Drug|Other|58|||
13460489|NCT00123487|26967908|FG000|Treated With Study Drug|Study Drug Toxicity|62|||
13460490|NCT00123487|26967909|FG001|Treated With Study Drug|Study Drug Toxicity|80|||
13460491|NCT00123487|26967908|FG000|Treated With Study Drug|Withdrawal by Subject|11|||
13460492|NCT00123487|26967909|FG001|Treated With Study Drug|Withdrawal by Subject|13|||
13460493|NCT00123487|26967908|FG000|Treated With Study Drug|Unknown (case report form lost)|0|||
13460494|NCT00123487|26967909|FG001|Treated With Study Drug|Unknown (case report form lost)|1|||
13460495|NCT00123474|26968013|FG000|Randomized to Treatment|Randomized, never treated|1|||
13460496|NCT00123474|26968014|FG001|Randomized to Treatment|Randomized, never treated|4|||
13460497|NCT00123474|26968015|FG002|Randomized to Treatment|Randomized, never treated|2|||
13460498|NCT00123474|26968016|FG003|Randomized to Treatment|Randomized, never treated|1|||
13460499|NCT00123474|26968013|FG000|As Treated at Study Closure|not reported when site closed|1|||
13460500|NCT00123474|26968014|FG001|As Treated at Study Closure|not reported when site closed|0|||
13460501|NCT00123474|26968015|FG002|As Treated at Study Closure|not reported when site closed|1|||
13460502|NCT00123474|26968016|FG003|As Treated at Study Closure|not reported when site closed|0|||
13460503|NCT00123474|26968013|FG000|As Treated at Study Closure|Adverse Event|10|||
13460504|NCT00123474|26968014|FG001|As Treated at Study Closure|Adverse Event|4|||
13460505|NCT00123474|26968015|FG002|As Treated at Study Closure|Adverse Event|10|||
13460506|NCT00123474|26968016|FG003|As Treated at Study Closure|Adverse Event|8|||
13460507|NCT00123474|26968013|FG000|As Treated at Study Closure|Disease Progression|35|||
13460508|NCT00123474|26968014|FG001|As Treated at Study Closure|Disease Progression|42|||
13460509|NCT00123474|26968015|FG002|As Treated at Study Closure|Disease Progression|29|||
13460510|NCT00123474|26968016|FG003|As Treated at Study Closure|Disease Progression|27|||
13460511|NCT00123474|26968013|FG000|As Treated at Study Closure|Investigator Request|12|||
13460512|NCT00123474|26968014|FG001|As Treated at Study Closure|Investigator Request|6|||
13460513|NCT00123474|26968015|FG002|As Treated at Study Closure|Investigator Request|7|||
13460514|NCT00123474|26968016|FG003|As Treated at Study Closure|Investigator Request|5|||
13460515|NCT00123474|26968013|FG000|As Treated at Study Closure|non-specified|54|||
13460516|NCT00123474|26968014|FG001|As Treated at Study Closure|non-specified|47|||
13460517|NCT00123474|26968015|FG002|As Treated at Study Closure|non-specified|57|||
13460518|NCT00123474|26968016|FG003|As Treated at Study Closure|non-specified|60|||
13460519|NCT00123474|26968013|FG000|As Treated at Study Closure|Study Drug Toxicity|39|||
13460520|NCT00123474|26968014|FG001|As Treated at Study Closure|Study Drug Toxicity|45|||
13460521|NCT00123474|26968015|FG002|As Treated at Study Closure|Study Drug Toxicity|45|||
13460522|NCT00123474|26968016|FG003|As Treated at Study Closure|Study Drug Toxicity|51|||
13460523|NCT00123474|26968013|FG000|As Treated at Study Closure|Withdrawal by Subject|14|||
13460524|NCT00123474|26968014|FG001|As Treated at Study Closure|Withdrawal by Subject|19|||
13460525|NCT00123474|26968015|FG002|As Treated at Study Closure|Withdrawal by Subject|18|||
13460526|NCT00123474|26968016|FG003|As Treated at Study Closure|Withdrawal by Subject|16|||
13460527|NCT00123422|26968037|FG000|Overall Study|Physician Decision|2|||
13460528|NCT00123422|26968038|FG001|Overall Study|Physician Decision|2|||
13460529|NCT00123422|26968039|FG002|Overall Study|Physician Decision|6|||
13460530|NCT00123422|26968037|FG000|Overall Study|Withdrawal by Subject|1|||
13460531|NCT00123422|26968038|FG001|Overall Study|Withdrawal by Subject|2|||
13460532|NCT00123422|26968039|FG002|Overall Study|Withdrawal by Subject|2|||
13460533|NCT00123422|26968037|FG000|Overall Study|Lost to Follow-up|1|||
13460534|NCT00123422|26968038|FG001|Overall Study|Lost to Follow-up|2|||
13460535|NCT00123422|26968039|FG002|Overall Study|Lost to Follow-up|2|||
13460536|NCT00122980|26968068|FG000|Overall Study|Death|0|||
13460537|NCT00122980|26968069|FG001|Overall Study|Death|1|||
13460538|NCT00122980|26968068|FG000|Overall Study|Physician Decision|2|||
13460539|NCT00122980|26968069|FG001|Overall Study|Physician Decision|0|||
13460540|NCT00122980|26968068|FG000|Overall Study|Protocol Violation|5|||
13460541|NCT00122980|26968069|FG001|Overall Study|Protocol Violation|1|||
13460542|NCT00122980|26968068|FG000|Overall Study|Withdrawal by Subject|2|||
13460543|NCT00122980|26968069|FG001|Overall Study|Withdrawal by Subject|3|||
13460544|NCT00122980|26968068|FG000|Overall Study|Adjudicated stroke (study endpoint)|7|||
13460545|NCT00122980|26968069|FG001|Overall Study|Adjudicated stroke (study endpoint)|0|||
13460546|NCT00122980|26968068|FG000|Overall Study|Study termination|27|||
13460547|NCT00122980|26968069|FG001|Overall Study|Study termination|35|||
13460548|NCT00122954|26968084|FG000|Overall Study|Withdrawal by Subject|2|||
13460549|NCT00122954|26968085|FG001|Overall Study|Withdrawal by Subject|2|||
13460550|NCT00122954|26968084|FG000|Overall Study|Protocol Violation|0|||
13460551|NCT00122954|26968085|FG001|Overall Study|Protocol Violation|1|||
13460552|NCT00122681|26968164|FG000|Overall Study|Adverse Event|20|||
13460553|NCT00122681|26968165|FG001|Overall Study|Adverse Event|16|||
13460554|NCT00122681|26968164|FG000|Overall Study|Lost to Follow-up|1080|||
13460555|NCT00122681|26968165|FG001|Overall Study|Lost to Follow-up|1097|||
13460556|NCT00122681|26968164|FG000|Overall Study|Protocol Violation|7|||
13460557|NCT00122681|26968165|FG001|Overall Study|Protocol Violation|10|||
13460558|NCT00122681|26968164|FG000|Overall Study|Withdrawal by Subject|257|||
13460559|NCT00122681|26968165|FG001|Overall Study|Withdrawal by Subject|251|||
13460560|NCT00122681|26968164|FG000|Overall Study|Personal reasons|150|||
13460561|NCT00122681|26968165|FG001|Overall Study|Personal reasons|147|||
13460562|NCT00122460|26968194|FG000|Overall Study|investigational study phase ongoing|7|||
13460563|NCT00122460|26968195|FG001|Overall Study|investigational study phase ongoing|1|||
13460564|NCT00122382|26968253|FG000|Double-Blind Study|Adverse Event|9|||
13460565|NCT00122382|26968254|FG001|Double-Blind Study|Adverse Event|11|||
13460566|NCT00122382|26968255|FG002|Double-Blind Study|Adverse Event|0|||
13460567|NCT00122382|26968253|FG000|Double-Blind Study|Death|2|||
13460568|NCT00122382|26968254|FG001|Double-Blind Study|Death|2|||
13460569|NCT00122382|26968255|FG002|Double-Blind Study|Death|0|||
13460570|NCT00122382|26968253|FG000|Double-Blind Study|Lack of Efficacy|0|||
13460571|NCT00122382|26968254|FG001|Double-Blind Study|Lack of Efficacy|8|||
13460572|NCT00122382|26968255|FG002|Double-Blind Study|Lack of Efficacy|0|||
13460573|NCT00122382|26968253|FG000|Double-Blind Study|Lost to Follow-up|2|||
13460574|NCT00122382|26968254|FG001|Double-Blind Study|Lost to Follow-up|1|||
13460575|NCT00122382|26968255|FG002|Double-Blind Study|Lost to Follow-up|0|||
13460576|NCT00122382|26968253|FG000|Double-Blind Study|Pregnancy|2|||
13460577|NCT00122382|26968254|FG001|Double-Blind Study|Pregnancy|0|||
13460578|NCT00122382|26968255|FG002|Double-Blind Study|Pregnancy|0|||
13460579|NCT00122382|26968253|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1|||
13460580|NCT00122382|26968254|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
13460581|NCT00122382|26968255|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
13460582|NCT00122382|26968253|FG000|Double-Blind Study|Withdrawal of Consent|7|||
13460583|NCT00122382|26968254|FG001|Double-Blind Study|Withdrawal of Consent|3|||
13460584|NCT00122382|26968255|FG002|Double-Blind Study|Withdrawal of Consent|0|||
13460585|NCT00122382|26968253|FG000|Double-Blind Study|Protocol Violation|1|||
13460586|NCT00122382|26968254|FG001|Double-Blind Study|Protocol Violation|0|||
13460587|NCT00122382|26968255|FG002|Double-Blind Study|Protocol Violation|0|||
13460588|NCT00122382|26968253|FG000|Double-Blind Study|Methotrexate Discontinued|0|||
13460589|NCT00122382|26968254|FG001|Double-Blind Study|Methotrexate Discontinued|1|||
13460590|NCT00122382|26968255|FG002|Double-Blind Study|Methotrexate Discontinued|0|||
13460591|NCT00122382|26968253|FG000|Double-Blind Study|Randomized but not treated|0|||
13460592|NCT00122382|26968254|FG001|Double-Blind Study|Randomized but not treated|2|||
13460593|NCT00122382|26968255|FG002|Double-Blind Study|Randomized but not treated|0|||
13460594|NCT00122382|26968253|FG000|Open-Label Study|Adverse Event|0|||
13460595|NCT00122382|26968254|FG001|Open-Label Study|Adverse Event|0|||
13460596|NCT00122382|26968255|FG002|Open-Label Study|Adverse Event|11|||
13460597|NCT00122382|26968253|FG000|Open-Label Study|Death|0|||
13460598|NCT00122382|26968254|FG001|Open-Label Study|Death|0|||
13460599|NCT00122382|26968255|FG002|Open-Label Study|Death|2|||
13460600|NCT00122382|26968253|FG000|Open-Label Study|Lack of Efficacy|0|||
13460601|NCT00122382|26968254|FG001|Open-Label Study|Lack of Efficacy|0|||
13460602|NCT00122382|26968255|FG002|Open-Label Study|Lack of Efficacy|3|||
13460603|NCT00122382|26968253|FG000|Open-Label Study|Lost to Follow-up|0|||
13460604|NCT00122382|26968254|FG001|Open-Label Study|Lost to Follow-up|0|||
13460605|NCT00122382|26968255|FG002|Open-Label Study|Lost to Follow-up|3|||
13460606|NCT00122382|26968253|FG000|Open-Label Study|Pregnancy|0|||
13460607|NCT00122382|26968254|FG001|Open-Label Study|Pregnancy|0|||
13460608|NCT00122382|26968255|FG002|Open-Label Study|Pregnancy|2|||
13460609|NCT00122382|26968253|FG000|Open-Label Study|Poor/Non-Compliance|0|||
13460610|NCT00122382|26968254|FG001|Open-Label Study|Poor/Non-Compliance|0|||
13460611|NCT00122382|26968255|FG002|Open-Label Study|Poor/Non-Compliance|1|||
13460612|NCT00122382|26968253|FG000|Open-Label Study|Withdrawal of Consent|0|||
13460613|NCT00122382|26968254|FG001|Open-Label Study|Withdrawal of Consent|0|||
13460614|NCT00122382|26968255|FG002|Open-Label Study|Withdrawal of Consent|4|||
13460615|NCT00122317|26968264|FG000|Overall Study|Death|3|||
13460616|NCT00122317|26968264|FG000|Overall Study|Adverse Event|4|||
13460617|NCT00122317|26968264|FG000|Overall Study|Physician Decision|2|||
13460618|NCT00122317|26968264|FG000|Overall Study|patient non-compliance|1|||
13460619|NCT00122317|26968264|FG000|Overall Study|Withdrawal by Subject|1|||
13460620|NCT00122278|26968279|FG000|Overall Study|Lost to Follow-up|2|||
13460621|NCT00122278|26968280|FG001|Overall Study|Lost to Follow-up|0|||
13460622|NCT00122187|26968299|FG000|Overall Study|Withdrew because of resource limitations|2|||
13460623|NCT00122187|26968300|FG001|Overall Study|Withdrew because of resource limitations|2|||
13460624|NCT00122135|26968313|FG000|Overall Study|Withdrawal by Subject|3|||
13460625|NCT00122135|26968314|FG001|Overall Study|Withdrawal by Subject|0|||
13460626|NCT00122109|26968345|FG000|Overall Study|Did not meet criteria|6|||
13460627|NCT00122109|26968346|FG001|Overall Study|Did not meet criteria|7|||
13460628|NCT00121992|26968373|FG000|Overall Study|Treatment not received|2|||
13460629|NCT00121992|26968374|FG001|Overall Study|Treatment not received|11|||
13460630|NCT00121667|26968481|FG000|Short Term (ST) Period|Lack of Efficacy|25|||
13460631|NCT00121667|26968482|FG001|Short Term (ST) Period|Lack of Efficacy|22|||
13460632|NCT00121667|26968483|FG002|Short Term (ST) Period|Lack of Efficacy|27|||
13460633|NCT00121667|26968484|FG003|Short Term (ST) Period|Lack of Efficacy|44|||
13460634|NCT00121667|26968481|FG000|Short Term (ST) Period|Subject Withdrew Consent|8|||
13460635|NCT00121667|26968482|FG001|Short Term (ST) Period|Subject Withdrew Consent|13|||
13460636|NCT00121667|26968483|FG002|Short Term (ST) Period|Subject Withdrew Consent|4|||
13460637|NCT00121667|26968484|FG003|Short Term (ST) Period|Subject Withdrew Consent|11|||
13460638|NCT00121667|26968481|FG000|Short Term (ST) Period|Adverse Event|5|||
13460639|NCT00121667|26968482|FG001|Short Term (ST) Period|Adverse Event|6|||
13460640|NCT00121667|26968483|FG002|Short Term (ST) Period|Adverse Event|5|||
13460641|NCT00121667|26968484|FG003|Short Term (ST) Period|Adverse Event|3|||
13460642|NCT00121667|26968481|FG000|Short Term (ST) Period|Lost to Follow-up|3|||
13460643|NCT00121667|26968482|FG001|Short Term (ST) Period|Lost to Follow-up|4|||
13460644|NCT00121667|26968483|FG002|Short Term (ST) Period|Lost to Follow-up|4|||
13460645|NCT00121667|26968484|FG003|Short Term (ST) Period|Lost to Follow-up|3|||
13460646|NCT00121667|26968481|FG000|Short Term (ST) Period|Poor / Non-compliance|0|||
13460647|NCT00121667|26968482|FG001|Short Term (ST) Period|Poor / Non-compliance|1|||
13460648|NCT00121667|26968483|FG002|Short Term (ST) Period|Poor / Non-compliance|1|||
13460649|NCT00121667|26968484|FG003|Short Term (ST) Period|Poor / Non-compliance|2|||
13460650|NCT00121667|26968481|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
13460651|NCT00121667|26968482|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
13460652|NCT00121667|26968483|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
13460653|NCT00121667|26968484|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
13460654|NCT00121667|26968481|FG000|Short Term (ST) Period|Other Reason|3|||
13460655|NCT00121667|26968482|FG001|Short Term (ST) Period|Other Reason|0|||
13460656|NCT00121667|26968483|FG002|Short Term (ST) Period|Other Reason|0|||
13460657|NCT00121667|26968484|FG003|Short Term (ST) Period|Other Reason|0|||
13460658|NCT00121667|26968481|FG000|Short Term (ST) Period|Death|0|||
13460659|NCT00121667|26968482|FG001|Short Term (ST) Period|Death|0|||
13460660|NCT00121667|26968483|FG002|Short Term (ST) Period|Death|0|||
13460661|NCT00121667|26968484|FG003|Short Term (ST) Period|Death|1|||
13460662|NCT00121667|26968481|FG000|Short Term (ST) Period|Pregnancy|0|||
13460663|NCT00121667|26968482|FG001|Short Term (ST) Period|Pregnancy|0|||
13460664|NCT00121667|26968483|FG002|Short Term (ST) Period|Pregnancy|0|||
13460665|NCT00121667|26968484|FG003|Short Term (ST) Period|Pregnancy|1|||
13460666|NCT00121667|26968481|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54|||
13460667|NCT00121667|26968482|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51|||
13460668|NCT00121667|26968483|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42|||
13460669|NCT00121667|26968484|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65|||
13460670|NCT00121667|26968481|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38|||
13460671|NCT00121667|26968482|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34|||
13460672|NCT00121667|26968483|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26|||
13460673|NCT00121667|26968484|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30|||
13460674|NCT00121667|26968481|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12|||
13460675|NCT00121667|26968482|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18|||
13460676|NCT00121667|26968483|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13|||
13460677|NCT00121667|26968484|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10|||
13460678|NCT00121667|26968481|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
13460679|NCT00121667|26968482|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
13460680|NCT00121667|26968483|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13|||
13460681|NCT00121667|26968484|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16|||
13460682|NCT00121667|26968481|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5|||
13460683|NCT00121667|26968482|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7|||
13460684|NCT00121667|26968483|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6|||
13460685|NCT00121667|26968484|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3|||
13460686|NCT00121667|26968481|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3|||
13460687|NCT00121667|26968482|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6|||
13460688|NCT00121667|26968483|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5|||
13460689|NCT00121667|26968484|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9|||
13460690|NCT00121667|26968481|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3|||
13460691|NCT00121667|26968482|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5|||
13460692|NCT00121667|26968483|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8|||
13460693|NCT00121667|26968484|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4|||
13460694|NCT00121667|26968481|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
13460695|NCT00121667|26968482|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
13460696|NCT00121667|26968483|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0|||
13460697|NCT00121667|26968484|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
13460698|NCT00121667|26968481|FG000|Short Term (ST) + Long Term (LT) Period|Death|1|||
13460699|NCT00121667|26968482|FG001|Short Term (ST) + Long Term (LT) Period|Death|0|||
13460700|NCT00121667|26968483|FG002|Short Term (ST) + Long Term (LT) Period|Death|0|||
13460701|NCT00121667|26968484|FG003|Short Term (ST) + Long Term (LT) Period|Death|2|||
13460702|NCT00121641|26968609|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15|||
13460703|NCT00121641|26968610|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21|||
13460704|NCT00121641|26968611|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14|||
13460705|NCT00121641|26968612|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25|||
13460706|NCT00121641|26968613|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30|||
13460707|NCT00121641|26968609|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9|||
13460708|NCT00121641|26968610|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11|||
13460709|NCT00121641|26968611|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5|||
13460710|NCT00121641|26968612|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10|||
13460711|NCT00121641|26968613|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3|||
13460712|NCT00121641|26968609|FG000|24-week Short-term Treatment Period|Adverse Event|3|||
13460713|NCT00121641|26968610|FG001|24-week Short-term Treatment Period|Adverse Event|3|||
13460714|NCT00121641|26968611|FG002|24-week Short-term Treatment Period|Adverse Event|4|||
13460715|NCT00121641|26968612|FG003|24-week Short-term Treatment Period|Adverse Event|0|||
13460716|NCT00121641|26968613|FG004|24-week Short-term Treatment Period|Adverse Event|2|||
13460717|NCT00121641|26968609|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0|||
13460718|NCT00121641|26968610|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2|||
13460719|NCT00121641|26968611|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3|||
13460720|NCT00121641|26968612|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4|||
13460721|NCT00121641|26968613|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4|||
13460722|NCT00121641|26968609|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
13460723|NCT00121641|26968610|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
13460724|NCT00121641|26968611|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3|||
13460725|NCT00121641|26968612|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
13460726|NCT00121641|26968613|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
13460727|NCT00121641|26968609|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
13460728|NCT00121641|26968610|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
13460729|NCT00121641|26968611|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
13460730|NCT00121641|26968612|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
13460731|NCT00121641|26968613|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
13460732|NCT00121641|26968609|FG000|24-week Short-term Treatment Period|Other Reason|1|||
13460733|NCT00121641|26968610|FG001|24-week Short-term Treatment Period|Other Reason|0|||
13460734|NCT00121641|26968611|FG002|24-week Short-term Treatment Period|Other Reason|0|||
13460735|NCT00121641|26968612|FG003|24-week Short-term Treatment Period|Other Reason|0|||
13460736|NCT00121641|26968613|FG004|24-week Short-term Treatment Period|Other Reason|0|||
13460737|NCT00121641|26968609|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
13460738|NCT00121641|26968610|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27|||
13460739|NCT00121641|26968611|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21|||
13460740|NCT00121641|26968612|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
13460741|NCT00121641|26968613|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25|||
13460742|NCT00121641|26968609|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25|||
13460743|NCT00121641|26968610|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28|||
13460744|NCT00121641|26968611|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17|||
13460745|NCT00121641|26968612|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24|||
13460746|NCT00121641|26968613|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10|||
13460747|NCT00121641|26968609|FG000|48-month Short Term + Long Term Period|Adverse Event|9|||
13460748|NCT00121641|26968610|FG001|48-month Short Term + Long Term Period|Adverse Event|10|||
13460749|NCT00121641|26968611|FG002|48-month Short Term + Long Term Period|Adverse Event|10|||
13460750|NCT00121641|26968612|FG003|48-month Short Term + Long Term Period|Adverse Event|5|||
13460751|NCT00121641|26968613|FG004|48-month Short Term + Long Term Period|Adverse Event|5|||
13460752|NCT00121641|26968609|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9|||
13460753|NCT00121641|26968610|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7|||
13460754|NCT00121641|26968611|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
13460755|NCT00121641|26968612|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11|||
13460756|NCT00121641|26968613|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
13460757|NCT00121641|26968609|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
13460758|NCT00121641|26968610|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1|||
13460759|NCT00121641|26968611|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
13460760|NCT00121641|26968612|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
13460761|NCT00121641|26968613|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
13460762|NCT00121641|26968609|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
13460763|NCT00121641|26968610|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3|||
13460764|NCT00121641|26968611|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
13460765|NCT00121641|26968612|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
13460766|NCT00121641|26968613|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
13460767|NCT00121641|26968609|FG000|48-month Short Term + Long Term Period|Pregnancy|0|||
13460768|NCT00121641|26968610|FG001|48-month Short Term + Long Term Period|Pregnancy|1|||
13460769|NCT00121641|26968611|FG002|48-month Short Term + Long Term Period|Pregnancy|0|||
13460770|NCT00121641|26968612|FG003|48-month Short Term + Long Term Period|Pregnancy|1|||
13460771|NCT00121641|26968613|FG004|48-month Short Term + Long Term Period|Pregnancy|0|||
13460772|NCT00121641|26968609|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
13460773|NCT00121641|26968610|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2|||
13460774|NCT00121641|26968611|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
13460775|NCT00121641|26968612|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
13460776|NCT00121641|26968613|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
13460777|NCT00121641|26968609|FG000|48-month Short Term + Long Term Period|Death|0|||
13460778|NCT00121641|26968610|FG001|48-month Short Term + Long Term Period|Death|0|||
13460779|NCT00121641|26968611|FG002|48-month Short Term + Long Term Period|Death|0|||
13460780|NCT00121641|26968612|FG003|48-month Short Term + Long Term Period|Death|1|||
13460781|NCT00121641|26968613|FG004|48-month Short Term + Long Term Period|Death|0|||
13460782|NCT00121641|26968609|FG000|48-month Short Term + Long Term Period|Missing|0|||
13460783|NCT00121641|26968610|FG001|48-month Short Term + Long Term Period|Missing|0|||
13460784|NCT00121641|26968611|FG002|48-month Short Term + Long Term Period|Missing|1|||
13460785|NCT00121641|26968612|FG003|48-month Short Term + Long Term Period|Missing|0|||
13460786|NCT00121641|26968613|FG004|48-month Short Term + Long Term Period|Missing|0|||
13460787|NCT00121641|26968609|FG000|48-month Short Term + Long Term Period|Other Reason|5|||
13460788|NCT00121641|26968610|FG001|48-month Short Term + Long Term Period|Other Reason|3|||
13460789|NCT00121641|26968611|FG002|48-month Short Term + Long Term Period|Other Reason|2|||
13460790|NCT00121641|26968612|FG003|48-month Short Term + Long Term Period|Other Reason|0|||
13460791|NCT00121641|26968613|FG004|48-month Short Term + Long Term Period|Other Reason|1|||
13460792|NCT00121485|26968654|FG000|Overall Study|Not implanted|1|||
13460793|NCT00121485|26968655|FG001|Overall Study|Not implanted|5|||
13460794|NCT00121485|26968654|FG000|Overall Study|Crossover|0|||
13460795|NCT00121485|26968655|FG001|Overall Study|Crossover|2|||
13460796|NCT00121238|26968665|FG000|Overall Study|disease progression before intervention|1|||
13460797|NCT00121238|26968665|FG000|Overall Study|Protocol Violation|2|||
13460798|NCT00121199|26968674|FG000|Overall Study|Adverse Event|11|||
13460799|NCT00121199|26968674|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
13460800|NCT00121199|26968674|FG000|Overall Study|Progression/Relapse|1|||
13460801|NCT00121199|26968674|FG000|Overall Study|Death|3|||
13460802|NCT00121199|26968674|FG000|Overall Study|Other - Not Protocol Specified|3|||
13460803|NCT00121199|26968674|FG000|Overall Study|Ineligible|9|||
13460804|NCT00121134|26968697|FG000|Overall Study|Progression of Disease|5|||
13460805|NCT00121134|26968698|FG001|Overall Study|Progression of Disease|3|||
13460806|NCT00121134|26968699|FG002|Overall Study|Progression of Disease|4|||
13460807|NCT00121134|26968700|FG003|Overall Study|Progression of Disease|2|||
13460808|NCT00121134|26968697|FG000|Overall Study|Toxicity|4|||
13460809|NCT00121134|26968698|FG001|Overall Study|Toxicity|7|||
13460810|NCT00121134|26968699|FG002|Overall Study|Toxicity|13|||
13460811|NCT00121134|26968700|FG003|Overall Study|Toxicity|5|||
13460812|NCT00121134|26968697|FG000|Overall Study|Physician Decision|6|||
13460813|NCT00121134|26968698|FG001|Overall Study|Physician Decision|4|||
13460814|NCT00121134|26968699|FG002|Overall Study|Physician Decision|4|||
13460815|NCT00121134|26968700|FG003|Overall Study|Physician Decision|1|||
13460816|NCT00121134|26968697|FG000|Overall Study|Treatment Delay|1|||
13460817|NCT00121134|26968698|FG001|Overall Study|Treatment Delay|0|||
13460818|NCT00121134|26968699|FG002|Overall Study|Treatment Delay|0|||
13460819|NCT00121134|26968700|FG003|Overall Study|Treatment Delay|0|||
13460820|NCT00121134|26968697|FG000|Overall Study|Intercurrent Illness|0|||
13460821|NCT00121134|26968698|FG001|Overall Study|Intercurrent Illness|0|||
13460822|NCT00121134|26968699|FG002|Overall Study|Intercurrent Illness|0|||
13460823|NCT00121134|26968700|FG003|Overall Study|Intercurrent Illness|1|||
13460824|NCT00121134|26968697|FG000|Overall Study|Patient Personal Reasons|0|||
13460825|NCT00121134|26968698|FG001|Overall Study|Patient Personal Reasons|1|||
13460826|NCT00121134|26968699|FG002|Overall Study|Patient Personal Reasons|0|||
13460827|NCT00121134|26968700|FG003|Overall Study|Patient Personal Reasons|0|||
13460828|NCT00120874|26968743|FG000|Overall Study|Death|0|||
13460829|NCT00120874|26968744|FG001|Overall Study|Death|1|||
13460830|NCT00120627|26968775|FG000|Overall Study|Withdrawal by Subject|5|||
13460831|NCT00120627|26968776|FG001|Overall Study|Withdrawal by Subject|5|||
13460832|NCT00120406|26968791|FG000|Overall Study|Death|9|||
13460833|NCT00120406|26968792|FG001|Overall Study|Death|4|||
13460834|NCT00120406|26968791|FG000|Overall Study|Withdrawal by Subject|5|||
13460835|NCT00120406|26968792|FG001|Overall Study|Withdrawal by Subject|7|||
13460836|NCT00120406|26968791|FG000|Overall Study|Lost to Follow-up|5|||
13460837|NCT00120406|26968792|FG001|Overall Study|Lost to Follow-up|2|||
13460838|NCT00120406|26968791|FG000|Overall Study|received non-study stent|0|||
13460839|NCT00120406|26968792|FG001|Overall Study|received non-study stent|2|||
13460840|NCT00120406|26968791|FG000|Overall Study|patient moved but has not withdrawn|0|||
13460841|NCT00120406|26968792|FG001|Overall Study|patient moved but has not withdrawn|1|||
13460842|NCT00120289|26968811|FG000|Overall Study|Death|96|||
13460843|NCT00120289|26968812|FG001|Overall Study|Death|82|||
13460844|NCT00120289|26968811|FG000|Overall Study|Lost to Follow-up|11|||
13460845|NCT00120289|26968812|FG001|Overall Study|Lost to Follow-up|14|||
13460846|NCT00120289|26968811|FG000|Overall Study|Withdrawal by Subject|14|||
13460847|NCT00120289|26968812|FG001|Overall Study|Withdrawal by Subject|13|||
13460848|NCT00120250|26968828|FG000|Overall Study|Lost to Follow-up|1|||
13460849|NCT00120250|26968829|FG001|Overall Study|Lost to Follow-up|1|||
13460850|NCT00120250|26968828|FG000|Overall Study|Protocol Violation|0|||
13460851|NCT00120250|26968829|FG001|Overall Study|Protocol Violation|1|||
13460852|NCT00119678|26968882|FG000|Double-blind Treatment Period|Death|1|||
13460853|NCT00119678|26968883|FG001|Double-blind Treatment Period|Death|0|||
13460854|NCT00119678|26968882|FG000|Double-blind Treatment Period|Adverse Event|7|||
13460855|NCT00119678|26968883|FG001|Double-blind Treatment Period|Adverse Event|1|||
13460856|NCT00119678|26968882|FG000|Double-blind Treatment Period|Lack of Efficacy|21|||
13460857|NCT00119678|26968883|FG001|Double-blind Treatment Period|Lack of Efficacy|12|||
13460858|NCT00119678|26968882|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
13460859|NCT00119678|26968883|FG001|Double-blind Treatment Period|Lost to Follow-up|2|||
13460860|NCT00119678|26968882|FG000|Double-blind Treatment Period|Participant withdrew consent|4|||
13460861|NCT00119678|26968883|FG001|Double-blind Treatment Period|Participant withdrew consent|4|||
13460862|NCT00119678|26968882|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0|||
13460863|NCT00119678|26968883|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1|||
13460864|NCT00119678|26968882|FG000|Double-blind Treatment Period|Poor/Non-compliance|3|||
13460865|NCT00119678|26968883|FG001|Double-blind Treatment Period|Poor/Non-compliance|0|||
13460866|NCT00119678|26968882|FG000|Double-blind Treatment Period|Pregnancy|0|||
13460867|NCT00119678|26968883|FG001|Double-blind Treatment Period|Pregnancy|2|||
13460868|NCT00119678|26968882|FG000|Double-blind Treatment Period|Not treated|1|||
13460869|NCT00119678|26968883|FG001|Double-blind Treatment Period|Not treated|2|||
13460870|NCT00119678|26968882|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3|||
13460871|NCT00119678|26968883|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2|||
13460872|NCT00119678|26968882|FG000|Open-label Treatment Period|Death|1|||
13460873|NCT00119678|26968883|FG001|Open-label Treatment Period|Death|0|||
13460874|NCT00119678|26968882|FG000|Open-label Treatment Period|Adverse Event|3|||
13460875|NCT00119678|26968883|FG001|Open-label Treatment Period|Adverse Event|0|||
13460876|NCT00119678|26968882|FG000|Open-label Treatment Period|Lack of Efficacy|9|||
13460877|NCT00119678|26968883|FG001|Open-label Treatment Period|Lack of Efficacy|0|||
13460878|NCT00119678|26968882|FG000|Open-label Treatment Period|Lost to Follow-up|3|||
13460879|NCT00119678|26968883|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
13460880|NCT00119678|26968882|FG000|Open-label Treatment Period|Participant withdrew consent|4|||
13460881|NCT00119678|26968883|FG001|Open-label Treatment Period|Participant withdrew consent|0|||
13460882|NCT00119678|26968882|FG000|Open-label Treatment Period|Participants not meeting study criteria|2|||
13460883|NCT00119678|26968883|FG001|Open-label Treatment Period|Participants not meeting study criteria|0|||
13460884|NCT00119678|26968882|FG000|Open-label Treatment Period|Pregnancy|1|||
13460885|NCT00119678|26968883|FG001|Open-label Treatment Period|Pregnancy|0|||
13460886|NCT00119678|26968882|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87|||
13460887|NCT00119678|26968883|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0|||
13460888|NCT00119405|26968889|FG000|Overall Study|Withdrawal by Subject|1|||
13460889|NCT00119379|26968912|FG000|Overall Study|Adverse Event|4|||
13460890|NCT00119379|26968913|FG001|Overall Study|Adverse Event|1|||
13460891|NCT00119262|26968930|FG000|Overall Study|Lack of Efficacy|0|||
13460892|NCT00119262|26968931|FG001|Overall Study|Lack of Efficacy|3|||
13460893|NCT00119262|26968930|FG000|Overall Study|Withdrawal by Subject|12|||
13460894|NCT00119262|26968931|FG001|Overall Study|Withdrawal by Subject|11|||
13460895|NCT00119262|26968930|FG000|Overall Study|Adverse Event|33|||
13460896|NCT00119262|26968931|FG001|Overall Study|Adverse Event|35|||
13460897|NCT00119262|26968930|FG000|Overall Study|other disease|0|||
13460898|NCT00119262|26968931|FG001|Overall Study|other disease|2|||
13460899|NCT00119262|26968930|FG000|Overall Study|ineligble|1|||
13460900|NCT00119262|26968931|FG001|Overall Study|ineligble|2|||
13460901|NCT00119262|26968930|FG000|Overall Study|others|0|||
13460902|NCT00119262|26968931|FG001|Overall Study|others|5|||
13460903|NCT00119106|26968958|FG000|Overall Study|HIV infected at baseline|179|||
13460904|NCT00119106|26968959|FG001|Overall Study|HIV infected at baseline|178|||
13460905|NCT00119015|26968981|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48|||
13460906|NCT00119015|26968982|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
13460907|NCT00119015|26968983|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
13460908|NCT00118911|26968998|FG000|Overall Study|Withdrawal by Subject|2|||
13460909|NCT00118911|26968999|FG001|Overall Study|Withdrawal by Subject|5|||
13460910|NCT00118898|26969106|FG000|Overall Study|Death|6|||
13460911|NCT00118898|26969107|FG001|Overall Study|Death|11|||
13460912|NCT00118898|26969108|FG002|Overall Study|Death|6|||
13460913|NCT00118898|26969109|FG003|Overall Study|Death|8|||
13460914|NCT00118898|26969106|FG000|Overall Study|Lost to Follow-up|26|||
13460915|NCT00118898|26969107|FG001|Overall Study|Lost to Follow-up|34|||
13460916|NCT00118898|26969108|FG002|Overall Study|Lost to Follow-up|33|||
13460917|NCT00118898|26969109|FG003|Overall Study|Lost to Follow-up|33|||
13460918|NCT00118898|26969106|FG000|Overall Study|Withdrawal by Subject|10|||
13460919|NCT00118898|26969107|FG001|Overall Study|Withdrawal by Subject|5|||
13460920|NCT00118898|26969108|FG002|Overall Study|Withdrawal by Subject|8|||
13460921|NCT00118898|26969109|FG003|Overall Study|Withdrawal by Subject|8|||
13460922|NCT00118898|26969106|FG000|Overall Study|Site Closure|33|||
13460923|NCT00118898|26969107|FG001|Overall Study|Site Closure|31|||
13460924|NCT00118898|26969108|FG002|Overall Study|Site Closure|28|||
13460925|NCT00118898|26969109|FG003|Overall Study|Site Closure|37|||
13460926|NCT00118898|26969106|FG000|Overall Study|Severe debilitation|1|||
13460927|NCT00118898|26969107|FG001|Overall Study|Severe debilitation|4|||
13460928|NCT00118898|26969108|FG002|Overall Study|Severe debilitation|6|||
13460929|NCT00118898|26969109|FG003|Overall Study|Severe debilitation|4|||
13460930|NCT00118898|26969106|FG000|Overall Study|Not compliant with requirements|11|||
13460931|NCT00118898|26969107|FG001|Overall Study|Not compliant with requirements|13|||
13460932|NCT00118898|26969108|FG002|Overall Study|Not compliant with requirements|11|||
13460933|NCT00118898|26969109|FG003|Overall Study|Not compliant with requirements|11|||
13460934|NCT00118898|26969106|FG000|Overall Study|Not able to get to clinic|34|||
13460935|NCT00118898|26969107|FG001|Overall Study|Not able to get to clinic|43|||
13460936|NCT00118898|26969108|FG002|Overall Study|Not able to get to clinic|31|||
13460937|NCT00118898|26969109|FG003|Overall Study|Not able to get to clinic|40|||
13460938|NCT00118716|26969134|FG000|Overall Study|Adverse Event|2|||
13460939|NCT00118716|26969135|FG001|Overall Study|Adverse Event|7|||
13460940|NCT00118716|26969134|FG000|Overall Study|Protocol Violation|5|||
13460941|NCT00118716|26969135|FG001|Overall Study|Protocol Violation|4|||
13460942|NCT00118716|26969134|FG000|Overall Study|Withdrawal by Subject|0|||
13460943|NCT00118716|26969135|FG001|Overall Study|Withdrawal by Subject|1|||
13460944|NCT00118716|26969134|FG000|Overall Study|Exacerbation|2|||
13460945|NCT00118716|26969135|FG001|Overall Study|Exacerbation|2|||
13460946|NCT00118716|26969134|FG000|Overall Study|Discontinued by sponsor|1|||
13460947|NCT00118716|26969135|FG001|Overall Study|Discontinued by sponsor|1|||
13460948|NCT00118716|26969134|FG000|Overall Study|Non-compliance|1|||
13460949|NCT00118716|26969135|FG001|Overall Study|Non-compliance|3|||
13460950|NCT00118716|26969134|FG000|Overall Study|misrandomized|1|||
13460951|NCT00118716|26969135|FG001|Overall Study|misrandomized|1|||
13460952|NCT00118716|26969134|FG000|Overall Study|Expired drug use|1|||
13460953|NCT00118716|26969135|FG001|Overall Study|Expired drug use|2|||
13460954|NCT00118716|26969134|FG000|Overall Study|Investigator discretion|0|||
13460955|NCT00118716|26969135|FG001|Overall Study|Investigator discretion|1|||
13460956|NCT00118703|26969152|FG000|Overall Study|Protocol Violation|1|||
13460957|NCT00118703|26969153|FG001|Overall Study|Protocol Violation|0|||
13460958|NCT00118703|26969152|FG000|Overall Study|Adverse Event|1|||
13460959|NCT00118703|26969153|FG001|Overall Study|Adverse Event|1|||
13460960|NCT00118703|26969152|FG000|Overall Study|Participant took two different treatment|0|||
13460961|NCT00118703|26969153|FG001|Overall Study|Participant took two different treatment|1|||
13460962|NCT00118703|26969152|FG000|Overall Study|Withdrawal by Subject|2|||
13460963|NCT00118703|26969153|FG001|Overall Study|Withdrawal by Subject|5|||
13460964|NCT00118703|26969152|FG000|Overall Study|Lost to Follow-up|1|||
13460965|NCT00118703|26969153|FG001|Overall Study|Lost to Follow-up|2|||
13460966|NCT00118482|26969172|FG000|Overall Study|Lost to Follow-up|7|||
13460967|NCT00118482|26969173|FG001|Overall Study|Lost to Follow-up|7|||
13460968|NCT00118482|26969172|FG000|Overall Study|Withdrawal by Subject|23|||
13460969|NCT00118482|26969173|FG001|Overall Study|Withdrawal by Subject|22|||
13460970|NCT00118430|26969198|FG000|Overall Study|Withdrawal by Subject|6|||
13460971|NCT00118430|26969199|FG001|Overall Study|Withdrawal by Subject|2|||
13460972|NCT00118430|26969200|FG002|Overall Study|Withdrawal by Subject|0|||
13460973|NCT00118430|26969198|FG000|Overall Study|Lost to Follow-up|15|||
13460974|NCT00118430|26969199|FG001|Overall Study|Lost to Follow-up|22|||
13460975|NCT00118430|26969200|FG002|Overall Study|Lost to Follow-up|28|||
13460976|NCT00118417|26969213|FG000|Phase I (Weeks 0 to 6)|Remission|8|||
13460977|NCT00118417|26969214|FG001|Phase I (Weeks 0 to 6)|Remission|0|||
13460978|NCT00118417|26969213|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6|||
13460979|NCT00118417|26969214|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0|||
13460980|NCT00118417|26969213|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4|||
13460981|NCT00118417|26969214|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0|||
13460982|NCT00118417|26969213|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
13460983|NCT00118417|26969214|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
13460984|NCT00118417|26969213|FG000|Phase II (Weeks 6 to 12)|Remission|1|||
13460985|NCT00118417|26969214|FG001|Phase II (Weeks 6 to 12)|Remission|2|||
13460986|NCT00118287|26969220|FG000|Overall Study|Intracranial haemorrhage|1|||
13460987|NCT00118287|26969220|FG000|Overall Study|Muscle pain|1|||
13460988|NCT00118157|26969227|FG000|Overall Study|Adverse Event|2|||
13460989|NCT00118157|26969227|FG000|Overall Study|Death|8|||
13460990|NCT00118157|26969227|FG000|Overall Study|Withdrawal by Subject|2|||
13460991|NCT00118092|26969237|FG000|Overall Study|Withdrawal by Subject|1|||
13460992|NCT00118092|26969237|FG000|Overall Study|Protocol Violation|1|||
13460993|NCT00118040|26969308|FG000|Overall Study|Adverse Event|0|||
13460994|NCT00118040|26969309|FG001|Overall Study|Adverse Event|1|||
13460995|NCT00118040|26969310|FG002|Overall Study|Adverse Event|0|||
13460996|NCT00118040|26969308|FG000|Overall Study|Withdrawal by Subject|0|||
13460997|NCT00118040|26969309|FG001|Overall Study|Withdrawal by Subject|0|||
13460998|NCT00118040|26969310|FG002|Overall Study|Withdrawal by Subject|2|||
13460999|NCT00118040|26969308|FG000|Overall Study|Medical Contraindication|0|||
13461000|NCT00118040|26969309|FG001|Overall Study|Medical Contraindication|0|||
13461001|NCT00118040|26969310|FG002|Overall Study|Medical Contraindication|1|||
13461002|NCT00118040|26969308|FG000|Overall Study|Non-Compliant Participant|1|||
13461003|NCT00118040|26969309|FG001|Overall Study|Non-Compliant Participant|1|||
13461004|NCT00118040|26969310|FG002|Overall Study|Non-Compliant Participant|2|||
13461005|NCT00118040|26969308|FG000|Overall Study|Other|0|||
13461006|NCT00118040|26969309|FG001|Overall Study|Other|0|||
13461007|NCT00118040|26969310|FG002|Overall Study|Other|1|||
13461008|NCT00117988|26969316|FG000|Overall Study|Death|3|||
13461009|NCT00117988|26969316|FG000|Overall Study|Adverse Event|1|||
13461010|NCT00117949|26969363|FG000|Overall Study|Testosterone >1.0 ng/mL|10|||
13461011|NCT00117949|26969364|FG001|Overall Study|Testosterone >1.0 ng/mL|18|||
13461012|NCT00117949|26969365|FG002|Overall Study|Testosterone >1.0 ng/mL|17|||
13461013|NCT00117949|26969366|FG003|Overall Study|Testosterone >1.0 ng/mL|15|||
13461014|NCT00117949|26969363|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
13461015|NCT00117949|26969364|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
13461016|NCT00117949|26969365|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
13461017|NCT00117949|26969366|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
13461018|NCT00117949|26969363|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
13461019|NCT00117949|26969364|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
13461020|NCT00117949|26969365|FG002|Overall Study|Prostate-specific antigen increase >=25%|1|||
13461021|NCT00117949|26969366|FG003|Overall Study|Prostate-specific antigen increase >=25%|2|||
13461022|NCT00117949|26969363|FG000|Overall Study|PSA increase >=10ng/mL|0|||
13461023|NCT00117949|26969364|FG001|Overall Study|PSA increase >=10ng/mL|1|||
13461024|NCT00117949|26969365|FG002|Overall Study|PSA increase >=10ng/mL|1|||
13461025|NCT00117949|26969366|FG003|Overall Study|PSA increase >=10ng/mL|0|||
13461026|NCT00117949|26969363|FG000|Overall Study|PSA reduction <=50%|0|||
13461027|NCT00117949|26969364|FG001|Overall Study|PSA reduction <=50%|2|||
13461028|NCT00117949|26969365|FG002|Overall Study|PSA reduction <=50%|2|||
13461029|NCT00117949|26969366|FG003|Overall Study|PSA reduction <=50%|4|||
13461030|NCT00117949|26969363|FG000|Overall Study|Hepatic abnormalities|0|||
13461031|NCT00117949|26969364|FG001|Overall Study|Hepatic abnormalities|1|||
13461032|NCT00117949|26969365|FG002|Overall Study|Hepatic abnormalities|0|||
13461033|NCT00117949|26969366|FG003|Overall Study|Hepatic abnormalities|1|||
13461034|NCT00117845|26969373|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1|||
13461035|NCT00117793|26969390|FG000|Overall Study|Withdrawal by Subject|12|||
13461036|NCT00117676|26969484|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4|||
13461037|NCT00117676|26969485|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3|||
13461038|NCT00117676|26969484|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1|||
13461039|NCT00117676|26969485|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0|||
13461040|NCT00117676|26969484|FG000|Double-blind Period Through Week 48|Protocol Violation|0|||
13461041|NCT00117676|26969485|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
13461042|NCT00117676|26969484|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5|||
13461043|NCT00117676|26969485|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2|||
13461044|NCT00117676|26969484|FG000|Double-blind Period Through Week 48|Withdrew Consent|0|||
13461045|NCT00117676|26969485|FG001|Double-blind Period Through Week 48|Withdrew Consent|1|||
13461046|NCT00117676|26969484|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2|||
13461047|NCT00117676|26969485|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0|||
13461048|NCT00117676|26969484|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3|||
13461049|NCT00117676|26969485|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
13461050|NCT00117676|26969484|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5|||
13461051|NCT00117676|26969485|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1|||
13461052|NCT00117676|26969484|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4|||
13461053|NCT00117676|26969485|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1|||
13461054|NCT00117676|26969484|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1|||
13461055|NCT00117676|26969485|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0|||
13461056|NCT00117676|26969484|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1|||
13461057|NCT00117676|26969485|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0|||
13461058|NCT00117676|26969484|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2|||
13461059|NCT00117676|26969485|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0|||
13461060|NCT00117676|26969484|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3|||
13461061|NCT00117676|26969485|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1|||
13461062|NCT00117676|26969484|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5|||
13461063|NCT00117676|26969485|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2|||
13461064|NCT00117676|26969484|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
13461065|NCT00117676|26969485|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
13461066|NCT00117676|26969484|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0|||
13461067|NCT00117676|26969485|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1|||
13461068|NCT00117676|26969484|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
13461069|NCT00117676|26969485|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0|||
13461070|NCT00117676|26969484|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4|||
13461071|NCT00117676|26969485|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1|||
13461072|NCT00117676|26969484|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0|||
13461073|NCT00117676|26969485|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1|||
13461074|NCT00117676|26969484|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2|||
13461075|NCT00117676|26969485|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1|||
13461076|NCT00117676|26969484|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2|||
13461077|NCT00117676|26969485|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0|||
13461078|NCT00117676|26969484|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1|||
13461079|NCT00117676|26969485|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
13461080|NCT00117676|26969484|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5|||
13461081|NCT00117676|26969485|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1|||
13461082|NCT00117676|26969484|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7|||
13461083|NCT00117676|26969485|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4|||
13461084|NCT00117676|26969484|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
13461085|NCT00117676|26969485|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
13461086|NCT00117676|26969484|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0|||
13461087|NCT00117676|26969485|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1|||
13461088|NCT00117676|26969484|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
13461089|NCT00117676|26969485|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
13461090|NCT00117676|26969484|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3|||
13461091|NCT00117676|26969485|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1|||
13461092|NCT00117676|26969484|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1|||
13461093|NCT00117676|26969485|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0|||
13461094|NCT00117676|26969484|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2|||
13461095|NCT00117676|26969485|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1|||
13461096|NCT00117676|26969484|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0|||
13461097|NCT00117676|26969485|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1|||
13461098|NCT00117676|26969484|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0|||
13461099|NCT00117676|26969485|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1|||
13461100|NCT00117676|26969484|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1|||
13461101|NCT00117676|26969485|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0|||
13461102|NCT00117676|26969484|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
13461103|NCT00117676|26969485|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
13461104|NCT00117676|26969484|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0|||
13461105|NCT00117676|26969485|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1|||
13461106|NCT00117637|26969564|FG000|First Intervention (Period 1)|Adverse Event|11|||
13461107|NCT00117637|26969565|FG001|First Intervention (Period 1)|Adverse Event|16|||
13461108|NCT00117637|26969564|FG000|First Intervention (Period 1)|Lost to Follow-up|0|||
13461109|NCT00117637|26969565|FG001|First Intervention (Period 1)|Lost to Follow-up|2|||
13461110|NCT00117637|26969564|FG000|First Intervention (Period 1)|Protocol Violation|1|||
13461111|NCT00117637|26969565|FG001|First Intervention (Period 1)|Protocol Violation|0|||
13461112|NCT00117637|26969564|FG000|First Intervention (Period 1)|Withdrawal by Subject|2|||
13461113|NCT00117637|26969565|FG001|First Intervention (Period 1)|Withdrawal by Subject|4|||
13461114|NCT00117637|26969564|FG000|First Intervention (Period 1)|study terminated by the sponsor|3|||
13461115|NCT00117637|26969565|FG001|First Intervention (Period 1)|study terminated by the sponsor|1|||
13461116|NCT00117637|26969564|FG000|First Intervention (Period 1)|protocol driven decision point|1|||
13461117|NCT00117637|26969565|FG001|First Intervention (Period 1)|protocol driven decision point|0|||
13461118|NCT00117637|26969564|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0|||
13461119|NCT00117637|26969565|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1|||
13461120|NCT00117637|26969564|FG000|First Intervention (Period 1)|reason not reported|0|||
13461121|NCT00117637|26969565|FG001|First Intervention (Period 1)|reason not reported|1|||
13461122|NCT00117637|26969564|FG000|Second Intervention (Period 2)|Adverse Event|0|||
13461123|NCT00117637|26969565|FG001|Second Intervention (Period 2)|Adverse Event|9|||
13461124|NCT00117637|26969564|FG000|Second Intervention (Period 2)|Lost to Follow-up|1|||
13461125|NCT00117637|26969565|FG001|Second Intervention (Period 2)|Lost to Follow-up|0|||
13461126|NCT00117637|26969564|FG000|Second Intervention (Period 2)|Protocol Violation|1|||
13461127|NCT00117637|26969565|FG001|Second Intervention (Period 2)|Protocol Violation|0|||
13461128|NCT00117637|26969564|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4|||
13461129|NCT00117637|26969565|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3|||
13461130|NCT00117637|26969564|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2|||
13461131|NCT00117637|26969565|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9|||
13461132|NCT00117637|26969564|FG000|Second Intervention (Period 2)|non compliant with study medication|1|||
13461133|NCT00117637|26969565|FG001|Second Intervention (Period 2)|non compliant with study medication|1|||
13461134|NCT00117637|26969564|FG000|Second Intervention (Period 2)|reason not reported|1|||
13461135|NCT00117637|26969565|FG001|Second Intervention (Period 2)|reason not reported|0|||
13461136|NCT00117598|26969605|FG000|Prior to Treatment Cross Over|Death|40|||
13461137|NCT00117598|26969606|FG001|Prior to Treatment Cross Over|Death|41|||
13461138|NCT00117598|26969607|FG002|Prior to Treatment Cross Over|Death|37|||
13461139|NCT00117598|26969608|FG003|Prior to Treatment Cross Over|Death|0|||
13461140|NCT00117598|26969609|FG004|Prior to Treatment Cross Over|Death|0|||
13461141|NCT00117598|26969605|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0|||
13461142|NCT00117598|26969606|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2|||
13461143|NCT00117598|26969607|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2|||
13461144|NCT00117598|26969608|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0|||
13461145|NCT00117598|26969609|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0|||
13461146|NCT00117598|26969605|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2|||
13461147|NCT00117598|26969606|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1|||
13461148|NCT00117598|26969607|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4|||
13461149|NCT00117598|26969608|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
13461150|NCT00117598|26969609|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
13461151|NCT00117598|26969605|FG000|Prior to Treatment Cross Over|Other|15|||
13461152|NCT00117598|26969606|FG001|Prior to Treatment Cross Over|Other|9|||
13461153|NCT00117598|26969607|FG002|Prior to Treatment Cross Over|Other|9|||
13461154|NCT00117598|26969608|FG003|Prior to Treatment Cross Over|Other|0|||
13461155|NCT00117598|26969609|FG004|Prior to Treatment Cross Over|Other|0|||
13461156|NCT00117598|26969605|FG000|After Treament Cross Over|Death|0|||
13461157|NCT00117598|26969606|FG001|After Treament Cross Over|Death|0|||
13461158|NCT00117598|26969607|FG002|After Treament Cross Over|Death|0|||
13461159|NCT00117598|26969608|FG003|After Treament Cross Over|Death|1|||
13461160|NCT00117598|26969609|FG004|After Treament Cross Over|Death|2|||
13461161|NCT00117598|26969605|FG000|After Treament Cross Over|Withdrawal by Subject|0|||
13461162|NCT00117598|26969606|FG001|After Treament Cross Over|Withdrawal by Subject|0|||
13461163|NCT00117598|26969607|FG002|After Treament Cross Over|Withdrawal by Subject|0|||
13461164|NCT00117598|26969608|FG003|After Treament Cross Over|Withdrawal by Subject|1|||
13461165|NCT00117598|26969609|FG004|After Treament Cross Over|Withdrawal by Subject|0|||
13461166|NCT00117598|26969605|FG000|After Treament Cross Over|Other|0|||
13461167|NCT00117598|26969606|FG001|After Treament Cross Over|Other|0|||
13461168|NCT00117598|26969607|FG002|After Treament Cross Over|Other|0|||
13461169|NCT00117598|26969608|FG003|After Treament Cross Over|Other|1|||
13461170|NCT00117598|26969609|FG004|After Treament Cross Over|Other|2|||
13461171|NCT00117572|26969646|FG000|Overall Study|Site withdrew before starting treatment|2|||
13461172|NCT00117572|26969647|FG001|Overall Study|Site withdrew before starting treatment|3|||
13461173|NCT00117572|26969646|FG000|Overall Study|Withdrawal by Subject|3|||
13461174|NCT00117572|26969647|FG001|Overall Study|Withdrawal by Subject|3|||
13461175|NCT00117572|26969646|FG000|Overall Study|Protocol Violation|1|||
13461176|NCT00117572|26969647|FG001|Overall Study|Protocol Violation|0|||
13461177|NCT00117507|26969660|FG000|Overall Study|Adverse Event|4|||
13461178|NCT00117507|26969660|FG000|Overall Study|Abnormal laboratory values|3|||
13461179|NCT00117507|26969660|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
13461180|NCT00117507|26969660|FG000|Overall Study|Patient withdrew consent|4|||
13461181|NCT00117507|26969660|FG000|Overall Study|Death|3|||
13461182|NCT00117338|26969685|FG000|Overall Study|Adverse Event|0|||
13461183|NCT00117338|26969686|FG001|Overall Study|Adverse Event|1|||
13461184|NCT00117338|26969685|FG000|Overall Study|Protocol Violation|3|||
13461185|NCT00117338|26969686|FG001|Overall Study|Protocol Violation|2|||
13461186|NCT00117338|26969685|FG000|Overall Study|Withdrawal by Subject|1|||
13461187|NCT00117338|26969686|FG001|Overall Study|Withdrawal by Subject|0|||
13461188|NCT00117338|26969685|FG000|Overall Study|Did not meet Inclusion Criteria|1|||
13461189|NCT00117338|26969686|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
13461190|NCT00117338|26969685|FG000|Overall Study|Lack of Efficacy|0|||
13461191|NCT00117338|26969686|FG001|Overall Study|Lack of Efficacy|1|||
13461192|NCT00117325|26969721|FG000|Overall Study|Adverse Event|3|||
13461193|NCT00117325|26969722|FG001|Overall Study|Adverse Event|3|||
13461194|NCT00117325|26969721|FG000|Overall Study|Lost to Follow-up|1|||
13461195|NCT00117325|26969722|FG001|Overall Study|Lost to Follow-up|1|||
13461196|NCT00117325|26969721|FG000|Overall Study|Protocol Violation|2|||
13461197|NCT00117325|26969722|FG001|Overall Study|Protocol Violation|3|||
13461198|NCT00117325|26969721|FG000|Overall Study|Withdrawal by Subject|3|||
13461199|NCT00117325|26969722|FG001|Overall Study|Withdrawal by Subject|2|||
13461200|NCT00117325|26969721|FG000|Overall Study|Lack of Efficacy|1|||
13461201|NCT00117325|26969722|FG001|Overall Study|Lack of Efficacy|0|||
13461202|NCT00117325|26969721|FG000|Overall Study|Use of prohibited medicine|1|||
13461203|NCT00117325|26969722|FG001|Overall Study|Use of prohibited medicine|2|||
13461204|NCT00117325|26969721|FG000|Overall Study|Early termination|1|||
13461205|NCT00117325|26969722|FG001|Overall Study|Early termination|1|||
13461206|NCT00117325|26969721|FG000|Overall Study|Admisnitrative|1|||
13461207|NCT00117325|26969722|FG001|Overall Study|Admisnitrative|0|||
13461208|NCT00117312|26969749|FG000|Overall Study|Testosterone >1.0 ng/mL|9|||
13461209|NCT00117312|26969750|FG001|Overall Study|Testosterone >1.0 ng/mL|9|||
13461210|NCT00117312|26969751|FG002|Overall Study|Testosterone >1.0 ng/mL|5|||
13461211|NCT00117312|26969752|FG003|Overall Study|Testosterone >1.0 ng/mL|9|||
13461212|NCT00117312|26969749|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
13461213|NCT00117312|26969750|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
13461214|NCT00117312|26969751|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
13461215|NCT00117312|26969752|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
13461216|NCT00117312|26969749|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
13461217|NCT00117312|26969750|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
13461218|NCT00117312|26969751|FG002|Overall Study|Prostate-specific antigen increase >=25%|5|||
13461219|NCT00117312|26969752|FG003|Overall Study|Prostate-specific antigen increase >=25%|3|||
13461220|NCT00117312|26969749|FG000|Overall Study|Other|0|||
13461221|NCT00117312|26969750|FG001|Overall Study|Other|1|||
13461222|NCT00117312|26969751|FG002|Overall Study|Other|3|||
13461223|NCT00117312|26969752|FG003|Overall Study|Other|1|||
13461224|NCT00117312|26969749|FG000|Overall Study|Patient choice|0|||
13461225|NCT00117312|26969750|FG001|Overall Study|Patient choice|0|||
13461226|NCT00117312|26969751|FG002|Overall Study|Patient choice|2|||
13461227|NCT00117312|26969752|FG003|Overall Study|Patient choice|1|||
13461228|NCT00117312|26969749|FG000|Overall Study|Adverse Event|0|||
13461229|NCT00117312|26969750|FG001|Overall Study|Adverse Event|2|||
13461230|NCT00117312|26969751|FG002|Overall Study|Adverse Event|0|||
13461231|NCT00117312|26969752|FG003|Overall Study|Adverse Event|0|||
13461232|NCT00117312|26969749|FG000|Overall Study|Protocol Violation|0|||
13461233|NCT00117312|26969750|FG001|Overall Study|Protocol Violation|1|||
13461234|NCT00117312|26969751|FG002|Overall Study|Protocol Violation|3|||
13461235|NCT00117312|26969752|FG003|Overall Study|Protocol Violation|0|||
13461236|NCT00117312|26969749|FG000|Overall Study|PSA decrease <=50%|0|||
13461237|NCT00117312|26969750|FG001|Overall Study|PSA decrease <=50%|2|||
13461238|NCT00117312|26969751|FG002|Overall Study|PSA decrease <=50%|2|||
13461239|NCT00117312|26969752|FG003|Overall Study|PSA decrease <=50%|4|||
13461240|NCT00117312|26969749|FG000|Overall Study|PSA increase >= 10ng/mL|0|||
13461241|NCT00117312|26969750|FG001|Overall Study|PSA increase >= 10ng/mL|1|||
13461242|NCT00117312|26969751|FG002|Overall Study|PSA increase >= 10ng/mL|1|||
13461243|NCT00117312|26969752|FG003|Overall Study|PSA increase >= 10ng/mL|0|||
13461244|NCT00117312|26969749|FG000|Overall Study|Hepatic abnormality|0|||
13461245|NCT00117312|26969750|FG001|Overall Study|Hepatic abnormality|1|||
13461246|NCT00117312|26969751|FG002|Overall Study|Hepatic abnormality|0|||
13461247|NCT00117312|26969752|FG003|Overall Study|Hepatic abnormality|1|||
13461248|NCT00117312|26969749|FG000|Overall Study|Withdrawal by Subject|0|||
13461249|NCT00117312|26969750|FG001|Overall Study|Withdrawal by Subject|2|||
13461250|NCT00117312|26969751|FG002|Overall Study|Withdrawal by Subject|0|||
13461251|NCT00117312|26969752|FG003|Overall Study|Withdrawal by Subject|0|||
13461252|NCT00117286|26969767|FG000|Overall Study|Adverse Event|12|||
13461253|NCT00117286|26969768|FG001|Overall Study|Adverse Event|6|||
13461254|NCT00117286|26969767|FG000|Overall Study|Lost to Follow-up|2|||
13461255|NCT00117286|26969768|FG001|Overall Study|Lost to Follow-up|0|||
13461256|NCT00117286|26969767|FG000|Overall Study|Protocol Violation|3|||
13461257|NCT00117286|26969768|FG001|Overall Study|Protocol Violation|3|||
13461258|NCT00117286|26969767|FG000|Overall Study|Withdrawal by Subject|6|||
13461259|NCT00117286|26969768|FG001|Overall Study|Withdrawal by Subject|2|||
13461260|NCT00117286|26969767|FG000|Overall Study|Physician Decision|3|||
13461261|NCT00117286|26969768|FG001|Overall Study|Physician Decision|7|||
13461262|NCT00117286|26969767|FG000|Overall Study|Lack of Efficacy|2|||
13461263|NCT00117286|26969768|FG001|Overall Study|Lack of Efficacy|1|||
13461264|NCT00117286|26969767|FG000|Overall Study|Research site closing|0|||
13461265|NCT00117286|26969768|FG001|Overall Study|Research site closing|2|||
13461266|NCT00117156|26969778|FG000|Overall Study|Adverse Event|9|||
13461267|NCT00117156|26969778|FG000|Overall Study|Physician Decision|1|||
13461268|NCT00117156|26969778|FG000|Overall Study|Trt for Pre-Exist Second Primary|1|||
13461269|NCT00116844|26969801|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
13461270|NCT00116844|26969802|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
13461271|NCT00116844|26969801|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0|||
13461272|NCT00116844|26969802|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1|||
13461273|NCT00116844|26969801|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5|||
13461274|NCT00116844|26969802|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0|||
13461275|NCT00116844|26969801|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1|||
13461276|NCT00116844|26969802|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1|||
13461277|NCT00116844|26969801|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1|||
13461278|NCT00116844|26969802|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0|||
13461279|NCT00116844|26969801|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2|||
13461280|NCT00116844|26969802|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1|||
13461281|NCT00116844|26969801|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0|||
13461282|NCT00116844|26969802|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2|||
13461283|NCT00116844|26969801|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0|||
13461284|NCT00116844|26969802|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1|||
13461285|NCT00116844|26969801|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
13461286|NCT00116844|26969802|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
13461287|NCT00116831|26969885|FG000|Overall Study|Adverse Event|14|||
13461288|NCT00116831|26969886|FG001|Overall Study|Adverse Event|16|||
13461289|NCT00116831|26969885|FG000|Overall Study|Baseline IVUS determined unevaluable|12|||
13461290|NCT00116831|26969886|FG001|Overall Study|Baseline IVUS determined unevaluable|11|||
13461291|NCT00116831|26969885|FG000|Overall Study|Lost to Follow-up|8|||
13461292|NCT00116831|26969886|FG001|Overall Study|Lost to Follow-up|6|||
13461293|NCT00116831|26969885|FG000|Overall Study|Protocol Violation|3|||
13461294|NCT00116831|26969886|FG001|Overall Study|Protocol Violation|6|||
13461295|NCT00116831|26969885|FG000|Overall Study|Hypoglycaemic events|1|||
13461296|NCT00116831|26969886|FG001|Overall Study|Hypoglycaemic events|0|||
13461297|NCT00116831|26969885|FG000|Overall Study|Low haemoglobin on screening|1|||
13461298|NCT00116831|26969886|FG001|Overall Study|Low haemoglobin on screening|0|||
13461299|NCT00116831|26969885|FG000|Overall Study|Withdrawn investigational product|1|||
13461300|NCT00116831|26969886|FG001|Overall Study|Withdrawn investigational product|0|||
13461301|NCT00116831|26969885|FG000|Overall Study|Withdrawal by Subject|32|||
13461302|NCT00116831|26969886|FG001|Overall Study|Withdrawal by Subject|32|||
13461303|NCT00116831|26969885|FG000|Overall Study|Insufficient therapeutic effect|0|||
13461304|NCT00116831|26969886|FG001|Overall Study|Insufficient therapeutic effect|1|||
13461305|NCT00116831|26969885|FG000|Overall Study|Missing data for participant|1|||
13461306|NCT00116831|26969886|FG001|Overall Study|Missing data for participant|0|||
13461307|NCT00116805|26969984|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6|||
13461308|NCT00116805|26969985|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2|||
13461309|NCT00116805|26969984|FG000|Double-blind Period Through Week 48|Protocol Violation|1|||
13461310|NCT00116805|26969985|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
13461311|NCT00116805|26969984|FG000|Double-blind Period Through Week 48|Withdrew Consent|4|||
13461312|NCT00116805|26969985|FG001|Double-blind Period Through Week 48|Withdrew Consent|2|||
13461313|NCT00116805|26969984|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1|||
13461314|NCT00116805|26969985|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0|||
13461315|NCT00116805|26969984|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2|||
13461316|NCT00116805|26969985|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0|||
13461317|NCT00116805|26969984|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2|||
13461318|NCT00116805|26969985|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0|||
13461319|NCT00116805|26969984|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
13461320|NCT00116805|26969985|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0|||
13461321|NCT00116805|26969984|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2|||
13461322|NCT00116805|26969985|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0|||
13461323|NCT00116805|26969984|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2|||
13461324|NCT00116805|26969985|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1|||
13461325|NCT00116805|26969984|FG000|Open-label Period Weeks 97 - 144|Completed Study|1|||
13461326|NCT00116805|26969985|FG001|Open-label Period Weeks 97 - 144|Completed Study|0|||
13461327|NCT00116805|26969984|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2|||
13461328|NCT00116805|26969985|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0|||
13461329|NCT00116805|26969984|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5|||
13461330|NCT00116805|26969985|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2|||
13461331|NCT00116805|26969984|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0|||
13461332|NCT00116805|26969985|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1|||
13461333|NCT00116805|26969984|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2|||
13461334|NCT00116805|26969985|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3|||
13461335|NCT00116805|26969984|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1|||
13461336|NCT00116805|26969985|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3|||
13461337|NCT00116805|26969984|FG000|Open-label Period Weeks 145 - 192|Completed Study|1|||
13461338|NCT00116805|26969985|FG001|Open-label Period Weeks 145 - 192|Completed Study|1|||
13461339|NCT00116805|26969984|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2|||
13461340|NCT00116805|26969985|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0|||
13461341|NCT00116805|26969984|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3|||
13461342|NCT00116805|26969985|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1|||
13461343|NCT00116805|26969984|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1|||
13461344|NCT00116805|26969985|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0|||
13461345|NCT00116805|26969984|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0|||
13461346|NCT00116805|26969985|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1|||
13461347|NCT00116805|26969984|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0|||
13461348|NCT00116805|26969985|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1|||
13461349|NCT00116805|26969984|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3|||
13461350|NCT00116805|26969985|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2|||
13461351|NCT00116805|26969984|FG000|Open-label Period Weeks 193 - 240|Completed Study|0|||
13461352|NCT00116805|26969985|FG001|Open-label Period Weeks 193 - 240|Completed Study|1|||
13461353|NCT00116805|26969984|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1|||
13461354|NCT00116805|26969985|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0|||
13461355|NCT00116805|26969984|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3|||
13461356|NCT00116805|26969985|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0|||
13461357|NCT00116805|26969984|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
13461358|NCT00116805|26969985|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
13461359|NCT00116805|26969984|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7|||
13461360|NCT00116805|26969985|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1|||
13461361|NCT00116805|26969984|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2|||
13461362|NCT00116805|26969985|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
13461363|NCT00116805|26969984|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4|||
13461364|NCT00116805|26969985|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0|||
13461365|NCT00116805|26969984|FG000|Open-label Period Weeks 289 - 336|Completed Study|0|||
13461366|NCT00116805|26969985|FG001|Open-label Period Weeks 289 - 336|Completed Study|1|||
13461367|NCT00116805|26969984|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3|||
13461368|NCT00116805|26969985|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2|||
13461369|NCT00116805|26969984|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
13461370|NCT00116805|26969985|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
13461371|NCT00116805|26969984|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0|||
13461372|NCT00116805|26969985|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1|||
13461373|NCT00116805|26969984|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0|||
13461374|NCT00116805|26969985|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1|||
13461375|NCT00116805|26969984|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0|||
13461376|NCT00116805|26969985|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1|||
13461377|NCT00116805|26969984|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2|||
13461378|NCT00116805|26969985|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0|||
13461379|NCT00116805|26969984|FG000|Open-label Period Weeks 337 - 384|Completed Study|1|||
13461380|NCT00116805|26969985|FG001|Open-label Period Weeks 337 - 384|Completed Study|0|||
13461381|NCT00116805|26969984|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1|||
13461382|NCT00116805|26969985|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0|||
13461383|NCT00116805|26969984|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2|||
13461384|NCT00116805|26969985|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0|||
13461385|NCT00116805|26969984|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1|||
13461386|NCT00116805|26969985|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0|||
13461387|NCT00116805|26969984|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3|||
13461388|NCT00116805|26969985|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1|||
13461389|NCT00116805|26969984|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1|||
13461390|NCT00116805|26969985|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0|||
13461391|NCT00116805|26969984|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1|||
13461392|NCT00116805|26969985|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0|||
13461393|NCT00116805|26969984|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1|||
13461394|NCT00116805|26969985|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0|||
13461395|NCT00116805|26969984|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3|||
13461396|NCT00116805|26969985|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0|||
13461397|NCT00116779|26970022|FG000|Overall Study|Adverse Event|4|||
13461398|NCT00116779|26970023|FG001|Overall Study|Adverse Event|2|||
13461399|NCT00116779|26970022|FG000|Overall Study|Protocol Violation|1|||
13461400|NCT00116779|26970023|FG001|Overall Study|Protocol Violation|4|||
13461401|NCT00116779|26970022|FG000|Overall Study|Withdrawal by Subject|4|||
13461402|NCT00116779|26970023|FG001|Overall Study|Withdrawal by Subject|1|||
13461403|NCT00116779|26970022|FG000|Overall Study|Inadequate testosterone suppression|7|||
13461404|NCT00116779|26970023|FG001|Overall Study|Inadequate testosterone suppression|9|||
13461405|NCT00116779|26970022|FG000|Overall Study|Physician Decision|3|||
13461406|NCT00116779|26970023|FG001|Overall Study|Physician Decision|1|||
13461407|NCT00116779|26970022|FG000|Overall Study|Elevated PSA levels|2|||
13461408|NCT00116779|26970023|FG001|Overall Study|Elevated PSA levels|2|||
13461409|NCT00116753|26970053|FG000|Overall Study|Adverse Event|16|||
13461410|NCT00116753|26970054|FG001|Overall Study|Adverse Event|10|||
13461411|NCT00116753|26970055|FG002|Overall Study|Adverse Event|7|||
13461412|NCT00116753|26970053|FG000|Overall Study|Withdrawal by Subject|11|||
13461413|NCT00116753|26970054|FG001|Overall Study|Withdrawal by Subject|12|||
13461414|NCT00116753|26970055|FG002|Overall Study|Withdrawal by Subject|8|||
13461415|NCT00116753|26970053|FG000|Overall Study|Lost to Follow-up|0|||
13461416|NCT00116753|26970054|FG001|Overall Study|Lost to Follow-up|2|||
13461417|NCT00116753|26970055|FG002|Overall Study|Lost to Follow-up|1|||
13461418|NCT00116753|26970053|FG000|Overall Study|Protocol Violation|0|||
13461419|NCT00116753|26970054|FG001|Overall Study|Protocol Violation|0|||
13461420|NCT00116753|26970055|FG002|Overall Study|Protocol Violation|1|||
13461421|NCT00116753|26970053|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1|||
13461422|NCT00116753|26970054|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1|||
13461423|NCT00116753|26970055|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3|||
13461424|NCT00116753|26970053|FG000|Overall Study|Disease Progression|3|||
13461425|NCT00116753|26970054|FG001|Overall Study|Disease Progression|4|||
13461426|NCT00116753|26970055|FG002|Overall Study|Disease Progression|3|||
13461427|NCT00116753|26970053|FG000|Overall Study|Abnormal Echocardiogram|0|||
13461428|NCT00116753|26970054|FG001|Overall Study|Abnormal Echocardiogram|0|||
13461429|NCT00116753|26970055|FG002|Overall Study|Abnormal Echocardiogram|1|||
13461430|NCT00116753|26970053|FG000|Overall Study|Progressive Parkinson's Disease|1|||
13461431|NCT00116753|26970054|FG001|Overall Study|Progressive Parkinson's Disease|0|||
13461432|NCT00116753|26970055|FG002|Overall Study|Progressive Parkinson's Disease|0|||
13461433|NCT00116753|26970053|FG000|Overall Study|Dosing Error|0|||
13461434|NCT00116753|26970054|FG001|Overall Study|Dosing Error|1|||
13461435|NCT00116753|26970055|FG002|Overall Study|Dosing Error|0|||
13461436|NCT00116688|26970077|FG000|Overall Study|Protocol deviation|1|||
13461437|NCT00116688|26970078|FG001|Overall Study|Protocol deviation|0|||
13461438|NCT00116688|26970077|FG000|Overall Study|Noncompliance|3|||
13461439|NCT00116688|26970078|FG001|Overall Study|Noncompliance|1|||
13461440|NCT00116688|26970077|FG000|Overall Study|Adverse Event|11|||
13461441|NCT00116688|26970078|FG001|Overall Study|Adverse Event|0|||
13461442|NCT00116688|26970077|FG000|Overall Study|Withdrawal by Subject|26|||
13461443|NCT00116688|26970078|FG001|Overall Study|Withdrawal by Subject|2|||
13461444|NCT00116688|26970077|FG000|Overall Study|Requirement for alternative therapy|11|||
13461445|NCT00116688|26970078|FG001|Overall Study|Requirement for alternative therapy|1|||
13461446|NCT00116688|26970077|FG000|Overall Study|Physician Decision|7|||
13461447|NCT00116688|26970078|FG001|Overall Study|Physician Decision|0|||
13461448|NCT00116688|26970077|FG000|Overall Study|Lost to Follow-up|3|||
13461449|NCT00116688|26970078|FG001|Overall Study|Lost to Follow-up|0|||
13461450|NCT00116688|26970077|FG000|Overall Study|Death|15|||
13461451|NCT00116688|26970078|FG001|Overall Study|Death|0|||
13461452|NCT00116688|26970077|FG000|Overall Study|Protocol-specified criteria|3|||
13461453|NCT00116688|26970078|FG001|Overall Study|Protocol-specified criteria|0|||
13461454|NCT00116688|26970077|FG000|Overall Study|Pregnancy|1|||
13461455|NCT00116688|26970078|FG001|Overall Study|Pregnancy|0|||
13461456|NCT00116688|26970077|FG000|Overall Study|Other|11|||
13461457|NCT00116688|26970078|FG001|Overall Study|Other|0|||
13461458|NCT00116649|26970085|FG000|Overall Study|Adverse Event|20|||
13461459|NCT00116649|26970085|FG000|Overall Study|Lack of Efficacy|1|||
13461460|NCT00116649|26970085|FG000|Overall Study|Lost to Follow-up|32|||
13461461|NCT00116649|26970085|FG000|Overall Study|Withdrawal by Subject|68|||
13461462|NCT00116649|26970085|FG000|Overall Study|Local Skin Reaction|9|||
13461463|NCT00116649|26970085|FG000|Overall Study|Various Reasons|18|||
13461464|NCT00116649|26970085|FG000|Overall Study|Protocol Specified|7|||
13461465|NCT00116584|26970102|FG000|Overall Study|Withdrawal by Subject|1|||
13461466|NCT00116584|26970103|FG001|Overall Study|Withdrawal by Subject|0|||
13461467|NCT00116584|26970102|FG000|Overall Study|Protocol Violation|1|||
13461468|NCT00116584|26970103|FG001|Overall Study|Protocol Violation|1|||
13461469|NCT00116558|26970122|FG000|Overall Study|Death|11|||
13461470|NCT00116558|26970123|FG001|Overall Study|Death|5|||
13461471|NCT00116558|26970124|FG002|Overall Study|Death|3|||
13461472|NCT00116558|26970122|FG000|Overall Study|Withdrawal by Subject|17|||
13461473|NCT00116558|26970123|FG001|Overall Study|Withdrawal by Subject|3|||
13461474|NCT00116558|26970124|FG002|Overall Study|Withdrawal by Subject|12|||
13461475|NCT00116558|26970122|FG000|Overall Study|disease progression|3|||
13461476|NCT00116558|26970123|FG001|Overall Study|disease progression|7|||
13461477|NCT00116558|26970124|FG002|Overall Study|disease progression|18|||
13461478|NCT00116428|26970147|FG000|Overall Study|Withdrawal by Subject|2|||
13461479|NCT00116428|26970148|FG001|Overall Study|Withdrawal by Subject|5|||
13461480|NCT00116428|26970147|FG000|Overall Study|Did not meet inclusion criteria|1|||
13461481|NCT00116428|26970148|FG001|Overall Study|Did not meet inclusion criteria|0|||
13461482|NCT00116272|26970205|FG000|Overall Study|Lost to Follow-up|11|||
13461483|NCT00116272|26970206|FG001|Overall Study|Lost to Follow-up|6|||
13461484|NCT00116168|26970281|FG000|Overall Study|Lost to Follow-up|6|||
13461485|NCT00116168|26970282|FG001|Overall Study|Lost to Follow-up|5|||
13461486|NCT00116168|26970283|FG002|Overall Study|Lost to Follow-up|0|||
13461487|NCT00116168|26970284|FG003|Overall Study|Lost to Follow-up|0|||
13461488|NCT00115934|26970329|FG000|Overall Study|Lost to Follow-up|1|||
13461489|NCT00115934|26970330|FG001|Overall Study|Lost to Follow-up|0|||
13461490|NCT00115934|26970329|FG000|Overall Study|Did not receive intervention|3|||
13461491|NCT00115934|26970330|FG001|Overall Study|Did not receive intervention|2|||
13461492|NCT00115804|26970343|FG000|Overall Study|Adverse Event|2|||
13461493|NCT00115778|26970362|FG000|Overall Study|Withdrawal by Subject|0|||
13461494|NCT00115778|26970363|FG001|Overall Study|Withdrawal by Subject|1|||
13461495|NCT00115765|26970414|FG000|Overall Study|Withdrawal by Subject|22|||
13461496|NCT00115765|26970415|FG001|Overall Study|Withdrawal by Subject|53|||
13461497|NCT00115765|26970416|FG002|Overall Study|Withdrawal by Subject|76|||
13461498|NCT00115765|26970417|FG003|Overall Study|Withdrawal by Subject|15|||
13461499|NCT00115765|26970414|FG000|Overall Study|Physician Decision|4|||
13461500|NCT00115765|26970415|FG001|Overall Study|Physician Decision|15|||
13461501|NCT00115765|26970416|FG002|Overall Study|Physician Decision|18|||
13461502|NCT00115765|26970417|FG003|Overall Study|Physician Decision|13|||
13461503|NCT00115765|26970414|FG000|Overall Study|Lost to Follow-up|3|||
13461504|NCT00115765|26970415|FG001|Overall Study|Lost to Follow-up|20|||
13461505|NCT00115765|26970416|FG002|Overall Study|Lost to Follow-up|18|||
13461506|NCT00115765|26970417|FG003|Overall Study|Lost to Follow-up|1|||
13461507|NCT00115765|26970414|FG000|Overall Study|Other|6|||
13461508|NCT00115765|26970415|FG001|Overall Study|Other|12|||
13461509|NCT00115765|26970416|FG002|Overall Study|Other|9|||
13461510|NCT00115765|26970417|FG003|Overall Study|Other|2|||
13461511|NCT00115739|26970426|FG000|Overall Study|Lost to Follow-up|3|||
13461512|NCT00115349|26970439|FG000|Overall Study|Study closed due to low enrollment.|11|||
13461513|NCT00115349|26970440|FG001|Overall Study|Study closed due to low enrollment.|9|||
13461514|NCT00115336|26970469|FG000|Overall Study|Hospital discharge before study drug|0|||
13461515|NCT00115336|26970470|FG001|Overall Study|Hospital discharge before study drug|1|||
13461516|NCT00115063|26970493|FG000|Overall Study|Lost to Follow-up|98|||
13461517|NCT00115063|26970494|FG001|Overall Study|Lost to Follow-up|104|||
13461518|NCT00115063|26970493|FG000|Overall Study|Death|1|||
13461519|NCT00115063|26970494|FG001|Overall Study|Death|0|||
13461520|NCT00115037|26970519|FG000|Phase1|Lost to Follow-up|16|||
13461521|NCT00115037|26970520|FG001|Phase1|Lost to Follow-up|23|||
13461522|NCT00115037|26970521|FG002|Phase1|Lost to Follow-up|0|||
13461523|NCT00115037|26970522|FG003|Phase1|Lost to Follow-up|0|||
13461524|NCT00115037|26970523|FG004|Phase1|Lost to Follow-up|0|||
13461525|NCT00115037|26970524|FG005|Phase1|Lost to Follow-up|0|||
13461526|NCT00115037|26970519|FG000|Phase1|Withdrawal by Subject|9|||
13461527|NCT00115037|26970520|FG001|Phase1|Withdrawal by Subject|4|||
13461528|NCT00115037|26970521|FG002|Phase1|Withdrawal by Subject|0|||
13461529|NCT00115037|26970522|FG003|Phase1|Withdrawal by Subject|0|||
13461530|NCT00115037|26970523|FG004|Phase1|Withdrawal by Subject|0|||
13461531|NCT00115037|26970524|FG005|Phase1|Withdrawal by Subject|0|||
13461532|NCT00115037|26970519|FG000|Phase2|Death|0|||
13461533|NCT00115037|26970520|FG001|Phase2|Death|0|||
13461534|NCT00115037|26970521|FG002|Phase2|Death|1|||
13461535|NCT00115037|26970522|FG003|Phase2|Death|0|||
13461536|NCT00115037|26970523|FG004|Phase2|Death|0|||
13461537|NCT00115037|26970524|FG005|Phase2|Death|1|||
13461538|NCT00115037|26970519|FG000|Phase2|Withdrawal by Subject|0|||
13461539|NCT00115037|26970520|FG001|Phase2|Withdrawal by Subject|0|||
13461540|NCT00115037|26970521|FG002|Phase2|Withdrawal by Subject|2|||
13461541|NCT00115037|26970522|FG003|Phase2|Withdrawal by Subject|1|||
13461542|NCT00115037|26970523|FG004|Phase2|Withdrawal by Subject|2|||
13461543|NCT00115037|26970524|FG005|Phase2|Withdrawal by Subject|1|||
13461544|NCT00115037|26970519|FG000|Phase2|Lost to Follow-up|0|||
13461545|NCT00115037|26970520|FG001|Phase2|Lost to Follow-up|0|||
13461546|NCT00115037|26970521|FG002|Phase2|Lost to Follow-up|12|||
13461547|NCT00115037|26970522|FG003|Phase2|Lost to Follow-up|14|||
13461548|NCT00115037|26970523|FG004|Phase2|Lost to Follow-up|4|||
13461549|NCT00115037|26970524|FG005|Phase2|Lost to Follow-up|10|||
13461550|NCT00114972|26970551|FG000|Overall Study|Withdrawal by Subject|40|||
13461551|NCT00114972|26970552|FG001|Overall Study|Withdrawal by Subject|7|||
13461552|NCT00114972|26970551|FG000|Overall Study|Lost to Follow-up|8|||
13461553|NCT00114972|26970552|FG001|Overall Study|Lost to Follow-up|5|||
13461554|NCT00114959|26970561|FG000|Overall Study|Lack of Efficacy|6|||
13461555|NCT00114959|26970561|FG000|Overall Study|Physician Decision|1|||
13461556|NCT00114959|26970561|FG000|Overall Study|Death|1|||
13461557|NCT00114777|26970645|FG000|Randomization to Month 36|Death|10|||
13461558|NCT00114777|26970646|FG001|Randomization to Month 36|Death|4|||
13461559|NCT00114777|26970647|FG002|Randomization to Month 36|Death|3|||
13461560|NCT00114777|26970645|FG000|Randomization to Month 36|No Longer Met Study Criteria|0|||
13461561|NCT00114777|26970646|FG001|Randomization to Month 36|No Longer Met Study Criteria|0|||
13461562|NCT00114777|26970647|FG002|Randomization to Month 36|No Longer Met Study Criteria|2|||
13461563|NCT00114777|26970645|FG000|Randomization to Month 36|Lack of Efficacy|19|||
13461564|NCT00114777|26970646|FG001|Randomization to Month 36|Lack of Efficacy|15|||
13461565|NCT00114777|26970647|FG002|Randomization to Month 36|Lack of Efficacy|17|||
13461566|NCT00114777|26970645|FG000|Randomization to Month 36|Poor or Non-Compliance|0|||
13461567|NCT00114777|26970646|FG001|Randomization to Month 36|Poor or Non-Compliance|0|||
13461568|NCT00114777|26970647|FG002|Randomization to Month 36|Poor or Non-Compliance|1|||
13461569|NCT00114777|26970645|FG000|Randomization to Month 36|Adverse Event|34|||
13461570|NCT00114777|26970646|FG001|Randomization to Month 36|Adverse Event|35|||
13461571|NCT00114777|26970647|FG002|Randomization to Month 36|Adverse Event|44|||
13461572|NCT00114777|26970645|FG000|Randomization to Month 36|Withdrawal by Subject|3|||
13461573|NCT00114777|26970646|FG001|Randomization to Month 36|Withdrawal by Subject|4|||
13461574|NCT00114777|26970647|FG002|Randomization to Month 36|Withdrawal by Subject|5|||
13461575|NCT00114777|26970645|FG000|Randomization to Month 36|Other|9|||
13461576|NCT00114777|26970646|FG001|Randomization to Month 36|Other|3|||
13461577|NCT00114777|26970647|FG002|Randomization to Month 36|Other|12|||
13461578|NCT00114777|26970645|FG000|Long-Term Extension to Month 84|Death|8|||
13461579|NCT00114777|26970646|FG001|Long-Term Extension to Month 84|Death|13|||
13461580|NCT00114777|26970647|FG002|Long-Term Extension to Month 84|Death|7|||
13461581|NCT00114777|26970645|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
13461582|NCT00114777|26970646|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0|||
13461583|NCT00114777|26970647|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
13461584|NCT00114777|26970645|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1|||
13461585|NCT00114777|26970646|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0|||
13461586|NCT00114777|26970647|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1|||
13461587|NCT00114777|26970645|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
13461588|NCT00114777|26970646|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
13461589|NCT00114777|26970647|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3|||
13461590|NCT00114777|26970645|FG000|Long-Term Extension to Month 84|Adverse Event|15|||
13461591|NCT00114777|26970646|FG001|Long-Term Extension to Month 84|Adverse Event|14|||
13461592|NCT00114777|26970647|FG002|Long-Term Extension to Month 84|Adverse Event|7|||
13461593|NCT00114777|26970645|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2|||
13461594|NCT00114777|26970646|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1|||
13461595|NCT00114777|26970647|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6|||
13461596|NCT00114777|26970645|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0|||
13461597|NCT00114777|26970646|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0|||
13461598|NCT00114777|26970647|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2|||
13461599|NCT00114777|26970645|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
13461600|NCT00114777|26970646|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
13461601|NCT00114777|26970647|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1|||
13461602|NCT00114777|26970645|FG000|Long-Term Extension to Month 84|Other|2|||
13461603|NCT00114777|26970646|FG001|Long-Term Extension to Month 84|Other|0|||
13461604|NCT00114777|26970647|FG002|Long-Term Extension to Month 84|Other|2|||
13461605|NCT00114738|26970664|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1|||
13461606|NCT00114738|26970665|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
13461607|NCT00114738|26970666|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
13461608|NCT00114738|26970664|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1|||
13461609|NCT00114738|26970665|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
13461610|NCT00114738|26970666|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
13461611|NCT00114738|26970664|FG000|Screening for Randomization|Neuropathy|17|||
13461612|NCT00114738|26970665|FG001|Screening for Randomization|Neuropathy|0|||
13461613|NCT00114738|26970666|FG002|Screening for Randomization|Neuropathy|0|||
13461614|NCT00114738|26970664|FG000|Screening for Randomization|Progressive disease|2|||
13461615|NCT00114738|26970665|FG001|Screening for Randomization|Progressive disease|0|||
13461616|NCT00114738|26970666|FG002|Screening for Randomization|Progressive disease|0|||
13461617|NCT00114738|26970664|FG000|Screening for Randomization|CNS Hemorrhage|1|||
13461618|NCT00114738|26970665|FG001|Screening for Randomization|CNS Hemorrhage|0|||
13461619|NCT00114738|26970666|FG002|Screening for Randomization|CNS Hemorrhage|0|||
13461620|NCT00114738|26970664|FG000|Screening for Randomization|Other|1|||
13461621|NCT00114738|26970665|FG001|Screening for Randomization|Other|0|||
13461622|NCT00114738|26970666|FG002|Screening for Randomization|Other|0|||
13461623|NCT00114634|26970682|FG000|Overall Study|failure to return forms|3|||
13461624|NCT00114530|26970794|FG000|Overall Study|Death|3|||
13461625|NCT00114530|26970795|FG001|Overall Study|Death|11|||
13461626|NCT00114530|26970794|FG000|Overall Study|Lost to Follow-up|1|||
13461627|NCT00114530|26970795|FG001|Overall Study|Lost to Follow-up|1|||
13461628|NCT00114530|26970794|FG000|Overall Study|Physician Decision|1|||
13461629|NCT00114530|26970795|FG001|Overall Study|Physician Decision|1|||
13461630|NCT00114530|26970794|FG000|Overall Study|Withdrawal by Subject|2|||
13461631|NCT00114530|26970795|FG001|Overall Study|Withdrawal by Subject|6|||
13461632|NCT00114530|26970794|FG000|Overall Study|Breast Cancer|1|||
13461633|NCT00114530|26970795|FG001|Overall Study|Breast Cancer|0|||
13461634|NCT00114530|26970794|FG000|Overall Study|Subject decision after endpoint failure|0|||
13461635|NCT00114530|26970795|FG001|Overall Study|Subject decision after endpoint failure|1|||
13461636|NCT00114530|26970794|FG000|Overall Study|Ineligible|1|||
13461637|NCT00114530|26970795|FG001|Overall Study|Ineligible|0|||
13461638|NCT00114244|26970812|FG000|Overall Study|Adverse Event|2|||
13461639|NCT00114244|26970813|FG001|Overall Study|Adverse Event|5|||
13461640|NCT00114244|26970812|FG000|Overall Study|Withdrawal by Subject|0|||
13461641|NCT00114244|26970813|FG001|Overall Study|Withdrawal by Subject|2|||
13461642|NCT00114231|26970829|FG000|Overall Study|No consent|2|||
13461643|NCT00114231|26970830|FG001|Overall Study|No consent|0|||
13461644|NCT00114231|26970829|FG000|Overall Study|QARC requirement not met|1|||
13461645|NCT00114231|26970830|FG001|Overall Study|QARC requirement not met|0|||
13461646|NCT00114231|26970829|FG000|Overall Study|Suspected metastatic disease|1|||
13461647|NCT00114231|26970830|FG001|Overall Study|Suspected metastatic disease|0|||
13461648|NCT00114231|26970829|FG000|Overall Study|No adenocarcinoma|1|||
13461649|NCT00114231|26970830|FG001|Overall Study|No adenocarcinoma|0|||
13461650|NCT00114231|26970829|FG000|Overall Study|Low creatinine clearance|0|||
13461651|NCT00114231|26970830|FG001|Overall Study|Low creatinine clearance|1|||
13461652|NCT00114231|26970829|FG000|Overall Study|Tumor size > 4cm|1|||
13461653|NCT00114231|26970830|FG001|Overall Study|Tumor size > 4cm|0|||
13461654|NCT00114231|26970829|FG000|Overall Study|Tumor fixed on digital exam|0|||
13461655|NCT00114231|26970830|FG001|Overall Study|Tumor fixed on digital exam|1|||
13461656|NCT00114231|26970829|FG000|Overall Study|No Absolute Neutrophil Count|2|||
13461657|NCT00114231|26970830|FG001|Overall Study|No Absolute Neutrophil Count|0|||
13461658|NCT00114231|26970829|FG000|Overall Study|Biopsy done after registration|1|||
13461659|NCT00114231|26970830|FG001|Overall Study|Biopsy done after registration|0|||
13461660|NCT00114218|26970837|FG000|Overall Study|Wrong Cell Type|2|||
13461661|NCT00114218|26970837|FG000|Overall Study|Wrong Primary|1|||
13461662|NCT00114218|26970837|FG000|Overall Study|Never Treated|1|||
13461663|NCT00114166|26970854|FG000|Overall Study|Wrong primary|0|||
13461664|NCT00114166|26970855|FG001|Overall Study|Wrong primary|1|||
13461665|NCT00114127|26970870|FG000|Overall Study|Adverse Event|2|||
13461666|NCT00114127|26970871|FG001|Overall Study|Adverse Event|1|||
13461667|NCT00114127|26970870|FG000|Overall Study|Lost to Follow-up|1|||
13461668|NCT00114127|26970871|FG001|Overall Study|Lost to Follow-up|0|||
13461669|NCT00114127|26970870|FG000|Overall Study|Withdrawal by Subject|1|||
13461670|NCT00114127|26970871|FG001|Overall Study|Withdrawal by Subject|3|||
13461671|NCT00113919|26970877|FG000|Overall Study|Physician Decision|8|||
13461672|NCT00113919|26970877|FG000|Overall Study|Death|6|||
13461673|NCT00113841|26970890|FG000|Overall Study|Disease progression|0|||
13461674|NCT00113841|26970891|FG001|Overall Study|Disease progression|2|||
13461675|NCT00113841|26970890|FG000|Overall Study|Non-compliant|1|||
13461676|NCT00113841|26970891|FG001|Overall Study|Non-compliant|0|||
13461677|NCT00113607|26970912|FG000|Overall Study|Adverse Event|40|||
13461678|NCT00113607|26970913|FG001|Overall Study|Adverse Event|71|||
13461679|NCT00113607|26970912|FG000|Overall Study|Death|8|||
13461680|NCT00113607|26970913|FG001|Overall Study|Death|8|||
13461681|NCT00113607|26970912|FG000|Overall Study|Withdrawal by Subject|50|||
13461682|NCT00113607|26970913|FG001|Overall Study|Withdrawal by Subject|58|||
13461683|NCT00113607|26970912|FG000|Overall Study|Lost to Follow-up|0|||
13461684|NCT00113607|26970913|FG001|Overall Study|Lost to Follow-up|2|||
13461685|NCT00113607|26970912|FG000|Overall Study|Disease Progression|180|||
13461686|NCT00113607|26970913|FG001|Overall Study|Disease Progression|142|||
13461687|NCT00113607|26970912|FG000|Overall Study|Complete Response (Confirmed)|14|||
13461688|NCT00113607|26970913|FG001|Overall Study|Complete Response (Confirmed)|24|||
13461689|NCT00113607|26970912|FG000|Overall Study|Other|43|||
13461690|NCT00113607|26970913|FG001|Overall Study|Other|32|||
13461691|NCT00113568|26970927|FG000|Overall Study|Adverse Event|97|||
13461692|NCT00113568|26970927|FG000|Overall Study|Death|1|||
13461693|NCT00113568|26970927|FG000|Overall Study|Lack of Efficacy|30|||
13461694|NCT00113568|26970927|FG000|Overall Study|Lost to Follow-up|156|||
13461695|NCT00113568|26970927|FG000|Overall Study|Protocol Violation|32|||
13461696|NCT00113568|26970927|FG000|Overall Study|Withdrawal by Subject|117|||
13461697|NCT00113568|26970927|FG000|Overall Study|Other|112|||
13461698|NCT00113555|26970939|FG000|Overall Study|Baseline Failure|59|||
13461699|NCT00113555|26970939|FG000|Overall Study|Permanently Explanted|7|||
13461700|NCT00113555|26970939|FG000|Overall Study|Death|1|||
13461701|NCT00113555|26970939|FG000|Overall Study|Missed Followup|4|||
13461702|NCT00113555|26970939|FG000|Overall Study|Lost to Follow-up|8|||
13461703|NCT00113529|26970974|FG000|Overall Study|Adverse Event|4|||
13461704|NCT00113529|26970974|FG000|Overall Study|Lack of Efficacy|20|||
13461705|NCT00113529|26970974|FG000|Overall Study|Decision of sponsor|6|||
13461706|NCT00113529|26970974|FG000|Overall Study|Withdrawal by Subject|4|||
13461707|NCT00113516|26971018|FG000|Part 1|Adverse Event|6|||
13461708|NCT00113516|26971019|FG001|Part 1|Adverse Event|0|||
13461709|NCT00113516|26971018|FG000|Part 1|Death|3|||
13461710|NCT00113516|26971019|FG001|Part 1|Death|0|||
13461711|NCT00113516|26971018|FG000|Part 1|Other|3|||
13461712|NCT00113516|26971019|FG001|Part 1|Other|0|||
13461713|NCT00113516|26971018|FG000|Part 1|Withdrawal by Subject|2|||
13461714|NCT00113516|26971019|FG001|Part 1|Withdrawal by Subject|0|||
13461715|NCT00113516|26971018|FG000|Part 1|Lack of Efficacy|2|||
13461716|NCT00113516|26971019|FG001|Part 1|Lack of Efficacy|0|||
13461717|NCT00113516|26971018|FG000|Part 1|Did Not Meet Entrance Criteria|1|||
13461718|NCT00113516|26971019|FG001|Part 1|Did Not Meet Entrance Criteria|0|||
13461719|NCT00113516|26971018|FG000|Part 1|Laboratory Abnormality|1|||
13461720|NCT00113516|26971019|FG001|Part 1|Laboratory Abnormality|0|||
13461721|NCT00113516|26971018|FG000|Part 1|Ongoing|1|||
13461722|NCT00113516|26971019|FG001|Part 1|Ongoing|0|||
13461723|NCT00113516|26971018|FG000|Part 1|Missing|65|||
13461724|NCT00113516|26971019|FG001|Part 1|Missing|0|||
13461725|NCT00113516|26971018|FG000|Part 2|Adverse Event|0|||
13461726|NCT00113516|26971019|FG001|Part 2|Adverse Event|16|||
13461727|NCT00113516|26971018|FG000|Part 2|Death|0|||
13461728|NCT00113516|26971019|FG001|Part 2|Death|5|||
13461729|NCT00113516|26971018|FG000|Part 2|Lack of Efficacy|0|||
13461730|NCT00113516|26971019|FG001|Part 2|Lack of Efficacy|37|||
13461731|NCT00113516|26971018|FG000|Part 2|Withdrawal by Subject|0|||
13461732|NCT00113516|26971019|FG001|Part 2|Withdrawal by Subject|3|||
13461733|NCT00113516|26971018|FG000|Part 2|Other|0|||
13461734|NCT00113516|26971019|FG001|Part 2|Other|3|||
13461735|NCT00113516|26971018|FG000|Part 2|Laboratory Abnormality|0|||
13461736|NCT00113516|26971019|FG001|Part 2|Laboratory Abnormality|1|||
13461737|NCT00113516|26971018|FG000|Part 2|Ongoing|0|||
13461738|NCT00113516|26971019|FG001|Part 2|Ongoing|1|||
13461739|NCT00113490|26971039|FG000|Overall Study|Withdrawal by Subject|1|||
13461740|NCT00113490|26971040|FG001|Overall Study|Withdrawal by Subject|3|||
13461741|NCT00113490|26971039|FG000|Overall Study|Lost to Follow-up|1|||
13461742|NCT00113490|26971040|FG001|Overall Study|Lost to Follow-up|0|||
13461743|NCT00113399|26971053|FG000|Overall Study|Death|1|||
13461744|NCT00113399|26971054|FG001|Overall Study|Death|1|||
13461745|NCT00113399|26971053|FG000|Overall Study|Withdrawal by Subject|1|||
13461746|NCT00113399|26971054|FG001|Overall Study|Withdrawal by Subject|2|||
13461747|NCT00113399|26971053|FG000|Overall Study|Complete Response|0|||
13461748|NCT00113399|26971054|FG001|Overall Study|Complete Response|1|||
13461749|NCT00113399|26971053|FG000|Overall Study|Other|0|||
13461750|NCT00113399|26971054|FG001|Overall Study|Other|1|||
13461751|NCT00113386|26971067|FG000|Overall Study|Withdrawal by Subject|1|||
13461752|NCT00113386|26971068|FG001|Overall Study|Withdrawal by Subject|0|||
13461753|NCT00113386|26971067|FG000|Overall Study|Physician Decision|0|||
13461754|NCT00113386|26971068|FG001|Overall Study|Physician Decision|1|||
13461755|NCT00113386|26971067|FG000|Overall Study|Toxicity|3|||
13461756|NCT00113386|26971068|FG001|Overall Study|Toxicity|0|||
13461757|NCT00113386|26971067|FG000|Overall Study|Ineligible|1|||
13461758|NCT00113386|26971068|FG001|Overall Study|Ineligible|2|||
13461759|NCT00113386|26971067|FG000|Overall Study|Unknown - Lost to Follow-Up|2|||
13461760|NCT00113386|26971068|FG001|Overall Study|Unknown - Lost to Follow-Up|1|||
13461761|NCT00113373|26971085|FG000|Overall Study|Ineligible: wrong primary|1|||
13461762|NCT00113373|26971085|FG000|Overall Study|Ineligible: second primary|1|||
13461763|NCT00113373|26971085|FG000|Overall Study|Never Treated|1|||
13461764|NCT00113360|26971091|FG000|Overall Study|Adverse Event|3|||
13461765|NCT00113360|26971091|FG000|Overall Study|Subject required surgery|1|||
13461766|NCT00113360|26971091|FG000|Overall Study|Did not meet eligibility criteria|3|||
13461767|NCT00113295|26971113|FG000|Overall Study|Adverse Event|4|||
13461768|NCT00113295|26971114|FG001|Overall Study|Adverse Event|1|||
13461769|NCT00113295|26971113|FG000|Overall Study|Unrelated Medical Illness|1|||
13461770|NCT00113295|26971114|FG001|Overall Study|Unrelated Medical Illness|0|||
13461771|NCT00113269|26971177|FG000|Overall Study|Not transplanted, donor issues|4|||
13461772|NCT00113269|26971178|FG001|Overall Study|Not transplanted, donor issues|0|||
13461773|NCT00113269|26971179|FG002|Overall Study|Not transplanted, donor issues|2|||
13461774|NCT00113269|26971180|FG003|Overall Study|Not transplanted, donor issues|2|||
13461775|NCT00113269|26971177|FG000|Overall Study|Not transplanted, recipient issues|2|||
13461776|NCT00113269|26971178|FG001|Overall Study|Not transplanted, recipient issues|1|||
13461777|NCT00113269|26971179|FG002|Overall Study|Not transplanted, recipient issues|7|||
13461778|NCT00113269|26971180|FG003|Overall Study|Not transplanted, recipient issues|4|||
13461779|NCT00113269|26971177|FG000|Overall Study|Early graft loss, technical|0|||
13461780|NCT00113269|26971178|FG001|Overall Study|Early graft loss, technical|0|||
13461781|NCT00113269|26971179|FG002|Overall Study|Early graft loss, technical|2|||
13461782|NCT00113269|26971180|FG003|Overall Study|Early graft loss, technical|0|||
13461783|NCT00113269|26971177|FG000|Overall Study|Death in operating room|0|||
13461784|NCT00113269|26971178|FG001|Overall Study|Death in operating room|0|||
13461785|NCT00113269|26971179|FG002|Overall Study|Death in operating room|0|||
13461786|NCT00113269|26971180|FG003|Overall Study|Death in operating room|1|||
13461787|NCT00113269|26971177|FG000|Overall Study|Did not meet eligibility - pre-treatment|0|||
13461788|NCT00113269|26971178|FG001|Overall Study|Did not meet eligibility - pre-treatment|0|||
13461789|NCT00113269|26971179|FG002|Overall Study|Did not meet eligibility - pre-treatment|0|||
13461790|NCT00113269|26971180|FG003|Overall Study|Did not meet eligibility - pre-treatment|2|||
13461791|NCT00113269|26971177|FG000|Overall Study|Adverse Event|2|||
13461792|NCT00113269|26971178|FG001|Overall Study|Adverse Event|7|||
13461793|NCT00113269|26971179|FG002|Overall Study|Adverse Event|11|||
13461794|NCT00113269|26971180|FG003|Overall Study|Adverse Event|7|||
13461795|NCT00113269|26971177|FG000|Overall Study|Withdrawal by Subject|4|||
13461796|NCT00113269|26971178|FG001|Overall Study|Withdrawal by Subject|3|||
13461797|NCT00113269|26971179|FG002|Overall Study|Withdrawal by Subject|4|||
13461798|NCT00113269|26971180|FG003|Overall Study|Withdrawal by Subject|2|||
13461799|NCT00113269|26971177|FG000|Overall Study|Graft loss|6|||
13461800|NCT00113269|26971178|FG001|Overall Study|Graft loss|6|||
13461801|NCT00113269|26971179|FG002|Overall Study|Graft loss|4|||
13461802|NCT00113269|26971180|FG003|Overall Study|Graft loss|9|||
13461803|NCT00113269|26971177|FG000|Overall Study|Protocol Violation|1|||
13461804|NCT00113269|26971178|FG001|Overall Study|Protocol Violation|0|||
13461805|NCT00113269|26971179|FG002|Overall Study|Protocol Violation|4|||
13461806|NCT00113269|26971180|FG003|Overall Study|Protocol Violation|2|||
13461807|NCT00113269|26971177|FG000|Overall Study|Lost to Follow-up|2|||
13461808|NCT00113269|26971178|FG001|Overall Study|Lost to Follow-up|3|||
13461809|NCT00113269|26971179|FG002|Overall Study|Lost to Follow-up|6|||
13461810|NCT00113269|26971180|FG003|Overall Study|Lost to Follow-up|3|||
13461811|NCT00113269|26971177|FG000|Overall Study|Sponsor elected to discontinue patient|1|||
13461812|NCT00113269|26971178|FG001|Overall Study|Sponsor elected to discontinue patient|0|||
13461813|NCT00113269|26971179|FG002|Overall Study|Sponsor elected to discontinue patient|0|||
13461814|NCT00113269|26971180|FG003|Overall Study|Sponsor elected to discontinue patient|1|||
13461815|NCT00113269|26971177|FG000|Overall Study|Discontinued due to rejection|0|||
13461816|NCT00113269|26971178|FG001|Overall Study|Discontinued due to rejection|0|||
13461817|NCT00113269|26971179|FG002|Overall Study|Discontinued due to rejection|1|||
13461818|NCT00113269|26971180|FG003|Overall Study|Discontinued due to rejection|0|||
13461819|NCT00113269|26971177|FG000|Overall Study|Moved|0|||
13461820|NCT00113269|26971178|FG001|Overall Study|Moved|1|||
13461821|NCT00113269|26971179|FG002|Overall Study|Moved|0|||
13461822|NCT00113269|26971180|FG003|Overall Study|Moved|3|||
13461823|NCT00113269|26971177|FG000|Overall Study|Received pancreas transplant|0|||
13461824|NCT00113269|26971178|FG001|Overall Study|Received pancreas transplant|0|||
13461825|NCT00113269|26971179|FG002|Overall Study|Received pancreas transplant|0|||
13461826|NCT00113269|26971180|FG003|Overall Study|Received pancreas transplant|2|||
13461827|NCT00113269|26971177|FG000|Overall Study|Withdrew consent, Prednisone initiated|0|||
13461828|NCT00113269|26971178|FG001|Overall Study|Withdrew consent, Prednisone initiated|0|||
13461829|NCT00113269|26971179|FG002|Overall Study|Withdrew consent, Prednisone initiated|0|||
13461830|NCT00113269|26971180|FG003|Overall Study|Withdrew consent, Prednisone initiated|1|||
13461831|NCT00113269|26971177|FG000|Overall Study|Did not meet eligibility criteria|1|||
13461832|NCT00113269|26971178|FG001|Overall Study|Did not meet eligibility criteria|0|||
13461833|NCT00113269|26971179|FG002|Overall Study|Did not meet eligibility criteria|0|||
13461834|NCT00113269|26971180|FG003|Overall Study|Did not meet eligibility criteria|1|||
13461835|NCT00113269|26971177|FG000|Overall Study|Unable to return for follow up|2|||
13461836|NCT00113269|26971178|FG001|Overall Study|Unable to return for follow up|1|||
13461837|NCT00113269|26971179|FG002|Overall Study|Unable to return for follow up|0|||
13461838|NCT00113269|26971180|FG003|Overall Study|Unable to return for follow up|0|||
13461839|NCT00113087|26971249|FG000|Overall Study|Death or Transplant|14|||
13461840|NCT00113087|26971250|FG001|Overall Study|Death or Transplant|16|||
13461841|NCT00113087|26971249|FG000|Overall Study|Family or MD withdrew subject|10|||
13461842|NCT00113087|26971250|FG001|Overall Study|Family or MD withdrew subject|5|||
13461843|NCT00112905|26971259|FG000|Overall Study|Adverse Event|4|||
13461844|NCT00112905|26971259|FG000|Overall Study|Death|1|||
13461845|NCT00112905|26971259|FG000|Overall Study|Ineligibility|5|||
13461846|NCT00112905|26971259|FG000|Overall Study|Alternative treatment|1|||
13461847|NCT00112905|26971259|FG000|Overall Study|performance status was deteiorating|1|||
13461848|NCT00112866|26971285|FG000|Overall Study|Protocol Violation|1|||
13461849|NCT00112866|26971286|FG001|Overall Study|Protocol Violation|0|||
13461850|NCT00112866|26971285|FG000|Overall Study|did not start treatment post-op|1|||
13461851|NCT00112866|26971286|FG001|Overall Study|did not start treatment post-op|2|||
13461852|NCT00112736|26971308|FG000|Overall Study|1 pt never had had RX due rapid decline|1|||
13461853|NCT00112736|26971309|FG001|Overall Study|1 pt never had had RX due rapid decline|0|||
13461854|NCT00112580|26971321|FG000|Overall Study|Adverse Event|1|||
13461855|NCT00112580|26971322|FG001|Overall Study|Adverse Event|2|||
13461856|NCT00112580|26971321|FG000|Overall Study|Disease progression|5|||
13461857|NCT00112580|26971322|FG001|Overall Study|Disease progression|16|||
13461858|NCT00112580|26971321|FG000|Overall Study|Participant withdrew consent|2|||
13461859|NCT00112580|26971322|FG001|Overall Study|Participant withdrew consent|1|||
13461860|NCT00112502|26971389|FG000|Overall Study|Withdrawal by Subject|0|||
13461861|NCT00112502|26971390|FG001|Overall Study|Withdrawal by Subject|1|||
13461862|NCT00112502|26971391|FG002|Overall Study|Withdrawal by Subject|1|||
13461863|NCT00112502|26971392|FG003|Overall Study|Withdrawal by Subject|4|||
13461864|NCT00112502|26971393|FG004|Overall Study|Withdrawal by Subject|2|||
13461865|NCT00112502|26971394|FG005|Overall Study|Withdrawal by Subject|5|||
13461866|NCT00112502|26971395|FG006|Overall Study|Withdrawal by Subject|3|||
13461867|NCT00112502|26971396|FG007|Overall Study|Withdrawal by Subject|7|||
13461868|NCT00112489|26971408|FG000|Overall Study|Refused further treatment|8|||
13461869|NCT00112489|26971408|FG000|Overall Study|Adverse Event|12|||
13461870|NCT00112489|26971408|FG000|Overall Study|Death|2|||
13461871|NCT00112489|26971408|FG000|Overall Study|Other, Not Specified|9|||
13461872|NCT00112489|26971408|FG000|Overall Study|Patient never treated|2|||
13461873|NCT00112489|26971408|FG000|Overall Study|Ineligible|7|||
13461874|NCT00112463|26971417|FG000|Overall Study|Physician Decision|1|||
13461875|NCT00112463|26971417|FG000|Overall Study|Progression|30|||
13461876|NCT00112463|26971417|FG000|Overall Study|Second Primary|1|||
13461877|NCT00112463|26971417|FG000|Overall Study|Toxicity|3|||
13461878|NCT00112463|26971417|FG000|Overall Study|Withdrawal by Subject|2|||
13461879|NCT00112463|26971417|FG000|Overall Study|Never started treatment|2|||
13461880|NCT00112437|26971732|FG000|Year 1 (12-Month Base Study)|Adverse Event|9|||
13461881|NCT00112437|26971733|FG001|Year 1 (12-Month Base Study)|Adverse Event|10|||
13461882|NCT00112437|26971734|FG002|Year 1 (12-Month Base Study)|Adverse Event|6|||
13461883|NCT00112437|26971735|FG003|Year 1 (12-Month Base Study)|Adverse Event|4|||
13461884|NCT00112437|26971736|FG004|Year 1 (12-Month Base Study)|Adverse Event|3|||
13461885|NCT00112437|26971737|FG005|Year 1 (12-Month Base Study)|Adverse Event|0|||
13461886|NCT00112437|26971738|FG006|Year 1 (12-Month Base Study)|Adverse Event|0|||
13461887|NCT00112437|26971739|FG007|Year 1 (12-Month Base Study)|Adverse Event|0|||
13461888|NCT00112437|26971740|FG008|Year 1 (12-Month Base Study)|Adverse Event|0|||
13461889|NCT00112437|26971741|FG009|Year 1 (12-Month Base Study)|Adverse Event|0|||
13461890|NCT00112437|26971742|FG010|Year 1 (12-Month Base Study)|Adverse Event|0|||
13461891|NCT00112437|26971743|FG011|Year 1 (12-Month Base Study)|Adverse Event|0|||
13461892|NCT00112437|26971744|FG012|Year 1 (12-Month Base Study)|Adverse Event|0|||
13461893|NCT00112437|26971745|FG013|Year 1 (12-Month Base Study)|Adverse Event|0|||
13461894|NCT00112437|26971746|FG014|Year 1 (12-Month Base Study)|Adverse Event|0|||
13461895|NCT00112437|26971747|FG015|Year 1 (12-Month Base Study)|Adverse Event|0|||
13461896|NCT00112437|26971748|FG016|Year 1 (12-Month Base Study)|Adverse Event|0|||
13461897|NCT00112437|26971749|FG017|Year 1 (12-Month Base Study)|Adverse Event|0|||
13461898|NCT00112437|26971750|FG018|Year 1 (12-Month Base Study)|Adverse Event|0|||
13461899|NCT00112437|26971751|FG019|Year 1 (12-Month Base Study)|Adverse Event|0|||
13461900|NCT00112437|26971752|FG020|Year 1 (12-Month Base Study)|Adverse Event|0|||
13461901|NCT00112437|26971753|FG021|Year 1 (12-Month Base Study)|Adverse Event|0|||
13461902|NCT00112437|26971754|FG022|Year 1 (12-Month Base Study)|Adverse Event|0|||
13461903|NCT00112437|26971755|FG023|Year 1 (12-Month Base Study)|Adverse Event|0|||
13461904|NCT00112437|26971756|FG024|Year 1 (12-Month Base Study)|Adverse Event|0|||
13461905|NCT00112437|26971757|FG025|Year 1 (12-Month Base Study)|Adverse Event|0|||
13461906|NCT00112437|26971732|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
13461907|NCT00112437|26971733|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1|||
13461908|NCT00112437|26971734|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
13461909|NCT00112437|26971735|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
13461910|NCT00112437|26971736|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
13461911|NCT00112437|26971737|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
13461912|NCT00112437|26971738|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
13461913|NCT00112437|26971739|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
13461914|NCT00112437|26971740|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
13461915|NCT00112437|26971741|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
13461916|NCT00112437|26971742|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
13461917|NCT00112437|26971743|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
13461918|NCT00112437|26971744|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
13461919|NCT00112437|26971745|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
13461920|NCT00112437|26971746|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
13461921|NCT00112437|26971747|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
13461922|NCT00112437|26971748|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
13461923|NCT00112437|26971749|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
13461924|NCT00112437|26971750|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
13461925|NCT00112437|26971751|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
13461926|NCT00112437|26971752|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
13461927|NCT00112437|26971753|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
13461928|NCT00112437|26971754|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
13461929|NCT00112437|26971755|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
13461930|NCT00112437|26971756|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
13461931|NCT00112437|26971757|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
13461932|NCT00112437|26971732|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
13461933|NCT00112437|26971733|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1|||
13461934|NCT00112437|26971734|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
13461935|NCT00112437|26971735|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
13461936|NCT00112437|26971736|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
13461937|NCT00112437|26971737|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
13461938|NCT00112437|26971738|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
13461939|NCT00112437|26971739|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
13461940|NCT00112437|26971740|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
13461941|NCT00112437|26971741|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
13461942|NCT00112437|26971742|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
13461943|NCT00112437|26971743|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
13461944|NCT00112437|26971744|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
13461945|NCT00112437|26971745|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
13461946|NCT00112437|26971746|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
13461947|NCT00112437|26971747|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
13461948|NCT00112437|26971748|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
13461949|NCT00112437|26971749|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
13461950|NCT00112437|26971750|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
13461951|NCT00112437|26971751|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
13461952|NCT00112437|26971752|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
13461953|NCT00112437|26971753|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
13461954|NCT00112437|26971754|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
13461955|NCT00112437|26971755|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
13461956|NCT00112437|26971756|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
13461957|NCT00112437|26971757|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
13461958|NCT00112437|26971732|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1|||
13461959|NCT00112437|26971733|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0|||
13461960|NCT00112437|26971734|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3|||
13461961|NCT00112437|26971735|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1|||
13461962|NCT00112437|26971736|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1|||
13461963|NCT00112437|26971737|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0|||
13461964|NCT00112437|26971738|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0|||
13461965|NCT00112437|26971739|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0|||
13461966|NCT00112437|26971740|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0|||
13461967|NCT00112437|26971741|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0|||
13461968|NCT00112437|26971742|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0|||
13461969|NCT00112437|26971743|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0|||
13461970|NCT00112437|26971744|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0|||
13461971|NCT00112437|26971745|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0|||
13461972|NCT00112437|26971746|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0|||
13461973|NCT00112437|26971747|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0|||
13461974|NCT00112437|26971748|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0|||
13461975|NCT00112437|26971749|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0|||
13461976|NCT00112437|26971750|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0|||
13461977|NCT00112437|26971751|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0|||
13461978|NCT00112437|26971752|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0|||
13461979|NCT00112437|26971753|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0|||
13461980|NCT00112437|26971754|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0|||
13461981|NCT00112437|26971755|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0|||
13461982|NCT00112437|26971756|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0|||
13461983|NCT00112437|26971757|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0|||
13461984|NCT00112437|26971732|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
13461985|NCT00112437|26971733|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
13461986|NCT00112437|26971734|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2|||
13461987|NCT00112437|26971735|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1|||
13461988|NCT00112437|26971736|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7|||
13461989|NCT00112437|26971737|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
13461990|NCT00112437|26971738|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
13461991|NCT00112437|26971739|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
13461992|NCT00112437|26971740|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
13461993|NCT00112437|26971741|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
13461994|NCT00112437|26971742|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
13461995|NCT00112437|26971743|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
13461996|NCT00112437|26971744|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
13461997|NCT00112437|26971745|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
13461998|NCT00112437|26971746|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
13461999|NCT00112437|26971747|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
13462000|NCT00112437|26971748|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
13462001|NCT00112437|26971749|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
13462002|NCT00112437|26971750|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
13462003|NCT00112437|26971751|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
13462004|NCT00112437|26971752|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
13462005|NCT00112437|26971753|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
13462006|NCT00112437|26971754|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
13462007|NCT00112437|26971755|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
13462008|NCT00112437|26971756|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
13462009|NCT00112437|26971757|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
13462010|NCT00112437|26971732|FG000|Year 1 (12-Month Base Study)|moved|0|||
13462011|NCT00112437|26971733|FG001|Year 1 (12-Month Base Study)|moved|1|||
13462012|NCT00112437|26971734|FG002|Year 1 (12-Month Base Study)|moved|1|||
13462013|NCT00112437|26971735|FG003|Year 1 (12-Month Base Study)|moved|0|||
13462014|NCT00112437|26971736|FG004|Year 1 (12-Month Base Study)|moved|0|||
13462015|NCT00112437|26971737|FG005|Year 1 (12-Month Base Study)|moved|0|||
13462016|NCT00112437|26971738|FG006|Year 1 (12-Month Base Study)|moved|0|||
13462017|NCT00112437|26971739|FG007|Year 1 (12-Month Base Study)|moved|0|||
13462018|NCT00112437|26971740|FG008|Year 1 (12-Month Base Study)|moved|0|||
13462019|NCT00112437|26971741|FG009|Year 1 (12-Month Base Study)|moved|0|||
13462020|NCT00112437|26971742|FG010|Year 1 (12-Month Base Study)|moved|0|||
13462021|NCT00112437|26971743|FG011|Year 1 (12-Month Base Study)|moved|0|||
13462022|NCT00112437|26971744|FG012|Year 1 (12-Month Base Study)|moved|0|||
13462023|NCT00112437|26971745|FG013|Year 1 (12-Month Base Study)|moved|0|||
13462024|NCT00112437|26971746|FG014|Year 1 (12-Month Base Study)|moved|0|||
13462025|NCT00112437|26971747|FG015|Year 1 (12-Month Base Study)|moved|0|||
13462026|NCT00112437|26971748|FG016|Year 1 (12-Month Base Study)|moved|0|||
13462027|NCT00112437|26971749|FG017|Year 1 (12-Month Base Study)|moved|0|||
13462028|NCT00112437|26971750|FG018|Year 1 (12-Month Base Study)|moved|0|||
13462029|NCT00112437|26971751|FG019|Year 1 (12-Month Base Study)|moved|0|||
13462030|NCT00112437|26971752|FG020|Year 1 (12-Month Base Study)|moved|0|||
13462031|NCT00112437|26971753|FG021|Year 1 (12-Month Base Study)|moved|0|||
13462032|NCT00112437|26971754|FG022|Year 1 (12-Month Base Study)|moved|0|||
13462033|NCT00112437|26971755|FG023|Year 1 (12-Month Base Study)|moved|0|||
13462034|NCT00112437|26971756|FG024|Year 1 (12-Month Base Study)|moved|0|||
13462035|NCT00112437|26971757|FG025|Year 1 (12-Month Base Study)|moved|0|||
13462036|NCT00112437|26971732|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
13462037|NCT00112437|26971733|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
13462038|NCT00112437|26971734|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
13462039|NCT00112437|26971735|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2|||
13462040|NCT00112437|26971736|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
13462041|NCT00112437|26971737|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
13462042|NCT00112437|26971738|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
13462043|NCT00112437|26971739|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
13462044|NCT00112437|26971740|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
13462045|NCT00112437|26971741|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
13462046|NCT00112437|26971742|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
13462047|NCT00112437|26971743|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
13462048|NCT00112437|26971744|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
13462049|NCT00112437|26971745|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
13462050|NCT00112437|26971746|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
13462051|NCT00112437|26971747|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
13462052|NCT00112437|26971748|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
13462053|NCT00112437|26971749|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
13462054|NCT00112437|26971750|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
13462055|NCT00112437|26971751|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
13462056|NCT00112437|26971752|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
13462057|NCT00112437|26971753|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
13462058|NCT00112437|26971754|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
13462059|NCT00112437|26971755|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
13462060|NCT00112437|26971756|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
13462061|NCT00112437|26971757|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
13462062|NCT00112437|26971732|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
13462063|NCT00112437|26971733|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
13462064|NCT00112437|26971734|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
13462065|NCT00112437|26971735|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
13462066|NCT00112437|26971736|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1|||
13462067|NCT00112437|26971737|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
13462068|NCT00112437|26971738|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
13462069|NCT00112437|26971739|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
13462070|NCT00112437|26971740|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
13462071|NCT00112437|26971741|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
13462072|NCT00112437|26971742|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
13462073|NCT00112437|26971743|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
13462074|NCT00112437|26971744|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
13462075|NCT00112437|26971745|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
13462076|NCT00112437|26971746|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
13462077|NCT00112437|26971747|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
13462078|NCT00112437|26971748|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
13462079|NCT00112437|26971749|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
13462080|NCT00112437|26971750|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
13462081|NCT00112437|26971751|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
13462082|NCT00112437|26971752|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
13462083|NCT00112437|26971753|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
13462084|NCT00112437|26971754|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
13462085|NCT00112437|26971755|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
13462086|NCT00112437|26971756|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
13462087|NCT00112437|26971757|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
13462088|NCT00112437|26971732|FG000|Year 2 (12-Month Extension)|Adverse Event|0|||
13462089|NCT00112437|26971733|FG001|Year 2 (12-Month Extension)|Adverse Event|0|||
13462090|NCT00112437|26971734|FG002|Year 2 (12-Month Extension)|Adverse Event|0|||
13462091|NCT00112437|26971735|FG003|Year 2 (12-Month Extension)|Adverse Event|0|||
13462092|NCT00112437|26971736|FG004|Year 2 (12-Month Extension)|Adverse Event|0|||
13462093|NCT00112437|26971737|FG005|Year 2 (12-Month Extension)|Adverse Event|1|||
13462094|NCT00112437|26971738|FG006|Year 2 (12-Month Extension)|Adverse Event|2|||
13462095|NCT00112437|26971739|FG007|Year 2 (12-Month Extension)|Adverse Event|6|||
13462096|NCT00112437|26971740|FG008|Year 2 (12-Month Extension)|Adverse Event|1|||
13462097|NCT00112437|26971741|FG009|Year 2 (12-Month Extension)|Adverse Event|7|||
13462098|NCT00112437|26971742|FG010|Year 2 (12-Month Extension)|Adverse Event|0|||
13462099|NCT00112437|26971743|FG011|Year 2 (12-Month Extension)|Adverse Event|0|||
13462100|NCT00112437|26971744|FG012|Year 2 (12-Month Extension)|Adverse Event|0|||
13462101|NCT00112437|26971745|FG013|Year 2 (12-Month Extension)|Adverse Event|0|||
13462102|NCT00112437|26971746|FG014|Year 2 (12-Month Extension)|Adverse Event|0|||
13462103|NCT00112437|26971747|FG015|Year 2 (12-Month Extension)|Adverse Event|0|||
13462104|NCT00112437|26971748|FG016|Year 2 (12-Month Extension)|Adverse Event|0|||
13462105|NCT00112437|26971749|FG017|Year 2 (12-Month Extension)|Adverse Event|0|||
13462106|NCT00112437|26971750|FG018|Year 2 (12-Month Extension)|Adverse Event|0|||
13462107|NCT00112437|26971751|FG019|Year 2 (12-Month Extension)|Adverse Event|0|||
13462108|NCT00112437|26971752|FG020|Year 2 (12-Month Extension)|Adverse Event|0|||
13462109|NCT00112437|26971753|FG021|Year 2 (12-Month Extension)|Adverse Event|0|||
13462110|NCT00112437|26971754|FG022|Year 2 (12-Month Extension)|Adverse Event|0|||
13462111|NCT00112437|26971755|FG023|Year 2 (12-Month Extension)|Adverse Event|0|||
13462112|NCT00112437|26971756|FG024|Year 2 (12-Month Extension)|Adverse Event|0|||
13462113|NCT00112437|26971757|FG025|Year 2 (12-Month Extension)|Adverse Event|0|||
13462114|NCT00112437|26971732|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
13462115|NCT00112437|26971733|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
13462116|NCT00112437|26971734|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
13462117|NCT00112437|26971735|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
13462118|NCT00112437|26971736|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
13462119|NCT00112437|26971737|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1|||
13462120|NCT00112437|26971738|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6|||
13462121|NCT00112437|26971739|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
13462122|NCT00112437|26971740|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
13462123|NCT00112437|26971741|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2|||
13462124|NCT00112437|26971742|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
13462125|NCT00112437|26971743|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
13462126|NCT00112437|26971744|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
13462127|NCT00112437|26971745|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
13462128|NCT00112437|26971746|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
13462129|NCT00112437|26971747|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
13462130|NCT00112437|26971748|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
13462131|NCT00112437|26971749|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
13462132|NCT00112437|26971750|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
13462133|NCT00112437|26971751|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
13462134|NCT00112437|26971752|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
13462135|NCT00112437|26971753|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
13462136|NCT00112437|26971754|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
13462137|NCT00112437|26971755|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
13462138|NCT00112437|26971756|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
13462139|NCT00112437|26971757|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
13462140|NCT00112437|26971732|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
13462141|NCT00112437|26971733|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
13462142|NCT00112437|26971734|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
13462143|NCT00112437|26971735|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
13462144|NCT00112437|26971736|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
13462145|NCT00112437|26971737|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
13462146|NCT00112437|26971738|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
13462147|NCT00112437|26971739|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
13462148|NCT00112437|26971740|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1|||
13462149|NCT00112437|26971741|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
13462150|NCT00112437|26971742|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
13462151|NCT00112437|26971743|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
13462152|NCT00112437|26971744|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
13462153|NCT00112437|26971745|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
13462154|NCT00112437|26971746|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
13462155|NCT00112437|26971747|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
13462156|NCT00112437|26971748|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
13462157|NCT00112437|26971749|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
13462158|NCT00112437|26971750|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
13462159|NCT00112437|26971751|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
13462160|NCT00112437|26971752|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
13462161|NCT00112437|26971753|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
13462162|NCT00112437|26971754|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
13462163|NCT00112437|26971755|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
13462164|NCT00112437|26971756|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
13462165|NCT00112437|26971757|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
13462166|NCT00112437|26971732|FG000|Year 2 (12-Month Extension)|Protocol Violation|0|||
13462167|NCT00112437|26971733|FG001|Year 2 (12-Month Extension)|Protocol Violation|0|||
13462168|NCT00112437|26971734|FG002|Year 2 (12-Month Extension)|Protocol Violation|0|||
13462169|NCT00112437|26971735|FG003|Year 2 (12-Month Extension)|Protocol Violation|0|||
13462170|NCT00112437|26971736|FG004|Year 2 (12-Month Extension)|Protocol Violation|0|||
13462171|NCT00112437|26971737|FG005|Year 2 (12-Month Extension)|Protocol Violation|0|||
13462172|NCT00112437|26971738|FG006|Year 2 (12-Month Extension)|Protocol Violation|0|||
13462173|NCT00112437|26971739|FG007|Year 2 (12-Month Extension)|Protocol Violation|0|||
13462174|NCT00112437|26971740|FG008|Year 2 (12-Month Extension)|Protocol Violation|1|||
13462175|NCT00112437|26971741|FG009|Year 2 (12-Month Extension)|Protocol Violation|0|||
13462176|NCT00112437|26971742|FG010|Year 2 (12-Month Extension)|Protocol Violation|0|||
13462177|NCT00112437|26971743|FG011|Year 2 (12-Month Extension)|Protocol Violation|0|||
13462178|NCT00112437|26971744|FG012|Year 2 (12-Month Extension)|Protocol Violation|0|||
13462179|NCT00112437|26971745|FG013|Year 2 (12-Month Extension)|Protocol Violation|0|||
13462180|NCT00112437|26971746|FG014|Year 2 (12-Month Extension)|Protocol Violation|0|||
13462181|NCT00112437|26971747|FG015|Year 2 (12-Month Extension)|Protocol Violation|0|||
13462182|NCT00112437|26971748|FG016|Year 2 (12-Month Extension)|Protocol Violation|0|||
13462183|NCT00112437|26971749|FG017|Year 2 (12-Month Extension)|Protocol Violation|0|||
13462184|NCT00112437|26971750|FG018|Year 2 (12-Month Extension)|Protocol Violation|0|||
13462185|NCT00112437|26971751|FG019|Year 2 (12-Month Extension)|Protocol Violation|0|||
13462186|NCT00112437|26971752|FG020|Year 2 (12-Month Extension)|Protocol Violation|0|||
13462187|NCT00112437|26971753|FG021|Year 2 (12-Month Extension)|Protocol Violation|0|||
13462188|NCT00112437|26971754|FG022|Year 2 (12-Month Extension)|Protocol Violation|0|||
13462189|NCT00112437|26971755|FG023|Year 2 (12-Month Extension)|Protocol Violation|0|||
13462190|NCT00112437|26971756|FG024|Year 2 (12-Month Extension)|Protocol Violation|0|||
13462191|NCT00112437|26971757|FG025|Year 2 (12-Month Extension)|Protocol Violation|0|||
13462192|NCT00112437|26971732|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
13462193|NCT00112437|26971733|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
13462194|NCT00112437|26971734|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
13462195|NCT00112437|26971735|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
13462196|NCT00112437|26971736|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
13462197|NCT00112437|26971737|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
13462198|NCT00112437|26971738|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
13462199|NCT00112437|26971739|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2|||
13462200|NCT00112437|26971740|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4|||
13462201|NCT00112437|26971741|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
13462202|NCT00112437|26971742|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
13462203|NCT00112437|26971743|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
13462204|NCT00112437|26971744|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
13462205|NCT00112437|26971745|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
13462206|NCT00112437|26971746|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
13462207|NCT00112437|26971747|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
13462208|NCT00112437|26971748|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
13462209|NCT00112437|26971749|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
13462210|NCT00112437|26971750|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
13462211|NCT00112437|26971751|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
13462212|NCT00112437|26971752|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
13462213|NCT00112437|26971753|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
13462214|NCT00112437|26971754|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
13462215|NCT00112437|26971755|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
13462216|NCT00112437|26971756|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
13462217|NCT00112437|26971757|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
13462218|NCT00112437|26971732|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
13462219|NCT00112437|26971733|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
13462220|NCT00112437|26971734|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
13462221|NCT00112437|26971735|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
13462222|NCT00112437|26971736|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
13462223|NCT00112437|26971737|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
13462224|NCT00112437|26971738|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
13462225|NCT00112437|26971739|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
13462226|NCT00112437|26971740|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
13462227|NCT00112437|26971741|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1|||
13462228|NCT00112437|26971742|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
13462229|NCT00112437|26971743|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
13462230|NCT00112437|26971744|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
13462231|NCT00112437|26971745|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
13462232|NCT00112437|26971746|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
13462233|NCT00112437|26971747|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
13462234|NCT00112437|26971748|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
13462235|NCT00112437|26971749|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
13462236|NCT00112437|26971750|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
13462237|NCT00112437|26971751|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
13462238|NCT00112437|26971752|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
13462239|NCT00112437|26971753|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
13462240|NCT00112437|26971754|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
13462241|NCT00112437|26971755|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
13462242|NCT00112437|26971756|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
13462243|NCT00112437|26971757|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
13462244|NCT00112437|26971732|FG000|Year 2 (12-Month Extension)|patient was out of windows|0|||
13462245|NCT00112437|26971733|FG001|Year 2 (12-Month Extension)|patient was out of windows|0|||
13462246|NCT00112437|26971734|FG002|Year 2 (12-Month Extension)|patient was out of windows|0|||
13462247|NCT00112437|26971735|FG003|Year 2 (12-Month Extension)|patient was out of windows|0|||
13462248|NCT00112437|26971736|FG004|Year 2 (12-Month Extension)|patient was out of windows|0|||
13462249|NCT00112437|26971737|FG005|Year 2 (12-Month Extension)|patient was out of windows|0|||
13462250|NCT00112437|26971738|FG006|Year 2 (12-Month Extension)|patient was out of windows|0|||
13462251|NCT00112437|26971739|FG007|Year 2 (12-Month Extension)|patient was out of windows|0|||
13462252|NCT00112437|26971740|FG008|Year 2 (12-Month Extension)|patient was out of windows|0|||
13462253|NCT00112437|26971741|FG009|Year 2 (12-Month Extension)|patient was out of windows|1|||
13462254|NCT00112437|26971742|FG010|Year 2 (12-Month Extension)|patient was out of windows|0|||
13462255|NCT00112437|26971743|FG011|Year 2 (12-Month Extension)|patient was out of windows|0|||
13462256|NCT00112437|26971744|FG012|Year 2 (12-Month Extension)|patient was out of windows|0|||
13462257|NCT00112437|26971745|FG013|Year 2 (12-Month Extension)|patient was out of windows|0|||
13462258|NCT00112437|26971746|FG014|Year 2 (12-Month Extension)|patient was out of windows|0|||
13462259|NCT00112437|26971747|FG015|Year 2 (12-Month Extension)|patient was out of windows|0|||
13462260|NCT00112437|26971748|FG016|Year 2 (12-Month Extension)|patient was out of windows|0|||
13462261|NCT00112437|26971749|FG017|Year 2 (12-Month Extension)|patient was out of windows|0|||
13462262|NCT00112437|26971750|FG018|Year 2 (12-Month Extension)|patient was out of windows|0|||
13462263|NCT00112437|26971751|FG019|Year 2 (12-Month Extension)|patient was out of windows|0|||
13462264|NCT00112437|26971752|FG020|Year 2 (12-Month Extension)|patient was out of windows|0|||
13462265|NCT00112437|26971753|FG021|Year 2 (12-Month Extension)|patient was out of windows|0|||
13462266|NCT00112437|26971754|FG022|Year 2 (12-Month Extension)|patient was out of windows|0|||
13462267|NCT00112437|26971755|FG023|Year 2 (12-Month Extension)|patient was out of windows|0|||
13462268|NCT00112437|26971756|FG024|Year 2 (12-Month Extension)|patient was out of windows|0|||
13462269|NCT00112437|26971757|FG025|Year 2 (12-Month Extension)|patient was out of windows|0|||
13462270|NCT00112437|26971732|FG000|Year 2 (12-Month Extension)|Moved|0|||
13462271|NCT00112437|26971733|FG001|Year 2 (12-Month Extension)|Moved|0|||
13462272|NCT00112437|26971734|FG002|Year 2 (12-Month Extension)|Moved|0|||
13462273|NCT00112437|26971735|FG003|Year 2 (12-Month Extension)|Moved|0|||
13462274|NCT00112437|26971736|FG004|Year 2 (12-Month Extension)|Moved|0|||
13462275|NCT00112437|26971737|FG005|Year 2 (12-Month Extension)|Moved|0|||
13462276|NCT00112437|26971738|FG006|Year 2 (12-Month Extension)|Moved|0|||
13462277|NCT00112437|26971739|FG007|Year 2 (12-Month Extension)|Moved|0|||
13462278|NCT00112437|26971740|FG008|Year 2 (12-Month Extension)|Moved|0|||
13462279|NCT00112437|26971741|FG009|Year 2 (12-Month Extension)|Moved|1|||
13462280|NCT00112437|26971742|FG010|Year 2 (12-Month Extension)|Moved|0|||
13462281|NCT00112437|26971743|FG011|Year 2 (12-Month Extension)|Moved|0|||
13462282|NCT00112437|26971744|FG012|Year 2 (12-Month Extension)|Moved|0|||
13462283|NCT00112437|26971745|FG013|Year 2 (12-Month Extension)|Moved|0|||
13462284|NCT00112437|26971746|FG014|Year 2 (12-Month Extension)|Moved|0|||
13462285|NCT00112437|26971747|FG015|Year 2 (12-Month Extension)|Moved|0|||
13462286|NCT00112437|26971748|FG016|Year 2 (12-Month Extension)|Moved|0|||
13462287|NCT00112437|26971749|FG017|Year 2 (12-Month Extension)|Moved|0|||
13462288|NCT00112437|26971750|FG018|Year 2 (12-Month Extension)|Moved|0|||
13462289|NCT00112437|26971751|FG019|Year 2 (12-Month Extension)|Moved|0|||
13462290|NCT00112437|26971752|FG020|Year 2 (12-Month Extension)|Moved|0|||
13462291|NCT00112437|26971753|FG021|Year 2 (12-Month Extension)|Moved|0|||
13462292|NCT00112437|26971754|FG022|Year 2 (12-Month Extension)|Moved|0|||
13462293|NCT00112437|26971755|FG023|Year 2 (12-Month Extension)|Moved|0|||
13462294|NCT00112437|26971756|FG024|Year 2 (12-Month Extension)|Moved|0|||
13462295|NCT00112437|26971757|FG025|Year 2 (12-Month Extension)|Moved|0|||
13462296|NCT00112437|26971732|FG000|Year 3 (12-Month Extension)|Adverse Event|0|||
13462297|NCT00112437|26971733|FG001|Year 3 (12-Month Extension)|Adverse Event|0|||
13462298|NCT00112437|26971734|FG002|Year 3 (12-Month Extension)|Adverse Event|0|||
13462299|NCT00112437|26971735|FG003|Year 3 (12-Month Extension)|Adverse Event|0|||
13462300|NCT00112437|26971736|FG004|Year 3 (12-Month Extension)|Adverse Event|0|||
13462301|NCT00112437|26971737|FG005|Year 3 (12-Month Extension)|Adverse Event|0|||
13462302|NCT00112437|26971738|FG006|Year 3 (12-Month Extension)|Adverse Event|0|||
13462303|NCT00112437|26971739|FG007|Year 3 (12-Month Extension)|Adverse Event|0|||
13462304|NCT00112437|26971740|FG008|Year 3 (12-Month Extension)|Adverse Event|0|||
13462305|NCT00112437|26971741|FG009|Year 3 (12-Month Extension)|Adverse Event|0|||
13462306|NCT00112437|26971742|FG010|Year 3 (12-Month Extension)|Adverse Event|1|||
13462307|NCT00112437|26971743|FG011|Year 3 (12-Month Extension)|Adverse Event|0|||
13462308|NCT00112437|26971744|FG012|Year 3 (12-Month Extension)|Adverse Event|0|||
13462309|NCT00112437|26971745|FG013|Year 3 (12-Month Extension)|Adverse Event|0|||
13462310|NCT00112437|26971746|FG014|Year 3 (12-Month Extension)|Adverse Event|0|||
13462311|NCT00112437|26971747|FG015|Year 3 (12-Month Extension)|Adverse Event|1|||
13462312|NCT00112437|26971748|FG016|Year 3 (12-Month Extension)|Adverse Event|3|||
13462313|NCT00112437|26971749|FG017|Year 3 (12-Month Extension)|Adverse Event|1|||
13462314|NCT00112437|26971750|FG018|Year 3 (12-Month Extension)|Adverse Event|0|||
13462315|NCT00112437|26971751|FG019|Year 3 (12-Month Extension)|Adverse Event|1|||
13462316|NCT00112437|26971752|FG020|Year 3 (12-Month Extension)|Adverse Event|0|||
13462317|NCT00112437|26971753|FG021|Year 3 (12-Month Extension)|Adverse Event|0|||
13462318|NCT00112437|26971754|FG022|Year 3 (12-Month Extension)|Adverse Event|0|||
13462319|NCT00112437|26971755|FG023|Year 3 (12-Month Extension)|Adverse Event|0|||
13462320|NCT00112437|26971756|FG024|Year 3 (12-Month Extension)|Adverse Event|0|||
13462321|NCT00112437|26971757|FG025|Year 3 (12-Month Extension)|Adverse Event|0|||
13462322|NCT00112437|26971732|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
13462323|NCT00112437|26971733|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
13462324|NCT00112437|26971734|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
13462325|NCT00112437|26971735|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
13462326|NCT00112437|26971736|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
13462327|NCT00112437|26971737|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
13462328|NCT00112437|26971738|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
13462329|NCT00112437|26971739|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
13462330|NCT00112437|26971740|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
13462331|NCT00112437|26971741|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
13462332|NCT00112437|26971742|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
13462333|NCT00112437|26971743|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
13462334|NCT00112437|26971744|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
13462335|NCT00112437|26971745|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
13462336|NCT00112437|26971746|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
13462337|NCT00112437|26971747|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
13462338|NCT00112437|26971748|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
13462339|NCT00112437|26971749|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
13462340|NCT00112437|26971750|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2|||
13462341|NCT00112437|26971751|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
13462342|NCT00112437|26971752|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
13462343|NCT00112437|26971753|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
13462344|NCT00112437|26971754|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
13462345|NCT00112437|26971755|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
13462346|NCT00112437|26971756|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
13462347|NCT00112437|26971757|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
13462348|NCT00112437|26971732|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
13462349|NCT00112437|26971733|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
13462350|NCT00112437|26971734|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
13462351|NCT00112437|26971735|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
13462352|NCT00112437|26971736|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
13462353|NCT00112437|26971737|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
13462354|NCT00112437|26971738|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
13462355|NCT00112437|26971739|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
13462356|NCT00112437|26971740|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
13462357|NCT00112437|26971741|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
13462358|NCT00112437|26971742|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
13462359|NCT00112437|26971743|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
13462360|NCT00112437|26971744|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
13462361|NCT00112437|26971745|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
13462362|NCT00112437|26971746|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
13462363|NCT00112437|26971747|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1|||
13462364|NCT00112437|26971748|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
13462365|NCT00112437|26971749|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
13462366|NCT00112437|26971750|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
13462367|NCT00112437|26971751|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
13462368|NCT00112437|26971752|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
13462369|NCT00112437|26971753|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
13462370|NCT00112437|26971754|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
13462371|NCT00112437|26971755|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
13462372|NCT00112437|26971756|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
13462373|NCT00112437|26971757|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
13462374|NCT00112437|26971732|FG000|Year 3 (12-Month Extension)|Protocol Violation|0|||
13462375|NCT00112437|26971733|FG001|Year 3 (12-Month Extension)|Protocol Violation|0|||
13462376|NCT00112437|26971734|FG002|Year 3 (12-Month Extension)|Protocol Violation|0|||
13462377|NCT00112437|26971735|FG003|Year 3 (12-Month Extension)|Protocol Violation|0|||
13462378|NCT00112437|26971736|FG004|Year 3 (12-Month Extension)|Protocol Violation|0|||
13462379|NCT00112437|26971737|FG005|Year 3 (12-Month Extension)|Protocol Violation|0|||
13462380|NCT00112437|26971738|FG006|Year 3 (12-Month Extension)|Protocol Violation|0|||
13462381|NCT00112437|26971739|FG007|Year 3 (12-Month Extension)|Protocol Violation|0|||
13462382|NCT00112437|26971740|FG008|Year 3 (12-Month Extension)|Protocol Violation|0|||
13462383|NCT00112437|26971741|FG009|Year 3 (12-Month Extension)|Protocol Violation|0|||
13462384|NCT00112437|26971742|FG010|Year 3 (12-Month Extension)|Protocol Violation|0|||
13462385|NCT00112437|26971743|FG011|Year 3 (12-Month Extension)|Protocol Violation|0|||
13462386|NCT00112437|26971744|FG012|Year 3 (12-Month Extension)|Protocol Violation|0|||
13462387|NCT00112437|26971745|FG013|Year 3 (12-Month Extension)|Protocol Violation|0|||
13462388|NCT00112437|26971746|FG014|Year 3 (12-Month Extension)|Protocol Violation|0|||
13462389|NCT00112437|26971747|FG015|Year 3 (12-Month Extension)|Protocol Violation|1|||
13462390|NCT00112437|26971748|FG016|Year 3 (12-Month Extension)|Protocol Violation|0|||
13462391|NCT00112437|26971749|FG017|Year 3 (12-Month Extension)|Protocol Violation|0|||
13462392|NCT00112437|26971750|FG018|Year 3 (12-Month Extension)|Protocol Violation|0|||
13462393|NCT00112437|26971751|FG019|Year 3 (12-Month Extension)|Protocol Violation|0|||
13462394|NCT00112437|26971752|FG020|Year 3 (12-Month Extension)|Protocol Violation|0|||
13462395|NCT00112437|26971753|FG021|Year 3 (12-Month Extension)|Protocol Violation|0|||
13462396|NCT00112437|26971754|FG022|Year 3 (12-Month Extension)|Protocol Violation|0|||
13462397|NCT00112437|26971755|FG023|Year 3 (12-Month Extension)|Protocol Violation|0|||
13462398|NCT00112437|26971756|FG024|Year 3 (12-Month Extension)|Protocol Violation|0|||
13462399|NCT00112437|26971757|FG025|Year 3 (12-Month Extension)|Protocol Violation|0|||
13462400|NCT00112437|26971732|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
13462401|NCT00112437|26971733|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
13462402|NCT00112437|26971734|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
13462403|NCT00112437|26971735|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
13462404|NCT00112437|26971736|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
13462405|NCT00112437|26971737|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
13462406|NCT00112437|26971738|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
13462407|NCT00112437|26971739|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
13462408|NCT00112437|26971740|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
13462409|NCT00112437|26971741|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
13462410|NCT00112437|26971742|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
13462411|NCT00112437|26971743|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3|||
13462412|NCT00112437|26971744|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
13462413|NCT00112437|26971745|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
13462414|NCT00112437|26971746|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1|||
13462415|NCT00112437|26971747|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
13462416|NCT00112437|26971748|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
13462417|NCT00112437|26971749|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
13462418|NCT00112437|26971750|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
13462419|NCT00112437|26971751|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
13462420|NCT00112437|26971752|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
13462421|NCT00112437|26971753|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
13462422|NCT00112437|26971754|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
13462423|NCT00112437|26971755|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
13462424|NCT00112437|26971756|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
13462425|NCT00112437|26971757|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
13462426|NCT00112437|26971732|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
13462427|NCT00112437|26971733|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
13462428|NCT00112437|26971734|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
13462429|NCT00112437|26971735|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
13462430|NCT00112437|26971736|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
13462431|NCT00112437|26971737|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
13462432|NCT00112437|26971738|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
13462433|NCT00112437|26971739|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
13462434|NCT00112437|26971740|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
13462435|NCT00112437|26971741|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
13462436|NCT00112437|26971742|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
13462437|NCT00112437|26971743|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
13462438|NCT00112437|26971744|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
13462439|NCT00112437|26971745|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
13462440|NCT00112437|26971746|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
13462441|NCT00112437|26971747|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
13462442|NCT00112437|26971748|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
13462443|NCT00112437|26971749|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
13462444|NCT00112437|26971750|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
13462445|NCT00112437|26971751|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
13462446|NCT00112437|26971752|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
13462447|NCT00112437|26971753|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
13462448|NCT00112437|26971754|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
13462449|NCT00112437|26971755|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
13462450|NCT00112437|26971756|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
13462451|NCT00112437|26971757|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
13462452|NCT00112437|26971732|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
13462453|NCT00112437|26971733|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
13462454|NCT00112437|26971734|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
13462455|NCT00112437|26971735|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
13462456|NCT00112437|26971736|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
13462457|NCT00112437|26971737|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
13462458|NCT00112437|26971738|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
13462459|NCT00112437|26971739|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
13462460|NCT00112437|26971740|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
13462461|NCT00112437|26971741|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
13462462|NCT00112437|26971742|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
13462463|NCT00112437|26971743|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
13462464|NCT00112437|26971744|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
13462465|NCT00112437|26971745|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
13462466|NCT00112437|26971746|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
13462467|NCT00112437|26971747|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
13462468|NCT00112437|26971748|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
13462469|NCT00112437|26971749|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
13462470|NCT00112437|26971750|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
13462471|NCT00112437|26971751|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
13462472|NCT00112437|26971752|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2|||
13462473|NCT00112437|26971753|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1|||
13462474|NCT00112437|26971754|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
13462475|NCT00112437|26971755|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
13462476|NCT00112437|26971756|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
13462477|NCT00112437|26971757|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
13462478|NCT00112437|26971732|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
13462479|NCT00112437|26971733|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
13462480|NCT00112437|26971734|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
13462481|NCT00112437|26971735|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
13462482|NCT00112437|26971736|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
13462483|NCT00112437|26971737|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
13462484|NCT00112437|26971738|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
13462485|NCT00112437|26971739|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
13462486|NCT00112437|26971740|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
13462487|NCT00112437|26971741|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
13462488|NCT00112437|26971742|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
13462489|NCT00112437|26971743|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
13462490|NCT00112437|26971744|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
13462491|NCT00112437|26971745|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
13462492|NCT00112437|26971746|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
13462493|NCT00112437|26971747|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
13462494|NCT00112437|26971748|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
13462495|NCT00112437|26971749|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
13462496|NCT00112437|26971750|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
13462497|NCT00112437|26971751|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
13462498|NCT00112437|26971752|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1|||
13462499|NCT00112437|26971753|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
13462500|NCT00112437|26971754|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
13462501|NCT00112437|26971755|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
13462502|NCT00112437|26971756|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
13462503|NCT00112437|26971757|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
13462504|NCT00112437|26971732|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0|||
13462505|NCT00112437|26971733|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0|||
13462506|NCT00112437|26971734|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0|||
13462507|NCT00112437|26971735|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0|||
13462508|NCT00112437|26971736|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0|||
13462509|NCT00112437|26971737|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0|||
13462510|NCT00112437|26971738|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0|||
13462511|NCT00112437|26971739|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0|||
13462512|NCT00112437|26971740|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0|||
13462513|NCT00112437|26971741|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0|||
13462514|NCT00112437|26971742|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0|||
13462515|NCT00112437|26971743|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0|||
13462516|NCT00112437|26971744|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0|||
13462517|NCT00112437|26971745|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0|||
13462518|NCT00112437|26971746|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0|||
13462519|NCT00112437|26971747|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0|||
13462520|NCT00112437|26971748|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0|||
13462521|NCT00112437|26971749|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0|||
13462522|NCT00112437|26971750|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0|||
13462523|NCT00112437|26971751|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0|||
13462524|NCT00112437|26971752|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0|||
13462525|NCT00112437|26971753|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4|||
13462526|NCT00112437|26971754|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0|||
13462527|NCT00112437|26971755|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0|||
13462528|NCT00112437|26971756|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0|||
13462529|NCT00112437|26971757|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0|||
13462530|NCT00112437|26971732|FG000|Years 4-5 (24-Month Extension)|Participant moved|0|||
13462531|NCT00112437|26971733|FG001|Years 4-5 (24-Month Extension)|Participant moved|0|||
13462532|NCT00112437|26971734|FG002|Years 4-5 (24-Month Extension)|Participant moved|0|||
13462533|NCT00112437|26971735|FG003|Years 4-5 (24-Month Extension)|Participant moved|0|||
13462534|NCT00112437|26971736|FG004|Years 4-5 (24-Month Extension)|Participant moved|0|||
13462535|NCT00112437|26971737|FG005|Years 4-5 (24-Month Extension)|Participant moved|0|||
13462536|NCT00112437|26971738|FG006|Years 4-5 (24-Month Extension)|Participant moved|0|||
13462537|NCT00112437|26971739|FG007|Years 4-5 (24-Month Extension)|Participant moved|0|||
13462538|NCT00112437|26971740|FG008|Years 4-5 (24-Month Extension)|Participant moved|0|||
13462539|NCT00112437|26971741|FG009|Years 4-5 (24-Month Extension)|Participant moved|0|||
13462540|NCT00112437|26971742|FG010|Years 4-5 (24-Month Extension)|Participant moved|0|||
13462541|NCT00112437|26971743|FG011|Years 4-5 (24-Month Extension)|Participant moved|0|||
13462542|NCT00112437|26971744|FG012|Years 4-5 (24-Month Extension)|Participant moved|0|||
13462543|NCT00112437|26971745|FG013|Years 4-5 (24-Month Extension)|Participant moved|0|||
13462544|NCT00112437|26971746|FG014|Years 4-5 (24-Month Extension)|Participant moved|0|||
13462545|NCT00112437|26971747|FG015|Years 4-5 (24-Month Extension)|Participant moved|0|||
13462546|NCT00112437|26971748|FG016|Years 4-5 (24-Month Extension)|Participant moved|0|||
13462547|NCT00112437|26971749|FG017|Years 4-5 (24-Month Extension)|Participant moved|0|||
13462548|NCT00112437|26971750|FG018|Years 4-5 (24-Month Extension)|Participant moved|0|||
13462549|NCT00112437|26971751|FG019|Years 4-5 (24-Month Extension)|Participant moved|0|||
13462550|NCT00112437|26971752|FG020|Years 4-5 (24-Month Extension)|Participant moved|0|||
13462551|NCT00112437|26971753|FG021|Years 4-5 (24-Month Extension)|Participant moved|1|||
13462552|NCT00112437|26971754|FG022|Years 4-5 (24-Month Extension)|Participant moved|0|||
13462553|NCT00112437|26971755|FG023|Years 4-5 (24-Month Extension)|Participant moved|0|||
13462554|NCT00112437|26971756|FG024|Years 4-5 (24-Month Extension)|Participant moved|0|||
13462555|NCT00112437|26971757|FG025|Years 4-5 (24-Month Extension)|Participant moved|0|||
13462556|NCT00112437|26971732|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
13462557|NCT00112437|26971733|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
13462558|NCT00112437|26971734|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
13462559|NCT00112437|26971735|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
13462560|NCT00112437|26971736|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
13462561|NCT00112437|26971737|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
13462562|NCT00112437|26971738|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
13462563|NCT00112437|26971739|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
13462564|NCT00112437|26971740|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
13462565|NCT00112437|26971741|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
13462566|NCT00112437|26971742|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
13462567|NCT00112437|26971743|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
13462568|NCT00112437|26971744|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
13462569|NCT00112437|26971745|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
13462570|NCT00112437|26971746|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
13462571|NCT00112437|26971747|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
13462572|NCT00112437|26971748|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
13462573|NCT00112437|26971749|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
13462574|NCT00112437|26971750|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
13462575|NCT00112437|26971751|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
13462576|NCT00112437|26971752|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1|||
13462577|NCT00112437|26971753|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2|||
13462578|NCT00112437|26971754|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
13462579|NCT00112437|26971755|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
13462580|NCT00112437|26971756|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
13462581|NCT00112437|26971757|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
13462582|NCT00112437|26971732|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0|||
13462583|NCT00112437|26971733|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0|||
13462584|NCT00112437|26971734|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0|||
13462585|NCT00112437|26971735|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0|||
13462586|NCT00112437|26971736|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0|||
13462587|NCT00112437|26971737|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0|||
13462588|NCT00112437|26971738|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0|||
13462589|NCT00112437|26971739|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0|||
13462590|NCT00112437|26971740|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0|||
13462591|NCT00112437|26971741|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0|||
13462592|NCT00112437|26971742|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0|||
13462593|NCT00112437|26971743|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0|||
13462594|NCT00112437|26971744|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0|||
13462595|NCT00112437|26971745|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0|||
13462596|NCT00112437|26971746|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0|||
13462597|NCT00112437|26971747|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0|||
13462598|NCT00112437|26971748|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0|||
13462599|NCT00112437|26971749|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0|||
13462600|NCT00112437|26971750|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0|||
13462601|NCT00112437|26971751|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0|||
13462602|NCT00112437|26971752|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0|||
13462603|NCT00112437|26971753|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0|||
13462604|NCT00112437|26971754|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1|||
13462605|NCT00112437|26971755|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2|||
13462606|NCT00112437|26971756|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0|||
13462607|NCT00112437|26971757|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1|||
13462608|NCT00112437|26971732|FG000|Years 6-10 (60-Month Extension)|Death|0|||
13462609|NCT00112437|26971733|FG001|Years 6-10 (60-Month Extension)|Death|0|||
13462610|NCT00112437|26971734|FG002|Years 6-10 (60-Month Extension)|Death|0|||
13462611|NCT00112437|26971735|FG003|Years 6-10 (60-Month Extension)|Death|0|||
13462612|NCT00112437|26971736|FG004|Years 6-10 (60-Month Extension)|Death|0|||
13462613|NCT00112437|26971737|FG005|Years 6-10 (60-Month Extension)|Death|0|||
13462614|NCT00112437|26971738|FG006|Years 6-10 (60-Month Extension)|Death|0|||
13462615|NCT00112437|26971739|FG007|Years 6-10 (60-Month Extension)|Death|0|||
13462616|NCT00112437|26971740|FG008|Years 6-10 (60-Month Extension)|Death|0|||
13462617|NCT00112437|26971741|FG009|Years 6-10 (60-Month Extension)|Death|0|||
13462618|NCT00112437|26971742|FG010|Years 6-10 (60-Month Extension)|Death|0|||
13462619|NCT00112437|26971743|FG011|Years 6-10 (60-Month Extension)|Death|0|||
13462620|NCT00112437|26971744|FG012|Years 6-10 (60-Month Extension)|Death|0|||
13462621|NCT00112437|26971745|FG013|Years 6-10 (60-Month Extension)|Death|0|||
13462622|NCT00112437|26971746|FG014|Years 6-10 (60-Month Extension)|Death|0|||
13462623|NCT00112437|26971747|FG015|Years 6-10 (60-Month Extension)|Death|0|||
13462624|NCT00112437|26971748|FG016|Years 6-10 (60-Month Extension)|Death|0|||
13462625|NCT00112437|26971749|FG017|Years 6-10 (60-Month Extension)|Death|0|||
13462626|NCT00112437|26971750|FG018|Years 6-10 (60-Month Extension)|Death|0|||
13462627|NCT00112437|26971751|FG019|Years 6-10 (60-Month Extension)|Death|0|||
13462628|NCT00112437|26971752|FG020|Years 6-10 (60-Month Extension)|Death|0|||
13462629|NCT00112437|26971753|FG021|Years 6-10 (60-Month Extension)|Death|0|||
13462630|NCT00112437|26971754|FG022|Years 6-10 (60-Month Extension)|Death|0|||
13462631|NCT00112437|26971755|FG023|Years 6-10 (60-Month Extension)|Death|2|||
13462632|NCT00112437|26971756|FG024|Years 6-10 (60-Month Extension)|Death|0|||
13462633|NCT00112437|26971757|FG025|Years 6-10 (60-Month Extension)|Death|0|||
13462634|NCT00112437|26971732|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
13462635|NCT00112437|26971733|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
13462636|NCT00112437|26971734|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
13462637|NCT00112437|26971735|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
13462638|NCT00112437|26971736|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
13462639|NCT00112437|26971737|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
13462640|NCT00112437|26971738|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
13462641|NCT00112437|26971739|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
13462642|NCT00112437|26971740|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
13462643|NCT00112437|26971741|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
13462644|NCT00112437|26971742|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
13462645|NCT00112437|26971743|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
13462646|NCT00112437|26971744|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
13462647|NCT00112437|26971745|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
13462648|NCT00112437|26971746|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
13462649|NCT00112437|26971747|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
13462650|NCT00112437|26971748|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
13462651|NCT00112437|26971749|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
13462652|NCT00112437|26971750|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
13462653|NCT00112437|26971751|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
13462654|NCT00112437|26971752|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
13462655|NCT00112437|26971753|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
13462656|NCT00112437|26971754|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
13462657|NCT00112437|26971755|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
13462658|NCT00112437|26971756|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
13462659|NCT00112437|26971757|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1|||
13462660|NCT00112437|26971732|FG000|Years 6-10 (60-Month Extension)|Other|0|||
13462661|NCT00112437|26971733|FG001|Years 6-10 (60-Month Extension)|Other|0|||
13462662|NCT00112437|26971734|FG002|Years 6-10 (60-Month Extension)|Other|0|||
13462663|NCT00112437|26971735|FG003|Years 6-10 (60-Month Extension)|Other|0|||
13462664|NCT00112437|26971736|FG004|Years 6-10 (60-Month Extension)|Other|0|||
13462665|NCT00112437|26971737|FG005|Years 6-10 (60-Month Extension)|Other|0|||
13462666|NCT00112437|26971738|FG006|Years 6-10 (60-Month Extension)|Other|0|||
13462667|NCT00112437|26971739|FG007|Years 6-10 (60-Month Extension)|Other|0|||
13462668|NCT00112437|26971740|FG008|Years 6-10 (60-Month Extension)|Other|0|||
13462669|NCT00112437|26971741|FG009|Years 6-10 (60-Month Extension)|Other|0|||
13462670|NCT00112437|26971742|FG010|Years 6-10 (60-Month Extension)|Other|0|||
13462671|NCT00112437|26971743|FG011|Years 6-10 (60-Month Extension)|Other|0|||
13462672|NCT00112437|26971744|FG012|Years 6-10 (60-Month Extension)|Other|0|||
13462673|NCT00112437|26971745|FG013|Years 6-10 (60-Month Extension)|Other|0|||
13462674|NCT00112437|26971746|FG014|Years 6-10 (60-Month Extension)|Other|0|||
13462675|NCT00112437|26971747|FG015|Years 6-10 (60-Month Extension)|Other|0|||
13462676|NCT00112437|26971748|FG016|Years 6-10 (60-Month Extension)|Other|0|||
13462677|NCT00112437|26971749|FG017|Years 6-10 (60-Month Extension)|Other|0|||
13462678|NCT00112437|26971750|FG018|Years 6-10 (60-Month Extension)|Other|0|||
13462679|NCT00112437|26971751|FG019|Years 6-10 (60-Month Extension)|Other|0|||
13462680|NCT00112437|26971752|FG020|Years 6-10 (60-Month Extension)|Other|0|||
13462681|NCT00112437|26971753|FG021|Years 6-10 (60-Month Extension)|Other|0|||
13462682|NCT00112437|26971754|FG022|Years 6-10 (60-Month Extension)|Other|0|||
13462683|NCT00112437|26971755|FG023|Years 6-10 (60-Month Extension)|Other|0|||
13462684|NCT00112437|26971756|FG024|Years 6-10 (60-Month Extension)|Other|1|||
13462685|NCT00112437|26971757|FG025|Years 6-10 (60-Month Extension)|Other|0|||
13462686|NCT00112437|26971732|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0|||
13462687|NCT00112437|26971733|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0|||
13462688|NCT00112437|26971734|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0|||
13462689|NCT00112437|26971735|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0|||
13462690|NCT00112437|26971736|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0|||
13462691|NCT00112437|26971737|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0|||
13462692|NCT00112437|26971738|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0|||
13462693|NCT00112437|26971739|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0|||
13462694|NCT00112437|26971740|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0|||
13462695|NCT00112437|26971741|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0|||
13462696|NCT00112437|26971742|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0|||
13462697|NCT00112437|26971743|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0|||
13462698|NCT00112437|26971744|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0|||
13462699|NCT00112437|26971745|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0|||
13462700|NCT00112437|26971746|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0|||
13462701|NCT00112437|26971747|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0|||
13462702|NCT00112437|26971748|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0|||
13462703|NCT00112437|26971749|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0|||
13462704|NCT00112437|26971750|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0|||
13462705|NCT00112437|26971751|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0|||
13462706|NCT00112437|26971752|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0|||
13462707|NCT00112437|26971753|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0|||
13462708|NCT00112437|26971754|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0|||
13462709|NCT00112437|26971755|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2|||
13462710|NCT00112437|26971756|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0|||
13462711|NCT00112437|26971757|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0|||
13462712|NCT00112437|26971732|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
13462713|NCT00112437|26971733|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
13462714|NCT00112437|26971734|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
13462715|NCT00112437|26971735|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
13462716|NCT00112437|26971736|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
13462717|NCT00112437|26971737|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
13462718|NCT00112437|26971738|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
13462719|NCT00112437|26971739|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
13462720|NCT00112437|26971740|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
13462721|NCT00112437|26971741|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
13462722|NCT00112437|26971742|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
13462723|NCT00112437|26971743|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
13462724|NCT00112437|26971744|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
13462725|NCT00112437|26971745|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
13462726|NCT00112437|26971746|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
13462727|NCT00112437|26971747|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
13462728|NCT00112437|26971748|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
13462729|NCT00112437|26971749|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
13462730|NCT00112437|26971750|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
13462731|NCT00112437|26971751|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
13462732|NCT00112437|26971752|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
13462733|NCT00112437|26971753|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
13462734|NCT00112437|26971754|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4|||
13306292|NCT01292603|26525399|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
13306293|NCT01292603|26525400|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2|||
13306294|NCT01292603|26525395|FG000|Part 2: Regular Follow-Up|Death|0|||
13306295|NCT01292603|26525396|FG001|Part 2: Regular Follow-Up|Death|0|||
13306296|NCT01292603|26525397|FG002|Part 2: Regular Follow-Up|Death|0|||
13462735|NCT00112437|26971755|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6|||
13462736|NCT00112437|26971756|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
13462737|NCT00112437|26971757|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3|||
13462738|NCT00112385|26971852|FG000|Overall Study|Lost to Follow-up|1|||
13462739|NCT00112385|26971853|FG001|Overall Study|Lost to Follow-up|0|||
13462740|NCT00112385|26971852|FG000|Overall Study|Withdrawal by Subject|0|||
13462741|NCT00112385|26971853|FG001|Overall Study|Withdrawal by Subject|1|||
13462742|NCT00112359|26971884|FG000|Overall Study|Unrelated adverse event|16|||
13462743|NCT00112359|26971885|FG001|Overall Study|Unrelated adverse event|8|||
13462744|NCT00112359|26971884|FG000|Overall Study|Trial drug intolerance (adverse event)|2|||
13462745|NCT00112359|26971885|FG001|Overall Study|Trial drug intolerance (adverse event)|0|||
13462746|NCT00112359|26971884|FG000|Overall Study|Related adverse event|5|||
13462747|NCT00112359|26971885|FG001|Overall Study|Related adverse event|3|||
13462748|NCT00112359|26971884|FG000|Overall Study|Lost to Follow-up|0|||
13462749|NCT00112359|26971885|FG001|Overall Study|Lost to Follow-up|1|||
13462750|NCT00112359|26971884|FG000|Overall Study|Personal/administrative|1|||
13462751|NCT00112359|26971885|FG001|Overall Study|Personal/administrative|1|||
13462752|NCT00112359|26971884|FG000|Overall Study|Other|3|||
13462753|NCT00112359|26971885|FG001|Overall Study|Other|0|||
13462754|NCT00112294|26971930|FG000|Overall Study|Still on study|5|||
13462755|NCT00112294|26971931|FG001|Overall Study|Still on study|0|||
13462756|NCT00112047|26972036|FG000|Randomized Phase|Lost to Follow-up|26|||
13462757|NCT00112047|26972037|FG001|Randomized Phase|Lost to Follow-up|33|||
13462758|NCT00112047|26972036|FG000|Randomized Phase|Adverse Event|10|||
13462759|NCT00112047|26972037|FG001|Randomized Phase|Adverse Event|10|||
13462760|NCT00112047|26972036|FG000|Randomized Phase|Withrawal of consent|10|||
13462761|NCT00112047|26972037|FG001|Randomized Phase|Withrawal of consent|18|||
13462762|NCT00112047|26972036|FG000|Randomized Phase|Sub-optimal virological response|3|||
13462763|NCT00112047|26972037|FG001|Randomized Phase|Sub-optimal virological response|13|||
13462764|NCT00112047|26972036|FG000|Randomized Phase|Noncompliance|8|||
13462765|NCT00112047|26972037|FG001|Randomized Phase|Noncompliance|4|||
13462766|NCT00112047|26972036|FG000|Randomized Phase|Protocol Violation|2|||
13462767|NCT00112047|26972037|FG001|Randomized Phase|Protocol Violation|0|||
13462768|NCT00112047|26972036|FG000|Randomized Phase|Pregnancy|3|||
13462769|NCT00112047|26972037|FG001|Randomized Phase|Pregnancy|1|||
13462770|NCT00112047|26972036|FG000|Randomized Phase|Death|1|||
13462771|NCT00112047|26972037|FG001|Randomized Phase|Death|3|||
13462772|NCT00112047|26972036|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0|||
13462773|NCT00112047|26972037|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1|||
13462774|NCT00112047|26972036|FG000|Randomized Phase|Inability to swallow pills|0|||
13462775|NCT00112047|26972037|FG001|Randomized Phase|Inability to swallow pills|1|||
13462776|NCT00112047|26972036|FG000|Randomized Phase|Incarceration|3|||
13462777|NCT00112047|26972037|FG001|Randomized Phase|Incarceration|2|||
13462778|NCT00112047|26972036|FG000|Randomized Phase|Moved out of State|0|||
13462779|NCT00112047|26972037|FG001|Randomized Phase|Moved out of State|1|||
13462780|NCT00112047|26972036|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4|||
13462781|NCT00112047|26972037|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0|||
13462782|NCT00112047|26972036|FG000|Randomized Phase|High Hepatitis B DNA|0|||
13462783|NCT00112047|26972037|FG001|Randomized Phase|High Hepatitis B DNA|1|||
13462784|NCT00112047|26972036|FG000|Atripla Phase|Adverse Event|2|||
13462785|NCT00112047|26972037|FG001|Atripla Phase|Adverse Event|1|||
13462786|NCT00112047|26972036|FG000|Atripla Phase|Lost to Follow-up|5|||
13462787|NCT00112047|26972037|FG001|Atripla Phase|Lost to Follow-up|7|||
13462788|NCT00112047|26972036|FG000|Atripla Phase|Pregnancy|0|||
13462789|NCT00112047|26972037|FG001|Atripla Phase|Pregnancy|1|||
13462790|NCT00112047|26972036|FG000|Atripla Phase|Death|0|||
13462791|NCT00112047|26972037|FG001|Atripla Phase|Death|2|||
13462792|NCT00112047|26972036|FG000|Atripla Phase|Withdrew consent|7|||
13462793|NCT00112047|26972037|FG001|Atripla Phase|Withdrew consent|7|||
13462794|NCT00112047|26972036|FG000|Atripla Phase|Sub-optimal virological response|0|||
13462795|NCT00112047|26972037|FG001|Atripla Phase|Sub-optimal virological response|1|||
13462796|NCT00112047|26972036|FG000|Atripla Phase|Non-compliance|1|||
13462797|NCT00112047|26972037|FG001|Atripla Phase|Non-compliance|0|||
13462798|NCT00112047|26972036|FG000|Atripla Phase|Other|3|||
13462799|NCT00112047|26972037|FG001|Atripla Phase|Other|1|||
13462800|NCT00111917|26972056|FG000|Overall Study|Withdrawal by Subject|1|||
13462801|NCT00111917|26972057|FG001|Overall Study|Withdrawal by Subject|1|||
13462802|NCT00111839|26972087|FG000|Overall Study|Disease Progression|30|||
13462803|NCT00111839|26972088|FG001|Overall Study|Disease Progression|33|||
13462804|NCT00111839|26972089|FG002|Overall Study|Disease Progression|33|||
13462805|NCT00111839|26972087|FG000|Overall Study|Adverse Event|5|||
13462806|NCT00111839|26972088|FG001|Overall Study|Adverse Event|3|||
13462807|NCT00111839|26972089|FG002|Overall Study|Adverse Event|1|||
13462808|NCT00111839|26972087|FG000|Overall Study|Protocol Violation|2|||
13462809|NCT00111839|26972088|FG001|Overall Study|Protocol Violation|4|||
13462810|NCT00111839|26972089|FG002|Overall Study|Protocol Violation|2|||
13462811|NCT00111839|26972087|FG000|Overall Study|Death|1|||
13462812|NCT00111839|26972088|FG001|Overall Study|Death|1|||
13462813|NCT00111839|26972089|FG002|Overall Study|Death|6|||
13462814|NCT00111839|26972087|FG000|Overall Study|Withdrawal by Subject|2|||
13462815|NCT00111839|26972088|FG001|Overall Study|Withdrawal by Subject|2|||
13462816|NCT00111839|26972089|FG002|Overall Study|Withdrawal by Subject|2|||
13462817|NCT00111839|26972087|FG000|Overall Study|Lost to Follow-up|1|||
13462818|NCT00111839|26972088|FG001|Overall Study|Lost to Follow-up|0|||
13462819|NCT00111839|26972089|FG002|Overall Study|Lost to Follow-up|0|||
13462820|NCT00111839|26972087|FG000|Overall Study|Logistical Constraint|1|||
13462821|NCT00111839|26972088|FG001|Overall Study|Logistical Constraint|0|||
13462822|NCT00111839|26972089|FG002|Overall Study|Logistical Constraint|0|||
13462823|NCT00111839|26972087|FG000|Overall Study|Other|6|||
13462824|NCT00111839|26972088|FG001|Overall Study|Other|3|||
13462825|NCT00111839|26972089|FG002|Overall Study|Other|3|||
13462826|NCT00111839|26972087|FG000|Overall Study|Randomized but Not Treated|0|||
13462827|NCT00111839|26972088|FG001|Overall Study|Randomized but Not Treated|0|||
13462828|NCT00111839|26972089|FG002|Overall Study|Randomized but Not Treated|2|||
13462829|NCT00111813|26972129|FG000|Overall Study|Adverse Event|1|||
13462830|NCT00111813|26972130|FG001|Overall Study|Adverse Event|2|||
13462831|NCT00111813|26972131|FG002|Overall Study|Adverse Event|4|||
13462832|NCT00111813|26972132|FG003|Overall Study|Adverse Event|2|||
13462833|NCT00111813|26972133|FG004|Overall Study|Adverse Event|2|||
13462834|NCT00111813|26972134|FG005|Overall Study|Adverse Event|2|||
13462835|NCT00111813|26972129|FG000|Overall Study|Progressive disease|2|||
13462836|NCT00111813|26972130|FG001|Overall Study|Progressive disease|1|||
13462837|NCT00111813|26972131|FG002|Overall Study|Progressive disease|5|||
13462838|NCT00111813|26972132|FG003|Overall Study|Progressive disease|3|||
13462839|NCT00111813|26972133|FG004|Overall Study|Progressive disease|4|||
13462840|NCT00111813|26972134|FG005|Overall Study|Progressive disease|3|||
13462841|NCT00111813|26972129|FG000|Overall Study|Lack of Efficacy|0|||
13462842|NCT00111813|26972130|FG001|Overall Study|Lack of Efficacy|0|||
13462843|NCT00111813|26972131|FG002|Overall Study|Lack of Efficacy|0|||
13462844|NCT00111813|26972132|FG003|Overall Study|Lack of Efficacy|0|||
13462845|NCT00111813|26972133|FG004|Overall Study|Lack of Efficacy|0|||
13462846|NCT00111813|26972134|FG005|Overall Study|Lack of Efficacy|1|||
13462847|NCT00111813|26972129|FG000|Overall Study|Other|0|||
13462848|NCT00111813|26972130|FG001|Overall Study|Other|0|||
13462849|NCT00111813|26972131|FG002|Overall Study|Other|1|||
13462850|NCT00111813|26972132|FG003|Overall Study|Other|0|||
13462851|NCT00111813|26972133|FG004|Overall Study|Other|0|||
13462852|NCT00111813|26972134|FG005|Overall Study|Other|0|||
13462853|NCT00111800|26972321|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5|||
13462854|NCT00111800|26972322|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4|||
13462855|NCT00111800|26972323|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
13462856|NCT00111800|26972324|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
13462857|NCT00111800|26972325|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1|||
13462858|NCT00111800|26972326|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
13462859|NCT00111800|26972321|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1|||
13462860|NCT00111800|26972322|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
13462861|NCT00111800|26972323|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
13462862|NCT00111800|26972324|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
13462863|NCT00111800|26972325|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
13462864|NCT00111800|26972326|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
13462865|NCT00111800|26972321|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0|||
13462866|NCT00111800|26972322|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
13462867|NCT00111800|26972323|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4|||
13462868|NCT00111800|26972324|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
13462869|NCT00111800|26972325|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
13462870|NCT00111800|26972326|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
13462871|NCT00111800|26972321|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
13462872|NCT00111800|26972322|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
13462873|NCT00111800|26972323|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3|||
13462874|NCT00111800|26972324|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
13462875|NCT00111800|26972325|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
13462876|NCT00111800|26972326|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1|||
13462877|NCT00111800|26972321|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3|||
13462878|NCT00111800|26972322|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
13462879|NCT00111800|26972323|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
13462880|NCT00111800|26972324|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1|||
13462881|NCT00111800|26972325|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
13462882|NCT00111800|26972326|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
13462883|NCT00111800|26972321|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
13462884|NCT00111800|26972322|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
13462885|NCT00111800|26972323|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
13462886|NCT00111800|26972324|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
13462887|NCT00111800|26972325|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
13462888|NCT00111800|26972326|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
13462889|NCT00111800|26972321|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
13462890|NCT00111800|26972322|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
13462891|NCT00111800|26972323|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
13462892|NCT00111800|26972324|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
13462893|NCT00111800|26972325|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
13462894|NCT00111800|26972326|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
13462895|NCT00111800|26972321|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
13462896|NCT00111800|26972322|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
13462897|NCT00111800|26972323|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
13462898|NCT00111800|26972324|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
13462899|NCT00111800|26972325|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
13462900|NCT00111800|26972326|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
13462901|NCT00111800|26972321|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1|||
13462902|NCT00111800|26972322|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
13462903|NCT00111800|26972323|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
13462904|NCT00111800|26972324|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
13462905|NCT00111800|26972325|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
13462906|NCT00111800|26972326|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
13462907|NCT00111800|26972321|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
13462908|NCT00111800|26972322|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1|||
13462909|NCT00111800|26972323|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
13462910|NCT00111800|26972324|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
13462911|NCT00111800|26972325|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
13462912|NCT00111800|26972326|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
13462913|NCT00111800|26972321|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
13462914|NCT00111800|26972322|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1|||
13462915|NCT00111800|26972323|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
13462916|NCT00111800|26972324|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
13462917|NCT00111800|26972325|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
13462918|NCT00111800|26972326|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
13462919|NCT00111800|26972321|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
13462920|NCT00111800|26972322|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1|||
13462921|NCT00111800|26972323|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
13462922|NCT00111800|26972324|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
13462923|NCT00111800|26972325|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
13462924|NCT00111800|26972326|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
13462925|NCT00111800|26972321|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
13462926|NCT00111800|26972322|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1|||
13462927|NCT00111800|26972323|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
13462928|NCT00111800|26972324|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
13462929|NCT00111800|26972325|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
13462930|NCT00111800|26972326|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
13462931|NCT00111800|26972321|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
13462932|NCT00111800|26972322|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
13462933|NCT00111800|26972323|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
13462934|NCT00111800|26972324|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1|||
13462935|NCT00111800|26972325|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
13462936|NCT00111800|26972326|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
13462937|NCT00111800|26972321|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
13462938|NCT00111800|26972322|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
13462939|NCT00111800|26972323|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
13462940|NCT00111800|26972324|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1|||
13462941|NCT00111800|26972325|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
13462942|NCT00111800|26972326|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
13462943|NCT00111800|26972321|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
13462944|NCT00111800|26972322|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
13462945|NCT00111800|26972323|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
13462946|NCT00111800|26972324|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
13462947|NCT00111800|26972325|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1|||
13462948|NCT00111800|26972326|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
13462949|NCT00111800|26972321|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
13462950|NCT00111800|26972322|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
13462951|NCT00111800|26972323|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
13462952|NCT00111800|26972324|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
13462953|NCT00111800|26972325|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1|||
13462954|NCT00111800|26972326|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
13462955|NCT00111800|26972321|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
13462956|NCT00111800|26972322|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
13462957|NCT00111800|26972323|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
13462958|NCT00111800|26972324|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
13462959|NCT00111800|26972325|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
13462960|NCT00111800|26972326|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1|||
13462961|NCT00111800|26972321|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
13462962|NCT00111800|26972322|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2|||
13462963|NCT00111800|26972323|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1|||
13462964|NCT00111800|26972324|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3|||
13462965|NCT00111800|26972325|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
13462966|NCT00111800|26972326|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
13462967|NCT00111800|26972321|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
13462968|NCT00111800|26972322|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
13462969|NCT00111800|26972323|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
13462970|NCT00111800|26972324|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
13462971|NCT00111800|26972325|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
13462972|NCT00111800|26972326|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
13219957|NCT01828281|26278821|FG001|Overall Study|Withdrawal by Subject|0|||
13219958|NCT01828099|26278834|FG000|Overall Study|Adverse Event|15|||
13219959|NCT01828099|26278835|FG001|Overall Study|Adverse Event|18|||
13219960|NCT01828099|26278834|FG000|Overall Study|Death|9|||
13219961|NCT01828099|26278835|FG001|Overall Study|Death|11|||
13219962|NCT01828099|26278834|FG000|Overall Study|Lost to Follow-up|2|||
13219963|NCT01828099|26278835|FG001|Overall Study|Lost to Follow-up|0|||
13219964|NCT01828099|26278834|FG000|Overall Study|Non-compliance with study treatment|2|||
13219965|NCT01828099|26278835|FG001|Overall Study|Non-compliance with study treatment|0|||
13219966|NCT01828099|26278834|FG000|Overall Study|Physician Decision|7|||
13219967|NCT01828099|26278835|FG001|Overall Study|Physician Decision|11|||
13219968|NCT01828099|26278834|FG000|Overall Study|Progressive disease|51|||
13219969|NCT01828099|26278835|FG001|Overall Study|Progressive disease|94|||
13219970|NCT01828099|26278834|FG000|Overall Study|Protocol Violation|1|||
13219971|NCT01828099|26278835|FG001|Overall Study|Protocol Violation|0|||
13219972|NCT01828099|26278834|FG000|Overall Study|Subject/guardian decision|7|||
13219973|NCT01828099|26278835|FG001|Overall Study|Subject/guardian decision|23|||
13219974|NCT01828073|26278862|FG000|Overall Study|Lost to Follow-up|1|||
13219975|NCT01828073|26278863|FG001|Overall Study|Lost to Follow-up|2|||
13219976|NCT01828034|26278888|FG000|Overall Study|Withdrawal by Subject|0|||
13219977|NCT01828034|26278889|FG001|Overall Study|Withdrawal by Subject|0|||
13219978|NCT01828034|26278890|FG002|Overall Study|Withdrawal by Subject|0|||
13219979|NCT01828034|26278891|FG003|Overall Study|Withdrawal by Subject|1|||
13219980|NCT01828021|26278898|FG000|Overall Study|Adverse Event|5|||
13219981|NCT01828021|26278898|FG000|Overall Study|Lack of Efficacy|17|||
13219982|NCT01828021|26278898|FG000|Overall Study|Withdrawal by Subject|2|||
13219983|NCT01828021|26278898|FG000|Overall Study|Ileal obstruction, unrelated|1|||
13219984|NCT01827943|26278906|FG000|Overall Study|Protocol Violation|8|||
13219985|NCT01827943|26278906|FG000|Overall Study|Never treated because of an rapid progression|1|||
13219986|NCT01827839|26278930|FG000|Overall Study|Adverse Event|1|||
13219987|NCT01827839|26278930|FG000|Overall Study|Consent Withdrawal|2|||
13219988|NCT01827670|26278953|FG000|Overall Study|Withdrawal of Consent|3|||
13219989|NCT01827670|26278954|FG001|Overall Study|Withdrawal of Consent|2|||
13219990|NCT01827670|26278953|FG000|Overall Study|Lost to Follow-up|0|||
13219991|NCT01827670|26278954|FG001|Overall Study|Lost to Follow-up|1|||
13219992|NCT01827592|26278993|FG000|Overall Study|Adverse Event|11|||
13219993|NCT01827592|26278994|FG001|Overall Study|Adverse Event|9|||
13219994|NCT01827592|26278995|FG002|Overall Study|Adverse Event|2|||
13219995|NCT01827592|26278993|FG000|Overall Study|Physician Decision|0|||
13219996|NCT01827592|26278994|FG001|Overall Study|Physician Decision|2|||
13219997|NCT01827592|26278995|FG002|Overall Study|Physician Decision|1|||
13219998|NCT01827592|26278993|FG000|Overall Study|Protocol Violation|2|||
13219999|NCT01827592|26278994|FG001|Overall Study|Protocol Violation|1|||
13220000|NCT01827592|26278995|FG002|Overall Study|Protocol Violation|0|||
13220001|NCT01827592|26278993|FG000|Overall Study|Lost to Follow-up|1|||
13220002|NCT01827592|26278994|FG001|Overall Study|Lost to Follow-up|2|||
13220003|NCT01827592|26278995|FG002|Overall Study|Lost to Follow-up|2|||
13462973|NCT00111800|26972321|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
13462974|NCT00111800|26972322|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
13462975|NCT00111800|26972323|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
13462976|NCT00111800|26972324|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
13462977|NCT00111800|26972325|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3|||
13462978|NCT00111800|26972326|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
13462979|NCT00111800|26972321|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
13462980|NCT00111800|26972322|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
13462981|NCT00111800|26972323|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
13462982|NCT00111800|26972324|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
13462983|NCT00111800|26972325|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
13462984|NCT00111800|26972326|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
13462985|NCT00111800|26972321|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
13462986|NCT00111800|26972322|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
13462987|NCT00111800|26972323|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0|||
13462988|NCT00111800|26972324|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
13462989|NCT00111800|26972325|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
13462990|NCT00111800|26972326|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
13462991|NCT00111800|26972321|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
13462992|NCT00111800|26972322|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1|||
13462993|NCT00111800|26972323|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
13462994|NCT00111800|26972324|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
13462995|NCT00111800|26972325|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
13462996|NCT00111800|26972326|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
13462997|NCT00111800|26972321|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
13462998|NCT00111800|26972322|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
13462999|NCT00111800|26972323|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1|||
13463000|NCT00111800|26972324|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
13463001|NCT00111800|26972325|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
13463002|NCT00111800|26972326|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
13463003|NCT00111800|26972321|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
13463004|NCT00111800|26972322|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
13463005|NCT00111800|26972323|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1|||
13463006|NCT00111800|26972324|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
13463007|NCT00111800|26972325|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
13463008|NCT00111800|26972326|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
13463009|NCT00111761|26972350|FG000|Part 1|Physician Decision|0|||
13463010|NCT00111761|26972351|FG001|Part 1|Physician Decision|1|||
13463011|NCT00111761|26972350|FG000|Part 1|Death|0|||
13463012|NCT00111761|26972351|FG001|Part 1|Death|2|||
13463013|NCT00111761|26972350|FG000|Part 1|Other|0|||
13463014|NCT00111761|26972351|FG001|Part 1|Other|1|||
13463015|NCT00111761|26972350|FG000|Part 1|Withdrawal by Subject|0|||
13463016|NCT00111761|26972351|FG001|Part 1|Withdrawal by Subject|1|||
13463017|NCT00111761|26972350|FG000|Part 2|Adverse Event|1|||
13463018|NCT00111761|26972351|FG001|Part 2|Adverse Event|0|||
13463019|NCT00111761|26972350|FG000|Part 2|Physician Decision|1|||
13463020|NCT00111761|26972351|FG001|Part 2|Physician Decision|0|||
13463021|NCT00111761|26972350|FG000|Part 2|Death|1|||
13463022|NCT00111761|26972351|FG001|Part 2|Death|0|||
13463023|NCT00111761|26972350|FG000|Part 2|Disease progression|3|||
13463024|NCT00111761|26972351|FG001|Part 2|Disease progression|0|||
13463025|NCT00111761|26972350|FG000|Part 2|Protocol-specified criteria|1|||
13463026|NCT00111761|26972351|FG001|Part 2|Protocol-specified criteria|0|||
13463027|NCT00111761|26972350|FG000|Part 2|Other|1|||
13463028|NCT00111761|26972351|FG001|Part 2|Other|0|||
13463029|NCT00111475|26972498|FG000|Overall Study|Lost to Follow-up|0|||
13463030|NCT00111475|26972499|FG001|Overall Study|Lost to Follow-up|0|||
13463031|NCT00111475|26972500|FG002|Overall Study|Lost to Follow-up|0|||
13463032|NCT00111475|26972501|FG003|Overall Study|Lost to Follow-up|0|||
13463033|NCT00111475|26972502|FG004|Overall Study|Lost to Follow-up|0|||
13463034|NCT00111475|26972503|FG005|Overall Study|Lost to Follow-up|1|||
13463035|NCT00111475|26972504|FG006|Overall Study|Lost to Follow-up|0|||
13463036|NCT00111475|26972505|FG007|Overall Study|Lost to Follow-up|0|||
13463037|NCT00111475|26972506|FG008|Overall Study|Lost to Follow-up|0|||
13463038|NCT00111475|26972507|FG009|Overall Study|Lost to Follow-up|0|||
13463039|NCT00111241|26972522|FG000|Overall Study|Lost to Follow-up|1|||
13463040|NCT00111241|26972523|FG001|Overall Study|Lost to Follow-up|0|||
13463041|NCT00111241|26972522|FG000|Overall Study|Withdrawal by Subject|4|||
13463042|NCT00111241|26972523|FG001|Overall Study|Withdrawal by Subject|0|||
13463043|NCT00111241|26972522|FG000|Overall Study|Protocol Violation|9|||
13463044|NCT00111241|26972523|FG001|Overall Study|Protocol Violation|8|||
13463045|NCT00111241|26972522|FG000|Overall Study|Adverse Event|1|||
13463046|NCT00111241|26972523|FG001|Overall Study|Adverse Event|0|||
13463047|NCT00111228|26972544|FG000|Overall Study|Withdrawal by Subject|5|||
13463048|NCT00111228|26972545|FG001|Overall Study|Withdrawal by Subject|1|||
13463049|NCT00111228|26972546|FG002|Overall Study|Withdrawal by Subject|0|||
13463050|NCT00111007|26972567|FG000|Double-blind (DB) Treatment|Adverse Event|12|||
13463051|NCT00111007|26972568|FG001|Double-blind (DB) Treatment|Adverse Event|4|||
13463052|NCT00111007|26972567|FG000|Double-blind (DB) Treatment|Death|5|||
13463053|NCT00111007|26972568|FG001|Double-blind (DB) Treatment|Death|2|||
13463054|NCT00111007|26972567|FG000|Double-blind (DB) Treatment|Protocol Violation|0|||
13463055|NCT00111007|26972568|FG001|Double-blind (DB) Treatment|Protocol Violation|1|||
13463056|NCT00111007|26972567|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6|||
13463057|NCT00111007|26972568|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8|||
13463058|NCT00111007|26972567|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1|||
13463059|NCT00111007|26972568|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0|||
13463060|NCT00111007|26972567|FG000|Double-blind (DB) Treatment|Relapse|1|||
13463061|NCT00111007|26972568|FG001|Double-blind (DB) Treatment|Relapse|0|||
13463062|NCT00111007|26972567|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0|||
13463063|NCT00111007|26972568|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
13463064|NCT00111007|26972567|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83|||
13463065|NCT00111007|26972568|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93|||
13463066|NCT00111007|26972567|FG000|Double-blind (DB) Treatment|Primary reason with other category|0|||
13463067|NCT00111007|26972568|FG001|Double-blind (DB) Treatment|Primary reason with other category|1|||
13463068|NCT00111007|26972567|FG000|Active Follow-up|Adverse Event|1|||
13463069|NCT00111007|26972568|FG001|Active Follow-up|Adverse Event|0|||
13463070|NCT00111007|26972567|FG000|Active Follow-up|Death|2|||
13463071|NCT00111007|26972568|FG001|Active Follow-up|Death|0|||
13463072|NCT00111007|26972567|FG000|Active Follow-up|Disease progression/recurrence/relapse|3|||
13463073|NCT00111007|26972568|FG001|Active Follow-up|Disease progression/recurrence/relapse|2|||
13463074|NCT00111007|26972567|FG000|Long Term Follow-up|Death|34|||
13463075|NCT00111007|26972568|FG001|Long Term Follow-up|Death|39|||
13463076|NCT00111007|26972567|FG000|Long Term Follow-up|Lost to Follow-up|1|||
13463077|NCT00111007|26972568|FG001|Long Term Follow-up|Lost to Follow-up|1|||
13463078|NCT00111007|26972567|FG000|Long Term Follow-up|Withdrawal by Subject|0|||
13463079|NCT00111007|26972568|FG001|Long Term Follow-up|Withdrawal by Subject|1|||
13463080|NCT00111007|26972567|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2|||
13463081|NCT00111007|26972568|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1|||
13463082|NCT00111007|26972567|FG000|Long Term Follow-up|Missing|10|||
13463083|NCT00111007|26972568|FG001|Long Term Follow-up|Missing|3|||
13463084|NCT00110994|26972599|FG000|Double-blind (DB) Treatment|Adverse Event|3|||
13463085|NCT00110994|26972600|FG001|Double-blind (DB) Treatment|Adverse Event|0|||
13463086|NCT00110994|26972599|FG000|Double-blind (DB) Treatment|Death|1|||
13463087|NCT00110994|26972600|FG001|Double-blind (DB) Treatment|Death|0|||
13463088|NCT00110994|26972599|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0|||
13463089|NCT00110994|26972600|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2|||
13463090|NCT00110994|26972599|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
13463091|NCT00110994|26972600|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1|||
13463092|NCT00110994|26972599|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34|||
13463093|NCT00110994|26972600|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41|||
13463094|NCT00110994|26972599|FG000|Double-blind (DB) Treatment|other reasons|2|||
13463095|NCT00110994|26972600|FG001|Double-blind (DB) Treatment|other reasons|3|||
13463096|NCT00110994|26972599|FG000|Active Follow-up|Disease progression/recurrence/replace|1|||
13463097|NCT00110994|26972600|FG001|Active Follow-up|Disease progression/recurrence/replace|0|||
13463098|NCT00110994|26972599|FG000|Active Follow-up|Other reasons|0|||
13463099|NCT00110994|26972600|FG001|Active Follow-up|Other reasons|2|||
13463100|NCT00110994|26972599|FG000|Long Term Follow-up|Death|19|||
13463101|NCT00110994|26972600|FG001|Long Term Follow-up|Death|17|||
13463102|NCT00110890|26972621|FG000|Overall Study|Adverse Event|30|||
13463103|NCT00110890|26972622|FG001|Overall Study|Adverse Event|7|||
13463104|NCT00110890|26972621|FG000|Overall Study|Death|16|||
13463105|NCT00110890|26972622|FG001|Overall Study|Death|9|||
13463106|NCT00110890|26972621|FG000|Overall Study|Lost to Follow-up|3|||
13463107|NCT00110890|26972622|FG001|Overall Study|Lost to Follow-up|1|||
13463108|NCT00110890|26972621|FG000|Overall Study|Physician Decision|4|||
13463109|NCT00110890|26972622|FG001|Overall Study|Physician Decision|5|||
13463110|NCT00110890|26972621|FG000|Overall Study|Withdrawal by Subject|17|||
13463111|NCT00110890|26972622|FG001|Overall Study|Withdrawal by Subject|5|||
13463112|NCT00110890|26972621|FG000|Overall Study|Protocol Deviation|1|||
13463113|NCT00110890|26972622|FG001|Overall Study|Protocol Deviation|0|||
13463114|NCT00110890|26972621|FG000|Overall Study|Noncompliance|10|||
13463115|NCT00110890|26972622|FG001|Overall Study|Noncompliance|0|||
13463116|NCT00110890|26972621|FG000|Overall Study|Kidney Transplant|16|||
13463117|NCT00110890|26972622|FG001|Overall Study|Kidney Transplant|12|||
13463118|NCT00110890|26972621|FG000|Overall Study|Invest. Product Commercially Available|217|||
13463119|NCT00110890|26972622|FG001|Overall Study|Invest. Product Commercially Available|110|||
13463120|NCT00110890|26972621|FG000|Overall Study|Other|34|||
13463121|NCT00110890|26972622|FG001|Overall Study|Other|23|||
13463122|NCT00110890|26972621|FG000|Overall Study|Ineligibility determined|3|||
13463123|NCT00110890|26972622|FG001|Overall Study|Ineligibility determined|0|||
13463124|NCT00110890|26972621|FG000|Overall Study|Requirement for alternative therapy|0|||
13463125|NCT00110890|26972622|FG001|Overall Study|Requirement for alternative therapy|1|||
13463126|NCT00110890|26972621|FG000|Overall Study|Disease progression|0|||
13463127|NCT00110890|26972622|FG001|Overall Study|Disease progression|1|||
13463128|NCT00110890|26972621|FG000|Overall Study|Parathyroidectomy|0|||
13463129|NCT00110890|26972622|FG001|Overall Study|Parathyroidectomy|1|||
13463130|NCT00110890|26972621|FG000|Overall Study|Did not enter follow-up phase|10|||
13463131|NCT00110890|26972622|FG001|Overall Study|Did not enter follow-up phase|4|||
13463132|NCT00110812|26972675|FG000|Main Study|Death|0|||
13463133|NCT00110812|26972676|FG001|Main Study|Death|0|||
13463134|NCT00110812|26972677|FG002|Main Study|Death|2|||
13463135|NCT00110812|26972675|FG000|Main Study|Withdrawal by Subject|0|||
13463136|NCT00110812|26972676|FG001|Main Study|Withdrawal by Subject|0|||
13463137|NCT00110812|26972677|FG002|Main Study|Withdrawal by Subject|1|||
13463138|NCT00110812|26972675|FG000|Main Study|Lost to Follow-up|8|||
13463139|NCT00110812|26972676|FG001|Main Study|Lost to Follow-up|11|||
13463140|NCT00110812|26972677|FG002|Main Study|Lost to Follow-up|10|||
13463141|NCT00110812|26972675|FG000|Extended Follow-up|Death|1|||
13463142|NCT00110812|26972676|FG001|Extended Follow-up|Death|0|||
13463143|NCT00110812|26972677|FG002|Extended Follow-up|Death|3|||
13463144|NCT00110812|26972675|FG000|Extended Follow-up|Withdrawal by Subject|0|||
13463145|NCT00110812|26972676|FG001|Extended Follow-up|Withdrawal by Subject|1|||
13463146|NCT00110812|26972677|FG002|Extended Follow-up|Withdrawal by Subject|0|||
13463147|NCT00110812|26972675|FG000|Extended Follow-up|Lost to Follow-up|1|||
13463148|NCT00110812|26972676|FG001|Extended Follow-up|Lost to Follow-up|3|||
13463149|NCT00110812|26972677|FG002|Extended Follow-up|Lost to Follow-up|1|||
13463150|NCT00110617|26972697|FG000|Overall Study|Adverse Event|2|||
13463151|NCT00110617|26972698|FG001|Overall Study|Adverse Event|4|||
13463152|NCT00110617|26972697|FG000|Overall Study|Abnormal Laboratory Value|4|||
13463153|NCT00110617|26972698|FG001|Overall Study|Abnormal Laboratory Value|2|||
13463154|NCT00110617|26972697|FG000|Overall Study|Lack of Efficacy|1|||
13463155|NCT00110617|26972698|FG001|Overall Study|Lack of Efficacy|0|||
13463156|NCT00110617|26972697|FG000|Overall Study|Patient no longer requires study drug|1|||
13463157|NCT00110617|26972698|FG001|Overall Study|Patient no longer requires study drug|0|||
13463158|NCT00110617|26972697|FG000|Overall Study|Protocol Violation|5|||
13463159|NCT00110617|26972698|FG001|Overall Study|Protocol Violation|0|||
13463160|NCT00110617|26972697|FG000|Overall Study|Withdrawal by Subject|10|||
13463161|NCT00110617|26972698|FG001|Overall Study|Withdrawal by Subject|4|||
13463162|NCT00110617|26972697|FG000|Overall Study|Lost to Follow-up|9|||
13463163|NCT00110617|26972698|FG001|Overall Study|Lost to Follow-up|1|||
13463164|NCT00110617|26972697|FG000|Overall Study|Administrative problems|6|||
13463165|NCT00110617|26972698|FG001|Overall Study|Administrative problems|5|||
13463166|NCT00110617|26972697|FG000|Overall Study|Death|1|||
13463167|NCT00110617|26972698|FG001|Overall Study|Death|1|||
13463168|NCT00110617|26972697|FG000|Overall Study|Did not receive study drug|0|||
13463169|NCT00110617|26972698|FG001|Overall Study|Did not receive study drug|12|||
13463170|NCT00110396|26972706|FG000|Overall Study|Adverse Event|15|||
13463171|NCT00110396|26972706|FG000|Overall Study|Lost to Follow-up|1|||
13463172|NCT00110396|26972706|FG000|Overall Study|Administration of plasmapheresis|1|||
13463173|NCT00110396|26972706|FG000|Overall Study|Initiated mitoxantrone therapy|1|||
13463174|NCT00110396|26972706|FG000|Overall Study|Lack of Efficacy|1|||
13463175|NCT00110396|26972706|FG000|Overall Study|Decided not to continue treatment|1|||
13463176|NCT00110396|26972706|FG000|Overall Study|Patient non-compliance|1|||
13463177|NCT00110396|26972706|FG000|Overall Study|Patient refused to continue|1|||
13463178|NCT00110396|26972706|FG000|Overall Study|Patient refused to participate|1|||
13463179|NCT00110396|26972706|FG000|Overall Study|Patient will|1|||
13463180|NCT00110396|26972706|FG000|Overall Study|Patient's decision|1|||
13463181|NCT00110396|26972706|FG000|Overall Study|Participation in MS vaccine study|1|||
13463182|NCT00110396|26972706|FG000|Overall Study|Pregnancy|1|||
13463183|NCT00110396|26972706|FG000|Overall Study|Pregnancy (Protocol violation)|2|||
13463184|NCT00110396|26972706|FG000|Overall Study|Protocol Violation|2|||
13463185|NCT00110396|26972706|FG000|Overall Study|Patient refused to come back|1|||
13463186|NCT00110396|26972706|FG000|Overall Study|The patient has refused|2|||
13463187|NCT00110396|26972706|FG000|Overall Study|The patient has refused to visit site|1|||
13463188|NCT00110396|26972706|FG000|Overall Study|Patient is to be administered copaxone|1|||
13463189|NCT00110357|26972797|FG000|Overall Study|Deterioration without progression|2|||
13463190|NCT00110357|26972798|FG001|Overall Study|Deterioration without progression|0|||
13463191|NCT00110357|26972797|FG000|Overall Study|Disease progression/relapse|20|||
13463192|NCT00110357|26972798|FG001|Overall Study|Disease progression/relapse|15|||
13463193|NCT00110357|26972797|FG000|Overall Study|Study Closure|1|||
13463194|NCT00110357|26972798|FG001|Overall Study|Study Closure|0|||
13463195|NCT00110357|26972797|FG000|Overall Study|Study Drug Toxicity|1|||
13463196|NCT00110357|26972798|FG001|Overall Study|Study Drug Toxicity|3|||
13463197|NCT00110357|26972797|FG000|Overall Study|Withdrawal by Subject|3|||
13463198|NCT00110357|26972798|FG001|Overall Study|Withdrawal by Subject|1|||
13463199|NCT00110305|26972860|FG000|Overall Study|Adverse Event|46|||
13463200|NCT00110305|26972861|FG001|Overall Study|Adverse Event|13|||
13463201|NCT00110305|26972860|FG000|Overall Study|Sponsors Decision|1|||
13463202|NCT00110305|26972861|FG001|Overall Study|Sponsors Decision|0|||
13463203|NCT00110305|26972860|FG000|Overall Study|Subject Non-Compliant|9|||
13463204|NCT00110305|26972861|FG001|Overall Study|Subject Non-Compliant|2|||
13463205|NCT00110305|26972860|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
13463206|NCT00110305|26972861|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
13463207|NCT00110305|26972860|FG000|Overall Study|Subject Reached A Virologic Endpoint|21|||
13463208|NCT00110305|26972861|FG001|Overall Study|Subject Reached A Virologic Endpoint|3|||
13463209|NCT00110305|26972860|FG000|Overall Study|Protocol Violation|0|||
13463210|NCT00110305|26972861|FG001|Overall Study|Protocol Violation|1|||
13463211|NCT00110305|26972860|FG000|Overall Study|Withdrawal by Subject|7|||
13463212|NCT00110305|26972861|FG001|Overall Study|Withdrawal by Subject|7|||
13463213|NCT00110305|26972860|FG000|Overall Study|Lost to Follow-up|20|||
13463214|NCT00110305|26972861|FG001|Overall Study|Lost to Follow-up|3|||
13463215|NCT00110305|26972860|FG000|Overall Study|Other|8|||
13463216|NCT00110305|26972861|FG001|Overall Study|Other|2|||
13463217|NCT00110266|26972879|FG000|Overall Study|Adverse Event|27|||
13463218|NCT00110266|26972879|FG000|Overall Study|Abnormal laboratory value|15|||
13463219|NCT00110266|26972879|FG000|Overall Study|Withdrawal by Subject|16|||
13463220|NCT00110266|26972879|FG000|Overall Study|Death|17|||
13463221|NCT00110266|26972879|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
13463222|NCT00110266|26972879|FG000|Overall Study|Participant condition no longer requires study drug|1|||
13463223|NCT00110214|26972898|FG000|Overall Study|Never started treatment|21|||
13463224|NCT00110214|26972899|FG001|Overall Study|Never started treatment|20|||
13463225|NCT00110214|26972898|FG000|Overall Study|Disease progression or death|260|||
13463226|NCT00110214|26972899|FG001|Overall Study|Disease progression or death|151|||
13463227|NCT00110214|26972898|FG000|Overall Study|Adverse Event|115|||
13463228|NCT00110214|26972899|FG001|Overall Study|Adverse Event|192|||
13463229|NCT00110214|26972898|FG000|Overall Study|Refused further treatment|52|||
13463230|NCT00110214|26972899|FG001|Overall Study|Refused further treatment|65|||
13463231|NCT00110214|26972898|FG000|Overall Study|Other (not specified)|61|||
13463232|NCT00110214|26972899|FG001|Overall Study|Other (not specified)|75|||
13463233|NCT00110149|26972906|FG000|Overall Study|Physician Decision|3|||
13463234|NCT00110084|26972915|FG000|Overall Study|Adverse Event|9|||
13463235|NCT00110084|26972915|FG000|Overall Study|Death|1|||
13463236|NCT00110084|26972915|FG000|Overall Study|Patient Refusal|10|||
13463237|NCT00110084|26972915|FG000|Overall Study|Alternate Therapy|5|||
13463238|NCT00110084|26972915|FG000|Overall Study|Intercurrent Illness|1|||
13463239|NCT00110084|26972915|FG000|Overall Study|Other|2|||
13463240|NCT00110019|26972932|FG000|Overall Study|Lack of Efficacy|253|||
13463241|NCT00110019|26972933|FG001|Overall Study|Lack of Efficacy|285|||
13463242|NCT00110019|26972932|FG000|Overall Study|Adverse Event|61|||
13463243|NCT00110019|26972933|FG001|Overall Study|Adverse Event|40|||
13463244|NCT00110019|26972932|FG000|Overall Study|Death|13|||
13463245|NCT00110019|26972933|FG001|Overall Study|Death|15|||
13463246|NCT00110019|26972932|FG000|Overall Study|Withdrawal by Subject|21|||
13463247|NCT00110019|26972933|FG001|Overall Study|Withdrawal by Subject|9|||
13463248|NCT00110019|26972932|FG000|Overall Study|alternative therapy|5|||
13463249|NCT00110019|26972933|FG001|Overall Study|alternative therapy|1|||
13463250|NCT00110019|26972932|FG000|Overall Study|complicating disease|1|||
13463251|NCT00110019|26972933|FG001|Overall Study|complicating disease|1|||
13463252|NCT00110019|26972932|FG000|Overall Study|symptom deterioration|13|||
13463253|NCT00110019|26972933|FG001|Overall Study|symptom deterioration|16|||
13463254|NCT00110019|26972932|FG000|Overall Study|Not start protocol therapy|17|||
13463255|NCT00110019|26972933|FG001|Overall Study|Not start protocol therapy|16|||
13463256|NCT00110019|26972932|FG000|Overall Study|other reasons|22|||
13463257|NCT00110019|26972933|FG001|Overall Study|other reasons|30|||
13463258|NCT00109707|26972968|FG000|Overall Study|Discontinued in core study without entering the extension study|215|||
13463259|NCT00109707|26972969|FG001|Overall Study|Discontinued in core study without entering the extension study|122|||
13463260|NCT00109707|26972970|FG002|Overall Study|Discontinued in core study without entering the extension study|34|||
13463261|NCT00109707|26972968|FG000|Overall Study|Abnormal laboratory values|1|||
13463262|NCT00109707|26972969|FG001|Overall Study|Abnormal laboratory values|0|||
13463263|NCT00109707|26972970|FG002|Overall Study|Abnormal laboratory values|0|||
13463264|NCT00109707|26972968|FG000|Overall Study|Administrative problems|2|||
13463265|NCT00109707|26972969|FG001|Overall Study|Administrative problems|0|||
13463266|NCT00109707|26972970|FG002|Overall Study|Administrative problems|1|||
13463267|NCT00109707|26972968|FG000|Overall Study|Adverse Event|10|||
13463268|NCT00109707|26972969|FG001|Overall Study|Adverse Event|2|||
13463269|NCT00109707|26972970|FG002|Overall Study|Adverse Event|3|||
13463270|NCT00109707|26972968|FG000|Overall Study|Death|4|||
13463271|NCT00109707|26972969|FG001|Overall Study|Death|0|||
13463272|NCT00109707|26972970|FG002|Overall Study|Death|0|||
13463273|NCT00109707|26972968|FG000|Overall Study|Disease progression|12|||
13463274|NCT00109707|26972969|FG001|Overall Study|Disease progression|4|||
13463275|NCT00109707|26972970|FG002|Overall Study|Disease progression|3|||
13463276|NCT00109707|26972968|FG000|Overall Study|Lost to Follow-up|3|||
13463277|NCT00109707|26972969|FG001|Overall Study|Lost to Follow-up|0|||
13463278|NCT00109707|26972970|FG002|Overall Study|Lost to Follow-up|0|||
13463279|NCT00109707|26972968|FG000|Overall Study|Protocol Violation|1|||
13463280|NCT00109707|26972969|FG001|Overall Study|Protocol Violation|0|||
13463281|NCT00109707|26972970|FG002|Overall Study|Protocol Violation|0|||
13463282|NCT00109707|26972968|FG000|Overall Study|Patient withdrew consent|6|||
13463283|NCT00109707|26972969|FG001|Overall Study|Patient withdrew consent|1|||
13463284|NCT00109707|26972970|FG002|Overall Study|Patient withdrew consent|0|||
13463285|NCT00109577|26972983|FG000|Overall Study|Withdrawal by Subject|3|||
13463286|NCT00109577|26972984|FG001|Overall Study|Withdrawal by Subject|3|||
13463287|NCT00109343|26973035|FG000|Overall Study|Adverse Event|1|||
13463288|NCT00109343|26973036|FG001|Overall Study|Adverse Event|0|||
13463289|NCT00109343|26973037|FG002|Overall Study|Adverse Event|2|||
13463290|NCT00109343|26973035|FG000|Overall Study|Lack of Efficacy|1|||
13463291|NCT00109343|26973036|FG001|Overall Study|Lack of Efficacy|0|||
13463292|NCT00109343|26973037|FG002|Overall Study|Lack of Efficacy|0|||
13463293|NCT00109343|26973035|FG000|Overall Study|Lost to Follow-up|35|||
13463294|NCT00109343|26973036|FG001|Overall Study|Lost to Follow-up|20|||
13463295|NCT00109343|26973037|FG002|Overall Study|Lost to Follow-up|14|||
13463296|NCT00109343|26973035|FG000|Overall Study|Protocol Violation|1|||
13463297|NCT00109343|26973036|FG001|Overall Study|Protocol Violation|2|||
13463298|NCT00109343|26973037|FG002|Overall Study|Protocol Violation|2|||
13463299|NCT00109343|26973035|FG000|Overall Study|Withdrawal by Subject|15|||
13463300|NCT00109343|26973036|FG001|Overall Study|Withdrawal by Subject|11|||
13463301|NCT00109343|26973037|FG002|Overall Study|Withdrawal by Subject|10|||
13463302|NCT00109343|26973035|FG000|Overall Study|Subject Moved|6|||
13463303|NCT00109343|26973036|FG001|Overall Study|Subject Moved|2|||
13463304|NCT00109343|26973037|FG002|Overall Study|Subject Moved|1|||
13463305|NCT00109343|26973035|FG000|Overall Study|Other|5|||
13463306|NCT00109343|26973036|FG001|Overall Study|Other|2|||
13463307|NCT00109343|26973037|FG002|Overall Study|Other|1|||
13463308|NCT00108485|26973050|FG000|Overall Study|Withdrawal by Subject|3|||
13463309|NCT00108485|26973051|FG001|Overall Study|Withdrawal by Subject|0|||
13463310|NCT00108485|26973050|FG000|Overall Study|Lost to Follow-up|0|||
13463311|NCT00108485|26973051|FG001|Overall Study|Lost to Follow-up|2|||
13463312|NCT00108433|26973072|FG000|Overall Study|Lack of Efficacy|1|||
13463313|NCT00108433|26973073|FG001|Overall Study|Lack of Efficacy|2|||
13463314|NCT00108433|26973072|FG000|Overall Study|Death|3|||
13463315|NCT00108433|26973073|FG001|Overall Study|Death|0|||
13463316|NCT00108433|26973072|FG000|Overall Study|Adverse Event|3|||
13463317|NCT00108433|26973073|FG001|Overall Study|Adverse Event|1|||
13463318|NCT00108433|26973072|FG000|Overall Study|Other|14|||
13463319|NCT00108433|26973073|FG001|Overall Study|Other|14|||
13463320|NCT00108355|26973088|FG000|Overall Study|Peritonitis at index paracentesis|1|||
13463321|NCT00108355|26973089|FG001|Overall Study|Peritonitis at index paracentesis|1|||
13463322|NCT00108355|26973088|FG000|Overall Study|Loculated ascites, limiting paracentesis|1|||
13463323|NCT00108355|26973089|FG001|Overall Study|Loculated ascites, limiting paracentesis|1|||
13463324|NCT00108069|26973110|FG000|Overall Study|Never rec'd study drug|0|||
13463325|NCT00108069|26973111|FG001|Overall Study|Never rec'd study drug|1|||
13463326|NCT00108069|26973110|FG000|Overall Study|Adverse Event|1|||
13463327|NCT00108069|26973111|FG001|Overall Study|Adverse Event|1|||
13463328|NCT00108069|26973110|FG000|Overall Study|Withdrawal by Subject|1|||
13463329|NCT00108069|26973111|FG001|Overall Study|Withdrawal by Subject|0|||
13463330|NCT00108069|26973110|FG000|Overall Study|Death|1|||
13463331|NCT00108069|26973111|FG001|Overall Study|Death|0|||
13463332|NCT00108069|26973110|FG000|Overall Study|Progessive disease|27|||
13463333|NCT00108069|26973111|FG001|Overall Study|Progessive disease|11|||
13463334|NCT00107783|26973132|FG000|Overall Study|Adverse Event|0|||
13463335|NCT00107783|26973133|FG001|Overall Study|Adverse Event|2|||
13463336|NCT00107783|26973132|FG000|Overall Study|Death|0|||
13463337|NCT00107783|26973133|FG001|Overall Study|Death|1|||
13463338|NCT00107783|26973132|FG000|Overall Study|Withdrawal by Subject|2|||
13463339|NCT00107783|26973133|FG001|Overall Study|Withdrawal by Subject|0|||
13463340|NCT00107783|26973132|FG000|Overall Study|Second hip replacement|1|||
13463341|NCT00107783|26973133|FG001|Overall Study|Second hip replacement|1|||
13463342|NCT00107653|26973186|FG000|Overall Study|Adverse Event|24|||
13463343|NCT00107653|26973187|FG001|Overall Study|Adverse Event|43|||
13463344|NCT00107653|26973186|FG000|Overall Study|Insufficient Therapeutic Response|25|||
13463345|NCT00107653|26973187|FG001|Overall Study|Insufficient Therapeutic Response|11|||
13463346|NCT00107653|26973186|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
13463347|NCT00107653|26973187|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
13463348|NCT00107653|26973186|FG000|Overall Study|Protocol Violation|1|||
13463349|NCT00107653|26973187|FG001|Overall Study|Protocol Violation|0|||
13463350|NCT00107653|26973186|FG000|Overall Study|Withdrawal by Subject|12|||
13463351|NCT00107653|26973187|FG001|Overall Study|Withdrawal by Subject|13|||
13463352|NCT00107653|26973186|FG000|Overall Study|Lost to Follow-up|13|||
13463353|NCT00107653|26973187|FG001|Overall Study|Lost to Follow-up|5|||
13463354|NCT00107653|26973186|FG000|Overall Study|Administrative Reasons|3|||
13463355|NCT00107653|26973187|FG001|Overall Study|Administrative Reasons|3|||
13463356|NCT00106704|26973202|FG000|Overall Study|Adverse Event|10|||
13463357|NCT00106704|26973203|FG001|Overall Study|Adverse Event|7|||
13463358|NCT00106704|26973202|FG000|Overall Study|Death|2|||
13463359|NCT00106704|26973203|FG001|Overall Study|Death|1|||
13463360|NCT00106704|26973202|FG000|Overall Study|Lack of Efficacy|67|||
13463361|NCT00106704|26973203|FG001|Overall Study|Lack of Efficacy|69|||
13463362|NCT00106704|26973202|FG000|Overall Study|Lost to Follow-up|7|||
13463363|NCT00106704|26973203|FG001|Overall Study|Lost to Follow-up|3|||
13463364|NCT00106704|26973202|FG000|Overall Study|Pregnancy|1|||
13463365|NCT00106704|26973203|FG001|Overall Study|Pregnancy|0|||
13463366|NCT00106704|26973202|FG000|Overall Study|Protocol Violation|4|||
13463367|NCT00106704|26973203|FG001|Overall Study|Protocol Violation|7|||
13463368|NCT00106704|26973202|FG000|Overall Study|Withdrawal by Subject|14|||
13463369|NCT00106704|26973203|FG001|Overall Study|Withdrawal by Subject|21|||
13463370|NCT00106704|26973202|FG000|Overall Study|Patient moved|1|||
13463371|NCT00106704|26973203|FG001|Overall Study|Patient moved|0|||
13463372|NCT00106704|26973202|FG000|Overall Study|Site terminated|0|||
13463373|NCT00106704|26973203|FG001|Overall Study|Site terminated|1|||
13463374|NCT00106704|26973202|FG000|Overall Study|Planned major surgery|1|||
13463375|NCT00106704|26973203|FG001|Overall Study|Planned major surgery|0|||
13463376|NCT00106704|26973202|FG000|Overall Study|Patient Received Glycemic Medication|22|||
13463377|NCT00106704|26973203|FG001|Overall Study|Patient Received Glycemic Medication|41|||
13463378|NCT00106704|26973202|FG000|Overall Study|Unable to re-enter US|1|||
13463379|NCT00106704|26973203|FG001|Overall Study|Unable to re-enter US|0|||
13463380|NCT00106704|26973202|FG000|Overall Study|Laboratory test|1|||
13463381|NCT00106704|26973203|FG001|Overall Study|Laboratory test|1|||
13463382|NCT00106639|26973336|FG000|Overall Study|Adverse Event|3|||
13463383|NCT00106639|26973337|FG001|Overall Study|Adverse Event|4|||
13463384|NCT00106639|26973338|FG002|Overall Study|Adverse Event|1|||
13463385|NCT00106639|26973336|FG000|Overall Study|Protocol Violation|0|||
13463386|NCT00106639|26973337|FG001|Overall Study|Protocol Violation|1|||
13463387|NCT00106639|26973338|FG002|Overall Study|Protocol Violation|0|||
13463388|NCT00106639|26973336|FG000|Overall Study|Withdrawal by Subject|0|||
13463389|NCT00106639|26973337|FG001|Overall Study|Withdrawal by Subject|1|||
13463390|NCT00106639|26973338|FG002|Overall Study|Withdrawal by Subject|0|||
13463391|NCT00106639|26973336|FG000|Overall Study|Participant defaulted|0|||
13463392|NCT00106639|26973337|FG001|Overall Study|Participant defaulted|1|||
13463393|NCT00106639|26973338|FG002|Overall Study|Participant defaulted|1|||
13463394|NCT00106353|26973475|FG000|Part 1|Disease progression|3|||
13463395|NCT00106353|26973476|FG001|Part 1|Disease progression|4|||
13463396|NCT00106353|26973477|FG002|Part 1|Disease progression|1|||
13463397|NCT00106353|26973478|FG003|Part 1|Disease progression|3|||
13463398|NCT00106353|26973479|FG004|Part 1|Disease progression|0|||
13463399|NCT00106353|26973480|FG005|Part 1|Disease progression|0|||
13463400|NCT00106353|26973481|FG006|Part 1|Disease progression|0|||
13463401|NCT00106353|26973475|FG000|Part 1|Withdrawal by Subject|0|||
13463402|NCT00106353|26973476|FG001|Part 1|Withdrawal by Subject|0|||
13463403|NCT00106353|26973477|FG002|Part 1|Withdrawal by Subject|1|||
13463404|NCT00106353|26973478|FG003|Part 1|Withdrawal by Subject|2|||
13463405|NCT00106353|26973479|FG004|Part 1|Withdrawal by Subject|0|||
13463406|NCT00106353|26973480|FG005|Part 1|Withdrawal by Subject|0|||
13463407|NCT00106353|26973481|FG006|Part 1|Withdrawal by Subject|0|||
13463408|NCT00106353|26973475|FG000|Part 1|Symptomatic deterioration|0|||
13463409|NCT00106353|26973476|FG001|Part 1|Symptomatic deterioration|0|||
13463410|NCT00106353|26973477|FG002|Part 1|Symptomatic deterioration|1|||
13463411|NCT00106353|26973478|FG003|Part 1|Symptomatic deterioration|0|||
13463412|NCT00106353|26973479|FG004|Part 1|Symptomatic deterioration|0|||
13463413|NCT00106353|26973480|FG005|Part 1|Symptomatic deterioration|0|||
13463414|NCT00106353|26973481|FG006|Part 1|Symptomatic deterioration|0|||
13463415|NCT00106353|26973475|FG000|Part 1|Entered follow-up phase|1|||
13463416|NCT00106353|26973476|FG001|Part 1|Entered follow-up phase|1|||
13463417|NCT00106353|26973477|FG002|Part 1|Entered follow-up phase|0|||
13463418|NCT00106353|26973478|FG003|Part 1|Entered follow-up phase|1|||
13463419|NCT00106353|26973479|FG004|Part 1|Entered follow-up phase|0|||
13463420|NCT00106353|26973480|FG005|Part 1|Entered follow-up phase|0|||
13463421|NCT00106353|26973481|FG006|Part 1|Entered follow-up phase|0|||
13463422|NCT00106353|26973475|FG000|Part 1|Adverse Event|0|||
13463423|NCT00106353|26973476|FG001|Part 1|Adverse Event|0|||
13463424|NCT00106353|26973477|FG002|Part 1|Adverse Event|0|||
13463425|NCT00106353|26973478|FG003|Part 1|Adverse Event|1|||
13463426|NCT00106353|26973479|FG004|Part 1|Adverse Event|0|||
13463427|NCT00106353|26973480|FG005|Part 1|Adverse Event|0|||
13463428|NCT00106353|26973481|FG006|Part 1|Adverse Event|0|||
13463429|NCT00106353|26973475|FG000|Part 2|Disease progression|0|||
13463430|NCT00106353|26973476|FG001|Part 2|Disease progression|0|||
13463431|NCT00106353|26973477|FG002|Part 2|Disease progression|0|||
13463432|NCT00106353|26973478|FG003|Part 2|Disease progression|0|||
13463433|NCT00106353|26973479|FG004|Part 2|Disease progression|8|||
13463434|NCT00106353|26973480|FG005|Part 2|Disease progression|14|||
13463435|NCT00106353|26973481|FG006|Part 2|Disease progression|13|||
13463436|NCT00106353|26973475|FG000|Part 2|Death|0|||
13463437|NCT00106353|26973476|FG001|Part 2|Death|0|||
13463438|NCT00106353|26973477|FG002|Part 2|Death|0|||
13463439|NCT00106353|26973478|FG003|Part 2|Death|0|||
13463440|NCT00106353|26973479|FG004|Part 2|Death|3|||
13463441|NCT00106353|26973480|FG005|Part 2|Death|0|||
13463442|NCT00106353|26973481|FG006|Part 2|Death|1|||
13463443|NCT00106353|26973475|FG000|Part 2|Symptomatic deterioration|0|||
13463444|NCT00106353|26973476|FG001|Part 2|Symptomatic deterioration|0|||
13463445|NCT00106353|26973477|FG002|Part 2|Symptomatic deterioration|0|||
13463446|NCT00106353|26973478|FG003|Part 2|Symptomatic deterioration|0|||
13463447|NCT00106353|26973479|FG004|Part 2|Symptomatic deterioration|3|||
13463448|NCT00106353|26973480|FG005|Part 2|Symptomatic deterioration|0|||
13463449|NCT00106353|26973481|FG006|Part 2|Symptomatic deterioration|0|||
13463450|NCT00106353|26973475|FG000|Part 2|Adverse Event|0|||
13463451|NCT00106353|26973476|FG001|Part 2|Adverse Event|0|||
13463452|NCT00106353|26973477|FG002|Part 2|Adverse Event|0|||
13463453|NCT00106353|26973478|FG003|Part 2|Adverse Event|0|||
13463454|NCT00106353|26973479|FG004|Part 2|Adverse Event|0|||
13463455|NCT00106353|26973480|FG005|Part 2|Adverse Event|2|||
13463456|NCT00106353|26973481|FG006|Part 2|Adverse Event|1|||
13463457|NCT00106353|26973475|FG000|Part 2|Other|0|||
13463458|NCT00106353|26973476|FG001|Part 2|Other|0|||
13463459|NCT00106353|26973477|FG002|Part 2|Other|0|||
13463460|NCT00106353|26973478|FG003|Part 2|Other|0|||
13463461|NCT00106353|26973479|FG004|Part 2|Other|1|||
13463462|NCT00106353|26973480|FG005|Part 2|Other|1|||
13463463|NCT00106353|26973481|FG006|Part 2|Other|1|||
13463464|NCT00106353|26973475|FG000|Part 2|Withdrawal by Subject|0|||
13463465|NCT00106353|26973476|FG001|Part 2|Withdrawal by Subject|0|||
13463466|NCT00106353|26973477|FG002|Part 2|Withdrawal by Subject|0|||
13463467|NCT00106353|26973478|FG003|Part 2|Withdrawal by Subject|0|||
13463468|NCT00106353|26973479|FG004|Part 2|Withdrawal by Subject|1|||
13463469|NCT00106353|26973480|FG005|Part 2|Withdrawal by Subject|0|||
13463470|NCT00106353|26973481|FG006|Part 2|Withdrawal by Subject|0|||
13463471|NCT00106353|26973475|FG000|Part 2|Physician Decision|0|||
13463472|NCT00106353|26973476|FG001|Part 2|Physician Decision|0|||
13463473|NCT00106353|26973477|FG002|Part 2|Physician Decision|0|||
13463474|NCT00106353|26973478|FG003|Part 2|Physician Decision|0|||
13463475|NCT00106353|26973479|FG004|Part 2|Physician Decision|0|||
13463476|NCT00106353|26973480|FG005|Part 2|Physician Decision|1|||
13463477|NCT00106353|26973481|FG006|Part 2|Physician Decision|0|||
13463478|NCT00106249|26973498|FG000|Overall Study|Lost to Follow-up|3|||
13463479|NCT00106249|26973499|FG001|Overall Study|Lost to Follow-up|2|||
13463480|NCT00105521|26973534|FG000|Overall Study|Other|1|||
13463481|NCT00105521|26973535|FG001|Overall Study|Other|1|||
13463482|NCT00105521|26973536|FG002|Overall Study|Other|2|||
13463483|NCT00105521|26973537|FG003|Overall Study|Other|0|||
13463484|NCT00105521|26973534|FG000|Overall Study|Adverse Event|10|||
13463485|NCT00105521|26973535|FG001|Overall Study|Adverse Event|4|||
13463486|NCT00105521|26973536|FG002|Overall Study|Adverse Event|10|||
13463487|NCT00105521|26973537|FG003|Overall Study|Adverse Event|8|||
13463488|NCT00105521|26973534|FG000|Overall Study|Withdrawal by Subject|1|||
13463489|NCT00105521|26973535|FG001|Overall Study|Withdrawal by Subject|0|||
13463490|NCT00105521|26973536|FG002|Overall Study|Withdrawal by Subject|1|||
13463491|NCT00105521|26973537|FG003|Overall Study|Withdrawal by Subject|4|||
13463492|NCT00105521|26973534|FG000|Overall Study|Lack of Efficacy|0|||
13463493|NCT00105521|26973535|FG001|Overall Study|Lack of Efficacy|0|||
13463494|NCT00105521|26973536|FG002|Overall Study|Lack of Efficacy|0|||
13463495|NCT00105521|26973537|FG003|Overall Study|Lack of Efficacy|1|||
13463496|NCT00105521|26973534|FG000|Overall Study|Protocol Violation|3|||
13463497|NCT00105521|26973535|FG001|Overall Study|Protocol Violation|5|||
13463498|NCT00105521|26973536|FG002|Overall Study|Protocol Violation|4|||
13463499|NCT00105521|26973537|FG003|Overall Study|Protocol Violation|4|||
13463500|NCT00105521|26973534|FG000|Overall Study|Lost to Follow-up|0|||
13463501|NCT00105521|26973535|FG001|Overall Study|Lost to Follow-up|1|||
13463502|NCT00105521|26973536|FG002|Overall Study|Lost to Follow-up|0|||
13463503|NCT00105521|26973537|FG003|Overall Study|Lost to Follow-up|0|||
13463504|NCT00105508|26973556|FG000|Overall Study|Prephase Dropout|1|||
13463505|NCT00105508|26973557|FG001|Overall Study|Prephase Dropout|0|||
13463506|NCT00105508|26973556|FG000|Overall Study|Adverse Event|16|||
13463507|NCT00105508|26973557|FG001|Overall Study|Adverse Event|19|||
13463508|NCT00105508|26973556|FG000|Overall Study|Insufficient Efficacy|1|||
13463509|NCT00105508|26973557|FG001|Overall Study|Insufficient Efficacy|0|||
13463510|NCT00105508|26973556|FG000|Overall Study|Withdrawal by Subject|10|||
13463511|NCT00105508|26973557|FG001|Overall Study|Withdrawal by Subject|6|||
13463512|NCT00105508|26973556|FG000|Overall Study|Lost to Follow-up|3|||
13463513|NCT00105508|26973557|FG001|Overall Study|Lost to Follow-up|0|||
13463514|NCT00105508|26973556|FG000|Overall Study|Protocol Violation|1|||
13463515|NCT00105508|26973557|FG001|Overall Study|Protocol Violation|2|||
13463516|NCT00105508|26973556|FG000|Overall Study|Other|8|||
13463517|NCT00105508|26973557|FG001|Overall Study|Other|9|||
13463518|NCT00105469|26973572|FG000|Overall Study|Adverse Event|9|||
13463519|NCT00105469|26973573|FG001|Overall Study|Adverse Event|8|||
13463520|NCT00105469|26973572|FG000|Overall Study|Protocol Violation|4|||
13463521|NCT00105469|26973573|FG001|Overall Study|Protocol Violation|0|||
13463522|NCT00105469|26973572|FG000|Overall Study|Withdrawal by Subject|2|||
13463523|NCT00105469|26973573|FG001|Overall Study|Withdrawal by Subject|3|||
13463524|NCT00105469|26973572|FG000|Overall Study|Lost to Follow-up|1|||
13463525|NCT00105469|26973573|FG001|Overall Study|Lost to Follow-up|0|||
13463526|NCT00105469|26973572|FG000|Overall Study|Lack of Efficacy|2|||
13463527|NCT00105469|26973573|FG001|Overall Study|Lack of Efficacy|0|||
13463528|NCT00105469|26973572|FG000|Overall Study|Other Reason|4|||
13463529|NCT00105469|26973573|FG001|Overall Study|Other Reason|0|||
13463530|NCT00105235|26973586|FG000|Overall Study|Death|4|||
13463531|NCT00105235|26973586|FG000|Overall Study|Physician Decision|1|||
13463532|NCT00105235|26973586|FG000|Overall Study|Withdrawal by Subject|2|||
13463533|NCT00105196|26973613|FG000|Overall Study|Lack of Efficacy|2|||
13463534|NCT00105196|26973614|FG001|Overall Study|Lack of Efficacy|3|||
13463535|NCT00105196|26973613|FG000|Overall Study|Adverse Event|11|||
13463536|NCT00105196|26973614|FG001|Overall Study|Adverse Event|3|||
13463537|NCT00105196|26973613|FG000|Overall Study|Withdrawal by Subject|6|||
13463538|NCT00105196|26973614|FG001|Overall Study|Withdrawal by Subject|6|||
13463539|NCT00105196|26973613|FG000|Overall Study|Lost to Follow-up|3|||
13463540|NCT00105196|26973614|FG001|Overall Study|Lost to Follow-up|2|||
13463541|NCT00105196|26973613|FG000|Overall Study|Poor/noncompliance|3|||
13463542|NCT00105196|26973614|FG001|Overall Study|Poor/noncompliance|4|||
13463543|NCT00105196|26973613|FG000|Overall Study|Protocol Violation|5|||
13463544|NCT00105196|26973614|FG001|Overall Study|Protocol Violation|2|||
13463545|NCT00105196|26973613|FG000|Overall Study|pending surgery|0|||
13463546|NCT00105196|26973614|FG001|Overall Study|pending surgery|1|||
13463547|NCT00105196|26973613|FG000|Overall Study|marijuana use|0|||
13463548|NCT00105196|26973614|FG001|Overall Study|marijuana use|1|||
13463549|NCT00105196|26973613|FG000|Overall Study|Subject became unblinded|0|||
13463550|NCT00105196|26973614|FG001|Overall Study|Subject became unblinded|1|||
13463551|NCT00105066|26973631|FG000|Overall Study|Adverse Event|2|||
13463552|NCT00105066|26973632|FG001|Overall Study|Adverse Event|5|||
13463553|NCT00104572|26973659|FG000|Overall Study|Withdrawal by Subject|3|||
13463554|NCT00104572|26973660|FG001|Overall Study|Withdrawal by Subject|3|||
13463555|NCT00104572|26973661|FG002|Overall Study|Withdrawal by Subject|0|||
13463556|NCT00104520|26973686|FG000|Overall Study|Unrelated adverse event|34|||
13463557|NCT00104520|26973687|FG001|Overall Study|Unrelated adverse event|47|||
13463558|NCT00104520|26973686|FG000|Overall Study|Study drug intolerance|0|||
13463559|NCT00104520|26973687|FG001|Overall Study|Study drug intolerance|1|||
13463560|NCT00104520|26973686|FG000|Overall Study|Related adverse event|13|||
13463561|NCT00104520|26973687|FG001|Overall Study|Related adverse event|15|||
13463562|NCT00104520|26973686|FG000|Overall Study|Lost to Follow-up|1|||
13463563|NCT00104520|26973687|FG001|Overall Study|Lost to Follow-up|0|||
13463564|NCT00104520|26973686|FG000|Overall Study|Noncompliance|0|||
13463565|NCT00104520|26973687|FG001|Overall Study|Noncompliance|2|||
13463566|NCT00104520|26973686|FG000|Overall Study|Personal/administrative|1|||
13463567|NCT00104520|26973687|FG001|Overall Study|Personal/administrative|1|||
13463568|NCT00104520|26973686|FG000|Overall Study|Other|1|||
13463569|NCT00104520|26973687|FG001|Overall Study|Other|5|||
13463570|NCT00104299|26973714|FG000|Overall Study|Adverse Event|3|||
13463571|NCT00104299|26973715|FG001|Overall Study|Adverse Event|1|||
13463572|NCT00104299|26973714|FG000|Overall Study|Death|2|||
13463573|NCT00104299|26973715|FG001|Overall Study|Death|2|||
13463574|NCT00104299|26973714|FG000|Overall Study|Withdrawal by Subject|2|||
13463575|NCT00104299|26973715|FG001|Overall Study|Withdrawal by Subject|6|||
13463576|NCT00104299|26973714|FG000|Overall Study|Physician Decision|1|||
13463577|NCT00104299|26973715|FG001|Overall Study|Physician Decision|1|||
13463578|NCT00104299|26973714|FG000|Overall Study|To have renal transplant|1|||
13463579|NCT00104299|26973715|FG001|Overall Study|To have renal transplant|0|||
13463580|NCT00104247|26973728|FG000|Overall Study|Withdrawal by Subject|1|||
13463581|NCT00104247|26973729|FG001|Overall Study|Withdrawal by Subject|0|||
13463582|NCT00104247|26973728|FG000|Overall Study|Noncompliant with dosing|0|||
13463583|NCT00104247|26973729|FG001|Overall Study|Noncompliant with dosing|1|||
13463584|NCT00103857|26973814|FG000|54-Week Base Study|Adverse Event|12|||
13463585|NCT00103857|26973815|FG001|54-Week Base Study|Adverse Event|9|||
13463586|NCT00103857|26973816|FG002|54-Week Base Study|Adverse Event|11|||
13463587|NCT00103857|26973817|FG003|54-Week Base Study|Adverse Event|6|||
13463588|NCT00103857|26973818|FG004|54-Week Base Study|Adverse Event|5|||
13463589|NCT00103857|26973819|FG005|54-Week Base Study|Adverse Event|11|||
13463590|NCT00103857|26973820|FG006|54-Week Base Study|Adverse Event|3|||
13463591|NCT00103857|26973814|FG000|54-Week Base Study|Death|0|||
13463592|NCT00103857|26973815|FG001|54-Week Base Study|Death|0|||
13463593|NCT00103857|26973816|FG002|54-Week Base Study|Death|0|||
13463594|NCT00103857|26973817|FG003|54-Week Base Study|Death|0|||
13463595|NCT00103857|26973818|FG004|54-Week Base Study|Death|1|||
13463596|NCT00103857|26973819|FG005|54-Week Base Study|Death|1|||
13463597|NCT00103857|26973820|FG006|54-Week Base Study|Death|0|||
13463598|NCT00103857|26973814|FG000|54-Week Base Study|Lack of Efficacy|11|||
13463599|NCT00103857|26973815|FG001|54-Week Base Study|Lack of Efficacy|14|||
13463600|NCT00103857|26973816|FG002|54-Week Base Study|Lack of Efficacy|8|||
13463601|NCT00103857|26973817|FG003|54-Week Base Study|Lack of Efficacy|4|||
13463602|NCT00103857|26973818|FG004|54-Week Base Study|Lack of Efficacy|3|||
13463603|NCT00103857|26973819|FG005|54-Week Base Study|Lack of Efficacy|14|||
13463604|NCT00103857|26973820|FG006|54-Week Base Study|Lack of Efficacy|19|||
13463605|NCT00103857|26973814|FG000|54-Week Base Study|Lost to Follow-up|5|||
13463606|NCT00103857|26973815|FG001|54-Week Base Study|Lost to Follow-up|4|||
13463607|NCT00103857|26973816|FG002|54-Week Base Study|Lost to Follow-up|7|||
13463608|NCT00103857|26973817|FG003|54-Week Base Study|Lost to Follow-up|5|||
13463609|NCT00103857|26973818|FG004|54-Week Base Study|Lost to Follow-up|10|||
13463610|NCT00103857|26973819|FG005|54-Week Base Study|Lost to Follow-up|9|||
13463611|NCT00103857|26973820|FG006|54-Week Base Study|Lost to Follow-up|3|||
13463612|NCT00103857|26973814|FG000|54-Week Base Study|Physician Decision|1|||
13463613|NCT00103857|26973815|FG001|54-Week Base Study|Physician Decision|1|||
13463614|NCT00103857|26973816|FG002|54-Week Base Study|Physician Decision|0|||
13463615|NCT00103857|26973817|FG003|54-Week Base Study|Physician Decision|0|||
13463616|NCT00103857|26973818|FG004|54-Week Base Study|Physician Decision|1|||
13463617|NCT00103857|26973819|FG005|54-Week Base Study|Physician Decision|0|||
13463618|NCT00103857|26973820|FG006|54-Week Base Study|Physician Decision|0|||
13463619|NCT00103857|26973814|FG000|54-Week Base Study|Pregnancy|1|||
13463620|NCT00103857|26973815|FG001|54-Week Base Study|Pregnancy|0|||
13463621|NCT00103857|26973816|FG002|54-Week Base Study|Pregnancy|0|||
13463622|NCT00103857|26973817|FG003|54-Week Base Study|Pregnancy|0|||
13463623|NCT00103857|26973818|FG004|54-Week Base Study|Pregnancy|1|||
13463624|NCT00103857|26973819|FG005|54-Week Base Study|Pregnancy|0|||
13463625|NCT00103857|26973820|FG006|54-Week Base Study|Pregnancy|1|||
13463626|NCT00103857|26973814|FG000|54-Week Base Study|Protocol Violation|6|||
13463627|NCT00103857|26973815|FG001|54-Week Base Study|Protocol Violation|4|||
13463628|NCT00103857|26973816|FG002|54-Week Base Study|Protocol Violation|2|||
13463629|NCT00103857|26973817|FG003|54-Week Base Study|Protocol Violation|4|||
13463630|NCT00103857|26973818|FG004|54-Week Base Study|Protocol Violation|0|||
13463631|NCT00103857|26973819|FG005|54-Week Base Study|Protocol Violation|3|||
13463632|NCT00103857|26973820|FG006|54-Week Base Study|Protocol Violation|3|||
13463633|NCT00103857|26973814|FG000|54-Week Base Study|Withdrawal by Subject|17|||
13463634|NCT00103857|26973815|FG001|54-Week Base Study|Withdrawal by Subject|16|||
13463635|NCT00103857|26973816|FG002|54-Week Base Study|Withdrawal by Subject|16|||
13463636|NCT00103857|26973817|FG003|54-Week Base Study|Withdrawal by Subject|15|||
13463637|NCT00103857|26973818|FG004|54-Week Base Study|Withdrawal by Subject|10|||
13463638|NCT00103857|26973819|FG005|54-Week Base Study|Withdrawal by Subject|15|||
13463639|NCT00103857|26973820|FG006|54-Week Base Study|Withdrawal by Subject|4|||
13463640|NCT00103857|26973814|FG000|54-Week Base Study|protocol discontinuation criteria|2|||
13463641|NCT00103857|26973815|FG001|54-Week Base Study|protocol discontinuation criteria|5|||
13463642|NCT00103857|26973816|FG002|54-Week Base Study|protocol discontinuation criteria|2|||
13463643|NCT00103857|26973817|FG003|54-Week Base Study|protocol discontinuation criteria|6|||
13463644|NCT00103857|26973818|FG004|54-Week Base Study|protocol discontinuation criteria|5|||
13463645|NCT00103857|26973819|FG005|54-Week Base Study|protocol discontinuation criteria|3|||
13463646|NCT00103857|26973820|FG006|54-Week Base Study|protocol discontinuation criteria|5|||
13463647|NCT00103857|26973814|FG000|54-Week Base Study|patient moved|0|||
13463648|NCT00103857|26973815|FG001|54-Week Base Study|patient moved|1|||
13463649|NCT00103857|26973816|FG002|54-Week Base Study|patient moved|1|||
13463650|NCT00103857|26973817|FG003|54-Week Base Study|patient moved|2|||
13463651|NCT00103857|26973818|FG004|54-Week Base Study|patient moved|3|||
13463652|NCT00103857|26973819|FG005|54-Week Base Study|patient moved|1|||
13463653|NCT00103857|26973820|FG006|54-Week Base Study|patient moved|0|||
13463654|NCT00103857|26973814|FG000|54-Week Base Study|non-compliance with study procedures|1|||
13463655|NCT00103857|26973815|FG001|54-Week Base Study|non-compliance with study procedures|2|||
13463656|NCT00103857|26973816|FG002|54-Week Base Study|non-compliance with study procedures|0|||
13463657|NCT00103857|26973817|FG003|54-Week Base Study|non-compliance with study procedures|0|||
13463658|NCT00103857|26973818|FG004|54-Week Base Study|non-compliance with study procedures|0|||
13463659|NCT00103857|26973819|FG005|54-Week Base Study|non-compliance with study procedures|2|||
13463660|NCT00103857|26973820|FG006|54-Week Base Study|non-compliance with study procedures|0|||
13463661|NCT00103857|26973814|FG000|54-Week Base Study|patient incarcerated|0|||
13463662|NCT00103857|26973815|FG001|54-Week Base Study|patient incarcerated|0|||
13463663|NCT00103857|26973816|FG002|54-Week Base Study|patient incarcerated|0|||
13463664|NCT00103857|26973817|FG003|54-Week Base Study|patient incarcerated|0|||
13463665|NCT00103857|26973818|FG004|54-Week Base Study|patient incarcerated|1|||
13463666|NCT00103857|26973819|FG005|54-Week Base Study|patient incarcerated|1|||
13463667|NCT00103857|26973820|FG006|54-Week Base Study|patient incarcerated|0|||
13463668|NCT00103857|26973814|FG000|54-Week Base Study|laboratory reporting error|0|||
13463669|NCT00103857|26973815|FG001|54-Week Base Study|laboratory reporting error|0|||
13463670|NCT00103857|26973816|FG002|54-Week Base Study|laboratory reporting error|0|||
13463671|NCT00103857|26973817|FG003|54-Week Base Study|laboratory reporting error|0|||
13463672|NCT00103857|26973818|FG004|54-Week Base Study|laboratory reporting error|1|||
13463673|NCT00103857|26973819|FG005|54-Week Base Study|laboratory reporting error|0|||
13463674|NCT00103857|26973820|FG006|54-Week Base Study|laboratory reporting error|0|||
13463675|NCT00103857|26973814|FG000|54-Week Base Study|site error|0|||
13463676|NCT00103857|26973815|FG001|54-Week Base Study|site error|0|||
13463677|NCT00103857|26973816|FG002|54-Week Base Study|site error|0|||
13463678|NCT00103857|26973817|FG003|54-Week Base Study|site error|0|||
13463679|NCT00103857|26973818|FG004|54-Week Base Study|site error|0|||
13463680|NCT00103857|26973819|FG005|54-Week Base Study|site error|1|||
13463681|NCT00103857|26973820|FG006|54-Week Base Study|site error|0|||
13463682|NCT00103857|26973814|FG000|54-Week Base Study|patient intolerance to rescue therapy|1|||
13463683|NCT00103857|26973815|FG001|54-Week Base Study|patient intolerance to rescue therapy|0|||
13463684|NCT00103857|26973816|FG002|54-Week Base Study|patient intolerance to rescue therapy|0|||
13463685|NCT00103857|26973817|FG003|54-Week Base Study|patient intolerance to rescue therapy|0|||
13463686|NCT00103857|26973818|FG004|54-Week Base Study|patient intolerance to rescue therapy|0|||
13463687|NCT00103857|26973819|FG005|54-Week Base Study|patient intolerance to rescue therapy|0|||
13463688|NCT00103857|26973820|FG006|54-Week Base Study|patient intolerance to rescue therapy|0|||
13463689|NCT00103857|26973814|FG000|50-Week Extension Study|Adverse Event|2|||
13463690|NCT00103857|26973815|FG001|50-Week Extension Study|Adverse Event|3|||
13463691|NCT00103857|26973816|FG002|50-Week Extension Study|Adverse Event|2|||
13463692|NCT00103857|26973817|FG003|50-Week Extension Study|Adverse Event|0|||
13463693|NCT00103857|26973818|FG004|50-Week Extension Study|Adverse Event|1|||
13463694|NCT00103857|26973819|FG005|50-Week Extension Study|Adverse Event|1|||
13463695|NCT00103857|26973820|FG006|50-Week Extension Study|Adverse Event|0|||
13463696|NCT00103857|26973814|FG000|50-Week Extension Study|Death|0|||
13463697|NCT00103857|26973815|FG001|50-Week Extension Study|Death|0|||
13463698|NCT00103857|26973816|FG002|50-Week Extension Study|Death|0|||
13463699|NCT00103857|26973817|FG003|50-Week Extension Study|Death|1|||
13463700|NCT00103857|26973818|FG004|50-Week Extension Study|Death|0|||
13463701|NCT00103857|26973819|FG005|50-Week Extension Study|Death|1|||
13463702|NCT00103857|26973820|FG006|50-Week Extension Study|Death|0|||
13463703|NCT00103857|26973814|FG000|50-Week Extension Study|Lack of Efficacy|26|||
13463704|NCT00103857|26973815|FG001|50-Week Extension Study|Lack of Efficacy|15|||
13463705|NCT00103857|26973816|FG002|50-Week Extension Study|Lack of Efficacy|13|||
13463706|NCT00103857|26973817|FG003|50-Week Extension Study|Lack of Efficacy|16|||
13463707|NCT00103857|26973818|FG004|50-Week Extension Study|Lack of Efficacy|8|||
13463708|NCT00103857|26973819|FG005|50-Week Extension Study|Lack of Efficacy|8|||
13463709|NCT00103857|26973820|FG006|50-Week Extension Study|Lack of Efficacy|0|||
13463710|NCT00103857|26973814|FG000|50-Week Extension Study|Lost to Follow-up|4|||
13463711|NCT00103857|26973815|FG001|50-Week Extension Study|Lost to Follow-up|0|||
13463712|NCT00103857|26973816|FG002|50-Week Extension Study|Lost to Follow-up|1|||
13463713|NCT00103857|26973817|FG003|50-Week Extension Study|Lost to Follow-up|4|||
13463714|NCT00103857|26973818|FG004|50-Week Extension Study|Lost to Follow-up|3|||
13463715|NCT00103857|26973819|FG005|50-Week Extension Study|Lost to Follow-up|3|||
13463716|NCT00103857|26973820|FG006|50-Week Extension Study|Lost to Follow-up|0|||
13463717|NCT00103857|26973814|FG000|50-Week Extension Study|Physician Decision|0|||
13463718|NCT00103857|26973815|FG001|50-Week Extension Study|Physician Decision|1|||
13463719|NCT00103857|26973816|FG002|50-Week Extension Study|Physician Decision|1|||
13463720|NCT00103857|26973817|FG003|50-Week Extension Study|Physician Decision|0|||
13463721|NCT00103857|26973818|FG004|50-Week Extension Study|Physician Decision|0|||
13463722|NCT00103857|26973819|FG005|50-Week Extension Study|Physician Decision|0|||
13463723|NCT00103857|26973820|FG006|50-Week Extension Study|Physician Decision|0|||
13463724|NCT00103857|26973814|FG000|50-Week Extension Study|Pregnancy|0|||
13463725|NCT00103857|26973815|FG001|50-Week Extension Study|Pregnancy|0|||
13463726|NCT00103857|26973816|FG002|50-Week Extension Study|Pregnancy|1|||
13463727|NCT00103857|26973817|FG003|50-Week Extension Study|Pregnancy|0|||
13463728|NCT00103857|26973818|FG004|50-Week Extension Study|Pregnancy|1|||
13463729|NCT00103857|26973819|FG005|50-Week Extension Study|Pregnancy|0|||
13463730|NCT00103857|26973820|FG006|50-Week Extension Study|Pregnancy|0|||
13463731|NCT00103857|26973814|FG000|50-Week Extension Study|Protocol Violation|1|||
13463732|NCT00103857|26973815|FG001|50-Week Extension Study|Protocol Violation|1|||
13463733|NCT00103857|26973816|FG002|50-Week Extension Study|Protocol Violation|1|||
13463734|NCT00103857|26973817|FG003|50-Week Extension Study|Protocol Violation|2|||
13463735|NCT00103857|26973818|FG004|50-Week Extension Study|Protocol Violation|0|||
13463736|NCT00103857|26973819|FG005|50-Week Extension Study|Protocol Violation|1|||
13463737|NCT00103857|26973820|FG006|50-Week Extension Study|Protocol Violation|0|||
13463738|NCT00103857|26973814|FG000|50-Week Extension Study|Withdrawal by Subject|2|||
13463739|NCT00103857|26973815|FG001|50-Week Extension Study|Withdrawal by Subject|5|||
13463740|NCT00103857|26973816|FG002|50-Week Extension Study|Withdrawal by Subject|2|||
13463741|NCT00103857|26973817|FG003|50-Week Extension Study|Withdrawal by Subject|8|||
13463742|NCT00103857|26973818|FG004|50-Week Extension Study|Withdrawal by Subject|3|||
13463743|NCT00103857|26973819|FG005|50-Week Extension Study|Withdrawal by Subject|3|||
13463744|NCT00103857|26973820|FG006|50-Week Extension Study|Withdrawal by Subject|0|||
13463745|NCT00103857|26973814|FG000|50-Week Extension Study|protocol discontinuation criteria|2|||
13463746|NCT00103857|26973815|FG001|50-Week Extension Study|protocol discontinuation criteria|2|||
13463747|NCT00103857|26973816|FG002|50-Week Extension Study|protocol discontinuation criteria|3|||
13463748|NCT00103857|26973817|FG003|50-Week Extension Study|protocol discontinuation criteria|2|||
13463749|NCT00103857|26973818|FG004|50-Week Extension Study|protocol discontinuation criteria|3|||
13463750|NCT00103857|26973819|FG005|50-Week Extension Study|protocol discontinuation criteria|3|||
13463751|NCT00103857|26973820|FG006|50-Week Extension Study|protocol discontinuation criteria|0|||
13463752|NCT00103857|26973814|FG000|50-Week Extension Study|non-compliance with study procedures|1|||
13463753|NCT00103857|26973815|FG001|50-Week Extension Study|non-compliance with study procedures|0|||
13463754|NCT00103857|26973816|FG002|50-Week Extension Study|non-compliance with study procedures|0|||
13463755|NCT00103857|26973817|FG003|50-Week Extension Study|non-compliance with study procedures|1|||
13463756|NCT00103857|26973818|FG004|50-Week Extension Study|non-compliance with study procedures|1|||
13463757|NCT00103857|26973819|FG005|50-Week Extension Study|non-compliance with study procedures|0|||
13463758|NCT00103857|26973820|FG006|50-Week Extension Study|non-compliance with study procedures|0|||
13463759|NCT00103857|26973814|FG000|50-Week Extension Study|patient moved|0|||
13463760|NCT00103857|26973815|FG001|50-Week Extension Study|patient moved|0|||
13463761|NCT00103857|26973816|FG002|50-Week Extension Study|patient moved|1|||
13463762|NCT00103857|26973817|FG003|50-Week Extension Study|patient moved|2|||
13463763|NCT00103857|26973818|FG004|50-Week Extension Study|patient moved|0|||
13463764|NCT00103857|26973819|FG005|50-Week Extension Study|patient moved|0|||
13463765|NCT00103857|26973820|FG006|50-Week Extension Study|patient moved|0|||
13463766|NCT00103857|26973814|FG000|50-Week Extension Study|patient scheduled for elective surgery|0|||
13463767|NCT00103857|26973815|FG001|50-Week Extension Study|patient scheduled for elective surgery|0|||
13463768|NCT00103857|26973816|FG002|50-Week Extension Study|patient scheduled for elective surgery|1|||
13463769|NCT00103857|26973817|FG003|50-Week Extension Study|patient scheduled for elective surgery|0|||
13463770|NCT00103857|26973818|FG004|50-Week Extension Study|patient scheduled for elective surgery|0|||
13463771|NCT00103857|26973819|FG005|50-Week Extension Study|patient scheduled for elective surgery|0|||
13463772|NCT00103857|26973820|FG006|50-Week Extension Study|patient scheduled for elective surgery|0|||
13463773|NCT00103857|26973814|FG000|50-Week Extension Study|reason unspecified|0|||
13463774|NCT00103857|26973815|FG001|50-Week Extension Study|reason unspecified|0|||
13463775|NCT00103857|26973816|FG002|50-Week Extension Study|reason unspecified|0|||
13463776|NCT00103857|26973817|FG003|50-Week Extension Study|reason unspecified|0|||
13463777|NCT00103857|26973818|FG004|50-Week Extension Study|reason unspecified|1|||
13463778|NCT00103857|26973819|FG005|50-Week Extension Study|reason unspecified|0|||
13463779|NCT00103857|26973820|FG006|50-Week Extension Study|reason unspecified|0|||
13463780|NCT00103402|26973847|FG000|Overall Study|Adverse Event|3|||
13463781|NCT00103402|26973848|FG001|Overall Study|Adverse Event|4|||
13463782|NCT00103402|26973847|FG000|Overall Study|Lost to Follow-up|8|||
13463783|NCT00103402|26973848|FG001|Overall Study|Lost to Follow-up|7|||
13463784|NCT00103402|26973847|FG000|Overall Study|Dissatisfied/No longer interested|6|||
13463785|NCT00103402|26973848|FG001|Overall Study|Dissatisfied/No longer interested|6|||
13463786|NCT00103402|26973847|FG000|Overall Study|Personal constraints/Other|5|||
13463787|NCT00103402|26973848|FG001|Overall Study|Personal constraints/Other|0|||
13463788|NCT00103012|26973866|FG000|Overall Study|Withdrawal by Subject|2|||
13463789|NCT00103012|26973867|FG001|Overall Study|Withdrawal by Subject|1|||
13463790|NCT00103012|26973868|FG002|Overall Study|Withdrawal by Subject|2|||
13463791|NCT00103012|26973866|FG000|Overall Study|Pregnancy|1|||
13463792|NCT00103012|26973867|FG001|Overall Study|Pregnancy|0|||
13463793|NCT00103012|26973868|FG002|Overall Study|Pregnancy|0|||
13463794|NCT00103012|26973866|FG000|Overall Study|Adverse Event|0|||
13463795|NCT00103012|26973867|FG001|Overall Study|Adverse Event|0|||
13463796|NCT00103012|26973868|FG002|Overall Study|Adverse Event|1|||
13463797|NCT00103012|26973866|FG000|Overall Study|Subject non-compliant with medications|0|||
13463798|NCT00103012|26973867|FG001|Overall Study|Subject non-compliant with medications|0|||
13463799|NCT00103012|26973868|FG002|Overall Study|Subject non-compliant with medications|1|||
13463800|NCT00102596|26973880|FG000|Part A|Screen failures|6|||
13463801|NCT00102596|26973881|FG001|Part A|Screen failures|0|||
13463802|NCT00102596|26973880|FG000|Part A|Adverse Event|1|||
13463803|NCT00102596|26973881|FG001|Part A|Adverse Event|0|||
13463804|NCT00102063|26973920|FG000|Overall Study|Lack of Efficacy|5|||
13463805|NCT00102063|26973921|FG001|Overall Study|Lack of Efficacy|1|||
13463806|NCT00102063|26973922|FG002|Overall Study|Lack of Efficacy|1|||
13463807|NCT00102063|26973920|FG000|Overall Study|Adverse Event|7|||
13463808|NCT00102063|26973921|FG001|Overall Study|Adverse Event|4|||
13463809|NCT00102063|26973922|FG002|Overall Study|Adverse Event|2|||
13463810|NCT00102063|26973920|FG000|Overall Study|Withdrawal by Subject|4|||
13463811|NCT00102063|26973921|FG001|Overall Study|Withdrawal by Subject|12|||
13463812|NCT00102063|26973922|FG002|Overall Study|Withdrawal by Subject|5|||
13463813|NCT00102063|26973920|FG000|Overall Study|Lost to Follow-up|0|||
13463814|NCT00102063|26973921|FG001|Overall Study|Lost to Follow-up|0|||
13463815|NCT00102063|26973922|FG002|Overall Study|Lost to Follow-up|1|||
13463816|NCT00102063|26973920|FG000|Overall Study|Protocol Violation|0|||
13463817|NCT00102063|26973921|FG001|Overall Study|Protocol Violation|1|||
13463818|NCT00102063|26973922|FG002|Overall Study|Protocol Violation|1|||
13463819|NCT00101868|26973939|FG000|Overall Study|Death|10|||
13463820|NCT00101868|26973940|FG001|Overall Study|Death|10|||
13463821|NCT00101868|26973939|FG000|Overall Study|Withdrawal by Subject|8|||
13463822|NCT00101868|26973940|FG001|Overall Study|Withdrawal by Subject|9|||
13463823|NCT00101868|26973939|FG000|Overall Study|Protocol Violation|3|||
13463824|NCT00101868|26973940|FG001|Overall Study|Protocol Violation|0|||
13463825|NCT00101868|26973939|FG000|Overall Study|Lost to Follow-up|8|||
13463826|NCT00101868|26973940|FG001|Overall Study|Lost to Follow-up|13|||
13463827|NCT00101400|26973951|FG000|Survival Follow-Up|Alive|7|||
13463828|NCT00100178|26973969|FG000|Overall Study|Lost to Follow-up|0|||
13463829|NCT00100178|26973970|FG001|Overall Study|Lost to Follow-up|6|||
13463830|NCT00100178|26973971|FG002|Overall Study|Lost to Follow-up|5|||
13463831|NCT00100178|26973969|FG000|Overall Study|Adverse Event|2|||
13463832|NCT00100178|26973970|FG001|Overall Study|Adverse Event|2|||
13463833|NCT00100178|26973971|FG002|Overall Study|Adverse Event|1|||
13463834|NCT00100178|26973969|FG000|Overall Study|Withdrawal by Subject|1|||
13463835|NCT00100178|26973970|FG001|Overall Study|Withdrawal by Subject|1|||
13463836|NCT00100178|26973971|FG002|Overall Study|Withdrawal by Subject|1|||
13463837|NCT00100178|26973969|FG000|Overall Study|Physician Decision|6|||
13463838|NCT00100178|26973970|FG001|Overall Study|Physician Decision|1|||
13463839|NCT00100178|26973971|FG002|Overall Study|Physician Decision|3|||
13463840|NCT00099983|26973984|FG000|Overall Study|Lost to Follow-up|2|||
13463841|NCT00099983|26973985|FG001|Overall Study|Lost to Follow-up|3|||
13463842|NCT00099983|26973984|FG000|Overall Study|Missing Source Documents|14|||
13463843|NCT00099983|26973985|FG001|Overall Study|Missing Source Documents|15|||
13463844|NCT00099983|26973984|FG000|Overall Study|Withdrawal by Subject|3|||
13463845|NCT00099983|26973985|FG001|Overall Study|Withdrawal by Subject|2|||
13463846|NCT00099983|26973984|FG000|Overall Study|Adverse Event|1|||
13463847|NCT00099983|26973985|FG001|Overall Study|Adverse Event|1|||
13463848|NCT00099983|26973984|FG000|Overall Study|Lack of Efficacy|0|||
13463849|NCT00099983|26973985|FG001|Overall Study|Lack of Efficacy|1|||
13463850|NCT00099983|26973984|FG000|Overall Study|Unable to return for appointments|1|||
13463851|NCT00099983|26973985|FG001|Overall Study|Unable to return for appointments|1|||
13463852|NCT00099983|26973984|FG000|Overall Study|Moved|1|||
13463853|NCT00099983|26973985|FG001|Overall Study|Moved|0|||
13463854|NCT00099983|26973984|FG000|Overall Study|Other psychiatric problem|1|||
13463855|NCT00099983|26973985|FG001|Overall Study|Other psychiatric problem|0|||
13463856|NCT00099983|26973984|FG000|Overall Study|Incarcerated|0|||
13463857|NCT00099983|26973985|FG001|Overall Study|Incarcerated|1|||
13463858|NCT00099983|26973984|FG000|Overall Study|Intolerant of burden of visits|0|||
13463859|NCT00099983|26973985|FG001|Overall Study|Intolerant of burden of visits|1|||
13463860|NCT00099983|26973984|FG000|Overall Study|Other issue|1|||
13463861|NCT00099983|26973985|FG001|Overall Study|Other issue|0|||
13463862|NCT00099632|26974042|FG000|Overall Study|Lost to Follow-up|1|||
13463863|NCT00099632|26974043|FG001|Overall Study|Lost to Follow-up|0|||
13463864|NCT00099632|26974044|FG002|Overall Study|Lost to Follow-up|3|||
13463865|NCT00099632|26974045|FG003|Overall Study|Lost to Follow-up|1|||
13463866|NCT00099632|26974046|FG004|Overall Study|Lost to Follow-up|1|||
13463867|NCT00099632|26974047|FG005|Overall Study|Lost to Follow-up|0|||
13463868|NCT00099632|26974042|FG000|Overall Study|Withdrawal by Subject|0|||
13463869|NCT00099632|26974043|FG001|Overall Study|Withdrawal by Subject|1|||
13463870|NCT00099632|26974044|FG002|Overall Study|Withdrawal by Subject|0|||
13463871|NCT00099632|26974045|FG003|Overall Study|Withdrawal by Subject|0|||
13463872|NCT00099632|26974046|FG004|Overall Study|Withdrawal by Subject|0|||
13463873|NCT00099632|26974047|FG005|Overall Study|Withdrawal by Subject|1|||
13463874|NCT00099632|26974042|FG000|Overall Study|Protocol Violation|0|||
13463875|NCT00099632|26974043|FG001|Overall Study|Protocol Violation|0|||
13463876|NCT00099632|26974044|FG002|Overall Study|Protocol Violation|0|||
13463877|NCT00099632|26974045|FG003|Overall Study|Protocol Violation|0|||
13463878|NCT00099632|26974046|FG004|Overall Study|Protocol Violation|0|||
13463879|NCT00099632|26974047|FG005|Overall Study|Protocol Violation|1|||
13463880|NCT00099359|26974078|FG000|Overall Study|Death|11|||
13463881|NCT00099359|26974079|FG001|Overall Study|Death|15|||
13463882|NCT00099359|26974080|FG002|Overall Study|Death|17|||
13463883|NCT00099359|26974078|FG000|Overall Study|Withdrawal by Subject|19|||
13463884|NCT00099359|26974079|FG001|Overall Study|Withdrawal by Subject|19|||
13463885|NCT00099359|26974080|FG002|Overall Study|Withdrawal by Subject|23|||
13463886|NCT00099359|26974078|FG000|Overall Study|Lost to Follow-up|15|||
13463887|NCT00099359|26974079|FG001|Overall Study|Lost to Follow-up|24|||
13463888|NCT00099359|26974080|FG002|Overall Study|Lost to Follow-up|24|||
13463889|NCT00099359|26974078|FG000|Overall Study|moved out of area|9|||
13463890|NCT00099359|26974079|FG001|Overall Study|moved out of area|7|||
13463891|NCT00099359|26974080|FG002|Overall Study|moved out of area|4|||
13463892|NCT00099268|26974103|FG000|Overall Study|Withdrawal by Subject|46|||
13463893|NCT00099268|26974104|FG001|Overall Study|Withdrawal by Subject|28|||
13463894|NCT00099268|26974103|FG000|Overall Study|Adverse Event|19|||
13463895|NCT00099268|26974104|FG001|Overall Study|Adverse Event|19|||
13463896|NCT00099268|26974103|FG000|Overall Study|Protocol Violation|9|||
13463897|NCT00099268|26974104|FG001|Overall Study|Protocol Violation|8|||
13463898|NCT00099268|26974103|FG000|Overall Study|Lost to Follow-up|6|||
13463899|NCT00099268|26974104|FG001|Overall Study|Lost to Follow-up|4|||
13463900|NCT00099268|26974103|FG000|Overall Study|Lack of Efficacy|5|||
13463901|NCT00099268|26974104|FG001|Overall Study|Lack of Efficacy|18|||
13463902|NCT00099268|26974103|FG000|Overall Study|Administrative problems|4|||
13463903|NCT00099268|26974104|FG001|Overall Study|Administrative problems|4|||
13463904|NCT00099268|26974103|FG000|Overall Study|Death|3|||
13463905|NCT00099268|26974104|FG001|Overall Study|Death|1|||
13463906|NCT00098865|26974112|FG000|Overall Study|Progressive Disease|6|||
13463907|NCT00098865|26974112|FG000|Overall Study|Adverse Event|2|||
13463908|NCT00098865|26974112|FG000|Overall Study|Alternative Therapy|1|||
13463909|NCT00098839|26974130|FG000|Overall Study|Adverse Event|5|||
13463910|NCT00098839|26974131|FG001|Overall Study|Adverse Event|2|||
13463911|NCT00098839|26974130|FG000|Overall Study|Death|1|||
13463912|NCT00098839|26974131|FG001|Overall Study|Death|2|||
13463913|NCT00098839|26974130|FG000|Overall Study|Physician Decision|4|||
13463914|NCT00098839|26974131|FG001|Overall Study|Physician Decision|14|||
13463915|NCT00098839|26974130|FG000|Overall Study|Withdrawal by Subject|1|||
13463916|NCT00098839|26974131|FG001|Overall Study|Withdrawal by Subject|0|||
13463917|NCT00098839|26974130|FG000|Overall Study|Refusal of further protocol therapy|3|||
13463918|NCT00098839|26974131|FG001|Overall Study|Refusal of further protocol therapy|1|||
13463919|NCT00098839|26974130|FG000|Overall Study|Relapse|6|||
13463920|NCT00098839|26974131|FG001|Overall Study|Relapse|3|||
13463921|NCT00098839|26974130|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10|||
13463922|NCT00098839|26974131|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11|||
13463923|NCT00098839|26974130|FG000|Overall Study|Ineligible|2|||
13463924|NCT00098839|26974131|FG001|Overall Study|Ineligible|0|||
13463925|NCT00098813|26974137|FG000|Overall Study|Death|8|||
13463926|NCT00098813|26974137|FG000|Overall Study|Protocol Violation|1|||
13463927|NCT00098813|26974137|FG000|Overall Study|Withdrawal by Subject|7|||
13463928|NCT00098813|26974137|FG000|Overall Study|Progression of Disease|1|||
13463929|NCT00098813|26974137|FG000|Overall Study|Other complicating disease|1|||
13463930|NCT00098813|26974137|FG000|Overall Study|Reversal of RAI resistance|1|||
13463931|NCT00098787|26974161|FG000|Overall Study|Never started treatment|3|||
13463932|NCT00098787|26974162|FG001|Overall Study|Never started treatment|2|||
13463933|NCT00098787|26974163|FG002|Overall Study|Never started treatment|1|||
13463934|NCT00098787|26974161|FG000|Overall Study|Ineligible|9|||
13463935|NCT00098787|26974162|FG001|Overall Study|Ineligible|7|||
13463936|NCT00098787|26974163|FG002|Overall Study|Ineligible|3|||
13463937|NCT00098787|26974161|FG000|Overall Study|Disease progression|28|||
13463938|NCT00098787|26974162|FG001|Overall Study|Disease progression|17|||
13463939|NCT00098787|26974163|FG002|Overall Study|Disease progression|23|||
13463940|NCT00098787|26974161|FG000|Overall Study|Adverse Event|8|||
13463941|NCT00098787|26974162|FG001|Overall Study|Adverse Event|17|||
13463942|NCT00098787|26974163|FG002|Overall Study|Adverse Event|8|||
13463943|NCT00098787|26974161|FG000|Overall Study|Death|6|||
13463944|NCT00098787|26974162|FG001|Overall Study|Death|1|||
13463945|NCT00098787|26974163|FG002|Overall Study|Death|0|||
13463946|NCT00098787|26974161|FG000|Overall Study|Withdrawal by Subject|4|||
13463947|NCT00098787|26974162|FG001|Overall Study|Withdrawal by Subject|12|||
13463948|NCT00098787|26974163|FG002|Overall Study|Withdrawal by Subject|6|||
13463949|NCT00098787|26974161|FG000|Overall Study|Alternative therapy|8|||
13463950|NCT00098787|26974162|FG001|Overall Study|Alternative therapy|13|||
13463951|NCT00098787|26974163|FG002|Overall Study|Alternative therapy|13|||
13463952|NCT00098787|26974161|FG000|Overall Study|Other|7|||
13463953|NCT00098787|26974162|FG001|Overall Study|Other|6|||
13463954|NCT00098787|26974163|FG002|Overall Study|Other|9|||
13463955|NCT00098774|26974172|FG000|Overall Study|Adverse Event|2|||
13463956|NCT00098774|26974172|FG000|Overall Study|Disease Progression|9|||
13463957|NCT00098774|26974172|FG000|Overall Study|Withdrawal by Subject|1|||
13463958|NCT00098774|26974172|FG000|Overall Study|Failed (to respond) during induction|4|||
13463959|NCT00098774|26974172|FG000|Overall Study|Physician Decision|2|||
13463960|NCT00098748|26974235|FG000|Assigned to Study Treatment|Randomized, but not treated|0|||
13463961|NCT00098748|26974236|FG001|Assigned to Study Treatment|Randomized, but not treated|2|||
13463962|NCT00098748|26974237|FG002|Assigned to Study Treatment|Randomized, but not treated|2|||
13463963|NCT00098748|26974235|FG000|Received Study Treatment|Death|2|||
13463964|NCT00098748|26974236|FG001|Received Study Treatment|Death|1|||
13463965|NCT00098748|26974237|FG002|Received Study Treatment|Death|2|||
13463966|NCT00098748|26974235|FG000|Received Study Treatment|Adverse Event|1|||
13463967|NCT00098748|26974236|FG001|Received Study Treatment|Adverse Event|2|||
13463968|NCT00098748|26974237|FG002|Received Study Treatment|Adverse Event|5|||
13463969|NCT00098748|26974235|FG000|Received Study Treatment|Lack of Efficacy|40|||
13463970|NCT00098748|26974236|FG001|Received Study Treatment|Lack of Efficacy|27|||
13463971|NCT00098748|26974237|FG002|Received Study Treatment|Lack of Efficacy|27|||
13463972|NCT00098748|26974235|FG000|Received Study Treatment|Other|2|||
13463973|NCT00098748|26974236|FG001|Received Study Treatment|Other|2|||
13463974|NCT00098748|26974237|FG002|Received Study Treatment|Other|6|||
13463975|NCT00098748|26974235|FG000|Received Study Treatment|Subject defaulted|3|||
13463976|NCT00098748|26974236|FG001|Received Study Treatment|Subject defaulted|4|||
13463977|NCT00098748|26974237|FG002|Received Study Treatment|Subject defaulted|4|||
13463978|NCT00098748|26974235|FG000|Continued on Open-Label Treatment|Adverse Event|0|||
13463979|NCT00098748|26974236|FG001|Continued on Open-Label Treatment|Adverse Event|1|||
13463980|NCT00098748|26974237|FG002|Continued on Open-Label Treatment|Adverse Event|0|||
13463981|NCT00098748|26974235|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1|||
13463982|NCT00098748|26974236|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2|||
13463983|NCT00098748|26974237|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0|||
13463984|NCT00098748|26974235|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6|||
13463985|NCT00098748|26974236|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7|||
13463986|NCT00098748|26974237|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0|||
13463987|NCT00098748|26974235|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1|||
13463988|NCT00098748|26974236|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1|||
13463989|NCT00098748|26974237|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0|||
13463990|NCT00098748|26974235|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
13463991|NCT00098748|26974236|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4|||
13463992|NCT00098748|26974237|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
13463993|NCT00098722|26974314|FG000|Double Blind Phase|Adverse Event|7|||
13463994|NCT00098722|26974315|FG001|Double Blind Phase|Adverse Event|7|||
13463995|NCT00098722|26974316|FG002|Double Blind Phase|Adverse Event|3|||
13463996|NCT00098722|26974317|FG003|Double Blind Phase|Adverse Event|0|||
13463997|NCT00098722|26974318|FG004|Double Blind Phase|Adverse Event|0|||
13463998|NCT00098722|26974319|FG005|Double Blind Phase|Adverse Event|0|||
13463999|NCT00098722|26974320|FG006|Double Blind Phase|Adverse Event|0|||
13464000|NCT00098722|26974314|FG000|Double Blind Phase|Death|2|||
13464001|NCT00098722|26974315|FG001|Double Blind Phase|Death|5|||
13464002|NCT00098722|26974316|FG002|Double Blind Phase|Death|0|||
13464003|NCT00098722|26974317|FG003|Double Blind Phase|Death|0|||
13464004|NCT00098722|26974318|FG004|Double Blind Phase|Death|0|||
13464005|NCT00098722|26974319|FG005|Double Blind Phase|Death|0|||
13464006|NCT00098722|26974320|FG006|Double Blind Phase|Death|0|||
13464007|NCT00098722|26974314|FG000|Double Blind Phase|Lack of Efficacy|21|||
13464008|NCT00098722|26974315|FG001|Double Blind Phase|Lack of Efficacy|23|||
13464009|NCT00098722|26974316|FG002|Double Blind Phase|Lack of Efficacy|15|||
13464010|NCT00098722|26974317|FG003|Double Blind Phase|Lack of Efficacy|0|||
13464011|NCT00098722|26974318|FG004|Double Blind Phase|Lack of Efficacy|0|||
13464012|NCT00098722|26974319|FG005|Double Blind Phase|Lack of Efficacy|0|||
13464013|NCT00098722|26974320|FG006|Double Blind Phase|Lack of Efficacy|0|||
13464014|NCT00098722|26974314|FG000|Double Blind Phase|Participant defaulted|16|||
13464015|NCT00098722|26974315|FG001|Double Blind Phase|Participant defaulted|11|||
13464016|NCT00098722|26974316|FG002|Double Blind Phase|Participant defaulted|9|||
13464017|NCT00098722|26974317|FG003|Double Blind Phase|Participant defaulted|0|||
13464018|NCT00098722|26974318|FG004|Double Blind Phase|Participant defaulted|0|||
13464019|NCT00098722|26974319|FG005|Double Blind Phase|Participant defaulted|0|||
13464020|NCT00098722|26974320|FG006|Double Blind Phase|Participant defaulted|0|||
13464021|NCT00098722|26974314|FG000|Double Blind Phase|Pregnancy|1|||
13464022|NCT00098722|26974315|FG001|Double Blind Phase|Pregnancy|0|||
13464023|NCT00098722|26974316|FG002|Double Blind Phase|Pregnancy|0|||
13464024|NCT00098722|26974317|FG003|Double Blind Phase|Pregnancy|0|||
13464025|NCT00098722|26974318|FG004|Double Blind Phase|Pregnancy|0|||
13464026|NCT00098722|26974319|FG005|Double Blind Phase|Pregnancy|0|||
13464027|NCT00098722|26974320|FG006|Double Blind Phase|Pregnancy|0|||
13464028|NCT00098722|26974314|FG000|Double Blind Phase|Randomized, not treated|4|||
13464029|NCT00098722|26974315|FG001|Double Blind Phase|Randomized, not treated|3|||
13464030|NCT00098722|26974316|FG002|Double Blind Phase|Randomized, not treated|3|||
13464031|NCT00098722|26974317|FG003|Double Blind Phase|Randomized, not treated|0|||
13464032|NCT00098722|26974318|FG004|Double Blind Phase|Randomized, not treated|0|||
13464033|NCT00098722|26974319|FG005|Double Blind Phase|Randomized, not treated|0|||
13464034|NCT00098722|26974320|FG006|Double Blind Phase|Randomized, not treated|0|||
13464035|NCT00098722|26974314|FG000|Double Blind Phase|Ongoing at cut-off date|128|||
13464036|NCT00098722|26974315|FG001|Double Blind Phase|Ongoing at cut-off date|137|||
13464037|NCT00098722|26974316|FG002|Double Blind Phase|Ongoing at cut-off date|57|||
13464038|NCT00098722|26974317|FG003|Double Blind Phase|Ongoing at cut-off date|0|||
13464039|NCT00098722|26974318|FG004|Double Blind Phase|Ongoing at cut-off date|0|||
13464040|NCT00098722|26974319|FG005|Double Blind Phase|Ongoing at cut-off date|0|||
13464041|NCT00098722|26974320|FG006|Double Blind Phase|Ongoing at cut-off date|0|||
13464042|NCT00098722|26974314|FG000|Double Blind Phase|Other|7|||
13464043|NCT00098722|26974315|FG001|Double Blind Phase|Other|8|||
13464044|NCT00098722|26974316|FG002|Double Blind Phase|Other|7|||
13464045|NCT00098722|26974317|FG003|Double Blind Phase|Other|0|||
13464046|NCT00098722|26974318|FG004|Double Blind Phase|Other|0|||
13464047|NCT00098722|26974319|FG005|Double Blind Phase|Other|0|||
13464048|NCT00098722|26974320|FG006|Double Blind Phase|Other|0|||
13464049|NCT00098722|26974314|FG000|Open Label Phase|Adverse Event|0|||
13464050|NCT00098722|26974315|FG001|Open Label Phase|Adverse Event|0|||
13464051|NCT00098722|26974316|FG002|Open Label Phase|Adverse Event|0|||
13464052|NCT00098722|26974317|FG003|Open Label Phase|Adverse Event|5|||
13464053|NCT00098722|26974318|FG004|Open Label Phase|Adverse Event|0|||
13464054|NCT00098722|26974319|FG005|Open Label Phase|Adverse Event|0|||
13464055|NCT00098722|26974320|FG006|Open Label Phase|Adverse Event|0|||
13464056|NCT00098722|26974314|FG000|Open Label Phase|Death|0|||
13464057|NCT00098722|26974315|FG001|Open Label Phase|Death|0|||
13464058|NCT00098722|26974316|FG002|Open Label Phase|Death|0|||
13464059|NCT00098722|26974317|FG003|Open Label Phase|Death|2|||
13464060|NCT00098722|26974318|FG004|Open Label Phase|Death|0|||
13464061|NCT00098722|26974319|FG005|Open Label Phase|Death|0|||
13464062|NCT00098722|26974320|FG006|Open Label Phase|Death|0|||
13464063|NCT00098722|26974314|FG000|Open Label Phase|Lack of Efficacy|0|||
13464064|NCT00098722|26974315|FG001|Open Label Phase|Lack of Efficacy|0|||
13464065|NCT00098722|26974316|FG002|Open Label Phase|Lack of Efficacy|0|||
13464066|NCT00098722|26974317|FG003|Open Label Phase|Lack of Efficacy|8|||
13464067|NCT00098722|26974318|FG004|Open Label Phase|Lack of Efficacy|0|||
13464068|NCT00098722|26974319|FG005|Open Label Phase|Lack of Efficacy|0|||
13464069|NCT00098722|26974320|FG006|Open Label Phase|Lack of Efficacy|0|||
13464070|NCT00098722|26974314|FG000|Open Label Phase|Pregnancy|0|||
13464071|NCT00098722|26974315|FG001|Open Label Phase|Pregnancy|0|||
13464072|NCT00098722|26974316|FG002|Open Label Phase|Pregnancy|0|||
13464073|NCT00098722|26974317|FG003|Open Label Phase|Pregnancy|1|||
13464074|NCT00098722|26974318|FG004|Open Label Phase|Pregnancy|0|||
13464075|NCT00098722|26974319|FG005|Open Label Phase|Pregnancy|0|||
13464076|NCT00098722|26974320|FG006|Open Label Phase|Pregnancy|0|||
13464077|NCT00098722|26974314|FG000|Open Label Phase|Participant defaulted|0|||
13464078|NCT00098722|26974315|FG001|Open Label Phase|Participant defaulted|0|||
13464079|NCT00098722|26974316|FG002|Open Label Phase|Participant defaulted|0|||
13464080|NCT00098722|26974317|FG003|Open Label Phase|Participant defaulted|18|||
13464081|NCT00098722|26974318|FG004|Open Label Phase|Participant defaulted|0|||
13464082|NCT00098722|26974319|FG005|Open Label Phase|Participant defaulted|0|||
13464083|NCT00098722|26974320|FG006|Open Label Phase|Participant defaulted|0|||
13464084|NCT00098722|26974314|FG000|Open Label Phase|Ongoing at cut-off date|0|||
13464085|NCT00098722|26974315|FG001|Open Label Phase|Ongoing at cut-off date|0|||
13464086|NCT00098722|26974316|FG002|Open Label Phase|Ongoing at cut-off date|0|||
13464087|NCT00098722|26974317|FG003|Open Label Phase|Ongoing at cut-off date|220|||
13464088|NCT00098722|26974318|FG004|Open Label Phase|Ongoing at cut-off date|50|||
13464089|NCT00098722|26974319|FG005|Open Label Phase|Ongoing at cut-off date|0|||
13464090|NCT00098722|26974320|FG006|Open Label Phase|Ongoing at cut-off date|0|||
13464091|NCT00098722|26974314|FG000|Open Label Phase|Other|0|||
13464092|NCT00098722|26974315|FG001|Open Label Phase|Other|0|||
13464093|NCT00098722|26974316|FG002|Open Label Phase|Other|0|||
13464094|NCT00098722|26974317|FG003|Open Label Phase|Other|18|||
13464095|NCT00098722|26974318|FG004|Open Label Phase|Other|0|||
13464096|NCT00098722|26974319|FG005|Open Label Phase|Other|0|||
13464097|NCT00098722|26974320|FG006|Open Label Phase|Other|0|||
13464098|NCT00098722|26974314|FG000|Observation Phase|Death|0|||
13464099|NCT00098722|26974315|FG001|Observation Phase|Death|0|||
13464100|NCT00098722|26974316|FG002|Observation Phase|Death|0|||
13464101|NCT00098722|26974317|FG003|Observation Phase|Death|0|||
13464102|NCT00098722|26974318|FG004|Observation Phase|Death|0|||
13464103|NCT00098722|26974319|FG005|Observation Phase|Death|5|||
13464104|NCT00098722|26974320|FG006|Observation Phase|Death|3|||
13464105|NCT00098722|26974314|FG000|Observation Phase|Lack of Efficacy|0|||
13464106|NCT00098722|26974315|FG001|Observation Phase|Lack of Efficacy|0|||
13464107|NCT00098722|26974316|FG002|Observation Phase|Lack of Efficacy|0|||
13464108|NCT00098722|26974317|FG003|Observation Phase|Lack of Efficacy|0|||
13464109|NCT00098722|26974318|FG004|Observation Phase|Lack of Efficacy|0|||
13464110|NCT00098722|26974319|FG005|Observation Phase|Lack of Efficacy|2|||
13464111|NCT00098722|26974320|FG006|Observation Phase|Lack of Efficacy|0|||
13464112|NCT00098722|26974314|FG000|Observation Phase|Participant defaulted|0|||
13464113|NCT00098722|26974315|FG001|Observation Phase|Participant defaulted|0|||
13464114|NCT00098722|26974316|FG002|Observation Phase|Participant defaulted|0|||
13464115|NCT00098722|26974317|FG003|Observation Phase|Participant defaulted|0|||
13464116|NCT00098722|26974318|FG004|Observation Phase|Participant defaulted|0|||
13464117|NCT00098722|26974319|FG005|Observation Phase|Participant defaulted|17|||
13464118|NCT00098722|26974320|FG006|Observation Phase|Participant defaulted|4|||
13464119|NCT00098722|26974314|FG000|Observation Phase|Other|0|||
13464120|NCT00098722|26974315|FG001|Observation Phase|Other|0|||
13464121|NCT00098722|26974316|FG002|Observation Phase|Other|0|||
13464122|NCT00098722|26974317|FG003|Observation Phase|Other|0|||
13464123|NCT00098722|26974318|FG004|Observation Phase|Other|0|||
13464124|NCT00098722|26974319|FG005|Observation Phase|Other|21|||
13464125|NCT00098722|26974320|FG006|Observation Phase|Other|10|||
13464126|NCT00098345|26974332|FG000|Overall Study|Adverse Event|7|||
13464127|NCT00098345|26974332|FG000|Overall Study|Withdrawal by Subject|2|||
13464128|NCT00098345|26974332|FG000|Overall Study|progression|4|||
13464129|NCT00098306|26974409|FG000|Double Blind|Randomized, not treated|9|||
13464130|NCT00098306|26974410|FG001|Double Blind|Randomized, not treated|5|||
13464131|NCT00098306|26974411|FG002|Double Blind|Randomized, not treated|2|||
13464132|NCT00098306|26974412|FG003|Double Blind|Randomized, not treated|0|||
13464133|NCT00098306|26974413|FG004|Double Blind|Randomized, not treated|0|||
13464134|NCT00098306|26974414|FG005|Double Blind|Randomized, not treated|0|||
13464135|NCT00098306|26974415|FG006|Double Blind|Randomized, not treated|0|||
13464136|NCT00098306|26974409|FG000|Double Blind|Ongoing at cut-off date|151|||
13464137|NCT00098306|26974410|FG001|Double Blind|Ongoing at cut-off date|166|||
13464138|NCT00098306|26974411|FG002|Double Blind|Ongoing at cut-off date|72|||
13464139|NCT00098306|26974412|FG003|Double Blind|Ongoing at cut-off date|0|||
13464140|NCT00098306|26974413|FG004|Double Blind|Ongoing at cut-off date|0|||
13464141|NCT00098306|26974414|FG005|Double Blind|Ongoing at cut-off date|0|||
13464142|NCT00098306|26974415|FG006|Double Blind|Ongoing at cut-off date|0|||
13464143|NCT00098306|26974409|FG000|Double Blind|Adverse Event|11|||
13464144|NCT00098306|26974410|FG001|Double Blind|Adverse Event|10|||
13464145|NCT00098306|26974411|FG002|Double Blind|Adverse Event|6|||
13464146|NCT00098306|26974412|FG003|Double Blind|Adverse Event|0|||
13464147|NCT00098306|26974413|FG004|Double Blind|Adverse Event|0|||
13464148|NCT00098306|26974414|FG005|Double Blind|Adverse Event|0|||
13464149|NCT00098306|26974415|FG006|Double Blind|Adverse Event|0|||
13464150|NCT00098306|26974409|FG000|Double Blind|Lack of Efficacy|43|||
13464151|NCT00098306|26974410|FG001|Double Blind|Lack of Efficacy|34|||
13464152|NCT00098306|26974411|FG002|Double Blind|Lack of Efficacy|17|||
13464153|NCT00098306|26974412|FG003|Double Blind|Lack of Efficacy|0|||
13464154|NCT00098306|26974413|FG004|Double Blind|Lack of Efficacy|0|||
13464155|NCT00098306|26974414|FG005|Double Blind|Lack of Efficacy|0|||
13464156|NCT00098306|26974415|FG006|Double Blind|Lack of Efficacy|0|||
13464157|NCT00098306|26974409|FG000|Double Blind|Death|1|||
13464158|NCT00098306|26974410|FG001|Double Blind|Death|4|||
13464159|NCT00098306|26974411|FG002|Double Blind|Death|1|||
13464160|NCT00098306|26974412|FG003|Double Blind|Death|0|||
13464161|NCT00098306|26974413|FG004|Double Blind|Death|0|||
13464162|NCT00098306|26974414|FG005|Double Blind|Death|0|||
13464163|NCT00098306|26974415|FG006|Double Blind|Death|0|||
13464164|NCT00098306|26974409|FG000|Double Blind|Participant defaulted|19|||
13464165|NCT00098306|26974410|FG001|Double Blind|Participant defaulted|18|||
13464166|NCT00098306|26974411|FG002|Double Blind|Participant defaulted|11|||
13464167|NCT00098306|26974412|FG003|Double Blind|Participant defaulted|0|||
13464168|NCT00098306|26974413|FG004|Double Blind|Participant defaulted|0|||
13464169|NCT00098306|26974414|FG005|Double Blind|Participant defaulted|0|||
13464170|NCT00098306|26974415|FG006|Double Blind|Participant defaulted|0|||
13464171|NCT00098306|26974409|FG000|Double Blind|Un-specified|7|||
13464172|NCT00098306|26974410|FG001|Double Blind|Un-specified|3|||
13464173|NCT00098306|26974411|FG002|Double Blind|Un-specified|11|||
13464174|NCT00098306|26974412|FG003|Double Blind|Un-specified|0|||
13464175|NCT00098306|26974413|FG004|Double Blind|Un-specified|0|||
13464176|NCT00098306|26974414|FG005|Double Blind|Un-specified|0|||
13464177|NCT00098306|26974415|FG006|Double Blind|Un-specified|0|||
13464178|NCT00098306|26974409|FG000|Open Label|Lack of Efficacy|0|||
13464179|NCT00098306|26974410|FG001|Open Label|Lack of Efficacy|0|||
13464180|NCT00098306|26974411|FG002|Open Label|Lack of Efficacy|0|||
13464181|NCT00098306|26974412|FG003|Open Label|Lack of Efficacy|13|||
13464182|NCT00098306|26974413|FG004|Open Label|Lack of Efficacy|0|||
13464183|NCT00098306|26974414|FG005|Open Label|Lack of Efficacy|0|||
13464184|NCT00098306|26974415|FG006|Open Label|Lack of Efficacy|0|||
13464185|NCT00098306|26974409|FG000|Open Label|Adverse Event|0|||
13464186|NCT00098306|26974410|FG001|Open Label|Adverse Event|0|||
13464187|NCT00098306|26974411|FG002|Open Label|Adverse Event|0|||
13464188|NCT00098306|26974412|FG003|Open Label|Adverse Event|2|||
13464189|NCT00098306|26974413|FG004|Open Label|Adverse Event|0|||
13464190|NCT00098306|26974414|FG005|Open Label|Adverse Event|0|||
13464191|NCT00098306|26974415|FG006|Open Label|Adverse Event|0|||
13464192|NCT00098306|26974409|FG000|Open Label|Death|0|||
13464193|NCT00098306|26974410|FG001|Open Label|Death|0|||
13464194|NCT00098306|26974411|FG002|Open Label|Death|0|||
13464195|NCT00098306|26974412|FG003|Open Label|Death|4|||
13464196|NCT00098306|26974413|FG004|Open Label|Death|0|||
13464197|NCT00098306|26974414|FG005|Open Label|Death|0|||
13464198|NCT00098306|26974415|FG006|Open Label|Death|0|||
13464199|NCT00098306|26974409|FG000|Open Label|Participant defaulted|0|||
13464200|NCT00098306|26974410|FG001|Open Label|Participant defaulted|0|||
13464201|NCT00098306|26974411|FG002|Open Label|Participant defaulted|0|||
13464202|NCT00098306|26974412|FG003|Open Label|Participant defaulted|24|||
13464203|NCT00098306|26974413|FG004|Open Label|Participant defaulted|0|||
13464204|NCT00098306|26974414|FG005|Open Label|Participant defaulted|0|||
13464205|NCT00098306|26974415|FG006|Open Label|Participant defaulted|0|||
13464206|NCT00098306|26974409|FG000|Open Label|Un-specified|0|||
13464207|NCT00098306|26974410|FG001|Open Label|Un-specified|0|||
13464208|NCT00098306|26974411|FG002|Open Label|Un-specified|0|||
13464209|NCT00098306|26974412|FG003|Open Label|Un-specified|15|||
13464210|NCT00098306|26974413|FG004|Open Label|Un-specified|0|||
13464211|NCT00098306|26974414|FG005|Open Label|Un-specified|0|||
13464212|NCT00098306|26974415|FG006|Open Label|Un-specified|0|||
13464213|NCT00098306|26974409|FG000|Open Label|Ongoing at cut-off date|0|||
13464214|NCT00098306|26974410|FG001|Open Label|Ongoing at cut-off date|0|||
13464215|NCT00098306|26974411|FG002|Open Label|Ongoing at cut-off date|0|||
13464216|NCT00098306|26974412|FG003|Open Label|Ongoing at cut-off date|269|||
13464217|NCT00098306|26974413|FG004|Open Label|Ongoing at cut-off date|62|||
13464218|NCT00098306|26974414|FG005|Open Label|Ongoing at cut-off date|0|||
13464219|NCT00098306|26974415|FG006|Open Label|Ongoing at cut-off date|0|||
13464220|NCT00098306|26974409|FG000|Observational Phase|Death|0|||
13464221|NCT00098306|26974410|FG001|Observational Phase|Death|0|||
13464222|NCT00098306|26974411|FG002|Observational Phase|Death|0|||
13464223|NCT00098306|26974412|FG003|Observational Phase|Death|0|||
13464224|NCT00098306|26974413|FG004|Observational Phase|Death|0|||
13464225|NCT00098306|26974414|FG005|Observational Phase|Death|5|||
13464226|NCT00098306|26974415|FG006|Observational Phase|Death|4|||
13464227|NCT00098306|26974409|FG000|Observational Phase|Participant defaulted|0|||
13464228|NCT00098306|26974410|FG001|Observational Phase|Participant defaulted|0|||
13464229|NCT00098306|26974411|FG002|Observational Phase|Participant defaulted|0|||
13464230|NCT00098306|26974412|FG003|Observational Phase|Participant defaulted|0|||
13464231|NCT00098306|26974413|FG004|Observational Phase|Participant defaulted|0|||
13464232|NCT00098306|26974414|FG005|Observational Phase|Participant defaulted|34|||
13464233|NCT00098306|26974415|FG006|Observational Phase|Participant defaulted|18|||
13464234|NCT00098306|26974409|FG000|Observational Phase|Un-specified|0|||
13306297|NCT01292603|26525398|FG003|Part 2: Regular Follow-Up|Death|0|||
13464235|NCT00098306|26974410|FG001|Observational Phase|Un-specified|0|||
13464236|NCT00098306|26974411|FG002|Observational Phase|Un-specified|0|||
13464237|NCT00098306|26974412|FG003|Observational Phase|Un-specified|0|||
13464238|NCT00098306|26974413|FG004|Observational Phase|Un-specified|0|||
13464239|NCT00098306|26974414|FG005|Observational Phase|Un-specified|7|||
13464240|NCT00098306|26974415|FG006|Observational Phase|Un-specified|4|||
13464241|NCT00098293|26974480|FG000|Double-blind (DB) Phase|Adverse Event|14|||
13464242|NCT00098293|26974481|FG001|Double-blind (DB) Phase|Adverse Event|27|||
13464243|NCT00098293|26974482|FG002|Double-blind (DB) Phase|Adverse Event|60|||
13464244|NCT00098293|26974483|FG003|Double-blind (DB) Phase|Adverse Event|0|||
13464245|NCT00098293|26974484|FG004|Double-blind (DB) Phase|Adverse Event|0|||
13464246|NCT00098293|26974480|FG000|Double-blind (DB) Phase|Pregnancy|0|||
13464247|NCT00098293|26974481|FG001|Double-blind (DB) Phase|Pregnancy|7|||
13464248|NCT00098293|26974482|FG002|Double-blind (DB) Phase|Pregnancy|9|||
13464249|NCT00098293|26974483|FG003|Double-blind (DB) Phase|Pregnancy|0|||
13464250|NCT00098293|26974484|FG004|Double-blind (DB) Phase|Pregnancy|0|||
13464251|NCT00098293|26974480|FG000|Double-blind (DB) Phase|Participant Defaulted|11|||
13464252|NCT00098293|26974481|FG001|Double-blind (DB) Phase|Participant Defaulted|40|||
13464253|NCT00098293|26974482|FG002|Double-blind (DB) Phase|Participant Defaulted|36|||
13464254|NCT00098293|26974483|FG003|Double-blind (DB) Phase|Participant Defaulted|0|||
13464255|NCT00098293|26974484|FG004|Double-blind (DB) Phase|Participant Defaulted|0|||
13464256|NCT00098293|26974480|FG000|Double-blind (DB) Phase|Lack of Efficacy|11|||
13464257|NCT00098293|26974481|FG001|Double-blind (DB) Phase|Lack of Efficacy|64|||
13464258|NCT00098293|26974482|FG002|Double-blind (DB) Phase|Lack of Efficacy|30|||
13464259|NCT00098293|26974483|FG003|Double-blind (DB) Phase|Lack of Efficacy|0|||
13464260|NCT00098293|26974484|FG004|Double-blind (DB) Phase|Lack of Efficacy|0|||
13464261|NCT00098293|26974480|FG000|Double-blind (DB) Phase|Death|1|||
13464262|NCT00098293|26974481|FG001|Double-blind (DB) Phase|Death|2|||
13464263|NCT00098293|26974482|FG002|Double-blind (DB) Phase|Death|2|||
13464264|NCT00098293|26974483|FG003|Double-blind (DB) Phase|Death|0|||
13464265|NCT00098293|26974484|FG004|Double-blind (DB) Phase|Death|0|||
13464266|NCT00098293|26974480|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3|||
13464267|NCT00098293|26974481|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8|||
13464268|NCT00098293|26974482|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11|||
13464269|NCT00098293|26974483|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0|||
13464270|NCT00098293|26974484|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0|||
13464271|NCT00098293|26974480|FG000|Double-blind (DB) Phase|Protocol Violation|2|||
13464272|NCT00098293|26974481|FG001|Double-blind (DB) Phase|Protocol Violation|18|||
13464273|NCT00098293|26974482|FG002|Double-blind (DB) Phase|Protocol Violation|22|||
13464274|NCT00098293|26974483|FG003|Double-blind (DB) Phase|Protocol Violation|0|||
13464275|NCT00098293|26974484|FG004|Double-blind (DB) Phase|Protocol Violation|0|||
13464276|NCT00098293|26974480|FG000|Double-blind (DB) Phase|Terminated by sponsor|135|||
13464277|NCT00098293|26974481|FG001|Double-blind (DB) Phase|Terminated by sponsor|0|||
13464278|NCT00098293|26974482|FG002|Double-blind (DB) Phase|Terminated by sponsor|0|||
13464279|NCT00098293|26974483|FG003|Double-blind (DB) Phase|Terminated by sponsor|0|||
13464280|NCT00098293|26974484|FG004|Double-blind (DB) Phase|Terminated by sponsor|0|||
13464281|NCT00098293|26974480|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
13464282|NCT00098293|26974481|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
13464283|NCT00098293|26974482|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3|||
13464284|NCT00098293|26974483|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
13464285|NCT00098293|26974484|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
13464286|NCT00098293|26974480|FG000|Open-label (OL) Phase|Adverse Event|0|||
13464287|NCT00098293|26974481|FG001|Open-label (OL) Phase|Adverse Event|3|||
13464288|NCT00098293|26974482|FG002|Open-label (OL) Phase|Adverse Event|7|||
13464289|NCT00098293|26974483|FG003|Open-label (OL) Phase|Adverse Event|6|||
13464290|NCT00098293|26974484|FG004|Open-label (OL) Phase|Adverse Event|0|||
13464291|NCT00098293|26974480|FG000|Open-label (OL) Phase|Lack of Efficacy|0|||
13464292|NCT00098293|26974481|FG001|Open-label (OL) Phase|Lack of Efficacy|7|||
13464293|NCT00098293|26974482|FG002|Open-label (OL) Phase|Lack of Efficacy|2|||
13464294|NCT00098293|26974483|FG003|Open-label (OL) Phase|Lack of Efficacy|20|||
13464295|NCT00098293|26974484|FG004|Open-label (OL) Phase|Lack of Efficacy|0|||
13464296|NCT00098293|26974480|FG000|Open-label (OL) Phase|Pregnancy|0|||
13464297|NCT00098293|26974481|FG001|Open-label (OL) Phase|Pregnancy|1|||
13464298|NCT00098293|26974482|FG002|Open-label (OL) Phase|Pregnancy|0|||
13464299|NCT00098293|26974483|FG003|Open-label (OL) Phase|Pregnancy|3|||
13464300|NCT00098293|26974484|FG004|Open-label (OL) Phase|Pregnancy|0|||
13464301|NCT00098293|26974480|FG000|Open-label (OL) Phase|Protocol Violation|0|||
13464302|NCT00098293|26974481|FG001|Open-label (OL) Phase|Protocol Violation|6|||
13464303|NCT00098293|26974482|FG002|Open-label (OL) Phase|Protocol Violation|13|||
13464304|NCT00098293|26974483|FG003|Open-label (OL) Phase|Protocol Violation|16|||
13464305|NCT00098293|26974484|FG004|Open-label (OL) Phase|Protocol Violation|0|||
13464306|NCT00098293|26974480|FG000|Open-label (OL) Phase|Participant Defaulted|0|||
13464307|NCT00098293|26974481|FG001|Open-label (OL) Phase|Participant Defaulted|6|||
13464308|NCT00098293|26974482|FG002|Open-label (OL) Phase|Participant Defaulted|16|||
13464309|NCT00098293|26974483|FG003|Open-label (OL) Phase|Participant Defaulted|20|||
13464310|NCT00098293|26974484|FG004|Open-label (OL) Phase|Participant Defaulted|0|||
13464311|NCT00098293|26974480|FG000|Open-label (OL) Phase|Death|0|||
13464312|NCT00098293|26974481|FG001|Open-label (OL) Phase|Death|2|||
13464313|NCT00098293|26974482|FG002|Open-label (OL) Phase|Death|3|||
13464314|NCT00098293|26974483|FG003|Open-label (OL) Phase|Death|0|||
13464315|NCT00098293|26974484|FG004|Open-label (OL) Phase|Death|0|||
13464316|NCT00098293|26974480|FG000|Supplemental Phase (SP)|Death|0|||
13464317|NCT00098293|26974481|FG001|Supplemental Phase (SP)|Death|0|||
13464318|NCT00098293|26974482|FG002|Supplemental Phase (SP)|Death|0|||
13464319|NCT00098293|26974483|FG003|Supplemental Phase (SP)|Death|0|||
13464320|NCT00098293|26974484|FG004|Supplemental Phase (SP)|Death|1|||
13464321|NCT00098293|26974480|FG000|Supplemental Phase (SP)|Lost to Follow-up|0|||
13464322|NCT00098293|26974481|FG001|Supplemental Phase (SP)|Lost to Follow-up|0|||
13464323|NCT00098293|26974482|FG002|Supplemental Phase (SP)|Lost to Follow-up|0|||
13464324|NCT00098293|26974483|FG003|Supplemental Phase (SP)|Lost to Follow-up|0|||
13464325|NCT00098293|26974484|FG004|Supplemental Phase (SP)|Lost to Follow-up|2|||
13464326|NCT00098293|26974480|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0|||
13464327|NCT00098293|26974481|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0|||
13464328|NCT00098293|26974482|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0|||
13464329|NCT00098293|26974483|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0|||
13464330|NCT00098293|26974484|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8|||
13464331|NCT00098293|26974480|FG000|Supplemental Phase (SP)|Other|0|||
13464332|NCT00098293|26974481|FG001|Supplemental Phase (SP)|Other|0|||
13464333|NCT00098293|26974482|FG002|Supplemental Phase (SP)|Other|0|||
13464334|NCT00098293|26974483|FG003|Supplemental Phase (SP)|Other|0|||
13464335|NCT00098293|26974484|FG004|Supplemental Phase (SP)|Other|22|||
13464336|NCT00098254|26974505|FG000|Overall Study|Adverse Event|2|||
13464337|NCT00098254|26974505|FG000|Overall Study|Death|1|||
13464338|NCT00098020|26974512|FG000|Overall Study|Adverse Event|2|||
13464339|NCT00098020|26974512|FG000|Overall Study|Lost to Follow-up|1|||
13464340|NCT00098020|26974512|FG000|Overall Study|elevated liver enzymes|1|||
13464341|NCT00098020|26974512|FG000|Overall Study|Low urine PCR|1|||
13464342|NCT00098020|26974512|FG000|Overall Study|Low epidermal growth factor receptor|1|||
13464343|NCT00097981|26974537|FG000|Overall Study|Adverse Event|31|||
13464344|NCT00097981|26974538|FG001|Overall Study|Adverse Event|44|||
13464345|NCT00097981|26974537|FG000|Overall Study|Withdrawal by Subject|10|||
13464346|NCT00097981|26974538|FG001|Overall Study|Withdrawal by Subject|8|||
13464347|NCT00097981|26974537|FG000|Overall Study|Protocol Violation|1|||
13464348|NCT00097981|26974538|FG001|Overall Study|Protocol Violation|1|||
13464349|NCT00097981|26974537|FG000|Overall Study|Death|2|||
13464350|NCT00097981|26974538|FG001|Overall Study|Death|4|||
13464351|NCT00097981|26974537|FG000|Overall Study|Physician Decision|7|||
13464352|NCT00097981|26974538|FG001|Overall Study|Physician Decision|1|||
13464353|NCT00097981|26974537|FG000|Overall Study|Disease Progression|8|||
13464354|NCT00097981|26974538|FG001|Overall Study|Disease Progression|2|||
13464355|NCT00097981|26974537|FG000|Overall Study|Transplant planned|28|||
13464356|NCT00097981|26974538|FG001|Overall Study|Transplant planned|27|||
13464357|NCT00097981|26974537|FG000|Overall Study|Other|19|||
13464358|NCT00097981|26974538|FG001|Overall Study|Other|13|||
13464359|NCT00097786|26974569|FG000|Overall Study|lost to follow-up for all-cause death|296|||
13464360|NCT00097786|26974570|FG001|Overall Study|lost to follow-up for all-cause death|292|||
13464361|NCT00097786|26974571|FG002|Overall Study|lost to follow-up for all-cause death|313|||
13464362|NCT00097786|26974572|FG003|Overall Study|lost to follow-up for all-cause death|310|||
13464363|NCT00097773|26974603|FG000|Overall Study|Lost to Follow-up|2|||
13464364|NCT00097773|26974604|FG001|Overall Study|Lost to Follow-up|2|||
13464365|NCT00097773|26974605|FG002|Overall Study|Lost to Follow-up|0|||
13464366|NCT00097773|26974606|FG003|Overall Study|Lost to Follow-up|1|||
13464367|NCT00097773|26974603|FG000|Overall Study|Physician Decision|2|||
13464368|NCT00097773|26974604|FG001|Overall Study|Physician Decision|2|||
13464369|NCT00097773|26974605|FG002|Overall Study|Physician Decision|3|||
13464370|NCT00097773|26974606|FG003|Overall Study|Physician Decision|1|||
13464371|NCT00097773|26974603|FG000|Overall Study|Withdrawal by Subject|3|||
13464372|NCT00097773|26974604|FG001|Overall Study|Withdrawal by Subject|3|||
13464373|NCT00097773|26974605|FG002|Overall Study|Withdrawal by Subject|3|||
13464374|NCT00097773|26974606|FG003|Overall Study|Withdrawal by Subject|1|||
13464375|NCT00097773|26974603|FG000|Overall Study|Adverse Event|0|||
13464376|NCT00097773|26974604|FG001|Overall Study|Adverse Event|1|||
13464377|NCT00097773|26974605|FG002|Overall Study|Adverse Event|0|||
13464378|NCT00097773|26974606|FG003|Overall Study|Adverse Event|0|||
13464379|NCT00097773|26974603|FG000|Overall Study|Other|1|||
13464380|NCT00097773|26974604|FG001|Overall Study|Other|0|||
13464381|NCT00097773|26974605|FG002|Overall Study|Other|2|||
13464382|NCT00097773|26974606|FG003|Overall Study|Other|0|||
13464383|NCT00097721|26974627|FG000|Overall Study|Adverse Event|8|||
13464384|NCT00097721|26974628|FG001|Overall Study|Adverse Event|1|||
13464385|NCT00097721|26974627|FG000|Overall Study|Withdrawal by Subject|6|||
13464386|NCT00097721|26974628|FG001|Overall Study|Withdrawal by Subject|1|||
13464387|NCT00097721|26974627|FG000|Overall Study|Progressive Disease|55|||
13464388|NCT00097721|26974628|FG001|Overall Study|Progressive Disease|27|||
13464389|NCT00097721|26974627|FG000|Overall Study|Physician Decision|1|||
13464390|NCT00097721|26974628|FG001|Overall Study|Physician Decision|3|||
13464391|NCT00097721|26974627|FG000|Overall Study|Reason not given|1|||
13464392|NCT00097721|26974628|FG001|Overall Study|Reason not given|1|||
13464393|NCT00097591|26974651|FG000|Overall Study|Withdrawal of consent|342|||
13464394|NCT00097591|26974652|FG001|Overall Study|Withdrawal of consent|323|||
13464395|NCT00097591|26974651|FG000|Overall Study|Less than 6 months on study drug|9|||
13464396|NCT00097591|26974652|FG001|Overall Study|Less than 6 months on study drug|7|||
13464397|NCT00097591|26974651|FG000|Overall Study|Unable to attend termination visit|53|||
13464398|NCT00097591|26974652|FG001|Overall Study|Unable to attend termination visit|51|||
13464399|NCT00097591|26974651|FG000|Overall Study|Lost to follow up|6|||
13464400|NCT00097591|26974652|FG001|Overall Study|Lost to follow up|10|||
13306298|NCT01292603|26525399|FG004|Part 2: Regular Follow-Up|Death|6|||
13464401|NCT00097591|26974651|FG000|Overall Study|Other|0|||
13464402|NCT00097591|26974652|FG001|Overall Study|Other|3|||
13464403|NCT00097539|26974718|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959|||
13464404|NCT00097539|26974719|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948|||
13464405|NCT00097539|26974720|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646|||
13464406|NCT00097539|26974721|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170|||
13464407|NCT00097539|26974722|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106|||
13464408|NCT00097539|26974723|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546|||
13464409|NCT00097539|26974724|FG006|Overall Study|Status Unknown (Or no final evaluation)|108|||
13464410|NCT00097539|26974718|FG000|Overall Study|Withdrawal by Subject|925|||
13464411|NCT00097539|26974719|FG001|Overall Study|Withdrawal by Subject|323|||
13464412|NCT00097539|26974720|FG002|Overall Study|Withdrawal by Subject|346|||
13464413|NCT00097539|26974721|FG003|Overall Study|Withdrawal by Subject|217|||
13464414|NCT00097539|26974722|FG004|Overall Study|Withdrawal by Subject|68|||
13464415|NCT00097539|26974723|FG005|Overall Study|Withdrawal by Subject|229|||
13464416|NCT00097539|26974724|FG006|Overall Study|Withdrawal by Subject|3|||
13464417|NCT00097539|26974718|FG000|Overall Study|Participant Non-compliant|2140|||
13464418|NCT00097539|26974719|FG001|Overall Study|Participant Non-compliant|567|||
13464419|NCT00097539|26974720|FG002|Overall Study|Participant Non-compliant|1067|||
13464420|NCT00097539|26974721|FG003|Overall Study|Participant Non-compliant|353|||
13464421|NCT00097539|26974722|FG004|Overall Study|Participant Non-compliant|136|||
13464422|NCT00097539|26974723|FG005|Overall Study|Participant Non-compliant|543|||
13464423|NCT00097539|26974724|FG006|Overall Study|Participant Non-compliant|18|||
13464424|NCT00097539|26974718|FG000|Overall Study|Lack of Efficacy|249|||
13464425|NCT00097539|26974719|FG001|Overall Study|Lack of Efficacy|122|||
13464426|NCT00097539|26974720|FG002|Overall Study|Lack of Efficacy|202|||
13464427|NCT00097539|26974721|FG003|Overall Study|Lack of Efficacy|105|||
13464428|NCT00097539|26974722|FG004|Overall Study|Lack of Efficacy|45|||
13464429|NCT00097539|26974723|FG005|Overall Study|Lack of Efficacy|228|||
13464430|NCT00097539|26974724|FG006|Overall Study|Lack of Efficacy|5|||
13464431|NCT00097539|26974718|FG000|Overall Study|Adverse Event|78|||
13464432|NCT00097539|26974719|FG001|Overall Study|Adverse Event|133|||
13464433|NCT00097539|26974720|FG002|Overall Study|Adverse Event|37|||
13464434|NCT00097539|26974721|FG003|Overall Study|Adverse Event|27|||
13464435|NCT00097539|26974722|FG004|Overall Study|Adverse Event|30|||
13464436|NCT00097539|26974723|FG005|Overall Study|Adverse Event|59|||
13464437|NCT00097539|26974724|FG006|Overall Study|Adverse Event|1|||
13464438|NCT00097539|26974718|FG000|Overall Study|Death|2|||
13464439|NCT00097539|26974719|FG001|Overall Study|Death|7|||
13464440|NCT00097539|26974720|FG002|Overall Study|Death|0|||
13464441|NCT00097539|26974721|FG003|Overall Study|Death|0|||
13464442|NCT00097539|26974722|FG004|Overall Study|Death|1|||
13464443|NCT00097539|26974723|FG005|Overall Study|Death|3|||
13464444|NCT00097539|26974724|FG006|Overall Study|Death|0|||
13464445|NCT00097539|26974718|FG000|Overall Study|Reasons Other Than Above|3602|||
13464446|NCT00097539|26974719|FG001|Overall Study|Reasons Other Than Above|1382|||
13464447|NCT00097539|26974720|FG002|Overall Study|Reasons Other Than Above|1757|||
13464448|NCT00097539|26974721|FG003|Overall Study|Reasons Other Than Above|692|||
13464449|NCT00097539|26974722|FG004|Overall Study|Reasons Other Than Above|361|||
13464450|NCT00097539|26974723|FG005|Overall Study|Reasons Other Than Above|1244|||
13464451|NCT00097539|26974724|FG006|Overall Study|Reasons Other Than Above|34|||
13464452|NCT00097539|26974718|FG000|Overall Study|Reason not Specified|111|||
13464453|NCT00097539|26974719|FG001|Overall Study|Reason not Specified|49|||
13464454|NCT00097539|26974720|FG002|Overall Study|Reason not Specified|53|||
13464455|NCT00097539|26974721|FG003|Overall Study|Reason not Specified|21|||
13464456|NCT00097539|26974722|FG004|Overall Study|Reason not Specified|11|||
13464457|NCT00097539|26974723|FG005|Overall Study|Reason not Specified|40|||
13464458|NCT00097539|26974724|FG006|Overall Study|Reason not Specified|2|||
13464459|NCT00097500|26974753|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
13464460|NCT00097500|26974754|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
13464461|NCT00097500|26974753|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5|||
13464462|NCT00097500|26974754|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0|||
13464463|NCT00097500|26974753|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0|||
13464464|NCT00097500|26974754|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1|||
13464465|NCT00097500|26974753|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0|||
13464466|NCT00097500|26974754|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1|||
13464467|NCT00097500|26974753|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2|||
13464468|NCT00097500|26974754|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1|||
13464469|NCT00097500|26974753|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0|||
13464470|NCT00097500|26974754|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1|||
13464471|NCT00097500|26974753|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3|||
13464472|NCT00097500|26974754|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2|||
13464473|NCT00097370|26974773|FG000|Stage 1|Adverse Event|3|||
13464474|NCT00097370|26974773|FG000|Stage 1|Withdrawal by Subject|1|||
13464475|NCT00097370|26974773|FG000|Stage 1|Lack of Efficacy|2|||
13464476|NCT00097370|26974773|FG000|Stage 2|Adverse Event|5|||
13464477|NCT00097370|26974773|FG000|Stage 2|Withdrawal by Subject|1|||
13464478|NCT00097370|26974773|FG000|Stage 2|Lack of Efficacy|3|||
13464479|NCT00097370|26974773|FG000|Stage 2|Pregnancy|1|||
13464480|NCT00097370|26974773|FG000|Stage 2|Sponsor Terminated Study|2|||
13464481|NCT00097370|26974773|FG000|Stage 2|Lost to Follow-up|1|||
13464482|NCT00097370|26974773|FG000|Stage 3|Adverse Event|2|||
13464483|NCT00097370|26974773|FG000|Stage 3|Withdrawal by Subject|3|||
13464484|NCT00097370|26974773|FG000|Stage 3|Lack of Efficacy|1|||
13464485|NCT00097370|26974773|FG000|Stage 3|Sponsor Terminated Study|52|||
13464486|NCT00097370|26974773|FG000|Stage 3|Lost to Follow-up|1|||
13464487|NCT00096993|26974794|FG000|Overall Study|Death|1|||
13464488|NCT00096993|26974795|FG001|Overall Study|Death|0|||
13464489|NCT00096993|26974794|FG000|Overall Study|Disease progression|56|||
13464490|NCT00096993|26974795|FG001|Overall Study|Disease progression|53|||
13464491|NCT00096993|26974794|FG000|Overall Study|Adverse Event|2|||
13464492|NCT00096993|26974795|FG001|Overall Study|Adverse Event|8|||
13464493|NCT00096993|26974794|FG000|Overall Study|Subject's decision|3|||
13464494|NCT00096993|26974795|FG001|Overall Study|Subject's decision|1|||
13464495|NCT00096993|26974794|FG000|Overall Study|Physician Decision|2|||
13464496|NCT00096993|26974795|FG001|Overall Study|Physician Decision|1|||
13464497|NCT00096993|26974794|FG000|Overall Study|Non-compliance|0|||
13464498|NCT00096993|26974795|FG001|Overall Study|Non-compliance|1|||
13464499|NCT00096993|26974794|FG000|Overall Study|Other unspecified|1|||
13464500|NCT00096993|26974795|FG001|Overall Study|Other unspecified|1|||
13464501|NCT00096954|26974814|FG000|Overall Study|Adverse Event|3|||
13464502|NCT00096954|26974815|FG001|Overall Study|Adverse Event|1|||
13464503|NCT00096954|26974814|FG000|Overall Study|Withdrawal by Subject|9|||
13464504|NCT00096954|26974815|FG001|Overall Study|Withdrawal by Subject|8|||
13464505|NCT00096954|26974814|FG000|Overall Study|Physician Decision|1|||
13464506|NCT00096954|26974815|FG001|Overall Study|Physician Decision|1|||
13464507|NCT00096954|26974814|FG000|Overall Study|Sponsors Decision|1|||
13464508|NCT00096954|26974815|FG001|Overall Study|Sponsors Decision|1|||
13464509|NCT00096954|26974814|FG000|Overall Study|Pregnancy|1|||
13464510|NCT00096954|26974815|FG001|Overall Study|Pregnancy|1|||
13464511|NCT00096954|26974814|FG000|Overall Study|Initiation of immunotherapy|1|||
13464512|NCT00096954|26974815|FG001|Overall Study|Initiation of immunotherapy|0|||
13464513|NCT00096954|26974814|FG000|Overall Study|Non-compliance|0|||
13464514|NCT00096954|26974815|FG001|Overall Study|Non-compliance|3|||
13464515|NCT00096954|26974814|FG000|Overall Study|Lost to Follow-up|8|||
13464516|NCT00096954|26974815|FG001|Overall Study|Lost to Follow-up|5|||
13464517|NCT00096941|26974822|FG000|Overall Study|disease progression|3|||
13464518|NCT00096785|26974853|FG000|Overall Study|Lost to Follow-up|1|||
13464519|NCT00096785|26974854|FG001|Overall Study|Lost to Follow-up|0|||
13464520|NCT00096785|26974853|FG000|Overall Study|Withdrawal by Subject|0|||
13464521|NCT00096785|26974854|FG001|Overall Study|Withdrawal by Subject|1|||
13464522|NCT00096785|26974853|FG000|Overall Study|Relocated|1|||
13464523|NCT00096785|26974854|FG001|Overall Study|Relocated|0|||
13464524|NCT00096538|26974860|FG000|Overall Study|Withdrawal by Subject|1|||
13464525|NCT00096486|26974883|FG000|Overall Study|Withdrawal by Subject|0|||
13464526|NCT00096486|26974884|FG001|Overall Study|Withdrawal by Subject|0|||
13464527|NCT00096486|26974885|FG002|Overall Study|Withdrawal by Subject|1|||
13464528|NCT00096486|26974886|FG003|Overall Study|Withdrawal by Subject|1|||
13464529|NCT00096486|26974883|FG000|Overall Study|Not Treated|0|||
13464530|NCT00096486|26974884|FG001|Overall Study|Not Treated|0|||
13464531|NCT00096486|26974885|FG002|Overall Study|Not Treated|1|||
13464532|NCT00096486|26974886|FG003|Overall Study|Not Treated|1|||
13464533|NCT00096447|26974902|FG000|Overall Study|Never treated|1|||
13464534|NCT00096382|26974917|FG000|Overall Study|Not treated|1|||
13464535|NCT00096382|26974918|FG001|Overall Study|Not treated|0|||
13464536|NCT00096382|26974917|FG000|Overall Study|Death during treatment|1|||
13464537|NCT00096382|26974918|FG001|Overall Study|Death during treatment|0|||
13464538|NCT00096356|26974935|FG000|Overall Study|Adverse Event|11|||
13464539|NCT00096356|26974936|FG001|Overall Study|Adverse Event|9|||
13464540|NCT00096356|26974935|FG000|Overall Study|Physician Decision|5|||
13464541|NCT00096356|26974936|FG001|Overall Study|Physician Decision|3|||
13464542|NCT00096356|26974935|FG000|Overall Study|Withdrawal by Subject|17|||
13464543|NCT00096356|26974936|FG001|Overall Study|Withdrawal by Subject|23|||
13464544|NCT00096356|26974935|FG000|Overall Study|Lack of Efficacy|1|||
13464545|NCT00096356|26974936|FG001|Overall Study|Lack of Efficacy|0|||
13464546|NCT00096356|26974935|FG000|Overall Study|multiple reasons|10|||
13464547|NCT00096356|26974936|FG001|Overall Study|multiple reasons|18|||
13464548|NCT00096278|26974959|FG000|Overall Study|No follow-up data|15|||
13464549|NCT00096278|26974960|FG001|Overall Study|No follow-up data|18|||
13464550|NCT00096278|26974959|FG000|Overall Study|Patient not at risk for primary endpoint|3|||
13464551|NCT00096278|26974960|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
13464552|NCT00096265|26974996|FG000|Overall Study|Ineligible|1|||
13464553|NCT00096265|26974997|FG001|Overall Study|Ineligible|0|||
13464554|NCT00096265|26974998|FG002|Overall Study|Ineligible|0|||
13464555|NCT00096226|26975011|FG000|Overall Study|Ineligible|2|||
13464556|NCT00096226|26975011|FG000|Overall Study|Protocol treatment not started|1|||
13464557|NCT00096200|26975035|FG000|Overall Study|Adverse Event|0|||
13464558|NCT00096200|26975036|FG001|Overall Study|Adverse Event|4|||
13464559|NCT00096200|26975037|FG002|Overall Study|Adverse Event|0|||
13464560|NCT00096200|26975035|FG000|Overall Study|Withdrawal by Subject|1|||
13464561|NCT00096200|26975036|FG001|Overall Study|Withdrawal by Subject|2|||
13464562|NCT00096200|26975037|FG002|Overall Study|Withdrawal by Subject|0|||
13464563|NCT00096200|26975035|FG000|Overall Study|Ineligible pathology|0|||
13464564|NCT00096200|26975036|FG001|Overall Study|Ineligible pathology|1|||
13464565|NCT00096200|26975037|FG002|Overall Study|Ineligible pathology|0|||
13464566|NCT00096174|26975045|FG000|Overall Study|Lack of Efficacy|9|||
13464567|NCT00096174|26975045|FG000|Overall Study|Adverse Event|15|||
13464568|NCT00096174|26975045|FG000|Overall Study|Death|6|||
13464569|NCT00096174|26975045|FG000|Overall Study|Withdrawal by Subject|15|||
13464570|NCT00096174|26975045|FG000|Overall Study|Not started protocol therapy|3|||
13464571|NCT00096174|26975045|FG000|Overall Study|Ineligible|6|||
13464572|NCT00096174|26975045|FG000|Overall Study|other reason|8|||
13464573|NCT00096135|26975058|FG000|Overall Study|Physician Decision|20|||
13464574|NCT00096135|26975059|FG001|Overall Study|Physician Decision|4|||
13464575|NCT00096135|26975058|FG000|Overall Study|Refusal of further protocol therapy|4|||
13464576|NCT00096135|26975059|FG001|Overall Study|Refusal of further protocol therapy|1|||
13464577|NCT00096135|26975058|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22|||
13464578|NCT00096135|26975059|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7|||
13464579|NCT00096135|26975058|FG000|Overall Study|Other, specify|15|||
13464580|NCT00096135|26975059|FG001|Overall Study|Other, specify|3|||
13464581|NCT00096135|26975058|FG000|Overall Study|Ineligible|2|||
13464582|NCT00096135|26975059|FG001|Overall Study|Ineligible|0|||
13464583|NCT00096044|26975070|FG000|Overall Study|Withdrawal by Subject|9|||
13464584|NCT00096044|26975070|FG000|Overall Study|Adverse Event|21|||
13464585|NCT00096044|26975070|FG000|Overall Study|Disease Progression|4|||
13464586|NCT00096031|26975078|FG000|Overall Study|Adverse Event|3|||
13464587|NCT00096031|26975078|FG000|Overall Study|Lack of Efficacy|42|||
13464588|NCT00096031|26975078|FG000|Overall Study|Death|4|||
13464589|NCT00096031|26975078|FG000|Overall Study|Withdrawal by Subject|1|||
13464590|NCT00096031|26975078|FG000|Overall Study|Ineligible|8|||
13464591|NCT00096031|26975078|FG000|Overall Study|Not protocol specified|5|||
13464592|NCT00096018|26975093|FG000|Overall Study|Became Ineligible (not treated)|0|||
13464593|NCT00096018|26975094|FG001|Overall Study|Became Ineligible (not treated)|3|||
13464594|NCT00096018|26975093|FG000|Overall Study|Miscellaneous (not treated)|0|||
13464595|NCT00096018|26975094|FG001|Overall Study|Miscellaneous (not treated)|2|||
13464596|NCT00096018|26975093|FG000|Overall Study|Adverse Event|0|||
13464597|NCT00096018|26975094|FG001|Overall Study|Adverse Event|5|||
13464598|NCT00096018|26975093|FG000|Overall Study|Death|0|||
13464599|NCT00096018|26975094|FG001|Overall Study|Death|1|||
13464600|NCT00096018|26975093|FG000|Overall Study|Withdrawal by Subject|0|||
13464601|NCT00096018|26975094|FG001|Overall Study|Withdrawal by Subject|2|||
13464602|NCT00096018|26975093|FG000|Overall Study|Miscellaneous|2|||
13464603|NCT00096018|26975094|FG001|Overall Study|Miscellaneous|1|||
13464604|NCT00095979|26975107|FG000|Overall Study|Ineligible: Second primary cancer site|2|||
13464605|NCT00095940|26975153|FG000|Lapatinib Continuation/Phase II|Disease Progression|1|||
13464606|NCT00095940|26975154|FG001|Lapatinib Continuation/Phase II|Disease Progression|1|||
13464607|NCT00095940|26975155|FG002|Lapatinib Continuation/Phase II|Disease Progression|15|||
13464608|NCT00095940|26975156|FG003|Lapatinib Continuation/Phase II|Disease Progression|0|||
13464609|NCT00095940|26975157|FG004|Lapatinib Continuation/Phase II|Disease Progression|0|||
13464610|NCT00095940|26975158|FG005|Lapatinib Continuation/Phase II|Disease Progression|13|||
13464611|NCT00095940|26975159|FG006|Lapatinib Continuation/Phase II|Disease Progression|2|||
13464612|NCT00095940|26975160|FG007|Lapatinib Continuation/Phase II|Disease Progression|1|||
13464613|NCT00095940|26975161|FG008|Lapatinib Continuation/Phase II|Disease Progression|12|||
13464614|NCT00095940|26975153|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
13464615|NCT00095940|26975154|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
13464616|NCT00095940|26975155|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
13464617|NCT00095940|26975156|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
13464618|NCT00095940|26975157|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
13464619|NCT00095940|26975158|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
13464620|NCT00095940|26975159|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
13464621|NCT00095940|26975160|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
13464622|NCT00095940|26975161|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
13464623|NCT00095940|26975153|FG000|Lapatinib Continuation/Phase II|Adverse Event|0|||
13464624|NCT00095940|26975154|FG001|Lapatinib Continuation/Phase II|Adverse Event|0|||
13464625|NCT00095940|26975155|FG002|Lapatinib Continuation/Phase II|Adverse Event|0|||
13464626|NCT00095940|26975156|FG003|Lapatinib Continuation/Phase II|Adverse Event|0|||
13464627|NCT00095940|26975157|FG004|Lapatinib Continuation/Phase II|Adverse Event|0|||
13464628|NCT00095940|26975158|FG005|Lapatinib Continuation/Phase II|Adverse Event|0|||
13464629|NCT00095940|26975159|FG006|Lapatinib Continuation/Phase II|Adverse Event|0|||
13464630|NCT00095940|26975160|FG007|Lapatinib Continuation/Phase II|Adverse Event|1|||
13464631|NCT00095940|26975161|FG008|Lapatinib Continuation/Phase II|Adverse Event|0|||
13464632|NCT00095836|26975170|FG000|Overall Study|Lost to Follow-up|1|||
13464633|NCT00095836|26975170|FG000|Overall Study|Adverse Event|1|||
13464634|NCT00095836|26975170|FG000|Overall Study|Death|2|||
13464635|NCT00095628|26975181|FG000|Overall Study|Disease progression prior to treatment|1|||
13464636|NCT00095576|26975200|FG000|Overall Study|Adverse Event|5|||
13464637|NCT00095576|26975201|FG001|Overall Study|Adverse Event|3|||
13464638|NCT00095576|26975200|FG000|Overall Study|Lost to Follow-up|233|||
13464639|NCT00095576|26975201|FG001|Overall Study|Lost to Follow-up|229|||
13464640|NCT00095576|26975200|FG000|Overall Study|Protocol Violation|1|||
13464641|NCT00095576|26975201|FG001|Overall Study|Protocol Violation|0|||
13464642|NCT00095576|26975200|FG000|Overall Study|Withdrawal by Subject|34|||
13464643|NCT00095576|26975201|FG001|Overall Study|Withdrawal by Subject|47|||
13464644|NCT00095576|26975200|FG000|Overall Study|Option to switch to a rollover study|1097|||
13464645|NCT00095576|26975201|FG001|Overall Study|Option to switch to a rollover study|1099|||
13464646|NCT00095576|26975200|FG000|Overall Study|Site terminated|75|||
13464647|NCT00095576|26975201|FG001|Overall Study|Site terminated|67|||
13464648|NCT00095576|26975200|FG000|Overall Study|Subject moved|30|||
13464649|NCT00095576|26975201|FG001|Overall Study|Subject moved|36|||
13464650|NCT00095498|26975636|FG000|Overall Study|Physician Decision|9|||
13464651|NCT00095498|26975637|FG001|Overall Study|Physician Decision|10|||
13464652|NCT00095498|26975638|FG002|Overall Study|Physician Decision|8|||
13464653|NCT00095498|26975636|FG000|Overall Study|Adverse Event|1|||
13464654|NCT00095498|26975637|FG001|Overall Study|Adverse Event|0|||
13464655|NCT00095498|26975638|FG002|Overall Study|Adverse Event|1|||
13464656|NCT00095498|26975636|FG000|Overall Study|Withdrawal by Subject|15|||
13464657|NCT00095498|26975637|FG001|Overall Study|Withdrawal by Subject|16|||
13464658|NCT00095498|26975638|FG002|Overall Study|Withdrawal by Subject|15|||
13464659|NCT00095498|26975636|FG000|Overall Study|Disease progression|0|||
13464660|NCT00095498|26975637|FG001|Overall Study|Disease progression|1|||
13464661|NCT00095498|26975638|FG002|Overall Study|Disease progression|1|||
13464662|NCT00095498|26975636|FG000|Overall Study|Ineligibility determined|3|||
13464663|NCT00095498|26975637|FG001|Overall Study|Ineligibility determined|0|||
13464664|NCT00095498|26975638|FG002|Overall Study|Ineligibility determined|2|||
13464665|NCT00095498|26975636|FG000|Overall Study|Lost to Follow-up|1|||
13464666|NCT00095498|26975637|FG001|Overall Study|Lost to Follow-up|1|||
13464667|NCT00095498|26975638|FG002|Overall Study|Lost to Follow-up|2|||
13464668|NCT00095498|26975636|FG000|Overall Study|Noncompliance|1|||
13464669|NCT00095498|26975637|FG001|Overall Study|Noncompliance|0|||
13464670|NCT00095498|26975638|FG002|Overall Study|Noncompliance|1|||
13464671|NCT00095498|26975636|FG000|Overall Study|Other|6|||
13464672|NCT00095498|26975637|FG001|Overall Study|Other|7|||
13464673|NCT00095498|26975638|FG002|Overall Study|Other|6|||
13464674|NCT00095498|26975636|FG000|Overall Study|Protocol Violation|0|||
13464675|NCT00095498|26975637|FG001|Overall Study|Protocol Violation|0|||
13464676|NCT00095498|26975638|FG002|Overall Study|Protocol Violation|1|||
13464677|NCT00095498|26975636|FG000|Overall Study|Requirement for alternative therapy|1|||
13464678|NCT00095498|26975637|FG001|Overall Study|Requirement for alternative therapy|0|||
13464679|NCT00095498|26975638|FG002|Overall Study|Requirement for alternative therapy|2|||
13464680|NCT00095303|26975711|FG000|Main Study|Lost to Follow-up|91|||
13464681|NCT00095303|26975712|FG001|Main Study|Lost to Follow-up|87|||
13464682|NCT00095303|26975711|FG000|Follow Up Study|Lost to Follow-up|59|||
13464683|NCT00095303|26975712|FG001|Follow Up Study|Lost to Follow-up|58|||
13464684|NCT00095238|26975779|FG000|Overall Study|Lack of Efficacy|9|||
13464685|NCT00095238|26975780|FG001|Overall Study|Lack of Efficacy|9|||
13464686|NCT00095238|26975779|FG000|Overall Study|Adverse Event|331|||
13464687|NCT00095238|26975780|FG001|Overall Study|Adverse Event|287|||
13464688|NCT00095238|26975779|FG000|Overall Study|Subject Withdrew Consent|208|||
13464689|NCT00095238|26975780|FG001|Overall Study|Subject Withdrew Consent|223|||
13464690|NCT00095238|26975779|FG000|Overall Study|Death|154|||
13464691|NCT00095238|26975780|FG001|Overall Study|Death|170|||
13464692|NCT00095238|26975779|FG000|Overall Study|Lost to Follow-up|19|||
13464693|NCT00095238|26975780|FG001|Overall Study|Lost to Follow-up|24|||
13464694|NCT00095238|26975779|FG000|Overall Study|Noncompliance|44|||
13464695|NCT00095238|26975780|FG001|Overall Study|Noncompliance|45|||
13464696|NCT00095238|26975779|FG000|Overall Study|No longer met study criteria|4|||
13464697|NCT00095238|26975780|FG001|Overall Study|No longer met study criteria|5|||
13464698|NCT00095238|26975779|FG000|Overall Study|Study terminated by sponsor|0|||
13464699|NCT00095238|26975780|FG001|Overall Study|Study terminated by sponsor|1|||
13464700|NCT00095238|26975779|FG000|Overall Study|Missing|1|||
13464701|NCT00095238|26975780|FG001|Overall Study|Missing|0|||
13464702|NCT00095238|26975779|FG000|Overall Study|Other Reasons|87|||
13464703|NCT00095238|26975780|FG001|Overall Study|Other Reasons|88|||
13464704|NCT00095212|26975813|FG000|Overall Study|Withdrawal by Subject|1|||
13464705|NCT00095212|26975814|FG001|Overall Study|Withdrawal by Subject|3|||
13464706|NCT00095199|26975865|FG000|Overall Study|Adverse Event|40|||
13464707|NCT00095199|26975866|FG001|Overall Study|Adverse Event|22|||
13464708|NCT00095199|26975867|FG002|Overall Study|Adverse Event|26|||
13464709|NCT00095199|26975868|FG003|Overall Study|Adverse Event|11|||
13464710|NCT00095199|26975865|FG000|Overall Study|Progressive disease|213|||
13464711|NCT00095199|26975866|FG001|Overall Study|Progressive disease|179|||
13464712|NCT00095199|26975867|FG002|Overall Study|Progressive disease|105|||
13464713|NCT00095199|26975868|FG003|Overall Study|Progressive disease|98|||
13464714|NCT00095199|26975865|FG000|Overall Study|Death|10|||
13464715|NCT00095199|26975866|FG001|Overall Study|Death|6|||
13464716|NCT00095199|26975867|FG002|Overall Study|Death|11|||
13464717|NCT00095199|26975868|FG003|Overall Study|Death|9|||
13464718|NCT00095199|26975865|FG000|Overall Study|Withdrawal by Subject|21|||
13464719|NCT00095199|26975866|FG001|Overall Study|Withdrawal by Subject|16|||
13464720|NCT00095199|26975867|FG002|Overall Study|Withdrawal by Subject|13|||
13464721|NCT00095199|26975868|FG003|Overall Study|Withdrawal by Subject|22|||
13464722|NCT00095199|26975865|FG000|Overall Study|Protocol Violation|4|||
13464723|NCT00095199|26975866|FG001|Overall Study|Protocol Violation|4|||
13464724|NCT00095199|26975867|FG002|Overall Study|Protocol Violation|2|||
13464725|NCT00095199|26975868|FG003|Overall Study|Protocol Violation|0|||
13464726|NCT00095199|26975865|FG000|Overall Study|Liver function test results elevated|0|||
13464727|NCT00095199|26975866|FG001|Overall Study|Liver function test results elevated|0|||
13464728|NCT00095199|26975867|FG002|Overall Study|Liver function test results elevated|1|||
13464729|NCT00095199|26975868|FG003|Overall Study|Liver function test results elevated|1|||
13464730|NCT00095199|26975865|FG000|Overall Study|Surgery needed could not start in 7 days|0|||
13464731|NCT00095199|26975866|FG001|Overall Study|Surgery needed could not start in 7 days|0|||
13464732|NCT00095199|26975867|FG002|Overall Study|Surgery needed could not start in 7 days|1|||
13464733|NCT00095199|26975868|FG003|Overall Study|Surgery needed could not start in 7 days|0|||
13464734|NCT00095199|26975865|FG000|Overall Study|Physician Decision|5|||
13464735|NCT00095199|26975866|FG001|Overall Study|Physician Decision|6|||
13464736|NCT00095199|26975867|FG002|Overall Study|Physician Decision|1|||
13464737|NCT00095199|26975868|FG003|Overall Study|Physician Decision|1|||
13464738|NCT00095199|26975865|FG000|Overall Study|Not eligible|1|||
13464739|NCT00095199|26975866|FG001|Overall Study|Not eligible|7|||
13464740|NCT00095199|26975867|FG002|Overall Study|Not eligible|0|||
13464741|NCT00095199|26975868|FG003|Overall Study|Not eligible|1|||
13464742|NCT00095199|26975865|FG000|Overall Study|Started Palliative Radiotherapy|1|||
13464743|NCT00095199|26975866|FG001|Overall Study|Started Palliative Radiotherapy|0|||
13464744|NCT00095199|26975867|FG002|Overall Study|Started Palliative Radiotherapy|0|||
13464745|NCT00095199|26975868|FG003|Overall Study|Started Palliative Radiotherapy|0|||
13464746|NCT00095199|26975865|FG000|Overall Study|Started radiotherapy regimen|0|||
13464747|NCT00095199|26975866|FG001|Overall Study|Started radiotherapy regimen|1|||
13464748|NCT00095199|26975867|FG002|Overall Study|Started radiotherapy regimen|0|||
13464749|NCT00095199|26975868|FG003|Overall Study|Started radiotherapy regimen|0|||
13464750|NCT00095199|26975865|FG000|Overall Study|Primary tumor removed in other surgery|0|||
13464751|NCT00095199|26975866|FG001|Overall Study|Primary tumor removed in other surgery|1|||
13464752|NCT00095199|26975867|FG002|Overall Study|Primary tumor removed in other surgery|0|||
13464753|NCT00095199|26975868|FG003|Overall Study|Primary tumor removed in other surgery|0|||
13464754|NCT00095199|26975865|FG000|Overall Study|Data inadvertently lost by site|1|||
13464755|NCT00095199|26975866|FG001|Overall Study|Data inadvertently lost by site|0|||
13464756|NCT00095199|26975867|FG002|Overall Study|Data inadvertently lost by site|0|||
13464757|NCT00095199|26975868|FG003|Overall Study|Data inadvertently lost by site|0|||
13464758|NCT00095173|26975910|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1|||
13464759|NCT00095173|26975911|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
13464760|NCT00095173|26975912|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
13464761|NCT00095173|26975913|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
13464762|NCT00095173|26975914|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
13464763|NCT00095173|26975915|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
13464764|NCT00095173|26975910|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17|||
13464765|NCT00095173|26975911|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
13464766|NCT00095173|26975912|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
13464767|NCT00095173|26975913|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
13464768|NCT00095173|26975914|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
13464769|NCT00095173|26975915|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
13464770|NCT00095173|26975910|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1|||
13464771|NCT00095173|26975911|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
13464772|NCT00095173|26975912|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
13464773|NCT00095173|26975913|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
13464774|NCT00095173|26975914|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
13464775|NCT00095173|26975915|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
13464776|NCT00095173|26975910|FG000|Open-Label Lead-In Phase (Period A)|Other|1|||
13464777|NCT00095173|26975911|FG001|Open-Label Lead-In Phase (Period A)|Other|0|||
13464778|NCT00095173|26975912|FG002|Open-Label Lead-In Phase (Period A)|Other|0|||
13464779|NCT00095173|26975913|FG003|Open-Label Lead-In Phase (Period A)|Other|0|||
13464780|NCT00095173|26975914|FG004|Open-Label Lead-In Phase (Period A)|Other|0|||
13464781|NCT00095173|26975915|FG005|Open-Label Lead-In Phase (Period A)|Other|0|||
13464782|NCT00095173|26975910|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
13464783|NCT00095173|26975911|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10|||
13464784|NCT00095173|26975912|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31|||
13464785|NCT00095173|26975913|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
13464786|NCT00095173|26975914|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
13464787|NCT00095173|26975915|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
13464788|NCT00095173|26975910|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
13464789|NCT00095173|26975911|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1|||
13464790|NCT00095173|26975912|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
13464791|NCT00095173|26975913|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
13464792|NCT00095173|26975914|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
13464793|NCT00095173|26975915|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
13464794|NCT00095173|26975910|FG000|Open-Label Extension Phase (Period C)|Death|0|||
13464795|NCT00095173|26975911|FG001|Open-Label Extension Phase (Period C)|Death|0|||
13464796|NCT00095173|26975912|FG002|Open-Label Extension Phase (Period C)|Death|0|||
13464797|NCT00095173|26975913|FG003|Open-Label Extension Phase (Period C)|Death|0|||
13464798|NCT00095173|26975914|FG004|Open-Label Extension Phase (Period C)|Death|0|||
13464799|NCT00095173|26975915|FG005|Open-Label Extension Phase (Period C)|Death|1|||
13464800|NCT00095173|26975910|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0|||
13464801|NCT00095173|26975911|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0|||
13464802|NCT00095173|26975912|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0|||
13464803|NCT00095173|26975913|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1|||
13464804|NCT00095173|26975914|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2|||
13464805|NCT00095173|26975915|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3|||
13464806|NCT00095173|26975910|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
13464807|NCT00095173|26975911|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
13464808|NCT00095173|26975912|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
13464809|NCT00095173|26975913|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11|||
13464810|NCT00095173|26975914|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5|||
13464811|NCT00095173|26975915|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8|||
13464812|NCT00095173|26975910|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
13464813|NCT00095173|26975911|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
13464814|NCT00095173|26975912|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
13464815|NCT00095173|26975913|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2|||
13464816|NCT00095173|26975914|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5|||
13464817|NCT00095173|26975915|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6|||
13464818|NCT00095173|26975910|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
13464819|NCT00095173|26975911|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
13464820|NCT00095173|26975912|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
13464821|NCT00095173|26975913|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4|||
13464822|NCT00095173|26975914|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6|||
13464823|NCT00095173|26975915|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
13464824|NCT00095173|26975910|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
13464825|NCT00095173|26975911|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
13464826|NCT00095173|26975912|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
13464827|NCT00095173|26975913|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
13464828|NCT00095173|26975914|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
13464829|NCT00095173|26975915|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
13464830|NCT00095173|26975910|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
13464831|NCT00095173|26975911|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
13464832|NCT00095173|26975912|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
13464833|NCT00095173|26975913|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
13464834|NCT00095173|26975914|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
13464835|NCT00095173|26975915|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
13464836|NCT00095173|26975910|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0|||
13464837|NCT00095173|26975911|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0|||
13464838|NCT00095173|26975912|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0|||
13464839|NCT00095173|26975913|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1|||
13464840|NCT00095173|26975914|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2|||
13464841|NCT00095173|26975915|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3|||
13464842|NCT00095173|26975910|FG000|Open-Label Extension Phase (Period C)|Other|0|||
13464843|NCT00095173|26975911|FG001|Open-Label Extension Phase (Period C)|Other|0|||
13464844|NCT00095173|26975912|FG002|Open-Label Extension Phase (Period C)|Other|0|||
13464845|NCT00095173|26975913|FG003|Open-Label Extension Phase (Period C)|Other|4|||
13464846|NCT00095173|26975914|FG004|Open-Label Extension Phase (Period C)|Other|6|||
13464847|NCT00095173|26975915|FG005|Open-Label Extension Phase (Period C)|Other|8|||
13464848|NCT00095147|26976120|FG000|Double-blind Period 1 (Days 1-197)|Death|1|||
13464849|NCT00095147|26976121|FG001|Double-blind Period 1 (Days 1-197)|Death|0|||
13464850|NCT00095147|26976122|FG002|Double-blind Period 1 (Days 1-197)|Death|0|||
13464851|NCT00095147|26976123|FG003|Double-blind Period 1 (Days 1-197)|Death|0|||
13464852|NCT00095147|26976124|FG004|Double-blind Period 1 (Days 1-197)|Death|0|||
13464853|NCT00095147|26976120|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2|||
13464854|NCT00095147|26976121|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8|||
13464855|NCT00095147|26976122|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1|||
13464856|NCT00095147|26976123|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
13464857|NCT00095147|26976124|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
13464858|NCT00095147|26976120|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
13464859|NCT00095147|26976121|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
13464860|NCT00095147|26976122|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1|||
13464861|NCT00095147|26976123|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
13464862|NCT00095147|26976124|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
13464863|NCT00095147|26976120|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
13464864|NCT00095147|26976121|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
13464865|NCT00095147|26976122|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
13464866|NCT00095147|26976123|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
13464867|NCT00095147|26976124|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
13464868|NCT00095147|26976120|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
13464869|NCT00095147|26976121|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
13464870|NCT00095147|26976122|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
13464871|NCT00095147|26976123|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
13464872|NCT00095147|26976124|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
13464873|NCT00095147|26976120|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
13464874|NCT00095147|26976121|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
13464875|NCT00095147|26976122|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
13464876|NCT00095147|26976123|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
13464877|NCT00095147|26976124|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
13464878|NCT00095147|26976120|FG000|Double-blind Period 2 (Days 198-365)|Death|0|||
13464879|NCT00095147|26976121|FG001|Double-blind Period 2 (Days 198-365)|Death|1|||
13464880|NCT00095147|26976122|FG002|Double-blind Period 2 (Days 198-365)|Death|0|||
13464881|NCT00095147|26976123|FG003|Double-blind Period 2 (Days 198-365)|Death|1|||
13464882|NCT00095147|26976124|FG004|Double-blind Period 2 (Days 198-365)|Death|0|||
13464883|NCT00095147|26976120|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2|||
13464884|NCT00095147|26976121|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4|||
13464885|NCT00095147|26976122|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
13464886|NCT00095147|26976123|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
13464887|NCT00095147|26976124|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
13464888|NCT00095147|26976120|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2|||
13464889|NCT00095147|26976121|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4|||
13464890|NCT00095147|26976122|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
13464891|NCT00095147|26976123|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1|||
13464892|NCT00095147|26976124|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
13464893|NCT00095147|26976120|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3|||
13464894|NCT00095147|26976121|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2|||
13464895|NCT00095147|26976122|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
13464896|NCT00095147|26976123|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
13464897|NCT00095147|26976124|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
13464898|NCT00095147|26976120|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
13464899|NCT00095147|26976121|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
13464900|NCT00095147|26976122|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
13464901|NCT00095147|26976123|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
13464902|NCT00095147|26976124|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
13464903|NCT00095147|26976120|FG000|Long-term Extension Period|Death|0|||
13464904|NCT00095147|26976121|FG001|Long-term Extension Period|Death|0|||
13464905|NCT00095147|26976122|FG002|Long-term Extension Period|Death|0|||
13464906|NCT00095147|26976123|FG003|Long-term Extension Period|Death|0|||
13464907|NCT00095147|26976124|FG004|Long-term Extension Period|Death|3|||
13464908|NCT00095147|26976120|FG000|Long-term Extension Period|Adverse Event|0|||
13464909|NCT00095147|26976121|FG001|Long-term Extension Period|Adverse Event|0|||
13464910|NCT00095147|26976122|FG002|Long-term Extension Period|Adverse Event|0|||
13464911|NCT00095147|26976123|FG003|Long-term Extension Period|Adverse Event|0|||
13464912|NCT00095147|26976124|FG004|Long-term Extension Period|Adverse Event|11|||
13464913|NCT00095147|26976120|FG000|Long-term Extension Period|Lack of Efficacy|0|||
13464914|NCT00095147|26976121|FG001|Long-term Extension Period|Lack of Efficacy|0|||
13464915|NCT00095147|26976122|FG002|Long-term Extension Period|Lack of Efficacy|0|||
13464916|NCT00095147|26976123|FG003|Long-term Extension Period|Lack of Efficacy|0|||
13464917|NCT00095147|26976124|FG004|Long-term Extension Period|Lack of Efficacy|9|||
13464918|NCT00095147|26976120|FG000|Long-term Extension Period|Lost to Follow-up|0|||
13464919|NCT00095147|26976121|FG001|Long-term Extension Period|Lost to Follow-up|0|||
13464920|NCT00095147|26976122|FG002|Long-term Extension Period|Lost to Follow-up|0|||
13464921|NCT00095147|26976123|FG003|Long-term Extension Period|Lost to Follow-up|0|||
13464922|NCT00095147|26976124|FG004|Long-term Extension Period|Lost to Follow-up|6|||
13464923|NCT00095147|26976120|FG000|Long-term Extension Period|Withdrawal of consent|0|||
13464924|NCT00095147|26976121|FG001|Long-term Extension Period|Withdrawal of consent|0|||
13464925|NCT00095147|26976122|FG002|Long-term Extension Period|Withdrawal of consent|0|||
13464926|NCT00095147|26976123|FG003|Long-term Extension Period|Withdrawal of consent|0|||
13464927|NCT00095147|26976124|FG004|Long-term Extension Period|Withdrawal of consent|12|||
13464928|NCT00095147|26976120|FG000|Long-term Extension Period|Pregnancy|0|||
13464929|NCT00095147|26976121|FG001|Long-term Extension Period|Pregnancy|0|||
13464930|NCT00095147|26976122|FG002|Long-term Extension Period|Pregnancy|0|||
13464931|NCT00095147|26976123|FG003|Long-term Extension Period|Pregnancy|0|||
13464932|NCT00095147|26976124|FG004|Long-term Extension Period|Pregnancy|1|||
13464933|NCT00095147|26976120|FG000|Long-term Extension Period|No longer meets study criteria|0|||
13464934|NCT00095147|26976121|FG001|Long-term Extension Period|No longer meets study criteria|0|||
13464935|NCT00095147|26976122|FG002|Long-term Extension Period|No longer meets study criteria|0|||
13464936|NCT00095147|26976123|FG003|Long-term Extension Period|No longer meets study criteria|0|||
13464937|NCT00095147|26976124|FG004|Long-term Extension Period|No longer meets study criteria|1|||
13464938|NCT00095147|26976120|FG000|Long-term Extension Period|Participant chose to use Revellex|0|||
13464939|NCT00095147|26976121|FG001|Long-term Extension Period|Participant chose to use Revellex|0|||
13464940|NCT00095147|26976122|FG002|Long-term Extension Period|Participant chose to use Revellex|0|||
13464941|NCT00095147|26976123|FG003|Long-term Extension Period|Participant chose to use Revellex|0|||
13464942|NCT00095147|26976124|FG004|Long-term Extension Period|Participant chose to use Revellex|1|||
13464943|NCT00095147|26976120|FG000|Long-term Extension Period|Leaving country|0|||
13464944|NCT00095147|26976121|FG001|Long-term Extension Period|Leaving country|0|||
13464945|NCT00095147|26976122|FG002|Long-term Extension Period|Leaving country|0|||
13464946|NCT00095147|26976123|FG003|Long-term Extension Period|Leaving country|0|||
13464947|NCT00095147|26976124|FG004|Long-term Extension Period|Leaving country|1|||
13464948|NCT00095121|26976175|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1|||
13464949|NCT00095121|26976176|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0|||
13464950|NCT00095121|26976175|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2|||
13464951|NCT00095121|26976176|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0|||
13464952|NCT00095056|26976191|FG000|Phase A (Weeks 0-12)|Adverse Event|1|||
13464953|NCT00095056|26976192|FG001|Phase A (Weeks 0-12)|Adverse Event|1|||
13464954|NCT00095056|26976191|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3|||
13464955|NCT00095056|26976192|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0|||
13464956|NCT00095056|26976191|FG000|Phase A (Weeks 0-12)|Death|1|||
13464957|NCT00095056|26976192|FG001|Phase A (Weeks 0-12)|Death|0|||
13464958|NCT00095056|26976191|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2|||
13464959|NCT00095056|26976192|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0|||
13464960|NCT00095056|26976191|FG000|Phase B (Weeks 12-54)|Adverse Event|2|||
13464961|NCT00095056|26976192|FG001|Phase B (Weeks 12-54)|Adverse Event|2|||
13464962|NCT00095056|26976191|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1|||
13464963|NCT00095056|26976192|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0|||
13464964|NCT00095056|26976191|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2|||
13464965|NCT00095056|26976192|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1|||
13464966|NCT00095056|26976191|FG000|Phase B (Weeks 12-54)|Patient Moved|1|||
13464967|NCT00095056|26976192|FG001|Phase B (Weeks 12-54)|Patient Moved|0|||
13464968|NCT00095056|26976191|FG000|Phase B (Weeks 12-54)|Death|3|||
13464969|NCT00095056|26976192|FG001|Phase B (Weeks 12-54)|Death|1|||
13464970|NCT00095056|26976191|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1|||
13464971|NCT00095056|26976192|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0|||
13464972|NCT00095056|26976191|FG000|Phase B (Weeks 12-54)|Protocol Violation|0|||
13464973|NCT00095056|26976192|FG001|Phase B (Weeks 12-54)|Protocol Violation|1|||
13464974|NCT00094861|26976219|FG000|Overall Study|Adverse Event|5|||
13464975|NCT00094861|26976220|FG001|Overall Study|Adverse Event|2|||
13464976|NCT00094861|26976219|FG000|Overall Study|Withdrawal by Subject|5|||
13464977|NCT00094861|26976220|FG001|Overall Study|Withdrawal by Subject|3|||
13464978|NCT00094861|26976219|FG000|Overall Study|Physician Decision|1|||
13464979|NCT00094861|26976220|FG001|Overall Study|Physician Decision|1|||
13464980|NCT00094861|26976219|FG000|Overall Study|Lost to Follow-up|0|||
13464981|NCT00094861|26976220|FG001|Overall Study|Lost to Follow-up|1|||
13464982|NCT00094861|26976219|FG000|Overall Study|Death|4|||
13464983|NCT00094861|26976220|FG001|Overall Study|Death|2|||
13464984|NCT00094861|26976219|FG000|Overall Study|Other|3|||
13464985|NCT00094861|26976220|FG001|Overall Study|Other|0|||
13464986|NCT00094835|26976318|FG000|Overall Study|Physician Decision|1|||
13464987|NCT00094835|26976319|FG001|Overall Study|Physician Decision|0|||
13464988|NCT00094835|26976320|FG002|Overall Study|Physician Decision|0|||
13464989|NCT00094835|26976321|FG003|Overall Study|Physician Decision|0|||
13464990|NCT00094835|26976322|FG004|Overall Study|Physician Decision|0|||
13464991|NCT00094835|26976323|FG005|Overall Study|Physician Decision|1|||
13464992|NCT00094835|26976324|FG006|Overall Study|Physician Decision|0|||
13464993|NCT00094835|26976318|FG000|Overall Study|Withdrawal by Subject|0|||
13464994|NCT00094835|26976319|FG001|Overall Study|Withdrawal by Subject|0|||
13464995|NCT00094835|26976320|FG002|Overall Study|Withdrawal by Subject|0|||
13464996|NCT00094835|26976321|FG003|Overall Study|Withdrawal by Subject|0|||
13464997|NCT00094835|26976322|FG004|Overall Study|Withdrawal by Subject|0|||
13464998|NCT00094835|26976323|FG005|Overall Study|Withdrawal by Subject|0|||
13464999|NCT00094835|26976324|FG006|Overall Study|Withdrawal by Subject|1|||
13465000|NCT00094835|26976318|FG000|Overall Study|Lost to Follow-up|0|||
13465001|NCT00094835|26976319|FG001|Overall Study|Lost to Follow-up|0|||
13465002|NCT00094835|26976320|FG002|Overall Study|Lost to Follow-up|0|||
13465003|NCT00094835|26976321|FG003|Overall Study|Lost to Follow-up|0|||
13465004|NCT00094835|26976322|FG004|Overall Study|Lost to Follow-up|1|||
13465005|NCT00094835|26976323|FG005|Overall Study|Lost to Follow-up|0|||
13465006|NCT00094835|26976324|FG006|Overall Study|Lost to Follow-up|0|||
13465007|NCT00094835|26976318|FG000|Overall Study|Death|1|||
13465008|NCT00094835|26976319|FG001|Overall Study|Death|0|||
13465009|NCT00094835|26976320|FG002|Overall Study|Death|0|||
13465010|NCT00094835|26976321|FG003|Overall Study|Death|0|||
13465011|NCT00094835|26976322|FG004|Overall Study|Death|1|||
13465012|NCT00094835|26976323|FG005|Overall Study|Death|0|||
13465013|NCT00094835|26976324|FG006|Overall Study|Death|0|||
13465014|NCT00094835|26976318|FG000|Overall Study|Non-compliance|1|||
13465015|NCT00094835|26976319|FG001|Overall Study|Non-compliance|2|||
13465016|NCT00094835|26976320|FG002|Overall Study|Non-compliance|2|||
13465017|NCT00094835|26976321|FG003|Overall Study|Non-compliance|0|||
13465018|NCT00094835|26976322|FG004|Overall Study|Non-compliance|2|||
13465019|NCT00094835|26976323|FG005|Overall Study|Non-compliance|2|||
13465020|NCT00094835|26976324|FG006|Overall Study|Non-compliance|1|||
13465021|NCT00094835|26976318|FG000|Overall Study|Other|1|||
13465022|NCT00094835|26976319|FG001|Overall Study|Other|1|||
13465023|NCT00094835|26976320|FG002|Overall Study|Other|1|||
13465024|NCT00094835|26976321|FG003|Overall Study|Other|1|||
13465025|NCT00094835|26976322|FG004|Overall Study|Other|0|||
13465026|NCT00094835|26976323|FG005|Overall Study|Other|0|||
13465027|NCT00094835|26976324|FG006|Overall Study|Other|0|||
13465028|NCT00094809|26976355|FG000|Overall Study|Protocol deviation|2|||
13465029|NCT00094809|26976356|FG001|Overall Study|Protocol deviation|2|||
13465030|NCT00094809|26976355|FG000|Overall Study|Noncompliance|1|||
13465031|NCT00094809|26976356|FG001|Overall Study|Noncompliance|0|||
13465032|NCT00094809|26976355|FG000|Overall Study|Adverse Event|3|||
13465033|NCT00094809|26976356|FG001|Overall Study|Adverse Event|1|||
13465034|NCT00094809|26976355|FG000|Overall Study|Withdrawal by Subject|8|||
13465035|NCT00094809|26976356|FG001|Overall Study|Withdrawal by Subject|9|||
13465036|NCT00094809|26976355|FG000|Overall Study|Disease progression|3|||
13465037|NCT00094809|26976356|FG001|Overall Study|Disease progression|3|||
13465038|NCT00094809|26976355|FG000|Overall Study|Physician Decision|3|||
13465039|NCT00094809|26976356|FG001|Overall Study|Physician Decision|5|||
13465040|NCT00094809|26976355|FG000|Overall Study|Lost to Follow-up|6|||
13465041|NCT00094809|26976356|FG001|Overall Study|Lost to Follow-up|6|||
13465042|NCT00094809|26976355|FG000|Overall Study|Death|19|||
13465043|NCT00094809|26976356|FG001|Overall Study|Death|25|||
13465044|NCT00094809|26976355|FG000|Overall Study|Protocol-specified criteria|1|||
13465045|NCT00094809|26976356|FG001|Overall Study|Protocol-specified criteria|1|||
13465046|NCT00094809|26976355|FG000|Overall Study|Other|2|||
13465047|NCT00094809|26976356|FG001|Overall Study|Other|4|||
13465048|NCT00094809|26976355|FG000|Overall Study|Informed consent signed after treatment|1|||
13465049|NCT00094809|26976356|FG001|Overall Study|Informed consent signed after treatment|0|||
13465050|NCT00094809|26976355|FG000|Overall Study|Study drug not received|2|||
13465051|NCT00094809|26976356|FG001|Overall Study|Study drug not received|8|||
13465052|NCT00094809|26976355|FG000|Overall Study|Other|1|||
13465053|NCT00094809|26976356|FG001|Overall Study|Other|1|||
13465054|NCT00094770|26976391|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25|||
13465055|NCT00094770|26976392|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26|||
13465056|NCT00094770|26976391|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86|||
13465057|NCT00094770|26976392|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58|||
13465058|NCT00094770|26976391|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19|||
13465059|NCT00094770|26976392|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10|||
13465060|NCT00094770|26976391|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
13465061|NCT00094770|26976392|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
13465062|NCT00094770|26976391|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19|||
13465063|NCT00094770|26976392|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25|||
13465064|NCT00094770|26976391|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6|||
13465065|NCT00094770|26976392|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2|||
13465066|NCT00094770|26976391|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25|||
13465067|NCT00094770|26976392|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28|||
13465068|NCT00094770|26976391|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
13465069|NCT00094770|26976392|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
13465070|NCT00094770|26976391|FG000|Year 1 ( Week 0 to Week 52)|Other|10|||
13465071|NCT00094770|26976392|FG001|Year 1 ( Week 0 to Week 52)|Other|11|||
13465072|NCT00094770|26976391|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35|||
13465073|NCT00094770|26976392|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36|||
13465074|NCT00094770|26976391|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180|||
13465075|NCT00094770|26976392|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162|||
13465076|NCT00094770|26976391|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25|||
13465077|NCT00094770|26976392|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15|||
13465078|NCT00094770|26976391|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13|||
13465079|NCT00094770|26976392|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12|||
13465080|NCT00094770|26976391|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29|||
13465081|NCT00094770|26976392|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30|||
13465082|NCT00094770|26976391|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6|||
13465083|NCT00094770|26976392|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2|||
13465084|NCT00094770|26976391|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28|||
13465085|NCT00094770|26976392|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38|||
13465086|NCT00094770|26976391|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
13465087|NCT00094770|26976392|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
13465088|NCT00094770|26976391|FG000|Year 2 (Week 0 to Week 104)|Other|15|||
13465089|NCT00094770|26976392|FG001|Year 2 (Week 0 to Week 104)|Other|23|||
13465090|NCT00094757|26976419|FG000|Overall Study|Adverse Event|11|||
13465091|NCT00094757|26976420|FG001|Overall Study|Adverse Event|9|||
13465092|NCT00094757|26976421|FG002|Overall Study|Adverse Event|6|||
13465093|NCT00094757|26976419|FG000|Overall Study|Lack of Efficacy|11|||
13465094|NCT00094757|26976420|FG001|Overall Study|Lack of Efficacy|15|||
13465095|NCT00094757|26976421|FG002|Overall Study|Lack of Efficacy|8|||
13465096|NCT00094757|26976419|FG000|Overall Study|Lost to Follow-up|3|||
13465097|NCT00094757|26976420|FG001|Overall Study|Lost to Follow-up|5|||
13465098|NCT00094757|26976421|FG002|Overall Study|Lost to Follow-up|6|||
13465099|NCT00094757|26976419|FG000|Overall Study|Patient Moved|2|||
13465100|NCT00094757|26976420|FG001|Overall Study|Patient Moved|1|||
13465101|NCT00094757|26976421|FG002|Overall Study|Patient Moved|1|||
13465102|NCT00094757|26976419|FG000|Overall Study|Protocol Violation|8|||
13465103|NCT00094757|26976420|FG001|Overall Study|Protocol Violation|5|||
13465104|NCT00094757|26976421|FG002|Overall Study|Protocol Violation|3|||
13465105|NCT00094757|26976419|FG000|Overall Study|Withdrawal by Subject|14|||
13465106|NCT00094757|26976420|FG001|Overall Study|Withdrawal by Subject|21|||
13465107|NCT00094757|26976421|FG002|Overall Study|Withdrawal by Subject|5|||
13465108|NCT00094757|26976419|FG000|Overall Study|Other|3|||
13465109|NCT00094757|26976420|FG001|Overall Study|Other|3|||
13465110|NCT00094757|26976421|FG002|Overall Study|Other|1|||
13465111|NCT00094757|26976419|FG000|Overall Study|Protocol specified discontinuation|1|||
13465112|NCT00094757|26976420|FG001|Overall Study|Protocol specified discontinuation|3|||
13465113|NCT00094757|26976421|FG002|Overall Study|Protocol specified discontinuation|0|||
13465114|NCT00094653|26976492|FG000|Overall Study|Death|306|||
13465115|NCT00094653|26976493|FG001|Overall Study|Death|100|||
13465116|NCT00094653|26976494|FG002|Overall Study|Death|119|||
13465117|NCT00094653|26976492|FG000|Overall Study|Subject Withdrew Consent|10|||
13465118|NCT00094653|26976493|FG001|Overall Study|Subject Withdrew Consent|2|||
13465119|NCT00094653|26976494|FG002|Overall Study|Subject Withdrew Consent|3|||
13465120|NCT00094653|26976492|FG000|Overall Study|Other|2|||
13465121|NCT00094653|26976493|FG001|Overall Study|Other|2|||
13465122|NCT00094653|26976494|FG002|Overall Study|Other|2|||
13465123|NCT00094653|26976492|FG000|Overall Study|Lost to Follow-up|3|||
13465124|NCT00094653|26976493|FG001|Overall Study|Lost to Follow-up|2|||
13465125|NCT00094653|26976494|FG002|Overall Study|Lost to Follow-up|1|||
13465126|NCT00094653|26976492|FG000|Overall Study|Protocol Violation|0|||
13465127|NCT00094653|26976493|FG001|Overall Study|Protocol Violation|0|||
13465128|NCT00094653|26976494|FG002|Overall Study|Protocol Violation|1|||
13465129|NCT00094575|26976521|FG000|Overall Study|Death|146|||
13465130|NCT00094575|26976522|FG001|Overall Study|Death|146|||
13465131|NCT00094536|26976528|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24|||
13465132|NCT00094536|26976528|FG000|Treatment and Follow-up|Adverse Event|4|||
13465133|NCT00094536|26976528|FG000|Treatment and Follow-up|Lack of Efficacy|9|||
13465134|NCT00094536|26976528|FG000|Treatment and Follow-up|Lost to Follow-up|7|||
13465135|NCT00094536|26976528|FG000|Treatment and Follow-up|Withdrawal by Subject|1|||
13465136|NCT00094536|26976528|FG000|Treatment and Follow-up|Subject non-compliance|9|||
13465137|NCT00094536|26976528|FG000|Treatment and Follow-up|Unable to attend visits|1|||
13465138|NCT00094458|26976579|FG000|Main Study: Through Week 30|Eligibility criteria not met|3|||
13465139|NCT00094458|26976580|FG001|Main Study: Through Week 30|Eligibility criteria not met|8|||
13465140|NCT00094458|26976581|FG002|Main Study: Through Week 30|Eligibility criteria not met|2|||
13465141|NCT00094458|26976582|FG003|Main Study: Through Week 30|Eligibility criteria not met|0|||
13465142|NCT00094458|26976583|FG004|Main Study: Through Week 30|Eligibility criteria not met|0|||
13465143|NCT00094458|26976584|FG005|Main Study: Through Week 30|Eligibility criteria not met|0|||
13465144|NCT00094458|26976579|FG000|Main Study: Through Week 30|Lost to Follow-up|5|||
13465145|NCT00094458|26976580|FG001|Main Study: Through Week 30|Lost to Follow-up|5|||
13465146|NCT00094458|26976581|FG002|Main Study: Through Week 30|Lost to Follow-up|2|||
13465147|NCT00094458|26976582|FG003|Main Study: Through Week 30|Lost to Follow-up|0|||
13465148|NCT00094458|26976583|FG004|Main Study: Through Week 30|Lost to Follow-up|0|||
13465149|NCT00094458|26976584|FG005|Main Study: Through Week 30|Lost to Follow-up|0|||
13465150|NCT00094458|26976579|FG000|Main Study: Through Week 30|Withdrawal by Subject|18|||
13465151|NCT00094458|26976580|FG001|Main Study: Through Week 30|Withdrawal by Subject|9|||
13465152|NCT00094458|26976581|FG002|Main Study: Through Week 30|Withdrawal by Subject|7|||
13465153|NCT00094458|26976582|FG003|Main Study: Through Week 30|Withdrawal by Subject|0|||
13465154|NCT00094458|26976583|FG004|Main Study: Through Week 30|Withdrawal by Subject|0|||
13465155|NCT00094458|26976584|FG005|Main Study: Through Week 30|Withdrawal by Subject|0|||
13465156|NCT00094458|26976579|FG000|Main Study: Through Week 30|Adverse Event|38|||
13465157|NCT00094458|26976580|FG001|Main Study: Through Week 30|Adverse Event|20|||
13465158|NCT00094458|26976581|FG002|Main Study: Through Week 30|Adverse Event|28|||
13465159|NCT00094458|26976582|FG003|Main Study: Through Week 30|Adverse Event|0|||
13465160|NCT00094458|26976583|FG004|Main Study: Through Week 30|Adverse Event|0|||
13465161|NCT00094458|26976584|FG005|Main Study: Through Week 30|Adverse Event|0|||
13465162|NCT00094458|26976579|FG000|Main Study: Through Week 30|Death|1|||
13465163|NCT00094458|26976580|FG001|Main Study: Through Week 30|Death|0|||
13465164|NCT00094458|26976581|FG002|Main Study: Through Week 30|Death|0|||
13465165|NCT00094458|26976582|FG003|Main Study: Through Week 30|Death|0|||
13465166|NCT00094458|26976583|FG004|Main Study: Through Week 30|Death|0|||
13465167|NCT00094458|26976584|FG005|Main Study: Through Week 30|Death|0|||
13465168|NCT00094458|26976579|FG000|Main Study: Through Week 30|Other|19|||
13465169|NCT00094458|26976580|FG001|Main Study: Through Week 30|Other|16|||
13465170|NCT00094458|26976581|FG002|Main Study: Through Week 30|Other|9|||
13465171|NCT00094458|26976582|FG003|Main Study: Through Week 30|Other|0|||
13465172|NCT00094458|26976583|FG004|Main Study: Through Week 30|Other|0|||
13465173|NCT00094458|26976584|FG005|Main Study: Through Week 30|Other|0|||
13465174|NCT00094458|26976579|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2|||
13465175|NCT00094458|26976580|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1|||
13465176|NCT00094458|26976581|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4|||
13465177|NCT00094458|26976582|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
13465178|NCT00094458|26976583|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
13465179|NCT00094458|26976584|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
13465180|NCT00094458|26976579|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2|||
13465181|NCT00094458|26976580|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
13465182|NCT00094458|26976581|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4|||
13465183|NCT00094458|26976582|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
13465184|NCT00094458|26976583|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
13465185|NCT00094458|26976584|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
13465186|NCT00094458|26976579|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3|||
13465187|NCT00094458|26976580|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9|||
13465188|NCT00094458|26976581|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7|||
13465189|NCT00094458|26976582|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
13465190|NCT00094458|26976583|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
13465191|NCT00094458|26976584|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
13465192|NCT00094458|26976579|FG000|Study Extension: Week 30 Through Week 50|Other|1|||
13465193|NCT00094458|26976580|FG001|Study Extension: Week 30 Through Week 50|Other|2|||
13465194|NCT00094458|26976581|FG002|Study Extension: Week 30 Through Week 50|Other|3|||
13465195|NCT00094458|26976582|FG003|Study Extension: Week 30 Through Week 50|Other|0|||
13465196|NCT00094458|26976583|FG004|Study Extension: Week 30 Through Week 50|Other|0|||
13465197|NCT00094458|26976584|FG005|Study Extension: Week 30 Through Week 50|Other|0|||
13465198|NCT00094458|26976579|FG000|OLE: Open-Label Extension|Adverse Event|0|||
13465199|NCT00094458|26976580|FG001|OLE: Open-Label Extension|Adverse Event|0|||
13465200|NCT00094458|26976581|FG002|OLE: Open-Label Extension|Adverse Event|0|||
13465201|NCT00094458|26976582|FG003|OLE: Open-Label Extension|Adverse Event|0|||
13465202|NCT00094458|26976583|FG004|OLE: Open-Label Extension|Adverse Event|3|||
13465203|NCT00094458|26976584|FG005|OLE: Open-Label Extension|Adverse Event|4|||
13465204|NCT00094458|26976579|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
13465205|NCT00094458|26976580|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
13465206|NCT00094458|26976581|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
13465207|NCT00094458|26976582|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
13465208|NCT00094458|26976583|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
13465209|NCT00094458|26976584|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
13465210|NCT00094458|26976579|FG000|OLE: Open-Label Extension|Patient decision|0|||
13465211|NCT00094458|26976580|FG001|OLE: Open-Label Extension|Patient decision|0|||
13465212|NCT00094458|26976581|FG002|OLE: Open-Label Extension|Patient decision|0|||
13465213|NCT00094458|26976582|FG003|OLE: Open-Label Extension|Patient decision|0|||
13465214|NCT00094458|26976583|FG004|OLE: Open-Label Extension|Patient decision|1|||
13465215|NCT00094458|26976584|FG005|OLE: Open-Label Extension|Patient decision|0|||
13465216|NCT00094445|26976590|FG000|Overall Study|Withdrawal by Subject|3|||
13465217|NCT00094445|26976590|FG000|Overall Study|Lost to Follow-up|1|||
13465218|NCT00094445|26976590|FG000|Overall Study|Progressive Disease|2|||
13465219|NCT00094328|26976604|FG000|Overall Study|Lost to Follow-up|1|||
13465220|NCT00094302|26976665|FG000|Overall Study|Lost to Follow-up|43|||
13465221|NCT00094302|26976666|FG001|Overall Study|Lost to Follow-up|41|||
13465222|NCT00094302|26976665|FG000|Overall Study|Physician Decision|5|||
13465223|NCT00094302|26976666|FG001|Overall Study|Physician Decision|8|||
13465224|NCT00094302|26976665|FG000|Overall Study|Withdrawal by Subject|103|||
13465225|NCT00094302|26976666|FG001|Overall Study|Withdrawal by Subject|111|||
13465226|NCT00094302|26976665|FG000|Overall Study|Death|266|||
13465227|NCT00094302|26976666|FG001|Overall Study|Death|246|||
13465228|NCT00094172|26976683|FG000|Overall Study|Adverse Event|0|||
13465229|NCT00094172|26976684|FG001|Overall Study|Adverse Event|1|||
13465230|NCT00094172|26976683|FG000|Overall Study|Lost to Follow-up|2|||
13465231|NCT00094172|26976684|FG001|Overall Study|Lost to Follow-up|0|||
13465232|NCT00094172|26976683|FG000|Overall Study|Protocol Violation|0|||
13465233|NCT00094172|26976684|FG001|Overall Study|Protocol Violation|1|||
13465234|NCT00094172|26976683|FG000|Overall Study|Withdrawal by Subject|10|||
13465235|NCT00094172|26976684|FG001|Overall Study|Withdrawal by Subject|5|||
13465236|NCT00094172|26976683|FG000|Overall Study|Primary endpoint met.|1|||
13465237|NCT00094172|26976684|FG001|Overall Study|Primary endpoint met.|0|||
13465238|NCT00094172|26976683|FG000|Overall Study|Started other MS therapy due to disease|1|||
13465239|NCT00094172|26976684|FG001|Overall Study|Started other MS therapy due to disease|0|||
13465240|NCT00094107|26976695|FG000|Overall Study|Lack of Efficacy|23|||
13465241|NCT00094107|26976695|FG000|Overall Study|Death|5|||
13465242|NCT00094107|26976695|FG000|Overall Study|Adverse Event|3|||
13465243|NCT00094107|26976695|FG000|Overall Study|Withdrawal due to Disease Progression|1|||
13465244|NCT00094094|26976706|FG000|Overall Study|Death|2|||
13465245|NCT00094094|26976706|FG000|Overall Study|Lack of Efficacy|23|||
13465246|NCT00094094|26976706|FG000|Overall Study|Adverse Event|7|||
13465247|NCT00094055|26976717|FG000|Overall Study|Adverse Event|11|||
13465248|NCT00094055|26976717|FG000|Overall Study|Death|4|||
13465249|NCT00094055|26976717|FG000|Overall Study|Lack of Efficacy|17|||
13465250|NCT00094055|26976717|FG000|Overall Study|Lost to Follow-up|2|||
13465251|NCT00094055|26976717|FG000|Overall Study|progressive disease|2|||
13465252|NCT00094055|26976717|FG000|Overall Study|clinical progression|1|||
13465253|NCT00094055|26976717|FG000|Overall Study|roll-over to another study|14|||
13465254|NCT00094055|26976717|FG000|Overall Study|Withdrawal by Subject|9|||
13465255|NCT00093808|26976726|FG000|Overall Study|Cancel participation before receiving tx|1|||
13465256|NCT00093808|26976726|FG000|Overall Study|Protocol Violation|1|||
13465257|NCT00093795|26976756|FG000|Overall Study|No follow up data|20|||
13465258|NCT00093795|26976757|FG001|Overall Study|No follow up data|16|||
13465259|NCT00093795|26976758|FG002|Overall Study|No follow up data|17|||
13465260|NCT00093496|26976776|FG000|Overall Study|Protocol Violation|1|||
13465261|NCT00093496|26976777|FG001|Overall Study|Protocol Violation|3|||
13465262|NCT00093470|26976792|FG000|Overall Study|Disease progression|39|||
13465263|NCT00093470|26976793|FG001|Overall Study|Disease progression|0|||
13465264|NCT00093470|26976792|FG000|Overall Study|Adverse Event|15|||
13465265|NCT00093470|26976793|FG001|Overall Study|Adverse Event|0|||
13465266|NCT00093470|26976792|FG000|Overall Study|Death|2|||
13465267|NCT00093470|26976793|FG001|Overall Study|Death|0|||
13465268|NCT00093470|26976792|FG000|Overall Study|Withdrawal by Subject|8|||
13465269|NCT00093470|26976793|FG001|Overall Study|Withdrawal by Subject|0|||
13465270|NCT00093470|26976792|FG000|Overall Study|Alternative therapy|2|||
13465271|NCT00093470|26976793|FG001|Overall Study|Alternative therapy|0|||
13465272|NCT00093470|26976792|FG000|Overall Study|Other complicating disease|3|||
13465273|NCT00093470|26976793|FG001|Overall Study|Other complicating disease|0|||
13465274|NCT00093470|26976792|FG000|Overall Study|Physician Decision|2|||
13465275|NCT00093470|26976793|FG001|Overall Study|Physician Decision|0|||
13465276|NCT00093470|26976792|FG000|Overall Study|Never started treatment|1|||
13465277|NCT00093470|26976793|FG001|Overall Study|Never started treatment|0|||
13465278|NCT00093470|26976792|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1|||
13465279|NCT00093470|26976793|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0|||
13465280|NCT00093145|26976804|FG000|Overall Study|Unacceptable Toxicity Only|2|||
13465281|NCT00093145|26976804|FG000|Overall Study|Physician Decision|5|||
13465282|NCT00093145|26976804|FG000|Overall Study|Withdrawal by Subject|9|||
13465283|NCT00093145|26976804|FG000|Overall Study|Other|1|||
13465284|NCT00092677|26976853|FG000|Overall Study|Lost to Follow-up|0|||
13465285|NCT00092677|26976854|FG001|Overall Study|Lost to Follow-up|2|||
13465286|NCT00092677|26976853|FG000|Overall Study|Adminstrative|5|||
13465287|NCT00092677|26976854|FG001|Overall Study|Adminstrative|9|||
13465288|NCT00092547|26976904|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5|||
13465289|NCT00092547|26976905|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1|||
13465290|NCT00092547|26976906|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0|||
13465291|NCT00092547|26976904|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4|||
13465292|NCT00092547|26976905|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1|||
13465293|NCT00092547|26976906|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0|||
13465294|NCT00092547|26976904|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18|||
13465295|NCT00092547|26976905|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7|||
13465296|NCT00092547|26976906|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0|||
13465297|NCT00092547|26976904|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28|||
13465298|NCT00092547|26976905|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21|||
13465299|NCT00092547|26976906|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0|||
13465300|NCT00092547|26976904|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3|||
13465301|NCT00092547|26976905|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1|||
13465302|NCT00092547|26976906|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0|||
13465303|NCT00092547|26976904|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
13465304|NCT00092547|26976905|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1|||
13465305|NCT00092547|26976906|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
13465306|NCT00092547|26976904|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
13465307|NCT00092547|26976905|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1|||
13465308|NCT00092547|26976906|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
13465309|NCT00092547|26976904|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5|||
13465310|NCT00092547|26976905|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3|||
13465311|NCT00092547|26976906|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0|||
13465312|NCT00092547|26976904|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1|||
13465313|NCT00092547|26976905|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5|||
13465314|NCT00092547|26976906|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0|||
13465315|NCT00092547|26976904|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4|||
13465316|NCT00092547|26976905|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2|||
13465317|NCT00092547|26976906|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0|||
13465318|NCT00092547|26976904|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13|||
13465319|NCT00092547|26976905|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7|||
13465320|NCT00092547|26976906|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0|||
13465321|NCT00092547|26976904|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1|||
13465322|NCT00092547|26976905|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
13465323|NCT00092547|26976906|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
13465324|NCT00092547|26976904|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1|||
13465325|NCT00092547|26976905|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
13465326|NCT00092547|26976906|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
13465327|NCT00092547|26976904|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4|||
13465328|NCT00092547|26976905|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2|||
13465329|NCT00092547|26976906|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0|||
13465330|NCT00092547|26976904|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1|||
13465331|NCT00092547|26976905|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3|||
13465332|NCT00092547|26976906|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0|||
13465333|NCT00092547|26976904|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2|||
13465334|NCT00092547|26976905|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
13465335|NCT00092547|26976906|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
13465336|NCT00092547|26976904|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1|||
13465337|NCT00092547|26976905|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
13465338|NCT00092547|26976906|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
13465339|NCT00092547|26976904|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3|||
13465340|NCT00092547|26976905|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
13465341|NCT00092547|26976906|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
13465342|NCT00092547|26976904|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6|||
13465343|NCT00092547|26976905|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0|||
13465344|NCT00092547|26976906|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9|||
13465345|NCT00092547|26976904|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14|||
13465346|NCT00092547|26976905|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0|||
13465347|NCT00092547|26976906|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7|||
13465348|NCT00092547|26976904|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1|||
13465349|NCT00092547|26976905|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
13465350|NCT00092547|26976906|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
13465351|NCT00092534|26976944|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5|||
13465352|NCT00092534|26976945|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5|||
13465353|NCT00092534|26976946|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
13465354|NCT00092534|26976947|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
13465355|NCT00092534|26976948|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
13465356|NCT00092534|26976944|FG000|Base Study Vaccination Period|Adverse Event|3|||
13465357|NCT00092534|26976945|FG001|Base Study Vaccination Period|Adverse Event|1|||
13465358|NCT00092534|26976946|FG002|Base Study Vaccination Period|Adverse Event|0|||
13465359|NCT00092534|26976947|FG003|Base Study Vaccination Period|Adverse Event|0|||
13465360|NCT00092534|26976948|FG004|Base Study Vaccination Period|Adverse Event|0|||
13465361|NCT00092534|26976944|FG000|Base Study Vaccination Period|Death|5|||
13465362|NCT00092534|26976945|FG001|Base Study Vaccination Period|Death|4|||
13465363|NCT00092534|26976946|FG002|Base Study Vaccination Period|Death|0|||
13465364|NCT00092534|26976947|FG003|Base Study Vaccination Period|Death|0|||
13465365|NCT00092534|26976948|FG004|Base Study Vaccination Period|Death|0|||
13465366|NCT00092534|26976944|FG000|Base Study Vaccination Period|Lost to Follow-up|41|||
13465367|NCT00092534|26976945|FG001|Base Study Vaccination Period|Lost to Follow-up|37|||
13465368|NCT00092534|26976946|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
13465369|NCT00092534|26976947|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
13465370|NCT00092534|26976948|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
13465371|NCT00092534|26976944|FG000|Base Study Vaccination Period|Physician Decision|1|||
13465372|NCT00092534|26976945|FG001|Base Study Vaccination Period|Physician Decision|0|||
13465373|NCT00092534|26976946|FG002|Base Study Vaccination Period|Physician Decision|0|||
13465374|NCT00092534|26976947|FG003|Base Study Vaccination Period|Physician Decision|0|||
13465375|NCT00092534|26976948|FG004|Base Study Vaccination Period|Physician Decision|0|||
13465376|NCT00092534|26976944|FG000|Base Study Vaccination Period|Pregnancy|9|||
13465377|NCT00092534|26976945|FG001|Base Study Vaccination Period|Pregnancy|7|||
13465378|NCT00092534|26976946|FG002|Base Study Vaccination Period|Pregnancy|0|||
13465379|NCT00092534|26976947|FG003|Base Study Vaccination Period|Pregnancy|0|||
13465380|NCT00092534|26976948|FG004|Base Study Vaccination Period|Pregnancy|0|||
13465381|NCT00092534|26976944|FG000|Base Study Vaccination Period|Protocol Violation|2|||
13465382|NCT00092534|26976945|FG001|Base Study Vaccination Period|Protocol Violation|1|||
13465383|NCT00092534|26976946|FG002|Base Study Vaccination Period|Protocol Violation|0|||
13465384|NCT00092534|26976947|FG003|Base Study Vaccination Period|Protocol Violation|0|||
13465385|NCT00092534|26976948|FG004|Base Study Vaccination Period|Protocol Violation|0|||
13465386|NCT00092534|26976944|FG000|Base Study Vaccination Period|Withdrawal by Subject|85|||
13465387|NCT00092534|26976945|FG001|Base Study Vaccination Period|Withdrawal by Subject|58|||
13465388|NCT00092534|26976946|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
13465389|NCT00092534|26976947|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
13465390|NCT00092534|26976948|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
13465391|NCT00092534|26976944|FG000|Base Study Vaccination Period|Moved|14|||
13465392|NCT00092534|26976945|FG001|Base Study Vaccination Period|Moved|12|||
13465393|NCT00092534|26976946|FG002|Base Study Vaccination Period|Moved|0|||
13465394|NCT00092534|26976947|FG003|Base Study Vaccination Period|Moved|0|||
13465395|NCT00092534|26976948|FG004|Base Study Vaccination Period|Moved|0|||
13465396|NCT00092534|26976944|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5|||
13465397|NCT00092534|26976945|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
13465398|NCT00092534|26976946|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
13465399|NCT00092534|26976947|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
13465400|NCT00092534|26976948|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
13465401|NCT00092534|26976944|FG000|Base Study Vaccination Period|Travel|1|||
13465402|NCT00092534|26976945|FG001|Base Study Vaccination Period|Travel|0|||
13465403|NCT00092534|26976946|FG002|Base Study Vaccination Period|Travel|0|||
13465404|NCT00092534|26976947|FG003|Base Study Vaccination Period|Travel|0|||
13465405|NCT00092534|26976948|FG004|Base Study Vaccination Period|Travel|0|||
13465406|NCT00092534|26976944|FG000|Base Study Vaccination Period|Site Closed|0|||
13465407|NCT00092534|26976945|FG001|Base Study Vaccination Period|Site Closed|1|||
13465408|NCT00092534|26976946|FG002|Base Study Vaccination Period|Site Closed|0|||
13465409|NCT00092534|26976947|FG003|Base Study Vaccination Period|Site Closed|0|||
13465410|NCT00092534|26976948|FG004|Base Study Vaccination Period|Site Closed|0|||
13465411|NCT00092534|26976944|FG000|Base Study Follow-Up Period|Adverse Event|2|||
13465412|NCT00092534|26976945|FG001|Base Study Follow-Up Period|Adverse Event|4|||
13465413|NCT00092534|26976946|FG002|Base Study Follow-Up Period|Adverse Event|0|||
13465414|NCT00092534|26976947|FG003|Base Study Follow-Up Period|Adverse Event|0|||
13465415|NCT00092534|26976948|FG004|Base Study Follow-Up Period|Adverse Event|0|||
13465416|NCT00092534|26976944|FG000|Base Study Follow-Up Period|Death|2|||
13465417|NCT00092534|26976945|FG001|Base Study Follow-Up Period|Death|1|||
13465418|NCT00092534|26976946|FG002|Base Study Follow-Up Period|Death|0|||
13465419|NCT00092534|26976947|FG003|Base Study Follow-Up Period|Death|0|||
13465420|NCT00092534|26976948|FG004|Base Study Follow-Up Period|Death|0|||
13465421|NCT00092534|26976944|FG000|Base Study Follow-Up Period|Lost to Follow-up|120|||
13465422|NCT00092534|26976945|FG001|Base Study Follow-Up Period|Lost to Follow-up|146|||
13465423|NCT00092534|26976946|FG002|Base Study Follow-Up Period|Lost to Follow-up|0|||
13465424|NCT00092534|26976947|FG003|Base Study Follow-Up Period|Lost to Follow-up|0|||
13465425|NCT00092534|26976948|FG004|Base Study Follow-Up Period|Lost to Follow-up|0|||
13465426|NCT00092534|26976944|FG000|Base Study Follow-Up Period|Pregnancy|6|||
13465427|NCT00092534|26976945|FG001|Base Study Follow-Up Period|Pregnancy|10|||
13465428|NCT00092534|26976946|FG002|Base Study Follow-Up Period|Pregnancy|0|||
13465429|NCT00092534|26976947|FG003|Base Study Follow-Up Period|Pregnancy|0|||
13465430|NCT00092534|26976948|FG004|Base Study Follow-Up Period|Pregnancy|0|||
13465431|NCT00092534|26976944|FG000|Base Study Follow-Up Period|Protocol Violation|1|||
13465432|NCT00092534|26976945|FG001|Base Study Follow-Up Period|Protocol Violation|2|||
13465433|NCT00092534|26976946|FG002|Base Study Follow-Up Period|Protocol Violation|0|||
13465434|NCT00092534|26976947|FG003|Base Study Follow-Up Period|Protocol Violation|0|||
13465435|NCT00092534|26976948|FG004|Base Study Follow-Up Period|Protocol Violation|0|||
13465436|NCT00092534|26976944|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71|||
13465437|NCT00092534|26976945|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62|||
13465438|NCT00092534|26976946|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0|||
13465439|NCT00092534|26976947|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0|||
13465440|NCT00092534|26976948|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0|||
13465441|NCT00092534|26976944|FG000|Base Study Follow-Up Period|Moved|62|||
13465442|NCT00092534|26976945|FG001|Base Study Follow-Up Period|Moved|58|||
13465443|NCT00092534|26976946|FG002|Base Study Follow-Up Period|Moved|0|||
13465444|NCT00092534|26976947|FG003|Base Study Follow-Up Period|Moved|0|||
13465445|NCT00092534|26976948|FG004|Base Study Follow-Up Period|Moved|0|||
13465446|NCT00092534|26976944|FG000|Base Study Follow-Up Period|Travel|10|||
13465447|NCT00092534|26976945|FG001|Base Study Follow-Up Period|Travel|7|||
13465448|NCT00092534|26976946|FG002|Base Study Follow-Up Period|Travel|0|||
13465449|NCT00092534|26976947|FG003|Base Study Follow-Up Period|Travel|0|||
13465450|NCT00092534|26976948|FG004|Base Study Follow-Up Period|Travel|0|||
13465451|NCT00092534|26976944|FG000|Base Study Follow-Up Period|Site Closed|0|||
13465452|NCT00092534|26976945|FG001|Base Study Follow-Up Period|Site Closed|2|||
13465453|NCT00092534|26976946|FG002|Base Study Follow-Up Period|Site Closed|0|||
13465454|NCT00092534|26976947|FG003|Base Study Follow-Up Period|Site Closed|0|||
13465455|NCT00092534|26976948|FG004|Base Study Follow-Up Period|Site Closed|0|||
13465456|NCT00092534|26976944|FG000|Base Study Follow-Up Period|Subjects continuing|27|||
13465457|NCT00092534|26976945|FG001|Base Study Follow-Up Period|Subjects continuing|31|||
13465458|NCT00092534|26976946|FG002|Base Study Follow-Up Period|Subjects continuing|0|||
13465459|NCT00092534|26976947|FG003|Base Study Follow-Up Period|Subjects continuing|0|||
13465460|NCT00092534|26976948|FG004|Base Study Follow-Up Period|Subjects continuing|0|||
13465461|NCT00092534|26976944|FG000|Base Study Follow-Up Period|Subjects in extension|15|||
13465462|NCT00092534|26976945|FG001|Base Study Follow-Up Period|Subjects in extension|371|||
13465463|NCT00092534|26976946|FG002|Base Study Follow-Up Period|Subjects in extension|0|||
13465464|NCT00092534|26976947|FG003|Base Study Follow-Up Period|Subjects in extension|0|||
13465465|NCT00092534|26976948|FG004|Base Study Follow-Up Period|Subjects in extension|0|||
13465466|NCT00092534|26976944|FG000|Base Study EXT|Lost to Follow-up|0|||
13465467|NCT00092534|26976945|FG001|Base Study EXT|Lost to Follow-up|0|||
13465468|NCT00092534|26976946|FG002|Base Study EXT|Lost to Follow-up|41|||
13465469|NCT00092534|26976947|FG003|Base Study EXT|Lost to Follow-up|0|||
13465470|NCT00092534|26976948|FG004|Base Study EXT|Lost to Follow-up|0|||
13465471|NCT00092534|26976944|FG000|Base Study EXT|Physician Decision|0|||
13465472|NCT00092534|26976945|FG001|Base Study EXT|Physician Decision|0|||
13465473|NCT00092534|26976946|FG002|Base Study EXT|Physician Decision|1|||
13465474|NCT00092534|26976947|FG003|Base Study EXT|Physician Decision|0|||
13465475|NCT00092534|26976948|FG004|Base Study EXT|Physician Decision|0|||
13465476|NCT00092534|26976944|FG000|Base Study EXT|Pregnancy|0|||
13465477|NCT00092534|26976945|FG001|Base Study EXT|Pregnancy|0|||
13465478|NCT00092534|26976946|FG002|Base Study EXT|Pregnancy|12|||
13465479|NCT00092534|26976947|FG003|Base Study EXT|Pregnancy|0|||
13465480|NCT00092534|26976948|FG004|Base Study EXT|Pregnancy|0|||
13465481|NCT00092534|26976944|FG000|Base Study EXT|Withdrawal by Subject|0|||
13465482|NCT00092534|26976945|FG001|Base Study EXT|Withdrawal by Subject|0|||
13465483|NCT00092534|26976946|FG002|Base Study EXT|Withdrawal by Subject|18|||
13465484|NCT00092534|26976947|FG003|Base Study EXT|Withdrawal by Subject|0|||
13465485|NCT00092534|26976948|FG004|Base Study EXT|Withdrawal by Subject|0|||
13465486|NCT00092534|26976944|FG000|Base Study EXT|Participant moved|0|||
13465487|NCT00092534|26976945|FG001|Base Study EXT|Participant moved|0|||
13465488|NCT00092534|26976946|FG002|Base Study EXT|Participant moved|6|||
13465489|NCT00092534|26976947|FG003|Base Study EXT|Participant moved|0|||
13465490|NCT00092534|26976948|FG004|Base Study EXT|Participant moved|0|||
13465491|NCT00092534|26976944|FG000|Base Study EXT|Travel|0|||
13465492|NCT00092534|26976945|FG001|Base Study EXT|Travel|0|||
13465493|NCT00092534|26976946|FG002|Base Study EXT|Travel|2|||
13465494|NCT00092534|26976947|FG003|Base Study EXT|Travel|0|||
13465495|NCT00092534|26976948|FG004|Base Study EXT|Travel|0|||
13465496|NCT00092534|26976944|FG000|Base Study EXT|Site closed|0|||
13465497|NCT00092534|26976945|FG001|Base Study EXT|Site closed|0|||
13465498|NCT00092534|26976946|FG002|Base Study EXT|Site closed|21|||
13465499|NCT00092534|26976947|FG003|Base Study EXT|Site closed|0|||
13465500|NCT00092534|26976948|FG004|Base Study EXT|Site closed|0|||
13465501|NCT00092534|26976944|FG000|Base Study EXT|Study ended|0|||
13465502|NCT00092534|26976945|FG001|Base Study EXT|Study ended|0|||
13465503|NCT00092534|26976946|FG002|Base Study EXT|Study ended|29|||
13465504|NCT00092534|26976947|FG003|Base Study EXT|Study ended|0|||
13465505|NCT00092534|26976948|FG004|Base Study EXT|Study ended|0|||
13465506|NCT00092534|26976944|FG000|Base Study EXT|Protocol Violation|0|||
13465507|NCT00092534|26976945|FG001|Base Study EXT|Protocol Violation|0|||
13465508|NCT00092534|26976946|FG002|Base Study EXT|Protocol Violation|15|||
13465509|NCT00092534|26976947|FG003|Base Study EXT|Protocol Violation|0|||
13465510|NCT00092534|26976948|FG004|Base Study EXT|Protocol Violation|0|||
13465511|NCT00092534|26976944|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
13465512|NCT00092534|26976945|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
13465513|NCT00092534|26976946|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
13465514|NCT00092534|26976947|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1|||
13465515|NCT00092534|26976948|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
13465516|NCT00092521|26976969|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6|||
13465517|NCT00092521|26976970|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
13465518|NCT00092521|26976971|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7|||
13465519|NCT00092521|26976972|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
13465520|NCT00092521|26976969|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1|||
13465521|NCT00092521|26976970|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
13465522|NCT00092521|26976971|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7|||
13465523|NCT00092521|26976972|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
13465524|NCT00092521|26976969|FG000|Vaccination (Day 1 Through Month 7)|Death|0|||
13465525|NCT00092521|26976970|FG001|Vaccination (Day 1 Through Month 7)|Death|0|||
13465526|NCT00092521|26976971|FG002|Vaccination (Day 1 Through Month 7)|Death|1|||
13465527|NCT00092521|26976972|FG003|Vaccination (Day 1 Through Month 7)|Death|0|||
13465528|NCT00092521|26976969|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51|||
13465529|NCT00092521|26976970|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6|||
13465530|NCT00092521|26976971|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44|||
13465531|NCT00092521|26976972|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0|||
13465532|NCT00092521|26976969|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5|||
13465533|NCT00092521|26976970|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
13465534|NCT00092521|26976971|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7|||
13465535|NCT00092521|26976972|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
13465536|NCT00092521|26976969|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59|||
13465537|NCT00092521|26976970|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7|||
13465538|NCT00092521|26976971|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62|||
13465539|NCT00092521|26976972|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0|||
13465540|NCT00092521|26976969|FG000|Vaccination (Day 1 Through Month 7)|Moved|14|||
13465541|NCT00092521|26976970|FG001|Vaccination (Day 1 Through Month 7)|Moved|1|||
13465542|NCT00092521|26976971|FG002|Vaccination (Day 1 Through Month 7)|Moved|18|||
13465543|NCT00092521|26976972|FG003|Vaccination (Day 1 Through Month 7)|Moved|0|||
13465544|NCT00092521|26976969|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2|||
13465545|NCT00092521|26976970|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
13465546|NCT00092521|26976971|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
13465547|NCT00092521|26976972|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
13465548|NCT00092521|26976969|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2|||
13465549|NCT00092521|26976970|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
13465550|NCT00092521|26976971|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
13465551|NCT00092521|26976972|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
13465552|NCT00092521|26976969|FG000|Follow-Up (After Month 7)|Subjects Continuing|34|||
13465553|NCT00092521|26976970|FG001|Follow-Up (After Month 7)|Subjects Continuing|4|||
13465554|NCT00092521|26976971|FG002|Follow-Up (After Month 7)|Subjects Continuing|35|||
13465555|NCT00092521|26976972|FG003|Follow-Up (After Month 7)|Subjects Continuing|0|||
13465556|NCT00092521|26976969|FG000|Follow-Up (After Month 7)|Subjects in Extension|13|||
13465557|NCT00092521|26976970|FG001|Follow-Up (After Month 7)|Subjects in Extension|109|||
13465558|NCT00092521|26976971|FG002|Follow-Up (After Month 7)|Subjects in Extension|412|||
13465559|NCT00092521|26976972|FG003|Follow-Up (After Month 7)|Subjects in Extension|0|||
13465560|NCT00092521|26976969|FG000|Follow-Up (After Month 7)|Adverse Event|1|||
13465561|NCT00092521|26976970|FG001|Follow-Up (After Month 7)|Adverse Event|0|||
13465562|NCT00092521|26976971|FG002|Follow-Up (After Month 7)|Adverse Event|0|||
13465563|NCT00092521|26976972|FG003|Follow-Up (After Month 7)|Adverse Event|0|||
13465564|NCT00092521|26976969|FG000|Follow-Up (After Month 7)|Death|2|||
13465565|NCT00092521|26976970|FG001|Follow-Up (After Month 7)|Death|0|||
13465566|NCT00092521|26976971|FG002|Follow-Up (After Month 7)|Death|1|||
13465567|NCT00092521|26976972|FG003|Follow-Up (After Month 7)|Death|0|||
13465568|NCT00092521|26976969|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113|||
13465569|NCT00092521|26976970|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14|||
13465570|NCT00092521|26976971|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108|||
13465571|NCT00092521|26976972|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0|||
13306299|NCT01292603|26525400|FG005|Part 2: Regular Follow-Up|Death|3|||
13465572|NCT00092521|26976969|FG000|Follow-Up (After Month 7)|Protocol Violation|1|||
13465573|NCT00092521|26976970|FG001|Follow-Up (After Month 7)|Protocol Violation|1|||
13465574|NCT00092521|26976971|FG002|Follow-Up (After Month 7)|Protocol Violation|5|||
13465575|NCT00092521|26976972|FG003|Follow-Up (After Month 7)|Protocol Violation|0|||
13465576|NCT00092521|26976969|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40|||
13465577|NCT00092521|26976970|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6|||
13465578|NCT00092521|26976971|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51|||
13465579|NCT00092521|26976972|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0|||
13465580|NCT00092521|26976969|FG000|Follow-Up (After Month 7)|Moved|32|||
13465581|NCT00092521|26976970|FG001|Follow-Up (After Month 7)|Moved|2|||
13465582|NCT00092521|26976971|FG002|Follow-Up (After Month 7)|Moved|28|||
13465583|NCT00092521|26976972|FG003|Follow-Up (After Month 7)|Moved|0|||
13465584|NCT00092521|26976969|FG000|Follow-Up (After Month 7)|Site Terminated|3|||
13465585|NCT00092521|26976970|FG001|Follow-Up (After Month 7)|Site Terminated|0|||
13465586|NCT00092521|26976971|FG002|Follow-Up (After Month 7)|Site Terminated|3|||
13465587|NCT00092521|26976972|FG003|Follow-Up (After Month 7)|Site Terminated|0|||
13465588|NCT00092521|26976969|FG000|Follow-Up (After Month 7)|Travel|2|||
13465589|NCT00092521|26976970|FG001|Follow-Up (After Month 7)|Travel|0|||
13465590|NCT00092521|26976971|FG002|Follow-Up (After Month 7)|Travel|0|||
13465591|NCT00092521|26976972|FG003|Follow-Up (After Month 7)|Travel|0|||
13465592|NCT00092521|26976969|FG000|Follow-Up (After Month 7)|Visits Compressed|5|||
13465593|NCT00092521|26976970|FG001|Follow-Up (After Month 7)|Visits Compressed|0|||
13465594|NCT00092521|26976971|FG002|Follow-Up (After Month 7)|Visits Compressed|5|||
13465595|NCT00092521|26976972|FG003|Follow-Up (After Month 7)|Visits Compressed|0|||
13465596|NCT00092521|26976969|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0|||
13465597|NCT00092521|26976970|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0|||
13465598|NCT00092521|26976971|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0|||
13465599|NCT00092521|26976972|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23|||
13465600|NCT00092521|26976969|FG000|Extension Study (Group 4)|Adverse Event|0|||
13465601|NCT00092521|26976970|FG001|Extension Study (Group 4)|Adverse Event|0|||
13465602|NCT00092521|26976971|FG002|Extension Study (Group 4)|Adverse Event|0|||
13465603|NCT00092521|26976972|FG003|Extension Study (Group 4)|Adverse Event|2|||
13465604|NCT00092521|26976969|FG000|Extension Study (Group 4)|Lost to Follow-up|0|||
13465605|NCT00092521|26976970|FG001|Extension Study (Group 4)|Lost to Follow-up|0|||
13465606|NCT00092521|26976971|FG002|Extension Study (Group 4)|Lost to Follow-up|0|||
13465607|NCT00092521|26976972|FG003|Extension Study (Group 4)|Lost to Follow-up|87|||
13465608|NCT00092521|26976969|FG000|Extension Study (Group 4)|Pregnancy|0|||
13465609|NCT00092521|26976970|FG001|Extension Study (Group 4)|Pregnancy|0|||
13465610|NCT00092521|26976971|FG002|Extension Study (Group 4)|Pregnancy|0|||
13465611|NCT00092521|26976972|FG003|Extension Study (Group 4)|Pregnancy|4|||
13465612|NCT00092521|26976969|FG000|Extension Study (Group 4)|Protocol Violation|0|||
13465613|NCT00092521|26976970|FG001|Extension Study (Group 4)|Protocol Violation|0|||
13465614|NCT00092521|26976971|FG002|Extension Study (Group 4)|Protocol Violation|0|||
13465615|NCT00092521|26976972|FG003|Extension Study (Group 4)|Protocol Violation|2|||
13465616|NCT00092521|26976969|FG000|Extension Study (Group 4)|Withdrawal by Subject|0|||
13465617|NCT00092521|26976970|FG001|Extension Study (Group 4)|Withdrawal by Subject|0|||
13465618|NCT00092521|26976971|FG002|Extension Study (Group 4)|Withdrawal by Subject|0|||
13465619|NCT00092521|26976972|FG003|Extension Study (Group 4)|Withdrawal by Subject|46|||
13465620|NCT00092521|26976969|FG000|Extension Study (Group 4)|Moved|0|||
13465621|NCT00092521|26976970|FG001|Extension Study (Group 4)|Moved|0|||
13465622|NCT00092521|26976971|FG002|Extension Study (Group 4)|Moved|0|||
13465623|NCT00092521|26976972|FG003|Extension Study (Group 4)|Moved|16|||
13465624|NCT00092521|26976969|FG000|Extension Study (Group 4)|Site Terminated|0|||
13465625|NCT00092521|26976970|FG001|Extension Study (Group 4)|Site Terminated|0|||
13465626|NCT00092521|26976971|FG002|Extension Study (Group 4)|Site Terminated|0|||
13465627|NCT00092521|26976972|FG003|Extension Study (Group 4)|Site Terminated|4|||
13465628|NCT00092521|26976969|FG000|Extension Study (Group 4)|Unable/unwilling to return|0|||
13465629|NCT00092521|26976970|FG001|Extension Study (Group 4)|Unable/unwilling to return|0|||
13465630|NCT00092521|26976971|FG002|Extension Study (Group 4)|Unable/unwilling to return|0|||
13465631|NCT00092521|26976972|FG003|Extension Study (Group 4)|Unable/unwilling to return|25|||
13465632|NCT00092495|26977048|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
13465633|NCT00092495|26977049|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
13465634|NCT00092495|26977050|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
13465635|NCT00092495|26977051|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4|||
13465636|NCT00092495|26977052|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
13465637|NCT00092495|26977048|FG000|Base Study Vaccination Period|Extended|0|||
13465638|NCT00092495|26977049|FG001|Base Study Vaccination Period|Extended|0|||
13465639|NCT00092495|26977050|FG002|Base Study Vaccination Period|Extended|0|||
13465640|NCT00092495|26977051|FG003|Base Study Vaccination Period|Extended|1|||
13465641|NCT00092495|26977052|FG004|Base Study Vaccination Period|Extended|0|||
13465642|NCT00092495|26977048|FG000|Base Study Vaccination Period|*Clinical AE|1|||
13465643|NCT00092495|26977049|FG001|Base Study Vaccination Period|*Clinical AE|0|||
13465644|NCT00092495|26977050|FG002|Base Study Vaccination Period|*Clinical AE|1|||
13465645|NCT00092495|26977051|FG003|Base Study Vaccination Period|*Clinical AE|2|||
13465646|NCT00092495|26977052|FG004|Base Study Vaccination Period|*Clinical AE|0|||
13465647|NCT00092495|26977048|FG000|Base Study Vaccination Period|*Other reasons|1|||
13465648|NCT00092495|26977049|FG001|Base Study Vaccination Period|*Other reasons|0|||
13465649|NCT00092495|26977050|FG002|Base Study Vaccination Period|*Other reasons|0|||
13465650|NCT00092495|26977051|FG003|Base Study Vaccination Period|*Other reasons|1|||
13465651|NCT00092495|26977052|FG004|Base Study Vaccination Period|*Other reasons|0|||
13465652|NCT00092495|26977048|FG000|Base Study Vaccination Period|*Pregnancy|0|||
13465653|NCT00092495|26977049|FG001|Base Study Vaccination Period|*Pregnancy|2|||
13465654|NCT00092495|26977050|FG002|Base Study Vaccination Period|*Pregnancy|5|||
13465655|NCT00092495|26977051|FG003|Base Study Vaccination Period|*Pregnancy|7|||
13465656|NCT00092495|26977052|FG004|Base Study Vaccination Period|*Pregnancy|0|||
13465657|NCT00092495|26977048|FG000|Base Study Vaccination Period|Adverse Event|1|||
13465658|NCT00092495|26977049|FG001|Base Study Vaccination Period|Adverse Event|0|||
13465659|NCT00092495|26977050|FG002|Base Study Vaccination Period|Adverse Event|0|||
13465660|NCT00092495|26977051|FG003|Base Study Vaccination Period|Adverse Event|3|||
13465661|NCT00092495|26977052|FG004|Base Study Vaccination Period|Adverse Event|0|||
13465662|NCT00092495|26977048|FG000|Base Study Vaccination Period|Lost to Follow-up|16|||
13465663|NCT00092495|26977049|FG001|Base Study Vaccination Period|Lost to Follow-up|6|||
13465664|NCT00092495|26977050|FG002|Base Study Vaccination Period|Lost to Follow-up|11|||
13465665|NCT00092495|26977051|FG003|Base Study Vaccination Period|Lost to Follow-up|36|||
13465666|NCT00092495|26977052|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
13465667|NCT00092495|26977048|FG000|Base Study Vaccination Period|Moved|3|||
13465668|NCT00092495|26977049|FG001|Base Study Vaccination Period|Moved|1|||
13465669|NCT00092495|26977050|FG002|Base Study Vaccination Period|Moved|2|||
13465670|NCT00092495|26977051|FG003|Base Study Vaccination Period|Moved|2|||
13465671|NCT00092495|26977052|FG004|Base Study Vaccination Period|Moved|0|||
13465672|NCT00092495|26977048|FG000|Base Study Vaccination Period|Other|1|||
13465673|NCT00092495|26977049|FG001|Base Study Vaccination Period|Other|1|||
13465674|NCT00092495|26977050|FG002|Base Study Vaccination Period|Other|0|||
13465675|NCT00092495|26977051|FG003|Base Study Vaccination Period|Other|2|||
13465676|NCT00092495|26977052|FG004|Base Study Vaccination Period|Other|0|||
13465677|NCT00092495|26977048|FG000|Base Study Vaccination Period|Pregnancy|2|||
13465678|NCT00092495|26977049|FG001|Base Study Vaccination Period|Pregnancy|0|||
13465679|NCT00092495|26977050|FG002|Base Study Vaccination Period|Pregnancy|0|||
13465680|NCT00092495|26977051|FG003|Base Study Vaccination Period|Pregnancy|0|||
13465681|NCT00092495|26977052|FG004|Base Study Vaccination Period|Pregnancy|0|||
13465682|NCT00092495|26977048|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1|||
13465683|NCT00092495|26977049|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1|||
13465684|NCT00092495|26977050|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1|||
13465685|NCT00092495|26977051|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5|||
13465686|NCT00092495|26977052|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0|||
13465687|NCT00092495|26977048|FG000|Base Study Vaccination Period|Protocol Violation|1|||
13465688|NCT00092495|26977049|FG001|Base Study Vaccination Period|Protocol Violation|0|||
13465689|NCT00092495|26977050|FG002|Base Study Vaccination Period|Protocol Violation|0|||
13465690|NCT00092495|26977051|FG003|Base Study Vaccination Period|Protocol Violation|0|||
13465691|NCT00092495|26977052|FG004|Base Study Vaccination Period|Protocol Violation|0|||
13465692|NCT00092495|26977048|FG000|Base Study Vaccination Period|Withdrawal by Subject|9|||
13465693|NCT00092495|26977049|FG001|Base Study Vaccination Period|Withdrawal by Subject|10|||
13465694|NCT00092495|26977050|FG002|Base Study Vaccination Period|Withdrawal by Subject|14|||
13465695|NCT00092495|26977051|FG003|Base Study Vaccination Period|Withdrawal by Subject|25|||
13465696|NCT00092495|26977052|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
13465697|NCT00092495|26977048|FG000|Base Study Follow-up Period|Extended|0|||
13465698|NCT00092495|26977049|FG001|Base Study Follow-up Period|Extended|0|||
13465699|NCT00092495|26977050|FG002|Base Study Follow-up Period|Extended|1|||
13465700|NCT00092495|26977051|FG003|Base Study Follow-up Period|Extended|2|||
13465701|NCT00092495|26977052|FG004|Base Study Follow-up Period|Extended|0|||
13465702|NCT00092495|26977048|FG000|Base Study Follow-up Period|Lost to Follow-up|1|||
13465703|NCT00092495|26977049|FG001|Base Study Follow-up Period|Lost to Follow-up|3|||
13465704|NCT00092495|26977050|FG002|Base Study Follow-up Period|Lost to Follow-up|3|||
13465705|NCT00092495|26977051|FG003|Base Study Follow-up Period|Lost to Follow-up|12|||
13465706|NCT00092495|26977052|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
13465707|NCT00092495|26977048|FG000|Base Study Follow-up Period|Withdrawal by Subject|2|||
13465708|NCT00092495|26977049|FG001|Base Study Follow-up Period|Withdrawal by Subject|0|||
13465709|NCT00092495|26977050|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
13465710|NCT00092495|26977051|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
13465711|NCT00092495|26977052|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
13465712|NCT00092456|26977111|FG000|Overall Study|Adverse Event|0|||
13465713|NCT00092456|26977112|FG001|Overall Study|Adverse Event|0|||
13465714|NCT00092456|26977113|FG002|Overall Study|Adverse Event|1|||
13465715|NCT00092456|26977114|FG003|Overall Study|Adverse Event|1|||
13465716|NCT00092456|26977111|FG000|Overall Study|Lost to Follow-up|2|||
13465717|NCT00092456|26977112|FG001|Overall Study|Lost to Follow-up|2|||
13465718|NCT00092456|26977113|FG002|Overall Study|Lost to Follow-up|1|||
13465719|NCT00092456|26977114|FG003|Overall Study|Lost to Follow-up|2|||
13465720|NCT00092456|26977111|FG000|Overall Study|Protocol Violation|5|||
13465721|NCT00092456|26977112|FG001|Overall Study|Protocol Violation|7|||
13465722|NCT00092456|26977113|FG002|Overall Study|Protocol Violation|8|||
13465723|NCT00092456|26977114|FG003|Overall Study|Protocol Violation|6|||
13465724|NCT00092456|26977111|FG000|Overall Study|Withdrawal by Subject|13|||
13465725|NCT00092456|26977112|FG001|Overall Study|Withdrawal by Subject|5|||
13465726|NCT00092456|26977113|FG002|Overall Study|Withdrawal by Subject|16|||
13465727|NCT00092456|26977114|FG003|Overall Study|Withdrawal by Subject|6|||
13465728|NCT00092456|26977111|FG000|Overall Study|Moved|1|||
13465729|NCT00092456|26977112|FG001|Overall Study|Moved|1|||
13465730|NCT00092456|26977113|FG002|Overall Study|Moved|0|||
13465731|NCT00092456|26977114|FG003|Overall Study|Moved|1|||
13465732|NCT00092456|26977111|FG000|Overall Study|Other|4|||
13465733|NCT00092456|26977112|FG001|Overall Study|Other|2|||
13465734|NCT00092456|26977113|FG002|Overall Study|Other|3|||
13465735|NCT00092456|26977114|FG003|Overall Study|Other|0|||
13465736|NCT00092443|26977137|FG000|Overall Study|Adverse Event|9|||
13465737|NCT00092443|26977138|FG001|Overall Study|Adverse Event|13|||
13465738|NCT00092443|26977137|FG000|Overall Study|Lost to Follow-up|7|||
13465739|NCT00092443|26977138|FG001|Overall Study|Lost to Follow-up|3|||
13465740|NCT00092443|26977137|FG000|Overall Study|Protocol Violation|11|||
13465741|NCT00092443|26977138|FG001|Overall Study|Protocol Violation|9|||
13465742|NCT00092443|26977137|FG000|Overall Study|Withdrawal by Subject|9|||
13465743|NCT00092443|26977138|FG001|Overall Study|Withdrawal by Subject|11|||
13465744|NCT00092443|26977137|FG000|Overall Study|Moved|5|||
13465745|NCT00092443|26977138|FG001|Overall Study|Moved|5|||
13465746|NCT00092443|26977137|FG000|Overall Study|Other|17|||
13465747|NCT00092443|26977138|FG001|Overall Study|Other|13|||
13465748|NCT00092417|26977159|FG000|Overall Study|Lost to Follow-up|2|||
13465749|NCT00092417|26977160|FG001|Overall Study|Lost to Follow-up|0|||
13465750|NCT00092417|26977159|FG000|Overall Study|Withdrawal by Subject|2|||
13465751|NCT00092417|26977160|FG001|Overall Study|Withdrawal by Subject|1|||
13465752|NCT00092417|26977159|FG000|Overall Study|Other|1|||
13465753|NCT00092417|26977160|FG001|Overall Study|Other|0|||
13465754|NCT00091949|26977185|FG000|Overall Study|Withdrawal by Subject|117|||
13465755|NCT00091949|26977186|FG001|Overall Study|Withdrawal by Subject|110|||
13465756|NCT00091949|26977185|FG000|Overall Study|Lost to Follow-up|58|||
13465757|NCT00091949|26977186|FG001|Overall Study|Lost to Follow-up|41|||
13465758|NCT00091832|26977321|FG000|Overall Study|Physician Decision|1|||
13465759|NCT00091832|26977322|FG001|Overall Study|Physician Decision|0|||
13465760|NCT00091832|26977323|FG002|Overall Study|Physician Decision|0|||
13465761|NCT00091832|26977324|FG003|Overall Study|Physician Decision|0|||
13465762|NCT00091832|26977325|FG004|Overall Study|Physician Decision|0|||
13465763|NCT00091832|26977326|FG005|Overall Study|Physician Decision|0|||
13465764|NCT00091832|26977321|FG000|Overall Study|Adverse Event|0|||
13465765|NCT00091832|26977322|FG001|Overall Study|Adverse Event|0|||
13465766|NCT00091832|26977323|FG002|Overall Study|Adverse Event|0|||
13465767|NCT00091832|26977324|FG003|Overall Study|Adverse Event|1|||
13465768|NCT00091832|26977325|FG004|Overall Study|Adverse Event|3|||
13465769|NCT00091832|26977326|FG005|Overall Study|Adverse Event|0|||
13465770|NCT00091832|26977321|FG000|Overall Study|Withdrawal by Subject|4|||
13465771|NCT00091832|26977322|FG001|Overall Study|Withdrawal by Subject|5|||
13465772|NCT00091832|26977323|FG002|Overall Study|Withdrawal by Subject|0|||
13465773|NCT00091832|26977324|FG003|Overall Study|Withdrawal by Subject|1|||
13465774|NCT00091832|26977325|FG004|Overall Study|Withdrawal by Subject|3|||
13465775|NCT00091832|26977326|FG005|Overall Study|Withdrawal by Subject|1|||
13465776|NCT00091832|26977321|FG000|Overall Study|Death|6|||
13465777|NCT00091832|26977322|FG001|Overall Study|Death|4|||
13465778|NCT00091832|26977323|FG002|Overall Study|Death|5|||
13465779|NCT00091832|26977324|FG003|Overall Study|Death|8|||
13465780|NCT00091832|26977325|FG004|Overall Study|Death|5|||
13465781|NCT00091832|26977326|FG005|Overall Study|Death|6|||
13465782|NCT00091832|26977321|FG000|Overall Study|Disease Progression|2|||
13465783|NCT00091832|26977322|FG001|Overall Study|Disease Progression|0|||
13465784|NCT00091832|26977323|FG002|Overall Study|Disease Progression|0|||
13465785|NCT00091832|26977324|FG003|Overall Study|Disease Progression|1|||
13465786|NCT00091832|26977325|FG004|Overall Study|Disease Progression|1|||
13465787|NCT00091832|26977326|FG005|Overall Study|Disease Progression|2|||
13465788|NCT00091832|26977321|FG000|Overall Study|Ineligibility Determined|0|||
13465789|NCT00091832|26977322|FG001|Overall Study|Ineligibility Determined|0|||
13465790|NCT00091832|26977323|FG002|Overall Study|Ineligibility Determined|1|||
13465791|NCT00091832|26977324|FG003|Overall Study|Ineligibility Determined|0|||
13465792|NCT00091832|26977325|FG004|Overall Study|Ineligibility Determined|1|||
13465793|NCT00091832|26977326|FG005|Overall Study|Ineligibility Determined|0|||
13465794|NCT00091832|26977321|FG000|Overall Study|Lost to Follow-up|1|||
13465795|NCT00091832|26977322|FG001|Overall Study|Lost to Follow-up|0|||
13465796|NCT00091832|26977323|FG002|Overall Study|Lost to Follow-up|3|||
13465797|NCT00091832|26977324|FG003|Overall Study|Lost to Follow-up|3|||
13465798|NCT00091832|26977325|FG004|Overall Study|Lost to Follow-up|2|||
13465799|NCT00091832|26977326|FG005|Overall Study|Lost to Follow-up|1|||
13465800|NCT00091832|26977321|FG000|Overall Study|Noncompliance|0|||
13465801|NCT00091832|26977322|FG001|Overall Study|Noncompliance|1|||
13465802|NCT00091832|26977323|FG002|Overall Study|Noncompliance|0|||
13465803|NCT00091832|26977324|FG003|Overall Study|Noncompliance|0|||
13465804|NCT00091832|26977325|FG004|Overall Study|Noncompliance|0|||
13465805|NCT00091832|26977326|FG005|Overall Study|Noncompliance|0|||
13465806|NCT00091832|26977321|FG000|Overall Study|Other|0|||
13465807|NCT00091832|26977322|FG001|Overall Study|Other|1|||
13465808|NCT00091832|26977323|FG002|Overall Study|Other|2|||
13465809|NCT00091832|26977324|FG003|Overall Study|Other|0|||
13465810|NCT00091832|26977325|FG004|Overall Study|Other|0|||
13465811|NCT00091832|26977326|FG005|Overall Study|Other|0|||
13465812|NCT00091832|26977321|FG000|Overall Study|Protocol Violation|0|||
13465813|NCT00091832|26977322|FG001|Overall Study|Protocol Violation|0|||
13465814|NCT00091832|26977323|FG002|Overall Study|Protocol Violation|1|||
13465815|NCT00091832|26977324|FG003|Overall Study|Protocol Violation|0|||
13465816|NCT00091832|26977325|FG004|Overall Study|Protocol Violation|0|||
13465817|NCT00091832|26977326|FG005|Overall Study|Protocol Violation|1|||
13465818|NCT00091819|26977339|FG000|Overall Study|Adverse Event|1|||
13465819|NCT00091819|26977340|FG001|Overall Study|Adverse Event|1|||
13465820|NCT00091819|26977339|FG000|Overall Study|Death|4|||
13465821|NCT00091819|26977340|FG001|Overall Study|Death|5|||
13465822|NCT00091819|26977339|FG000|Overall Study|Lost to Follow-up|26|||
13465823|NCT00091819|26977340|FG001|Overall Study|Lost to Follow-up|23|||
13465824|NCT00091819|26977339|FG000|Overall Study|Withdrawal by Subject|5|||
13465825|NCT00091819|26977340|FG001|Overall Study|Withdrawal by Subject|8|||
13465826|NCT00091819|26977339|FG000|Overall Study|Protocol Violation|1|||
13465827|NCT00091819|26977340|FG001|Overall Study|Protocol Violation|2|||
13465828|NCT00091819|26977339|FG000|Overall Study|Other|2|||
13465829|NCT00091819|26977340|FG001|Overall Study|Other|3|||
13465830|NCT00091819|26977339|FG000|Overall Study|Never received study treatment|3|||
13465831|NCT00091819|26977340|FG001|Overall Study|Never received study treatment|4|||
13465832|NCT00091793|26977369|FG000|Overall Study|Adverse Event|1|||
13465833|NCT00091793|26977370|FG001|Overall Study|Adverse Event|2|||
13465834|NCT00091793|26977369|FG000|Overall Study|Withdrawal by Subject|10|||
13465835|NCT00091793|26977370|FG001|Overall Study|Withdrawal by Subject|15|||
13465836|NCT00091793|26977369|FG000|Overall Study|Ineligibility determined|2|||
13465837|NCT00091793|26977370|FG001|Overall Study|Ineligibility determined|0|||
13465838|NCT00091793|26977369|FG000|Overall Study|Lost to Follow-up|7|||
13465839|NCT00091793|26977370|FG001|Overall Study|Lost to Follow-up|5|||
13465840|NCT00091793|26977369|FG000|Overall Study|Noncompliance|2|||
13465841|NCT00091793|26977370|FG001|Overall Study|Noncompliance|0|||
13465842|NCT00091793|26977369|FG000|Overall Study|Other|2|||
13465843|NCT00091793|26977370|FG001|Overall Study|Other|0|||
13465844|NCT00091572|26977389|FG000|Overall Study|Lost to Follow-up|1|||
13465845|NCT00091572|26977390|FG001|Overall Study|Lost to Follow-up|1|||
13465846|NCT00091572|26977389|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14|||
13465847|NCT00091572|26977390|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22|||
13465848|NCT00091572|26977389|FG000|Overall Study|Death not due to malignancy/toxicity|1|||
13465849|NCT00091572|26977390|FG001|Overall Study|Death not due to malignancy/toxicity|3|||
13465850|NCT00091572|26977389|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10|||
13465851|NCT00091572|26977390|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22|||
13465852|NCT00091572|26977389|FG000|Overall Study|Other Reason|6|||
13465853|NCT00091572|26977390|FG001|Overall Study|Other Reason|13|||
13465854|NCT00091572|26977389|FG000|Overall Study|Ongoing (still on treatment)|8|||
13465855|NCT00091572|26977390|FG001|Overall Study|Ongoing (still on treatment)|12|||
13465856|NCT00091572|26977389|FG000|Overall Study|Major Protocol Violation|2|||
13465857|NCT00091572|26977390|FG001|Overall Study|Major Protocol Violation|0|||
13465858|NCT00091572|26977389|FG000|Overall Study|Toxicity (Related AE)|53|||
13465859|NCT00091572|26977390|FG001|Overall Study|Toxicity (Related AE)|9|||
13465860|NCT00091442|26977407|FG000|Overall Study|Progressive Disease|220|||
13465861|NCT00091442|26977408|FG001|Overall Study|Progressive Disease|189|||
13465862|NCT00091442|26977407|FG000|Overall Study|Physician Decision|61|||
13465863|NCT00091442|26977408|FG001|Overall Study|Physician Decision|58|||
13465864|NCT00091442|26977407|FG000|Overall Study|Withdrawal by Subject|38|||
13465865|NCT00091442|26977408|FG001|Overall Study|Withdrawal by Subject|46|||
13465866|NCT00091442|26977407|FG000|Overall Study|Adverse Event|29|||
13465867|NCT00091442|26977408|FG001|Overall Study|Adverse Event|48|||
13465868|NCT00091442|26977407|FG000|Overall Study|2cycles therapy beyond Complete response|9|||
13465869|NCT00091442|26977408|FG001|Overall Study|2cycles therapy beyond Complete response|16|||
13465870|NCT00091442|26977407|FG000|Overall Study|Death|9|||
13465871|NCT00091442|26977408|FG001|Overall Study|Death|7|||
13465872|NCT00091442|26977407|FG000|Overall Study|Lost to Follow-up|1|||
13465873|NCT00091442|26977408|FG001|Overall Study|Lost to Follow-up|3|||
13465874|NCT00091442|26977407|FG000|Overall Study|Other|2|||
13465875|NCT00091442|26977408|FG001|Overall Study|Other|6|||
13465876|NCT00091390|26977421|FG000|Overall Study|Protocol Violation|1|||
13465877|NCT00091390|26977421|FG000|Overall Study|No protocol treatment|3|||
13465878|NCT00091169|26977444|FG000|Overall Study|Disease progression|3|||
13465879|NCT00091169|26977445|FG001|Overall Study|Disease progression|1|||
13465880|NCT00091169|26977444|FG000|Overall Study|Adverse Event|11|||
13465881|NCT00091169|26977445|FG001|Overall Study|Adverse Event|17|||
13465882|NCT00091169|26977444|FG000|Overall Study|Death|4|||
13465883|NCT00091169|26977445|FG001|Overall Study|Death|1|||
13465884|NCT00091169|26977444|FG000|Overall Study|Withdrawal by Subject|10|||
13465885|NCT00091169|26977445|FG001|Overall Study|Withdrawal by Subject|13|||
13465886|NCT00091169|26977444|FG000|Overall Study|Other|3|||
13465887|NCT00091169|26977445|FG001|Overall Study|Other|4|||
13465888|NCT00091169|26977444|FG000|Overall Study|Not start protocol therapy|26|||
13465889|NCT00091169|26977445|FG001|Overall Study|Not start protocol therapy|17|||
13465890|NCT00091026|26977462|FG000|Overall Study|Patient deemed non eligible-never receiv|1|||
13465891|NCT00091026|26977463|FG001|Overall Study|Patient deemed non eligible-never receiv|0|||
13465892|NCT00091026|26977462|FG000|Overall Study|Patient withdrew and never received trea|0|||
13465893|NCT00091026|26977463|FG001|Overall Study|Patient withdrew and never received trea|2|||
13465894|NCT00091026|26977462|FG000|Overall Study|Unknown-never received treatment|0|||
13465895|NCT00091026|26977463|FG001|Overall Study|Unknown-never received treatment|1|||
13465896|NCT00090987|26977469|FG000|Overall Study|Adverse Event|5|||
13465897|NCT00090987|26977469|FG000|Overall Study|Lack of Efficacy|7|||
13465898|NCT00090987|26977469|FG000|Overall Study|Withdrawal by Subject|3|||
13465899|NCT00090987|26977469|FG000|Overall Study|alternative therapy|1|||
13465900|NCT00090987|26977469|FG000|Overall Study|Non-compliance|4|||
13465901|NCT00090987|26977469|FG000|Overall Study|Incarcerated|1|||
13465902|NCT00090857|26977504|FG000|Overall Study|Lost to Follow-up|0|||
13465903|NCT00090857|26977505|FG001|Overall Study|Lost to Follow-up|1|||
13465904|NCT00090857|26977504|FG000|Overall Study|Withdrawal by Subject|2|||
13465905|NCT00090857|26977505|FG001|Overall Study|Withdrawal by Subject|0|||
13465906|NCT00090857|26977504|FG000|Overall Study|Adverse Event|2|||
13465907|NCT00090857|26977505|FG001|Overall Study|Adverse Event|2|||
13465908|NCT00090779|26977533|FG000|Step 1|Withdrawal by Subject|4|||
13465909|NCT00090779|26977534|FG001|Step 1|Withdrawal by Subject|2|||
13465910|NCT00090779|26977533|FG000|Step 1|Lost to Follow-up|3|||
13465911|NCT00090779|26977534|FG001|Step 1|Lost to Follow-up|2|||
13465912|NCT00090779|26977533|FG000|Step 1|Death|0|||
13465913|NCT00090779|26977534|FG001|Step 1|Death|2|||
13465914|NCT00090779|26977533|FG000|Step 1|Physician Decision|1|||
13465915|NCT00090779|26977534|FG001|Step 1|Physician Decision|0|||
13465916|NCT00090779|26977533|FG000|Step 1|Pregnancy|1|||
13465917|NCT00090779|26977534|FG001|Step 1|Pregnancy|0|||
13465918|NCT00090779|26977533|FG000|Step 1|Non-compliance to study requirements|0|||
13465919|NCT00090779|26977534|FG001|Step 1|Non-compliance to study requirements|1|||
13465920|NCT00090779|26977533|FG000|Step 1|Subject relocated|2|||
13465921|NCT00090779|26977534|FG001|Step 1|Subject relocated|8|||
13465922|NCT00090779|26977533|FG000|Step 2|Off study per study closure|6|||
13465923|NCT00090779|26977534|FG001|Step 2|Off study per study closure|16|||
13465924|NCT00090779|26977533|FG000|Step 2|Subject relocated|0|||
13465925|NCT00090779|26977534|FG001|Step 2|Subject relocated|1|||
13465926|NCT00090779|26977533|FG000|Step 2|Non-compliance to study requirements|0|||
13465927|NCT00090779|26977534|FG001|Step 2|Non-compliance to study requirements|1|||
13465928|NCT00090779|26977533|FG000|Step 3|Initiation of ART and off extended study|3|||
13465929|NCT00090779|26977534|FG001|Step 3|Initiation of ART and off extended study|2|||
13465930|NCT00090779|26977533|FG000|Step 3|Off extended study due to study closure|4|||
13465931|NCT00090779|26977534|FG001|Step 3|Off extended study due to study closure|3|||
13465932|NCT00090766|26977584|FG000|Overall Study|Nephrectomy Planned|0|||
13465933|NCT00090766|26977585|FG001|Overall Study|Nephrectomy Planned|0|||
13465934|NCT00090766|26977586|FG002|Overall Study|Nephrectomy Planned|1|||
13465935|NCT00090766|26977584|FG000|Overall Study|Death|1|||
13465936|NCT00090766|26977585|FG001|Overall Study|Death|0|||
13465937|NCT00090766|26977586|FG002|Overall Study|Death|0|||
13465938|NCT00090766|26977584|FG000|Overall Study|Admin|0|||
13465939|NCT00090766|26977585|FG001|Overall Study|Admin|2|||
13465940|NCT00090766|26977586|FG002|Overall Study|Admin|0|||
13465941|NCT00090766|26977584|FG000|Overall Study|Lost to Follow-up|2|||
13465942|NCT00090766|26977585|FG001|Overall Study|Lost to Follow-up|0|||
13465943|NCT00090766|26977586|FG002|Overall Study|Lost to Follow-up|2|||
13465944|NCT00090753|26977601|FG000|First Treatment Period|Adverse Event|20|||
13465945|NCT00090753|26977602|FG001|First Treatment Period|Adverse Event|8|||
13465946|NCT00090753|26977601|FG000|First Treatment Period|Death|88|||
13465947|NCT00090753|26977602|FG001|First Treatment Period|Death|62|||
13465948|NCT00090753|26977601|FG000|First Treatment Period|Lack of Efficacy|2|||
13465949|NCT00090753|26977602|FG001|First Treatment Period|Lack of Efficacy|1|||
13465950|NCT00090753|26977601|FG000|First Treatment Period|Refused Treatment|32|||
13465951|NCT00090753|26977602|FG001|First Treatment Period|Refused Treatment|25|||
13465952|NCT00090753|26977601|FG000|First Treatment Period|Lost to Follow-up|4|||
13465953|NCT00090753|26977602|FG001|First Treatment Period|Lost to Follow-up|4|||
13465954|NCT00090753|26977601|FG000|First Treatment Period|Renal Transplant|70|||
13465955|NCT00090753|26977602|FG001|First Treatment Period|Renal Transplant|50|||
13465956|NCT00090753|26977601|FG000|First Treatment Period|Mircera Commercialization|1|||
13465957|NCT00090753|26977602|FG001|First Treatment Period|Mircera Commercialization|0|||
13465958|NCT00090753|26977601|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39|||
13465959|NCT00090753|26977602|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28|||
13465960|NCT00090753|26977601|FG000|Extended Treatment Period|Adverse Event|11|||
13465961|NCT00090753|26977602|FG001|Extended Treatment Period|Adverse Event|0|||
13465962|NCT00090753|26977601|FG000|Extended Treatment Period|Death|58|||
13465963|NCT00090753|26977602|FG001|Extended Treatment Period|Death|30|||
13465964|NCT00090753|26977601|FG000|Extended Treatment Period|Lack of Efficacy|1|||
13465965|NCT00090753|26977602|FG001|Extended Treatment Period|Lack of Efficacy|0|||
13465966|NCT00090753|26977601|FG000|Extended Treatment Period|Refused Treatment|18|||
13465967|NCT00090753|26977602|FG001|Extended Treatment Period|Refused Treatment|12|||
13465968|NCT00090753|26977601|FG000|Extended Treatment Period|Lost to Follow-up|3|||
13465969|NCT00090753|26977602|FG001|Extended Treatment Period|Lost to Follow-up|1|||
13465970|NCT00090753|26977601|FG000|Extended Treatment Period|Renal Transplant|15|||
13465971|NCT00090753|26977602|FG001|Extended Treatment Period|Renal Transplant|12|||
13465972|NCT00090753|26977601|FG000|Extended Treatment Period|Mircera Commercialization|188|||
13465973|NCT00090753|26977602|FG001|Extended Treatment Period|Mircera Commercialization|93|||
13465974|NCT00090753|26977601|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65|||
13465975|NCT00090753|26977602|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43|||
13465976|NCT00090610|26977623|FG000|Overall Study|Withdrawal by Subject|1|||
13465977|NCT00090610|26977624|FG001|Overall Study|Withdrawal by Subject|1|||
13465978|NCT00090584|26977661|FG000|Baseline to 10 Weeks|Lost to Follow-up|15|||
13465979|NCT00090584|26977662|FG001|Baseline to 10 Weeks|Lost to Follow-up|12|||
13465980|NCT00090584|26977661|FG000|Baseline to 8 Months|Lost to Follow-up|44|||
13465981|NCT00090584|26977662|FG001|Baseline to 8 Months|Lost to Follow-up|41|||
13465982|NCT00090545|26977687|FG000|Overall Study|Disease progression on study|21|||
13465983|NCT00090545|26977688|FG001|Overall Study|Disease progression on study|17|||
13465984|NCT00090545|26977687|FG000|Overall Study|Refused further treatment|1|||
13465985|NCT00090545|26977688|FG001|Overall Study|Refused further treatment|4|||
13465986|NCT00090545|26977687|FG000|Overall Study|Death|0|||
13465987|NCT00090545|26977688|FG001|Overall Study|Death|1|||
13465988|NCT00090545|26977687|FG000|Overall Study|Adverse Event|0|||
13465989|NCT00090545|26977688|FG001|Overall Study|Adverse Event|2|||
13465990|NCT00090519|26977719|FG000|Overall Study|Adverse Event|5|||
13465991|NCT00090519|26977720|FG001|Overall Study|Adverse Event|4|||
13465992|NCT00090519|26977719|FG000|Overall Study|Death|9|||
13465993|NCT00090519|26977720|FG001|Overall Study|Death|9|||
13465994|NCT00090519|26977719|FG000|Overall Study|Lost to Follow-up|26|||
13465995|NCT00090519|26977720|FG001|Overall Study|Lost to Follow-up|29|||
13465996|NCT00090519|26977719|FG000|Overall Study|Withdrawal by Subject|28|||
13465997|NCT00090519|26977720|FG001|Overall Study|Withdrawal by Subject|29|||
13465998|NCT00090519|26977719|FG000|Overall Study|Physician Decision|2|||
13465999|NCT00090519|26977720|FG001|Overall Study|Physician Decision|3|||
13466000|NCT00090519|26977719|FG000|Overall Study|Sponsor Decision|3|||
13466001|NCT00090519|26977720|FG001|Overall Study|Sponsor Decision|1|||
13466002|NCT00090493|26977726|FG000|Overall Study|Physician Decision|2|||
13466003|NCT00090402|26977750|FG000|Overall Study|Death|1|||
13466004|NCT00090402|26977751|FG001|Overall Study|Death|1|||
13466005|NCT00090402|26977752|FG002|Overall Study|Death|0|||
13466006|NCT00090402|26977750|FG000|Overall Study|subject moved|0|||
13466007|NCT00090402|26977751|FG001|Overall Study|subject moved|1|||
13466008|NCT00090402|26977752|FG002|Overall Study|subject moved|0|||
13466009|NCT00090402|26977750|FG000|Overall Study|stopped taking study medication|1|||
13466010|NCT00090402|26977751|FG001|Overall Study|stopped taking study medication|0|||
13466011|NCT00090402|26977752|FG002|Overall Study|stopped taking study medication|1|||
13466012|NCT00090363|26977782|FG000|Overall Study|Lost to Follow-up|1|||
13466013|NCT00090363|26977783|FG001|Overall Study|Lost to Follow-up|2|||
13466014|NCT00090363|26977784|FG002|Overall Study|Lost to Follow-up|1|||
13466015|NCT00090363|26977782|FG000|Overall Study|Withdrawal by Subject|7|||
13466016|NCT00090363|26977783|FG001|Overall Study|Withdrawal by Subject|7|||
13466017|NCT00090363|26977784|FG002|Overall Study|Withdrawal by Subject|6|||
13466018|NCT00090363|26977782|FG000|Overall Study|Study-specific discontinuation criteria|75|||
13466019|NCT00090363|26977783|FG001|Overall Study|Study-specific discontinuation criteria|74|||
13466020|NCT00090363|26977784|FG002|Overall Study|Study-specific discontinuation criteria|62|||
13466021|NCT00090363|26977782|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
13466022|NCT00090363|26977783|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
13466023|NCT00090363|26977784|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
13466024|NCT00090363|26977782|FG000|Overall Study|Consent expired|7|||
13466025|NCT00090363|26977783|FG001|Overall Study|Consent expired|10|||
13466026|NCT00090363|26977784|FG002|Overall Study|Consent expired|9|||
13466027|NCT00090363|26977782|FG000|Overall Study|Reasons not specified|2|||
13466028|NCT00090363|26977783|FG001|Overall Study|Reasons not specified|1|||
13466029|NCT00090363|26977784|FG002|Overall Study|Reasons not specified|1|||
13466030|NCT00090363|26977782|FG000|Overall Study|Continuing on study off treatment|14|||
13466031|NCT00090363|26977783|FG001|Overall Study|Continuing on study off treatment|13|||
13466032|NCT00090363|26977784|FG002|Overall Study|Continuing on study off treatment|16|||
13466033|NCT00090285|26977830|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7|||
13466034|NCT00090285|26977831|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3|||
13466035|NCT00090285|26977832|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
13466036|NCT00090285|26977833|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
13466037|NCT00090285|26977834|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
13466038|NCT00090285|26977835|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
13466039|NCT00090285|26977830|FG000|Base Study Vaccination Period|Adverse Event|2|||
13466040|NCT00090285|26977831|FG001|Base Study Vaccination Period|Adverse Event|4|||
13466041|NCT00090285|26977832|FG002|Base Study Vaccination Period|Adverse Event|0|||
13466042|NCT00090285|26977833|FG003|Base Study Vaccination Period|Adverse Event|0|||
13466043|NCT00090285|26977834|FG004|Base Study Vaccination Period|Adverse Event|0|||
13466044|NCT00090285|26977835|FG005|Base Study Vaccination Period|Adverse Event|0|||
13466045|NCT00090285|26977830|FG000|Base Study Vaccination Period|Lost to Follow-up|111|||
13466046|NCT00090285|26977831|FG001|Base Study Vaccination Period|Lost to Follow-up|112|||
13466047|NCT00090285|26977832|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
13466048|NCT00090285|26977833|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
13466049|NCT00090285|26977834|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
13466050|NCT00090285|26977835|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
13466051|NCT00090285|26977830|FG000|Base Study Vaccination Period|Protocol Violation|2|||
13466052|NCT00090285|26977831|FG001|Base Study Vaccination Period|Protocol Violation|3|||
13466053|NCT00090285|26977832|FG002|Base Study Vaccination Period|Protocol Violation|0|||
13466054|NCT00090285|26977833|FG003|Base Study Vaccination Period|Protocol Violation|0|||
13466055|NCT00090285|26977834|FG004|Base Study Vaccination Period|Protocol Violation|0|||
13466056|NCT00090285|26977835|FG005|Base Study Vaccination Period|Protocol Violation|0|||
13466057|NCT00090285|26977830|FG000|Base Study Vaccination Period|Withdrawal by Subject|64|||
13466058|NCT00090285|26977831|FG001|Base Study Vaccination Period|Withdrawal by Subject|69|||
13466059|NCT00090285|26977832|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
13466060|NCT00090285|26977833|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
13466061|NCT00090285|26977834|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
13466062|NCT00090285|26977835|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
13466063|NCT00090285|26977830|FG000|Base Study Vaccination Period|Uncooperative|2|||
13466064|NCT00090285|26977831|FG001|Base Study Vaccination Period|Uncooperative|2|||
13466065|NCT00090285|26977832|FG002|Base Study Vaccination Period|Uncooperative|0|||
13466066|NCT00090285|26977833|FG003|Base Study Vaccination Period|Uncooperative|0|||
13466067|NCT00090285|26977834|FG004|Base Study Vaccination Period|Uncooperative|0|||
13466068|NCT00090285|26977835|FG005|Base Study Vaccination Period|Uncooperative|0|||
13466069|NCT00090285|26977830|FG000|Base Study Vaccination Period|Moved|20|||
13466070|NCT00090285|26977831|FG001|Base Study Vaccination Period|Moved|21|||
13466071|NCT00090285|26977832|FG002|Base Study Vaccination Period|Moved|0|||
13466072|NCT00090285|26977833|FG003|Base Study Vaccination Period|Moved|0|||
13466073|NCT00090285|26977834|FG004|Base Study Vaccination Period|Moved|0|||
13466074|NCT00090285|26977835|FG005|Base Study Vaccination Period|Moved|0|||
13466075|NCT00090285|26977830|FG000|Base Study Vaccination Period|Site Terminated|1|||
13466076|NCT00090285|26977831|FG001|Base Study Vaccination Period|Site Terminated|0|||
13466077|NCT00090285|26977832|FG002|Base Study Vaccination Period|Site Terminated|0|||
13466078|NCT00090285|26977833|FG003|Base Study Vaccination Period|Site Terminated|0|||
13466079|NCT00090285|26977834|FG004|Base Study Vaccination Period|Site Terminated|0|||
13466080|NCT00090285|26977835|FG005|Base Study Vaccination Period|Site Terminated|0|||
13466081|NCT00090285|26977830|FG000|Base Study Vaccination Period|Other|2|||
13466082|NCT00090285|26977831|FG001|Base Study Vaccination Period|Other|2|||
13466083|NCT00090285|26977832|FG002|Base Study Vaccination Period|Other|0|||
13466084|NCT00090285|26977833|FG003|Base Study Vaccination Period|Other|0|||
13466085|NCT00090285|26977834|FG004|Base Study Vaccination Period|Other|0|||
13466086|NCT00090285|26977835|FG005|Base Study Vaccination Period|Other|0|||
13466087|NCT00090285|26977830|FG000|Base Study Vaccination Period|Subject Incarcerated|2|||
13466088|NCT00090285|26977831|FG001|Base Study Vaccination Period|Subject Incarcerated|2|||
13466089|NCT00090285|26977832|FG002|Base Study Vaccination Period|Subject Incarcerated|0|||
13466090|NCT00090285|26977833|FG003|Base Study Vaccination Period|Subject Incarcerated|0|||
13466091|NCT00090285|26977834|FG004|Base Study Vaccination Period|Subject Incarcerated|0|||
13466092|NCT00090285|26977835|FG005|Base Study Vaccination Period|Subject Incarcerated|0|||
13466093|NCT00090285|26977830|FG000|Base Study Vaccination Period|HIV positive|1|||
13466094|NCT00090285|26977831|FG001|Base Study Vaccination Period|HIV positive|1|||
13466095|NCT00090285|26977832|FG002|Base Study Vaccination Period|HIV positive|0|||
13466096|NCT00090285|26977833|FG003|Base Study Vaccination Period|HIV positive|0|||
13466097|NCT00090285|26977834|FG004|Base Study Vaccination Period|HIV positive|0|||
13466098|NCT00090285|26977835|FG005|Base Study Vaccination Period|HIV positive|0|||
13466099|NCT00090285|26977830|FG000|Base Study Follow-up Period|Adverse Event|3|||
13466100|NCT00090285|26977831|FG001|Base Study Follow-up Period|Adverse Event|10|||
13466101|NCT00090285|26977832|FG002|Base Study Follow-up Period|Adverse Event|0|||
13466102|NCT00090285|26977833|FG003|Base Study Follow-up Period|Adverse Event|0|||
13466103|NCT00090285|26977834|FG004|Base Study Follow-up Period|Adverse Event|0|||
13466104|NCT00090285|26977835|FG005|Base Study Follow-up Period|Adverse Event|0|||
13466105|NCT00090285|26977830|FG000|Base Study Follow-up Period|Lost to Follow-up|232|||
13466106|NCT00090285|26977831|FG001|Base Study Follow-up Period|Lost to Follow-up|226|||
13466107|NCT00090285|26977832|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
13466108|NCT00090285|26977833|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
13466109|NCT00090285|26977834|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
13466110|NCT00090285|26977835|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
13466111|NCT00090285|26977830|FG000|Base Study Follow-up Period|Withdrawal by Subject|53|||
13466112|NCT00090285|26977831|FG001|Base Study Follow-up Period|Withdrawal by Subject|64|||
13466113|NCT00090285|26977832|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
13466114|NCT00090285|26977833|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
13466115|NCT00090285|26977834|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
13466116|NCT00090285|26977835|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
13466117|NCT00090285|26977830|FG000|Base Study Follow-up Period|Moved|41|||
13466118|NCT00090285|26977831|FG001|Base Study Follow-up Period|Moved|36|||
13466119|NCT00090285|26977832|FG002|Base Study Follow-up Period|Moved|0|||
13466120|NCT00090285|26977833|FG003|Base Study Follow-up Period|Moved|0|||
13466121|NCT00090285|26977834|FG004|Base Study Follow-up Period|Moved|0|||
13466122|NCT00090285|26977835|FG005|Base Study Follow-up Period|Moved|0|||
13466123|NCT00090285|26977830|FG000|Base Study Follow-up Period|Other|2|||
13466124|NCT00090285|26977831|FG001|Base Study Follow-up Period|Other|0|||
13466125|NCT00090285|26977832|FG002|Base Study Follow-up Period|Other|0|||
13466126|NCT00090285|26977833|FG003|Base Study Follow-up Period|Other|0|||
13466127|NCT00090285|26977834|FG004|Base Study Follow-up Period|Other|0|||
13466128|NCT00090285|26977835|FG005|Base Study Follow-up Period|Other|0|||
13466129|NCT00090285|26977830|FG000|Base Study Follow-up Period|Protocol Violation|1|||
13466130|NCT00090285|26977831|FG001|Base Study Follow-up Period|Protocol Violation|0|||
13466131|NCT00090285|26977832|FG002|Base Study Follow-up Period|Protocol Violation|0|||
13466132|NCT00090285|26977833|FG003|Base Study Follow-up Period|Protocol Violation|0|||
13466133|NCT00090285|26977834|FG004|Base Study Follow-up Period|Protocol Violation|0|||
13466134|NCT00090285|26977835|FG005|Base Study Follow-up Period|Protocol Violation|0|||
13466135|NCT00090285|26977830|FG000|Base Study Follow-up Period|Uncooperative|3|||
13466136|NCT00090285|26977831|FG001|Base Study Follow-up Period|Uncooperative|4|||
13466137|NCT00090285|26977832|FG002|Base Study Follow-up Period|Uncooperative|0|||
13466138|NCT00090285|26977833|FG003|Base Study Follow-up Period|Uncooperative|0|||
13466139|NCT00090285|26977834|FG004|Base Study Follow-up Period|Uncooperative|0|||
13466140|NCT00090285|26977835|FG005|Base Study Follow-up Period|Uncooperative|0|||
13466141|NCT00090285|26977830|FG000|Base Study Follow-up Period|Subject Incarcerated|0|||
13466142|NCT00090285|26977831|FG001|Base Study Follow-up Period|Subject Incarcerated|2|||
13466143|NCT00090285|26977832|FG002|Base Study Follow-up Period|Subject Incarcerated|0|||
13466144|NCT00090285|26977833|FG003|Base Study Follow-up Period|Subject Incarcerated|0|||
13466145|NCT00090285|26977834|FG004|Base Study Follow-up Period|Subject Incarcerated|0|||
13466146|NCT00090285|26977835|FG005|Base Study Follow-up Period|Subject Incarcerated|0|||
13466147|NCT00090285|26977830|FG000|Extension 1|Adverse Event|0|||
13466148|NCT00090285|26977831|FG001|Extension 1|Adverse Event|0|||
13466149|NCT00090285|26977832|FG002|Extension 1|Adverse Event|2|||
13466150|NCT00090285|26977833|FG003|Extension 1|Adverse Event|0|||
13466151|NCT00090285|26977834|FG004|Extension 1|Adverse Event|0|||
13466152|NCT00090285|26977835|FG005|Extension 1|Adverse Event|0|||
13466153|NCT00090285|26977830|FG000|Extension 1|Lost to Follow-up|0|||
13466154|NCT00090285|26977831|FG001|Extension 1|Lost to Follow-up|0|||
13466155|NCT00090285|26977832|FG002|Extension 1|Lost to Follow-up|35|||
13466156|NCT00090285|26977833|FG003|Extension 1|Lost to Follow-up|0|||
13466157|NCT00090285|26977834|FG004|Extension 1|Lost to Follow-up|0|||
13466158|NCT00090285|26977835|FG005|Extension 1|Lost to Follow-up|0|||
13466159|NCT00090285|26977830|FG000|Extension 1|Withdrawal by Subject|0|||
13466160|NCT00090285|26977831|FG001|Extension 1|Withdrawal by Subject|0|||
13466161|NCT00090285|26977832|FG002|Extension 1|Withdrawal by Subject|13|||
13466162|NCT00090285|26977833|FG003|Extension 1|Withdrawal by Subject|1|||
13466163|NCT00090285|26977834|FG004|Extension 1|Withdrawal by Subject|0|||
13466164|NCT00090285|26977835|FG005|Extension 1|Withdrawal by Subject|0|||
13466165|NCT00090285|26977830|FG000|Extension 1|Other|0|||
13466166|NCT00090285|26977831|FG001|Extension 1|Other|0|||
13466167|NCT00090285|26977832|FG002|Extension 1|Other|4|||
13466168|NCT00090285|26977833|FG003|Extension 1|Other|0|||
13466169|NCT00090285|26977834|FG004|Extension 1|Other|0|||
13466170|NCT00090285|26977835|FG005|Extension 1|Other|0|||
13466171|NCT00090285|26977830|FG000|Extension 1|Moved|0|||
13466172|NCT00090285|26977831|FG001|Extension 1|Moved|0|||
13466173|NCT00090285|26977832|FG002|Extension 1|Moved|3|||
13466174|NCT00090285|26977833|FG003|Extension 1|Moved|0|||
13466175|NCT00090285|26977834|FG004|Extension 1|Moved|0|||
13466176|NCT00090285|26977835|FG005|Extension 1|Moved|0|||
13466177|NCT00090285|26977830|FG000|Long-term Follow-up (EXT2)|Adverse Event|0|||
13466178|NCT00090285|26977831|FG001|Long-term Follow-up (EXT2)|Adverse Event|0|||
13466179|NCT00090285|26977832|FG002|Long-term Follow-up (EXT2)|Adverse Event|0|||
13466180|NCT00090285|26977833|FG003|Long-term Follow-up (EXT2)|Adverse Event|0|||
13466181|NCT00090285|26977834|FG004|Long-term Follow-up (EXT2)|Adverse Event|5|||
13466182|NCT00090285|26977835|FG005|Long-term Follow-up (EXT2)|Adverse Event|2|||
13466183|NCT00090285|26977830|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
13466184|NCT00090285|26977831|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
13466185|NCT00090285|26977832|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
13466186|NCT00090285|26977833|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
13466187|NCT00090285|26977834|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156|||
13466188|NCT00090285|26977835|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143|||
13466189|NCT00090285|26977830|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
13466190|NCT00090285|26977831|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
13466191|NCT00090285|26977832|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
13466192|NCT00090285|26977833|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
13466193|NCT00090285|26977834|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60|||
13466194|NCT00090285|26977835|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53|||
13466195|NCT00090285|26977830|FG000|Long-term Follow-up (EXT2)|Physician Decision|0|||
13466196|NCT00090285|26977831|FG001|Long-term Follow-up (EXT2)|Physician Decision|0|||
13466197|NCT00090285|26977832|FG002|Long-term Follow-up (EXT2)|Physician Decision|0|||
13466198|NCT00090285|26977833|FG003|Long-term Follow-up (EXT2)|Physician Decision|0|||
13466199|NCT00090285|26977834|FG004|Long-term Follow-up (EXT2)|Physician Decision|6|||
13466200|NCT00090285|26977835|FG005|Long-term Follow-up (EXT2)|Physician Decision|5|||
13466201|NCT00090259|26977856|FG000|Overall Study|Lost to Follow-up|30|||
13466202|NCT00090259|26977857|FG001|Overall Study|Lost to Follow-up|26|||
13466203|NCT00090259|26977856|FG000|Overall Study|Withdrawal by Subject|21|||
13466204|NCT00090259|26977857|FG001|Overall Study|Withdrawal by Subject|15|||
13466205|NCT00090259|26977856|FG000|Overall Study|Investigator site closed|11|||
13466206|NCT00090259|26977857|FG001|Overall Study|Investigator site closed|7|||
13466207|NCT00090233|26977886|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609|||
13466208|NCT00090233|26977887|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627|||
13466209|NCT00090233|26977886|FG000|Overall Study|Adverse Event|214|||
13466210|NCT00090233|26977887|FG001|Overall Study|Adverse Event|198|||
13466211|NCT00090233|26977886|FG000|Overall Study|Lost to Follow-up|68|||
13466212|NCT00090233|26977887|FG001|Overall Study|Lost to Follow-up|95|||
13466213|NCT00090233|26977886|FG000|Overall Study|Protocol Violation|960|||
13466214|NCT00090233|26977887|FG001|Overall Study|Protocol Violation|1022|||
13466215|NCT00090233|26977886|FG000|Overall Study|Withdrawal by Subject|182|||
13466216|NCT00090233|26977887|FG001|Overall Study|Withdrawal by Subject|211|||
13466217|NCT00090233|26977886|FG000|Overall Study|Moved|203|||
13466218|NCT00090233|26977887|FG001|Overall Study|Moved|189|||
13466219|NCT00090233|26977886|FG000|Overall Study|Other|1211|||
13466220|NCT00090233|26977887|FG001|Overall Study|Other|1160|||
13466221|NCT00090233|26977886|FG000|Overall Study|Data not available at data cut-off point|1552|||
13466222|NCT00090233|26977887|FG001|Overall Study|Data not available at data cut-off point|1563|||
13466223|NCT00090220|26977990|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1|||
13466224|NCT00090220|26977991|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1|||
13466225|NCT00090220|26977992|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
13466226|NCT00090220|26977993|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
13466227|NCT00090220|26977994|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
13466228|NCT00090220|26977995|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0|||
13466229|NCT00090220|26977990|FG000|Base Study Vaccination Period|Adverse Event|6|||
13466230|NCT00090220|26977991|FG001|Base Study Vaccination Period|Adverse Event|1|||
13466231|NCT00090220|26977992|FG002|Base Study Vaccination Period|Adverse Event|0|||
13466232|NCT00090220|26977993|FG003|Base Study Vaccination Period|Adverse Event|0|||
13466233|NCT00090220|26977994|FG004|Base Study Vaccination Period|Adverse Event|0|||
13466234|NCT00090220|26977995|FG005|Base Study Vaccination Period|Adverse Event|0|||
13466235|NCT00090220|26977990|FG000|Base Study Vaccination Period|Lost to Follow-up|24|||
13466236|NCT00090220|26977991|FG001|Base Study Vaccination Period|Lost to Follow-up|28|||
13466237|NCT00090220|26977992|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
13466238|NCT00090220|26977993|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
13466239|NCT00090220|26977994|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
13466240|NCT00090220|26977995|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
13466241|NCT00090220|26977990|FG000|Base Study Vaccination Period|Withdrawal by Subject|23|||
13466242|NCT00090220|26977991|FG001|Base Study Vaccination Period|Withdrawal by Subject|27|||
13466243|NCT00090220|26977992|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
13466244|NCT00090220|26977993|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
13466245|NCT00090220|26977994|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
13466246|NCT00090220|26977995|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
13466247|NCT00090220|26977990|FG000|Base Study Vaccination Period|Patient Moved|6|||
13466248|NCT00090220|26977991|FG001|Base Study Vaccination Period|Patient Moved|2|||
13466249|NCT00090220|26977992|FG002|Base Study Vaccination Period|Patient Moved|0|||
13466250|NCT00090220|26977993|FG003|Base Study Vaccination Period|Patient Moved|0|||
13466251|NCT00090220|26977994|FG004|Base Study Vaccination Period|Patient Moved|0|||
13466252|NCT00090220|26977995|FG005|Base Study Vaccination Period|Patient Moved|0|||
13466253|NCT00090220|26977990|FG000|Base Study Vaccination Period|Other|4|||
13466254|NCT00090220|26977991|FG001|Base Study Vaccination Period|Other|4|||
13466255|NCT00090220|26977992|FG002|Base Study Vaccination Period|Other|0|||
13466256|NCT00090220|26977993|FG003|Base Study Vaccination Period|Other|0|||
13466257|NCT00090220|26977994|FG004|Base Study Vaccination Period|Other|0|||
13466258|NCT00090220|26977995|FG005|Base Study Vaccination Period|Other|0|||
13466259|NCT00090220|26977990|FG000|Base Study Follow-up Period|Adverse Event|6|||
13466260|NCT00090220|26977991|FG001|Base Study Follow-up Period|Adverse Event|1|||
13466261|NCT00090220|26977992|FG002|Base Study Follow-up Period|Adverse Event|0|||
13466262|NCT00090220|26977993|FG003|Base Study Follow-up Period|Adverse Event|0|||
13466263|NCT00090220|26977994|FG004|Base Study Follow-up Period|Adverse Event|0|||
13466264|NCT00090220|26977995|FG005|Base Study Follow-up Period|Adverse Event|0|||
13466265|NCT00090220|26977990|FG000|Base Study Follow-up Period|Lost to Follow-up|88|||
13466266|NCT00090220|26977991|FG001|Base Study Follow-up Period|Lost to Follow-up|78|||
13466267|NCT00090220|26977992|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
13466268|NCT00090220|26977993|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
13466269|NCT00090220|26977994|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
13466270|NCT00090220|26977995|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
13466271|NCT00090220|26977990|FG000|Base Study Follow-up Period|Withdrawal by Subject|27|||
13466272|NCT00090220|26977991|FG001|Base Study Follow-up Period|Withdrawal by Subject|36|||
13466273|NCT00090220|26977992|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
13466274|NCT00090220|26977993|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
13466275|NCT00090220|26977994|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
13466276|NCT00090220|26977995|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
13466277|NCT00090220|26977990|FG000|Base Study Follow-up Period|Patient Moved|20|||
13466278|NCT00090220|26977991|FG001|Base Study Follow-up Period|Patient Moved|28|||
13466279|NCT00090220|26977992|FG002|Base Study Follow-up Period|Patient Moved|0|||
13466280|NCT00090220|26977993|FG003|Base Study Follow-up Period|Patient Moved|0|||
13466281|NCT00090220|26977994|FG004|Base Study Follow-up Period|Patient Moved|0|||
13466282|NCT00090220|26977995|FG005|Base Study Follow-up Period|Patient Moved|0|||
13466283|NCT00090220|26977990|FG000|Base Study Follow-up Period|Other|19|||
13466284|NCT00090220|26977991|FG001|Base Study Follow-up Period|Other|21|||
13466285|NCT00090220|26977992|FG002|Base Study Follow-up Period|Other|0|||
13466286|NCT00090220|26977993|FG003|Base Study Follow-up Period|Other|0|||
13466287|NCT00090220|26977994|FG004|Base Study Follow-up Period|Other|0|||
13466288|NCT00090220|26977995|FG005|Base Study Follow-up Period|Other|0|||
13466289|NCT00090220|26977990|FG000|Extension 1 (EXT1)|Adverse Event|0|||
13466290|NCT00090220|26977991|FG001|Extension 1 (EXT1)|Adverse Event|0|||
13466291|NCT00090220|26977992|FG002|Extension 1 (EXT1)|Adverse Event|4|||
13466292|NCT00090220|26977993|FG003|Extension 1 (EXT1)|Adverse Event|0|||
13466293|NCT00090220|26977994|FG004|Extension 1 (EXT1)|Adverse Event|0|||
13466294|NCT00090220|26977995|FG005|Extension 1 (EXT1)|Adverse Event|0|||
13466295|NCT00090220|26977990|FG000|Extension 1 (EXT1)|Lost to Follow-up|0|||
13466296|NCT00090220|26977991|FG001|Extension 1 (EXT1)|Lost to Follow-up|0|||
13466297|NCT00090220|26977992|FG002|Extension 1 (EXT1)|Lost to Follow-up|22|||
13466298|NCT00090220|26977993|FG003|Extension 1 (EXT1)|Lost to Follow-up|0|||
13466299|NCT00090220|26977994|FG004|Extension 1 (EXT1)|Lost to Follow-up|0|||
13466300|NCT00090220|26977995|FG005|Extension 1 (EXT1)|Lost to Follow-up|0|||
13466301|NCT00090220|26977990|FG000|Extension 1 (EXT1)|Moved|0|||
13466302|NCT00090220|26977991|FG001|Extension 1 (EXT1)|Moved|0|||
13466303|NCT00090220|26977992|FG002|Extension 1 (EXT1)|Moved|2|||
13466304|NCT00090220|26977993|FG003|Extension 1 (EXT1)|Moved|1|||
13466305|NCT00090220|26977994|FG004|Extension 1 (EXT1)|Moved|0|||
13466306|NCT00090220|26977995|FG005|Extension 1 (EXT1)|Moved|0|||
13466307|NCT00090220|26977990|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0|||
13466308|NCT00090220|26977991|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0|||
13466309|NCT00090220|26977992|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25|||
13466310|NCT00090220|26977993|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0|||
13466311|NCT00090220|26977994|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0|||
13466312|NCT00090220|26977995|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0|||
13466313|NCT00090220|26977990|FG000|Extension 1 (EXT1)|Protocol Violation|0|||
13466314|NCT00090220|26977991|FG001|Extension 1 (EXT1)|Protocol Violation|0|||
13466315|NCT00090220|26977992|FG002|Extension 1 (EXT1)|Protocol Violation|0|||
13466316|NCT00090220|26977993|FG003|Extension 1 (EXT1)|Protocol Violation|1|||
13466317|NCT00090220|26977994|FG004|Extension 1 (EXT1)|Protocol Violation|0|||
13466318|NCT00090220|26977995|FG005|Extension 1 (EXT1)|Protocol Violation|0|||
13466319|NCT00090220|26977990|FG000|Extension 1 (EXT1)|Other reason|0|||
13466320|NCT00090220|26977991|FG001|Extension 1 (EXT1)|Other reason|0|||
13466321|NCT00090220|26977992|FG002|Extension 1 (EXT1)|Other reason|2|||
13466322|NCT00090220|26977993|FG003|Extension 1 (EXT1)|Other reason|0|||
13466323|NCT00090220|26977994|FG004|Extension 1 (EXT1)|Other reason|0|||
13466324|NCT00090220|26977995|FG005|Extension 1 (EXT1)|Other reason|0|||
13466325|NCT00090220|26977990|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
13466326|NCT00090220|26977991|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
13466327|NCT00090220|26977992|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
13466328|NCT00090220|26977993|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
13466329|NCT00090220|26977994|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38|||
13466330|NCT00090220|26977995|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23|||
13466331|NCT00090220|26977990|FG000|Long-term Follow-up (EXT2)|Death|0|||
13466332|NCT00090220|26977991|FG001|Long-term Follow-up (EXT2)|Death|0|||
13466333|NCT00090220|26977992|FG002|Long-term Follow-up (EXT2)|Death|0|||
13466334|NCT00090220|26977993|FG003|Long-term Follow-up (EXT2)|Death|0|||
13466335|NCT00090220|26977994|FG004|Long-term Follow-up (EXT2)|Death|1|||
13466336|NCT00090220|26977995|FG005|Long-term Follow-up (EXT2)|Death|1|||
13466337|NCT00090220|26977990|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
13466338|NCT00090220|26977991|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
13466339|NCT00090220|26977992|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
13466340|NCT00090220|26977993|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
13466341|NCT00090220|26977994|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
13466342|NCT00090220|26977995|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
13466343|NCT00090220|26977990|FG000|Long-term Follow-up (EXT2)|Other|0|||
13466344|NCT00090220|26977991|FG001|Long-term Follow-up (EXT2)|Other|0|||
13466345|NCT00090220|26977992|FG002|Long-term Follow-up (EXT2)|Other|0|||
13466346|NCT00090220|26977993|FG003|Long-term Follow-up (EXT2)|Other|0|||
13466347|NCT00090220|26977994|FG004|Long-term Follow-up (EXT2)|Other|1|||
13466348|NCT00090220|26977995|FG005|Long-term Follow-up (EXT2)|Other|0|||
13466349|NCT00090103|26978103|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211|||
13466350|NCT00090103|26978104|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185|||
13466351|NCT00090103|26978105|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210|||
13466352|NCT00090103|26978103|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114|||
13466353|NCT00090103|26978104|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160|||
13466354|NCT00090103|26978105|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148|||
13466355|NCT00090103|26978103|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53|||
13466356|NCT00090103|26978104|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48|||
13466357|NCT00090103|26978105|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58|||
13466358|NCT00090103|26978103|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
13466359|NCT00090103|26978104|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
13466360|NCT00090103|26978105|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34|||
13466361|NCT00090103|26978103|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53|||
13466362|NCT00090103|26978104|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71|||
13466363|NCT00090103|26978105|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104|||
13466364|NCT00090103|26978103|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7|||
13466365|NCT00090103|26978104|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2|||
13466366|NCT00090103|26978105|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8|||
13466367|NCT00090103|26978103|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
13466368|NCT00090103|26978104|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
13466369|NCT00090103|26978105|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4|||
13466370|NCT00090103|26978103|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6|||
13466371|NCT00090103|26978104|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4|||
13466372|NCT00090103|26978105|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7|||
13466373|NCT00090103|26978103|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3|||
13466374|NCT00090103|26978104|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7|||
13466375|NCT00090103|26978105|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19|||
13466376|NCT00090103|26978103|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2|||
13466377|NCT00090103|26978104|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0|||
13466378|NCT00090103|26978105|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4|||
13466379|NCT00090103|26978103|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2|||
13466380|NCT00090103|26978104|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3|||
13466381|NCT00090103|26978105|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6|||
13466382|NCT00090103|26978103|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
13466383|NCT00090103|26978104|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
13466384|NCT00090103|26978105|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8|||
13466385|NCT00090103|26978103|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2|||
13466386|NCT00090103|26978104|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
13466387|NCT00090103|26978105|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
13466388|NCT00090103|26978103|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1|||
13466389|NCT00090103|26978104|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
13466390|NCT00090103|26978105|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
13466391|NCT00090103|26978103|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1|||
13466392|NCT00090103|26978104|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
13466393|NCT00090103|26978105|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
13466394|NCT00090103|26978103|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1|||
13466395|NCT00090103|26978104|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0|||
13466396|NCT00090103|26978105|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0|||
13466397|NCT00090103|26978103|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1|||
13466398|NCT00090103|26978104|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0|||
13466399|NCT00090103|26978105|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5|||
13466400|NCT00090103|26978103|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1|||
13466401|NCT00090103|26978104|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
13466402|NCT00090103|26978105|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
13466403|NCT00090103|26978103|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1|||
13466404|NCT00090103|26978104|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
13466405|NCT00090103|26978105|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
13466406|NCT00090103|26978103|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
13466407|NCT00090103|26978104|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2|||
13466408|NCT00090103|26978105|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
13466409|NCT00090103|26978103|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
13466410|NCT00090103|26978104|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1|||
13466411|NCT00090103|26978105|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
13466412|NCT00090103|26978103|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0|||
13466413|NCT00090103|26978104|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
13466414|NCT00090103|26978105|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
13466415|NCT00090103|26978103|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
13466416|NCT00090103|26978104|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2|||
13466417|NCT00090103|26978105|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
13466418|NCT00090103|26978103|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
13466419|NCT00090103|26978104|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1|||
13466420|NCT00090103|26978105|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
13466421|NCT00090103|26978103|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0|||
13466422|NCT00090103|26978104|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1|||
13466423|NCT00090103|26978105|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0|||
13466424|NCT00090103|26978103|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
13466425|NCT00090103|26978104|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1|||
13466426|NCT00090103|26978105|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
13466427|NCT00090103|26978103|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
13466428|NCT00090103|26978104|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1|||
13466429|NCT00090103|26978105|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
13466430|NCT00090103|26978103|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0|||
13466431|NCT00090103|26978104|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1|||
13466432|NCT00090103|26978105|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3|||
13466433|NCT00090103|26978103|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
13466434|NCT00090103|26978104|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
13466435|NCT00090103|26978105|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2|||
13466436|NCT00090103|26978103|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
13466437|NCT00090103|26978104|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
13466438|NCT00090103|26978105|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1|||
13466439|NCT00090103|26978103|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
13466440|NCT00090103|26978104|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1|||
13466441|NCT00090103|26978105|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
13466442|NCT00090103|26978103|FG000|16-Week Safety Follow-up Period|Adverse Event|34|||
13466443|NCT00090103|26978104|FG001|16-Week Safety Follow-up Period|Adverse Event|39|||
13466444|NCT00090103|26978105|FG002|16-Week Safety Follow-up Period|Adverse Event|44|||
13466445|NCT00090103|26978103|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185|||
13466446|NCT00090103|26978104|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212|||
13466447|NCT00090103|26978105|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229|||
13466448|NCT00090103|26978103|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101|||
13466449|NCT00090103|26978104|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97|||
13466450|NCT00090103|26978105|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111|||
13466451|NCT00090103|26978103|FG000|16-Week Safety Follow-up Period|Protocol Violation|18|||
13466452|NCT00090103|26978104|FG001|16-Week Safety Follow-up Period|Protocol Violation|18|||
13466453|NCT00090103|26978105|FG002|16-Week Safety Follow-up Period|Protocol Violation|17|||
13466454|NCT00090103|26978103|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8|||
13466455|NCT00090103|26978104|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5|||
13466456|NCT00090103|26978105|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4|||
13466457|NCT00090103|26978103|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8|||
13466458|NCT00090103|26978104|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6|||
13466459|NCT00090103|26978105|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4|||
13466460|NCT00090103|26978103|FG000|16-Week Safety Follow-up Period|Loss of Contact|4|||
13466461|NCT00090103|26978104|FG001|16-Week Safety Follow-up Period|Loss of Contact|0|||
13466462|NCT00090103|26978105|FG002|16-Week Safety Follow-up Period|Loss of Contact|2|||
13466463|NCT00090103|26978103|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3|||
13466464|NCT00090103|26978104|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
13466465|NCT00090103|26978105|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
13466466|NCT00090103|26978103|FG000|16-Week Safety Follow-up Period|Participant relocated|2|||
13466467|NCT00090103|26978104|FG001|16-Week Safety Follow-up Period|Participant relocated|3|||
13466468|NCT00090103|26978105|FG002|16-Week Safety Follow-up Period|Participant relocated|1|||
13466469|NCT00090103|26978103|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
13466470|NCT00090103|26978104|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1|||
13466471|NCT00090103|26978105|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
13466472|NCT00090103|26978103|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2|||
13466473|NCT00090103|26978104|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3|||
13466474|NCT00090103|26978105|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5|||
13466475|NCT00090103|26978103|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
13466476|NCT00090103|26978104|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0|||
13466477|NCT00090103|26978105|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
13466478|NCT00090103|26978103|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1|||
13466479|NCT00090103|26978104|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5|||
13466480|NCT00090103|26978105|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13|||
13466481|NCT00090103|26978103|FG000|16-Week Safety Follow-up Period|Loss of Libido|1|||
13466482|NCT00090103|26978104|FG001|16-Week Safety Follow-up Period|Loss of Libido|0|||
13466483|NCT00090103|26978105|FG002|16-Week Safety Follow-up Period|Loss of Libido|0|||
13466484|NCT00090103|26978103|FG000|16-Week Safety Follow-up Period|Enrollment Error|1|||
13466485|NCT00090103|26978104|FG001|16-Week Safety Follow-up Period|Enrollment Error|0|||
13466486|NCT00090103|26978105|FG002|16-Week Safety Follow-up Period|Enrollment Error|2|||
13466487|NCT00090103|26978103|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1|||
13466488|NCT00090103|26978104|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3|||
13466489|NCT00090103|26978105|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6|||
13466490|NCT00090103|26978103|FG000|16-Week Safety Follow-up Period|Death|1|||
13466491|NCT00090103|26978104|FG001|16-Week Safety Follow-up Period|Death|0|||
13466492|NCT00090103|26978105|FG002|16-Week Safety Follow-up Period|Death|1|||
13466493|NCT00090103|26978103|FG000|16-Week Safety Follow-up Period|Gyneomastia|1|||
13466494|NCT00090103|26978104|FG001|16-Week Safety Follow-up Period|Gyneomastia|0|||
13466495|NCT00090103|26978105|FG002|16-Week Safety Follow-up Period|Gyneomastia|0|||
13466496|NCT00090103|26978103|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0|||
13466497|NCT00090103|26978104|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5|||
13466498|NCT00090103|26978105|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4|||
13466499|NCT00090103|26978103|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0|||
13466500|NCT00090103|26978104|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2|||
13466501|NCT00090103|26978105|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3|||
13466502|NCT00090103|26978103|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0|||
13466503|NCT00090103|26978104|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1|||
13466504|NCT00090103|26978105|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0|||
13466505|NCT00090103|26978103|FG000|16-Week Safety Follow-up Period|Back Pain|0|||
13466506|NCT00090103|26978104|FG001|16-Week Safety Follow-up Period|Back Pain|1|||
13466507|NCT00090103|26978105|FG002|16-Week Safety Follow-up Period|Back Pain|0|||
13466508|NCT00090103|26978103|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0|||
13466509|NCT00090103|26978104|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2|||
13466510|NCT00090103|26978105|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4|||
13466511|NCT00090103|26978103|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0|||
13466512|NCT00090103|26978104|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2|||
13466513|NCT00090103|26978105|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3|||
13466514|NCT00090103|26978103|FG000|16-Week Safety Follow-up Period|Depression|0|||
13466515|NCT00090103|26978104|FG001|16-Week Safety Follow-up Period|Depression|1|||
13466516|NCT00090103|26978105|FG002|16-Week Safety Follow-up Period|Depression|0|||
13466517|NCT00090103|26978103|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
13466518|NCT00090103|26978104|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1|||
13466519|NCT00090103|26978105|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
13466520|NCT00090103|26978103|FG000|16-Week Safety Follow-up Period|Jailed|0|||
13466521|NCT00090103|26978104|FG001|16-Week Safety Follow-up Period|Jailed|1|||
13466522|NCT00090103|26978105|FG002|16-Week Safety Follow-up Period|Jailed|0|||
13466523|NCT00090103|26978103|FG000|16-Week Safety Follow-up Period|Other|0|||
13466524|NCT00090103|26978104|FG001|16-Week Safety Follow-up Period|Other|1|||
13466525|NCT00090103|26978105|FG002|16-Week Safety Follow-up Period|Other|0|||
13466526|NCT00089674|26978136|FG000|Overall Study|Physician Decision|4|||
13466527|NCT00089674|26978137|FG001|Overall Study|Physician Decision|2|||
13466528|NCT00089674|26978136|FG000|Overall Study|Adverse Event|23|||
13466529|NCT00089674|26978137|FG001|Overall Study|Adverse Event|29|||
13466530|NCT00089674|26978136|FG000|Overall Study|Withdrawal by Subject|143|||
13466531|NCT00089674|26978137|FG001|Overall Study|Withdrawal by Subject|127|||
13466532|NCT00089674|26978136|FG000|Overall Study|Death|43|||
13466533|NCT00089674|26978137|FG001|Overall Study|Death|43|||
13466534|NCT00089674|26978136|FG000|Overall Study|Disease progression|21|||
13466535|NCT00089674|26978137|FG001|Overall Study|Disease progression|23|||
13466536|NCT00089674|26978136|FG000|Overall Study|Ineligibility determined|8|||
13466537|NCT00089674|26978137|FG001|Overall Study|Ineligibility determined|10|||
13466538|NCT00089674|26978136|FG000|Overall Study|Lost to Follow-up|21|||
13466539|NCT00089674|26978137|FG001|Overall Study|Lost to Follow-up|17|||
13466540|NCT00089674|26978136|FG000|Overall Study|Noncompliance|7|||
13466541|NCT00089674|26978137|FG001|Overall Study|Noncompliance|3|||
13466542|NCT00089674|26978136|FG000|Overall Study|Other|5|||
13466543|NCT00089674|26978137|FG001|Overall Study|Other|9|||
13466544|NCT00089674|26978136|FG000|Overall Study|Requirement for alternative therapy|14|||
13466545|NCT00089674|26978137|FG001|Overall Study|Requirement for alternative therapy|4|||
13466546|NCT00089648|26978155|FG000|Overall Study|Adverse Event|7|||
13466547|NCT00089648|26978155|FG000|Overall Study|Withdrawal by Subject|1|||
13466548|NCT00089648|26978155|FG000|Overall Study|Lack of Efficacy|33|||
13466549|NCT00089505|26978210|FG000|Overall Study|Death|4|||
13466550|NCT00089505|26978211|FG001|Overall Study|Death|1|||
13466551|NCT00089505|26978212|FG002|Overall Study|Death|5|||
13466552|NCT00089505|26978213|FG003|Overall Study|Death|8|||
13466553|NCT00089505|26978210|FG000|Overall Study|Withdrawal by Subject|3|||
13466554|NCT00089505|26978211|FG001|Overall Study|Withdrawal by Subject|0|||
13466555|NCT00089505|26978212|FG002|Overall Study|Withdrawal by Subject|6|||
13466556|NCT00089505|26978213|FG003|Overall Study|Withdrawal by Subject|6|||
13466557|NCT00089505|26978210|FG000|Overall Study|Lost to Follow-up|1|||
13466558|NCT00089505|26978211|FG001|Overall Study|Lost to Follow-up|1|||
13466559|NCT00089505|26978212|FG002|Overall Study|Lost to Follow-up|9|||
13466560|NCT00089505|26978213|FG003|Overall Study|Lost to Follow-up|7|||
13466561|NCT00089505|26978210|FG000|Overall Study|Physician Decision|1|||
13466562|NCT00089505|26978211|FG001|Overall Study|Physician Decision|0|||
13466563|NCT00089505|26978212|FG002|Overall Study|Physician Decision|0|||
13466564|NCT00089505|26978213|FG003|Overall Study|Physician Decision|0|||
13466565|NCT00089505|26978210|FG000|Overall Study|Protocol Violation|0|||
13466566|NCT00089505|26978211|FG001|Overall Study|Protocol Violation|0|||
13466567|NCT00089505|26978212|FG002|Overall Study|Protocol Violation|1|||
13466568|NCT00089505|26978213|FG003|Overall Study|Protocol Violation|0|||
13466569|NCT00088530|26978232|FG000|Overall Study|Progressive/Relapsed Disease|28|||
13466570|NCT00088530|26978233|FG001|Overall Study|Progressive/Relapsed Disease|39|||
13466571|NCT00088530|26978232|FG000|Overall Study|Adverse Event|15|||
13466572|NCT00088530|26978233|FG001|Overall Study|Adverse Event|9|||
13466573|NCT00088530|26978232|FG000|Overall Study|Withdrawal by Subject|2|||
13466574|NCT00088530|26978233|FG001|Overall Study|Withdrawal by Subject|5|||
13466575|NCT00088530|26978232|FG000|Overall Study|Lost to Follow-up|2|||
13466576|NCT00088530|26978233|FG001|Overall Study|Lost to Follow-up|0|||
13466577|NCT00088530|26978232|FG000|Overall Study|Physician Decision|2|||
13466578|NCT00088530|26978233|FG001|Overall Study|Physician Decision|0|||
13466579|NCT00088530|26978232|FG000|Overall Study|Sponsor decision|0|||
13466580|NCT00088530|26978233|FG001|Overall Study|Sponsor decision|1|||
13466581|NCT00088530|26978232|FG000|Overall Study|Patient never treated|1|||
13466582|NCT00088530|26978233|FG001|Overall Study|Patient never treated|0|||
13466583|NCT00088413|26978260|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
13466584|NCT00088413|26978261|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
13466585|NCT00088413|26978262|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1|||
13466586|NCT00088413|26978263|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
13466587|NCT00088413|26978260|FG000|Overall Study|Adverse Events/Side Effects|0|||
13466588|NCT00088413|26978261|FG001|Overall Study|Adverse Events/Side Effects|1|||
13466589|NCT00088413|26978262|FG002|Overall Study|Adverse Events/Side Effects|1|||
13466590|NCT00088413|26978263|FG003|Overall Study|Adverse Events/Side Effects|0|||
13466591|NCT00088413|26978260|FG000|Overall Study|Refused trmt Off-study per pt wishes|0|||
13466592|NCT00088413|26978261|FG001|Overall Study|Refused trmt Off-study per pt wishes|1|||
13466593|NCT00088413|26978262|FG002|Overall Study|Refused trmt Off-study per pt wishes|1|||
13466594|NCT00088413|26978263|FG003|Overall Study|Refused trmt Off-study per pt wishes|0|||
13466595|NCT00088413|26978260|FG000|Overall Study|Off study due to missing a vaccine dose|1|||
13466596|NCT00088413|26978261|FG001|Overall Study|Off study due to missing a vaccine dose|0|||
13466597|NCT00088413|26978262|FG002|Overall Study|Off study due to missing a vaccine dose|0|||
13466598|NCT00088413|26978263|FG003|Overall Study|Off study due to missing a vaccine dose|0|||
13466599|NCT00088413|26978260|FG000|Overall Study|Death|0|||
13466600|NCT00088413|26978261|FG001|Overall Study|Death|1|||
13466601|NCT00088413|26978262|FG002|Overall Study|Death|0|||
13466602|NCT00088413|26978263|FG003|Overall Study|Death|0|||
13466603|NCT00088413|26978260|FG000|Overall Study|Progressive disease|9|||
13466604|NCT00088413|26978261|FG001|Overall Study|Progressive disease|11|||
13466605|NCT00088413|26978262|FG002|Overall Study|Progressive disease|8|||
13466606|NCT00088413|26978263|FG003|Overall Study|Progressive disease|14|||
13466607|NCT00088413|26978260|FG000|Overall Study|Other|0|||
13466608|NCT00088413|26978261|FG001|Overall Study|Other|1|||
13466609|NCT00088413|26978262|FG002|Overall Study|Other|0|||
13466610|NCT00088413|26978263|FG003|Overall Study|Other|0|||
13466611|NCT00088413|26978260|FG000|Overall Study|Patient unevaluable due to adverse event|0|||
13466612|NCT00088413|26978261|FG001|Overall Study|Patient unevaluable due to adverse event|0|||
13466613|NCT00088413|26978262|FG002|Overall Study|Patient unevaluable due to adverse event|1|||
13466614|NCT00088413|26978263|FG003|Overall Study|Patient unevaluable due to adverse event|0|||
13466615|NCT00087607|26978308|FG000|Overall Study|Adverse Event|14|||
13466616|NCT00087607|26978309|FG001|Overall Study|Adverse Event|24|||
13466617|NCT00087607|26978308|FG000|Overall Study|Death|0|||
13466618|NCT00087607|26978309|FG001|Overall Study|Death|1|||
13466619|NCT00087607|26978308|FG000|Overall Study|Insufficient Therapeutic Response|53|||
13466620|NCT00087607|26978309|FG001|Overall Study|Insufficient Therapeutic Response|42|||
13466621|NCT00087607|26978308|FG000|Overall Study|Failure to return|21|||
13466622|NCT00087607|26978309|FG001|Overall Study|Failure to return|17|||
13466623|NCT00087607|26978308|FG000|Overall Study|Withdrew Consent|12|||
13466624|NCT00087607|26978309|FG001|Overall Study|Withdrew Consent|16|||
13466625|NCT00087607|26978308|FG000|Overall Study|Administrative|12|||
13466626|NCT00087607|26978309|FG001|Overall Study|Administrative|12|||
13466627|NCT00087607|26978308|FG000|Overall Study|Refused Treatment|5|||
13466628|NCT00087607|26978309|FG001|Overall Study|Refused Treatment|7|||
13466629|NCT00087607|26978308|FG000|Overall Study|Other Protocol Violation|5|||
13466630|NCT00087607|26978309|FG001|Overall Study|Other Protocol Violation|2|||
13466631|NCT00087607|26978308|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
13466632|NCT00087607|26978309|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
13466633|NCT00087490|26978350|FG000|Overall Study|Death|6|||
13466634|NCT00087490|26978351|FG001|Overall Study|Death|4|||
13466635|NCT00087490|26978350|FG000|Overall Study|Adverse Event|3|||
13466636|NCT00087490|26978351|FG001|Overall Study|Adverse Event|8|||
13466637|NCT00087490|26978350|FG000|Overall Study|Lack of Efficacy|0|||
13466638|NCT00087490|26978351|FG001|Overall Study|Lack of Efficacy|2|||
13466639|NCT00087490|26978350|FG000|Overall Study|Protocol Violation or (/) Unspecified|214|||
13466640|NCT00087490|26978351|FG001|Overall Study|Protocol Violation or (/) Unspecified|201|||
13466641|NCT00087490|26978350|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28|||
13466642|NCT00087490|26978351|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36|||
13466643|NCT00087490|26978350|FG000|Overall Study|Randomized but not treated|7|||
13466644|NCT00087490|26978351|FG001|Overall Study|Randomized but not treated|18|||
13466645|NCT00087438|26978363|FG000|Overall Study|Ineligible / No protocol treatment|4|||
13466646|NCT00087178|26978392|FG000|Overall Study|No follow up data|5|||
13466647|NCT00087178|26978393|FG001|Overall Study|No follow up data|15|||
13466648|NCT00087178|26978392|FG000|Overall Study|No clinical assessment|1|||
13466649|NCT00087178|26978393|FG001|Overall Study|No clinical assessment|2|||
13466650|NCT00087178|26978392|FG000|Overall Study|Patient not at risk for primary endpoint|0|||
13466651|NCT00087178|26978393|FG001|Overall Study|Patient not at risk for primary endpoint|1|||
13466652|NCT00086580|26978444|FG000|Treatment Period|Disease progression|9|||
13466653|NCT00086580|26978445|FG001|Treatment Period|Disease progression|8|||
13466654|NCT00086580|26978444|FG000|Treatment Period|Unable to comply with protocol|3|||
13466655|NCT00086580|26978445|FG001|Treatment Period|Unable to comply with protocol|1|||
13466656|NCT00086580|26978444|FG000|Treatment Period|Withdrawal by Subject|7|||
13466657|NCT00086580|26978445|FG001|Treatment Period|Withdrawal by Subject|8|||
13466658|NCT00086580|26978444|FG000|Treatment Period|Physician Decision|13|||
13466659|NCT00086580|26978445|FG001|Treatment Period|Physician Decision|7|||
13466660|NCT00086580|26978444|FG000|Treatment Period|AE - not treatment related|7|||
13466661|NCT00086580|26978445|FG001|Treatment Period|AE - not treatment related|7|||
13466662|NCT00086580|26978444|FG000|Treatment Period|Toxicity - treatment related|15|||
13466663|NCT00086580|26978445|FG001|Treatment Period|Toxicity - treatment related|15|||
13466664|NCT00086580|26978444|FG000|Treatment Period|Anemia or thrombocytopenia|1|||
13466665|NCT00086580|26978445|FG001|Treatment Period|Anemia or thrombocytopenia|4|||
13466666|NCT00086580|26978444|FG000|Treatment Period|Death|5|||
13466667|NCT00086580|26978445|FG001|Treatment Period|Death|7|||
13466668|NCT00086580|26978444|FG000|Treatment Period|Other|5|||
13466669|NCT00086580|26978445|FG001|Treatment Period|Other|3|||
13466670|NCT00086580|26978444|FG000|Follow-up Period|Disease progression|72|||
13466671|NCT00086580|26978445|FG001|Follow-up Period|Disease progression|99|||
13466672|NCT00086580|26978444|FG000|Follow-up Period|Unable to comply with protocol|5|||
13466673|NCT00086580|26978445|FG001|Follow-up Period|Unable to comply with protocol|0|||
13466674|NCT00086580|26978444|FG000|Follow-up Period|Withdrawal by Subject|6|||
13466675|NCT00086580|26978445|FG001|Follow-up Period|Withdrawal by Subject|6|||
13466676|NCT00086580|26978444|FG000|Follow-up Period|Physician Decision|0|||
13466677|NCT00086580|26978445|FG001|Follow-up Period|Physician Decision|1|||
13466678|NCT00086580|26978444|FG000|Follow-up Period|AE - not related|1|||
13466679|NCT00086580|26978445|FG001|Follow-up Period|AE - not related|0|||
13466680|NCT00086580|26978444|FG000|Follow-up Period|Death|13|||
13466681|NCT00086580|26978445|FG001|Follow-up Period|Death|7|||
13466682|NCT00086580|26978444|FG000|Follow-up Period|Other|7|||
13466683|NCT00086580|26978445|FG001|Follow-up Period|Other|6|||
13466684|NCT00086580|26978444|FG000|Observation Period|Unable to comply with protocol|1|||
13466685|NCT00086580|26978445|FG001|Observation Period|Unable to comply with protocol|1|||
13466686|NCT00086580|26978444|FG000|Observation Period|Withdrawal by Subject|4|||
13466687|NCT00086580|26978445|FG001|Observation Period|Withdrawal by Subject|2|||
13466688|NCT00086580|26978444|FG000|Observation Period|Death|33|||
13466689|NCT00086580|26978445|FG001|Observation Period|Death|55|||
13466690|NCT00086580|26978444|FG000|Observation Period|Other|8|||
13466691|NCT00086580|26978445|FG001|Observation Period|Other|7|||
13466692|NCT00086515|26978462|FG000|Phase A (Weeks 0-24)|Adverse Event|17|||
13466693|NCT00086515|26978463|FG001|Phase A (Weeks 0-24)|Adverse Event|9|||
13466694|NCT00086515|26978462|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7|||
13466695|NCT00086515|26978463|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13|||
13466696|NCT00086515|26978462|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4|||
13466697|NCT00086515|26978463|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
13466698|NCT00086515|26978462|FG000|Phase A (Weeks 0-24)|Protocol Violation|3|||
13466699|NCT00086515|26978463|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
13466700|NCT00086515|26978462|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
13466701|NCT00086515|26978463|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
13466702|NCT00086515|26978462|FG000|Phase A (Weeks 0-24)|Patient Moved|2|||
13466703|NCT00086515|26978463|FG001|Phase A (Weeks 0-24)|Patient Moved|3|||
13466704|NCT00086515|26978462|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4|||
13466705|NCT00086515|26978463|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3|||
13466706|NCT00086515|26978462|FG000|Phase A (Weeks 0-24)|Poor compliance|1|||
13466707|NCT00086515|26978463|FG001|Phase A (Weeks 0-24)|Poor compliance|0|||
13466708|NCT00086515|26978462|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0|||
13466709|NCT00086515|26978463|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1|||
13466710|NCT00086515|26978462|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1|||
13466711|NCT00086515|26978463|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0|||
13466712|NCT00086515|26978462|FG000|Phase A to Phase B Transition Period|Adverse Event|2|||
13466713|NCT00086515|26978463|FG001|Phase A to Phase B Transition Period|Adverse Event|1|||
13466714|NCT00086515|26978462|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
13466715|NCT00086515|26978463|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
13466716|NCT00086515|26978462|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1|||
13466717|NCT00086515|26978463|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0|||
13466718|NCT00086515|26978462|FG000|Phase A to Phase B Transition Period|Protocol Violation|0|||
13466719|NCT00086515|26978463|FG001|Phase A to Phase B Transition Period|Protocol Violation|1|||
13466720|NCT00086515|26978462|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16|||
13466721|NCT00086515|26978463|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23|||
13466722|NCT00086515|26978462|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
13466723|NCT00086515|26978463|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
13466724|NCT00086515|26978462|FG000|Phase A to Phase B Transition Period|Poor compliance|1|||
13466725|NCT00086515|26978463|FG001|Phase A to Phase B Transition Period|Poor compliance|0|||
13466726|NCT00086515|26978462|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1|||
13466727|NCT00086515|26978463|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0|||
13466728|NCT00086515|26978462|FG000|Phase B (Weeks 24-104)|Adverse Event|16|||
13466729|NCT00086515|26978463|FG001|Phase B (Weeks 24-104)|Adverse Event|10|||
13466730|NCT00086515|26978462|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94|||
13466731|NCT00086515|26978463|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19|||
13466732|NCT00086515|26978462|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13|||
13466733|NCT00086515|26978463|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4|||
13466734|NCT00086515|26978462|FG000|Phase B (Weeks 24-104)|Physician Decision|3|||
13466735|NCT00086515|26978463|FG001|Phase B (Weeks 24-104)|Physician Decision|0|||
13466736|NCT00086515|26978462|FG000|Phase B (Weeks 24-104)|Protocol Violation|1|||
13466737|NCT00086515|26978463|FG001|Phase B (Weeks 24-104)|Protocol Violation|0|||
13466738|NCT00086515|26978462|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15|||
13466739|NCT00086515|26978463|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5|||
13466740|NCT00086515|26978462|FG000|Phase B (Weeks 24-104)|Patient Moved|2|||
13466741|NCT00086515|26978463|FG001|Phase B (Weeks 24-104)|Patient Moved|2|||
13466742|NCT00086515|26978462|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5|||
13466743|NCT00086515|26978463|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3|||
13466744|NCT00086515|26978462|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36|||
13466745|NCT00086515|26978463|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10|||
13466746|NCT00086515|26978462|FG000|Phase B (Weeks 24-104)|Patient Died|3|||
13466747|NCT00086515|26978463|FG001|Phase B (Weeks 24-104)|Patient Died|1|||
13466748|NCT00086515|26978462|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0|||
13466749|NCT00086515|26978463|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1|||
13466750|NCT00086515|26978462|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1|||
13466751|NCT00086515|26978463|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0|||
13466752|NCT00086515|26978462|FG000|Phase B (Weeks 24-104)|Discontinued in error|1|||
13466753|NCT00086515|26978463|FG001|Phase B (Weeks 24-104)|Discontinued in error|0|||
13466754|NCT00086502|26978478|FG000|Overall Study|Adverse Event|11|||
13466755|NCT00086502|26978479|FG001|Overall Study|Adverse Event|2|||
13466756|NCT00086502|26978478|FG000|Overall Study|Lack of Efficacy|0|||
13466757|NCT00086502|26978479|FG001|Overall Study|Lack of Efficacy|2|||
13466758|NCT00086502|26978478|FG000|Overall Study|Lost to Follow-up|3|||
13466759|NCT00086502|26978479|FG001|Overall Study|Lost to Follow-up|1|||
13466760|NCT00086502|26978478|FG000|Overall Study|Physician Decision|1|||
13466761|NCT00086502|26978479|FG001|Overall Study|Physician Decision|1|||
13466762|NCT00086502|26978478|FG000|Overall Study|Pregnancy|0|||
13466763|NCT00086502|26978479|FG001|Overall Study|Pregnancy|1|||
13466764|NCT00086502|26978478|FG000|Overall Study|Protocol Violation|3|||
13466765|NCT00086502|26978479|FG001|Overall Study|Protocol Violation|3|||
13466766|NCT00086502|26978478|FG000|Overall Study|Withdrawal by Subject|5|||
13466767|NCT00086502|26978479|FG001|Overall Study|Withdrawal by Subject|6|||
13466768|NCT00086502|26978478|FG000|Overall Study|Patient Moved|1|||
13466769|NCT00086502|26978479|FG001|Overall Study|Patient Moved|1|||
13466770|NCT00086502|26978478|FG000|Overall Study|Protocol Discontinuation Criteria|1|||
13466771|NCT00086502|26978479|FG001|Overall Study|Protocol Discontinuation Criteria|3|||
13466772|NCT00086502|26978478|FG000|Overall Study|Patient Accidentally Unblinded|1|||
13466773|NCT00086502|26978479|FG001|Overall Study|Patient Accidentally Unblinded|0|||
13466774|NCT00086411|26978506|FG000|Overall Study|Lost to Follow-up|11|||
13466775|NCT00086411|26978507|FG001|Overall Study|Lost to Follow-up|11|||
13466776|NCT00086411|26978508|FG002|Overall Study|Lost to Follow-up|13|||
13466777|NCT00086411|26978509|FG003|Overall Study|Lost to Follow-up|12|||
13466778|NCT00086385|26978532|FG000|Overall Study|Death|2|||
13466779|NCT00086385|26978533|FG001|Overall Study|Death|2|||
13466780|NCT00086385|26978534|FG002|Overall Study|Death|1|||
13466781|NCT00086385|26978535|FG003|Overall Study|Death|1|||
13466782|NCT00086307|26978553|FG000|Overall Study|Lack of Efficacy|1|||
13466783|NCT00086307|26978554|FG001|Overall Study|Lack of Efficacy|1|||
13466784|NCT00086307|26978555|FG002|Overall Study|Lack of Efficacy|2|||
13466785|NCT00086307|26978553|FG000|Overall Study|Shortness of breath and muscle spasms|1|||
13466786|NCT00086307|26978554|FG001|Overall Study|Shortness of breath and muscle spasms|0|||
13466787|NCT00086307|26978555|FG002|Overall Study|Shortness of breath and muscle spasms|0|||
13466788|NCT00086307|26978553|FG000|Overall Study|Nausea and headaches|0|||
13466789|NCT00086307|26978554|FG001|Overall Study|Nausea and headaches|0|||
13466790|NCT00086307|26978555|FG002|Overall Study|Nausea and headaches|1|||
13466791|NCT00086307|26978553|FG000|Overall Study|Constipation and sleepiness|0|||
13466792|NCT00086307|26978554|FG001|Overall Study|Constipation and sleepiness|0|||
13466793|NCT00086307|26978555|FG002|Overall Study|Constipation and sleepiness|1|||
13466794|NCT00086307|26978553|FG000|Overall Study|Suicidal ideation|0|||
13466795|NCT00086307|26978554|FG001|Overall Study|Suicidal ideation|0|||
13466796|NCT00086307|26978555|FG002|Overall Study|Suicidal ideation|1|||
13466797|NCT00086307|26978553|FG000|Overall Study|Fatigue and difficulty falling asleep|0|||
13466798|NCT00086307|26978554|FG001|Overall Study|Fatigue and difficulty falling asleep|0|||
13466799|NCT00086307|26978555|FG002|Overall Study|Fatigue and difficulty falling asleep|1|||
13466800|NCT00086307|26978553|FG000|Overall Study|Withdrawal by Subject|0|||
13466801|NCT00086307|26978554|FG001|Overall Study|Withdrawal by Subject|0|||
13466802|NCT00086307|26978555|FG002|Overall Study|Withdrawal by Subject|2|||
13466803|NCT00086190|26978621|FG000|Overall Study|Adverse Event|6|||
13466804|NCT00086190|26978622|FG001|Overall Study|Adverse Event|2|||
13466805|NCT00086190|26978623|FG002|Overall Study|Adverse Event|2|||
13466806|NCT00086190|26978621|FG000|Overall Study|Withdrawal by Subject|0|||
13466807|NCT00086190|26978622|FG001|Overall Study|Withdrawal by Subject|2|||
13466808|NCT00086190|26978623|FG002|Overall Study|Withdrawal by Subject|2|||
13466809|NCT00086190|26978621|FG000|Overall Study|Protocol Violation|1|||
13466810|NCT00086190|26978622|FG001|Overall Study|Protocol Violation|0|||
13466811|NCT00086190|26978623|FG002|Overall Study|Protocol Violation|0|||
13466812|NCT00086190|26978621|FG000|Overall Study|Moved|1|||
13466813|NCT00086190|26978622|FG001|Overall Study|Moved|0|||
13466814|NCT00086190|26978623|FG002|Overall Study|Moved|0|||
13466815|NCT00086190|26978621|FG000|Overall Study|Worsening depression|0|||
13466816|NCT00086190|26978622|FG001|Overall Study|Worsening depression|0|||
13466817|NCT00086190|26978623|FG002|Overall Study|Worsening depression|2|||
13466818|NCT00085644|26978672|FG000|Double-Blind Period|Adverse Event|5|||
13466819|NCT00085644|26978673|FG001|Double-Blind Period|Adverse Event|2|||
13466820|NCT00085644|26978674|FG002|Double-Blind Period|Adverse Event|0|||
13466821|NCT00085644|26978672|FG000|Double-Blind Period|Withdrawal by Subject|3|||
13466822|NCT00085644|26978673|FG001|Double-Blind Period|Withdrawal by Subject|0|||
13466823|NCT00085644|26978674|FG002|Double-Blind Period|Withdrawal by Subject|0|||
13466824|NCT00085644|26978672|FG000|Double-Blind Period|Lost to Follow-up|2|||
13466825|NCT00085644|26978673|FG001|Double-Blind Period|Lost to Follow-up|1|||
13466826|NCT00085644|26978674|FG002|Double-Blind Period|Lost to Follow-up|0|||
13466827|NCT00085644|26978672|FG000|Double-Blind Period|Lack/loss of efficacy|2|||
13466828|NCT00085644|26978673|FG001|Double-Blind Period|Lack/loss of efficacy|2|||
13466829|NCT00085644|26978674|FG002|Double-Blind Period|Lack/loss of efficacy|0|||
13466830|NCT00085644|26978672|FG000|Double-Blind Period|Contemplating pregnancy|1|||
13466831|NCT00085644|26978673|FG001|Double-Blind Period|Contemplating pregnancy|0|||
13466832|NCT00085644|26978674|FG002|Double-Blind Period|Contemplating pregnancy|0|||
13466833|NCT00085644|26978672|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0|||
13466834|NCT00085644|26978673|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1|||
13466835|NCT00085644|26978674|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0|||
13466836|NCT00085644|26978672|FG000|Open-Label Period|Adverse Event|0|||
13466837|NCT00085644|26978673|FG001|Open-Label Period|Adverse Event|0|||
13466838|NCT00085644|26978674|FG002|Open-Label Period|Adverse Event|38|||
13466839|NCT00085644|26978672|FG000|Open-Label Period|Withdrawal by Subject|0|||
13466840|NCT00085644|26978673|FG001|Open-Label Period|Withdrawal by Subject|0|||
13466841|NCT00085644|26978674|FG002|Open-Label Period|Withdrawal by Subject|29|||
13466842|NCT00085644|26978672|FG000|Open-Label Period|Lost to Follow-up|0|||
13466843|NCT00085644|26978673|FG001|Open-Label Period|Lost to Follow-up|0|||
13466844|NCT00085644|26978674|FG002|Open-Label Period|Lost to Follow-up|13|||
13466845|NCT00085644|26978672|FG000|Open-Label Period|Lack of Efficacy|0|||
13466846|NCT00085644|26978673|FG001|Open-Label Period|Lack of Efficacy|0|||
13466847|NCT00085644|26978674|FG002|Open-Label Period|Lack of Efficacy|15|||
13466848|NCT00085644|26978672|FG000|Open-Label Period|Pregnancy|0|||
13466849|NCT00085644|26978673|FG001|Open-Label Period|Pregnancy|0|||
13466850|NCT00085644|26978674|FG002|Open-Label Period|Pregnancy|3|||
13466851|NCT00085644|26978672|FG000|Open-Label Period|Contemplating pregnancy|0|||
13466852|NCT00085644|26978673|FG001|Open-Label Period|Contemplating pregnancy|0|||
13466853|NCT00085644|26978674|FG002|Open-Label Period|Contemplating pregnancy|3|||
13466854|NCT00085644|26978672|FG000|Open-Label Period|Protocol Violation|0|||
13466855|NCT00085644|26978673|FG001|Open-Label Period|Protocol Violation|0|||
13466856|NCT00085644|26978674|FG002|Open-Label Period|Protocol Violation|4|||
13466857|NCT00085644|26978672|FG000|Open-Label Period|Personal reason|0|||
13466858|NCT00085644|26978673|FG001|Open-Label Period|Personal reason|0|||
13466859|NCT00085644|26978674|FG002|Open-Label Period|Personal reason|4|||
13466860|NCT00085202|26978715|FG000|Overall Study|Still on therapy|2|||
13466861|NCT00085202|26978716|FG001|Overall Study|Still on therapy|0|||
13466862|NCT00085202|26978715|FG000|Overall Study|Bone involvement confirmed by bone scan|0|||
13466863|NCT00085202|26978716|FG001|Overall Study|Bone involvement confirmed by bone scan|1|||
13466864|NCT00085202|26978715|FG000|Overall Study|Excessive toxicity|6|||
13466865|NCT00085202|26978716|FG001|Overall Study|Excessive toxicity|5|||
13466866|NCT00085202|26978715|FG000|Overall Study|Non-specified|3|||
13466867|NCT00085202|26978716|FG001|Overall Study|Non-specified|5|||
13466868|NCT00085202|26978715|FG000|Overall Study|Withdrawal by Subject|2|||
13466869|NCT00085202|26978716|FG001|Overall Study|Withdrawal by Subject|1|||
13466870|NCT00085202|26978715|FG000|Overall Study|Physician Decision|4|||
13466871|NCT00085202|26978716|FG001|Overall Study|Physician Decision|1|||
13466872|NCT00085202|26978715|FG000|Overall Study|Progressive disease|1|||
13466873|NCT00085202|26978716|FG001|Overall Study|Progressive disease|11|||
13466874|NCT00084799|26978741|FG000|Overall Study|Disease Progression|1|||
13466875|NCT00084799|26978742|FG001|Overall Study|Disease Progression|0|||
13466876|NCT00084656|26978775|FG000|Overall Study|Other reasons|0|||
13466877|NCT00084656|26978776|FG001|Overall Study|Other reasons|12|||
13466878|NCT00084656|26978777|FG002|Overall Study|Other reasons|11|||
13466879|NCT00084656|26978775|FG000|Overall Study|Withdrawal by Subject|15|||
13466880|NCT00084656|26978776|FG001|Overall Study|Withdrawal by Subject|4|||
13466881|NCT00084656|26978777|FG002|Overall Study|Withdrawal by Subject|4|||
13466882|NCT00084656|26978775|FG000|Overall Study|Disease relapse|0|||
13466883|NCT00084656|26978776|FG001|Overall Study|Disease relapse|9|||
13466884|NCT00084656|26978777|FG002|Overall Study|Disease relapse|10|||
13466885|NCT00084656|26978775|FG000|Overall Study|Disease progression|9|||
13466886|NCT00084656|26978776|FG001|Overall Study|Disease progression|0|||
13466887|NCT00084656|26978777|FG002|Overall Study|Disease progression|0|||
13466888|NCT00084656|26978775|FG000|Overall Study|Lost to Follow-up|1|||
13466889|NCT00084656|26978776|FG001|Overall Study|Lost to Follow-up|0|||
13466890|NCT00084656|26978777|FG002|Overall Study|Lost to Follow-up|1|||
13466891|NCT00084266|26978818|FG000|Overall Study|Death|42|||
13466892|NCT00084266|26978819|FG001|Overall Study|Death|39|||
13466893|NCT00084266|26978818|FG000|Overall Study|Adverse Event|8|||
13466894|NCT00084266|26978819|FG001|Overall Study|Adverse Event|5|||
13466895|NCT00084266|26978818|FG000|Overall Study|Lack of Efficacy|2|||
13466896|NCT00084266|26978819|FG001|Overall Study|Lack of Efficacy|4|||
13466897|NCT00084266|26978818|FG000|Overall Study|Lost to Follow-up|5|||
13466898|NCT00084266|26978819|FG001|Overall Study|Lost to Follow-up|3|||
13466899|NCT00084266|26978818|FG000|Overall Study|Participant not willing to participate|3|||
13466900|NCT00084266|26978819|FG001|Overall Study|Participant not willing to participate|8|||
13466901|NCT00084266|26978818|FG000|Overall Study|Other|360|||
13466902|NCT00084266|26978819|FG001|Overall Study|Other|344|||
13466903|NCT00084266|26978818|FG000|Overall Study|Randomized not treated|21|||
13466904|NCT00084266|26978819|FG001|Overall Study|Randomized not treated|20|||
13466905|NCT00084136|26978888|FG000|PI Comparison|Death|10|||
13466906|NCT00084136|26978889|FG001|PI Comparison|Death|9|||
13466907|NCT00084136|26978890|FG002|PI Comparison|Death|0|||
13466908|NCT00084136|26978888|FG000|PI Comparison|Lost to Follow-up|11|||
13466909|NCT00084136|26978889|FG001|PI Comparison|Lost to Follow-up|8|||
13466910|NCT00084136|26978890|FG002|PI Comparison|Lost to Follow-up|0|||
13466911|NCT00084136|26978888|FG000|PI Comparison|Withdrawal by Subject|33|||
13466912|NCT00084136|26978889|FG001|PI Comparison|Withdrawal by Subject|30|||
13466913|NCT00084136|26978890|FG002|PI Comparison|Withdrawal by Subject|0|||
13466914|NCT00084136|26978888|FG000|PI Comparison|Clinic site closed|1|||
13466915|NCT00084136|26978889|FG001|PI Comparison|Clinic site closed|0|||
13466916|NCT00084136|26978890|FG002|PI Comparison|Clinic site closed|0|||
13466917|NCT00084136|26978888|FG000|NRTI Comparison|Death|20|||
13466918|NCT00084136|26978889|FG001|NRTI Comparison|Death|0|||
13466919|NCT00084136|26978890|FG002|NRTI Comparison|Death|18|||
13466920|NCT00084136|26978888|FG000|NRTI Comparison|Lost to Follow-up|14|||
13466921|NCT00084136|26978889|FG001|NRTI Comparison|Lost to Follow-up|0|||
13466922|NCT00084136|26978890|FG002|NRTI Comparison|Lost to Follow-up|12|||
13466923|NCT00084136|26978888|FG000|NRTI Comparison|Withdrawal by Subject|54|||
13466924|NCT00084136|26978889|FG001|NRTI Comparison|Withdrawal by Subject|0|||
13466925|NCT00084136|26978890|FG002|NRTI Comparison|Withdrawal by Subject|38|||
13466926|NCT00084136|26978888|FG000|NRTI Comparison|Clinic site closed|12|||
13466927|NCT00084136|26978889|FG001|NRTI Comparison|Clinic site closed|0|||
13466928|NCT00084136|26978890|FG002|NRTI Comparison|Clinic site closed|14|||
13466929|NCT00084136|26978888|FG000|NRTI Comparison|Not reason above|1|||
13466930|NCT00084136|26978889|FG001|NRTI Comparison|Not reason above|0|||
13466931|NCT00084136|26978890|FG002|NRTI Comparison|Not reason above|0|||
13466932|NCT00083889|26978946|FG000|Overall Study|Adverse Event|76|||
13466933|NCT00083889|26978947|FG001|Overall Study|Adverse Event|86|||
13466934|NCT00083889|26978946|FG000|Overall Study|Protocol Violation|2|||
13466935|NCT00083889|26978947|FG001|Overall Study|Protocol Violation|2|||
13466936|NCT00083889|26978946|FG000|Overall Study|Withdrawal by Subject|22|||
13466937|NCT00083889|26978947|FG001|Overall Study|Withdrawal by Subject|24|||
13466938|NCT00083889|26978946|FG000|Overall Study|Lack of Efficacy|240|||
13466939|NCT00083889|26978947|FG001|Overall Study|Lack of Efficacy|219|||
13466940|NCT00083889|26978946|FG000|Overall Study|Decision of sponsor|32|||
13466941|NCT00083889|26978947|FG001|Overall Study|Decision of sponsor|4|||
13466942|NCT00083889|26978946|FG000|Overall Study|Randomized: did not take study drug|0|||
13466943|NCT00083889|26978947|FG001|Overall Study|Randomized: did not take study drug|15|||
13466944|NCT00083889|26978946|FG000|Overall Study|Completed on marketed sunitinub|3|||
13466945|NCT00083889|26978947|FG001|Overall Study|Completed on marketed sunitinub|0|||
13466946|NCT00083889|26978946|FG000|Overall Study|Crossover to SU011248|0|||
13466947|NCT00083889|26978947|FG001|Overall Study|Crossover to SU011248|25|||
13466948|NCT00082433|26978972|FG000|Overall Study|Adverse Event|12|||
13466949|NCT00082433|26978973|FG001|Overall Study|Adverse Event|17|||
13466950|NCT00082433|26978972|FG000|Overall Study|Death|8|||
13466951|NCT00082433|26978973|FG001|Overall Study|Death|18|||
13466952|NCT00082433|26978972|FG000|Overall Study|Disease Progression/Relapse|270|||
13466953|NCT00082433|26978973|FG001|Overall Study|Disease Progression/Relapse|388|||
13466954|NCT00082433|26978972|FG000|Overall Study|Physician Decision|50|||
13466955|NCT00082433|26978973|FG001|Overall Study|Physician Decision|61|||
13466956|NCT00082433|26978972|FG000|Overall Study|Lost to Follow-up|1|||
13466957|NCT00082433|26978973|FG001|Overall Study|Lost to Follow-up|2|||
13466958|NCT00082433|26978972|FG000|Overall Study|Study Drug Toxicity|179|||
13466959|NCT00082433|26978973|FG001|Overall Study|Study Drug Toxicity|66|||
13466960|NCT00082433|26978972|FG000|Overall Study|Withdrawal by Subject|55|||
13466961|NCT00082433|26978973|FG001|Overall Study|Withdrawal by Subject|30|||
13466962|NCT00082433|26978972|FG000|Overall Study|Still On Treatment|2|||
13466963|NCT00082433|26978973|FG001|Overall Study|Still On Treatment|1|||
13466964|NCT00082433|26978972|FG000|Overall Study|Not Treated|12|||
13466965|NCT00082433|26978973|FG001|Overall Study|Not Treated|11|||
13466966|NCT00082433|26978972|FG000|Overall Study|Ineligible|2|||
13466967|NCT00082433|26978973|FG001|Overall Study|Ineligible|1|||
13466968|NCT00082433|26978972|FG000|Overall Study|Noncompliance|2|||
13466969|NCT00082433|26978973|FG001|Overall Study|Noncompliance|1|||
13466970|NCT00082433|26978972|FG000|Overall Study|New primary cancer|1|||
13466971|NCT00082433|26978973|FG001|Overall Study|New primary cancer|0|||
13466972|NCT00082433|26978972|FG000|Overall Study|Impending surgery|0|||
13466973|NCT00082433|26978973|FG001|Overall Study|Impending surgery|1|||
13466974|NCT00082407|26978998|FG000|Overall Study|Adverse Event|20|||
13466975|NCT00082407|26978999|FG001|Overall Study|Adverse Event|0|||
13466976|NCT00082407|26978998|FG000|Overall Study|Protocol Violation|14|||
13466977|NCT00082407|26978999|FG001|Overall Study|Protocol Violation|12|||
13466978|NCT00082407|26978998|FG000|Overall Study|Patient Decision|13|||
13466979|NCT00082407|26978999|FG001|Overall Study|Patient Decision|6|||
13466980|NCT00082407|26978998|FG000|Overall Study|Physician Decision|5|||
13466981|NCT00082407|26978999|FG001|Overall Study|Physician Decision|3|||
13466982|NCT00082407|26978998|FG000|Overall Study|Loss of Glucose Control|2|||
13466983|NCT00082407|26978999|FG001|Overall Study|Loss of Glucose Control|2|||
13466984|NCT00082407|26978998|FG000|Overall Study|Death|2|||
13466985|NCT00082407|26978999|FG001|Overall Study|Death|1|||
13466986|NCT00082407|26978998|FG000|Overall Study|Lost to Follow-up|0|||
13466987|NCT00082407|26978999|FG001|Overall Study|Lost to Follow-up|3|||
13466988|NCT00082381|26979024|FG000|Overall Study|Adverse Event|27|||
13466989|NCT00082381|26979025|FG001|Overall Study|Adverse Event|2|||
13466990|NCT00082381|26979024|FG000|Overall Study|Lost to Follow-up|5|||
13466991|NCT00082381|26979025|FG001|Overall Study|Lost to Follow-up|7|||
13466992|NCT00082381|26979024|FG000|Overall Study|Patient Decision|8|||
13466993|NCT00082381|26979025|FG001|Overall Study|Patient Decision|4|||
13466994|NCT00082381|26979024|FG000|Overall Study|Physician Decision|1|||
13466995|NCT00082381|26979025|FG001|Overall Study|Physician Decision|2|||
13466996|NCT00082381|26979024|FG000|Overall Study|Protocol Violation|10|||
13466997|NCT00082381|26979025|FG001|Overall Study|Protocol Violation|11|||
13466998|NCT00082381|26979024|FG000|Overall Study|Loss of Glucose Control|4|||
13466999|NCT00082381|26979025|FG001|Overall Study|Loss of Glucose Control|0|||
13467000|NCT00082368|26979032|FG000|Overall Study|Not treated-pt had poor IV access|1|||
13467001|NCT00082355|26979039|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1|||
13467002|NCT00082355|26979039|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1|||
13467003|NCT00082355|26979039|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28|||
13467004|NCT00082173|26979054|FG000|Overall Study|Withdrawal by Subject|3|||
13467005|NCT00082173|26979055|FG001|Overall Study|Withdrawal by Subject|5|||
13467006|NCT00082173|26979054|FG000|Overall Study|Lost to Follow-up|1|||
13467007|NCT00082173|26979055|FG001|Overall Study|Lost to Follow-up|0|||
13467008|NCT00082173|26979054|FG000|Overall Study|Adverse Event|1|||
13467009|NCT00082173|26979055|FG001|Overall Study|Adverse Event|0|||
13467010|NCT00082173|26979054|FG000|Overall Study|Culture negative or resistant at baselin|5|||
13467011|NCT00082173|26979055|FG001|Overall Study|Culture negative or resistant at baselin|6|||
13467012|NCT00081731|26979080|FG000|Overall Study|scientific integrity issue|8|||
13467013|NCT00081731|26979081|FG001|Overall Study|scientific integrity issue|8|||
13467014|NCT00080301|26979106|FG000|Overall Study|Randomized but Never Treated|5|||
13467015|NCT00080301|26979107|FG001|Overall Study|Randomized but Never Treated|10|||
13467016|NCT00080301|26979106|FG000|Overall Study|Still on Treatment as of CSR date|0|||
13467017|NCT00080301|26979107|FG001|Overall Study|Still on Treatment as of CSR date|1|||
13467018|NCT00080119|26979152|FG000|Overall Study|Discontinued because of study closure|0|||
13467019|NCT00080119|26979153|FG001|Overall Study|Discontinued because of study closure|0|||
13467020|NCT00080119|26979154|FG002|Overall Study|Discontinued because of study closure|130|||
13467021|NCT00080119|26979155|FG003|Overall Study|Discontinued because of study closure|141|||
13467022|NCT00080119|26979152|FG000|Overall Study|Unable to get to clinic|24|||
13467023|NCT00080119|26979153|FG001|Overall Study|Unable to get to clinic|24|||
13467024|NCT00080119|26979154|FG002|Overall Study|Unable to get to clinic|7|||
13467025|NCT00080119|26979155|FG003|Overall Study|Unable to get to clinic|1|||
13467026|NCT00080119|26979152|FG000|Overall Study|Consent withdrawn|13|||
13467027|NCT00080119|26979153|FG001|Overall Study|Consent withdrawn|17|||
13467028|NCT00080119|26979154|FG002|Overall Study|Consent withdrawn|4|||
13467029|NCT00080119|26979155|FG003|Overall Study|Consent withdrawn|6|||
13467030|NCT00080119|26979152|FG000|Overall Study|Unwilling to adhere to study requirement|3|||
13467031|NCT00080119|26979153|FG001|Overall Study|Unwilling to adhere to study requirement|2|||
13467032|NCT00080119|26979154|FG002|Overall Study|Unwilling to adhere to study requirement|5|||
13467033|NCT00080119|26979155|FG003|Overall Study|Unwilling to adhere to study requirement|1|||
13467034|NCT00080119|26979152|FG000|Overall Study|Lost to Follow-up|16|||
13467035|NCT00080119|26979153|FG001|Overall Study|Lost to Follow-up|19|||
13467036|NCT00080119|26979154|FG002|Overall Study|Lost to Follow-up|19|||
13467037|NCT00080119|26979155|FG003|Overall Study|Lost to Follow-up|14|||
13467038|NCT00079937|26979178|FG000|Overall Study|Adverse Event|2|||
13467039|NCT00079937|26979179|FG001|Overall Study|Adverse Event|1|||
13467040|NCT00079937|26979178|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
13467041|NCT00079937|26979179|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
13467042|NCT00079937|26979178|FG000|Overall Study|Subject no longer requires study drug|3|||
13467043|NCT00079937|26979179|FG001|Overall Study|Subject no longer requires study drug|0|||
13467044|NCT00079937|26979178|FG000|Overall Study|Protocol Violation|8|||
13467045|NCT00079937|26979179|FG001|Overall Study|Protocol Violation|6|||
13467046|NCT00079937|26979178|FG000|Overall Study|Withdrawal by Subject|21|||
13467047|NCT00079937|26979179|FG001|Overall Study|Withdrawal by Subject|7|||
13467048|NCT00079937|26979178|FG000|Overall Study|Lost to Follow-up|12|||
13467049|NCT00079937|26979179|FG001|Overall Study|Lost to Follow-up|5|||
13467050|NCT00079937|26979178|FG000|Overall Study|Administrative problems|22|||
13467051|NCT00079937|26979179|FG001|Overall Study|Administrative problems|11|||
13467052|NCT00079781|26979196|FG000|Pre-implant Period|Withdrawal by Subject|2|||
13467053|NCT00079781|26979197|FG001|Pre-implant Period|Withdrawal by Subject|0|||
13467054|NCT00079781|26979198|FG002|Pre-implant Period|Withdrawal by Subject|0|||
13467055|NCT00079781|26979196|FG000|Pre-implant Period|Did not meet I/E criteria|1|||
13467056|NCT00079781|26979197|FG001|Pre-implant Period|Did not meet I/E criteria|1|||
13467057|NCT00079781|26979198|FG002|Pre-implant Period|Did not meet I/E criteria|1|||
13467058|NCT00079781|26979196|FG000|Follow-up Period|Withdrawal by Subject|3|||
13467059|NCT00079781|26979197|FG001|Follow-up Period|Withdrawal by Subject|0|||
13467060|NCT00079781|26979198|FG002|Follow-up Period|Withdrawal by Subject|1|||
13467061|NCT00079781|26979196|FG000|Follow-up Period|Lost to Follow-up|1|||
13467062|NCT00079781|26979197|FG001|Follow-up Period|Lost to Follow-up|0|||
13467063|NCT00079781|26979198|FG002|Follow-up Period|Lost to Follow-up|0|||
13467064|NCT00079781|26979196|FG000|Follow-up Period|Death|0|||
13467065|NCT00079781|26979197|FG001|Follow-up Period|Death|0|||
13467066|NCT00079781|26979198|FG002|Follow-up Period|Death|1|||
13467067|NCT00079677|26979213|FG000|Overall Study|Adverse Event|5|||
13467068|NCT00079677|26979214|FG001|Overall Study|Adverse Event|6|||
13467069|NCT00079677|26979213|FG000|Overall Study|Lack of Efficacy|1|||
13467070|NCT00079677|26979214|FG001|Overall Study|Lack of Efficacy|0|||
13467071|NCT00079677|26979213|FG000|Overall Study|Lost to Follow-up|2|||
13467072|NCT00079677|26979214|FG001|Overall Study|Lost to Follow-up|2|||
13467073|NCT00079677|26979213|FG000|Overall Study|Physician Decision|3|||
13467074|NCT00079677|26979214|FG001|Overall Study|Physician Decision|0|||
13467075|NCT00079677|26979213|FG000|Overall Study|Protocol Violation|2|||
13467076|NCT00079677|26979214|FG001|Overall Study|Protocol Violation|3|||
13467077|NCT00079677|26979213|FG000|Overall Study|Withdrawal by Subject|5|||
13467078|NCT00079677|26979214|FG001|Overall Study|Withdrawal by Subject|3|||
13467079|NCT00079677|26979213|FG000|Overall Study|Miscellaneous|2|||
13467080|NCT00079677|26979214|FG001|Overall Study|Miscellaneous|0|||
13467081|NCT00079417|26979224|FG000|Overall Study|Physician Decision|2|||
13467082|NCT00079417|26979224|FG000|Overall Study|Ineligible|7|||
13467083|NCT00079391|26979235|FG000|Overall Study|Withdrawal by Subject|1|||
13467084|NCT00079339|26979259|FG000|Overall Study|Adverse Event|1|||
13467085|NCT00079339|26979260|FG001|Overall Study|Adverse Event|7|||
13467086|NCT00079339|26979261|FG002|Overall Study|Adverse Event|2|||
13467087|NCT00079339|26979259|FG000|Overall Study|Death|1|||
13467088|NCT00079339|26979260|FG001|Overall Study|Death|0|||
13467089|NCT00079339|26979261|FG002|Overall Study|Death|0|||
13467090|NCT00079339|26979259|FG000|Overall Study|Non-compliance|0|||
13467091|NCT00079339|26979260|FG001|Overall Study|Non-compliance|0|||
13467092|NCT00079339|26979261|FG002|Overall Study|Non-compliance|1|||
13467093|NCT00079339|26979259|FG000|Overall Study|Withdrawal by Subject|0|||
13467094|NCT00079339|26979260|FG001|Overall Study|Withdrawal by Subject|4|||
13467095|NCT00079339|26979261|FG002|Overall Study|Withdrawal by Subject|1|||
13467096|NCT00079339|26979259|FG000|Overall Study|Disease progression|3|||
13467097|NCT00079339|26979260|FG001|Overall Study|Disease progression|28|||
13467098|NCT00079339|26979261|FG002|Overall Study|Disease progression|2|||
13467099|NCT00079274|26979304|FG000|Overall Study|Withdrawal by Subject|111|||
13467100|NCT00079274|26979305|FG001|Overall Study|Withdrawal by Subject|10|||
13467101|NCT00079274|26979306|FG002|Overall Study|Withdrawal by Subject|12|||
13467102|NCT00079274|26979307|FG003|Overall Study|Withdrawal by Subject|163|||
13467103|NCT00079274|26979308|FG004|Overall Study|Withdrawal by Subject|7|||
13467104|NCT00079274|26979309|FG005|Overall Study|Withdrawal by Subject|8|||
13467105|NCT00079274|26979310|FG006|Overall Study|Withdrawal by Subject|0|||
13467106|NCT00079274|26979304|FG000|Overall Study|Adverse Event|130|||
13467107|NCT00079274|26979305|FG001|Overall Study|Adverse Event|8|||
13467108|NCT00079274|26979306|FG002|Overall Study|Adverse Event|8|||
13467109|NCT00079274|26979307|FG003|Overall Study|Adverse Event|184|||
13467110|NCT00079274|26979308|FG004|Overall Study|Adverse Event|7|||
13467111|NCT00079274|26979309|FG005|Overall Study|Adverse Event|8|||
13467112|NCT00079274|26979310|FG006|Overall Study|Adverse Event|0|||
13467113|NCT00079274|26979304|FG000|Overall Study|Recurrence|21|||
13467114|NCT00079274|26979305|FG001|Overall Study|Recurrence|0|||
13467115|NCT00079274|26979306|FG002|Overall Study|Recurrence|1|||
13467116|NCT00079274|26979307|FG003|Overall Study|Recurrence|15|||
13467117|NCT00079274|26979308|FG004|Overall Study|Recurrence|0|||
13467118|NCT00079274|26979309|FG005|Overall Study|Recurrence|2|||
13467119|NCT00079274|26979310|FG006|Overall Study|Recurrence|0|||
13467120|NCT00079274|26979304|FG000|Overall Study|Alternate Treatment|6|||
13467121|NCT00079274|26979305|FG001|Overall Study|Alternate Treatment|1|||
13467122|NCT00079274|26979306|FG002|Overall Study|Alternate Treatment|0|||
13467123|NCT00079274|26979307|FG003|Overall Study|Alternate Treatment|3|||
13467124|NCT00079274|26979308|FG004|Overall Study|Alternate Treatment|0|||
13467125|NCT00079274|26979309|FG005|Overall Study|Alternate Treatment|0|||
13467126|NCT00079274|26979310|FG006|Overall Study|Alternate Treatment|0|||
13467127|NCT00079274|26979304|FG000|Overall Study|Other Medical Problems|6|||
13467128|NCT00079274|26979305|FG001|Overall Study|Other Medical Problems|1|||
13467129|NCT00079274|26979306|FG002|Overall Study|Other Medical Problems|0|||
13467130|NCT00079274|26979307|FG003|Overall Study|Other Medical Problems|7|||
13467131|NCT00079274|26979308|FG004|Overall Study|Other Medical Problems|0|||
13467132|NCT00079274|26979309|FG005|Overall Study|Other Medical Problems|0|||
13467133|NCT00079274|26979310|FG006|Overall Study|Other Medical Problems|0|||
13467134|NCT00079274|26979304|FG000|Overall Study|Death|4|||
13467135|NCT00079274|26979305|FG001|Overall Study|Death|0|||
13467136|NCT00079274|26979306|FG002|Overall Study|Death|1|||
13467137|NCT00079274|26979307|FG003|Overall Study|Death|15|||
13467138|NCT00079274|26979308|FG004|Overall Study|Death|0|||
13467139|NCT00079274|26979309|FG005|Overall Study|Death|0|||
13467140|NCT00079274|26979310|FG006|Overall Study|Death|0|||
13467141|NCT00079274|26979304|FG000|Overall Study|Cytogenetic resistance|0|||
13467142|NCT00079274|26979305|FG001|Overall Study|Cytogenetic resistance|0|||
13467143|NCT00079274|26979306|FG002|Overall Study|Cytogenetic resistance|0|||
13467144|NCT00079274|26979307|FG003|Overall Study|Cytogenetic resistance|2|||
13467145|NCT00079274|26979308|FG004|Overall Study|Cytogenetic resistance|0|||
13467146|NCT00079274|26979309|FG005|Overall Study|Cytogenetic resistance|0|||
13467147|NCT00079274|26979310|FG006|Overall Study|Cytogenetic resistance|0|||
13467148|NCT00079274|26979304|FG000|Overall Study|Other|43|||
13467149|NCT00079274|26979305|FG001|Overall Study|Other|7|||
13467150|NCT00079274|26979306|FG002|Overall Study|Other|5|||
13467151|NCT00079274|26979307|FG003|Overall Study|Other|55|||
13467152|NCT00079274|26979308|FG004|Overall Study|Other|1|||
13467153|NCT00079274|26979309|FG005|Overall Study|Other|2|||
13467154|NCT00079274|26979310|FG006|Overall Study|Other|0|||
13467155|NCT00079183|26979327|FG000|Overall Study|Withdrawal by Subject|4|||
13467156|NCT00079183|26979327|FG000|Overall Study|Study medication non-compliance|2|||
13467157|NCT00079183|26979327|FG000|Overall Study|Specimen collection non-compliance|1|||
13467158|NCT00079040|26979335|FG000|Overall Study|Withdrew before treatment|1|||
13467159|NCT00079040|26979335|FG000|Overall Study|Ineligible|1|||
13467160|NCT00078949|26979364|FG000|Overall Study|No treated|4|||
13467161|NCT00078949|26979365|FG001|Overall Study|No treated|5|||
13467162|NCT00078949|26979366|FG002|Overall Study|No treated|3|||
13467163|NCT00078949|26979367|FG003|Overall Study|No treated|3|||
13467164|NCT00078819|26979401|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
13467165|NCT00078819|26979402|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1|||
13467166|NCT00078819|26979403|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
13467167|NCT00078819|26979404|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
13467168|NCT00078819|26979401|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1|||
13467169|NCT00078819|26979402|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
13467170|NCT00078819|26979403|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
13467171|NCT00078819|26979404|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
13467172|NCT00078819|26979401|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
13467173|NCT00078819|26979402|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
13467174|NCT00078819|26979403|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
13467175|NCT00078819|26979404|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
13467176|NCT00078819|26979401|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3|||
13467177|NCT00078819|26979402|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2|||
13467178|NCT00078819|26979403|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
13467179|NCT00078819|26979404|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
13467180|NCT00078819|26979401|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
13467181|NCT00078819|26979402|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
13467182|NCT00078819|26979403|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
13467183|NCT00078819|26979404|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
13467184|NCT00078819|26979401|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34|||
13467185|NCT00078819|26979402|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25|||
13467186|NCT00078819|26979403|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
13467187|NCT00078819|26979404|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
13467188|NCT00078819|26979401|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
13467189|NCT00078819|26979402|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
13467190|NCT00078819|26979403|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29|||
13467191|NCT00078819|26979404|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13|||
13467192|NCT00078819|26979401|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
13467193|NCT00078819|26979402|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
13467194|NCT00078819|26979403|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
13467195|NCT00078819|26979404|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1|||
13467196|NCT00078806|26979443|FG000|Part 1A|Adverse Event|2|||
13467197|NCT00078806|26979444|FG001|Part 1A|Adverse Event|0|||
13467198|NCT00078806|26979445|FG002|Part 1A|Adverse Event|0|||
13467199|NCT00078806|26979446|FG003|Part 1A|Adverse Event|0|||
13467200|NCT00078806|26979443|FG000|Part 1A|Lack of Efficacy|7|||
13467201|NCT00078806|26979444|FG001|Part 1A|Lack of Efficacy|0|||
13467202|NCT00078806|26979445|FG002|Part 1A|Lack of Efficacy|0|||
13467203|NCT00078806|26979446|FG003|Part 1A|Lack of Efficacy|0|||
13467204|NCT00078806|26979443|FG000|Part 1A|Other|1|||
13467205|NCT00078806|26979444|FG001|Part 1A|Other|0|||
13467206|NCT00078806|26979445|FG002|Part 1A|Other|0|||
13467207|NCT00078806|26979446|FG003|Part 1A|Other|0|||
13467208|NCT00078806|26979443|FG000|Part 1B|Adverse Event|1|||
13467209|NCT00078806|26979444|FG001|Part 1B|Adverse Event|0|||
13467210|NCT00078806|26979445|FG002|Part 1B|Adverse Event|0|||
13467211|NCT00078806|26979446|FG003|Part 1B|Adverse Event|0|||
13467212|NCT00078806|26979443|FG000|Part 1B|Lack of Efficacy|7|||
13467213|NCT00078806|26979444|FG001|Part 1B|Lack of Efficacy|0|||
13467214|NCT00078806|26979445|FG002|Part 1B|Lack of Efficacy|0|||
13467215|NCT00078806|26979446|FG003|Part 1B|Lack of Efficacy|0|||
13467216|NCT00078806|26979443|FG000|Part 2|Adverse Event|0|||
13467217|NCT00078806|26979444|FG001|Part 2|Adverse Event|1|||
13467218|NCT00078806|26979445|FG002|Part 2|Adverse Event|0|||
13467219|NCT00078806|26979446|FG003|Part 2|Adverse Event|0|||
13467220|NCT00078767|26979467|FG000|Overall Study|Withdrawal by Subject|1|||
13467221|NCT00078767|26979468|FG001|Overall Study|Withdrawal by Subject|1|||
13467222|NCT00078377|26979491|FG000|Overall Study|Adverse Event|2|||
13467223|NCT00078377|26979492|FG001|Overall Study|Adverse Event|5|||
13467224|NCT00078377|26979493|FG002|Overall Study|Adverse Event|1|||
13467225|NCT00078377|26979491|FG000|Overall Study|Lack of Efficacy|2|||
13467226|NCT00078377|26979492|FG001|Overall Study|Lack of Efficacy|0|||
13467227|NCT00078377|26979493|FG002|Overall Study|Lack of Efficacy|2|||
13467228|NCT00078377|26979491|FG000|Overall Study|Lost to Follow-up|0|||
13467229|NCT00078377|26979492|FG001|Overall Study|Lost to Follow-up|1|||
13467230|NCT00078377|26979493|FG002|Overall Study|Lost to Follow-up|1|||
13467231|NCT00078377|26979491|FG000|Overall Study|Physician Decision|2|||
13467232|NCT00078377|26979492|FG001|Overall Study|Physician Decision|0|||
13467233|NCT00078377|26979493|FG002|Overall Study|Physician Decision|0|||
13467234|NCT00078377|26979491|FG000|Overall Study|Withdrawal by Subject|3|||
13467235|NCT00078377|26979492|FG001|Overall Study|Withdrawal by Subject|4|||
13467236|NCT00078377|26979493|FG002|Overall Study|Withdrawal by Subject|4|||
13467237|NCT00078377|26979491|FG000|Overall Study|Miscellaneous|2|||
13467238|NCT00078377|26979492|FG001|Overall Study|Miscellaneous|6|||
13467239|NCT00078377|26979493|FG002|Overall Study|Miscellaneous|1|||
13467240|NCT00078338|26979506|FG000|Overall Study|Adverse Event|31|||
13467241|NCT00078338|26979507|FG001|Overall Study|Adverse Event|24|||
13467242|NCT00078338|26979506|FG000|Overall Study|Lost to Follow-up|17|||
13467243|NCT00078338|26979507|FG001|Overall Study|Lost to Follow-up|2|||
13467244|NCT00078338|26979506|FG000|Overall Study|Protocol Violation|2|||
13467245|NCT00078338|26979507|FG001|Overall Study|Protocol Violation|2|||
13467246|NCT00078338|26979506|FG000|Overall Study|Disease Progression|4|||
13467247|NCT00078338|26979507|FG001|Overall Study|Disease Progression|7|||
13467248|NCT00078338|26979506|FG000|Overall Study|Other|28|||
13467249|NCT00078338|26979507|FG001|Overall Study|Other|16|||
13467250|NCT00078338|26979506|FG000|Overall Study|Subjects randomized, but not treated|3|||
13467251|NCT00078338|26979507|FG001|Overall Study|Subjects randomized, but not treated|3|||
13467252|NCT00078325|26979528|FG000|Overall Study|Adverse Event|15|||
13467253|NCT00078325|26979529|FG001|Overall Study|Adverse Event|10|||
13467254|NCT00078325|26979530|FG002|Overall Study|Adverse Event|5|||
13467255|NCT00078325|26979528|FG000|Overall Study|Protocol Violation|2|||
13467256|NCT00078325|26979529|FG001|Overall Study|Protocol Violation|2|||
13467257|NCT00078325|26979530|FG002|Overall Study|Protocol Violation|0|||
13467258|NCT00078325|26979528|FG000|Overall Study|Withdrawal by Subject|1|||
13467259|NCT00078325|26979529|FG001|Overall Study|Withdrawal by Subject|5|||
13467260|NCT00078325|26979530|FG002|Overall Study|Withdrawal by Subject|3|||
13467261|NCT00078325|26979528|FG000|Overall Study|Lost to Follow-up|0|||
13467262|NCT00078325|26979529|FG001|Overall Study|Lost to Follow-up|1|||
13467263|NCT00078325|26979530|FG002|Overall Study|Lost to Follow-up|1|||
13467264|NCT00078325|26979528|FG000|Overall Study|Physician Decision|2|||
13467265|NCT00078325|26979529|FG001|Overall Study|Physician Decision|0|||
13467266|NCT00078325|26979530|FG002|Overall Study|Physician Decision|1|||
13467267|NCT00078325|26979528|FG000|Overall Study|Miscellaneous|1|||
13467268|NCT00078325|26979529|FG001|Overall Study|Miscellaneous|1|||
13467269|NCT00078325|26979530|FG002|Overall Study|Miscellaneous|1|||
13467270|NCT00078312|26979536|FG000|Overall Study|Adverse Event|43|||
13467271|NCT00078312|26979536|FG000|Overall Study|Lack of Efficacy|15|||
13467272|NCT00078312|26979536|FG000|Overall Study|Lost to Follow-up|41|||
13467273|NCT00078312|26979536|FG000|Overall Study|Physician Decision|9|||
13467274|NCT00078312|26979536|FG000|Overall Study|Protocol Violation|3|||
13467275|NCT00078312|26979536|FG000|Overall Study|Withdrawal by Subject|33|||
13467276|NCT00078312|26979536|FG000|Overall Study|Miscellaneous|33|||
13467277|NCT00077974|26979553|FG000|Overall Study|Adverse Event|22|||
13467278|NCT00077974|26979553|FG000|Overall Study|Protocol Violation|1|||
13467279|NCT00077974|26979553|FG000|Overall Study|Withdrawal by Subject|3|||
13467280|NCT00077974|26979553|FG000|Overall Study|Lack of Efficacy|76|||
13467281|NCT00077974|26979553|FG000|Overall Study|Decision of Sponsor|2|||
13467282|NCT00077857|26979578|FG000|Overall Study|Adverse Event|30|||
13467283|NCT00077857|26979579|FG001|Overall Study|Adverse Event|32|||
13467284|NCT00077857|26979578|FG000|Overall Study|Death|7|||
13467285|NCT00077857|26979579|FG001|Overall Study|Death|3|||
13467286|NCT00077857|26979578|FG000|Overall Study|Insufficient therapeutic response|112|||
13467287|NCT00077857|26979579|FG001|Overall Study|Insufficient therapeutic response|128|||
13467288|NCT00077857|26979578|FG000|Overall Study|Violation of selection criteria at entry|3|||
13467289|NCT00077857|26979579|FG001|Overall Study|Violation of selection criteria at entry|1|||
13467290|NCT00077857|26979578|FG000|Overall Study|Other protocol violation|0|||
13467291|NCT00077857|26979579|FG001|Overall Study|Other protocol violation|1|||
13467292|NCT00077857|26979578|FG000|Overall Study|Refused treatment|29|||
13467293|NCT00077857|26979579|FG001|Overall Study|Refused treatment|21|||
13467294|NCT00077857|26979578|FG000|Overall Study|Failure to return|5|||
13467295|NCT00077857|26979579|FG001|Overall Study|Failure to return|5|||
13467296|NCT00077857|26979578|FG000|Overall Study|Other|15|||
13467297|NCT00077857|26979579|FG001|Overall Study|Other|13|||
13467298|NCT00077766|26979604|FG000|Overall Study|Adverse Event|1|||
13467299|NCT00077766|26979605|FG001|Overall Study|Adverse Event|1|||
13467300|NCT00077766|26979604|FG000|Overall Study|Withdrawal by Subject|4|||
13467301|NCT00077766|26979605|FG001|Overall Study|Withdrawal by Subject|3|||
13467302|NCT00077766|26979604|FG000|Overall Study|Death|12|||
13467303|NCT00077766|26979605|FG001|Overall Study|Death|10|||
13467304|NCT00077766|26979604|FG000|Overall Study|Lost to Follow-up|2|||
13467305|NCT00077766|26979605|FG001|Overall Study|Lost to Follow-up|0|||
13467306|NCT00077766|26979604|FG000|Overall Study|Protocol Violation|1|||
13467307|NCT00077766|26979605|FG001|Overall Study|Protocol Violation|0|||
13467308|NCT00077766|26979604|FG000|Overall Study|Kidney Transplantation|9|||
13467309|NCT00077766|26979605|FG001|Overall Study|Kidney Transplantation|5|||
13467310|NCT00077766|26979604|FG000|Overall Study|Transplantation|5|||
13467311|NCT00077766|26979605|FG001|Overall Study|Transplantation|1|||
13467312|NCT00077766|26979604|FG000|Overall Study|Investigators Discretion|1|||
13467313|NCT00077766|26979605|FG001|Overall Study|Investigators Discretion|0|||
13467314|NCT00077766|26979604|FG000|Overall Study|Participant's decision|1|||
13467315|NCT00077766|26979605|FG001|Overall Study|Participant's decision|0|||
13467316|NCT00077766|26979604|FG000|Overall Study|Dialysis Discontinued|1|||
13467317|NCT00077766|26979605|FG001|Overall Study|Dialysis Discontinued|0|||
13467318|NCT00077766|26979604|FG000|Overall Study|Dialysis|0|||
13467319|NCT00077766|26979605|FG001|Overall Study|Dialysis|1|||
13467320|NCT00077766|26979604|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0|||
13467321|NCT00077766|26979605|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1|||
13467322|NCT00077766|26979604|FG000|Overall Study|Started Nocturnal Dialysis|0|||
13467323|NCT00077766|26979605|FG001|Overall Study|Started Nocturnal Dialysis|1|||
13467324|NCT00077766|26979604|FG000|Overall Study|Stop Dialysis|0|||
13467325|NCT00077766|26979605|FG001|Overall Study|Stop Dialysis|1|||
13467326|NCT00077766|26979604|FG000|Overall Study|Participants Vacation|2|||
13467327|NCT00077766|26979605|FG001|Overall Study|Participants Vacation|1|||
13467328|NCT00077675|26979618|FG000|Overall Study|Adverse Event|1|||
13467329|NCT00077675|26979619|FG001|Overall Study|Adverse Event|2|||
13467330|NCT00077675|26979618|FG000|Overall Study|Lost to Follow-up|6|||
13467331|NCT00077675|26979619|FG001|Overall Study|Lost to Follow-up|3|||
13467332|NCT00077675|26979618|FG000|Overall Study|Withdrawal by Subject|1|||
13467333|NCT00077675|26979619|FG001|Overall Study|Withdrawal by Subject|0|||
13467334|NCT00077675|26979618|FG000|Overall Study|Other|0|||
13467335|NCT00077675|26979619|FG001|Overall Study|Other|1|||
13467336|NCT00077675|26979618|FG000|Overall Study|Never received study treatment|3|||
13467337|NCT00077675|26979619|FG001|Overall Study|Never received study treatment|3|||
13467338|NCT00077649|26979678|FG000|Overall Study|Adverse Event|5|||
13467339|NCT00077649|26979679|FG001|Overall Study|Adverse Event|1|||
13467340|NCT00077649|26979680|FG002|Overall Study|Adverse Event|7|||
13467341|NCT00077649|26979681|FG003|Overall Study|Adverse Event|9|||
13467342|NCT00077649|26979678|FG000|Overall Study|Lack of Efficacy|5|||
13467343|NCT00077649|26979679|FG001|Overall Study|Lack of Efficacy|3|||
13467344|NCT00077649|26979680|FG002|Overall Study|Lack of Efficacy|3|||
13467345|NCT00077649|26979681|FG003|Overall Study|Lack of Efficacy|2|||
13467346|NCT00077649|26979678|FG000|Overall Study|Withdrawal by Subject|0|||
13467347|NCT00077649|26979679|FG001|Overall Study|Withdrawal by Subject|1|||
13467348|NCT00077649|26979680|FG002|Overall Study|Withdrawal by Subject|1|||
13467349|NCT00077649|26979681|FG003|Overall Study|Withdrawal by Subject|2|||
13467350|NCT00077649|26979678|FG000|Overall Study|Lost to Follow-up|2|||
13467351|NCT00077649|26979679|FG001|Overall Study|Lost to Follow-up|2|||
13467352|NCT00077649|26979680|FG002|Overall Study|Lost to Follow-up|3|||
13467353|NCT00077649|26979681|FG003|Overall Study|Lost to Follow-up|2|||
13467354|NCT00077649|26979678|FG000|Overall Study|Abnormality of Laboratory Test|1|||
13467355|NCT00077649|26979679|FG001|Overall Study|Abnormality of Laboratory Test|2|||
13467356|NCT00077649|26979680|FG002|Overall Study|Abnormality of Laboratory Test|1|||
13467357|NCT00077649|26979681|FG003|Overall Study|Abnormality of Laboratory Test|2|||
13467358|NCT00077649|26979678|FG000|Overall Study|Randomized but never dosed|1|||
13467359|NCT00077649|26979679|FG001|Overall Study|Randomized but never dosed|0|||
13467360|NCT00077649|26979680|FG002|Overall Study|Randomized but never dosed|0|||
13467361|NCT00077649|26979681|FG003|Overall Study|Randomized but never dosed|0|||
13467362|NCT00077636|26979706|FG000|Overall Study|Refused Treatment|9|||
13467363|NCT00077636|26979707|FG001|Overall Study|Refused Treatment|31|||
13467364|NCT00077636|26979706|FG000|Overall Study|Admin|3|||
13467365|NCT00077636|26979707|FG001|Overall Study|Admin|3|||
13467366|NCT00077636|26979706|FG000|Overall Study|Withdrawal by Subject|2|||
13467367|NCT00077636|26979707|FG001|Overall Study|Withdrawal by Subject|2|||
13467368|NCT00077636|26979706|FG000|Overall Study|Adverse Event|17|||
13467369|NCT00077636|26979707|FG001|Overall Study|Adverse Event|34|||
13467370|NCT00077636|26979706|FG000|Overall Study|Protocol Violation|0|||
13467371|NCT00077636|26979707|FG001|Overall Study|Protocol Violation|2|||
13467372|NCT00077636|26979706|FG000|Overall Study|Lost to Follow-up|10|||
13467373|NCT00077636|26979707|FG001|Overall Study|Lost to Follow-up|18|||
13467374|NCT00077636|26979706|FG000|Overall Study|Abnormality Of Laboratory Test|3|||
13467375|NCT00077636|26979707|FG001|Overall Study|Abnormality Of Laboratory Test|2|||
13467376|NCT00077623|26979749|FG000|Overall Study|Adverse Event|1|||
13467377|NCT00077623|26979750|FG001|Overall Study|Adverse Event|0|||
13467378|NCT00077623|26979751|FG002|Overall Study|Adverse Event|1|||
13467379|NCT00077623|26979749|FG000|Overall Study|Withdrawal by Subject|2|||
13467380|NCT00077623|26979750|FG001|Overall Study|Withdrawal by Subject|10|||
13467381|NCT00077623|26979751|FG002|Overall Study|Withdrawal by Subject|1|||
13467382|NCT00077623|26979749|FG000|Overall Study|Other-Non safety reason|18|||
13467383|NCT00077623|26979750|FG001|Overall Study|Other-Non safety reason|15|||
13467384|NCT00077623|26979751|FG002|Overall Study|Other-Non safety reason|19|||
13467385|NCT00077623|26979749|FG000|Overall Study|Insufficient therapeutic response|2|||
13467386|NCT00077623|26979750|FG001|Overall Study|Insufficient therapeutic response|0|||
13467387|NCT00077623|26979751|FG002|Overall Study|Insufficient therapeutic response|0|||
13467388|NCT00077623|26979749|FG000|Overall Study|Death|12|||
13467389|NCT00077623|26979750|FG001|Overall Study|Death|18|||
13467390|NCT00077623|26979751|FG002|Overall Study|Death|11|||
13467391|NCT00077623|26979749|FG000|Overall Study|Failure to return|1|||
13467392|NCT00077623|26979750|FG001|Overall Study|Failure to return|0|||
13467393|NCT00077623|26979751|FG002|Overall Study|Failure to return|0|||
13467394|NCT00077610|26979790|FG000|Overall Study|Adverse Event|9|||
13467395|NCT00077610|26979791|FG001|Overall Study|Adverse Event|7|||
13467396|NCT00077610|26979792|FG002|Overall Study|Adverse Event|1|||
13467397|NCT00077610|26979790|FG000|Overall Study|Lost to Follow-up|0|||
13467398|NCT00077610|26979791|FG001|Overall Study|Lost to Follow-up|1|||
13467399|NCT00077610|26979792|FG002|Overall Study|Lost to Follow-up|2|||
13467400|NCT00077610|26979790|FG000|Overall Study|Withdrawal by Subject|4|||
13467401|NCT00077610|26979791|FG001|Overall Study|Withdrawal by Subject|10|||
13467402|NCT00077610|26979792|FG002|Overall Study|Withdrawal by Subject|6|||
13467403|NCT00077610|26979790|FG000|Overall Study|Death|17|||
13467404|NCT00077610|26979791|FG001|Overall Study|Death|13|||
13467405|NCT00077610|26979792|FG002|Overall Study|Death|13|||
13467406|NCT00077610|26979790|FG000|Overall Study|Renal transplant|12|||
13467407|NCT00077610|26979791|FG001|Overall Study|Renal transplant|15|||
13467408|NCT00077610|26979792|FG002|Overall Study|Renal transplant|11|||
13467409|NCT00077610|26979790|FG000|Overall Study|Withdrew from dialysis care|5|||
13467410|NCT00077610|26979791|FG001|Overall Study|Withdrew from dialysis care|0|||
13467411|NCT00077610|26979792|FG002|Overall Study|Withdrew from dialysis care|3|||
13467412|NCT00077610|26979790|FG000|Overall Study|Insufficient Therapeutic Response|1|||
13467413|NCT00077610|26979791|FG001|Overall Study|Insufficient Therapeutic Response|0|||
13467414|NCT00077610|26979792|FG002|Overall Study|Insufficient Therapeutic Response|0|||
13467415|NCT00077610|26979790|FG000|Overall Study|Multiple blood transfusions|0|||
13467416|NCT00077610|26979791|FG001|Overall Study|Multiple blood transfusions|0|||
13467417|NCT00077610|26979792|FG002|Overall Study|Multiple blood transfusions|1|||
13467418|NCT00077610|26979790|FG000|Overall Study|Principal Investigator's decision|1|||
13467419|NCT00077610|26979791|FG001|Overall Study|Principal Investigator's decision|0|||
13467420|NCT00077610|26979792|FG002|Overall Study|Principal Investigator's decision|1|||
13467421|NCT00077610|26979790|FG000|Overall Study|Worsening of health condition|1|||
13467422|NCT00077610|26979791|FG001|Overall Study|Worsening of health condition|1|||
13467423|NCT00077610|26979792|FG002|Overall Study|Worsening of health condition|0|||
13467424|NCT00077610|26979790|FG000|Overall Study|Given Epogen in hospital|1|||
13467425|NCT00077610|26979791|FG001|Overall Study|Given Epogen in hospital|0|||
13467426|NCT00077610|26979792|FG002|Overall Study|Given Epogen in hospital|0|||
13467427|NCT00077610|26979790|FG000|Overall Study|Transferred to other unit|0|||
13467428|NCT00077610|26979791|FG001|Overall Study|Transferred to other unit|0|||
13467429|NCT00077610|26979792|FG002|Overall Study|Transferred to other unit|1|||
13467430|NCT00077610|26979790|FG000|Overall Study|Transferred to nursing home|0|||
13467431|NCT00077610|26979791|FG001|Overall Study|Transferred to nursing home|0|||
13467432|NCT00077610|26979792|FG002|Overall Study|Transferred to nursing home|1|||
13467433|NCT00077610|26979790|FG000|Overall Study|Transfer to satellite unit|1|||
13467434|NCT00077610|26979791|FG001|Overall Study|Transfer to satellite unit|0|||
13467435|NCT00077610|26979792|FG002|Overall Study|Transfer to satellite unit|0|||
13467436|NCT00077610|26979790|FG000|Overall Study|Transfer to other center for surgery|1|||
13467437|NCT00077610|26979791|FG001|Overall Study|Transfer to other center for surgery|0|||
13467438|NCT00077610|26979792|FG002|Overall Study|Transfer to other center for surgery|0|||
13467439|NCT00077610|26979790|FG000|Overall Study|Change in dialysis modality|1|||
13467440|NCT00077610|26979791|FG001|Overall Study|Change in dialysis modality|0|||
13467441|NCT00077610|26979792|FG002|Overall Study|Change in dialysis modality|0|||
13467442|NCT00077610|26979790|FG000|Overall Study|Relocation|0|||
13467443|NCT00077610|26979791|FG001|Overall Study|Relocation|8|||
13467444|NCT00077610|26979792|FG002|Overall Study|Relocation|5|||
13467445|NCT00077610|26979790|FG000|Overall Study|Financial issues|0|||
13467446|NCT00077610|26979791|FG001|Overall Study|Financial issues|1|||
13467447|NCT00077610|26979792|FG002|Overall Study|Financial issues|0|||
13467448|NCT00077610|26979790|FG000|Overall Study|Sponsors decision to withdraw|0|||
13467449|NCT00077610|26979791|FG001|Overall Study|Sponsors decision to withdraw|0|||
13467450|NCT00077610|26979792|FG002|Overall Study|Sponsors decision to withdraw|1|||
13467451|NCT00077376|26979805|FG000|Overall Study|Adverse Event|8|||
13467452|NCT00077376|26979805|FG000|Overall Study|Withdrawal by Subject|2|||
13467453|NCT00077376|26979805|FG000|Overall Study|Death|1|||
13467454|NCT00077376|26979805|FG000|Overall Study|Physician Decision|1|||
13467455|NCT00077376|26979805|FG000|Overall Study|Alternative therapy|5|||
13467456|NCT00077376|26979805|FG000|Overall Study|Complicating disease|1|||
13467457|NCT00077376|26979805|FG000|Overall Study|Still on treatment|1|||
13467458|NCT00077376|26979805|FG000|Overall Study|Symptomatic deterioration|1|||
13467459|NCT00077376|26979805|FG000|Overall Study|Surgery|1|||
13467460|NCT00077376|26979805|FG000|Overall Study|Insurance ran out|1|||
13467461|NCT00077207|26979817|FG000|Overall Study|Adverse Event|5|||
13467462|NCT00077207|26979817|FG000|Overall Study|Lack of Efficacy|12|||
13467463|NCT00077207|26979817|FG000|Overall Study|Physician Decision|6|||
13467464|NCT00077207|26979817|FG000|Overall Study|Withdrawal by Subject|6|||
13467465|NCT00077207|26979817|FG000|Overall Study|Ineligible|1|||
13467466|NCT00077064|26979836|FG000|Overall Study|Adverse Event|0|||
13467467|NCT00077064|26979837|FG001|Overall Study|Adverse Event|4|||
13467468|NCT00077064|26979836|FG000|Overall Study|Patient refusal|0|||
13467469|NCT00077064|26979837|FG001|Overall Study|Patient refusal|2|||
13467470|NCT00076999|26979968|FG000|Overall Study|Adverse Event|2|||
13467471|NCT00076999|26979969|FG001|Overall Study|Adverse Event|8|||
13467472|NCT00076999|26979970|FG002|Overall Study|Adverse Event|6|||
13467473|NCT00076999|26979971|FG003|Overall Study|Adverse Event|0|||
13467474|NCT00076999|26979972|FG004|Overall Study|Adverse Event|2|||
13467475|NCT00076999|26979968|FG000|Overall Study|Protocol Violation|0|||
13467476|NCT00076999|26979969|FG001|Overall Study|Protocol Violation|3|||
13467477|NCT00076999|26979970|FG002|Overall Study|Protocol Violation|4|||
13467478|NCT00076999|26979971|FG003|Overall Study|Protocol Violation|0|||
13467479|NCT00076999|26979972|FG004|Overall Study|Protocol Violation|9|||
13467480|NCT00076999|26979968|FG000|Overall Study|Lost to Follow-up|2|||
13467481|NCT00076999|26979969|FG001|Overall Study|Lost to Follow-up|1|||
13467482|NCT00076999|26979970|FG002|Overall Study|Lost to Follow-up|0|||
13467483|NCT00076999|26979971|FG003|Overall Study|Lost to Follow-up|0|||
13467484|NCT00076999|26979972|FG004|Overall Study|Lost to Follow-up|0|||
13467485|NCT00076999|26979968|FG000|Overall Study|Withdrawal by Subject|0|||
13467486|NCT00076999|26979969|FG001|Overall Study|Withdrawal by Subject|4|||
13467487|NCT00076999|26979970|FG002|Overall Study|Withdrawal by Subject|3|||
13467488|NCT00076999|26979971|FG003|Overall Study|Withdrawal by Subject|0|||
13467489|NCT00076999|26979972|FG004|Overall Study|Withdrawal by Subject|1|||
13467490|NCT00076999|26979968|FG000|Overall Study|Other reason (not specified)|8|||
13467491|NCT00076999|26979969|FG001|Overall Study|Other reason (not specified)|8|||
13467492|NCT00076999|26979970|FG002|Overall Study|Other reason (not specified)|4|||
13467493|NCT00076999|26979971|FG003|Overall Study|Other reason (not specified)|1|||
13467494|NCT00076999|26979972|FG004|Overall Study|Other reason (not specified)|13|||
13467495|NCT00076804|26979991|FG000|Overall Study|Death|9|||
13467496|NCT00076804|26979992|FG001|Overall Study|Death|20|||
13467497|NCT00076804|26979991|FG000|Overall Study|Lost to Follow-up|9|||
13467498|NCT00076804|26979992|FG001|Overall Study|Lost to Follow-up|9|||
13467499|NCT00076804|26979991|FG000|Overall Study|Withdrawal by Subject|10|||
13467500|NCT00076804|26979992|FG001|Overall Study|Withdrawal by Subject|8|||
13467501|NCT00076804|26979991|FG000|Overall Study|Early study Closure|32|||
13467502|NCT00076804|26979992|FG001|Overall Study|Early study Closure|32|||
13467503|NCT00076752|26980013|FG000|Overall Study|Death|2|||
13467504|NCT00076752|26980013|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1|||
13467505|NCT00076570|26980028|FG000|Overall Study|Drug intolerance|8|||
13467506|NCT00076570|26980029|FG001|Overall Study|Drug intolerance|8|||
13467507|NCT00076336|26980050|FG000|Overall Study|Death|13|||
13467508|NCT00076336|26980051|FG001|Overall Study|Death|17|||
13467509|NCT00076336|26980050|FG000|Overall Study|Adverse Event|4|||
13467510|NCT00076336|26980051|FG001|Overall Study|Adverse Event|4|||
13467511|NCT00076336|26980050|FG000|Overall Study|Lost to Follow-up|4|||
13467512|NCT00076336|26980051|FG001|Overall Study|Lost to Follow-up|4|||
13467513|NCT00076336|26980050|FG000|Overall Study|Non-Compliance|2|||
13467514|NCT00076336|26980051|FG001|Overall Study|Non-Compliance|0|||
13467515|NCT00076336|26980050|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0|||
13467516|NCT00076336|26980051|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1|||
13467517|NCT00076336|26980050|FG000|Overall Study|Patient, Investigator, Sponsor request|8|||
13467518|NCT00076336|26980051|FG001|Overall Study|Patient, Investigator, Sponsor request|6|||
13467519|NCT00076336|26980050|FG000|Overall Study|Liver Transplantation|3|||
13467520|NCT00076336|26980051|FG001|Overall Study|Liver Transplantation|3|||
13467521|NCT00076336|26980050|FG000|Overall Study|Virologic Breakthrough|14|||
13467522|NCT00076336|26980051|FG001|Overall Study|Virologic Breakthrough|16|||
13467523|NCT00076336|26980050|FG000|Overall Study|Treatment failure|4|||
13467524|NCT00076336|26980051|FG001|Overall Study|Treatment failure|5|||
13467525|NCT00076102|26980065|FG000|Overall Study|Clinical progression|1|||
13467526|NCT00076102|26980065|FG000|Overall Study|Progression in pre-existing brain tumor|1|||
13467527|NCT00076102|26980065|FG000|Overall Study|plexiform neurofibroma surgery|1|||
13467528|NCT00076102|26980065|FG000|Overall Study|refusal of further therapy|2|||
13467529|NCT00076024|26980090|FG000|Phase 1, Lead-in|Lack of Efficacy|4|||
13467530|NCT00076024|26980091|FG001|Phase 1, Lead-in|Lack of Efficacy|0|||
13467531|NCT00076024|26980092|FG002|Phase 1, Lead-in|Lack of Efficacy|0|||
13467532|NCT00076024|26980093|FG003|Phase 1, Lead-in|Lack of Efficacy|0|||
13467533|NCT00076024|26980090|FG000|Phase 1, Lead-in|Adverse Event|1|||
13467534|NCT00076024|26980091|FG001|Phase 1, Lead-in|Adverse Event|0|||
13467535|NCT00076024|26980092|FG002|Phase 1, Lead-in|Adverse Event|0|||
13467536|NCT00076024|26980093|FG003|Phase 1, Lead-in|Adverse Event|0|||
13467537|NCT00076024|26980090|FG000|Phase 1, Lead-in|Clinical progression|1|||
13467538|NCT00076024|26980091|FG001|Phase 1, Lead-in|Clinical progression|0|||
13467539|NCT00076024|26980092|FG002|Phase 1, Lead-in|Clinical progression|0|||
13467540|NCT00076024|26980093|FG003|Phase 1, Lead-in|Clinical progression|0|||
13467541|NCT00076024|26980090|FG000|Phase 2, Double-blind|Lack of Efficacy|0|||
13467542|NCT00076024|26980091|FG001|Phase 2, Double-blind|Lack of Efficacy|59|||
13467543|NCT00076024|26980092|FG002|Phase 2, Double-blind|Lack of Efficacy|40|||
13467544|NCT00076024|26980093|FG003|Phase 2, Double-blind|Lack of Efficacy|0|||
13467545|NCT00076024|26980090|FG000|Phase 2, Double-blind|Withdrawal by Subject|0|||
13467546|NCT00076024|26980091|FG001|Phase 2, Double-blind|Withdrawal by Subject|13|||
13467547|NCT00076024|26980092|FG002|Phase 2, Double-blind|Withdrawal by Subject|4|||
13467548|NCT00076024|26980093|FG003|Phase 2, Double-blind|Withdrawal by Subject|0|||
13467549|NCT00076024|26980090|FG000|Phase 2, Double-blind|Adverse Event|0|||
13467550|NCT00076024|26980091|FG001|Phase 2, Double-blind|Adverse Event|25|||
13467551|NCT00076024|26980092|FG002|Phase 2, Double-blind|Adverse Event|6|||
13467552|NCT00076024|26980093|FG003|Phase 2, Double-blind|Adverse Event|0|||
13467553|NCT00076024|26980090|FG000|Phase 2, Double-blind|Un-specified|0|||
13467554|NCT00076024|26980091|FG001|Phase 2, Double-blind|Un-specified|14|||
13467555|NCT00076024|26980092|FG002|Phase 2, Double-blind|Un-specified|6|||
13467556|NCT00076024|26980093|FG003|Phase 2, Double-blind|Un-specified|0|||
13467557|NCT00076024|26980090|FG000|Phase 2, Double-blind|Randomized but not treated|0|||
13467558|NCT00076024|26980091|FG001|Phase 2, Double-blind|Randomized but not treated|1|||
13467559|NCT00076024|26980092|FG002|Phase 2, Double-blind|Randomized but not treated|0|||
13467560|NCT00076024|26980093|FG003|Phase 2, Double-blind|Randomized but not treated|0|||
13467561|NCT00076024|26980090|FG000|Phase 2, Open-label|Adverse Event|0|||
13467562|NCT00076024|26980091|FG001|Phase 2, Open-label|Adverse Event|0|||
13467563|NCT00076024|26980092|FG002|Phase 2, Open-label|Adverse Event|0|||
13467564|NCT00076024|26980093|FG003|Phase 2, Open-label|Adverse Event|2|||
13467565|NCT00076024|26980090|FG000|Phase 2, Open-label|Lack of Efficacy|0|||
13467566|NCT00076024|26980091|FG001|Phase 2, Open-label|Lack of Efficacy|0|||
13467567|NCT00076024|26980092|FG002|Phase 2, Open-label|Lack of Efficacy|0|||
13467568|NCT00076024|26980093|FG003|Phase 2, Open-label|Lack of Efficacy|11|||
13467569|NCT00076024|26980090|FG000|Phase 2, Open-label|Withdrawal by Subject|0|||
13467570|NCT00076024|26980091|FG001|Phase 2, Open-label|Withdrawal by Subject|0|||
13467571|NCT00076024|26980092|FG002|Phase 2, Open-label|Withdrawal by Subject|0|||
13467572|NCT00076024|26980093|FG003|Phase 2, Open-label|Withdrawal by Subject|1|||
13467573|NCT00076024|26980090|FG000|Phase 2, Open-label|Other|0|||
13467574|NCT00076024|26980091|FG001|Phase 2, Open-label|Other|0|||
13467575|NCT00076024|26980092|FG002|Phase 2, Open-label|Other|0|||
13467576|NCT00076024|26980093|FG003|Phase 2, Open-label|Other|2|||
13467577|NCT00076011|26980103|FG000|Overall Study|Death|1|||
13467578|NCT00076011|26980103|FG000|Overall Study|Adverse Event|10|||
13467579|NCT00076011|26980103|FG000|Overall Study|Lack of Efficacy|25|||
13467580|NCT00076011|26980103|FG000|Overall Study|Withdrawal by Subject|1|||
13467581|NCT00076011|26980103|FG000|Overall Study|Study terminated by sponsor|3|||
13467582|NCT00076011|26980103|FG000|Overall Study|Other|11|||
13467583|NCT00076011|26980103|FG000|Overall Study|Ongoing|1|||
13467584|NCT00075881|26980112|FG000|Overall Study|Lack of Efficacy|18|||
13467585|NCT00075881|26980112|FG000|Overall Study|Adverse Event|7|||
13467586|NCT00075881|26980112|FG000|Overall Study|Death|1|||
13467587|NCT00075881|26980112|FG000|Overall Study|Withdrawal by Subject|2|||
13467588|NCT00075881|26980112|FG000|Overall Study|Protocol Violation|4|||
13467589|NCT00075881|26980112|FG000|Overall Study|other complicating disease|3|||
13467590|NCT00075881|26980112|FG000|Overall Study|other|4|||
13467591|NCT00075881|26980112|FG000|Overall Study|missing data|2|||
13467592|NCT00075881|26980112|FG000|Overall Study|Ineligible|1|||
13467593|NCT00075881|26980112|FG000|Overall Study|never start protocol therapy|1|||
13467594|NCT00075764|26980131|FG000|Overall Study|Adverse Event|5|||
13467595|NCT00075764|26980132|FG001|Overall Study|Adverse Event|12|||
13467596|NCT00075764|26980131|FG000|Overall Study|Death|4|||
13467597|NCT00075764|26980132|FG001|Overall Study|Death|8|||
13467598|NCT00075764|26980131|FG000|Overall Study|Withdrawal by Subject|28|||
13467599|NCT00075764|26980132|FG001|Overall Study|Withdrawal by Subject|18|||
13467600|NCT00075764|26980131|FG000|Overall Study|Progression|269|||
13467601|NCT00075764|26980132|FG001|Overall Study|Progression|274|||
13467602|NCT00075764|26980131|FG000|Overall Study|Still on treatment|8|||
13467603|NCT00075764|26980132|FG001|Overall Study|Still on treatment|15|||
13467604|NCT00075764|26980131|FG000|Overall Study|Delinquent|4|||
13467605|NCT00075764|26980132|FG001|Overall Study|Delinquent|2|||
13467606|NCT00075764|26980131|FG000|Overall Study|Not protocol specified|27|||
13467607|NCT00075764|26980132|FG001|Overall Study|Not protocol specified|19|||
13467608|NCT00075764|26980131|FG000|Overall Study|Under review|0|||
13467609|NCT00075764|26980132|FG001|Overall Study|Under review|1|||
13467610|NCT00075725|26980258|FG000|Overall Study|Adverse Event|6|||
13467611|NCT00075725|26980259|FG001|Overall Study|Adverse Event|6|||
13467612|NCT00075725|26980260|FG002|Overall Study|Adverse Event|20|||
13467613|NCT00075725|26980261|FG003|Overall Study|Adverse Event|8|||
13467614|NCT00075725|26980262|FG004|Overall Study|Adverse Event|4|||
13467615|NCT00075725|26980263|FG005|Overall Study|Adverse Event|38|||
13467616|NCT00075725|26980264|FG006|Overall Study|Adverse Event|3|||
13467617|NCT00075725|26980265|FG007|Overall Study|Adverse Event|51|||
13467618|NCT00075725|26980266|FG008|Overall Study|Adverse Event|15|||
13467619|NCT00075725|26980267|FG009|Overall Study|Adverse Event|4|||
13467620|NCT00075725|26980268|FG010|Overall Study|Adverse Event|2|||
13467621|NCT00075725|26980269|FG011|Overall Study|Adverse Event|2|||
13467622|NCT00075725|26980258|FG000|Overall Study|Death|3|||
13467623|NCT00075725|26980259|FG001|Overall Study|Death|5|||
13467624|NCT00075725|26980260|FG002|Overall Study|Death|10|||
13467625|NCT00075725|26980261|FG003|Overall Study|Death|2|||
13467626|NCT00075725|26980262|FG004|Overall Study|Death|3|||
13467627|NCT00075725|26980263|FG005|Overall Study|Death|25|||
13467628|NCT00075725|26980264|FG006|Overall Study|Death|4|||
13467629|NCT00075725|26980265|FG007|Overall Study|Death|22|||
13467630|NCT00075725|26980266|FG008|Overall Study|Death|14|||
13467631|NCT00075725|26980267|FG009|Overall Study|Death|4|||
13467632|NCT00075725|26980268|FG010|Overall Study|Death|3|||
13467633|NCT00075725|26980269|FG011|Overall Study|Death|0|||
13467634|NCT00075725|26980258|FG000|Overall Study|Lost to Follow-up|1|||
13467635|NCT00075725|26980259|FG001|Overall Study|Lost to Follow-up|1|||
13467636|NCT00075725|26980260|FG002|Overall Study|Lost to Follow-up|4|||
13467637|NCT00075725|26980261|FG003|Overall Study|Lost to Follow-up|1|||
13467638|NCT00075725|26980262|FG004|Overall Study|Lost to Follow-up|0|||
13467639|NCT00075725|26980263|FG005|Overall Study|Lost to Follow-up|13|||
13467640|NCT00075725|26980264|FG006|Overall Study|Lost to Follow-up|2|||
13467641|NCT00075725|26980265|FG007|Overall Study|Lost to Follow-up|4|||
13467642|NCT00075725|26980266|FG008|Overall Study|Lost to Follow-up|1|||
13467643|NCT00075725|26980267|FG009|Overall Study|Lost to Follow-up|0|||
13467644|NCT00075725|26980268|FG010|Overall Study|Lost to Follow-up|0|||
13467645|NCT00075725|26980269|FG011|Overall Study|Lost to Follow-up|0|||
13467646|NCT00075725|26980258|FG000|Overall Study|Physician Decision|2|||
13467647|NCT00075725|26980259|FG001|Overall Study|Physician Decision|6|||
13467648|NCT00075725|26980260|FG002|Overall Study|Physician Decision|5|||
13467649|NCT00075725|26980261|FG003|Overall Study|Physician Decision|8|||
13467650|NCT00075725|26980262|FG004|Overall Study|Physician Decision|4|||
13467651|NCT00075725|26980263|FG005|Overall Study|Physician Decision|19|||
13467652|NCT00075725|26980264|FG006|Overall Study|Physician Decision|3|||
13467653|NCT00075725|26980265|FG007|Overall Study|Physician Decision|17|||
13467654|NCT00075725|26980266|FG008|Overall Study|Physician Decision|5|||
13467655|NCT00075725|26980267|FG009|Overall Study|Physician Decision|0|||
13467656|NCT00075725|26980268|FG010|Overall Study|Physician Decision|1|||
13467657|NCT00075725|26980269|FG011|Overall Study|Physician Decision|0|||
13467658|NCT00075725|26980258|FG000|Overall Study|Pregnancy|0|||
13467659|NCT00075725|26980259|FG001|Overall Study|Pregnancy|0|||
13467660|NCT00075725|26980260|FG002|Overall Study|Pregnancy|0|||
13467661|NCT00075725|26980261|FG003|Overall Study|Pregnancy|0|||
13467662|NCT00075725|26980262|FG004|Overall Study|Pregnancy|0|||
13467663|NCT00075725|26980263|FG005|Overall Study|Pregnancy|1|||
13467664|NCT00075725|26980264|FG006|Overall Study|Pregnancy|0|||
13467665|NCT00075725|26980265|FG007|Overall Study|Pregnancy|1|||
13467666|NCT00075725|26980266|FG008|Overall Study|Pregnancy|0|||
13467667|NCT00075725|26980267|FG009|Overall Study|Pregnancy|0|||
13467668|NCT00075725|26980268|FG010|Overall Study|Pregnancy|0|||
13467669|NCT00075725|26980269|FG011|Overall Study|Pregnancy|0|||
13467670|NCT00075725|26980258|FG000|Overall Study|Protocol Violation|1|||
13467671|NCT00075725|26980259|FG001|Overall Study|Protocol Violation|1|||
13467672|NCT00075725|26980260|FG002|Overall Study|Protocol Violation|0|||
13467673|NCT00075725|26980261|FG003|Overall Study|Protocol Violation|3|||
13467674|NCT00075725|26980262|FG004|Overall Study|Protocol Violation|3|||
13467675|NCT00075725|26980263|FG005|Overall Study|Protocol Violation|2|||
13467676|NCT00075725|26980264|FG006|Overall Study|Protocol Violation|1|||
13467677|NCT00075725|26980265|FG007|Overall Study|Protocol Violation|2|||
13467678|NCT00075725|26980266|FG008|Overall Study|Protocol Violation|3|||
13467679|NCT00075725|26980267|FG009|Overall Study|Protocol Violation|0|||
13467680|NCT00075725|26980268|FG010|Overall Study|Protocol Violation|0|||
13467681|NCT00075725|26980269|FG011|Overall Study|Protocol Violation|1|||
13467682|NCT00075725|26980258|FG000|Overall Study|Withdrawal by Subject|12|||
13467683|NCT00075725|26980259|FG001|Overall Study|Withdrawal by Subject|3|||
13467684|NCT00075725|26980260|FG002|Overall Study|Withdrawal by Subject|6|||
13467685|NCT00075725|26980261|FG003|Overall Study|Withdrawal by Subject|10|||
13467686|NCT00075725|26980262|FG004|Overall Study|Withdrawal by Subject|6|||
13467687|NCT00075725|26980263|FG005|Overall Study|Withdrawal by Subject|27|||
13467688|NCT00075725|26980264|FG006|Overall Study|Withdrawal by Subject|7|||
13467689|NCT00075725|26980265|FG007|Overall Study|Withdrawal by Subject|31|||
13467690|NCT00075725|26980266|FG008|Overall Study|Withdrawal by Subject|10|||
13467691|NCT00075725|26980267|FG009|Overall Study|Withdrawal by Subject|2|||
13467692|NCT00075725|26980268|FG010|Overall Study|Withdrawal by Subject|0|||
13467693|NCT00075725|26980269|FG011|Overall Study|Withdrawal by Subject|0|||
13467694|NCT00075725|26980258|FG000|Overall Study|Disease Progression, all other reasons|17|||
13467695|NCT00075725|26980259|FG001|Overall Study|Disease Progression, all other reasons|5|||
13467696|NCT00075725|26980260|FG002|Overall Study|Disease Progression, all other reasons|33|||
13467697|NCT00075725|26980261|FG003|Overall Study|Disease Progression, all other reasons|6|||
13467698|NCT00075725|26980262|FG004|Overall Study|Disease Progression, all other reasons|21|||
13467699|NCT00075725|26980263|FG005|Overall Study|Disease Progression, all other reasons|59|||
13467700|NCT00075725|26980264|FG006|Overall Study|Disease Progression, all other reasons|20|||
13467701|NCT00075725|26980265|FG007|Overall Study|Disease Progression, all other reasons|46|||
13467702|NCT00075725|26980266|FG008|Overall Study|Disease Progression, all other reasons|21|||
13467703|NCT00075725|26980267|FG009|Overall Study|Disease Progression, all other reasons|4|||
13467704|NCT00075725|26980268|FG010|Overall Study|Disease Progression, all other reasons|0|||
13467705|NCT00075725|26980269|FG011|Overall Study|Disease Progression, all other reasons|5|||
13467706|NCT00075725|26980258|FG000|Overall Study|Patient off treatment|0|||
13467707|NCT00075725|26980259|FG001|Overall Study|Patient off treatment|0|||
13467708|NCT00075725|26980260|FG002|Overall Study|Patient off treatment|1|||
13467709|NCT00075725|26980261|FG003|Overall Study|Patient off treatment|2|||
13467710|NCT00075725|26980262|FG004|Overall Study|Patient off treatment|1|||
13467711|NCT00075725|26980263|FG005|Overall Study|Patient off treatment|0|||
13467712|NCT00075725|26980264|FG006|Overall Study|Patient off treatment|0|||
13467713|NCT00075725|26980265|FG007|Overall Study|Patient off treatment|2|||
13467714|NCT00075725|26980266|FG008|Overall Study|Patient off treatment|1|||
13467715|NCT00075725|26980267|FG009|Overall Study|Patient off treatment|0|||
13467716|NCT00075725|26980268|FG010|Overall Study|Patient off treatment|0|||
13467717|NCT00075725|26980269|FG011|Overall Study|Patient off treatment|0|||
13467718|NCT00075725|26980258|FG000|Overall Study|Ineligible or wrong diagnosis|8|||
13467719|NCT00075725|26980259|FG001|Overall Study|Ineligible or wrong diagnosis|3|||
13467720|NCT00075725|26980260|FG002|Overall Study|Ineligible or wrong diagnosis|3|||
13467721|NCT00075725|26980261|FG003|Overall Study|Ineligible or wrong diagnosis|10|||
13467722|NCT00075725|26980262|FG004|Overall Study|Ineligible or wrong diagnosis|3|||
13467723|NCT00075725|26980263|FG005|Overall Study|Ineligible or wrong diagnosis|17|||
13467724|NCT00075725|26980264|FG006|Overall Study|Ineligible or wrong diagnosis|6|||
13467725|NCT00075725|26980265|FG007|Overall Study|Ineligible or wrong diagnosis|9|||
13467726|NCT00075725|26980266|FG008|Overall Study|Ineligible or wrong diagnosis|10|||
13467727|NCT00075725|26980267|FG009|Overall Study|Ineligible or wrong diagnosis|1|||
13467728|NCT00075725|26980268|FG010|Overall Study|Ineligible or wrong diagnosis|2|||
13467729|NCT00075725|26980269|FG011|Overall Study|Ineligible or wrong diagnosis|4|||
13467730|NCT00075725|26980258|FG000|Overall Study|Pt/Guardian refused RT therapy|1|||
13467731|NCT00075725|26980259|FG001|Overall Study|Pt/Guardian refused RT therapy|0|||
13467732|NCT00075725|26980260|FG002|Overall Study|Pt/Guardian refused RT therapy|1|||
13467733|NCT00075725|26980261|FG003|Overall Study|Pt/Guardian refused RT therapy|2|||
13467734|NCT00075725|26980262|FG004|Overall Study|Pt/Guardian refused RT therapy|1|||
13467735|NCT00075725|26980263|FG005|Overall Study|Pt/Guardian refused RT therapy|0|||
13467736|NCT00075725|26980264|FG006|Overall Study|Pt/Guardian refused RT therapy|0|||
13467737|NCT00075725|26980265|FG007|Overall Study|Pt/Guardian refused RT therapy|0|||
13467738|NCT00075725|26980266|FG008|Overall Study|Pt/Guardian refused RT therapy|0|||
13467739|NCT00075725|26980267|FG009|Overall Study|Pt/Guardian refused RT therapy|0|||
13467740|NCT00075725|26980268|FG010|Overall Study|Pt/Guardian refused RT therapy|0|||
13467741|NCT00075725|26980269|FG011|Overall Study|Pt/Guardian refused RT therapy|0|||
13467742|NCT00075725|26980258|FG000|Overall Study|Pt non compliant with therapy|2|||
13467743|NCT00075725|26980259|FG001|Overall Study|Pt non compliant with therapy|1|||
13467744|NCT00075725|26980260|FG002|Overall Study|Pt non compliant with therapy|1|||
13467745|NCT00075725|26980261|FG003|Overall Study|Pt non compliant with therapy|0|||
13467746|NCT00075725|26980262|FG004|Overall Study|Pt non compliant with therapy|2|||
13467747|NCT00075725|26980263|FG005|Overall Study|Pt non compliant with therapy|14|||
13467748|NCT00075725|26980264|FG006|Overall Study|Pt non compliant with therapy|2|||
13467749|NCT00075725|26980265|FG007|Overall Study|Pt non compliant with therapy|5|||
13467750|NCT00075725|26980266|FG008|Overall Study|Pt non compliant with therapy|3|||
13467751|NCT00075725|26980267|FG009|Overall Study|Pt non compliant with therapy|0|||
13467752|NCT00075725|26980268|FG010|Overall Study|Pt non compliant with therapy|0|||
13467753|NCT00075725|26980269|FG011|Overall Study|Pt non compliant with therapy|0|||
13467754|NCT00075725|26980258|FG000|Overall Study|Pt age out of range for treatment|0|||
13467755|NCT00075725|26980259|FG001|Overall Study|Pt age out of range for treatment|1|||
13467756|NCT00075725|26980260|FG002|Overall Study|Pt age out of range for treatment|0|||
13467757|NCT00075725|26980261|FG003|Overall Study|Pt age out of range for treatment|0|||
13467758|NCT00075725|26980262|FG004|Overall Study|Pt age out of range for treatment|0|||
13467759|NCT00075725|26980263|FG005|Overall Study|Pt age out of range for treatment|1|||
13467760|NCT00075725|26980264|FG006|Overall Study|Pt age out of range for treatment|0|||
13467761|NCT00075725|26980265|FG007|Overall Study|Pt age out of range for treatment|1|||
13467762|NCT00075725|26980266|FG008|Overall Study|Pt age out of range for treatment|0|||
13467763|NCT00075725|26980267|FG009|Overall Study|Pt age out of range for treatment|0|||
13467764|NCT00075725|26980268|FG010|Overall Study|Pt age out of range for treatment|0|||
13467765|NCT00075725|26980269|FG011|Overall Study|Pt age out of range for treatment|0|||
13467766|NCT00075725|26980258|FG000|Overall Study|Insurance issues|0|||
13467767|NCT00075725|26980259|FG001|Overall Study|Insurance issues|1|||
13467768|NCT00075725|26980260|FG002|Overall Study|Insurance issues|0|||
13467769|NCT00075725|26980261|FG003|Overall Study|Insurance issues|1|||
13467770|NCT00075725|26980262|FG004|Overall Study|Insurance issues|1|||
13467771|NCT00075725|26980263|FG005|Overall Study|Insurance issues|1|||
13467772|NCT00075725|26980264|FG006|Overall Study|Insurance issues|0|||
13467773|NCT00075725|26980265|FG007|Overall Study|Insurance issues|1|||
13467774|NCT00075725|26980266|FG008|Overall Study|Insurance issues|0|||
13467775|NCT00075725|26980267|FG009|Overall Study|Insurance issues|0|||
13467776|NCT00075725|26980268|FG010|Overall Study|Insurance issues|0|||
13467777|NCT00075725|26980269|FG011|Overall Study|Insurance issues|0|||
13467778|NCT00075725|26980258|FG000|Overall Study|MRD positive after extended ind|0|||
13467779|NCT00075725|26980259|FG001|Overall Study|MRD positive after extended ind|1|||
13467780|NCT00075725|26980260|FG002|Overall Study|MRD positive after extended ind|1|||
13467781|NCT00075725|26980261|FG003|Overall Study|MRD positive after extended ind|0|||
13467782|NCT00075725|26980262|FG004|Overall Study|MRD positive after extended ind|1|||
13467783|NCT00075725|26980263|FG005|Overall Study|MRD positive after extended ind|2|||
13467784|NCT00075725|26980264|FG006|Overall Study|MRD positive after extended ind|0|||
13467785|NCT00075725|26980265|FG007|Overall Study|MRD positive after extended ind|1|||
13467786|NCT00075725|26980266|FG008|Overall Study|MRD positive after extended ind|0|||
13467787|NCT00075725|26980267|FG009|Overall Study|MRD positive after extended ind|0|||
13467788|NCT00075725|26980268|FG010|Overall Study|MRD positive after extended ind|0|||
13467789|NCT00075725|26980269|FG011|Overall Study|MRD positive after extended ind|0|||
13467790|NCT00075725|26980258|FG000|Overall Study|Pt has very high risk ALL characteristic|15|||
13467791|NCT00075725|26980259|FG001|Overall Study|Pt has very high risk ALL characteristic|11|||
13467792|NCT00075725|26980260|FG002|Overall Study|Pt has very high risk ALL characteristic|26|||
13467793|NCT00075725|26980261|FG003|Overall Study|Pt has very high risk ALL characteristic|18|||
13467794|NCT00075725|26980262|FG004|Overall Study|Pt has very high risk ALL characteristic|11|||
13467795|NCT00075725|26980263|FG005|Overall Study|Pt has very high risk ALL characteristic|75|||
13467796|NCT00075725|26980264|FG006|Overall Study|Pt has very high risk ALL characteristic|23|||
13467797|NCT00075725|26980265|FG007|Overall Study|Pt has very high risk ALL characteristic|74|||
13467798|NCT00075725|26980266|FG008|Overall Study|Pt has very high risk ALL characteristic|29|||
13467799|NCT00075725|26980267|FG009|Overall Study|Pt has very high risk ALL characteristic|1|||
13467800|NCT00075725|26980268|FG010|Overall Study|Pt has very high risk ALL characteristic|0|||
13467801|NCT00075725|26980269|FG011|Overall Study|Pt has very high risk ALL characteristic|3|||
13467802|NCT00075725|26980258|FG000|Overall Study|Inevaluable|1|||
13467803|NCT00075725|26980259|FG001|Overall Study|Inevaluable|1|||
13467804|NCT00075725|26980260|FG002|Overall Study|Inevaluable|4|||
13467805|NCT00075725|26980261|FG003|Overall Study|Inevaluable|2|||
13467806|NCT00075725|26980262|FG004|Overall Study|Inevaluable|2|||
13467807|NCT00075725|26980263|FG005|Overall Study|Inevaluable|9|||
13467808|NCT00075725|26980264|FG006|Overall Study|Inevaluable|1|||
13467809|NCT00075725|26980265|FG007|Overall Study|Inevaluable|11|||
13467810|NCT00075725|26980266|FG008|Overall Study|Inevaluable|2|||
13467811|NCT00075725|26980267|FG009|Overall Study|Inevaluable|0|||
13467812|NCT00075725|26980268|FG010|Overall Study|Inevaluable|1|||
13467813|NCT00075725|26980269|FG011|Overall Study|Inevaluable|0|||
13467814|NCT00075725|26980258|FG000|Overall Study|Other|4|||
13467815|NCT00075725|26980259|FG001|Overall Study|Other|2|||
13467816|NCT00075725|26980260|FG002|Overall Study|Other|1|||
13467817|NCT00075725|26980261|FG003|Overall Study|Other|1|||
13467818|NCT00075725|26980262|FG004|Overall Study|Other|1|||
13467819|NCT00075725|26980263|FG005|Overall Study|Other|4|||
13467820|NCT00075725|26980264|FG006|Overall Study|Other|2|||
13467821|NCT00075725|26980265|FG007|Overall Study|Other|9|||
13467822|NCT00075725|26980266|FG008|Overall Study|Other|2|||
13467823|NCT00075725|26980267|FG009|Overall Study|Other|1|||
13467824|NCT00075725|26980268|FG010|Overall Study|Other|0|||
13467825|NCT00075725|26980269|FG011|Overall Study|Other|3|||
13467826|NCT00075725|26980258|FG000|Overall Study|Pt trying to find a BM donor|0|||
13467827|NCT00075725|26980259|FG001|Overall Study|Pt trying to find a BM donor|1|||
13467828|NCT00075725|26980260|FG002|Overall Study|Pt trying to find a BM donor|0|||
13467829|NCT00075725|26980261|FG003|Overall Study|Pt trying to find a BM donor|0|||
13467830|NCT00075725|26980262|FG004|Overall Study|Pt trying to find a BM donor|0|||
13467831|NCT00075725|26980263|FG005|Overall Study|Pt trying to find a BM donor|0|||
13467832|NCT00075725|26980264|FG006|Overall Study|Pt trying to find a BM donor|0|||
13467833|NCT00075725|26980265|FG007|Overall Study|Pt trying to find a BM donor|0|||
13467834|NCT00075725|26980266|FG008|Overall Study|Pt trying to find a BM donor|0|||
13467835|NCT00075725|26980267|FG009|Overall Study|Pt trying to find a BM donor|0|||
13467836|NCT00075725|26980268|FG010|Overall Study|Pt trying to find a BM donor|0|||
13467837|NCT00075725|26980269|FG011|Overall Study|Pt trying to find a BM donor|0|||
13467838|NCT00075725|26980258|FG000|Overall Study|Clinic chart lost unable to recreate|0|||
13467839|NCT00075725|26980259|FG001|Overall Study|Clinic chart lost unable to recreate|0|||
13467840|NCT00075725|26980260|FG002|Overall Study|Clinic chart lost unable to recreate|1|||
13467841|NCT00075725|26980261|FG003|Overall Study|Clinic chart lost unable to recreate|0|||
13467842|NCT00075725|26980262|FG004|Overall Study|Clinic chart lost unable to recreate|0|||
13467843|NCT00075725|26980263|FG005|Overall Study|Clinic chart lost unable to recreate|0|||
13467844|NCT00075725|26980264|FG006|Overall Study|Clinic chart lost unable to recreate|0|||
13467845|NCT00075725|26980265|FG007|Overall Study|Clinic chart lost unable to recreate|0|||
13467846|NCT00075725|26980266|FG008|Overall Study|Clinic chart lost unable to recreate|0|||
13467847|NCT00075725|26980267|FG009|Overall Study|Clinic chart lost unable to recreate|0|||
13467848|NCT00075725|26980268|FG010|Overall Study|Clinic chart lost unable to recreate|0|||
13467849|NCT00075725|26980269|FG011|Overall Study|Clinic chart lost unable to recreate|0|||
13467850|NCT00075725|26980258|FG000|Overall Study|Unsuccessful institutional transfer|0|||
13467851|NCT00075725|26980259|FG001|Overall Study|Unsuccessful institutional transfer|0|||
13467852|NCT00075725|26980260|FG002|Overall Study|Unsuccessful institutional transfer|2|||
13467853|NCT00075725|26980261|FG003|Overall Study|Unsuccessful institutional transfer|0|||
13467854|NCT00075725|26980262|FG004|Overall Study|Unsuccessful institutional transfer|0|||
13467855|NCT00075725|26980263|FG005|Overall Study|Unsuccessful institutional transfer|0|||
13467856|NCT00075725|26980264|FG006|Overall Study|Unsuccessful institutional transfer|0|||
13467857|NCT00075725|26980265|FG007|Overall Study|Unsuccessful institutional transfer|0|||
13467858|NCT00075725|26980266|FG008|Overall Study|Unsuccessful institutional transfer|0|||
13467859|NCT00075725|26980267|FG009|Overall Study|Unsuccessful institutional transfer|1|||
13467860|NCT00075725|26980268|FG010|Overall Study|Unsuccessful institutional transfer|0|||
13467861|NCT00075725|26980269|FG011|Overall Study|Unsuccessful institutional transfer|0|||
13467862|NCT00075725|26980258|FG000|Overall Study|specimen(s) not submitted|0|||
13467863|NCT00075725|26980259|FG001|Overall Study|specimen(s) not submitted|0|||
13467864|NCT00075725|26980260|FG002|Overall Study|specimen(s) not submitted|2|||
13467865|NCT00075725|26980261|FG003|Overall Study|specimen(s) not submitted|0|||
13467866|NCT00075725|26980262|FG004|Overall Study|specimen(s) not submitted|0|||
13467867|NCT00075725|26980263|FG005|Overall Study|specimen(s) not submitted|0|||
13467868|NCT00075725|26980264|FG006|Overall Study|specimen(s) not submitted|0|||
13467869|NCT00075725|26980265|FG007|Overall Study|specimen(s) not submitted|0|||
13467870|NCT00075725|26980266|FG008|Overall Study|specimen(s) not submitted|0|||
13467871|NCT00075725|26980267|FG009|Overall Study|specimen(s) not submitted|0|||
13467872|NCT00075725|26980268|FG010|Overall Study|specimen(s) not submitted|0|||
13467873|NCT00075725|26980269|FG011|Overall Study|specimen(s) not submitted|0|||
13467874|NCT00075725|26980258|FG000|Overall Study|Pt went to transplant|0|||
13467875|NCT00075725|26980259|FG001|Overall Study|Pt went to transplant|0|||
13467876|NCT00075725|26980260|FG002|Overall Study|Pt went to transplant|0|||
13467877|NCT00075725|26980261|FG003|Overall Study|Pt went to transplant|1|||
13467878|NCT00075725|26980262|FG004|Overall Study|Pt went to transplant|0|||
13467879|NCT00075725|26980263|FG005|Overall Study|Pt went to transplant|1|||
13467880|NCT00075725|26980264|FG006|Overall Study|Pt went to transplant|0|||
13467881|NCT00075725|26980265|FG007|Overall Study|Pt went to transplant|0|||
13467882|NCT00075725|26980266|FG008|Overall Study|Pt went to transplant|0|||
13467883|NCT00075725|26980267|FG009|Overall Study|Pt went to transplant|0|||
13467884|NCT00075725|26980268|FG010|Overall Study|Pt went to transplant|0|||
13467885|NCT00075725|26980269|FG011|Overall Study|Pt went to transplant|0|||
13467886|NCT00075725|26980258|FG000|Overall Study|Pt received additional steroids|0|||
13467887|NCT00075725|26980259|FG001|Overall Study|Pt received additional steroids|0|||
13467888|NCT00075725|26980260|FG002|Overall Study|Pt received additional steroids|0|||
13467889|NCT00075725|26980261|FG003|Overall Study|Pt received additional steroids|1|||
13467890|NCT00075725|26980262|FG004|Overall Study|Pt received additional steroids|0|||
13467891|NCT00075725|26980263|FG005|Overall Study|Pt received additional steroids|0|||
13467892|NCT00075725|26980264|FG006|Overall Study|Pt received additional steroids|0|||
13467893|NCT00075725|26980265|FG007|Overall Study|Pt received additional steroids|0|||
13467894|NCT00075725|26980266|FG008|Overall Study|Pt received additional steroids|0|||
13467895|NCT00075725|26980267|FG009|Overall Study|Pt received additional steroids|0|||
13467896|NCT00075725|26980268|FG010|Overall Study|Pt received additional steroids|0|||
13467897|NCT00075725|26980269|FG011|Overall Study|Pt received additional steroids|0|||
13467898|NCT00075725|26980258|FG000|Overall Study|Pt relocated|0|||
13467899|NCT00075725|26980259|FG001|Overall Study|Pt relocated|0|||
13467900|NCT00075725|26980260|FG002|Overall Study|Pt relocated|0|||
13467901|NCT00075725|26980261|FG003|Overall Study|Pt relocated|2|||
13467902|NCT00075725|26980262|FG004|Overall Study|Pt relocated|0|||
13467903|NCT00075725|26980263|FG005|Overall Study|Pt relocated|1|||
13467904|NCT00075725|26980264|FG006|Overall Study|Pt relocated|1|||
13467905|NCT00075725|26980265|FG007|Overall Study|Pt relocated|2|||
13467906|NCT00075725|26980266|FG008|Overall Study|Pt relocated|1|||
13467907|NCT00075725|26980267|FG009|Overall Study|Pt relocated|0|||
13467908|NCT00075725|26980268|FG010|Overall Study|Pt relocated|0|||
13467909|NCT00075725|26980269|FG011|Overall Study|Pt relocated|0|||
13467910|NCT00075725|26980258|FG000|Overall Study|Institution Terminated|0|||
13467911|NCT00075725|26980259|FG001|Overall Study|Institution Terminated|0|||
13467912|NCT00075725|26980260|FG002|Overall Study|Institution Terminated|0|||
13467913|NCT00075725|26980261|FG003|Overall Study|Institution Terminated|0|||
13467914|NCT00075725|26980262|FG004|Overall Study|Institution Terminated|1|||
13467915|NCT00075725|26980263|FG005|Overall Study|Institution Terminated|0|||
13467916|NCT00075725|26980264|FG006|Overall Study|Institution Terminated|0|||
13467917|NCT00075725|26980265|FG007|Overall Study|Institution Terminated|3|||
13467918|NCT00075725|26980266|FG008|Overall Study|Institution Terminated|0|||
13467919|NCT00075725|26980267|FG009|Overall Study|Institution Terminated|0|||
13467920|NCT00075725|26980268|FG010|Overall Study|Institution Terminated|0|||
13467921|NCT00075725|26980269|FG011|Overall Study|Institution Terminated|0|||
13467922|NCT00075725|26980258|FG000|Overall Study|Study Closure|1|||
13467923|NCT00075725|26980259|FG001|Overall Study|Study Closure|0|||
13467924|NCT00075725|26980260|FG002|Overall Study|Study Closure|0|||
13467925|NCT00075725|26980261|FG003|Overall Study|Study Closure|0|||
13467926|NCT00075725|26980262|FG004|Overall Study|Study Closure|1|||
13467927|NCT00075725|26980263|FG005|Overall Study|Study Closure|3|||
13467928|NCT00075725|26980264|FG006|Overall Study|Study Closure|0|||
13467929|NCT00075725|26980265|FG007|Overall Study|Study Closure|1|||
13467930|NCT00075725|26980266|FG008|Overall Study|Study Closure|0|||
13467931|NCT00075725|26980267|FG009|Overall Study|Study Closure|0|||
13467932|NCT00075725|26980268|FG010|Overall Study|Study Closure|0|||
13467933|NCT00075725|26980269|FG011|Overall Study|Study Closure|0|||
13467934|NCT00075725|26980258|FG000|Overall Study|Other complications|0|||
13467935|NCT00075725|26980259|FG001|Overall Study|Other complications|0|||
13467936|NCT00075725|26980260|FG002|Overall Study|Other complications|0|||
13467937|NCT00075725|26980261|FG003|Overall Study|Other complications|0|||
13467938|NCT00075725|26980262|FG004|Overall Study|Other complications|0|||
13467939|NCT00075725|26980263|FG005|Overall Study|Other complications|1|||
13467940|NCT00075725|26980264|FG006|Overall Study|Other complications|0|||
13467941|NCT00075725|26980265|FG007|Overall Study|Other complications|0|||
13467942|NCT00075725|26980266|FG008|Overall Study|Other complications|0|||
13467943|NCT00075725|26980267|FG009|Overall Study|Other complications|0|||
13467944|NCT00075725|26980268|FG010|Overall Study|Other complications|0|||
13467945|NCT00075725|26980269|FG011|Overall Study|Other complications|0|||
13467946|NCT00075725|26980258|FG000|Overall Study|Pt care terminated due to pt behavior|0|||
13467947|NCT00075725|26980259|FG001|Overall Study|Pt care terminated due to pt behavior|0|||
13467948|NCT00075725|26980260|FG002|Overall Study|Pt care terminated due to pt behavior|0|||
13467949|NCT00075725|26980261|FG003|Overall Study|Pt care terminated due to pt behavior|0|||
13467950|NCT00075725|26980262|FG004|Overall Study|Pt care terminated due to pt behavior|0|||
13467951|NCT00075725|26980263|FG005|Overall Study|Pt care terminated due to pt behavior|0|||
13467952|NCT00075725|26980264|FG006|Overall Study|Pt care terminated due to pt behavior|0|||
13467953|NCT00075725|26980265|FG007|Overall Study|Pt care terminated due to pt behavior|1|||
13467954|NCT00075725|26980266|FG008|Overall Study|Pt care terminated due to pt behavior|0|||
13467955|NCT00075725|26980267|FG009|Overall Study|Pt care terminated due to pt behavior|0|||
13467956|NCT00075725|26980268|FG010|Overall Study|Pt care terminated due to pt behavior|0|||
13467957|NCT00075725|26980269|FG011|Overall Study|Pt care terminated due to pt behavior|0|||
13467958|NCT00075725|26980258|FG000|Overall Study|Pt incarcerated|0|||
13467959|NCT00075725|26980259|FG001|Overall Study|Pt incarcerated|0|||
13467960|NCT00075725|26980260|FG002|Overall Study|Pt incarcerated|0|||
13467961|NCT00075725|26980261|FG003|Overall Study|Pt incarcerated|0|||
13467962|NCT00075725|26980262|FG004|Overall Study|Pt incarcerated|0|||
13467963|NCT00075725|26980263|FG005|Overall Study|Pt incarcerated|0|||
13467964|NCT00075725|26980264|FG006|Overall Study|Pt incarcerated|0|||
13467965|NCT00075725|26980265|FG007|Overall Study|Pt incarcerated|1|||
13467966|NCT00075725|26980266|FG008|Overall Study|Pt incarcerated|0|||
13467967|NCT00075725|26980267|FG009|Overall Study|Pt incarcerated|0|||
13467968|NCT00075725|26980268|FG010|Overall Study|Pt incarcerated|0|||
13467969|NCT00075725|26980269|FG011|Overall Study|Pt incarcerated|0|||
13467970|NCT00075582|26980288|FG000|Overall Study|Adverse Event|3|||
13467971|NCT00075582|26980289|FG001|Overall Study|Adverse Event|1|||
13467972|NCT00075582|26980288|FG000|Overall Study|Lack of Efficacy|4|||
13467973|NCT00075582|26980289|FG001|Overall Study|Lack of Efficacy|8|||
13467974|NCT00075582|26980288|FG000|Overall Study|Physician Decision|5|||
13467975|NCT00075582|26980289|FG001|Overall Study|Physician Decision|8|||
13467976|NCT00075582|26980288|FG000|Overall Study|Withdrawal by Subject|2|||
13467977|NCT00075582|26980289|FG001|Overall Study|Withdrawal by Subject|2|||
13467978|NCT00075582|26980288|FG000|Overall Study|Ineligible for study|36|||
13467979|NCT00075582|26980289|FG001|Overall Study|Ineligible for study|16|||
13467980|NCT00075504|26980306|FG000|Overall Study|Withdrawal by Subject|9|||
13467981|NCT00075504|26980307|FG001|Overall Study|Withdrawal by Subject|7|||
13467982|NCT00075478|26980334|FG000|Overall Study|not eligible|1|||
13467983|NCT00075478|26980335|FG001|Overall Study|not eligible|0|||
13467984|NCT00075478|26980334|FG000|Overall Study|Physician Decision|0|||
13467985|NCT00075478|26980335|FG001|Overall Study|Physician Decision|1|||
13467986|NCT00075400|26980351|FG000|Overall Study|Ineligible: wrong primary|1|||
13467987|NCT00075400|26980351|FG000|Overall Study|Never treated|2|||
13467988|NCT00075270|26980402|FG000|Overall Study|Withdrawal by Subject|28|||
13467989|NCT00075270|26980403|FG001|Overall Study|Withdrawal by Subject|21|||
13467990|NCT00075270|26980402|FG000|Overall Study|Lost to Follow-up|25|||
13467991|NCT00075270|26980403|FG001|Overall Study|Lost to Follow-up|28|||
13467992|NCT00075270|26980402|FG000|Overall Study|Protocol Violation|0|||
13467993|NCT00075270|26980403|FG001|Overall Study|Protocol Violation|2|||
13467994|NCT00075270|26980402|FG000|Overall Study|Death|198|||
13467995|NCT00075270|26980403|FG001|Overall Study|Death|215|||
13467996|NCT00075270|26980402|FG000|Overall Study|Other/Unknown|9|||
13467997|NCT00075270|26980403|FG001|Overall Study|Other/Unknown|5|||
13467998|NCT00075270|26980402|FG000|Overall Study|Missing|26|||
13467999|NCT00075270|26980403|FG001|Overall Study|Missing|13|||
13468000|NCT00075218|26980444|FG000|Double-Blind Treatment|Adverse Event|23|||
13468001|NCT00075218|26980445|FG001|Double-Blind Treatment|Adverse Event|4|||
13468002|NCT00075218|26980446|FG002|Double-Blind Treatment|Adverse Event|0|||
13468003|NCT00075218|26980444|FG000|Double-Blind Treatment|Withdrawal by Subject|7|||
13468004|NCT00075218|26980445|FG001|Double-Blind Treatment|Withdrawal by Subject|4|||
13468005|NCT00075218|26980446|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
13468006|NCT00075218|26980444|FG000|Double-Blind Treatment|Lost to Follow-up|1|||
13468007|NCT00075218|26980445|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
13468008|NCT00075218|26980446|FG002|Double-Blind Treatment|Lost to Follow-up|0|||
13468009|NCT00075218|26980444|FG000|Double-Blind Treatment|Lack of Efficacy|58|||
13468010|NCT00075218|26980445|FG001|Double-Blind Treatment|Lack of Efficacy|6|||
13468011|NCT00075218|26980446|FG002|Double-Blind Treatment|Lack of Efficacy|0|||
13468012|NCT00075218|26980444|FG000|Double-Blind Treatment|Decision of Sponsor|0|||
13468013|NCT00075218|26980445|FG001|Double-Blind Treatment|Decision of Sponsor|1|||
13468014|NCT00075218|26980446|FG002|Double-Blind Treatment|Decision of Sponsor|0|||
13468015|NCT00075218|26980444|FG000|Double-Blind Treatment|No study medication taken|2|||
13468016|NCT00075218|26980445|FG001|Double-Blind Treatment|No study medication taken|0|||
13468017|NCT00075218|26980446|FG002|Double-Blind Treatment|No study medication taken|0|||
13468018|NCT00075218|26980444|FG000|Open-Label Treatment|Lack of Efficacy|0|||
13468019|NCT00075218|26980445|FG001|Open-Label Treatment|Lack of Efficacy|0|||
13468020|NCT00075218|26980446|FG002|Open-Label Treatment|Lack of Efficacy|174|||
13468021|NCT00075218|26980444|FG000|Open-Label Treatment|Adverse Event|0|||
13468022|NCT00075218|26980445|FG001|Open-Label Treatment|Adverse Event|0|||
13468023|NCT00075218|26980446|FG002|Open-Label Treatment|Adverse Event|51|||
13468024|NCT00075218|26980444|FG000|Open-Label Treatment|Withdrawal by Subject|0|||
13468025|NCT00075218|26980445|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
13468026|NCT00075218|26980446|FG002|Open-Label Treatment|Withdrawal by Subject|12|||
13468027|NCT00075218|26980444|FG000|Open-Label Treatment|Decision of Sponsor|0|||
13468028|NCT00075218|26980445|FG001|Open-Label Treatment|Decision of Sponsor|0|||
13468029|NCT00075218|26980446|FG002|Open-Label Treatment|Decision of Sponsor|8|||
13468030|NCT00075218|26980444|FG000|Open-Label Treatment|Protocol Violation|0|||
13468031|NCT00075218|26980445|FG001|Open-Label Treatment|Protocol Violation|0|||
13468032|NCT00075218|26980446|FG002|Open-Label Treatment|Protocol Violation|1|||
13468033|NCT00075218|26980444|FG000|Open-Label Treatment|enrolled in a separate continuation|0|||
13468034|NCT00075218|26980445|FG001|Open-Label Treatment|enrolled in a separate continuation|0|||
13468035|NCT00075218|26980446|FG002|Open-Label Treatment|enrolled in a separate continuation|9|||
13468036|NCT00075023|26980460|FG000|Pilot Study|Physician Decision|1|||
13468037|NCT00075023|26980461|FG001|Pilot Study|Physician Decision|2|||
13468038|NCT00075023|26980460|FG000|Pilot Study|Withdrawal by Subject|1|||
13468039|NCT00075023|26980461|FG001|Pilot Study|Withdrawal by Subject|0|||
13468040|NCT00074984|26980483|FG000|Overall Study|Death|1|||
13468041|NCT00074984|26980484|FG001|Overall Study|Death|2|||
13468042|NCT00074984|26980483|FG000|Overall Study|Withdrawal by Subject|2|||
13468043|NCT00074984|26980484|FG001|Overall Study|Withdrawal by Subject|3|||
13468044|NCT00074984|26980483|FG000|Overall Study|Patient Withdrawn Per Protocol|0|||
13468045|NCT00074984|26980484|FG001|Overall Study|Patient Withdrawn Per Protocol|3|||
13468046|NCT00074958|26980491|FG000|Overall Study|Adverse Event|1|||
13468047|NCT00074711|26980514|FG000|Overall Study|Withdrawal by Subject|1|||
13468048|NCT00074711|26980515|FG001|Overall Study|Withdrawal by Subject|1|||
13468049|NCT00074711|26980514|FG000|Overall Study|Lost to Follow-up|10|||
13468050|NCT00074711|26980515|FG001|Overall Study|Lost to Follow-up|8|||
13468051|NCT00074711|26980514|FG000|Overall Study|Participant stopped study drug|4|||
13468052|NCT00074711|26980515|FG001|Overall Study|Participant stopped study drug|6|||
13468053|NCT00074581|26980530|FG000|Overall Study|Death|15|||
13468054|NCT00074581|26980531|FG001|Overall Study|Death|16|||
13468055|NCT00074581|26980530|FG000|Overall Study|Withdrawal by Subject|50|||
13468056|NCT00074581|26980531|FG001|Overall Study|Withdrawal by Subject|49|||
13468057|NCT00074581|26980530|FG000|Overall Study|Unable to adhere to visit schedule|13|||
13468058|NCT00074581|26980531|FG001|Overall Study|Unable to adhere to visit schedule|14|||
13468059|NCT00074581|26980530|FG000|Overall Study|Relocated|14|||
13468060|NCT00074581|26980531|FG001|Overall Study|Relocated|9|||
13468061|NCT00074581|26980530|FG000|Overall Study|Were withdrawn by investigator|5|||
13468062|NCT00074581|26980531|FG001|Overall Study|Were withdrawn by investigator|2|||
13468063|NCT00074581|26980530|FG000|Overall Study|Lost to Follow-up|16|||
13468064|NCT00074581|26980531|FG001|Overall Study|Lost to Follow-up|11|||
13468065|NCT00074581|26980530|FG000|Overall Study|Ended relationship w. index participant|117|||
13468066|NCT00074581|26980531|FG001|Overall Study|Ended relationship w. index participant|106|||
13468067|NCT00074581|26980530|FG000|Overall Study|Other|14|||
13468068|NCT00074581|26980531|FG001|Overall Study|Other|19|||
13468069|NCT00074490|26980580|FG000|Overall Study|Progressive malignancy|0|||
13468070|NCT00074490|26980581|FG001|Overall Study|Progressive malignancy|7|||
13468071|NCT00074490|26980582|FG002|Overall Study|Progressive malignancy|0|||
13468072|NCT00074490|26980583|FG003|Overall Study|Progressive malignancy|0|||
13468073|NCT00074490|26980584|FG004|Overall Study|Progressive malignancy|3|||
13468074|NCT00074490|26980585|FG005|Overall Study|Progressive malignancy|0|||
13468075|NCT00074412|26980606|FG000|Overall Study|Death|30|||
13468076|NCT00074412|26980607|FG001|Overall Study|Death|26|||
13468077|NCT00074412|26980606|FG000|Overall Study|Lost to Follow-up|52|||
13468078|NCT00074412|26980607|FG001|Overall Study|Lost to Follow-up|58|||
13468079|NCT00074282|26980621|FG000|Step 1|Adverse Event|32|||
13468080|NCT00074282|26980622|FG001|Step 1|Adverse Event|0|||
13468081|NCT00074282|26980623|FG002|Step 1|Adverse Event|0|||
13468082|NCT00074282|26980621|FG000|Step 1|Death|6|||
13468083|NCT00074282|26980622|FG001|Step 1|Death|0|||
13468084|NCT00074282|26980623|FG002|Step 1|Death|0|||
13468085|NCT00074282|26980621|FG000|Step 1|Withdrawal by Subject|7|||
13468086|NCT00074282|26980622|FG001|Step 1|Withdrawal by Subject|0|||
13468087|NCT00074282|26980623|FG002|Step 1|Withdrawal by Subject|0|||
13468088|NCT00074282|26980621|FG000|Step 1|Disease progression|2|||
13468089|NCT00074282|26980622|FG001|Step 1|Disease progression|0|||
13468090|NCT00074282|26980623|FG002|Step 1|Disease progression|0|||
13468091|NCT00074282|26980621|FG000|Step 1|Alternative therapy|2|||
13468092|NCT00074282|26980622|FG001|Step 1|Alternative therapy|0|||
13468093|NCT00074282|26980623|FG002|Step 1|Alternative therapy|0|||
13468094|NCT00074282|26980621|FG000|Step 1|Other complicating disease|2|||
13468095|NCT00074282|26980622|FG001|Step 1|Other complicating disease|0|||
13468096|NCT00074282|26980623|FG002|Step 1|Other complicating disease|0|||
13468097|NCT00074282|26980621|FG000|Step 1|Physician Decision|1|||
13468098|NCT00074282|26980622|FG001|Step 1|Physician Decision|0|||
13468099|NCT00074282|26980623|FG002|Step 1|Physician Decision|0|||
13468100|NCT00074282|26980621|FG000|Step 1|Ineligible|4|||
13468101|NCT00074282|26980622|FG001|Step 1|Ineligible|0|||
13468102|NCT00074282|26980623|FG002|Step 1|Ineligible|0|||
13468103|NCT00074282|26980621|FG000|Step 1|Never started treatment|2|||
13468104|NCT00074282|26980622|FG001|Step 1|Never started treatment|0|||
13468105|NCT00074282|26980623|FG002|Step 1|Never started treatment|0|||
13468106|NCT00074282|26980621|FG000|Step 2|Adverse Event|0|||
13468107|NCT00074282|26980622|FG001|Step 2|Adverse Event|2|||
13468108|NCT00074282|26980623|FG002|Step 2|Adverse Event|12|||
13468109|NCT00074282|26980621|FG000|Step 2|Disease progression|0|||
13468110|NCT00074282|26980622|FG001|Step 2|Disease progression|0|||
13468111|NCT00074282|26980623|FG002|Step 2|Disease progression|5|||
13468112|NCT00074282|26980621|FG000|Step 2|Death|0|||
13468113|NCT00074282|26980622|FG001|Step 2|Death|0|||
13468114|NCT00074282|26980623|FG002|Step 2|Death|3|||
13468115|NCT00074282|26980621|FG000|Step 2|Withdrawal by Subject|0|||
13468116|NCT00074282|26980622|FG001|Step 2|Withdrawal by Subject|0|||
13468117|NCT00074282|26980623|FG002|Step 2|Withdrawal by Subject|2|||
13468118|NCT00074282|26980621|FG000|Step 2|Physician Decision|0|||
13468119|NCT00074282|26980622|FG001|Step 2|Physician Decision|0|||
13468120|NCT00074282|26980623|FG002|Step 2|Physician Decision|1|||
13468121|NCT00074282|26980621|FG000|Step 2|Ineligible|0|||
13468122|NCT00074282|26980622|FG001|Step 2|Ineligible|0|||
13468123|NCT00074282|26980623|FG002|Step 2|Ineligible|1|||
13468124|NCT00074152|26980640|FG000|Overall Study|Death|21|||
13468125|NCT00074152|26980641|FG001|Overall Study|Death|9|||
13220004|NCT01827592|26278993|FG000|Overall Study|Withdrawal by Subject|12|||
13468126|NCT00074152|26980640|FG000|Overall Study|Lack of Efficacy|34|||
13468127|NCT00074152|26980641|FG001|Overall Study|Lack of Efficacy|24|||
13468128|NCT00073983|26980658|FG000|Overall Study|not evaluable|1|||
13468129|NCT00073918|26980667|FG000|Overall Study|Eligibility requirement not met - HAMA+|1|||
13468130|NCT00073918|26980667|FG000|Overall Study|Rapid disease progression|2|||
13468131|NCT00073918|26980667|FG000|Overall Study|Eligibility requirement not met-low CD20|1|||
13468132|NCT00073749|26980718|FG000|Overall Study|Disease Progression|2|||
13468133|NCT00073749|26980719|FG001|Overall Study|Disease Progression|0|||
13468134|NCT00073749|26980720|FG002|Overall Study|Disease Progression|3|||
13468135|NCT00073749|26980721|FG003|Overall Study|Disease Progression|2|||
13468136|NCT00073749|26980722|FG004|Overall Study|Disease Progression|3|||
13468137|NCT00073749|26980723|FG005|Overall Study|Disease Progression|1|||
13468138|NCT00073749|26980724|FG006|Overall Study|Disease Progression|3|||
13468139|NCT00073749|26980718|FG000|Overall Study|Death|0|||
13468140|NCT00073749|26980719|FG001|Overall Study|Death|1|||
13468141|NCT00073749|26980720|FG002|Overall Study|Death|1|||
13468142|NCT00073749|26980721|FG003|Overall Study|Death|0|||
13468143|NCT00073749|26980722|FG004|Overall Study|Death|0|||
13468144|NCT00073749|26980723|FG005|Overall Study|Death|0|||
13468145|NCT00073749|26980724|FG006|Overall Study|Death|29|||
13468146|NCT00073749|26980718|FG000|Overall Study|Adverse Event|0|||
13468147|NCT00073749|26980719|FG001|Overall Study|Adverse Event|3|||
13468148|NCT00073749|26980720|FG002|Overall Study|Adverse Event|6|||
13468149|NCT00073749|26980721|FG003|Overall Study|Adverse Event|4|||
13468150|NCT00073749|26980722|FG004|Overall Study|Adverse Event|2|||
13468151|NCT00073749|26980723|FG005|Overall Study|Adverse Event|1|||
13468152|NCT00073749|26980724|FG006|Overall Study|Adverse Event|0|||
13468153|NCT00073749|26980718|FG000|Overall Study|Physician Decision|0|||
13468154|NCT00073749|26980719|FG001|Overall Study|Physician Decision|0|||
13468155|NCT00073749|26980720|FG002|Overall Study|Physician Decision|1|||
13468156|NCT00073749|26980721|FG003|Overall Study|Physician Decision|0|||
13468157|NCT00073749|26980722|FG004|Overall Study|Physician Decision|0|||
13468158|NCT00073749|26980723|FG005|Overall Study|Physician Decision|2|||
13468159|NCT00073749|26980724|FG006|Overall Study|Physician Decision|0|||
13468160|NCT00073749|26980718|FG000|Overall Study|Withdrawal by Subject|0|||
13468161|NCT00073749|26980719|FG001|Overall Study|Withdrawal by Subject|1|||
13468162|NCT00073749|26980720|FG002|Overall Study|Withdrawal by Subject|0|||
13468163|NCT00073749|26980721|FG003|Overall Study|Withdrawal by Subject|0|||
13468164|NCT00073749|26980722|FG004|Overall Study|Withdrawal by Subject|1|||
13468165|NCT00073749|26980723|FG005|Overall Study|Withdrawal by Subject|0|||
13468166|NCT00073749|26980724|FG006|Overall Study|Withdrawal by Subject|2|||
13468167|NCT00073749|26980718|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
13468168|NCT00073749|26980719|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
13468169|NCT00073749|26980720|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
13468170|NCT00073749|26980721|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
13468171|NCT00073749|26980722|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
13468172|NCT00073749|26980723|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
13468173|NCT00073749|26980724|FG006|Overall Study|Discontinuation of Study by Sponsor|4|||
13468174|NCT00073749|26980718|FG000|Overall Study|Lost to Follow-up|0|||
13468175|NCT00073749|26980719|FG001|Overall Study|Lost to Follow-up|0|||
13468176|NCT00073749|26980720|FG002|Overall Study|Lost to Follow-up|0|||
13468177|NCT00073749|26980721|FG003|Overall Study|Lost to Follow-up|0|||
13468178|NCT00073749|26980722|FG004|Overall Study|Lost to Follow-up|0|||
13468179|NCT00073749|26980723|FG005|Overall Study|Lost to Follow-up|0|||
13468180|NCT00073749|26980724|FG006|Overall Study|Lost to Follow-up|2|||
13468181|NCT00073749|26980718|FG000|Overall Study|Other|0|||
13468182|NCT00073749|26980719|FG001|Overall Study|Other|0|||
13468183|NCT00073749|26980720|FG002|Overall Study|Other|0|||
13468184|NCT00073749|26980721|FG003|Overall Study|Other|0|||
13468185|NCT00073749|26980722|FG004|Overall Study|Other|0|||
13468186|NCT00073749|26980723|FG005|Overall Study|Other|2|||
13468187|NCT00073749|26980724|FG006|Overall Study|Other|0|||
13468188|NCT00073528|26980803|FG000|Overall Study|Death|488|||
13468189|NCT00073528|26980804|FG001|Overall Study|Death|473|||
13468190|NCT00073528|26980803|FG000|Overall Study|Lost to Follow-up|52|||
13468191|NCT00073528|26980804|FG001|Overall Study|Lost to Follow-up|45|||
13468192|NCT00073528|26980803|FG000|Overall Study|Withdrawal by Subject|50|||
13468193|NCT00073528|26980804|FG001|Overall Study|Withdrawal by Subject|45|||
13468194|NCT00073528|26980803|FG000|Overall Study|Study terminated by Sponsor|10|||
13468195|NCT00073528|26980804|FG001|Overall Study|Study terminated by Sponsor|29|||
13468196|NCT00073528|26980803|FG000|Overall Study|Other|18|||
13468197|NCT00073528|26980804|FG001|Overall Study|Other|19|||
13468198|NCT00073528|26980803|FG000|Overall Study|Other|9|||
13468199|NCT00073528|26980804|FG001|Overall Study|Other|12|||
13468200|NCT00073528|26980803|FG000|Overall Study|Protocol Violation|3|||
13468201|NCT00073528|26980804|FG001|Overall Study|Protocol Violation|5|||
13468202|NCT00073307|26980830|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22|||
13468203|NCT00073307|26980831|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17|||
13468204|NCT00073307|26980832|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0|||
13468205|NCT00073307|26980830|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1|||
13468206|NCT00073307|26980831|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6|||
13468207|NCT00073307|26980832|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0|||
13468208|NCT00073307|26980830|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6|||
13468209|NCT00073307|26980831|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11|||
13468210|NCT00073307|26980832|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0|||
13468211|NCT00073307|26980830|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
13468212|NCT00073307|26980831|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
13468213|NCT00073307|26980832|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0|||
13468214|NCT00073307|26980830|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1|||
13468215|NCT00073307|26980831|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2|||
13468216|NCT00073307|26980832|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0|||
13468217|NCT00073307|26980830|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1|||
13468218|NCT00073307|26980831|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
13468219|NCT00073307|26980832|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
13468220|NCT00073307|26980830|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
13468221|NCT00073307|26980831|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1|||
13468222|NCT00073307|26980832|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
13468223|NCT00073307|26980830|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165|||
13468224|NCT00073307|26980831|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114|||
13468225|NCT00073307|26980832|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0|||
13468226|NCT00073307|26980830|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
13468227|NCT00073307|26980831|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1|||
13468228|NCT00073307|26980832|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
13468229|NCT00073307|26980830|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17|||
13468230|NCT00073307|26980831|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0|||
13468231|NCT00073307|26980832|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19|||
13468232|NCT00073307|26980830|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
13468233|NCT00073307|26980831|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0|||
13468234|NCT00073307|26980832|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
13468235|NCT00073307|26980830|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19|||
13468236|NCT00073307|26980831|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0|||
13468237|NCT00073307|26980832|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9|||
13468238|NCT00073307|26980830|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37|||
13468239|NCT00073307|26980831|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0|||
13468240|NCT00073307|26980832|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28|||
13468241|NCT00073307|26980830|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
13468242|NCT00073307|26980831|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0|||
13468243|NCT00073307|26980832|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
13468244|NCT00073307|26980830|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
13468245|NCT00073307|26980831|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0|||
13468246|NCT00073307|26980832|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
13468247|NCT00073307|26980830|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
13468248|NCT00073307|26980831|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
13468249|NCT00073307|26980832|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3|||
13468250|NCT00073307|26980830|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3|||
13468251|NCT00073307|26980831|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0|||
13468252|NCT00073307|26980832|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1|||
13468253|NCT00073307|26980830|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19|||
13468254|NCT00073307|26980831|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0|||
13468255|NCT00073307|26980832|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9|||
13468256|NCT00073307|26980830|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35|||
13468257|NCT00073307|26980831|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0|||
13468258|NCT00073307|26980832|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83|||
13468259|NCT00073021|26980867|FG000|Overall Study|Protocol Violation|2|||
13468260|NCT00073021|26980868|FG001|Overall Study|Protocol Violation|1|||
13468261|NCT00073021|26980867|FG000|Overall Study|Adverse Event|4|||
13468262|NCT00073021|26980868|FG001|Overall Study|Adverse Event|4|||
13468263|NCT00073021|26980867|FG000|Overall Study|Withdrawal by Subject|6|||
13468264|NCT00073021|26980868|FG001|Overall Study|Withdrawal by Subject|5|||
13468265|NCT00073021|26980867|FG000|Overall Study|Physician Decision|3|||
13468266|NCT00073021|26980868|FG001|Overall Study|Physician Decision|1|||
13468267|NCT00073021|26980867|FG000|Overall Study|Lack of Efficacy|11|||
13468268|NCT00073021|26980868|FG001|Overall Study|Lack of Efficacy|5|||
13468269|NCT00073008|26980905|FG000|Overall Study|Missing|6|||
13468270|NCT00073008|26980906|FG001|Overall Study|Missing|6|||
13468271|NCT00073008|26980905|FG000|Overall Study|Withdrawal by Subject|2|||
13468272|NCT00073008|26980906|FG001|Overall Study|Withdrawal by Subject|2|||
13468273|NCT00073008|26980905|FG000|Overall Study|Lost to Follow-up|1|||
13468274|NCT00073008|26980906|FG001|Overall Study|Lost to Follow-up|3|||
13468275|NCT00073008|26980905|FG000|Overall Study|Death|46|||
13468276|NCT00073008|26980906|FG001|Overall Study|Death|47|||
13468277|NCT00073008|26980905|FG000|Overall Study|"Other selected on Case Report Form"|7|||
13468278|NCT00073008|26980906|FG001|Overall Study|"Other selected on Case Report Form"|5|||
13468279|NCT00072475|26980916|FG000|Overall Study|Adverse Event|44|||
13468280|NCT00072475|26980916|FG000|Overall Study|Death|3|||
13468281|NCT00072475|26980916|FG000|Overall Study|Withdrawal by Subject|46|||
13468282|NCT00072475|26980916|FG000|Overall Study|Patient/Investigator Decision|4|||
13468283|NCT00072410|26980933|FG000|Overall Study|Progressive disease|0|||
13468284|NCT00072410|26980934|FG001|Overall Study|Progressive disease|3|||
13468285|NCT00072384|26980947|FG000|Overall Study|Physician Decision|1|||
13468286|NCT00072384|26980947|FG000|Overall Study|Ineligible|8|||
13468287|NCT00072293|26980964|FG000|Overall Study|Lost to Follow-up|1|||
13468288|NCT00072293|26980965|FG001|Overall Study|Lost to Follow-up|1|||
13468289|NCT00072293|26980964|FG000|Overall Study|Withdrawal by Subject|0|||
13468290|NCT00072293|26980965|FG001|Overall Study|Withdrawal by Subject|1|||
13468291|NCT00072280|26980977|FG000|Treatment|Found ineligible|1|||
13468292|NCT00072280|26980978|FG001|Treatment|Found ineligible|2|||
13468293|NCT00072280|26980977|FG000|Follow-up|Early termination of study|2|||
13468294|NCT00072280|26980978|FG001|Follow-up|Early termination of study|2|||
13468295|NCT00072189|26980986|FG000|Overall Study|Withdrawal by Subject|1|||
13468296|NCT00072176|26981001|FG000|Overall Study|Withdrawal by Subject|1|||
13468297|NCT00072176|26981002|FG001|Overall Study|Withdrawal by Subject|0|||
13468298|NCT00072176|26981001|FG000|Overall Study|Protocol Violation|0|||
13468299|NCT00072176|26981002|FG001|Overall Study|Protocol Violation|1|||
13468300|NCT00071981|26981041|FG000|Overall Study|Lack of Efficacy|37|||
13468301|NCT00071981|26981042|FG001|Overall Study|Lack of Efficacy|29|||
13468302|NCT00071981|26981043|FG002|Overall Study|Lack of Efficacy|30|||
13468303|NCT00071981|26981044|FG003|Overall Study|Lack of Efficacy|43|||
13468304|NCT00071981|26981041|FG000|Overall Study|Adverse Event|4|||
13468305|NCT00071981|26981042|FG001|Overall Study|Adverse Event|4|||
13468306|NCT00071981|26981043|FG002|Overall Study|Adverse Event|3|||
13468307|NCT00071981|26981044|FG003|Overall Study|Adverse Event|1|||
13468308|NCT00071981|26981041|FG000|Overall Study|Death|0|||
13468309|NCT00071981|26981042|FG001|Overall Study|Death|0|||
13468310|NCT00071981|26981043|FG002|Overall Study|Death|1|||
13468311|NCT00071981|26981044|FG003|Overall Study|Death|1|||
13468312|NCT00071981|26981041|FG000|Overall Study|Withdrawal by Subject|3|||
13468313|NCT00071981|26981042|FG001|Overall Study|Withdrawal by Subject|1|||
13468314|NCT00071981|26981043|FG002|Overall Study|Withdrawal by Subject|0|||
13468315|NCT00071981|26981044|FG003|Overall Study|Withdrawal by Subject|0|||
13468316|NCT00071981|26981041|FG000|Overall Study|No protocol therapy|2|||
13468317|NCT00071981|26981042|FG001|Overall Study|No protocol therapy|5|||
13468318|NCT00071981|26981043|FG002|Overall Study|No protocol therapy|1|||
13468319|NCT00071981|26981044|FG003|Overall Study|No protocol therapy|0|||
13468320|NCT00071981|26981041|FG000|Overall Study|others (not specified in the study)|0|||
13468321|NCT00071981|26981042|FG001|Overall Study|others (not specified in the study)|2|||
13468322|NCT00071981|26981043|FG002|Overall Study|others (not specified in the study)|2|||
13468323|NCT00071981|26981044|FG003|Overall Study|others (not specified in the study)|0|||
13468324|NCT00071812|26981097|FG000|24-Week Double-Blind Period|Adverse Event|2|||
13468325|NCT00071812|26981098|FG001|24-Week Double-Blind Period|Adverse Event|3|||
13468326|NCT00071812|26981099|FG002|24-Week Double-Blind Period|Adverse Event|4|||
13468327|NCT00071812|26981100|FG003|24-Week Double-Blind Period|Adverse Event|4|||
13468328|NCT00071812|26981097|FG000|24-Week Double-Blind Period|Lack of Efficacy|3|||
13468329|NCT00071812|26981098|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
13468330|NCT00071812|26981099|FG002|24-Week Double-Blind Period|Lack of Efficacy|2|||
13468331|NCT00071812|26981100|FG003|24-Week Double-Blind Period|Lack of Efficacy|1|||
13468332|NCT00071812|26981097|FG000|24-Week Double-Blind Period|Lost to Follow-up|0|||
13468333|NCT00071812|26981098|FG001|24-Week Double-Blind Period|Lost to Follow-up|1|||
13468334|NCT00071812|26981099|FG002|24-Week Double-Blind Period|Lost to Follow-up|1|||
13468335|NCT00071812|26981100|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
13468336|NCT00071812|26981097|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5|||
13468337|NCT00071812|26981098|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1|||
13468338|NCT00071812|26981099|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1|||
13468339|NCT00071812|26981100|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5|||
13468340|NCT00071812|26981097|FG000|24-Week Double-Blind Period|Protocol Violation|0|||
13468341|NCT00071812|26981098|FG001|24-Week Double-Blind Period|Protocol Violation|0|||
13468342|NCT00071812|26981099|FG002|24-Week Double-Blind Period|Protocol Violation|0|||
13468343|NCT00071812|26981100|FG003|24-Week Double-Blind Period|Protocol Violation|1|||
13468344|NCT00071812|26981097|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
13468345|NCT00071812|26981098|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
13468346|NCT00071812|26981099|FG002|24-Week Open-Label Extension Period|Adverse Event|0|||
13468347|NCT00071812|26981100|FG003|24-Week Open-Label Extension Period|Adverse Event|7|||
13468348|NCT00071812|26981097|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
13468349|NCT00071812|26981098|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
13468350|NCT00071812|26981099|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
13468351|NCT00071812|26981100|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17|||
13468352|NCT00071812|26981097|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
13468353|NCT00071812|26981098|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
13468354|NCT00071812|26981099|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
13468355|NCT00071812|26981100|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
13468356|NCT00071812|26981097|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
13468357|NCT00071812|26981098|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
13468358|NCT00071812|26981099|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
13468359|NCT00071812|26981100|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12|||
13468360|NCT00071812|26981097|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
13468361|NCT00071812|26981098|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
13468362|NCT00071812|26981099|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1|||
13468363|NCT00071812|26981100|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
13468364|NCT00071799|26981147|FG000|Overall Study|Adverse Event|19|||
13468365|NCT00071799|26981148|FG001|Overall Study|Adverse Event|10|||
13468366|NCT00071799|26981147|FG000|Overall Study|Protocol Violation|1|||
13468367|NCT00071799|26981148|FG001|Overall Study|Protocol Violation|7|||
13468368|NCT00071799|26981147|FG000|Overall Study|Lost to Follow-up|1|||
13468369|NCT00071799|26981148|FG001|Overall Study|Lost to Follow-up|1|||
13468370|NCT00071799|26981147|FG000|Overall Study|Withdrawal by Subject|15|||
13468371|NCT00071799|26981148|FG001|Overall Study|Withdrawal by Subject|37|||
13468372|NCT00071799|26981147|FG000|Overall Study|Physician Decision|0|||
13468373|NCT00071799|26981148|FG001|Overall Study|Physician Decision|2|||
13468374|NCT00071799|26981147|FG000|Overall Study|Lack of Efficacy|11|||
13468375|NCT00071799|26981148|FG001|Overall Study|Lack of Efficacy|18|||
13468376|NCT00071799|26981147|FG000|Overall Study|Disease Progression|23|||
13468377|NCT00071799|26981148|FG001|Overall Study|Disease Progression|20|||
13468378|NCT00071799|26981147|FG000|Overall Study|Different Central+Local Pathology Review|0|||
13468379|NCT00071799|26981148|FG001|Overall Study|Different Central+Local Pathology Review|1|||
13468380|NCT00071799|26981147|FG000|Overall Study|Not Documented|0|||
13468381|NCT00071799|26981148|FG001|Overall Study|Not Documented|2|||
13468382|NCT00071760|26981209|FG000|Overall Study|Adverse Event|3|||
13468383|NCT00071760|26981209|FG000|Overall Study|Lost to Follow-up|4|||
13468384|NCT00071760|26981209|FG000|Overall Study|Protocol Violation|1|||
13468385|NCT00071760|26981209|FG000|Overall Study|Withdrawal by Subject|3|||
13468386|NCT00071760|26981209|FG000|Overall Study|Insufficient Viral Load Response|3|||
13468387|NCT00071760|26981209|FG000|Overall Study|Pulmonary Tuberculosis|1|||
13468388|NCT00071760|26981209|FG000|Overall Study|Unavailability of RTV|8|||
13468389|NCT00071760|26981209|FG000|Overall Study|Relocation|1|||
13468390|NCT00071760|26981209|FG000|Overall Study|Investigator's Recommendation (Rec.)|4|||
13468391|NCT00071760|26981209|FG000|Overall Study|Study Team Rec./Resistance|1|||
13468392|NCT00071760|26981209|FG000|Overall Study|Ongoing|25|||
13468393|NCT00071513|26981224|FG000|Intervention Component|Withdrawal by Subject|2|||
13468394|NCT00071513|26981225|FG001|Intervention Component|Withdrawal by Subject|3|||
13468395|NCT00071513|26981224|FG000|Follow-up Assessment|Withdrawal by Subject|6|||
13468396|NCT00071513|26981225|FG001|Follow-up Assessment|Withdrawal by Subject|6|||
13468397|NCT00071487|26981282|FG000|52-Week Double-Blind Period|Adverse Event|5|||
13468398|NCT00071487|26981283|FG001|52-Week Double-Blind Period|Adverse Event|8|||
13468399|NCT00071487|26981284|FG002|52-Week Double-Blind Period|Adverse Event|4|||
13468400|NCT00071487|26981285|FG003|52-Week Double-Blind Period|Adverse Event|8|||
13468401|NCT00071487|26981282|FG000|52-Week Double-Blind Period|Lack of Efficacy|1|||
13468402|NCT00071487|26981283|FG001|52-Week Double-Blind Period|Lack of Efficacy|2|||
13468403|NCT00071487|26981284|FG002|52-Week Double-Blind Period|Lack of Efficacy|0|||
13468404|NCT00071487|26981285|FG003|52-Week Double-Blind Period|Lack of Efficacy|1|||
13468405|NCT00071487|26981282|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7|||
13468406|NCT00071487|26981283|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11|||
13468407|NCT00071487|26981284|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7|||
13468408|NCT00071487|26981285|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7|||
13468409|NCT00071487|26981282|FG000|52-Week Double-Blind Period|Physician Decision|1|||
13468410|NCT00071487|26981283|FG001|52-Week Double-Blind Period|Physician Decision|0|||
13468411|NCT00071487|26981284|FG002|52-Week Double-Blind Period|Physician Decision|0|||
13468412|NCT00071487|26981285|FG003|52-Week Double-Blind Period|Physician Decision|0|||
13468413|NCT00071487|26981282|FG000|52-Week Double-Blind Period|Lost to Follow-up|0|||
13468414|NCT00071487|26981283|FG001|52-Week Double-Blind Period|Lost to Follow-up|0|||
13468415|NCT00071487|26981284|FG002|52-Week Double-Blind Period|Lost to Follow-up|2|||
13468416|NCT00071487|26981285|FG003|52-Week Double-Blind Period|Lost to Follow-up|2|||
13468417|NCT00071487|26981282|FG000|52-Week Double-Blind Period|Pregnancy|0|||
13468418|NCT00071487|26981283|FG001|52-Week Double-Blind Period|Pregnancy|1|||
13468419|NCT00071487|26981284|FG002|52-Week Double-Blind Period|Pregnancy|0|||
13468420|NCT00071487|26981285|FG003|52-Week Double-Blind Period|Pregnancy|0|||
13468421|NCT00071487|26981282|FG000|52-Week Double-Blind Period|Protocol Violation|0|||
13468422|NCT00071487|26981283|FG001|52-Week Double-Blind Period|Protocol Violation|1|||
13468423|NCT00071487|26981284|FG002|52-Week Double-Blind Period|Protocol Violation|1|||
13468424|NCT00071487|26981285|FG003|52-Week Double-Blind Period|Protocol Violation|0|||
13468425|NCT00071487|26981282|FG000|52-Week Double-Blind Period|Death|0|||
13468426|NCT00071487|26981283|FG001|52-Week Double-Blind Period|Death|1|||
13468427|NCT00071487|26981284|FG002|52-Week Double-Blind Period|Death|0|||
13468428|NCT00071487|26981285|FG003|52-Week Double-Blind Period|Death|0|||
13468429|NCT00071487|26981282|FG000|52-Week Double-Blind Period|Lack of Compliance|6|||
13468430|NCT00071487|26981283|FG001|52-Week Double-Blind Period|Lack of Compliance|3|||
13468431|NCT00071487|26981284|FG002|52-Week Double-Blind Period|Lack of Compliance|3|||
13468432|NCT00071487|26981285|FG003|52-Week Double-Blind Period|Lack of Compliance|3|||
13468433|NCT00071487|26981282|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
13468434|NCT00071487|26981283|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
13468435|NCT00071487|26981284|FG002|24-Week Open-Label Extension Period|Adverse Event|1|||
13468436|NCT00071487|26981285|FG003|24-Week Open-Label Extension Period|Adverse Event|6|||
13468437|NCT00071487|26981282|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
13468438|NCT00071487|26981283|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
13468439|NCT00071487|26981284|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
13468440|NCT00071487|26981285|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3|||
13468441|NCT00071487|26981282|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
13468442|NCT00071487|26981283|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
13468443|NCT00071487|26981284|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
13468444|NCT00071487|26981285|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9|||
13468445|NCT00071487|26981282|FG000|24-Week Open-Label Extension Period|Pregnancy|0|||
13468446|NCT00071487|26981283|FG001|24-Week Open-Label Extension Period|Pregnancy|0|||
13468447|NCT00071487|26981284|FG002|24-Week Open-Label Extension Period|Pregnancy|0|||
13468448|NCT00071487|26981285|FG003|24-Week Open-Label Extension Period|Pregnancy|1|||
13468449|NCT00071487|26981282|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
13468450|NCT00071487|26981283|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
13468451|NCT00071487|26981284|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
13468452|NCT00071487|26981285|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
13468453|NCT00071487|26981282|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
13468454|NCT00071487|26981283|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
13468455|NCT00071487|26981284|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0|||
13468456|NCT00071487|26981285|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
13468457|NCT00071396|26981291|FG000|Overall Study|Withdrawal by Subject|1|||
13468458|NCT00071396|26981291|FG000|Overall Study|Physician Decision|2|||
13468459|NCT00071110|26981310|FG000|Overall Study|Protocol Violation|0|||
13468460|NCT00071110|26981311|FG001|Overall Study|Protocol Violation|4|||
13468461|NCT00071058|26981318|FG000|Overall Study|brain tumor-removed from study|1|||
13468462|NCT00071032|26981361|FG000|Overall Study|Lost to Follow-up|1|||
13468463|NCT00071032|26981362|FG001|Overall Study|Lost to Follow-up|1|||
13468464|NCT00071032|26981361|FG000|Overall Study|Withdrawal by Subject|8|||
13468465|NCT00071032|26981362|FG001|Overall Study|Withdrawal by Subject|6|||
13468466|NCT00071032|26981361|FG000|Overall Study|Missing Primary Outcome|0|||
13468467|NCT00071032|26981362|FG001|Overall Study|Missing Primary Outcome|1|||
13468468|NCT00071006|26981374|FG000|Overall Study|Lack of Efficacy|7|||
13468469|NCT00071006|26981374|FG000|Overall Study|Adverse Event|1|||
13468470|NCT00071006|26981374|FG000|Overall Study|Withdrawal by Subject|1|||
13468471|NCT00071006|26981374|FG000|Overall Study|Other|3|||
13468472|NCT00070941|26981392|FG000|Overall Study|Adverse Event|10|||
13468473|NCT00070941|26981393|FG001|Overall Study|Adverse Event|8|||
13468474|NCT00070941|26981394|FG002|Overall Study|Adverse Event|4|||
13468475|NCT00070707|26981447|FG000|Overall Study|Adverse Event|1|||
13468476|NCT00070707|26981448|FG001|Overall Study|Adverse Event|2|||
13468477|NCT00070707|26981447|FG000|Overall Study|Lack of Efficacy|4|||
13468478|NCT00070707|26981448|FG001|Overall Study|Lack of Efficacy|1|||
13468479|NCT00070707|26981447|FG000|Overall Study|Protocol Violation|8|||
13468480|NCT00070707|26981448|FG001|Overall Study|Protocol Violation|4|||
13468481|NCT00070707|26981447|FG000|Overall Study|Unrelated to Study Medication|1|||
13468482|NCT00070707|26981448|FG001|Overall Study|Unrelated to Study Medication|0|||
13468483|NCT00070317|26981455|FG000|Overall Study|Inevaluable (Never Treated)|1|||
13468484|NCT00070317|26981455|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3|||
13468485|NCT00070317|26981455|FG000|Overall Study|Ineligible required test not done|1|||
13468486|NCT00070317|26981455|FG000|Overall Study|Ineligible-Improper prior treatment|2|||
13468487|NCT00070317|26981455|FG000|Overall Study|Ineligible-Inadequate pathology|6|||
13468488|NCT00070291|26981462|FG000|Step 1|Withdrawal by Subject|1|||
13468489|NCT00070291|26981462|FG000|Step 1|Adverse Event|1|||
13468490|NCT00070291|26981462|FG000|Step 2|Adverse Event|1|||
13468491|NCT00070109|26981506|FG000|Overall Study|Death|1|||
13468492|NCT00070109|26981507|FG001|Overall Study|Death|1|||
13468493|NCT00070109|26981508|FG002|Overall Study|Death|0|||
13468494|NCT00070109|26981509|FG003|Overall Study|Death|0|||
13468495|NCT00070109|26981510|FG004|Overall Study|Death|1|||
13468496|NCT00070109|26981506|FG000|Overall Study|Lack of Efficacy|6|||
13468497|NCT00070109|26981507|FG001|Overall Study|Lack of Efficacy|4|||
13468498|NCT00070109|26981508|FG002|Overall Study|Lack of Efficacy|5|||
13468499|NCT00070109|26981509|FG003|Overall Study|Lack of Efficacy|15|||
13468500|NCT00070109|26981510|FG004|Overall Study|Lack of Efficacy|5|||
13468501|NCT00070109|26981506|FG000|Overall Study|Physician Decision|1|||
13468502|NCT00070109|26981507|FG001|Overall Study|Physician Decision|0|||
13468503|NCT00070109|26981508|FG002|Overall Study|Physician Decision|0|||
13468504|NCT00070109|26981509|FG003|Overall Study|Physician Decision|0|||
13468505|NCT00070109|26981510|FG004|Overall Study|Physician Decision|0|||
13468506|NCT00070109|26981506|FG000|Overall Study|Withdrawal by Subject|0|||
13468507|NCT00070109|26981507|FG001|Overall Study|Withdrawal by Subject|1|||
13468508|NCT00070109|26981508|FG002|Overall Study|Withdrawal by Subject|1|||
13468509|NCT00070109|26981509|FG003|Overall Study|Withdrawal by Subject|0|||
13468510|NCT00070109|26981510|FG004|Overall Study|Withdrawal by Subject|0|||
13468511|NCT00070109|26981506|FG000|Overall Study|Adverse Event|0|||
13468512|NCT00070109|26981507|FG001|Overall Study|Adverse Event|0|||
13468513|NCT00070109|26981508|FG002|Overall Study|Adverse Event|2|||
13468514|NCT00070109|26981509|FG003|Overall Study|Adverse Event|4|||
13468515|NCT00070109|26981510|FG004|Overall Study|Adverse Event|2|||
13468516|NCT00070109|26981506|FG000|Overall Study|removed from prot thpy prior to chemo|0|||
13468517|NCT00070109|26981507|FG001|Overall Study|removed from prot thpy prior to chemo|0|||
13468518|NCT00070109|26981508|FG002|Overall Study|removed from prot thpy prior to chemo|0|||
13468519|NCT00070109|26981509|FG003|Overall Study|removed from prot thpy prior to chemo|1|||
13468520|NCT00070109|26981510|FG004|Overall Study|removed from prot thpy prior to chemo|0|||
13468521|NCT00069953|26981516|FG000|Overall Study|Protocol Violation|2|||
13468522|NCT00069823|26981563|FG000|Overall Study|Did not have follow-up diary cards|6|||
13468523|NCT00069823|26981564|FG001|Overall Study|Did not have follow-up diary cards|3|||
13468524|NCT00069784|26981589|FG000|Overall Study|Adverse Event|105|||
13468525|NCT00069784|26981590|FG001|Overall Study|Adverse Event|0|||
13468526|NCT00069784|26981589|FG000|Overall Study|Withdrawal by Subject|1090|||
13468527|NCT00069784|26981590|FG001|Overall Study|Withdrawal by Subject|0|||
13468528|NCT00069784|26981589|FG000|Overall Study|Other|17|||
13468529|NCT00069784|26981590|FG001|Overall Study|Other|0|||
13468530|NCT00069641|26981625|FG000|Overall Study|Death|1|||
13468531|NCT00069641|26981626|FG001|Overall Study|Death|0|||
13468532|NCT00069641|26981627|FG002|Overall Study|Death|1|||
13468533|NCT00069576|26981684|FG000|Original Trial|Lost to Follow-up|25|||
13468534|NCT00069576|26981685|FG001|Original Trial|Lost to Follow-up|33|||
13468535|NCT00069576|26981684|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196|||
13468536|NCT00069576|26981685|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204|||
13468537|NCT00069277|26981691|FG000|Overall Study|Adverse Event|3|||
13468538|NCT00069277|26981691|FG000|Overall Study|Withdrawal by Subject|1|||
13468539|NCT00069277|26981691|FG000|Overall Study|Progressive Disease|15|||
13468540|NCT00069277|26981691|FG000|Overall Study|Physician Decision|2|||
13468541|NCT00069264|26981697|FG000|Overall Study|Adverse Event|3|||
13468542|NCT00069264|26981697|FG000|Overall Study|Progressive Disease|23|||
13468543|NCT00069264|26981697|FG000|Overall Study|Withdrawal by Subject|3|||
13468544|NCT00069264|26981697|FG000|Overall Study|Discon Therapy|3|||
13468545|NCT00069121|26981724|FG000|Overall Study|Death|286|||
13468546|NCT00069121|26981725|FG001|Overall Study|Death|242|||
13468547|NCT00069121|26981724|FG000|Overall Study|Withdrawal by Subject|18|||
13468548|NCT00069121|26981725|FG001|Overall Study|Withdrawal by Subject|20|||
13468549|NCT00069121|26981724|FG000|Overall Study|Lost to Follow-up|63|||
13468550|NCT00069121|26981725|FG001|Overall Study|Lost to Follow-up|63|||
13468551|NCT00069108|26981758|FG000|Overall Study|Withdrawal by Subject|5|||
13468552|NCT00069108|26981759|FG001|Overall Study|Withdrawal by Subject|9|||
13468553|NCT00069108|26981758|FG000|Overall Study|Adverse Event|64|||
13468554|NCT00069108|26981759|FG001|Overall Study|Adverse Event|42|||
13468555|NCT00069108|26981758|FG000|Overall Study|Death|6|||
13468556|NCT00069108|26981759|FG001|Overall Study|Death|6|||
13468557|NCT00069108|26981758|FG000|Overall Study|Administration|15|||
13468558|NCT00069108|26981759|FG001|Overall Study|Administration|4|||
13468559|NCT00069108|26981758|FG000|Overall Study|Insufficient therapy|117|||
13468560|NCT00069108|26981759|FG001|Overall Study|Insufficient therapy|144|||
13468561|NCT00069108|26981758|FG000|Overall Study|Violation criteria|1|||
13468562|NCT00069108|26981759|FG001|Overall Study|Violation criteria|4|||
13468563|NCT00069108|26981758|FG000|Overall Study|Refused treatment|5|||
13468564|NCT00069108|26981759|FG001|Overall Study|Refused treatment|10|||
13468565|NCT00069095|26981830|FG000|Primary Treatment Phase|Ongoing|0|||
13468566|NCT00069095|26981831|FG001|Primary Treatment Phase|Ongoing|0|||
13468567|NCT00069095|26981832|FG002|Primary Treatment Phase|Ongoing|5|||
13468568|NCT00069095|26981833|FG003|Primary Treatment Phase|Ongoing|7|||
13468569|NCT00069095|26981834|FG004|Primary Treatment Phase|Ongoing|7|||
13468570|NCT00069095|26981835|FG005|Primary Treatment Phase|Ongoing|4|||
13468571|NCT00069095|26981830|FG000|Primary Treatment Phase|Admin/Other|29|||
13468572|NCT00069095|26981831|FG001|Primary Treatment Phase|Admin/Other|38|||
13468573|NCT00069095|26981832|FG002|Primary Treatment Phase|Admin/Other|31|||
13468574|NCT00069095|26981833|FG003|Primary Treatment Phase|Admin/Other|45|||
13468575|NCT00069095|26981834|FG004|Primary Treatment Phase|Admin/Other|48|||
13468576|NCT00069095|26981835|FG005|Primary Treatment Phase|Admin/Other|42|||
13468577|NCT00069095|26981830|FG000|Primary Treatment Phase|Adverse Event|99|||
13468578|NCT00069095|26981831|FG001|Primary Treatment Phase|Adverse Event|92|||
13468579|NCT00069095|26981832|FG002|Primary Treatment Phase|Adverse Event|71|||
13468580|NCT00069095|26981833|FG003|Primary Treatment Phase|Adverse Event|72|||
13468581|NCT00069095|26981834|FG004|Primary Treatment Phase|Adverse Event|109|||
13468582|NCT00069095|26981835|FG005|Primary Treatment Phase|Adverse Event|101|||
13468583|NCT00069095|26981830|FG000|Primary Treatment Phase|Death|14|||
13468584|NCT00069095|26981831|FG001|Primary Treatment Phase|Death|8|||
13468585|NCT00069095|26981832|FG002|Primary Treatment Phase|Death|2|||
13468586|NCT00069095|26981833|FG003|Primary Treatment Phase|Death|5|||
13468587|NCT00069095|26981834|FG004|Primary Treatment Phase|Death|8|||
13468588|NCT00069095|26981835|FG005|Primary Treatment Phase|Death|8|||
13468589|NCT00069095|26981830|FG000|Primary Treatment Phase|Failure to return|5|||
13468590|NCT00069095|26981831|FG001|Primary Treatment Phase|Failure to return|5|||
13468591|NCT00069095|26981832|FG002|Primary Treatment Phase|Failure to return|0|||
13468592|NCT00069095|26981833|FG003|Primary Treatment Phase|Failure to return|0|||
13468593|NCT00069095|26981834|FG004|Primary Treatment Phase|Failure to return|0|||
13468594|NCT00069095|26981835|FG005|Primary Treatment Phase|Failure to return|2|||
13468595|NCT00069095|26981830|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131|||
13468596|NCT00069095|26981831|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127|||
13468597|NCT00069095|26981832|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175|||
13468598|NCT00069095|26981833|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154|||
13468599|NCT00069095|26981834|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101|||
13468600|NCT00069095|26981835|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102|||
13468601|NCT00069095|26981830|FG000|Primary Treatment Phase|Refused treatment|15|||
13468602|NCT00069095|26981831|FG001|Primary Treatment Phase|Refused treatment|26|||
13468603|NCT00069095|26981832|FG002|Primary Treatment Phase|Refused treatment|17|||
13468604|NCT00069095|26981833|FG003|Primary Treatment Phase|Refused treatment|31|||
13468605|NCT00069095|26981834|FG004|Primary Treatment Phase|Refused treatment|24|||
13468606|NCT00069095|26981835|FG005|Primary Treatment Phase|Refused treatment|27|||
13468607|NCT00069095|26981830|FG000|Primary Treatment Phase|Withdrew|2|||
13468608|NCT00069095|26981831|FG001|Primary Treatment Phase|Withdrew|3|||
13468609|NCT00069095|26981832|FG002|Primary Treatment Phase|Withdrew|8|||
13468610|NCT00069095|26981833|FG003|Primary Treatment Phase|Withdrew|2|||
13468611|NCT00069095|26981834|FG004|Primary Treatment Phase|Withdrew|4|||
13468612|NCT00069095|26981835|FG005|Primary Treatment Phase|Withdrew|9|||
13468613|NCT00069095|26981830|FG000|Primary Treatment Phase|Other Violation|0|||
13468614|NCT00069095|26981831|FG001|Primary Treatment Phase|Other Violation|1|||
13468615|NCT00069095|26981832|FG002|Primary Treatment Phase|Other Violation|1|||
13468616|NCT00069095|26981833|FG003|Primary Treatment Phase|Other Violation|1|||
13468617|NCT00069095|26981834|FG004|Primary Treatment Phase|Other Violation|0|||
13468618|NCT00069095|26981835|FG005|Primary Treatment Phase|Other Violation|1|||
13468619|NCT00069095|26981830|FG000|Primary Treatment Phase|Violation criteria|0|||
13468620|NCT00069095|26981831|FG001|Primary Treatment Phase|Violation criteria|2|||
13468621|NCT00069095|26981832|FG002|Primary Treatment Phase|Violation criteria|4|||
13468622|NCT00069095|26981833|FG003|Primary Treatment Phase|Violation criteria|3|||
13468623|NCT00069095|26981834|FG004|Primary Treatment Phase|Violation criteria|1|||
13468624|NCT00069095|26981835|FG005|Primary Treatment Phase|Violation criteria|5|||
13468625|NCT00069095|26981830|FG000|Post-study Treatment Phase|Missing reason|1|||
13468626|NCT00069095|26981831|FG001|Post-study Treatment Phase|Missing reason|3|||
13468627|NCT00069095|26981832|FG002|Post-study Treatment Phase|Missing reason|12|||
13468628|NCT00069095|26981833|FG003|Post-study Treatment Phase|Missing reason|8|||
13468629|NCT00069095|26981834|FG004|Post-study Treatment Phase|Missing reason|18|||
13468630|NCT00069095|26981835|FG005|Post-study Treatment Phase|Missing reason|17|||
13468631|NCT00069095|26981830|FG000|Post-study Treatment Phase|Adverse Event|2|||
13468632|NCT00069095|26981831|FG001|Post-study Treatment Phase|Adverse Event|3|||
13468633|NCT00069095|26981832|FG002|Post-study Treatment Phase|Adverse Event|1|||
13468634|NCT00069095|26981833|FG003|Post-study Treatment Phase|Adverse Event|0|||
13468635|NCT00069095|26981834|FG004|Post-study Treatment Phase|Adverse Event|5|||
13468636|NCT00069095|26981835|FG005|Post-study Treatment Phase|Adverse Event|1|||
13468637|NCT00069095|26981830|FG000|Post-study Treatment Phase|Eligible for surgery|2|||
13468638|NCT00069095|26981831|FG001|Post-study Treatment Phase|Eligible for surgery|0|||
13468639|NCT00069095|26981832|FG002|Post-study Treatment Phase|Eligible for surgery|0|||
13468640|NCT00069095|26981833|FG003|Post-study Treatment Phase|Eligible for surgery|0|||
13468641|NCT00069095|26981834|FG004|Post-study Treatment Phase|Eligible for surgery|0|||
13468642|NCT00069095|26981835|FG005|Post-study Treatment Phase|Eligible for surgery|0|||
13468643|NCT00069095|26981830|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1|||
13468644|NCT00069095|26981831|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4|||
13468645|NCT00069095|26981832|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5|||
13468646|NCT00069095|26981833|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6|||
13468647|NCT00069095|26981834|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7|||
13468648|NCT00069095|26981835|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9|||
13468649|NCT00069095|26981830|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
13468650|NCT00069095|26981831|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
13468651|NCT00069095|26981832|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
13468652|NCT00069095|26981833|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
13468653|NCT00069095|26981834|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
13468654|NCT00069095|26981835|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
13468655|NCT00069095|26981830|FG000|Post-study Treatment Phase|Participant had complete response|1|||
13468656|NCT00069095|26981831|FG001|Post-study Treatment Phase|Participant had complete response|1|||
13468657|NCT00069095|26981832|FG002|Post-study Treatment Phase|Participant had complete response|0|||
13468658|NCT00069095|26981833|FG003|Post-study Treatment Phase|Participant had complete response|0|||
13468659|NCT00069095|26981834|FG004|Post-study Treatment Phase|Participant had complete response|0|||
13468660|NCT00069095|26981835|FG005|Post-study Treatment Phase|Participant had complete response|0|||
13468661|NCT00069095|26981830|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
13468662|NCT00069095|26981831|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1|||
13468663|NCT00069095|26981832|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
13468664|NCT00069095|26981833|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
13468665|NCT00069095|26981834|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
13468666|NCT00069095|26981835|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
13468667|NCT00069095|26981830|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
13468668|NCT00069095|26981831|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
13468669|NCT00069095|26981832|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
13468670|NCT00069095|26981833|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
13468671|NCT00069095|26981834|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
13468672|NCT00069095|26981835|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
13468673|NCT00069095|26981830|FG000|Post-study Treatment Phase|Participant withdrew consent|0|||
13468674|NCT00069095|26981831|FG001|Post-study Treatment Phase|Participant withdrew consent|0|||
13468675|NCT00069095|26981832|FG002|Post-study Treatment Phase|Participant withdrew consent|1|||
13468676|NCT00069095|26981833|FG003|Post-study Treatment Phase|Participant withdrew consent|0|||
13468677|NCT00069095|26981834|FG004|Post-study Treatment Phase|Participant withdrew consent|0|||
13468678|NCT00069095|26981835|FG005|Post-study Treatment Phase|Participant withdrew consent|0|||
13468679|NCT00069095|26981830|FG000|Post-study Treatment Phase|Participant will start new treatment|0|||
13468680|NCT00069095|26981831|FG001|Post-study Treatment Phase|Participant will start new treatment|0|||
13468681|NCT00069095|26981832|FG002|Post-study Treatment Phase|Participant will start new treatment|1|||
13468682|NCT00069095|26981833|FG003|Post-study Treatment Phase|Participant will start new treatment|0|||
13468683|NCT00069095|26981834|FG004|Post-study Treatment Phase|Participant will start new treatment|0|||
13468684|NCT00069095|26981835|FG005|Post-study Treatment Phase|Participant will start new treatment|0|||
13468685|NCT00069095|26981830|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0|||
13468686|NCT00069095|26981831|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0|||
13468687|NCT00069095|26981832|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0|||
13468688|NCT00069095|26981833|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1|||
13468689|NCT00069095|26981834|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0|||
13468690|NCT00069095|26981835|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0|||
13468691|NCT00069095|26981830|FG000|Post-study Treatment Phase|Participant completed treatment|0|||
13468692|NCT00069095|26981831|FG001|Post-study Treatment Phase|Participant completed treatment|0|||
13468693|NCT00069095|26981832|FG002|Post-study Treatment Phase|Participant completed treatment|0|||
13468694|NCT00069095|26981833|FG003|Post-study Treatment Phase|Participant completed treatment|1|||
13468695|NCT00069095|26981834|FG004|Post-study Treatment Phase|Participant completed treatment|0|||
13468696|NCT00069095|26981835|FG005|Post-study Treatment Phase|Participant completed treatment|0|||
13468697|NCT00069095|26981830|FG000|Post-study Treatment Phase|Surgery|0|||
13468698|NCT00069095|26981831|FG001|Post-study Treatment Phase|Surgery|0|||
13468699|NCT00069095|26981832|FG002|Post-study Treatment Phase|Surgery|0|||
13468700|NCT00069095|26981833|FG003|Post-study Treatment Phase|Surgery|1|||
13468701|NCT00069095|26981834|FG004|Post-study Treatment Phase|Surgery|1|||
13468702|NCT00069095|26981835|FG005|Post-study Treatment Phase|Surgery|0|||
13468703|NCT00069095|26981830|FG000|Post-study Treatment Phase|Death|0|||
13468704|NCT00069095|26981831|FG001|Post-study Treatment Phase|Death|0|||
13468705|NCT00069095|26981832|FG002|Post-study Treatment Phase|Death|0|||
13468706|NCT00069095|26981833|FG003|Post-study Treatment Phase|Death|0|||
13468707|NCT00069095|26981834|FG004|Post-study Treatment Phase|Death|1|||
13468708|NCT00069095|26981835|FG005|Post-study Treatment Phase|Death|0|||
13468709|NCT00069095|26981830|FG000|Post-study Treatment Phase|Participant had progressive disease|0|||
13468710|NCT00069095|26981831|FG001|Post-study Treatment Phase|Participant had progressive disease|0|||
13468711|NCT00069095|26981832|FG002|Post-study Treatment Phase|Participant had progressive disease|0|||
13468712|NCT00069095|26981833|FG003|Post-study Treatment Phase|Participant had progressive disease|0|||
13468713|NCT00069095|26981834|FG004|Post-study Treatment Phase|Participant had progressive disease|1|||
13468714|NCT00069095|26981835|FG005|Post-study Treatment Phase|Participant had progressive disease|0|||
13468715|NCT00069095|26981830|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
13468716|NCT00069095|26981831|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
13468717|NCT00069095|26981832|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
13468718|NCT00069095|26981833|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
13468719|NCT00069095|26981834|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1|||
13468720|NCT00069095|26981835|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
13468721|NCT00069095|26981830|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
13468722|NCT00069095|26981831|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
13468723|NCT00069095|26981832|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
13468724|NCT00069095|26981833|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
13468725|NCT00069095|26981834|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1|||
13468726|NCT00069095|26981835|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
13468727|NCT00069095|26981830|FG000|Post-study Treatment Phase|Investigator decision|0|||
13468728|NCT00069095|26981831|FG001|Post-study Treatment Phase|Investigator decision|0|||
13468729|NCT00069095|26981832|FG002|Post-study Treatment Phase|Investigator decision|0|||
13468730|NCT00069095|26981833|FG003|Post-study Treatment Phase|Investigator decision|0|||
13468731|NCT00069095|26981834|FG004|Post-study Treatment Phase|Investigator decision|0|||
13468732|NCT00069095|26981835|FG005|Post-study Treatment Phase|Investigator decision|1|||
13468733|NCT00069095|26981830|FG000|Follow-up Phase|Death|174|||
13468734|NCT00069095|26981831|FG001|Follow-up Phase|Death|206|||
13468735|NCT00069095|26981832|FG002|Follow-up Phase|Death|120|||
13468736|NCT00069095|26981833|FG003|Follow-up Phase|Death|112|||
13468737|NCT00069095|26981834|FG004|Follow-up Phase|Death|92|||
13468738|NCT00069095|26981835|FG005|Follow-up Phase|Death|101|||
13468739|NCT00068822|26981852|FG000|First Randomized Intervention|Lost to Follow-up|1|||
13468740|NCT00068822|26981853|FG001|First Randomized Intervention|Lost to Follow-up|2|||
13468741|NCT00068692|26981889|FG000|Step 1: Registration|Disese progression/relapse|5|||
13468742|NCT00068692|26981890|FG001|Step 1: Registration|Disese progression/relapse|0|||
13468743|NCT00068692|26981891|FG002|Step 1: Registration|Disese progression/relapse|0|||
13468744|NCT00068692|26981892|FG003|Step 1: Registration|Disese progression/relapse|0|||
13468745|NCT00068692|26981893|FG004|Step 1: Registration|Disese progression/relapse|0|||
13468746|NCT00068692|26981894|FG005|Step 1: Registration|Disese progression/relapse|0|||
13468747|NCT00068692|26981895|FG006|Step 1: Registration|Disese progression/relapse|0|||
13468748|NCT00068692|26981896|FG007|Step 1: Registration|Disese progression/relapse|0|||
13468749|NCT00068692|26981889|FG000|Step 1: Registration|Adverse Event|7|||
13468750|NCT00068692|26981890|FG001|Step 1: Registration|Adverse Event|0|||
13468751|NCT00068692|26981891|FG002|Step 1: Registration|Adverse Event|0|||
13468752|NCT00068692|26981892|FG003|Step 1: Registration|Adverse Event|0|||
13468753|NCT00068692|26981893|FG004|Step 1: Registration|Adverse Event|0|||
13468754|NCT00068692|26981894|FG005|Step 1: Registration|Adverse Event|0|||
13468755|NCT00068692|26981895|FG006|Step 1: Registration|Adverse Event|0|||
13468756|NCT00068692|26981896|FG007|Step 1: Registration|Adverse Event|0|||
13468757|NCT00068692|26981889|FG000|Step 1: Registration|Death|1|||
13468758|NCT00068692|26981890|FG001|Step 1: Registration|Death|0|||
13468759|NCT00068692|26981891|FG002|Step 1: Registration|Death|0|||
13468760|NCT00068692|26981892|FG003|Step 1: Registration|Death|0|||
13468761|NCT00068692|26981893|FG004|Step 1: Registration|Death|0|||
13468762|NCT00068692|26981894|FG005|Step 1: Registration|Death|0|||
13468763|NCT00068692|26981895|FG006|Step 1: Registration|Death|0|||
13468764|NCT00068692|26981896|FG007|Step 1: Registration|Death|0|||
13468765|NCT00068692|26981889|FG000|Step 1: Registration|Withdrawal by Subject|11|||
13468766|NCT00068692|26981890|FG001|Step 1: Registration|Withdrawal by Subject|0|||
13468767|NCT00068692|26981891|FG002|Step 1: Registration|Withdrawal by Subject|0|||
13468768|NCT00068692|26981892|FG003|Step 1: Registration|Withdrawal by Subject|0|||
13468769|NCT00068692|26981893|FG004|Step 1: Registration|Withdrawal by Subject|0|||
13468770|NCT00068692|26981894|FG005|Step 1: Registration|Withdrawal by Subject|0|||
13468771|NCT00068692|26981895|FG006|Step 1: Registration|Withdrawal by Subject|0|||
13468772|NCT00068692|26981896|FG007|Step 1: Registration|Withdrawal by Subject|0|||
13468773|NCT00068692|26981889|FG000|Step 1: Registration|Alternative therapy|2|||
13468774|NCT00068692|26981890|FG001|Step 1: Registration|Alternative therapy|0|||
13468775|NCT00068692|26981891|FG002|Step 1: Registration|Alternative therapy|0|||
13468776|NCT00068692|26981892|FG003|Step 1: Registration|Alternative therapy|0|||
13468777|NCT00068692|26981893|FG004|Step 1: Registration|Alternative therapy|0|||
13468778|NCT00068692|26981894|FG005|Step 1: Registration|Alternative therapy|0|||
13468779|NCT00068692|26981895|FG006|Step 1: Registration|Alternative therapy|0|||
13468780|NCT00068692|26981896|FG007|Step 1: Registration|Alternative therapy|0|||
13468781|NCT00068692|26981889|FG000|Step 1: Registration|Complicating disease|2|||
13468782|NCT00068692|26981890|FG001|Step 1: Registration|Complicating disease|0|||
13468783|NCT00068692|26981891|FG002|Step 1: Registration|Complicating disease|0|||
13468784|NCT00068692|26981892|FG003|Step 1: Registration|Complicating disease|0|||
13468785|NCT00068692|26981893|FG004|Step 1: Registration|Complicating disease|0|||
13468786|NCT00068692|26981894|FG005|Step 1: Registration|Complicating disease|0|||
13468787|NCT00068692|26981895|FG006|Step 1: Registration|Complicating disease|0|||
13468788|NCT00068692|26981896|FG007|Step 1: Registration|Complicating disease|0|||
13468789|NCT00068692|26981889|FG000|Step 1: Registration|Protocol Violation|1|||
13468790|NCT00068692|26981890|FG001|Step 1: Registration|Protocol Violation|0|||
13468791|NCT00068692|26981891|FG002|Step 1: Registration|Protocol Violation|0|||
13468792|NCT00068692|26981892|FG003|Step 1: Registration|Protocol Violation|0|||
13468793|NCT00068692|26981893|FG004|Step 1: Registration|Protocol Violation|0|||
13468794|NCT00068692|26981894|FG005|Step 1: Registration|Protocol Violation|0|||
13468795|NCT00068692|26981895|FG006|Step 1: Registration|Protocol Violation|0|||
13468796|NCT00068692|26981896|FG007|Step 1: Registration|Protocol Violation|0|||
13468797|NCT00068692|26981889|FG000|Step 1: Registration|Not eligible|6|||
13468798|NCT00068692|26981890|FG001|Step 1: Registration|Not eligible|0|||
13468799|NCT00068692|26981891|FG002|Step 1: Registration|Not eligible|0|||
13468800|NCT00068692|26981892|FG003|Step 1: Registration|Not eligible|0|||
13468801|NCT00068692|26981893|FG004|Step 1: Registration|Not eligible|0|||
13468802|NCT00068692|26981894|FG005|Step 1: Registration|Not eligible|0|||
13468803|NCT00068692|26981895|FG006|Step 1: Registration|Not eligible|0|||
13468804|NCT00068692|26981896|FG007|Step 1: Registration|Not eligible|0|||
13468805|NCT00068692|26981889|FG000|Step 1: Registration|Other|2|||
13468806|NCT00068692|26981890|FG001|Step 1: Registration|Other|0|||
13468807|NCT00068692|26981891|FG002|Step 1: Registration|Other|0|||
13468808|NCT00068692|26981892|FG003|Step 1: Registration|Other|0|||
13468809|NCT00068692|26981893|FG004|Step 1: Registration|Other|0|||
13468810|NCT00068692|26981894|FG005|Step 1: Registration|Other|0|||
13468811|NCT00068692|26981895|FG006|Step 1: Registration|Other|0|||
13468812|NCT00068692|26981896|FG007|Step 1: Registration|Other|0|||
13468813|NCT00068692|26981889|FG000|Step 1: Registration|Not start protocol therapy|3|||
13468814|NCT00068692|26981890|FG001|Step 1: Registration|Not start protocol therapy|0|||
13468815|NCT00068692|26981891|FG002|Step 1: Registration|Not start protocol therapy|0|||
13468816|NCT00068692|26981892|FG003|Step 1: Registration|Not start protocol therapy|0|||
13468817|NCT00068692|26981893|FG004|Step 1: Registration|Not start protocol therapy|0|||
13468818|NCT00068692|26981894|FG005|Step 1: Registration|Not start protocol therapy|0|||
13468819|NCT00068692|26981895|FG006|Step 1: Registration|Not start protocol therapy|0|||
13468820|NCT00068692|26981896|FG007|Step 1: Registration|Not start protocol therapy|0|||
13468821|NCT00068692|26981889|FG000|Step 1: Registration|Registered but not randomized|0|||
13468822|NCT00068692|26981890|FG001|Step 1: Registration|Registered but not randomized|1|||
13468823|NCT00068692|26981891|FG002|Step 1: Registration|Registered but not randomized|0|||
13468824|NCT00068692|26981892|FG003|Step 1: Registration|Registered but not randomized|0|||
13468825|NCT00068692|26981893|FG004|Step 1: Registration|Registered but not randomized|0|||
13468826|NCT00068692|26981894|FG005|Step 1: Registration|Registered but not randomized|0|||
13468827|NCT00068692|26981895|FG006|Step 1: Registration|Registered but not randomized|0|||
13468828|NCT00068692|26981896|FG007|Step 1: Registration|Registered but not randomized|0|||
13468829|NCT00068692|26981889|FG000|Step 2: Randomization|Disesae progression/replase|0|||
13468830|NCT00068692|26981890|FG001|Step 2: Randomization|Disesae progression/replase|0|||
13468831|NCT00068692|26981891|FG002|Step 2: Randomization|Disesae progression/replase|1|||
13468832|NCT00068692|26981892|FG003|Step 2: Randomization|Disesae progression/replase|1|||
13468833|NCT00068692|26981893|FG004|Step 2: Randomization|Disesae progression/replase|0|||
13468834|NCT00068692|26981894|FG005|Step 2: Randomization|Disesae progression/replase|0|||
13468835|NCT00068692|26981895|FG006|Step 2: Randomization|Disesae progression/replase|0|||
13468836|NCT00068692|26981896|FG007|Step 2: Randomization|Disesae progression/replase|0|||
13468837|NCT00068692|26981889|FG000|Step 2: Randomization|Adverse Event|0|||
13468838|NCT00068692|26981890|FG001|Step 2: Randomization|Adverse Event|0|||
13468839|NCT00068692|26981891|FG002|Step 2: Randomization|Adverse Event|4|||
13468840|NCT00068692|26981892|FG003|Step 2: Randomization|Adverse Event|2|||
13468841|NCT00068692|26981893|FG004|Step 2: Randomization|Adverse Event|2|||
13468842|NCT00068692|26981894|FG005|Step 2: Randomization|Adverse Event|3|||
13468843|NCT00068692|26981895|FG006|Step 2: Randomization|Adverse Event|4|||
13468844|NCT00068692|26981896|FG007|Step 2: Randomization|Adverse Event|4|||
13468845|NCT00068692|26981889|FG000|Step 2: Randomization|Death|0|||
13468846|NCT00068692|26981890|FG001|Step 2: Randomization|Death|0|||
13468847|NCT00068692|26981891|FG002|Step 2: Randomization|Death|0|||
13468848|NCT00068692|26981892|FG003|Step 2: Randomization|Death|0|||
13468849|NCT00068692|26981893|FG004|Step 2: Randomization|Death|1|||
13468850|NCT00068692|26981894|FG005|Step 2: Randomization|Death|0|||
13468851|NCT00068692|26981895|FG006|Step 2: Randomization|Death|0|||
13468852|NCT00068692|26981896|FG007|Step 2: Randomization|Death|1|||
13468853|NCT00068692|26981889|FG000|Step 2: Randomization|Withdrawal by Subject|0|||
13468854|NCT00068692|26981890|FG001|Step 2: Randomization|Withdrawal by Subject|0|||
13468855|NCT00068692|26981891|FG002|Step 2: Randomization|Withdrawal by Subject|4|||
13468856|NCT00068692|26981892|FG003|Step 2: Randomization|Withdrawal by Subject|6|||
13468857|NCT00068692|26981893|FG004|Step 2: Randomization|Withdrawal by Subject|3|||
13468858|NCT00068692|26981894|FG005|Step 2: Randomization|Withdrawal by Subject|2|||
13468859|NCT00068692|26981895|FG006|Step 2: Randomization|Withdrawal by Subject|0|||
13468860|NCT00068692|26981896|FG007|Step 2: Randomization|Withdrawal by Subject|3|||
13468861|NCT00068692|26981889|FG000|Step 2: Randomization|alternative therapy|0|||
13468862|NCT00068692|26981890|FG001|Step 2: Randomization|alternative therapy|0|||
13468863|NCT00068692|26981891|FG002|Step 2: Randomization|alternative therapy|0|||
13468864|NCT00068692|26981892|FG003|Step 2: Randomization|alternative therapy|1|||
13468865|NCT00068692|26981893|FG004|Step 2: Randomization|alternative therapy|1|||
13468866|NCT00068692|26981894|FG005|Step 2: Randomization|alternative therapy|0|||
13468867|NCT00068692|26981895|FG006|Step 2: Randomization|alternative therapy|0|||
13468868|NCT00068692|26981896|FG007|Step 2: Randomization|alternative therapy|0|||
13468869|NCT00068692|26981889|FG000|Step 2: Randomization|Physician Decision|0|||
13468870|NCT00068692|26981890|FG001|Step 2: Randomization|Physician Decision|0|||
13468871|NCT00068692|26981891|FG002|Step 2: Randomization|Physician Decision|0|||
13468872|NCT00068692|26981892|FG003|Step 2: Randomization|Physician Decision|1|||
13468873|NCT00068692|26981893|FG004|Step 2: Randomization|Physician Decision|1|||
13468874|NCT00068692|26981894|FG005|Step 2: Randomization|Physician Decision|0|||
13468875|NCT00068692|26981895|FG006|Step 2: Randomization|Physician Decision|0|||
13468876|NCT00068692|26981896|FG007|Step 2: Randomization|Physician Decision|0|||
13468877|NCT00068692|26981889|FG000|Step 2: Randomization|Other|0|||
13468878|NCT00068692|26981890|FG001|Step 2: Randomization|Other|0|||
13468879|NCT00068692|26981891|FG002|Step 2: Randomization|Other|0|||
13468880|NCT00068692|26981892|FG003|Step 2: Randomization|Other|1|||
13468881|NCT00068692|26981893|FG004|Step 2: Randomization|Other|0|||
13468882|NCT00068692|26981894|FG005|Step 2: Randomization|Other|1|||
13468883|NCT00068692|26981895|FG006|Step 2: Randomization|Other|0|||
13468884|NCT00068692|26981896|FG007|Step 2: Randomization|Other|0|||
13468885|NCT00068692|26981889|FG000|Step 2: Randomization|never start protocol therapy|0|||
13468886|NCT00068692|26981890|FG001|Step 2: Randomization|never start protocol therapy|0|||
13468887|NCT00068692|26981891|FG002|Step 2: Randomization|never start protocol therapy|1|||
13468888|NCT00068692|26981892|FG003|Step 2: Randomization|never start protocol therapy|0|||
13468889|NCT00068692|26981893|FG004|Step 2: Randomization|never start protocol therapy|1|||
13468890|NCT00068692|26981894|FG005|Step 2: Randomization|never start protocol therapy|0|||
13468891|NCT00068692|26981895|FG006|Step 2: Randomization|never start protocol therapy|0|||
13468892|NCT00068692|26981896|FG007|Step 2: Randomization|never start protocol therapy|0|||
13468893|NCT00068601|26981913|FG000|Overall Study|Ineligible|11|||
13468894|NCT00068601|26981914|FG001|Overall Study|Ineligible|13|||
13468895|NCT00068601|26981913|FG000|Overall Study|Not evaluable: withdrew consent|5|||
13468896|NCT00068601|26981914|FG001|Overall Study|Not evaluable: withdrew consent|4|||
13468897|NCT00068601|26981913|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2|||
13468898|NCT00068601|26981914|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4|||
13468899|NCT00068601|26981913|FG000|Overall Study|Death|11|||
13468900|NCT00068601|26981914|FG001|Overall Study|Death|3|||
13468901|NCT00068601|26981913|FG000|Overall Study|Lost to Follow-up|3|||
13468902|NCT00068601|26981914|FG001|Overall Study|Lost to Follow-up|2|||
13468903|NCT00068601|26981913|FG000|Overall Study|Missing primary outcome data|30|||
13468904|NCT00068601|26981914|FG001|Overall Study|Missing primary outcome data|34|||
13468905|NCT00068588|26981934|FG000|Overall Study|Adverse Event|0|||
13468906|NCT00068588|26981935|FG001|Overall Study|Adverse Event|0|||
13468907|NCT00068588|26981936|FG002|Overall Study|Adverse Event|2|||
13468908|NCT00068588|26981934|FG000|Overall Study|Withdrawal by Subject|0|||
13468909|NCT00068588|26981935|FG001|Overall Study|Withdrawal by Subject|0|||
13468910|NCT00068588|26981936|FG002|Overall Study|Withdrawal by Subject|1|||
13468911|NCT00068588|26981934|FG000|Overall Study|Poor KPS|0|||
13468912|NCT00068588|26981935|FG001|Overall Study|Poor KPS|0|||
13468913|NCT00068588|26981936|FG002|Overall Study|Poor KPS|1|||
13468914|NCT00068445|26981967|FG000|Randomization|Cancel|1|||
13468915|NCT00068445|26981968|FG001|Randomization|Cancel|3|||
13468916|NCT00068445|26981967|FG000|Randomization|Ineligible|1|||
13468917|NCT00068445|26981968|FG001|Randomization|Ineligible|1|||
13468918|NCT00068445|26981967|FG000|Treatment|Refused Further Treatment|13|||
13468919|NCT00068445|26981968|FG001|Treatment|Refused Further Treatment|10|||
13468920|NCT00068445|26981967|FG000|Treatment|Adverse Event|7|||
13468921|NCT00068445|26981968|FG001|Treatment|Adverse Event|1|||
13468922|NCT00068445|26981967|FG000|Treatment|Other (Specifics not available)|9|||
13468923|NCT00068445|26981968|FG001|Treatment|Other (Specifics not available)|5|||
13468924|NCT00068419|26981979|FG000|Overall Study|Adverse Event|3|||
13468925|NCT00068419|26981979|FG000|Overall Study|Lack of Efficacy|24|||
13468926|NCT00068419|26981979|FG000|Overall Study|Lost to Follow-up|1|||
13468927|NCT00068419|26981979|FG000|Overall Study|Physician Decision|7|||
13468928|NCT00068419|26981979|FG000|Overall Study|Withdrawal by Subject|14|||
13468929|NCT00068419|26981979|FG000|Overall Study|Ineligible|11|||
13468930|NCT00068406|26981986|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1|||
13468931|NCT00068406|26981986|FG000|Overall Study|Ineligible-Inadequate Pathology|2|||
13468932|NCT00068393|26981994|FG000|Overall Study|Adverse Event|2|||
13468933|NCT00068393|26981994|FG000|Overall Study|Death|3|||
13468934|NCT00068393|26981994|FG000|Overall Study|Withdrawal by Subject|3|||
13468935|NCT00068393|26981994|FG000|Overall Study|Alternative treatment|1|||
13468936|NCT00068393|26981994|FG000|Overall Study|Quality of life worsening|1|||
13468937|NCT00068380|26982005|FG000|Overall Study|Withdrawal by Subject|3|||
13468938|NCT00068380|26982005|FG000|Overall Study|Adverse Event|2|||
13468939|NCT00068250|26982026|FG000|Phase I: Dose Level 2|Protocol Violation|0|||
13468940|NCT00068250|26982027|FG001|Phase I: Dose Level 2|Protocol Violation|1|||
13468941|NCT00068250|26982028|FG002|Phase I: Dose Level 2|Protocol Violation|0|||
13468942|NCT00068250|26982029|FG003|Phase I: Dose Level 2|Protocol Violation|0|||
13468943|NCT00068237|26982043|FG000|Overall Study|Ineligible|3|||
13468944|NCT00068237|26982043|FG000|Overall Study|No protocol treatment received|2|||
13468945|NCT00068107|26982056|FG000|Overall Study|end-stage renal disease|6|||
13468946|NCT00068107|26982056|FG000|Overall Study|Death|2|||
13468947|NCT00068107|26982056|FG000|Overall Study|Withdrawal by Subject|1|||
13468948|NCT00067990|26982071|FG000|Overall Study|Death|5|||
13468949|NCT00067990|26982072|FG001|Overall Study|Death|7|||
13468950|NCT00067990|26982071|FG000|Overall Study|ESRD, Non IF/TA|1|||
13468951|NCT00067990|26982072|FG001|Overall Study|ESRD, Non IF/TA|3|||
13468952|NCT00067990|26982071|FG000|Overall Study|Withdrawal by Subject|4|||
13468953|NCT00067990|26982072|FG001|Overall Study|Withdrawal by Subject|12|||
13468954|NCT00067470|26982089|FG000|Overall Study|Withdrawal by Subject|0|||
13468955|NCT00067470|26982090|FG001|Overall Study|Withdrawal by Subject|1|||
13468956|NCT00067002|26982111|FG000|Overall Study|Early Death|1|||
13468957|NCT00067002|26982112|FG001|Overall Study|Early Death|2|||
13468958|NCT00067002|26982111|FG000|Overall Study|Delayed|1|||
13468959|NCT00067002|26982112|FG001|Overall Study|Delayed|1|||
13468960|NCT00067002|26982111|FG000|Overall Study|Graft Failure|5|||
13468961|NCT00067002|26982112|FG001|Overall Study|Graft Failure|6|||
13468962|NCT00066807|26982131|FG000|Overall Study|Study was terminated early|14|||
13468963|NCT00066807|26982132|FG001|Overall Study|Study was terminated early|15|||
13468964|NCT00066742|26982141|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1|||
13468965|NCT00066742|26982141|FG000|Induction Chemoradiotherapy|Adverse Event|21|||
13468966|NCT00066742|26982141|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2|||
13468967|NCT00066742|26982141|FG000|Induction Chemoradiotherapy|not protocol specified|2|||
13468968|NCT00066742|26982141|FG000|Induction Chemoradiotherapy|Ineligible|3|||
13468969|NCT00066742|26982141|FG000|Consolidation Chemotherapy|not protocol specified|1|||
13468970|NCT00066742|26982141|FG000|Consolidation Chemotherapy|Ineligible|2|||
13468971|NCT00066729|26982152|FG000|Overall Study|Lost to Follow-up|1|||
13468972|NCT00066729|26982152|FG000|Overall Study|Disease progression|1|||
13468973|NCT00066703|26982171|FG000|Overall Study|Adverse Event|80|||
13468974|NCT00066703|26982172|FG001|Overall Study|Adverse Event|111|||
13468975|NCT00066703|26982171|FG000|Overall Study|Death|3|||
13468976|NCT00066703|26982172|FG001|Overall Study|Death|0|||
13468977|NCT00066703|26982171|FG000|Overall Study|Lack of Efficacy|114|||
13468978|NCT00066703|26982172|FG001|Overall Study|Lack of Efficacy|69|||
13468979|NCT00066703|26982171|FG000|Overall Study|Lost to Follow-up|31|||
13468980|NCT00066703|26982172|FG001|Overall Study|Lost to Follow-up|28|||
13468981|NCT00066703|26982171|FG000|Overall Study|Withdrawal by Subject|38|||
13468982|NCT00066703|26982172|FG001|Overall Study|Withdrawal by Subject|63|||
13468983|NCT00066703|26982171|FG000|Overall Study|Treatment ongoing|346|||
13468984|NCT00066703|26982172|FG001|Overall Study|Treatment ongoing|311|||
13468985|NCT00066690|26982199|FG000|Overall Study|Adverse Event|145|||
13468986|NCT00066690|26982200|FG001|Overall Study|Adverse Event|58|||
13468987|NCT00066690|26982201|FG002|Overall Study|Adverse Event|126|||
13468988|NCT00066690|26982199|FG000|Overall Study|Death|3|||
13468989|NCT00066690|26982200|FG001|Overall Study|Death|0|||
13468990|NCT00066690|26982201|FG002|Overall Study|Death|2|||
13468991|NCT00066690|26982199|FG000|Overall Study|Lack of Efficacy|114|||
13468992|NCT00066690|26982200|FG001|Overall Study|Lack of Efficacy|110|||
13468993|NCT00066690|26982201|FG002|Overall Study|Lack of Efficacy|76|||
13468994|NCT00066690|26982199|FG000|Overall Study|Lost to Follow-up|40|||
13468995|NCT00066690|26982200|FG001|Overall Study|Lost to Follow-up|21|||
13468996|NCT00066690|26982201|FG002|Overall Study|Lost to Follow-up|29|||
13468997|NCT00066690|26982199|FG000|Overall Study|Withdrawal by Subject|50|||
13468998|NCT00066690|26982200|FG001|Overall Study|Withdrawal by Subject|55|||
13468999|NCT00066690|26982201|FG002|Overall Study|Withdrawal by Subject|49|||
13469000|NCT00066690|26982199|FG000|Overall Study|Treatment Ongoing|246|||
13469001|NCT00066690|26982200|FG001|Overall Study|Treatment Ongoing|278|||
13469002|NCT00066690|26982201|FG002|Overall Study|Treatment Ongoing|282|||
13469003|NCT00066573|26982220|FG000|Overall Study|Did not received protocol treatment|28|||
13469004|NCT00066573|26982221|FG001|Overall Study|Did not received protocol treatment|28|||
13469005|NCT00066469|26982227|FG000|Overall Study|Death|3|||
13469006|NCT00066469|26982227|FG000|Overall Study|Lack of Efficacy|9|||
13469007|NCT00066469|26982227|FG000|Overall Study|Lost to Follow-up|1|||
13469008|NCT00066469|26982227|FG000|Overall Study|Physician Decision|1|||
13469009|NCT00066469|26982227|FG000|Overall Study|Withdrawal by Subject|1|||
13469010|NCT00066469|26982227|FG000|Overall Study|ineligible|1|||
13469011|NCT00066365|26982262|FG000|Overall Study|Adverse Event|1|||
13469012|NCT00066365|26982263|FG001|Overall Study|Adverse Event|0|||
13469013|NCT00066365|26982262|FG000|Overall Study|Lack of Efficacy|15|||
13469014|NCT00066365|26982263|FG001|Overall Study|Lack of Efficacy|12|||
13469015|NCT00066365|26982262|FG000|Overall Study|Physician Decision|1|||
13469016|NCT00066365|26982263|FG001|Overall Study|Physician Decision|0|||
13469017|NCT00066365|26982262|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2|||
13469018|NCT00066365|26982263|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0|||
13469019|NCT00066365|26982262|FG000|Overall Study|Ineligible|4|||
13469020|NCT00066365|26982263|FG001|Overall Study|Ineligible|2|||
13469021|NCT00066222|26982274|FG000|Overall Study|No protocol treatment received|1|||
13469022|NCT00066170|26982297|FG000|Overall Study|Adverse Event|2|||
13469023|NCT00066170|26982298|FG001|Overall Study|Adverse Event|4|||
13469024|NCT00066170|26982299|FG002|Overall Study|Adverse Event|1|||
13469025|NCT00066170|26982300|FG003|Overall Study|Adverse Event|7|||
13469026|NCT00066170|26982297|FG000|Overall Study|Serious Adverse Event|0|||
13469027|NCT00066170|26982298|FG001|Overall Study|Serious Adverse Event|0|||
13469028|NCT00066170|26982299|FG002|Overall Study|Serious Adverse Event|1|||
13469029|NCT00066170|26982300|FG003|Overall Study|Serious Adverse Event|1|||
13469030|NCT00066170|26982297|FG000|Overall Study|Lost to Follow-up|0|||
13469031|NCT00066170|26982298|FG001|Overall Study|Lost to Follow-up|1|||
13469032|NCT00066170|26982299|FG002|Overall Study|Lost to Follow-up|0|||
13469033|NCT00066170|26982300|FG003|Overall Study|Lost to Follow-up|0|||
13469034|NCT00066170|26982297|FG000|Overall Study|Non-Compliance with Trial Medicine|1|||
13469035|NCT00066170|26982298|FG001|Overall Study|Non-Compliance with Trial Medicine|0|||
13469036|NCT00066170|26982299|FG002|Overall Study|Non-Compliance with Trial Medicine|0|||
13469037|NCT00066170|26982300|FG003|Overall Study|Non-Compliance with Trial Medicine|1|||
13469038|NCT00066170|26982297|FG000|Overall Study|Protocol Violation|3|||
13469039|NCT00066170|26982298|FG001|Overall Study|Protocol Violation|0|||
13469040|NCT00066170|26982299|FG002|Overall Study|Protocol Violation|0|||
13469041|NCT00066170|26982300|FG003|Overall Study|Protocol Violation|0|||
13469042|NCT00066170|26982297|FG000|Overall Study|Other|1|||
13469043|NCT00066170|26982298|FG001|Overall Study|Other|5|||
13469044|NCT00066170|26982299|FG002|Overall Study|Other|2|||
13469045|NCT00066170|26982300|FG003|Overall Study|Other|0|||
13469046|NCT00066066|26982327|FG000|Overall Study|Lost to Follow-up|6|||
13469047|NCT00066066|26982328|FG001|Overall Study|Lost to Follow-up|4|||
13469048|NCT00066066|26982329|FG002|Overall Study|Lost to Follow-up|7|||
13469049|NCT00066066|26982330|FG003|Overall Study|Lost to Follow-up|4|||
13469050|NCT00066066|26982331|FG004|Overall Study|Lost to Follow-up|3|||
13469051|NCT00066066|26982332|FG005|Overall Study|Lost to Follow-up|5|||
13469052|NCT00065507|26982401|FG000|Overall Study|Death|16|||
13469053|NCT00065507|26982402|FG001|Overall Study|Death|17|||
13469054|NCT00065507|26982401|FG000|Overall Study|Adverse Event|4|||
13469055|NCT00065507|26982402|FG001|Overall Study|Adverse Event|3|||
13469056|NCT00065507|26982401|FG000|Overall Study|Lack of Efficacy|0|||
13469057|NCT00065507|26982402|FG001|Overall Study|Lack of Efficacy|6|||
13469058|NCT00065507|26982401|FG000|Overall Study|Poor/Non-compliance|3|||
13469059|NCT00065507|26982402|FG001|Overall Study|Poor/Non-compliance|2|||
13469060|NCT00065507|26982401|FG000|Overall Study|Lost to Follow-up|3|||
13469061|NCT00065507|26982402|FG001|Overall Study|Lost to Follow-up|0|||
13469062|NCT00065507|26982401|FG000|Overall Study|Subject Withdrew Consent|2|||
13469063|NCT00065507|26982402|FG001|Overall Study|Subject Withdrew Consent|1|||
13469064|NCT00065507|26982401|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
13469065|NCT00065507|26982402|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
13469066|NCT00065468|26982441|FG000|Overall Study|Death|172|||
13469067|NCT00065468|26982442|FG001|Overall Study|Death|169|||
13469068|NCT00065468|26982443|FG002|Overall Study|Death|171|||
13469069|NCT00065468|26982441|FG000|Overall Study|Withdrawal by Subject|3|||
13469070|NCT00065468|26982442|FG001|Overall Study|Withdrawal by Subject|4|||
13469071|NCT00065468|26982443|FG002|Overall Study|Withdrawal by Subject|5|||
13469072|NCT00065468|26982441|FG000|Overall Study|Lost to Follow-up|5|||
13469073|NCT00065468|26982442|FG001|Overall Study|Lost to Follow-up|3|||
13469074|NCT00065468|26982443|FG002|Overall Study|Lost to Follow-up|2|||
13469075|NCT00065468|26982441|FG000|Overall Study|Discontinuation of study by Sponsor|13|||
13469076|NCT00065468|26982442|FG001|Overall Study|Discontinuation of study by Sponsor|9|||
13469077|NCT00065468|26982443|FG002|Overall Study|Discontinuation of study by Sponsor|13|||
13469078|NCT00065468|26982441|FG000|Overall Study|Disease progression|0|||
13469079|NCT00065468|26982442|FG001|Overall Study|Disease progression|0|||
13469080|NCT00065468|26982443|FG002|Overall Study|Disease progression|1|||
13469081|NCT00065468|26982441|FG000|Overall Study|Other|14|||
13469082|NCT00065468|26982442|FG001|Overall Study|Other|24|||
13469083|NCT00065468|26982443|FG002|Overall Study|Other|18|||
13469084|NCT00065442|26982458|FG000|Overall Study|Lost to Follow-up|1|||
13469085|NCT00065442|26982459|FG001|Overall Study|Lost to Follow-up|1|||
13469086|NCT00065442|26982458|FG000|Overall Study|Death|121|||
13469087|NCT00065442|26982459|FG001|Overall Study|Death|210|||
13469088|NCT00065442|26982458|FG000|Overall Study|Withdrawal by Subject|3|||
13469089|NCT00065442|26982459|FG001|Overall Study|Withdrawal by Subject|9|||
13469090|NCT00065429|26982493|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
13469091|NCT00065429|26982494|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
13469092|NCT00065429|26982495|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
13469093|NCT00065429|26982496|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
13469094|NCT00065429|26982497|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
13469095|NCT00065429|26982498|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1|||
13469096|NCT00065429|26982499|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
13469097|NCT00065429|26982493|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
13469098|NCT00065429|26982494|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
13469099|NCT00065429|26982495|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1|||
13469100|NCT00065429|26982496|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
13469101|NCT00065429|26982497|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
13469102|NCT00065429|26982498|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
13469103|NCT00065429|26982499|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
13469104|NCT00065429|26982493|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1|||
13469105|NCT00065429|26982494|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
13469106|NCT00065429|26982495|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
13469107|NCT00065429|26982496|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
13469108|NCT00065429|26982497|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
13469109|NCT00065429|26982498|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
13469110|NCT00065429|26982499|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
13469111|NCT00065429|26982493|FG000|Phase I - May 2001 - Oct 2002|Death|0|||
13469112|NCT00065429|26982494|FG001|Phase I - May 2001 - Oct 2002|Death|0|||
13469113|NCT00065429|26982495|FG002|Phase I - May 2001 - Oct 2002|Death|0|||
13469114|NCT00065429|26982496|FG003|Phase I - May 2001 - Oct 2002|Death|0|||
13469115|NCT00065429|26982497|FG004|Phase I - May 2001 - Oct 2002|Death|1|||
13469116|NCT00065429|26982498|FG005|Phase I - May 2001 - Oct 2002|Death|0|||
13469117|NCT00065429|26982499|FG006|Phase I - May 2001 - Oct 2002|Death|0|||
13469118|NCT00065429|26982493|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
13469119|NCT00065429|26982494|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
13469120|NCT00065429|26982495|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
13469121|NCT00065429|26982496|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
13469122|NCT00065429|26982497|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
13469123|NCT00065429|26982498|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
13469124|NCT00065429|26982499|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2|||
13469125|NCT00065429|26982493|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
13469126|NCT00065429|26982494|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
13469127|NCT00065429|26982495|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
13469128|NCT00065429|26982496|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
13469129|NCT00065429|26982497|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4|||
13469130|NCT00065429|26982498|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
13469131|NCT00065429|26982499|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
13469132|NCT00065429|26982493|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
13469133|NCT00065429|26982494|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
13469134|NCT00065429|26982495|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
13469135|NCT00065429|26982496|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
13469136|NCT00065429|26982497|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2|||
13469137|NCT00065429|26982498|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
13469138|NCT00065429|26982499|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
13469139|NCT00065260|26982520|FG000|Overall Study|Death|0|||
13469140|NCT00065260|26982521|FG001|Overall Study|Death|1|||
13469141|NCT00065182|26982554|FG000|Overall Study|Adverse Event|24|||
13469142|NCT00065182|26982555|FG001|Overall Study|Adverse Event|17|||
13469143|NCT00065182|26982554|FG000|Overall Study|Lost to Follow-up|0|||
13469144|NCT00065182|26982555|FG001|Overall Study|Lost to Follow-up|4|||
13469145|NCT00065182|26982554|FG000|Overall Study|Protocol Violation|3|||
13469146|NCT00065182|26982555|FG001|Overall Study|Protocol Violation|4|||
13469147|NCT00065182|26982554|FG000|Overall Study|Serious adverse events (SAE)|1|||
13469148|NCT00065182|26982555|FG001|Overall Study|Serious adverse events (SAE)|0|||
13469149|NCT00065182|26982554|FG000|Overall Study|Sponsor Decision|11|||
13469150|NCT00065182|26982555|FG001|Overall Study|Sponsor Decision|7|||
13469151|NCT00065182|26982554|FG000|Overall Study|Withdrawal by Subject|8|||
13469152|NCT00065182|26982555|FG001|Overall Study|Withdrawal by Subject|3|||
13469153|NCT00065182|26982554|FG000|Overall Study|No clinical benefit|1|||
13469154|NCT00065182|26982555|FG001|Overall Study|No clinical benefit|0|||
13469155|NCT00065182|26982554|FG000|Overall Study|Death|0|||
13469156|NCT00065182|26982555|FG001|Overall Study|Death|1|||
13469157|NCT00065182|26982554|FG000|Overall Study|Decline in Status|0|||
13469158|NCT00065182|26982555|FG001|Overall Study|Decline in Status|1|||
13469159|NCT00065156|26982572|FG000|Overall Study|Adverse Event|37|||
13469160|NCT00065156|26982572|FG000|Overall Study|Lack of Efficacy|52|||
13469161|NCT00065156|26982572|FG000|Overall Study|Withdrawal by Subject|8|||
13469162|NCT00065156|26982572|FG000|Overall Study|Lost to Follow-up|1|||
13469163|NCT00065156|26982572|FG000|Overall Study|Death|11|||
13469164|NCT00065156|26982572|FG000|Overall Study|Study Closed by Sponsor|2|||
13469165|NCT00065156|26982572|FG000|Overall Study|Disease Progression|7|||
13469166|NCT00065156|26982572|FG000|Overall Study|Investigator Decision|2|||
13469167|NCT00065156|26982572|FG000|Overall Study|Non-Compliance|2|||
13469168|NCT00065156|26982572|FG000|Overall Study|Loss of Response|1|||
13469169|NCT00065156|26982572|FG000|Overall Study|Secondary Malign Disease|1|||
13469170|NCT00065065|26982589|FG000|Overall Study|Adverse Event|3|||
13469171|NCT00065065|26982590|FG001|Overall Study|Adverse Event|2|||
13469172|NCT00065065|26982589|FG000|Overall Study|Withdrawal by Subject|1|||
13469173|NCT00065065|26982590|FG001|Overall Study|Withdrawal by Subject|5|||
13469174|NCT00065065|26982589|FG000|Overall Study|Lack of Efficacy|4|||
13469175|NCT00065065|26982590|FG001|Overall Study|Lack of Efficacy|11|||
13469176|NCT00065065|26982589|FG000|Overall Study|Other|2|||
13469177|NCT00065065|26982590|FG001|Overall Study|Other|2|||
13469178|NCT00064987|26982615|FG000|Overall Study|Physician Decision|3|||
13469179|NCT00064987|26982616|FG001|Overall Study|Physician Decision|0|||
13469180|NCT00064792|26982631|FG000|Overall Study|Withdrawal by Subject|2|||
13469181|NCT00064792|26982632|FG001|Overall Study|Withdrawal by Subject|0|||
13469182|NCT00064792|26982631|FG000|Overall Study|Adverse Event|3|||
13469183|NCT00064792|26982632|FG001|Overall Study|Adverse Event|0|||
13469184|NCT00064753|26982667|FG000|Overall Study|Death|251|||
13469185|NCT00064753|26982668|FG001|Overall Study|Death|242|||
13469186|NCT00064753|26982667|FG000|Overall Study|Withdrawal by Subject|198|||
13469187|NCT00064753|26982668|FG001|Overall Study|Withdrawal by Subject|171|||
13469188|NCT00064753|26982667|FG000|Overall Study|Lost to Follow-up|225|||
13469189|NCT00064753|26982668|FG001|Overall Study|Lost to Follow-up|235|||
13469190|NCT00064701|26982728|FG000|One Year Post-transplant|Did not receive study drug|7|||
13469191|NCT00064701|26982729|FG001|One Year Post-transplant|Did not receive study drug|12|||
13469192|NCT00064701|26982730|FG002|One Year Post-transplant|Did not receive study drug|11|||
13469193|NCT00064701|26982728|FG000|One Year Post-transplant|Adverse Event|23|||
13469194|NCT00064701|26982729|FG001|One Year Post-transplant|Adverse Event|19|||
13469195|NCT00064701|26982730|FG002|One Year Post-transplant|Adverse Event|37|||
13469196|NCT00064701|26982728|FG000|One Year Post-transplant|Rejection|0|||
13469197|NCT00064701|26982729|FG001|One Year Post-transplant|Rejection|1|||
13469198|NCT00064701|26982730|FG002|One Year Post-transplant|Rejection|16|||
13469199|NCT00064701|26982728|FG000|One Year Post-transplant|Non-compliance|4|||
13469200|NCT00064701|26982729|FG001|One Year Post-transplant|Non-compliance|2|||
13469201|NCT00064701|26982730|FG002|One Year Post-transplant|Non-compliance|5|||
13469202|NCT00064701|26982728|FG000|One Year Post-transplant|Graft Failure|3|||
13469203|NCT00064701|26982729|FG001|One Year Post-transplant|Graft Failure|2|||
13469204|NCT00064701|26982730|FG002|One Year Post-transplant|Graft Failure|1|||
13469205|NCT00064701|26982728|FG000|One Year Post-transplant|Withdrawal by Subject|0|||
13469206|NCT00064701|26982729|FG001|One Year Post-transplant|Withdrawal by Subject|4|||
13469207|NCT00064701|26982730|FG002|One Year Post-transplant|Withdrawal by Subject|1|||
13469208|NCT00064701|26982728|FG000|One Year Post-transplant|Lost to Follow-up|1|||
13469209|NCT00064701|26982729|FG001|One Year Post-transplant|Lost to Follow-up|0|||
13469210|NCT00064701|26982730|FG002|One Year Post-transplant|Lost to Follow-up|0|||
13469211|NCT00064701|26982728|FG000|One Year Post-transplant|Converted to rapamycin|1|||
13469212|NCT00064701|26982729|FG001|One Year Post-transplant|Converted to rapamycin|0|||
13469213|NCT00064701|26982730|FG002|One Year Post-transplant|Converted to rapamycin|0|||
13469214|NCT00064701|26982728|FG000|One Year Post-transplant|Acute tubular necrosis|1|||
13469215|NCT00064701|26982729|FG001|One Year Post-transplant|Acute tubular necrosis|0|||
13469216|NCT00064701|26982730|FG002|One Year Post-transplant|Acute tubular necrosis|0|||
13469217|NCT00064701|26982728|FG000|One Year Post-transplant|Incorrect study drug dispensed|0|||
13469218|NCT00064701|26982729|FG001|One Year Post-transplant|Incorrect study drug dispensed|1|||
13469219|NCT00064701|26982730|FG002|One Year Post-transplant|Incorrect study drug dispensed|0|||
13469220|NCT00064701|26982728|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
13469221|NCT00064701|26982729|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1|||
13469222|NCT00064701|26982730|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
13469223|NCT00064701|26982728|FG000|One Year Post-transplant|Poor absorption|0|||
13469224|NCT00064701|26982729|FG001|One Year Post-transplant|Poor absorption|1|||
13469225|NCT00064701|26982730|FG002|One Year Post-transplant|Poor absorption|0|||
13469226|NCT00064701|26982728|FG000|One Year Post-transplant|Pancreas transplant|0|||
13469227|NCT00064701|26982729|FG001|One Year Post-transplant|Pancreas transplant|0|||
13469228|NCT00064701|26982730|FG002|One Year Post-transplant|Pancreas transplant|1|||
13469229|NCT00064701|26982728|FG000|Clinical Continuation Phase|Adverse Event|12|||
13469230|NCT00064701|26982729|FG001|Clinical Continuation Phase|Adverse Event|21|||
13469231|NCT00064701|26982730|FG002|Clinical Continuation Phase|Adverse Event|14|||
13469232|NCT00064701|26982728|FG000|Clinical Continuation Phase|Non-compliance|8|||
13469233|NCT00064701|26982729|FG001|Clinical Continuation Phase|Non-compliance|6|||
13469234|NCT00064701|26982730|FG002|Clinical Continuation Phase|Non-compliance|7|||
13469235|NCT00064701|26982728|FG000|Clinical Continuation Phase|Withdrawal by Subject|22|||
13469236|NCT00064701|26982729|FG001|Clinical Continuation Phase|Withdrawal by Subject|3|||
13469237|NCT00064701|26982730|FG002|Clinical Continuation Phase|Withdrawal by Subject|22|||
13469238|NCT00064701|26982728|FG000|Clinical Continuation Phase|Lost to Follow-up|6|||
13469239|NCT00064701|26982729|FG001|Clinical Continuation Phase|Lost to Follow-up|3|||
13469240|NCT00064701|26982730|FG002|Clinical Continuation Phase|Lost to Follow-up|6|||
13469241|NCT00064701|26982728|FG000|Clinical Continuation Phase|Graft Failure|5|||
13469242|NCT00064701|26982729|FG001|Clinical Continuation Phase|Graft Failure|5|||
13469243|NCT00064701|26982730|FG002|Clinical Continuation Phase|Graft Failure|2|||
13469244|NCT00064701|26982728|FG000|Clinical Continuation Phase|Rejection|1|||
13469245|NCT00064701|26982729|FG001|Clinical Continuation Phase|Rejection|2|||
13469246|NCT00064701|26982730|FG002|Clinical Continuation Phase|Rejection|2|||
13469247|NCT00064701|26982728|FG000|Clinical Continuation Phase|Sponsor discontinued study|113|||
13469248|NCT00064701|26982729|FG001|Clinical Continuation Phase|Sponsor discontinued study|129|||
13469249|NCT00064701|26982730|FG002|Clinical Continuation Phase|Sponsor discontinued study|79|||
13469250|NCT00064701|26982728|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0|||
13469251|NCT00064701|26982729|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3|||
13469252|NCT00064701|26982730|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6|||
13469253|NCT00064701|26982728|FG000|Clinical Continuation Phase|Physician Decision|1|||
13469254|NCT00064701|26982729|FG001|Clinical Continuation Phase|Physician Decision|3|||
13469255|NCT00064701|26982730|FG002|Clinical Continuation Phase|Physician Decision|0|||
13469256|NCT00064701|26982728|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1|||
13469257|NCT00064701|26982729|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0|||
13469258|NCT00064701|26982730|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1|||
13469259|NCT00064701|26982728|FG000|Clinical Continuation Phase|Pancreas transplant|1|||
13469260|NCT00064701|26982729|FG001|Clinical Continuation Phase|Pancreas transplant|0|||
13469261|NCT00064701|26982730|FG002|Clinical Continuation Phase|Pancreas transplant|0|||
13469262|NCT00064701|26982728|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
13469263|NCT00064701|26982729|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1|||
13469264|NCT00064701|26982730|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
13469265|NCT00064701|26982728|FG000|Clinical Continuation Phase|Discharged to nursing home|0|||
13469266|NCT00064701|26982729|FG001|Clinical Continuation Phase|Discharged to nursing home|1|||
13469267|NCT00064701|26982730|FG002|Clinical Continuation Phase|Discharged to nursing home|0|||
13469268|NCT00064701|26982728|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
13469269|NCT00064701|26982729|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1|||
13469270|NCT00064701|26982730|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
13469271|NCT00064701|26982728|FG000|Clinical Continuation Phase|Patient opted out|0|||
13469272|NCT00064701|26982729|FG001|Clinical Continuation Phase|Patient opted out|0|||
13469273|NCT00064701|26982730|FG002|Clinical Continuation Phase|Patient opted out|1|||
13469274|NCT00064662|26982745|FG000|Overall Study|Death|1|||
13469275|NCT00064662|26982746|FG001|Overall Study|Death|1|||
13469276|NCT00064662|26982745|FG000|Overall Study|Lost to Follow-up|57|||
13469277|NCT00064662|26982746|FG001|Overall Study|Lost to Follow-up|44|||
13469278|NCT00064662|26982745|FG000|Overall Study|Withdrawal by Subject|14|||
13469279|NCT00064662|26982746|FG001|Overall Study|Withdrawal by Subject|14|||
13469280|NCT00064662|26982745|FG000|Overall Study|Administratively withdrawn|2|||
13469281|NCT00064662|26982746|FG001|Overall Study|Administratively withdrawn|2|||
13469282|NCT00064350|26982771|FG000|Induction Treatment|Disease Progression|5|||
13469283|NCT00064350|26982772|FG001|Induction Treatment|Disease Progression|1|||
13469284|NCT00064350|26982773|FG002|Induction Treatment|Disease Progression|110|||
13469285|NCT00064350|26982771|FG000|Induction Treatment|Adverse Event|0|||
13469286|NCT00064350|26982772|FG001|Induction Treatment|Adverse Event|2|||
13469287|NCT00064350|26982773|FG002|Induction Treatment|Adverse Event|49|||
13469288|NCT00064350|26982771|FG000|Induction Treatment|Death|0|||
13469289|NCT00064350|26982772|FG001|Induction Treatment|Death|0|||
13469290|NCT00064350|26982773|FG002|Induction Treatment|Death|9|||
13469291|NCT00064350|26982771|FG000|Induction Treatment|Withdrawal by Subject|0|||
13469292|NCT00064350|26982772|FG001|Induction Treatment|Withdrawal by Subject|0|||
13469293|NCT00064350|26982773|FG002|Induction Treatment|Withdrawal by Subject|21|||
13469294|NCT00064350|26982771|FG000|Induction Treatment|Ineligible or never started treatment|3|||
13469295|NCT00064350|26982772|FG001|Induction Treatment|Ineligible or never started treatment|6|||
13469296|NCT00064350|26982773|FG002|Induction Treatment|Ineligible or never started treatment|34|||
13469297|NCT00064350|26982771|FG000|Induction Treatment|Other|0|||
13469298|NCT00064350|26982772|FG001|Induction Treatment|Other|0|||
13469299|NCT00064350|26982773|FG002|Induction Treatment|Other|13|||
13469300|NCT00064350|26982771|FG000|Randomization|Adverse Event|8|||
13469301|NCT00064350|26982772|FG001|Randomization|Adverse Event|3|||
13469302|NCT00064350|26982773|FG002|Randomization|Adverse Event|0|||
13469303|NCT00064350|26982771|FG000|Randomization|Death|3|||
13469304|NCT00064350|26982772|FG001|Randomization|Death|0|||
13469305|NCT00064350|26982773|FG002|Randomization|Death|0|||
13469306|NCT00064350|26982771|FG000|Randomization|Withdrawal by Subject|1|||
13469307|NCT00064350|26982772|FG001|Randomization|Withdrawal by Subject|0|||
13469308|NCT00064350|26982773|FG002|Randomization|Withdrawal by Subject|0|||
13469309|NCT00064350|26982771|FG000|Randomization|Ineligible or never started treatment|9|||
13469310|NCT00064350|26982772|FG001|Randomization|Ineligible or never started treatment|15|||
13469311|NCT00064350|26982773|FG002|Randomization|Ineligible or never started treatment|0|||
13469312|NCT00064350|26982771|FG000|Randomization|Other|5|||
13469313|NCT00064350|26982772|FG001|Randomization|Other|0|||
13469314|NCT00064350|26982773|FG002|Randomization|Other|0|||
13469315|NCT00064350|26982771|FG000|Cross-Over|Adverse Event|0|||
13469316|NCT00064350|26982772|FG001|Cross-Over|Adverse Event|1|||
13469317|NCT00064350|26982773|FG002|Cross-Over|Adverse Event|0|||
13469318|NCT00064350|26982771|FG000|Cross-Over|Death|1|||
13469319|NCT00064350|26982772|FG001|Cross-Over|Death|3|||
13469320|NCT00064350|26982773|FG002|Cross-Over|Death|0|||
13469321|NCT00064350|26982771|FG000|Cross-Over|Withdrawal by Subject|2|||
13469322|NCT00064350|26982772|FG001|Cross-Over|Withdrawal by Subject|2|||
13469323|NCT00064350|26982773|FG002|Cross-Over|Withdrawal by Subject|0|||
13469324|NCT00064350|26982771|FG000|Cross-Over|Ineligible or never started treatment|3|||
13469325|NCT00064350|26982772|FG001|Cross-Over|Ineligible or never started treatment|6|||
13469326|NCT00064350|26982773|FG002|Cross-Over|Ineligible or never started treatment|0|||
13469327|NCT00064350|26982771|FG000|Cross-Over|Other|0|||
13469328|NCT00064350|26982772|FG001|Cross-Over|Other|2|||
13469329|NCT00064350|26982773|FG002|Cross-Over|Other|0|||
13469330|NCT00064337|26982782|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7|||
13469331|NCT00064337|26982782|FG000|PBSCC or Induction/PBSCC|Adverse Event|6|||
13469332|NCT00064337|26982782|FG000|PBSCC or Induction/PBSCC|Progression|3|||
13469333|NCT00064337|26982782|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2|||
13469334|NCT00064337|26982782|FG000|PBSCC or Induction/PBSCC|Death|2|||
13469335|NCT00064337|26982782|FG000|Transplant|Adverse Event|9|||
13469336|NCT00064337|26982782|FG000|Transplant|Not protocol-specified|5|||
13469337|NCT00064337|26982782|FG000|Transplant|Death|3|||
13469338|NCT00064337|26982782|FG000|Transplant|Patient Refusal|2|||
13469339|NCT00064337|26982782|FG000|Transplant|Progression|2|||
13469340|NCT00064337|26982782|FG000|Maintenance|Adverse Event|3|||
13469341|NCT00064337|26982782|FG000|Maintenance|Progression|2|||
13469342|NCT00064337|26982782|FG000|Maintenance|On treatment at time of analysis|2|||
13469343|NCT00064337|26982782|FG000|Maintenance|Not protocol-specified|2|||
13469344|NCT00064337|26982782|FG000|Maintenance|Death|1|||
13469345|NCT00064298|26982797|FG000|Overall Study|Withdrawal by Subject|2|||
13469346|NCT00064298|26982798|FG001|Overall Study|Withdrawal by Subject|1|||
13469347|NCT00064298|26982797|FG000|Overall Study|Lost to Follow-up|2|||
13469348|NCT00064298|26982798|FG001|Overall Study|Lost to Follow-up|2|||
13469349|NCT00064298|26982797|FG000|Overall Study|Death|0|||
13469350|NCT00064298|26982798|FG001|Overall Study|Death|1|||
13469351|NCT00064298|26982797|FG000|Overall Study|Disease Progression|2|||
13469352|NCT00064298|26982798|FG001|Overall Study|Disease Progression|1|||
13469353|NCT00064259|26982808|FG000|Overall Study|Adverse Event|1|||
13469354|NCT00064259|26982809|FG001|Overall Study|Adverse Event|0|||
13469355|NCT00064259|26982810|FG002|Overall Study|Adverse Event|0|||
13469356|NCT00064259|26982811|FG003|Overall Study|Adverse Event|1|||
13469357|NCT00064077|26982854|FG000|Overall Study|Improper prior treatment|1|||
13469358|NCT00064077|26982855|FG001|Overall Study|Improper prior treatment|0|||
13469359|NCT00064077|26982856|FG002|Overall Study|Improper prior treatment|0|||
13469360|NCT00064077|26982857|FG003|Overall Study|Improper prior treatment|0|||
13469361|NCT00064077|26982854|FG000|Overall Study|Poor risk|2|||
13469362|NCT00064077|26982855|FG001|Overall Study|Poor risk|0|||
13469363|NCT00064077|26982856|FG002|Overall Study|Poor risk|1|||
13469364|NCT00064077|26982857|FG003|Overall Study|Poor risk|1|||
13469365|NCT00064077|26982854|FG000|Overall Study|Pathology|10|||
13469366|NCT00064077|26982855|FG001|Overall Study|Pathology|7|||
13469367|NCT00064077|26982856|FG002|Overall Study|Pathology|3|||
13469368|NCT00064077|26982857|FG003|Overall Study|Pathology|4|||
13469369|NCT00064077|26982854|FG000|Overall Study|No surgery|0|||
13469370|NCT00064077|26982855|FG001|Overall Study|No surgery|0|||
13469371|NCT00064077|26982856|FG002|Overall Study|No surgery|1|||
13469372|NCT00064077|26982857|FG003|Overall Study|No surgery|0|||
13469373|NCT00064077|26982854|FG000|Overall Study|No tumor|0|||
13469374|NCT00064077|26982855|FG001|Overall Study|No tumor|0|||
13469375|NCT00064077|26982856|FG002|Overall Study|No tumor|1|||
13469376|NCT00064077|26982857|FG003|Overall Study|No tumor|0|||
13469377|NCT00064077|26982854|FG000|Overall Study|Other reasons|2|||
13469378|NCT00064077|26982855|FG001|Overall Study|Other reasons|2|||
13469379|NCT00064077|26982856|FG002|Overall Study|Other reasons|1|||
13469380|NCT00064077|26982857|FG003|Overall Study|Other reasons|2|||
13469381|NCT00064025|26982866|FG000|Overall Study|Ineligible|4|||
13469382|NCT00064025|26982866|FG000|Overall Study|Inevaluable|3|||
13469383|NCT00063999|26982889|FG000|Overall Study|Withdrawal by Subject|1|||
13469384|NCT00063999|26982890|FG001|Overall Study|Withdrawal by Subject|0|||
13469385|NCT00063999|26982889|FG000|Overall Study|Ineligible|44|||
13469386|NCT00063999|26982890|FG001|Overall Study|Ineligible|24|||
13469387|NCT00063986|26982904|FG000|Overall Study|Withdrawal by Subject|1|||
13469388|NCT00063986|26982904|FG000|Overall Study|Ineligible|1|||
13469389|NCT00063986|26982904|FG000|Overall Study|Intra-operatively ineligible|4|||
13469390|NCT00063934|26982913|FG000|Overall Study|Ineligible|1|||
13469391|NCT00063882|26982948|FG000|Overall Study|Protocol Violation|3|||
13469392|NCT00063882|26982949|FG001|Overall Study|Protocol Violation|3|||
13469393|NCT00063882|26982948|FG000|Overall Study|Withdrawal by Subject|2|||
13469394|NCT00063882|26982949|FG001|Overall Study|Withdrawal by Subject|1|||
13469395|NCT00063258|26982962|FG000|Overall Study|Physician Decision|2|||
13469396|NCT00063258|26982963|FG001|Overall Study|Physician Decision|0|||
13469397|NCT00063258|26982962|FG000|Overall Study|Lack of Efficacy|2|||
13469398|NCT00063258|26982963|FG001|Overall Study|Lack of Efficacy|0|||
13469399|NCT00063154|26982972|FG000|Overall Study|Disease progression|27|||
13469400|NCT00063154|26982972|FG000|Overall Study|Adverse Event|2|||
13469401|NCT00063154|26982972|FG000|Overall Study|Physician Decision|10|||
13469402|NCT00063154|26982972|FG000|Overall Study|Death|3|||
13469403|NCT00063154|26982972|FG000|Overall Study|Reason unspecified|1|||
13469404|NCT00063154|26982972|FG000|Overall Study|Did not receive treatment|8|||
13469405|NCT00062868|26983122|FG000|Dose Level 1|Death|2|||
13469406|NCT00062868|26983123|FG001|Dose Level 1|Death|0|||
13469407|NCT00062868|26983124|FG002|Dose Level 1|Death|0|||
13469408|NCT00062868|26983125|FG003|Dose Level 1|Death|2|||
13469409|NCT00062868|26983126|FG004|Dose Level 1|Death|0|||
13469410|NCT00062868|26983127|FG005|Dose Level 1|Death|0|||
13469411|NCT00062868|26983128|FG006|Dose Level 1|Death|3|||
13469412|NCT00062868|26983129|FG007|Dose Level 1|Death|0|||
13469413|NCT00062868|26983130|FG008|Dose Level 1|Death|0|||
13469414|NCT00062868|26983131|FG009|Dose Level 1|Death|0|||
13469415|NCT00062868|26983132|FG010|Dose Level 1|Death|0|||
13469416|NCT00062868|26983133|FG011|Dose Level 1|Death|0|||
13469417|NCT00062868|26983134|FG012|Dose Level 1|Death|0|||
13469418|NCT00062868|26983135|FG013|Dose Level 1|Death|0|||
13469419|NCT00062868|26983136|FG014|Dose Level 1|Death|0|||
13469420|NCT00062868|26983137|FG015|Dose Level 1|Death|0|||
13469421|NCT00062868|26983138|FG016|Dose Level 1|Death|0|||
13469422|NCT00062868|26983139|FG017|Dose Level 1|Death|0|||
13469423|NCT00062868|26983140|FG018|Dose Level 1|Death|7|||
13469424|NCT00062868|26983141|FG019|Dose Level 1|Death|0|||
13469425|NCT00062868|26983142|FG020|Dose Level 1|Death|1|||
13469426|NCT00062868|26983122|FG000|Dose Level 1|Lost to Follow-up|0|||
13469427|NCT00062868|26983123|FG001|Dose Level 1|Lost to Follow-up|0|||
13469428|NCT00062868|26983124|FG002|Dose Level 1|Lost to Follow-up|0|||
13469429|NCT00062868|26983125|FG003|Dose Level 1|Lost to Follow-up|0|||
13469430|NCT00062868|26983126|FG004|Dose Level 1|Lost to Follow-up|0|||
13469431|NCT00062868|26983127|FG005|Dose Level 1|Lost to Follow-up|0|||
13469432|NCT00062868|26983128|FG006|Dose Level 1|Lost to Follow-up|0|||
13469433|NCT00062868|26983129|FG007|Dose Level 1|Lost to Follow-up|0|||
13469434|NCT00062868|26983130|FG008|Dose Level 1|Lost to Follow-up|0|||
13469435|NCT00062868|26983131|FG009|Dose Level 1|Lost to Follow-up|0|||
13469436|NCT00062868|26983132|FG010|Dose Level 1|Lost to Follow-up|0|||
13469437|NCT00062868|26983133|FG011|Dose Level 1|Lost to Follow-up|0|||
13469438|NCT00062868|26983134|FG012|Dose Level 1|Lost to Follow-up|1|||
13469439|NCT00062868|26983135|FG013|Dose Level 1|Lost to Follow-up|0|||
13469440|NCT00062868|26983136|FG014|Dose Level 1|Lost to Follow-up|0|||
13469441|NCT00062868|26983137|FG015|Dose Level 1|Lost to Follow-up|0|||
13469442|NCT00062868|26983138|FG016|Dose Level 1|Lost to Follow-up|0|||
13469443|NCT00062868|26983139|FG017|Dose Level 1|Lost to Follow-up|0|||
13469444|NCT00062868|26983140|FG018|Dose Level 1|Lost to Follow-up|2|||
13469445|NCT00062868|26983141|FG019|Dose Level 1|Lost to Follow-up|0|||
13469446|NCT00062868|26983142|FG020|Dose Level 1|Lost to Follow-up|1|||
13469447|NCT00062868|26983122|FG000|Dose Level 2|Death|0|||
13469448|NCT00062868|26983123|FG001|Dose Level 2|Death|3|||
13469449|NCT00062868|26983124|FG002|Dose Level 2|Death|0|||
13469450|NCT00062868|26983125|FG003|Dose Level 2|Death|0|||
13469451|NCT00062868|26983126|FG004|Dose Level 2|Death|2|||
13469452|NCT00062868|26983127|FG005|Dose Level 2|Death|0|||
13469453|NCT00062868|26983128|FG006|Dose Level 2|Death|0|||
13469454|NCT00062868|26983129|FG007|Dose Level 2|Death|0|||
13469455|NCT00062868|26983130|FG008|Dose Level 2|Death|0|||
13469456|NCT00062868|26983131|FG009|Dose Level 2|Death|0|||
13469457|NCT00062868|26983132|FG010|Dose Level 2|Death|1|||
13469458|NCT00062868|26983133|FG011|Dose Level 2|Death|0|||
13469459|NCT00062868|26983134|FG012|Dose Level 2|Death|0|||
13469460|NCT00062868|26983135|FG013|Dose Level 2|Death|0|||
13469461|NCT00062868|26983136|FG014|Dose Level 2|Death|0|||
13469462|NCT00062868|26983137|FG015|Dose Level 2|Death|0|||
13469463|NCT00062868|26983138|FG016|Dose Level 2|Death|2|||
13469464|NCT00062868|26983139|FG017|Dose Level 2|Death|0|||
13469465|NCT00062868|26983140|FG018|Dose Level 2|Death|0|||
13469466|NCT00062868|26983141|FG019|Dose Level 2|Death|0|||
13469467|NCT00062868|26983142|FG020|Dose Level 2|Death|0|||
13469468|NCT00062868|26983122|FG000|Dose Level 2|Lost to Follow-up|0|||
13469469|NCT00062868|26983123|FG001|Dose Level 2|Lost to Follow-up|0|||
13469470|NCT00062868|26983124|FG002|Dose Level 2|Lost to Follow-up|0|||
13469471|NCT00062868|26983125|FG003|Dose Level 2|Lost to Follow-up|0|||
13469472|NCT00062868|26983126|FG004|Dose Level 2|Lost to Follow-up|0|||
13469473|NCT00062868|26983127|FG005|Dose Level 2|Lost to Follow-up|0|||
13469474|NCT00062868|26983128|FG006|Dose Level 2|Lost to Follow-up|0|||
13469475|NCT00062868|26983129|FG007|Dose Level 2|Lost to Follow-up|0|||
13469476|NCT00062868|26983130|FG008|Dose Level 2|Lost to Follow-up|0|||
13469477|NCT00062868|26983131|FG009|Dose Level 2|Lost to Follow-up|0|||
13469478|NCT00062868|26983132|FG010|Dose Level 2|Lost to Follow-up|0|||
13469479|NCT00062868|26983133|FG011|Dose Level 2|Lost to Follow-up|0|||
13469480|NCT00062868|26983134|FG012|Dose Level 2|Lost to Follow-up|0|||
13469481|NCT00062868|26983135|FG013|Dose Level 2|Lost to Follow-up|1|||
13469482|NCT00062868|26983136|FG014|Dose Level 2|Lost to Follow-up|0|||
13469483|NCT00062868|26983137|FG015|Dose Level 2|Lost to Follow-up|0|||
13469484|NCT00062868|26983138|FG016|Dose Level 2|Lost to Follow-up|1|||
13469485|NCT00062868|26983139|FG017|Dose Level 2|Lost to Follow-up|0|||
13469486|NCT00062868|26983140|FG018|Dose Level 2|Lost to Follow-up|0|||
13469487|NCT00062868|26983141|FG019|Dose Level 2|Lost to Follow-up|0|||
13469488|NCT00062868|26983142|FG020|Dose Level 2|Lost to Follow-up|0|||
13469489|NCT00062868|26983122|FG000|Dose Level 3|Death|0|||
13469490|NCT00062868|26983123|FG001|Dose Level 3|Death|0|||
13469491|NCT00062868|26983124|FG002|Dose Level 3|Death|0|||
13469492|NCT00062868|26983125|FG003|Dose Level 3|Death|0|||
13469493|NCT00062868|26983126|FG004|Dose Level 3|Death|0|||
13469494|NCT00062868|26983127|FG005|Dose Level 3|Death|0|||
13469495|NCT00062868|26983128|FG006|Dose Level 3|Death|0|||
13469496|NCT00062868|26983129|FG007|Dose Level 3|Death|0|||
13469497|NCT00062868|26983130|FG008|Dose Level 3|Death|0|||
13469498|NCT00062868|26983131|FG009|Dose Level 3|Death|0|||
13469499|NCT00062868|26983132|FG010|Dose Level 3|Death|0|||
13469500|NCT00062868|26983133|FG011|Dose Level 3|Death|1|||
13469501|NCT00062868|26983134|FG012|Dose Level 3|Death|0|||
13469502|NCT00062868|26983135|FG013|Dose Level 3|Death|0|||
13469503|NCT00062868|26983136|FG014|Dose Level 3|Death|0|||
13469504|NCT00062868|26983137|FG015|Dose Level 3|Death|0|||
13469505|NCT00062868|26983138|FG016|Dose Level 3|Death|0|||
13469506|NCT00062868|26983139|FG017|Dose Level 3|Death|1|||
13469507|NCT00062868|26983140|FG018|Dose Level 3|Death|0|||
13469508|NCT00062868|26983141|FG019|Dose Level 3|Death|0|||
13469509|NCT00062868|26983142|FG020|Dose Level 3|Death|0|||
13469510|NCT00062868|26983122|FG000|Dose Level 3|Lost to Follow-up|0|||
13469511|NCT00062868|26983123|FG001|Dose Level 3|Lost to Follow-up|0|||
13469512|NCT00062868|26983124|FG002|Dose Level 3|Lost to Follow-up|0|||
13469513|NCT00062868|26983125|FG003|Dose Level 3|Lost to Follow-up|0|||
13469514|NCT00062868|26983126|FG004|Dose Level 3|Lost to Follow-up|0|||
13469515|NCT00062868|26983127|FG005|Dose Level 3|Lost to Follow-up|0|||
13469516|NCT00062868|26983128|FG006|Dose Level 3|Lost to Follow-up|0|||
13469517|NCT00062868|26983129|FG007|Dose Level 3|Lost to Follow-up|0|||
13469518|NCT00062868|26983130|FG008|Dose Level 3|Lost to Follow-up|0|||
13469519|NCT00062868|26983131|FG009|Dose Level 3|Lost to Follow-up|0|||
13469520|NCT00062868|26983132|FG010|Dose Level 3|Lost to Follow-up|0|||
13469521|NCT00062868|26983133|FG011|Dose Level 3|Lost to Follow-up|0|||
13469522|NCT00062868|26983134|FG012|Dose Level 3|Lost to Follow-up|0|||
13469523|NCT00062868|26983135|FG013|Dose Level 3|Lost to Follow-up|0|||
13469524|NCT00062868|26983136|FG014|Dose Level 3|Lost to Follow-up|1|||
13469525|NCT00062868|26983137|FG015|Dose Level 3|Lost to Follow-up|0|||
13469526|NCT00062868|26983138|FG016|Dose Level 3|Lost to Follow-up|0|||
13469527|NCT00062868|26983139|FG017|Dose Level 3|Lost to Follow-up|0|||
13469528|NCT00062868|26983140|FG018|Dose Level 3|Lost to Follow-up|0|||
13469529|NCT00062868|26983141|FG019|Dose Level 3|Lost to Follow-up|0|||
13469530|NCT00062868|26983142|FG020|Dose Level 3|Lost to Follow-up|0|||
13469531|NCT00062868|26983122|FG000|Dose Level 3|Withdrew|0|||
13469532|NCT00062868|26983123|FG001|Dose Level 3|Withdrew|0|||
13469533|NCT00062868|26983124|FG002|Dose Level 3|Withdrew|2|||
13469534|NCT00062868|26983125|FG003|Dose Level 3|Withdrew|0|||
13469535|NCT00062868|26983126|FG004|Dose Level 3|Withdrew|0|||
13469536|NCT00062868|26983127|FG005|Dose Level 3|Withdrew|0|||
13469537|NCT00062868|26983128|FG006|Dose Level 3|Withdrew|0|||
13469538|NCT00062868|26983129|FG007|Dose Level 3|Withdrew|0|||
13469539|NCT00062868|26983130|FG008|Dose Level 3|Withdrew|0|||
13469540|NCT00062868|26983131|FG009|Dose Level 3|Withdrew|0|||
13469541|NCT00062868|26983132|FG010|Dose Level 3|Withdrew|0|||
13469542|NCT00062868|26983133|FG011|Dose Level 3|Withdrew|0|||
13469543|NCT00062868|26983134|FG012|Dose Level 3|Withdrew|0|||
13469544|NCT00062868|26983135|FG013|Dose Level 3|Withdrew|0|||
13469545|NCT00062868|26983136|FG014|Dose Level 3|Withdrew|0|||
13469546|NCT00062868|26983137|FG015|Dose Level 3|Withdrew|0|||
13469547|NCT00062868|26983138|FG016|Dose Level 3|Withdrew|0|||
13469548|NCT00062868|26983139|FG017|Dose Level 3|Withdrew|0|||
13469549|NCT00062868|26983140|FG018|Dose Level 3|Withdrew|0|||
13469550|NCT00062868|26983141|FG019|Dose Level 3|Withdrew|0|||
13469551|NCT00062868|26983142|FG020|Dose Level 3|Withdrew|0|||
13469552|NCT00062751|26983226|FG000|Overall Study|Disease progression|24|||
13469553|NCT00062751|26983227|FG001|Overall Study|Disease progression|17|||
13469554|NCT00062751|26983228|FG002|Overall Study|Disease progression|24|||
13469555|NCT00062751|26983229|FG003|Overall Study|Disease progression|2|||
13469556|NCT00062751|26983230|FG004|Overall Study|Disease progression|2|||
13469557|NCT00062751|26983226|FG000|Overall Study|Adverse Event|4|||
13469558|NCT00062751|26983227|FG001|Overall Study|Adverse Event|7|||
13469559|NCT00062751|26983228|FG002|Overall Study|Adverse Event|2|||
13469560|NCT00062751|26983229|FG003|Overall Study|Adverse Event|2|||
13469561|NCT00062751|26983230|FG004|Overall Study|Adverse Event|2|||
13469562|NCT00062751|26983226|FG000|Overall Study|Other|2|||
13469563|NCT00062751|26983227|FG001|Overall Study|Other|3|||
13469564|NCT00062751|26983228|FG002|Overall Study|Other|1|||
13469565|NCT00062751|26983229|FG003|Overall Study|Other|0|||
13469566|NCT00062751|26983230|FG004|Overall Study|Other|1|||
13469567|NCT00062751|26983226|FG000|Overall Study|Withdrawal by Subject|1|||
13469568|NCT00062751|26983227|FG001|Overall Study|Withdrawal by Subject|2|||
13469569|NCT00062751|26983228|FG002|Overall Study|Withdrawal by Subject|2|||
13469570|NCT00062751|26983229|FG003|Overall Study|Withdrawal by Subject|1|||
13469571|NCT00062751|26983230|FG004|Overall Study|Withdrawal by Subject|0|||
13469572|NCT00062751|26983226|FG000|Overall Study|Symptomatic deterioration|1|||
13469573|NCT00062751|26983227|FG001|Overall Study|Symptomatic deterioration|1|||
13469574|NCT00062751|26983228|FG002|Overall Study|Symptomatic deterioration|0|||
13469575|NCT00062751|26983229|FG003|Overall Study|Symptomatic deterioration|0|||
13469576|NCT00062751|26983230|FG004|Overall Study|Symptomatic deterioration|1|||
13469577|NCT00062751|26983226|FG000|Overall Study|Death|1|||
13469578|NCT00062751|26983227|FG001|Overall Study|Death|0|||
13469579|NCT00062751|26983228|FG002|Overall Study|Death|1|||
13469580|NCT00062751|26983229|FG003|Overall Study|Death|0|||
13469581|NCT00062751|26983230|FG004|Overall Study|Death|0|||
13469582|NCT00062647|26983243|FG000|Overall Study|Death|2|||
13469583|NCT00062647|26983244|FG001|Overall Study|Death|2|||
13469584|NCT00062647|26983243|FG000|Overall Study|Adverse Event|1|||
13469585|NCT00062647|26983244|FG001|Overall Study|Adverse Event|1|||
13469586|NCT00062647|26983243|FG000|Overall Study|Withdrawal by Subject|2|||
13469587|NCT00062647|26983244|FG001|Overall Study|Withdrawal by Subject|1|||
13469588|NCT00062647|26983243|FG000|Overall Study|Protocol Violation|1|||
13469589|NCT00062647|26983244|FG001|Overall Study|Protocol Violation|0|||
13469590|NCT00062647|26983243|FG000|Overall Study|Lost to Follow-up|1|||
13469591|NCT00062647|26983244|FG001|Overall Study|Lost to Follow-up|2|||
13469592|NCT00062647|26983243|FG000|Overall Study|Failed continuation criteria|4|||
13469593|NCT00062647|26983244|FG001|Overall Study|Failed continuation criteria|2|||
13469594|NCT00062647|26983243|FG000|Overall Study|Other|4|||
13469595|NCT00062647|26983244|FG001|Overall Study|Other|4|||
13469596|NCT00062647|26983243|FG000|Overall Study|Never received study treatment|1|||
13469597|NCT00062647|26983244|FG001|Overall Study|Never received study treatment|1|||
13469598|NCT00062439|26983258|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1|||
13469599|NCT00062439|26983258|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1|||
13469600|NCT00062439|26983258|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3|||
13469601|NCT00062439|26983258|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3|||
13469602|NCT00062439|26983258|FG000|Post Chemoradiation Assessment|Death|1|||
13469603|NCT00062439|26983258|FG000|Post Chemoradiation Assessment|Disease progression|2|||
13469604|NCT00062439|26983258|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1|||
13469605|NCT00062439|26983258|FG000|Post Chemoradiation Assessment|Physician Decision|1|||
13469606|NCT00062439|26983258|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4|||
13469607|NCT00062439|26983258|FG000|Surgery|Physician Decision|4|||
13469608|NCT00062439|26983258|FG000|Surgery|Death|1|||
13469609|NCT00062439|26983258|FG000|Surgery|Adverse Event|2|||
13469610|NCT00062439|26983258|FG000|Consolidation Chemotherapy|Adverse Event|2|||
13469611|NCT00062374|26983265|FG000|Overall Study|Not treated|12|||
13469612|NCT00062166|26983275|FG000|Overall Study|Withdrawal by Subject|6|||
13469613|NCT00062010|26983283|FG000|Overall Study|Ineligible|3|||
13469614|NCT00061945|26983303|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18|||
13469615|NCT00061945|26983304|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25|||
13469616|NCT00061945|26983303|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76|||
13469617|NCT00061945|26983304|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90|||
13469618|NCT00061945|26983303|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
13469619|NCT00061945|26983304|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
13469620|NCT00061945|26983303|FG000|Course IV: Alemtuzumab|Early exits|6|||
13469621|NCT00061945|26983304|FG001|Course IV: Alemtuzumab|Early exits|15|||
13469622|NCT00061932|26983319|FG000|Overall Study|Withdrawal by Subject|13|||
13469623|NCT00061932|26983320|FG001|Overall Study|Withdrawal by Subject|4|||
13469624|NCT00061633|26983333|FG000|Overall Study|Adverse Event|1|||
13469625|NCT00061633|26983334|FG001|Overall Study|Adverse Event|2|||
13469626|NCT00061633|26983333|FG000|Overall Study|Withdrawal by Subject|2|||
13469627|NCT00061633|26983334|FG001|Overall Study|Withdrawal by Subject|2|||
13469628|NCT00061633|26983333|FG000|Overall Study|Lost to Follow-up|1|||
13469629|NCT00061633|26983334|FG001|Overall Study|Lost to Follow-up|4|||
13469630|NCT00061633|26983333|FG000|Overall Study|Other|1|||
13469631|NCT00061633|26983334|FG001|Overall Study|Other|1|||
13469632|NCT00061633|26983333|FG000|Overall Study|Never received study treatment|0|||
13469633|NCT00061633|26983334|FG001|Overall Study|Never received study treatment|2|||
13469634|NCT00061048|26983344|FG000|Overall Study|Adverse Event|2|||
13469635|NCT00061048|26983344|FG000|Overall Study|disease progression|20|||
13469636|NCT00060944|26983365|FG000|Overall Study|Adverse Event|12|||
13469637|NCT00060944|26983366|FG001|Overall Study|Adverse Event|10|||
13469638|NCT00060944|26983365|FG000|Overall Study|Death|2|||
13469639|NCT00060944|26983366|FG001|Overall Study|Death|3|||
13469640|NCT00060944|26983365|FG000|Overall Study|Withdrawal by Subject|18|||
13469641|NCT00060944|26983366|FG001|Overall Study|Withdrawal by Subject|5|||
13469642|NCT00060944|26983365|FG000|Overall Study|Disease Progression|93|||
13469643|NCT00060944|26983366|FG001|Overall Study|Disease Progression|94|||
13469644|NCT00060944|26983365|FG000|Overall Study|Lost to Follow-up|1|||
13469645|NCT00060944|26983366|FG001|Overall Study|Lost to Follow-up|0|||
13469646|NCT00060944|26983365|FG000|Overall Study|Subject Ineligible To Continue|2|||
13469647|NCT00060944|26983366|FG001|Overall Study|Subject Ineligible To Continue|1|||
13469648|NCT00060944|26983365|FG000|Overall Study|Treatment Switch|0|||
13469649|NCT00060944|26983366|FG001|Overall Study|Treatment Switch|13|||
13469650|NCT00060944|26983365|FG000|Overall Study|Other|2|||
13469651|NCT00060944|26983366|FG001|Overall Study|Other|4|||
13469652|NCT00060944|26983365|FG000|Overall Study|randomized but not treated|6|||
13469653|NCT00060944|26983366|FG001|Overall Study|randomized but not treated|4|||
13469654|NCT00060840|26983379|FG000|Overall Study|Change in surgical plan|2|||
13469655|NCT00060840|26983380|FG001|Overall Study|Change in surgical plan|6|||
13469656|NCT00060840|26983379|FG000|Overall Study|Death|0|||
13469657|NCT00060840|26983380|FG001|Overall Study|Death|1|||
13469658|NCT00060840|26983379|FG000|Overall Study|Withdrawal by Subject|0|||
13469659|NCT00060840|26983380|FG001|Overall Study|Withdrawal by Subject|1|||
13469660|NCT00060840|26983379|FG000|Overall Study|Subinvestigator unavailable|0|||
13469661|NCT00060840|26983380|FG001|Overall Study|Subinvestigator unavailable|1|||
13469662|NCT00060840|26983379|FG000|Overall Study|Physician Decision|1|||
13469663|NCT00060840|26983380|FG001|Overall Study|Physician Decision|0|||
13469664|NCT00060840|26983379|FG000|Overall Study|Other|1|||
13469665|NCT00060840|26983380|FG001|Overall Study|Other|0|||
13469666|NCT00059839|26983393|FG000|Overall Study|Death|1|||
13469667|NCT00059839|26983394|FG001|Overall Study|Death|1|||
13469668|NCT00059839|26983393|FG000|Overall Study|Lack of Efficacy|6|||
13469669|NCT00059839|26983394|FG001|Overall Study|Lack of Efficacy|5|||
13469670|NCT00059839|26983393|FG000|Overall Study|Lost to Follow-up|2|||
13469671|NCT00059839|26983394|FG001|Overall Study|Lost to Follow-up|0|||
13469672|NCT00059839|26983393|FG000|Overall Study|Physician Decision|1|||
13469673|NCT00059839|26983394|FG001|Overall Study|Physician Decision|2|||
13469674|NCT00059839|26983393|FG000|Overall Study|Withdrawal by Subject|1|||
13469675|NCT00059839|26983394|FG001|Overall Study|Withdrawal by Subject|6|||
13469676|NCT00059839|26983393|FG000|Overall Study|Ineligible|1|||
13469677|NCT00059839|26983394|FG001|Overall Study|Ineligible|3|||
13469678|NCT00059787|26983404|FG000|Overall Study|Adverse Event|13|||
13469679|NCT00059787|26983404|FG000|Overall Study|disease progression|2|||
13469680|NCT00059787|26983404|FG000|Overall Study|ineligible|1|||
13469681|NCT00059787|26983404|FG000|Overall Study|Other|4|||
13469682|NCT00059332|26983433|FG000|Overall Study|Withdrawal by Subject|2|||
13469683|NCT00059332|26983434|FG001|Overall Study|Withdrawal by Subject|1|||
13469684|NCT00059332|26983433|FG000|Overall Study|Lost to Follow-up|1|||
13469685|NCT00059332|26983434|FG001|Overall Study|Lost to Follow-up|1|||
13469686|NCT00059215|26983473|FG000|Overall Study|Adverse Event|5|||
13469687|NCT00059215|26983474|FG001|Overall Study|Adverse Event|5|||
13469688|NCT00059215|26983475|FG002|Overall Study|Adverse Event|9|||
13469689|NCT00059215|26983476|FG003|Overall Study|Adverse Event|9|||
13469690|NCT00059215|26983473|FG000|Overall Study|Death|0|||
13469691|NCT00059215|26983474|FG001|Overall Study|Death|0|||
13469692|NCT00059215|26983475|FG002|Overall Study|Death|3|||
13469693|NCT00059215|26983476|FG003|Overall Study|Death|0|||
13469694|NCT00059215|26983473|FG000|Overall Study|Lost to Follow-up|1|||
13469695|NCT00059215|26983474|FG001|Overall Study|Lost to Follow-up|2|||
13469696|NCT00059215|26983475|FG002|Overall Study|Lost to Follow-up|0|||
13469697|NCT00059215|26983476|FG003|Overall Study|Lost to Follow-up|0|||
13469698|NCT00059215|26983473|FG000|Overall Study|Withdrawal by Subject|4|||
13469699|NCT00059215|26983474|FG001|Overall Study|Withdrawal by Subject|4|||
13469700|NCT00059215|26983475|FG002|Overall Study|Withdrawal by Subject|1|||
13469701|NCT00059215|26983476|FG003|Overall Study|Withdrawal by Subject|3|||
13469702|NCT00059215|26983473|FG000|Overall Study|Protocol Violation|1|||
13469703|NCT00059215|26983474|FG001|Overall Study|Protocol Violation|0|||
13469704|NCT00059215|26983475|FG002|Overall Study|Protocol Violation|1|||
13469705|NCT00059215|26983476|FG003|Overall Study|Protocol Violation|0|||
13469706|NCT00059215|26983473|FG000|Overall Study|Protocol entry criteria not met|1|||
13469707|NCT00059215|26983474|FG001|Overall Study|Protocol entry criteria not met|1|||
13469708|NCT00059215|26983475|FG002|Overall Study|Protocol entry criteria not met|0|||
13469709|NCT00059215|26983476|FG003|Overall Study|Protocol entry criteria not met|2|||
13469710|NCT00059215|26983473|FG000|Overall Study|Physician Decision|1|||
13469711|NCT00059215|26983474|FG001|Overall Study|Physician Decision|2|||
13469712|NCT00059215|26983475|FG002|Overall Study|Physician Decision|1|||
13469713|NCT00059215|26983476|FG003|Overall Study|Physician Decision|1|||
13469714|NCT00059202|26983519|FG000|Overall Study|Withdrawal by Subject|5|||
13469715|NCT00059202|26983520|FG001|Overall Study|Withdrawal by Subject|9|||
13469716|NCT00059202|26983519|FG000|Overall Study|Protocol Violation|1|||
13469717|NCT00059202|26983520|FG001|Overall Study|Protocol Violation|3|||
13469718|NCT00059202|26983519|FG000|Overall Study|drug toxicity|0|||
13469719|NCT00059202|26983520|FG001|Overall Study|drug toxicity|3|||
13469720|NCT00058825|26983536|FG000|Overall Study|Relapse|9|||
13469721|NCT00058825|26983536|FG000|Overall Study|Progressive Disease|5|||
13469722|NCT00058825|26983536|FG000|Overall Study|Graft Failure|5|||
13469723|NCT00058825|26983536|FG000|Overall Study|Death|3|||
13469724|NCT00058552|26983561|FG000|Overall Study|Died prior to receiving treatment|4|||
13469725|NCT00058552|26983562|FG001|Overall Study|Died prior to receiving treatment|2|||
13469726|NCT00058552|26983561|FG000|Overall Study|Disease progression|52|||
13469727|NCT00058552|26983562|FG001|Overall Study|Disease progression|44|||
13469728|NCT00058552|26983561|FG000|Overall Study|Adverse Event|4|||
13469729|NCT00058552|26983562|FG001|Overall Study|Adverse Event|2|||
13469730|NCT00058552|26983561|FG000|Overall Study|Withdrawal by Subject|3|||
13469731|NCT00058552|26983562|FG001|Overall Study|Withdrawal by Subject|5|||
13469732|NCT00058552|26983561|FG000|Overall Study|Physician Decision|2|||
13469733|NCT00058552|26983562|FG001|Overall Study|Physician Decision|5|||
13469734|NCT00058552|26983561|FG000|Overall Study|Clinical disease progression|0|||
13469735|NCT00058552|26983562|FG001|Overall Study|Clinical disease progression|4|||
13469736|NCT00058539|26983574|FG000|Overall Study|Disease progression|24|||
13469737|NCT00058539|26983574|FG000|Overall Study|Adverse Event|3|||
13469738|NCT00058539|26983574|FG000|Overall Study|Withdrawal by Subject|5|||
13469739|NCT00058539|26983574|FG000|Overall Study|Physician Decision|9|||
13469740|NCT00058539|26983574|FG000|Overall Study|Death|1|||
13469741|NCT00058422|26983584|FG000|Overall Study|Not treated|2|||
13469742|NCT00058214|26983591|FG000|Overall Study|Adverse Event|1|||
13469743|NCT00058123|26983600|FG000|Overall Study|Wrong histology|9|||
13469744|NCT00058123|26983600|FG000|Overall Study|Received >3 prior treatments|1|||
13469745|NCT00058058|26983611|FG000|Overall Study|Withdrawal by Subject|4|||
13469746|NCT00058058|26983611|FG000|Overall Study|Ineligible|20|||
13469747|NCT00058058|26983611|FG000|Overall Study|Claustrophobic|5|||
13469748|NCT00058058|26983611|FG000|Overall Study|technical issues|6|||
13469749|NCT00058058|26983611|FG000|Overall Study|Poor positioning, illness,pain|3|||
13469750|NCT00057954|26983619|FG000|Overall Study|Death|1|||
13469751|NCT00057954|26983619|FG000|Overall Study|Disease progression|1|||
13469752|NCT00057941|26983632|FG000|Overall Study|Death|1|||
13469753|NCT00057941|26983633|FG001|Overall Study|Death|2|||
13469754|NCT00057941|26983632|FG000|Overall Study|Adverse Event|7|||
13469755|NCT00057941|26983633|FG001|Overall Study|Adverse Event|9|||
13469756|NCT00057941|26983632|FG000|Overall Study|Lack of Efficacy|54|||
13469757|NCT00057941|26983633|FG001|Overall Study|Lack of Efficacy|53|||
13469758|NCT00057941|26983632|FG000|Overall Study|Withdrawal by Subject|6|||
13469759|NCT00057941|26983633|FG001|Overall Study|Withdrawal by Subject|1|||
13469760|NCT00057941|26983632|FG000|Overall Study|still on treatment|3|||
13469761|NCT00057941|26983633|FG001|Overall Study|still on treatment|1|||
13469762|NCT00057941|26983632|FG000|Overall Study|insurance, symptomatic deterioration|1|||
13469763|NCT00057941|26983633|FG001|Overall Study|insurance, symptomatic deterioration|3|||
13469764|NCT00057941|26983632|FG000|Overall Study|Ineligible|2|||
13469765|NCT00057941|26983633|FG001|Overall Study|Ineligible|5|||
13469766|NCT00057876|26983650|FG000|Overall Study|Adverse Event|8|||
13469767|NCT00057876|26983651|FG001|Overall Study|Adverse Event|8|||
13469768|NCT00057876|26983650|FG000|Overall Study|Death|2|||
13469769|NCT00057876|26983651|FG001|Overall Study|Death|1|||
13469770|NCT00057876|26983650|FG000|Overall Study|Withdrawal by Subject|5|||
13469771|NCT00057876|26983651|FG001|Overall Study|Withdrawal by Subject|6|||
13469772|NCT00057876|26983650|FG000|Overall Study|Lack of Efficacy|10|||
13469773|NCT00057876|26983651|FG001|Overall Study|Lack of Efficacy|8|||
13469774|NCT00057876|26983650|FG000|Overall Study|Ineligible|1|||
13469775|NCT00057876|26983651|FG001|Overall Study|Ineligible|2|||
13469776|NCT00057876|26983650|FG000|Overall Study|other reason|2|||
13469777|NCT00057876|26983651|FG001|Overall Study|other reason|2|||
13469778|NCT00057876|26983650|FG000|Overall Study|other complicating disease|1|||
13469779|NCT00057876|26983651|FG001|Overall Study|other complicating disease|0|||
13469780|NCT00057863|26983660|FG000|Overall Study|Death|1|||
13469781|NCT00057863|26983660|FG000|Overall Study|Withdrawal by Subject|2|||
13469782|NCT00057837|26983677|FG000|Overall Study|Progression/relapse|12|||
13469783|NCT00057837|26983678|FG001|Overall Study|Progression/relapse|14|||
13469784|NCT00057837|26983677|FG000|Overall Study|Adverse Event|2|||
13469785|NCT00057837|26983678|FG001|Overall Study|Adverse Event|12|||
13469786|NCT00057837|26983677|FG000|Overall Study|Death|5|||
13469787|NCT00057837|26983678|FG001|Overall Study|Death|4|||
13469788|NCT00057837|26983677|FG000|Overall Study|Withdrawal by Subject|5|||
13469789|NCT00057837|26983678|FG001|Overall Study|Withdrawal by Subject|3|||
13469790|NCT00057837|26983677|FG000|Overall Study|Alternative therapy|0|||
13469791|NCT00057837|26983678|FG001|Overall Study|Alternative therapy|1|||
13469792|NCT00057837|26983677|FG000|Overall Study|Other complicating disease|2|||
13469793|NCT00057837|26983678|FG001|Overall Study|Other complicating disease|1|||
13469794|NCT00057837|26983677|FG000|Overall Study|Physician Decision|1|||
13469795|NCT00057837|26983678|FG001|Overall Study|Physician Decision|0|||
13469796|NCT00057837|26983677|FG000|Overall Study|Ineligible|3|||
13469797|NCT00057837|26983678|FG001|Overall Study|Ineligible|3|||
13469798|NCT00057837|26983677|FG000|Overall Study|Never started treatment|1|||
13469799|NCT00057837|26983678|FG001|Overall Study|Never started treatment|1|||
13469800|NCT00057811|26983697|FG000|Overall Study|Lack of Efficacy|1|||
13469801|NCT00057811|26983698|FG001|Overall Study|Lack of Efficacy|4|||
13469802|NCT00057811|26983697|FG000|Overall Study|Physician Decision|1|||
13469803|NCT00057811|26983698|FG001|Overall Study|Physician Decision|0|||
13469804|NCT00057811|26983697|FG000|Overall Study|Withdrawal by Subject|3|||
13469805|NCT00057811|26983698|FG001|Overall Study|Withdrawal by Subject|4|||
13469806|NCT00057811|26983697|FG000|Overall Study|Ineligible|4|||
13469807|NCT00057811|26983698|FG001|Overall Study|Ineligible|2|||
13469808|NCT00057811|26983697|FG000|Overall Study|Inevaluable|1|||
13469809|NCT00057811|26983698|FG001|Overall Study|Inevaluable|2|||
13469810|NCT00057746|26983716|FG000|Overall Study|Withdrawal by Subject|0|||
13469811|NCT00057746|26983717|FG001|Overall Study|Withdrawal by Subject|0|||
13469812|NCT00057746|26983718|FG002|Overall Study|Withdrawal by Subject|1|||
13469813|NCT00057330|26983753|FG000|Overall Study|Adverse Event|9|||
13469814|NCT00057330|26983754|FG001|Overall Study|Adverse Event|12|||
13469815|NCT00057330|26983753|FG000|Overall Study|Death|1|||
13469816|NCT00057330|26983754|FG001|Overall Study|Death|0|||
13469817|NCT00057330|26983753|FG000|Overall Study|Protocol Violation|1|||
13469818|NCT00057330|26983754|FG001|Overall Study|Protocol Violation|1|||
13469819|NCT00057330|26983753|FG000|Overall Study|Withdrawal by Subject|115|||
13469820|NCT00057330|26983754|FG001|Overall Study|Withdrawal by Subject|84|||
13469821|NCT00057330|26983753|FG000|Overall Study|Lost to Follow-up|745|||
13469822|NCT00057330|26983754|FG001|Overall Study|Lost to Follow-up|617|||
13469823|NCT00057330|26983753|FG000|Overall Study|Physician Decision|1|||
13469824|NCT00057330|26983754|FG001|Overall Study|Physician Decision|0|||
13469825|NCT00057330|26983753|FG000|Overall Study|Other|260|||
13469826|NCT00057330|26983754|FG001|Overall Study|Other|206|||
13469827|NCT00056862|26983775|FG000|Overall Study|Protocol Violation|1|||
13469828|NCT00056862|26983776|FG001|Overall Study|Protocol Violation|0|||
13469829|NCT00056407|26983839|FG000|Overall Study|Adverse Event|282|||
13469830|NCT00056407|26983840|FG001|Overall Study|Adverse Event|364|||
13469831|NCT00056407|26983839|FG000|Overall Study|Withdrawal by Subject|377|||
13469832|NCT00056407|26983840|FG001|Overall Study|Withdrawal by Subject|361|||
13469833|NCT00056407|26983839|FG000|Overall Study|Lost to Follow-up|123|||
13469834|NCT00056407|26983840|FG001|Overall Study|Lost to Follow-up|113|||
13469835|NCT00056407|26983839|FG000|Overall Study|Protocol Violation|104|||
13469836|NCT00056407|26983840|FG001|Overall Study|Protocol Violation|95|||
13469837|NCT00056407|26983839|FG000|Overall Study|Diagnosed with Prostate Cancer|202|||
13469838|NCT00056407|26983840|FG001|Overall Study|Diagnosed with Prostate Cancer|166|||
13469839|NCT00056407|26983839|FG000|Overall Study|"Listed as Other on Case Report Form"|98|||
13469840|NCT00056407|26983840|FG001|Overall Study|"Listed as Other on Case Report Form"|60|||
13469841|NCT00056407|26983839|FG000|Overall Study|Missing|25|||
13469842|NCT00056407|26983840|FG001|Overall Study|Missing|34|||
13469843|NCT00056316|26983859|FG000|Overall Study|Withdrawal by Subject|2|||
13469844|NCT00056316|26983860|FG001|Overall Study|Withdrawal by Subject|2|||
13469845|NCT00056316|26983859|FG000|Overall Study|Death/NH placement of pt|1|||
13469846|NCT00056316|26983860|FG001|Overall Study|Death/NH placement of pt|1|||
13469847|NCT00056160|26983879|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35|||
13469848|NCT00056160|26983880|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18|||
13469849|NCT00056160|26983879|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57|||
13469850|NCT00056160|26983880|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124|||
13469851|NCT00056160|26983879|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3|||
13469852|NCT00056160|26983880|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5|||
13469853|NCT00056160|26983879|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
13469854|NCT00056160|26983880|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
13469855|NCT00056160|26983879|FG000|Up to Unblinding (07 Jun 2005)|Death|2|||
13469856|NCT00056160|26983880|FG001|Up to Unblinding (07 Jun 2005)|Death|1|||
13469857|NCT00056160|26983879|FG000|Up to Unblinding (07 Jun 2005)|Other|8|||
13469858|NCT00056160|26983880|FG001|Up to Unblinding (07 Jun 2005)|Other|7|||
13469859|NCT00056160|26983879|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44|||
13469860|NCT00056160|26983880|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0|||
13469861|NCT00056160|26983879|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87|||
13469862|NCT00056160|26983880|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0|||
13469863|NCT00056160|26983879|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3|||
13469864|NCT00056160|26983880|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0|||
13469865|NCT00056160|26983879|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11|||
13469866|NCT00056160|26983880|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0|||
13469867|NCT00056160|26983879|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5|||
13469868|NCT00056160|26983880|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0|||
13469869|NCT00056160|26983879|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21|||
13469870|NCT00056160|26983880|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0|||
13469871|NCT00056160|26983879|FG000|Final Follow-up|Transferred into expanded access study.|3|||
13469872|NCT00056160|26983880|FG001|Final Follow-up|Transferred into expanded access study.|0|||
13469873|NCT00056160|26983879|FG000|Final Follow-up|Transferred into RevAssist Program|2|||
13469874|NCT00056160|26983880|FG001|Final Follow-up|Transferred into RevAssist Program|0|||
13469875|NCT00056160|26983879|FG000|Final Follow-up|Adverse Event|1|||
13469876|NCT00056160|26983880|FG001|Final Follow-up|Adverse Event|0|||
13469877|NCT00055601|26983897|FG000|Overall Study|Protocol Violation|1|||
13469878|NCT00055601|26983898|FG001|Overall Study|Protocol Violation|1|||
13469879|NCT00055601|26983897|FG000|Overall Study|No protocol treatment received|1|||
13469880|NCT00055601|26983898|FG001|Overall Study|No protocol treatment received|1|||
13469881|NCT00055497|26983953|FG000|Overall Study|Adverse Event|1|||
13469882|NCT00055497|26983954|FG001|Overall Study|Adverse Event|1|||
13469883|NCT00055497|26983955|FG002|Overall Study|Adverse Event|1|||
13469884|NCT00055497|26983956|FG003|Overall Study|Adverse Event|28|||
13469885|NCT00055497|26983953|FG000|Overall Study|Withdrawal by Subject|3|||
13469886|NCT00055497|26983954|FG001|Overall Study|Withdrawal by Subject|1|||
13469887|NCT00055497|26983955|FG002|Overall Study|Withdrawal by Subject|1|||
13469888|NCT00055497|26983956|FG003|Overall Study|Withdrawal by Subject|15|||
13469889|NCT00055497|26983953|FG000|Overall Study|Lost to Follow-up|0|||
13469890|NCT00055497|26983954|FG001|Overall Study|Lost to Follow-up|1|||
13469891|NCT00055497|26983955|FG002|Overall Study|Lost to Follow-up|0|||
13469892|NCT00055497|26983956|FG003|Overall Study|Lost to Follow-up|5|||
13469893|NCT00055497|26983953|FG000|Overall Study|Protocol Violation|0|||
13469894|NCT00055497|26983954|FG001|Overall Study|Protocol Violation|0|||
13469895|NCT00055497|26983955|FG002|Overall Study|Protocol Violation|0|||
13469896|NCT00055497|26983956|FG003|Overall Study|Protocol Violation|3|||
13469897|NCT00055497|26983953|FG000|Overall Study|Lack of Efficacy|1|||
13469898|NCT00055497|26983954|FG001|Overall Study|Lack of Efficacy|0|||
13469899|NCT00055497|26983955|FG002|Overall Study|Lack of Efficacy|0|||
13469900|NCT00055497|26983956|FG003|Overall Study|Lack of Efficacy|27|||
13469901|NCT00055497|26983953|FG000|Overall Study|Administrative Reasons|0|||
13469902|NCT00055497|26983954|FG001|Overall Study|Administrative Reasons|0|||
13469903|NCT00055497|26983955|FG002|Overall Study|Administrative Reasons|0|||
13469904|NCT00055497|26983956|FG003|Overall Study|Administrative Reasons|1|||
13469905|NCT00055497|26983953|FG000|Overall Study|Other|0|||
13469906|NCT00055497|26983954|FG001|Overall Study|Other|0|||
13469907|NCT00055497|26983955|FG002|Overall Study|Other|0|||
13469908|NCT00055497|26983956|FG003|Overall Study|Other|11|||
13469909|NCT00055471|26983992|FG000|Period 1: Dose Escalation Period|Adverse Event|0|||
13469910|NCT00055471|26983993|FG001|Period 1: Dose Escalation Period|Adverse Event|1|||
13469911|NCT00055471|26983994|FG002|Period 1: Dose Escalation Period|Adverse Event|2|||
13469912|NCT00055471|26983992|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
13469913|NCT00055471|26983993|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
13469914|NCT00055471|26983994|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1|||
13469915|NCT00055471|26983992|FG000|Period 1: Dose Escalation Period|Disease progression|0|||
13469916|NCT00055471|26983993|FG001|Period 1: Dose Escalation Period|Disease progression|1|||
13469917|NCT00055471|26983994|FG002|Period 1: Dose Escalation Period|Disease progression|0|||
13469918|NCT00054717|26984187|FG000|Overall Study|Randomized but not treated|2|||
13469919|NCT00054717|26984188|FG001|Overall Study|Randomized but not treated|8|||
13469920|NCT00054717|26984187|FG000|Overall Study|Adverse Event|70|||
13469921|NCT00054717|26984188|FG001|Overall Study|Adverse Event|22|||
13469922|NCT00054717|26984187|FG000|Overall Study|Protocol Violation|18|||
13469923|NCT00054717|26984188|FG001|Overall Study|Protocol Violation|19|||
13469924|NCT00054717|26984187|FG000|Overall Study|Lost to Follow-up|23|||
13469925|NCT00054717|26984188|FG001|Overall Study|Lost to Follow-up|13|||
13469926|NCT00054717|26984187|FG000|Overall Study|Withdrawal by Subject|32|||
13469927|NCT00054717|26984188|FG001|Overall Study|Withdrawal by Subject|20|||
13469928|NCT00054717|26984187|FG000|Overall Study|Other reason not defined above|117|||
13469929|NCT00054717|26984188|FG001|Overall Study|Other reason not defined above|217|||
13469930|NCT00054704|26984201|FG000|Overall Study|Lack of Efficacy|2|||
13469931|NCT00054704|26984202|FG001|Overall Study|Lack of Efficacy|3|||
13469932|NCT00054704|26984201|FG000|Overall Study|Adverse Event|3|||
13469933|NCT00054704|26984202|FG001|Overall Study|Adverse Event|1|||
13469934|NCT00054704|26984201|FG000|Overall Study|Lost to Follow-up|0|||
13469935|NCT00054704|26984202|FG001|Overall Study|Lost to Follow-up|1|||
13469936|NCT00054691|26984209|FG000|Overall Study|Unmeasurable Disease|2|||
13469937|NCT00054691|26984209|FG000|Overall Study|Noncompliant|1|||
13469938|NCT00054639|26984215|FG000|Overall Study|Lack of Efficacy|1|||
13469939|NCT00054639|26984215|FG000|Overall Study|Physician Decision|1|||
13469940|NCT00054327|26984272|FG000|Overall Study|Engraftment failure|1|||
13469941|NCT00054327|26984273|FG001|Overall Study|Engraftment failure|0|||
13469942|NCT00054327|26984274|FG002|Overall Study|Engraftment failure|0|||
13469943|NCT00054327|26984275|FG003|Overall Study|Engraftment failure|0|||
13469944|NCT00054327|26984276|FG004|Overall Study|Engraftment failure|0|||
13469945|NCT00054327|26984277|FG005|Overall Study|Engraftment failure|0|||
13469946|NCT00054275|26984285|FG000|Overall Study|Withdrawal by Subject|4|||
13469947|NCT00054275|26984285|FG000|Overall Study|Adverse Event|5|||
13469948|NCT00054275|26984285|FG000|Overall Study|Progressive disease in cycle 1|1|||
13469949|NCT00054275|26984285|FG000|Overall Study|Physician Decision|1|||
13469950|NCT00054132|26984296|FG000|Overall Study|Not Treated|1|||
13469951|NCT00053898|26984327|FG000|Overall Study|No follow-up data from any source|9|||
13469952|NCT00053898|26984328|FG001|Overall Study|No follow-up data from any source|12|||
13469953|NCT00053898|26984327|FG000|Overall Study|Follow-up from telephone contact only|5|||
13469954|NCT00053898|26984328|FG001|Overall Study|Follow-up from telephone contact only|1|||
13469955|NCT00053846|26984341|FG000|Overall Study|Changed mind|8|||
13469956|NCT00053846|26984342|FG001|Overall Study|Changed mind|13|||
13469957|NCT00053846|26984341|FG000|Overall Study|Became too ill|8|||
13469958|NCT00053846|26984342|FG001|Overall Study|Became too ill|7|||
13469959|NCT00053846|26984341|FG000|Overall Study|Expired|5|||
13469960|NCT00053846|26984342|FG001|Overall Study|Expired|0|||
13469961|NCT00053846|26984341|FG000|Overall Study|Became ineligible|3|||
13469962|NCT00053846|26984342|FG001|Overall Study|Became ineligible|1|||
13469963|NCT00053846|26984341|FG000|Overall Study|Did not return data|1|||
13469964|NCT00053846|26984342|FG001|Overall Study|Did not return data|2|||
13469965|NCT00053846|26984341|FG000|Overall Study|Quit due to side effects|1|||
13469966|NCT00053846|26984342|FG001|Overall Study|Quit due to side effects|3|||
13469967|NCT00053846|26984341|FG000|Overall Study|Pills too large|0|||
13469968|NCT00053846|26984342|FG001|Overall Study|Pills too large|1|||
13469969|NCT00053417|26984365|FG000|Overall Study|Adverse Event|1|||
13469970|NCT00053417|26984366|FG001|Overall Study|Adverse Event|0|||
13469971|NCT00053417|26984367|FG002|Overall Study|Adverse Event|1|||
13469972|NCT00053417|26984368|FG003|Overall Study|Adverse Event|5|||
13469973|NCT00053417|26984365|FG000|Overall Study|Non-Compliance|0|||
13469974|NCT00053417|26984366|FG001|Overall Study|Non-Compliance|0|||
13469975|NCT00053417|26984367|FG002|Overall Study|Non-Compliance|0|||
13469976|NCT00053417|26984368|FG003|Overall Study|Non-Compliance|1|||
13469977|NCT00053417|26984365|FG000|Overall Study|Withdrawal by Subject|0|||
13469978|NCT00053417|26984366|FG001|Overall Study|Withdrawal by Subject|1|||
13469979|NCT00053417|26984367|FG002|Overall Study|Withdrawal by Subject|0|||
13469980|NCT00053417|26984368|FG003|Overall Study|Withdrawal by Subject|0|||
13469981|NCT00053417|26984365|FG000|Overall Study|Lost to Follow-up|1|||
13469982|NCT00053417|26984366|FG001|Overall Study|Lost to Follow-up|1|||
13469983|NCT00053417|26984367|FG002|Overall Study|Lost to Follow-up|0|||
13469984|NCT00053417|26984368|FG003|Overall Study|Lost to Follow-up|0|||
13469985|NCT00053365|26984377|FG000|Overall Study|Incorrect cell type|1|||
13469986|NCT00053365|26984377|FG000|Overall Study|Platinum-sensitive interval >12 months|1|||
13469987|NCT00053365|26984377|FG000|Overall Study|Never treated|4|||
13469988|NCT00053352|26984393|FG000|Overall Study|Lost to Follow-up|0|||
13469989|NCT00053352|26984394|FG001|Overall Study|Lost to Follow-up|1|||
13469990|NCT00053352|26984393|FG000|Overall Study|Physician Decision|11|||
13469991|NCT00053352|26984394|FG001|Overall Study|Physician Decision|1|||
13469992|NCT00053352|26984393|FG000|Overall Study|Withdrawal by Subject|1|||
13469993|NCT00053352|26984394|FG001|Overall Study|Withdrawal by Subject|0|||
13469994|NCT00053352|26984393|FG000|Overall Study|Ineligible|8|||
13469995|NCT00053352|26984394|FG001|Overall Study|Ineligible|8|||
13469996|NCT00053352|26984393|FG000|Overall Study|Disease at new site|1|||
13469997|NCT00053352|26984394|FG001|Overall Study|Disease at new site|0|||
13469998|NCT00052962|26984409|FG000|Overall Study|Not evaluable|0|||
13469999|NCT00052962|26984410|FG001|Overall Study|Not evaluable|2|||
13470000|NCT00052962|26984409|FG000|Overall Study|Not randomized/not evaluable|1|||
13470001|NCT00052962|26984410|FG001|Overall Study|Not randomized/not evaluable|0|||
13470002|NCT00052715|26984421|FG000|Overall Study|wrong histology|1|||
13470003|NCT00051636|26984454|FG000|Period 1 - Core|Adverse Event|2|||
13470004|NCT00051636|26984455|FG001|Period 1 - Core|Adverse Event|2|||
13470005|NCT00051636|26984454|FG000|Period 1 - Core|Protocol Violation|1|||
13470006|NCT00051636|26984455|FG001|Period 1 - Core|Protocol Violation|0|||
13470007|NCT00051636|26984454|FG000|Period 1 - Core|Withdrawal by Subject|1|||
13470008|NCT00051636|26984455|FG001|Period 1 - Core|Withdrawal by Subject|2|||
13470009|NCT00051636|26984454|FG000|Period 1 - Core|Lost to Follow-up|0|||
13470010|NCT00051636|26984455|FG001|Period 1 - Core|Lost to Follow-up|2|||
13470011|NCT00051636|26984454|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5|||
13470012|NCT00051636|26984455|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4|||
13470013|NCT00051636|26984454|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12|||
13470014|NCT00051636|26984455|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7|||
13470015|NCT00051636|26984454|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9|||
13470016|NCT00051636|26984455|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2|||
13470017|NCT00051636|26984454|FG000|Period 2- Extended Observation Period|Death|4|||
13470018|NCT00051636|26984455|FG001|Period 2- Extended Observation Period|Death|5|||
13470019|NCT00051636|26984454|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40|||
13470020|NCT00051636|26984455|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12|||
13470021|NCT00051558|26984496|FG000|Overall Study|Adverse Event|30|||
13470022|NCT00051558|26984497|FG001|Overall Study|Adverse Event|18|||
13470023|NCT00051558|26984496|FG000|Overall Study|Withdrawal by Subject|29|||
13470024|NCT00051558|26984497|FG001|Overall Study|Withdrawal by Subject|42|||
13470025|NCT00051558|26984496|FG000|Overall Study|Death|9|||
13470026|NCT00051558|26984497|FG001|Overall Study|Death|15|||
13470027|NCT00051558|26984496|FG000|Overall Study|Lost to Follow-up|4|||
13470028|NCT00051558|26984497|FG001|Overall Study|Lost to Follow-up|13|||
13470029|NCT00051558|26984496|FG000|Overall Study|Protocol Violation|3|||
13470030|NCT00051558|26984497|FG001|Overall Study|Protocol Violation|4|||
13470031|NCT00051558|26984496|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
13470032|NCT00051558|26984497|FG001|Overall Study|Protocol Entry Criteria Unmet|2|||
13470033|NCT00051558|26984496|FG000|Overall Study|Sponsor Decision|6|||
13470034|NCT00051558|26984497|FG001|Overall Study|Sponsor Decision|1|||
13470035|NCT00051558|26984496|FG000|Overall Study|Other|2|||
13470036|NCT00051558|26984497|FG001|Overall Study|Other|1|||
13470037|NCT00051558|26984496|FG000|Overall Study|Significant Lab Value|2|||
13470038|NCT00051558|26984497|FG001|Overall Study|Significant Lab Value|0|||
13470039|NCT00051558|26984496|FG000|Overall Study|Physician Decision|5|||
13470040|NCT00051558|26984497|FG001|Overall Study|Physician Decision|0|||
13470041|NCT00051363|26984538|FG000|Overall Study|Dropped Post-Rand for Any Reason|102|||
13470042|NCT00051363|26984539|FG001|Overall Study|Dropped Post-Rand for Any Reason|126|||
13470043|NCT00051363|26984538|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9|||
13470044|NCT00051363|26984539|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11|||
13470045|NCT00051363|26984538|FG000|Overall Study|Death|2|||
13470046|NCT00051363|26984539|FG001|Overall Study|Death|2|||
13470047|NCT00051363|26984538|FG000|Overall Study|Excluded Pre-Randomization|2|||
13470048|NCT00051363|26984539|FG001|Overall Study|Excluded Pre-Randomization|5|||
13470049|NCT00051311|26984558|FG000|Overall Study|Starting new study|0|||
13470050|NCT00051311|26984559|FG001|Overall Study|Starting new study|1|||
13470051|NCT00051311|26984558|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0|||
13470052|NCT00051311|26984559|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1|||
13470053|NCT00051311|26984558|FG000|Overall Study|Death of recipient|8|||
13470054|NCT00051311|26984559|FG001|Overall Study|Death of recipient|8|||
13470055|NCT00051311|26984558|FG000|Overall Study|Recipient taken off study|4|||
13470056|NCT00051311|26984559|FG001|Overall Study|Recipient taken off study|4|||
13470057|NCT00051025|26984574|FG000|Overall Study|Progressive Disease|1|||
13470058|NCT00051025|26984575|FG001|Overall Study|Progressive Disease|1|||
13470059|NCT00051025|26984574|FG000|Overall Study|Adverse Event|1|||
13470060|NCT00051025|26984575|FG001|Overall Study|Adverse Event|1|||
13470061|NCT00051025|26984574|FG000|Overall Study|Withdrawal by Subject|0|||
13470062|NCT00051025|26984575|FG001|Overall Study|Withdrawal by Subject|1|||
13470063|NCT00051025|26984574|FG000|Overall Study|Death|0|||
13470064|NCT00051025|26984575|FG001|Overall Study|Death|1|||
13470065|NCT00050960|26984588|FG000|Overall Study|Progressive Disease|137|||
13470066|NCT00050960|26984589|FG001|Overall Study|Progressive Disease|93|||
13470067|NCT00050960|26984588|FG000|Overall Study|Stable Disease|19|||
13470068|NCT00050960|26984589|FG001|Overall Study|Stable Disease|48|||
13470069|NCT00050960|26984588|FG000|Overall Study|Partial Response|14|||
13470070|NCT00050960|26984589|FG001|Overall Study|Partial Response|19|||
13470071|NCT00050960|26984588|FG000|Overall Study|Complete Response|0|||
13470072|NCT00050960|26984589|FG001|Overall Study|Complete Response|2|||
13470073|NCT00050960|26984588|FG000|Overall Study|Adverse Event|62|||
13470074|NCT00050960|26984589|FG001|Overall Study|Adverse Event|61|||
13470075|NCT00050960|26984588|FG000|Overall Study|Lost to Follow-up|0|||
13470076|NCT00050960|26984589|FG001|Overall Study|Lost to Follow-up|1|||
13470077|NCT00050960|26984588|FG000|Overall Study|Withdrawal by Subject|23|||
13470078|NCT00050960|26984589|FG001|Overall Study|Withdrawal by Subject|18|||
13470079|NCT00050960|26984588|FG000|Overall Study|Administrative|31|||
13470080|NCT00050960|26984589|FG001|Overall Study|Administrative|46|||
13470081|NCT00050960|26984588|FG000|Overall Study|Non-compliance|3|||
13470082|NCT00050960|26984589|FG001|Overall Study|Non-compliance|1|||
13470083|NCT00050960|26984588|FG000|Overall Study|Death|13|||
13470084|NCT00050960|26984589|FG001|Overall Study|Death|15|||
13470085|NCT00050778|26984625|FG000|Overall Study|Adverse Event|13|||
13470086|NCT00050778|26984626|FG001|Overall Study|Adverse Event|3|||
13470087|NCT00050778|26984627|FG002|Overall Study|Adverse Event|2|||
13470088|NCT00050778|26984625|FG000|Overall Study|Death|0|||
13470089|NCT00050778|26984626|FG001|Overall Study|Death|1|||
13470090|NCT00050778|26984627|FG002|Overall Study|Death|1|||
13470091|NCT00050778|26984625|FG000|Overall Study|Lack of Efficacy|16|||
13470092|NCT00050778|26984626|FG001|Overall Study|Lack of Efficacy|2|||
13470093|NCT00050778|26984627|FG002|Overall Study|Lack of Efficacy|2|||
13470094|NCT00050778|26984625|FG000|Overall Study|Lost to Follow-up|0|||
13470095|NCT00050778|26984626|FG001|Overall Study|Lost to Follow-up|2|||
13470096|NCT00050778|26984627|FG002|Overall Study|Lost to Follow-up|4|||
13470097|NCT00050778|26984625|FG000|Overall Study|Physician Decision|3|||
13470098|NCT00050778|26984626|FG001|Overall Study|Physician Decision|0|||
13470099|NCT00050778|26984627|FG002|Overall Study|Physician Decision|2|||
13470100|NCT00050778|26984625|FG000|Overall Study|Protocol Violation|2|||
13470101|NCT00050778|26984626|FG001|Overall Study|Protocol Violation|0|||
13470102|NCT00050778|26984627|FG002|Overall Study|Protocol Violation|1|||
13470103|NCT00050778|26984625|FG000|Overall Study|Withdrawal by Subject|6|||
13470104|NCT00050778|26984626|FG001|Overall Study|Withdrawal by Subject|8|||
13470105|NCT00050778|26984627|FG002|Overall Study|Withdrawal by Subject|4|||
13470106|NCT00050778|26984625|FG000|Overall Study|Randomized but not treated|4|||
13470107|NCT00050778|26984626|FG001|Overall Study|Randomized but not treated|5|||
13470108|NCT00050778|26984627|FG002|Overall Study|Randomized but not treated|2|||
13470109|NCT00050778|26984625|FG000|Overall Study|Familial and personal reasons|1|||
13470110|NCT00050778|26984626|FG001|Overall Study|Familial and personal reasons|0|||
13470111|NCT00050778|26984627|FG002|Overall Study|Familial and personal reasons|0|||
13470112|NCT00050622|26984665|FG000|Overall Study|Adverse Event|1|||
13470113|NCT00050167|26984678|FG000|Overall Study|not eligible not invasive|1|||
13470114|NCT00050167|26984679|FG001|Overall Study|not eligible not invasive|1|||
13470115|NCT00050011|26984706|FG000|Overall Study|Adverse Event|41|||
13470116|NCT00050011|26984707|FG001|Overall Study|Adverse Event|46|||
13470117|NCT00050011|26984706|FG000|Overall Study|Abnormal laboratory value(s)|1|||
13470118|NCT00050011|26984707|FG001|Overall Study|Abnormal laboratory value(s)|1|||
13470119|NCT00050011|26984706|FG000|Overall Study|Abnormal test procedure results|0|||
13470120|NCT00050011|26984707|FG001|Overall Study|Abnormal test procedure results|1|||
13470121|NCT00050011|26984706|FG000|Overall Study|Lack of Efficacy|16|||
13470122|NCT00050011|26984707|FG001|Overall Study|Lack of Efficacy|21|||
13470123|NCT00050011|26984706|FG000|Overall Study|Participant condition no longer required|1|||
13470124|NCT00050011|26984707|FG001|Overall Study|Participant condition no longer required|0|||
13470125|NCT00050011|26984706|FG000|Overall Study|Protocol Violation|4|||
13470126|NCT00050011|26984707|FG001|Overall Study|Protocol Violation|10|||
13470127|NCT00050011|26984706|FG000|Overall Study|Withdrawal by Subject|34|||
13470128|NCT00050011|26984707|FG001|Overall Study|Withdrawal by Subject|26|||
13470129|NCT00050011|26984706|FG000|Overall Study|Lost to Follow-up|7|||
13470130|NCT00050011|26984707|FG001|Overall Study|Lost to Follow-up|9|||
13470131|NCT00050011|26984706|FG000|Overall Study|Administrative problems|10|||
13470132|NCT00050011|26984707|FG001|Overall Study|Administrative problems|6|||
13470133|NCT00050011|26984706|FG000|Overall Study|Death|7|||
13470134|NCT00050011|26984707|FG001|Overall Study|Death|4|||
13470135|NCT00050011|26984706|FG000|Overall Study|Unknown - Reason is missing|0|||
13470136|NCT00050011|26984707|FG001|Overall Study|Unknown - Reason is missing|2|||
13470137|NCT00049842|26984730|FG000|Treatment Phase|Adverse Event|47|||
13470138|NCT00049842|26984731|FG001|Treatment Phase|Adverse Event|12|||
13470139|NCT00049842|26984730|FG000|Treatment Phase|Withdrawal by Subject|35|||
13470140|NCT00049842|26984731|FG001|Treatment Phase|Withdrawal by Subject|46|||
13470141|NCT00049842|26984730|FG000|Treatment Phase|Non-compliance with protocol|7|||
13470142|NCT00049842|26984731|FG001|Treatment Phase|Non-compliance with protocol|8|||
13470143|NCT00049842|26984730|FG000|Treatment Phase|Lost to Follow-up|4|||
13470144|NCT00049842|26984731|FG001|Treatment Phase|Lost to Follow-up|8|||
13470145|NCT00049842|26984730|FG000|Treatment Phase|Administrative|0|||
13470146|NCT00049842|26984731|FG001|Treatment Phase|Administrative|3|||
13470147|NCT00049842|26984730|FG000|Treatment Phase|Did not meet protocol eligibility|0|||
13470148|NCT00049842|26984731|FG001|Treatment Phase|Did not meet protocol eligibility|1|||
13470149|NCT00049842|26984730|FG000|Follow-up Phase|Adverse Event|6|||
13470150|NCT00049842|26984731|FG001|Follow-up Phase|Adverse Event|1|||
13470151|NCT00049842|26984730|FG000|Follow-up Phase|Other|1|||
13470152|NCT00049842|26984731|FG001|Follow-up Phase|Other|4|||
13470153|NCT00049673|26984746|FG000|Overall Study|No receive treatment/lost to follow-up|1|||
13470154|NCT00049673|26984747|FG001|Overall Study|No receive treatment/lost to follow-up|3|||
13470155|NCT00049543|26984764|FG000|Overall Study|still on treatment|2|||
13470156|NCT00049543|26984765|FG001|Overall Study|still on treatment|9|||
13470157|NCT00049530|26984774|FG000|Overall Study|Lack of Efficacy|25|||
13470158|NCT00049530|26984774|FG000|Overall Study|Adverse Event|2|||
13470159|NCT00049530|26984774|FG000|Overall Study|Death|1|||
13470160|NCT00049530|26984774|FG000|Overall Study|symptomatic deterioration|1|||
13470161|NCT00049530|26984774|FG000|Overall Study|ineligible|3|||
13470162|NCT00049517|26984795|FG000|Induction|Disease progression|0|||
13470163|NCT00049517|26984796|FG001|Induction|Disease progression|0|||
13470164|NCT00049517|26984797|FG002|Induction|Disease progression|0|||
13470165|NCT00049517|26984798|FG003|Induction|Disease progression|0|||
13470166|NCT00049517|26984799|FG004|Induction|Disease progression|18|||
13470167|NCT00049517|26984800|FG005|Induction|Disease progression|11|||
13470168|NCT00049517|26984795|FG000|Induction|Adverse Event|0|||
13470169|NCT00049517|26984796|FG001|Induction|Adverse Event|0|||
13470170|NCT00049517|26984797|FG002|Induction|Adverse Event|0|||
13470171|NCT00049517|26984798|FG003|Induction|Adverse Event|0|||
13470172|NCT00049517|26984799|FG004|Induction|Adverse Event|5|||
13470173|NCT00049517|26984800|FG005|Induction|Adverse Event|7|||
13470174|NCT00049517|26984795|FG000|Induction|Death|0|||
13470175|NCT00049517|26984796|FG001|Induction|Death|0|||
13470176|NCT00049517|26984797|FG002|Induction|Death|0|||
13470177|NCT00049517|26984798|FG003|Induction|Death|0|||
13470178|NCT00049517|26984799|FG004|Induction|Death|9|||
13470179|NCT00049517|26984800|FG005|Induction|Death|6|||
13470180|NCT00049517|26984795|FG000|Induction|Withdrawal by Subject|0|||
13470181|NCT00049517|26984796|FG001|Induction|Withdrawal by Subject|0|||
13470182|NCT00049517|26984797|FG002|Induction|Withdrawal by Subject|0|||
13470183|NCT00049517|26984798|FG003|Induction|Withdrawal by Subject|0|||
13470184|NCT00049517|26984799|FG004|Induction|Withdrawal by Subject|1|||
13470185|NCT00049517|26984800|FG005|Induction|Withdrawal by Subject|3|||
13470186|NCT00049517|26984795|FG000|Induction|Alternative therapy|0|||
13470187|NCT00049517|26984796|FG001|Induction|Alternative therapy|0|||
13470188|NCT00049517|26984797|FG002|Induction|Alternative therapy|0|||
13470189|NCT00049517|26984798|FG003|Induction|Alternative therapy|0|||
13470190|NCT00049517|26984799|FG004|Induction|Alternative therapy|2|||
13470191|NCT00049517|26984800|FG005|Induction|Alternative therapy|2|||
13470192|NCT00049517|26984795|FG000|Induction|Other complicating disease|0|||
13470193|NCT00049517|26984796|FG001|Induction|Other complicating disease|0|||
13470194|NCT00049517|26984797|FG002|Induction|Other complicating disease|0|||
13470195|NCT00049517|26984798|FG003|Induction|Other complicating disease|0|||
13470196|NCT00049517|26984799|FG004|Induction|Other complicating disease|3|||
13470197|NCT00049517|26984800|FG005|Induction|Other complicating disease|0|||
13470198|NCT00049517|26984795|FG000|Induction|Reasons not reported|0|||
13470199|NCT00049517|26984796|FG001|Induction|Reasons not reported|0|||
13470200|NCT00049517|26984797|FG002|Induction|Reasons not reported|0|||
13470201|NCT00049517|26984798|FG003|Induction|Reasons not reported|0|||
13470202|NCT00049517|26984799|FG004|Induction|Reasons not reported|22|||
13470203|NCT00049517|26984800|FG005|Induction|Reasons not reported|25|||
13470204|NCT00049517|26984795|FG000|Conditioning/Transplant|Disease progression|14|||
13470205|NCT00049517|26984796|FG001|Conditioning/Transplant|Disease progression|6|||
13470206|NCT00049517|26984797|FG002|Conditioning/Transplant|Disease progression|10|||
13470207|NCT00049517|26984798|FG003|Conditioning/Transplant|Disease progression|6|||
13470208|NCT00049517|26984799|FG004|Conditioning/Transplant|Disease progression|0|||
13470209|NCT00049517|26984800|FG005|Conditioning/Transplant|Disease progression|0|||
13470210|NCT00049517|26984795|FG000|Conditioning/Transplant|Adverse Event|2|||
13470211|NCT00049517|26984796|FG001|Conditioning/Transplant|Adverse Event|1|||
13470212|NCT00049517|26984797|FG002|Conditioning/Transplant|Adverse Event|4|||
13470213|NCT00049517|26984798|FG003|Conditioning/Transplant|Adverse Event|8|||
13470214|NCT00049517|26984799|FG004|Conditioning/Transplant|Adverse Event|0|||
13470215|NCT00049517|26984800|FG005|Conditioning/Transplant|Adverse Event|0|||
13470216|NCT00049517|26984795|FG000|Conditioning/Transplant|Death|1|||
13470217|NCT00049517|26984796|FG001|Conditioning/Transplant|Death|0|||
13470218|NCT00049517|26984797|FG002|Conditioning/Transplant|Death|0|||
13470219|NCT00049517|26984798|FG003|Conditioning/Transplant|Death|2|||
13470220|NCT00049517|26984799|FG004|Conditioning/Transplant|Death|0|||
13470221|NCT00049517|26984800|FG005|Conditioning/Transplant|Death|0|||
13470222|NCT00049517|26984795|FG000|Conditioning/Transplant|Withdrawal by Subject|4|||
13470223|NCT00049517|26984796|FG001|Conditioning/Transplant|Withdrawal by Subject|8|||
13470224|NCT00049517|26984797|FG002|Conditioning/Transplant|Withdrawal by Subject|4|||
13470225|NCT00049517|26984798|FG003|Conditioning/Transplant|Withdrawal by Subject|7|||
13470226|NCT00049517|26984799|FG004|Conditioning/Transplant|Withdrawal by Subject|0|||
13470227|NCT00049517|26984800|FG005|Conditioning/Transplant|Withdrawal by Subject|0|||
13470228|NCT00049517|26984795|FG000|Conditioning/Transplant|Alternative therapy|4|||
13470229|NCT00049517|26984796|FG001|Conditioning/Transplant|Alternative therapy|4|||
13470230|NCT00049517|26984797|FG002|Conditioning/Transplant|Alternative therapy|2|||
13470231|NCT00049517|26984798|FG003|Conditioning/Transplant|Alternative therapy|1|||
13470232|NCT00049517|26984799|FG004|Conditioning/Transplant|Alternative therapy|1|||
13470233|NCT00049517|26984800|FG005|Conditioning/Transplant|Alternative therapy|0|||
13470234|NCT00049517|26984795|FG000|Conditioning/Transplant|Other complicating disease|2|||
13470235|NCT00049517|26984796|FG001|Conditioning/Transplant|Other complicating disease|0|||
13470236|NCT00049517|26984797|FG002|Conditioning/Transplant|Other complicating disease|0|||
13470237|NCT00049517|26984798|FG003|Conditioning/Transplant|Other complicating disease|4|||
13470238|NCT00049517|26984799|FG004|Conditioning/Transplant|Other complicating disease|0|||
13470239|NCT00049517|26984800|FG005|Conditioning/Transplant|Other complicating disease|1|||
13470240|NCT00049517|26984795|FG000|Conditioning/Transplant|Reasons not reported|25|||
13470241|NCT00049517|26984796|FG001|Conditioning/Transplant|Reasons not reported|31|||
13470242|NCT00049517|26984797|FG002|Conditioning/Transplant|Reasons not reported|18|||
13470243|NCT00049517|26984798|FG003|Conditioning/Transplant|Reasons not reported|15|||
13470244|NCT00049517|26984799|FG004|Conditioning/Transplant|Reasons not reported|5|||
13470245|NCT00049517|26984800|FG005|Conditioning/Transplant|Reasons not reported|5|||
13470246|NCT00049322|26984819|FG000|Overall Study|disease burden|0|||
13470247|NCT00049322|26984820|FG001|Overall Study|disease burden|3|||
13470248|NCT00049322|26984819|FG000|Overall Study|Adverse Event|1|||
13470249|NCT00049322|26984820|FG001|Overall Study|Adverse Event|0|||
13470250|NCT00049322|26984819|FG000|Overall Study|refused angio|0|||
13470251|NCT00049322|26984820|FG001|Overall Study|refused angio|3|||
13470252|NCT00049257|26984829|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10|||
13470253|NCT00049257|26984829|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1|||
13470254|NCT00049257|26984829|FG000|Carboplatin, Paclitaxel|Death|2|||
13470255|NCT00049257|26984829|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4|||
13470256|NCT00049127|26984872|FG000|Overall Study|Withdrawal by Subject|0|||
13470257|NCT00049127|26984873|FG001|Overall Study|Withdrawal by Subject|0|||
13470258|NCT00049127|26984874|FG002|Overall Study|Withdrawal by Subject|1|||
13470259|NCT00049127|26984875|FG003|Overall Study|Withdrawal by Subject|0|||
13470260|NCT00049127|26984876|FG004|Overall Study|Withdrawal by Subject|0|||
13470261|NCT00048997|26984904|FG000|Overall Study|Protocol Violation|7|||
13470262|NCT00048997|26984905|FG001|Overall Study|Protocol Violation|2|||
13470263|NCT00048997|26984904|FG000|Overall Study|Withdrawal by Subject|6|||
13470264|NCT00048997|26984905|FG001|Overall Study|Withdrawal by Subject|1|||
13470265|NCT00048932|26984937|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1|||
13470266|NCT00048932|26984938|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
13470267|NCT00048932|26984939|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
13470268|NCT00048932|26984937|FG000|Double Blind Period (DB)|Adverse Event|51|||
13470269|NCT00048932|26984938|FG001|Double Blind Period (DB)|Adverse Event|19|||
13470270|NCT00048932|26984939|FG002|Double Blind Period (DB)|Adverse Event|0|||
13470271|NCT00048932|26984937|FG000|Double Blind Period (DB)|Death|5|||
13470272|NCT00048932|26984938|FG001|Double Blind Period (DB)|Death|3|||
13470273|NCT00048932|26984939|FG002|Double Blind Period (DB)|Death|0|||
13470274|NCT00048932|26984937|FG000|Double Blind Period (DB)|Lack of Efficacy|26|||
13470275|NCT00048932|26984938|FG001|Double Blind Period (DB)|Lack of Efficacy|44|||
13470276|NCT00048932|26984939|FG002|Double Blind Period (DB)|Lack of Efficacy|0|||
13470277|NCT00048932|26984937|FG000|Double Blind Period (DB)|Lost to Follow-up|3|||
13470278|NCT00048932|26984938|FG001|Double Blind Period (DB)|Lost to Follow-up|4|||
13470279|NCT00048932|26984939|FG002|Double Blind Period (DB)|Lost to Follow-up|0|||
13470280|NCT00048932|26984937|FG000|Double Blind Period (DB)|Relocation|1|||
13470281|NCT00048932|26984938|FG001|Double Blind Period (DB)|Relocation|0|||
13470282|NCT00048932|26984939|FG002|Double Blind Period (DB)|Relocation|0|||
13470283|NCT00048932|26984937|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0|||
13470284|NCT00048932|26984938|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1|||
13470285|NCT00048932|26984939|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0|||
13470286|NCT00048932|26984937|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1|||
13470287|NCT00048932|26984938|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
13470288|NCT00048932|26984939|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
13470289|NCT00048932|26984937|FG000|Double Blind Period (DB)|Pregnancy|1|||
13470290|NCT00048932|26984938|FG001|Double Blind Period (DB)|Pregnancy|0|||
13470291|NCT00048932|26984939|FG002|Double Blind Period (DB)|Pregnancy|0|||
13470292|NCT00048932|26984937|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8|||
13470293|NCT00048932|26984938|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2|||
13470294|NCT00048932|26984939|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0|||
13470295|NCT00048932|26984937|FG000|Double Blind Period (DB)|Withdrawal by Subject|24|||
13470296|NCT00048932|26984938|FG001|Double Blind Period (DB)|Withdrawal by Subject|10|||
13470297|NCT00048932|26984939|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
13470298|NCT00048932|26984937|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2|||
13470299|NCT00048932|26984938|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4|||
13470300|NCT00048932|26984939|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0|||
13470301|NCT00048932|26984937|FG000|Open Label Period (OL)|Death|0|||
13470302|NCT00048932|26984938|FG001|Open Label Period (OL)|Death|0|||
13470303|NCT00048932|26984939|FG002|Open Label Period (OL)|Death|25|||
13470304|NCT00048932|26984937|FG000|Open Label Period (OL)|Adverse Event|0|||
13470305|NCT00048932|26984938|FG001|Open Label Period (OL)|Adverse Event|0|||
13470306|NCT00048932|26984939|FG002|Open Label Period (OL)|Adverse Event|103|||
13470307|NCT00048932|26984937|FG000|Open Label Period (OL)|Lack of Efficacy|0|||
13470308|NCT00048932|26984938|FG001|Open Label Period (OL)|Lack of Efficacy|0|||
13470309|NCT00048932|26984939|FG002|Open Label Period (OL)|Lack of Efficacy|81|||
13470310|NCT00048932|26984937|FG000|Open Label Period (OL)|Lost to Follow-up|0|||
13470311|NCT00048932|26984938|FG001|Open Label Period (OL)|Lost to Follow-up|0|||
13470312|NCT00048932|26984939|FG002|Open Label Period (OL)|Lost to Follow-up|27|||
13470313|NCT00048932|26984937|FG000|Open Label Period (OL)|Withdrawal by Subject|0|||
13470314|NCT00048932|26984938|FG001|Open Label Period (OL)|Withdrawal by Subject|0|||
13470315|NCT00048932|26984939|FG002|Open Label Period (OL)|Withdrawal by Subject|117|||
13470316|NCT00048932|26984937|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
13470317|NCT00048932|26984938|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
13470318|NCT00048932|26984939|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5|||
13470319|NCT00048932|26984937|FG000|Open Label Period (OL)|Poor/Non-Compliance|0|||
13470320|NCT00048932|26984938|FG001|Open Label Period (OL)|Poor/Non-Compliance|0|||
13470321|NCT00048932|26984939|FG002|Open Label Period (OL)|Poor/Non-Compliance|13|||
13470322|NCT00048932|26984937|FG000|Open Label Period (OL)|Pregnancy|0|||
13470323|NCT00048932|26984938|FG001|Open Label Period (OL)|Pregnancy|0|||
13470324|NCT00048932|26984939|FG002|Open Label Period (OL)|Pregnancy|6|||
13470325|NCT00048932|26984937|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
13470326|NCT00048932|26984938|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
13470327|NCT00048932|26984939|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20|||
13470328|NCT00048932|26984937|FG000|Open Label Period (OL)|Investigator Retiring|0|||
13470329|NCT00048932|26984938|FG001|Open Label Period (OL)|Investigator Retiring|0|||
13470330|NCT00048932|26984939|FG002|Open Label Period (OL)|Investigator Retiring|2|||
13470331|NCT00048932|26984937|FG000|Open Label Period (OL)|Participant Transportation Issues|0|||
13470332|NCT00048932|26984938|FG001|Open Label Period (OL)|Participant Transportation Issues|0|||
13470333|NCT00048932|26984939|FG002|Open Label Period (OL)|Participant Transportation Issues|1|||
13470334|NCT00048932|26984937|FG000|Open Label Period (OL)|Participant Relocated|0|||
13470335|NCT00048932|26984938|FG001|Open Label Period (OL)|Participant Relocated|0|||
13470336|NCT00048932|26984939|FG002|Open Label Period (OL)|Participant Relocated|6|||
13470337|NCT00048932|26984937|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0|||
13470338|NCT00048932|26984938|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0|||
13470339|NCT00048932|26984939|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1|||
13470340|NCT00048932|26984937|FG000|Open Label Period (OL)|Site Closure|0|||
13470341|NCT00048932|26984938|FG001|Open Label Period (OL)|Site Closure|0|||
13470342|NCT00048932|26984939|FG002|Open Label Period (OL)|Site Closure|3|||
13470343|NCT00048932|26984937|FG000|Open Label Period (OL)|Trial Terminated|0|||
13470344|NCT00048932|26984938|FG001|Open Label Period (OL)|Trial Terminated|0|||
13470345|NCT00048932|26984939|FG002|Open Label Period (OL)|Trial Terminated|1|||
13470346|NCT00048932|26984937|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0|||
13470347|NCT00048932|26984938|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0|||
13470348|NCT00048932|26984939|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1|||
13470349|NCT00048932|26984937|FG000|Open Label Period (OL)|Patient Decision|0|||
13470350|NCT00048932|26984938|FG001|Open Label Period (OL)|Patient Decision|0|||
13470351|NCT00048932|26984939|FG002|Open Label Period (OL)|Patient Decision|4|||
13470352|NCT00048932|26984937|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0|||
13470353|NCT00048932|26984938|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0|||
13470354|NCT00048932|26984939|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1|||
13470355|NCT00048932|26984937|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0|||
13470356|NCT00048932|26984938|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0|||
13470357|NCT00048932|26984939|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2|||
13470358|NCT00048932|26984937|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
13470359|NCT00048932|26984938|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
13470360|NCT00048932|26984939|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5|||
13470361|NCT00048932|26984937|FG000|Open Label Period (OL)|Medication Lost Efficacy|0|||
13470362|NCT00048932|26984938|FG001|Open Label Period (OL)|Medication Lost Efficacy|0|||
13470363|NCT00048932|26984939|FG002|Open Label Period (OL)|Medication Lost Efficacy|1|||
13470364|NCT00048932|26984937|FG000|Open Label Period (OL)|Investigator Decision|0|||
13470365|NCT00048932|26984938|FG001|Open Label Period (OL)|Investigator Decision|0|||
13470366|NCT00048932|26984939|FG002|Open Label Period (OL)|Investigator Decision|4|||
13470367|NCT00048932|26984937|FG000|Open Label Period (OL)|Site Staff Issues|0|||
13470368|NCT00048932|26984938|FG001|Open Label Period (OL)|Site Staff Issues|0|||
13470369|NCT00048932|26984939|FG002|Open Label Period (OL)|Site Staff Issues|2|||
13470370|NCT00048932|26984937|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0|||
13470371|NCT00048932|26984938|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0|||
13470372|NCT00048932|26984939|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9|||
13470373|NCT00048932|26984937|FG000|Open Label Period (OL)|Participant Surgery|0|||
13470374|NCT00048932|26984938|FG001|Open Label Period (OL)|Participant Surgery|0|||
13470375|NCT00048932|26984939|FG002|Open Label Period (OL)|Participant Surgery|1|||
13470376|NCT00048724|26984954|FG000|Overall Study|Adverse Event|53|||
13470377|NCT00048724|26984955|FG001|Overall Study|Adverse Event|12|||
13470378|NCT00048724|26984954|FG000|Overall Study|Withdrawal by Subject|34|||
13470379|NCT00048724|26984955|FG001|Overall Study|Withdrawal by Subject|54|||
13470380|NCT00048724|26984954|FG000|Overall Study|Lost to Follow-up|5|||
13470381|NCT00048724|26984955|FG001|Overall Study|Lost to Follow-up|5|||
13470382|NCT00048724|26984954|FG000|Overall Study|Protocol-defined Clinical Event|17|||
13470383|NCT00048724|26984955|FG001|Overall Study|Protocol-defined Clinical Event|32|||
13470384|NCT00048724|26984954|FG000|Overall Study|Noncompliance With Protocol|4|||
13470385|NCT00048724|26984955|FG001|Overall Study|Noncompliance With Protocol|12|||
13470386|NCT00048724|26984954|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
13470387|NCT00048724|26984955|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
13470388|NCT00048724|26984954|FG000|Overall Study|Administrative|1|||
13470389|NCT00048724|26984955|FG001|Overall Study|Administrative|1|||
13470390|NCT00048581|26985128|FG000|Double-Blind Period|Adverse Event|9|||
13470391|NCT00048581|26985129|FG001|Double-Blind Period|Adverse Event|5|||
13470392|NCT00048581|26985130|FG002|Double-Blind Period|Adverse Event|0|||
13470393|NCT00048581|26985128|FG000|Double-Blind Period|Lack of Efficacy|14|||
13470394|NCT00048581|26985129|FG001|Double-Blind Period|Lack of Efficacy|27|||
13470395|NCT00048581|26985130|FG002|Double-Blind Period|Lack of Efficacy|0|||
13470396|NCT00048581|26985128|FG000|Double-Blind Period|Lost to Follow-up|5|||
13470397|NCT00048581|26985129|FG001|Double-Blind Period|Lost to Follow-up|0|||
13470398|NCT00048581|26985130|FG002|Double-Blind Period|Lost to Follow-up|0|||
13470399|NCT00048581|26985128|FG000|Double-Blind Period|Withdrawal by Subject|5|||
13470400|NCT00048581|26985129|FG001|Double-Blind Period|Withdrawal by Subject|2|||
13470401|NCT00048581|26985130|FG002|Double-Blind Period|Withdrawal by Subject|0|||
13470402|NCT00048581|26985128|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1|||
13470403|NCT00048581|26985129|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0|||
13470404|NCT00048581|26985130|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0|||
13470405|NCT00048581|26985128|FG000|Double-Blind Period|Investigator Decision|1|||
13470406|NCT00048581|26985129|FG001|Double-Blind Period|Investigator Decision|0|||
13470407|NCT00048581|26985130|FG002|Double-Blind Period|Investigator Decision|0|||
13470408|NCT00048581|26985128|FG000|Open-Label Period|Death|0|||
13470409|NCT00048581|26985129|FG001|Open-Label Period|Death|0|||
13470410|NCT00048581|26985130|FG002|Open-Label Period|Death|4|||
13470411|NCT00048581|26985128|FG000|Open-Label Period|Adverse Event|0|||
13470412|NCT00048581|26985129|FG001|Open-Label Period|Adverse Event|0|||
13470413|NCT00048581|26985130|FG002|Open-Label Period|Adverse Event|37|||
13470414|NCT00048581|26985128|FG000|Open-Label Period|Lack of Efficacy|0|||
13470415|NCT00048581|26985129|FG001|Open-Label Period|Lack of Efficacy|0|||
13470416|NCT00048581|26985130|FG002|Open-Label Period|Lack of Efficacy|69|||
13470417|NCT00048581|26985128|FG000|Open-Label Period|Lost to Follow-up|0|||
13470418|NCT00048581|26985129|FG001|Open-Label Period|Lost to Follow-up|0|||
13470419|NCT00048581|26985130|FG002|Open-Label Period|Lost to Follow-up|14|||
13470420|NCT00048581|26985128|FG000|Open-Label Period|Withdrawal by Subject|0|||
13470421|NCT00048581|26985129|FG001|Open-Label Period|Withdrawal by Subject|0|||
13470422|NCT00048581|26985130|FG002|Open-Label Period|Withdrawal by Subject|20|||
13470423|NCT00048581|26985128|FG000|Open-Label Period|No Longer Meets Study Criteria|0|||
13470424|NCT00048581|26985129|FG001|Open-Label Period|No Longer Meets Study Criteria|0|||
13470425|NCT00048581|26985130|FG002|Open-Label Period|No Longer Meets Study Criteria|2|||
13470426|NCT00048581|26985128|FG000|Open-Label Period|Poor/Non-compliance|0|||
13470427|NCT00048581|26985129|FG001|Open-Label Period|Poor/Non-compliance|0|||
13470428|NCT00048581|26985130|FG002|Open-Label Period|Poor/Non-compliance|5|||
13470429|NCT00048581|26985128|FG000|Open-Label Period|Pregnancy|0|||
13470430|NCT00048581|26985129|FG001|Open-Label Period|Pregnancy|0|||
13470431|NCT00048581|26985130|FG002|Open-Label Period|Pregnancy|7|||
13470432|NCT00048581|26985128|FG000|Open-Label Period|Study Site Closure|0|||
13470433|NCT00048581|26985129|FG001|Open-Label Period|Study Site Closure|0|||
13470434|NCT00048581|26985130|FG002|Open-Label Period|Study Site Closure|2|||
13470435|NCT00048581|26985128|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
13470436|NCT00048581|26985129|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
13470437|NCT00048581|26985130|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3|||
13470438|NCT00048581|26985128|FG000|Open-Label Period|Problem With Transportation To Site|0|||
13470439|NCT00048581|26985129|FG001|Open-Label Period|Problem With Transportation To Site|0|||
13470440|NCT00048581|26985130|FG002|Open-Label Period|Problem With Transportation To Site|1|||
13470441|NCT00048581|26985128|FG000|Open-Label Period|Primary Investigator Retired|0|||
13470442|NCT00048581|26985129|FG001|Open-Label Period|Primary Investigator Retired|0|||
13470443|NCT00048581|26985130|FG002|Open-Label Period|Primary Investigator Retired|2|||
13470444|NCT00048581|26985128|FG000|Open-Label Period|Study Ended By Sponsor|0|||
13470445|NCT00048581|26985129|FG001|Open-Label Period|Study Ended By Sponsor|0|||
13470446|NCT00048581|26985130|FG002|Open-Label Period|Study Ended By Sponsor|1|||
13470447|NCT00048568|26985426|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11|||
13470448|NCT00048568|26985427|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3|||
13470449|NCT00048568|26985428|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0|||
13470450|NCT00048568|26985426|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11|||
13470451|NCT00048568|26985427|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33|||
13470452|NCT00048568|26985428|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0|||
13470453|NCT00048568|26985426|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
13470454|NCT00048568|26985427|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
13470455|NCT00048568|26985428|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0|||
13470456|NCT00048568|26985426|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7|||
13470457|NCT00048568|26985427|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4|||
13470458|NCT00048568|26985428|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0|||
13470459|NCT00048568|26985426|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2|||
13470460|NCT00048568|26985427|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4|||
13470461|NCT00048568|26985428|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0|||
13470462|NCT00048568|26985426|FG000|Double-Blind Period Days 170 to 365|Death|1|||
13470463|NCT00048568|26985427|FG001|Double-Blind Period Days 170 to 365|Death|1|||
13470464|NCT00048568|26985428|FG002|Double-Blind Period Days 170 to 365|Death|0|||
13470465|NCT00048568|26985426|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7|||
13470466|NCT00048568|26985427|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1|||
13470467|NCT00048568|26985428|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0|||
13470468|NCT00048568|26985426|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2|||
13470469|NCT00048568|26985427|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7|||
13470470|NCT00048568|26985428|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0|||
13470471|NCT00048568|26985426|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3|||
13470472|NCT00048568|26985427|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1|||
13470473|NCT00048568|26985428|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0|||
13470474|NCT00048568|26985426|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
13470475|NCT00048568|26985427|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1|||
13470476|NCT00048568|26985428|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
13470477|NCT00048568|26985426|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2|||
13470478|NCT00048568|26985427|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0|||
13470479|NCT00048568|26985428|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0|||
13470480|NCT00048568|26985426|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
13470481|NCT00048568|26985427|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
13470482|NCT00048568|26985428|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0|||
13470483|NCT00048568|26985426|FG000|Open-Label Period|Death|0|||
13470484|NCT00048568|26985427|FG001|Open-Label Period|Death|0|||
13470485|NCT00048568|26985428|FG002|Open-Label Period|Death|13|||
13470486|NCT00048568|26985426|FG000|Open-Label Period|Adverse Event|0|||
13470487|NCT00048568|26985427|FG001|Open-Label Period|Adverse Event|0|||
13470488|NCT00048568|26985428|FG002|Open-Label Period|Adverse Event|49|||
13470489|NCT00048568|26985426|FG000|Open-Label Period|Lack of Efficacy|0|||
13470490|NCT00048568|26985427|FG001|Open-Label Period|Lack of Efficacy|0|||
13470491|NCT00048568|26985428|FG002|Open-Label Period|Lack of Efficacy|32|||
13470492|NCT00048568|26985426|FG000|Open-Label Period|Withdrawal by Subject|0|||
13470493|NCT00048568|26985427|FG001|Open-Label Period|Withdrawal by Subject|0|||
13470494|NCT00048568|26985428|FG002|Open-Label Period|Withdrawal by Subject|26|||
13470495|NCT00048568|26985426|FG000|Open-Label Period|Pregnancy|0|||
13470496|NCT00048568|26985427|FG001|Open-Label Period|Pregnancy|0|||
13470497|NCT00048568|26985428|FG002|Open-Label Period|Pregnancy|5|||
13470498|NCT00048568|26985426|FG000|Open-Label Period|No Longer Met Study Criteria|0|||
13470499|NCT00048568|26985427|FG001|Open-Label Period|No Longer Met Study Criteria|0|||
13470500|NCT00048568|26985428|FG002|Open-Label Period|No Longer Met Study Criteria|2|||
13470501|NCT00048568|26985426|FG000|Open-Label Period|Administrative Decision By Sponsor|0|||
13470502|NCT00048568|26985427|FG001|Open-Label Period|Administrative Decision By Sponsor|0|||
13470503|NCT00048568|26985428|FG002|Open-Label Period|Administrative Decision By Sponsor|1|||
13470504|NCT00048568|26985426|FG000|Open-Label Period|Unknown Reasons|0|||
13470505|NCT00048568|26985427|FG001|Open-Label Period|Unknown Reasons|0|||
13470506|NCT00048568|26985428|FG002|Open-Label Period|Unknown Reasons|25|||
13470507|NCT00048568|26985426|FG000|Open-Label Period|Lost to Follow-up|0|||
13470508|NCT00048568|26985427|FG001|Open-Label Period|Lost to Follow-up|0|||
13470509|NCT00048568|26985428|FG002|Open-Label Period|Lost to Follow-up|7|||
13470510|NCT00048542|26985511|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
13470511|NCT00048542|26985512|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
13470512|NCT00048542|26985513|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
13470513|NCT00048542|26985514|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
13470514|NCT00048542|26985515|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
13470515|NCT00048542|26985516|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
13470516|NCT00048542|26985517|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
13470517|NCT00048542|26985518|FG007|Double-Blind Phase|Withdrawal by Subject|0|||
13470518|NCT00048542|26985511|FG000|Double-Blind Phase|Protocol Violation|0|||
13470519|NCT00048542|26985512|FG001|Double-Blind Phase|Protocol Violation|0|||
13470520|NCT00048542|26985513|FG002|Double-Blind Phase|Protocol Violation|1|||
13470521|NCT00048542|26985514|FG003|Double-Blind Phase|Protocol Violation|0|||
13470522|NCT00048542|26985515|FG004|Double-Blind Phase|Protocol Violation|0|||
13470523|NCT00048542|26985516|FG005|Double-Blind Phase|Protocol Violation|0|||
13470524|NCT00048542|26985517|FG006|Double-Blind Phase|Protocol Violation|0|||
13470525|NCT00048542|26985518|FG007|Double-Blind Phase|Protocol Violation|0|||
13470526|NCT00048542|26985511|FG000|Double-Blind Phase|Sponsor request or decision|2|||
13470527|NCT00048542|26985512|FG001|Double-Blind Phase|Sponsor request or decision|0|||
13470528|NCT00048542|26985513|FG002|Double-Blind Phase|Sponsor request or decision|0|||
13470529|NCT00048542|26985514|FG003|Double-Blind Phase|Sponsor request or decision|0|||
13470530|NCT00048542|26985515|FG004|Double-Blind Phase|Sponsor request or decision|0|||
13470531|NCT00048542|26985516|FG005|Double-Blind Phase|Sponsor request or decision|0|||
13470532|NCT00048542|26985517|FG006|Double-Blind Phase|Sponsor request or decision|0|||
13470533|NCT00048542|26985518|FG007|Double-Blind Phase|Sponsor request or decision|0|||
13470534|NCT00048542|26985511|FG000|Double-Blind Phase|Randomized in error|1|||
13470535|NCT00048542|26985512|FG001|Double-Blind Phase|Randomized in error|0|||
13470536|NCT00048542|26985513|FG002|Double-Blind Phase|Randomized in error|0|||
13470537|NCT00048542|26985514|FG003|Double-Blind Phase|Randomized in error|0|||
13470538|NCT00048542|26985515|FG004|Double-Blind Phase|Randomized in error|0|||
13470539|NCT00048542|26985516|FG005|Double-Blind Phase|Randomized in error|0|||
13470540|NCT00048542|26985517|FG006|Double-Blind Phase|Randomized in error|0|||
13470541|NCT00048542|26985518|FG007|Double-Blind Phase|Randomized in error|0|||
13470542|NCT00048542|26985511|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
13470543|NCT00048542|26985512|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
13470544|NCT00048542|26985513|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
13470545|NCT00048542|26985514|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
13470546|NCT00048542|26985515|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3|||
13470547|NCT00048542|26985516|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6|||
13470548|NCT00048542|26985517|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
13470549|NCT00048542|26985518|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
13470550|NCT00048542|26985511|FG000|Open-Label Extension BSA Phase|Protocol Violation|0|||
13470551|NCT00048542|26985512|FG001|Open-Label Extension BSA Phase|Protocol Violation|0|||
13470552|NCT00048542|26985513|FG002|Open-Label Extension BSA Phase|Protocol Violation|0|||
13470553|NCT00048542|26985514|FG003|Open-Label Extension BSA Phase|Protocol Violation|0|||
13470554|NCT00048542|26985515|FG004|Open-Label Extension BSA Phase|Protocol Violation|0|||
13470555|NCT00048542|26985516|FG005|Open-Label Extension BSA Phase|Protocol Violation|1|||
13470556|NCT00048542|26985517|FG006|Open-Label Extension BSA Phase|Protocol Violation|0|||
13470557|NCT00048542|26985518|FG007|Open-Label Extension BSA Phase|Protocol Violation|0|||
13470558|NCT00048542|26985511|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
13470559|NCT00048542|26985512|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
13470560|NCT00048542|26985513|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
13470561|NCT00048542|26985514|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
13470562|NCT00048542|26985515|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5|||
13470563|NCT00048542|26985516|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1|||
13470564|NCT00048542|26985517|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
13470565|NCT00048542|26985518|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
13470566|NCT00048542|26985511|FG000|Open-Label Extension BSA Phase|Adverse Event|0|||
13470567|NCT00048542|26985512|FG001|Open-Label Extension BSA Phase|Adverse Event|0|||
13470568|NCT00048542|26985513|FG002|Open-Label Extension BSA Phase|Adverse Event|0|||
13470569|NCT00048542|26985514|FG003|Open-Label Extension BSA Phase|Adverse Event|0|||
13470570|NCT00048542|26985515|FG004|Open-Label Extension BSA Phase|Adverse Event|1|||
13470571|NCT00048542|26985516|FG005|Open-Label Extension BSA Phase|Adverse Event|1|||
13470572|NCT00048542|26985517|FG006|Open-Label Extension BSA Phase|Adverse Event|0|||
13470573|NCT00048542|26985518|FG007|Open-Label Extension BSA Phase|Adverse Event|0|||
13470574|NCT00048542|26985511|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
13470575|NCT00048542|26985512|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
13470576|NCT00048542|26985513|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
13470577|NCT00048542|26985514|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
13470578|NCT00048542|26985515|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3|||
13470579|NCT00048542|26985516|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1|||
13470580|NCT00048542|26985517|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
13470581|NCT00048542|26985518|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
13133958|NCT02761629|25989881|FG000|Overall Study|Insufficient Therapeutic Response|2|||
13133959|NCT02761629|25989882|FG001|Overall Study|Insufficient Therapeutic Response|7|||
13133960|NCT02761629|25989881|FG000|Overall Study|Failure to Return|2|||
13133961|NCT02761629|25989882|FG001|Overall Study|Failure to Return|4|||
13133962|NCT02761629|25989881|FG000|Overall Study|Did not Cooperate/Refused Treatment|2|||
13133963|NCT02761629|25989882|FG001|Overall Study|Did not Cooperate/Refused Treatment|4|||
13133964|NCT02761629|25989881|FG000|Overall Study|Protocol Violation|2|||
13470582|NCT00048542|26985511|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
13470583|NCT00048542|26985512|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
13470584|NCT00048542|26985513|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
13470585|NCT00048542|26985514|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
13470586|NCT00048542|26985515|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
13470587|NCT00048542|26985516|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
13470588|NCT00048542|26985517|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6|||
13470589|NCT00048542|26985518|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3|||
13470590|NCT00048542|26985511|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
13470591|NCT00048542|26985512|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
13470592|NCT00048542|26985513|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
13470593|NCT00048542|26985514|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
13470594|NCT00048542|26985515|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
13470595|NCT00048542|26985516|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
13470596|NCT00048542|26985517|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
13470597|NCT00048542|26985518|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
13470598|NCT00048542|26985511|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
13470599|NCT00048542|26985512|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
13470600|NCT00048542|26985513|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
13470601|NCT00048542|26985514|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
13470602|NCT00048542|26985515|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
13470603|NCT00048542|26985516|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
13470604|NCT00048542|26985517|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6|||
13470605|NCT00048542|26985518|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7|||
13470606|NCT00048542|26985511|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
13470607|NCT00048542|26985512|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
13470608|NCT00048542|26985513|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
13470609|NCT00048542|26985514|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
13470610|NCT00048542|26985515|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
13470611|NCT00048542|26985516|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
13470612|NCT00048542|26985517|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
13470613|NCT00048542|26985518|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
13470614|NCT00048542|26985511|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
13470615|NCT00048542|26985512|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
13470616|NCT00048542|26985513|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
13470617|NCT00048542|26985514|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
13470618|NCT00048542|26985515|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
13470619|NCT00048542|26985516|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
13470620|NCT00048542|26985517|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2|||
13470621|NCT00048542|26985518|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1|||
13470622|NCT00048542|26985511|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
13470623|NCT00048542|26985512|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
13470624|NCT00048542|26985513|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
13470625|NCT00048542|26985514|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
13470626|NCT00048542|26985515|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
13470627|NCT00048542|26985516|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
13470628|NCT00048542|26985517|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5|||
13470629|NCT00048542|26985518|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8|||
13470630|NCT00048347|26985524|FG000|Overall Study|Screen failure|2|||
13470631|NCT00048165|26985563|FG000|Completed 6 Months Study|Administration/Other|8|||
13470632|NCT00048165|26985564|FG001|Completed 6 Months Study|Administration/Other|8|||
13470633|NCT00048165|26985563|FG000|Completed 6 Months Study|Abnormality of laboratory test|1|||
13470634|NCT00048165|26985564|FG001|Completed 6 Months Study|Abnormality of laboratory test|0|||
13470635|NCT00048165|26985563|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14|||
13470636|NCT00048165|26985564|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11|||
13470637|NCT00048165|26985563|FG000|Completed 6 Months Study|Death|12|||
13470638|NCT00048165|26985564|FG001|Completed 6 Months Study|Death|6|||
13470639|NCT00048165|26985563|FG000|Completed 6 Months Study|Insufficient therapy|1|||
13470640|NCT00048165|26985564|FG001|Completed 6 Months Study|Insufficient therapy|4|||
13470641|NCT00048165|26985563|FG000|Completed 6 Months Study|Other violation|4|||
13470642|NCT00048165|26985564|FG001|Completed 6 Months Study|Other violation|6|||
13470643|NCT00048165|26985563|FG000|Completed 6 Months Study|Refused treatment|5|||
13470644|NCT00048165|26985564|FG001|Completed 6 Months Study|Refused treatment|5|||
13470645|NCT00048165|26985563|FG000|Completed 6 Months Study|Violation criteria|0|||
13470646|NCT00048165|26985564|FG001|Completed 6 Months Study|Violation criteria|2|||
13470647|NCT00048165|26985563|FG000|Completed 6 Months Study|Did not receive study drug|6|||
13470648|NCT00048165|26985564|FG001|Completed 6 Months Study|Did not receive study drug|6|||
13470649|NCT00048165|26985563|FG000|Completed 12 Months Study|Administration/Other|0|||
13470650|NCT00048165|26985564|FG001|Completed 12 Months Study|Administration/Other|2|||
13470651|NCT00048165|26985563|FG000|Completed 12 Months Study|Death|2|||
13470652|NCT00048165|26985564|FG001|Completed 12 Months Study|Death|1|||
13470653|NCT00048165|26985563|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1|||
13470654|NCT00048165|26985564|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0|||
13470655|NCT00048074|26985627|FG000|Overall Study|Adverse Event|46|||
13470656|NCT00048074|26985628|FG001|Overall Study|Adverse Event|41|||
13470657|NCT00048074|26985629|FG002|Overall Study|Adverse Event|53|||
13470658|NCT00048074|26985627|FG000|Overall Study|Death|3|||
13470659|NCT00048074|26985628|FG001|Overall Study|Death|3|||
13470660|NCT00048074|26985629|FG002|Overall Study|Death|2|||
13470661|NCT00048074|26985627|FG000|Overall Study|Lost to Follow-up|2|||
13470662|NCT00048074|26985628|FG001|Overall Study|Lost to Follow-up|6|||
13470663|NCT00048074|26985629|FG002|Overall Study|Lost to Follow-up|6|||
13470664|NCT00048074|26985627|FG000|Overall Study|Withdrawal by Subject|28|||
13470665|NCT00048074|26985628|FG001|Overall Study|Withdrawal by Subject|30|||
13470666|NCT00048074|26985629|FG002|Overall Study|Withdrawal by Subject|35|||
13470667|NCT00048074|26985627|FG000|Overall Study|Protocol Violation|1|||
13470668|NCT00048074|26985628|FG001|Overall Study|Protocol Violation|3|||
13470669|NCT00048074|26985629|FG002|Overall Study|Protocol Violation|0|||
13470670|NCT00048074|26985627|FG000|Overall Study|Study participation was terminated|0|||
13470671|NCT00048074|26985628|FG001|Overall Study|Study participation was terminated|1|||
13470672|NCT00048074|26985629|FG002|Overall Study|Study participation was terminated|0|||
13470673|NCT00048074|26985627|FG000|Overall Study|Husband ill|0|||
13470674|NCT00048074|26985628|FG001|Overall Study|Husband ill|1|||
13470675|NCT00048074|26985629|FG002|Overall Study|Husband ill|0|||
13470676|NCT00048074|26985627|FG000|Overall Study|Poor compliance|0|||
13470677|NCT00048074|26985628|FG001|Overall Study|Poor compliance|1|||
13470678|NCT00048074|26985629|FG002|Overall Study|Poor compliance|0|||
13470679|NCT00048074|26985627|FG000|Overall Study|Out of station|0|||
13470680|NCT00048074|26985628|FG001|Overall Study|Out of station|1|||
13470681|NCT00048074|26985629|FG002|Overall Study|Out of station|1|||
13470682|NCT00048074|26985627|FG000|Overall Study|Social reasons|1|||
13470683|NCT00048074|26985628|FG001|Overall Study|Social reasons|0|||
13470684|NCT00048074|26985629|FG002|Overall Study|Social reasons|0|||
13470685|NCT00048061|26985712|FG000|Overall Study|Adverse Event|41|||
13470686|NCT00048061|26985713|FG001|Overall Study|Adverse Event|32|||
13470687|NCT00048061|26985714|FG002|Overall Study|Adverse Event|44|||
13470688|NCT00048061|26985715|FG003|Overall Study|Adverse Event|37|||
13470689|NCT00048061|26985712|FG000|Overall Study|Lost to Follow-up|3|||
13470690|NCT00048061|26985713|FG001|Overall Study|Lost to Follow-up|2|||
13470691|NCT00048061|26985714|FG002|Overall Study|Lost to Follow-up|4|||
13470692|NCT00048061|26985715|FG003|Overall Study|Lost to Follow-up|5|||
13470693|NCT00048061|26985712|FG000|Overall Study|Withdrawal by Subject|20|||
13470694|NCT00048061|26985713|FG001|Overall Study|Withdrawal by Subject|29|||
13470695|NCT00048061|26985714|FG002|Overall Study|Withdrawal by Subject|29|||
13470696|NCT00048061|26985715|FG003|Overall Study|Withdrawal by Subject|32|||
13470697|NCT00048061|26985712|FG000|Overall Study|Did not follow-up|5|||
13470698|NCT00048061|26985713|FG001|Overall Study|Did not follow-up|5|||
13470699|NCT00048061|26985714|FG002|Overall Study|Did not follow-up|4|||
13470700|NCT00048061|26985715|FG003|Overall Study|Did not follow-up|5|||
13470701|NCT00048061|26985712|FG000|Overall Study|Early improvement|6|||
13470702|NCT00048061|26985713|FG001|Overall Study|Early improvement|5|||
13470703|NCT00048061|26985714|FG002|Overall Study|Early improvement|3|||
13470704|NCT00048061|26985715|FG003|Overall Study|Early improvement|0|||
13470705|NCT00048048|26985796|FG000|Core Treatment|Withdrawal by Subject|0|||
13470706|NCT00048048|26985797|FG001|Core Treatment|Withdrawal by Subject|0|||
13470707|NCT00048048|26985798|FG002|Core Treatment|Withdrawal by Subject|1|||
13470708|NCT00048048|26985799|FG003|Core Treatment|Withdrawal by Subject|0|||
13470709|NCT00048048|26985800|FG004|Core Treatment|Withdrawal by Subject|0|||
13470710|NCT00048048|26985801|FG005|Core Treatment|Withdrawal by Subject|0|||
13470711|NCT00048048|26985802|FG006|Core Treatment|Withdrawal by Subject|0|||
13470712|NCT00048048|26985803|FG007|Core Treatment|Withdrawal by Subject|0|||
13470713|NCT00048048|26985804|FG008|Core Treatment|Withdrawal by Subject|0|||
13470714|NCT00048048|26985805|FG009|Core Treatment|Withdrawal by Subject|0|||
13470715|NCT00048048|26985806|FG010|Core Treatment|Withdrawal by Subject|0|||
13470716|NCT00048048|26985807|FG011|Core Treatment|Withdrawal by Subject|0|||
13470717|NCT00048048|26985796|FG000|Core Treatment|Adverse Event|0|||
13470718|NCT00048048|26985797|FG001|Core Treatment|Adverse Event|0|||
13470719|NCT00048048|26985798|FG002|Core Treatment|Adverse Event|0|||
13470720|NCT00048048|26985799|FG003|Core Treatment|Adverse Event|0|||
13470721|NCT00048048|26985800|FG004|Core Treatment|Adverse Event|0|||
13470722|NCT00048048|26985801|FG005|Core Treatment|Adverse Event|0|||
13470723|NCT00048048|26985802|FG006|Core Treatment|Adverse Event|0|||
13470724|NCT00048048|26985803|FG007|Core Treatment|Adverse Event|1|||
13470725|NCT00048048|26985804|FG008|Core Treatment|Adverse Event|0|||
13470726|NCT00048048|26985805|FG009|Core Treatment|Adverse Event|0|||
13470727|NCT00048048|26985806|FG010|Core Treatment|Adverse Event|0|||
13470728|NCT00048048|26985807|FG011|Core Treatment|Adverse Event|0|||
13470729|NCT00048048|26985796|FG000|Extension Year 1|Early withdrawals|0|||
13470730|NCT00048048|26985797|FG001|Extension Year 1|Early withdrawals|0|||
13470731|NCT00048048|26985798|FG002|Extension Year 1|Early withdrawals|0|||
13470732|NCT00048048|26985799|FG003|Extension Year 1|Early withdrawals|0|||
13470733|NCT00048048|26985800|FG004|Extension Year 1|Early withdrawals|0|||
13470734|NCT00048048|26985801|FG005|Extension Year 1|Early withdrawals|0|||
13470735|NCT00048048|26985802|FG006|Extension Year 1|Early withdrawals|0|||
13470736|NCT00048048|26985803|FG007|Extension Year 1|Early withdrawals|0|||
13470737|NCT00048048|26985804|FG008|Extension Year 1|Early withdrawals|0|||
13470738|NCT00048048|26985805|FG009|Extension Year 1|Early withdrawals|2|||
13470739|NCT00048048|26985806|FG010|Extension Year 1|Early withdrawals|2|||
13470740|NCT00048048|26985807|FG011|Extension Year 1|Early withdrawals|4|||
13470741|NCT00048048|26985796|FG000|Extension Year 2|Early withdrawals|0|||
13470742|NCT00048048|26985797|FG001|Extension Year 2|Early withdrawals|0|||
13470743|NCT00048048|26985798|FG002|Extension Year 2|Early withdrawals|0|||
13470744|NCT00048048|26985799|FG003|Extension Year 2|Early withdrawals|0|||
13470745|NCT00048048|26985800|FG004|Extension Year 2|Early withdrawals|0|||
13470746|NCT00048048|26985801|FG005|Extension Year 2|Early withdrawals|0|||
13470747|NCT00048048|26985802|FG006|Extension Year 2|Early withdrawals|0|||
13470748|NCT00048048|26985803|FG007|Extension Year 2|Early withdrawals|0|||
13470749|NCT00048048|26985804|FG008|Extension Year 2|Early withdrawals|0|||
13470750|NCT00048048|26985805|FG009|Extension Year 2|Early withdrawals|0|||
13470751|NCT00048048|26985806|FG010|Extension Year 2|Early withdrawals|4|||
13470752|NCT00048048|26985807|FG011|Extension Year 2|Early withdrawals|2|||
13470753|NCT00048035|26985864|FG000|Core Period|Early Withdrawals|4|||
13470754|NCT00048035|26985865|FG001|Core Period|Early Withdrawals|2|||
13470755|NCT00048035|26985866|FG002|Core Period|Early Withdrawals|1|||
13470756|NCT00048035|26985867|FG003|Core Period|Early Withdrawals|1|||
13470757|NCT00048035|26985868|FG004|Core Period|Early Withdrawals|1|||
13470758|NCT00048035|26985869|FG005|Core Period|Early Withdrawals|1|||
13470759|NCT00048035|26985870|FG006|Core Period|Early Withdrawals|0|||
13470760|NCT00048035|26985871|FG007|Core Period|Early Withdrawals|0|||
13470761|NCT00048035|26985864|FG000|Extension Year 1|Early Withdrawals|0|||
13470762|NCT00048035|26985865|FG001|Extension Year 1|Early Withdrawals|0|||
13470763|NCT00048035|26985866|FG002|Extension Year 1|Early Withdrawals|0|||
13470764|NCT00048035|26985867|FG003|Extension Year 1|Early Withdrawals|0|||
13470765|NCT00048035|26985868|FG004|Extension Year 1|Early Withdrawals|0|||
13470766|NCT00048035|26985869|FG005|Extension Year 1|Early Withdrawals|0|||
13470767|NCT00048035|26985870|FG006|Extension Year 1|Early Withdrawals|11|||
13470768|NCT00048035|26985871|FG007|Extension Year 1|Early Withdrawals|11|||
13470769|NCT00048035|26985864|FG000|Extension Year 2|Early Withdrawals|0|||
13470770|NCT00048035|26985865|FG001|Extension Year 2|Early Withdrawals|0|||
13470771|NCT00048035|26985866|FG002|Extension Year 2|Early Withdrawals|0|||
13470772|NCT00048035|26985867|FG003|Extension Year 2|Early Withdrawals|0|||
13470773|NCT00048035|26985868|FG004|Extension Year 2|Early Withdrawals|0|||
13470774|NCT00048035|26985869|FG005|Extension Year 2|Early Withdrawals|0|||
13470775|NCT00048035|26985870|FG006|Extension Year 2|Early Withdrawals|3|||
13470776|NCT00048035|26985871|FG007|Extension Year 2|Early Withdrawals|3|||
13470777|NCT00047879|26985888|FG000|Overall Study|Progressive disease|4|||
13470778|NCT00047879|26985889|FG001|Overall Study|Progressive disease|3|||
13470779|NCT00047463|26985905|FG000|Overall Study|Withdrawal by Subject|0|||
13470780|NCT00047463|26985906|FG001|Overall Study|Withdrawal by Subject|3|||
13470781|NCT00047385|26985931|FG000|Overall Study|Death before any screening|2|||
13470782|NCT00047385|26985932|FG001|Overall Study|Death before any screening|5|||
13470783|NCT00047385|26985931|FG000|Overall Study|Lung Cancer diagnosed before screening|5|||
13470784|NCT00047385|26985932|FG001|Overall Study|Lung Cancer diagnosed before screening|3|||
13470785|NCT00047385|26985931|FG000|Overall Study|Eligible for screening but had no screen|260|||
13470786|NCT00047385|26985932|FG001|Overall Study|Eligible for screening but had no screen|492|||
13470787|NCT00047320|26985943|FG000|Overall Study|Lack of Efficacy|8|||
13470788|NCT00047320|26985943|FG000|Overall Study|Lost to Follow-up|1|||
13470789|NCT00047320|26985943|FG000|Overall Study|Physician Decision|8|||
13470790|NCT00047320|26985943|FG000|Overall Study|Withdrawal by Subject|9|||
13470791|NCT00047320|26985943|FG000|Overall Study|Ineligible|2|||
13470792|NCT00046930|26985963|FG000|Overall Study|Ineligible|12|||
13470793|NCT00046930|26985964|FG001|Overall Study|Ineligible|4|||
13470794|NCT00046891|26985989|FG000|Overall Study|Cancels|5|||
13470795|NCT00046891|26985990|FG001|Overall Study|Cancels|9|||
13470796|NCT00046891|26985989|FG000|Overall Study|Ineligible|1|||
13470797|NCT00046891|26985990|FG001|Overall Study|Ineligible|1|||
13470798|NCT00046891|26985989|FG000|Overall Study|Withdrawal by Subject|18|||
13470799|NCT00046891|26985990|FG001|Overall Study|Withdrawal by Subject|15|||
13470800|NCT00046891|26985989|FG000|Overall Study|Adverse Event|5|||
13470801|NCT00046891|26985990|FG001|Overall Study|Adverse Event|5|||
13470802|NCT00046839|26986004|FG000|Overall Study|Ineligible / No protocol treatment|0|||
13470803|NCT00046839|26986005|FG001|Overall Study|Ineligible / No protocol treatment|2|||
13470804|NCT00046839|26986004|FG000|Overall Study|Withdrawal of consent|1|||
13470805|NCT00046839|26986005|FG001|Overall Study|Withdrawal of consent|0|||
13470806|NCT00045942|26986113|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1|||
13470807|NCT00045942|26986114|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0|||
13470808|NCT00045942|26986115|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0|||
13470809|NCT00045942|26986116|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0|||
13470810|NCT00045942|26986117|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0|||
13470811|NCT00045942|26986118|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0|||
13470812|NCT00045942|26986119|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0|||
13470813|NCT00045942|26986120|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0|||
13470814|NCT00045942|26986121|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0|||
13470815|NCT00045942|26986113|FG000|PKC412A2104 (Core)|Adverse Event|5|||
13470816|NCT00045942|26986114|FG001|PKC412A2104 (Core)|Adverse Event|0|||
13470817|NCT00045942|26986115|FG002|PKC412A2104 (Core)|Adverse Event|0|||
13470818|NCT00045942|26986116|FG003|PKC412A2104 (Core)|Adverse Event|0|||
13470819|NCT00045942|26986117|FG004|PKC412A2104 (Core)|Adverse Event|0|||
13470820|NCT00045942|26986118|FG005|PKC412A2104 (Core)|Adverse Event|0|||
13470821|NCT00045942|26986119|FG006|PKC412A2104 (Core)|Adverse Event|0|||
13470822|NCT00045942|26986120|FG007|PKC412A2104 (Core)|Adverse Event|0|||
13470823|NCT00045942|26986121|FG008|PKC412A2104 (Core)|Adverse Event|0|||
13470824|NCT00045942|26986113|FG000|PKC412A2104 (Core)|Lack of Efficacy|13|||
13470825|NCT00045942|26986114|FG001|PKC412A2104 (Core)|Lack of Efficacy|0|||
13470826|NCT00045942|26986115|FG002|PKC412A2104 (Core)|Lack of Efficacy|0|||
13470827|NCT00045942|26986116|FG003|PKC412A2104 (Core)|Lack of Efficacy|0|||
13470828|NCT00045942|26986117|FG004|PKC412A2104 (Core)|Lack of Efficacy|0|||
13470829|NCT00045942|26986118|FG005|PKC412A2104 (Core)|Lack of Efficacy|0|||
13470830|NCT00045942|26986119|FG006|PKC412A2104 (Core)|Lack of Efficacy|0|||
13470831|NCT00045942|26986120|FG007|PKC412A2104 (Core)|Lack of Efficacy|0|||
13470832|NCT00045942|26986121|FG008|PKC412A2104 (Core)|Lack of Efficacy|0|||
13470833|NCT00045942|26986113|FG000|PKC412A2104 (Core)|Death|1|||
13470834|NCT00045942|26986114|FG001|PKC412A2104 (Core)|Death|0|||
13470835|NCT00045942|26986115|FG002|PKC412A2104 (Core)|Death|0|||
13470836|NCT00045942|26986116|FG003|PKC412A2104 (Core)|Death|0|||
13470837|NCT00045942|26986117|FG004|PKC412A2104 (Core)|Death|0|||
13470838|NCT00045942|26986118|FG005|PKC412A2104 (Core)|Death|0|||
13470839|NCT00045942|26986119|FG006|PKC412A2104 (Core)|Death|0|||
13470840|NCT00045942|26986120|FG007|PKC412A2104 (Core)|Death|0|||
13470841|NCT00045942|26986121|FG008|PKC412A2104 (Core)|Death|0|||
13470842|NCT00045942|26986113|FG000|PKC412A2104E1|Withdrawal by Subject|0|||
13470843|NCT00045942|26986114|FG001|PKC412A2104E1|Withdrawal by Subject|0|||
13470844|NCT00045942|26986115|FG002|PKC412A2104E1|Withdrawal by Subject|2|||
13470845|NCT00045942|26986116|FG003|PKC412A2104E1|Withdrawal by Subject|5|||
13470846|NCT00045942|26986117|FG004|PKC412A2104E1|Withdrawal by Subject|2|||
13470847|NCT00045942|26986118|FG005|PKC412A2104E1|Withdrawal by Subject|0|||
13470848|NCT00045942|26986119|FG006|PKC412A2104E1|Withdrawal by Subject|0|||
13470849|NCT00045942|26986120|FG007|PKC412A2104E1|Withdrawal by Subject|0|||
13470850|NCT00045942|26986121|FG008|PKC412A2104E1|Withdrawal by Subject|0|||
13470851|NCT00045942|26986113|FG000|PKC412A2104E1|Condition no longer requires study drug|0|||
13470852|NCT00045942|26986114|FG001|PKC412A2104E1|Condition no longer requires study drug|1|||
13470853|NCT00045942|26986115|FG002|PKC412A2104E1|Condition no longer requires study drug|1|||
13470854|NCT00045942|26986116|FG003|PKC412A2104E1|Condition no longer requires study drug|0|||
13470855|NCT00045942|26986117|FG004|PKC412A2104E1|Condition no longer requires study drug|1|||
13470856|NCT00045942|26986118|FG005|PKC412A2104E1|Condition no longer requires study drug|0|||
13470857|NCT00045942|26986119|FG006|PKC412A2104E1|Condition no longer requires study drug|0|||
13470858|NCT00045942|26986120|FG007|PKC412A2104E1|Condition no longer requires study drug|0|||
13470859|NCT00045942|26986121|FG008|PKC412A2104E1|Condition no longer requires study drug|0|||
13470860|NCT00045942|26986113|FG000|PKC412A2104E1|Lack of Efficacy|0|||
13470861|NCT00045942|26986114|FG001|PKC412A2104E1|Lack of Efficacy|11|||
13470862|NCT00045942|26986115|FG002|PKC412A2104E1|Lack of Efficacy|11|||
13470863|NCT00045942|26986116|FG003|PKC412A2104E1|Lack of Efficacy|23|||
13470864|NCT00045942|26986117|FG004|PKC412A2104E1|Lack of Efficacy|17|||
13470865|NCT00045942|26986118|FG005|PKC412A2104E1|Lack of Efficacy|0|||
13470866|NCT00045942|26986119|FG006|PKC412A2104E1|Lack of Efficacy|0|||
13470867|NCT00045942|26986120|FG007|PKC412A2104E1|Lack of Efficacy|0|||
13470868|NCT00045942|26986121|FG008|PKC412A2104E1|Lack of Efficacy|0|||
13470869|NCT00045942|26986113|FG000|PKC412A2104E1|Abnormal laboratory value|0|||
13470870|NCT00045942|26986114|FG001|PKC412A2104E1|Abnormal laboratory value|1|||
13470871|NCT00045942|26986115|FG002|PKC412A2104E1|Abnormal laboratory value|0|||
13470872|NCT00045942|26986116|FG003|PKC412A2104E1|Abnormal laboratory value|0|||
13470873|NCT00045942|26986117|FG004|PKC412A2104E1|Abnormal laboratory value|0|||
13470874|NCT00045942|26986118|FG005|PKC412A2104E1|Abnormal laboratory value|0|||
13470875|NCT00045942|26986119|FG006|PKC412A2104E1|Abnormal laboratory value|0|||
13470876|NCT00045942|26986120|FG007|PKC412A2104E1|Abnormal laboratory value|0|||
13470877|NCT00045942|26986121|FG008|PKC412A2104E1|Abnormal laboratory value|0|||
13470878|NCT00045942|26986113|FG000|PKC412A2104E1|Adverse Event|0|||
13470879|NCT00045942|26986114|FG001|PKC412A2104E1|Adverse Event|1|||
13470880|NCT00045942|26986115|FG002|PKC412A2104E1|Adverse Event|1|||
13470881|NCT00045942|26986116|FG003|PKC412A2104E1|Adverse Event|3|||
13470882|NCT00045942|26986117|FG004|PKC412A2104E1|Adverse Event|6|||
13470883|NCT00045942|26986118|FG005|PKC412A2104E1|Adverse Event|0|||
13470884|NCT00045942|26986119|FG006|PKC412A2104E1|Adverse Event|0|||
13470885|NCT00045942|26986120|FG007|PKC412A2104E1|Adverse Event|0|||
13470886|NCT00045942|26986121|FG008|PKC412A2104E1|Adverse Event|0|||
13470887|NCT00045942|26986113|FG000|PKC412A2104E1|Death|0|||
13470888|NCT00045942|26986114|FG001|PKC412A2104E1|Death|4|||
13470889|NCT00045942|26986115|FG002|PKC412A2104E1|Death|1|||
13470890|NCT00045942|26986116|FG003|PKC412A2104E1|Death|1|||
13470891|NCT00045942|26986117|FG004|PKC412A2104E1|Death|1|||
13470892|NCT00045942|26986118|FG005|PKC412A2104E1|Death|0|||
13470893|NCT00045942|26986119|FG006|PKC412A2104E1|Death|0|||
13470894|NCT00045942|26986120|FG007|PKC412A2104E1|Death|0|||
13470895|NCT00045942|26986121|FG008|PKC412A2104E1|Death|0|||
13470896|NCT00045942|26986113|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
13470897|NCT00045942|26986114|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
13470898|NCT00045942|26986115|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
13470899|NCT00045942|26986116|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
13470900|NCT00045942|26986117|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
13470901|NCT00045942|26986118|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
13470902|NCT00045942|26986119|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
13470903|NCT00045942|26986120|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
13470904|NCT00045942|26986121|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
13470905|NCT00045942|26986113|FG000|PKC412A2104E2|Lost to Follow-up|0|||
13470906|NCT00045942|26986114|FG001|PKC412A2104E2|Lost to Follow-up|0|||
13470907|NCT00045942|26986115|FG002|PKC412A2104E2|Lost to Follow-up|0|||
13470908|NCT00045942|26986116|FG003|PKC412A2104E2|Lost to Follow-up|0|||
13470909|NCT00045942|26986117|FG004|PKC412A2104E2|Lost to Follow-up|0|||
13470910|NCT00045942|26986118|FG005|PKC412A2104E2|Lost to Follow-up|0|||
13470911|NCT00045942|26986119|FG006|PKC412A2104E2|Lost to Follow-up|0|||
13470912|NCT00045942|26986120|FG007|PKC412A2104E2|Lost to Follow-up|3|||
13470913|NCT00045942|26986121|FG008|PKC412A2104E2|Lost to Follow-up|0|||
13470914|NCT00045942|26986113|FG000|PKC412A2104E2|Withdrawal by Subject|0|||
13470915|NCT00045942|26986114|FG001|PKC412A2104E2|Withdrawal by Subject|0|||
13470916|NCT00045942|26986115|FG002|PKC412A2104E2|Withdrawal by Subject|0|||
13470917|NCT00045942|26986116|FG003|PKC412A2104E2|Withdrawal by Subject|0|||
13470918|NCT00045942|26986117|FG004|PKC412A2104E2|Withdrawal by Subject|0|||
13470919|NCT00045942|26986118|FG005|PKC412A2104E2|Withdrawal by Subject|1|||
13470920|NCT00045942|26986119|FG006|PKC412A2104E2|Withdrawal by Subject|0|||
13470921|NCT00045942|26986120|FG007|PKC412A2104E2|Withdrawal by Subject|1|||
13470922|NCT00045942|26986121|FG008|PKC412A2104E2|Withdrawal by Subject|0|||
13470923|NCT00045942|26986113|FG000|PKC412A2104E2|Lack of Efficacy|0|||
13470924|NCT00045942|26986114|FG001|PKC412A2104E2|Lack of Efficacy|0|||
13470925|NCT00045942|26986115|FG002|PKC412A2104E2|Lack of Efficacy|0|||
13470926|NCT00045942|26986116|FG003|PKC412A2104E2|Lack of Efficacy|0|||
13470927|NCT00045942|26986117|FG004|PKC412A2104E2|Lack of Efficacy|0|||
13470928|NCT00045942|26986118|FG005|PKC412A2104E2|Lack of Efficacy|3|||
13470929|NCT00045942|26986119|FG006|PKC412A2104E2|Lack of Efficacy|2|||
13470930|NCT00045942|26986120|FG007|PKC412A2104E2|Lack of Efficacy|2|||
13470931|NCT00045942|26986121|FG008|PKC412A2104E2|Lack of Efficacy|6|||
13470932|NCT00045942|26986113|FG000|PKC412A2104E2|Adverse Event|0|||
13470933|NCT00045942|26986114|FG001|PKC412A2104E2|Adverse Event|0|||
13470934|NCT00045942|26986115|FG002|PKC412A2104E2|Adverse Event|0|||
13470935|NCT00045942|26986116|FG003|PKC412A2104E2|Adverse Event|0|||
13470936|NCT00045942|26986117|FG004|PKC412A2104E2|Adverse Event|0|||
13470937|NCT00045942|26986118|FG005|PKC412A2104E2|Adverse Event|4|||
13470938|NCT00045942|26986119|FG006|PKC412A2104E2|Adverse Event|3|||
13470939|NCT00045942|26986120|FG007|PKC412A2104E2|Adverse Event|1|||
13470940|NCT00045942|26986121|FG008|PKC412A2104E2|Adverse Event|0|||
13470941|NCT00045942|26986113|FG000|PKC412A2104E2|Death|0|||
13470942|NCT00045942|26986114|FG001|PKC412A2104E2|Death|0|||
13470943|NCT00045942|26986115|FG002|PKC412A2104E2|Death|0|||
13470944|NCT00045942|26986116|FG003|PKC412A2104E2|Death|0|||
13470945|NCT00045942|26986117|FG004|PKC412A2104E2|Death|0|||
13470946|NCT00045942|26986118|FG005|PKC412A2104E2|Death|1|||
13470947|NCT00045942|26986119|FG006|PKC412A2104E2|Death|2|||
13470948|NCT00045942|26986120|FG007|PKC412A2104E2|Death|0|||
13470949|NCT00045942|26986121|FG008|PKC412A2104E2|Death|0|||
13470950|NCT00045734|26986135|FG000|Overall Study|Protocol Violation|1|||
13470951|NCT00045708|26986170|FG000|Phase 1|early progressive disease|0|||
13470952|NCT00045708|26986171|FG001|Phase 1|early progressive disease|1|||
13470953|NCT00045708|26986172|FG002|Phase 1|early progressive disease|0|||
13470954|NCT00045630|26986180|FG000|Overall Study|Adverse Event|1|||
13470955|NCT00045630|26986180|FG000|Overall Study|Refusal unrelated to adverse event|1|||
13470956|NCT00045630|26986180|FG000|Overall Study|Progression/relapse|1|||
13470957|NCT00045630|26986180|FG000|Overall Study|Death|1|||
13470958|NCT00045630|26986180|FG000|Overall Study|Ineligible|2|||
13470959|NCT00045305|26986191|FG000|Overall Study|Lack of Efficacy|6|||
13470960|NCT00045305|26986191|FG000|Overall Study|Adverse Event|3|||
13470961|NCT00045305|26986191|FG000|Overall Study|Death|3|||
13470962|NCT00045305|26986191|FG000|Overall Study|site error|2|||
13470963|NCT00045162|26986210|FG000|Overall Study|Ineligible|12|||
13470964|NCT00045162|26986211|FG001|Overall Study|Ineligible|8|||
13470965|NCT00045162|26986210|FG000|Overall Study|Not treated|7|||
13470966|NCT00045162|26986211|FG001|Overall Study|Not treated|2|||
13470967|NCT00045162|26986210|FG000|Overall Study|Adverse Event|55|||
13470968|NCT00045162|26986211|FG001|Overall Study|Adverse Event|50|||
13470969|NCT00045162|26986210|FG000|Overall Study|Lack of Efficacy|32|||
13470970|NCT00045162|26986211|FG001|Overall Study|Lack of Efficacy|29|||
13470971|NCT00045162|26986210|FG000|Overall Study|Death|10|||
13470972|NCT00045162|26986211|FG001|Overall Study|Death|10|||
13470973|NCT00045162|26986210|FG000|Overall Study|Withdrawal by Subject|5|||
13470974|NCT00045162|26986211|FG001|Overall Study|Withdrawal by Subject|3|||
13470975|NCT00045162|26986210|FG000|Overall Study|Other|21|||
13470976|NCT00045162|26986211|FG001|Overall Study|Other|16|||
13470977|NCT00045110|26986267|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0|||
13470978|NCT00045110|26986268|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2|||
13470979|NCT00045110|26986269|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1|||
13470980|NCT00045110|26986267|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
13470981|NCT00045110|26986268|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4|||
13470982|NCT00045110|26986269|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
13470983|NCT00045110|26986267|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
13470984|NCT00045110|26986268|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
13470985|NCT00045110|26986269|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1|||
13470986|NCT00045032|26986406|FG000|Overall Study|Adverse Event/Intercurrent Illness|2|||
13470987|NCT00045032|26986407|FG001|Overall Study|Adverse Event/Intercurrent Illness|2|||
13470988|NCT00045032|26986408|FG002|Overall Study|Adverse Event/Intercurrent Illness|7|||
13470989|NCT00045032|26986406|FG000|Overall Study|Death|22|||
13470990|NCT00045032|26986407|FG001|Overall Study|Death|24|||
13470991|NCT00045032|26986408|FG002|Overall Study|Death|17|||
13470992|NCT00045032|26986406|FG000|Overall Study|Insufficient Therapeutic Response|542|||
13470993|NCT00045032|26986407|FG001|Overall Study|Insufficient Therapeutic Response|437|||
13470994|NCT00045032|26986408|FG002|Overall Study|Insufficient Therapeutic Response|445|||
13470995|NCT00045032|26986406|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
13470996|NCT00045032|26986407|FG001|Overall Study|Violation of Selection Criteria at Entry|6|||
13470997|NCT00045032|26986408|FG002|Overall Study|Violation of Selection Criteria at Entry|6|||
13470998|NCT00045032|26986406|FG000|Overall Study|Other Protocol Violation|2|||
13470999|NCT00045032|26986407|FG001|Overall Study|Other Protocol Violation|0|||
13471000|NCT00045032|26986408|FG002|Overall Study|Other Protocol Violation|1|||
13471001|NCT00045032|26986406|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142|||
13471002|NCT00045032|26986407|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93|||
13471003|NCT00045032|26986408|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84|||
13471004|NCT00045032|26986406|FG000|Overall Study|Failure to Return|57|||
13471005|NCT00045032|26986407|FG001|Overall Study|Failure to Return|62|||
13471006|NCT00045032|26986408|FG002|Overall Study|Failure to Return|61|||
13471007|NCT00045032|26986406|FG000|Overall Study|Other|93|||
13471008|NCT00045032|26986407|FG001|Overall Study|Other|84|||
13471009|NCT00045032|26986408|FG002|Overall Study|Other|105|||
13471010|NCT00044512|26986421|FG000|Follow Up|Lost to Follow-up|2|||
13471011|NCT00044213|26986448|FG000|Overall Study|Withdrawal by Subject|50|||
13471012|NCT00044213|26986449|FG001|Overall Study|Withdrawal by Subject|65|||
13471013|NCT00044213|26986450|FG002|Overall Study|Withdrawal by Subject|91|||
13471014|NCT00044213|26986451|FG003|Overall Study|Withdrawal by Subject|83|||
13471015|NCT00044213|26986448|FG000|Overall Study|Death|42|||
13471016|NCT00044213|26986449|FG001|Overall Study|Death|42|||
13471017|NCT00044213|26986450|FG002|Overall Study|Death|42|||
13471018|NCT00044213|26986451|FG003|Overall Study|Death|49|||
13471019|NCT00044213|26986448|FG000|Overall Study|Lost to Follow-up|8|||
13471020|NCT00044213|26986449|FG001|Overall Study|Lost to Follow-up|5|||
13471021|NCT00044213|26986450|FG002|Overall Study|Lost to Follow-up|5|||
13471022|NCT00044213|26986451|FG003|Overall Study|Lost to Follow-up|4|||
13471023|NCT00044083|26986494|FG000|First Intervention (One Week)- HV's|Adverse Event|1|||
13471024|NCT00044083|26986495|FG001|First Intervention (One Week)- HV's|Adverse Event|0|||
13471025|NCT00044083|26986494|FG000|First Intervention (One Week)- HV's|Not follow directions|2|||
13471026|NCT00044083|26986495|FG001|First Intervention (One Week)- HV's|Not follow directions|2|||
13471027|NCT00044083|26986494|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5|||
13471028|NCT00044083|26986495|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3|||
13471029|NCT00044083|26986494|FG000|First Intervention (One Week)- HV's|Pregnancy|1|||
13471030|NCT00044083|26986495|FG001|First Intervention (One Week)- HV's|Pregnancy|0|||
13471031|NCT00044083|26986494|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1|||
13471032|NCT00044083|26986495|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0|||
13471033|NCT00044083|26986494|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0|||
13471034|NCT00044083|26986495|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1|||
13471035|NCT00044083|26986494|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0|||
13471036|NCT00044083|26986495|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1|||
13471037|NCT00044083|26986494|FG000|First Intervention (One Week) Patients|Not follow directions|0|||
13471038|NCT00044083|26986495|FG001|First Intervention (One Week) Patients|Not follow directions|2|||
13471039|NCT00044083|26986494|FG000|First Intervention (One Week) Patients|Used illegal drug|1|||
13471040|NCT00044083|26986495|FG001|First Intervention (One Week) Patients|Used illegal drug|0|||
13471041|NCT00044083|26986494|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0|||
13471042|NCT00044083|26986495|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1|||
13471043|NCT00043979|26986521|FG000|Period 1|recipient with progressive disease|7|||
13471044|NCT00043979|26986522|FG001|Period 1|recipient with progressive disease|4|||
13471045|NCT00043979|26986523|FG002|Period 1|recipient with progressive disease|3|||
13471046|NCT00043550|26986541|FG000|Overall Study|Withdrawal by Subject|22|||
13471047|NCT00043550|26986542|FG001|Overall Study|Withdrawal by Subject|12|||
13471048|NCT00043550|26986543|FG002|Overall Study|Withdrawal by Subject|20|||
13471049|NCT00043186|26986897|FG000|Overall Study|Physician Decision|0|||
13471050|NCT00043186|26986898|FG001|Overall Study|Physician Decision|0|||
13471051|NCT00043186|26986899|FG002|Overall Study|Physician Decision|3|||
13471052|NCT00043186|26986900|FG003|Overall Study|Physician Decision|0|||
13471053|NCT00043186|26986901|FG004|Overall Study|Physician Decision|1|||
13471054|NCT00043186|26986902|FG005|Overall Study|Physician Decision|0|||
13471055|NCT00043186|26986903|FG006|Overall Study|Physician Decision|0|||
13471056|NCT00043186|26986904|FG007|Overall Study|Physician Decision|1|||
13471057|NCT00043186|26986905|FG008|Overall Study|Physician Decision|1|||
13471058|NCT00043186|26986897|FG000|Overall Study|Adverse Event|2|||
13471059|NCT00043186|26986898|FG001|Overall Study|Adverse Event|2|||
13471060|NCT00043186|26986899|FG002|Overall Study|Adverse Event|2|||
13471061|NCT00043186|26986900|FG003|Overall Study|Adverse Event|3|||
13471062|NCT00043186|26986901|FG004|Overall Study|Adverse Event|2|||
13471063|NCT00043186|26986902|FG005|Overall Study|Adverse Event|1|||
13471064|NCT00043186|26986903|FG006|Overall Study|Adverse Event|2|||
13471065|NCT00043186|26986904|FG007|Overall Study|Adverse Event|1|||
13471066|NCT00043186|26986905|FG008|Overall Study|Adverse Event|3|||
13471067|NCT00043186|26986897|FG000|Overall Study|Withdrawal by Subject|11|||
13471068|NCT00043186|26986898|FG001|Overall Study|Withdrawal by Subject|8|||
13471069|NCT00043186|26986899|FG002|Overall Study|Withdrawal by Subject|11|||
13471070|NCT00043186|26986900|FG003|Overall Study|Withdrawal by Subject|13|||
13471071|NCT00043186|26986901|FG004|Overall Study|Withdrawal by Subject|14|||
13471072|NCT00043186|26986902|FG005|Overall Study|Withdrawal by Subject|6|||
13471073|NCT00043186|26986903|FG006|Overall Study|Withdrawal by Subject|12|||
13471074|NCT00043186|26986904|FG007|Overall Study|Withdrawal by Subject|9|||
13471075|NCT00043186|26986905|FG008|Overall Study|Withdrawal by Subject|10|||
13471076|NCT00043186|26986897|FG000|Overall Study|Death|0|||
13471077|NCT00043186|26986898|FG001|Overall Study|Death|0|||
13471078|NCT00043186|26986899|FG002|Overall Study|Death|1|||
13471079|NCT00043186|26986900|FG003|Overall Study|Death|0|||
13471080|NCT00043186|26986901|FG004|Overall Study|Death|0|||
13471081|NCT00043186|26986902|FG005|Overall Study|Death|0|||
13471082|NCT00043186|26986903|FG006|Overall Study|Death|2|||
13471083|NCT00043186|26986904|FG007|Overall Study|Death|0|||
13471084|NCT00043186|26986905|FG008|Overall Study|Death|0|||
13471085|NCT00043186|26986897|FG000|Overall Study|Disease progression|1|||
13471086|NCT00043186|26986898|FG001|Overall Study|Disease progression|0|||
13471087|NCT00043186|26986899|FG002|Overall Study|Disease progression|0|||
13471088|NCT00043186|26986900|FG003|Overall Study|Disease progression|3|||
13471089|NCT00043186|26986901|FG004|Overall Study|Disease progression|0|||
13471090|NCT00043186|26986902|FG005|Overall Study|Disease progression|0|||
13471091|NCT00043186|26986903|FG006|Overall Study|Disease progression|0|||
13471092|NCT00043186|26986904|FG007|Overall Study|Disease progression|4|||
13471093|NCT00043186|26986905|FG008|Overall Study|Disease progression|0|||
13471094|NCT00043186|26986897|FG000|Overall Study|Ineligibility determined|0|||
13471095|NCT00043186|26986898|FG001|Overall Study|Ineligibility determined|0|||
13471096|NCT00043186|26986899|FG002|Overall Study|Ineligibility determined|0|||
13471097|NCT00043186|26986900|FG003|Overall Study|Ineligibility determined|0|||
13471098|NCT00043186|26986901|FG004|Overall Study|Ineligibility determined|0|||
13471099|NCT00043186|26986902|FG005|Overall Study|Ineligibility determined|0|||
13471100|NCT00043186|26986903|FG006|Overall Study|Ineligibility determined|0|||
13471101|NCT00043186|26986904|FG007|Overall Study|Ineligibility determined|0|||
13471102|NCT00043186|26986905|FG008|Overall Study|Ineligibility determined|1|||
13471103|NCT00043186|26986897|FG000|Overall Study|Lost to Follow-up|3|||
13471104|NCT00043186|26986898|FG001|Overall Study|Lost to Follow-up|5|||
13471105|NCT00043186|26986899|FG002|Overall Study|Lost to Follow-up|1|||
13471106|NCT00043186|26986900|FG003|Overall Study|Lost to Follow-up|1|||
13471107|NCT00043186|26986901|FG004|Overall Study|Lost to Follow-up|1|||
13471108|NCT00043186|26986902|FG005|Overall Study|Lost to Follow-up|1|||
13471109|NCT00043186|26986903|FG006|Overall Study|Lost to Follow-up|1|||
13471110|NCT00043186|26986904|FG007|Overall Study|Lost to Follow-up|1|||
13471111|NCT00043186|26986905|FG008|Overall Study|Lost to Follow-up|2|||
13471112|NCT00043186|26986897|FG000|Overall Study|Noncompliance|0|||
13471113|NCT00043186|26986898|FG001|Overall Study|Noncompliance|0|||
13471114|NCT00043186|26986899|FG002|Overall Study|Noncompliance|1|||
13471115|NCT00043186|26986900|FG003|Overall Study|Noncompliance|1|||
13471116|NCT00043186|26986901|FG004|Overall Study|Noncompliance|0|||
13471117|NCT00043186|26986902|FG005|Overall Study|Noncompliance|0|||
13471118|NCT00043186|26986903|FG006|Overall Study|Noncompliance|0|||
13471119|NCT00043186|26986904|FG007|Overall Study|Noncompliance|0|||
13471120|NCT00043186|26986905|FG008|Overall Study|Noncompliance|0|||
13471121|NCT00043186|26986897|FG000|Overall Study|Other|0|||
13471122|NCT00043186|26986898|FG001|Overall Study|Other|0|||
13471123|NCT00043186|26986899|FG002|Overall Study|Other|1|||
13471124|NCT00043186|26986900|FG003|Overall Study|Other|1|||
13471125|NCT00043186|26986901|FG004|Overall Study|Other|0|||
13471126|NCT00043186|26986902|FG005|Overall Study|Other|0|||
13471127|NCT00043186|26986903|FG006|Overall Study|Other|0|||
13471128|NCT00043186|26986904|FG007|Overall Study|Other|0|||
13471129|NCT00043186|26986905|FG008|Overall Study|Other|0|||
13471130|NCT00042991|26986968|FG000|Overall Study|Adverse Event|1|||
13471131|NCT00042991|26986969|FG001|Overall Study|Adverse Event|4|||
13471132|NCT00042991|26986970|FG002|Overall Study|Adverse Event|2|||
13471133|NCT00042991|26986971|FG003|Overall Study|Adverse Event|0|||
13471134|NCT00042991|26986972|FG004|Overall Study|Adverse Event|0|||
13471135|NCT00042991|26986973|FG005|Overall Study|Adverse Event|1|||
13471136|NCT00042991|26986974|FG006|Overall Study|Adverse Event|0|||
13471137|NCT00042991|26986968|FG000|Overall Study|Withdrawal by Subject|0|||
13471138|NCT00042991|26986969|FG001|Overall Study|Withdrawal by Subject|7|||
13471139|NCT00042991|26986970|FG002|Overall Study|Withdrawal by Subject|2|||
13471140|NCT00042991|26986971|FG003|Overall Study|Withdrawal by Subject|0|||
13471141|NCT00042991|26986972|FG004|Overall Study|Withdrawal by Subject|1|||
13471142|NCT00042991|26986973|FG005|Overall Study|Withdrawal by Subject|0|||
13471143|NCT00042991|26986974|FG006|Overall Study|Withdrawal by Subject|0|||
13471144|NCT00042991|26986968|FG000|Overall Study|Disease Progression|5|||
13471145|NCT00042991|26986969|FG001|Overall Study|Disease Progression|29|||
13471146|NCT00042991|26986970|FG002|Overall Study|Disease Progression|2|||
13471147|NCT00042991|26986971|FG003|Overall Study|Disease Progression|2|||
13471148|NCT00042991|26986972|FG004|Overall Study|Disease Progression|1|||
13471149|NCT00042991|26986973|FG005|Overall Study|Disease Progression|4|||
13471150|NCT00042991|26986974|FG006|Overall Study|Disease Progression|2|||
13471151|NCT00042991|26986968|FG000|Overall Study|Alternative Therapy|0|||
13471152|NCT00042991|26986969|FG001|Overall Study|Alternative Therapy|0|||
13471153|NCT00042991|26986970|FG002|Overall Study|Alternative Therapy|0|||
13471154|NCT00042991|26986971|FG003|Overall Study|Alternative Therapy|0|||
13471155|NCT00042991|26986972|FG004|Overall Study|Alternative Therapy|1|||
13471156|NCT00042991|26986973|FG005|Overall Study|Alternative Therapy|0|||
13471157|NCT00042991|26986974|FG006|Overall Study|Alternative Therapy|0|||
13471158|NCT00042939|26986995|FG000|Overall Study|Adverse Event|6|||
13471159|NCT00042939|26986996|FG001|Overall Study|Adverse Event|7|||
13471160|NCT00042939|26986995|FG000|Overall Study|Death|3|||
13471161|NCT00042939|26986996|FG001|Overall Study|Death|2|||
13471162|NCT00042939|26986995|FG000|Overall Study|Withdrawal by Subject|3|||
13471163|NCT00042939|26986996|FG001|Overall Study|Withdrawal by Subject|4|||
13471164|NCT00042939|26986995|FG000|Overall Study|Other disease|1|||
13471165|NCT00042939|26986996|FG001|Overall Study|Other disease|0|||
13471166|NCT00042939|26986995|FG000|Overall Study|Ineligible|2|||
13471167|NCT00042939|26986996|FG001|Overall Study|Ineligible|2|||
13471168|NCT00042939|26986995|FG000|Overall Study|Deterioration of health|3|||
13471169|NCT00042939|26986996|FG001|Overall Study|Deterioration of health|4|||
13471170|NCT00042939|26986995|FG000|Overall Study|QOL diminished|1|||
13471171|NCT00042939|26986996|FG001|Overall Study|QOL diminished|0|||
13471172|NCT00042939|26986995|FG000|Overall Study|Rising ca 19-9|1|||
13471173|NCT00042939|26986996|FG001|Overall Study|Rising ca 19-9|0|||
13471174|NCT00042939|26986995|FG000|Overall Study|Patient non-compliance|1|||
13471175|NCT00042939|26986996|FG001|Overall Study|Patient non-compliance|0|||
13471176|NCT00042939|26986995|FG000|Overall Study|Still on treatment|1|||
13471177|NCT00042939|26986996|FG001|Overall Study|Still on treatment|0|||
13471178|NCT00042939|26986995|FG000|Overall Study|Treatment break > 4 weeks|0|||
13471179|NCT00042939|26986996|FG001|Overall Study|Treatment break > 4 weeks|1|||
13471180|NCT00042939|26986995|FG000|Overall Study|Did not start treatment|2|||
13471181|NCT00042939|26986996|FG001|Overall Study|Did not start treatment|1|||
13471182|NCT00042666|26987008|FG000|Overall Study|Adverse Event|2|||
13471183|NCT00042666|26987008|FG000|Overall Study|Death|4|||
13471184|NCT00042666|26987008|FG000|Overall Study|Protocol Violation|1|||
13471185|NCT00042666|26987008|FG000|Overall Study|Participant/Physician Perception|1|||
13471186|NCT00042666|26987008|FG000|Overall Study|Progressive Disease|41|||
13471187|NCT00042666|26987008|FG000|Overall Study|Other|1|||
13471188|NCT00042666|26987008|FG000|Overall Study|Other|4|||
13471189|NCT00042432|26987023|FG000|Overall Study|Adverse Event|4|||
13471190|NCT00042432|26987024|FG001|Overall Study|Adverse Event|1|||
13471191|NCT00042432|26987023|FG000|Overall Study|Withdrawal by Subject|1|||
13471192|NCT00042432|26987024|FG001|Overall Study|Withdrawal by Subject|3|||
13471193|NCT00042432|26987023|FG000|Overall Study|Death|0|||
13471194|NCT00042432|26987024|FG001|Overall Study|Death|2|||
13471195|NCT00042432|26987023|FG000|Overall Study|Ineligibility determined|1|||
13471196|NCT00042432|26987024|FG001|Overall Study|Ineligibility determined|0|||
13471197|NCT00042432|26987023|FG000|Overall Study|Initiation of maintenance dialysis|1|||
13471198|NCT00042432|26987024|FG001|Overall Study|Initiation of maintenance dialysis|1|||
13471199|NCT00042432|26987023|FG000|Overall Study|Other|2|||
13471200|NCT00042432|26987024|FG001|Overall Study|Other|0|||
13471201|NCT00042289|26987377|FG000|Overall Study|Lost to Follow-up|3|||
13471202|NCT00042289|26987378|FG001|Overall Study|Lost to Follow-up|0|||
13471203|NCT00042289|26987379|FG002|Overall Study|Lost to Follow-up|0|||
13471204|NCT00042289|26987380|FG003|Overall Study|Lost to Follow-up|1|||
13471205|NCT00042289|26987381|FG004|Overall Study|Lost to Follow-up|3|||
13471206|NCT00042289|26987382|FG005|Overall Study|Lost to Follow-up|3|||
13471207|NCT00042289|26987383|FG006|Overall Study|Lost to Follow-up|6|||
13471208|NCT00042289|26987384|FG007|Overall Study|Lost to Follow-up|1|||
13471209|NCT00042289|26987385|FG008|Overall Study|Lost to Follow-up|1|||
13471210|NCT00042289|26987386|FG009|Overall Study|Lost to Follow-up|0|||
13471211|NCT00042289|26987387|FG010|Overall Study|Lost to Follow-up|0|||
13471212|NCT00042289|26987388|FG011|Overall Study|Lost to Follow-up|0|||
13471213|NCT00042289|26987389|FG012|Overall Study|Lost to Follow-up|0|||
13471214|NCT00042289|26987390|FG013|Overall Study|Lost to Follow-up|0|||
13471215|NCT00042289|26987391|FG014|Overall Study|Lost to Follow-up|0|||
13471216|NCT00042289|26987392|FG015|Overall Study|Lost to Follow-up|1|||
13471217|NCT00042289|26987393|FG016|Overall Study|Lost to Follow-up|1|||
13471218|NCT00042289|26987394|FG017|Overall Study|Lost to Follow-up|0|||
13471219|NCT00042289|26987395|FG018|Overall Study|Lost to Follow-up|3|||
13471220|NCT00042289|26987396|FG019|Overall Study|Lost to Follow-up|2|||
13471221|NCT00042289|26987397|FG020|Overall Study|Lost to Follow-up|0|||
13471222|NCT00042289|26987398|FG021|Overall Study|Lost to Follow-up|0|||
13471223|NCT00042289|26987399|FG022|Overall Study|Lost to Follow-up|0|||
13471224|NCT00042289|26987400|FG023|Overall Study|Lost to Follow-up|0|||
13471225|NCT00042289|26987401|FG024|Overall Study|Lost to Follow-up|0|||
13471226|NCT00042289|26987402|FG025|Overall Study|Lost to Follow-up|0|||
13471227|NCT00042289|26987403|FG026|Overall Study|Lost to Follow-up|2|||
13471228|NCT00042289|26987404|FG027|Overall Study|Lost to Follow-up|2|||
13471229|NCT00042289|26987405|FG028|Overall Study|Lost to Follow-up|2|||
13471230|NCT00042289|26987406|FG029|Overall Study|Lost to Follow-up|0|||
13471231|NCT00042289|26987407|FG030|Overall Study|Lost to Follow-up|0|||
13471232|NCT00042289|26987408|FG031|Overall Study|Lost to Follow-up|2|||
13471233|NCT00042289|26987409|FG032|Overall Study|Lost to Follow-up|1|||
13471234|NCT00042289|26987410|FG033|Overall Study|Lost to Follow-up|1|||
13471235|NCT00042289|26987411|FG034|Overall Study|Lost to Follow-up|1|||
13471236|NCT00042289|26987412|FG035|Overall Study|Lost to Follow-up|2|||
13471237|NCT00042289|26987413|FG036|Overall Study|Lost to Follow-up|1|||
13471238|NCT00042289|26987414|FG037|Overall Study|Lost to Follow-up|1|||
13471239|NCT00042289|26987415|FG038|Overall Study|Lost to Follow-up|0|||
13471240|NCT00042289|26987416|FG039|Overall Study|Lost to Follow-up|5|||
13471241|NCT00042289|26987417|FG040|Overall Study|Lost to Follow-up|0|||
13471242|NCT00042289|26987418|FG041|Overall Study|Lost to Follow-up|2|||
13471243|NCT00042289|26987419|FG042|Overall Study|Lost to Follow-up|2|||
13471244|NCT00042289|26987420|FG043|Overall Study|Lost to Follow-up|0|||
13471245|NCT00042289|26987421|FG044|Overall Study|Lost to Follow-up|0|||
13471246|NCT00042289|26987422|FG045|Overall Study|Lost to Follow-up|1|||
13471247|NCT00042289|26987423|FG046|Overall Study|Lost to Follow-up|0|||
13471248|NCT00042289|26987377|FG000|Overall Study|Other reason|0|||
13471249|NCT00042289|26987378|FG001|Overall Study|Other reason|0|||
13471250|NCT00042289|26987379|FG002|Overall Study|Other reason|0|||
13471251|NCT00042289|26987380|FG003|Overall Study|Other reason|2|||
13471252|NCT00042289|26987381|FG004|Overall Study|Other reason|0|||
13471253|NCT00042289|26987382|FG005|Overall Study|Other reason|0|||
13471254|NCT00042289|26987383|FG006|Overall Study|Other reason|0|||
13471255|NCT00042289|26987384|FG007|Overall Study|Other reason|0|||
13471256|NCT00042289|26987385|FG008|Overall Study|Other reason|0|||
13471257|NCT00042289|26987386|FG009|Overall Study|Other reason|0|||
13471258|NCT00042289|26987387|FG010|Overall Study|Other reason|0|||
13471259|NCT00042289|26987388|FG011|Overall Study|Other reason|0|||
13471260|NCT00042289|26987389|FG012|Overall Study|Other reason|0|||
13471261|NCT00042289|26987390|FG013|Overall Study|Other reason|0|||
13471262|NCT00042289|26987391|FG014|Overall Study|Other reason|0|||
13471263|NCT00042289|26987392|FG015|Overall Study|Other reason|0|||
13471264|NCT00042289|26987393|FG016|Overall Study|Other reason|0|||
13471265|NCT00042289|26987394|FG017|Overall Study|Other reason|0|||
13471266|NCT00042289|26987395|FG018|Overall Study|Other reason|1|||
13471267|NCT00042289|26987396|FG019|Overall Study|Other reason|0|||
13471268|NCT00042289|26987397|FG020|Overall Study|Other reason|0|||
13471269|NCT00042289|26987398|FG021|Overall Study|Other reason|0|||
13471270|NCT00042289|26987399|FG022|Overall Study|Other reason|0|||
13471271|NCT00042289|26987400|FG023|Overall Study|Other reason|1|||
13471272|NCT00042289|26987401|FG024|Overall Study|Other reason|0|||
13471273|NCT00042289|26987402|FG025|Overall Study|Other reason|0|||
13471274|NCT00042289|26987403|FG026|Overall Study|Other reason|1|||
13471275|NCT00042289|26987404|FG027|Overall Study|Other reason|0|||
13471276|NCT00042289|26987405|FG028|Overall Study|Other reason|3|||
13471277|NCT00042289|26987406|FG029|Overall Study|Other reason|0|||
13471278|NCT00042289|26987407|FG030|Overall Study|Other reason|0|||
13471279|NCT00042289|26987408|FG031|Overall Study|Other reason|1|||
13471280|NCT00042289|26987409|FG032|Overall Study|Other reason|0|||
13471281|NCT00042289|26987410|FG033|Overall Study|Other reason|1|||
13471282|NCT00042289|26987411|FG034|Overall Study|Other reason|0|||
13471283|NCT00042289|26987412|FG035|Overall Study|Other reason|2|||
13471284|NCT00042289|26987413|FG036|Overall Study|Other reason|0|||
13471285|NCT00042289|26987414|FG037|Overall Study|Other reason|0|||
13471286|NCT00042289|26987415|FG038|Overall Study|Other reason|0|||
13471287|NCT00042289|26987416|FG039|Overall Study|Other reason|0|||
13471288|NCT00042289|26987417|FG040|Overall Study|Other reason|0|||
13471289|NCT00042289|26987418|FG041|Overall Study|Other reason|0|||
13471290|NCT00042289|26987419|FG042|Overall Study|Other reason|0|||
13471291|NCT00042289|26987420|FG043|Overall Study|Other reason|1|||
13471292|NCT00042289|26987421|FG044|Overall Study|Other reason|0|||
13471293|NCT00042289|26987422|FG045|Overall Study|Other reason|0|||
13471294|NCT00042289|26987423|FG046|Overall Study|Other reason|0|||
13471295|NCT00042289|26987377|FG000|Overall Study|Severe debilitation, unable to continue|0|||
13471296|NCT00042289|26987378|FG001|Overall Study|Severe debilitation, unable to continue|0|||
13471297|NCT00042289|26987379|FG002|Overall Study|Severe debilitation, unable to continue|0|||
13471298|NCT00042289|26987380|FG003|Overall Study|Severe debilitation, unable to continue|0|||
13133965|NCT02761629|25989882|FG001|Overall Study|Protocol Violation|2|||
13471299|NCT00042289|26987381|FG004|Overall Study|Severe debilitation, unable to continue|0|||
13471300|NCT00042289|26987382|FG005|Overall Study|Severe debilitation, unable to continue|0|||
13471301|NCT00042289|26987383|FG006|Overall Study|Severe debilitation, unable to continue|0|||
13471302|NCT00042289|26987384|FG007|Overall Study|Severe debilitation, unable to continue|0|||
13471303|NCT00042289|26987385|FG008|Overall Study|Severe debilitation, unable to continue|0|||
13471304|NCT00042289|26987386|FG009|Overall Study|Severe debilitation, unable to continue|0|||
13471305|NCT00042289|26987387|FG010|Overall Study|Severe debilitation, unable to continue|0|||
13471306|NCT00042289|26987388|FG011|Overall Study|Severe debilitation, unable to continue|0|||
13471307|NCT00042289|26987389|FG012|Overall Study|Severe debilitation, unable to continue|0|||
13471308|NCT00042289|26987390|FG013|Overall Study|Severe debilitation, unable to continue|0|||
13471309|NCT00042289|26987391|FG014|Overall Study|Severe debilitation, unable to continue|0|||
13471310|NCT00042289|26987392|FG015|Overall Study|Severe debilitation, unable to continue|0|||
13471311|NCT00042289|26987393|FG016|Overall Study|Severe debilitation, unable to continue|0|||
13471312|NCT00042289|26987394|FG017|Overall Study|Severe debilitation, unable to continue|0|||
13471313|NCT00042289|26987395|FG018|Overall Study|Severe debilitation, unable to continue|0|||
13471314|NCT00042289|26987396|FG019|Overall Study|Severe debilitation, unable to continue|0|||
13471315|NCT00042289|26987397|FG020|Overall Study|Severe debilitation, unable to continue|0|||
13471316|NCT00042289|26987398|FG021|Overall Study|Severe debilitation, unable to continue|1|||
13471317|NCT00042289|26987399|FG022|Overall Study|Severe debilitation, unable to continue|0|||
13471318|NCT00042289|26987400|FG023|Overall Study|Severe debilitation, unable to continue|1|||
13471319|NCT00042289|26987401|FG024|Overall Study|Severe debilitation, unable to continue|0|||
13471320|NCT00042289|26987402|FG025|Overall Study|Severe debilitation, unable to continue|0|||
13471321|NCT00042289|26987403|FG026|Overall Study|Severe debilitation, unable to continue|0|||
13471322|NCT00042289|26987404|FG027|Overall Study|Severe debilitation, unable to continue|1|||
13471323|NCT00042289|26987405|FG028|Overall Study|Severe debilitation, unable to continue|0|||
13471324|NCT00042289|26987406|FG029|Overall Study|Severe debilitation, unable to continue|0|||
13471325|NCT00042289|26987407|FG030|Overall Study|Severe debilitation, unable to continue|0|||
13471326|NCT00042289|26987408|FG031|Overall Study|Severe debilitation, unable to continue|1|||
13471327|NCT00042289|26987409|FG032|Overall Study|Severe debilitation, unable to continue|1|||
13471328|NCT00042289|26987410|FG033|Overall Study|Severe debilitation, unable to continue|0|||
13471329|NCT00042289|26987411|FG034|Overall Study|Severe debilitation, unable to continue|0|||
13471330|NCT00042289|26987412|FG035|Overall Study|Severe debilitation, unable to continue|0|||
13471331|NCT00042289|26987413|FG036|Overall Study|Severe debilitation, unable to continue|0|||
13471332|NCT00042289|26987414|FG037|Overall Study|Severe debilitation, unable to continue|0|||
13471333|NCT00042289|26987415|FG038|Overall Study|Severe debilitation, unable to continue|0|||
13471334|NCT00042289|26987416|FG039|Overall Study|Severe debilitation, unable to continue|0|||
13471335|NCT00042289|26987417|FG040|Overall Study|Severe debilitation, unable to continue|0|||
13471336|NCT00042289|26987418|FG041|Overall Study|Severe debilitation, unable to continue|0|||
13471337|NCT00042289|26987419|FG042|Overall Study|Severe debilitation, unable to continue|0|||
13471338|NCT00042289|26987420|FG043|Overall Study|Severe debilitation, unable to continue|0|||
13471339|NCT00042289|26987421|FG044|Overall Study|Severe debilitation, unable to continue|0|||
13471340|NCT00042289|26987422|FG045|Overall Study|Severe debilitation, unable to continue|0|||
13471341|NCT00042289|26987423|FG046|Overall Study|Severe debilitation, unable to continue|0|||
13471342|NCT00042289|26987377|FG000|Overall Study|Site closed|0|||
13471343|NCT00042289|26987378|FG001|Overall Study|Site closed|0|||
13471344|NCT00042289|26987379|FG002|Overall Study|Site closed|0|||
13471345|NCT00042289|26987380|FG003|Overall Study|Site closed|0|||
13471346|NCT00042289|26987381|FG004|Overall Study|Site closed|0|||
13471347|NCT00042289|26987382|FG005|Overall Study|Site closed|0|||
13471348|NCT00042289|26987383|FG006|Overall Study|Site closed|0|||
13471349|NCT00042289|26987384|FG007|Overall Study|Site closed|0|||
13471350|NCT00042289|26987385|FG008|Overall Study|Site closed|0|||
13471351|NCT00042289|26987386|FG009|Overall Study|Site closed|0|||
13471352|NCT00042289|26987387|FG010|Overall Study|Site closed|0|||
13471353|NCT00042289|26987388|FG011|Overall Study|Site closed|0|||
13471354|NCT00042289|26987389|FG012|Overall Study|Site closed|0|||
13471355|NCT00042289|26987390|FG013|Overall Study|Site closed|0|||
13471356|NCT00042289|26987391|FG014|Overall Study|Site closed|0|||
13471357|NCT00042289|26987392|FG015|Overall Study|Site closed|0|||
13471358|NCT00042289|26987393|FG016|Overall Study|Site closed|0|||
13471359|NCT00042289|26987394|FG017|Overall Study|Site closed|0|||
13471360|NCT00042289|26987395|FG018|Overall Study|Site closed|0|||
13471361|NCT00042289|26987396|FG019|Overall Study|Site closed|0|||
13471362|NCT00042289|26987397|FG020|Overall Study|Site closed|0|||
13471363|NCT00042289|26987398|FG021|Overall Study|Site closed|0|||
13471364|NCT00042289|26987399|FG022|Overall Study|Site closed|0|||
13471365|NCT00042289|26987400|FG023|Overall Study|Site closed|0|||
13471366|NCT00042289|26987401|FG024|Overall Study|Site closed|0|||
13471367|NCT00042289|26987402|FG025|Overall Study|Site closed|0|||
13471368|NCT00042289|26987403|FG026|Overall Study|Site closed|0|||
13471369|NCT00042289|26987404|FG027|Overall Study|Site closed|0|||
13471370|NCT00042289|26987405|FG028|Overall Study|Site closed|0|||
13471371|NCT00042289|26987406|FG029|Overall Study|Site closed|0|||
13471372|NCT00042289|26987407|FG030|Overall Study|Site closed|0|||
13471373|NCT00042289|26987408|FG031|Overall Study|Site closed|3|||
13471374|NCT00042289|26987409|FG032|Overall Study|Site closed|0|||
13471375|NCT00042289|26987410|FG033|Overall Study|Site closed|0|||
13471376|NCT00042289|26987411|FG034|Overall Study|Site closed|0|||
13471377|NCT00042289|26987412|FG035|Overall Study|Site closed|0|||
13471378|NCT00042289|26987413|FG036|Overall Study|Site closed|1|||
13471379|NCT00042289|26987414|FG037|Overall Study|Site closed|0|||
13471380|NCT00042289|26987415|FG038|Overall Study|Site closed|0|||
13471381|NCT00042289|26987416|FG039|Overall Study|Site closed|0|||
13471382|NCT00042289|26987417|FG040|Overall Study|Site closed|0|||
13471383|NCT00042289|26987418|FG041|Overall Study|Site closed|0|||
13471384|NCT00042289|26987419|FG042|Overall Study|Site closed|1|||
13471385|NCT00042289|26987420|FG043|Overall Study|Site closed|0|||
13471386|NCT00042289|26987421|FG044|Overall Study|Site closed|0|||
13471387|NCT00042289|26987422|FG045|Overall Study|Site closed|0|||
13471388|NCT00042289|26987423|FG046|Overall Study|Site closed|0|||
13471389|NCT00042289|26987377|FG000|Overall Study|Participant not willing to adhere to requirements|0|||
13471390|NCT00042289|26987378|FG001|Overall Study|Participant not willing to adhere to requirements|0|||
13471391|NCT00042289|26987379|FG002|Overall Study|Participant not willing to adhere to requirements|0|||
13471392|NCT00042289|26987380|FG003|Overall Study|Participant not willing to adhere to requirements|3|||
13471393|NCT00042289|26987381|FG004|Overall Study|Participant not willing to adhere to requirements|0|||
13471394|NCT00042289|26987382|FG005|Overall Study|Participant not willing to adhere to requirements|0|||
13471395|NCT00042289|26987383|FG006|Overall Study|Participant not willing to adhere to requirements|0|||
13471396|NCT00042289|26987384|FG007|Overall Study|Participant not willing to adhere to requirements|0|||
13471397|NCT00042289|26987385|FG008|Overall Study|Participant not willing to adhere to requirements|0|||
13471398|NCT00042289|26987386|FG009|Overall Study|Participant not willing to adhere to requirements|0|||
13471399|NCT00042289|26987387|FG010|Overall Study|Participant not willing to adhere to requirements|0|||
13471400|NCT00042289|26987388|FG011|Overall Study|Participant not willing to adhere to requirements|0|||
13471401|NCT00042289|26987389|FG012|Overall Study|Participant not willing to adhere to requirements|0|||
13471402|NCT00042289|26987390|FG013|Overall Study|Participant not willing to adhere to requirements|0|||
13471403|NCT00042289|26987391|FG014|Overall Study|Participant not willing to adhere to requirements|0|||
13471404|NCT00042289|26987392|FG015|Overall Study|Participant not willing to adhere to requirements|0|||
13471405|NCT00042289|26987393|FG016|Overall Study|Participant not willing to adhere to requirements|0|||
13471406|NCT00042289|26987394|FG017|Overall Study|Participant not willing to adhere to requirements|0|||
13471407|NCT00042289|26987395|FG018|Overall Study|Participant not willing to adhere to requirements|4|||
13471408|NCT00042289|26987396|FG019|Overall Study|Participant not willing to adhere to requirements|2|||
13471409|NCT00042289|26987397|FG020|Overall Study|Participant not willing to adhere to requirements|0|||
13471410|NCT00042289|26987398|FG021|Overall Study|Participant not willing to adhere to requirements|2|||
13471411|NCT00042289|26987399|FG022|Overall Study|Participant not willing to adhere to requirements|1|||
13471412|NCT00042289|26987400|FG023|Overall Study|Participant not willing to adhere to requirements|1|||
13471413|NCT00042289|26987401|FG024|Overall Study|Participant not willing to adhere to requirements|0|||
13471414|NCT00042289|26987402|FG025|Overall Study|Participant not willing to adhere to requirements|1|||
13471415|NCT00042289|26987403|FG026|Overall Study|Participant not willing to adhere to requirements|2|||
13471416|NCT00042289|26987404|FG027|Overall Study|Participant not willing to adhere to requirements|0|||
13471417|NCT00042289|26987405|FG028|Overall Study|Participant not willing to adhere to requirements|1|||
13471418|NCT00042289|26987406|FG029|Overall Study|Participant not willing to adhere to requirements|0|||
13471419|NCT00042289|26987407|FG030|Overall Study|Participant not willing to adhere to requirements|0|||
13471420|NCT00042289|26987408|FG031|Overall Study|Participant not willing to adhere to requirements|1|||
13471421|NCT00042289|26987409|FG032|Overall Study|Participant not willing to adhere to requirements|1|||
13471422|NCT00042289|26987410|FG033|Overall Study|Participant not willing to adhere to requirements|3|||
13471423|NCT00042289|26987411|FG034|Overall Study|Participant not willing to adhere to requirements|1|||
13471424|NCT00042289|26987412|FG035|Overall Study|Participant not willing to adhere to requirements|1|||
13471425|NCT00042289|26987413|FG036|Overall Study|Participant not willing to adhere to requirements|2|||
13471426|NCT00042289|26987414|FG037|Overall Study|Participant not willing to adhere to requirements|0|||
13471427|NCT00042289|26987415|FG038|Overall Study|Participant not willing to adhere to requirements|2|||
13471428|NCT00042289|26987416|FG039|Overall Study|Participant not willing to adhere to requirements|0|||
13471429|NCT00042289|26987417|FG040|Overall Study|Participant not willing to adhere to requirements|0|||
13471430|NCT00042289|26987418|FG041|Overall Study|Participant not willing to adhere to requirements|0|||
13471431|NCT00042289|26987419|FG042|Overall Study|Participant not willing to adhere to requirements|2|||
13471432|NCT00042289|26987420|FG043|Overall Study|Participant not willing to adhere to requirements|1|||
13471433|NCT00042289|26987421|FG044|Overall Study|Participant not willing to adhere to requirements|0|||
13471434|NCT00042289|26987422|FG045|Overall Study|Participant not willing to adhere to requirements|0|||
13471435|NCT00042289|26987423|FG046|Overall Study|Participant not willing to adhere to requirements|1|||
13471436|NCT00042289|26987377|FG000|Overall Study|Protocol Violation|0|||
13471437|NCT00042289|26987378|FG001|Overall Study|Protocol Violation|0|||
13471438|NCT00042289|26987379|FG002|Overall Study|Protocol Violation|0|||
13471439|NCT00042289|26987380|FG003|Overall Study|Protocol Violation|0|||
13471440|NCT00042289|26987381|FG004|Overall Study|Protocol Violation|0|||
13471441|NCT00042289|26987382|FG005|Overall Study|Protocol Violation|1|||
13471442|NCT00042289|26987383|FG006|Overall Study|Protocol Violation|0|||
13471443|NCT00042289|26987384|FG007|Overall Study|Protocol Violation|1|||
13471444|NCT00042289|26987385|FG008|Overall Study|Protocol Violation|0|||
13471445|NCT00042289|26987386|FG009|Overall Study|Protocol Violation|0|||
13471446|NCT00042289|26987387|FG010|Overall Study|Protocol Violation|0|||
13471447|NCT00042289|26987388|FG011|Overall Study|Protocol Violation|0|||
13471448|NCT00042289|26987389|FG012|Overall Study|Protocol Violation|0|||
13471449|NCT00042289|26987390|FG013|Overall Study|Protocol Violation|0|||
13471450|NCT00042289|26987391|FG014|Overall Study|Protocol Violation|0|||
13471451|NCT00042289|26987392|FG015|Overall Study|Protocol Violation|0|||
13471452|NCT00042289|26987393|FG016|Overall Study|Protocol Violation|0|||
13471453|NCT00042289|26987394|FG017|Overall Study|Protocol Violation|0|||
13471454|NCT00042289|26987395|FG018|Overall Study|Protocol Violation|0|||
13471455|NCT00042289|26987396|FG019|Overall Study|Protocol Violation|0|||
13471456|NCT00042289|26987397|FG020|Overall Study|Protocol Violation|0|||
13471457|NCT00042289|26987398|FG021|Overall Study|Protocol Violation|0|||
13471458|NCT00042289|26987399|FG022|Overall Study|Protocol Violation|0|||
13471459|NCT00042289|26987400|FG023|Overall Study|Protocol Violation|1|||
13471460|NCT00042289|26987401|FG024|Overall Study|Protocol Violation|1|||
13471461|NCT00042289|26987402|FG025|Overall Study|Protocol Violation|0|||
13471462|NCT00042289|26987403|FG026|Overall Study|Protocol Violation|2|||
13471463|NCT00042289|26987404|FG027|Overall Study|Protocol Violation|0|||
13471464|NCT00042289|26987405|FG028|Overall Study|Protocol Violation|0|||
13471465|NCT00042289|26987406|FG029|Overall Study|Protocol Violation|0|||
13471466|NCT00042289|26987407|FG030|Overall Study|Protocol Violation|1|||
13471467|NCT00042289|26987408|FG031|Overall Study|Protocol Violation|0|||
13471468|NCT00042289|26987409|FG032|Overall Study|Protocol Violation|0|||
13471469|NCT00042289|26987410|FG033|Overall Study|Protocol Violation|0|||
13471470|NCT00042289|26987411|FG034|Overall Study|Protocol Violation|0|||
13471471|NCT00042289|26987412|FG035|Overall Study|Protocol Violation|0|||
13471472|NCT00042289|26987413|FG036|Overall Study|Protocol Violation|0|||
13471473|NCT00042289|26987414|FG037|Overall Study|Protocol Violation|0|||
13471474|NCT00042289|26987415|FG038|Overall Study|Protocol Violation|0|||
13471475|NCT00042289|26987416|FG039|Overall Study|Protocol Violation|0|||
13471476|NCT00042289|26987417|FG040|Overall Study|Protocol Violation|0|||
13471477|NCT00042289|26987418|FG041|Overall Study|Protocol Violation|1|||
13471478|NCT00042289|26987419|FG042|Overall Study|Protocol Violation|1|||
13471479|NCT00042289|26987420|FG043|Overall Study|Protocol Violation|1|||
13471480|NCT00042289|26987421|FG044|Overall Study|Protocol Violation|0|||
13471481|NCT00042289|26987422|FG045|Overall Study|Protocol Violation|0|||
13471482|NCT00042289|26987423|FG046|Overall Study|Protocol Violation|0|||
13471483|NCT00042289|26987377|FG000|Overall Study|Withdrawal by Subject|4|||
13471484|NCT00042289|26987378|FG001|Overall Study|Withdrawal by Subject|1|||
13471485|NCT00042289|26987379|FG002|Overall Study|Withdrawal by Subject|0|||
13471486|NCT00042289|26987380|FG003|Overall Study|Withdrawal by Subject|2|||
13471487|NCT00042289|26987381|FG004|Overall Study|Withdrawal by Subject|0|||
13471488|NCT00042289|26987382|FG005|Overall Study|Withdrawal by Subject|2|||
13471489|NCT00042289|26987383|FG006|Overall Study|Withdrawal by Subject|0|||
13471490|NCT00042289|26987384|FG007|Overall Study|Withdrawal by Subject|0|||
13471491|NCT00042289|26987385|FG008|Overall Study|Withdrawal by Subject|0|||
13471492|NCT00042289|26987386|FG009|Overall Study|Withdrawal by Subject|1|||
13471493|NCT00042289|26987387|FG010|Overall Study|Withdrawal by Subject|0|||
13471494|NCT00042289|26987388|FG011|Overall Study|Withdrawal by Subject|0|||
13471495|NCT00042289|26987389|FG012|Overall Study|Withdrawal by Subject|2|||
13471496|NCT00042289|26987390|FG013|Overall Study|Withdrawal by Subject|0|||
13471497|NCT00042289|26987391|FG014|Overall Study|Withdrawal by Subject|0|||
13471498|NCT00042289|26987392|FG015|Overall Study|Withdrawal by Subject|0|||
13471499|NCT00042289|26987393|FG016|Overall Study|Withdrawal by Subject|0|||
13471500|NCT00042289|26987394|FG017|Overall Study|Withdrawal by Subject|0|||
13471501|NCT00042289|26987395|FG018|Overall Study|Withdrawal by Subject|0|||
13471502|NCT00042289|26987396|FG019|Overall Study|Withdrawal by Subject|0|||
13471503|NCT00042289|26987397|FG020|Overall Study|Withdrawal by Subject|0|||
13471504|NCT00042289|26987398|FG021|Overall Study|Withdrawal by Subject|1|||
13471505|NCT00042289|26987399|FG022|Overall Study|Withdrawal by Subject|1|||
13471506|NCT00042289|26987400|FG023|Overall Study|Withdrawal by Subject|1|||
13471507|NCT00042289|26987401|FG024|Overall Study|Withdrawal by Subject|0|||
13471508|NCT00042289|26987402|FG025|Overall Study|Withdrawal by Subject|0|||
13471509|NCT00042289|26987403|FG026|Overall Study|Withdrawal by Subject|1|||
13471510|NCT00042289|26987404|FG027|Overall Study|Withdrawal by Subject|0|||
13471511|NCT00042289|26987405|FG028|Overall Study|Withdrawal by Subject|2|||
13471512|NCT00042289|26987406|FG029|Overall Study|Withdrawal by Subject|0|||
13471513|NCT00042289|26987407|FG030|Overall Study|Withdrawal by Subject|0|||
13471514|NCT00042289|26987408|FG031|Overall Study|Withdrawal by Subject|1|||
13471515|NCT00042289|26987409|FG032|Overall Study|Withdrawal by Subject|2|||
13471516|NCT00042289|26987410|FG033|Overall Study|Withdrawal by Subject|1|||
13471517|NCT00042289|26987411|FG034|Overall Study|Withdrawal by Subject|0|||
13471518|NCT00042289|26987412|FG035|Overall Study|Withdrawal by Subject|0|||
13471519|NCT00042289|26987413|FG036|Overall Study|Withdrawal by Subject|0|||
13471520|NCT00042289|26987414|FG037|Overall Study|Withdrawal by Subject|1|||
13471521|NCT00042289|26987415|FG038|Overall Study|Withdrawal by Subject|0|||
13471522|NCT00042289|26987416|FG039|Overall Study|Withdrawal by Subject|0|||
13471523|NCT00042289|26987417|FG040|Overall Study|Withdrawal by Subject|0|||
13471524|NCT00042289|26987418|FG041|Overall Study|Withdrawal by Subject|0|||
13471525|NCT00042289|26987419|FG042|Overall Study|Withdrawal by Subject|1|||
13471526|NCT00042289|26987420|FG043|Overall Study|Withdrawal by Subject|0|||
13471527|NCT00042289|26987421|FG044|Overall Study|Withdrawal by Subject|0|||
13471528|NCT00042289|26987422|FG045|Overall Study|Withdrawal by Subject|0|||
13471529|NCT00042289|26987423|FG046|Overall Study|Withdrawal by Subject|0|||
13471530|NCT00041756|26987456|FG000|Overall Study|Adverse Event|4|||
13471531|NCT00041756|26987457|FG001|Overall Study|Adverse Event|10|||
13471532|NCT00041756|26987458|FG002|Overall Study|Adverse Event|6|||
13471533|NCT00041756|26987459|FG003|Overall Study|Adverse Event|11|||
13471534|NCT00041756|26987460|FG004|Overall Study|Adverse Event|34|||
13471535|NCT00041756|26987456|FG000|Overall Study|Protocol Violation|1|||
13390683|NCT00685178|26774220|FG000|Overall Study|voluntary study discharge|4|||
13390684|NCT00685178|26774221|FG001|Overall Study|voluntary study discharge|5|||
13390685|NCT00685178|26774222|FG002|Overall Study|voluntary study discharge|1|||
13390686|NCT00685178|26774223|FG003|Overall Study|voluntary study discharge|1|||
13390687|NCT00685178|26774220|FG000|Overall Study|incarcerated|1|||
13390688|NCT00685178|26774221|FG001|Overall Study|incarcerated|3|||
13390689|NCT00685178|26774222|FG002|Overall Study|incarcerated|7|||
13390690|NCT00685178|26774223|FG003|Overall Study|incarcerated|0|||
13390691|NCT00685178|26774220|FG000|Overall Study|administrative (disciplinary) discharge|0|||
13390692|NCT00685178|26774221|FG001|Overall Study|administrative (disciplinary) discharge|1|||
13390693|NCT00685178|26774222|FG002|Overall Study|administrative (disciplinary) discharge|0|||
13390694|NCT00685178|26774223|FG003|Overall Study|administrative (disciplinary) discharge|2|||
13471536|NCT00041756|26987457|FG001|Overall Study|Protocol Violation|1|||
13471537|NCT00041756|26987458|FG002|Overall Study|Protocol Violation|2|||
13471538|NCT00041756|26987459|FG003|Overall Study|Protocol Violation|2|||
13471539|NCT00041756|26987460|FG004|Overall Study|Protocol Violation|1|||
13471540|NCT00041756|26987456|FG000|Overall Study|Withdrawal by Subject|3|||
13471541|NCT00041756|26987457|FG001|Overall Study|Withdrawal by Subject|3|||
13471542|NCT00041756|26987458|FG002|Overall Study|Withdrawal by Subject|4|||
13471543|NCT00041756|26987459|FG003|Overall Study|Withdrawal by Subject|2|||
13471544|NCT00041756|26987460|FG004|Overall Study|Withdrawal by Subject|3|||
13471545|NCT00041756|26987456|FG000|Overall Study|Lost to Follow-up|0|||
13471546|NCT00041756|26987457|FG001|Overall Study|Lost to Follow-up|1|||
13471547|NCT00041756|26987458|FG002|Overall Study|Lost to Follow-up|0|||
13471548|NCT00041756|26987459|FG003|Overall Study|Lost to Follow-up|1|||
13471549|NCT00041756|26987460|FG004|Overall Study|Lost to Follow-up|0|||
13471550|NCT00041756|26987456|FG000|Overall Study|Unable to meet protocol criteria|0|||
13471551|NCT00041756|26987457|FG001|Overall Study|Unable to meet protocol criteria|0|||
13471552|NCT00041756|26987458|FG002|Overall Study|Unable to meet protocol criteria|1|||
13471553|NCT00041756|26987459|FG003|Overall Study|Unable to meet protocol criteria|0|||
13471554|NCT00041756|26987460|FG004|Overall Study|Unable to meet protocol criteria|1|||
13471555|NCT00041756|26987456|FG000|Overall Study|Data Monitoring Committee Recommendation|0|||
13471556|NCT00041756|26987457|FG001|Overall Study|Data Monitoring Committee Recommendation|0|||
13471557|NCT00041756|26987458|FG002|Overall Study|Data Monitoring Committee Recommendation|0|||
13471558|NCT00041756|26987459|FG003|Overall Study|Data Monitoring Committee Recommendation|0|||
13471559|NCT00041756|26987460|FG004|Overall Study|Data Monitoring Committee Recommendation|21|||
13471560|NCT00041470|26987467|FG000|Overall Study|Loss of Funding|38|||
13471561|NCT00041132|26987475|FG000|Overall Study|Adverse Event|19|||
13471562|NCT00041132|26987475|FG000|Overall Study|Death|1|||
13471563|NCT00041132|26987475|FG000|Overall Study|Not Eligible|7|||
13471564|NCT00041132|26987475|FG000|Overall Study|Withdrawal by Subject|1|||
13471565|NCT00041132|26987475|FG000|Overall Study|Physician Decision|2|||
13471566|NCT00041080|26987488|FG000|Overall Study|Adverse Event|21|||
13471567|NCT00041080|26987489|FG001|Overall Study|Adverse Event|1|||
13471568|NCT00041080|26987488|FG000|Overall Study|Withdrawal by Subject|6|||
13471569|NCT00041080|26987489|FG001|Overall Study|Withdrawal by Subject|6|||
13471570|NCT00041080|26987488|FG000|Overall Study|Concommitant Illness/Other|1|||
13471571|NCT00041080|26987489|FG001|Overall Study|Concommitant Illness/Other|2|||
13471572|NCT00041080|26987488|FG000|Overall Study|Did not start therapy|1|||
13471573|NCT00041080|26987489|FG001|Overall Study|Did not start therapy|1|||
13471574|NCT00041080|26987488|FG000|Overall Study|Ineligible|1|||
13471575|NCT00041080|26987489|FG001|Overall Study|Ineligible|0|||
13471576|NCT00041067|26987498|FG000|Overall Study|Adverse Event|20|||
13471577|NCT00041067|26987498|FG000|Overall Study|Progression|19|||
13471578|NCT00041067|26987498|FG000|Overall Study|Patient refusal|12|||
13471579|NCT00041067|26987498|FG000|Overall Study|Other reasons|23|||
13471580|NCT00041067|26987498|FG000|Overall Study|Ineligible|2|||
13471581|NCT00040742|26987525|FG000|Overall Study|Death|0|||
13471582|NCT00040742|26987526|FG001|Overall Study|Death|0|||
13471583|NCT00040742|26987527|FG002|Overall Study|Death|1|||
13471584|NCT00040742|26987528|FG003|Overall Study|Death|0|||
13471585|NCT00040742|26987525|FG000|Overall Study|Adverse Event|15|||
13471586|NCT00040742|26987526|FG001|Overall Study|Adverse Event|16|||
13471587|NCT00040742|26987527|FG002|Overall Study|Adverse Event|21|||
13471588|NCT00040742|26987528|FG003|Overall Study|Adverse Event|9|||
13471589|NCT00040742|26987525|FG000|Overall Study|Withdrawal by Subject|7|||
13471590|NCT00040742|26987526|FG001|Overall Study|Withdrawal by Subject|15|||
13471591|NCT00040742|26987527|FG002|Overall Study|Withdrawal by Subject|10|||
13471592|NCT00040742|26987528|FG003|Overall Study|Withdrawal by Subject|13|||
13471593|NCT00040742|26987525|FG000|Overall Study|Chemotoxicity|4|||
13471594|NCT00040742|26987526|FG001|Overall Study|Chemotoxicity|3|||
13471595|NCT00040742|26987527|FG002|Overall Study|Chemotoxicity|5|||
13471596|NCT00040742|26987528|FG003|Overall Study|Chemotoxicity|2|||
13471597|NCT00040742|26987525|FG000|Overall Study|Incomplete Forms|6|||
13471598|NCT00040742|26987526|FG001|Overall Study|Incomplete Forms|10|||
13471599|NCT00040742|26987527|FG002|Overall Study|Incomplete Forms|4|||
13471600|NCT00040742|26987528|FG003|Overall Study|Incomplete Forms|5|||
13471601|NCT00040742|26987525|FG000|Overall Study|Other medical|7|||
13471602|NCT00040742|26987526|FG001|Overall Study|Other medical|5|||
13471603|NCT00040742|26987527|FG002|Overall Study|Other medical|5|||
13471604|NCT00040742|26987528|FG003|Overall Study|Other medical|5|||
13471605|NCT00040664|26987581|FG000|Overall Study|Adverse Event|12|||
13471606|NCT00040664|26987582|FG001|Overall Study|Adverse Event|3|||
13471607|NCT00040664|26987583|FG002|Overall Study|Adverse Event|2|||
13471608|NCT00040664|26987584|FG003|Overall Study|Adverse Event|7|||
13471609|NCT00040664|26987581|FG000|Overall Study|Lack of Efficacy|9|||
13471610|NCT00040664|26987582|FG001|Overall Study|Lack of Efficacy|2|||
13471611|NCT00040664|26987583|FG002|Overall Study|Lack of Efficacy|3|||
13471612|NCT00040664|26987584|FG003|Overall Study|Lack of Efficacy|4|||
13471613|NCT00040664|26987581|FG000|Overall Study|Insufficient CD4 response|1|||
13471614|NCT00040664|26987582|FG001|Overall Study|Insufficient CD4 response|0|||
13471615|NCT00040664|26987583|FG002|Overall Study|Insufficient CD4 response|1|||
13471616|NCT00040664|26987584|FG003|Overall Study|Insufficient CD4 response|0|||
13471617|NCT00040664|26987581|FG000|Overall Study|Lost to Follow-up|4|||
13471618|NCT00040664|26987582|FG001|Overall Study|Lost to Follow-up|2|||
13471619|NCT00040664|26987583|FG002|Overall Study|Lost to Follow-up|0|||
13471620|NCT00040664|26987584|FG003|Overall Study|Lost to Follow-up|2|||
13471621|NCT00040664|26987581|FG000|Overall Study|Protocol Violation|2|||
13471622|NCT00040664|26987582|FG001|Overall Study|Protocol Violation|1|||
13471623|NCT00040664|26987583|FG002|Overall Study|Protocol Violation|0|||
13471624|NCT00040664|26987584|FG003|Overall Study|Protocol Violation|1|||
13471625|NCT00040664|26987581|FG000|Overall Study|Withdrawal by Subject|7|||
13471626|NCT00040664|26987582|FG001|Overall Study|Withdrawal by Subject|0|||
13471627|NCT00040664|26987583|FG002|Overall Study|Withdrawal by Subject|3|||
13471628|NCT00040664|26987584|FG003|Overall Study|Withdrawal by Subject|4|||
13471629|NCT00040664|26987581|FG000|Overall Study|Pregnancy|3|||
13471630|NCT00040664|26987582|FG001|Overall Study|Pregnancy|0|||
13471631|NCT00040664|26987583|FG002|Overall Study|Pregnancy|0|||
13471632|NCT00040664|26987584|FG003|Overall Study|Pregnancy|3|||
13471633|NCT00040664|26987581|FG000|Overall Study|Medication adherence/compliance problems|8|||
13471634|NCT00040664|26987582|FG001|Overall Study|Medication adherence/compliance problems|2|||
13471635|NCT00040664|26987583|FG002|Overall Study|Medication adherence/compliance problems|1|||
13471636|NCT00040664|26987584|FG003|Overall Study|Medication adherence/compliance problems|5|||
13471637|NCT00040664|26987581|FG000|Overall Study|Poor taste|2|||
13471638|NCT00040664|26987582|FG001|Overall Study|Poor taste|0|||
13471639|NCT00040664|26987583|FG002|Overall Study|Poor taste|2|||
13471640|NCT00040664|26987584|FG003|Overall Study|Poor taste|0|||
13471641|NCT00040664|26987581|FG000|Overall Study|Pharmacokinetic target not achieved|2|||
13471642|NCT00040664|26987582|FG001|Overall Study|Pharmacokinetic target not achieved|1|||
13471643|NCT00040664|26987583|FG002|Overall Study|Pharmacokinetic target not achieved|0|||
13471644|NCT00040664|26987584|FG003|Overall Study|Pharmacokinetic target not achieved|1|||
13471645|NCT00040664|26987581|FG000|Overall Study|Change of formulation|2|||
13471646|NCT00040664|26987582|FG001|Overall Study|Change of formulation|2|||
13471647|NCT00040664|26987583|FG002|Overall Study|Change of formulation|0|||
13471648|NCT00040664|26987584|FG003|Overall Study|Change of formulation|0|||
13471649|NCT00040664|26987581|FG000|Overall Study|Non-viability of oral suspension|1|||
13471650|NCT00040664|26987582|FG001|Overall Study|Non-viability of oral suspension|0|||
13471651|NCT00040664|26987583|FG002|Overall Study|Non-viability of oral suspension|1|||
13471652|NCT00040664|26987584|FG003|Overall Study|Non-viability of oral suspension|0|||
13471653|NCT00040365|26987595|FG000|Overall Study|Death|1|||
13471654|NCT00040365|26987595|FG000|Overall Study|Progressive disease|7|||
13471655|NCT00040365|26987595|FG000|Overall Study|Lost to Follow-up|3|||
13471656|NCT00039871|26987603|FG000|Overall Study|Adverse Event|165|||
13471657|NCT00039871|26987603|FG000|Overall Study|Lost to Follow-up|18|||
13471658|NCT00039871|26987603|FG000|Overall Study|Protocol Violation|24|||
13471659|NCT00039871|26987603|FG000|Overall Study|Withdrawal by Subject|97|||
13471660|NCT00039871|26987603|FG000|Overall Study|Did not meet eligibility criteria|11|||
13471661|NCT00039871|26987603|FG000|Overall Study|Administrative|1|||
13471662|NCT00039871|26987603|FG000|Overall Study|Discontinued at Week 12 per protocol|1061|||
13471663|NCT00039871|26987603|FG000|Overall Study|Never entered follow-up|7|||
13471664|NCT00039741|26987658|FG000|Overall Study|Death|0|||
13471665|NCT00039741|26987659|FG001|Overall Study|Death|1|||
13471666|NCT00039741|26987660|FG002|Overall Study|Death|0|||
13471667|NCT00039741|26987661|FG003|Overall Study|Death|0|||
13471668|NCT00039741|26987658|FG000|Overall Study|Lost to Follow-up|3|||
13471669|NCT00039741|26987659|FG001|Overall Study|Lost to Follow-up|1|||
13471670|NCT00039741|26987660|FG002|Overall Study|Lost to Follow-up|5|||
13471671|NCT00039741|26987661|FG003|Overall Study|Lost to Follow-up|2|||
13471672|NCT00039741|26987658|FG000|Overall Study|Confounding medical condition|1|||
13471673|NCT00039741|26987659|FG001|Overall Study|Confounding medical condition|0|||
13471674|NCT00039741|26987660|FG002|Overall Study|Confounding medical condition|0|||
13471675|NCT00039741|26987661|FG003|Overall Study|Confounding medical condition|0|||
13471676|NCT00039741|26987658|FG000|Overall Study|Not able to get to clinic|5|||
13471677|NCT00039741|26987659|FG001|Overall Study|Not able to get to clinic|2|||
13471678|NCT00039741|26987660|FG002|Overall Study|Not able to get to clinic|0|||
13471679|NCT00039741|26987661|FG003|Overall Study|Not able to get to clinic|3|||
13471680|NCT00039741|26987658|FG000|Overall Study|Moved|3|||
13471681|NCT00039741|26987659|FG001|Overall Study|Moved|2|||
13471682|NCT00039741|26987660|FG002|Overall Study|Moved|3|||
13471683|NCT00039741|26987661|FG003|Overall Study|Moved|6|||
13471684|NCT00039741|26987658|FG000|Overall Study|Non-compliance with protocol|1|||
13471685|NCT00039741|26987659|FG001|Overall Study|Non-compliance with protocol|0|||
13471686|NCT00039741|26987660|FG002|Overall Study|Non-compliance with protocol|1|||
13471687|NCT00039741|26987661|FG003|Overall Study|Non-compliance with protocol|0|||
13471688|NCT00039741|26987658|FG000|Overall Study|Withdrew consent|0|||
13471689|NCT00039741|26987659|FG001|Overall Study|Withdrew consent|5|||
13471690|NCT00039741|26987660|FG002|Overall Study|Withdrew consent|0|||
13471691|NCT00039741|26987661|FG003|Overall Study|Withdrew consent|1|||
13471692|NCT00039741|26987658|FG000|Overall Study|Missed final visit|2|||
13471693|NCT00039741|26987659|FG001|Overall Study|Missed final visit|1|||
13471694|NCT00039741|26987660|FG002|Overall Study|Missed final visit|2|||
13471695|NCT00039741|26987661|FG003|Overall Study|Missed final visit|2|||
13471696|NCT00039377|26987678|FG000|Initial Registration|Adverse Event|2|||
13471697|NCT00039377|26987679|FG001|Initial Registration|Adverse Event|0|||
13471698|NCT00039377|26987680|FG002|Initial Registration|Adverse Event|0|||
13471699|NCT00039377|26987681|FG003|Initial Registration|Adverse Event|0|||
13471700|NCT00039377|26987678|FG000|Initial Registration|Relapsed|6|||
13471701|NCT00039377|26987679|FG001|Initial Registration|Relapsed|0|||
13471702|NCT00039377|26987680|FG002|Initial Registration|Relapsed|0|||
13471703|NCT00039377|26987681|FG003|Initial Registration|Relapsed|0|||
13471704|NCT00039377|26987678|FG000|Initial Registration|Received non-protocol therapy|11|||
13471705|NCT00039377|26987679|FG001|Initial Registration|Received non-protocol therapy|0|||
13471706|NCT00039377|26987680|FG002|Initial Registration|Received non-protocol therapy|0|||
13471707|NCT00039377|26987681|FG003|Initial Registration|Received non-protocol therapy|0|||
13471708|NCT00039377|26987678|FG000|Initial Registration|Withdrawal by Subject|3|||
13471709|NCT00039377|26987679|FG001|Initial Registration|Withdrawal by Subject|0|||
13471710|NCT00039377|26987680|FG002|Initial Registration|Withdrawal by Subject|0|||
13471711|NCT00039377|26987681|FG003|Initial Registration|Withdrawal by Subject|0|||
13471712|NCT00039130|26987689|FG000|Overall Study|Adverse Event|11|||
13471713|NCT00039130|26987689|FG000|Overall Study|Death|9|||
13471714|NCT00039130|26987689|FG000|Overall Study|Withdrawal by Subject|3|||
13471715|NCT00039130|26987689|FG000|Overall Study|Progression|2|||
13471716|NCT00039130|26987689|FG000|Overall Study|Subsequent treatment|2|||
13471717|NCT00039130|26987689|FG000|Overall Study|Physician Decision|3|||
13471718|NCT00038948|26987708|FG000|Overall Study|Adverse Event|131|||
13471719|NCT00038948|26987709|FG001|Overall Study|Adverse Event|43|||
13471720|NCT00038948|26987708|FG000|Overall Study|Lost to Follow-up|4|||
13471721|NCT00038948|26987709|FG001|Overall Study|Lost to Follow-up|4|||
13471722|NCT00038948|26987708|FG000|Overall Study|Nonmedical event|5|||
13471723|NCT00038948|26987709|FG001|Overall Study|Nonmedical event|7|||
13471724|NCT00038948|26987708|FG000|Overall Study|Withdrawal by Subject|23|||
13471725|NCT00038948|26987709|FG001|Overall Study|Withdrawal by Subject|10|||
13471726|NCT00038948|26987708|FG000|Overall Study|Protocol Violation|3|||
13471727|NCT00038948|26987709|FG001|Overall Study|Protocol Violation|7|||
13471728|NCT00038948|26987708|FG000|Overall Study|Lack of Efficacy|3|||
13471729|NCT00038948|26987709|FG001|Overall Study|Lack of Efficacy|6|||
13471730|NCT00038649|26987716|FG000|Overall Study|Adverse Event|9|||
13471731|NCT00038467|26987783|FG000|Overall Study|Adverse Event|170|||
13471732|NCT00038467|26987784|FG001|Overall Study|Adverse Event|145|||
13471733|NCT00038467|26987783|FG000|Overall Study|Withdrawal by Subject|150|||
13471734|NCT00038467|26987784|FG001|Overall Study|Withdrawal by Subject|107|||
13471735|NCT00038467|26987783|FG000|Overall Study|Protocol Violation|19|||
13471736|NCT00038467|26987784|FG001|Overall Study|Protocol Violation|22|||
13471737|NCT00038467|26987783|FG000|Overall Study|Death|22|||
13471738|NCT00038467|26987784|FG001|Overall Study|Death|16|||
13471739|NCT00038467|26987783|FG000|Overall Study|Lost to Follow-up|15|||
13471740|NCT00038467|26987784|FG001|Overall Study|Lost to Follow-up|10|||
13471741|NCT00038467|26987783|FG000|Overall Study|Recurrence|109|||
13471742|NCT00038467|26987784|FG001|Overall Study|Recurrence|179|||
13471743|NCT00038467|26987783|FG000|Overall Study|Randomized, but not treated|31|||
13471744|NCT00038467|26987784|FG001|Overall Study|Randomized, but not treated|35|||
13471745|NCT00038467|26987783|FG000|Overall Study|Other|26|||
13471746|NCT00038467|26987784|FG001|Overall Study|Other|28|||
13471747|NCT00038142|26987797|FG000|Overall Study|Ineligible|1|||
13471748|NCT00038142|26987798|FG001|Overall Study|Ineligible|0|||
13471749|NCT00038142|26987797|FG000|Overall Study|Progressive Disease|11|||
13471750|NCT00038142|26987798|FG001|Overall Study|Progressive Disease|7|||
13471751|NCT00038142|26987797|FG000|Overall Study|Death|1|||
13471752|NCT00038142|26987798|FG001|Overall Study|Death|0|||
13471753|NCT00038142|26987797|FG000|Overall Study|Adverse Event|1|||
13471754|NCT00038142|26987798|FG001|Overall Study|Adverse Event|0|||
13471755|NCT00038142|26987797|FG000|Overall Study|Unknown Reason|8|||
13471756|NCT00038142|26987798|FG001|Overall Study|Unknown Reason|0|||
13471757|NCT00038103|26987825|FG000|Overall Study|Adverse Event|5|||
13390695|NCT00685178|26774220|FG000|Overall Study|Pregnancy|0|||
13390696|NCT00685178|26774221|FG001|Overall Study|Pregnancy|0|||
13390697|NCT00685178|26774222|FG002|Overall Study|Pregnancy|0|||
13390698|NCT00685178|26774223|FG003|Overall Study|Pregnancy|1|||
13390699|NCT00685165|26774236|FG000|Washout Period of 14 Days|Adverse Event|1|||
13390700|NCT00685165|26774237|FG001|Washout Period of 14 Days|Adverse Event|0|||
13390701|NCT00685035|26774264|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1|||
13390702|NCT00685035|26774265|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0|||
13390703|NCT00684996|26774280|FG000|Overall Study|Adverse Event|1|||
13390704|NCT00684996|26774280|FG000|Overall Study|Refusal unrelated to adverse event|1|||
13390705|NCT00684996|26774280|FG000|Overall Study|Progression/relapse|2|||
13390706|NCT00684996|26774280|FG000|Overall Study|Other reasons not protocol specified|1|||
13390707|NCT00684814|26774293|FG000|Washout Period of 7 Days|Adverse Event|1|||
13390708|NCT00684814|26774294|FG001|Washout Period of 7 Days|Adverse Event|2|||
13390709|NCT00684814|26774293|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
13390710|NCT00684814|26774294|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
13390711|NCT00684814|26774293|FG000|Second Intervention|Adverse Event|1|||
13390712|NCT00684814|26774294|FG001|Second Intervention|Adverse Event|0|||
13390713|NCT00684762|26774307|FG000|Washout Period of 7 Days|Withdrawal by Subject|2|||
13390714|NCT00684762|26774308|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
13390715|NCT00684671|26774347|FG000|Overall Study|Adverse Event|1|||
13390716|NCT00684671|26774348|FG001|Overall Study|Adverse Event|0|||
13390717|NCT00684671|26774349|FG002|Overall Study|Adverse Event|0|||
13390718|NCT00684671|26774347|FG000|Overall Study|Lost to Follow-up|1|||
13390719|NCT00684671|26774348|FG001|Overall Study|Lost to Follow-up|0|||
13390720|NCT00684671|26774349|FG002|Overall Study|Lost to Follow-up|0|||
13390721|NCT00684671|26774347|FG000|Overall Study|Alcoholic dependance|1|||
13390722|NCT00684671|26774348|FG001|Overall Study|Alcoholic dependance|0|||
13390723|NCT00684671|26774349|FG002|Overall Study|Alcoholic dependance|0|||
13390724|NCT00684645|26774369|FG000|Overall Study|Death|2|||
13390725|NCT00684645|26774369|FG000|Overall Study|Progressive disease|67|||
13390726|NCT00684645|26774369|FG000|Overall Study|Adverse Event|27|||
13390727|NCT00684645|26774369|FG000|Overall Study|Lost to Follow-up|3|||
13390728|NCT00684645|26774369|FG000|Overall Study|Other|15|||
13390729|NCT00684593|26774388|FG000|Overall Study|Adverse Event|0|||
13390730|NCT00684593|26774389|FG001|Overall Study|Adverse Event|2|||
13471758|NCT00038103|26987826|FG001|Overall Study|Adverse Event|6|||
13471759|NCT00038103|26987825|FG000|Overall Study|Lack of Efficacy|48|||
13471760|NCT00038103|26987826|FG001|Overall Study|Lack of Efficacy|41|||
13471761|NCT00038103|26987825|FG000|Overall Study|Withdrawal by Subject|0|||
13471762|NCT00038103|26987826|FG001|Overall Study|Withdrawal by Subject|3|||
13471763|NCT00038103|26987825|FG000|Overall Study|Lost to Follow-up|0|||
13471764|NCT00038103|26987826|FG001|Overall Study|Lost to Follow-up|3|||
13471765|NCT00038103|26987825|FG000|Overall Study|Protocol Violation|0|||
13471766|NCT00038103|26987826|FG001|Overall Study|Protocol Violation|2|||
13471767|NCT00038103|26987825|FG000|Overall Study|Sponsor Decision|0|||
13471768|NCT00038103|26987826|FG001|Overall Study|Sponsor Decision|1|||
13471769|NCT00038103|26987825|FG000|Overall Study|Randomized/never treated|2|||
13471770|NCT00038103|26987826|FG001|Overall Study|Randomized/never treated|0|||
13471771|NCT00037830|26987857|FG000|Overall Study|Adverse Event|2|||
13471772|NCT00037830|26987858|FG001|Overall Study|Adverse Event|0|||
13471773|NCT00037830|26987859|FG002|Overall Study|Adverse Event|0|||
13471774|NCT00037830|26987857|FG000|Overall Study|Withdrawal by Subject|4|||
13471775|NCT00037830|26987858|FG001|Overall Study|Withdrawal by Subject|5|||
13471776|NCT00037830|26987859|FG002|Overall Study|Withdrawal by Subject|1|||
13471777|NCT00037830|26987857|FG000|Overall Study|Protocol Violation|2|||
13471778|NCT00037830|26987858|FG001|Overall Study|Protocol Violation|2|||
13471779|NCT00037830|26987859|FG002|Overall Study|Protocol Violation|0|||
13471780|NCT00037830|26987857|FG000|Overall Study|Unrelated Medical Problem|2|||
13471781|NCT00037830|26987858|FG001|Overall Study|Unrelated Medical Problem|0|||
13471782|NCT00037830|26987859|FG002|Overall Study|Unrelated Medical Problem|0|||
13471783|NCT00036270|26987882|FG000|Randomized to Study Treatment|Withdrawal by Subject|6|||
13471784|NCT00036270|26987883|FG001|Randomized to Study Treatment|Withdrawal by Subject|7|||
13471785|NCT00036270|26987882|FG000|Study Treatment to 5 Year Report|Ongoing|1081|||
13471786|NCT00036270|26987883|FG001|Study Treatment to 5 Year Report|Ongoing|736|||
13471787|NCT00036270|26987882|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507|||
13471788|NCT00036270|26987883|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447|||
13471789|NCT00036270|26987882|FG000|Study Treatment to 5 Year Report|Adverse Event|501|||
13471790|NCT00036270|26987883|FG001|Study Treatment to 5 Year Report|Adverse Event|782|||
13471791|NCT00036270|26987882|FG000|Study Treatment to 5 Year Report|Other|277|||
13471792|NCT00036270|26987883|FG001|Study Treatment to 5 Year Report|Other|288|||
13471793|NCT00036270|26987882|FG000|Study Treatment to 5 Year Report|Treatment refusal|113|||
13471794|NCT00036270|26987883|FG001|Study Treatment to 5 Year Report|Treatment refusal|208|||
13471795|NCT00036270|26987882|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46|||
13471796|NCT00036270|26987883|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54|||
13471797|NCT00036270|26987882|FG000|Study Treatment to 5 Year Report|Protocol Violation|23|||
13471798|NCT00036270|26987883|FG001|Study Treatment to 5 Year Report|Protocol Violation|91|||
13471799|NCT00036270|26987882|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17|||
13471800|NCT00036270|26987883|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29|||
13471801|NCT00036270|26987882|FG000|Study Treatment to 5 Year Report|Too early switch|0|||
13471802|NCT00036270|26987883|FG001|Study Treatment to 5 Year Report|Too early switch|103|||
13471803|NCT00036270|26987882|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0|||
13471804|NCT00036270|26987883|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750|||
13471805|NCT00035932|26988017|FG000|Overall Study|Adverse Event|10|||
13471806|NCT00035932|26988018|FG001|Overall Study|Adverse Event|9|||
13471807|NCT00035932|26988019|FG002|Overall Study|Adverse Event|9|||
13471808|NCT00035932|26988017|FG000|Overall Study|Death|0|||
13471809|NCT00035932|26988018|FG001|Overall Study|Death|0|||
13471810|NCT00035932|26988019|FG002|Overall Study|Death|1|||
13471811|NCT00035932|26988017|FG000|Overall Study|Disease Progression / Relapse|1|||
13471812|NCT00035932|26988018|FG001|Overall Study|Disease Progression / Relapse|1|||
13471813|NCT00035932|26988019|FG002|Overall Study|Disease Progression / Relapse|0|||
13471814|NCT00035932|26988017|FG000|Overall Study|Lost to Follow-up|4|||
13471815|NCT00035932|26988018|FG001|Overall Study|Lost to Follow-up|4|||
13471816|NCT00035932|26988019|FG002|Overall Study|Lost to Follow-up|3|||
13471817|NCT00035932|26988017|FG000|Overall Study|Noncompliance|6|||
13471818|NCT00035932|26988018|FG001|Overall Study|Noncompliance|7|||
13471819|NCT00035932|26988019|FG002|Overall Study|Noncompliance|6|||
13471820|NCT00035932|26988017|FG000|Overall Study|Protocol Violation While on Study|0|||
13471821|NCT00035932|26988018|FG001|Overall Study|Protocol Violation While on Study|1|||
13471822|NCT00035932|26988019|FG002|Overall Study|Protocol Violation While on Study|2|||
13471823|NCT00035932|26988017|FG000|Overall Study|Withdrawal by Subject|1|||
13471824|NCT00035932|26988018|FG001|Overall Study|Withdrawal by Subject|5|||
13471825|NCT00035932|26988019|FG002|Overall Study|Withdrawal by Subject|0|||
13471826|NCT00035932|26988017|FG000|Overall Study|Study Termination by Sponsor|1|||
13471827|NCT00035932|26988018|FG001|Overall Study|Study Termination by Sponsor|0|||
13471828|NCT00035932|26988019|FG002|Overall Study|Study Termination by Sponsor|0|||
13471829|NCT00035932|26988017|FG000|Overall Study|Lack of Efficacy|33|||
13471830|NCT00035932|26988018|FG001|Overall Study|Lack of Efficacy|33|||
13471831|NCT00035932|26988019|FG002|Overall Study|Lack of Efficacy|28|||
13471832|NCT00035815|26988036|FG000|Overall Study|Withdrawal by Subject|17|||
13471833|NCT00035815|26988037|FG001|Overall Study|Withdrawal by Subject|11|||
13471834|NCT00035555|26988088|FG000|Overall Study|Adverse Event|5|||
13471835|NCT00035555|26988089|FG001|Overall Study|Adverse Event|8|||
13471836|NCT00035555|26988090|FG002|Overall Study|Adverse Event|9|||
13471837|NCT00035555|26988088|FG000|Overall Study|Allograft loss|1|||
13471838|NCT00035555|26988089|FG001|Overall Study|Allograft loss|1|||
13471839|NCT00035555|26988090|FG002|Overall Study|Allograft loss|2|||
13471840|NCT00035555|26988088|FG000|Overall Study|Death|0|||
13471841|NCT00035555|26988089|FG001|Overall Study|Death|0|||
13471842|NCT00035555|26988090|FG002|Overall Study|Death|2|||
13471843|NCT00035555|26988088|FG000|Overall Study|Lost to Follow-up|0|||
13471844|NCT00035555|26988089|FG001|Overall Study|Lost to Follow-up|0|||
13471845|NCT00035555|26988090|FG002|Overall Study|Lost to Follow-up|1|||
13471846|NCT00035555|26988088|FG000|Overall Study|Noncompliance|0|||
13471847|NCT00035555|26988089|FG001|Overall Study|Noncompliance|1|||
13471848|NCT00035555|26988090|FG002|Overall Study|Noncompliance|1|||
13471849|NCT00035555|26988088|FG000|Overall Study|Prohibited medication|1|||
13471850|NCT00035555|26988089|FG001|Overall Study|Prohibited medication|1|||
13471851|NCT00035555|26988090|FG002|Overall Study|Prohibited medication|0|||
13471852|NCT00035555|26988088|FG000|Overall Study|Treatment failure/lack of efficacy|7|||
13471853|NCT00035555|26988089|FG001|Overall Study|Treatment failure/lack of efficacy|5|||
13471854|NCT00035555|26988090|FG002|Overall Study|Treatment failure/lack of efficacy|3|||
13471855|NCT00035555|26988088|FG000|Overall Study|Withdrawal by Subject|2|||
13471856|NCT00035555|26988089|FG001|Overall Study|Withdrawal by Subject|0|||
13471857|NCT00035555|26988090|FG002|Overall Study|Withdrawal by Subject|2|||
13471858|NCT00035555|26988088|FG000|Overall Study|Investigator deemed not a good candidate|0|||
13471859|NCT00035555|26988089|FG001|Overall Study|Investigator deemed not a good candidate|0|||
13471860|NCT00035555|26988090|FG002|Overall Study|Investigator deemed not a good candidate|1|||
13471861|NCT00035555|26988088|FG000|Overall Study|Received cyclosporin in error|0|||
13471862|NCT00035555|26988089|FG001|Overall Study|Received cyclosporin in error|0|||
13471863|NCT00035555|26988090|FG002|Overall Study|Received cyclosporin in error|1|||
13471864|NCT00033657|26988109|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1|||
13471865|NCT00033657|26988110|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2|||
13471866|NCT00033657|26988109|FG000|Neoadjuvant Chemotherapy|Adverse Event|0|||
13471867|NCT00033657|26988110|FG001|Neoadjuvant Chemotherapy|Adverse Event|2|||
13471868|NCT00033657|26988109|FG000|Neoadjuvant Chemotherapy|Death|1|||
13471869|NCT00033657|26988110|FG001|Neoadjuvant Chemotherapy|Death|1|||
13471870|NCT00033657|26988109|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
13471871|NCT00033657|26988110|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0|||
13471872|NCT00033657|26988109|FG000|Neoadjuvant Chemotherapy|other complicating disease|0|||
13471873|NCT00033657|26988110|FG001|Neoadjuvant Chemotherapy|other complicating disease|1|||
13471874|NCT00033657|26988109|FG000|Neoadjuvant Chemotherapy|Ineligible|8|||
13471875|NCT00033657|26988110|FG001|Neoadjuvant Chemotherapy|Ineligible|4|||
13471876|NCT00033657|26988109|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3|||
13471877|NCT00033657|26988110|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1|||
13471878|NCT00033657|26988109|FG000|Surgical Resection|not complete resection|0|||
13471879|NCT00033657|26988110|FG001|Surgical Resection|not complete resection|3|||
13471880|NCT00033657|26988109|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3|||
13471881|NCT00033657|26988110|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1|||
13471882|NCT00033657|26988109|FG000|Adjuvant Chemotherapy|Adverse Event|7|||
13471883|NCT00033657|26988110|FG001|Adjuvant Chemotherapy|Adverse Event|10|||
13471884|NCT00033657|26988109|FG000|Adjuvant Chemotherapy|Death|2|||
13471885|NCT00033657|26988110|FG001|Adjuvant Chemotherapy|Death|1|||
13471886|NCT00033657|26988109|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5|||
13471887|NCT00033657|26988110|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3|||
13471888|NCT00033657|26988109|FG000|Adjuvant Chemotherapy|alternative therapy|1|||
13471889|NCT00033657|26988110|FG001|Adjuvant Chemotherapy|alternative therapy|0|||
13471890|NCT00033657|26988109|FG000|Adjuvant Chemotherapy|Other|0|||
13471891|NCT00033657|26988110|FG001|Adjuvant Chemotherapy|Other|2|||
13471892|NCT00033540|26988120|FG000|Overall Study|Adverse Event|14|||
13471893|NCT00033540|26988120|FG000|Overall Study|Death|1|||
13471894|NCT00033540|26988120|FG000|Overall Study|Progression|26|||
13471895|NCT00033540|26988120|FG000|Overall Study|Withdrawal by Subject|6|||
13471896|NCT00033540|26988120|FG000|Overall Study|Other|5|||
13471897|NCT00033540|26988120|FG000|Overall Study|Ineligible|3|||
13471898|NCT00033540|26988120|FG000|Overall Study|Never received treatment|2|||
13471899|NCT00033514|26988135|FG000|Overall Study|Lost to Follow-up|1|||
13471900|NCT00033514|26988136|FG001|Overall Study|Lost to Follow-up|1|||
13471901|NCT00033514|26988135|FG000|Overall Study|Withdrawal by Subject|0|||
13471902|NCT00033514|26988136|FG001|Overall Study|Withdrawal by Subject|3|||
13471903|NCT00033371|26988159|FG000|Overall Study|Adverse Event|1|||
13471904|NCT00033371|26988160|FG001|Overall Study|Adverse Event|5|||
13471905|NCT00033371|26988159|FG000|Overall Study|Lost to Follow-up|2|||
13471906|NCT00033371|26988160|FG001|Overall Study|Lost to Follow-up|1|||
13471907|NCT00033371|26988159|FG000|Overall Study|Withdrawal by Subject|3|||
13471908|NCT00033371|26988160|FG001|Overall Study|Withdrawal by Subject|3|||
13471909|NCT00033371|26988159|FG000|Overall Study|Disease Progression|0|||
13471910|NCT00033371|26988160|FG001|Overall Study|Disease Progression|1|||
13471911|NCT00032487|26988175|FG000|Overall Study|Withdrawal by Subject|67|||
13471912|NCT00032487|26988176|FG001|Overall Study|Withdrawal by Subject|43|||
13471913|NCT00032487|26988175|FG000|Overall Study|Adverse Event|3|||
13471914|NCT00032487|26988176|FG001|Overall Study|Adverse Event|7|||
13471915|NCT00032487|26988175|FG000|Overall Study|Lost to Follow-up|57|||
13471916|NCT00032487|26988176|FG001|Overall Study|Lost to Follow-up|58|||
13471917|NCT00032487|26988175|FG000|Overall Study|Had other reason|12|||
13471918|NCT00032487|26988176|FG001|Overall Study|Had other reason|12|||
13471919|NCT00031694|26988184|FG000|Overall Study|Adverse Event|12|||
13471920|NCT00031694|26988184|FG000|Overall Study|Death|2|||
13471921|NCT00031694|26988184|FG000|Overall Study|Withdrawal by Subject|5|||
13471922|NCT00031590|26988191|FG000|Overall Study|Adverse Event|1|||
13471923|NCT00031590|26988191|FG000|Overall Study|Withdrawal by parents|2|||
13471924|NCT00031551|26988208|FG000|Overall Study|Withdrew due to chemotherapy effects|2|||
13471925|NCT00031551|26988209|FG001|Overall Study|Withdrew due to chemotherapy effects|0|||
13471926|NCT00031486|26988240|FG000|Overall Study|Adverse Event|1|||
13471927|NCT00031486|26988241|FG001|Overall Study|Adverse Event|0|||
13471928|NCT00031486|26988240|FG000|Overall Study|Lost to Follow-up|0|||
13471929|NCT00031486|26988241|FG001|Overall Study|Lost to Follow-up|1|||
13471930|NCT00031486|26988240|FG000|Overall Study|Withdrawal by Subject|3|||
13471931|NCT00031486|26988241|FG001|Overall Study|Withdrawal by Subject|2|||
13471932|NCT00031486|26988240|FG000|Overall Study|Death|0|||
13471933|NCT00031486|26988241|FG001|Overall Study|Death|3|||
13471934|NCT00031486|26988240|FG000|Overall Study|Non-compliant|0|||
13471935|NCT00031486|26988241|FG001|Overall Study|Non-compliant|4|||
13471936|NCT00031486|26988240|FG000|Overall Study|Did not meet eligibility requirement|2|||
13471937|NCT00031486|26988241|FG001|Overall Study|Did not meet eligibility requirement|1|||
13471938|NCT00031486|26988240|FG000|Overall Study|Other|1|||
13471939|NCT00031486|26988241|FG001|Overall Study|Other|1|||
13471940|NCT00031460|26988260|FG000|Overall Study|Lost to Follow-up|0|||
13471941|NCT00031460|26988261|FG001|Overall Study|Lost to Follow-up|1|||
13471942|NCT00031460|26988260|FG000|Overall Study|Withdrawal by Subject|1|||
13471943|NCT00031460|26988261|FG001|Overall Study|Withdrawal by Subject|1|||
13471944|NCT00031460|26988260|FG000|Overall Study|Non-Compliant|1|||
13471945|NCT00031460|26988261|FG001|Overall Study|Non-Compliant|1|||
13471946|NCT00031460|26988260|FG000|Overall Study|Death|0|||
13471947|NCT00031460|26988261|FG001|Overall Study|Death|1|||
13471948|NCT00031460|26988260|FG000|Overall Study|Reactivation of Disease|5|||
13471949|NCT00031460|26988261|FG001|Overall Study|Reactivation of Disease|9|||
13471950|NCT00031460|26988260|FG000|Overall Study|Disruption of blinded drug supply|2|||
13471951|NCT00031460|26988261|FG001|Overall Study|Disruption of blinded drug supply|0|||
13471952|NCT00031460|26988260|FG000|Overall Study|Confirmed unevaluable|0|||
13471953|NCT00031460|26988261|FG001|Overall Study|Confirmed unevaluable|1|||
13471954|NCT00031447|26988280|FG000|Overall Study|Lost to Follow-up|0|||
13471955|NCT00031447|26988281|FG001|Overall Study|Lost to Follow-up|1|||
13471956|NCT00031447|26988280|FG000|Overall Study|Non-compliant|1|||
13471957|NCT00031447|26988281|FG001|Overall Study|Non-compliant|1|||
13471958|NCT00031447|26988280|FG000|Overall Study|Re-activation of Disease|2|||
13471959|NCT00031447|26988281|FG001|Overall Study|Re-activation of Disease|1|||
13471960|NCT00031447|26988280|FG000|Overall Study|Disruption of blinded study drug supply|7|||
13471961|NCT00031447|26988281|FG001|Overall Study|Disruption of blinded study drug supply|4|||
13471962|NCT00030901|26988297|FG000|Initial Registration|Ineligible|167|||
13471963|NCT00030901|26988298|FG001|Initial Registration|Ineligible|0|||
13471964|NCT00030901|26988299|FG002|Initial Registration|Ineligible|0|||
13471965|NCT00030901|26988297|FG000|Randomization|Adverse Event|0|||
13471966|NCT00030901|26988298|FG001|Randomization|Adverse Event|11|||
13471967|NCT00030901|26988299|FG002|Randomization|Adverse Event|7|||
13471968|NCT00030901|26988297|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
13471969|NCT00030901|26988298|FG001|Randomization|Refusal Unrelated to Adverse Event|16|||
13471970|NCT00030901|26988299|FG002|Randomization|Refusal Unrelated to Adverse Event|10|||
13471971|NCT00030901|26988297|FG000|Randomization|Progression/Relapse|0|||
13471972|NCT00030901|26988298|FG001|Randomization|Progression/Relapse|22|||
13471973|NCT00030901|26988299|FG002|Randomization|Progression/Relapse|21|||
13471974|NCT00030901|26988297|FG000|Randomization|Death|0|||
13471975|NCT00030901|26988298|FG001|Randomization|Death|1|||
13471976|NCT00030901|26988299|FG002|Randomization|Death|3|||
13471977|NCT00030901|26988297|FG000|Randomization|Other|0|||
13471978|NCT00030901|26988298|FG001|Randomization|Other|36|||
13471979|NCT00030901|26988299|FG002|Randomization|Other|33|||
13471980|NCT00030901|26988297|FG000|Randomization|Ineligible|0|||
13471981|NCT00030901|26988298|FG001|Randomization|Ineligible|15|||
13471982|NCT00030901|26988299|FG002|Randomization|Ineligible|14|||
13471983|NCT00030823|26988305|FG000|Overall Study|Withdrawal by Subject|1|||
13471984|NCT00029146|26988339|FG000|Overall Study|Lost to Follow-up|2|||
13471985|NCT00029146|26988340|FG001|Overall Study|Lost to Follow-up|1|||
13471986|NCT00028769|26988348|FG000|Overall Study|Adverse Event|2|||
13471987|NCT00028769|26988348|FG000|Overall Study|Refusal Unrelated to Adverse Events|1|||
13471988|NCT00028769|26988348|FG000|Overall Study|Progression or Death|31|||
13471989|NCT00028769|26988348|FG000|Overall Study|Other - Not Protocol Specified|1|||
13471990|NCT00028769|26988348|FG000|Overall Study|Ineligible|5|||
13471991|NCT00028769|26988348|FG000|Overall Study|Not Analyzable|1|||
13471992|NCT00028002|26988357|FG000|Overall Study|Withdrawal by Subject|3|||
13471993|NCT00028002|26988357|FG000|Overall Study|Ineligible|8|||
13471994|NCT00027846|26988385|FG000|Overall Study|Lost to Follow-up|0|||
13471995|NCT00027846|26988386|FG001|Overall Study|Lost to Follow-up|41|||
13471996|NCT00027846|26988387|FG002|Overall Study|Lost to Follow-up|9|||
13471997|NCT00027846|26988385|FG000|Overall Study|Withdrawal by Subject|0|||
13471998|NCT00027846|26988386|FG001|Overall Study|Withdrawal by Subject|14|||
13471999|NCT00027846|26988387|FG002|Overall Study|Withdrawal by Subject|7|||
13472000|NCT00027846|26988385|FG000|Overall Study|Ineligible for study|2|||
13472001|NCT00027846|26988386|FG001|Overall Study|Ineligible for study|6|||
13472002|NCT00027846|26988387|FG002|Overall Study|Ineligible for study|14|||
13472003|NCT00027846|26988385|FG000|Overall Study|Entry into another COG therapeutic study|0|||
13472004|NCT00027846|26988386|FG001|Overall Study|Entry into another COG therapeutic study|5|||
13472005|NCT00027846|26988387|FG002|Overall Study|Entry into another COG therapeutic study|2|||
13472006|NCT00027846|26988385|FG000|Overall Study|Neuraxis dissemination during/after ther|0|||
13472007|NCT00027846|26988386|FG001|Overall Study|Neuraxis dissemination during/after ther|2|||
13472008|NCT00027846|26988387|FG002|Overall Study|Neuraxis dissemination during/after ther|5|||
13472009|NCT00027560|26988398|FG000|Overall Study|Withdrawal by Subject|1|||
13472010|NCT00027378|26988413|FG000|Overall Study|Physician Decision|0|||
13472011|NCT00027378|26988414|FG001|Overall Study|Physician Decision|3|||
13472012|NCT00027027|26988475|FG000|Overall Study|Adverse Event|0|||
13472013|NCT00027027|26988476|FG001|Overall Study|Adverse Event|0|||
13472014|NCT00027027|26988477|FG002|Overall Study|Adverse Event|1|||
13472015|NCT00027027|26988478|FG003|Overall Study|Adverse Event|0|||
13472016|NCT00027027|26988479|FG004|Overall Study|Adverse Event|1|||
13472017|NCT00027027|26988475|FG000|Overall Study|Admitted for Signs of PD|0|||
13472018|NCT00027027|26988476|FG001|Overall Study|Admitted for Signs of PD|0|||
13472019|NCT00027027|26988477|FG002|Overall Study|Admitted for Signs of PD|0|||
13472020|NCT00027027|26988478|FG003|Overall Study|Admitted for Signs of PD|0|||
13472021|NCT00027027|26988479|FG004|Overall Study|Admitted for Signs of PD|1|||
13472022|NCT00027027|26988475|FG000|Overall Study|Clinical Symptoms Progression not PD|1|||
13472023|NCT00027027|26988476|FG001|Overall Study|Clinical Symptoms Progression not PD|0|||
13472024|NCT00027027|26988477|FG002|Overall Study|Clinical Symptoms Progression not PD|0|||
13472025|NCT00027027|26988478|FG003|Overall Study|Clinical Symptoms Progression not PD|0|||
13472026|NCT00027027|26988479|FG004|Overall Study|Clinical Symptoms Progression not PD|0|||
13472027|NCT00027027|26988475|FG000|Overall Study|PD Requiring Surgery|0|||
13472028|NCT00027027|26988476|FG001|Overall Study|PD Requiring Surgery|0|||
13472029|NCT00027027|26988477|FG002|Overall Study|PD Requiring Surgery|1|||
13472030|NCT00027027|26988478|FG003|Overall Study|PD Requiring Surgery|0|||
13472031|NCT00027027|26988479|FG004|Overall Study|PD Requiring Surgery|0|||
13472032|NCT00027027|26988475|FG000|Overall Study|Physician Decision Due To PD|2|||
13472033|NCT00027027|26988476|FG001|Overall Study|Physician Decision Due To PD|3|||
13472034|NCT00027027|26988477|FG002|Overall Study|Physician Decision Due To PD|2|||
13472035|NCT00027027|26988478|FG003|Overall Study|Physician Decision Due To PD|3|||
13472036|NCT00027027|26988479|FG004|Overall Study|Physician Decision Due To PD|5|||
13472037|NCT00027027|26988475|FG000|Overall Study|Withdrawal by Subject|0|||
13472038|NCT00027027|26988476|FG001|Overall Study|Withdrawal by Subject|0|||
13472039|NCT00027027|26988477|FG002|Overall Study|Withdrawal by Subject|0|||
13472040|NCT00027027|26988478|FG003|Overall Study|Withdrawal by Subject|0|||
13472041|NCT00027027|26988479|FG004|Overall Study|Withdrawal by Subject|1|||
13472042|NCT00026793|26988489|FG000|Overall Study|Death on study due to underlying disease|4|||
13472043|NCT00026793|26988489|FG000|Overall Study|Physician Decision|2|||
13472044|NCT00026793|26988489|FG000|Overall Study|Off study|2|||
13472045|NCT00026494|26988512|FG000|Overall Study|Withdrawal by Subject|1|||
13472046|NCT00026494|26988513|FG001|Overall Study|Withdrawal by Subject|0|||
13472047|NCT00026494|26988514|FG002|Overall Study|Withdrawal by Subject|1|||
13472048|NCT00026494|26988515|FG003|Overall Study|Withdrawal by Subject|0|||
13472049|NCT00026494|26988512|FG000|Overall Study|Patient non-compliance|1|||
13472050|NCT00026494|26988513|FG001|Overall Study|Patient non-compliance|0|||
13472051|NCT00026494|26988514|FG002|Overall Study|Patient non-compliance|0|||
13472052|NCT00026494|26988515|FG003|Overall Study|Patient non-compliance|0|||
13472053|NCT00026494|26988512|FG000|Overall Study|Patient not treated|0|||
13472054|NCT00026494|26988513|FG001|Overall Study|Patient not treated|0|||
13472055|NCT00026494|26988514|FG002|Overall Study|Patient not treated|2|||
13472056|NCT00026494|26988515|FG003|Overall Study|Patient not treated|0|||
13472057|NCT00026494|26988512|FG000|Overall Study|Clinical progression|0|||
13472058|NCT00026494|26988513|FG001|Overall Study|Clinical progression|0|||
13472059|NCT00026494|26988514|FG002|Overall Study|Clinical progression|3|||
13472060|NCT00026494|26988515|FG003|Overall Study|Clinical progression|0|||
13472061|NCT00026208|26988540|FG000|Overall Study|Complications of auto accident|1|||
13472062|NCT00026208|26988541|FG001|Overall Study|Complications of auto accident|0|||
13472063|NCT00025883|26988554|FG000|Overall Study|had atypical progeriod lipodystrophy|4|||
13472064|NCT00025883|26988554|FG000|Overall Study|no baseline data|1|||
13472065|NCT00025883|26988554|FG000|Overall Study|Death|1|||
13472066|NCT00025883|26988554|FG000|Overall Study|Adverse Event|1|||
13472067|NCT00025883|26988554|FG000|Overall Study|didn't reach 6 months of Metreleptin|10|||
13472068|NCT00025662|26988564|FG000|Overall Study|Withdrawal by Subject|2|||
13472069|NCT00025662|26988564|FG000|Overall Study|Technical failure of manipulation|1|||
13472070|NCT00025506|26988580|FG000|Overall Study|Ineligible: clerical error|1|||
13472071|NCT00025506|26988580|FG000|Overall Study|Ineligible: wrong cell type|5|||
13472072|NCT00025506|26988580|FG000|Overall Study|Ineligible: inadequate pathology|2|||
13472073|NCT00025506|26988580|FG000|Overall Study|Never Treated|2|||
13472074|NCT00025259|26988638|FG000|Overall Study|Death|1|||
13472075|NCT00025259|26988639|FG001|Overall Study|Death|3|||
13472076|NCT00025259|26988640|FG002|Overall Study|Death|0|||
13472077|NCT00025259|26988641|FG003|Overall Study|Death|3|||
13472078|NCT00025259|26988642|FG004|Overall Study|Death|0|||
13472079|NCT00025259|26988643|FG005|Overall Study|Death|1|||
13472080|NCT00025259|26988644|FG006|Overall Study|Death|2|||
13472081|NCT00025259|26988638|FG000|Overall Study|Lack of Efficacy|2|||
13472082|NCT00025259|26988639|FG001|Overall Study|Lack of Efficacy|46|||
13472083|NCT00025259|26988640|FG002|Overall Study|Lack of Efficacy|60|||
13472084|NCT00025259|26988641|FG003|Overall Study|Lack of Efficacy|78|||
13472085|NCT00025259|26988642|FG004|Overall Study|Lack of Efficacy|11|||
13472086|NCT00025259|26988643|FG005|Overall Study|Lack of Efficacy|30|||
13472087|NCT00025259|26988644|FG006|Overall Study|Lack of Efficacy|38|||
13472088|NCT00025259|26988638|FG000|Overall Study|Lost to Follow-up|2|||
13472089|NCT00025259|26988639|FG001|Overall Study|Lost to Follow-up|9|||
13472090|NCT00025259|26988640|FG002|Overall Study|Lost to Follow-up|13|||
13472091|NCT00025259|26988641|FG003|Overall Study|Lost to Follow-up|13|||
13472092|NCT00025259|26988642|FG004|Overall Study|Lost to Follow-up|1|||
13472093|NCT00025259|26988643|FG005|Overall Study|Lost to Follow-up|3|||
13472094|NCT00025259|26988644|FG006|Overall Study|Lost to Follow-up|1|||
13472095|NCT00025259|26988638|FG000|Overall Study|Physician Decision|12|||
13472096|NCT00025259|26988639|FG001|Overall Study|Physician Decision|1|||
13472097|NCT00025259|26988640|FG002|Overall Study|Physician Decision|0|||
13472098|NCT00025259|26988641|FG003|Overall Study|Physician Decision|5|||
13472099|NCT00025259|26988642|FG004|Overall Study|Physician Decision|4|||
13472100|NCT00025259|26988643|FG005|Overall Study|Physician Decision|2|||
13472101|NCT00025259|26988644|FG006|Overall Study|Physician Decision|1|||
13472102|NCT00025259|26988638|FG000|Overall Study|Protocol Violation|3|||
13472103|NCT00025259|26988639|FG001|Overall Study|Protocol Violation|2|||
13472104|NCT00025259|26988640|FG002|Overall Study|Protocol Violation|2|||
13472105|NCT00025259|26988641|FG003|Overall Study|Protocol Violation|1|||
13472106|NCT00025259|26988642|FG004|Overall Study|Protocol Violation|2|||
13472107|NCT00025259|26988643|FG005|Overall Study|Protocol Violation|1|||
13472108|NCT00025259|26988644|FG006|Overall Study|Protocol Violation|3|||
13472109|NCT00025259|26988638|FG000|Overall Study|Withdrawal by Subject|9|||
13472110|NCT00025259|26988639|FG001|Overall Study|Withdrawal by Subject|27|||
13472111|NCT00025259|26988640|FG002|Overall Study|Withdrawal by Subject|6|||
13472112|NCT00025259|26988641|FG003|Overall Study|Withdrawal by Subject|14|||
13472113|NCT00025259|26988642|FG004|Overall Study|Withdrawal by Subject|11|||
13472114|NCT00025259|26988643|FG005|Overall Study|Withdrawal by Subject|8|||
13472115|NCT00025259|26988644|FG006|Overall Study|Withdrawal by Subject|3|||
13472116|NCT00025259|26988638|FG000|Overall Study|Ineligible|14|||
13472117|NCT00025259|26988639|FG001|Overall Study|Ineligible|1|||
13472118|NCT00025259|26988640|FG002|Overall Study|Ineligible|0|||
13472119|NCT00025259|26988641|FG003|Overall Study|Ineligible|0|||
13472120|NCT00025259|26988642|FG004|Overall Study|Ineligible|6|||
13472121|NCT00025259|26988643|FG005|Overall Study|Ineligible|0|||
13472122|NCT00025259|26988644|FG006|Overall Study|Ineligible|1|||
13472123|NCT00025259|26988638|FG000|Overall Study|Randomization error|1|||
13472124|NCT00025259|26988639|FG001|Overall Study|Randomization error|0|||
13472125|NCT00025259|26988640|FG002|Overall Study|Randomization error|0|||
13472126|NCT00025259|26988641|FG003|Overall Study|Randomization error|0|||
13472127|NCT00025259|26988642|FG004|Overall Study|Randomization error|1|||
13472128|NCT00025259|26988643|FG005|Overall Study|Randomization error|7|||
13472129|NCT00025259|26988644|FG006|Overall Study|Randomization error|2|||
13472130|NCT00025259|26988638|FG000|Overall Study|Adverse Event|1|||
13472131|NCT00025259|26988639|FG001|Overall Study|Adverse Event|0|||
13472132|NCT00025259|26988640|FG002|Overall Study|Adverse Event|0|||
13472133|NCT00025259|26988641|FG003|Overall Study|Adverse Event|0|||
13472134|NCT00025259|26988642|FG004|Overall Study|Adverse Event|0|||
13472135|NCT00025259|26988643|FG005|Overall Study|Adverse Event|0|||
13472136|NCT00025259|26988644|FG006|Overall Study|Adverse Event|0|||
13472137|NCT00025233|26988661|FG000|Overall Study|Ineligible: wrong cell type|1|||
13472138|NCT00025233|26988661|FG000|Overall Study|Ineligible: wrong primary|1|||
13472139|NCT00025233|26988661|FG000|Overall Study|Ineligible: improper prior treatment|1|||
13472140|NCT00025233|26988661|FG000|Overall Study|Never treated|1|||
13472141|NCT00025155|26988674|FG000|Overall Study|Ineligible: Wrong primary cancer site|1|||
13472142|NCT00025155|26988674|FG000|Overall Study|Ineligible: Second primary cancer site|1|||
13472143|NCT00024258|26988680|FG000|Overall Study|Withdrawal by Subject|1|||
13472144|NCT00024258|26988680|FG000|Overall Study|Disease Progression|8|||
13472145|NCT00024167|26988698|FG000|Overall Study|Death|53|||
13472146|NCT00024167|26988699|FG001|Overall Study|Death|47|||
13472147|NCT00023764|26988706|FG000|Overall Study|Other|1|||
13472148|NCT00023764|26988706|FG000|Overall Study|Adverse Event|4|||
13472149|NCT00023764|26988706|FG000|Overall Study|Withdrawal by Subject|1|||
13472150|NCT00023764|26988706|FG000|Overall Study|Progression of disease|6|||
13472151|NCT00023764|26988706|FG000|Overall Study|patient received other treatment|1|||
13472152|NCT00023764|26988706|FG000|Overall Study|delay in obtaining staging images|1|||
13472153|NCT00023712|26988735|FG000|Overall Study|Not platinum sensitive|1|||
13472154|NCT00023712|26988736|FG001|Overall Study|Not platinum sensitive|0|||
13472155|NCT00023712|26988735|FG000|Overall Study|Never treated|1|||
13472156|NCT00023712|26988736|FG001|Overall Study|Never treated|1|||
13472157|NCT00023673|26988760|FG000|Overall Study|Ineligible / no protocol treatment|0|||
13472158|NCT00023673|26988761|FG001|Overall Study|Ineligible / no protocol treatment|0|||
13472159|NCT00023673|26988762|FG002|Overall Study|Ineligible / no protocol treatment|0|||
13472160|NCT00023673|26988763|FG003|Overall Study|Ineligible / no protocol treatment|1|||
13472161|NCT00023673|26988760|FG000|Overall Study|Patient withdrew consent|0|||
13472162|NCT00023673|26988761|FG001|Overall Study|Patient withdrew consent|0|||
13472163|NCT00023673|26988762|FG002|Overall Study|Patient withdrew consent|0|||
13472164|NCT00023673|26988763|FG003|Overall Study|Patient withdrew consent|1|||
13472165|NCT00023595|26988988|FG000|5 Year Follow up|Lost to Follow-up|2|||
13472166|NCT00023595|26988989|FG001|5 Year Follow up|Lost to Follow-up|2|||
13472167|NCT00023595|26988990|FG002|5 Year Follow up|Lost to Follow-up|1|||
13472168|NCT00023595|26988991|FG003|5 Year Follow up|Lost to Follow-up|7|||
13472169|NCT00023595|26988992|FG004|5 Year Follow up|Lost to Follow-up|3|||
13472170|NCT00023595|26988988|FG000|10 Year Follow up|Lost to Follow-up|12|||
13472171|NCT00023595|26988989|FG001|10 Year Follow up|Lost to Follow-up|10|||
13472172|NCT00023595|26988990|FG002|10 Year Follow up|Lost to Follow-up|3|||
13472173|NCT00023595|26988991|FG003|10 Year Follow up|Lost to Follow-up|0|||
13472174|NCT00023595|26988992|FG004|10 Year Follow up|Lost to Follow-up|0|||
13472175|NCT00023452|26989023|FG000|Overall Study|Ineligible for Study|163|||
13472176|NCT00023452|26989024|FG001|Overall Study|Ineligible for Study|159|||
13472177|NCT00023452|26989023|FG000|Overall Study|Out of Window|129|||
13472178|NCT00023452|26989024|FG001|Overall Study|Out of Window|69|||
13472179|NCT00023452|26989023|FG000|Overall Study|Death|2|||
13472180|NCT00023452|26989024|FG001|Overall Study|Death|0|||
13472181|NCT00023452|26989023|FG000|Overall Study|Withdrawal by Subject|66|||
13472182|NCT00023452|26989024|FG001|Overall Study|Withdrawal by Subject|54|||
13472183|NCT00023452|26989023|FG000|Overall Study|Adverse Event|139|||
13472184|NCT00023452|26989024|FG001|Overall Study|Adverse Event|196|||
13472185|NCT00023452|26989023|FG000|Overall Study|Lost to Follow-up|293|||
13472186|NCT00023452|26989024|FG001|Overall Study|Lost to Follow-up|60|||
13472187|NCT00023452|26989023|FG000|Overall Study|Physician Decision|49|||
13472188|NCT00023452|26989024|FG001|Overall Study|Physician Decision|21|||
13472189|NCT00023452|26989023|FG000|Overall Study|Refused Treatment (continued follow-up)|225|||
13472190|NCT00023452|26989024|FG001|Overall Study|Refused Treatment (continued follow-up)|224|||
13472191|NCT00023452|26989023|FG000|Overall Study|Pregnant|53|||
13472192|NCT00023452|26989024|FG001|Overall Study|Pregnant|20|||
13472193|NCT00023452|26989023|FG000|Overall Study|Other|204|||
13472194|NCT00023452|26989024|FG001|Overall Study|Other|69|||
13472195|NCT00023322|26989031|FG000|Overall Study|Lost to Follow-up|1|||
13472196|NCT00022763|26989061|FG000|Overall Study|Adverse Event|1|||
13472197|NCT00022763|26989062|FG001|Overall Study|Adverse Event|2|||
13472198|NCT00022763|26989061|FG000|Overall Study|Injection Site Reactions|0|||
13472199|NCT00022763|26989062|FG001|Overall Study|Injection Site Reactions|2|||
13472200|NCT00022763|26989061|FG000|Overall Study|Death|0|||
13472201|NCT00022763|26989062|FG001|Overall Study|Death|1|||
13472202|NCT00022763|26989061|FG000|Overall Study|Lost to Follow-up|0|||
13472203|NCT00022763|26989062|FG001|Overall Study|Lost to Follow-up|3|||
13472204|NCT00022763|26989061|FG000|Overall Study|Withdrawal by Subject|4|||
13472205|NCT00022763|26989062|FG001|Overall Study|Withdrawal by Subject|7|||
13472206|NCT00022763|26989061|FG000|Overall Study|Insufficient Therapy|1|||
13472207|NCT00022763|26989062|FG001|Overall Study|Insufficient Therapy|0|||
13472208|NCT00022763|26989061|FG000|Overall Study|Admin|3|||
13472209|NCT00022763|26989062|FG001|Overall Study|Admin|2|||
13472210|NCT00022698|26989092|FG000|Overall Study|Adverse Event|5|||
13472211|NCT00022698|26989093|FG001|Overall Study|Adverse Event|9|||
13472212|NCT00022698|26989092|FG000|Overall Study|Death|0|||
13472213|NCT00022698|26989093|FG001|Overall Study|Death|2|||
13472214|NCT00022698|26989092|FG000|Overall Study|Failure to return|0|||
13472215|NCT00022698|26989093|FG001|Overall Study|Failure to return|1|||
13472216|NCT00022698|26989092|FG000|Overall Study|Refused treatment|0|||
13472217|NCT00022698|26989093|FG001|Overall Study|Refused treatment|2|||
13472218|NCT00022698|26989092|FG000|Overall Study|Insufficient therapeutic response|2|||
13472219|NCT00022698|26989093|FG001|Overall Study|Insufficient therapeutic response|14|||
13472220|NCT00022698|26989092|FG000|Overall Study|Administrative /other|1|||
13472221|NCT00022698|26989093|FG001|Overall Study|Administrative /other|7|||
13472222|NCT00022672|26989133|FG000|Main Phase: 24 Months|Adverse Event|6|||
13472223|NCT00022672|26989134|FG001|Main Phase: 24 Months|Adverse Event|0|||
13472224|NCT00022672|26989133|FG000|Main Phase: 24 Months|Death|0|||
13472225|NCT00022672|26989134|FG001|Main Phase: 24 Months|Death|3|||
13472226|NCT00022672|26989133|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75|||
13472227|NCT00022672|26989134|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91|||
13472228|NCT00022672|26989133|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0|||
13472229|NCT00022672|26989134|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1|||
13472230|NCT00022672|26989133|FG000|Main Phase: 24 Months|Other Protocol Violation|1|||
13472231|NCT00022672|26989134|FG001|Main Phase: 24 Months|Other Protocol Violation|0|||
13472232|NCT00022672|26989133|FG000|Main Phase: 24 Months|Refused Treatment|3|||
13472233|NCT00022672|26989134|FG001|Main Phase: 24 Months|Refused Treatment|4|||
13472234|NCT00022672|26989133|FG000|Main Phase: 24 Months|Failure to Return|1|||
13472235|NCT00022672|26989134|FG001|Main Phase: 24 Months|Failure to Return|1|||
13472236|NCT00022672|26989133|FG000|Main Phase: 24 Months|Other|1|||
13472237|NCT00022672|26989134|FG001|Main Phase: 24 Months|Other|0|||
13472238|NCT00022672|26989133|FG000|Extension Phase|Adverse Event|1|||
13472239|NCT00022672|26989134|FG001|Extension Phase|Adverse Event|3|||
13472240|NCT00022672|26989133|FG000|Extension Phase|Death|0|||
13472241|NCT00022672|26989134|FG001|Extension Phase|Death|1|||
13472242|NCT00022672|26989133|FG000|Extension Phase|Insufficient Therapeutic Response|1|||
13472243|NCT00022672|26989134|FG001|Extension Phase|Insufficient Therapeutic Response|44|||
13472244|NCT00022672|26989133|FG000|Extension Phase|Refused Treatment|0|||
13472245|NCT00022672|26989134|FG001|Extension Phase|Refused Treatment|2|||
13472246|NCT00022672|26989133|FG000|Extension Phase|Other|1|||
13472247|NCT00022672|26989134|FG001|Extension Phase|Other|1|||
13472248|NCT00022659|26989147|FG000|Overall Study|Ineligible: wrong primary|1|||
13472249|NCT00022659|26989147|FG000|Overall Study|Never treated|1|||
13472250|NCT00022633|26989165|FG000|Overall Study|Adverse Event|11|||
13472251|NCT00022633|26989166|FG001|Overall Study|Adverse Event|1|||
13472252|NCT00022633|26989165|FG000|Overall Study|Refusal unrelated to adverse event|1|||
13472253|NCT00022633|26989166|FG001|Overall Study|Refusal unrelated to adverse event|0|||
13472254|NCT00022633|26989165|FG000|Overall Study|Progression/relapse|9|||
13472255|NCT00022633|26989166|FG001|Overall Study|Progression/relapse|2|||
13472256|NCT00022633|26989165|FG000|Overall Study|Death|4|||
13472257|NCT00022633|26989166|FG001|Overall Study|Death|0|||
13472258|NCT00022633|26989165|FG000|Overall Study|Other - not protocol specified|3|||
13472259|NCT00022633|26989166|FG001|Overall Study|Other - not protocol specified|2|||
13472260|NCT00022633|26989165|FG000|Overall Study|Ineligible|4|||
13472261|NCT00022633|26989166|FG001|Overall Study|Ineligible|0|||
13472262|NCT00022516|26989185|FG000|Overall Study|Adverse Event|0|||
13472263|NCT00022516|26989186|FG001|Overall Study|Adverse Event|59|||
13472264|NCT00022516|26989185|FG000|Overall Study|Lack of Efficacy|0|||
13472265|NCT00022516|26989186|FG001|Overall Study|Lack of Efficacy|27|||
13472266|NCT00022516|26989185|FG000|Overall Study|Physician Decision|0|||
13472267|NCT00022516|26989186|FG001|Overall Study|Physician Decision|1|||
13472268|NCT00022516|26989185|FG000|Overall Study|Protocol Violation|1|||
13472269|NCT00022516|26989186|FG001|Overall Study|Protocol Violation|3|||
13472270|NCT00022516|26989185|FG000|Overall Study|Withdrawal by Subject|2|||
13472271|NCT00022516|26989186|FG001|Overall Study|Withdrawal by Subject|113|||
13472272|NCT00022516|26989185|FG000|Overall Study|Incomplete documentation|0|||
13472273|NCT00022516|26989186|FG001|Overall Study|Incomplete documentation|27|||
13472274|NCT00021541|26989203|FG000|Period 1-First Treatment|Withdrawal by Subject|3|||
13472275|NCT00021541|26989204|FG001|Period 1-First Treatment|Withdrawal by Subject|3|||
13472276|NCT00021541|26989203|FG000|Period 1-First Treatment|Adverse Event|2|||
13472277|NCT00021541|26989204|FG001|Period 1-First Treatment|Adverse Event|1|||
13472278|NCT00021541|26989203|FG000|Period 1-First Treatment|non-adherence|3|||
13472279|NCT00021541|26989204|FG001|Period 1-First Treatment|non-adherence|0|||
13472280|NCT00021541|26989203|FG000|Period 1-First Treatment|Death|1|||
13472281|NCT00021541|26989204|FG001|Period 1-First Treatment|Death|0|||
13472282|NCT00021541|26989203|FG000|Period 1-First Treatment|Pts that did not progress|2|||
13472283|NCT00021541|26989204|FG001|Period 1-First Treatment|Pts that did not progress|2|||
13472284|NCT00021541|26989203|FG000|Period 1-First Treatment|Ineligible|0|||
13472285|NCT00021541|26989204|FG001|Period 1-First Treatment|Ineligible|2|||
13472286|NCT00021541|26989203|FG000|Period 2-crossover|refused phase B|2|||
13472287|NCT00021541|26989204|FG001|Period 2-crossover|refused phase B|2|||
13472288|NCT00021541|26989203|FG000|Period 2-crossover|Withdrawal by Subject|3|||
13472289|NCT00021541|26989204|FG001|Period 2-crossover|Withdrawal by Subject|4|||
13472290|NCT00021541|26989203|FG000|Period 2-crossover|Adverse Event|2|||
13472291|NCT00021541|26989204|FG001|Period 2-crossover|Adverse Event|2|||
13472292|NCT00021541|26989203|FG000|Period 2-crossover|non-adherence|1|||
13472293|NCT00021541|26989204|FG001|Period 2-crossover|non-adherence|0|||
13472294|NCT00021541|26989203|FG000|Period 2-crossover|Pts that did not progress|2|||
13472295|NCT00021541|26989204|FG001|Period 2-crossover|Pts that did not progress|3|||
13472296|NCT00021255|26989228|FG000|Overall Study|Death|1|||
13472297|NCT00021255|26989229|FG001|Overall Study|Death|0|||
13472298|NCT00021255|26989230|FG002|Overall Study|Death|2|||
13472299|NCT00021255|26989228|FG000|Overall Study|Breast cancer relapse|5|||
13472300|NCT00021255|26989229|FG001|Overall Study|Breast cancer relapse|18|||
13472301|NCT00021255|26989230|FG002|Overall Study|Breast cancer relapse|11|||
13472302|NCT00021255|26989228|FG000|Overall Study|Second primary malignancy|0|||
13472303|NCT00021255|26989229|FG001|Overall Study|Second primary malignancy|4|||
13472304|NCT00021255|26989230|FG002|Overall Study|Second primary malignancy|1|||
13472305|NCT00021255|26989228|FG000|Overall Study|Withdrawal by Subject|41|||
13472306|NCT00021255|26989229|FG001|Overall Study|Withdrawal by Subject|64|||
13472307|NCT00021255|26989230|FG002|Overall Study|Withdrawal by Subject|26|||
13472308|NCT00021255|26989228|FG000|Overall Study|Lost to Follow-up|0|||
13472309|NCT00021255|26989229|FG001|Overall Study|Lost to Follow-up|2|||
13472310|NCT00021255|26989230|FG002|Overall Study|Lost to Follow-up|3|||
13472311|NCT00021255|26989228|FG000|Overall Study|Cardiac toxicity|0|||
13472312|NCT00021255|26989229|FG001|Overall Study|Cardiac toxicity|61|||
13472313|NCT00021255|26989230|FG002|Overall Study|Cardiac toxicity|32|||
13472314|NCT00021255|26989228|FG000|Overall Study|Herceptin toxicity|0|||
13472315|NCT00021255|26989229|FG001|Overall Study|Herceptin toxicity|22|||
13472316|NCT00021255|26989230|FG002|Overall Study|Herceptin toxicity|6|||
13472317|NCT00021255|26989228|FG000|Overall Study|Adverse Event|46|||
13472318|NCT00021255|26989229|FG001|Overall Study|Adverse Event|30|||
13472319|NCT00021255|26989230|FG002|Overall Study|Adverse Event|18|||
13472320|NCT00021255|26989228|FG000|Overall Study|Protocol Violation|0|||
13472321|NCT00021255|26989229|FG001|Overall Study|Protocol Violation|2|||
13472322|NCT00021255|26989230|FG002|Overall Study|Protocol Violation|0|||
13472323|NCT00021255|26989228|FG000|Overall Study|Other than specified above|0|||
13472324|NCT00021255|26989229|FG001|Overall Study|Other than specified above|38|||
13472325|NCT00021255|26989230|FG002|Overall Study|Other than specified above|19|||
13472326|NCT00021255|26989228|FG000|Overall Study|Missing|0|||
13472327|NCT00021255|26989229|FG001|Overall Study|Missing|27|||
13472328|NCT00021255|26989230|FG002|Overall Study|Missing|13|||
13472329|NCT00021255|26989228|FG000|Overall Study|Randomized but not treated|28|||
13472330|NCT00021255|26989229|FG001|Overall Study|Randomized but not treated|2|||
13472331|NCT00021255|26989230|FG002|Overall Study|Randomized but not treated|18|||
13472332|NCT00021229|26989266|FG000|Overall Study|Adverse Event|10|||
13472333|NCT00021229|26989267|FG001|Overall Study|Adverse Event|5|||
13472334|NCT00021229|26989268|FG002|Overall Study|Adverse Event|2|||
13472335|NCT00021229|26989266|FG000|Overall Study|Death|0|||
13472336|NCT00021229|26989267|FG001|Overall Study|Death|1|||
13472337|NCT00021229|26989268|FG002|Overall Study|Death|0|||
13472338|NCT00021229|26989266|FG000|Overall Study|Withdrawal by Subject|7|||
13472339|NCT00021229|26989267|FG001|Overall Study|Withdrawal by Subject|7|||
13472340|NCT00021229|26989268|FG002|Overall Study|Withdrawal by Subject|1|||
13472341|NCT00021229|26989266|FG000|Overall Study|Progressive Disease|15|||
13472342|NCT00021229|26989267|FG001|Overall Study|Progressive Disease|19|||
13472343|NCT00021229|26989268|FG002|Overall Study|Progressive Disease|12|||
13472344|NCT00021229|26989266|FG000|Overall Study|Protocol Violation|1|||
13472345|NCT00021229|26989267|FG001|Overall Study|Protocol Violation|1|||
13472346|NCT00021229|26989268|FG002|Overall Study|Protocol Violation|0|||
13472347|NCT00021229|26989266|FG000|Overall Study|Physician Decision|0|||
13472348|NCT00021229|26989267|FG001|Overall Study|Physician Decision|0|||
13472349|NCT00021229|26989268|FG002|Overall Study|Physician Decision|1|||
13472350|NCT00021229|26989266|FG000|Overall Study|Punctate hemmorrhage post RT|2|||
13472351|NCT00021229|26989267|FG001|Overall Study|Punctate hemmorrhage post RT|0|||
13472352|NCT00021229|26989268|FG002|Overall Study|Punctate hemmorrhage post RT|0|||
13472353|NCT00015457|26989279|FG000|First Intervention|Adverse Event|0|||
13472354|NCT00015457|26989280|FG001|First Intervention|Adverse Event|2|||
13472355|NCT00015457|26989279|FG000|First Intervention|Lack of Efficacy|0|||
13472356|NCT00015457|26989280|FG001|First Intervention|Lack of Efficacy|1|||
13472357|NCT00015457|26989279|FG000|Second Intervention|Withdrawal by Subject|1|||
13472358|NCT00015457|26989280|FG001|Second Intervention|Withdrawal by Subject|0|||
13472359|NCT00010803|26989297|FG000|Overall Study|Withdrawal by Subject|97|||
13472360|NCT00010803|26989298|FG001|Overall Study|Withdrawal by Subject|98|||
13472361|NCT00009945|26989319|FG000|Overall Study|no follow up data|7|||
13472362|NCT00009945|26989320|FG001|Overall Study|no follow up data|5|||
13472363|NCT00009737|26989343|FG000|Overall Study|Adverse Event|112|||
13472364|NCT00009737|26989344|FG001|Overall Study|Adverse Event|75|||
13472365|NCT00009737|26989343|FG000|Overall Study|Death|4|||
13472366|NCT00009737|26989344|FG001|Overall Study|Death|6|||
13472367|NCT00009737|26989343|FG000|Overall Study|Lack of Efficacy|17|||
13472368|NCT00009737|26989344|FG001|Overall Study|Lack of Efficacy|15|||
13472369|NCT00009737|26989343|FG000|Overall Study|Violation of Selection Criteria at Entry|13|||
13472370|NCT00009737|26989344|FG001|Overall Study|Violation of Selection Criteria at Entry|9|||
13472371|NCT00009737|26989343|FG000|Overall Study|Other Protocol Violation|1|||
13472372|NCT00009737|26989344|FG001|Overall Study|Other Protocol Violation|0|||
13472373|NCT00009737|26989343|FG000|Overall Study|Refused Treatment|15|||
13472374|NCT00009737|26989344|FG001|Overall Study|Refused Treatment|16|||
13472375|NCT00009737|26989343|FG000|Overall Study|Lost to Follow-up|1|||
13472376|NCT00009737|26989344|FG001|Overall Study|Lost to Follow-up|1|||
13472377|NCT00009737|26989343|FG000|Overall Study|Administrative/Other Reasons|7|||
13472378|NCT00009737|26989344|FG001|Overall Study|Administrative/Other Reasons|1|||
13472379|NCT00008385|26989361|FG000|Overall Study|Off treatment reasons not reported|79|||
13472380|NCT00008385|26989362|FG001|Overall Study|Off treatment reasons not reported|70|||
13472381|NCT00008385|26989361|FG000|Overall Study|Progressive disease|52|||
13472382|NCT00008385|26989362|FG001|Overall Study|Progressive disease|117|||
13472383|NCT00008385|26989361|FG000|Overall Study|Adverse Event|8|||
13472384|NCT00008385|26989362|FG001|Overall Study|Adverse Event|20|||
13472385|NCT00008385|26989361|FG000|Overall Study|Death|12|||
13472386|NCT00008385|26989362|FG001|Overall Study|Death|18|||
13472387|NCT00008385|26989361|FG000|Overall Study|Withdrawal by Subject|67|||
13472388|NCT00008385|26989362|FG001|Overall Study|Withdrawal by Subject|157|||
13472389|NCT00008385|26989361|FG000|Overall Study|Start non-protocol therapy|3|||
13472390|NCT00008385|26989362|FG001|Overall Study|Start non-protocol therapy|1|||
13472391|NCT00008385|26989361|FG000|Overall Study|Other complicating disease|17|||
13472392|NCT00008385|26989362|FG001|Overall Study|Other complicating disease|30|||
13472393|NCT00008385|26989361|FG000|Overall Study|Maximum dose reached|0|||
13472394|NCT00008385|26989362|FG001|Overall Study|Maximum dose reached|2|||
13472395|NCT00008385|26989361|FG000|Overall Study|Other|105|||
13472396|NCT00008385|26989362|FG001|Overall Study|Other|212|||
13472397|NCT00008385|26989361|FG000|Overall Study|Not start protocol therapy|44|||
13472398|NCT00008385|26989362|FG001|Overall Study|Not start protocol therapy|175|||
13472399|NCT00008138|26989370|FG000|Neoadjuvant Chemotherapy|Adverse Event|3|||
13472400|NCT00008138|26989370|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3|||
13472401|NCT00008138|26989370|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6|||
13472402|NCT00008138|26989370|FG000|Neoadjuvant Chemotherapy|not protocol specified|8|||
13472403|NCT00008138|26989370|FG000|Interval Debulking|Withdrawal by Subject|2|||
13472404|NCT00008138|26989370|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6|||
13472405|NCT00008138|26989370|FG000|Post-Cytoreduction Chemotherapy|Progression|1|||
13472406|NCT00008138|26989370|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1|||
13472407|NCT00007475|26989401|FG000|Overall Study|Withdrawal by Subject|1|||
13472408|NCT00007475|26989402|FG001|Overall Study|Withdrawal by Subject|0|||
13472409|NCT00007475|26989403|FG002|Overall Study|Withdrawal by Subject|0|||
13472410|NCT00007475|26989404|FG003|Overall Study|Withdrawal by Subject|0|||
13472411|NCT00007475|26989401|FG000|Overall Study|Adverse Event|3|||
13472412|NCT00007475|26989402|FG001|Overall Study|Adverse Event|0|||
13472413|NCT00007475|26989403|FG002|Overall Study|Adverse Event|0|||
13472414|NCT00007475|26989404|FG003|Overall Study|Adverse Event|0|||
13472415|NCT00007345|26989429|FG000|Overall Study|Refused further treatment|0|||
13472416|NCT00007345|26989430|FG001|Overall Study|Refused further treatment|7|||
13472417|NCT00007345|26989429|FG000|Overall Study|Switched to alternative treatment|0|||
13472418|NCT00007345|26989430|FG001|Overall Study|Switched to alternative treatment|3|||
13472419|NCT00007345|26989429|FG000|Overall Study|Intercurrent illness|1|||
13472420|NCT00007345|26989430|FG001|Overall Study|Intercurrent illness|0|||
13472421|NCT00007345|26989429|FG000|Overall Study|Death on study|1|||
13472422|NCT00007345|26989430|FG001|Overall Study|Death on study|1|||
13472423|NCT00007020|26989441|FG000|Overall Study|Death|16|||
13472424|NCT00007020|26989441|FG000|Overall Study|Lost to Follow-up|13|||
13472425|NCT00007020|26989441|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1|||
13472426|NCT00007020|26989441|FG000|Overall Study|Pt withdrawn (liver transplant)|4|||
13472427|NCT00007020|26989441|FG000|Overall Study|Pt cared for by outside physician|4|||
13472428|NCT00007020|26989441|FG000|Overall Study|No evidence of treatment|6|||
13472429|NCT00006916|26989447|FG000|Overall Study|Device not inserted|4|||
13472430|NCT00006916|26989447|FG000|Overall Study|Complication of device insertion|1|||
13472431|NCT00006903|26989465|FG000|Overall Study|Still receiving treatment|0|||
13472432|NCT00006903|26989466|FG001|Overall Study|Still receiving treatment|0|||
13472433|NCT00006903|26989467|FG002|Overall Study|Still receiving treatment|1|||
13472434|NCT00006903|26989465|FG000|Overall Study|Refused further treatment|0|||
13472435|NCT00006903|26989466|FG001|Overall Study|Refused further treatment|2|||
13472436|NCT00006903|26989467|FG002|Overall Study|Refused further treatment|1|||
13472437|NCT00006903|26989465|FG000|Overall Study|Adverse Event|0|||
13472438|NCT00006903|26989466|FG001|Overall Study|Adverse Event|0|||
13472439|NCT00006903|26989467|FG002|Overall Study|Adverse Event|1|||
13472440|NCT00006903|26989465|FG000|Overall Study|Death|0|||
13472441|NCT00006903|26989466|FG001|Overall Study|Death|1|||
13472442|NCT00006903|26989467|FG002|Overall Study|Death|0|||
13472443|NCT00006903|26989465|FG000|Overall Study|Patient never treated|0|||
13472444|NCT00006903|26989466|FG001|Overall Study|Patient never treated|0|||
13472445|NCT00006903|26989467|FG002|Overall Study|Patient never treated|1|||
13472446|NCT00006903|26989465|FG000|Overall Study|Ineligible|10|||
13472447|NCT00006903|26989466|FG001|Overall Study|Ineligible|1|||
13472448|NCT00006903|26989467|FG002|Overall Study|Ineligible|2|||
13472449|NCT00006721|26989495|FG000|Overall Study|Adverse Event|0|||
13472450|NCT00006721|26989496|FG001|Overall Study|Adverse Event|4|||
13472451|NCT00006721|26989497|FG002|Overall Study|Adverse Event|4|||
13472452|NCT00006721|26989495|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
13472453|NCT00006721|26989496|FG001|Overall Study|Refusal Unrelated to Adverse Event|0|||
13472454|NCT00006721|26989497|FG002|Overall Study|Refusal Unrelated to Adverse Event|8|||
13472455|NCT00006721|26989495|FG000|Overall Study|Progression/Relapse|0|||
13472456|NCT00006721|26989496|FG001|Overall Study|Progression/Relapse|1|||
13472457|NCT00006721|26989497|FG002|Overall Study|Progression/Relapse|2|||
13472458|NCT00006721|26989495|FG000|Overall Study|Death|0|||
13472459|NCT00006721|26989496|FG001|Overall Study|Death|1|||
13472460|NCT00006721|26989497|FG002|Overall Study|Death|2|||
13472461|NCT00006721|26989495|FG000|Overall Study|Other - Not Protocol Specified|0|||
13472462|NCT00006721|26989496|FG001|Overall Study|Other - Not Protocol Specified|7|||
13472463|NCT00006721|26989497|FG002|Overall Study|Other - Not Protocol Specified|7|||
13472464|NCT00006721|26989495|FG000|Overall Study|Ineligible|2|||
13472465|NCT00006721|26989496|FG001|Overall Study|Ineligible|12|||
13472466|NCT00006721|26989497|FG002|Overall Study|Ineligible|10|||
13472467|NCT00006721|26989495|FG000|Overall Study|Eligible but no Treatment Received|1|||
13472468|NCT00006721|26989496|FG001|Overall Study|Eligible but no Treatment Received|0|||
13472469|NCT00006721|26989497|FG002|Overall Study|Eligible but no Treatment Received|0|||
13472470|NCT00006604|26989643|FG000|Overall Study|Met study objective - no further FU|1|||
13472471|NCT00006604|26989644|FG001|Overall Study|Met study objective - no further FU|0|||
13472472|NCT00006604|26989645|FG002|Overall Study|Met study objective - no further FU|0|||
13472473|NCT00006604|26989646|FG003|Overall Study|Met study objective - no further FU|0|||
13472474|NCT00006604|26989647|FG004|Overall Study|Met study objective - no further FU|0|||
13472475|NCT00006604|26989648|FG005|Overall Study|Met study objective - no further FU|0|||
13472476|NCT00006604|26989649|FG006|Overall Study|Met study objective - no further FU|0|||
13472477|NCT00006604|26989650|FG007|Overall Study|Met study objective - no further FU|0|||
13472478|NCT00006604|26989651|FG008|Overall Study|Met study objective - no further FU|0|||
13472479|NCT00006604|26989652|FG009|Overall Study|Met study objective - no further FU|0|||
13472480|NCT00006604|26989653|FG010|Overall Study|Met study objective - no further FU|0|||
13472481|NCT00006604|26989654|FG011|Overall Study|Met study objective - no further FU|0|||
13472482|NCT00006604|26989655|FG012|Overall Study|Met study objective - no further FU|0|||
13472483|NCT00006604|26989656|FG013|Overall Study|Met study objective - no further FU|0|||
13472484|NCT00006604|26989657|FG014|Overall Study|Met study objective - no further FU|1|||
13472485|NCT00006604|26989658|FG015|Overall Study|Met study objective - no further FU|1|||
13472486|NCT00006604|26989659|FG016|Overall Study|Met study objective - no further FU|0|||
13472487|NCT00006604|26989643|FG000|Overall Study|Randomization entry error-no RX, no FU|0|||
13472488|NCT00006604|26989644|FG001|Overall Study|Randomization entry error-no RX, no FU|0|||
13472489|NCT00006604|26989645|FG002|Overall Study|Randomization entry error-no RX, no FU|0|||
13472490|NCT00006604|26989646|FG003|Overall Study|Randomization entry error-no RX, no FU|0|||
13472491|NCT00006604|26989647|FG004|Overall Study|Randomization entry error-no RX, no FU|0|||
13472492|NCT00006604|26989648|FG005|Overall Study|Randomization entry error-no RX, no FU|0|||
13472493|NCT00006604|26989649|FG006|Overall Study|Randomization entry error-no RX, no FU|0|||
13472494|NCT00006604|26989650|FG007|Overall Study|Randomization entry error-no RX, no FU|0|||
13472495|NCT00006604|26989651|FG008|Overall Study|Randomization entry error-no RX, no FU|0|||
13472496|NCT00006604|26989652|FG009|Overall Study|Randomization entry error-no RX, no FU|0|||
13472497|NCT00006604|26989653|FG010|Overall Study|Randomization entry error-no RX, no FU|0|||
13472498|NCT00006604|26989654|FG011|Overall Study|Randomization entry error-no RX, no FU|1|||
13472499|NCT00006604|26989655|FG012|Overall Study|Randomization entry error-no RX, no FU|0|||
13472500|NCT00006604|26989656|FG013|Overall Study|Randomization entry error-no RX, no FU|0|||
13472501|NCT00006604|26989657|FG014|Overall Study|Randomization entry error-no RX, no FU|0|||
13472502|NCT00006604|26989658|FG015|Overall Study|Randomization entry error-no RX, no FU|0|||
13472503|NCT00006604|26989659|FG016|Overall Study|Randomization entry error-no RX, no FU|0|||
13472504|NCT00006604|26989643|FG000|Overall Study|Death|0|||
13472505|NCT00006604|26989644|FG001|Overall Study|Death|0|||
13472506|NCT00006604|26989645|FG002|Overall Study|Death|0|||
13472507|NCT00006604|26989646|FG003|Overall Study|Death|0|||
13472508|NCT00006604|26989647|FG004|Overall Study|Death|0|||
13472509|NCT00006604|26989648|FG005|Overall Study|Death|0|||
13472510|NCT00006604|26989649|FG006|Overall Study|Death|0|||
13472511|NCT00006604|26989650|FG007|Overall Study|Death|0|||
13472512|NCT00006604|26989651|FG008|Overall Study|Death|0|||
13472513|NCT00006604|26989652|FG009|Overall Study|Death|1|||
13472514|NCT00006604|26989653|FG010|Overall Study|Death|1|||
13472515|NCT00006604|26989654|FG011|Overall Study|Death|1|||
13472516|NCT00006604|26989655|FG012|Overall Study|Death|0|||
13472517|NCT00006604|26989656|FG013|Overall Study|Death|0|||
13472518|NCT00006604|26989657|FG014|Overall Study|Death|0|||
13472519|NCT00006604|26989658|FG015|Overall Study|Death|0|||
13472520|NCT00006604|26989659|FG016|Overall Study|Death|0|||
13472521|NCT00006604|26989643|FG000|Overall Study|Severe debilitation, unable to continue|0|||
13472522|NCT00006604|26989644|FG001|Overall Study|Severe debilitation, unable to continue|0|||
13472523|NCT00006604|26989645|FG002|Overall Study|Severe debilitation, unable to continue|0|||
13472524|NCT00006604|26989646|FG003|Overall Study|Severe debilitation, unable to continue|0|||
13472525|NCT00006604|26989647|FG004|Overall Study|Severe debilitation, unable to continue|0|||
13472526|NCT00006604|26989648|FG005|Overall Study|Severe debilitation, unable to continue|0|||
13472527|NCT00006604|26989649|FG006|Overall Study|Severe debilitation, unable to continue|3|||
13472528|NCT00006604|26989650|FG007|Overall Study|Severe debilitation, unable to continue|0|||
13472529|NCT00006604|26989651|FG008|Overall Study|Severe debilitation, unable to continue|0|||
13472530|NCT00006604|26989652|FG009|Overall Study|Severe debilitation, unable to continue|5|||
13472531|NCT00006604|26989653|FG010|Overall Study|Severe debilitation, unable to continue|0|||
13472532|NCT00006604|26989654|FG011|Overall Study|Severe debilitation, unable to continue|2|||
13472533|NCT00006604|26989655|FG012|Overall Study|Severe debilitation, unable to continue|1|||
13472534|NCT00006604|26989656|FG013|Overall Study|Severe debilitation, unable to continue|0|||
13472535|NCT00006604|26989657|FG014|Overall Study|Severe debilitation, unable to continue|2|||
13472536|NCT00006604|26989658|FG015|Overall Study|Severe debilitation, unable to continue|0|||
13472537|NCT00006604|26989659|FG016|Overall Study|Severe debilitation, unable to continue|0|||
13472538|NCT00006604|26989643|FG000|Overall Study|Subj/Parent not able to get to clinic|0|||
13472539|NCT00006604|26989644|FG001|Overall Study|Subj/Parent not able to get to clinic|0|||
13472540|NCT00006604|26989645|FG002|Overall Study|Subj/Parent not able to get to clinic|0|||
13472541|NCT00006604|26989646|FG003|Overall Study|Subj/Parent not able to get to clinic|1|||
13472542|NCT00006604|26989647|FG004|Overall Study|Subj/Parent not able to get to clinic|1|||
13472543|NCT00006604|26989648|FG005|Overall Study|Subj/Parent not able to get to clinic|0|||
13472544|NCT00006604|26989649|FG006|Overall Study|Subj/Parent not able to get to clinic|1|||
13472545|NCT00006604|26989650|FG007|Overall Study|Subj/Parent not able to get to clinic|0|||
13472546|NCT00006604|26989651|FG008|Overall Study|Subj/Parent not able to get to clinic|0|||
13472547|NCT00006604|26989652|FG009|Overall Study|Subj/Parent not able to get to clinic|1|||
13472548|NCT00006604|26989653|FG010|Overall Study|Subj/Parent not able to get to clinic|2|||
13472549|NCT00006604|26989654|FG011|Overall Study|Subj/Parent not able to get to clinic|1|||
13472550|NCT00006604|26989655|FG012|Overall Study|Subj/Parent not able to get to clinic|1|||
13472551|NCT00006604|26989656|FG013|Overall Study|Subj/Parent not able to get to clinic|1|||
13472552|NCT00006604|26989657|FG014|Overall Study|Subj/Parent not able to get to clinic|3|||
13472553|NCT00006604|26989658|FG015|Overall Study|Subj/Parent not able to get to clinic|0|||
13472554|NCT00006604|26989659|FG016|Overall Study|Subj/Parent not able to get to clinic|0|||
13472555|NCT00006604|26989643|FG000|Overall Study|Site closing|0|||
13472556|NCT00006604|26989644|FG001|Overall Study|Site closing|0|||
13472557|NCT00006604|26989645|FG002|Overall Study|Site closing|1|||
13472558|NCT00006604|26989646|FG003|Overall Study|Site closing|1|||
13472559|NCT00006604|26989647|FG004|Overall Study|Site closing|0|||
13472560|NCT00006604|26989648|FG005|Overall Study|Site closing|0|||
13472561|NCT00006604|26989649|FG006|Overall Study|Site closing|0|||
13472562|NCT00006604|26989650|FG007|Overall Study|Site closing|1|||
13472563|NCT00006604|26989651|FG008|Overall Study|Site closing|0|||
13472564|NCT00006604|26989652|FG009|Overall Study|Site closing|0|||
13472565|NCT00006604|26989653|FG010|Overall Study|Site closing|0|||
13472566|NCT00006604|26989654|FG011|Overall Study|Site closing|1|||
13472567|NCT00006604|26989655|FG012|Overall Study|Site closing|1|||
13472568|NCT00006604|26989656|FG013|Overall Study|Site closing|1|||
13472569|NCT00006604|26989657|FG014|Overall Study|Site closing|0|||
13472570|NCT00006604|26989658|FG015|Overall Study|Site closing|0|||
13472571|NCT00006604|26989659|FG016|Overall Study|Site closing|1|||
13472572|NCT00006604|26989643|FG000|Overall Study|Withdrawal by Subject|1|||
13472573|NCT00006604|26989644|FG001|Overall Study|Withdrawal by Subject|0|||
13472574|NCT00006604|26989645|FG002|Overall Study|Withdrawal by Subject|2|||
13472575|NCT00006604|26989646|FG003|Overall Study|Withdrawal by Subject|0|||
13472576|NCT00006604|26989647|FG004|Overall Study|Withdrawal by Subject|1|||
13472577|NCT00006604|26989648|FG005|Overall Study|Withdrawal by Subject|2|||
13472578|NCT00006604|26989649|FG006|Overall Study|Withdrawal by Subject|2|||
13472579|NCT00006604|26989650|FG007|Overall Study|Withdrawal by Subject|0|||
13472580|NCT00006604|26989651|FG008|Overall Study|Withdrawal by Subject|1|||
13472581|NCT00006604|26989652|FG009|Overall Study|Withdrawal by Subject|3|||
13472582|NCT00006604|26989653|FG010|Overall Study|Withdrawal by Subject|2|||
13472583|NCT00006604|26989654|FG011|Overall Study|Withdrawal by Subject|0|||
13472584|NCT00006604|26989655|FG012|Overall Study|Withdrawal by Subject|1|||
13472585|NCT00006604|26989656|FG013|Overall Study|Withdrawal by Subject|2|||
13472586|NCT00006604|26989657|FG014|Overall Study|Withdrawal by Subject|1|||
13472587|NCT00006604|26989658|FG015|Overall Study|Withdrawal by Subject|0|||
13472588|NCT00006604|26989659|FG016|Overall Study|Withdrawal by Subject|1|||
13472589|NCT00006604|26989643|FG000|Overall Study|Subj/parent not willing to adhere to req|0|||
13472590|NCT00006604|26989644|FG001|Overall Study|Subj/parent not willing to adhere to req|0|||
13472591|NCT00006604|26989645|FG002|Overall Study|Subj/parent not willing to adhere to req|1|||
13472592|NCT00006604|26989646|FG003|Overall Study|Subj/parent not willing to adhere to req|3|||
13472593|NCT00006604|26989647|FG004|Overall Study|Subj/parent not willing to adhere to req|0|||
13472594|NCT00006604|26989648|FG005|Overall Study|Subj/parent not willing to adhere to req|0|||
13472595|NCT00006604|26989649|FG006|Overall Study|Subj/parent not willing to adhere to req|3|||
13472596|NCT00006604|26989650|FG007|Overall Study|Subj/parent not willing to adhere to req|1|||
13472597|NCT00006604|26989651|FG008|Overall Study|Subj/parent not willing to adhere to req|0|||
13472598|NCT00006604|26989652|FG009|Overall Study|Subj/parent not willing to adhere to req|6|||
13472599|NCT00006604|26989653|FG010|Overall Study|Subj/parent not willing to adhere to req|3|||
13472600|NCT00006604|26989654|FG011|Overall Study|Subj/parent not willing to adhere to req|0|||
13472601|NCT00006604|26989655|FG012|Overall Study|Subj/parent not willing to adhere to req|0|||
13472602|NCT00006604|26989656|FG013|Overall Study|Subj/parent not willing to adhere to req|2|||
13472603|NCT00006604|26989657|FG014|Overall Study|Subj/parent not willing to adhere to req|3|||
13472604|NCT00006604|26989658|FG015|Overall Study|Subj/parent not willing to adhere to req|3|||
13472605|NCT00006604|26989659|FG016|Overall Study|Subj/parent not willing to adhere to req|4|||
13472606|NCT00006604|26989643|FG000|Overall Study|Lost to Follow-up|0|||
13472607|NCT00006604|26989644|FG001|Overall Study|Lost to Follow-up|0|||
13472608|NCT00006604|26989645|FG002|Overall Study|Lost to Follow-up|0|||
13472609|NCT00006604|26989646|FG003|Overall Study|Lost to Follow-up|0|||
13472610|NCT00006604|26989647|FG004|Overall Study|Lost to Follow-up|0|||
13472611|NCT00006604|26989648|FG005|Overall Study|Lost to Follow-up|0|||
13472612|NCT00006604|26989649|FG006|Overall Study|Lost to Follow-up|0|||
13472613|NCT00006604|26989650|FG007|Overall Study|Lost to Follow-up|1|||
13472614|NCT00006604|26989651|FG008|Overall Study|Lost to Follow-up|0|||
13472615|NCT00006604|26989652|FG009|Overall Study|Lost to Follow-up|2|||
13472616|NCT00006604|26989653|FG010|Overall Study|Lost to Follow-up|0|||
13472617|NCT00006604|26989654|FG011|Overall Study|Lost to Follow-up|0|||
13472618|NCT00006604|26989655|FG012|Overall Study|Lost to Follow-up|0|||
13472619|NCT00006604|26989656|FG013|Overall Study|Lost to Follow-up|0|||
13472620|NCT00006604|26989657|FG014|Overall Study|Lost to Follow-up|0|||
13472621|NCT00006604|26989658|FG015|Overall Study|Lost to Follow-up|1|||
13472622|NCT00006604|26989659|FG016|Overall Study|Lost to Follow-up|3|||
13472623|NCT00006604|26989643|FG000|Overall Study|Other Reason|0|||
13472624|NCT00006604|26989644|FG001|Overall Study|Other Reason|0|||
13472625|NCT00006604|26989645|FG002|Overall Study|Other Reason|0|||
13472626|NCT00006604|26989646|FG003|Overall Study|Other Reason|0|||
13472627|NCT00006604|26989647|FG004|Overall Study|Other Reason|0|||
13472628|NCT00006604|26989648|FG005|Overall Study|Other Reason|1|||
13472629|NCT00006604|26989649|FG006|Overall Study|Other Reason|0|||
13472630|NCT00006604|26989650|FG007|Overall Study|Other Reason|0|||
13472631|NCT00006604|26989651|FG008|Overall Study|Other Reason|0|||
13472632|NCT00006604|26989652|FG009|Overall Study|Other Reason|1|||
13472633|NCT00006604|26989653|FG010|Overall Study|Other Reason|0|||
13472634|NCT00006604|26989654|FG011|Overall Study|Other Reason|0|||
13472635|NCT00006604|26989655|FG012|Overall Study|Other Reason|0|||
13472636|NCT00006604|26989656|FG013|Overall Study|Other Reason|0|||
13472637|NCT00006604|26989657|FG014|Overall Study|Other Reason|0|||
13472638|NCT00006604|26989658|FG015|Overall Study|Other Reason|0|||
13472639|NCT00006604|26989659|FG016|Overall Study|Other Reason|0|||
13472640|NCT00006489|26989690|FG000|Overall Study|Adverse Event|3|||
13472641|NCT00006489|26989691|FG001|Overall Study|Adverse Event|2|||
13472642|NCT00006489|26989692|FG002|Overall Study|Adverse Event|4|||
13472643|NCT00006489|26989693|FG003|Overall Study|Adverse Event|3|||
13472644|NCT00006489|26989690|FG000|Overall Study|Withdrawal by Subject|10|||
13472645|NCT00006489|26989691|FG001|Overall Study|Withdrawal by Subject|9|||
13472646|NCT00006489|26989692|FG002|Overall Study|Withdrawal by Subject|9|||
13472647|NCT00006489|26989693|FG003|Overall Study|Withdrawal by Subject|6|||
13472648|NCT00006489|26989690|FG000|Overall Study|Scheduling Conflict|0|||
13472649|NCT00006489|26989691|FG001|Overall Study|Scheduling Conflict|3|||
13472650|NCT00006489|26989692|FG002|Overall Study|Scheduling Conflict|2|||
13472651|NCT00006489|26989693|FG003|Overall Study|Scheduling Conflict|1|||
13472652|NCT00006489|26989690|FG000|Overall Study|Death|0|||
13472653|NCT00006489|26989691|FG001|Overall Study|Death|0|||
13472654|NCT00006489|26989692|FG002|Overall Study|Death|0|||
13472655|NCT00006489|26989693|FG003|Overall Study|Death|1|||
13472656|NCT00006478|26989702|FG000|Overall Study|Vaccine could not be produced|1|||
13472657|NCT00006478|26989702|FG000|Overall Study|Physician Decision|6|||
13472658|NCT00006436|26989725|FG000|Overall Study|Refused further treatment|2|||
13472659|NCT00006436|26989725|FG000|Overall Study|Declined to participate (before treatment started)|1|||
13472660|NCT00006409|26989764|FG000|Baseline|Protocol Violation|48|||
13472661|NCT00006409|26989765|FG001|Baseline|Protocol Violation|70|||
13472662|NCT00006409|26989766|FG002|Baseline|Protocol Violation|0|||
13472663|NCT00006409|26989767|FG003|Baseline|Protocol Violation|0|||
13472664|NCT00006409|26989768|FG004|Baseline|Protocol Violation|0|||
13472665|NCT00006409|26989769|FG005|Baseline|Protocol Violation|0|||
13472666|NCT00006409|26989764|FG000|Post-2 Year Intervention|Protocol Violation|0|||
13472667|NCT00006409|26989765|FG001|Post-2 Year Intervention|Protocol Violation|0|||
13472668|NCT00006409|26989766|FG002|Post-2 Year Intervention|Protocol Violation|251|||
13472669|NCT00006409|26989767|FG003|Post-2 Year Intervention|Protocol Violation|168|||
13472670|NCT00006409|26989768|FG004|Post-2 Year Intervention|Protocol Violation|0|||
13472671|NCT00006409|26989769|FG005|Post-2 Year Intervention|Protocol Violation|0|||
13472672|NCT00006409|26989764|FG000|Post-3 Year Intervention|Protocol Violation|0|||
13472673|NCT00006409|26989765|FG001|Post-3 Year Intervention|Protocol Violation|0|||
13472674|NCT00006409|26989766|FG002|Post-3 Year Intervention|Protocol Violation|0|||
13472675|NCT00006409|26989767|FG003|Post-3 Year Intervention|Protocol Violation|0|||
13472676|NCT00006409|26989768|FG004|Post-3 Year Intervention|Protocol Violation|62|||
13472677|NCT00006409|26989769|FG005|Post-3 Year Intervention|Protocol Violation|62|||
13472678|NCT00006392|26989812|FG000|Overall Study|Ineligible|11|||
13472679|NCT00006392|26989813|FG001|Overall Study|Ineligible|3|||
13472680|NCT00006392|26989814|FG002|Overall Study|Ineligible|5|||
13472681|NCT00006392|26989815|FG003|Overall Study|Ineligible|5|||
13472682|NCT00006392|26989812|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156|||
13472683|NCT00006392|26989813|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
13472684|NCT00006392|26989814|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
13472685|NCT00006392|26989815|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
13472686|NCT00006389|26989823|FG000|Overall Study|Adverse Event|1|||
13472687|NCT00006305|26989850|FG000|Overall Study|Withdrawal by Subject|17|||
13472688|NCT00006305|26989851|FG001|Overall Study|Withdrawal by Subject|10|||
13472689|NCT00006305|26989852|FG002|Overall Study|Withdrawal by Subject|15|||
13472690|NCT00006305|26989853|FG003|Overall Study|Withdrawal by Subject|14|||
13472691|NCT00006289|26989876|FG000|First Intervention (5 Weeks)|Adverse Event|1|||
13472692|NCT00006289|26989877|FG001|First Intervention (5 Weeks)|Adverse Event|0|||
13472693|NCT00006289|26989876|FG000|Second Intervention (5 Weeks)|Protocol Violation|1|||
13472694|NCT00006289|26989877|FG001|Second Intervention (5 Weeks)|Protocol Violation|1|||
13472695|NCT00006237|26989894|FG000|Overall Study|Adverse Event|39|||
13472696|NCT00006237|26989895|FG001|Overall Study|Adverse Event|29|||
13472697|NCT00006237|26989894|FG000|Overall Study|Death|1|||
13472698|NCT00006237|26989895|FG001|Overall Study|Death|0|||
13472699|NCT00006237|26989894|FG000|Overall Study|Refusal unrelated to adverse effects|8|||
13472700|NCT00006237|26989895|FG001|Overall Study|Refusal unrelated to adverse effects|4|||
13472701|NCT00006237|26989894|FG000|Overall Study|Progression/relapse|54|||
13472702|NCT00006237|26989895|FG001|Overall Study|Progression/relapse|2|||
13472703|NCT00006237|26989894|FG000|Overall Study|Not eligible|9|||
13472704|NCT00006237|26989895|FG001|Overall Study|Not eligible|20|||
13472705|NCT00006237|26989894|FG000|Overall Study|Withdrawal by Subject|0|||
13472706|NCT00006237|26989895|FG001|Overall Study|Withdrawal by Subject|1|||
13472707|NCT00006237|26989894|FG000|Overall Study|Not protocol specified|14|||
13472708|NCT00006237|26989895|FG001|Overall Study|Not protocol specified|5|||
13472709|NCT00006184|26989909|FG000|Overall Study|Death|1|||
13472710|NCT00006184|26989910|FG001|Overall Study|Death|0|||
13472711|NCT00006164|26989951|FG000|Overall Study|Withdrew or lost to follow-up|70|||
13472712|NCT00006164|26989952|FG001|Overall Study|Withdrew or lost to follow-up|81|||
13472713|NCT00006046|26989985|FG000|Overall Study|Adverse Event|3|||
13472714|NCT00006046|26989986|FG001|Overall Study|Adverse Event|0|||
13472715|NCT00006046|26989987|FG002|Overall Study|Adverse Event|0|||
13472716|NCT00006046|26989988|FG003|Overall Study|Adverse Event|0|||
13472717|NCT00006046|26989989|FG004|Overall Study|Adverse Event|0|||
13472718|NCT00006046|26989985|FG000|Overall Study|Disease Progression|2|||
13472719|NCT00006046|26989986|FG001|Overall Study|Disease Progression|0|||
13472720|NCT00006046|26989987|FG002|Overall Study|Disease Progression|0|||
13472721|NCT00006046|26989988|FG003|Overall Study|Disease Progression|0|||
13472722|NCT00006046|26989989|FG004|Overall Study|Disease Progression|0|||
13472723|NCT00006011|26990005|FG000|Overall Study|Disease progression|13|||
13472724|NCT00006011|26990006|FG001|Overall Study|Disease progression|6|||
13472725|NCT00006011|26990007|FG002|Overall Study|Disease progression|26|||
13472726|NCT00006011|26990005|FG000|Overall Study|Refused further treatment|15|||
13472727|NCT00006011|26990006|FG001|Overall Study|Refused further treatment|13|||
13472728|NCT00006011|26990007|FG002|Overall Study|Refused further treatment|26|||
13472729|NCT00006011|26990005|FG000|Overall Study|Adverse Event|15|||
13472730|NCT00006011|26990006|FG001|Overall Study|Adverse Event|39|||
13472731|NCT00006011|26990007|FG002|Overall Study|Adverse Event|5|||
13472732|NCT00006011|26990005|FG000|Overall Study|Death|0|||
13472733|NCT00006011|26990006|FG001|Overall Study|Death|1|||
13472734|NCT00006011|26990007|FG002|Overall Study|Death|2|||
13472735|NCT00006011|26990005|FG000|Overall Study|Other|4|||
13472736|NCT00006011|26990006|FG001|Overall Study|Other|2|||
13472737|NCT00006011|26990007|FG002|Overall Study|Other|5|||
13472738|NCT00006011|26990005|FG000|Overall Study|Ineligible|18|||
13472739|NCT00006011|26990006|FG001|Overall Study|Ineligible|16|||
13472740|NCT00006011|26990007|FG002|Overall Study|Ineligible|9|||
13472741|NCT00005957|26990022|FG000|Overall Study|No treated|3|||
13472742|NCT00005957|26990023|FG001|Overall Study|No treated|9|||
13472743|NCT00005957|26990022|FG000|Overall Study|Crossover to the other arm|5|||
13472744|NCT00005957|26990023|FG001|Overall Study|Crossover to the other arm|19|||
13472745|NCT00005947|26990038|FG000|Overall Study|Death|54|||
13472746|NCT00005947|26990039|FG001|Overall Study|Death|40|||
13472747|NCT00005947|26990038|FG000|Overall Study|Patient Refused to Continue|2|||
13472748|NCT00005947|26990039|FG001|Overall Study|Patient Refused to Continue|1|||
13472749|NCT00005947|26990038|FG000|Overall Study|Site Closure|1|||
13472750|NCT00005947|26990039|FG001|Overall Study|Site Closure|0|||
13472751|NCT00005937|26990045|FG000|Overall Study|Lack of Efficacy|5|||
13472752|NCT00005908|26990057|FG000|Overall Study|Withdrawal by Subject|1|||
13472753|NCT00005908|26990058|FG001|Overall Study|Withdrawal by Subject|0|||
13472754|NCT00005906|26990066|FG000|Overall Study|Lack of Efficacy|3|||
13472755|NCT00005879|26990081|FG000|Overall Study|Withdrawal by Subject|8|||
13472756|NCT00005879|26990082|FG001|Overall Study|Withdrawal by Subject|10|||
13472757|NCT00005047|26990109|FG000|Overall Study|Withdrawal by Subject|12|||
13472758|NCT00005047|26990110|FG001|Overall Study|Withdrawal by Subject|0|||
13472759|NCT00005047|26990111|FG002|Overall Study|Withdrawal by Subject|0|||
13472760|NCT00005047|26990112|FG003|Overall Study|Withdrawal by Subject|0|||
13472761|NCT00005047|26990109|FG000|Overall Study|Adverse Event|5|||
13472762|NCT00005047|26990110|FG001|Overall Study|Adverse Event|0|||
13472763|NCT00005047|26990111|FG002|Overall Study|Adverse Event|0|||
13472764|NCT00005047|26990112|FG003|Overall Study|Adverse Event|0|||
13472765|NCT00005047|26990109|FG000|Overall Study|Lost to Follow-up|1|||
13472766|NCT00005047|26990110|FG001|Overall Study|Lost to Follow-up|0|||
13472767|NCT00005047|26990111|FG002|Overall Study|Lost to Follow-up|0|||
13472768|NCT00005047|26990112|FG003|Overall Study|Lost to Follow-up|0|||
13472769|NCT00005047|26990109|FG000|Overall Study|Lack of Efficacy|1|||
13472770|NCT00005047|26990110|FG001|Overall Study|Lack of Efficacy|0|||
13472771|NCT00005047|26990111|FG002|Overall Study|Lack of Efficacy|0|||
13472772|NCT00005047|26990112|FG003|Overall Study|Lack of Efficacy|0|||
13472773|NCT00004980|26990131|FG000|Overall Study|Withdrawal by Subject|1|||
13472774|NCT00004980|26990132|FG001|Overall Study|Withdrawal by Subject|0|||
13472775|NCT00004980|26990131|FG000|Overall Study|memory difficulties|1|||
13472776|NCT00004980|26990132|FG001|Overall Study|memory difficulties|1|||
13472777|NCT00004980|26990131|FG000|Overall Study|Physician Decision|0|||
13472778|NCT00004980|26990132|FG001|Overall Study|Physician Decision|1|||
13472779|NCT00004978|26990163|FG000|Overall Study|Death|107|||
13472780|NCT00004978|26990164|FG001|Overall Study|Death|116|||
13472781|NCT00004978|26990163|FG000|Overall Study|Lost to Follow-up|101|||
13472782|NCT00004978|26990164|FG001|Overall Study|Lost to Follow-up|108|||
13472783|NCT00004978|26990163|FG000|Overall Study|Withdrawal by Subject|17|||
13472784|NCT00004978|26990164|FG001|Overall Study|Withdrawal by Subject|26|||
13472785|NCT00004978|26990163|FG000|Overall Study|site closure - not in analysis cohort|19|||
13472786|NCT00004978|26990164|FG001|Overall Study|site closure - not in analysis cohort|20|||
13472787|NCT00004888|26990187|FG000|Overall Study|Adverse Event|5|||
13472788|NCT00004888|26990188|FG001|Overall Study|Adverse Event|10|||
13472789|NCT00004888|26990187|FG000|Overall Study|Withdrawal by Subject|0|||
13472790|NCT00004888|26990188|FG001|Overall Study|Withdrawal by Subject|3|||
13472791|NCT00004888|26990187|FG000|Overall Study|Physician Decision|1|||
13472792|NCT00004888|26990188|FG001|Overall Study|Physician Decision|1|||
13472793|NCT00004888|26990187|FG000|Overall Study|Progressive Disease|4|||
13472794|NCT00004888|26990188|FG001|Overall Study|Progressive Disease|9|||
13472795|NCT00004888|26990187|FG000|Overall Study|Death without progressive disease|0|||
13472796|NCT00004888|26990188|FG001|Overall Study|Death without progressive disease|1|||
13472797|NCT00004888|26990187|FG000|Overall Study|Toxic death|1|||
13472798|NCT00004888|26990188|FG001|Overall Study|Toxic death|0|||
13472799|NCT00004859|26990205|FG000|Overall Study|Lack of Efficacy|43|||
13472800|NCT00004859|26990206|FG001|Overall Study|Lack of Efficacy|113|||
13472801|NCT00004859|26990205|FG000|Overall Study|Adverse Event|31|||
13472802|NCT00004859|26990206|FG001|Overall Study|Adverse Event|93|||
13472803|NCT00004859|26990205|FG000|Overall Study|Death|5|||
13472804|NCT00004859|26990206|FG001|Overall Study|Death|5|||
13472805|NCT00004859|26990205|FG000|Overall Study|Withdrawal by Subject|7|||
13472806|NCT00004859|26990206|FG001|Overall Study|Withdrawal by Subject|33|||
13472807|NCT00004859|26990205|FG000|Overall Study|Protocol Violation|2|||
13472808|NCT00004859|26990206|FG001|Overall Study|Protocol Violation|2|||
13472809|NCT00004859|26990205|FG000|Overall Study|other disease|0|||
13472810|NCT00004859|26990206|FG001|Overall Study|other disease|3|||
13472811|NCT00004859|26990205|FG000|Overall Study|error|3|||
13472812|NCT00004859|26990206|FG001|Overall Study|error|1|||
13472813|NCT00004859|26990205|FG000|Overall Study|missing data|14|||
13472814|NCT00004859|26990206|FG001|Overall Study|missing data|11|||
13472815|NCT00004859|26990205|FG000|Overall Study|Other|13|||
13472816|NCT00004859|26990206|FG001|Overall Study|Other|21|||
13472817|NCT00004732|26990221|FG000|Overall Study|Withdrawal by Subject|36|||
13472818|NCT00004732|26990222|FG001|Overall Study|Withdrawal by Subject|64|||
13472819|NCT00004732|26990221|FG000|Overall Study|Lost to Follow-up|33|||
13472820|NCT00004732|26990222|FG001|Overall Study|Lost to Follow-up|47|||
13472821|NCT00004635|26990239|FG000|Period One|refused|2|||
13472822|NCT00004635|26990240|FG001|Period One|refused|1|||
13472823|NCT00004635|26990239|FG000|Period One|Withdrawal by Subject|1|||
13472824|NCT00004635|26990240|FG001|Period One|Withdrawal by Subject|1|||
13472825|NCT00004635|26990239|FG000|Period One|Protocol Violation|1|||
13472826|NCT00004635|26990240|FG001|Period One|Protocol Violation|0|||
13472827|NCT00004635|26990239|FG000|Period One|PSA did not go <5 ng/mL|1|||
13472828|NCT00004635|26990240|FG001|Period One|PSA did not go <5 ng/mL|0|||
13472829|NCT00004635|26990239|FG000|Period One|second malignancy|1|||
13472830|NCT00004635|26990240|FG001|Period One|second malignancy|0|||
13472831|NCT00004635|26990239|FG000|Period One|progressed|0|||
13472832|NCT00004635|26990240|FG001|Period One|progressed|2|||
13472833|NCT00004635|26990239|FG000|Period One|health problem|0|||
13472834|NCT00004635|26990240|FG001|Period One|health problem|1|||
13472835|NCT00004635|26990239|FG000|Period One|discrepancy in data entry|0|||
13472836|NCT00004635|26990240|FG001|Period One|discrepancy in data entry|1|||
13472837|NCT00004635|26990239|FG000|Period Two|progression|2|||
13472838|NCT00004635|26990240|FG001|Period Two|progression|3|||
13472839|NCT00004635|26990239|FG000|Period Two|Adverse Event|1|||
13472840|NCT00004635|26990240|FG001|Period Two|Adverse Event|0|||
13472841|NCT00004635|26990239|FG000|Period Two|refused|0|||
13472842|NCT00004635|26990240|FG001|Period Two|refused|2|||
13472843|NCT00004635|26990239|FG000|Period Two|health problem|1|||
13472844|NCT00004635|26990240|FG001|Period Two|health problem|1|||
13472845|NCT00004635|26990239|FG000|Period Two|travel issues|0|||
13472846|NCT00004635|26990240|FG001|Period Two|travel issues|1|||
13472847|NCT00004635|26990239|FG000|Period Two|secondary malignancy|1|||
13472848|NCT00004635|26990240|FG001|Period Two|secondary malignancy|1|||
13472849|NCT00004635|26990239|FG000|Period Two|Lost to Follow-up|1|||
13472850|NCT00004635|26990240|FG001|Period Two|Lost to Follow-up|0|||
13472851|NCT00004635|26990239|FG000|Period Two|discrepancy in data entry|0|||
13472852|NCT00004635|26990240|FG001|Period Two|discrepancy in data entry|1|||
13472853|NCT00004563|26990257|FG000|Overall Study|Withdrawal by Subject|20|||
13472854|NCT00004563|26990258|FG001|Overall Study|Withdrawal by Subject|16|||
13472855|NCT00004563|26990257|FG000|Overall Study|Lack of Efficacy|3|||
13472856|NCT00004563|26990258|FG001|Overall Study|Lack of Efficacy|5|||
13472857|NCT00004563|26990257|FG000|Overall Study|Death|2|||
13472858|NCT00004563|26990258|FG001|Overall Study|Death|3|||
13472859|NCT00004562|26990273|FG000|Overall Study|Lost to Follow-up|102|||
13472860|NCT00004562|26990274|FG001|Overall Study|Lost to Follow-up|91|||
13472861|NCT00004412|26990292|FG000|Randomized Period|Moved to Crossover Period|3|||
13472862|NCT00004412|26990293|FG001|Randomized Period|Moved to Crossover Period|0|||
13472863|NCT00004412|26990294|FG002|Randomized Period|Moved to Crossover Period|0|||
13472864|NCT00004259|26990325|FG000|Overall Study|Protocol Violation|1|||
13472865|NCT00004259|26990326|FG001|Overall Study|Protocol Violation|2|||
13472866|NCT00004259|26990327|FG002|Overall Study|Protocol Violation|0|||
13472867|NCT00004259|26990328|FG003|Overall Study|Protocol Violation|0|||
13472868|NCT00004259|26990325|FG000|Overall Study|Withdrawal by Subject|0|||
13472869|NCT00004259|26990326|FG001|Overall Study|Withdrawal by Subject|2|||
13472870|NCT00004259|26990327|FG002|Overall Study|Withdrawal by Subject|0|||
13472871|NCT00004259|26990328|FG003|Overall Study|Withdrawal by Subject|0|||
13472872|NCT00004228|26990373|FG000|Overall Study|Adverse Event|0|||
13472873|NCT00004228|26990374|FG001|Overall Study|Adverse Event|1|||
13472874|NCT00004228|26990375|FG002|Overall Study|Adverse Event|0|||
13472875|NCT00004228|26990376|FG003|Overall Study|Adverse Event|0|||
13472876|NCT00004228|26990377|FG004|Overall Study|Adverse Event|1|||
13472877|NCT00004228|26990378|FG005|Overall Study|Adverse Event|0|||
13472878|NCT00004228|26990379|FG006|Overall Study|Adverse Event|0|||
13472879|NCT00004228|26990373|FG000|Overall Study|Death|0|||
13472880|NCT00004228|26990374|FG001|Overall Study|Death|1|||
13472881|NCT00004228|26990375|FG002|Overall Study|Death|2|||
13472882|NCT00004228|26990376|FG003|Overall Study|Death|0|||
13472883|NCT00004228|26990377|FG004|Overall Study|Death|1|||
13472884|NCT00004228|26990378|FG005|Overall Study|Death|0|||
13472885|NCT00004228|26990379|FG006|Overall Study|Death|0|||
13472886|NCT00004228|26990373|FG000|Overall Study|Lack of Efficacy|1|||
13472887|NCT00004228|26990374|FG001|Overall Study|Lack of Efficacy|6|||
13472888|NCT00004228|26990375|FG002|Overall Study|Lack of Efficacy|5|||
13472889|NCT00004228|26990376|FG003|Overall Study|Lack of Efficacy|3|||
13472890|NCT00004228|26990377|FG004|Overall Study|Lack of Efficacy|9|||
13472891|NCT00004228|26990378|FG005|Overall Study|Lack of Efficacy|8|||
13472892|NCT00004228|26990379|FG006|Overall Study|Lack of Efficacy|4|||
13472893|NCT00004228|26990373|FG000|Overall Study|Lost to Follow-up|0|||
13472894|NCT00004228|26990374|FG001|Overall Study|Lost to Follow-up|0|||
13472895|NCT00004228|26990375|FG002|Overall Study|Lost to Follow-up|1|||
13472896|NCT00004228|26990376|FG003|Overall Study|Lost to Follow-up|0|||
13472897|NCT00004228|26990377|FG004|Overall Study|Lost to Follow-up|0|||
13472898|NCT00004228|26990378|FG005|Overall Study|Lost to Follow-up|0|||
13472899|NCT00004228|26990379|FG006|Overall Study|Lost to Follow-up|0|||
13472900|NCT00004228|26990373|FG000|Overall Study|Physician Decision|1|||
13472901|NCT00004228|26990374|FG001|Overall Study|Physician Decision|0|||
13472902|NCT00004228|26990375|FG002|Overall Study|Physician Decision|3|||
13472903|NCT00004228|26990376|FG003|Overall Study|Physician Decision|2|||
13472904|NCT00004228|26990377|FG004|Overall Study|Physician Decision|1|||
13472905|NCT00004228|26990378|FG005|Overall Study|Physician Decision|1|||
13472906|NCT00004228|26990379|FG006|Overall Study|Physician Decision|1|||
13472907|NCT00004228|26990373|FG000|Overall Study|Protocol Violation|0|||
13472908|NCT00004228|26990374|FG001|Overall Study|Protocol Violation|5|||
13472909|NCT00004228|26990375|FG002|Overall Study|Protocol Violation|2|||
13472910|NCT00004228|26990376|FG003|Overall Study|Protocol Violation|1|||
13472911|NCT00004228|26990377|FG004|Overall Study|Protocol Violation|1|||
13472912|NCT00004228|26990378|FG005|Overall Study|Protocol Violation|2|||
13472913|NCT00004228|26990379|FG006|Overall Study|Protocol Violation|0|||
13472914|NCT00004228|26990373|FG000|Overall Study|Withdrawal by Subject|3|||
13472915|NCT00004228|26990374|FG001|Overall Study|Withdrawal by Subject|0|||
13472916|NCT00004228|26990375|FG002|Overall Study|Withdrawal by Subject|1|||
13472917|NCT00004228|26990376|FG003|Overall Study|Withdrawal by Subject|0|||
13472918|NCT00004228|26990377|FG004|Overall Study|Withdrawal by Subject|2|||
13472919|NCT00004228|26990378|FG005|Overall Study|Withdrawal by Subject|1|||
13472920|NCT00004228|26990379|FG006|Overall Study|Withdrawal by Subject|2|||
13472921|NCT00004228|26990373|FG000|Overall Study|Other|0|||
13472922|NCT00004228|26990374|FG001|Overall Study|Other|0|||
13472923|NCT00004228|26990375|FG002|Overall Study|Other|1|||
13472924|NCT00004228|26990376|FG003|Overall Study|Other|0|||
13472925|NCT00004228|26990377|FG004|Overall Study|Other|0|||
13472926|NCT00004228|26990378|FG005|Overall Study|Other|0|||
13472927|NCT00004228|26990379|FG006|Overall Study|Other|0|||
13472928|NCT00004228|26990373|FG000|Overall Study|ineligible|4|||
13472929|NCT00004228|26990374|FG001|Overall Study|ineligible|2|||
13472930|NCT00004228|26990375|FG002|Overall Study|ineligible|4|||
13472931|NCT00004228|26990376|FG003|Overall Study|ineligible|1|||
13472932|NCT00004228|26990377|FG004|Overall Study|ineligible|1|||
13472933|NCT00004228|26990378|FG005|Overall Study|ineligible|2|||
13472934|NCT00004228|26990379|FG006|Overall Study|ineligible|5|||
13472935|NCT00004088|26990390|FG000|Overall Study|No C2 given due to study on hold by IRB|4|||
13472936|NCT00004088|26990390|FG000|Overall Study|Withdrawal by Subject|1|||
13472937|NCT00004088|26990390|FG000|Overall Study|Protocol Violation|3|||
13472938|NCT00004088|26990390|FG000|Overall Study|Physician Decision|1|||
13472939|NCT00004031|26990407|FG000|Overall Study|Adverse Event|5|||
13472940|NCT00004031|26990408|FG001|Overall Study|Adverse Event|0|||
13472941|NCT00004031|26990407|FG000|Overall Study|Refusal unrelated to adverse events|2|||
13472942|NCT00004031|26990408|FG001|Overall Study|Refusal unrelated to adverse events|11|||
13472943|NCT00004031|26990407|FG000|Overall Study|Progression/relapse|9|||
13472944|NCT00004031|26990408|FG001|Overall Study|Progression/relapse|4|||
13472945|NCT00004031|26990407|FG000|Overall Study|Death|3|||
13472946|NCT00004031|26990408|FG001|Overall Study|Death|1|||
13472947|NCT00004031|26990407|FG000|Overall Study|Other- not protocol specified|3|||
13472948|NCT00004031|26990408|FG001|Overall Study|Other- not protocol specified|3|||
13472949|NCT00004031|26990407|FG000|Overall Study|Reason under review|3|||
13472950|NCT00004031|26990408|FG001|Overall Study|Reason under review|2|||
13472951|NCT00003907|26990425|FG000|Overall Study|Adverse Event|2|||
13472952|NCT00003907|26990426|FG001|Overall Study|Adverse Event|11|||
13472953|NCT00003907|26990425|FG000|Overall Study|Death|2|||
13472954|NCT00003907|26990426|FG001|Overall Study|Death|0|||
13472955|NCT00003907|26990425|FG000|Overall Study|Withdrawal by Subject|1|||
13472956|NCT00003907|26990426|FG001|Overall Study|Withdrawal by Subject|3|||
13472957|NCT00003907|26990425|FG000|Overall Study|Progressive disease|4|||
13472958|NCT00003907|26990426|FG001|Overall Study|Progressive disease|4|||
13472959|NCT00003907|26990425|FG000|Overall Study|Complicating disease|1|||
13472960|NCT00003907|26990426|FG001|Overall Study|Complicating disease|0|||
13472961|NCT00003907|26990425|FG000|Overall Study|Other|1|||
13472962|NCT00003907|26990426|FG001|Overall Study|Other|3|||
13472963|NCT00003907|26990425|FG000|Overall Study|ineligible or not treated|2|||
13472964|NCT00003907|26990426|FG001|Overall Study|ineligible or not treated|2|||
13472965|NCT00003901|26990439|FG000|Overall Study|Adverse Event|1|||
13472966|NCT00003901|26990439|FG000|Overall Study|Withdrawal by Subject|1|||
13472967|NCT00003901|26990439|FG000|Overall Study|Ineligible|6|||
13472968|NCT00003901|26990439|FG000|Overall Study|CT Scan not within protocol requirement|2|||
13472969|NCT00003901|26990439|FG000|Overall Study|Chest X-Ray not done prior registration|1|||
13472970|NCT00003901|26990439|FG000|Overall Study|Medical problems|6|||
13472971|NCT00003896|26990447|FG000|Overall Study|Adverse Event|16|||
13472972|NCT00003896|26990447|FG000|Overall Study|Withdrawal by Subject|1|||
13472973|NCT00003896|26990447|FG000|Overall Study|Lack of Efficacy|1|||
13472974|NCT00003896|26990447|FG000|Overall Study|Death|3|||
13472975|NCT00003896|26990447|FG000|Overall Study|not protocol specified|3|||
13472976|NCT00003896|26990447|FG000|Overall Study|ineligible|5|||
13472977|NCT00003895|26990460|FG000|Overall Study|Adverse Event|4|||
13472978|NCT00003895|26990461|FG001|Overall Study|Adverse Event|0|||
13472979|NCT00003895|26990460|FG000|Overall Study|Lack of Efficacy|1|||
13472980|NCT00003895|26990461|FG001|Overall Study|Lack of Efficacy|1|||
13472981|NCT00003895|26990460|FG000|Overall Study|Patient Vacation|2|||
13472982|NCT00003895|26990461|FG001|Overall Study|Patient Vacation|0|||
13472983|NCT00003895|26990460|FG000|Overall Study|Withdrawal by Subject|0|||
13472984|NCT00003895|26990461|FG001|Overall Study|Withdrawal by Subject|3|||
13472985|NCT00003875|26990470|FG000|Overall Study|Screen Failed|1|||
13472986|NCT00003869|26990493|FG000|Overall Study|Adverse Event|14|||
13472987|NCT00003869|26990494|FG001|Overall Study|Adverse Event|3|||
13472988|NCT00003869|26990493|FG000|Overall Study|Withdrawal by Subject|21|||
13472989|NCT00003869|26990494|FG001|Overall Study|Withdrawal by Subject|3|||
13472990|NCT00003869|26990493|FG000|Overall Study|Death|1|||
13472991|NCT00003869|26990494|FG001|Overall Study|Death|2|||
13472992|NCT00003869|26990493|FG000|Overall Study|Alternative treatmnt, medical problems|5|||
13472993|NCT00003869|26990494|FG001|Overall Study|Alternative treatmnt, medical problems|4|||
13472994|NCT00003830|26990525|FG000|Overall Study|No follow up data|3|||
13472995|NCT00003830|26990526|FG001|Overall Study|No follow up data|0|||
13472996|NCT00003830|26990525|FG000|Overall Study|Sentinel node positive patients|829|||
13472997|NCT00003830|26990526|FG001|Overall Study|Sentinel node positive patients|793|||
13472998|NCT00003782|26990544|FG000|Overall Study|No follow up data|30|||
13472999|NCT00003782|26990545|FG001|Overall Study|No follow up data|31|||
13473000|NCT00003782|26990546|FG002|Overall Study|No follow up data|26|||
13473001|NCT00003702|26990562|FG000|Overall Study|Ineligible cell types|2|||
13473002|NCT00003702|26990563|FG001|Overall Study|Ineligible cell types|2|||
13473003|NCT00003702|26990562|FG000|Overall Study|Did not meet criteria for persistence|8|||
13473004|NCT00003702|26990563|FG001|Overall Study|Did not meet criteria for persistence|5|||
13473005|NCT00003702|26990562|FG000|Overall Study|WHO score > 6|2|||
13473006|NCT00003702|26990563|FG001|Overall Study|WHO score > 6|1|||
13473007|NCT00003702|26990562|FG000|Overall Study|Inadequate documentation of disease|1|||
13473008|NCT00003702|26990563|FG001|Overall Study|Inadequate documentation of disease|3|||
13473009|NCT00003659|26990571|FG000|Overall Study|Withdrawal by Subject|3|||
13473010|NCT00003656|26990589|FG000|Overall Study|Adverse Event|0|||
13473011|NCT00003656|26990590|FG001|Overall Study|Adverse Event|1|||
13473012|NCT00003645|26990609|FG000|Overall Study|Death|4|||
13473013|NCT00003645|26990610|FG001|Overall Study|Death|1|||
13473014|NCT00003645|26990609|FG000|Overall Study|Lost to Follow-up|7|||
13473015|NCT00003645|26990610|FG001|Overall Study|Lost to Follow-up|8|||
13473016|NCT00003645|26990609|FG000|Overall Study|Withdrawal by Subject|1|||
13473017|NCT00003645|26990610|FG001|Overall Study|Withdrawal by Subject|3|||
13473018|NCT00003631|26990628|FG000|Overall Study|Patient not treated|1|||
13473019|NCT00003631|26990629|FG001|Overall Study|Patient not treated|0|||
13473020|NCT00003631|26990630|FG002|Overall Study|Patient not treated|1|||
13473021|NCT00003631|26990628|FG000|Overall Study|Protocol Violation|1|||
13473022|NCT00003631|26990629|FG001|Overall Study|Protocol Violation|0|||
13473023|NCT00003631|26990630|FG002|Overall Study|Protocol Violation|0|||
13473024|NCT00003631|26990628|FG000|Overall Study|Adverse Event|1|||
13473025|NCT00003631|26990629|FG001|Overall Study|Adverse Event|1|||
13473026|NCT00003631|26990630|FG002|Overall Study|Adverse Event|5|||
13473027|NCT00003631|26990628|FG000|Overall Study|Death|0|||
13473028|NCT00003631|26990629|FG001|Overall Study|Death|0|||
13473029|NCT00003631|26990630|FG002|Overall Study|Death|1|||
13473030|NCT00003631|26990628|FG000|Overall Study|Evaluable for toxicity only|0|||
13473031|NCT00003631|26990629|FG001|Overall Study|Evaluable for toxicity only|0|||
13473032|NCT00003631|26990630|FG002|Overall Study|Evaluable for toxicity only|2|||
13473033|NCT00003590|26990637|FG000|Overall Study|Ineligible Patient|1|||
13473034|NCT00003590|26990637|FG000|Overall Study|Adverse Event|7|||
13473035|NCT00003590|26990637|FG000|Overall Study|Withdrawal by Subject|1|||
13473036|NCT00003590|26990637|FG000|Overall Study|Lack of Efficacy|11|||
13473037|NCT00003590|26990637|FG000|Overall Study|Death|1|||
13473038|NCT00003590|26990637|FG000|Overall Study|Physician Decision|1|||
13473039|NCT00003537|26990644|FG000|Overall Study|Not evalauable|1|||
13473040|NCT00003535|26990651|FG000|Overall Study|Not evaluable|5|||
13473041|NCT00003531|26990657|FG000|Overall Study|Not evaluable|10|||
13473042|NCT00003526|26990663|FG000|Overall Study|Not evaluable|6|||
13473043|NCT00003511|26990669|FG000|Overall Study|Not evaluable|4|||
13473044|NCT00003509|26990675|FG000|Overall Study|Not evaluable|5|||
13473045|NCT00003508|26990681|FG000|Overall Study|Not evaluable|5|||
13473046|NCT00003499|26990688|FG000|Overall Study|Not evaluable|8|||
13473047|NCT00003498|26990694|FG000|Overall Study|Not evaluable.|4|||
13473048|NCT00003492|26990700|FG000|Overall Study|Not evaluable|6|||
13473049|NCT00003487|26990706|FG000|Overall Study|Not evaluable|2|||
13473050|NCT00003483|26990713|FG000|Overall Study|Not evaluable|1|||
13473051|NCT00003477|26990720|FG000|Overall Study|Not evalauable|4|||
13473052|NCT00003476|26990727|FG000|Overall Study|Not evaluable|1|||
13473053|NCT00003475|26990734|FG000|Overall Study|Not evaluable|13|||
13473054|NCT00003474|26990741|FG000|Overall Study|Not Evaluable|14|||
13473055|NCT00003473|26990748|FG000|Overall Study|Three patients were not evaluable.|3|||
13473056|NCT00003472|26990755|FG000|Overall Study|Not evaluable|3|||
13473057|NCT00003471|26990762|FG000|Overall Study|Not evaluable|4|||
13473058|NCT00003470|26990769|FG000|Overall Study|Not evaluable|6|||
13473059|NCT00003457|26990776|FG000|Overall Study|Not evaluable|9|||
13473060|NCT00003456|26990783|FG000|Overall Study|Not evaluable|8|||
13473061|NCT00003389|26990800|FG000|Overall Study|Disease progression|6|||
13473062|NCT00003389|26990801|FG001|Overall Study|Disease progression|1|||
13473063|NCT00003389|26990800|FG000|Overall Study|Adverse Event|13|||
13473064|NCT00003389|26990801|FG001|Overall Study|Adverse Event|2|||
13473065|NCT00003389|26990800|FG000|Overall Study|Death|0|||
13473066|NCT00003389|26990801|FG001|Overall Study|Death|3|||
13473067|NCT00003389|26990800|FG000|Overall Study|Withdrawal by Subject|12|||
13473068|NCT00003389|26990801|FG001|Overall Study|Withdrawal by Subject|5|||
13473069|NCT00003389|26990800|FG000|Overall Study|Alternative therapy|2|||
13473070|NCT00003389|26990801|FG001|Overall Study|Alternative therapy|1|||
13473071|NCT00003389|26990800|FG000|Overall Study|Complicating disease|1|||
13473072|NCT00003389|26990801|FG001|Overall Study|Complicating disease|0|||
13473073|NCT00003389|26990800|FG000|Overall Study|Off-treatment reason missing|31|||
13473074|NCT00003389|26990801|FG001|Overall Study|Off-treatment reason missing|21|||
13473075|NCT00003389|26990800|FG000|Overall Study|Ineligible|33|||
13473076|NCT00003389|26990801|FG001|Overall Study|Ineligible|27|||
13473077|NCT00003377|26990831|FG000|Period I|Dose Limiting Toxicity(DLT)|0|||
13473078|NCT00003377|26990832|FG001|Period I|Dose Limiting Toxicity(DLT)|0|||
13473079|NCT00003377|26990833|FG002|Period I|Dose Limiting Toxicity(DLT)|1|||
13473080|NCT00003377|26990834|FG003|Period I|Dose Limiting Toxicity(DLT)|1|||
13473081|NCT00003377|26990835|FG004|Period I|Dose Limiting Toxicity(DLT)|0|||
13473082|NCT00003377|26990831|FG000|Period II|Ureteral stent complications|0|||
13473083|NCT00003377|26990832|FG001|Period II|Ureteral stent complications|0|||
13473084|NCT00003377|26990833|FG002|Period II|Ureteral stent complications|0|||
13473085|NCT00003377|26990834|FG003|Period II|Ureteral stent complications|0|||
13473086|NCT00003377|26990835|FG004|Period II|Ureteral stent complications|1|||
13473087|NCT00003298|26990845|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1|||
13473088|NCT00003298|26990845|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3|||
13473089|NCT00003298|26990845|FG000|Surgery|Unresectable at surgery|3|||
13473090|NCT00003298|26990845|FG000|Surgery|Progression before surgery|2|||
13473091|NCT00003298|26990845|FG000|Surgery|Unevaluable and off study|2|||
13473092|NCT00003298|26990845|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7|||
13473093|NCT00003298|26990845|FG000|Re-register to Step 2 After Surgery|Positive margins|5|||
13473094|NCT00003298|26990845|FG000|Re-register to Step 2 After Surgery|Other complications|2|||
13473095|NCT00003298|26990845|FG000|Re-register to Step 2 After Surgery|Reason unknown|1|||
13473096|NCT00003298|26990845|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3|||
13473097|NCT00003298|26990845|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1|||
13473098|NCT00003298|26990845|FG000|Step 2 (Adjuvant Therapy)|Death|1|||
13473099|NCT00003298|26990845|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1|||
13473100|NCT00003298|26990845|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1|||
13473101|NCT00003298|26990845|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2|||
13473102|NCT00003222|26990862|FG000|Overall Study|Physician Decision|0|||
13473103|NCT00003222|26990863|FG001|Overall Study|Physician Decision|1|||
13473104|NCT00003199|26990871|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5|||
13473105|NCT00003199|26990871|FG000|Overall Study|Lack of insurance clearance|2|||
13473106|NCT00003199|26990871|FG000|Overall Study|Screen fail|15|||
13473107|NCT00003138|26990891|FG000|Step 1|Reasons off treatment not documented|60|||
13473108|NCT00003138|26990892|FG001|Step 1|Reasons off treatment not documented|57|||
13473109|NCT00003138|26990891|FG000|Step 1|Never started treatment|1|||
13473110|NCT00003138|26990892|FG001|Step 1|Never started treatment|0|||
13473111|NCT00003138|26990891|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26|||
13473112|NCT00003138|26990892|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0|||
13473113|NCT00003138|26990891|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12|||
13473114|NCT00003138|26990892|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19|||
13473115|NCT00003138|26990891|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0|||
13473116|NCT00003138|26990892|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1|||
13473117|NCT00003138|26990891|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6|||
13473118|NCT00003138|26990892|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7|||
13473119|NCT00003102|26990919|FG000|Overall Study|Physician Decision|1|||
13473120|NCT00003102|26990920|FG001|Overall Study|Physician Decision|1|||
13473121|NCT00003102|26990921|FG002|Overall Study|Physician Decision|0|||
13473122|NCT00003102|26990919|FG000|Overall Study|Progressive Disease|0|||
13473123|NCT00003102|26990920|FG001|Overall Study|Progressive Disease|1|||
13473124|NCT00003102|26990921|FG002|Overall Study|Progressive Disease|0|||
13473125|NCT00003102|26990919|FG000|Overall Study|Adverse Event|0|||
13473126|NCT00003102|26990920|FG001|Overall Study|Adverse Event|1|||
13473127|NCT00003102|26990921|FG002|Overall Study|Adverse Event|1|||
13473128|NCT00003102|26990919|FG000|Overall Study|Death|0|||
13473129|NCT00003102|26990920|FG001|Overall Study|Death|0|||
13473130|NCT00003102|26990921|FG002|Overall Study|Death|1|||
13473131|NCT00002931|26990929|FG000|Overall Study|rapidly progressing disease during|2|||
13473132|NCT00002850|26990947|FG000|Overall Study|Death|4|||
13473133|NCT00002850|26990948|FG001|Overall Study|Death|1|||
13473134|NCT00002850|26990949|FG002|Overall Study|Death|3|||
13473135|NCT00002850|26990947|FG000|Overall Study|Protocol Violation|1|||
13473136|NCT00002850|26990948|FG001|Overall Study|Protocol Violation|0|||
13473137|NCT00002850|26990949|FG002|Overall Study|Protocol Violation|1|||
13473138|NCT00002850|26990947|FG000|Overall Study|Withdrawal by Subject|0|||
13473139|NCT00002850|26990948|FG001|Overall Study|Withdrawal by Subject|1|||
13473140|NCT00002850|26990949|FG002|Overall Study|Withdrawal by Subject|0|||
13473141|NCT00002842|26990955|FG000|Overall Study|ineligible for surgical resection|27|||
13473142|NCT00002766|26990968|FG000|Overall Study|Withdrawal by Subject|0|||
13473143|NCT00002766|26990969|FG001|Overall Study|Withdrawal by Subject|1|||
13473144|NCT00002766|26990968|FG000|Overall Study|Patient Not Treated|1|||
13473145|NCT00002766|26990969|FG001|Overall Study|Patient Not Treated|2|||
13473146|NCT00002766|26990968|FG000|Overall Study|Adverse Event|1|||
13473147|NCT00002766|26990969|FG001|Overall Study|Adverse Event|1|||
13473148|NCT00002766|26990968|FG000|Overall Study|Protocol Violation|1|||
13473149|NCT00002766|26990969|FG001|Overall Study|Protocol Violation|0|||
13473150|NCT00002651|26990993|FG000|Induction|Adverse Event|44|||
13473151|NCT00002651|26990994|FG001|Induction|Adverse Event|0|||
13473152|NCT00002651|26990995|FG002|Induction|Adverse Event|0|||
13473153|NCT00002651|26990993|FG000|Induction|Refusal unrelated to adverse event|50|||
13473154|NCT00002651|26990994|FG001|Induction|Refusal unrelated to adverse event|0|||
13473155|NCT00002651|26990995|FG002|Induction|Refusal unrelated to adverse event|0|||
13473156|NCT00002651|26990993|FG000|Induction|Progression/relapse|274|||
13473157|NCT00002651|26990994|FG001|Induction|Progression/relapse|0|||
13473158|NCT00002651|26990995|FG002|Induction|Progression/relapse|0|||
13473159|NCT00002651|26990993|FG000|Induction|Death|62|||
13473160|NCT00002651|26990994|FG001|Induction|Death|0|||
13473161|NCT00002651|26990995|FG002|Induction|Death|0|||
13473162|NCT00002651|26990993|FG000|Induction|Other|823|||
13473163|NCT00002651|26990994|FG001|Induction|Other|0|||
13473164|NCT00002651|26990995|FG002|Induction|Other|0|||
13473165|NCT00002651|26990993|FG000|Induction|not eligible|90|||
13473166|NCT00002651|26990994|FG001|Induction|not eligible|0|||
13473167|NCT00002651|26990995|FG002|Induction|not eligible|0|||
13473168|NCT00002651|26990993|FG000|Consolidation and Randomization|Adverse Event|0|||
13473169|NCT00002651|26990994|FG001|Consolidation and Randomization|Adverse Event|36|||
13473170|NCT00002651|26990995|FG002|Consolidation and Randomization|Adverse Event|14|||
13473171|NCT00002651|26990993|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0|||
13473172|NCT00002651|26990994|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53|||
13473173|NCT00002651|26990995|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75|||
13473174|NCT00002651|26990993|FG000|Consolidation and Randomization|Progression/relapse|0|||
13473175|NCT00002651|26990994|FG001|Consolidation and Randomization|Progression/relapse|295|||
13473176|NCT00002651|26990995|FG002|Consolidation and Randomization|Progression/relapse|298|||
13473177|NCT00002651|26990993|FG000|Consolidation and Randomization|Death|0|||
13473178|NCT00002651|26990994|FG001|Consolidation and Randomization|Death|38|||
13473179|NCT00002651|26990995|FG002|Consolidation and Randomization|Death|48|||
13473180|NCT00002651|26990993|FG000|Consolidation and Randomization|Other|0|||
13473181|NCT00002651|26990994|FG001|Consolidation and Randomization|Other|314|||
13473182|NCT00002651|26990995|FG002|Consolidation and Randomization|Other|313|||
13473183|NCT00002651|26990993|FG000|Consolidation and Randomization|not eligible|0|||
13473184|NCT00002651|26990994|FG001|Consolidation and Randomization|not eligible|102|||
13473185|NCT00002651|26990995|FG002|Consolidation and Randomization|not eligible|112|||
13473186|NCT00002597|26991024|FG000|Overall Study|Protocol Violation|19|||
13473187|NCT00002597|26991025|FG001|Overall Study|Protocol Violation|17|||
13473188|NCT00002597|26991024|FG000|Overall Study|Withdrawal by Subject|7|||
13473189|NCT00002597|26991025|FG001|Overall Study|Withdrawal by Subject|6|||
13473190|NCT00002558|26991038|FG000|Overall Study|Withdrawal by Subject|0|||
13473191|NCT00002558|26991039|FG001|Overall Study|Withdrawal by Subject|1|||
13473192|NCT00002540|26991072|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0|||
13473193|NCT00002540|26991073|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25|||
13473194|NCT00002540|26991072|FG000|Overall Study|Died Before Randomization|2|||
13473195|NCT00002540|26991073|FG001|Overall Study|Died Before Randomization|6|||
13473196|NCT00002540|26991072|FG000|Overall Study|Died Before ASU (Control)|202|||
13473197|NCT00002540|26991073|FG001|Overall Study|Died Before ASU (Control)|0|||
13473198|NCT00002540|26991072|FG000|Overall Study|Refused ASU (Control)|597|||
13473199|NCT00002540|26991073|FG001|Overall Study|Refused ASU (Control)|0|||
13473200|NCT00002540|26991072|FG000|Overall Study|Refused Screen (Prostate Screening)|0|||
13473201|NCT00002540|26991073|FG001|Overall Study|Refused Screen (Prostate Screening)|2433|||
13473202|NCT00002525|26991094|FG000|Overall Study|Adverse Event|36|||
13473203|NCT00002525|26991095|FG001|Overall Study|Adverse Event|0|||
13473204|NCT00002525|26991094|FG000|Overall Study|Death|5|||
13473205|NCT00002525|26991095|FG001|Overall Study|Death|0|||
13473206|NCT00002525|26991094|FG000|Overall Study|Withdrawal by Subject|11|||
13473207|NCT00002525|26991095|FG001|Overall Study|Withdrawal by Subject|0|||
13473208|NCT00002525|26991094|FG000|Overall Study|Start non-protocol therapy|1|||
13473209|NCT00002525|26991095|FG001|Overall Study|Start non-protocol therapy|0|||
13473210|NCT00002525|26991094|FG000|Overall Study|Other complicating disease|1|||
13473211|NCT00002525|26991095|FG001|Overall Study|Other complicating disease|0|||
13473212|NCT00002525|26991094|FG000|Overall Study|Duke's A, B1, D disease|92|||
13473213|NCT00002525|26991095|FG001|Overall Study|Duke's A, B1, D disease|0|||
13473214|NCT00002525|26991094|FG000|Overall Study|Error|6|||
13473215|NCT00002525|26991095|FG001|Overall Study|Error|0|||
13473216|NCT00002525|26991094|FG000|Overall Study|Other|26|||
13473217|NCT00002525|26991095|FG001|Overall Study|Other|0|||
13473218|NCT00002525|26991094|FG000|Overall Study|Never start protocol therapy|8|||
13473219|NCT00002525|26991095|FG001|Overall Study|Never start protocol therapy|0|||
13473220|NCT00001962|26991103|FG000|Overall Study|Lack of Efficacy|18|||
13473221|NCT00001962|26991103|FG000|Overall Study|Lack of Accrual|6|||
13473222|NCT00001962|26991103|FG000|Overall Study|Death|1|||
13473223|NCT00001962|26991103|FG000|Overall Study|Lost to Follow-up|2|||
13473224|NCT00001962|26991103|FG000|Overall Study|Adverse Event|1|||
13473225|NCT00001959|26991111|FG000|Overall Study|newly diagnosed colon cancer|1|||
13473226|NCT00001959|26991111|FG000|Overall Study|disabling sedation|1|||
13473227|NCT00001959|26991111|FG000|Overall Study|non-compliance|1|||
13473228|NCT00001941|26991124|FG000|Overall Study|not treated- rapidly progressing disease|0|||
13473229|NCT00001941|26991125|FG001|Overall Study|not treated- rapidly progressing disease|0|||
13473230|NCT00001941|26991126|FG002|Overall Study|not treated- rapidly progressing disease|0|||
13473231|NCT00001941|26991127|FG003|Overall Study|not treated- rapidly progressing disease|0|||
13473232|NCT00001941|26991128|FG004|Overall Study|not treated- rapidly progressing disease|1|||
13473233|NCT00001880|26991138|FG000|Overall Study|Death|14|||
13473234|NCT00001849|26991155|FG000|Overall Study|Death|4|||
13473235|NCT00001849|26991155|FG000|Overall Study|Lost to Follow-up|2|||
13473236|NCT00001849|26991155|FG000|Overall Study|Withdrawal by Subject|2|||
13473237|NCT00001849|26991155|FG000|Overall Study|tumor remained occult|6|||
13473238|NCT03616964|26991215|FG000|Overall Study|Adverse Event|15|||
13473239|NCT03616964|26991216|FG001|Overall Study|Adverse Event|10|||
13473240|NCT03616964|26991217|FG002|Overall Study|Adverse Event|16|||
13473241|NCT03616964|26991215|FG000|Overall Study|Death|3|||
13473242|NCT03616964|26991216|FG001|Overall Study|Death|0|||
13473243|NCT03616964|26991217|FG002|Overall Study|Death|4|||
13473244|NCT03616964|26991215|FG000|Overall Study|Lack of Efficacy|4|||
13473245|NCT03616964|26991216|FG001|Overall Study|Lack of Efficacy|8|||
13473246|NCT03616964|26991217|FG002|Overall Study|Lack of Efficacy|8|||
13473247|NCT03616964|26991215|FG000|Overall Study|Lost to Follow-up|2|||
13473248|NCT03616964|26991216|FG001|Overall Study|Lost to Follow-up|1|||
13473249|NCT03616964|26991217|FG002|Overall Study|Lost to Follow-up|3|||
13473250|NCT03616964|26991215|FG000|Overall Study|Withdrawal by Subject|18|||
13473251|NCT03616964|26991216|FG001|Overall Study|Withdrawal by Subject|14|||
13473252|NCT03616964|26991217|FG002|Overall Study|Withdrawal by Subject|21|||
13473253|NCT03616964|26991215|FG000|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
13473254|NCT03616964|26991216|FG001|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
13473255|NCT03616964|26991217|FG002|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
13473256|NCT03616964|26991215|FG000|Overall Study|Sponsor's Decision|1|||
13473257|NCT03616964|26991216|FG001|Overall Study|Sponsor's Decision|0|||
13473258|NCT03616964|26991217|FG002|Overall Study|Sponsor's Decision|0|||
13473259|NCT03616964|26991215|FG000|Overall Study|Physician Decision|0|||
13473260|NCT03616964|26991216|FG001|Overall Study|Physician Decision|2|||
13473261|NCT03616964|26991217|FG002|Overall Study|Physician Decision|0|||
13473262|NCT03616964|26991215|FG000|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
13473263|NCT03616964|26991216|FG001|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|1|||
13473264|NCT03616964|26991217|FG002|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
13473265|NCT03616964|26991215|FG000|Overall Study|Protocol Violation|0|||
13473266|NCT03616964|26991216|FG001|Overall Study|Protocol Violation|1|||
13473267|NCT03616964|26991217|FG002|Overall Study|Protocol Violation|0|||
13473268|NCT03616964|26991215|FG000|Overall Study|Due to Epidemic/Pandemic|0|||
13473269|NCT03616964|26991216|FG001|Overall Study|Due to Epidemic/Pandemic|1|||
13473270|NCT03616964|26991217|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
13473271|NCT03616964|26991215|FG000|Overall Study|Randomized but Never Treated|1|||
13473272|NCT03616964|26991216|FG001|Overall Study|Randomized but Never Treated|1|||
13473273|NCT03616964|26991217|FG002|Overall Study|Randomized but Never Treated|1|||
13473274|NCT03345849|26991260|FG000|Part 1: Induction Period (Weeks 1-12)|Adverse Event|8|||
13473275|NCT03345849|26991261|FG001|Part 1: Induction Period (Weeks 1-12)|Adverse Event|12|||
13473276|NCT03345849|26991262|FG002|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
13473277|NCT03345849|26991263|FG003|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
13473278|NCT03345849|26991260|FG000|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|6|||
13473279|NCT03345849|26991261|FG001|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|3|||
13473280|NCT03345849|26991262|FG002|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
13473281|NCT03345849|26991263|FG003|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
13473282|NCT03345849|26991260|FG000|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
13473283|NCT03345849|26991261|FG001|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|1|||
13473284|NCT03345849|26991262|FG002|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
13473285|NCT03345849|26991263|FG003|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
13473286|NCT03345849|26991260|FG000|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|8|||
13473287|NCT03345849|26991261|FG001|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|3|||
13473288|NCT03345849|26991262|FG002|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
13473289|NCT03345849|26991263|FG003|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
13473290|NCT03345849|26991260|FG000|Part 1: Induction Period (Weeks 1-12)|Other|0|||
13473291|NCT03345849|26991261|FG001|Part 1: Induction Period (Weeks 1-12)|Other|1|||
13473292|NCT03345849|26991262|FG002|Part 1: Induction Period (Weeks 1-12)|Other|0|||
13473293|NCT03345849|26991263|FG003|Part 1: Induction Period (Weeks 1-12)|Other|0|||
13473294|NCT03345849|26991260|FG000|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
13473295|NCT03345849|26991261|FG001|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
13473296|NCT03345849|26991262|FG002|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
13473297|NCT03345849|26991263|FG003|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
13473298|NCT03345849|26991260|FG000|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
13473299|NCT03345849|26991261|FG001|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
13473300|NCT03345849|26991262|FG002|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|3|||
13473301|NCT03345849|26991263|FG003|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|1|||
13473302|NCT03345849|26991260|FG000|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
13473303|NCT03345849|26991261|FG001|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
13473304|NCT03345849|26991262|FG002|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|1|||
13473305|NCT03345849|26991263|FG003|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|5|||
13473306|NCT03345849|26991260|FG000|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
13473307|NCT03345849|26991261|FG001|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
13473308|NCT03345849|26991262|FG002|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
13473309|NCT03345849|26991263|FG003|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|1|||
13473310|NCT03345849|26991260|FG000|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
13473311|NCT03345849|26991261|FG001|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
13473312|NCT03345849|26991262|FG002|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|1|||
13473313|NCT03345849|26991263|FG003|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
13473314|NCT03345849|26991260|FG000|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
13473315|NCT03345849|26991261|FG001|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
13473316|NCT03345849|26991262|FG002|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
13473317|NCT03345849|26991263|FG003|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
13473318|NCT03187262|26991274|FG000|Induction|Lack of Efficacy|2|||
13473319|NCT03187262|26991274|FG000|Induction|Progressive Disease|4|||
13473320|NCT03187262|26991274|FG000|Consolidation|Progressive Disease|5|||
13473321|NCT03011307|26991307|FG000|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|3|||
13473322|NCT03011307|26991308|FG001|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|2|||
13473323|NCT03011307|26991307|FG000|Overall Study|Did not receive study drug: unable to place spinal needle|2|||
13473324|NCT03011307|26991308|FG001|Overall Study|Did not receive study drug: unable to place spinal needle|0|||
13473325|NCT03011307|26991307|FG000|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|1|||
13473326|NCT03011307|26991308|FG001|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|0|||
13473327|NCT02951052|26991479|FG000|Overall Study|Adverse Event|13|||
13473328|NCT02951052|26991480|FG001|Overall Study|Adverse Event|5|||
13473329|NCT02951052|26991479|FG000|Overall Study|Withdrawal by Subject|1|||
13473330|NCT02951052|26991480|FG001|Overall Study|Withdrawal by Subject|5|||
13473331|NCT02951052|26991479|FG000|Overall Study|Physician Decision|2|||
13473332|NCT02951052|26991480|FG001|Overall Study|Physician Decision|0|||
13473333|NCT02951052|26991479|FG000|Overall Study|Lost to Follow-up|1|||
13473334|NCT02951052|26991480|FG001|Overall Study|Lost to Follow-up|1|||
13473335|NCT02951052|26991479|FG000|Overall Study|Protocol-specified withdrawal criterion|1|||
13473336|NCT02951052|26991480|FG001|Overall Study|Protocol-specified withdrawal criterion|0|||
13473337|NCT02951052|26991479|FG000|Overall Study|Protocol Violation|5|||
13473338|NCT02951052|26991480|FG001|Overall Study|Protocol Violation|3|||
13473339|NCT02951052|26991479|FG000|Overall Study|Lack of Efficacy|3|||
13473340|NCT02951052|26991480|FG001|Overall Study|Lack of Efficacy|4|||
13473341|NCT02951052|26991479|FG000|Overall Study|Ongoing|1|||
13473342|NCT02951052|26991480|FG001|Overall Study|Ongoing|0|||
13473343|NCT02603809|26991555|FG000|Overall Study|Withdrawal by Subject|4|||
13473344|NCT02603809|26991556|FG001|Overall Study|Withdrawal by Subject|1|||
13473345|NCT02603809|26991557|FG002|Overall Study|Withdrawal by Subject|2|||
13473346|NCT02603809|26991558|FG003|Overall Study|Withdrawal by Subject|3|||
13473347|NCT02603809|26991559|FG004|Overall Study|Withdrawal by Subject|3|||
13473348|NCT02603809|26991560|FG005|Overall Study|Withdrawal by Subject|4|||
13473349|NCT02603809|26991555|FG000|Overall Study|Lost to Follow-up|2|||
13473350|NCT02603809|26991556|FG001|Overall Study|Lost to Follow-up|3|||
13473351|NCT02603809|26991557|FG002|Overall Study|Lost to Follow-up|1|||
13473352|NCT02603809|26991558|FG003|Overall Study|Lost to Follow-up|4|||
13473353|NCT02603809|26991559|FG004|Overall Study|Lost to Follow-up|2|||
13473354|NCT02603809|26991560|FG005|Overall Study|Lost to Follow-up|2|||
13473355|NCT02603809|26991555|FG000|Overall Study|Pre-specified discontinuation criteria|3|||
13473356|NCT02603809|26991556|FG001|Overall Study|Pre-specified discontinuation criteria|3|||
13473357|NCT02603809|26991557|FG002|Overall Study|Pre-specified discontinuation criteria|2|||
13473358|NCT02603809|26991558|FG003|Overall Study|Pre-specified discontinuation criteria|2|||
13473359|NCT02603809|26991559|FG004|Overall Study|Pre-specified discontinuation criteria|3|||
13473360|NCT02603809|26991560|FG005|Overall Study|Pre-specified discontinuation criteria|1|||
13473361|NCT02603809|26991555|FG000|Overall Study|Physician Decision|0|||
13473362|NCT02603809|26991556|FG001|Overall Study|Physician Decision|0|||
13473363|NCT02603809|26991557|FG002|Overall Study|Physician Decision|0|||
13473364|NCT02603809|26991558|FG003|Overall Study|Physician Decision|1|||
13473365|NCT02603809|26991559|FG004|Overall Study|Physician Decision|2|||
13473366|NCT02603809|26991560|FG005|Overall Study|Physician Decision|1|||
13473367|NCT02603809|26991555|FG000|Overall Study|Adverse Event|3|||
13473368|NCT02603809|26991556|FG001|Overall Study|Adverse Event|0|||
13473369|NCT02603809|26991557|FG002|Overall Study|Adverse Event|2|||
13473370|NCT02603809|26991558|FG003|Overall Study|Adverse Event|2|||
13473371|NCT02603809|26991559|FG004|Overall Study|Adverse Event|1|||
13473372|NCT02603809|26991560|FG005|Overall Study|Adverse Event|1|||
13473373|NCT02603809|26991555|FG000|Overall Study|Lack of Efficacy|0|||
13473374|NCT02603809|26991556|FG001|Overall Study|Lack of Efficacy|1|||
13473375|NCT02603809|26991557|FG002|Overall Study|Lack of Efficacy|0|||
13473376|NCT02603809|26991558|FG003|Overall Study|Lack of Efficacy|0|||
13473377|NCT02603809|26991559|FG004|Overall Study|Lack of Efficacy|0|||
13473378|NCT02603809|26991560|FG005|Overall Study|Lack of Efficacy|1|||
13473379|NCT02492711|26991597|FG000|Overall Study|Adverse Event|9|||
13473380|NCT02492711|26991598|FG001|Overall Study|Adverse Event|9|||
13473381|NCT02492711|26991599|FG002|Overall Study|Adverse Event|2|||
13473382|NCT02492711|26991597|FG000|Overall Study|Death|3|||
13473383|NCT02492711|26991598|FG001|Overall Study|Death|3|||
13473384|NCT02492711|26991599|FG002|Overall Study|Death|0|||
13473385|NCT02492711|26991597|FG000|Overall Study|Withdrawal by Subject|10|||
13473386|NCT02492711|26991598|FG001|Overall Study|Withdrawal by Subject|16|||
13473387|NCT02492711|26991599|FG002|Overall Study|Withdrawal by Subject|5|||
13473388|NCT02492711|26991597|FG000|Overall Study|Physician Decision|10|||
13473389|NCT02492711|26991598|FG001|Overall Study|Physician Decision|6|||
13473390|NCT02492711|26991599|FG002|Overall Study|Physician Decision|4|||
13473391|NCT02492711|26991597|FG000|Overall Study|Lost to Follow-up|0|||
13473392|NCT02492711|26991598|FG001|Overall Study|Lost to Follow-up|0|||
13473393|NCT02492711|26991599|FG002|Overall Study|Lost to Follow-up|1|||
13473394|NCT02492711|26991597|FG000|Overall Study|study treatment delay|2|||
13473395|NCT02492711|26991598|FG001|Overall Study|study treatment delay|1|||
13473396|NCT02492711|26991599|FG002|Overall Study|study treatment delay|0|||
13473397|NCT02492711|26991597|FG000|Overall Study|change in chemotherapy|0|||
13473398|NCT02492711|26991598|FG001|Overall Study|change in chemotherapy|1|||
13473399|NCT02492711|26991599|FG002|Overall Study|change in chemotherapy|0|||
13473400|NCT02492711|26991597|FG000|Overall Study|never treated|2|||
13473401|NCT02492711|26991598|FG001|Overall Study|never treated|4|||
13473402|NCT02492711|26991599|FG002|Overall Study|never treated|0|||
13473403|NCT02492711|26991597|FG000|Overall Study|Other|0|||
13473404|NCT02492711|26991598|FG001|Overall Study|Other|0|||
13473405|NCT02492711|26991599|FG002|Overall Study|Other|1|||
13473406|NCT01946204|26991646|FG000|Overall Study|Death|38|||
13473407|NCT01946204|26991647|FG001|Overall Study|Death|59|||
13473408|NCT01946204|26991646|FG000|Overall Study|Withdrawal by Subject|37|||
13473409|NCT01946204|26991647|FG001|Overall Study|Withdrawal by Subject|50|||
13473410|NCT01946204|26991646|FG000|Overall Study|Lost to Follow-up|3|||
13473411|NCT01946204|26991647|FG001|Overall Study|Lost to Follow-up|7|||
13473412|NCT01946204|26991646|FG000|Overall Study|Ongoing|316|||
13473413|NCT01946204|26991647|FG001|Overall Study|Ongoing|687|||
13473414|NCT01946204|26991646|FG000|Overall Study|Other|7|||
13473415|NCT01946204|26991647|FG001|Overall Study|Other|3|||
13473416|NCT00130286|26991687|FG000|Overall Study|Withdrawal by Subject|0|||
13473417|NCT00130286|26991688|FG001|Overall Study|Withdrawal by Subject|1|||
13473418|NCT00130286|26991689|FG002|Overall Study|Withdrawal by Subject|2|||
13473419|NCT00130286|26991690|FG003|Overall Study|Withdrawal by Subject|2|||
13473420|NCT00130286|26991687|FG000|Overall Study|Adverse Event|0|||
13473421|NCT00130286|26991688|FG001|Overall Study|Adverse Event|0|||
13473422|NCT00130286|26991689|FG002|Overall Study|Adverse Event|2|||
13473423|NCT00130286|26991690|FG003|Overall Study|Adverse Event|0|||
13473424|NCT00130286|26991687|FG000|Overall Study|Missing lab specimens|0|||
13473425|NCT00130286|26991688|FG001|Overall Study|Missing lab specimens|2|||
13473426|NCT00130286|26991689|FG002|Overall Study|Missing lab specimens|0|||
13473427|NCT00130286|26991690|FG003|Overall Study|Missing lab specimens|0|||
13473428|NCT01235962|26991775|FG000|Overall Study|Withdrawal by Subject|20|||
13473429|NCT01235962|26991776|FG001|Overall Study|Withdrawal by Subject|19|||
13473430|NCT01235962|26991777|FG002|Overall Study|Withdrawal by Subject|62|||
13473431|NCT01235962|26991778|FG003|Overall Study|Withdrawal by Subject|49|||
13473432|NCT01235962|26991775|FG000|Overall Study|Lost to Follow-up|21|||
13473433|NCT01235962|26991776|FG001|Overall Study|Lost to Follow-up|16|||
13473434|NCT01235962|26991777|FG002|Overall Study|Lost to Follow-up|47|||
13473435|NCT01235962|26991778|FG003|Overall Study|Lost to Follow-up|32|||
13473436|NCT01235962|26991775|FG000|Overall Study|Physician Decision|5|||
13473437|NCT01235962|26991776|FG001|Overall Study|Physician Decision|0|||
13473438|NCT01235962|26991777|FG002|Overall Study|Physician Decision|9|||
13473439|NCT01235962|26991778|FG003|Overall Study|Physician Decision|5|||
13473440|NCT01239368|26991853|FG000|Overall Study|Principal investigator discretion|1|||
13473441|NCT01239368|26991854|FG001|Overall Study|Principal investigator discretion|0|||
13473442|NCT01239368|26991855|FG002|Overall Study|Principal investigator discretion|0|||
13473443|NCT01239368|26991856|FG003|Overall Study|Principal investigator discretion|0|||
13473444|NCT01239368|26991857|FG004|Overall Study|Principal investigator discretion|1|||
13473445|NCT01239368|26991858|FG005|Overall Study|Principal investigator discretion|2|||
13473446|NCT01239368|26991859|FG006|Overall Study|Principal investigator discretion|0|||
13473447|NCT01239368|26991860|FG007|Overall Study|Principal investigator discretion|0|||
13473448|NCT01239368|26991861|FG008|Overall Study|Principal investigator discretion|0|||
13473449|NCT01239368|26991862|FG009|Overall Study|Principal investigator discretion|1|||
13473450|NCT01239368|26991853|FG000|Overall Study|Disease progression on study|1|||
13473451|NCT01239368|26991854|FG001|Overall Study|Disease progression on study|1|||
13473452|NCT01239368|26991855|FG002|Overall Study|Disease progression on study|1|||
13473453|NCT01239368|26991856|FG003|Overall Study|Disease progression on study|1|||
13473454|NCT01239368|26991857|FG004|Overall Study|Disease progression on study|4|||
13473455|NCT01239368|26991858|FG005|Overall Study|Disease progression on study|2|||
13473456|NCT01239368|26991859|FG006|Overall Study|Disease progression on study|5|||
13473457|NCT01239368|26991860|FG007|Overall Study|Disease progression on study|0|||
13473458|NCT01239368|26991861|FG008|Overall Study|Disease progression on study|0|||
13473459|NCT01239368|26991862|FG009|Overall Study|Disease progression on study|2|||
13473460|NCT01239368|26991853|FG000|Overall Study|Refused further treatment|0|||
13473461|NCT01239368|26991854|FG001|Overall Study|Refused further treatment|0|||
13473462|NCT01239368|26991855|FG002|Overall Study|Refused further treatment|0|||
13473463|NCT01239368|26991856|FG003|Overall Study|Refused further treatment|0|||
13473464|NCT01239368|26991857|FG004|Overall Study|Refused further treatment|0|||
13473465|NCT01239368|26991858|FG005|Overall Study|Refused further treatment|0|||
13473466|NCT01239368|26991859|FG006|Overall Study|Refused further treatment|0|||
13473467|NCT01239368|26991860|FG007|Overall Study|Refused further treatment|0|||
13473468|NCT01239368|26991861|FG008|Overall Study|Refused further treatment|0|||
13473469|NCT01239368|26991862|FG009|Overall Study|Refused further treatment|1|||
13473470|NCT01239368|26991853|FG000|Overall Study|Death|0|||
13473471|NCT01239368|26991854|FG001|Overall Study|Death|0|||
13473472|NCT01239368|26991855|FG002|Overall Study|Death|0|||
13473473|NCT01239368|26991856|FG003|Overall Study|Death|0|||
13473474|NCT01239368|26991857|FG004|Overall Study|Death|0|||
13473475|NCT01239368|26991858|FG005|Overall Study|Death|0|||
13473476|NCT01239368|26991859|FG006|Overall Study|Death|1|||
13473477|NCT01239368|26991860|FG007|Overall Study|Death|0|||
13473478|NCT01239368|26991861|FG008|Overall Study|Death|0|||
13473479|NCT01239368|26991862|FG009|Overall Study|Death|0|||
13473480|NCT01266031|26991899|FG000|Overall Study|Not treated|0|||
13473481|NCT01266031|26991900|FG001|Overall Study|Not treated|3|||
13473482|NCT01266031|26991901|FG002|Overall Study|Not treated|2|||
13473483|NCT01287741|26991942|FG000|Overall Study|Withdrawal by Subject|35|||
13473484|NCT01287741|26991943|FG001|Overall Study|Withdrawal by Subject|38|||
13473485|NCT01287741|26991942|FG000|Overall Study|Protocol Violation|2|||
13473486|NCT01287741|26991943|FG001|Overall Study|Protocol Violation|0|||
13473487|NCT01287741|26991942|FG000|Overall Study|Physician Decision|15|||
13473488|NCT01287741|26991943|FG001|Overall Study|Physician Decision|23|||
13473489|NCT01287741|26991942|FG000|Overall Study|Non-compliance|8|||
13473490|NCT01287741|26991943|FG001|Overall Study|Non-compliance|6|||
13473491|NCT01287741|26991942|FG000|Overall Study|Lost to Follow-up|10|||
13473492|NCT01287741|26991943|FG001|Overall Study|Lost to Follow-up|8|||
13473493|NCT01287741|26991942|FG000|Overall Study|Death|32|||
13473494|NCT01287741|26991943|FG001|Overall Study|Death|44|||
13473495|NCT01287741|26991942|FG000|Overall Study|Adverse Event|4|||
13473496|NCT01287741|26991943|FG001|Overall Study|Adverse Event|6|||
13473497|NCT01287741|26991942|FG000|Overall Study|Study terminated by Sponsor|307|||
13473498|NCT01287741|26991943|FG001|Overall Study|Study terminated by Sponsor|315|||
13473499|NCT01287741|26991942|FG000|Overall Study|Progressive disease|190|||
13473500|NCT01287741|26991943|FG001|Overall Study|Progressive disease|166|||
13473501|NCT01287741|26991942|FG000|Overall Study|Reason not specified|23|||
13473502|NCT01287741|26991943|FG001|Overall Study|Reason not specified|9|||
13473503|NCT04419506|26991970|FG000|Overall Study|Adverse Event|0|||
13473504|NCT04419506|26991971|FG001|Overall Study|Adverse Event|10|||
13473505|NCT04419506|26991972|FG002|Overall Study|Adverse Event|0|||
13473506|NCT04419506|26991973|FG003|Overall Study|Adverse Event|3|||
13473507|NCT04419506|26991970|FG000|Overall Study|Withdrawal by Subject|0|||
13473508|NCT04419506|26991971|FG001|Overall Study|Withdrawal by Subject|0|||
13473509|NCT04419506|26991972|FG002|Overall Study|Withdrawal by Subject|0|||
13473510|NCT04419506|26991973|FG003|Overall Study|Withdrawal by Subject|1|||
13473511|NCT04419506|26991970|FG000|Overall Study|poor-compliance|0|||
13473512|NCT04419506|26991971|FG001|Overall Study|poor-compliance|0|||
13473513|NCT04419506|26991972|FG002|Overall Study|poor-compliance|0|||
13473514|NCT04419506|26991973|FG003|Overall Study|poor-compliance|1|||
13473515|NCT03930615|26992124|FG000|Overall Study|Death|9|||
13473516|NCT03930615|26992125|FG001|Overall Study|Death|3|||
13473517|NCT03930615|26992124|FG000|Overall Study|Lost to Follow-up|1|||
13473518|NCT03930615|26992125|FG001|Overall Study|Lost to Follow-up|2|||
13473519|NCT03930615|26992124|FG000|Overall Study|Physician Decision|3|||
13473520|NCT03930615|26992125|FG001|Overall Study|Physician Decision|4|||
13473521|NCT03930615|26992124|FG000|Overall Study|Withdrawal by Subject|13|||
13473522|NCT03930615|26992125|FG001|Overall Study|Withdrawal by Subject|2|||
13473523|NCT03930615|26992124|FG000|Overall Study|Not treated|1|||
13473524|NCT03930615|26992125|FG001|Overall Study|Not treated|1|||
13473601|NCT02618408|26992575|FG002|Overall Study|Other, Multiple Categories|4|||
13473602|NCT02563002|26992599|FG000|Overall Study|Death|62|||
13473603|NCT02563002|26992600|FG001|Overall Study|Death|75|||
13473604|NCT02563002|26992599|FG000|Overall Study|Lost to Follow-up|1|||
13473605|NCT02563002|26992600|FG001|Overall Study|Lost to Follow-up|0|||
13473606|NCT02563002|26992599|FG000|Overall Study|Withdrawal by Subject|0|||
13473607|NCT02563002|26992600|FG001|Overall Study|Withdrawal by Subject|9|||
13473608|NCT02563002|26992599|FG000|Overall Study|Ongoing|90|||
13473609|NCT02563002|26992600|FG001|Overall Study|Ongoing|70|||
13473525|NCT03810235|26992171|FG000|Overall Study|Withdrawal by Subject|2|||
13473526|NCT03810235|26992172|FG001|Overall Study|Withdrawal by Subject|0|||
13473527|NCT03674112|26992250|FG000|Overall Study|Adverse Event|1|||
13473528|NCT03674112|26992251|FG001|Overall Study|Adverse Event|0|||
13473529|NCT03674112|26992250|FG000|Overall Study|Ongoing in the Study|79|||
13473530|NCT03674112|26992251|FG001|Overall Study|Ongoing in the Study|80|||
13473531|NCT03668808|26992278|FG000|First Intervention|Withdrawal by Subject|2|||
13473532|NCT03668808|26992279|FG001|First Intervention|Withdrawal by Subject|2|||
13473533|NCT03537651|26992293|FG000|Overall Study|Adverse Event|2|||
13473534|NCT03537651|26992293|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
13473535|NCT03537651|26992293|FG000|Overall Study|Commercial Drug is Available for Participant|56|||
13473536|NCT03537651|26992293|FG000|Overall Study|Other|1|||
13473537|NCT02982954|26992356|FG000|Overall Study|Death|55|||
13473538|NCT02982954|26992357|FG001|Overall Study|Death|29|||
13473539|NCT02982954|26992358|FG002|Overall Study|Death|15|||
13473540|NCT02982954|26992359|FG003|Overall Study|Death|20|||
13473541|NCT02982954|26992356|FG000|Overall Study|Lost to Follow-up|2|||
13473542|NCT02982954|26992357|FG001|Overall Study|Lost to Follow-up|1|||
13473543|NCT02982954|26992358|FG002|Overall Study|Lost to Follow-up|0|||
13473544|NCT02982954|26992359|FG003|Overall Study|Lost to Follow-up|0|||
13473545|NCT02982954|26992356|FG000|Overall Study|Participant withdrew consent|7|||
13473546|NCT02982954|26992357|FG001|Overall Study|Participant withdrew consent|5|||
13473547|NCT02982954|26992358|FG002|Overall Study|Participant withdrew consent|1|||
13473548|NCT02982954|26992359|FG003|Overall Study|Participant withdrew consent|1|||
13473549|NCT02982954|26992356|FG000|Overall Study|Other reasons|42|||
13473550|NCT02982954|26992357|FG001|Overall Study|Other reasons|17|||
13473551|NCT02982954|26992358|FG002|Overall Study|Other reasons|12|||
13473552|NCT02982954|26992359|FG003|Overall Study|Other reasons|3|||
13473553|NCT02982954|26992356|FG000|Overall Study|Premature site closure|0|||
13473554|NCT02982954|26992357|FG001|Overall Study|Premature site closure|0|||
13473555|NCT02982954|26992358|FG002|Overall Study|Premature site closure|0|||
13473556|NCT02982954|26992359|FG003|Overall Study|Premature site closure|1|||
13473557|NCT02966314|26992394|FG000|Overall Study|Lost to Follow-up|1|||
13473558|NCT02966314|26992395|FG001|Overall Study|Lost to Follow-up|0|||
13473559|NCT02796170|26992439|FG000|Overall Study|Lost to Follow-up|3|||
13473560|NCT02796170|26992440|FG001|Overall Study|Lost to Follow-up|0|||
13473561|NCT02654132|26992507|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
13473562|NCT02654132|26992508|FG001|Pre-Treatment Period|Participant Withdrew Consent|2|||
13473563|NCT02654132|26992507|FG000|Treatment Period|Disease progression|43|||
13473564|NCT02654132|26992508|FG001|Treatment Period|Disease progression|38|||
13473565|NCT02654132|26992507|FG000|Treatment Period|Adverse Event unrelated to study drug|6|||
13473566|NCT02654132|26992508|FG001|Treatment Period|Adverse Event unrelated to study drug|9|||
13473567|NCT02654132|26992507|FG000|Treatment Period|Other reasons|4|||
13473568|NCT02654132|26992508|FG001|Treatment Period|Other reasons|2|||
13473569|NCT02654132|26992507|FG000|Treatment Period|Study drug toxicity|2|||
13473570|NCT02654132|26992508|FG001|Treatment Period|Study drug toxicity|2|||
13473571|NCT02654132|26992507|FG000|Treatment Period|Withdrawal by Subject|2|||
13473572|NCT02654132|26992508|FG001|Treatment Period|Withdrawal by Subject|1|||
13473573|NCT02654132|26992507|FG000|Treatment Period|Maximum Clinical Benefit|0|||
13473574|NCT02654132|26992508|FG001|Treatment Period|Maximum Clinical Benefit|2|||
13473575|NCT02654132|26992507|FG000|Treatment Period|Participant request to discontinue|2|||
13473576|NCT02654132|26992508|FG001|Treatment Period|Participant request to discontinue|0|||
13473577|NCT02654132|26992507|FG000|Treatment Period|Administrative reasons by sponsor|0|||
13473578|NCT02654132|26992508|FG001|Treatment Period|Administrative reasons by sponsor|1|||
13473579|NCT02654132|26992507|FG000|Treatment Period|Death|1|||
13473580|NCT02654132|26992508|FG001|Treatment Period|Death|0|||
13473581|NCT02618408|26992573|FG000|Overall Study|Withdrawal by Subject|1|||
13473582|NCT02618408|26992574|FG001|Overall Study|Withdrawal by Subject|0|||
13473583|NCT02618408|26992575|FG002|Overall Study|Withdrawal by Subject|4|||
13473584|NCT02618408|26992573|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
13473585|NCT02618408|26992574|FG001|Overall Study|Withdrawal By Parent/Guardian|3|||
13473586|NCT02618408|26992575|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
13473587|NCT02618408|26992573|FG000|Overall Study|Lost to Follow-up|4|||
13473588|NCT02618408|26992574|FG001|Overall Study|Lost to Follow-up|2|||
13473589|NCT02618408|26992575|FG002|Overall Study|Lost to Follow-up|6|||
13473590|NCT02618408|26992573|FG000|Overall Study|Adverse Event|4|||
13473591|NCT02618408|26992574|FG001|Overall Study|Adverse Event|0|||
13473592|NCT02618408|26992575|FG002|Overall Study|Adverse Event|10|||
13473593|NCT02618408|26992573|FG000|Overall Study|Physician Decision|1|||
13473594|NCT02618408|26992574|FG001|Overall Study|Physician Decision|1|||
13473595|NCT02618408|26992575|FG002|Overall Study|Physician Decision|2|||
13473596|NCT02618408|26992573|FG000|Overall Study|Protocol Violation|1|||
13473597|NCT02618408|26992574|FG001|Overall Study|Protocol Violation|1|||
13473598|NCT02618408|26992575|FG002|Overall Study|Protocol Violation|2|||
13473599|NCT02618408|26992573|FG000|Overall Study|Other, Multiple Categories|0|||
13473600|NCT02618408|26992574|FG001|Overall Study|Other, Multiple Categories|0|||
13473610|NCT02387996|26992621|FG000|Overall Study|Disease Progression|167|||
13473611|NCT02387996|26992621|FG000|Overall Study|Study Drug Toxicity|31|||
13473612|NCT02387996|26992621|FG000|Overall Study|Adverse Event Unrelated to Study Drug|39|||
13473613|NCT02387996|26992621|FG000|Overall Study|Participant Request to Discontinue Treatment|20|||
13473614|NCT02387996|26992621|FG000|Overall Study|Subject Withdrew Consent|5|||
13473615|NCT02387996|26992621|FG000|Overall Study|Lost to Follow-up|1|||
13473616|NCT02387996|26992621|FG000|Overall Study|Poor/Non-Compliance|1|||
13473617|NCT02387996|26992621|FG000|Overall Study|Other Reasons|5|||
13473618|NCT02387996|26992621|FG000|Overall Study|Death|1|||
13473619|NCT02374476|26992644|FG000|VT Induced Ablation|Screening Failures|36|||
13473620|NCT02374476|26992645|FG001|VT Induced Ablation|Screening Failures|0|||
13473621|NCT02374476|26992646|FG002|VT Induced Ablation|Screening Failures|0|||
13473622|NCT02374476|26992644|FG000|Arm Assignment|Withdrawal by Subject|0|||
13473623|NCT02374476|26992645|FG001|Arm Assignment|Withdrawal by Subject|0|||
13473624|NCT02374476|26992646|FG002|Arm Assignment|Withdrawal by Subject|1|||
13473625|NCT01779050|26992663|FG000|Overall Study|Withdrawal by Subject|1|||
13473626|NCT01779050|26992664|FG001|Overall Study|Withdrawal by Subject|0|||
13473627|NCT01495598|26992714|FG000|Overall Study|Death during follow up period|2|||
13473628|NCT01495598|26992714|FG000|Overall Study|Death on study|1|||
13473629|NCT01495598|26992714|FG000|Overall Study|Lost to Follow-up|3|||
13473630|NCT01495598|26992714|FG000|Overall Study|Physician Decision|8|||
13473631|NCT00843882|26992754|FG000|Step 1|Lack of Efficacy|14|||
13473632|NCT00843882|26992755|FG001|Step 1|Lack of Efficacy|10|||
13473633|NCT00843882|26992756|FG002|Step 1|Lack of Efficacy|21|||
13473634|NCT00843882|26992754|FG000|Step 1|Adverse Event|8|||
13473635|NCT00843882|26992755|FG001|Step 1|Adverse Event|17|||
13473636|NCT00843882|26992756|FG002|Step 1|Adverse Event|20|||
13473637|NCT00843882|26992754|FG000|Step 1|Death|1|||
13473638|NCT00843882|26992755|FG001|Step 1|Death|2|||
13473639|NCT00843882|26992756|FG002|Step 1|Death|4|||
13473640|NCT00843882|26992754|FG000|Step 1|Withdrawal by Subject|6|||
13473641|NCT00843882|26992755|FG001|Step 1|Withdrawal by Subject|12|||
13473642|NCT00843882|26992756|FG002|Step 1|Withdrawal by Subject|9|||
13473643|NCT00843882|26992754|FG000|Step 1|Physician Decision|0|||
13473644|NCT00843882|26992755|FG001|Step 1|Physician Decision|5|||
13473645|NCT00843882|26992756|FG002|Step 1|Physician Decision|1|||
13473646|NCT00843882|26992754|FG000|Step 1|Patient and physician's decision|0|||
13473647|NCT00843882|26992755|FG001|Step 1|Patient and physician's decision|0|||
13473648|NCT00843882|26992756|FG002|Step 1|Patient and physician's decision|1|||
13473649|NCT00843882|26992754|FG000|Step 1|Other complicating disease|1|||
13473650|NCT00843882|26992755|FG001|Step 1|Other complicating disease|3|||
13473651|NCT00843882|26992756|FG002|Step 1|Other complicating disease|4|||
13473652|NCT00843882|26992754|FG000|Step 1|Alternative therapy|0|||
13473653|NCT00843882|26992755|FG001|Step 1|Alternative therapy|1|||
13473654|NCT00843882|26992756|FG002|Step 1|Alternative therapy|1|||
13473655|NCT00843882|26992754|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0|||
13473656|NCT00843882|26992755|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4|||
13473657|NCT00843882|26992756|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0|||
13473658|NCT00843882|26992754|FG000|Step 1|Off treatment reason unknown|0|||
13473659|NCT00843882|26992755|FG001|Step 1|Off treatment reason unknown|1|||
13473660|NCT00843882|26992756|FG002|Step 1|Off treatment reason unknown|4|||
13473661|NCT00843882|26992754|FG000|Step 1|Never started treatment|2|||
13473662|NCT00843882|26992755|FG001|Step 1|Never started treatment|0|||
13473663|NCT00843882|26992756|FG002|Step 1|Never started treatment|0|||
13473664|NCT00843882|26992754|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1|||
13473665|NCT00843882|26992755|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9|||
13473666|NCT00843882|26992756|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0|||
13473667|NCT00843882|26992754|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
13473668|NCT00843882|26992755|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6|||
13473669|NCT00843882|26992756|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
13473670|NCT00843882|26992754|FG000|Step 2 (Cross-over to Arm B)|Death|0|||
13473671|NCT00843882|26992755|FG001|Step 2 (Cross-over to Arm B)|Death|3|||
13473672|NCT00843882|26992756|FG002|Step 2 (Cross-over to Arm B)|Death|0|||
13473673|NCT00843882|26992754|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2|||
13473674|NCT00843882|26992755|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5|||
13473675|NCT00843882|26992756|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0|||
13473676|NCT00843882|26992754|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
13473677|NCT00843882|26992755|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
13473678|NCT00843882|26992756|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0|||
13473679|NCT00843882|26992754|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
13473680|NCT00843882|26992755|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1|||
13473681|NCT00843882|26992756|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
13473682|NCT00843882|26992754|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
13473683|NCT00843882|26992755|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1|||
13473684|NCT00843882|26992756|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
13473685|NCT01313689|26992869|FG000|24-Week Randomization 1|Adverse Event|10|||
13473686|NCT01313689|26992870|FG001|24-Week Randomization 1|Adverse Event|5|||
13473687|NCT01313689|26992871|FG002|24-Week Randomization 1|Adverse Event|0|||
13473688|NCT01313689|26992872|FG003|24-Week Randomization 1|Adverse Event|0|||
13473689|NCT01313689|26992873|FG004|24-Week Randomization 1|Adverse Event|0|||
13473690|NCT01313689|26992869|FG000|24-Week Randomization 1|Physician Decision|4|||
13473691|NCT01313689|26992870|FG001|24-Week Randomization 1|Physician Decision|5|||
13473692|NCT01313689|26992871|FG002|24-Week Randomization 1|Physician Decision|0|||
13473693|NCT01313689|26992872|FG003|24-Week Randomization 1|Physician Decision|0|||
13473694|NCT01313689|26992873|FG004|24-Week Randomization 1|Physician Decision|0|||
13473695|NCT01313689|26992869|FG000|24-Week Randomization 1|Withdrawal by Subject|5|||
13473696|NCT01313689|26992870|FG001|24-Week Randomization 1|Withdrawal by Subject|0|||
13473697|NCT01313689|26992871|FG002|24-Week Randomization 1|Withdrawal by Subject|0|||
13473698|NCT01313689|26992872|FG003|24-Week Randomization 1|Withdrawal by Subject|0|||
13473699|NCT01313689|26992873|FG004|24-Week Randomization 1|Withdrawal by Subject|0|||
13473700|NCT01313689|26992869|FG000|24-Week Randomization 2|Adverse Event|0|||
13473701|NCT01313689|26992870|FG001|24-Week Randomization 2|Adverse Event|0|||
13473702|NCT01313689|26992871|FG002|24-Week Randomization 2|Adverse Event|2|||
13473703|NCT01313689|26992872|FG003|24-Week Randomization 2|Adverse Event|0|||
13473704|NCT01313689|26992873|FG004|24-Week Randomization 2|Adverse Event|8|||
13473705|NCT01313689|26992869|FG000|24-Week Randomization 2|Withdrawal by Subject|0|||
13473706|NCT01313689|26992870|FG001|24-Week Randomization 2|Withdrawal by Subject|0|||
13473707|NCT01313689|26992871|FG002|24-Week Randomization 2|Withdrawal by Subject|1|||
13473708|NCT01313689|26992872|FG003|24-Week Randomization 2|Withdrawal by Subject|1|||
13473709|NCT01313689|26992873|FG004|24-Week Randomization 2|Withdrawal by Subject|3|||
13473710|NCT01313689|26992869|FG000|24-Week Randomization 2|Physician Decision|0|||
13473711|NCT01313689|26992870|FG001|24-Week Randomization 2|Physician Decision|0|||
13473712|NCT01313689|26992871|FG002|24-Week Randomization 2|Physician Decision|0|||
13473713|NCT01313689|26992872|FG003|24-Week Randomization 2|Physician Decision|0|||
13473714|NCT01313689|26992873|FG004|24-Week Randomization 2|Physician Decision|4|||
13473715|NCT01315353|26992908|FG000|Overall Study|Death|2|||
13473716|NCT01315353|26992909|FG001|Overall Study|Death|1|||
13473717|NCT01315353|26992910|FG002|Overall Study|Death|0|||
13473718|NCT01315353|26992908|FG000|Overall Study|Withdrawal by Subject|2|||
13473719|NCT01315353|26992909|FG001|Overall Study|Withdrawal by Subject|6|||
13473720|NCT01315353|26992910|FG002|Overall Study|Withdrawal by Subject|1|||
13473721|NCT01315353|26992908|FG000|Overall Study|Lost to Follow-up|13|||
13473722|NCT01315353|26992909|FG001|Overall Study|Lost to Follow-up|6|||
13473723|NCT01315353|26992910|FG002|Overall Study|Lost to Follow-up|6|||
13473724|NCT01315353|26992908|FG000|Overall Study|Unwilling to adhere to requirements|5|||
13473725|NCT01315353|26992909|FG001|Overall Study|Unwilling to adhere to requirements|5|||
13473726|NCT01315353|26992910|FG002|Overall Study|Unwilling to adhere to requirements|4|||
13473727|NCT01315353|26992908|FG000|Overall Study|Site closing|7|||
13473728|NCT01315353|26992909|FG001|Overall Study|Site closing|4|||
13473729|NCT01315353|26992910|FG002|Overall Study|Site closing|0|||
13473730|NCT01315353|26992908|FG000|Overall Study|Taken off study by site in error|0|||
13473731|NCT01315353|26992909|FG001|Overall Study|Taken off study by site in error|1|||
13473732|NCT01315353|26992910|FG002|Overall Study|Taken off study by site in error|0|||
13473733|NCT01315353|26992908|FG000|Overall Study|Inadvertent randomization/assignment|0|||
13473734|NCT01315353|26992909|FG001|Overall Study|Inadvertent randomization/assignment|0|||
13473735|NCT01315353|26992910|FG002|Overall Study|Inadvertent randomization/assignment|2|||
13473736|NCT01318993|26992928|FG000|Overall Study|Adverse Event|53|||
13473737|NCT01318993|26992928|FG000|Overall Study|Lack of Efficacy|121|||
13473738|NCT01318993|26992928|FG000|Overall Study|Protocol Violation|3|||
13473739|NCT01318993|26992928|FG000|Overall Study|Protocol based stopping criteria|6|||
13473740|NCT01318993|26992928|FG000|Overall Study|Study closed or terminated|174|||
13473741|NCT01318993|26992928|FG000|Overall Study|Lost to Follow-up|4|||
13473742|NCT01318993|26992928|FG000|Overall Study|Physician Decision|13|||
13473743|NCT01318993|26992928|FG000|Overall Study|Withdrawal by Subject|24|||
13473744|NCT04480710|26992986|FG000|Overall Study|Adverse Event|0|||
13473745|NCT04480710|26992987|FG001|Overall Study|Adverse Event|2|||
13473746|NCT04480710|26992988|FG002|Overall Study|Adverse Event|0|||
13473747|NCT04480710|26992989|FG003|Overall Study|Adverse Event|0|||
13473748|NCT04480710|26992986|FG000|Overall Study|Withdrawal by Subject|0|||
13473749|NCT04480710|26992987|FG001|Overall Study|Withdrawal by Subject|1|||
13473750|NCT04480710|26992988|FG002|Overall Study|Withdrawal by Subject|0|||
13473751|NCT04480710|26992989|FG003|Overall Study|Withdrawal by Subject|0|||
13473752|NCT04480710|26992986|FG000|Overall Study|Physician Decision|0|||
13473753|NCT04480710|26992987|FG001|Overall Study|Physician Decision|0|||
13473754|NCT04480710|26992988|FG002|Overall Study|Physician Decision|1|||
13473755|NCT04480710|26992989|FG003|Overall Study|Physician Decision|0|||
13473836|NCT02567825|26993656|FG000|Overall Study|No follow-up post-randomization|5|||
13473837|NCT02567825|26993657|FG001|Overall Study|No follow-up post-randomization|1|||
13473838|NCT02567825|26993656|FG000|Overall Study|Follow-up less than 23 months|16|||
13473756|NCT04225676|26992999|FG000|Overall Study|Physician Decision|1|||
13473757|NCT04225676|26992999|FG000|Overall Study|Lack of Efficacy|1|||
13473758|NCT04225676|26992999|FG000|Overall Study|Study terminated by sponsor|3|||
13473759|NCT04045132|26993030|FG000|Overall Study|Lost to Follow-up|3|||
13473760|NCT04045132|26993031|FG001|Overall Study|Lost to Follow-up|6|||
13473761|NCT03891524|26993267|FG000|Overall Study|Death|0|||
13473762|NCT03891524|26993268|FG001|Overall Study|Death|0|||
13473763|NCT03891524|26993269|FG002|Overall Study|Death|0|||
13473764|NCT03891524|26993270|FG003|Overall Study|Death|0|||
13473765|NCT03891524|26993271|FG004|Overall Study|Death|0|||
13473766|NCT03891524|26993272|FG005|Overall Study|Death|0|||
13473767|NCT03891524|26993273|FG006|Overall Study|Death|0|||
13473768|NCT03891524|26993274|FG007|Overall Study|Death|1|||
13473769|NCT03891524|26993267|FG000|Overall Study|Withdrawal by Subject|0|||
13473770|NCT03891524|26993268|FG001|Overall Study|Withdrawal by Subject|1|||
13473771|NCT03891524|26993269|FG002|Overall Study|Withdrawal by Subject|2|||
13473772|NCT03891524|26993270|FG003|Overall Study|Withdrawal by Subject|1|||
13473773|NCT03891524|26993271|FG004|Overall Study|Withdrawal by Subject|2|||
13473774|NCT03891524|26993272|FG005|Overall Study|Withdrawal by Subject|2|||
13473775|NCT03891524|26993273|FG006|Overall Study|Withdrawal by Subject|2|||
13473776|NCT03891524|26993274|FG007|Overall Study|Withdrawal by Subject|1|||
13473777|NCT03796208|26993301|FG000|Overall Study|Withdrawal by Subject|3|||
13473778|NCT03796208|26993302|FG001|Overall Study|Withdrawal by Subject|0|||
13473779|NCT03796208|26993301|FG000|Overall Study|Loss of pregnancy|1|||
13473780|NCT03796208|26993302|FG001|Overall Study|Loss of pregnancy|1|||
13473781|NCT03796208|26993301|FG000|Overall Study|Changed prenatal clinics|0|||
13473782|NCT03796208|26993302|FG001|Overall Study|Changed prenatal clinics|5|||
13473783|NCT03796208|26993301|FG000|Overall Study|Lost to Follow-up|20|||
13473784|NCT03796208|26993302|FG001|Overall Study|Lost to Follow-up|16|||
13473785|NCT03611010|26993369|FG000|Period 2: 15 Day Treatment|Inaccessible veins|1|||
13473786|NCT03611010|26993370|FG001|Period 2: 15 Day Treatment|Inaccessible veins|0|||
13473787|NCT03611010|26993371|FG002|Period 2: 15 Day Treatment|Inaccessible veins|0|||
13473788|NCT03611010|26993372|FG003|Period 2: 15 Day Treatment|Inaccessible veins|0|||
13473789|NCT03476798|26993403|FG000|Overall Study|Death|1|||
13473790|NCT03476798|26993403|FG000|Overall Study|Withdrawal by Subject|2|||
13473791|NCT03476798|26993403|FG000|Overall Study|Protocol Violation|2|||
13473792|NCT03355664|26993430|FG000|Overall Study|Adverse Event|1|||
13473793|NCT03355664|26993431|FG001|Overall Study|Adverse Event|2|||
13473794|NCT03355664|26993430|FG000|Overall Study|Lost to Follow-up|11|||
13473795|NCT03355664|26993431|FG001|Overall Study|Lost to Follow-up|7|||
13473796|NCT03355664|26993430|FG000|Overall Study|Protocol Violation|1|||
13473797|NCT03355664|26993431|FG001|Overall Study|Protocol Violation|2|||
13473798|NCT03355664|26993430|FG000|Overall Study|Withdrawal by Subject|2|||
13473799|NCT03355664|26993431|FG001|Overall Study|Withdrawal by Subject|1|||
13473800|NCT03290131|26993452|FG000|Overall Study|Adverse Event|22|||
13473801|NCT03290131|26993453|FG001|Overall Study|Adverse Event|57|||
13473802|NCT03290131|26993454|FG002|Overall Study|Adverse Event|11|||
13473803|NCT03290131|26993452|FG000|Overall Study|Withdrawal by Subject|18|||
13473804|NCT03290131|26993453|FG001|Overall Study|Withdrawal by Subject|13|||
13473805|NCT03290131|26993454|FG002|Overall Study|Withdrawal by Subject|8|||
13473806|NCT03290131|26993452|FG000|Overall Study|MS Relapse|2|||
13473807|NCT03290131|26993453|FG001|Overall Study|MS Relapse|1|||
13473808|NCT03290131|26993454|FG002|Overall Study|MS Relapse|0|||
13473809|NCT03290131|26993452|FG000|Overall Study|Unknown reason|0|||
13473810|NCT03290131|26993453|FG001|Overall Study|Unknown reason|1|||
13473811|NCT03290131|26993454|FG002|Overall Study|Unknown reason|0|||
13473812|NCT03117049|26993495|FG000|Overall Study|Continued the follow-up period|109|||
13473813|NCT03117049|26993496|FG001|Overall Study|Continued the follow-up period|129|||
13473814|NCT03117049|26993495|FG000|Overall Study|Died|82|||
13473815|NCT03117049|26993496|FG001|Overall Study|Died|93|||
13473816|NCT03117049|26993495|FG000|Overall Study|Consent withdrawal|7|||
13473817|NCT03117049|26993496|FG001|Overall Study|Consent withdrawal|6|||
13473818|NCT03117049|26993495|FG000|Overall Study|Missing contact|3|||
13473819|NCT03117049|26993496|FG001|Overall Study|Missing contact|3|||
13473820|NCT02663622|26993564|FG000|Overall Study|Death|3|||
13473821|NCT02663622|26993565|FG001|Overall Study|Death|1|||
13473822|NCT02663622|26993566|FG002|Overall Study|Death|1|||
13473823|NCT02663622|26993567|FG003|Overall Study|Death|8|||
13473824|NCT02663622|26993564|FG000|Overall Study|Protocol Violation|0|||
13473825|NCT02663622|26993565|FG001|Overall Study|Protocol Violation|0|||
13473826|NCT02663622|26993566|FG002|Overall Study|Protocol Violation|0|||
13473827|NCT02663622|26993567|FG003|Overall Study|Protocol Violation|1|||
13473828|NCT02636439|26993594|FG000|Overall Study|Adverse Event|2|||
13473829|NCT02636439|26993595|FG001|Overall Study|Adverse Event|2|||
13473830|NCT02636439|26993594|FG000|Overall Study|Lost to Follow-up|1|||
13473831|NCT02636439|26993595|FG001|Overall Study|Lost to Follow-up|0|||
13473832|NCT02636439|26993594|FG000|Overall Study|Non-compliance|1|||
13473833|NCT02636439|26993595|FG001|Overall Study|Non-compliance|1|||
13473834|NCT02636439|26993594|FG000|Overall Study|Personal reasons|2|||
13473835|NCT02636439|26993595|FG001|Overall Study|Personal reasons|0|||
13473839|NCT02567825|26993657|FG001|Overall Study|Follow-up less than 23 months|20|||
13473840|NCT02536755|26993707|FG000|Overall Study|Adverse Event|4|||
13473841|NCT02201108|26993769|FG000|Double-blind Period (up to Week 96)|Adverse Event|0|||
13473842|NCT02201108|26993770|FG001|Double-blind Period (up to Week 96)|Adverse Event|6|||
13473843|NCT02201108|26993769|FG000|Double-blind Period (up to Week 96)|Lack of Efficacy|2|||
13473844|NCT02201108|26993770|FG001|Double-blind Period (up to Week 96)|Lack of Efficacy|1|||
13473845|NCT02201108|26993769|FG000|Double-blind Period (up to Week 96)|Withdrawal by Subject|2|||
13473846|NCT02201108|26993770|FG001|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
13473847|NCT02201108|26993769|FG000|Open Label Period (up to Week 192)|Lack of Efficacy|10|||
13473848|NCT02201108|26993770|FG001|Open Label Period (up to Week 192)|Lack of Efficacy|14|||
13473849|NCT02201108|26993769|FG000|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
13473850|NCT02201108|26993770|FG001|Open Label Period (up to Week 192)|Poor compliance to protocol|1|||
13473851|NCT02201108|26993769|FG000|Open Label Period (up to Week 192)|Other reason|4|||
13473852|NCT02201108|26993770|FG001|Open Label Period (up to Week 192)|Other reason|7|||
13473853|NCT02201108|26993769|FG000|Open Label Period (up to Week 192)|Adverse Event|7|||
13473854|NCT02201108|26993770|FG001|Open Label Period (up to Week 192)|Adverse Event|5|||
13473855|NCT05085964|26993897|FG000|Overall Study|Premature termination of study|21|||
13473856|NCT05085964|26993898|FG001|Overall Study|Premature termination of study|0|||
13473857|NCT04570670|26993963|FG000|Overall Study|Withdrawal by Subject|1|||
13473858|NCT04570670|26993964|FG001|Overall Study|Withdrawal by Subject|0|||
13473929|NCT04405076|26994187|FG003|Part A (Blinded Phase)|Other than Specified|0|||
13473930|NCT04405076|26994188|FG004|Part A (Blinded Phase)|Other than Specified|0|||
13473931|NCT04405076|26994189|FG005|Part A (Blinded Phase)|Other than Specified|0|||
13473932|NCT04405076|26994190|FG006|Part A (Blinded Phase)|Other than Specified|0|||
13473933|NCT04405076|26994191|FG007|Part A (Blinded Phase)|Other than Specified|0|||
13473934|NCT04405076|26994192|FG008|Part A (Blinded Phase)|Other than Specified|0|||
13473935|NCT04405076|26994184|FG000|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
13473936|NCT04405076|26994185|FG001|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
13473937|NCT04405076|26994186|FG002|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
13473938|NCT04405076|26994187|FG003|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|6|||
13473939|NCT04405076|26994188|FG004|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|1|||
13473940|NCT04405076|26994189|FG005|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|4|||
13473941|NCT04405076|26994190|FG006|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
13473942|NCT04405076|26994191|FG007|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
13473943|NCT04405076|26994192|FG008|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
13473944|NCT04405076|26994184|FG000|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
13473945|NCT04405076|26994185|FG001|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
13473946|NCT04405076|26994186|FG002|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
13473947|NCT04405076|26994187|FG003|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
13473948|NCT04405076|26994188|FG004|Part B (Open-Label Interventional Phase)|Physician Decision|1|||
13473949|NCT04405076|26994189|FG005|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
13473950|NCT04405076|26994190|FG006|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
13473951|NCT04405076|26994191|FG007|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
13473952|NCT04405076|26994192|FG008|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
13473953|NCT04405076|26994184|FG000|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
13473954|NCT04405076|26994185|FG001|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
13473955|NCT04405076|26994186|FG002|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
13473956|NCT04405076|26994187|FG003|Part B (Open-Label Interventional Phase)|Lost to Follow-up|6|||
13473957|NCT04405076|26994188|FG004|Part B (Open-Label Interventional Phase)|Lost to Follow-up|3|||
13473958|NCT04405076|26994189|FG005|Part B (Open-Label Interventional Phase)|Lost to Follow-up|2|||
13473959|NCT04405076|26994190|FG006|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
13473960|NCT04405076|26994191|FG007|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
13473961|NCT04405076|26994192|FG008|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
13473962|NCT04405076|26994184|FG000|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
13473963|NCT04405076|26994185|FG001|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
13473964|NCT04405076|26994186|FG002|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
13473965|NCT04405076|26994187|FG003|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
13473966|NCT04405076|26994188|FG004|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
13473967|NCT04405076|26994189|FG005|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
13473968|NCT04405076|26994190|FG006|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
13473969|NCT04405076|26994191|FG007|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|2|||
13473970|NCT04405076|26994192|FG008|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|1|||
13473971|NCT04405076|26994184|FG000|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
13473972|NCT04405076|26994185|FG001|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
13473973|NCT04405076|26994186|FG002|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
13473974|NCT04405076|26994187|FG003|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
13473975|NCT04405076|26994188|FG004|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
13473976|NCT04405076|26994189|FG005|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
13473977|NCT04405076|26994190|FG006|Part C (Rollover Proof of Concept)|Lost to Follow-up|2|||
13473978|NCT04405076|26994191|FG007|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
13473979|NCT04405076|26994192|FG008|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
13473980|NCT04316741|26994208|FG000|Baseline Enrollment|Lost to Follow-up|1|||
13473981|NCT04316741|26994209|FG001|Baseline Enrollment|Lost to Follow-up|1|||
13473982|NCT04316741|26994208|FG000|Immediate Post-Test|Lost to Follow-up|5|||
13473983|NCT04316741|26994209|FG001|Immediate Post-Test|Lost to Follow-up|1|||
13473984|NCT04316741|26994208|FG000|1-month Post-test|Lost to Follow-up|7|||
13473985|NCT04316741|26994209|FG001|1-month Post-test|Lost to Follow-up|2|||
13473986|NCT04316741|26994208|FG000|3-month Follow-up|Lost to Follow-up|10|||
13473987|NCT04316741|26994209|FG001|3-month Follow-up|Lost to Follow-up|2|||
13473859|NCT04528069|26993989|FG000|Overall Study|Adverse Event|1|||
13473860|NCT04528069|26993989|FG000|Overall Study|Lost to Follow-up|1|||
13473861|NCT04528069|26993989|FG000|Overall Study|Patient Unable to Come|1|||
13473862|NCT04528069|26993989|FG000|Overall Study|Patient Unable to Attend|1|||
13473863|NCT04517864|26994052|FG000|Placebo-Controlled Phase|Adverse Event|1|||
13473864|NCT04517864|26994053|FG001|Placebo-Controlled Phase|Adverse Event|0|||
13473865|NCT04517864|26994052|FG000|Placebo-Controlled Phase|Lost to Follow-up|1|||
13473866|NCT04517864|26994053|FG001|Placebo-Controlled Phase|Lost to Follow-up|1|||
13473867|NCT04517864|26994052|FG000|Placebo-Controlled Phase|Protocol Violation|1|||
13473868|NCT04517864|26994053|FG001|Placebo-Controlled Phase|Protocol Violation|0|||
13473869|NCT04517864|26994052|FG000|Placebo-Controlled Phase|Withdrawal by Subject|1|||
13473870|NCT04517864|26994053|FG001|Placebo-Controlled Phase|Withdrawal by Subject|1|||
13473871|NCT04517864|26994052|FG000|Active Therapy Extension Phase|Adverse Event|1|||
13473872|NCT04517864|26994053|FG001|Active Therapy Extension Phase|Adverse Event|0|||
13473873|NCT04439136|26994061|FG000|Overall Study|Ineligible|1|||
13473874|NCT04439136|26994061|FG000|Overall Study|Never Started Treatment|2|||
13473875|NCT04439136|26994061|FG000|Overall Study|Adverse Event|4|||
13473876|NCT04439136|26994061|FG000|Overall Study|Death|3|||
13473877|NCT04439136|26994061|FG000|Overall Study|Disease Progression|27|||
13473878|NCT04439136|26994061|FG000|Overall Study|Alternative Therapy|1|||
13473879|NCT04439136|26994061|FG000|Overall Study|Increased Tumor Burden|1|||
13473880|NCT04439136|26994061|FG000|Overall Study|Symptomatic Detrioration|1|||
13473881|NCT04405076|26994184|FG000|Part A (Blinded Phase)|Lost to Follow-up|6|||
13473882|NCT04405076|26994185|FG001|Part A (Blinded Phase)|Lost to Follow-up|6|||
13473883|NCT04405076|26994186|FG002|Part A (Blinded Phase)|Lost to Follow-up|7|||
13473884|NCT04405076|26994187|FG003|Part A (Blinded Phase)|Lost to Follow-up|0|||
13473885|NCT04405076|26994188|FG004|Part A (Blinded Phase)|Lost to Follow-up|0|||
13473886|NCT04405076|26994189|FG005|Part A (Blinded Phase)|Lost to Follow-up|0|||
13473887|NCT04405076|26994190|FG006|Part A (Blinded Phase)|Lost to Follow-up|0|||
13473888|NCT04405076|26994191|FG007|Part A (Blinded Phase)|Lost to Follow-up|0|||
13473889|NCT04405076|26994192|FG008|Part A (Blinded Phase)|Lost to Follow-up|0|||
13473890|NCT04405076|26994184|FG000|Part A (Blinded Phase)|Physician Decision|1|||
13473891|NCT04405076|26994185|FG001|Part A (Blinded Phase)|Physician Decision|2|||
13473892|NCT04405076|26994186|FG002|Part A (Blinded Phase)|Physician Decision|0|||
13473893|NCT04405076|26994187|FG003|Part A (Blinded Phase)|Physician Decision|0|||
13473894|NCT04405076|26994188|FG004|Part A (Blinded Phase)|Physician Decision|0|||
13473895|NCT04405076|26994189|FG005|Part A (Blinded Phase)|Physician Decision|0|||
13473896|NCT04405076|26994190|FG006|Part A (Blinded Phase)|Physician Decision|0|||
13473897|NCT04405076|26994191|FG007|Part A (Blinded Phase)|Physician Decision|0|||
13473898|NCT04405076|26994192|FG008|Part A (Blinded Phase)|Physician Decision|0|||
13473899|NCT04405076|26994184|FG000|Part A (Blinded Phase)|Protocol Violation|3|||
13473900|NCT04405076|26994185|FG001|Part A (Blinded Phase)|Protocol Violation|3|||
13473901|NCT04405076|26994186|FG002|Part A (Blinded Phase)|Protocol Violation|8|||
13473902|NCT04405076|26994187|FG003|Part A (Blinded Phase)|Protocol Violation|0|||
13473903|NCT04405076|26994188|FG004|Part A (Blinded Phase)|Protocol Violation|0|||
13473904|NCT04405076|26994189|FG005|Part A (Blinded Phase)|Protocol Violation|0|||
13473905|NCT04405076|26994190|FG006|Part A (Blinded Phase)|Protocol Violation|0|||
13473906|NCT04405076|26994191|FG007|Part A (Blinded Phase)|Protocol Violation|0|||
13473907|NCT04405076|26994192|FG008|Part A (Blinded Phase)|Protocol Violation|0|||
13473908|NCT04405076|26994184|FG000|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|1|||
13473909|NCT04405076|26994185|FG001|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
13473910|NCT04405076|26994186|FG002|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
13473911|NCT04405076|26994187|FG003|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
13473912|NCT04405076|26994188|FG004|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
13473913|NCT04405076|26994189|FG005|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
13473914|NCT04405076|26994190|FG006|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
13473915|NCT04405076|26994191|FG007|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
13473916|NCT04405076|26994192|FG008|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
13473917|NCT04405076|26994184|FG000|Part A (Blinded Phase)|Withdrawal of consent (other)|1|||
13473918|NCT04405076|26994185|FG001|Part A (Blinded Phase)|Withdrawal of consent (other)|4|||
13473919|NCT04405076|26994186|FG002|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
13473920|NCT04405076|26994187|FG003|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
13473921|NCT04405076|26994188|FG004|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
13473922|NCT04405076|26994189|FG005|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
13473923|NCT04405076|26994190|FG006|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
13473924|NCT04405076|26994191|FG007|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
13473925|NCT04405076|26994192|FG008|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
13473926|NCT04405076|26994184|FG000|Part A (Blinded Phase)|Other than Specified|0|||
13473927|NCT04405076|26994185|FG001|Part A (Blinded Phase)|Other than Specified|0|||
13473928|NCT04405076|26994186|FG002|Part A (Blinded Phase)|Other than Specified|3|||
13473988|NCT04120233|26994272|FG000|Overall Study|Adverse Event|0|||
13473989|NCT04120233|26994273|FG001|Overall Study|Adverse Event|0|||
13473990|NCT04120233|26994274|FG002|Overall Study|Adverse Event|0|||
13473991|NCT04120233|26994275|FG003|Overall Study|Adverse Event|0|||
13473992|NCT04120233|26994276|FG004|Overall Study|Adverse Event|1|||
13473993|NCT04120233|26994277|FG005|Overall Study|Adverse Event|0|||
13473994|NCT04034225|26994317|FG000|Overall Study|Death|3|||
13473995|NCT04034225|26994317|FG000|Overall Study|Withdrawal by Subject|2|||
13473996|NCT04034225|26994317|FG000|Overall Study|Study termination by Sponsor|18|||
13473997|NCT04034225|26994317|FG000|Overall Study|Physician Decision|1|||
13473998|NCT04034225|26994317|FG000|Overall Study|Lack of Efficacy|1|||
13473999|NCT03981614|26994342|FG000|Overall Study|Patient withdrawn prior to treatment|5|||
13474000|NCT03981614|26994343|FG001|Overall Study|Patient withdrawn prior to treatment|5|||
13474001|NCT03981614|26994344|FG002|Overall Study|Patient withdrawn prior to treatment|1|||
13474002|NCT03934216|26994363|FG000|Randomization|Randomized in Error|1|||
13474003|NCT03934216|26994364|FG001|Randomization|Randomized in Error|1|||
13474004|NCT03934216|26994363|FG000|Treatment Period|Adverse Event|10|||
13474005|NCT03934216|26994364|FG001|Treatment Period|Adverse Event|3|||
13474006|NCT03934216|26994363|FG000|Treatment Period|Withdrawal by Participant|6|||
13474007|NCT03934216|26994364|FG001|Treatment Period|Withdrawal by Participant|2|||
13474008|NCT03934216|26994363|FG000|Treatment Period|Other Reasons|2|||
13474009|NCT03934216|26994364|FG001|Treatment Period|Other Reasons|2|||
13474010|NCT03829241|26994405|FG000|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|16|||
13474011|NCT03829241|26994406|FG001|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|19|||
13474012|NCT03829241|26994405|FG000|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|5|||
13474013|NCT03829241|26994406|FG001|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|11|||
13474014|NCT03829241|26994405|FG000|Randomization Phase (Week 1 to Week 8)|Sponsor Request|0|||
13474015|NCT03829241|26994406|FG001|Randomization Phase (Week 1 to Week 8)|Sponsor Request|1|||
13474016|NCT03829241|26994405|FG000|Randomization Phase (Week 1 to Week 8)|Adverse Event|8|||
13474017|NCT03829241|26994406|FG001|Randomization Phase (Week 1 to Week 8)|Adverse Event|9|||
13474018|NCT03829241|26994405|FG000|Randomization Phase (Week 1 to Week 8)|Non compliance|2|||
13474019|NCT03829241|26994406|FG001|Randomization Phase (Week 1 to Week 8)|Non compliance|1|||
13474020|NCT03829241|26994405|FG000|Randomization Phase (Week 1 to Week 8)|Pregnancy|0|||
13474021|NCT03829241|26994406|FG001|Randomization Phase (Week 1 to Week 8)|Pregnancy|1|||
13474022|NCT03829241|26994405|FG000|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|20|||
13474023|NCT03829241|26994406|FG001|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|24|||
13474024|NCT03829241|26994405|FG000|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|9|||
13474025|NCT03829241|26994406|FG001|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|7|||
13474026|NCT03829241|26994405|FG000|Extension Phase (Week 9 up to Week 48)|Physician Decision|1|||
13474027|NCT03829241|26994406|FG001|Extension Phase (Week 9 up to Week 48)|Physician Decision|0|||
13474028|NCT03829241|26994405|FG000|Extension Phase (Week 9 up to Week 48)|Sponsor Request|117|||
13474029|NCT03829241|26994406|FG001|Extension Phase (Week 9 up to Week 48)|Sponsor Request|108|||
13474030|NCT03829241|26994405|FG000|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|0|||
13474031|NCT03829241|26994406|FG001|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|1|||
13474032|NCT03829241|26994405|FG000|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
13474033|NCT03829241|26994406|FG001|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
13474034|NCT03829241|26994405|FG000|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
13474035|NCT03829241|26994406|FG001|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
13474036|NCT03829241|26994405|FG000|Extension Phase (Week 9 up to Week 48)|Pregnancy|0|||
13474037|NCT03829241|26994406|FG001|Extension Phase (Week 9 up to Week 48)|Pregnancy|2|||
13474038|NCT03820323|26994427|FG000|Overall Study|Lost to Follow-up|2|||
13474039|NCT03820323|26994428|FG001|Overall Study|Lost to Follow-up|1|||
13474040|NCT03820323|26994427|FG000|Overall Study|Missed 12-month visit|22|||
13474041|NCT03820323|26994428|FG001|Overall Study|Missed 12-month visit|14|||
13474042|NCT03820323|26994427|FG000|Overall Study|Death|2|||
13474043|NCT03820323|26994428|FG001|Overall Study|Death|1|||
13474044|NCT03820323|26994427|FG000|Overall Study|Transferred out|13|||
13474045|NCT03820323|26994428|FG001|Overall Study|Transferred out|11|||
13474046|NCT03820323|26994427|FG000|Overall Study|Terminated|0|||
13474047|NCT03820323|26994428|FG001|Overall Study|Terminated|3|||
13474048|NCT03820323|26994427|FG000|Overall Study|Withdrawal by Subject|1|||
13474049|NCT03820323|26994428|FG001|Overall Study|Withdrawal by Subject|6|||
13474050|NCT03768336|26994438|FG000|Overall Study|Lost to Follow-up|3|||
13474051|NCT03768336|26994439|FG001|Overall Study|Lost to Follow-up|2|||
13474052|NCT03768336|26994438|FG000|Overall Study|Became Ineligible|2|||
13474053|NCT03768336|26994439|FG001|Overall Study|Became Ineligible|0|||
13474054|NCT03768336|26994438|FG000|Overall Study|Missed final survey (3-month follow-up)|1|||
13474055|NCT03768336|26994439|FG001|Overall Study|Missed final survey (3-month follow-up)|0|||
13474056|NCT03768336|26994438|FG000|Overall Study|Missed final survey (post-treatment|0|||
13474057|NCT03768336|26994439|FG001|Overall Study|Missed final survey (post-treatment|1|||
13474058|NCT03668613|26994510|FG000|Overall Study|Adverse Event|0|||
13474059|NCT03668613|26994511|FG001|Overall Study|Adverse Event|2|||
13474060|NCT03668613|26994510|FG000|Overall Study|Lack of Efficacy|0|||
13474061|NCT03668613|26994511|FG001|Overall Study|Lack of Efficacy|1|||
13474062|NCT03649711|26994532|FG000|Overall Study|Adverse Event|0|||
13474063|NCT03649711|26994533|FG001|Overall Study|Adverse Event|1|||
13474064|NCT03649711|26994534|FG002|Overall Study|Adverse Event|0|||
13474065|NCT03649711|26994532|FG000|Overall Study|Kidney Transplant|1|||
13474066|NCT03649711|26994533|FG001|Overall Study|Kidney Transplant|0|||
13474067|NCT03649711|26994534|FG002|Overall Study|Kidney Transplant|0|||
13474068|NCT03633617|26994637|FG000|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|1|||
13474069|NCT03633617|26994638|FG001|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|3|||
13474070|NCT03633617|26994639|FG002|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
13474071|NCT03633617|26994640|FG003|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
13474072|NCT03633617|26994641|FG004|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
13474073|NCT03633617|26994637|FG000|Part A|Unconfirmed early termination visit|1|||
13474074|NCT03633617|26994638|FG001|Part A|Unconfirmed early termination visit|0|||
13474075|NCT03633617|26994639|FG002|Part A|Unconfirmed early termination visit|0|||
13474076|NCT03633617|26994640|FG003|Part A|Unconfirmed early termination visit|0|||
13474077|NCT03633617|26994641|FG004|Part A|Unconfirmed early termination visit|0|||
13474078|NCT03633617|26994637|FG000|Part A|Adverse Event|0|||
13474079|NCT03633617|26994638|FG001|Part A|Adverse Event|1|||
13474080|NCT03633617|26994639|FG002|Part A|Adverse Event|0|||
13474081|NCT03633617|26994640|FG003|Part A|Adverse Event|0|||
13474082|NCT03633617|26994641|FG004|Part A|Adverse Event|0|||
13474083|NCT03633617|26994637|FG000|Part A|Pregnancy|1|||
13474084|NCT03633617|26994638|FG001|Part A|Pregnancy|0|||
13474085|NCT03633617|26994639|FG002|Part A|Pregnancy|0|||
13474086|NCT03633617|26994640|FG003|Part A|Pregnancy|0|||
13474087|NCT03633617|26994641|FG004|Part A|Pregnancy|0|||
13474088|NCT03633617|26994637|FG000|Part A|Withdrawal by Subject|0|||
13474089|NCT03633617|26994638|FG001|Part A|Withdrawal by Subject|1|||
13474090|NCT03633617|26994639|FG002|Part A|Withdrawal by Subject|0|||
13474091|NCT03633617|26994640|FG003|Part A|Withdrawal by Subject|0|||
13474092|NCT03633617|26994641|FG004|Part A|Withdrawal by Subject|0|||
13474093|NCT03633617|26994637|FG000|Part B|Adverse Event|0|||
13474094|NCT03633617|26994638|FG001|Part B|Adverse Event|0|||
13474095|NCT03633617|26994639|FG002|Part B|Adverse Event|2|||
13474096|NCT03633617|26994640|FG003|Part B|Adverse Event|2|||
13474097|NCT03633617|26994641|FG004|Part B|Adverse Event|1|||
13474098|NCT03633617|26994637|FG000|Part B|Withdrawal by Subject|0|||
13474099|NCT03633617|26994638|FG001|Part B|Withdrawal by Subject|0|||
13474100|NCT03633617|26994639|FG002|Part B|Withdrawal by Subject|1|||
13474101|NCT03633617|26994640|FG003|Part B|Withdrawal by Subject|0|||
13474102|NCT03633617|26994641|FG004|Part B|Withdrawal by Subject|2|||
13474103|NCT03633617|26994637|FG000|Part B|Lost to Follow-up|0|||
13474104|NCT03633617|26994638|FG001|Part B|Lost to Follow-up|0|||
13474105|NCT03633617|26994639|FG002|Part B|Lost to Follow-up|0|||
13474106|NCT03633617|26994640|FG003|Part B|Lost to Follow-up|0|||
13474107|NCT03633617|26994641|FG004|Part B|Lost to Follow-up|1|||
13474108|NCT03633617|26994637|FG000|Part B|Physician Decision|0|||
13474109|NCT03633617|26994638|FG001|Part B|Physician Decision|0|||
13474110|NCT03633617|26994639|FG002|Part B|Physician Decision|0|||
13474111|NCT03633617|26994640|FG003|Part B|Physician Decision|0|||
13474112|NCT03633617|26994641|FG004|Part B|Physician Decision|1|||
13474113|NCT03633617|26994637|FG000|Part B|COVID-19 Restrictions|0|||
13474114|NCT03633617|26994638|FG001|Part B|COVID-19 Restrictions|0|||
13474115|NCT03633617|26994639|FG002|Part B|COVID-19 Restrictions|1|||
13474116|NCT03633617|26994640|FG003|Part B|COVID-19 Restrictions|0|||
13474117|NCT03633617|26994641|FG004|Part B|COVID-19 Restrictions|0|||
13474118|NCT03633617|26994637|FG000|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
13474119|NCT03633617|26994638|FG001|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
13474120|NCT03633617|26994639|FG002|Part B|Subject randomized, but did not receive study drug; did not qualify for study|1|||
13474121|NCT03633617|26994640|FG003|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
13474122|NCT03633617|26994641|FG004|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
13474123|NCT03621761|26994668|FG000|Overall Study|Lost to Follow-up|1|||
13474124|NCT03621761|26994669|FG001|Overall Study|Lost to Follow-up|1|||
13474125|NCT03621761|26994670|FG002|Overall Study|Lost to Follow-up|2|||
13474126|NCT03621761|26994668|FG000|Overall Study|Withdrawal by Subject|2|||
13474127|NCT03621761|26994669|FG001|Overall Study|Withdrawal by Subject|1|||
13474128|NCT03621761|26994670|FG002|Overall Study|Withdrawal by Subject|1|||
13474129|NCT03621761|26994668|FG000|Overall Study|Became Ineligible|0|||
13474130|NCT03621761|26994669|FG001|Overall Study|Became Ineligible|2|||
13474131|NCT03621761|26994670|FG002|Overall Study|Became Ineligible|0|||
13474132|NCT03580369|26994771|FG000|Overall Study|No treatment due to mis-randomization|1|||
13474133|NCT03580369|26994772|FG001|Overall Study|No treatment due to mis-randomization|0|||
13474134|NCT03580369|26994773|FG002|Overall Study|No treatment due to mis-randomization|0|||
13474135|NCT03580369|26994774|FG003|Overall Study|No treatment due to mis-randomization|0|||
13474136|NCT03580369|26994775|FG004|Overall Study|No treatment due to mis-randomization|3|||
13474137|NCT03580369|26994776|FG005|Overall Study|No treatment due to mis-randomization|0|||
13474138|NCT03580369|26994777|FG006|Overall Study|No treatment due to mis-randomization|0|||
13474139|NCT03580369|26994778|FG007|Overall Study|No treatment due to mis-randomization|0|||
13474140|NCT03580369|26994771|FG000|Overall Study|Reason unknown|0|||
13474141|NCT03580369|26994772|FG001|Overall Study|Reason unknown|0|||
13474142|NCT03580369|26994773|FG002|Overall Study|Reason unknown|1|||
13474143|NCT03580369|26994774|FG003|Overall Study|Reason unknown|0|||
13474144|NCT03580369|26994775|FG004|Overall Study|Reason unknown|0|||
13474145|NCT03580369|26994776|FG005|Overall Study|Reason unknown|0|||
13474146|NCT03580369|26994777|FG006|Overall Study|Reason unknown|0|||
13474147|NCT03580369|26994778|FG007|Overall Study|Reason unknown|0|||
13474148|NCT03580369|26994771|FG000|Overall Study|Technical problems|0|||
13474149|NCT03580369|26994772|FG001|Overall Study|Technical problems|0|||
13474150|NCT03580369|26994773|FG002|Overall Study|Technical problems|0|||
13474151|NCT03580369|26994774|FG003|Overall Study|Technical problems|0|||
13474152|NCT03580369|26994775|FG004|Overall Study|Technical problems|1|||
13474153|NCT03580369|26994776|FG005|Overall Study|Technical problems|0|||
13474154|NCT03580369|26994777|FG006|Overall Study|Technical problems|2|||
13474155|NCT03580369|26994778|FG007|Overall Study|Technical problems|0|||
13474156|NCT03580369|26994771|FG000|Overall Study|Pregnancy|2|||
13474157|NCT03580369|26994772|FG001|Overall Study|Pregnancy|0|||
13474158|NCT03580369|26994773|FG002|Overall Study|Pregnancy|3|||
13474159|NCT03580369|26994774|FG003|Overall Study|Pregnancy|0|||
13474160|NCT03580369|26994775|FG004|Overall Study|Pregnancy|2|||
13474161|NCT03580369|26994776|FG005|Overall Study|Pregnancy|0|||
13474162|NCT03580369|26994777|FG006|Overall Study|Pregnancy|0|||
13474163|NCT03580369|26994778|FG007|Overall Study|Pregnancy|0|||
13474164|NCT03580369|26994771|FG000|Overall Study|Lost to Follow-up|2|||
13474165|NCT03580369|26994772|FG001|Overall Study|Lost to Follow-up|0|||
13474166|NCT03580369|26994773|FG002|Overall Study|Lost to Follow-up|2|||
13474167|NCT03580369|26994774|FG003|Overall Study|Lost to Follow-up|0|||
13474168|NCT03580369|26994775|FG004|Overall Study|Lost to Follow-up|3|||
13474169|NCT03580369|26994776|FG005|Overall Study|Lost to Follow-up|0|||
13474170|NCT03580369|26994777|FG006|Overall Study|Lost to Follow-up|1|||
13474171|NCT03580369|26994778|FG007|Overall Study|Lost to Follow-up|0|||
13474172|NCT03580369|26994771|FG000|Overall Study|Physician Decision|4|||
13474173|NCT03580369|26994772|FG001|Overall Study|Physician Decision|0|||
13474174|NCT03580369|26994773|FG002|Overall Study|Physician Decision|4|||
13474175|NCT03580369|26994774|FG003|Overall Study|Physician Decision|1|||
13474176|NCT03580369|26994775|FG004|Overall Study|Physician Decision|1|||
13474177|NCT03580369|26994776|FG005|Overall Study|Physician Decision|0|||
13474178|NCT03580369|26994777|FG006|Overall Study|Physician Decision|0|||
13474179|NCT03580369|26994778|FG007|Overall Study|Physician Decision|0|||
13474180|NCT03580369|26994771|FG000|Overall Study|Lack of Efficacy|3|||
13474181|NCT03580369|26994772|FG001|Overall Study|Lack of Efficacy|0|||
13474182|NCT03580369|26994773|FG002|Overall Study|Lack of Efficacy|7|||
13474183|NCT03580369|26994774|FG003|Overall Study|Lack of Efficacy|0|||
13474184|NCT03580369|26994775|FG004|Overall Study|Lack of Efficacy|2|||
13474185|NCT03580369|26994776|FG005|Overall Study|Lack of Efficacy|0|||
13474186|NCT03580369|26994777|FG006|Overall Study|Lack of Efficacy|3|||
13474187|NCT03580369|26994778|FG007|Overall Study|Lack of Efficacy|0|||
13474188|NCT03580369|26994771|FG000|Overall Study|Protocol Violation|6|||
13474189|NCT03580369|26994772|FG001|Overall Study|Protocol Violation|0|||
13474190|NCT03580369|26994773|FG002|Overall Study|Protocol Violation|6|||
13474191|NCT03580369|26994774|FG003|Overall Study|Protocol Violation|1|||
13474192|NCT03580369|26994775|FG004|Overall Study|Protocol Violation|8|||
13474193|NCT03580369|26994776|FG005|Overall Study|Protocol Violation|2|||
13474194|NCT03580369|26994777|FG006|Overall Study|Protocol Violation|1|||
13474195|NCT03580369|26994778|FG007|Overall Study|Protocol Violation|0|||
13474196|NCT03580369|26994771|FG000|Overall Study|Adverse Event|7|||
13474197|NCT03580369|26994772|FG001|Overall Study|Adverse Event|0|||
13474198|NCT03580369|26994773|FG002|Overall Study|Adverse Event|14|||
13474199|NCT03580369|26994774|FG003|Overall Study|Adverse Event|1|||
13474200|NCT03580369|26994775|FG004|Overall Study|Adverse Event|6|||
13474201|NCT03580369|26994776|FG005|Overall Study|Adverse Event|0|||
13474202|NCT03580369|26994777|FG006|Overall Study|Adverse Event|1|||
13474203|NCT03580369|26994778|FG007|Overall Study|Adverse Event|0|||
13474204|NCT03580369|26994771|FG000|Overall Study|Withdrawal by Subject|19|||
13474205|NCT03580369|26994772|FG001|Overall Study|Withdrawal by Subject|0|||
13474206|NCT03580369|26994773|FG002|Overall Study|Withdrawal by Subject|17|||
13474207|NCT03580369|26994774|FG003|Overall Study|Withdrawal by Subject|0|||
13474208|NCT03580369|26994775|FG004|Overall Study|Withdrawal by Subject|16|||
13474209|NCT03580369|26994776|FG005|Overall Study|Withdrawal by Subject|1|||
13474210|NCT03580369|26994777|FG006|Overall Study|Withdrawal by Subject|7|||
13474211|NCT03580369|26994778|FG007|Overall Study|Withdrawal by Subject|0|||
13474212|NCT03567174|26994826|FG000|Overall Study|Death|24|||
13474213|NCT03567174|26994827|FG001|Overall Study|Death|31|||
13474214|NCT03567174|26994826|FG000|Overall Study|Lost to Follow-up|165|||
13474215|NCT03567174|26994827|FG001|Overall Study|Lost to Follow-up|174|||
13474220|NCT03350503|26994981|FG000|Overall Study|Adverse Event|5|||
13474221|NCT03350503|26994981|FG000|Overall Study|Withdrawal by Subject|5|||
13474222|NCT03350503|26994981|FG000|Overall Study|Continuation impossible due to move|4|||
13474223|NCT03350503|26994981|FG000|Overall Study|Physician Decision|3|||
13474224|NCT03331562|26995012|FG000|Overall Study|Adverse Event|2|||
13474225|NCT03331562|26995013|FG001|Overall Study|Adverse Event|0|||
13474226|NCT03331562|26995012|FG000|Overall Study|Death|1|||
13474227|NCT03331562|26995013|FG001|Overall Study|Death|0|||
13474228|NCT03268954|26995098|FG000|Overall Study|Ongoing|23|||
13474229|NCT03268954|26995099|FG001|Overall Study|Ongoing|31|||
13474230|NCT03268954|26995098|FG000|Overall Study|Adverse Event|53|||
13474231|NCT03268954|26995099|FG001|Overall Study|Adverse Event|62|||
13474232|NCT03268954|26995098|FG000|Overall Study|Withdrawal by Subject|25|||
13474233|NCT03268954|26995099|FG001|Overall Study|Withdrawal by Subject|16|||
13474234|NCT03268954|26995098|FG000|Overall Study|Progressive Disease|61|||
13474235|NCT03268954|26995099|FG001|Overall Study|Progressive Disease|48|||
13474236|NCT03268954|26995098|FG000|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|25|||
13474237|NCT03268954|26995099|FG001|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|30|||
13474238|NCT03268954|26995098|FG000|Overall Study|Reason not Specified|40|||
13474239|NCT03268954|26995099|FG001|Overall Study|Reason not Specified|40|||
13474252|NCT03126110|26995661|FG000|Phase 1|Death|2|||
13474253|NCT03126110|26995662|FG001|Phase 1|Death|2|||
13474254|NCT03126110|26995663|FG002|Phase 1|Death|4|||
13474255|NCT03126110|26995664|FG003|Phase 1|Death|3|||
13474256|NCT03126110|26995665|FG004|Phase 1|Death|4|||
13474257|NCT03126110|26995666|FG005|Phase 1|Death|4|||
13474258|NCT03126110|26995667|FG006|Phase 1|Death|3|||
13474259|NCT03126110|26995668|FG007|Phase 1|Death|4|||
13474260|NCT03126110|26995669|FG008|Phase 1|Death|5|||
13474261|NCT03126110|26995670|FG009|Phase 1|Death|2|||
13474262|NCT03126110|26995671|FG010|Phase 1|Death|6|||
13474263|NCT03126110|26995672|FG011|Phase 1|Death|0|||
13474264|NCT03126110|26995673|FG012|Phase 1|Death|0|||
13474265|NCT03126110|26995674|FG013|Phase 1|Death|0|||
13474266|NCT03126110|26995675|FG014|Phase 1|Death|0|||
13474267|NCT03126110|26995676|FG015|Phase 1|Death|0|||
13474268|NCT03126110|26995677|FG016|Phase 1|Death|0|||
13474269|NCT03126110|26995661|FG000|Phase 1|Lost to Follow-up|0|||
13474270|NCT03126110|26995662|FG001|Phase 1|Lost to Follow-up|1|||
13474271|NCT03126110|26995663|FG002|Phase 1|Lost to Follow-up|0|||
13474272|NCT03126110|26995664|FG003|Phase 1|Lost to Follow-up|0|||
13474273|NCT03126110|26995665|FG004|Phase 1|Lost to Follow-up|0|||
13474274|NCT03126110|26995666|FG005|Phase 1|Lost to Follow-up|0|||
13474275|NCT03126110|26995667|FG006|Phase 1|Lost to Follow-up|0|||
13474276|NCT03126110|26995668|FG007|Phase 1|Lost to Follow-up|0|||
13474277|NCT03126110|26995669|FG008|Phase 1|Lost to Follow-up|1|||
13474278|NCT03126110|26995670|FG009|Phase 1|Lost to Follow-up|0|||
13474279|NCT03126110|26995671|FG010|Phase 1|Lost to Follow-up|0|||
13474280|NCT03126110|26995672|FG011|Phase 1|Lost to Follow-up|0|||
13474281|NCT03126110|26995673|FG012|Phase 1|Lost to Follow-up|0|||
13474282|NCT03126110|26995674|FG013|Phase 1|Lost to Follow-up|0|||
13474283|NCT03126110|26995675|FG014|Phase 1|Lost to Follow-up|0|||
13474284|NCT03126110|26995676|FG015|Phase 1|Lost to Follow-up|0|||
13474285|NCT03126110|26995677|FG016|Phase 1|Lost to Follow-up|0|||
13474286|NCT03126110|26995661|FG000|Phase 1|Withdrawal by Subject|1|||
13474287|NCT03126110|26995662|FG001|Phase 1|Withdrawal by Subject|0|||
13474288|NCT03126110|26995663|FG002|Phase 1|Withdrawal by Subject|0|||
13474289|NCT03126110|26995664|FG003|Phase 1|Withdrawal by Subject|1|||
13474290|NCT03126110|26995665|FG004|Phase 1|Withdrawal by Subject|1|||
13474291|NCT03126110|26995666|FG005|Phase 1|Withdrawal by Subject|0|||
13474292|NCT03126110|26995667|FG006|Phase 1|Withdrawal by Subject|0|||
13474293|NCT03126110|26995668|FG007|Phase 1|Withdrawal by Subject|0|||
13474294|NCT03126110|26995669|FG008|Phase 1|Withdrawal by Subject|2|||
13474295|NCT03126110|26995670|FG009|Phase 1|Withdrawal by Subject|1|||
13474296|NCT03126110|26995671|FG010|Phase 1|Withdrawal by Subject|0|||
13474297|NCT03126110|26995672|FG011|Phase 1|Withdrawal by Subject|0|||
13474298|NCT03126110|26995673|FG012|Phase 1|Withdrawal by Subject|0|||
13474299|NCT03126110|26995674|FG013|Phase 1|Withdrawal by Subject|0|||
13474300|NCT03126110|26995675|FG014|Phase 1|Withdrawal by Subject|0|||
13474301|NCT03126110|26995676|FG015|Phase 1|Withdrawal by Subject|0|||
13474302|NCT03126110|26995677|FG016|Phase 1|Withdrawal by Subject|0|||
13474303|NCT03126110|26995661|FG000|Phase 1|Safety follow-up no longer necessary|1|||
13474304|NCT03126110|26995662|FG001|Phase 1|Safety follow-up no longer necessary|0|||
13474305|NCT03126110|26995663|FG002|Phase 1|Safety follow-up no longer necessary|0|||
13474306|NCT03126110|26995664|FG003|Phase 1|Safety follow-up no longer necessary|0|||
13474307|NCT03126110|26995665|FG004|Phase 1|Safety follow-up no longer necessary|0|||
13474308|NCT03126110|26995666|FG005|Phase 1|Safety follow-up no longer necessary|0|||
13474309|NCT03126110|26995667|FG006|Phase 1|Safety follow-up no longer necessary|0|||
13474310|NCT03126110|26995668|FG007|Phase 1|Safety follow-up no longer necessary|0|||
13474311|NCT03126110|26995669|FG008|Phase 1|Safety follow-up no longer necessary|0|||
13474312|NCT03126110|26995670|FG009|Phase 1|Safety follow-up no longer necessary|0|||
13474313|NCT03126110|26995671|FG010|Phase 1|Safety follow-up no longer necessary|0|||
13474314|NCT03126110|26995672|FG011|Phase 1|Safety follow-up no longer necessary|0|||
13474315|NCT03126110|26995673|FG012|Phase 1|Safety follow-up no longer necessary|0|||
13474316|NCT03126110|26995674|FG013|Phase 1|Safety follow-up no longer necessary|0|||
13474317|NCT03126110|26995675|FG014|Phase 1|Safety follow-up no longer necessary|0|||
13474318|NCT03126110|26995676|FG015|Phase 1|Safety follow-up no longer necessary|0|||
13474319|NCT03126110|26995677|FG016|Phase 1|Safety follow-up no longer necessary|0|||
13474320|NCT03126110|26995661|FG000|Phase 1|Survival follow-up no longer necessary|0|||
13474321|NCT03126110|26995662|FG001|Phase 1|Survival follow-up no longer necessary|0|||
13474322|NCT03126110|26995663|FG002|Phase 1|Survival follow-up no longer necessary|1|||
13474323|NCT03126110|26995664|FG003|Phase 1|Survival follow-up no longer necessary|0|||
13474324|NCT03126110|26995665|FG004|Phase 1|Survival follow-up no longer necessary|0|||
13474325|NCT03126110|26995666|FG005|Phase 1|Survival follow-up no longer necessary|0|||
13474326|NCT03126110|26995667|FG006|Phase 1|Survival follow-up no longer necessary|0|||
13474327|NCT03126110|26995668|FG007|Phase 1|Survival follow-up no longer necessary|0|||
13474328|NCT03126110|26995669|FG008|Phase 1|Survival follow-up no longer necessary|0|||
13474329|NCT03126110|26995670|FG009|Phase 1|Survival follow-up no longer necessary|0|||
13474330|NCT03126110|26995671|FG010|Phase 1|Survival follow-up no longer necessary|0|||
13474331|NCT03126110|26995672|FG011|Phase 1|Survival follow-up no longer necessary|0|||
13474332|NCT03126110|26995673|FG012|Phase 1|Survival follow-up no longer necessary|0|||
13474333|NCT03126110|26995674|FG013|Phase 1|Survival follow-up no longer necessary|0|||
13474334|NCT03126110|26995675|FG014|Phase 1|Survival follow-up no longer necessary|0|||
13474335|NCT03126110|26995676|FG015|Phase 1|Survival follow-up no longer necessary|0|||
13474336|NCT03126110|26995677|FG016|Phase 1|Survival follow-up no longer necessary|0|||
13474337|NCT03126110|26995661|FG000|Phase 2|Study terminated by the sponsor|0|||
13474338|NCT03126110|26995662|FG001|Phase 2|Study terminated by the sponsor|0|||
13474339|NCT03126110|26995663|FG002|Phase 2|Study terminated by the sponsor|0|||
13474340|NCT03126110|26995664|FG003|Phase 2|Study terminated by the sponsor|0|||
13474341|NCT03126110|26995665|FG004|Phase 2|Study terminated by the sponsor|0|||
13474342|NCT03126110|26995666|FG005|Phase 2|Study terminated by the sponsor|0|||
13474343|NCT03126110|26995667|FG006|Phase 2|Study terminated by the sponsor|0|||
13474344|NCT03126110|26995668|FG007|Phase 2|Study terminated by the sponsor|0|||
13474345|NCT03126110|26995669|FG008|Phase 2|Study terminated by the sponsor|0|||
13474346|NCT03126110|26995670|FG009|Phase 2|Study terminated by the sponsor|0|||
13474347|NCT03126110|26995671|FG010|Phase 2|Study terminated by the sponsor|0|||
13474348|NCT03126110|26995672|FG011|Phase 2|Study terminated by the sponsor|0|||
13474349|NCT03126110|26995673|FG012|Phase 2|Study terminated by the sponsor|0|||
13474350|NCT03126110|26995674|FG013|Phase 2|Study terminated by the sponsor|4|||
13474351|NCT03126110|26995675|FG014|Phase 2|Study terminated by the sponsor|0|||
13474352|NCT03126110|26995676|FG015|Phase 2|Study terminated by the sponsor|0|||
13474353|NCT03126110|26995677|FG016|Phase 2|Study terminated by the sponsor|0|||
13474354|NCT03126110|26995661|FG000|Phase 2|Withdrawal by Subject|0|||
13474355|NCT03126110|26995662|FG001|Phase 2|Withdrawal by Subject|0|||
13474356|NCT03126110|26995663|FG002|Phase 2|Withdrawal by Subject|0|||
13474357|NCT03126110|26995664|FG003|Phase 2|Withdrawal by Subject|0|||
13474358|NCT03126110|26995665|FG004|Phase 2|Withdrawal by Subject|0|||
13474359|NCT03126110|26995666|FG005|Phase 2|Withdrawal by Subject|0|||
13474360|NCT03126110|26995667|FG006|Phase 2|Withdrawal by Subject|0|||
13474361|NCT03126110|26995668|FG007|Phase 2|Withdrawal by Subject|0|||
13474362|NCT03126110|26995669|FG008|Phase 2|Withdrawal by Subject|0|||
13474363|NCT03126110|26995670|FG009|Phase 2|Withdrawal by Subject|0|||
13474364|NCT03126110|26995671|FG010|Phase 2|Withdrawal by Subject|0|||
13474365|NCT03126110|26995672|FG011|Phase 2|Withdrawal by Subject|1|||
13474366|NCT03126110|26995673|FG012|Phase 2|Withdrawal by Subject|3|||
13474367|NCT03126110|26995674|FG013|Phase 2|Withdrawal by Subject|3|||
13474368|NCT03126110|26995675|FG014|Phase 2|Withdrawal by Subject|2|||
13474369|NCT03126110|26995676|FG015|Phase 2|Withdrawal by Subject|1|||
13474370|NCT03126110|26995677|FG016|Phase 2|Withdrawal by Subject|0|||
13474371|NCT03126110|26995661|FG000|Phase 2|Lost to Follow-up|0|||
13474372|NCT03126110|26995662|FG001|Phase 2|Lost to Follow-up|0|||
13474373|NCT03126110|26995663|FG002|Phase 2|Lost to Follow-up|0|||
13474374|NCT03126110|26995664|FG003|Phase 2|Lost to Follow-up|0|||
13474375|NCT03126110|26995665|FG004|Phase 2|Lost to Follow-up|0|||
13474376|NCT03126110|26995666|FG005|Phase 2|Lost to Follow-up|0|||
13474377|NCT03126110|26995667|FG006|Phase 2|Lost to Follow-up|0|||
13474378|NCT03126110|26995668|FG007|Phase 2|Lost to Follow-up|0|||
13474379|NCT03126110|26995669|FG008|Phase 2|Lost to Follow-up|0|||
13474380|NCT03126110|26995670|FG009|Phase 2|Lost to Follow-up|0|||
13474381|NCT03126110|26995671|FG010|Phase 2|Lost to Follow-up|0|||
13474382|NCT03126110|26995672|FG011|Phase 2|Lost to Follow-up|1|||
13474383|NCT03126110|26995673|FG012|Phase 2|Lost to Follow-up|1|||
13474384|NCT03126110|26995674|FG013|Phase 2|Lost to Follow-up|1|||
13474385|NCT03126110|26995675|FG014|Phase 2|Lost to Follow-up|2|||
13474386|NCT03126110|26995676|FG015|Phase 2|Lost to Follow-up|0|||
13474387|NCT03126110|26995677|FG016|Phase 2|Lost to Follow-up|0|||
13474388|NCT03126110|26995661|FG000|Phase 2|Death|0|||
13474389|NCT03126110|26995662|FG001|Phase 2|Death|0|||
13474390|NCT03126110|26995663|FG002|Phase 2|Death|0|||
13474391|NCT03126110|26995664|FG003|Phase 2|Death|0|||
13474392|NCT03126110|26995665|FG004|Phase 2|Death|0|||
13474393|NCT03126110|26995666|FG005|Phase 2|Death|0|||
13474394|NCT03126110|26995667|FG006|Phase 2|Death|0|||
13474395|NCT03126110|26995668|FG007|Phase 2|Death|0|||
13474396|NCT03126110|26995669|FG008|Phase 2|Death|0|||
13474397|NCT03126110|26995670|FG009|Phase 2|Death|0|||
13474398|NCT03126110|26995671|FG010|Phase 2|Death|0|||
13474399|NCT03126110|26995672|FG011|Phase 2|Death|6|||
13474400|NCT03126110|26995673|FG012|Phase 2|Death|12|||
13474401|NCT03126110|26995674|FG013|Phase 2|Death|25|||
13474402|NCT03126110|26995675|FG014|Phase 2|Death|11|||
13474403|NCT03126110|26995676|FG015|Phase 2|Death|3|||
13474404|NCT03126110|26995677|FG016|Phase 2|Death|2|||
13474405|NCT03126110|26995661|FG000|Phase 2|Progressive Disease|0|||
13474406|NCT03126110|26995662|FG001|Phase 2|Progressive Disease|0|||
13474407|NCT03126110|26995663|FG002|Phase 2|Progressive Disease|0|||
13474408|NCT03126110|26995664|FG003|Phase 2|Progressive Disease|0|||
13474409|NCT03126110|26995665|FG004|Phase 2|Progressive Disease|0|||
13474410|NCT03126110|26995666|FG005|Phase 2|Progressive Disease|0|||
13474411|NCT03126110|26995667|FG006|Phase 2|Progressive Disease|0|||
13474412|NCT03126110|26995668|FG007|Phase 2|Progressive Disease|0|||
13474413|NCT03126110|26995669|FG008|Phase 2|Progressive Disease|0|||
13474414|NCT03126110|26995670|FG009|Phase 2|Progressive Disease|0|||
13474415|NCT03126110|26995671|FG010|Phase 2|Progressive Disease|0|||
13474416|NCT03126110|26995672|FG011|Phase 2|Progressive Disease|0|||
13474417|NCT03126110|26995673|FG012|Phase 2|Progressive Disease|0|||
13474418|NCT03126110|26995674|FG013|Phase 2|Progressive Disease|1|||
13474419|NCT03126110|26995675|FG014|Phase 2|Progressive Disease|0|||
13474420|NCT03126110|26995676|FG015|Phase 2|Progressive Disease|0|||
13474421|NCT03126110|26995677|FG016|Phase 2|Progressive Disease|0|||
13474422|NCT03126110|26995661|FG000|Phase 2|Started new treatment|0|||
13474423|NCT03126110|26995662|FG001|Phase 2|Started new treatment|0|||
13474424|NCT03126110|26995663|FG002|Phase 2|Started new treatment|0|||
13474425|NCT03126110|26995664|FG003|Phase 2|Started new treatment|0|||
13474426|NCT03126110|26995665|FG004|Phase 2|Started new treatment|0|||
13474427|NCT03126110|26995666|FG005|Phase 2|Started new treatment|0|||
13474428|NCT03126110|26995667|FG006|Phase 2|Started new treatment|0|||
13474429|NCT03126110|26995668|FG007|Phase 2|Started new treatment|0|||
13474430|NCT03126110|26995669|FG008|Phase 2|Started new treatment|0|||
13474431|NCT03126110|26995670|FG009|Phase 2|Started new treatment|0|||
13474432|NCT03126110|26995671|FG010|Phase 2|Started new treatment|0|||
13474433|NCT03126110|26995672|FG011|Phase 2|Started new treatment|0|||
13474434|NCT03126110|26995673|FG012|Phase 2|Started new treatment|0|||
13474435|NCT03126110|26995674|FG013|Phase 2|Started new treatment|0|||
13474436|NCT03126110|26995675|FG014|Phase 2|Started new treatment|1|||
13474437|NCT03126110|26995676|FG015|Phase 2|Started new treatment|0|||
13474438|NCT03126110|26995677|FG016|Phase 2|Started new treatment|0|||
13474439|NCT03040141|26995841|FG000|Overall Study|Death|1|||
13474440|NCT03040141|26995842|FG001|Overall Study|Death|2|||
13474441|NCT03040141|26995843|FG002|Overall Study|Death|3|||
13474442|NCT03040141|26995841|FG000|Overall Study|Withdrawal by Subject|3|||
13474443|NCT03040141|26995842|FG001|Overall Study|Withdrawal by Subject|1|||
13474444|NCT03040141|26995843|FG002|Overall Study|Withdrawal by Subject|1|||
13474445|NCT03040141|26995841|FG000|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
13474446|NCT03040141|26995842|FG001|Overall Study|Subject discharged to nursing home, not able to attend visits|1|||
13474447|NCT03040141|26995843|FG002|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
13474448|NCT03040141|26995841|FG000|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|0|||
13474449|NCT03040141|26995842|FG001|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
13474450|NCT03040141|26995843|FG002|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
13474451|NCT03011034|26995878|FG000|Overall Study|Adverse Event|1|||
13474452|NCT03011034|26995879|FG001|Overall Study|Adverse Event|0|||
13474453|NCT02996474|26995938|FG000|Overall Study|Physician Decision|5|||
13474454|NCT02924389|26996021|FG000|Overall Study|Lost to Follow-up|1|||
13474455|NCT02924389|26996022|FG001|Overall Study|Lost to Follow-up|0|||
13474456|NCT02924389|26996021|FG000|Overall Study|Physician Decision|2|||
13474457|NCT02924389|26996022|FG001|Overall Study|Physician Decision|0|||
13474458|NCT02924389|26996021|FG000|Overall Study|Withdrawal by Subject|3|||
13474459|NCT02924389|26996022|FG001|Overall Study|Withdrawal by Subject|0|||
13474460|NCT02924389|26996021|FG000|Overall Study|Participant began ARVs prior to study intervention|2|||
13474461|NCT02924389|26996022|FG001|Overall Study|Participant began ARVs prior to study intervention|0|||
13474462|NCT02923531|26996038|FG000|Overall Study|Adverse Event|4|||
13474463|NCT02923531|26996038|FG000|Overall Study|Clinical Deterioration|1|||
13474464|NCT02923531|26996038|FG000|Overall Study|Disease Progression|3|||
13474465|NCT02923531|26996038|FG000|Overall Study|Study Termination|1|||
13474466|NCT02918019|26996100|FG000|Overall Study|Death|0|||
13474467|NCT02918019|26996101|FG001|Overall Study|Death|0|||
13474468|NCT02918019|26996102|FG002|Overall Study|Death|1|||
13474469|NCT02918019|26996103|FG003|Overall Study|Death|0|||
13474470|NCT02918019|26996100|FG000|Overall Study|Lost to Follow-up|1|||
13474471|NCT02918019|26996101|FG001|Overall Study|Lost to Follow-up|1|||
13474472|NCT02918019|26996102|FG002|Overall Study|Lost to Follow-up|0|||
13474473|NCT02918019|26996103|FG003|Overall Study|Lost to Follow-up|1|||
13474474|NCT02918019|26996100|FG000|Overall Study|Principal investigator request|0|||
13474475|NCT02918019|26996101|FG001|Overall Study|Principal investigator request|0|||
13474476|NCT02918019|26996102|FG002|Overall Study|Principal investigator request|0|||
13474477|NCT02918019|26996103|FG003|Overall Study|Principal investigator request|1|||
13474478|NCT02918019|26996100|FG000|Overall Study|Physician Decision|1|||
13474479|NCT02918019|26996101|FG001|Overall Study|Physician Decision|3|||
13474480|NCT02918019|26996102|FG002|Overall Study|Physician Decision|2|||
13474481|NCT02918019|26996103|FG003|Overall Study|Physician Decision|0|||
13474482|NCT02918019|26996100|FG000|Overall Study|Protocol deviation|1|||
13474483|NCT02918019|26996101|FG001|Overall Study|Protocol deviation|1|||
13474484|NCT02918019|26996102|FG002|Overall Study|Protocol deviation|0|||
13474485|NCT02918019|26996103|FG003|Overall Study|Protocol deviation|2|||
13474486|NCT02918019|26996100|FG000|Overall Study|Withdrawal by Subject|3|||
13474487|NCT02918019|26996101|FG001|Overall Study|Withdrawal by Subject|4|||
13474488|NCT02918019|26996102|FG002|Overall Study|Withdrawal by Subject|6|||
13474489|NCT02918019|26996103|FG003|Overall Study|Withdrawal by Subject|4|||
13474490|NCT02918019|26996100|FG000|Overall Study|Adverse Event|0|||
13474491|NCT02918019|26996101|FG001|Overall Study|Adverse Event|1|||
13474492|NCT02918019|26996102|FG002|Overall Study|Adverse Event|0|||
13474493|NCT02918019|26996103|FG003|Overall Study|Adverse Event|1|||
13474494|NCT02888119|26996128|FG000|Overall Study|Lost to Follow-up|5|||
13474495|NCT02888119|26996129|FG001|Overall Study|Lost to Follow-up|4|||
13474496|NCT02888119|26996130|FG002|Overall Study|Lost to Follow-up|0|||
13474497|NCT02871297|26996149|FG000|Overall Study|Adverse Event|34|||
13474498|NCT02871297|26996149|FG000|Overall Study|Lack of Efficacy|10|||
13474499|NCT02871297|26996149|FG000|Overall Study|Non-compliance with study drug|15|||
13474500|NCT02871297|26996149|FG000|Overall Study|Protocol Violation|3|||
13474501|NCT02871297|26996149|FG000|Overall Study|Withdrawal by Subject|20|||
13474502|NCT02871297|26996149|FG000|Overall Study|Lost to Follow-up|13|||
13474503|NCT02871297|26996149|FG000|Overall Study|Rolled over to 13546A|2|||
13474504|NCT02871297|26996149|FG000|Overall Study|Other than specified|39|||
13474505|NCT02849171|26996155|FG000|Overall Study|Withdrawal by Subject|1|||
13474506|NCT02849171|26996155|FG000|Overall Study|Not treated|1|||
13474507|NCT02677896|26996209|FG000|Double Blind Period (up to 35 Months)|Death|113|||
13474508|NCT02677896|26996210|FG001|Double Blind Period (up to 35 Months)|Death|189|||
13474509|NCT02677896|26996209|FG000|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
13474510|NCT02677896|26996210|FG001|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
13474511|NCT02677896|26996209|FG000|Double Blind Period (up to 35 Months)|Progressive disease|3|||
13474512|NCT02677896|26996210|FG001|Double Blind Period (up to 35 Months)|Progressive disease|4|||
13474513|NCT02677896|26996209|FG000|Double Blind Period (up to 35 Months)|Withdrawal by Subject|41|||
13474514|NCT02677896|26996210|FG001|Double Blind Period (up to 35 Months)|Withdrawal by Subject|69|||
13474515|NCT02677896|26996209|FG000|Double Blind Period (up to 35 Months)|Miscellaneous|9|||
13474516|NCT02677896|26996210|FG001|Double Blind Period (up to 35 Months)|Miscellaneous|14|||
13474517|NCT02677896|26996209|FG000|Double Blind Period (up to 35 Months)|Continued in OLE|365|||
13474518|NCT02677896|26996210|FG001|Double Blind Period (up to 35 Months)|Continued in OLE|180|||
13474519|NCT02677896|26996209|FG000|Double Blind Period (up to 35 Months)|Followed-up for OS|31|||
13474520|NCT02677896|26996210|FG001|Double Blind Period (up to 35 Months)|Followed-up for OS|108|||
13474521|NCT02677896|26996209|FG000|Open-Label Extension (up to 25 Months)|Death|40|||
13474522|NCT02677896|26996210|FG001|Open-Label Extension (up to 25 Months)|Death|14|||
13474523|NCT02677896|26996209|FG000|Open-Label Extension (up to 25 Months)|Lost to Follow-up|2|||
13474524|NCT02677896|26996210|FG001|Open-Label Extension (up to 25 Months)|Lost to Follow-up|1|||
13474525|NCT02677896|26996209|FG000|Open-Label Extension (up to 25 Months)|Progressive disease|3|||
13474526|NCT02677896|26996210|FG001|Open-Label Extension (up to 25 Months)|Progressive disease|1|||
13474527|NCT02677896|26996209|FG000|Open-Label Extension (up to 25 Months)|Withdrawal by Subject|10|||
13474528|NCT02677896|26996210|FG001|Open-Label Extension (up to 25 Months)|Withdrawal by Subject|9|||
13474529|NCT02677896|26996209|FG000|Open-Label Extension (up to 25 Months)|Miscellaneous|0|||
13474530|NCT02677896|26996210|FG001|Open-Label Extension (up to 25 Months)|Miscellaneous|1|||
13474531|NCT02677896|26996209|FG000|Open-Label Extension (up to 25 Months)|OLE treatment ongoing|261|||
13474532|NCT02677896|26996210|FG001|Open-Label Extension (up to 25 Months)|OLE treatment ongoing|136|||
13474533|NCT02677896|26996209|FG000|Open-Label Extension (up to 25 Months)|Followed up for OS|49|||
13474534|NCT02677896|26996210|FG001|Open-Label Extension (up to 25 Months)|Followed up for OS|18|||
13474535|NCT02668653|26996231|FG000|Overall Study|Refractory disease|41|||
13474536|NCT02668653|26996232|FG001|Overall Study|Refractory disease|70|||
13474537|NCT02668653|26996231|FG000|Overall Study|Relapse|44|||
13474538|NCT02668653|26996232|FG001|Overall Study|Relapse|65|||
13474539|NCT02668653|26996231|FG000|Overall Study|Adverse Event|58|||
13474540|NCT02668653|26996232|FG001|Overall Study|Adverse Event|23|||
13474541|NCT02668653|26996231|FG000|Overall Study|Subject decision to stop study drug|25|||
13474542|NCT02668653|26996232|FG001|Overall Study|Subject decision to stop study drug|23|||
13474543|NCT02668653|26996231|FG000|Overall Study|Other reasons not specified|16|||
13474544|NCT02668653|26996232|FG001|Overall Study|Other reasons not specified|11|||
13474545|NCT02668653|26996231|FG000|Overall Study|Non-protocol-specified AML therapy|12|||
13474546|NCT02668653|26996232|FG001|Overall Study|Non-protocol-specified AML therapy|6|||
13474547|NCT02668653|26996231|FG000|Overall Study|Investigator decision|10|||
13474548|NCT02668653|26996232|FG001|Overall Study|Investigator decision|7|||
13474549|NCT02668653|26996231|FG000|Overall Study|Failure to meet continuation criteria|5|||
13474550|NCT02668653|26996232|FG001|Overall Study|Failure to meet continuation criteria|12|||
13474551|NCT02668653|26996231|FG000|Overall Study|Lost to Follow-up|1|||
13474552|NCT02668653|26996232|FG001|Overall Study|Lost to Follow-up|0|||
13474553|NCT02668653|26996231|FG000|Overall Study|Pregnancy|0|||
13474554|NCT02668653|26996232|FG001|Overall Study|Pregnancy|1|||
13474555|NCT02668653|26996231|FG000|Overall Study|Death|0|||
13474556|NCT02668653|26996232|FG001|Overall Study|Death|1|||
13474557|NCT02667587|26996253|FG000|Pre-Treatment|Not reported|1|||
13474558|NCT02667587|26996254|FG001|Pre-Treatment|Not reported|0|||
13474559|NCT02667587|26996253|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
13474560|NCT02667587|26996254|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
13474561|NCT02667587|26996253|FG000|Pre-Treatment|Participant withdrew consent|0|||
13474562|NCT02667587|26996254|FG001|Pre-Treatment|Participant withdrew consent|1|||
13474563|NCT02667587|26996253|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
13474564|NCT02667587|26996254|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
13474565|NCT02667587|26996253|FG000|End of Treatment|Other reasons|11|||
13474566|NCT02667587|26996254|FG001|End of Treatment|Other reasons|8|||
13474567|NCT02667587|26996253|FG000|End of Treatment|Participant no Longer Meets Study Criteria|1|||
13474568|NCT02667587|26996254|FG001|End of Treatment|Participant no Longer Meets Study Criteria|2|||
13474569|NCT02667587|26996253|FG000|End of Treatment|Poor/Non-Compliance|0|||
13474570|NCT02667587|26996254|FG001|End of Treatment|Poor/Non-Compliance|1|||
13474571|NCT02667587|26996253|FG000|End of Treatment|Maximum Clinical Benefit|3|||
13474572|NCT02667587|26996254|FG001|End of Treatment|Maximum Clinical Benefit|3|||
13474573|NCT02667587|26996253|FG000|End of Treatment|Participant Withdrew Consent|5|||
13474574|NCT02667587|26996254|FG001|End of Treatment|Participant Withdrew Consent|6|||
13474575|NCT02667587|26996253|FG000|End of Treatment|Participants Request to Discontinue Study Treatment|25|||
13474576|NCT02667587|26996254|FG001|End of Treatment|Participants Request to Discontinue Study Treatment|26|||
13474577|NCT02667587|26996253|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19|||
13474578|NCT02667587|26996254|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20|||
13474579|NCT02667587|26996253|FG000|End of Treatment|Death|2|||
13474580|NCT02667587|26996254|FG001|End of Treatment|Death|1|||
13474581|NCT02667587|26996253|FG000|End of Treatment|Study Drug Toxicity|74|||
13474582|NCT02667587|26996254|FG001|End of Treatment|Study Drug Toxicity|18|||
13474583|NCT02667587|26996253|FG000|End of Treatment|Disease progression|177|||
13474584|NCT02667587|26996254|FG001|End of Treatment|Disease progression|222|||
13474585|NCT02667587|26996253|FG000|End of Treatment|Lost to Follow-up|1|||
13474586|NCT02667587|26996254|FG001|End of Treatment|Lost to Follow-up|3|||
13474587|NCT02642029|26996299|FG000|Washout 1 (≥ 36 Hours)|Adverse Event|1|||
13474588|NCT02642029|26996300|FG001|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
13474589|NCT02642029|26996301|FG002|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
13474590|NCT02642029|26996302|FG003|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
13474591|NCT02642029|26996303|FG004|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
13474592|NCT02642029|26996304|FG005|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
13474593|NCT02642029|26996299|FG000|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
13474594|NCT02642029|26996300|FG001|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|1|||
13474595|NCT02642029|26996301|FG002|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
13474596|NCT02642029|26996302|FG003|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
13474597|NCT02642029|26996303|FG004|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
13474598|NCT02642029|26996304|FG005|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
13474599|NCT02642029|26996299|FG000|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
13474600|NCT02642029|26996300|FG001|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
13474601|NCT02642029|26996301|FG002|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
13474602|NCT02642029|26996302|FG003|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
13474603|NCT02642029|26996303|FG004|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|1|||
13474604|NCT02642029|26996304|FG005|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
13474605|NCT02642029|26996299|FG000|Study Visit 2 (1 Day)|Adverse Event|1|||
13474606|NCT02642029|26996300|FG001|Study Visit 2 (1 Day)|Adverse Event|0|||
13474607|NCT02642029|26996301|FG002|Study Visit 2 (1 Day)|Adverse Event|0|||
13474608|NCT02642029|26996302|FG003|Study Visit 2 (1 Day)|Adverse Event|0|||
13474609|NCT02642029|26996303|FG004|Study Visit 2 (1 Day)|Adverse Event|0|||
13474610|NCT02642029|26996304|FG005|Study Visit 2 (1 Day)|Adverse Event|0|||
13474611|NCT02642029|26996299|FG000|Washout 2 (≥ 36 Hours)|Adverse Event|1|||
13474612|NCT02642029|26996300|FG001|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
13474613|NCT02642029|26996301|FG002|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
13474614|NCT02642029|26996302|FG003|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
13474615|NCT02642029|26996303|FG004|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
13474616|NCT02642029|26996304|FG005|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
13474617|NCT02642029|26996299|FG000|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|1|||
13474618|NCT02642029|26996300|FG001|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
13474619|NCT02642029|26996301|FG002|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
13474620|NCT02642029|26996302|FG003|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
13474621|NCT02642029|26996303|FG004|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
13474622|NCT02642029|26996304|FG005|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
13474623|NCT02591615|26996353|FG000|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
13474624|NCT02591615|26996354|FG001|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
13474625|NCT02591615|26996355|FG002|Arm B Pembro Lead in Phase|Withdrawal by Subject|1|||
13474626|NCT02591615|26996356|FG003|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
13474627|NCT02591615|26996353|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
13474628|NCT02591615|26996354|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|1|||
13474629|NCT02591615|26996355|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
13474630|NCT02591615|26996356|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
13474631|NCT02591615|26996353|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|1|||
13474632|NCT02591615|26996354|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
13474633|NCT02591615|26996355|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|0|||
13474634|NCT02591615|26996356|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
13474635|NCT02591615|26996353|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|1|||
13474636|NCT02591615|26996354|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|3|||
13474637|NCT02591615|26996355|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|4|||
13474638|NCT02591615|26996356|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|12|||
13474639|NCT02591615|26996353|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Death|1|||
13474640|NCT02591615|26996354|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
13474641|NCT02591615|26996355|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Death|0|||
13474642|NCT02591615|26996356|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
13474643|NCT02591615|26996353|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
13474644|NCT02591615|26996354|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|1|||
13474645|NCT02591615|26996355|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
13474646|NCT02591615|26996356|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
13474647|NCT02591615|26996353|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
13474648|NCT02591615|26996354|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
13474649|NCT02591615|26996355|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
13474650|NCT02591615|26996356|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
13474651|NCT02591615|26996353|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|1|||
13474652|NCT02591615|26996354|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
13474653|NCT02591615|26996355|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
13474654|NCT02591615|26996356|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
13474655|NCT02591615|26996353|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
13474656|NCT02591615|26996354|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|2|||
13474657|NCT02591615|26996355|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
13474658|NCT02591615|26996356|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|1|||
13474659|NCT02591615|26996353|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|2|||
13474660|NCT02591615|26996354|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|6|||
13474661|NCT02591615|26996355|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
13474662|NCT02591615|26996356|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
13474663|NCT02591615|26996353|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
13474664|NCT02591615|26996354|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
13474665|NCT02591615|26996355|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
13474666|NCT02591615|26996356|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
13474667|NCT02591615|26996353|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
13474668|NCT02591615|26996354|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
13474669|NCT02591615|26996355|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|1|||
13474670|NCT02591615|26996356|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
13474671|NCT02591615|26996353|FG000|Maintenance MK-3475|Adverse Event|0|||
13474672|NCT02591615|26996354|FG001|Maintenance MK-3475|Adverse Event|3|||
13474673|NCT02591615|26996355|FG002|Maintenance MK-3475|Adverse Event|1|||
13474674|NCT02591615|26996356|FG003|Maintenance MK-3475|Adverse Event|2|||
13474675|NCT02591615|26996353|FG000|Maintenance MK-3475|Lack of Efficacy|0|||
13474676|NCT02591615|26996354|FG001|Maintenance MK-3475|Lack of Efficacy|9|||
13474677|NCT02591615|26996355|FG002|Maintenance MK-3475|Lack of Efficacy|0|||
13474678|NCT02591615|26996356|FG003|Maintenance MK-3475|Lack of Efficacy|8|||
13474679|NCT02591615|26996353|FG000|Maintenance MK-3475|Death|0|||
13474680|NCT02591615|26996354|FG001|Maintenance MK-3475|Death|1|||
13474681|NCT02591615|26996355|FG002|Maintenance MK-3475|Death|1|||
13474682|NCT02591615|26996356|FG003|Maintenance MK-3475|Death|0|||
13474683|NCT02591615|26996353|FG000|Maintenance MK-3475|Physician discretion|0|||
13474684|NCT02591615|26996354|FG001|Maintenance MK-3475|Physician discretion|0|||
13474685|NCT02591615|26996355|FG002|Maintenance MK-3475|Physician discretion|1|||
13474686|NCT02591615|26996356|FG003|Maintenance MK-3475|Physician discretion|0|||
13474687|NCT02591615|26996353|FG000|Maintenance MK-3475|Withdrew to hospice|0|||
13474688|NCT02591615|26996354|FG001|Maintenance MK-3475|Withdrew to hospice|1|||
13474689|NCT02591615|26996355|FG002|Maintenance MK-3475|Withdrew to hospice|0|||
13474690|NCT02591615|26996356|FG003|Maintenance MK-3475|Withdrew to hospice|0|||
13474691|NCT02591615|26996353|FG000|Maintenance MK-3475|In active treatment|2|||
13474692|NCT02591615|26996354|FG001|Maintenance MK-3475|In active treatment|0|||
13474693|NCT02591615|26996355|FG002|Maintenance MK-3475|In active treatment|0|||
13474694|NCT02591615|26996356|FG003|Maintenance MK-3475|In active treatment|1|||
13474695|NCT02576444|26996378|FG000|Overall Study|Death|1|||
13474696|NCT02576444|26996379|FG001|Overall Study|Death|1|||
13474697|NCT02576444|26996380|FG002|Overall Study|Death|0|||
13474698|NCT02576444|26996381|FG003|Overall Study|Death|0|||
13474699|NCT02576444|26996378|FG000|Overall Study|Withdrawal by Subject|0|||
13474700|NCT02576444|26996379|FG001|Overall Study|Withdrawal by Subject|0|||
13474701|NCT02576444|26996380|FG002|Overall Study|Withdrawal by Subject|2|||
13474702|NCT02576444|26996381|FG003|Overall Study|Withdrawal by Subject|0|||
13474703|NCT02576444|26996378|FG000|Overall Study|Adverse Event|0|||
13474704|NCT02576444|26996379|FG001|Overall Study|Adverse Event|0|||
13474705|NCT02576444|26996380|FG002|Overall Study|Adverse Event|1|||
13474706|NCT02576444|26996381|FG003|Overall Study|Adverse Event|0|||
13474707|NCT02576444|26996378|FG000|Overall Study|Physician Decision|0|||
13474708|NCT02576444|26996379|FG001|Overall Study|Physician Decision|0|||
13474709|NCT02576444|26996380|FG002|Overall Study|Physician Decision|1|||
13474710|NCT02576444|26996381|FG003|Overall Study|Physician Decision|0|||
13474711|NCT02522429|26996391|FG000|Overall Study|Lost to Follow-up|8|||
13474712|NCT02522429|26996391|FG000|Overall Study|Adverse Event|2|||
13474713|NCT02522429|26996391|FG000|Overall Study|Death|1|||
13474714|NCT02522429|26996391|FG000|Overall Study|Patient exceeded inclusion criteria after enrollment but prior to undergoing study procedures|1|||
13474715|NCT02509507|26996463|FG000|Overall Study|Death|21|||
13474716|NCT02509507|26996464|FG001|Overall Study|Death|3|||
13474717|NCT02509507|26996465|FG002|Overall Study|Death|22|||
13474718|NCT02509507|26996466|FG003|Overall Study|Death|13|||
13474719|NCT02509507|26996467|FG004|Overall Study|Death|6|||
13474720|NCT02509507|26996468|FG005|Overall Study|Death|9|||
13474721|NCT02509507|26996469|FG006|Overall Study|Death|4|||
13474722|NCT02509507|26996470|FG007|Overall Study|Death|3|||
13474723|NCT02509507|26996471|FG008|Overall Study|Death|7|||
13474724|NCT02509507|26996463|FG000|Overall Study|Lost to Follow-up|0|||
13474725|NCT02509507|26996464|FG001|Overall Study|Lost to Follow-up|1|||
13474726|NCT02509507|26996465|FG002|Overall Study|Lost to Follow-up|0|||
13474727|NCT02509507|26996466|FG003|Overall Study|Lost to Follow-up|0|||
13474728|NCT02509507|26996467|FG004|Overall Study|Lost to Follow-up|0|||
13474729|NCT02509507|26996468|FG005|Overall Study|Lost to Follow-up|1|||
13474730|NCT02509507|26996469|FG006|Overall Study|Lost to Follow-up|0|||
13474731|NCT02509507|26996470|FG007|Overall Study|Lost to Follow-up|0|||
13474732|NCT02509507|26996471|FG008|Overall Study|Lost to Follow-up|0|||
13474733|NCT02509507|26996463|FG000|Overall Study|Withdrawal by Subject|2|||
13474734|NCT02509507|26996464|FG001|Overall Study|Withdrawal by Subject|0|||
13474735|NCT02509507|26996465|FG002|Overall Study|Withdrawal by Subject|1|||
13474736|NCT02509507|26996466|FG003|Overall Study|Withdrawal by Subject|4|||
13474737|NCT02509507|26996467|FG004|Overall Study|Withdrawal by Subject|0|||
13474738|NCT02509507|26996468|FG005|Overall Study|Withdrawal by Subject|3|||
13474739|NCT02509507|26996469|FG006|Overall Study|Withdrawal by Subject|3|||
13474740|NCT02509507|26996470|FG007|Overall Study|Withdrawal by Subject|0|||
13474741|NCT02509507|26996471|FG008|Overall Study|Withdrawal by Subject|0|||
13474742|NCT02509507|26996463|FG000|Overall Study|Continuing Study|0|||
13474743|NCT02509507|26996464|FG001|Overall Study|Continuing Study|1|||
13474744|NCT02509507|26996465|FG002|Overall Study|Continuing Study|1|||
13474745|NCT02509507|26996466|FG003|Overall Study|Continuing Study|5|||
13474746|NCT02509507|26996467|FG004|Overall Study|Continuing Study|4|||
13474747|NCT02509507|26996468|FG005|Overall Study|Continuing Study|5|||
13474748|NCT02509507|26996469|FG006|Overall Study|Continuing Study|3|||
13474749|NCT02509507|26996470|FG007|Overall Study|Continuing Study|2|||
13474750|NCT02509507|26996471|FG008|Overall Study|Continuing Study|3|||
13474751|NCT02486042|26996496|FG000|Overall Study|Physician Decision|1|||
13474752|NCT02486042|26996497|FG001|Overall Study|Physician Decision|7|||
13474753|NCT02486042|26996496|FG000|Overall Study|Hospital transfer|2|||
13474754|NCT02486042|26996497|FG001|Overall Study|Hospital transfer|2|||
13474755|NCT02486042|26996496|FG000|Overall Study|Withdrawal by Subject|0|||
13220005|NCT01827592|26278994|FG001|Overall Study|Withdrawal by Subject|11|||
13220006|NCT01827592|26278995|FG002|Overall Study|Withdrawal by Subject|11|||
13220007|NCT01827592|26278993|FG000|Overall Study|Patient's substantial non-compliance|1|||
13220008|NCT01827592|26278994|FG001|Overall Study|Patient's substantial non-compliance|1|||
13220009|NCT01827592|26278995|FG002|Overall Study|Patient's substantial non-compliance|6|||
13220010|NCT01827592|26278993|FG000|Overall Study|Trial terminated by Sponsor|47|||
13220011|NCT01827592|26278994|FG001|Overall Study|Trial terminated by Sponsor|53|||
13220012|NCT01827592|26278995|FG002|Overall Study|Trial terminated by Sponsor|51|||
13220013|NCT01827592|26278993|FG000|Overall Study|Others|0|||
13220014|NCT01827592|26278994|FG001|Overall Study|Others|1|||
13220015|NCT01827592|26278995|FG002|Overall Study|Others|3|||
13220016|NCT01827384|26279094|FG000|Overall Study|Switched to alternative treatment|0|||
13220017|NCT01827384|26279095|FG001|Overall Study|Switched to alternative treatment|0|||
13220018|NCT01827384|26279096|FG002|Overall Study|Switched to alternative treatment|0|||
13220019|NCT01827384|26279097|FG003|Overall Study|Switched to alternative treatment|0|||
13220020|NCT01827384|26279098|FG004|Overall Study|Switched to alternative treatment|0|||
13220021|NCT01827384|26279099|FG005|Overall Study|Switched to alternative treatment|0|||
13220022|NCT01827384|26279100|FG006|Overall Study|Switched to alternative treatment|0|||
13220023|NCT01827384|26279101|FG007|Overall Study|Switched to alternative treatment|0|||
13220024|NCT01827384|26279102|FG008|Overall Study|Switched to alternative treatment|0|||
13220025|NCT01827384|26279103|FG009|Overall Study|Switched to alternative treatment|0|||
13220026|NCT01827384|26279104|FG010|Overall Study|Switched to alternative treatment|0|||
13220027|NCT01827384|26279105|FG011|Overall Study|Switched to alternative treatment|0|||
13220028|NCT01827384|26279106|FG012|Overall Study|Switched to alternative treatment|0|||
13220029|NCT01827384|26279107|FG013|Overall Study|Switched to alternative treatment|2|||
13220030|NCT01827384|26279094|FG000|Overall Study|Disease progression before treatment|0|||
13220031|NCT01827384|26279095|FG001|Overall Study|Disease progression before treatment|0|||
13220032|NCT01827384|26279096|FG002|Overall Study|Disease progression before treatment|0|||
13220033|NCT01827384|26279097|FG003|Overall Study|Disease progression before treatment|0|||
13220034|NCT01827384|26279098|FG004|Overall Study|Disease progression before treatment|0|||
13220035|NCT01827384|26279099|FG005|Overall Study|Disease progression before treatment|0|||
13220036|NCT01827384|26279100|FG006|Overall Study|Disease progression before treatment|0|||
13220037|NCT01827384|26279101|FG007|Overall Study|Disease progression before treatment|0|||
13220038|NCT01827384|26279102|FG008|Overall Study|Disease progression before treatment|0|||
13220039|NCT01827384|26279103|FG009|Overall Study|Disease progression before treatment|0|||
13220040|NCT01827384|26279104|FG010|Overall Study|Disease progression before treatment|0|||
13220041|NCT01827384|26279105|FG011|Overall Study|Disease progression before treatment|0|||
13220042|NCT01827384|26279106|FG012|Overall Study|Disease progression before treatment|0|||
13220043|NCT01827384|26279107|FG013|Overall Study|Disease progression before treatment|4|||
13220044|NCT01827384|26279094|FG000|Overall Study|Ineligible|0|||
13220045|NCT01827384|26279095|FG001|Overall Study|Ineligible|0|||
13220046|NCT01827384|26279096|FG002|Overall Study|Ineligible|0|||
13220047|NCT01827384|26279097|FG003|Overall Study|Ineligible|0|||
13220048|NCT01827384|26279098|FG004|Overall Study|Ineligible|0|||
13220049|NCT01827384|26279099|FG005|Overall Study|Ineligible|0|||
13220050|NCT01827384|26279100|FG006|Overall Study|Ineligible|0|||
13220051|NCT01827384|26279101|FG007|Overall Study|Ineligible|0|||
13220052|NCT01827384|26279102|FG008|Overall Study|Ineligible|0|||
13220053|NCT01827384|26279103|FG009|Overall Study|Ineligible|0|||
13220054|NCT01827384|26279104|FG010|Overall Study|Ineligible|0|||
13220055|NCT01827384|26279105|FG011|Overall Study|Ineligible|0|||
13220056|NCT01827384|26279106|FG012|Overall Study|Ineligible|0|||
13220057|NCT01827384|26279107|FG013|Overall Study|Ineligible|19|||
13220058|NCT01827384|26279094|FG000|Overall Study|Participant died before treatment|0|||
13220059|NCT01827384|26279095|FG001|Overall Study|Participant died before treatment|0|||
13220060|NCT01827384|26279096|FG002|Overall Study|Participant died before treatment|0|||
13220061|NCT01827384|26279097|FG003|Overall Study|Participant died before treatment|0|||
13220062|NCT01827384|26279098|FG004|Overall Study|Participant died before treatment|0|||
13220063|NCT01827384|26279099|FG005|Overall Study|Participant died before treatment|0|||
13220064|NCT01827384|26279100|FG006|Overall Study|Participant died before treatment|0|||
13220065|NCT01827384|26279101|FG007|Overall Study|Participant died before treatment|0|||
13220066|NCT01827384|26279102|FG008|Overall Study|Participant died before treatment|0|||
13220067|NCT01827384|26279103|FG009|Overall Study|Participant died before treatment|0|||
13220068|NCT01827384|26279104|FG010|Overall Study|Participant died before treatment|0|||
13220069|NCT01827384|26279105|FG011|Overall Study|Participant died before treatment|0|||
13220070|NCT01827384|26279106|FG012|Overall Study|Participant died before treatment|0|||
13220071|NCT01827384|26279107|FG013|Overall Study|Participant died before treatment|5|||
13220072|NCT01827384|26279094|FG000|Overall Study|Insufficient tumor cells|0|||
13220073|NCT01827384|26279095|FG001|Overall Study|Insufficient tumor cells|0|||
13220074|NCT01827384|26279096|FG002|Overall Study|Insufficient tumor cells|0|||
13220075|NCT01827384|26279097|FG003|Overall Study|Insufficient tumor cells|0|||
13220076|NCT01827384|26279098|FG004|Overall Study|Insufficient tumor cells|0|||
13133966|NCT02761629|25989881|FG000|Overall Study|Withdrawal by Subject|0|||
13133967|NCT02761629|25989882|FG001|Overall Study|Withdrawal by Subject|3|||
13133968|NCT02761629|25989881|FG000|Overall Study|Other|0|||
13133969|NCT02761629|25989882|FG001|Overall Study|Other|2|||
13133970|NCT02761629|25989881|FG000|Overall Study|Lost to Follow-up|4|||
13133971|NCT02761629|25989882|FG001|Overall Study|Lost to Follow-up|1|||
13133972|NCT02761629|25989881|FG000|Overall Study|Randomized But Not Treated|8|||
13133973|NCT02761629|25989882|FG001|Overall Study|Randomized But Not Treated|4|||
13133974|NCT02761330|25989932|FG000|Treatment Week 1|Withdrawal by Subject|0|||
13133975|NCT02761330|25989933|FG001|Treatment Week 1|Withdrawal by Subject|0|||
13220077|NCT01827384|26279099|FG005|Overall Study|Insufficient tumor cells|0|||
13220078|NCT01827384|26279100|FG006|Overall Study|Insufficient tumor cells|0|||
13220079|NCT01827384|26279101|FG007|Overall Study|Insufficient tumor cells|0|||
13220080|NCT01827384|26279102|FG008|Overall Study|Insufficient tumor cells|0|||
13220081|NCT01827384|26279103|FG009|Overall Study|Insufficient tumor cells|0|||
13220082|NCT01827384|26279104|FG010|Overall Study|Insufficient tumor cells|0|||
13220083|NCT01827384|26279105|FG011|Overall Study|Insufficient tumor cells|0|||
13220084|NCT01827384|26279106|FG012|Overall Study|Insufficient tumor cells|0|||
13220085|NCT01827384|26279107|FG013|Overall Study|Insufficient tumor cells|13|||
13220086|NCT01827384|26279094|FG000|Overall Study|No actionable mutation|0|||
13133976|NCT02761330|25989934|FG002|Treatment Week 1|Withdrawal by Subject|0|||
13306300|NCT01292603|26525395|FG000|Part 2: Regular Follow-Up|Disease Progression|0|||
13133977|NCT02761330|25989935|FG003|Treatment Week 1|Withdrawal by Subject|1|||
13133978|NCT02761330|25989936|FG004|Treatment Week 1|Withdrawal by Subject|0|||
13133979|NCT02761330|25989937|FG005|Treatment Week 1|Withdrawal by Subject|1|||
13133980|NCT02761057|25989972|FG000|Overall Study|Currently On Study Treatment|0|||
13133981|NCT02761057|25989973|FG001|Overall Study|Currently On Study Treatment|3|||
13133982|NCT02761057|25989974|FG002|Overall Study|Currently On Study Treatment|0|||
13133983|NCT02761057|25989975|FG003|Overall Study|Currently On Study Treatment|0|||
13133984|NCT02761057|25989972|FG000|Overall Study|Adverse Event|11|||
13133985|NCT02761057|25989973|FG001|Overall Study|Adverse Event|9|||
13133986|NCT02761057|25989974|FG002|Overall Study|Adverse Event|5|||
13133987|NCT02761057|25989975|FG003|Overall Study|Adverse Event|3|||
13133988|NCT02761057|25989972|FG000|Overall Study|Refusal Unrelated to Adverse Event|2|||
13133989|NCT02761057|25989973|FG001|Overall Study|Refusal Unrelated to Adverse Event|2|||
13133990|NCT02761057|25989974|FG002|Overall Study|Refusal Unrelated to Adverse Event|0|||
13133991|NCT02761057|25989975|FG003|Overall Study|Refusal Unrelated to Adverse Event|2|||
13133992|NCT02761057|25989972|FG000|Overall Study|Progression/Relapse|29|||
13133993|NCT02761057|25989973|FG001|Overall Study|Progression/Relapse|27|||
13133994|NCT02761057|25989974|FG002|Overall Study|Progression/Relapse|20|||
13133995|NCT02761057|25989975|FG003|Overall Study|Progression/Relapse|23|||
13133996|NCT02761057|25989972|FG000|Overall Study|Death|2|||
13133997|NCT02761057|25989973|FG001|Overall Study|Death|2|||
13133998|NCT02761057|25989974|FG002|Overall Study|Death|1|||
13133999|NCT02761057|25989975|FG003|Overall Study|Death|1|||
13134000|NCT02761057|25989972|FG000|Overall Study|Other - Not Protocol Specified|2|||
13134001|NCT02761057|25989973|FG001|Overall Study|Other - Not Protocol Specified|1|||
13134002|NCT02761057|25989974|FG002|Overall Study|Other - Not Protocol Specified|2|||
13134003|NCT02761057|25989975|FG003|Overall Study|Other - Not Protocol Specified|0|||
13134004|NCT02760927|25989985|FG000|Overall Study|Tube Slippage from Device|1|||
13134005|NCT02760810|25989993|FG000|Overall Study|Protocol Violation|1|||
13134006|NCT02760654|25990024|FG000|Overall Study|Lost to Follow-up|3|||
13134007|NCT02760654|25990025|FG001|Overall Study|Lost to Follow-up|3|||
13220087|NCT01827384|26279095|FG001|Overall Study|No actionable mutation|0|||
13220088|NCT01827384|26279096|FG002|Overall Study|No actionable mutation|0|||
13220089|NCT01827384|26279097|FG003|Overall Study|No actionable mutation|0|||
13220090|NCT01827384|26279098|FG004|Overall Study|No actionable mutation|0|||
13220091|NCT01827384|26279099|FG005|Overall Study|No actionable mutation|0|||
13134008|NCT02760654|25990024|FG000|Overall Study|Withdrawal by Subject|4|||
13134009|NCT02760654|25990025|FG001|Overall Study|Withdrawal by Subject|3|||
13134010|NCT02760602|25990070|FG000|Overall Study|Withdrawal by Subject|1|||
13134011|NCT02760602|25990071|FG001|Overall Study|Withdrawal by Subject|0|||
13134012|NCT02760602|25990070|FG000|Overall Study|Terminated by sponsor|12|||
13134013|NCT02760602|25990071|FG001|Overall Study|Terminated by sponsor|13|||
13134014|NCT02760433|25990112|FG000|Overall Study|Lost to Follow-up|1|||
13134015|NCT02760433|25990113|FG001|Overall Study|Lost to Follow-up|0|||
13134016|NCT02760433|25990114|FG002|Overall Study|Lost to Follow-up|1|||
13134017|NCT02760433|25990115|FG003|Overall Study|Lost to Follow-up|0|||
13134018|NCT02760433|25990116|FG004|Overall Study|Lost to Follow-up|0|||
13134019|NCT02760433|25990112|FG000|Overall Study|Withdrawal by Subject|23|||
13134020|NCT02760433|25990113|FG001|Overall Study|Withdrawal by Subject|9|||
13134021|NCT02760433|25990114|FG002|Overall Study|Withdrawal by Subject|0|||
13134022|NCT02760433|25990115|FG003|Overall Study|Withdrawal by Subject|2|||
13134023|NCT02760433|25990116|FG004|Overall Study|Withdrawal by Subject|9|||
13134024|NCT02760433|25990112|FG000|Overall Study|Lack of Response At Week 14|0|||
13134025|NCT02760433|25990113|FG001|Overall Study|Lack of Response At Week 14|0|||
13134026|NCT02760433|25990114|FG002|Overall Study|Lack of Response At Week 14|0|||
13134027|NCT02760433|25990115|FG003|Overall Study|Lack of Response At Week 14|0|||
13134028|NCT02760433|25990116|FG004|Overall Study|Lack of Response At Week 14|1|||
13134029|NCT02760433|25990112|FG000|Overall Study|Subject refused to continue the study|1|||
13134030|NCT02760433|25990113|FG001|Overall Study|Subject refused to continue the study|0|||
13134031|NCT02760433|25990114|FG002|Overall Study|Subject refused to continue the study|0|||
13134032|NCT02760433|25990115|FG003|Overall Study|Subject refused to continue the study|0|||
13134033|NCT02760433|25990116|FG004|Overall Study|Subject refused to continue the study|0|||
13134034|NCT02760433|25990112|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2|||
13134035|NCT02760433|25990113|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
13134036|NCT02760433|25990114|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
13134037|NCT02760433|25990115|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
13134038|NCT02760433|25990116|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
13134039|NCT02760433|25990112|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
13134040|NCT02760433|25990113|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1|||
13134041|NCT02760433|25990114|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
13134042|NCT02760433|25990115|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
13134043|NCT02760433|25990116|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
13134044|NCT02760407|25990163|FG000|Overall Study|Death|2|||
13134045|NCT02760407|25990164|FG001|Overall Study|Death|3|||
13134046|NCT02760407|25990165|FG002|Overall Study|Death|1|||
13134047|NCT02760407|25990166|FG003|Overall Study|Death|1|||
13134048|NCT02760407|25990163|FG000|Overall Study|Lost to Follow-up|1|||
13134049|NCT02760407|25990164|FG001|Overall Study|Lost to Follow-up|7|||
13134050|NCT02760407|25990165|FG002|Overall Study|Lost to Follow-up|4|||
13134051|NCT02760407|25990166|FG003|Overall Study|Lost to Follow-up|6|||
13134052|NCT02760407|25990163|FG000|Overall Study|Withdrawal by Subject|25|||
13134053|NCT02760407|25990164|FG001|Overall Study|Withdrawal by Subject|31|||
13134054|NCT02760407|25990165|FG002|Overall Study|Withdrawal by Subject|37|||
13134055|NCT02760407|25990166|FG003|Overall Study|Withdrawal by Subject|25|||
13134056|NCT02760407|25990163|FG000|Overall Study|Violation of Eligibility criteria|0|||
13134057|NCT02760407|25990164|FG001|Overall Study|Violation of Eligibility criteria|0|||
13134058|NCT02760407|25990165|FG002|Overall Study|Violation of Eligibility criteria|1|||
13134059|NCT02760407|25990166|FG003|Overall Study|Violation of Eligibility criteria|1|||
13134060|NCT02760407|25990163|FG000|Overall Study|Personal reasons|0|||
13134061|NCT02760407|25990164|FG001|Overall Study|Personal reasons|0|||
13134062|NCT02760407|25990165|FG002|Overall Study|Personal reasons|0|||
13134063|NCT02760407|25990166|FG003|Overall Study|Personal reasons|1|||
13135091|NCT02746627|25993548|FG002|Overall Study|Withdrawal by Subject|1|||
13220092|NCT01827384|26279100|FG006|Overall Study|No actionable mutation|0|||
13220093|NCT01827384|26279101|FG007|Overall Study|No actionable mutation|0|||
13220094|NCT01827384|26279102|FG008|Overall Study|No actionable mutation|0|||
13220095|NCT01827384|26279103|FG009|Overall Study|No actionable mutation|0|||
13220096|NCT01827384|26279104|FG010|Overall Study|No actionable mutation|0|||
13220097|NCT01827384|26279105|FG011|Overall Study|No actionable mutation|0|||
13220098|NCT01827384|26279106|FG012|Overall Study|No actionable mutation|0|||
13220099|NCT01827384|26279107|FG013|Overall Study|No actionable mutation|73|||
13220100|NCT01827384|26279094|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
13220101|NCT01827384|26279095|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
13220102|NCT01827384|26279096|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
13220103|NCT01827384|26279097|FG003|Overall Study|Participant declined to participate (before treatment started)|0|||
13220104|NCT01827384|26279098|FG004|Overall Study|Participant declined to participate (before treatment started)|0|||
13220105|NCT01827384|26279099|FG005|Overall Study|Participant declined to participate (before treatment started)|0|||
13220106|NCT01827384|26279100|FG006|Overall Study|Participant declined to participate (before treatment started)|0|||
13220107|NCT01827384|26279101|FG007|Overall Study|Participant declined to participate (before treatment started)|0|||
13220108|NCT01827384|26279102|FG008|Overall Study|Participant declined to participate (before treatment started)|0|||
13220109|NCT01827384|26279103|FG009|Overall Study|Participant declined to participate (before treatment started)|0|||
13220110|NCT01827384|26279104|FG010|Overall Study|Participant declined to participate (before treatment started)|0|||
13220111|NCT01827384|26279105|FG011|Overall Study|Participant declined to participate (before treatment started)|0|||
13220112|NCT01827384|26279106|FG012|Overall Study|Participant declined to participate (before treatment started)|0|||
13220113|NCT01827384|26279107|FG013|Overall Study|Participant declined to participate (before treatment started)|15|||
13220114|NCT01827371|26279142|FG000|Overall Study|Adverse Event|0|||
13220115|NCT01827371|26279143|FG001|Overall Study|Adverse Event|0|||
13220116|NCT01827371|26279144|FG002|Overall Study|Adverse Event|4|||
13220117|NCT01827371|26279145|FG003|Overall Study|Adverse Event|2|||
13220118|NCT01827371|26279142|FG000|Overall Study|Lost to Follow-up|0|||
13220119|NCT01827371|26279143|FG001|Overall Study|Lost to Follow-up|2|||
13220120|NCT01827371|26279144|FG002|Overall Study|Lost to Follow-up|0|||
13220121|NCT01827371|26279145|FG003|Overall Study|Lost to Follow-up|4|||
13220122|NCT01827371|26279142|FG000|Overall Study|Protocol Violation|1|||
13220123|NCT01827371|26279143|FG001|Overall Study|Protocol Violation|0|||
13220124|NCT01827371|26279144|FG002|Overall Study|Protocol Violation|0|||
13220125|NCT01827371|26279145|FG003|Overall Study|Protocol Violation|0|||
13220126|NCT01827371|26279142|FG000|Overall Study|Withdrawal by Subject|1|||
13220127|NCT01827371|26279143|FG001|Overall Study|Withdrawal by Subject|2|||
13220128|NCT01827371|26279144|FG002|Overall Study|Withdrawal by Subject|2|||
13220129|NCT01827371|26279145|FG003|Overall Study|Withdrawal by Subject|3|||
13220130|NCT01827371|26279142|FG000|Overall Study|Physician Decision|0|||
13220131|NCT01827371|26279143|FG001|Overall Study|Physician Decision|1|||
13220132|NCT01827371|26279144|FG002|Overall Study|Physician Decision|0|||
13220133|NCT01827371|26279145|FG003|Overall Study|Physician Decision|1|||
13220134|NCT01827371|26279142|FG000|Overall Study|Temporary study halt to vaccinations|11|||
13220135|NCT01827371|26279143|FG001|Overall Study|Temporary study halt to vaccinations|2|||
13220136|NCT01827371|26279144|FG002|Overall Study|Temporary study halt to vaccinations|5|||
13220137|NCT01827371|26279145|FG003|Overall Study|Temporary study halt to vaccinations|13|||
13220138|NCT01827332|26279160|FG000|Overall Study|Lost to Follow-up|2|||
13220139|NCT01827332|26279161|FG001|Overall Study|Lost to Follow-up|1|||
13220140|NCT01827319|26279169|FG000|Overall Study|Lost to Follow-up|3|||
13220141|NCT01827267|26279191|FG000|Overall Study|Did not receive study drug|1|||
13220142|NCT01827267|26279192|FG001|Overall Study|Did not receive study drug|1|||
13220143|NCT01827267|26279191|FG000|Overall Study|Physician Decision|1|||
13134064|NCT02760407|25990163|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1|||
13134065|NCT02760407|25990164|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
13134066|NCT02760407|25990165|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
13134067|NCT02760407|25990166|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
13134068|NCT02760407|25990163|FG000|Overall Study|Use of prohibited Medication|0|||
13134069|NCT02760407|25990164|FG001|Overall Study|Use of prohibited Medication|0|||
13134070|NCT02760407|25990165|FG002|Overall Study|Use of prohibited Medication|1|||
13134071|NCT02760407|25990166|FG003|Overall Study|Use of prohibited Medication|0|||
13134072|NCT02760407|25990163|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
13134073|NCT02760407|25990164|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
13134074|NCT02760407|25990165|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1|||
13134075|NCT02760407|25990166|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
13134076|NCT02760407|25990163|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1|||
13134077|NCT02760407|25990164|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
13134078|NCT02760407|25990165|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
13134079|NCT02760407|25990166|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
13134080|NCT02760407|25990163|FG000|Overall Study|Investigator's Decision (Adverse Event)|0|||
13134081|NCT02760407|25990164|FG001|Overall Study|Investigator's Decision (Adverse Event)|1|||
13134082|NCT02760407|25990165|FG002|Overall Study|Investigator's Decision (Adverse Event)|0|||
13134083|NCT02760407|25990166|FG003|Overall Study|Investigator's Decision (Adverse Event)|0|||
13134084|NCT02760407|25990163|FG000|Overall Study|Inadequately Enrolled|0|||
13134085|NCT02760407|25990164|FG001|Overall Study|Inadequately Enrolled|0|||
13134086|NCT02760407|25990165|FG002|Overall Study|Inadequately Enrolled|0|||
13134087|NCT02760407|25990166|FG003|Overall Study|Inadequately Enrolled|1|||
13134088|NCT02760407|25990163|FG000|Overall Study|Withdrawal By PI's Decision|0|||
13134089|NCT02760407|25990164|FG001|Overall Study|Withdrawal By PI's Decision|1|||
13134090|NCT02760407|25990165|FG002|Overall Study|Withdrawal By PI's Decision|0|||
13134091|NCT02760407|25990166|FG003|Overall Study|Withdrawal By PI's Decision|0|||
13134092|NCT02760407|25990163|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
13134093|NCT02760407|25990164|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
13134094|NCT02760407|25990165|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
13134095|NCT02760407|25990166|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
13134096|NCT02760407|25990163|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
13134097|NCT02760407|25990164|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
13134098|NCT02760407|25990165|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1|||
13134099|NCT02760407|25990166|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
13134100|NCT02760407|25990163|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1|||
13220144|NCT01827267|26279192|FG001|Overall Study|Physician Decision|0|||
13220145|NCT01827267|26279191|FG000|Overall Study|Disease Progression|1|||
13220146|NCT01827267|26279192|FG001|Overall Study|Disease Progression|1|||
13220147|NCT01827267|26279191|FG000|Overall Study|Sponsor Discontinued Study|2|||
13220148|NCT01827267|26279192|FG001|Overall Study|Sponsor Discontinued Study|8|||
13220149|NCT01827267|26279191|FG000|Overall Study|Still on study|0|||
13220150|NCT01827267|26279192|FG001|Overall Study|Still on study|2|||
13220151|NCT01827254|26279204|FG000|Overall Study|Death|10|||
13220152|NCT01827254|26279204|FG000|Overall Study|Case report form not completed|4|||
13220153|NCT01827254|26279204|FG000|Overall Study|Invalidated centre|3|||
13220154|NCT01827254|26279204|FG000|Overall Study|Discontinued prior initiation: sunitinib|1|||
13220155|NCT01827254|26279204|FG000|Overall Study|Did not complete re-challenge|1|||
13220156|NCT01827254|26279204|FG000|Overall Study|Disease progression|36|||
13220157|NCT01827254|26279204|FG000|Overall Study|Intolerance to treatment|4|||
13220158|NCT01827163|26279211|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2|||
13220159|NCT01827163|26279211|FG000|Overall Study|Adverse Event|9|||
13220160|NCT01827111|26279218|FG000|Overall Study|Disease Progression|1|||
13220161|NCT01827046|26279265|FG000|Overall Study|Lost to Follow-up|1|||
13220162|NCT01827046|26279266|FG001|Overall Study|Lost to Follow-up|5|||
13220163|NCT01827046|26279265|FG000|Overall Study|Withdrawal by Subject|0|||
13220164|NCT01827046|26279266|FG001|Overall Study|Withdrawal by Subject|4|||
13220165|NCT01826981|26279458|FG000|Overall Study|Lack of Efficacy|0|||
13220166|NCT01826981|26279459|FG001|Overall Study|Lack of Efficacy|1|||
13220167|NCT01826981|26279460|FG002|Overall Study|Lack of Efficacy|0|||
13220168|NCT01826981|26279461|FG003|Overall Study|Lack of Efficacy|0|||
13220169|NCT01826981|26279462|FG004|Overall Study|Lack of Efficacy|5|||
13220170|NCT01826981|26279463|FG005|Overall Study|Lack of Efficacy|0|||
13220171|NCT01826981|26279464|FG006|Overall Study|Lack of Efficacy|0|||
13220172|NCT01826981|26279465|FG007|Overall Study|Lack of Efficacy|8|||
13220173|NCT01826981|26279466|FG008|Overall Study|Lack of Efficacy|7|||
13220174|NCT01826981|26279467|FG009|Overall Study|Lack of Efficacy|0|||
13220175|NCT01826981|26279468|FG010|Overall Study|Lack of Efficacy|1|||
13220176|NCT01826981|26279469|FG011|Overall Study|Lack of Efficacy|0|||
13220177|NCT01826981|26279470|FG012|Overall Study|Lack of Efficacy|0|||
13220178|NCT01826981|26279471|FG013|Overall Study|Lack of Efficacy|3|||
13220179|NCT01826981|26279472|FG014|Overall Study|Lack of Efficacy|0|||
13220180|NCT01826981|26279458|FG000|Overall Study|Lost to Follow-up|0|||
13220181|NCT01826981|26279459|FG001|Overall Study|Lost to Follow-up|0|||
13220182|NCT01826981|26279460|FG002|Overall Study|Lost to Follow-up|0|||
13220183|NCT01826981|26279461|FG003|Overall Study|Lost to Follow-up|0|||
13220184|NCT01826981|26279462|FG004|Overall Study|Lost to Follow-up|1|||
13220185|NCT01826981|26279463|FG005|Overall Study|Lost to Follow-up|1|||
13220186|NCT01826981|26279464|FG006|Overall Study|Lost to Follow-up|0|||
13220187|NCT01826981|26279465|FG007|Overall Study|Lost to Follow-up|1|||
13220188|NCT01826981|26279466|FG008|Overall Study|Lost to Follow-up|0|||
13220189|NCT01826981|26279467|FG009|Overall Study|Lost to Follow-up|1|||
13220190|NCT01826981|26279468|FG010|Overall Study|Lost to Follow-up|1|||
13220191|NCT01826981|26279469|FG011|Overall Study|Lost to Follow-up|1|||
13220192|NCT01826981|26279470|FG012|Overall Study|Lost to Follow-up|1|||
13220193|NCT01826981|26279471|FG013|Overall Study|Lost to Follow-up|0|||
13220194|NCT01826981|26279472|FG014|Overall Study|Lost to Follow-up|0|||
13220195|NCT01826981|26279458|FG000|Overall Study|Withdrew Consent|0|||
13220196|NCT01826981|26279459|FG001|Overall Study|Withdrew Consent|0|||
13220197|NCT01826981|26279460|FG002|Overall Study|Withdrew Consent|0|||
13220198|NCT01826981|26279461|FG003|Overall Study|Withdrew Consent|0|||
13220199|NCT01826981|26279462|FG004|Overall Study|Withdrew Consent|0|||
13220200|NCT01826981|26279463|FG005|Overall Study|Withdrew Consent|0|||
13220201|NCT01826981|26279464|FG006|Overall Study|Withdrew Consent|1|||
13220202|NCT01826981|26279465|FG007|Overall Study|Withdrew Consent|1|||
13220203|NCT01826981|26279466|FG008|Overall Study|Withdrew Consent|0|||
13220204|NCT01826981|26279467|FG009|Overall Study|Withdrew Consent|0|||
13220205|NCT01826981|26279468|FG010|Overall Study|Withdrew Consent|0|||
13220206|NCT01826981|26279469|FG011|Overall Study|Withdrew Consent|1|||
13220207|NCT01826981|26279470|FG012|Overall Study|Withdrew Consent|0|||
13220208|NCT01826981|26279471|FG013|Overall Study|Withdrew Consent|1|||
13220209|NCT01826981|26279472|FG014|Overall Study|Withdrew Consent|0|||
13220210|NCT01826981|26279458|FG000|Overall Study|Adverse Event|0|||
13220211|NCT01826981|26279459|FG001|Overall Study|Adverse Event|0|||
13220212|NCT01826981|26279460|FG002|Overall Study|Adverse Event|0|||
13220213|NCT01826981|26279461|FG003|Overall Study|Adverse Event|0|||
13220214|NCT01826981|26279462|FG004|Overall Study|Adverse Event|1|||
13220215|NCT01826981|26279463|FG005|Overall Study|Adverse Event|0|||
13220216|NCT01826981|26279464|FG006|Overall Study|Adverse Event|0|||
13220217|NCT01826981|26279465|FG007|Overall Study|Adverse Event|0|||
13220218|NCT01826981|26279466|FG008|Overall Study|Adverse Event|0|||
13220219|NCT01826981|26279467|FG009|Overall Study|Adverse Event|0|||
13220220|NCT01826981|26279468|FG010|Overall Study|Adverse Event|0|||
13220221|NCT01826981|26279469|FG011|Overall Study|Adverse Event|0|||
13220222|NCT01826981|26279470|FG012|Overall Study|Adverse Event|0|||
13220223|NCT01826981|26279471|FG013|Overall Study|Adverse Event|0|||
13220224|NCT01826981|26279472|FG014|Overall Study|Adverse Event|0|||
13220225|NCT01826981|26279458|FG000|Overall Study|Upper G-I Haemorrhage|0|||
13220226|NCT01826981|26279459|FG001|Overall Study|Upper G-I Haemorrhage|0|||
13220227|NCT01826981|26279460|FG002|Overall Study|Upper G-I Haemorrhage|0|||
13220228|NCT01826981|26279461|FG003|Overall Study|Upper G-I Haemorrhage|0|||
13220229|NCT01826981|26279462|FG004|Overall Study|Upper G-I Haemorrhage|0|||
13220230|NCT01826981|26279463|FG005|Overall Study|Upper G-I Haemorrhage|0|||
13220231|NCT01826981|26279464|FG006|Overall Study|Upper G-I Haemorrhage|0|||
13220232|NCT01826981|26279465|FG007|Overall Study|Upper G-I Haemorrhage|0|||
13220233|NCT01826981|26279466|FG008|Overall Study|Upper G-I Haemorrhage|0|||
13220234|NCT01826981|26279467|FG009|Overall Study|Upper G-I Haemorrhage|0|||
13220235|NCT01826981|26279468|FG010|Overall Study|Upper G-I Haemorrhage|0|||
13220236|NCT01826981|26279469|FG011|Overall Study|Upper G-I Haemorrhage|0|||
13220237|NCT01826981|26279470|FG012|Overall Study|Upper G-I Haemorrhage|0|||
13220238|NCT01826981|26279471|FG013|Overall Study|Upper G-I Haemorrhage|1|||
13220239|NCT01826981|26279472|FG014|Overall Study|Upper G-I Haemorrhage|0|||
13220240|NCT01826981|26279458|FG000|Overall Study|Enrolled/Randomized but Not Treated|0|||
13220241|NCT01826981|26279459|FG001|Overall Study|Enrolled/Randomized but Not Treated|0|||
13220242|NCT01826981|26279460|FG002|Overall Study|Enrolled/Randomized but Not Treated|0|||
13220243|NCT01826981|26279461|FG003|Overall Study|Enrolled/Randomized but Not Treated|0|||
13220244|NCT01826981|26279462|FG004|Overall Study|Enrolled/Randomized but Not Treated|0|||
13220245|NCT01826981|26279463|FG005|Overall Study|Enrolled/Randomized but Not Treated|0|||
13220246|NCT01826981|26279464|FG006|Overall Study|Enrolled/Randomized but Not Treated|0|||
13220247|NCT01826981|26279465|FG007|Overall Study|Enrolled/Randomized but Not Treated|1|||
13220248|NCT01826981|26279466|FG008|Overall Study|Enrolled/Randomized but Not Treated|0|||
13220249|NCT01826981|26279467|FG009|Overall Study|Enrolled/Randomized but Not Treated|0|||
13220250|NCT01826981|26279468|FG010|Overall Study|Enrolled/Randomized but Not Treated|0|||
13220251|NCT01826981|26279469|FG011|Overall Study|Enrolled/Randomized but Not Treated|0|||
13220252|NCT01826981|26279470|FG012|Overall Study|Enrolled/Randomized but Not Treated|0|||
13220253|NCT01826981|26279471|FG013|Overall Study|Enrolled/Randomized but Not Treated|0|||
13220254|NCT01826981|26279472|FG014|Overall Study|Enrolled/Randomized but Not Treated|0|||
13220255|NCT01826825|26279489|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0|||
13220256|NCT01826825|26279490|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2|||
13220257|NCT01826604|26279505|FG000|Overall Study|Lost to Follow-up|8|||
13220258|NCT01826604|26279506|FG001|Overall Study|Lost to Follow-up|9|||
13220259|NCT01826487|26279538|FG000|Overall Study|Adverse Event|1|||
13220260|NCT01826487|26279539|FG001|Overall Study|Adverse Event|1|||
13220261|NCT01826487|26279538|FG000|Overall Study|Lost to Follow-up|1|||
13220262|NCT01826487|26279539|FG001|Overall Study|Lost to Follow-up|0|||
13220263|NCT01826487|26279538|FG000|Overall Study|Withdrawal by Subject|1|||
13220264|NCT01826487|26279539|FG001|Overall Study|Withdrawal by Subject|3|||
13220265|NCT01826487|26279538|FG000|Overall Study|Protocol Violation|1|||
13220266|NCT01826487|26279539|FG001|Overall Study|Protocol Violation|1|||
13220267|NCT01826448|26279552|FG000|Overall Study|Adverse Event|1|||
13220268|NCT01826448|26279553|FG001|Overall Study|Adverse Event|3|||
13220269|NCT01826448|26279552|FG000|Overall Study|Disease progression|2|||
13220270|NCT01826448|26279553|FG001|Overall Study|Disease progression|4|||
13220271|NCT01826448|26279552|FG000|Overall Study|Withdrawal by Subject|1|||
13220272|NCT01826448|26279553|FG001|Overall Study|Withdrawal by Subject|0|||
13220273|NCT01826448|26279552|FG000|Overall Study|Physician Decision|0|||
13220274|NCT01826448|26279553|FG001|Overall Study|Physician Decision|1|||
13220275|NCT01826448|26279552|FG000|Overall Study|2 active cancers|0|||
13220276|NCT01826448|26279553|FG001|Overall Study|2 active cancers|1|||
13220277|NCT01826422|26279604|FG000|Overall Study|Withdrawal by Subject|1|||
13220278|NCT01826422|26279605|FG001|Overall Study|Withdrawal by Subject|3|||
13220279|NCT01826370|26279613|FG000|Overall Study|Protocol Violation|6|||
13220280|NCT01826370|26279613|FG000|Overall Study|Lost to Follow-up|12|||
13220281|NCT01826370|26279613|FG000|Overall Study|Other reason not defined above|2|||
13220282|NCT01826214|26279638|FG000|Overall Study|Adverse Event|7|||
13220283|NCT01826214|26279639|FG001|Overall Study|Adverse Event|6|||
13220284|NCT01826214|26279638|FG000|Overall Study|Death|3|||
13220285|NCT01826214|26279639|FG001|Overall Study|Death|1|||
13220286|NCT01826214|26279638|FG000|Overall Study|Lost to Follow-up|1|||
13220287|NCT01826214|26279639|FG001|Overall Study|Lost to Follow-up|0|||
13220288|NCT01826214|26279638|FG000|Overall Study|Physician Decision|0|||
13474756|NCT02486042|26996497|FG001|Overall Study|Withdrawal by Subject|2|||
13474757|NCT02352753|26996523|FG000|6-Month Dosing Period|Decision by sponsor|2|||
13474758|NCT02352753|26996523|FG000|6-Month Dosing Period|Withdrawal by Subject|34|||
13474759|NCT02352753|26996523|FG000|6-Month Dosing Period|Lost to Follow-up|2|||
13474760|NCT02352753|26996523|FG000|6-Month Dosing Period|Transitioning to Q3M|60|||
13474761|NCT02352753|26996523|FG000|3-Month Dosing Period|Decision by sponsor|14|||
13474762|NCT02352753|26996523|FG000|3-Month Dosing Period|Withdrawal by Subject|6|||
13474763|NCT02339090|26996550|FG000|Overall Study|Adverse Event|1|||
13474764|NCT02339090|26996551|FG001|Overall Study|Adverse Event|0|||
13474765|NCT02339090|26996550|FG000|Overall Study|Lost to Follow-up|0|||
13474766|NCT02339090|26996551|FG001|Overall Study|Lost to Follow-up|1|||
13474767|NCT02339090|26996550|FG000|Overall Study|Non-compliance With Study Drug|0|||
13474768|NCT02339090|26996551|FG001|Overall Study|Non-compliance With Study Drug|1|||
13474769|NCT02339090|26996550|FG000|Overall Study|Withdrawal by Subject|2|||
13134101|NCT02760407|25990164|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
13134102|NCT02760407|25990165|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
13134103|NCT02760407|25990166|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
13134104|NCT02760407|25990163|FG000|Overall Study|Study Treatment Was Terminated At The Site|0|||
13134105|NCT02760407|25990164|FG001|Overall Study|Study Treatment Was Terminated At The Site|0|||
13134106|NCT02760407|25990165|FG002|Overall Study|Study Treatment Was Terminated At The Site|1|||
13134107|NCT02760407|25990166|FG003|Overall Study|Study Treatment Was Terminated At The Site|0|||
13134108|NCT02760407|25990163|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1|||
13134109|NCT02760407|25990164|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
13134110|NCT02760407|25990165|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
13134111|NCT02760407|25990166|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
13134112|NCT02760407|25990163|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1|||
13134113|NCT02760407|25990164|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
13134114|NCT02760407|25990165|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
13134115|NCT02760407|25990166|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
13134116|NCT02760407|25990163|FG000|Overall Study|Lack Of Efficacy Per PI|0|||
13134117|NCT02760407|25990164|FG001|Overall Study|Lack Of Efficacy Per PI|0|||
13134118|NCT02760407|25990165|FG002|Overall Study|Lack Of Efficacy Per PI|0|||
13134119|NCT02760407|25990166|FG003|Overall Study|Lack Of Efficacy Per PI|1|||
13134120|NCT02760407|25990163|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1|||
13134121|NCT02760407|25990164|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
13134122|NCT02760407|25990165|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
13134123|NCT02760407|25990166|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
13134124|NCT02760407|25990163|FG000|Overall Study|Investigator recorded as Adverse Event|1|||
13134125|NCT02760407|25990164|FG001|Overall Study|Investigator recorded as Adverse Event|0|||
13134126|NCT02760407|25990165|FG002|Overall Study|Investigator recorded as Adverse Event|2|||
13134127|NCT02760407|25990166|FG003|Overall Study|Investigator recorded as Adverse Event|0|||
13134128|NCT02760368|25990196|FG000|Overall Study|Withdrawal by Subject|12|||
13134129|NCT02760368|25990197|FG001|Overall Study|Withdrawal by Subject|8|||
13134130|NCT02760368|25990198|FG002|Overall Study|Withdrawal by Subject|9|||
13134131|NCT02760368|25990196|FG000|Overall Study|Screen Failure|0|||
13134132|NCT02760368|25990197|FG001|Overall Study|Screen Failure|0|||
13134133|NCT02760368|25990198|FG002|Overall Study|Screen Failure|1|||
13134134|NCT02760368|25990196|FG000|Overall Study|Death|1|||
13134135|NCT02760368|25990197|FG001|Overall Study|Death|0|||
13134136|NCT02760368|25990198|FG002|Overall Study|Death|0|||
13134137|NCT02760368|25990196|FG000|Overall Study|Withdrawal by Sponsor|0|||
13134138|NCT02760368|25990197|FG001|Overall Study|Withdrawal by Sponsor|0|||
13134139|NCT02760368|25990198|FG002|Overall Study|Withdrawal by Sponsor|1|||
13134140|NCT02760069|25990219|FG000|Overall Study|Withdrawal by Subject|0|||
13134141|NCT02760069|25990220|FG001|Overall Study|Withdrawal by Subject|1|||
13134142|NCT02760069|25990221|FG002|Overall Study|Withdrawal by Subject|1|||
13134143|NCT02759939|25990244|FG000|Overall Study|Missing data on first outcome assessed|11|||
13134144|NCT02759939|25990245|FG001|Overall Study|Missing data on first outcome assessed|2|||
13134145|NCT02759939|25990246|FG002|Overall Study|Missing data on first outcome assessed|5|||
13134146|NCT02759939|25990247|FG003|Overall Study|Missing data on first outcome assessed|2|||
13134147|NCT02759939|25990244|FG000|Overall Study|Ineligible for T2 and T3|310|||
13134148|NCT02759939|25990245|FG001|Overall Study|Ineligible for T2 and T3|179|||
13134149|NCT02759939|25990246|FG002|Overall Study|Ineligible for T2 and T3|366|||
13134150|NCT02759939|25990247|FG003|Overall Study|Ineligible for T2 and T3|391|||
13134151|NCT02759939|25990244|FG000|Overall Study|Lost to Follow-up|735|||
13134152|NCT02759939|25990245|FG001|Overall Study|Lost to Follow-up|791|||
13134153|NCT02759939|25990246|FG002|Overall Study|Lost to Follow-up|783|||
13134154|NCT02759939|25990247|FG003|Overall Study|Lost to Follow-up|650|||
13220289|NCT01826214|26279639|FG001|Overall Study|Physician Decision|2|||
13220290|NCT01826214|26279638|FG000|Overall Study|Progressive disease|22|||
13220291|NCT01826214|26279639|FG001|Overall Study|Progressive disease|21|||
13220292|NCT01826214|26279638|FG000|Overall Study|Study terminated by Sponsor|0|||
13220293|NCT01826214|26279639|FG001|Overall Study|Study terminated by Sponsor|1|||
13220294|NCT01826214|26279638|FG000|Overall Study|Subject/guardian decision|2|||
13220295|NCT01826214|26279639|FG001|Overall Study|Subject/guardian decision|3|||
13220296|NCT01826201|26279647|FG000|Overall Study|Non compliance with protocol|4|||
13220297|NCT01825941|26279660|FG000|Overall Study|Lost to Follow-up|4|||
13220298|NCT01825941|26279661|FG001|Overall Study|Lost to Follow-up|1|||
13220299|NCT01825876|26279681|FG000|Period 2|Withdrawal by Subject|0|||
13220300|NCT01825876|26279682|FG001|Period 2|Withdrawal by Subject|1|||
13220301|NCT01825837|26279703|FG000|PART I|Withdrawal by Subject|0|||
13220302|NCT01825837|26279704|FG001|PART I|Withdrawal by Subject|0|||
13220303|NCT01825837|26279705|FG002|PART I|Withdrawal by Subject|0|||
13220304|NCT01825837|26279706|FG003|PART I|Withdrawal by Subject|6|||
13220305|NCT01825837|26279703|FG000|PART I|Patient non-compliance|0|||
13220306|NCT01825837|26279704|FG001|PART I|Patient non-compliance|0|||
13220307|NCT01825837|26279705|FG002|PART I|Patient non-compliance|0|||
13220308|NCT01825837|26279706|FG003|PART I|Patient non-compliance|1|||
13220309|NCT01825837|26279703|FG000|PART I|Treatment failure|0|||
13220310|NCT01825837|26279704|FG001|PART I|Treatment failure|0|||
13220311|NCT01825837|26279705|FG002|PART I|Treatment failure|0|||
13220312|NCT01825837|26279706|FG003|PART I|Treatment failure|7|||
13220313|NCT01825837|26279703|FG000|PART I|reason unspecified|0|||
13220314|NCT01825837|26279704|FG001|PART I|reason unspecified|0|||
13220315|NCT01825837|26279705|FG002|PART I|reason unspecified|0|||
13220316|NCT01825837|26279706|FG003|PART I|reason unspecified|3|||
13220317|NCT01825837|26279703|FG000|PART II|Withdrawal by Subject|3|||
13220318|NCT01825837|26279704|FG001|PART II|Withdrawal by Subject|3|||
13220319|NCT01825837|26279705|FG002|PART II|Withdrawal by Subject|7|||
13220320|NCT01825837|26279706|FG003|PART II|Withdrawal by Subject|0|||
13220321|NCT01825837|26279703|FG000|PART II|Patient non-compliance|5|||
13220322|NCT01825837|26279704|FG001|PART II|Patient non-compliance|2|||
13220323|NCT01825837|26279705|FG002|PART II|Patient non-compliance|4|||
13220324|NCT01825837|26279706|FG003|PART II|Patient non-compliance|0|||
13220325|NCT01825837|26279703|FG000|PART II|Adverse Event|3|||
13220326|NCT01825837|26279704|FG001|PART II|Adverse Event|3|||
13220327|NCT01825837|26279705|FG002|PART II|Adverse Event|1|||
13220328|NCT01825837|26279706|FG003|PART II|Adverse Event|0|||
13220329|NCT01825837|26279703|FG000|PART II|Treatment failure|6|||
13220330|NCT01825837|26279704|FG001|PART II|Treatment failure|4|||
13220331|NCT01825837|26279705|FG002|PART II|Treatment failure|5|||
13220332|NCT01825837|26279706|FG003|PART II|Treatment failure|0|||
13220333|NCT01825837|26279703|FG000|PART II|reason unspecified|2|||
13220334|NCT01825837|26279704|FG001|PART II|reason unspecified|2|||
13220335|NCT01825837|26279705|FG002|PART II|reason unspecified|2|||
13220336|NCT01825837|26279706|FG003|PART II|reason unspecified|0|||
13220337|NCT01825798|26279741|FG000|Overall Study|Adverse Event|1|||
13220338|NCT01825798|26279742|FG001|Overall Study|Adverse Event|5|||
13220339|NCT01825798|26279741|FG000|Overall Study|Lost to Follow-up|1|||
13220340|NCT01825798|26279742|FG001|Overall Study|Lost to Follow-up|0|||
13220341|NCT01825785|26279908|FG000|Overall Study|Adverse Event|0|||
13220342|NCT01825785|26279909|FG001|Overall Study|Adverse Event|0|||
13220343|NCT01825785|26279910|FG002|Overall Study|Adverse Event|0|||
13306301|NCT01292603|26525396|FG001|Part 2: Regular Follow-Up|Disease Progression|0|||
13220344|NCT01825785|26279911|FG003|Overall Study|Adverse Event|0|||
13220345|NCT01825785|26279912|FG004|Overall Study|Adverse Event|1|||
13220346|NCT01825785|26279913|FG005|Overall Study|Adverse Event|0|||
13220347|NCT01825785|26279914|FG006|Overall Study|Adverse Event|0|||
13220348|NCT01825785|26279908|FG000|Overall Study|Withdrawal by Subject|0|||
13220349|NCT01825785|26279909|FG001|Overall Study|Withdrawal by Subject|0|||
13220350|NCT01825785|26279910|FG002|Overall Study|Withdrawal by Subject|0|||
13220351|NCT01825785|26279911|FG003|Overall Study|Withdrawal by Subject|0|||
13220352|NCT01825785|26279912|FG004|Overall Study|Withdrawal by Subject|1|||
13220353|NCT01825785|26279913|FG005|Overall Study|Withdrawal by Subject|1|||
13220354|NCT01825785|26279914|FG006|Overall Study|Withdrawal by Subject|0|||
13220355|NCT01825577|26279921|FG000|Overall Study|Physician Decision|2|||
13220356|NCT01825577|26279921|FG000|Overall Study|Withdrawal by Subject|1|||
13220357|NCT01825577|26279921|FG000|Overall Study|Withdrawn by family members|2|||
13220358|NCT01825577|26279921|FG000|Overall Study|Lack of Efficacy|3|||
13220359|NCT01825200|26279940|FG000|Overall Study|Lost to Follow-up|5|||
13220360|NCT01825200|26279941|FG001|Overall Study|Lost to Follow-up|6|||
13220361|NCT01825200|26279940|FG000|Overall Study|Withdrawal by Subject|0|||
13220362|NCT01825200|26279941|FG001|Overall Study|Withdrawal by Subject|1|||
13220363|NCT01824979|26279956|FG000|Overall Study|Withdrawal by Subject|5|||
13220364|NCT01824979|26279957|FG001|Overall Study|Withdrawal by Subject|0|||
13220365|NCT01824979|26279956|FG000|Overall Study|Physician Decision|2|||
13220366|NCT01824979|26279957|FG001|Overall Study|Physician Decision|0|||
13220367|NCT01824979|26279956|FG000|Overall Study|Protocol Violation|6|||
13220368|NCT01824979|26279957|FG001|Overall Study|Protocol Violation|13|||
13306302|NCT01292603|26525397|FG002|Part 2: Regular Follow-Up|Disease Progression|0|||
13306303|NCT01292603|26525398|FG003|Part 2: Regular Follow-Up|Disease Progression|0|||
13306304|NCT01292603|26525399|FG004|Part 2: Regular Follow-Up|Disease Progression|5|||
13306305|NCT01292603|26525400|FG005|Part 2: Regular Follow-Up|Disease Progression|5|||
13306306|NCT01292603|26525395|FG000|Part 2: Regular Follow-Up|Noncompliance|0|||
13306307|NCT01292603|26525396|FG001|Part 2: Regular Follow-Up|Noncompliance|0|||
13306308|NCT01292603|26525397|FG002|Part 2: Regular Follow-Up|Noncompliance|0|||
13306309|NCT01292603|26525398|FG003|Part 2: Regular Follow-Up|Noncompliance|0|||
13306310|NCT01292603|26525399|FG004|Part 2: Regular Follow-Up|Noncompliance|1|||
13306311|NCT01292603|26525400|FG005|Part 2: Regular Follow-Up|Noncompliance|0|||
13306312|NCT01292603|26525395|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
13306313|NCT01292603|26525396|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
13306314|NCT01292603|26525397|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
13306315|NCT01292603|26525398|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
13306316|NCT01292603|26525399|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
13306317|NCT01292603|26525400|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1|||
13134155|NCT02759692|25990266|FG000|Period 1|Test article no longer available|1|||
13134156|NCT02759692|25990267|FG001|Period 1|Test article no longer available|1|||
13134157|NCT02759692|25990266|FG000|Period 1|No longer meets eligibility criteria.|1|||
13134158|NCT02759692|25990267|FG001|Period 1|No longer meets eligibility criteria.|0|||
13134159|NCT02759692|25990266|FG000|Period 1|Miss-Randomized|1|||
13134160|NCT02759692|25990267|FG001|Period 1|Miss-Randomized|1|||
13134161|NCT02759692|25990266|FG000|Period 2|Lost to Follow-up|1|||
13134162|NCT02759692|25990267|FG001|Period 2|Lost to Follow-up|0|||
13134163|NCT02759692|25990266|FG000|Period 2|Test article no longer available|0|||
13134164|NCT02759692|25990267|FG001|Period 2|Test article no longer available|1|||
13134165|NCT02759562|25990287|FG000|Open-Label Treatment Period|Withdrew Consent|1|||
13134166|NCT02759562|25990288|FG001|Open-Label Treatment Period|Withdrew Consent|0|||
13134167|NCT02759562|25990287|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
13134168|NCT02759562|25990288|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
13134169|NCT02759471|25990300|FG000|Overall Study|discomfort|2|||
13134170|NCT02759315|25990360|FG000|Overall Study|Adverse Event|0|||
13134171|NCT02759315|25990361|FG001|Overall Study|Adverse Event|0|||
13134172|NCT02759315|25990362|FG002|Overall Study|Adverse Event|0|||
13134173|NCT02759315|25990363|FG003|Overall Study|Adverse Event|1|||
13134174|NCT02759315|25990364|FG004|Overall Study|Adverse Event|0|||
13134175|NCT02759315|25990360|FG000|Overall Study|Death|0|||
13134176|NCT02759315|25990361|FG001|Overall Study|Death|0|||
13134177|NCT02759315|25990362|FG002|Overall Study|Death|1|||
13134178|NCT02759315|25990363|FG003|Overall Study|Death|0|||
13134179|NCT02759315|25990364|FG004|Overall Study|Death|0|||
13134180|NCT02759315|25990360|FG000|Overall Study|Lost to Follow-up|2|||
13134181|NCT02759315|25990361|FG001|Overall Study|Lost to Follow-up|0|||
13134182|NCT02759315|25990362|FG002|Overall Study|Lost to Follow-up|4|||
13134183|NCT02759315|25990363|FG003|Overall Study|Lost to Follow-up|0|||
13134184|NCT02759315|25990364|FG004|Overall Study|Lost to Follow-up|0|||
13134185|NCT02759315|25990360|FG000|Overall Study|Protocol Violation|0|||
13134186|NCT02759315|25990361|FG001|Overall Study|Protocol Violation|1|||
13306318|NCT01292603|26525395|FG000|Part 2: Regular Follow-Up|Protocol Violation|0|||
13134187|NCT02759315|25990362|FG002|Overall Study|Protocol Violation|0|||
13134188|NCT02759315|25990363|FG003|Overall Study|Protocol Violation|0|||
13134189|NCT02759315|25990364|FG004|Overall Study|Protocol Violation|0|||
13220369|NCT01824875|26279978|FG000|Overall Study|Disease progression|22|||
13220370|NCT01824875|26279979|FG001|Overall Study|Disease progression|15|||
13220371|NCT01824875|26279978|FG000|Overall Study|Withdrawal by Subject|5|||
13220372|NCT01824875|26279979|FG001|Overall Study|Withdrawal by Subject|4|||
13220373|NCT01824875|26279978|FG000|Overall Study|Adverse Event|4|||
13220374|NCT01824875|26279979|FG001|Overall Study|Adverse Event|10|||
13220375|NCT01824875|26279978|FG000|Overall Study|Alternative therapy|3|||
13220376|NCT01824875|26279979|FG001|Overall Study|Alternative therapy|0|||
13220377|NCT01824875|26279978|FG000|Overall Study|Complicating disease|1|||
13220378|NCT01824875|26279979|FG001|Overall Study|Complicating disease|0|||
13220379|NCT01824875|26279978|FG000|Overall Study|Physician Decision|0|||
13220380|NCT01824875|26279979|FG001|Overall Study|Physician Decision|1|||
13220381|NCT01824875|26279978|FG000|Overall Study|Non-compliance|1|||
13220382|NCT01824875|26279979|FG001|Overall Study|Non-compliance|1|||
13220383|NCT01824875|26279978|FG000|Overall Study|Treatment ended early due to mis-interpretation of protocol|1|||
13220384|NCT01824875|26279979|FG001|Overall Study|Treatment ended early due to mis-interpretation of protocol|0|||
13220385|NCT01824875|26279978|FG000|Overall Study|Administrative issues|0|||
13220386|NCT01824875|26279979|FG001|Overall Study|Administrative issues|2|||
13220387|NCT01824875|26279978|FG000|Overall Study|Ineligible or never started treatment|9|||
13220388|NCT01824875|26279979|FG001|Overall Study|Ineligible or never started treatment|5|||
13220389|NCT01824875|26279978|FG000|Overall Study|Other|0|||
13220390|NCT01824875|26279979|FG001|Overall Study|Other|2|||
13220391|NCT01824823|26279992|FG000|Overall Study|Lack of Efficacy|1|||
13220392|NCT01824823|26279993|FG001|Overall Study|Lack of Efficacy|1|||
13220393|NCT01824823|26279992|FG000|Overall Study|Off-treatment reason not submitted|1|||
13220394|NCT01824823|26279993|FG001|Overall Study|Off-treatment reason not submitted|0|||
13220395|NCT01824693|26280016|FG000|Overall Study|Death|0|||
13220396|NCT01824693|26280017|FG001|Overall Study|Death|1|||
13220397|NCT01824693|26280018|FG002|Overall Study|Death|0|||
13220398|NCT01824693|26280016|FG000|Overall Study|Physician Decision|1|||
13220399|NCT01824693|26280017|FG001|Overall Study|Physician Decision|1|||
13220400|NCT01824693|26280018|FG002|Overall Study|Physician Decision|1|||
13220401|NCT01824693|26280016|FG000|Overall Study|Withdrawal by Subject|0|||
13220402|NCT01824693|26280017|FG001|Overall Study|Withdrawal by Subject|0|||
13220403|NCT01824693|26280018|FG002|Overall Study|Withdrawal by Subject|1|||
13220404|NCT01824693|26280016|FG000|Overall Study|Progressive Disease|0|||
13220405|NCT01824693|26280017|FG001|Overall Study|Progressive Disease|5|||
13220406|NCT01824693|26280018|FG002|Overall Study|Progressive Disease|0|||
13220407|NCT01824693|26280016|FG000|Overall Study|Ineligible|0|||
13220408|NCT01824693|26280017|FG001|Overall Study|Ineligible|0|||
13220409|NCT01824693|26280018|FG002|Overall Study|Ineligible|3|||
13220410|NCT01824693|26280016|FG000|Overall Study|No Transplant Planned|0|||
13220411|NCT01824693|26280017|FG001|Overall Study|No Transplant Planned|0|||
13220412|NCT01824693|26280018|FG002|Overall Study|No Transplant Planned|10|||
13220413|NCT01824602|26280041|FG000|Overall Study|Withdrawal by Subject|0|||
13220414|NCT01824602|26280042|FG001|Overall Study|Withdrawal by Subject|0|||
13220415|NCT01824602|26280043|FG002|Overall Study|Withdrawal by Subject|1|||
13220416|NCT01824602|26280044|FG003|Overall Study|Withdrawal by Subject|2|||
13220417|NCT01824602|26280041|FG000|Overall Study|Patient non-compliance|0|||
13220418|NCT01824602|26280042|FG001|Overall Study|Patient non-compliance|0|||
13220419|NCT01824602|26280043|FG002|Overall Study|Patient non-compliance|1|||
13220420|NCT01824602|26280044|FG003|Overall Study|Patient non-compliance|0|||
13220421|NCT01824602|26280041|FG000|Overall Study|Adverse Event|1|||
13220422|NCT01824602|26280042|FG001|Overall Study|Adverse Event|0|||
13220423|NCT01824602|26280043|FG002|Overall Study|Adverse Event|2|||
13220424|NCT01824602|26280044|FG003|Overall Study|Adverse Event|2|||
13220425|NCT01824602|26280041|FG000|Overall Study|Treatment failure|0|||
13220426|NCT01824602|26280042|FG001|Overall Study|Treatment failure|0|||
13220427|NCT01824602|26280043|FG002|Overall Study|Treatment failure|0|||
13220428|NCT01824602|26280044|FG003|Overall Study|Treatment failure|1|||
13220429|NCT01824576|26280058|FG000|Overall Study|Device deficiency|2|||
13220430|NCT01824498|26280085|FG000|Washout (8 Weeks)|Withdrawal by Subject|2|||
13220431|NCT01824498|26280086|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
13220432|NCT01824498|26280087|FG002|Washout (8 Weeks)|Withdrawal by Subject|2|||
13220433|NCT01824498|26280088|FG003|Washout (8 Weeks)|Withdrawal by Subject|1|||
13220434|NCT01824498|26280089|FG004|Washout (8 Weeks)|Withdrawal by Subject|1|||
13134190|NCT02759315|25990360|FG000|Overall Study|Study terminated prior to completion|2|||
13134191|NCT02759315|25990361|FG001|Overall Study|Study terminated prior to completion|0|||
13134192|NCT02759315|25990362|FG002|Overall Study|Study terminated prior to completion|5|||
13134193|NCT02759315|25990363|FG003|Overall Study|Study terminated prior to completion|0|||
13134194|NCT02759315|25990364|FG004|Overall Study|Study terminated prior to completion|1|||
13134195|NCT02759185|25990425|FG000|Stage 1|Adverse Event|0|||
13134196|NCT02759185|25990426|FG001|Stage 1|Adverse Event|1|||
13134197|NCT02759185|25990427|FG002|Stage 1|Adverse Event|3|||
13134198|NCT02759185|25990428|FG003|Stage 1|Adverse Event|0|||
13134199|NCT02759185|25990429|FG004|Stage 1|Adverse Event|0|||
13134200|NCT02759185|25990430|FG005|Stage 1|Adverse Event|0|||
13134201|NCT02759185|25990431|FG006|Stage 1|Adverse Event|0|||
13134202|NCT02759185|25990425|FG000|Stage 1|Withdrawal by Subject|1|||
13134203|NCT02759185|25990426|FG001|Stage 1|Withdrawal by Subject|0|||
13134204|NCT02759185|25990427|FG002|Stage 1|Withdrawal by Subject|0|||
13134205|NCT02759185|25990428|FG003|Stage 1|Withdrawal by Subject|0|||
13134206|NCT02759185|25990429|FG004|Stage 1|Withdrawal by Subject|0|||
13134207|NCT02759185|25990430|FG005|Stage 1|Withdrawal by Subject|0|||
13134208|NCT02759185|25990431|FG006|Stage 1|Withdrawal by Subject|0|||
13134209|NCT02759185|25990425|FG000|Stage 2|Adverse Event|0|||
13134210|NCT02759185|25990426|FG001|Stage 2|Adverse Event|0|||
13134211|NCT02759185|25990427|FG002|Stage 2|Adverse Event|0|||
13134212|NCT02759185|25990428|FG003|Stage 2|Adverse Event|0|||
13134213|NCT02759185|25990429|FG004|Stage 2|Adverse Event|1|||
13134214|NCT02759185|25990430|FG005|Stage 2|Adverse Event|2|||
13134215|NCT02759185|25990431|FG006|Stage 2|Adverse Event|0|||
13134216|NCT02759185|25990425|FG000|Stage 2|Withdrawal by Subject|0|||
13134217|NCT02759185|25990426|FG001|Stage 2|Withdrawal by Subject|0|||
13134218|NCT02759185|25990427|FG002|Stage 2|Withdrawal by Subject|0|||
13134219|NCT02759185|25990428|FG003|Stage 2|Withdrawal by Subject|0|||
13134220|NCT02759185|25990429|FG004|Stage 2|Withdrawal by Subject|1|||
13134221|NCT02759185|25990430|FG005|Stage 2|Withdrawal by Subject|1|||
13134222|NCT02759185|25990431|FG006|Stage 2|Withdrawal by Subject|1|||
13134223|NCT02759120|25990476|FG000|Overall Study|Death|34|||
13134224|NCT02759120|25990477|FG001|Overall Study|Death|36|||
13134225|NCT02759120|25990476|FG000|Overall Study|Lost to Follow-up|4|||
13134226|NCT02759120|25990477|FG001|Overall Study|Lost to Follow-up|7|||
13134227|NCT02759120|25990476|FG000|Overall Study|Physician Decision|3|||
13134228|NCT02759120|25990477|FG001|Overall Study|Physician Decision|0|||
13134229|NCT02759120|25990476|FG000|Overall Study|Withdrawal by Subject|28|||
13134230|NCT02759120|25990477|FG001|Overall Study|Withdrawal by Subject|15|||
13134231|NCT02759120|25990476|FG000|Overall Study|Moved out of area|3|||
13134232|NCT02759120|25990477|FG001|Overall Study|Moved out of area|4|||
13220435|NCT01824498|26280090|FG005|Washout (8 Weeks)|Withdrawal by Subject|0|||
13220436|NCT01824472|26280108|FG000|Overall Study|Lost to Follow-up|0|||
13220437|NCT01824472|26280109|FG001|Overall Study|Lost to Follow-up|0|||
13220438|NCT01824472|26280110|FG002|Overall Study|Lost to Follow-up|1|||
13220439|NCT01824472|26280108|FG000|Overall Study|Withdrawal by Subject|1|||
13220440|NCT01824472|26280109|FG001|Overall Study|Withdrawal by Subject|5|||
13220441|NCT01824472|26280110|FG002|Overall Study|Withdrawal by Subject|3|||
13220442|NCT01824472|26280108|FG000|Overall Study|Ineligible post randomization&screening|0|||
13220443|NCT01824472|26280109|FG001|Overall Study|Ineligible post randomization&screening|2|||
13220444|NCT01824472|26280110|FG002|Overall Study|Ineligible post randomization&screening|0|||
13220445|NCT01824394|26280130|FG000|Overall Study|Early Termination|1|||
13220446|NCT01824394|26280131|FG001|Overall Study|Early Termination|1|||
13220447|NCT01824394|26280132|FG002|Overall Study|Early Termination|3|||
13306319|NCT01292603|26525396|FG001|Part 2: Regular Follow-Up|Protocol Violation|0|||
13306320|NCT01292603|26525397|FG002|Part 2: Regular Follow-Up|Protocol Violation|0|||
13306321|NCT01292603|26525398|FG003|Part 2: Regular Follow-Up|Protocol Violation|0|||
13306322|NCT01292603|26525399|FG004|Part 2: Regular Follow-Up|Protocol Violation|2|||
13306323|NCT01292603|26525400|FG005|Part 2: Regular Follow-Up|Protocol Violation|0|||
13306324|NCT01292603|26525395|FG000|Part 2: Regular Follow-Up|Physician Decision|0|||
13306325|NCT01292603|26525396|FG001|Part 2: Regular Follow-Up|Physician Decision|0|||
13306326|NCT01292603|26525397|FG002|Part 2: Regular Follow-Up|Physician Decision|0|||
13306327|NCT01292603|26525398|FG003|Part 2: Regular Follow-Up|Physician Decision|0|||
13306328|NCT01292603|26525399|FG004|Part 2: Regular Follow-Up|Physician Decision|2|||
13306329|NCT01292603|26525400|FG005|Part 2: Regular Follow-Up|Physician Decision|0|||
13306330|NCT01292603|26525395|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
13306331|NCT01292603|26525396|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
13306332|NCT01292603|26525397|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
13306333|NCT01292603|26525398|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
13306334|NCT01292603|26525399|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
13306335|NCT01292603|26525400|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
13306336|NCT01292603|26525395|FG000|Part 2: Regular Follow-Up|Adverse Event|0|||
13306337|NCT01292603|26525396|FG001|Part 2: Regular Follow-Up|Adverse Event|0|||
13306338|NCT01292603|26525397|FG002|Part 2: Regular Follow-Up|Adverse Event|0|||
13306339|NCT01292603|26525398|FG003|Part 2: Regular Follow-Up|Adverse Event|0|||
13306340|NCT01292603|26525399|FG004|Part 2: Regular Follow-Up|Adverse Event|2|||
13306341|NCT01292603|26525400|FG005|Part 2: Regular Follow-Up|Adverse Event|2|||
13306342|NCT01292603|26525395|FG000|Overall Survival Status|Death|3|||
13306343|NCT01292603|26525396|FG001|Overall Survival Status|Death|1|||
13306344|NCT01292603|26525397|FG002|Overall Survival Status|Death|3|||
13306345|NCT01292603|26525398|FG003|Overall Survival Status|Death|1|||
13306346|NCT01292603|26525399|FG004|Overall Survival Status|Death|16|||
13306347|NCT01292603|26525400|FG005|Overall Survival Status|Death|10|||
13306348|NCT01292486|26525412|FG000|Overall Study|Protocol Violation|2|||
13306349|NCT01292486|26525412|FG000|Overall Study|Did not meet screening criteria|2|||
13306350|NCT01292486|26525412|FG000|Overall Study|Adverse Event|1|||
13306351|NCT01292486|26525412|FG000|Overall Study|Physician Decision|1|||
13134233|NCT02759120|25990476|FG000|Overall Study|Lung transplant|3|||
13134234|NCT02759120|25990477|FG001|Overall Study|Lung transplant|5|||
13134235|NCT02759120|25990476|FG000|Overall Study|Other reason not completed|10|||
13134236|NCT02759120|25990477|FG001|Overall Study|Other reason not completed|12|||
13134237|NCT02759055|25990490|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927|||
13134238|NCT02759055|25990491|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508|||
13134239|NCT02759016|25990506|FG000|Overall Study|Not treated with BI 836826|1|||
13220448|NCT01824394|26280130|FG000|Overall Study|Withdrawn due to Study Termination|91|||
13220449|NCT01824394|26280131|FG001|Overall Study|Withdrawn due to Study Termination|83|||
13220450|NCT01824394|26280132|FG002|Overall Study|Withdrawn due to Study Termination|41|||
13220451|NCT01824394|26280130|FG000|Overall Study|Lost to Follow-up|0|||
13220452|NCT01824394|26280131|FG001|Overall Study|Lost to Follow-up|9|||
13220453|NCT01824394|26280132|FG002|Overall Study|Lost to Follow-up|3|||
13220454|NCT01824394|26280130|FG000|Overall Study|Death|3|||
13220455|NCT01824394|26280131|FG001|Overall Study|Death|2|||
13220456|NCT01824394|26280132|FG002|Overall Study|Death|4|||
13220457|NCT01824394|26280130|FG000|Overall Study|Discontinued Subjects|1|||
13220458|NCT01824394|26280131|FG001|Overall Study|Discontinued Subjects|1|||
13220459|NCT01824394|26280132|FG002|Overall Study|Discontinued Subjects|2|||
13220460|NCT01824394|26280130|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23|||
13220461|NCT01824394|26280131|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20|||
13220462|NCT01824394|26280132|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21|||
13220463|NCT01824355|26280143|FG000|Overall Study|Adverse Event|2|||
13220464|NCT01824355|26280143|FG000|Overall Study|unevaluable reference method results per|1|||
13220465|NCT01824342|26280162|FG000|Overall Study|Withdrawal by Subject|0|||
13220466|NCT01824342|26280163|FG001|Overall Study|Withdrawal by Subject|3|||
13220467|NCT01824342|26280162|FG000|Overall Study|Adverse Event|1|||
13220468|NCT01824342|26280163|FG001|Overall Study|Adverse Event|1|||
13220469|NCT01824342|26280162|FG000|Overall Study|Disease Progression|1|||
13220470|NCT01824342|26280163|FG001|Overall Study|Disease Progression|1|||
13220471|NCT01824342|26280162|FG000|Overall Study|Physician Decision|5|||
13220472|NCT01824342|26280163|FG001|Overall Study|Physician Decision|0|||
13220473|NCT01824342|26280162|FG000|Overall Study|Death|2|||
13220474|NCT01824342|26280163|FG001|Overall Study|Death|0|||
13220475|NCT01824303|26280194|FG000|Randomized Study|Withdrawal by Subject|1|||
13220476|NCT01824303|26280195|FG001|Randomized Study|Withdrawal by Subject|1|||
13220477|NCT01824303|26280194|FG000|Randomized Study|Other Miscellaneous Reasons|1|||
13220478|NCT01824303|26280195|FG001|Randomized Study|Other Miscellaneous Reasons|0|||
13220479|NCT01824290|26280222|FG000|Period 1: Double Blind|Entry Criteria Not Met|1|||
13220480|NCT01824290|26280223|FG001|Period 1: Double Blind|Entry Criteria Not Met|0|||
13220481|NCT01824290|26280224|FG002|Period 1: Double Blind|Entry Criteria Not Met|0|||
13220482|NCT01824290|26280225|FG003|Period 1: Double Blind|Entry Criteria Not Met|0|||
13306352|NCT01292473|26525467|FG000|Overall Study|Adverse Event|1|||
13220483|NCT01824290|26280222|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1|||
13220484|NCT01824290|26280223|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1|||
13220485|NCT01824290|26280224|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0|||
13220486|NCT01824290|26280225|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0|||
13220487|NCT01824290|26280222|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
13220488|NCT01824290|26280223|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
13220489|NCT01824290|26280224|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
13220490|NCT01824290|26280225|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
13220491|NCT01824290|26280222|FG000|Period 2: Open-Label Treatment|Adverse Event|0|||
13220492|NCT01824290|26280223|FG001|Period 2: Open-Label Treatment|Adverse Event|0|||
13220493|NCT01824290|26280224|FG002|Period 2: Open-Label Treatment|Adverse Event|0|||
13220494|NCT01824290|26280225|FG003|Period 2: Open-Label Treatment|Adverse Event|1|||
13220495|NCT01824290|26280222|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
13220496|NCT01824290|26280223|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
13220497|NCT01824290|26280224|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
13220498|NCT01824290|26280225|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
13220499|NCT01824290|26280222|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
13220500|NCT01824290|26280223|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
13220501|NCT01824290|26280224|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2|||
13220502|NCT01824290|26280225|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1|||
13220503|NCT01823991|26280264|FG000|Overall Study|Withdrawal by Subject|8|||
13220504|NCT01823991|26280265|FG001|Overall Study|Withdrawal by Subject|5|||
13220505|NCT01823835|26280438|FG000|Overall Study|Adverse Event|0|||
13220506|NCT01823835|26280439|FG001|Overall Study|Adverse Event|0|||
13220507|NCT01823835|26280440|FG002|Overall Study|Adverse Event|0|||
13220508|NCT01823835|26280441|FG003|Overall Study|Adverse Event|0|||
13220509|NCT01823835|26280442|FG004|Overall Study|Adverse Event|1|||
13220510|NCT01823835|26280443|FG005|Overall Study|Adverse Event|0|||
13220511|NCT01823835|26280444|FG006|Overall Study|Adverse Event|1|||
13220512|NCT01823835|26280445|FG007|Overall Study|Adverse Event|0|||
13220513|NCT01823835|26280446|FG008|Overall Study|Adverse Event|0|||
13220514|NCT01823835|26280447|FG009|Overall Study|Adverse Event|0|||
13220515|NCT01823835|26280448|FG010|Overall Study|Adverse Event|1|||
13220516|NCT01823835|26280449|FG011|Overall Study|Adverse Event|2|||
13220517|NCT01823835|26280450|FG012|Overall Study|Adverse Event|0|||
13220518|NCT01823835|26280451|FG013|Overall Study|Adverse Event|0|||
13220519|NCT01823835|26280452|FG014|Overall Study|Adverse Event|0|||
13220520|NCT01823835|26280438|FG000|Overall Study|Physician Decision|0|||
13220521|NCT01823835|26280439|FG001|Overall Study|Physician Decision|0|||
13220522|NCT01823835|26280440|FG002|Overall Study|Physician Decision|0|||
13220523|NCT01823835|26280441|FG003|Overall Study|Physician Decision|0|||
13220524|NCT01823835|26280442|FG004|Overall Study|Physician Decision|0|||
13220525|NCT01823835|26280443|FG005|Overall Study|Physician Decision|0|||
13220526|NCT01823835|26280444|FG006|Overall Study|Physician Decision|0|||
13220527|NCT01823835|26280445|FG007|Overall Study|Physician Decision|0|||
13220528|NCT01823835|26280446|FG008|Overall Study|Physician Decision|0|||
13220529|NCT01823835|26280447|FG009|Overall Study|Physician Decision|0|||
13220530|NCT01823835|26280448|FG010|Overall Study|Physician Decision|0|||
13220531|NCT01823835|26280449|FG011|Overall Study|Physician Decision|2|||
13220532|NCT01823835|26280450|FG012|Overall Study|Physician Decision|0|||
13220533|NCT01823835|26280451|FG013|Overall Study|Physician Decision|0|||
13220534|NCT01823835|26280452|FG014|Overall Study|Physician Decision|0|||
13220535|NCT01823835|26280438|FG000|Overall Study|Progressive Disease|3|||
13220536|NCT01823835|26280439|FG001|Overall Study|Progressive Disease|4|||
13220537|NCT01823835|26280440|FG002|Overall Study|Progressive Disease|3|||
13220538|NCT01823835|26280441|FG003|Overall Study|Progressive Disease|6|||
13220539|NCT01823835|26280442|FG004|Overall Study|Progressive Disease|4|||
13220540|NCT01823835|26280443|FG005|Overall Study|Progressive Disease|6|||
13220541|NCT01823835|26280444|FG006|Overall Study|Progressive Disease|5|||
13220542|NCT01823835|26280445|FG007|Overall Study|Progressive Disease|3|||
13220543|NCT01823835|26280446|FG008|Overall Study|Progressive Disease|3|||
13220544|NCT01823835|26280447|FG009|Overall Study|Progressive Disease|18|||
13220545|NCT01823835|26280448|FG010|Overall Study|Progressive Disease|8|||
13220546|NCT01823835|26280449|FG011|Overall Study|Progressive Disease|46|||
13220547|NCT01823835|26280450|FG012|Overall Study|Progressive Disease|18|||
13220548|NCT01823835|26280451|FG013|Overall Study|Progressive Disease|4|||
13220549|NCT01823835|26280452|FG014|Overall Study|Progressive Disease|6|||
13220550|NCT01823835|26280438|FG000|Overall Study|Study Termination|0|||
13220551|NCT01823835|26280439|FG001|Overall Study|Study Termination|0|||
13220552|NCT01823835|26280440|FG002|Overall Study|Study Termination|0|||
13220553|NCT01823835|26280441|FG003|Overall Study|Study Termination|0|||
13220554|NCT01823835|26280442|FG004|Overall Study|Study Termination|1|||
13220555|NCT01823835|26280443|FG005|Overall Study|Study Termination|0|||
13220556|NCT01823835|26280444|FG006|Overall Study|Study Termination|0|||
13220557|NCT01823835|26280445|FG007|Overall Study|Study Termination|0|||
13220558|NCT01823835|26280446|FG008|Overall Study|Study Termination|0|||
13220559|NCT01823835|26280447|FG009|Overall Study|Study Termination|0|||
13220560|NCT01823835|26280448|FG010|Overall Study|Study Termination|0|||
13220561|NCT01823835|26280449|FG011|Overall Study|Study Termination|1|||
13220562|NCT01823835|26280450|FG012|Overall Study|Study Termination|0|||
13220563|NCT01823835|26280451|FG013|Overall Study|Study Termination|0|||
13220564|NCT01823835|26280452|FG014|Overall Study|Study Termination|0|||
13220565|NCT01823835|26280438|FG000|Overall Study|Withdrawal by Subject|0|||
13220566|NCT01823835|26280439|FG001|Overall Study|Withdrawal by Subject|0|||
13220567|NCT01823835|26280440|FG002|Overall Study|Withdrawal by Subject|1|||
13220568|NCT01823835|26280441|FG003|Overall Study|Withdrawal by Subject|0|||
13220569|NCT01823835|26280442|FG004|Overall Study|Withdrawal by Subject|0|||
13220570|NCT01823835|26280443|FG005|Overall Study|Withdrawal by Subject|0|||
13220571|NCT01823835|26280444|FG006|Overall Study|Withdrawal by Subject|0|||
13220572|NCT01823835|26280445|FG007|Overall Study|Withdrawal by Subject|0|||
13220573|NCT01823835|26280446|FG008|Overall Study|Withdrawal by Subject|0|||
13220574|NCT01823835|26280447|FG009|Overall Study|Withdrawal by Subject|1|||
13220575|NCT01823835|26280448|FG010|Overall Study|Withdrawal by Subject|1|||
13220576|NCT01823835|26280449|FG011|Overall Study|Withdrawal by Subject|2|||
13220577|NCT01823835|26280450|FG012|Overall Study|Withdrawal by Subject|1|||
13220578|NCT01823835|26280451|FG013|Overall Study|Withdrawal by Subject|0|||
13220579|NCT01823835|26280452|FG014|Overall Study|Withdrawal by Subject|0|||
13220580|NCT01823679|26280462|FG000|Overall Study|Death|1|||
13220581|NCT01823536|26280519|FG000|Overall Study|Lost to Follow-up|1|||
13220582|NCT01823536|26280520|FG001|Overall Study|Lost to Follow-up|0|||
13220583|NCT01823536|26280521|FG002|Overall Study|Lost to Follow-up|0|||
13220584|NCT01823536|26280522|FG003|Overall Study|Lost to Follow-up|1|||
13220585|NCT01823536|26280523|FG004|Overall Study|Lost to Follow-up|1|||
13220586|NCT01823536|26280524|FG005|Overall Study|Lost to Follow-up|0|||
13220587|NCT01823536|26280519|FG000|Overall Study|Protocol Violation|0|||
13220588|NCT01823536|26280520|FG001|Overall Study|Protocol Violation|1|||
13220589|NCT01823536|26280521|FG002|Overall Study|Protocol Violation|0|||
13220590|NCT01823536|26280522|FG003|Overall Study|Protocol Violation|0|||
13220591|NCT01823536|26280523|FG004|Overall Study|Protocol Violation|0|||
13220592|NCT01823536|26280524|FG005|Overall Study|Protocol Violation|0|||
13220593|NCT01823536|26280519|FG000|Overall Study|Withdrawal by Subject|1|||
13220594|NCT01823536|26280520|FG001|Overall Study|Withdrawal by Subject|1|||
13220595|NCT01823536|26280521|FG002|Overall Study|Withdrawal by Subject|0|||
13220596|NCT01823536|26280522|FG003|Overall Study|Withdrawal by Subject|0|||
13220597|NCT01823536|26280523|FG004|Overall Study|Withdrawal by Subject|0|||
13220598|NCT01823536|26280524|FG005|Overall Study|Withdrawal by Subject|0|||
13306353|NCT01292473|26525468|FG001|Overall Study|Adverse Event|0|||
13306354|NCT01292473|26525469|FG002|Overall Study|Adverse Event|1|||
13306355|NCT01292473|26525470|FG003|Overall Study|Adverse Event|1|||
13306356|NCT01292473|26525467|FG000|Overall Study|Lost to Follow-up|1|||
13306357|NCT01292473|26525468|FG001|Overall Study|Lost to Follow-up|1|||
13306358|NCT01292473|26525469|FG002|Overall Study|Lost to Follow-up|2|||
13306359|NCT01292473|26525470|FG003|Overall Study|Lost to Follow-up|2|||
13306360|NCT01292473|26525467|FG000|Overall Study|Withdrawal by Subject|3|||
13306361|NCT01292473|26525468|FG001|Overall Study|Withdrawal by Subject|4|||
13306362|NCT01292473|26525469|FG002|Overall Study|Withdrawal by Subject|3|||
13306363|NCT01292473|26525470|FG003|Overall Study|Withdrawal by Subject|3|||
13306364|NCT01292473|26525467|FG000|Overall Study|Physician Decision|0|||
13306365|NCT01292473|26525468|FG001|Overall Study|Physician Decision|1|||
13306366|NCT01292473|26525469|FG002|Overall Study|Physician Decision|0|||
13306367|NCT01292473|26525470|FG003|Overall Study|Physician Decision|0|||
13306368|NCT01292473|26525467|FG000|Overall Study|Disease Progression|0|||
13306369|NCT01292473|26525468|FG001|Overall Study|Disease Progression|1|||
13306370|NCT01292473|26525469|FG002|Overall Study|Disease Progression|3|||
13306371|NCT01292473|26525470|FG003|Overall Study|Disease Progression|6|||
13306372|NCT01292239|26525498|FG000|Overall Study|Other|1|||
13306373|NCT01292239|26525499|FG001|Overall Study|Other|1|||
13306374|NCT01292239|26525498|FG000|Overall Study|Withdrawal by Subject|3|||
13306375|NCT01292239|26525499|FG001|Overall Study|Withdrawal by Subject|6|||
13306376|NCT01292226|26525532|FG000|Overall Study|Adverse Event|5|||
13306377|NCT01292226|26525532|FG000|Overall Study|Death|1|||
13306378|NCT01292226|26525532|FG000|Overall Study|Graft loss|1|||
13306379|NCT01292226|26525532|FG000|Overall Study|Protocol Violation|3|||
13306380|NCT01292226|26525532|FG000|Overall Study|Withdrawal by Subject|1|||
13306381|NCT01292226|26525532|FG000|Overall Study|Other|2|||
13306382|NCT01292187|26525547|FG000|Overall Study|Adverse Event|10|||
13306383|NCT01292187|26525548|FG001|Overall Study|Adverse Event|5|||
13306384|NCT01292187|26525547|FG000|Overall Study|Withdrawal by Subject|6|||
13306385|NCT01292187|26525548|FG001|Overall Study|Withdrawal by Subject|5|||
13306386|NCT01292187|26525547|FG000|Overall Study|All other reasons|1|||
13306387|NCT01292187|26525548|FG001|Overall Study|All other reasons|3|||
13306388|NCT01292057|26525563|FG000|Overall Study|Protocol Violation|1|||
13306389|NCT01292057|26525564|FG001|Overall Study|Protocol Violation|1|||
13306390|NCT01292057|26525563|FG000|Overall Study|Lost to Follow-up|1|||
13306391|NCT01292057|26525564|FG001|Overall Study|Lost to Follow-up|1|||
13306392|NCT01291277|26525577|FG000|Overall Study|Death|2|||
13306393|NCT01291277|26525578|FG001|Overall Study|Death|2|||
13306394|NCT01291277|26525577|FG000|Overall Study|Lost to Follow-up|3|||
13306395|NCT01291277|26525578|FG001|Overall Study|Lost to Follow-up|1|||
13306396|NCT01291225|26525595|FG000|Overall Study|Lost to Follow-up|85|||
13306397|NCT01291225|26525596|FG001|Overall Study|Lost to Follow-up|39|||
13306398|NCT01291173|26525671|FG000|Overall Study|Adverse Event|0|||
13306399|NCT01291173|26525672|FG001|Overall Study|Adverse Event|3|||
13306400|NCT01291173|26525673|FG002|Overall Study|Adverse Event|1|||
13306401|NCT01291173|26525674|FG003|Overall Study|Adverse Event|3|||
13306402|NCT01291173|26525671|FG000|Overall Study|Protocol Violation|7|||
13306403|NCT01291173|26525672|FG001|Overall Study|Protocol Violation|2|||
13306404|NCT01291173|26525673|FG002|Overall Study|Protocol Violation|2|||
13306405|NCT01291173|26525674|FG003|Overall Study|Protocol Violation|5|||
13220599|NCT01823536|26280519|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0|||
13220600|NCT01823536|26280520|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0|||
13220601|NCT01823536|26280521|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1|||
13220602|NCT01823536|26280522|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0|||
13220603|NCT01823536|26280523|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0|||
13220604|NCT01823536|26280524|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0|||
13220605|NCT01823536|26280519|FG000|Overall Study|Met exclusion criterion No 6|0|||
13220606|NCT01823536|26280520|FG001|Overall Study|Met exclusion criterion No 6|0|||
13220607|NCT01823536|26280521|FG002|Overall Study|Met exclusion criterion No 6|0|||
13220608|NCT01823536|26280522|FG003|Overall Study|Met exclusion criterion No 6|1|||
13220609|NCT01823536|26280523|FG004|Overall Study|Met exclusion criterion No 6|0|||
13220610|NCT01823536|26280524|FG005|Overall Study|Met exclusion criterion No 6|0|||
13220611|NCT01823536|26280519|FG000|Overall Study|Subject moved out of the state|0|||
13220612|NCT01823536|26280520|FG001|Overall Study|Subject moved out of the state|0|||
13220613|NCT01823536|26280521|FG002|Overall Study|Subject moved out of the state|0|||
13220614|NCT01823536|26280522|FG003|Overall Study|Subject moved out of the state|0|||
13220615|NCT01823536|26280523|FG004|Overall Study|Subject moved out of the state|1|||
13220616|NCT01823536|26280524|FG005|Overall Study|Subject moved out of the state|0|||
13220617|NCT01823341|26280569|FG000|Overall Study|Failed run-in|7|||
13220618|NCT01823341|26280569|FG000|Overall Study|Withdrawal by Subject|7|||
13220619|NCT01823341|26280569|FG000|Overall Study|Adverse Event|1|||
13220620|NCT01823328|26280596|FG000|Overall Study|Withdrawal by Subject|8|||
13220621|NCT01823328|26280597|FG001|Overall Study|Withdrawal by Subject|6|||
13220622|NCT01823289|26280605|FG000|Overall Study|Lost to Follow-up|5|||
13220623|NCT01823289|26280605|FG000|Overall Study|Adverse Event|5|||
13220624|NCT01823289|26280605|FG000|Overall Study|Lack of Efficacy|1|||
13220625|NCT01823289|26280605|FG000|Overall Study|Physician Decision|9|||
13220626|NCT01823289|26280605|FG000|Overall Study|Administered contraindicated medicine|1|||
13220627|NCT01823289|26280605|FG000|Overall Study|Transaminase increased more than 3 times|1|||
13220628|NCT01823289|26280605|FG000|Overall Study|Drug affected efficacy and safety|1|||
13220629|NCT01823289|26280605|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1|||
13220630|NCT01823224|26280620|FG000|Overall Study|Lost to Follow-up|5|||
13220631|NCT01823224|26280621|FG001|Overall Study|Lost to Follow-up|6|||
13220632|NCT01823224|26280620|FG000|Overall Study|didn't qualify|1|||
13220633|NCT01823224|26280621|FG001|Overall Study|didn't qualify|2|||
13220634|NCT01823224|26280620|FG000|Overall Study|pharmacy error|0|||
13220635|NCT01823224|26280621|FG001|Overall Study|pharmacy error|1|||
13220636|NCT01823224|26280620|FG000|Overall Study|missed med dose|0|||
13220637|NCT01823224|26280621|FG001|Overall Study|missed med dose|1|||
13220638|NCT01823224|26280620|FG000|Overall Study|Withdrawal by Subject|0|||
13220639|NCT01823224|26280621|FG001|Overall Study|Withdrawal by Subject|1|||
13220640|NCT01823146|26280638|FG000|Overall Study|Withdrawal by Subject|0|||
13220641|NCT01823146|26280639|FG001|Overall Study|Withdrawal by Subject|1|||
13220642|NCT01823146|26280638|FG000|Overall Study|Lost to Follow-up|2|||
13220643|NCT01823146|26280639|FG001|Overall Study|Lost to Follow-up|1|||
13220644|NCT01823107|26280647|FG000|Overall Study|Withdrawal by Subject|1|||
13220645|NCT01822925|26280710|FG000|Overall Study|Adverse Event|1|||
13220646|NCT01822925|26280711|FG001|Overall Study|Adverse Event|1|||
13220647|NCT01822925|26280712|FG002|Overall Study|Adverse Event|1|||
13220648|NCT01822925|26280713|FG003|Overall Study|Adverse Event|1|||
13220649|NCT01822925|26280710|FG000|Overall Study|Lost to Follow-up|0|||
13220650|NCT01822925|26280711|FG001|Overall Study|Lost to Follow-up|1|||
13220651|NCT01822925|26280712|FG002|Overall Study|Lost to Follow-up|0|||
13220652|NCT01822925|26280713|FG003|Overall Study|Lost to Follow-up|0|||
13220653|NCT01822925|26280710|FG000|Overall Study|Protocol Violation|1|||
13220654|NCT01822925|26280711|FG001|Overall Study|Protocol Violation|0|||
13220655|NCT01822925|26280712|FG002|Overall Study|Protocol Violation|0|||
13220656|NCT01822925|26280713|FG003|Overall Study|Protocol Violation|1|||
13220657|NCT01822925|26280710|FG000|Overall Study|Withdrawal by Subject|2|||
13220658|NCT01822925|26280711|FG001|Overall Study|Withdrawal by Subject|0|||
13220659|NCT01822925|26280712|FG002|Overall Study|Withdrawal by Subject|2|||
13220660|NCT01822925|26280713|FG003|Overall Study|Withdrawal by Subject|2|||
13220661|NCT01822925|26280710|FG000|Overall Study|Taking prohibited medication|2|||
13220662|NCT01822925|26280711|FG001|Overall Study|Taking prohibited medication|0|||
13220663|NCT01822925|26280712|FG002|Overall Study|Taking prohibited medication|0|||
13220664|NCT01822925|26280713|FG003|Overall Study|Taking prohibited medication|1|||
13220665|NCT01822899|26280728|FG000|Overall Study|Adverse Event|6|||
13306406|NCT01291173|26525671|FG000|Overall Study|Withdrawal by Subject|6|||
13306407|NCT01291173|26525672|FG001|Overall Study|Withdrawal by Subject|4|||
13306408|NCT01291173|26525673|FG002|Overall Study|Withdrawal by Subject|4|||
13306409|NCT01291173|26525674|FG003|Overall Study|Withdrawal by Subject|2|||
13306410|NCT01291173|26525671|FG000|Overall Study|Lost to Follow-up|4|||
13306411|NCT01291173|26525672|FG001|Overall Study|Lost to Follow-up|6|||
13306412|NCT01291173|26525673|FG002|Overall Study|Lost to Follow-up|3|||
13306413|NCT01291173|26525674|FG003|Overall Study|Lost to Follow-up|2|||
13306414|NCT01291173|26525671|FG000|Overall Study|Unable to meet visit schedule|0|||
13306415|NCT01291173|26525672|FG001|Overall Study|Unable to meet visit schedule|0|||
13306416|NCT01291173|26525673|FG002|Overall Study|Unable to meet visit schedule|1|||
13306417|NCT01291173|26525674|FG003|Overall Study|Unable to meet visit schedule|0|||
13306418|NCT01291173|26525671|FG000|Overall Study|Lack of compliance|0|||
13306419|NCT01291173|26525672|FG001|Overall Study|Lack of compliance|0|||
13306420|NCT01291173|26525673|FG002|Overall Study|Lack of compliance|0|||
13306421|NCT01291173|26525674|FG003|Overall Study|Lack of compliance|1|||
13306422|NCT01291173|26525671|FG000|Overall Study|Subject was unblinded|0|||
13306423|NCT01291173|26525672|FG001|Overall Study|Subject was unblinded|0|||
13306424|NCT01291173|26525673|FG002|Overall Study|Subject was unblinded|1|||
13306425|NCT01291173|26525674|FG003|Overall Study|Subject was unblinded|0|||
13306426|NCT01291173|26525671|FG000|Overall Study|Excluded therapy|0|||
13306427|NCT01291173|26525672|FG001|Overall Study|Excluded therapy|0|||
13306428|NCT01291173|26525673|FG002|Overall Study|Excluded therapy|1|||
13306429|NCT01291173|26525674|FG003|Overall Study|Excluded therapy|0|||
13306430|NCT01291017|26525684|FG000|Overall Study|Lost to Follow-up|2|||
13306431|NCT01291017|26525684|FG000|Overall Study|Withdrawal by Subject|3|||
13306432|NCT01290887|26525729|FG000|Overall Study|Adverse Event|6|||
13306433|NCT01290887|26525730|FG001|Overall Study|Adverse Event|11|||
13306434|NCT01290887|26525729|FG000|Overall Study|Lack of Efficacy|4|||
13306435|NCT01290887|26525730|FG001|Overall Study|Lack of Efficacy|5|||
13306436|NCT01290887|26525729|FG000|Overall Study|Withdrawal by Subject|26|||
13306437|NCT01290887|26525730|FG001|Overall Study|Withdrawal by Subject|32|||
13306438|NCT01290887|26525729|FG000|Overall Study|Protocol Violation|2|||
13306439|NCT01290887|26525730|FG001|Overall Study|Protocol Violation|1|||
13306440|NCT01290887|26525729|FG000|Overall Study|Lost to Follow-up|4|||
13306441|NCT01290887|26525730|FG001|Overall Study|Lost to Follow-up|4|||
13306442|NCT01290887|26525729|FG000|Overall Study|Non-compliance to study procedures|0|||
13306443|NCT01290887|26525730|FG001|Overall Study|Non-compliance to study procedures|1|||
13306444|NCT01290887|26525729|FG000|Overall Study|Non-compliance to study medications|1|||
13306445|NCT01290887|26525730|FG001|Overall Study|Non-compliance to study medications|0|||
13306446|NCT01290887|26525729|FG000|Overall Study|Sponsor closure of study|420|||
13306447|NCT01290887|26525730|FG001|Overall Study|Sponsor closure of study|476|||
13306448|NCT01290887|26525729|FG000|Overall Study|Other|3|||
13306449|NCT01290887|26525730|FG001|Overall Study|Other|6|||
13306450|NCT01290822|26525741|FG000|Overall Study|Withdrawal by Subject|1|||
13306451|NCT01290822|26525741|FG000|Overall Study|Physician Decision|10|||
13306452|NCT01290796|26525757|FG000|Overall Study|Lost to Follow-up|21|||
13306453|NCT01290796|26525757|FG000|Overall Study|Withdrawal by Subject|4|||
13306454|NCT01290796|26525757|FG000|Overall Study|Physician Decision|2|||
13306455|NCT01290796|26525757|FG000|Overall Study|Secondary Surgical Intervention|2|||
13306456|NCT01290796|26525757|FG000|Overall Study|Withdrawal by Sponsor|1|||
13306457|NCT01290757|26525780|FG000|Overall Study|Adverse Event|1|||
13306458|NCT01290757|26525781|FG001|Overall Study|Adverse Event|0|||
13306459|NCT01290757|26525780|FG000|Overall Study|Protocol Violation|1|||
13306460|NCT01290757|26525781|FG001|Overall Study|Protocol Violation|1|||
13306461|NCT01290757|26525780|FG000|Overall Study|Other|0|||
13306462|NCT01290757|26525781|FG001|Overall Study|Other|1|||
13306463|NCT01290731|26525795|FG000|Overall Study|Withdrawal by Subject|1|||
13220666|NCT01822899|26280729|FG001|Overall Study|Adverse Event|5|||
13220667|NCT01822899|26280728|FG000|Overall Study|Lack of Efficacy|6|||
13220668|NCT01822899|26280729|FG001|Overall Study|Lack of Efficacy|3|||
13220669|NCT01822899|26280728|FG000|Overall Study|Protocol Violation|6|||
13220670|NCT01822899|26280729|FG001|Overall Study|Protocol Violation|3|||
13220671|NCT01822899|26280728|FG000|Overall Study|Lost to Follow-up|1|||
13220672|NCT01822899|26280729|FG001|Overall Study|Lost to Follow-up|0|||
13220673|NCT01822899|26280728|FG000|Overall Study|Withdrawal by Subject|5|||
13220674|NCT01822899|26280729|FG001|Overall Study|Withdrawal by Subject|7|||
13220675|NCT01822821|26280760|FG000|Overall Study|Eligible surgery cancelled|1|||
13220676|NCT01822821|26280761|FG001|Overall Study|Eligible surgery cancelled|1|||
13220677|NCT01822821|26280760|FG000|Overall Study|Other reasons|1|||
13220678|NCT01822821|26280761|FG001|Overall Study|Other reasons|0|||
13220679|NCT01822756|26280819|FG000|Overall Study|Adverse Event|0|||
13220680|NCT01822756|26280820|FG001|Overall Study|Adverse Event|0|||
13220681|NCT01822756|26280821|FG002|Overall Study|Adverse Event|0|||
13220682|NCT01822756|26280822|FG003|Overall Study|Adverse Event|2|||
13220683|NCT01822756|26280823|FG004|Overall Study|Adverse Event|0|||
13220684|NCT01822756|26280819|FG000|Overall Study|Disease progression|11|||
13220685|NCT01822756|26280820|FG001|Overall Study|Disease progression|1|||
13220686|NCT01822756|26280821|FG002|Overall Study|Disease progression|7|||
13220687|NCT01822756|26280822|FG003|Overall Study|Disease progression|2|||
13220688|NCT01822756|26280823|FG004|Overall Study|Disease progression|6|||
13220689|NCT01822756|26280819|FG000|Overall Study|Death|2|||
13220690|NCT01822756|26280820|FG001|Overall Study|Death|2|||
13220691|NCT01822756|26280821|FG002|Overall Study|Death|1|||
13220692|NCT01822756|26280822|FG003|Overall Study|Death|0|||
13220693|NCT01822756|26280823|FG004|Overall Study|Death|0|||
13220694|NCT01822756|26280819|FG000|Overall Study|Lost to Follow-up|1|||
13474770|NCT02339090|26996551|FG001|Overall Study|Withdrawal by Subject|1|||
13474771|NCT02339090|26996550|FG000|Overall Study|Poor Growth|3|||
13474772|NCT02339090|26996551|FG001|Overall Study|Poor Growth|0|||
13474773|NCT02339090|26996550|FG000|Overall Study|Randomized but not treated|0|||
13474774|NCT02339090|26996551|FG001|Overall Study|Randomized but not treated|2|||
13474775|NCT02288247|26996577|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Adverse Event|52|||
13474776|NCT02288247|26996578|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Adverse Event|0|||
13474777|NCT02288247|26996577|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Death|35|||
13220695|NCT01822756|26280820|FG001|Overall Study|Lost to Follow-up|0|||
13474778|NCT02288247|26996578|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Death|0|||
13220696|NCT01822756|26280821|FG002|Overall Study|Lost to Follow-up|1|||
13134240|NCT02759016|25990507|FG001|Overall Study|Not treated with BI 836826|0|||
13134241|NCT02759016|25990506|FG000|Overall Study|Progressive disease|1|||
13134242|NCT02759016|25990507|FG001|Overall Study|Progressive disease|0|||
13134243|NCT02759016|25990506|FG000|Overall Study|SD, PR-MRDpos or PR-L|0|||
13134244|NCT02759016|25990507|FG001|Overall Study|SD, PR-MRDpos or PR-L|2|||
13134245|NCT02759016|25990506|FG000|Overall Study|Other not defined above|2|||
13134246|NCT02759016|25990507|FG001|Overall Study|Other not defined above|1|||
13134247|NCT02758613|25990536|FG000|Treatment|Physician and Sponsor Decision|1|||
13134248|NCT02758613|25990537|FG001|Treatment|Physician and Sponsor Decision|0|||
13134249|NCT02758613|25990538|FG002|Treatment|Physician and Sponsor Decision|0|||
13134250|NCT02758613|25990539|FG003|Treatment|Physician and Sponsor Decision|0|||
13134251|NCT02758613|25990536|FG000|Treatment|Withdrawal by Subject|1|||
13134252|NCT02758613|25990537|FG001|Treatment|Withdrawal by Subject|0|||
13134253|NCT02758613|25990538|FG002|Treatment|Withdrawal by Subject|1|||
13134254|NCT02758613|25990539|FG003|Treatment|Withdrawal by Subject|0|||
13134255|NCT02758301|25990554|FG000|Overall Study|Death|12|||
13134256|NCT02758301|25990555|FG001|Overall Study|Death|0|||
13134257|NCT02758301|25990554|FG000|Overall Study|Physician Decision|10|||
13134258|NCT02758301|25990555|FG001|Overall Study|Physician Decision|1|||
13134259|NCT02758301|25990554|FG000|Overall Study|Withdrawal by Subject|5|||
13134260|NCT02758301|25990555|FG001|Overall Study|Withdrawal by Subject|6|||
13134261|NCT02758301|25990554|FG000|Overall Study|Lost to Follow-up|7|||
13134262|NCT02758301|25990555|FG001|Overall Study|Lost to Follow-up|0|||
13134263|NCT02758301|25990554|FG000|Overall Study|Protocol Violation|0|||
13134264|NCT02758301|25990555|FG001|Overall Study|Protocol Violation|1|||
13134265|NCT02758171|25990578|FG000|Wash-out|Withdrawal by Subject|1|||
13134266|NCT02758171|25990579|FG001|Wash-out|Withdrawal by Subject|0|||
13134267|NCT02758171|25990578|FG000|Wash-out|Other reason|1|||
13134268|NCT02758171|25990579|FG001|Wash-out|Other reason|0|||
13134269|NCT02757963|25990597|FG000|Overall Study|Adverse Event|3|||
13134270|NCT02757963|25990597|FG000|Overall Study|Reached Stopping Criteria|1054|||
13134271|NCT02757963|25990597|FG000|Overall Study|Lost to Follow-up|5|||
13134272|NCT02757963|25990597|FG000|Overall Study|Physician Decision|1|||
13134273|NCT02757963|25990597|FG000|Overall Study|Withdrawal by Subject|34|||
13134274|NCT02757768|25990650|FG000|Overall Study|Randomized Never Received Study Drug|3|||
13134275|NCT02757768|25990651|FG001|Overall Study|Randomized Never Received Study Drug|4|||
13134276|NCT02757768|25990650|FG000|Overall Study|Adverse Event|5|||
13134277|NCT02757768|25990651|FG001|Overall Study|Adverse Event|3|||
13134278|NCT02757768|25990650|FG000|Overall Study|Lack of Efficacy|2|||
13134279|NCT02757768|25990651|FG001|Overall Study|Lack of Efficacy|1|||
13134280|NCT02757768|25990650|FG000|Overall Study|Lost to Follow-up|1|||
13134281|NCT02757768|25990651|FG001|Overall Study|Lost to Follow-up|0|||
13134282|NCT02757768|25990650|FG000|Overall Study|Protocol Deviation|2|||
13134283|NCT02757768|25990651|FG001|Overall Study|Protocol Deviation|9|||
13134284|NCT02757768|25990650|FG000|Overall Study|Withdrawal by Subject|16|||
13134285|NCT02757768|25990651|FG001|Overall Study|Withdrawal by Subject|9|||
13134286|NCT02757768|25990650|FG000|Overall Study|Miscellaneous|4|||
13134287|NCT02757768|25990651|FG001|Overall Study|Miscellaneous|2|||
13134288|NCT02757625|25990816|FG000|Overall Study|Investigator's discretion|0|||
13134289|NCT02757625|25990817|FG001|Overall Study|Investigator's discretion|0|||
13134290|NCT02757625|25990818|FG002|Overall Study|Investigator's discretion|1|||
13134291|NCT02757625|25990819|FG003|Overall Study|Investigator's discretion|0|||
13134292|NCT02757625|25990816|FG000|Overall Study|Adverse Event|0|||
13134293|NCT02757625|25990817|FG001|Overall Study|Adverse Event|0|||
13220697|NCT01822756|26280822|FG003|Overall Study|Lost to Follow-up|0|||
13220698|NCT01822756|26280823|FG004|Overall Study|Lost to Follow-up|1|||
13220699|NCT01822756|26280819|FG000|Overall Study|Physician Decision|0|||
13220700|NCT01822756|26280820|FG001|Overall Study|Physician Decision|1|||
13220701|NCT01822756|26280821|FG002|Overall Study|Physician Decision|0|||
13220702|NCT01822756|26280822|FG003|Overall Study|Physician Decision|0|||
13220703|NCT01822756|26280823|FG004|Overall Study|Physician Decision|0|||
13220704|NCT01822756|26280819|FG000|Overall Study|disease progression & patient preference|2|||
13220705|NCT01822756|26280820|FG001|Overall Study|disease progression & patient preference|0|||
13220706|NCT01822756|26280821|FG002|Overall Study|disease progression & patient preference|1|||
13220707|NCT01822756|26280822|FG003|Overall Study|disease progression & patient preference|0|||
13220708|NCT01822756|26280823|FG004|Overall Study|disease progression & patient preference|0|||
13220709|NCT01822691|26280833|FG000|Overall Study|Withdrawal by Subject|2|||
13220710|NCT01822678|26280851|FG000|Overall Study|Withdrawal by Subject|5|||
13220711|NCT01822678|26280852|FG001|Overall Study|Withdrawal by Subject|4|||
13306464|NCT01290718|26525804|FG000|Overall Study|Early termination of the study|4|||
13306465|NCT01290679|26525880|FG000|Overall Study|Adverse Event|2|||
13306466|NCT01290679|26525881|FG001|Overall Study|Adverse Event|0|||
13306467|NCT01290679|26525880|FG000|Overall Study|Lost to Follow-up|8|||
13306468|NCT01290679|26525881|FG001|Overall Study|Lost to Follow-up|10|||
13306469|NCT01290679|26525880|FG000|Overall Study|Protocol Violation|0|||
13306470|NCT01290679|26525881|FG001|Overall Study|Protocol Violation|1|||
13306471|NCT01290679|26525880|FG000|Overall Study|Withdrawal by Subject|6|||
13306472|NCT01290679|26525881|FG001|Overall Study|Withdrawal by Subject|5|||
13306473|NCT01290679|26525880|FG000|Overall Study|Subject Entered Another Trial|0|||
13306474|NCT01290679|26525881|FG001|Overall Study|Subject Entered Another Trial|5|||
13306475|NCT01290666|26525887|FG000|Overall Study|Lost to Follow-up|11|||
13306476|NCT01290666|26525887|FG000|Overall Study|Withdrawal by Subject|23|||
13306477|NCT01290666|26525887|FG000|Overall Study|Early Termination of Study|4|||
13306478|NCT01290601|26525910|FG000|Overall Study|Adverse Event|0|||
13306479|NCT01290601|26525911|FG001|Overall Study|Adverse Event|2|||
13134294|NCT02757625|25990818|FG002|Overall Study|Adverse Event|1|||
13220712|NCT01822678|26280853|FG002|Overall Study|Withdrawal by Subject|4|||
13220713|NCT01822678|26280851|FG000|Overall Study|Adverse Event|4|||
13220714|NCT01822678|26280852|FG001|Overall Study|Adverse Event|3|||
13220715|NCT01822678|26280853|FG002|Overall Study|Adverse Event|1|||
13220716|NCT01822678|26280851|FG000|Overall Study|Lack of Efficacy|3|||
13220717|NCT01822678|26280852|FG001|Overall Study|Lack of Efficacy|6|||
13220718|NCT01822678|26280853|FG002|Overall Study|Lack of Efficacy|5|||
13220719|NCT01822678|26280851|FG000|Overall Study|Lost to Follow-up|0|||
13220720|NCT01822678|26280852|FG001|Overall Study|Lost to Follow-up|2|||
13220721|NCT01822678|26280853|FG002|Overall Study|Lost to Follow-up|1|||
13220722|NCT01822665|26280879|FG000|Overall Study|Adverse Event|3|||
13220723|NCT01822665|26280879|FG000|Overall Study|Other Reason|5|||
13220724|NCT01822587|26280909|FG000|Overall Study|Lost to Follow-up|7|||
13220725|NCT01822587|26280910|FG001|Overall Study|Lost to Follow-up|9|||
13220726|NCT01822587|26280911|FG002|Overall Study|Lost to Follow-up|12|||
13220727|NCT01822587|26280909|FG000|Overall Study|Physician Decision|9|||
13220728|NCT01822587|26280910|FG001|Overall Study|Physician Decision|6|||
13220729|NCT01822587|26280911|FG002|Overall Study|Physician Decision|6|||
13220730|NCT01822561|26280921|FG000|Overall Study|Withdrawal by Subject|2|||
13220731|NCT01822535|26280940|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2|||
13220732|NCT01822535|26280941|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0|||
13220733|NCT01822535|26280940|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4|||
13220734|NCT01822535|26280941|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2|||
13220735|NCT01822535|26280940|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1|||
13220736|NCT01822535|26280941|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0|||
13220737|NCT01822496|26280988|FG000|Overall Study|Protocol Violation|2|||
13220738|NCT01822496|26280989|FG001|Overall Study|Protocol Violation|2|||
13220739|NCT01822496|26280990|FG002|Overall Study|Protocol Violation|0|||
13220740|NCT01822496|26280991|FG003|Overall Study|Protocol Violation|1|||
13220741|NCT01822496|26280988|FG000|Overall Study|Withdrawal by Subject|0|||
13220742|NCT01822496|26280989|FG001|Overall Study|Withdrawal by Subject|0|||
13220743|NCT01822496|26280990|FG002|Overall Study|Withdrawal by Subject|0|||
13220744|NCT01822496|26280991|FG003|Overall Study|Withdrawal by Subject|3|||
13220745|NCT01822366|26281064|FG000|Overall Study|Lost to Follow-up|5|||
13220746|NCT01822366|26281065|FG001|Overall Study|Lost to Follow-up|1|||
13220747|NCT01822366|26281066|FG002|Overall Study|Lost to Follow-up|5|||
13220748|NCT01822366|26281067|FG003|Overall Study|Lost to Follow-up|1|||
13220749|NCT01822366|26281064|FG000|Overall Study|Withdrawal by Subject|0|||
13220750|NCT01822366|26281065|FG001|Overall Study|Withdrawal by Subject|6|||
13220751|NCT01822366|26281066|FG002|Overall Study|Withdrawal by Subject|0|||
13220752|NCT01822366|26281067|FG003|Overall Study|Withdrawal by Subject|6|||
13220753|NCT01822366|26281064|FG000|Overall Study|Partial Intervention Completion|0|||
13220754|NCT01822366|26281065|FG001|Overall Study|Partial Intervention Completion|15|||
13220755|NCT01822366|26281066|FG002|Overall Study|Partial Intervention Completion|0|||
13220756|NCT01822366|26281067|FG003|Overall Study|Partial Intervention Completion|15|||
13220757|NCT01822353|26281100|FG000|Overall Study|Adverse Event|1|||
13220758|NCT01822353|26281101|FG001|Overall Study|Adverse Event|3|||
13220759|NCT01822353|26281102|FG002|Overall Study|Adverse Event|1|||
13220760|NCT01822353|26281100|FG000|Overall Study|Pregnancy|0|||
13220761|NCT01822353|26281101|FG001|Overall Study|Pregnancy|1|||
13220762|NCT01822353|26281102|FG002|Overall Study|Pregnancy|0|||
13220763|NCT01822353|26281100|FG000|Overall Study|Withdrawal by Subject|3|||
13220764|NCT01822353|26281101|FG001|Overall Study|Withdrawal by Subject|1|||
13220765|NCT01822353|26281102|FG002|Overall Study|Withdrawal by Subject|0|||
13220766|NCT01822223|26281125|FG000|Overall Study|Death|0|||
13220767|NCT01822223|26281126|FG001|Overall Study|Death|1|||
13220768|NCT01822132|26281147|FG000|Overall Study|Lost to Follow-up|4|||
13220769|NCT01822132|26281148|FG001|Overall Study|Lost to Follow-up|2|||
13220770|NCT01821963|26281154|FG000|Overall Study|Adverse Event|1|||
13220771|NCT01821937|26281179|FG000|Overall Study|Adverse Event|0|||
13220772|NCT01821937|26281180|FG001|Overall Study|Adverse Event|3|||
13220773|NCT01821898|26281199|FG000|Overall Study|Withdrawal by Subject|2|||
13220774|NCT01821898|26281200|FG001|Overall Study|Withdrawal by Subject|1|||
13220775|NCT01821807|26281215|FG000|Overall Study|Lost to Follow-up|3|||
13220776|NCT01821807|26281216|FG001|Overall Study|Lost to Follow-up|1|||
13220777|NCT01821729|26281223|FG000|Overall Study|Withdrawal by Subject|1|||
13220778|NCT01821677|26281246|FG000|Overall Study|Adverse Event|4|||
13220779|NCT01821677|26281247|FG001|Overall Study|Adverse Event|6|||
13220780|NCT01821677|26281248|FG002|Overall Study|Adverse Event|5|||
13220781|NCT01821677|26281246|FG000|Overall Study|Physician Decision|1|||
13220782|NCT01821677|26281247|FG001|Overall Study|Physician Decision|4|||
13220783|NCT01821677|26281248|FG002|Overall Study|Physician Decision|1|||
13220784|NCT01821677|26281246|FG000|Overall Study|Non-compliance|0|||
13220785|NCT01821677|26281247|FG001|Overall Study|Non-compliance|1|||
13220786|NCT01821677|26281248|FG002|Overall Study|Non-compliance|2|||
13220787|NCT01821677|26281246|FG000|Overall Study|Lost to Follow-up|2|||
13220788|NCT01821677|26281247|FG001|Overall Study|Lost to Follow-up|1|||
13220789|NCT01821677|26281248|FG002|Overall Study|Lost to Follow-up|3|||
13220790|NCT01821677|26281246|FG000|Overall Study|Protocol Violation|0|||
13220791|NCT01821677|26281247|FG001|Overall Study|Protocol Violation|0|||
13220792|NCT01821677|26281248|FG002|Overall Study|Protocol Violation|2|||
13220793|NCT01821677|26281246|FG000|Overall Study|Withdrawal by Subject|7|||
13220794|NCT01821677|26281247|FG001|Overall Study|Withdrawal by Subject|3|||
13220795|NCT01821677|26281248|FG002|Overall Study|Withdrawal by Subject|2|||
13220796|NCT01821677|26281246|FG000|Overall Study|Other|9|||
13220797|NCT01821677|26281247|FG001|Overall Study|Other|0|||
13220798|NCT01821677|26281248|FG002|Overall Study|Other|0|||
13220799|NCT01821625|26281254|FG000|Overall Study|Withdrawal by Subject|2|||
13220800|NCT01821625|26281254|FG000|Overall Study|Lack of Efficacy|2|||
13220801|NCT01821625|26281254|FG000|Overall Study|Adverse Event|1|||
13220802|NCT01821625|26281254|FG000|Overall Study|Medical contraindication|1|||
13220803|NCT01821560|26281267|FG000|Overall Study|Lost to Follow-up|5|||
13220804|NCT01821560|26281268|FG001|Overall Study|Lost to Follow-up|5|||
13220805|NCT01821560|26281267|FG000|Overall Study|Withdrawal by Subject|1|||
13220806|NCT01821560|26281268|FG001|Overall Study|Withdrawal by Subject|1|||
13220807|NCT01821560|26281267|FG000|Overall Study|Protocol Violation|0|||
13220808|NCT01821560|26281268|FG001|Overall Study|Protocol Violation|1|||
13220809|NCT01821391|26281283|FG000|Overall Study|Adverse Event|1|||
13220810|NCT01821391|26281284|FG001|Overall Study|Adverse Event|0|||
13220811|NCT01821118|26281324|FG000|Overall Study|Death|0|||
13220812|NCT01821118|26281325|FG001|Overall Study|Death|1|||
13220813|NCT01820637|26281332|FG000|Overall Study|Death|2|||
13220814|NCT01820637|26281332|FG000|Overall Study|Withdrawal by Subject|1|||
13220815|NCT01820585|26281355|FG000|Overall Study|Adverse Event|9|||
13220816|NCT01820585|26281356|FG001|Overall Study|Adverse Event|13|||
13220817|NCT01820585|26281357|FG002|Overall Study|Adverse Event|23|||
13220818|NCT01820585|26281358|FG003|Overall Study|Adverse Event|34|||
13220819|NCT01820585|26281355|FG000|Overall Study|Lack of Efficacy|9|||
13220820|NCT01820585|26281356|FG001|Overall Study|Lack of Efficacy|7|||
13220821|NCT01820585|26281357|FG002|Overall Study|Lack of Efficacy|5|||
13220822|NCT01820585|26281358|FG003|Overall Study|Lack of Efficacy|1|||
13220823|NCT01820585|26281355|FG000|Overall Study|Withdrawal by Subject|3|||
13220824|NCT01820585|26281356|FG001|Overall Study|Withdrawal by Subject|7|||
13220825|NCT01820585|26281357|FG002|Overall Study|Withdrawal by Subject|3|||
13220826|NCT01820585|26281358|FG003|Overall Study|Withdrawal by Subject|8|||
13220827|NCT01820585|26281355|FG000|Overall Study|Lost to Follow-up|3|||
13220828|NCT01820585|26281356|FG001|Overall Study|Lost to Follow-up|3|||
13220829|NCT01820585|26281357|FG002|Overall Study|Lost to Follow-up|0|||
13220830|NCT01820585|26281358|FG003|Overall Study|Lost to Follow-up|3|||
13220831|NCT01820585|26281355|FG000|Overall Study|Protocol Violation|3|||
13220832|NCT01820585|26281356|FG001|Overall Study|Protocol Violation|1|||
13220833|NCT01820585|26281357|FG002|Overall Study|Protocol Violation|1|||
13220834|NCT01820585|26281358|FG003|Overall Study|Protocol Violation|1|||
13220835|NCT01820585|26281355|FG000|Overall Study|Subject non-compliance|0|||
13220836|NCT01820585|26281356|FG001|Overall Study|Subject non-compliance|0|||
13220837|NCT01820585|26281357|FG002|Overall Study|Subject non-compliance|1|||
13134295|NCT02757625|25990819|FG003|Overall Study|Adverse Event|0|||
13306480|NCT01290601|26525912|FG002|Overall Study|Adverse Event|0|||
13220838|NCT01820585|26281358|FG003|Overall Study|Subject non-compliance|2|||
13220839|NCT01820585|26281355|FG000|Overall Study|at sponsor request|0|||
13220840|NCT01820585|26281356|FG001|Overall Study|at sponsor request|0|||
13220841|NCT01820585|26281357|FG002|Overall Study|at sponsor request|1|||
13220842|NCT01820585|26281358|FG003|Overall Study|at sponsor request|0|||
13220843|NCT01820585|26281355|FG000|Overall Study|Pregnancy|0|||
13220844|NCT01820585|26281356|FG001|Overall Study|Pregnancy|1|||
13220845|NCT01820585|26281357|FG002|Overall Study|Pregnancy|0|||
13220846|NCT01820585|26281358|FG003|Overall Study|Pregnancy|0|||
13220847|NCT01820572|26281405|FG000|Randomization|Not Treated|2|||
13220848|NCT01820572|26281406|FG001|Randomization|Not Treated|1|||
13220849|NCT01820572|26281405|FG000|Treatment Period|Adverse Event|12|||
13220850|NCT01820572|26281406|FG001|Treatment Period|Adverse Event|7|||
13220851|NCT01820572|26281405|FG000|Treatment Period|Death|3|||
13220852|NCT01820572|26281406|FG001|Treatment Period|Death|3|||
13220853|NCT01820572|26281405|FG000|Treatment Period|Lack of Efficacy|1|||
13220854|NCT01820572|26281406|FG001|Treatment Period|Lack of Efficacy|0|||
13220855|NCT01820572|26281405|FG000|Treatment Period|poor/non compliance|0|||
13220856|NCT01820572|26281406|FG001|Treatment Period|poor/non compliance|3|||
13220857|NCT01820572|26281405|FG000|Treatment Period|request to discontinue|6|||
13220858|NCT01820572|26281406|FG001|Treatment Period|request to discontinue|11|||
13220859|NCT01820572|26281405|FG000|Treatment Period|No longer meets study criteria|3|||
13220860|NCT01820572|26281406|FG001|Treatment Period|No longer meets study criteria|10|||
13220861|NCT01820572|26281405|FG000|Treatment Period|withdrew consent|1|||
13220862|NCT01820572|26281406|FG001|Treatment Period|withdrew consent|2|||
13220863|NCT01820559|26281424|FG000|Overall Study|Adverse Event|4|||
13220864|NCT01820559|26281425|FG001|Overall Study|Adverse Event|6|||
13220865|NCT01820559|26281426|FG002|Overall Study|Adverse Event|13|||
13220866|NCT01820559|26281424|FG000|Overall Study|Withdrawal by Subject|1|||
13220867|NCT01820559|26281425|FG001|Overall Study|Withdrawal by Subject|2|||
13220868|NCT01820559|26281426|FG002|Overall Study|Withdrawal by Subject|5|||
13220869|NCT01820559|26281424|FG000|Overall Study|Protocol Violation|2|||
13220870|NCT01820559|26281425|FG001|Overall Study|Protocol Violation|1|||
13220871|NCT01820559|26281426|FG002|Overall Study|Protocol Violation|3|||
13220872|NCT01820559|26281424|FG000|Overall Study|Subject's non-compliance|1|||
13220873|NCT01820559|26281425|FG001|Overall Study|Subject's non-compliance|0|||
13220874|NCT01820559|26281426|FG002|Overall Study|Subject's non-compliance|2|||
13220875|NCT01820559|26281424|FG000|Overall Study|Lost to Follow-up|3|||
13220876|NCT01820559|26281425|FG001|Overall Study|Lost to Follow-up|2|||
13220877|NCT01820559|26281426|FG002|Overall Study|Lost to Follow-up|2|||
13220878|NCT01820559|26281424|FG000|Overall Study|At sponsor request|0|||
13220879|NCT01820559|26281425|FG001|Overall Study|At sponsor request|0|||
13220880|NCT01820559|26281426|FG002|Overall Study|At sponsor request|1|||
13220881|NCT01820559|26281424|FG000|Overall Study|Lack of Efficacy|3|||
13220882|NCT01820559|26281425|FG001|Overall Study|Lack of Efficacy|2|||
13220883|NCT01820559|26281426|FG002|Overall Study|Lack of Efficacy|3|||
13220884|NCT01820364|26281441|FG000|Part I: LGX818|Death|1|||
13220885|NCT01820364|26281442|FG001|Part I: LGX818|Death|0|||
13220886|NCT01820364|26281441|FG000|Part I: LGX818|Administrative Problems|3|||
13220887|NCT01820364|26281442|FG001|Part I: LGX818|Administrative Problems|0|||
13220888|NCT01820364|26281441|FG000|Part I: LGX818|Adverse Event|6|||
13220889|NCT01820364|26281442|FG001|Part I: LGX818|Adverse Event|0|||
13220890|NCT01820364|26281441|FG000|Part I: LGX818|Disease Progression|4|||
13220891|NCT01820364|26281442|FG001|Part I: LGX818|Disease Progression|0|||
13220892|NCT01820364|26281441|FG000|Part II: LGX818 + MEK162|Study Termination|0|||
13220893|NCT01820364|26281442|FG001|Part II: LGX818 + MEK162|Study Termination|1|||
13220894|NCT01820260|26281527|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
13220895|NCT01820260|26281528|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
13220896|NCT01820260|26281529|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
13220897|NCT01820260|26281530|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
13220898|NCT01820260|26281531|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
13220899|NCT01820260|26281532|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
13220900|NCT01820260|26281533|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1|||
13220901|NCT01820260|26281534|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
13220902|NCT01820260|26281535|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
13220903|NCT01820260|26281536|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
13220904|NCT01820260|26281537|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
13220905|NCT01820260|26281538|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
13220906|NCT01820260|26281539|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
13220907|NCT01820260|26281540|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
13220908|NCT01820260|26281527|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0|||
13220909|NCT01820260|26281528|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0|||
13220910|NCT01820260|26281529|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0|||
13220911|NCT01820260|26281530|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0|||
13220912|NCT01820260|26281531|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0|||
13220913|NCT01820260|26281532|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0|||
13220914|NCT01820260|26281533|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0|||
13220915|NCT01820260|26281534|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0|||
13220916|NCT01820260|26281535|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0|||
13220917|NCT01820260|26281536|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1|||
13220918|NCT01820260|26281537|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0|||
13220919|NCT01820260|26281538|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0|||
13220920|NCT01820260|26281539|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0|||
13220921|NCT01820260|26281540|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0|||
13220922|NCT01819727|26281557|FG000|Overall Study|Adverse Event|8|||
13220923|NCT01819727|26281558|FG001|Overall Study|Adverse Event|9|||
13220924|NCT01819727|26281557|FG000|Overall Study|Death|1|||
13220925|NCT01819727|26281558|FG001|Overall Study|Death|0|||
13220926|NCT01819727|26281557|FG000|Overall Study|Lost to Follow-up|1|||
13220927|NCT01819727|26281558|FG001|Overall Study|Lost to Follow-up|1|||
13220928|NCT01819727|26281557|FG000|Overall Study|Physician Decision|3|||
13220929|NCT01819727|26281558|FG001|Overall Study|Physician Decision|2|||
13220930|NCT01819727|26281557|FG000|Overall Study|Pregnancy|1|||
13220931|NCT01819727|26281558|FG001|Overall Study|Pregnancy|0|||
13220932|NCT01819727|26281557|FG000|Overall Study|Protocol Violation|0|||
13220933|NCT01819727|26281558|FG001|Overall Study|Protocol Violation|2|||
13220934|NCT01819727|26281557|FG000|Overall Study|Study Terminated by Sponsor|0|||
13220935|NCT01819727|26281558|FG001|Overall Study|Study Terminated by Sponsor|1|||
13220936|NCT01819727|26281557|FG000|Overall Study|Withdrawal by Subject|6|||
13220937|NCT01819727|26281558|FG001|Overall Study|Withdrawal by Subject|11|||
13220938|NCT01819727|26281557|FG000|Overall Study|Unable to demostrate ability self-inject|0|||
13220939|NCT01819727|26281558|FG001|Overall Study|Unable to demostrate ability self-inject|1|||
13220940|NCT01819727|26281557|FG000|Overall Study|Quit due to lack of health benifits|0|||
13220941|NCT01819727|26281558|FG001|Overall Study|Quit due to lack of health benifits|1|||
13220942|NCT01819506|26281575|FG000|Overall Study|Physician Decision|5|||
13220943|NCT01819506|26281576|FG001|Overall Study|Physician Decision|2|||
13220944|NCT01819506|26281575|FG000|Overall Study|Withdrawal by Subject|3|||
13220945|NCT01819506|26281576|FG001|Overall Study|Withdrawal by Subject|3|||
13220946|NCT01819272|26281621|FG000|Overall Study|Adverse Event|1|||
13220947|NCT01819272|26281622|FG001|Overall Study|Adverse Event|0|||
13220948|NCT01819272|26281623|FG002|Overall Study|Adverse Event|0|||
13220949|NCT01819272|26281624|FG003|Overall Study|Adverse Event|2|||
13220950|NCT01819272|26281625|FG004|Overall Study|Adverse Event|0|||
13220951|NCT01819272|26281626|FG005|Overall Study|Adverse Event|0|||
13220952|NCT01819272|26281621|FG000|Overall Study|Lost to Follow-up|3|||
13220953|NCT01819272|26281622|FG001|Overall Study|Lost to Follow-up|0|||
13220954|NCT01819272|26281623|FG002|Overall Study|Lost to Follow-up|1|||
13220955|NCT01819272|26281624|FG003|Overall Study|Lost to Follow-up|0|||
13220956|NCT01819272|26281625|FG004|Overall Study|Lost to Follow-up|0|||
13220957|NCT01819272|26281626|FG005|Overall Study|Lost to Follow-up|3|||
13220958|NCT01819272|26281621|FG000|Overall Study|Protocol Violation|0|||
13220959|NCT01819272|26281622|FG001|Overall Study|Protocol Violation|0|||
13220960|NCT01819272|26281623|FG002|Overall Study|Protocol Violation|0|||
13220961|NCT01819272|26281624|FG003|Overall Study|Protocol Violation|1|||
13220962|NCT01819272|26281625|FG004|Overall Study|Protocol Violation|2|||
13220963|NCT01819272|26281626|FG005|Overall Study|Protocol Violation|3|||
13220964|NCT01819272|26281621|FG000|Overall Study|Physician Decision|0|||
13220965|NCT01819272|26281622|FG001|Overall Study|Physician Decision|1|||
13220966|NCT01819272|26281623|FG002|Overall Study|Physician Decision|0|||
13220967|NCT01819272|26281624|FG003|Overall Study|Physician Decision|0|||
13220968|NCT01819272|26281625|FG004|Overall Study|Physician Decision|0|||
13220969|NCT01819272|26281626|FG005|Overall Study|Physician Decision|0|||
13220970|NCT01819272|26281621|FG000|Overall Study|Withdrawal of Consent|0|||
13220971|NCT01819272|26281622|FG001|Overall Study|Withdrawal of Consent|1|||
13220972|NCT01819272|26281623|FG002|Overall Study|Withdrawal of Consent|2|||
13220973|NCT01819272|26281624|FG003|Overall Study|Withdrawal of Consent|1|||
13220974|NCT01819272|26281625|FG004|Overall Study|Withdrawal of Consent|0|||
13220975|NCT01819272|26281626|FG005|Overall Study|Withdrawal of Consent|1|||
13220976|NCT01819272|26281621|FG000|Overall Study|Loss of Glucose Control|2|||
13306481|NCT01290601|26525913|FG003|Overall Study|Adverse Event|0|||
13306482|NCT01290601|26525910|FG000|Overall Study|Lack of Efficacy|2|||
13134296|NCT02757521|25990832|FG000|Overall Study|Adverse Event|1|||
13134297|NCT02757521|25990833|FG001|Overall Study|Adverse Event|0|||
13134298|NCT02757430|25990851|FG000|Overall Study|Physician Decision|6|||
13134299|NCT02757430|25990851|FG000|Overall Study|Inclusion/Exclusion criteria not met|3|||
13134300|NCT02757430|25990851|FG000|Overall Study|No informed consent|1|||
13134301|NCT02757430|25990851|FG000|Overall Study|No procedure performed|2|||
13134302|NCT02757352|25990975|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2|||
13134303|NCT02757352|25990976|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
13134304|NCT02757352|25990977|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1|||
13134305|NCT02757352|25990978|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
13134306|NCT02757352|25990979|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
13134307|NCT02757352|25990980|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
13134308|NCT02757352|25990981|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
13134309|NCT02757352|25990982|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
13134310|NCT02757352|25990983|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
13134311|NCT02757352|25990984|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
13134312|NCT02757352|25990975|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
13134313|NCT02757352|25990976|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
13134314|NCT02757352|25990977|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1|||
13134315|NCT02757352|25990978|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
13134316|NCT02757352|25990979|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
13134317|NCT02757352|25990980|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
13134318|NCT02757352|25990981|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
13134319|NCT02757352|25990982|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
13134320|NCT02757352|25990983|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
13134321|NCT02757352|25990984|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
13134322|NCT02757352|25990975|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6|||
13134323|NCT02757352|25990976|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1|||
13134324|NCT02757352|25990977|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2|||
13134325|NCT02757352|25990978|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
13134326|NCT02757352|25990979|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
13134327|NCT02757352|25990980|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
13134328|NCT02757352|25990981|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
13134329|NCT02757352|25990982|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
13134330|NCT02757352|25990983|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
13134331|NCT02757352|25990984|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
13220977|NCT01819272|26281622|FG001|Overall Study|Loss of Glucose Control|1|||
13220978|NCT01819272|26281623|FG002|Overall Study|Loss of Glucose Control|0|||
13220979|NCT01819272|26281624|FG003|Overall Study|Loss of Glucose Control|1|||
13220980|NCT01819272|26281625|FG004|Overall Study|Loss of Glucose Control|2|||
13220981|NCT01819272|26281626|FG005|Overall Study|Loss of Glucose Control|0|||
13220982|NCT01819194|26281633|FG000|Overall Study|Loss of study articles|2|||
13220983|NCT01819129|26281652|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1|||
13220984|NCT01819129|26281653|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0|||
13220985|NCT01819129|26281652|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1|||
13220986|NCT01819129|26281653|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0|||
13220987|NCT01819129|26281652|FG000|Overall Study|Other, Subject moved out of the country|0|||
13220988|NCT01819129|26281653|FG001|Overall Study|Other, Subject moved out of the country|1|||
13220989|NCT01819129|26281652|FG000|Overall Study|Withdrawal by Subject|15|||
13220990|NCT01819129|26281653|FG001|Overall Study|Withdrawal by Subject|15|||
13220991|NCT01819129|26281652|FG000|Overall Study|Lost to Follow-up|5|||
13220992|NCT01819129|26281653|FG001|Overall Study|Lost to Follow-up|2|||
13220993|NCT01819129|26281652|FG000|Overall Study|Lack of Efficacy|0|||
13220994|NCT01819129|26281653|FG001|Overall Study|Lack of Efficacy|1|||
13220995|NCT01819129|26281652|FG000|Overall Study|Adverse Event|1|||
13220996|NCT01819129|26281653|FG001|Overall Study|Adverse Event|4|||
13220997|NCT01819129|26281652|FG000|Overall Study|Death|1|||
13220998|NCT01819129|26281653|FG001|Overall Study|Death|1|||
13220999|NCT01819129|26281652|FG000|Overall Study|Withdrawal Criteria|20|||
13221000|NCT01819129|26281653|FG001|Overall Study|Withdrawal Criteria|15|||
13221001|NCT01818765|26281666|FG000|Overall Study|Death|2|||
13221002|NCT01818752|26281691|FG000|Overall Study|Adverse Event|64|||
13221003|NCT01818752|26281692|FG001|Overall Study|Adverse Event|74|||
13221004|NCT01818752|26281691|FG000|Overall Study|Death|14|||
13221005|NCT01818752|26281692|FG001|Overall Study|Death|18|||
13221006|NCT01818752|26281691|FG000|Overall Study|Non-compliance|16|||
13221007|NCT01818752|26281692|FG001|Overall Study|Non-compliance|20|||
13221008|NCT01818752|26281691|FG000|Overall Study|Withdrawal by Subject|15|||
13221009|NCT01818752|26281692|FG001|Overall Study|Withdrawal by Subject|14|||
13221010|NCT01818752|26281691|FG000|Overall Study|Physician Decision|9|||
13221011|NCT01818752|26281692|FG001|Overall Study|Physician Decision|8|||
13221012|NCT01818752|26281691|FG000|Overall Study|Disease Progression|54|||
13221013|NCT01818752|26281692|FG001|Overall Study|Disease Progression|48|||
13221014|NCT01818752|26281691|FG000|Overall Study|Other|7|||
13221015|NCT01818752|26281692|FG001|Overall Study|Other|8|||
13221016|NCT01818752|26281691|FG000|Overall Study|Continuing Treatment|1|||
13221017|NCT01818752|26281692|FG001|Overall Study|Continuing Treatment|4|||
13221018|NCT01818752|26281691|FG000|Overall Study|Randomized but not Dosed|7|||
13221019|NCT01818752|26281692|FG001|Overall Study|Randomized but not Dosed|4|||
13221020|NCT01818726|26281709|FG000|Overall Study|Administrative reasons|5|||
13221021|NCT01818726|26281710|FG001|Overall Study|Administrative reasons|1|||
13221022|NCT01818726|26281709|FG000|Overall Study|Withdrawal by Subject|0|||
13221023|NCT01818726|26281710|FG001|Overall Study|Withdrawal by Subject|1|||
13221024|NCT01818726|26281709|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1|||
13221025|NCT01818726|26281710|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0|||
13306483|NCT01290601|26525911|FG001|Overall Study|Lack of Efficacy|1|||
13306484|NCT01290601|26525912|FG002|Overall Study|Lack of Efficacy|0|||
13306485|NCT01290601|26525913|FG003|Overall Study|Lack of Efficacy|0|||
13306486|NCT01290601|26525910|FG000|Overall Study|Lost to Follow-up|7|||
13306487|NCT01290601|26525911|FG001|Overall Study|Lost to Follow-up|2|||
13306488|NCT01290601|26525912|FG002|Overall Study|Lost to Follow-up|0|||
13306489|NCT01290601|26525913|FG003|Overall Study|Lost to Follow-up|0|||
13306490|NCT01290601|26525910|FG000|Overall Study|Other|1|||
13306491|NCT01290601|26525911|FG001|Overall Study|Other|0|||
13306492|NCT01290601|26525912|FG002|Overall Study|Other|0|||
13306493|NCT01290601|26525913|FG003|Overall Study|Other|0|||
13306494|NCT01290601|26525910|FG000|Overall Study|Protocol Violation|1|||
13306495|NCT01290601|26525911|FG001|Overall Study|Protocol Violation|0|||
13306496|NCT01290601|26525912|FG002|Overall Study|Protocol Violation|0|||
13306497|NCT01290601|26525913|FG003|Overall Study|Protocol Violation|0|||
13306498|NCT01290523|26525920|FG000|Overall Study|Death|3|||
13306499|NCT01290341|26525935|FG000|Overall Study|Protocol Violation|7|||
13306500|NCT01290341|26525936|FG001|Overall Study|Protocol Violation|3|||
13306501|NCT01290341|26525935|FG000|Overall Study|Adverse Event|1|||
13306502|NCT01290341|26525936|FG001|Overall Study|Adverse Event|0|||
13306503|NCT01290341|26525935|FG000|Overall Study|Lost to Follow-up|21|||
13306504|NCT01290341|26525936|FG001|Overall Study|Lost to Follow-up|10|||
13306505|NCT01290341|26525935|FG000|Overall Study|Withdrawal by Subject|19|||
13306506|NCT01290341|26525936|FG001|Overall Study|Withdrawal by Subject|5|||
13306507|NCT01290341|26525935|FG000|Overall Study|Negative baseline culture and others|44|||
13306508|NCT01290341|26525936|FG001|Overall Study|Negative baseline culture and others|11|||
13306509|NCT01290315|26525969|FG000|Overall Study|Adverse Event|0|||
13306510|NCT01290315|26525970|FG001|Overall Study|Adverse Event|0|||
13306511|NCT01290315|26525971|FG002|Overall Study|Adverse Event|0|||
13306512|NCT01290315|26525972|FG003|Overall Study|Adverse Event|3|||
13306513|NCT01290315|26525969|FG000|Overall Study|Selection criteria/compliance|2|||
13306514|NCT01290315|26525970|FG001|Overall Study|Selection criteria/compliance|1|||
13306515|NCT01290315|26525971|FG002|Overall Study|Selection criteria/compliance|0|||
13306516|NCT01290315|26525972|FG003|Overall Study|Selection criteria/compliance|2|||
13306517|NCT01290315|26525969|FG000|Overall Study|Lost to Follow-up|0|||
13306518|NCT01290315|26525970|FG001|Overall Study|Lost to Follow-up|1|||
13306519|NCT01290315|26525971|FG002|Overall Study|Lost to Follow-up|0|||
13306520|NCT01290315|26525972|FG003|Overall Study|Lost to Follow-up|0|||
13306521|NCT01290315|26525969|FG000|Overall Study|Withdrawal by Subject|1|||
13306522|NCT01290315|26525970|FG001|Overall Study|Withdrawal by Subject|1|||
13306523|NCT01290315|26525971|FG002|Overall Study|Withdrawal by Subject|0|||
13306524|NCT01290315|26525972|FG003|Overall Study|Withdrawal by Subject|0|||
13306525|NCT01290263|26525998|FG000|Overall Study|Adverse Event|0|||
13306526|NCT01290263|26525999|FG001|Overall Study|Adverse Event|0|||
13306527|NCT01290263|26526000|FG002|Overall Study|Adverse Event|0|||
13306528|NCT01290263|26526001|FG003|Overall Study|Adverse Event|1|||
13306529|NCT01290263|26526002|FG004|Overall Study|Adverse Event|1|||
13306530|NCT01290263|26525998|FG000|Overall Study|Lack of Efficacy|8|||
13306531|NCT01290263|26525999|FG001|Overall Study|Lack of Efficacy|2|||
13306532|NCT01290263|26526000|FG002|Overall Study|Lack of Efficacy|7|||
13221026|NCT01818700|26281721|FG000|Overall Study|Adverse Event|67|||
13221027|NCT01818700|26281721|FG000|Overall Study|Lack of Efficacy|2|||
13306533|NCT01290263|26526001|FG003|Overall Study|Lack of Efficacy|24|||
13306534|NCT01290263|26526002|FG004|Overall Study|Lack of Efficacy|33|||
13306535|NCT01290263|26525998|FG000|Overall Study|Withdrawal by Subject|3|||
13306536|NCT01290263|26525999|FG001|Overall Study|Withdrawal by Subject|1|||
13306537|NCT01290263|26526000|FG002|Overall Study|Withdrawal by Subject|0|||
13306538|NCT01290263|26526001|FG003|Overall Study|Withdrawal by Subject|1|||
13306539|NCT01290263|26526002|FG004|Overall Study|Withdrawal by Subject|2|||
13306540|NCT01290263|26525998|FG000|Overall Study|Participant Non-Compliance|0|||
13306541|NCT01290263|26525999|FG001|Overall Study|Participant Non-Compliance|0|||
13306542|NCT01290263|26526000|FG002|Overall Study|Participant Non-Compliance|0|||
13306543|NCT01290263|26526001|FG003|Overall Study|Participant Non-Compliance|1|||
13306544|NCT01290263|26526002|FG004|Overall Study|Participant Non-Compliance|1|||
13306545|NCT01290224|26526015|FG000|Overall Study|Adverse Event|1|||
13306546|NCT01290224|26526015|FG000|Overall Study|Refused Further Treatment|4|||
13306547|NCT01290094|26526028|FG000|Overall Study|Withdrawal by Subject|1|||
13306548|NCT01290094|26526028|FG000|Overall Study|Lost to Follow-up|5|||
13306549|NCT01290068|26526047|FG000|Overall Study|Adverse Event|1|||
13390731|NCT00684567|26774399|FG000|Concomitant Radiotherapy Period|Adverse Event|2|||
13390732|NCT00684567|26774399|FG000|Monotherapy Period|Adverse Event|2|||
13390733|NCT00684567|26774399|FG000|Monotherapy Period|Death|1|||
13390734|NCT00684567|26774399|FG000|Monotherapy Period|Progression of primary disease|11|||
13390735|NCT00684515|26774432|FG000|Overall Study|Adverse Event|3|||
13221028|NCT01818700|26281721|FG000|Overall Study|Lost to Follow-up|5|||
13221029|NCT01818700|26281721|FG000|Overall Study|Withdrawal by Subject|27|||
13221030|NCT01818700|26281721|FG000|Overall Study|Protocol Violation|2|||
13221031|NCT01818700|26281721|FG000|Overall Study|Other|1|||
13221032|NCT01818596|26281765|FG000|Overall Study|Enrolled but Not Treated|4|||
13221033|NCT01818596|26281766|FG001|Overall Study|Enrolled but Not Treated|0|||
13221034|NCT01818596|26281765|FG000|Overall Study|Adverse Event|7|||
13221035|NCT01818596|26281766|FG001|Overall Study|Adverse Event|0|||
13221036|NCT01818596|26281765|FG000|Overall Study|Death|3|||
13221037|NCT01818596|26281766|FG001|Overall Study|Death|0|||
13221038|NCT01818596|26281765|FG000|Overall Study|Investigator's Discretion|4|||
13221039|NCT01818596|26281766|FG001|Overall Study|Investigator's Discretion|0|||
13221040|NCT01818596|26281765|FG000|Overall Study|Protocol Violation|1|||
13221041|NCT01818596|26281766|FG001|Overall Study|Protocol Violation|0|||
13221042|NCT01818596|26281765|FG000|Overall Study|Withdrew Consent|5|||
13221043|NCT01818596|26281766|FG001|Overall Study|Withdrew Consent|0|||
13221044|NCT01818596|26281765|FG000|Overall Study|Lost to Follow-up|7|||
13221045|NCT01818596|26281766|FG001|Overall Study|Lost to Follow-up|0|||
13221046|NCT01818531|26281787|FG000|Overall Study|Withdrawn for case delay after block|1|||
13221047|NCT01818531|26281788|FG001|Overall Study|Withdrawn for case delay after block|0|||
13221048|NCT01818531|26281787|FG000|Overall Study|Withdrawn for long-acting opioid patch|0|||
13221049|NCT01818531|26281788|FG001|Overall Study|Withdrawn for long-acting opioid patch|1|||
13221050|NCT01818531|26281787|FG000|Overall Study|Withdrawn for failure to place block|0|||
13221051|NCT01818531|26281788|FG001|Overall Study|Withdrawn for failure to place block|1|||
13221052|NCT01818492|26281805|FG000|Overall Study|Adverse Event|2|||
13221053|NCT01818492|26281805|FG000|Overall Study|Death|3|||
13221054|NCT01818492|26281805|FG000|Overall Study|Withdrawal by Subject|1|||
13221055|NCT01818492|26281805|FG000|Overall Study|Additional therapy when not allowed PP|4|||
13221056|NCT01818336|26281814|FG000|Overall Study|Declined retest visit|0|||
13221057|NCT01818336|26281815|FG001|Overall Study|Declined retest visit|11|||
13221058|NCT01818336|26281814|FG000|Overall Study|Lost to Follow-up|0|||
13221059|NCT01818336|26281815|FG001|Overall Study|Lost to Follow-up|1|||
13221060|NCT01818297|26281838|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0|||
13221061|NCT01818297|26281839|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1|||
13221062|NCT01818297|26281838|FG000|Open Label Phase (3-12 Months)|Physician Decision|1|||
13221063|NCT01818297|26281839|FG001|Open Label Phase (3-12 Months)|Physician Decision|0|||
13221064|NCT01818297|26281838|FG000|Open Label Phase (3-12 Months)|Early study closure|17|||
13221065|NCT01818297|26281839|FG001|Open Label Phase (3-12 Months)|Early study closure|10|||
13221066|NCT01818284|26281852|FG000|Overall Study|Not eligible due to White Blood Counts|4|||
13221067|NCT01818284|26281853|FG001|Overall Study|Not eligible due to White Blood Counts|4|||
13221068|NCT01818284|26281852|FG000|Overall Study|Death|0|||
13221069|NCT01818284|26281853|FG001|Overall Study|Death|2|||
13221070|NCT01818258|26281898|FG000|Overall Study|Death|3|||
13221071|NCT01818258|26281899|FG001|Overall Study|Death|0|||
13306550|NCT01290068|26526048|FG001|Overall Study|Adverse Event|3|||
13221072|NCT01818258|26281898|FG000|Overall Study|Withdrawal by Subject|0|||
13221073|NCT01818258|26281899|FG001|Overall Study|Withdrawal by Subject|1|||
13221074|NCT01818258|26281898|FG000|Overall Study|Lost to Follow-up|0|||
13221075|NCT01818258|26281899|FG001|Overall Study|Lost to Follow-up|1|||
13221076|NCT01818258|26281898|FG000|Overall Study|Unable to Travel to Clinic|0|||
13221077|NCT01818258|26281899|FG001|Overall Study|Unable to Travel to Clinic|1|||
13221078|NCT01818141|26281914|FG000|Overall Study|Withdrawal by Subject|2|||
13221079|NCT01818141|26281915|FG001|Overall Study|Withdrawal by Subject|0|||
13221080|NCT01818141|26281914|FG000|Overall Study|No baseline C.diff colonies|1|||
13221081|NCT01818141|26281915|FG001|Overall Study|No baseline C.diff colonies|1|||
13221082|NCT01818141|26281914|FG000|Overall Study|Lost to Follow-up|0|||
13221083|NCT01818141|26281915|FG001|Overall Study|Lost to Follow-up|2|||
13221084|NCT01817959|26281966|FG000|Overall Study|Graft loss|1|||
13221085|NCT01817959|26281967|FG001|Overall Study|Graft loss|1|||
13221086|NCT01817959|26281966|FG000|Overall Study|forbidden medication|1|||
13221087|NCT01817959|26281967|FG001|Overall Study|forbidden medication|1|||
13221088|NCT01817959|26281966|FG000|Overall Study|Adverse Event|1|||
13221089|NCT01817959|26281967|FG001|Overall Study|Adverse Event|0|||
13221090|NCT01817959|26281966|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
13221091|NCT01817959|26281967|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
13221092|NCT01817790|26282016|FG000|Overall Study|Adverse Event|0|||
13221093|NCT01817790|26282017|FG001|Overall Study|Adverse Event|2|||
13221094|NCT01817790|26282016|FG000|Overall Study|Lost to Follow-up|0|||
13221095|NCT01817790|26282017|FG001|Overall Study|Lost to Follow-up|1|||
13221096|NCT01817790|26282016|FG000|Overall Study|Protocol Violation|2|||
13221097|NCT01817790|26282017|FG001|Overall Study|Protocol Violation|1|||
13221098|NCT01817790|26282016|FG000|Overall Study|Withdrawal by Subject|1|||
13221099|NCT01817790|26282017|FG001|Overall Study|Withdrawal by Subject|3|||
13221100|NCT01817790|26282016|FG000|Overall Study|Other: Could not attend appointment|1|||
13221101|NCT01817790|26282017|FG001|Overall Study|Other: Could not attend appointment|1|||
13221102|NCT01817777|26282047|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3|||
13221103|NCT01817777|26282048|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
13221104|NCT01817777|26282049|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
13221105|NCT01817777|26282047|FG000|Observational Phase (8 Weeks)|Early Study Termination|2|||
13221106|NCT01817777|26282048|FG001|Observational Phase (8 Weeks)|Early Study Termination|0|||
13221107|NCT01817777|26282049|FG002|Observational Phase (8 Weeks)|Early Study Termination|0|||
13221108|NCT01817777|26282047|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
13221109|NCT01817777|26282048|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3|||
13306551|NCT01290068|26526047|FG000|Overall Study|Lost to Follow-up|3|||
13306552|NCT01290068|26526048|FG001|Overall Study|Lost to Follow-up|0|||
13306553|NCT01290068|26526047|FG000|Overall Study|Withdrawal by subject prior to implant|0|||
13306554|NCT01290068|26526048|FG001|Overall Study|Withdrawal by subject prior to implant|2|||
13306555|NCT01290068|26526047|FG000|Overall Study|Other|3|||
13306556|NCT01290068|26526048|FG001|Overall Study|Other|1|||
13306557|NCT01290029|26526063|FG000|Overall Study|Other|2|||
13306558|NCT01289990|26526287|FG000|Overall Study|Death|0|||
13306559|NCT01289990|26526288|FG001|Overall Study|Death|0|||
13306560|NCT01289990|26526289|FG002|Overall Study|Death|0|||
13306561|NCT01289990|26526290|FG003|Overall Study|Death|1|||
13306562|NCT01289990|26526291|FG004|Overall Study|Death|2|||
13306563|NCT01289990|26526292|FG005|Overall Study|Death|1|||
13306564|NCT01289990|26526293|FG006|Overall Study|Death|0|||
13306565|NCT01289990|26526294|FG007|Overall Study|Death|0|||
13306566|NCT01289990|26526295|FG008|Overall Study|Death|0|||
13306567|NCT01289990|26526296|FG009|Overall Study|Death|0|||
13306568|NCT01289990|26526297|FG010|Overall Study|Death|0|||
13306569|NCT01289990|26526298|FG011|Overall Study|Death|1|||
13306570|NCT01289990|26526299|FG012|Overall Study|Death|0|||
13306571|NCT01289990|26526287|FG000|Overall Study|Lost to Follow-up|3|||
13306572|NCT01289990|26526288|FG001|Overall Study|Lost to Follow-up|2|||
13306573|NCT01289990|26526289|FG002|Overall Study|Lost to Follow-up|5|||
13306574|NCT01289990|26526290|FG003|Overall Study|Lost to Follow-up|5|||
13306575|NCT01289990|26526291|FG004|Overall Study|Lost to Follow-up|3|||
13306576|NCT01289990|26526292|FG005|Overall Study|Lost to Follow-up|4|||
13306577|NCT01289990|26526293|FG006|Overall Study|Lost to Follow-up|2|||
13306578|NCT01289990|26526294|FG007|Overall Study|Lost to Follow-up|2|||
13306579|NCT01289990|26526295|FG008|Overall Study|Lost to Follow-up|1|||
13306580|NCT01289990|26526296|FG009|Overall Study|Lost to Follow-up|4|||
13306581|NCT01289990|26526297|FG010|Overall Study|Lost to Follow-up|2|||
13306582|NCT01289990|26526298|FG011|Overall Study|Lost to Follow-up|1|||
13306583|NCT01289990|26526299|FG012|Overall Study|Lost to Follow-up|2|||
13306584|NCT01289990|26526287|FG000|Overall Study|Withdrawal by Subject|15|||
13306585|NCT01289990|26526288|FG001|Overall Study|Withdrawal by Subject|14|||
13306586|NCT01289990|26526289|FG002|Overall Study|Withdrawal by Subject|12|||
13306587|NCT01289990|26526290|FG003|Overall Study|Withdrawal by Subject|13|||
13306588|NCT01289990|26526291|FG004|Overall Study|Withdrawal by Subject|8|||
13306589|NCT01289990|26526292|FG005|Overall Study|Withdrawal by Subject|7|||
13306590|NCT01289990|26526293|FG006|Overall Study|Withdrawal by Subject|13|||
13306591|NCT01289990|26526294|FG007|Overall Study|Withdrawal by Subject|9|||
13306592|NCT01289990|26526295|FG008|Overall Study|Withdrawal by Subject|12|||
13306593|NCT01289990|26526296|FG009|Overall Study|Withdrawal by Subject|13|||
13306594|NCT01289990|26526297|FG010|Overall Study|Withdrawal by Subject|11|||
13306595|NCT01289990|26526298|FG011|Overall Study|Withdrawal by Subject|13|||
13306596|NCT01289990|26526299|FG012|Overall Study|Withdrawal by Subject|16|||
13306597|NCT01289990|26526287|FG000|Overall Study|discontinued in preceding trial|18|||
13306598|NCT01289990|26526288|FG001|Overall Study|discontinued in preceding trial|20|||
13306599|NCT01289990|26526289|FG002|Overall Study|discontinued in preceding trial|41|||
13306600|NCT01289990|26526290|FG003|Overall Study|discontinued in preceding trial|17|||
13306601|NCT01289990|26526291|FG004|Overall Study|discontinued in preceding trial|11|||
13306602|NCT01289990|26526292|FG005|Overall Study|discontinued in preceding trial|12|||
13306603|NCT01289990|26526293|FG006|Overall Study|discontinued in preceding trial|18|||
13306604|NCT01289990|26526294|FG007|Overall Study|discontinued in preceding trial|8|||
13306605|NCT01289990|26526295|FG008|Overall Study|discontinued in preceding trial|17|||
13306606|NCT01289990|26526296|FG009|Overall Study|discontinued in preceding trial|21|||
13306607|NCT01289990|26526297|FG010|Overall Study|discontinued in preceding trial|17|||
13306608|NCT01289990|26526298|FG011|Overall Study|discontinued in preceding trial|17|||
13306609|NCT01289990|26526299|FG012|Overall Study|discontinued in preceding trial|24|||
13306610|NCT01289990|26526287|FG000|Overall Study|did not continue in extension|41|||
13306611|NCT01289990|26526288|FG001|Overall Study|did not continue in extension|45|||
13306612|NCT01289990|26526289|FG002|Overall Study|did not continue in extension|51|||
13306613|NCT01289990|26526290|FG003|Overall Study|did not continue in extension|51|||
13306614|NCT01289990|26526291|FG004|Overall Study|did not continue in extension|48|||
13306615|NCT01289990|26526292|FG005|Overall Study|did not continue in extension|50|||
13306616|NCT01289990|26526293|FG006|Overall Study|did not continue in extension|54|||
13306617|NCT01289990|26526294|FG007|Overall Study|did not continue in extension|36|||
13306618|NCT01289990|26526295|FG008|Overall Study|did not continue in extension|44|||
13306619|NCT01289990|26526296|FG009|Overall Study|did not continue in extension|48|||
13306620|NCT01289990|26526297|FG010|Overall Study|did not continue in extension|45|||
13306621|NCT01289990|26526298|FG011|Overall Study|did not continue in extension|34|||
13306622|NCT01289990|26526299|FG012|Overall Study|did not continue in extension|56|||
13306623|NCT01289990|26526287|FG000|Overall Study|Not treated|0|||
13306624|NCT01289990|26526288|FG001|Overall Study|Not treated|0|||
13306625|NCT01289990|26526289|FG002|Overall Study|Not treated|0|||
13306626|NCT01289990|26526290|FG003|Overall Study|Not treated|0|||
13306627|NCT01289990|26526291|FG004|Overall Study|Not treated|0|||
13306628|NCT01289990|26526292|FG005|Overall Study|Not treated|0|||
13306629|NCT01289990|26526293|FG006|Overall Study|Not treated|1|||
13306630|NCT01289990|26526294|FG007|Overall Study|Not treated|0|||
13306631|NCT01289990|26526295|FG008|Overall Study|Not treated|1|||
13306632|NCT01289990|26526296|FG009|Overall Study|Not treated|0|||
13306633|NCT01289990|26526297|FG010|Overall Study|Not treated|1|||
13306634|NCT01289990|26526298|FG011|Overall Study|Not treated|2|||
13306635|NCT01289990|26526299|FG012|Overall Study|Not treated|0|||
13134332|NCT02757352|25990975|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
13134333|NCT02757352|25990976|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1|||
13134334|NCT02757352|25990977|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
13134335|NCT02757352|25990978|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
13390736|NCT00684515|26774433|FG001|Overall Study|Adverse Event|3|||
13134336|NCT02757352|25990979|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
13134337|NCT02757352|25990980|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
13134338|NCT02757352|25990981|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
13390737|NCT00684515|26774434|FG002|Overall Study|Adverse Event|1|||
13390738|NCT00684515|26774432|FG000|Overall Study|Protocol-Defined Clinical Event|1|||
13390739|NCT00684515|26774433|FG001|Overall Study|Protocol-Defined Clinical Event|0|||
13390740|NCT00684515|26774434|FG002|Overall Study|Protocol-Defined Clinical Event|0|||
13390741|NCT00684424|26774451|FG000|Overall Study|Adverse Event|1|||
13390742|NCT00684424|26774451|FG000|Overall Study|Lost to Follow-up|2|||
13390743|NCT00684424|26774451|FG000|Overall Study|Other|2|||
13390744|NCT00684411|26774459|FG000|Overall Study|New Primary Cancer|1|||
13390745|NCT00684411|26774459|FG000|Overall Study|Disease Progression|10|||
13390746|NCT00684411|26774459|FG000|Overall Study|Adverse Event|1|||
13390747|NCT00684307|26774542|FG000|Overall Study|Adverse Event|11|||
13390748|NCT00684307|26774543|FG001|Overall Study|Adverse Event|6|||
13390749|NCT00684307|26774544|FG002|Overall Study|Adverse Event|15|||
13390750|NCT00684307|26774545|FG003|Overall Study|Adverse Event|16|||
13390751|NCT00684307|26774546|FG004|Overall Study|Adverse Event|8|||
13390752|NCT00684307|26774542|FG000|Overall Study|Development of increasing Liver Function|0|||
13390753|NCT00684307|26774543|FG001|Overall Study|Development of increasing Liver Function|2|||
13390754|NCT00684307|26774544|FG002|Overall Study|Development of increasing Liver Function|0|||
13390755|NCT00684307|26774545|FG003|Overall Study|Development of increasing Liver Function|1|||
13390756|NCT00684307|26774546|FG004|Overall Study|Development of increasing Liver Function|0|||
13390757|NCT00684307|26774542|FG000|Overall Study|Fullfillment of exclusion criteria|1|||
13390758|NCT00684307|26774543|FG001|Overall Study|Fullfillment of exclusion criteria|0|||
13390759|NCT00684307|26774544|FG002|Overall Study|Fullfillment of exclusion criteria|0|||
13390760|NCT00684307|26774545|FG003|Overall Study|Fullfillment of exclusion criteria|3|||
13390761|NCT00684307|26774546|FG004|Overall Study|Fullfillment of exclusion criteria|1|||
13390762|NCT00684307|26774542|FG000|Overall Study|Incorrect enrolment or randomization|4|||
13390763|NCT00684307|26774543|FG001|Overall Study|Incorrect enrolment or randomization|0|||
13390764|NCT00684307|26774544|FG002|Overall Study|Incorrect enrolment or randomization|0|||
13390765|NCT00684307|26774545|FG003|Overall Study|Incorrect enrolment or randomization|0|||
13390766|NCT00684307|26774546|FG004|Overall Study|Incorrect enrolment or randomization|0|||
13390767|NCT00684307|26774542|FG000|Overall Study|Interupted IP for more than 7 days|0|||
13390768|NCT00684307|26774543|FG001|Overall Study|Interupted IP for more than 7 days|4|||
13390769|NCT00684307|26774544|FG002|Overall Study|Interupted IP for more than 7 days|1|||
13390770|NCT00684307|26774545|FG003|Overall Study|Interupted IP for more than 7 days|3|||
13390771|NCT00684307|26774546|FG004|Overall Study|Interupted IP for more than 7 days|3|||
13390772|NCT00684307|26774542|FG000|Overall Study|Severe non compliance to protocol|1|||
13390773|NCT00684307|26774543|FG001|Overall Study|Severe non compliance to protocol|0|||
13390774|NCT00684307|26774544|FG002|Overall Study|Severe non compliance to protocol|0|||
13390775|NCT00684307|26774545|FG003|Overall Study|Severe non compliance to protocol|1|||
13390776|NCT00684307|26774546|FG004|Overall Study|Severe non compliance to protocol|2|||
13390777|NCT00684307|26774542|FG000|Overall Study|Participant not willing to continue|7|||
13390778|NCT00684307|26774543|FG001|Overall Study|Participant not willing to continue|10|||
13390779|NCT00684307|26774544|FG002|Overall Study|Participant not willing to continue|11|||
13390780|NCT00684307|26774545|FG003|Overall Study|Participant not willing to continue|5|||
13390781|NCT00684307|26774546|FG004|Overall Study|Participant not willing to continue|8|||
13390782|NCT00684307|26774542|FG000|Overall Study|Criteria from the CSR|0|||
13390783|NCT00684307|26774543|FG001|Overall Study|Criteria from the CSR|0|||
13390784|NCT00684307|26774544|FG002|Overall Study|Criteria from the CSR|1|||
13390785|NCT00684307|26774545|FG003|Overall Study|Criteria from the CSR|3|||
13390786|NCT00684307|26774546|FG004|Overall Study|Criteria from the CSR|3|||
13390787|NCT00684203|26774624|FG000|Overall Study|Adverse Event|6|||
13390788|NCT00684203|26774625|FG001|Overall Study|Adverse Event|4|||
13390789|NCT00684203|26774626|FG002|Overall Study|Adverse Event|8|||
13390790|NCT00684203|26774627|FG003|Overall Study|Adverse Event|0|||
13390791|NCT00684203|26774628|FG004|Overall Study|Adverse Event|0|||
13390792|NCT00684203|26774629|FG005|Overall Study|Adverse Event|0|||
13390793|NCT00684203|26774624|FG000|Overall Study|Protocol-defined clinical event|3|||
13390794|NCT00684203|26774625|FG001|Overall Study|Protocol-defined clinical event|1|||
13390795|NCT00684203|26774626|FG002|Overall Study|Protocol-defined clinical event|0|||
13390796|NCT00684203|26774627|FG003|Overall Study|Protocol-defined clinical event|0|||
13390797|NCT00684203|26774628|FG004|Overall Study|Protocol-defined clinical event|0|||
13390798|NCT00684203|26774629|FG005|Overall Study|Protocol-defined clinical event|0|||
13390799|NCT00684203|26774624|FG000|Overall Study|Withdrawal by Subject|0|||
13390800|NCT00684203|26774625|FG001|Overall Study|Withdrawal by Subject|2|||
13390801|NCT00684203|26774626|FG002|Overall Study|Withdrawal by Subject|1|||
13390802|NCT00684203|26774627|FG003|Overall Study|Withdrawal by Subject|0|||
13390803|NCT00684203|26774628|FG004|Overall Study|Withdrawal by Subject|0|||
13390804|NCT00684203|26774629|FG005|Overall Study|Withdrawal by Subject|0|||
13390805|NCT00684203|26774624|FG000|Overall Study|Did not meet protocol eligibility|0|||
13390806|NCT00684203|26774625|FG001|Overall Study|Did not meet protocol eligibility|1|||
13390807|NCT00684203|26774626|FG002|Overall Study|Did not meet protocol eligibility|0|||
13390808|NCT00684203|26774627|FG003|Overall Study|Did not meet protocol eligibility|0|||
13390809|NCT00684203|26774628|FG004|Overall Study|Did not meet protocol eligibility|0|||
13390810|NCT00684203|26774629|FG005|Overall Study|Did not meet protocol eligibility|0|||
13390811|NCT00684177|26774652|FG000|Overall Study|Adverse Event|4|||
13390812|NCT00684177|26774653|FG001|Overall Study|Adverse Event|3|||
13390813|NCT00684177|26774652|FG000|Overall Study|Lack of Efficacy|10|||
13390814|NCT00684177|26774653|FG001|Overall Study|Lack of Efficacy|15|||
13390815|NCT00684177|26774652|FG000|Overall Study|Protocol Violation|1|||
13390816|NCT00684177|26774653|FG001|Overall Study|Protocol Violation|0|||
13390817|NCT00684177|26774652|FG000|Overall Study|Lost to Follow-up|2|||
13390818|NCT00684177|26774653|FG001|Overall Study|Lost to Follow-up|1|||
13221110|NCT01817777|26282049|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
13221111|NCT01817777|26282047|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0|||
13221112|NCT01817777|26282048|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1|||
13221113|NCT01817777|26282049|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2|||
13221114|NCT01817777|26282047|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0|||
13221115|NCT01817777|26282048|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1|||
13221116|NCT01817777|26282049|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3|||
13221117|NCT01817764|26282064|FG000|Overall Study|Adverse Event|7|||
13221118|NCT01817764|26282065|FG001|Overall Study|Adverse Event|10|||
13221119|NCT01817764|26282064|FG000|Overall Study|Lack of Efficacy|9|||
13221120|NCT01817764|26282065|FG001|Overall Study|Lack of Efficacy|7|||
13221121|NCT01817764|26282064|FG000|Overall Study|Protocol Violation|7|||
13221122|NCT01817764|26282065|FG001|Overall Study|Protocol Violation|5|||
13221123|NCT01817764|26282064|FG000|Overall Study|Lost to Follow-up|1|||
13221124|NCT01817764|26282065|FG001|Overall Study|Lost to Follow-up|4|||
13221125|NCT01817764|26282064|FG000|Overall Study|Withdrawal by Subject|10|||
13221126|NCT01817764|26282065|FG001|Overall Study|Withdrawal by Subject|12|||
13221127|NCT01817725|26282072|FG000|Overall Study|Withdrawal by Subject|1|||
13221128|NCT01817582|26282144|FG000|Overall Study|Withdrawal by Subject|0|||
13221129|NCT01817582|26282145|FG001|Overall Study|Withdrawal by Subject|1|||
13221130|NCT01817582|26282146|FG002|Overall Study|Withdrawal by Subject|0|||
13221131|NCT01817582|26282144|FG000|Overall Study|Participant revealed masked treatment|1|||
13221132|NCT01817582|26282145|FG001|Overall Study|Participant revealed masked treatment|0|||
13221133|NCT01817582|26282146|FG002|Overall Study|Participant revealed masked treatment|0|||
13221134|NCT01817582|26282144|FG000|Overall Study|Randomized but exclusion criteria met|1|||
13221135|NCT01817582|26282145|FG001|Overall Study|Randomized but exclusion criteria met|0|||
13221136|NCT01817582|26282146|FG002|Overall Study|Randomized but exclusion criteria met|0|||
13221137|NCT01817530|26282333|FG000|Overall Study|Exclusionary Medication Received|0|||
13221138|NCT01817530|26282334|FG001|Overall Study|Exclusionary Medication Received|0|||
13221139|NCT01817530|26282335|FG002|Overall Study|Exclusionary Medication Received|0|||
13221140|NCT01817530|26282336|FG003|Overall Study|Exclusionary Medication Received|0|||
13221141|NCT01817530|26282337|FG004|Overall Study|Exclusionary Medication Received|1|||
13221142|NCT01817530|26282338|FG005|Overall Study|Exclusionary Medication Received|0|||
13221143|NCT01817530|26282339|FG006|Overall Study|Exclusionary Medication Received|0|||
13221144|NCT01817530|26282340|FG007|Overall Study|Exclusionary Medication Received|0|||
13221145|NCT01817530|26282333|FG000|Overall Study|Adverse Event|6|||
13221146|NCT01817530|26282334|FG001|Overall Study|Adverse Event|3|||
13221147|NCT01817530|26282335|FG002|Overall Study|Adverse Event|2|||
13221148|NCT01817530|26282336|FG003|Overall Study|Adverse Event|5|||
13221149|NCT01817530|26282337|FG004|Overall Study|Adverse Event|0|||
13221150|NCT01817530|26282338|FG005|Overall Study|Adverse Event|10|||
13221151|NCT01817530|26282339|FG006|Overall Study|Adverse Event|5|||
13221152|NCT01817530|26282340|FG007|Overall Study|Adverse Event|8|||
13221153|NCT01817530|26282333|FG000|Overall Study|Subject Noncompliant|3|||
13221154|NCT01817530|26282334|FG001|Overall Study|Subject Noncompliant|1|||
13221155|NCT01817530|26282335|FG002|Overall Study|Subject Noncompliant|0|||
13221156|NCT01817530|26282336|FG003|Overall Study|Subject Noncompliant|4|||
13221157|NCT01817530|26282337|FG004|Overall Study|Subject Noncompliant|0|||
13221158|NCT01817530|26282338|FG005|Overall Study|Subject Noncompliant|1|||
13221159|NCT01817530|26282339|FG006|Overall Study|Subject Noncompliant|1|||
13221160|NCT01817530|26282340|FG007|Overall Study|Subject Noncompliant|1|||
13221161|NCT01817530|26282333|FG000|Overall Study|Lack of Efficacy|1|||
13221162|NCT01817530|26282334|FG001|Overall Study|Lack of Efficacy|0|||
13221163|NCT01817530|26282335|FG002|Overall Study|Lack of Efficacy|0|||
13221164|NCT01817530|26282336|FG003|Overall Study|Lack of Efficacy|0|||
13221165|NCT01817530|26282337|FG004|Overall Study|Lack of Efficacy|0|||
13221166|NCT01817530|26282338|FG005|Overall Study|Lack of Efficacy|1|||
13221167|NCT01817530|26282339|FG006|Overall Study|Lack of Efficacy|0|||
13474779|NCT02288247|26996577|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Lost to Follow-up|1|||
13474780|NCT02288247|26996578|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Lost to Follow-up|0|||
13474781|NCT02288247|26996577|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Progressive Disease|392|||
13474782|NCT02288247|26996578|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Progressive Disease|0|||
13474783|NCT02288247|26996577|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Protocol Violation|9|||
13474784|NCT02288247|26996578|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Protocol Violation|0|||
13474785|NCT02288247|26996577|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Withdrawal by Subject|52|||
13474786|NCT02288247|26996578|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Withdrawal by Subject|0|||
13474787|NCT02288247|26996577|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Other|106|||
13474788|NCT02288247|26996578|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Other|0|||
13474789|NCT02288247|26996577|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10|||
13474790|NCT02288247|26996578|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8|||
13221168|NCT01817530|26282340|FG007|Overall Study|Lack of Efficacy|1|||
13134339|NCT02757352|25990982|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
13134340|NCT02757352|25990983|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
13134341|NCT02757352|25990984|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
13134342|NCT02757352|25990975|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
13134343|NCT02757352|25990976|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1|||
13134344|NCT02757352|25990977|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
13134345|NCT02757352|25990978|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
13134346|NCT02757352|25990979|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
13134347|NCT02757352|25990980|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
13134348|NCT02757352|25990981|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
13134349|NCT02757352|25990982|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
13134350|NCT02757352|25990983|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
13134351|NCT02757352|25990984|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
13134352|NCT02757352|25990975|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
13134353|NCT02757352|25990976|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
13134354|NCT02757352|25990977|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4|||
13134355|NCT02757352|25990978|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
13134356|NCT02757352|25990979|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
13134357|NCT02757352|25990980|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
13134358|NCT02757352|25990981|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
13134359|NCT02757352|25990982|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
13134360|NCT02757352|25990983|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
13134361|NCT02757352|25990984|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
13134362|NCT02757352|25990975|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62|||
13134363|NCT02757352|25990976|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40|||
13134364|NCT02757352|25990977|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42|||
13134365|NCT02757352|25990978|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
13134366|NCT02757352|25990979|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
13134367|NCT02757352|25990980|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
13134368|NCT02757352|25990981|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
13134369|NCT02757352|25990982|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
13134370|NCT02757352|25990983|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
13134371|NCT02757352|25990984|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
13134372|NCT02757352|25990975|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
13134373|NCT02757352|25990976|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
13134374|NCT02757352|25990977|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
13134375|NCT02757352|25990978|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3|||
13134376|NCT02757352|25990979|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
13134377|NCT02757352|25990980|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1|||
13390819|NCT00684177|26774652|FG000|Overall Study|Physician Decision|2|||
13390820|NCT00684177|26774653|FG001|Overall Study|Physician Decision|0|||
13390821|NCT00684177|26774652|FG000|Overall Study|Withdrawal by Subject|1|||
13390822|NCT00684177|26774653|FG001|Overall Study|Withdrawal by Subject|2|||
13390823|NCT00684177|26774652|FG000|Overall Study|Other|1|||
13390824|NCT00684177|26774653|FG001|Overall Study|Other|2|||
13390825|NCT00684073|26774663|FG000|Selection|Selection/non-selection criteria|3|||
13390826|NCT00684073|26774663|FG000|Selection|Death|1|||
13390827|NCT00684073|26774663|FG000|Selection|noncompliance|1|||
13390828|NCT00684073|26774663|FG000|Selection|Lost to Follow-up|1|||
13390829|NCT00684073|26774663|FG000|Selection|request of the sponsor|1|||
13390830|NCT00684073|26774663|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1|||
13390831|NCT00684060|26774690|FG000|Overall Study|Lost to Follow-up|1|||
13390832|NCT00684060|26774691|FG001|Overall Study|Lost to Follow-up|0|||
13390833|NCT00684060|26774690|FG000|Overall Study|New stenosis identified|1|||
13390834|NCT00684060|26774691|FG001|Overall Study|New stenosis identified|0|||
13390835|NCT00684060|26774690|FG000|Overall Study|Unable to collect MRI|1|||
13390836|NCT00684060|26774691|FG001|Overall Study|Unable to collect MRI|2|||
13390837|NCT00684060|26774690|FG000|Overall Study|Death|0|||
13390838|NCT00684060|26774691|FG001|Overall Study|Death|1|||
13390839|NCT00684021|26774742|FG000|Overall Study|MRI Contraindicated|1|||
13390840|NCT00684021|26774743|FG001|Overall Study|MRI Contraindicated|1|||
13390841|NCT00684021|26774744|FG002|Overall Study|MRI Contraindicated|1|||
13390842|NCT00684021|26774745|FG003|Overall Study|MRI Contraindicated|0|||
13390843|NCT00684021|26774742|FG000|Overall Study|MRI not performed|0|||
13390844|NCT00684021|26774743|FG001|Overall Study|MRI not performed|1|||
13390845|NCT00684021|26774744|FG002|Overall Study|MRI not performed|1|||
13390846|NCT00684021|26774745|FG003|Overall Study|MRI not performed|2|||
13390847|NCT00684021|26774742|FG000|Overall Study|Death|1|||
13390848|NCT00684021|26774743|FG001|Overall Study|Death|0|||
13390849|NCT00684021|26774744|FG002|Overall Study|Death|0|||
13390850|NCT00684021|26774745|FG003|Overall Study|Death|0|||
13390851|NCT00683917|26774761|FG000|Overall Study|Study prematurely terminated|10|||
13390852|NCT00683904|26774801|FG000|Dose Level 1|Disease progression|2|||
13390853|NCT00683904|26774802|FG001|Dose Level 1|Disease progression|0|||
13390854|NCT00683904|26774801|FG000|Dose Level 1|Adverse Event|1|||
13390855|NCT00683904|26774802|FG001|Dose Level 1|Adverse Event|0|||
13390856|NCT00683904|26774801|FG000|Dose Level 2|Adverse Event|0|||
13390857|NCT00683904|26774802|FG001|Dose Level 2|Adverse Event|2|||
13221169|NCT01817530|26282333|FG000|Overall Study|Pregnancy|0|||
13221170|NCT01817530|26282334|FG001|Overall Study|Pregnancy|0|||
13221171|NCT01817530|26282335|FG002|Overall Study|Pregnancy|0|||
13221172|NCT01817530|26282336|FG003|Overall Study|Pregnancy|0|||
13221173|NCT01817530|26282337|FG004|Overall Study|Pregnancy|0|||
13221174|NCT01817530|26282338|FG005|Overall Study|Pregnancy|1|||
13221175|NCT01817530|26282339|FG006|Overall Study|Pregnancy|0|||
13221176|NCT01817530|26282340|FG007|Overall Study|Pregnancy|0|||
13221177|NCT01817530|26282333|FG000|Overall Study|Other|0|||
13221178|NCT01817530|26282334|FG001|Overall Study|Other|1|||
13221179|NCT01817530|26282335|FG002|Overall Study|Other|0|||
13221180|NCT01817530|26282336|FG003|Overall Study|Other|0|||
13221181|NCT01817530|26282337|FG004|Overall Study|Other|1|||
13221182|NCT01817530|26282338|FG005|Overall Study|Other|0|||
13221183|NCT01817530|26282339|FG006|Overall Study|Other|5|||
13221184|NCT01817530|26282340|FG007|Overall Study|Other|0|||
13221185|NCT01817530|26282333|FG000|Overall Study|Surgery or Invasive Intervention|1|||
13221186|NCT01817530|26282334|FG001|Overall Study|Surgery or Invasive Intervention|0|||
13221187|NCT01817530|26282335|FG002|Overall Study|Surgery or Invasive Intervention|0|||
13221188|NCT01817530|26282336|FG003|Overall Study|Surgery or Invasive Intervention|0|||
13221189|NCT01817530|26282337|FG004|Overall Study|Surgery or Invasive Intervention|1|||
13221190|NCT01817530|26282338|FG005|Overall Study|Surgery or Invasive Intervention|1|||
13221191|NCT01817530|26282339|FG006|Overall Study|Surgery or Invasive Intervention|1|||
13221192|NCT01817530|26282340|FG007|Overall Study|Surgery or Invasive Intervention|0|||
13221193|NCT01817530|26282333|FG000|Overall Study|Consent Withdrawn by Subject|3|||
13221194|NCT01817530|26282334|FG001|Overall Study|Consent Withdrawn by Subject|4|||
13221195|NCT01817530|26282335|FG002|Overall Study|Consent Withdrawn by Subject|7|||
13221196|NCT01817530|26282336|FG003|Overall Study|Consent Withdrawn by Subject|3|||
13221197|NCT01817530|26282337|FG004|Overall Study|Consent Withdrawn by Subject|5|||
13221198|NCT01817530|26282338|FG005|Overall Study|Consent Withdrawn by Subject|3|||
13221199|NCT01817530|26282339|FG006|Overall Study|Consent Withdrawn by Subject|3|||
13221200|NCT01817530|26282340|FG007|Overall Study|Consent Withdrawn by Subject|10|||
13221201|NCT01817530|26282333|FG000|Overall Study|Lost to Follow-up|1|||
13221202|NCT01817530|26282334|FG001|Overall Study|Lost to Follow-up|4|||
13221203|NCT01817530|26282335|FG002|Overall Study|Lost to Follow-up|2|||
13221204|NCT01817530|26282336|FG003|Overall Study|Lost to Follow-up|1|||
13221205|NCT01817530|26282337|FG004|Overall Study|Lost to Follow-up|3|||
13221206|NCT01817530|26282338|FG005|Overall Study|Lost to Follow-up|2|||
13221207|NCT01817530|26282339|FG006|Overall Study|Lost to Follow-up|8|||
13221208|NCT01817530|26282340|FG007|Overall Study|Lost to Follow-up|4|||
13221209|NCT01817075|26282359|FG000|Overall Study|Adverse Event|7|||
13221210|NCT01817075|26282360|FG001|Overall Study|Adverse Event|5|||
13221211|NCT01817075|26282359|FG000|Overall Study|Physician Decision|9|||
13221212|NCT01817075|26282360|FG001|Overall Study|Physician Decision|12|||
13221213|NCT01817075|26282359|FG000|Overall Study|Withdrawal by Subject|31|||
13221214|NCT01817075|26282360|FG001|Overall Study|Withdrawal by Subject|15|||
13221215|NCT01817075|26282359|FG000|Overall Study|Received Sorafenib after enrollment|0|||
13221216|NCT01817075|26282360|FG001|Overall Study|Received Sorafenib after enrollment|1|||
13221217|NCT01817075|26282359|FG000|Overall Study|Ineligible|0|||
13221218|NCT01817075|26282360|FG001|Overall Study|Ineligible|2|||
13221219|NCT01816984|26282373|FG000|Overall Study|declining health status|1|||
13221220|NCT01816906|26282396|FG000|Six Months|Did Not Show Up for Baseline Measurement|7|||
13221221|NCT01816906|26282397|FG001|Six Months|Did Not Show Up for Baseline Measurement|6|||
13221222|NCT01816906|26282396|FG000|Six Months|Lost to Follow-up|14|||
13221223|NCT01816906|26282397|FG001|Six Months|Lost to Follow-up|16|||
13221224|NCT01816906|26282396|FG000|12 Months|Adverse Event|2|||
13221225|NCT01816906|26282397|FG001|12 Months|Adverse Event|2|||
13221226|NCT01816906|26282396|FG000|12 Months|Death|0|||
13221227|NCT01816906|26282397|FG001|12 Months|Death|2|||
13221228|NCT01816906|26282396|FG000|12 Months|Lost to Follow-up|2|||
13221229|NCT01816906|26282397|FG001|12 Months|Lost to Follow-up|1|||
13221230|NCT01816893|26282414|FG000|Washout Period|Withdrawal by Subject|2|||
13221231|NCT01816893|26282415|FG001|Washout Period|Withdrawal by Subject|0|||
13221232|NCT01816763|26282439|FG000|Overall Study|The main reason for an incomplete survey|4|||
13221233|NCT01816763|26282440|FG001|Overall Study|The main reason for an incomplete survey|15|||
13221234|NCT01816763|26282441|FG002|Overall Study|The main reason for an incomplete survey|11|||
13221235|NCT01816685|26282456|FG000|Overall Study|Lost to Follow-up|7|||
13221236|NCT01816685|26282457|FG001|Overall Study|Lost to Follow-up|9|||
13221237|NCT01816685|26282456|FG000|Overall Study|Surgery Cancelled|3|||
13221238|NCT01816685|26282457|FG001|Overall Study|Surgery Cancelled|2|||
13221239|NCT01816594|26282500|FG000|Overall Study|Local Progress|0|||
13221240|NCT01816594|26282501|FG001|Overall Study|Local Progress|2|||
13221241|NCT01816594|26282500|FG000|Overall Study|Adverse Event|9|||
13221242|NCT01816594|26282501|FG001|Overall Study|Adverse Event|0|||
13221243|NCT01816594|26282500|FG000|Overall Study|Withdrawal by Subject|1|||
13221244|NCT01816594|26282501|FG001|Overall Study|Withdrawal by Subject|0|||
13221245|NCT01816594|26282500|FG000|Overall Study|Physician Decision|1|||
13221246|NCT01816594|26282501|FG001|Overall Study|Physician Decision|0|||
13221247|NCT01816477|26282518|FG000|Overall Study|Withdrawal by Subject|13|||
13221248|NCT01816477|26282519|FG001|Overall Study|Withdrawal by Subject|1|||
13221249|NCT01816477|26282518|FG000|Overall Study|Unable to tolerate catheter placement|3|||
13221250|NCT01816477|26282519|FG001|Overall Study|Unable to tolerate catheter placement|0|||
13221251|NCT01816295|26282541|FG000|Double Blind Phase|Adverse Event|11|||
13221252|NCT01816295|26282542|FG001|Double Blind Phase|Adverse Event|8|||
13221253|NCT01816295|26282541|FG000|Double Blind Phase|Entry Criteria Not Met|0|||
13221254|NCT01816295|26282542|FG001|Double Blind Phase|Entry Criteria Not Met|2|||
13221255|NCT01816295|26282541|FG000|Double Blind Phase|Lost to Follow-up|3|||
13221256|NCT01816295|26282542|FG001|Double Blind Phase|Lost to Follow-up|5|||
13221257|NCT01816295|26282541|FG000|Double Blind Phase|Physician Decision|2|||
13221258|NCT01816295|26282542|FG001|Double Blind Phase|Physician Decision|2|||
13221259|NCT01816295|26282541|FG000|Double Blind Phase|Protocol Violation|17|||
13221260|NCT01816295|26282542|FG001|Double Blind Phase|Protocol Violation|11|||
13221261|NCT01816295|26282541|FG000|Double Blind Phase|Sponsor Decision|8|||
13221262|NCT01816295|26282542|FG001|Double Blind Phase|Sponsor Decision|8|||
13221263|NCT01816295|26282541|FG000|Double Blind Phase|Withdrawal by Subject|22|||
13221264|NCT01816295|26282542|FG001|Double Blind Phase|Withdrawal by Subject|20|||
13221265|NCT01816295|26282541|FG000|OLE Phase|Adverse Event|17|||
13221266|NCT01816295|26282542|FG001|OLE Phase|Adverse Event|15|||
13221267|NCT01816295|26282541|FG000|OLE Phase|Death|1|||
13221268|NCT01816295|26282542|FG001|OLE Phase|Death|0|||
13221269|NCT01816295|26282541|FG000|OLE Phase|Entry Criteria Not Met|3|||
13221270|NCT01816295|26282542|FG001|OLE Phase|Entry Criteria Not Met|5|||
13221271|NCT01816295|26282541|FG000|OLE Phase|Lost to Follow-up|5|||
13221272|NCT01816295|26282542|FG001|OLE Phase|Lost to Follow-up|5|||
13221273|NCT01816295|26282541|FG000|OLE Phase|Physician Decision|3|||
13221274|NCT01816295|26282542|FG001|OLE Phase|Physician Decision|1|||
13221275|NCT01816295|26282541|FG000|OLE Phase|Protocol Violation|4|||
13221276|NCT01816295|26282542|FG001|OLE Phase|Protocol Violation|4|||
13221277|NCT01816295|26282541|FG000|OLE Phase|Sponsor Decision|7|||
13221278|NCT01816295|26282542|FG001|OLE Phase|Sponsor Decision|9|||
13221279|NCT01816295|26282541|FG000|OLE Phase|Withdrawal by Subject|10|||
13221280|NCT01816295|26282542|FG001|OLE Phase|Withdrawal by Subject|10|||
13221281|NCT01816295|26282541|FG000|OLE Phase|Lack of Efficacy|3|||
13221282|NCT01816295|26282542|FG001|OLE Phase|Lack of Efficacy|7|||
13306636|NCT01289847|26526310|FG000|Overall Study|Patient could not comply with visits|1|||
13306637|NCT01289821|26526321|FG000|Treatment Period|Withdrawal by Subject|1|||
13306638|NCT01289821|26526321|FG000|Treatment Period|Physician Decision|3|||
13306639|NCT01289821|26526321|FG000|Treatment Period|Adverse Event|4|||
13306640|NCT01289821|26526321|FG000|Treatment Period|Radiological Progression|43|||
13306641|NCT01289821|26526321|FG000|Treatment Period|Clinical Progression|2|||
13306642|NCT01289821|26526321|FG000|Treatment Period|Therapeutic procedure required|1|||
13306643|NCT01289821|26526321|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
13306644|NCT01289821|26526321|FG000|Safety Follow-up Period|Protocol Violation|3|||
13306645|NCT01289821|26526321|FG000|Safety Follow-up Period|Unspecified reason|1|||
13306646|NCT01289821|26526321|FG000|Survival Follow-up Period|Protocol Violation|1|||
13306647|NCT01289821|26526321|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
13306648|NCT01289821|26526321|FG000|Survival Follow-up Period|Clinical endpoint reached|16|||
13306649|NCT01289782|26526397|FG000|Overall Study|Lost to Follow-up|14|||
13306650|NCT01289782|26526398|FG001|Overall Study|Lost to Follow-up|7|||
13390858|NCT00683878|26774838|FG000|Overall Study|Lack of Efficacy|3|||
13390859|NCT00683878|26774839|FG001|Overall Study|Lack of Efficacy|0|||
13390860|NCT00683878|26774840|FG002|Overall Study|Lack of Efficacy|1|||
13306651|NCT01289782|26526397|FG000|Overall Study|Protocol Violation|1|||
13134378|NCT02757352|25990981|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
13134379|NCT02757352|25990982|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
13134380|NCT02757352|25990983|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
13134381|NCT02757352|25990984|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
13134382|NCT02757352|25990975|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
13134383|NCT02757352|25990976|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
13134384|NCT02757352|25990977|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
13134385|NCT02757352|25990978|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2|||
13134386|NCT02757352|25990979|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
13134387|NCT02757352|25990980|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4|||
13134388|NCT02757352|25990981|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
13134389|NCT02757352|25990982|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
13134390|NCT02757352|25990983|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
13134391|NCT02757352|25990984|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
13134392|NCT02757352|25990975|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
13134393|NCT02757352|25990976|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
13134394|NCT02757352|25990977|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
13134395|NCT02757352|25990978|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
13134396|NCT02757352|25990979|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1|||
13134397|NCT02757352|25990980|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
13134398|NCT02757352|25990981|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
13134399|NCT02757352|25990982|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
13134400|NCT02757352|25990983|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
13134401|NCT02757352|25990984|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
13134402|NCT02757352|25990975|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
13134403|NCT02757352|25990976|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
13134404|NCT02757352|25990977|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
13134405|NCT02757352|25990978|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
13134406|NCT02757352|25990979|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
13134407|NCT02757352|25990980|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1|||
13134408|NCT02757352|25990981|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
13134409|NCT02757352|25990982|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
13134410|NCT02757352|25990983|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
13134411|NCT02757352|25990984|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
13134412|NCT02757352|25990975|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
13134413|NCT02757352|25990976|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
13134414|NCT02757352|25990977|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
13134415|NCT02757352|25990978|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2|||
13134416|NCT02757352|25990979|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
13134417|NCT02757352|25990980|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
13134418|NCT02757352|25990981|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
13134419|NCT02757352|25990982|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
13134420|NCT02757352|25990983|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
13134421|NCT02757352|25990984|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
13134422|NCT02757352|25990975|FG000|Follow-Up Period|Adverse Event|0|||
13134423|NCT02757352|25990976|FG001|Follow-Up Period|Adverse Event|0|||
13134424|NCT02757352|25990977|FG002|Follow-Up Period|Adverse Event|0|||
13134425|NCT02757352|25990978|FG003|Follow-Up Period|Adverse Event|0|||
13134426|NCT02757352|25990979|FG004|Follow-Up Period|Adverse Event|0|||
13134427|NCT02757352|25990980|FG005|Follow-Up Period|Adverse Event|0|||
13134428|NCT02757352|25990981|FG006|Follow-Up Period|Adverse Event|1|||
13134429|NCT02757352|25990982|FG007|Follow-Up Period|Adverse Event|0|||
13134430|NCT02757352|25990983|FG008|Follow-Up Period|Adverse Event|2|||
13306652|NCT01289782|26526398|FG001|Overall Study|Protocol Violation|1|||
13134431|NCT02757352|25990984|FG009|Follow-Up Period|Adverse Event|0|||
13306653|NCT01289782|26526397|FG000|Overall Study|Withdrawal by Subject|8|||
13306654|NCT01289782|26526398|FG001|Overall Study|Withdrawal by Subject|2|||
13306655|NCT01289782|26526397|FG000|Overall Study|Sponsor's Decision|1|||
13306656|NCT01289782|26526398|FG001|Overall Study|Sponsor's Decision|0|||
13306657|NCT01289782|26526397|FG000|Overall Study|Reason not specified|1|||
13306658|NCT01289782|26526398|FG001|Overall Study|Reason not specified|2|||
13306659|NCT01289678|26526404|FG000|Overall Study|Physician Decision|6|||
13306660|NCT01289639|26526437|FG000|Overall Study|Lost to Follow-up|1|||
13306661|NCT01289639|26526438|FG001|Overall Study|Lost to Follow-up|0|||
13306662|NCT01289639|26526439|FG002|Overall Study|Lost to Follow-up|0|||
13390861|NCT00683878|26774838|FG000|Overall Study|Adverse Event|4|||
13390862|NCT00683878|26774839|FG001|Overall Study|Adverse Event|3|||
13390863|NCT00683878|26774840|FG002|Overall Study|Adverse Event|3|||
13390864|NCT00683878|26774838|FG000|Overall Study|Withdrawal by Subject|9|||
13390865|NCT00683878|26774839|FG001|Overall Study|Withdrawal by Subject|8|||
13390866|NCT00683878|26774840|FG002|Overall Study|Withdrawal by Subject|6|||
13390867|NCT00683878|26774838|FG000|Overall Study|Death|0|||
13390868|NCT00683878|26774839|FG001|Overall Study|Death|1|||
13390869|NCT00683878|26774840|FG002|Overall Study|Death|0|||
13390870|NCT00683878|26774838|FG000|Overall Study|Lost to Follow-up|4|||
13390871|NCT00683878|26774839|FG001|Overall Study|Lost to Follow-up|2|||
13390872|NCT00683878|26774840|FG002|Overall Study|Lost to Follow-up|4|||
13390873|NCT00683878|26774838|FG000|Overall Study|Non-compliance, not met criteria etc.|3|||
13390874|NCT00683878|26774839|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
13390875|NCT00683878|26774840|FG002|Overall Study|Non-compliance, not met criteria etc.|0|||
13390876|NCT00683800|26774911|FG000|Overall Study|Adverse Event|195|||
13390877|NCT00683800|26774912|FG001|Overall Study|Adverse Event|102|||
13390878|NCT00683800|26774911|FG000|Overall Study|Death|0|||
13390879|NCT00683800|26774912|FG001|Overall Study|Death|1|||
13390880|NCT00683800|26774911|FG000|Overall Study|Lost to Follow-up|57|||
13390881|NCT00683800|26774912|FG001|Overall Study|Lost to Follow-up|44|||
13390882|NCT00683800|26774911|FG000|Overall Study|Other|5|||
13390883|NCT00683800|26774912|FG001|Overall Study|Other|2|||
13390884|NCT00683800|26774911|FG000|Overall Study|Protocol Violation|13|||
13390885|NCT00683800|26774912|FG001|Overall Study|Protocol Violation|16|||
13390886|NCT00683800|26774911|FG000|Overall Study|Withdrawal by Subject|66|||
13390887|NCT00683800|26774912|FG001|Overall Study|Withdrawal by Subject|64|||
13390888|NCT00683800|26774911|FG000|Overall Study|Lack of Efficacy|61|||
13390889|NCT00683800|26774912|FG001|Overall Study|Lack of Efficacy|104|||
13390890|NCT00683800|26774911|FG000|Overall Study|Randomized, not treated|35|||
13390891|NCT00683800|26774912|FG001|Overall Study|Randomized, not treated|33|||
13390892|NCT00683787|26774939|FG000|Overall Study|Progression|3|||
13390893|NCT00683787|26774940|FG001|Overall Study|Progression|3|||
13390894|NCT00683787|26774941|FG002|Overall Study|Progression|0|||
13390895|NCT00683787|26774939|FG000|Overall Study|Adverse Event|0|||
13390896|NCT00683787|26774940|FG001|Overall Study|Adverse Event|0|||
13390897|NCT00683787|26774941|FG002|Overall Study|Adverse Event|2|||
13390898|NCT00683774|26774956|FG000|Overall Study|Withdrawal by Subject|0|||
13390899|NCT00683774|26774957|FG001|Overall Study|Withdrawal by Subject|1|||
13390900|NCT00683774|26774956|FG000|Overall Study|Physician Decision|3|||
13390901|NCT00683774|26774957|FG001|Overall Study|Physician Decision|0|||
13390902|NCT00683696|26774981|FG000|Overall Study|Withdrawn due to study closure|337|||
13390903|NCT00683696|26774982|FG001|Overall Study|Withdrawn due to study closure|338|||
13390904|NCT00683696|26774981|FG000|Overall Study|Withdrawn prior to study closure|13|||
13390905|NCT00683696|26774982|FG001|Overall Study|Withdrawn prior to study closure|28|||
13390906|NCT00683696|26774981|FG000|Overall Study|Lost to Follow-up|5|||
13390907|NCT00683696|26774982|FG001|Overall Study|Lost to Follow-up|6|||
13390908|NCT00683696|26774981|FG000|Overall Study|Vital status follow-up only|3|||
13390909|NCT00683696|26774982|FG001|Overall Study|Vital status follow-up only|3|||
13390910|NCT00683696|26774981|FG000|Overall Study|Death|46|||
13390911|NCT00683696|26774982|FG001|Overall Study|Death|30|||
13390912|NCT00683657|26775003|FG000|Overall Study|Adverse Event|0|||
13390913|NCT00683657|26775004|FG001|Overall Study|Adverse Event|1|||
13390914|NCT00683657|26775003|FG000|Overall Study|Subject Withdrew Consent|1|||
13390915|NCT00683657|26775004|FG001|Overall Study|Subject Withdrew Consent|0|||
13390916|NCT00683644|26775021|FG000|Overall Study|Withdrawal by Subject|4|||
13390917|NCT00683644|26775022|FG001|Overall Study|Withdrawal by Subject|2|||
13390918|NCT00683644|26775021|FG000|Overall Study|Lost to Follow-up|1|||
13390919|NCT00683644|26775022|FG001|Overall Study|Lost to Follow-up|4|||
13390920|NCT00683644|26775021|FG000|Overall Study|Adverse Event|1|||
13390921|NCT00683644|26775022|FG001|Overall Study|Adverse Event|2|||
13390922|NCT00683644|26775021|FG000|Overall Study|Low copper, other health problems,|7|||
13390923|NCT00683644|26775022|FG001|Overall Study|Low copper, other health problems,|6|||
13390924|NCT00683618|26775080|FG000|Randomised Treatment Period|Withdrawal by Subject|4|||
13390925|NCT00683618|26775081|FG001|Randomised Treatment Period|Withdrawal by Subject|1|||
13390926|NCT00683618|26775082|FG002|Randomised Treatment Period|Withdrawal by Subject|2|||
13390927|NCT00683618|26775080|FG000|Randomised Treatment Period|Protocol Violation|0|||
13390928|NCT00683618|26775081|FG001|Randomised Treatment Period|Protocol Violation|1|||
13390929|NCT00683618|26775082|FG002|Randomised Treatment Period|Protocol Violation|0|||
13390930|NCT00683618|26775080|FG000|Randomised Treatment Period|Adverse Event|2|||
13390931|NCT00683618|26775081|FG001|Randomised Treatment Period|Adverse Event|0|||
13390932|NCT00683618|26775082|FG002|Randomised Treatment Period|Adverse Event|2|||
13390933|NCT00683618|26775080|FG000|Randomised Treatment Period|Reason not provided|0|||
13390934|NCT00683618|26775081|FG001|Randomised Treatment Period|Reason not provided|0|||
13390935|NCT00683618|26775082|FG002|Randomised Treatment Period|Reason not provided|2|||
13390936|NCT00683618|26775080|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
13390937|NCT00683618|26775081|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
13390938|NCT00683618|26775082|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
13390939|NCT00683618|26775080|FG000|Extension Treatment Period|Adverse Event|1|||
13390940|NCT00683618|26775081|FG001|Extension Treatment Period|Adverse Event|0|||
13390941|NCT00683618|26775082|FG002|Extension Treatment Period|Adverse Event|0|||
13390942|NCT00683618|26775080|FG000|Extension Treatment Period|Protocol Violation|1|||
13390943|NCT00683618|26775081|FG001|Extension Treatment Period|Protocol Violation|0|||
13390944|NCT00683618|26775082|FG002|Extension Treatment Period|Protocol Violation|0|||
13390945|NCT00683592|26775105|FG000|Overall Study|Adverse Event|12|||
13390946|NCT00683592|26775106|FG001|Overall Study|Adverse Event|4|||
13390947|NCT00683592|26775105|FG000|Overall Study|Withdrawal by Subject|11|||
13390948|NCT00683592|26775106|FG001|Overall Study|Withdrawal by Subject|11|||
13390949|NCT00683592|26775105|FG000|Overall Study|Lost to Follow-up|17|||
13390950|NCT00683592|26775106|FG001|Overall Study|Lost to Follow-up|17|||
13390951|NCT00683592|26775105|FG000|Overall Study|Lack of Efficacy|3|||
13390952|NCT00683592|26775106|FG001|Overall Study|Lack of Efficacy|7|||
13390953|NCT00683592|26775105|FG000|Overall Study|Physician Decision|0|||
13134432|NCT02757352|25990975|FG000|Follow-Up Period|Lost to Follow-up|0|||
13134433|NCT02757352|25990976|FG001|Follow-Up Period|Lost to Follow-up|0|||
13134434|NCT02757352|25990977|FG002|Follow-Up Period|Lost to Follow-up|0|||
13134435|NCT02757352|25990978|FG003|Follow-Up Period|Lost to Follow-up|0|||
13134436|NCT02757352|25990979|FG004|Follow-Up Period|Lost to Follow-up|0|||
13134437|NCT02757352|25990980|FG005|Follow-Up Period|Lost to Follow-up|0|||
13134438|NCT02757352|25990981|FG006|Follow-Up Period|Lost to Follow-up|0|||
13134439|NCT02757352|25990982|FG007|Follow-Up Period|Lost to Follow-up|0|||
13134440|NCT02757352|25990983|FG008|Follow-Up Period|Lost to Follow-up|1|||
13134441|NCT02757352|25990984|FG009|Follow-Up Period|Lost to Follow-up|0|||
13134442|NCT02757352|25990975|FG000|Follow-Up Period|Lack of Efficacy|0|||
13134443|NCT02757352|25990976|FG001|Follow-Up Period|Lack of Efficacy|0|||
13134444|NCT02757352|25990977|FG002|Follow-Up Period|Lack of Efficacy|0|||
13134445|NCT02757352|25990978|FG003|Follow-Up Period|Lack of Efficacy|0|||
13134446|NCT02757352|25990979|FG004|Follow-Up Period|Lack of Efficacy|0|||
13134447|NCT02757352|25990980|FG005|Follow-Up Period|Lack of Efficacy|0|||
13134448|NCT02757352|25990981|FG006|Follow-Up Period|Lack of Efficacy|0|||
13134449|NCT02757352|25990982|FG007|Follow-Up Period|Lack of Efficacy|0|||
13134450|NCT02757352|25990983|FG008|Follow-Up Period|Lack of Efficacy|1|||
13134451|NCT02757352|25990984|FG009|Follow-Up Period|Lack of Efficacy|1|||
13134452|NCT02757352|25990975|FG000|Follow-Up Period|Withdrawal by Subject|0|||
13134453|NCT02757352|25990976|FG001|Follow-Up Period|Withdrawal by Subject|0|||
13134454|NCT02757352|25990977|FG002|Follow-Up Period|Withdrawal by Subject|0|||
13134455|NCT02757352|25990978|FG003|Follow-Up Period|Withdrawal by Subject|0|||
13134456|NCT02757352|25990979|FG004|Follow-Up Period|Withdrawal by Subject|0|||
13134457|NCT02757352|25990980|FG005|Follow-Up Period|Withdrawal by Subject|0|||
13134458|NCT02757352|25990981|FG006|Follow-Up Period|Withdrawal by Subject|0|||
13134459|NCT02757352|25990982|FG007|Follow-Up Period|Withdrawal by Subject|1|||
13134460|NCT02757352|25990983|FG008|Follow-Up Period|Withdrawal by Subject|6|||
13134461|NCT02757352|25990984|FG009|Follow-Up Period|Withdrawal by Subject|2|||
13134462|NCT02756832|25991000|FG000|Overall Study|Lost for Observation after Baseline|6|||
13134463|NCT02756832|25991000|FG000|Overall Study|Lost for Observation|13|||
13134464|NCT02756832|25991000|FG000|Overall Study|Patient's Unwillingness|12|||
13134465|NCT02756832|25991000|FG000|Overall Study|Insufficient Efficacy|2|||
13134466|NCT02756832|25991000|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1|||
13134467|NCT02756832|25991000|FG000|Overall Study|Reason not Specified|9|||
13134468|NCT02756832|25991000|FG000|Overall Study|Protocol Deviation|10|||
13134469|NCT02756819|25991012|FG000|Overall Study|Lost for observation|23|||
13134470|NCT02756819|25991012|FG000|Overall Study|Patient's unwillingness|16|||
13134471|NCT02756819|25991012|FG000|Overall Study|Insufficient efficacy|2|||
13134472|NCT02756819|25991012|FG000|Overall Study|Adverse Event|2|||
13134473|NCT02756819|25991012|FG000|Overall Study|Reason not Specified|9|||
13134474|NCT02756650|25991035|FG000|Overall Study|Physician Decision|1|||
13134475|NCT02756650|25991035|FG000|Overall Study|Adverse Event|1|||
13134476|NCT02756637|25991048|FG000|Overall Study|Not eligible for initial SWOG study|10|||
13134477|NCT02756637|25991049|FG001|Overall Study|Not eligible for initial SWOG study|10|||
13134478|NCT02756637|25991048|FG000|Overall Study|No available NLR value|44|||
13134479|NCT02756637|25991049|FG001|Overall Study|No available NLR value|44|||
13134480|NCT02756637|25991048|FG000|Overall Study|Did not complete curative therapy|33|||
13134481|NCT02756637|25991049|FG001|Overall Study|Did not complete curative therapy|0|||
13134482|NCT02756611|25991062|FG000|Overall Study|Death|39|||
13134483|NCT02756611|25991062|FG000|Overall Study|Withdrawal by Subject|1|||
13134484|NCT02756611|25991062|FG000|Overall Study|Lost to Follow-up|2|||
13134485|NCT02756611|25991062|FG000|Overall Study|Other|7|||
13134486|NCT02756611|25991062|FG000|Overall Study|Missing|2|||
13134487|NCT02756611|25991062|FG000|Overall Study|Active on Study|205|||
13134488|NCT02756403|25991100|FG000|Overall Study|Unable to swallow medication|0|||
13134489|NCT02756403|25991101|FG001|Overall Study|Unable to swallow medication|1|||
13134490|NCT02756403|25991102|FG002|Overall Study|Unable to swallow medication|1|||
13134491|NCT02756403|25991103|FG003|Overall Study|Unable to swallow medication|1|||
13134492|NCT02756403|25991100|FG000|Overall Study|Did not complete Procedure|0|||
13134493|NCT02756403|25991101|FG001|Overall Study|Did not complete Procedure|1|||
13134494|NCT02756403|25991102|FG002|Overall Study|Did not complete Procedure|0|||
13134495|NCT02756403|25991103|FG003|Overall Study|Did not complete Procedure|0|||
13134496|NCT02756403|25991100|FG000|Overall Study|Changed Mind About Procedure|0|||
13134497|NCT02756403|25991101|FG001|Overall Study|Changed Mind About Procedure|0|||
13134498|NCT02756403|25991102|FG002|Overall Study|Changed Mind About Procedure|1|||
13134499|NCT02756403|25991103|FG003|Overall Study|Changed Mind About Procedure|0|||
13134500|NCT02756403|25991100|FG000|Overall Study|Protocol Violation|0|||
13134501|NCT02756403|25991101|FG001|Overall Study|Protocol Violation|1|||
13134502|NCT02756403|25991102|FG002|Overall Study|Protocol Violation|0|||
13134503|NCT02756403|25991103|FG003|Overall Study|Protocol Violation|1|||
13134504|NCT02756364|25991136|FG000|Overall Study|Site Terminated by Sponsor|24|||
13390954|NCT00683592|26775106|FG001|Overall Study|Physician Decision|1|||
13134505|NCT02756364|25991137|FG001|Overall Study|Site Terminated by Sponsor|30|||
13134506|NCT02756364|25991138|FG002|Overall Study|Site Terminated by Sponsor|21|||
13134507|NCT02756364|25991136|FG000|Overall Study|Death|20|||
13134508|NCT02756364|25991137|FG001|Overall Study|Death|15|||
13134509|NCT02756364|25991138|FG002|Overall Study|Death|18|||
13134510|NCT02756364|25991136|FG000|Overall Study|Withdrawal by Patient|2|||
13134511|NCT02756364|25991137|FG001|Overall Study|Withdrawal by Patient|1|||
13134512|NCT02756364|25991138|FG002|Overall Study|Withdrawal by Patient|8|||
13134513|NCT02756364|25991136|FG000|Overall Study|Lost to Follow-up|0|||
13134514|NCT02756364|25991137|FG001|Overall Study|Lost to Follow-up|1|||
13134515|NCT02756364|25991138|FG002|Overall Study|Lost to Follow-up|1|||
13134516|NCT02756338|25991149|FG000|Overall Study|Withdrawn by Investigator|1|||
13134517|NCT02756338|25991149|FG000|Overall Study|Device Replaced with Pacemaker|4|||
13134518|NCT02756182|25991166|FG000|Overall Study|StudyTechnical Difficulties|4|||
13134519|NCT02756078|25991187|FG000|Period 1|Unsatisfactory Lens Fitting|0|||
13134520|NCT02756078|25991188|FG001|Period 1|Unsatisfactory Lens Fitting|1|||
13134521|NCT02756078|25991187|FG000|Period 1|Lost to Follow-up|0|||
13134522|NCT02756078|25991188|FG001|Period 1|Lost to Follow-up|2|||
13134523|NCT02756078|25991187|FG000|Period 1|Protocol Violation|0|||
13134524|NCT02756078|25991188|FG001|Period 1|Protocol Violation|1|||
13134525|NCT02756078|25991187|FG000|Period 1|Adverse Event|1|||
13134526|NCT02756078|25991188|FG001|Period 1|Adverse Event|10|||
13134527|NCT02756078|25991187|FG000|Period 1|Withdrawal by Subject|6|||
13134528|NCT02756078|25991188|FG001|Period 1|Withdrawal by Subject|6|||
13134529|NCT02756078|25991187|FG000|Period 1|Lens Discomfort|2|||
13134530|NCT02756078|25991188|FG001|Period 1|Lens Discomfort|2|||
13134531|NCT02756078|25991187|FG000|Period 2|Adverse Event|3|||
13134532|NCT02756078|25991188|FG001|Period 2|Adverse Event|5|||
13134533|NCT02756078|25991187|FG000|Period 2|Unsatisfactory Lens Fitting|0|||
13134534|NCT02756078|25991188|FG001|Period 2|Unsatisfactory Lens Fitting|1|||
13134535|NCT02756078|25991187|FG000|Period 2|Withdrawal by Subject|3|||
13134536|NCT02756078|25991188|FG001|Period 2|Withdrawal by Subject|1|||
13134537|NCT02755831|25991207|FG000|Overall Study|Lost to Follow-up|3|||
13134538|NCT02755831|25991208|FG001|Overall Study|Lost to Follow-up|3|||
13134539|NCT02755818|25991255|FG000|Overall Study|Withdrawal by Subject|0|||
13134540|NCT02755818|25991256|FG001|Overall Study|Withdrawal by Subject|0|||
13390955|NCT00683592|26775105|FG000|Overall Study|Non-compliance|3|||
13134541|NCT02755818|25991257|FG002|Overall Study|Withdrawal by Subject|0|||
13134542|NCT02755818|25991258|FG003|Overall Study|Withdrawal by Subject|2|||
13134543|NCT02755818|25991255|FG000|Overall Study|withdrawal by PI|0|||
13134544|NCT02755818|25991256|FG001|Overall Study|withdrawal by PI|0|||
13134545|NCT02755818|25991257|FG002|Overall Study|withdrawal by PI|1|||
13134546|NCT02755818|25991258|FG003|Overall Study|withdrawal by PI|1|||
13134547|NCT02755805|25991277|FG000|Overall Study|Lost to Follow-up|1|||
13134548|NCT02755805|25991278|FG001|Overall Study|Lost to Follow-up|2|||
13134549|NCT02755805|25991277|FG000|Overall Study|Refused assessments|1|||
13134550|NCT02755805|25991278|FG001|Overall Study|Refused assessments|0|||
13134551|NCT02755805|25991277|FG000|Overall Study|Withdrawal by Subject|0|||
13134552|NCT02755805|25991278|FG001|Overall Study|Withdrawal by Subject|2|||
13134553|NCT02755649|25991350|FG000|Overall Study|Transitioned into OLE study|99|||
13134554|NCT02755649|25991351|FG001|Overall Study|Transitioned into OLE study|98|||
13134555|NCT02755649|25991352|FG002|Overall Study|Transitioned into OLE study|100|||
13134556|NCT02755649|25991350|FG000|Overall Study|Did Not Complete Follow-up Visits|1|||
13134557|NCT02755649|25991351|FG001|Overall Study|Did Not Complete Follow-up Visits|0|||
13134558|NCT02755649|25991352|FG002|Overall Study|Did Not Complete Follow-up Visits|0|||
13134559|NCT02755649|25991350|FG000|Overall Study|Physician Decision|0|||
13134560|NCT02755649|25991351|FG001|Overall Study|Physician Decision|0|||
13134561|NCT02755649|25991352|FG002|Overall Study|Physician Decision|2|||
13134562|NCT02755649|25991350|FG000|Overall Study|Withdrawal by Subject|0|||
13134563|NCT02755649|25991351|FG001|Overall Study|Withdrawal by Subject|1|||
13134564|NCT02755649|25991352|FG002|Overall Study|Withdrawal by Subject|0|||
13134565|NCT02755649|25991350|FG000|Overall Study|Undecided|1|||
13134566|NCT02755649|25991351|FG001|Overall Study|Undecided|0|||
13134567|NCT02755649|25991352|FG002|Overall Study|Undecided|0|||
13134568|NCT02755116|25991373|FG000|Overall Study|surgery converted to open, pt admitted|3|||
13134569|NCT02755116|25991374|FG001|Overall Study|surgery converted to open, pt admitted|1|||
13134570|NCT02755090|25991389|FG000|Overall Study|equipment malfunction|1|||
13134571|NCT02755090|25991390|FG001|Overall Study|equipment malfunction|0|||
13134572|NCT02754492|25991415|FG000|Overall Study|Protocol Violation|2|||
13134573|NCT02754492|25991416|FG001|Overall Study|Protocol Violation|2|||
13134574|NCT02754492|25991417|FG002|Overall Study|Protocol Violation|0|||
13134575|NCT02754492|25991418|FG003|Overall Study|Protocol Violation|1|||
13134576|NCT02754492|25991415|FG000|Overall Study|Withdrawal by Subject|2|||
13134577|NCT02754492|25991416|FG001|Overall Study|Withdrawal by Subject|0|||
13134578|NCT02754492|25991417|FG002|Overall Study|Withdrawal by Subject|0|||
13134579|NCT02754492|25991418|FG003|Overall Study|Withdrawal by Subject|0|||
13134580|NCT02754492|25991415|FG000|Overall Study|Equipment malfuntion|0|||
13134581|NCT02754492|25991416|FG001|Overall Study|Equipment malfuntion|0|||
13134582|NCT02754492|25991417|FG002|Overall Study|Equipment malfuntion|2|||
13134583|NCT02754492|25991418|FG003|Overall Study|Equipment malfuntion|5|||
13134584|NCT02754492|25991415|FG000|Overall Study|Adverse Event|0|||
13134585|NCT02754492|25991416|FG001|Overall Study|Adverse Event|0|||
13134586|NCT02754492|25991417|FG002|Overall Study|Adverse Event|0|||
13134587|NCT02754492|25991418|FG003|Overall Study|Adverse Event|13|||
13134588|NCT02754492|25991415|FG000|Overall Study|Venous access issues not resulting in AE|0|||
13134589|NCT02754492|25991416|FG001|Overall Study|Venous access issues not resulting in AE|0|||
13134590|NCT02754492|25991417|FG002|Overall Study|Venous access issues not resulting in AE|0|||
13134591|NCT02754492|25991418|FG003|Overall Study|Venous access issues not resulting in AE|4|||
13134592|NCT02754440|25991443|FG000|Overall Study|Protocol Violation|3|||
13134593|NCT02754440|25991444|FG001|Overall Study|Protocol Violation|2|||
13134594|NCT02754440|25991445|FG002|Overall Study|Protocol Violation|2|||
13134595|NCT02754440|25991446|FG003|Overall Study|Protocol Violation|6|||
13134596|NCT02754440|25991443|FG000|Overall Study|Adverse Event|3|||
13134597|NCT02754440|25991444|FG001|Overall Study|Adverse Event|1|||
13134598|NCT02754440|25991445|FG002|Overall Study|Adverse Event|0|||
13134599|NCT02754440|25991446|FG003|Overall Study|Adverse Event|9|||
13134600|NCT02754440|25991443|FG000|Overall Study|Withdrawal by Subject|0|||
13134601|NCT02754440|25991444|FG001|Overall Study|Withdrawal by Subject|0|||
13134602|NCT02754440|25991445|FG002|Overall Study|Withdrawal by Subject|0|||
13134603|NCT02754440|25991446|FG003|Overall Study|Withdrawal by Subject|1|||
13390956|NCT00683592|26775106|FG001|Overall Study|Non-compliance|5|||
13390957|NCT00683592|26775105|FG000|Overall Study|Other|1|||
13390958|NCT00683592|26775106|FG001|Overall Study|Other|1|||
13390959|NCT00683475|26775143|FG000|Overall Study|Withdrawal by Subject|1|||
13390960|NCT00683475|26775144|FG001|Overall Study|Withdrawal by Subject|0|||
13390961|NCT00683475|26775143|FG000|Overall Study|Never Treated: Adverse Event|2|||
13390962|NCT00683475|26775144|FG001|Overall Study|Never Treated: Adverse Event|3|||
13390963|NCT00683475|26775143|FG000|Overall Study|Never Treated: Progressive Disease|1|||
13390964|NCT00683475|26775144|FG001|Overall Study|Never Treated: Progressive Disease|0|||
13390965|NCT00683449|26775182|FG000|Overall Study|Lost to Follow-up|0|||
13390966|NCT00683449|26775183|FG001|Overall Study|Lost to Follow-up|1|||
13390967|NCT00683449|26775184|FG002|Overall Study|Lost to Follow-up|0|||
13390968|NCT00683449|26775185|FG003|Overall Study|Lost to Follow-up|0|||
13390969|NCT00683449|26775186|FG004|Overall Study|Lost to Follow-up|0|||
13390970|NCT00683384|26775192|FG000|Overall Study|Death|1|||
13390971|NCT00683384|26775192|FG000|Overall Study|Adverse Event|1|||
13390972|NCT00683293|26775207|FG000|Overall Study|Withdrawal by Subject|2|||
13390973|NCT00683293|26775208|FG001|Overall Study|Withdrawal by Subject|3|||
13390974|NCT00682929|26775385|FG000|Overall Study|Adverse Event|4|||
13390975|NCT00682929|26775386|FG001|Overall Study|Adverse Event|1|||
13390976|NCT00682929|26775387|FG002|Overall Study|Adverse Event|1|||
13390977|NCT00682929|26775385|FG000|Overall Study|Withdrawal by Subject|1|||
13390978|NCT00682929|26775386|FG001|Overall Study|Withdrawal by Subject|2|||
13390979|NCT00682929|26775387|FG002|Overall Study|Withdrawal by Subject|1|||
13390980|NCT00682929|26775385|FG000|Overall Study|dosing compliance < 80%|0|||
13390981|NCT00682929|26775386|FG001|Overall Study|dosing compliance < 80%|2|||
13390982|NCT00682929|26775387|FG002|Overall Study|dosing compliance < 80%|0|||
13390983|NCT00682929|26775385|FG000|Overall Study|lag in DEA renewal|1|||
13390984|NCT00682929|26775386|FG001|Overall Study|lag in DEA renewal|0|||
13390985|NCT00682929|26775387|FG002|Overall Study|lag in DEA renewal|0|||
13390986|NCT00682890|26775402|FG000|Overall Study|Lost to Follow-up|1|||
13390987|NCT00682890|26775403|FG001|Overall Study|Lost to Follow-up|1|||
13390988|NCT00682890|26775402|FG000|Overall Study|subject moved away|0|||
13390989|NCT00682890|26775403|FG001|Overall Study|subject moved away|1|||
13390990|NCT00682890|26775402|FG000|Overall Study|heavy menstrual bleeding|1|||
13390991|NCT00682890|26775403|FG001|Overall Study|heavy menstrual bleeding|0|||
13390992|NCT00682786|26775444|FG000|Overall Study|Withdrawal by Subject|2|||
13390993|NCT00682786|26775445|FG001|Overall Study|Withdrawal by Subject|2|||
13390994|NCT00682786|26775444|FG000|Overall Study|Did not receive irinotecan|0|||
13390995|NCT00682786|26775445|FG001|Overall Study|Did not receive irinotecan|1|||
13390996|NCT00682643|26775484|FG000|Overall Study|Adverse Event|12|||
13390997|NCT00682643|26775485|FG001|Overall Study|Adverse Event|23|||
13390998|NCT00682643|26775484|FG000|Overall Study|Lack of Efficacy|2|||
13390999|NCT00682643|26775485|FG001|Overall Study|Lack of Efficacy|0|||
13391000|NCT00682643|26775484|FG000|Overall Study|Protocol Violation|38|||
13391001|NCT00682643|26775485|FG001|Overall Study|Protocol Violation|76|||
13391002|NCT00682643|26775484|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
13391003|NCT00682643|26775485|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4|||
13391004|NCT00682643|26775484|FG000|Overall Study|Lost to Follow-up|1|||
13391005|NCT00682643|26775485|FG001|Overall Study|Lost to Follow-up|6|||
13391006|NCT00682643|26775484|FG000|Overall Study|Physician Decision|2|||
13391007|NCT00682643|26775485|FG001|Overall Study|Physician Decision|6|||
13391008|NCT00682643|26775484|FG000|Overall Study|Withdrawal by Subject|19|||
13391009|NCT00682643|26775485|FG001|Overall Study|Withdrawal by Subject|53|||
13391010|NCT00682643|26775484|FG000|Overall Study|Did Not Receive Study Drug|1|||
13391011|NCT00682643|26775485|FG001|Overall Study|Did Not Receive Study Drug|1|||
13391012|NCT00682539|26775506|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3|||
13391013|NCT00682539|26775507|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1|||
13391014|NCT00682539|26775508|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0|||
13391015|NCT00682539|26775506|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0|||
13391016|NCT00682539|26775507|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3|||
13391017|NCT00682539|26775508|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8|||
13391018|NCT00682461|26775529|FG000|Overall Study|Adverse Event|5|||
13391019|NCT00682461|26775530|FG001|Overall Study|Adverse Event|7|||
13391020|NCT00682461|26775529|FG000|Overall Study|Lost to Follow-up|8|||
13391021|NCT00682461|26775530|FG001|Overall Study|Lost to Follow-up|5|||
13391022|NCT00682461|26775529|FG000|Overall Study|Withdrawal by Subject|12|||
13391023|NCT00682461|26775530|FG001|Overall Study|Withdrawal by Subject|19|||
13391024|NCT00682448|26775545|FG000|Overall Study|Adverse Event|1|||
13391025|NCT00682448|26775546|FG001|Overall Study|Adverse Event|2|||
13391026|NCT00682448|26775545|FG000|Overall Study|Lack of Efficacy|1|||
13391027|NCT00682448|26775546|FG001|Overall Study|Lack of Efficacy|0|||
13391028|NCT00682448|26775545|FG000|Overall Study|Lost to Follow-up|1|||
13391029|NCT00682448|26775546|FG001|Overall Study|Lost to Follow-up|3|||
13391030|NCT00682448|26775545|FG000|Overall Study|Pregnancy|0|||
13391031|NCT00682448|26775546|FG001|Overall Study|Pregnancy|1|||
13391032|NCT00682448|26775545|FG000|Overall Study|Withdrawal by Subject|2|||
13391033|NCT00682448|26775546|FG001|Overall Study|Withdrawal by Subject|0|||
13391034|NCT00682435|26775555|FG000|Overall Study|Insufficient data|5|||
13391035|NCT00682435|26775555|FG000|Overall Study|Erroneously enrolled twice|2|||
13134604|NCT02754440|25991443|FG000|Overall Study|Equipment failure|0|||
13134605|NCT02754440|25991444|FG001|Overall Study|Equipment failure|5|||
13134606|NCT02754440|25991445|FG002|Overall Study|Equipment failure|5|||
13134607|NCT02754440|25991446|FG003|Overall Study|Equipment failure|7|||
13134608|NCT02754440|25991443|FG000|Overall Study|Subject issues not resulting in AE|0|||
13134609|NCT02754440|25991444|FG001|Overall Study|Subject issues not resulting in AE|0|||
13134610|NCT02754440|25991445|FG002|Overall Study|Subject issues not resulting in AE|0|||
13134611|NCT02754440|25991446|FG003|Overall Study|Subject issues not resulting in AE|12|||
13134612|NCT02753946|25991463|FG000|Overall Study|Adverse Event|7|||
13134613|NCT02753946|25991464|FG001|Overall Study|Adverse Event|6|||
13134614|NCT02753946|25991463|FG000|Overall Study|Withdrawal by Subject|6|||
13134615|NCT02753946|25991464|FG001|Overall Study|Withdrawal by Subject|1|||
13134616|NCT02753946|25991463|FG000|Overall Study|Lack of Efficacy|1|||
13134617|NCT02753946|25991464|FG001|Overall Study|Lack of Efficacy|0|||
13134618|NCT02753946|25991463|FG000|Overall Study|Physician Decision|0|||
13134619|NCT02753946|25991464|FG001|Overall Study|Physician Decision|2|||
13134620|NCT02753816|25991484|FG000|Overall Study|Protocol Violation|0|||
13134621|NCT02753816|25991485|FG001|Overall Study|Protocol Violation|1|||
13134622|NCT02753816|25991486|FG002|Overall Study|Protocol Violation|0|||
13134623|NCT02753595|25991499|FG000|Overall Study|Sponsor termination|2|||
13134624|NCT02753595|25991500|FG001|Overall Study|Sponsor termination|2|||
13134625|NCT02753400|25991513|FG000|Overall Study|Adverse Event|3|||
13134626|NCT02753400|25991514|FG001|Overall Study|Adverse Event|0|||
13134627|NCT02753400|25991513|FG000|Overall Study|Withdrawal by Subject|2|||
13134628|NCT02753400|25991514|FG001|Overall Study|Withdrawal by Subject|1|||
13134629|NCT02753127|25991539|FG000|Overall Study|Lost to Follow-up|13|||
13134630|NCT02753127|25991540|FG001|Overall Study|Lost to Follow-up|11|||
13134631|NCT02753127|25991539|FG000|Overall Study|Withdrawal by Subject|37|||
13134632|NCT02753127|25991540|FG001|Overall Study|Withdrawal by Subject|47|||
13134633|NCT02753127|25991539|FG000|Overall Study|Other|3|||
13134634|NCT02753127|25991540|FG001|Overall Study|Other|8|||
13134635|NCT02753127|25991539|FG000|Overall Study|Hospice|0|||
13134636|NCT02753127|25991540|FG001|Overall Study|Hospice|2|||
13134637|NCT02753075|25991575|FG000|Overall Study|Adverse Event|2|||
13134638|NCT02753075|25991576|FG001|Overall Study|Adverse Event|1|||
13134639|NCT02753075|25991577|FG002|Overall Study|Adverse Event|0|||
13134640|NCT02753075|25991575|FG000|Overall Study|Lost to Follow-up|2|||
13134641|NCT02753075|25991576|FG001|Overall Study|Lost to Follow-up|0|||
13134642|NCT02753075|25991577|FG002|Overall Study|Lost to Follow-up|0|||
13134643|NCT02753075|25991575|FG000|Overall Study|Withdrawal of Consent|1|||
13134644|NCT02753075|25991576|FG001|Overall Study|Withdrawal of Consent|1|||
13391036|NCT00681863|26775602|FG000|Overall Study|Adverse Event|1|||
13391037|NCT00681863|26775602|FG000|Overall Study|Lost to Follow-up|2|||
13391038|NCT00681863|26775602|FG000|Overall Study|Lack of Efficacy|2|||
13391039|NCT00681863|26775602|FG000|Overall Study|Other|18|||
13391040|NCT00681824|26775628|FG000|Overall Study|withdrawn by investigator|0|||
13391041|NCT00681824|26775629|FG001|Overall Study|withdrawn by investigator|0|||
13391042|NCT00681824|26775630|FG002|Overall Study|withdrawn by investigator|1|||
13391043|NCT00681824|26775628|FG000|Overall Study|scheduling conflict|1|||
13391044|NCT00681824|26775629|FG001|Overall Study|scheduling conflict|0|||
13391045|NCT00681824|26775630|FG002|Overall Study|scheduling conflict|0|||
13391046|NCT00681824|26775628|FG000|Overall Study|Death|0|||
13391047|NCT00681824|26775629|FG001|Overall Study|Death|1|||
13391048|NCT00681824|26775630|FG002|Overall Study|Death|0|||
13391049|NCT00681811|26775665|FG000|Overall Study|Adverse Event|1|||
13391050|NCT00681811|26775666|FG001|Overall Study|Adverse Event|1|||
13391051|NCT00681811|26775665|FG000|Overall Study|Withdrawal by Subject|2|||
13391052|NCT00681811|26775666|FG001|Overall Study|Withdrawal by Subject|2|||
13391053|NCT00681811|26775665|FG000|Overall Study|Non-compliance|0|||
13391054|NCT00681811|26775666|FG001|Overall Study|Non-compliance|1|||
13391055|NCT00681668|26775675|FG000|Overall Study|Protocol Violation|1|||
13391056|NCT00681668|26775675|FG000|Overall Study|Withdrawal by Subject|1|||
13391057|NCT00681629|26775726|FG000|Overall Study|Study termination|4|||
13391058|NCT00681629|26775727|FG001|Overall Study|Study termination|2|||
13391059|NCT00681629|26775726|FG000|Overall Study|Adverse Event|1|||
13391060|NCT00681629|26775727|FG001|Overall Study|Adverse Event|0|||
13474791|NCT02288247|26996577|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8|||
13474792|NCT02288247|26996578|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4|||
13474793|NCT02288247|26996577|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1|||
13474794|NCT02288247|26996578|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0|||
13474795|NCT02288247|26996577|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87|||
13474796|NCT02288247|26996578|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94|||
13474797|NCT02288247|26996577|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2|||
13474798|NCT02288247|26996578|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1|||
13474799|NCT02288247|26996577|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
13474800|NCT02288247|26996578|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
13474801|NCT02288247|26996577|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|20|||
13474802|NCT02288247|26996578|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
13474803|NCT02288247|26996577|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1|||
13474804|NCT02288247|26996578|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0|||
13474805|NCT02281383|26996585|FG000|Overall Study|Not Treated|3|||
13474806|NCT02281383|26996585|FG000|Overall Study|Inadequate testing|2|||
13474821|NCT02177695|26996629|FG000|ITT Analysis|Ineligible|5|||
13474822|NCT02177695|26996630|FG001|ITT Analysis|Ineligible|5|||
13474823|NCT02177695|26996629|FG000|Primary COXEN Analysis|inadequate tissue submitted|5|||
13474824|NCT02177695|26996630|FG001|Primary COXEN Analysis|inadequate tissue submitted|6|||
13474825|NCT02177695|26996629|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15|||
13474826|NCT02177695|26996630|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8|||
13474827|NCT02177695|26996629|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13|||
13474828|NCT02177695|26996630|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13|||
13474829|NCT02158091|26996648|FG000|Overall Study|DLT|2|||
13474830|NCT02158091|26996649|FG001|Overall Study|DLT|1|||
13474831|NCT02158091|26996650|FG002|Overall Study|DLT|0|||
13474832|NCT02152995|26996681|FG000|Overall Study|Withdrawal by Subject|1|||
13474833|NCT02152995|26996682|FG001|Overall Study|Withdrawal by Subject|0|||
13474834|NCT02120352|26996834|FG000|Induction Period (20 Weeks)|Adverse Event|3|||
13474835|NCT02120352|26996835|FG001|Induction Period (20 Weeks)|Adverse Event|0|||
13474836|NCT02120352|26996836|FG002|Induction Period (20 Weeks)|Adverse Event|0|||
13474837|NCT02120352|26996837|FG003|Induction Period (20 Weeks)|Adverse Event|0|||
13474838|NCT02120352|26996834|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5|||
13474839|NCT02120352|26996835|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0|||
13134645|NCT02753075|25991577|FG002|Overall Study|Withdrawal of Consent|3|||
13134646|NCT02753075|25991575|FG000|Overall Study|Physician Decision|3|||
13134647|NCT02753075|25991576|FG001|Overall Study|Physician Decision|1|||
13134648|NCT02753075|25991577|FG002|Overall Study|Physician Decision|0|||
13134649|NCT02752958|25991648|FG000|Overall Study|Adverse Event|3|||
13134650|NCT02752958|25991648|FG000|Overall Study|Lost to Follow-up|1|||
13134651|NCT02752958|25991648|FG000|Overall Study|Protocol Violation|1|||
13134652|NCT02752958|25991648|FG000|Overall Study|Withdrawal by Subject|2|||
13134653|NCT02752958|25991648|FG000|Overall Study|Other (Reason not specified)|2|||
13134654|NCT02752906|25991667|FG000|Overall Study|Protocol Violation|2|||
13134655|NCT02752906|25991668|FG001|Overall Study|Protocol Violation|1|||
13134656|NCT02752906|25991667|FG000|Overall Study|Withdrawal by Subject|2|||
13134657|NCT02752906|25991668|FG001|Overall Study|Withdrawal by Subject|2|||
13134658|NCT02752906|25991667|FG000|Overall Study|Lost to Follow-up|3|||
13134659|NCT02752906|25991668|FG001|Overall Study|Lost to Follow-up|2|||
13134660|NCT02752802|25991684|FG000|Overall Study|Contrast Volume Not Collected|1|||
13134661|NCT02752802|25991685|FG001|Overall Study|Contrast Volume Not Collected|0|||
13134662|NCT02752776|25991741|FG000|Overall Study|Adverse Event|15|||
13134663|NCT02752776|25991742|FG001|Overall Study|Adverse Event|23|||
13134664|NCT02752776|25991743|FG002|Overall Study|Adverse Event|11|||
13134665|NCT02752776|25991741|FG000|Overall Study|Lack of Efficacy|2|||
13134666|NCT02752776|25991742|FG001|Overall Study|Lack of Efficacy|6|||
13134667|NCT02752776|25991743|FG002|Overall Study|Lack of Efficacy|14|||
13134668|NCT02752776|25991741|FG000|Overall Study|Lost to Follow-up|11|||
13134669|NCT02752776|25991742|FG001|Overall Study|Lost to Follow-up|12|||
13134670|NCT02752776|25991743|FG002|Overall Study|Lost to Follow-up|4|||
13134671|NCT02752776|25991741|FG000|Overall Study|Non-compliance with study treatment|0|||
13134672|NCT02752776|25991742|FG001|Overall Study|Non-compliance with study treatment|0|||
13134673|NCT02752776|25991743|FG002|Overall Study|Non-compliance with study treatment|1|||
13134674|NCT02752776|25991741|FG000|Overall Study|Physician Decision|2|||
13134675|NCT02752776|25991742|FG001|Overall Study|Physician Decision|6|||
13134676|NCT02752776|25991743|FG002|Overall Study|Physician Decision|2|||
13134677|NCT02752776|25991741|FG000|Overall Study|Pregnancy|1|||
13134678|NCT02752776|25991742|FG001|Overall Study|Pregnancy|6|||
13134679|NCT02752776|25991743|FG002|Overall Study|Pregnancy|3|||
13134680|NCT02752776|25991741|FG000|Overall Study|Protocol Violation|10|||
13134681|NCT02752776|25991742|FG001|Overall Study|Protocol Violation|13|||
13134682|NCT02752776|25991743|FG002|Overall Study|Protocol Violation|6|||
13134683|NCT02752776|25991741|FG000|Overall Study|Subject/guardian decision|8|||
13134684|NCT02752776|25991742|FG001|Overall Study|Subject/guardian decision|6|||
13134685|NCT02752776|25991743|FG002|Overall Study|Subject/guardian decision|4|||
13134686|NCT02752776|25991741|FG000|Overall Study|Death|0|||
13134687|NCT02752776|25991742|FG001|Overall Study|Death|0|||
13134688|NCT02752776|25991743|FG002|Overall Study|Death|1|||
13134689|NCT02752776|25991741|FG000|Overall Study|Withdrawal by Subject|3|||
13134690|NCT02752776|25991742|FG001|Overall Study|Withdrawal by Subject|4|||
13134691|NCT02752776|25991743|FG002|Overall Study|Withdrawal by Subject|2|||
13134692|NCT02752633|25991749|FG000|Overall Study|Withdrawal by Subject|1|||
13134693|NCT02752087|25991760|FG000|Washout|Physician Decision|1|||
13134694|NCT02752087|25991761|FG001|Washout|Physician Decision|0|||
13134695|NCT02752074|25991790|FG000|Overall Study|Lost to Follow-up|1|||
13134696|NCT02752074|25991791|FG001|Overall Study|Lost to Follow-up|4|||
13134697|NCT02752074|25991790|FG000|Overall Study|Death|146|||
13134698|NCT02752074|25991791|FG001|Overall Study|Death|129|||
13134699|NCT02752074|25991790|FG000|Overall Study|Withdrawal by Subject|9|||
13134700|NCT02752074|25991791|FG001|Overall Study|Withdrawal by Subject|10|||
13135092|NCT02746575|25993554|FG000|Overall Study|Surgery cancelled or time chaned|13|||
13135093|NCT02746575|25993554|FG000|Overall Study|Received epidural|10|||
13135094|NCT02746575|25993554|FG000|Overall Study|Withdrawal by Subject|3|||
13135095|NCT02746575|25993554|FG000|Overall Study|Bradycardia/hypotension|9|||
13135096|NCT02746575|25993554|FG000|Overall Study|Study paused|8|||
13135097|NCT02746575|25993554|FG000|Overall Study|put on beta-blocker|3|||
13135098|NCT02746575|25993554|FG000|Overall Study|type of surgery|1|||
13135099|NCT02746575|25993554|FG000|Overall Study|typ of surgery|1|||
13135100|NCT02746575|25993554|FG000|Overall Study|PI unavailable|1|||
13135101|NCT02746575|25993554|FG000|Overall Study|Unknown history of CVA|1|||
13135102|NCT02745392|25993581|FG000|Overall Study|Lost to Follow-up|0|||
13135103|NCT02745392|25993582|FG001|Overall Study|Lost to Follow-up|1|||
13135104|NCT02745392|25993583|FG002|Overall Study|Lost to Follow-up|0|||
13134701|NCT02752048|25991818|FG000|Overall Study|Withdrawal by Subject|0|||
13134702|NCT02752048|25991819|FG001|Overall Study|Withdrawal by Subject|0|||
13134703|NCT02752048|25991820|FG002|Overall Study|Withdrawal by Subject|3|||
13134704|NCT02751983|25991846|FG000|Treatment|Stopped ACT, but Remained in study|2|||
13134705|NCT02751983|25991847|FG001|Treatment|Stopped ACT, but Remained in study|0|||
13134706|NCT02751983|25991846|FG000|Treatment|Discharged prior to beginning ACT|2|||
13134707|NCT02751983|25991847|FG001|Treatment|Discharged prior to beginning ACT|0|||
13134708|NCT02751983|25991846|FG000|Post-Treatment Assessment|Lost to Follow-up|5|||
13134709|NCT02751983|25991847|FG001|Post-Treatment Assessment|Lost to Follow-up|0|||
13134710|NCT02751983|25991846|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14|||
13134711|NCT02751983|25991847|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12|||
13134712|NCT02751983|25991846|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12|||
13134713|NCT02751983|25991847|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16|||
13134714|NCT02751931|25991932|FG000|Overall Study|Adverse Event|3|||
13134715|NCT02751931|25991933|FG001|Overall Study|Adverse Event|0|||
13134716|NCT02751931|25991932|FG000|Overall Study|Other: Miscelleneous|10|||
13134717|NCT02751931|25991933|FG001|Overall Study|Other: Miscelleneous|8|||
13134718|NCT02751827|25991951|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
13134719|NCT02751827|25991952|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
13134720|NCT02751827|25991953|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1|||
13134721|NCT02751580|25991966|FG000|Overall Study|Lost to Follow-up|4|||
13134722|NCT02751580|25991966|FG000|Overall Study|Death|2|||
13134723|NCT02751502|25991973|FG000|Overall Study|Lack of funding|4|||
13134724|NCT02751450|25991992|FG000|Overall Study|Adverse Event|1|||
13134725|NCT02751450|25991993|FG001|Overall Study|Adverse Event|0|||
13134726|NCT02751424|25992164|FG000|Part 2|Adverse Event|0|||
13134727|NCT02751424|25992165|FG001|Part 2|Adverse Event|0|||
13134728|NCT02751424|25992166|FG002|Part 2|Adverse Event|0|||
13134729|NCT02751424|25992167|FG003|Part 2|Adverse Event|0|||
13134730|NCT02751424|25992168|FG004|Part 2|Adverse Event|0|||
13134731|NCT02751424|25992169|FG005|Part 2|Adverse Event|0|||
13134732|NCT02751424|25992170|FG006|Part 2|Adverse Event|0|||
13134733|NCT02751424|25992171|FG007|Part 2|Adverse Event|5|||
13134734|NCT02751424|25992172|FG008|Part 2|Adverse Event|0|||
13134735|NCT02751359|25992188|FG000|Overall Study|Lost to Follow-up|1|||
13134736|NCT02751320|25992226|FG000|Overall Study|Adverse Event|2|||
13134737|NCT02751320|25992226|FG000|Overall Study|Withdrawal by Subject|1|||
13134738|NCT02750943|25992247|FG000|Overall Study|Lost to Follow-up|1|||
13134739|NCT02750943|25992248|FG001|Overall Study|Lost to Follow-up|2|||
13134740|NCT02750943|25992247|FG000|Overall Study|Withdrawal by Subject|5|||
13134741|NCT02750943|25992248|FG001|Overall Study|Withdrawal by Subject|7|||
13134742|NCT02750930|25992262|FG000|Overall Study|Study closed/terminated|8|||
13134743|NCT02750813|25992274|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1|||
13134744|NCT02750813|25992275|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0|||
13134745|NCT02750813|25992274|FG000|Period 1, First 14 Days of Wear|Reason not given|0|||
13134746|NCT02750813|25992275|FG001|Period 1, First 14 Days of Wear|Reason not given|1|||
13134747|NCT02750800|25992388|FG000|Overall Study|Adverse Event|18|||
13134748|NCT02750800|25992388|FG000|Overall Study|Lost to Follow-up|12|||
13134749|NCT02750800|25992388|FG000|Overall Study|Investigator decision|53|||
13134750|NCT02750800|25992388|FG000|Overall Study|Patient request|12|||
13134751|NCT02750800|25992388|FG000|Overall Study|Other, not specified|3|||
13134752|NCT02750761|25992503|FG000|Overall Study|Lost to Follow-up|0|||
13134753|NCT02750761|25992504|FG001|Overall Study|Lost to Follow-up|0|||
13134754|NCT02750761|25992505|FG002|Overall Study|Lost to Follow-up|1|||
13134755|NCT02750761|25992506|FG003|Overall Study|Lost to Follow-up|0|||
13134756|NCT02750761|25992507|FG004|Overall Study|Lost to Follow-up|0|||
13134757|NCT02750761|25992508|FG005|Overall Study|Lost to Follow-up|0|||
13134758|NCT02750709|25992541|FG000|Treatment Period 1|Adverse Event|0|||
13134759|NCT02750709|25992542|FG001|Treatment Period 1|Adverse Event|0|||
13134760|NCT02750709|25992543|FG002|Treatment Period 1|Adverse Event|0|||
13134761|NCT02750709|25992544|FG003|Treatment Period 1|Adverse Event|0|||
13134762|NCT02750709|25992545|FG004|Treatment Period 1|Adverse Event|0|||
13134763|NCT02750709|25992546|FG005|Treatment Period 1|Adverse Event|1|||
13134764|NCT02750618|25992564|FG000|Overall Study|Withdrawal by Subject|1|||
13134765|NCT02750592|25992585|FG000|Overall Study|Adverse Event|3|||
13134766|NCT02750592|25992585|FG000|Overall Study|Lack of Efficacy|2|||
13134767|NCT02750514|25992661|FG000|Track 1|Disease progression|20|||
13134768|NCT02750514|25992662|FG001|Track 1|Disease progression|1|||
13134769|NCT02750514|25992663|FG002|Track 1|Disease progression|0|||
13134770|NCT02750514|25992664|FG003|Track 1|Disease progression|1|||
13134771|NCT02750514|25992665|FG004|Track 1|Disease progression|0|||
13134772|NCT02750514|25992661|FG000|Track 1|Adverse event unrelated to study drug|1|||
13134773|NCT02750514|25992662|FG001|Track 1|Adverse event unrelated to study drug|0|||
13134774|NCT02750514|25992663|FG002|Track 1|Adverse event unrelated to study drug|0|||
13134775|NCT02750514|25992664|FG003|Track 1|Adverse event unrelated to study drug|0|||
13134776|NCT02750514|25992665|FG004|Track 1|Adverse event unrelated to study drug|0|||
13134777|NCT02750514|25992661|FG000|Track 1|Study drug toxicity|4|||
13134778|NCT02750514|25992662|FG001|Track 1|Study drug toxicity|1|||
13134779|NCT02750514|25992663|FG002|Track 1|Study drug toxicity|0|||
13134780|NCT02750514|25992664|FG003|Track 1|Study drug toxicity|1|||
13134781|NCT02750514|25992665|FG004|Track 1|Study drug toxicity|0|||
13134782|NCT02750514|25992661|FG000|Track 1|Participant request to discontinue|1|||
13134783|NCT02750514|25992662|FG001|Track 1|Participant request to discontinue|0|||
13134784|NCT02750514|25992663|FG002|Track 1|Participant request to discontinue|0|||
13134785|NCT02750514|25992664|FG003|Track 1|Participant request to discontinue|0|||
13134786|NCT02750514|25992665|FG004|Track 1|Participant request to discontinue|0|||
13134787|NCT02750514|25992661|FG000|Track 1|Other reasons|1|||
13134788|NCT02750514|25992662|FG001|Track 1|Other reasons|0|||
13134789|NCT02750514|25992663|FG002|Track 1|Other reasons|0|||
13134790|NCT02750514|25992664|FG003|Track 1|Other reasons|0|||
13134791|NCT02750514|25992665|FG004|Track 1|Other reasons|0|||
13134792|NCT02750514|25992661|FG000|Track 2|Disease progression|4|||
13134793|NCT02750514|25992662|FG001|Track 2|Disease progression|5|||
13134794|NCT02750514|25992663|FG002|Track 2|Disease progression|2|||
13134795|NCT02750514|25992664|FG003|Track 2|Disease progression|5|||
13134796|NCT02750514|25992665|FG004|Track 2|Disease progression|0|||
13134797|NCT02750514|25992661|FG000|Track 2|Adverse event unrelated to study drug|1|||
13134798|NCT02750514|25992662|FG001|Track 2|Adverse event unrelated to study drug|0|||
13134799|NCT02750514|25992663|FG002|Track 2|Adverse event unrelated to study drug|0|||
13134800|NCT02750514|25992664|FG003|Track 2|Adverse event unrelated to study drug|0|||
13134801|NCT02750514|25992665|FG004|Track 2|Adverse event unrelated to study drug|0|||
13134802|NCT02750514|25992661|FG000|Track 2|Study drug toxicity|1|||
13134803|NCT02750514|25992662|FG001|Track 2|Study drug toxicity|2|||
13134804|NCT02750514|25992663|FG002|Track 2|Study drug toxicity|0|||
13134805|NCT02750514|25992664|FG003|Track 2|Study drug toxicity|2|||
13134806|NCT02750514|25992665|FG004|Track 2|Study drug toxicity|0|||
13134807|NCT02750514|25992661|FG000|Track 2|Participant withdrew consent|0|||
13134808|NCT02750514|25992662|FG001|Track 2|Participant withdrew consent|1|||
13134809|NCT02750514|25992663|FG002|Track 2|Participant withdrew consent|0|||
13134810|NCT02750514|25992664|FG003|Track 2|Participant withdrew consent|0|||
13134811|NCT02750514|25992665|FG004|Track 2|Participant withdrew consent|0|||
13134812|NCT02750514|25992661|FG000|Track 3|Disease progression|0|||
13134813|NCT02750514|25992662|FG001|Track 3|Disease progression|24|||
13134814|NCT02750514|25992663|FG002|Track 3|Disease progression|13|||
13391061|NCT00681590|26775742|FG000|Overall Study|Withdrawal by Subject|2|||
13391062|NCT00681590|26775743|FG001|Overall Study|Withdrawal by Subject|12|||
13391063|NCT00681564|26775778|FG000|Overall Study|Lost to Follow-up|6|||
13391064|NCT00681564|26775779|FG001|Overall Study|Lost to Follow-up|6|||
13391065|NCT00681564|26775778|FG000|Overall Study|Withdrawal by Subject|0|||
13391066|NCT00681564|26775779|FG001|Overall Study|Withdrawal by Subject|1|||
13391067|NCT00681564|26775778|FG000|Overall Study|Death|0|||
13391068|NCT00681564|26775779|FG001|Overall Study|Death|1|||
13134815|NCT02750514|25992664|FG003|Track 3|Disease progression|14|||
13474840|NCT02120352|26996836|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0|||
13474841|NCT02120352|26996837|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0|||
13474842|NCT02120352|26996834|FG000|Induction Period (20 Weeks)|Protocol Violation|2|||
13474843|NCT02120352|26996835|FG001|Induction Period (20 Weeks)|Protocol Violation|0|||
13474844|NCT02120352|26996836|FG002|Induction Period (20 Weeks)|Protocol Violation|0|||
13474845|NCT02120352|26996837|FG003|Induction Period (20 Weeks)|Protocol Violation|0|||
13474846|NCT02120352|26996834|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3|||
13474847|NCT02120352|26996835|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
13134816|NCT02750514|25992665|FG004|Track 3|Disease progression|0|||
13134817|NCT02750514|25992661|FG000|Track 3|Adverse event unrelated to study drug|0|||
13134818|NCT02750514|25992662|FG001|Track 3|Adverse event unrelated to study drug|1|||
13134819|NCT02750514|25992663|FG002|Track 3|Adverse event unrelated to study drug|1|||
13134820|NCT02750514|25992664|FG003|Track 3|Adverse event unrelated to study drug|1|||
13134821|NCT02750514|25992665|FG004|Track 3|Adverse event unrelated to study drug|0|||
13134822|NCT02750514|25992661|FG000|Track 3|Study drug toxicity|0|||
13134823|NCT02750514|25992662|FG001|Track 3|Study drug toxicity|3|||
13134824|NCT02750514|25992663|FG002|Track 3|Study drug toxicity|0|||
13134825|NCT02750514|25992664|FG003|Track 3|Study drug toxicity|1|||
13134826|NCT02750514|25992665|FG004|Track 3|Study drug toxicity|0|||
13134827|NCT02750514|25992661|FG000|Track 3|Participant request to discontinue|0|||
13134828|NCT02750514|25992662|FG001|Track 3|Participant request to discontinue|2|||
13134829|NCT02750514|25992663|FG002|Track 3|Participant request to discontinue|0|||
13134830|NCT02750514|25992664|FG003|Track 3|Participant request to discontinue|0|||
13134831|NCT02750514|25992665|FG004|Track 3|Participant request to discontinue|0|||
13134832|NCT02750514|25992661|FG000|Track 3|Participant withdrew consent|0|||
13134833|NCT02750514|25992662|FG001|Track 3|Participant withdrew consent|3|||
13134834|NCT02750514|25992663|FG002|Track 3|Participant withdrew consent|1|||
13134835|NCT02750514|25992664|FG003|Track 3|Participant withdrew consent|0|||
13134836|NCT02750514|25992665|FG004|Track 3|Participant withdrew consent|0|||
13134837|NCT02750514|25992661|FG000|Track 3|Other reasons|0|||
13134838|NCT02750514|25992662|FG001|Track 3|Other reasons|3|||
13134839|NCT02750514|25992663|FG002|Track 3|Other reasons|0|||
13134840|NCT02750514|25992664|FG003|Track 3|Other reasons|0|||
13134841|NCT02750514|25992665|FG004|Track 3|Other reasons|0|||
13134842|NCT02750514|25992661|FG000|Track 4|Study drug toxicity|0|||
13134843|NCT02750514|25992662|FG001|Track 4|Study drug toxicity|6|||
13134844|NCT02750514|25992663|FG002|Track 4|Study drug toxicity|0|||
13134845|NCT02750514|25992664|FG003|Track 4|Study drug toxicity|5|||
13134846|NCT02750514|25992665|FG004|Track 4|Study drug toxicity|0|||
13134847|NCT02750514|25992661|FG000|Track 4|Participant request to discontinue|0|||
13134848|NCT02750514|25992662|FG001|Track 4|Participant request to discontinue|1|||
13134849|NCT02750514|25992663|FG002|Track 4|Participant request to discontinue|0|||
13134850|NCT02750514|25992664|FG003|Track 4|Participant request to discontinue|1|||
13134851|NCT02750514|25992665|FG004|Track 4|Participant request to discontinue|0|||
13134852|NCT02750514|25992661|FG000|Track 4|Participant withdrew consent|0|||
13134853|NCT02750514|25992662|FG001|Track 4|Participant withdrew consent|1|||
13134854|NCT02750514|25992663|FG002|Track 4|Participant withdrew consent|0|||
13134855|NCT02750514|25992664|FG003|Track 4|Participant withdrew consent|0|||
13134856|NCT02750514|25992665|FG004|Track 4|Participant withdrew consent|0|||
13134857|NCT02750514|25992661|FG000|Track 4|Other reasons|0|||
13134858|NCT02750514|25992662|FG001|Track 4|Other reasons|5|||
13134859|NCT02750514|25992663|FG002|Track 4|Other reasons|0|||
13134860|NCT02750514|25992664|FG003|Track 4|Other reasons|3|||
13134861|NCT02750514|25992665|FG004|Track 4|Other reasons|0|||
13134862|NCT02750514|25992661|FG000|Track 4|Disease progression|0|||
13134863|NCT02750514|25992662|FG001|Track 4|Disease progression|33|||
13134864|NCT02750514|25992663|FG002|Track 4|Disease progression|0|||
13134865|NCT02750514|25992664|FG003|Track 4|Disease progression|32|||
13134866|NCT02750514|25992665|FG004|Track 4|Disease progression|0|||
13134867|NCT02750514|25992661|FG000|Track 4|Adverse event unrelated to study drug|0|||
13134868|NCT02750514|25992662|FG001|Track 4|Adverse event unrelated to study drug|5|||
13134869|NCT02750514|25992663|FG002|Track 4|Adverse event unrelated to study drug|0|||
13134870|NCT02750514|25992664|FG003|Track 4|Adverse event unrelated to study drug|0|||
13134871|NCT02750514|25992665|FG004|Track 4|Adverse event unrelated to study drug|0|||
13134872|NCT02750514|25992661|FG000|Track 4|Death|0|||
13134873|NCT02750514|25992662|FG001|Track 4|Death|0|||
13134874|NCT02750514|25992663|FG002|Track 4|Death|0|||
13134875|NCT02750514|25992664|FG003|Track 4|Death|1|||
13134876|NCT02750514|25992665|FG004|Track 4|Death|0|||
13134877|NCT02750514|25992661|FG000|Track 5|Disease progression|0|||
13134878|NCT02750514|25992662|FG001|Track 5|Disease progression|0|||
13134879|NCT02750514|25992663|FG002|Track 5|Disease progression|0|||
13134880|NCT02750514|25992664|FG003|Track 5|Disease progression|0|||
13134881|NCT02750514|25992665|FG004|Track 5|Disease progression|34|||
13134882|NCT02750514|25992661|FG000|Track 5|Adverse event unrelated to study drug|0|||
13134883|NCT02750514|25992662|FG001|Track 5|Adverse event unrelated to study drug|0|||
13134884|NCT02750514|25992663|FG002|Track 5|Adverse event unrelated to study drug|0|||
13134885|NCT02750514|25992664|FG003|Track 5|Adverse event unrelated to study drug|0|||
13134886|NCT02750514|25992665|FG004|Track 5|Adverse event unrelated to study drug|2|||
13134887|NCT02750514|25992661|FG000|Track 5|Study drug toxicity|0|||
13391069|NCT00681187|26775818|FG000|Overall Study|Withdrawal by Subject|1|||
13391070|NCT00681187|26775819|FG001|Overall Study|Withdrawal by Subject|0|||
13391071|NCT00681187|26775818|FG000|Overall Study|Death|0|||
13391072|NCT00681187|26775819|FG001|Overall Study|Death|1|||
13391073|NCT00681187|26775818|FG000|Overall Study|Adverse Event|0|||
13391074|NCT00681187|26775819|FG001|Overall Study|Adverse Event|1|||
13391075|NCT00681109|26775846|FG000|Overall Study|Lost to Follow-up|2|||
13391076|NCT00681109|26775847|FG001|Overall Study|Lost to Follow-up|6|||
13391077|NCT00681109|26775848|FG002|Overall Study|Lost to Follow-up|0|||
13391078|NCT00680992|26775871|FG000|Overall Study|Complete Resection (as per protocol)|25|||
13391079|NCT00680992|26775872|FG001|Overall Study|Complete Resection (as per protocol)|121|||
13391080|NCT00680992|26775873|FG002|Overall Study|Complete Resection (as per protocol)|0|||
13391081|NCT00680992|26775871|FG000|Overall Study|Administrative Decision|83|||
13391082|NCT00680992|26775872|FG001|Overall Study|Administrative Decision|42|||
13391083|NCT00680992|26775873|FG002|Overall Study|Administrative Decision|5|||
13391084|NCT00680992|26775871|FG000|Overall Study|End of Trial|32|||
13391085|NCT00680992|26775872|FG001|Overall Study|End of Trial|12|||
13391086|NCT00680992|26775873|FG002|Overall Study|End of Trial|3|||
13391087|NCT00680992|26775871|FG000|Overall Study|Withdrawal by Subject|33|||
13391088|NCT00680992|26775872|FG001|Overall Study|Withdrawal by Subject|11|||
13391089|NCT00680992|26775873|FG002|Overall Study|Withdrawal by Subject|1|||
13391090|NCT00680992|26775871|FG000|Overall Study|Adverse Event|21|||
13391091|NCT00680992|26775872|FG001|Overall Study|Adverse Event|19|||
13391092|NCT00680992|26775873|FG002|Overall Study|Adverse Event|1|||
13391093|NCT00680992|26775871|FG000|Overall Study|Other|19|||
13391094|NCT00680992|26775872|FG001|Overall Study|Other|14|||
13391095|NCT00680992|26775873|FG002|Overall Study|Other|1|||
13391096|NCT00680992|26775871|FG000|Overall Study|Disease Progression|21|||
13391097|NCT00680992|26775872|FG001|Overall Study|Disease Progression|9|||
13391098|NCT00680992|26775873|FG002|Overall Study|Disease Progression|0|||
13391099|NCT00680992|26775871|FG000|Overall Study|Lost to Follow-up|12|||
13391100|NCT00680992|26775872|FG001|Overall Study|Lost to Follow-up|14|||
13391101|NCT00680992|26775873|FG002|Overall Study|Lost to Follow-up|0|||
13391102|NCT00680992|26775871|FG000|Overall Study|Noncompliance|4|||
13391103|NCT00680992|26775872|FG001|Overall Study|Noncompliance|6|||
13391104|NCT00680992|26775873|FG002|Overall Study|Noncompliance|0|||
13391105|NCT00680992|26775871|FG000|Overall Study|Requirement for Alternative Therapy|8|||
13391106|NCT00680992|26775872|FG001|Overall Study|Requirement for Alternative Therapy|2|||
13391107|NCT00680992|26775873|FG002|Overall Study|Requirement for Alternative Therapy|0|||
13391108|NCT00680992|26775871|FG000|Overall Study|Pregnancy|5|||
13391109|NCT00680992|26775872|FG001|Overall Study|Pregnancy|0|||
13391110|NCT00680992|26775873|FG002|Overall Study|Pregnancy|1|||
13391111|NCT00680992|26775871|FG000|Overall Study|Death|5|||
13391112|NCT00680992|26775872|FG001|Overall Study|Death|1|||
13391113|NCT00680992|26775873|FG002|Overall Study|Death|0|||
13391114|NCT00680992|26775871|FG000|Overall Study|Ineligibility Determined|0|||
13391115|NCT00680992|26775872|FG001|Overall Study|Ineligibility Determined|1|||
13391116|NCT00680992|26775873|FG002|Overall Study|Ineligibility Determined|0|||
13391117|NCT00680914|26775912|FG000|Overall Study|Consent withdrawal|6|||
13391118|NCT00680914|26775913|FG001|Overall Study|Consent withdrawal|3|||
13391119|NCT00680914|26775912|FG000|Overall Study|Lost to Follow-up|4|||
13391120|NCT00680914|26775913|FG001|Overall Study|Lost to Follow-up|0|||
13391121|NCT00680914|26775912|FG000|Overall Study|serious adverse event (SAE)|0|||
13391122|NCT00680914|26775913|FG001|Overall Study|serious adverse event (SAE)|1|||
13391123|NCT00680901|26775952|FG000|Overall Study|Lost to Follow-up|8|||
13391124|NCT00680901|26775953|FG001|Overall Study|Lost to Follow-up|8|||
13391125|NCT00680901|26775952|FG000|Overall Study|Withdrawal by Subject|4|||
13391126|NCT00680901|26775953|FG001|Overall Study|Withdrawal by Subject|13|||
13391127|NCT00680901|26775952|FG000|Overall Study|Physician Decision|0|||
13391128|NCT00680901|26775953|FG001|Overall Study|Physician Decision|1|||
13391129|NCT00680901|26775952|FG000|Overall Study|Ongoing: On Study Treatment|16|||
13391130|NCT00680901|26775953|FG001|Overall Study|Ongoing: On Study Treatment|13|||
13391131|NCT00680901|26775952|FG000|Overall Study|Ongoing: In Follow Up|45|||
13391132|NCT00680901|26775953|FG001|Overall Study|Ongoing: In Follow Up|41|||
13391133|NCT00680836|26775976|FG000|Overall Study|Withdrawal by Subject|3|||
13391134|NCT00680836|26775977|FG001|Overall Study|Withdrawal by Subject|0|||
13391135|NCT00680836|26775976|FG000|Overall Study|Lost to Follow-up|3|||
13391136|NCT00680836|26775977|FG001|Overall Study|Lost to Follow-up|1|||
13391137|NCT00680836|26775976|FG000|Overall Study|Physician Decision|2|||
13391138|NCT00680836|26775977|FG001|Overall Study|Physician Decision|1|||
13391139|NCT00680771|26775990|FG000|Overall Study|Withdrawal by Subject|1|||
13391140|NCT00680771|26775991|FG001|Overall Study|Withdrawal by Subject|0|||
13391141|NCT00680771|26775990|FG000|Overall Study|Sleep Apnea suspected after PSG|1|||
13391142|NCT00680771|26775991|FG001|Overall Study|Sleep Apnea suspected after PSG|0|||
13391143|NCT00680771|26775990|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4|||
13391144|NCT00680771|26775991|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2|||
13391145|NCT00680745|26776034|FG000|Overall Study|Withdrawal by Subject|8|||
13391146|NCT00680745|26776035|FG001|Overall Study|Withdrawal by Subject|3|||
13391147|NCT00680745|26776036|FG002|Overall Study|Withdrawal by Subject|2|||
13391148|NCT00680745|26776037|FG003|Overall Study|Withdrawal by Subject|8|||
13391149|NCT00680745|26776034|FG000|Overall Study|Lost to Follow-up|0|||
13391150|NCT00680745|26776035|FG001|Overall Study|Lost to Follow-up|1|||
13474848|NCT02120352|26996836|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
13474849|NCT02120352|26996837|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
13474850|NCT02120352|26996834|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2|||
13474851|NCT02120352|26996835|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0|||
13474852|NCT02120352|26996836|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0|||
13474853|NCT02120352|26996837|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0|||
13474854|NCT02120352|26996834|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5|||
13474855|NCT02120352|26996835|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
13474856|NCT02120352|26996836|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
13474857|NCT02120352|26996837|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
13474858|NCT02120352|26996834|FG000|Induction Period (20 Weeks)|Physician Decision|1|||
13474859|NCT02120352|26996835|FG001|Induction Period (20 Weeks)|Physician Decision|0|||
13474860|NCT02120352|26996836|FG002|Induction Period (20 Weeks)|Physician Decision|0|||
13474861|NCT02120352|26996837|FG003|Induction Period (20 Weeks)|Physician Decision|0|||
13474862|NCT02120352|26996834|FG000|Maintenance Period (32 Weeks)|Adverse Event|0|||
13474863|NCT02120352|26996835|FG001|Maintenance Period (32 Weeks)|Adverse Event|0|||
13474864|NCT02120352|26996836|FG002|Maintenance Period (32 Weeks)|Adverse Event|6|||
13474865|NCT02120352|26996837|FG003|Maintenance Period (32 Weeks)|Adverse Event|1|||
13474866|NCT02120352|26996834|FG000|Maintenance Period (32 Weeks)|Lack of Efficacy|0|||
13474867|NCT02120352|26996835|FG001|Maintenance Period (32 Weeks)|Lack of Efficacy|1|||
13474868|NCT02120352|26996836|FG002|Maintenance Period (32 Weeks)|Lack of Efficacy|0|||
13474869|NCT02120352|26996837|FG003|Maintenance Period (32 Weeks)|Lack of Efficacy|1|||
13474870|NCT02120352|26996834|FG000|Maintenance Period (32 Weeks)|Protocol Violation|0|||
13474871|NCT02120352|26996835|FG001|Maintenance Period (32 Weeks)|Protocol Violation|0|||
13474872|NCT02120352|26996836|FG002|Maintenance Period (32 Weeks)|Protocol Violation|2|||
13474873|NCT02120352|26996837|FG003|Maintenance Period (32 Weeks)|Protocol Violation|0|||
13474874|NCT02120352|26996834|FG000|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|0|||
13474875|NCT02120352|26996835|FG001|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|0|||
13474876|NCT02120352|26996836|FG002|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|1|||
13474877|NCT02120352|26996837|FG003|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|1|||
13474878|NCT02120352|26996834|FG000|Maintenance Period (32 Weeks)|Lost to Follow-up|0|||
13474879|NCT02120352|26996835|FG001|Maintenance Period (32 Weeks)|Lost to Follow-up|0|||
13474880|NCT02120352|26996836|FG002|Maintenance Period (32 Weeks)|Lost to Follow-up|0|||
13474881|NCT02120352|26996837|FG003|Maintenance Period (32 Weeks)|Lost to Follow-up|1|||
13474882|NCT02120352|26996834|FG000|Maintenance Period (32 Weeks)|Withdrawal by Subject|0|||
13474883|NCT02120352|26996835|FG001|Maintenance Period (32 Weeks)|Withdrawal by Subject|2|||
13474884|NCT02120352|26996836|FG002|Maintenance Period (32 Weeks)|Withdrawal by Subject|1|||
13391151|NCT00680745|26776036|FG002|Overall Study|Lost to Follow-up|1|||
13391152|NCT00680745|26776037|FG003|Overall Study|Lost to Follow-up|0|||
13391153|NCT00680745|26776034|FG000|Overall Study|Death|1|||
13391154|NCT00680745|26776035|FG001|Overall Study|Death|0|||
13391155|NCT00680745|26776036|FG002|Overall Study|Death|1|||
13391156|NCT00680745|26776037|FG003|Overall Study|Death|0|||
13391157|NCT00680745|26776034|FG000|Overall Study|Adverse Event|5|||
13391158|NCT00680745|26776035|FG001|Overall Study|Adverse Event|3|||
13391159|NCT00680745|26776036|FG002|Overall Study|Adverse Event|3|||
13391160|NCT00680745|26776037|FG003|Overall Study|Adverse Event|3|||
13391161|NCT00680745|26776034|FG000|Overall Study|Poor/Non-compliance|0|||
13391162|NCT00680745|26776035|FG001|Overall Study|Poor/Non-compliance|3|||
13391163|NCT00680745|26776036|FG002|Overall Study|Poor/Non-compliance|0|||
13391164|NCT00680745|26776037|FG003|Overall Study|Poor/Non-compliance|0|||
13391165|NCT00680745|26776034|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
13391166|NCT00680745|26776035|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
13391167|NCT00680745|26776036|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
13391168|NCT00680745|26776037|FG003|Overall Study|Subject No Longer Meets Study Criteria|2|||
13391169|NCT00680745|26776034|FG000|Overall Study|False Treatment|0|||
13391170|NCT00680745|26776035|FG001|Overall Study|False Treatment|1|||
13391171|NCT00680745|26776036|FG002|Overall Study|False Treatment|3|||
13391172|NCT00680745|26776037|FG003|Overall Study|False Treatment|0|||
13391173|NCT00680407|26776061|FG000|Overall Study|Lost to Follow-up|3|||
13391174|NCT00680407|26776062|FG001|Overall Study|Lost to Follow-up|3|||
13391175|NCT00680407|26776063|FG002|Overall Study|Lost to Follow-up|1|||
13391176|NCT00680407|26776061|FG000|Overall Study|Withdrawal by Subject|5|||
13391177|NCT00680407|26776062|FG001|Overall Study|Withdrawal by Subject|2|||
13391178|NCT00680407|26776063|FG002|Overall Study|Withdrawal by Subject|2|||
13391179|NCT00680368|26776071|FG000|Overall Study|not supervised, not eligible|15|||
13391180|NCT00680186|26776102|FG000|Overall Study|Adverse Event|47|||
13391181|NCT00680186|26776103|FG001|Overall Study|Adverse Event|44|||
13391182|NCT00680186|26776102|FG000|Overall Study|Protocol Violation|31|||
13391183|NCT00680186|26776103|FG001|Overall Study|Protocol Violation|26|||
13391184|NCT00680186|26776102|FG000|Overall Study|Lost to Follow-up|11|||
13391185|NCT00680186|26776103|FG001|Overall Study|Lost to Follow-up|6|||
13391186|NCT00680186|26776102|FG000|Overall Study|Withdrawal by Subject|32|||
13134888|NCT02750514|25992662|FG001|Track 5|Study drug toxicity|0|||
13134889|NCT02750514|25992663|FG002|Track 5|Study drug toxicity|0|||
13134890|NCT02750514|25992664|FG003|Track 5|Study drug toxicity|0|||
13134891|NCT02750514|25992665|FG004|Track 5|Study drug toxicity|2|||
13134892|NCT02750514|25992661|FG000|Track 5|Participant request to discontinue|0|||
13134893|NCT02750514|25992662|FG001|Track 5|Participant request to discontinue|0|||
13134894|NCT02750514|25992663|FG002|Track 5|Participant request to discontinue|0|||
13134895|NCT02750514|25992664|FG003|Track 5|Participant request to discontinue|0|||
13134896|NCT02750514|25992665|FG004|Track 5|Participant request to discontinue|3|||
13134897|NCT02750514|25992661|FG000|Track 5|Other reasons|0|||
13134898|NCT02750514|25992662|FG001|Track 5|Other reasons|0|||
13134899|NCT02750514|25992663|FG002|Track 5|Other reasons|0|||
13134900|NCT02750514|25992664|FG003|Track 5|Other reasons|0|||
13134901|NCT02750514|25992665|FG004|Track 5|Other reasons|2|||
13134902|NCT02750501|25992679|FG000|Overall Study|Adverse Event|4|||
13134903|NCT02750501|25992679|FG000|Overall Study|Physician Decision|1|||
13134904|NCT02750501|25992679|FG000|Overall Study|Protocol Violation|1|||
13134905|NCT02750501|25992679|FG000|Overall Study|G-tube came out|1|||
13134906|NCT02750501|25992679|FG000|Overall Study|Non-compliant use of PERT|1|||
13134907|NCT02750410|25992704|FG000|Double-Blind Treatment Period|Adverse Event|2|||
13134908|NCT02750410|25992705|FG001|Double-Blind Treatment Period|Adverse Event|2|||
13134909|NCT02750410|25992704|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
13134910|NCT02750410|25992705|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
13134911|NCT02750410|25992704|FG000|Open-Label Extension Period|Adverse Event|5|||
13134912|NCT02750410|25992705|FG001|Open-Label Extension Period|Adverse Event|3|||
13134913|NCT02750410|25992704|FG000|Open-Label Extension Period|Protocol Violation|0|||
13134914|NCT02750410|25992705|FG001|Open-Label Extension Period|Protocol Violation|1|||
13134915|NCT02750410|25992704|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
13134916|NCT02750410|25992705|FG001|Open-Label Extension Period|Withdrawal by Subject|2|||
13134917|NCT02750345|25992738|FG000|Intervention 1|Adverse Event|0|||
13134918|NCT02750345|25992739|FG001|Intervention 1|Adverse Event|0|||
13134919|NCT02750345|25992740|FG002|Intervention 1|Adverse Event|0|||
13134920|NCT02750345|25992741|FG003|Intervention 1|Adverse Event|0|||
13134921|NCT02750345|25992742|FG004|Intervention 1|Adverse Event|1|||
13134922|NCT02750345|25992743|FG005|Intervention 1|Adverse Event|0|||
13134923|NCT02750332|25992764|FG000|Treatment Period 1|Withdrawal by Subject|0|||
13134924|NCT02750332|25992765|FG001|Treatment Period 1|Withdrawal by Subject|1|||
13134925|NCT02750306|25992784|FG000|Overall Study|Withdrawal by Subject|5|||
13134926|NCT02750306|25992785|FG001|Overall Study|Withdrawal by Subject|2|||
13134927|NCT02750306|25992784|FG000|Overall Study|Protocol Violation|1|||
13134928|NCT02750306|25992785|FG001|Overall Study|Protocol Violation|0|||
13134929|NCT02749799|25992793|FG000|Overall Study|Adverse Event|2|||
13134930|NCT02749799|25992793|FG000|Overall Study|Lost to Follow-up|4|||
13134931|NCT02749799|25992793|FG000|Overall Study|Protocol Violation|1|||
13134932|NCT02749799|25992793|FG000|Overall Study|Withdrawal by Subject|1|||
13134933|NCT02749721|25992808|FG000|Screening|Withdrawal by Subject|1|||
13134934|NCT02749721|25992808|FG000|Screening|Lost to Follow-up|2|||
13134935|NCT02749721|25992808|FG000|Screening|Protocol Violation|3|||
13134936|NCT02749721|25992808|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2|||
13134937|NCT02749721|25992808|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1|||
13134938|NCT02749370|25992837|FG000|Overall Study|Withdrawal by Subject|11|||
13134939|NCT02749370|25992837|FG000|Overall Study|Lost to Follow-up|3|||
13134940|NCT02748863|25992871|FG000|Treatment Period 1|Adverse Event|0|||
13134941|NCT02748863|25992872|FG001|Treatment Period 1|Adverse Event|1|||
13134942|NCT02748863|25992873|FG002|Treatment Period 1|Adverse Event|0|||
13134943|NCT02748863|25992874|FG003|Treatment Period 1|Adverse Event|0|||
13134944|NCT02748863|25992875|FG004|Treatment Period 1|Adverse Event|0|||
13134945|NCT02748863|25992871|FG000|Treatment Period 1|Lack of Efficacy|0|||
13134946|NCT02748863|25992872|FG001|Treatment Period 1|Lack of Efficacy|0|||
13134947|NCT02748863|25992873|FG002|Treatment Period 1|Lack of Efficacy|1|||
13134948|NCT02748863|25992874|FG003|Treatment Period 1|Lack of Efficacy|0|||
13134949|NCT02748863|25992875|FG004|Treatment Period 1|Lack of Efficacy|0|||
13134950|NCT02748863|25992871|FG000|Treatment Period 1|Withdrawal by Subject|0|||
13134951|NCT02748863|25992872|FG001|Treatment Period 1|Withdrawal by Subject|1|||
13134952|NCT02748863|25992873|FG002|Treatment Period 1|Withdrawal by Subject|1|||
13134953|NCT02748863|25992874|FG003|Treatment Period 1|Withdrawal by Subject|0|||
13134954|NCT02748863|25992875|FG004|Treatment Period 1|Withdrawal by Subject|0|||
13134955|NCT02748863|25992871|FG000|Treatment Period 2|Lost to Follow-up|2|||
13134956|NCT02748863|25992872|FG001|Treatment Period 2|Lost to Follow-up|0|||
13134957|NCT02748863|25992873|FG002|Treatment Period 2|Lost to Follow-up|0|||
13134958|NCT02748863|25992874|FG003|Treatment Period 2|Lost to Follow-up|0|||
13134959|NCT02748863|25992875|FG004|Treatment Period 2|Lost to Follow-up|0|||
13134960|NCT02748863|25992871|FG000|Treatment Period 2|Adverse Event|3|||
13134961|NCT02748863|25992872|FG001|Treatment Period 2|Adverse Event|2|||
13134962|NCT02748863|25992873|FG002|Treatment Period 2|Adverse Event|0|||
13134963|NCT02748863|25992874|FG003|Treatment Period 2|Adverse Event|2|||
13134964|NCT02748863|25992875|FG004|Treatment Period 2|Adverse Event|0|||
13134965|NCT02748863|25992871|FG000|Treatment Period 2|Lack of Efficacy|0|||
13135105|NCT02745392|25993584|FG003|Overall Study|Lost to Follow-up|0|||
13391187|NCT00680186|26776103|FG001|Overall Study|Withdrawal by Subject|39|||
13391188|NCT00680186|26776102|FG000|Overall Study|Other|4|||
13391189|NCT00680186|26776103|FG001|Overall Study|Other|1|||
13391190|NCT00680121|26776122|FG000|Overall Study|Lost to Follow-up|27|||
13391191|NCT00680121|26776123|FG001|Overall Study|Lost to Follow-up|23|||
13391192|NCT00680056|26776138|FG000|First Intervention|Mainly Exacerbation of COPD|1|||
13391193|NCT00680056|26776139|FG001|First Intervention|Mainly Exacerbation of COPD|2|||
13391194|NCT00680056|26776138|FG000|Second Intervention|Protocol Violation|3|||
13391195|NCT00680056|26776139|FG001|Second Intervention|Protocol Violation|1|||
13391196|NCT00680043|26776163|FG000|Overall Study|Withdrawal by Subject|1|||
13391197|NCT00680043|26776164|FG001|Overall Study|Withdrawal by Subject|0|||
13391198|NCT00680043|26776165|FG002|Overall Study|Withdrawal by Subject|0|||
13391199|NCT00680043|26776163|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0|||
13391200|NCT00680043|26776164|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1|||
13391201|NCT00680043|26776165|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0|||
13391202|NCT00680043|26776163|FG000|Overall Study|Renal Transplant|1|||
13391203|NCT00680043|26776164|FG001|Overall Study|Renal Transplant|0|||
13391204|NCT00680043|26776165|FG002|Overall Study|Renal Transplant|4|||
13391205|NCT00680017|26776180|FG000|Overall Study|Adverse Event|13|||
13391206|NCT00680017|26776181|FG001|Overall Study|Adverse Event|7|||
13391207|NCT00680017|26776180|FG000|Overall Study|Withdrawal by Subject|2|||
13391208|NCT00680017|26776181|FG001|Overall Study|Withdrawal by Subject|5|||
13391209|NCT00680017|26776180|FG000|Overall Study|Lost to Follow-up|2|||
13391210|NCT00680017|26776181|FG001|Overall Study|Lost to Follow-up|0|||
13391211|NCT00679939|26776337|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17|||
13391212|NCT00679939|26776338|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13|||
13391213|NCT00679939|26776337|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14|||
13391214|NCT00679939|26776338|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12|||
13391215|NCT00679939|26776337|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5|||
13391216|NCT00679939|26776338|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0|||
13391217|NCT00679939|26776337|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1|||
13134966|NCT02748863|25992872|FG001|Treatment Period 2|Lack of Efficacy|1|||
13134967|NCT02748863|25992873|FG002|Treatment Period 2|Lack of Efficacy|0|||
13134968|NCT02748863|25992874|FG003|Treatment Period 2|Lack of Efficacy|0|||
13134969|NCT02748863|25992875|FG004|Treatment Period 2|Lack of Efficacy|0|||
13134970|NCT02748863|25992871|FG000|Treatment Period 2|Pregnancy|0|||
13134971|NCT02748863|25992872|FG001|Treatment Period 2|Pregnancy|0|||
13134972|NCT02748863|25992873|FG002|Treatment Period 2|Pregnancy|0|||
13134973|NCT02748863|25992874|FG003|Treatment Period 2|Pregnancy|0|||
13134974|NCT02748863|25992875|FG004|Treatment Period 2|Pregnancy|1|||
13134975|NCT02748694|25993129|FG000|Overall Study|Voluntary Withdrawal|0|||
13134976|NCT02748694|25993130|FG001|Overall Study|Voluntary Withdrawal|0|||
13134977|NCT02748694|25993131|FG002|Overall Study|Voluntary Withdrawal|0|||
13134978|NCT02748694|25993132|FG003|Overall Study|Voluntary Withdrawal|0|||
13134979|NCT02748694|25993133|FG004|Overall Study|Voluntary Withdrawal|0|||
13134980|NCT02748694|25993134|FG005|Overall Study|Voluntary Withdrawal|0|||
13134981|NCT02748694|25993135|FG006|Overall Study|Voluntary Withdrawal|0|||
13134982|NCT02748694|25993136|FG007|Overall Study|Voluntary Withdrawal|0|||
13134983|NCT02748694|25993137|FG008|Overall Study|Voluntary Withdrawal|0|||
13134984|NCT02748694|25993138|FG009|Overall Study|Voluntary Withdrawal|0|||
13134985|NCT02748694|25993139|FG010|Overall Study|Voluntary Withdrawal|0|||
13134986|NCT02748694|25993140|FG011|Overall Study|Voluntary Withdrawal|0|||
13134987|NCT02748694|25993141|FG012|Overall Study|Voluntary Withdrawal|0|||
13134988|NCT02748694|25993142|FG013|Overall Study|Voluntary Withdrawal|0|||
13134989|NCT02748694|25993143|FG014|Overall Study|Voluntary Withdrawal|2|||
13134990|NCT02748512|25993158|FG000|Overall Study|Lost to Follow-up|1|||
13134991|NCT02748512|25993159|FG001|Overall Study|Lost to Follow-up|1|||
13134992|NCT02748356|25993166|FG000|Overall Study|Withdrawal by Subject|1|||
13134993|NCT02748317|25993173|FG000|Overall Study|Withdrawal by Subject|14|||
13134994|NCT02748317|25993173|FG000|Overall Study|Lost to Follow-up|8|||
13134995|NCT02748317|25993173|FG000|Overall Study|Death|1|||
13134996|NCT02748213|25993196|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
13134997|NCT02748213|25993197|FG001|Overall Study|Withdrawal Prior to Treatment|2|||
13474885|NCT02120352|26996837|FG003|Maintenance Period (32 Weeks)|Withdrawal by Subject|2|||
13474886|NCT02120352|26996834|FG000|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|0|||
13474887|NCT02120352|26996835|FG001|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|112|||
13474888|NCT02120352|26996836|FG002|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|105|||
13474889|NCT02120352|26996837|FG003|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|50|||
13474890|NCT02097121|26996907|FG000|Overall Study|Other, not specified|4|||
13474891|NCT02097121|26996908|FG001|Overall Study|Other, not specified|2|||
13474892|NCT02097121|26996909|FG002|Overall Study|Other, not specified|3|||
13474893|NCT02097121|26996907|FG000|Overall Study|Lack of Efficacy|2|||
13474894|NCT02097121|26996908|FG001|Overall Study|Lack of Efficacy|1|||
13391218|NCT00679939|26776338|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
13391219|NCT00679939|26776337|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
13391220|NCT00679939|26776338|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2|||
13391221|NCT00679939|26776337|FG000|24-Week Open-Label (OL) Period|Adverse Event|0|||
13391222|NCT00679939|26776338|FG001|24-Week Open-Label (OL) Period|Adverse Event|1|||
13391223|NCT00679939|26776337|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1|||
13391224|NCT00679939|26776338|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1|||
13391225|NCT00679939|26776337|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3|||
13391226|NCT00679939|26776338|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1|||
13391227|NCT00679939|26776337|FG000|24-Week Open-Label (OL) Period|Physician Decision|1|||
13391228|NCT00679939|26776338|FG001|24-Week Open-Label (OL) Period|Physician Decision|0|||
13391229|NCT00679939|26776337|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2|||
13391230|NCT00679939|26776338|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1|||
13391231|NCT00679913|26776353|FG000|Overall Study|Protocol Violation|18|||
13391232|NCT00679913|26776354|FG001|Overall Study|Protocol Violation|13|||
13391233|NCT00679783|26776427|FG000|Overall Study|Adverse Event|0|||
13391234|NCT00679783|26776428|FG001|Overall Study|Adverse Event|0|||
13391235|NCT00679783|26776429|FG002|Overall Study|Adverse Event|0|||
13391236|NCT00679783|26776430|FG003|Overall Study|Adverse Event|3|||
13391237|NCT00679783|26776431|FG004|Overall Study|Adverse Event|0|||
13391238|NCT00679783|26776432|FG005|Overall Study|Adverse Event|0|||
13391239|NCT00679783|26776433|FG006|Overall Study|Adverse Event|1|||
13391240|NCT00679783|26776427|FG000|Overall Study|Lack of Efficacy|0|||
13391241|NCT00679783|26776428|FG001|Overall Study|Lack of Efficacy|1|||
13391242|NCT00679783|26776429|FG002|Overall Study|Lack of Efficacy|0|||
13391243|NCT00679783|26776430|FG003|Overall Study|Lack of Efficacy|2|||
13391244|NCT00679783|26776431|FG004|Overall Study|Lack of Efficacy|0|||
13391245|NCT00679783|26776432|FG005|Overall Study|Lack of Efficacy|0|||
13391246|NCT00679783|26776433|FG006|Overall Study|Lack of Efficacy|0|||
13391247|NCT00679783|26776427|FG000|Overall Study|Withdrawal by Subject|0|||
13391248|NCT00679783|26776428|FG001|Overall Study|Withdrawal by Subject|0|||
13391249|NCT00679783|26776429|FG002|Overall Study|Withdrawal by Subject|1|||
13391250|NCT00679783|26776430|FG003|Overall Study|Withdrawal by Subject|1|||
13391251|NCT00679783|26776431|FG004|Overall Study|Withdrawal by Subject|0|||
13391252|NCT00679783|26776432|FG005|Overall Study|Withdrawal by Subject|0|||
13391253|NCT00679783|26776433|FG006|Overall Study|Withdrawal by Subject|0|||
13391254|NCT00679783|26776427|FG000|Overall Study|Not Captured|0|||
13391255|NCT00679783|26776428|FG001|Overall Study|Not Captured|0|||
13391256|NCT00679783|26776429|FG002|Overall Study|Not Captured|0|||
13391257|NCT00679783|26776430|FG003|Overall Study|Not Captured|5|||
13391258|NCT00679783|26776431|FG004|Overall Study|Not Captured|0|||
13391259|NCT00679783|26776432|FG005|Overall Study|Not Captured|0|||
13391260|NCT00679783|26776433|FG006|Overall Study|Not Captured|0|||
13391261|NCT00679783|26776427|FG000|Overall Study|Ongoing at data cut-off|2|||
13391262|NCT00679783|26776428|FG001|Overall Study|Ongoing at data cut-off|2|||
13391263|NCT00679783|26776429|FG002|Overall Study|Ongoing at data cut-off|0|||
13391264|NCT00679783|26776430|FG003|Overall Study|Ongoing at data cut-off|9|||
13391265|NCT00679783|26776431|FG004|Overall Study|Ongoing at data cut-off|1|||
13391266|NCT00679783|26776432|FG005|Overall Study|Ongoing at data cut-off|0|||
13391267|NCT00679783|26776433|FG006|Overall Study|Ongoing at data cut-off|0|||
13391268|NCT00679627|26776462|FG000|Overall Study|Death|41|||
13391269|NCT00679627|26776463|FG001|Overall Study|Death|29|||
13391270|NCT00679627|26776462|FG000|Overall Study|Adverse Event|43|||
13391271|NCT00679627|26776463|FG001|Overall Study|Adverse Event|53|||
13391272|NCT00679627|26776462|FG000|Overall Study|Withdrawal by Subject|168|||
13391273|NCT00679627|26776463|FG001|Overall Study|Withdrawal by Subject|172|||
13391274|NCT00679627|26776462|FG000|Overall Study|Lost to Follow-up|22|||
13391275|NCT00679627|26776463|FG001|Overall Study|Lost to Follow-up|26|||
13134998|NCT02748213|25993196|FG000|Overall Study|Abnormal Laboratory Test|1|||
13134999|NCT02748213|25993197|FG001|Overall Study|Abnormal Laboratory Test|0|||
13135000|NCT02748213|25993196|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
13135001|NCT02748213|25993197|FG001|Overall Study|Adverse Event or Intercurrent Illness|11|||
13135002|NCT02748213|25993196|FG000|Overall Study|Death|5|||
13135003|NCT02748213|25993197|FG001|Overall Study|Death|3|||
13135004|NCT02748213|25993196|FG000|Overall Study|Insufficient Therapeutic Response|56|||
13135005|NCT02748213|25993197|FG001|Overall Study|Insufficient Therapeutic Response|57|||
13135006|NCT02748213|25993196|FG000|Overall Study|Violation of Selection Criteria|2|||
13135007|NCT02748213|25993197|FG001|Overall Study|Violation of Selection Criteria|0|||
13135008|NCT02748213|25993196|FG000|Overall Study|Protocol Violation|6|||
13135009|NCT02748213|25993197|FG001|Overall Study|Protocol Violation|4|||
13135010|NCT02748213|25993196|FG000|Overall Study|Refused Treatment*|6|||
13135011|NCT02748213|25993197|FG001|Overall Study|Refused Treatment*|6|||
13135012|NCT02748213|25993196|FG000|Overall Study|Failure to Return|1|||
13135013|NCT02748213|25993197|FG001|Overall Study|Failure to Return|0|||
13135014|NCT02748213|25993196|FG000|Overall Study|Other|30|||
13135015|NCT02748213|25993197|FG001|Overall Study|Other|29|||
13135016|NCT02748057|25993214|FG000|Overall Study|Adverse Event|1|||
13135017|NCT02748057|25993215|FG001|Overall Study|Adverse Event|0|||
13135018|NCT02748057|25993214|FG000|Overall Study|Physician Decision|0|||
13135019|NCT02748057|25993215|FG001|Overall Study|Physician Decision|1|||
13135020|NCT02748057|25993214|FG000|Overall Study|Protocol Violation|2|||
13135021|NCT02748057|25993215|FG001|Overall Study|Protocol Violation|1|||
13135022|NCT02748057|25993214|FG000|Overall Study|Participant Moved|1|||
13135023|NCT02748057|25993215|FG001|Overall Study|Participant Moved|0|||
13135024|NCT02748057|25993214|FG000|Overall Study|Withdrawal by Subject|1|||
13135025|NCT02748057|25993215|FG001|Overall Study|Withdrawal by Subject|0|||
13135026|NCT02747927|25993228|FG000|Overall Study|Adverse Event|5|||
13135027|NCT02747927|25993229|FG001|Overall Study|Adverse Event|14|||
13135028|NCT02747927|25993228|FG000|Overall Study|Lost to Follow-up|22|||
13135029|NCT02747927|25993229|FG001|Overall Study|Lost to Follow-up|43|||
13135030|NCT02747927|25993228|FG000|Overall Study|Pregnancy|34|||
13135031|NCT02747927|25993229|FG001|Overall Study|Pregnancy|66|||
13135032|NCT02747927|25993228|FG000|Overall Study|Protocol Violation|2|||
13135033|NCT02747927|25993229|FG001|Overall Study|Protocol Violation|4|||
13135034|NCT02747927|25993228|FG000|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|147|||
13135106|NCT02745145|25993629|FG000|Overall Study|Adverse Event|1|||
13391276|NCT00679627|26776462|FG000|Overall Study|Early Study Closure|425|||
13391277|NCT00679627|26776463|FG001|Overall Study|Early Study Closure|405|||
13391278|NCT00679549|26776476|FG000|Overall Study|dropout|2|||
13391279|NCT00679549|26776477|FG001|Overall Study|dropout|4|||
13391280|NCT00679549|26776476|FG000|Overall Study|missing outcome echocardiograms|4|||
13391281|NCT00679549|26776477|FG001|Overall Study|missing outcome echocardiograms|5|||
13391282|NCT00679432|26776508|FG000|Overall Study|Adverse Event|5|||
13391283|NCT00679432|26776509|FG001|Overall Study|Adverse Event|6|||
13391284|NCT00679432|26776510|FG002|Overall Study|Adverse Event|10|||
13391285|NCT00679432|26776511|FG003|Overall Study|Adverse Event|7|||
13391286|NCT00679432|26776508|FG000|Overall Study|Protocol Violation|1|||
13391287|NCT00679432|26776509|FG001|Overall Study|Protocol Violation|1|||
13391288|NCT00679432|26776510|FG002|Overall Study|Protocol Violation|2|||
13391289|NCT00679432|26776511|FG003|Overall Study|Protocol Violation|1|||
13391290|NCT00679432|26776508|FG000|Overall Study|Withdrawal by Subject|8|||
13391291|NCT00679432|26776509|FG001|Overall Study|Withdrawal by Subject|11|||
13391292|NCT00679432|26776510|FG002|Overall Study|Withdrawal by Subject|10|||
13391293|NCT00679432|26776511|FG003|Overall Study|Withdrawal by Subject|9|||
13391294|NCT00679432|26776508|FG000|Overall Study|Lost to Follow-up|1|||
13391295|NCT00679432|26776509|FG001|Overall Study|Lost to Follow-up|5|||
13391296|NCT00679432|26776510|FG002|Overall Study|Lost to Follow-up|4|||
13391297|NCT00679432|26776511|FG003|Overall Study|Lost to Follow-up|2|||
13391298|NCT00679432|26776508|FG000|Overall Study|Physician Decision|3|||
13391299|NCT00679432|26776509|FG001|Overall Study|Physician Decision|2|||
13391300|NCT00679432|26776510|FG002|Overall Study|Physician Decision|2|||
13391301|NCT00679432|26776511|FG003|Overall Study|Physician Decision|2|||
13391302|NCT00679432|26776508|FG000|Overall Study|Sponsor decision|1|||
13391303|NCT00679432|26776509|FG001|Overall Study|Sponsor decision|0|||
13391304|NCT00679432|26776510|FG002|Overall Study|Sponsor decision|0|||
13391305|NCT00679432|26776511|FG003|Overall Study|Sponsor decision|0|||
13391306|NCT00679432|26776508|FG000|Overall Study|Lack of Efficacy|13|||
13391307|NCT00679432|26776509|FG001|Overall Study|Lack of Efficacy|9|||
13391308|NCT00679432|26776510|FG002|Overall Study|Lack of Efficacy|14|||
13391309|NCT00679432|26776511|FG003|Overall Study|Lack of Efficacy|8|||
13391310|NCT00679432|26776508|FG000|Overall Study|Infectious colitis, normal histology|5|||
13391311|NCT00679432|26776509|FG001|Overall Study|Infectious colitis, normal histology|4|||
13391312|NCT00679432|26776510|FG002|Overall Study|Infectious colitis, normal histology|8|||
13391313|NCT00679432|26776511|FG003|Overall Study|Infectious colitis, normal histology|3|||
13391314|NCT00679432|26776508|FG000|Overall Study|Randomization error, return to prior Rx|0|||
13391315|NCT00679432|26776509|FG001|Overall Study|Randomization error, return to prior Rx|0|||
13391316|NCT00679432|26776510|FG002|Overall Study|Randomization error, return to prior Rx|3|||
13391317|NCT00679432|26776511|FG003|Overall Study|Randomization error, return to prior Rx|0|||
13391318|NCT00679367|26776519|FG000|Overall Study|Adverse Event|7|||
13391319|NCT00679367|26776519|FG000|Overall Study|inability to swallow oral drugs|1|||
13391320|NCT00679367|26776519|FG000|Overall Study|Lack of Efficacy|3|||
13391321|NCT00679367|26776519|FG000|Overall Study|Withdrawal by Subject|1|||
13391322|NCT00679354|26776537|FG000|Overall Study|Death|3|||
13391323|NCT00679354|26776537|FG000|Overall Study|Lack of Efficacy|22|||
13391324|NCT00679354|26776537|FG000|Overall Study|Physician Decision|4|||
13391325|NCT00679354|26776537|FG000|Overall Study|Ineligible|1|||
13391326|NCT00679341|26776562|FG000|Overall Study|Disease progression|42|||
13391327|NCT00679341|26776563|FG001|Overall Study|Disease progression|36|||
13391328|NCT00679341|26776562|FG000|Overall Study|Adverse Event|5|||
13391329|NCT00679341|26776563|FG001|Overall Study|Adverse Event|6|||
13391330|NCT00679341|26776562|FG000|Overall Study|Subject/guardian decision to discontinue|3|||
13391331|NCT00679341|26776563|FG001|Overall Study|Subject/guardian decision to discontinue|0|||
13391332|NCT00679341|26776562|FG000|Overall Study|Death|1|||
13391333|NCT00679341|26776563|FG001|Overall Study|Death|1|||
13391334|NCT00679341|26776562|FG000|Overall Study|Other|1|||
13391335|NCT00679341|26776563|FG001|Overall Study|Other|0|||
13391336|NCT00679341|26776562|FG000|Overall Study|Physician Decision|1|||
13391337|NCT00679341|26776563|FG001|Overall Study|Physician Decision|0|||
13391338|NCT00679341|26776562|FG000|Overall Study|Not treated|0|||
13391339|NCT00679341|26776563|FG001|Overall Study|Not treated|2|||
13391340|NCT00679341|26776562|FG000|Overall Study|Physician/patient decision to withdraw|0|||
13391341|NCT00679341|26776563|FG001|Overall Study|Physician/patient decision to withdraw|6|||
13391342|NCT00679302|26776578|FG000|Overall Study|Lost to Follow-up|8|||
13391343|NCT00679302|26776579|FG001|Overall Study|Lost to Follow-up|4|||
13391344|NCT00679289|26776608|FG000|Overall Study|Progressive disease|4|||
13391345|NCT00679289|26776609|FG001|Overall Study|Progressive disease|5|||
13391346|NCT00679289|26776610|FG002|Overall Study|Progressive disease|18|||
13391347|NCT00679289|26776608|FG000|Overall Study|Withdrawal by Subject|0|||
13391348|NCT00679289|26776609|FG001|Overall Study|Withdrawal by Subject|1|||
13391349|NCT00679289|26776610|FG002|Overall Study|Withdrawal by Subject|1|||
13391350|NCT00679289|26776608|FG000|Overall Study|Adverse Event|0|||
13391351|NCT00679289|26776609|FG001|Overall Study|Adverse Event|0|||
13391352|NCT00679289|26776610|FG002|Overall Study|Adverse Event|3|||
13391353|NCT00679289|26776608|FG000|Overall Study|Physician Decision|1|||
13391354|NCT00679289|26776609|FG001|Overall Study|Physician Decision|0|||
13391355|NCT00679289|26776610|FG002|Overall Study|Physician Decision|1|||
13391356|NCT00679263|26776631|FG000|Visit 2/Dose 1|Adverse Event|1|||
13391357|NCT00679263|26776632|FG001|Visit 2/Dose 1|Adverse Event|0|||
13391358|NCT00679263|26776633|FG002|Visit 2/Dose 1|Adverse Event|0|||
13391359|NCT00679263|26776631|FG000|Visit 2/Dose 1|subject not compliance|1|||
13391360|NCT00679263|26776632|FG001|Visit 2/Dose 1|subject not compliance|1|||
13391361|NCT00679263|26776633|FG002|Visit 2/Dose 1|subject not compliance|0|||
13391362|NCT00679211|26776647|FG000|Overall Study|Progressive disease|82|||
13391363|NCT00679211|26776647|FG000|Overall Study|Adverse Event|7|||
13391364|NCT00679211|26776647|FG000|Overall Study|Withdrawal by Subject|2|||
13391365|NCT00679211|26776647|FG000|Overall Study|Physician Decision|5|||
13391366|NCT00679211|26776647|FG000|Overall Study|Refused to undergo protocol procedures|1|||
13391367|NCT00679211|26776647|FG000|Overall Study|Transferred to extension study TDM4529g|12|||
13391368|NCT00679211|26776647|FG000|Overall Study|Other|1|||
13391369|NCT00679172|26776726|FG000|Overall Study|Non-compliance|1|||
13391370|NCT00679172|26776727|FG001|Overall Study|Non-compliance|1|||
13391371|NCT00679172|26776728|FG002|Overall Study|Non-compliance|0|||
13391372|NCT00679172|26776729|FG003|Overall Study|Non-compliance|1|||
13391373|NCT00679172|26776730|FG004|Overall Study|Non-compliance|0|||
13391374|NCT00679172|26776726|FG000|Overall Study|Other not specified|0|||
13391375|NCT00679172|26776727|FG001|Overall Study|Other not specified|0|||
13391376|NCT00679172|26776728|FG002|Overall Study|Other not specified|1|||
13391377|NCT00679172|26776729|FG003|Overall Study|Other not specified|0|||
13391378|NCT00679172|26776730|FG004|Overall Study|Other not specified|0|||
13391379|NCT00679081|26776740|FG000|Overall Study|Lost to Follow-up|1|||
13391380|NCT00679055|26776757|FG000|Overall Study|Adverse Event|0|||
13391381|NCT00679055|26776758|FG001|Overall Study|Adverse Event|1|||
13391382|NCT00679055|26776757|FG000|Overall Study|Other|0|||
13391383|NCT00679055|26776758|FG001|Overall Study|Other|3|||
13391384|NCT00679055|26776757|FG000|Overall Study|Study Terminated|2|||
13391385|NCT00679055|26776758|FG001|Overall Study|Study Terminated|1|||
13391386|NCT00679042|26776768|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2|||
13391387|NCT00679042|26776768|FG000|5-Year Follow Up|In follow-up (ongoing)|6|||
13391388|NCT00679042|26776768|FG000|5-Year Follow Up|Death|1|||
13391389|NCT00679042|26776768|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7|||
13391390|NCT00679042|26776768|FG000|10-Year Follow Up|In follow-up (ongoing)|5|||
13391391|NCT00679029|26776777|FG000|Overall Study|Adverse Event|3|||
13391392|NCT00679029|26776777|FG000|Overall Study|Withdrawal by Subject|1|||
13391393|NCT00679029|26776777|FG000|Overall Study|Lost to Follow-up|1|||
13391394|NCT00678899|26776786|FG000|Overall Study|Adverse Event|1|||
13391395|NCT00678886|26776839|FG000|Overall Study|Withdrawal by Subject|0|||
13391396|NCT00678886|26776840|FG001|Overall Study|Withdrawal by Subject|0|||
13391397|NCT00678886|26776841|FG002|Overall Study|Withdrawal by Subject|4|||
13391398|NCT00678886|26776842|FG003|Overall Study|Withdrawal by Subject|6|||
13391399|NCT00678886|26776839|FG000|Overall Study|Physician Decision|0|||
13391400|NCT00678886|26776840|FG001|Overall Study|Physician Decision|0|||
13391401|NCT00678886|26776841|FG002|Overall Study|Physician Decision|1|||
13391402|NCT00678886|26776842|FG003|Overall Study|Physician Decision|1|||
13391403|NCT00678886|26776839|FG000|Overall Study|Lost to Follow-up|0|||
13391404|NCT00678886|26776840|FG001|Overall Study|Lost to Follow-up|0|||
13391405|NCT00678886|26776841|FG002|Overall Study|Lost to Follow-up|3|||
13391406|NCT00678886|26776842|FG003|Overall Study|Lost to Follow-up|2|||
13391407|NCT00678886|26776839|FG000|Overall Study|Other|0|||
13391408|NCT00678886|26776840|FG001|Overall Study|Other|0|||
13391409|NCT00678886|26776841|FG002|Overall Study|Other|1|||
13391410|NCT00678886|26776842|FG003|Overall Study|Other|0|||
13391411|NCT00678795|26776869|FG000|Overall Study|Adverse Event|7|||
13391412|NCT00678795|26776870|FG001|Overall Study|Adverse Event|3|||
13391413|NCT00678795|26776869|FG000|Overall Study|Withdrawal by Subject|3|||
13391414|NCT00678795|26776870|FG001|Overall Study|Withdrawal by Subject|0|||
13391415|NCT00678795|26776869|FG000|Overall Study|Protocol Violation|0|||
13391416|NCT00678795|26776870|FG001|Overall Study|Protocol Violation|1|||
13391417|NCT00678795|26776869|FG000|Overall Study|Lost to Follow-up|0|||
13391418|NCT00678795|26776870|FG001|Overall Study|Lost to Follow-up|1|||
13391419|NCT00678795|26776869|FG000|Overall Study|Lack of Efficacy|1|||
13391420|NCT00678795|26776870|FG001|Overall Study|Lack of Efficacy|1|||
13391421|NCT00678691|26776883|FG000|Overall Study|Adverse Event|6|||
13391422|NCT00678691|26776884|FG001|Overall Study|Adverse Event|4|||
13391423|NCT00678652|26776919|FG000|Overall Study|Protocol Violation|2|||
13391424|NCT00678652|26776920|FG001|Overall Study|Protocol Violation|0|||
13391425|NCT00678652|26776921|FG002|Overall Study|Protocol Violation|0|||
13391426|NCT00678652|26776922|FG003|Overall Study|Protocol Violation|0|||
13391427|NCT00678652|26776919|FG000|Overall Study|Pregnancy|0|||
13391428|NCT00678652|26776920|FG001|Overall Study|Pregnancy|0|||
13391429|NCT00678652|26776921|FG002|Overall Study|Pregnancy|1|||
13391430|NCT00678652|26776922|FG003|Overall Study|Pregnancy|0|||
13391431|NCT00678652|26776919|FG000|Overall Study|Relocation|1|||
13391432|NCT00678652|26776920|FG001|Overall Study|Relocation|0|||
13391433|NCT00678652|26776921|FG002|Overall Study|Relocation|0|||
13391434|NCT00678652|26776922|FG003|Overall Study|Relocation|0|||
13391435|NCT00678639|26776942|FG000|Overall Study|Lost to Follow-up at 30 days|2|||
13391436|NCT00678639|26776943|FG001|Overall Study|Lost to Follow-up at 30 days|0|||
13391437|NCT00678587|26776982|FG000|Overall Study|Adverse Event|3|||
13391438|NCT00678587|26776983|FG001|Overall Study|Adverse Event|3|||
13391439|NCT00678587|26776982|FG000|Overall Study|Lack of Efficacy|1|||
13391440|NCT00678587|26776983|FG001|Overall Study|Lack of Efficacy|0|||
13391441|NCT00678587|26776982|FG000|Overall Study|Protocol Violation|2|||
13391442|NCT00678587|26776983|FG001|Overall Study|Protocol Violation|1|||
13391443|NCT00678587|26776982|FG000|Overall Study|Study Closed/Terminated|1|||
13391444|NCT00678587|26776983|FG001|Overall Study|Study Closed/Terminated|0|||
13391445|NCT00678587|26776982|FG000|Overall Study|Lost to Follow-up|3|||
13391446|NCT00678587|26776983|FG001|Overall Study|Lost to Follow-up|5|||
13391447|NCT00678587|26776982|FG000|Overall Study|Investigator Discretion|2|||
13391448|NCT00678587|26776983|FG001|Overall Study|Investigator Discretion|6|||
13391449|NCT00678587|26776982|FG000|Overall Study|Withdrew Consent|8|||
13391450|NCT00678587|26776983|FG001|Overall Study|Withdrew Consent|3|||
13391451|NCT00678561|26777061|FG000|Overall Study|Adverse Event|0|||
13391452|NCT00678561|26777062|FG001|Overall Study|Adverse Event|1|||
13391453|NCT00678561|26777063|FG002|Overall Study|Adverse Event|1|||
13391454|NCT00678561|26777064|FG003|Overall Study|Adverse Event|0|||
13391455|NCT00678561|26777065|FG004|Overall Study|Adverse Event|1|||
13391456|NCT00678561|26777066|FG005|Overall Study|Adverse Event|0|||
13391457|NCT00678561|26777067|FG006|Overall Study|Adverse Event|0|||
13391458|NCT00678561|26777068|FG007|Overall Study|Adverse Event|0|||
13391459|NCT00678561|26777061|FG000|Overall Study|Protocol Violation|0|||
13391460|NCT00678561|26777062|FG001|Overall Study|Protocol Violation|0|||
13391461|NCT00678561|26777063|FG002|Overall Study|Protocol Violation|0|||
13391462|NCT00678561|26777064|FG003|Overall Study|Protocol Violation|0|||
13391463|NCT00678561|26777065|FG004|Overall Study|Protocol Violation|1|||
13391464|NCT00678561|26777066|FG005|Overall Study|Protocol Violation|1|||
13391465|NCT00678561|26777067|FG006|Overall Study|Protocol Violation|0|||
13391466|NCT00678561|26777068|FG007|Overall Study|Protocol Violation|0|||
13391467|NCT00678561|26777061|FG000|Overall Study|Withdrawal by Subject|0|||
13391468|NCT00678561|26777062|FG001|Overall Study|Withdrawal by Subject|0|||
13391469|NCT00678561|26777063|FG002|Overall Study|Withdrawal by Subject|0|||
13391470|NCT00678561|26777064|FG003|Overall Study|Withdrawal by Subject|0|||
13391471|NCT00678561|26777065|FG004|Overall Study|Withdrawal by Subject|0|||
13391472|NCT00678561|26777066|FG005|Overall Study|Withdrawal by Subject|0|||
13391473|NCT00678561|26777067|FG006|Overall Study|Withdrawal by Subject|0|||
13391474|NCT00678561|26777068|FG007|Overall Study|Withdrawal by Subject|1|||
13391475|NCT00678392|26777107|FG000|Overall Study|Adverse Event|0|||
13391476|NCT00678392|26777108|FG001|Overall Study|Adverse Event|6|||
13391477|NCT00678392|26777107|FG000|Overall Study|Death|280|||
13391478|NCT00678392|26777108|FG001|Overall Study|Death|269|||
13391479|NCT00678392|26777107|FG000|Overall Study|Lost to Follow-up|15|||
13391480|NCT00678392|26777108|FG001|Overall Study|Lost to Follow-up|13|||
13391481|NCT00678392|26777107|FG000|Overall Study|Objective Progression or Relapse|3|||
13391482|NCT00678392|26777108|FG001|Overall Study|Objective Progression or Relapse|8|||
13391483|NCT00678392|26777107|FG000|Overall Study|Sponsor's Decision|1|||
13391484|NCT00678392|26777108|FG001|Overall Study|Sponsor's Decision|2|||
13391485|NCT00678392|26777107|FG000|Overall Study|Withdrawal by Subject|4|||
13391486|NCT00678392|26777108|FG001|Overall Study|Withdrawal by Subject|4|||
13391487|NCT00678392|26777107|FG000|Overall Study|Randomized But Not Treated|2|||
13391488|NCT00678392|26777108|FG001|Overall Study|Randomized But Not Treated|7|||
13391489|NCT00678392|26777107|FG000|Overall Study|Other|56|||
13391490|NCT00678392|26777108|FG001|Overall Study|Other|53|||
13391491|NCT00678379|26777144|FG000|Overall Study|Injection performed after tonsillectomy|2|||
13391492|NCT00678379|26777145|FG001|Overall Study|Injection performed after tonsillectomy|0|||
13391493|NCT00678379|26777146|FG002|Overall Study|Injection performed after tonsillectomy|1|||
13391494|NCT00678379|26777144|FG000|Overall Study|Incomplete Data|4|||
13391495|NCT00678379|26777145|FG001|Overall Study|Incomplete Data|3|||
13391496|NCT00678379|26777146|FG002|Overall Study|Incomplete Data|3|||
13391497|NCT00678301|26777209|FG000|Overall Study|Non-compliance with study procedures|0|||
13391498|NCT00678301|26777210|FG001|Overall Study|Non-compliance with study procedures|1|||
13391499|NCT00678301|26777209|FG000|Overall Study|Adverse Event|1|||
13391500|NCT00678301|26777210|FG001|Overall Study|Adverse Event|0|||
13391501|NCT00678301|26777209|FG000|Overall Study|Withdrawal by Subject|4|||
13391502|NCT00678301|26777210|FG001|Overall Study|Withdrawal by Subject|0|||
13391503|NCT00678301|26777209|FG000|Overall Study|Lost to Follow-up|3|||
13391504|NCT00678301|26777210|FG001|Overall Study|Lost to Follow-up|1|||
13391505|NCT00678288|26777231|FG000|Overall Study|Adverse Event|0|||
13391506|NCT00678288|26777232|FG001|Overall Study|Adverse Event|2|||
13391507|NCT00678288|26777231|FG000|Overall Study|Withdrawal by Subject|1|||
13391508|NCT00678288|26777232|FG001|Overall Study|Withdrawal by Subject|1|||
13391509|NCT00678288|26777231|FG000|Overall Study|Study terminated by the sponsor|2|||
13391510|NCT00678288|26777232|FG001|Overall Study|Study terminated by the sponsor|0|||
13391511|NCT00678288|26777231|FG000|Overall Study|Not compliant with study medication|0|||
13391512|NCT00678288|26777232|FG001|Overall Study|Not compliant with study medication|1|||
13391513|NCT00678288|26777231|FG000|Overall Study|Switch to commercial drug|0|||
13391514|NCT00678288|26777232|FG001|Overall Study|Switch to commercial drug|1|||
13391515|NCT00678288|26777231|FG000|Overall Study|Reason not reported|1|||
13391516|NCT00678288|26777232|FG001|Overall Study|Reason not reported|0|||
13391517|NCT00678288|26777231|FG000|Overall Study|Disease progression/recurrence/relapse|6|||
13391518|NCT00678288|26777232|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
13391519|NCT00678210|26777279|FG000|Overall Study|Adverse Event|1|||
13391520|NCT00678210|26777280|FG001|Overall Study|Adverse Event|2|||
13391521|NCT00678210|26777281|FG002|Overall Study|Adverse Event|3|||
13391522|NCT00678210|26777282|FG003|Overall Study|Adverse Event|3|||
13391523|NCT00678210|26777279|FG000|Overall Study|Lack of Efficacy|2|||
13391524|NCT00678210|26777280|FG001|Overall Study|Lack of Efficacy|3|||
13391525|NCT00678210|26777281|FG002|Overall Study|Lack of Efficacy|1|||
13391526|NCT00678210|26777282|FG003|Overall Study|Lack of Efficacy|9|||
13391527|NCT00678210|26777279|FG000|Overall Study|Lost to Follow-up|4|||
13391528|NCT00678210|26777280|FG001|Overall Study|Lost to Follow-up|2|||
13391529|NCT00678210|26777281|FG002|Overall Study|Lost to Follow-up|0|||
13391530|NCT00678210|26777282|FG003|Overall Study|Lost to Follow-up|1|||
13391531|NCT00678210|26777279|FG000|Overall Study|Withdrawal by Subject|3|||
13391532|NCT00678210|26777280|FG001|Overall Study|Withdrawal by Subject|4|||
13391533|NCT00678210|26777281|FG002|Overall Study|Withdrawal by Subject|1|||
13391534|NCT00678210|26777282|FG003|Overall Study|Withdrawal by Subject|7|||
13391535|NCT00678210|26777279|FG000|Overall Study|Other|1|||
13391536|NCT00678210|26777280|FG001|Overall Study|Other|0|||
13391537|NCT00678210|26777281|FG002|Overall Study|Other|1|||
13391538|NCT00678210|26777282|FG003|Overall Study|Other|0|||
13391539|NCT00678080|26777313|FG000|Overall Study|Physician Decision|2|||
13391540|NCT00678080|26777314|FG001|Overall Study|Physician Decision|0|||
13391541|NCT00678080|26777313|FG000|Overall Study|Lost to Follow-up|1|||
13391542|NCT00678080|26777314|FG001|Overall Study|Lost to Follow-up|0|||
13391543|NCT00678080|26777313|FG000|Overall Study|Withdrawal by Subject|0|||
13391544|NCT00678080|26777314|FG001|Overall Study|Withdrawal by Subject|1|||
13391545|NCT00678041|26777333|FG000|Overall Study|Physician Decision|5|||
13391546|NCT00678041|26777334|FG001|Overall Study|Physician Decision|5|||
13391547|NCT00677833|26777395|FG000|Overall Study|Withdrawal by Subject|4|||
13391548|NCT00677833|26777396|FG001|Overall Study|Withdrawal by Subject|0|||
13391549|NCT00677833|26777397|FG002|Overall Study|Withdrawal by Subject|1|||
13391550|NCT00677833|26777398|FG003|Overall Study|Withdrawal by Subject|3|||
13391551|NCT00677833|26777395|FG000|Overall Study|Lost to Follow-up|0|||
13391552|NCT00677833|26777396|FG001|Overall Study|Lost to Follow-up|0|||
13391553|NCT00677833|26777397|FG002|Overall Study|Lost to Follow-up|1|||
13391554|NCT00677833|26777398|FG003|Overall Study|Lost to Follow-up|0|||
13391555|NCT00677820|26777423|FG000|Overall Study|Lost to Follow-up|1|||
13391556|NCT00677820|26777424|FG001|Overall Study|Lost to Follow-up|0|||
13391557|NCT00677807|26777463|FG000|Overall Study|Adverse Event|4|||
13391558|NCT00677807|26777464|FG001|Overall Study|Adverse Event|1|||
13391559|NCT00677807|26777465|FG002|Overall Study|Adverse Event|6|||
13391560|NCT00677807|26777463|FG000|Overall Study|Lack of Efficacy|0|||
13391561|NCT00677807|26777464|FG001|Overall Study|Lack of Efficacy|0|||
13391562|NCT00677807|26777465|FG002|Overall Study|Lack of Efficacy|2|||
13391563|NCT00677807|26777463|FG000|Overall Study|Participant no longer needs study drug|0|||
13391564|NCT00677807|26777464|FG001|Overall Study|Participant no longer needs study drug|0|||
13391565|NCT00677807|26777465|FG002|Overall Study|Participant no longer needs study drug|1|||
13391566|NCT00677807|26777463|FG000|Overall Study|Withdrawal by Subject|10|||
13391567|NCT00677807|26777464|FG001|Overall Study|Withdrawal by Subject|3|||
13391568|NCT00677807|26777465|FG002|Overall Study|Withdrawal by Subject|6|||
13391569|NCT00677807|26777463|FG000|Overall Study|Lost to Follow-up|2|||
13391570|NCT00677807|26777464|FG001|Overall Study|Lost to Follow-up|2|||
13391571|NCT00677807|26777465|FG002|Overall Study|Lost to Follow-up|2|||
13391572|NCT00677807|26777463|FG000|Overall Study|Administrative problems|1|||
13391573|NCT00677807|26777464|FG001|Overall Study|Administrative problems|1|||
13391574|NCT00677807|26777465|FG002|Overall Study|Administrative problems|2|||
13391575|NCT00677807|26777463|FG000|Overall Study|Death|0|||
13391576|NCT00677807|26777464|FG001|Overall Study|Death|1|||
13391577|NCT00677807|26777465|FG002|Overall Study|Death|1|||
13391578|NCT00677807|26777463|FG000|Overall Study|Protocol Deviation|1|||
13391579|NCT00677807|26777464|FG001|Overall Study|Protocol Deviation|3|||
13391580|NCT00677807|26777465|FG002|Overall Study|Protocol Deviation|0|||
13391581|NCT00677534|26777471|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1|||
13391582|NCT00677534|26777471|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
13391583|NCT00677534|26777471|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
13391584|NCT00677365|26777514|FG000|Overall Study|Adverse Event|2|||
13391585|NCT00677365|26777515|FG001|Overall Study|Adverse Event|1|||
13391586|NCT00677365|26777516|FG002|Overall Study|Adverse Event|1|||
13391587|NCT00677365|26777517|FG003|Overall Study|Adverse Event|2|||
13391588|NCT00677365|26777514|FG000|Overall Study|Withdrawal by Subject|0|||
13391589|NCT00677365|26777515|FG001|Overall Study|Withdrawal by Subject|0|||
13391590|NCT00677365|26777516|FG002|Overall Study|Withdrawal by Subject|1|||
13391591|NCT00677365|26777517|FG003|Overall Study|Withdrawal by Subject|0|||
13391592|NCT00677365|26777514|FG000|Overall Study|Other reason|0|||
13391593|NCT00677365|26777515|FG001|Overall Study|Other reason|0|||
13391594|NCT00677365|26777516|FG002|Overall Study|Other reason|0|||
13391595|NCT00677365|26777517|FG003|Overall Study|Other reason|1|||
13391596|NCT00677352|26777542|FG000|Treatment Phase|Adverse Event|14|||
13391597|NCT00677352|26777543|FG001|Treatment Phase|Adverse Event|22|||
13391598|NCT00677352|26777542|FG000|Treatment Phase|Lack of Efficacy|2|||
13391599|NCT00677352|26777543|FG001|Treatment Phase|Lack of Efficacy|3|||
13391600|NCT00677352|26777542|FG000|Treatment Phase|Lost to Follow-up|0|||
13391601|NCT00677352|26777543|FG001|Treatment Phase|Lost to Follow-up|1|||
13391602|NCT00677352|26777542|FG000|Treatment Phase|Withdrawal by Subject|7|||
13391603|NCT00677352|26777543|FG001|Treatment Phase|Withdrawal by Subject|7|||
13391604|NCT00677352|26777542|FG000|Treatment Phase|Physician Decision|1|||
13391605|NCT00677352|26777543|FG001|Treatment Phase|Physician Decision|0|||
13391606|NCT00677352|26777542|FG000|Treatment Phase|Pregnancy|0|||
13391607|NCT00677352|26777543|FG001|Treatment Phase|Pregnancy|1|||
13391608|NCT00677352|26777542|FG000|Treatment Phase|Protocol Violation|1|||
13391609|NCT00677352|26777543|FG001|Treatment Phase|Protocol Violation|1|||
13391610|NCT00677352|26777542|FG000|Treatment Phase|Transference or work related matter|0|||
13391611|NCT00677352|26777543|FG001|Treatment Phase|Transference or work related matter|5|||
13391612|NCT00677352|26777542|FG000|Treatment Phase|Not treated|0|||
13391613|NCT00677352|26777543|FG001|Treatment Phase|Not treated|2|||
13391614|NCT00677352|26777542|FG000|Tapering Phase|Adverse Event|1|||
13391615|NCT00677352|26777543|FG001|Tapering Phase|Adverse Event|5|||
13391616|NCT00677352|26777542|FG000|Tapering Phase|Withdrawal by Subject|5|||
13391617|NCT00677352|26777543|FG001|Tapering Phase|Withdrawal by Subject|3|||
13391618|NCT00677352|26777542|FG000|Tapering Phase|Pregnancy|0|||
13391619|NCT00677352|26777543|FG001|Tapering Phase|Pregnancy|1|||
13391620|NCT00677352|26777542|FG000|Tapering Phase|Job transfer|0|||
13391621|NCT00677352|26777543|FG001|Tapering Phase|Job transfer|1|||
13391622|NCT00677235|26777590|FG000|Overall Study|Withdrawal by Subject|1|||
13391623|NCT00677235|26777591|FG001|Overall Study|Withdrawal by Subject|1|||
13391624|NCT00677235|26777590|FG000|Overall Study|Lost to Follow-up|2|||
13391625|NCT00677235|26777591|FG001|Overall Study|Lost to Follow-up|1|||
13391626|NCT00677235|26777590|FG000|Overall Study|Death|37|||
13391627|NCT00677235|26777591|FG001|Overall Study|Death|36|||
13391628|NCT00677235|26777590|FG000|Overall Study|Adverse Experience|1|||
13391629|NCT00677235|26777591|FG001|Overall Study|Adverse Experience|0|||
13391630|NCT00677092|26777602|FG000|Overall Study|Adverse Event|1|||
13391631|NCT00677092|26777602|FG000|Overall Study|Lost to Follow-up|1|||
13391632|NCT00677092|26777602|FG000|Overall Study|Withdrawal by Subject|3|||
13135107|NCT02745145|25993630|FG001|Overall Study|Adverse Event|0|||
13474895|NCT02097121|26996909|FG002|Overall Study|Lack of Efficacy|3|||
13391633|NCT00677092|26777602|FG000|Overall Study|Death Prior to Receiving Treatment|1|||
13391634|NCT00677014|26777620|FG000|Overall Study|Lost to Follow-up|20|||
13391635|NCT00677014|26777621|FG001|Overall Study|Lost to Follow-up|12|||
13391636|NCT00677014|26777622|FG002|Overall Study|Lost to Follow-up|24|||
13391637|NCT00677014|26777620|FG000|Overall Study|Death|6|||
13391638|NCT00677014|26777621|FG001|Overall Study|Death|15|||
13391639|NCT00677014|26777622|FG002|Overall Study|Death|7|||
13391640|NCT00677014|26777620|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
13391641|NCT00677014|26777621|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14|||
13391642|NCT00677014|26777622|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
13391643|NCT00676689|26777630|FG000|Overall Study|Screen Failure|2|||
13391644|NCT00676689|26777630|FG000|Overall Study|Death|2|||
13391645|NCT00676689|26777630|FG000|Overall Study|Lost to Follow-up|4|||
13391646|NCT00676689|26777630|FG000|Overall Study|Physician Decision|1|||
13391647|NCT00676689|26777630|FG000|Overall Study|Withdrawal by Subject|3|||
13391648|NCT00676689|26777630|FG000|Overall Study|Continuing FU|49|||
13391649|NCT00676663|26777651|FG000|Overall Study|Death|43|||
13391650|NCT00676663|26777652|FG001|Overall Study|Death|27|||
13391651|NCT00676663|26777651|FG000|Overall Study|Withdrew Consent|1|||
13391652|NCT00676663|26777652|FG001|Overall Study|Withdrew Consent|8|||
13391653|NCT00676663|26777651|FG000|Overall Study|Lost to Follow-up|1|||
13391654|NCT00676663|26777652|FG001|Overall Study|Lost to Follow-up|3|||
13391655|NCT00676650|26777677|FG000|Overall Study|Death|45|||
13391656|NCT00676650|26777678|FG001|Overall Study|Death|14|||
13391657|NCT00676650|26777677|FG000|Overall Study|Adverse Event|159|||
13391658|NCT00676650|26777678|FG001|Overall Study|Adverse Event|21|||
13391659|NCT00676650|26777677|FG000|Overall Study|Global deterioration of health status|66|||
13391660|NCT00676650|26777678|FG001|Overall Study|Global deterioration of health status|31|||
13391661|NCT00676650|26777677|FG000|Overall Study|Lost to Follow-up|0|||
13391662|NCT00676650|26777678|FG001|Overall Study|Lost to Follow-up|1|||
13391663|NCT00676650|26777677|FG000|Overall Study|Objective progression or relapse|189|||
13391664|NCT00676650|26777678|FG001|Overall Study|Objective progression or relapse|140|||
13391665|NCT00676650|26777677|FG000|Overall Study|Other|14|||
13391666|NCT00676650|26777678|FG001|Overall Study|Other|10|||
13391667|NCT00676650|26777677|FG000|Overall Study|Protocol Violation|3|||
13391668|NCT00676650|26777678|FG001|Overall Study|Protocol Violation|1|||
13391669|NCT00676650|26777677|FG000|Overall Study|Study terminated by sponsor|57|||
13391670|NCT00676650|26777678|FG001|Overall Study|Study terminated by sponsor|43|||
13391671|NCT00676650|26777677|FG000|Overall Study|Withdrawal by Subject|48|||
13391672|NCT00676650|26777678|FG001|Overall Study|Withdrawal by Subject|24|||
13391673|NCT00676650|26777677|FG000|Overall Study|Randomized but not treated|3|||
13391674|NCT00676650|26777678|FG001|Overall Study|Randomized but not treated|4|||
13391675|NCT00676520|26777737|FG000|Overall Study|Withdrawal by Subject|163|||
13391676|NCT00676520|26777737|FG000|Overall Study|Lost to Follow-up|162|||
13391677|NCT00676520|26777737|FG000|Overall Study|Death|159|||
13391678|NCT00676520|26777737|FG000|Overall Study|Physician Decision|20|||
13391679|NCT00676520|26777737|FG000|Overall Study|Ineligible for Randomization to DAPT|209|||
13391680|NCT00676520|26777737|FG000|Overall Study|Other Reason|18|||
13391681|NCT00676403|26777884|FG000|Overall Study|Adverse Event|1|||
13391682|NCT00676403|26777885|FG001|Overall Study|Adverse Event|2|||
13391683|NCT00676403|26777886|FG002|Overall Study|Adverse Event|0|||
13391684|NCT00676403|26777887|FG003|Overall Study|Adverse Event|5|||
13391685|NCT00676403|26777888|FG004|Overall Study|Adverse Event|1|||
13391686|NCT00676403|26777889|FG005|Overall Study|Adverse Event|2|||
13391687|NCT00676403|26777884|FG000|Overall Study|Lost to Follow-up|0|||
13391688|NCT00676403|26777885|FG001|Overall Study|Lost to Follow-up|0|||
13391689|NCT00676403|26777886|FG002|Overall Study|Lost to Follow-up|0|||
13391690|NCT00676403|26777887|FG003|Overall Study|Lost to Follow-up|0|||
13391691|NCT00676403|26777888|FG004|Overall Study|Lost to Follow-up|0|||
13391692|NCT00676403|26777889|FG005|Overall Study|Lost to Follow-up|1|||
13391693|NCT00676403|26777884|FG000|Overall Study|Reason Unspecified|1|||
13391694|NCT00676403|26777885|FG001|Overall Study|Reason Unspecified|0|||
13391695|NCT00676403|26777886|FG002|Overall Study|Reason Unspecified|1|||
13391696|NCT00676403|26777887|FG003|Overall Study|Reason Unspecified|0|||
13391697|NCT00676403|26777888|FG004|Overall Study|Reason Unspecified|0|||
13391698|NCT00676403|26777889|FG005|Overall Study|Reason Unspecified|1|||
13391699|NCT00676403|26777884|FG000|Overall Study|Withdrawal by Subject|0|||
13391700|NCT00676403|26777885|FG001|Overall Study|Withdrawal by Subject|0|||
13391701|NCT00676403|26777886|FG002|Overall Study|Withdrawal by Subject|0|||
13391702|NCT00676403|26777887|FG003|Overall Study|Withdrawal by Subject|0|||
13391703|NCT00676403|26777888|FG004|Overall Study|Withdrawal by Subject|0|||
13391704|NCT00676403|26777889|FG005|Overall Study|Withdrawal by Subject|1|||
13391705|NCT00676338|26777952|FG000|Overall Study|Adverse Event|6|||
13391706|NCT00676338|26777953|FG001|Overall Study|Adverse Event|6|||
13391707|NCT00676338|26777954|FG002|Overall Study|Adverse Event|5|||
13391708|NCT00676338|26777955|FG003|Overall Study|Adverse Event|1|||
13391709|NCT00676338|26777952|FG000|Overall Study|Lost to Follow-up|4|||
13391710|NCT00676338|26777953|FG001|Overall Study|Lost to Follow-up|1|||
13391711|NCT00676338|26777954|FG002|Overall Study|Lost to Follow-up|3|||
13391712|NCT00676338|26777955|FG003|Overall Study|Lost to Follow-up|4|||
13391713|NCT00676338|26777952|FG000|Overall Study|Physician Decision|3|||
13391714|NCT00676338|26777953|FG001|Overall Study|Physician Decision|3|||
13391715|NCT00676338|26777954|FG002|Overall Study|Physician Decision|2|||
13391716|NCT00676338|26777955|FG003|Overall Study|Physician Decision|3|||
13391717|NCT00676338|26777952|FG000|Overall Study|Protocol Violation|5|||
13391718|NCT00676338|26777953|FG001|Overall Study|Protocol Violation|9|||
13391719|NCT00676338|26777954|FG002|Overall Study|Protocol Violation|2|||
13391720|NCT00676338|26777955|FG003|Overall Study|Protocol Violation|5|||
13391721|NCT00676338|26777952|FG000|Overall Study|Withdrawal by Subject|17|||
13391722|NCT00676338|26777953|FG001|Overall Study|Withdrawal by Subject|9|||
13391723|NCT00676338|26777954|FG002|Overall Study|Withdrawal by Subject|12|||
13391724|NCT00676338|26777955|FG003|Overall Study|Withdrawal by Subject|6|||
13391725|NCT00676338|26777952|FG000|Overall Study|Entry Criteria Not Met|0|||
13391726|NCT00676338|26777953|FG001|Overall Study|Entry Criteria Not Met|2|||
13391727|NCT00676338|26777954|FG002|Overall Study|Entry Criteria Not Met|1|||
13391728|NCT00676338|26777955|FG003|Overall Study|Entry Criteria Not Met|1|||
13391729|NCT00676338|26777952|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
13391730|NCT00676338|26777953|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
13391731|NCT00676338|26777954|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5|||
13391732|NCT00676338|26777955|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
13391733|NCT00676208|26777970|FG000|Overall Study|Lost to Follow-up|0|||
13391734|NCT00676208|26777971|FG001|Overall Study|Lost to Follow-up|2|||
13391735|NCT00676208|26777970|FG000|Overall Study|Incomplete data|2|||
13391736|NCT00676208|26777971|FG001|Overall Study|Incomplete data|4|||
13391737|NCT00676195|26777981|FG000|Overall Study|Lost to Follow-up|1|||
13391738|NCT00676195|26777981|FG000|Overall Study|Adverse Event|1|||
13391739|NCT00676195|26777981|FG000|Overall Study|Physician Decision|1|||
13391740|NCT00676143|26778026|FG000|Overall Study|Adverse Event|34|||
13391741|NCT00676143|26778027|FG001|Overall Study|Adverse Event|60|||
13391742|NCT00676143|26778026|FG000|Overall Study|Death|4|||
13391743|NCT00676143|26778027|FG001|Overall Study|Death|4|||
13391744|NCT00676143|26778026|FG000|Overall Study|Lack of Efficacy|0|||
13391745|NCT00676143|26778027|FG001|Overall Study|Lack of Efficacy|6|||
13391746|NCT00676143|26778026|FG000|Overall Study|Lost to Follow-up|0|||
13391747|NCT00676143|26778027|FG001|Overall Study|Lost to Follow-up|13|||
13391748|NCT00676143|26778026|FG000|Overall Study|Physician Decision|5|||
13391749|NCT00676143|26778027|FG001|Overall Study|Physician Decision|8|||
13391750|NCT00676143|26778026|FG000|Overall Study|Protocol Violation|4|||
13391751|NCT00676143|26778027|FG001|Overall Study|Protocol Violation|8|||
13391752|NCT00676143|26778026|FG000|Overall Study|Withdrawal by Subject|24|||
13391753|NCT00676143|26778027|FG001|Overall Study|Withdrawal by Subject|42|||
13391754|NCT00676143|26778026|FG000|Overall Study|Discontinuation of study by sponsor|65|||
13391755|NCT00676143|26778027|FG001|Overall Study|Discontinuation of study by sponsor|88|||
13391756|NCT00676143|26778026|FG000|Overall Study|Failed to return|2|||
13391757|NCT00676143|26778027|FG001|Overall Study|Failed to return|1|||
13391758|NCT00676143|26778026|FG000|Overall Study|Loss of caregiver|5|||
13391759|NCT00676143|26778027|FG001|Overall Study|Loss of caregiver|3|||
13391760|NCT00676143|26778026|FG000|Overall Study|Other|11|||
13391761|NCT00676143|26778027|FG001|Overall Study|Other|20|||
13391762|NCT00676143|26778026|FG000|Overall Study|Participant participation unknown|1|||
13391763|NCT00676143|26778027|FG001|Overall Study|Participant participation unknown|4|||
13391764|NCT00676143|26778026|FG000|Overall Study|Vasogenic edema recurrence|1|||
13391765|NCT00676143|26778027|FG001|Overall Study|Vasogenic edema recurrence|3|||
13391766|NCT00676130|26778042|FG000|Overall Study|Lost to Follow-up|0|||
13391767|NCT00676130|26778043|FG001|Overall Study|Lost to Follow-up|1|||
13391768|NCT00676130|26778042|FG000|Overall Study|Found ineligible|3|||
13391769|NCT00676130|26778043|FG001|Overall Study|Found ineligible|2|||
13391770|NCT00676130|26778042|FG000|Overall Study|Withdrawal by Subject|0|||
13391771|NCT00676130|26778043|FG001|Overall Study|Withdrawal by Subject|1|||
13391772|NCT00676091|26778082|FG000|Infant Series|Parent or legal guardian request|10|||
13391773|NCT00676091|26778083|FG001|Infant Series|Parent or legal guardian request|8|||
13391774|NCT00676091|26778082|FG000|Infant Series|Protocol Violation|6|||
13391775|NCT00676091|26778083|FG001|Infant Series|Protocol Violation|3|||
13391776|NCT00676091|26778082|FG000|Infant Series|Adverse Event|2|||
13391777|NCT00676091|26778083|FG001|Infant Series|Adverse Event|3|||
13391778|NCT00676091|26778082|FG000|Infant Series|Failed to return|1|||
13391779|NCT00676091|26778083|FG001|Infant Series|Failed to return|3|||
13391780|NCT00676091|26778082|FG000|Infant Series|Lost to Follow-up|1|||
13391781|NCT00676091|26778083|FG001|Infant Series|Lost to Follow-up|0|||
13391782|NCT00676091|26778082|FG000|Infant Series|Died prior to receiving 7vPnC|0|||
13391783|NCT00676091|26778083|FG001|Infant Series|Died prior to receiving 7vPnC|1|||
13391784|NCT00676091|26778082|FG000|After Infant Series|Adverse Event|0|||
13391785|NCT00676091|26778083|FG001|After Infant Series|Adverse Event|1|||
13391786|NCT00676091|26778082|FG000|After Infant Series|Protocol Violation|0|||
13391787|NCT00676091|26778083|FG001|After Infant Series|Protocol Violation|1|||
13391788|NCT00676091|26778082|FG000|After Infant Series|Failed to return|1|||
13391789|NCT00676091|26778083|FG001|After Infant Series|Failed to return|1|||
13391790|NCT00676091|26778082|FG000|Toddler Dose|Failed to return|2|||
13391791|NCT00676091|26778083|FG001|Toddler Dose|Failed to return|0|||
13391792|NCT00676091|26778082|FG000|Toddler Dose|Parent or legal guardian request|1|||
13391793|NCT00676091|26778083|FG001|Toddler Dose|Parent or legal guardian request|0|||
13391794|NCT00676052|26778134|FG000|Overall Study|Adverse Event|0|||
13391795|NCT00676052|26778135|FG001|Overall Study|Adverse Event|1|||
13391796|NCT00676052|26778136|FG002|Overall Study|Adverse Event|1|||
13391797|NCT00676052|26778137|FG003|Overall Study|Adverse Event|2|||
13391798|NCT00676052|26778138|FG004|Overall Study|Adverse Event|2|||
13391799|NCT00676052|26778139|FG005|Overall Study|Adverse Event|2|||
13391800|NCT00676052|26778134|FG000|Overall Study|Lack of Efficacy|2|||
13391801|NCT00676052|26778135|FG001|Overall Study|Lack of Efficacy|2|||
13391802|NCT00676052|26778136|FG002|Overall Study|Lack of Efficacy|1|||
13391803|NCT00676052|26778137|FG003|Overall Study|Lack of Efficacy|1|||
13391804|NCT00676052|26778138|FG004|Overall Study|Lack of Efficacy|2|||
13391805|NCT00676052|26778139|FG005|Overall Study|Lack of Efficacy|1|||
13391806|NCT00676052|26778134|FG000|Overall Study|Protocol Violation|5|||
13391807|NCT00676052|26778135|FG001|Overall Study|Protocol Violation|3|||
13391808|NCT00676052|26778136|FG002|Overall Study|Protocol Violation|2|||
13391809|NCT00676052|26778137|FG003|Overall Study|Protocol Violation|2|||
13391810|NCT00676052|26778138|FG004|Overall Study|Protocol Violation|1|||
13391811|NCT00676052|26778139|FG005|Overall Study|Protocol Violation|2|||
13391812|NCT00676052|26778134|FG000|Overall Study|Lost to Follow-up|0|||
13391813|NCT00676052|26778135|FG001|Overall Study|Lost to Follow-up|0|||
13391814|NCT00676052|26778136|FG002|Overall Study|Lost to Follow-up|0|||
13391815|NCT00676052|26778137|FG003|Overall Study|Lost to Follow-up|0|||
13391816|NCT00676052|26778138|FG004|Overall Study|Lost to Follow-up|1|||
13391817|NCT00676052|26778139|FG005|Overall Study|Lost to Follow-up|0|||
13391818|NCT00676052|26778134|FG000|Overall Study|Physician Decision|1|||
13391819|NCT00676052|26778135|FG001|Overall Study|Physician Decision|1|||
13391820|NCT00676052|26778136|FG002|Overall Study|Physician Decision|1|||
13391821|NCT00676052|26778137|FG003|Overall Study|Physician Decision|0|||
13391822|NCT00676052|26778138|FG004|Overall Study|Physician Decision|0|||
13391823|NCT00676052|26778139|FG005|Overall Study|Physician Decision|1|||
13391824|NCT00676052|26778134|FG000|Overall Study|Withdrawal by Subject|1|||
13391825|NCT00676052|26778135|FG001|Overall Study|Withdrawal by Subject|0|||
13391826|NCT00676052|26778136|FG002|Overall Study|Withdrawal by Subject|1|||
13391827|NCT00676052|26778137|FG003|Overall Study|Withdrawal by Subject|0|||
13391828|NCT00676052|26778138|FG004|Overall Study|Withdrawal by Subject|0|||
13391829|NCT00676052|26778139|FG005|Overall Study|Withdrawal by Subject|0|||
13391830|NCT00675948|26778156|FG000|Overall Study|Adverse Event|23|||
13391831|NCT00675948|26778157|FG001|Overall Study|Adverse Event|1|||
13391832|NCT00675948|26778156|FG000|Overall Study|Lack of Efficacy|3|||
13391833|NCT00675948|26778157|FG001|Overall Study|Lack of Efficacy|0|||
13391834|NCT00675948|26778156|FG000|Overall Study|Withdrawal by Subject|7|||
13391835|NCT00675948|26778157|FG001|Overall Study|Withdrawal by Subject|0|||
13391836|NCT00675948|26778156|FG000|Overall Study|Lost to Follow-up|2|||
13391837|NCT00675948|26778157|FG001|Overall Study|Lost to Follow-up|0|||
13391838|NCT00675948|26778156|FG000|Overall Study|Protocol Violation|1|||
13391839|NCT00675948|26778157|FG001|Overall Study|Protocol Violation|0|||
13391840|NCT00675948|26778156|FG000|Overall Study|Pain under control|1|||
13391841|NCT00675948|26778157|FG001|Overall Study|Pain under control|0|||
13391842|NCT00675948|26778156|FG000|Overall Study|Sponsor decision|0|||
13391843|NCT00675948|26778157|FG001|Overall Study|Sponsor decision|1|||
13391844|NCT00675948|26778156|FG000|Overall Study|Patient died|1|||
13391845|NCT00675948|26778157|FG001|Overall Study|Patient died|0|||
13391846|NCT00675948|26778156|FG000|Overall Study|Patient unable to comply with diaries|1|||
13391847|NCT00675948|26778157|FG001|Overall Study|Patient unable to comply with diaries|0|||
13391848|NCT00675948|26778156|FG000|Overall Study|Patient feels unable to take medication|0|||
13391849|NCT00675948|26778157|FG001|Overall Study|Patient feels unable to take medication|1|||
13391850|NCT00675766|26778180|FG000|Overall Study|Lost to Follow-up|6|||
13391851|NCT00675766|26778181|FG001|Overall Study|Lost to Follow-up|5|||
13391852|NCT00675766|26778182|FG002|Overall Study|Lost to Follow-up|21|||
13391853|NCT00675766|26778183|FG003|Overall Study|Lost to Follow-up|26|||
13391854|NCT00675597|26778189|FG000|Overall Study|Withdrawal by Subject|3|||
13391855|NCT00675506|26778212|FG000|Overall Study|Lost to Follow-up|1|||
13391856|NCT00675506|26778213|FG001|Overall Study|Lost to Follow-up|5|||
13391857|NCT00675506|26778212|FG000|Overall Study|Lost interest|3|||
13391858|NCT00675506|26778213|FG001|Overall Study|Lost interest|5|||
13391859|NCT00675506|26778212|FG000|Overall Study|Elevated fasting glucose|2|||
13391860|NCT00675506|26778213|FG001|Overall Study|Elevated fasting glucose|1|||
13391861|NCT00675506|26778212|FG000|Overall Study|Elevated IGF-1 prior to treatment|1|||
13391862|NCT00675506|26778213|FG001|Overall Study|Elevated IGF-1 prior to treatment|0|||
13391863|NCT00675506|26778212|FG000|Overall Study|Elevated IGF-1|2|||
13391864|NCT00675506|26778213|FG001|Overall Study|Elevated IGF-1|0|||
13391865|NCT00675506|26778212|FG000|Overall Study|Hypersensitivity Reaction|1|||
13391866|NCT00675506|26778213|FG001|Overall Study|Hypersensitivity Reaction|0|||
13391867|NCT00675506|26778212|FG000|Overall Study|Disclosed history of cancer|1|||
13391868|NCT00675506|26778213|FG001|Overall Study|Disclosed history of cancer|0|||
13391869|NCT00675506|26778212|FG000|Overall Study|Declined participation|1|||
13391870|NCT00675506|26778213|FG001|Overall Study|Declined participation|0|||
13391871|NCT00675506|26778212|FG000|Overall Study|Schedule conflict|0|||
13391872|NCT00675506|26778213|FG001|Overall Study|Schedule conflict|1|||
13391873|NCT00675441|26778219|FG000|Overall Study|Withdrawal by Subject|2|||
13391874|NCT00675441|26778219|FG000|Overall Study|Death|1|||
13391875|NCT00675428|26778244|FG000|Overall Study|Disease Progression|2|||
13391876|NCT00675428|26778245|FG001|Overall Study|Disease Progression|2|||
13391877|NCT00675428|26778244|FG000|Overall Study|No Disease Response After Cycle 6|0|||
13391878|NCT00675428|26778245|FG001|Overall Study|No Disease Response After Cycle 6|1|||
13391879|NCT00675428|26778244|FG000|Overall Study|Physician Decision|1|||
13391880|NCT00675428|26778245|FG001|Overall Study|Physician Decision|0|||
13391881|NCT00675103|26778252|FG000|Overall Study|Lack of Efficacy|2|||
13391882|NCT00675103|26778252|FG000|Overall Study|Adverse Event|1|||
13391883|NCT00675025|26778265|FG000|Overall Study|Study Terminated by Sponsor|38|||
13391884|NCT00675025|26778266|FG001|Overall Study|Study Terminated by Sponsor|42|||
13391885|NCT00675025|26778265|FG000|Overall Study|Adverse Event|6|||
13391886|NCT00675025|26778266|FG001|Overall Study|Adverse Event|11|||
13391887|NCT00675025|26778265|FG000|Overall Study|Lost to Follow-up|6|||
13391888|NCT00675025|26778266|FG001|Overall Study|Lost to Follow-up|4|||
13391889|NCT00675025|26778265|FG000|Overall Study|Withdrawal by Subject|4|||
13391890|NCT00675025|26778266|FG001|Overall Study|Withdrawal by Subject|6|||
13391891|NCT00674986|26778292|FG000|Overall Study|Adverse Event|2|||
13391892|NCT00674986|26778293|FG001|Overall Study|Adverse Event|1|||
13391893|NCT00674986|26778292|FG000|Overall Study|Subject withdrew consent|12|||
13391894|NCT00674986|26778293|FG001|Overall Study|Subject withdrew consent|19|||
13391895|NCT00674986|26778292|FG000|Overall Study|Lost to Follow-up|25|||
13391896|NCT00674986|26778293|FG001|Overall Study|Lost to Follow-up|53|||
13391897|NCT00674986|26778292|FG000|Overall Study|Other reasons|4|||
13391898|NCT00674986|26778293|FG001|Overall Study|Other reasons|8|||
13391899|NCT00674973|26778314|FG000|Overall Study|Insufficient Therapeutic Response|77|||
13391900|NCT00674973|26778315|FG001|Overall Study|Insufficient Therapeutic Response|72|||
13391901|NCT00674973|26778314|FG000|Overall Study|Refused Treatment|1|||
13391902|NCT00674973|26778315|FG001|Overall Study|Refused Treatment|5|||
13391903|NCT00674973|26778314|FG000|Overall Study|Failure to Return|1|||
13391904|NCT00674973|26778315|FG001|Overall Study|Failure to Return|0|||
13391905|NCT00674973|26778314|FG000|Overall Study|Adverse Event|2|||
13391906|NCT00674973|26778315|FG001|Overall Study|Adverse Event|9|||
13391907|NCT00674973|26778314|FG000|Overall Study|Death|19|||
13391908|NCT00674973|26778315|FG001|Overall Study|Death|15|||
13391909|NCT00674973|26778314|FG000|Overall Study|Protocol Violation|0|||
13391910|NCT00674973|26778315|FG001|Overall Study|Protocol Violation|1|||
13391911|NCT00674817|26778463|FG000|Period 1|Withdrawal by Subject|2|||
13391912|NCT00674817|26778463|FG000|Period 1|Protocol Violation|1|||
13391913|NCT00674817|26778463|FG000|Period 3|Adverse Event|1|||
13391914|NCT00674817|26778463|FG000|Period 3|Protocol Violation|1|||
13391915|NCT00674817|26778463|FG000|Period 4|Adverse Event|1|||
13391916|NCT00674700|26778484|FG000|Year 1|Adverse Event|17|||
13391917|NCT00674700|26778485|FG001|Year 1|Adverse Event|20|||
13391918|NCT00674700|26778486|FG002|Year 1|Adverse Event|5|||
13391919|NCT00674700|26778484|FG000|Year 1|Withdrawal by Subject|7|||
13391920|NCT00674700|26778485|FG001|Year 1|Withdrawal by Subject|7|||
13391921|NCT00674700|26778486|FG002|Year 1|Withdrawal by Subject|6|||
13391922|NCT00674700|26778484|FG000|Year 1|Any other reason not above-mentioned|7|||
13391923|NCT00674700|26778485|FG001|Year 1|Any other reason not above-mentioned|7|||
13391924|NCT00674700|26778486|FG002|Year 1|Any other reason not above-mentioned|6|||
13391925|NCT00674700|26778484|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0|||
13391926|NCT00674700|26778485|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1|||
13391927|NCT00674700|26778486|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1|||
13391928|NCT00674700|26778484|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
13391929|NCT00674700|26778485|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
13391930|NCT00674700|26778486|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4|||
13391931|NCT00674700|26778484|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5|||
13391932|NCT00674700|26778485|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10|||
13391933|NCT00674700|26778486|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7|||
13391934|NCT00674661|26778499|FG000|Overall Study|Other|5|||
13391935|NCT00674661|26778500|FG001|Overall Study|Other|7|||
13391936|NCT00674661|26778499|FG000|Overall Study|Lost to Follow-up|6|||
13391937|NCT00674661|26778500|FG001|Overall Study|Lost to Follow-up|3|||
13391938|NCT00674661|26778499|FG000|Overall Study|Withdrawal by Subject|0|||
13391939|NCT00674661|26778500|FG001|Overall Study|Withdrawal by Subject|5|||
13391940|NCT00674570|26778518|FG000|Overall Study|Withdrawal by Subject|0|||
13391941|NCT00674570|26778519|FG001|Overall Study|Withdrawal by Subject|2|||
13391942|NCT00674570|26778520|FG002|Overall Study|Withdrawal by Subject|0|||
13391943|NCT00674362|26778592|FG000|Double Blind|Adverse Event|6|||
13391944|NCT00674362|26778593|FG001|Double Blind|Adverse Event|6|||
13391945|NCT00674362|26778592|FG000|Double Blind|Lack of Efficacy|2|||
13391946|NCT00674362|26778593|FG001|Double Blind|Lack of Efficacy|6|||
13391947|NCT00674362|26778592|FG000|Double Blind|Loss of efficacy|0|||
13391948|NCT00674362|26778593|FG001|Double Blind|Loss of efficacy|1|||
13391949|NCT00674362|26778592|FG000|Double Blind|Withdrawal by Subject|4|||
13391950|NCT00674362|26778593|FG001|Double Blind|Withdrawal by Subject|3|||
13391951|NCT00674362|26778592|FG000|Double Blind|Other: Loss of Patient Compliance|0|||
13391952|NCT00674362|26778593|FG001|Double Blind|Other: Loss of Patient Compliance|1|||
13391953|NCT00674362|26778592|FG000|Double Blind|Other: Surgery|0|||
13391954|NCT00674362|26778593|FG001|Double Blind|Other: Surgery|1|||
13391955|NCT00674362|26778592|FG000|Open Label|Adverse Event|1|||
13391956|NCT00674362|26778593|FG001|Open Label|Adverse Event|0|||
13391957|NCT00674362|26778592|FG000|Open Label|Other: Subject moved to extension study|1|||
13391958|NCT00674362|26778593|FG001|Open Label|Other: Subject moved to extension study|0|||
13391959|NCT00674323|26778620|FG000|Overall Study|Adverse Event|0|||
13391960|NCT00674323|26778621|FG001|Overall Study|Adverse Event|1|||
13391961|NCT00674323|26778622|FG002|Overall Study|Adverse Event|0|||
13391962|NCT00674323|26778620|FG000|Overall Study|Protocol Violation|1|||
13391963|NCT00674323|26778621|FG001|Overall Study|Protocol Violation|0|||
13391964|NCT00674323|26778622|FG002|Overall Study|Protocol Violation|0|||
13391965|NCT00674154|26778635|FG000|Overall Study|Withdrawal by Subject|3|||
13391966|NCT00674154|26778636|FG001|Overall Study|Withdrawal by Subject|1|||
13391967|NCT00674154|26778635|FG000|Overall Study|Did not want parathyroidectomy|0|||
13391968|NCT00674154|26778636|FG001|Overall Study|Did not want parathyroidectomy|2|||
13391969|NCT00674128|26778649|FG000|Overall Study|Withdrawal by Subject|25|||
13391970|NCT00674128|26778650|FG001|Overall Study|Withdrawal by Subject|23|||
13391971|NCT00673933|26778668|FG000|Overall Study|Withdrawal by Subject|2|||
13391972|NCT00673933|26778668|FG000|Overall Study|Lost to Follow-up|1|||
13391973|NCT00673920|26778837|FG000|Baseline up to Week 48|Withdrew consent|1|||
13391974|NCT00673920|26778838|FG001|Baseline up to Week 48|Withdrew consent|0|||
13391975|NCT00673920|26778839|FG002|Baseline up to Week 48|Withdrew consent|2|||
13391976|NCT00673920|26778840|FG003|Baseline up to Week 48|Withdrew consent|0|||
13391977|NCT00673920|26778841|FG004|Baseline up to Week 48|Withdrew consent|0|||
13391978|NCT00673920|26778842|FG005|Baseline up to Week 48|Withdrew consent|0|||
13391979|NCT00673920|26778843|FG006|Baseline up to Week 48|Withdrew consent|0|||
13391980|NCT00673920|26778844|FG007|Baseline up to Week 48|Withdrew consent|0|||
13391981|NCT00673920|26778837|FG000|Baseline up to Week 48|Refused treatment|1|||
13391982|NCT00673920|26778838|FG001|Baseline up to Week 48|Refused treatment|0|||
13391983|NCT00673920|26778839|FG002|Baseline up to Week 48|Refused treatment|0|||
13391984|NCT00673920|26778840|FG003|Baseline up to Week 48|Refused treatment|0|||
13391985|NCT00673920|26778841|FG004|Baseline up to Week 48|Refused treatment|0|||
13391986|NCT00673920|26778842|FG005|Baseline up to Week 48|Refused treatment|0|||
13391987|NCT00673920|26778843|FG006|Baseline up to Week 48|Refused treatment|0|||
13391988|NCT00673920|26778844|FG007|Baseline up to Week 48|Refused treatment|0|||
13391989|NCT00673920|26778837|FG000|Baseline up to Week 48|Insufficient therapeutic response|2|||
13391990|NCT00673920|26778838|FG001|Baseline up to Week 48|Insufficient therapeutic response|1|||
13391991|NCT00673920|26778839|FG002|Baseline up to Week 48|Insufficient therapeutic response|0|||
13391992|NCT00673920|26778840|FG003|Baseline up to Week 48|Insufficient therapeutic response|0|||
13391993|NCT00673920|26778841|FG004|Baseline up to Week 48|Insufficient therapeutic response|0|||
13391994|NCT00673920|26778842|FG005|Baseline up to Week 48|Insufficient therapeutic response|0|||
13391995|NCT00673920|26778843|FG006|Baseline up to Week 48|Insufficient therapeutic response|0|||
13391996|NCT00673920|26778844|FG007|Baseline up to Week 48|Insufficient therapeutic response|0|||
13391997|NCT00673920|26778837|FG000|Baseline up to Week 48|Protocol Violation|0|||
13391998|NCT00673920|26778838|FG001|Baseline up to Week 48|Protocol Violation|0|||
13391999|NCT00673920|26778839|FG002|Baseline up to Week 48|Protocol Violation|1|||
13392000|NCT00673920|26778840|FG003|Baseline up to Week 48|Protocol Violation|0|||
13392001|NCT00673920|26778841|FG004|Baseline up to Week 48|Protocol Violation|0|||
13392002|NCT00673920|26778842|FG005|Baseline up to Week 48|Protocol Violation|0|||
13392003|NCT00673920|26778843|FG006|Baseline up to Week 48|Protocol Violation|0|||
13392004|NCT00673920|26778844|FG007|Baseline up to Week 48|Protocol Violation|0|||
13392005|NCT00673920|26778837|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0|||
13392006|NCT00673920|26778838|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0|||
13392007|NCT00673920|26778839|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1|||
13392008|NCT00673920|26778840|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0|||
13392009|NCT00673920|26778841|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0|||
13392010|NCT00673920|26778842|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0|||
13392011|NCT00673920|26778843|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0|||
13392012|NCT00673920|26778844|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0|||
13392013|NCT00673920|26778837|FG000|Baseline up to Week 48|Administrative/Other|0|||
13392014|NCT00673920|26778838|FG001|Baseline up to Week 48|Administrative/Other|1|||
13392015|NCT00673920|26778839|FG002|Baseline up to Week 48|Administrative/Other|2|||
13392016|NCT00673920|26778840|FG003|Baseline up to Week 48|Administrative/Other|0|||
13392017|NCT00673920|26778841|FG004|Baseline up to Week 48|Administrative/Other|0|||
13392018|NCT00673920|26778842|FG005|Baseline up to Week 48|Administrative/Other|0|||
13392019|NCT00673920|26778843|FG006|Baseline up to Week 48|Administrative/Other|0|||
13392020|NCT00673920|26778844|FG007|Baseline up to Week 48|Administrative/Other|0|||
13392021|NCT00673920|26778837|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
13392022|NCT00673920|26778838|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
13392023|NCT00673920|26778839|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
13392024|NCT00673920|26778840|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
13392025|NCT00673920|26778841|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
13392026|NCT00673920|26778842|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
13392027|NCT00673920|26778843|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
13392028|NCT00673920|26778844|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
13392029|NCT00673920|26778837|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
13392030|NCT00673920|26778838|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
13392031|NCT00673920|26778839|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
13392032|NCT00673920|26778840|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
13392033|NCT00673920|26778841|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
13392034|NCT00673920|26778842|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
13392035|NCT00673920|26778843|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1|||
13392036|NCT00673920|26778844|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
13392037|NCT00673920|26778837|FG000|Week 24 to Week 48|Failure to return|0|||
13392038|NCT00673920|26778838|FG001|Week 24 to Week 48|Failure to return|0|||
13392039|NCT00673920|26778839|FG002|Week 24 to Week 48|Failure to return|0|||
13392040|NCT00673920|26778840|FG003|Week 24 to Week 48|Failure to return|0|||
13392041|NCT00673920|26778841|FG004|Week 24 to Week 48|Failure to return|0|||
13392042|NCT00673920|26778842|FG005|Week 24 to Week 48|Failure to return|1|||
13392043|NCT00673920|26778843|FG006|Week 24 to Week 48|Failure to return|0|||
13392044|NCT00673920|26778844|FG007|Week 24 to Week 48|Failure to return|0|||
13392045|NCT00673920|26778837|FG000|Week 24 to Week 48|Insufficient therapeutic response|0|||
13392046|NCT00673920|26778838|FG001|Week 24 to Week 48|Insufficient therapeutic response|0|||
13392047|NCT00673920|26778839|FG002|Week 24 to Week 48|Insufficient therapeutic response|0|||
13392048|NCT00673920|26778840|FG003|Week 24 to Week 48|Insufficient therapeutic response|0|||
13392049|NCT00673920|26778841|FG004|Week 24 to Week 48|Insufficient therapeutic response|0|||
13392050|NCT00673920|26778842|FG005|Week 24 to Week 48|Insufficient therapeutic response|1|||
13392051|NCT00673920|26778843|FG006|Week 24 to Week 48|Insufficient therapeutic response|0|||
13392052|NCT00673920|26778844|FG007|Week 24 to Week 48|Insufficient therapeutic response|0|||
13392053|NCT00673920|26778837|FG000|Week 24 to Week 48|Death|0|||
13392054|NCT00673920|26778838|FG001|Week 24 to Week 48|Death|0|||
13392055|NCT00673920|26778839|FG002|Week 24 to Week 48|Death|0|||
13392056|NCT00673920|26778840|FG003|Week 24 to Week 48|Death|0|||
13392057|NCT00673920|26778841|FG004|Week 24 to Week 48|Death|0|||
13392058|NCT00673920|26778842|FG005|Week 24 to Week 48|Death|1|||
13392059|NCT00673920|26778843|FG006|Week 24 to Week 48|Death|0|||
13392060|NCT00673920|26778844|FG007|Week 24 to Week 48|Death|0|||
13392061|NCT00673920|26778837|FG000|Week 24 to Week 48|Adminstrative/Other|0|||
13392062|NCT00673920|26778838|FG001|Week 24 to Week 48|Adminstrative/Other|0|||
13392063|NCT00673920|26778839|FG002|Week 24 to Week 48|Adminstrative/Other|0|||
13392064|NCT00673920|26778840|FG003|Week 24 to Week 48|Adminstrative/Other|1|||
13392065|NCT00673920|26778841|FG004|Week 24 to Week 48|Adminstrative/Other|0|||
13392066|NCT00673920|26778842|FG005|Week 24 to Week 48|Adminstrative/Other|0|||
13392067|NCT00673920|26778843|FG006|Week 24 to Week 48|Adminstrative/Other|0|||
13392068|NCT00673920|26778844|FG007|Week 24 to Week 48|Adminstrative/Other|0|||
13392069|NCT00673894|26778859|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1|||
13392070|NCT00673894|26778860|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0|||
13392071|NCT00673894|26778859|FG000|First Intervention 4 Weeks|Adverse Event|1|||
13392072|NCT00673894|26778860|FG001|First Intervention 4 Weeks|Adverse Event|0|||
13392073|NCT00673881|26778869|FG000|Overall Study|Withdrawal by Subject|1|||
13392074|NCT00673816|26778878|FG000|Overall Study|Adverse Event|1|||
13392075|NCT00673816|26778878|FG000|Overall Study|Withdrawal by Subject|1|||
13392076|NCT00673790|26778898|FG000|Overall Study|Adverse Event|23|||
13392077|NCT00673790|26778899|FG001|Overall Study|Adverse Event|14|||
13392078|NCT00673790|26778900|FG002|Overall Study|Adverse Event|2|||
13392079|NCT00673790|26778898|FG000|Overall Study|Lack of Efficacy|2|||
13392080|NCT00673790|26778899|FG001|Overall Study|Lack of Efficacy|2|||
13392081|NCT00673790|26778900|FG002|Overall Study|Lack of Efficacy|2|||
13392082|NCT00673790|26778898|FG000|Overall Study|Protocol Violation|6|||
13392083|NCT00673790|26778899|FG001|Overall Study|Protocol Violation|9|||
13392084|NCT00673790|26778900|FG002|Overall Study|Protocol Violation|1|||
13392085|NCT00673790|26778898|FG000|Overall Study|Withdrawal by Subject|7|||
13392086|NCT00673790|26778899|FG001|Overall Study|Withdrawal by Subject|4|||
13392087|NCT00673790|26778900|FG002|Overall Study|Withdrawal by Subject|1|||
13392088|NCT00673790|26778898|FG000|Overall Study|Lost to Follow-up|6|||
13392089|NCT00673790|26778899|FG001|Overall Study|Lost to Follow-up|6|||
13392090|NCT00673790|26778900|FG002|Overall Study|Lost to Follow-up|5|||
13392091|NCT00673790|26778898|FG000|Overall Study|Sponsor Terminated due to PI oversight|0|||
13392092|NCT00673790|26778899|FG001|Overall Study|Sponsor Terminated due to PI oversight|1|||
13392093|NCT00673790|26778900|FG002|Overall Study|Sponsor Terminated due to PI oversight|0|||
13392094|NCT00673790|26778898|FG000|Overall Study|Poor compliance|1|||
13392095|NCT00673790|26778899|FG001|Overall Study|Poor compliance|0|||
13392096|NCT00673790|26778900|FG002|Overall Study|Poor compliance|0|||
13392097|NCT00673790|26778898|FG000|Overall Study|Participated in two Nebivolol studies|0|||
13392098|NCT00673790|26778899|FG001|Overall Study|Participated in two Nebivolol studies|0|||
13392099|NCT00673790|26778900|FG002|Overall Study|Participated in two Nebivolol studies|1|||
13392100|NCT00673790|26778898|FG000|Overall Study|Unconfirmed pregnancy|0|||
13392101|NCT00673790|26778899|FG001|Overall Study|Unconfirmed pregnancy|1|||
13392102|NCT00673790|26778900|FG002|Overall Study|Unconfirmed pregnancy|0|||
13392103|NCT00673790|26778898|FG000|Overall Study|Randomization criteria not met|0|||
13392104|NCT00673790|26778899|FG001|Overall Study|Randomization criteria not met|1|||
13392105|NCT00673790|26778900|FG002|Overall Study|Randomization criteria not met|0|||
13392106|NCT00673673|26778908|FG000|Overall Study|Progressive disease|27|||
13392107|NCT00673673|26778908|FG000|Overall Study|Adverse Event|4|||
13392108|NCT00673673|26778908|FG000|Overall Study|Withdrawal by Subject|3|||
13392109|NCT00673673|26778908|FG000|Overall Study|Investigators' discretion|2|||
13392110|NCT00673660|26778921|FG000|Overall Study|Lost to Follow-up|107|||
13392111|NCT00673465|26778981|FG000|Part 1/Period 1 (United States)|Protocol Violation|0|||
13392112|NCT00673465|26778982|FG001|Part 1/Period 1 (United States)|Protocol Violation|0|||
13392113|NCT00673465|26778983|FG002|Part 1/Period 1 (United States)|Protocol Violation|0|||
13392114|NCT00673465|26778984|FG003|Part 1/Period 1 (United States)|Protocol Violation|0|||
13392115|NCT00673465|26778985|FG004|Part 1/Period 1 (United States)|Protocol Violation|1|||
13392116|NCT00673465|26778986|FG005|Part 1/Period 1 (United States)|Protocol Violation|1|||
13392117|NCT00673465|26778987|FG006|Part 1/Period 1 (United States)|Protocol Violation|0|||
13392118|NCT00673465|26778988|FG007|Part 1/Period 1 (United States)|Protocol Violation|0|||
13392119|NCT00673465|26778989|FG008|Part 1/Period 1 (United States)|Protocol Violation|0|||
13392120|NCT00673465|26778990|FG009|Part 1/Period 1 (United States)|Protocol Violation|0|||
13392121|NCT00673465|26778991|FG010|Part 1/Period 1 (United States)|Protocol Violation|0|||
13392122|NCT00673465|26778992|FG011|Part 1/Period 1 (United States)|Protocol Violation|0|||
13392123|NCT00673465|26778981|FG000|Part 1/Period 2 (United States)|Protocol Violation|0|||
13392124|NCT00673465|26778982|FG001|Part 1/Period 2 (United States)|Protocol Violation|0|||
13392125|NCT00673465|26778983|FG002|Part 1/Period 2 (United States)|Protocol Violation|0|||
13392126|NCT00673465|26778984|FG003|Part 1/Period 2 (United States)|Protocol Violation|0|||
13392127|NCT00673465|26778985|FG004|Part 1/Period 2 (United States)|Protocol Violation|1|||
13392128|NCT00673465|26778986|FG005|Part 1/Period 2 (United States)|Protocol Violation|0|||
13392129|NCT00673465|26778987|FG006|Part 1/Period 2 (United States)|Protocol Violation|0|||
13392130|NCT00673465|26778988|FG007|Part 1/Period 2 (United States)|Protocol Violation|0|||
13392131|NCT00673465|26778989|FG008|Part 1/Period 2 (United States)|Protocol Violation|0|||
13392132|NCT00673465|26778990|FG009|Part 1/Period 2 (United States)|Protocol Violation|0|||
13392133|NCT00673465|26778991|FG010|Part 1/Period 2 (United States)|Protocol Violation|0|||
13392134|NCT00673465|26778992|FG011|Part 1/Period 2 (United States)|Protocol Violation|0|||
13392135|NCT00673452|26779033|FG000|Acute Double-Blind Phase|Adverse Event|41|||
13392136|NCT00673452|26779034|FG001|Acute Double-Blind Phase|Adverse Event|24|||
13392137|NCT00673452|26779033|FG000|Acute Double-Blind Phase|Lack of Efficacy|9|||
13392138|NCT00673452|26779034|FG001|Acute Double-Blind Phase|Lack of Efficacy|14|||
13392139|NCT00673452|26779033|FG000|Acute Double-Blind Phase|Lost to Follow-up|16|||
13392140|NCT00673452|26779034|FG001|Acute Double-Blind Phase|Lost to Follow-up|19|||
13392141|NCT00673452|26779033|FG000|Acute Double-Blind Phase|Physician Decision|0|||
13392142|NCT00673452|26779034|FG001|Acute Double-Blind Phase|Physician Decision|6|||
13392143|NCT00673452|26779033|FG000|Acute Double-Blind Phase|Protocol Violation|5|||
13392144|NCT00673452|26779034|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
13392145|NCT00673452|26779033|FG000|Acute Double-Blind Phase|Sponsor Decision|0|||
13392146|NCT00673452|26779034|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
13392147|NCT00673452|26779033|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16|||
13392148|NCT00673452|26779034|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13|||
13392149|NCT00673452|26779033|FG000|Continuation Double-Blind Phase|Adverse Event|5|||
13392150|NCT00673452|26779034|FG001|Continuation Double-Blind Phase|Adverse Event|13|||
13392151|NCT00673452|26779033|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9|||
13392152|NCT00673452|26779034|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5|||
13392153|NCT00673452|26779033|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4|||
13392154|NCT00673452|26779034|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5|||
13392155|NCT00673452|26779033|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2|||
13392156|NCT00673452|26779034|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5|||
13392157|NCT00673452|26779033|FG000|Continuation Double-Blind Phase|Protocol Violation|2|||
13392158|NCT00673452|26779034|FG001|Continuation Double-Blind Phase|Protocol Violation|3|||
13392159|NCT00673452|26779033|FG000|Continuation Double-Blind Phase|Sponsor Decision|0|||
13392160|NCT00673452|26779034|FG001|Continuation Double-Blind Phase|Sponsor Decision|3|||
13392161|NCT00673452|26779033|FG000|Continuation Double-Blind Phase|Physician Decision|2|||
13392162|NCT00673452|26779034|FG001|Continuation Double-Blind Phase|Physician Decision|0|||
13392163|NCT00673452|26779033|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1|||
13392164|NCT00673452|26779034|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0|||
13392165|NCT00673387|26779275|FG000|Overall Study|Withdrawal by Subject|15|||
13392166|NCT00673387|26779276|FG001|Overall Study|Withdrawal by Subject|16|||
13392167|NCT00673387|26779277|FG002|Overall Study|Withdrawal by Subject|20|||
13392168|NCT00673387|26779278|FG003|Overall Study|Withdrawal by Subject|16|||
13392169|NCT00673387|26779279|FG004|Overall Study|Withdrawal by Subject|18|||
13392170|NCT00673387|26779280|FG005|Overall Study|Withdrawal by Subject|21|||
13392171|NCT00673387|26779281|FG006|Overall Study|Withdrawal by Subject|15|||
13392172|NCT00673387|26779282|FG007|Overall Study|Withdrawal by Subject|21|||
13392173|NCT00673387|26779275|FG000|Overall Study|Adverse Event|3|||
13392174|NCT00673387|26779276|FG001|Overall Study|Adverse Event|1|||
13392175|NCT00673387|26779277|FG002|Overall Study|Adverse Event|5|||
13392176|NCT00673387|26779278|FG003|Overall Study|Adverse Event|2|||
13392177|NCT00673387|26779279|FG004|Overall Study|Adverse Event|6|||
13392178|NCT00673387|26779280|FG005|Overall Study|Adverse Event|2|||
13392179|NCT00673387|26779281|FG006|Overall Study|Adverse Event|5|||
13392180|NCT00673387|26779282|FG007|Overall Study|Adverse Event|5|||
13392181|NCT00673387|26779275|FG000|Overall Study|Physician Decision|0|||
13392182|NCT00673387|26779276|FG001|Overall Study|Physician Decision|0|||
13392183|NCT00673387|26779277|FG002|Overall Study|Physician Decision|0|||
13392184|NCT00673387|26779278|FG003|Overall Study|Physician Decision|0|||
13392185|NCT00673387|26779279|FG004|Overall Study|Physician Decision|0|||
13392186|NCT00673387|26779280|FG005|Overall Study|Physician Decision|5|||
13392187|NCT00673387|26779281|FG006|Overall Study|Physician Decision|1|||
13392188|NCT00673387|26779282|FG007|Overall Study|Physician Decision|1|||
13392189|NCT00673387|26779275|FG000|Overall Study|Protocol Violation|3|||
13392190|NCT00673387|26779276|FG001|Overall Study|Protocol Violation|0|||
13392191|NCT00673387|26779277|FG002|Overall Study|Protocol Violation|1|||
13392192|NCT00673387|26779278|FG003|Overall Study|Protocol Violation|2|||
13392193|NCT00673387|26779279|FG004|Overall Study|Protocol Violation|0|||
13392194|NCT00673387|26779280|FG005|Overall Study|Protocol Violation|1|||
13392195|NCT00673387|26779281|FG006|Overall Study|Protocol Violation|1|||
13392196|NCT00673387|26779282|FG007|Overall Study|Protocol Violation|3|||
13392197|NCT00673387|26779275|FG000|Overall Study|Lost to Follow-up|8|||
13392198|NCT00673387|26779276|FG001|Overall Study|Lost to Follow-up|6|||
13392199|NCT00673387|26779277|FG002|Overall Study|Lost to Follow-up|5|||
13392200|NCT00673387|26779278|FG003|Overall Study|Lost to Follow-up|6|||
13392201|NCT00673387|26779279|FG004|Overall Study|Lost to Follow-up|6|||
13392202|NCT00673387|26779280|FG005|Overall Study|Lost to Follow-up|5|||
13392203|NCT00673387|26779281|FG006|Overall Study|Lost to Follow-up|8|||
13392204|NCT00673387|26779282|FG007|Overall Study|Lost to Follow-up|5|||
13474896|NCT02097121|26996907|FG000|Overall Study|Withdrawal by Subject|0|||
13474897|NCT02097121|26996908|FG001|Overall Study|Withdrawal by Subject|1|||
13474898|NCT02097121|26996909|FG002|Overall Study|Withdrawal by Subject|2|||
13474899|NCT02097121|26996907|FG000|Overall Study|Adverse Event|0|||
13474900|NCT02097121|26996908|FG001|Overall Study|Adverse Event|1|||
13474901|NCT02097121|26996909|FG002|Overall Study|Adverse Event|0|||
13474902|NCT02097121|26996907|FG000|Overall Study|Lost to Follow-up|1|||
13474903|NCT02097121|26996908|FG001|Overall Study|Lost to Follow-up|1|||
13474904|NCT02097121|26996909|FG002|Overall Study|Lost to Follow-up|2|||
13474905|NCT02038634|26996954|FG000|Overall Study|Lost to Follow-up|0|||
13474906|NCT02038634|26996955|FG001|Overall Study|Lost to Follow-up|1|||
13474907|NCT02004522|26997013|FG000|Overall Study|Adverse Event|55|||
13474908|NCT02004522|26997014|FG001|Overall Study|Adverse Event|6|||
13474909|NCT02004522|26997013|FG000|Overall Study|Withdrawal by Subject|13|||
13474910|NCT02004522|26997014|FG001|Overall Study|Withdrawal by Subject|7|||
13474911|NCT02004522|26997013|FG000|Overall Study|Death|12|||
13474912|NCT02004522|26997014|FG001|Overall Study|Death|3|||
13474913|NCT02004522|26997013|FG000|Overall Study|Physician Decision|3|||
13474914|NCT02004522|26997014|FG001|Overall Study|Physician Decision|4|||
13474915|NCT02004522|26997013|FG000|Overall Study|Protocol Violation|1|||
13474916|NCT02004522|26997014|FG001|Overall Study|Protocol Violation|0|||
13474917|NCT02004522|26997013|FG000|Overall Study|Other is reason listed by PI|4|||
13474918|NCT02004522|26997014|FG001|Overall Study|Other is reason listed by PI|1|||
13474919|NCT02004522|26997013|FG000|Overall Study|Never Dosed|2|||
13474920|NCT02004522|26997014|FG001|Overall Study|Never Dosed|4|||
13474921|NCT02004522|26997013|FG000|Overall Study|Disease Progression|35|||
13474922|NCT02004522|26997014|FG001|Overall Study|Disease Progression|31|||
13474923|NCT02004522|26997013|FG000|Overall Study|Completed Treatment Cycles Per Protocol|1|||
13474924|NCT02004522|26997014|FG001|Overall Study|Completed Treatment Cycles Per Protocol|103|||
13474925|NCT01957176|26997028|FG000|Overall Study|Adverse Event|2|||
13474926|NCT01957176|26997029|FG001|Overall Study|Adverse Event|0|||
13474927|NCT01957176|26997028|FG000|Overall Study|Physician Decision|2|||
13392205|NCT00673361|26779288|FG000|Overall Study|Screen Failure|2|||
13392206|NCT00673257|26779295|FG000|Overall Study|Withdrawal by Subject|4|||
13392207|NCT00673257|26779295|FG000|Overall Study|Unable to obtain specimen|1|||
13474928|NCT01957176|26997029|FG001|Overall Study|Physician Decision|1|||
13474929|NCT01957176|26997028|FG000|Overall Study|Withdrawal by Subject|1|||
13474930|NCT01957176|26997029|FG001|Overall Study|Withdrawal by Subject|0|||
13474931|NCT01928199|26997050|FG000|Overall Study|Lost to Follow-up|2|||
13474932|NCT01928199|26997051|FG001|Overall Study|Lost to Follow-up|1|||
13474933|NCT01928199|26997050|FG000|Overall Study|Withdrawal by Subject|3|||
13474934|NCT01928199|26997051|FG001|Overall Study|Withdrawal by Subject|5|||
13474935|NCT01822275|26997113|FG000|Overall Study|Withdrawal by Subject|3|||
13474936|NCT01822275|26997113|FG000|Overall Study|Adverse Event|3|||
13474937|NCT01822275|26997113|FG000|Overall Study|Progression|14|||
13474938|NCT01822275|26997113|FG000|Overall Study|Physician Decision|2|||
13474939|NCT01759537|26997128|FG000|Overall Study|Death|1|||
13474940|NCT01759537|26997129|FG001|Overall Study|Death|1|||
13474941|NCT01759537|26997128|FG000|Overall Study|Pregnancy|1|||
13474942|NCT01759537|26997129|FG001|Overall Study|Pregnancy|1|||
13474943|NCT01759537|26997128|FG000|Overall Study|Lost to Follow-up|9|||
13474944|NCT01759537|26997129|FG001|Overall Study|Lost to Follow-up|9|||
13474945|NCT01759537|26997128|FG000|Overall Study|Accident involving jaw fracture|1|||
13474946|NCT01759537|26997129|FG001|Overall Study|Accident involving jaw fracture|1|||
13474947|NCT01759537|26997128|FG000|Overall Study|Subcrestal implant too coronal|1|||
13474948|NCT01759537|26997129|FG001|Overall Study|Subcrestal implant too coronal|1|||
13474949|NCT01755195|26997141|FG000|Overall Study|Participant noncompliance|2|||
13474950|NCT01755195|26997141|FG000|Overall Study|Switched to alternative treatment|4|||
13474951|NCT01755195|26997141|FG000|Overall Study|Withdrawal by Subject|1|||
13474952|NCT01755195|26997141|FG000|Overall Study|Participant refused to start treatment|1|||
13474953|NCT01755195|26997141|FG000|Overall Study|Participant has been consented for another trial|1|||
13474954|NCT01755195|26997141|FG000|Overall Study|Refused further treatment|3|||
13474955|NCT01755195|26997141|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
13474956|NCT01730950|26997162|FG000|Overall Study|Protocol Violation|6|||
13474957|NCT01730950|26997163|FG001|Overall Study|Protocol Violation|6|||
13474958|NCT01642186|26997196|FG000|Overall Study|Death|0|||
13474959|NCT01642186|26997197|FG001|Overall Study|Death|2|||
13474960|NCT01642186|26997198|FG002|Overall Study|Death|2|||
13474961|NCT01642186|26997196|FG000|Overall Study|Lost to Follow-up|0|||
13474962|NCT01642186|26997197|FG001|Overall Study|Lost to Follow-up|0|||
13474963|NCT01642186|26997198|FG002|Overall Study|Lost to Follow-up|1|||
13474964|NCT01642004|26997240|FG000|Randomization|Adverse Event unrelated to study drug|1|||
13474965|NCT01642004|26997241|FG001|Randomization|Adverse Event unrelated to study drug|0|||
13474966|NCT01642004|26997240|FG000|Randomization|Participant withdrew consent|1|||
13474967|NCT01642004|26997241|FG001|Randomization|Participant withdrew consent|6|||
13474968|NCT01642004|26997240|FG000|Randomization|No longer meets study criteria|2|||
13474969|NCT01642004|26997241|FG001|Randomization|No longer meets study criteria|2|||
13474970|NCT01642004|26997240|FG000|Treatment|Disease progression|95|||
13474971|NCT01642004|26997241|FG001|Treatment|Disease progression|79|||
13474972|NCT01642004|26997240|FG000|Treatment|Study drug toxicity|10|||
13474973|NCT01642004|26997241|FG001|Treatment|Study drug toxicity|13|||
13474974|NCT01642004|26997240|FG000|Treatment|Death|1|||
13474975|NCT01642004|26997241|FG001|Treatment|Death|1|||
13474976|NCT01642004|26997240|FG000|Treatment|Adverse event unrelated to study drug|9|||
13474977|NCT01642004|26997241|FG001|Treatment|Adverse event unrelated to study drug|13|||
13474978|NCT01642004|26997240|FG000|Treatment|Maximum clinical benefit|1|||
13474979|NCT01642004|26997241|FG001|Treatment|Maximum clinical benefit|9|||
13474980|NCT01642004|26997240|FG000|Treatment|Poor/non-compliance|1|||
13474981|NCT01642004|26997241|FG001|Treatment|Poor/non-compliance|0|||
13474982|NCT01642004|26997240|FG000|Treatment|No longer meets study criteria|1|||
13474983|NCT01642004|26997241|FG001|Treatment|No longer meets study criteria|2|||
13474984|NCT01642004|26997240|FG000|Treatment|Other reasons|2|||
13474985|NCT01642004|26997241|FG001|Treatment|Other reasons|0|||
13474986|NCT01642004|26997240|FG000|Treatment|Not reported|0|||
13474987|NCT01642004|26997241|FG001|Treatment|Not reported|3|||
13474988|NCT01642004|26997240|FG000|Treatment|Participant request to discontinue study treatment|6|||
13474989|NCT01642004|26997241|FG001|Treatment|Participant request to discontinue study treatment|4|||
13474990|NCT01642004|26997240|FG000|Treatment|Participant withdrew consent|5|||
13474991|NCT01642004|26997241|FG001|Treatment|Participant withdrew consent|5|||
13474992|NCT01596257|26997286|FG000|Overall Study|Inadequate Collection|23|||
13474993|NCT01596257|26997287|FG001|Overall Study|Inadequate Collection|19|||
13474994|NCT01439802|26997308|FG000|6 Weeks Postpartum Status|Lost to Follow-up|36|||
13474995|NCT01439802|26997308|FG000|6 Months Postpartum Status|Lost to Follow-up|12|||
13474996|NCT01412333|26997346|FG000|Overall Study|Death|1|||
13474997|NCT01412333|26997347|FG001|Overall Study|Death|1|||
13474998|NCT01412333|26997346|FG000|Overall Study|Physician Decision|0|||
13474999|NCT01412333|26997347|FG001|Overall Study|Physician Decision|1|||
13475000|NCT01412333|26997346|FG000|Overall Study|Reason not specified|16|||
13475001|NCT01412333|26997347|FG001|Overall Study|Reason not specified|10|||
13475002|NCT01412333|26997346|FG000|Overall Study|Non-compliance with study drug|1|||
13475003|NCT01412333|26997347|FG001|Overall Study|Non-compliance with study drug|1|||
13475004|NCT01412333|26997346|FG000|Overall Study|Protocol Violation|1|||
13475005|NCT01412333|26997347|FG001|Overall Study|Protocol Violation|1|||
13475006|NCT01412333|26997346|FG000|Overall Study|Non-compliance|1|||
13475007|NCT01412333|26997347|FG001|Overall Study|Non-compliance|3|||
13475008|NCT01412333|26997346|FG000|Overall Study|Lack of Efficacy|15|||
13475009|NCT01412333|26997347|FG001|Overall Study|Lack of Efficacy|6|||
13475010|NCT01412333|26997346|FG000|Overall Study|Pregnancy|3|||
13475011|NCT01412333|26997347|FG001|Overall Study|Pregnancy|0|||
13475012|NCT01412333|26997346|FG000|Overall Study|Consent withdrawn by participant|25|||
13475013|NCT01412333|26997347|FG001|Overall Study|Consent withdrawn by participant|12|||
13475014|NCT01412333|26997346|FG000|Overall Study|Adverse Event|25|||
13475015|NCT01412333|26997347|FG001|Overall Study|Adverse Event|16|||
13475016|NCT01412333|26997346|FG000|Overall Study|Lost to Follow-up|10|||
13475017|NCT01412333|26997347|FG001|Overall Study|Lost to Follow-up|6|||
13475018|NCT01389024|26997364|FG000|Overall Study|Withdrawal by Subject|0|||
13475019|NCT01389024|26997365|FG001|Overall Study|Withdrawal by Subject|1|||
13475020|NCT01389024|26997364|FG000|Overall Study|Lost to Follow-up|1|||
13475021|NCT01389024|26997365|FG001|Overall Study|Lost to Follow-up|0|||
13475022|NCT01342952|26997600|FG000|Overall Study|Adverse Event|0|||
13475023|NCT01342952|26997601|FG001|Overall Study|Adverse Event|5|||
13475024|NCT01342952|26997602|FG002|Overall Study|Adverse Event|1|||
13475025|NCT01342952|26997603|FG003|Overall Study|Adverse Event|0|||
13475026|NCT01342952|26997600|FG000|Overall Study|Lost to Follow-up|0|||
13475027|NCT01342952|26997601|FG001|Overall Study|Lost to Follow-up|2|||
13475028|NCT01342952|26997602|FG002|Overall Study|Lost to Follow-up|0|||
13475029|NCT01342952|26997603|FG003|Overall Study|Lost to Follow-up|0|||
13475030|NCT01342952|26997600|FG000|Overall Study|Withdrawal by Subject|1|||
13475031|NCT01342952|26997601|FG001|Overall Study|Withdrawal by Subject|1|||
13475032|NCT01342952|26997602|FG002|Overall Study|Withdrawal by Subject|0|||
13475033|NCT01342952|26997603|FG003|Overall Study|Withdrawal by Subject|0|||
13475034|NCT01342952|26997600|FG000|Overall Study|Physician Decision|3|||
13475035|NCT01342952|26997601|FG001|Overall Study|Physician Decision|3|||
13475036|NCT01342952|26997602|FG002|Overall Study|Physician Decision|1|||
13475037|NCT01342952|26997603|FG003|Overall Study|Physician Decision|0|||
13475038|NCT01339689|26997654|FG000|Overall Study|Adverse Event|1|||
13475039|NCT01339689|26997655|FG001|Overall Study|Adverse Event|2|||
13475040|NCT01339689|26997654|FG000|Overall Study|Lost to Follow-up|9|||
13475041|NCT01339689|26997655|FG001|Overall Study|Lost to Follow-up|3|||
13475042|NCT01339689|26997654|FG000|Overall Study|Withdrawal by Subject|3|||
13475043|NCT01339689|26997655|FG001|Overall Study|Withdrawal by Subject|0|||
13475044|NCT01339689|26997654|FG000|Overall Study|Noncompliance|1|||
13475045|NCT01339689|26997655|FG001|Overall Study|Noncompliance|0|||
13475046|NCT01339689|26997654|FG000|Overall Study|Relocated out of area|0|||
13475047|NCT01339689|26997655|FG001|Overall Study|Relocated out of area|1|||
13475048|NCT01339689|26997654|FG000|Overall Study|Other|2|||
13475049|NCT01339689|26997655|FG001|Overall Study|Other|2|||
13475050|NCT01339689|26997654|FG000|Overall Study|multiple reasons|1|||
13475051|NCT01339689|26997655|FG001|Overall Study|multiple reasons|1|||
13475052|NCT01240694|26997690|FG000|Overall Study|Adverse Event|9|||
13475053|NCT01240694|26997690|FG000|Overall Study|Lack of Efficacy|6|||
13475054|NCT01240694|26997690|FG000|Overall Study|Withdrawal by Subject|6|||
13475055|NCT01240694|26997690|FG000|Overall Study|Protocol Violation|2|||
13475056|NCT01240694|26997690|FG000|Overall Study|Lost to Follow-up|2|||
13475057|NCT01240694|26997690|FG000|Overall Study|Other than specified|3|||
13475058|NCT01240694|26997690|FG000|Overall Study|Withdrawn due to early study termination|107|||
13475059|NCT01194570|26997715|FG000|Overall Study|Death|1|||
13475060|NCT01194570|26997716|FG001|Overall Study|Death|3|||
13475061|NCT01194570|26997715|FG000|Overall Study|Ongoing at CCOD|162|||
13475062|NCT01194570|26997716|FG001|Overall Study|Ongoing at CCOD|387|||
13475063|NCT01194570|26997715|FG000|Overall Study|Physician Decision|2|||
13475064|NCT01194570|26997716|FG001|Overall Study|Physician Decision|6|||
13475065|NCT01194570|26997715|FG000|Overall Study|Reason not specified|13|||
13475066|NCT01194570|26997716|FG001|Overall Study|Reason not specified|20|||
13475067|NCT01194570|26997715|FG000|Overall Study|Protocol Violation|0|||
13475068|NCT01194570|26997716|FG001|Overall Study|Protocol Violation|2|||
13475069|NCT01194570|26997715|FG000|Overall Study|Non-compliance with study drug|2|||
13475070|NCT01194570|26997716|FG001|Overall Study|Non-compliance with study drug|2|||
13475071|NCT01194570|26997715|FG000|Overall Study|Adverse Event|12|||
13475072|NCT01194570|26997716|FG001|Overall Study|Adverse Event|18|||
13475073|NCT01194570|26997715|FG000|Overall Study|Non-compliance|2|||
13475074|NCT01194570|26997716|FG001|Overall Study|Non-compliance|2|||
13475075|NCT01194570|26997715|FG000|Overall Study|Lack of Efficacy|27|||
13475076|NCT01194570|26997716|FG001|Overall Study|Lack of Efficacy|21|||
13475077|NCT01194570|26997715|FG000|Overall Study|Withdrawal by Subject|21|||
13475078|NCT01194570|26997716|FG001|Overall Study|Withdrawal by Subject|22|||
13475079|NCT01194570|26997715|FG000|Overall Study|Pregnancy|1|||
13475080|NCT01194570|26997716|FG001|Overall Study|Pregnancy|1|||
13475081|NCT01194570|26997715|FG000|Overall Study|Lost to Follow-up|1|||
13475082|NCT01194570|26997716|FG001|Overall Study|Lost to Follow-up|4|||
13475083|NCT01112306|26997724|FG000|Overall Study|Death|175|||
13475084|NCT01112306|26997724|FG000|Overall Study|Lost to Follow-up|9|||
13475085|NCT01112306|26997724|FG000|Overall Study|Withdrawal by Subject|31|||
13475086|NCT01112306|26997724|FG000|Overall Study|Other|70|||
13475087|NCT01071395|26997737|FG000|Overall Study|Withdrawal by Subject|2|||
13475088|NCT01071395|26997738|FG001|Overall Study|Withdrawal by Subject|1|||
13475089|NCT01071395|26997737|FG000|Overall Study|Adverse Event|3|||
13475090|NCT01071395|26997738|FG001|Overall Study|Adverse Event|1|||
13475091|NCT00936390|26997785|FG000|Overall Study|Protocol Violation|21|||
13475092|NCT00936390|26997786|FG001|Overall Study|Protocol Violation|25|||
13475093|NCT00908076|26997799|FG000|Overall Study|Lack of Efficacy|1|||
13475094|NCT00908076|26997800|FG001|Overall Study|Lack of Efficacy|1|||
13475095|NCT00849667|26997871|FG000|Overall Study|Withdrawal by Subject|16|||
13475096|NCT00849667|26997872|FG001|Overall Study|Withdrawal by Subject|33|||
13475097|NCT00849667|26997873|FG002|Overall Study|Withdrawal by Subject|35|||
13475098|NCT00849667|26997871|FG000|Overall Study|Lost to Follow-up|8|||
13475099|NCT00849667|26997872|FG001|Overall Study|Lost to Follow-up|8|||
13475100|NCT00849667|26997873|FG002|Overall Study|Lost to Follow-up|8|||
13475101|NCT00849667|26997871|FG000|Overall Study|Adverse Event|1|||
13475102|NCT00849667|26997872|FG001|Overall Study|Adverse Event|2|||
13475103|NCT00849667|26997873|FG002|Overall Study|Adverse Event|0|||
13475104|NCT00849667|26997871|FG000|Overall Study|Other|18|||
13475105|NCT00849667|26997872|FG001|Overall Study|Other|19|||
13475106|NCT00849667|26997873|FG002|Overall Study|Other|18|||
13475107|NCT00849667|26997871|FG000|Overall Study|Progressive disease|119|||
13475108|NCT00849667|26997872|FG001|Overall Study|Progressive disease|100|||
13475109|NCT00849667|26997873|FG002|Overall Study|Progressive disease|112|||
13475110|NCT00849667|26997871|FG000|Overall Study|Sponsor decision|208|||
13475111|NCT00849667|26997872|FG001|Overall Study|Sponsor decision|204|||
13475112|NCT00849667|26997873|FG002|Overall Study|Sponsor decision|190|||
13475113|NCT00849667|26997871|FG000|Overall Study|Investigator discretion|0|||
13475114|NCT00849667|26997872|FG001|Overall Study|Investigator discretion|0|||
13475115|NCT00849667|26997873|FG002|Overall Study|Investigator discretion|1|||
13475116|NCT00840177|26997900|FG000|Overall Study|Adverse Event|5|||
13475117|NCT00840177|26997901|FG001|Overall Study|Adverse Event|1|||
13475118|NCT00840177|26997902|FG002|Overall Study|Adverse Event|1|||
13475119|NCT00840177|26997900|FG000|Overall Study|Refusal unrelated to adverse events|1|||
13475120|NCT00840177|26997901|FG001|Overall Study|Refusal unrelated to adverse events|0|||
13475121|NCT00840177|26997902|FG002|Overall Study|Refusal unrelated to adverse events|1|||
13475122|NCT00840177|26997900|FG000|Overall Study|Progression/relapse|2|||
13475123|NCT00840177|26997901|FG001|Overall Study|Progression/relapse|0|||
13475124|NCT00840177|26997902|FG002|Overall Study|Progression/relapse|0|||
13475125|NCT00840177|26997900|FG000|Overall Study|Death|4|||
13475126|NCT00840177|26997901|FG001|Overall Study|Death|5|||
13475127|NCT00840177|26997902|FG002|Overall Study|Death|5|||
13475128|NCT00840177|26997900|FG000|Overall Study|not protocol specified|6|||
13475129|NCT00840177|26997901|FG001|Overall Study|not protocol specified|3|||
13475130|NCT00840177|26997902|FG002|Overall Study|not protocol specified|0|||
13475131|NCT00840177|26997900|FG000|Overall Study|Ineligible|0|||
13475132|NCT00840177|26997901|FG001|Overall Study|Ineligible|0|||
13135035|NCT02747927|25993229|FG001|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|304|||
13135036|NCT02747927|25993228|FG000|Overall Study|Reason not Specified|11|||
13135037|NCT02747927|25993229|FG001|Overall Study|Reason not Specified|27|||
13135038|NCT02747875|25993244|FG000|Overall Study|Physician Decision|1|||
13135039|NCT02747875|25993245|FG001|Overall Study|Physician Decision|0|||
13135040|NCT02747875|25993244|FG000|Overall Study|Adverse Event|0|||
13135041|NCT02747875|25993245|FG001|Overall Study|Adverse Event|1|||
13135042|NCT02747420|25993258|FG000|Overall Study|Lost to Follow-up|4|||
13135043|NCT02747420|25993259|FG001|Overall Study|Lost to Follow-up|2|||
13135044|NCT02747420|25993258|FG000|Overall Study|Withdrawal by Subject|3|||
13135045|NCT02747420|25993259|FG001|Overall Study|Withdrawal by Subject|2|||
13135046|NCT02747238|25993278|FG000|Overall Study|Lack of Efficacy|0|||
13135047|NCT02747238|25993279|FG001|Overall Study|Lack of Efficacy|1|||
13135048|NCT02747238|25993278|FG000|Overall Study|Data lost|3|||
13135049|NCT02747238|25993279|FG001|Overall Study|Data lost|5|||
13135050|NCT02747108|25993326|FG000|Overall Study|Death|2|||
13135051|NCT02747108|25993327|FG001|Overall Study|Death|2|||
13475133|NCT00840177|26997902|FG002|Overall Study|Ineligible|3|||
13475134|NCT00840177|26997900|FG000|Overall Study|Did not start treatment|0|||
13475135|NCT00840177|26997901|FG001|Overall Study|Did not start treatment|0|||
13475136|NCT00840177|26997902|FG002|Overall Study|Did not start treatment|1|||
13475137|NCT00423514|26997967|FG000|Overall Study|Ineligible|1|||
13475138|NCT00423514|26997968|FG001|Overall Study|Ineligible|0|||
13475139|NCT00004124|26997989|FG000|Overall Study|Received no protocol therapy|12|||
13475140|NCT00004124|26997990|FG001|Overall Study|Received no protocol therapy|20|||
13475141|NCT01335685|26998109|FG000|Overall Study|Study Terminated by Sponsor|2|||
13475142|NCT01335685|26998110|FG001|Overall Study|Study Terminated by Sponsor|1|||
13475143|NCT01335685|26998111|FG002|Overall Study|Study Terminated by Sponsor|1|||
13475144|NCT01335685|26998112|FG003|Overall Study|Study Terminated by Sponsor|10|||
13475145|NCT01335685|26998113|FG004|Overall Study|Study Terminated by Sponsor|0|||
13475146|NCT01335685|26998114|FG005|Overall Study|Study Terminated by Sponsor|4|||
13475147|NCT01335685|26998115|FG006|Overall Study|Study Terminated by Sponsor|2|||
13475148|NCT01335685|26998116|FG007|Overall Study|Study Terminated by Sponsor|3|||
13475149|NCT01335685|26998109|FG000|Overall Study|Withdrawal by Subject|1|||
13475150|NCT01335685|26998110|FG001|Overall Study|Withdrawal by Subject|0|||
13475151|NCT01335685|26998111|FG002|Overall Study|Withdrawal by Subject|0|||
13475152|NCT01335685|26998112|FG003|Overall Study|Withdrawal by Subject|1|||
13475153|NCT01335685|26998113|FG004|Overall Study|Withdrawal by Subject|0|||
13475154|NCT01335685|26998114|FG005|Overall Study|Withdrawal by Subject|0|||
13475155|NCT01335685|26998115|FG006|Overall Study|Withdrawal by Subject|0|||
13475156|NCT01335685|26998116|FG007|Overall Study|Withdrawal by Subject|0|||
13475157|NCT01335685|26998109|FG000|Overall Study|Reason not Specified|0|||
13475158|NCT01335685|26998110|FG001|Overall Study|Reason not Specified|0|||
13475159|NCT01335685|26998111|FG002|Overall Study|Reason not Specified|1|||
13475160|NCT01335685|26998112|FG003|Overall Study|Reason not Specified|0|||
13475161|NCT01335685|26998113|FG004|Overall Study|Reason not Specified|0|||
13475162|NCT01335685|26998114|FG005|Overall Study|Reason not Specified|1|||
13475163|NCT01335685|26998115|FG006|Overall Study|Reason not Specified|0|||
13475164|NCT01335685|26998116|FG007|Overall Study|Reason not Specified|0|||
13475179|NCT04170296|26998210|FG000|Overall Study|Adverse Event|1|||
13475180|NCT04170296|26998211|FG001|Overall Study|Adverse Event|0|||
13475181|NCT04170296|26998210|FG000|Overall Study|Withdrawal by Subject|3|||
13475182|NCT04170296|26998211|FG001|Overall Study|Withdrawal by Subject|2|||
13475183|NCT04170296|26998210|FG000|Overall Study|Lost to Follow-up|4|||
13475184|NCT04170296|26998211|FG001|Overall Study|Lost to Follow-up|2|||
13475185|NCT04039217|26998227|FG000|Overall Study|Lost to Follow-up|1|||
13475186|NCT03078192|26998343|FG000|Overall Study|Withdrawal by Subject|2|||
13475187|NCT03078192|26998344|FG001|Overall Study|Withdrawal by Subject|1|||
13475188|NCT03078192|26998343|FG000|Overall Study|screen failure|0|||
13475189|NCT03078192|26998344|FG001|Overall Study|screen failure|3|||
13475190|NCT02903823|26998399|FG000|Overall Study|Physician Decision|5|||
13475191|NCT02903823|26998399|FG000|Overall Study|Could not advance catheter|1|||
13475192|NCT02903823|26998399|FG000|Overall Study|Catheter dislodgement|1|||
13475193|NCT01547117|26998464|FG000|Overall Study|Physician Decision|0|||
13475194|NCT01547117|26998465|FG001|Overall Study|Physician Decision|1|||
13475195|NCT01547117|26998466|FG002|Overall Study|Physician Decision|1|||
13475196|NCT01547117|26998467|FG003|Overall Study|Physician Decision|3|||
13475197|NCT01547117|26998464|FG000|Overall Study|Withdrawal by Subject|1|||
13475198|NCT01547117|26998465|FG001|Overall Study|Withdrawal by Subject|2|||
13475199|NCT01547117|26998466|FG002|Overall Study|Withdrawal by Subject|1|||
13475200|NCT01547117|26998467|FG003|Overall Study|Withdrawal by Subject|2|||
13475201|NCT01431508|26998473|FG000|Overall Study|Lack of Efficacy|1|||
13475202|NCT01431508|26998473|FG000|Overall Study|Unable to Follow Protocol Procedures|1|||
13475203|NCT00871351|26998503|FG000|Overall Study|Withdrawal by Subject|1|||
13475204|NCT00871351|26998504|FG001|Overall Study|Withdrawal by Subject|0|||
13475205|NCT00871351|26998505|FG002|Overall Study|Withdrawal by Subject|0|||
13475206|NCT00871351|26998503|FG000|Overall Study|Adverse Event|3|||
13475207|NCT00871351|26998504|FG001|Overall Study|Adverse Event|1|||
13475208|NCT00871351|26998505|FG002|Overall Study|Adverse Event|0|||
13475209|NCT00832455|26998527|FG000|Overall Study|Adverse Event|13|||
13475210|NCT00832455|26998527|FG000|Overall Study|Lost to Follow-up|26|||
13475211|NCT00832455|26998527|FG000|Overall Study|Protocol Violation|4|||
13475212|NCT00832455|26998527|FG000|Overall Study|Withdrawal by Subject|17|||
13475213|NCT00832455|26998527|FG000|Overall Study|Screening Failure|2|||
13475214|NCT00832455|26998527|FG000|Overall Study|Stopped Medication|4|||
13475215|NCT00832455|26998527|FG000|Overall Study|Parent misunderstood study|1|||
13475216|NCT00832455|26998527|FG000|Overall Study|Parent dissatisfied|1|||
13475217|NCT00832455|26998527|FG000|Overall Study|No improvement|3|||
13475218|NCT00832455|26998527|FG000|Overall Study|Patient moved|1|||
13475219|NCT00812006|26998551|FG000|Overall Study|Lost to Follow-up|0|||
13475220|NCT00812006|26998552|FG001|Overall Study|Lost to Follow-up|0|||
13475221|NCT00812006|26998553|FG002|Overall Study|Lost to Follow-up|2|||
13475222|NCT00812006|26998551|FG000|Overall Study|Physician Decision|0|||
13475223|NCT00812006|26998552|FG001|Overall Study|Physician Decision|0|||
13475224|NCT00812006|26998553|FG002|Overall Study|Physician Decision|1|||
13475225|NCT00812006|26998551|FG000|Overall Study|Withdrawal by Subject|2|||
13475226|NCT00812006|26998552|FG001|Overall Study|Withdrawal by Subject|1|||
13475227|NCT00812006|26998553|FG002|Overall Study|Withdrawal by Subject|1|||
13475228|NCT00812006|26998551|FG000|Overall Study|Lack of Qualifying Event|4|||
13475229|NCT00812006|26998552|FG001|Overall Study|Lack of Qualifying Event|2|||
13475230|NCT00812006|26998553|FG002|Overall Study|Lack of Qualifying Event|2|||
13475165|NCT01336621|26998165|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11|||
13475166|NCT01336621|26998165|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2|||
13475167|NCT01336621|26998165|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12|||
13475168|NCT01336621|26998165|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27|||
13475169|NCT01336621|26998165|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11|||
13475170|NCT01336621|26998165|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2|||
13475171|NCT01336621|26998165|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22|||
13475172|NCT01336621|26998165|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2|||
13475173|NCT01336621|26998165|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9|||
13475174|NCT01336621|26998165|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1|||
13475175|NCT01336621|26998165|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1|||
13475176|NCT01336621|26998165|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3|||
13475177|NCT01336621|26998165|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1|||
13475178|NCT01336621|26998165|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3|||
13475231|NCT00687531|26998585|FG000|Overall Study|Did not meet protocol eligibility|104|||
13475232|NCT00687531|26998585|FG000|Overall Study|Adverse Event|5|||
13475233|NCT00687531|26998585|FG000|Overall Study|Lost to Follow-up|26|||
13475234|NCT00654628|26998602|FG000|6-week Active Treatment Period|Adverse Event|9|||
13475235|NCT00654628|26998602|FG000|6-week Active Treatment Period|Lost to Follow-up|10|||
13475236|NCT00654628|26998602|FG000|6-week Active Treatment Period|Transferred to branch hospital|1|||
13475237|NCT00654628|26998602|FG000|6-week Active Treatment Period|Out of window period|1|||
13475238|NCT00654628|26998602|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4|||
13475239|NCT00654628|26998602|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1|||
13475240|NCT00536380|26998658|FG000|Overall Study|Adverse Event|0|||
13475241|NCT00536380|26998659|FG001|Overall Study|Adverse Event|2|||
13475242|NCT00536380|26998660|FG002|Overall Study|Adverse Event|2|||
13475243|NCT00536380|26998658|FG000|Overall Study|Lost to Follow-up|0|||
13475244|NCT00536380|26998659|FG001|Overall Study|Lost to Follow-up|0|||
13475245|NCT00536380|26998660|FG002|Overall Study|Lost to Follow-up|1|||
13475246|NCT00536380|26998658|FG000|Overall Study|Withdrawal unrelated to study drug|2|||
13475247|NCT00536380|26998659|FG001|Overall Study|Withdrawal unrelated to study drug|0|||
13475248|NCT00536380|26998660|FG002|Overall Study|Withdrawal unrelated to study drug|1|||
13475249|NCT00536380|26998658|FG000|Overall Study|Withdrawal related to study drug|7|||
13475250|NCT00536380|26998659|FG001|Overall Study|Withdrawal related to study drug|5|||
13475251|NCT00536380|26998660|FG002|Overall Study|Withdrawal related to study drug|2|||
13475252|NCT00536380|26998658|FG000|Overall Study|Noncompliance with protocol|3|||
13475253|NCT00536380|26998659|FG001|Overall Study|Noncompliance with protocol|2|||
13475254|NCT00536380|26998660|FG002|Overall Study|Noncompliance with protocol|2|||
13475255|NCT00536380|26998658|FG000|Overall Study|Did not meet protocol eligibility|0|||
13475256|NCT00536380|26998659|FG001|Overall Study|Did not meet protocol eligibility|0|||
13475257|NCT00536380|26998660|FG002|Overall Study|Did not meet protocol eligibility|1|||
13475258|NCT00536380|26998658|FG000|Overall Study|Administrative|0|||
13475259|NCT00536380|26998659|FG001|Overall Study|Administrative|0|||
13475260|NCT00536380|26998660|FG002|Overall Study|Administrative|1|||
13475261|NCT00521599|26998679|FG000|Overall Study|Adverse Event|5|||
13475262|NCT00521599|26998680|FG001|Overall Study|Adverse Event|7|||
13475263|NCT00521599|26998681|FG002|Overall Study|Adverse Event|6|||
13475264|NCT00521599|26998679|FG000|Overall Study|Treatment Failure|8|||
13475265|NCT00521599|26998680|FG001|Overall Study|Treatment Failure|9|||
13475266|NCT00521599|26998681|FG002|Overall Study|Treatment Failure|22|||
13475267|NCT00521599|26998679|FG000|Overall Study|Lost to Follow-up|2|||
13475268|NCT00521599|26998680|FG001|Overall Study|Lost to Follow-up|1|||
13475269|NCT00521599|26998681|FG002|Overall Study|Lost to Follow-up|2|||
13475270|NCT00521599|26998679|FG000|Overall Study|Withdrawal by Subject|3|||
13475271|NCT00521599|26998680|FG001|Overall Study|Withdrawal by Subject|5|||
13475272|NCT00521599|26998681|FG002|Overall Study|Withdrawal by Subject|1|||
13475273|NCT00521599|26998679|FG000|Overall Study|Withdrawal by subject treatment related|3|||
13475274|NCT00521599|26998680|FG001|Overall Study|Withdrawal by subject treatment related|1|||
13475275|NCT00521599|26998681|FG002|Overall Study|Withdrawal by subject treatment related|2|||
13475276|NCT00521599|26998679|FG000|Overall Study|Protocol Violation|2|||
13475277|NCT00521599|26998680|FG001|Overall Study|Protocol Violation|4|||
13475278|NCT00521599|26998681|FG002|Overall Study|Protocol Violation|2|||
13475279|NCT00521599|26998679|FG000|Overall Study|Did not meet protocol eligibility|2|||
13475280|NCT00521599|26998680|FG001|Overall Study|Did not meet protocol eligibility|2|||
13475281|NCT00521599|26998681|FG002|Overall Study|Did not meet protocol eligibility|1|||
13475282|NCT00496834|26998700|FG000|Overall Study|Withdrawal by Subject|4|||
13475283|NCT00496834|26998701|FG001|Overall Study|Withdrawal by Subject|6|||
13475284|NCT00496834|26998700|FG000|Overall Study|Contraindicated medication administered|0|||
13475285|NCT00496834|26998701|FG001|Overall Study|Contraindicated medication administered|1|||
13475286|NCT00496834|26998700|FG000|Overall Study|Inclusion/exclusion criteria not met|3|||
13475287|NCT00496834|26998701|FG001|Overall Study|Inclusion/exclusion criteria not met|2|||
13475288|NCT00496834|26998700|FG000|Overall Study|Adverse Event|5|||
13475289|NCT00496834|26998701|FG001|Overall Study|Adverse Event|3|||
13475290|NCT00496834|26998700|FG000|Overall Study|IP administration violation|2|||
13475291|NCT00496834|26998701|FG001|Overall Study|IP administration violation|0|||
13475292|NCT00496834|26998700|FG000|Overall Study|Lost to Follow-up|2|||
13475293|NCT00496834|26998701|FG001|Overall Study|Lost to Follow-up|0|||
13475294|NCT00496834|26998700|FG000|Overall Study|Blood Pressure control failure|2|||
13475295|NCT00496834|26998701|FG001|Overall Study|Blood Pressure control failure|1|||
13475296|NCT00442897|26998716|FG000|Base Study (12 Week Follow-up)|Adverse Event|1|||
13475297|NCT00442897|26998717|FG001|Base Study (12 Week Follow-up)|Adverse Event|0|||
13475298|NCT00442897|26998716|FG000|Base Study (12 Week Follow-up)|Death|0|||
13475299|NCT00442897|26998717|FG001|Base Study (12 Week Follow-up)|Death|1|||
13475300|NCT00442897|26998716|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7|||
13475301|NCT00442897|26998717|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3|||
13475302|NCT00442897|26998716|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9|||
13475303|NCT00442897|26998717|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8|||
13475304|NCT00442897|26998716|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1|||
13475305|NCT00442897|26998717|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0|||
13475306|NCT00442897|26998716|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
13475307|NCT00442897|26998717|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
13475308|NCT00442897|26998716|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2|||
13475309|NCT00442897|26998717|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1|||
13475310|NCT00442897|26998716|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1|||
13475311|NCT00442897|26998717|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3|||
13475312|NCT00423579|26998730|FG000|Overall Study|Lost to Follow-up|3|||
13475313|NCT00423579|26998731|FG001|Overall Study|Lost to Follow-up|0|||
13475314|NCT00423579|26998730|FG000|Overall Study|Protocol Violation|1|||
13475315|NCT00423579|26998731|FG001|Overall Study|Protocol Violation|3|||
13475316|NCT00423579|26998730|FG000|Overall Study|Diagnosis of diabetes|0|||
13135052|NCT02747108|25993326|FG000|Overall Study|Withdrawal by Subject|1|||
13135053|NCT02747108|25993327|FG001|Overall Study|Withdrawal by Subject|0|||
13135054|NCT02747108|25993326|FG000|Overall Study|Protocol Violation|2|||
13135055|NCT02747108|25993327|FG001|Overall Study|Protocol Violation|0|||
13135056|NCT02747043|25993360|FG000|Overall Study|Other|1|||
13135057|NCT02747043|25993361|FG001|Overall Study|Other|1|||
13135058|NCT02747043|25993360|FG000|Overall Study|Adverse Event|3|||
13135059|NCT02747043|25993361|FG001|Overall Study|Adverse Event|1|||
13135060|NCT02747043|25993360|FG000|Overall Study|Withdrawal by Subject|1|||
13135061|NCT02747043|25993361|FG001|Overall Study|Withdrawal by Subject|1|||
13135062|NCT02747043|25993360|FG000|Overall Study|Physician Decision|1|||
13135063|NCT02747043|25993361|FG001|Overall Study|Physician Decision|1|||
13135064|NCT02747043|25993360|FG000|Overall Study|Protocol Violation|0|||
13135065|NCT02747043|25993361|FG001|Overall Study|Protocol Violation|1|||
13135066|NCT02747043|25993360|FG000|Overall Study|Disease progression|4|||
13135067|NCT02747043|25993361|FG001|Overall Study|Disease progression|0|||
13135068|NCT02747004|25993399|FG000|Overall Study|Withdrawal by Subject|8|||
13135069|NCT02747004|25993400|FG001|Overall Study|Withdrawal by Subject|5|||
13135070|NCT02747004|25993401|FG002|Overall Study|Withdrawal by Subject|4|||
13135071|NCT02747004|25993399|FG000|Overall Study|Lost to Follow-up|1|||
13135072|NCT02747004|25993400|FG001|Overall Study|Lost to Follow-up|2|||
13135073|NCT02747004|25993401|FG002|Overall Study|Lost to Follow-up|2|||
13135074|NCT02747004|25993399|FG000|Overall Study|on study treatment/follow-up|48|||
13135075|NCT02747004|25993400|FG001|Overall Study|on study treatment/follow-up|42|||
13135076|NCT02747004|25993401|FG002|Overall Study|on study treatment/follow-up|41|||
13135077|NCT02746874|25993454|FG000|Overall Study|Withdrawal by Subject|0|||
13135078|NCT02746874|25993455|FG001|Overall Study|Withdrawal by Subject|1|||
13135079|NCT02746874|25993454|FG000|Overall Study|Surgery Date Changed|0|||
13135080|NCT02746874|25993455|FG001|Overall Study|Surgery Date Changed|2|||
13135081|NCT02746705|25993474|FG000|Overall Study|Physician Decision|1|||
13135082|NCT02746705|25993475|FG001|Overall Study|Physician Decision|1|||
13135083|NCT02746705|25993474|FG000|Overall Study|Lost to Follow-up|1|||
13135084|NCT02746705|25993475|FG001|Overall Study|Lost to Follow-up|0|||
13135085|NCT02746705|25993474|FG000|Overall Study|outlier scores deemed not valid|0|||
13135086|NCT02746705|25993475|FG001|Overall Study|outlier scores deemed not valid|1|||
13135087|NCT02746679|25993512|FG000|Overall Study|Lost to Follow-up|4|||
13135088|NCT02746679|25993513|FG001|Overall Study|Lost to Follow-up|6|||
13135089|NCT02746627|25993546|FG000|Overall Study|Withdrawal by Subject|1|||
13135090|NCT02746627|25993547|FG001|Overall Study|Withdrawal by Subject|1|||
13475317|NCT00423579|26998731|FG001|Overall Study|Diagnosis of diabetes|1|||
13475318|NCT00394355|26998766|FG000|Overall Study|Adverse Event|10|||
13475319|NCT00394355|26998767|FG001|Overall Study|Adverse Event|6|||
13475320|NCT00394355|26998768|FG002|Overall Study|Adverse Event|7|||
13475321|NCT00394355|26998769|FG003|Overall Study|Adverse Event|8|||
13475322|NCT00394355|26998766|FG000|Overall Study|Did not meet protocol eligibility|1|||
13475323|NCT00394355|26998767|FG001|Overall Study|Did not meet protocol eligibility|5|||
13475324|NCT00394355|26998768|FG002|Overall Study|Did not meet protocol eligibility|4|||
13475325|NCT00394355|26998769|FG003|Overall Study|Did not meet protocol eligibility|2|||
13475326|NCT00394355|26998766|FG000|Overall Study|Subject withdrawal - unrelated to drug|12|||
13475327|NCT00394355|26998767|FG001|Overall Study|Subject withdrawal - unrelated to drug|14|||
13475328|NCT00394355|26998768|FG002|Overall Study|Subject withdrawal - unrelated to drug|10|||
13475329|NCT00394355|26998769|FG003|Overall Study|Subject withdrawal - unrelated to drug|6|||
13475330|NCT00394355|26998766|FG000|Overall Study|Subject withdrawal - related to drug|1|||
13475331|NCT00394355|26998767|FG001|Overall Study|Subject withdrawal - related to drug|0|||
13475332|NCT00394355|26998768|FG002|Overall Study|Subject withdrawal - related to drug|0|||
13475333|NCT00394355|26998769|FG003|Overall Study|Subject withdrawal - related to drug|0|||
13475334|NCT00394355|26998766|FG000|Overall Study|Lost to Follow-up|7|||
13475335|NCT00394355|26998767|FG001|Overall Study|Lost to Follow-up|5|||
13475336|NCT00394355|26998768|FG002|Overall Study|Lost to Follow-up|4|||
13475337|NCT00394355|26998769|FG003|Overall Study|Lost to Follow-up|3|||
13475338|NCT00394355|26998766|FG000|Overall Study|Noncompliance with protocol|4|||
13475339|NCT00394355|26998767|FG001|Overall Study|Noncompliance with protocol|3|||
13475340|NCT00394355|26998768|FG002|Overall Study|Noncompliance with protocol|10|||
13475341|NCT00394355|26998769|FG003|Overall Study|Noncompliance with protocol|8|||
13475342|NCT00394355|26998766|FG000|Overall Study|Administrative|0|||
13475343|NCT00394355|26998767|FG001|Overall Study|Administrative|1|||
13475344|NCT00394355|26998768|FG002|Overall Study|Administrative|1|||
13475345|NCT00394355|26998769|FG003|Overall Study|Administrative|1|||
13475346|NCT00394355|26998766|FG000|Overall Study|Lack of Efficacy|0|||
13475347|NCT00394355|26998767|FG001|Overall Study|Lack of Efficacy|0|||
13475348|NCT00394355|26998768|FG002|Overall Study|Lack of Efficacy|2|||
13475349|NCT00394355|26998769|FG003|Overall Study|Lack of Efficacy|3|||
13475350|NCT00166504|26998796|FG000|Overall Study|Adverse Event|3|||
13475351|NCT00166504|26998797|FG001|Overall Study|Adverse Event|3|||
13475352|NCT00166504|26998796|FG000|Overall Study|Lost to Follow-up|1|||
13475353|NCT00166504|26998797|FG001|Overall Study|Lost to Follow-up|1|||
13475354|NCT00166504|26998796|FG000|Overall Study|Withdrawal by Subject|1|||
13475355|NCT00166504|26998797|FG001|Overall Study|Withdrawal by Subject|0|||
13475356|NCT01345240|26998933|FG000|Overall Study|Adverse Event|3|||
13475357|NCT01345240|26998934|FG001|Overall Study|Adverse Event|5|||
13475358|NCT01345240|26998935|FG002|Overall Study|Adverse Event|4|||
13475359|NCT01345240|26998936|FG003|Overall Study|Adverse Event|2|||
13475360|NCT01345240|26998937|FG004|Overall Study|Adverse Event|1|||
13475361|NCT01345240|26998933|FG000|Overall Study|Lost to Follow-up|8|||
13475362|NCT01345240|26998934|FG001|Overall Study|Lost to Follow-up|9|||
13475363|NCT01345240|26998935|FG002|Overall Study|Lost to Follow-up|14|||
13475364|NCT01345240|26998936|FG003|Overall Study|Lost to Follow-up|7|||
13475365|NCT01345240|26998937|FG004|Overall Study|Lost to Follow-up|9|||
13475366|NCT01371305|26999027|FG000|Overall Study|Adverse Event|0|||
13475367|NCT01371305|26999028|FG001|Overall Study|Adverse Event|0|||
13475368|NCT01371305|26999029|FG002|Overall Study|Adverse Event|0|||
13475369|NCT01371305|26999030|FG003|Overall Study|Adverse Event|2|||
13475370|NCT01371305|26999031|FG004|Overall Study|Adverse Event|1|||
13475371|NCT01371305|26999032|FG005|Overall Study|Adverse Event|0|||
13475372|NCT01371305|26999027|FG000|Overall Study|Study terminated by sponsor|0|||
13475373|NCT01371305|26999028|FG001|Overall Study|Study terminated by sponsor|0|||
13475374|NCT01371305|26999029|FG002|Overall Study|Study terminated by sponsor|0|||
13475375|NCT01371305|26999030|FG003|Overall Study|Study terminated by sponsor|0|||
13475376|NCT01371305|26999031|FG004|Overall Study|Study terminated by sponsor|3|||
13475377|NCT01371305|26999032|FG005|Overall Study|Study terminated by sponsor|1|||
13475378|NCT01371305|26999027|FG000|Overall Study|Subject request|0|||
13475379|NCT01371305|26999028|FG001|Overall Study|Subject request|0|||
13475380|NCT01371305|26999029|FG002|Overall Study|Subject request|0|||
13475381|NCT01371305|26999030|FG003|Overall Study|Subject request|0|||
13475382|NCT01371305|26999031|FG004|Overall Study|Subject request|0|||
13475383|NCT01371305|26999032|FG005|Overall Study|Subject request|1|||
13475384|NCT01376323|26999130|FG000|Overall Study|Adverse Event|1|||
13475385|NCT01376323|26999131|FG001|Overall Study|Adverse Event|0|||
13475386|NCT01376323|26999132|FG002|Overall Study|Adverse Event|0|||
13475387|NCT01376323|26999133|FG003|Overall Study|Adverse Event|2|||
13475388|NCT01376323|26999134|FG004|Overall Study|Adverse Event|0|||
13475389|NCT01376323|26999130|FG000|Overall Study|Lost to Follow-up|0|||
13475390|NCT01376323|26999131|FG001|Overall Study|Lost to Follow-up|0|||
13475391|NCT01376323|26999132|FG002|Overall Study|Lost to Follow-up|0|||
13475392|NCT01376323|26999133|FG003|Overall Study|Lost to Follow-up|2|||
13475393|NCT01376323|26999134|FG004|Overall Study|Lost to Follow-up|0|||
13475394|NCT01376323|26999130|FG000|Overall Study|Physician Decision|1|||
13475395|NCT01376323|26999131|FG001|Overall Study|Physician Decision|0|||
13475396|NCT01376323|26999132|FG002|Overall Study|Physician Decision|2|||
13475397|NCT01376323|26999133|FG003|Overall Study|Physician Decision|1|||
13475398|NCT01376323|26999134|FG004|Overall Study|Physician Decision|1|||
13475399|NCT01376323|26999130|FG000|Overall Study|Withdrawal by Subject|0|||
13475400|NCT01376323|26999131|FG001|Overall Study|Withdrawal by Subject|1|||
13475401|NCT01376323|26999132|FG002|Overall Study|Withdrawal by Subject|1|||
13475402|NCT01376323|26999133|FG003|Overall Study|Withdrawal by Subject|0|||
13475403|NCT01376323|26999134|FG004|Overall Study|Withdrawal by Subject|0|||
13475404|NCT01386658|26999204|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0|||
13475405|NCT01386658|26999205|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9|||
13475406|NCT01386658|26999204|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0|||
13475407|NCT01386658|26999205|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3|||
13475408|NCT01386684|26999246|FG000|Overall Study|Lost to Follow-up|51|||
13475409|NCT01386684|26999246|FG000|Overall Study|Other|51|||
13475410|NCT01386684|26999246|FG000|Overall Study|Death|47|||
13475411|NCT01386684|26999246|FG000|Overall Study|Withdrawal of Consent|44|||
13475412|NCT01386684|26999246|FG000|Overall Study|Alternative Therapy Required|37|||
13475413|NCT01386684|26999246|FG000|Overall Study|Disease Progression|28|||
13475414|NCT01386684|26999246|FG000|Overall Study|Adverse Event|20|||
13475415|NCT01386684|26999246|FG000|Overall Study|Noncompliance|8|||
13475416|NCT01386684|26999246|FG000|Overall Study|Protocol Violation|4|||
13475417|NCT01386684|26999246|FG000|Overall Study|Missing|3|||
13475418|NCT04980014|26999300|FG000|Overall Study|Participants who are Duplicated|1|||
13475419|NCT04980014|26999300|FG000|Overall Study|Follow-up Failure|13|||
13475420|NCT04980014|26999300|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2|||
13475421|NCT04980014|26999300|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2|||
13475422|NCT04980014|26999300|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57|||
13475423|NCT03735849|26999407|FG000|Overall Study|Lost to Follow-up|1|||
13475424|NCT03735849|26999408|FG001|Overall Study|Lost to Follow-up|0|||
13475425|NCT03735849|26999409|FG002|Overall Study|Lost to Follow-up|0|||
13475426|NCT03735849|26999407|FG000|Overall Study|Participant unable to adhere to visit|1|||
13475427|NCT03735849|26999408|FG001|Overall Study|Participant unable to adhere to visit|0|||
13475428|NCT03735849|26999409|FG002|Overall Study|Participant unable to adhere to visit|0|||
13475429|NCT03735849|26999407|FG000|Overall Study|Not Randomized|0|||
13475430|NCT03735849|26999408|FG001|Overall Study|Not Randomized|0|||
13475431|NCT03735849|26999409|FG002|Overall Study|Not Randomized|4|||
13475432|NCT03552393|26999421|FG000|Core Period|Kidney Transplant|1|||
13475433|NCT03552393|26999421|FG000|Core Period|Prohibited Medication|1|||
13475434|NCT03552393|26999421|FG000|Safety Extension Period|Kidney Transplant|4|||
13475435|NCT03333382|26999452|FG000|Overall Study|Lost to Follow-up|1|||
13475436|NCT03333382|26999453|FG001|Overall Study|Lost to Follow-up|0|||
13475437|NCT03107611|26999536|FG000|Overall Study|Adverse Event|1|||
13475438|NCT03107611|26999537|FG001|Overall Study|Adverse Event|0|||
13475439|NCT03107611|26999538|FG002|Overall Study|Adverse Event|2|||
13475440|NCT03107611|26999536|FG000|Overall Study|Lost to Follow-up|3|||
13475441|NCT03107611|26999537|FG001|Overall Study|Lost to Follow-up|3|||
13475442|NCT03107611|26999538|FG002|Overall Study|Lost to Follow-up|3|||
13475443|NCT03107611|26999536|FG000|Overall Study|Protocol Violation|0|||
13475444|NCT03107611|26999537|FG001|Overall Study|Protocol Violation|0|||
13475445|NCT03107611|26999538|FG002|Overall Study|Protocol Violation|1|||
13475446|NCT03107611|26999536|FG000|Overall Study|Withdrawal by Subject|1|||
13475447|NCT03107611|26999537|FG001|Overall Study|Withdrawal by Subject|0|||
13475448|NCT03107611|26999538|FG002|Overall Study|Withdrawal by Subject|1|||
13475449|NCT03107611|26999536|FG000|Overall Study|Worsening signs/symptoms|2|||
13475450|NCT03107611|26999537|FG001|Overall Study|Worsening signs/symptoms|1|||
13475451|NCT03107611|26999538|FG002|Overall Study|Worsening signs/symptoms|2|||
13475452|NCT02720016|26999664|FG000|Overall Study|Separation of couple|6|||
13475453|NCT02720016|26999665|FG001|Overall Study|Separation of couple|8|||
13475454|NCT02720016|26999666|FG002|Overall Study|Separation of couple|2|||
13475455|NCT02720016|26999664|FG000|Overall Study|Withdrawal by Subject|6|||
13475456|NCT02720016|26999665|FG001|Overall Study|Withdrawal by Subject|6|||
13475457|NCT02720016|26999666|FG002|Overall Study|Withdrawal by Subject|4|||
13475458|NCT02720016|26999664|FG000|Overall Study|Scheduling issues|2|||
13475459|NCT02720016|26999665|FG001|Overall Study|Scheduling issues|4|||
13475460|NCT02720016|26999666|FG002|Overall Study|Scheduling issues|7|||
13475461|NCT02720016|26999664|FG000|Overall Study|Childcare|2|||
13475462|NCT02720016|26999665|FG001|Overall Study|Childcare|0|||
13475463|NCT02720016|26999666|FG002|Overall Study|Childcare|2|||
13475464|NCT02720016|26999664|FG000|Overall Study|Withdrawal by PI|2|||
13475465|NCT02720016|26999665|FG001|Overall Study|Withdrawal by PI|2|||
13475466|NCT02720016|26999666|FG002|Overall Study|Withdrawal by PI|0|||
13475467|NCT02720016|26999664|FG000|Overall Study|Moved away|2|||
13475468|NCT02720016|26999665|FG001|Overall Study|Moved away|0|||
13475469|NCT02720016|26999666|FG002|Overall Study|Moved away|0|||
13475470|NCT02720016|26999664|FG000|Overall Study|Not Primary Health Concern|0|||
13475471|NCT02720016|26999665|FG001|Overall Study|Not Primary Health Concern|0|||
13475472|NCT02720016|26999666|FG002|Overall Study|Not Primary Health Concern|2|||
13475473|NCT02720016|26999664|FG000|Overall Study|Transportation issues|0|||
13475474|NCT02720016|26999665|FG001|Overall Study|Transportation issues|0|||
13475475|NCT02720016|26999666|FG002|Overall Study|Transportation issues|1|||
13475476|NCT02720016|26999664|FG000|Overall Study|Other|0|||
13475477|NCT02720016|26999665|FG001|Overall Study|Other|0|||
13475478|NCT02720016|26999666|FG002|Overall Study|Other|2|||
13475479|NCT02607956|26999717|FG000|Double-Blinded Phase|Withdrew Consent|17|||
13475480|NCT02607956|26999718|FG001|Double-Blinded Phase|Withdrew Consent|19|||
13475481|NCT02607956|26999719|FG002|Double-Blinded Phase|Withdrew Consent|0|||
13475482|NCT02607956|26999720|FG003|Double-Blinded Phase|Withdrew Consent|0|||
13475483|NCT02607956|26999717|FG000|Double-Blinded Phase|Lost to Follow-up|19|||
13475484|NCT02607956|26999718|FG001|Double-Blinded Phase|Lost to Follow-up|16|||
13475485|NCT02607956|26999719|FG002|Double-Blinded Phase|Lost to Follow-up|0|||
13475486|NCT02607956|26999720|FG003|Double-Blinded Phase|Lost to Follow-up|0|||
13475487|NCT02607956|26999717|FG000|Double-Blinded Phase|Randomized but never treated|7|||
13475488|NCT02607956|26999718|FG001|Double-Blinded Phase|Randomized but never treated|5|||
13475489|NCT02607956|26999719|FG002|Double-Blinded Phase|Randomized but never treated|0|||
13475490|NCT02607956|26999720|FG003|Double-Blinded Phase|Randomized but never treated|0|||
13475491|NCT02607956|26999717|FG000|Double-Blinded Phase|Investigator's Discretion|7|||
13475492|NCT02607956|26999718|FG001|Double-Blinded Phase|Investigator's Discretion|2|||
13475493|NCT02607956|26999719|FG002|Double-Blinded Phase|Investigator's Discretion|0|||
13475494|NCT02607956|26999720|FG003|Double-Blinded Phase|Investigator's Discretion|0|||
13475495|NCT02607956|26999717|FG000|Double-Blinded Phase|Death|4|||
13475496|NCT02607956|26999718|FG001|Double-Blinded Phase|Death|4|||
13475497|NCT02607956|26999719|FG002|Double-Blinded Phase|Death|0|||
13475498|NCT02607956|26999720|FG003|Double-Blinded Phase|Death|0|||
13475499|NCT02607956|26999717|FG000|Double-Blinded Phase|Adverse Event|4|||
13475500|NCT02607956|26999718|FG001|Double-Blinded Phase|Adverse Event|3|||
13475501|NCT02607956|26999719|FG002|Double-Blinded Phase|Adverse Event|0|||
13475502|NCT02607956|26999720|FG003|Double-Blinded Phase|Adverse Event|0|||
13475503|NCT02607956|26999717|FG000|Double-Blinded Phase|Protocol Violation|3|||
13475504|NCT02607956|26999718|FG001|Double-Blinded Phase|Protocol Violation|1|||
13475505|NCT02607956|26999719|FG002|Double-Blinded Phase|Protocol Violation|0|||
13475506|NCT02607956|26999720|FG003|Double-Blinded Phase|Protocol Violation|0|||
13475507|NCT02607956|26999717|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
13475508|NCT02607956|26999718|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3|||
13475509|NCT02607956|26999719|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
13475510|NCT02607956|26999720|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
13475511|NCT02607956|26999717|FG000|Open-Label Extension Phase|Withdrew Consent|0|||
13475512|NCT02607956|26999718|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
13475513|NCT02607956|26999719|FG002|Open-Label Extension Phase|Withdrew Consent|10|||
13475514|NCT02607956|26999720|FG003|Open-Label Extension Phase|Withdrew Consent|16|||
13475515|NCT02607956|26999717|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
13475516|NCT02607956|26999718|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
13475517|NCT02607956|26999719|FG002|Open-Label Extension Phase|Lost to Follow-up|14|||
13475518|NCT02607956|26999720|FG003|Open-Label Extension Phase|Lost to Follow-up|6|||
13475519|NCT02607956|26999717|FG000|Open-Label Extension Phase|Death|0|||
13475520|NCT02607956|26999718|FG001|Open-Label Extension Phase|Death|0|||
13475521|NCT02607956|26999719|FG002|Open-Label Extension Phase|Death|1|||
13475522|NCT02607956|26999720|FG003|Open-Label Extension Phase|Death|3|||
13475523|NCT02607956|26999717|FG000|Open-Label Extension Phase|Investigator's Discretion|0|||
13475524|NCT02607956|26999718|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
13475525|NCT02607956|26999719|FG002|Open-Label Extension Phase|Investigator's Discretion|2|||
13475526|NCT02607956|26999720|FG003|Open-Label Extension Phase|Investigator's Discretion|2|||
13475527|NCT02607956|26999717|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
13475528|NCT02607956|26999718|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
13475529|NCT02607956|26999719|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2|||
13475530|NCT02607956|26999720|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
13475531|NCT02607956|26999717|FG000|Open-Label Extension Phase|Protocol Violation|0|||
13475532|NCT02607956|26999718|FG001|Open-Label Extension Phase|Protocol Violation|0|||
13475533|NCT02607956|26999719|FG002|Open-Label Extension Phase|Protocol Violation|0|||
13475534|NCT02607956|26999720|FG003|Open-Label Extension Phase|Protocol Violation|2|||
13475535|NCT02607956|26999717|FG000|Open-Label Extension Phase|Pregnancy|0|||
13475536|NCT02607956|26999718|FG001|Open-Label Extension Phase|Pregnancy|0|||
13475537|NCT02607956|26999719|FG002|Open-Label Extension Phase|Pregnancy|0|||
13475538|NCT02607956|26999720|FG003|Open-Label Extension Phase|Pregnancy|1|||
13475539|NCT02564523|26999973|FG000|Overall Study|Withdrawal by Subject|3|||
13475540|NCT02564523|26999974|FG001|Overall Study|Withdrawal by Subject|0|||
13475541|NCT02564523|26999975|FG002|Overall Study|Withdrawal by Subject|1|||
13475542|NCT02564523|26999976|FG003|Overall Study|Withdrawal by Subject|0|||
13475543|NCT02564523|26999977|FG004|Overall Study|Withdrawal by Subject|1|||
13475544|NCT02564523|26999978|FG005|Overall Study|Withdrawal by Subject|0|||
13475545|NCT02564523|26999979|FG006|Overall Study|Withdrawal by Subject|1|||
13475546|NCT02564523|26999980|FG007|Overall Study|Withdrawal by Subject|0|||
13475547|NCT02564523|26999981|FG008|Overall Study|Withdrawal by Subject|0|||
13475548|NCT02564523|26999982|FG009|Overall Study|Withdrawal by Subject|0|||
13475549|NCT02564523|26999983|FG010|Overall Study|Withdrawal by Subject|1|||
13475550|NCT02564523|26999984|FG011|Overall Study|Withdrawal by Subject|0|||
13475551|NCT02564523|26999985|FG012|Overall Study|Withdrawal by Subject|1|||
13475552|NCT02564523|26999986|FG013|Overall Study|Withdrawal by Subject|0|||
13475553|NCT02564523|26999987|FG014|Overall Study|Withdrawal by Subject|0|||
13475554|NCT02564523|26999988|FG015|Overall Study|Withdrawal by Subject|0|||
13475555|NCT02564523|26999989|FG016|Overall Study|Withdrawal by Subject|0|||
13475556|NCT02564523|26999990|FG017|Overall Study|Withdrawal by Subject|0|||
13475557|NCT02564523|26999973|FG000|Overall Study|Adverse Event|0|||
13475558|NCT02564523|26999974|FG001|Overall Study|Adverse Event|0|||
13475559|NCT02564523|26999975|FG002|Overall Study|Adverse Event|0|||
13475560|NCT02564523|26999976|FG003|Overall Study|Adverse Event|0|||
13475561|NCT02564523|26999977|FG004|Overall Study|Adverse Event|0|||
13475562|NCT02564523|26999978|FG005|Overall Study|Adverse Event|0|||
13475563|NCT02564523|26999979|FG006|Overall Study|Adverse Event|0|||
13475564|NCT02564523|26999980|FG007|Overall Study|Adverse Event|0|||
13475565|NCT02564523|26999981|FG008|Overall Study|Adverse Event|0|||
13475566|NCT02564523|26999982|FG009|Overall Study|Adverse Event|0|||
13475567|NCT02564523|26999983|FG010|Overall Study|Adverse Event|0|||
13475568|NCT02564523|26999984|FG011|Overall Study|Adverse Event|0|||
13475569|NCT02564523|26999985|FG012|Overall Study|Adverse Event|0|||
13475570|NCT02564523|26999986|FG013|Overall Study|Adverse Event|0|||
13475571|NCT02564523|26999987|FG014|Overall Study|Adverse Event|0|||
13475572|NCT02564523|26999988|FG015|Overall Study|Adverse Event|0|||
13475573|NCT02564523|26999989|FG016|Overall Study|Adverse Event|0|||
13475574|NCT02564523|26999990|FG017|Overall Study|Adverse Event|1|||
13475575|NCT02564523|26999973|FG000|Overall Study|Death|0|||
13475576|NCT02564523|26999974|FG001|Overall Study|Death|0|||
13475577|NCT02564523|26999975|FG002|Overall Study|Death|0|||
13475578|NCT02564523|26999976|FG003|Overall Study|Death|0|||
13475579|NCT02564523|26999977|FG004|Overall Study|Death|0|||
13475580|NCT02564523|26999978|FG005|Overall Study|Death|0|||
13475581|NCT02564523|26999979|FG006|Overall Study|Death|1|||
13475582|NCT02564523|26999980|FG007|Overall Study|Death|0|||
13475583|NCT02564523|26999981|FG008|Overall Study|Death|0|||
13475584|NCT02564523|26999982|FG009|Overall Study|Death|0|||
13475585|NCT02564523|26999983|FG010|Overall Study|Death|1|||
13475586|NCT02564523|26999984|FG011|Overall Study|Death|0|||
13475587|NCT02564523|26999985|FG012|Overall Study|Death|0|||
13475588|NCT02564523|26999986|FG013|Overall Study|Death|0|||
13475589|NCT02564523|26999987|FG014|Overall Study|Death|0|||
13475590|NCT02564523|26999988|FG015|Overall Study|Death|0|||
13475591|NCT02564523|26999989|FG016|Overall Study|Death|0|||
13475592|NCT02564523|26999990|FG017|Overall Study|Death|0|||
13475593|NCT02564523|26999973|FG000|Overall Study|Lost to Follow-up|2|||
13475594|NCT02564523|26999974|FG001|Overall Study|Lost to Follow-up|1|||
13475595|NCT02564523|26999975|FG002|Overall Study|Lost to Follow-up|4|||
13475596|NCT02564523|26999976|FG003|Overall Study|Lost to Follow-up|0|||
13475597|NCT02564523|26999977|FG004|Overall Study|Lost to Follow-up|1|||
13475598|NCT02564523|26999978|FG005|Overall Study|Lost to Follow-up|0|||
13475599|NCT02564523|26999979|FG006|Overall Study|Lost to Follow-up|1|||
13475600|NCT02564523|26999980|FG007|Overall Study|Lost to Follow-up|0|||
13475601|NCT02564523|26999981|FG008|Overall Study|Lost to Follow-up|0|||
13475602|NCT02564523|26999982|FG009|Overall Study|Lost to Follow-up|0|||
13475603|NCT02564523|26999983|FG010|Overall Study|Lost to Follow-up|0|||
13475604|NCT02564523|26999984|FG011|Overall Study|Lost to Follow-up|1|||
13475605|NCT02564523|26999985|FG012|Overall Study|Lost to Follow-up|1|||
13475606|NCT02564523|26999986|FG013|Overall Study|Lost to Follow-up|0|||
13475607|NCT02564523|26999987|FG014|Overall Study|Lost to Follow-up|0|||
13475608|NCT02564523|26999988|FG015|Overall Study|Lost to Follow-up|0|||
13475609|NCT02564523|26999989|FG016|Overall Study|Lost to Follow-up|0|||
13475610|NCT02564523|26999990|FG017|Overall Study|Lost to Follow-up|0|||
13475611|NCT02564523|26999973|FG000|Overall Study|Physician Decision|0|||
13475612|NCT02564523|26999974|FG001|Overall Study|Physician Decision|0|||
13475613|NCT02564523|26999975|FG002|Overall Study|Physician Decision|0|||
13475614|NCT02564523|26999976|FG003|Overall Study|Physician Decision|0|||
13475615|NCT02564523|26999977|FG004|Overall Study|Physician Decision|1|||
13475616|NCT02564523|26999978|FG005|Overall Study|Physician Decision|0|||
13475617|NCT02564523|26999979|FG006|Overall Study|Physician Decision|0|||
13475618|NCT02564523|26999980|FG007|Overall Study|Physician Decision|0|||
13475619|NCT02564523|26999981|FG008|Overall Study|Physician Decision|0|||
13475620|NCT02564523|26999982|FG009|Overall Study|Physician Decision|0|||
13475621|NCT02564523|26999983|FG010|Overall Study|Physician Decision|1|||
13475622|NCT02564523|26999984|FG011|Overall Study|Physician Decision|0|||
13475623|NCT02564523|26999985|FG012|Overall Study|Physician Decision|0|||
13475624|NCT02564523|26999986|FG013|Overall Study|Physician Decision|0|||
13475625|NCT02564523|26999987|FG014|Overall Study|Physician Decision|0|||
13475626|NCT02564523|26999988|FG015|Overall Study|Physician Decision|0|||
13475627|NCT02564523|26999989|FG016|Overall Study|Physician Decision|0|||
13475628|NCT02564523|26999990|FG017|Overall Study|Physician Decision|0|||
13475629|NCT02564523|26999973|FG000|Overall Study|Protocol Violation|2|||
13475630|NCT02564523|26999974|FG001|Overall Study|Protocol Violation|2|||
13475631|NCT02564523|26999975|FG002|Overall Study|Protocol Violation|5|||
13475632|NCT02564523|26999976|FG003|Overall Study|Protocol Violation|0|||
13475633|NCT02564523|26999977|FG004|Overall Study|Protocol Violation|1|||
13475634|NCT02564523|26999978|FG005|Overall Study|Protocol Violation|0|||
13475635|NCT02564523|26999979|FG006|Overall Study|Protocol Violation|0|||
13475636|NCT02564523|26999980|FG007|Overall Study|Protocol Violation|0|||
13475637|NCT02564523|26999981|FG008|Overall Study|Protocol Violation|0|||
13475638|NCT02564523|26999982|FG009|Overall Study|Protocol Violation|0|||
13475639|NCT02564523|26999983|FG010|Overall Study|Protocol Violation|0|||
13475640|NCT02564523|26999984|FG011|Overall Study|Protocol Violation|0|||
13475641|NCT02564523|26999985|FG012|Overall Study|Protocol Violation|0|||
13475642|NCT02564523|26999986|FG013|Overall Study|Protocol Violation|0|||
13475643|NCT02564523|26999987|FG014|Overall Study|Protocol Violation|0|||
13475644|NCT02564523|26999988|FG015|Overall Study|Protocol Violation|0|||
13475645|NCT02564523|26999989|FG016|Overall Study|Protocol Violation|0|||
13475646|NCT02564523|26999990|FG017|Overall Study|Protocol Violation|0|||
13475647|NCT02564523|26999973|FG000|Overall Study|Other|3|||
13475648|NCT02564523|26999974|FG001|Overall Study|Other|0|||
13475649|NCT02564523|26999975|FG002|Overall Study|Other|0|||
13475650|NCT02564523|26999976|FG003|Overall Study|Other|1|||
13475651|NCT02564523|26999977|FG004|Overall Study|Other|0|||
13475652|NCT02564523|26999978|FG005|Overall Study|Other|0|||
13475653|NCT02564523|26999979|FG006|Overall Study|Other|0|||
13475654|NCT02564523|26999980|FG007|Overall Study|Other|0|||
13475655|NCT02564523|26999981|FG008|Overall Study|Other|0|||
13475656|NCT02564523|26999982|FG009|Overall Study|Other|0|||
13475657|NCT02564523|26999983|FG010|Overall Study|Other|0|||
13475658|NCT02564523|26999984|FG011|Overall Study|Other|0|||
13475659|NCT02564523|26999985|FG012|Overall Study|Other|0|||
13475660|NCT02564523|26999986|FG013|Overall Study|Other|0|||
13475661|NCT02564523|26999987|FG014|Overall Study|Other|0|||
13475662|NCT02564523|26999988|FG015|Overall Study|Other|0|||
13475663|NCT02564523|26999989|FG016|Overall Study|Other|0|||
13475664|NCT02564523|26999990|FG017|Overall Study|Other|0|||
13475665|NCT01447628|27000174|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
13475666|NCT01447628|27000175|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
13475667|NCT01447628|27000176|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
13475668|NCT01447628|27000177|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1|||
13475669|NCT01175356|27000185|FG000|Overall Study|Death|1|||
13475670|NCT01175356|27000185|FG000|Overall Study|Lack of Efficacy|12|||
13475671|NCT01175356|27000185|FG000|Overall Study|Lost to Follow-up|1|||
13475672|NCT01175356|27000185|FG000|Overall Study|Physician Decision|23|||
13475673|NCT01175356|27000185|FG000|Overall Study|Ineligible|1|||
13475674|NCT01175356|27000185|FG000|Overall Study|Treatment Slot Not Available|18|||
13475675|NCT01175356|27000185|FG000|Overall Study|Refusal by patient/parent/guardian|6|||
13475676|NCT01175356|27000185|FG000|Overall Study|Pts MIBG non-avid after enrollment|2|||
13475677|NCT01175356|27000185|FG000|Overall Study|On other COG study w/tumor tx intent|7|||
13475678|NCT01175356|27000185|FG000|Overall Study|Inadequate stem cell for transplant|1|||
13475679|NCT01175356|27000185|FG000|Overall Study|Initiation other tx prior to completion|9|||
13475680|NCT00515853|27000198|FG000|Overall Study|Lost to Follow-up|9|||
13475681|NCT00515853|27000199|FG001|Overall Study|Lost to Follow-up|13|||
13475682|NCT00515853|27000198|FG000|Overall Study|Withdrawal by Subject|6|||
13475683|NCT00515853|27000199|FG001|Overall Study|Withdrawal by Subject|4|||
13475684|NCT00003458|27000206|FG000|Overall Study|Not evaluable|4|||
13475685|NCT04613739|27000249|FG000|Overall Study|Lost to Follow-up|6|||
13475686|NCT04613739|27000250|FG001|Overall Study|Lost to Follow-up|9|||
13475687|NCT04613739|27000249|FG000|Overall Study|potentially duplicative/fraudulent|1|||
13475688|NCT04613739|27000250|FG001|Overall Study|potentially duplicative/fraudulent|3|||
13475689|NCT04573972|27000275|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32|||
13475690|NCT04573972|27000276|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14|||
13475691|NCT04407806|27000343|FG000|Overall Study|Withdrawal by Subject|1|||
13475692|NCT04407806|27000344|FG001|Overall Study|Withdrawal by Subject|2|||
13475693|NCT04324021|27000455|FG000|Overall Study|Adverse Event|1|||
13475694|NCT04324021|27000456|FG001|Overall Study|Adverse Event|0|||
13475695|NCT04324021|27000457|FG002|Overall Study|Adverse Event|0|||
13475696|NCT04324021|27000455|FG000|Overall Study|Lack of Efficacy|0|||
13475697|NCT04324021|27000456|FG001|Overall Study|Lack of Efficacy|0|||
13475698|NCT04324021|27000457|FG002|Overall Study|Lack of Efficacy|1|||
13475699|NCT04324021|27000455|FG000|Overall Study|Death|1|||
13475700|NCT04324021|27000456|FG001|Overall Study|Death|1|||
13475701|NCT04324021|27000457|FG002|Overall Study|Death|0|||
13475702|NCT04209621|27000468|FG000|Overall Study|Death|1|||
13475703|NCT04209621|27000468|FG000|Overall Study|Study Terminated Early|2|||
13475704|NCT04186663|27000480|FG000|Overall Study|Lost to Follow-up|1|||
13475705|NCT04186663|27000480|FG000|Overall Study|Unable to complete blood draw|3|||
13475706|NCT04158219|27000491|FG000|Overall Study|Lost to Follow-up|1|||
13475707|NCT03954743|27000592|FG000|Overall Study|Adverse Event|1|||
13475708|NCT03954743|27000593|FG001|Overall Study|Adverse Event|0|||
13475709|NCT03954743|27000592|FG000|Overall Study|Lost to Follow-up|6|||
13475710|NCT03954743|27000593|FG001|Overall Study|Lost to Follow-up|4|||
13475711|NCT03954743|27000592|FG000|Overall Study|Protocol Violation|1|||
13475712|NCT03954743|27000593|FG001|Overall Study|Protocol Violation|0|||
13475713|NCT03954743|27000592|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13|||
13475714|NCT03954743|27000593|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12|||
13475715|NCT03954743|27000592|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
13475716|NCT03954743|27000593|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
13475717|NCT03880565|27000612|FG000|Overall Study|Withdrawal by Subject|1|||
13475718|NCT03880565|27000613|FG001|Overall Study|Withdrawal by Subject|0|||
13475719|NCT03782792|27000658|FG000|Overall Study|Patient left the country|0|||
13475720|NCT03782792|27000659|FG001|Overall Study|Patient left the country|1|||
13475721|NCT03782792|27000658|FG000|Overall Study|Withdrawal by Subject|1|||
13475722|NCT03782792|27000659|FG001|Overall Study|Withdrawal by Subject|2|||
13475723|NCT03733119|27000704|FG000|Overall Study|Physician Decision|2|||
13475724|NCT03733119|27000705|FG001|Overall Study|Physician Decision|1|||
13475725|NCT03733119|27000704|FG000|Overall Study|ineligible to treat per protocol|0|||
13475726|NCT03733119|27000705|FG001|Overall Study|ineligible to treat per protocol|1|||
13475727|NCT03661996|27000760|FG000|Overall Study|Adverse Event|0|||
13475728|NCT03661996|27000761|FG001|Overall Study|Adverse Event|0|||
13475729|NCT03661996|27000762|FG002|Overall Study|Adverse Event|1|||
13475730|NCT03661996|27000763|FG003|Overall Study|Adverse Event|1|||
13475731|NCT03661996|27000764|FG004|Overall Study|Adverse Event|0|||
13475732|NCT03661996|27000760|FG000|Overall Study|Lost to Follow-up|5|||
13475733|NCT03661996|27000761|FG001|Overall Study|Lost to Follow-up|1|||
13475734|NCT03661996|27000762|FG002|Overall Study|Lost to Follow-up|2|||
13475735|NCT03661996|27000763|FG003|Overall Study|Lost to Follow-up|2|||
13475736|NCT03661996|27000764|FG004|Overall Study|Lost to Follow-up|6|||
13475737|NCT03661996|27000760|FG000|Overall Study|Physician Decision|1|||
13475738|NCT03661996|27000761|FG001|Overall Study|Physician Decision|1|||
13475739|NCT03661996|27000762|FG002|Overall Study|Physician Decision|1|||
13475740|NCT03661996|27000763|FG003|Overall Study|Physician Decision|2|||
13475741|NCT03661996|27000764|FG004|Overall Study|Physician Decision|0|||
13475742|NCT03661996|27000760|FG000|Overall Study|Protocol Violation|0|||
13475743|NCT03661996|27000761|FG001|Overall Study|Protocol Violation|0|||
13475744|NCT03661996|27000762|FG002|Overall Study|Protocol Violation|0|||
13475745|NCT03661996|27000763|FG003|Overall Study|Protocol Violation|0|||
13475746|NCT03661996|27000764|FG004|Overall Study|Protocol Violation|1|||
13475747|NCT03661996|27000760|FG000|Overall Study|Withdrawal by Subject|3|||
13475748|NCT03661996|27000761|FG001|Overall Study|Withdrawal by Subject|5|||
13475749|NCT03661996|27000762|FG002|Overall Study|Withdrawal by Subject|1|||
13475750|NCT03661996|27000763|FG003|Overall Study|Withdrawal by Subject|7|||
13475751|NCT03661996|27000764|FG004|Overall Study|Withdrawal by Subject|7|||
13475752|NCT03661996|27000760|FG000|Overall Study|Sponsors Decision|2|||
13475753|NCT03661996|27000761|FG001|Overall Study|Sponsors Decision|0|||
13475754|NCT03661996|27000762|FG002|Overall Study|Sponsors Decision|0|||
13475755|NCT03661996|27000763|FG003|Overall Study|Sponsors Decision|0|||
13475756|NCT03661996|27000764|FG004|Overall Study|Sponsors Decision|0|||
13475757|NCT03661996|27000760|FG000|Overall Study|Other|1|||
13475758|NCT03661996|27000761|FG001|Overall Study|Other|1|||
13475759|NCT03661996|27000762|FG002|Overall Study|Other|1|||
13475760|NCT03661996|27000763|FG003|Overall Study|Other|1|||
13475761|NCT03661996|27000764|FG004|Overall Study|Other|0|||
13475762|NCT03633461|27000777|FG000|Overall Study|Lost to Follow-up|0|||
13475763|NCT03633461|27000778|FG001|Overall Study|Lost to Follow-up|1|||
13135137|NCT02745119|25993666|FG000|Overall Study|Withdrawal by Subject|7|||
13135138|NCT02745119|25993667|FG001|Overall Study|Withdrawal by Subject|15|||
13135139|NCT02745119|25993668|FG002|Overall Study|Withdrawal by Subject|8|||
13135140|NCT02745119|25993669|FG003|Overall Study|Withdrawal by Subject|14|||
13135141|NCT02745119|25993666|FG000|Overall Study|Study Terminated by Sponsor|134|||
13135142|NCT02745119|25993667|FG001|Overall Study|Study Terminated by Sponsor|252|||
13135143|NCT02745119|25993668|FG002|Overall Study|Study Terminated by Sponsor|135|||
13135144|NCT02745119|25993669|FG003|Overall Study|Study Terminated by Sponsor|251|||
13135145|NCT02745119|25993666|FG000|Overall Study|Physician Decision|0|||
13135146|NCT02745119|25993667|FG001|Overall Study|Physician Decision|2|||
13135147|NCT02745119|25993668|FG002|Overall Study|Physician Decision|2|||
13135148|NCT02745119|25993669|FG003|Overall Study|Physician Decision|2|||
13135149|NCT02745119|25993666|FG000|Overall Study|Reason Not Specified|0|||
13135150|NCT02745119|25993667|FG001|Overall Study|Reason Not Specified|2|||
13135151|NCT02745119|25993668|FG002|Overall Study|Reason Not Specified|0|||
13135152|NCT02745119|25993669|FG003|Overall Study|Reason Not Specified|1|||
13135153|NCT02745080|25993691|FG000|Overall Study|Adverse Event|13|||
13135154|NCT02745080|25993692|FG001|Overall Study|Adverse Event|21|||
13135155|NCT02745080|25993691|FG000|Overall Study|Lack of Efficacy|11|||
13135156|NCT02745080|25993692|FG001|Overall Study|Lack of Efficacy|23|||
13135157|NCT02745080|25993691|FG000|Overall Study|Lost to Follow-up|3|||
13135158|NCT02745080|25993692|FG001|Overall Study|Lost to Follow-up|3|||
13135159|NCT02745080|25993691|FG000|Overall Study|Physician Decision|3|||
13135160|NCT02745080|25993692|FG001|Overall Study|Physician Decision|0|||
13135161|NCT02745080|25993691|FG000|Overall Study|Protocol Violation|3|||
13135162|NCT02745080|25993692|FG001|Overall Study|Protocol Violation|1|||
13135163|NCT02745080|25993691|FG000|Overall Study|Withdrawal by Subject|22|||
13135164|NCT02745080|25993692|FG001|Overall Study|Withdrawal by Subject|41|||
13135165|NCT02744898|25993698|FG000|Overall Study|Progressive Disease|2|||
13135166|NCT02744898|25993698|FG000|Overall Study|Physician Decision|1|||
13135167|NCT02744898|25993698|FG000|Overall Study|Toxicity|1|||
13135168|NCT02744755|25993759|FG000|Study Period 1|Protocol Violation|2|||
13135169|NCT02744755|25993760|FG001|Study Period 1|Protocol Violation|1|||
13135170|NCT02744755|25993759|FG000|Study Period 1|not defined|0|||
13135171|NCT02744755|25993760|FG001|Study Period 1|not defined|1|||
13135172|NCT02744755|25993759|FG000|Study Period 1|Pregnancy|1|||
13135173|NCT02744755|25993760|FG001|Study Period 1|Pregnancy|0|||
13135174|NCT02744755|25993759|FG000|Study Period 1|Adverse Event|1|||
13135175|NCT02744755|25993760|FG001|Study Period 1|Adverse Event|1|||
13135176|NCT02744755|25993759|FG000|Study Period 1|Lost to Follow-up|1|||
13135177|NCT02744755|25993760|FG001|Study Period 1|Lost to Follow-up|1|||
13135178|NCT02744755|25993759|FG000|Study Period 1|Lack of Efficacy|1|||
13135179|NCT02744755|25993760|FG001|Study Period 1|Lack of Efficacy|0|||
13135180|NCT02744755|25993759|FG000|Study Period 1|Withdrawal by Subject|8|||
13135181|NCT02744755|25993760|FG001|Study Period 1|Withdrawal by Subject|4|||
13135182|NCT02744755|25993759|FG000|Study Period 2|Adverse Event|5|||
13135183|NCT02744755|25993760|FG001|Study Period 2|Adverse Event|0|||
13135184|NCT02744755|25993759|FG000|Study Period 2|Protocol Violation|1|||
13135185|NCT02744755|25993760|FG001|Study Period 2|Protocol Violation|0|||
13135186|NCT02744755|25993759|FG000|Study Period 2|not defined|3|||
13135187|NCT02744755|25993760|FG001|Study Period 2|not defined|2|||
13135188|NCT02744755|25993759|FG000|Study Period 2|Lost to Follow-up|0|||
13135189|NCT02744755|25993760|FG001|Study Period 2|Lost to Follow-up|2|||
13135190|NCT02744755|25993759|FG000|Study Period 2|Withdrawal by Subject|2|||
13135191|NCT02744755|25993760|FG001|Study Period 2|Withdrawal by Subject|2|||
13135192|NCT02744755|25993759|FG000|Study Period 2|Lack of Efficacy|3|||
13135193|NCT02744755|25993760|FG001|Study Period 2|Lack of Efficacy|2|||
13135194|NCT02744391|25993784|FG000|Overall Study|Lost to Follow-up|9|||
13135195|NCT02744391|25993784|FG000|Overall Study|Physician Decision|2|||
13135196|NCT02744391|25993784|FG000|Overall Study|Withdrawal by Subject|3|||
13135197|NCT02744066|25993799|FG000|Overall Study|Withdrawal by parent|0|||
13135198|NCT02744066|25993800|FG001|Overall Study|Withdrawal by parent|1|||
13135199|NCT02744066|25993799|FG000|Overall Study|Discharged from NICU prior to completion|0|||
13135200|NCT02744066|25993800|FG001|Overall Study|Discharged from NICU prior to completion|4|||
13135201|NCT02744040|25993854|FG000|Overall Study|Withdrawal by Subject|3|||
13135202|NCT02744040|25993855|FG001|Overall Study|Withdrawal by Subject|2|||
13135203|NCT02744040|25993856|FG002|Overall Study|Withdrawal by Subject|2|||
13135204|NCT02744040|25993854|FG000|Overall Study|Physician Decision|0|||
13135205|NCT02744040|25993855|FG001|Overall Study|Physician Decision|8|||
13135206|NCT02744040|25993856|FG002|Overall Study|Physician Decision|13|||
13135207|NCT02744040|25993854|FG000|Overall Study|Lost to Follow-up|3|||
13135208|NCT02744040|25993855|FG001|Overall Study|Lost to Follow-up|1|||
13135209|NCT02744040|25993856|FG002|Overall Study|Lost to Follow-up|7|||
13135210|NCT02743962|25993882|FG000|Overall Study|Atrophic vaginitis diagnosed|1|||
13135211|NCT02743962|25993883|FG001|Overall Study|Atrophic vaginitis diagnosed|0|||
13135212|NCT02743949|25993904|FG000|Overall Study|Adverse Event|0|||
13135213|NCT02743949|25993905|FG001|Overall Study|Adverse Event|0|||
13135214|NCT02743949|25993906|FG002|Overall Study|Adverse Event|2|||
13135215|NCT02743949|25993904|FG000|Overall Study|Significant Protocol Deviation|2|||
13135216|NCT02743949|25993905|FG001|Overall Study|Significant Protocol Deviation|0|||
13135217|NCT02743949|25993906|FG002|Overall Study|Significant Protocol Deviation|1|||
13135218|NCT02743949|25993904|FG000|Overall Study|Voluntary Withdrawal|2|||
13135219|NCT02743949|25993905|FG001|Overall Study|Voluntary Withdrawal|1|||
13135220|NCT02743949|25993906|FG002|Overall Study|Voluntary Withdrawal|0|||
13135221|NCT02743871|25994157|FG000|Overall Study|Lost to Follow-up|0|||
13135222|NCT02743871|25994158|FG001|Overall Study|Lost to Follow-up|0|||
13135223|NCT02743871|25994159|FG002|Overall Study|Lost to Follow-up|0|||
13135224|NCT02743871|25994160|FG003|Overall Study|Lost to Follow-up|1|||
13135225|NCT02743871|25994161|FG004|Overall Study|Lost to Follow-up|0|||
13135226|NCT02743871|25994162|FG005|Overall Study|Lost to Follow-up|0|||
13135227|NCT02743871|25994163|FG006|Overall Study|Lost to Follow-up|1|||
13135228|NCT02743871|25994164|FG007|Overall Study|Lost to Follow-up|0|||
13135229|NCT02743871|25994165|FG008|Overall Study|Lost to Follow-up|0|||
13135230|NCT02743871|25994166|FG009|Overall Study|Lost to Follow-up|0|||
13135231|NCT02743871|25994167|FG010|Overall Study|Lost to Follow-up|0|||
13135232|NCT02743871|25994168|FG011|Overall Study|Lost to Follow-up|2|||
13135233|NCT02743871|25994169|FG012|Overall Study|Lost to Follow-up|0|||
13135234|NCT02743871|25994170|FG013|Overall Study|Lost to Follow-up|0|||
13135235|NCT02743871|25994157|FG000|Overall Study|Withdrawal by Subject|0|||
13135236|NCT02743871|25994158|FG001|Overall Study|Withdrawal by Subject|0|||
13135237|NCT02743871|25994159|FG002|Overall Study|Withdrawal by Subject|0|||
13135238|NCT02743871|25994160|FG003|Overall Study|Withdrawal by Subject|0|||
13135239|NCT02743871|25994161|FG004|Overall Study|Withdrawal by Subject|0|||
13135240|NCT02743871|25994162|FG005|Overall Study|Withdrawal by Subject|0|||
13135241|NCT02743871|25994163|FG006|Overall Study|Withdrawal by Subject|0|||
13135242|NCT02743871|25994164|FG007|Overall Study|Withdrawal by Subject|0|||
13135243|NCT02743871|25994165|FG008|Overall Study|Withdrawal by Subject|0|||
13135244|NCT02743871|25994166|FG009|Overall Study|Withdrawal by Subject|0|||
13135245|NCT02743871|25994167|FG010|Overall Study|Withdrawal by Subject|1|||
13135246|NCT02743871|25994168|FG011|Overall Study|Withdrawal by Subject|0|||
13135247|NCT02743871|25994169|FG012|Overall Study|Withdrawal by Subject|12|||
13135248|NCT02743871|25994170|FG013|Overall Study|Withdrawal by Subject|6|||
13135249|NCT02743871|25994157|FG000|Overall Study|Adverse Event|1|||
13135250|NCT02743871|25994158|FG001|Overall Study|Adverse Event|0|||
13135251|NCT02743871|25994159|FG002|Overall Study|Adverse Event|0|||
13135252|NCT02743871|25994160|FG003|Overall Study|Adverse Event|0|||
13135253|NCT02743871|25994161|FG004|Overall Study|Adverse Event|0|||
13135254|NCT02743871|25994162|FG005|Overall Study|Adverse Event|0|||
13135255|NCT02743871|25994163|FG006|Overall Study|Adverse Event|0|||
13135256|NCT02743871|25994164|FG007|Overall Study|Adverse Event|0|||
13135257|NCT02743871|25994165|FG008|Overall Study|Adverse Event|0|||
13135258|NCT02743871|25994166|FG009|Overall Study|Adverse Event|0|||
13135259|NCT02743871|25994167|FG010|Overall Study|Adverse Event|0|||
13135260|NCT02743871|25994168|FG011|Overall Study|Adverse Event|0|||
13135261|NCT02743871|25994169|FG012|Overall Study|Adverse Event|0|||
13135262|NCT02743871|25994170|FG013|Overall Study|Adverse Event|0|||
13135263|NCT02743871|25994157|FG000|Overall Study|Other|0|||
13135264|NCT02743871|25994158|FG001|Overall Study|Other|0|||
13135265|NCT02743871|25994159|FG002|Overall Study|Other|0|||
13135266|NCT02743871|25994160|FG003|Overall Study|Other|0|||
13135267|NCT02743871|25994161|FG004|Overall Study|Other|0|||
13135268|NCT02743871|25994162|FG005|Overall Study|Other|0|||
13135269|NCT02743871|25994163|FG006|Overall Study|Other|0|||
13135270|NCT02743871|25994164|FG007|Overall Study|Other|0|||
13135271|NCT02743871|25994165|FG008|Overall Study|Other|0|||
13135272|NCT02743871|25994166|FG009|Overall Study|Other|0|||
13135273|NCT02743871|25994167|FG010|Overall Study|Other|0|||
13135274|NCT02743871|25994168|FG011|Overall Study|Other|1|||
13135275|NCT02743871|25994169|FG012|Overall Study|Other|1|||
13135276|NCT02743871|25994170|FG013|Overall Study|Other|1|||
13135277|NCT02743871|25994157|FG000|Overall Study|Protocol Violation|0|||
13135278|NCT02743871|25994158|FG001|Overall Study|Protocol Violation|0|||
13135279|NCT02743871|25994159|FG002|Overall Study|Protocol Violation|0|||
13135280|NCT02743871|25994160|FG003|Overall Study|Protocol Violation|0|||
13135281|NCT02743871|25994161|FG004|Overall Study|Protocol Violation|0|||
13135282|NCT02743871|25994162|FG005|Overall Study|Protocol Violation|0|||
13135283|NCT02743871|25994163|FG006|Overall Study|Protocol Violation|0|||
13135284|NCT02743871|25994164|FG007|Overall Study|Protocol Violation|0|||
13135285|NCT02743871|25994165|FG008|Overall Study|Protocol Violation|0|||
13135286|NCT02743871|25994166|FG009|Overall Study|Protocol Violation|0|||
13135287|NCT02743871|25994167|FG010|Overall Study|Protocol Violation|0|||
13135288|NCT02743871|25994168|FG011|Overall Study|Protocol Violation|0|||
13135289|NCT02743871|25994169|FG012|Overall Study|Protocol Violation|2|||
13135290|NCT02743871|25994170|FG013|Overall Study|Protocol Violation|0|||
13135291|NCT02743819|25994178|FG000|Overall Study|Lack of Efficacy|5|||
13135292|NCT02743819|25994178|FG000|Overall Study|Death|2|||
13135293|NCT02743819|25994178|FG000|Overall Study|Adverse Event|1|||
13135294|NCT02743793|25994192|FG000|Overall Study|Death|1|||
13135295|NCT02743793|25994193|FG001|Overall Study|Death|1|||
13135296|NCT02743793|25994192|FG000|Overall Study|Withdrawal by Subject|0|||
13135297|NCT02743793|25994193|FG001|Overall Study|Withdrawal by Subject|1|||
13135298|NCT02743793|25994192|FG000|Overall Study|Screen Failure|4|||
13135299|NCT02743793|25994193|FG001|Overall Study|Screen Failure|0|||
13135300|NCT02743793|25994192|FG000|Overall Study|No Primary Care Physician|0|||
13135301|NCT02743793|25994193|FG001|Overall Study|No Primary Care Physician|1|||
13135302|NCT02743793|25994192|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0|||
13135303|NCT02743793|25994193|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1|||
13135304|NCT02743793|25994192|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0|||
13135305|NCT02743793|25994193|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32|||
13135306|NCT02743780|25994254|FG000|Part 3 (7 Days)|Adverse Event|0|||
13135307|NCT02743780|25994255|FG001|Part 3 (7 Days)|Adverse Event|0|||
13135308|NCT02743780|25994256|FG002|Part 3 (7 Days)|Adverse Event|1|||
13135309|NCT02743780|25994257|FG003|Part 3 (7 Days)|Adverse Event|0|||
13135310|NCT02743780|25994258|FG004|Part 3 (7 Days)|Adverse Event|0|||
13135311|NCT02743520|25994268|FG000|Overall Study|Withdrawal by Subject|1|||
13135312|NCT02743221|25994289|FG000|Overall Study|Progressive disease|29|||
13135313|NCT02743221|25994290|FG001|Overall Study|Progressive disease|38|||
13135314|NCT02743221|25994289|FG000|Overall Study|Adverse Event|17|||
13135315|NCT02743221|25994290|FG001|Overall Study|Adverse Event|14|||
13135316|NCT02743221|25994289|FG000|Overall Study|non medical reason|8|||
13135317|NCT02743221|25994290|FG001|Overall Study|non medical reason|2|||
13135318|NCT02743221|25994289|FG000|Overall Study|Physician Decision|2|||
13135319|NCT02743221|25994290|FG001|Overall Study|Physician Decision|5|||
13135320|NCT02743221|25994289|FG000|Overall Study|Patient not eligible, not treated|0|||
13135321|NCT02743221|25994290|FG001|Overall Study|Patient not eligible, not treated|1|||
13135322|NCT02743117|25994311|FG000|Overall Study|Lost to Follow-up|0|||
13135323|NCT02743117|25994312|FG001|Overall Study|Lost to Follow-up|1|||
13135324|NCT02743117|25994311|FG000|Overall Study|Other|1|||
13135325|NCT02743117|25994312|FG001|Overall Study|Other|0|||
13135326|NCT02742818|25994333|FG000|Overall Study|Adverse Event|0|||
13135327|NCT02742818|25994334|FG001|Overall Study|Adverse Event|1|||
13135328|NCT02742818|25994333|FG000|Overall Study|Protocol Violation|0|||
13135329|NCT02742818|25994334|FG001|Overall Study|Protocol Violation|1|||
13135330|NCT02742766|25994649|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
13135331|NCT02742766|25994650|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
13135332|NCT02742766|25994651|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
13135333|NCT02742766|25994652|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
13135334|NCT02742766|25994653|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
13135335|NCT02742766|25994654|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
13135336|NCT02742766|25994655|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
13135337|NCT02742766|25994656|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
13135338|NCT02742766|25994657|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
13135339|NCT02742766|25994658|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
13135340|NCT02742766|25994659|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
13135341|NCT02742766|25994660|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
13135342|NCT02742766|25994661|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
13135343|NCT02742766|25994662|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1|||
13135344|NCT02742766|25994663|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
13135345|NCT02742766|25994664|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
13135346|NCT02742766|25994665|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
13135347|NCT02742766|25994666|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
13135348|NCT02742766|25994667|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
13135349|NCT02742766|25994649|FG000|Part 2 (Up to 22 Days)|Physician Decision|0|||
13135350|NCT02742766|25994650|FG001|Part 2 (Up to 22 Days)|Physician Decision|0|||
13135351|NCT02742766|25994651|FG002|Part 2 (Up to 22 Days)|Physician Decision|0|||
13135352|NCT02742766|25994652|FG003|Part 2 (Up to 22 Days)|Physician Decision|0|||
13135353|NCT02742766|25994653|FG004|Part 2 (Up to 22 Days)|Physician Decision|0|||
13135354|NCT02742766|25994654|FG005|Part 2 (Up to 22 Days)|Physician Decision|0|||
13135355|NCT02742766|25994655|FG006|Part 2 (Up to 22 Days)|Physician Decision|0|||
13135356|NCT02742766|25994656|FG007|Part 2 (Up to 22 Days)|Physician Decision|0|||
13135357|NCT02742766|25994657|FG008|Part 2 (Up to 22 Days)|Physician Decision|0|||
13135358|NCT02742766|25994658|FG009|Part 2 (Up to 22 Days)|Physician Decision|0|||
13135359|NCT02742766|25994659|FG010|Part 2 (Up to 22 Days)|Physician Decision|0|||
13135360|NCT02742766|25994660|FG011|Part 2 (Up to 22 Days)|Physician Decision|0|||
13135361|NCT02742766|25994661|FG012|Part 2 (Up to 22 Days)|Physician Decision|2|||
13135362|NCT02742766|25994662|FG013|Part 2 (Up to 22 Days)|Physician Decision|5|||
13135363|NCT02742766|25994663|FG014|Part 2 (Up to 22 Days)|Physician Decision|0|||
13135364|NCT02742766|25994664|FG015|Part 2 (Up to 22 Days)|Physician Decision|1|||
13135365|NCT02742766|25994665|FG016|Part 2 (Up to 22 Days)|Physician Decision|0|||
13135366|NCT02742766|25994666|FG017|Part 2 (Up to 22 Days)|Physician Decision|0|||
13135367|NCT02742766|25994667|FG018|Part 2 (Up to 22 Days)|Physician Decision|0|||
13135368|NCT02742649|25994705|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5|||
13135369|NCT02742649|25994706|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
13135370|NCT02742649|25994707|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
13135371|NCT02742649|25994708|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
13135372|NCT02742649|25994709|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
13135373|NCT02742649|25994705|FG000|Double-Blind Treatment Period|Adverse Event|0|||
13135374|NCT02742649|25994706|FG001|Double-Blind Treatment Period|Adverse Event|1|||
13135375|NCT02742649|25994707|FG002|Double-Blind Treatment Period|Adverse Event|0|||
13135376|NCT02742649|25994708|FG003|Double-Blind Treatment Period|Adverse Event|0|||
13135377|NCT02742649|25994709|FG004|Double-Blind Treatment Period|Adverse Event|0|||
13135378|NCT02742649|25994705|FG000|Open-Label Period|Lost to Follow-up|0|||
13135379|NCT02742649|25994706|FG001|Open-Label Period|Lost to Follow-up|0|||
13135380|NCT02742649|25994707|FG002|Open-Label Period|Lost to Follow-up|0|||
13135381|NCT02742649|25994708|FG003|Open-Label Period|Lost to Follow-up|0|||
13135382|NCT02742649|25994709|FG004|Open-Label Period|Lost to Follow-up|1|||
13135383|NCT02742519|25994735|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
13135384|NCT02742519|25994736|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
13135385|NCT02742519|25994737|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0|||
13135386|NCT02742519|25994735|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
13135387|NCT02742519|25994736|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
13135388|NCT02742519|25994737|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9|||
13135389|NCT02742519|25994735|FG000|Part 2 Open Label Period (32 Weeks)|Other|0|||
13135390|NCT02742519|25994736|FG001|Part 2 Open Label Period (32 Weeks)|Other|0|||
13135391|NCT02742519|25994737|FG002|Part 2 Open Label Period (32 Weeks)|Other|1|||
13135392|NCT02742441|25994760|FG000|Overall Study|Lost to Follow-up|4|||
13135393|NCT02742441|25994761|FG001|Overall Study|Lost to Follow-up|4|||
13135394|NCT02742441|25994760|FG000|Overall Study|Withdrawal by Subject|2|||
13135395|NCT02742441|25994761|FG001|Overall Study|Withdrawal by Subject|2|||
13135396|NCT02742441|25994760|FG000|Overall Study|Adverse Event|0|||
13135397|NCT02742441|25994761|FG001|Overall Study|Adverse Event|2|||
13135398|NCT02742181|25994782|FG000|Overall Study|Physician Decision|1|||
13135399|NCT02742181|25994783|FG001|Overall Study|Physician Decision|0|||
13135400|NCT02742103|25994827|FG000|Overall Study|Protocol Violation|1|||
13135401|NCT02742103|25994828|FG001|Overall Study|Protocol Violation|0|||
13135402|NCT02742103|25994827|FG000|Overall Study|Death|2|||
13135403|NCT02742103|25994828|FG001|Overall Study|Death|2|||
13135404|NCT02742103|25994827|FG000|Overall Study|Adverse Event|1|||
13135405|NCT02742103|25994828|FG001|Overall Study|Adverse Event|0|||
13135406|NCT02742103|25994827|FG000|Overall Study|Moved to another town|0|||
13135407|NCT02742103|25994828|FG001|Overall Study|Moved to another town|1|||
13135408|NCT02742103|25994827|FG000|Overall Study|Withdrawal by Subject|5|||
13135409|NCT02742103|25994828|FG001|Overall Study|Withdrawal by Subject|2|||
13135410|NCT02741713|25994848|FG000|Overall Study|Surgery type changed intra-operatively|2|||
13135411|NCT02741713|25994849|FG001|Overall Study|Surgery type changed intra-operatively|1|||
13135412|NCT02741700|25994868|FG000|Overall Study|Lost to Follow-up|17|||
13135413|NCT02741700|25994869|FG001|Overall Study|Lost to Follow-up|8|||
13135414|NCT02741700|25994868|FG000|Overall Study|Withdrawal by Subject|2|||
13135415|NCT02741700|25994869|FG001|Overall Study|Withdrawal by Subject|5|||
13135416|NCT02741700|25994868|FG000|Overall Study|Physician Decision|3|||
13135417|NCT02741700|25994869|FG001|Overall Study|Physician Decision|0|||
13135418|NCT02741700|25994868|FG000|Overall Study|Moved out of State|0|||
13135419|NCT02741700|25994869|FG001|Overall Study|Moved out of State|1|||
13135420|NCT02741700|25994868|FG000|Overall Study|Death|4|||
13135421|NCT02741700|25994869|FG001|Overall Study|Death|5|||
13135422|NCT02741635|25994877|FG000|Overall Study|Withdrawal by Subject|1|||
13135423|NCT02741596|25994900|FG000|Overall Study|Adverse Event|1|||
13135424|NCT02741596|25994901|FG001|Overall Study|Adverse Event|5|||
13135425|NCT02741596|25994900|FG000|Overall Study|Lost to Follow-up|1|||
13135426|NCT02741596|25994901|FG001|Overall Study|Lost to Follow-up|1|||
13135427|NCT02741596|25994900|FG000|Overall Study|Physician Decision|2|||
13135428|NCT02741596|25994901|FG001|Overall Study|Physician Decision|1|||
13135429|NCT02741596|25994900|FG000|Overall Study|Pregnancy|3|||
13135430|NCT02741596|25994901|FG001|Overall Study|Pregnancy|1|||
13135431|NCT02741596|25994900|FG000|Overall Study|Other (Unspecified)|0|||
13135432|NCT02741596|25994901|FG001|Overall Study|Other (Unspecified)|3|||
13135433|NCT02741596|25994900|FG000|Overall Study|Subject withdrawn-Other|17|||
13135434|NCT02741596|25994901|FG001|Overall Study|Subject withdrawn-Other|4|||
13135435|NCT02741596|25994900|FG000|Overall Study|Subject withdrawn-to commercial product|54|||
13135436|NCT02741596|25994901|FG001|Overall Study|Subject withdrawn-to commercial product|63|||
13135437|NCT02741570|25994924|FG000|Pre-Treatment Period|Other reasons|0|||
13135438|NCT02741570|25994925|FG001|Pre-Treatment Period|Other reasons|3|||
13135439|NCT02741570|25994924|FG000|Pre-Treatment Period|Participant no longer meets study criteria|3|||
13135440|NCT02741570|25994925|FG001|Pre-Treatment Period|Participant no longer meets study criteria|6|||
13135441|NCT02741570|25994924|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
13135442|NCT02741570|25994925|FG001|Pre-Treatment Period|Poor/non-compliance|1|||
13135443|NCT02741570|25994924|FG000|Pre-Treatment Period|Lost to Follow-up|0|||
13135444|NCT02741570|25994925|FG001|Pre-Treatment Period|Lost to Follow-up|2|||
13135445|NCT02741570|25994924|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
13135446|NCT02741570|25994925|FG001|Pre-Treatment Period|Participant withdrew consent|18|||
13135447|NCT02741570|25994924|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
13135448|NCT02741570|25994925|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|2|||
13135449|NCT02741570|25994924|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
13135450|NCT02741570|25994925|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
13135451|NCT02741570|25994924|FG000|Pre-Treatment Period|Death|0|||
13135452|NCT02741570|25994925|FG001|Pre-Treatment Period|Death|1|||
13135453|NCT02741570|25994924|FG000|Pre-Treatment Period|Disease progression|0|||
13135454|NCT02741570|25994925|FG001|Pre-Treatment Period|Disease progression|1|||
13135455|NCT02741570|25994924|FG000|Treatment Period|Other reasons|47|||
13135456|NCT02741570|25994925|FG001|Treatment Period|Other reasons|8|||
13135457|NCT02741570|25994924|FG000|Treatment Period|Poor/non-compliance|0|||
13135458|NCT02741570|25994925|FG001|Treatment Period|Poor/non-compliance|1|||
13135459|NCT02741570|25994924|FG000|Treatment Period|Maximum clinical benefit|3|||
13135460|NCT02741570|25994925|FG001|Treatment Period|Maximum clinical benefit|5|||
13135461|NCT02741570|25994924|FG000|Treatment Period|Lost to Follow-up|1|||
13135462|NCT02741570|25994925|FG001|Treatment Period|Lost to Follow-up|3|||
13135463|NCT02741570|25994924|FG000|Treatment Period|Participant withdrew consent|9|||
13135464|NCT02741570|25994925|FG001|Treatment Period|Participant withdrew consent|13|||
13135465|NCT02741570|25994924|FG000|Treatment Period|Participant request to discontinue treatment|8|||
13135466|NCT02741570|25994925|FG001|Treatment Period|Participant request to discontinue treatment|23|||
13135467|NCT02741570|25994924|FG000|Treatment Period|Adverse event unrelated to study drug|41|||
13135468|NCT02741570|25994925|FG001|Treatment Period|Adverse event unrelated to study drug|25|||
13135469|NCT02741570|25994924|FG000|Treatment Period|Death|9|||
13135470|NCT02741570|25994925|FG001|Treatment Period|Death|7|||
13135471|NCT02741570|25994924|FG000|Treatment Period|Study drug toxicity|55|||
13135472|NCT02741570|25994925|FG001|Treatment Period|Study drug toxicity|45|||
13135473|NCT02741570|25994924|FG000|Treatment Period|Disease progression|295|||
13135474|NCT02741570|25994925|FG001|Treatment Period|Disease progression|304|||
13135475|NCT02741518|25994940|FG000|Overall Study|Withdrawal by Subject|1|||
13135476|NCT02741518|25994941|FG001|Overall Study|Withdrawal by Subject|1|||
13135477|NCT02741310|25994968|FG000|Overall Study|Sponsor Decision|2|||
13135478|NCT02741310|25994969|FG001|Overall Study|Sponsor Decision|2|||
13135479|NCT02741271|25995004|FG000|Overall Study|Lost to Follow-up|2|||
13135480|NCT02741271|25995005|FG001|Overall Study|Lost to Follow-up|0|||
13135481|NCT02741271|25995004|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
13135482|NCT02741271|25995005|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
13135483|NCT02741245|25995123|FG000|Overall Study|Adverse Event|0|||
13135484|NCT02741245|25995124|FG001|Overall Study|Adverse Event|0|||
13135485|NCT02741245|25995125|FG002|Overall Study|Adverse Event|0|||
13135486|NCT02741245|25995126|FG003|Overall Study|Adverse Event|2|||
13135487|NCT02741245|25995127|FG004|Overall Study|Adverse Event|2|||
13135488|NCT02741245|25995123|FG000|Overall Study|Protocol Violation|0|||
13135489|NCT02741245|25995124|FG001|Overall Study|Protocol Violation|1|||
13135490|NCT02741245|25995125|FG002|Overall Study|Protocol Violation|0|||
13135491|NCT02741245|25995126|FG003|Overall Study|Protocol Violation|1|||
13135492|NCT02741245|25995127|FG004|Overall Study|Protocol Violation|0|||
13135493|NCT02741245|25995123|FG000|Overall Study|Withdrawal by Subject|0|||
13135494|NCT02741245|25995124|FG001|Overall Study|Withdrawal by Subject|0|||
13135495|NCT02741245|25995125|FG002|Overall Study|Withdrawal by Subject|0|||
13135496|NCT02741245|25995126|FG003|Overall Study|Withdrawal by Subject|1|||
13135497|NCT02741245|25995127|FG004|Overall Study|Withdrawal by Subject|0|||
13135498|NCT02741076|25995198|FG000|Overall Study|Adverse Event|0|||
13135499|NCT02741076|25995199|FG001|Overall Study|Adverse Event|1|||
13135500|NCT02741076|25995200|FG002|Overall Study|Adverse Event|1|||
13135501|NCT02741076|25995201|FG003|Overall Study|Adverse Event|0|||
13135502|NCT02741076|25995198|FG000|Overall Study|Lack of Efficacy|1|||
13135503|NCT02741076|25995199|FG001|Overall Study|Lack of Efficacy|0|||
13135504|NCT02741076|25995200|FG002|Overall Study|Lack of Efficacy|0|||
13135505|NCT02741076|25995201|FG003|Overall Study|Lack of Efficacy|0|||
13135506|NCT02741076|25995198|FG000|Overall Study|Withdrawal by Subject|0|||
13135507|NCT02741076|25995199|FG001|Overall Study|Withdrawal by Subject|1|||
13135508|NCT02741076|25995200|FG002|Overall Study|Withdrawal by Subject|0|||
13135509|NCT02741076|25995201|FG003|Overall Study|Withdrawal by Subject|0|||
13135510|NCT02741076|25995198|FG000|Overall Study|Sponsor Request|2|||
13135511|NCT02741076|25995199|FG001|Overall Study|Sponsor Request|3|||
13135512|NCT02741076|25995200|FG002|Overall Study|Sponsor Request|0|||
13135513|NCT02741076|25995201|FG003|Overall Study|Sponsor Request|1|||
13135514|NCT02741076|25995198|FG000|Overall Study|No additional information available|0|||
13135515|NCT02741076|25995199|FG001|Overall Study|No additional information available|0|||
13135516|NCT02741076|25995200|FG002|Overall Study|No additional information available|1|||
13135517|NCT02741076|25995201|FG003|Overall Study|No additional information available|1|||
13135518|NCT02740478|25995207|FG000|Overall Study|Withdrawal by Subject|1|||
13135519|NCT02740049|25995215|FG000|Overall Study|Isolated cells did not grow sufficiently|1|||
13135521|NCT02739997|25995229|FG000|Overall Study|Withdrawal by Subject|1|||
13135522|NCT02739984|25995284|FG000|Overall Study|Sponsor Decision|1|||
13135523|NCT02739984|25995285|FG001|Overall Study|Sponsor Decision|0|||
13135524|NCT02739984|25995284|FG000|Overall Study|Withdrawal by Subject|1|||
13135525|NCT02739984|25995285|FG001|Overall Study|Withdrawal by Subject|1|||
13135526|NCT02739984|25995284|FG000|Overall Study|Death|0|||
13135527|NCT02739984|25995285|FG001|Overall Study|Death|1|||
13135528|NCT02739984|25995284|FG000|Overall Study|Lost to Follow-up|3|||
13135529|NCT02739984|25995285|FG001|Overall Study|Lost to Follow-up|0|||
13135530|NCT02739828|25995321|FG000|Overall Study|Adverse Event|1|||
13135531|NCT02739828|25995321|FG000|Overall Study|Lost to Follow-up|4|||
13135532|NCT02739594|25995358|FG000|Overall Study|Undesired Event|3|||
13135533|NCT02739594|25995359|FG001|Overall Study|Undesired Event|4|||
13135534|NCT02739594|25995358|FG000|Overall Study|Violation of Eligibility Criteria|1|||
13135535|NCT02739594|25995359|FG001|Overall Study|Violation of Eligibility Criteria|2|||
13135536|NCT02739594|25995358|FG000|Overall Study|Protocol Violation|5|||
13135537|NCT02739594|25995359|FG001|Overall Study|Protocol Violation|6|||
13135538|NCT02739594|25995358|FG000|Overall Study|Death|4|||
13135539|NCT02739594|25995359|FG001|Overall Study|Death|2|||
13135540|NCT02739594|25995358|FG000|Overall Study|Renal Insufficiency|4|||
13135541|NCT02739594|25995359|FG001|Overall Study|Renal Insufficiency|6|||
13135542|NCT02739594|25995358|FG000|Overall Study|Administrative Reasons|1|||
13135543|NCT02739594|25995359|FG001|Overall Study|Administrative Reasons|3|||
13135544|NCT02739594|25995358|FG000|Overall Study|Withdrawal by Subject|1|||
13135545|NCT02739594|25995359|FG001|Overall Study|Withdrawal by Subject|1|||
13135546|NCT02739594|25995358|FG000|Overall Study|Lost to Follow-up|0|||
13135547|NCT02739594|25995359|FG001|Overall Study|Lost to Follow-up|1|||
13135548|NCT02739594|25995358|FG000|Overall Study|Elevated Serum Creatinine|0|||
13135549|NCT02739594|25995359|FG001|Overall Study|Elevated Serum Creatinine|1|||
13135550|NCT02739594|25995358|FG000|Overall Study|Other|6|||
13135551|NCT02739594|25995359|FG001|Overall Study|Other|2|||
13135552|NCT02739360|25995365|FG000|Overall Study|Adverse Event|1|||
13135553|NCT02739360|25995365|FG000|Overall Study|Study terminated by Sponsor|2|||
13135554|NCT02739347|25995384|FG000|Overall Study|Adverse Event|3|||
13135555|NCT02739347|25995385|FG001|Overall Study|Adverse Event|0|||
13135556|NCT02739347|25995384|FG000|Overall Study|Protocol Violation|0|||
13135557|NCT02739347|25995385|FG001|Overall Study|Protocol Violation|1|||
13135558|NCT02739347|25995384|FG000|Overall Study|Lost to Follow-up|0|||
13135559|NCT02739347|25995385|FG001|Overall Study|Lost to Follow-up|2|||
13135560|NCT02739321|25995436|FG000|Overall Study|Lack of Efficacy|1|||
13135561|NCT02739321|25995437|FG001|Overall Study|Lack of Efficacy|1|||
13135562|NCT02739321|25995436|FG000|Overall Study|Lost to Follow-up|1|||
13135563|NCT02739321|25995437|FG001|Overall Study|Lost to Follow-up|1|||
13135564|NCT02739321|25995436|FG000|Overall Study|Withdrawal by Subject|1|||
13135565|NCT02739321|25995437|FG001|Overall Study|Withdrawal by Subject|2|||
13135566|NCT02739269|25995452|FG000|Overall Study|Protocol Violation|5|||
13135567|NCT02739269|25995453|FG001|Overall Study|Protocol Violation|0|||
13135568|NCT02739269|25995452|FG000|Overall Study|Cycle cancellation|2|||
13135569|NCT02739269|25995453|FG001|Overall Study|Cycle cancellation|2|||
13135570|NCT02739269|25995452|FG000|Overall Study|Withdrawal by Subject|0|||
13135571|NCT02739269|25995453|FG001|Overall Study|Withdrawal by Subject|2|||
13135572|NCT02738879|25995494|FG000|Overall Study|Adverse Event|1|||
13135573|NCT02738879|25995495|FG001|Overall Study|Adverse Event|1|||
13135574|NCT02738879|25995494|FG000|Overall Study|Death|0|||
13135575|NCT02738879|25995495|FG001|Overall Study|Death|2|||
13135576|NCT02738879|25995494|FG000|Overall Study|Lost to Follow-up|1|||
13135577|NCT02738879|25995495|FG001|Overall Study|Lost to Follow-up|5|||
13135578|NCT02738879|25995494|FG000|Overall Study|Protocol Violation|1|||
13135579|NCT02738879|25995495|FG001|Overall Study|Protocol Violation|3|||
13135580|NCT02738879|25995494|FG000|Overall Study|Physician Decision|3|||
13135581|NCT02738879|25995495|FG001|Overall Study|Physician Decision|4|||
13135582|NCT02738879|25995494|FG000|Overall Study|Pregnancy|0|||
13135583|NCT02738879|25995495|FG001|Overall Study|Pregnancy|1|||
13135584|NCT02738879|25995494|FG000|Overall Study|Screen Failure|1|||
13135585|NCT02738879|25995495|FG001|Overall Study|Screen Failure|2|||
13135586|NCT02738879|25995494|FG000|Overall Study|Site Discontinued Study Participation|1|||
13135587|NCT02738879|25995495|FG001|Overall Study|Site Discontinued Study Participation|0|||
13135588|NCT02738879|25995494|FG000|Overall Study|Withdrawal by Subject|5|||
13135589|NCT02738879|25995495|FG001|Overall Study|Withdrawal by Subject|7|||
13135590|NCT02738840|25995512|FG000|Overall Study|MRI Scan not Performed|5|||
13135591|NCT02738840|25995512|FG000|Overall Study|Lost to Follow-up|1|||
13135592|NCT02738840|25995512|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
13135593|NCT02738840|25995512|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1|||
13135594|NCT02738801|25995533|FG000|Overall Study|Adverse Event|1|||
13135595|NCT02738801|25995534|FG001|Overall Study|Adverse Event|1|||
13135596|NCT02738801|25995533|FG000|Overall Study|Withdrawal by Subject|0|||
13135597|NCT02738801|25995534|FG001|Overall Study|Withdrawal by Subject|1|||
13135598|NCT02738775|25995640|FG000|Overall Study|Withdrawal by Subject|0|||
13135599|NCT02738775|25995641|FG001|Overall Study|Withdrawal by Subject|1|||
13135600|NCT02738775|25995642|FG002|Overall Study|Withdrawal by Subject|0|||
13135601|NCT02738775|25995643|FG003|Overall Study|Withdrawal by Subject|0|||
13135602|NCT02738775|25995644|FG004|Overall Study|Withdrawal by Subject|0|||
13135603|NCT02738775|25995645|FG005|Overall Study|Withdrawal by Subject|0|||
13135604|NCT02738775|25995640|FG000|Overall Study|Adverse Event|0|||
13135605|NCT02738775|25995641|FG001|Overall Study|Adverse Event|0|||
13135606|NCT02738775|25995642|FG002|Overall Study|Adverse Event|0|||
13135607|NCT02738775|25995643|FG003|Overall Study|Adverse Event|1|||
13135608|NCT02738775|25995644|FG004|Overall Study|Adverse Event|0|||
13135609|NCT02738775|25995645|FG005|Overall Study|Adverse Event|0|||
13135610|NCT02738775|25995640|FG000|Overall Study|Pregnancy|0|||
13135611|NCT02738775|25995641|FG001|Overall Study|Pregnancy|1|||
13135612|NCT02738775|25995642|FG002|Overall Study|Pregnancy|0|||
13135613|NCT02738775|25995643|FG003|Overall Study|Pregnancy|0|||
13135614|NCT02738775|25995644|FG004|Overall Study|Pregnancy|0|||
13135615|NCT02738775|25995645|FG005|Overall Study|Pregnancy|0|||
13135616|NCT02738775|25995640|FG000|Overall Study|Missing|0|||
13135617|NCT02738775|25995641|FG001|Overall Study|Missing|0|||
13135618|NCT02738775|25995642|FG002|Overall Study|Missing|0|||
13135619|NCT02738775|25995643|FG003|Overall Study|Missing|0|||
13135620|NCT02738775|25995644|FG004|Overall Study|Missing|0|||
13135621|NCT02738775|25995645|FG005|Overall Study|Missing|1|||
13135622|NCT02738580|25995660|FG000|Overall Study|Adverse Event|1|||
13135623|NCT02738580|25995661|FG001|Overall Study|Adverse Event|0|||
13135624|NCT02738580|25995660|FG000|Overall Study|Lack of Efficacy|3|||
13135625|NCT02738580|25995661|FG001|Overall Study|Lack of Efficacy|2|||
13135626|NCT02738580|25995660|FG000|Overall Study|Withdrawal by Subject|0|||
13135627|NCT02738580|25995661|FG001|Overall Study|Withdrawal by Subject|1|||
13135628|NCT02738580|25995660|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0|||
13135629|NCT02738580|25995661|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1|||
13135630|NCT02738450|25995709|FG000|Overall Study|Withdrawal by Subject|0|||
13135631|NCT02738450|25995710|FG001|Overall Study|Withdrawal by Subject|2|||
13135632|NCT02738450|25995711|FG002|Overall Study|Withdrawal by Subject|0|||
13135633|NCT02738333|25995795|FG000|Overall Study|Death|1|||
13135634|NCT02738333|25995796|FG001|Overall Study|Death|0|||
13135635|NCT02738333|25995797|FG002|Overall Study|Death|0|||
13135636|NCT02738333|25995795|FG000|Overall Study|Lost to Follow-up|1|||
13135637|NCT02738333|25995796|FG001|Overall Study|Lost to Follow-up|0|||
13135638|NCT02738333|25995797|FG002|Overall Study|Lost to Follow-up|0|||
13135639|NCT02738203|25995818|FG000|Overall Study|Failed IUD Insertion|2|||
13135640|NCT02738203|25995819|FG001|Overall Study|Failed IUD Insertion|2|||
13135641|NCT02738203|25995818|FG000|Overall Study|Protocol Violation|0|||
13135642|NCT02738203|25995819|FG001|Overall Study|Protocol Violation|1|||
13135643|NCT02738151|25995868|FG000|Overall Study|Randomized but not treated|4|||
13135644|NCT02738151|25995869|FG001|Overall Study|Randomized but not treated|1|||
13135645|NCT02738151|25995868|FG000|Overall Study|Adverse Event|4|||
13135646|NCT02738151|25995869|FG001|Overall Study|Adverse Event|5|||
13135647|NCT02738151|25995868|FG000|Overall Study|Hypoglycemia|0|||
13135648|NCT02738151|25995869|FG001|Overall Study|Hypoglycemia|1|||
13135649|NCT02738151|25995868|FG000|Overall Study|Poor Compliance to Protocol|4|||
13135650|NCT02738151|25995869|FG001|Overall Study|Poor Compliance to Protocol|3|||
13135651|NCT02738151|25995868|FG000|Overall Study|Other than specified above|11|||
13135652|NCT02738151|25995869|FG001|Overall Study|Other than specified above|21|||
13475764|NCT03517722|27000842|FG000|Double Blind Period: Week 0-52|Adverse Event|9|||
13475765|NCT03517722|27000843|FG001|Double Blind Period: Week 0-52|Adverse Event|11|||
13475766|NCT03517722|27000842|FG000|Double Blind Period: Week 0-52|Death|0|||
13475767|NCT03517722|27000843|FG001|Double Blind Period: Week 0-52|Death|4|||
13475768|NCT03517722|27000842|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2|||
13475769|NCT03517722|27000843|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3|||
13475770|NCT03517722|27000842|FG000|Double Blind Period: Week 0-52|Pregnancy|0|||
13475771|NCT03517722|27000843|FG001|Double Blind Period: Week 0-52|Pregnancy|1|||
13475772|NCT03517722|27000842|FG000|Double Blind Period: Week 0-52|Protocol Violation|1|||
13475773|NCT03517722|27000843|FG001|Double Blind Period: Week 0-52|Protocol Violation|0|||
13475774|NCT03517722|27000842|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
13475775|NCT03517722|27000843|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
13475776|NCT03517722|27000842|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76|||
13475777|NCT03517722|27000843|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120|||
13475778|NCT03517722|27000842|FG000|Double Blind Period: Week 0-52|Other|4|||
13475779|NCT03517722|27000843|FG001|Double Blind Period: Week 0-52|Other|3|||
13475780|NCT03517722|27000842|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0|||
13475781|NCT03517722|27000843|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2|||
13475782|NCT03517722|27000842|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0|||
13475783|NCT03517722|27000843|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1|||
13475784|NCT03517722|27000842|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0|||
13475785|NCT03517722|27000843|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1|||
13475786|NCT03517722|27000842|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
13135657|NCT02738138|25995883|FG000|Overall Study|Other - not further specified|1|||
13135658|NCT02738138|25995884|FG001|Overall Study|Other - not further specified|0|||
13135659|NCT02738008|25995908|FG000|Overall Study|Study Terminated by Sponsor|1|||
13135660|NCT02738008|25995909|FG001|Overall Study|Study Terminated by Sponsor|5|||
13135661|NCT02738008|25995910|FG002|Overall Study|Study Terminated by Sponsor|3|||
13135662|NCT02738008|25995908|FG000|Overall Study|Adverse Event|0|||
13135663|NCT02738008|25995909|FG001|Overall Study|Adverse Event|1|||
13135664|NCT02738008|25995910|FG002|Overall Study|Adverse Event|2|||
13475787|NCT03517722|27000843|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
13475788|NCT03517722|27000842|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87|||
13475789|NCT03517722|27000843|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134|||
13475790|NCT03499314|27000856|FG000|Overall Study|Time Commitment|1|||
13475791|NCT03499314|27000857|FG001|Overall Study|Time Commitment|2|||
13475792|NCT03499314|27000856|FG000|Overall Study|Medical issue unrelated to research study|1|||
13475793|NCT03499314|27000857|FG001|Overall Study|Medical issue unrelated to research study|1|||
13475794|NCT03439124|27000878|FG000|Overall Study|Adverse Event|2|||
13475795|NCT03439124|27000879|FG001|Overall Study|Adverse Event|0|||
13475796|NCT03439124|27000878|FG000|Overall Study|Lost to Follow-up|1|||
13475797|NCT03439124|27000879|FG001|Overall Study|Lost to Follow-up|0|||
13475798|NCT03439124|27000878|FG000|Overall Study|Other reasons|1|||
13475799|NCT03439124|27000879|FG001|Overall Study|Other reasons|0|||
13475800|NCT03369431|27000898|FG000|Overall Study|Lost to Follow-up|1|||
13475801|NCT03369431|27000899|FG001|Overall Study|Lost to Follow-up|3|||
13475802|NCT03369431|27000898|FG000|Overall Study|Withdrawal by Subject|2|||
13475803|NCT03369431|27000899|FG001|Overall Study|Withdrawal by Subject|3|||
13475804|NCT03369431|27000898|FG000|Overall Study|Protocol Violation|1|||
13475805|NCT03369431|27000899|FG001|Overall Study|Protocol Violation|1|||
13475806|NCT03336866|27000950|FG000|Overall Study|Lost to Follow-up|2|||
13475807|NCT03336866|27000951|FG001|Overall Study|Lost to Follow-up|0|||
13475808|NCT03336866|27000952|FG002|Overall Study|Lost to Follow-up|3|||
13475809|NCT03336866|27000950|FG000|Overall Study|Withdrawal by Subject|1|||
13475810|NCT03336866|27000951|FG001|Overall Study|Withdrawal by Subject|1|||
13475811|NCT03336866|27000952|FG002|Overall Study|Withdrawal by Subject|0|||
13475812|NCT03336866|27000950|FG000|Overall Study|Noncompliance with clinic house rules|0|||
13475813|NCT03336866|27000951|FG001|Overall Study|Noncompliance with clinic house rules|0|||
13475814|NCT03336866|27000952|FG002|Overall Study|Noncompliance with clinic house rules|1|||
13475815|NCT03332173|27000966|FG000|Overall Study|Death|7|||
13475816|NCT03332173|27000966|FG000|Overall Study|Withdrawal by Subject|6|||
13475817|NCT03332173|27000966|FG000|Overall Study|Lost to Follow-up|2|||
13475818|NCT03332173|27000966|FG000|Overall Study|Transferred to long-term extension study|29|||
13475819|NCT03322293|27000996|FG000|Overall Study|Lost to Follow-up|0|||
13475820|NCT03322293|27000997|FG001|Overall Study|Lost to Follow-up|0|||
13475821|NCT03322293|27000998|FG002|Overall Study|Lost to Follow-up|1|||
13475822|NCT03254394|27001034|FG000|Overall Study|Withdrawal by Subject|0|||
13475823|NCT03254394|27001035|FG001|Overall Study|Withdrawal by Subject|2|||
13475824|NCT03253809|27001041|FG000|Overall Study|Unable to obtain study related data|14|||
